"NGenes","Direction","PValue","FDR","Contrast"
225,"Down",8.45884536773342e-36,4.67689560381981e-32,"B.LvsP.REACTOME_RRNA_PROCESSING"
110,"Down",1.77151218996761e-35,4.89734544916547e-32,"B.LvsP.REACTOME_EUKARYOTIC_TRANSLATION_ELONGATION"
104,"Down",5.22772487940252e-35,9.63469695273885e-32,"B.LvsP.KEGG_RIBOSOME"
137,"Down",1.39726940741556e-31,1.93137563840015e-28,"B.LvsP.REACTOME_SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE"
119,"Down",1.8850967000703e-29,2.08453993093774e-26,"B.LvsP.REACTOME_RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY"
140,"Down",3.50440759535014e-28,3.22931159911515e-25,"B.LvsP.REACTOME_NONSENSE_MEDIATED_DECAY_NMD"
160,"Down",5.59238817342686e-28,4.41718774441102e-25,"B.LvsP.REACTOME_EUKARYOTIC_TRANSLATION_INITIATION"
135,"Down",1.34080268190392e-27,9.26662253530844e-25,"B.LvsP.REACTOME_SELENOAMINO_ACID_METABOLISM"
189,"Down",1.65126706175483e-21,1.01442839827138e-18,"B.LvsP.REACTOME_INFLUENZA_INFECTION"
196,"Down",2.31050778484471e-20,1.27747975424064e-17,"B.LvsP.SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP"
219,"Down",4.95510456497447e-20,2.49061573997671e-17,"B.LvsP.REACTOME_REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS"
61,"Down",8.99272055521074e-20,4.14339599581335e-17,"B.LvsP.REACTOME_RRNA_MODIFICATION_IN_THE_NUCLEUS_AND_CYTOSOL"
346,"Down",2.7197941390387e-18,1.15674936882654e-15,"B.LvsP.REACTOME_TRANSLATION"
415,"Down",6.92244394484061e-18,2.73387089793027e-15,"B.LvsP.WONG_EMBRYONIC_STEM_CELL_CORE"
84,"Down",1.10193211087839e-17,4.06172176069776e-15,"B.LvsP.BILANGES_SERUM_AND_RAPAMYCIN_SENSITIVE_GENES"
107,"Down",4.36284965352389e-17,1.50763723339585e-14,"B.LvsP.GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN"
84,"Down",4.96829805652199e-17,1.61586587967707e-14,"B.LvsP.REACTOME_ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S"
94,"Down",5.83394579575746e-17,1.79199368359683e-14,"B.LvsP.MOOTHA_VOXPHOS"
186,"Down",7.22446096264873e-16,2.10231814013078e-13,"B.LvsP.ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER"
58,"Down",2.24636655065375e-15,6.21008032928229e-13,"B.LvsP.ISHIDA_E2F_TARGETS"
83,"Down",3.64793113630695e-15,9.60448154887672e-13,"B.LvsP.CHNG_MULTIPLE_MYELOMA_HYPERPLOID_UP"
335,"Down",9.91562355126406e-15,2.49197648249723e-12,"B.LvsP.KOBAYASHI_EGFR_SIGNALING_24HR_DN"
172,"Down",1.39990659089951e-14,3.36525371351451e-12,"B.LvsP.DANG_MYC_TARGETS_UP"
135,"Down",7.50339045032122e-14,1.72859357499275e-11,"B.LvsP.KEGG_PARKINSONS_DISEASE"
56,"Down",2.27856542991516e-13,5.03927530480037e-11,"B.LvsP.ZHAN_MULTIPLE_MYELOMA_PR_UP"
69,"Down",6.04466393849354e-13,1.28542103522811e-10,"B.LvsP.IRITANI_MAD1_TARGETS_DN"
100,"Down",7.11574713052493e-13,1.45714688461749e-10,"B.LvsP.CROONQUIST_NRAS_SIGNALING_DN"
775,"Down",1.33448159841095e-12,2.63512455629076e-10,"B.LvsP.REACTOME_METABOLISM_OF_RNA"
125,"Down",1.39069498629731e-12,2.65143192387512e-10,"B.LvsP.CROONQUIST_IL6_DEPRIVATION_DN"
278,"Down",1.88364555972579e-12,3.47155876657464e-10,"B.LvsP.REACTOME_SIGNALING_BY_ROBO_RECEPTORS"
61,"Down",2.40780002595904e-12,4.29442785275082e-10,"B.LvsP.POMEROY_MEDULLOBLASTOMA_PROGNOSIS_DN"
133,"Down",3.15513051233943e-12,5.45147393835146e-10,"B.LvsP.REACTOME_RESPIRATORY_ELECTRON_TRANSPORT_ATP_SYNTHESIS_BY_CHEMIOSMOTIC_COUPLING_AND_HEAT_PRODUCTION_BY_UNCOUPLING_PROTEINS"
763,"Down",5.87178297715293e-12,9.8379054789935e-10,"B.LvsP.CAIRO_HEPATOBLASTOMA_CLASSES_UP"
1184,"Down",7.85415883633073e-12,1.27722482959037e-09,"B.LvsP.LEE_BMP2_TARGETS_DN"
117,"Down",1.05031989050988e-11,1.64937546702512e-09,"B.LvsP.ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR"
176,"Down",1.07392868173095e-11,1.64937546702512e-09,"B.LvsP.ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR"
49,"Down",1.23608200147415e-11,1.84710740166232e-09,"B.LvsP.YU_MYC_TARGETS_UP"
174,"Down",1.51675020414767e-11,2.20687154703486e-09,"B.LvsP.KARLSSON_TGFB1_TARGETS_UP"
31,"Down",4.53148981204102e-11,6.42425824891661e-09,"B.LvsP.REACTOME_CRISTAE_FORMATION"
69,"Down",5.42682671460793e-11,7.50123122626682e-09,"B.LvsP.KANG_DOXORUBICIN_RESISTANCE_UP"
47,"Down",7.03669697990366e-11,9.42996945568978e-09,"B.LvsP.WHITFIELD_CELL_CYCLE_LITERATURE"
370,"Down",7.30230582785428e-11,9.42996945568978e-09,"B.LvsP.MANALO_HYPOXIA_DN"
215,"Down",7.33385217208646e-11,9.42996945568978e-09,"B.LvsP.WINNEPENNINCKX_MELANOMA_METASTASIS_UP"
108,"Down",1.02742431039476e-10,1.29105204822106e-08,"B.LvsP.REACTOME_RESPIRATORY_ELECTRON_TRANSPORT"
73,"Down",1.16313725547907e-10,1.42910797456529e-08,"B.LvsP.SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_UP"
13,"Down",2.31707406556116e-10,2.78502228445384e-08,"B.LvsP.KUMAMOTO_RESPONSE_TO_NUTLIN_3A_DN"
22,"Down",2.69887638520087e-10,3.17491224122885e-08,"B.LvsP.EGUCHI_CELL_CYCLE_RB1_TARGETS"
167,"Down",3.51955072669786e-10,4.0540824933151e-08,"B.LvsP.KONG_E2F3_TARGETS"
189,"Down",3.71721310630613e-10,4.18148809571279e-08,"B.LvsP.REACTOME_THE_CITRIC_ACID_TCA_CYCLE_AND_RESPIRATORY_ELECTRON_TRANSPORT"
185,"Down",3.78141444719912e-10,4.18148809571279e-08,"B.LvsP.WHITEFORD_PEDIATRIC_CANCER_MARKERS"
105,"Down",5.94194039931629e-10,6.44176244467054e-08,"B.LvsP.SCHUHMACHER_MYC_TARGETS_UP"
73,"Down",6.18602498714488e-10,6.57741002960078e-08,"B.LvsP.REACTOME_MITOCHONDRIAL_PROTEIN_IMPORT"
31,"Down",6.86929386952484e-10,7.16609920841563e-08,"B.LvsP.REICHERT_MITOSIS_LIN9_TARGETS"
50,"Up",7.45324953219726e-10,7.63129938213308e-08,"B.LvsP.REACTOME_ACTIVATION_OF_GENE_EXPRESSION_BY_SREBF_SREBP"
95,"Down",8.10290746882625e-10,8.14563189002552e-08,"B.LvsP.DANG_REGULATED_BY_MYC_UP"
131,"Down",9.64152042274482e-10,9.51927971738502e-08,"B.LvsP.LEE_EARLY_T_LYMPHOCYTE_UP"
192,"Down",1.39876104549719e-09,1.35679821413228e-07,"B.LvsP.BENPORATH_PROLIFERATION"
54,"Down",1.67352457979244e-09,1.59533058649524e-07,"B.LvsP.NAKAMURA_CANCER_MICROENVIRONMENT_DN"
211,"Down",1.88300104217828e-09,1.76459538342436e-07,"B.LvsP.SCHLOSSER_MYC_TARGETS_REPRESSED_BY_SERUM"
266,"Down",2.3116598139099e-09,2.13019451851798e-07,"B.LvsP.FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_DN"
833,"Down",2.49901266605953e-09,2.26508869354806e-07,"B.LvsP.BERENJENO_TRANSFORMED_BY_RHOA_UP"
18,"Down",2.84643477197329e-09,2.53837707326456e-07,"B.LvsP.REACTOME_FORMATION_OF_ATP_BY_CHEMIOSMOTIC_COUPLING"
292,"Down",3.15888687825137e-09,2.77229929362727e-07,"B.LvsP.GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP"
88,"Down",3.30830106345884e-09,2.85806196560374e-07,"B.LvsP.REACTOME_DNA_REPLICATION_PRE_INITIATION"
149,"Down",3.54035090344031e-09,3.00466011009855e-07,"B.LvsP.GAVIN_FOXP3_TARGETS_CLUSTER_P6"
67,"Down",3.58668054379643e-09,3.00466011009855e-07,"B.LvsP.PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_UP"
80,"Down",4.4593036231852e-09,3.64791318319825e-07,"B.LvsP.MODY_HIPPOCAMPUS_PRENATAL"
70,"Down",4.48649116399857e-09,3.64791318319825e-07,"B.LvsP.MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_DN"
221,"Down",5.15016501968881e-09,4.12684962229847e-07,"B.LvsP.HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP"
47,"Down",5.23634662531835e-09,4.13596578448359e-07,"B.LvsP.KAMMINGA_EZH2_TARGETS"
165,"Down",5.81567034333473e-09,4.52885089130954e-07,"B.LvsP.REACTOME_MITOTIC_G1_PHASE_AND_G1_S_TRANSITION"
18,"Down",6.42005266566787e-09,4.93006544284412e-07,"B.LvsP.FINETTI_BREAST_CANCER_KINOME_RED"
414,"Down",7.2105086913524e-09,5.46121952801198e-07,"B.LvsP.DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP"
36,"Down",9.47926902177486e-09,7.08255113802611e-07,"B.LvsP.FARMER_BREAST_CANCER_CLUSTER_2"
735,"Down",1.03020892995996e-08,7.59470023166485e-07,"B.LvsP.GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP"
407,"Down",1.1301739616254e-08,8.22201557082478e-07,"B.LvsP.REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES"
29,"Up",1.230036640143e-08,8.83230205629957e-07,"B.LvsP.HORTON_SREBF_TARGETS"
139,"Down",1.46688234132587e-08,1.03979390579368e-06,"B.LvsP.KEGG_OXIDATIVE_PHOSPHORYLATION"
151,"Down",2.03456445943153e-08,1.42393758179708e-06,"B.LvsP.MORI_IMMATURE_B_LYMPHOCYTE_DN"
44,"Down",2.10333321644615e-08,1.43605662236026e-06,"B.LvsP.KEGG_PROTEASOME"
90,"Down",2.10382684773342e-08,1.43605662236026e-06,"B.LvsP.ZHANG_RESPONSE_TO_CANTHARIDIN_DN"
74,"Down",2.59802931037743e-08,1.75176878744839e-06,"B.LvsP.SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_DN"
29,"Down",3.30486805071302e-08,2.18085902707595e-06,"B.LvsP.COLLER_MYC_TARGETS_UP"
29,"Up",3.31329640575836e-08,2.18085902707595e-06,"B.LvsP.REACTOME_CHOLESTEROL_BIOSYNTHESIS"
106,"Down",4.17418446080636e-08,2.71518422162333e-06,"B.LvsP.RHODES_CANCER_META_SIGNATURE"
251,"Down",5.53385993859356e-08,3.55775716284695e-06,"B.LvsP.WONG_MITOCHONDRIA_GENE_MODULE"
56,"Down",5.69268092099098e-08,3.61779687496082e-06,"B.LvsP.FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_UP"
66,"Up",5.81312335551735e-08,3.65235898098357e-06,"B.LvsP.NIKOLSKY_BREAST_CANCER_19Q13.1_AMPLICON"
26,"Down",6.15851003394674e-08,3.82588786266197e-06,"B.LvsP.SCIAN_CELL_CYCLE_TARGETS_OF_TP53_AND_TP73_DN"
209,"Down",7.62423897418687e-08,4.68382414314213e-06,"B.LvsP.YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_14"
35,"Up",8.17090766451063e-08,4.96449983264607e-06,"B.LvsP.SCHMIDT_POR_TARGETS_IN_LIMB_BUD_UP"
131,"Down",8.354869656295e-08,5.02109503583207e-06,"B.LvsP.RHODES_UNDIFFERENTIATED_CANCER"
70,"Down",8.92469023475306e-08,5.30587229117739e-06,"B.LvsP.YAMASHITA_LIVER_CANCER_WITH_EPCAM_UP"
274,"Down",9.63484320111876e-08,5.66713277223251e-06,"B.LvsP.SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP"
147,"Down",1.14791289279494e-07,6.68085303606656e-06,"B.LvsP.PUJANA_BRCA_CENTERED_NETWORK"
295,"Down",1.31442134001106e-07,7.5702454051262e-06,"B.LvsP.LI_AMPLIFIED_IN_LUNG_CANCER"
99,"Down",1.578437178655e-07,8.99709191833347e-06,"B.LvsP.LY_AGING_OLD_DN"
59,"Down",1.92859367940977e-07,1.08808106667925e-05,"B.LvsP.REACTOME_COMPLEX_I_BIOGENESIS"
50,"Down",2.41400610075493e-07,1.34818583142162e-05,"B.LvsP.PID_AURORA_B_PATHWAY"
108,"Down",2.49886664089119e-07,1.38162336574874e-05,"B.LvsP.PID_MYC_ACTIV_PATHWAY"
72,"Down",2.64463522700166e-07,1.44774140297942e-05,"B.LvsP.REACTOME_ASSEMBLY_OF_THE_PRE_REPLICATIVE_COMPLEX"
68,"Down",3.43870282488016e-07,1.8639792077218e-05,"B.LvsP.REACTOME_SCF_SKP2_MEDIATED_DEGRADATION_OF_P27_P21"
192,"Down",3.75121707142753e-07,2.01363875610901e-05,"B.LvsP.LE_EGR2_TARGETS_UP"
361,"Down",3.928104515804e-07,2.08831633345003e-05,"B.LvsP.MARKEY_RB1_ACUTE_LOF_UP"
393,"Down",4.2156769569609e-07,2.21985503762255e-05,"B.LvsP.MUELLER_PLURINET"
173,"Down",4.38727728285701e-07,2.28842038650155e-05,"B.LvsP.BROWN_MYELOID_CELL_DEVELOPMENT_DN"
77,"Down",4.59301079889792e-07,2.37334174832772e-05,"B.LvsP.REACTOME_ORC1_REMOVAL_FROM_CHROMATIN"
177,"Down",5.44575277722425e-07,2.78792288011786e-05,"B.LvsP.BURTON_ADIPOGENESIS_3"
95,"Down",5.60694154194847e-07,2.8441082371957e-05,"B.LvsP.BURTON_ADIPOGENESIS_PEAK_AT_24HR"
1053,"Down",5.84736744124311e-07,2.93909950751211e-05,"B.LvsP.PUJANA_CHEK2_PCC_NETWORK"
181,"Down",5.9242932483025e-07,2.95093850178959e-05,"B.LvsP.MISSIAGLIA_REGULATED_BY_METHYLATION_DN"
134,"Down",6.42528749884671e-07,3.17191201617174e-05,"B.LvsP.FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_DN"
156,"Down",7.28562172830142e-07,3.56479668458217e-05,"B.LvsP.YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_11"
96,"Down",7.66585166536593e-07,3.71793805770247e-05,"B.LvsP.REACTOME_CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY"
32,"Down",7.90728683930178e-07,3.80168599430431e-05,"B.LvsP.REACTOME_G1_S_SPECIFIC_TRANSCRIPTION"
38,"Down",8.0062463785178e-07,3.81608070920904e-05,"B.LvsP.LUI_THYROID_CANCER_CLUSTER_3"
12,"Down",8.684471234875e-07,4.10396935535247e-05,"B.LvsP.REACTOME_CONDENSATION_OF_PROMETAPHASE_CHROMOSOMES"
246,"Down",1.09817643871097e-06,5.14560807596014e-05,"B.LvsP.CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP"
66,"Up",1.25786313465811e-06,5.8443069508611e-05,"B.LvsP.REACTOME_REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF"
601,"Down",1.35130750746451e-06,6.19701244913654e-05,"B.LvsP.VECCHI_GASTRIC_CANCER_EARLY_UP"
10,"Down",1.35619190874574e-06,6.19701244913654e-05,"B.LvsP.BIOCARTA_ETC_PATHWAY"
60,"Down",1.39169483116407e-06,6.30711534549683e-05,"B.LvsP.REACTOME_DEGRADATION_OF_AXIN"
14,"Down",1.53859316712196e-06,6.91616391952627e-05,"B.LvsP.MONTERO_THYROID_CANCER_POOR_SURVIVAL_UP"
134,"Down",1.66479857671722e-06,7.36407686122027e-05,"B.LvsP.MORI_PRE_BI_LYMPHOCYTE_UP"
96,"Down",1.66487539817785e-06,7.36407686122027e-05,"B.LvsP.REACTOME_APC_C_MEDIATED_DEGRADATION_OF_CELL_CYCLE_PROTEINS"
53,"Down",1.76489908592463e-06,7.72093067259359e-05,"B.LvsP.REACTOME_CROSS_PRESENTATION_OF_SOLUBLE_EXOGENOUS_ANTIGENS_ENDOSOMES"
58,"Down",1.77348199569431e-06,7.72093067259359e-05,"B.LvsP.ODONNELL_TARGETS_OF_MYC_AND_TFRC_DN"
75,"Down",1.86704225727766e-06,8.06474737538138e-05,"B.LvsP.FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_DN"
135,"Down",2.11257478781463e-06,9.05459379986597e-05,"B.LvsP.REACTOME_DNA_REPLICATION"
187,"Down",2.50111547929775e-06,0.000104792220227057,"B.LvsP.REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS"
134,"Down",2.5038620908616e-06,0.000104792220227057,"B.LvsP.CHICAS_RB1_TARGETS_LOW_SERUM"
66,"Down",2.50425702527626e-06,0.000104792220227057,"B.LvsP.REACTOME_NEGATIVE_REGULATION_OF_NOTCH4_SIGNALING"
430,"Down",2.52077505700824e-06,0.000104792220227057,"B.LvsP.TARTE_PLASMA_CELL_VS_PLASMABLAST_DN"
19,"Down",2.68584746445023e-06,0.000110821273365264,"B.LvsP.MOOTHA_TCA"
18,"Down",2.71823860150269e-06,0.000111326972057099,"B.LvsP.LI_WILMS_TUMOR_ANAPLASTIC_UP"
63,"Down",3.09133238571465e-06,0.000125676299710414,"B.LvsP.KAUFFMANN_MELANOMA_RELAPSE_UP"
303,"Down",3.21578802605558e-06,0.000129781693401907,"B.LvsP.REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA"
190,"Up",3.41492525274417e-06,0.00013634129038773,"B.LvsP.SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A5"
243,"Down",3.42764322009305e-06,0.00013634129038773,"B.LvsP.REACTOME_MRNA_SPLICING"
17,"Down",3.54706725141112e-06,0.000140083820236086,"B.LvsP.BIOCARTA_SM_PATHWAY"
237,"Down",3.63106300248239e-06,0.000142384023693086,"B.LvsP.LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN"
31,"Down",3.97493878590805e-06,0.000154770679910462,"B.LvsP.REACTOME_INTERCONVERSION_OF_NUCLEOTIDE_DI_AND_TRIPHOSPHATES"
173,"Down",4.24343087341753e-06,0.00016406943565822,"B.LvsP.CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP"
48,"Down",4.73336667297131e-06,0.000181741557880961,"B.LvsP.DELPUECH_FOXO3_TARGETS_DN"
80,"Down",4.8117505684523e-06,0.000183477026848088,"B.LvsP.TONG_INTERACT_WITH_PTTG1"
104,"Down",5.43839275383913e-06,0.000205951188602579,"B.LvsP.LI_DCP2_BOUND_MRNA"
30,"Down",5.57081943524954e-06,0.000209531024880916,"B.LvsP.CAIRO_PML_TARGETS_BOUND_BY_MYC_UP"
659,"Down",5.86440077856388e-06,0.000219082918274863,"B.LvsP.SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6"
67,"Down",6.91355976568e-06,0.000256544107009696,"B.LvsP.REACTOME_AUF1_HNRNP_D0_BINDS_AND_DESTABILIZES_MRNA"
9,"Down",7.16090757630281e-06,0.000263951053262522,"B.LvsP.SEMBA_FHIT_TARGETS_DN"
31,"Down",7.27218703636185e-06,0.000266277629960561,"B.LvsP.REACTOME_POSTMITOTIC_NUCLEAR_PORE_COMPLEX_NPC_REFORMATION"
42,"Down",7.778407193987e-06,0.000282939561681277,"B.LvsP.REACTOME_INTERACTIONS_OF_VPR_WITH_HOST_CELLULAR_PROTEINS"
25,"Down",8.81156919454492e-06,0.000318425922069535,"B.LvsP.SMID_BREAST_CANCER_LUMINAL_A_DN"
411,"Down",9.08294620751489e-06,0.000326101360917856,"B.LvsP.GRADE_COLON_AND_RECTAL_CANCER_UP"
103,"Down",9.23660735607337e-06,0.000329478723043417,"B.LvsP.MORI_MATURE_B_LYMPHOCYTE_DN"
265,"Down",9.86686161006873e-06,0.000349704345141475,"B.LvsP.SHEPARD_CRUSH_AND_BURN_MUTANT_UP"
101,"Down",1.00265344163429e-05,0.000352028274700795,"B.LvsP.FURUKAWA_DUSP6_TARGETS_PCI35_DN"
64,"Down",1.00597698322889e-05,0.000352028274700795,"B.LvsP.REACTOME_METABOLISM_OF_POLYAMINES"
83,"Down",1.05039861055582e-05,0.000365261252689506,"B.LvsP.MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_DN"
29,"Down",1.06224395352114e-05,0.000367071676188648,"B.LvsP.MULLIGAN_NTF3_SIGNALING_VIA_INSR_AND_IGF1R_UP"
82,"Down",1.07499496411178e-05,0.000369170630843109,"B.LvsP.REACTOME_THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT"
64,"Down",1.24606985064863e-05,0.000425279024952855,"B.LvsP.REACTOME_REGULATION_OF_RUNX3_EXPRESSION_AND_ACTIVITY"
48,"Down",1.31852770204947e-05,0.000447247832185982,"B.LvsP.HOLLEMAN_ASPARAGINASE_RESISTANCE_B_ALL_UP"
81,"Down",1.36811495300922e-05,0.00046115044846006,"B.LvsP.SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_UP"
42,"Down",1.37619504423783e-05,0.00046115044846006,"B.LvsP.REACTOME_INTERACTIONS_OF_REV_WITH_HOST_CELLULAR_PROTEINS"
528,"Down",1.39411977206222e-05,0.000464342663839277,"B.LvsP.RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN"
106,"Down",1.44755852961679e-05,0.000479254557500073,"B.LvsP.BILANGES_RAPAMYCIN_SENSITIVE_VIA_TSC1_AND_TSC2"
21,"Up",1.47397739486207e-05,0.000483072927934713,"B.LvsP.NIKOLSKY_BREAST_CANCER_21Q22_AMPLICON"
32,"Down",1.47656583145174e-05,0.000483072927934713,"B.LvsP.REACTOME_ACTIVATION_OF_THE_PRE_REPLICATIVE_COMPLEX"
7,"Down",1.51539414467241e-05,0.000492859660346692,"B.LvsP.REACTOME_PHOSPHORYLATION_OF_EMI1"
496,"Down",1.62186068398856e-05,0.000521492206589464,"B.LvsP.MOOTHA_HUMAN_MITODB_6_2002"
70,"Up",1.62229443901949e-05,0.000521492206589464,"B.LvsP.REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_CYTOCHROME_C_RELEASE"
166,"Down",1.7252838956113e-05,0.000551392754845947,"B.LvsP.KEGG_SPLICEOSOME"
1217,"Down",1.78724586868533e-05,0.000567912782066736,"B.LvsP.FISCHER_DREAM_TARGETS"
158,"Down",2.02660671837757e-05,0.000640291916909119,"B.LvsP.NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP"
39,"Down",2.08210708382275e-05,0.000654089208321361,"B.LvsP.REACTOME_NUCLEAR_IMPORT_OF_REV_PROTEIN"
27,"Down",2.09769139176781e-05,0.000655261904242047,"B.LvsP.REACTOME_CITRIC_ACID_CYCLE_TCA_CYCLE"
679,"Down",2.1293316411747e-05,0.000661408687868253,"B.LvsP.HSIAO_HOUSEKEEPING_GENES"
151,"Down",2.24524880150723e-05,0.000692735413683345,"B.LvsP.MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_UP"
51,"Down",2.25524280092245e-05,0.000692735413683345,"B.LvsP.BILANGES_SERUM_RESPONSE_TRANSLATION"
68,"Down",2.27884067251104e-05,0.000696116578912349,"B.LvsP.REACTOME_INTERLEUKIN_10_SIGNALING"
445,"Down",2.37690370226887e-05,0.000722082448892558,"B.LvsP.HORIUCHI_WTAP_TARGETS_DN"
67,"Down",2.49017933929129e-05,0.000752360741362924,"B.LvsP.REACTOME_DECTIN_1_MEDIATED_NONCANONICAL_NF_KB_SIGNALING"
213,"Down",2.59715830953666e-05,0.000778885027499726,"B.LvsP.RUIZ_TNC_TARGETS_DN"
25,"Up",2.60614451234309e-05,0.000778885027499726,"B.LvsP.REACTOME_TYPE_I_HEMIDESMOSOME_ASSEMBLY"
415,"Down",2.67816887833157e-05,0.000796107297220175,"B.LvsP.FOURNIER_ACINAR_DEVELOPMENT_LATE_2"
33,"Down",2.8270396019625e-05,0.000835866414933191,"B.LvsP.KEGG_CITRATE_CYCLE_TCA_CYCLE"
79,"Down",2.95666034414596e-05,0.000869541225679946,"B.LvsP.HESS_TARGETS_OF_HOXA9_AND_MEIS1_UP"
201,"Down",3.04703670188727e-05,0.000891379149456863,"B.LvsP.KEGG_HUNTINGTONS_DISEASE"
278,"Down",3.16325149188076e-05,0.0009205061841373,"B.LvsP.FUJII_YBX1_TARGETS_DN"
31,"Down",3.31743810727564e-05,0.00096032017251974,"B.LvsP.REACTOME_G0_AND_EARLY_G1"
28,"Down",3.34401451071797e-05,0.000962971678633315,"B.LvsP.REACTOME_CYTOSOLIC_TRNA_AMINOACYLATION"
58,"Down",3.40468558058577e-05,0.000975363034977137,"B.LvsP.REACTOME_SNRNP_ASSEMBLY"
22,"Up",3.48118760144848e-05,0.000992138466412818,"B.LvsP.BIOCARTA_CALCINEURIN_PATHWAY"
92,"Down",3.56238373738313e-05,0.00100986181738681,"B.LvsP.TIEN_INTESTINE_PROBIOTICS_6HR_UP"
157,"Down",3.57990443493966e-05,0.00100986181738681,"B.LvsP.MORI_LARGE_PRE_BII_LYMPHOCYTE_UP"
128,"Up",3.63265159250975e-05,0.00101953962715667,"B.LvsP.REACTOME_RAB_REGULATION_OF_TRAFFICKING"
15,"Down",3.66648489342006e-05,0.00102383813008684,"B.LvsP.LIANG_SILENCED_BY_METHYLATION_DN"
268,"Down",3.7577345700468e-05,0.00104234687562613,"B.LvsP.KIM_MYC_AMPLIFICATION_TARGETS_UP"
55,"Down",3.77047160653329e-05,0.00104234687562613,"B.LvsP.HU_ANGIOGENESIS_DN"
237,"Up",3.87815640556461e-05,0.0010667824261874,"B.LvsP.KIM_MYCN_AMPLIFICATION_TARGETS_DN"
13,"Down",3.96546724477631e-05,0.00108539942556278,"B.LvsP.BIOCARTA_RANMS_PATHWAY"
272,"Down",4.0911765347973e-05,0.00111429138231006,"B.LvsP.BOYAULT_LIVER_CANCER_SUBCLASS_G3_UP"
61,"Down",4.19189857782306e-05,0.00113612780572469,"B.LvsP.PID_PLK1_PATHWAY"
64,"Down",4.77734872566925e-05,0.00128848590752318,"B.LvsP.REACTOME_DEGRADATION_OF_DVL"
62,"Down",4.83021439139795e-05,0.00129642016359414,"B.LvsP.GREENBAUM_E2A_TARGETS_UP"
178,"Down",4.95446966733932e-05,0.00132334602853716,"B.LvsP.REACTOME_S_PHASE"
60,"Down",5.04662664116652e-05,0.00134148070668316,"B.LvsP.LANDIS_BREAST_CANCER_PROGRESSION_UP"
107,"Down",6.09054017481268e-05,0.00161122471897317,"B.LvsP.GAURNIER_PSMD4_TARGETS"
59,"Down",6.13745548688226e-05,0.00161590435176057,"B.LvsP.REACTOME_MRNA_SPLICING_MINOR_PATHWAY"
75,"Down",6.17809446271128e-05,0.0016188949897787,"B.LvsP.REACTOME_REGULATION_OF_RAS_BY_GAPS"
69,"Down",6.22051731978212e-05,0.00162232265382431,"B.LvsP.JIANG_AGING_HYPOTHALAMUS_UP"
77,"Down",6.29179637863427e-05,0.00163320855293281,"B.LvsP.BURTON_ADIPOGENESIS_PEAK_AT_16HR"
74,"Down",6.33166694232081e-05,0.00163587787495756,"B.LvsP.MARSON_FOXP3_TARGETS_DN"
73,"Down",6.62299355734469e-05,0.00170318750597948,"B.LvsP.REACTOME_G1_S_DNA_DAMAGE_CHECKPOINTS"
625,"Down",6.72074366428633e-05,0.00171138760854549,"B.LvsP.CUI_TCF21_TARGETS_2_UP"
51,"Down",6.73253058323406e-05,0.00171138760854549,"B.LvsP.JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_UP"
62,"Down",6.74773916916109e-05,0.00171138760854549,"B.LvsP.REACTOME_STABILIZATION_OF_P53"
48,"Down",6.78388670458832e-05,0.00171269906802141,"B.LvsP.YU_BAP1_TARGETS"
112,"Down",7.0370478543203e-05,0.00176853807211532,"B.LvsP.TANG_SENESCENCE_TP53_TARGETS_DN"
89,"Up",7.16472071688037e-05,0.0017924769612503,"B.LvsP.REACTOME_PI_METABOLISM"
96,"Down",7.41002061774195e-05,0.0018395448011232,"B.LvsP.REACTOME_DEGRADATION_OF_BETA_CATENIN_BY_THE_DESTRUCTION_COMPLEX"
84,"Down",7.41939755200711e-05,0.0018395448011232,"B.LvsP.YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_10"
40,"Down",7.47190868545746e-05,0.00184429388937028,"B.LvsP.REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY"
346,"Down",7.66745390272366e-05,0.00188256408796139,"B.LvsP.FISCHER_G2_M_CELL_CYCLE"
17,"Down",7.69505306347032e-05,0.00188256408796139,"B.LvsP.RAY_ALZHEIMERS_DISEASE"
99,"Up",8.03809065266098e-05,0.00195782393033315,"B.LvsP.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_UP"
60,"Up",8.38593766783311e-05,0.00203358988444953,"B.LvsP.REACTOME_SYNTHESIS_OF_PIPS_AT_THE_PLASMA_MEMBRANE"
65,"Down",8.45648416149612e-05,0.00204174239864245,"B.LvsP.REACTOME_DEFECTIVE_CFTR_CAUSES_CYSTIC_FIBROSIS"
73,"Down",8.5009204228178e-05,0.00204354734859824,"B.LvsP.LUI_TARGETS_OF_PAX8_PPARG_FUSION"
277,"Down",9.51022315413523e-05,0.00227627808741185,"B.LvsP.REACTOME_MITOTIC_METAPHASE_AND_ANAPHASE"
77,"Up",9.82546214124889e-05,0.00234159397323126,"B.LvsP.KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM"
55,"Up",9.9479985750715e-05,0.0023606216361189,"B.LvsP.SPIRA_SMOKERS_LUNG_CANCER_DN"
159,"Down",0.000101220787184537,0.00239166552283464,"B.LvsP.OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_UP"
65,"Down",0.000102933403800238,0.00242178208345327,"B.LvsP.WONG_PROTEASOME_GENE_MODULE"
80,"Down",0.000105821137009561,0.0024791740107028,"B.LvsP.REACTOME_APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1"
397,"Down",0.000107242997297152,0.00250188410150192,"B.LvsP.BASAKI_YBX1_TARGETS_UP"
121,"Down",0.000108886140657278,0.00252003397633951,"B.LvsP.GROSS_HYPOXIA_VIA_HIF1A_UP"
78,"Down",0.000108932559295559,0.00252003397633951,"B.LvsP.SONG_TARGETS_OF_IE86_CMV_PROTEIN"
8,"Down",0.000111766134462399,0.00256450971080117,"B.LvsP.REACTOME_DNA_REPLICATION_INITIATION"
10,"Down",0.000111782752813001,0.00256450971080117,"B.LvsP.BIOCARTA_MSP_PATHWAY"
6,"Up",0.000116506359789334,0.00266183331931913,"B.LvsP.PALOMERO_GSI_SENSITIVITY_DN"
24,"Down",0.000118834065751672,0.00270384176765841,"B.LvsP.BIOCARTA_COMP_PATHWAY"
116,"Down",0.000120459765432957,0.00272959853720828,"B.LvsP.DAZARD_UV_RESPONSE_CLUSTER_G1"
35,"Down",0.000121900121883112,0.00275096234241521,"B.LvsP.REACTOME_REGULATION_OF_GLUCOKINASE_BY_GLUCOKINASE_REGULATORY_PROTEIN"
72,"Down",0.00012249098653175,0.00275305961192702,"B.LvsP.REACTOME_HEDGEHOG_LIGAND_BIOGENESIS"
518,"Down",0.000123121118782096,0.00275368360924168,"B.LvsP.MOOTHA_MITOCHONDRIA"
886,"Down",0.000123514837238549,0.00275368360924168,"B.LvsP.FEVR_CTNNB1_TARGETS_DN"
18,"Down",0.000126807819408903,0.00281095507592487,"B.LvsP.REACTOME_NUCLEOBASE_BIOSYNTHESIS"
12,"Down",0.000127100518896946,0.00281095507592487,"B.LvsP.REACTOME_FOLDING_OF_ACTIN_BY_CCT_TRIC"
99,"Down",0.000129091134446824,0.00283296571410451,"B.LvsP.REACTOME_SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE"
36,"Up",0.000129137365589055,0.00283296571410451,"B.LvsP.KEGG_SNARE_INTERACTIONS_IN_VESICULAR_TRANSPORT"
42,"Down",0.000129632903900966,0.00283296571410451,"B.LvsP.MOOTHA_GLUCONEOGENESIS"
59,"Down",0.000130577799379216,0.00284238052270742,"B.LvsP.REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN"
167,"Down",0.000133916603775833,0.00289644487930203,"B.LvsP.HILLION_HMGA1B_TARGETS"
9,"Down",0.000134109222119971,0.00289644487930203,"B.LvsP.REACTOME_RUNX1_REGULATES_EXPRESSION_OF_COMPONENTS_OF_TIGHT_JUNCTIONS"
53,"Down",0.000135221274481805,0.00290350478510938,"B.LvsP.REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS"
30,"Down",0.000135525075810799,0.00290350478510938,"B.LvsP.HOLLEMAN_VINCRISTINE_RESISTANCE_ALL_DN"
90,"Down",0.00013601309626189,0.00290350478510938,"B.LvsP.REACTOME_REGULATION_OF_RUNX2_EXPRESSION_AND_ACTIVITY"
17,"Up",0.000136536669222,0.00290350478510938,"B.LvsP.KEGG_STEROID_BIOSYNTHESIS"
32,"Down",0.000141654172869841,0.00300078897240364,"B.LvsP.REACTOME_DNA_STRAND_ELONGATION"
109,"Down",0.000149578620562642,0.00315656562248416,"B.LvsP.REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS"
40,"Down",0.000154203449206297,0.0032417903827438,"B.LvsP.LY_AGING_MIDDLE_DN"
189,"Down",0.000155188135944476,0.00325013334710988,"B.LvsP.KEGG_ALZHEIMERS_DISEASE"
12,"Up",0.000160163229032215,0.00334166978610988,"B.LvsP.REACTOME_ACTIVATION_OF_PPARGC1A_PGC_1ALPHA_BY_PHOSPHORYLATION"
28,"Down",0.000162725834408451,0.00336223561032974,"B.LvsP.WEST_ADRENOCORTICAL_TUMOR_MARKERS_UP"
35,"Down",0.000162738179085571,0.00336223561032974,"B.LvsP.KEGG_DNA_REPLICATION"
55,"Up",0.000162973258015621,0.00336223561032974,"B.LvsP.KEGG_INOSITOL_PHOSPHATE_METABOLISM"
284,"Down",0.000165116859156953,0.00339379596386169,"B.LvsP.BIDUS_METASTASIS_UP"
25,"Down",0.000172103421847431,0.00352429562738683,"B.LvsP.REACTOME_INITIATION_OF_NUCLEAR_ENVELOPE_NE_REFORMATION"
59,"Up",0.000175573088697138,0.00358207973212723,"B.LvsP.PID_RHOA_REG_PATHWAY"
109,"Down",0.000176793405715717,0.00359371595662572,"B.LvsP.THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP"
223,"Down",0.000183469530411741,0.00371576202800921,"B.LvsP.REACTOME_SEPARATION_OF_SISTER_CHROMATIDS"
34,"Up",0.000185558489198137,0.00374435360137408,"B.LvsP.SHIN_B_CELL_LYMPHOMA_CLUSTER_7"
37,"Up",0.00019110511262893,0.00383705124072973,"B.LvsP.BIOCARTA_HDAC_PATHWAY"
23,"Down",0.000191540268121072,0.00383705124072973,"B.LvsP.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_UP"
93,"Down",0.00019600850627797,0.00391238639426316,"B.LvsP.VERNELL_RETINOBLASTOMA_PATHWAY_UP"
43,"Down",0.000198380074498204,0.00394547997086536,"B.LvsP.REACTOME_TRNA_AMINOACYLATION"
63,"Down",0.000199793080139298,0.00395934028706157,"B.LvsP.BOYAULT_LIVER_CANCER_SUBCLASS_G123_UP"
28,"Down",0.000216304763253422,0.00427124655724347,"B.LvsP.RAHMAN_TP53_TARGETS_PHOSPHORYLATED"
62,"Down",0.000217482783651343,0.00427922530536753,"B.LvsP.LY_AGING_PREMATURE_DN"
18,"Down",0.000235303171096293,0.00461344408862199,"B.LvsP.BIOCARTA_NPC_PATHWAY"
103,"Down",0.000238198291132351,0.0046537044228649,"B.LvsP.REACTOME_GLUCOSE_METABOLISM"
65,"Up",0.000252915886680103,0.00492384485019115,"B.LvsP.REACTOME_INTRAFLAGELLAR_TRANSPORT"
54,"Down",0.000257556502131544,0.00499659614135196,"B.LvsP.KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS"
13,"Down",0.000259829435042259,0.00502306624597431,"B.LvsP.FUNG_IL2_SIGNALING_1"
28,"Down",0.000298835388269509,0.00573721450074204,"B.LvsP.TIAN_TNF_SIGNALING_VIA_NFKB"
1333,"Down",0.000298845682078804,0.00573721450074204,"B.LvsP.KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_DN"
18,"Down",0.000310298280939251,0.00593646780385161,"B.LvsP.BIOCARTA_CLASSIC_PATHWAY"
37,"Up",0.000321503441963896,0.00612962941592545,"B.LvsP.REACTOME_SUMOYLATION_OF_INTRACELLULAR_RECEPTORS"
121,"Down",0.000326594540870839,0.00620529627654593,"B.LvsP.REACTOME_TRNA_PROCESSING"
25,"Down",0.000331356203406492,0.00627420701587156,"B.LvsP.RASHI_NFKB1_TARGETS"
47,"Down",0.000338573763607709,0.00638899091804445,"B.LvsP.HOUSTIS_ROS"
1038,"Down",0.000339732161488007,0.00638904462879997,"B.LvsP.WEI_MYCN_TARGETS_WITH_E_BOX"
236,"Down",0.000342037664807109,0.00640617811245829,"B.LvsP.REACTOME_DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS"
83,"Down",0.000342960521122744,0.00640617811245829,"B.LvsP.REACTOME_GLYCOLYSIS"
200,"Down",0.000353904906226849,0.00658835093107153,"B.LvsP.ODONNELL_TFRC_TARGETS_DN"
110,"Down",0.000357301890847414,0.00661412515545307,"B.LvsP.REACTOME_TNFR2_NON_CANONICAL_NF_KB_PATHWAY"
485,"Down",0.000357681935518261,0.00661412515545307,"B.LvsP.LINDGREN_BLADDER_CANCER_CLUSTER_3_UP"
99,"Down",0.000363669437182307,0.00670242772726991,"B.LvsP.APPIERTO_RESPONSE_TO_FENRETINIDE_DN"
22,"Down",0.000367116058011971,0.00674347071344913,"B.LvsP.REACTOME_TRANSCRIPTION_OF_E2F_TARGETS_UNDER_NEGATIVE_CONTROL_BY_DREAM_COMPLEX"
142,"Down",0.000386200450982424,0.00707053739563517,"B.LvsP.REACTOME_TCR_SIGNALING"
120,"Down",0.000399384530012654,0.00728777909716161,"B.LvsP.REACTOME_UCH_PROTEINASES"
188,"Down",0.000415842973265167,0.00756314407626022,"B.LvsP.DAIRKEE_CANCER_PRONE_RESPONSE_BPA_E2"
11,"Up",0.000419217308901532,0.00759951639644776,"B.LvsP.MIZUSHIMA_AUTOPHAGOSOME_FORMATION"
109,"Down",0.000436678931211336,0.00789018892374993,"B.LvsP.REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM"
279,"Down",0.000438932546259389,0.00790507507579205,"B.LvsP.BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP"
40,"Down",0.000441715811933809,0.00792937248111049,"B.LvsP.GUTIERREZ_MULTIPLE_MYELOMA_UP"
129,"Down",0.000450805866259603,0.00806636127685872,"B.LvsP.SANA_RESPONSE_TO_IFNG_DN"
40,"Down",0.000458228731963699,0.00817273115815255,"B.LvsP.CHEN_ETV5_TARGETS_SERTOLI"
276,"Down",0.000469819812410505,0.00835252007336875,"B.LvsP.FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP"
83,"Down",0.000472034125811754,0.00836498936414483,"B.LvsP.PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_DN"
14,"Down",0.000479075825102616,0.0084626525143526,"B.LvsP.REACTOME_PURINE_RIBONUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHESIS"
90,"Down",0.000497555480470704,0.00872911104623453,"B.LvsP.CAFFAREL_RESPONSE_TO_THC_24HR_5_DN"
122,"Down",0.000498595253955283,0.00872911104623453,"B.LvsP.BURTON_ADIPOGENESIS_2"
260,"Up",0.000498896561875585,0.00872911104623453,"B.LvsP.SCHLOSSER_SERUM_RESPONSE_UP"
17,"Down",0.000505318728250343,0.00881358753468816,"B.LvsP.FU_INTERACT_WITH_ALKBH8"
800,"Down",0.000518883142347647,0.00898957696595904,"B.LvsP.MARSON_BOUND_BY_E2F4_UNSTIMULATED"
607,"Down",0.000519466338404708,0.00898957696595904,"B.LvsP.GARY_CD5_TARGETS_DN"
556,"Down",0.000520286603202549,0.00898957696595904,"B.LvsP.POOLA_INVASIVE_BREAST_CANCER_UP"
206,"Down",0.000523195673231094,0.00901167874546641,"B.LvsP.PECE_MAMMARY_STEM_CELL_UP"
36,"Up",0.000540431205284249,0.0092608144177006,"B.LvsP.KEGG_REGULATION_OF_AUTOPHAGY"
28,"Down",0.000541009776979073,0.0092608144177006,"B.LvsP.REACTOME_CYCLIN_A_B1_B2_ASSOCIATED_EVENTS_DURING_G2_M_TRANSITION"
24,"Down",0.000547687489077907,0.0093461855775054,"B.LvsP.LOPEZ_MESOTELIOMA_SURVIVAL_TIME_UP"
66,"Down",0.000552916588139139,0.009406387125604,"B.LvsP.REACTOME_TRNA_PROCESSING_IN_THE_NUCLEUS"
115,"Down",0.000558246318557421,0.00946719623380329,"B.LvsP.DEMAGALHAES_AGING_UP"
163,"Down",0.000559915566730634,0.00946719623380329,"B.LvsP.HILLION_HMGA1_TARGETS"
68,"Down",0.000561922054907289,0.00947215561458049,"B.LvsP.REACTOME_DEGRADATION_OF_GLI1_BY_THE_PROTEASOME"
26,"Down",0.000569296236490868,0.00956729146370216,"B.LvsP.CAIRO_HEPATOBLASTOMA_POOR_SURVIVAL"
153,"Down",0.000586817653448757,0.00983186304823691,"B.LvsP.REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION"
15,"Up",0.000596483007000509,0.00996360889941333,"B.LvsP.REACTOME_SYNTHESIS_OF_PIPS_AT_THE_LATE_ENDOSOME_MEMBRANE"
1187,"Down",0.000627543086081683,0.0104208814357474,"B.LvsP.KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_DN"
197,"Up",0.000627627693634268,0.0104208814357474,"B.LvsP.GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_UP"
119,"Down",0.000632902664983523,0.0104473545418626,"B.LvsP.SHEPARD_BMYB_TARGETS"
17,"Up",0.000633001224728516,0.0104473545418626,"B.LvsP.KEGG_TERPENOID_BACKBONE_BIOSYNTHESIS"
45,"Down",0.00063609873080094,0.0104672317934476,"B.LvsP.REACTOME_NS1_MEDIATED_EFFECTS_ON_HOST_PATHWAYS"
129,"Down",0.000643185895469283,0.0105524475253699,"B.LvsP.SEKI_INFLAMMATORY_RESPONSE_LPS_UP"
54,"Up",0.000651511756300789,0.01065742159937,"B.LvsP.REACTOME_SMOOTH_MUSCLE_CONTRACTION"
48,"Down",0.000692877467210701,0.0113006475404365,"B.LvsP.REACTOME_VIRAL_MESSENGER_RNA_SYNTHESIS"
36,"Down",0.000719516361038933,0.0116975301300597,"B.LvsP.REACTOME_TERMINATION_OF_TRANSLESION_DNA_SYNTHESIS"
49,"Up",0.00072144289642799,0.0116975301300597,"B.LvsP.REACTOME_TBC_RABGAPS"
87,"Down",0.000724993666819202,0.0117207309469104,"B.LvsP.REACTOME_CELLULAR_RESPONSE_TO_HYPOXIA"
269,"Down",0.000727849366470543,0.0117325922659348,"B.LvsP.CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN"
162,"Down",0.00073225821099952,0.0117693478157452,"B.LvsP.MARZEC_IL2_SIGNALING_UP"
12,"Down",0.00074171071417117,0.011852745496426,"B.LvsP.NADELLA_PRKAR1A_TARGETS_UP"
50,"Up",0.000741734480333406,0.011852745496426,"B.LvsP.REACTOME_RETROGRADE_TRANSPORT_AT_THE_TRANS_GOLGI_NETWORK"
114,"Down",0.000745289069170263,0.0118752255430616,"B.LvsP.REACTOME_METABOLISM_OF_NUCLEOTIDES"
36,"Down",0.000755527297917923,0.0120037656039891,"B.LvsP.NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_UP"
261,"Down",0.000757763028218203,0.0120047902092219,"B.LvsP.YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_17"
665,"Down",0.000787809598154102,0.0124451407662686,"B.LvsP.GOLDRATH_ANTIGEN_RESPONSE"
8,"Down",0.000804494757745908,0.0126725114403907,"B.LvsP.GAUTSCHI_SRC_SIGNALING"
55,"Down",0.000809855959331415,0.0127207204521119,"B.LvsP.ANDERSEN_LIVER_CANCER_KRT19_UP"
47,"Down",0.000822888092122396,0.0128888052729312,"B.LvsP.PID_ATR_PATHWAY"
92,"Up",0.000826897947669325,0.0129007846048892,"B.LvsP.REACTOME_RAB_GEFS_EXCHANGE_GTP_FOR_GDP_ON_RABS"
66,"Down",0.000828319503479049,0.0129007846048892,"B.LvsP.BOYAULT_LIVER_CANCER_SUBCLASS_G23_UP"
150,"Down",0.000832793692091757,0.0129340346167846,"B.LvsP.SWEET_KRAS_ONCOGENIC_SIGNATURE"
45,"Down",0.000837158042189409,0.0129653972416393,"B.LvsP.REACTOME_EXTENSION_OF_TELOMERES"
100,"Down",0.000841435300977917,0.0129952396064439,"B.LvsP.RAMASWAMY_METASTASIS_UP"
5,"Down",0.000844447550627591,0.0130054331683007,"B.LvsP.REACTOME_G2_PHASE"
301,"Down",0.000856940416099319,0.0131611765572587,"B.LvsP.KIM_WT1_TARGETS_12HR_DN"
40,"Down",0.00086954659422996,0.0133177925747852,"B.LvsP.SIMBULAN_PARP1_TARGETS_DN"
22,"Up",0.000882753283862989,0.0134827152112665,"B.LvsP.REACTOME_CASPASE_MEDIATED_CLEAVAGE_OF_CYTOSKELETAL_PROTEINS"
45,"Down",0.000898040431807973,0.013678417486133,"B.LvsP.BILANGES_RAPAMYCIN_SENSITIVE_GENES"
103,"Down",0.000905289351644965,0.0137403323731945,"B.LvsP.WU_APOPTOSIS_BY_CDKN1A_VIA_TP53"
150,"Down",0.000907465755695949,0.0137403323731945,"B.LvsP.REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION"
63,"Up",0.000909560797357422,0.0137403323731945,"B.LvsP.SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_DN"
621,"Up",0.000942775135009471,0.0142032798950065,"B.LvsP.WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_UP"
591,"Down",0.000947800121094481,0.0142401817106831,"B.LvsP.WANG_TUMOR_INVASIVENESS_UP"
95,"Up",0.000975895598052525,0.0146225657496813,"B.LvsP.REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_CELL_DEATH_GENES"
14,"Up",0.000986395668882949,0.0147399504141995,"B.LvsP.BIOCARTA_RARRXR_PATHWAY"
39,"Down",0.00100691466880729,0.0150060140265107,"B.LvsP.REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS"
296,"Down",0.0010168887183026,0.0150975824682768,"B.LvsP.DUTERTRE_ESTRADIOL_RESPONSE_6HR_UP"
24,"Up",0.00101901763636016,0.0150975824682768,"B.LvsP.REACTOME_RORA_ACTIVATES_GENE_EXPRESSION"
1873,"Down",0.0010223350839173,0.0150975824682768,"B.LvsP.DODD_NASOPHARYNGEAL_CARCINOMA_DN"
6,"Down",0.00102609373082476,0.0150975824682768,"B.LvsP.CROSBY_E2F4_TARGETS"
163,"Down",0.00102894041361853,0.0150975824682768,"B.LvsP.KAUFFMANN_DNA_REPLICATION_GENES"
96,"Down",0.00102944268231875,0.0150975824682768,"B.LvsP.REACTOME_ABC_TRANSPORTER_DISORDERS"
54,"Up",0.00105495042153669,0.0154307430705724,"B.LvsP.PID_ERB_GENOMIC_PATHWAY"
211,"Down",0.00108429009129067,0.0158180472684594,"B.LvsP.WELCSH_BRCA1_TARGETS_DN"
95,"Down",0.00109929179328504,0.0159614150353382,"B.LvsP.KRIEG_HYPOXIA_VIA_KDM3A"
70,"Down",0.00109989132365054,0.0159614150353382,"B.LvsP.REACTOME_INTERLEUKIN_12_SIGNALING"
413,"Down",0.00112646509445296,0.0163042552545299,"B.LvsP.ZHENG_GLIOBLASTOMA_PLASTICITY_UP"
9,"Down",0.00113516217111635,0.0163713083092755,"B.LvsP.MAINA_HYPOXIA_VHL_TARGETS_UP"
105,"Down",0.00113701978490899,0.0163713083092755,"B.LvsP.KEGG_PYRIMIDINE_METABOLISM"
74,"Down",0.00115079255280904,0.0165112244197954,"B.LvsP.NAKAJIMA_MAST_CELL"
64,"Down",0.00115270982565401,0.0165112244197954,"B.LvsP.REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS"
19,"Down",0.00117493155024332,0.0167727514978764,"B.LvsP.REACTOME_TRANSCRIPTION_OF_E2F_TARGETS_UNDER_NEGATIVE_CONTROL_BY_P107_RBL1_AND_P130_RBL2_IN_COMPLEX_WITH_HDAC1"
306,"Down",0.00117703519283343,0.0167727514978764,"B.LvsP.CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_UP"
22,"Down",0.00118280592983408,0.0168116554911379,"B.LvsP.LE_NEURONAL_DIFFERENTIATION_DN"
74,"Down",0.00128148596209858,0.0181675279088283,"B.LvsP.REACTOME_ASYMMETRIC_LOCALIZATION_OF_PCP_PROTEINS"
19,"Down",0.00130223295183325,0.018372833515799,"B.LvsP.THUM_MIR21_TARGETS_HEART_DISEASE_DN"
12,"Up",0.00130466013362719,0.018372833515799,"B.LvsP.REACTOME_ROLE_OF_ABL_IN_ROBO_SLIT_SIGNALING"
11,"Down",0.00130593661995099,0.018372833515799,"B.LvsP.KALMA_E2F1_TARGETS"
6,"Down",0.00138216552763973,0.0193959218332997,"B.LvsP.REACTOME_G2_M_DNA_REPLICATION_CHECKPOINT"
46,"Down",0.00139141655087442,0.0194763091386953,"B.LvsP.SCHLOSSER_MYC_AND_SERUM_RESPONSE_SYNERGY"
231,"Down",0.00144618728727628,0.0201918422003802,"B.LvsP.BASSO_B_LYMPHOCYTE_NETWORK"
89,"Up",0.00145839156825669,0.0202661165147103,"B.LvsP.GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_UP"
45,"Down",0.00145883783195057,0.0202661165147103,"B.LvsP.REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS"
183,"Down",0.00148446439771042,0.0205704352254158,"B.LvsP.GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP"
710,"Down",0.00149969240528516,0.0206985155861917,"B.LvsP.REACTOME_CELLULAR_RESPONSES_TO_EXTERNAL_STIMULI"
20,"Up",0.00150119456503217,0.0206985155861917,"B.LvsP.REACTOME_RAP1_SIGNALLING"
11,"Up",0.00156179050780502,0.0214804470588406,"B.LvsP.REACTOME_REGULATION_OF_FOXO_TRANSCRIPTIONAL_ACTIVITY_BY_ACETYLATION"
19,"Down",0.00158633278734007,0.0217638560327624,"B.LvsP.XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_DN"
58,"Down",0.00160000968369702,0.0218971622305961,"B.LvsP.TOMLINS_PROSTATE_CANCER_UP"
224,"Down",0.00161208936860952,0.0220080052322025,"B.LvsP.PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_UP"
254,"Down",0.00163995634520868,0.0223332971247753,"B.LvsP.PUJANA_XPRSS_INT_NETWORK"
55,"Down",0.00164897056130076,0.0224008801804224,"B.LvsP.REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA"
31,"Down",0.00166339637745137,0.0225414670856093,"B.LvsP.MAINA_VHL_TARGETS_DN"
38,"Down",0.00167386331199574,0.0226278490269546,"B.LvsP.REACTOME_ACTIVATION_OF_ATR_IN_RESPONSE_TO_REPLICATION_STRESS"
779,"Up",0.00168810777186568,0.0227647509040131,"B.LvsP.MIKKELSEN_NPC_ICP_WITH_H3K4ME3"
144,"Up",0.00170845868062867,0.0229591836350089,"B.LvsP.MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_UP"
7,"Down",0.00171456307884966,0.0229591836350089,"B.LvsP.REACTOME_APOBEC3G_MEDIATED_RESISTANCE_TO_HIV_1_INFECTION"
544,"Down",0.00171498333175234,0.0229591836350089,"B.LvsP.WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN"
2390,"Down",0.00176223721538256,0.0235348057097831,"B.LvsP.PUJANA_BRCA1_PCC_NETWORK"
60,"Down",0.00186209025901168,0.024808426607411,"B.LvsP.REACTOME_GENE_AND_PROTEIN_EXPRESSION_BY_JAK_STAT_SIGNALING_AFTER_INTERLEUKIN_12_STIMULATION"
296,"Down",0.00187858821560146,0.0249680630866838,"B.LvsP.REACTOME_HIV_INFECTION"
349,"Down",0.00192524951042742,0.0255268694080413,"B.LvsP.BENPORATH_MYC_TARGETS_WITH_EBOX"
46,"Down",0.00194489255414971,0.0257256242389803,"B.LvsP.MOREIRA_RESPONSE_TO_TSA_UP"
119,"Down",0.0019816806402396,0.0261496712646414,"B.LvsP.REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT"
20,"Down",0.00201928681048134,0.0265824685122651,"B.LvsP.REACTOME_POLO_LIKE_KINASE_MEDIATED_EVENTS"
17,"Down",0.00204786132373823,0.0268945968146049,"B.LvsP.REACTOME_REPRESSION_OF_WNT_TARGET_GENES"
20,"Down",0.00207298123659344,0.0271473653964871,"B.LvsP.HEDVAT_ELF4_TARGETS_UP"
63,"Down",0.00207692811769109,0.0271473653964871,"B.LvsP.SUNG_METASTASIS_STROMA_DN"
25,"Up",0.00211155226858372,0.027534840785376,"B.LvsP.VICENT_METASTASIS_UP"
9,"Down",0.00213334021986394,0.0277535013544182,"B.LvsP.BIOCARTA_PARKIN_PATHWAY"
51,"Down",0.00217589318430539,0.0282406418216538,"B.LvsP.REACTOME_RNA_POLYMERASE_I_TRANSCRIPTION_INITIATION"
56,"Down",0.00219904667323796,0.0284743069234957,"B.LvsP.SEMENZA_HIF1_TARGETS"
38,"Down",0.00224794007933093,0.0290393941556559,"B.LvsP.WANG_METASTASIS_OF_BREAST_CANCER_ESR1_UP"
252,"Up",0.00225411114894507,0.0290512366958445,"B.LvsP.REACTOME_CILIUM_ASSEMBLY"
196,"Up",0.0022710580646693,0.0291796576935735,"B.LvsP.REACTOME_METABOLISM_OF_STEROIDS"
60,"Down",0.00227463057803042,0.0291796576935735,"B.LvsP.LUI_THYROID_CANCER_PAX8_PPARG_DN"
41,"Down",0.00229913448425868,0.0294257281561718,"B.LvsP.KEGG_AMINOACYL_TRNA_BIOSYNTHESIS"
10,"Up",0.0023429717735788,0.0298227506519359,"B.LvsP.BIOCARTA_PPARG_PATHWAY"
58,"Down",0.00234583785866975,0.0298227506519359,"B.LvsP.TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_DN"
18,"Down",0.00234633686626734,0.0298227506519359,"B.LvsP.REACTOME_EARLY_PHASE_OF_HIV_LIFE_CYCLE"
20,"Up",0.0023638785106649,0.0299767988198767,"B.LvsP.REACTOME_ACTIVATION_OF_SMO"
13,"Down",0.00239044611112563,0.03024433992772,"B.LvsP.REACTOME_MASTL_FACILITATES_MITOTIC_PROGRESSION"
103,"Up",0.00242782732911833,0.0306471627915417,"B.LvsP.PID_CDC42_PATHWAY"
37,"Up",0.00243444539066486,0.0306607028815171,"B.LvsP.BURTON_ADIPOGENESIS_10"
115,"Down",0.00244932159926601,0.030732436095659,"B.LvsP.REACTOME_INTERLEUKIN_1_SIGNALING"
314,"Down",0.00245125778950726,0.030732436095659,"B.LvsP.SHEPARD_BMYB_MORPHOLINO_DN"
15,"Up",0.00246517383990529,0.0308068634160989,"B.LvsP.REACTOME_TRAF3_DEPENDENT_IRF_ACTIVATION_PATHWAY"
276,"Down",0.00246833794417287,0.0308068634160989,"B.LvsP.JISON_SICKLE_CELL_DISEASE_DN"
140,"Down",0.0024798075465145,0.0308492388084308,"B.LvsP.REACTOME_SLC_TRANSPORTER_DISORDERS"
120,"Down",0.00248289225352716,0.0308492388084308,"B.LvsP.SESTO_RESPONSE_TO_UV_C1"
264,"Down",0.00256929162153356,0.0318511510660517,"B.LvsP.VANTVEER_BREAST_CANCER_METASTASIS_DN"
14,"Down",0.00259062717294496,0.0320437978505877,"B.LvsP.REACTOME_CHK1_CHK2_CDS1_MEDIATED_INACTIVATION_OF_CYCLIN_B_CDK1_COMPLEX"
38,"Down",0.00262890177681044,0.0324446382231807,"B.LvsP.REACTOME_GLUCONEOGENESIS"
34,"Up",0.0026378489950025,0.0324825547736499,"B.LvsP.PID_TCR_CALCIUM_PATHWAY"
12,"Down",0.00265411017735115,0.0325645952999786,"B.LvsP.REACTOME_UNWINDING_OF_DNA"
6,"Up",0.00265629091703569,0.0325645952999786,"B.LvsP.REACTOME_LRR_FLII_INTERACTING_PROTEIN_1_LRRFIP1_ACTIVATES_TYPE_I_IFN_PRODUCTION"
19,"Down",0.00271462986991117,0.0330949908898815,"B.LvsP.BIOCARTA_EFP_PATHWAY"
26,"Down",0.00271567102853894,0.0330949908898815,"B.LvsP.NAM_FXYD5_TARGETS_DN"
27,"Up",0.00271751236462402,0.0330949908898815,"B.LvsP.KAMIKUBO_MYELOID_MN1_NETWORK"
111,"Down",0.00272615984198372,0.0331273357501714,"B.LvsP.POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN"
63,"Up",0.00274917626941129,0.0333337622666119,"B.LvsP.TOMLINS_PROSTATE_CANCER_DN"
31,"Down",0.00276664706137674,0.0334721916900481,"B.LvsP.MOOTHA_GLYCOLYSIS"
31,"Down",0.00278563870016479,0.033628376360723,"B.LvsP.MEINHOLD_OVARIAN_CANCER_LOW_GRADE_DN"
1874,"Down",0.00284375785843964,0.0342552008699625,"B.LvsP.KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP"
8,"Down",0.00286091216139107,0.0343869203050679,"B.LvsP.TSAI_DNAJB4_TARGETS_DN"
96,"Up",0.00287855711985903,0.0345095111618826,"B.LvsP.REACTOME_TRANSLOCATION_OF_SLC2A4_GLUT4_TO_THE_PLASMA_MEMBRANE"
24,"Down",0.00288359453007592,0.0345095111618826,"B.LvsP.WU_HBX_TARGETS_1_UP"
10,"Down",0.0028926904986155,0.0345435977685639,"B.LvsP.LUDWICZEK_TREATING_IRON_OVERLOAD"
24,"Up",0.00291463463914858,0.0346963657984653,"B.LvsP.JI_CARCINOGENESIS_BY_KRAS_AND_STK11_UP"
355,"Down",0.0029180340199469,0.0346963657984653,"B.LvsP.REACTOME_CELL_CYCLE_CHECKPOINTS"
12,"Up",0.00295487167300727,0.0349964030322812,"B.LvsP.KREPPEL_CD99_TARGETS_DN"
9,"Down",0.00296219725880419,0.0349964030322812,"B.LvsP.REACTOME_UPTAKE_AND_FUNCTION_OF_DIPHTHERIA_TOXIN"
171,"Down",0.00296225657788164,0.0349964030322812,"B.LvsP.REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX2"
37,"Down",0.00298194733797546,0.0351268664630713,"B.LvsP.FRIDMAN_SENESCENCE_DN"
60,"Down",0.00298600601151086,0.0351268664630713,"B.LvsP.REACTOME_PYRUVATE_METABOLISM_AND_CITRIC_ACID_TCA_CYCLE"
82,"Down",0.00299389427114292,0.0351448862529707,"B.LvsP.REACTOME_REGULATION_OF_PTEN_STABILITY_AND_ACTIVITY"
63,"Down",0.00301904811877757,0.0353650784930533,"B.LvsP.KORKOLA_EMBRYONAL_CARCINOMA_UP"
41,"Up",0.003057909200391,0.0357445665305748,"B.LvsP.HASLINGER_B_CLL_WITH_13Q14_DELETION"
556,"Down",0.00310414635047516,0.0362084919235805,"B.LvsP.MCLACHLAN_DENTAL_CARIES_UP"
79,"Down",0.00311568371279216,0.0362665584169008,"B.LvsP.REACTOME_INTERLEUKIN_12_FAMILY_SIGNALING"
29,"Down",0.00313594969027314,0.0364257685662189,"B.LvsP.REACTOME_BASIGIN_INTERACTIONS"
114,"Down",0.00319550570701422,0.0370397296731271,"B.LvsP.SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP"
34,"Down",0.00321210851832605,0.0371542845142777,"B.LvsP.SOUCEK_MYC_TARGETS"
157,"Down",0.00322226350227893,0.0371939350816288,"B.LvsP.BURTON_ADIPOGENESIS_5"
43,"Down",0.00324168241132651,0.0373401292754672,"B.LvsP.REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS"
136,"Down",0.0032565702412588,0.0374336317337212,"B.LvsP.BENPORATH_ES_CORE_NINE_CORRELATED"
82,"Down",0.00326733865010066,0.037479492523665,"B.LvsP.LINDSTEDT_DENDRITIC_CELL_MATURATION_A"
9,"Down",0.00328747650350568,0.0376324173662172,"B.LvsP.BIOCARTA_IRES_PATHWAY"
21,"Up",0.0033165780571452,0.0378871075990822,"B.LvsP.REACTOME_CLASS_I_PEROXISOMAL_MEMBRANE_PROTEIN_IMPORT"
19,"Up",0.00332725453466956,0.037930701695233,"B.LvsP.REACTOME_SYNTHESIS_OF_PIPS_AT_THE_EARLY_ENDOSOME_MEMBRANE"
292,"Down",0.00334038028980013,0.0380019807043312,"B.LvsP.LEE_LIVER_CANCER_SURVIVAL_DN"
87,"Down",0.00334744744471403,0.0380041825910141,"B.LvsP.LIM_MAMMARY_LUMINAL_PROGENITOR_UP"
158,"Up",0.00336812891286655,0.0381606245066376,"B.LvsP.REACTOME_RHO_GTPASE_CYCLE"
48,"Down",0.00339934769571994,0.0384355693448579,"B.LvsP.IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_DN"
5,"Up",0.00341691168503263,0.0385553157276437,"B.LvsP.JONES_TCOF1_TARGETS"
169,"Down",0.00345090002419165,0.0388595238976694,"B.LvsP.NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP"
25,"Down",0.00346825213126612,0.0389755407190454,"B.LvsP.NAKAMURA_LUNG_CANCER"
108,"Down",0.00348715649178839,0.0391084954221055,"B.LvsP.REN_BOUND_BY_E2F"
67,"Down",0.0035049512343179,0.0392284926610196,"B.LvsP.MORI_PLASMA_CELL_UP"
12,"Down",0.00354179892520799,0.0395338904181742,"B.LvsP.REACTOME_INTEGRATION_OF_PROVIRUS"
165,"Down",0.00354653818907839,0.0395338904181742,"B.LvsP.MALONEY_RESPONSE_TO_17AAG_DN"
17,"Down",0.00358479487624249,0.0398799413898284,"B.LvsP.REACTOME_TELOMERE_EXTENSION_BY_TELOMERASE"
170,"Down",0.00364748013183031,0.0404958185720678,"B.LvsP.KEGG_PURINE_METABOLISM"
191,"Down",0.00366292017163985,0.0405857427434804,"B.LvsP.SESTO_RESPONSE_TO_UV_C0"
452,"Up",0.00369910948336206,0.0409047526670177,"B.LvsP.GABRIELY_MIR21_TARGETS"
454,"Up",0.00371874935003422,0.0409556585953393,"B.LvsP.DOUGLAS_BMI1_TARGETS_DN"
249,"Down",0.00372029340551422,0.0409556585953393,"B.LvsP.RAMALHO_STEMNESS_UP"
46,"Down",0.00372593529995581,0.0409556585953393,"B.LvsP.REACTOME_DETOXIFICATION_OF_REACTIVE_OXYGEN_SPECIES"
96,"Down",0.00382691276341947,0.0419273392733703,"B.LvsP.REACTOME_MITOCHONDRIAL_TRANSLATION"
17,"Down",0.00382950015066956,0.0419273392733703,"B.LvsP.MARSHALL_VIRAL_INFECTION_RESPONSE_UP"
544,"Up",0.00383777264103356,0.0419348714076572,"B.LvsP.SHEN_SMARCA2_TARGETS_UP"
74,"Down",0.00394948596095145,0.0430704297398433,"B.LvsP.BURTON_ADIPOGENESIS_PEAK_AT_8HR"
64,"Up",0.00406914590978128,0.0442880073527179,"B.LvsP.HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_UP"
140,"Down",0.00408181765529749,0.0443386440395674,"B.LvsP.REACTOME_MITOTIC_SPINDLE_CHECKPOINT"
71,"Down",0.00413714521188858,0.044805966637518,"B.LvsP.KEGG_TYPE_I_DIABETES_MELLITUS"
24,"Down",0.00414315896363956,0.044805966637518,"B.LvsP.DEBOSSCHER_NFKB_TARGETS_REPRESSED_BY_GLUCOCORTICOIDS"
43,"Down",0.00414915082626319,0.044805966637518,"B.LvsP.REACTOME_TRANSLESION_SYNTHESIS_BY_Y_FAMILY_DNA_POLYMERASES_BYPASSES_LESIONS_ON_DNA_TEMPLATE"
27,"Up",0.00417372509178994,0.0449834815448471,"B.LvsP.BIOCARTA_PML_PATHWAY"
51,"Down",0.00419931469176694,0.0451712274917887,"B.LvsP.REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS"
39,"Down",0.00422636876182856,0.04537396676534,"B.LvsP.FERRANDO_TAL1_NEIGHBORS"
57,"Down",0.00431164327769036,0.0461984272450906,"B.LvsP.VILIMAS_NOTCH1_TARGETS_DN"
37,"Up",0.00431987464020833,0.0461984272450906,"B.LvsP.YANAGIHARA_ESX1_TARGETS"
7,"Down",0.00436377721252054,0.0465778459614403,"B.LvsP.BIOCARTA_RAN_PATHWAY"
116,"Down",0.00451606551714303,0.0481104551912982,"B.LvsP.REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX3"
144,"Down",0.00455249368276402,0.0484052645615429,"B.LvsP.TAKAO_RESPONSE_TO_UVB_RADIATION_UP"
295,"Down",0.00458929135186998,0.0487028635018985,"B.LvsP.WHITFIELD_CELL_CYCLE_G2_M"
13,"Down",0.00460679694992735,0.0487949814868742,"B.LvsP.WANG_ESOPHAGUS_CANCER_PROGRESSION_UP"
107,"Down",0.00462220656442695,0.0488645890912364,"B.LvsP.SCIBETTA_KDM5B_TARGETS_DN"
56,"Up",0.00463657642903309,0.0489229600689388,"B.LvsP.WANG_NFKB_TARGETS"
66,"Down",0.00470323157510149,0.0495317473880688,"B.LvsP.LEE_LIVER_CANCER_MYC_UP"
24,"Down",0.00471413419474603,0.0495517078858325,"B.LvsP.XU_CREBBP_TARGETS_UP"
55,"Up",0.00472305119476102,0.0495517078858325,"B.LvsP.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_DN"
389,"Down",0.00473686791046022,0.0496025429487396,"B.LvsP.CHICAS_RB1_TARGETS_GROWING"
201,"Down",0.00476570503893311,0.0498101761063538,"B.LvsP.REACTOME_G2_M_CHECKPOINTS"
17,"Down",0.00477730304523972,0.049837185919114,"B.LvsP.DAZARD_UV_RESPONSE_CLUSTER_G3"
37,"Down",0.00479797222174392,0.049876975698069,"B.LvsP.BIOCARTA_EIF_PATHWAY"
138,"Down",0.00479915917369736,0.049876975698069,"B.LvsP.ZHENG_IL22_SIGNALING_UP"
106,"Down",0.00484965942131858,0.0503072550477869,"B.LvsP.PID_HIF1_TFPATHWAY"
255,"Down",0.0049098745897235,0.0508365104992158,"B.LvsP.ALCALAY_AML_BY_NPM1_LOCALIZATION_DN"
934,"Down",0.00500059678015778,0.051506787109245,"B.LvsP.CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN"
31,"Up",0.00500239461729209,0.051506787109245,"B.LvsP.LIM_MAMMARY_LUMINAL_PROGENITOR_DN"
20,"Up",0.0050031040680303,0.051506787109245,"B.LvsP.BIOCARTA_EGFR_SMRTE_PATHWAY"
121,"Down",0.00501187402148197,0.051506787109245,"B.LvsP.PEART_HDAC_PROLIFERATION_CLUSTER_DN"
84,"Down",0.00504092514544547,0.051598180171319,"B.LvsP.REACTOME_NUCLEAR_ENVELOPE_NE_REASSEMBLY"
575,"Down",0.00504327617754848,0.051598180171319,"B.LvsP.LINDGREN_BLADDER_CANCER_CLUSTER_1_DN"
35,"Up",0.00504876387641229,0.051598180171319,"B.LvsP.PID_S1P_S1P2_PATHWAY"
20,"Down",0.00511893079160816,0.0521743034626466,"B.LvsP.REACTOME_LAGGING_STRAND_SYNTHESIS"
15,"Up",0.00512400918434022,0.0521743034626466,"B.LvsP.REACTOME_RHO_GTPASES_ACTIVATE_KTN1"
50,"Up",0.00515514662552484,0.0523948634053803,"B.LvsP.BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_DN"
149,"Down",0.00520661082739477,0.0527584151934727,"B.LvsP.ZHONG_SECRETOME_OF_LUNG_CANCER_AND_MACROPHAGE"
62,"Up",0.00521833324488198,0.0527584151934727,"B.LvsP.PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_DN"
389,"Down",0.0052195429753716,0.0527584151934727,"B.LvsP.GAL_LEUKEMIC_STEM_CELL_DN"
53,"Down",0.0053106408562011,0.0535812651349195,"B.LvsP.GROSS_HYPOXIA_VIA_ELK3_ONLY_UP"
546,"Down",0.00533782895073487,0.0536749282170671,"B.LvsP.BLUM_RESPONSE_TO_SALIRASIB_DN"
60,"Up",0.00533933993839517,0.0536749282170671,"B.LvsP.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_UP"
50,"Up",0.00536445848796751,0.0538295662068464,"B.LvsP.RIZ_ERYTHROID_DIFFERENTIATION_APOBEC2"
57,"Down",0.00541372823806804,0.0542255496889097,"B.LvsP.THILLAINADESAN_ZNF217_TARGETS_UP"
14,"Up",0.00548446882630964,0.0548347705979494,"B.LvsP.MEINHOLD_OVARIAN_CANCER_LOW_GRADE_UP"
182,"Down",0.00549567408520541,0.0548476209694958,"B.LvsP.KIM_GLIS2_TARGETS_UP"
16,"Up",0.00560760139639974,0.0558638344517012,"B.LvsP.REACTOME_AKT_PHOSPHORYLATES_TARGETS_IN_THE_CYTOSOL"
121,"Down",0.00566471366416237,0.0563312982898448,"B.LvsP.LIAN_LIPA_TARGETS_3M"
25,"Up",0.00573372820421513,0.0569152302353778,"B.LvsP.STARK_HYPPOCAMPUS_22Q11_DELETION_DN"
101,"Up",0.0057512446891808,0.056986795495485,"B.LvsP.TURASHVILI_BREAST_NORMAL_DUCTAL_VS_LOBULAR_UP"
82,"Down",0.00579458017467166,0.0573134772553839,"B.LvsP.DAIRKEE_CANCER_PRONE_RESPONSE_BPA"
26,"Down",0.00582272460966642,0.0574890077979386,"B.LvsP.WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_UP"
124,"Down",0.00583733078129366,0.0575304846520011,"B.LvsP.LU_IL4_SIGNALING"
61,"Up",0.00591828319455423,0.0582245334211572,"B.LvsP.PID_ERBB1_INTERNALIZATION_PATHWAY"
340,"Down",0.00603407250014878,0.0592367032560436,"B.LvsP.WINTER_HYPOXIA_METAGENE"
16,"Up",0.0060425937124993,0.0592367032560436,"B.LvsP.REACTOME_SYNTHESIS_OF_IP2_IP_AND_INS_IN_THE_CYTOSOL"
166,"Down",0.00608244327994926,0.0595218210528132,"B.LvsP.REACTOME_INTERLEUKIN_1_FAMILY_SIGNALING"
93,"Down",0.00623378882638094,0.0608950855495764,"B.LvsP.REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR"
144,"Down",0.00628336475903396,0.0612711177296274,"B.LvsP.NEMETH_INFLAMMATORY_RESPONSE_LPS_UP"
75,"Down",0.00634450480008762,0.0617583926755008,"B.LvsP.NATSUME_RESPONSE_TO_INTERFERON_BETA_DN"
120,"Down",0.00638649241994086,0.0620578498942935,"B.LvsP.REACTOME_CLEC7A_DECTIN_1_SIGNALING"
202,"Down",0.00644101994466864,0.0624778934632858,"B.LvsP.MOREAUX_MULTIPLE_MYELOMA_BY_TACI_DN"
1480,"Up",0.00651676993804876,0.0631019632004756,"B.LvsP.CUI_TCF21_TARGETS_2_DN"
50,"Up",0.00656314478257776,0.0633402000162358,"B.LvsP.REACTOME_INTRA_GOLGI_TRAFFIC"
5,"Down",0.00656428551443356,0.0633402000162358,"B.LvsP.TOMIDA_LUNG_CANCER_POOR_SURVIVAL"
46,"Up",0.00661062071561178,0.0636761706212849,"B.LvsP.PETRETTO_HEART_MASS_QTL_CIS_UP"
632,"Up",0.00666021194020685,0.0640422814215716,"B.LvsP.ZHOU_INFLAMMATORY_RESPONSE_LIVE_DN"
21,"Down",0.00667925529946949,0.0641138933173035,"B.LvsP.REACTOME_PCNA_DEPENDENT_LONG_PATCH_BASE_EXCISION_REPAIR"
106,"Down",0.00669180159764433,0.0641230000578432,"B.LvsP.REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE"
13,"Up",0.00673187784823912,0.0643659686180235,"B.LvsP.CHASSOT_SKIN_WOUND"
68,"Down",0.00675013321620917,0.0643659686180235,"B.LvsP.DIRMEIER_LMP1_RESPONSE_LATE_DN"
246,"Down",0.00675604839362366,0.0643659686180235,"B.LvsP.ZHONG_SECRETOME_OF_LUNG_CANCER_AND_FIBROBLAST"
244,"Down",0.00676372359686592,0.0643659686180235,"B.LvsP.CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_UP"
40,"Down",0.00678791414050305,0.064429925912845,"B.LvsP.CHOW_RASSF1_TARGETS_DN"
46,"Up",0.006793750552937,0.064429925912845,"B.LvsP.BIOCARTA_GPCR_PATHWAY"
13,"Down",0.00689025713711537,0.0652332734779296,"B.LvsP.REACTOME_INHIBITION_OF_REPLICATION_INITIATION_OF_DAMAGED_DNA_BY_RB1_E2F1"
305,"Down",0.00694572483320117,0.0656460044491782,"B.LvsP.PAL_PRMT5_TARGETS_UP"
93,"Up",0.00697825025906832,0.0658408629392299,"B.LvsP.ULE_SPLICING_VIA_NOVA2"
23,"Down",0.00700596766540297,0.0659897703952522,"B.LvsP.GRASEMANN_RETINOBLASTOMA_WITH_6P_AMPLIFICATION"
34,"Down",0.00703272048310246,0.0661291012773359,"B.LvsP.DEMAGALHAES_AGING_DN"
135,"Down",0.00712206319432093,0.0668554964370126,"B.LvsP.REACTOME_CHROMOSOME_MAINTENANCE"
61,"Down",0.00714660179349081,0.0669567301888186,"B.LvsP.XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_UP"
17,"Down",0.00715706774128988,0.0669567301888186,"B.LvsP.REACTOME_POLYMERASE_SWITCHING_ON_THE_C_STRAND_OF_THE_TELOMERE"
94,"Down",0.00718382081653605,0.0670934886733578,"B.LvsP.ONDER_CDH1_TARGETS_3_DN"
64,"Down",0.00720831809950214,0.0672087534100292,"B.LvsP.KEGG_ALLOGRAFT_REJECTION"
9,"Up",0.00725126100471298,0.0674953233923537,"B.LvsP.REACTOME_REGULATION_OF_PTEN_MRNA_TRANSLATION"
97,"Up",0.00729102791023055,0.0676879991773649,"B.LvsP.WEIGEL_OXIDATIVE_STRESS_RESPONSE"
642,"Down",0.00729787710991691,0.0676879991773649,"B.LvsP.REACTOME_CELL_CYCLE_MITOTIC"
10,"Down",0.00730868791985655,0.0676879991773649,"B.LvsP.KONDO_HYPOXIA"
115,"Up",0.00737136894972277,0.0681543460251124,"B.LvsP.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_UP"
40,"Down",0.00751605348259067,0.0693760596080865,"B.LvsP.REACTOME_AMINO_ACID_TRANSPORT_ACROSS_THE_PLASMA_MEMBRANE"
19,"Down",0.00754188385716143,0.0694127838963711,"B.LvsP.MARTINELLI_IMMATURE_NEUTROPHIL_DN"
45,"Down",0.00754514073462092,0.0694127838963711,"B.LvsP.SARTIPY_NORMAL_AT_INSULIN_RESISTANCE_UP"
256,"Down",0.00757110233096039,0.0695359215745515,"B.LvsP.BURTON_ADIPOGENESIS_6"
347,"Down",0.00762911630032432,0.0699525439875508,"B.LvsP.MITSIADES_RESPONSE_TO_APLIDIN_DN"
12,"Up",0.00768516117064297,0.0703497617756374,"B.LvsP.REACTOME_PI5P_REGULATES_TP53_ACETYLATION"
23,"Up",0.00770316900216028,0.0703980519222218,"B.LvsP.REACTOME_DEFECTS_IN_VITAMIN_AND_COFACTOR_METABOLISM"
77,"Up",0.00779764181167546,0.071059726905647,"B.LvsP.POMEROY_MEDULLOBLASTOMA_PROGNOSIS_UP"
87,"Up",0.00780127586032334,0.071059726905647,"B.LvsP.EBAUER_MYOGENIC_TARGETS_OF_PAX3_FOXO1_FUSION"
453,"Down",0.00781850290871495,0.0710995108261265,"B.LvsP.HELLER_HDAC_TARGETS_DN"
203,"Down",0.00783841936904819,0.0711635807741665,"B.LvsP.CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN"
23,"Down",0.00796324663530957,0.0721783453223387,"B.LvsP.REACTOME_E2F_MEDIATED_REGULATION_OF_DNA_REPLICATION"
46,"Down",0.00802323373617571,0.072603043088896,"B.LvsP.PLASARI_TGFB1_TARGETS_1HR_UP"
43,"Down",0.008077084798211,0.072872786920313,"B.LvsP.REACTOME_EXPORT_OF_VIRAL_RIBONUCLEOPROTEINS_FROM_NUCLEUS"
14,"Down",0.00807940285443151,0.072872786920313,"B.LvsP.REACTOME_MITOCHONDRIAL_FATTY_ACID_BETA_OXIDATION_OF_SATURATED_FATTY_ACIDS"
24,"Down",0.00810541110384623,0.0729074413793604,"B.LvsP.BIOCARTA_VITCB_PATHWAY"
87,"Down",0.00810961773346114,0.0729074413793604,"B.LvsP.REACTOME_TRANSCRIPTION_COUPLED_NUCLEOTIDE_EXCISION_REPAIR_TC_NER"
59,"Down",0.00819283218790385,0.0735359889073382,"B.LvsP.KAMIKUBO_MYELOID_CEBPA_NETWORK"
14,"Down",0.0082482018878934,0.0739129793163089,"B.LvsP.BIOCARTA_IL5_PATHWAY"
155,"Down",0.00829247652667394,0.0741894865954373,"B.LvsP.WINTER_HYPOXIA_UP"
32,"Down",0.008322301247893,0.0743360316633286,"B.LvsP.KEGG_PROXIMAL_TUBULE_BICARBONATE_RECLAMATION"
65,"Down",0.00835146396661639,0.0744260848858867,"B.LvsP.AMIT_EGF_RESPONSE_120_MCF10A"
8,"Down",0.00835930524762808,0.0744260848858867,"B.LvsP.REACTOME_ACTIVATION_OF_NIMA_KINASES_NEK9_NEK6_NEK7"
24,"Down",0.00847246460874289,0.0753123100027965,"B.LvsP.LEE_METASTASIS_AND_RNA_PROCESSING_UP"
59,"Down",0.00853589925899585,0.0757543932632232,"B.LvsP.REACTOME_HSF1_ACTIVATION"
24,"Down",0.00863076814185365,0.076473585026136,"B.LvsP.HOLLEMAN_VINCRISTINE_RESISTANCE_B_ALL_DN"
5,"Up",0.00871595409279397,0.0771048162864926,"B.LvsP.NIKOLSKY_BREAST_CANCER_19P13_AMPLICON"
45,"Up",0.00875204039712522,0.0773003695778041,"B.LvsP.PID_REELIN_PATHWAY"
457,"Up",0.00880795529248792,0.0776701512155753,"B.LvsP.ZWANG_DOWN_BY_2ND_EGF_PULSE"
27,"Down",0.00885658491793877,0.0779746146676488,"B.LvsP.WACKER_HYPOXIA_TARGETS_OF_VHL"
9,"Down",0.00893201096162857,0.0785136543829004,"B.LvsP.REACTOME_2_LTR_CIRCLE_FORMATION"
56,"Down",0.00897880101659132,0.0787117870191506,"B.LvsP.LIAN_NEUTROPHIL_GRANULE_CONSTITUENTS"
204,"Down",0.00898698462625751,0.0787117870191506,"B.LvsP.CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_DN"
59,"Down",0.00902444607400077,0.0787117870191506,"B.LvsP.KEGG_RNA_DEGRADATION"
8,"Up",0.00904436077566009,0.0787117870191506,"B.LvsP.IM_SREBF1A_TARGETS"
74,"Up",0.00904809413127258,0.0787117870191506,"B.LvsP.FRASOR_TAMOXIFEN_RESPONSE_UP"
137,"Up",0.00905269720835161,0.0787117870191506,"B.LvsP.DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN"
89,"Down",0.00906668371699194,0.0787117870191506,"B.LvsP.REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION_TERMINATION"
1092,"Down",0.00906844064590322,0.0787117870191506,"B.LvsP.REACTOME_INFECTIOUS_DISEASE"
47,"Down",0.00913195887563185,0.0791388724504208,"B.LvsP.REACTOME_TRNA_MODIFICATION_IN_THE_NUCLEUS_AND_CYTOSOL"
15,"Down",0.00920809820822869,0.0796738262805891,"B.LvsP.REACTOME_PROCESSIVE_SYNTHESIS_ON_THE_LAGGING_STRAND"
317,"Up",0.00935698156956221,0.080835548590796,"B.LvsP.WANG_CLIM2_TARGETS_DN"
1217,"Down",0.00939804732244778,0.0810636562337189,"B.LvsP.MARTENS_TRETINOIN_RESPONSE_DN"
19,"Down",0.00943387614749355,0.0812355883414253,"B.LvsP.KEGG_GLYOXYLATE_AND_DICARBOXYLATE_METABOLISM"
675,"Down",0.00945874762835127,0.0812355883414253,"B.LvsP.STARK_PREFRONTAL_CORTEX_22Q11_DELETION_DN"
39,"Up",0.00946205803795946,0.0812355883414253,"B.LvsP.IKEDA_MIR30_TARGETS_DN"
7,"Up",0.00959189879155797,0.08222264871089,"B.LvsP.CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_HD_MTX_UP"
60,"Up",0.00981797274096773,0.0840044900403221,"B.LvsP.PID_ERBB2_ERBB3_PATHWAY"
31,"Up",0.00983015103202901,0.0840044900403221,"B.LvsP.REACTOME_VXPX_CARGO_TARGETING_TO_CILIUM"
53,"Up",0.00996522129277047,0.0850037500305489,"B.LvsP.BRACHAT_RESPONSE_TO_CAMPTOTHECIN_UP"
31,"Down",0.00997783211608361,0.0850037500305489,"B.LvsP.JEON_SMAD6_TARGETS_DN"
858,"Down",0.0100712055495798,0.085667223820964,"B.LvsP.RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP"
29,"Down",0.0101510211046699,0.0862135110410445,"B.LvsP.ZHANG_GATA6_TARGETS_UP"
194,"Up",0.0101795311611096,0.0862685244674571,"B.LvsP.RODRIGUES_DCC_TARGETS_DN"
34,"Down",0.0101887043728069,0.0862685244674571,"B.LvsP.REACTOME_COOPERATION_OF_PREFOLDIN_AND_TRIC_CCT_IN_ACTIN_AND_TUBULIN_FOLDING"
48,"Up",0.0102279064124983,0.0864680344873137,"B.LvsP.BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_DN"
1632,"Up",0.0103573600089628,0.0874287686863436,"B.LvsP.GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN"
166,"Down",0.0104480978260746,0.0879630405532472,"B.LvsP.REACTOME_RHO_GTPASES_ACTIVATE_FORMINS"
317,"Down",0.0104524719919485,0.0879630405532472,"B.LvsP.TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP"
588,"Down",0.0104789471964908,0.0880518222635222,"B.LvsP.MOOTHA_PGC"
9,"Down",0.010598268224636,0.0889193095812029,"B.LvsP.REACTOME_RUNX1_REGULATES_ESTROGEN_RECEPTOR_MEDIATED_TRANSCRIPTION"
6,"Down",0.0108580575677604,0.0909326332047584,"B.LvsP.REACTOME_METHIONINE_SALVAGE_PATHWAY"
53,"Up",0.0108711286938588,0.0909326332047584,"B.LvsP.EINAV_INTERFERON_SIGNATURE_IN_CANCER"
35,"Down",0.0110469437439479,0.0922636736560242,"B.LvsP.REACTOME_DOWNREGULATION_OF_TGF_BETA_RECEPTOR_SIGNALING"
6,"Down",0.0110827385221387,0.0924230185353014,"B.LvsP.PASTURAL_RIZ1_TARGETS_DN"
65,"Down",0.0113005646954236,0.0939779339978704,"B.LvsP.PRAMOONJAGO_SOX4_TARGETS_DN"
7,"Down",0.0113031879378882,0.0939779339978704,"B.LvsP.ZERBINI_RESPONSE_TO_SULINDAC_DN"
207,"Down",0.0113551969517588,0.0942685945139256,"B.LvsP.GOLDRATH_HOMEOSTATIC_PROLIFERATION"
97,"Down",0.0114669489911078,0.0950536146504274,"B.LvsP.HU_GENOTOXIC_DAMAGE_4HR"
222,"Down",0.0115578424114445,0.095560482542559,"B.LvsP.WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP"
70,"Down",0.0115626628361317,0.095560482542559,"B.LvsP.KEGG_GLYCOLYSIS_GLUCONEOGENESIS"
52,"Down",0.0115807944042071,0.0955674809863601,"B.LvsP.PID_FOXM1_PATHWAY"
15,"Up",0.0117028329830645,0.0964306461451025,"B.LvsP.REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_TO_CONTROL_BILE_ACID_HOMEOSTASIS"
1242,"Up",0.0117306683580793,0.0965161686783045,"B.LvsP.BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP"
22,"Down",0.0117500000412828,0.0965315753763043,"B.LvsP.BIOCARTA_GRANULOCYTES_PATHWAY"
37,"Up",0.0117727119352559,0.0965746651187389,"B.LvsP.SHI_SPARC_TARGETS_UP"
27,"Down",0.0118127086235229,0.0967592088584561,"B.LvsP.KEGG_RNA_POLYMERASE"
16,"Up",0.0119033337398663,0.0970037266433183,"B.LvsP.REACTOME_CLEC7A_DECTIN_1_INDUCES_NFAT_ACTIVATION"
37,"Up",0.0119046833553696,0.0970037266433183,"B.LvsP.BIOCARTA_RHO_PATHWAY"
8,"Down",0.0119222060408953,0.0970037266433183,"B.LvsP.LU_TUMOR_ENDOTHELIAL_MARKERS_DN"
35,"Down",0.0119292497382487,0.0970037266433183,"B.LvsP.ZHAN_MULTIPLE_MYELOMA_SUBGROUPS"
12,"Up",0.0119302828933725,0.0970037266433183,"B.LvsP.REACTOME_ACTIVATED_NTRK3_SIGNALS_THROUGH_PI3K"
34,"Up",0.0119564881519099,0.0970740425725546,"B.LvsP.BIOCARTA_RAS_PATHWAY"
177,"Down",0.0120752822089508,0.0978947732159661,"B.LvsP.KEGG_CELL_ADHESION_MOLECULES_CAMS"
129,"Down",0.0121674614238167,0.0983047376141066,"B.LvsP.REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS"
29,"Down",0.0121721651989633,0.0983047376141066,"B.LvsP.PETROVA_PROX1_TARGETS_UP"
14,"Down",0.0121791906792662,0.0983047376141066,"B.LvsP.BIOCARTA_LECTIN_PATHWAY"
5,"Down",0.0123199492585501,0.099295917566361,"B.LvsP.REACTOME_BETA_OXIDATION_OF_LAUROYL_COA_TO_DECANOYL_COA_COA"
916,"Down",0.0123709368698154,0.0995617321007413,"B.LvsP.SWEET_LUNG_CANCER_KRAS_UP"
62,"Up",0.0124047559010782,0.0995647794853349,"B.LvsP.KEGG_VASOPRESSIN_REGULATED_WATER_REABSORPTION"
72,"Up",0.0124073309939222,0.0995647794853349,"B.LvsP.GOBERT_CORE_OLIGODENDROCYTE_DIFFERENTIATION"
154,"Up",0.0124811105710812,0.100011681663055,"B.LvsP.SASSON_RESPONSE_TO_GONADOTROPHINS_DN"
15,"Down",0.0125870646331455,0.100629459517882,"B.LvsP.BIOCARTA_STEM_PATHWAY"
88,"Down",0.0126394752683712,0.100629459517882,"B.LvsP.KEGG_LEISHMANIA_INFECTION"
187,"Down",0.0126520104376421,0.100629459517882,"B.LvsP.ELVIDGE_HYPOXIA_DN"
25,"Down",0.012652423902394,0.100629459517882,"B.LvsP.REACTOME_RESOLUTION_OF_AP_SITES_VIA_THE_MULTIPLE_NUCLEOTIDE_PATCH_REPLACEMENT_PATHWAY"
133,"Down",0.0126550435436327,0.100629459517882,"B.LvsP.GAVIN_FOXP3_TARGETS_CLUSTER_T7"
70,"Up",0.0126674089029564,0.100629459517882,"B.LvsP.REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK"
23,"Down",0.0127347667832416,0.101019405372371,"B.LvsP.REACTOME_ASSEMBLY_OF_THE_HIV_VIRION"
294,"Down",0.0127724240707895,0.101172969466182,"B.LvsP.FERNANDEZ_BOUND_BY_MYC"
10,"Down",0.012876215754887,0.101718463635356,"B.LvsP.BIOCARTA_LDL_PATHWAY"
17,"Down",0.0128780836579399,0.101718463635356,"B.LvsP.REACTOME_MRNA_DECAY_BY_3_TO_5_EXORIBONUCLEASE"
538,"Down",0.0129710059985836,0.10230626557228,"B.LvsP.AFFAR_YY1_TARGETS_DN"
21,"Up",0.0130147418651465,0.102504996826774,"B.LvsP.TIAN_BHLHA15_TARGETS"
102,"Down",0.0130510915007822,0.102645070992638,"B.LvsP.REACTOME_SIGNALING_BY_NOTCH4"
63,"Down",0.013252310048254,0.104079577069313,"B.LvsP.SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2"
157,"Up",0.0133599513568241,0.104776129151603,"B.LvsP.DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN"
5,"Up",0.013399265260477,0.104935605701384,"B.LvsP.REACTOME_DISINHIBITION_OF_SNARE_FORMATION"
14,"Down",0.0135481250603,0.105851718846646,"B.LvsP.REACTOME_POLYMERASE_SWITCHING"
19,"Down",0.013554533721003,0.105851718846646,"B.LvsP.KOINUMA_COLON_CANCER_MSI_UP"
8,"Down",0.0135946874617404,0.106015552857493,"B.LvsP.LOPEZ_MESOTHELIOMA_SURVIVAL_WORST_VS_BEST_DN"
82,"Up",0.0137485261283298,0.107064226709205,"B.LvsP.BIOCARTA_NFAT_PATHWAY"
17,"Up",0.0137754702578226,0.107123171667372,"B.LvsP.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_8"
43,"Down",0.013850037395952,0.107544215170017,"B.LvsP.FOURNIER_ACINAR_DEVELOPMENT_LATE_DN"
134,"Down",0.0138685160817909,0.107544215170017,"B.LvsP.SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM3"
29,"Up",0.0139398745882024,0.107761961547996,"B.LvsP.LEI_HOXC8_TARGETS_DN"
131,"Down",0.0139482411703958,0.107761961547996,"B.LvsP.KEGG_CELL_CYCLE"
252,"Down",0.0139550668237231,0.107761961547996,"B.LvsP.SERVITJA_LIVER_HNF1A_TARGETS_UP"
39,"Down",0.0139849591645501,0.107842174645464,"B.LvsP.KEGG_ASTHMA"
143,"Up",0.0141921306074165,0.109287312156554,"B.LvsP.SASSON_RESPONSE_TO_FORSKOLIN_DN"
13,"Down",0.0142232549855849,0.109372859034317,"B.LvsP.SCHLESINGER_METHYLATED_IN_COLON_CANCER"
99,"Down",0.0142428031298079,0.109372859034317,"B.LvsP.GHANDHI_BYSTANDER_IRRADIATION_UP"
51,"Down",0.0142761199705085,0.109476653698948,"B.LvsP.KORKOLA_TERATOMA"
23,"Up",0.0143654881992546,0.110009396473239,"B.LvsP.REACTOME_PLATELET_SENSITIZATION_BY_LDL"
15,"Up",0.0143951624381375,0.110084167524844,"B.LvsP.REACTOME_LIPOPHAGY"
731,"Down",0.0144271325010263,0.110176264638363,"B.LvsP.TIEN_INTESTINE_PROBIOTICS_24HR_UP"
166,"Up",0.0144853589692089,0.110468344470009,"B.LvsP.WALLACE_PROSTATE_CANCER_RACE_DN"
16,"Down",0.014593936624813,0.111143079336902,"B.LvsP.BIOCARTA_P27_PATHWAY"
175,"Down",0.0146966734627736,0.11177153724302,"B.LvsP.REACTOME_INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING"
590,"Down",0.0147578544012167,0.112082660692757,"B.LvsP.BENPORATH_ES_1"
9,"Down",0.01478095994278,0.11210415298166,"B.LvsP.FUNG_IL2_TARGETS_WITH_STAT5_BINDING_SITES"
100,"Up",0.0148738239284286,0.112653934931893,"B.LvsP.CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_DN"
15,"Down",0.0149166578711867,0.112823804883435,"B.LvsP.SA_MMP_CYTOKINE_CONNECTION"
10,"Down",0.0149456486419241,0.112888649373222,"B.LvsP.REACTOME_CALCITONIN_LIKE_LIGAND_RECEPTORS"
17,"Down",0.0149822410757611,0.113010656081696,"B.LvsP.INAMURA_LUNG_CANCER_SCC_SUBTYPES_UP"
8,"Down",0.0152500477534872,0.114714219405617,"B.LvsP.KORKOLA_CHORIOCARCINOMA_UP"
7,"Up",0.0152559961698397,0.114714219405617,"B.LvsP.REACTOME_PROTEIN_REPAIR"
60,"Up",0.0152703319736904,0.114714219405617,"B.LvsP.GENTILE_UV_RESPONSE_CLUSTER_D8"
152,"Down",0.0153215800385482,0.114943033966259,"B.LvsP.LIAN_LIPA_TARGETS_6M"
62,"Down",0.0154214461425657,0.115493654571793,"B.LvsP.REACTOME_FORMATION_OF_RNA_POL_II_ELONGATION_COMPLEX"
173,"Up",0.0154519521789406,0.115493654571793,"B.LvsP.RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_UP"
7,"Up",0.0154576423192488,0.115493654571793,"B.LvsP.REACTOME_GLI_PROTEINS_BIND_PROMOTERS_OF_HH_RESPONSIVE_GENES_TO_PROMOTE_TRANSCRIPTION"
13,"Down",0.0155120764502407,0.115743955051796,"B.LvsP.SASAKI_TARGETS_OF_TP73_AND_TP63"
41,"Down",0.0155946179895882,0.116203022728347,"B.LvsP.REACTOME_PERK_REGULATES_GENE_EXPRESSION"
1200,"Up",0.0158165689384587,0.117698263338813,"B.LvsP.RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN"
7,"Up",0.0158477724732516,0.117771954307269,"B.LvsP.REACTOME_LOSS_OF_MECP2_BINDING_ABILITY_TO_THE_NCOR_SMRT_COMPLEX"
8,"Up",0.0159127692300162,0.118096243050684,"B.LvsP.REACTOME_COMPETING_ENDOGENOUS_RNAS_CERNAS_REGULATE_PTEN_TRANSLATION"
274,"Down",0.0159425636590112,0.118158759344065,"B.LvsP.CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN"
27,"Down",0.016004044326795,0.118322682659886,"B.LvsP.REACTOME_MITOCHONDRIAL_TRNA_AMINOACYLATION"
91,"Up",0.0160074817561213,0.118322682659886,"B.LvsP.DAUER_STAT3_TARGETS_DN"
91,"Up",0.0160365807498997,0.118379512638445,"B.LvsP.REACTOME_SPHINGOLIPID_METABOLISM"
41,"Down",0.0160781118693145,0.118527840700586,"B.LvsP.REACTOME_SMAD2_SMAD3_SMAD4_HETEROTRIMER_REGULATES_TRANSCRIPTION"
663,"Up",0.0161616892284847,0.118985325891201,"B.LvsP.BERENJENO_TRANSFORMED_BY_RHOA_DN"
20,"Up",0.0163653549029263,0.120227982952629,"B.LvsP.REACTOME_SYNTHESIS_OF_PIPS_AT_THE_GOLGI_MEMBRANE"
91,"Down",0.0163739683782473,0.120227982952629,"B.LvsP.SHAFFER_IRF4_TARGETS_IN_ACTIVATED_DENDRITIC_CELL"
11,"Down",0.0164074008590106,0.12031368613988,"B.LvsP.HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_DN"
31,"Up",0.016563489567071,0.121292975291702,"B.LvsP.KANG_DOXORUBICIN_RESISTANCE_DN"
12,"Down",0.0165848235341882,0.121292975291702,"B.LvsP.BIOCARTA_EOSINOPHILS_PATHWAY"
6,"Up",0.0166211013316364,0.121397713689059,"B.LvsP.REACTOME_N_GLYCAN_TRIMMING_AND_ELONGATION_IN_THE_CIS_GOLGI"
439,"Down",0.0166991070480623,0.121806547320232,"B.LvsP.MCBRYAN_PUBERTAL_BREAST_4_5WK_UP"
6,"Down",0.0167486536203144,0.122006990601737,"B.LvsP.SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_DN"
243,"Down",0.0167862559453374,0.122099960331838,"B.LvsP.ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP"
113,"Up",0.0168055832542103,0.122099960331838,"B.LvsP.BURTON_ADIPOGENESIS_11"
117,"Down",0.0170664288551471,0.123832395196993,"B.LvsP.TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_UP"
20,"Up",0.0172109190608642,0.124717131700548,"B.LvsP.BIOCARTA_PGC1A_PATHWAY"
35,"Down",0.0172850063753064,0.125090052682028,"B.LvsP.JIANG_TIP30_TARGETS_DN"
30,"Down",0.017376668759416,0.12553523535209,"B.LvsP.IWANAGA_E2F1_TARGETS_INDUCED_BY_SERUM"
11,"Up",0.0173919316837948,0.12553523535209,"B.LvsP.NIKOLSKY_BREAST_CANCER_17P11_AMPLICON"
11,"Up",0.0175640793137999,0.126612509160365,"B.LvsP.REACTOME_SPERM_MOTILITY_AND_TAXES"
36,"Down",0.0176285679884355,0.12671710830105,"B.LvsP.REACTOME_SCAVENGING_BY_CLASS_A_RECEPTORS"
108,"Down",0.0176562739016356,0.12671710830105,"B.LvsP.HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_DN"
34,"Up",0.0176717264374118,0.12671710830105,"B.LvsP.REACTOME_RHO_GTPASES_ACTIVATE_ROCKS"
300,"Up",0.0176813863538822,0.12671710830105,"B.LvsP.THUM_SYSTOLIC_HEART_FAILURE_DN"
29,"Up",0.0176931827832177,0.12671710830105,"B.LvsP.REACTOME_CONSTITUTIVE_SIGNALING_BY_AKT1_E17K_IN_CANCER"
27,"Down",0.0178299009191866,0.127126668363923,"B.LvsP.REACTOME_GAP_FILLING_DNA_REPAIR_SYNTHESIS_AND_LIGATION_IN_GG_NER"
30,"Down",0.0178477488439596,0.127126668363923,"B.LvsP.MATZUK_SPERMATOGONIA"
139,"Down",0.0178498500786289,0.127126668363923,"B.LvsP.BRUECKNER_TARGETS_OF_MIRLET7A3_DN"
7,"Down",0.0178620510055749,0.127126668363923,"B.LvsP.REACTOME_ACTIVATION_OF_C3_AND_C5"
103,"Down",0.0178653321249354,0.127126668363923,"B.LvsP.REACTOME_PCP_CE_PATHWAY"
74,"Down",0.0178928152692341,0.127153013820956,"B.LvsP.GEORGES_CELL_CYCLE_MIR192_TARGETS"
180,"Down",0.0179348084497015,0.127153013820956,"B.LvsP.LENAOUR_DENDRITIC_CELL_MATURATION_UP"
78,"Down",0.0179380269090876,0.127153013820956,"B.LvsP.PAL_PRMT5_TARGETS_DN"
165,"Down",0.0180987637506265,0.12799178951772,"B.LvsP.IVANOVA_HEMATOPOIESIS_INTERMEDIATE_PROGENITOR"
1203,"Up",0.0181026549833345,0.12799178951772,"B.LvsP.MIKKELSEN_ES_ICP_WITH_H3K4ME3"
306,"Down",0.018224780821618,0.128690693694414,"B.LvsP.ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP"
34,"Down",0.0183380381517547,0.129325271608485,"B.LvsP.MAHADEVAN_IMATINIB_RESISTANCE_DN"
38,"Up",0.0184602371859805,0.129973892159676,"B.LvsP.REACTOME_KERATAN_SULFATE_KERATIN_METABOLISM"
11,"Up",0.0184896946787481,0.129973892159676,"B.LvsP.RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_MAPK1_UP"
41,"Down",0.0185005341164162,0.129973892159676,"B.LvsP.BIOCARTA_MHC_PATHWAY"
49,"Down",0.0186376773014503,0.130771215481877,"B.LvsP.WANG_ADIPOGENIC_GENES_REPRESSED_BY_SIRT1"
11,"Down",0.0186683250026175,0.130820239467011,"B.LvsP.BIOCARTA_NOTCH_PATHWAY"
20,"Down",0.0187003135128667,0.130831743504451,"B.LvsP.REACTOME_REGULATION_OF_TLR_BY_ENDOGENOUS_LIGAND"
83,"Up",0.018717292297345,0.130831743504451,"B.LvsP.KEGG_VEGF_SIGNALING_PATHWAY"
82,"Down",0.0188566376817042,0.131639330482503,"B.LvsP.PID_TGFBR_PATHWAY"
109,"Down",0.0190765022890939,0.133006281407819,"B.LvsP.SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN"
69,"Down",0.0192105586770873,0.133640457312627,"B.LvsP.REACTOME_HDR_THROUGH_HOMOLOGOUS_RECOMBINATION_HRR"
341,"Up",0.0192194560929745,0.133640457312627,"B.LvsP.BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_DN"
237,"Down",0.0192399717889041,0.133640457312627,"B.LvsP.YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_13"
16,"Up",0.0193065425643987,0.133806649645162,"B.LvsP.BIOCARTA_CARM1_PATHWAY"
151,"Up",0.0193122999487863,0.133806649645162,"B.LvsP.LE_EGR2_TARGETS_DN"
32,"Down",0.019379545013523,0.134104511113603,"B.LvsP.REACTOME_RNA_POLYMERASE_I_TRANSCRIPTION_TERMINATION"
28,"Down",0.0194416619937553,0.134275193925666,"B.LvsP.REACTOME_TELOMERE_C_STRAND_LAGGING_STRAND_SYNTHESIS"
1549,"Down",0.0194527817570009,0.134275193925666,"B.LvsP.DANG_BOUND_BY_MYC"
30,"Up",0.0195123514662076,0.134495750372221,"B.LvsP.REACTOME_ENERGY_DEPENDENT_REGULATION_OF_MTOR_BY_LKB1_AMPK"
41,"Up",0.0195333853407296,0.134495750372221,"B.LvsP.MAYBURD_RESPONSE_TO_L663536_UP"
16,"Up",0.0195614611554668,0.134521540707184,"B.LvsP.REACTOME_PI3K_AKT_ACTIVATION"
106,"Down",0.0196095538206439,0.134684749160671,"B.LvsP.VANTVEER_BREAST_CANCER_POOR_PROGNOSIS"
303,"Up",0.0196991148117016,0.135132017114018,"B.LvsP.ZWANG_EGF_INTERVAL_DN"
768,"Up",0.0197303535623114,0.135178593365576,"B.LvsP.RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_DN"
64,"Up",0.0197701484573214,0.135283602500656,"B.LvsP.REACTOME_COPI_INDEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC"
450,"Up",0.0198343594716824,0.13555522066617,"B.LvsP.ZHOU_INFLAMMATORY_RESPONSE_FIMA_DN"
42,"Down",0.0199678493249838,0.136299060392389,"B.LvsP.REACTOME_GENERATION_OF_SECOND_MESSENGER_MOLECULES"
55,"Down",0.0200249292983612,0.136502363105954,"B.LvsP.REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC"
200,"Down",0.020047253919543,0.136502363105954,"B.LvsP.ALTEMEIER_RESPONSE_TO_LPS_WITH_MECHANICAL_VENTILATION"
18,"Up",0.020071698535927,0.136502363105954,"B.LvsP.XU_RESPONSE_TO_TRETINOIN_DN"
51,"Up",0.0201091220995059,0.136588864973179,"B.LvsP.TERAO_AOX4_TARGETS_SKIN_DN"
33,"Up",0.0201978464531017,0.137023181643189,"B.LvsP.REACTOME_ENDOSOMAL_SORTING_COMPLEX_REQUIRED_FOR_TRANSPORT_ESCRT"
14,"Down",0.0203964243863307,0.138200772588263,"B.LvsP.REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_G1_CELL_CYCLE_ARREST"
718,"Down",0.0204980573262477,0.138719411207862,"B.LvsP.REACTOME_NERVOUS_SYSTEM_DEVELOPMENT"
350,"Down",0.0206794221829945,0.139775703239336,"B.LvsP.RODWELL_AGING_KIDNEY_NO_BLOOD_UP"
63,"Down",0.0207477824300242,0.140040211870667,"B.LvsP.AMIT_EGF_RESPONSE_60_HELA"
6,"Down",0.0207890030579925,0.140040211870667,"B.LvsP.REACTOME_SIGNALING_BY_MST1"
14,"Up",0.0207945404134234,0.140040211870667,"B.LvsP.BARRIER_CANCER_RELAPSE_TUMOR_SAMPLE_DN"
117,"Up",0.0208454084461103,0.140193056421637,"B.LvsP.PID_FAK_PATHWAY"
40,"Up",0.020888107151496,0.140193056421637,"B.LvsP.YIH_RESPONSE_TO_ARSENITE_C1"
607,"Down",0.0208933041221612,0.140193056421637,"B.LvsP.REACTOME_SIGNALING_BY_INTERLEUKINS"
16,"Down",0.0209262162224358,0.140243696356179,"B.LvsP.BIOCARTA_RB_PATHWAY"
39,"Down",0.0210080793618416,0.140479738517436,"B.LvsP.KOBAYASHI_EGFR_SIGNALING_6HR_DN"
30,"Up",0.0210122524423801,0.140479738517436,"B.LvsP.REACTOME_SYNTHESIS_OF_IP3_AND_IP4_IN_THE_CYTOSOL"
16,"Up",0.0211162190257035,0.141004317624535,"B.LvsP.BIOCARTA_TSP1_PATHWAY"
12,"Up",0.0211639298042172,0.141152434122457,"B.LvsP.REACTOME_PREGNENOLONE_BIOSYNTHESIS"
16,"Up",0.0212314974828893,0.14135961164899,"B.LvsP.KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_KERATAN_SULFATE"
92,"Down",0.0212461271984645,0.14135961164899,"B.LvsP.KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP"
224,"Up",0.0214233307236916,0.14236730236934,"B.LvsP.REACTOME_INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC"
154,"Up",0.0214855463324182,0.142609346544946,"B.LvsP.OUILLETTE_CLL_13Q14_DELETION_UP"
135,"Up",0.0215156536654628,0.142637948580748,"B.LvsP.FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_DN"
71,"Down",0.0216768041572236,0.14353419183867,"B.LvsP.KEGG_GRAFT_VERSUS_HOST_DISEASE"
409,"Up",0.0217262247052389,0.143689349755103,"B.LvsP.CHEN_HOXA5_TARGETS_9HR_UP"
20,"Up",0.0218085116489538,0.144061243616566,"B.LvsP.ROETH_TERT_TARGETS_UP"
6,"Up",0.0220334465614438,0.145373420093345,"B.LvsP.MCGOWAN_RSP6_TARGETS_DN"
39,"Down",0.0221693441269669,0.145880683360252,"B.LvsP.ZHAN_V1_LATE_DIFFERENTIATION_GENES_DN"
45,"Up",0.0221767897632528,0.145880683360252,"B.LvsP.SAMOLS_TARGETS_OF_KHSV_MIRNAS_UP"
30,"Down",0.0221940819681547,0.145880683360252,"B.LvsP.SUZUKI_RESPONSE_TO_TSA_AND_DECITABINE_1B"
46,"Down",0.0222158682201722,0.145880683360252,"B.LvsP.IIZUKA_LIVER_CANCER_PROGRESSION_G2_G3_UP"
25,"Down",0.0223194053874111,0.146386705085405,"B.LvsP.AUJLA_IL22_AND_IL17A_SIGNALING"
14,"Up",0.0224201363245957,0.146873144240154,"B.LvsP.REACTOME_CALCINEURIN_ACTIVATES_NFAT"
16,"Down",0.0224923826503412,0.14716519826947,"B.LvsP.BIOCARTA_FREE_PATHWAY"
30,"Down",0.022540124348664,0.14716519826947,"B.LvsP.REACTOME_ATF4_ACTIVATES_GENES_IN_RESPONSE_TO_ENDOPLASMIC_RETICULUM_STRESS"
138,"Down",0.0225502612127481,0.14716519826947,"B.LvsP.HARRIS_HYPOXIA"
17,"Down",0.0225850032772582,0.14716519826947,"B.LvsP.SHI_SPARC_TARGETS_DN"
431,"Down",0.0225978030983505,0.14716519826947,"B.LvsP.JAATINEN_HEMATOPOIETIC_STEM_CELL_DN"
188,"Up",0.0226555370536978,0.147367605141053,"B.LvsP.KIM_MYC_AMPLIFICATION_TARGETS_DN"
65,"Down",0.0226920691301599,0.147431786393248,"B.LvsP.REACTOME_DEADENYLATION_DEPENDENT_MRNA_DECAY"
51,"Up",0.022843013193521,0.148238286322744,"B.LvsP.VALK_AML_CLUSTER_13"
289,"Up",0.0230802803135846,0.149602426557807,"B.LvsP.ZHENG_FOXP3_TARGETS_IN_THYMUS_UP"
100,"Down",0.0231851650394201,0.150106296841866,"B.LvsP.REACTOME_TRANSPORT_OF_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS"
196,"Up",0.023316424463595,0.150779544864581,"B.LvsP.STEARMAN_LUNG_CANCER_EARLY_VS_LATE_UP"
25,"Down",0.0234367649567268,0.151380693277737,"B.LvsP.FINETTI_BREAST_CANCER_KINOME_GREEN"
40,"Up",0.0234987748877805,0.151604114766089,"B.LvsP.REACTOME_CARBOXYTERMINAL_POST_TRANSLATIONAL_MODIFICATIONS_OF_TUBULIN"
9,"Down",0.0236353549133478,0.152307549319231,"B.LvsP.REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_BCR_SIGNALING"
19,"Down",0.0236697201478051,0.152351435037502,"B.LvsP.REACTOME_ORGANIC_CATION_ANION_ZWITTERION_TRANSPORT"
57,"Down",0.0237803271039168,0.15288538204367,"B.LvsP.WANG_TARGETS_OF_MLL_CBP_FUSION_DN"
49,"Up",0.0238250775030276,0.152995184104808,"B.LvsP.PID_MAPK_TRK_PATHWAY"
109,"Up",0.0239459046420359,0.153592699264288,"B.LvsP.KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM"
22,"Down",0.0239986844683753,0.153664470126583,"B.LvsP.MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_4"
36,"Down",0.0240126789997048,0.153664470126583,"B.LvsP.WILENSKY_RESPONSE_TO_DARAPLADIB"
782,"Up",0.0240502800152566,0.153727165554166,"B.LvsP.BONOME_OVARIAN_CANCER_SURVIVAL_SUBOPTIMAL_DEBULKING"
106,"Down",0.024135638179976,0.154086285113426,"B.LvsP.KEGG_HEMATOPOIETIC_CELL_LINEAGE"
29,"Up",0.024162200975464,0.154086285113426,"B.LvsP.DORN_ADENOVIRUS_INFECTION_32HR_UP"
40,"Down",0.0243802558810025,0.155297735905602,"B.LvsP.BIOCARTA_INFLAM_PATHWAY"
35,"Down",0.0244859166776627,0.155723252199394,"B.LvsP.KANNAN_TP53_TARGETS_DN"
7,"Down",0.0245280155056853,0.155723252199394,"B.LvsP.REACTOME_NECTIN_NECL_TRANS_HETERODIMERIZATION"
64,"Down",0.0245315522998141,0.155723252199394,"B.LvsP.SCHOEN_NFKB_SIGNALING"
28,"Down",0.0245655965983585,0.155760531642574,"B.LvsP.MARSON_FOXP3_CORE_DIRECT_TARGETS"
10,"Down",0.0246092367492081,0.15576900356236,"B.LvsP.REACTOME_SCAVENGING_BY_CLASS_F_RECEPTORS"
79,"Up",0.0246232789136376,0.15576900356236,"B.LvsP.PID_TAP63_PATHWAY"
32,"Up",0.0248636974072649,0.156946657341233,"B.LvsP.FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_UP"
10,"Down",0.024866209410548,0.156946657341233,"B.LvsP.BIERIE_INFLAMMATORY_RESPONSE_TGFB1"
101,"Down",0.024983413979081,0.157506608768915,"B.LvsP.KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN"
141,"Down",0.0253037238905646,0.159344293155958,"B.LvsP.HINATA_NFKB_TARGETS_KERATINOCYTE_UP"
13,"Up",0.0254016980233911,0.159779281423583,"B.LvsP.REACTOME_P38MAPK_EVENTS"
23,"Up",0.0255341608118798,0.160303656553653,"B.LvsP.BIOCARTA_RAB_PATHWAY"
26,"Down",0.0255430496335265,0.160303656553653,"B.LvsP.REACTOME_FORMATION_OF_TUBULIN_FOLDING_INTERMEDIATES_BY_CCT_TRIC"
67,"Up",0.0256928767495713,0.161061128739659,"B.LvsP.REACTOME_NR1H2_AND_NR1H3_MEDIATED_SIGNALING"
333,"Down",0.0257486988171217,0.161098864010396,"B.LvsP.BILD_MYC_ONCOGENIC_SIGNATURE"
103,"Down",0.0257571705164026,0.161098864010396,"B.LvsP.SANSOM_WNT_PATHWAY_REQUIRE_MYC"
102,"Up",0.0258626876896392,0.161512966972945,"B.LvsP.REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION"
47,"Down",0.0259208122385595,0.161512966972945,"B.LvsP.GALE_APL_WITH_FLT3_MUTATED_DN"
197,"Down",0.0259493405675213,0.161512966972945,"B.LvsP.WIELAND_UP_BY_HBV_INFECTION"
17,"Down",0.0259548018439009,0.161512966972945,"B.LvsP.BENPORATH_ES_CORE_NINE"
89,"Down",0.0259694388929189,0.161512966972945,"B.LvsP.DORN_ADENOVIRUS_INFECTION_48HR_DN"
831,"Down",0.0262760870285709,0.163236500203335,"B.LvsP.REACTOME_CELL_CYCLE"
14,"Up",0.026370228482066,0.163637478425749,"B.LvsP.BIOCARTA_LEPTIN_PATHWAY"
50,"Down",0.0264657748148625,0.164046265640555,"B.LvsP.TOMIDA_METASTASIS_UP"
15,"Up",0.0265323717801912,0.164274897617779,"B.LvsP.YAMASHITA_SILENCED_BY_METHYLATION"
18,"Down",0.0265849058965001,0.164359993326785,"B.LvsP.REACTOME_CONSTITUTIVE_SIGNALING_BY_OVEREXPRESSED_ERBB2"
230,"Up",0.0266098728643391,0.164359993326785,"B.LvsP.MILI_PSEUDOPODIA_CHEMOTAXIS_UP"
633,"Up",0.0266352964407305,0.164359993326785,"B.LvsP.HADDAD_B_LYMPHOCYTE_PROGENITOR"
78,"Down",0.0266920456262935,0.164526555482471,"B.LvsP.STEARMAN_TUMOR_FIELD_EFFECT_UP"
8,"Down",0.0268296443164298,0.165190538335791,"B.LvsP.REACTOME_TRNA_MODIFICATION_IN_THE_MITOCHONDRION"
41,"Up",0.0268728581329272,0.1652595485202,"B.LvsP.PID_AR_NONGENOMIC_PATHWAY"
10,"Down",0.026900631880662,0.1652595485202,"B.LvsP.REACTOME_INTERLEUKIN_18_SIGNALING"
63,"Up",0.0269999966304442,0.16568588387317,"B.LvsP.ZHAN_MULTIPLE_MYELOMA_LB_DN"
117,"Down",0.0271088660851365,0.166169535016319,"B.LvsP.KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION"
97,"Up",0.0271560656883717,0.166274515161691,"B.LvsP.MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_UP"
308,"Up",0.0272677828730343,0.166773862284299,"B.LvsP.VERHAAK_GLIOBLASTOMA_CLASSICAL"
49,"Up",0.027300906950984,0.166791949759106,"B.LvsP.BIOCARTA_FMLP_PATHWAY"
83,"Up",0.0273645036564562,0.166942514994564,"B.LvsP.BAKKER_FOXO3_TARGETS_UP"
19,"Down",0.0274030239995406,0.166942514994564,"B.LvsP.REACTOME_METABOLISM_OF_FOLATE_AND_PTERINES"
303,"Down",0.0274161337701328,0.166942514994564,"B.LvsP.SANSOM_APC_TARGETS_REQUIRE_MYC"
19,"Down",0.0275045787730704,0.167208497551119,"B.LvsP.LU_TUMOR_VASCULATURE_DN"
25,"Down",0.027520298927748,0.167208497551119,"B.LvsP.KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS_AND_CYCLIC_RGD"
9,"Up",0.0275749735464326,0.167356782369073,"B.LvsP.KIM_GLIS2_TARGETS_DN"
177,"Down",0.027623410426253,0.167466925709159,"B.LvsP.REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS"
55,"Down",0.027700938983167,0.167636715512695,"B.LvsP.REACTOME_DNA_DAMAGE_BYPASS"
85,"Down",0.0277120560641351,0.167636715512695,"B.LvsP.ELVIDGE_HIF1A_TARGETS_UP"
575,"Down",0.027769451635519,0.167649718439946,"B.LvsP.MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP"
99,"Up",0.0277748493563014,0.167649718439946,"B.LvsP.REACTOME_PLATELET_HOMEOSTASIS"
53,"Up",0.0279210526423856,0.168314252045505,"B.LvsP.REACTOME_INOSITOL_PHOSPHATE_METABOLISM"
40,"Down",0.0279458280661555,0.168314252045505,"B.LvsP.MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_UP"
262,"Down",0.0280065617412682,0.168496496047303,"B.LvsP.CAIRO_LIVER_DEVELOPMENT_UP"
8,"Down",0.0280930914014426,0.168687365935589,"B.LvsP.HOLLEMAN_DAUNORUBICIN_ALL_UP"
9,"Up",0.0280993062084784,0.168687365935589,"B.LvsP.REACTOME_AMPK_INHIBITS_CHREBP_TRANSCRIPTIONAL_ACTIVATION_ACTIVITY"
107,"Down",0.0281328436077346,0.168705523109723,"B.LvsP.ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_UP"
150,"Down",0.0281845606377061,0.168832541458155,"B.LvsP.JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP"
13,"Down",0.0283261709119355,0.169497185034731,"B.LvsP.REACTOME_MET_ACTIVATES_RAS_SIGNALING"
97,"Down",0.0284178578593184,0.169681112464768,"B.LvsP.REACTOME_COLLAGEN_DEGRADATION"
12,"Down",0.0284182872386282,0.169681112464768,"B.LvsP.REACTOME_ASPARTATE_AND_ASPARAGINE_METABOLISM"
279,"Down",0.0284807787818733,0.169870793834927,"B.LvsP.REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT"
178,"Up",0.0285254475199882,0.169953878596999,"B.LvsP.LINDGREN_BLADDER_CANCER_WITH_LOH_IN_CHR9Q"
33,"Down",0.0285569423841614,0.169958379377856,"B.LvsP.PID_BARD1_PATHWAY"
37,"Down",0.0286856523043324,0.170502207617002,"B.LvsP.REACTOME_DOWNREGULATION_OF_SMAD2_3_SMAD4_TRANSCRIPTIONAL_ACTIVITY"
71,"Down",0.0287121844733728,0.170502207617002,"B.LvsP.BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_UP"
28,"Down",0.0287408315245155,0.170502207617002,"B.LvsP.BIOCARTA_NKT_PATHWAY"
95,"Down",0.029016957600474,0.171955796970012,"B.LvsP.KEGG_COMPLEMENT_AND_COAGULATION_CASCADES"
105,"Down",0.0290656610004503,0.172059999648276,"B.LvsP.HUPER_BREAST_BASAL_VS_LUMINAL_DN"
111,"Down",0.0291545101916741,0.17240137630991,"B.LvsP.FONTAINE_FOLLICULAR_THYROID_ADENOMA_DN"
86,"Down",0.0293242586736842,0.17321989979359,"B.LvsP.DIRMEIER_LMP1_RESPONSE_LATE_UP"
33,"Up",0.0293914619742002,0.173431582983301,"B.LvsP.SABATES_COLORECTAL_ADENOMA_SIZE_UP"
103,"Down",0.0294928649315737,0.17372319604741,"B.LvsP.PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_UP"
78,"Down",0.0295037223889524,0.17372319604741,"B.LvsP.FAELT_B_CLL_WITH_VH3_21_UP"
9,"Down",0.0295644242659714,0.17389542741123,"B.LvsP.REACTOME_SYNTHESIS_OF_DIPHTHAMIDE_EEF2"
23,"Up",0.0297409308204458,0.174569490691317,"B.LvsP.LIU_IL13_PRIMING_MODEL"
270,"Down",0.0297421704162092,0.174569490691317,"B.LvsP.ONDER_CDH1_TARGETS_1_DN"
62,"Down",0.029876687387975,0.17511363708972,"B.LvsP.KEGG_ARGININE_AND_PROLINE_METABOLISM"
15,"Down",0.0299047940717204,0.17511363708972,"B.LvsP.REACTOME_ORGANIC_CATION_TRANSPORT"
25,"Up",0.0299586404491385,0.17511363708972,"B.LvsP.REACTOME_CELL_EXTRACELLULAR_MATRIX_INTERACTIONS"
32,"Up",0.0299615664110825,0.17511363708972,"B.LvsP.BIOCARTA_PDZS_PATHWAY"
113,"Down",0.0301602861952822,0.175797027542516,"B.LvsP.CROMER_TUMORIGENESIS_UP"
237,"Down",0.0301653639399368,0.175797027542516,"B.LvsP.DARWICHE_PAPILLOMA_RISK_HIGH_UP"
169,"Down",0.0301738793882887,0.175797027542516,"B.LvsP.REACTOME_HIV_LIFE_CYCLE"
64,"Up",0.0303402128757596,0.176517937145835,"B.LvsP.REACTOME_RAB_GERANYLGERANYLATION"
645,"Up",0.0303614682990936,0.176517937145835,"B.LvsP.CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_2"
73,"Up",0.0303984105488347,0.176547071349272,"B.LvsP.HOFMANN_CELL_LYMPHOMA_DN"
22,"Down",0.0305362704115566,0.177019368913562,"B.LvsP.LANDIS_ERBB2_BREAST_PRENEOPLASTIC_UP"
49,"Up",0.0305437652276249,0.177019368913562,"B.LvsP.PID_WNT_NONCANONICAL_PATHWAY"
1106,"Up",0.0307426716965979,0.177985583047633,"B.LvsP.KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP"
116,"Up",0.0308708007056633,0.178540436298757,"B.LvsP.REACTOME_STIMULI_SENSING_CHANNELS"
8,"Up",0.0309680373176201,0.178915651336595,"B.LvsP.IKEDA_MIR133_TARGETS_DN"
167,"Down",0.0311219411808664,0.17961713234761,"B.LvsP.QI_PLASMACYTOMA_DN"
107,"Down",0.0311717178538118,0.179660116495069,"B.LvsP.REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX"
201,"Up",0.0311943772536203,0.179660116495069,"B.LvsP.CHENG_IMPRINTED_BY_ESTRADIOL"
54,"Down",0.0313071684672548,0.179793604598847,"B.LvsP.ZHAN_EARLY_DIFFERENTIATION_GENES_DN"
31,"Down",0.0313103968146329,0.179793604598847,"B.LvsP.KYNG_RESPONSE_TO_H2O2_VIA_ERCC6"
486,"Down",0.0313151096452685,0.179793604598847,"B.LvsP.REACTOME_M_PHASE"
14,"Up",0.0314568501101839,0.180236249292654,"B.LvsP.REACTOME_DEFECTS_IN_COBALAMIN_B12_METABOLISM"
56,"Down",0.0314574028879383,0.180236249292654,"B.LvsP.TSENG_ADIPOGENIC_POTENTIAL_UP"
425,"Up",0.0315268375187937,0.180358589388582,"B.LvsP.PLASARI_TGFB1_TARGETS_10HR_DN"
9,"Up",0.031543996371633,0.180358589388582,"B.LvsP.REACTOME_IRS_ACTIVATION"
106,"Down",0.0315964102421049,0.180471644864254,"B.LvsP.REACTOME_MAPK6_MAPK4_SIGNALING"
27,"Up",0.0317313359766972,0.181055269984684,"B.LvsP.CHEMELLO_SOLEUS_VS_EDL_MYOFIBERS_UP"
131,"Down",0.0319898574843793,0.182342187660962,"B.LvsP.GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP"
36,"Up",0.0320508340016137,0.182501607821753,"B.LvsP.REACTOME_RHO_GTPASES_ACTIVATE_PAKS"
436,"Down",0.0321290148222734,0.182758562708179,"B.LvsP.VANTVEER_BREAST_CANCER_ESR1_DN"
36,"Up",0.0322178045985179,0.183075274023849,"B.LvsP.HOLLEMAN_ASPARAGINASE_RESISTANCE_B_ALL_DN"
88,"Down",0.0322759469146698,0.183217361900626,"B.LvsP.DORN_ADENOVIRUS_INFECTION_32HR_DN"
49,"Down",0.0323508760750132,0.183454352634613,"B.LvsP.LU_TUMOR_ENDOTHELIAL_MARKERS_UP"
137,"Down",0.0326554607235813,0.184991846660534,"B.LvsP.KIM_MYCN_AMPLIFICATION_TARGETS_UP"
40,"Up",0.0327578486019217,0.185263577106117,"B.LvsP.MURAKAMI_UV_RESPONSE_24HR"
445,"Down",0.0327704428304905,0.185263577106117,"B.LvsP.BORCZUK_MALIGNANT_MESOTHELIOMA_UP"
8,"Up",0.032873985240167,0.185659105610708,"B.LvsP.REACTOME_SYNTHESIS_OF_PIPS_AT_THE_ER_MEMBRANE"
18,"Down",0.0330062078593557,0.186215635973855,"B.LvsP.REACTOME_DEPOLYMERISATION_OF_THE_NUCLEAR_LAMINA"
288,"Down",0.0330973019769506,0.186539227961835,"B.LvsP.FOSTER_TOLERANT_MACROPHAGE_UP"
75,"Down",0.0334681209168766,0.188437108502455,"B.LvsP.LIU_TARGETS_OF_VMYB_VS_CMYB_DN"
87,"Down",0.0335803088924542,0.188876427127547,"B.LvsP.ZHOU_TNF_SIGNALING_4HR"
73,"Up",0.0336408781592066,0.189024812339688,"B.LvsP.IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_DN"
179,"Up",0.0337491404405343,0.189440606594633,"B.LvsP.REACTOME_AUTOPHAGY"
49,"Up",0.0338876871433002,0.190025377500311,"B.LvsP.REACTOME_STRIATED_MUSCLE_CONTRACTION"
12,"Up",0.0340533693835317,0.190655240750608,"B.LvsP.REACTOME_ACTIVATION_OF_THE_TFAP2_AP_2_FAMILY_OF_TRANSCRIPTION_FACTORS"
35,"Down",0.0340927143599245,0.190655240750608,"B.LvsP.KEGG_PROTEIN_EXPORT"
64,"Down",0.0341034604996114,0.190655240750608,"B.LvsP.REACTOME_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER"
106,"Down",0.0341641840194461,0.190801791357088,"B.LvsP.INGRAM_SHH_TARGETS_DN"
41,"Down",0.0343912984724167,0.191876376643786,"B.LvsP.BIOCARTA_DC_PATHWAY"
310,"Up",0.0345063704905592,0.192099533131826,"B.LvsP.KARLSSON_TGFB1_TARGETS_DN"
10,"Down",0.0345207690324545,0.192099533131826,"B.LvsP.REACTOME_RECYCLING_OF_EIF2_GDP"
13,"Down",0.0345355282931877,0.192099533131826,"B.LvsP.KEGG_CIRCADIAN_RHYTHM_MAMMAL"
108,"Down",0.034641324079846,0.192494352600471,"B.LvsP.NADLER_OBESITY_UP"
30,"Up",0.034683359817425,0.192534434167212,"B.LvsP.REACTOME_SEALING_OF_THE_NUCLEAR_ENVELOPE_NE_BY_ESCRT_III"
190,"Up",0.0347470726938126,0.192694648870702,"B.LvsP.KOBAYASHI_EGFR_SIGNALING_24HR_UP"
15,"Up",0.0348274222159046,0.192946710853443,"B.LvsP.WORSCHECH_TUMOR_EVASION_AND_TOLEROGENICITY_DN"
16,"Down",0.0348722044791337,0.193001419985115,"B.LvsP.REACTOME_DEFECTIVE_GALNT3_CAUSES_FAMILIAL_HYPERPHOSPHATEMIC_TUMORAL_CALCINOSIS_HFTC"
26,"Down",0.0349364385895867,0.193163568961825,"B.LvsP.OHASHI_AURKB_TARGETS"
59,"Down",0.0350414140988596,0.19355042812447,"B.LvsP.WENG_POR_TARGETS_GLOBAL_DN"
35,"Up",0.0351260805313639,0.193824450357197,"B.LvsP.PID_RXR_VDR_PATHWAY"
74,"Down",0.0351935037147141,0.194002873418399,"B.LvsP.REACTOME_DUAL_INCISION_IN_TC_NER"
144,"Up",0.0352865935492984,0.194266103658278,"B.LvsP.REACTOME_ANCHORING_OF_THE_BASAL_BODY_TO_THE_PLASMA_MEMBRANE"
21,"Up",0.0353115272520473,0.194266103658278,"B.LvsP.BIOCARTA_MYOSIN_PATHWAY"
12,"Down",0.0356126317493541,0.195536276615478,"B.LvsP.WANG_THOC1_TARGETS_UP"
27,"Down",0.0356189987930671,0.195536276615478,"B.LvsP.LEE_NAIVE_T_LYMPHOCYTE"
368,"Up",0.0356485018680415,0.195536276615478,"B.LvsP.THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN"
22,"Down",0.0357368752044337,0.195700495716179,"B.LvsP.ZEILSTRA_CD44_TARGETS_UP"
39,"Up",0.035804008180114,0.195700495716179,"B.LvsP.PID_RETINOIC_ACID_PATHWAY"
254,"Down",0.0358140372407218,0.195700495716179,"B.LvsP.MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_UP"
65,"Up",0.0358200220048424,0.195700495716179,"B.LvsP.YANG_BREAST_CANCER_ESR1_UP"
54,"Up",0.0358922834322742,0.195798609428481,"B.LvsP.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_PINK_DN"
20,"Down",0.0359466176753403,0.195798609428481,"B.LvsP.REACTOME_BUTYRATE_RESPONSE_FACTOR_1_BRF1_BINDS_AND_DESTABILIZES_MRNA"
118,"Up",0.0359780736212023,0.195798609428481,"B.LvsP.BOYLAN_MULTIPLE_MYELOMA_PCA3_DN"
31,"Up",0.0359796323348412,0.195798609428481,"B.LvsP.REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION"
39,"Down",0.0362279605880247,0.196912886599702,"B.LvsP.REACTOME_TRANSCRIPTIONAL_REGULATION_BY_E2F6"
10,"Down",0.0362556192003068,0.196912886599702,"B.LvsP.BIOCARTA_FBW7_PATHWAY"
32,"Down",0.0363351449920033,0.197151144907543,"B.LvsP.MARIADASON_RESPONSE_TO_CURCUMIN_SULINDAC_5"
527,"Up",0.0364492068218642,0.197485649286167,"B.LvsP.OISHI_CHOLANGIOMA_STEM_CELL_LIKE_UP"
37,"Down",0.036468230768887,0.197485649286167,"B.LvsP.TOMIDA_METASTASIS_DN"
58,"Up",0.0366750317901378,0.198411204273652,"B.LvsP.EPPERT_LSC_R"
55,"Down",0.0369026114768831,0.199278351869086,"B.LvsP.PID_IL23_PATHWAY"
67,"Down",0.0369386932936055,0.199278351869086,"B.LvsP.LEONARD_HYPOXIA"
57,"Down",0.0369434455897655,0.199278351869086,"B.LvsP.TERAO_AOX4_TARGETS_SKIN_UP"
61,"Down",0.0370025138397671,0.199402435692079,"B.LvsP.GENTILE_UV_RESPONSE_CLUSTER_D2"
10,"Up",0.0370427340039112,0.19942480653128,"B.LvsP.REACTOME_REACTIONS_SPECIFIC_TO_THE_COMPLEX_N_GLYCAN_SYNTHESIS_PATHWAY"
117,"Up",0.0372218492083849,0.200097828887535,"B.LvsP.HANN_RESISTANCE_TO_BCL2_INHIBITOR_UP"
160,"Down",0.0372401276768445,0.200097828887535,"B.LvsP.TAKAO_RESPONSE_TO_UVB_RADIATION_DN"
190,"Down",0.0375971155653516,0.201819856272649,"B.LvsP.MCBRYAN_PUBERTAL_BREAST_5_6WK_UP"
48,"Up",0.0376379140210164,0.201842896820756,"B.LvsP.REACTOME_NR1H3_NR1H2_REGULATE_GENE_EXPRESSION_LINKED_TO_CHOLESTEROL_TRANSPORT_AND_EFFLUX"
12,"Down",0.0378038800628867,0.202536485336919,"B.LvsP.REACTOME_SEROTONIN_RECEPTORS"
10,"Up",0.0378715411891679,0.202702566539118,"B.LvsP.MIKKELSEN_DEDIFFERENTIATED_STATE_DN"
90,"Up",0.0379223417487041,0.202778169756852,"B.LvsP.GOTTWEIN_TARGETS_OF_KSHV_MIR_K12_11"
36,"Down",0.0380228310011579,0.203119065319229,"B.LvsP.REACTOME_FGFR2_ALTERNATIVE_SPLICING"
83,"Down",0.0380688235275819,0.203168460698842,"B.LvsP.PARENT_MTOR_SIGNALING_DN"
17,"Down",0.0381098101631754,0.203191070773574,"B.LvsP.REACTOME_INTERLEUKIN_2_SIGNALING"
67,"Down",0.0381991338437686,0.203471108884582,"B.LvsP.KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_DN"
167,"Down",0.0383096682765764,0.203597832533645,"B.LvsP.SANA_TNF_SIGNALING_UP"
63,"Down",0.0383263486855071,0.203597832533645,"B.LvsP.HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_DN"
50,"Down",0.0383333954905995,0.203597832533645,"B.LvsP.LOPEZ_TRANSLATION_VIA_FN1_SIGNALING"
61,"Down",0.0383870528280609,0.203687154593425,"B.LvsP.REACTOME_FORMATION_OF_TC_NER_PRE_INCISION_COMPLEX"
6,"Up",0.0384953155870254,0.204065771697664,"B.LvsP.REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_TO_LIMIT_CHOLESTEROL_UPTAKE"
63,"Up",0.0385734078159896,0.204283881048474,"B.LvsP.AMIT_EGF_RESPONSE_40_HELA"
240,"Down",0.0387072019984327,0.204796286937162,"B.LvsP.REACTOME_MITOTIC_PROMETAPHASE"
318,"Down",0.03885920835508,0.205212528352729,"B.LvsP.ALONSO_METASTASIS_UP"
120,"Up",0.0388601043923508,0.205212528352729,"B.LvsP.REACTOME_COPI_MEDIATED_ANTEROGRADE_TRANSPORT"
165,"Down",0.0389313553877114,0.205225233399411,"B.LvsP.BHATTACHARYA_EMBRYONIC_STEM_CELL"
78,"Down",0.0389598750108105,0.205225233399411,"B.LvsP.REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS"
867,"Up",0.0389738641832848,0.205225233399411,"B.LvsP.PARENT_MTOR_SIGNALING_UP"
9,"Down",0.0390332618299029,0.205342440206977,"B.LvsP.REACTOME_MODULATION_BY_MTB_OF_HOST_IMMUNE_SYSTEM"
328,"Down",0.0391207427332606,0.205607021456462,"B.LvsP.BOYLAN_MULTIPLE_MYELOMA_PCA1_UP"
39,"Down",0.0391974102148993,0.205814322011565,"B.LvsP.PID_INTEGRIN2_PATHWAY"
126,"Down",0.0392984195612928,0.206148920070577,"B.LvsP.REACTOME_NUCLEOTIDE_EXCISION_REPAIR"
232,"Up",0.0394898955120002,0.206956997427345,"B.LvsP.BROWNE_HCMV_INFECTION_12HR_UP"
30,"Down",0.039631703159035,0.20750349125597,"B.LvsP.KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_UP"
405,"Up",0.0398258558734772,0.208322759815,"B.LvsP.IVANOVA_HEMATOPOIESIS_STEM_CELL_LONG_TERM"
190,"Down",0.03992491932526,0.208643552882195,"B.LvsP.KIM_ALL_DISORDERS_DURATION_CORR_DN"
135,"Down",0.0399985769511273,0.208831097226424,"B.LvsP.LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP"
12,"Up",0.0403150459461432,0.209693243260104,"B.LvsP.REACTOME_NF_KB_ACTIVATION_THROUGH_FADD_RIP_1_PATHWAY_MEDIATED_BY_CASPASE_8_AND_10"
222,"Up",0.0403230132330732,0.209693243260104,"B.LvsP.IKEDA_MIR30_TARGETS_UP"
209,"Down",0.0403642910568803,0.209693243260104,"B.LvsP.LANDIS_ERBB2_BREAST_TUMORS_324_UP"
10,"Up",0.0403684885391973,0.209693243260104,"B.LvsP.REACTOME_BETA_OXIDATION_OF_PRISTANOYL_COA"
180,"Down",0.0403790550276278,0.209693243260104,"B.LvsP.WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_UP"
46,"Up",0.0403912649795642,0.209693243260104,"B.LvsP.SAKAI_TUMOR_INFILTRATING_MONOCYTES_UP"
73,"Down",0.0405331423199306,0.210125748358196,"B.LvsP.SHIN_B_CELL_LYMPHOMA_CLUSTER_8"
119,"Down",0.0405505830164939,0.210125748358196,"B.LvsP.GALINDO_IMMUNE_RESPONSE_TO_ENTEROTOXIN"
477,"Down",0.0406675474277945,0.210379561342738,"B.LvsP.SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP"
10,"Down",0.0406756648716562,0.210379561342738,"B.LvsP.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_21"
104,"Up",0.0407816642186951,0.21073067426651,"B.LvsP.FIGUEROA_AML_METHYLATION_CLUSTER_1_DN"
43,"Up",0.0408998937194691,0.211144269257651,"B.LvsP.REACTOME_DISASSEMBLY_OF_THE_DESTRUCTION_COMPLEX_AND_RECRUITMENT_OF_AXIN_TO_THE_MEMBRANE"
162,"Down",0.0411222361725799,0.212084697173632,"B.LvsP.BASSO_CD40_SIGNALING_UP"
122,"Up",0.0411691046311658,0.212084697173632,"B.LvsP.BOYLAN_MULTIPLE_MYELOMA_D_DN"
41,"Down",0.0411971359675313,0.212084697173632,"B.LvsP.REACTOME_INFECTION_WITH_MYCOBACTERIUM_TUBERCULOSIS"
268,"Down",0.0412580814138315,0.212200867104255,"B.LvsP.DARWICHE_PAPILLOMA_RISK_LOW_UP"
17,"Down",0.0414408455694185,0.212942783599735,"B.LvsP.BIOCARTA_MONOCYTE_PATHWAY"
320,"Down",0.0416498581570746,0.213795196833151,"B.LvsP.KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION"
15,"Up",0.0416840698473751,0.213795196833151,"B.LvsP.REACTOME_KERATAN_SULFATE_DEGRADATION"
121,"Down",0.0418418060264766,0.214405324856709,"B.LvsP.REACTOME_UNFOLDED_PROTEIN_RESPONSE_UPR"
71,"Down",0.0419360730774444,0.214689396338139,"B.LvsP.REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES"
26,"Up",0.0419847998745764,0.214739969090217,"B.LvsP.BIOCARTA_MEF2D_PATHWAY"
33,"Up",0.0420236293281994,0.214739969090217,"B.LvsP.HOWLIN_CITED1_TARGETS_2_UP"
284,"Down",0.0420935836568756,0.214898821827207,"B.LvsP.ANDERSEN_CHOLANGIOCARCINOMA_CLASS2"
142,"Down",0.0422887271933516,0.215606355033794,"B.LvsP.MAHAJAN_RESPONSE_TO_IL1A_UP"
33,"Down",0.0423101637206848,0.215606355033794,"B.LvsP.KIM_LIVER_CANCER_POOR_SURVIVAL_UP"
37,"Down",0.0429830285412839,0.218809147111016,"B.LvsP.REACTOME_DECTIN_2_FAMILY"
27,"Up",0.0430466802412765,0.218809147111016,"B.LvsP.FOURNIER_ACINAR_DEVELOPMENT_EARLY_UP"
81,"Down",0.0430573977313774,0.218809147111016,"B.LvsP.KEGG_AUTOIMMUNE_THYROID_DISEASE"
126,"Down",0.0432237160477359,0.219340298036143,"B.LvsP.NADERI_BREAST_CANCER_PROGNOSIS_UP"
13,"Up",0.0432616108680379,0.219340298036143,"B.LvsP.PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_5"
165,"Up",0.0433153925293744,0.219340298036143,"B.LvsP.HATADA_METHYLATED_IN_LUNG_CANCER_DN"
214,"Down",0.0433206014569484,0.219340298036143,"B.LvsP.FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP"
56,"Up",0.0435490162357574,0.220295069320679,"B.LvsP.HUMMERICH_MALIGNANT_SKIN_TUMOR_DN"
37,"Up",0.0436377194138674,0.220542002412498,"B.LvsP.WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_36HR"
48,"Up",0.043783520058792,0.221076787584531,"B.LvsP.BONOME_OVARIAN_CANCER_POOR_SURVIVAL_UP"
19,"Down",0.043906105393193,0.221493482407814,"B.LvsP.REACTOME_TRISTETRAPROLIN_TTP_ZFP36_BINDS_AND_DESTABILIZES_MRNA"
11,"Down",0.0440041051373985,0.221785503468255,"B.LvsP.BIOCARTA_SKP2E2F_PATHWAY"
87,"Down",0.0441308599072814,0.222221789095955,"B.LvsP.CAVARD_LIVER_CANCER_MALIGNANT_VS_BENIGN"
31,"Up",0.0442279889162974,0.222508235412383,"B.LvsP.REACTOME_MISCELLANEOUS_TRANSPORT_AND_BINDING_EVENTS"
12,"Down",0.0443369669582027,0.222853718465366,"B.LvsP.BIOCARTA_GABA_PATHWAY"
48,"Down",0.0446001723085113,0.223973072383069,"B.LvsP.VIETOR_IFRD1_TARGETS"
36,"Up",0.0446973737272158,0.224257513010686,"B.LvsP.REACTOME_NEPHRIN_FAMILY_INTERACTIONS"
81,"Up",0.0448455209700879,0.224796813638818,"B.LvsP.SESTO_RESPONSE_TO_UV_C5"
6,"Down",0.0449085187085192,0.224908695597285,"B.LvsP.REACTOME_VLDL_ASSEMBLY"
752,"Up",0.0450954722115574,0.225640602586155,"B.LvsP.REACTOME_MEMBRANE_TRAFFICKING"
33,"Down",0.0454580701274757,0.227249249308149,"B.LvsP.KIM_HYPOXIA"
168,"Up",0.04578242292373,0.228663971404971,"B.LvsP.REACTOME_DEATH_RECEPTOR_SIGNALLING"
5,"Up",0.0459819934349939,0.229453467240146,"B.LvsP.TURJANSKI_MAPK11_TARGETS"
99,"Down",0.0463219248447815,0.230941318725696,"B.LvsP.NUTT_GBM_VS_AO_GLIOMA_UP"
27,"Up",0.0463958861498279,0.2311016707409,"B.LvsP.REACTOME_SIGNALING_BY_NTRK3_TRKC"
44,"Down",0.0464787934548823,0.231215283608488,"B.LvsP.LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_UP"
9,"Down",0.0465131253512154,0.231215283608488,"B.LvsP.REACTOME_DEFECTIVE_CHSY1_CAUSES_TPBS"
155,"Down",0.0465441509597119,0.231215283608488,"B.LvsP.ALCALA_APOPTOSIS"
132,"Down",0.0466375039210876,0.231274367572715,"B.LvsP.REACTOME_SIGNALING_BY_TGF_BETA_FAMILY_MEMBERS"
61,"Up",0.0466397033538754,0.231274367572715,"B.LvsP.PID_THROMBIN_PAR1_PATHWAY"
8,"Down",0.0467371261663199,0.231549794420773,"B.LvsP.ZIRN_TRETINOIN_RESPONSE_DN"
31,"Up",0.0468037973276089,0.231593004574215,"B.LvsP.PID_S1P_META_PATHWAY"
59,"Down",0.0468296218328762,0.231593004574215,"B.LvsP.YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_5"
93,"Up",0.0469344018996908,0.231903760592842,"B.LvsP.KEGG_PEROXISOME"
23,"Up",0.0470666801626959,0.232349709481737,"B.LvsP.REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_CELL_CYCLE_GENES"
232,"Down",0.0471857975259648,0.232729950509419,"B.LvsP.SMITH_TERT_TARGETS_UP"
13,"Up",0.047536775322004,0.234252077322068,"B.LvsP.REACTOME_MUCOPOLYSACCHARIDOSES"
86,"Down",0.0475946838448357,0.234284011439258,"B.LvsP.ZAMORA_NOS2_TARGETS_UP"
44,"Up",0.0476649593573228,0.234284011439258,"B.LvsP.DING_LUNG_CANCER_BY_MUTATION_RATE"
48,"Down",0.0476703767171577,0.234284011439258,"B.LvsP.AIGNER_ZEB1_TARGETS"
35,"Up",0.0477868991024422,0.234572306214553,"B.LvsP.HOFMANN_MYELODYSPLASTIC_SYNDROM_HIGH_RISK_DN"
23,"Down",0.0478223392492352,0.234572306214553,"B.LvsP.BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER"
31,"Up",0.0478563142358501,0.234572306214553,"B.LvsP.PID_WNT_CANONICAL_PATHWAY"
50,"Up",0.0482075981383621,0.236084862805141,"B.LvsP.REACTOME_SPHINGOLIPID_DE_NOVO_BIOSYNTHESIS"
47,"Down",0.0483192851095856,0.236370411541208,"B.LvsP.KEGG_PRIMARY_IMMUNODEFICIENCY"
46,"Down",0.0483545247150928,0.236370411541208,"B.LvsP.REACTOME_SYNTHESIS_OF_ACTIVE_UBIQUITIN_ROLES_OF_E1_AND_E2_ENZYMES"
28,"Down",0.0483941591363081,0.236370411541208,"B.LvsP.KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_HEPARAN_SULFATE"
7,"Down",0.0485559348115557,0.236951247637327,"B.LvsP.REACTOME_SUMO_IS_TRANSFERRED_FROM_E1_TO_E2_UBE2I_UBC9"
829,"Up",0.048627031762451,0.237088940577241,"B.LvsP.LIU_PROSTATE_CANCER_DN"
16,"Up",0.0487004286501242,0.237237594719416,"B.LvsP.REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_CELL_DEATH_GENES"
60,"Up",0.0492488959073517,0.239698191436397,"B.LvsP.BIOCARTA_FCER1_PATHWAY"
914,"Down",0.0494407889873934,0.24042051214714,"B.LvsP.BENPORATH_CYCLING_GENES"
112,"Up",0.0494903291476091,0.240449938363032,"B.LvsP.ASGHARZADEH_NEUROBLASTOMA_POOR_SURVIVAL_DN"
25,"Down",0.0501239498477107,0.243314590612812,"B.LvsP.BIOCARTA_ETS_PATHWAY"
27,"Down",0.0502136837397061,0.243466014712864,"B.LvsP.VANDESLUIS_COMMD1_TARGETS_GROUP_2_UP"
251,"Down",0.0502432126582344,0.243466014712864,"B.LvsP.GROSS_HYPOXIA_VIA_ELK3_DN"
330,"Up",0.0502929108822226,0.243493436311566,"B.LvsP.SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4"
33,"Down",0.0504004236298385,0.243800474408904,"B.LvsP.KORKOLA_YOLK_SAC_TUMOR_UP"
80,"Down",0.0505877405624333,0.244492672700781,"B.LvsP.GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_UP"
43,"Up",0.050952195563348,0.245956437548711,"B.LvsP.VALK_AML_WITH_EVI1"
40,"Down",0.050979576312321,0.245956437548711,"B.LvsP.SHIN_B_CELL_LYMPHOMA_CLUSTER_2"
50,"Down",0.0511579186863279,0.246601684757373,"B.LvsP.ONO_FOXP3_TARGETS_DN"
182,"Down",0.0512291822530814,0.246730094666627,"B.LvsP.EPPERT_PROGENITOR"
203,"Down",0.0513260865042036,0.246981664300907,"B.LvsP.REACTOME_PROTEIN_LOCALIZATION"
248,"Up",0.0515370757403054,0.247572021056501,"B.LvsP.CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN"
54,"Up",0.0515658255688432,0.247572021056501,"B.LvsP.RIZ_ERYTHROID_DIFFERENTIATION_12HR"
12,"Down",0.0516052536917087,0.247572021056501,"B.LvsP.OHM_EMBRYONIC_CARCINOMA_UP"
17,"Down",0.0516278785093409,0.247572021056501,"B.LvsP.TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_MONOCYTE_DN"
14,"Up",0.0521386724787284,0.24933013704105,"B.LvsP.REACTOME_REDUCTION_OF_CYTOSOLIC_CA_LEVELS"
17,"Down",0.0521532970270137,0.24933013704105,"B.LvsP.PID_CIRCADIAN_PATHWAY"
94,"Down",0.0521627340236196,0.24933013704105,"B.LvsP.MCDOWELL_ACUTE_LUNG_INJURY_UP"
28,"Down",0.0521894156050557,0.24933013704105,"B.LvsP.OSAWA_TNF_TARGETS"
52,"Down",0.0522687938637979,0.24933013704105,"B.LvsP.REACTOME_FORMATION_OF_FIBRIN_CLOT_CLOTTING_CASCADE"
645,"Up",0.0523235007486258,0.24933013704105,"B.LvsP.MONNIER_POSTRADIATION_TUMOR_ESCAPE_DN"
29,"Up",0.0523383124995288,0.24933013704105,"B.LvsP.REACTOME_ACTIVATION_OF_AMPK_DOWNSTREAM_OF_NMDARS"
93,"Down",0.0523552702305406,0.24933013704105,"B.LvsP.KRASNOSELSKAYA_ILF3_TARGETS_DN"
16,"Down",0.0525172762536725,0.249791881819991,"B.LvsP.CHESLER_BRAIN_D6MIT150_QTL_TRANS"
59,"Down",0.0525425861017634,0.249791881819991,"B.LvsP.AMIT_EGF_RESPONSE_480_MCF10A"
54,"Down",0.052654442994776,0.250058280794627,"B.LvsP.FARMER_BREAST_CANCER_CLUSTER_4"
26,"Down",0.0526890752623875,0.250058280794627,"B.LvsP.BIOCARTA_LAIR_PATHWAY"
256,"Up",0.0527921690832414,0.250234957888162,"B.LvsP.BROWNE_HCMV_INFECTION_6HR_DN"
15,"Down",0.0528365638840048,0.250234957888162,"B.LvsP.BIOCARTA_ERYTH_PATHWAY"
31,"Up",0.0528878222923713,0.250234957888162,"B.LvsP.TIAN_TNF_SIGNALING_NOT_VIA_NFKB"
64,"Down",0.0529899665727157,0.250234957888162,"B.LvsP.RIZ_ERYTHROID_DIFFERENTIATION_CCNE1"
13,"Down",0.0529953038698227,0.250234957888162,"B.LvsP.REACTOME_ALPHA_PROTEIN_KINASE_1_SIGNALING_PATHWAY"
83,"Up",0.0530197653560402,0.250234957888162,"B.LvsP.REACTOME_CA2_PATHWAY"
78,"Down",0.0530574943074654,0.250234957888162,"B.LvsP.VILIMAS_NOTCH1_TARGETS_UP"
36,"Down",0.0531559595464632,0.250234957888162,"B.LvsP.REACTOME_HIV_ELONGATION_ARREST_AND_RECOVERY"
92,"Down",0.0531733130767565,0.250234957888162,"B.LvsP.REACTOME_RMTS_METHYLATE_HISTONE_ARGININES"
32,"Up",0.0532031596020907,0.250234957888162,"B.LvsP.DORN_ADENOVIRUS_INFECTION_48HR_UP"
50,"Up",0.0532699417232804,0.250234957888162,"B.LvsP.BRACHAT_RESPONSE_TO_CISPLATIN"
33,"Down",0.0533127027943412,0.250234957888162,"B.LvsP.OZEN_MIR125B1_TARGETS"
9,"Up",0.0533146645672373,0.250234957888162,"B.LvsP.REACTOME_SYNTHESIS_OF_PG"
405,"Up",0.053524102870733,0.251004889543921,"B.LvsP.WANG_CLIM2_TARGETS_UP"
34,"Down",0.053626749256812,0.251092078426262,"B.LvsP.CREIGHTON_AKT1_SIGNALING_VIA_MTOR_DN"
22,"Down",0.0537037111342077,0.251092078426262,"B.LvsP.KYNG_WERNER_SYNDROM_UP"
15,"Up",0.0537547058939963,0.251092078426262,"B.LvsP.MIKKELSEN_PARTIALLY_REPROGRAMMED_TO_PLURIPOTENCY"
98,"Down",0.0537683734124489,0.251092078426262,"B.LvsP.SLEBOS_HEAD_AND_NECK_CANCER_WITH_HPV_UP"
564,"Down",0.053769763222408,0.251092078426262,"B.LvsP.COLINA_TARGETS_OF_4EBP1_AND_4EBP2"
77,"Up",0.0540388350804278,0.251892040030642,"B.LvsP.ASTON_MAJOR_DEPRESSIVE_DISORDER_UP"
51,"Up",0.0540761420630335,0.251892040030642,"B.LvsP.BIOCARTA_AGR_PATHWAY"
86,"Up",0.0540777448935381,0.251892040030642,"B.LvsP.KENNY_CTNNB1_TARGETS_DN"
51,"Up",0.0541754882283009,0.251982018028021,"B.LvsP.BIOCARTA_BCR_PATHWAY"
11,"Down",0.0541882111476428,0.251982018028021,"B.LvsP.REACTOME_SYNTHESIS_OF_LIPOXINS_LX"
19,"Up",0.0543105990983728,0.25225377981871,"B.LvsP.LIU_CDX2_TARGETS_DN"
30,"Down",0.0543379004818382,0.25225377981871,"B.LvsP.RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_DN"
13,"Down",0.0544463234020636,0.252449490065996,"B.LvsP.REACTOME_BINDING_OF_TCF_LEF_CTNNB1_TO_TARGET_GENE_PROMOTERS"
19,"Down",0.0545009270361143,0.252449490065996,"B.LvsP.REACTOME_INTERLEUKIN_15_SIGNALING"
41,"Up",0.0545170358362813,0.252449490065996,"B.LvsP.REACTOME_GLYCOSPHINGOLIPID_METABOLISM"
191,"Down",0.0547196496464576,0.253175684431183,"B.LvsP.BOYLAN_MULTIPLE_MYELOMA_C_D_UP"
5,"Down",0.0548579838576223,0.253236658626601,"B.LvsP.REACTOME_EXTRINSIC_PATHWAY_OF_FIBRIN_CLOT_FORMATION"
18,"Down",0.0548580539708909,0.253236658626601,"B.LvsP.MARIADASON_RESPONSE_TO_CURCUMIN_SULINDAC_7"
36,"Down",0.0548702327789234,0.253236658626601,"B.LvsP.GROSS_HIF1A_TARGETS_DN"
100,"Up",0.0549257508315908,0.253278321951987,"B.LvsP.REACTOME_G_ALPHA_12_13_SIGNALLING_EVENTS"
9,"Down",0.0549708783400949,0.253278321951987,"B.LvsP.GLINSKY_CANCER_DEATH_UP"
1255,"Up",0.0551054832800777,0.253687108289383,"B.LvsP.DACOSTA_UV_RESPONSE_VIA_ERCC3_DN"
16,"Down",0.0551738714397211,0.253790628278052,"B.LvsP.GAUSSMANN_MLL_AF4_FUSION_TARGETS_D_DN"
59,"Down",0.0552530397276113,0.253943521740618,"B.LvsP.CAFFAREL_RESPONSE_TO_THC_24HR_5_UP"
15,"Down",0.0553838951310827,0.254333518421724,"B.LvsP.BIOCARTA_IL17_PATHWAY"
88,"Down",0.0554750733495221,0.254406246775788,"B.LvsP.DORN_ADENOVIRUS_INFECTION_12HR_DN"
16,"Down",0.0555388442040691,0.254406246775788,"B.LvsP.SHANK_TAL1_TARGETS_DN"
31,"Up",0.0556427255689074,0.254406246775788,"B.LvsP.HASLINGER_B_CLL_WITH_17P13_DELETION"
11,"Down",0.0556479033902837,0.254406246775788,"B.LvsP.REACTOME_RUNX3_REGULATES_YAP1_MEDIATED_TRANSCRIPTION"
6,"Up",0.0556794586150629,0.254406246775788,"B.LvsP.REACTOME_SYNTHESIS_OF_WYBUTOSINE_AT_G37_OF_TRNA_PHE"
46,"Down",0.0556864195865363,0.254406246775788,"B.LvsP.REACTOME_MITOCHONDRIAL_FATTY_ACID_BETA_OXIDATION"
420,"Down",0.0558856053734655,0.254406246775788,"B.LvsP.NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP"
57,"Up",0.0559512430402205,0.254406246775788,"B.LvsP.PID_INSULIN_PATHWAY"
50,"Up",0.0559805263747681,0.254406246775788,"B.LvsP.ABBUD_LIF_SIGNALING_1_DN"
32,"Up",0.055991534599102,0.254406246775788,"B.LvsP.BIOCARTA_PAR1_PATHWAY"
10,"Down",0.056010937812044,0.254406246775788,"B.LvsP.BYSTRYKH_HEMATOPOIESIS_STEM_CELL_FGF3"
746,"Up",0.0560184128328867,0.254406246775788,"B.LvsP.MITSIADES_RESPONSE_TO_APLIDIN_UP"
11,"Down",0.0560202885466764,0.254406246775788,"B.LvsP.ZHU_SKIL_TARGETS_DN"
402,"Down",0.0561734264934109,0.254406246775788,"B.LvsP.WANG_CISPLATIN_RESPONSE_AND_XPC_UP"
144,"Up",0.0561841962778031,0.254406246775788,"B.LvsP.DUTERTRE_ESTRADIOL_RESPONSE_6HR_DN"
18,"Down",0.0562030023191654,0.254406246775788,"B.LvsP.BIOCARTA_TCRA_PATHWAY"
195,"Up",0.0562471904781402,0.254406246775788,"B.LvsP.REACTOME_ION_CHANNEL_TRANSPORT"
478,"Down",0.0562493440659602,0.254406246775788,"B.LvsP.DAZARD_RESPONSE_TO_UV_NHEK_UP"
32,"Up",0.0562739807934144,0.254406246775788,"B.LvsP.BIOCARTA_VIP_PATHWAY"
14,"Down",0.0564578472834847,0.255028952312408,"B.LvsP.FUJIWARA_PARK2_HEPATOCYTE_PROLIFERATION_DN"
92,"Up",0.0565165446452688,0.255085694158115,"B.LvsP.NIKOLSKY_BREAST_CANCER_8P12_P11_AMPLICON"
75,"Down",0.0566583234648055,0.255276075651778,"B.LvsP.CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN"
25,"Down",0.0566805291224187,0.255276075651778,"B.LvsP.BIOCARTA_CELLCYCLE_PATHWAY"
147,"Up",0.0566972365527914,0.255276075651778,"B.LvsP.RODRIGUES_THYROID_CARCINOMA_DN"
493,"Up",0.0569600069159665,0.256250511178502,"B.LvsP.CHANDRAN_METASTASIS_DN"
124,"Down",0.0570479293227286,0.256437399370216,"B.LvsP.MCBRYAN_PUBERTAL_BREAST_6_7WK_DN"
7,"Up",0.0571398058187658,0.256606849047172,"B.LvsP.REACTOME_SULFIDE_OXIDATION_TO_SULFATE"
983,"Up",0.057256848137613,0.256606849047172,"B.LvsP.HAMAI_APOPTOSIS_VIA_TRAIL_UP"
33,"Up",0.0572599257627507,0.256606849047172,"B.LvsP.REACTOME_BMAL1_CLOCK_NPAS2_ACTIVATES_CIRCADIAN_GENE_EXPRESSION"
99,"Down",0.0573960235959714,0.256606849047172,"B.LvsP.LEE_TARGETS_OF_PTCH1_AND_SUFU_UP"
13,"Up",0.057399947065728,0.256606849047172,"B.LvsP.REACTOME_RECEPTOR_MEDIATED_MITOPHAGY"
162,"Up",0.0574089484678916,0.256606849047172,"B.LvsP.ZHAN_MULTIPLE_MYELOMA_UP"
8,"Up",0.0574105032142073,0.256606849047172,"B.LvsP.KIM_PTEN_TARGETS_DN"
30,"Up",0.057530361736138,0.256641182907796,"B.LvsP.PID_TRAIL_PATHWAY"
78,"Down",0.0575457649359717,0.256641182907796,"B.LvsP.HANN_RESISTANCE_TO_BCL2_INHIBITOR_DN"
63,"Down",0.0575574365718334,0.256641182907796,"B.LvsP.BENPORATH_ES_2"
66,"Up",0.0576338278336793,0.256765054381167,"B.LvsP.LUI_THYROID_CANCER_CLUSTER_2"
36,"Up",0.0576780968604467,0.256765054381167,"B.LvsP.REACTOME_COBALAMIN_CBL_VITAMIN_B12_TRANSPORT_AND_METABOLISM"
6,"Up",0.0579147798656734,0.257611277455598,"B.LvsP.BIOCARTA_BOTULIN_PATHWAY"
76,"Down",0.0579906002067265,0.257691644172615,"B.LvsP.CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_UP"
72,"Down",0.0580260620356132,0.257691644172615,"B.LvsP.DORSEY_GAB2_TARGETS"
60,"Down",0.0581094608570207,0.25780217469001,"B.LvsP.NOUSHMEHR_GBM_SILENCED_BY_METHYLATION"
43,"Up",0.0581746757703477,0.25780217469001,"B.LvsP.WENDT_COHESIN_TARGETS_UP"
113,"Up",0.0581908327026826,0.25780217469001,"B.LvsP.LEIN_OLIGODENDROCYTE_MARKERS"
12,"Down",0.0584385548607169,0.25867621496458,"B.LvsP.GROSS_HIF1A_TARGETS_UP"
80,"Down",0.0584816908492901,0.25867621496458,"B.LvsP.ELVIDGE_HYPOXIA_BY_DMOG_DN"
10,"Up",0.0585575229060961,0.258687556704511,"B.LvsP.BIOCARTA_S1P_PATHWAY"
112,"Down",0.0585778298053985,0.258687556704511,"B.LvsP.PID_E2F_PATHWAY"
23,"Up",0.0590611919153846,0.260588948034543,"B.LvsP.GOUYER_TATI_TARGETS_DN"
27,"Down",0.0591026480078345,0.260588948034543,"B.LvsP.KORKOLA_TERATOMA_UP"
52,"Down",0.0591977221309683,0.260800163874202,"B.LvsP.REACTOME_CYCLIN_D_ASSOCIATED_EVENTS_IN_G1"
31,"Down",0.0592757337863497,0.260935933204401,"B.LvsP.SASAI_TARGETS_OF_CXCR6_AND_PTCH1_UP"
104,"Down",0.0596461878184828,0.262357814199198,"B.LvsP.CHIBA_RESPONSE_TO_TSA_UP"
18,"Up",0.0599178522368155,0.2633432472316,"B.LvsP.BIOCARTA_PCAF_PATHWAY"
12,"Up",0.0601882143075872,0.264321395477879,"B.LvsP.REACTOME_ACTIVATION_OF_THE_AP_1_FAMILY_OF_TRANSCRIPTION_FACTORS"
45,"Down",0.060266833506727,0.264344519099654,"B.LvsP.REACTOME_AMINE_LIGAND_BINDING_RECEPTORS"
13,"Up",0.0602891008472894,0.264344519099654,"B.LvsP.KOBAYASHI_EGFR_SIGNALING_6HR_UP"
6,"Down",0.0603573579108546,0.264434098168871,"B.LvsP.REACTOME_BETA_OXIDATION_OF_DECANOYL_COA_TO_OCTANOYL_COA_COA"
23,"Up",0.0605098061223495,0.264892096635369,"B.LvsP.REACTOME_SYNAPTIC_ADHESION_LIKE_MOLECULES"
82,"Up",0.0606330306933885,0.265221540113722,"B.LvsP.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_DN"
15,"Up",0.0606836802274984,0.265233255318449,"B.LvsP.MCCABE_HOXC6_TARGETS_UP"
27,"Down",0.0608036933397958,0.265547883472141,"B.LvsP.REACTOME_CELLULAR_HEXOSE_TRANSPORT"
6,"Down",0.0609188231055575,0.265840704775554,"B.LvsP.REACTOME_MET_INTERACTS_WITH_TNS_PROTEINS"
38,"Down",0.0610560441043188,0.266020272928873,"B.LvsP.MATTIOLI_MULTIPLE_MYELOMA_SUBGROUPS"
249,"Down",0.0610561993754277,0.266020272928873,"B.LvsP.IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_UP"
21,"Down",0.0611464288234515,0.266203625956585,"B.LvsP.BIOCARTA_TH1TH2_PATHWAY"
23,"Down",0.0616995953680817,0.26840052147138,"B.LvsP.MARKS_HDAC_TARGETS_DN"
50,"Up",0.0620879709677254,0.269877666258297,"B.LvsP.BOWIE_RESPONSE_TO_TAMOXIFEN"
90,"Up",0.0622281734891857,0.270274604259001,"B.LvsP.REACTOME_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE"
5,"Down",0.0623824725476673,0.270587014078696,"B.LvsP.REACTOME_PTK6_REGULATES_PROTEINS_INVOLVED_IN_RNA_PROCESSING"
363,"Down",0.0624053354246341,0.270587014078696,"B.LvsP.OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP"
34,"Up",0.0624569408993037,0.270587014078696,"B.LvsP.REACTOME_INSULIN_PROCESSING"
9,"Down",0.062495861273014,0.270587014078696,"B.LvsP.REACTOME_INTERLEUKIN_1_PROCESSING"
361,"Up",0.0626292335647227,0.270952294506535,"B.LvsP.REACTOME_ORGANELLE_BIOGENESIS_AND_MAINTENANCE"
88,"Down",0.0628611059234929,0.271742810516804,"B.LvsP.ZHANG_PROLIFERATING_VS_QUIESCENT"
27,"Up",0.062987655751078,0.271877154070931,"B.LvsP.REACTOME_ADP_SIGNALLING_THROUGH_P2Y_PURINOCEPTOR_1"
57,"Up",0.0629905289138836,0.271877154070931,"B.LvsP.WENG_POR_TARGETS_GLOBAL_UP"
52,"Down",0.0631513639494765,0.272358729544973,"B.LvsP.HUNSBERGER_EXERCISE_REGULATED_GENES"
75,"Down",0.0632496410300579,0.272569965124856,"B.LvsP.JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP"
202,"Up",0.0633461271647707,0.272773159730543,"B.LvsP.BROWNE_HCMV_INFECTION_20HR_DN"
136,"Down",0.0634504674002504,0.273009832105824,"B.LvsP.GHANDHI_DIRECT_IRRADIATION_UP"
945,"Down",0.0637968930752376,0.274286953198281,"B.LvsP.KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_UP"
32,"Down",0.0641869332495495,0.275749459158321,"B.LvsP.SCHMIDT_POR_TARGETS_IN_LIMB_BUD_DN"
31,"Up",0.0643074987650483,0.275900065383268,"B.LvsP.REACTOME_RECYCLING_OF_BILE_ACIDS_AND_SALTS"
89,"Up",0.0643253503716238,0.275900065383268,"B.LvsP.REACTOME_SIGNALING_BY_INSULIN_RECEPTOR"
65,"Down",0.0644006389260175,0.275900065383268,"B.LvsP.SMID_BREAST_CANCER_RELAPSE_IN_PLEURA_DN"
346,"Down",0.0644215924054619,0.275900065383268,"B.LvsP.TIEN_INTESTINE_PROBIOTICS_24HR_DN"
19,"Down",0.0647306654831029,0.277000897144194,"B.LvsP.REACTOME_RNA_POLYMERASE_III_CHAIN_ELONGATION"
23,"Up",0.0647788316164664,0.277000897144194,"B.LvsP.CHEN_HOXA5_TARGETS_6HR_UP"
17,"Up",0.0650143713079144,0.277623976488779,"B.LvsP.REACTOME_NOTCH4_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS"
150,"Up",0.0650249682678548,0.277623976488779,"B.LvsP.DING_LUNG_CANCER_EXPRESSION_BY_COPY_NUMBER"
10,"Down",0.065289909845228,0.278540055196193,"B.LvsP.REACTOME_SYNTHESIS_OF_12_EICOSATETRAENOIC_ACID_DERIVATIVES"
69,"Down",0.0656006914471762,0.279650133393552,"B.LvsP.PRAMOONJAGO_SOX4_TARGETS_UP"
21,"Down",0.0657119794630287,0.279908732242747,"B.LvsP.KUROKAWA_LIVER_CANCER_EARLY_RECURRENCE_UP"
183,"Down",0.0661218334760204,0.2814377346335,"B.LvsP.FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP"
204,"Down",0.0661938109297199,0.281474941602029,"B.LvsP.GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_UP"
46,"Up",0.066232392661284,0.281474941602029,"B.LvsP.PID_RAC1_REG_PATHWAY"
14,"Up",0.0664699058640714,0.282267365224617,"B.LvsP.BRUNEAU_HEART_GREAT_VESSELS_AND_VALVULOGENESIS"
2398,"Up",0.0666713965787148,0.28290571886701,"B.LvsP.DODD_NASOPHARYNGEAL_CARCINOMA_UP"
18,"Up",0.0667984551310105,0.283227498787851,"B.LvsP.JIANG_CORE_DUPLICON_GENES"
167,"Down",0.066854627237811,0.283248455170772,"B.LvsP.REACTOME_MITOTIC_PROPHASE"
19,"Up",0.0669146452159775,0.28325555634711,"B.LvsP.BIOCARTA_SHH_PATHWAY"
61,"Down",0.0669587650833195,0.28325555634711,"B.LvsP.GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP"
151,"Up",0.0670135901330263,0.283270749117357,"B.LvsP.SMITH_TERT_TARGETS_DN"
71,"Down",0.0672837010095636,0.284195250482717,"B.LvsP.MCBRYAN_PUBERTAL_BREAST_3_4WK_DN"
89,"Down",0.0675465168999208,0.284957862235969,"B.LvsP.REACTOME_DEPOSITION_OF_NEW_CENPA_CONTAINING_NUCLEOSOMES_AT_THE_CENTROMERE"
39,"Down",0.0676130882808046,0.284957862235969,"B.LvsP.REACTOME_RESOLUTION_OF_ABASIC_SITES_AP_SITES"
246,"Down",0.0676188669295698,0.284957862235969,"B.LvsP.SASAKI_ADULT_T_CELL_LEUKEMIA"
252,"Up",0.0680697151142543,0.286639341101837,"B.LvsP.IWANAGA_CARCINOGENESIS_BY_KRAS_DN"
19,"Down",0.0682761468745613,0.287289814360312,"B.LvsP.MIZUKAMI_HYPOXIA_UP"
49,"Down",0.068393755152785,0.28756583440285,"B.LvsP.ONO_AML1_TARGETS_DN"
46,"Down",0.0685551242961366,0.287845216674524,"B.LvsP.YANG_BREAST_CANCER_ESR1_DN"
395,"Down",0.0686247911231578,0.287845216674524,"B.LvsP.SENESE_HDAC1_AND_HDAC2_TARGETS_UP"
218,"Up",0.0686584769210035,0.287845216674524,"B.LvsP.MCBRYAN_PUBERTAL_BREAST_5_6WK_DN"
85,"Down",0.0686684465172177,0.287845216674524,"B.LvsP.HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_DN"
137,"Up",0.0688067637118157,0.288206512547446,"B.LvsP.BECKER_TAMOXIFEN_RESISTANCE_DN"
44,"Up",0.0692500164159841,0.289843558489006,"B.LvsP.BIOCARTA_GH_PATHWAY"
23,"Down",0.0693147165084939,0.28989490739445,"B.LvsP.REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_G2_CELL_CYCLE_ARREST"
10,"Up",0.0694066269172389,0.290059894350275,"B.LvsP.REACTOME_RHO_GTPASES_ACTIVATE_RHOTEKIN_AND_RHOPHILINS"
92,"Down",0.0698344179872321,0.291530803493318,"B.LvsP.TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_UP"
237,"Down",0.0699031798870965,0.291530803493318,"B.LvsP.LENAOUR_DENDRITIC_CELL_MATURATION_DN"
13,"Up",0.0699614063485798,0.291530803493318,"B.LvsP.REACTOME_SIGNALING_BY_FGFR3_FUSIONS_IN_CANCER"
41,"Down",0.0699695019416953,0.291530803493318,"B.LvsP.KYNG_NORMAL_AGING_DN"
34,"Down",0.0700958930368778,0.291837494428386,"B.LvsP.REACTOME_TIGHT_JUNCTION_INTERACTIONS"
361,"Down",0.070547179555666,0.293495376797048,"B.LvsP.MATTIOLI_MGUS_VS_PCL"
53,"Down",0.0708792077888971,0.294654992379558,"B.LvsP.REACTOME_NEF_MEDIATES_DOWN_MODULATION_OF_CELL_SURFACE_RECEPTORS_BY_RECRUITING_THEM_TO_CLATHRIN_ADAPTERS"
412,"Down",0.0711276981756009,0.295465847643048,"B.LvsP.BHAT_ESR1_TARGETS_VIA_AKT1_UP"
34,"Up",0.0713062552007924,0.295985198952839,"B.LvsP.BIOCARTA_MAL_PATHWAY"
521,"Down",0.0714325189760357,0.296286869781321,"B.LvsP.WALLACE_PROSTATE_CANCER_RACE_UP"
73,"Down",0.0715113495407144,0.296348687557886,"B.LvsP.TAVOR_CEBPA_TARGETS_UP"
61,"Down",0.07155462070714,0.296348687557886,"B.LvsP.REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_CELL_CYCLE_GENES"
35,"Down",0.0722993366367635,0.299208856485528,"B.LvsP.PID_ALK1_PATHWAY"
12,"Down",0.0727644568994961,0.300908513236585,"B.LvsP.REACTOME_IRAK2_MEDIATED_ACTIVATION_OF_TAK1_COMPLEX"
250,"Down",0.0728855631670289,0.301184064835951,"B.LvsP.DARWICHE_SQUAMOUS_CELL_CARCINOMA_UP"
6,"Down",0.0730563609531738,0.301664391120312,"B.LvsP.OHASHI_AURKA_TARGETS"
54,"Down",0.073132818624793,0.301745124854188,"B.LvsP.BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_DN"
52,"Down",0.073188471584864,0.301745124854188,"B.LvsP.REACTOME_ATTENUATION_PHASE"
19,"Down",0.0732502933328696,0.301745124854188,"B.LvsP.REACTOME_ACYL_CHAIN_REMODELLING_OF_PI"
33,"Down",0.0732942128195289,0.301745124854188,"B.LvsP.MAHADEVAN_IMATINIB_RESISTANCE_UP"
77,"Down",0.0733927031059519,0.30192578532203,"B.LvsP.TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP"
45,"Up",0.0737590020283504,0.302957433223894,"B.LvsP.REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS"
73,"Down",0.0738034888375081,0.302957433223894,"B.LvsP.ENGELMANN_CANCER_PROGENITORS_UP"
116,"Down",0.073807860834253,0.302957433223894,"B.LvsP.BURTON_ADIPOGENESIS_4"
219,"Up",0.0738812854268675,0.30303384801569,"B.LvsP.XU_GH1_EXOGENOUS_TARGETS_DN"
107,"Up",0.0743564673757242,0.30463922257002,"B.LvsP.JOHNSTONE_PARVB_TARGETS_1_DN"
59,"Up",0.0743828812569229,0.30463922257002,"B.LvsP.BRACHAT_RESPONSE_TO_METHOTREXATE_UP"
9,"Up",0.0747753751802956,0.306020021740825,"B.LvsP.REACTOME_DEFECTS_IN_BIOTIN_BTN_METABOLISM"
64,"Up",0.0749263279132485,0.306245185669589,"B.LvsP.REACTOME_CARGO_TRAFFICKING_TO_THE_PERICILIARY_MEMBRANE"
129,"Down",0.0749411713168663,0.306245185669589,"B.LvsP.JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_DN"
33,"Down",0.0751710816556064,0.30695783639132,"B.LvsP.REACTOME_PROCESSING_OF_CAPPED_INTRONLESS_PRE_MRNA"
24,"Down",0.0754511152894735,0.307827545017767,"B.LvsP.REACTOME_RNA_POLYMERASE_III_TRANSCRIPTION_TERMINATION"
33,"Down",0.0755486001983208,0.307827545017767,"B.LvsP.REACTOME_RESOLUTION_OF_D_LOOP_STRUCTURES"
240,"Down",0.0755510903579509,0.307827545017767,"B.LvsP.GARCIA_TARGETS_OF_FLI1_AND_DAX1_DN"
6,"Up",0.0756698887316013,0.307885671449483,"B.LvsP.REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_LINKED_TO_TRIGLYCERIDE_LIPOLYSIS_IN_ADIPOSE"
30,"Up",0.0756767277084187,0.307885671449483,"B.LvsP.REACTOME_KERATAN_SULFATE_BIOSYNTHESIS"
789,"Up",0.0758477588432765,0.30826037144113,"B.LvsP.DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN"
79,"Down",0.0758803337911699,0.30826037144113,"B.LvsP.JOHANSSON_GLIOMAGENESIS_BY_PDGFB_UP"
75,"Down",0.0760808803969732,0.3088481554441,"B.LvsP.LEE_CALORIE_RESTRICTION_MUSCLE_DN"
388,"Down",0.0765270634487907,0.310431499492563,"B.LvsP.VERHAAK_AML_WITH_NPM1_MUTATED_UP"
86,"Down",0.0767590793079799,0.311144391124502,"B.LvsP.CUI_TCF21_TARGETS_UP"
58,"Down",0.076870316675818,0.311287650858971,"B.LvsP.COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_DN"
33,"Down",0.0769070231639274,0.311287650858971,"B.LvsP.TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_DN"
15,"Down",0.0773275271214846,0.312760715036349,"B.LvsP.GOUYER_TATI_TARGETS_UP"
31,"Down",0.0779049367359794,0.314865785974584,"B.LvsP.DEN_INTERACT_WITH_LCA5"
87,"Down",0.0780468022682089,0.315208743419231,"B.LvsP.GENTILE_UV_RESPONSE_CLUSTER_D4"
138,"Down",0.0782574008019365,0.315828590535699,"B.LvsP.WORSCHECH_TUMOR_REJECTION_UP"
60,"Up",0.0783507331344526,0.315974619620998,"B.LvsP.HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_4HR"
296,"Down",0.0787084376965263,0.316656005737782,"B.LvsP.SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP"
40,"Down",0.0787277674316946,0.316656005737782,"B.LvsP.REACTOME_NEF_MEDIATED_DOWNREGULATION_OF_MHC_CLASS_I_COMPLEX_CELL_SURFACE_EXPRESSION"
24,"Down",0.0787298250215015,0.316656005737782,"B.LvsP.SU_THYMUS"
117,"Up",0.0787487805913275,0.316656005737782,"B.LvsP.KEGG_DILATED_CARDIOMYOPATHY"
60,"Down",0.0790621940590375,0.317685225982862,"B.LvsP.LU_TUMOR_VASCULATURE_UP"
1129,"Down",0.0792365257064713,0.318154503000058,"B.LvsP.BENPORATH_MYC_MAX_TARGETS"
48,"Down",0.0794967291184014,0.318839533848255,"B.LvsP.WILLIAMS_ESR1_TARGETS_UP"
113,"Up",0.0795224664815959,0.318839533848255,"B.LvsP.HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_UP"
12,"Down",0.0799324146169977,0.320022255585871,"B.LvsP.REACTOME_BIOSYNTHESIS_OF_EPA_DERIVED_SPMS"
37,"Down",0.079933213051924,0.320022255585871,"B.LvsP.SARTIPY_BLUNTED_BY_INSULIN_RESISTANCE_UP"
68,"Down",0.0800628514952615,0.320309338579813,"B.LvsP.YANG_BREAST_CANCER_ESR1_LASER_DN"
30,"Down",0.0802869105254391,0.320623876127101,"B.LvsP.MILICIC_FAMILIAL_ADENOMATOUS_POLYPOSIS_DN"
69,"Up",0.0803364506184629,0.320623876127101,"B.LvsP.REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR"
80,"Down",0.0803414612000268,0.320623876127101,"B.LvsP.MARTIN_NFKB_TARGETS_UP"
14,"Up",0.0803734296097236,0.320623876127101,"B.LvsP.REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_LINKED_TO_LIPOGENESIS"
111,"Down",0.0804772071631486,0.320713557083965,"B.LvsP.REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES"
8,"Down",0.0805169362844543,0.320713557083965,"B.LvsP.MOOTHA_ROS"
95,"Up",0.0805699277970027,0.320713557083965,"B.LvsP.KIM_GERMINAL_CENTER_T_HELPER_UP"
58,"Up",0.0808543804683789,0.321537739513797,"B.LvsP.REACTOME_AMINO_ACIDS_REGULATE_MTORC1"
5,"Down",0.0809106798068391,0.321537739513797,"B.LvsP.REACTOME_BETA_OXIDATION_OF_HEXANOYL_COA_TO_BUTANOYL_COA"
343,"Up",0.0809514439144883,0.321537739513797,"B.LvsP.GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP"
6,"Down",0.0810686035546521,0.321577785063862,"B.LvsP.SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX2_UP"
110,"Down",0.08107784995099,0.321577785063862,"B.LvsP.STEARMAN_LUNG_CANCER_EARLY_VS_LATE_DN"
8,"Down",0.0812974705884171,0.322217716762264,"B.LvsP.REACTOME_MET_RECEPTOR_ACTIVATION"
633,"Down",0.0818094826829459,0.323818776001648,"B.LvsP.WANG_SMARCE1_TARGETS_DN"
455,"Up",0.0818185621404056,0.323818776001648,"B.LvsP.SENESE_HDAC1_TARGETS_DN"
830,"Up",0.081898083025717,0.323890523257726,"B.LvsP.GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN"
26,"Up",0.0820509167094415,0.323890523257726,"B.LvsP.REACTOME_N_GLYCAN_ANTENNAE_ELONGATION_IN_THE_MEDIAL_TRANS_GOLGI"
48,"Up",0.0821331319503915,0.323890523257726,"B.LvsP.PIEPOLI_LGI1_TARGETS_DN"
60,"Down",0.0821421087815802,0.323890523257726,"B.LvsP.TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_DN"
354,"Down",0.0821469226141629,0.323890523257726,"B.LvsP.MARTORIATI_MDM4_TARGETS_FETAL_LIVER_UP"
35,"Down",0.0821881722066538,0.323890523257726,"B.LvsP.NIKOLSKY_BREAST_CANCER_15Q26_AMPLICON"
225,"Down",0.0822813934178062,0.324026940318412,"B.LvsP.KAYO_AGING_MUSCLE_DN"
5,"Down",0.0824254201569953,0.324363094696104,"B.LvsP.WILSON_PROTEASES_AT_TUMOR_BONE_INTERFACE_DN"
302,"Up",0.0826549224819086,0.32453873689071,"B.LvsP.RODRIGUES_NTN1_TARGETS_DN"
39,"Up",0.0827590821999288,0.32453873689071,"B.LvsP.WU_HBX_TARGETS_1_DN"
54,"Down",0.0827710907657235,0.32453873689071,"B.LvsP.HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_24HR"
73,"Up",0.0828138388019845,0.32453873689071,"B.LvsP.BIOCARTA_PPARA_PATHWAY"
46,"Down",0.082821109777609,0.32453873689071,"B.LvsP.HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_DN"
45,"Up",0.0828222386964717,0.32453873689071,"B.LvsP.FINETTI_BREAST_CANCERS_KINOME_BLUE"
14,"Down",0.0829823952143441,0.324936022053901,"B.LvsP.REACTOME_ETHANOL_OXIDATION"
11,"Up",0.0833497980061536,0.326143689438092,"B.LvsP.REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_CASPASE_ACTIVATORS_AND_CASPASES"
8,"Up",0.0834997785303575,0.326499487619764,"B.LvsP.REACTOME_COENZYME_A_BIOSYNTHESIS"
167,"Up",0.0835989328705752,0.326656183633505,"B.LvsP.HOOI_ST7_TARGETS_UP"
5,"Up",0.0836649494751382,0.326683266700592,"B.LvsP.REACTOME_PROPIONYL_COA_CATABOLISM"
58,"Down",0.0837683291796883,0.326856098824627,"B.LvsP.BYSTRYKH_HEMATOPOIESIS_STEM_CELL_SCP2_QTL_TRANS"
204,"Down",0.083887486956143,0.327090208307838,"B.LvsP.BOSCO_TH1_CYTOTOXIC_MODULE"
28,"Down",0.0843118545279688,0.328513209080437,"B.LvsP.PID_HIF1A_PATHWAY"
82,"Down",0.0844526102617607,0.328673484316408,"B.LvsP.AMIT_EGF_RESPONSE_240_HELA"
15,"Down",0.0844718794019923,0.328673484316408,"B.LvsP.NEBEN_AML_WITH_FLT3_OR_NRAS_UP"
29,"Down",0.0845421650851372,0.328715633442844,"B.LvsP.LUND_SILENCED_BY_METHYLATION"
19,"Up",0.0846925312856163,0.329068872437226,"B.LvsP.REACTOME_OAS_ANTIVIRAL_RESPONSE"
34,"Down",0.0847597232871142,0.329098672791049,"B.LvsP.LEE_DOUBLE_POLAR_THYMOCYTE"
14,"Down",0.0850464685642882,0.329964458859434,"B.LvsP.BIOCARTA_CTBP1_PATHWAY"
165,"Up",0.0851020651715595,0.329964458859434,"B.LvsP.NIKOLSKY_BREAST_CANCER_8Q12_Q22_AMPLICON"
13,"Down",0.0852525038300416,0.330316113298038,"B.LvsP.SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX6_UP"
5,"Up",0.0855683451537321,0.331307689324219,"B.LvsP.REACTOME_ARACHIDONATE_PRODUCTION_FROM_DAG"
39,"Up",0.0857624963912136,0.331827041670413,"B.LvsP.PID_RAS_PATHWAY"
19,"Down",0.0858290432885066,0.331852293945562,"B.LvsP.REACTOME_SYNTHESIS_SECRETION_AND_INACTIVATION_OF_GLUCOSE_DEPENDENT_INSULINOTROPIC_POLYPEPTIDE_GIP"
82,"Down",0.0860974036194172,0.332657263879635,"B.LvsP.NADLER_OBESITY_DN"
131,"Down",0.0861665351042897,0.332691880301409,"B.LvsP.SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE"
28,"Up",0.0863861357279815,0.333307009378932,"B.LvsP.REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS"
74,"Down",0.0865873549854872,0.333850408448228,"B.LvsP.YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_15"
10,"Up",0.0866608996671704,0.333901124919711,"B.LvsP.FERRARI_RESPONSE_TO_FENRETINIDE_DN"
16,"Down",0.0871708823723645,0.335544560776121,"B.LvsP.KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_UV_IN_WS"
202,"Down",0.0872088142223342,0.335544560776121,"B.LvsP.HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN"
10,"Down",0.087361002377202,0.33576249756051,"B.LvsP.BAKER_HEMATOPOESIS_STAT1_TARGETS"
32,"Down",0.087386911555358,0.33576249756051,"B.LvsP.REACTOME_HS_GAG_BIOSYNTHESIS"
29,"Up",0.0874690867969559,0.335844847847478,"B.LvsP.REACTOME_INSULIN_RECEPTOR_RECYCLING"
16,"Up",0.0880618514943294,0.337886174123628,"B.LvsP.REACTOME_PHENYLALANINE_AND_TYROSINE_METABOLISM"
146,"Down",0.0882211554009774,0.337892483589348,"B.LvsP.PUJANA_BREAST_CANCER_LIT_INT_NETWORK"
17,"Down",0.0882820157060448,0.337892483589348,"B.LvsP.ZHENG_FOXP3_TARGETS_DN"
67,"Up",0.0882900202605095,0.337892483589348,"B.LvsP.PID_NFAT_3PATHWAY"
137,"Up",0.088307946968097,0.337892483589348,"B.LvsP.SHIPP_DLBCL_CURED_VS_FATAL_UP"
66,"Up",0.0883819678655303,0.33794183978459,"B.LvsP.REACTOME_BILE_ACID_AND_BILE_SALT_METABOLISM"
45,"Down",0.0885106283988772,0.337946300146254,"B.LvsP.REACTOME_ENDOSOMAL_VACUOLAR_PATHWAY"
74,"Down",0.0885221280208567,0.337946300146254,"B.LvsP.PLASARI_NFIC_TARGETS_BASAL_UP"
48,"Down",0.0886053156094597,0.337946300146254,"B.LvsP.YUAN_ZNF143_PARTNERS"
57,"Down",0.0886276243827216,0.337946300146254,"B.LvsP.WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_UP"
31,"Down",0.0887768616388846,0.338245732306731,"B.LvsP.BIOCARTA_AMI_PATHWAY"
22,"Down",0.088868566238708,0.338245732306731,"B.LvsP.SA_REG_CASCADE_OF_CYCLIN_EXPR"
116,"Down",0.0888896815050968,0.338245732306731,"B.LvsP.REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES"
11,"Up",0.0890268183081258,0.338534579384888,"B.LvsP.BIOCARTA_SALMONELLA_PATHWAY"
32,"Down",0.0892183644811335,0.339029785028307,"B.LvsP.WANG_LSD1_TARGETS_UP"
44,"Down",0.0894691327505673,0.33974919984745,"B.LvsP.SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_DN"
97,"Down",0.0895601995508159,0.339861594589198,"B.LvsP.KUNINGER_IGF1_VS_PDGFB_TARGETS_DN"
278,"Up",0.0898967021719031,0.340904572228019,"B.LvsP.LIN_NPAS4_TARGETS_UP"
13,"Up",0.089971470818427,0.340954257817055,"B.LvsP.REACTOME_REGULATION_OF_CYTOSKELETAL_REMODELING_AND_CELL_SPREADING_BY_IPP_COMPLEX_COMPONENTS"
35,"Down",0.0900678917812857,0.341055837497554,"B.LvsP.KEGG_BASE_EXCISION_REPAIR"
74,"Down",0.0901698403494225,0.341055837497554,"B.LvsP.JIANG_HYPOXIA_CANCER"
31,"Down",0.090240924781313,0.341055837497554,"B.LvsP.TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_TOP20_UP"
711,"Up",0.090245015420315,0.341055837497554,"B.LvsP.CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5"
1768,"Up",0.0904467841999239,0.341584883771434,"B.LvsP.PEREZ_TP53_TARGETS"
24,"Up",0.0907351703204435,0.34244010696364,"B.LvsP.REACTOME_ER_QUALITY_CONTROL_COMPARTMENT_ERQC"
227,"Up",0.0909476141852567,0.342825047821985,"B.LvsP.REACTOME_PHOSPHOLIPID_METABOLISM"
123,"Down",0.090961176551791,0.342825047821985,"B.LvsP.LEE_LIVER_CANCER_ACOX1_UP"
5,"Up",0.0913994234378739,0.344242106395098,"B.LvsP.BASSO_HAIRY_CELL_LEUKEMIA_DN"
44,"Up",0.0915140288467274,0.344439118783904,"B.LvsP.RODRIGUES_NTN1_TARGETS_UP"
664,"Down",0.0916893829143459,0.344745021550498,"B.LvsP.PUJANA_BRCA2_PCC_NETWORK"
18,"Down",0.0917200084465152,0.344745021550498,"B.LvsP.PARK_TRETINOIN_RESPONSE"
9,"Down",0.0920293340629477,0.345672682088341,"B.LvsP.REACTOME_PHOSPHATE_BOND_HYDROLYSIS_BY_NTPDASE_PROTEINS"
133,"Up",0.0921996423521531,0.346077272617145,"B.LvsP.GRABARCZYK_BCL11B_TARGETS_UP"
92,"Up",0.0924410363571339,0.346747957950199,"B.LvsP.YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_2"
59,"Up",0.0926664700684361,0.347146856034814,"B.LvsP.PID_HDAC_CLASSIII_PATHWAY"
81,"Down",0.0926729534287188,0.347146856034814,"B.LvsP.DAZARD_UV_RESPONSE_CLUSTER_G2"
50,"Down",0.0932629696270129,0.349120486843436,"B.LvsP.REACTOME_GAP_JUNCTION_TRAFFICKING_AND_REGULATION"
568,"Up",0.0934035332023115,0.349410104922585,"B.LvsP.DAVICIONI_MOLECULAR_ARMS_VS_ERMS_UP"
32,"Down",0.0936254790895919,0.350003565846081,"B.LvsP.BIOCARTA_MTA3_PATHWAY"
16,"Up",0.093995557602549,0.350570734659207,"B.LvsP.MARTIN_NFKB_TARGETS_DN"
143,"Down",0.0940587755124504,0.350570734659207,"B.LvsP.SCHLOSSER_SERUM_RESPONSE_AUGMENTED_BY_MYC"
9,"Up",0.0940884066329796,0.350570734659207,"B.LvsP.REACTOME_LIGAND_RECEPTOR_INTERACTIONS"
22,"Up",0.0940885300644442,0.350570734659207,"B.LvsP.REACTOME_ACETYLCHOLINE_NEUROTRANSMITTER_RELEASE_CYCLE"
32,"Down",0.0940942250378484,0.350570734659207,"B.LvsP.KEGG_PENTOSE_PHOSPHATE_PATHWAY"
119,"Up",0.0941593633629366,0.350577185207863,"B.LvsP.WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_DN"
59,"Down",0.09427321844749,0.350764888826495,"B.LvsP.NIKOLSKY_BREAST_CANCER_12Q13_Q21_AMPLICON"
24,"Down",0.0943753300046593,0.350908674913088,"B.LvsP.SHIN_B_CELL_LYMPHOMA_CLUSTER_9"
6,"Up",0.0948058842361576,0.352069625333325,"B.LvsP.BIOCARTA_TERC_PATHWAY"
308,"Down",0.0948149162816641,0.352069625333325,"B.LvsP.PLASARI_TGFB1_TARGETS_10HR_UP"
9,"Up",0.0949137295808475,0.352200007283561,"B.LvsP.REACTOME_SMALL_INTERFERING_RNA_SIRNA_BIOGENESIS"
31,"Down",0.0950800233679736,0.352580448827314,"B.LvsP.REACTOME_ACYL_CHAIN_REMODELLING_OF_PC"
60,"Down",0.0952212379873275,0.352867442916846,"B.LvsP.REACTOME_NCAM1_INTERACTIONS"
41,"Up",0.0953199683425293,0.352996721343499,"B.LvsP.PID_EPHA2_FWD_PATHWAY"
127,"Down",0.0954855559236575,0.353264469984848,"B.LvsP.PYEON_HPV_POSITIVE_TUMORS_UP"
156,"Down",0.0955200547345539,0.353264469984848,"B.LvsP.REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_DIFFERENTIATION_OF_HSCS"
35,"Down",0.0957564730359133,0.353902098539816,"B.LvsP.REACTOME_RESPONSE_OF_MTB_TO_PHAGOCYTOSIS"
13,"Down",0.09601533079961,0.354621752833029,"B.LvsP.REACTOME_FGFRL1_MODULATION_OF_FGFR1_SIGNALING"
6,"Up",0.0961801157373246,0.354993230915666,"B.LvsP.BIOCARTA_PELP1_PATHWAY"
114,"Up",0.0965002896346405,0.355779408825362,"B.LvsP.REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES"
156,"Up",0.0965218146569078,0.355779408825362,"B.LvsP.ZWANG_EGF_INTERVAL_UP"
8,"Up",0.0967530339048638,0.356394086915384,"B.LvsP.MATZUK_STEROIDOGENESIS"
318,"Down",0.0970752914158368,0.357343066736459,"B.LvsP.BHAT_ESR1_TARGETS_NOT_VIA_AKT1_UP"
155,"Up",0.0971718879741023,0.357460657757027,"B.LvsP.REACTOME_ACTIVATION_OF_ANTERIOR_HOX_GENES_IN_HINDBRAIN_DEVELOPMENT_DURING_EARLY_EMBRYOGENESIS"
64,"Down",0.0972632454271473,0.357558832424666,"B.LvsP.TIEN_INTESTINE_PROBIOTICS_2HR_UP"
522,"Down",0.0973755132851191,0.357733696314567,"B.LvsP.YANG_BCL3_TARGETS_UP"
82,"Down",0.0975356442613881,0.358084048553263,"B.LvsP.PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_1"
26,"Down",0.0976168211102675,0.358144262719754,"B.LvsP.REACTOME_RESOLUTION_OF_D_LOOP_STRUCTURES_THROUGH_SYNTHESIS_DEPENDENT_STRAND_ANNEALING_SDSA"
99,"Down",0.0976930535475398,0.35817268199333,"B.LvsP.LINDSTEDT_DENDRITIC_CELL_MATURATION_C"
7,"Down",0.0977541286178215,0.35817268199333,"B.LvsP.REACTOME_TELOMERE_C_STRAND_SYNTHESIS_INITIATION"
65,"Down",0.0982550595687741,0.359769685003809,"B.LvsP.CHOI_ATL_STAGE_PREDICTOR"
53,"Up",0.0983629110250516,0.359926231010927,"B.LvsP.REACTOME_TNF_SIGNALING"
154,"Up",0.0985834111032063,0.360494497347637,"B.LvsP.REN_ALVEOLAR_RHABDOMYOSARCOMA_UP"
71,"Down",0.0987567522819973,0.360889678365607,"B.LvsP.TSAI_RESPONSE_TO_RADIATION_THERAPY"
34,"Down",0.0988328669527561,0.360929274360494,"B.LvsP.NIKOLSKY_BREAST_CANCER_5P15_AMPLICON"
15,"Down",0.0990158153940399,0.361358708457853,"B.LvsP.YAMANAKA_GLIOBLASTOMA_SURVIVAL_UP"
181,"Down",0.0992553332108404,0.361993890054575,"B.LvsP.RICKMAN_HEAD_AND_NECK_CANCER_E"
59,"Down",0.100222662633053,0.364456301340854,"B.LvsP.CAFFAREL_RESPONSE_TO_THC_DN"
338,"Down",0.100327555598116,0.364456301340854,"B.LvsP.TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN"
337,"Up",0.100348318572576,0.364456301340854,"B.LvsP.MCBRYAN_PUBERTAL_BREAST_6_7WK_UP"
119,"Down",0.100383886655064,0.364456301340854,"B.LvsP.RIZ_ERYTHROID_DIFFERENTIATION"
44,"Down",0.100432789313442,0.364456301340854,"B.LvsP.CHIARETTI_T_ALL_RELAPSE_PROGNOSIS"
154,"Up",0.100465757970084,0.364456301340854,"B.LvsP.LEE_TARGETS_OF_PTCH1_AND_SUFU_DN"
66,"Down",0.100541130964642,0.364456301340854,"B.LvsP.VALK_AML_WITH_CEBPA"
129,"Down",0.100545633390935,0.364456301340854,"B.LvsP.LEE_CALORIE_RESTRICTION_NEOCORTEX_DN"
35,"Down",0.100552903905969,0.364456301340854,"B.LvsP.HAHTOLA_MYCOSIS_FUNGOIDES_DN"
38,"Up",0.100622399051124,0.364456301340854,"B.LvsP.VALK_AML_CLUSTER_8"
55,"Up",0.100655592719748,0.364456301340854,"B.LvsP.VALK_AML_CLUSTER_10"
49,"Down",0.100751143375395,0.364561344152264,"B.LvsP.PID_IL2_PI3K_PATHWAY"
18,"Down",0.100816475892351,0.364561344152264,"B.LvsP.REACTOME_TRAF6_MEDIATED_INDUCTION_OF_TAK1_COMPLEX_WITHIN_TLR4_COMPLEX"
40,"Down",0.101028128674968,0.365068660133569,"B.LvsP.KEGG_CYSTEINE_AND_METHIONINE_METABOLISM"
36,"Up",0.101088825947639,0.365068660133569,"B.LvsP.ABDULRAHMAN_KIDNEY_CANCER_VHL_DN"
27,"Up",0.101453296015946,0.365943479583038,"B.LvsP.REACTOME_NEGATIVE_REGULATION_OF_NMDA_RECEPTOR_MEDIATED_NEURONAL_TRANSMISSION"
43,"Up",0.101463438994537,0.365943479583038,"B.LvsP.REACTOME_REGULATION_OF_TNFR1_SIGNALING"
33,"Down",0.101634771283729,0.36627712369639,"B.LvsP.BIOCARTA_G1_PATHWAY"
58,"Down",0.101688440020611,0.36627712369639,"B.LvsP.HUMMERICH_MALIGNANT_SKIN_TUMOR_UP"
104,"Down",0.102122001114141,0.367368006988758,"B.LvsP.LEE_LIVER_CANCER_E2F1_DN"
26,"Down",0.102124186424619,0.367368006988758,"B.LvsP.DORMOY_ELAVL1_TARGETS"
91,"Down",0.10268872478461,0.369158621153516,"B.LvsP.ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_DN"
47,"Down",0.102898555368648,0.369672587805885,"B.LvsP.SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_DN"
155,"Up",0.103159527089889,0.370338864816975,"B.LvsP.LEIN_CEREBELLUM_MARKERS"
12,"Down",0.103238926464833,0.370338864816975,"B.LvsP.REACTOME_SLBP_DEPENDENT_PROCESSING_OF_REPLICATION_DEPENDENT_HISTONE_PRE_MRNAS"
71,"Up",0.103290722470414,0.370338864816975,"B.LvsP.REACTOME_ION_HOMEOSTASIS"
30,"Down",0.103351938580682,0.370338864816975,"B.LvsP.IIZUKA_LIVER_CANCER_PROGRESSION_L1_G1_UP"
214,"Down",0.103596248676692,0.37089084424216,"B.LvsP.RASHI_RESPONSE_TO_IONIZING_RADIATION_2"
51,"Up",0.103713621642521,0.37089084424216,"B.LvsP.NIKOLSKY_BREAST_CANCER_20Q11_AMPLICON"
14,"Down",0.103765550541456,0.37089084424216,"B.LvsP.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_12"
117,"Up",0.103778029300909,0.37089084424216,"B.LvsP.REACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING"
156,"Up",0.103841386667908,0.37089084424216,"B.LvsP.KEGG_AXON_GUIDANCE"
63,"Down",0.104090648689485,0.371541121113081,"B.LvsP.REACTOME_CARGO_CONCENTRATION_IN_THE_ER"
73,"Down",0.10417815100894,0.371571183389171,"B.LvsP.MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_DN"
220,"Up",0.104279672760418,0.371571183389171,"B.LvsP.KEGG_ENDOCYTOSIS"
522,"Up",0.104371597805351,0.371571183389171,"B.LvsP.BROWNE_HCMV_INFECTION_20HR_UP"
26,"Down",0.104391323196026,0.371571183389171,"B.LvsP.REACTOME_METAL_ION_SLC_TRANSPORTERS"
9,"Up",0.104487337896875,0.371571183389171,"B.LvsP.REACTOME_CREB3_FACTORS_ACTIVATE_GENES"
9,"Down",0.104502295201693,0.371571183389171,"B.LvsP.REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_WNT_SIGNALING"
12,"Down",0.104744998841254,0.372100373318034,"B.LvsP.BOYLAN_MULTIPLE_MYELOMA_PCA1_DN"
67,"Down",0.104785726398296,0.372100373318034,"B.LvsP.VANTVEER_BREAST_CANCER_BRCA1_UP"
17,"Down",0.104923078209424,0.372348972670027,"B.LvsP.REACTOME_NF_KB_IS_ACTIVATED_AND_SIGNALS_SURVIVAL"
160,"Down",0.105467518165293,0.374040992903083,"B.LvsP.CUI_GLUCOSE_DEPRIVATION"
27,"Down",0.105603976019876,0.374064152024275,"B.LvsP.MEISSNER_BRAIN_HCP_WITH_H3K4ME2"
10,"Up",0.105609358167823,0.374064152024275,"B.LvsP.RANKIN_ANGIOGENIC_TARGETS_OF_VHL_HIF2A_UP"
13,"Down",0.105715413295893,0.374200076896921,"B.LvsP.POS_RESPONSE_TO_HISTAMINE_DN"
70,"Down",0.105833487788796,0.374265055629371,"B.LvsP.HONMA_DOCETAXEL_RESISTANCE"
26,"Down",0.105869153012179,0.374265055629371,"B.LvsP.REACTOME_PD_1_SIGNALING"
8,"Down",0.106257390023612,0.375397514019522,"B.LvsP.REACTOME_POLB_DEPENDENT_LONG_PATCH_BASE_EXCISION_REPAIR"
113,"Up",0.107423108516837,0.379048404791424,"B.LvsP.BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_UP"
49,"Down",0.107427898409868,0.379048404791424,"B.LvsP.KAMMINGA_SENESCENCE"
62,"Down",0.107572652974686,0.379317090750663,"B.LvsP.VALK_AML_CLUSTER_6"
9,"Up",0.107901463561022,0.38023402933645,"B.LvsP.REACTOME_TFAP2_AP_2_FAMILY_REGULATES_TRANSCRIPTION_OF_CELL_CYCLE_FACTORS"
43,"Down",0.108022295600778,0.380417370940575,"B.LvsP.REACTOME_HOMOLOGOUS_DNA_PAIRING_AND_STRAND_EXCHANGE"
12,"Down",0.10835192257947,0.381334903121313,"B.LvsP.BIOCARTA_CDC25_PATHWAY"
125,"Up",0.108420775494068,0.381334903121313,"B.LvsP.IVANOVSKA_MIR106B_TARGETS"
1049,"Down",0.108638500555422,0.381595239217001,"B.LvsP.KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_UP"
38,"Up",0.108678223927383,0.381595239217001,"B.LvsP.BIOCARTA_INSULIN_PATHWAY"
21,"Down",0.108701845137778,0.381595239217001,"B.LvsP.FARMER_BREAST_CANCER_CLUSTER_3"
27,"Down",0.108948933294061,0.381945863348436,"B.LvsP.BIOCARTA_TGFB_PATHWAY"
28,"Up",0.108957505769427,0.381945863348436,"B.LvsP.SEKI_INFLAMMATORY_RESPONSE_LPS_DN"
41,"Down",0.109011823245209,0.381945863348436,"B.LvsP.ABE_VEGFA_TARGETS_30MIN"
92,"Down",0.109078046342409,0.381945863348436,"B.LvsP.KEGG_TGF_BETA_SIGNALING_PATHWAY"
74,"Up",0.109223323568001,0.382080604940756,"B.LvsP.KUUSELO_PANCREATIC_CANCER_19Q13_AMPLIFICATION"
54,"Up",0.109254736193043,0.382080604940756,"B.LvsP.MARZEC_IL2_SIGNALING_DN"
171,"Down",0.10939770865868,0.38228382260129,"B.LvsP.WOOD_EBV_EBNA1_TARGETS_UP"
40,"Down",0.109483103981755,0.38228382260129,"B.LvsP.DUTTA_APOPTOSIS_VIA_NFKB"
19,"Down",0.109520270392556,0.38228382260129,"B.LvsP.SASSON_FSH_RESPONSE"
41,"Down",0.109623572647048,0.382402986224307,"B.LvsP.PASTURAL_RIZ1_TARGETS_UP"
21,"Down",0.110648386534343,0.385642141739966,"B.LvsP.IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_UP"
100,"Down",0.11070304175211,0.385642141739966,"B.LvsP.LEE_LIVER_CANCER_MYC_TGFA_DN"
68,"Down",0.110761389235497,0.385642141739966,"B.LvsP.KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY"
8,"Down",0.111027065196522,0.386323878836735,"B.LvsP.REACTOME_SUPPRESSION_OF_APOPTOSIS"
10,"Down",0.111214170243931,0.386353755871957,"B.LvsP.REICHERT_G1S_REGULATORS_AS_PI3K_TARGETS"
209,"Down",0.111226745805536,0.386353755871957,"B.LvsP.SANSOM_APC_TARGETS_UP"
175,"Up",0.111245284743743,0.386353755871957,"B.LvsP.REACTOME_CELL_CELL_COMMUNICATION"
19,"Down",0.111406717376624,0.386598044686554,"B.LvsP.BIOCARTA_BLYMPHOCYTE_PATHWAY"
78,"Up",0.111455468119075,0.386598044686554,"B.LvsP.WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_DN"
19,"Down",0.111737518248498,0.386850892412033,"B.LvsP.MINGUEZ_LIVER_CANCER_VASCULAR_INVASION_UP"
29,"Down",0.111747181725713,0.386850892412033,"B.LvsP.REACTOME_ACYL_CHAIN_REMODELLING_OF_PE"
85,"Up",0.111799980945737,0.386850892412033,"B.LvsP.PID_AR_TF_PATHWAY"
106,"Up",0.111808234052167,0.386850892412033,"B.LvsP.KANNAN_TP53_TARGETS_UP"
155,"Up",0.111959790591176,0.387133009492565,"B.LvsP.ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_UP"
67,"Up",0.112146485367006,0.387482962552426,"B.LvsP.PID_NCADHERIN_PATHWAY"
109,"Down",0.11220116170129,0.387482962552426,"B.LvsP.LEE_LIVER_CANCER_MYC_E2F1_UP"
17,"Up",0.112787363310613,0.389112763735072,"B.LvsP.BIOCARTA_GATA3_PATHWAY"
7,"Down",0.112813847036954,0.389112763735072,"B.LvsP.STONER_ESOPHAGEAL_CARCINOGENESIS_DN"
303,"Up",0.113347508385744,0.390709709392008,"B.LvsP.FOSTER_KDM1A_TARGETS_DN"
206,"Down",0.113578220593119,0.391261047762837,"B.LvsP.HOLLERN_EMT_BREAST_TUMOR_DN"
73,"Down",0.113843571131958,0.3919309494325,"B.LvsP.SCHLESINGER_H3K27ME3_IN_NORMAL_AND_METHYLATED_IN_CANCER"
668,"Up",0.114323402364016,0.393284678049509,"B.LvsP.HATADA_METHYLATED_IN_LUNG_CANCER_UP"
114,"Down",0.114427997523825,0.393284678049509,"B.LvsP.AMIT_EGF_RESPONSE_120_HELA"
51,"Down",0.114450180318622,0.393284678049509,"B.LvsP.BOYAULT_LIVER_CANCER_SUBCLASS_G2"
12,"Down",0.114720562919288,0.39396893936692,"B.LvsP.NAGY_STAGA_COMPONENTS_HUMAN"
74,"Down",0.1150721607046,0.39487401497468,"B.LvsP.BOYAULT_LIVER_CANCER_SUBCLASS_G3_DN"
259,"Up",0.115126951010885,0.39487401497468,"B.LvsP.BROCKE_APOPTOSIS_REVERSED_BY_IL6"
170,"Up",0.115563921122441,0.396127042706742,"B.LvsP.ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_DN"
60,"Down",0.115870168438532,0.396930707123074,"B.LvsP.STONER_ESOPHAGEAL_CARCINOGENESIS_UP"
7,"Up",0.116708309986367,0.399554331835682,"B.LvsP.LIU_CMYB_TARGETS_DN"
8,"Down",0.117031207390717,0.400411847563907,"B.LvsP.MOOTHA_PYR"
34,"Down",0.117331548972785,0.401191177656481,"B.LvsP.KEGG_ALANINE_ASPARTATE_AND_GLUTAMATE_METABOLISM"
9,"Up",0.117440022613674,0.401313896805317,"B.LvsP.BIOCARTA_ERBB3_PATHWAY"
92,"Down",0.117871877791016,0.402540835272718,"B.LvsP.OLSSON_E2F3_TARGETS_DN"
35,"Down",0.118110660604828,0.402908917615806,"B.LvsP.ZIRN_TRETINOIN_RESPONSE_WT1_UP"
6,"Down",0.118125403410241,0.402908917615806,"B.LvsP.REACTOME_PROTON_COUPLED_MONOCARBOXYLATE_TRANSPORT"
38,"Down",0.118402804969216,0.403481942008948,"B.LvsP.SESTO_RESPONSE_TO_UV_C4"
21,"Down",0.118439354653739,0.403481942008948,"B.LvsP.MCBRYAN_TERMINAL_END_BUD_UP"
297,"Down",0.118709694887675,0.404153881178544,"B.LvsP.OKUMURA_INFLAMMATORY_RESPONSE_LPS"
14,"Down",0.118931105261849,0.404313662788421,"B.LvsP.BIOCARTA_NEUTROPHIL_PATHWAY"
73,"Down",0.118978414681804,0.404313662788421,"B.LvsP.BILANGES_SERUM_SENSITIVE_VIA_TSC2"
53,"Down",0.119032976796477,0.404313662788421,"B.LvsP.KIM_TIAL1_TARGETS"
115,"Up",0.119120209408163,0.404313662788421,"B.LvsP.REACTOME_RECRUITMENT_OF_MITOTIC_CENTROSOME_PROTEINS_AND_COMPLEXES"
22,"Down",0.119259018651308,0.404313662788421,"B.LvsP.REACTOME_YAP1_AND_WWTR1_TAZ_STIMULATED_GENE_EXPRESSION"
145,"Down",0.119314926642254,0.404313662788421,"B.LvsP.MARCHINI_TRABECTEDIN_RESISTANCE_DN"
103,"Up",0.119368525309313,0.404313662788421,"B.LvsP.NAGASHIMA_NRG1_SIGNALING_DN"
1901,"Down",0.11939952512621,0.404313662788421,"B.LvsP.REACTOME_DISEASE"
24,"Up",0.119418102565309,0.404313662788421,"B.LvsP.BIOCARTA_NOS1_PATHWAY"
133,"Up",0.119487886597265,0.404313662788421,"B.LvsP.KUNINGER_IGF1_VS_PDGFB_TARGETS_UP"
14,"Down",0.119677276193424,0.404457090358346,"B.LvsP.REACTOME_SIGNALING_BY_ACTIVIN"
184,"Down",0.11968119896167,0.404457090358346,"B.LvsP.NIKOLSKY_BREAST_CANCER_20Q12_Q13_AMPLICON"
82,"Down",0.119749729954171,0.404457090358346,"B.LvsP.LI_LUNG_CANCER"
107,"Up",0.120074459106312,0.405306278631747,"B.LvsP.REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS"
95,"Down",0.120305007002252,0.40576033397282,"B.LvsP.WIERENGA_STAT5A_TARGETS_GROUP2"
7,"Down",0.120355751078934,0.40576033397282,"B.LvsP.MIKHAYLOVA_OXIDATIVE_STRESS_RESPONSE_VIA_VHL_DN"
188,"Down",0.120667736945494,0.406103886643448,"B.LvsP.BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_UP"
7,"Up",0.120762011591131,0.406103886643448,"B.LvsP.CALVET_IRINOTECAN_SENSITIVE_VS_REVERTED_DN"
184,"Up",0.120783818261234,0.406103886643448,"B.LvsP.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP"
74,"Up",0.120830620107362,0.406103886643448,"B.LvsP.DALESSIO_TSA_RESPONSE"
9,"Down",0.12083159500498,0.406103886643448,"B.LvsP.REACTOME_ACTIVATION_OF_PUMA_AND_TRANSLOCATION_TO_MITOCHONDRIA"
73,"Up",0.120898353665241,0.406103886643448,"B.LvsP.ZWANG_CLASS_2_TRANSIENTLY_INDUCED_BY_EGF"
247,"Up",0.121018078769304,0.406259233464167,"B.LvsP.PODAR_RESPONSE_TO_ADAPHOSTIN_UP"
385,"Down",0.121227294377747,0.406540406886031,"B.LvsP.NABA_SECRETED_FACTORS"
14,"Down",0.121296906412884,0.406540406886031,"B.LvsP.BIOCARTA_EXTRINSIC_PATHWAY"
246,"Up",0.121322422022418,0.406540406886031,"B.LvsP.REACTOME_MUSCLE_CONTRACTION"
13,"Down",0.121602847100564,0.407233277782568,"B.LvsP.MCCOLLUM_GELDANAMYCIN_RESISTANCE_DN"
231,"Down",0.121697920508958,0.407304965190091,"B.LvsP.REACTOME_MITOTIC_G2_G2_M_PHASES"
272,"Down",0.12178193408067,0.407339572614656,"B.LvsP.REACTOME_FCERI_MEDIATED_NF_KB_ACTIVATION"
20,"Down",0.121901677598114,0.407493576444966,"B.LvsP.REACTOME_ABACAVIR_TRANSPORT_AND_METABOLISM"
19,"Down",0.122206342878388,0.408265178111544,"B.LvsP.BIOCARTA_IL4_PATHWAY"
41,"Down",0.122447673101675,0.408824386823166,"B.LvsP.GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_DN"
747,"Up",0.122551812523518,0.408925148728142,"B.LvsP.ODONNELL_TFRC_TARGETS_UP"
37,"Up",0.122652716558783,0.409014999911647,"B.LvsP.REACTOME_FERTILIZATION"
24,"Up",0.122904688578764,0.409608211664849,"B.LvsP.PID_P38_MK2_PATHWAY"
51,"Down",0.123011343841142,0.409715970488679,"B.LvsP.WENG_POR_TARGETS_LIVER_DN"
43,"Down",0.123108957592517,0.409715970488679,"B.LvsP.NEWMAN_ERCC6_TARGETS_UP"
225,"Down",0.123159331335175,0.409715970488679,"B.LvsP.REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS"
27,"Down",0.123306946225026,0.409870428714245,"B.LvsP.REACTOME_CD163_MEDIATING_AN_ANTI_INFLAMMATORY_RESPONSE"
21,"Up",0.123418634178791,0.409870428714245,"B.LvsP.REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_METHYLATION"
126,"Down",0.123428154062076,0.409870428714245,"B.LvsP.GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN"
18,"Down",0.123596283710874,0.410182384536268,"B.LvsP.KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_4NQO_IN_OLD"
102,"Down",0.123867220160796,0.410834949171591,"B.LvsP.KEGG_CARDIAC_MUSCLE_CONTRACTION"
97,"Down",0.124265085602701,0.411545608638131,"B.LvsP.ABRAMSON_INTERACT_WITH_AIRE"
29,"Down",0.124303866110573,0.411545608638131,"B.LvsP.BIOCARTA_ACE2_PATHWAY"
18,"Down",0.124304786837707,0.411545608638131,"B.LvsP.BIOCARTA_AHSP_PATHWAY"
105,"Down",0.124654714839234,0.412457162385472,"B.LvsP.SESTO_RESPONSE_TO_UV_C7"
40,"Down",0.124828785793392,0.412786098475876,"B.LvsP.KYNG_WERNER_SYNDROM_DN"
62,"Down",0.12491965258216,0.412839664750008,"B.LvsP.HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_DN"
16,"Down",0.125325914429131,0.41393487507686,"B.LvsP.REACTOME_ERYTHROCYTES_TAKE_UP_OXYGEN_AND_RELEASE_CARBON_DIOXIDE"
49,"Down",0.125430431536047,0.414032749828539,"B.LvsP.REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_OXIDATIVE_STRESS_METABOLIC_AND_NEURONAL_GENES"
130,"Down",0.12553810698335,0.414140926915836,"B.LvsP.REACTOME_PROTEIN_UBIQUITINATION"
64,"Up",0.125669026586186,0.414325610014921,"B.LvsP.FAELT_B_CLL_WITH_VH3_21_DN"
53,"Down",0.125750510641544,0.41433857902422,"B.LvsP.BOQUEST_STEM_CELL_CULTURED_VS_FRESH_DN"
21,"Down",0.125822838520829,0.41433857902422,"B.LvsP.REACTOME_TRANSLESION_SYNTHESIS_BY_POLH"
43,"Up",0.126022455705114,0.41474890332951,"B.LvsP.KEGG_SPHINGOLIPID_METABOLISM"
14,"Down",0.126186448321904,0.415041566193817,"B.LvsP.SMID_BREAST_CANCER_RELAPSE_IN_LIVER_DN"
106,"Up",0.126291598466975,0.415140456554046,"B.LvsP.MARSON_FOXP3_TARGETS_UP"
21,"Down",0.126516342178906,0.415632118780257,"B.LvsP.KYNG_NORMAL_AGING_UP"
238,"Down",0.1269683168737,0.416714581244413,"B.LvsP.MARKEY_RB1_CHRONIC_LOF_DN"
35,"Up",0.127020249449222,0.416714581244413,"B.LvsP.BIOCARTA_IGF1_PATHWAY"
77,"Down",0.127071945013218,0.416714581244413,"B.LvsP.DOANE_BREAST_CANCER_ESR1_DN"
89,"Up",0.127398265956195,0.417089623646696,"B.LvsP.KEGG_LONG_TERM_POTENTIATION"
33,"Up",0.127480033898902,0.417089623646696,"B.LvsP.YORDY_RECIPROCAL_REGULATION_BY_ETS1_AND_SP100_UP"
116,"Down",0.127514028170319,0.417089623646696,"B.LvsP.ZHAN_MULTIPLE_MYELOMA_DN"
5,"Up",0.127524001649945,0.417089623646696,"B.LvsP.BIOCARTA_DICER_PATHWAY"
69,"Up",0.127576271898748,0.417089623646696,"B.LvsP.SCHEIDEREIT_IKK_INTERACTING_PROTEINS"
101,"Down",0.127638929862581,0.417089623646696,"B.LvsP.BRIDEAU_IMPRINTED_GENES"
76,"Down",0.127988357704894,0.417745383774844,"B.LvsP.PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_DN"
710,"Up",0.127990718052918,0.417745383774844,"B.LvsP.DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN"
11,"Up",0.128162397884963,0.418058936817677,"B.LvsP.MATZUK_FERTILIZATION"
1555,"Down",0.129119646500256,0.420933092865517,"B.LvsP.MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3"
52,"Up",0.129298895431891,0.421269058834958,"B.LvsP.HUMMERICH_BENIGN_SKIN_TUMOR_DN"
65,"Up",0.129456763383863,0.421535008686324,"B.LvsP.REACTOME_INSULIN_RECEPTOR_SIGNALLING_CASCADE"
19,"Up",0.129856420475651,0.42238413447955,"B.LvsP.BIOCARTA_HES_PATHWAY"
8,"Down",0.129870325305704,0.42238413447955,"B.LvsP.REACTOME_UBIQUINOL_BIOSYNTHESIS"
9,"Down",0.130027912077959,0.422648045784265,"B.LvsP.REACTOME_LECTIN_PATHWAY_OF_COMPLEMENT_ACTIVATION"
573,"Up",0.130495788204549,0.423474004638001,"B.LvsP.CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP"
378,"Down",0.13051050378273,0.423474004638001,"B.LvsP.REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL"
20,"Up",0.130511793073459,0.423474004638001,"B.LvsP.TERAMOTO_OPN_TARGETS_CLUSTER_1"
24,"Up",0.13092553519791,0.424540443687226,"B.LvsP.PID_THROMBIN_PAR4_PATHWAY"
1243,"Up",0.131031946712354,0.424540443687226,"B.LvsP.LEE_BMP2_TARGETS_UP"
137,"Down",0.131070815224108,0.424540443687226,"B.LvsP.KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS"
896,"Up",0.131313369940512,0.42507706229572,"B.LvsP.REACTOME_METABOLISM_OF_LIPIDS"
46,"Down",0.131759434975003,0.426023814058988,"B.LvsP.REACTOME_HIV_TRANSCRIPTION_ELONGATION"
39,"Down",0.13175994249247,0.426023814058988,"B.LvsP.YIH_RESPONSE_TO_ARSENITE_C3"
71,"Down",0.13190117542185,0.426231209180252,"B.LvsP.SCHLINGEMANN_SKIN_CARCINOGENESIS_TPA_UP"
427,"Up",0.13205138924948,0.426422540842465,"B.LvsP.RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_DN"
17,"Up",0.132121832475195,0.426422540842465,"B.LvsP.PID_S1P_S1P4_PATHWAY"
33,"Down",0.132191758908299,0.426422540842465,"B.LvsP.BOYERINAS_ONCOFETAL_TARGETS_OF_LET7A1"
619,"Up",0.132681346611685,0.427752283041402,"B.LvsP.YAGI_AML_WITH_11Q23_REARRANGED"
142,"Down",0.132928123697887,0.428298132823786,"B.LvsP.REACTOME_ANTIMICROBIAL_PEPTIDES"
41,"Down",0.133240299298871,0.429053939908827,"B.LvsP.REACTOME_GAMMA_CARBOXYLATION_HYPUSINE_FORMATION_AND_ARYLSULFATASE_ACTIVATION"
59,"Up",0.133391583991197,0.42923475592554,"B.LvsP.BOYAULT_LIVER_CANCER_SUBCLASS_G12_UP"
572,"Up",0.133451717387593,0.42923475592554,"B.LvsP.HELLER_HDAC_TARGETS_UP"
40,"Up",0.133825338968716,0.429817311178615,"B.LvsP.REACTOME_SIGNALLING_TO_ERKS"
35,"Up",0.133908457552755,0.429817311178615,"B.LvsP.BIOCARTA_CREB_PATHWAY"
735,"Up",0.13393534561904,0.429817311178615,"B.LvsP.BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP"
223,"Down",0.133943792215727,0.429817311178615,"B.LvsP.VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_DN"
93,"Down",0.134144173883655,0.430192575084657,"B.LvsP.WEIGEL_OXIDATIVE_STRESS_BY_TBH_AND_H2O2"
18,"Up",0.134216348710623,0.430192575084657,"B.LvsP.PID_TCR_RAS_PATHWAY"
42,"Down",0.13446019102823,0.430724447389967,"B.LvsP.GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_UP"
134,"Down",0.134745862073128,0.431389618646395,"B.LvsP.HINATA_NFKB_TARGETS_FIBROBLAST_UP"
2477,"Up",0.135024700366615,0.432032157596651,"B.LvsP.GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN"
118,"Down",0.135309665410476,0.432234284248102,"B.LvsP.ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_DN"
331,"Up",0.135316068812715,0.432234284248102,"B.LvsP.LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP"
92,"Down",0.135414786978617,0.432234284248102,"B.LvsP.PID_NOTCH_PATHWAY"
586,"Up",0.135431558451611,0.432234284248102,"B.LvsP.KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN"
11,"Up",0.135478751058412,0.432234284248102,"B.LvsP.REACTOME_BIOTIN_TRANSPORT_AND_METABOLISM"
1169,"Down",0.135567628021977,0.432268405613329,"B.LvsP.JOHNSTONE_PARVB_TARGETS_3_DN"
15,"Down",0.135690213485581,0.432284905482771,"B.LvsP.DACOSTA_LOW_DOSE_UV_RESPONSE_VIA_ERCC3_XPCS_DN"
54,"Up",0.135729172710814,0.432284905482771,"B.LvsP.WANG_RESPONSE_TO_BEXAROTENE_DN"
44,"Down",0.135822544629203,0.432333246548568,"B.LvsP.REACTOME_COOPERATION_OF_PDCL_PHLP1_AND_TRIC_CCT_IN_G_PROTEIN_BETA_FOLDING"
27,"Up",0.135964899857399,0.43253735978801,"B.LvsP.REACTOME_RAS_ACTIVATION_UPON_CA2_INFLUX_THROUGH_NMDA_RECEPTOR"
15,"Up",0.136146328668086,0.432679424140293,"B.LvsP.MONTERO_THYROID_CANCER_POOR_SURVIVAL_DN"
876,"Down",0.136166069452724,0.432679424140293,"B.LvsP.ENK_UV_RESPONSE_KERATINOCYTE_UP"
15,"Up",0.136260857816403,0.432731925828196,"B.LvsP.PID_P38_GAMMA_DELTA_PATHWAY"
56,"Up",0.136625146658908,0.433639745050001,"B.LvsP.REACTOME_IRS_MEDIATED_SIGNALLING"
34,"Down",0.136986428332481,0.433707359910253,"B.LvsP.WELCH_GATA1_TARGETS"
15,"Down",0.137173881803133,0.433707359910253,"B.LvsP.RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_SMAD4_DN"
24,"Down",0.13728822368653,0.433707359910253,"B.LvsP.VISALA_RESPONSE_TO_HEAT_SHOCK_AND_AGING_DN"
14,"Down",0.137303709058459,0.433707359910253,"B.LvsP.BIOCARTA_SRCRPTP_PATHWAY"
117,"Up",0.137383285469457,0.433707359910253,"B.LvsP.TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_DN"
80,"Down",0.137394671348361,0.433707359910253,"B.LvsP.LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_DN"
16,"Down",0.137413294957899,0.433707359910253,"B.LvsP.BIOCARTA_PRC2_PATHWAY"
25,"Down",0.137759635503362,0.433707359910253,"B.LvsP.REACTOME_ACYL_CHAIN_REMODELLING_OF_PS"
6,"Down",0.137847027601844,0.433707359910253,"B.LvsP.BIOCARTA_SUMO_PATHWAY"
65,"Up",0.1378693382804,0.433707359910253,"B.LvsP.SESTO_RESPONSE_TO_UV_C3"
15,"Down",0.137884742655891,0.433707359910253,"B.LvsP.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_DN"
13,"Down",0.138047427540399,0.433707359910253,"B.LvsP.REACTOME_RRNA_PROCESSING_IN_THE_MITOCHONDRION"
19,"Down",0.138047631633582,0.433707359910253,"B.LvsP.REACTOME_KSRP_KHSRP_BINDS_AND_DESTABILIZES_MRNA"
98,"Down",0.138067509761249,0.433707359910253,"B.LvsP.VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_UP"
34,"Down",0.13814464832329,0.433707359910253,"B.LvsP.WILLIAMS_ESR2_TARGETS_UP"
76,"Down",0.138335847316419,0.433707359910253,"B.LvsP.REACTOME_SIGNALING_BY_PDGF"
93,"Up",0.138381234190942,0.433707359910253,"B.LvsP.DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_UP"
125,"Up",0.138390690491379,0.433707359910253,"B.LvsP.ZHENG_GLIOBLASTOMA_PLASTICITY_DN"
79,"Down",0.138429479356154,0.433707359910253,"B.LvsP.REACTOME_ACTIVATION_OF_MATRIX_METALLOPROTEINASES"
368,"Up",0.138436841416621,0.433707359910253,"B.LvsP.AMUNDSON_RESPONSE_TO_ARSENITE"
97,"Up",0.138500459418943,0.433707359910253,"B.LvsP.PID_MTOR_4PATHWAY"
15,"Down",0.13860363579404,0.433707359910253,"B.LvsP.MARSON_FOXP3_TARGETS_STIMULATED_DN"
1893,"Down",0.138620367346823,0.433707359910253,"B.LvsP.DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_UP"
12,"Up",0.13868564014706,0.433707359910253,"B.LvsP.YAMANAKA_GLIOBLASTOMA_SURVIVAL_DN"
45,"Down",0.138699601012945,0.433707359910253,"B.LvsP.NABA_COLLAGENS"
45,"Down",0.138699601012945,0.433707359910253,"B.LvsP.REACTOME_COLLAGEN_CHAIN_TRIMERIZATION"
62,"Up",0.138764391333195,0.433707359910253,"B.LvsP.BIOCARTA_INTEGRIN_PATHWAY"
14,"Up",0.138874974662758,0.433807759836379,"B.LvsP.REACTOME_ROBO_RECEPTORS_BIND_AKAP5"
63,"Up",0.13913291132077,0.434368078313122,"B.LvsP.REACTOME_EPHB_MEDIATED_FORWARD_SIGNALING"
21,"Up",0.139361103222146,0.434752448971823,"B.LvsP.DELASERNA_TARGETS_OF_MYOD_AND_SMARCA4"
36,"Down",0.139413292101111,0.434752448971823,"B.LvsP.BIOCARTA_INTRINSIC_PATHWAY"
28,"Down",0.139779039921347,0.435445720024978,"B.LvsP.REACTOME_MITOCHONDRIAL_CALCIUM_ION_TRANSPORT"
110,"Down",0.139793118655152,0.435445720024978,"B.LvsP.POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_UP"
34,"Up",0.139989683075549,0.435812476196346,"B.LvsP.KIM_MYCL1_AMPLIFICATION_TARGETS_DN"
11,"Down",0.140122228005873,0.435979627824689,"B.LvsP.KEGG_VALINE_LEUCINE_AND_ISOLEUCINE_BIOSYNTHESIS"
833,"Down",0.14075492943233,0.437701914978264,"B.LvsP.RODWELL_AGING_KIDNEY_UP"
72,"Up",0.141056441071555,0.438392952605188,"B.LvsP.MOSERLE_IFNA_RESPONSE"
67,"Down",0.141240641652106,0.438718824547468,"B.LvsP.MA_MYELOID_DIFFERENTIATION_UP"
62,"Up",0.141394817680216,0.438951121254302,"B.LvsP.KORKOLA_CORRELATED_WITH_POU5F1"
12,"Up",0.141562213680817,0.439069318115349,"B.LvsP.VANDESLUIS_NORMAL_EMBRYOS_UP"
60,"Up",0.141608577128639,0.439069318115349,"B.LvsP.PID_NFAT_TFPATHWAY"
30,"Up",0.141671127422279,0.439069318115349,"B.LvsP.REACTOME_BUDDING_AND_MATURATION_OF_HIV_VIRION"
18,"Down",0.141783653712561,0.43917188872647,"B.LvsP.NADELLA_PRKAR1A_TARGETS_DN"
11,"Up",0.141951950264787,0.439446994968648,"B.LvsP.WALLACE_PROSTATE_CANCER_DN"
13,"Up",0.142064090550462,0.439548045133467,"B.LvsP.REACTOME_RNF_MUTANTS_SHOW_ENHANCED_WNT_SIGNALING_AND_PROLIFERATION"
330,"Down",0.142311678146901,0.439682713385905,"B.LvsP.ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP"
26,"Up",0.142371920156361,0.439682713385905,"B.LvsP.BARRIER_COLON_CANCER_RECURRENCE_DN"
42,"Up",0.142384613432454,0.439682713385905,"B.LvsP.REACTOME_MYOGENESIS"
353,"Up",0.142508326708246,0.439682713385905,"B.LvsP.TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP"
162,"Down",0.14254058765312,0.439682713385905,"B.LvsP.PURBEY_TARGETS_OF_CTBP1_AND_SATB1_UP"
10,"Down",0.14262561223839,0.439682713385905,"B.LvsP.MATZUK_CUMULUS_EXPANSION"
34,"Up",0.14266427705088,0.439682713385905,"B.LvsP.REACTOME_CD209_DC_SIGN_SIGNALING"
19,"Up",0.142784701347368,0.439808698467744,"B.LvsP.MATZUK_PREOVULATORY_FOLLICLE"
189,"Up",0.142946465898937,0.440033624508521,"B.LvsP.ROSS_ACUTE_MYELOID_LEUKEMIA_CBF"
759,"Up",0.143037399959559,0.440033624508521,"B.LvsP.FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN"
199,"Up",0.143115343168966,0.440033624508521,"B.LvsP.WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN"
225,"Up",0.143281308863558,0.440033624508521,"B.LvsP.SENGUPTA_EBNA1_ANTICORRELATED"
112,"Up",0.143313138074604,0.440033624508521,"B.LvsP.BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_CIS"
181,"Up",0.143335242854014,0.440033624508521,"B.LvsP.NIKOLSKY_MUTATED_AND_AMPLIFIED_IN_BREAST_CANCER"
57,"Down",0.14408144852628,0.441844566410884,"B.LvsP.ABBUD_LIF_SIGNALING_1_UP"
706,"Up",0.144084961699914,0.441844566410884,"B.LvsP.JOHNSTONE_PARVB_TARGETS_3_UP"
63,"Down",0.144226538779108,0.442033554827987,"B.LvsP.TSUNODA_CISPLATIN_RESISTANCE_DN"
298,"Down",0.144751371528183,0.442934508666281,"B.LvsP.VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP"
65,"Up",0.144834985373745,0.442934508666281,"B.LvsP.GROSS_HYPOXIA_VIA_ELK3_ONLY_DN"
27,"Up",0.144839565659962,0.442934508666281,"B.LvsP.GRANDVAUX_IFN_RESPONSE_NOT_VIA_IRF3"
35,"Down",0.144840946223302,0.442934508666281,"B.LvsP.REACTOME_RECOGNITION_OF_DNA_DAMAGE_BY_PCNA_CONTAINING_REPLICATION_COMPLEX"
67,"Up",0.144954728564918,0.44303742080455,"B.LvsP.ZHAN_MULTIPLE_MYELOMA_PR_DN"
5,"Down",0.145649698335048,0.444915570217945,"B.LvsP.REACTOME_SUMO_IS_CONJUGATED_TO_E1_UBA2_SAE1"
114,"Up",0.146193170177782,0.446329120879601,"B.LvsP.STAMBOLSKY_TARGETS_OF_MUTATED_TP53_DN"
303,"Up",0.146321442430354,0.446474202647587,"B.LvsP.FIGUEROA_AML_METHYLATION_CLUSTER_3_UP"
214,"Up",0.14677076572729,0.447214200256658,"B.LvsP.NIKOLSKY_BREAST_CANCER_8Q23_Q24_AMPLICON"
168,"Up",0.146920137429965,0.447214200256658,"B.LvsP.BROWNE_HCMV_INFECTION_16HR_DN"
82,"Down",0.146947884075327,0.447214200256658,"B.LvsP.HALMOS_CEBPA_TARGETS_UP"
191,"Up",0.146997422316926,0.447214200256658,"B.LvsP.ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP"
32,"Up",0.147023306238587,0.447214200256658,"B.LvsP.TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_TOP20_DN"
12,"Down",0.147049270404522,0.447214200256658,"B.LvsP.REACTOME_INTERLEUKIN_23_SIGNALING"
1302,"Down",0.147277645177007,0.447514938125242,"B.LvsP.SMID_BREAST_CANCER_BASAL_UP"
62,"Down",0.147310035700477,0.447514938125242,"B.LvsP.REACTOME_HSF1_DEPENDENT_TRANSACTIVATION"
37,"Up",0.14748200812997,0.447748808396932,"B.LvsP.BIOCARTA_LIS1_PATHWAY"
22,"Down",0.147548983342234,0.447748808396932,"B.LvsP.REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS"
37,"Up",0.147826149596117,0.448343818495299,"B.LvsP.BIOCARTA_ECM_PATHWAY"
39,"Down",0.148414462924467,0.449713585168785,"B.LvsP.PID_IL2_STAT5_PATHWAY"
21,"Down",0.148440458117749,0.449713585168785,"B.LvsP.REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_DIFFERENTIATION_OF_KERATINOCYTES"
36,"Up",0.148571857966543,0.449865171246997,"B.LvsP.REACTOME_DIGESTION"
95,"Up",0.148940702380424,0.450735163361449,"B.LvsP.KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC"
18,"Down",0.149074410770081,0.450794364798732,"B.LvsP.BAKER_HEMATOPOIESIS_STAT3_TARGETS"
14,"Down",0.149123330297862,0.450794364798732,"B.LvsP.REACTOME_GLUTAMATE_AND_GLUTAMINE_METABOLISM"
53,"Down",0.149229408487314,0.450868524331345,"B.LvsP.BIOCARTA_CTL_PATHWAY"
7,"Up",0.149620599587923,0.451799236904612,"B.LvsP.SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX3"
19,"Down",0.149700886599611,0.451799236904612,"B.LvsP.REACTOME_TRANSPORT_OF_ORGANIC_ANIONS"
1130,"Up",0.150008430332294,0.452480420789555,"B.LvsP.FORTSCHEGGER_PHF8_TARGETS_DN"
196,"Up",0.15028238257521,0.453053638686581,"B.LvsP.AMBROSINI_FLAVOPIRIDOL_TREATMENT_TP53"
37,"Up",0.150362348885852,0.453053638686581,"B.LvsP.SIG_CD40PATHWAYMAP"
21,"Up",0.150588054470514,0.453298740022249,"B.LvsP.REACTOME_BRANCHED_CHAIN_AMINO_ACID_CATABOLISM"
160,"Up",0.150648931145287,0.453298740022249,"B.LvsP.GAVIN_FOXP3_TARGETS_CLUSTER_P7"
357,"Down",0.15068965168401,0.453298740022249,"B.LvsP.REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS"
17,"Up",0.151009397209053,0.454007293011915,"B.LvsP.TURASHVILI_BREAST_NORMAL_DUCTAL_VS_LOBULAR_DN"
28,"Down",0.151089422886946,0.454007293011915,"B.LvsP.REACTOME_MECP2_REGULATES_NEURONAL_RECEPTORS_AND_CHANNELS"
75,"Down",0.152255313297209,0.456917023865168,"B.LvsP.VARELA_ZMPSTE24_TARGETS_UP"
23,"Down",0.152288140604924,0.456917023865168,"B.LvsP.REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI"
172,"Up",0.152355102583194,0.456917023865168,"B.LvsP.REACTOME_SIGNALING_BY_NTRKS"
181,"Up",0.15238831470562,0.456917023865168,"B.LvsP.GRADE_COLON_AND_RECTAL_CANCER_DN"
244,"Up",0.15247442474988,0.456927422461835,"B.LvsP.FIRESTEIN_PROLIFERATION"
981,"Up",0.152726090358997,0.457433669336345,"B.LvsP.BROWNE_HCMV_INFECTION_48HR_DN"
74,"Down",0.152906942026558,0.457727386283074,"B.LvsP.KLEIN_TARGETS_OF_BCR_ABL1_FUSION"
160,"Down",0.153574775194951,0.459477777084893,"B.LvsP.REACTOME_PTEN_REGULATION"
429,"Down",0.154271355052285,0.461312234766946,"B.LvsP.HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN"
13,"Up",0.154529424430605,0.46183415550098,"B.LvsP.JOHNSTONE_PARVB_TARGETS_1_UP"
29,"Down",0.154659589491154,0.461973457750725,"B.LvsP.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_15"
22,"Up",0.154937397840358,0.462553386965085,"B.LvsP.MEISSNER_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3"
24,"Up",0.155130378792887,0.462879581406299,"B.LvsP.BIOCARTA_ACTINY_PATHWAY"
13,"Down",0.155369155152403,0.463341995058056,"B.LvsP.REACTOME_MITOCHONDRIAL_IRON_SULFUR_CLUSTER_BIOGENESIS"
134,"Up",0.155544633057811,0.463615243221906,"B.LvsP.DELASERNA_MYOD_TARGETS_UP"
49,"Down",0.155634998005235,0.463634646536069,"B.LvsP.VANDESLUIS_NORMAL_EMBRYOS_DN"
18,"Down",0.155820957128088,0.463938649413678,"B.LvsP.REACTOME_PROCESSING_OF_SMDT1"
96,"Down",0.155926545593678,0.464003159627257,"B.LvsP.REACTOME_GLOBAL_GENOME_NUCLEOTIDE_EXCISION_REPAIR_GG_NER"
9,"Up",0.156015211026018,0.464017268296317,"B.LvsP.GROSS_HYPOXIA_VIA_HIF1A_ONLY"
165,"Down",0.156184548066454,0.464271164655603,"B.LvsP.SENESE_HDAC2_TARGETS_UP"
94,"Down",0.156510847701992,0.464991121410162,"B.LvsP.GERHOLD_ADIPOGENESIS_DN"
72,"Down",0.156700418298271,0.465144924359894,"B.LvsP.VALK_AML_CLUSTER_11"
17,"Up",0.156730872505423,0.465144924359894,"B.LvsP.REACTOME_GLYCOGEN_BREAKDOWN_GLYCOGENOLYSIS"
30,"Down",0.156931360381685,0.465490070574215,"B.LvsP.BIOCARTA_CTLA4_PATHWAY"
18,"Up",0.157065417753167,0.465637906036066,"B.LvsP.STEINER_ERYTHROCYTE_MEMBRANE_GENES"
6,"Down",0.157201604440106,0.465791892255813,"B.LvsP.REACTOME_NADE_MODULATES_DEATH_SIGNALLING"
54,"Up",0.157453536133067,0.466288484884695,"B.LvsP.BIOCARTA_MET_PATHWAY"
9,"Down",0.157745549695277,0.466667444753629,"B.LvsP.REACTOME_RUNX3_REGULATES_IMMUNE_RESPONSE_AND_CELL_MIGRATION"
34,"Down",0.157750308237391,0.466667444753629,"B.LvsP.REACTOME_DOWNREGULATION_OF_ERBB2_SIGNALING"
28,"Down",0.157953462558114,0.466860514016797,"B.LvsP.HASEGAWA_TUMORIGENESIS_BY_RET_C634R"
51,"Down",0.15806122017227,0.466860514016797,"B.LvsP.REACTOME_INTERLEUKIN_2_FAMILY_SIGNALING"
23,"Up",0.158068888088161,0.466860514016797,"B.LvsP.CHEOK_RESPONSE_TO_MERCAPTOPURINE_DN"
22,"Up",0.158303691104219,0.467304382335946,"B.LvsP.KIM_PTEN_TARGETS_UP"
26,"Up",0.158501698774534,0.467639216928707,"B.LvsP.SCIBETTA_KDM5B_TARGETS_UP"
68,"Down",0.15876521475716,0.468166865275913,"B.LvsP.BRACHAT_RESPONSE_TO_CAMPTOTHECIN_DN"
35,"Up",0.158980678031041,0.468552328802572,"B.LvsP.BIOCARTA_STRESS_PATHWAY"
17,"Up",0.159095814948854,0.468641854476405,"B.LvsP.BRUNEAU_SEPTATION_VENTRICULAR"
41,"Up",0.159401048852919,0.46929094734174,"B.LvsP.REACTOME_EGR2_AND_SOX10_MEDIATED_INITIATION_OF_SCHWANN_CELL_MYELINATION"
64,"Up",0.159748928738925,0.469565299911766,"B.LvsP.WHITEHURST_PACLITAXEL_SENSITIVITY"
110,"Up",0.159750445732722,0.469565299911766,"B.LvsP.LIN_MELANOMA_COPY_NUMBER_UP"
36,"Down",0.159826771775074,0.469565299911766,"B.LvsP.GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_UP"
39,"Down",0.159953904893234,0.469565299911766,"B.LvsP.MARSON_FOXP3_TARGETS_STIMULATED_UP"
87,"Down",0.159957189011885,0.469565299911766,"B.LvsP.HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_DN"
162,"Down",0.160046212018956,0.469565299911766,"B.LvsP.DASU_IL6_SIGNALING_UP"
42,"Up",0.160088730391333,0.469565299911766,"B.LvsP.PID_IGF1_PATHWAY"
227,"Up",0.160963309472606,0.471880242881251,"B.LvsP.BROWNE_HCMV_INFECTION_10HR_UP"
60,"Up",0.161719792896922,0.473426092478396,"B.LvsP.CROONQUIST_NRAS_VS_STROMAL_STIMULATION_UP"
325,"Up",0.161723537406489,0.473426092478396,"B.LvsP.LINSLEY_MIR16_TARGETS"
325,"Down",0.161747492980953,0.473426092478396,"B.LvsP.WIERENGA_STAT5A_TARGETS_UP"
291,"Down",0.162085777080434,0.474060307097645,"B.LvsP.SHEPARD_BMYB_MORPHOLINO_UP"
10,"Up",0.16213565576445,0.474060307097645,"B.LvsP.DONATO_CELL_CYCLE_TRETINOIN"
79,"Down",0.162270356469731,0.474203383150711,"B.LvsP.SPIRA_SMOKERS_LUNG_CANCER_UP"
16,"Up",0.162407997494231,0.474354896009298,"B.LvsP.REACTOME_ERYTHROPOIETIN_ACTIVATES_PHOSPHOINOSITIDE_3_KINASE_PI3K"
321,"Up",0.162839096746268,0.475362917587178,"B.LvsP.WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN"
9,"Down",0.163353670090561,0.476613425820956,"B.LvsP.REACTOME_ADRENOCEPTORS"
27,"Down",0.163579447585989,0.476864386573339,"B.LvsP.REACTOME_COMMON_PATHWAY_OF_FIBRIN_CLOT_FORMATION"
10,"Up",0.163612179658098,0.476864386573339,"B.LvsP.SA_FAS_SIGNALING"
20,"Down",0.163790885648779,0.476913422819843,"B.LvsP.VANDESLUIS_COMMD1_TARGETS_GROUP_4_UP"
29,"Down",0.163880702085474,0.476913422819843,"B.LvsP.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_DN"
25,"Up",0.163887774164894,0.476913422819843,"B.LvsP.VERRECCHIA_RESPONSE_TO_TGFB1_C3"
36,"Down",0.164691554744663,0.478849839269705,"B.LvsP.GENTILE_UV_RESPONSE_CLUSTER_D9"
358,"Up",0.164750827168899,0.478849839269705,"B.LvsP.BROWNE_HCMV_INFECTION_18HR_DN"
124,"Down",0.164813030227934,0.478849839269705,"B.LvsP.CHEBOTAEV_GR_TARGETS_UP"
18,"Down",0.16491728841002,0.478901096438551,"B.LvsP.REACTOME_SHC1_EVENTS_IN_EGFR_SIGNALING"
6,"Up",0.165103693709149,0.479071518633249,"B.LvsP.REACTOME_SENSING_OF_DNA_DOUBLE_STRAND_BREAKS"
109,"Down",0.165149270123887,0.479071518633249,"B.LvsP.LEE_EARLY_T_LYMPHOCYTE_DN"
30,"Up",0.16540865363091,0.479572336615259,"B.LvsP.AMIT_SERUM_RESPONSE_20_MCF10A"
34,"Up",0.166037476945604,0.4811431918408,"B.LvsP.REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_7ALPHA_HYDROXYCHOLESTEROL"
595,"Up",0.166295047745303,0.48148138994646,"B.LvsP.BROWNE_HCMV_INFECTION_4HR_DN"
15,"Up",0.166328351383205,0.48148138994646,"B.LvsP.RAFFEL_VEGFA_TARGETS_UP"
29,"Down",0.166521537334552,0.48178837253937,"B.LvsP.REACTOME_METABOLISM_OF_COFACTORS"
18,"Down",0.166718301029739,0.482105379912881,"B.LvsP.BIOCARTA_MCM_PATHWAY"
67,"Up",0.167783655547599,0.484932478579548,"B.LvsP.PID_ILK_PATHWAY"
135,"Down",0.167996533196677,0.485229307998206,"B.LvsP.CORRE_MULTIPLE_MYELOMA_UP"
27,"Up",0.168108371124529,0.485229307998206,"B.LvsP.TSAI_DNAJB4_TARGETS_UP"
14,"Down",0.168157158242983,0.485229307998206,"B.LvsP.REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_SEVERAL_ADDITIONAL_CELL_DEATH_GENES_WHOSE_SPECIFIC_ROLES_IN_P53_DEPENDENT_APOPTOSIS_REMAIN_UNCERTAIN"
171,"Down",0.168237399788852,0.485229307998206,"B.LvsP.REACTOME_HOMOLOGY_DIRECTED_REPAIR"
438,"Up",0.168573918184454,0.485946399187616,"B.LvsP.OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN"
19,"Up",0.16867034051758,0.485970981095207,"B.LvsP.SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX5_UP"
32,"Down",0.169098680506313,0.486909967811359,"B.LvsP.LEE_SP4_THYMOCYTE"
27,"Down",0.169172372610892,0.486909967811359,"B.LvsP.KARAKAS_TGFB1_SIGNALING"
13,"Down",0.16954552283385,0.487555323431136,"B.LvsP.BIOCARTA_FIBRINOLYSIS_PATHWAY"
13,"Up",0.169572958393575,0.487555323431136,"B.LvsP.THILLAINADESAN_ZNF217_TARGETS_DN"
28,"Up",0.169865135652084,0.488141546268385,"B.LvsP.REACTOME_NOTCH4_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION"
165,"Down",0.169985669903157,0.48823416565951,"B.LvsP.FURUKAWA_DUSP6_TARGETS_PCI35_UP"
319,"Down",0.170097126721357,0.488300630136232,"B.LvsP.SHEPARD_CRUSH_AND_BURN_MUTANT_DN"
79,"Down",0.170308698923909,0.488404029087157,"B.LvsP.HOWLIN_CITED1_TARGETS_1_UP"
36,"Up",0.170363975949798,0.488404029087157,"B.LvsP.REACTOME_CREB1_PHOSPHORYLATION_THROUGH_NMDA_RECEPTOR_MEDIATED_ACTIVATION_OF_RAS_SIGNALING"
19,"Up",0.170398150137299,0.488404029087157,"B.LvsP.TSUTSUMI_FBXW8_TARGETS"
32,"Down",0.170599732040139,0.488536649259221,"B.LvsP.CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_HD_MTX_DN"
33,"Up",0.170677394739438,0.488536649259221,"B.LvsP.REACTOME_LONG_TERM_POTENTIATION"
259,"Up",0.170709496539847,0.488536649259221,"B.LvsP.MIKKELSEN_MCV6_LCP_WITH_H3K4ME3"
8,"Down",0.170848235762002,0.488680752989192,"B.LvsP.FARDIN_HYPOXIA_9"
12,"Up",0.171144031220314,0.488748187303396,"B.LvsP.OHM_EMBRYONIC_CARCINOMA_DN"
330,"Up",0.171190368225072,0.488748187303396,"B.LvsP.TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP"
35,"Down",0.171218497675206,0.488748187303396,"B.LvsP.GENTLES_LEUKEMIC_STEM_CELL_DN"
465,"Up",0.17122540039911,0.488748187303396,"B.LvsP.RICKMAN_METASTASIS_UP"
264,"Up",0.17176718813287,0.489792344383742,"B.LvsP.POOLA_INVASIVE_BREAST_CANCER_DN"
97,"Down",0.171768376878292,0.489792344383742,"B.LvsP.AMIT_SERUM_RESPONSE_120_MCF10A"
71,"Up",0.171902243638605,0.489921394370025,"B.LvsP.PID_AJDISS_2PATHWAY"
990,"Up",0.172166118067435,0.490144134536321,"B.LvsP.REACTOME_VESICLE_MEDIATED_TRANSPORT"
48,"Down",0.172176569056661,0.490144134536321,"B.LvsP.YANG_BREAST_CANCER_ESR1_BULK_UP"
42,"Down",0.172318217415202,0.490144134536321,"B.LvsP.ABBUD_LIF_SIGNALING_2_UP"
34,"Down",0.172334996841853,0.490144134536321,"B.LvsP.PARK_HSC_VS_MULTIPOTENT_PROGENITORS_UP"
261,"Down",0.172524685445312,0.490431355181045,"B.LvsP.KAUFFMANN_DNA_REPAIR_GENES"
63,"Down",0.172886436052209,0.491207145391912,"B.LvsP.SU_PLACENTA"
30,"Down",0.173742464106072,0.493148054986714,"B.LvsP.STREICHER_LSM1_TARGETS_DN"
59,"Up",0.173747949197706,0.493148054986714,"B.LvsP.PID_CXCR3_PATHWAY"
289,"Down",0.173876577838559,0.493249334856819,"B.LvsP.BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_DN"
36,"Up",0.173962055158401,0.493249334856819,"B.LvsP.KEGG_BASAL_TRANSCRIPTION_FACTORS"
31,"Up",0.174055936333058,0.493262568931563,"B.LvsP.CAFFAREL_RESPONSE_TO_THC_8HR_5_UP"
9,"Up",0.174268200418211,0.493537404502291,"B.LvsP.REACTOME_SIGNALLING_TO_P38_VIA_RIT_AND_RIN"
218,"Down",0.174331443478563,0.493537404502291,"B.LvsP.KATSANOU_ELAVL1_TARGETS_DN"
47,"Up",0.174865680146849,0.494436754156645,"B.LvsP.REACTOME_SEMA4D_IN_SEMAPHORIN_SIGNALING"
225,"Up",0.174916013501804,0.494436754156645,"B.LvsP.BIDUS_METASTASIS_DN"
637,"Down",0.174917397563827,0.494436754156645,"B.LvsP.MOHANKUMAR_HOXA1_TARGETS_UP"
313,"Down",0.175136630414192,0.494615665809307,"B.LvsP.CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN"
1260,"Down",0.175198339072762,0.494615665809307,"B.LvsP.ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_UP"
58,"Up",0.175249066616103,0.494615665809307,"B.LvsP.NAKAMURA_ADIPOGENESIS_EARLY_DN"
54,"Down",0.175514260047177,0.495031975900145,"B.LvsP.AIYAR_COBRA1_TARGETS_DN"
16,"Up",0.175575638404808,0.495031975900145,"B.LvsP.REACTOME_PYRIMIDINE_CATABOLISM"
43,"Down",0.176276464018746,0.496754622609403,"B.LvsP.ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_DN"
50,"Up",0.176482584452012,0.497082124011805,"B.LvsP.PID_P38_ALPHA_BETA_DOWNSTREAM_PATHWAY"
10,"Up",0.176932972891018,0.497884307890311,"B.LvsP.REACTOME_NEUROTOXICITY_OF_CLOSTRIDIUM_TOXINS"
42,"Down",0.17702651002826,0.497884307890311,"B.LvsP.DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_DN"
51,"Up",0.17723617842382,0.497884307890311,"B.LvsP.REACTOME_SIGNALING_BY_FGFR1_IN_DISEASE"
12,"Up",0.177339190041989,0.497884307890311,"B.LvsP.BOYAULT_LIVER_CANCER_SUBCLASS_G23_DN"
12,"Up",0.177357689765732,0.497884307890311,"B.LvsP.TCGA_GLIOBLASTOMA_MUTATED"
11,"Down",0.177617015231159,0.497884307890311,"B.LvsP.REACTOME_UREA_CYCLE"
194,"Up",0.177872976821466,0.497884307890311,"B.LvsP.FIGUEROA_AML_METHYLATION_CLUSTER_6_UP"
443,"Down",0.177951714983987,0.497884307890311,"B.LvsP.WEST_ADRENOCORTICAL_TUMOR_UP"
33,"Down",0.178013875274741,0.497884307890311,"B.LvsP.REACTOME_PIWI_INTERACTING_RNA_PIRNA_BIOGENESIS"
8,"Up",0.178053271424436,0.497884307890311,"B.LvsP.REACTOME_CHREBP_ACTIVATES_METABOLIC_GENE_EXPRESSION"
183,"Up",0.178100597586911,0.497884307890311,"B.LvsP.YORDY_RECIPROCAL_REGULATION_BY_ETS1_AND_SP100_DN"
6,"Up",0.178114756009522,0.497884307890311,"B.LvsP.REACTOME_SYNTHESIS_OF_PI"
195,"Up",0.1781162819773,0.497884307890311,"B.LvsP.FIGUEROA_AML_METHYLATION_CLUSTER_7_UP"
96,"Down",0.178193410421534,0.497884307890311,"B.LvsP.OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_UP"
56,"Down",0.178289808276497,0.497884307890311,"B.LvsP.KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION"
15,"Down",0.178402763724185,0.497884307890311,"B.LvsP.REACTOME_MRNA_DECAY_BY_5_TO_3_EXORIBONUCLEASE"
27,"Up",0.178434998434169,0.497884307890311,"B.LvsP.REACTOME_ERK_MAPK_TARGETS"
11,"Up",0.17847640611547,0.497884307890311,"B.LvsP.REACTOME_ERYTHROPOIETIN_ACTIVATES_STAT5"
19,"Up",0.178478332110435,0.497884307890311,"B.LvsP.WILLIAMS_ESR2_TARGETS_DN"
12,"Down",0.178584748602056,0.497929942017533,"B.LvsP.REACTOME_SYNTHESIS_OF_15_EICOSATETRAENOIC_ACID_DERIVATIVES"
240,"Down",0.178684300357592,0.49795639953484,"B.LvsP.TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN"
12,"Down",0.179388641126836,0.499667403924573,"B.LvsP.REACTOME_VITAMIN_D_CALCIFEROL_METABOLISM"
323,"Down",0.179537199473108,0.499689045725538,"B.LvsP.VILLANUEVA_LIVER_CANCER_KRT19_UP"
75,"Up",0.179658568390885,0.499689045725538,"B.LvsP.PID_HEDGEHOG_GLI_PATHWAY"
26,"Down",0.179685704666996,0.499689045725538,"B.LvsP.FERRANDO_HOX11_NEIGHBORS"
11,"Up",0.179757914984282,0.499689045725538,"B.LvsP.LINDGREN_BLADDER_CANCER_CLUSTER_2A_UP"
92,"Up",0.17987721810343,0.499769416529579,"B.LvsP.KEGG_ERBB_SIGNALING_PATHWAY"
26,"Up",0.180286518624585,0.500466297068304,"B.LvsP.ZHENG_FOXP3_TARGETS_IN_THYMUS_DN"
161,"Down",0.180364514869534,0.500466297068304,"B.LvsP.MARTIN_VIRAL_GPCR_SIGNALING_UP"
72,"Up",0.180399589447844,0.500466297068304,"B.LvsP.NICK_RESPONSE_TO_PROC_TREATMENT_DN"
8,"Up",0.180686459695631,0.501010750078808,"B.LvsP.REACTOME_DEFECTIVE_CHST6_CAUSES_MCDC1"
62,"Down",0.181263251409697,0.502131684043173,"B.LvsP.KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_UP"
10,"Up",0.181272353291766,0.502131684043173,"B.LvsP.MIKKELSEN_DEDIFFERENTIATED_STATE_UP"
28,"Up",0.181393778552035,0.502216425445269,"B.LvsP.BIOCARTA_EPHA4_PATHWAY"
5,"Up",0.182071889747495,0.503841580787739,"B.LvsP.REACTOME_SYNTHESIS_OF_GDP_MANNOSE"
16,"Up",0.182346620642599,0.504148658994144,"B.LvsP.HOFMANN_MYELODYSPLASTIC_SYNDROM_HIGH_RISK_UP"
10,"Down",0.182458281017395,0.504148658994144,"B.LvsP.SASAI_TARGETS_OF_CXCR6_AND_PTCH1_DN"
8,"Up",0.182575945090605,0.504148658994144,"B.LvsP.REACTOME_PHOSPHATE_BOND_HYDROLYSIS_BY_NUDT_PROTEINS"
5,"Down",0.182616428124399,0.504148658994144,"B.LvsP.REACTOME_MELANIN_BIOSYNTHESIS"
13,"Up",0.182638770838356,0.504148658994144,"B.LvsP.REACTOME_ACETYLCHOLINE_REGULATES_INSULIN_SECRETION"
10,"Up",0.183071184160205,0.505090108394098,"B.LvsP.BIOCARTA_MITR_PATHWAY"
31,"Down",0.183271240627481,0.505389870039573,"B.LvsP.TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_MONOCYTE_UP"
19,"Up",0.183411115278571,0.505523457814167,"B.LvsP.REACTOME_CARNITINE_METABOLISM"
29,"Down",0.183701307518656,0.505962214013809,"B.LvsP.LEI_HOXC8_TARGETS_UP"
179,"Down",0.183837865935811,0.505962214013809,"B.LvsP.TSENG_IRS1_TARGETS_UP"
177,"Down",0.183844834138857,0.505962214013809,"B.LvsP.JAZAG_TGFB1_SIGNALING_UP"
22,"Down",0.184055224757963,0.50628922272974,"B.LvsP.BIOCARTA_NPP1_PATHWAY"
18,"Up",0.184477891871618,0.507199534638576,"B.LvsP.REACTOME_RUNX3_REGULATES_P14_ARF"
103,"Up",0.184654079362923,0.507358319435186,"B.LvsP.FIGUEROA_AML_METHYLATION_CLUSTER_2_UP"
106,"Down",0.184719171102013,0.507358319435186,"B.LvsP.GUO_HEX_TARGETS_DN"
127,"Down",0.185045041853202,0.508001011125299,"B.LvsP.MORI_SMALL_PRE_BII_LYMPHOCYTE_DN"
73,"Down",0.185187058464822,0.508138583747892,"B.LvsP.WENG_POR_DOSAGE"
1095,"Down",0.185568309768334,0.508932135272381,"B.LvsP.SMID_BREAST_CANCER_LUMINAL_B_DN"
52,"Down",0.185896227548779,0.509578702090827,"B.LvsP.ELVIDGE_HIF1A_AND_HIF2A_TARGETS_UP"
143,"Down",0.18652533296593,0.510792930460009,"B.LvsP.PID_AP1_PATHWAY"
385,"Up",0.186562031064226,0.510792930460009,"B.LvsP.COLDREN_GEFITINIB_RESISTANCE_DN"
49,"Down",0.186632799682381,0.510792930460009,"B.LvsP.PACHER_TARGETS_OF_IGF1_AND_IGF2_UP"
194,"Down",0.186743324231977,0.510792930460009,"B.LvsP.GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_DN"
132,"Up",0.186801104248533,0.510792930460009,"B.LvsP.REACTOME_SIGNALING_BY_VEGF"
87,"Down",0.187219855779501,0.511684914782433,"B.LvsP.SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE"
20,"Down",0.187381534382405,0.511802312827431,"B.LvsP.BIOCARTA_CBL_PATHWAY"
64,"Down",0.187534567009091,0.511802312827431,"B.LvsP.POS_HISTAMINE_RESPONSE_NETWORK"
132,"Up",0.187543230109408,0.511802312827431,"B.LvsP.BOSCO_INTERFERON_INDUCED_ANTIVIRAL_MODULE"
48,"Up",0.187723342693884,0.511802312827431,"B.LvsP.LI_PROSTATE_CANCER_EPIGENETIC"
33,"Down",0.187759802554768,0.511802312827431,"B.LvsP.REACTOME_SYNTHESIS_OF_PROSTAGLANDINS_PG_AND_THROMBOXANES_TX"
5,"Down",0.187818211742966,0.511802312827431,"B.LvsP.REACTOME_ACTIVATION_OF_NOXA_AND_TRANSLOCATION_TO_MITOCHONDRIA"
36,"Up",0.187932977660326,0.511862775115242,"B.LvsP.YAO_HOXA10_TARGETS_VIA_PROGESTERONE_DN"
29,"Down",0.188401680723001,0.512614104648501,"B.LvsP.LANDEMAINE_LUNG_METASTASIS"
24,"Down",0.188406580645507,0.512614104648501,"B.LvsP.RUAN_RESPONSE_TO_TROGLITAZONE_DN"
46,"Down",0.188486973186906,0.512614104648501,"B.LvsP.KEGG_NUCLEOTIDE_EXCISION_REPAIR"
19,"Down",0.188668166960632,0.512854619039003,"B.LvsP.REACTOME_TRANSLESION_SYNTHESIS_BY_POLK"
16,"Up",0.189055092352845,0.513269881422277,"B.LvsP.REACTOME_SIGNALING_BY_LEPTIN"
13,"Down",0.18906135696762,0.513269881422277,"B.LvsP.BIOCARTA_PLCE_PATHWAY"
22,"Down",0.189099429997681,0.513269881422277,"B.LvsP.REACTOME_REGULATION_OF_KIT_SIGNALING"
30,"Down",0.189234823286991,0.513385347376728,"B.LvsP.SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_UP"
84,"Up",0.189400967217803,0.513584084231109,"B.LvsP.REACTOME_RNA_POLYMERASE_II_TRANSCRIBES_SNRNA_GENES"
216,"Up",0.189586198603015,0.513834358860819,"B.LvsP.PECE_MAMMARY_STEM_CELL_DN"
29,"Up",0.189708206062505,0.513913116766089,"B.LvsP.MURAKAMI_UV_RESPONSE_1HR_UP"
53,"Down",0.189806780590022,0.513928349599525,"B.LvsP.XU_HGF_SIGNALING_NOT_VIA_AKT1_6HR"
20,"Down",0.190620019173648,0.515691191149858,"B.LvsP.MIKKELSEN_ES_LCP_WITH_H3K4ME3_AND_H3K27ME3"
96,"Up",0.19064438319955,0.515691191149858,"B.LvsP.REACTOME_NONHOMOLOGOUS_END_JOINING_NHEJ"
556,"Down",0.190776526750612,0.515796291640164,"B.LvsP.MEISSNER_NPC_HCP_WITH_H3K4ME2_AND_H3K27ME3"
13,"Down",0.191285354076195,0.516871432328137,"B.LvsP.BIOCARTA_RNA_PATHWAY"
251,"Down",0.191361154273051,0.516871432328137,"B.LvsP.HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_UP"
109,"Up",0.191708829871491,0.517399633912289,"B.LvsP.KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_DN"
512,"Up",0.191824357111177,0.517399633912289,"B.LvsP.DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP"
56,"Down",0.191837447914667,0.517399633912289,"B.LvsP.SHAFFER_IRF4_MULTIPLE_MYELOMA_PROGRAM"
353,"Up",0.191960395865861,0.517461876341289,"B.LvsP.CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP"
11,"Down",0.192073475961386,0.517461876341289,"B.LvsP.REACTOME_ABACAVIR_METABOLISM"
124,"Up",0.192205799406694,0.517461876341289,"B.LvsP.MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_DN"
55,"Up",0.192234887684031,0.517461876341289,"B.LvsP.FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_DN"
238,"Down",0.192336930512926,0.517484617423829,"B.LvsP.WHITFIELD_CELL_CYCLE_G2"
5,"Down",0.19272491354866,0.518237050253615,"B.LvsP.REACTOME_BETA_OXIDATION_OF_OCTANOYL_COA_TO_HEXANOYL_COA"
16,"Up",0.192804053603126,0.518237050253615,"B.LvsP.KEGG_OTHER_GLYCAN_DEGRADATION"
9,"Up",0.193003245949295,0.518477717807748,"B.LvsP.REACTOME_FATTY_ACIDS_BOUND_TO_GPR40_FFAR1_REGULATE_INSULIN_SECRETION"
185,"Down",0.193097259498439,0.518477717807748,"B.LvsP.PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_4"
62,"Up",0.193174913851322,0.518477717807748,"B.LvsP.SIG_BCR_SIGNALING_PATHWAY"
50,"Down",0.193354421439776,0.518707712828978,"B.LvsP.LOPEZ_MESOTHELIOMA_SURVIVAL_OVERALL_DN"
97,"Up",0.193481378995384,0.518796578305276,"B.LvsP.BROWNE_HCMV_INFECTION_30MIN_UP"
35,"Down",0.193746630559998,0.519255996299675,"B.LvsP.REACTOME_GAP_JUNCTION_ASSEMBLY"
181,"Down",0.19404907807598,0.519814608857603,"B.LvsP.ONDER_CDH1_SIGNALING_VIA_CTNNB1"
20,"Up",0.194176965168897,0.519905298023647,"B.LvsP.SU_SALIVARY_GLAND"
37,"Up",0.194295591728447,0.519971116489151,"B.LvsP.BIOCARTA_EDG1_PATHWAY"
81,"Up",0.194763431155959,0.520970977678422,"B.LvsP.KEGG_RIG_I_LIKE_RECEPTOR_SIGNALING_PATHWAY"
8,"Down",0.19508840560895,0.521587908419673,"B.LvsP.RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_MAPK1_DN"
110,"Down",0.195491158173824,0.522412089677657,"B.LvsP.ROSS_AML_WITH_CBFB_MYH11_FUSION"
38,"Down",0.195951252970905,0.523388636558519,"B.LvsP.NAKAJIMA_EOSINOPHIL"
10,"Up",0.19627596598766,0.523793795591039,"B.LvsP.BIOCARTA_CB1R_PATHWAY"
73,"Down",0.196627788874731,0.523793795591039,"B.LvsP.ZHAN_MULTIPLE_MYELOMA_HP_UP"
30,"Up",0.196649192585385,0.523793795591039,"B.LvsP.YIH_RESPONSE_TO_ARSENITE_C2"
15,"Up",0.1968092410033,0.523793795591039,"B.LvsP.STANHILL_HRAS_TRANSFROMATION_UP"
98,"Up",0.196960059686869,0.523793795591039,"B.LvsP.ZWANG_EGF_PERSISTENTLY_DN"
31,"Up",0.196982186165487,0.523793795591039,"B.LvsP.REACTOME_PI_3K_CASCADE_FGFR1"
41,"Down",0.19710389938343,0.523793795591039,"B.LvsP.ZHAN_MULTIPLE_MYELOMA_SPIKED"
863,"Down",0.197230881358784,0.523793795591039,"B.LvsP.CHICAS_RB1_TARGETS_SENESCENT"
29,"Up",0.197254128932336,0.523793795591039,"B.LvsP.PID_HEDGEHOG_2PATHWAY"
44,"Down",0.197365031944678,0.523793795591039,"B.LvsP.YANG_BREAST_CANCER_ESR1_BULK_DN"
11,"Down",0.197399404059887,0.523793795591039,"B.LvsP.REACTOME_PYRIMIDINE_SALVAGE"
36,"Up",0.197529193925504,0.523793795591039,"B.LvsP.PID_ECADHERIN_KERATINOCYTE_PATHWAY"
1863,"Down",0.197534287867926,0.523793795591039,"B.LvsP.BLALOCK_ALZHEIMERS_DISEASE_DN"
105,"Up",0.197591206536592,0.523793795591039,"B.LvsP.GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_DN"
251,"Down",0.19759715818057,0.523793795591039,"B.LvsP.SABATES_COLORECTAL_ADENOMA_UP"
302,"Down",0.197656180934566,0.523793795591039,"B.LvsP.MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP"
9,"Up",0.197824509518869,0.523793795591039,"B.LvsP.PALOMERO_GSI_SENSITIVITY_UP"
29,"Down",0.197972699445507,0.523793795591039,"B.LvsP.RUAN_RESPONSE_TO_TNF_UP"
168,"Up",0.198093628993141,0.523793795591039,"B.LvsP.REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA"
14,"Down",0.198285859233832,0.523793795591039,"B.LvsP.XU_HGF_TARGETS_REPRESSED_BY_AKT1_UP"
330,"Down",0.198296809567243,0.523793795591039,"B.LvsP.REACTOME_METABOLISM_OF_CARBOHYDRATES"
45,"Down",0.198349270401944,0.523793795591039,"B.LvsP.MURATA_VIRULENCE_OF_H_PILORI"
46,"Down",0.198406060121793,0.523793795591039,"B.LvsP.REACTOME_DUAL_INCISION_IN_GG_NER"
11,"Up",0.198443591768807,0.523793795591039,"B.LvsP.REACTOME_PHENYLALANINE_METABOLISM"
78,"Up",0.19847133329051,0.523793795591039,"B.LvsP.OSADA_ASCL1_TARGETS_UP"
46,"Down",0.199150102632574,0.524847593208485,"B.LvsP.MARSHALL_VIRAL_INFECTION_RESPONSE_DN"
9,"Down",0.199160396637526,0.524847593208485,"B.LvsP.REACTOME_SODIUM_PROTON_EXCHANGERS"
1090,"Up",0.199256932582443,0.524847593208485,"B.LvsP.LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN"
342,"Down",0.199378181140736,0.524847593208485,"B.LvsP.ZWANG_CLASS_3_TRANSIENTLY_INDUCED_BY_EGF"
54,"Down",0.19945841524816,0.524847593208485,"B.LvsP.CREIGHTON_AKT1_SIGNALING_VIA_MTOR_UP"
15,"Up",0.199494988827252,0.524847593208485,"B.LvsP.REACTOME_VLDLR_INTERNALISATION_AND_DEGRADATION"
197,"Up",0.199535113207494,0.524847593208485,"B.LvsP.HUMMERICH_SKIN_CANCER_PROGRESSION_DN"
25,"Down",0.199709568541452,0.525056683055486,"B.LvsP.WALLACE_PROSTATE_CANCER_UP"
64,"Down",0.199883036480569,0.525262979420659,"B.LvsP.BYSTROEM_CORRELATED_WITH_IL5_UP"
58,"Up",0.200049514416245,0.5254507198135,"B.LvsP.KEGG_BASAL_CELL_CARCINOMA"
117,"Up",0.200562013356918,0.526546710280341,"B.LvsP.BHAT_ESR1_TARGETS_VIA_AKT1_DN"
6,"Up",0.201043657598503,0.527538602796213,"B.LvsP.ZIRN_TRETINOIN_RESPONSE_WT1_DN"
31,"Up",0.201185472703383,0.527538602796213,"B.LvsP.REACTOME_PLATELET_CALCIUM_HOMEOSTASIS"
26,"Down",0.201226064984123,0.527538602796213,"B.LvsP.BIOCARTA_CSK_PATHWAY"
196,"Down",0.201400575513531,0.527745868253228,"B.LvsP.SU_TESTIS"
118,"Down",0.201627989817941,0.528091499622642,"B.LvsP.KEGG_OOCYTE_MEIOSIS"
67,"Up",0.201924343091903,0.528413328985778,"B.LvsP.PID_ECADHERIN_NASCENT_AJ_PATHWAY"
42,"Up",0.201942008346346,0.528413328985778,"B.LvsP.PID_S1P_S1P1_PATHWAY"
22,"Up",0.202148749818099,0.528704085971746,"B.LvsP.MIKKELSEN_IPS_LCP_WITH_H3K27ME3"
57,"Down",0.202669233330477,0.529814747557546,"B.LvsP.KEGG_TRYPTOPHAN_METABOLISM"
23,"Down",0.203058205469752,0.530580726863071,"B.LvsP.ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN"
651,"Down",0.203445104715118,0.531111721736813,"B.LvsP.TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C"
125,"Up",0.20349619165599,0.531111721736813,"B.LvsP.REACTOME_CELL_JUNCTION_ORGANIZATION"
53,"Up",0.203551972972365,0.531111721736813,"B.LvsP.SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_DN"
15,"Up",0.20364565926606,0.531111721736813,"B.LvsP.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_9"
276,"Down",0.203777991538717,0.531206277801776,"B.LvsP.AMIT_EGF_RESPONSE_480_HELA"
73,"Down",0.204113867621674,0.531672080664192,"B.LvsP.ZHAN_MULTIPLE_MYELOMA_CD2_DN"
68,"Down",0.204149001130418,0.531672080664192,"B.LvsP.CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_DN"
867,"Down",0.204298448477118,0.531810791727865,"B.LvsP.NABA_MATRISOME_ASSOCIATED"
16,"Up",0.204580481663632,0.53229434499681,"B.LvsP.BIOCARTA_CDC42RAC_PATHWAY"
90,"Up",0.205151406020207,0.532949200345766,"B.LvsP.PID_LYSOPHOSPHOLIPID_PATHWAY"
61,"Down",0.20519593026853,0.532949200345766,"B.LvsP.ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_DN"
82,"Up",0.205251796316755,0.532949200345766,"B.LvsP.KEGG_GLYCEROPHOSPHOLIPID_METABOLISM"
768,"Down",0.205343657436751,0.532949200345766,"B.LvsP.SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP"
72,"Up",0.205439143888432,0.532949200345766,"B.LvsP.SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_DN"
37,"Down",0.205497174207348,0.532949200345766,"B.LvsP.GAJATE_RESPONSE_TO_TRABECTEDIN_DN"
36,"Down",0.205506908145627,0.532949200345766,"B.LvsP.KONG_E2F1_TARGETS"
20,"Down",0.205640944164493,0.533040782037515,"B.LvsP.REACTOME_MAP3K8_TPL2_DEPENDENT_MAPK1_3_ACTIVATION"
762,"Up",0.205771212954516,0.533040782037515,"B.LvsP.LIM_MAMMARY_STEM_CELL_UP"
12,"Down",0.205876242712782,0.533040782037515,"B.LvsP.MUNSHI_MULTIPLE_MYELOMA_DN"
15,"Down",0.205930030003334,0.533040782037515,"B.LvsP.REACTOME_PTK6_REGULATES_RTKS_AND_THEIR_EFFECTORS_AKT1_AND_DOK1"
173,"Down",0.20602426319663,0.533040782037515,"B.LvsP.HUANG_GATA2_TARGETS_DN"
23,"Down",0.206138766860367,0.533087578096805,"B.LvsP.REACTOME_NA_CL_DEPENDENT_NEUROTRANSMITTER_TRANSPORTERS"
151,"Up",0.20635691270085,0.53340223016503,"B.LvsP.KEGG_INSULIN_SIGNALING_PATHWAY"
121,"Up",0.207260005351344,0.535319877370899,"B.LvsP.DELPUECH_FOXO3_TARGETS_UP"
13,"Up",0.207292432166955,0.535319877370899,"B.LvsP.KEGG_NON_HOMOLOGOUS_END_JOINING"
11,"Down",0.207733657095463,0.535996337325803,"B.LvsP.REACTOME_ARYL_HYDROCARBON_RECEPTOR_SIGNALLING"
1160,"Up",0.207748263861312,0.535996337325803,"B.LvsP.WONG_ADULT_TISSUE_STEM_MODULE"
54,"Up",0.208377402239897,0.537368776578541,"B.LvsP.REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY"
254,"Up",0.209283961686179,0.539209047161278,"B.LvsP.CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_DN"
75,"Down",0.209315980207463,0.539209047161278,"B.LvsP.NUTT_GBM_VS_AO_GLIOMA_DN"
12,"Down",0.209473440930758,0.539209047161278,"B.LvsP.MATZUK_MATERNAL_EFFECT"
38,"Down",0.209481105679585,0.539209047161278,"B.LvsP.KANG_AR_TARGETS_DN"
8,"Down",0.210706559220926,0.54144236320793,"B.LvsP.REACTOME_METAL_SEQUESTRATION_BY_ANTIMICROBIAL_PROTEINS"
90,"Up",0.210747685197162,0.54144236320793,"B.LvsP.JI_RESPONSE_TO_FSH_DN"
61,"Down",0.210850789853306,0.54144236320793,"B.LvsP.REACTOME_RUNX2_REGULATES_BONE_DEVELOPMENT"
28,"Up",0.210856598508341,0.54144236320793,"B.LvsP.REACTOME_DOPAMINE_NEUROTRANSMITTER_RELEASE_CYCLE"
29,"Down",0.211025742405198,0.54144236320793,"B.LvsP.TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN"
1127,"Down",0.21109731487063,0.54144236320793,"B.LvsP.REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM"
22,"Up",0.211125948072029,0.54144236320793,"B.LvsP.BIOCARTA_ARAP_PATHWAY"
176,"Down",0.21113216405793,0.54144236320793,"B.LvsP.ZHONG_SECRETOME_OF_LUNG_CANCER_AND_ENDOTHELIUM"
7,"Up",0.211272276289618,0.541550494021929,"B.LvsP.BIOCARTA_FOSB_PATHWAY"
33,"Up",0.212102380758753,0.543104066445072,"B.LvsP.RAMPON_ENRICHED_LEARNING_ENVIRONMENT_LATE_UP"
9,"Up",0.212172779904334,0.543104066445072,"B.LvsP.DER_IFN_GAMMA_RESPONSE_DN"
24,"Down",0.212238799345053,0.543104066445072,"B.LvsP.REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_BETA_CELLS"
71,"Down",0.212271276467318,0.543104066445072,"B.LvsP.SHIPP_DLBCL_CURED_VS_FATAL_DN"
112,"Down",0.212532567793031,0.54332012509253,"B.LvsP.JAZAG_TGFB1_SIGNALING_VIA_SMAD4_DN"
5,"Up",0.212649837038193,0.54332012509253,"B.LvsP.REACTOME_TYROSINE_CATABOLISM"
33,"Up",0.212650524633792,0.54332012509253,"B.LvsP.BIOCARTA_TOLL_PATHWAY"
42,"Down",0.212903518807244,0.543567884041226,"B.LvsP.BRACHAT_RESPONSE_TO_METHOTREXATE_DN"
8,"Up",0.212944119521305,0.543567884041226,"B.LvsP.REACTOME_SIGNALING_BY_NOTCH1_T_7_9_NOTCH1_M1580_K2555_TRANSLOCATION_MUTANT"
62,"Down",0.213268278741536,0.543894882731067,"B.LvsP.AIYAR_COBRA1_TARGETS_UP"
46,"Up",0.213268964688181,0.543894882731067,"B.LvsP.REACTOME_ASSEMBLY_AND_CELL_SURFACE_PRESENTATION_OF_NMDA_RECEPTORS"
25,"Down",0.213550520322761,0.544361838111825,"B.LvsP.HOLLERN_PAPILLARY_BREAST_TUMOR"
25,"Up",0.213840961634378,0.544747893776039,"B.LvsP.KEGG_GLYCOSAMINOGLYCAN_DEGRADATION"
236,"Down",0.213943054766816,0.544747893776039,"B.LvsP.REACTOME_PROGRAMMED_CELL_DEATH"
186,"Down",0.21406547109518,0.544747893776039,"B.LvsP.CHUNG_BLISTER_CYTOTOXICITY_UP"
16,"Down",0.214112766393535,0.544747893776039,"B.LvsP.SHIN_B_CELL_LYMPHOMA_CLUSTER_6"
106,"Down",0.214194595961134,0.544747893776039,"B.LvsP.RICKMAN_HEAD_AND_NECK_CANCER_B"
39,"Up",0.214340841640976,0.544869201578371,"B.LvsP.JOHANSSON_GLIOMAGENESIS_BY_PDGFB_DN"
415,"Up",0.214474855967228,0.544959319229228,"B.LvsP.TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_UP"
108,"Down",0.214724932083654,0.545190737923784,"B.LvsP.LEE_LIVER_CANCER_DENA_UP"
386,"Down",0.214763144727437,0.545190737923784,"B.LvsP.KONDO_PROSTATE_CANCER_WITH_H3K27ME3"
27,"Up",0.214982823430801,0.545497948943965,"B.LvsP.BIOCARTA_BCELLSURVIVAL_PATHWAY"
130,"Down",0.215492855540872,0.546255678261904,"B.LvsP.REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS"
19,"Down",0.215540668287646,0.546255678261904,"B.LvsP.GALLUZZI_PREVENT_MITOCHONDIAL_PERMEABILIZATION"
18,"Down",0.215929863391128,0.546255678261904,"B.LvsP.REACTOME_SHC1_EVENTS_IN_ERBB4_SIGNALING"
13,"Down",0.216039605686899,0.546255678261904,"B.LvsP.BIOCARTA_EIF2_PATHWAY"
6,"Down",0.21607281211663,0.546255678261904,"B.LvsP.REACTOME_MITOCHONDRIAL_FATTY_ACID_BETA_OXIDATION_OF_UNSATURATED_FATTY_ACIDS"
563,"Up",0.216076084981693,0.546255678261904,"B.LvsP.RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN"
17,"Up",0.216097044785961,0.546255678261904,"B.LvsP.REACTOME_PHOSPHORYLATION_SITE_MUTANTS_OF_CTNNB1_ARE_NOT_TARGETED_TO_THE_PROTEASOME_BY_THE_DESTRUCTION_COMPLEX"
7,"Down",0.216106313591054,0.546255678261904,"B.LvsP.REACTOME_MET_ACTIVATES_PTPN11"
105,"Down",0.21628894611474,0.546255678261904,"B.LvsP.REACTOME_TELOMERE_MAINTENANCE"
15,"Down",0.21630914881004,0.546255678261904,"B.LvsP.REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_ASSOCIATION_WITH_CO_FACTORS"
70,"Down",0.216368228503087,0.546255678261904,"B.LvsP.LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_UP"
9,"Down",0.216921757405079,0.547403193378676,"B.LvsP.ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_2HR"
67,"Down",0.217380088745436,0.548309539540836,"B.LvsP.YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_8"
25,"Up",0.218021346013431,0.549486786964359,"B.LvsP.REACTOME_NITRIC_OXIDE_STIMULATES_GUANYLATE_CYCLASE"
16,"Up",0.21804557977931,0.549486786964359,"B.LvsP.WAESCH_ANAPHASE_PROMOTING_COMPLEX"
26,"Down",0.218922550295314,0.551445458124279,"B.LvsP.SMID_BREAST_CANCER_NORMAL_LIKE_DN"
16,"Down",0.219047884263928,0.55150990532571,"B.LvsP.NIKOLSKY_BREAST_CANCER_1Q32_AMPLICON"
62,"Up",0.219430393903294,0.551903367030939,"B.LvsP.REACTOME_APOPTOTIC_CLEAVAGE_OF_CELLULAR_PROTEINS"
100,"Down",0.21950622665099,0.551903367030939,"B.LvsP.REACTOME_DAP12_INTERACTIONS"
24,"Up",0.219529230690199,0.551903367030939,"B.LvsP.CAIRO_PML_TARGETS_BOUND_BY_MYC_DN"
65,"Up",0.219603437776825,0.551903367030939,"B.LvsP.CHIARETTI_T_ALL_REFRACTORY_TO_THERAPY"
145,"Down",0.220240526392376,0.553253007916149,"B.LvsP.UEDA_CENTRAL_CLOCK"
5,"Up",0.220474673546125,0.553375210097231,"B.LvsP.REACTOME_ACTIVATION_OF_RAS_IN_B_CELLS"
28,"Up",0.220825562016118,0.553375210097231,"B.LvsP.KRISHNAN_FURIN_TARGETS_UP"
80,"Down",0.22084912125706,0.553375210097231,"B.LvsP.MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_6"
195,"Up",0.22094403151918,0.553375210097231,"B.LvsP.BOYAULT_LIVER_CANCER_SUBCLASS_G1_UP"
26,"Down",0.22096282102866,0.553375210097231,"B.LvsP.REACTOME_PROTEIN_METHYLATION"
259,"Down",0.220976564640748,0.553375210097231,"B.LvsP.RICKMAN_HEAD_AND_NECK_CANCER_C"
19,"Up",0.220989774623745,0.553375210097231,"B.LvsP.REACTOME_ALPHA_LINOLENIC_OMEGA3_AND_LINOLEIC_OMEGA6_ACID_METABOLISM"
129,"Down",0.222379563378065,0.556603262072124,"B.LvsP.REACTOME_NEGATIVE_EPIGENETIC_REGULATION_OF_RRNA_EXPRESSION"
355,"Down",0.223213002162712,0.558406204052579,"B.LvsP.IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_UP"
26,"Up",0.223301884094819,0.558406204052579,"B.LvsP.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_DN"
143,"Down",0.223771341139204,0.559080223165736,"B.LvsP.SWEET_KRAS_TARGETS_DN"
12,"Up",0.223773654162737,0.559080223165736,"B.LvsP.MIKKELSEN_PLURIPOTENT_STATE_UP"
133,"Up",0.223920403999909,0.559194179636629,"B.LvsP.VANTVEER_BREAST_CANCER_METASTASIS_UP"
19,"Down",0.224192280424727,0.559620369511655,"B.LvsP.REACTOME_PENTOSE_PHOSPHATE_PATHWAY"
49,"Up",0.224408349246271,0.559906932753895,"B.LvsP.PID_NECTIN_PATHWAY"
11,"Up",0.224686700334008,0.560282656335178,"B.LvsP.MARIADASON_RESPONSE_TO_BUTYRATE_CURCUMIN_SULINDAC_TSA_8"
17,"Down",0.224800291185691,0.560282656335178,"B.LvsP.PID_ERBB_NETWORK_PATHWAY"
77,"Down",0.224862943463151,0.560282656335178,"B.LvsP.DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_DN"
107,"Down",0.225123648048172,0.560679572098352,"B.LvsP.PHONG_TNF_TARGETS_UP"
29,"Up",0.225447635668174,0.560986923123197,"B.LvsP.REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY"
206,"Up",0.225524358484692,0.560986923123197,"B.LvsP.ROPERO_HDAC2_TARGETS"
291,"Up",0.225551443317574,0.560986923123197,"B.LvsP.DARWICHE_PAPILLOMA_RISK_LOW_DN"
101,"Down",0.226023164753261,0.561907409137041,"B.LvsP.MARTINEZ_RESPONSE_TO_TRABECTEDIN_UP"
14,"Up",0.226247303092049,0.561976512614307,"B.LvsP.XU_AKT1_TARGETS_48HR"
83,"Down",0.226415782929059,0.561976512614307,"B.LvsP.DELACROIX_RAR_TARGETS_UP"
166,"Up",0.226447768773865,0.561976512614307,"B.LvsP.KESHELAVA_MULTIPLE_DRUG_RESISTANCE"
188,"Down",0.226569018372419,0.561976512614307,"B.LvsP.WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_UP"
6,"Down",0.226610160410687,0.561976512614307,"B.LvsP.ZHAN_EARLY_DIFFERENTIATION_GENES_UP"
20,"Down",0.226660810839194,0.561976512614307,"B.LvsP.SABATES_COLORECTAL_ADENOMA_SIZE_DN"
60,"Down",0.226769531297269,0.561994055823666,"B.LvsP.BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_UP"
19,"Down",0.226988403565469,0.56220258394438,"B.LvsP.NIKOLSKY_BREAST_CANCER_12Q24_AMPLICON"
31,"Up",0.227083859131715,0.56220258394438,"B.LvsP.GOERING_BLOOD_HDL_CHOLESTEROL_QTL_TRANS"
837,"Up",0.227348863013413,0.56220258394438,"B.LvsP.GRYDER_PAX3FOXO1_ENHANCERS_KO_DOWN"
35,"Up",0.227428386492124,0.56220258394438,"B.LvsP.REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS"
137,"Down",0.227585360631776,0.56220258394438,"B.LvsP.KYNG_DNA_DAMAGE_BY_GAMMA_RADIATION"
22,"Up",0.227592501379686,0.56220258394438,"B.LvsP.PID_ARF6_DOWNSTREAM_PATHWAY"
27,"Up",0.227617231930515,0.56220258394438,"B.LvsP.PHESSE_TARGETS_OF_APC_AND_MBD2_DN"
7,"Up",0.227727903805591,0.56220258394438,"B.LvsP.WEBER_METHYLATED_HCP_IN_FIBROBLAST_UP"
15,"Up",0.227768816790633,0.56220258394438,"B.LvsP.REACTOME_SIGNALING_BY_FGFR4_IN_DISEASE"
29,"Up",0.228118607155671,0.562814716181929,"B.LvsP.REACTOME_G_PROTEIN_ACTIVATION"
29,"Down",0.228274119056115,0.562843959524956,"B.LvsP.KEGG_PHENYLALANINE_METABOLISM"
13,"Down",0.228334057011119,0.562843959524956,"B.LvsP.REACTOME_RUNX2_REGULATES_GENES_INVOLVED_IN_CELL_MIGRATION"
36,"Up",0.228525900814052,0.563014580898793,"B.LvsP.REACTOME_SIGNAL_AMPLIFICATION"
129,"Down",0.228675294035769,0.563014580898793,"B.LvsP.REACTOME_POSITIVE_EPIGENETIC_REGULATION_OF_RRNA_EXPRESSION"
318,"Down",0.228708762651237,0.563014580898793,"B.LvsP.REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR"
347,"Down",0.228896319262085,0.563071818314315,"B.LvsP.BLUM_RESPONSE_TO_SALIRASIB_UP"
26,"Up",0.228935693176086,0.563071818314315,"B.LvsP.AMIT_DELAYED_EARLY_GENES"
725,"Up",0.229041883627148,0.563082514261674,"B.LvsP.PEDRIOLI_MIR31_TARGETS_DN"
66,"Up",0.229223879436099,0.563092292477579,"B.LvsP.TING_SILENCED_BY_DICER"
149,"Up",0.229249547905052,0.563092292477579,"B.LvsP.GUO_TARGETS_OF_IRS1_AND_IRS2"
2169,"Down",0.229430435445844,0.563286357717615,"B.LvsP.PUJANA_ATM_PCC_NETWORK"
977,"Up",0.229558325892455,0.56333368121017,"B.LvsP.WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_8D"
48,"Down",0.229733937239091,0.56333368121017,"B.LvsP.WIKMAN_ASBESTOS_LUNG_CANCER_DN"
176,"Up",0.229755371880798,0.56333368121017,"B.LvsP.MACAEVA_PBMC_RESPONSE_TO_IR"
110,"Down",0.230297566949719,0.564168549259113,"B.LvsP.TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_UP"
28,"Down",0.230366777159823,0.564168549259113,"B.LvsP.REACTOME_SULFUR_AMINO_ACID_METABOLISM"
208,"Down",0.230422020729069,0.564168549259113,"B.LvsP.REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX"
94,"Up",0.230504024737988,0.564168549259113,"B.LvsP.BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_UP"
76,"Down",0.231109369767624,0.565399869666015,"B.LvsP.ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_DN"
45,"Down",0.231390537729442,0.565837365371997,"B.LvsP.LOPES_METHYLATED_IN_COLON_CANCER_UP"
235,"Up",0.231551497887226,0.565980650671296,"B.LvsP.REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION"
6,"Up",0.231657726663055,0.565990088696435,"B.LvsP.CALVET_IRINOTECAN_SENSITIVE_VS_RESISTANT_UP"
45,"Up",0.232102497996063,0.566504000418857,"B.LvsP.HOFMANN_MYELODYSPLASTIC_SYNDROM_RISK_DN"
87,"Down",0.232122874924852,0.566504000418857,"B.LvsP.SATO_SILENCED_BY_DEACETYLATION_IN_PANCREATIC_CANCER"
21,"Up",0.232335034432815,0.566504000418857,"B.LvsP.REACTOME_PI_3K_CASCADE_FGFR3"
112,"Up",0.232490206810192,0.566504000418857,"B.LvsP.REACTOME_DNA_DOUBLE_STRAND_BREAK_RESPONSE"
24,"Up",0.232518457436297,0.566504000418857,"B.LvsP.MATZUK_EARLY_ANTRAL_FOLLICLE"
260,"Down",0.232555791959887,0.566504000418857,"B.LvsP.DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN"
32,"Up",0.232622321612509,0.566504000418857,"B.LvsP.SILIGAN_TARGETS_OF_EWS_FLI1_FUSION_DN"
32,"Down",0.232832613516056,0.566504000418857,"B.LvsP.COLLER_MYC_TARGETS_DN"
26,"Down",0.232916763247172,0.566504000418857,"B.LvsP.REACTOME_TRAFFICKING_AND_PROCESSING_OF_ENDOSOMAL_TLR"
115,"Down",0.232975428314978,0.566504000418857,"B.LvsP.BASSO_CD40_SIGNALING_DN"
53,"Up",0.233179456138643,0.566504000418857,"B.LvsP.HU_ANGIOGENESIS_UP"
46,"Down",0.233304891298755,0.566504000418857,"B.LvsP.RAY_TARGETS_OF_P210_BCR_ABL_FUSION_UP"
39,"Up",0.233358706367604,0.566504000418857,"B.LvsP.BIOCARTA_RACCYCD_PATHWAY"
24,"Down",0.233382314785114,0.566504000418857,"B.LvsP.REACTOME_SYNTHESIS_SECRETION_AND_DEACYLATION_OF_GHRELIN"
13,"Up",0.233668171070786,0.566504000418857,"B.LvsP.FIRESTEIN_CTNNB1_PATHWAY_AND_PROLIFERATION"
8,"Up",0.23367972957061,0.566504000418857,"B.LvsP.TERAMOTO_OPN_TARGETS_CLUSTER_8"
43,"Down",0.233711497434715,0.566504000418857,"B.LvsP.LA_MEN1_TARGETS"
20,"Up",0.233712357561116,0.566504000418857,"B.LvsP.ONGUSAHA_BRCA1_TARGETS_DN"
67,"Up",0.234134083258353,0.567277540024292,"B.LvsP.NAKAMURA_METASTASIS"
6,"Up",0.234339094046905,0.567525558907287,"B.LvsP.NAKAMURA_BRONCHIAL_AND_BRONCHIOLAR_EPITHELIA"
111,"Down",0.234592132240364,0.56788304279,"B.LvsP.MCBRYAN_PUBERTAL_TGFB1_TARGETS_DN"
33,"Down",0.234692765424611,0.56788304279,"B.LvsP.KUROKAWA_LIVER_CANCER_EARLY_RECURRENCE_DN"
318,"Down",0.234794833752566,0.56788304279,"B.LvsP.REACTOME_FLT3_SIGNALING"
69,"Down",0.235043602810097,0.568236152136872,"B.LvsP.REACTOME_THE_ROLE_OF_NEF_IN_HIV_1_REPLICATION_AND_DISEASE_PATHOGENESIS"
60,"Down",0.235240324859708,0.568463180135196,"B.LvsP.PID_SYNDECAN_1_PATHWAY"
193,"Down",0.235462180307143,0.568750718618695,"B.LvsP.KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP"
74,"Down",0.235576553615758,0.568778499974466,"B.LvsP.KENNY_CTNNB1_TARGETS_UP"
80,"Down",0.236003204945466,0.569371028898451,"B.LvsP.HU_GENOTOXIC_DAMAGE_24HR"
83,"Down",0.236054568434108,0.569371028898451,"B.LvsP.DAUER_STAT3_TARGETS_UP"
201,"Up",0.236212456005109,0.569371028898451,"B.LvsP.STEIN_ESRRA_TARGETS_DN"
7,"Down",0.236274446381978,0.569371028898451,"B.LvsP.CAFFAREL_RESPONSE_TO_THC_8HR_3_UP"
9,"Up",0.236336862239455,0.569371028898451,"B.LvsP.TURJANSKI_MAPK8_AND_MAPK9_TARGETS"
142,"Down",0.236637382312579,0.569643857715811,"B.LvsP.KORKOLA_YOLK_SAC_TUMOR"
16,"Down",0.236676783793758,0.569643857715811,"B.LvsP.BIOCARTA_THELPER_PATHWAY"
89,"Down",0.236759194254103,0.569643857715811,"B.LvsP.KOHOUTEK_CCNT1_TARGETS"
21,"Down",0.237856672438493,0.572035468426457,"B.LvsP.REACTOME_ACYL_CHAIN_REMODELLING_OF_PG"
325,"Up",0.238021239352936,0.572182361905385,"B.LvsP.TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN"
266,"Up",0.238203679606916,0.572372074987673,"B.LvsP.MIKKELSEN_IPS_LCP_WITH_H3K4ME3"
21,"Up",0.238467467287955,0.572467905543005,"B.LvsP.BIOCARTA_NDKDYNAMIN_PATHWAY"
25,"Down",0.238541659056318,0.572467905543005,"B.LvsP.REACTOME_JNK_C_JUN_KINASES_PHOSPHORYLATION_AND_ACTIVATION_MEDIATED_BY_ACTIVATED_HUMAN_TAK1"
84,"Up",0.238554178761274,0.572467905543005,"B.LvsP.MIKKELSEN_NPC_LCP_WITH_H3K4ME3"
10,"Up",0.239093722741449,0.573267528967647,"B.LvsP.CASTELLANO_HRAS_AND_NRAS_TARGETS_UP"
32,"Up",0.239094758871296,0.573267528967647,"B.LvsP.REACTOME_SIGNALING_BY_ERYTHROPOIETIN"
92,"Down",0.239351964751395,0.573334238342392,"B.LvsP.MALONEY_RESPONSE_TO_17AAG_UP"
60,"Down",0.239428898211539,0.573334238342392,"B.LvsP.REACTOME_METABOLIC_DISORDERS_OF_BIOLOGICAL_OXIDATION_ENZYMES"
12,"Up",0.239433669078058,0.573334238342392,"B.LvsP.REACTOME_ACTIVATED_NTRK2_SIGNALS_THROUGH_PI3K"
709,"Down",0.240033622245252,0.574522033503897,"B.LvsP.MIKKELSEN_MCV6_HCP_WITH_H3K27ME3"
135,"Up",0.240204167787468,0.574681455515755,"B.LvsP.HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP"
125,"Up",0.24089533025381,0.57608576166666,"B.LvsP.FLORIO_HUMAN_NEOCORTEX"
8,"Down",0.241498494199893,0.577152603704552,"B.LvsP.REACTOME_BETA_OXIDATION_OF_BUTANOYL_COA_TO_ACETYL_COA"
8,"Up",0.241555344899255,0.577152603704552,"B.LvsP.NAISHIRO_CTNNB1_TARGETS_WITH_LEF1_MOTIF"
107,"Up",0.241809221859358,0.577152603704552,"B.LvsP.REACTOME_SELECTIVE_AUTOPHAGY"
102,"Up",0.24202226557161,0.577152603704552,"B.LvsP.REACTOME_SEMAPHORIN_INTERACTIONS"
22,"Up",0.242048697555606,0.577152603704552,"B.LvsP.REACTOME_SEROTONIN_NEUROTRANSMITTER_RELEASE_CYCLE"
72,"Down",0.242065690594184,0.577152603704552,"B.LvsP.REACTOME_IRE1ALPHA_ACTIVATES_CHAPERONES"
168,"Up",0.242072144689972,0.577152603704552,"B.LvsP.LINDGREN_BLADDER_CANCER_CLUSTER_1_UP"
8,"Down",0.242289322001531,0.577421405752788,"B.LvsP.NIKOLSKY_BREAST_CANCER_19Q13.4_AMPLICON"
153,"Down",0.242535194211513,0.577691835828065,"B.LvsP.REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION"
105,"Up",0.242611763934304,0.577691835828065,"B.LvsP.PID_VEGFR1_2_PATHWAY"
843,"Up",0.243184390258352,0.57880606704194,"B.LvsP.MCCABE_BOUND_BY_HOXC6"
22,"Up",0.243444692438214,0.579176292810192,"B.LvsP.REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_27_HYDROXYCHOLESTEROL"
31,"Down",0.243557718949048,0.579195969062058,"B.LvsP.FERRARI_RESPONSE_TO_FENRETINIDE_UP"
185,"Down",0.24384175237961,0.579622119048523,"B.LvsP.MORI_MATURE_B_LYMPHOCYTE_UP"
96,"Down",0.244317507680334,0.579632460624766,"B.LvsP.CORRE_MULTIPLE_MYELOMA_DN"
23,"Down",0.244350783538438,0.579632460624766,"B.LvsP.REACTOME_RAF_INDEPENDENT_MAPK1_3_ACTIVATION"
29,"Down",0.244388061729445,0.579632460624766,"B.LvsP.GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_DN"
84,"Up",0.244440804803987,0.579632460624766,"B.LvsP.LEIN_ASTROCYTE_MARKERS"
60,"Up",0.2444515846849,0.579632460624766,"B.LvsP.PID_TNF_PATHWAY"
160,"Up",0.244475112710609,0.579632460624766,"B.LvsP.HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_UP"
233,"Down",0.244656043318592,0.579812800475137,"B.LvsP.REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES"
25,"Down",0.244965342055121,0.580297076359367,"B.LvsP.MIKKELSEN_ES_LCP_WITH_H3K27ME3"
173,"Down",0.245206059548219,0.580532369386725,"B.LvsP.REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION"
636,"Down",0.245274663571602,0.580532369386725,"B.LvsP.RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP"
103,"Up",0.2456564362394,0.580844986181356,"B.LvsP.BILD_SRC_ONCOGENIC_SIGNATURE"
103,"Up",0.245672841414165,0.580844986181356,"B.LvsP.LINDVALL_IMMORTALIZED_BY_TERT_UP"
533,"Up",0.245721906796562,0.580844986181356,"B.LvsP.HORIUCHI_WTAP_TARGETS_UP"
25,"Down",0.246057992429176,0.58139087185509,"B.LvsP.NGO_MALIGNANT_GLIOMA_1P_LOH"
73,"Down",0.246371795477352,0.581883663901872,"B.LvsP.URS_ADIPOCYTE_DIFFERENTIATION_DN"
518,"Up",0.246610030496539,0.582020833047941,"B.LvsP.CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN"
36,"Down",0.24664040727642,0.582020833047941,"B.LvsP.PID_IL3_PATHWAY"
26,"Up",0.246891383620765,0.582263950516563,"B.LvsP.SCHWAB_TARGETS_OF_BMYB_POLYMORPHIC_VARIANTS_DN"
48,"Down",0.247130027950318,0.582263950516563,"B.LvsP.JACKSON_DNMT1_TARGETS_DN"
76,"Down",0.247198317793908,0.582263950516563,"B.LvsP.REACTOME_DAP12_SIGNALING"
75,"Down",0.247252996845161,0.582263950516563,"B.LvsP.PID_AMB2_NEUTROPHILS_PATHWAY"
848,"Down",0.247361434227259,0.582263950516563,"B.LvsP.MATSUDA_NATURAL_KILLER_DIFFERENTIATION"
125,"Down",0.247462925103994,0.582263950516563,"B.LvsP.TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP"
140,"Up",0.247480608376546,0.582263950516563,"B.LvsP.KEGG_LYSOSOME"
13,"Down",0.247635486936632,0.582376236294059,"B.LvsP.REACTOME_PROCESSIVE_SYNTHESIS_ON_THE_C_STRAND_OF_THE_TELOMERE"
143,"Up",0.247738995797364,0.582376236294059,"B.LvsP.REACTOME_INTEGRATION_OF_ENERGY_METABOLISM"
101,"Down",0.247976692674833,0.582519089842202,"B.LvsP.ZHOU_TNF_SIGNALING_30MIN"
287,"Down",0.248051425973,0.582519089842202,"B.LvsP.KYNG_DNA_DAMAGE_DN"
129,"Up",0.248132919367688,0.582519089842202,"B.LvsP.REACTOME_RUNX1_REGULATES_GENES_INVOLVED_IN_MEGAKARYOCYTE_DIFFERENTIATION_AND_PLATELET_FUNCTION"
30,"Up",0.24822119292245,0.582519089842202,"B.LvsP.REACTOME_REGULATION_OF_IFNA_SIGNALING"
19,"Up",0.248336443498582,0.582542297880211,"B.LvsP.REACTOME_REGULATION_OF_RUNX1_EXPRESSION_AND_ACTIVITY"
27,"Down",0.248486329789285,0.582550805592081,"B.LvsP.WILSON_PROTEASES_AT_TUMOR_BONE_INTERFACE_UP"
54,"Down",0.248550795874791,0.582550805592081,"B.LvsP.PLASARI_TGFB1_SIGNALING_VIA_NFIC_10HR_DN"
80,"Up",0.248981689424475,0.58312181759195,"B.LvsP.REACTOME_APOPTOTIC_EXECUTION_PHASE"
105,"Down",0.249028853869428,0.58312181759195,"B.LvsP.LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_DN"
42,"Up",0.249224267020299,0.58312181759195,"B.LvsP.BONOME_OVARIAN_CANCER_POOR_SURVIVAL_DN"
307,"Up",0.249474223743138,0.58312181759195,"B.LvsP.CAIRO_HEPATOBLASTOMA_UP"
31,"Up",0.249502838249926,0.58312181759195,"B.LvsP.KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_UV_IN_OLD"
8,"Down",0.249528935924623,0.58312181759195,"B.LvsP.LE_SKI_TARGETS_DN"
175,"Down",0.249555154961478,0.58312181759195,"B.LvsP.COATES_MACROPHAGE_M1_VS_M2_DN"
24,"Up",0.249638151969641,0.58312181759195,"B.LvsP.KIM_GERMINAL_CENTER_T_HELPER_DN"
965,"Down",0.250054555552513,0.583439601661254,"B.LvsP.PATIL_LIVER_CANCER"
25,"Up",0.250063695407221,0.583439601661254,"B.LvsP.REACTOME_PURINE_CATABOLISM"
22,"Up",0.250124801964409,0.583439601661254,"B.LvsP.SARTIPY_NORMAL_AT_INSULIN_RESISTANCE_DN"
17,"Down",0.250221828735212,0.583439601661254,"B.LvsP.BIOCARTA_IL10_PATHWAY"
43,"Down",0.250325560251414,0.583439601661254,"B.LvsP.WILLERT_WNT_SIGNALING"
40,"Up",0.25055746871223,0.583439601661254,"B.LvsP.REACTOME_MAPK_TARGETS_NUCLEAR_EVENTS_MEDIATED_BY_MAP_KINASES"
29,"Down",0.250678032724163,0.583439601661254,"B.LvsP.ELLWOOD_MYC_TARGETS_UP"
90,"Up",0.250728026784146,0.583439601661254,"B.LvsP.KEGG_LONG_TERM_DEPRESSION"
12,"Up",0.250818531291574,0.583439601661254,"B.LvsP.REACTOME_REGULATION_OF_GENE_EXPRESSION_BY_HYPOXIA_INDUCIBLE_FACTOR"
52,"Down",0.250829432654875,0.583439601661254,"B.LvsP.WANG_RESPONSE_TO_BEXAROTENE_UP"
17,"Down",0.25097814493942,0.583540018238037,"B.LvsP.REACTOME_RETINOID_CYCLE_DISEASE_EVENTS"
16,"Up",0.251216012485935,0.583847554869581,"B.LvsP.REACTOME_TNFR1_INDUCED_PROAPOPTOTIC_SIGNALING"
78,"Up",0.251578372547423,0.584444042779286,"B.LvsP.PID_CASPASE_PATHWAY"
8,"Down",0.251766079062583,0.584634460788334,"B.LvsP.REACTOME_DEFECTIVE_CHST3_CAUSES_SEDCJD"
24,"Down",0.251918305717564,0.58474236453082,"B.LvsP.HOLLEMAN_DAUNORUBICIN_B_ALL_UP"
9,"Down",0.252412322041568,0.585427238478106,"B.LvsP.RODRIGUES_DCC_TARGETS_UP"
16,"Down",0.252425128690867,0.585427238478106,"B.LvsP.REACTOME_GOLGI_CISTERNAE_PERICENTRIOLAR_STACK_REORGANIZATION"
58,"Down",0.252556816740031,0.585487060694186,"B.LvsP.SCHLINGEMANN_SKIN_CARCINOGENESIS_TPA_DN"
118,"Up",0.252992346959253,0.5858910060144,"B.LvsP.LEE_AGING_NEOCORTEX_DN"
10,"Up",0.253026359188691,0.5858910060144,"B.LvsP.BIOCARTA_TUBBY_PATHWAY"
234,"Down",0.253241013176996,0.5858910060144,"B.LvsP.DARWICHE_SKIN_TUMOR_PROMOTER_UP"
40,"Down",0.253357396880622,0.5858910060144,"B.LvsP.WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_DN"
185,"Down",0.253407344821818,0.5858910060144,"B.LvsP.REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS"
48,"Down",0.253545359304284,0.5858910060144,"B.LvsP.GRADE_COLON_VS_RECTAL_CANCER_UP"
309,"Down",0.25365427331969,0.5858910060144,"B.LvsP.NABA_ECM_REGULATORS"
56,"Down",0.2536661224587,0.5858910060144,"B.LvsP.KEGG_GLUTATHIONE_METABOLISM"
18,"Down",0.253684765490771,0.5858910060144,"B.LvsP.REACTOME_NEUROTRANSMITTER_CLEARANCE"
32,"Up",0.254018806768774,0.586388206066147,"B.LvsP.BIOCARTA_RAC1_PATHWAY"
38,"Up",0.254237087818594,0.586388206066147,"B.LvsP.HOEGERKORP_CD44_TARGETS_DIRECT_DN"
251,"Up",0.2543575857906,0.586388206066147,"B.LvsP.ONDER_CDH1_TARGETS_1_UP"
75,"Down",0.254364349423381,0.586388206066147,"B.LvsP.PID_INTEGRIN3_PATHWAY"
82,"Down",0.254450594220527,0.586388206066147,"B.LvsP.CHEN_ETV5_TARGETS_TESTIS"
8,"Up",0.254591056036698,0.586388206066147,"B.LvsP.REACTOME_DEFECTIVE_ST3GAL3_CAUSES_MCT12_AND_EIEE15"
96,"Up",0.254826709417955,0.586388206066147,"B.LvsP.MIKKELSEN_ES_HCP_WITH_H3K27ME3"
18,"Down",0.255051481709067,0.586388206066147,"B.LvsP.MALIK_REPRESSED_BY_ESTROGEN"
27,"Down",0.255190127327165,0.586388206066147,"B.LvsP.REACTOME_SHC1_EVENTS_IN_ERBB2_SIGNALING"
92,"Up",0.25519247619245,0.586388206066147,"B.LvsP.ZHU_CMV_8_HR_DN"
13,"Up",0.255284365301424,0.586388206066147,"B.LvsP.TURJANSKI_MAPK14_TARGETS"
123,"Down",0.255330506072287,0.586388206066147,"B.LvsP.BILANGES_SERUM_SENSITIVE_GENES"
36,"Up",0.255393709422975,0.586388206066147,"B.LvsP.PID_P38_MKK3_6PATHWAY"
462,"Down",0.255528935673566,0.586388206066147,"B.LvsP.YAMAZAKI_TCEB3_TARGETS_DN"
152,"Up",0.255559700060462,0.586388206066147,"B.LvsP.REACTOME_GOLGI_TO_ER_RETROGRADE_TRANSPORT"
16,"Down",0.255666506819514,0.586388206066147,"B.LvsP.BIOCARTA_TCYTOTOXIC_PATHWAY"
94,"Down",0.255703014075869,0.586388206066147,"B.LvsP.REACTOME_TP53_REGULATES_METABOLIC_GENES"
338,"Down",0.255867871100432,0.58652299308221,"B.LvsP.MIKKELSEN_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3"
65,"Down",0.256379907500003,0.58745317387796,"B.LvsP.BOYAULT_LIVER_CANCER_SUBCLASS_G1_DN"
10,"Down",0.257014669129501,0.588607817982802,"B.LvsP.REACTOME_E2F_ENABLED_INHIBITION_OF_PRE_REPLICATION_COMPLEX_FORMATION"
49,"Up",0.25720080615343,0.588607817982802,"B.LvsP.VERRECCHIA_RESPONSE_TO_TGFB1_C5"
48,"Down",0.257228250812614,0.588607817982802,"B.LvsP.PID_HIF2PATHWAY"
6,"Down",0.257457644492392,0.588607817982802,"B.LvsP.ISHIDA_TARGETS_OF_SYT_SSX_FUSIONS"
21,"Down",0.257461473105778,0.588607817982802,"B.LvsP.KRISHNAN_FURIN_TARGETS_DN"
28,"Down",0.257522574009839,0.588607817982802,"B.LvsP.KEGG_DORSO_VENTRAL_AXIS_FORMATION"
95,"Up",0.25776570104311,0.588864765442451,"B.LvsP.RAMASWAMY_METASTASIS_DN"
49,"Down",0.257898245780485,0.588864765442451,"B.LvsP.GENTILE_UV_RESPONSE_CLUSTER_D6"
1437,"Down",0.257954505679439,0.588864765442451,"B.LvsP.NUYTTEN_EZH2_TARGETS_DN"
92,"Down",0.258307127848281,0.589426376340548,"B.LvsP.LUCAS_HNF4A_TARGETS_UP"
7,"Down",0.258641754232451,0.589946476547533,"B.LvsP.REACTOME_TRNA_PROCESSING_IN_THE_MITOCHONDRION"
57,"Up",0.259024678372244,0.590576266688717,"B.LvsP.KEGG_MTOR_SIGNALING_PATHWAY"
151,"Up",0.259549788337276,0.591529587682111,"B.LvsP.IGARASHI_ATF4_TARGETS_DN"
9,"Up",0.259982318364425,0.591878506448608,"B.LvsP.CHEMELLO_SOLEUS_VS_EDL_MYOFIBERS_DN"
141,"Up",0.260017688953445,0.591878506448608,"B.LvsP.PID_REG_GR_PATHWAY"
166,"Down",0.26002403547905,0.591878506448608,"B.LvsP.LIU_PROSTATE_CANCER_UP"
423,"Up",0.260242507239682,0.59213202573177,"B.LvsP.GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP"
27,"Down",0.260457959449783,0.592378468859666,"B.LvsP.HEDENFALK_BREAST_CANCER_BRACX_UP"
57,"Up",0.260716902469307,0.592723582957565,"B.LvsP.PID_NETRIN_PATHWAY"
32,"Up",0.261004113488297,0.593132652477105,"B.LvsP.REACTOME_RHO_GTPASES_ACTIVATE_CIT"
10,"Down",0.261386950364884,0.593758606642335,"B.LvsP.BIOCARTA_FLUMAZENIL_PATHWAY"
119,"Up",0.261602322950146,0.594003796136081,"B.LvsP.REACTOME_EPH_EPHRIN_SIGNALING"
51,"Up",0.261927733036811,0.594016821962068,"B.LvsP.PID_ERBB1_RECEPTOR_PROXIMAL_PATHWAY"
299,"Down",0.261941443312038,0.594016821962068,"B.LvsP.TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN"
826,"Down",0.262070175538971,0.594016821962068,"B.LvsP.FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP"
459,"Up",0.262330876886381,0.594016821962068,"B.LvsP.LU_AGING_BRAIN_UP"
972,"Down",0.262335576833026,0.594016821962068,"B.LvsP.BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN"
19,"Up",0.262486810329186,0.594016821962068,"B.LvsP.REACTOME_DIGESTION_OF_DIETARY_CARBOHYDRATE"
18,"Up",0.262612819748197,0.594016821962068,"B.LvsP.REACTOME_PECAM1_INTERACTIONS"
6,"Up",0.262634089420915,0.594016821962068,"B.LvsP.REACTOME_MECP2_REGULATES_TRANSCRIPTION_FACTORS"
27,"Down",0.262684058126646,0.594016821962068,"B.LvsP.BIOCARTA_PLATELETAPP_PATHWAY"
193,"Down",0.262780510252489,0.594016821962068,"B.LvsP.ZHU_CMV_24_HR_UP"
77,"Down",0.262789861913405,0.594016821962068,"B.LvsP.REACTOME_CELL_CELL_JUNCTION_ORGANIZATION"
131,"Up",0.262996313717087,0.594240547013393,"B.LvsP.KEGG_T_CELL_RECEPTOR_SIGNALING_PATHWAY"
65,"Up",0.263372667915308,0.594726964079381,"B.LvsP.ZHANG_INTERFERON_RESPONSE"
8,"Down",0.263426720027203,0.594726964079381,"B.LvsP.BIOCARTA_BARD1_PATHWAY"
298,"Up",0.264241006606866,0.595673478690802,"B.LvsP.SMID_BREAST_CANCER_LUMINAL_B_UP"
611,"Down",0.264243114741383,0.595673478690802,"B.LvsP.GRUETZMANN_PANCREATIC_CANCER_UP"
43,"Down",0.264286644306528,0.595673478690802,"B.LvsP.MAGRANGEAS_MULTIPLE_MYELOMA_IGG_VS_IGA_DN"
39,"Up",0.264336125825713,0.595673478690802,"B.LvsP.KANG_FLUOROURACIL_RESISTANCE_UP"
38,"Up",0.264582799780063,0.595673478690802,"B.LvsP.CHOW_RASSF1_TARGETS_UP"
12,"Down",0.264595658298675,0.595673478690802,"B.LvsP.REACTOME_INTERLEUKIN_9_SIGNALING"
90,"Up",0.26460012003339,0.595673478690802,"B.LvsP.PID_FCER1_PATHWAY"
1244,"Up",0.264802983246447,0.595887543495972,"B.LvsP.NUYTTEN_NIPP1_TARGETS_UP"
23,"Down",0.265114139946366,0.596345028382205,"B.LvsP.LY_AGING_MIDDLE_UP"
827,"Down",0.265310844961945,0.596544799428465,"B.LvsP.REACTOME_TRANSPORT_OF_SMALL_MOLECULES"
168,"Down",0.265797280603819,0.597186730420271,"B.LvsP.HAHTOLA_MYCOSIS_FUNGOIDES_CD4_DN"
25,"Down",0.265812360926802,0.597186730420271,"B.LvsP.REACTOME_NUCLEOTIDE_SALVAGE"
13,"Down",0.266104563231911,0.597406976992728,"B.LvsP.PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_DN"
91,"Up",0.266263741628423,0.597406976992728,"B.LvsP.MASSARWEH_RESPONSE_TO_ESTRADIOL"
21,"Up",0.266275596622281,0.597406976992728,"B.LvsP.NIKOLSKY_BREAST_CANCER_7P15_AMPLICON"
28,"Up",0.266422152092522,0.597406976992728,"B.LvsP.REACTOME_SIGNALING_BY_PDGFR_IN_DISEASE"
37,"Up",0.266450643021173,0.597406976992728,"B.LvsP.ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_UP"
20,"Up",0.266561379704913,0.597412998941412,"B.LvsP.BIOCARTA_PLC_PATHWAY"
14,"Up",0.267120548946852,0.597963452213445,"B.LvsP.REACTOME_PEXOPHAGY"
45,"Down",0.267224177569455,0.597963452213445,"B.LvsP.XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_UP"
105,"Down",0.267252703461292,0.597963452213445,"B.LvsP.REACTOME_HEDGEHOG_ON_STATE"
136,"Up",0.267262286348349,0.597963452213445,"B.LvsP.REACTOME_RHO_GTPASES_ACTIVATE_PKNS"
58,"Up",0.267373631332734,0.597963452213445,"B.LvsP.CHANDRAN_METASTASIS_TOP50_DN"
233,"Down",0.267455890273802,0.597963452213445,"B.LvsP.RASHI_RESPONSE_TO_IONIZING_RADIATION_6"
169,"Down",0.267942213028066,0.598808607854558,"B.LvsP.RAMALHO_STEMNESS_DN"
43,"Up",0.268085506238452,0.598886773330262,"B.LvsP.REACTOME_FGFR1_MUTANT_RECEPTOR_ACTIVATION"
83,"Down",0.26865588278464,0.599850705990984,"B.LvsP.KEGG_P53_SIGNALING_PATHWAY"
34,"Down",0.268733984217701,0.599850705990984,"B.LvsP.REACTOME_IKK_COMPLEX_RECRUITMENT_MEDIATED_BY_RIP1"
103,"Down",0.26896607305515,0.599979963099701,"B.LvsP.MARTIN_VIRAL_GPCR_SIGNALING_DN"
97,"Down",0.269246535956749,0.599979963099701,"B.LvsP.NADLER_HYPERGLYCEMIA_AT_OBESITY"
92,"Down",0.269402430190872,0.599979963099701,"B.LvsP.LEE_LIVER_CANCER_CIPROFIBRATE_UP"
390,"Up",0.269420052757637,0.599979963099701,"B.LvsP.ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP"
30,"Down",0.269492872103915,0.599979963099701,"B.LvsP.WAGNER_APO2_SENSITIVITY"
10,"Down",0.269526607141601,0.599979963099701,"B.LvsP.CHANG_POU5F1_TARGETS_DN"
167,"Up",0.269619862753381,0.599979963099701,"B.LvsP.REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE"
94,"Down",0.269660012353546,0.599979963099701,"B.LvsP.COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_UP"
95,"Up",0.269993663687492,0.600480678410356,"B.LvsP.GU_PDEF_TARGETS_DN"
1149,"Down",0.270181270352073,0.600513009450875,"B.LvsP.NABA_MATRISOME"
15,"Down",0.270225423677659,0.600513009450875,"B.LvsP.MANN_RESPONSE_TO_AMIFOSTINE_DN"
18,"Down",0.270340135570047,0.600526560693769,"B.LvsP.MARKS_ACETYLATED_NON_HISTONE_PROTEINS"
165,"Up",0.270462442923244,0.600556966635589,"B.LvsP.TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_UP"
323,"Down",0.271125876591527,0.601719862317737,"B.LvsP.DURAND_STROMA_NS_UP"
13,"Up",0.271203815680195,0.601719862317737,"B.LvsP.HOLLERN_SOLID_NODULAR_BREAST_TUMOR_UP"
18,"Down",0.271667550998326,0.602347449653138,"B.LvsP.MIKKELSEN_IPS_LCP_WITH_H3K4ME3_AND_H3K27ME3"
33,"Down",0.271704564918598,0.602347449653138,"B.LvsP.BIOCARTA_CYTOKINE_PATHWAY"
10,"Down",0.271962022068219,0.602676561128329,"B.LvsP.TESAR_ALK_TARGETS_EPISC_4D_UP"
122,"Down",0.272227341069106,0.603022824026877,"B.LvsP.ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN"
29,"Up",0.272876608546278,0.60421897022522,"B.LvsP.PID_ARF_3PATHWAY"
63,"Down",0.273143019495267,0.604566755319989,"B.LvsP.KORKOLA_SEMINOMA_UP"
179,"Up",0.273377184194056,0.604773919489342,"B.LvsP.MIKKELSEN_IPS_HCP_WITH_H3_UNMETHYLATED"
110,"Down",0.273455380488941,0.604773919489342,"B.LvsP.PID_IL12_2PATHWAY"
8,"Up",0.27403503817128,0.605813564993605,"B.LvsP.ELVIDGE_HIF2A_TARGETS_UP"
57,"Up",0.274569350666398,0.605944437953031,"B.LvsP.SIG_REGULATION_OF_THE_ACTIN_CYTOSKELETON_BY_RHO_GTPASES"
63,"Up",0.274575165010357,0.605944437953031,"B.LvsP.REACTOME_SIGNALING_BY_TYPE_1_INSULIN_LIKE_GROWTH_FACTOR_1_RECEPTOR_IGF1R"
8,"Down",0.274586980668762,0.605944437953031,"B.LvsP.REACTOME_ACYL_CHAIN_REMODELING_OF_DAG_AND_TAG"
68,"Up",0.27461847219977,0.605944437953031,"B.LvsP.REACTOME_TRANSCRIPTIONAL_ACTIVATION_OF_MITOCHONDRIAL_BIOGENESIS"
14,"Down",0.274722753951357,0.605944437953031,"B.LvsP.REACTOME_RUNX3_REGULATES_WNT_SIGNALING"
153,"Up",0.274751800677925,0.605944437953031,"B.LvsP.CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP"
9,"Down",0.275981191888201,0.60841308211717,"B.LvsP.TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_GRANULOCYTE_DN"
515,"Down",0.276106877979512,0.608447560123045,"B.LvsP.RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN"
56,"Down",0.276600424988805,0.608657030993381,"B.LvsP.REACTOME_HEPARAN_SULFATE_HEPARIN_HS_GAG_METABOLISM"
46,"Up",0.276655953288077,0.608657030993381,"B.LvsP.BOWIE_RESPONSE_TO_EXTRACELLULAR_MATRIX"
20,"Down",0.277057892352076,0.608657030993381,"B.LvsP.REACTOME_RETROGRADE_NEUROTROPHIN_SIGNALLING"
127,"Down",0.277186953754748,0.608657030993381,"B.LvsP.VANDESLUIS_COMMD1_TARGETS_GROUP_3_UP"
43,"Down",0.277333768749337,0.608657030993381,"B.LvsP.BIOCARTA_WNT_PATHWAY"
58,"Up",0.2773403601347,0.608657030993381,"B.LvsP.MORI_PLASMA_CELL_DN"
29,"Down",0.277354763208444,0.608657030993381,"B.LvsP.REACTOME_TNFS_BIND_THEIR_PHYSIOLOGICAL_RECEPTORS"
51,"Up",0.277482387770952,0.608657030993381,"B.LvsP.PID_AVB3_OPN_PATHWAY"
37,"Down",0.277562892041393,0.608657030993381,"B.LvsP.TERAMOTO_OPN_TARGETS_CLUSTER_4"
101,"Down",0.277667697894277,0.608657030993381,"B.LvsP.RIZKI_TUMOR_INVASIVENESS_2D_DN"
448,"Up",0.277714401202019,0.608657030993381,"B.LvsP.IVANOVA_HEMATOPOIESIS_MATURE_CELL"
21,"Up",0.277771245811778,0.608657030993381,"B.LvsP.GRATIAS_RETINOBLASTOMA_16Q24"
19,"Down",0.277823968422233,0.608657030993381,"B.LvsP.YIH_RESPONSE_TO_ARSENITE_C5"
644,"Up",0.277883155269444,0.608657030993381,"B.LvsP.PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_UP"
379,"Down",0.277995851392609,0.608657030993381,"B.LvsP.REACTOME_DNA_REPAIR"
129,"Down",0.278199793444284,0.608657030993381,"B.LvsP.REACTOME_RNA_POLYMERASE_I_TRANSCRIPTION"
16,"Down",0.278217542831654,0.608657030993381,"B.LvsP.REACTOME_UPTAKE_AND_FUNCTION_OF_ANTHRAX_TOXINS"
210,"Up",0.278349557295645,0.608657030993381,"B.LvsP.MIKKELSEN_ES_LCP_WITH_H3K4ME3"
77,"Down",0.27854976780608,0.608657030993381,"B.LvsP.TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_DN"
1236,"Up",0.278590697975423,0.608657030993381,"B.LvsP.GEORGES_TARGETS_OF_MIR192_AND_MIR215"
16,"Up",0.278595593530765,0.608657030993381,"B.LvsP.NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN"
33,"Down",0.278789231131669,0.608657030993381,"B.LvsP.MACLACHLAN_BRCA1_TARGETS_UP"
262,"Up",0.278818021100581,0.608657030993381,"B.LvsP.NOUZOVA_TRETINOIN_AND_H4_ACETYLATION"
939,"Up",0.278843960843956,0.608657030993381,"B.LvsP.GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP"
23,"Down",0.27943261992053,0.60970124528043,"B.LvsP.REACTOME_PROCESSING_OF_INTRONLESS_PRE_MRNAS"
166,"Down",0.279692451270469,0.610027441054998,"B.LvsP.HUMMERICH_SKIN_CANCER_PROGRESSION_UP"
54,"Up",0.279898766216645,0.610055557554168,"B.LvsP.QI_HYPOXIA_TARGETS_OF_HIF1A_AND_FOXA2"
28,"Up",0.279950970192672,0.610055557554168,"B.LvsP.HOLLERN_ADENOMYOEPITHELIAL_BREAST_TUMOR"
13,"Down",0.280041763793092,0.610055557554168,"B.LvsP.MCBRYAN_TERMINAL_END_BUD_DN"
212,"Down",0.280146692101652,0.610055557554168,"B.LvsP.WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_UP"
12,"Up",0.280499505965559,0.610583373418731,"B.LvsP.REACTOME_REGULATION_OF_SIGNALING_BY_NODAL"
92,"Up",0.280656772906908,0.610685280362964,"B.LvsP.REACTOME_DDX58_IFIH1_MEDIATED_INDUCTION_OF_INTERFERON_ALPHA_BETA"
99,"Up",0.281124772958674,0.611462969979743,"B.LvsP.BOYLAN_MULTIPLE_MYELOMA_C_DN"
61,"Up",0.281318280088409,0.611643244439172,"B.LvsP.LIU_CDX2_TARGETS_UP"
26,"Down",0.281571107485063,0.611701099517766,"B.LvsP.VISALA_AGING_LYMPHOCYTE_DN"
6,"Up",0.281623522921995,0.611701099517766,"B.LvsP.REACTOME_SYNTHESIS_OF_DOLICHYL_PHOSPHATE"
34,"Down",0.281676794966944,0.611701099517766,"B.LvsP.PETRETTO_HEART_MASS_QTL_CIS_DN"
18,"Up",0.282216043249894,0.612631528515376,"B.LvsP.REACTOME_LOSS_OF_FUNCTION_OF_MECP2_IN_RETT_SYNDROME"
40,"Down",0.282750522981138,0.613550879734188,"B.LvsP.REACTOME_HDR_THROUGH_SINGLE_STRAND_ANNEALING_SSA"
23,"Down",0.284014958304599,0.616052846004757,"B.LvsP.REACTOME_ASSEMBLY_OF_ACTIVE_LPL_AND_LIPC_LIPASE_COMPLEXES"
38,"Up",0.284282776678792,0.616391949904722,"B.LvsP.REACTOME_PEROXISOMAL_LIPID_METABOLISM"
389,"Down",0.284415581548467,0.616438161654832,"B.LvsP.HOSHIDA_LIVER_CANCER_SUBCLASS_S1"
51,"Up",0.284698787002738,0.616810185477327,"B.LvsP.KASLER_HDAC7_TARGETS_2_DN"
148,"Up",0.284874270474088,0.616929969876737,"B.LvsP.REACTOME_INTERFERON_GAMMA_SIGNALING"
1149,"Up",0.284977236944328,0.616929969876737,"B.LvsP.SMID_BREAST_CANCER_BASAL_DN"
21,"Down",0.285786827370094,0.618377006853528,"B.LvsP.GOERING_BLOOD_HDL_CHOLESTEROL_QTL_CIS"
31,"Up",0.285869348800437,0.618377006853528,"B.LvsP.BIOCARTA_UCALPAIN_PATHWAY"
140,"Up",0.286061388147493,0.618550416530108,"B.LvsP.BILBAN_B_CLL_LPL_UP"
73,"Down",0.286200776775498,0.618609888503413,"B.LvsP.JAEGER_METASTASIS_UP"
108,"Down",0.286690402138153,0.619426038851837,"B.LvsP.LIN_NPAS4_TARGETS_DN"
95,"Down",0.286939227109564,0.619490512344635,"B.LvsP.DIRMEIER_LMP1_RESPONSE_EARLY"
26,"Down",0.287038327828652,0.619490512344635,"B.LvsP.PARK_HSC_VS_MULTIPOTENT_PROGENITORS_DN"
15,"Down",0.287056374141247,0.619490512344635,"B.LvsP.HOLLEMAN_PREDNISOLONE_RESISTANCE_ALL_DN"
21,"Down",0.287281090657333,0.61966444801961,"B.LvsP.IYENGAR_RESPONSE_TO_ADIPOCYTE_FACTORS"
56,"Up",0.28748996419202,0.61966444801961,"B.LvsP.PID_RET_PATHWAY"
80,"Up",0.287519670341143,0.61966444801961,"B.LvsP.HEIDENBLAD_AMPLIFIED_IN_PANCREATIC_CANCER"
806,"Down",0.28764660072433,0.61966444801961,"B.LvsP.REACTOME_NEUTROPHIL_DEGRANULATION"
15,"Down",0.287773053667694,0.61966444801961,"B.LvsP.BIOCARTA_AKAP95_PATHWAY"
500,"Up",0.2878094234969,0.61966444801961,"B.LvsP.WANG_SMARCE1_TARGETS_UP"
8,"Down",0.287960190425032,0.619743476950856,"B.LvsP.REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_INTERLEUKIN_SIGNALING"
140,"Down",0.288072452733344,0.619743476950856,"B.LvsP.HOEBEKE_LYMPHOID_STEM_CELL_DN"
45,"Down",0.288182398126361,0.619743476950856,"B.LvsP.REACTOME_MET_ACTIVATES_PTK2_SIGNALING"
309,"Down",0.288540233876319,0.620271754705352,"B.LvsP.CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_UP"
14,"Down",0.288984596188887,0.620985554733135,"B.LvsP.BIOCARTA_ASBCELL_PATHWAY"
88,"Up",0.289260996625713,0.621298758858134,"B.LvsP.BROWNE_HCMV_INFECTION_10HR_DN"
107,"Down",0.289355092070844,0.621298758858134,"B.LvsP.YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_7"
99,"Up",0.289636860345967,0.621662345051574,"B.LvsP.BIOCARTA_MAPK_PATHWAY"
647,"Up",0.290142713853146,0.622506427975958,"B.LvsP.YAUCH_HEDGEHOG_SIGNALING_PARACRINE_DN"
32,"Down",0.290804879582138,0.623254162248123,"B.LvsP.REACTOME_GLYOXYLATE_METABOLISM_AND_GLYCINE_DEGRADATION"
109,"Up",0.290861622177517,0.623254162248123,"B.LvsP.REACTOME_AURKA_ACTIVATION_BY_TPX2"
184,"Up",0.290959532850298,0.623254162248123,"B.LvsP.FIGUEROA_AML_METHYLATION_CLUSTER_1_UP"
151,"Up",0.291007124505014,0.623254162248123,"B.LvsP.CHANG_IMMORTALIZED_BY_HPV31_DN"
47,"Down",0.291054846613249,0.623254162248123,"B.LvsP.VALK_AML_CLUSTER_12"
60,"Down",0.291220281560041,0.623366990609938,"B.LvsP.LIN_MELANOMA_COPY_NUMBER_DN"
57,"Down",0.291881010299752,0.6245395146855,"B.LvsP.WAKASUGI_HAVE_ZNF143_BINDING_SITES"
16,"Down",0.292035897427305,0.624629198017628,"B.LvsP.BIOCARTA_CFTR_PATHWAY"
27,"Down",0.292219202587776,0.62477957119405,"B.LvsP.TERAMOTO_OPN_TARGETS_CLUSTER_7"
48,"Up",0.292387635525676,0.624898042837828,"B.LvsP.REACTOME_EPHA_MEDIATED_GROWTH_CONE_COLLAPSE"
86,"Down",0.292655756894173,0.625229397166879,"B.LvsP.CHANDRAN_METASTASIS_TOP50_UP"
8,"Up",0.292868906446892,0.62544309916758,"B.LvsP.BIOCARTA_PLCD_PATHWAY"
522,"Up",0.293096536707254,0.625687548824095,"B.LvsP.PASINI_SUZ12_TARGETS_DN"
42,"Up",0.293294606127399,0.625868729169582,"B.LvsP.REACTOME_SEMA4D_INDUCED_CELL_MIGRATION_AND_GROWTH_CONE_COLLAPSE"
384,"Down",0.293711115953505,0.626515725349896,"B.LvsP.SERVITJA_ISLET_HNF1A_TARGETS_UP"
42,"Up",0.294643051305261,0.628158469964706,"B.LvsP.REACTOME_SIGNALING_BY_WNT_IN_CANCER"
80,"Down",0.294708459231045,0.628158469964706,"B.LvsP.MODY_HIPPOCAMPUS_NEONATAL"
105,"Down",0.295408938128252,0.629408870485976,"B.LvsP.REACTOME_SIGNALING_BY_FGFR"
13,"Down",0.295549975130087,0.629466799882223,"B.LvsP.GALI_TP53_TARGETS_APOPTOTIC_UP"
43,"Down",0.296009728821898,0.630203230903455,"B.LvsP.PID_CD40_PATHWAY"
33,"Down",0.296750297775827,0.631536719169571,"B.LvsP.REACTOME_DEADENYLATION_OF_MRNA"
421,"Up",0.296990880295345,0.631660917540361,"B.LvsP.KOYAMA_SEMA3B_TARGETS_UP"
796,"Up",0.29710217092658,0.631660917540361,"B.LvsP.MILI_PSEUDOPODIA_HAPTOTAXIS_UP"
117,"Up",0.29715139202794,0.631660917540361,"B.LvsP.HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_UP"
13,"Down",0.297395858488593,0.631937625512463,"B.LvsP.REACTOME_INTERLEUKIN_35_SIGNALLING"
232,"Down",0.297792383857,0.632459202908702,"B.LvsP.DER_IFN_GAMMA_RESPONSE_UP"
71,"Down",0.297870096649351,0.632459202908702,"B.LvsP.BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_UP"
12,"Up",0.298152179813286,0.632815125599869,"B.LvsP.REACTOME_HDL_REMODELING"
26,"Up",0.298458189488948,0.632930244231752,"B.LvsP.GAVIN_IL2_RESPONSIVE_FOXP3_TARGETS_UP"
29,"Up",0.298545458051104,0.632930244231752,"B.LvsP.REACTOME_PI_3K_CASCADE_FGFR2"
130,"Down",0.298684410965607,0.632930244231752,"B.LvsP.CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_UP"
59,"Up",0.298852873513794,0.632930244231752,"B.LvsP.KEGG_VALINE_LEUCINE_AND_ISOLEUCINE_DEGRADATION"
531,"Down",0.298889400347111,0.632930244231752,"B.LvsP.ENK_UV_RESPONSE_EPIDERMIS_UP"
5,"Up",0.298893265995497,0.632930244231752,"B.LvsP.NAKAMURA_ALVEOLAR_EPITHELIUM"
36,"Down",0.299184883885797,0.633133492538937,"B.LvsP.KANG_AR_TARGETS_UP"
95,"Down",0.299218270212379,0.633133492538937,"B.LvsP.KYNG_DNA_DAMAGE_BY_4NQO_OR_UV"
253,"Down",0.299356102772307,0.633182820286184,"B.LvsP.BROWNE_HCMV_INFECTION_24HR_UP"
13,"Up",0.299699072670918,0.633487249764458,"B.LvsP.BIOCARTA_MELANOCYTE_PATHWAY"
22,"Up",0.299840356793433,0.633487249764458,"B.LvsP.REACTOME_CONVERSION_FROM_APC_C_CDC20_TO_APC_C_CDH1_IN_LATE_ANAPHASE"
7,"Up",0.299843757032662,0.633487249764458,"B.LvsP.REACTOME_WAX_AND_PLASMALOGEN_BIOSYNTHESIS"
11,"Up",0.300159399538565,0.633911886955204,"B.LvsP.REACTOME_CHYLOMICRON_REMODELING"
14,"Down",0.300366515153829,0.634005941157191,"B.LvsP.CHEOK_RESPONSE_TO_MERCAPTOPURINE_UP"
227,"Down",0.300433272894165,0.634005941157191,"B.LvsP.JACKSON_DNMT1_TARGETS_UP"
322,"Up",0.300717608386891,0.634359626958412,"B.LvsP.DARWICHE_PAPILLOMA_RISK_HIGH_DN"
56,"Down",0.300830338557597,0.634359626958412,"B.LvsP.KEGG_TYROSINE_METABOLISM"
26,"Down",0.301616644623058,0.635467685911193,"B.LvsP.REACTOME_A_TETRASACCHARIDE_LINKER_SEQUENCE_IS_REQUIRED_FOR_GAG_SYNTHESIS"
868,"Up",0.30168281565445,0.635467685911193,"B.LvsP.HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP"
36,"Down",0.301700610511282,0.635467685911193,"B.LvsP.REACTOME_SIGNALING_BY_EGFR_IN_CANCER"
15,"Down",0.302053265343407,0.635471648148929,"B.LvsP.BIOCARTA_PTC1_PATHWAY"
18,"Down",0.302074198126511,0.635471648148929,"B.LvsP.LOPEZ_MESOTHELIOMA_SURVIVAL_UP"
25,"Up",0.30210290963071,0.635471648148929,"B.LvsP.REACTOME_SIGNALING_BY_CYTOSOLIC_FGFR1_FUSION_MUTANTS"
14,"Down",0.302162228790656,0.635471648148929,"B.LvsP.ZHOU_PANCREATIC_BETA_CELL"
33,"Up",0.302331622515027,0.635586137218854,"B.LvsP.PID_P38_ALPHA_BETA_PATHWAY"
426,"Down",0.302607655995954,0.635630383191856,"B.LvsP.GENTILE_UV_HIGH_DOSE_DN"
65,"Down",0.302710165083281,0.635630383191856,"B.LvsP.ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_UP"
43,"Up",0.30272332125964,0.635630383191856,"B.LvsP.ZWANG_EGF_PERSISTENTLY_UP"
41,"Down",0.302893829206693,0.635630383191856,"B.LvsP.REACTOME_FANCONI_ANEMIA_PATHWAY"
11,"Down",0.302927484122001,0.635630383191856,"B.LvsP.MATHEW_FANCONI_ANEMIA_GENES"
80,"Down",0.303105036001431,0.635761663145641,"B.LvsP.MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_DN"
37,"Down",0.303338860951838,0.636010831324502,"B.LvsP.DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_UP"
36,"Down",0.303626854115159,0.63637334207836,"B.LvsP.KRIGE_AMINO_ACID_DEPRIVATION"
19,"Down",0.304001071741302,0.636865747329456,"B.LvsP.EHLERS_ANEUPLOIDY_DN"
61,"Up",0.304109151112959,0.636865747329456,"B.LvsP.KEGG_ENDOMETRIAL_CANCER"
107,"Down",0.30420735009895,0.636865747329456,"B.LvsP.KYNG_RESPONSE_TO_H2O2"
46,"Up",0.304341626540359,0.636888100805259,"B.LvsP.REACTOME_RET_SIGNALING"
176,"Down",0.304451071128278,0.636888100805259,"B.LvsP.RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_UP"
104,"Down",0.304563598938163,0.636888100805259,"B.LvsP.KEGG_VIRAL_MYOCARDITIS"
22,"Up",0.30521402305262,0.637765124819407,"B.LvsP.TAGHAVI_NEOPLASTIC_TRANSFORMATION"
162,"Down",0.305218124509217,0.637765124819407,"B.LvsP.YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_6"
25,"Up",0.305329044202744,0.637765124819407,"B.LvsP.BIOCARTA_IL7_PATHWAY"
527,"Up",0.305834905632014,0.638580511042071,"B.LvsP.DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN"
70,"Up",0.306424422975414,0.639569888497947,"B.LvsP.SIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES"
290,"Up",0.306744291462694,0.63985976530135,"B.LvsP.KEGG_MAPK_SIGNALING_PATHWAY"
38,"Down",0.306794761767748,0.63985976530135,"B.LvsP.DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_UP"
10,"Down",0.307230031359136,0.64052595904399,"B.LvsP.GALIE_TUMOR_ANGIOGENESIS"
173,"Down",0.307353224658576,0.640541266165574,"B.LvsP.KIM_WT1_TARGETS_8HR_DN"
26,"Down",0.307505162750217,0.640547878503563,"B.LvsP.REACTOME_TRIGLYCERIDE_CATABOLISM"
35,"Up",0.30768559408551,0.640547878503563,"B.LvsP.MARKS_HDAC_TARGETS_UP"
116,"Down",0.307775253508336,0.640547878503563,"B.LvsP.BAUS_TFF2_TARGETS_UP"
33,"Up",0.307819807050817,0.640547878503563,"B.LvsP.REACTOME_THROMBIN_SIGNALLING_THROUGH_PROTEINASE_ACTIVATED_RECEPTORS_PARS"
13,"Down",0.308091769757316,0.64087260910015,"B.LvsP.BIOCARTA_LYMPHOCYTE_PATHWAY"
26,"Down",0.308439243381167,0.641193357435406,"B.LvsP.BIOCARTA_HIF_PATHWAY"
337,"Down",0.3085719250071,0.641193357435406,"B.LvsP.YAMAZAKI_TCEB3_TARGETS_UP"
13,"Up",0.308593873057626,0.641193357435406,"B.LvsP.GOUYER_TUMOR_INVASIVENESS"
29,"Down",0.308797037696583,0.641374463345007,"B.LvsP.BIOCARTA_NO2IL12_PATHWAY"
79,"Down",0.309405982228208,0.642397925550041,"B.LvsP.PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_UP"
83,"Up",0.309669534016703,0.642572297346793,"B.LvsP.CHENG_RESPONSE_TO_NICKEL_ACETATE"
19,"Down",0.310028328813524,0.642572297346793,"B.LvsP.LI_CYTIDINE_ANALOGS_CYCTOTOXICITY"
110,"Down",0.310070255400196,0.642572297346793,"B.LvsP.REACTOME_COLLAGEN_FORMATION"
9,"Down",0.310070875315512,0.642572297346793,"B.LvsP.REACTOME_WNT_MEDIATED_ACTIVATION_OF_DVL"
10,"Down",0.310071059743397,0.642572297346793,"B.LvsP.GALI_TP53_TARGETS_APOPTOTIC_DN"
22,"Up",0.310464841895927,0.643146766557541,"B.LvsP.FARMER_BREAST_CANCER_CLUSTER_6"
354,"Down",0.310630235216266,0.643146766557541,"B.LvsP.GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN"
15,"Down",0.310706877401485,0.643146766557541,"B.LvsP.REACTOME_TICAM1_TRAF6_DEPENDENT_INDUCTION_OF_TAK1_COMPLEX"
31,"Down",0.310957348417734,0.643146766557541,"B.LvsP.MATZUK_POSTIMPLANTATION_AND_POSTPARTUM"
187,"Up",0.311041271635812,0.643146766557541,"B.LvsP.ROSS_AML_WITH_AML1_ETO_FUSION"
24,"Down",0.311077968026558,0.643146766557541,"B.LvsP.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_24"
23,"Up",0.311290505549016,0.643146766557541,"B.LvsP.REACTOME_NOREPINEPHRINE_NEUROTRANSMITTER_RELEASE_CYCLE"
136,"Up",0.31138231356016,0.643146766557541,"B.LvsP.MIKKELSEN_ES_HCP_WITH_H3_UNMETHYLATED"
9,"Up",0.311395169845277,0.643146766557541,"B.LvsP.REACTOME_TRANSPORT_OF_NUCLEOTIDE_SUGARS"
67,"Up",0.311666590653679,0.643270399199335,"B.LvsP.BIOCARTA_TCR_PATHWAY"
16,"Down",0.311740819794706,0.643270399199335,"B.LvsP.LOPEZ_MESOTELIOMA_SURVIVAL_TIME_DN"
146,"Up",0.311804063999678,0.643270399199335,"B.LvsP.YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_16"
90,"Up",0.312123410181668,0.64344131056539,"B.LvsP.KAAB_FAILED_HEART_ATRIUM_UP"
12,"Up",0.312184826647274,0.64344131056539,"B.LvsP.REACTOME_FGFR2B_LIGAND_BINDING_AND_ACTIVATION"
132,"Up",0.31254351060686,0.64344131056539,"B.LvsP.MILI_PSEUDOPODIA"
22,"Up",0.312588896643958,0.64344131056539,"B.LvsP.ZHENG_RESPONSE_TO_ARSENITE_DN"
92,"Up",0.312723942214688,0.64344131056539,"B.LvsP.RICKMAN_HEAD_AND_NECK_CANCER_F"
48,"Up",0.312754622452239,0.64344131056539,"B.LvsP.HEIDENBLAD_AMPLICON_12P11_12_UP"
19,"Up",0.312791524999908,0.64344131056539,"B.LvsP.HEIDENBLAD_AMPLIFIED_IN_SOFT_TISSUE_CANCER"
107,"Down",0.312910188853195,0.64344131056539,"B.LvsP.RADAEVA_RESPONSE_TO_IFNA1_UP"
75,"Down",0.312934289041478,0.64344131056539,"B.LvsP.REACTOME_CHEMOKINE_RECEPTORS_BIND_CHEMOKINES"
103,"Down",0.313113415034663,0.643570286887232,"B.LvsP.DORN_ADENOVIRUS_INFECTION_24HR_DN"
256,"Down",0.31332369251487,0.643763172023305,"B.LvsP.MEISSNER_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3"
8,"Up",0.31347014306904,0.643824822076048,"B.LvsP.REACTOME_MRNA_EDITING"
109,"Down",0.313685122036432,0.644027122071828,"B.LvsP.REACTOME_MITOCHONDRIAL_BIOGENESIS"
20,"Down",0.314159265240862,0.644761164631302,"B.LvsP.LI_CYTIDINE_ANALOG_PATHWAY"
409,"Up",0.314450010393067,0.645118407221992,"B.LvsP.PEDRIOLI_MIR31_TARGETS_UP"
15,"Up",0.315161904860625,0.645306934692601,"B.LvsP.HOLLEMAN_DAUNORUBICIN_B_ALL_DN"
125,"Down",0.315167302682503,0.645306934692601,"B.LvsP.PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP"
25,"Down",0.315194134935021,0.645306934692601,"B.LvsP.REACTOME_SYNTHESIS_OF_VERY_LONG_CHAIN_FATTY_ACYL_COAS"
14,"Up",0.315245942953338,0.645306934692601,"B.LvsP.REACTOME_SUMOYLATION_OF_IMMUNE_RESPONSE_PROTEINS"
103,"Down",0.315264551921488,0.645306934692601,"B.LvsP.BOSCO_EPITHELIAL_DIFFERENTIATION_MODULE"
26,"Up",0.315280195593837,0.645306934692601,"B.LvsP.WIKMAN_ASBESTOS_LUNG_CANCER_UP"
48,"Up",0.315358896281318,0.645306934692601,"B.LvsP.REACTOME_LATE_ENDOSOMAL_MICROAUTOPHAGY"
12,"Down",0.315656851820803,0.645507202816315,"B.LvsP.REACTOME_INTERLEUKIN_21_SIGNALING"
463,"Down",0.315891038480879,0.645507202816315,"B.LvsP.MARKEY_RB1_ACUTE_LOF_DN"
36,"Up",0.316286564473093,0.645507202816315,"B.LvsP.REACTOME_NOTCH3_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS"
160,"Down",0.316610513420048,0.645507202816315,"B.LvsP.HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS"
16,"Down",0.316614835365764,0.645507202816315,"B.LvsP.REACTOME_INTESTINAL_ABSORPTION"
13,"Up",0.316714174472647,0.645507202816315,"B.LvsP.NAKAMURA_LUNG_CANCER_DIFFERENTIATION_MARKERS"
11,"Down",0.316788951055369,0.645507202816315,"B.LvsP.REACTOME_BH3_ONLY_PROTEINS_ASSOCIATE_WITH_AND_INACTIVATE_ANTI_APOPTOTIC_BCL_2_MEMBERS"
46,"Up",0.316812601886707,0.645507202816315,"B.LvsP.MEISSNER_BRAIN_ICP_WITH_H3K4ME3"
38,"Up",0.316835525450264,0.645507202816315,"B.LvsP.BIOCARTA_IGF1R_PATHWAY"
26,"Down",0.31688092789179,0.645507202816315,"B.LvsP.MATZUK_EMBRYONIC_GERM_CELL"
463,"Up",0.316916788183066,0.645507202816315,"B.LvsP.JAEGER_METASTASIS_DN"
5,"Down",0.316948776713954,0.645507202816315,"B.LvsP.REACTOME_PTK6_EXPRESSION"
5,"Down",0.316974508165364,0.645507202816315,"B.LvsP.REACTOME_TACHYKININ_RECEPTORS_BIND_TACHYKININS"
36,"Up",0.317421517996283,0.646179518778147,"B.LvsP.AKL_HTLV1_INFECTION_UP"
28,"Up",0.317589998462294,0.646284542325367,"B.LvsP.LI_ADIPOGENESIS_BY_ACTIVATED_PPARG"
100,"Up",0.317915333405435,0.646708564532247,"B.LvsP.FIGUEROA_AML_METHYLATION_CLUSTER_3_DN"
59,"Down",0.318208007115371,0.647065859264762,"B.LvsP.GALLUZZI_PERMEABILIZE_MITOCHONDRIA"
14,"Up",0.318475249107332,0.647307105852685,"B.LvsP.TAKADA_GASTRIC_CANCER_COPY_NUMBER_UP"
17,"Up",0.318601390865993,0.647307105852685,"B.LvsP.BIOCARTA_RANKL_PATHWAY"
7,"Down",0.318677869801231,0.647307105852685,"B.LvsP.REACTOME_CLEC7A_INFLAMMASOME_PATHWAY"
6,"Up",0.319022606364685,0.647769368560538,"B.LvsP.REACTOME_ASSEMBLY_OF_THE_ORC_COMPLEX_AT_THE_ORIGIN_OF_REPLICATION"
54,"Down",0.319233709637401,0.647960051609834,"B.LvsP.BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_UP"
19,"Up",0.319634529317076,0.648472462111386,"B.LvsP.KEGG_PANTOTHENATE_AND_COA_BIOSYNTHESIS"
25,"Down",0.319746318173628,0.648472462111386,"B.LvsP.BIOCARTA_CHEMICAL_PATHWAY"
19,"Up",0.31990380612384,0.648472462111386,"B.LvsP.AMIT_EGF_RESPONSE_20_HELA"
16,"Up",0.320008063156576,0.648472462111386,"B.LvsP.KONDO_COLON_CANCER_HCP_WITH_H3K27ME3"
25,"Down",0.320072589817683,0.648472462111386,"B.LvsP.REACTOME_PINK_PARKIN_MEDIATED_MITOPHAGY"
106,"Down",0.320293800896865,0.64851761590617,"B.LvsP.MAGRANGEAS_MULTIPLE_MYELOMA_IGG_VS_IGA_UP"
324,"Down",0.320329464467309,0.64851761590617,"B.LvsP.REACTOME_SIGNALING_BY_NOTCH"
46,"Down",0.320666305146767,0.64896193307338,"B.LvsP.YAMASHITA_LIVER_CANCER_WITH_EPCAM_DN"
18,"Down",0.321188327470659,0.649634287175307,"B.LvsP.CROONQUIST_STROMAL_STIMULATION_DN"
49,"Up",0.321370813780372,0.649634287175307,"B.LvsP.DORSAM_HOXA9_TARGETS_DN"
33,"Up",0.321375448297902,0.649634287175307,"B.LvsP.BIOCARTA_HER2_PATHWAY"
169,"Down",0.321468513241389,0.649634287175307,"B.LvsP.KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_DN"
239,"Up",0.321992365201762,0.650339547691298,"B.LvsP.REACTOME_REPRODUCTION"
29,"Up",0.32205575854809,0.650339547691298,"B.LvsP.BIOCARTA_CXCR4_PATHWAY"
20,"Down",0.322170378210611,0.650339547691298,"B.LvsP.REACTOME_DEFECTIVE_B4GALT7_CAUSES_EDS_PROGEROID_TYPE"
98,"Down",0.322374939349339,0.650514977979012,"B.LvsP.KIM_LRRC3B_TARGETS"
352,"Down",0.322719010124063,0.650971691709574,"B.LvsP.REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL"
13,"Down",0.322983738336993,0.651268085071201,"B.LvsP.REACTOME_REGULATION_OF_LOCALIZATION_OF_FOXO_TRANSCRIPTION_FACTORS"
112,"Up",0.323114089128498,0.651293400944756,"B.LvsP.LEIN_NEURON_MARKERS"
17,"Up",0.323845708219837,0.65234616435618,"B.LvsP.REACTOME_SIGNALING_BY_PDGFRA_TRANSMEMBRANE_JUXTAMEMBRANE_AND_KINASE_DOMAIN_MUTANTS"
8,"Up",0.323963486028659,0.65234616435618,"B.LvsP.REACTOME_ESTROGEN_STIMULATED_SIGNALING_THROUGH_PRKCZ"
498,"Up",0.323990335923688,0.65234616435618,"B.LvsP.JOHNSTONE_PARVB_TARGETS_2_DN"
12,"Up",0.32446181004121,0.652836949307241,"B.LvsP.NIKOLSKY_BREAST_CANCER_20P13_AMPLICON"
24,"Up",0.324475214197032,0.652836949307241,"B.LvsP.REACTOME_PI_3K_CASCADE_FGFR4"
95,"Up",0.324601144458494,0.652836949307241,"B.LvsP.REACTOME_EXTRA_NUCLEAR_ESTROGEN_SIGNALING"
35,"Down",0.324884726011853,0.652836949307241,"B.LvsP.PID_PRL_SIGNALING_EVENTS_PATHWAY"
27,"Down",0.324930107996322,0.652836949307241,"B.LvsP.ABE_VEGFA_TARGETS"
300,"Down",0.324942536533465,0.652836949307241,"B.LvsP.REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1"
87,"Down",0.325092203816624,0.652900397712355,"B.LvsP.KYNG_DNA_DAMAGE_BY_UV"
7,"Up",0.325331196750694,0.65304470365089,"B.LvsP.REACTOME_CATION_COUPLED_CHLORIDE_COTRANSPORTERS"
51,"Up",0.325516296677635,0.65304470365089,"B.LvsP.BERNARD_PPAPDC1B_TARGETS_UP"
44,"Up",0.325518394512905,0.65304470365089,"B.LvsP.REACTOME_METABOLISM_OF_STEROID_HORMONES"
69,"Down",0.326961695327245,0.655702289976183,"B.LvsP.PID_UPA_UPAR_PATHWAY"
815,"Down",0.327232401723102,0.655819118497813,"B.LvsP.ONDER_CDH1_TARGETS_2_DN"
32,"Up",0.327257179948538,0.655819118497813,"B.LvsP.XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_UP"
67,"Up",0.32744955738145,0.655966885058708,"B.LvsP.JAZAG_TGFB1_SIGNALING_DN"
6,"Up",0.328129421577597,0.656895458832159,"B.LvsP.REACTOME_THE_FATTY_ACID_CYCLING_MODEL"
105,"Up",0.328150706690979,0.656895458832159,"B.LvsP.OUILLETTE_CLL_13Q14_DELETION_DN"
78,"Up",0.328325349721851,0.657007187336994,"B.LvsP.AMIT_SERUM_RESPONSE_60_MCF10A"
172,"Down",0.329336594354494,0.658792340877712,"B.LvsP.YAMASHITA_LIVER_CANCER_STEM_CELL_DN"
100,"Down",0.329697673436876,0.659276107208855,"B.LvsP.PID_CD8_TCR_PATHWAY"
189,"Up",0.329980382762183,0.659488171034411,"B.LvsP.PUIFFE_INVASION_INHIBITED_BY_ASCITES_DN"
11,"Up",0.330042280566507,0.659488171034411,"B.LvsP.MULLIGAN_NTF3_SIGNALING_VIA_INSR_AND_IGF1R_DN"
90,"Up",0.330308108034189,0.659780899321181,"B.LvsP.DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP"
43,"Down",0.330573860747314,0.660073266909316,"B.LvsP.MARTINELLI_IMMATURE_NEUTROPHIL_UP"
263,"Down",0.330924072070156,0.660346055504511,"B.LvsP.REACTOME_BINDING_AND_UPTAKE_OF_LIGANDS_BY_SCAVENGER_RECEPTORS"
18,"Up",0.330949343426117,0.660346055504511,"B.LvsP.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_DN"
2751,"Up",0.331175445289027,0.660558815657659,"B.LvsP.BLALOCK_ALZHEIMERS_DISEASE_UP"
88,"Down",0.33160606549784,0.660979922680302,"B.LvsP.SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM6"
28,"Up",0.331625665674653,0.660979922680302,"B.LvsP.HEDENFALK_BREAST_CANCER_BRACX_DN"
24,"Down",0.332647399632869,0.662777467592841,"B.LvsP.REACTOME_SIGNALING_BY_NODAL"
34,"Down",0.333234367180869,0.663707786795038,"B.LvsP.PID_WNT_SIGNALING_PATHWAY"
47,"Up",0.333423007431812,0.663844367335429,"B.LvsP.BIOCARTA_BIOPEPTIDES_PATHWAY"
109,"Up",0.33377697348493,0.664202696307488,"B.LvsP.ENGELMANN_CANCER_PROGENITORS_DN"
33,"Up",0.333843243450625,0.664202696307488,"B.LvsP.HOEGERKORP_CD44_TARGETS_TEMPORAL_DN"
39,"Up",0.334211823440289,0.664205139916818,"B.LvsP.PID_VEGFR1_PATHWAY"
42,"Up",0.334381300049446,0.664205139916818,"B.LvsP.REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR1"
56,"Up",0.334469274092026,0.664205139916818,"B.LvsP.KEGG_HEDGEHOG_SIGNALING_PATHWAY"
72,"Up",0.334529424714548,0.664205139916818,"B.LvsP.CONRAD_STEM_CELL"
65,"Down",0.334661228978961,0.664205139916818,"B.LvsP.REACTOME_PLATELET_AGGREGATION_PLUG_FORMATION"
7,"Down",0.334664142779149,0.664205139916818,"B.LvsP.REACTOME_ELECTRIC_TRANSMISSION_ACROSS_GAP_JUNCTIONS"
72,"Down",0.334708715587154,0.664205139916818,"B.LvsP.JIANG_TIP30_TARGETS_UP"
9,"Down",0.334814004136566,0.664205139916818,"B.LvsP.REACTOME_ABACAVIR_TRANSMEMBRANE_TRANSPORT"
38,"Down",0.334925652032572,0.664205139916818,"B.LvsP.BURTON_ADIPOGENESIS_1"
61,"Down",0.335096918374236,0.664306511900735,"B.LvsP.DORSAM_HOXA9_TARGETS_UP"
99,"Up",0.335767680053374,0.665204839206804,"B.LvsP.REACTOME_TRANS_GOLGI_NETWORK_VESICLE_BUDDING"
18,"Up",0.335946548724681,0.665204839206804,"B.LvsP.PID_DNA_PK_PATHWAY"
363,"Up",0.335969948470885,0.665204839206804,"B.LvsP.REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION"
36,"Up",0.336031310527149,0.665204839206804,"B.LvsP.BIOCARTA_TNFR1_PATHWAY"
296,"Up",0.336522419210219,0.66567243187318,"B.LvsP.SMIRNOV_RESPONSE_TO_IR_6HR_UP"
9,"Up",0.336597364371343,0.66567243187318,"B.LvsP.REACTOME_SERINE_BIOSYNTHESIS"
36,"Up",0.33662870673131,0.66567243187318,"B.LvsP.HEIDENBLAD_AMPLICON_12P11_12_DN"
35,"Down",0.337130603144884,0.66617522854055,"B.LvsP.SEIDEN_MET_SIGNALING"
106,"Down",0.337144611021495,0.66617522854055,"B.LvsP.REACTOME_RNA_POLYMERASE_I_PROMOTER_ESCAPE"
69,"Up",0.337244432028396,0.66617522854055,"B.LvsP.PID_RHOA_PATHWAY"
189,"Down",0.337526872620858,0.666495028114545,"B.LvsP.LIU_VAV3_PROSTATE_CARCINOGENESIS_UP"
24,"Up",0.33786624945392,0.666706245354072,"B.LvsP.REACTOME_G_BETA_GAMMA_SIGNALLING_THROUGH_CDC42"
29,"Down",0.337875004427945,0.666706245354072,"B.LvsP.SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_2FC_DN"
26,"Up",0.338028101024361,0.666770378367354,"B.LvsP.PODAR_RESPONSE_TO_ADAPHOSTIN_DN"
168,"Up",0.338362137771475,0.667191248123569,"B.LvsP.COATES_MACROPHAGE_M1_VS_M2_UP"
12,"Down",0.338621746046264,0.667465110121139,"B.LvsP.REACTOME_MAPK3_ERK1_ACTIVATION"
51,"Up",0.339051486917133,0.667994549005178,"B.LvsP.NIKOLSKY_BREAST_CANCER_7P22_AMPLICON"
482,"Up",0.339131976678881,0.667994549005178,"B.LvsP.HOLLMANN_APOPTOSIS_VIA_CD40_DN"
87,"Down",0.339749510354486,0.668972593571921,"B.LvsP.BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN"
45,"Up",0.340138423568318,0.669435026072115,"B.LvsP.REACTOME_SYNTHESIS_OF_PA"
165,"Up",0.34047140023192,0.669435026072115,"B.LvsP.RAGHAVACHARI_PLATELET_SPECIFIC_GENES"
25,"Up",0.340683466343391,0.669435026072115,"B.LvsP.LEE_LIVER_CANCER_HEPATOBLAST"
11,"Down",0.340690025380012,0.669435026072115,"B.LvsP.WORSCHECH_TUMOR_REJECTION_DN"
37,"Down",0.340701005630202,0.669435026072115,"B.LvsP.REACTOME_UPTAKE_AND_ACTIONS_OF_BACTERIAL_TOXINS"
51,"Up",0.340710827159872,0.669435026072115,"B.LvsP.PID_FAS_PATHWAY"
1053,"Up",0.34102249270337,0.669809364887009,"B.LvsP.NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN"
118,"Up",0.341597953063152,0.670701378723782,"B.LvsP.KEGG_PROSTATE_CANCER"
279,"Up",0.341812811606317,0.670819990378093,"B.LvsP.GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_UP"
45,"Up",0.341901018789196,0.670819990378093,"B.LvsP.REACTOME_MTOR_SIGNALLING"
526,"Down",0.342258685298595,0.671159197874651,"B.LvsP.SABATES_COLORECTAL_ADENOMA_DN"
26,"Up",0.342316682583924,0.671159197874651,"B.LvsP.REACTOME_UNBLOCKING_OF_NMDA_RECEPTORS_GLUTAMATE_BINDING_AND_ACTIVATION"
10,"Down",0.342717581286704,0.671707021245724,"B.LvsP.REACTOME_FRUCTOSE_CATABOLISM"
52,"Down",0.343365814218112,0.672361175147693,"B.LvsP.WOTTON_RUNX_TARGETS_DN"
63,"Down",0.343413619682534,0.672361175147693,"B.LvsP.BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_DN"
66,"Down",0.343416161804501,0.672361175147693,"B.LvsP.REACTOME_SIGNALING_BY_ERBB2"
13,"Down",0.343754691058362,0.67259573043629,"B.LvsP.TESAR_ALK_TARGETS_EPISC_3D_UP"
205,"Up",0.343779261026037,0.67259573043629,"B.LvsP.SENESE_HDAC2_TARGETS_DN"
51,"Up",0.344057832456578,0.672820303135631,"B.LvsP.PID_EPO_PATHWAY"
77,"Up",0.344332374222011,0.672820303135631,"B.LvsP.BALDWIN_PRKCI_TARGETS_UP"
87,"Down",0.344355119122754,0.672820303135631,"B.LvsP.PID_HDAC_CLASSI_PATHWAY"
26,"Down",0.344596778149254,0.672820303135631,"B.LvsP.PLASARI_TGFB1_TARGETS_1HR_DN"
94,"Up",0.34476554794944,0.672820303135631,"B.LvsP.GARCIA_TARGETS_OF_FLI1_AND_DAX1_UP"
27,"Down",0.344814997343931,0.672820303135631,"B.LvsP.MELLMAN_TUT1_TARGETS_UP"
6,"Down",0.344881573333955,0.672820303135631,"B.LvsP.BIOCARTA_SAM68_PATHWAY"
518,"Down",0.345116468010533,0.672820303135631,"B.LvsP.LEI_MYB_TARGETS"
42,"Up",0.345200840870491,0.672820303135631,"B.LvsP.REACTOME_DISEASES_OF_CARBOHYDRATE_METABOLISM"
73,"Up",0.345331939926692,0.672820303135631,"B.LvsP.CHANGOLKAR_H2AFY_TARGETS_UP"
95,"Down",0.345407812643007,0.672820303135631,"B.LvsP.BORLAK_LIVER_CANCER_EGF_UP"
12,"Down",0.345604218903074,0.672820303135631,"B.LvsP.REACTOME_TRANSPORT_OF_NUCLEOSIDES_AND_FREE_PURINE_AND_PYRIMIDINE_BASES_ACROSS_THE_PLASMA_MEMBRANE"
268,"Up",0.345605392004401,0.672820303135631,"B.LvsP.BROWNE_HCMV_INFECTION_18HR_UP"
18,"Down",0.345640202210238,0.672820303135631,"B.LvsP.PARK_OSTEOBLAST_DIFFERENTIATION_BY_PHENYLAMIL_UP"
22,"Up",0.345846847862215,0.672820303135631,"B.LvsP.ISHIKAWA_STING_SIGNALING"
548,"Up",0.345940351103481,0.672820303135631,"B.LvsP.DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN"
73,"Up",0.346051347739374,0.672820303135631,"B.LvsP.REACTOME_NETRIN_1_SIGNALING"
782,"Down",0.346159674457982,0.672820303135631,"B.LvsP.CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1"
171,"Down",0.346206142597372,0.672820303135631,"B.LvsP.LIU_NASOPHARYNGEAL_CARCINOMA"
40,"Down",0.346683406347764,0.673511087033305,"B.LvsP.WU_HBX_TARGETS_2_UP"
39,"Up",0.347519665371365,0.674704095110196,"B.LvsP.DACOSTA_LOW_DOSE_UV_RESPONSE_VIA_ERCC3_XPCS_UP"
70,"Up",0.347655643931005,0.674704095110196,"B.LvsP.PETRETTO_CARDIAC_HYPERTROPHY"
74,"Up",0.347663585995469,0.674704095110196,"B.LvsP.RASHI_RESPONSE_TO_IONIZING_RADIATION_3"
75,"Up",0.348203565670233,0.675325810442481,"B.LvsP.MCDOWELL_ACUTE_LUNG_INJURY_DN"
28,"Down",0.348498004601487,0.675325810442481,"B.LvsP.REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS"
81,"Down",0.348659546719897,0.675325810442481,"B.LvsP.HEIDENBLAD_AMPLICON_8Q24_UP"
635,"Down",0.348777215949482,0.675325810442481,"B.LvsP.LINDGREN_BLADDER_CANCER_CLUSTER_2B"
107,"Up",0.348807423044908,0.675325810442481,"B.LvsP.BERNARD_PPAPDC1B_TARGETS_DN"
373,"Down",0.348809615249327,0.675325810442481,"B.LvsP.MEISSNER_BRAIN_HCP_WITH_H3K27ME3"
54,"Up",0.348838942778753,0.675325810442481,"B.LvsP.VALK_AML_CLUSTER_9"
53,"Down",0.349046850560115,0.675491787450779,"B.LvsP.WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_UP"
11,"Down",0.349324982571989,0.675793501973593,"B.LvsP.REACTOME_BICARBONATE_TRANSPORTERS"
13,"Up",0.349538930660138,0.675867919649475,"B.LvsP.REACTOME_IONOTROPIC_ACTIVITY_OF_KAINATE_RECEPTORS"
82,"Up",0.349607930945469,0.675867919649475,"B.LvsP.PID_SHP2_PATHWAY"
103,"Down",0.349777856966015,0.675960073808143,"B.LvsP.NIKOLSKY_BREAST_CANCER_7Q21_Q22_AMPLICON"
11,"Up",0.350104981225263,0.676295150351569,"B.LvsP.REACTOME_ERYTHROPOIETIN_ACTIVATES_PHOSPHOLIPASE_C_GAMMA_PLCG"
39,"Up",0.3501958790842,0.676295150351569,"B.LvsP.REACTOME_SIGNALING_BY_NTRK2_TRKB"
55,"Down",0.350676086536501,0.676888761229096,"B.LvsP.REACTOME_TRANSPORT_OF_VITAMINS_NUCLEOSIDES_AND_RELATED_MOLECULES"
35,"Down",0.350850280694236,0.676888761229096,"B.LvsP.HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_DN"
335,"Up",0.350870535301608,0.676888761229096,"B.LvsP.WANG_CISPLATIN_RESPONSE_AND_XPC_DN"
19,"Down",0.351074069824546,0.677045180348767,"B.LvsP.REACTOME_TFAP2_AP_2_FAMILY_REGULATES_TRANSCRIPTION_OF_GROWTH_FACTORS_AND_THEIR_RECEPTORS"
18,"Down",0.351341800058696,0.677094035379244,"B.LvsP.REACTOME_DISEASES_ASSOCIATED_WITH_N_GLYCOSYLATION_OF_PROTEINS"
93,"Up",0.351455000685283,0.677094035379244,"B.LvsP.MCCLUNG_DELTA_FOSB_TARGETS_8WK"
566,"Down",0.351466789932796,0.677094035379244,"B.LvsP.SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP"
86,"Up",0.351600286698625,0.677115285669347,"B.LvsP.REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS"
63,"Up",0.351927899486574,0.677510221539439,"B.LvsP.NAKAMURA_METASTASIS_MODEL_DN"
25,"Down",0.352128482620986,0.677660417825072,"B.LvsP.WANG_RECURRENT_LIVER_CANCER_UP"
66,"Up",0.352309799605875,0.677773445379571,"B.LvsP.REACTOME_SIGNALING_BY_NOTCH1_PEST_DOMAIN_MUTANTS_IN_CANCER"
127,"Up",0.35314669158037,0.679147150520997,"B.LvsP.REACTOME_REGULATION_OF_PLK1_ACTIVITY_AT_G2_M_TRANSITION"
120,"Up",0.353817204995942,0.680200043957777,"B.LvsP.CHUNG_BLISTER_CYTOTOXICITY_DN"
6,"Up",0.35430870900344,0.680677211834751,"B.LvsP.REACTOME_SIGNALING_BY_MEMBRANE_TETHERED_FUSIONS_OF_PDGFRA_OR_PDGFRB"
58,"Up",0.354526220025014,0.680677211834751,"B.LvsP.HARRIS_BRAIN_CANCER_PROGENITORS"
34,"Up",0.354584223063013,0.680677211834751,"B.LvsP.BYSTRYKH_HEMATOPOIESIS_STEM_CELL_IL3RA"
63,"Up",0.354586319221638,0.680677211834751,"B.LvsP.APRELIKOVA_BRCA1_TARGETS"
5,"Down",0.354680963518885,0.680677211834751,"B.LvsP.REACTOME_DOPAMINE_RECEPTORS"
28,"Up",0.355256180200437,0.681537855555204,"B.LvsP.HOWLIN_CITED1_TARGETS_2_DN"
20,"Up",0.355375951811476,0.681537855555204,"B.LvsP.BIOCARTA_HSP27_PATHWAY"
72,"Down",0.355758380998946,0.682034704765315,"B.LvsP.SCHRAETS_MLL_TARGETS_DN"
112,"Up",0.356027560279103,0.682154261865818,"B.LvsP.WIEDERSCHAIN_TARGETS_OF_BMI1_AND_PCGF2"
248,"Down",0.35606749859735,0.682154261865818,"B.LvsP.ZHU_CMV_ALL_UP"
10,"Down",0.356450771716712,0.682506974849834,"B.LvsP.AGARWAL_AKT_PATHWAY_TARGETS"
13,"Up",0.356498488581356,0.682506974849834,"B.LvsP.REACTOME_LINOLEIC_ACID_LA_METABOLISM"
96,"Down",0.356734755716755,0.682722902166126,"B.LvsP.GRABARCZYK_BCL11B_TARGETS_DN"
944,"Down",0.357077018105543,0.682984426473,"B.LvsP.MIKKELSEN_MEF_HCP_WITH_H3K27ME3"
111,"Up",0.357198720849912,0.682984426473,"B.LvsP.HOFMANN_CELL_LYMPHOMA_UP"
102,"Down",0.357241989755818,0.682984426473,"B.LvsP.REACTOME_E3_UBIQUITIN_LIGASES_UBIQUITINATE_TARGET_PROTEINS"
187,"Down",0.35744615580982,0.683132141909755,"B.LvsP.BRUECKNER_TARGETS_OF_MIRLET7A3_UP"
87,"Down",0.357638372507713,0.683132141909755,"B.LvsP.ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_DN"
11,"Up",0.357689916952205,0.683132141909755,"B.LvsP.SMID_BREAST_CANCER_RELAPSE_IN_PLEURA_UP"
243,"Up",0.357886072961266,0.683270751865622,"B.LvsP.KEGG_REGULATION_OF_ACTIN_CYTOSKELETON"
49,"Down",0.358314902111196,0.683853328882568,"B.LvsP.WANG_NEOPLASTIC_TRANSFORMATION_BY_CCND1_MYC"
273,"Down",0.358697343920834,0.68434700294627,"B.LvsP.VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP"
144,"Down",0.359219809088203,0.684813704598209,"B.LvsP.WINZEN_DEGRADED_VIA_KHSRP"
17,"Down",0.359231320952146,0.684813704598209,"B.LvsP.BIOCARTA_CD40_PATHWAY"
18,"Down",0.359313538983433,0.684813704598209,"B.LvsP.BIOCARTA_DNAFRAGMENT_PATHWAY"
52,"Down",0.359862912017861,0.685624410939612,"B.LvsP.LEIN_LOCALIZED_TO_PROXIMAL_DENDRITES"
5,"Down",0.360274557107534,0.686172244659855,"B.LvsP.RAFFEL_VEGFA_TARGETS_DN"
21,"Up",0.360464455724262,0.686246943215501,"B.LvsP.CHESLER_BRAIN_QTL_TRANS"
15,"Down",0.360562013029667,0.686246943215501,"B.LvsP.CHESLER_BRAIN_D6MIT150_QTL_CIS"
465,"Down",0.361263942259932,0.687346296199299,"B.LvsP.HSIAO_LIVER_SPECIFIC_GENES"
86,"Up",0.36180994513817,0.687953977788946,"B.LvsP.REACTOME_PEROXISOMAL_PROTEIN_IMPORT"
71,"Down",0.36183218799245,0.687953977788946,"B.LvsP.WEINMANN_ADAPTATION_TO_HYPOXIA_DN"
79,"Down",0.362727513026311,0.689419188560493,"B.LvsP.HOLLERN_MICROACINAR_BREAST_TUMOR_UP"
448,"Down",0.363189436519035,0.689836778039764,"B.LvsP.KAAB_HEART_ATRIUM_VS_VENTRICLE_DN"
201,"Down",0.363196755448319,0.689836778039764,"B.LvsP.WIERENGA_STAT5A_TARGETS_GROUP1"
120,"Up",0.363888014134502,0.690295017815461,"B.LvsP.BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_DN"
128,"Up",0.363895983297363,0.690295017815461,"B.LvsP.URS_ADIPOCYTE_DIFFERENTIATION_UP"
7,"Down",0.364122152309333,0.690295017815461,"B.LvsP.JU_AGING_TERC_TARGETS_UP"
106,"Up",0.364178055284481,0.690295017815461,"B.LvsP.WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_TBH"
523,"Up",0.364269891263104,0.690295017815461,"B.LvsP.FISCHER_DIRECT_P53_TARGETS_META_ANALYSIS"
66,"Down",0.364275603194642,0.690295017815461,"B.LvsP.RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_UP"
35,"Up",0.364311966356577,0.690295017815461,"B.LvsP.REACTOME_ACTIVATION_OF_KAINATE_RECEPTORS_UPON_GLUTAMATE_BINDING"
35,"Up",0.36497248479591,0.691038301941804,"B.LvsP.MASRI_RESISTANCE_TO_TAMOXIFEN_AND_AROMATASE_INHIBITORS_UP"
13,"Down",0.365048979496037,0.691038301941804,"B.LvsP.REACTOME_EGFR_INTERACTS_WITH_PHOSPHOLIPASE_C_GAMMA"
8,"Down",0.365079196956414,0.691038301941804,"B.LvsP.REACTOME_DEFECTIVE_CHST14_CAUSES_EDS_MUSCULOCONTRACTURAL_TYPE"
111,"Down",0.365261572819504,0.691073864623708,"B.LvsP.REACTOME_B_WICH_COMPLEX_POSITIVELY_REGULATES_RRNA_EXPRESSION"
86,"Down",0.365397580099881,0.691073864623708,"B.LvsP.CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_DN"
62,"Up",0.365472957163994,0.691073864623708,"B.LvsP.AMIT_SERUM_RESPONSE_480_MCF10A"
5,"Down",0.365727262781743,0.691318302878721,"B.LvsP.REACTOME_GALACTOSE_CATABOLISM"
31,"Down",0.365986057498434,0.691571056701587,"B.LvsP.DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_DN"
79,"Up",0.366275380971376,0.691881305565678,"B.LvsP.REACTOME_BASE_EXCISION_REPAIR_AP_SITE_FORMATION"
846,"Down",0.36663747965204,0.692328765367531,"B.LvsP.SMID_BREAST_CANCER_NORMAL_LIKE_UP"
102,"Down",0.366771875691227,0.692346091053872,"B.LvsP.PID_IL4_2PATHWAY"
1318,"Up",0.367136777706567,0.692798376771197,"B.LvsP.GOZGIT_ESR1_TARGETS_DN"
505,"Down",0.367335635194739,0.692897209299945,"B.LvsP.REACTOME_GPCR_LIGAND_BINDING"
401,"Up",0.367439793392555,0.692897209299945,"B.LvsP.WELCSH_BRCA1_TARGETS_UP"
72,"Down",0.367759556547594,0.693056482012311,"B.LvsP.ALONSO_METASTASIS_EMT_UP"
94,"Up",0.367774953558351,0.693056482012311,"B.LvsP.BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_UP"
5,"Up",0.36832069667216,0.693491628474987,"B.LvsP.REACTOME_FASL_CD95L_SIGNALING"
34,"Down",0.368384779385863,0.693491628474987,"B.LvsP.REACTOME_PYRUVATE_METABOLISM"
65,"Down",0.368467799825484,0.693491628474987,"B.LvsP.HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_UP"
48,"Down",0.368507579030478,0.693491628474987,"B.LvsP.KEGG_PRION_DISEASES"
344,"Up",0.368861438119627,0.693921364873568,"B.LvsP.LINDGREN_BLADDER_CANCER_CLUSTER_3_DN"
413,"Up",0.369111445204052,0.693965861676679,"B.LvsP.AFFAR_YY1_TARGETS_UP"
48,"Up",0.369172714771858,0.693965861676679,"B.LvsP.GHANDHI_DIRECT_IRRADIATION_DN"
377,"Down",0.36938345105006,0.693965861676679,"B.LvsP.QI_PLASMACYTOMA_UP"
12,"Down",0.369387146123072,0.693965861676679,"B.LvsP.REACTOME_SYNTHESIS_OF_5_EICOSATETRAENOIC_ACIDS"
32,"Up",0.369660202202213,0.694161341746017,"B.LvsP.SAGIV_CD24_TARGETS_UP"
37,"Down",0.369787094362283,0.694161341746017,"B.LvsP.CHANG_POU5F1_TARGETS_UP"
150,"Up",0.369885479150476,0.694161341746017,"B.LvsP.BURTON_ADIPOGENESIS_8"
5,"Down",0.370104730023297,0.694161341746017,"B.LvsP.BAFNA_MUC4_TARGETS_UP"
170,"Up",0.370118942931318,0.694161341746017,"B.LvsP.JI_RESPONSE_TO_FSH_UP"
203,"Up",0.370291672694899,0.69424979936592,"B.LvsP.MIKKELSEN_MEF_LCP_WITH_H3K4ME3"
30,"Down",0.371168683968383,0.69565818768176,"B.LvsP.REACTOME_RNA_POLYMERASE_III_TRANSCRIPTION_INITIATION_FROM_TYPE_1_PROMOTER"
35,"Down",0.37140459377375,0.69586445238057,"B.LvsP.OZANNE_AP1_TARGETS_UP"
87,"Down",0.371817820568837,0.696125516023164,"B.LvsP.LEE_LIVER_CANCER_MYC_TGFA_UP"
137,"Up",0.371969832596948,0.696125516023164,"B.LvsP.KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION"
12,"Down",0.372101188121285,0.696125516023164,"B.LvsP.BIOCARTA_SARS_PATHWAY"
20,"Up",0.372109782882358,0.696125516023164,"B.LvsP.REACTOME_BETA_CATENIN_PHOSPHORYLATION_CASCADE"
134,"Down",0.372203617056597,0.696125516023164,"B.LvsP.VANHARANTA_UTERINE_FIBROID_DN"
417,"Down",0.372403854581008,0.696125516023164,"B.LvsP.PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_UP"
69,"Down",0.372435096584815,0.696125516023164,"B.LvsP.REACTOME_SIGNALING_BY_PTK6"
11,"Down",0.372551166922146,0.696125516023164,"B.LvsP.REACTOME_ACTIVATED_NTRK3_SIGNALS_THROUGH_RAS"
349,"Down",0.372783415593126,0.69630271465367,"B.LvsP.REACTOME_MAPK_FAMILY_SIGNALING_CASCADES"
38,"Up",0.37289787268756,0.69630271465367,"B.LvsP.REACTOME_NICOTINATE_METABOLISM"
52,"Up",0.373052827941884,0.696356882407386,"B.LvsP.SANCHEZ_MDM2_TARGETS"
149,"Down",0.373364643572011,0.69670371728304,"B.LvsP.NIKOLSKY_BREAST_CANCER_16P13_AMPLICON"
42,"Down",0.373630072515017,0.696963789114551,"B.LvsP.VANDESLUIS_COMMD1_TARGETS_GROUP_4_DN"
271,"Down",0.373879883708717,0.697194562234569,"B.LvsP.PHONG_TNF_RESPONSE_VIA_P38_PARTIAL"
113,"Up",0.374434375175617,0.697993142395814,"B.LvsP.JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN"
35,"Down",0.374678537130455,0.69821288567384,"B.LvsP.CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_LD_MTX_DN"
19,"Up",0.376209429381052,0.700829492940646,"B.LvsP.TAKAYAMA_BOUND_BY_AR"
820,"Up",0.376763360349904,0.701624998105294,"B.LvsP.SENESE_HDAC3_TARGETS_UP"
51,"Up",0.376956151735383,0.701747664291222,"B.LvsP.REACTOME_GROWTH_HORMONE_RECEPTOR_SIGNALING"
94,"Up",0.377377642071648,0.702295854262586,"B.LvsP.MAYBURD_RESPONSE_TO_L663536_DN"
305,"Up",0.378191049510798,0.703572783561643,"B.LvsP.WIERENGA_STAT5A_TARGETS_DN"
11,"Down",0.378822256938449,0.704357008561636,"B.LvsP.VALK_AML_WITH_T_8_21_TRANSLOCATION"
22,"Down",0.378867379899133,0.704357008561636,"B.LvsP.BOYAULT_LIVER_CANCER_SUBCLASS_G12_DN"
236,"Down",0.379003054502342,0.704372399443176,"B.LvsP.BOSCO_ALLERGEN_INDUCED_TH2_ASSOCIATED_MODULE"
33,"Up",0.379262789248581,0.704618266718887,"B.LvsP.FIGUEROA_AML_METHYLATION_CLUSTER_4_DN"
162,"Down",0.3796345486967,0.704886460590844,"B.LvsP.REACTOME_GENE_SILENCING_BY_RNA"
171,"Up",0.379977462885851,0.704886460590844,"B.LvsP.KEGG_WNT_SIGNALING_PATHWAY"
101,"Up",0.38015629643716,0.704886460590844,"B.LvsP.REACTOME_ONCOGENIC_MAPK_SIGNALING"
11,"Down",0.380187087147925,0.704886460590844,"B.LvsP.KOINUMA_COLON_CANCER_MSI_DN"
25,"Up",0.38021091417313,0.704886460590844,"B.LvsP.KYNG_ENVIRONMENTAL_STRESS_RESPONSE_DN"
19,"Up",0.380272605129114,0.704886460590844,"B.LvsP.BIOCARTA_ACH_PATHWAY"
53,"Up",0.380489580430931,0.704886460590844,"B.LvsP.PID_LIS1_PATHWAY"
116,"Down",0.380490224985114,0.704886460590844,"B.LvsP.MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_DN"
188,"Up",0.380554546005366,0.704886460590844,"B.LvsP.PID_PDGFRB_PATHWAY"
34,"Down",0.380988364011409,0.70545367200907,"B.LvsP.STEGER_ADIPOGENESIS_UP"
61,"Down",0.3815250670955,0.705629537934473,"B.LvsP.FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_DN"
18,"Down",0.381534215157416,0.705629537934473,"B.LvsP.REACTOME_BETA_OXIDATION_OF_VERY_LONG_CHAIN_FATTY_ACIDS"
43,"Down",0.381813936216009,0.705629537934473,"B.LvsP.WANG_CLASSIC_ADIPOGENIC_TARGETS_OF_PPARG"
18,"Down",0.381824885498348,0.705629537934473,"B.LvsP.REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION_IN_TLR7_8_OR_9_SIGNALING"
44,"Up",0.381842134052621,0.705629537934473,"B.LvsP.AMIT_SERUM_RESPONSE_40_MCF10A"
381,"Down",0.382004335881045,0.705629537934473,"B.LvsP.MCBRYAN_PUBERTAL_BREAST_3_4WK_UP"
23,"Up",0.382052839610573,0.705629537934473,"B.LvsP.SARTIPY_BLUNTED_BY_INSULIN_RESISTANCE_DN"
96,"Down",0.382252516933786,0.705629537934473,"B.LvsP.MUELLER_METHYLATED_IN_GLIOBLASTOMA"
32,"Up",0.382286193760637,0.705629537934473,"B.LvsP.REACTOME_GLYCOGEN_METABOLISM"
27,"Down",0.382359575990537,0.705629537934473,"B.LvsP.REACTOME_TGF_BETA_RECEPTOR_SIGNALING_IN_EMT_EPITHELIAL_TO_MESENCHYMAL_TRANSITION"
222,"Down",0.382551920877653,0.705748939116631,"B.LvsP.GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_DN"
44,"Down",0.383136016744937,0.70638766933197,"B.LvsP.DAZARD_UV_RESPONSE_CLUSTER_G28"
52,"Up",0.383153666183139,0.70638766933197,"B.LvsP.BIOCARTA_IL2RB_PATHWAY"
22,"Down",0.383322997217894,0.706464283872579,"B.LvsP.BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_24HR_DN"
5,"Up",0.383682025094999,0.706820014991597,"B.LvsP.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_18"
79,"Up",0.383799610072785,0.706820014991597,"B.LvsP.DAZARD_UV_RESPONSE_CLUSTER_G24"
72,"Up",0.383949837071162,0.706820014991597,"B.LvsP.ROESSLER_LIVER_CANCER_METASTASIS_DN"
44,"Down",0.384027369331662,0.706820014991597,"B.LvsP.REACTOME_BETA_DEFENSINS"
323,"Up",0.384424997067888,0.707316408914593,"B.LvsP.SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_DN"
27,"Down",0.384644075914641,0.707318581715478,"B.LvsP.BIOCARTA_GCR_PATHWAY"
277,"Up",0.384717059639302,0.707318581715478,"B.LvsP.LU_AGING_BRAIN_DN"
258,"Up",0.384809964514408,0.707318581715478,"B.LvsP.RUIZ_TNC_TARGETS_UP"
18,"Up",0.384999152609322,0.707431144824506,"B.LvsP.SHIN_B_CELL_LYMPHOMA_CLUSTER_1"
9,"Down",0.38554630927202,0.707559454766382,"B.LvsP.MIKHAYLOVA_OXIDATIVE_STRESS_RESPONSE_VIA_VHL_UP"
20,"Down",0.385596073199358,0.707559454766382,"B.LvsP.REACTOME_ERYTHROCYTES_TAKE_UP_CARBON_DIOXIDE_AND_RELEASE_OXYGEN"
150,"Up",0.385606472189782,0.707559454766382,"B.LvsP.TANAKA_METHYLATED_IN_ESOPHAGEAL_CARCINOMA"
42,"Up",0.385734010424387,0.707559454766382,"B.LvsP.BIOCARTA_PYK2_PATHWAY"
84,"Down",0.385856311386606,0.707559454766382,"B.LvsP.KEGG_MELANOMA"
144,"Down",0.385943672682504,0.707559454766382,"B.LvsP.SWEET_KRAS_TARGETS_UP"
12,"Down",0.385964788492568,0.707559454766382,"B.LvsP.REACTOME_MET_RECEPTOR_RECYCLING"
8,"Down",0.386429013945743,0.708031232163634,"B.LvsP.REACTOME_PTK6_REGULATES_CELL_CYCLE"
1122,"Down",0.386478252608039,0.708031232163634,"B.LvsP.RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP"
15,"Up",0.386837743028386,0.708291640250232,"B.LvsP.PID_INTEGRIN4_PATHWAY"
150,"Up",0.386993505114585,0.708291640250232,"B.LvsP.REACTOME_OXIDATIVE_STRESS_INDUCED_SENESCENCE"
40,"Up",0.387004710652189,0.708291640250232,"B.LvsP.REACTOME_REGULATION_OF_MECP2_EXPRESSION_AND_ACTIVITY"
34,"Up",0.387217946071826,0.708447393723072,"B.LvsP.BIOCARTA_SPPA_PATHWAY"
91,"Down",0.38763130175429,0.708969059675643,"B.LvsP.REACTOME_SIGNALING_BY_FGFR2"
50,"Up",0.387801195971578,0.709045242237717,"B.LvsP.BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_DN"
18,"Down",0.388032544637548,0.70923369894248,"B.LvsP.BIOCARTA_LYM_PATHWAY"
8,"Down",0.388914124006942,0.71025474682372,"B.LvsP.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_5"
21,"Up",0.388966683998085,0.71025474682372,"B.LvsP.IRITANI_MAD1_TARGETS_UP"
27,"Up",0.389052909207783,0.71025474682372,"B.LvsP.REACTOME_WNT_LIGAND_BIOGENESIS_AND_TRAFFICKING"
47,"Up",0.389105015035097,0.71025474682372,"B.LvsP.REACTOME_METALLOPROTEASE_DUBS"
13,"Up",0.389406577525747,0.710570616217773,"B.LvsP.REACTOME_INACTIVATION_OF_CDC42_AND_RAC1"
56,"Up",0.38972197590962,0.710677224038922,"B.LvsP.DAIRKEE_CANCER_PRONE_RESPONSE_E2"
49,"Down",0.389722073301865,0.710677224038922,"B.LvsP.REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT"
38,"Up",0.390191549412278,0.710678138795048,"B.LvsP.MEISSNER_NPC_ICP_WITH_H3_UNMETHYLATED"
12,"Up",0.390232703223199,0.710678138795048,"B.LvsP.REACTOME_REVERSIBLE_HYDRATION_OF_CARBON_DIOXIDE"
107,"Up",0.390283556756689,0.710678138795048,"B.LvsP.KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY"
17,"Down",0.390337748660701,0.710678138795048,"B.LvsP.REACTOME_RESPONSE_OF_EIF2AK1_HRI_TO_HEME_DEFICIENCY"
1070,"Up",0.390365257283516,0.710678138795048,"B.LvsP.SCHLOSSER_SERUM_RESPONSE_DN"
51,"Up",0.390840298729486,0.711137995474546,"B.LvsP.EHLERS_ANEUPLOIDY_UP"
199,"Up",0.390875089210914,0.711137995474546,"B.LvsP.PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_DN"
55,"Down",0.391161017702281,0.711424100946023,"B.LvsP.PID_INTEGRIN_A4B1_PATHWAY"
14,"Down",0.391934740169728,0.712327517566159,"B.LvsP.REACTOME_FGFR3_LIGAND_BINDING_AND_ACTIVATION"
32,"Down",0.391987411759383,0.712327517566159,"B.LvsP.CAFFAREL_RESPONSE_TO_THC_24HR_3_DN"
9,"Down",0.392044245967412,0.712327517566159,"B.LvsP.BRUNEAU_SEPTATION_ATRIAL"
44,"Down",0.39229928507817,0.712486644098591,"B.LvsP.JEPSEN_SMRT_TARGETS"
384,"Up",0.392389551687504,0.712486644098591,"B.LvsP.YAGI_AML_FAB_MARKERS"
117,"Down",0.392603757791748,0.712641555098679,"B.LvsP.REACTOME_ARACHIDONIC_ACID_METABOLISM"
78,"Up",0.392753247653081,0.712678932154211,"B.LvsP.PID_RAC1_PATHWAY"
20,"Up",0.392950423821364,0.712753307996102,"B.LvsP.BARRIER_CANCER_RELAPSE_TUMOR_SAMPLE_UP"
1388,"Down",0.393052059338057,0.712753307996102,"B.LvsP.REACTOME_DEVELOPMENTAL_BIOLOGY"
4,"Down",0.393477425206639,0.71329071605492,"B.LvsP.REACTOME_ORGANIC_ANION_TRANSPORT"
71,"Up",0.393609548834441,0.713296360375491,"B.LvsP.REACTOME_RECOGNITION_AND_ASSOCIATION_OF_DNA_GLYCOSYLASE_WITH_SITE_CONTAINING_AN_AFFECTED_PURINE"
47,"Down",0.393909345995798,0.713484079646046,"B.LvsP.REACTOME_DNA_DAMAGE_RECOGNITION_IN_GG_NER"
211,"Down",0.393985149397129,0.713484079646046,"B.LvsP.REACTOME_INITIAL_TRIGGERING_OF_COMPLEMENT"
22,"Down",0.394100267541874,0.713484079646046,"B.LvsP.SHIN_B_CELL_LYMPHOMA_CLUSTER_5"
23,"Down",0.394368819801159,0.71373656454357,"B.LvsP.WANG_RECURRENT_LIVER_CANCER_DN"
59,"Down",0.394748898041459,0.714190660101841,"B.LvsP.VALK_AML_CLUSTER_15"
49,"Down",0.395445080233604,0.714929247869652,"B.LvsP.REACTOME_RUNX2_REGULATES_OSTEOBLAST_DIFFERENTIATION"
30,"Up",0.395504937682184,0.714929247869652,"B.LvsP.KYNG_DNA_DAMAGE_BY_4NQO_OR_GAMMA_RADIATION"
159,"Up",0.39575248417112,0.714929247869652,"B.LvsP.FIGUEROA_AML_METHYLATION_CLUSTER_4_UP"
66,"Down",0.395901511886492,0.714929247869652,"B.LvsP.FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN"
22,"Up",0.396074330315976,0.714929247869652,"B.LvsP.LOPEZ_EPITHELIOID_MESOTHELIOMA"
31,"Up",0.39607671394897,0.714929247869652,"B.LvsP.CARDOSO_RESPONSE_TO_GAMMA_RADIATION_AND_3AB"
109,"Up",0.396186814095867,0.714929247869652,"B.LvsP.KEGG_MELANOGENESIS"
116,"Up",0.396226417569835,0.714929247869652,"B.LvsP.REACTOME_INTERFERON_ALPHA_BETA_SIGNALING"
15,"Down",0.396320879855396,0.714929247869652,"B.LvsP.REACTOME_MISMATCH_REPAIR"
119,"Down",0.396585976048741,0.715174123148561,"B.LvsP.LINDVALL_IMMORTALIZED_BY_TERT_DN"
63,"Up",0.397034975268149,0.715654303631656,"B.LvsP.BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_48HR_DN"
325,"Down",0.397111123809354,0.715654303631656,"B.LvsP.PURBEY_TARGETS_OF_CTBP1_AND_SATB1_DN"
70,"Down",0.397423159925032,0.715873640689147,"B.LvsP.MA_MYELOID_DIFFERENTIATION_DN"
119,"Up",0.39758688667936,0.715873640689147,"B.LvsP.REACTOME_PI3K_AKT_SIGNALING_IN_CANCER"
26,"Down",0.397621260726419,0.715873640689147,"B.LvsP.REACTOME_MTORC1_MEDIATED_SIGNALLING"
226,"Up",0.397829485100441,0.716015372109486,"B.LvsP.HOLLERN_EMT_BREAST_TUMOR_UP"
25,"Down",0.398641255758655,0.717055845863667,"B.LvsP.NEBEN_AML_WITH_FLT3_OR_NRAS_DN"
22,"Down",0.39866696874388,0.717055845863667,"B.LvsP.REACTOME_SHC_MEDIATED_CASCADE_FGFR4"
65,"Down",0.398930292143541,0.717296125288338,"B.LvsP.ABE_INNER_EAR"
19,"Up",0.399246752765207,0.71760266055547,"B.LvsP.REACTOME_CGMP_EFFECTS"
27,"Up",0.399395166330849,0.71760266055547,"B.LvsP.IGLESIAS_E2F_TARGETS_DN"
269,"Down",0.399490140927788,0.71760266055547,"B.LvsP.LEE_NEURAL_CREST_STEM_CELL_UP"
97,"Up",0.399780071454918,0.717890228994557,"B.LvsP.BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_DN"
51,"Up",0.400256574524489,0.718512532644773,"B.LvsP.SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_DN"
309,"Up",0.400589998092927,0.718877669411163,"B.LvsP.DARWICHE_SQUAMOUS_CELL_CARCINOMA_DN"
13,"Down",0.400727485730587,0.718891067035826,"B.LvsP.REACTOME_PROCESSING_AND_ACTIVATION_OF_SUMO"
78,"Up",0.40098283838032,0.719115833086211,"B.LvsP.PID_ERBB4_PATHWAY"
1329,"Up",0.40137764934065,0.719590474450211,"B.LvsP.KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_UP"
51,"Down",0.401655400734563,0.719679910126782,"B.LvsP.SIMBULAN_PARP1_TARGETS_UP"
358,"Down",0.40178364086646,0.719679910126782,"B.LvsP.BOQUEST_STEM_CELL_DN"
377,"Down",0.401818029039858,0.719679910126782,"B.LvsP.MANALO_HYPOXIA_UP"
8,"Down",0.402426031319135,0.720535468641029,"B.LvsP.FARMER_BREAST_CANCER_CLUSTER_8"
82,"Down",0.402845252725681,0.721052574399576,"B.LvsP.TUOMISTO_TUMOR_SUPPRESSION_BY_COL13A1_UP"
174,"Down",0.403763478464646,0.722302622790355,"B.LvsP.UDAYAKUMAR_MED1_TARGETS_UP"
541,"Down",0.403804920789471,0.722302622790355,"B.LvsP.BOYLAN_MULTIPLE_MYELOMA_C_D_DN"
74,"Down",0.40401733464595,0.722448849695167,"B.LvsP.KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP"
100,"Up",0.404234318714537,0.722603151688546,"B.LvsP.CADWELL_ATG16L1_TARGETS_DN"
36,"Down",0.404493795711664,0.722625910557903,"B.LvsP.UROSEVIC_RESPONSE_TO_IMIQUIMOD"
24,"Up",0.404508445139575,0.722625910557903,"B.LvsP.YAGUE_PRETUMOR_DRUG_RESISTANCE_DN"
44,"Down",0.404923928497237,0.723134496337604,"B.LvsP.PID_AURORA_A_PATHWAY"
8,"Up",0.405285716328248,0.723546892340615,"B.LvsP.REACTOME_NEF_MEDIATED_CD8_DOWN_REGULATION"
16,"Up",0.406165491788745,0.724824633045424,"B.LvsP.BIOCARTA_RELA_PATHWAY"
35,"Up",0.406263616894152,0.724824633045424,"B.LvsP.SIG_IL4RECEPTOR_IN_B_LYPHOCYTES"
338,"Down",0.406523260799764,0.724825389387411,"B.LvsP.REACTOME_FC_EPSILON_RECEPTOR_FCERI_SIGNALING"
29,"Up",0.406702829474532,0.724825389387411,"B.LvsP.REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR3"
44,"Down",0.406713586877179,0.724825389387411,"B.LvsP.VALK_AML_CLUSTER_7"
203,"Up",0.406788421643902,0.724825389387411,"B.LvsP.BORCZUK_MALIGNANT_MESOTHELIOMA_DN"
17,"Down",0.407008467442974,0.724902037681619,"B.LvsP.REACTOME_ZINC_TRANSPORTERS"
149,"Down",0.407093656538511,0.724902037681619,"B.LvsP.NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN"
48,"Down",0.408208366653574,0.726524816862653,"B.LvsP.FARDIN_HYPOXIA_11"
150,"Down",0.408295193985577,0.726524816862653,"B.LvsP.GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP"
239,"Up",0.40846789437349,0.726524816862653,"B.LvsP.KEGG_FOCAL_ADHESION"
61,"Up",0.408606571585867,0.726524816862653,"B.LvsP.MIKKELSEN_MEF_ICP_WITH_H3K4ME3_AND_H3K27ME3"
12,"Up",0.408661996824535,0.726524816862653,"B.LvsP.REACTOME_COHESIN_LOADING_ONTO_CHROMATIN"
37,"Up",0.409031327114102,0.726861088503345,"B.LvsP.IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_UP"
33,"Up",0.409114072603076,0.726861088503345,"B.LvsP.REACTOME_TRANSFERRIN_ENDOCYTOSIS_AND_RECYCLING"
179,"Down",0.409807472534523,0.727859144119298,"B.LvsP.BOUDOUKHA_BOUND_BY_IGF2BP2"
95,"Up",0.410250257590312,0.728411584526923,"B.LvsP.FAELT_B_CLL_WITH_VH_REARRANGEMENTS_DN"
176,"Up",0.410497407096141,0.728457586988674,"B.LvsP.LAIHO_COLORECTAL_CANCER_SERRATED_UP"
497,"Down",0.410539671017672,0.728457586988674,"B.LvsP.DACOSTA_UV_RESPONSE_VIA_ERCC3_UP"
584,"Down",0.411654912359142,0.730202120767948,"B.LvsP.MIKKELSEN_NPC_HCP_WITH_H3K27ME3"
160,"Down",0.41179216737891,0.73021131925529,"B.LvsP.SANA_RESPONSE_TO_IFNG_UP"
62,"Down",0.41235165297741,0.730968993046522,"B.LvsP.REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS"
19,"Up",0.413061123606163,0.731991971928999,"B.LvsP.REACTOME_PRESYNAPTIC_DEPOLARIZATION_AND_CALCIUM_CHANNEL_OPENING"
178,"Down",0.413326214938815,0.732227056198882,"B.LvsP.WHITFIELD_CELL_CYCLE_G1_S"
6,"Down",0.413628050607054,0.732527063358873,"B.LvsP.REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_KEY_METABOLIC_FACTORS"
135,"Down",0.413776249800479,0.732554878369147,"B.LvsP.SEIDEN_ONCOGENESIS_BY_MET"
31,"Down",0.414178661077952,0.733032591901407,"B.LvsP.KEGG_MATURITY_ONSET_DIABETES_OF_THE_YOUNG"
74,"Down",0.414575573641316,0.733500270932108,"B.LvsP.REACTOME_INTRINSIC_PATHWAY_FOR_APOPTOSIS"
17,"Down",0.415296760797736,0.734541199760295,"B.LvsP.PARK_APL_PATHOGENESIS_UP"
31,"Down",0.41584417440868,0.735274205406329,"B.LvsP.REACTOME_POU5F1_OCT4_SOX2_NANOG_ACTIVATE_GENES_RELATED_TO_PROLIFERATION"
42,"Up",0.416212194520268,0.735491433505753,"B.LvsP.BIOCARTA_GLEEVEC_PATHWAY"
106,"Down",0.41636152995083,0.735491433505753,"B.LvsP.WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER"
84,"Down",0.416615353563631,0.735491433505753,"B.LvsP.ROVERSI_GLIOMA_LOH_REGIONS"
81,"Down",0.416665878509736,0.735491433505753,"B.LvsP.BOYAULT_LIVER_CANCER_SUBCLASS_G123_DN"
8,"Up",0.416770708687563,0.735491433505753,"B.LvsP.KERLEY_RESPONSE_TO_CISPLATIN_DN"
118,"Down",0.416839174628707,0.735491433505753,"B.LvsP.ANASTASSIOU_MULTICANCER_INVASIVENESS_SIGNATURE"
77,"Down",0.416898200869421,0.735491433505753,"B.LvsP.SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_DN"
30,"Down",0.417311303838285,0.735495140306164,"B.LvsP.REACTOME_RNA_POLYMERASE_III_TRANSCRIPTION_INITIATION_FROM_TYPE_3_PROMOTER"
12,"Down",0.417390609412583,0.735495140306164,"B.LvsP.REACTOME_TRANSPORT_OF_FATTY_ACIDS"
425,"Up",0.417405079469351,0.735495140306164,"B.LvsP.ALFANO_MYC_TARGETS"
245,"Down",0.417432401931768,0.735495140306164,"B.LvsP.JOHNSTONE_PARVB_TARGETS_2_UP"
291,"Down",0.417706582649045,0.735743770457652,"B.LvsP.REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT"
23,"Up",0.418356797362494,0.736654373444978,"B.LvsP.KOBAYASHI_RESPONSE_TO_ROMIDEPSIN"
1526,"Up",0.418737396170807,0.737085642101755,"B.LvsP.MARSON_BOUND_BY_FOXP3_UNSTIMULATED"
22,"Up",0.418994913509325,0.737085642101755,"B.LvsP.REACTOME_HS_GAG_DEGRADATION"
130,"Down",0.419173415361687,0.737085642101755,"B.LvsP.SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER"
51,"Down",0.41925916817209,0.737085642101755,"B.LvsP.REACTOME_ASSOCIATION_OF_TRIC_CCT_WITH_TARGET_PROTEINS_DURING_BIOSYNTHESIS"
36,"Down",0.419421418155271,0.737085642101755,"B.LvsP.HOLLEMAN_ASPARAGINASE_RESISTANCE_ALL_UP"
136,"Down",0.419461042773653,0.737085642101755,"B.LvsP.ROSS_AML_WITH_PML_RARA_FUSION"
115,"Up",0.419534909693294,0.737085642101755,"B.LvsP.MCCLUNG_COCAIN_REWARD_4WK"
152,"Down",0.419824054221116,0.737359337925207,"B.LvsP.LEIN_MIDBRAIN_MARKERS"
10,"Up",0.420200365686123,0.73778590723359,"B.LvsP.DER_IFN_BETA_RESPONSE_DN"
34,"Up",0.420522198811583,0.737923090349564,"B.LvsP.FARMER_BREAST_CANCER_CLUSTER_7"
30,"Up",0.420545425518444,0.737923090349564,"B.LvsP.REACTOME_ESTROGEN_DEPENDENT_NUCLEAR_EVENTS_DOWNSTREAM_OF_ESR_MEMBRANE_SIGNALING"
13,"Up",0.421154589659626,0.738556250846063,"B.LvsP.SHIRAISHI_PLZF_TARGETS_UP"
1130,"Down",0.421220789656145,0.738556250846063,"B.LvsP.REACTOME_ADAPTIVE_IMMUNE_SYSTEM"
84,"Down",0.421307002200847,0.738556250846063,"B.LvsP.BROWNE_HCMV_INFECTION_2HR_DN"
875,"Up",0.421786852787883,0.738968509841792,"B.LvsP.BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_B"
265,"Up",0.421809480387176,0.738968509841792,"B.LvsP.BROWNE_HCMV_INFECTION_24HR_DN"
140,"Down",0.422060543011991,0.739061042406824,"B.LvsP.NATSUME_RESPONSE_TO_INTERFERON_BETA_UP"
17,"Down",0.42212963861833,0.739061042406824,"B.LvsP.NAGY_TFTC_COMPONENTS_HUMAN"
11,"Up",0.422595655322075,0.739486234985515,"B.LvsP.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_LIGHTGREEN_DN"
37,"Down",0.422639989610097,0.739486234985515,"B.LvsP.OLSSON_E2F3_TARGETS_UP"
19,"Up",0.423011855745992,0.739590040091123,"B.LvsP.REACTOME_PROLONGED_ERK_ACTIVATION_EVENTS"
50,"Up",0.42308452821688,0.739590040091123,"B.LvsP.DASU_IL6_SIGNALING_SCAR_UP"
21,"Down",0.423252394575035,0.739590040091123,"B.LvsP.REACTOME_P75NTR_SIGNALS_VIA_NF_KB"
260,"Up",0.42328580845809,0.739590040091123,"B.LvsP.REACTOME_KERATINIZATION"
123,"Down",0.423471604242768,0.739590040091123,"B.LvsP.FALVELLA_SMOKERS_WITH_LUNG_CANCER"
114,"Down",0.423501911182582,0.739590040091123,"B.LvsP.KEGG_ARACHIDONIC_ACID_METABOLISM"
56,"Down",0.42459137206624,0.741258508416243,"B.LvsP.KEGG_STARCH_AND_SUCROSE_METABOLISM"
11,"Down",0.42501338873361,0.741662592775453,"B.LvsP.REACTOME_PP2A_MEDIATED_DEPHOSPHORYLATION_OF_KEY_METABOLIC_FACTORS"
488,"Up",0.425091111684828,0.741662592775453,"B.LvsP.BROWNE_HCMV_INFECTION_14HR_DN"
16,"Down",0.425725415810975,0.742346066693195,"B.LvsP.BIOCARTA_EPONFKB_PATHWAY"
611,"Up",0.425751379541349,0.742346066693195,"B.LvsP.REN_ALVEOLAR_RHABDOMYOSARCOMA_DN"
28,"Up",0.426216872314734,0.742923419617958,"B.LvsP.REACTOME_TRP_CHANNELS"
25,"Up",0.426653273268412,0.743105573085688,"B.LvsP.BIOCARTA_IFNA_PATHWAY"
24,"Up",0.426672722131674,0.743105573085688,"B.LvsP.REACTOME_RECEPTOR_TYPE_TYROSINE_PROTEIN_PHOSPHATASES"
388,"Up",0.426724578503718,0.743105573085688,"B.LvsP.PEREZ_TP53_AND_TP63_TARGETS"
14,"Up",0.427070448760407,0.743114723337362,"B.LvsP.BIOCARTA_FXR_PATHWAY"
32,"Down",0.427199862648155,0.743114723337362,"B.LvsP.FINAK_BREAST_CANCER_SDPP_SIGNATURE"
37,"Down",0.427447703682689,0.743114723337362,"B.LvsP.REACTOME_SURFACTANT_METABOLISM"
44,"Down",0.4277389504649,0.743114723337362,"B.LvsP.LOPEZ_MESOTHELIOMA_SURVIVAL_DN"
61,"Down",0.42788468924501,0.743114723337362,"B.LvsP.GENTILE_RESPONSE_CLUSTER_D3"
7,"Down",0.428022299805756,0.743114723337362,"B.LvsP.REACTOME_TFAP2A_ACTS_AS_A_TRANSCRIPTIONAL_REPRESSOR_DURING_RETINOIC_ACID_INDUCED_CELL_DIFFERENTIATION"
32,"Down",0.428037145820409,0.743114723337362,"B.LvsP.REACTOME_INCRETIN_SYNTHESIS_SECRETION_AND_INACTIVATION"
99,"Down",0.428210959326778,0.743114723337362,"B.LvsP.LEE_LIVER_CANCER_MYC_E2F1_DN"
81,"Up",0.42821688377497,0.743114723337362,"B.LvsP.LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN"
22,"Down",0.428219206655874,0.743114723337362,"B.LvsP.KEGG_MISMATCH_REPAIR"
30,"Up",0.428284311539274,0.743114723337362,"B.LvsP.REACTOME_CD28_DEPENDENT_PI3K_AKT_SIGNALING"
7,"Up",0.428465095525569,0.743114723337362,"B.LvsP.TERAMOTO_OPN_TARGETS_CLUSTER_3"
69,"Up",0.428477073250047,0.743114723337362,"B.LvsP.APPIERTO_RESPONSE_TO_FENRETINIDE_UP"
6,"Up",0.428723937885652,0.743309706042575,"B.LvsP.FIGUEROA_AML_METHYLATION_CLUSTER_7_DN"
29,"Up",0.428897480077292,0.743377481927067,"B.LvsP.REACTOME_GABA_SYNTHESIS_RELEASE_REUPTAKE_AND_DEGRADATION"
41,"Up",0.429545759242109,0.744244253423253,"B.LvsP.BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_UP"
657,"Down",0.429721663271896,0.744244253423253,"B.LvsP.SENESE_HDAC1_TARGETS_UP"
77,"Up",0.429891458559534,0.744244253423253,"B.LvsP.PID_ECADHERIN_STABILIZATION_PATHWAY"
221,"Up",0.429936000259336,0.744244253423253,"B.LvsP.REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION"
159,"Up",0.430101796462928,0.744298226179509,"B.LvsP.TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_DN"
303,"Down",0.430286441968612,0.744384773981369,"B.LvsP.PROVENZANI_METASTASIS_UP"
56,"Down",0.430483808967843,0.744493268621583,"B.LvsP.KEGG_FATTY_ACID_METABOLISM"
9,"Down",0.430867012053461,0.744851327459266,"B.LvsP.NAGY_PCAF_COMPONENTS_HUMAN"
11,"Up",0.430960281523276,0.744851327459266,"B.LvsP.SCHMAHL_PDGF_SIGNALING"
28,"Up",0.431265015397803,0.74494755654556,"B.LvsP.REACTOME_VEGFR2_MEDIATED_CELL_PROLIFERATION"
19,"Up",0.431285427473745,0.74494755654556,"B.LvsP.VERRECCHIA_RESPONSE_TO_TGFB1_C6"
25,"Up",0.431539028262588,0.745046573219668,"B.LvsP.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_22"
9,"Down",0.431741658325294,0.745046573219668,"B.LvsP.REACTOME_TRIF_MEDIATED_PROGRAMMED_CELL_DEATH"
46,"Down",0.43174701041704,0.745046573219668,"B.LvsP.HWANG_PROSTATE_CANCER_MARKERS"
43,"Down",0.431900313881776,0.745078575804163,"B.LvsP.WEST_ADRENOCORTICAL_TUMOR_MARKERS_DN"
63,"Up",0.432485447012086,0.745483895281766,"B.LvsP.KEGG_NON_SMALL_CELL_LUNG_CANCER"
10,"Up",0.432701858132161,0.745483895281766,"B.LvsP.REACTOME_NEGATIVE_REGULATION_OF_ACTIVITY_OF_TFAP2_AP_2_FAMILY_TRANSCRIPTION_FACTORS"
233,"Up",0.433066283831606,0.745483895281766,"B.LvsP.CHEBOTAEV_GR_TARGETS_DN"
19,"Down",0.433108598923475,0.745483895281766,"B.LvsP.REACTOME_SHC_MEDIATED_CASCADE_FGFR3"
8,"Up",0.433110659679321,0.745483895281766,"B.LvsP.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_6"
185,"Down",0.433207672999678,0.745483895281766,"B.LvsP.SMIRNOV_RESPONSE_TO_IR_6HR_DN"
41,"Up",0.433236761070709,0.745483895281766,"B.LvsP.HOEGERKORP_CD44_TARGETS_DIRECT_UP"
464,"Up",0.433259451525805,0.745483895281766,"B.LvsP.RAO_BOUND_BY_SALL4_ISOFORM_A"
233,"Up",0.433348750124,0.745483895281766,"B.LvsP.ZHU_CMV_ALL_DN"
8,"Up",0.43366254027933,0.745545486655656,"B.LvsP.TERAMOTO_OPN_TARGETS_CLUSTER_5"
17,"Up",0.433813324607634,0.745545486655656,"B.LvsP.IVANOV_MUTATED_IN_COLON_CANCER"
78,"Down",0.433981495510979,0.745545486655656,"B.LvsP.KAAB_FAILED_HEART_VENTRICLE_DN"
1198,"Up",0.434053208315532,0.745545486655656,"B.LvsP.FEVR_CTNNB1_TARGETS_UP"
627,"Up",0.434058766783244,0.745545486655656,"B.LvsP.LIM_MAMMARY_STEM_CELL_DN"
62,"Up",0.434204060890733,0.745563432504616,"B.LvsP.SAGIV_CD24_TARGETS_DN"
6,"Down",0.434453846054364,0.74576073108804,"B.LvsP.REACTOME_TNFR1_MEDIATED_CERAMIDE_PRODUCTION"
33,"Down",0.435084154171892,0.746395013502454,"B.LvsP.BIOCARTA_CASPASE_PATHWAY"
34,"Down",0.435189218192993,0.746395013502454,"B.LvsP.SYED_ESTRADIOL_RESPONSE"
42,"Up",0.435228345728325,0.746395013502454,"B.LvsP.REACTOME_RAF_ACTIVATION"
14,"Down",0.435911955511017,0.747179425261522,"B.LvsP.REACTOME_HUR_ELAVL1_BINDS_AND_STABILIZES_MRNA"
14,"Up",0.436029635722575,0.747179425261522,"B.LvsP.REACTOME_REGULATION_BY_C_FLIP"
16,"Down",0.436261837199501,0.747179425261522,"B.LvsP.REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TN_POLYAGGLUTINATION_SYNDROME_TNPS"
682,"Up",0.436342999488348,0.747179425261522,"B.LvsP.YAGI_AML_WITH_T_8_21_TRANSLOCATION"
77,"Up",0.436401845350368,0.747179425261522,"B.LvsP.DORN_ADENOVIRUS_INFECTION_12HR_UP"
204,"Down",0.436553672692341,0.747179425261522,"B.LvsP.REACTOME_DNA_DOUBLE_STRAND_BREAK_REPAIR"
53,"Up",0.436681173764925,0.747179425261522,"B.LvsP.REACTOME_SYNDECAN_INTERACTIONS"
15,"Up",0.436820527133225,0.747179425261522,"B.LvsP.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_LIGHTYELLOW_UP"
82,"Up",0.436901986230874,0.747179425261522,"B.LvsP.PID_IL2_1PATHWAY"
130,"Down",0.437218318448404,0.747489203061604,"B.LvsP.LEE_LIVER_CANCER_E2F1_UP"
92,"Up",0.437399587275017,0.747567949936188,"B.LvsP.VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1"
114,"Down",0.437589280095398,0.747661041300203,"B.LvsP.HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_UP"
6,"Down",0.437828005211297,0.747671527331025,"B.LvsP.REACTOME_VITAMINS"
381,"Down",0.437865871857091,0.747671527331025,"B.LvsP.SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM1"
44,"Down",0.438135187974326,0.747872719301666,"B.LvsP.SHIN_B_CELL_LYMPHOMA_CLUSTER_3"
28,"Up",0.438254225092675,0.747872719301666,"B.LvsP.HO_LIVER_CANCER_VASCULAR_INVASION"
933,"Down",0.439438573778402,0.749662411114096,"B.LvsP.FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP"
13,"Down",0.439832315409345,0.750007386540384,"B.LvsP.BIOCARTA_GHRELIN_PATHWAY"
111,"Down",0.439912091617013,0.750007386540384,"B.LvsP.MEISSNER_BRAIN_HCP_WITH_H3K4ME2_AND_H3K27ME3"
14,"Up",0.4402338533281,0.750321101168021,"B.LvsP.REACTOME_ACTIVATED_NTRK2_SIGNALS_THROUGH_FRS2_AND_FRS3"
156,"Down",0.440367511899119,0.750321101168021,"B.LvsP.ZAMORA_NOS2_TARGETS_DN"
67,"Down",0.440548876981677,0.750398872714631,"B.LvsP.NGUYEN_NOTCH1_TARGETS_UP"
48,"Down",0.440887523076048,0.750744414871411,"B.LvsP.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_UP"
27,"Down",0.441074772183748,0.750832024447028,"B.LvsP.KEGG_HOMOLOGOUS_RECOMBINATION"
161,"Up",0.441246928030823,0.750893895069996,"B.LvsP.WANG_ESOPHAGUS_CANCER_VS_NORMAL_DN"
20,"Down",0.441625817521342,0.751307429254,"B.LvsP.ALONSO_METASTASIS_EMT_DN"
16,"Up",0.442151962088013,0.751971146842394,"B.LvsP.KORKOLA_EMBRYONAL_CARCINOMA"
9,"Down",0.442473021591035,0.752159284942289,"B.LvsP.BIOCARTA_IFNG_PATHWAY"
340,"Up",0.44263639645752,0.752159284942289,"B.LvsP.STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP"
39,"Up",0.442670702333552,0.752159284942289,"B.LvsP.REACTOME_TNFR1_INDUCED_NFKAPPAB_SIGNALING_PATHWAY"
31,"Down",0.443406653916036,0.752815075686763,"B.LvsP.MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH"
23,"Up",0.443687928985566,0.752815075686763,"B.LvsP.ZHANG_ADIPOGENESIS_BY_BMP7"
32,"Down",0.44372610680787,0.752815075686763,"B.LvsP.REACTOME_DISEASES_OF_PROGRAMMED_CELL_DEATH"
25,"Up",0.443731587077046,0.752815075686763,"B.LvsP.KANG_FLUOROURACIL_RESISTANCE_DN"
23,"Up",0.443829209276883,0.752815075686763,"B.LvsP.BIOCARTA_PS1_PATHWAY"
66,"Down",0.443957059056959,0.752815075686763,"B.LvsP.WEBER_METHYLATED_HCP_IN_FIBROBLAST_DN"
14,"Down",0.444009759778357,0.752815075686763,"B.LvsP.REACTOME_IRAK4_DEFICIENCY_TLR2_4"
165,"Down",0.444151667445361,0.752824821982036,"B.LvsP.HELLER_SILENCED_BY_METHYLATION_DN"
273,"Down",0.444456482440945,0.752987821485304,"B.LvsP.PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP"
39,"Down",0.444549118026799,0.752987821485304,"B.LvsP.GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_DN"
95,"Down",0.444656400280253,0.752987821485304,"B.LvsP.PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP"
68,"Down",0.445096535112175,0.753502370678265,"B.LvsP.PID_FANCONI_PATHWAY"
204,"Up",0.44524541145996,0.753523685326636,"B.LvsP.SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_DN"
28,"Down",0.44545407165994,0.753646132866527,"B.LvsP.WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_DN"
48,"Up",0.445872134306832,0.753783291192263,"B.LvsP.KEGG_NOTCH_SIGNALING_PATHWAY"
79,"Up",0.445889183696005,0.753783291192263,"B.LvsP.SMIRNOV_RESPONSE_TO_IR_2HR_DN"
180,"Down",0.446207013208777,0.753783291192263,"B.LvsP.DAZARD_RESPONSE_TO_UV_SCC_DN"
26,"Up",0.446714713561391,0.753783291192263,"B.LvsP.BIOCARTA_PTEN_PATHWAY"
17,"Up",0.446744896089736,0.753783291192263,"B.LvsP.SANDERSON_PPARA_TARGETS"
32,"Down",0.447092155911071,0.753783291192263,"B.LvsP.HOLLEMAN_PREDNISOLONE_RESISTANCE_B_ALL_DN"
37,"Up",0.447099791347935,0.753783291192263,"B.LvsP.REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR2"
71,"Up",0.44711449244535,0.753783291192263,"B.LvsP.HUANG_FOXA2_TARGETS_DN"
32,"Down",0.447161902318448,0.753783291192263,"B.LvsP.REACTOME_INTRINSIC_PATHWAY_OF_FIBRIN_CLOT_FORMATION"
127,"Down",0.447227951889514,0.753783291192263,"B.LvsP.PID_SMAD2_3NUCLEAR_PATHWAY"
59,"Up",0.447229945347005,0.753783291192263,"B.LvsP.WOOD_EBV_EBNA1_TARGETS_DN"
73,"Up",0.447567246379798,0.753783291192263,"B.LvsP.WANG_LSD1_TARGETS_DN"
269,"Down",0.448163201517178,0.753783291192263,"B.LvsP.RIGGI_EWING_SARCOMA_PROGENITOR_DN"
30,"Down",0.448454081118725,0.753783291192263,"B.LvsP.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_17"
237,"Up",0.448480725017637,0.753783291192263,"B.LvsP.DAZARD_UV_RESPONSE_CLUSTER_G6"
14,"Up",0.448523641834711,0.753783291192263,"B.LvsP.WEBER_METHYLATED_LCP_IN_FIBROBLAST_DN"
228,"Up",0.448569737599922,0.753783291192263,"B.LvsP.EPPERT_HSC_R"
25,"Up",0.448654365160731,0.753783291192263,"B.LvsP.REACTOME_SUMOYLATION_OF_TRANSCRIPTION_FACTORS"
203,"Down",0.448688970796807,0.753783291192263,"B.LvsP.WHITFIELD_CELL_CYCLE_M_G1"
12,"Down",0.448799654096948,0.753783291192263,"B.LvsP.SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX2_DN"
33,"Down",0.448810318870409,0.753783291192263,"B.LvsP.REACTOME_PLASMA_LIPOPROTEIN_ASSEMBLY"
203,"Up",0.448918574817196,0.753783291192263,"B.LvsP.IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_DN"
10,"Down",0.448960593527064,0.753783291192263,"B.LvsP.REACTOME_SHC_RELATED_EVENTS_TRIGGERED_BY_IGF1R"
385,"Up",0.449016294324221,0.753783291192263,"B.LvsP.BROWNE_HCMV_INFECTION_48HR_UP"
17,"Down",0.449080029491385,0.753783291192263,"B.LvsP.WEBER_METHYLATED_ICP_IN_SPERM_UP"
69,"Down",0.449141925833472,0.753783291192263,"B.LvsP.BOYLAN_MULTIPLE_MYELOMA_C_UP"
765,"Down",0.449562386997855,0.753783291192263,"B.LvsP.SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN"
163,"Down",0.449613705321034,0.753783291192263,"B.LvsP.RHEIN_ALL_GLUCOCORTICOID_THERAPY_UP"
32,"Down",0.449776549297158,0.753783291192263,"B.LvsP.REACTOME_TICAM1_RIP1_MEDIATED_IKK_COMPLEX_RECRUITMENT"
51,"Up",0.450049177645042,0.753783291192263,"B.LvsP.XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_DN"
181,"Down",0.450064759081274,0.753783291192263,"B.LvsP.HOSHIDA_LIVER_CANCER_SUBCLASS_S2"
79,"Down",0.450118534474662,0.753783291192263,"B.LvsP.KEGG_DRUG_METABOLISM_OTHER_ENZYMES"
21,"Up",0.450177947713966,0.753783291192263,"B.LvsP.REACTOME_ERYTHROPOIETIN_ACTIVATES_RAS"
17,"Down",0.450401264953789,0.753783291192263,"B.LvsP.STARK_BRAIN_22Q11_DELETION"
55,"Down",0.450420355876047,0.753783291192263,"B.LvsP.WONG_ENDMETRIUM_CANCER_UP"
92,"Down",0.450443117037301,0.753783291192263,"B.LvsP.BURTON_ADIPOGENESIS_7"
15,"Down",0.450812892712766,0.754112958085692,"B.LvsP.REACTOME_PURINE_SALVAGE"
29,"Down",0.450912902772888,0.754112958085692,"B.LvsP.NOUSHMEHR_GBM_SOMATIC_MUTATED"
82,"Up",0.451062514531886,0.75413505982667,"B.LvsP.PID_FGF_PATHWAY"
8,"Down",0.451513397028182,0.754333277874611,"B.LvsP.REACTOME_FBXW7_MUTANTS_AND_NOTCH1_IN_CANCER"
23,"Up",0.451567903080794,0.754333277874611,"B.LvsP.BIOCARTA_PITX2_PATHWAY"
68,"Down",0.451595155836261,0.754333277874611,"B.LvsP.REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_DNA_REPAIR_GENES"
35,"Up",0.451726801056762,0.754333277874611,"B.LvsP.PID_PDGFRA_PATHWAY"
187,"Up",0.452226662747644,0.754939981380351,"B.LvsP.TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP"
67,"Down",0.452530845233623,0.75521975348527,"B.LvsP.HAN_JNK_SINGALING_DN"
142,"Up",0.453194626169369,0.755733446615893,"B.LvsP.QUINTENS_EMBRYONIC_BRAIN_RESPONSE_TO_IR"
453,"Up",0.453238277897764,0.755733446615893,"B.LvsP.SANSOM_APC_TARGETS"
93,"Up",0.453248708442449,0.755733446615893,"B.LvsP.REACTOME_FOXO_MEDIATED_TRANSCRIPTION"
62,"Up",0.453555437599982,0.756016887093851,"B.LvsP.REACTOME_GPVI_MEDIATED_ACTIVATION_CASCADE"
12,"Down",0.453962535165146,0.756340661695995,"B.LvsP.SIMBULAN_UV_RESPONSE_NORMAL_UP"
97,"Up",0.454023269337857,0.756340661695995,"B.LvsP.REACTOME_ACTIVATED_PKN1_STIMULATES_TRANSCRIPTION_OF_AR_ANDROGEN_RECEPTOR_REGULATED_GENES_KLK2_AND_KLK3"
92,"Up",0.45433761298055,0.756591807988719,"B.LvsP.KEGG_PPAR_SIGNALING_PATHWAY"
33,"Up",0.454646168242458,0.756591807988719,"B.LvsP.BIOCARTA_ARENRF2_PATHWAY"
6,"Up",0.454720522454946,0.756591807988719,"B.LvsP.REACTOME_TRANSPORT_AND_SYNTHESIS_OF_PAPS"
191,"Down",0.454885069525386,0.756591807988719,"B.LvsP.VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN"
173,"Up",0.454944796072328,0.756591807988719,"B.LvsP.HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_UP"
58,"Up",0.454995073532735,0.756591807988719,"B.LvsP.PID_SYNDECAN_4_PATHWAY"
21,"Up",0.455667925922944,0.75678115354766,"B.LvsP.AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_DN"
48,"Down",0.455753891856526,0.75678115354766,"B.LvsP.MILICIC_FAMILIAL_ADENOMATOUS_POLYPOSIS_UP"
38,"Up",0.4558000949226,0.75678115354766,"B.LvsP.DELACROIX_RAR_TARGETS_DN"
63,"Down",0.455907104758576,0.75678115354766,"B.LvsP.DOANE_BREAST_CANCER_CLASSES_DN"
6,"Up",0.455969373417953,0.75678115354766,"B.LvsP.REACTOME_PRE_NOTCH_PROCESSING_IN_THE_ENDOPLASMIC_RETICULUM"
87,"Up",0.45607895207436,0.75678115354766,"B.LvsP.GOLDRATH_IMMUNE_MEMORY"
127,"Up",0.456119478702239,0.75678115354766,"B.LvsP.WANG_PROSTATE_CANCER_ANDROGEN_INDEPENDENT"
13,"Up",0.456203940093028,0.75678115354766,"B.LvsP.CASTELLANO_HRAS_AND_NRAS_TARGETS_DN"
153,"Up",0.456427268012243,0.756924524546998,"B.LvsP.ROSS_LEUKEMIA_WITH_MLL_FUSIONS"
100,"Down",0.456945698067112,0.757362409012169,"B.LvsP.DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP"
83,"Up",0.456965273370338,0.757362409012169,"B.LvsP.KEGG_EPITHELIAL_CELL_SIGNALING_IN_HELICOBACTER_PYLORI_INFECTION"
181,"Up",0.457284420971086,0.757664238402497,"B.LvsP.MUNSHI_MULTIPLE_MYELOMA_UP"
101,"Up",0.458058144703687,0.758275079483486,"B.LvsP.REACTOME_MEIOTIC_RECOMBINATION"
9,"Up",0.458109670728731,0.758275079483486,"B.LvsP.REACTOME_SOS_MEDIATED_SIGNALLING"
38,"Down",0.458324878209001,0.758275079483486,"B.LvsP.REACTOME_CHAPERONE_MEDIATED_AUTOPHAGY"
18,"Down",0.458468866848423,0.758275079483486,"B.LvsP.REACTOME_NEUROFASCIN_INTERACTIONS"
87,"Down",0.458471853615954,0.758275079483486,"B.LvsP.BYSTROEM_CORRELATED_WITH_IL5_DN"
179,"Up",0.458475961424,0.758275079483486,"B.LvsP.REACTOME_CLATHRIN_MEDIATED_ENDOCYTOSIS"
18,"Down",0.458741955851848,0.758488120186862,"B.LvsP.REACTOME_PHASE_4_RESTING_MEMBRANE_POTENTIAL"
21,"Down",0.459962173319841,0.760042274024649,"B.LvsP.JOHANSSON_BRAIN_CANCER_EARLY_VS_LATE_UP"
12,"Down",0.459990060437791,0.760042274024649,"B.LvsP.REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_EARLY_PANCREATIC_PRECURSOR_CELLS"
80,"Up",0.460160300788681,0.760042274024649,"B.LvsP.ROVERSI_GLIOMA_COPY_NUMBER_DN"
11,"Down",0.460248186004878,0.760042274024649,"B.LvsP.REACTOME_ADENYLATE_CYCLASE_ACTIVATING_PATHWAY"
58,"Up",0.46059448697629,0.760042274024649,"B.LvsP.PID_PI3K_PLC_TRK_PATHWAY"
65,"Up",0.461075300049021,0.760042274024649,"B.LvsP.TANG_SENESCENCE_TP53_TARGETS_UP"
15,"Down",0.461107533074173,0.760042274024649,"B.LvsP.GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_1_DN"
48,"Down",0.461135726931434,0.760042274024649,"B.LvsP.WANG_THOC1_TARGETS_DN"
44,"Up",0.461176959547444,0.760042274024649,"B.LvsP.REACTOME_RHO_GTPASES_ACTIVATE_WASPS_AND_WAVES"
957,"Up",0.461239525872113,0.760042274024649,"B.LvsP.MASSARWEH_TAMOXIFEN_RESISTANCE_UP"
256,"Up",0.461255844002702,0.760042274024649,"B.LvsP.TSENG_IRS1_TARGETS_DN"
154,"Up",0.461331501469836,0.760042274024649,"B.LvsP.PID_ERBB1_DOWNSTREAM_PATHWAY"
47,"Down",0.461998766023441,0.760914857713316,"B.LvsP.DAZARD_UV_RESPONSE_CLUSTER_G5"
17,"Down",0.46216402739099,0.760960365528525,"B.LvsP.REACTOME_PKA_ACTIVATION_IN_GLUCAGON_SIGNALLING"
695,"Up",0.462407878472996,0.7610798552835,"B.LvsP.RATTENBACHER_BOUND_BY_CELF1"
69,"Up",0.462525093478462,0.7610798552835,"B.LvsP.SMITH_LIVER_CANCER"
236,"Down",0.462649555725781,0.7610798552835,"B.LvsP.COULOUARN_TEMPORAL_TGFB1_SIGNATURE_DN"
9,"Up",0.462953120645249,0.761352707926109,"B.LvsP.REACTOME_REELIN_SIGNALLING_PATHWAY"
39,"Down",0.463427634007923,0.761404175111406,"B.LvsP.REACTOME_TRIGLYCERIDE_METABOLISM"
339,"Down",0.463452370215513,0.761404175111406,"B.LvsP.SANSOM_APC_MYC_TARGETS"
34,"Up",0.463595664463862,0.761404175111406,"B.LvsP.REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION"
675,"Up",0.463696308976593,0.761404175111406,"B.LvsP.IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_DN"
354,"Down",0.463718288285839,0.761404175111406,"B.LvsP.OHGUCHI_LIVER_HNF4A_TARGETS_DN"
9,"Up",0.463810682180361,0.761404175111406,"B.LvsP.CASTELLANO_HRAS_TARGETS_DN"
102,"Down",0.464043634391236,0.761560479236908,"B.LvsP.REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION"
8,"Down",0.464519938680019,0.762111217569852,"B.LvsP.LIU_IL13_MEMORY_MODEL_DN"
62,"Down",0.464876460193004,0.762111217569852,"B.LvsP.ZHAN_MULTIPLE_MYELOMA_HP_DN"
12,"Up",0.464922430806429,0.762111217569852,"B.LvsP.BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_24HR_UP"
63,"Up",0.464991616679411,0.762111217569852,"B.LvsP.ZHAN_MULTIPLE_MYELOMA_CD2_UP"
36,"Down",0.465337381350386,0.762111217569852,"B.LvsP.KONDO_COLON_CANCER_HCP_WITH_H3K27ME1"
24,"Down",0.465591055858615,0.762111217569852,"B.LvsP.REACTOME_ANCHORING_FIBRIL_FORMATION"
68,"Down",0.465596611237923,0.762111217569852,"B.LvsP.BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_24HR_DN"
138,"Up",0.465651500024128,0.762111217569852,"B.LvsP.BONCI_TARGETS_OF_MIR15A_AND_MIR16_1"
187,"Up",0.465882594415614,0.762111217569852,"B.LvsP.QI_HYPOXIA"
324,"Down",0.466072276214008,0.762111217569852,"B.LvsP.GRUETZMANN_PANCREATIC_CANCER_DN"
76,"Down",0.466117192998466,0.762111217569852,"B.LvsP.NEMETH_INFLAMMATORY_RESPONSE_LPS_DN"
158,"Down",0.466121830857168,0.762111217569852,"B.LvsP.SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_UP"
77,"Up",0.466607084872479,0.762111217569852,"B.LvsP.REACTOME_NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION"
402,"Up",0.466643986637449,0.762111217569852,"B.LvsP.BROWNE_HCMV_INFECTION_16HR_UP"
19,"Up",0.466723094304291,0.762111217569852,"B.LvsP.REACTOME_PI3K_EVENTS_IN_ERBB2_SIGNALING"
18,"Up",0.466730007680758,0.762111217569852,"B.LvsP.KEGG_RIBOFLAVIN_METABOLISM"
103,"Up",0.466931798228533,0.762111217569852,"B.LvsP.OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN"
60,"Up",0.467003124931496,0.762111217569852,"B.LvsP.MATZUK_SPERMATID_DIFFERENTIATION"
20,"Down",0.467026864637094,0.762111217569852,"B.LvsP.AMIT_EGF_RESPONSE_40_MCF10A"
166,"Down",0.467760588558963,0.762111217569852,"B.LvsP.LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_UP"
86,"Down",0.467816570490478,0.762111217569852,"B.LvsP.MCGARVEY_SILENCED_BY_METHYLATION_IN_COLON_CANCER"
12,"Down",0.467915053993073,0.762111217569852,"B.LvsP.REACTOME_FRUCTOSE_METABOLISM"
432,"Up",0.468064134631528,0.762111217569852,"B.LvsP.ONDER_CDH1_TARGETS_2_UP"
56,"Up",0.468126617975033,0.762111217569852,"B.LvsP.MCCABE_HOXC6_TARGETS_CANCER_UP"
88,"Down",0.468208837314276,0.762111217569852,"B.LvsP.KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION"
87,"Down",0.46853186963778,0.762111217569852,"B.LvsP.MATTIOLI_MGUS_VS_MULTIPLE_MYELOMA"
22,"Down",0.468795992853661,0.762111217569852,"B.LvsP.VETTER_TARGETS_OF_PRKCA_AND_ETS1_UP"
66,"Up",0.46881505125915,0.762111217569852,"B.LvsP.KEGG_TYPE_II_DIABETES_MELLITUS"
145,"Down",0.468870309115602,0.762111217569852,"B.LvsP.YU_MYC_TARGETS_DN"
71,"Down",0.468912860271748,0.762111217569852,"B.LvsP.ZHENG_FOXP3_TARGETS_IN_T_LYMPHOCYTE_DN"
47,"Up",0.468920808278391,0.762111217569852,"B.LvsP.CEBALLOS_TARGETS_OF_TP53_AND_MYC_DN"
14,"Down",0.469051945946309,0.762111217569852,"B.LvsP.BERENJENO_TRANSFORMED_BY_RHOA_REVERSIBLY_UP"
10,"Up",0.469063405670722,0.762111217569852,"B.LvsP.REACTOME_DIGESTION_OF_DIETARY_LIPID"
640,"Up",0.469065739444783,0.762111217569852,"B.LvsP.LU_EZH2_TARGETS_DN"
16,"Up",0.46934659793364,0.762166348420424,"B.LvsP.REACTOME_TICAM1_DEPENDENT_ACTIVATION_OF_IRF3_IRF7"
35,"Up",0.46937536921171,0.762166348420424,"B.LvsP.BIOCARTA_VDR_PATHWAY"
27,"Up",0.469763435898938,0.762572529972175,"B.LvsP.BIOCARTA_CDMAC_PATHWAY"
15,"Up",0.470028504775103,0.762664546858336,"B.LvsP.REACTOME_SIGNAL_ATTENUATION"
145,"Down",0.470219482845035,0.762664546858336,"B.LvsP.YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_12"
19,"Down",0.470315633596287,0.762664546858336,"B.LvsP.REACTOME_METABOLISM_OF_AMINE_DERIVED_HORMONES"
378,"Up",0.470371876430987,0.762664546858336,"B.LvsP.EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_UP"
11,"Up",0.470774159634123,0.763057349566339,"B.LvsP.LUCAS_HNF4A_TARGETS_DN"
38,"Up",0.47089015675897,0.763057349566339,"B.LvsP.PID_CDC42_REG_PATHWAY"
37,"Down",0.47108597137185,0.763150992005555,"B.LvsP.BIOCARTA_IL2_PATHWAY"
96,"Down",0.471822588265197,0.763782515577955,"B.LvsP.LIU_SMARCA4_TARGETS"
152,"Down",0.471951434741297,0.763782515577955,"B.LvsP.PID_CMYB_PATHWAY"
36,"Down",0.472149588525616,0.763782515577955,"B.LvsP.ZHAN_LATE_DIFFERENTIATION_GENES_DN"
83,"Up",0.472258647457378,0.763782515577955,"B.LvsP.REACTOME_SIRT1_NEGATIVELY_REGULATES_RRNA_EXPRESSION"
32,"Down",0.472348716442298,0.763782515577955,"B.LvsP.DASU_IL6_SIGNALING_SCAR_DN"
27,"Down",0.472434599697804,0.763782515577955,"B.LvsP.REACTOME_NEGATIVE_REGULATION_OF_MET_ACTIVITY"
24,"Up",0.472639108755081,0.763782515577955,"B.LvsP.BIOCARTA_HCMV_PATHWAY"
205,"Up",0.472670799156802,0.763782515577955,"B.LvsP.CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_UP"
249,"Down",0.472719075476173,0.763782515577955,"B.LvsP.AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_UP"
116,"Up",0.473529217105519,0.763902022976433,"B.LvsP.KEGG_GNRH_SIGNALING_PATHWAY"
37,"Down",0.473650235915788,0.763902022976433,"B.LvsP.REACTOME_FGFR2_MUTANT_RECEPTOR_ACTIVATION"
26,"Up",0.473683266755549,0.763902022976433,"B.LvsP.ZHENG_RESPONSE_TO_ARSENITE_UP"
172,"Down",0.473728476197493,0.763902022976433,"B.LvsP.REACTOME_BETA_CATENIN_INDEPENDENT_WNT_SIGNALING"
1648,"Down",0.473757505802433,0.763902022976433,"B.LvsP.REACTOME_INNATE_IMMUNE_SYSTEM"
50,"Down",0.473760166513476,0.763902022976433,"B.LvsP.JAERVINEN_AMPLIFIED_IN_LARYNGEAL_CANCER"
92,"Up",0.473760180283268,0.763902022976433,"B.LvsP.PID_TRKR_PATHWAY"
145,"Up",0.473950946501968,0.763986817262211,"B.LvsP.SASSON_RESPONSE_TO_FORSKOLIN_UP"
65,"Down",0.474259589369368,0.764120793367439,"B.LvsP.MMS_MOUSE_LYMPH_HIGH_4HRS_UP"
6,"Down",0.474342759654595,0.764120793367439,"B.LvsP.REACTOME_FICOLINS_BIND_TO_REPETITIVE_CARBOHYDRATE_STRUCTURES_ON_THE_TARGET_CELL_SURFACE"
6,"Up",0.474448667685009,0.764120793367439,"B.LvsP.BIOCARTA_ACETAMINOPHEN_PATHWAY"
30,"Up",0.474936964442584,0.764684471870427,"B.LvsP.WOTTON_RUNX_TARGETS_UP"
24,"Down",0.475451962866162,0.765290801364486,"B.LvsP.WHITESIDE_CISPLATIN_RESISTANCE_DN"
15,"Down",0.475878226582482,0.765461123237887,"B.LvsP.MIKKELSEN_PLURIPOTENT_STATE_DN"
48,"Down",0.476306929645025,0.765461123237887,"B.LvsP.WORSCHECH_TUMOR_EVASION_AND_TOLEROGENICITY_UP"
37,"Up",0.476389915021946,0.765461123237887,"B.LvsP.SINGH_NFE2L2_TARGETS"
81,"Up",0.476423671039914,0.765461123237887,"B.LvsP.VANTVEER_BREAST_CANCER_BRCA1_DN"
113,"Down",0.476473248100704,0.765461123237887,"B.LvsP.RUAN_RESPONSE_TO_TNF_DN"
19,"Down",0.476603846632267,0.765461123237887,"B.LvsP.BIOCARTA_P53_PATHWAY"
248,"Up",0.476702638612141,0.765461123237887,"B.LvsP.GOZGIT_ESR1_TARGETS_UP"
217,"Up",0.476749331365414,0.765461123237887,"B.LvsP.YAGI_AML_WITH_T_9_11_TRANSLOCATION"
385,"Up",0.476828221727929,0.765461123237887,"B.LvsP.RIGGINS_TAMOXIFEN_RESISTANCE_DN"
30,"Down",0.476942226361823,0.765461123237887,"B.LvsP.BIOCARTA_TEL_PATHWAY"
7,"Down",0.477488386949543,0.76611529061057,"B.LvsP.REACTOME_ALTERNATIVE_COMPLEMENT_ACTIVATION"
30,"Up",0.477919280931167,0.766537334349984,"B.LvsP.REACTOME_CRMPS_IN_SEMA3A_SIGNALING"
28,"Up",0.478028708417208,0.766537334349984,"B.LvsP.PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_3"
13,"Down",0.478178737353268,0.76655559258516,"B.LvsP.REACTOME_ESTABLISHMENT_OF_SISTER_CHROMATID_COHESION"
222,"Down",0.478350584905541,0.766608806939924,"B.LvsP.HOELZEL_NF1_TARGETS_UP"
57,"Down",0.478729821680248,0.766994257916573,"B.LvsP.REACTOME_MET_PROMOTES_CELL_MOTILITY"
18,"Up",0.479129428734615,0.767301645038242,"B.LvsP.ROZANOV_MMP14_CORRELATED"
45,"Up",0.479199236809016,0.767301645038242,"B.LvsP.RODRIGUES_NTN1_AND_DCC_TARGETS"
22,"Down",0.479549136052802,0.767437519256372,"B.LvsP.BIOCARTA_TOB1_PATHWAY"
330,"Up",0.479749743149009,0.767437519256372,"B.LvsP.TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP"
139,"Down",0.479827910190338,0.767437519256372,"B.LvsP.MIKKELSEN_MCV6_ICP_WITH_H3K27ME3"
32,"Down",0.480511404724298,0.767437519256372,"B.LvsP.REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS"
31,"Down",0.480557427460794,0.767437519256372,"B.LvsP.REACTOME_INTERLEUKIN_RECEPTOR_SHC_SIGNALING"
2088,"Down",0.480576349396034,0.767437519256372,"B.LvsP.YOSHIMURA_MAPK8_TARGETS_UP"
203,"Up",0.480694778801402,0.767437519256372,"B.LvsP.REACTOME_ER_TO_GOLGI_ANTEROGRADE_TRANSPORT"
51,"Up",0.480698221721489,0.767437519256372,"B.LvsP.HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_UP"
245,"Down",0.480782515097367,0.767437519256372,"B.LvsP.GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN"
1220,"Up",0.4810516940115,0.767437519256372,"B.LvsP.ONKEN_UVEAL_MELANOMA_UP"
20,"Up",0.48118954251669,0.767437519256372,"B.LvsP.PID_TCR_JNK_PATHWAY"
31,"Up",0.481218886379809,0.767437519256372,"B.LvsP.VERNOCHET_ADIPOGENESIS"
42,"Up",0.481393385755266,0.767437519256372,"B.LvsP.REACTOME_FATTY_ACYL_COA_BIOSYNTHESIS"
66,"Down",0.481606534800558,0.767437519256372,"B.LvsP.JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_DN"
290,"Down",0.481606925503789,0.767437519256372,"B.LvsP.GREGORY_SYNTHETIC_LETHAL_WITH_IMATINIB"
103,"Down",0.481729128065972,0.767437519256372,"B.LvsP.SAMOLS_TARGETS_OF_KHSV_MIRNAS_DN"
684,"Up",0.482010508379465,0.767437519256372,"B.LvsP.CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_UP"
86,"Down",0.482279052969429,0.767437519256372,"B.LvsP.KHETCHOUMIAN_TRIM24_TARGETS_UP"
24,"Up",0.482302232258823,0.767437519256372,"B.LvsP.SUZUKI_AMPLIFIED_IN_ORAL_CANCER"
12,"Down",0.482441408640172,0.767437519256372,"B.LvsP.REACTOME_ACTIVATED_NTRK2_SIGNALS_THROUGH_RAS"
71,"Down",0.482539277162715,0.767437519256372,"B.LvsP.VERRECCHIA_RESPONSE_TO_TGFB1_C2"
75,"Up",0.482745144642061,0.767437519256372,"B.LvsP.EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_DN"
33,"Down",0.482874201192326,0.767437519256372,"B.LvsP.BUCKANOVICH_T_LYMPHOCYTE_HOMING_ON_TUMOR_DN"
509,"Up",0.482974411402568,0.767437519256372,"B.LvsP.KUMAR_PATHOGEN_LOAD_BY_MACROPHAGES"
26,"Up",0.482992987161773,0.767437519256372,"B.LvsP.FOURNIER_ACINAR_DEVELOPMENT_LATE_UP"
307,"Down",0.483067444126407,0.767437519256372,"B.LvsP.MCBRYAN_PUBERTAL_BREAST_4_5WK_DN"
134,"Up",0.483141254799698,0.767437519256372,"B.LvsP.SASSON_RESPONSE_TO_GONADOTROPHINS_UP"
202,"Down",0.48317055607369,0.767437519256372,"B.LvsP.REACTOME_CREATION_OF_C4_AND_C2_ACTIVATORS"
48,"Up",0.483955784557952,0.768463966921572,"B.LvsP.BIOCARTA_EGF_PATHWAY"
87,"Up",0.484228562357247,0.768676348341435,"B.LvsP.WANG_BARRETTS_ESOPHAGUS_UP"
38,"Up",0.484680784153511,0.769034208455485,"B.LvsP.BIOCARTA_FAS_PATHWAY"
52,"Down",0.484732178778688,0.769034208455485,"B.LvsP.LANG_MYB_FAMILY_TARGETS"
67,"Up",0.485007193904972,0.769180753484736,"B.LvsP.PID_ARF6_TRAFFICKING_PATHWAY"
55,"Up",0.485238183872772,0.769180753484736,"B.LvsP.NABA_BASEMENT_MEMBRANES"
317,"Down",0.485241900552498,0.769180753484736,"B.LvsP.FISCHER_G1_S_CELL_CYCLE"
394,"Down",0.485506621721714,0.769379796933034,"B.LvsP.RUTELLA_RESPONSE_TO_HGF_DN"
37,"Down",0.485737753071642,0.76952551195791,"B.LvsP.PID_NFKAPPAB_CANONICAL_PATHWAY"
262,"Up",0.485997094190564,0.769677449447697,"B.LvsP.LIU_CMYB_TARGETS_UP"
19,"Down",0.486112073335388,0.769677449447697,"B.LvsP.REACTOME_INLB_MEDIATED_ENTRY_OF_LISTERIA_MONOCYTOGENES_INTO_HOST_CELL"
32,"Down",0.486509912206627,0.770086832118649,"B.LvsP.HANSON_HRAS_SIGNALING_VIA_NFKB"
7,"Up",0.487210956650219,0.77097578114455,"B.LvsP.REACTOME_NEGATIVE_FEEDBACK_REGULATION_OF_MAPK_PATHWAY"
88,"Down",0.487453851736274,0.771136549962119,"B.LvsP.GALE_APL_WITH_FLT3_MUTATED_UP"
455,"Up",0.487949048136838,0.771136549962119,"B.LvsP.DURCHDEWALD_SKIN_CARCINOGENESIS_DN"
202,"Up",0.487963341858848,0.771136549962119,"B.LvsP.REACTOME_MEIOSIS"
23,"Up",0.487973911171196,0.771136549962119,"B.LvsP.MANN_RESPONSE_TO_AMIFOSTINE_UP"
28,"Down",0.48801780160988,0.771136549962119,"B.LvsP.REACTOME_OTHER_SEMAPHORIN_INTERACTIONS"
205,"Up",0.488149380514997,0.771136549962119,"B.LvsP.ODONNELL_METASTASIS_UP"
18,"Up",0.48832459666124,0.771193000554127,"B.LvsP.CLAUS_PGR_POSITIVE_MENINGIOMA_UP"
24,"Down",0.489352861643165,0.772467130355511,"B.LvsP.EHRLICH_ICF_SYNDROM_UP"
34,"Down",0.489410808036779,0.772467130355511,"B.LvsP.WANG_TNF_TARGETS"
200,"Up",0.489775318061384,0.772821841769804,"B.LvsP.REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2"
7,"Up",0.490221634207099,0.773237698015559,"B.LvsP.REACTOME_ACROSOME_REACTION_AND_SPERM_OOCYTE_MEMBRANE_BINDING"
20,"Down",0.490394879071603,0.773237698015559,"B.LvsP.MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_UP"
516,"Down",0.490583113988267,0.773237698015559,"B.LvsP.LI_INDUCED_T_TO_NATURAL_KILLER_UP"
189,"Down",0.490598271774024,0.773237698015559,"B.LvsP.HAHTOLA_SEZARY_SYNDROM_UP"
47,"Down",0.491044493340489,0.773436041607823,"B.LvsP.REACTOME_NEGATIVE_REGULATION_OF_MAPK_PATHWAY"
32,"Up",0.491104274749704,0.773436041607823,"B.LvsP.MURAKAMI_UV_RESPONSE_6HR_DN"
56,"Down",0.491143776828552,0.773436041607823,"B.LvsP.SIG_PIP3_SIGNALING_IN_B_LYMPHOCYTES"
175,"Down",0.492106519601549,0.774731476901186,"B.LvsP.HOSHIDA_LIVER_CANCER_SURVIVAL_DN"
13,"Up",0.492455838078237,0.775060725515108,"B.LvsP.REACTOME_CASPASE_ACTIVATION_VIA_DEPENDENCE_RECEPTORS_IN_THE_ABSENCE_OF_LIGAND"
43,"Down",0.49283322834027,0.775433955461967,"B.LvsP.BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_UP"
85,"Down",0.493122251755298,0.775497277938964,"B.LvsP.DUNNE_TARGETS_OF_AML1_MTG8_FUSION_UP"
14,"Down",0.493153993350226,0.775497277938964,"B.LvsP.REACTOME_JOSEPHIN_DOMAIN_DUBS"
794,"Up",0.49359769873237,0.775705624678402,"B.LvsP.PILON_KLF1_TARGETS_UP"
15,"Up",0.493700787611579,0.775705624678402,"B.LvsP.REACTOME_N_GLYCAN_ANTENNAE_ELONGATION"
50,"Down",0.493978933903299,0.775705624678402,"B.LvsP.BIOCARTA_IL1R_PATHWAY"
369,"Up",0.494058098328577,0.775705624678402,"B.LvsP.HAMAI_APOPTOSIS_VIA_TRAIL_DN"
37,"Down",0.494303857794644,0.775705624678402,"B.LvsP.KEGG_HISTIDINE_METABOLISM"
100,"Down",0.494424520044283,0.775705624678402,"B.LvsP.PID_MYC_REPRESS_PATHWAY"
38,"Down",0.494734031326599,0.775705624678402,"B.LvsP.CEBALLOS_TARGETS_OF_TP53_AND_MYC_UP"
22,"Down",0.494748810053512,0.775705624678402,"B.LvsP.REACTOME_CHONDROITIN_SULFATE_BIOSYNTHESIS"
45,"Up",0.495117320165005,0.775705624678402,"B.LvsP.MEISSNER_ES_ICP_WITH_H3K4ME3"
40,"Down",0.495206062190297,0.775705624678402,"B.LvsP.WIEMANN_TELOMERE_SHORTENING_AND_CHRONIC_LIVER_DAMAGE_UP"
9,"Up",0.495224490740516,0.775705624678402,"B.LvsP.REACTOME_FGFR1B_LIGAND_BINDING_AND_ACTIVATION"
125,"Down",0.495229330160312,0.775705624678402,"B.LvsP.MORI_LARGE_PRE_BII_LYMPHOCYTE_DN"
24,"Up",0.495400024498498,0.775705624678402,"B.LvsP.CASTELLANO_NRAS_TARGETS_DN"
46,"Up",0.495478434331486,0.775705624678402,"B.LvsP.PID_PI3KCI_AKT_PATHWAY"
23,"Up",0.495524829267136,0.775705624678402,"B.LvsP.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BROWN_UP"
32,"Up",0.495531247307672,0.775705624678402,"B.LvsP.REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR4"
37,"Up",0.495781478561384,0.775877666279618,"B.LvsP.BIOCARTA_PTDINS_PATHWAY"
73,"Down",0.496063985091866,0.776100105708241,"B.LvsP.ZHAN_V1_LATE_DIFFERENTIATION_GENES_UP"
1519,"Down",0.496286515117603,0.776228611622412,"B.LvsP.BENPORATH_EED_TARGETS"
34,"Down",0.49652186742813,0.776377094177073,"B.LvsP.LAMB_CCND1_TARGETS"
198,"Down",0.496733398409012,0.776488255528252,"B.LvsP.REACTOME_TOLL_LIKE_RECEPTOR_CASCADES"
136,"Up",0.497018350332945,0.776714092422513,"B.LvsP.CROMER_METASTASIS_UP"
17,"Up",0.497591892041383,0.777202149860542,"B.LvsP.BIOCARTA_DREAM_PATHWAY"
121,"Up",0.497680865492706,0.777202149860542,"B.LvsP.YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_1"
14,"Down",0.497752362571203,0.777202149860542,"B.LvsP.CHEN_HOXA5_TARGETS_6HR_DN"
9,"Down",0.497900484623654,0.777213941130486,"B.LvsP.REACTOME_HISTIDINE_CATABOLISM"
130,"Up",0.498545415523235,0.777952389845305,"B.LvsP.PID_CXCR4_PATHWAY"
17,"Up",0.498654959235261,0.777952389845305,"B.LvsP.SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_UP"
41,"Up",0.498973548932735,0.778229831325554,"B.LvsP.BIOCARTA_EIF4_PATHWAY"
109,"Down",0.499127087010306,0.778249764263954,"B.LvsP.PARK_APL_PATHOGENESIS_DN"
17,"Down",0.499673302259427,0.778540078797889,"B.LvsP.OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_DN"
424,"Up",0.499821548094576,0.778540078797889,"B.LvsP.DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP"
162,"Down",0.499836741627251,0.778540078797889,"B.LvsP.WESTON_VEGFA_TARGETS"
118,"Down",0.499906982479819,0.778540078797889,"B.LvsP.KEGG_DRUG_METABOLISM_CYTOCHROME_P450"
102,"Down",0.500121359070958,0.778540078797889,"B.LvsP.MCCLUNG_CREB1_TARGETS_DN"
1597,"Up",0.500171463974407,0.778540078797889,"B.LvsP.REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION"
43,"Up",0.500298950980086,0.778540078797889,"B.LvsP.GENTLES_LEUKEMIC_STEM_CELL_UP"
34,"Down",0.500461851904333,0.778574445464,"B.LvsP.GOLUB_ALL_VS_AML_UP"
41,"Up",0.500761097818641,0.778820846649583,"B.LvsP.BIOCARTA_P53HYPOXIA_PATHWAY"
169,"Up",0.500985780400169,0.778917556463425,"B.LvsP.GAVIN_FOXP3_TARGETS_CLUSTER_P4"
1407,"Up",0.501217995952082,0.778917556463425,"B.LvsP.BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_A"
124,"Up",0.501245915336746,0.778917556463425,"B.LvsP.FONTAINE_FOLLICULAR_THYROID_ADENOMA_UP"
143,"Up",0.501482906806868,0.779066870394822,"B.LvsP.LAIHO_COLORECTAL_CANCER_SERRATED_DN"
98,"Up",0.501712951245144,0.779205311077079,"B.LvsP.REACTOME_DNA_DAMAGE_TELOMERE_STRESS_INDUCED_SENESCENCE"
45,"Up",0.50186166666371,0.779217398198161,"B.LvsP.PID_IL1_PATHWAY"
110,"Down",0.502126608299291,0.779325917479485,"B.LvsP.LEE_LIVER_CANCER_MYC_DN"
15,"Down",0.50221346427553,0.779325917479485,"B.LvsP.REACTOME_MITOTIC_TELOPHASE_CYTOKINESIS"
157,"Up",0.50292764692693,0.780215196368966,"B.LvsP.WILCOX_RESPONSE_TO_PROGESTERONE_DN"
23,"Up",0.503071715062141,0.780219779124426,"B.LvsP.WU_HBX_TARGETS_2_DN"
87,"Down",0.503237085801595,0.780257388501688,"B.LvsP.STOSSI_RESPONSE_TO_ESTRADIOL"
19,"Down",0.503859894874551,0.780822121602373,"B.LvsP.REACTOME_TETRAHYDROBIOPTERIN_BH4_SYNTHESIS_RECYCLING_SALVAGE_AND_REGULATION"
162,"Up",0.503883763768723,0.780822121602373,"B.LvsP.REACTOME_MEIOTIC_SYNAPSIS"
23,"Up",0.50424996677587,0.781170654610194,"B.LvsP.REACTOME_SIGNALLING_TO_RAS"
61,"Up",0.504445644287011,0.781254892790724,"B.LvsP.CHEOK_RESPONSE_TO_HD_MTX_UP"
18,"Down",0.504646699533619,0.781347410171206,"B.LvsP.LOPEZ_MESOTHELIOMA_SURVIVAL_OVERALL_UP"
52,"Up",0.505183983249113,0.781535704658547,"B.LvsP.KEGG_ALDOSTERONE_REGULATED_SODIUM_REABSORPTION"
113,"Up",0.505261689750665,0.781535704658547,"B.LvsP.HOWLIN_CITED1_TARGETS_1_DN"
30,"Down",0.505551307222767,0.781535704658547,"B.LvsP.STEGER_ADIPOGENESIS_DN"
29,"Up",0.50561006895,0.781535704658547,"B.LvsP.IVANOVA_HEMATOPOIESIS_STEM_CELL_SHORT_TERM"
122,"Down",0.505710363049731,0.781535704658547,"B.LvsP.VANASSE_BCL2_TARGETS_DN"
10,"Down",0.505733364021701,0.781535704658547,"B.LvsP.REACTOME_PTK6_PROMOTES_HIF1A_STABILIZATION"
15,"Down",0.505903398036826,0.781535704658547,"B.LvsP.KANG_CISPLATIN_RESISTANCE_DN"
307,"Down",0.506030508384626,0.781535704658547,"B.LvsP.SMID_BREAST_CANCER_ERBB2_UP"
247,"Down",0.506040481583939,0.781535704658547,"B.LvsP.REACTOME_COMPLEMENT_CASCADE"
89,"Up",0.506196369395865,0.781558147553683,"B.LvsP.CUI_TCF21_TARGETS_DN"
154,"Down",0.506486123137791,0.78178720681989,"B.LvsP.ANDERSEN_LIVER_CANCER_KRT19_DN"
36,"Down",0.506660141613432,0.781807964894676,"B.LvsP.LIU_IL13_MEMORY_MODEL_UP"
71,"Up",0.506782374060865,0.781807964894676,"B.LvsP.TAVOR_CEBPA_TARGETS_DN"
77,"Down",0.507374996660505,0.78250386514252,"B.LvsP.LINDSTEDT_DENDRITIC_CELL_MATURATION_B"
18,"Down",0.508280990407343,0.783564751450202,"B.LvsP.BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_24HR_UP"
184,"Down",0.508346312796505,0.783564751450202,"B.LvsP.REACTOME_PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS"
16,"Down",0.508653688396075,0.783820023172212,"B.LvsP.REACTOME_EGFR_TRANSACTIVATION_BY_GASTRIN"
16,"Up",0.509704447547933,0.78522036514141,"B.LvsP.RADAEVA_RESPONSE_TO_IFNA1_DN"
19,"Down",0.509953572797136,0.785360846916437,"B.LvsP.REACTOME_BUTYROPHILIN_BTN_FAMILY_INTERACTIONS"
40,"Down",0.510086818357129,0.785360846916437,"B.LvsP.PARK_TRETINOIN_RESPONSE_AND_RARA_PLZF_FUSION"
15,"Down",0.510227201854935,0.785360846916437,"B.LvsP.REACTOME_ADENYLATE_CYCLASE_INHIBITORY_PATHWAY"
10,"Down",0.510421662554699,0.785360846916437,"B.LvsP.REACTOME_PHASE_3_RAPID_REPOLARISATION"
18,"Up",0.510505857084043,0.785360846916437,"B.LvsP.REACTOME_SYNTHESIS_OF_GLYCOSYLPHOSPHATIDYLINOSITOL_GPI"
33,"Down",0.511187730099141,0.786022852575028,"B.LvsP.KEGG_BIOSYNTHESIS_OF_UNSATURATED_FATTY_ACIDS"
430,"Up",0.511293939936746,0.786022852575028,"B.LvsP.LU_EZH2_TARGETS_UP"
57,"Up",0.511367918403068,0.786022852575028,"B.LvsP.SMID_BREAST_CANCER_RELAPSE_IN_LUNG_DN"
73,"Down",0.511536197329561,0.786022852575028,"B.LvsP.ELLWOOD_MYC_TARGETS_DN"
13,"Down",0.511646997000819,0.786022852575028,"B.LvsP.REACTOME_NEF_MEDIATED_CD4_DOWN_REGULATION"
154,"Up",0.511845959657949,0.786110086374666,"B.LvsP.LEE_AGING_CEREBELLUM_DN"
575,"Down",0.512132841013346,0.7861122969881,"B.LvsP.SHEN_SMARCA2_TARGETS_DN"
203,"Up",0.512210753247669,0.7861122969881,"B.LvsP.VERHAAK_GLIOBLASTOMA_NEURAL"
12,"Up",0.512273938514763,0.7861122969881,"B.LvsP.SCIAN_CELL_CYCLE_TARGETS_OF_TP53_AND_TP73_UP"
111,"Up",0.512613389297487,0.786340046873618,"B.LvsP.REACTOME_REGULATION_OF_INSULIN_SECRETION"
574,"Up",0.512727428983223,0.786340046873618,"B.LvsP.WANG_LMO4_TARGETS_DN"
62,"Up",0.51284901592083,0.786340046873618,"B.LvsP.STAMBOLSKY_TARGETS_OF_MUTATED_TP53_UP"
45,"Down",0.512999392254633,0.786352547761538,"B.LvsP.KEGG_PYRUVATE_METABOLISM"
90,"Down",0.513161835117331,0.786383532805909,"B.LvsP.REACTOME_CONDENSATION_OF_PROPHASE_CHROMOSOMES"
16,"Up",0.513410964947554,0.786507617588527,"B.LvsP.POS_RESPONSE_TO_HISTAMINE_UP"
7,"Down",0.51352731045299,0.786507617588527,"B.LvsP.REACTOME_INTERLEUKIN_36_PATHWAY"
20,"Down",0.513782318111392,0.786571538272168,"B.LvsP.RODRIGUES_THYROID_CARCINOMA_UP"
559,"Up",0.513853571394297,0.786571538272168,"B.LvsP.MULLIGHAN_NPM1_SIGNATURE_3_UP"
52,"Up",0.514559266265908,0.787433762298424,"B.LvsP.REACTOME_DIGESTION_AND_ABSORPTION"
33,"Down",0.51473770650245,0.78748887085004,"B.LvsP.CHUANG_OXIDATIVE_STRESS_RESPONSE_DN"
41,"Up",0.514907275528254,0.787530380745703,"B.LvsP.REACTOME_CD28_CO_STIMULATION"
54,"Up",0.515266183235273,0.787758019657495,"B.LvsP.REACTOME_HDMS_DEMETHYLATE_HISTONES"
79,"Down",0.515341066576444,0.787758019657495,"B.LvsP.CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN"
68,"Up",0.515889684758702,0.788165877280995,"B.LvsP.CASORELLI_APL_SECONDARY_VS_DE_NOVO_UP"
54,"Down",0.515909951420864,0.788165877280995,"B.LvsP.VANDESLUIS_COMMD1_TARGETS_GROUP_3_DN"
259,"Up",0.516159303059606,0.788165877280995,"B.LvsP.BROWNE_HCMV_INFECTION_30MIN_DN"
55,"Down",0.516270820552221,0.788165877280995,"B.LvsP.AMIT_EGF_RESPONSE_60_MCF10A"
363,"Up",0.516320638001766,0.788165877280995,"B.LvsP.ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_DN"
31,"Up",0.516733206544957,0.78840799317181,"B.LvsP.REACTOME_FRS_MEDIATED_FGFR1_SIGNALING"
43,"Down",0.516764436110443,0.78840799317181,"B.LvsP.GROSS_ELK3_TARGETS_UP"
390,"Up",0.51732401762556,0.788453896754396,"B.LvsP.REACTOME_SIGNALING_BY_NUCLEAR_RECEPTORS"
35,"Up",0.517353749557993,0.788453896754396,"B.LvsP.BIOCARTA_MPR_PATHWAY"
17,"Up",0.517355157702203,0.788453896754396,"B.LvsP.CONRAD_GERMLINE_STEM_CELL"
14,"Down",0.517364937136001,0.788453896754396,"B.LvsP.REACTOME_INLA_MEDIATED_ENTRY_OF_LISTERIA_MONOCYTOGENES_INTO_HOST_CELLS"
32,"Up",0.517810487019902,0.788915454046028,"B.LvsP.REACTOME_SEMA3A_PLEXIN_REPULSION_SIGNALING_BY_INHIBITING_INTEGRIN_ADHESION"
60,"Down",0.51816356926489,0.789196588744087,"B.LvsP.CROONQUIST_NRAS_SIGNALING_UP"
51,"Up",0.518598563870051,0.789196588744087,"B.LvsP.RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_DN"
36,"Down",0.518602125238067,0.789196588744087,"B.LvsP.GAVIN_PDE3B_TARGETS"
811,"Down",0.518692870902658,0.789196588744087,"B.LvsP.SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1"
42,"Down",0.518708700216316,0.789196588744087,"B.LvsP.KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM"
73,"Down",0.518905725148334,0.789279162130713,"B.LvsP.HUANG_FOXA2_TARGETS_UP"
24,"Up",0.519188021245048,0.789455601360579,"B.LvsP.REACTOME_NOTCH2_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION"
18,"Down",0.519307292846523,0.789455601360579,"B.LvsP.REACTOME_BLOOD_GROUP_SYSTEMS_BIOSYNTHESIS"
68,"Down",0.519753118915175,0.789767025426469,"B.LvsP.PID_FRA_PATHWAY"
48,"Down",0.519797830625235,0.789767025426469,"B.LvsP.FRASOR_RESPONSE_TO_ESTRADIOL_UP"
11,"Up",0.520121106128724,0.790041097743328,"B.LvsP.MARIADASON_RESPONSE_TO_BUTYRATE_CURCUMIN_SULINDAC_TSA_2"
17,"Down",0.521249939138313,0.791321701905072,"B.LvsP.REACTOME_ADVANCED_GLYCOSYLATION_ENDPRODUCT_RECEPTOR_SIGNALING"
89,"Up",0.521285707392114,0.791321701905072,"B.LvsP.PID_DELTA_NP63_PATHWAY"
48,"Down",0.521393553995329,0.791321701905072,"B.LvsP.BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_UP"
714,"Down",0.521649772339115,0.791367193328869,"B.LvsP.BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP"
32,"Down",0.521709788331295,0.791367193328869,"B.LvsP.SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_2FC_UP"
50,"Down",0.521957051743116,0.791525106716317,"B.LvsP.BIOCARTA_ALK_PATHWAY"
93,"Up",0.522185725758964,0.791654751226024,"B.LvsP.SILIGAN_BOUND_BY_EWS_FLT1_FUSION"
24,"Down",0.522588979355642,0.791846767741269,"B.LvsP.REACTOME_SIGNALING_BY_HIPPO"
99,"Up",0.522651722251,0.791846767741269,"B.LvsP.BILBAN_B_CLL_LPL_DN"
76,"Down",0.522742033325309,0.791846767741269,"B.LvsP.PID_P53_REGULATION_PATHWAY"
46,"Up",0.523073970865469,0.792132562288463,"B.LvsP.BIOCARTA_NGF_PATHWAY"
77,"Down",0.523332715109483,0.792307388236674,"B.LvsP.VARELA_ZMPSTE24_TARGETS_DN"
46,"Up",0.523605390583712,0.792503204089061,"B.LvsP.DELLA_RESPONSE_TO_TSA_AND_BUTYRATE"
133,"Down",0.523903767537573,0.79253221701188,"B.LvsP.MIKKELSEN_MEF_LCP_WITH_H3K27ME3"
46,"Up",0.524363617944475,0.79253221701188,"B.LvsP.CLIMENT_BREAST_CANCER_COPY_NUMBER_UP"
14,"Up",0.524411613822181,0.79253221701188,"B.LvsP.BIOCARTA_AMAN_PATHWAY"
15,"Down",0.524456072510075,0.79253221701188,"B.LvsP.REACTOME_REMOVAL_OF_AMINOTERMINAL_PROPEPTIDES_FROM_GAMMA_CARBOXYLATED_PROTEINS"
143,"Down",0.524497247708892,0.79253221701188,"B.LvsP.LIN_APC_TARGETS"
121,"Up",0.524686563064177,0.79253221701188,"B.LvsP.HENDRICKS_SMARCA4_TARGETS_UP"
386,"Down",0.524948759115713,0.79253221701188,"B.LvsP.CAIRO_LIVER_DEVELOPMENT_DN"
6,"Down",0.524956057108717,0.79253221701188,"B.LvsP.REACTOME_P75NTR_NEGATIVELY_REGULATES_CELL_CYCLE_VIA_SC1"
176,"Up",0.525211235802586,0.79253221701188,"B.LvsP.CADWELL_ATG16L1_TARGETS_UP"
1133,"Down",0.525253958842427,0.79253221701188,"B.LvsP.KRIEG_HYPOXIA_NOT_VIA_KDM3A"
1973,"Down",0.52554955471917,0.79253221701188,"B.LvsP.CHEN_METABOLIC_SYNDROM_NETWORK"
21,"Up",0.525555141699006,0.79253221701188,"B.LvsP.SCHWAB_TARGETS_OF_BMYB_POLYMORPHIC_VARIANTS_UP"
33,"Down",0.525725700263719,0.79253221701188,"B.LvsP.REACTOME_SIGNALING_BY_ERBB2_IN_CANCER"
8,"Up",0.52584926625513,0.79253221701188,"B.LvsP.REACTOME_VEGF_LIGAND_RECEPTOR_INTERACTIONS"
42,"Down",0.525860091759163,0.79253221701188,"B.LvsP.ODONNELL_METASTASIS_DN"
148,"Up",0.525972693570913,0.79253221701188,"B.LvsP.SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_DN"
28,"Up",0.526061355838958,0.79253221701188,"B.LvsP.REACTOME_TRAF6_MEDIATED_NF_KB_ACTIVATION"
316,"Down",0.526595344557564,0.793120582963436,"B.LvsP.KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION"
16,"Up",0.526759039900443,0.793151070699768,"B.LvsP.REACTOME_SUMOYLATION_OF_DNA_METHYLATION_PROTEINS"
147,"Up",0.527228984989919,0.793514273523364,"B.LvsP.KYNG_DNA_DAMAGE_BY_GAMMA_AND_UV_RADIATION"
29,"Down",0.52728729262522,0.793514273523364,"B.LvsP.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_SALMON_DN"
6,"Down",0.527549780309757,0.793693261315006,"B.LvsP.BIOCARTA_SLRP_PATHWAY"
1356,"Up",0.528756324108362,0.794612707385578,"B.LvsP.WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_8D"
439,"Down",0.528791232401418,0.794612707385578,"B.LvsP.LIU_SOX4_TARGETS_DN"
24,"Up",0.528909809936,0.794612707385578,"B.LvsP.BIOCARTA_RACC_PATHWAY"
35,"Up",0.528926751166499,0.794612707385578,"B.LvsP.AMIT_EGF_RESPONSE_240_MCF10A"
42,"Up",0.528949943461084,0.794612707385578,"B.LvsP.TERAO_AOX4_TARGETS_HG_UP"
33,"Up",0.529023218644658,0.794612707385578,"B.LvsP.GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_UP"
11,"Up",0.529248994448721,0.794735928926393,"B.LvsP.REACTOME_KETONE_BODY_METABOLISM"
154,"Up",0.529541695447396,0.794745363680525,"B.LvsP.ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_DN"
460,"Down",0.529542759956422,0.794745363680525,"B.LvsP.BOQUEST_STEM_CELL_UP"
57,"Down",0.530370237011017,0.795771245707982,"B.LvsP.WESTON_VEGFA_TARGETS_12HR"
83,"Up",0.530946733389712,0.796420100084568,"B.LvsP.HAN_JNK_SINGALING_UP"
80,"Down",0.531205283303856,0.79659181214728,"B.LvsP.HOQUE_METHYLATED_IN_CANCER"
250,"Up",0.531353204140755,0.796597577465898,"B.LvsP.KASLER_HDAC7_TARGETS_1_UP"
10,"Up",0.531681095104995,0.796742141623137,"B.LvsP.SMID_BREAST_CANCER_ERBB2_DN"
42,"Down",0.53180847587321,0.796742141623137,"B.LvsP.BURTON_ADIPOGENESIS_12"
32,"Up",0.532005124058392,0.796742141623137,"B.LvsP.REACTOME_CASPASE_ACTIVATION_VIA_EXTRINSIC_APOPTOTIC_SIGNALLING_PATHWAY"
7,"Up",0.532105122594583,0.796742141623137,"B.LvsP.REACTOME_LIPID_PARTICLE_ORGANIZATION"
406,"Up",0.532206787252619,0.796742141623137,"B.LvsP.DANG_REGULATED_BY_MYC_DN"
6,"Up",0.532424163846539,0.796742141623137,"B.LvsP.REACTOME_NEGATIVE_REGULATION_OF_TCF_DEPENDENT_SIGNALING_BY_DVL_INTERACTING_PROTEINS"
325,"Down",0.532458349303218,0.796742141623137,"B.LvsP.REACTOME_DEUBIQUITINATION"
488,"Up",0.532723978270124,0.796923938272597,"B.LvsP.BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_D"
8,"Down",0.533193166139386,0.797142448672054,"B.LvsP.CHOI_ATL_ACUTE_STAGE"
69,"Up",0.533224510918659,0.797142448672054,"B.LvsP.PEART_HDAC_PROLIFERATION_CLUSTER_UP"
65,"Down",0.533302571466437,0.797142448672054,"B.LvsP.REACTOME_INTERLEUKIN_3_INTERLEUKIN_5_AND_GM_CSF_SIGNALING"
249,"Down",0.533947623688774,0.797877024644373,"B.LvsP.WHITFIELD_CELL_CYCLE_S"
129,"Up",0.534082631254987,0.797877024644373,"B.LvsP.DOANE_BREAST_CANCER_CLASSES_UP"
10,"Down",0.53424436398584,0.79788630404719,"B.LvsP.REACTOME_ZINC_INFLUX_INTO_CELLS_BY_THE_SLC39_GENE_FAMILY"
56,"Down",0.534377461364938,0.79788630404719,"B.LvsP.BIOCARTA_ERK_PATHWAY"
36,"Down",0.534756853686648,0.798237214911846,"B.LvsP.REACTOME_PLATELET_ADHESION_TO_EXPOSED_COLLAGEN"
6,"Up",0.535493793497575,0.798733059057532,"B.LvsP.MIKI_COEXPRESSED_WITH_CYP19A1"
8,"Down",0.535534209124059,0.798733059057532,"B.LvsP.LAU_APOPTOSIS_CDKN2A_DN"
975,"Down",0.5357700159837,0.798733059057532,"B.LvsP.BENPORATH_PRC2_TARGETS"
59,"Up",0.535794447877286,0.798733059057532,"B.LvsP.REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES"
313,"Up",0.535811343108046,0.798733059057532,"B.LvsP.REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES"
7,"Up",0.536025341176763,0.798836687699818,"B.LvsP.REACTOME_MITOCHONDRIAL_UNCOUPLING"
74,"Down",0.536508902199346,0.799341880964749,"B.LvsP.LI_CISPLATIN_RESISTANCE_UP"
135,"Down",0.536813712270264,0.799580553648246,"B.LvsP.PLASARI_TGFB1_SIGNALING_VIA_NFIC_10HR_UP"
63,"Up",0.537088331237704,0.799615343924237,"B.LvsP.SNIJDERS_AMPLIFIED_IN_HEAD_AND_NECK_TUMORS"
30,"Up",0.537245511302705,0.799615343924237,"B.LvsP.BIOCARTA_CCR5_PATHWAY"
23,"Up",0.537270935554086,0.799615343924237,"B.LvsP.ZEILSTRA_CD44_TARGETS_DN"
699,"Up",0.537798481545464,0.800145168977364,"B.LvsP.GARY_CD5_TARGETS_UP"
143,"Down",0.537916366990208,0.800145168977364,"B.LvsP.LIU_COMMON_CANCER_GENES"
21,"Down",0.538068143037301,0.800155665103076,"B.LvsP.REACTOME_NRIF_SIGNALS_CELL_DEATH_FROM_THE_NUCLEUS"
10,"Down",0.53828309991858,0.8002600858967,"B.LvsP.TESAR_ALK_TARGETS_HUMAN_ES_5D_UP"
77,"Up",0.538784942105456,0.800790845403513,"B.LvsP.ASTIER_INTEGRIN_SIGNALING"
30,"Down",0.540976801328308,0.803410689345145,"B.LvsP.PID_INTEGRIN_A9B1_PATHWAY"
105,"Up",0.540986190377874,0.803410689345145,"B.LvsP.HUTTMANN_B_CLL_POOR_SURVIVAL_DN"
46,"Up",0.541447361970756,0.803410689345145,"B.LvsP.REACTOME_NOD1_2_SIGNALING_PATHWAY"
599,"Down",0.541449563938106,0.803410689345145,"B.LvsP.IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR"
515,"Up",0.541630810237868,0.803410689345145,"B.LvsP.SENGUPTA_NASOPHARYNGEAL_CARCINOMA_DN"
89,"Down",0.541677857224856,0.803410689345145,"B.LvsP.REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH"
17,"Up",0.541837091494251,0.803410689345145,"B.LvsP.MURAKAMI_UV_RESPONSE_1HR_DN"
496,"Up",0.541923036860711,0.803410689345145,"B.LvsP.VERHAAK_AML_WITH_NPM1_MUTATED_DN"
9,"Down",0.54226071859303,0.803410689345145,"B.LvsP.REACTOME_DNA_DAMAGE_REVERSAL"
32,"Down",0.542262594881374,0.803410689345145,"B.LvsP.WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_DN"
213,"Down",0.54232272354745,0.803410689345145,"B.LvsP.CERVERA_SDHB_TARGETS_2"
88,"Down",0.542512469767944,0.803410689345145,"B.LvsP.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_DN"
26,"Up",0.5425658406367,0.803410689345145,"B.LvsP.PHESSE_TARGETS_OF_APC_AND_MBD2_UP"
48,"Down",0.542581934167982,0.803410689345145,"B.LvsP.LOPEZ_MBD_TARGETS_IMPRINTED_AND_X_LINKED"
41,"Down",0.542798115480065,0.803515603879325,"B.LvsP.LUI_THYROID_CANCER_CLUSTER_4"
26,"Up",0.543069845570841,0.803702670278689,"B.LvsP.REACTOME_NICOTINAMIDE_SALVAGING"
6,"Up",0.543669266115446,0.804374464102837,"B.LvsP.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_13"
140,"Up",0.543819064816223,0.804380847878249,"B.LvsP.WARTERS_RESPONSE_TO_IR_SKIN"
133,"Up",0.544277815739141,0.804582436625772,"B.LvsP.SMID_BREAST_CANCER_LUMINAL_A_UP"
638,"Up",0.544297239947664,0.804582436625772,"B.LvsP.PEREZ_TP63_TARGETS"
12,"Up",0.544465316697009,0.804582436625772,"B.LvsP.KUMAMOTO_RESPONSE_TO_NUTLIN_3A_UP"
80,"Up",0.544537434952729,0.804582436625772,"B.LvsP.REACTOME_TRANSCRIPTIONAL_REGULATION_BY_MECP2"
37,"Down",0.545091979203843,0.805186629179281,"B.LvsP.PID_GLYPICAN_1PATHWAY"
86,"Down",0.54527144660348,0.805236599431261,"B.LvsP.GUILLAUMOND_KLF10_TARGETS_UP"
197,"Down",0.545471869194707,0.805317480581451,"B.LvsP.WOO_LIVER_CANCER_RECURRENCE_UP"
131,"Up",0.545808414683492,0.805599232457294,"B.LvsP.HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_UP"
17,"Up",0.546343914516468,0.805797966180038,"B.LvsP.REACTOME_VITAMIN_B5_PANTOTHENATE_METABOLISM"
200,"Down",0.546437249619462,0.805797966180038,"B.LvsP.GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_UP"
78,"Down",0.546442611036433,0.805797966180038,"B.LvsP.SMIRNOV_RESPONSE_TO_IR_2HR_UP"
57,"Up",0.546675484046428,0.805797966180038,"B.LvsP.SCHRAETS_MLL_TARGETS_UP"
13,"Up",0.546802125451171,0.805797966180038,"B.LvsP.REACTOME_SODIUM_CALCIUM_EXCHANGERS"
476,"Up",0.546817502099386,0.805797966180038,"B.LvsP.MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_UP"
181,"Down",0.547262317223962,0.806032168446323,"B.LvsP.LIN_SILENCED_BY_TUMOR_MICROENVIRONMENT"
29,"Down",0.547267997892476,0.806032168446323,"B.LvsP.JI_CARCINOGENESIS_BY_KRAS_AND_STK11_DN"
70,"Down",0.547450964103043,0.806086918914974,"B.LvsP.VALK_AML_CLUSTER_3"
210,"Up",0.547612887667367,0.806110664513545,"B.LvsP.HOELZEL_NF1_TARGETS_DN"
13,"Down",0.548041386368545,0.806296932439097,"B.LvsP.VANLOO_SP3_TARGETS_UP"
94,"Up",0.548238870174589,0.806296932439097,"B.LvsP.ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_UP"
14,"Down",0.54827234683454,0.806296932439097,"B.LvsP.REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_DEATH_RECEPTORS_AND_LIGANDS"
61,"Up",0.548322746603546,0.806296932439097,"B.LvsP.HASLINGER_B_CLL_WITH_11Q23_DELETION"
41,"Down",0.548542831590422,0.806406093024047,"B.LvsP.HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_DN"
7,"Up",0.54904865614214,0.806692326606184,"B.LvsP.MOTAMED_RESPONSE_TO_ANDROGEN_DN"
36,"Up",0.549119403638245,0.806692326606184,"B.LvsP.REACTOME_RHO_GTPASES_ACTIVATE_IQGAPS"
150,"Up",0.549175242782723,0.806692326606184,"B.LvsP.REACTOME_METABOLISM_OF_WATER_SOLUBLE_VITAMINS_AND_COFACTORS"
119,"Up",0.549575996097743,0.806860867245862,"B.LvsP.LANDIS_BREAST_CANCER_PROGRESSION_DN"
89,"Up",0.549718185413216,0.806860867245862,"B.LvsP.ZHAN_MULTIPLE_MYELOMA_MS_DN"
7,"Down",0.549727778425604,0.806860867245862,"B.LvsP.REACTOME_ZINC_EFFLUX_AND_COMPARTMENTALIZATION_BY_THE_SLC30_FAMILY"
52,"Down",0.549946629422997,0.806967864670847,"B.LvsP.REACTOME_ELASTIC_FIBRE_FORMATION"
28,"Up",0.550476456723996,0.807366286261559,"B.LvsP.HOLLERN_MICROACINAR_BREAST_TUMOR_DN"
473,"Up",0.550510200616039,0.807366286261559,"B.LvsP.DURAND_STROMA_S_UP"
10,"Down",0.551134945836251,0.807957013453204,"B.LvsP.KIM_ALL_DISORDERS_DURATION_CORR_UP"
19,"Up",0.551205254972958,0.807957013453204,"B.LvsP.REACTOME_DSCAM_INTERACTIONS"
735,"Up",0.551837879145701,0.808352087578959,"B.LvsP.BAELDE_DIABETIC_NEPHROPATHY_DN"
87,"Down",0.551910185701637,0.808352087578959,"B.LvsP.BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN"
119,"Up",0.551913389511769,0.808352087578959,"B.LvsP.HOWLIN_PUBERTAL_MAMMARY_GLAND"
345,"Up",0.552372186998566,0.808627225663455,"B.LvsP.IVANOVA_HEMATOPOIESIS_STEM_CELL"
13,"Down",0.55239374775382,0.808627225663455,"B.LvsP.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_7"
35,"Down",0.552689741315742,0.808846368378703,"B.LvsP.NIKOLSKY_OVERCONNECTED_IN_BREAST_CANCER"
51,"Up",0.553222677580463,0.809412062540984,"B.LvsP.PID_EPHRINB_REV_PATHWAY"
22,"Up",0.553566463051981,0.809700786829207,"B.LvsP.BIOCARTA_D4GDI_PATHWAY"
1501,"Down",0.553807017924727,0.809838403095957,"B.LvsP.LOPEZ_MBD_TARGETS"
207,"Up",0.554142477815759,0.809892883063375,"B.LvsP.WANG_HCP_PROSTATE_CANCER"
153,"Down",0.554230297185614,0.809892883063375,"B.LvsP.DAZARD_RESPONSE_TO_UV_SCC_UP"
30,"Down",0.554283716677846,0.809892883063375,"B.LvsP.SUZUKI_RESPONSE_TO_TSA"
266,"Up",0.554470935871389,0.809922065419916,"B.LvsP.ALCALAY_AML_BY_NPM1_LOCALIZATION_UP"
518,"Down",0.554596661182818,0.809922065419916,"B.LvsP.FARMER_BREAST_CANCER_APOCRINE_VS_BASAL"
17,"Up",0.555026594643358,0.810257451167945,"B.LvsP.NIKOLSKY_BREAST_CANCER_14Q22_AMPLICON"
7,"Down",0.555395789227624,0.810257451167945,"B.LvsP.REACTOME_VITAMIN_B2_RIBOFLAVIN_METABOLISM"
16,"Up",0.555528525763647,0.810257451167945,"B.LvsP.YAGUE_PRETUMOR_DRUG_RESISTANCE_UP"
14,"Down",0.555546345155033,0.810257451167945,"B.LvsP.ABBUD_LIF_SIGNALING_2_DN"
147,"Down",0.555626022737079,0.810257451167945,"B.LvsP.BAE_BRCA1_TARGETS_UP"
57,"Down",0.555705598630647,0.810257451167945,"B.LvsP.RIZ_ERYTHROID_DIFFERENTIATION_HBZ"
1485,"Up",0.555993118380843,0.810462945301261,"B.LvsP.NUYTTEN_EZH2_TARGETS_UP"
39,"Up",0.556368894830412,0.810796947685121,"B.LvsP.BIOCARTA_TPO_PATHWAY"
7,"Up",0.556888644593277,0.811240743994778,"B.LvsP.REACTOME_IKBA_VARIANT_LEADS_TO_EDA_ID"
24,"Down",0.557115929878736,0.811240743994778,"B.LvsP.BIOCARTA_ARF_PATHWAY"
179,"Up",0.557279985956379,0.811240743994778,"B.LvsP.MATZUK_SPERMATOZOA"
380,"Down",0.557393000365988,0.811240743994778,"B.LvsP.REACTOME_ANTI_INFLAMMATORY_RESPONSE_FAVOURING_LEISHMANIA_PARASITE_INFECTION"
120,"Up",0.557407051263549,0.811240743994778,"B.LvsP.BILD_CTNNB1_ONCOGENIC_SIGNATURE"
674,"Down",0.558047822835388,0.811724766724501,"B.LvsP.ZHANG_BREAST_CANCER_PROGENITORS_UP"
263,"Down",0.558264819033355,0.811724766724501,"B.LvsP.LEE_NEURAL_CREST_STEM_CELL_DN"
28,"Up",0.558355038927521,0.811724766724501,"B.LvsP.BIOCARTA_CDK5_PATHWAY"
1739,"Up",0.558513181269921,0.811724766724501,"B.LvsP.GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP"
233,"Up",0.55856273582921,0.811724766724501,"B.LvsP.REACTOME_CELLULAR_SENESCENCE"
8,"Down",0.558708312362954,0.811724766724501,"B.LvsP.REACTOME_ACTIVATION_OF_TRKA_RECEPTORS"
1034,"Down",0.559104591888083,0.811724766724501,"B.LvsP.GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP"
53,"Up",0.559107080729006,0.811724766724501,"B.LvsP.REACTOME_MAP2K_AND_MAPK_ACTIVATION"
63,"Up",0.559136515965312,0.811724766724501,"B.LvsP.STREICHER_LSM1_TARGETS_UP"
8,"Down",0.559288773838829,0.811724766724501,"B.LvsP.SA_G2_AND_M_PHASES"
46,"Down",0.559354559815581,0.811724766724501,"B.LvsP.REACTOME_TRANSCRIPTIONAL_REGULATION_BY_THE_AP_2_TFAP2_FAMILY_OF_TRANSCRIPTION_FACTORS"
22,"Down",0.559972547008697,0.812282761890718,"B.LvsP.BIOCARTA_NFKB_PATHWAY"
91,"Down",0.560196596462977,0.812282761890718,"B.LvsP.PID_ATF2_PATHWAY"
44,"Up",0.560465157467598,0.812282761890718,"B.LvsP.REACTOME_RA_BIOSYNTHESIS_PATHWAY"
32,"Down",0.560565865614747,0.812282761890718,"B.LvsP.WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_UP"
325,"Up",0.560598613690852,0.812282761890718,"B.LvsP.LEE_DIFFERENTIATING_T_LYMPHOCYTE"
10,"Down",0.560620549715135,0.812282761890718,"B.LvsP.REACTOME_DISPLACEMENT_OF_DNA_GLYCOSYLASE_BY_APEX1"
16,"Down",0.560795988933971,0.812324082477319,"B.LvsP.REACTOME_ROLE_OF_SECOND_MESSENGERS_IN_NETRIN_1_SIGNALING"
33,"Up",0.561462542585107,0.813076584063137,"B.LvsP.BIOCARTA_CTCF_PATHWAY"
154,"Down",0.561660840126981,0.813150768542047,"B.LvsP.RADMACHER_AML_PROGNOSIS"
58,"Down",0.562055814026682,0.813400671585252,"B.LvsP.BAE_BRCA1_TARGETS_DN"
559,"Up",0.562127684233541,0.813400671585252,"B.LvsP.REACTOME_SIGNALING_BY_RHO_GTPASES"
54,"Up",0.562434612075735,0.813523435457608,"B.LvsP.PID_IFNG_PATHWAY"
7,"Down",0.562617665108848,0.813523435457608,"B.LvsP.REACTOME_RAS_SIGNALING_DOWNSTREAM_OF_NF1_LOSS_OF_FUNCTION_VARIANTS"
9,"Down",0.562668737437522,0.813523435457608,"B.LvsP.KUWANO_RNA_STABILIZED_BY_NO"
46,"Up",0.563000499509586,0.813523435457608,"B.LvsP.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_UP"
238,"Up",0.563089475899525,0.813523435457608,"B.LvsP.YAUCH_HEDGEHOG_SIGNALING_PARACRINE_UP"
20,"Down",0.563095349520033,0.813523435457608,"B.LvsP.GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_2"
51,"Down",0.563492593143202,0.813884678027367,"B.LvsP.VALK_AML_CLUSTER_5"
61,"Down",0.563842425814194,0.814177271435539,"B.LvsP.BIOCARTA_NKCELLS_PATHWAY"
41,"Up",0.564117678941457,0.814362048790422,"B.LvsP.PID_IL12_STAT4_PATHWAY"
42,"Down",0.564453447429612,0.81463406704211,"B.LvsP.REACTOME_REGULATION_OF_TP53_EXPRESSION_AND_DEGRADATION"
379,"Up",0.564895358369183,0.814751597959369,"B.LvsP.CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP"
392,"Down",0.564979046784313,0.814751597959369,"B.LvsP.REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION"
36,"Down",0.565353632316922,0.814751597959369,"B.LvsP.REACTOME_ACTIVATION_OF_BH3_ONLY_PROTEINS"
431,"Up",0.565400371702962,0.814751597959369,"B.LvsP.BONOME_OVARIAN_CANCER_SURVIVAL_OPTIMAL_DEBULKING"
8,"Up",0.565407340005468,0.814751597959369,"B.LvsP.REACTOME_SYNTHESIS_OF_KETONE_BODIES"
29,"Down",0.565534913773885,0.814751597959369,"B.LvsP.PID_IL27_PATHWAY"
219,"Down",0.565695547124981,0.814751597959369,"B.LvsP.XU_GH1_AUTOCRINE_TARGETS_DN"
23,"Down",0.565935681755114,0.814751597959369,"B.LvsP.REACTOME_CHL1_INTERACTIONS"
65,"Down",0.566052323501514,0.814751597959369,"B.LvsP.REACTOME_IRON_UPTAKE_AND_TRANSPORT"
73,"Down",0.566118393161801,0.814751597959369,"B.LvsP.LIAO_HAVE_SOX4_BINDING_SITES"
130,"Down",0.566155839999981,0.814751597959369,"B.LvsP.REACTOME_PROCESSING_OF_DNA_DOUBLE_STRAND_BREAK_ENDS"
52,"Up",0.566437376463312,0.814851092116522,"B.LvsP.REACTOME_TRANSCRIPTIONAL_REGULATION_BY_VENTX"
34,"Up",0.56651973197611,0.814851092116522,"B.LvsP.MASRI_RESISTANCE_TO_TAMOXIFEN_AND_AROMATASE_INHIBITORS_DN"
50,"Down",0.567553509409518,0.815914110581423,"B.LvsP.WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_DN"
159,"Down",0.567677743989538,0.815914110581423,"B.LvsP.REACTOME_TOLL_LIKE_RECEPTOR_4_TLR4_CASCADE"
10,"Down",0.567701498174487,0.815914110581423,"B.LvsP.BIOCARTA_TERT_PATHWAY"
37,"Up",0.568257731270165,0.816362763695201,"B.LvsP.GHO_ATF5_TARGETS_UP"
38,"Up",0.568308966804635,0.816362763695201,"B.LvsP.DE_YY1_TARGETS_UP"
7,"Up",0.568480258649968,0.816396714305369,"B.LvsP.REACTOME_DEFECTIVE_LFNG_CAUSES_SCDO3"
465,"Down",0.568821336952352,0.816674414959635,"B.LvsP.GRESHOCK_CANCER_COPY_NUMBER_UP"
81,"Down",0.569399307270524,0.817189961541608,"B.LvsP.CROMER_TUMORIGENESIS_DN"
15,"Up",0.569476021309426,0.817189961541608,"B.LvsP.REACTOME_PI3K_EVENTS_IN_ERBB4_SIGNALING"
16,"Up",0.569806003364263,0.817251330411642,"B.LvsP.ITO_PTTG1_TARGETS_DN"
11,"Down",0.570160166969557,0.817251330411642,"B.LvsP.REACTOME_CREB_PHOSPHORYLATION"
16,"Up",0.570248422516603,0.817251330411642,"B.LvsP.REACTOME_SYNTHESIS_OF_PE"
9,"Down",0.570331527522824,0.817251330411642,"B.LvsP.REACTOME_DEFECTIVE_CSF2RB_CAUSES_PULMONARY_SURFACTANT_METABOLISM_DYSFUNCTION_5_SMDP5"
183,"Down",0.570490199695407,0.817251330411642,"B.LvsP.REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION"
24,"Down",0.570541740621509,0.817251330411642,"B.LvsP.REACTOME_BBSOME_MEDIATED_CARGO_TARGETING_TO_CILIUM"
10,"Down",0.570587165056496,0.817251330411642,"B.LvsP.REACTOME_LOSS_OF_FUNCTION_OF_SMAD2_3_IN_CANCER"
31,"Up",0.570701281736182,0.817251330411642,"B.LvsP.MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_DN"
26,"Down",0.572182790193218,0.819159111806484,"B.LvsP.REACTOME_SYNTHESIS_SECRETION_AND_INACTIVATION_OF_GLUCAGON_LIKE_PEPTIDE_1_GLP_1"
23,"Down",0.572329833407207,0.819159111806484,"B.LvsP.GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN"
240,"Down",0.572732326461728,0.819434908469322,"B.LvsP.NAGASHIMA_NRG1_SIGNALING_UP"
18,"Up",0.572818940357014,0.819434908469322,"B.LvsP.WEBER_METHYLATED_LCP_IN_SPERM_UP"
23,"Down",0.572978474521345,0.81945110854333,"B.LvsP.REACTOME_NEGATIVE_REGULATION_OF_TCF_DEPENDENT_SIGNALING_BY_WNT_LIGAND_ANTAGONISTS"
139,"Up",0.573145179809156,0.819477553443192,"B.LvsP.ROSS_AML_WITH_MLL_FUSIONS"
32,"Down",0.573378350593204,0.819598991838115,"B.LvsP.KEGG_O_GLYCAN_BIOSYNTHESIS"
78,"Down",0.573868501292963,0.820087604975134,"B.LvsP.NAGASHIMA_EGF_SIGNALING_UP"
733,"Up",0.574031729942594,0.82010889789473,"B.LvsP.HAN_SATB1_TARGETS_UP"
191,"Down",0.574765559814983,0.820945177012927,"B.LvsP.DER_IFN_ALPHA_RESPONSE_UP"
51,"Down",0.575232368385651,0.821399732645729,"B.LvsP.JIANG_AGING_HYPOTHALAMUS_DN"
879,"Up",0.575530260525055,0.821448459820225,"B.LvsP.WEST_ADRENOCORTICAL_TUMOR_DN"
35,"Down",0.575691532804743,0.821448459820225,"B.LvsP.OUYANG_PROSTATE_CANCER_MARKERS"
13,"Down",0.575718886611009,0.821448459820225,"B.LvsP.REACTOME_REGULATED_PROTEOLYSIS_OF_P75NTR"
79,"Up",0.575860775956446,0.821448459820225,"B.LvsP.HOLLERN_SOLID_NODULAR_BREAST_TUMOR_DN"
134,"Up",0.576204481572271,0.821726741968812,"B.LvsP.MIKKELSEN_IPS_ICP_WITH_H3K27ME3"
12,"Down",0.576574797450414,0.82194542358254,"B.LvsP.REACTOME_CHYLOMICRON_ASSEMBLY"
449,"Up",0.576655145248087,0.82194542358254,"B.LvsP.DOANE_RESPONSE_TO_ANDROGEN_DN"
27,"Up",0.576909304741424,0.822013907522578,"B.LvsP.IIZUKA_LIVER_CANCER_EARLY_RECURRENCE"
327,"Up",0.577372414799474,0.822013907522578,"B.LvsP.LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER"
30,"Down",0.577419875574603,0.822013907522578,"B.LvsP.REACTOME_APC_CDC20_MEDIATED_DEGRADATION_OF_NEK2A"
53,"Down",0.57750722734292,0.822013907522578,"B.LvsP.BIOCARTA_P38MAPK_PATHWAY"
64,"Down",0.577677747057313,0.822013907522578,"B.LvsP.PIONTEK_PKD1_TARGETS_DN"
9,"Up",0.577758009462645,0.822013907522578,"B.LvsP.IIZUKA_LIVER_CANCER_PROGRESSION_G2_G3_DN"
25,"Up",0.57779640548191,0.822013907522578,"B.LvsP.REACTOME_INTERLEUKIN_20_FAMILY_SIGNALING"
726,"Up",0.578081196841487,0.822013907522578,"B.LvsP.PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_DN"
471,"Down",0.578160719861275,0.822013907522578,"B.LvsP.REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION"
56,"Down",0.578312251735113,0.822013907522578,"B.LvsP.RUAN_RESPONSE_TO_TNF_TROGLITAZONE_DN"
20,"Down",0.578469059350375,0.822013907522578,"B.LvsP.WIEMANN_TELOMERE_SHORTENING_AND_CHRONIC_LIVER_DAMAGE_DN"
279,"Down",0.578487269699828,0.822013907522578,"B.LvsP.UEDA_PERIFERAL_CLOCK"
46,"Down",0.578845724143842,0.822087492412778,"B.LvsP.KEGG_N_GLYCAN_BIOSYNTHESIS"
17,"Down",0.578946889095362,0.822087492412778,"B.LvsP.BIOCARTA_RANBP2_PATHWAY"
24,"Up",0.579010164436232,0.822087492412778,"B.LvsP.RAY_TARGETS_OF_P210_BCR_ABL_FUSION_DN"
12,"Down",0.579133800496974,0.822087492412778,"B.LvsP.REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX_IN_CANCER"
10,"Down",0.579504514973132,0.822342766413168,"B.LvsP.BYSTRYKH_HEMATOPOIESIS_STEM_CELL_FLI1"
253,"Up",0.579769501852706,0.822342766413168,"B.LvsP.ELVIDGE_HYPOXIA_UP"
33,"Up",0.579841497333184,0.822342766413168,"B.LvsP.GAZIN_EPIGENETIC_SILENCING_BY_KRAS"
24,"Down",0.579988802026768,0.822342766413168,"B.LvsP.FARMER_BREAST_CANCER_CLUSTER_5"
345,"Down",0.580057295896429,0.822342766413168,"B.LvsP.DAVICIONI_MOLECULAR_ARMS_VS_ERMS_DN"
129,"Up",0.58075892032463,0.823126395917682,"B.LvsP.MENSE_HYPOXIA_UP"
79,"Up",0.581447114186314,0.823229473504432,"B.LvsP.YOKOE_CANCER_TESTIS_ANTIGENS"
33,"Down",0.581468051605046,0.823229473504432,"B.LvsP.HAEGERSTRAND_RESPONSE_TO_IMATINIB"
20,"Down",0.5815863186255,0.823229473504432,"B.LvsP.FERRANDO_LYL1_NEIGHBORS"
215,"Up",0.581645685950688,0.823229473504432,"B.LvsP.NIKOLSKY_BREAST_CANCER_11Q12_Q14_AMPLICON"
28,"Up",0.581726386282777,0.823229473504432,"B.LvsP.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_23"
45,"Down",0.582107762023695,0.823229473504432,"B.LvsP.WATANABE_COLON_CANCER_MSI_VS_MSS_UP"
31,"Up",0.582561665171814,0.823229473504432,"B.LvsP.LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_QTL"
53,"Down",0.582656501643548,0.823229473504432,"B.LvsP.BIOCARTA_VEGF_PATHWAY"
37,"Up",0.582692406516147,0.823229473504432,"B.LvsP.BIOCARTA_CCR3_PATHWAY"
43,"Up",0.582712477334413,0.823229473504432,"B.LvsP.MATZUK_MALE_REPRODUCTION_SERTOLI"
56,"Up",0.583172437888144,0.823229473504432,"B.LvsP.THEODOROU_MAMMARY_TUMORIGENESIS"
42,"Down",0.5833886400755,0.823229473504432,"B.LvsP.REACTOME_BIOSYNTHESIS_OF_MARESINS"
105,"Up",0.583437164094576,0.823229473504432,"B.LvsP.PID_AVB3_INTEGRIN_PATHWAY"
677,"Up",0.583629904038848,0.823229473504432,"B.LvsP.BASAKI_YBX1_TARGETS_DN"
35,"Down",0.583725699686673,0.823229473504432,"B.LvsP.TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_GRANULOCYTE_UP"
321,"Down",0.583813693769632,0.823229473504432,"B.LvsP.BROWN_MYELOID_CELL_DEVELOPMENT_UP"
4,"Down",0.584186541471647,0.823229473504432,"B.LvsP.REACTOME_METALLOTHIONEINS_BIND_METALS"
394,"Up",0.584203543867033,0.823229473504432,"B.LvsP.BILD_E2F3_ONCOGENIC_SIGNATURE"
318,"Up",0.584242159731582,0.823229473504432,"B.LvsP.VANTVEER_BREAST_CANCER_ESR1_UP"
74,"Up",0.584534157206464,0.823229473504432,"B.LvsP.KEGG_ACUTE_MYELOID_LEUKEMIA"
38,"Down",0.584585830444195,0.823229473504432,"B.LvsP.SEMBA_FHIT_TARGETS_UP"
74,"Up",0.584597537181524,0.823229473504432,"B.LvsP.DAVIES_MULTIPLE_MYELOMA_VS_MGUS_DN"
148,"Down",0.584599005321259,0.823229473504432,"B.LvsP.GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_DN"
59,"Down",0.5846089075715,0.823229473504432,"B.LvsP.PID_HNF3B_PATHWAY"
27,"Up",0.584707371940528,0.823229473504432,"B.LvsP.OUYANG_PROSTATE_CANCER_PROGRESSION_DN"
1586,"Up",0.585217191652499,0.823229473504432,"B.LvsP.BRUINS_UVC_RESPONSE_LATE"
38,"Down",0.585256598217726,0.823229473504432,"B.LvsP.REACTOME_TAK1_ACTIVATES_NFKB_BY_PHOSPHORYLATION_AND_ACTIVATION_OF_IKKS_COMPLEX"
66,"Down",0.585306295670188,0.823229473504432,"B.LvsP.SIMBULAN_UV_RESPONSE_IMMORTALIZED_DN"
43,"Up",0.585369264732989,0.823229473504432,"B.LvsP.REACTOME_ADRENALINE_NORADRENALINE_INHIBITS_INSULIN_SECRETION"
394,"Up",0.585411706279842,0.823229473504432,"B.LvsP.SENESE_HDAC1_AND_HDAC2_TARGETS_DN"
28,"Up",0.585447330406842,0.823229473504432,"B.LvsP.BIOCARTA_ATM_PATHWAY"
30,"Down",0.585881259738614,0.823630176733993,"B.LvsP.CHOI_ATL_CHRONIC_VS_ACUTE_DN"
59,"Down",0.586243990149667,0.823773022394099,"B.LvsP.GEISS_RESPONSE_TO_DSRNA_UP"
39,"Up",0.586280854245031,0.823773022394099,"B.LvsP.REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_ACETYLATION"
96,"Down",0.586624538686389,0.824046512804127,"B.LvsP.FIGUEROA_AML_METHYLATION_CLUSTER_6_DN"
186,"Up",0.586775679015293,0.824049461334914,"B.LvsP.BROWNE_HCMV_INFECTION_12HR_DN"
174,"Down",0.587025019763635,0.824185952214622,"B.LvsP.YAMASHITA_METHYLATED_IN_PROSTATE_CANCER"
15,"Down",0.587171001225067,0.824185952214622,"B.LvsP.GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP"
6,"Up",0.587466728596489,0.824391762032992,"B.LvsP.REACTOME_VASOPRESSIN_LIKE_RECEPTORS"
27,"Down",0.587817448698138,0.824407596029511,"B.LvsP.MOOTHA_FFA_OXYDATION"
116,"Down",0.587910368576748,0.824407596029511,"B.LvsP.RASHI_RESPONSE_TO_IONIZING_RADIATION_4"
186,"Down",0.587925330284746,0.824407596029511,"B.LvsP.MATZUK_SPERMATOCYTE"
138,"Down",0.588871694460781,0.824843046962108,"B.LvsP.KEGG_TIGHT_JUNCTION"
1060,"Down",0.588941953957285,0.824843046962108,"B.LvsP.MARTINEZ_TP53_TARGETS_DN"
34,"Down",0.588947577919773,0.824843046962108,"B.LvsP.KAPOSI_LIVER_CANCER_MET_UP"
14,"Up",0.588969815890986,0.824843046962108,"B.LvsP.BIOCARTA_AKAP13_PATHWAY"
81,"Down",0.588981795877447,0.824843046962108,"B.LvsP.HENDRICKS_SMARCA4_TARGETS_DN"
40,"Up",0.589689971793842,0.825625691073222,"B.LvsP.STAMBOLSKY_BOUND_BY_MUTATED_TP53"
380,"Down",0.59001513138217,0.825871813015701,"B.LvsP.WAMUNYOKOLI_OVARIAN_CANCER_LMP_UP"
740,"Down",0.590720478347669,0.826488128492596,"B.LvsP.DELYS_THYROID_CANCER_UP"
12,"Down",0.590754401121856,0.826488128492596,"B.LvsP.HOFFMAN_CLOCK_TARGETS_DN"
30,"Down",0.591124483330514,0.826681661980209,"B.LvsP.CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_UP"
208,"Up",0.591191769120953,0.826681661980209,"B.LvsP.GAL_LEUKEMIC_STEM_CELL_UP"
29,"Down",0.591437952325318,0.826816798585761,"B.LvsP.REACTOME_RIPK1_MEDIATED_REGULATED_NECROSIS"
5,"Down",0.591962373085076,0.827013974985376,"B.LvsP.REACTOME_DISEASES_OF_BASE_EXCISION_REPAIR"
32,"Up",0.591997236787515,0.827013974985376,"B.LvsP.KEGG_NICOTINATE_AND_NICOTINAMIDE_METABOLISM"
133,"Down",0.592108926503997,0.827013974985376,"B.LvsP.SU_LIVER"
500,"Down",0.592177306378568,0.827013974985376,"B.LvsP.TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_DN"
15,"Down",0.592642954782702,0.827372396561822,"B.LvsP.BIOCARTA_CPSF_PATHWAY"
26,"Up",0.592833409608829,0.827372396561822,"B.LvsP.REACTOME_THROMBOXANE_SIGNALLING_THROUGH_TP_RECEPTOR"
1483,"Down",0.592882878491217,0.827372396561822,"B.LvsP.BENPORATH_SUZ12_TARGETS"
32,"Down",0.593097454346157,0.827462988917462,"B.LvsP.KEGG_GLYCINE_SERINE_AND_THREONINE_METABOLISM"
829,"Down",0.593277304266802,0.827505099720269,"B.LvsP.IVANOVA_HEMATOPOIESIS_LATE_PROGENITOR"
25,"Up",0.593612454223773,0.827763747642684,"B.LvsP.HOLLEMAN_PREDNISOLONE_RESISTANCE_ALL_UP"
23,"Up",0.59384330720736,0.827876864737643,"B.LvsP.DING_LUNG_CANCER_MUTATED_FREQUENTLY"
203,"Up",0.594327162339935,0.828342546150114,"B.LvsP.MIKKELSEN_IPS_WITH_HCP_H3K27ME3"
6,"Up",0.594523096110692,0.828406804031254,"B.LvsP.REACTOME_THE_RETINOID_CYCLE_IN_CONES_DAYLIGHT_VISION"
20,"Down",0.595422223468802,0.829450610622072,"B.LvsP.REACTOME_CD28_DEPENDENT_VAV1_PATHWAY"
140,"Down",0.59582042335084,0.829796252067203,"B.LvsP.REACTOME_ADORA2B_MEDIATED_ANTI_INFLAMMATORY_CYTOKINES_PRODUCTION"
6,"Down",0.596297172414931,0.830251086950933,"B.LvsP.REACTOME_VITAMIN_B1_THIAMIN_METABOLISM"
71,"Down",0.597109861777914,0.831031959417496,"B.LvsP.BEIER_GLIOMA_STEM_CELL_UP"
663,"Up",0.597314865978658,0.831031959417496,"B.LvsP.VECCHI_GASTRIC_CANCER_EARLY_DN"
650,"Down",0.597403125081436,0.831031959417496,"B.LvsP.ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP"
47,"Down",0.59751339388625,0.831031959417496,"B.LvsP.VALK_AML_CLUSTER_1"
750,"Down",0.597872717192256,0.831031959417496,"B.LvsP.MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN"
35,"Up",0.597873712058707,0.831031959417496,"B.LvsP.BIOCARTA_MCALPAIN_PATHWAY"
11,"Down",0.598054342242135,0.831031959417496,"B.LvsP.BYSTRYKH_SCP2_QTL"
138,"Up",0.598180480915628,0.831031959417496,"B.LvsP.REACTOME_GLYCOSAMINOGLYCAN_METABOLISM"
175,"Down",0.59828579932994,0.831031959417496,"B.LvsP.KAN_RESPONSE_TO_ARSENIC_TRIOXIDE"
72,"Up",0.598454310379768,0.831031959417496,"B.LvsP.ZHAN_MULTIPLE_MYELOMA_CD1_UP"
56,"Up",0.598878657733339,0.831031959417496,"B.LvsP.HASLINGER_B_CLL_WITH_6Q21_DELETION"
19,"Up",0.599039497055749,0.831031959417496,"B.LvsP.REACTOME_SIGNAL_REGULATORY_PROTEIN_FAMILY_INTERACTIONS"
279,"Down",0.599062079796521,0.831031959417496,"B.LvsP.PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_DN"
62,"Up",0.599098611802004,0.831031959417496,"B.LvsP.PID_SYNDECAN_2_PATHWAY"
76,"Down",0.599112568319432,0.831031959417496,"B.LvsP.GILDEA_METASTASIS"
11,"Down",0.599656367190308,0.831577640881668,"B.LvsP.STEGMEIER_PREMITOTIC_CELL_CYCLE_REGULATORS"
119,"Up",0.60049132492704,0.832258145424081,"B.LvsP.GUO_HEX_TARGETS_UP"
194,"Up",0.600698637634513,0.832258145424081,"B.LvsP.ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_UP"
25,"Down",0.60073291459887,0.832258145424081,"B.LvsP.HONRADO_BREAST_CANCER_BRCA1_VS_BRCA2"
29,"Down",0.600854742650086,0.832258145424081,"B.LvsP.REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_CYCLIN_B"
159,"Up",0.600899713606969,0.832258145424081,"B.LvsP.MAHAJAN_RESPONSE_TO_IL1A_DN"
12,"Up",0.601464119589921,0.832359874586479,"B.LvsP.REACTOME_HYALURONAN_BIOSYNTHESIS_AND_EXPORT"
243,"Down",0.601472752572535,0.832359874586479,"B.LvsP.IGLESIAS_E2F_TARGETS_UP"
835,"Up",0.60162185245852,0.832359874586479,"B.LvsP.ZWANG_CLASS_1_TRANSIENTLY_INDUCED_BY_EGF"
151,"Down",0.601645070250481,0.832359874586479,"B.LvsP.COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP"
15,"Down",0.60172588510077,0.832359874586479,"B.LvsP.GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_1_UP"
39,"Up",0.602010498252247,0.832424060025024,"B.LvsP.CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_DN"
370,"Up",0.602073397728354,0.832424060025024,"B.LvsP.HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_UP"
301,"Up",0.60257267353122,0.832906077988528,"B.LvsP.ASTON_MAJOR_DEPRESSIVE_DISORDER_DN"
427,"Up",0.602878840418031,0.833120996918593,"B.LvsP.UDAYAKUMAR_MED1_TARGETS_DN"
26,"Down",0.603400973583065,0.833634178645868,"B.LvsP.BALLIF_DEVELOPMENTAL_DISABILITY_P16_P12_DELETION"
92,"Up",0.603833329178965,0.833806628224711,"B.LvsP.REACTOME_SIGNALING_BY_NOTCH1"
810,"Up",0.603888540986468,0.833806628224711,"B.LvsP.SWEET_LUNG_CANCER_KRAS_DN"
201,"Up",0.603980694338989,0.833806628224711,"B.LvsP.WEI_MIR34A_TARGETS"
797,"Down",0.604129020196815,0.833806628224711,"B.LvsP.KIM_ALL_DISORDERS_CALB1_CORR_UP"
40,"Up",0.605630816264009,0.835670771930049,"B.LvsP.REACTOME_ROS_AND_RNS_PRODUCTION_IN_PHAGOCYTES"
94,"Up",0.606291405978193,0.836373548815725,"B.LvsP.WARTERS_IR_RESPONSE_5GY"
20,"Down",0.606640283229301,0.836606591164555,"B.LvsP.BIOCARTA_AKAPCENTROSOME_PATHWAY"
117,"Up",0.606762964472755,0.836606591164555,"B.LvsP.JIANG_VHL_TARGETS"
220,"Up",0.607372956225672,0.837238861872785,"B.LvsP.RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN"
141,"Up",0.608297975259543,0.838200389232767,"B.LvsP.NELSON_RESPONSE_TO_ANDROGEN_UP"
230,"Down",0.608373695422517,0.838200389232767,"B.LvsP.ZHANG_BREAST_CANCER_PROGENITORS_DN"
13,"Down",0.608681507830625,0.838415559739792,"B.LvsP.REACTOME_INTERLEUKIN_27_SIGNALING"
10,"Up",0.608848400524636,0.838436564508273,"B.LvsP.NIKOLSKY_BREAST_CANCER_10Q22_AMPLICON"
101,"Down",0.60906133866375,0.838520951561722,"B.LvsP.REACTOME_COPII_MEDIATED_VESICLE_TRANSPORT"
42,"Down",0.609384146039945,0.838616631133678,"B.LvsP.OHM_METHYLATED_IN_ADULT_CANCERS"
127,"Down",0.609434187718415,0.838616631133678,"B.LvsP.HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_DN"
32,"Up",0.609834055973513,0.838958073022531,"B.LvsP.BIOCARTA_EPO_PATHWAY"
65,"Up",0.610215647394918,0.839110575354391,"B.LvsP.REACTOME_SIGNALING_BY_RETINOIC_ACID"
173,"Up",0.610248439772112,0.839110575354391,"B.LvsP.HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_DN"
4,"Up",0.610419057569649,0.839136491621728,"B.LvsP.DER_IFN_ALPHA_RESPONSE_DN"
43,"Down",0.610673025563165,0.839276947138638,"B.LvsP.REACTOME_VOLTAGE_GATED_POTASSIUM_CHANNELS"
27,"Up",0.610833810133509,0.839289298267439,"B.LvsP.PID_INTEGRIN_CS_PATHWAY"
50,"Up",0.611259705860221,0.839665817068612,"B.LvsP.REACTOME_SUMOYLATION_OF_TRANSCRIPTION_COFACTORS"
115,"Down",0.612022082430031,0.840428627378527,"B.LvsP.COLDREN_GEFITINIB_RESISTANCE_UP"
32,"Up",0.612119023775245,0.840428627378527,"B.LvsP.LE_NEURONAL_DIFFERENTIATION_UP"
1037,"Up",0.612398915752468,0.840528649754937,"B.LvsP.CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_3"
49,"Up",0.612495917862659,0.840528649754937,"B.LvsP.UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN"
38,"Down",0.613194310628435,0.840984658788454,"B.LvsP.ONO_FOXP3_TARGETS_UP"
189,"Down",0.613413464417082,0.840984658788454,"B.LvsP.ROESSLER_LIVER_CANCER_METASTASIS_UP"
700,"Up",0.61349504022542,0.840984658788454,"B.LvsP.MILI_PSEUDOPODIA_CHEMOTAXIS_DN"
246,"Down",0.613537262893953,0.840984658788454,"B.LvsP.SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP"
297,"Down",0.613588734590816,0.840984658788454,"B.LvsP.VANOEVELEN_MYOGENESIS_SIN3A_TARGETS"
66,"Up",0.613760712398014,0.841011890668803,"B.LvsP.REACTOME_SIGNALING_BY_MODERATE_KINASE_ACTIVITY_BRAF_MUTANTS"
46,"Down",0.614105963464054,0.84127647968106,"B.LvsP.CHANGOLKAR_H2AFY_TARGETS_DN"
79,"Down",0.61442029929051,0.841498596675063,"B.LvsP.BURTON_ADIPOGENESIS_PEAK_AT_2HR"
587,"Up",0.614627994497531,0.84152267602331,"B.LvsP.DELACROIX_RARG_BOUND_MEF"
193,"Up",0.614844646793514,0.84152267602331,"B.LvsP.ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_DN"
87,"Down",0.614928832989747,0.84152267602331,"B.LvsP.KEGG_CHRONIC_MYELOID_LEUKEMIA"
38,"Down",0.615046687250895,0.84152267602331,"B.LvsP.BIOCARTA_BAD_PATHWAY"
206,"Up",0.615676652149148,0.842176202308917,"B.LvsP.LIU_VMYB_TARGETS_UP"
14,"Up",0.616061345743507,0.842493984817178,"B.LvsP.REACTOME_NRCAM_INTERACTIONS"
144,"Down",0.616339715137128,0.842666242579917,"B.LvsP.YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_9"
130,"Up",0.616964107447076,0.843032457657583,"B.LvsP.WOO_LIVER_CANCER_RECURRENCE_DN"
639,"Up",0.617057141856302,0.843032457657583,"B.LvsP.HAN_SATB1_TARGETS_DN"
42,"Up",0.617143690390172,0.843032457657583,"B.LvsP.REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS"
1498,"Up",0.6172174694516,0.843032457657583,"B.LvsP.ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN"
9,"Down",0.617425120126195,0.843107801723323,"B.LvsP.TESAR_ALK_AND_JAK_TARGETS_MOUSE_ES_D4_UP"
87,"Down",0.617637486254337,0.84318954604944,"B.LvsP.TSENG_ADIPOGENIC_POTENTIAL_DN"
34,"Down",0.618548921683082,0.844144856575626,"B.LvsP.HAHTOLA_CTCL_PATHOGENESIS"
27,"Down",0.618720176246491,0.844144856575626,"B.LvsP.REACTOME_LISTERIA_MONOCYTOGENES_ENTRY_INTO_HOST_CELLS"
277,"Up",0.618795280105084,0.844144856575626,"B.LvsP.REACTOME_ESR_MEDIATED_SIGNALING"
10,"Up",0.619346272877368,0.844688096383564,"B.LvsP.KAUFFMANN_MELANOMA_RELAPSE_DN"
47,"Up",0.61973935289894,0.845015753928049,"B.LvsP.REACTOME_LAMININ_INTERACTIONS"
612,"Down",0.620410974049754,0.845669147290233,"B.LvsP.HELLER_SILENCED_BY_METHYLATION_UP"
436,"Up",0.620589764936169,0.845669147290233,"B.LvsP.MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED"
46,"Down",0.620677409966317,0.845669147290233,"B.LvsP.PARK_TRETINOIN_RESPONSE_AND_PML_RARA_FUSION"
152,"Down",0.621169008699358,0.846110196118216,"B.LvsP.WONG_ENDMETRIUM_CANCER_DN"
111,"Up",0.621527255169062,0.846110196118216,"B.LvsP.REACTOME_TOLL_LIKE_RECEPTOR_9_TLR9_CASCADE"
19,"Up",0.621565939985442,0.846110196118216,"B.LvsP.MATTHEWS_AP1_TARGETS"
48,"Down",0.621693735229518,0.846110196118216,"B.LvsP.CHIBA_RESPONSE_TO_TSA_DN"
1584,"Up",0.621766273616985,0.846110196118216,"B.LvsP.GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS"
87,"Down",0.622772011969787,0.847270288922478,"B.LvsP.WESTON_VEGFA_TARGETS_6HR"
12,"Up",0.623482250374883,0.848027887410265,"B.LvsP.REACTOME_ACTIVATION_OF_RAC1_DOWNSTREAM_OF_NMDARS"
25,"Up",0.623692222419279,0.84810484450472,"B.LvsP.KEGG_GLYCOSYLPHOSPHATIDYLINOSITOL_GPI_ANCHOR_BIOSYNTHESIS"
84,"Down",0.623849327621089,0.848109892406443,"B.LvsP.REACTOME_DEFENSINS"
20,"Up",0.624394648628988,0.848184168166945,"B.LvsP.WU_HBX_TARGETS_3_DN"
77,"Up",0.624409036071615,0.848184168166945,"B.LvsP.KEGG_ADIPOCYTOKINE_SIGNALING_PATHWAY"
23,"Up",0.624443968316591,0.848184168166945,"B.LvsP.STEIN_ESTROGEN_RESPONSE_NOT_VIA_ESRRA"
492,"Down",0.624517588823953,0.848184168166945,"B.LvsP.WANG_MLL_TARGETS"
12,"Down",0.625070210631028,0.848726226566541,"B.LvsP.REACTOME_PASSIVE_TRANSPORT_BY_AQUAPORINS"
192,"Down",0.625243429903605,0.848752988936173,"B.LvsP.KEGG_JAK_STAT_SIGNALING_PATHWAY"
257,"Up",0.625612064237753,0.848843008121501,"B.LvsP.LANDIS_ERBB2_BREAST_TUMORS_324_DN"
107,"Down",0.625616794735959,0.848843008121501,"B.LvsP.FONTAINE_PAPILLARY_THYROID_CARCINOMA_UP"
63,"Up",0.625986726249037,0.849136557760285,"B.LvsP.REACTOME_G_PROTEIN_MEDIATED_EVENTS"
30,"Up",0.62650145329129,0.84957299905679,"B.LvsP.BYSTRYKH_HEMATOPOIESIS_STEM_CELL_RUNX1"
8,"Up",0.626615787692818,0.84957299905679,"B.LvsP.REACTOME_FGFR3B_LIGAND_BINDING_AND_ACTIVATION"
7,"Down",0.627185505596933,0.850136960148429,"B.LvsP.REACTOME_ATTACHMENT_OF_GPI_ANCHOR_TO_UPAR"
49,"Down",0.627664950816923,0.850578312026169,"B.LvsP.WEBER_METHYLATED_HCP_IN_SPERM_DN"
20,"Down",0.628369952889877,0.850986360229661,"B.LvsP.ZHOU_PANCREATIC_ENDOCRINE_PROGENITOR"
10,"Down",0.628621725634571,0.850986360229661,"B.LvsP.DASU_IL6_SIGNALING_DN"
102,"Down",0.628992698176479,0.850986360229661,"B.LvsP.REACTOME_PLASMA_LIPOPROTEIN_ASSEMBLY_REMODELING_AND_CLEARANCE"
46,"Up",0.628999939081883,0.850986360229661,"B.LvsP.BIOCARTA_NO1_PATHWAY"
757,"Down",0.629055395693985,0.850986360229661,"B.LvsP.SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP"
10,"Down",0.629133912973592,0.850986360229661,"B.LvsP.REACTOME_METABOLISM_OF_INGESTED_SEMET_SEC_MESEC_INTO_H2SE"
20,"Up",0.629208534419294,0.850986360229661,"B.LvsP.BIOCARTA_TALL1_PATHWAY"
47,"Down",0.629241701402228,0.850986360229661,"B.LvsP.NOJIMA_SFRP2_TARGETS_UP"
17,"Down",0.629351279974514,0.850986360229661,"B.LvsP.BIOCARTA_BTG2_PATHWAY"
21,"Up",0.629508665485864,0.850991054149472,"B.LvsP.BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_48HR_UP"
12,"Up",0.630379545434936,0.851536517830678,"B.LvsP.REACTOME_NONCANONICAL_ACTIVATION_OF_NOTCH3"
49,"Up",0.630659713214715,0.851536517830678,"B.LvsP.REACTOME_METABOLISM_OF_PORPHYRINS"
23,"Up",0.630816407863955,0.851536517830678,"B.LvsP.KEGG_NITROGEN_METABOLISM"
352,"Up",0.630892628121052,0.851536517830678,"B.LvsP.ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_UP"
60,"Down",0.631102432979652,0.851536517830678,"B.LvsP.REACTOME_BIOSYNTHESIS_OF_SPECIALIZED_PRORESOLVING_MEDIATORS_SPMS"
9,"Down",0.631105393030354,0.851536517830678,"B.LvsP.BIOCARTA_CIRCADIAN_PATHWAY"
36,"Down",0.631220744111149,0.851536517830678,"B.LvsP.PID_MYC_PATHWAY"
94,"Down",0.631316975890671,0.851536517830678,"B.LvsP.SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_DN"
64,"Up",0.631379588806692,0.851536517830678,"B.LvsP.MATTIOLI_MULTIPLE_MYELOMA_WITH_14Q32_TRANSLOCATIONS"
11,"Up",0.631452292115351,0.851536517830678,"B.LvsP.BIOCARTA_CACAM_PATHWAY"
47,"Down",0.631873503487954,0.851896757079956,"B.LvsP.PID_ALPHA_SYNUCLEIN_PATHWAY"
25,"Down",0.63219478397767,0.852017322222262,"B.LvsP.REACTOME_ABORTIVE_ELONGATION_OF_HIV_1_TRANSCRIPT_IN_THE_ABSENCE_OF_TAT"
23,"Up",0.632271129151373,0.852017322222262,"B.LvsP.REACTOME_ADP_SIGNALLING_THROUGH_P2Y_PURINOCEPTOR_12"
136,"Down",0.632467536509946,0.852074320020345,"B.LvsP.DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_DN"
72,"Up",0.632771404540586,0.85227192587261,"B.LvsP.REACTOME_SIGNALING_BY_FGFR_IN_DISEASE"
8,"Down",0.633193572453166,0.85227192587261,"B.LvsP.KASLER_HDAC7_TARGETS_2_UP"
7,"Up",0.633208236906857,0.85227192587261,"B.LvsP.GAVIN_IL2_RESPONSIVE_FOXP3_TARGETS_DN"
100,"Up",0.633363614272247,0.85227192587261,"B.LvsP.REACTOME_TOLL_LIKE_RECEPTOR_10_TLR10_CASCADE"
86,"Down",0.633384941835875,0.85227192587261,"B.LvsP.PID_INTEGRIN1_PATHWAY"
35,"Up",0.634045586260418,0.852953295969307,"B.LvsP.MAGRANGEAS_MULTIPLE_MYELOMA_IGLL_VS_IGLK_DN"
788,"Up",0.634407734558661,0.853122902679208,"B.LvsP.SENESE_HDAC3_TARGETS_DN"
90,"Down",0.634480263305643,0.853122902679208,"B.LvsP.ZHAN_MULTIPLE_MYELOMA_MF_UP"
51,"Up",0.634917822705475,0.853133680241762,"B.LvsP.REACTOME_CLASS_C_3_METABOTROPIC_GLUTAMATE_PHEROMONE_RECEPTORS"
231,"Down",0.634923166667308,0.853133680241762,"B.LvsP.BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_DN"
45,"Up",0.634992243509135,0.853133680241762,"B.LvsP.REACTOME_NEGATIVE_REGULATORS_OF_DDX58_IFIH1_SIGNALING"
9,"Down",0.635105485236949,0.853133680241762,"B.LvsP.REACTOME_VITAMIN_C_ASCORBATE_METABOLISM"
33,"Down",0.636392976138392,0.854270343929735,"B.LvsP.REACTOME_PURINERGIC_SIGNALING_IN_LEISHMANIASIS_INFECTION"
51,"Up",0.636397939577021,0.854270343929735,"B.LvsP.REACTOME_HIV_TRANSCRIPTION_INITIATION"
26,"Down",0.636471122198388,0.854270343929735,"B.LvsP.TRAYNOR_RETT_SYNDROM_DN"
45,"Down",0.636569690177339,0.854270343929735,"B.LvsP.CHNG_MULTIPLE_MYELOMA_HYPERPLOID_DN"
34,"Down",0.636879373410506,0.854333628637746,"B.LvsP.THUM_MIR21_TARGETS_HEART_DISEASE_UP"
22,"Down",0.636925884833566,0.854333628637746,"B.LvsP.PYEON_HPV_POSITIVE_TUMORS_DN"
70,"Up",0.637566662823993,0.854985709132636,"B.LvsP.ROZANOV_MMP14_TARGETS_SUBSET"
198,"Up",0.6377748665741,0.855057526015568,"B.LvsP.CERVERA_SDHB_TARGETS_1_UP"
91,"Down",0.638078059525725,0.855256628149754,"B.LvsP.PID_TCR_PATHWAY"
105,"Down",0.638435444063144,0.8555282525994,"B.LvsP.PID_MET_PATHWAY"
23,"Down",0.639538123596918,0.856775733542723,"B.LvsP.REACTOME_SPRY_REGULATION_OF_FGF_SIGNALING"
68,"Down",0.639676293735641,0.856775733542723,"B.LvsP.HALMOS_CEBPA_TARGETS_DN"
82,"Down",0.639943515920778,0.856790841636707,"B.LvsP.WIERENGA_PML_INTERACTOME"
6,"Up",0.639997499721396,0.856790841636707,"B.LvsP.SMID_BREAST_CANCER_RELAPSE_IN_LIVER_UP"
8,"Down",0.640476248429149,0.857224201782805,"B.LvsP.HESSON_TUMOR_SUPPRESSOR_CLUSTER_3P21_3"
11,"Up",0.640862298745852,0.857440711342373,"B.LvsP.GALIE_TUMOR_STEMNESS_GENES"
265,"Up",0.640948175072893,0.857440711342373,"B.LvsP.TSAI_RESPONSE_TO_IONIZING_RADIATION"
189,"Down",0.641150322456855,0.857503660586346,"B.LvsP.DURCHDEWALD_SKIN_CARCINOGENESIS_UP"
28,"Up",0.641486847058272,0.857746258134264,"B.LvsP.NIKOLSKY_BREAST_CANCER_22Q13_AMPLICON"
40,"Up",0.64167311923514,0.857787881105195,"B.LvsP.RIZ_ERYTHROID_DIFFERENTIATION_HEMGN"
35,"Down",0.642112482918419,0.857918436929252,"B.LvsP.SHARMA_PILOCYTIC_ASTROCYTOMA_LOCATION_UP"
66,"Down",0.64211656118574,0.857918436929252,"B.LvsP.KEGG_PATHOGENIC_ESCHERICHIA_COLI_INFECTION"
57,"Down",0.642236283315279,0.857918436929252,"B.LvsP.STANELLE_E2F1_TARGETS"
15,"Down",0.642798954881749,0.85827114240701,"B.LvsP.PARK_OSTEOBLAST_DIFFERENTIATION_BY_PHENYLAMIL_DN"
140,"Up",0.643087504871321,0.85827114240701,"B.LvsP.MCCLUNG_COCAINE_REWARD_5D"
80,"Up",0.643191058011722,0.85827114240701,"B.LvsP.SU_PANCREAS"
161,"Down",0.643272029492608,0.85827114240701,"B.LvsP.REACTOME_HCMV_EARLY_EVENTS"
19,"Down",0.643276472080783,0.85827114240701,"B.LvsP.BIOCARTA_SET_PATHWAY"
74,"Up",0.643575112473437,0.858371650529225,"B.LvsP.FUJII_YBX1_TARGETS_UP"
56,"Down",0.643714605537298,0.858371650529225,"B.LvsP.BARRIER_COLON_CANCER_RECURRENCE_UP"
10,"Down",0.643817550143733,0.858371650529225,"B.LvsP.BIOCARTA_STAT3_PATHWAY"
29,"Down",0.644143067411124,0.858598606488935,"B.LvsP.BIOCARTA_BARR_MAPK_PATHWAY"
917,"Up",0.644768951071949,0.859077253865918,"B.LvsP.CHICAS_RB1_TARGETS_CONFLUENT"
128,"Up",0.644812914368522,0.859077253865918,"B.LvsP.TIEN_INTESTINE_PROBIOTICS_2HR_DN"
59,"Down",0.64566208486619,0.859757820079353,"B.LvsP.GYORFFY_MITOXANTRONE_RESISTANCE"
38,"Down",0.645733901825877,0.859757820079353,"B.LvsP.MALTA_CURATED_STEMNESS_MARKERS"
21,"Down",0.645790238160527,0.859757820079353,"B.LvsP.REACTOME_TNF_RECEPTOR_SUPERFAMILY_TNFSF_MEMBERS_MEDIATING_NON_CANONICAL_NF_KB_PATHWAY"
56,"Up",0.64602586039206,0.859864463675421,"B.LvsP.DAVIES_MULTIPLE_MYELOMA_VS_MGUS_UP"
58,"Up",0.646469328338235,0.86024718770762,"B.LvsP.REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION"
47,"Up",0.646624581680751,0.86024718770762,"B.LvsP.MIKKELSEN_MCV6_LCP_WITH_H3K27ME3"
7,"Down",0.646970847249332,0.860349934101108,"B.LvsP.REACTOME_NGF_INDEPENDANT_TRKA_ACTIVATION"
39,"Down",0.647013026947442,0.860349934101108,"B.LvsP.HASLINGER_B_CLL_WITH_MUTATED_VH_GENES"
30,"Up",0.647302026420312,0.860527267150254,"B.LvsP.HOLLEMAN_ASPARAGINASE_RESISTANCE_ALL_DN"
349,"Up",0.647693088467918,0.860809745278254,"B.LvsP.MIKKELSEN_MEF_ICP_WITH_H3K27ME3"
25,"Up",0.647826422101323,0.860809745278254,"B.LvsP.MOOTHA_GLYCOGEN_METABOLISM"
31,"Down",0.647981580728539,0.860809745278254,"B.LvsP.BIOCARTA_MTOR_PATHWAY"
14,"Down",0.648284717266309,0.860863806179395,"B.LvsP.REACTOME_RUNX1_AND_FOXP3_CONTROL_THE_DEVELOPMENT_OF_REGULATORY_T_LYMPHOCYTES_TREGS"
222,"Down",0.648333674973955,0.860863806179395,"B.LvsP.DER_IFN_BETA_RESPONSE_UP"
334,"Up",0.649120767411556,0.861234054118515,"B.LvsP.VERHAAK_GLIOBLASTOMA_PRONEURAL"
9,"Up",0.649130376529161,0.861234054118515,"B.LvsP.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_2"
185,"Down",0.649244907137492,0.861234054118515,"B.LvsP.GROSS_HYPOXIA_VIA_HIF1A_DN"
337,"Down",0.649471830766468,0.861234054118515,"B.LvsP.HOLLERN_SQUAMOUS_BREAST_TUMOR"
324,"Down",0.649530425322768,0.861234054118515,"B.LvsP.SERVITJA_LIVER_HNF1A_TARGETS_DN"
24,"Up",0.64954711623697,0.861234054118515,"B.LvsP.INAMURA_LUNG_CANCER_SCC_DN"
17,"Down",0.649851484348769,0.861337391076012,"B.LvsP.SUZUKI_CTCFL_TARGETS_UP"
13,"Down",0.649936624266436,0.861337391076012,"B.LvsP.FUNG_IL2_SIGNALING_2"
81,"Down",0.650181407444065,0.861455308353279,"B.LvsP.KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN"
892,"Up",0.650634099378382,0.861631409616852,"B.LvsP.IVANOVA_HEMATOPOIESIS_STEM_CELL_AND_PROGENITOR"
59,"Up",0.650726066408354,0.861631409616852,"B.LvsP.VALK_AML_CLUSTER_4"
17,"Down",0.650781835152826,0.861631409616852,"B.LvsP.FUJIWARA_PARK2_IN_LIVER_CANCER_DN"
47,"Down",0.651670073952814,0.862577367274152,"B.LvsP.YAGI_AML_RELAPSE_PROGNOSIS"
24,"Down",0.651808327088336,0.862577367274152,"B.LvsP.HASINA_NOL7_TARGETS_DN"
260,"Up",0.652196281807382,0.86288424075449,"B.LvsP.INGRAM_SHH_TARGETS_UP"
494,"Down",0.652426253272495,0.862886993323127,"B.LvsP.REACTOME_G_ALPHA_I_SIGNALLING_EVENTS"
55,"Down",0.652510493594501,0.862886993323127,"B.LvsP.STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_DN"
152,"Down",0.652928575776652,0.863039402370257,"B.LvsP.RIGGINS_TAMOXIFEN_RESISTANCE_UP"
13,"Up",0.652937930930509,0.863039402370257,"B.LvsP.REACTOME_GLUTATHIONE_SYNTHESIS_AND_RECYCLING"
39,"Down",0.653345357699051,0.863371530286342,"B.LvsP.REACTOME_N_GLYCAN_TRIMMING_IN_THE_ER_AND_CALNEXIN_CALRETICULIN_CYCLE"
150,"Down",0.653579469557464,0.863474525013912,"B.LvsP.BURTON_ADIPOGENESIS_PEAK_AT_0HR"
27,"Down",0.65394651973142,0.863753059626139,"B.LvsP.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_CYAN_UP"
9,"Up",0.654761933108994,0.864114562546907,"B.LvsP.REACTOME_ACTIVATED_NTRK2_SIGNALS_THROUGH_CDK5"
63,"Down",0.654985637809551,0.864114562546907,"B.LvsP.TRAYNOR_RETT_SYNDROM_UP"
8,"Up",0.655000187104797,0.864114562546907,"B.LvsP.BIOCARTA_ION_PATHWAY"
39,"Down",0.655280140699907,0.864114562546907,"B.LvsP.MCCABE_HOXC6_TARGETS_DN"
56,"Up",0.655285495653457,0.864114562546907,"B.LvsP.MURAKAMI_UV_RESPONSE_6HR_UP"
19,"Up",0.655586243205816,0.864114562546907,"B.LvsP.HOFFMAN_CLOCK_TARGETS_UP"
72,"Down",0.655612941321971,0.864114562546907,"B.LvsP.DAZARD_UV_RESPONSE_CLUSTER_G4"
57,"Up",0.655760452253605,0.864114562546907,"B.LvsP.DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY"
16,"Up",0.655820421183803,0.864114562546907,"B.LvsP.BIOCARTA_AGPCR_PATHWAY"
38,"Up",0.655896500288771,0.864114562546907,"B.LvsP.PID_S1P_S1P3_PATHWAY"
18,"Up",0.655939377646838,0.864114562546907,"B.LvsP.BIOCARTA_MRP_PATHWAY"
50,"Up",0.656268375052266,0.86415019661416,"B.LvsP.BERENJENO_TRANSFORMED_BY_RHOA_REVERSIBLY_DN"
34,"Down",0.656279015298039,0.86415019661416,"B.LvsP.REACTOME_SIGNALING_BY_BMP"
13,"Up",0.656750571961262,0.864497555295282,"B.LvsP.LIU_TARGETS_OF_VMYB_VS_CMYB_UP"
35,"Up",0.656855530800412,0.864497555295282,"B.LvsP.TERAMOTO_OPN_TARGETS_CLUSTER_6"
41,"Up",0.65707095551119,0.864575276778051,"B.LvsP.REACTOME_MISCELLANEOUS_SUBSTRATES"
73,"Down",0.657524831359104,0.864966641109799,"B.LvsP.CHESLER_BRAIN_HIGHEST_GENETIC_VARIANCE"
12,"Down",0.658293862717961,0.865772304226357,"B.LvsP.LY_AGING_OLD_UP"
227,"Up",0.658855793204953,0.866103768865359,"B.LvsP.SUNG_METASTASIS_STROMA_UP"
59,"Up",0.659089264604544,0.866103768865359,"B.LvsP.REACTOME_TRANSCRIPTIONAL_REGULATION_OF_PLURIPOTENT_STEM_CELLS"
135,"Up",0.659453045638109,0.866103768865359,"B.LvsP.SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_UP"
13,"Down",0.659519254260897,0.866103768865359,"B.LvsP.MIKKELSEN_NPC_ICP_WITH_H3K27ME3"
10,"Down",0.65953383783314,0.866103768865359,"B.LvsP.REACTOME_ORGANIC_ANION_TRANSPORTERS"
314,"Down",0.659569622804607,0.866103768865359,"B.LvsP.REACTOME_BIOLOGICAL_OXIDATIONS"
303,"Up",0.659642425518543,0.866103768865359,"B.LvsP.REACTOME_CHROMATIN_MODIFYING_ENZYMES"
116,"Down",0.659806665210012,0.866113735029951,"B.LvsP.REACTOME_POST_TRANSLATIONAL_MODIFICATION_SYNTHESIS_OF_GPI_ANCHORED_PROTEINS"
34,"Up",0.659973477737803,0.866124343395998,"B.LvsP.REACTOME_VEGFR2_MEDIATED_VASCULAR_PERMEABILITY"
127,"Up",0.660128049027082,0.866124343395998,"B.LvsP.SANA_TNF_SIGNALING_DN"
36,"Up",0.660486403037032,0.866187991839958,"B.LvsP.AMUNDSON_DNA_DAMAGE_RESPONSE_TP53"
12,"Down",0.660489884897317,0.866187991839958,"B.LvsP.SHIRAISHI_PLZF_TARGETS_DN"
128,"Down",0.660657651510725,0.866202550439364,"B.LvsP.BOYLAN_MULTIPLE_MYELOMA_D_UP"
10,"Up",0.66084596950669,0.86624404111012,"B.LvsP.WEBER_METHYLATED_LCP_IN_SPERM_DN"
94,"Up",0.661151923988317,0.866439674740793,"B.LvsP.SESTO_RESPONSE_TO_UV_C2"
51,"Up",0.661444125515921,0.866617196677139,"B.LvsP.PLASARI_NFIC_TARGETS_BASAL_DN"
474,"Down",0.661931690414248,0.866702151095121,"B.LvsP.RIZKI_TUMOR_INVASIVENESS_3D_DN"
22,"Up",0.661935512531195,0.866702151095121,"B.LvsP.MEISSNER_NPC_ICP_WITH_H3K4ME3"
26,"Down",0.66205539724449,0.866702151095121,"B.LvsP.NIKOLSKY_BREAST_CANCER_6P24_P22_AMPLICON"
41,"Up",0.662265985781727,0.866702151095121,"B.LvsP.WU_ALZHEIMER_DISEASE_UP"
41,"Down",0.662292745230039,0.866702151095121,"B.LvsP.REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS"
886,"Up",0.663456502614573,0.868018890790036,"B.LvsP.STEIN_ESRRA_TARGETS"
101,"Up",0.663866778204469,0.868018890790036,"B.LvsP.REACTOME_PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES"
145,"Up",0.663917739495213,0.868018890790036,"B.LvsP.CROMER_METASTASIS_DN"
84,"Down",0.664040004972851,0.868018890790036,"B.LvsP.KEGG_PANCREATIC_CANCER"
356,"Down",0.664210304077901,0.868018890790036,"B.LvsP.LEE_RECENT_THYMIC_EMIGRANT"
893,"Down",0.66424089834195,0.868018890790036,"B.LvsP.ENK_UV_RESPONSE_EPIDERMIS_DN"
20,"Down",0.664703956274697,0.868122298773798,"B.LvsP.REACTOME_FORMATION_OF_SENESCENCE_ASSOCIATED_HETEROCHROMATIN_FOCI_SAHF"
10,"Down",0.664809720938703,0.868122298773798,"B.LvsP.REACTOME_THYROXINE_BIOSYNTHESIS"
30,"Up",0.664819610030715,0.868122298773798,"B.LvsP.REACTOME_ZBP1_DAI_MEDIATED_INDUCTION_OF_TYPE_I_IFNS"
969,"Up",0.664948080178519,0.868122298773798,"B.LvsP.RAO_BOUND_BY_SALL4_ISOFORM_B"
86,"Up",0.665257449679963,0.868132813963441,"B.LvsP.PID_HNF3A_PATHWAY"
271,"Down",0.665270163277826,0.868132813963441,"B.LvsP.REACTOME_NEDDYLATION"
654,"Down",0.665693979847811,0.868480890650908,"B.LvsP.THUM_SYSTOLIC_HEART_FAILURE_UP"
334,"Down",0.666141063829116,0.868859151193957,"B.LvsP.KIM_WT1_TARGETS_UP"
38,"Down",0.666576902014366,0.869222568688072,"B.LvsP.BIOCARTA_BARRESTIN_SRC_PATHWAY"
406,"Down",0.66682967578615,0.869347153365156,"B.LvsP.MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN"
161,"Up",0.666992969316227,0.869355051237487,"B.LvsP.REACTOME_CARDIAC_CONDUCTION"
123,"Up",0.667321047830626,0.869577674630103,"B.LvsP.KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_UP"
33,"Down",0.667986192952669,0.870202393385205,"B.LvsP.PIEPOLI_LGI1_TARGETS_UP"
34,"Down",0.668115239631072,0.870202393385205,"B.LvsP.RUAN_RESPONSE_TO_TROGLITAZONE_UP"
38,"Down",0.66865086500372,0.870574366908565,"B.LvsP.VALK_AML_WITH_11Q23_REARRANGED"
47,"Down",0.668734002067805,0.870574366908565,"B.LvsP.REACTOME_SYNTHESIS_OF_LEUKOTRIENES_LT_AND_EOXINS_EX"
32,"Up",0.668873197798442,0.870574366908565,"B.LvsP.PID_RHODOPSIN_PATHWAY"
14,"Down",0.669114676135628,0.870683700718731,"B.LvsP.BIOCARTA_DSP_PATHWAY"
23,"Down",0.66928493548318,0.87070033136153,"B.LvsP.BIOCARTA_MITOCHONDRIA_PATHWAY"
126,"Up",0.669644501497737,0.870963173084212,"B.LvsP.YAO_HOXA10_TARGETS_VIA_PROGESTERONE_UP"
455,"Up",0.669847367079254,0.871022129017214,"B.LvsP.RAO_BOUND_BY_SALL4"
46,"Up",0.670349676323543,0.871366641013225,"B.LvsP.ONGUSAHA_TP53_TARGETS"
671,"Down",0.670713126591286,0.871366641013225,"B.LvsP.PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_7"
57,"Up",0.670773416384708,0.871366641013225,"B.LvsP.NAKAMURA_ADIPOGENESIS_LATE_DN"
73,"Up",0.670793002190958,0.871366641013225,"B.LvsP.REACTOME_SIGNALING_BY_ERBB4"
23,"Down",0.670900305804539,0.871366641013225,"B.LvsP.SA_TRKA_RECEPTOR"
16,"Down",0.671540121053192,0.871645622558397,"B.LvsP.REACTOME_ATF6_ATF6_ALPHA_ACTIVATES_CHAPERONE_GENES"
13,"Down",0.671642636903521,0.871645622558397,"B.LvsP.REACTOME_GAP_JUNCTION_DEGRADATION"
110,"Down",0.671814913557767,0.871645622558397,"B.LvsP.OHGUCHI_LIVER_HNF4A_TARGETS_UP"
14,"Down",0.671884472589032,0.871645622558397,"B.LvsP.REACTOME_DEFECTIVE_EXT2_CAUSES_EXOSTOSES_2"
115,"Down",0.671903353833223,0.871645622558397,"B.LvsP.REACTOME_PROTEIN_FOLDING"
19,"Up",0.672074101898618,0.871662610696096,"B.LvsP.YANG_BCL3_TARGETS_DN"
36,"Up",0.672325524073435,0.871762682062186,"B.LvsP.BIOCARTA_TFF_PATHWAY"
227,"Down",0.672615887424429,0.871762682062186,"B.LvsP.REACTOME_FCGR3A_MEDIATED_IL10_SYNTHESIS"
308,"Up",0.672669935002324,0.871762682062186,"B.LvsP.BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_TRANS"
61,"Up",0.672796064059363,0.871762682062186,"B.LvsP.KEGG_GLYCEROLIPID_METABOLISM"
15,"Up",0.673178514435396,0.871762682062186,"B.LvsP.REACTOME_DOWNREGULATION_OF_ERBB4_SIGNALING"
978,"Down",0.673230702656614,0.871762682062186,"B.LvsP.MILI_PSEUDOPODIA_HAPTOTAXIS_DN"
62,"Down",0.673254956123265,0.871762682062186,"B.LvsP.REACTOME_SIGNALING_BY_SCF_KIT"
161,"Up",0.673528250425528,0.871912361648968,"B.LvsP.SESTO_RESPONSE_TO_UV_C8"
9,"Down",0.674198156338382,0.872575282395813,"B.LvsP.REACTOME_TRAIL_SIGNALING"
106,"Down",0.674962989659846,0.873205326446147,"B.LvsP.KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450"
104,"Down",0.675059351708782,0.873205326446147,"B.LvsP.BARIS_THYROID_CANCER_DN"
181,"Down",0.675158757561454,0.873205326446147,"B.LvsP.PID_P53_DOWNSTREAM_PATHWAY"
131,"Up",0.675494250252067,0.873434918064471,"B.LvsP.DITTMER_PTHLH_TARGETS_DN"
76,"Up",0.676021505089663,0.873572811532749,"B.LvsP.BIOCARTA_HIVNEF_PATHWAY"
588,"Up",0.676204777461717,0.873572811532749,"B.LvsP.HUTTMANN_B_CLL_POOR_SURVIVAL_UP"
19,"Up",0.676349162949976,0.873572811532749,"B.LvsP.REACTOME_REGULATION_OF_IFNG_SIGNALING"
67,"Up",0.676418390109874,0.873572811532749,"B.LvsP.PID_EPHB_FWD_PATHWAY"
48,"Up",0.676471688272558,0.873572811532749,"B.LvsP.PID_HIV_NEF_PATHWAY"
26,"Down",0.676548883881937,0.873572811532749,"B.LvsP.BIOCARTA_BARRESTIN_PATHWAY"
289,"Down",0.678215191526503,0.875220504059052,"B.LvsP.NABA_CORE_MATRISOME"
115,"Down",0.678285273455031,0.875220504059052,"B.LvsP.SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE"
33,"Down",0.678299848054447,0.875220504059052,"B.LvsP.GHO_ATF5_TARGETS_DN"
9,"Down",0.678685213704299,0.87551342663814,"B.LvsP.FUJIWARA_PARK2_IN_LIVER_CANCER_UP"
44,"Up",0.678980254911452,0.875689719945281,"B.LvsP.MACLACHLAN_BRCA1_TARGETS_DN"
143,"Up",0.679695310213474,0.87631418414106,"B.LvsP.KEGG_NEUROTROPHIN_SIGNALING_PATHWAY"
266,"Up",0.679781431684031,0.87631418414106,"B.LvsP.KIM_RESPONSE_TO_TSA_AND_DECITABINE_UP"
1007,"Down",0.680242349977407,0.876349241156714,"B.LvsP.MARTINEZ_RB1_AND_TP53_TARGETS_DN"
127,"Up",0.680721338856756,0.876349241156714,"B.LvsP.CARD_MIR302A_TARGETS"
33,"Up",0.680964314457727,0.876349241156714,"B.LvsP.REACTOME_REGULATION_OF_SIGNALING_BY_CBL"
28,"Up",0.680994706805923,0.876349241156714,"B.LvsP.RAMPON_ENRICHED_LEARNING_ENVIRONMENT_EARLY_UP"
149,"Up",0.681013648387451,0.876349241156714,"B.LvsP.KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS"
163,"Down",0.681065438918888,0.876349241156714,"B.LvsP.TAYLOR_METHYLATED_IN_ACUTE_LYMPHOBLASTIC_LEUKEMIA"
130,"Down",0.681142490556693,0.876349241156714,"B.LvsP.PID_ERA_GENOMIC_PATHWAY"
137,"Up",0.681194001775455,0.876349241156714,"B.LvsP.KRASNOSELSKAYA_ILF3_TARGETS_UP"
103,"Down",0.681235130853962,0.876349241156714,"B.LvsP.WESTON_VEGFA_TARGETS_3HR"
68,"Down",0.681478560951535,0.876458470225875,"B.LvsP.VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_DN"
36,"Down",0.681654331229549,0.876472244541979,"B.LvsP.BARIS_THYROID_CANCER_UP"
33,"Down",0.682145750679487,0.876472244541979,"B.LvsP.HASLINGER_B_CLL_WITH_CHROMOSOME_12_TRISOMY"
170,"Down",0.682207525592949,0.876472244541979,"B.LvsP.KAYO_CALORIE_RESTRICTION_MUSCLE_DN"
72,"Down",0.682249354531975,0.876472244541979,"B.LvsP.ZHAN_MULTIPLE_MYELOMA_LB_UP"
11,"Down",0.68228188470043,0.876472244541979,"B.LvsP.REACTOME_CDC6_ASSOCIATION_WITH_THE_ORC_ORIGIN_COMPLEX"
25,"Up",0.682948529248045,0.877124835821706,"B.LvsP.BIOCARTA_ERK5_PATHWAY"
12,"Up",0.683902269377986,0.878098881258406,"B.LvsP.REACTOME_FREE_FATTY_ACIDS_REGULATE_INSULIN_SECRETION"
140,"Down",0.684024576158429,0.878098881258406,"B.LvsP.LEIN_PONS_MARKERS"
190,"Down",0.684202146364574,0.878122949686566,"B.LvsP.KEGG_CALCIUM_SIGNALING_PATHWAY"
168,"Down",0.684920119583958,0.878735714065548,"B.LvsP.KANG_IMMORTALIZED_BY_TERT_UP"
34,"Down",0.685062154111477,0.878735714065548,"B.LvsP.REACTOME_MITOPHAGY"
23,"Up",0.685379830631536,0.878735714065548,"B.LvsP.REACTOME_THE_NLRP3_INFLAMMASOME"
614,"Down",0.68557069933004,0.878735714065548,"B.LvsP.RUTELLA_RESPONSE_TO_HGF_UP"
58,"Down",0.685618946227682,0.878735714065548,"B.LvsP.PARK_HSC_MARKERS"
207,"Up",0.685860470465981,0.878735714065548,"B.LvsP.MCCLUNG_CREB1_TARGETS_UP"
462,"Up",0.685876095265337,0.878735714065548,"B.LvsP.MULLIGHAN_MLL_SIGNATURE_2_DN"
11,"Up",0.686067630153166,0.878735714065548,"B.LvsP.REACTOME_MISSPLICED_LRP5_MUTANTS_HAVE_ENHANCED_BETA_CATENIN_DEPENDENT_SIGNALING"
252,"Down",0.686325764964939,0.878735714065548,"B.LvsP.HUANG_GATA2_TARGETS_UP"
415,"Down",0.686387531051046,0.878735714065548,"B.LvsP.REACTOME_RHO_GTPASE_EFFECTORS"
209,"Up",0.686427843922789,0.878735714065548,"B.LvsP.KAYO_CALORIE_RESTRICTION_MUSCLE_UP"
30,"Down",0.687221534320984,0.879548116495537,"B.LvsP.REACTOME_CONSTITUTIVE_SIGNALING_BY_LIGAND_RESPONSIVE_EGFR_CANCER_VARIANTS"
12,"Up",0.687881819517514,0.88008899807164,"B.LvsP.REACTOME_NETRIN_MEDIATED_REPULSION_SIGNALS"
463,"Up",0.687962497678717,0.88008899807164,"B.LvsP.BRUINS_UVC_RESPONSE_EARLY_LATE"
8,"Down",0.689412939119602,0.881535528555779,"B.LvsP.IWANAGA_E2F1_TARGETS_NOT_INDUCED_BY_SERUM"
238,"Down",0.689438221988783,0.881535528555779,"B.LvsP.LI_INDUCED_T_TO_NATURAL_KILLER_DN"
37,"Down",0.689967338178529,0.881535528555779,"B.LvsP.REACTOME_SYNTHESIS_OF_16_20_HYDROXYEICOSATETRAENOIC_ACIDS_HETE"
59,"Down",0.690033125988344,0.881535528555779,"B.LvsP.CAFFAREL_RESPONSE_TO_THC_UP"
8,"Down",0.690038748625086,0.881535528555779,"B.LvsP.REACTOME_SYNTHESIS_OF_UDP_N_ACETYL_GLUCOSAMINE"
87,"Down",0.690049876576128,0.881535528555779,"B.LvsP.KEGG_TASTE_TRANSDUCTION"
344,"Up",0.690574281631546,0.882001663927193,"B.LvsP.DOANE_RESPONSE_TO_ANDROGEN_UP"
22,"Up",0.691072421473718,0.882434045803276,"B.LvsP.REACTOME_GRB2_SOS_PROVIDES_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS"
19,"Down",0.691504099807525,0.882781382552715,"B.LvsP.KEGG_ONE_CARBON_POOL_BY_FOLATE"
115,"Up",0.692185546829276,0.883447342663681,"B.LvsP.MORI_SMALL_PRE_BII_LYMPHOCYTE_UP"
54,"Down",0.693032769440517,0.883543243239009,"B.LvsP.LEE_CALORIE_RESTRICTION_MUSCLE_UP"
26,"Up",0.693489436696553,0.883543243239009,"B.LvsP.SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX1_UP"
43,"Up",0.693541138332942,0.883543243239009,"B.LvsP.BIOCARTA_AT1R_PATHWAY"
456,"Down",0.693589886026988,0.883543243239009,"B.LvsP.CAIRO_HEPATOBLASTOMA_DN"
162,"Down",0.693671708166962,0.883543243239009,"B.LvsP.HOEBEKE_LYMPHOID_STEM_CELL_UP"
16,"Down",0.693740027057458,0.883543243239009,"B.LvsP.ZHOU_PANCREATIC_EXOCRINE_PROGENITOR"
39,"Down",0.693816040530209,0.883543243239009,"B.LvsP.REACTOME_ONCOGENE_INDUCED_SENESCENCE"
11,"Down",0.693902626644533,0.883543243239009,"B.LvsP.REACTOME_REMOVAL_OF_THE_FLAP_INTERMEDIATE_FROM_THE_C_STRAND"
12,"Down",0.6941054131418,0.883543243239009,"B.LvsP.BIOCARTA_RECK_PATHWAY"
8,"Up",0.694131088473563,0.883543243239009,"B.LvsP.BIOCARTA_WNT_LRP6_PATHWAY"
91,"Up",0.694163878428609,0.883543243239009,"B.LvsP.FARMER_BREAST_CANCER_CLUSTER_1"
31,"Up",0.694267550554593,0.883543243239009,"B.LvsP.GRANDVAUX_IRF3_TARGETS_UP"
8,"Down",0.694485219863407,0.883543243239009,"B.LvsP.REACTOME_RUNX3_REGULATES_BCL2L11_BIM_TRANSCRIPTION"
27,"Down",0.694603031244395,0.883543243239009,"B.LvsP.REACTOME_GASTRIN_CREB_SIGNALLING_PATHWAY_VIA_PKC_AND_MAPK"
26,"Down",0.694657709958396,0.883543243239009,"B.LvsP.SA_G1_AND_S_PHASES"
58,"Up",0.695308732072371,0.884167888598928,"B.LvsP.LI_CISPLATIN_RESISTANCE_DN"
11,"Down",0.696108176363305,0.884941058598207,"B.LvsP.REACTOME_MAPK1_ERK2_ACTIVATION"
21,"Up",0.696501522585645,0.884941058598207,"B.LvsP.REACTOME_P130CAS_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS"
110,"Down",0.69701288424914,0.884941058598207,"B.LvsP.REACTOME_POTASSIUM_CHANNELS"
373,"Up",0.69704979402971,0.884941058598207,"B.LvsP.RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_UP"
56,"Down",0.69710567593851,0.884941058598207,"B.LvsP.MARTIN_INTERACT_WITH_HDAC"
10,"Up",0.697164216212683,0.884941058598207,"B.LvsP.PID_VEGF_VEGFR_PATHWAY"
94,"Down",0.697185910525112,0.884941058598207,"B.LvsP.NAKAMURA_ADIPOGENESIS_EARLY_UP"
55,"Up",0.697217904111767,0.884941058598207,"B.LvsP.CHEN_LUNG_CANCER_SURVIVAL"
546,"Down",0.697357242234109,0.884941058598207,"B.LvsP.ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_UP"
153,"Up",0.698021650416978,0.885510851677938,"B.LvsP.HUANG_DASATINIB_RESISTANCE_UP"
77,"Down",0.698329770622732,0.885510851677938,"B.LvsP.PID_HES_HEY_PATHWAY"
8,"Up",0.698803212271875,0.885510851677938,"B.LvsP.REACTOME_TYSND1_CLEAVES_PEROXISOMAL_PROTEINS"
31,"Up",0.698909147518165,0.885510851677938,"B.LvsP.BIOCARTA_AKT_PATHWAY"
36,"Up",0.698968251506138,0.885510851677938,"B.LvsP.KEGG_PROPANOATE_METABOLISM"
20,"Up",0.698975789732008,0.885510851677938,"B.LvsP.YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_4"
77,"Up",0.699071866370569,0.885510851677938,"B.LvsP.MELLMAN_TUT1_TARGETS_DN"
140,"Down",0.699188755336626,0.885510851677938,"B.LvsP.DUAN_PRDM5_TARGETS"
25,"Up",0.699247671988764,0.885510851677938,"B.LvsP.FINETTI_BREAST_CANCERS_KINOME_GRAY"
96,"Down",0.700213237445863,0.886530567858524,"B.LvsP.HUANG_DASATINIB_RESISTANCE_DN"
39,"Down",0.700451747685515,0.886629513038738,"B.LvsP.REACTOME_NOTCH3_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION"
312,"Down",0.700859202750597,0.88694221378074,"B.LvsP.GERY_CEBP_TARGETS"
211,"Down",0.701317854211931,0.887319545981182,"B.LvsP.RODWELL_AGING_KIDNEY_DN"
21,"Up",0.701753487857325,0.887642395232288,"B.LvsP.REACTOME_FRS_MEDIATED_FGFR3_SIGNALING"
200,"Up",0.701982587308034,0.887642395232288,"B.LvsP.ELVIDGE_HYPOXIA_BY_DMOG_UP"
12,"Up",0.70205465623997,0.887642395232288,"B.LvsP.REACTOME_INTERLEUKIN_6_SIGNALING"
8,"Down",0.702538788571102,0.887848448459343,"B.LvsP.REACTOME_AMINO_ACID_CONJUGATION"
8,"Down",0.702538788571102,0.887848448459343,"B.LvsP.REACTOME_CONJUGATION_OF_BENZOATE_WITH_GLYCINE"
146,"Up",0.70297541863549,0.888197232549274,"B.LvsP.REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING"
29,"Down",0.703442035817653,0.888583736814211,"B.LvsP.BIOCARTA_CK1_PATHWAY"
567,"Up",0.703963917844493,0.889039858785336,"B.LvsP.PHONG_TNF_RESPONSE_NOT_VIA_P38"
18,"Up",0.704834554610346,0.889936116108839,"B.LvsP.CHIN_BREAST_CANCER_COPY_NUMBER_DN"
50,"Down",0.705308200257195,0.890298848280108,"B.LvsP.REACTOME_DAG_AND_IP3_SIGNALING"
750,"Down",0.705443887559261,0.890298848280108,"B.LvsP.ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP"
81,"Down",0.705703579208004,0.890423343094718,"B.LvsP.NEWMAN_ERCC6_TARGETS_DN"
362,"Up",0.706494272700869,0.891088519921511,"B.LvsP.REACTOME_ASPARAGINE_N_LINKED_GLYCOSYLATION"
35,"Up",0.706553096642413,0.891088519921511,"B.LvsP.GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN"
355,"Down",0.706717487202769,0.891092585346433,"B.LvsP.RIZKI_TUMOR_INVASIVENESS_3D_UP"
10,"Down",0.706961500795841,0.891103065760552,"B.LvsP.BIOCARTA_IL22BP_PATHWAY"
88,"Down",0.707280336363132,0.891103065760552,"B.LvsP.PID_RB_1PATHWAY"
342,"Up",0.707286633532164,0.891103065760552,"B.LvsP.DARWICHE_SKIN_TUMOR_PROMOTER_DN"
20,"Up",0.707370474882088,0.891103065760552,"B.LvsP.REACTOME_ENOS_ACTIVATION"
145,"Up",0.708008426075279,0.891663679631427,"B.LvsP.MORI_PRE_BI_LYMPHOCYTE_DN"
113,"Down",0.70821886527283,0.891663679631427,"B.LvsP.PID_PTP1B_PATHWAY"
317,"Down",0.708698173191678,0.891663679631427,"B.LvsP.BROWNE_HCMV_INFECTION_14HR_UP"
185,"Down",0.708750201837524,0.891663679631427,"B.LvsP.FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP"
38,"Up",0.708866841123927,0.891663679631427,"B.LvsP.HOLLEMAN_VINCRISTINE_RESISTANCE_ALL_UP"
16,"Down",0.708994912076405,0.891663679631427,"B.LvsP.REACTOME_GAMMA_CARBOXYLATION_TRANSPORT_AND_AMINO_TERMINAL_CLEAVAGE_OF_PROTEINS"
13,"Down",0.70900669416706,0.891663679631427,"B.LvsP.REACTOME_FIBRONECTIN_MATRIX_FORMATION"
65,"Up",0.709179271451759,0.891663679631427,"B.LvsP.NAKAMURA_METASTASIS_MODEL_UP"
127,"Up",0.709843401727537,0.891663679631427,"B.LvsP.REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK"
316,"Down",0.709982800510795,0.891663679631427,"B.LvsP.SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN"
34,"Down",0.710396279552409,0.891663679631427,"B.LvsP.FUJIWARA_PARK2_HEPATOCYTE_PROLIFERATION_UP"
83,"Up",0.710432374364335,0.891663679631427,"B.LvsP.CHEN_HOXA5_TARGETS_9HR_DN"
49,"Down",0.71052598562932,0.891663679631427,"B.LvsP.KEGG_ABC_TRANSPORTERS"
29,"Up",0.710733427713373,0.891663679631427,"B.LvsP.REACTOME_FRS_MEDIATED_FGFR2_SIGNALING"
28,"Up",0.710793734610909,0.891663679631427,"B.LvsP.TOMLINS_METASTASIS_DN"
1026,"Down",0.710947018103677,0.891663679631427,"B.LvsP.GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN"
19,"Up",0.710958387239534,0.891663679631427,"B.LvsP.REACTOME_ACTIVATION_OF_IRF3_IRF7_MEDIATED_BY_TBK1_IKK_EPSILON"
18,"Down",0.71126033714801,0.891663679631427,"B.LvsP.REACTOME_ACTIVATION_OF_BAD_AND_TRANSLOCATION_TO_MITOCHONDRIA"
76,"Up",0.711267885288035,0.891663679631427,"B.LvsP.HAHTOLA_MYCOSIS_FUNGOIDES_UP"
493,"Down",0.711309818311672,0.891663679631427,"B.LvsP.ROZANOV_MMP14_TARGETS_UP"
67,"Up",0.711530417631792,0.891663679631427,"B.LvsP.REACTOME_SIGNALING_BY_EGFR"
5,"Down",0.711753725578931,0.891663679631427,"B.LvsP.REACTOME_LEUKOTRIENE_RECEPTORS"
23,"Up",0.711836597323317,0.891663679631427,"B.LvsP.PID_SYNDECAN_3_PATHWAY"
745,"Down",0.711978102130966,0.891663679631427,"B.LvsP.MEISSNER_NPC_HCP_WITH_H3K4ME2"
59,"Up",0.712077904956266,0.891663679631427,"B.LvsP.HOLLEMAN_VINCRISTINE_RESISTANCE_B_ALL_UP"
62,"Up",0.712217541375286,0.891663679631427,"B.LvsP.SUBTIL_PROGESTIN_TARGETS"
25,"Up",0.712245121113935,0.891663679631427,"B.LvsP.GENTILE_UV_RESPONSE_CLUSTER_D1"
137,"Down",0.712331067631039,0.891663679631427,"B.LvsP.BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_C"
24,"Up",0.712898465993206,0.891993107586438,"B.LvsP.LIU_TOPBP1_TARGETS"
80,"Up",0.712916900420414,0.891993107586438,"B.LvsP.KERLEY_RESPONSE_TO_CISPLATIN_UP"
153,"Up",0.713565478882279,0.892219800165032,"B.LvsP.DE_YY1_TARGETS_DN"
305,"Up",0.713836210969807,0.892219800165032,"B.LvsP.REACTOME_FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS"
8,"Down",0.713845068050453,0.892219800165032,"B.LvsP.REACTOME_OPSINS"
131,"Down",0.713858688770739,0.892219800165032,"B.LvsP.SMID_BREAST_CANCER_RELAPSE_IN_LUNG_UP"
22,"Up",0.713999156928788,0.892219800165032,"B.LvsP.REACTOME_TIE2_SIGNALING"
14,"Up",0.714417321880547,0.892219800165032,"B.LvsP.REACTOME_POU5F1_OCT4_SOX2_NANOG_REPRESS_GENES_RELATED_TO_DIFFERENTIATION"
53,"Up",0.714602060884127,0.892219800165032,"B.LvsP.WANG_METASTASIS_OF_BREAST_CANCER_ESR1_DN"
208,"Up",0.714728637523562,0.892219800165032,"B.LvsP.PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN"
225,"Down",0.714778097190038,0.892219800165032,"B.LvsP.PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_DN"
36,"Up",0.714983326472902,0.892219800165032,"B.LvsP.REACTOME_GLUCAGON_TYPE_LIGAND_RECEPTORS"
50,"Up",0.71501648062616,0.892219800165032,"B.LvsP.WU_ALZHEIMER_DISEASE_DN"
65,"Down",0.715034533284727,0.892219800165032,"B.LvsP.GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_UP"
50,"Down",0.71526380015809,0.892304501596137,"B.LvsP.REACTOME_G_ALPHA_Z_SIGNALLING_EVENTS"
92,"Down",0.715678739462519,0.892581519483243,"B.LvsP.JIANG_AGING_CEREBRAL_CORTEX_DN"
185,"Up",0.715964625309807,0.892581519483243,"B.LvsP.REACTOME_AMYLOID_FIBER_FORMATION"
173,"Up",0.716042010984598,0.892581519483243,"B.LvsP.LIM_MAMMARY_LUMINAL_MATURE_DN"
24,"Up",0.716184046188225,0.892581519483243,"B.LvsP.BIOCARTA_ATRBRCA_PATHWAY"
90,"Down",0.716389638317182,0.892581519483243,"B.LvsP.TENEDINI_MEGAKARYOCYTE_MARKERS"
246,"Up",0.716454473406879,0.892581519483243,"B.LvsP.SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_UP"
10,"Down",0.716860315407542,0.892885939150327,"B.LvsP.REACTOME_MULTIFUNCTIONAL_ANION_EXCHANGERS"
164,"Up",0.717365263671953,0.893313635775276,"B.LvsP.ZHU_CMV_24_HR_DN"
34,"Down",0.717674078233481,0.893496955314775,"B.LvsP.YANAGISAWA_LUNG_CANCER_RECURRENCE"
141,"Up",0.718353615470409,0.89391946858791,"B.LvsP.FRIDMAN_SENESCENCE_UP"
10,"Down",0.7185608314859,0.89391946858791,"B.LvsP.KAPOSI_LIVER_CANCER_MET_DN"
39,"Up",0.718569467231939,0.89391946858791,"B.LvsP.BUCKANOVICH_T_LYMPHOCYTE_HOMING_ON_TUMOR_UP"
35,"Up",0.718759750818577,0.89391946858791,"B.LvsP.NABA_PROTEOGLYCANS"
379,"Up",0.718982666284669,0.89391946858791,"B.LvsP.PHONG_TNF_RESPONSE_VIA_P38_COMPLETE"
49,"Down",0.719068675626793,0.89391946858791,"B.LvsP.KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_4NQO_IN_WS"
142,"Up",0.719302849383547,0.89391946858791,"B.LvsP.BROWNE_INTERFERON_RESPONSIVE_GENES"
96,"Down",0.719444016813958,0.89391946858791,"B.LvsP.PETROVA_PROX1_TARGETS_DN"
5,"Up",0.719689019313642,0.89391946858791,"B.LvsP.REACTOME_TOXICITY_OF_BOTULINUM_TOXIN_TYPE_D_BONT_D"
20,"Up",0.719705590034224,0.89391946858791,"B.LvsP.REACTOME_ACTIVATION_OF_THE_PHOTOTRANSDUCTION_CASCADE"
15,"Down",0.719791910680661,0.89391946858791,"B.LvsP.COLLIS_PRKDC_REGULATORS"
61,"Up",0.720161810674425,0.894178003866808,"B.LvsP.PID_CERAMIDE_PATHWAY"
10,"Up",0.720464494187128,0.894352983466688,"B.LvsP.TURASHVILI_BREAST_CARCINOMA_DUCTAL_VS_LOBULAR_DN"
159,"Up",0.720847187858232,0.894627183314963,"B.LvsP.ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN"
147,"Up",0.721019708956317,0.894640478191086,"B.LvsP.CHEN_LIVER_METABOLISM_QTL_CIS"
33,"Up",0.721343140782894,0.894780593098796,"B.LvsP.TURASHVILI_BREAST_CARCINOMA_DUCTAL_VS_LOBULAR_UP"
110,"Down",0.721456300241352,0.894780593098796,"B.LvsP.TOOKER_GEMCITABINE_RESISTANCE_UP"
93,"Up",0.721833408622095,0.89504752551504,"B.LvsP.KEGG_FC_EPSILON_RI_SIGNALING_PATHWAY"
35,"Down",0.72205127901707,0.895116933113314,"B.LvsP.REACTOME_FORMATION_OF_THE_EARLY_ELONGATION_COMPLEX"
1622,"Down",0.722365249799497,0.895305417202739,"B.LvsP.BENPORATH_ES_WITH_H3K27ME3"
26,"Down",0.722735324583035,0.895474185624902,"B.LvsP.REACTOME_ACTIVATED_TAK1_MEDIATES_P38_MAPK_ACTIVATION"
22,"Up",0.722825337392646,0.895474185624902,"B.LvsP.PETRETTO_BLOOD_PRESSURE_UP"
44,"Up",0.723910019868135,0.89628905430305,"B.LvsP.YANG_BREAST_CANCER_ESR1_LASER_UP"
371,"Down",0.723964564987287,0.89628905430305,"B.LvsP.GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_UP"
177,"Up",0.723969418794975,0.89628905430305,"B.LvsP.REACTOME_SIGNALING_BY_HEDGEHOG"
504,"Down",0.724416883253206,0.896642253751281,"B.LvsP.FARMER_BREAST_CANCER_BASAL_VS_LULMINAL"
22,"Up",0.724957644422107,0.897097082757052,"B.LvsP.REACTOME_FGFR2_LIGAND_BINDING_AND_ACTIVATION"
14,"Down",0.725165049394477,0.897097082757052,"B.LvsP.REACTOME_LGI_ADAM_INTERACTIONS"
35,"Down",0.725271108685842,0.897097082757052,"B.LvsP.WU_HBX_TARGETS_3_UP"
17,"Up",0.725722980345716,0.897455235591918,"B.LvsP.REACTOME_ACTIVATION_OF_RAC1"
65,"Down",0.726718110306323,0.89848489085055,"B.LvsP.REACTOME_GABA_RECEPTOR_ACTIVATION"
41,"Down",0.727039246516441,0.898534611774639,"B.LvsP.CHIN_BREAST_CANCER_COPY_NUMBER_UP"
65,"Down",0.727083351976802,0.898534611774639,"B.LvsP.LAU_APOPTOSIS_CDKN2A_UP"
25,"Up",0.727600516967872,0.89891833417057,"B.LvsP.MCCOLLUM_GELDANAMYCIN_RESISTANCE_UP"
67,"Down",0.727804738065275,0.89891833417057,"B.LvsP.HUMMEL_BURKITTS_LYMPHOMA_UP"
73,"Down",0.727913123907375,0.89891833417057,"B.LvsP.IKEDA_MIR1_TARGETS_UP"
98,"Up",0.728082965518663,0.89891833417057,"B.LvsP.REACTOME_CLASS_B_2_SECRETIN_FAMILY_RECEPTORS"
105,"Up",0.728210277268043,0.89891833417057,"B.LvsP.REACTOME_OPIOID_SIGNALLING"
826,"Down",0.728369350168955,0.89891833417057,"B.LvsP.TARTE_PLASMA_CELL_VS_PLASMABLAST_UP"
37,"Up",0.729110987318729,0.899456410543239,"B.LvsP.BIOCARTA_DEATH_PATHWAY"
51,"Down",0.729130698508735,0.899456410543239,"B.LvsP.GUILLAUMOND_KLF10_TARGETS_DN"
61,"Down",0.729531985807688,0.899750691396544,"B.LvsP.PID_PI3KCI_PATHWAY"
360,"Up",0.729835086586773,0.899923772020131,"B.LvsP.RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN"
492,"Down",0.730879965463817,0.901011221638672,"B.LvsP.REACTOME_LEISHMANIA_INFECTION"
6,"Up",0.731067822034745,0.901041905490438,"B.LvsP.REN_MIF_TARGETS_DN"
14,"Up",0.731366734234611,0.901200545746764,"B.LvsP.REACTOME_LYSOSPHINGOLIPID_AND_LPA_RECEPTORS"
28,"Down",0.731522526552989,0.901200545746764,"B.LvsP.LEE_INTRATHYMIC_T_PROGENITOR"
88,"Up",0.731915328404323,0.901324139489373,"B.LvsP.WEBER_METHYLATED_ICP_IN_SPERM_DN"
27,"Down",0.731948885206599,0.901324139489373,"B.LvsP.REACTOME_SYNTHESIS_OF_EPOXY_EET_AND_DIHYDROXYEICOSATRIENOIC_ACIDS_DHET"
17,"Up",0.732859318824286,0.90224430500545,"B.LvsP.REACTOME_DISSOLUTION_OF_FIBRIN_CLOT"
7,"Down",0.733024751999816,0.902247073420967,"B.LvsP.DIERICK_SEROTONIN_FUNCTION_GENES"
48,"Down",0.733371467077126,0.902472922650663,"B.LvsP.GENTILE_UV_RESPONSE_CLUSTER_D5"
9,"Up",0.733947582067927,0.902980903705734,"B.LvsP.REACTOME_PROSTANOID_LIGAND_RECEPTORS"
143,"Down",0.734257061133539,0.903069984770585,"B.LvsP.SAFFORD_T_LYMPHOCYTE_ANERGY"
40,"Down",0.73434665428261,0.903069984770585,"B.LvsP.SCHEIDEREIT_IKK_TARGETS"
18,"Up",0.734668929033811,0.903265401073592,"B.LvsP.ZAIDI_OSTEOBLAST_TRANSCRIPTION_FACTORS"
250,"Up",0.734923034779437,0.903376936259562,"B.LvsP.TAVAZOIE_METASTASIS"
8,"Up",0.73512800842936,0.903428041477202,"B.LvsP.REACTOME_DEFECTIVE_B4GALT1_CAUSES_B4GALT1_CDG_CDG_2D"
77,"Up",0.735467195996101,0.90364402814721,"B.LvsP.MAGRANGEAS_MULTIPLE_MYELOMA_IGLL_VS_IGLK_UP"
137,"Down",0.735636754108039,0.903651547092501,"B.LvsP.GAVIN_FOXP3_TARGETS_CLUSTER_T4"
44,"Up",0.736007523423609,0.903805665570417,"B.LvsP.HINATA_NFKB_TARGETS_KERATINOCYTE_DN"
476,"Up",0.736089150309927,0.903805665570417,"B.LvsP.MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_UP"
29,"Down",0.736374963673317,0.903821120711915,"B.LvsP.REACTOME_AFLATOXIN_ACTIVATION_AND_DETOXIFICATION"
53,"Up",0.736428675855883,0.903821120711915,"B.LvsP.ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP"
140,"Down",0.737002954106034,0.904053670093293,"B.LvsP.REACTOME_GLYCEROPHOSPHOLIPID_BIOSYNTHESIS"
42,"Up",0.737161735049499,0.904053670093293,"B.LvsP.SUZUKI_RESPONSE_TO_TSA_AND_DECITABINE_1A"
6,"Down",0.73719900239308,0.904053670093293,"B.LvsP.REACTOME_MOLYBDENUM_COFACTOR_BIOSYNTHESIS"
167,"Down",0.737536733743458,0.904053670093293,"B.LvsP.MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_UP"
141,"Down",0.737559651657258,0.904053670093293,"B.LvsP.CROONQUIST_STROMAL_STIMULATION_UP"
72,"Up",0.737693019387654,0.904053670093293,"B.LvsP.PARK_HSC_AND_MULTIPOTENT_PROGENITORS"
412,"Down",0.737762734574233,0.904053670093293,"B.LvsP.CHYLA_CBFA2T3_TARGETS_DN"
65,"Up",0.738195927087499,0.904384064007707,"B.LvsP.PID_TCPTP_PATHWAY"
738,"Up",0.738508581321433,0.90456666950071,"B.LvsP.CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN"
7,"Up",0.738728597540623,0.904635751008218,"B.LvsP.REACTOME_GRB7_EVENTS_IN_ERBB2_SIGNALING"
99,"Up",0.738951924287379,0.904691370875023,"B.LvsP.NOUZOVA_METHYLATED_IN_APL"
39,"Down",0.739134923349733,0.904691370875023,"B.LvsP.BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_UP"
135,"Up",0.739264896656422,0.904691370875023,"B.LvsP.ROVERSI_GLIOMA_COPY_NUMBER_UP"
36,"Down",0.739702926020172,0.905027102891244,"B.LvsP.REACTOME_METABOLISM_OF_ANGIOTENSINOGEN_TO_ANGIOTENSINS"
168,"Down",0.740009042350322,0.905157926120451,"B.LvsP.TOOKER_GEMCITABINE_RESISTANCE_DN"
21,"Up",0.740138058620205,0.905157926120451,"B.LvsP.MARIADASON_RESPONSE_TO_BUTYRATE_CURCUMIN_SULINDAC_TSA_1"
64,"Down",0.740300984249716,0.905157926120451,"B.LvsP.LIU_BREAST_CANCER"
12,"Up",0.740845885409347,0.905457864877614,"B.LvsP.REACTOME_ARMS_MEDIATED_ACTIVATION"
26,"Down",0.740873825412611,0.905457864877614,"B.LvsP.SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_UP"
16,"Up",0.741245025983562,0.905711325671407,"B.LvsP.REACTOME_FGFR2C_LIGAND_BINDING_AND_ACTIVATION"
5,"Down",0.741840487937428,0.905854648697038,"B.LvsP.REACTOME_FREE_FATTY_ACID_RECEPTORS"
98,"Up",0.741909828110918,0.905854648697038,"B.LvsP.LIANG_SILENCED_BY_METHYLATION_UP"
257,"Down",0.742125247211204,0.905854648697038,"B.LvsP.RICKMAN_HEAD_AND_NECK_CANCER_A"
23,"Down",0.742471122173386,0.905854648697038,"B.LvsP.WHITE_NEUROBLASTOMA_WITH_1P36.3_DELETION"
35,"Down",0.742908975338253,0.905854648697038,"B.LvsP.SA_B_CELL_RECEPTOR_COMPLEXES"
13,"Down",0.743160714230685,0.905854648697038,"B.LvsP.REACTOME_ERBB2_ACTIVATES_PTK6_SIGNALING"
11,"Down",0.743267384077656,0.905854648697038,"B.LvsP.BIOCARTA_TCAPOPTOSIS_PATHWAY"
212,"Up",0.743290909061677,0.905854648697038,"B.LvsP.LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN"
171,"Up",0.743472269286164,0.905854648697038,"B.LvsP.DOANE_BREAST_CANCER_ESR1_UP"
253,"Down",0.743487676140463,0.905854648697038,"B.LvsP.LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_UP"
47,"Up",0.743575313065993,0.905854648697038,"B.LvsP.LIU_LIVER_CANCER"
7,"Up",0.743579960722354,0.905854648697038,"B.LvsP.TESAR_ALK_TARGETS_HUMAN_ES_4D_DN"
57,"Up",0.743707726856768,0.905854648697038,"B.LvsP.REACTOME_EPH_EPHRIN_MEDIATED_REPULSION_OF_CELLS"
238,"Up",0.74372958774542,0.905854648697038,"B.LvsP.TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN"
137,"Up",0.743819877931733,0.905854648697038,"B.LvsP.GAJATE_RESPONSE_TO_TRABECTEDIN_UP"
13,"Down",0.74405793294164,0.905945014585846,"B.LvsP.REACTOME_CREATINE_METABOLISM"
124,"Down",0.744546323325665,0.906340075224042,"B.LvsP.HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_UP"
382,"Down",0.744913011788502,0.906432002568641,"B.LvsP.VERHAAK_GLIOBLASTOMA_MESENCHYMAL"
22,"Up",0.745074382042732,0.906432002568641,"B.LvsP.PID_IL5_PATHWAY"
38,"Down",0.745196400573577,0.906432002568641,"B.LvsP.RUAN_RESPONSE_TO_TNF_TROGLITAZONE_UP"
13,"Down",0.745531263664776,0.906432002568641,"B.LvsP.MIKKELSEN_NPC_WITH_LCP_H3K27ME3"
25,"Down",0.745606284249416,0.906432002568641,"B.LvsP.MCGOWAN_RSP6_TARGETS_UP"
7,"Down",0.745688834327997,0.906432002568641,"B.LvsP.REACTOME_VLDL_CLEARANCE"
84,"Down",0.745769430219705,0.906432002568641,"B.LvsP.GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN"
17,"Down",0.746093500293445,0.906626585301639,"B.LvsP.REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE_FGFR4"
61,"Up",0.746347358680342,0.906735782496949,"B.LvsP.FRIDMAN_IMMORTALIZATION_DN"
25,"Down",0.74658807053582,0.906828963530876,"B.LvsP.YIH_RESPONSE_TO_ARSENITE_C4"
37,"Down",0.74698072458388,0.907087922320391,"B.LvsP.STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_UP"
104,"Down",0.747143050763155,0.907087922320391,"B.LvsP.REACTOME_SIGNALING_BY_MET"
11,"Down",0.747293450202457,0.907087922320391,"B.LvsP.KEGG_FOLATE_BIOSYNTHESIS"
341,"Down",0.747741289946118,0.907432307311696,"B.LvsP.LEE_LIVER_CANCER_SURVIVAL_UP"
1013,"Down",0.747949313736965,0.907485572888234,"B.LvsP.MARTINEZ_RB1_TARGETS_DN"
141,"Down",0.748258804999467,0.907661898385707,"B.LvsP.YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_0"
101,"Down",0.749023903346243,0.908275548063013,"B.LvsP.TCGA_GLIOBLASTOMA_COPY_NUMBER_UP"
90,"Up",0.749339714730313,0.908275548063013,"B.LvsP.REACTOME_CIRCADIAN_CLOCK"
145,"Up",0.74943809804837,0.908275548063013,"B.LvsP.ELVIDGE_HIF1A_TARGETS_DN"
197,"Up",0.749693773061239,0.908275548063013,"B.LvsP.LIU_SOX4_TARGETS_UP"
31,"Down",0.749909800326665,0.908275548063013,"B.LvsP.ALONSO_METASTASIS_NEURAL_UP"
10,"Down",0.75021794850465,0.908275548063013,"B.LvsP.REACTOME_NOSTRIN_MEDIATED_ENOS_TRAFFICKING"
128,"Down",0.750220176613921,0.908275548063013,"B.LvsP.REACTOME_HEDGEHOG_OFF_STATE"
27,"Up",0.750234878586661,0.908275548063013,"B.LvsP.ABDELMOHSEN_ELAVL4_TARGETS"
15,"Down",0.750243159342337,0.908275548063013,"B.LvsP.CLAUS_PGR_POSITIVE_MENINGIOMA_DN"
8,"Down",0.750497355444841,0.908343515908548,"B.LvsP.SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX6_DN"
39,"Down",0.750667954912378,0.908343515908548,"B.LvsP.CHEOK_RESPONSE_TO_HD_MTX_DN"
198,"Down",0.750792162724194,0.908343515908548,"B.LvsP.REACTOME_FCGR_ACTIVATION"
38,"Up",0.750959729402627,0.908347482797445,"B.LvsP.CAFFAREL_RESPONSE_TO_THC_8HR_3_DN"
21,"Down",0.751359999565702,0.908632860367185,"B.LvsP.GEISS_RESPONSE_TO_DSRNA_DN"
123,"Up",0.751907355464824,0.9090508839092,"B.LvsP.REACTOME_PEPTIDE_HORMONE_METABOLISM"
17,"Up",0.752129092058297,0.9090508839092,"B.LvsP.FIGUEROA_AML_METHYLATION_CLUSTER_5_UP"
27,"Up",0.752198913706744,0.9090508839092,"B.LvsP.MOREIRA_RESPONSE_TO_TSA_DN"
35,"Up",0.752830510248079,0.909260568403658,"B.LvsP.BIOCARTA_GSK3_PATHWAY"
50,"Down",0.75286408236276,0.909260568403658,"B.LvsP.VERRECCHIA_RESPONSE_TO_TGFB1_C4"
60,"Up",0.752865777202377,0.909260568403658,"B.LvsP.REACTOME_AGGREPHAGY"
23,"Down",0.753321795519248,0.90961262446515,"B.LvsP.FREDERICK_PRKCI_TARGETS"
46,"Down",0.753751873912296,0.909781964931025,"B.LvsP.PID_ANTHRAX_PATHWAY"
57,"Down",0.754279063039064,0.909781964931025,"B.LvsP.PID_ATM_PATHWAY"
47,"Down",0.75436782725934,0.909781964931025,"B.LvsP.KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_WS"
35,"Up",0.754490237806139,0.909781964931025,"B.LvsP.PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN"
81,"Down",0.754568964879165,0.909781964931025,"B.LvsP.RASHI_RESPONSE_TO_IONIZING_RADIATION_1"
22,"Down",0.75476216164991,0.909781964931025,"B.LvsP.GRAHAM_CML_DIVIDING_VS_NORMAL_DIVIDING_DN"
310,"Down",0.754787656963603,0.909781964931025,"B.LvsP.CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN"
10,"Down",0.754905067271323,0.909781964931025,"B.LvsP.REACTOME_SYNTHESIS_OF_PYROPHOSPHATES_IN_THE_CYTOSOL"
20,"Up",0.755009638116901,0.909781964931025,"B.LvsP.REACTOME_DISEASES_ASSOCIATED_WITH_GLYCOSYLATION_PRECURSOR_BIOSYNTHESIS"
7,"Down",0.755107512582469,0.909781964931025,"B.LvsP.BAKER_HEMATOPOESIS_STAT5_TARGETS"
120,"Up",0.755396487674636,0.909931847571473,"B.LvsP.PID_BETA_CATENIN_NUC_PATHWAY"
26,"Up",0.755749276575207,0.910061930977395,"B.LvsP.PID_BETA_CATENIN_DEG_PATHWAY"
115,"Up",0.755927279886708,0.910061930977395,"B.LvsP.REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX"
114,"Up",0.755998272559084,0.910061930977395,"B.LvsP.GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_DN"
113,"Up",0.756462157597941,0.910422130900961,"B.LvsP.FAELT_B_CLL_WITH_VH_REARRANGEMENTS_UP"
61,"Up",0.756647881999649,0.910447473248326,"B.LvsP.REACTOME_KINESINS"
41,"Up",0.757397210618033,0.911065964054496,"B.LvsP.VALK_AML_CLUSTER_16"
20,"Up",0.757595105919808,0.911065964054496,"B.LvsP.SA_PTEN_PATHWAY"
368,"Down",0.75765623127556,0.911065964054496,"B.LvsP.KYNG_DNA_DAMAGE_UP"
28,"Up",0.758034957913852,0.911103610371006,"B.LvsP.MARCINIAK_ER_STRESS_RESPONSE_VIA_CHOP"
353,"Down",0.758130194705856,0.911103610371006,"B.LvsP.REACTOME_INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS"
25,"Down",0.758181897507144,0.911103610371006,"B.LvsP.BOYAULT_LIVER_CANCER_SUBCLASS_G56_DN"
54,"Up",0.758714179277328,0.911459357279271,"B.LvsP.REACTOME_GLUCAGON_LIKE_PEPTIDE_1_GLP1_REGULATES_INSULIN_SECRETION"
449,"Down",0.758919795087577,0.911459357279271,"B.LvsP.CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_4"
52,"Up",0.758972487052589,0.911459357279271,"B.LvsP.VALK_AML_CLUSTER_2"
69,"Down",0.759241010345577,0.911462899878456,"B.LvsP.WAGSCHAL_EHMT2_TARGETS_UP"
104,"Up",0.759541317115639,0.911462899878456,"B.LvsP.STEIN_ESR1_TARGETS"
11,"Down",0.759555596868057,0.911462899878456,"B.LvsP.REACTOME_DERMATAN_SULFATE_BIOSYNTHESIS"
30,"Up",0.759634842221003,0.911462899878456,"B.LvsP.LUI_THYROID_CANCER_CLUSTER_5"
16,"Up",0.760140087081275,0.911835055446592,"B.LvsP.HOEGERKORP_CD44_TARGETS_TEMPORAL_UP"
85,"Up",0.760274842757966,0.911835055446592,"B.LvsP.ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN"
89,"Down",0.760643186485071,0.912078980281057,"B.LvsP.VANHARANTA_UTERINE_FIBROID_UP"
11,"Down",0.760821337571843,0.912094790857485,"B.LvsP.DING_LUNG_CANCER_MUTATED_RECURRENTLY"
316,"Down",0.761341371934998,0.91252036536497,"B.LvsP.MOHANKUMAR_HOXA1_TARGETS_DN"
495,"Down",0.76154739252614,0.912569469717605,"B.LvsP.NIKOLSKY_BREAST_CANCER_17Q21_Q25_AMPLICON"
178,"Down",0.76248227540997,0.913491766141218,"B.LvsP.LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_DN"
45,"Down",0.762726174353653,0.913586009099079,"B.LvsP.REACTOME_GABA_B_RECEPTOR_ACTIVATION"
15,"Up",0.762911717699683,0.913610328603324,"B.LvsP.KOMMAGANI_TP63_GAMMA_TARGETS"
23,"Down",0.763331085730652,0.913643594277708,"B.LvsP.REACTOME_CTLA4_INHIBITORY_SIGNALING"
19,"Up",0.763384312848713,0.913643594277708,"B.LvsP.REACTOME_CASPASE_ACTIVATION_VIA_DEATH_RECEPTORS_IN_THE_PRESENCE_OF_LIGAND"
58,"Down",0.763479774852945,0.913643594277708,"B.LvsP.REACTOME_RECYCLING_PATHWAY_OF_L1"
217,"Up",0.763600479138595,0.913643594277708,"B.LvsP.MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_UP"
22,"Up",0.764007339108918,0.913768465848403,"B.LvsP.REACTOME_POST_CHAPERONIN_TUBULIN_FOLDING_PATHWAY"
756,"Up",0.76412166613566,0.913768465848403,"B.LvsP.ZHENG_BOUND_BY_FOXP3"
29,"Up",0.76444336380611,0.913768465848403,"B.LvsP.AMIT_EGF_RESPONSE_20_MCF10A"
18,"Up",0.764494585455725,0.913768465848403,"B.LvsP.NOUSHMEHR_GBM_GERMLINE_MUTATED"
212,"Down",0.764531185207942,0.913768465848403,"B.LvsP.REACTOME_SCAVENGING_OF_HEME_FROM_PLASMA"
7,"Up",0.765081928282699,0.914062123688454,"B.LvsP.REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_LINKED_TO_GLUCONEOGENESIS"
18,"Down",0.765209660504107,0.914062123688454,"B.LvsP.REACTOME_APOPTOTIC_CLEAVAGE_OF_CELL_ADHESION_PROTEINS"
50,"Down",0.765272846907913,0.914062123688454,"B.LvsP.MINGUEZ_LIVER_CANCER_VASCULAR_INVASION_DN"
37,"Up",0.765620367568402,0.914198857755157,"B.LvsP.REACTOME_STING_MEDIATED_INDUCTION_OF_HOST_IMMUNE_RESPONSES"
13,"Up",0.765864849218589,0.914198857755157,"B.LvsP.REACTOME_MINERALOCORTICOID_BIOSYNTHESIS"
516,"Down",0.765883362112839,0.914198857755157,"B.LvsP.ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_DN"
36,"Up",0.766053610361256,0.914204707897126,"B.LvsP.REACTOME_THE_CANONICAL_RETINOID_CYCLE_IN_RODS_TWILIGHT_VISION"
16,"Down",0.767350343336247,0.91555460688522,"B.LvsP.REACTOME_GLUCOCORTICOID_BIOSYNTHESIS"
10,"Up",0.768604105890556,0.916630429551796,"B.LvsP.HEIDENBLAD_AMPLIFIED_IN_BONE_CANCER"
142,"Up",0.768829657246374,0.916630429551796,"B.LvsP.REACTOME_VISUAL_PHOTOTRANSDUCTION"
6,"Down",0.769015972609177,0.916630429551796,"B.LvsP.REACTOME_ACYL_CHAIN_REMODELING_OF_CL"
126,"Down",0.769074728399936,0.916630429551796,"B.LvsP.LEE_LIVER_CANCER_ACOX1_DN"
38,"Down",0.769226809579051,0.916630429551796,"B.LvsP.REACTOME_INFLAMMASOMES"
19,"Down",0.769398828145022,0.916630429551796,"B.LvsP.KINNEY_DNMT1_METHYLATION_TARGETS"
39,"Down",0.769498353601386,0.916630429551796,"B.LvsP.REACTOME_NEGATIVE_REGULATION_OF_FGFR4_SIGNALING"
76,"Down",0.76970024914088,0.916630429551796,"B.LvsP.REACTOME_TRANSCRIPTION_OF_THE_HIV_GENOME"
120,"Down",0.769744091953154,0.916630429551796,"B.LvsP.HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_DN"
27,"Up",0.770072724987365,0.916824310175526,"B.LvsP.REACTOME_HYALURONAN_METABOLISM"
41,"Down",0.77084917941259,0.917327201278036,"B.LvsP.ZHANG_RESPONSE_TO_CANTHARIDIN_UP"
241,"Up",0.77098593946875,0.917327201278036,"B.LvsP.KIM_WT1_TARGETS_12HR_UP"
13,"Up",0.770992856635745,0.917327201278036,"B.LvsP.ZHENG_FOXP3_TARGETS_IN_T_LYMPHOCYTE_UP"
1381,"Down",0.771646264619364,0.917907099199756,"B.LvsP.BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_TRANS"
64,"Down",0.771823553386584,0.917920504769718,"B.LvsP.PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_6"
99,"Down",0.772160008413639,0.918123158391185,"B.LvsP.REACTOME_ECM_PROTEOGLYCANS"
127,"Down",0.773441337855721,0.919448969469852,"B.LvsP.REACTOME_HCMV_LATE_EVENTS"
101,"Up",0.7741205021611,0.920058524602047,"B.LvsP.XU_GH1_EXOGENOUS_TARGETS_UP"
16,"Down",0.774503894497838,0.920303245302492,"B.LvsP.HASINA_NOL7_TARGETS_UP"
47,"Up",0.774710303442599,0.920303245302492,"B.LvsP.BIOCARTA_PDGF_PATHWAY"
230,"Down",0.774980048112489,0.920303245302492,"B.LvsP.KEGG_CHEMOKINE_SIGNALING_PATHWAY"
50,"Up",0.774993296333523,0.920303245302492,"B.LvsP.REACTOME_LYSOSOME_VESICLE_BIOGENESIS"
5,"Up",0.775239004199122,0.920303245302492,"B.LvsP.REACTOME_DISEASES_OF_MISMATCH_REPAIR_MMR"
45,"Down",0.775325107002895,0.920303245302492,"B.LvsP.ABE_VEGFA_TARGETS_2HR"
76,"Up",0.775694325232404,0.920543877271938,"B.LvsP.PID_KIT_PATHWAY"
140,"Down",0.776196613989814,0.920942291577185,"B.LvsP.GU_PDEF_TARGETS_UP"
39,"Down",0.776388856389479,0.920972749834248,"B.LvsP.REACTOME_NUCLEAR_SIGNALING_BY_ERBB4"
37,"Down",0.776665367066474,0.921103134815644,"B.LvsP.BIOCARTA_IL12_PATHWAY"
523,"Up",0.777175185828802,0.921428577753095,"B.LvsP.GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP"
7,"Up",0.777317078516284,0.921428577753095,"B.LvsP.TERAO_AOX4_TARGETS_HG_DN"
122,"Down",0.777439738690213,0.921428577753095,"B.LvsP.CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_UP"
340,"Down",0.778770593798504,0.922200677162602,"B.LvsP.AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_DN"
64,"Up",0.778871390319401,0.922200677162602,"B.LvsP.BIOCARTA_KERATINOCYTE_PATHWAY"
27,"Down",0.778874589582246,0.922200677162602,"B.LvsP.BIOCARTA_CHREBP_PATHWAY"
93,"Down",0.779030401333044,0.922200677162602,"B.LvsP.WATANABE_COLON_CANCER_MSI_VS_MSS_DN"
18,"Down",0.779070797963427,0.922200677162602,"B.LvsP.YEMELYANOV_GR_TARGETS_DN"
104,"Down",0.779091944841113,0.922200677162602,"B.LvsP.KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_DN"
52,"Up",0.779514981858028,0.92232097774484,"B.LvsP.REACTOME_SIGNALING_BY_FGFR4"
57,"Up",0.779527207271051,0.92232097774484,"B.LvsP.SIG_CHEMOTAXIS"
565,"Down",0.779730606414022,0.922364253928783,"B.LvsP.ZHOU_INFLAMMATORY_RESPONSE_LPS_UP"
37,"Down",0.780112071975746,0.922618106086396,"B.LvsP.ONO_AML1_TARGETS_UP"
9,"Down",0.780322715488017,0.922669866110617,"B.LvsP.BIOCARTA_HBX_PATHWAY"
935,"Up",0.780950241603103,0.923214429297318,"B.LvsP.FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN"
22,"Up",0.781311991311174,0.923444634450509,"B.LvsP.BAUS_TFF2_TARGETS_DN"
130,"Down",0.781636553311039,0.923621112631686,"B.LvsP.PEDERSEN_TARGETS_OF_611CTF_ISOFORM_OF_ERBB2"
33,"Up",0.781800583809869,0.923621112631686,"B.LvsP.MARCHINI_TRABECTEDIN_RESISTANCE_UP"
154,"Down",0.781962457628671,0.923621112631686,"B.LvsP.NGUYEN_NOTCH1_TARGETS_DN"
115,"Down",0.782317363240054,0.923793240721674,"B.LvsP.BROWNE_HCMV_INFECTION_1HR_UP"
206,"Down",0.782442348761005,0.923793240721674,"B.LvsP.MIKKELSEN_IPS_ICP_WITH_H3K4ME3_AND_H327ME3"
30,"Down",0.78271905540114,0.923840750630304,"B.LvsP.REACTOME_DARPP_32_EVENTS"
60,"Up",0.782940109736692,0.923840750630304,"B.LvsP.PID_ER_NONGENOMIC_PATHWAY"
140,"Down",0.78298385918857,0.923840750630304,"B.LvsP.GNATENKO_PLATELET_SIGNATURE"
19,"Down",0.783551311126474,0.924169558909141,"B.LvsP.REACTOME_GLYCOGEN_STORAGE_DISEASES"
92,"Up",0.783596833453799,0.924169558909141,"B.LvsP.STARK_HYPPOCAMPUS_22Q11_DELETION_UP"
71,"Up",0.784358110118079,0.924434345275311,"B.LvsP.REACTOME_SIGNALING_BY_NOTCH3"
96,"Down",0.784359328879619,0.924434345275311,"B.LvsP.PID_BCR_5PATHWAY"
12,"Down",0.784472776635703,0.924434345275311,"B.LvsP.SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX1_DN"
18,"Down",0.784634825328794,0.924434345275311,"B.LvsP.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_1"
49,"Up",0.784657330869422,0.924434345275311,"B.LvsP.REACTOME_NGF_STIMULATED_TRANSCRIPTION"
23,"Down",0.784867470722158,0.9244849266346,"B.LvsP.REACTOME_SIGNALING_BY_FGFR2_IIIA_TM"
252,"Up",0.785052067943889,0.924505406530727,"B.LvsP.REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS"
35,"Down",0.785396837265425,0.924534076011854,"B.LvsP.GOLUB_ALL_VS_AML_DN"
85,"Down",0.785686358357068,0.924534076011854,"B.LvsP.YAMASHITA_LIVER_CANCER_STEM_CELL_UP"
42,"Down",0.785708970631555,0.924534076011854,"B.LvsP.WALLACE_JAK2_TARGETS_UP"
83,"Up",0.785745274584862,0.924534076011854,"B.LvsP.REACTOME_GOLGI_ASSOCIATED_VESICLE_BIOGENESIS"
79,"Down",0.785969157025377,0.924538388509014,"B.LvsP.MEDINA_SMARCA4_TARGETS"
226,"Down",0.78608337210723,0.924538388509014,"B.LvsP.REACTOME_SUMOYLATION"
886,"Up",0.786750180793272,0.924931771495071,"B.LvsP.SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_DN"
53,"Up",0.786849822795387,0.924931771495071,"B.LvsP.FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN"
35,"Down",0.787022849418778,0.924931771495071,"B.LvsP.REACTOME_GLUCAGON_SIGNALING_IN_METABOLIC_REGULATION"
46,"Down",0.787143435711671,0.924931771495071,"B.LvsP.ZHAN_LATE_DIFFERENTIATION_GENES_UP"
26,"Up",0.787309721557681,0.924931771495071,"B.LvsP.REACTOME_PRESYNAPTIC_FUNCTION_OF_KAINATE_RECEPTORS"
51,"Down",0.787429560495621,0.924931771495071,"B.LvsP.GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_DN"
46,"Down",0.787588855163464,0.924931771495071,"B.LvsP.REACTOME_PHASE_0_RAPID_DEPOLARISATION"
817,"Down",0.78787345065963,0.925069507049712,"B.LvsP.ACEVEDO_LIVER_CANCER_DN"
362,"Up",0.788692497780302,0.925253154999199,"B.LvsP.MULLIGHAN_NPM1_SIGNATURE_3_DN"
504,"Up",0.788699513032729,0.925253154999199,"B.LvsP.OISHI_CHOLANGIOMA_STEM_CELL_LIKE_DN"
528,"Down",0.788766156036538,0.925253154999199,"B.LvsP.WANG_LMO4_TARGETS_UP"
158,"Up",0.788787604027484,0.925253154999199,"B.LvsP.REACTOME_HATS_ACETYLATE_HISTONES"
313,"Up",0.788904135304133,0.925253154999199,"B.LvsP.BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_DN"
8,"Up",0.789033934856434,0.925253154999199,"B.LvsP.REACTOME_TLR3_MEDIATED_TICAM1_DEPENDENT_PROGRAMMED_CELL_DEATH"
10,"Down",0.789392867457123,0.92547777018033,"B.LvsP.PHONG_TNF_TARGETS_DN"
67,"Up",0.789911552030933,0.925889542331784,"B.LvsP.BROWNE_HCMV_INFECTION_2HR_UP"
15,"Down",0.790731344152844,0.926654006320702,"B.LvsP.BIOCARTA_SODD_PATHWAY"
180,"Up",0.791129066288773,0.92674385167921,"B.LvsP.LIM_MAMMARY_LUMINAL_MATURE_UP"
364,"Down",0.791287241792414,0.92674385167921,"B.LvsP.RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_UP"
59,"Up",0.79138183363404,0.92674385167921,"B.LvsP.PID_A6B1_A6B4_INTEGRIN_PATHWAY"
129,"Down",0.791518167763806,0.92674385167921,"B.LvsP.HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_DN"
26,"Down",0.791646086359361,0.92674385167921,"B.LvsP.ZIRN_TRETINOIN_RESPONSE_UP"
137,"Up",0.792579378882347,0.927601041670185,"B.LvsP.REACTOME_SENESCENCE_ASSOCIATED_SECRETORY_PHENOTYPE_SASP"
68,"Down",0.792713858182605,0.927601041670185,"B.LvsP.GERHOLD_ADIPOGENESIS_UP"
124,"Down",0.792892564581107,0.927613836133927,"B.LvsP.REACTOME_G2_M_DNA_DAMAGE_CHECKPOINT"
61,"Down",0.793506413600752,0.927952301211053,"B.LvsP.ZHAN_MULTIPLE_MYELOMA_MF_DN"
34,"Up",0.793701975550655,0.927952301211053,"B.LvsP.HUMMERICH_BENIGN_SKIN_TUMOR_UP"
669,"Down",0.793716861023458,0.927952301211053,"B.LvsP.KUMAR_TARGETS_OF_MLL_AF9_FUSION"
106,"Up",0.794030509115772,0.927952301211053,"B.LvsP.PID_AR_PATHWAY"
72,"Down",0.794393559187341,0.927952301211053,"B.LvsP.KEGG_GLIOMA"
11,"Down",0.794415450799007,0.927952301211053,"B.LvsP.BIOCARTA_ALTERNATIVE_PATHWAY"
26,"Up",0.794452677071444,0.927952301211053,"B.LvsP.PID_NFKAPPAB_ATYPICAL_PATHWAY"
237,"Up",0.794583223725252,0.927952301211053,"B.LvsP.MIKKELSEN_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3"
19,"Up",0.79475544528546,0.927952301211053,"B.LvsP.MOROSETTI_FACIOSCAPULOHUMERAL_MUSCULAR_DISTROPHY_DN"
55,"Down",0.794910149712727,0.927952301211053,"B.LvsP.FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN"
28,"Down",0.795028043197099,0.927952301211053,"B.LvsP.BIOCARTA_NTHI_PATHWAY"
29,"Down",0.795290719544407,0.928062977703889,"B.LvsP.TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_DN"
97,"Down",0.796090204118053,0.928291448660998,"B.LvsP.GRADE_COLON_VS_RECTAL_CANCER_DN"
45,"Up",0.796361327642876,0.928291448660998,"B.LvsP.XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_DN"
16,"Up",0.796757161235987,0.928291448660998,"B.LvsP.REACTOME_ERKS_ARE_INACTIVATED"
32,"Down",0.79676723643778,0.928291448660998,"B.LvsP.LANDIS_ERBB2_BREAST_TUMORS_65_UP"
18,"Up",0.796875515691149,0.928291448660998,"B.LvsP.FRASOR_TAMOXIFEN_RESPONSE_DN"
26,"Up",0.796878405442856,0.928291448660998,"B.LvsP.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_UP"
55,"Down",0.797061524199449,0.928291448660998,"B.LvsP.ROY_WOUND_BLOOD_VESSEL_DN"
14,"Up",0.797250257400444,0.928291448660998,"B.LvsP.WEBER_METHYLATED_LCP_IN_FIBROBLAST_UP"
7,"Up",0.797317488744814,0.928291448660998,"B.LvsP.TESAR_ALK_AND_JAK_TARGETS_MOUSE_ES_D4_DN"
510,"Up",0.797357888061963,0.928291448660998,"B.LvsP.FARMER_BREAST_CANCER_APOCRINE_VS_LUMINAL"
29,"Down",0.797388758492734,0.928291448660998,"B.LvsP.KEGG_ASCORBATE_AND_ALDARATE_METABOLISM"
487,"Up",0.797501244554122,0.928291448660998,"B.LvsP.SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM4"
156,"Down",0.797764999388702,0.928339568804985,"B.LvsP.FONTAINE_PAPILLARY_THYROID_CARCINOMA_DN"
110,"Down",0.797921812231812,0.928339568804985,"B.LvsP.MATZUK_MEIOTIC_AND_DNA_REPAIR"
83,"Up",0.79804629599025,0.928339568804985,"B.LvsP.REACTOME_NUCLEOTIDE_BINDING_DOMAIN_LEUCINE_RICH_REPEAT_CONTAINING_RECEPTOR_NLR_SIGNALING_PATHWAYS"
83,"Up",0.798226030344888,0.928353328097788,"B.LvsP.PID_TXA2PATHWAY"
33,"Down",0.798504906284013,0.928482361060843,"B.LvsP.REACTOME_SIALIC_ACID_METABOLISM"
6,"Down",0.798863676272006,0.928704219114366,"B.LvsP.REACTOME_CHOLINE_CATABOLISM"
79,"Down",0.799044879593647,0.928719600435837,"B.LvsP.KEGG_RENAL_CELL_CARCINOMA"
27,"Up",0.799592510980271,0.929010736333657,"B.LvsP.KEGG_PRIMARY_BILE_ACID_BIOSYNTHESIS"
236,"Up",0.799698197346085,0.929010736333657,"B.LvsP.TIEN_INTESTINE_PROBIOTICS_6HR_DN"
154,"Up",0.799928371442685,0.929010736333657,"B.LvsP.LEE_LIVER_CANCER_DENA_DN"
33,"Up",0.800066660762823,0.929010736333657,"B.LvsP.REACTOME_GP1B_IX_V_ACTIVATION_SIGNALLING"
90,"Up",0.800135490399869,0.929010736333657,"B.LvsP.BENNETT_SYSTEMIC_LUPUS_ERYTHEMATOSUS"
666,"Up",0.800361246155949,0.929077751416385,"B.LvsP.FOSTER_KDM1A_TARGETS_UP"
11,"Down",0.800603704073365,0.929164122548622,"B.LvsP.BIOCARTA_REELIN_PATHWAY"
162,"Up",0.801173413969164,0.929448377626211,"B.LvsP.HOSHIDA_LIVER_CANCER_SURVIVAL_UP"
27,"Down",0.801184837722286,0.929448377626211,"B.LvsP.PID_INTEGRIN5_PATHWAY"
17,"Up",0.801413741620909,0.929518896039858,"B.LvsP.FUKUSHIMA_TNFSF11_TARGETS"
383,"Down",0.801660377160143,0.929609946585241,"B.LvsP.DELYS_THYROID_CANCER_DN"
67,"Up",0.802519951313812,0.930059071995669,"B.LvsP.FIRESTEIN_CTNNB1_PATHWAY"
104,"Down",0.802525157853198,0.930059071995669,"B.LvsP.FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP"
770,"Down",0.802552329985773,0.930059071995669,"B.LvsP.BOCHKIS_FOXA2_TARGETS"
9,"Down",0.802786121690391,0.930135051723841,"B.LvsP.CALVET_IRINOTECAN_SENSITIVE_VS_REVERTED_UP"
29,"Down",0.803054767214789,0.930251373964083,"B.LvsP.REACTOME_SHC_MEDIATED_CASCADE_FGFR1"
305,"Down",0.803962776934166,0.930815630030001,"B.LvsP.WANG_TUMOR_INVASIVENESS_DN"
30,"Down",0.804086864248036,0.930815630030001,"B.LvsP.REACTOME_RHO_GTPASES_ACTIVATE_NADPH_OXIDASES"
130,"Down",0.804444098067527,0.930815630030001,"B.LvsP.KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION"
32,"Down",0.804475811982923,0.930815630030001,"B.LvsP.BIOCARTA_IL6_PATHWAY"
68,"Down",0.804530832409381,0.930815630030001,"B.LvsP.CERVERA_SDHB_TARGETS_1_DN"
23,"Down",0.804551979727505,0.930815630030001,"B.LvsP.FIGUEROA_AML_METHYLATION_CLUSTER_2_DN"
470,"Down",0.804812563095326,0.930830012647546,"B.LvsP.HOSHIDA_LIVER_CANCER_SUBCLASS_S3"
5,"Down",0.805013458457041,0.930830012647546,"B.LvsP.REACTOME_MUSCARINIC_ACETYLCHOLINE_RECEPTORS"
46,"Up",0.805244861858626,0.930830012647546,"B.LvsP.OSADA_ASCL1_TARGETS_DN"
32,"Up",0.805395013975058,0.930830012647546,"B.LvsP.VETTER_TARGETS_OF_PRKCA_AND_ETS1_DN"
336,"Down",0.805406182041211,0.930830012647546,"B.LvsP.IWANAGA_CARCINOGENESIS_BY_KRAS_UP"
18,"Down",0.806083240180665,0.931259131746682,"B.LvsP.REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_LATE_STAGE_BRANCHING_MORPHOGENESIS_PANCREATIC_BUD_PRECURSOR_CELLS"
684,"Up",0.806226669206449,0.931259131746682,"B.LvsP.KIM_WT1_TARGETS_DN"
46,"Down",0.806282775125948,0.931259131746682,"B.LvsP.STAEGE_EWING_FAMILY_TUMOR"
239,"Down",0.806666601536745,0.93139901749863,"B.LvsP.SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM5"
4,"Up",0.806763975380697,0.93139901749863,"B.LvsP.IGARASHI_ATF4_TARGETS_UP"
14,"Up",0.806940988881824,0.93139901749863,"B.LvsP.REACTOME_CS_DS_DEGRADATION"
40,"Up",0.807265923772588,0.93139901749863,"B.LvsP.KEGG_FRUCTOSE_AND_MANNOSE_METABOLISM"
43,"Down",0.807400271774216,0.93139901749863,"B.LvsP.DISTECHE_ESCAPED_FROM_X_INACTIVATION"
16,"Down",0.807414630289552,0.93139901749863,"B.LvsP.REACTOME_REGULATION_OF_COMMISSURAL_AXON_PATHFINDING_BY_SLIT_AND_ROBO"
648,"Up",0.807740156256686,0.931549036770787,"B.LvsP.SANSOM_APC_TARGETS_DN"
36,"Up",0.807881647913895,0.931549036770787,"B.LvsP.BIOCARTA_TRKA_PATHWAY"
134,"Up",0.808472835312009,0.931979341520828,"B.LvsP.BASSO_HAIRY_CELL_LEUKEMIA_UP"
302,"Down",0.808697168169955,0.931979341520828,"B.LvsP.XU_GH1_AUTOCRINE_TARGETS_UP"
30,"Down",0.808760513766854,0.931979341520828,"B.LvsP.REACTOME_MRNA_CAPPING"
51,"Up",0.809015688449047,0.93207912928418,"B.LvsP.GROSS_ELK3_TARGETS_DN"
25,"Up",0.809667537554023,0.932634406616246,"B.LvsP.KEGG_RENIN_ANGIOTENSIN_SYSTEM"
23,"Up",0.809835012871151,0.932634406616246,"B.LvsP.REACTOME_INHIBITION_OF_THE_PROTEOLYTIC_ACTIVITY_OF_APC_C_REQUIRED_FOR_THE_ONSET_OF_ANAPHASE_BY_MITOTIC_SPINDLE_CHECKPOINT_COMPONENTS"
17,"Down",0.811913414395685,0.934833250352716,"B.LvsP.REACTOME_ERBB2_REGULATES_CELL_MOTILITY"
18,"Down",0.812434470604054,0.935195508359852,"B.LvsP.REACTOME_GRB2_EVENTS_IN_ERBB2_SIGNALING"
149,"Up",0.812566327032145,0.935195508359852,"B.LvsP.BHAT_ESR1_TARGETS_NOT_VIA_AKT1_DN"
6,"Up",0.813371082413395,0.935803849110967,"B.LvsP.REACTOME_TRAFFICKING_OF_MYRISTOYLATED_PROTEINS_TO_THE_CILIUM"
58,"Down",0.813484966213744,0.935803849110967,"B.LvsP.KEGG_LINOLEIC_ACID_METABOLISM"
115,"Up",0.81363633323083,0.935803849110967,"B.LvsP.DARWICHE_PAPILLOMA_PROGRESSION_RISK"
24,"Up",0.813771912918345,0.935803849110967,"B.LvsP.REACTOME_FRS_MEDIATED_FGFR4_SIGNALING"
217,"Down",0.814599142287904,0.936560336392144,"B.LvsP.NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN"
9,"Up",0.814908102709316,0.936720769205781,"B.LvsP.CASTELLANO_HRAS_TARGETS_UP"
63,"Up",0.815297572901089,0.936915619541156,"B.LvsP.SIMBULAN_UV_RESPONSE_NORMAL_DN"
44,"Down",0.815416524006519,0.936915619541156,"B.LvsP.DANG_MYC_TARGETS_DN"
643,"Up",0.815879057427882,0.937252297635313,"B.LvsP.MULLIGHAN_MLL_SIGNATURE_2_UP"
317,"Down",0.816680060174777,0.937871303910146,"B.LvsP.TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP"
51,"Up",0.816757158315673,0.937871303910146,"B.LvsP.CHO_NR4A1_TARGETS"
85,"Down",0.817339615379032,0.938313614207002,"B.LvsP.CHIBA_RESPONSE_TO_TSA"
11,"Down",0.817629113891327,0.938313614207002,"B.LvsP.REACTOME_ACTIVATION_OF_CASPASES_THROUGH_APOPTOSOME_MEDIATED_CLEAVAGE"
41,"Down",0.817651472824984,0.938313614207002,"B.LvsP.WANG_METASTASIS_OF_BREAST_CANCER"
30,"Up",0.818187543723819,0.93873395502158,"B.LvsP.REACTOME_GLUTAMATE_NEUROTRANSMITTER_RELEASE_CYCLE"
47,"Down",0.818670770964581,0.939023605986208,"B.LvsP.PID_IL8_CXCR1_PATHWAY"
129,"Up",0.819053186736757,0.939023605986208,"B.LvsP.VERRECCHIA_EARLY_RESPONSE_TO_TGFB1"
228,"Down",0.819176438212594,0.939023605986208,"B.LvsP.REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_BCR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS"
16,"Up",0.819178453283018,0.939023605986208,"B.LvsP.RAMPON_ENRICHED_LEARNING_ENVIRONMENT_EARLY_DN"
85,"Down",0.819289179829529,0.939023605986208,"B.LvsP.SASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION"
1306,"Up",0.819669778926766,0.939265120763957,"B.LvsP.MARSON_BOUND_BY_FOXP3_STIMULATED"
588,"Down",0.820065152393344,0.939377716617731,"B.LvsP.YOSHIMURA_MAPK8_TARGETS_DN"
217,"Up",0.820476920522614,0.939377716617731,"B.LvsP.REACTOME_FCERI_MEDIATED_CA_2_MOBILIZATION"
26,"Up",0.820554017851539,0.939377716617731,"B.LvsP.BIOCARTA_41BB_PATHWAY"
146,"Down",0.820751018133628,0.939377716617731,"B.LvsP.KONDO_PROSTATE_CANCER_HCP_WITH_H3K27ME3"
31,"Down",0.821012795994113,0.939377716617731,"B.LvsP.REACTOME_EICOSANOIDS"
2689,"Down",0.821031008466563,0.939377716617731,"B.LvsP.ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY"
8,"Up",0.82114150946028,0.939377716617731,"B.LvsP.BIOCARTA_RNAPOL3_PATHWAY"
229,"Down",0.821187260173279,0.939377716617731,"B.LvsP.MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_DN"
181,"Down",0.821297139108358,0.939377716617731,"B.LvsP.MCLACHLAN_DENTAL_CARIES_DN"
74,"Up",0.82180273334832,0.939630177460822,"B.LvsP.LIEN_BREAST_CARCINOMA_METAPLASTIC"
77,"Down",0.821857756954338,0.939630177460822,"B.LvsP.MARTINEZ_RESPONSE_TO_TRABECTEDIN"
357,"Up",0.822308261365506,0.939861834674075,"B.LvsP.JISON_SICKLE_CELL_DISEASE_UP"
18,"Up",0.822400353798729,0.939861834674075,"B.LvsP.REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING"
50,"Down",0.823115669756435,0.940484922108562,"B.LvsP.REACTOME_FORMATION_OF_INCISION_COMPLEX_IN_GG_NER"
99,"Up",0.823686922938289,0.940943181183016,"B.LvsP.MIKKELSEN_ES_ICP_WITH_H3K27ME3"
37,"Down",0.824295795996588,0.941216090876881,"B.LvsP.HOFMANN_MYELODYSPLASTIC_SYNDROM_RISK_UP"
59,"Up",0.824453261175464,0.941216090876881,"B.LvsP.GENTILE_UV_RESPONSE_CLUSTER_D7"
26,"Down",0.824593189701568,0.941216090876881,"B.LvsP.OKAWA_NEUROBLASTOMA_1P36_31_DELETION"
43,"Down",0.82460675424265,0.941216090876881,"B.LvsP.REACTOME_RNA_POLYMERASE_III_TRANSCRIPTION"
37,"Up",0.824920080737942,0.941316220746736,"B.LvsP.KEGG_ETHER_LIPID_METABOLISM"
79,"Up",0.825139592700205,0.941316220746736,"B.LvsP.REACTOME_DNA_METHYLATION"
33,"Up",0.82530056837879,0.941316220746736,"B.LvsP.BILANGES_SERUM_SENSITIVE_VIA_TSC1"
66,"Up",0.825510909415843,0.941316220746736,"B.LvsP.REACTOME_NEUREXINS_AND_NEUROLIGINS"
156,"Down",0.825545732393005,0.941316220746736,"B.LvsP.LEIN_CHOROID_PLEXUS_MARKERS"
53,"Up",0.825732614278471,0.941335180277457,"B.LvsP.REACTOME_SIGNALING_BY_NOTCH2"
11,"Up",0.826145776447427,0.941612038338039,"B.LvsP.WILLIAMS_ESR1_TARGETS_DN"
184,"Up",0.826708712042358,0.942059453603091,"B.LvsP.YAGI_AML_SURVIVAL"
70,"Up",0.827336914731324,0.942581042973313,"B.LvsP.ZHAN_MULTIPLE_MYELOMA_MS_UP"
16,"Up",0.828106731964966,0.943263724976164,"B.LvsP.TSUDA_ALVEOLAR_SOFT_PART_SARCOMA"
172,"Down",0.828308147287916,0.943298814903169,"B.LvsP.BAELDE_DIABETIC_NEPHROPATHY_UP"
36,"Down",0.828891672961269,0.943502942706552,"B.LvsP.REACTOME_NEGATIVE_REGULATION_OF_FGFR3_SIGNALING"
69,"Up",0.829045618110312,0.943502942706552,"B.LvsP.CERIBELLI_GENES_INACTIVE_AND_BOUND_BY_NFY"
118,"Down",0.829318121535793,0.943502942706552,"B.LvsP.KEGG_SMALL_CELL_LUNG_CANCER"
67,"Up",0.829398868218561,0.943502942706552,"B.LvsP.KYNG_DNA_DAMAGE_BY_4NQO"
77,"Up",0.829451965058624,0.943502942706552,"B.LvsP.REACTOME_PKMTS_METHYLATE_HISTONE_LYSINES"
114,"Up",0.829706787414471,0.943502942706552,"B.LvsP.KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS"
96,"Down",0.829718237816743,0.943502942706552,"B.LvsP.REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS"
69,"Down",0.829886354263992,0.943502942706552,"B.LvsP.KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY"
140,"Up",0.830326532633779,0.943502942706552,"B.LvsP.HECKER_IFNB1_TARGETS"
8,"Down",0.830408147979892,0.943502942706552,"B.LvsP.HOLLEMAN_DAUNORUBICIN_ALL_DN"
66,"Down",0.830584668375438,0.943502942706552,"B.LvsP.CHEN_NEUROBLASTOMA_COPY_NUMBER_GAINS"
19,"Down",0.830678436725753,0.943502942706552,"B.LvsP.BIOCARTA_TNFR2_PATHWAY"
32,"Down",0.830778817615744,0.943502942706552,"B.LvsP.MATZUK_IMPLANTATION_AND_UTERINE"
359,"Up",0.830905307393405,0.943502942706552,"B.LvsP.MASSARWEH_TAMOXIFEN_RESISTANCE_DN"
101,"Down",0.831140610951302,0.943502942706552,"B.LvsP.PID_ENDOTHELIN_PATHWAY"
1419,"Up",0.831491046598272,0.943502942706552,"B.LvsP.BENPORATH_NANOG_TARGETS"
46,"Up",0.831557262849825,0.943502942706552,"B.LvsP.REACTOME_NUCLEOBASE_CATABOLISM"
39,"Up",0.83168459346902,0.943502942706552,"B.LvsP.DUNNE_TARGETS_OF_AML1_MTG8_FUSION_DN"
26,"Down",0.831729669515597,0.943502942706552,"B.LvsP.REACTOME_ABC_TRANSPORTERS_IN_LIPID_HOMEOSTASIS"
7,"Down",0.832463404660641,0.943839233277579,"B.LvsP.PETRETTO_LEFT_VENTRICLE_MASS_QTL_CIS_UP"
19,"Up",0.832538146268103,0.943839233277579,"B.LvsP.REACTOME_NEF_AND_SIGNAL_TRANSDUCTION"
243,"Down",0.83275062265492,0.943839233277579,"B.LvsP.PROVENZANI_METASTASIS_DN"
107,"Down",0.832928554618401,0.943839233277579,"B.LvsP.REACTOME_BASE_EXCISION_REPAIR"
156,"Down",0.832962209754182,0.943839233277579,"B.LvsP.KOHOUTEK_CCNT2_TARGETS"
30,"Down",0.833218460356926,0.943839233277579,"B.LvsP.PID_TOLL_ENDOGENOUS_PATHWAY"
81,"Down",0.833221070288997,0.943839233277579,"B.LvsP.REACTOME_COSTIMULATION_BY_THE_CD28_FAMILY"
78,"Up",0.833403475468499,0.943852481742182,"B.LvsP.MIDORIKAWA_AMPLIFIED_IN_LIVER_CANCER"
337,"Down",0.83393183187112,0.944257443869634,"B.LvsP.KATSANOU_ELAVL1_TARGETS_UP"
134,"Down",0.834776226002372,0.944892373669164,"B.LvsP.SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_UP"
37,"Up",0.834834372467692,0.944892373669164,"B.LvsP.REACTOME_HEME_DEGRADATION"
138,"Up",0.835594780353946,0.945218178387823,"B.LvsP.LEIN_MEDULLA_MARKERS"
27,"Up",0.835595023529813,0.945218178387823,"B.LvsP.BIOCARTA_CERAMIDE_PATHWAY"
198,"Down",0.835690275876226,0.945218178387823,"B.LvsP.NIKOLSKY_BREAST_CANCER_17Q11_Q21_AMPLICON"
21,"Down",0.835806054284331,0.945218178387823,"B.LvsP.HUMMEL_BURKITTS_LYMPHOMA_DN"
10,"Down",0.836276647825893,0.945556970517252,"B.LvsP.REACTOME_HDR_THROUGH_MMEJ_ALT_NHEJ"
102,"Down",0.836525990259506,0.945645512194808,"B.LvsP.KEGG_RETINOL_METABOLISM"
9,"Down",0.83741009728517,0.946442397361485,"B.LvsP.REACTOME_OREXIN_AND_NEUROPEPTIDES_FF_AND_QRFP_BIND_TO_THEIR_RESPECTIVE_RECEPTORS"
7,"Up",0.837766599956467,0.946442397361485,"B.LvsP.REACTOME_LTC4_CYSLTR_MEDIATED_IL4_PRODUCTION"
29,"Up",0.837778415785237,0.946442397361485,"B.LvsP.GREENBAUM_E2A_TARGETS_DN"
108,"Down",0.838026273620469,0.946442397361485,"B.LvsP.GAVIN_FOXP3_TARGETS_CLUSTER_P2"
31,"Down",0.838673318784444,0.946442397361485,"B.LvsP.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_PURPLE_DN"
226,"Up",0.838695225668265,0.946442397361485,"B.LvsP.WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_WITH_H4K20ME1_MARK"
41,"Down",0.838698468056996,0.946442397361485,"B.LvsP.REACTOME_GLUTATHIONE_CONJUGATION"
38,"Up",0.838705126458899,0.946442397361485,"B.LvsP.KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_OLD"
34,"Down",0.838771522349662,0.946442397361485,"B.LvsP.REACTOME_IRF3_MEDIATED_INDUCTION_OF_TYPE_I_IFN"
9,"Down",0.839080066200643,0.946597365032311,"B.LvsP.REACTOME_TERMINAL_PATHWAY_OF_COMPLEMENT"
89,"Up",0.839597616836128,0.94698800968726,"B.LvsP.PID_P75_NTR_PATHWAY"
106,"Down",0.839871386623138,0.947103588953565,"B.LvsP.KEGG_GAP_JUNCTION"
474,"Up",0.840412413637517,0.947276906270244,"B.LvsP.REACTOME_NEURONAL_SYSTEM"
53,"Up",0.840428271278686,0.947276906270244,"B.LvsP.SESTO_RESPONSE_TO_UV_C6"
112,"Down",0.840764839332991,0.947276906270244,"B.LvsP.ZHU_CMV_8_HR_UP"
97,"Up",0.84088105330324,0.947276906270244,"B.LvsP.KEGG_ECM_RECEPTOR_INTERACTION"
32,"Up",0.840881724719543,0.947276906270244,"B.LvsP.REACTOME_EPHRIN_SIGNALING"
36,"Up",0.841286003508537,0.947539277530801,"B.LvsP.GRAHAM_CML_DIVIDING_VS_NORMAL_DIVIDING_UP"
21,"Up",0.842359752031101,0.948200526838457,"B.LvsP.SUH_COEXPRESSED_WITH_ID1_AND_ID2_UP"
11,"Down",0.842388356482886,0.948200526838457,"B.LvsP.KIM_RESPONSE_TO_TSA_AND_DECITABINE_DN"
19,"Up",0.842459053444908,0.948200526838457,"B.LvsP.REACTOME_PTK6_REGULATES_RHO_GTPASES_RAS_GTPASE_AND_MAP_KINASES"
13,"Down",0.842559086337012,0.948200526838457,"B.LvsP.KHETCHOUMIAN_TRIM24_TARGETS_DN"
292,"Up",0.842883456779376,0.948372534093034,"B.LvsP.SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM2"
9,"Up",0.843574692600352,0.948831497424325,"B.LvsP.SCHUHMACHER_MYC_TARGETS_DN"
20,"Up",0.843634588775182,0.948831497424325,"B.LvsP.CAFFAREL_RESPONSE_TO_THC_8HR_5_DN"
14,"Up",0.843865084830916,0.948897712839157,"B.LvsP.REACTOME_LYSINE_CATABOLISM"
267,"Up",0.844050063975881,0.948912729508468,"B.LvsP.REACTOME_PARASITE_INFECTION"
67,"Up",0.8442792885612,0.948954390910539,"B.LvsP.REACTOME_SIGNALING_BY_FGFR1"
13,"Up",0.844528327738472,0.948954390910539,"B.LvsP.CLIMENT_BREAST_CANCER_COPY_NUMBER_DN"
41,"Down",0.844602018026906,0.948954390910539,"B.LvsP.LU_TUMOR_ANGIOGENESIS_UP"
640,"Up",0.845346562905475,0.949597957396256,"B.LvsP.STEIN_ESRRA_TARGETS_UP"
20,"Up",0.845542640603596,0.949625281311656,"B.LvsP.REACTOME_WNT5A_DEPENDENT_INTERNALIZATION_OF_FZD4"
440,"Up",0.846106665578156,0.949910531981189,"B.LvsP.DAZARD_RESPONSE_TO_UV_NHEK_DN"
258,"Down",0.846140236933868,0.949910531981189,"B.LvsP.MADAN_DPPA4_TARGETS"
51,"Down",0.846652273567931,0.950292411806149,"B.LvsP.KANG_GLIS3_TARGETS"
93,"Down",0.848421377392436,0.951900485107152,"B.LvsP.VILLANUEVA_LIVER_CANCER_KRT19_DN"
183,"Up",0.848429298355588,0.951900485107152,"B.LvsP.DITTMER_PTHLH_TARGETS_UP"
99,"Down",0.849222646137431,0.952597283524823,"B.LvsP.REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS"
413,"Down",0.849789010773988,0.952784805410701,"B.LvsP.KEGG_PATHWAYS_IN_CANCER"
720,"Up",0.849924289865866,0.952784805410701,"B.LvsP.SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN"
12,"Up",0.849988467909386,0.952784805410701,"B.LvsP.IIZUKA_LIVER_CANCER_PROGRESSION_L1_G1_DN"
58,"Down",0.850079118301861,0.952784805410701,"B.LvsP.PID_HDAC_CLASSII_PATHWAY"
41,"Up",0.850350269846251,0.952895549651382,"B.LvsP.JEON_SMAD6_TARGETS_UP"
135,"Up",0.851012263099425,0.953352670579322,"B.LvsP.ANDERSEN_CHOLANGIOCARCINOMA_CLASS1"
63,"Down",0.851406872157891,0.953352670579322,"B.LvsP.JOHANSSON_BRAIN_CANCER_EARLY_VS_LATE_DN"
10,"Down",0.851476670180054,0.953352670579322,"B.LvsP.BIOCARTA_PEPI_PATHWAY"
19,"Down",0.851488508352887,0.953352670579322,"B.LvsP.KIM_MYCL1_AMPLIFICATION_TARGETS_UP"
49,"Up",0.851645033255516,0.953352670579322,"B.LvsP.NIKOLSKY_BREAST_CANCER_1Q21_AMPLICON"
17,"Down",0.85179276409149,0.953352670579322,"B.LvsP.REACTOME_REGULATION_OF_PYRUVATE_DEHYDROGENASE_PDH_COMPLEX"
59,"Down",0.852904389061352,0.953699566927361,"B.LvsP.WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2"
83,"Down",0.85306770601548,0.953699566927361,"B.LvsP.COWLING_MYCN_TARGETS"
40,"Down",0.853130139171699,0.953699566927361,"B.LvsP.TAKADA_GASTRIC_CANCER_COPY_NUMBER_DN"
29,"Down",0.853130834068435,0.953699566927361,"B.LvsP.ITO_PTTG1_TARGETS_UP"
487,"Down",0.853131991655103,0.953699566927361,"B.LvsP.BENPORATH_OCT4_TARGETS"
12,"Up",0.853413256228923,0.953699566927361,"B.LvsP.REACTOME_MYOCLONIC_EPILEPSY_OF_LAFORA"
1093,"Up",0.853419290661309,0.953699566927361,"B.LvsP.BENPORATH_SOX2_TARGETS"
182,"Up",0.853628488276536,0.953699566927361,"B.LvsP.LEE_CALORIE_RESTRICTION_NEOCORTEX_UP"
12,"Up",0.853655119682313,0.953699566927361,"B.LvsP.REACTOME_TANDEM_PORE_DOMAIN_POTASSIUM_CHANNELS"
70,"Down",0.854222235765689,0.954140351827979,"B.LvsP.WANG_TARGETS_OF_MLL_CBP_FUSION_UP"
84,"Down",0.854507139721662,0.954173530199221,"B.LvsP.SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER"
13,"Up",0.854597091978033,0.954173530199221,"B.LvsP.WANG_RESPONSE_TO_FORSKOLIN_DN"
62,"Up",0.854898703341988,0.954317571326035,"B.LvsP.REACTOME_DEACTIVATION_OF_THE_BETA_CATENIN_TRANSACTIVATING_COMPLEX"
17,"Up",0.855838704538432,0.955039423840797,"B.LvsP.REACTOME_CYTOCHROME_C_MEDIATED_APOPTOTIC_RESPONSE"
32,"Down",0.855890820244375,0.955039423840797,"B.LvsP.WEBER_METHYLATED_HCP_IN_SPERM_UP"
89,"Down",0.856641735604581,0.955607719123477,"B.LvsP.ZHAN_V2_LATE_DIFFERENTIATION_GENES"
45,"Down",0.856875286187681,0.955607719123477,"B.LvsP.LOPES_METHYLATED_IN_COLON_CANCER_DN"
78,"Down",0.856918623876686,0.955607719123477,"B.LvsP.WANG_METHYLATED_IN_BREAST_CANCER"
29,"Up",0.857401621520574,0.955953532040181,"B.LvsP.GESERICK_TERT_TARGETS_DN"
45,"Up",0.857708788471331,0.956103203922981,"B.LvsP.PID_EPHA_FWDPATHWAY"
12,"Up",0.858224173122567,0.956436741259567,"B.LvsP.VISALA_AGING_LYMPHOCYTE_UP"
21,"Up",0.858520543386727,0.956436741259567,"B.LvsP.WHITESIDE_CISPLATIN_RESISTANCE_UP"
176,"Down",0.858613923814829,0.956436741259567,"B.LvsP.NABA_ECM_AFFILIATED"
15,"Down",0.858823175234267,0.956436741259567,"B.LvsP.BERGER_MBD2_TARGETS"
14,"Down",0.858945120500099,0.956436741259567,"B.LvsP.REACTOME_CYTOSOLIC_IRON_SULFUR_CLUSTER_ASSEMBLY"
42,"Down",0.859045913744802,0.956436741259567,"B.LvsP.NOJIMA_SFRP2_TARGETS_DN"
9,"Down",0.859367995829309,0.956472833636027,"B.LvsP.REACTOME_HIGHLY_SODIUM_PERMEABLE_POSTSYNAPTIC_ACETYLCHOLINE_NICOTINIC_RECEPTORS"
14,"Up",0.859424314976267,0.956472833636027,"B.LvsP.BIOCARTA_PKC_PATHWAY"
91,"Down",0.859868276117801,0.956774340643051,"B.LvsP.ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_UP"
17,"Down",0.860198883549514,0.956949623168061,"B.LvsP.REACTOME_P75NTR_RECRUITS_SIGNALLING_COMPLEXES"
281,"Down",0.86040900113814,0.956952622036923,"B.LvsP.REACTOME_INTERFERON_SIGNALING"
78,"Down",0.860636497934138,0.956952622036923,"B.LvsP.RICKMAN_HEAD_AND_NECK_CANCER_D"
72,"Up",0.860780011741543,0.956952622036923,"B.LvsP.HAHTOLA_SEZARY_SYNDROM_DN"
661,"Down",0.861182548993057,0.956952622036923,"B.LvsP.DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_UP"
10,"Down",0.861205091034489,0.956952622036923,"B.LvsP.BIOCARTA_BBCELL_PATHWAY"
55,"Down",0.861340887803032,0.956952622036923,"B.LvsP.GENTILE_UV_LOW_DOSE_UP"
43,"Down",0.861645766870106,0.956952622036923,"B.LvsP.KEGG_BUTANOATE_METABOLISM"
6,"Down",0.861686278678531,0.956952622036923,"B.LvsP.REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_ENDOCRINE_COMMITTED_NEUROG3_PROGENITOR_CELLS"
456,"Down",0.861759288320101,0.956952622036923,"B.LvsP.REACTOME_TRANSCRIPTIONAL_REGULATION_BY_TP53"
111,"Down",0.862547534548004,0.957547081277244,"B.LvsP.BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_DN"
10,"Down",0.862640986044846,0.957547081277244,"B.LvsP.REACTOME_DISEASES_OF_DNA_REPAIR"
50,"Down",0.86286761514364,0.957606391836448,"B.LvsP.LASTOWSKA_COAMPLIFIED_WITH_MYCN"
300,"Up",0.863217462530236,0.957802398219882,"B.LvsP.REACTOME_DISEASES_OF_METABOLISM"
5,"Up",0.863501127004268,0.957898072867988,"B.LvsP.REACTOME_SODIUM_COUPLED_PHOSPHATE_COTRANSPORTERS"
176,"Down",0.863650188686366,0.957898072867988,"B.LvsP.STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_UP"
209,"Down",0.863834617439249,0.957910469278301,"B.LvsP.NABA_ECM_GLYCOPROTEINS"
24,"Up",0.864244325074411,0.957966596526146,"B.LvsP.KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_CHONDROITIN_SULFATE"
30,"Up",0.864386515035535,0.957966596526146,"B.LvsP.REACTOME_SYNTHESIS_OF_PC"
33,"Down",0.864499133797373,0.957966596526146,"B.LvsP.MCCABE_HOXC6_TARGETS_CANCER_DN"
104,"Up",0.864875832139223,0.957966596526146,"B.LvsP.REACTOME_HDACS_DEACETYLATE_HISTONES"
927,"Down",0.865091649076035,0.957966596526146,"B.LvsP.REACTOME_G_ALPHA_S_SIGNALLING_EVENTS"
19,"Up",0.865159216629909,0.957966596526146,"B.LvsP.REACTOME_INTERACTION_WITH_CUMULUS_CELLS_AND_THE_ZONA_PELLUCIDA"
33,"Down",0.865268095597568,0.957966596526146,"B.LvsP.KEGG_GALACTOSE_METABOLISM"
31,"Down",0.865556590909735,0.957966596526146,"B.LvsP.INAMURA_LUNG_CANCER_SCC_UP"
52,"Down",0.865704748233182,0.957966596526146,"B.LvsP.PID_GMCSF_PATHWAY"
10,"Down",0.865810252233002,0.957966596526146,"B.LvsP.REACTOME_CA2_ACTIVATED_K_CHANNELS"
89,"Down",0.865901521748322,0.957966596526146,"B.LvsP.REACTOME_CONSTITUTIVE_SIGNALING_BY_ABERRANT_PI3K_IN_CANCER"
89,"Down",0.866031121213455,0.957966596526146,"B.LvsP.CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_UP"
33,"Down",0.866157313126669,0.957966596526146,"B.LvsP.MATZUK_LUTEAL_GENES"
216,"Down",0.866310902989822,0.957966596526146,"B.LvsP.WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_36HR"
61,"Up",0.866810372372831,0.958318711899833,"B.LvsP.WINNEPENNINCKX_MELANOMA_METASTASIS_DN"
85,"Down",0.866975980633562,0.958318711899833,"B.LvsP.GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN"
7,"Down",0.867164520526981,0.958335525483445,"B.LvsP.REACTOME_PHASE_1_INACTIVATION_OF_FAST_NA_CHANNELS"
11,"Down",0.867491825983528,0.958505656647268,"B.LvsP.REACTOME_AKT_PHOSPHORYLATES_TARGETS_IN_THE_NUCLEUS"
13,"Up",0.868096564842363,0.958982199203481,"B.LvsP.PID_ALK2_PATHWAY"
18,"Down",0.868704256276497,0.959358194437267,"B.LvsP.REACTOME_GLYCOGEN_SYNTHESIS"
62,"Up",0.86886970289783,0.959358194437267,"B.LvsP.REACTOME_XENOBIOTICS"
701,"Up",0.869084657279903,0.959358194437267,"B.LvsP.ENK_UV_RESPONSE_KERATINOCYTE_DN"
51,"Down",0.869130981359427,0.959358194437267,"B.LvsP.KEGG_AMINO_SUGAR_AND_NUCLEOTIDE_SUGAR_METABOLISM"
64,"Down",0.869611196812184,0.959415768799687,"B.LvsP.SAENZ_DETOX_PATHWAY_AND_CARCINOGENESIS_DN"
25,"Down",0.869712807850134,0.959415768799687,"B.LvsP.BIOCARTA_IL3_PATHWAY"
10,"Down",0.869839304061933,0.959415768799687,"B.LvsP.REACTOME_HYDROLYSIS_OF_LPC"
19,"Up",0.869993429550089,0.959415768799687,"B.LvsP.REACTOME_TRANSPORT_OF_CONNEXONS_TO_THE_PLASMA_MEMBRANE"
6,"Down",0.870050762300892,0.959415768799687,"B.LvsP.REACTOME_SEROTONIN_AND_MELATONIN_BIOSYNTHESIS"
13,"Up",0.870279319682183,0.959476442377425,"B.LvsP.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_29"
557,"Up",0.870701338428051,0.959750338949102,"B.LvsP.OSMAN_BLADDER_CANCER_UP"
892,"Up",0.870900805929025,0.959778863061905,"B.LvsP.DOUGLAS_BMI1_TARGETS_UP"
111,"Down",0.871259492515657,0.959870147608041,"B.LvsP.CHESLER_BRAIN_QTL_CIS"
23,"Down",0.871330850216089,0.959870147608041,"B.LvsP.REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB"
73,"Down",0.872135303870609,0.960564959183386,"B.LvsP.PID_ANGIOPOIETIN_RECEPTOR_PATHWAY"
126,"Down",0.872529928299059,0.960658804656484,"B.LvsP.REACTOME_CARGO_RECOGNITION_FOR_CLATHRIN_MEDIATED_ENDOCYTOSIS"
484,"Down",0.872568008136166,0.960658804656484,"B.LvsP.RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP"
34,"Up",0.873301438926207,0.961274866777423,"B.LvsP.ZHU_SKIL_TARGETS_UP"
25,"Down",0.873891613272655,0.961721796541205,"B.LvsP.BIOCARTA_ERAD_PATHWAY"
93,"Down",0.874522729564636,0.961721796541205,"B.LvsP.REACTOME_ERCC6_CSB_AND_EHMT2_G9A_POSITIVELY_REGULATE_RRNA_EXPRESSION"
67,"Up",0.874555630217172,0.961721796541205,"B.LvsP.TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN"
48,"Up",0.874585343006156,0.961721796541205,"B.LvsP.BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_UP"
12,"Up",0.875565164872953,0.961721796541205,"B.LvsP.BIOCARTA_MALATEX_PATHWAY"
45,"Down",0.875684670926601,0.961721796541205,"B.LvsP.REACTOME_OVARIAN_TUMOR_DOMAIN_PROTEASES"
18,"Up",0.875970445625962,0.961721796541205,"B.LvsP.REACTOME_SEMA4D_MEDIATED_INHIBITION_OF_CELL_ATTACHMENT_AND_MIGRATION"
28,"Up",0.876055708193576,0.961721796541205,"B.LvsP.NELSON_RESPONSE_TO_ANDROGEN_DN"
200,"Up",0.876116622223741,0.961721796541205,"B.LvsP.CAMPS_COLON_CANCER_COPY_NUMBER_DN"
11,"Down",0.876263591036408,0.961721796541205,"B.LvsP.REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_DIFFERENTIATION_OF_MYELOID_CELLS"
18,"Down",0.876309768842822,0.961721796541205,"B.LvsP.LI_WILMS_TUMOR_ANAPLASTIC_DN"
658,"Down",0.87639095847098,0.961721796541205,"B.LvsP.DELACROIX_RAR_BOUND_ES"
84,"Up",0.876487026805691,0.961721796541205,"B.LvsP.BECKER_TAMOXIFEN_RESISTANCE_UP"
18,"Down",0.876571450629577,0.961721796541205,"B.LvsP.REACTOME_ATF6_ATF6_ALPHA_ACTIVATES_CHAPERONES"
26,"Up",0.876595325521033,0.961721796541205,"B.LvsP.KEGG_SELENOAMINO_ACID_METABOLISM"
17,"Up",0.87665606967813,0.961721796541205,"B.LvsP.REACTOME_IRAK1_RECRUITS_IKK_COMPLEX"
10,"Up",0.876664469988727,0.961721796541205,"B.LvsP.RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_SMAD4_UP"
28,"Up",0.876879118285498,0.961766444158008,"B.LvsP.REACTOME_ENDOGENOUS_STEROLS"
27,"Up",0.877648886012955,0.962312093228775,"B.LvsP.REACTOME_PHASE_2_PLATEAU_PHASE"
293,"Up",0.877805541989882,0.962312093228775,"B.LvsP.TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP"
13,"Down",0.878072497440066,0.962312093228775,"B.LvsP.GERHOLD_RESPONSE_TO_TZD_DN"
15,"Up",0.878072799844306,0.962312093228775,"B.LvsP.REACTOME_HEME_BIOSYNTHESIS"
13,"Up",0.87825434548407,0.962320308399013,"B.LvsP.REACTOME_PREVENTION_OF_PHAGOSOMAL_LYSOSOMAL_FUSION"
181,"Down",0.878458128794969,0.962352881733185,"B.LvsP.REACTOME_REGULATION_OF_TP53_ACTIVITY"
12,"Down",0.879127940737279,0.962497996979831,"B.LvsP.GILMORE_CORE_NFKB_PATHWAY"
9,"Up",0.879369617382578,0.962497996979831,"B.LvsP.REACTOME_SUMO_IS_PROTEOLYTICALLY_PROCESSED"
8,"Down",0.879533499129206,0.962497996979831,"B.LvsP.CHENG_TAF7L_TARGETS"
186,"Up",0.879595764361041,0.962497996979831,"B.LvsP.REACTOME_HCMV_INFECTION"
499,"Up",0.879631954907419,0.962497996979831,"B.LvsP.KAYO_AGING_MUSCLE_UP"
30,"Up",0.879740671175175,0.962497996979831,"B.LvsP.REACTOME_OTHER_INTERLEUKIN_SIGNALING"
51,"Up",0.879809165624175,0.962497996979831,"B.LvsP.REACTOME_SIGNALING_BY_FGFR2_IN_DISEASE"
28,"Up",0.880486646435014,0.96264397393652,"B.LvsP.PID_CONE_PATHWAY"
31,"Up",0.880569261831509,0.96264397393652,"B.LvsP.GHANDHI_BYSTANDER_IRRADIATION_DN"
9,"Down",0.88066929572721,0.96264397393652,"B.LvsP.REACTOME_THE_ACTIVATION_OF_ARYLSULFATASES"
91,"Down",0.8806860324043,0.96264397393652,"B.LvsP.PID_TELOMERASE_PATHWAY"
169,"Down",0.880813142366586,0.96264397393652,"B.LvsP.SERVITJA_ISLET_HNF1A_TARGETS_DN"
52,"Up",0.881437729035066,0.963136206291478,"B.LvsP.REACTOME_CHONDROITIN_SULFATE_DERMATAN_SULFATE_METABOLISM"
54,"Down",0.881983346524421,0.963162169900674,"B.LvsP.ROZANOV_MMP14_TARGETS_DN"
421,"Up",0.882022264611618,0.963162169900674,"B.LvsP.FORTSCHEGGER_PHF8_TARGETS_UP"
167,"Down",0.882072700747973,0.963162169900674,"B.LvsP.SMID_BREAST_CANCER_RELAPSE_IN_BONE_UP"
78,"Down",0.882432325960377,0.963162169900674,"B.LvsP.KIM_ALL_DISORDERS_CALB1_CORR_DN"
6,"Down",0.882632199563127,0.963162169900674,"B.LvsP.REACTOME_GDP_FUCOSE_BIOSYNTHESIS"
44,"Down",0.882728270473327,0.963162169900674,"B.LvsP.REACTOME_NEGATIVE_REGULATION_OF_FGFR2_SIGNALING"
46,"Up",0.882801318489321,0.963162169900674,"B.LvsP.VERNELL_RETINOBLASTOMA_PATHWAY_DN"
63,"Up",0.882855105273398,0.963162169900674,"B.LvsP.REACTOME_SYNTHESIS_OF_SUBSTRATES_IN_N_GLYCAN_BIOSYTHESIS"
221,"Down",0.883475095129855,0.963548984165376,"B.LvsP.RODWELL_AGING_KIDNEY_NO_BLOOD_DN"
94,"Up",0.883558211198853,0.963548984165376,"B.LvsP.ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_DN"
49,"Down",0.884906722172182,0.964455222850814,"B.LvsP.REACTOME_THE_PHOTOTRANSDUCTION_CASCADE"
126,"Up",0.884991365925187,0.964455222850814,"B.LvsP.REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS"
20,"Down",0.885057888509194,0.964455222850814,"B.LvsP.REACTOME_HDL_ASSEMBLY"
365,"Up",0.885643807512961,0.964455222850814,"B.LvsP.PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP"
452,"Down",0.885707347476319,0.964455222850814,"B.LvsP.REACTOME_DISEASES_OF_SIGNAL_TRANSDUCTION_BY_GROWTH_FACTOR_RECEPTORS_AND_SECOND_MESSENGERS"
48,"Up",0.885750368105654,0.964455222850814,"B.LvsP.BIOCARTA_CARM_ER_PATHWAY"
127,"Down",0.885922731431651,0.964455222850814,"B.LvsP.ZHANG_GATA6_TARGETS_DN"
102,"Up",0.88614879486525,0.964455222850814,"B.LvsP.HUPER_BREAST_BASAL_VS_LUMINAL_UP"
391,"Down",0.886174938688342,0.964455222850814,"B.LvsP.AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_UP"
14,"Down",0.886337861834233,0.964455222850814,"B.LvsP.KEGG_LIMONENE_AND_PINENE_DEGRADATION"
33,"Down",0.886417535032364,0.964455222850814,"B.LvsP.KORKOLA_CHORIOCARCINOMA_DN"
58,"Down",0.886482445745675,0.964455222850814,"B.LvsP.WEINMANN_ADAPTATION_TO_HYPOXIA_UP"
31,"Up",0.887009293359859,0.96473970931905,"B.LvsP.OUYANG_PROSTATE_CANCER_PROGRESSION_UP"
65,"Up",0.887263300329298,0.96473970931905,"B.LvsP.NAKAMURA_CANCER_MICROENVIRONMENT_UP"
44,"Down",0.887267394083445,0.96473970931905,"B.LvsP.BIOCARTA_EICOSANOID_PATHWAY"
102,"Down",0.887964293826436,0.96526308579137,"B.LvsP.DAWSON_METHYLATED_IN_LYMPHOMA_TCL1"
78,"Up",0.888140735806219,0.96526308579137,"B.LvsP.PID_PS1_PATHWAY"
646,"Up",0.888417230762864,0.96526308579137,"B.LvsP.MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP"
17,"Down",0.888501505618703,0.96526308579137,"B.LvsP.REACTOME_DISEASES_ASSOCIATED_WITH_SURFACTANT_METABOLISM"
630,"Down",0.888621650692363,0.96526308579137,"B.LvsP.FOSTER_TOLERANT_MACROPHAGE_DN"
97,"Up",0.889112801058234,0.965606890011978,"B.LvsP.BEIER_GLIOMA_STEM_CELL_DN"
28,"Down",0.889890173207905,0.966083538410618,"B.LvsP.MATZUK_OVULATION"
72,"Down",0.890034634957694,0.966083538410618,"B.LvsP.PIONTEK_PKD1_TARGETS_UP"
116,"Up",0.890137067424252,0.966083538410618,"B.LvsP.PID_P73PATHWAY"
122,"Up",0.890297333990479,0.966083538410618,"B.LvsP.WNT_SIGNALING"
12,"Down",0.890546040387051,0.966083538410618,"B.LvsP.KORKOLA_CHORIOCARCINOMA"
55,"Down",0.890658511884233,0.966083538410618,"B.LvsP.PID_LYMPH_ANGIOGENESIS_PATHWAY"
12,"Down",0.890774801739434,0.966083538410618,"B.LvsP.ZERBINI_RESPONSE_TO_SULINDAC_UP"
15,"Up",0.891182142193922,0.966335764697038,"B.LvsP.KEGG_GLYCOSPHINGOLIPID_BIOSYNTHESIS_GANGLIO_SERIES"
69,"Up",0.891609062489734,0.966609118922694,"B.LvsP.REACTOME_REGULATION_OF_PTEN_GENE_TRANSCRIPTION"
27,"Down",0.8920973926234,0.966842050585018,"B.LvsP.BIOCARTA_STATHMIN_PATHWAY"
7,"Up",0.892247674858851,0.966842050585018,"B.LvsP.REACTOME_RESPONSE_TO_METAL_IONS"
38,"Down",0.89245182890751,0.966842050585018,"B.LvsP.REACTOME_INTEGRIN_SIGNALING"
780,"Down",0.892523390520154,0.966842050585018,"B.LvsP.REACTOME_OLFACTORY_SIGNALING_PATHWAY"
21,"Down",0.892846927819423,0.967003068347422,"B.LvsP.SILIGAN_TARGETS_OF_EWS_FLI1_FUSION_UP"
77,"Up",0.893118906668608,0.967108193296266,"B.LvsP.HAHTOLA_CTCL_CUTANEOUS"
22,"Up",0.8936835836564,0.967530161354266,"B.LvsP.KEGG_SULFUR_METABOLISM"
85,"Up",0.893909808718629,0.967585617150607,"B.LvsP.WINTER_HYPOXIA_DN"
584,"Down",0.894413965067021,0.967941830662666,"B.LvsP.MULLIGHAN_MLL_SIGNATURE_1_UP"
10,"Up",0.894744414073449,0.9680267418968,"B.LvsP.REACTOME_MET_ACTIVATES_PI3K_AKT_SIGNALING"
32,"Down",0.894842589588451,0.9680267418968,"B.LvsP.REACTOME_SEMA3A_PAK_DEPENDENT_AXON_REPULSION"
26,"Up",0.896178848070047,0.969282639080456,"B.LvsP.LOPEZ_MESOTHELIOMA_SURVIVAL_WORST_VS_BEST_UP"
51,"Down",0.896980269970854,0.969539367808037,"B.LvsP.XU_AKT1_TARGETS_6HR"
13,"Down",0.897041200935453,0.969539367808037,"B.LvsP.REACTOME_REGULATION_OF_GLYCOLYSIS_BY_FRUCTOSE_2_6_BISPHOSPHATE_METABOLISM"
39,"Up",0.897049437569135,0.969539367808037,"B.LvsP.KEGG_THYROID_CANCER"
23,"Down",0.897117635323914,0.969539367808037,"B.LvsP.HE_PTEN_TARGETS_UP"
315,"Down",0.897761148866771,0.970045220262728,"B.LvsP.KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_DN"
30,"Up",0.897996208485019,0.970099057221097,"B.LvsP.KEGG_BETA_ALANINE_METABOLISM"
64,"Up",0.898161887125121,0.970099057221097,"B.LvsP.PID_LKB1_PATHWAY"
31,"Down",0.898578192483411,0.970359145750152,"B.LvsP.XU_HGF_TARGETS_INDUCED_BY_AKT1_6HR"
78,"Down",0.899452008145107,0.970995844865087,"B.LvsP.REACTOME_BIOSYNTHESIS_OF_THE_N_GLYCAN_PRECURSOR_DOLICHOL_LIPID_LINKED_OLIGOSACCHARIDE_LLO_AND_TRANSFER_TO_A_NASCENT_PROTEIN"
20,"Down",0.899519030095673,0.970995844865087,"B.LvsP.PID_LPA4_PATHWAY"
110,"Down",0.89971443664149,0.971017200896116,"B.LvsP.KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY"
97,"Down",0.900186061620637,0.971336599278006,"B.LvsP.AUNG_GASTRIC_CANCER"
9,"Down",0.900807262269476,0.971573993084099,"B.LvsP.REACTOME_ESTROGEN_BIOSYNTHESIS"
242,"Up",0.900851192481255,0.971573993084099,"B.LvsP.REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS"
101,"Down",0.900933236126276,0.971573993084099,"B.LvsP.KEGG_APOPTOSIS"
25,"Down",0.901311900557824,0.971792803858075,"B.LvsP.REACTOME_GLUCURONIDATION"
246,"Down",0.901667909778278,0.971987107265373,"B.LvsP.KAAB_FAILED_HEART_ATRIUM_DN"
18,"Down",0.901902990338632,0.972051000698304,"B.LvsP.REACTOME_WNT5A_DEPENDENT_INTERNALIZATION_OF_FZD2_FZD5_AND_ROR2"
13,"Down",0.903000049807592,0.973032521889503,"B.LvsP.PETRETTO_BLOOD_PRESSURE_DN"
23,"Up",0.903165654247952,0.973032521889503,"B.LvsP.REACTOME_GAB1_SIGNALOSOME"
37,"Up",0.903994151787721,0.973668076427541,"B.LvsP.REACTOME_CYP2E1_REACTIONS"
7,"Down",0.904107777966901,0.973668076427541,"B.LvsP.REACTOME_ALPHA_OXIDATION_OF_PHYTANATE"
180,"Down",0.904436840430438,0.973832773269697,"B.LvsP.KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY"
56,"Up",0.904864446488332,0.974103489998829,"B.LvsP.BOYAULT_LIVER_CANCER_SUBCLASS_G5_DN"
366,"Down",0.905645931153049,0.974664880896162,"B.LvsP.GROSS_HYPOXIA_VIA_ELK3_UP"
1113,"Up",0.905738498470696,0.974664880896162,"B.LvsP.MARTINEZ_RB1_TARGETS_UP"
58,"Up",0.906477516728831,0.975270323018818,"B.LvsP.WANG_RESPONSE_TO_ANDROGEN_UP"
1397,"Down",0.906921019490004,0.975557649175143,"B.LvsP.ACEVEDO_LIVER_CANCER_UP"
341,"Down",0.907280661390774,0.975647726954481,"B.LvsP.GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_DN"
382,"Down",0.907368546867073,0.975647726954481,"B.LvsP.CAIRO_HEPATOBLASTOMA_CLASSES_DN"
30,"Up",0.907654169818604,0.975647726954481,"B.LvsP.BIOCARTA_CARDIACEGF_PATHWAY"
12,"Up",0.90771060000974,0.975647726954481,"B.LvsP.REACTOME_P2Y_RECEPTORS"
13,"Up",0.90815140897547,0.975931805680344,"B.LvsP.REACTOME_TRIGLYCERIDE_BIOSYNTHESIS"
175,"Up",0.908461419336076,0.976075240479822,"B.LvsP.REACTOME_L1CAM_INTERACTIONS"
75,"Up",0.908855346119584,0.976308764075224,"B.LvsP.LUI_THYROID_CANCER_PAX8_PPARG_UP"
336,"Down",0.909498154322025,0.976809497911126,"B.LvsP.CHANDRAN_METASTASIS_UP"
28,"Down",0.909806345808054,0.976950725572487,"B.LvsP.REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_ADDITIONAL_CELL_CYCLE_GENES_WHOSE_EXACT_ROLE_IN_THE_P53_PATHWAY_REMAIN_UNCERTAIN"
56,"Down",0.910391332836912,0.977270850034685,"B.LvsP.REACTOME_AQUAPORIN_MEDIATED_TRANSPORT"
153,"Down",0.91047409222567,0.977270850034685,"B.LvsP.CASTELLANO_NRAS_TARGETS_UP"
25,"Up",0.910634729495153,0.977270850034685,"B.LvsP.GRANDVAUX_IRF3_TARGETS_DN"
1681,"Down",0.91112132502877,0.977461430647611,"B.LvsP.REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION"
40,"Up",0.9111658914013,0.977461430647611,"B.LvsP.REACTOME_ALPHA_DEFENSINS"
41,"Down",0.911574720535763,0.977569032906702,"B.LvsP.TUOMISTO_TUMOR_SUPPRESSION_BY_COL13A1_DN"
7,"Down",0.911619810755463,0.977569032906702,"B.LvsP.REACTOME_CHYLOMICRON_CLEARANCE"
233,"Up",0.91182350678253,0.977597860965795,"B.LvsP.PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_UP"
112,"Down",0.91254793621405,0.977791062973886,"B.LvsP.DELASERNA_MYOD_TARGETS_DN"
37,"Down",0.912872407872813,0.977791062973886,"B.LvsP.MATTHEWS_SKIN_CARCINOGENESIS_VIA_JUN"
56,"Down",0.913029851243543,0.977791062973886,"B.LvsP.KEGG_BLADDER_CANCER"
42,"Down",0.913168729767593,0.977791062973886,"B.LvsP.REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES"
156,"Down",0.913258792505226,0.977791062973886,"B.LvsP.LEE_AGING_CEREBELLUM_UP"
69,"Up",0.913409165472347,0.977791062973886,"B.LvsP.GENTILE_UV_HIGH_DOSE_UP"
89,"Down",0.913443508627685,0.977791062973886,"B.LvsP.ROY_WOUND_BLOOD_VESSEL_UP"
627,"Up",0.913478357896801,0.977791062973886,"B.LvsP.SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12"
7,"Up",0.913595339360299,0.977791062973886,"B.LvsP.REACTOME_APEX1_INDEPENDENT_RESOLUTION_OF_AP_SITES_VIA_THE_SINGLE_NUCLEOTIDE_REPLACEMENT_PATHWAY"
60,"Up",0.913838833862454,0.977843352188578,"B.LvsP.PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_UP"
15,"Up",0.914132954035131,0.977843352188578,"B.LvsP.KEGG_GLYCOSPHINGOLIPID_BIOSYNTHESIS_GLOBO_SERIES"
127,"Down",0.91431676598463,0.977843352188578,"B.LvsP.BURTON_ADIPOGENESIS_9"
70,"Up",0.914707957988348,0.977843352188578,"B.LvsP.ZHAN_MULTIPLE_MYELOMA_CD1_DN"
28,"Down",0.914799992893474,0.977843352188578,"B.LvsP.REACTOME_G_BETA_GAMMA_SIGNALLING_THROUGH_PI3KGAMMA"
15,"Down",0.91499082768361,0.977843352188578,"B.LvsP.REACTOME_REGULATION_OF_PTEN_LOCALIZATION"
42,"Down",0.915004749762628,0.977843352188578,"B.LvsP.REACTOME_EGFR_DOWNREGULATION"
57,"Up",0.915059053033767,0.977843352188578,"B.LvsP.LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_DN"
20,"Up",0.915359321515031,0.977895443747782,"B.LvsP.SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX5_DN"
27,"Up",0.915461533159436,0.977895443747782,"B.LvsP.REACTOME_METABOLISM_OF_NITRIC_OXIDE_ENOS_ACTIVATION_AND_REGULATION"
51,"Down",0.915976476523406,0.9780567022171,"B.LvsP.LE_SKI_TARGETS_UP"
9,"Down",0.916109203874566,0.9780567022171,"B.LvsP.HE_PTEN_TARGETS_DN"
19,"Up",0.916143183357273,0.9780567022171,"B.LvsP.REACTOME_RIP_MEDIATED_NFKB_ACTIVATION_VIA_ZBP1"
58,"Up",0.916536053986777,0.978134794898503,"B.LvsP.PID_FOXO_PATHWAY"
400,"Up",0.916926740591876,0.978134794898503,"B.LvsP.ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN"
1236,"Down",0.917201548114171,0.978134794898503,"B.LvsP.NUYTTEN_NIPP1_TARGETS_DN"
61,"Down",0.917256721479615,0.978134794898503,"B.LvsP.RIZ_ERYTHROID_DIFFERENTIATION_6HR"
9,"Down",0.917298622215379,0.978134794898503,"B.LvsP.REACTOME_RRNA_MODIFICATION_IN_THE_MITOCHONDRION"
12,"Up",0.917431581713514,0.978134794898503,"B.LvsP.BIOCARTA_RHODOPSIN_PATHWAY"
64,"Down",0.918027625182714,0.978134794898503,"B.LvsP.REACTOME_METABOLISM_OF_FAT_SOLUBLE_VITAMINS"
201,"Down",0.918168221650015,0.978134794898503,"B.LvsP.BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_CIS"
28,"Down",0.918220750751862,0.978134794898503,"B.LvsP.SU_KIDNEY"
12,"Down",0.918425745399357,0.978134794898503,"B.LvsP.MIZUKAMI_HYPOXIA_DN"
109,"Down",0.918534678551809,0.978134794898503,"B.LvsP.FIGUEROA_AML_METHYLATION_CLUSTER_5_DN"
25,"Up",0.91856630339605,0.978134794898503,"B.LvsP.INGA_TP53_TARGETS"
667,"Up",0.91859797836767,0.978134794898503,"B.LvsP.CHYLA_CBFA2T3_TARGETS_UP"
37,"Down",0.918693071063109,0.978134794898503,"B.LvsP.MATZUK_CENTRAL_FOR_FEMALE_FERTILITY"
43,"Up",0.919058826577733,0.978335820590737,"B.LvsP.LIU_VAV3_PROSTATE_CARCINOGENESIS_DN"
13,"Up",0.919622768660359,0.978567242705132,"B.LvsP.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_16"
164,"Down",0.919735146609483,0.978567242705132,"B.LvsP.XU_HGF_TARGETS_REPRESSED_BY_AKT1_DN"
24,"Up",0.919807191235046,0.978567242705132,"B.LvsP.REACTOME_DCC_MEDIATED_ATTRACTIVE_SIGNALING"
494,"Down",0.920249480344527,0.978765034382703,"B.LvsP.KAAB_HEART_ATRIUM_VS_VENTRICLE_UP"
47,"Up",0.920347153871527,0.978765034382703,"B.LvsP.REACTOME_FATTY_ACIDS"
42,"Up",0.920538638879968,0.978780410455258,"B.LvsP.JI_METASTASIS_REPRESSED_BY_STK11"
118,"Down",0.920752314737742,0.978819370925779,"B.LvsP.GENTILE_UV_LOW_DOSE_DN"
139,"Down",0.920948724854206,0.978839965343888,"B.LvsP.GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP"
14,"Down",0.921741944148115,0.979106771566815,"B.LvsP.REACTOME_DEGRADATION_OF_CYSTEINE_AND_HOMOCYSTEINE"
84,"Down",0.921918611927342,0.979106771566815,"B.LvsP.REACTOME_INTERLEUKIN_17_SIGNALING"
18,"Up",0.922119535531486,0.979106771566815,"B.LvsP.RANKIN_ANGIOGENIC_TARGETS_OF_VHL_HIF2A_DN"
36,"Down",0.922183817818444,0.979106771566815,"B.LvsP.WANG_BARRETTS_ESOPHAGUS_DN"
501,"Up",0.922243400031041,0.979106771566815,"B.LvsP.JAATINEN_HEMATOPOIETIC_STEM_CELL_UP"
6,"Down",0.922262265567005,0.979106771566815,"B.LvsP.REACTOME_FORMATION_OF_XYLULOSE_5_PHOSPHATE"
37,"Up",0.922968751102991,0.97955686604583,"B.LvsP.PID_INSULIN_GLUCOSE_PATHWAY"
9,"Down",0.92305714892245,0.97955686604583,"B.LvsP.BIOCARTA_CREM_PATHWAY"
33,"Down",0.92321772996289,0.97955686604583,"B.LvsP.REACTOME_CYTOSOLIC_SULFONATION_OF_SMALL_MOLECULES"
38,"Up",0.924559607356328,0.979565054238759,"B.LvsP.MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP"
1242,"Down",0.924661258217316,0.979565054238759,"B.LvsP.KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3"
11,"Up",0.925182045487636,0.979565054238759,"B.LvsP.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_25"
443,"Up",0.925226172030721,0.979565054238759,"B.LvsP.BILD_HRAS_ONCOGENIC_SIGNATURE"
13,"Down",0.925543762343422,0.979565054238759,"B.LvsP.REACTOME_P75NTR_REGULATES_AXONOGENESIS"
119,"Down",0.925745584829814,0.979565054238759,"B.LvsP.BRUNO_HEMATOPOIESIS"
14,"Down",0.925758247334147,0.979565054238759,"B.LvsP.REACTOME_ACETYLCHOLINE_BINDING_AND_DOWNSTREAM_EVENTS"
454,"Up",0.925772680811225,0.979565054238759,"B.LvsP.KONDO_EZH2_TARGETS"
28,"Up",0.925832031179053,0.979565054238759,"B.LvsP.REACTOME_DISEASES_OF_IMMUNE_SYSTEM"
14,"Down",0.926737006497479,0.979565054238759,"B.LvsP.BIOCARTA_P35ALZHEIMERS_PATHWAY"
183,"Up",0.927164070678675,0.979565054238759,"B.LvsP.REACTOME_CD22_MEDIATED_BCR_REGULATION"
214,"Up",0.927272879493926,0.979565054238759,"B.LvsP.REACTOME_ROLE_OF_PHOSPHOLIPIDS_IN_PHAGOCYTOSIS"
19,"Down",0.927276999217189,0.979565054238759,"B.LvsP.DORN_ADENOVIRUS_INFECTION_24HR_UP"
22,"Up",0.927354325037786,0.979565054238759,"B.LvsP.NADERI_BREAST_CANCER_PROGNOSIS_DN"
63,"Down",0.927374069065807,0.979565054238759,"B.LvsP.KEGG_VIBRIO_CHOLERAE_INFECTION"
15,"Down",0.927511060029076,0.979565054238759,"B.LvsP.REACTOME_APOPTOSIS_INDUCED_DNA_FRAGMENTATION"
104,"Down",0.92789501378255,0.979565054238759,"B.LvsP.ZHENG_IL22_SIGNALING_DN"
119,"Up",0.927932321728274,0.979565054238759,"B.LvsP.MEISSNER_BRAIN_HCP_WITH_H3_UNMETHYLATED"
13,"Up",0.92808668374469,0.979565054238759,"B.LvsP.REACTOME_CAMK_IV_MEDIATED_PHOSPHORYLATION_OF_CREB"
13,"Up",0.92808668374469,0.979565054238759,"B.LvsP.REACTOME_CREB1_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_CAMKII_CAMKK_CAMKIV_CASCASDE"
5,"Up",0.928727973001565,0.979565054238759,"B.LvsP.REACTOME_SODIUM_COUPLED_SULPHATE_DI_AND_TRI_CARBOXYLATE_TRANSPORTERS"
25,"Down",0.928866314554702,0.979565054238759,"B.LvsP.REACTOME_REGULATION_OF_INNATE_IMMUNE_RESPONSES_TO_CYTOSOLIC_DNA"
29,"Up",0.929012285656533,0.979565054238759,"B.LvsP.EHRLICH_ICF_SYNDROM_DN"
22,"Down",0.929160991316162,0.979565054238759,"B.LvsP.REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE_FGFR2"
52,"Down",0.929225384231951,0.979565054238759,"B.LvsP.SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_DN"
283,"Down",0.929262233075041,0.979565054238759,"B.LvsP.TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP"
28,"Up",0.929371025323383,0.979565054238759,"B.LvsP.HOLLEMAN_PREDNISOLONE_RESISTANCE_B_ALL_UP"
53,"Up",0.929371536424427,0.979565054238759,"B.LvsP.HEIDENBLAD_AMPLICON_8Q24_DN"
27,"Down",0.929416438792424,0.979565054238759,"B.LvsP.KASLER_HDAC7_TARGETS_1_DN"
128,"Down",0.929475782653267,0.979565054238759,"B.LvsP.ISSAEVA_MLL2_TARGETS"
25,"Down",0.929803424413272,0.979565054238759,"B.LvsP.REACTOME_SIGNALING_BY_ERBB2_ECD_MUTANTS"
258,"Down",0.929822419148459,0.979565054238759,"B.LvsP.REACTOME_FATTY_ACID_METABOLISM"
156,"Down",0.930227076170657,0.979565054238759,"B.LvsP.MARKEY_RB1_CHRONIC_LOF_UP"
83,"Up",0.930371918837884,0.979565054238759,"B.LvsP.BIOCARTA_NUCLEARRS_PATHWAY"
13,"Up",0.930488033411592,0.979565054238759,"B.LvsP.REACTOME_SMAC_XIAP_REGULATED_APOPTOTIC_RESPONSE"
27,"Down",0.930529645383655,0.979565054238759,"B.LvsP.JIANG_HYPOXIA_VIA_VHL"
17,"Up",0.930578925150596,0.979565054238759,"B.LvsP.REACTOME_ELEVATION_OF_CYTOSOLIC_CA2_LEVELS"
9,"Up",0.930683000931628,0.979565054238759,"B.LvsP.SHARMA_PILOCYTIC_ASTROCYTOMA_LOCATION_DN"
16,"Down",0.930916666296445,0.979565054238759,"B.LvsP.REACTOME_NUCLEOTIDE_LIKE_PURINERGIC_RECEPTORS"
17,"Down",0.931018675929887,0.979565054238759,"B.LvsP.REACTOME_CREB1_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_ADENYLATE_CYCLASE"
103,"Up",0.931076500284573,0.979565054238759,"B.LvsP.KUMAR_AUTOPHAGY_NETWORK"
117,"Up",0.931351069513573,0.979565054238759,"B.LvsP.REACTOME_TRANSCRIPTIONAL_REGULATION_OF_GRANULOPOIESIS"
24,"Up",0.931484343450646,0.979565054238759,"B.LvsP.REACTOME_CONSTITUTIVE_SIGNALING_BY_EGFRVIII"
43,"Down",0.931581072485386,0.979565054238759,"B.LvsP.REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN"
201,"Up",0.931660984568952,0.979565054238759,"B.LvsP.REACTOME_ROLE_OF_LAT2_NTAL_LAB_ON_CALCIUM_MOBILIZATION"
20,"Up",0.931912752051567,0.979565054238759,"B.LvsP.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_27"
144,"Down",0.932008295840371,0.979565054238759,"B.LvsP.LIANG_SILENCED_BY_METHYLATION_2"
11,"Up",0.93202830937448,0.979565054238759,"B.LvsP.REACTOME_HORMONE_LIGAND_BINDING_RECEPTORS"
7,"Up",0.93206041109557,0.979565054238759,"B.LvsP.REACTOME_RSK_ACTIVATION"
60,"Up",0.932083875990253,0.979565054238759,"B.LvsP.MIKKELSEN_MCV6_ICP_WITH_H3K4ME3_AND_H3K27ME3"
48,"Up",0.932634324258206,0.979704773678343,"B.LvsP.REACTOME_VASOPRESSIN_REGULATES_RENAL_WATER_HOMEOSTASIS_VIA_AQUAPORINS"
18,"Down",0.932732167320995,0.979704773678343,"B.LvsP.MAINA_VHL_TARGETS_UP"
22,"Down",0.932748404529353,0.979704773678343,"B.LvsP.BIOCARTA_PRION_PATHWAY"
5,"Up",0.933493717367562,0.980301379548955,"B.LvsP.REACTOME_MRNA_EDITING_C_TO_U_CONVERSION"
141,"Up",0.934179687164757,0.980711285903059,"B.LvsP.BRUINS_UVC_RESPONSE_MIDDLE"
257,"Down",0.93440204861019,0.980711285903059,"B.LvsP.GAVIN_FOXP3_TARGETS_CLUSTER_P3"
104,"Down",0.934416179080723,0.980711285903059,"B.LvsP.MORI_IMMATURE_B_LYMPHOCYTE_UP"
14,"Up",0.93490473482386,0.980879224202481,"B.LvsP.REACTOME_CROSS_PRESENTATION_OF_PARTICULATE_EXOGENOUS_ANTIGENS_PHAGOSOMES"
116,"Up",0.93493100226932,0.980879224202481,"B.LvsP.JAIN_NFKB_SIGNALING"
87,"Down",0.935353214538151,0.981136012745482,"B.LvsP.BROWNE_HCMV_INFECTION_8HR_DN"
456,"Up",0.935569244588224,0.981176470661664,"B.LvsP.GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN"
44,"Up",0.935927519702214,0.981366064182352,"B.LvsP.REACTOME_CA_DEPENDENT_EVENTS"
12,"Up",0.936260778498833,0.981529359939335,"B.LvsP.REACTOME_RUNX2_REGULATES_CHONDROCYTE_MATURATION"
123,"Up",0.936787166764131,0.981727224982346,"B.LvsP.LI_WILMS_TUMOR"
11,"Down",0.936870342925422,0.981727224982346,"B.LvsP.REACTOME_PEPTIDE_HORMONE_BIOSYNTHESIS"
734,"Up",0.936982196822543,0.981727224982346,"B.LvsP.FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_UP"
7,"Down",0.937300553986843,0.981874718263216,"B.LvsP.REACTOME_DEX_H_BOX_HELICASES_ACTIVATE_TYPE_I_IFN_AND_INFLAMMATORY_CYTOKINES_PRODUCTION"
15,"Down",0.937874784410819,0.981914053039539,"B.LvsP.PETRETTO_LEFT_VENTRICLE_MASS_QTL_CIS_DN"
12,"Down",0.938132968002428,0.981914053039539,"B.LvsP.FOURNIER_ACINAR_DEVELOPMENT_EARLY_DN"
1509,"Down",0.938229697427875,0.981914053039539,"B.LvsP.MARTENS_TRETINOIN_RESPONSE_UP"
165,"Up",0.938398827001654,0.981914053039539,"B.LvsP.DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_UP"
44,"Down",0.938813123550245,0.981914053039539,"B.LvsP.REACTOME_DISEASES_ASSOCIATED_WITH_GLYCOSAMINOGLYCAN_METABOLISM"
94,"Up",0.938845465238174,0.981914053039539,"B.LvsP.YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_3"
10,"Up",0.938927481623678,0.981914053039539,"B.LvsP.BIOCARTA_VOBESITY_PATHWAY"
21,"Up",0.939354032913416,0.981914053039539,"B.LvsP.TOMLINS_METASTASIS_UP"
1063,"Up",0.939365318842715,0.981914053039539,"B.LvsP.MARTINEZ_TP53_TARGETS_UP"
18,"Up",0.93945469426976,0.981914053039539,"B.LvsP.REACTOME_METHYLATION"
241,"Up",0.939558646195536,0.981914053039539,"B.LvsP.BAKKER_FOXO3_TARGETS_DN"
8,"Up",0.939686048928306,0.981914053039539,"B.LvsP.REACTOME_RELAXIN_RECEPTORS"
28,"Up",0.939867554909706,0.981914053039539,"B.LvsP.SCHAVOLT_TARGETS_OF_TP53_AND_TP63"
84,"Down",0.939955771909019,0.981914053039539,"B.LvsP.LUI_THYROID_CANCER_CLUSTER_1"
168,"Up",0.940048101294567,0.981914053039539,"B.LvsP.KIM_GASTRIC_CANCER_CHEMOSENSITIVITY"
927,"Down",0.940561656843594,0.981914053039539,"B.LvsP.REACTOME_HEMOSTASIS"
213,"Up",0.940694912665531,0.981914053039539,"B.LvsP.BROWNE_HCMV_INFECTION_8HR_UP"
31,"Up",0.940702290935316,0.981914053039539,"B.LvsP.SA_CASPASE_CASCADE"
17,"Up",0.940712378178774,0.981914053039539,"B.LvsP.BOYAULT_LIVER_CANCER_SUBCLASS_G56_UP"
48,"Down",0.941466691898151,0.982515919121343,"B.LvsP.REACTOME_NEGATIVE_REGULATION_OF_FGFR1_SIGNALING"
156,"Down",0.941970055022609,0.982518590373048,"B.LvsP.REACTOME_DISEASES_OF_GLYCOSYLATION"
89,"Down",0.942111332720977,0.982518590373048,"B.LvsP.SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES"
33,"Up",0.942422524706632,0.982518590373048,"B.LvsP.HUI_MAPK14_TARGETS_UP"
40,"Down",0.942902393069697,0.982518590373048,"B.LvsP.CHEN_PDGF_TARGETS"
25,"Up",0.943024023218773,0.982518590373048,"B.LvsP.KEGG_GLYCOSPHINGOLIPID_BIOSYNTHESIS_LACTO_AND_NEOLACTO_SERIES"
140,"Up",0.943405591701836,0.982518590373048,"B.LvsP.MCCLUNG_DELTA_FOSB_TARGETS_2WK"
67,"Up",0.943542131413928,0.982518590373048,"B.LvsP.REACTOME_NEUROTRANSMITTER_RELEASE_CYCLE"
270,"Up",0.943620904549072,0.982518590373048,"B.LvsP.KIM_WT1_TARGETS_8HR_UP"
21,"Up",0.943986849568308,0.982518590373048,"B.LvsP.ROETH_TERT_TARGETS_DN"
12,"Up",0.944017335424426,0.982518590373048,"B.LvsP.TESAR_JAK_TARGETS_MOUSE_ES_D3_DN"
105,"Up",0.944056723274025,0.982518590373048,"B.LvsP.WEBER_METHYLATED_ICP_IN_FIBROBLAST"
8,"Down",0.944069176891037,0.982518590373048,"B.LvsP.REACTOME_STAT5_ACTIVATION"
317,"Down",0.944117802560047,0.982518590373048,"B.LvsP.WU_CELL_MIGRATION"
17,"Up",0.944126764266658,0.982518590373048,"B.LvsP.PID_RANBP2_PATHWAY"
21,"Down",0.944257953749919,0.982518590373048,"B.LvsP.REACTOME_IL_6_TYPE_CYTOKINE_RECEPTOR_LIGAND_INTERACTIONS"
15,"Up",0.944475667506915,0.982518590373048,"B.LvsP.TURJANSKI_MAPK1_AND_MAPK2_TARGETS"
52,"Down",0.944490198559007,0.982518590373048,"B.LvsP.MAEKAWA_ATF2_TARGETS"
172,"Up",0.945209873278303,0.982547763811127,"B.LvsP.KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP"
114,"Up",0.945325320643938,0.982547763811127,"B.LvsP.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_DN"
46,"Up",0.945491919611614,0.982547763811127,"B.LvsP.REACTOME_PLASMA_LIPOPROTEIN_CLEARANCE"
24,"Up",0.945563668840362,0.982547763811127,"B.LvsP.WONG_ENDOMETRIAL_CANCER_LATE"
31,"Down",0.945657281469563,0.982547763811127,"B.LvsP.BOYAULT_LIVER_CANCER_SUBCLASS_G6_DN"
28,"Down",0.94580125272347,0.982547763811127,"B.LvsP.KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS"
12,"Down",0.94588112342771,0.982547763811127,"B.LvsP.KEGG_TAURINE_AND_HYPOTAURINE_METABOLISM"
89,"Up",0.945939907174286,0.982547763811127,"B.LvsP.LANDIS_ERBB2_BREAST_PRENEOPLASTIC_DN"
49,"Up",0.946712646527871,0.983106197932426,"B.LvsP.KEGG_LYSINE_DEGRADATION"
37,"Up",0.946902977357745,0.983106197932426,"B.LvsP.REACTOME_BIOSYNTHESIS_OF_MARESIN_LIKE_SPMS"
110,"Down",0.947194057447769,0.983106197932426,"B.LvsP.AMIT_SERUM_RESPONSE_240_MCF10A"
28,"Down",0.947286903178523,0.983106197932426,"B.LvsP.BIOCARTA_TID_PATHWAY"
8,"Down",0.947366580319039,0.983106197932426,"B.LvsP.REACTOME_GLYCEROPHOSPHOLIPID_CATABOLISM"
47,"Up",0.947583564495523,0.983146843328157,"B.LvsP.CHUANG_OXIDATIVE_STRESS_RESPONSE_UP"
223,"Down",0.948066555476688,0.983431344486711,"B.LvsP.WILCOX_RESPONSE_TO_PROGESTERONE_UP"
1060,"Up",0.948213510120936,0.983431344486711,"B.LvsP.MARTINEZ_RB1_AND_TP53_TARGETS_UP"
9,"Up",0.948676008126196,0.983726490797025,"B.LvsP.TESAR_ALK_TARGETS_HUMAN_ES_5D_DN"
35,"Up",0.949056163099936,0.983936157093484,"B.LvsP.MOROSETTI_FACIOSCAPULOHUMERAL_MUSCULAR_DISTROPHY_UP"
52,"Up",0.949457240866742,0.984076517415849,"B.LvsP.FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_UP"
209,"Up",0.949831791212631,0.984076517415849,"B.LvsP.KANG_IMMORTALIZED_BY_TERT_DN"
103,"Up",0.950029664624625,0.984076517415849,"B.LvsP.BROWNE_HCMV_INFECTION_4HR_UP"
14,"Up",0.950079886197865,0.984076517415849,"B.LvsP.GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_DN"
137,"Down",0.950180733639445,0.984076517415849,"B.LvsP.BROWNE_HCMV_INFECTION_6HR_UP"
30,"Up",0.950328318477858,0.984076517415849,"B.LvsP.REACTOME_CALNEXIN_CALRETICULIN_CYCLE"
67,"Up",0.95055640686521,0.984076517415849,"B.LvsP.GYORFFY_DOXORUBICIN_RESISTANCE"
72,"Down",0.950615424040161,0.984076517415849,"B.LvsP.NIKOLSKY_BREAST_CANCER_16Q24_AMPLICON"
33,"Up",0.9513736758532,0.984677097302947,"B.LvsP.BIOCARTA_G2_PATHWAY"
113,"Up",0.951854046096146,0.984927072092616,"B.LvsP.PID_CD8_TCR_DOWNSTREAM_PATHWAY"
117,"Down",0.951971472827444,0.984927072092616,"B.LvsP.ROSS_AML_OF_FAB_M7_TYPE"
104,"Up",0.952425725307344,0.985212691342247,"B.LvsP.REACTOME_COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC"
431,"Down",0.95277666550372,0.985305269877914,"B.LvsP.BROWNE_HCMV_INFECTION_1HR_DN"
34,"Down",0.952970344879051,0.985305269877914,"B.LvsP.RUNNE_GENDER_EFFECT_UP"
61,"Down",0.953210338425394,0.985305269877914,"B.LvsP.LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_UP"
27,"Down",0.953228050022963,0.985305269877914,"B.LvsP.WU_APOPTOSIS_BY_CDKN1A_NOT_VIA_TP53"
25,"Up",0.954156226167773,0.986080331678807,"B.LvsP.WEBER_METHYLATED_IN_COLON_CANCER"
10,"Down",0.954569094517721,0.986151273413685,"B.LvsP.IKEDA_MIR1_TARGETS_DN"
23,"Down",0.954581590759638,0.986151273413685,"B.LvsP.REACTOME_PHOSPHORYLATION_OF_THE_APC_C"
315,"Down",0.954939784271311,0.98624036235988,"B.LvsP.BENPORATH_NOS_TARGETS"
96,"Down",0.95527824552626,0.98624036235988,"B.LvsP.CERIBELLI_PROMOTERS_INACTIVE_AND_BOUND_BY_NFY"
100,"Down",0.955413004047888,0.98624036235988,"B.LvsP.CHANG_IMMORTALIZED_BY_HPV31_UP"
33,"Down",0.955609936935754,0.98624036235988,"B.LvsP.REACTOME_NOTCH2_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS"
80,"Down",0.955660012084338,0.98624036235988,"B.LvsP.REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES"
28,"Up",0.95587291446321,0.98624036235988,"B.LvsP.VISALA_RESPONSE_TO_HEAT_SHOCK_AND_AGING_UP"
604,"Down",0.955916459013673,0.98624036235988,"B.LvsP.GRYDER_PAX3FOXO1_TOP_ENHANCERS"
14,"Up",0.956491078459137,0.986373694194577,"B.LvsP.REACTOME_EICOSANOID_LIGAND_BINDING_RECEPTORS"
93,"Down",0.956539962601102,0.986373694194577,"B.LvsP.MODY_HIPPOCAMPUS_POSTNATAL"
342,"Up",0.956725050821385,0.986373694194577,"B.LvsP.JIANG_HYPOXIA_NORMAL"
17,"Down",0.956915478034637,0.986373694194577,"B.LvsP.REACTOME_FORMYL_PEPTIDE_RECEPTORS_BIND_FORMYL_PEPTIDES_AND_MANY_OTHER_LIGANDS"
117,"Up",0.956937691383561,0.986373694194577,"B.LvsP.RIZKI_TUMOR_INVASIVENESS_2D_UP"
19,"Up",0.957758142747903,0.987035372088193,"B.LvsP.SA_PROGRAMMED_CELL_DEATH"
97,"Up",0.958139232714884,0.987244095728772,"B.LvsP.WENG_POR_TARGETS_LIVER_UP"
1673,"Down",0.958430351743643,0.987300025918138,"B.LvsP.REACTOME_SIGNALING_BY_GPCR"
52,"Down",0.95855064914606,0.987300025918138,"B.LvsP.XU_RESPONSE_TO_TRETINOIN_UP"
87,"Up",0.959161908412778,0.987304592176666,"B.LvsP.KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN"
63,"Down",0.959181519483908,0.987304592176666,"B.LvsP.GAUSSMANN_MLL_AF4_FUSION_TARGETS_D_UP"
19,"Down",0.959235749170736,0.987304592176666,"B.LvsP.REACTOME_TRAFFICKING_OF_GLUR2_CONTAINING_AMPA_RECEPTORS"
114,"Down",0.95947812876993,0.987304592176666,"B.LvsP.REACTOME_TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE"
44,"Up",0.959616380420797,0.987304592176666,"B.LvsP.COLLIS_PRKDC_SUBSTRATES"
168,"Down",0.960203907253584,0.987304592176666,"B.LvsP.NAKAMURA_ADIPOGENESIS_LATE_UP"
11,"Up",0.960725723053185,0.987304592176666,"B.LvsP.REACTOME_RUNX3_REGULATES_CDKN1A_TRANSCRIPTION"
12,"Down",0.960758798985194,0.987304592176666,"B.LvsP.BIOCARTA_EEA1_PATHWAY"
184,"Down",0.961010624958832,0.987304592176666,"B.LvsP.JAZAG_TGFB1_SIGNALING_VIA_SMAD4_UP"
15,"Down",0.961030273003361,0.987304592176666,"B.LvsP.REACTOME_HYALURONAN_UPTAKE_AND_DEGRADATION"
43,"Up",0.961398758428933,0.987304592176666,"B.LvsP.TCGA_GLIOBLASTOMA_COPY_NUMBER_DN"
42,"Down",0.961443941526055,0.987304592176666,"B.LvsP.REACTOME_ACTIVATED_NOTCH1_TRANSMITS_SIGNAL_TO_THE_NUCLEUS"
43,"Up",0.961497160400142,0.987304592176666,"B.LvsP.REACTOME_PROLACTIN_RECEPTOR_SIGNALING"
44,"Up",0.96152355563344,0.987304592176666,"B.LvsP.AZARE_STAT3_TARGETS"
97,"Down",0.961524026887725,0.987304592176666,"B.LvsP.BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_DN"
17,"Up",0.961572170052636,0.987304592176666,"B.LvsP.CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_LD_MTX_UP"
402,"Up",0.96159074495774,0.987304592176666,"B.LvsP.REACTOME_SIGNALING_BY_WNT"
55,"Down",0.961836002727074,0.987373052186779,"B.LvsP.STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_DN"
113,"Up",0.962787621799969,0.988024186643301,"B.LvsP.REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE"
8,"Up",0.962827693549305,0.988024186643301,"B.LvsP.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_30"
9,"Down",0.963088142729251,0.988108061078128,"B.LvsP.BIOCARTA_PLK3_PATHWAY"
25,"Up",0.963383630520803,0.988227846595458,"B.LvsP.ONDER_CDH1_TARGETS_3_UP"
51,"Up",0.963800945429631,0.988337029433957,"B.LvsP.REACTOME_SIGNALING_BY_FGFR3"
41,"Up",0.963888361669363,0.988337029433957,"B.LvsP.CROONQUIST_IL6_DEPRIVATION_UP"
159,"Down",0.964026333828419,0.988337029433957,"B.LvsP.CAMPS_COLON_CANCER_COPY_NUMBER_UP"
11,"Up",0.964370359703791,0.988506436559558,"B.LvsP.BIOCARTA_ERBB4_PATHWAY"
63,"Up",0.964805046099207,0.9887686932127,"B.LvsP.KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS"
607,"Down",0.96520407263478,0.988969212590573,"B.LvsP.REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES"
879,"Up",0.965425825808158,0.988969212590573,"B.LvsP.ONKEN_UVEAL_MELANOMA_DN"
757,"Up",0.96553731408282,0.988969212590573,"B.LvsP.CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN"
230,"Down",0.965829516820065,0.989085274772762,"B.LvsP.PASINI_SUZ12_TARGETS_UP"
11,"Up",0.966020872348404,0.989098037632283,"B.LvsP.REACTOME_HIGHLY_CALCIUM_PERMEABLE_POSTSYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS"
398,"Up",0.966569795526608,0.989476837523906,"B.LvsP.RICKMAN_METASTASIS_DN"
44,"Up",0.967733544438972,0.990484777342295,"B.LvsP.ALONSO_METASTASIS_DN"
102,"Up",0.967956830663291,0.9905299494239,"B.LvsP.KEGG_ADHERENS_JUNCTION"
11,"Up",0.969104866708067,0.991165895300953,"B.LvsP.REACTOME_SCAVENGING_BY_CLASS_B_RECEPTORS"
24,"Up",0.969353823917033,0.991165895300953,"B.LvsP.REACTOME_FGFR1_LIGAND_BINDING_AND_ACTIVATION"
32,"Up",0.96938904020925,0.991165895300953,"B.LvsP.NUMATA_CSF3_SIGNALING_VIA_STAT3"
215,"Up",0.96941154128112,0.991165895300953,"B.LvsP.REACTOME_FCERI_MEDIATED_MAPK_ACTIVATION"
30,"Down",0.969570746603462,0.991165895300953,"B.LvsP.BIOCARTA_IGF1MTOR_PATHWAY"
82,"Down",0.969687450903963,0.991165895300953,"B.LvsP.KIM_LIVER_CANCER_POOR_SURVIVAL_DN"
75,"Up",0.96996371783819,0.991165895300953,"B.LvsP.REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS"
47,"Up",0.970077093856207,0.991165895300953,"B.LvsP.PID_NEPHRIN_NEPH1_PATHWAY"
38,"Down",0.970441109294869,0.991165895300953,"B.LvsP.REACTOME_PLASMA_LIPOPROTEIN_REMODELING"
69,"Up",0.970626571848752,0.991165895300953,"B.LvsP.BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_DN"
199,"Down",0.970854912785217,0.991165895300953,"B.LvsP.GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN"
42,"Up",0.970889304788072,0.991165895300953,"B.LvsP.REACTOME_G_PROTEIN_BETA_GAMMA_SIGNALLING"
865,"Down",0.970978410164063,0.991165895300953,"B.LvsP.RIGGI_EWING_SARCOMA_PROGENITOR_UP"
74,"Down",0.97108801860106,0.991165895300953,"B.LvsP.LEE_AGING_MUSCLE_UP"
161,"Up",0.9714401696327,0.991181458784129,"B.LvsP.CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_UP"
29,"Down",0.971816618781938,0.991181458784129,"B.LvsP.REACTOME_LDL_CLEARANCE"
728,"Up",0.971932577955059,0.991181458784129,"B.LvsP.YAGI_AML_WITH_INV_16_TRANSLOCATION"
60,"Up",0.971932739765873,0.991181458784129,"B.LvsP.APPEL_IMATINIB_RESPONSE"
39,"Down",0.972174745751265,0.991181458784129,"B.LvsP.ZHENG_FOXP3_TARGETS_UP"
818,"Down",0.97232311110405,0.991181458784129,"B.LvsP.LIAO_METASTASIS"
36,"Up",0.972358153815359,0.991181458784129,"B.LvsP.REACTOME_SIGNAL_TRANSDUCTION_BY_L1"
17,"Up",0.972689856364072,0.991336813979162,"B.LvsP.REACTOME_DOWNREGULATION_OF_ERBB2_ERBB3_SIGNALING"
225,"Up",0.972898703149736,0.991366924016751,"B.LvsP.HOOI_ST7_TARGETS_DN"
12,"Down",0.97321976900171,0.991474802374197,"B.LvsP.REACTOME_MECP2_REGULATES_TRANSCRIPTION_OF_NEURONAL_LIGANDS"
29,"Up",0.973363217089372,0.991474802374197,"B.LvsP.REACTOME_INTERLEUKIN_6_FAMILY_SIGNALING"
13,"Down",0.973649050022318,0.991583274557635,"B.LvsP.REACTOME_MET_ACTIVATES_RAP1_AND_RAC1"
8,"Up",0.974587809331073,0.991735063257376,"B.LvsP.REACTOME_HDL_CLEARANCE"
117,"Up",0.974705429688146,0.991735063257376,"B.LvsP.LINDSTEDT_DENDRITIC_CELL_MATURATION_D"
28,"Up",0.974938194236347,0.991735063257376,"B.LvsP.REACTOME_INTERLEUKIN_37_SIGNALING"
308,"Down",0.974958950155018,0.991735063257376,"B.LvsP.MISSIAGLIA_REGULATED_BY_METHYLATION_UP"
17,"Up",0.975040751699816,0.991735063257376,"B.LvsP.REACTOME_TRYPTOPHAN_CATABOLISM"
83,"Down",0.975351028917881,0.991735063257376,"B.LvsP.VALK_AML_WITH_FLT3_ITD"
16,"Up",0.975377781697639,0.991735063257376,"B.LvsP.REACTOME_PHYSIOLOGICAL_FACTORS"
23,"Up",0.975461098839665,0.991735063257376,"B.LvsP.REACTOME_APOPTOTIC_FACTOR_MEDIATED_RESPONSE"
27,"Down",0.9755395729352,0.991735063257376,"B.LvsP.LEIN_LOCALIZED_TO_DISTAL_AND_PROXIMAL_DENDRITES"
28,"Up",0.975591790388292,0.991735063257376,"B.LvsP.REACTOME_MICRORNA_MIRNA_BIOGENESIS"
59,"Down",0.976349902198105,0.992304594475193,"B.LvsP.PID_IL8_CXCR2_PATHWAY"
289,"Down",0.976510996299426,0.992304594475193,"B.LvsP.KRIEG_KDM3A_TARGETS_NOT_HYPOXIA"
700,"Down",0.97731372788729,0.992937817252633,"B.LvsP.MARTENS_BOUND_BY_PML_RARA_FUSION"
161,"Down",0.977790754740285,0.99323995645031,"B.LvsP.VANLOO_SP3_TARGETS_DN"
24,"Up",0.978318472564399,0.9935934670846,"B.LvsP.BIOCARTA_SPRY_PATHWAY"
52,"Down",0.979065237396027,0.993858659754541,"B.LvsP.PID_BMP_PATHWAY"
161,"Down",0.979127853793665,0.993858659754541,"B.LvsP.FRASOR_RESPONSE_TO_ESTRADIOL_DN"
126,"Down",0.979519846004581,0.993858659754541,"B.LvsP.TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN"
14,"Down",0.979903246421087,0.993858659754541,"B.LvsP.CAFFAREL_RESPONSE_TO_THC_24HR_3_UP"
67,"Down",0.980159902069447,0.993858659754541,"B.LvsP.CHESLER_BRAIN_HIGHEST_EXPRESSION"
46,"Up",0.980192812672936,0.993858659754541,"B.LvsP.REACTOME_INTERLEUKIN_7_SIGNALING"
55,"Down",0.980219381939723,0.993858659754541,"B.LvsP.NAKAYAMA_FRA2_TARGETS"
18,"Up",0.980236532348907,0.993858659754541,"B.LvsP.REACTOME_FGFR1C_LIGAND_BINDING_AND_ACTIVATION"
127,"Down",0.980341004651189,0.993858659754541,"B.LvsP.MEISSNER_NPC_HCP_WITH_H3K27ME3"
19,"Down",0.980377126117068,0.993858659754541,"B.LvsP.BIOCARTA_LONGEVITY_PATHWAY"
88,"Down",0.980650060196528,0.993953104092869,"B.LvsP.REACTOME_PRC2_METHYLATES_HISTONES_AND_DNA"
388,"Down",0.980895442122571,0.994019593016073,"B.LvsP.MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_DN"
132,"Up",0.981338661878115,0.994231524808905,"B.LvsP.AKL_HTLV1_INFECTION_DN"
21,"Up",0.981464218196238,0.994231524808905,"B.LvsP.REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_24_HYDROXYCHOLESTEROL"
89,"Down",0.982569439192839,0.994950068881254,"B.LvsP.LINDGREN_BLADDER_CANCER_HIGH_RECURRENCE"
14,"Down",0.98270799842844,0.994950068881254,"B.LvsP.BIOCARTA_CELL2CELL_PATHWAY"
90,"Up",0.982713388706914,0.994950068881254,"B.LvsP.IKEDA_MIR133_TARGETS_UP"
67,"Up",0.98290561323007,0.994962492777199,"B.LvsP.BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_UP"
34,"Up",0.983323571639853,0.99512124969254,"B.LvsP.KORKOLA_EMBRYONAL_CARCINOMA_DN"
67,"Down",0.983422410620372,0.99512124969254,"B.LvsP.LANDIS_ERBB2_BREAST_TUMORS_65_DN"
39,"Down",0.983808170720536,0.995329437495672,"B.LvsP.VERRECCHIA_RESPONSE_TO_TGFB1_C1"
6,"Up",0.984071622876027,0.995413831482172,"B.LvsP.REACTOME_RELEASE_OF_APOPTOTIC_FACTORS_FROM_THE_MITOCHONDRIA"
41,"Up",0.98478665443744,0.995954895259668,"B.LvsP.REACTOME_INWARDLY_RECTIFYING_K_CHANNELS"
167,"Down",0.985262862276881,0.996218847373341,"B.LvsP.BOYLAN_MULTIPLE_MYELOMA_PCA3_UP"
523,"Down",0.98540800800955,0.996218847373341,"B.LvsP.KOYAMA_SEMA3B_TARGETS_DN"
761,"Down",0.985763569699902,0.996221521298272,"B.LvsP.KEGG_OLFACTORY_TRANSDUCTION"
218,"Up",0.985771015196753,0.996221521298272,"B.LvsP.RASHI_RESPONSE_TO_IONIZING_RADIATION_5"
701,"Down",0.986169369653192,0.996441967253746,"B.LvsP.SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN"
120,"Down",0.986834913451199,0.996932255887389,"B.LvsP.REACTOME_MYD88_INDEPENDENT_TLR4_CASCADE"
343,"Up",0.987229354189487,0.996958511647599,"B.LvsP.YEGNASUBRAMANIAN_PROSTATE_CANCER"
195,"Up",0.987300994146602,0.996958511647599,"B.LvsP.REACTOME_ESTROGEN_DEPENDENT_GENE_EXPRESSION"
342,"Down",0.987401846587494,0.996958511647599,"B.LvsP.HOLLMANN_APOPTOSIS_VIA_CD40_UP"
88,"Up",0.988455402178138,0.997725121335821,"B.LvsP.LEE_AGING_MUSCLE_DN"
17,"Down",0.988522013868263,0.997725121335821,"B.LvsP.ONGUSAHA_BRCA1_TARGETS_UP"
29,"Down",0.98904348187464,0.997810401647619,"B.LvsP.REACTOME_INSERTION_OF_TAIL_ANCHORED_PROTEINS_INTO_THE_ENDOPLASMIC_RETICULUM_MEMBRANE"
37,"Up",0.989217769357091,0.997810401647619,"B.LvsP.MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_DN"
667,"Up",0.989383019740908,0.997810401647619,"B.LvsP.OSMAN_BLADDER_CANCER_DN"
28,"Up",0.989428216320804,0.997810401647619,"B.LvsP.REACTOME_REGULATION_OF_FZD_BY_UBIQUITINATION"
14,"Down",0.989508850105606,0.997810401647619,"B.LvsP.REACTOME_NTRK2_ACTIVATES_RAC1"
16,"Down",0.989831000399368,0.997953246026278,"B.LvsP.REACTOME_ACTIVATED_NTRK2_SIGNALS_THROUGH_FYN"
32,"Up",0.99025862765424,0.998074279501259,"B.LvsP.KORKOLA_SEMINOMA_DN"
22,"Down",0.990328039088892,0.998074279501259,"B.LvsP.TSUNODA_CISPLATIN_RESISTANCE_UP"
10,"Up",0.990693211266167,0.998074279501259,"B.LvsP.GERHOLD_RESPONSE_TO_TZD_UP"
112,"Down",0.990866214152876,0.998074279501259,"B.LvsP.LEE_LIVER_CANCER_CIPROFIBRATE_DN"
34,"Up",0.991549728883497,0.998074279501259,"B.LvsP.KANG_CISPLATIN_RESISTANCE_UP"
112,"Up",0.991557326107808,0.998074279501259,"B.LvsP.BOYAULT_LIVER_CANCER_SUBCLASS_G6_UP"
75,"Down",0.991573608834703,0.998074279501259,"B.LvsP.PID_IL6_7_PATHWAY"
9,"Down",0.991760255363588,0.998074279501259,"B.LvsP.REACTOME_HIGHLY_CALCIUM_PERMEABLE_NICOTINIC_ACETYLCHOLINE_RECEPTORS"
383,"Down",0.99176726867184,0.998074279501259,"B.LvsP.MULLIGHAN_MLL_SIGNATURE_1_DN"
19,"Down",0.991808519770039,0.998074279501259,"B.LvsP.BIOCARTA_HSWI_SNF_PATHWAY"
65,"Down",0.992033204792362,0.998074279501259,"B.LvsP.JIANG_AGING_CEREBRAL_CORTEX_UP"
18,"Down",0.992117243649651,0.998074279501259,"B.LvsP.REACTOME_SIGNALING_BY_NOTCH1_HD_DOMAIN_MUTANTS_IN_CANCER"
153,"Up",0.992983055729406,0.998259692060139,"B.LvsP.XU_CREBBP_TARGETS_DN"
114,"Down",0.993549382122623,0.998259692060139,"B.LvsP.REACTOME_O_LINKED_GLYCOSYLATION"
40,"Down",0.9936723961995,0.998259692060139,"B.LvsP.VANASSE_BCL2_TARGETS_UP"
18,"Up",0.993699633133475,0.998259692060139,"B.LvsP.PID_SMAD2_3PATHWAY"
29,"Down",0.99385004011431,0.998259692060139,"B.LvsP.YAN_ESCAPE_FROM_ANOIKIS"
607,"Down",0.99392018125005,0.998259692060139,"B.LvsP.SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP"
81,"Up",0.994317649922058,0.998259692060139,"B.LvsP.TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP"
22,"Down",0.994473408949879,0.998259692060139,"B.LvsP.KEGG_ALPHA_LINOLENIC_ACID_METABOLISM"
10,"Down",0.994475487068059,0.998259692060139,"B.LvsP.FUNG_IL2_TARGETS_WITH_STAT5_BINDING_SITES_T1"
94,"Down",0.9946976125813,0.998259692060139,"B.LvsP.CHIARETTI_ACUTE_LYMPHOBLASTIC_LEUKEMIA_ZAP70"
8,"Up",0.994708456139979,0.998259692060139,"B.LvsP.TURJANSKI_MAPK7_TARGETS"
62,"Up",0.994876150063892,0.998259692060139,"B.LvsP.PID_ARF6_PATHWAY"
66,"Down",0.994900866708186,0.998259692060139,"B.LvsP.EPPERT_CE_HSC_LSC"
266,"Up",0.99498683786287,0.998259692060139,"B.LvsP.PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_DN"
879,"Up",0.995041385907575,0.998259692060139,"B.LvsP.MEISSNER_NPC_HCP_WITH_H3_UNMETHYLATED"
12,"Up",0.995190345927923,0.998259692060139,"B.LvsP.REACTOME_IRF3_MEDIATED_ACTIVATION_OF_TYPE_1_IFN"
117,"Up",0.995672639344967,0.998562311434486,"B.LvsP.LIN_TUMOR_ESCAPE_FROM_IMMUNE_ATTACK"
45,"Up",0.995878858465857,0.998587995730454,"B.LvsP.SUMI_HNF4A_TARGETS"
20,"Up",0.996061182445639,0.99858971491241,"B.LvsP.REACTOME_KILLING_MECHANISMS"
90,"Down",0.996735690342671,0.99908477735762,"B.LvsP.REACTOME_CYTOSOLIC_SENSORS_OF_PATHOGEN_ASSOCIATED_DNA"
9,"Up",0.997214812032597,0.999383849144141,"B.LvsP.REACTOME_RELEASE_OF_HH_NP_FROM_THE_SECRETING_CELL"
137,"Down",0.997768585024009,0.999658772583278,"B.LvsP.LEE_AGING_NEOCORTEX_UP"
20,"Up",0.998011616807422,0.999658772583278,"B.LvsP.REACTOME_SUPPRESSION_OF_PHAGOSOMAL_MATURATION"
188,"Up",0.998076987279919,0.999658772583278,"B.LvsP.ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION"
17,"Up",0.998614048636465,0.999658772583278,"B.LvsP.REACTOME_ANDROGEN_BIOSYNTHESIS"
9,"Down",0.998691221974519,0.999658772583278,"B.LvsP.BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_AND_PAX3"
77,"Down",0.998828906247416,0.999658772583278,"B.LvsP.KEGG_COLORECTAL_CANCER"
267,"Down",0.999009808379159,0.999658772583278,"B.LvsP.MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_DN"
357,"Down",0.999298644317625,0.999658772583278,"B.LvsP.REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION"
15,"Down",0.999402601401528,0.999658772583278,"B.LvsP.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TAN_DN"
52,"Up",0.999563886955472,0.999658772583278,"B.LvsP.WANG_RESPONSE_TO_FORSKOLIN_UP"
87,"Down",0.999569653649428,0.999658772583278,"B.LvsP.KEGG_STEROID_HORMONE_BIOSYNTHESIS"
21,"Down",0.999658772583278,0.999658772583278,"B.LvsP.REACTOME_PROSTACYCLIN_SIGNALLING_THROUGH_PROSTACYCLIN_RECEPTOR"
133,"Up",6.99509663312444e-24,1.95382749751124e-20,"B.PvsV.REACTOME_RESPIRATORY_ELECTRON_TRANSPORT_ATP_SYNTHESIS_BY_CHEMIOSMOTIC_COUPLING_AND_HEAT_PRODUCTION_BY_UNCOUPLING_PROTEINS"
94,"Up",7.06756193709981e-24,1.95382749751124e-20,"B.PvsV.MOOTHA_VOXPHOS"
189,"Up",4.1884752690514e-23,7.71935992086172e-20,"B.PvsV.REACTOME_THE_CITRIC_ACID_TCA_CYCLE_AND_RESPIRATORY_ELECTRON_TRANSPORT"
108,"Up",2.35458231385225e-22,3.25462140332228e-19,"B.PvsV.REACTOME_RESPIRATORY_ELECTRON_TRANSPORT"
59,"Up",4.41308650572184e-21,4.87999105802721e-18,"B.PvsV.REACTOME_COMPLEX_I_BIOGENESIS"
139,"Up",2.2247328119624e-18,2.05009128622336e-15,"B.PvsV.KEGG_OXIDATIVE_PHOSPHORYLATION"
135,"Up",3.65958252245175e-18,2.89054739523368e-15,"B.PvsV.KEGG_PARKINSONS_DISEASE"
33,"Up",6.27776757350286e-15,4.33872211423716e-12,"B.PvsV.KEGG_CITRATE_CYCLE_TCA_CYCLE"
27,"Up",1.1440810977891e-13,7.02847154408439e-11,"B.PvsV.REACTOME_CITRIC_ACID_CYCLE_TCA_CYCLE"
31,"Up",7.90122580243979e-13,4.36858774616896e-10,"B.PvsV.REACTOME_CRISTAE_FORMATION"
19,"Up",1.289399985254e-12,6.48099319860853e-10,"B.PvsV.MOOTHA_TCA"
18,"Up",3.14162213319973e-12,1.44750239787177e-09,"B.PvsV.REACTOME_FORMATION_OF_ATP_BY_CHEMIOSMOTIC_COUPLING"
60,"Up",4.40214021748059e-10,1.87226409711155e-07,"B.PvsV.REACTOME_PYRUVATE_METABOLISM_AND_CITRIC_ACID_TCA_CYCLE"
10,"Up",4.77491214841909e-10,1.88574923347208e-07,"B.PvsV.BIOCARTA_ETC_PATHWAY"
251,"Up",9.67025849842656e-10,3.56445728252003e-07,"B.PvsV.WONG_MITOCHONDRIA_GENE_MODULE"
23,"Up",1.56844560614309e-09,5.22911762214487e-07,"B.PvsV.BIOCARTA_RAB_PATHWAY"
189,"Up",1.60779525368896e-09,5.22911762214487e-07,"B.PvsV.KEGG_ALZHEIMERS_DISEASE"
42,"Up",2.63791606179084e-09,8.10279883646752e-07,"B.PvsV.MOOTHA_GLUCONEOGENESIS"
62,"Up",1.02748277602068e-08,2.98997487822017e-06,"B.PvsV.BIOCARTA_INTEGRIN_PATHWAY"
496,"Up",2.36379664036981e-08,6.53471581230235e-06,"B.PvsV.MOOTHA_HUMAN_MITODB_6_2002"
18,"Up",3.39953684445651e-08,8.95049486333336e-06,"B.PvsV.NADELLA_PRKAR1A_TARGETS_DN"
54,"Up",1.53892479058505e-07,3.86759780324762e-05,"B.PvsV.REACTOME_SMOOTH_MUSCLE_CONTRACTION"
31,"Up",2.60110483854088e-07,6.25282984882284e-05,"B.PvsV.MOOTHA_GLYCOLYSIS"
34,"Up",3.3916159048551e-07,7.81343514080994e-05,"B.PvsV.BIOCARTA_MAL_PATHWAY"
518,"Up",3.76470998621048e-07,8.3260326055031e-05,"B.PvsV.MOOTHA_MITOCHONDRIA"
201,"Up",4.0847935380998e-07,8.686470566213e-05,"B.PvsV.KEGG_HUNTINGTONS_DISEASE"
66,"Down",5.12213987257469e-07,0.00010489004205728,"B.PvsV.NIKOLSKY_BREAST_CANCER_19Q13.1_AMPLICON"
44,"Up",8.72614504928254e-07,0.000168763696757131,"B.PvsV.KEGG_PROTEASOME"
57,"Up",8.85177646221162e-07,0.000168763696757131,"B.PvsV.SIG_REGULATION_OF_THE_ACTIN_CYTOSKELETON_BY_RHO_GTPASES"
73,"Up",9.5064954771317e-07,0.000175204711643537,"B.PvsV.REACTOME_MITOCHONDRIAL_PROTEIN_IMPORT"
45,"Up",1.33050757792517e-06,0.000237302464462847,"B.PvsV.KEGG_PYRUVATE_METABOLISM"
12,"Up",1.6292474438299e-06,0.000281503409904234,"B.PvsV.REACTOME_ARMS_MEDIATED_ACTIVATION"
11,"Up",2.3248325666207e-06,0.000385308533940889,"B.PvsV.BIOCARTA_SALMONELLA_PATHWAY"
38,"Up",2.41456475348705e-06,0.000385308533940889,"B.PvsV.REACTOME_GLUCONEOGENESIS"
70,"Up",2.43910267461224e-06,0.000385308533940889,"B.PvsV.KEGG_GLYCOLYSIS_GLUCONEOGENESIS"
55,"Down",3.31646663110895e-06,0.000509354000094482,"B.PvsV.SPIRA_SMOKERS_LUNG_CANCER_DN"
22,"Up",3.84285487424099e-06,0.000574247151342661,"B.PvsV.BAUS_TFF2_TARGETS_DN"
237,"Up",4.86375393206793e-06,0.000707676197115883,"B.PvsV.YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_13"
34,"Up",9.53824244920914e-06,0.0013522292949148,"B.PvsV.DEMAGALHAES_AGING_DN"
24,"Down",9.8562759901568e-06,0.00135693391434909,"B.PvsV.VISALA_RESPONSE_TO_HEAT_SHOCK_AND_AGING_DN"
32,"Up",1.00622699382009e-05,0.00135693391434909,"B.PvsV.REACTOME_GLYOXYLATE_METABOLISM_AND_GLYCINE_DEGRADATION"
28,"Up",1.0812022163038e-05,0.00142332548903422,"B.PvsV.HOLLERN_ADENOMYOEPITHELIAL_BREAST_TUMOR"
29,"Up",1.15868533827877e-05,0.00148985377566123,"B.PvsV.LEI_HOXC8_TARGETS_DN"
256,"Up",1.40943907178943e-05,0.00177108832452813,"B.PvsV.BURTON_ADIPOGENESIS_6"
51,"Down",1.55997908836828e-05,0.00191669430657516,"B.PvsV.XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_DN"
10,"Up",1.67129558665766e-05,0.00200882463013701,"B.PvsV.BIOCARTA_LDL_PATHWAY"
53,"Up",2.06326417546128e-05,0.00242718885662243,"B.PvsV.REACTOME_CROSS_PRESENTATION_OF_SOLUBLE_EXOGENOUS_ANTIGENS_ENDOSOMES"
46,"Up",2.32634260408194e-05,0.00267965588707689,"B.PvsV.REACTOME_MITOCHONDRIAL_FATTY_ACID_BETA_OXIDATION"
35,"Up",2.52259304402557e-05,0.00284641162049335,"B.PvsV.BIOCARTA_MPR_PATHWAY"
25,"Down",2.74368611551155e-05,0.00303396810653268,"B.PvsV.VICENT_METASTASIS_UP"
11,"Down",3.16837829118882e-05,0.00341768729761152,"B.PvsV.RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_MAPK1_UP"
157,"Up",3.21431975901246e-05,0.00341768729761152,"B.PvsV.BURTON_ADIPOGENESIS_5"
36,"Up",3.66781509898407e-05,0.00382629239288357,"B.PvsV.REACTOME_RHO_GTPASES_ACTIVATE_PAKS"
64,"Up",3.78878178156368e-05,0.0038792915685677,"B.PvsV.REACTOME_METABOLISM_OF_POLYAMINES"
17,"Up",3.93328512125621e-05,0.00395402426098647,"B.PvsV.FUJIWARA_PARK2_IN_LIVER_CANCER_DN"
70,"Down",4.19681569141646e-05,0.00414360606390029,"B.PvsV.REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_CYTOCHROME_C_RELEASE"
203,"Up",4.33367928337294e-05,0.00420366890487175,"B.PvsV.REACTOME_PROTEIN_LOCALIZATION"
20,"Down",4.77399793343923e-05,0.00453404907959843,"B.PvsV.CAFFAREL_RESPONSE_TO_THC_8HR_5_DN"
675,"Up",4.91801762015663e-05,0.00453404907959843,"B.PvsV.STARK_PREFRONTAL_CORTEX_22Q11_DELETION_DN"
31,"Up",4.9202920017346e-05,0.00453404907959843,"B.PvsV.BIOCARTA_UCALPAIN_PATHWAY"
82,"Down",5.60468549881527e-05,0.00508005018409011,"B.PvsV.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_DN"
84,"Down",5.73004867002704e-05,0.00510990953170637,"B.PvsV.REACTOME_RNA_POLYMERASE_II_TRANSCRIBES_SNRNA_GENES"
27,"Up",6.25694442326249e-05,0.00545718943809246,"B.PvsV.MOOTHA_FFA_OXYDATION"
31,"Down",6.316876904285e-05,0.00545718943809246,"B.PvsV.TIAN_TNF_SIGNALING_NOT_VIA_NFKB"
24,"Up",6.71423232204649e-05,0.00571122930901462,"B.PvsV.BIOCARTA_ACTINY_PATHWAY"
54,"Up",7.68696838996808e-05,0.00643958306486871,"B.PvsV.BIOCARTA_MET_PATHWAY"
96,"Up",8.40121992000309e-05,0.0069328873041339,"B.PvsV.REACTOME_DEGRADATION_OF_BETA_CATENIN_BY_THE_DESTRUCTION_COMPLEX"
29,"Down",8.83605616088639e-05,0.00718449331081483,"B.PvsV.PETROVA_PROX1_TARGETS_UP"
57,"Up",9.00250816889722e-05,0.00721374893707721,"B.PvsV.REACTOME_MET_PROMOTES_CELL_MOTILITY"
32,"Down",9.2337782202668e-05,0.00729336568283645,"B.PvsV.REACTOME_DNA_STRAND_ELONGATION"
102,"Up",9.48521302179629e-05,0.00738644264753685,"B.PvsV.KEGG_CARDIAC_MUSCLE_CONTRACTION"
108,"Up",9.87714658052661e-05,0.00748678012242629,"B.PvsV.NADLER_OBESITY_UP"
87,"Up",9.96596406796384e-05,0.00748678012242629,"B.PvsV.REACTOME_CELLULAR_RESPONSE_TO_HYPOXIA"
34,"Up",0.000100202881001907,0.00748678012242629,"B.PvsV.REACTOME_RHO_GTPASES_ACTIVATE_ROCKS"
96,"Up",0.000122493261490437,0.00893132086770586,"B.PvsV.REACTOME_MITOCHONDRIAL_TRANSLATION"
47,"Down",0.000122767297150596,0.00893132086770586,"B.PvsV.WHITFIELD_CELL_CYCLE_LITERATURE"
20,"Up",0.000132745045657411,0.00953178386285489,"B.PvsV.REACTOME_RAP1_SIGNALLING"
188,"Up",0.000148408685668835,0.0104218997703634,"B.PvsV.PID_PDGFRB_PATHWAY"
35,"Down",0.000148911210319897,0.0104218997703634,"B.PvsV.KEGG_DNA_REPLICATION"
45,"Down",0.000158464606968938,0.0108355890514443,"B.PvsV.REACTOME_EXTENSION_OF_TELOMERES"
19,"Up",0.000158741673569721,0.0108355890514443,"B.PvsV.REACTOME_PROLONGED_ERK_ACTIVATION_EVENTS"
16,"Down",0.00017337928157781,0.0116904152176062,"B.PvsV.REACTOME_ATF6_ATF6_ALPHA_ACTIVATES_CHAPERONE_GENES"
90,"Up",0.000183415116569861,0.0122180985483707,"B.PvsV.REACTOME_REGULATION_OF_RUNX2_EXPRESSION_AND_ACTIVITY"
28,"Up",0.000188321990424516,0.0123956224411565,"B.PvsV.RAHMAN_TP53_TARGETS_PHOSPHORYLATED"
49,"Up",0.000192223917159746,0.0125036004467792,"B.PvsV.PID_MAPK_TRK_PATHWAY"
12,"Up",0.00021349335931444,0.0136335625182724,"B.PvsV.BIOCARTA_MALATEX_PATHWAY"
62,"Up",0.00021452702823109,0.0136335625182724,"B.PvsV.REACTOME_STABILIZATION_OF_P53"
588,"Up",0.000233581262366009,0.0146758045411553,"B.PvsV.MOOTHA_PGC"
60,"Up",0.000236424783580422,0.0146875576226534,"B.PvsV.REACTOME_GENE_AND_PROTEIN_EXPRESSION_BY_JAK_STAT_SIGNALING_AFTER_INTERLEUKIN_12_STIMULATION"
14,"Down",0.000241923932410164,0.0148621935810644,"B.PvsV.REACTOME_EICOSANOID_LIGAND_BINDING_RECEPTORS"
18,"Down",0.000244713656517704,0.014868371504246,"B.PvsV.REACTOME_ATF6_ATF6_ALPHA_ACTIVATES_CHAPERONES"
78,"Down",0.000248917222115184,0.0148942503558281,"B.PvsV.SONG_TARGETS_OF_IE86_CMV_PROTEIN"
28,"Up",0.000250527271313441,0.0148942503558281,"B.PvsV.REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS"
19,"Up",0.000265862697968555,0.0152313095424524,"B.PvsV.TAKAYAMA_BOUND_BY_AR"
43,"Down",0.000266820141068608,0.0152313095424524,"B.PvsV.REACTOME_EXPORT_OF_VIRAL_RIBONUCLEOPROTEINS_FROM_NUCLEUS"
13,"Up",0.000267671232188113,0.0152313095424524,"B.PvsV.REACTOME_NEF_MEDIATED_CD4_DOWN_REGULATION"
51,"Up",0.000271130783975444,0.0152313095424524,"B.PvsV.JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_UP"
67,"Up",0.000271553497071833,0.0152313095424524,"B.PvsV.LANDIS_ERBB2_BREAST_TUMORS_65_DN"
67,"Up",0.000275381250071781,0.0152313095424524,"B.PvsV.REACTOME_DECTIN_1_MEDIATED_NONCANONICAL_NF_KB_SIGNALING"
68,"Up",0.000275480367922814,0.0152313095424524,"B.PvsV.REACTOME_DEGRADATION_OF_GLI1_BY_THE_PROTEASOME"
25,"Up",0.000291575679205718,0.0159616032705784,"B.PvsV.REACTOME_CELL_EXTRACELLULAR_MATRIX_INTERACTIONS"
93,"Up",0.000298525686827099,0.0161818482594807,"B.PvsV.REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR"
64,"Up",0.000308267658144764,0.0165476881736155,"B.PvsV.REACTOME_DEGRADATION_OF_DVL"
59,"Down",0.000330010958739433,0.0175445249122146,"B.PvsV.CAFFAREL_RESPONSE_TO_THC_DN"
23,"Down",0.000340026574755716,0.0179048279221367,"B.PvsV.KOBAYASHI_RESPONSE_TO_ROMIDEPSIN"
35,"Up",0.000366172272768761,0.0190048189430464,"B.PvsV.BIOCARTA_MCALPAIN_PATHWAY"
261,"Up",0.000371677687533995,0.0190048189430464,"B.PvsV.YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_17"
150,"Up",0.000371755672862371,0.0190048189430464,"B.PvsV.REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION"
95,"Down",0.000375018269019682,0.0190048189430464,"B.PvsV.REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_CELL_DEATH_GENES"
28,"Down",0.000383827717650618,0.0190048189430464,"B.PvsV.HOLLERN_MICROACINAR_BREAST_TUMOR_DN"
142,"Up",0.000384956555882686,0.0190048189430464,"B.PvsV.REACTOME_TCR_SIGNALING"
17,"Down",0.00038497734158459,0.0190048189430464,"B.PvsV.REACTOME_POLYMERASE_SWITCHING_ON_THE_C_STRAND_OF_THE_TELOMERE"
109,"Up",0.000392927883980468,0.019185443670726,"B.PvsV.REACTOME_MITOCHONDRIAL_BIOGENESIS"
46,"Down",0.000395576158159299,0.019185443670726,"B.PvsV.PLASARI_TGFB1_TARGETS_1HR_UP"
61,"Down",0.000416448689041215,0.020022128710512,"B.PvsV.REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_CELL_CYCLE_GENES"
735,"Down",0.000421824348769088,0.0201057484857266,"B.PvsV.GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP"
28,"Down",0.000428954187845049,0.0202708350820109,"B.PvsV.REACTOME_TELOMERE_C_STRAND_LAGGING_STRAND_SYNTHESIS"
14,"Down",0.000435578238945396,0.0203737137487374,"B.PvsV.REACTOME_POLYMERASE_SWITCHING"
38,"Down",0.000438500983197639,0.0203737137487374,"B.PvsV.CEBALLOS_TARGETS_OF_TP53_AND_MYC_UP"
414,"Down",0.000443860143468437,0.0204508561103083,"B.PvsV.DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP"
68,"Down",0.000459636184965185,0.0210027146005992,"B.PvsV.REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_DNA_REPAIR_GENES"
117,"Down",0.000476261041559477,0.0215839942523143,"B.PvsV.ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR"
80,"Up",0.000512183848947866,0.0228939028962566,"B.PvsV.REACTOME_APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1"
37,"Up",0.000513446185410711,0.0228939028962566,"B.PvsV.BIOCARTA_CCR3_PATHWAY"
8,"Down",0.000519654265337522,0.0229801347055461,"B.PvsV.LOPEZ_MESOTHELIOMA_SURVIVAL_WORST_VS_BEST_DN"
303,"Down",0.000523692706257697,0.0229801347055461,"B.PvsV.SANSOM_APC_TARGETS_REQUIRE_MYC"
55,"Down",0.00055556365012999,0.0240443643976742,"B.PvsV.GENTILE_UV_LOW_DOSE_UP"
24,"Up",0.000556642908826604,0.0240443643976742,"B.PvsV.EHRLICH_ICF_SYNDROM_UP"
65,"Up",0.000592635835243019,0.0251787969508811,"B.PvsV.REACTOME_DEFECTIVE_CFTR_CAUSES_CYSTIC_FIBROSIS"
37,"Up",0.000595238024354563,0.0251787969508811,"B.PvsV.BIOCARTA_ECM_PATHWAY"
42,"Up",0.000596567625350954,0.0251787969508811,"B.PvsV.REACTOME_RAF_ACTIVATION"
115,"Up",0.000624741668596802,0.0261681567096342,"B.PvsV.REACTOME_INTERLEUKIN_1_SIGNALING"
44,"Up",0.000673510859537525,0.0279988085893457,"B.PvsV.REACTOME_RHO_GTPASES_ACTIVATE_WASPS_AND_WAVES"
239,"Up",0.000694412781926348,0.0286523005318715,"B.PvsV.KEGG_FOCAL_ADHESION"
88,"Down",0.0007217488618268,0.0295596256077065,"B.PvsV.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_DN"
60,"Up",0.000732324669143307,0.029772228644804,"B.PvsV.REACTOME_DEGRADATION_OF_AXIN"
45,"Up",0.000743631636112202,0.0300112358836815,"B.PvsV.REACTOME_MET_ACTIVATES_PTK2_SIGNALING"
25,"Up",0.000750290400931094,0.0300605480199132,"B.PvsV.WANG_RECURRENT_LIVER_CANCER_UP"
64,"Up",0.00083724885636419,0.0332242383774195,"B.PvsV.REACTOME_RAB_GERANYLGERANYLATION"
28,"Down",0.000848315576989173,0.0332242383774195,"B.PvsV.REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_ADDITIONAL_CELL_CYCLE_GENES_WHOSE_EXACT_ROLE_IN_THE_P53_PATHWAY_REMAIN_UNCERTAIN"
110,"Down",0.000855261247383273,0.0332242383774195,"B.PvsV.REACTOME_EUKARYOTIC_TRANSLATION_ELONGATION"
26,"Down",0.000856465829754881,0.0332242383774195,"B.PvsV.AMIT_DELAYED_EARLY_GENES"
66,"Up",0.000859299346712062,0.0332242383774195,"B.PvsV.REACTOME_NEGATIVE_REGULATION_OF_NOTCH4_SIGNALING"
189,"Down",0.000881082145732564,0.0334250660536813,"B.PvsV.REACTOME_INFLUENZA_INFECTION"
26,"Up",0.000885032746759767,0.0334250660536813,"B.PvsV.REACTOME_MTORC1_MEDIATED_SIGNALLING"
184,"Down",0.00088633375380444,0.0334250660536813,"B.PvsV.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP"
27,"Up",0.00088867511482929,0.0334250660536813,"B.PvsV.ABDELMOHSEN_ELAVL4_TARGETS"
13,"Down",0.000907984186085778,0.0337215948665005,"B.PvsV.CHASSOT_SKIN_WOUND"
53,"Up",0.000928222253727736,0.0337215948665005,"B.PvsV.REACTOME_MAP2K_AND_MAPK_ACTIVATION"
70,"Up",0.000938619515474705,0.0337215948665005,"B.PvsV.REACTOME_INTERLEUKIN_12_SIGNALING"
50,"Down",0.000941116607873691,0.0337215948665005,"B.PvsV.BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_DN"
69,"Up",0.000945420437149072,0.0337215948665005,"B.PvsV.REACTOME_THE_ROLE_OF_NEF_IN_HIV_1_REPLICATION_AND_DISEASE_PATHOGENESIS"
47,"Up",0.000948672161946514,0.0337215948665005,"B.PvsV.REACTOME_LAMININ_INTERACTIONS"
45,"Up",0.000949438136518115,0.0337215948665005,"B.PvsV.REACTOME_MTOR_SIGNALLING"
15,"Down",0.000951094856034335,0.0337215948665005,"B.PvsV.STANHILL_HRAS_TRANSFROMATION_UP"
38,"Down",0.000951450316363552,0.0337215948665005,"B.PvsV.REACTOME_ACTIVATION_OF_ATR_IN_RESPONSE_TO_REPLICATION_STRESS"
33,"Up",0.00096560979338017,0.0340054557171908,"B.PvsV.REACTOME_GP1B_IX_V_ACTIVATION_SIGNALLING"
62,"Up",0.000992796787364571,0.0345246629956967,"B.PvsV.PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_DN"
24,"Up",0.000992841637966317,0.0345246629956967,"B.PvsV.REACTOME_SIGNALING_BY_HIPPO"
13,"Down",0.00101414578619462,0.0350450753241877,"B.PvsV.REACTOME_EGFR_INTERACTS_WITH_PHOSPHOLIPASE_C_GAMMA"
34,"Up",0.00102539072099594,0.0352135732694818,"B.PvsV.REACTOME_PYRUVATE_METABOLISM"
48,"Down",0.00105587015653023,0.0358768638693852,"B.PvsV.REACTOME_VIRAL_MESSENGER_RNA_SYNTHESIS"
63,"Down",0.0010576829102387,0.0358768638693852,"B.PvsV.SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_DN"
20,"Down",0.00106866887319238,0.035926326633428,"B.PvsV.REACTOME_LAGGING_STRAND_SYNTHESIS"
49,"Up",0.00107213671450816,0.035926326633428,"B.PvsV.BIOCARTA_FMLP_PATHWAY"
43,"Down",0.00112009187883701,0.0373071566149988,"B.PvsV.REACTOME_HOMOLOGOUS_DNA_PAIRING_AND_STRAND_EXCHANGE"
35,"Up",0.00116683920177991,0.03863146075833,"B.PvsV.GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN"
73,"Down",0.00119994934484867,0.0394078194847571,"B.PvsV.IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_DN"
49,"Down",0.00120454358707252,0.0394078194847571,"B.PvsV.UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN"
59,"Up",0.00124925302057548,0.0406301173574226,"B.PvsV.KEGG_VALINE_LEUCINE_AND_ISOLEUCINE_DEGRADATION"
28,"Down",0.00125752212930507,0.0406598821808639,"B.PvsV.NIKOLSKY_BREAST_CANCER_22Q13_AMPLICON"
94,"Up",0.00127501938907265,0.0409859430359457,"B.PvsV.REACTOME_TP53_REGULATES_METABOLIC_GENES"
64,"Down",0.00130412982579067,0.0415173649617542,"B.PvsV.HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_UP"
33,"Up",0.00131058847494104,0.0415173649617542,"B.PvsV.KEGG_BIOSYNTHESIS_OF_UNSATURATED_FATTY_ACIDS"
13,"Up",0.00131768357779665,0.0415173649617542,"B.PvsV.REACTOME_GAP_JUNCTION_DEGRADATION"
84,"Down",0.00132158730932696,0.0415173649617542,"B.PvsV.BILANGES_SERUM_AND_RAPAMYCIN_SENSITIVE_GENES"
154,"Down",0.00141791775743333,0.044291905541519,"B.PvsV.ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_DN"
254,"Down",0.00143145867665894,0.0444636799058837,"B.PvsV.PUJANA_XPRSS_INT_NETWORK"
33,"Down",0.00144962426097504,0.0447763828990559,"B.PvsV.REACTOME_DEADENYLATION_OF_MRNA"
86,"Down",0.00151716059968154,0.0466021164202181,"B.PvsV.ZAMORA_NOS2_TARGETS_UP"
57,"Up",0.00152782855465327,0.0466705197717013,"B.PvsV.NAKAMURA_ADIPOGENESIS_LATE_DN"
7,"Up",0.00155756062281025,0.0473173224369115,"B.PvsV.REACTOME_MET_ACTIVATES_PTPN11"
10,"Down",0.00157096674691912,0.0474637985995399,"B.PvsV.PHONG_TNF_TARGETS_DN"
67,"Down",0.00158741785072904,0.0474906712514504,"B.PvsV.PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_UP"
9,"Up",0.00158903493968499,0.0474906712514504,"B.PvsV.REACTOME_SIGNALLING_TO_P38_VIA_RIT_AND_RIN"
16,"Down",0.00164668987668817,0.0489491845602628,"B.PvsV.LOPEZ_MESOTELIOMA_SURVIVAL_TIME_DN"
58,"Down",0.00170498734520021,0.0504110964257324,"B.PvsV.KEGG_BASAL_CELL_CARCINOMA"
448,"Up",0.00175455829837526,0.0516008129346638,"B.PvsV.KAAB_HEART_ATRIUM_VS_VENTRICLE_DN"
273,"Down",0.00177356580818074,0.0518838378488429,"B.PvsV.PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP"
20,"Up",0.00178937690545496,0.051890262519133,"B.PvsV.REACTOME_RETROGRADE_NEUROTROPHIN_SIGNALLING"
10,"Up",0.00179453376681159,0.051890262519133,"B.PvsV.BIOCARTA_MSP_PATHWAY"
68,"Up",0.00180194074944358,0.051890262519133,"B.PvsV.GERHOLD_ADIPOGENESIS_UP"
58,"Down",0.00182640854750796,0.0523223464205777,"B.PvsV.ISHIDA_E2F_TARGETS"
15,"Up",0.00184401194258889,0.0525543403637835,"B.PvsV.REACTOME_VLDLR_INTERNALISATION_AND_DEGRADATION"
26,"Down",0.00190158491750113,0.0537364581149349,"B.PvsV.REACTOME_RESOLUTION_OF_D_LOOP_STRUCTURES_THROUGH_SYNTHESIS_DEPENDENT_STRAND_ANNEALING_SDSA"
166,"Down",0.00190492779716535,0.0537364581149349,"B.PvsV.KEGG_SPLICEOSOME"
171,"Up",0.00191824121946959,0.0538373385911035,"B.PvsV.REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX2"
150,"Up",0.0019363334052097,0.0538542802798517,"B.PvsV.BURTON_ADIPOGENESIS_PEAK_AT_0HR"
33,"Up",0.0019383255155888,0.0538542802798517,"B.PvsV.KEGG_GALACTOSE_METABOLISM"
14,"Down",0.00198286621460298,0.0548163365026993,"B.PvsV.MEINHOLD_OVARIAN_CANCER_LOW_GRADE_UP"
36,"Down",0.00201937456318367,0.0555478704469775,"B.PvsV.REACTOME_HIV_ELONGATION_ARREST_AND_RECOVERY"
28,"Up",0.00208527729965453,0.0570767237118312,"B.PvsV.BIOCARTA_EPHA4_PATHWAY"
8,"Up",0.00210491116283173,0.0573303143807715,"B.PvsV.MOOTHA_PYR"
13,"Down",0.00215742019279528,0.0576066429907814,"B.PvsV.MIKKELSEN_NPC_WITH_LCP_H3K27ME3"
53,"Up",0.00216619368003215,0.0576066429907814,"B.PvsV.REACTOME_NEF_MEDIATES_DOWN_MODULATION_OF_CELL_SURFACE_RECEPTORS_BY_RECRUITING_THEM_TO_CLATHRIN_ADAPTERS"
103,"Down",0.00217220818218757,0.0576066429907814,"B.PvsV.WU_APOPTOSIS_BY_CDKN1A_VIA_TP53"
58,"Up",0.00217341926664916,0.0576066429907814,"B.PvsV.NAKAMURA_ADIPOGENESIS_EARLY_DN"
69,"Down",0.00217521624465961,0.0576066429907814,"B.PvsV.KANG_DOXORUBICIN_RESISTANCE_UP"
49,"Up",0.00218787495852126,0.0576066429907814,"B.PvsV.WANG_ADIPOGENIC_GENES_REPRESSED_BY_SIRT1"
82,"Up",0.00219403367865135,0.0576066429907814,"B.PvsV.REACTOME_REGULATION_OF_PTEN_STABILITY_AND_ACTIVITY"
64,"Up",0.00219840869434887,0.0576066429907814,"B.PvsV.REACTOME_REGULATION_OF_RUNX3_EXPRESSION_AND_ACTIVITY"
32,"Up",0.00223113462041967,0.0577199422153488,"B.PvsV.BIOCARTA_IL6_PATHWAY"
186,"Down",0.00224210733547911,0.0577199422153488,"B.PvsV.ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER"
10,"Down",0.0022462850481984,0.0577199422153488,"B.PvsV.REACTOME_SCAVENGING_BY_CLASS_F_RECEPTORS"
22,"Down",0.00225323351535755,0.0577199422153488,"B.PvsV.EGUCHI_CELL_CYCLE_RB1_TARGETS"
28,"Up",0.00226448691741745,0.0577199422153488,"B.PvsV.REACTOME_MITOCHONDRIAL_CALCIUM_ION_TRANSPORT"
85,"Up",0.00226536940870513,0.0577199422153488,"B.PvsV.CHIBA_RESPONSE_TO_TSA"
32,"Down",0.00227895663948125,0.0577997764206048,"B.PvsV.REACTOME_ACTIVATION_OF_THE_PRE_REPLICATIVE_COMPLEX"
307,"Up",0.0023690022585284,0.0598091940064088,"B.PvsV.MCBRYAN_PUBERTAL_BREAST_4_5WK_DN"
6,"Down",0.00240110566597993,0.0603441510327412,"B.PvsV.CALVET_IRINOTECAN_SENSITIVE_VS_RESISTANT_UP"
97,"Up",0.00243328593157248,0.0608761896636392,"B.PvsV.BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_DN"
58,"Down",0.0024711915130042,0.0615460264657669,"B.PvsV.ODONNELL_TARGETS_OF_MYC_AND_TFRC_DN"
1217,"Down",0.0025107981152858,0.0622520304009651,"B.PvsV.FISCHER_DREAM_TARGETS"
30,"Up",0.00262100373070478,0.0645083268745461,"B.PvsV.REACTOME_ENERGY_DEPENDENT_REGULATION_OF_MTOR_BY_LKB1_AMPK"
27,"Up",0.00263391462299042,0.0645083268745461,"B.PvsV.BIOCARTA_CHREBP_PATHWAY"
246,"Up",0.00263680265394238,0.0645083268745461,"B.PvsV.KAAB_FAILED_HEART_ATRIUM_DN"
69,"Down",0.00267120263566722,0.0650620236678592,"B.PvsV.REACTOME_HDR_THROUGH_HOMOLOGOUS_RECOMBINATION_HRR"
130,"Up",0.00269268331145025,0.0652975703026685,"B.PvsV.PID_CXCR4_PATHWAY"
120,"Up",0.00273326834769293,0.0656045143146965,"B.PvsV.REACTOME_CLEC7A_DECTIN_1_SIGNALING"
121,"Down",0.00273664939122737,0.0656045143146965,"B.PvsV.YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_1"
48,"Down",0.00274093738590973,0.0656045143146965,"B.PvsV.BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_UP"
409,"Down",0.00276617481536195,0.0657958780765126,"B.PvsV.CHEN_HOXA5_TARGETS_9HR_UP"
21,"Up",0.00277273278926161,0.0657958780765126,"B.PvsV.REACTOME_BRANCHED_CHAIN_AMINO_ACID_CATABOLISM"
79,"Up",0.0028172170016237,0.0663517041471004,"B.PvsV.KEGG_RENAL_CELL_CARCINOMA"
37,"Up",0.00282015743797587,0.0663517041471004,"B.PvsV.CHANG_POU5F1_TARGETS_UP"
18,"Up",0.00283351821858293,0.066383568773496,"B.PvsV.REACTOME_BETA_OXIDATION_OF_VERY_LONG_CHAIN_FATTY_ACIDS"
41,"Up",0.00287148336831709,0.0667419151897484,"B.PvsV.PASTURAL_RIZ1_TARGETS_UP"
119,"Down",0.0028729563782167,0.0667419151897484,"B.PvsV.REACTOME_RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY"
56,"Up",0.00301971998061622,0.0698578735264731,"B.PvsV.RUAN_RESPONSE_TO_TNF_TROGLITAZONE_DN"
166,"Up",0.00310028611127577,0.0714228412885155,"B.PvsV.REACTOME_INTERLEUKIN_1_FAMILY_SIGNALING"
68,"Up",0.00311963094754296,0.0715702884189419,"B.PvsV.REACTOME_SCF_SKP2_MEDIATED_DEGRADATION_OF_P27_P21"
79,"Down",0.00315671255787403,0.072121750960684,"B.PvsV.SMIRNOV_RESPONSE_TO_IR_2HR_DN"
15,"Down",0.00322737485530281,0.0733771742133737,"B.PvsV.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_DN"
165,"Down",0.00323820410708323,0.0733771742133737,"B.PvsV.BHATTACHARYA_EMBRYONIC_STEM_CELL"
9,"Down",0.00329789509431019,0.0744247427609839,"B.PvsV.REACTOME_PROSTANOID_LIGAND_RECEPTORS"
79,"Up",0.00337316116487754,0.0754815799584084,"B.PvsV.REACTOME_INTERLEUKIN_12_FAMILY_SIGNALING"
38,"Up",0.00338704049063584,0.0754815799584084,"B.PvsV.REACTOME_PEROXISOMAL_LIPID_METABOLISM"
91,"Down",0.00340309844853105,0.0754815799584084,"B.PvsV.PID_TELOMERASE_PATHWAY"
72,"Down",0.00342390687009866,0.0754815799584084,"B.PvsV.REACTOME_SIGNALING_BY_FGFR_IN_DISEASE"
303,"Down",0.00342567654478475,0.0754815799584084,"B.PvsV.REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA"
117,"Down",0.00342663710789664,0.0754815799584084,"B.PvsV.HANN_RESISTANCE_TO_BCL2_INHIBITOR_UP"
58,"Up",0.00344540114820501,0.0755937418588314,"B.PvsV.TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_DN"
177,"Down",0.00346542889447286,0.0757326338242706,"B.PvsV.BURTON_ADIPOGENESIS_3"
103,"Up",0.00348552338617559,0.0758087992527582,"B.PvsV.REACTOME_GLUCOSE_METABOLISM"
36,"Up",0.00351835977270138,0.0758087992527582,"B.PvsV.ABDULRAHMAN_KIDNEY_CANCER_VHL_DN"
16,"Up",0.0035222736882339,0.0758087992527582,"B.PvsV.REACTOME_INTESTINAL_ABSORPTION"
11,"Up",0.00352375861963445,0.0758087992527582,"B.PvsV.REACTOME_ACTIVATED_NTRK3_SIGNALS_THROUGH_RAS"
134,"Up",0.00363895115013654,0.0770451487744973,"B.PvsV.SASSON_RESPONSE_TO_GONADOTROPHINS_UP"
337,"Down",0.00364461353533503,0.0770451487744973,"B.PvsV.HOLLERN_SQUAMOUS_BREAST_TUMOR"
104,"Down",0.00364943485198838,0.0770451487744973,"B.PvsV.KEGG_RIBOSOME"
22,"Down",0.00365024547888579,0.0770451487744973,"B.PvsV.KEGG_MISMATCH_REPAIR"
68,"Down",0.00365090805163717,0.0770451487744973,"B.PvsV.PID_FANCONI_PATHWAY"
177,"Up",0.0036782017329051,0.0770451487744973,"B.PvsV.REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS"
22,"Up",0.0036851452969032,0.0770451487744973,"B.PvsV.BIOCARTA_NPP1_PATHWAY"
358,"Down",0.00369270472512964,0.0770451487744973,"B.PvsV.BOQUEST_STEM_CELL_DN"
63,"Up",0.003751433486732,0.0776917742406943,"B.PvsV.KEGG_VIBRIO_CHOLERAE_INFECTION"
44,"Down",0.00375180027532382,0.0776917742406943,"B.PvsV.LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_UP"
109,"Down",0.0037727458900055,0.0778340000964194,"B.PvsV.ENGELMANN_CANCER_PROGENITORS_DN"
66,"Up",0.00381416339872259,0.0783923715182627,"B.PvsV.REACTOME_SIGNALING_BY_MODERATE_KINASE_ACTIVITY_BRAF_MUTANTS"
5,"Up",0.00382816789834164,0.0783923715182627,"B.PvsV.REACTOME_PROPIONYL_COA_CATABOLISM"
15,"Down",0.00389672956650761,0.0795019106022899,"B.PvsV.REACTOME_MRNA_DECAY_BY_5_TO_3_EXORIBONUCLEASE"
20,"Up",0.00393360972415398,0.0799592947237036,"B.PvsV.REACTOME_CD28_DEPENDENT_VAV1_PATHWAY"
18,"Up",0.00397191768729749,0.0804422450295526,"B.PvsV.REACTOME_PROCESSING_OF_SMDT1"
373,"Down",0.00399224255698799,0.0805587923269583,"B.PvsV.MEISSNER_BRAIN_HCP_WITH_H3K27ME3"
106,"Up",0.00406018149066123,0.0812417670893174,"B.PvsV.REACTOME_MAPK6_MAPK4_SIGNALING"
13,"Up",0.00406917412748565,0.0812417670893174,"B.PvsV.REACTOME_MET_ACTIVATES_RAP1_AND_RAC1"
201,"Down",0.00407016991928756,0.0812417670893174,"B.PvsV.CHENG_IMPRINTED_BY_ESTRADIOL"
12,"Up",0.00413948533751151,0.0820986334311292,"B.PvsV.VANDESLUIS_NORMAL_EMBRYOS_UP"
25,"Down",0.00415566801172534,0.0820986334311292,"B.PvsV.REACTOME_ABORTIVE_ELONGATION_OF_HIV_1_TRANSCRIPT_IN_THE_ABSENCE_OF_TAT"
159,"Up",0.00415764466643447,0.0820986334311292,"B.PvsV.OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_UP"
30,"Down",0.00419401350196856,0.0822959040316276,"B.PvsV.REACTOME_RNA_POLYMERASE_III_TRANSCRIPTION_INITIATION_FROM_TYPE_1_PROMOTER"
60,"Up",0.00419982153844875,0.0822959040316276,"B.PvsV.PID_ERBB2_ERBB3_PATHWAY"
82,"Up",0.00421228808843382,0.0822959040316276,"B.PvsV.NADLER_OBESITY_DN"
27,"Up",0.00427466631476985,0.0832205283604314,"B.PvsV.REACTOME_CELLULAR_HEXOSE_TRANSPORT"
113,"Up",0.0043651628933446,0.0845211635664665,"B.PvsV.RUAN_RESPONSE_TO_TNF_DN"
50,"Up",0.00437204788931261,0.0845211635664665,"B.PvsV.BERENJENO_TRANSFORMED_BY_RHOA_REVERSIBLY_DN"
30,"Up",0.00441653315263882,0.0850836648116378,"B.PvsV.REACTOME_DARPP_32_EVENTS"
111,"Up",0.00446508383432945,0.0857203073611373,"B.PvsV.CHESLER_BRAIN_QTL_CIS"
51,"Down",0.00454639792271339,0.086763199966721,"B.PvsV.REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS"
8,"Up",0.00455079182317762,0.086763199966721,"B.PvsV.REACTOME_NEF_MEDIATED_CD8_DOWN_REGULATION"
123,"Up",0.00458477655843143,0.0871107546101972,"B.PvsV.LEE_LIVER_CANCER_ACOX1_UP"
276,"Down",0.00462611782304636,0.0874325408199632,"B.PvsV.JISON_SICKLE_CELL_DISEASE_DN"
12,"Up",0.00464934724455165,0.0874325408199632,"B.PvsV.REACTOME_MET_RECEPTOR_RECYCLING"
107,"Down",0.00467169351275056,0.0874325408199632,"B.PvsV.GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN"
640,"Up",0.00467675532089474,0.0874325408199632,"B.PvsV.STEIN_ESRRA_TARGETS_UP"
167,"Down",0.00468077990282313,0.0874325408199632,"B.PvsV.KONG_E2F3_TARGETS"
11,"Down",0.00481916193728868,0.0897142974790207,"B.PvsV.GALIE_TUMOR_STEMNESS_GENES"
65,"Up",0.00485920847618129,0.0901562539087462,"B.PvsV.REACTOME_PLATELET_AGGREGATION_PLUG_FORMATION"
11,"Up",0.00491774359840644,0.0908963415168405,"B.PvsV.BIOCARTA_REELIN_PATHWAY"
20,"Up",0.00494874181239143,0.0908963415168405,"B.PvsV.REACTOME_DISEASES_ASSOCIATED_WITH_GLYCOSYLATION_PRECURSOR_BIOSYNTHESIS"
9,"Up",0.00496294658833346,0.0908963415168405,"B.PvsV.SCHUHMACHER_MYC_TARGETS_DN"
27,"Up",0.00496485714199418,0.0908963415168405,"B.PvsV.GRANDVAUX_IFN_RESPONSE_NOT_VIA_IRF3"
93,"Up",0.00506074198632174,0.0920929595553753,"B.PvsV.KEGG_PEROXISOME"
38,"Up",0.00507397899550917,0.0920929595553753,"B.PvsV.KANG_AR_TARGETS_DN"
65,"Down",0.0050955938866504,0.0920929595553753,"B.PvsV.REACTOME_DEADENYLATION_DEPENDENT_MRNA_DECAY"
22,"Down",0.00510339762525972,0.0920929595553753,"B.PvsV.SHIN_B_CELL_LYMPHOMA_CLUSTER_5"
70,"Down",0.00511688786996983,0.0920929595553753,"B.PvsV.MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_DN"
137,"Up",0.00513015582258195,0.0920929595553753,"B.PvsV.KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION"
13,"Down",0.00521955258149276,0.093292480416338,"B.PvsV.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_7"
5,"Up",0.00523072326443566,0.093292480416338,"B.PvsV.REACTOME_BETA_OXIDATION_OF_HEXANOYL_COA_TO_BUTANOYL_COA"
112,"Down",0.00527639930542081,0.093756944047888,"B.PvsV.PID_E2F_PATHWAY"
21,"Up",0.00529067942538272,0.093756944047888,"B.PvsV.KRISHNAN_FURIN_TARGETS_DN"
11,"Down",0.00531813070905207,0.093942315304629,"B.PvsV.KALMA_E2F1_TARGETS"
102,"Up",0.00538838499475712,0.0944705290786994,"B.PvsV.REACTOME_SIGNALING_BY_NOTCH4"
10,"Up",0.00538917564852943,0.0944705290786994,"B.PvsV.REACTOME_CA2_ACTIVATED_K_CHANNELS"
63,"Up",0.0054022844830352,0.0944705290786994,"B.PvsV.REACTOME_EPHB_MEDIATED_FORWARD_SIGNALING"
43,"Up",0.00541637867931773,0.0944705290786994,"B.PvsV.WANG_CLASSIC_ADIPOGENIC_TARGETS_OF_PPARG"
67,"Up",0.00546269416252804,0.0948293834580326,"B.PvsV.PID_EPHB_FWD_PATHWAY"
40,"Up",0.0055016233194164,0.0948293834580326,"B.PvsV.KEGG_FRUCTOSE_AND_MANNOSE_METABOLISM"
34,"Up",0.00550210462233186,0.0948293834580326,"B.PvsV.FUJIWARA_PARK2_HEPATOCYTE_PROLIFERATION_UP"
105,"Up",0.00550555834509468,0.0948293834580326,"B.PvsV.PID_MET_PATHWAY"
29,"Down",0.00552282165472194,0.0948313072327876,"B.PvsV.GESERICK_TERT_TARGETS_DN"
6,"Up",0.00557407876684089,0.0954151130088646,"B.PvsV.REACTOME_MET_INTERACTS_WITH_TNS_PROTEINS"
35,"Up",0.00564594213542087,0.0963469569961173,"B.PvsV.SEIDEN_MET_SIGNALING"
38,"Up",0.00572505828017897,0.0973964530187986,"B.PvsV.BIOCARTA_IGF1R_PATHWAY"
97,"Down",0.00580071388346757,0.0983808192076447,"B.PvsV.AMIT_SERUM_RESPONSE_120_MCF10A"
181,"Down",0.00584467832978168,0.0987792880252771,"B.PvsV.MISSIAGLIA_REGULATED_BY_METHYLATION_DN"
257,"Up",0.00585993967666682,0.0987792880252771,"B.PvsV.LANDIS_ERBB2_BREAST_TUMORS_324_DN"
7,"Down",0.00588456263830498,0.0988928474990524,"B.PvsV.CALVET_IRINOTECAN_SENSITIVE_VS_REVERTED_DN"
16,"Up",0.00591848337054241,0.0991379065187926,"B.PvsV.BIOCARTA_EPONFKB_PATHWAY"
14,"Down",0.00593500579810461,0.0991379065187926,"B.PvsV.ZHOU_PANCREATIC_BETA_CELL"
15,"Up",0.00605776814884317,0.100883735225765,"B.PvsV.MONTERO_THYROID_CANCER_POOR_SURVIVAL_DN"
22,"Down",0.00616390694907439,0.102343067631929,"B.PvsV.REACTOME_CASPASE_MEDIATED_CLEAVAGE_OF_CYTOSKELETAL_PROTEINS"
7,"Up",0.00618870072374067,0.102447084735216,"B.PvsV.REACTOME_NEGATIVE_FEEDBACK_REGULATION_OF_MAPK_PATHWAY"
105,"Up",0.00623094123114241,0.102731855270517,"B.PvsV.PID_VEGFR1_2_PATHWAY"
40,"Down",0.00627152661589087,0.102731855270517,"B.PvsV.MURAKAMI_UV_RESPONSE_24HR"
17,"Up",0.00628531317336332,0.102731855270517,"B.PvsV.REACTOME_REGULATION_OF_PYRUVATE_DEHYDROGENASE_PDH_COMPLEX"
64,"Up",0.00630906771968204,0.102731855270517,"B.PvsV.KEGG_ALLOGRAFT_REJECTION"
109,"Down",0.00633919777928734,0.102731855270517,"B.PvsV.REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM"
11,"Down",0.00635694964622698,0.102731855270517,"B.PvsV.REACTOME_UREA_CYCLE"
40,"Up",0.00636182495280707,0.102731855270517,"B.PvsV.REACTOME_SIGNALLING_TO_ERKS"
47,"Down",0.00636921211066488,0.102731855270517,"B.PvsV.VALK_AML_CLUSTER_1"
14,"Down",0.00637312829766456,0.102731855270517,"B.PvsV.REACTOME_LYSOSPHINGOLIPID_AND_LPA_RECEPTORS"
181,"Down",0.00648516328018094,0.104233917953838,"B.PvsV.NIKOLSKY_MUTATED_AND_AMPLIFIED_IN_BREAST_CANCER"
73,"Down",0.0067333862377373,0.107909833357825,"B.PvsV.ZWANG_CLASS_2_TRANSIENTLY_INDUCED_BY_EGF"
13,"Down",0.00675718139826663,0.10797819639022,"B.PvsV.MCCOLLUM_GELDANAMYCIN_RESISTANCE_DN"
243,"Down",0.00678616528134283,0.108128841039033,"B.PvsV.REACTOME_MRNA_SPLICING"
46,"Up",0.00685283082022318,0.108877303462684,"B.PvsV.SAKAI_TUMOR_INFILTRATING_MONOCYTES_UP"
36,"Up",0.00697821605293612,0.110551737984767,"B.PvsV.BARIS_THYROID_CANCER_UP"
104,"Up",0.00700848115116047,0.110713977956475,"B.PvsV.REACTOME_SIGNALING_BY_MET"
8,"Down",0.00708125153300465,0.111544842524167,"B.PvsV.GAUTSCHI_SRC_SIGNALING"
190,"Up",0.00714059651511575,0.11207518437455,"B.PvsV.KIM_ALL_DISORDERS_DURATION_CORR_DN"
18,"Down",0.00715546031546685,0.11207518437455,"B.PvsV.BIOCARTA_MCM_PATHWAY"
24,"Up",0.00721354964895903,0.112125408152887,"B.PvsV.PID_P38_MK2_PATHWAY"
87,"Down",0.00721903889363874,0.112125408152887,"B.PvsV.BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN"
16,"Down",0.00722497601359261,0.112125408152887,"B.PvsV.REACTOME_SUMOYLATION_OF_DNA_METHYLATION_PROTEINS"
10,"Up",0.00724096053143979,0.112125408152887,"B.PvsV.REACTOME_BETA_OXIDATION_OF_PRISTANOYL_COA"
47,"Down",0.00726006440924826,0.112125408152887,"B.PvsV.KAMMINGA_EZH2_TARGETS"
9,"Down",0.00745826703686181,0.114699177425799,"B.PvsV.RODRIGUES_DCC_TARGETS_UP"
15,"Down",0.00746820471573301,0.114699177425799,"B.PvsV.REACTOME_MISMATCH_REPAIR"
77,"Up",0.00752326139684347,0.114944395599083,"B.PvsV.MELLMAN_TUT1_TARGETS_DN"
117,"Up",0.00752574990176671,0.114944395599083,"B.PvsV.PID_FAK_PATHWAY"
46,"Up",0.00758542676053946,0.115027517527492,"B.PvsV.IIZUKA_LIVER_CANCER_PROGRESSION_G2_G3_UP"
26,"Up",0.00758726778516424,0.115027517527492,"B.PvsV.REACTOME_TRIGLYCERIDE_CATABOLISM"
75,"Up",0.00759360533505778,0.115027517527492,"B.PvsV.REACTOME_REGULATION_OF_RAS_BY_GAPS"
103,"Up",0.00774885142029883,0.116783589120005,"B.PvsV.REACTOME_PCP_CE_PATHWAY"
13,"Up",0.00775177739320704,0.116783589120005,"B.PvsV.REACTOME_FIBRONECTIN_MATRIX_FORMATION"
41,"Up",0.00778557879028808,0.116788355683336,"B.PvsV.BIOCARTA_MHC_PATHWAY"
6,"Down",0.0077943395274283,0.116788355683336,"B.PvsV.MCGOWAN_RSP6_TARGETS_DN"
17,"Up",0.00785036615038048,0.117309930933659,"B.PvsV.RAY_ALZHEIMERS_DISEASE"
187,"Up",0.00800044157672775,0.11923030047905,"B.PvsV.REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS"
176,"Down",0.00810145662498499,0.12041116580522,"B.PvsV.ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR"
453,"Down",0.0081896607132376,0.121241158326691,"B.PvsV.SANSOM_APC_TARGETS"
31,"Down",0.00820115630569403,0.121241158326691,"B.PvsV.REICHERT_MITOSIS_LIN9_TARGETS"
147,"Down",0.0082662914935481,0.121878201780873,"B.PvsV.PUJANA_BRCA_CENTERED_NETWORK"
21,"Up",0.00833973052333453,0.122633962934885,"B.PvsV.REACTOME_P130CAS_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS"
47,"Up",0.00847607522851577,0.124207130139676,"B.PvsV.GALE_APL_WITH_FLT3_MUTATED_DN"
319,"Down",0.00849164318914766,0.124207130139676,"B.PvsV.SHEPARD_CRUSH_AND_BURN_MUTANT_DN"
170,"Up",0.0085168270297234,0.124246798541796,"B.PvsV.KAYO_CALORIE_RESTRICTION_MUSCLE_DN"
106,"Up",0.008697271513189,0.126013703029586,"B.PvsV.PID_HIF1_TFPATHWAY"
13,"Up",0.00869772259809228,0.126013703029586,"B.PvsV.REACTOME_MET_ACTIVATES_RAS_SIGNALING"
74,"Up",0.00870631842237329,0.126013703029586,"B.PvsV.LI_CISPLATIN_RESISTANCE_UP"
335,"Down",0.00873381008395872,0.126081556016208,"B.PvsV.KOBAYASHI_EGFR_SIGNALING_24HR_DN"
37,"Down",0.00883833297350605,0.127073359806674,"B.PvsV.REACTOME_FGFR2_MUTANT_RECEPTOR_ACTIVATION"
24,"Down",0.00884847956693243,0.127073359806674,"B.PvsV.CAIRO_PML_TARGETS_BOUND_BY_MYC_DN"
94,"Up",0.00889171085128186,0.12736339196046,"B.PvsV.COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_UP"
75,"Down",0.00891967885827249,0.1274338615178,"B.PvsV.FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_DN"
60,"Down",0.00903671261654499,0.128773154785766,"B.PvsV.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_UP"
6,"Up",0.00908496734572461,0.1290348219732,"B.PvsV.REACTOME_FORMATION_OF_XYLULOSE_5_PHOSPHATE"
30,"Up",0.00912030433114749,0.1290348219732,"B.PvsV.REACTOME_SYNTHESIS_OF_PC"
19,"Up",0.00912508869443324,0.1290348219732,"B.PvsV.REACTOME_PTK6_REGULATES_RHO_GTPASES_RAS_GTPASE_AND_MAP_KINASES"
7,"Up",0.00915303204839149,0.129099781111114,"B.PvsV.REACTOME_PROTEIN_REPAIR"
40,"Down",0.00921834815465214,0.129690195794076,"B.PvsV.REACTOME_HDR_THROUGH_SINGLE_STRAND_ANNEALING_SSA"
11,"Up",0.00924887586026338,0.129789427998468,"B.PvsV.HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_DN"
544,"Up",0.00939414210165575,0.131365183432092,"B.PvsV.SHEN_SMARCA2_TARGETS_UP"
31,"Down",0.0094515719574707,0.131365183432092,"B.PvsV.INAMURA_LUNG_CANCER_SCC_UP"
32,"Up",0.00946709122565709,0.131365183432092,"B.PvsV.KEGG_PENTOSE_PHOSPHATE_PATHWAY"
74,"Down",0.00949937618204894,0.131365183432092,"B.PvsV.KUUSELO_PANCREATIC_CANCER_19Q13_AMPLIFICATION"
59,"Down",0.00950211852381509,0.131365183432092,"B.PvsV.REACTOME_MRNA_SPLICING_MINOR_PATHWAY"
17,"Up",0.00950372099345937,0.131365183432092,"B.PvsV.MARSHALL_VIRAL_INFECTION_RESPONSE_UP"
8,"Up",0.00959502694850516,0.131992173620712,"B.PvsV.REACTOME_METAL_SEQUESTRATION_BY_ANTIMICROBIAL_PROTEINS"
26,"Down",0.00961468119934089,0.131992173620712,"B.PvsV.TRAYNOR_RETT_SYNDROM_DN"
23,"Down",0.00964122260657645,0.131992173620712,"B.PvsV.REACTOME_CHL1_INTERACTIONS"
42,"Up",0.00964457191947329,0.131992173620712,"B.PvsV.BIOCARTA_PYK2_PATHWAY"
27,"Down",0.00970180110081382,0.132447551324443,"B.PvsV.KEGG_RNA_POLYMERASE"
20,"Up",0.00977125867001116,0.133067214745054,"B.PvsV.BIOCARTA_HSP27_PATHWAY"
36,"Up",0.00985782181566164,0.133916208399983,"B.PvsV.REACTOME_PLATELET_ADHESION_TO_EXPOSED_COLLAGEN"
56,"Up",0.0099961963190252,0.135463160411496,"B.PvsV.DAVIES_MULTIPLE_MYELOMA_VS_MGUS_UP"
17,"Down",0.0101477637825171,0.137097784804777,"B.PvsV.REACTOME_RETINOID_CYCLE_DISEASE_EVENTS"
137,"Down",0.0101664119677986,0.137097784804777,"B.PvsV.SHIPP_DLBCL_CURED_VS_FATAL_UP"
119,"Up",0.0102326368271081,0.137377449314295,"B.PvsV.REACTOME_EPH_EPHRIN_SIGNALING"
196,"Down",0.0102368437542936,0.137377449314295,"B.PvsV.SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP"
48,"Up",0.0103128135123699,0.137806470460322,"B.PvsV.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_UP"
63,"Up",0.0103186613801001,0.137806470460322,"B.PvsV.GAUSSMANN_MLL_AF4_FUSION_TARGETS_D_UP"
12,"Down",0.010484310252826,0.139498732637976,"B.PvsV.REACTOME_UNWINDING_OF_DNA"
155,"Up",0.0104958351921501,0.139498732637976,"B.PvsV.ALCALA_APOPTOSIS"
42,"Up",0.0105367893121198,0.139653529224775,"B.PvsV.REACTOME_GENERATION_OF_SECOND_MESSENGER_MOLECULES"
39,"Up",0.010557998773007,0.139653529224775,"B.PvsV.KEGG_THYROID_CANCER"
33,"Down",0.0105984044670216,0.139838152878508,"B.PvsV.REACTOME_RESOLUTION_OF_D_LOOP_STRUCTURES"
21,"Down",0.0106365763275026,0.139838152878508,"B.PvsV.AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_DN"
36,"Up",0.010647831861431,0.139838152878508,"B.PvsV.KEGG_PROPANOATE_METABOLISM"
38,"Up",0.0106775587634989,0.139896261619397,"B.PvsV.SEMBA_FHIT_TARGETS_UP"
89,"Up",0.0108950379995168,0.140518684318438,"B.PvsV.LANDIS_ERBB2_BREAST_PRENEOPLASTIC_DN"
40,"Up",0.0109069918859934,0.140518684318438,"B.PvsV.GUTIERREZ_MULTIPLE_MYELOMA_UP"
185,"Down",0.0109212314699441,0.140518684318438,"B.PvsV.WHITEFORD_PEDIATRIC_CANCER_MARKERS"
32,"Down",0.0109272994257488,0.140518684318438,"B.PvsV.HOLLEMAN_PREDNISOLONE_RESISTANCE_B_ALL_DN"
35,"Down",0.0109315128342658,0.140518684318438,"B.PvsV.MAGRANGEAS_MULTIPLE_MYELOMA_IGLL_VS_IGLK_DN"
21,"Down",0.0109619615523343,0.140518684318438,"B.PvsV.REACTOME_PCNA_DEPENDENT_LONG_PATCH_BASE_EXCISION_REPAIR"
82,"Up",0.0109659269686728,0.140518684318438,"B.PvsV.PID_TGFBR_PATHWAY"
13,"Up",0.0109734895489665,0.140518684318438,"B.PvsV.REACTOME_REGULATION_OF_GLYCOLYSIS_BY_FRUCTOSE_2_6_BISPHOSPHATE_METABOLISM"
55,"Down",0.0109772172595987,0.140518684318438,"B.PvsV.STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_DN"
101,"Up",0.0109792135332908,0.140518684318438,"B.PvsV.REACTOME_COPII_MEDIATED_VESICLE_TRANSPORT"
6,"Up",0.0111581569027029,0.14247909818717,"B.PvsV.BIOCARTA_SLRP_PATHWAY"
172,"Up",0.0114243824528836,0.145354072037962,"B.PvsV.REACTOME_BETA_CATENIN_INDEPENDENT_WNT_SIGNALING"
7,"Up",0.0114358873822596,0.145354072037962,"B.PvsV.LIU_CMYB_TARGETS_DN"
32,"Down",0.0114823323839629,0.145609669153511,"B.PvsV.NUMATA_CSF3_SIGNALING_VIA_STAT3"
78,"Down",0.0115522351401456,0.14615710331076,"B.PvsV.NAGASHIMA_EGF_SIGNALING_UP"
15,"Up",0.0115783706366636,0.14615710331076,"B.PvsV.MANN_RESPONSE_TO_AMIFOSTINE_DN"
69,"Up",0.0116329790397964,0.146416553995073,"B.PvsV.PID_RHOA_PATHWAY"
8,"Up",0.0116518870967322,0.146416553995073,"B.PvsV.REACTOME_TYSND1_CLEAVES_PEROXISOMAL_PROTEINS"
54,"Down",0.0117498536061712,0.14731279045016,"B.PvsV.PLASARI_TGFB1_SIGNALING_VIA_NFIC_10HR_DN"
78,"Down",0.0117975178752715,0.147575738308543,"B.PvsV.REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS"
115,"Up",0.0118487175994289,0.147881624395581,"B.PvsV.SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE"
15,"Up",0.0119715982930674,0.148795574152761,"B.PvsV.REACTOME_RHO_GTPASES_ACTIVATE_KTN1"
67,"Up",0.0119757696686523,0.148795574152761,"B.PvsV.PID_ECADHERIN_NASCENT_AJ_PATHWAY"
34,"Up",0.0120671910793967,0.14927343706051,"B.PvsV.REACTOME_MITOPHAGY"
69,"Up",0.0120682268703288,0.14927343706051,"B.PvsV.JIANG_AGING_HYPOTHALAMUS_UP"
11,"Up",0.0122442319555894,0.151112407326906,"B.PvsV.REACTOME_DERMATAN_SULFATE_BIOSYNTHESIS"
90,"Up",0.0124397391769709,0.152090662976569,"B.PvsV.IKEDA_MIR133_TARGETS_UP"
73,"Up",0.0124429436766613,0.152090662976569,"B.PvsV.REACTOME_G1_S_DNA_DAMAGE_CHECKPOINTS"
19,"Up",0.012443312725226,0.152090662976569,"B.PvsV.REACTOME_ALPHA_LINOLENIC_OMEGA3_AND_LINOLEIC_OMEGA6_ACID_METABOLISM"
45,"Down",0.0124659974645644,0.152090662976569,"B.PvsV.SAMOLS_TARGETS_OF_KHSV_MIRNAS_UP"
7,"Down",0.0124829192364741,0.152090662976569,"B.PvsV.REACTOME_SULFIDE_OXIDATION_TO_SULFATE"
15,"Down",0.0125137592604076,0.152090662976569,"B.PvsV.REACTOME_PROCESSIVE_SYNTHESIS_ON_THE_LAGGING_STRAND"
14,"Up",0.0125183274868853,0.152090662976569,"B.PvsV.REACTOME_MITOCHONDRIAL_FATTY_ACID_BETA_OXIDATION_OF_SATURATED_FATTY_ACIDS"
92,"Up",0.0125435598331191,0.152090662976569,"B.PvsV.REACTOME_RAB_GEFS_EXCHANGE_GTP_FOR_GDP_ON_RABS"
116,"Up",0.0126092543875296,0.152368450078429,"B.PvsV.REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX3"
23,"Up",0.0126464729434485,0.152368450078429,"B.PvsV.ZEILSTRA_CD44_TARGETS_DN"
38,"Down",0.0126850861179253,0.152368450078429,"B.PvsV.HOEGERKORP_CD44_TARGETS_DIRECT_DN"
131,"Down",0.0127210817937753,0.152368450078429,"B.PvsV.LEE_EARLY_T_LYMPHOCYTE_UP"
98,"Down",0.0127292502622596,0.152368450078429,"B.PvsV.SLEBOS_HEAD_AND_NECK_CANCER_WITH_HPV_UP"
13,"Down",0.0127318184004764,0.152368450078429,"B.PvsV.REACTOME_PROCESSIVE_SYNTHESIS_ON_THE_C_STRAND_OF_THE_TELOMERE"
522,"Up",0.012849739373901,0.153447535633474,"B.PvsV.PASINI_SUZ12_TARGETS_DN"
15,"Down",0.012908529791355,0.15381737331121,"B.PvsV.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TAN_DN"
128,"Up",0.0129757886011475,0.154286312205903,"B.PvsV.REACTOME_RAB_REGULATION_OF_TRAFFICKING"
56,"Down",0.0131127907967469,0.155088062574243,"B.PvsV.THEODOROU_MAMMARY_TUMORIGENESIS"
69,"Down",0.0131260002078104,0.155088062574243,"B.PvsV.BOYLAN_MULTIPLE_MYELOMA_C_UP"
32,"Up",0.0131371503912637,0.155088062574243,"B.PvsV.REACTOME_RHO_GTPASES_ACTIVATE_CIT"
8,"Up",0.0131554171364297,0.155088062574243,"B.PvsV.REACTOME_ACTIVATION_OF_TRKA_RECEPTORS"
86,"Up",0.0133356483477421,0.156878297265247,"B.PvsV.REACTOME_PEROXISOMAL_PROTEIN_IMPORT"
12,"Up",0.0134847202797376,0.158142148954395,"B.PvsV.BIOCARTA_SARS_PATHWAY"
11,"Up",0.0135002883534951,0.158142148954395,"B.PvsV.REACTOME_BICARBONATE_TRANSPORTERS"
183,"Up",0.013534876330467,0.158201962842367,"B.PvsV.FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP"
223,"Down",0.0136049608925864,0.158201962842367,"B.PvsV.WILCOX_RESPONSE_TO_PROGESTERONE_UP"
130,"Up",0.0136183491080791,0.158201962842367,"B.PvsV.LEE_LIVER_CANCER_E2F1_UP"
10,"Up",0.0136198470452101,0.158201962842367,"B.PvsV.REACTOME_SYNTHESIS_OF_PYROPHOSPHATES_IN_THE_CYTOSOL"
76,"Down",0.0136723483934202,0.158478855906122,"B.PvsV.REACTOME_TRANSCRIPTION_OF_THE_HIV_GENOME"
55,"Down",0.0137703129581673,0.158963573769486,"B.PvsV.FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_DN"
96,"Up",0.0137716679029814,0.158963573769486,"B.PvsV.REACTOME_APC_C_MEDIATED_DEGRADATION_OF_CELL_CYCLE_PROTEINS"
31,"Up",0.013950316636406,0.160690209755601,"B.PvsV.MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH"
12,"Up",0.0140248732432877,0.161213147946232,"B.PvsV.REACTOME_FOLDING_OF_ACTIN_BY_CCT_TRIC"
25,"Down",0.0142606778697776,0.163583584941909,"B.PvsV.REACTOME_RESOLUTION_OF_AP_SITES_VIA_THE_MULTIPLE_NUCLEOTIDE_PATCH_REPLACEMENT_PATHWAY"
221,"Down",0.0144333185834726,0.164910159672312,"B.PvsV.HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP"
24,"Up",0.0144359770810995,0.164910159672312,"B.PvsV.REACTOME_ANCHORING_FIBRIL_FORMATION"
33,"Up",0.0146132131218118,0.16632277546732,"B.PvsV.RAMPON_ENRICHED_LEARNING_ENVIRONMENT_LATE_UP"
6,"Up",0.0146759190201603,0.16632277546732,"B.PvsV.REACTOME_METHIONINE_SALVAGE_PATHWAY"
56,"Down",0.0146829698418284,0.16632277546732,"B.PvsV.ZHAN_MULTIPLE_MYELOMA_PR_UP"
61,"Down",0.0146894692730923,0.16632277546732,"B.PvsV.REACTOME_KINESINS"
16,"Down",0.014710044710349,0.16632277546732,"B.PvsV.BIOCARTA_TSP1_PATHWAY"
1863,"Up",0.0151138085332129,0.170539280367621,"B.PvsV.BLALOCK_ALZHEIMERS_DISEASE_DN"
6,"Up",0.0152073053844112,0.171004482601438,"B.PvsV.REACTOME_MOLYBDENUM_COFACTOR_BIOSYNTHESIS"
546,"Down",0.0152168937312186,0.171004482601438,"B.PvsV.BLUM_RESPONSE_TO_SALIRASIB_DN"
178,"Down",0.0152600860600419,0.171142019930977,"B.PvsV.WHITFIELD_CELL_CYCLE_G1_S"
18,"Up",0.0152911094818117,0.1711428022772,"B.PvsV.MAINA_VHL_TARGETS_UP"
64,"Down",0.015343909494379,0.17138681938267,"B.PvsV.REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS"
165,"Up",0.0153755136201204,0.171393578237189,"B.PvsV.IVANOVA_HEMATOPOIESIS_INTERMEDIATE_PROGENITOR"
24,"Down",0.0155231119942043,0.172645805539267,"B.PvsV.FARMER_BREAST_CANCER_CLUSTER_5"
51,"Down",0.0156262911118992,0.172645805539267,"B.PvsV.REACTOME_SIGNALING_BY_FGFR2_IN_DISEASE"
274,"Down",0.0156572895927522,0.172645805539267,"B.PvsV.SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP"
144,"Up",0.0156582069516884,0.172645805539267,"B.PvsV.SWEET_KRAS_TARGETS_UP"
266,"Up",0.0156661763369492,0.172645805539267,"B.PvsV.PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_DN"
51,"Down",0.0156752024562691,0.172645805539267,"B.PvsV.PLASARI_NFIC_TARGETS_BASAL_DN"
39,"Down",0.0157070779880165,0.172652950687363,"B.PvsV.REACTOME_NUCLEAR_IMPORT_OF_REV_PROTEIN"
14,"Down",0.0157501875116946,0.172783307047936,"B.PvsV.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_12"
213,"Down",0.0158022093229853,0.172871556796213,"B.PvsV.RUIZ_TNC_TARGETS_DN"
32,"Down",0.0158503826023595,0.172871556796213,"B.PvsV.REACTOME_G1_S_SPECIFIC_TRANSCRIPTION"
63,"Up",0.0158520309813131,0.172871556796213,"B.PvsV.BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_48HR_DN"
120,"Up",0.0159571541502735,0.173285500476757,"B.PvsV.REACTOME_UCH_PROTEINASES"
44,"Up",0.0159756609413253,0.173285500476757,"B.PvsV.MACLACHLAN_BRCA1_TARGETS_DN"
115,"Down",0.0159840125236293,0.173285500476757,"B.PvsV.MCCLUNG_COCAIN_REWARD_4WK"
38,"Up",0.01603388779345,0.173410631719362,"B.PvsV.REACTOME_INTEGRIN_SIGNALING"
35,"Up",0.0160980014119648,0.173410631719362,"B.PvsV.REACTOME_GLUCAGON_SIGNALING_IN_METABOLIC_REGULATION"
12,"Up",0.0161093062407143,0.173410631719362,"B.PvsV.REACTOME_ACTIVATED_NTRK2_SIGNALS_THROUGH_RAS"
24,"Up",0.016121010074833,0.173410631719362,"B.PvsV.WU_HBX_TARGETS_1_UP"
167,"Up",0.0161922155513776,0.17383836851178,"B.PvsV.SANA_TNF_SIGNALING_UP"
24,"Down",0.0162516147893886,0.174032471665345,"B.PvsV.LOPEZ_MESOTELIOMA_SURVIVAL_TIME_UP"
140,"Down",0.0162732479383222,0.174032471665345,"B.PvsV.REACTOME_NONSENSE_MEDIATED_DECAY_NMD"
456,"Down",0.0163745687895535,0.174777974589655,"B.PvsV.GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN"
42,"Down",0.0164152412469846,0.174874506463542,"B.PvsV.REACTOME_INTERACTIONS_OF_REV_WITH_HOST_CELLULAR_PROTEINS"
41,"Down",0.0165402675839428,0.175724670973645,"B.PvsV.REACTOME_GLYCOSPHINGOLIPID_METABOLISM"
112,"Down",0.0165892709687919,0.175724670973645,"B.PvsV.ASGHARZADEH_NEUROBLASTOMA_POOR_SURVIVAL_DN"
12,"Up",0.0165903921592047,0.175724670973645,"B.PvsV.BIOCARTA_EOSINOPHILS_PATHWAY"
19,"Up",0.0166234580804944,0.175738240395896,"B.PvsV.KEGG_GLYOXYLATE_AND_DICARBOXYLATE_METABOLISM"
34,"Up",0.0168148617581565,0.177241197741272,"B.PvsV.RUAN_RESPONSE_TO_TROGLITAZONE_UP"
24,"Up",0.0168297393405983,0.177241197741272,"B.PvsV.RUAN_RESPONSE_TO_TROGLITAZONE_DN"
117,"Up",0.0168944542456406,0.17758448198507,"B.PvsV.KEGG_DILATED_CARDIOMYOPATHY"
64,"Down",0.016947419583484,0.177803193315148,"B.PvsV.LIU_BREAST_CANCER"
13,"Down",0.01699453173756,0.177959784047291,"B.PvsV.PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_5"
5,"Down",0.0171478408978857,0.179225732182249,"B.PvsV.REACTOME_LEUKOTRIENE_RECEPTORS"
49,"Up",0.0172229198388585,0.179670799601979,"B.PvsV.REACTOME_STRIATED_MUSCLE_CONTRACTION"
65,"Up",0.0173536675105108,0.180693837411702,"B.PvsV.WONG_PROTEASOME_GENE_MODULE"
27,"Up",0.0174214748821548,0.181058899668109,"B.PvsV.WACKER_HYPOXIA_TARGETS_OF_VHL"
106,"Up",0.017599590203573,0.182566855976651,"B.PvsV.KEGG_HEMATOPOIETIC_CELL_LINEAGE"
56,"Up",0.0176381368818729,0.182624080187032,"B.PvsV.HASLINGER_B_CLL_WITH_6Q21_DELETION"
8,"Down",0.0176876951679402,0.182794890810357,"B.PvsV.BIOCARTA_RNAPOL3_PATHWAY"
93,"Down",0.0179008730222579,0.184652848768776,"B.PvsV.VERNELL_RETINOBLASTOMA_PATHWAY_UP"
6,"Down",0.0181121118993727,0.18602567365482,"B.PvsV.REACTOME_PRE_NOTCH_PROCESSING_IN_THE_ENDOPLASMIC_RETICULUM"
138,"Up",0.0181301521370842,0.18602567365482,"B.PvsV.LEIN_MEDULLA_MARKERS"
29,"Up",0.0181348956592418,0.18602567365482,"B.PvsV.REACTOME_LDL_CLEARANCE"
109,"Down",0.0181785172110132,0.186127817888319,"B.PvsV.REACTOME_AURKA_ACTIVATION_BY_TPX2"
9,"Up",0.0183415895200568,0.186939956763288,"B.PvsV.REACTOME_INTERLEUKIN_1_PROCESSING"
167,"Down",0.0183487658876013,0.186939956763288,"B.PvsV.HOOI_ST7_TARGETS_UP"
30,"Down",0.0183592686783261,0.186939956763288,"B.PvsV.MILICIC_FAMILIAL_ADENOMATOUS_POLYPOSIS_DN"
17,"Up",0.0185146515709692,0.187833916423911,"B.PvsV.KEGG_STEROID_BIOSYNTHESIS"
81,"Up",0.0185150089439377,0.187833916423911,"B.PvsV.REACTOME_COSTIMULATION_BY_THE_CD28_FAMILY"
51,"Up",0.018564336137063,0.187989403849489,"B.PvsV.JIANG_AGING_HYPOTHALAMUS_DN"
109,"Up",0.0188209979124982,0.190141550729399,"B.PvsV.KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM"
12,"Up",0.018845644745833,0.190141550729399,"B.PvsV.YAMANAKA_GLIOBLASTOMA_SURVIVAL_DN"
63,"Down",0.018974398018268,0.191091888238622,"B.PvsV.AMIT_EGF_RESPONSE_40_HELA"
96,"Up",0.0190853711919402,0.191415024781428,"B.PvsV.PETROVA_PROX1_TARGETS_DN"
27,"Down",0.0190965214550993,0.191415024781428,"B.PvsV.WU_APOPTOSIS_BY_CDKN1A_NOT_VIA_TP53"
41,"Up",0.0191103443080753,0.191415024781428,"B.PvsV.REACTOME_EGR2_AND_SOX10_MEDIATED_INITIATION_OF_SCHWANN_CELL_MYELINATION"
46,"Down",0.0191620609474752,0.191585958369964,"B.PvsV.REACTOME_HIV_TRANSCRIPTION_ELONGATION"
103,"Up",0.0192017237314862,0.191635975652323,"B.PvsV.DORN_ADENOVIRUS_INFECTION_24HR_DN"
664,"Down",0.0194729873520298,0.193993057782653,"B.PvsV.PUJANA_BRCA2_PCC_NETWORK"
145,"Up",0.01961043734077,0.194450119291401,"B.PvsV.SASSON_RESPONSE_TO_FORSKOLIN_UP"
211,"Up",0.0196165683563965,0.194450119291401,"B.PvsV.RODWELL_AGING_KIDNEY_DN"
56,"Down",0.0196243744916986,0.194450119291401,"B.PvsV.KEGG_HEDGEHOG_SIGNALING_PATHWAY"
16,"Up",0.0196841125585154,0.194693127613653,"B.PvsV.REACTOME_UPTAKE_AND_FUNCTION_OF_ANTHRAX_TOXINS"
800,"Down",0.0198706189325614,0.196030921179938,"B.PvsV.MARSON_BOUND_BY_E2F4_UNSTIMULATED"
70,"Down",0.0199242737998965,0.196030921179938,"B.PvsV.ZHAN_MULTIPLE_MYELOMA_CD1_DN"
55,"Down",0.019925732990256,0.196030921179938,"B.PvsV.REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA"
130,"Up",0.0201081362498389,0.197376715309493,"B.PvsV.WOO_LIVER_CANCER_RECURRENCE_DN"
11,"Down",0.0201451824826603,0.197376715309493,"B.PvsV.MATHEW_FANCONI_ANEMIA_GENES"
29,"Up",0.0201696227436903,0.197376715309493,"B.PvsV.GREENBAUM_E2A_TARGETS_DN"
9,"Down",0.020276094391489,0.198068066944421,"B.PvsV.IIZUKA_LIVER_CANCER_PROGRESSION_G2_G3_DN"
89,"Up",0.0203277374968853,0.198222329136294,"B.PvsV.KEGG_LONG_TERM_POTENTIATION"
11,"Up",0.0204358862564113,0.19892608294313,"B.PvsV.REACTOME_CREB_PHOSPHORYLATION"
28,"Down",0.0205295410572221,0.199486524614026,"B.PvsV.REACTOME_TRP_CHANNELS"
51,"Up",0.0206144862926919,0.199960517039112,"B.PvsV.BERNARD_PPAPDC1B_TARGETS_UP"
22,"Up",0.0206587034149124,0.200025058084772,"B.PvsV.REACTOME_GRB2_SOS_PROVIDES_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS"
43,"Up",0.0207257972901002,0.200025058084772,"B.PvsV.MAGRANGEAS_MULTIPLE_MYELOMA_IGG_VS_IGA_DN"
41,"Down",0.0208033555474015,0.200025058084772,"B.PvsV.REACTOME_FANCONI_ANEMIA_PATHWAY"
99,"Up",0.0208064311582407,0.200025058084772,"B.PvsV.REACTOME_SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE"
153,"Up",0.0208152732779307,0.200025058084772,"B.PvsV.HUANG_DASATINIB_RESISTANCE_UP"
29,"Up",0.0208382046404103,0.200025058084772,"B.PvsV.HORTON_SREBF_TARGETS"
85,"Up",0.0209401976012221,0.200365541929878,"B.PvsV.GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN"
61,"Down",0.0209461535965762,0.200365541929878,"B.PvsV.RIZ_ERYTHROID_DIFFERENTIATION_6HR"
94,"Down",0.0210238220673446,0.200761160985057,"B.PvsV.MAYBURD_RESPONSE_TO_L663536_DN"
86,"Down",0.021206535291608,0.201905597399569,"B.PvsV.CHANDRAN_METASTASIS_TOP50_UP"
29,"Down",0.0212167032174262,0.201905597399569,"B.PvsV.REACTOME_TNFS_BIND_THEIR_PHYSIOLOGICAL_RECEPTORS"
154,"Up",0.0212614103027278,0.201983397875914,"B.PvsV.PID_ERBB1_DOWNSTREAM_PATHWAY"
71,"Up",0.0214921758058037,0.203537168582213,"B.PvsV.KEGG_GRAFT_VERSUS_HOST_DISEASE"
121,"Up",0.021498590423587,0.203537168582213,"B.PvsV.HENDRICKS_SMARCA4_TARGETS_UP"
62,"Down",0.0215998920220547,0.204146671777676,"B.PvsV.SAGIV_CD24_TARGETS_DN"
15,"Down",0.0217808044278036,0.205505234951069,"B.PvsV.NEBEN_AML_WITH_FLT3_OR_NRAS_UP"
34,"Up",0.0218482067140319,0.20553966560742,"B.PvsV.MASRI_RESISTANCE_TO_TAMOXIFEN_AND_AROMATASE_INHIBITORS_DN"
55,"Up",0.0218588032876041,0.20553966560742,"B.PvsV.PID_LYMPH_ANGIOGENESIS_PATHWAY"
27,"Down",0.0219099067701279,0.205670415164749,"B.PvsV.REACTOME_GAP_FILLING_DNA_REPAIR_SYNTHESIS_AND_LIGATION_IN_GG_NER"
62,"Down",0.0219995385833952,0.206069380123019,"B.PvsV.VALK_AML_CLUSTER_6"
54,"Up",0.0220453146165598,0.206069380123019,"B.PvsV.KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS"
71,"Up",0.0220642201180733,0.206069380123019,"B.PvsV.KEGG_TYPE_I_DIABETES_MELLITUS"
7,"Down",0.0221652776779479,0.206664115145656,"B.PvsV.REACTOME_DEFECTIVE_LFNG_CAUSES_SCDO3"
6,"Up",0.0223036874729548,0.20741007559192,"B.PvsV.REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_KEY_METABOLIC_FACTORS"
14,"Down",0.0223305846400172,0.20741007559192,"B.PvsV.REACTOME_FGFR3_LIGAND_BINDING_AND_ACTIVATION"
7,"Up",0.0223875179884148,0.20741007559192,"B.PvsV.REACTOME_NGF_INDEPENDANT_TRKA_ACTIVATION"
796,"Up",0.022395336431249,0.20741007559192,"B.PvsV.MILI_PSEUDOPODIA_HAPTOTAXIS_UP"
35,"Down",0.0225428329691649,0.208350477041596,"B.PvsV.HOFMANN_MYELODYSPLASTIC_SYNDROM_HIGH_RISK_DN"
49,"Up",0.0225722437597967,0.208350477041596,"B.PvsV.REACTOME_TBC_RABGAPS"
221,"Up",0.0226646532774307,0.208854779951524,"B.PvsV.RODWELL_AGING_KIDNEY_NO_BLOOD_DN"
39,"Up",0.0227066076482023,0.208893234088038,"B.PvsV.REACTOME_TRIGLYCERIDE_METABOLISM"
28,"Down",0.0227836803129829,0.209254100416084,"B.PvsV.REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS"
33,"Down",0.0229260711324569,0.209410703312809,"B.PvsV.SABATES_COLORECTAL_ADENOMA_SIZE_UP"
88,"Up",0.0229794498208367,0.209410703312809,"B.PvsV.DORN_ADENOVIRUS_INFECTION_12HR_DN"
17,"Down",0.0230162389598877,0.209410703312809,"B.PvsV.REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE_FGFR4"
83,"Up",0.0230164039140072,0.209410703312809,"B.PvsV.PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_DN"
11,"Down",0.0230174640924933,0.209410703312809,"B.PvsV.REACTOME_RUNX3_REGULATES_CDKN1A_TRANSCRIPTION"
289,"Up",0.0230310744899318,0.209410703312809,"B.PvsV.BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_DN"
17,"Down",0.0230658560892568,0.209410703312809,"B.PvsV.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_8"
136,"Up",0.023148570277383,0.209817123055165,"B.PvsV.REACTOME_RHO_GTPASES_ACTIVATE_PKNS"
23,"Up",0.0233308544326646,0.21079214205424,"B.PvsV.REACTOME_SPRY_REGULATION_OF_FGF_SIGNALING"
45,"Down",0.0233323911986245,0.21079214205424,"B.PvsV.HOFMANN_MYELODYSPLASTIC_SYNDROM_RISK_DN"
51,"Down",0.0234894313876854,0.211864708225959,"B.PvsV.REACTOME_SIGNALING_BY_FGFR1_IN_DISEASE"
41,"Up",0.0235926083004959,0.212448748034922,"B.PvsV.VALK_AML_CLUSTER_16"
156,"Down",0.0236844521935112,0.212929001915323,"B.PvsV.LEIN_CHOROID_PLEXUS_MARKERS"
104,"Up",0.0237974991195714,0.213392746786595,"B.PvsV.LI_DCP2_BOUND_MRNA"
25,"Down",0.0238803658671066,0.213392746786595,"B.PvsV.BIOCARTA_IL7_PATHWAY"
180,"Up",0.0238890791551358,0.213392746786595,"B.PvsV.LENAOUR_DENDRITIC_CELL_MATURATION_UP"
182,"Up",0.0238956292952943,0.213392746786595,"B.PvsV.KIM_GLIS2_TARGETS_UP"
61,"Down",0.0239290112149917,0.213392746786595,"B.PvsV.REACTOME_RRNA_MODIFICATION_IN_THE_NUCLEUS_AND_CYTOSOL"
75,"Up",0.0243191698297488,0.2164431845963,"B.PvsV.PID_AMB2_NEUTROPHILS_PATHWAY"
18,"Up",0.0243493689308914,0.2164431845963,"B.PvsV.BIOCARTA_TCRA_PATHWAY"
89,"Down",0.0244156056215832,0.216670099933865,"B.PvsV.REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION_TERMINATION"
75,"Up",0.0244532722660032,0.216670099933865,"B.PvsV.NATSUME_RESPONSE_TO_INTERFERON_BETA_DN"
5,"Down",0.0248604355040129,0.219624040258796,"B.PvsV.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_18"
42,"Down",0.0248660967990607,0.219624040258796,"B.PvsV.REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES"
32,"Up",0.0250442711453203,0.220844936463279,"B.PvsV.DORN_ADENOVIRUS_INFECTION_48HR_UP"
41,"Up",0.0251210973981462,0.221169661647054,"B.PvsV.PID_EPHA2_FWD_PATHWAY"
50,"Down",0.0253917494546009,0.223197110865641,"B.PvsV.LOPEZ_TRANSLATION_VIA_FN1_SIGNALING"
114,"Down",0.0254528178389248,0.223378777510183,"B.PvsV.REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES"
32,"Down",0.0255137224694539,0.223463449176364,"B.PvsV.MURAKAMI_UV_RESPONSE_6HR_DN"
11,"Down",0.0255432989472712,0.223463449176364,"B.PvsV.LUCAS_HNF4A_TARGETS_DN"
143,"Up",0.0256047928975922,0.223647551233471,"B.PvsV.SASSON_RESPONSE_TO_FORSKOLIN_DN"
1049,"Up",0.0258280655796344,0.224790742291076,"B.PvsV.KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_UP"
16,"Down",0.0258777970591901,0.224790742291076,"B.PvsV.SHIN_B_CELL_LYMPHOMA_CLUSTER_6"
90,"Up",0.0258929961309666,0.224790742291076,"B.PvsV.JI_RESPONSE_TO_FSH_DN"
18,"Down",0.0258983003869444,0.224790742291076,"B.PvsV.ZAIDI_OSTEOBLAST_TRANSCRIPTION_FACTORS"
39,"Down",0.0260085670608189,0.225269148441554,"B.PvsV.DUNNE_TARGETS_OF_AML1_MTG8_FUSION_DN"
63,"Down",0.0260491679424979,0.225269148441554,"B.PvsV.KAUFFMANN_MELANOMA_RELAPSE_UP"
29,"Up",0.0260756474954954,0.225269148441554,"B.PvsV.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_SALMON_DN"
145,"Up",0.0264830403869406,0.227988246987828,"B.PvsV.YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_12"
23,"Down",0.026490513047367,0.227988246987828,"B.PvsV.REACTOME_SIGNALING_BY_FGFR2_IIIA_TM"
36,"Down",0.0265140970904637,0.227988246987828,"B.PvsV.HEIDENBLAD_AMPLICON_12P11_12_DN"
115,"Down",0.0265685507777314,0.228101734860368,"B.PvsV.REACTOME_RECRUITMENT_OF_MITOTIC_CENTROSOME_PROTEINS_AND_COMPLEXES"
46,"Up",0.026688040725982,0.228772367711558,"B.PvsV.BIOCARTA_GPCR_PATHWAY"
154,"Up",0.0269228680058305,0.230428076167549,"B.PvsV.LEE_TARGETS_OF_PTCH1_AND_SUFU_DN"
246,"Up",0.0270076295973073,0.230796265909601,"B.PvsV.SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP"
63,"Up",0.027187140344266,0.23197175765964,"B.PvsV.APRELIKOVA_BRCA1_TARGETS"
72,"Down",0.0273075254057404,0.232639919827949,"B.PvsV.NICK_RESPONSE_TO_PROC_TREATMENT_DN"
246,"Down",0.0273812757322411,0.232653500211416,"B.PvsV.CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP"
215,"Up",0.0274256078563324,0.232653500211416,"B.PvsV.NIKOLSKY_BREAST_CANCER_11Q12_Q14_AMPLICON"
39,"Up",0.0274353557854664,0.232653500211416,"B.PvsV.KEGG_ASTHMA"
22,"Down",0.0276969739369495,0.234512356657571,"B.PvsV.SA_REG_CASCADE_OF_CYCLIN_EXPR"
49,"Down",0.0278890106169361,0.235777277830336,"B.PvsV.ONO_AML1_TARGETS_DN"
225,"Down",0.0281470812994245,0.237595744281707,"B.PvsV.REACTOME_RRNA_PROCESSING"
40,"Down",0.0282616566538861,0.238199237255086,"B.PvsV.YIH_RESPONSE_TO_ARSENITE_C1"
14,"Down",0.0285943588321683,0.24006973698911,"B.PvsV.BARRIER_CANCER_RELAPSE_TUMOR_SAMPLE_DN"
93,"Up",0.028597865039117,0.24006973698911,"B.PvsV.MODY_HIPPOCAMPUS_POSTNATAL"
339,"Down",0.0286523179541459,0.24006973698911,"B.PvsV.SANSOM_APC_MYC_TARGETS"
18,"Down",0.0286572664881195,0.24006973698911,"B.PvsV.LI_WILMS_TUMOR_ANAPLASTIC_UP"
73,"Up",0.0288821988101151,0.241334501517316,"B.PvsV.HUANG_FOXA2_TARGETS_UP"
47,"Up",0.0289160940294211,0.241334501517316,"B.PvsV.REACTOME_NEGATIVE_REGULATION_OF_MAPK_PATHWAY"
100,"Down",0.0289778319663095,0.241334501517316,"B.PvsV.CROONQUIST_NRAS_SIGNALING_DN"
17,"Up",0.029005865793673,0.241334501517316,"B.PvsV.REACTOME_REPRESSION_OF_WNT_TARGET_GENES"
47,"Up",0.0290264864367906,0.241334501517316,"B.PvsV.DAZARD_UV_RESPONSE_CLUSTER_G5"
66,"Up",0.029095244725465,0.241542955085729,"B.PvsV.RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_UP"
43,"Down",0.0291699584209477,0.241800150089085,"B.PvsV.REACTOME_RNA_POLYMERASE_III_TRANSCRIPTION"
6,"Down",0.0292259761490058,0.241901829532714,"B.PvsV.BIOCARTA_PELP1_PATHWAY"
13,"Down",0.0293604405343303,0.242590938423466,"B.PvsV.FIRESTEIN_CTNNB1_PATHWAY_AND_PROLIFERATION"
68,"Up",0.0294625310759921,0.242590938423466,"B.PvsV.REACTOME_INTERLEUKIN_10_SIGNALING"
151,"Down",0.0294699928401925,0.242590938423466,"B.PvsV.MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_UP"
28,"Up",0.0295145365958641,0.242590938423466,"B.PvsV.LI_ADIPOGENESIS_BY_ACTIVATED_PPARG"
32,"Up",0.0295475994212637,0.242590938423466,"B.PvsV.KEGG_GLYCINE_SERINE_AND_THREONINE_METABOLISM"
260,"Down",0.0296362882313987,0.242590938423466,"B.PvsV.SCHLOSSER_SERUM_RESPONSE_UP"
16,"Up",0.0296585902265071,0.242590938423466,"B.PvsV.BIOCARTA_CDC42RAC_PATHWAY"
59,"Up",0.0296602413409772,0.242590938423466,"B.PvsV.PID_CXCR3_PATHWAY"
63,"Down",0.0297312293647029,0.242812359169043,"B.PvsV.BENPORATH_ES_2"
17,"Down",0.0298097550006069,0.242995094635612,"B.PvsV.REACTOME_P75NTR_RECRUITS_SIGNALLING_COMPLEXES"
945,"Up",0.0298415028499874,0.242995094635612,"B.PvsV.KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_UP"
271,"Up",0.0299672699353031,0.243516537149491,"B.PvsV.REACTOME_NEDDYLATION"
39,"Down",0.0299972626856725,0.243516537149491,"B.PvsV.REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS"
797,"Up",0.0300376701638548,0.243516537149491,"B.PvsV.KIM_ALL_DISORDERS_CALB1_CORR_UP"
31,"Up",0.0300926285597484,0.243556332700237,"B.PvsV.MAINA_VHL_TARGETS_DN"
12,"Up",0.0301306803340499,0.243556332700237,"B.PvsV.REACTOME_INTERLEUKIN_6_SIGNALING"
156,"Down",0.0304331663384596,0.245642301730428,"B.PvsV.MARKEY_RB1_CHRONIC_LOF_UP"
144,"Down",0.0305514393445215,0.246237475416705,"B.PvsV.REACTOME_ANCHORING_OF_THE_BASAL_BODY_TO_THE_PLASMA_MEMBRANE"
15,"Up",0.0307674576943236,0.2476175743696,"B.PvsV.GOUYER_TATI_TARGETS_UP"
64,"Down",0.0308373167068904,0.247819075686623,"B.PvsV.RIZ_ERYTHROID_DIFFERENTIATION_CCNE1"
150,"Up",0.0311192028673237,0.249721440716158,"B.PvsV.JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP"
26,"Down",0.0314107250209333,0.251695505276435,"B.PvsV.OKAWA_NEUROBLASTOMA_1P36_31_DELETION"
35,"Up",0.0314618939447228,0.251740682518629,"B.PvsV.KEGG_PROTEIN_EXPORT"
173,"Up",0.0315833513802289,0.252018340954037,"B.PvsV.HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_DN"
27,"Up",0.0316133411189853,0.252018340954037,"B.PvsV.BIOCARTA_PLATELETAPP_PATHWAY"
663,"Up",0.0316501773080544,0.252018340954037,"B.PvsV.BERENJENO_TRANSFORMED_BY_RHOA_DN"
137,"Up",0.0316789196894657,0.252018340954037,"B.PvsV.GAVIN_FOXP3_TARGETS_CLUSTER_T4"
14,"Down",0.0318581166862962,0.253079780400189,"B.PvsV.REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_G1_CELL_CYCLE_ARREST"
67,"Up",0.0319697827670236,0.253275030811775,"B.PvsV.REACTOME_AUF1_HNRNP_D0_BINDS_AND_DESTABILIZES_MRNA"
36,"Up",0.0320577250619587,0.253275030811775,"B.PvsV.REACTOME_SIGNAL_TRANSDUCTION_BY_L1"
130,"Up",0.0321088842732471,0.253275030811775,"B.PvsV.PEDERSEN_TARGETS_OF_611CTF_ISOFORM_OF_ERBB2"
104,"Up",0.0321585000523109,0.253275030811775,"B.PvsV.KEGG_VIRAL_MYOCARDITIS"
36,"Down",0.0322010510205558,0.253275030811775,"B.PvsV.REACTOME_FGFR2_ALTERNATIVE_SPLICING"
49,"Down",0.0322106807648519,0.253275030811775,"B.PvsV.YU_MYC_TARGETS_UP"
108,"Down",0.0322943758850802,0.253275030811775,"B.PvsV.REN_BOUND_BY_E2F"
112,"Down",0.0323190794989533,0.253275030811775,"B.PvsV.TANG_SENESCENCE_TP53_TARGETS_DN"
25,"Up",0.0323519329095212,0.253275030811775,"B.PvsV.REACTOME_PINK_PARKIN_MEDIATED_MITOPHAGY"
16,"Down",0.0323702929081048,0.253275030811775,"B.PvsV.MARTIN_NFKB_TARGETS_DN"
35,"Up",0.0323965650193447,0.253275030811775,"B.PvsV.NIKOLSKY_OVERCONNECTED_IN_BREAST_CANCER"
26,"Up",0.0324344063693025,0.253275030811775,"B.PvsV.BIOCARTA_CSK_PATHWAY"
59,"Up",0.0325340894624799,0.253275030811775,"B.PvsV.PID_IL8_CXCR2_PATHWAY"
346,"Down",0.0325509936003348,0.253275030811775,"B.PvsV.FISCHER_G2_M_CELL_CYCLE"
10,"Down",0.0325698221933754,0.253275030811775,"B.PvsV.DONATO_CELL_CYCLE_TRETINOIN"
138,"Down",0.0328388962060108,0.255008788094148,"B.PvsV.ZHENG_IL22_SIGNALING_UP"
27,"Up",0.0329553006541823,0.255190513902523,"B.PvsV.PHESSE_TARGETS_OF_APC_AND_MBD2_DN"
13,"Up",0.0329780709661838,0.255190513902523,"B.PvsV.SASAKI_TARGETS_OF_TP73_AND_TP63"
140,"Up",0.0330429655853784,0.255190513902523,"B.PvsV.GNATENKO_PLATELET_SIGNATURE"
94,"Up",0.0330844603257405,0.255190513902523,"B.PvsV.SESTO_RESPONSE_TO_UV_C2"
94,"Down",0.0330961201817043,0.255190513902523,"B.PvsV.WARTERS_IR_RESPONSE_5GY"
50,"Up",0.0331392275243284,0.255190513902523,"B.PvsV.WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_DN"
99,"Up",0.0333514136189398,0.256158959383216,"B.PvsV.APPIERTO_RESPONSE_TO_FENRETINIDE_DN"
154,"Down",0.0333576507064417,0.256158959383216,"B.PvsV.OUILLETTE_CLL_13Q14_DELETION_UP"
57,"Down",0.0335739072386155,0.257462043165472,"B.PvsV.LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_DN"
197,"Up",0.0336467507669837,0.257663275610323,"B.PvsV.WIELAND_UP_BY_HBV_INFECTION"
147,"Up",0.033700541423587,0.257718248313987,"B.PvsV.BAE_BRCA1_TARGETS_UP"
78,"Up",0.0338351733316119,0.257949296797443,"B.PvsV.PID_RAC1_PATHWAY"
8,"Down",0.0338730518805234,0.257949296797443,"B.PvsV.BIOCARTA_BARD1_PATHWAY"
27,"Up",0.0339272847278432,0.257949296797443,"B.PvsV.IIZUKA_LIVER_CANCER_EARLY_RECURRENCE"
140,"Up",0.033958725603182,0.257949296797443,"B.PvsV.LEIN_PONS_MARKERS"
39,"Up",0.0340090963671937,0.257949296797443,"B.PvsV.GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_DN"
225,"Up",0.0340156568555034,0.257949296797443,"B.PvsV.KAYO_AGING_MUSCLE_DN"
120,"Up",0.0340647918183333,0.257949296797443,"B.PvsV.SESTO_RESPONSE_TO_UV_C1"
19,"Down",0.0342140916622924,0.257949296797443,"B.PvsV.BIOCARTA_HES_PATHWAY"
43,"Down",0.0342180456936061,0.257949296797443,"B.PvsV.REACTOME_FGFR1_MUTANT_RECEPTOR_ACTIVATION"
13,"Up",0.0342662246031333,0.257949296797443,"B.PvsV.REACTOME_REGULATION_OF_CYTOSKELETAL_REMODELING_AND_CELL_SPREADING_BY_IPP_COMPLEX_COMPONENTS"
93,"Up",0.0342896089986377,0.257949296797443,"B.PvsV.MCCLUNG_DELTA_FOSB_TARGETS_8WK"
16,"Up",0.0343867194614955,0.257949296797443,"B.PvsV.TSUDA_ALVEOLAR_SOFT_PART_SARCOMA"
68,"Down",0.0344371771285457,0.257949296797443,"B.PvsV.CERVERA_SDHB_TARGETS_1_DN"
17,"Down",0.0345123429699459,0.257949296797443,"B.PvsV.REACTOME_TELOMERE_EXTENSION_BY_TELOMERASE"
59,"Up",0.0345736006093187,0.257949296797443,"B.PvsV.GALLUZZI_PERMEABILIZE_MITOCHONDRIA"
54,"Up",0.0345932521917563,0.257949296797443,"B.PvsV.FARMER_BREAST_CANCER_CLUSTER_4"
151,"Down",0.0346614035489341,0.257949296797443,"B.PvsV.MORI_IMMATURE_B_LYMPHOCYTE_DN"
41,"Up",0.0346741890147822,0.257949296797443,"B.PvsV.REACTOME_GLUTATHIONE_CONJUGATION"
9,"Down",0.0347068547783427,0.257949296797443,"B.PvsV.SEMBA_FHIT_TARGETS_DN"
6,"Up",0.0347664567844327,0.257949296797443,"B.PvsV.REACTOME_MITOCHONDRIAL_FATTY_ACID_BETA_OXIDATION_OF_UNSATURATED_FATTY_ACIDS"
20,"Down",0.0347672837293776,0.257949296797443,"B.PvsV.SU_SALIVARY_GLAND"
96,"Up",0.0348006396440493,0.257949296797443,"B.PvsV.REACTOME_CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY"
26,"Up",0.0348271772534723,0.257949296797443,"B.PvsV.PLASARI_TGFB1_TARGETS_1HR_DN"
18,"Down",0.0349020715252356,0.257949296797443,"B.PvsV.BIOCARTA_PCAF_PATHWAY"
12,"Down",0.0349057192356398,0.257949296797443,"B.PvsV.OHM_EMBRYONIC_CARCINOMA_DN"
110,"Up",0.0349437553447792,0.257949296797443,"B.PvsV.REACTOME_TNFR2_NON_CANONICAL_NF_KB_PATHWAY"
24,"Up",0.0356445647487652,0.262771731327897,"B.PvsV.INAMURA_LUNG_CANCER_SCC_DN"
27,"Down",0.0357911471645432,0.263501002227376,"B.PvsV.BIOCARTA_STATHMIN_PATHWAY"
49,"Down",0.0358431162672076,0.263532699257169,"B.PvsV.REACTOME_NGF_STIMULATED_TRANSCRIPTION"
72,"Down",0.0358912105906028,0.263535861029805,"B.PvsV.NIKOLSKY_BREAST_CANCER_16Q24_AMPLICON"
62,"Down",0.036049371840805,0.264346123219908,"B.PvsV.REACTOME_FORMATION_OF_RNA_POL_II_ELONGATION_COMPLEX"
5,"Down",0.0363659231500798,0.266314157744094,"B.PvsV.RAFFEL_VEGFA_TARGETS_DN"
101,"Up",0.0366178696443998,0.267794509944235,"B.PvsV.PID_ENDOTHELIN_PATHWAY"
33,"Up",0.0366649383302199,0.267794509944235,"B.PvsV.KIM_LIVER_CANCER_POOR_SURVIVAL_UP"
12,"Up",0.036792589935042,0.268372334763651,"B.PvsV.REACTOME_ASPARTATE_AND_ASPARAGINE_METABOLISM"
8,"Up",0.0368474414131079,0.268418318278094,"B.PvsV.ZIRN_TRETINOIN_RESPONSE_DN"
73,"Down",0.0370321651630206,0.269395021095721,"B.PvsV.BIOCARTA_PPARA_PATHWAY"
41,"Up",0.0370789674541226,0.269395021095721,"B.PvsV.KEGG_AMINOACYL_TRNA_BIOSYNTHESIS"
22,"Up",0.0371957015512367,0.269888495901296,"B.PvsV.ZEILSTRA_CD44_TARGETS_UP"
6,"Down",0.037407133415271,0.270870796748189,"B.PvsV.CROSBY_E2F4_TARGETS"
573,"Down",0.0374290628894224,0.270870796748189,"B.PvsV.CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP"
378,"Up",0.0375028038992777,0.271049676809289,"B.PvsV.EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_UP"
55,"Up",0.0376562516650378,0.271589159085622,"B.PvsV.STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_DN"
190,"Down",0.0376756890972458,0.271589159085622,"B.PvsV.SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A5"
51,"Up",0.0377806298391577,0.271877893806737,"B.PvsV.WENG_POR_TARGETS_LIVER_DN"
35,"Down",0.0378140894080992,0.271877893806737,"B.PvsV.REACTOME_REGULATION_OF_GLUCOKINASE_BY_GLUCOKINASE_REGULATORY_PROTEIN"
35,"Down",0.0379198927585807,0.272113372921429,"B.PvsV.REACTOME_FORMATION_OF_THE_EARLY_ELONGATION_COMPLEX"
16,"Down",0.0379975015522173,0.272113372921429,"B.PvsV.REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_CELL_DEATH_GENES"
23,"Up",0.0380526097965854,0.272113372921429,"B.PvsV.SA_TRKA_RECEPTOR"
87,"Up",0.0380867786127148,0.272113372921429,"B.PvsV.LIM_MAMMARY_LUMINAL_PROGENITOR_UP"
10,"Down",0.038103980255234,0.272113372921429,"B.PvsV.MIKKELSEN_DEDIFFERENTIATED_STATE_DN"
13,"Down",0.0381421349274928,0.272113372921429,"B.PvsV.BIOCARTA_FIBRINOLYSIS_PATHWAY"
9,"Down",0.0384447499193043,0.273918843175043,"B.PvsV.REACTOME_DEFECTIVE_CSF2RB_CAUSES_PULMONARY_SURFACTANT_METABOLISM_DYSFUNCTION_5_SMDP5"
105,"Up",0.0386695593955577,0.275166015312791,"B.PvsV.REACTOME_HEDGEHOG_ON_STATE"
31,"Down",0.0388229652860268,0.275902538645813,"B.PvsV.REACTOME_G0_AND_EARLY_G1"
6,"Down",0.038966773479586,0.276569050794135,"B.PvsV.REACTOME_SEROTONIN_AND_MELATONIN_BIOSYNTHESIS"
43,"Down",0.0391161954902376,0.277273647263492,"B.PvsV.REACTOME_VOLTAGE_GATED_POTASSIUM_CHANNELS"
35,"Down",0.0392114883694373,0.277288028431364,"B.PvsV.PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN"
29,"Up",0.0392318659631132,0.277288028431364,"B.PvsV.REACTOME_INTERLEUKIN_6_FAMILY_SIGNALING"
146,"Up",0.0392806249971039,0.277288028431364,"B.PvsV.YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_16"
150,"Up",0.039318830582418,0.277288028431364,"B.PvsV.BURTON_ADIPOGENESIS_8"
77,"Up",0.0394539072506572,0.277610742871428,"B.PvsV.REACTOME_ORC1_REMOVAL_FROM_CHROMATIN"
13,"Down",0.0394650106523679,0.277610742871428,"B.PvsV.SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX6_UP"
19,"Up",0.0396058542535844,0.278247481789159,"B.PvsV.REACTOME_NEF_AND_SIGNAL_TRANSDUCTION"
40,"Down",0.0396666993373009,0.27832129522327,"B.PvsV.SHIN_B_CELL_LYMPHOMA_CLUSTER_2"
119,"Up",0.0398252669332793,0.278331694110173,"B.PvsV.REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT"
10,"Down",0.039838782123077,0.278331694110173,"B.PvsV.FERRARI_RESPONSE_TO_FENRETINIDE_DN"
336,"Down",0.0398662160950797,0.278331694110173,"B.PvsV.CHANDRAN_METASTASIS_UP"
445,"Up",0.039898005451745,0.278331694110173,"B.PvsV.BORCZUK_MALIGNANT_MESOTHELIOMA_UP"
9,"Down",0.0399281427986399,0.278331694110173,"B.PvsV.HE_PTEN_TARGETS_DN"
975,"Down",0.0399702233900302,0.278331694110173,"B.PvsV.BENPORATH_PRC2_TARGETS"
25,"Up",0.0400243399186771,0.278357956491026,"B.PvsV.FINETTI_BREAST_CANCERS_KINOME_GRAY"
32,"Up",0.0401925268688258,0.279150783817759,"B.PvsV.REACTOME_GLYCOGEN_METABOLISM"
268,"Down",0.0402393153739833,0.279150783817759,"B.PvsV.BROWNE_HCMV_INFECTION_18HR_UP"
192,"Down",0.0405823705507821,0.281177853101848,"B.PvsV.LE_EGR2_TARGETS_UP"
36,"Down",0.0407738652828561,0.282151065267724,"B.PvsV.REACTOME_TERMINATION_OF_TRANSLESION_DNA_SYNTHESIS"
42,"Up",0.0409749504866505,0.283188126550863,"B.PvsV.ABBUD_LIF_SIGNALING_2_UP"
52,"Down",0.041080737510218,0.283564791128584,"B.PvsV.LANG_MYB_FAMILY_TARGETS"
935,"Up",0.0412007869568271,0.284038841750994,"B.PvsV.FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN"
56,"Up",0.0414308331878139,0.28507084499078,"B.PvsV.PID_RET_PATHWAY"
153,"Up",0.041495642958871,0.28507084499078,"B.PvsV.DAZARD_RESPONSE_TO_UV_SCC_UP"
72,"Up",0.0415051601044634,0.28507084499078,"B.PvsV.REACTOME_HEDGEHOG_LIGAND_BIOGENESIS"
33,"Up",0.0416848601021916,0.28594986539084,"B.PvsV.BOYERINAS_ONCOFETAL_TARGETS_OF_LET7A1"
48,"Up",0.0419948348275451,0.287719258688348,"B.PvsV.CHIBA_RESPONSE_TO_TSA_DN"
17,"Up",0.0420834352627128,0.287969447484578,"B.PvsV.BIOCARTA_GATA3_PATHWAY"
46,"Down",0.0423336196289699,0.289165167054686,"B.PvsV.PID_RAC1_REG_PATHWAY"
16,"Up",0.0423627754230956,0.289165167054686,"B.PvsV.BIOCARTA_TCYTOTOXIC_PATHWAY"
28,"Down",0.0424615252293565,0.289481840928622,"B.PvsV.KRISHNAN_FURIN_TARGETS_UP"
35,"Up",0.0426128762361184,0.289529592294516,"B.PvsV.BIOCARTA_CREB_PATHWAY"
66,"Down",0.0426391771534726,0.289529592294516,"B.PvsV.JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_DN"
287,"Up",0.0426573044838902,0.289529592294516,"B.PvsV.KYNG_DNA_DAMAGE_DN"
23,"Down",0.042677991991324,0.289529592294516,"B.PvsV.WHITE_NEUROBLASTOMA_WITH_1P36.3_DELETION"
53,"Up",0.0427393932856225,0.289590815534567,"B.PvsV.BIOCARTA_P38MAPK_PATHWAY"
296,"Down",0.0427942168957249,0.289607374805952,"B.PvsV.DUTERTRE_ESTRADIOL_RESPONSE_6HR_UP"
64,"Up",0.0430659715585731,0.289624667232437,"B.PvsV.PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_6"
46,"Up",0.0431036372597299,0.289624667232437,"B.PvsV.BIOCARTA_NO1_PATHWAY"
19,"Down",0.0431086311542231,0.289624667232437,"B.PvsV.BIOCARTA_ACH_PATHWAY"
49,"Up",0.0431458546840485,0.289624667232437,"B.PvsV.REACTOME_RUNX2_REGULATES_OSTEOBLAST_DIFFERENTIATION"
36,"Down",0.0431888008204714,0.289624667232437,"B.PvsV.FARMER_BREAST_CANCER_CLUSTER_2"
31,"Down",0.043188877844008,0.289624667232437,"B.PvsV.TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_MONOCYTE_UP"
74,"Down",0.0432611108337053,0.289624667232437,"B.PvsV.REACTOME_DUAL_INCISION_IN_TC_NER"
186,"Down",0.0432616153981876,0.289624667232437,"B.PvsV.BROWNE_HCMV_INFECTION_12HR_DN"
72,"Down",0.0432682176042671,0.289624667232437,"B.PvsV.CONRAD_STEM_CELL"
21,"Down",0.0436365906327522,0.291518631479436,"B.PvsV.SUH_COEXPRESSED_WITH_ID1_AND_ID2_UP"
41,"Down",0.0436842162536731,0.291518631479436,"B.PvsV.REACTOME_SMAD2_SMAD3_SMAD4_HETEROTRIMER_REGULATES_TRANSCRIPTION"
82,"Down",0.0437093408385698,0.291518631479436,"B.PvsV.WIERENGA_PML_INTERACTOME"
81,"Up",0.043845519336304,0.292074549892078,"B.PvsV.KEGG_AUTOIMMUNE_THYROID_DISEASE"
10,"Up",0.0439674903692285,0.292534601987322,"B.PvsV.REACTOME_METABOLISM_OF_INGESTED_SEMET_SEC_MESEC_INTO_H2SE"
121,"Down",0.0441417924382021,0.292997849808381,"B.PvsV.DELPUECH_FOXO3_TARGETS_UP"
110,"Up",0.0441431016260411,0.292997849808381,"B.PvsV.AMIT_SERUM_RESPONSE_240_MCF10A"
41,"Up",0.0442467233102168,0.293049132518093,"B.PvsV.PID_AR_NONGENOMIC_PATHWAY"
50,"Up",0.0442568322757474,0.293049132518093,"B.PvsV.VERRECCHIA_RESPONSE_TO_TGFB1_C4"
99,"Down",0.0443441223202865,0.29311636159625,"B.PvsV.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_UP"
41,"Up",0.0443730140452273,0.29311636159625,"B.PvsV.REACTOME_CD28_CO_STIMULATION"
30,"Up",0.0444910742468418,0.293545524475881,"B.PvsV.PID_TOLL_ENDOGENOUS_PATHWAY"
30,"Down",0.044552383373184,0.293599675411602,"B.PvsV.CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_UP"
82,"Up",0.0446118464742282,0.293641546614295,"B.PvsV.BIOCARTA_NFAT_PATHWAY"
96,"Down",0.0448327002606454,0.294744351654112,"B.PvsV.REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS"
45,"Up",0.0451448750813885,0.296075659079202,"B.PvsV.XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_UP"
9,"Up",0.045195558175446,0.296075659079202,"B.PvsV.REACTOME_REELIN_SIGNALLING_PATHWAY"
43,"Down",0.0452329547188999,0.296075659079202,"B.PvsV.REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS"
43,"Up",0.04525452902544,0.296075659079202,"B.PvsV.BIOCARTA_AT1R_PATHWAY"
11,"Down",0.0453029494630141,0.296075659079202,"B.PvsV.KOINUMA_COLON_CANCER_MSI_DN"
22,"Up",0.0453753820481463,0.296198922484298,"B.PvsV.REACTOME_CONVERSION_FROM_APC_C_CDC20_TO_APC_C_CDH1_IN_LATE_ANAPHASE"
116,"Up",0.0456560986619168,0.297679916865257,"B.PvsV.MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_DN"
259,"Down",0.0457157557967347,0.297717801884742,"B.PvsV.BROWNE_HCMV_INFECTION_30MIN_DN"
39,"Down",0.0458197340023899,0.298043893293193,"B.PvsV.PID_RAS_PATHWAY"
183,"Down",0.0460569928780109,0.299235151142799,"B.PvsV.YORDY_RECIPROCAL_REGULATION_BY_ETS1_AND_SP100_DN"
97,"Up",0.0464642203668813,0.301526613155501,"B.PvsV.BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_DN"
36,"Up",0.0466485418191404,0.302367863678813,"B.PvsV.YAO_HOXA10_TARGETS_VIA_PROGESTERONE_DN"
16,"Up",0.0467903143064793,0.302931671897569,"B.PvsV.BIOCARTA_AGPCR_PATHWAY"
14,"Up",0.0470326593624426,0.303943799565305,"B.PvsV.REACTOME_LYSINE_CATABOLISM"
1242,"Down",0.0471312567782913,0.303943799565305,"B.PvsV.BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP"
26,"Up",0.0471762083657124,0.303943799565305,"B.PvsV.SMID_BREAST_CANCER_NORMAL_LIKE_DN"
245,"Down",0.0472275545653872,0.303943799565305,"B.PvsV.GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN"
44,"Down",0.047256764109257,0.303943799565305,"B.PvsV.HINATA_NFKB_TARGETS_KERATINOCYTE_DN"
37,"Up",0.0472764817555005,0.303943799565305,"B.PvsV.SINGH_NFE2L2_TARGETS"
22,"Down",0.0473830914009151,0.30427539181842,"B.PvsV.REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE_FGFR2"
17,"Up",0.0475992206524722,0.304751651552866,"B.PvsV.REACTOME_CREB1_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_ADENYLATE_CYCLASE"
36,"Down",0.0476186463487996,0.304751651552866,"B.PvsV.REACTOME_SIGNALING_BY_EGFR_IN_CANCER"
96,"Up",0.0476226129393518,0.304751651552866,"B.PvsV.REACTOME_ABC_TRANSPORTER_DISORDERS"
48,"Up",0.0477182289287999,0.304777994180672,"B.PvsV.JACKSON_DNMT1_TARGETS_DN"
21,"Up",0.0477369764804598,0.304777994180672,"B.PvsV.IYENGAR_RESPONSE_TO_ADIPOCYTE_FACTORS"
14,"Up",0.0478774451556228,0.305322254054716,"B.PvsV.REACTOME_CALCINEURIN_ACTIVATES_NFAT"
155,"Up",0.048045496303928,0.306040955143339,"B.PvsV.WINTER_HYPOXIA_UP"
341,"Up",0.0481622961077363,0.306092340532383,"B.PvsV.BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_DN"
106,"Down",0.04816428581356,0.306092340532383,"B.PvsV.REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE"
19,"Down",0.0484425494009368,0.30750729694349,"B.PvsV.YANG_BCL3_TARGETS_DN"
58,"Up",0.0487841749348016,0.309302883059146,"B.PvsV.REACTOME_AMINO_ACIDS_REGULATE_MTORC1"
92,"Up",0.0488372973251283,0.309302883059146,"B.PvsV.KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP"
10,"Down",0.0489250069822732,0.309503848518293,"B.PvsV.REACTOME_HYDROLYSIS_OF_LPC"
87,"Up",0.0490822636530341,0.309800738733435,"B.PvsV.EBAUER_MYOGENIC_TARGETS_OF_PAX3_FOXO1_FUSION"
226,"Up",0.0492098319062566,0.309800738733435,"B.PvsV.HOLLERN_EMT_BREAST_TUMOR_UP"
30,"Down",0.049308924707254,0.309800738733435,"B.PvsV.REACTOME_MRNA_CAPPING"
59,"Up",0.0493334421878329,0.309800738733435,"B.PvsV.PID_A6B1_A6B4_INTEGRIN_PATHWAY"
49,"Up",0.0493438920811433,0.309800738733435,"B.PvsV.WANG_NEOPLASTIC_TRANSFORMATION_BY_CCND1_MYC"
76,"Up",0.0493632999404951,0.309800738733435,"B.PvsV.GILDEA_METASTASIS"
5,"Down",0.0493641618419527,0.309800738733435,"B.PvsV.NIKOLSKY_BREAST_CANCER_19P13_AMPLICON"
10,"Up",0.0495085445932257,0.310354583963656,"B.PvsV.BIOCARTA_TUBBY_PATHWAY"
70,"Up",0.04964588965131,0.310804741960707,"B.PvsV.ROZANOV_MMP14_TARGETS_SUBSET"
39,"Down",0.0497263449752401,0.310804741960707,"B.PvsV.REACTOME_RESOLUTION_OF_ABASIC_SITES_AP_SITES"
237,"Down",0.0497489955932765,0.310804741960707,"B.PvsV.KIM_MYCN_AMPLIFICATION_TARGETS_DN"
21,"Up",0.0498303393155918,0.31096156441976,"B.PvsV.DELASERNA_TARGETS_OF_MYOD_AND_SMARCA4"
22,"Down",0.0499794454909293,0.311094791785122,"B.PvsV.LE_NEURONAL_DIFFERENTIATION_DN"
9,"Up",0.0500240882786399,0.311094791785122,"B.PvsV.REACTOME_DEFECTIVE_CHSY1_CAUSES_TPBS"
27,"Up",0.0500699343810079,0.311094791785122,"B.PvsV.BIOCARTA_CDMAC_PATHWAY"
24,"Down",0.0500963714410364,0.311094791785122,"B.PvsV.JI_CARCINOGENESIS_BY_KRAS_AND_STK11_UP"
92,"Up",0.0501330185350956,0.311094791785122,"B.PvsV.RICKMAN_HEAD_AND_NECK_CANCER_F"
55,"Down",0.0502143635331221,0.311250242124027,"B.PvsV.NAKAYAMA_FRA2_TARGETS"
1622,"Down",0.0503706959528977,0.311869628133898,"B.PvsV.BENPORATH_ES_WITH_H3K27ME3"
14,"Up",0.0505715912386343,0.312680100670473,"B.PvsV.BIOCARTA_IL5_PATHWAY"
6,"Up",0.0506147024959439,0.312680100670473,"B.PvsV.REACTOME_SYNTHESIS_OF_DOLICHYL_PHOSPHATE"
153,"Down",0.0508245090663851,0.313625793111655,"B.PvsV.REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION"
31,"Down",0.0509524164592238,0.31406456031555,"B.PvsV.GOERING_BLOOD_HDL_CHOLESTEROL_QTL_TRANS"
23,"Down",0.0510428541590512,0.31423992047434,"B.PvsV.REACTOME_NA_CL_DEPENDENT_NEUROTRANSMITTER_TRANSPORTERS"
243,"Up",0.0510945358123407,0.31423992047434,"B.PvsV.PROVENZANI_METASTASIS_DN"
38,"Down",0.0511945422787945,0.314361159413022,"B.PvsV.NAKAJIMA_EOSINOPHIL"
43,"Up",0.0512809389955831,0.314361159413022,"B.PvsV.REACTOME_TRNA_AMINOACYLATION"
9,"Down",0.0512848192784493,0.314361159413022,"B.PvsV.TESAR_ALK_AND_JAK_TARGETS_MOUSE_ES_D4_UP"
12,"Down",0.0514133974727148,0.314800304126955,"B.PvsV.REACTOME_PASSIVE_TRANSPORT_BY_AQUAPORINS"
94,"Up",0.0517337771557414,0.315753820683622,"B.PvsV.ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_UP"
60,"Down",0.0517503103824081,0.315753820683622,"B.PvsV.PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_UP"
246,"Up",0.0517903796687133,0.315753820683622,"B.PvsV.ZHONG_SECRETOME_OF_LUNG_CANCER_AND_FIBROBLAST"
12,"Down",0.051797561106899,0.315753820683622,"B.PvsV.REACTOME_NF_KB_ACTIVATION_THROUGH_FADD_RIP_1_PATHWAY_MEDIATED_BY_CASPASE_8_AND_10"
7,"Down",0.0519375935025588,0.316087826018085,"B.PvsV.REACTOME_TFAP2A_ACTS_AS_A_TRANSCRIPTIONAL_REPRESSOR_DURING_RETINOIC_ACID_INDUCED_CELL_DIFFERENTIATION"
47,"Up",0.0519666908754639,0.316087826018085,"B.PvsV.BIOCARTA_BIOPEPTIDES_PATHWAY"
119,"Down",0.0522880406414805,0.317692941435984,"B.PvsV.RIZ_ERYTHROID_DIFFERENTIATION"
101,"Down",0.0526310441451387,0.318622251931191,"B.PvsV.FURUKAWA_DUSP6_TARGETS_PCI35_DN"
56,"Up",0.0526498244461737,0.318622251931191,"B.PvsV.KEGG_FATTY_ACID_METABOLISM"
5,"Up",0.0526552125964306,0.318622251931191,"B.PvsV.REACTOME_PTK6_EXPRESSION"
38,"Down",0.0526715026704844,0.318622251931191,"B.PvsV.DE_YY1_TARGETS_UP"
191,"Down",0.0529209323808301,0.319735033646339,"B.PvsV.BOYLAN_MULTIPLE_MYELOMA_C_D_UP"
160,"Up",0.0530409391262255,0.319735033646339,"B.PvsV.SANA_RESPONSE_TO_IFNG_UP"
98,"Down",0.0530726433409082,0.319735033646339,"B.PvsV.REACTOME_CLASS_B_2_SECRETIN_FAMILY_RECEPTORS"
10,"Down",0.0530867717285836,0.319735033646339,"B.PvsV.TESAR_ALK_TARGETS_EPISC_4D_UP"
22,"Up",0.0532049375629752,0.320098041116093,"B.PvsV.KYNG_WERNER_SYNDROM_UP"
30,"Down",0.053305067083286,0.320132080998192,"B.PvsV.CAIRO_PML_TARGETS_BOUND_BY_MYC_UP"
72,"Down",0.0533666842380533,0.320132080998192,"B.PvsV.ROESSLER_LIVER_CANCER_METASTASIS_DN"
11,"Down",0.0533842971026105,0.320132080998192,"B.PvsV.DING_LUNG_CANCER_MUTATED_RECURRENTLY"
92,"Up",0.0534995317847458,0.320475526801581,"B.PvsV.LEE_LIVER_CANCER_CIPROFIBRATE_UP"
53,"Down",0.0536562082782178,0.321066207327128,"B.PvsV.REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS"
169,"Down",0.0538098941613587,0.321637734938543,"B.PvsV.REACTOME_HIV_LIFE_CYCLE"
65,"Up",0.0538774486848865,0.321687153213617,"B.PvsV.AMIT_EGF_RESPONSE_120_MCF10A"
38,"Down",0.0539345254167161,0.321687153213617,"B.PvsV.REACTOME_CHAPERONE_MEDIATED_AUTOPHAGY"
28,"Up",0.054154966082849,0.322088359394418,"B.PvsV.HEDENFALK_BREAST_CANCER_BRACX_DN"
19,"Down",0.0542111242809945,0.322088359394418,"B.PvsV.BIOCARTA_P53_PATHWAY"
25,"Down",0.0542183558769828,0.322088359394418,"B.PvsV.NEBEN_AML_WITH_FLT3_OR_NRAS_DN"
126,"Up",0.0543118539905306,0.322088359394418,"B.PvsV.REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS"
72,"Up",0.0543268038770031,0.322088359394418,"B.PvsV.REACTOME_ASSEMBLY_OF_THE_PRE_REPLICATIVE_COMPLEX"
20,"Down",0.0543513183785481,0.322088359394418,"B.PvsV.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_27"
8,"Down",0.0544914030042744,0.322572770032798,"B.PvsV.FARMER_BREAST_CANCER_CLUSTER_8"
26,"Down",0.0546335324400122,0.323068236214789,"B.PvsV.REACTOME_N_GLYCAN_ANTENNAE_ELONGATION_IN_THE_MEDIAL_TRANS_GOLGI"
59,"Up",0.054832144310889,0.323751732754993,"B.PvsV.YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_5"
64,"Down",0.0549889625989394,0.323751732754993,"B.PvsV.PIONTEK_PKD1_TARGETS_DN"
83,"Up",0.0549939183017544,0.323751732754993,"B.PvsV.REACTOME_GLYCOLYSIS"
5,"Up",0.0550285022967583,0.323751732754993,"B.PvsV.REACTOME_BETA_OXIDATION_OF_LAUROYL_COA_TO_DECANOYL_COA_COA"
21,"Down",0.0550418934327534,0.323751732754993,"B.PvsV.NIKOLSKY_BREAST_CANCER_7P15_AMPLICON"
26,"Down",0.0553587474796872,0.325265336650087,"B.PvsV.REACTOME_PROTEIN_METHYLATION"
63,"Up",0.055497982288231,0.325265336650087,"B.PvsV.TOMLINS_PROSTATE_CANCER_DN"
46,"Up",0.0555270948058501,0.325265336650087,"B.PvsV.VERNELL_RETINOBLASTOMA_PATHWAY_DN"
48,"Up",0.0555870622479979,0.325265336650087,"B.PvsV.IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_DN"
127,"Down",0.0555933700731294,0.325265336650087,"B.PvsV.PYEON_HPV_POSITIVE_TUMORS_UP"
53,"Down",0.055669383282167,0.325288082077105,"B.PvsV.SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_DN"
88,"Up",0.0557324621623172,0.325288082077105,"B.PvsV.KEGG_LEISHMANIA_INFECTION"
92,"Up",0.0559024750666473,0.325288082077105,"B.PvsV.KEGG_PPAR_SIGNALING_PATHWAY"
35,"Up",0.0559063196111537,0.325288082077105,"B.PvsV.ZHAN_MULTIPLE_MYELOMA_SUBGROUPS"
142,"Up",0.0559127791977751,0.325288082077105,"B.PvsV.BROWNE_INTERFERON_RESPONSIVE_GENES"
50,"Down",0.0560005001593781,0.325288082077105,"B.PvsV.ONO_FOXP3_TARGETS_DN"
24,"Down",0.0560500381700781,0.325288082077105,"B.PvsV.BIOCARTA_ATRBRCA_PATHWAY"
156,"Down",0.0560679222679474,0.325288082077105,"B.PvsV.YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_11"
48,"Up",0.0561438454735145,0.325387129583922,"B.PvsV.VIETOR_IFRD1_TARGETS"
23,"Up",0.0563633602436499,0.326093434330764,"B.PvsV.REACTOME_CTLA4_INHIBITORY_SIGNALING"
57,"Up",0.0563836721324309,0.326093434330764,"B.PvsV.PID_NETRIN_PATHWAY"
27,"Down",0.056555522626157,0.326479263555703,"B.PvsV.REACTOME_HYALURONAN_METABOLISM"
44,"Down",0.0565684815493514,0.326479263555703,"B.PvsV.ALONSO_METASTASIS_DN"
16,"Up",0.0567847350430485,0.326859741984162,"B.PvsV.BIOCARTA_THELPER_PATHWAY"
38,"Down",0.0568493069780687,0.326859741984162,"B.PvsV.REACTOME_NICOTINATE_METABOLISM"
71,"Down",0.0568519582674818,0.326859741984162,"B.PvsV.BEIER_GLIOMA_STEM_CELL_UP"
163,"Down",0.0568708757078611,0.326859741984162,"B.PvsV.KAUFFMANN_DNA_REPLICATION_GENES"
44,"Down",0.0570832797400466,0.327739827292542,"B.PvsV.BIOCARTA_EICOSANOID_PATHWAY"
40,"Down",0.0572097182168886,0.327968820573079,"B.PvsV.RIZ_ERYTHROID_DIFFERENTIATION_HEMGN"
29,"Down",0.0572417999372439,0.327968820573079,"B.PvsV.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_DN"
14,"Down",0.0574540260812425,0.328844006421522,"B.PvsV.REACTOME_POU5F1_OCT4_SOX2_NANOG_REPRESS_GENES_RELATED_TO_DIFFERENTIATION"
157,"Down",0.0577912452954225,0.330432052986961,"B.PvsV.MORI_LARGE_PRE_BII_LYMPHOCYTE_UP"
60,"Up",0.0579924528161886,0.330888246565771,"B.PvsV.LANDIS_BREAST_CANCER_PROGRESSION_UP"
78,"Down",0.0580475306900554,0.330888246565771,"B.PvsV.OSADA_ASCL1_TARGETS_UP"
183,"Up",0.0580505695729423,0.330888246565771,"B.PvsV.DITTMER_PTHLH_TARGETS_UP"
151,"Up",0.058249217671119,0.331678604020203,"B.PvsV.KEGG_INSULIN_SIGNALING_PATHWAY"
251,"Down",0.0584737804379652,0.332548778574768,"B.PvsV.ONDER_CDH1_TARGETS_1_UP"
56,"Up",0.0585416731594552,0.332548778574768,"B.PvsV.BIOCARTA_ERK_PATHWAY"
240,"Down",0.0586311834917903,0.332548778574768,"B.PvsV.REACTOME_MITOTIC_PROMETAPHASE"
595,"Down",0.0586426223748234,0.332548778574768,"B.PvsV.BROWNE_HCMV_INFECTION_4HR_DN"
65,"Down",0.0588515249988132,0.333391477170531,"B.PvsV.REACTOME_INTRAFLAGELLAR_TRANSPORT"
72,"Up",0.059188063416962,0.334954762162111,"B.PvsV.VALK_AML_CLUSTER_11"
457,"Down",0.0592577979202443,0.335006507874264,"B.PvsV.ZWANG_DOWN_BY_2ND_EGF_PULSE"
59,"Up",0.0594716884770135,0.335872283543828,"B.PvsV.CAFFAREL_RESPONSE_TO_THC_UP"
21,"Down",0.0596070100086322,0.335905558800971,"B.PvsV.REACTOME_ACYL_CHAIN_REMODELLING_OF_PG"
42,"Up",0.0596477408497456,0.335905558800971,"B.PvsV.KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM"
39,"Up",0.05976902266213,0.335905558800971,"B.PvsV.BUCKANOVICH_T_LYMPHOCYTE_HOMING_ON_TUMOR_UP"
51,"Down",0.0597797790781662,0.335905558800971,"B.PvsV.RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_DN"
10,"Up",0.059781347415474,0.335905558800971,"B.PvsV.KIM_ALL_DISORDERS_DURATION_CORR_UP"
6,"Down",0.0600551526020108,0.336673733697758,"B.PvsV.NAKAMURA_BRONCHIAL_AND_BRONCHIOLAR_EPITHELIA"
55,"Up",0.060112993369771,0.336673733697758,"B.PvsV.PID_INTEGRIN_A4B1_PATHWAY"
174,"Up",0.0601346969803404,0.336673733697758,"B.PvsV.KARLSSON_TGFB1_TARGETS_UP"
406,"Up",0.06016162938929,0.336673733697758,"B.PvsV.DANG_REGULATED_BY_MYC_DN"
12,"Down",0.0603126522577028,0.336991966955083,"B.PvsV.NIKOLSKY_BREAST_CANCER_20P13_AMPLICON"
65,"Up",0.0603403956023751,0.336991966955083,"B.PvsV.NAKAMURA_CANCER_MICROENVIRONMENT_UP"
18,"Down",0.0604309888017045,0.337157353264,"B.PvsV.REACTOME_RUNX3_REGULATES_P14_ARF"
44,"Up",0.0608421072100697,0.339108881819028,"B.PvsV.REACTOME_COOPERATION_OF_PDCL_PHLP1_AND_TRIC_CCT_IN_G_PROTEIN_BETA_FOLDING"
11,"Down",0.0609162538786244,0.339180229300014,"B.PvsV.REACTOME_REMOVAL_OF_THE_FLAP_INTERMEDIATE_FROM_THE_C_STRAND"
77,"Up",0.0609910212471107,0.339254885790015,"B.PvsV.PID_ECADHERIN_STABILIZATION_PATHWAY"
226,"Up",0.061112051522017,0.339280812280425,"B.PvsV.WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_WITH_H4K20ME1_MARK"
28,"Down",0.0611184100255567,0.339280812280425,"B.PvsV.PID_CONE_PATHWAY"
11,"Down",0.0612283083175206,0.339549966587334,"B.PvsV.REACTOME_CDC6_ASSOCIATION_WITH_THE_ORC_ORIGIN_COMPLEX"
143,"Up",0.0614821872374501,0.340616245727316,"B.PvsV.PID_AP1_PATHWAY"
30,"Up",0.0615745307353621,0.340674475654553,"B.PvsV.IIZUKA_LIVER_CANCER_PROGRESSION_L1_G1_UP"
68,"Up",0.0616159297620823,0.340674475654553,"B.PvsV.BRACHAT_RESPONSE_TO_CAMPTOTHECIN_DN"
68,"Down",0.0621316453490521,0.343182684450459,"B.PvsV.VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_DN"
37,"Up",0.0624501798957203,0.344597848945546,"B.PvsV.TERAMOTO_OPN_TARGETS_CLUSTER_4"
173,"Up",0.0626841622646841,0.345544100858862,"B.PvsV.LIM_MAMMARY_LUMINAL_MATURE_DN"
325,"Down",0.0629351005270464,0.346108115997881,"B.PvsV.LEE_DIFFERENTIATING_T_LYMPHOCYTE"
12,"Down",0.0629474632890959,0.346108115997881,"B.PvsV.REACTOME_HYALURONAN_BIOSYNTHESIS_AND_EXPORT"
93,"Up",0.0629895476244363,0.346108115997881,"B.PvsV.VILLANUEVA_LIVER_CANCER_KRT19_DN"
23,"Down",0.0631275359265493,0.346108115997881,"B.PvsV.CHEN_HOXA5_TARGETS_6HR_UP"
40,"Up",0.0632021172492721,0.346108115997881,"B.PvsV.REACTOME_NEF_MEDIATED_DOWNREGULATION_OF_MHC_CLASS_I_COMPLEX_CELL_SURFACE_EXPRESSION"
32,"Up",0.0632046478385522,0.346108115997881,"B.PvsV.COLLER_MYC_TARGETS_DN"
37,"Down",0.0632246694081859,0.346108115997881,"B.PvsV.REACTOME_SURFACTANT_METABOLISM"
35,"Up",0.0633001786232096,0.346178721669363,"B.PvsV.HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_DN"
14,"Down",0.0637175597910596,0.347736284320879,"B.PvsV.REACTOME_CYTOSOLIC_IRON_SULFUR_CLUSTER_ASSEMBLY"
105,"Up",0.0638368579617007,0.347736284320879,"B.PvsV.REACTOME_OPIOID_SIGNALLING"
37,"Down",0.0638435879362533,0.347736284320879,"B.PvsV.BIOCARTA_DEATH_PATHWAY"
16,"Up",0.06387414103774,0.347736284320879,"B.PvsV.BIOCARTA_CFTR_PATHWAY"
56,"Up",0.0639149640143568,0.347736284320879,"B.PvsV.SEMENZA_HIF1_TARGETS"
43,"Up",0.0639623442131187,0.347736284320879,"B.PvsV.TCGA_GLIOBLASTOMA_COPY_NUMBER_DN"
191,"Down",0.0641014389927763,0.348069161993196,"B.PvsV.VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN"
25,"Down",0.0641494802081872,0.348069161993196,"B.PvsV.REACTOME_TYPE_I_HEMIDESMOSOME_ASSEMBLY"
11,"Up",0.0642883554794909,0.348480703378534,"B.PvsV.REACTOME_MAPK1_ERK2_ACTIVATION"
15,"Down",0.0646785428108647,0.350252363566377,"B.PvsV.REACTOME_MITOTIC_TELOPHASE_CYTOKINESIS"
33,"Down",0.0647569463330257,0.350333812402445,"B.PvsV.REACTOME_PIWI_INTERACTING_RNA_PIRNA_BIOGENESIS"
137,"Down",0.0649165948131454,0.350854205984243,"B.PvsV.BECKER_TAMOXIFEN_RESISTANCE_DN"
15,"Down",0.0655018433822834,0.353671574277974,"B.PvsV.BIOCARTA_PTC1_PATHWAY"
70,"Up",0.0656531426947646,0.35414265947254,"B.PvsV.PETRETTO_CARDIAC_HYPERTROPHY"
17,"Up",0.0657244422478133,0.35418171655766,"B.PvsV.DAZARD_UV_RESPONSE_CLUSTER_G3"
20,"Up",0.0662216690892763,0.356513737482579,"B.PvsV.REACTOME_REGULATION_OF_TLR_BY_ENDOGENOUS_LIGAND"
160,"Down",0.0663412157797444,0.356809904714209,"B.PvsV.REACTOME_EUKARYOTIC_TRANSLATION_INITIATION"
18,"Down",0.0666759860037837,0.358261930626744,"B.PvsV.REACTOME_NUCLEOBASE_BIOSYNTHESIS"
102,"Down",0.0668899783698308,0.359062806220189,"B.PvsV.REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION"
23,"Down",0.067003622633406,0.359082014563643,"B.PvsV.BIOCARTA_PITX2_PATHWAY"
30,"Down",0.0670234471024922,0.359082014563643,"B.PvsV.AMIT_SERUM_RESPONSE_20_MCF10A"
8,"Down",0.0673487392554402,0.360475488231683,"B.PvsV.REACTOME_FGFR3B_LIGAND_BINDING_AND_ACTIVATION"
23,"Up",0.0675647377093783,0.361153386506408,"B.PvsV.REACTOME_PHOSPHORYLATION_OF_THE_APC_C"
73,"Up",0.0676060327426538,0.361153386506408,"B.PvsV.ELLWOOD_MYC_TARGETS_DN"
13,"Down",0.0680020654781217,0.36146476864642,"B.PvsV.GOUYER_TUMOR_INVASIVENESS"
149,"Up",0.0680132217929992,0.36146476864642,"B.PvsV.KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS"
27,"Down",0.0680353805005024,0.36146476864642,"B.PvsV.BIOCARTA_BCELLSURVIVAL_PATHWAY"
156,"Up",0.068047623165496,0.36146476864642,"B.PvsV.REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_DIFFERENTIATION_OF_HSCS"
26,"Up",0.0681111355672134,0.36146476864642,"B.PvsV.VISALA_AGING_LYMPHOCYTE_DN"
17,"Up",0.0681756061497882,0.36146476864642,"B.PvsV.STARK_BRAIN_22Q11_DELETION"
91,"Down",0.0682150962076606,0.36146476864642,"B.PvsV.MASSARWEH_RESPONSE_TO_ESTRADIOL"
92,"Up",0.0682696629801757,0.36146476864642,"B.PvsV.STARK_HYPPOCAMPUS_22Q11_DELETION_UP"
60,"Up",0.0683119297087765,0.36146476864642,"B.PvsV.MIKKELSEN_MCV6_ICP_WITH_H3K4ME3_AND_H3K27ME3"
77,"Down",0.0684075160579734,0.36146476864642,"B.PvsV.BURTON_ADIPOGENESIS_PEAK_AT_16HR"
125,"Down",0.0684147663909128,0.36146476864642,"B.PvsV.CROONQUIST_IL6_DEPRIVATION_DN"
85,"Down",0.0685085996775171,0.36146476864642,"B.PvsV.PID_AR_TF_PATHWAY"
191,"Up",0.0685225255302484,0.36146476864642,"B.PvsV.DER_IFN_ALPHA_RESPONSE_UP"
42,"Up",0.0686152248700307,0.36146476864642,"B.PvsV.REACTOME_MYOGENESIS"
87,"Up",0.0686476416125752,0.36146476864642,"B.PvsV.CAVARD_LIVER_CANCER_MALIGNANT_VS_BENIGN"
15,"Down",0.0687406618481118,0.36146476864642,"B.PvsV.CLAUS_PGR_POSITIVE_MENINGIOMA_DN"
73,"Down",0.0688382854104658,0.36146476864642,"B.PvsV.WANG_LSD1_TARGETS_DN"
84,"Down",0.0688410926722157,0.36146476864642,"B.PvsV.SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER"
58,"Up",0.0689586539203743,0.361599864065845,"B.PvsV.COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_DN"
5,"Up",0.0689976228231989,0.361599864065845,"B.PvsV.REACTOME_BETA_OXIDATION_OF_OCTANOYL_COA_TO_HEXANOYL_COA"
28,"Up",0.0691327194791387,0.361926957215817,"B.PvsV.OSAWA_TNF_TARGETS"
73,"Up",0.0691909556478782,0.361926957215817,"B.PvsV.TAVOR_CEBPA_TARGETS_UP"
14,"Down",0.0695969456799103,0.363706533709096,"B.PvsV.REACTOME_PURINE_RIBONUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHESIS"
40,"Up",0.0697349781754541,0.36403269173298,"B.PvsV.WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_DN"
26,"Up",0.0698295193729288,0.36403269173298,"B.PvsV.ZHENG_RESPONSE_TO_ARSENITE_UP"
19,"Down",0.0698568793504596,0.36403269173298,"B.PvsV.REACTOME_RNA_POLYMERASE_III_CHAIN_ELONGATION"
77,"Up",0.069975824937975,0.364309167685559,"B.PvsV.HAHTOLA_CTCL_CUTANEOUS"
31,"Down",0.0701663575533708,0.364729929091126,"B.PvsV.DEN_INTERACT_WITH_LCA5"
39,"Down",0.0701885774195982,0.364729929091126,"B.PvsV.REACTOME_ONCOGENE_INDUCED_SENESCENCE"
24,"Up",0.0704581747024258,0.365787087257946,"B.PvsV.REACTOME_G_BETA_GAMMA_SIGNALLING_THROUGH_CDC42"
6,"Down",0.0706303049776765,0.366132726182969,"B.PvsV.ISHIDA_TARGETS_OF_SYT_SSX_FUSIONS"
28,"Down",0.0706571927721518,0.366132726182969,"B.PvsV.WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_DN"
114,"Up",0.0710938251925316,0.368050336600662,"B.PvsV.KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS"
35,"Up",0.0714558925418926,0.369578699592258,"B.PvsV.BIOCARTA_STRESS_PATHWAY"
27,"Up",0.07158097562023,0.36974289424522,"B.PvsV.PID_INTEGRIN_CS_PATHWAY"
119,"Up",0.0716339560815717,0.36974289424522,"B.PvsV.LANDIS_BREAST_CANCER_PROGRESSION_DN"
51,"Up",0.0718390888442076,0.36974289424522,"B.PvsV.SIMBULAN_PARP1_TARGETS_UP"
269,"Up",0.0719185471568691,0.36974289424522,"B.PvsV.CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN"
61,"Down",0.0719470181474636,0.36974289424522,"B.PvsV.MIKKELSEN_MEF_ICP_WITH_H3K4ME3_AND_H3K27ME3"
92,"Up",0.0719655545350028,0.36974289424522,"B.PvsV.PID_TRKR_PATHWAY"
57,"Down",0.0721079594243778,0.36974289424522,"B.PvsV.STANELLE_E2F1_TARGETS"
33,"Up",0.0721092676121414,0.36974289424522,"B.PvsV.KIM_HYPOXIA"
10,"Up",0.0721580459036147,0.36974289424522,"B.PvsV.REACTOME_NOSTRIN_MEDIATED_ENOS_TRAFFICKING"
154,"Up",0.0721603885839747,0.36974289424522,"B.PvsV.SASSON_RESPONSE_TO_GONADOTROPHINS_DN"
62,"Down",0.0722232457559844,0.36974289424522,"B.PvsV.STAMBOLSKY_TARGETS_OF_MUTATED_TP53_UP"
75,"Down",0.0725997124347685,0.370972042164776,"B.PvsV.MCDOWELL_ACUTE_LUNG_INJURY_DN"
18,"Up",0.072721148370214,0.370972042164776,"B.PvsV.CLAUS_PGR_POSITIVE_MENINGIOMA_UP"
47,"Down",0.0727241382049265,0.370972042164776,"B.PvsV.NOJIMA_SFRP2_TARGETS_UP"
30,"Down",0.0727922410343549,0.370972042164776,"B.PvsV.REACTOME_RNA_POLYMERASE_III_TRANSCRIPTION_INITIATION_FROM_TYPE_3_PROMOTER"
84,"Up",0.0728302617709362,0.370972042164776,"B.PvsV.BECKER_TAMOXIFEN_RESISTANCE_UP"
40,"Down",0.0728659138706723,0.370972042164776,"B.PvsV.REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY"
10,"Up",0.0730479979045189,0.371286948782831,"B.PvsV.SASAI_TARGETS_OF_CXCR6_AND_PTCH1_DN"
73,"Down",0.07306207275741,0.371286948782831,"B.PvsV.ZHAN_MULTIPLE_MYELOMA_HP_UP"
105,"Down",0.0732990543734749,0.371854841820023,"B.PvsV.GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_DN"
14,"Up",0.0733319232983312,0.371854841820023,"B.PvsV.BIOCARTA_PKC_PATHWAY"
17,"Up",0.0734017018257905,0.371854841820023,"B.PvsV.REACTOME_FORMYL_PEPTIDE_RECEPTORS_BIND_FORMYL_PEPTIDES_AND_MANY_OTHER_LIGANDS"
53,"Up",0.0734428445048771,0.371854841820023,"B.PvsV.BIOCARTA_CTL_PATHWAY"
38,"Down",0.0735540067844757,0.372076947402897,"B.PvsV.BURTON_ADIPOGENESIS_1"
48,"Down",0.0740469119580594,0.374227949009242,"B.PvsV.YU_BAP1_TARGETS"
74,"Up",0.074166653458206,0.374490800886229,"B.PvsV.FUJII_YBX1_TARGETS_UP"
288,"Up",0.0742871045719642,0.374595848662261,"B.PvsV.FOSTER_TOLERANT_MACROPHAGE_UP"
405,"Down",0.0743229600257732,0.374595848662261,"B.PvsV.IVANOVA_HEMATOPOIESIS_STEM_CELL_LONG_TERM"
12,"Up",0.0745897557539601,0.375070471431296,"B.PvsV.BOYLAN_MULTIPLE_MYELOMA_PCA1_DN"
13,"Down",0.0745916322762358,0.375070471431296,"B.PvsV.REACTOME_ESTABLISHMENT_OF_SISTER_CHROMATID_COHESION"
8,"Up",0.0746206400026091,0.375070471431296,"B.PvsV.REACTOME_BETA_OXIDATION_OF_BUTANOYL_COA_TO_ACETYL_COA"
246,"Up",0.0747777689241165,0.375282878349927,"B.PvsV.REACTOME_MUSCLE_CONTRACTION"
118,"Up",0.0747986492931127,0.375282878349927,"B.PvsV.ANASTASSIOU_MULTICANCER_INVASIVENESS_SIGNATURE"
62,"Up",0.0750363667304878,0.376134244472227,"B.PvsV.REACTOME_GPVI_MEDIATED_ACTIVATION_CASCADE"
20,"Down",0.0751787855195595,0.376506798131925,"B.PvsV.REACTOME_POLO_LIKE_KINASE_MEDIATED_EVENTS"
51,"Down",0.0753032363806633,0.376772158941701,"B.PvsV.KANG_GLIS3_TARGETS"
102,"Up",0.075410959510876,0.376772158941701,"B.PvsV.KEGG_ADHERENS_JUNCTION"
5,"Down",0.0754362054527876,0.376772158941701,"B.PvsV.REACTOME_DISEASES_OF_MISMATCH_REPAIR_MMR"
308,"Down",0.0755993647754783,0.377246288667527,"B.PvsV.VERHAAK_GLIOBLASTOMA_CLASSICAL"
19,"Down",0.0757164744020642,0.377489979232654,"B.PvsV.LIU_CDX2_TARGETS_DN"
65,"Up",0.0762810739352477,0.379701098009692,"B.PvsV.BOYAULT_LIVER_CANCER_SUBCLASS_G1_DN"
29,"Down",0.0763426621082541,0.379701098009692,"B.PvsV.IVANOVA_HEMATOPOIESIS_STEM_CELL_SHORT_TERM"
51,"Up",0.076367025095228,0.379701098009692,"B.PvsV.BIOCARTA_AGR_PATHWAY"
15,"Down",0.0765560881726074,0.379701098009692,"B.PvsV.REACTOME_N_GLYCAN_ANTENNAE_ELONGATION"
471,"Up",0.0765588615503854,0.379701098009692,"B.PvsV.REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION"
238,"Down",0.0766636292572774,0.379701098009692,"B.PvsV.WHITFIELD_CELL_CYCLE_G2"
14,"Up",0.0766791687113046,0.379701098009692,"B.PvsV.REACTOME_JOSEPHIN_DOMAIN_DUBS"
89,"Up",0.0767093735715004,0.379701098009692,"B.PvsV.ROY_WOUND_BLOOD_VESSEL_UP"
77,"Down",0.076795425827762,0.379787038820837,"B.PvsV.REACTOME_PKMTS_METHYLATE_HISTONE_LYSINES"
54,"Down",0.0768760551270829,0.379846031097088,"B.PvsV.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_PINK_DN"
73,"Up",0.0771904191035337,0.381048873839127,"B.PvsV.MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_DN"
95,"Up",0.0773177540890788,0.381048873839127,"B.PvsV.KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC"
42,"Up",0.0773262500357208,0.381048873839127,"B.PvsV.BRACHAT_RESPONSE_TO_METHOTREXATE_DN"
67,"Up",0.0776448746144556,0.382278282941518,"B.PvsV.PID_ARF6_TRAFFICKING_PATHWAY"
6,"Up",0.0777489395212656,0.382450077057898,"B.PvsV.REACTOME_MECP2_REGULATES_TRANSCRIPTION_FACTORS"
29,"Down",0.0781078272629748,0.383540863982429,"B.PvsV.REACTOME_GABA_SYNTHESIS_RELEASE_REUPTAKE_AND_DEGRADATION"
12,"Up",0.0781094253652044,0.383540863982429,"B.PvsV.REACTOME_REVERSIBLE_HYDRATION_OF_CARBON_DIOXIDE"
25,"Up",0.0783707999935456,0.384316311597731,"B.PvsV.NAKAMURA_LUNG_CANCER"
27,"Up",0.0784389879951494,0.384316311597731,"B.PvsV.REACTOME_ERK_MAPK_TARGETS"
20,"Down",0.0784758755279143,0.384316311597731,"B.PvsV.SABATES_COLORECTAL_ADENOMA_SIZE_DN"
22,"Up",0.078665903557831,0.38490600068252,"B.PvsV.BOYAULT_LIVER_CANCER_SUBCLASS_G12_DN"
56,"Up",0.0790335587563621,0.386362994132561,"B.PvsV.KEGG_STARCH_AND_SUCROSE_METABOLISM"
9,"Up",0.0792886712140544,0.387267723624122,"B.PvsV.REACTOME_SMALL_INTERFERING_RNA_SIRNA_BIOGENESIS"
51,"Down",0.0795804515003417,0.388004167794541,"B.PvsV.REACTOME_HIV_TRANSCRIPTION_INITIATION"
69,"Down",0.0797005267208949,0.388004167794541,"B.PvsV.PRAMOONJAGO_SOX4_TARGETS_UP"
73,"Up",0.0797592797164061,0.388004167794541,"B.PvsV.CHESLER_BRAIN_HIGHEST_GENETIC_VARIANCE"
129,"Down",0.0798531879302788,0.388004167794541,"B.PvsV.REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS"
19,"Down",0.0798546495319982,0.388004167794541,"B.PvsV.REACTOME_ACYL_CHAIN_REMODELLING_OF_PI"
38,"Up",0.079872793127474,0.388004167794541,"B.PvsV.RUAN_RESPONSE_TO_TNF_TROGLITAZONE_UP"
37,"Up",0.0799306831466778,0.388004167794541,"B.PvsV.BIOCARTA_RHO_PATHWAY"
10,"Down",0.0800550648770197,0.388151389722174,"B.PvsV.REICHERT_G1S_REGULATORS_AS_PI3K_TARGETS"
57,"Down",0.0801014171953338,0.388151389722174,"B.PvsV.RIZ_ERYTHROID_DIFFERENTIATION_HBZ"
54,"Up",0.0803903735049437,0.389210486084793,"B.PvsV.LEE_CALORIE_RESTRICTION_MUSCLE_UP"
42,"Down",0.0804850129274966,0.389327765945869,"B.PvsV.JI_METASTASIS_REPRESSED_BY_STK11"
49,"Up",0.0805740778368625,0.389417898916095,"B.PvsV.REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_OXIDATIVE_STRESS_METABOLIC_AND_NEURONAL_GENES"
38,"Down",0.0806542934414143,0.389465142740244,"B.PvsV.PID_CDC42_REG_PATHWAY"
61,"Up",0.080993561683647,0.390402857645487,"B.PvsV.BIOCARTA_NKCELLS_PATHWAY"
104,"Up",0.0810746360341828,0.390402857645487,"B.PvsV.CHIBA_RESPONSE_TO_TSA_UP"
82,"Up",0.0812176922080719,0.390402857645487,"B.PvsV.REACTOME_THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT"
36,"Down",0.0812227012301346,0.390402857645487,"B.PvsV.REACTOME_NOTCH3_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS"
13,"Down",0.0812683947407253,0.390402857645487,"B.PvsV.JOHNSTONE_PARVB_TARGETS_1_UP"
14,"Up",0.0812721448996121,0.390402857645487,"B.PvsV.BIOCARTA_LEPTIN_PATHWAY"
23,"Up",0.0814866775310278,0.390807615206654,"B.PvsV.REACTOME_ASSEMBLY_OF_ACTIVE_LPL_AND_LIPC_LIPASE_COMPLEXES"
63,"Down",0.0815270973180365,0.390807615206654,"B.PvsV.SU_PLACENTA"
59,"Up",0.0815684550458453,0.390807615206654,"B.PvsV.WENG_POR_TARGETS_GLOBAL_DN"
38,"Up",0.081802134275717,0.391587879143238,"B.PvsV.BIOCARTA_BARRESTIN_SRC_PATHWAY"
20,"Down",0.0819594373394349,0.392001495717764,"B.PvsV.VANDESLUIS_COMMD1_TARGETS_GROUP_4_UP"
385,"Down",0.0821821666112161,0.392727052025423,"B.PvsV.BROWNE_HCMV_INFECTION_48HR_UP"
11,"Down",0.0822742252929362,0.392827453924563,"B.PvsV.WILLIAMS_ESR1_TARGETS_DN"
31,"Up",0.0823470799987659,0.392836070158047,"B.PvsV.REACTOME_MISCELLANEOUS_TRANSPORT_AND_BINDING_EVENTS"
36,"Up",0.0824448793016609,0.392963566947313,"B.PvsV.WILENSKY_RESPONSE_TO_DARAPLADIB"
103,"Up",0.0827412898606259,0.394036685305254,"B.PvsV.PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_UP"
17,"Up",0.0828567303315117,0.394077074540362,"B.PvsV.REACTOME_PKA_ACTIVATION_IN_GLUCAGON_SIGNALLING"
4,"Up",0.0829195775905023,0.394077074540362,"B.PvsV.DER_IFN_ALPHA_RESPONSE_DN"
43,"Up",0.0830293396964921,0.394077074540362,"B.PvsV.ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_DN"
97,"Down",0.0830348692059181,0.394077074540362,"B.PvsV.AUNG_GASTRIC_CANCER"
18,"Up",0.0831177810220941,0.394132256664801,"B.PvsV.PID_TCR_RAS_PATHWAY"
73,"Up",0.0833399190862511,0.394846968832804,"B.PvsV.IKEDA_MIR1_TARGETS_UP"
249,"Up",0.0834482723070204,0.395021830124586,"B.PvsV.RAMALHO_STEMNESS_UP"
85,"Up",0.0839923321638109,0.397053980235981,"B.PvsV.SASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION"
66,"Down",0.0840211895236204,0.397053980235981,"B.PvsV.BOYAULT_LIVER_CANCER_SUBCLASS_G23_UP"
95,"Down",0.08435204756465,0.398119352588664,"B.PvsV.GU_PDEF_TARGETS_DN"
32,"Up",0.0843906459095522,0.398119352588664,"B.PvsV.BIOCARTA_PDZS_PATHWAY"
23,"Down",0.084688504429439,0.399183922412931,"B.PvsV.REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_CELL_CYCLE_GENES"
26,"Up",0.0852179442460341,0.401337320047975,"B.PvsV.REACTOME_PD_1_SIGNALING"
172,"Down",0.0853239117491531,0.401494389839207,"B.PvsV.DANG_MYC_TARGETS_UP"
18,"Up",0.0855185800665659,0.40184854242508,"B.PvsV.REACTOME_SYNTHESIS_OF_GLYCOSYLPHOSPHATIDYLINOSITOL_GPI"
41,"Down",0.08554453507584,0.40184854242508,"B.PvsV.HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_DN"
25,"Down",0.0856509560747355,0.402006906737871,"B.PvsV.KEGG_RENIN_ANGIOTENSIN_SYSTEM"
53,"Down",0.0858611479608287,0.402501365435156,"B.PvsV.BOQUEST_STEM_CELL_CULTURED_VS_FRESH_DN"
8,"Up",0.0859019011057124,0.402501365435156,"B.PvsV.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_6"
24,"Up",0.086176514114863,0.403446186740963,"B.PvsV.BIOCARTA_SPRY_PATHWAY"
87,"Up",0.0862617503112403,0.403503568080243,"B.PvsV.ZHOU_TNF_SIGNALING_4HR"
80,"Up",0.0864336495549019,0.403750196546744,"B.PvsV.REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES"
886,"Up",0.0864605231888849,0.403750196546744,"B.PvsV.STEIN_ESRRA_TARGETS"
58,"Down",0.0867168939665769,0.404605659697218,"B.PvsV.REACTOME_SNRNP_ASSEMBLY"
233,"Up",0.0870077405094123,0.405620402425414,"B.PvsV.REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES"
17,"Down",0.0871709770453614,0.405955255339603,"B.PvsV.REACTOME_DISSOLUTION_OF_FIBRIN_CLOT"
14,"Up",0.0872264140610325,0.405955255339603,"B.PvsV.REACTOME_ACTIVATED_NTRK2_SIGNALS_THROUGH_FRS2_AND_FRS3"
51,"Up",0.0873065768701529,0.405986596732612,"B.PvsV.REACTOME_ASSOCIATION_OF_TRIC_CCT_WITH_TARGET_PROTEINS_DURING_BIOSYNTHESIS"
302,"Down",0.0875454734714082,0.406755397330602,"B.PvsV.RODRIGUES_NTN1_TARGETS_DN"
42,"Up",0.0877806446321148,0.407505612234226,"B.PvsV.NOJIMA_SFRP2_TARGETS_DN"
29,"Up",0.0878746211471611,0.407599647921689,"B.PvsV.BIOCARTA_CK1_PATHWAY"
9,"Up",0.0879718711139479,0.40770869688937,"B.PvsV.MAINA_HYPOXIA_VHL_TARGETS_UP"
9,"Down",0.0880788227726362,0.407862488366755,"B.PvsV.REACTOME_TRAIL_SIGNALING"
140,"Up",0.0882105602557849,0.408060019167275,"B.PvsV.HECKER_IFNB1_TARGETS"
775,"Down",0.0882690871629701,0.408060019167275,"B.PvsV.REACTOME_METABOLISM_OF_RNA"
15,"Up",0.0884688134786255,0.408641662258413,"B.PvsV.KANG_CISPLATIN_RESISTANCE_DN"
27,"Up",0.088562706076188,0.408733891398367,"B.PvsV.JIANG_HYPOXIA_VIA_VHL"
236,"Up",0.0887933623316332,0.409023129043769,"B.PvsV.REACTOME_PROGRAMMED_CELL_DEATH"
176,"Up",0.0888236254990604,0.409023129043769,"B.PvsV.LAIHO_COLORECTAL_CANCER_SERRATED_UP"
127,"Down",0.0892122680141327,0.409023129043769,"B.PvsV.MEISSNER_NPC_HCP_WITH_H3K27ME3"
72,"Up",0.0892163461377799,0.409023129043769,"B.PvsV.ZHAN_MULTIPLE_MYELOMA_CD1_UP"
25,"Up",0.0892552590738036,0.409023129043769,"B.PvsV.MOOTHA_GLYCOGEN_METABOLISM"
63,"Up",0.0893145133719635,0.409023129043769,"B.PvsV.HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_DN"
15,"Up",0.0893654533943112,0.409023129043769,"B.PvsV.WORSCHECH_TUMOR_EVASION_AND_TOLEROGENICITY_DN"
63,"Up",0.0893731949550282,0.409023129043769,"B.PvsV.JOHANSSON_BRAIN_CANCER_EARLY_VS_LATE_DN"
102,"Up",0.089411300606946,0.409023129043769,"B.PvsV.REACTOME_E3_UBIQUITIN_LIGASES_UBIQUITINATE_TARGET_PROTEINS"
115,"Up",0.0894737621860557,0.409023129043769,"B.PvsV.DEMAGALHAES_AGING_UP"
57,"Up",0.089487740582847,0.409023129043769,"B.PvsV.WENG_POR_TARGETS_GLOBAL_UP"
8,"Up",0.0896616889601227,0.409023129043769,"B.PvsV.REACTOME_DEFECTIVE_CHST3_CAUSES_SEDCJD"
493,"Up",0.0896845069567502,0.409023129043769,"B.PvsV.ROZANOV_MMP14_TARGETS_UP"
11,"Up",0.0897003898337917,0.409023129043769,"B.PvsV.REACTOME_RUNX3_REGULATES_YAP1_MEDIATED_TRANSCRIPTION"
42,"Up",0.0897350435033627,0.409023129043769,"B.PvsV.DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_DN"
9,"Down",0.0899430428337135,0.40963351221384,"B.PvsV.BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_AND_PAX3"
119,"Down",0.0901677383091501,0.410318868404355,"B.PvsV.SHEPARD_BMYB_TARGETS"
18,"Down",0.0902669092344685,0.410432352925474,"B.PvsV.JIANG_CORE_DUPLICON_GENES"
15,"Down",0.0905017843729241,0.411162174032784,"B.PvsV.LIANG_SILENCED_BY_METHYLATION_DN"
176,"Up",0.0907706038405136,0.411997021705113,"B.PvsV.ZHONG_SECRETOME_OF_LUNG_CANCER_AND_ENDOTHELIUM"
52,"Down",0.0908521224441842,0.411997021705113,"B.PvsV.PID_FOXM1_PATHWAY"
189,"Up",0.0910928513787321,0.411997021705113,"B.PvsV.DURCHDEWALD_SKIN_CARCINOGENESIS_UP"
76,"Up",0.091095970900644,0.411997021705113,"B.PvsV.PID_KIT_PATHWAY"
130,"Up",0.0911469144762054,0.411997021705113,"B.PvsV.REACTOME_PROTEIN_UBIQUITINATION"
38,"Up",0.0911922993882332,0.411997021705113,"B.PvsV.DELACROIX_RAR_TARGETS_DN"
370,"Down",0.0912071540182778,0.411997021705113,"B.PvsV.MANALO_HYPOXIA_DN"
24,"Up",0.0913225506612605,0.412181536821314,"B.PvsV.PID_THROMBIN_PAR4_PATHWAY"
762,"Up",0.0915262930015846,0.412764171293443,"B.PvsV.LIM_MAMMARY_STEM_CELL_UP"
28,"Up",0.0916903809772931,0.41316716904927,"B.PvsV.HASEGAWA_TUMORIGENESIS_BY_RET_C634R"
33,"Up",0.0918187025475165,0.413408474255064,"B.PvsV.KUROKAWA_LIVER_CANCER_EARLY_RECURRENCE_DN"
28,"Down",0.0923464496889252,0.415189371181904,"B.PvsV.BIOCARTA_TID_PATHWAY"
171,"Up",0.0923644287490942,0.415189371181904,"B.PvsV.LIU_NASOPHARYNGEAL_CARCINOMA"
29,"Up",0.0924541094206786,0.415252527026099,"B.PvsV.DORN_ADENOVIRUS_INFECTION_32HR_UP"
209,"Up",0.0926039538871971,0.415252527026099,"B.PvsV.YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_14"
200,"Down",0.0926459727607705,0.415252527026099,"B.PvsV.ODONNELL_TFRC_TARGETS_DN"
132,"Up",0.0927029192884062,0.415252527026099,"B.PvsV.REACTOME_SIGNALING_BY_VEGF"
13,"Down",0.0928269818494448,0.415252527026099,"B.PvsV.BIOCARTA_RANMS_PATHWAY"
35,"Down",0.0928291053362738,0.415252527026099,"B.PvsV.AMIT_EGF_RESPONSE_240_MCF10A"
41,"Down",0.0933008025350124,0.416534746405301,"B.PvsV.ZHAN_MULTIPLE_MYELOMA_SPIKED"
92,"Up",0.0933301384953627,0.416534746405301,"B.PvsV.VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1"
86,"Up",0.0933417527213181,0.416534746405301,"B.PvsV.PID_INTEGRIN1_PATHWAY"
35,"Up",0.0935358374476242,0.41706423003864,"B.PvsV.WU_HBX_TARGETS_3_UP"
220,"Up",0.0937242269155612,0.417567486394954,"B.PvsV.KEGG_ENDOCYTOSIS"
56,"Down",0.0940653726631973,0.418749956082784,"B.PvsV.MURAKAMI_UV_RESPONSE_6HR_UP"
19,"Down",0.0944842750306556,0.420243770248205,"B.PvsV.MATZUK_PREOVULATORY_FOLLICLE"
25,"Up",0.0946283812873775,0.420243770248205,"B.PvsV.KEGG_GLYCOSYLPHOSPHATIDYLINOSITOL_GPI_ANCHOR_BIOSYNTHESIS"
37,"Down",0.0946886497093629,0.420243770248205,"B.PvsV.MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_DN"
41,"Down",0.0947049625120751,0.420243770248205,"B.PvsV.BIOCARTA_P53HYPOXIA_PATHWAY"
62,"Down",0.0951192090757891,0.421134899779029,"B.PvsV.LY_AGING_PREMATURE_DN"
16,"Down",0.0951450567547341,0.421134899779029,"B.PvsV.HOFMANN_MYELODYSPLASTIC_SYNDROM_HIGH_RISK_UP"
7,"Down",0.0951922283564633,0.421134899779029,"B.PvsV.REACTOME_PHOSPHORYLATION_OF_EMI1"
9,"Up",0.0952104584416325,0.421134899779029,"B.PvsV.BIOCARTA_PARKIN_PATHWAY"
7,"Up",0.095572721351226,0.422399341607457,"B.PvsV.REACTOME_VLDL_CLEARANCE"
25,"Up",0.0957145185147146,0.422688157242697,"B.PvsV.RASHI_NFKB1_TARGETS"
103,"Down",0.0959191459814956,0.423030551503742,"B.PvsV.NAGASHIMA_NRG1_SIGNALING_DN"
12,"Down",0.0959596757741374,0.423030551503742,"B.PvsV.REACTOME_NONCANONICAL_ACTIVATION_OF_NOTCH3"
150,"Up",0.0960215847598473,0.423030551503742,"B.PvsV.SWEET_KRAS_ONCOGENIC_SIGNATURE"
12,"Down",0.0963656826242206,0.423997875079255,"B.PvsV.REACTOME_HDL_REMODELING"
1130,"Up",0.0964362919845249,0.423997875079255,"B.PvsV.REACTOME_ADAPTIVE_IMMUNE_SYSTEM"
31,"Down",0.0964712112225905,0.423997875079255,"B.PvsV.KEGG_MATURITY_ONSET_DIABETES_OF_THE_YOUNG"
197,"Up",0.0970960672931544,0.425666386631772,"B.PvsV.WOO_LIVER_CANCER_RECURRENCE_UP"
96,"Up",0.0971021999194898,0.425666386631772,"B.PvsV.REACTOME_TRANSLOCATION_OF_SLC2A4_GLUT4_TO_THE_PLASMA_MEMBRANE"
30,"Down",0.0971371109293591,0.425666386631772,"B.PvsV.STREICHER_LSM1_TARGETS_DN"
31,"Down",0.097158795429426,0.425666386631772,"B.PvsV.REACTOME_ACYL_CHAIN_REMODELLING_OF_PC"
47,"Up",0.097378018912701,0.426005615935543,"B.PvsV.PID_ALPHA_SYNUCLEIN_PATHWAY"
38,"Down",0.0973903234839079,0.426005615935543,"B.PvsV.HOLLEMAN_VINCRISTINE_RESISTANCE_ALL_UP"
114,"Up",0.0976692127588084,0.426486225385878,"B.PvsV.STAMBOLSKY_TARGETS_OF_MUTATED_TP53_DN"
16,"Down",0.0977035512982672,0.426486225385878,"B.PvsV.RAMPON_ENRICHED_LEARNING_ENVIRONMENT_EARLY_DN"
14,"Up",0.0978727702725738,0.426486225385878,"B.PvsV.REACTOME_CROSS_PRESENTATION_OF_PARTICULATE_EXOGENOUS_ANTIGENS_PHAGOSOMES"
8,"Up",0.0979124182761058,0.426486225385878,"B.PvsV.REACTOME_UBIQUINOL_BIOSYNTHESIS"
23,"Down",0.0979645577988217,0.426486225385878,"B.PvsV.ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN"
111,"Up",0.0980215597688343,0.426486225385878,"B.PvsV.REACTOME_TOLL_LIKE_RECEPTOR_9_TLR9_CASCADE"
33,"Up",0.0981245325509317,0.426486225385878,"B.PvsV.MCCABE_HOXC6_TARGETS_CANCER_DN"
7,"Down",0.0981853194183785,0.426486225385878,"B.PvsV.JU_AGING_TERC_TARGETS_UP"
588,"Up",0.0981944230269892,0.426486225385878,"B.PvsV.YOSHIMURA_MAPK8_TARGETS_DN"
102,"Down",0.0983207125353402,0.4266995444332,"B.PvsV.REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION"
39,"Down",0.0985785371792442,0.427220279749449,"B.PvsV.REACTOME_TRANSCRIPTIONAL_REGULATION_BY_E2F6"
54,"Up",0.0986148023808888,0.427220279749449,"B.PvsV.ROZANOV_MMP14_TARGETS_DN"
29,"Up",0.0986725080918875,0.427220279749449,"B.PvsV.TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN"
60,"Up",0.0988031140157644,0.42745103082407,"B.PvsV.PID_SYNDECAN_1_PATHWAY"
13,"Down",0.0991188422909479,0.428481688058367,"B.PvsV.NAKAMURA_LUNG_CANCER_DIFFERENTIATION_MARKERS"
53,"Down",0.099404570984112,0.429244349935965,"B.PvsV.WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_UP"
19,"Down",0.0994505357692116,0.429244349935965,"B.PvsV.REACTOME_TRANSLESION_SYNTHESIS_BY_POLK"
8,"Down",0.0996334245068236,0.429698287128103,"B.PvsV.KORKOLA_CHORIOCARCINOMA_UP"
99,"Up",0.0998038802022491,0.429902398285624,"B.PvsV.BIOCARTA_MAPK_PATHWAY"
7,"Up",0.0998362596127222,0.429902398285624,"B.PvsV.REACTOME_PHASE_1_INACTIVATION_OF_FAST_NA_CHANNELS"
37,"Down",0.100013213010266,0.430329225473743,"B.PvsV.SARTIPY_BLUNTED_BY_INSULIN_RESISTANCE_UP"
138,"Up",0.100348808300263,0.43143745030494,"B.PvsV.KEGG_TIGHT_JUNCTION"
59,"Down",0.100471479672589,0.43158684742665,"B.PvsV.PID_RHOA_REG_PATHWAY"
59,"Down",0.100539674350791,0.43158684742665,"B.PvsV.KEGG_RNA_DEGRADATION"
51,"Up",0.10109935246228,0.433410323503241,"B.PvsV.GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_DN"
16,"Up",0.101121236628537,0.433410323503241,"B.PvsV.WAESCH_ANAPHASE_PROMOTING_COMPLEX"
284,"Down",0.101591138158927,0.434612132250323,"B.PvsV.ANDERSEN_CHOLANGIOCARCINOMA_CLASS2"
56,"Down",0.101630669605969,0.434612132250323,"B.PvsV.SIG_PIP3_SIGNALING_IN_B_LYMPHOCYTES"
104,"Up",0.101658915512851,0.434612132250323,"B.PvsV.LEE_LIVER_CANCER_E2F1_DN"
180,"Down",0.101716060613478,0.434612132250323,"B.PvsV.LIM_MAMMARY_LUMINAL_MATURE_UP"
64,"Up",0.101949996752961,0.434978769133163,"B.PvsV.SCHOEN_NFKB_SIGNALING"
11,"Up",0.10195921229817,0.434978769133163,"B.PvsV.REACTOME_PP2A_MEDIATED_DEPHOSPHORYLATION_OF_KEY_METABOLIC_FACTORS"
22,"Down",0.102215876087353,0.435737531909771,"B.PvsV.REACTOME_POST_CHAPERONIN_TUBULIN_FOLDING_PATHWAY"
32,"Up",0.102663576136708,0.437308869383559,"B.PvsV.LANDIS_ERBB2_BREAST_TUMORS_65_UP"
27,"Down",0.102836854553446,0.437709752752888,"B.PvsV.FOURNIER_ACINAR_DEVELOPMENT_EARLY_UP"
33,"Up",0.103012982907615,0.438122140381693,"B.PvsV.REACTOME_TRANSFERRIN_ENDOCYTOSIS_AND_RECYCLING"
69,"Up",0.10323501320617,0.438728968498782,"B.PvsV.SMITH_LIVER_CANCER"
121,"Down",0.103405274263378,0.439115024118447,"B.PvsV.GROSS_HYPOXIA_VIA_HIF1A_UP"
25,"Down",0.103492656860596,0.439148810270326,"B.PvsV.BOYAULT_LIVER_CANCER_SUBCLASS_G56_DN"
258,"Up",0.10403378238986,0.441106428553327,"B.PvsV.REACTOME_FATTY_ACID_METABOLISM"
41,"Up",0.104161236783124,0.441308412393787,"B.PvsV.KYNG_NORMAL_AGING_DN"
33,"Down",0.104462178088749,0.442244550270058,"B.PvsV.REACTOME_NOTCH2_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS"
67,"Down",0.104626430566168,0.442343426257633,"B.PvsV.ZHAN_MULTIPLE_MYELOMA_PR_DN"
19,"Down",0.104645541968708,0.442343426257633,"B.PvsV.HOFFMAN_CLOCK_TARGETS_UP"
61,"Up",0.10496159244796,0.443118221652837,"B.PvsV.REACTOME_RUNX2_REGULATES_BONE_DEVELOPMENT"
12,"Down",0.104989124681718,0.443118221652837,"B.PvsV.REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_EARLY_PANCREATIC_PRECURSOR_CELLS"
364,"Down",0.105189296020352,0.443367622199876,"B.PvsV.RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_UP"
73,"Up",0.105355617526787,0.443367622199876,"B.PvsV.WENG_POR_DOSAGE"
42,"Up",0.105419090368297,0.443367622199876,"B.PvsV.REACTOME_G_PROTEIN_BETA_GAMMA_SIGNALLING"
29,"Down",0.105467708377474,0.443367622199876,"B.PvsV.MURAKAMI_UV_RESPONSE_1HR_UP"
188,"Down",0.105483332829529,0.443367622199876,"B.PvsV.KIM_MYC_AMPLIFICATION_TARGETS_DN"
101,"Up",0.105649116707833,0.443367622199876,"B.PvsV.REACTOME_ONCOGENIC_MAPK_SIGNALING"
204,"Down",0.10567712644836,0.443367622199876,"B.PvsV.SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_DN"
30,"Down",0.105689731607784,0.443367622199876,"B.PvsV.REACTOME_ESTROGEN_DEPENDENT_NUCLEAR_EVENTS_DOWNSTREAM_OF_ESR_MEMBRANE_SIGNALING"
155,"Down",0.105818933053233,0.443496479880697,"B.PvsV.REACTOME_ACTIVATION_OF_ANTERIOR_HOX_GENES_IN_HINDBRAIN_DEVELOPMENT_DURING_EARLY_EMBRYOGENESIS"
636,"Up",0.105953540964442,0.443496479880697,"B.PvsV.RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP"
58,"Up",0.105972297053831,0.443496479880697,"B.PvsV.BYSTRYKH_HEMATOPOIESIS_STEM_CELL_SCP2_QTL_TRANS"
456,"Down",0.106087150037033,0.443496479880697,"B.PvsV.REACTOME_TRANSCRIPTIONAL_REGULATION_BY_TP53"
30,"Down",0.106121512548772,0.443496479880697,"B.PvsV.IWANAGA_E2F1_TARGETS_INDUCED_BY_SERUM"
16,"Down",0.106677423567238,0.444760129313978,"B.PvsV.KORKOLA_EMBRYONAL_CARCINOMA"
15,"Up",0.106768722207596,0.444760129313978,"B.PvsV.COLLIS_PRKDC_REGULATORS"
48,"Down",0.106974164130609,0.444760129313978,"B.PvsV.HOLLEMAN_ASPARAGINASE_RESISTANCE_B_ALL_UP"
12,"Up",0.106981331436636,0.444760129313978,"B.PvsV.REACTOME_MAPK3_ERK1_ACTIVATION"
590,"Down",0.106996667943768,0.444760129313978,"B.PvsV.BENPORATH_ES_1"
7,"Down",0.106997592994045,0.444760129313978,"B.PvsV.DIERICK_SEROTONIN_FUNCTION_GENES"
48,"Up",0.107026086285444,0.444760129313978,"B.PvsV.REACTOME_VASOPRESSIN_REGULATES_RENAL_WATER_HOMEOSTASIS_VIA_AQUAPORINS"
110,"Up",0.107067414020059,0.444760129313978,"B.PvsV.REACTOME_COLLAGEN_FORMATION"
21,"Up",0.107164900081561,0.444830880293507,"B.PvsV.REACTOME_CLASS_I_PEROXISOMAL_MEMBRANE_PROTEIN_IMPORT"
9,"Down",0.107811927252843,0.446888284419304,"B.PvsV.REACTOME_IRS_ACTIVATION"
8,"Up",0.107822204994638,0.446888284419304,"B.PvsV.REACTOME_DEFECTIVE_CHST14_CAUSES_EDS_MUSCULOCONTRACTURAL_TYPE"
46,"Down",0.108076294628474,0.447605867416354,"B.PvsV.STAEGE_EWING_FAMILY_TUMOR"
209,"Down",0.108216457641492,0.447850893936981,"B.PvsV.NABA_ECM_GLYCOPROTEINS"
68,"Down",0.108591243504467,0.448948236786612,"B.PvsV.HALMOS_CEBPA_TARGETS_DN"
6,"Down",0.108644011723727,0.448948236786612,"B.PvsV.SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_DN"
56,"Up",0.108746331250715,0.449035448457958,"B.PvsV.MARTIN_INTERACT_WITH_HDAC"
110,"Up",0.108979203114293,0.449445882218263,"B.PvsV.PID_IL12_2PATHWAY"
53,"Up",0.109008306756139,0.449445882218263,"B.PvsV.FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN"
19,"Down",0.109143501977652,0.449649481588811,"B.PvsV.REACTOME_TRANSPORT_OF_ORGANIC_ANIONS"
35,"Down",0.109348756299515,0.449649481588811,"B.PvsV.REACTOME_RECOGNITION_OF_DNA_DAMAGE_BY_PCNA_CONTAINING_REPLICATION_COMPLEX"
243,"Up",0.109365261776745,0.449649481588811,"B.PvsV.IGLESIAS_E2F_TARGETS_UP"
16,"Up",0.109484690243792,0.449649481588811,"B.PvsV.REACTOME_NUCLEOTIDE_LIKE_PURINERGIC_RECEPTORS"
11,"Up",0.109518846668649,0.449649481588811,"B.PvsV.KEGG_VALINE_LEUCINE_AND_ISOLEUCINE_BIOSYNTHESIS"
135,"Down",0.109636403890704,0.449649481588811,"B.PvsV.REACTOME_CHROMOSOME_MAINTENANCE"
27,"Up",0.10970285784086,0.449649481588811,"B.PvsV.VANDESLUIS_COMMD1_TARGETS_GROUP_2_UP"
42,"Down",0.109719075611499,0.449649481588811,"B.PvsV.REACTOME_EGFR_DOWNREGULATION"
139,"Up",0.109789618402043,0.449649481588811,"B.PvsV.GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP"
80,"Up",0.110138030793241,0.450518095117361,"B.PvsV.ELVIDGE_HYPOXIA_BY_DMOG_DN"
16,"Up",0.110164670753965,0.450518095117361,"B.PvsV.HASINA_NOL7_TARGETS_UP"
58,"Up",0.110576850368888,0.451689046918807,"B.PvsV.PID_SYNDECAN_4_PATHWAY"
7,"Up",0.11066804791835,0.451689046918807,"B.PvsV.MIKHAYLOVA_OXIDATIVE_STRESS_RESPONSE_VIA_VHL_DN"
25,"Down",0.110696085833783,0.451689046918807,"B.PvsV.BIOCARTA_CELLCYCLE_PATHWAY"
189,"Up",0.110800495310212,0.451781665612214,"B.PvsV.ROESSLER_LIVER_CANCER_METASTASIS_UP"
379,"Down",0.110975098666022,0.452160147770401,"B.PvsV.REACTOME_DNA_REPAIR"
115,"Down",0.11113901908975,0.452220472925738,"B.PvsV.BASSO_CD40_SIGNALING_DN"
23,"Up",0.111262144828026,0.452220472925738,"B.PvsV.REACTOME_INHIBITION_OF_THE_PROTEOLYTIC_ACTIVITY_OF_APC_C_REQUIRED_FOR_THE_ONSET_OF_ANAPHASE_BY_MITOTIC_SPINDLE_CHECKPOINT_COMPONENTS"
20,"Down",0.111311363730949,0.452220472925738,"B.PvsV.ZHOU_PANCREATIC_ENDOCRINE_PROGENITOR"
8,"Up",0.111317067037788,0.452220472925738,"B.PvsV.TURJANSKI_MAPK7_TARGETS"
33,"Down",0.111556281049502,0.452553617211188,"B.PvsV.BIOCARTA_G1_PATHWAY"
607,"Up",0.111621451603284,0.452553617211188,"B.PvsV.REACTOME_SIGNALING_BY_INTERLEUKINS"
24,"Up",0.111644625407137,0.452553617211188,"B.PvsV.BIOCARTA_NOS1_PATHWAY"
74,"Up",0.111826996364958,0.452697361333233,"B.PvsV.REACTOME_ASYMMETRIC_LOCALIZATION_OF_PCP_PROTEINS"
67,"Up",0.111861628104856,0.452697361333233,"B.PvsV.CHESLER_BRAIN_HIGHEST_EXPRESSION"
203,"Up",0.111988742924709,0.452697361333233,"B.PvsV.VERHAAK_GLIOBLASTOMA_NEURAL"
19,"Down",0.112086044002231,0.452697361333233,"B.PvsV.KEGG_ONE_CARBON_POOL_BY_FOLATE"
15,"Down",0.112161798072222,0.452697361333233,"B.PvsV.REACTOME_TRAF3_DEPENDENT_IRF_ACTIVATION_PATHWAY"
37,"Up",0.112171348349888,0.452697361333233,"B.PvsV.BIOCARTA_EDG1_PATHWAY"
103,"Down",0.112331782104527,0.452827232997688,"B.PvsV.SAMOLS_TARGETS_OF_KHSV_MIRNAS_DN"
22,"Up",0.11236732929514,0.452827232997688,"B.PvsV.REACTOME_CHONDROITIN_SULFATE_BIOSYNTHESIS"
430,"Up",0.112676588570773,0.453502308977288,"B.PvsV.TARTE_PLASMA_CELL_VS_PLASMABLAST_DN"
71,"Down",0.11269889175887,0.453502308977288,"B.PvsV.REACTOME_SIGNALING_BY_NOTCH3"
52,"Up",0.113072747441026,0.454511873562734,"B.PvsV.ELVIDGE_HIF1A_AND_HIF2A_TARGETS_UP"
17,"Up",0.113261490930979,0.454511873562734,"B.PvsV.PARK_APL_PATHOGENESIS_UP"
7,"Up",0.113391580603472,0.454511873562734,"B.PvsV.REACTOME_WAX_AND_PLASMALOGEN_BIOSYNTHESIS"
12,"Up",0.113405927245633,0.454511873562734,"B.PvsV.BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_24HR_UP"
114,"Down",0.113465706278262,0.454511873562734,"B.PvsV.GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_DN"
19,"Up",0.113517468701768,0.454511873562734,"B.PvsV.MARTINELLI_IMMATURE_NEUTROPHIL_DN"
62,"Down",0.113556272585003,0.454511873562734,"B.PvsV.KORKOLA_CORRELATED_WITH_POU5F1"
19,"Up",0.113607417121306,0.454511873562734,"B.PvsV.BIOCARTA_BLYMPHOCYTE_PATHWAY"
361,"Down",0.113820557802319,0.455035331951572,"B.PvsV.MARKEY_RB1_ACUTE_LOF_UP"
46,"Down",0.114066674672011,0.455689771865283,"B.PvsV.REACTOME_TRANSCRIPTIONAL_REGULATION_BY_THE_AP_2_TFAP2_FAMILY_OF_TRANSCRIPTION_FACTORS"
100,"Up",0.114346303483908,0.456477048348395,"B.PvsV.REACTOME_TOLL_LIKE_RECEPTOR_10_TLR10_CASCADE"
40,"Up",0.114671920512172,0.456813084970433,"B.PvsV.BIOCARTA_INFLAM_PATHWAY"
9,"Down",0.114679786359977,0.456813084970433,"B.PvsV.TURJANSKI_MAPK8_AND_MAPK9_TARGETS"
544,"Down",0.114785265780874,0.456813084970433,"B.PvsV.WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN"
12,"Down",0.114863556073675,0.456813084970433,"B.PvsV.REACTOME_ACTIVATION_OF_THE_AP_1_FAMILY_OF_TRANSCRIPTION_FACTORS"
57,"Up",0.114961528639694,0.456813084970433,"B.PvsV.KEGG_MTOR_SIGNALING_PATHWAY"
175,"Down",0.115048308501284,0.456813084970433,"B.PvsV.KAN_RESPONSE_TO_ARSENIC_TRIOXIDE"
17,"Up",0.115059197443033,0.456813084970433,"B.PvsV.WEBER_METHYLATED_ICP_IN_SPERM_UP"
43,"Up",0.115091450056758,0.456813084970433,"B.PvsV.KEGG_BUTANOATE_METABOLISM"
20,"Up",0.115229097218134,0.457031333227447,"B.PvsV.PID_LPA4_PATHWAY"
27,"Up",0.115374973991348,0.457281886163558,"B.PvsV.TERAMOTO_OPN_TARGETS_CLUSTER_7"
83,"Up",0.115652833337133,0.457774038142177,"B.PvsV.COWLING_MYCN_TARGETS"
80,"Up",0.115773374499333,0.457774038142177,"B.PvsV.MODY_HIPPOCAMPUS_NEONATAL"
59,"Down",0.115804403715344,0.457774038142177,"B.PvsV.REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN"
36,"Down",0.115897701324316,0.457774038142177,"B.PvsV.KEGG_BASAL_TRANSCRIPTION_FACTORS"
66,"Down",0.115913122336597,0.457774038142177,"B.PvsV.CHEN_NEUROBLASTOMA_COPY_NUMBER_GAINS"
253,"Down",0.116174741643179,0.458164004888752,"B.PvsV.LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_UP"
120,"Up",0.1162321669453,0.458164004888752,"B.PvsV.REACTOME_MYD88_INDEPENDENT_TLR4_CASCADE"
141,"Down",0.116260462806822,0.458164004888752,"B.PvsV.BRUINS_UVC_RESPONSE_MIDDLE"
60,"Up",0.116737924596406,0.459655954314954,"B.PvsV.HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_4HR"
47,"Up",0.116805320277177,0.459655954314954,"B.PvsV.KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_WS"
63,"Down",0.116928943679126,0.459815170413861,"B.PvsV.SUNG_METASTASIS_STROMA_DN"
165,"Up",0.117176452114649,0.460291515997984,"B.PvsV.FURUKAWA_DUSP6_TARGETS_PCI35_UP"
69,"Up",0.117216577052842,0.460291515997984,"B.PvsV.PID_UPA_UPAR_PATHWAY"
43,"Down",0.117589361050667,0.461427663058294,"B.PvsV.REACTOME_TRANSLESION_SYNTHESIS_BY_Y_FAMILY_DNA_POLYMERASES_BYPASSES_LESIONS_ON_DNA_TEMPLATE"
16,"Down",0.117727248690723,0.461641104972345,"B.PvsV.KEGG_OTHER_GLYCAN_DEGRADATION"
188,"Up",0.117831049214131,0.461644358923063,"B.PvsV.DAIRKEE_CANCER_PRONE_RESPONSE_BPA_E2"
11,"Up",0.117895068692235,0.461644358923063,"B.PvsV.BIOCARTA_TCAPOPTOSIS_PATHWAY"
29,"Up",0.117988021838696,0.461681367831669,"B.PvsV.RUAN_RESPONSE_TO_TNF_UP"
17,"Down",0.11848826694736,0.463310910857109,"B.PvsV.BIOCARTA_BTG2_PATHWAY"
64,"Down",0.118643726802849,0.463585122277486,"B.PvsV.WHITEHURST_PACLITAXEL_SENSITIVITY"
645,"Down",0.118726086660322,0.463585122277486,"B.PvsV.CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_2"
318,"Up",0.118866748514339,0.463799466310656,"B.PvsV.ALONSO_METASTASIS_UP"
6,"Down",0.118948750810004,0.463799466310656,"B.PvsV.BIOCARTA_TERC_PATHWAY"
53,"Up",0.119038813133265,0.463823536161962,"B.PvsV.KIM_TIAL1_TARGETS"
347,"Down",0.119889196625079,0.466808005732437,"B.PvsV.MITSIADES_RESPONSE_TO_APLIDIN_DN"
38,"Up",0.120098665064838,0.467294524379655,"B.PvsV.MATTIOLI_MULTIPLE_MYELOMA_SUBGROUPS"
556,"Down",0.120315190523769,0.46780779775381,"B.PvsV.MEISSNER_NPC_HCP_WITH_H3K4ME2_AND_H3K27ME3"
1597,"Down",0.120451983354285,0.467834853333509,"B.PvsV.REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION"
65,"Up",0.120491378395174,0.467834853333509,"B.PvsV.SMID_BREAST_CANCER_RELAPSE_IN_PLEURA_DN"
46,"Up",0.121225599715716,0.470355326896977,"B.PvsV.OSADA_ASCL1_TARGETS_DN"
117,"Up",0.121786022355943,0.471432596019802,"B.PvsV.TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_DN"
26,"Down",0.121996612355196,0.471432596019802,"B.PvsV.SCIAN_CELL_CYCLE_TARGETS_OF_TP53_AND_TP73_DN"
6,"Up",0.12200235031284,0.471432596019802,"B.PvsV.REACTOME_BETA_OXIDATION_OF_DECANOYL_COA_TO_OCTANOYL_COA_COA"
231,"Up",0.12204102171376,0.471432596019802,"B.PvsV.BASSO_B_LYMPHOCYTE_NETWORK"
32,"Down",0.122107768276688,0.471432596019802,"B.PvsV.KEGG_O_GLYCAN_BIOSYNTHESIS"
34,"Down",0.122141654758796,0.471432596019802,"B.PvsV.ZHU_SKIL_TARGETS_UP"
107,"Up",0.122209856360489,0.471432596019802,"B.PvsV.GAURNIER_PSMD4_TARGETS"
191,"Down",0.122237020492957,0.471432596019802,"B.PvsV.ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP"
46,"Up",0.122321221082181,0.471432596019802,"B.PvsV.PID_PI3KCI_AKT_PATHWAY"
83,"Down",0.122355900757536,0.471432596019802,"B.PvsV.CHNG_MULTIPLE_MYELOMA_HYPERPLOID_UP"
1893,"Up",0.122551677688453,0.471858096058117,"B.PvsV.DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_UP"
354,"Up",0.122682948243259,0.471959050323833,"B.PvsV.MARTORIATI_MDM4_TARGETS_FETAL_LIVER_UP"
30,"Up",0.122748618984567,0.471959050323833,"B.PvsV.BIOCARTA_CTLA4_PATHWAY"
75,"Down",0.123228059091523,0.473169379749814,"B.PvsV.REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS"
14,"Up",0.123234564449219,0.473169379749814,"B.PvsV.BIOCARTA_P35ALZHEIMERS_PATHWAY"
77,"Down",0.123436891833645,0.473339255866763,"B.PvsV.DOANE_BREAST_CANCER_ESR1_DN"
97,"Down",0.123456952323969,0.473339255866763,"B.PvsV.WEIGEL_OXIDATIVE_STRESS_RESPONSE"
119,"Up",0.123535638671684,0.473339255866763,"B.PvsV.GALINDO_IMMUNE_RESPONSE_TO_ENTEROTOXIN"
41,"Up",0.123698390328367,0.47363462612572,"B.PvsV.WANG_METASTASIS_OF_BREAST_CANCER"
62,"Up",0.12402787273508,0.474567549032703,"B.PvsV.AIYAR_COBRA1_TARGETS_UP"
236,"Up",0.124162673737131,0.474752278381718,"B.PvsV.COULOUARN_TEMPORAL_TGFB1_SIGNATURE_DN"
330,"Up",0.124247883309522,0.474752278381718,"B.PvsV.REACTOME_METABOLISM_OF_CARBOHYDRATES"
29,"Down",0.124546423898007,0.475319102855741,"B.PvsV.REACTOME_ACYL_CHAIN_REMODELLING_OF_PE"
23,"Down",0.124568164231863,0.475319102855741,"B.PvsV.REACTOME_PROCESSING_OF_INTRONLESS_PRE_MRNAS"
67,"Up",0.124893821922784,0.47623306304212,"B.PvsV.BIOCARTA_TCR_PATHWAY"
11,"Up",0.125013082753602,0.476297960727679,"B.PvsV.BYSTRYKH_SCP2_QTL"
103,"Down",0.125083132388604,0.476297960727679,"B.PvsV.BROWNE_HCMV_INFECTION_4HR_UP"
463,"Down",0.12533480064079,0.476927813312406,"B.PvsV.JAEGER_METASTASIS_DN"
60,"Up",0.125494802940452,0.477208229338213,"B.PvsV.PID_ER_NONGENOMIC_PATHWAY"
26,"Down",0.125805168179451,0.478042775205542,"B.PvsV.LOPEZ_MESOTHELIOMA_SURVIVAL_WORST_VS_BEST_UP"
112,"Up",0.125887191300284,0.478042775205542,"B.PvsV.LEIN_NEURON_MARKERS"
37,"Up",0.126382026543609,0.479581975419172,"B.PvsV.PID_GLYPICAN_1PATHWAY"
97,"Up",0.12651293721719,0.479581975419172,"B.PvsV.WENG_POR_TARGETS_LIVER_UP"
9,"Down",0.126552740484097,0.479581975419172,"B.PvsV.REACTOME_VITAMIN_C_ASCORBATE_METABOLISM"
20,"Down",0.126681062145531,0.47973944698811,"B.PvsV.SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX5_DN"
41,"Up",0.126809531584661,0.479897262239281,"B.PvsV.BIOCARTA_DC_PATHWAY"
14,"Down",0.126900466297499,0.479912912557367,"B.PvsV.REACTOME_NRCAM_INTERACTIONS"
172,"Down",0.126990512120362,0.47992518216916,"B.PvsV.BAELDE_DIABETIC_NEPHROPATHY_UP"
5,"Up",0.127371110374489,0.481034746762669,"B.PvsV.JONES_TCOF1_TARGETS"
69,"Up",0.127999423447639,0.483077687537197,"B.PvsV.BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_DN"
13,"Up",0.128132861585054,0.483251426810208,"B.PvsV.REACTOME_INTERLEUKIN_27_SIGNALING"
45,"Up",0.128357883506623,0.483323702607157,"B.PvsV.CHNG_MULTIPLE_MYELOMA_HYPERPLOID_DN"
266,"Down",0.128361054866415,0.483323702607157,"B.PvsV.FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_DN"
31,"Down",0.128453491557446,0.483323702607157,"B.PvsV.SASAI_TARGETS_OF_CXCR6_AND_PTCH1_UP"
61,"Up",0.12855753374519,0.483323702607157,"B.PvsV.LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_UP"
19,"Down",0.128589105902537,0.483323702607157,"B.PvsV.AMIT_EGF_RESPONSE_20_HELA"
1519,"Down",0.128769145304843,0.48367160624353,"B.PvsV.BENPORATH_EED_TARGETS"
261,"Down",0.128910426054442,0.483768623801797,"B.PvsV.KAUFFMANN_DNA_REPAIR_GENES"
26,"Up",0.129047325846445,0.483768623801797,"B.PvsV.NAM_FXYD5_TARGETS_DN"
33,"Down",0.1291395718466,0.483768623801797,"B.PvsV.REACTOME_PROCESSING_OF_CAPPED_INTRONLESS_PRE_MRNA"
124,"Down",0.129269117809137,0.483768623801797,"B.PvsV.MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_DN"
37,"Up",0.129314858424872,0.483768623801797,"B.PvsV.BIOCARTA_IL12_PATHWAY"
195,"Down",0.129319954056621,0.483768623801797,"B.PvsV.BOYAULT_LIVER_CANCER_SUBCLASS_G1_UP"
26,"Down",0.129576815063461,0.4844017650344,"B.PvsV.REACTOME_NICOTINAMIDE_SALVAGING"
187,"Up",0.129750646604336,0.484443427549235,"B.PvsV.QI_HYPOXIA"
25,"Down",0.129763196997724,0.484443427549235,"B.PvsV.INGA_TP53_TARGETS"
346,"Down",0.130355527493073,0.48603028375783,"B.PvsV.TIEN_INTESTINE_PROBIOTICS_24HR_DN"
97,"Up",0.130364064173062,0.48603028375783,"B.PvsV.PID_MTOR_4PATHWAY"
14,"Up",0.130693859682686,0.486931502820467,"B.PvsV.BERENJENO_TRANSFORMED_BY_RHOA_REVERSIBLY_UP"
35,"Up",0.130978878716892,0.487637817490473,"B.PvsV.BIOCARTA_IGF1_PATHWAY"
52,"Up",0.131059829406917,0.487637817490473,"B.PvsV.PID_GMCSF_PATHWAY"
1509,"Down",0.131232153741271,0.487950624099183,"B.PvsV.MARTENS_TRETINOIN_RESPONSE_UP"
90,"Up",0.131505499204044,0.488638377082769,"B.PvsV.BENNETT_SYSTEMIC_LUPUS_ERYTHEMATOSUS"
12,"Down",0.131744352477531,0.488784436378554,"B.PvsV.REACTOME_COHESIN_LOADING_ONTO_CHROMATIN"
6,"Down",0.131781815784615,0.488784436378554,"B.PvsV.FIGUEROA_AML_METHYLATION_CLUSTER_7_DN"
37,"Up",0.131810018925741,0.488784436378554,"B.PvsV.FRIDMAN_SENESCENCE_DN"
26,"Down",0.131917762867959,0.488856106499292,"B.PvsV.ZHENG_FOXP3_TARGETS_IN_THYMUS_DN"
60,"Up",0.132181915180696,0.489506904912302,"B.PvsV.LIN_MELANOMA_COPY_NUMBER_DN"
212,"Up",0.132369084478218,0.489644790776992,"B.PvsV.LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN"
32,"Up",0.13239626735605,0.489644790776992,"B.PvsV.DASU_IL6_SIGNALING_SCAR_DN"
159,"Up",0.132677302876492,0.490169824498011,"B.PvsV.TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_DN"
323,"Down",0.132753276210318,0.490169824498011,"B.PvsV.VILLANUEVA_LIVER_CANCER_KRT19_UP"
4,"Down",0.132804195532288,0.490169824498011,"B.PvsV.IGARASHI_ATF4_TARGETS_UP"
48,"Up",0.13303849207588,0.490707019804896,"B.PvsV.REACTOME_EPHA_MEDIATED_GROWTH_CONE_COLLAPSE"
12,"Down",0.133333555960454,0.491467487270233,"B.PvsV.MIKKELSEN_PLURIPOTENT_STATE_UP"
203,"Down",0.133657124984063,0.49167212191136,"B.PvsV.MIKKELSEN_IPS_WITH_HCP_H3K27ME3"
103,"Up",0.133751259959829,0.49167212191136,"B.PvsV.OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN"
1555,"Down",0.133755148524417,0.49167212191136,"B.PvsV.MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3"
23,"Up",0.133778647837718,0.49167212191136,"B.PvsV.MANN_RESPONSE_TO_AMIFOSTINE_UP"
64,"Down",0.133860896257755,0.49167212191136,"B.PvsV.REACTOME_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER"
10,"Up",0.133964136649995,0.49167212191136,"B.PvsV.REACTOME_MET_ACTIVATES_PI3K_AKT_SIGNALING"
7,"Up",0.134028278022939,0.49167212191136,"B.PvsV.REACTOME_CHYLOMICRON_CLEARANCE"
340,"Up",0.134157285074729,0.49167212191136,"B.PvsV.STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP"
7,"Down",0.134257222910937,0.49167212191136,"B.PvsV.REACTOME_TELOMERE_C_STRAND_SYNTHESIS_INITIATION"
100,"Up",0.134324635773016,0.49167212191136,"B.PvsV.PID_CD8_TCR_PATHWAY"
32,"Up",0.134367259216506,0.49167212191136,"B.PvsV.MARIADASON_RESPONSE_TO_CURCUMIN_SULINDAC_5"
90,"Down",0.134543478817486,0.49180736219286,"B.PvsV.REACTOME_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE"
47,"Up",0.134683409478042,0.49180736219286,"B.PvsV.HOUSTIS_ROS"
34,"Up",0.134834290745457,0.49180736219286,"B.PvsV.BIOCARTA_RAS_PATHWAY"
127,"Down",0.134880219465217,0.49180736219286,"B.PvsV.REACTOME_REGULATION_OF_PLK1_ACTIVITY_AT_G2_M_TRANSITION"
179,"Up",0.134898627458223,0.49180736219286,"B.PvsV.TSENG_IRS1_TARGETS_UP"
394,"Down",0.134956598261513,0.49180736219286,"B.PvsV.BILD_E2F3_ONCOGENIC_SIGNATURE"
13,"Up",0.135115374853891,0.49180736219286,"B.PvsV.REACTOME_RECEPTOR_MEDIATED_MITOPHAGY"
32,"Up",0.1352033634677,0.49180736219286,"B.PvsV.BIOCARTA_MTA3_PATHWAY"
23,"Down",0.135320181205619,0.49180736219286,"B.PvsV.REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_G2_CELL_CYCLE_ARREST"
41,"Up",0.135365022237,0.49180736219286,"B.PvsV.CROONQUIST_IL6_DEPRIVATION_UP"
99,"Up",0.135382674128691,0.49180736219286,"B.PvsV.MIKKELSEN_ES_ICP_WITH_H3K27ME3"
42,"Up",0.135526047097404,0.492004933947174,"B.PvsV.VANDESLUIS_COMMD1_TARGETS_GROUP_4_DN"
368,"Down",0.136069089262644,0.493652227383962,"B.PvsV.AMUNDSON_RESPONSE_TO_ARSENITE"
26,"Down",0.13668576931073,0.495250704342557,"B.PvsV.FERRANDO_HOX11_NEIGHBORS"
12,"Up",0.136688836105397,0.495250704342557,"B.PvsV.GROSS_HIF1A_TARGETS_UP"
135,"Down",0.137273292449387,0.49643166412311,"B.PvsV.REACTOME_SELENOAMINO_ACID_METABOLISM"
19,"Up",0.137282516459219,0.49643166412311,"B.PvsV.REACTOME_DSCAM_INTERACTIONS"
18,"Up",0.137299001456158,0.49643166412311,"B.PvsV.REACTOME_ACTIVATION_OF_BAD_AND_TRANSLOCATION_TO_MITOCHONDRIA"
72,"Up",0.137397680112589,0.49643166412311,"B.PvsV.DORSEY_GAB2_TARGETS"
208,"Down",0.13750198706199,0.49643166412311,"B.PvsV.PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN"
147,"Down",0.13760130692615,0.49643166412311,"B.PvsV.RODRIGUES_THYROID_CARCINOMA_DN"
23,"Down",0.137688900788909,0.49643166412311,"B.PvsV.LIU_IL13_PRIMING_MODEL"
30,"Up",0.137733075197115,0.49643166412311,"B.PvsV.PID_INTEGRIN_A9B1_PATHWAY"
277,"Up",0.137974042060657,0.49697516676219,"B.PvsV.LU_AGING_BRAIN_DN"
57,"Up",0.138063638297472,0.49697516676219,"B.PvsV.SIG_CHEMOTAXIS"
63,"Up",0.13827110070758,0.497223630647266,"B.PvsV.NAKAMURA_METASTASIS_MODEL_DN"
27,"Up",0.138312523772019,0.497223630647266,"B.PvsV.MEISSNER_BRAIN_HCP_WITH_H3K4ME2"
88,"Up",0.138479598912169,0.497467897867104,"B.PvsV.ZHANG_PROLIFERATING_VS_QUIESCENT"
270,"Down",0.138560420096824,0.497467897867104,"B.PvsV.ONDER_CDH1_TARGETS_1_DN"
15,"Up",0.139173299307276,0.499344044042782,"B.PvsV.MARSON_FOXP3_TARGETS_STIMULATED_DN"
39,"Up",0.13926839739919,0.499361199234838,"B.PvsV.MCCABE_HOXC6_TARGETS_DN"
18,"Up",0.139801144637167,0.500754203409902,"B.PvsV.REACTOME_SHC1_EVENTS_IN_ERBB4_SIGNALING"
43,"Down",0.139911675831817,0.500754203409902,"B.PvsV.LIU_VAV3_PROSTATE_CARCINOGENESIS_DN"
113,"Up",0.139936219892581,0.500754203409902,"B.PvsV.PID_PTP1B_PATHWAY"
10,"Down",0.140019171364028,0.500754203409902,"B.PvsV.REACTOME_REACTIONS_SPECIFIC_TO_THE_COMPLEX_N_GLYCAN_SYNTHESIS_PATHWAY"
138,"Up",0.140131949795803,0.500772036576754,"B.PvsV.HARRIS_HYPOXIA"
39,"Up",0.140205301613459,0.500772036576754,"B.PvsV.YIH_RESPONSE_TO_ARSENITE_C3"
292,"Down",0.140377097307352,0.500974585347047,"B.PvsV.GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP"
48,"Down",0.140499261536375,0.500974585347047,"B.PvsV.KEGG_NOTCH_SIGNALING_PATHWAY"
105,"Down",0.140599148419228,0.500974585347047,"B.PvsV.REACTOME_TELOMERE_MAINTENANCE"
60,"Up",0.140624445009697,0.500974585347047,"B.PvsV.CROONQUIST_NRAS_VS_STROMAL_STIMULATION_UP"
401,"Up",0.140866393264291,0.501082078204178,"B.PvsV.WELCSH_BRCA1_TARGETS_UP"
227,"Down",0.140952644033422,0.501082078204178,"B.PvsV.BROWNE_HCMV_INFECTION_10HR_UP"
18,"Down",0.14098486592454,0.501082078204178,"B.PvsV.PARK_OSTEOBLAST_DIFFERENTIATION_BY_PHENYLAMIL_UP"
94,"Up",0.141017130346482,0.501082078204178,"B.PvsV.NAKAMURA_ADIPOGENESIS_EARLY_UP"
48,"Down",0.141221846495306,0.50118354123796,"B.PvsV.REACTOME_LATE_ENDOSOMAL_MICROAUTOPHAGY"
85,"Down",0.141227685465799,0.50118354123796,"B.PvsV.WINTER_HYPOXIA_DN"
206,"Up",0.141317623582923,0.50118354123796,"B.PvsV.PECE_MAMMARY_STEM_CELL_UP"
55,"Up",0.141425975126293,0.501246292611071,"B.PvsV.NABA_BASEMENT_MEMBRANES"
26,"Up",0.141604137566849,0.50155623101032,"B.PvsV.BALLIF_DEVELOPMENTAL_DISABILITY_P16_P12_DELETION"
36,"Down",0.141716961732211,0.501589965103649,"B.PvsV.REACTOME_THE_CANONICAL_RETINOID_CYCLE_IN_RODS_TWILIGHT_VISION"
138,"Down",0.141795101366794,0.501589965103649,"B.PvsV.BONCI_TARGETS_OF_MIR15A_AND_MIR16_1"
13,"Up",0.142139415164078,0.502373938384064,"B.PvsV.BIOCARTA_PLCE_PATHWAY"
23,"Up",0.142277739154938,0.502373938384064,"B.PvsV.REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB"
7,"Down",0.142300311941687,0.502373938384064,"B.PvsV.PETRETTO_LEFT_VENTRICLE_MASS_QTL_CIS_UP"
357,"Up",0.142578149767365,0.502373938384064,"B.PvsV.REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION"
933,"Up",0.142648469199974,0.502373938384064,"B.PvsV.FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP"
12,"Up",0.142680049752006,0.502373938384064,"B.PvsV.REACTOME_ACTIVATED_NTRK2_SIGNALS_THROUGH_PI3K"
24,"Down",0.142715174739033,0.502373938384064,"B.PvsV.REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_BETA_CELLS"
35,"Down",0.142743616784475,0.502373938384064,"B.PvsV.MARKS_HDAC_TARGETS_UP"
4,"Up",0.142837681659769,0.502385204768998,"B.PvsV.REACTOME_ORGANIC_ANION_TRANSPORT"
12,"Up",0.143088151283296,0.502946210073327,"B.PvsV.REACTOME_INTEGRATION_OF_PROVIRUS"
240,"Down",0.1432819417911,0.503307405440274,"B.PvsV.GARCIA_TARGETS_OF_FLI1_AND_DAX1_DN"
79,"Up",0.143495557775829,0.503737739011149,"B.PvsV.HOLLERN_MICROACINAR_BREAST_TUMOR_UP"
85,"Up",0.143595773303757,0.503769689464765,"B.PvsV.HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_DN"
35,"Up",0.143759632105787,0.504024734250409,"B.PvsV.SCHMIDT_POR_TARGETS_IN_LIMB_BUD_UP"
105,"Up",0.144229597269488,0.505351991953737,"B.PvsV.PID_AVB3_INTEGRIN_PATHWAY"
79,"Up",0.144476179923756,0.505895376059815,"B.PvsV.HOLLERN_SOLID_NODULAR_BREAST_TUMOR_DN"
40,"Down",0.145211915179274,0.508149796852029,"B.PvsV.STAMBOLSKY_BOUND_BY_MUTATED_TP53"
291,"Down",0.145712615398402,0.509352682324508,"B.PvsV.DARWICHE_PAPILLOMA_RISK_LOW_DN"
516,"Up",0.145859813011556,0.509352682324508,"B.PvsV.LI_INDUCED_T_TO_NATURAL_KILLER_UP"
17,"Up",0.145896359375884,0.509352682324508,"B.PvsV.REACTOME_GLYCOGEN_BREAKDOWN_GLYCOGENOLYSIS"
33,"Up",0.145924154241639,0.509352682324508,"B.PvsV.HAEGERSTRAND_RESPONSE_TO_IMATINIB"
84,"Up",0.146072642998415,0.509540005171195,"B.PvsV.GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN"
17,"Down",0.146162135684846,0.509540005171195,"B.PvsV.PID_ERBB_NETWORK_PATHWAY"
18,"Up",0.146294976943317,0.509681743868684,"B.PvsV.REACTOME_GLYCOGEN_SYNTHESIS"
60,"Down",0.146664577605598,0.510647638275412,"B.PvsV.PID_NFAT_TFPATHWAY"
12,"Down",0.147357189257647,0.512404579376631,"B.PvsV.TCGA_GLIOBLASTOMA_MUTATED"
16,"Down",0.147373178392722,0.512404579376631,"B.PvsV.KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_UV_IN_WS"
243,"Up",0.147656382195965,0.512404579376631,"B.PvsV.ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP"
19,"Down",0.147725791703537,0.512404579376631,"B.PvsV.REACTOME_TRANSCRIPTION_OF_E2F_TARGETS_UNDER_NEGATIVE_CONTROL_BY_P107_RBL1_AND_P130_RBL2_IN_COMPLEX_WITH_HDAC1"
21,"Down",0.147761367333311,0.512404579376631,"B.PvsV.REACTOME_P75NTR_SIGNALS_VIA_NF_KB"
60,"Down",0.14779852398128,0.512404579376631,"B.PvsV.REACTOME_AGGREPHAGY"
130,"Down",0.147873537505867,0.512404579376631,"B.PvsV.SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER"
89,"Up",0.148101856914777,0.512404579376631,"B.PvsV.GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_UP"
13,"Down",0.148185384847832,0.512404579376631,"B.PvsV.REACTOME_IONOTROPIC_ACTIVITY_OF_KAINATE_RECEPTORS"
31,"Down",0.148202475631831,0.512404579376631,"B.PvsV.REACTOME_RECYCLING_OF_BILE_ACIDS_AND_SALTS"
944,"Down",0.148242644766137,0.512404579376631,"B.PvsV.MIKKELSEN_MEF_HCP_WITH_H3K27ME3"
35,"Down",0.148281303491157,0.512404579376631,"B.PvsV.REACTOME_GAP_JUNCTION_ASSEMBLY"
57,"Down",0.14858155083814,0.512833287851564,"B.PvsV.WAKASUGI_HAVE_ZNF143_BINDING_SITES"
59,"Down",0.148590871249449,0.512833287851564,"B.PvsV.NIKOLSKY_BREAST_CANCER_12Q13_Q21_AMPLICON"
14,"Down",0.148919721581605,0.51344074861508,"B.PvsV.REACTOME_REGULATION_BY_C_FLIP"
105,"Up",0.148952606398732,0.51344074861508,"B.PvsV.SESTO_RESPONSE_TO_UV_C7"
213,"Down",0.149347239188666,0.514480302476096,"B.PvsV.BROWNE_HCMV_INFECTION_8HR_UP"
173,"Up",0.150098808969351,0.516146395135143,"B.PvsV.KIM_WT1_TARGETS_8HR_DN"
7,"Down",0.150102373838112,0.516146395135143,"B.PvsV.CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_HD_MTX_UP"
96,"Up",0.150152411042711,0.516146395135143,"B.PvsV.PID_BCR_5PATHWAY"
37,"Up",0.150259241840497,0.516146395135143,"B.PvsV.BIOCARTA_IL2_PATHWAY"
19,"Down",0.150369894596436,0.516146395135143,"B.PvsV.REACTOME_TRANSPORT_OF_CONNEXONS_TO_THE_PLASMA_MEMBRANE"
230,"Up",0.150391000644369,0.516146395135143,"B.PvsV.KEGG_CHEMOKINE_SIGNALING_PATHWAY"
18,"Up",0.150824241550137,0.517312178368925,"B.PvsV.MALIK_REPRESSED_BY_ESTROGEN"
32,"Down",0.150995952163278,0.517439861805445,"B.PvsV.BIOCARTA_RAC1_PATHWAY"
195,"Down",0.151048641156446,0.517439861805445,"B.PvsV.REACTOME_ESTROGEN_DEPENDENT_GENE_EXPRESSION"
88,"Up",0.151384312859429,0.518268647554045,"B.PvsV.DORN_ADENOVIRUS_INFECTION_32HR_DN"
38,"Up",0.151614540001479,0.518351215490203,"B.PvsV.BIOCARTA_INSULIN_PATHWAY"
28,"Up",0.151683847726371,0.518351215490203,"B.PvsV.KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS"
126,"Down",0.151689684692195,0.518351215490203,"B.PvsV.NADERI_BREAST_CANCER_PROGNOSIS_UP"
10,"Down",0.151879178313923,0.518678182148042,"B.PvsV.REACTOME_DISEASES_OF_DNA_REPAIR"
25,"Down",0.152049145508213,0.518733256606086,"B.PvsV.LEE_LIVER_CANCER_HEPATOBLAST"
254,"Up",0.152313826826286,0.518733256606086,"B.PvsV.MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_UP"
256,"Down",0.152338891965862,0.518733256606086,"B.PvsV.BROWNE_HCMV_INFECTION_6HR_DN"
91,"Down",0.152443933293028,0.518733256606086,"B.PvsV.PID_ATF2_PATHWAY"
25,"Up",0.152682773602715,0.518733256606086,"B.PvsV.VERRECCHIA_RESPONSE_TO_TGFB1_C3"
70,"Down",0.152887105098151,0.518733256606086,"B.PvsV.REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK"
73,"Up",0.153003944451104,0.518733256606086,"B.PvsV.SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_UP"
133,"Down",0.153011923193734,0.518733256606086,"B.PvsV.SMID_BREAST_CANCER_LUMINAL_A_UP"
40,"Down",0.153081135321379,0.518733256606086,"B.PvsV.LY_AGING_MIDDLE_DN"
6,"Down",0.153091656174045,0.518733256606086,"B.PvsV.SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX2_UP"
51,"Down",0.15318113666545,0.518733256606086,"B.PvsV.REACTOME_RNA_POLYMERASE_I_TRANSCRIPTION_INITIATION"
61,"Up",0.15331486438541,0.518733256606086,"B.PvsV.KEGG_ENDOMETRIAL_CANCER"
48,"Up",0.153384646114248,0.518733256606086,"B.PvsV.LI_PROSTATE_CANCER_EPIGENETIC"
10,"Down",0.15341032135135,0.518733256606086,"B.PvsV.BIOCARTA_FLUMAZENIL_PATHWAY"
45,"Up",0.153413043475209,0.518733256606086,"B.PvsV.PID_REELIN_PATHWAY"
45,"Up",0.153463662398972,0.518733256606086,"B.PvsV.REACTOME_GABA_B_RECEPTOR_ACTIVATION"
21,"Up",0.153538190253522,0.518733256606086,"B.PvsV.REACTOME_PROSTACYCLIN_SIGNALLING_THROUGH_PROSTACYCLIN_RECEPTOR"
79,"Down",0.15358407326174,0.518733256606086,"B.PvsV.CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN"
45,"Down",0.153856569251597,0.519103080654385,"B.PvsV.BILANGES_RAPAMYCIN_SENSITIVE_GENES"
12,"Down",0.153987143596463,0.519103080654385,"B.PvsV.REACTOME_SYNTHESIS_OF_15_EICOSATETRAENOIC_ACID_DERIVATIVES"
614,"Up",0.154027210222043,0.519103080654385,"B.PvsV.RUTELLA_RESPONSE_TO_HGF_UP"
32,"Up",0.154069118349402,0.519103080654385,"B.PvsV.BIOCARTA_EPO_PATHWAY"
29,"Down",0.154261298769437,0.519243336140433,"B.PvsV.AMIT_EGF_RESPONSE_20_MCF10A"
8,"Down",0.154298571401471,0.519243336140433,"B.PvsV.SA_G2_AND_M_PHASES"
243,"Up",0.154551480707325,0.519778063765693,"B.PvsV.KEGG_REGULATION_OF_ACTIN_CYTOSKELETON"
14,"Up",0.155006123024234,0.520990184924613,"B.PvsV.BIOCARTA_ASBCELL_PATHWAY"
5,"Down",0.155260181462788,0.521527061547848,"B.PvsV.NAKAMURA_ALVEOLAR_EPITHELIUM"
39,"Down",0.155416312168326,0.521734541577824,"B.PvsV.BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_UP"
305,"Up",0.155730744089411,0.522472866547545,"B.PvsV.WIERENGA_STAT5A_TARGETS_DN"
58,"Down",0.156098758714906,0.523389955691157,"B.PvsV.KEGG_LINOLEIC_ACID_METABOLISM"
95,"Up",0.156359683887313,0.523787703553422,"B.PvsV.FAELT_B_CLL_WITH_VH_REARRANGEMENTS_DN"
42,"Up",0.156406854506547,0.523787703553422,"B.PvsV.PID_IGF1_PATHWAY"
137,"Up",0.156665633473469,0.524336735759571,"B.PvsV.KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS"
99,"Up",0.157375579905203,0.526095324735941,"B.PvsV.LEE_LIVER_CANCER_MYC_E2F1_DN"
6,"Down",0.157381383091562,0.526095324735941,"B.PvsV.REACTOME_SENSING_OF_DNA_DOUBLE_STRAND_BREAKS"
13,"Up",0.157676552152252,0.526763538882055,"B.PvsV.LIU_TARGETS_OF_VMYB_VS_CMYB_UP"
59,"Down",0.157871822218938,0.52709740643026,"B.PvsV.VALK_AML_CLUSTER_15"
9,"Up",0.15806677120671,0.527429799639047,"B.PvsV.CASTELLANO_HRAS_TARGETS_UP"
611,"Up",0.158174536229726,0.527471055979586,"B.PvsV.GRUETZMANN_PANCREATIC_CANCER_UP"
679,"Up",0.158492381802339,0.528212404451558,"B.PvsV.HSIAO_HOUSEKEEPING_GENES"
11,"Down",0.158752136380369,0.528408012615963,"B.PvsV.REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_DIFFERENTIATION_OF_MYELOID_CELLS"
106,"Up",0.15882970633201,0.528408012615963,"B.PvsV.KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450"
25,"Down",0.159002851828385,0.528408012615963,"B.PvsV.REACTOME_SIGNALING_BY_CYTOSOLIC_FGFR1_FUSION_MUTANTS"
103,"Down",0.159182176975318,0.528408012615963,"B.PvsV.FIGUEROA_AML_METHYLATION_CLUSTER_2_UP"
317,"Down",0.159295235789686,0.528408012615963,"B.PvsV.BROWNE_HCMV_INFECTION_14HR_UP"
8,"Down",0.159303963738449,0.528408012615963,"B.PvsV.REACTOME_GLYCEROPHOSPHOLIPID_CATABOLISM"
26,"Down",0.159339282303596,0.528408012615963,"B.PvsV.PID_BETA_CATENIN_DEG_PATHWAY"
11,"Down",0.159469502681092,0.528408012615963,"B.PvsV.REACTOME_REGULATION_OF_FOXO_TRANSCRIPTIONAL_ACTIVITY_BY_ACETYLATION"
1483,"Down",0.159500454802335,0.528408012615963,"B.PvsV.BENPORATH_SUZ12_TARGETS"
13,"Up",0.159585939577136,0.528408012615963,"B.PvsV.REACTOME_INTERLEUKIN_35_SIGNALLING"
397,"Down",0.159746934125832,0.528408012615963,"B.PvsV.BASAKI_YBX1_TARGETS_UP"
99,"Down",0.15975204086285,0.528408012615963,"B.PvsV.LINDSTEDT_DENDRITIC_CELL_MATURATION_C"
54,"Up",0.159793488351219,0.528408012615963,"B.PvsV.WANG_RESPONSE_TO_BEXAROTENE_DN"
52,"Up",0.160472594345767,0.530336505760757,"B.PvsV.REACTOME_TRANSCRIPTIONAL_REGULATION_BY_VENTX"
51,"Down",0.16062585746282,0.530468382557545,"B.PvsV.REACTOME_GROWTH_HORMONE_RECEPTOR_SIGNALING"
67,"Up",0.160772814151037,0.530468382557545,"B.PvsV.PID_NCADHERIN_PATHWAY"
13,"Up",0.160836487132014,0.530468382557545,"B.PvsV.REACTOME_LINOLEIC_ACID_LA_METABOLISM"
30,"Down",0.160896270130042,0.530468382557545,"B.PvsV.BIOCARTA_TEL_PATHWAY"
118,"Up",0.161094238032796,0.530607229475498,"B.PvsV.KEGG_DRUG_METABOLISM_CYTOCHROME_P450"
34,"Up",0.161130319820829,0.530607229475498,"B.PvsV.REACTOME_CD209_DC_SIGN_SIGNALING"
9,"Up",0.161776171365176,0.532366531036164,"B.PvsV.BIOCARTA_HBX_PATHWAY"
338,"Down",0.161857142100161,0.532366531036164,"B.PvsV.MIKKELSEN_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3"
187,"Up",0.162164229362703,0.533059467387862,"B.PvsV.TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP"
209,"Down",0.162388538100506,0.533233736606864,"B.PvsV.SANSOM_APC_TARGETS_UP"
66,"Up",0.162424331658065,0.533233736606864,"B.PvsV.LEE_LIVER_CANCER_MYC_UP"
35,"Up",0.162506573735317,0.533233736606864,"B.PvsV.PID_PDGFRA_PATHWAY"
59,"Down",0.162619817641813,0.533288832586943,"B.PvsV.REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES"
105,"Up",0.163062541083957,0.533515813816869,"B.PvsV.LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_DN"
10,"Down",0.163116919410684,0.533515813816869,"B.PvsV.RANKIN_ANGIOGENIC_TARGETS_OF_VHL_HIF2A_UP"
105,"Down",0.163154282033895,0.533515813816869,"B.PvsV.KEGG_PYRIMIDINE_METABOLISM"
886,"Up",0.163287440663597,0.533515813816869,"B.PvsV.SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_DN"
306,"Up",0.163311367318891,0.533515813816869,"B.PvsV.ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP"
74,"Up",0.163336074470576,0.533515813816869,"B.PvsV.BOYAULT_LIVER_CANCER_SUBCLASS_G3_DN"
30,"Down",0.163441650612302,0.533515813816869,"B.PvsV.REACTOME_CONSTITUTIVE_SIGNALING_BY_LIGAND_RESPONSIVE_EGFR_CANCER_VARIANTS"
7,"Down",0.163460985459536,0.533515813816869,"B.PvsV.REACTOME_CATION_COUPLED_CHLORIDE_COTRANSPORTERS"
66,"Up",0.164115473718546,0.535335961173947,"B.PvsV.KEGG_PATHOGENIC_ESCHERICHIA_COLI_INFECTION"
36,"Up",0.164238422565856,0.535421131112393,"B.PvsV.GROSS_HIF1A_TARGETS_DN"
9,"Down",0.164417051270527,0.535687611358128,"B.PvsV.GLINSKY_CANCER_DEATH_UP"
50,"Down",0.164572204975226,0.535796559815114,"B.PvsV.RIZ_ERYTHROID_DIFFERENTIATION_APOBEC2"
24,"Up",0.164701155420614,0.535796559815114,"B.PvsV.BIOCARTA_VITCB_PATHWAY"
224,"Down",0.164741210288604,0.535796559815114,"B.PvsV.PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_UP"
12,"Up",0.164861957620658,0.535874052724643,"B.PvsV.OHM_EMBRYONIC_CARCINOMA_UP"
49,"Down",0.16507918496979,0.53587689907618,"B.PvsV.REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT"
47,"Up",0.165084095518994,0.53587689907618,"B.PvsV.SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_DN"
31,"Down",0.165311678781959,0.53587689907618,"B.PvsV.JEON_SMAD6_TARGETS_DN"
52,"Up",0.16536930184246,0.53587689907618,"B.PvsV.WANG_RESPONSE_TO_BEXAROTENE_UP"
20,"Up",0.16537629599029,0.53587689907618,"B.PvsV.WU_HBX_TARGETS_3_DN"
16,"Up",0.165444360051192,0.53587689907618,"B.PvsV.REACTOME_PI3K_AKT_ACTIVATION"
167,"Up",0.166218925011023,0.538070513106526,"B.PvsV.BOYLAN_MULTIPLE_MYELOMA_PCA3_UP"
16,"Down",0.166478396271033,0.538595115847011,"B.PvsV.REACTOME_FGFR2C_LIGAND_BINDING_AND_ACTIVATION"
19,"Up",0.166663829024022,0.538879713844339,"B.PvsV.REACTOME_TRAFFICKING_OF_GLUR2_CONTAINING_AMPA_RECEPTORS"
125,"Up",0.166835100072344,0.539118216423139,"B.PvsV.ZHENG_GLIOBLASTOMA_PLASTICITY_DN"
11,"Up",0.166948995093357,0.539171141279888,"B.PvsV.KIM_RESPONSE_TO_TSA_AND_DECITABINE_DN"
45,"Up",0.167153514578946,0.539516510278455,"B.PvsV.REACTOME_ENDOSOMAL_VACUOLAR_PATHWAY"
125,"Down",0.167262756439108,0.539535664409045,"B.PvsV.TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP"
45,"Down",0.167354614661152,0.539535664409045,"B.PvsV.REACTOME_NS1_MEDIATED_EFFECTS_ON_HOST_PATHWAYS"
114,"Up",0.167658185945001,0.540199364854259,"B.PvsV.REACTOME_TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE"
8,"Up",0.167819671237872,0.540399651952236,"B.PvsV.IWANAGA_E2F1_TARGETS_NOT_INDUCED_BY_SERUM"
48,"Up",0.168031772241882,0.540399651952236,"B.PvsV.WORSCHECH_TUMOR_EVASION_AND_TOLEROGENICITY_UP"
211,"Down",0.168076874091723,0.540399651952236,"B.PvsV.WELCSH_BRCA1_TARGETS_DN"
161,"Up",0.168118875226446,0.540399651952236,"B.PvsV.SESTO_RESPONSE_TO_UV_C8"
66,"Down",0.16820904340926,0.540399651952236,"B.PvsV.KEGG_TYPE_II_DIABETES_MELLITUS"
17,"Up",0.168475620591055,0.540511942709943,"B.PvsV.ZHENG_FOXP3_TARGETS_DN"
402,"Up",0.168511549167918,0.540511942709943,"B.PvsV.REACTOME_SIGNALING_BY_WNT"
16,"Up",0.168690728487712,0.540511942709943,"B.PvsV.HOEGERKORP_CD44_TARGETS_TEMPORAL_UP"
28,"Up",0.168945336886735,0.540511942709943,"B.PvsV.REACTOME_SULFUR_AMINO_ACID_METABOLISM"
61,"Up",0.168951593665802,0.540511942709943,"B.PvsV.PID_CERAMIDE_PATHWAY"
118,"Down",0.168957856681493,0.540511942709943,"B.PvsV.GENTILE_UV_LOW_DOSE_DN"
23,"Up",0.169007879802011,0.540511942709943,"B.PvsV.REACTOME_PLATELET_SENSITIZATION_BY_LDL"
95,"Down",0.169052809122727,0.540511942709943,"B.PvsV.DIRMEIER_LMP1_RESPONSE_EARLY"
32,"Down",0.169166226916016,0.540511942709943,"B.PvsV.REACTOME_RNA_POLYMERASE_I_TRANSCRIPTION_TERMINATION"
203,"Up",0.169313423093063,0.540511942709943,"B.PvsV.REACTOME_ER_TO_GOLGI_ANTEROGRADE_TRANSPORT"
101,"Down",0.169319349751062,0.540511942709943,"B.PvsV.TURASHVILI_BREAST_NORMAL_DUCTAL_VS_LOBULAR_UP"
23,"Down",0.169489094956984,0.540741607626754,"B.PvsV.GRASEMANN_RETINOBLASTOMA_WITH_6P_AMPLIFICATION"
54,"Down",0.17039449128134,0.542618924268155,"B.PvsV.VANDESLUIS_COMMD1_TARGETS_GROUP_3_DN"
160,"Up",0.17065959881152,0.542618924268155,"B.PvsV.REACTOME_PTEN_REGULATION"
68,"Up",0.170775964738502,0.542618924268155,"B.PvsV.KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY"
232,"Down",0.170833672254956,0.542618924268155,"B.PvsV.BROWNE_HCMV_INFECTION_12HR_UP"
84,"Up",0.170863706022512,0.542618924268155,"B.PvsV.KEGG_PANCREATIC_CANCER"
26,"Up",0.170951981272566,0.542618924268155,"B.PvsV.REACTOME_SYNTHESIS_SECRETION_AND_INACTIVATION_OF_GLUCAGON_LIKE_PEPTIDE_1_GLP_1"
7,"Up",0.171031594131859,0.542618924268155,"B.PvsV.REACTOME_APOBEC3G_MEDIATED_RESISTANCE_TO_HIV_1_INFECTION"
143,"Down",0.171157970071482,0.542618924268155,"B.PvsV.LIU_COMMON_CANCER_GENES"
14,"Up",0.171333961304971,0.542618924268155,"B.PvsV.REACTOME_RUNX3_REGULATES_WNT_SIGNALING"
23,"Up",0.171351487222903,0.542618924268155,"B.PvsV.REACTOME_DEFECTS_IN_VITAMIN_AND_COFACTOR_METABOLISM"
162,"Down",0.171380163954442,0.542618924268155,"B.PvsV.MARZEC_IL2_SIGNALING_UP"
18,"Up",0.171420822063892,0.542618924268155,"B.PvsV.MARIADASON_RESPONSE_TO_CURCUMIN_SULINDAC_7"
17,"Up",0.171486246944395,0.542618924268155,"B.PvsV.BIOCARTA_IL10_PATHWAY"
40,"Up",0.171655675506325,0.542618924268155,"B.PvsV.PARK_TRETINOIN_RESPONSE_AND_RARA_PLZF_FUSION"
40,"Down",0.171726881756989,0.542618924268155,"B.PvsV.REACTOME_CARBOXYTERMINAL_POST_TRANSLATIONAL_MODIFICATIONS_OF_TUBULIN"
23,"Down",0.171825432027355,0.542618924268155,"B.PvsV.REACTOME_NEGATIVE_REGULATION_OF_TCF_DEPENDENT_SIGNALING_BY_WNT_LIGAND_ANTAGONISTS"
153,"Up",0.171876577622568,0.542618924268155,"B.PvsV.REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION"
289,"Up",0.171902763713678,0.542618924268155,"B.PvsV.KRIEG_KDM3A_TARGETS_NOT_HYPOXIA"
48,"Down",0.171942187614,0.542618924268155,"B.PvsV.MILICIC_FAMILIAL_ADENOMATOUS_POLYPOSIS_UP"
24,"Down",0.172112539964731,0.542846681953792,"B.PvsV.LEE_METASTASIS_AND_RNA_PROCESSING_UP"
51,"Up",0.172263207997895,0.54301213057033,"B.PvsV.KEGG_AMINO_SUGAR_AND_NUCLEOTIDE_SUGAR_METABOLISM"
13,"Down",0.172459796523557,0.54332205981695,"B.PvsV.REACTOME_RNF_MUTANTS_SHOW_ENHANCED_WNT_SIGNALING_AND_PROLIFERATION"
91,"Up",0.172609205607001,0.543324031756687,"B.PvsV.PID_TCR_PATHWAY"
46,"Down",0.172749756789535,0.543324031756687,"B.PvsV.REACTOME_DUAL_INCISION_IN_GG_NER"
82,"Up",0.172755226592197,0.543324031756687,"B.PvsV.DAIRKEE_CANCER_PRONE_RESPONSE_BPA"
100,"Down",0.172942377011932,0.543378474068484,"B.PvsV.REACTOME_G_ALPHA_12_13_SIGNALLING_EVENTS"
13,"Up",0.172969092848713,0.543378474068484,"B.PvsV.BIOCARTA_RNA_PATHWAY"
64,"Down",0.173095778270525,0.543467664995874,"B.PvsV.POS_HISTAMINE_RESPONSE_NETWORK"
584,"Down",0.173311523723704,0.54383621717841,"B.PvsV.MIKKELSEN_NPC_HCP_WITH_H3K27ME3"
9,"Down",0.173420329533634,0.543868974470484,"B.PvsV.REACTOME_RRNA_MODIFICATION_IN_THE_MITOCHONDRION"
7,"Down",0.173809223161645,0.544779588923319,"B.PvsV.GAVIN_IL2_RESPONSIVE_FOXP3_TARGETS_DN"
19,"Down",0.173987456641054,0.54502926219172,"B.PvsV.KEGG_PANTOTHENATE_AND_COA_BIOSYNTHESIS"
8,"Down",0.174225904210155,0.54546717122194,"B.PvsV.REACTOME_POLB_DEPENDENT_LONG_PATCH_BASE_EXCISION_REPAIR"
88,"Down",0.174487152012681,0.545803891440184,"B.PvsV.GALE_APL_WITH_FLT3_MUTATED_UP"
9,"Up",0.174530888056836,0.545803891440184,"B.PvsV.REACTOME_ACTIVATED_NTRK2_SIGNALS_THROUGH_CDK5"
83,"Up",0.174899378473328,0.546366653532411,"B.PvsV.CHEN_HOXA5_TARGETS_9HR_DN"
599,"Down",0.1749084783419,0.546366653532411,"B.PvsV.IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR"
226,"Down",0.175104814261322,0.546671099972247,"B.PvsV.REACTOME_SUMOYLATION"
94,"Down",0.175330893486978,0.547068007951186,"B.PvsV.GERHOLD_ADIPOGENESIS_DN"
41,"Down",0.175620066028186,0.54766122113358,"B.PvsV.MAYBURD_RESPONSE_TO_L663536_UP"
249,"Up",0.175789235459156,0.547879753581551,"B.PvsV.AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_UP"
651,"Down",0.17603984185569,0.548123430664526,"B.PvsV.TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C"
99,"Up",0.176255879149726,0.548123430664526,"B.PvsV.NUTT_GBM_VS_AO_GLIOMA_UP"
8,"Up",0.176367297916035,0.548123430664526,"B.PvsV.CHENG_TAF7L_TARGETS"
36,"Down",0.176492800337214,0.548123430664526,"B.PvsV.WANG_BARRETTS_ESOPHAGUS_DN"
59,"Down",0.176496676770489,0.548123430664526,"B.PvsV.REACTOME_TRANSCRIPTIONAL_REGULATION_OF_PLURIPOTENT_STEM_CELLS"
317,"Down",0.176497311192885,0.548123430664526,"B.PvsV.FISCHER_G1_S_CELL_CYCLE"
53,"Down",0.176561372764247,0.548123430664526,"B.PvsV.BRACHAT_RESPONSE_TO_CAMPTOTHECIN_UP"
46,"Up",0.176807568990793,0.548516269085032,"B.PvsV.REACTOME_PLASMA_LIPOPROTEIN_CLEARANCE"
18,"Down",0.177004472511365,0.548516269085032,"B.PvsV.CROONQUIST_STROMAL_STIMULATION_DN"
30,"Down",0.177070167138794,0.548516269085032,"B.PvsV.REACTOME_CALNEXIN_CALRETICULIN_CYCLE"
181,"Up",0.177084742325336,0.548516269085032,"B.PvsV.ONDER_CDH1_SIGNALING_VIA_CTNNB1"
57,"Up",0.17761513465334,0.549851108341722,"B.PvsV.WESTON_VEGFA_TARGETS_12HR"
18,"Down",0.177874821878626,0.549963001253733,"B.PvsV.SHIN_B_CELL_LYMPHOMA_CLUSTER_1"
27,"Down",0.178037833395592,0.549963001253733,"B.PvsV.ABE_VEGFA_TARGETS"
26,"Up",0.178087493575144,0.549963001253733,"B.PvsV.NIKOLSKY_BREAST_CANCER_6P24_P22_AMPLICON"
245,"Up",0.178103034883146,0.549963001253733,"B.PvsV.JOHNSTONE_PARVB_TARGETS_2_UP"
13,"Down",0.1781782673187,0.549963001253733,"B.PvsV.ZHENG_FOXP3_TARGETS_IN_T_LYMPHOCYTE_UP"
185,"Up",0.178248091562071,0.549963001253733,"B.PvsV.REACTOME_AMYLOID_FIBER_FORMATION"
22,"Up",0.178389599166986,0.550092634575719,"B.PvsV.REACTOME_YAP1_AND_WWTR1_TAZ_STIMULATED_GENE_EXPRESSION"
222,"Up",0.178751952075776,0.55090275531046,"B.PvsV.DER_IFN_BETA_RESPONSE_UP"
34,"Up",0.178916298478343,0.551102069240535,"B.PvsV.FARMER_BREAST_CANCER_CLUSTER_7"
127,"Down",0.179156578432433,0.551534923247729,"B.PvsV.WANG_PROSTATE_CANCER_ANDROGEN_INDEPENDENT"
43,"Down",0.179811400504187,0.553099941024124,"B.PvsV.WEST_ADRENOCORTICAL_TUMOR_MARKERS_DN"
40,"Up",0.179865019707248,0.553099941024124,"B.PvsV.REACTOME_MAPK_TARGETS_NUCLEAR_EVENTS_MEDIATED_BY_MAP_KINASES"
17,"Down",0.17997781753325,0.553139162390963,"B.PvsV.REACTOME_ELEVATION_OF_CYTOSOLIC_CA2_LEVELS"
10,"Down",0.180146387168301,0.553349652585297,"B.PvsV.REACTOME_MULTIFUNCTIONAL_ANION_EXCHANGERS"
16,"Down",0.180347039789589,0.553404206884624,"B.PvsV.BIOCARTA_PRC2_PATHWAY"
87,"Down",0.180364330042701,0.553404206884624,"B.PvsV.REACTOME_TRANSCRIPTION_COUPLED_NUCLEOTIDE_EXCISION_REPAIR_TC_NER"
11,"Down",0.180639337135251,0.55364496454734,"B.PvsV.BIOCARTA_SKP2E2F_PATHWAY"
265,"Up",0.180750079427459,0.55364496454734,"B.PvsV.BROWNE_HCMV_INFECTION_24HR_DN"
11,"Down",0.180791676312961,0.55364496454734,"B.PvsV.SMID_BREAST_CANCER_RELAPSE_IN_PLEURA_UP"
62,"Up",0.180843336222191,0.55364496454734,"B.PvsV.KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_UP"
405,"Down",0.181135215786944,0.554068947004718,"B.PvsV.WANG_CLIM2_TARGETS_UP"
253,"Up",0.181182249264701,0.554068947004718,"B.PvsV.ELVIDGE_HYPOXIA_UP"
65,"Up",0.18149895074553,0.554254566249067,"B.PvsV.REACTOME_GABA_RECEPTOR_ACTIVATION"
24,"Up",0.181499394526242,0.554254566249067,"B.PvsV.CASTELLANO_NRAS_TARGETS_DN"
21,"Up",0.1815436823073,0.554254566249067,"B.PvsV.REACTOME_IL_6_TYPE_CYTOKINE_RECEPTOR_LIGAND_INTERACTIONS"
735,"Up",0.181884207999024,0.554987740632785,"B.PvsV.BAELDE_DIABETIC_NEPHROPATHY_DN"
73,"Down",0.182038164563374,0.555151137270212,"B.PvsV.JAEGER_METASTASIS_UP"
17,"Up",0.182313281998967,0.555315642028846,"B.PvsV.SANDERSON_PPARA_TARGETS"
35,"Down",0.182356648016905,0.555315642028846,"B.PvsV.JIANG_TIP30_TARGETS_DN"
829,"Up",0.182393417602529,0.555315642028846,"B.PvsV.LIU_PROSTATE_CANCER_DN"
73,"Up",0.182811876104936,0.55628335882454,"B.PvsV.URS_ADIPOCYTE_DIFFERENTIATION_DN"
325,"Up",0.183090243932719,0.556823959683171,"B.PvsV.REACTOME_DEUBIQUITINATION"
67,"Up",0.183612831382414,0.557849933003958,"B.PvsV.HAN_JNK_SINGALING_DN"
33,"Down",0.183629386519661,0.557849933003958,"B.PvsV.GAZIN_EPIGENETIC_SILENCING_BY_KRAS"
108,"Up",0.183799304998019,0.557870149829971,"B.PvsV.HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_DN"
8,"Up",0.183837839209659,0.557870149829971,"B.PvsV.FARDIN_HYPOXIA_9"
201,"Down",0.184449454134293,0.559230649141143,"B.PvsV.STEIN_ESRRA_TARGETS_DN"
22,"Up",0.184488461572336,0.559230649141143,"B.PvsV.MIKKELSEN_IPS_LCP_WITH_H3K27ME3"
172,"Up",0.185194685180994,0.561063788693542,"B.PvsV.REACTOME_SIGNALING_BY_NTRKS"
36,"Up",0.18534350675713,0.561207146144671,"B.PvsV.HOLLEMAN_ASPARAGINASE_RESISTANCE_B_ALL_DN"
17,"Down",0.185842930135774,0.562411363284453,"B.PvsV.CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_LD_MTX_UP"
77,"Up",0.186199623818226,0.56318256022482,"B.PvsV.DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_DN"
731,"Up",0.186337362434625,0.563212346072125,"B.PvsV.TIEN_INTESTINE_PROBIOTICS_24HR_UP"
12,"Up",0.186483486303032,0.563212346072125,"B.PvsV.BOYAULT_LIVER_CANCER_SUBCLASS_G23_DN"
12,"Up",0.186515067038897,0.563212346072125,"B.PvsV.REACTOME_P2Y_RECEPTORS"
21,"Down",0.186673296576106,0.563382454568389,"B.PvsV.REACTOME_PI_3K_CASCADE_FGFR3"
37,"Up",0.187209475597393,0.56469241166284,"B.PvsV.BURTON_ADIPOGENESIS_10"
36,"Down",0.187339665223252,0.564694479046671,"B.PvsV.KONDO_COLON_CANCER_HCP_WITH_H3K27ME1"
14,"Down",0.187450618120111,0.564694479046671,"B.PvsV.BRUNEAU_HEART_GREAT_VESSELS_AND_VALVULOGENESIS"
165,"Down",0.187704050822165,0.564694479046671,"B.PvsV.HELLER_SILENCED_BY_METHYLATION_DN"
18,"Down",0.187753030244435,0.564694479046671,"B.PvsV.FINETTI_BREAST_CANCER_KINOME_RED"
21,"Up",0.187810814518199,0.564694479046671,"B.PvsV.BIOCARTA_NDKDYNAMIN_PATHWAY"
28,"Up",0.187822960203803,0.564694479046671,"B.PvsV.REACTOME_G_BETA_GAMMA_SIGNALLING_THROUGH_PI3KGAMMA"
93,"Up",0.188034914658887,0.565024479972275,"B.PvsV.ULE_SPLICING_VIA_NOVA2"
35,"Down",0.188437623563703,0.565715138404496,"B.PvsV.BIOCARTA_VDR_PATHWAY"
31,"Down",0.188497656897614,0.565715138404496,"B.PvsV.MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_DN"
106,"Up",0.188571712801499,0.565715138404496,"B.PvsV.GUO_HEX_TARGETS_DN"
48,"Down",0.188691250743732,0.565766770803738,"B.PvsV.PIEPOLI_LGI1_TARGETS_DN"
61,"Up",0.188862442671269,0.565973141208372,"B.PvsV.HASLINGER_B_CLL_WITH_11Q23_DELETION"
65,"Up",0.189002562241859,0.566086222445959,"B.PvsV.REACTOME_IRON_UPTAKE_AND_TRANSPORT"
47,"Up",0.189123135843268,0.566140670318045,"B.PvsV.PID_IL8_CXCR1_PATHWAY"
45,"Up",0.189605017612182,0.566969249528262,"B.PvsV.NABA_COLLAGENS"
45,"Up",0.189605017612182,0.566969249528262,"B.PvsV.REACTOME_COLLAGEN_CHAIN_TRIMERIZATION"
15,"Down",0.189735836194472,0.567006602930134,"B.PvsV.GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_1_DN"
109,"Up",0.18982261204986,0.567006602930134,"B.PvsV.THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP"
654,"Up",0.190045875188037,0.567366978355647,"B.PvsV.THUM_SYSTOLIC_HEART_FAILURE_UP"
352,"Up",0.190214234891275,0.567483387736005,"B.PvsV.ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_UP"
76,"Up",0.190290143038986,0.567483387736005,"B.PvsV.REACTOME_DAP12_SIGNALING"
109,"Up",0.190507333620784,0.567816134966623,"B.PvsV.REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS"
16,"Up",0.190673771804492,0.567816134966623,"B.PvsV.REACTOME_PYRIMIDINE_CATABOLISM"
22,"Up",0.190709814185751,0.567816134966623,"B.PvsV.REACTOME_REGULATION_OF_KIT_SIGNALING"
34,"Down",0.191455906894732,0.569216491943891,"B.PvsV.RUNNE_GENDER_EFFECT_UP"
252,"Down",0.191475628183109,0.569216491943891,"B.PvsV.REACTOME_CILIUM_ASSEMBLY"
879,"Down",0.191488998917641,0.569216491943891,"B.PvsV.MEISSNER_NPC_HCP_WITH_H3_UNMETHYLATED"
8,"Down",0.191699796094361,0.569536900916563,"B.PvsV.REACTOME_CHREBP_ACTIVATES_METABOLIC_GENE_EXPRESSION"
159,"Up",0.192199291062866,0.570652087137946,"B.PvsV.REACTOME_TOLL_LIKE_RECEPTOR_4_TLR4_CASCADE"
86,"Up",0.192341829847655,0.570652087137946,"B.PvsV.CUI_TCF21_TARGETS_UP"
48,"Down",0.192394734332216,0.570652087137946,"B.PvsV.REACTOME_NR1H3_NR1H2_REGULATE_GENE_EXPRESSION_LINKED_TO_CHOLESTEROL_TRANSPORT_AND_EFFLUX"
99,"Up",0.192487998284006,0.570652087137946,"B.PvsV.REACTOME_PLATELET_HOMEOSTASIS"
256,"Down",0.192933778238069,0.571317742672859,"B.PvsV.MEISSNER_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3"
52,"Down",0.193008659235698,0.571317742672859,"B.PvsV.FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_UP"
29,"Down",0.19315439992795,0.571317742672859,"B.PvsV.ITO_PTTG1_TARGETS_UP"
333,"Down",0.193170351691177,0.571317742672859,"B.PvsV.BILD_MYC_ONCOGENIC_SIGNATURE"
8,"Down",0.193365857226734,0.571317742672859,"B.PvsV.REACTOME_DNA_REPLICATION_INITIATION"
35,"Down",0.193439705230306,0.571317742672859,"B.PvsV.PID_RXR_VDR_PATHWAY"
97,"Up",0.193499865516385,0.571317742672859,"B.PvsV.REACTOME_COLLAGEN_DEGRADATION"
29,"Down",0.193586620401701,0.571317742672859,"B.PvsV.REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR3"
166,"Up",0.193642512166565,0.571317742672859,"B.PvsV.HUMMERICH_SKIN_CANCER_PROGRESSION_UP"
9,"Down",0.194093071399323,0.572341648942323,"B.PvsV.PALOMERO_GSI_SENSITIVITY_UP"
269,"Down",0.194224074054895,0.572422657489081,"B.PvsV.RIGGI_EWING_SARCOMA_PROGENITOR_DN"
29,"Up",0.194433329237797,0.57273408489919,"B.PvsV.BIOCARTA_BARR_MAPK_PATHWAY"
113,"Up",0.194665727850004,0.573113316976929,"B.PvsV.CROMER_TUMORIGENESIS_UP"
132,"Up",0.195143244695738,0.574213411347917,"B.PvsV.MILI_PSEUDOPODIA"
154,"Up",0.195561582653923,0.574900048104555,"B.PvsV.LEE_LIVER_CANCER_DENA_DN"
26,"Up",0.195584552447941,0.574900048104555,"B.PvsV.BIOCARTA_PTEN_PATHWAY"
31,"Down",0.196220847487655,0.576463903166441,"B.PvsV.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_PURPLE_DN"
117,"Up",0.196663524862621,0.577457583093697,"B.PvsV.LINDSTEDT_DENDRITIC_CELL_MATURATION_D"
13,"Down",0.19709542408791,0.578001242102196,"B.PvsV.HOLLERN_SOLID_NODULAR_BREAST_TUMOR_UP"
207,"Up",0.197142511210189,0.578001242102196,"B.PvsV.GOLDRATH_HOMEOSTATIC_PROLIFERATION"
30,"Down",0.197162297450668,0.578001242102196,"B.PvsV.REACTOME_CRMPS_IN_SEMA3A_SIGNALING"
128,"Up",0.197556187443567,0.578849051603328,"B.PvsV.URS_ADIPOCYTE_DIFFERENTIATION_UP"
63,"Down",0.197735628730938,0.579067950875718,"B.PvsV.REACTOME_SIGNALING_BY_TYPE_1_INSULIN_LIKE_GROWTH_FACTOR_1_RECEPTOR_IGF1R"
29,"Down",0.197843606825495,0.579070680747515,"B.PvsV.REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY"
74,"Down",0.197946027602243,0.579070680747515,"B.PvsV.LIEN_BREAST_CARCINOMA_METAPLASTIC"
113,"Down",0.198142848027933,0.579228059122377,"B.PvsV.JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN"
26,"Down",0.198306665055011,0.579228059122377,"B.PvsV.BIOCARTA_HIF_PATHWAY"
92,"Up",0.198314110312653,0.579228059122377,"B.PvsV.JIANG_AGING_CEREBRAL_CORTEX_DN"
34,"Down",0.198892975356821,0.580612070088629,"B.PvsV.LAMB_CCND1_TARGETS"
94,"Up",0.199144333580733,0.581039060880145,"B.PvsV.ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_DN"
25,"Up",0.199295010271531,0.581131976490902,"B.PvsV.ONDER_CDH1_TARGETS_3_UP"
26,"Down",0.199386391644645,0.581131976490902,"B.PvsV.SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_UP"
61,"Down",0.199739567903291,0.581629880268279,"B.PvsV.GENTILE_RESPONSE_CLUSTER_D3"
22,"Down",0.199896667455624,0.581629880268279,"B.PvsV.SARTIPY_NORMAL_AT_INSULIN_RESISTANCE_DN"
114,"Down",0.199926053104757,0.581629880268279,"B.PvsV.REACTOME_O_LINKED_GLYCOSYLATION"
34,"Down",0.200061364728598,0.581629880268279,"B.PvsV.KANG_CISPLATIN_RESISTANCE_UP"
21,"Up",0.200223014514831,0.581629880268279,"B.PvsV.MARIADASON_RESPONSE_TO_BUTYRATE_CURCUMIN_SULINDAC_TSA_1"
100,"Up",0.200243428253195,0.581629880268279,"B.PvsV.LEE_LIVER_CANCER_MYC_TGFA_DN"
13,"Up",0.200293595954206,0.581629880268279,"B.PvsV.POS_RESPONSE_TO_HISTAMINE_DN"
8,"Down",0.201285317704957,0.584202898472811,"B.PvsV.TERAMOTO_OPN_TARGETS_CLUSTER_5"
19,"Down",0.201485908229726,0.584478272089272,"B.PvsV.BIOCARTA_EFP_PATHWAY"
101,"Up",0.20222272059241,0.586308034690842,"B.PvsV.MARTINEZ_RESPONSE_TO_TRABECTEDIN_UP"
357,"Up",0.202459571342211,0.586687091169332,"B.PvsV.JISON_SICKLE_CELL_DISEASE_UP"
190,"Up",0.202780833039462,0.58674346961514,"B.PvsV.MCBRYAN_PUBERTAL_BREAST_5_6WK_UP"
5,"Up",0.202789549220698,0.58674346961514,"B.PvsV.REACTOME_DISINHIBITION_OF_SNARE_FORMATION"
9,"Up",0.202878594722025,0.58674346961514,"B.PvsV.SHARMA_PILOCYTIC_ASTROCYTOMA_LOCATION_DN"
24,"Up",0.202903511286697,0.58674346961514,"B.PvsV.KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_CHONDROITIN_SULFATE"
127,"Down",0.203225804560898,0.587368255837537,"B.PvsV.PID_SMAD2_3NUCLEAR_PATHWAY"
71,"Up",0.203612401911062,0.58747826806804,"B.PvsV.TSAI_RESPONSE_TO_RADIATION_THERAPY"
9,"Up",0.20361554263765,0.58747826806804,"B.PvsV.BIOCARTA_IFNG_PATHWAY"
12,"Up",0.20364930278224,0.58747826806804,"B.PvsV.REACTOME_ACTIVATION_OF_PPARGC1A_PGC_1ALPHA_BY_PHOSPHORYLATION"
89,"Up",0.203721827592357,0.58747826806804,"B.PvsV.ZHAN_V2_LATE_DIFFERENTIATION_GENES"
61,"Down",0.203894951065809,0.58747826806804,"B.PvsV.LIU_CDX2_TARGETS_UP"
116,"Up",0.203959185395241,0.58747826806804,"B.PvsV.ZHAN_MULTIPLE_MYELOMA_DN"
5,"Down",0.204110352884337,0.58747826806804,"B.PvsV.REACTOME_FASL_CD95L_SIGNALING"
46,"Up",0.204119924735506,0.58747826806804,"B.PvsV.RAY_TARGETS_OF_P210_BCR_ABL_FUSION_UP"
18,"Up",0.204220153956732,0.58747826806804,"B.PvsV.REACTOME_LOSS_OF_FUNCTION_OF_MECP2_IN_RETT_SYNDROME"
65,"Up",0.204460530237581,0.587592321786257,"B.PvsV.ZHANG_INTERFERON_RESPONSE"
19,"Down",0.204472350717446,0.587592321786257,"B.PvsV.BIOCARTA_SET_PATHWAY"
6,"Up",0.204625784846311,0.587727773722209,"B.PvsV.MIKI_COEXPRESSED_WITH_CYP19A1"
92,"Up",0.204800445556329,0.587924020498932,"B.PvsV.PID_NOTCH_PATHWAY"
13,"Down",0.205178984527304,0.588705036560178,"B.PvsV.TESAR_ALK_TARGETS_EPISC_3D_UP"
31,"Down",0.205441004942806,0.589151097680898,"B.PvsV.ALONSO_METASTASIS_NEURAL_UP"
30,"Up",0.205648176239823,0.589333685382169,"B.PvsV.CHOI_ATL_CHRONIC_VS_ACUTE_DN"
308,"Down",0.205717853642175,0.589333685382169,"B.PvsV.PLASARI_TGFB1_TARGETS_10HR_UP"
33,"Down",0.205921348792733,0.58961115353445,"B.PvsV.PID_BARD1_PATHWAY"
54,"Down",0.206389382076016,0.590645390009468,"B.PvsV.BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_DN"
5,"Up",0.207152744810541,0.591878243653084,"B.PvsV.REACTOME_EXTRINSIC_PATHWAY_OF_FIBRIN_CLOT_FORMATION"
131,"Up",0.207165755086284,0.591878243653084,"B.PvsV.KEGG_T_CELL_RECEPTOR_SIGNALING_PATHWAY"
39,"Down",0.207232249728185,0.591878243653084,"B.PvsV.REACTOME_NOTCH3_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION"
14,"Down",0.207307467517958,0.591878243653084,"B.PvsV.CHEOK_RESPONSE_TO_MERCAPTOPURINE_UP"
377,"Up",0.207408681622156,0.591878243653084,"B.PvsV.QI_PLASMACYTOMA_UP"
42,"Down",0.207462477156751,0.591878243653084,"B.PvsV.REACTOME_ACTIVATED_NOTCH1_TRANSMITS_SIGNAL_TO_THE_NUCLEUS"
303,"Down",0.207620021943052,0.592022228634932,"B.PvsV.ZWANG_EGF_INTERVAL_DN"
10,"Up",0.207842966721007,0.592352455154871,"B.PvsV.KONDO_HYPOXIA"
1122,"Down",0.208045090178573,0.592416084206884,"B.PvsV.RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP"
349,"Up",0.20807958682036,0.592416084206884,"B.PvsV.REACTOME_MAPK_FAMILY_SIGNALING_CASCADES"
421,"Down",0.208228825992241,0.592451000686473,"B.PvsV.FORTSCHEGGER_PHF8_TARGETS_UP"
14,"Down",0.208354087780446,0.592451000686473,"B.PvsV.REACTOME_LGI_ADAM_INTERACTIONS"
64,"Up",0.208526340176465,0.592451000686473,"B.PvsV.REACTOME_CARGO_TRAFFICKING_TO_THE_PERICILIARY_MEMBRANE"
89,"Up",0.20853772331688,0.592451000686473,"B.PvsV.DORN_ADENOVIRUS_INFECTION_48HR_DN"
62,"Down",0.208627617713251,0.592451000686473,"B.PvsV.AMIT_SERUM_RESPONSE_480_MCF10A"
66,"Down",0.208804209786273,0.592535013473717,"B.PvsV.EPPERT_CE_HSC_LSC"
41,"Up",0.20887153938511,0.592535013473717,"B.PvsV.LUI_THYROID_CANCER_CLUSTER_4"
56,"Up",0.209016703280595,0.59261580480403,"B.PvsV.KEGG_TYROSINE_METABOLISM"
63,"Down",0.209114385091818,0.59261580480403,"B.PvsV.SIMBULAN_UV_RESPONSE_NORMAL_DN"
7,"Down",0.209320260632667,0.592895348892428,"B.PvsV.REACTOME_GLI_PROTEINS_BIND_PROMOTERS_OF_HH_RESPONSIVE_GENES_TO_PROMOTE_TRANSCRIPTION"
358,"Up",0.209683758879993,0.593410807766641,"B.PvsV.BROWNE_HCMV_INFECTION_18HR_DN"
26,"Up",0.209716896070902,0.593410807766641,"B.PvsV.DORMOY_ELAVL1_TARGETS"
8,"Down",0.210094272099004,0.594162951007195,"B.PvsV.REACTOME_DEFECTIVE_CHST6_CAUSES_MCDC1"
415,"Up",0.210262278722338,0.594162951007195,"B.PvsV.REACTOME_RHO_GTPASE_EFFECTORS"
34,"Down",0.210474000161544,0.594162951007195,"B.PvsV.MAHADEVAN_IMATINIB_RESISTANCE_DN"
35,"Down",0.210482667736765,0.594162951007195,"B.PvsV.MASRI_RESISTANCE_TO_TAMOXIFEN_AND_AROMATASE_INHIBITORS_UP"
46,"Up",0.21053625196327,0.594162951007195,"B.PvsV.REACTOME_SYNTHESIS_OF_ACTIVE_UBIQUITIN_ROLES_OF_E1_AND_E2_ENZYMES"
13,"Up",0.210646075680882,0.594162951007195,"B.PvsV.REACTOME_ACETYLCHOLINE_REGULATES_INSULIN_SECRETION"
41,"Up",0.210806461657294,0.594162951007195,"B.PvsV.WU_ALZHEIMER_DISEASE_UP"
17,"Up",0.210940362469358,0.594162951007195,"B.PvsV.REACTOME_ERBB2_REGULATES_CELL_MOTILITY"
31,"Down",0.210949877523444,0.594162951007195,"B.PvsV.FERRARI_RESPONSE_TO_FENRETINIDE_UP"
125,"Up",0.211092315844332,0.594261412578062,"B.PvsV.FLORIO_HUMAN_NEOCORTEX"
42,"Down",0.211253690512574,0.594413055900265,"B.PvsV.REACTOME_INTERACTIONS_OF_VPR_WITH_HOST_CELLULAR_PROTEINS"
42,"Down",0.211541642689303,0.594920520055522,"B.PvsV.GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_UP"
113,"Up",0.211846664784104,0.595433235911887,"B.PvsV.BURTON_ADIPOGENESIS_11"
6,"Up",0.211939339532392,0.595433235911887,"B.PvsV.PASTURAL_RIZ1_TARGETS_DN"
27,"Up",0.212211542794552,0.59572881751373,"B.PvsV.BIOCARTA_CERAMIDE_PATHWAY"
74,"Up",0.212260041689645,0.59572881751373,"B.PvsV.KEGG_ACUTE_MYELOID_LEUKEMIA"
232,"Up",0.212612734295515,0.596320354492024,"B.PvsV.DER_IFN_GAMMA_RESPONSE_UP"
12,"Up",0.212774965026319,0.596320354492024,"B.PvsV.REACTOME_REGULATION_OF_GENE_EXPRESSION_BY_HYPOXIA_INDUCIBLE_FACTOR"
33,"Down",0.212847910044117,0.596320354492024,"B.PvsV.CHUANG_OXIDATIVE_STRESS_RESPONSE_DN"
22,"Down",0.212902220974363,0.596320354492024,"B.PvsV.PETRETTO_BLOOD_PRESSURE_UP"
28,"Down",0.213301483490229,0.597136153021506,"B.PvsV.MATZUK_OVULATION"
14,"Up",0.213485112246041,0.597321396005577,"B.PvsV.REACTOME_DEFECTS_IN_COBALAMIN_B12_METABOLISM"
185,"Up",0.213583722174539,0.597321396005577,"B.PvsV.GROSS_HYPOXIA_VIA_HIF1A_DN"
14,"Up",0.213922633183725,0.597924932318365,"B.PvsV.FUJIWARA_PARK2_HEPATOCYTE_PROLIFERATION_DN"
13,"Up",0.214015814986082,0.597924932318365,"B.PvsV.REACTOME_MITOCHONDRIAL_IRON_SULFUR_CLUSTER_BIOGENESIS"
303,"Down",0.21435121309346,0.598436578411932,"B.PvsV.REACTOME_CHROMATIN_MODIFYING_ENZYMES"
61,"Up",0.21441542084175,0.598436578411932,"B.PvsV.DORSAM_HOXA9_TARGETS_UP"
10,"Up",0.214617357716593,0.598697967111524,"B.PvsV.BIOCARTA_VOBESITY_PATHWAY"
207,"Down",0.214813755589357,0.598943648337646,"B.PvsV.WANG_HCP_PROSTATE_CANCER"
26,"Up",0.214924810939898,0.598951249842085,"B.PvsV.BIOCARTA_MEF2D_PATHWAY"
115,"Up",0.215115727646955,0.59916913918723,"B.PvsV.REACTOME_PROTEIN_FOLDING"
10,"Up",0.215219734206156,0.59916913918723,"B.PvsV.BIOCARTA_S1P_PATHWAY"
37,"Up",0.215523695035344,0.599713391973033,"B.PvsV.SHI_SPARC_TARGETS_UP"
15,"Up",0.215640916795916,0.599737740927877,"B.PvsV.YAMASHITA_SILENCED_BY_METHYLATION"
43,"Up",0.216170940089206,0.600909566492318,"B.PvsV.BIOCARTA_WNT_PATHWAY"
92,"Up",0.216417931552674,0.601055958972408,"B.PvsV.KEGG_ERBB_SIGNALING_PATHWAY"
47,"Up",0.21644102266487,0.601055958972408,"B.PvsV.BIOCARTA_PDGF_PATHWAY"
625,"Down",0.216616878345022,0.601094909324667,"B.PvsV.CUI_TCF21_TARGETS_2_UP"
328,"Up",0.216702363453706,0.601094909324667,"B.PvsV.BOYLAN_MULTIPLE_MYELOMA_PCA1_UP"
14,"Up",0.21679898364368,0.601094909324667,"B.PvsV.REACTOME_CHK1_CHK2_CDS1_MEDIATED_INACTIVATION_OF_CYCLIN_B_CDK1_COMPLEX"
61,"Up",0.216889915735705,0.601094909324667,"B.PvsV.XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_UP"
355,"Up",0.217318898248423,0.601982058324414,"B.PvsV.IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_UP"
13,"Up",0.217802382358419,0.60292905331063,"B.PvsV.SHIRAISHI_PLZF_TARGETS_UP"
110,"Up",0.218085120364178,0.60292905331063,"B.PvsV.POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_UP"
55,"Down",0.21827508776326,0.60292905331063,"B.PvsV.REACTOME_DNA_DAMAGE_BYPASS"
8,"Down",0.218297613061521,0.60292905331063,"B.PvsV.KIM_PTEN_TARGETS_DN"
78,"Up",0.218300816840208,0.60292905331063,"B.PvsV.KAAB_FAILED_HEART_VENTRICLE_DN"
114,"Down",0.218347805959945,0.60292905331063,"B.PvsV.AMIT_EGF_RESPONSE_120_HELA"
41,"Down",0.218607314636185,0.60292905331063,"B.PvsV.REACTOME_MISCELLANEOUS_SUBSTRATES"
32,"Down",0.218640708005523,0.60292905331063,"B.PvsV.LEE_SP4_THYMOCYTE"
30,"Up",0.218642205080089,0.60292905331063,"B.PvsV.WOTTON_RUNX_TARGETS_UP"
8,"Down",0.218882074479634,0.603289626020886,"B.PvsV.BIOCARTA_ION_PATHWAY"
20,"Down",0.219059852816519,0.603478787355524,"B.PvsV.ROETH_TERT_TARGETS_UP"
17,"Down",0.219538589947408,0.603935443616086,"B.PvsV.REACTOME_IRAK1_RECRUITS_IKK_COMPLEX"
33,"Up",0.219554070138824,0.603935443616086,"B.PvsV.BIOCARTA_HER2_PATHWAY"
160,"Up",0.219656194800301,0.603935443616086,"B.PvsV.TAKAO_RESPONSE_TO_UVB_RADIATION_DN"
135,"Up",0.21966253881569,0.603935443616086,"B.PvsV.PLASARI_TGFB1_SIGNALING_VIA_NFIC_10HR_UP"
10,"Down",0.220016228969164,0.604607221655322,"B.PvsV.REACTOME_E2F_ENABLED_INHIBITION_OF_PRE_REPLICATION_COMPLEX_FORMATION"
604,"Up",0.220433419466425,0.605452745270673,"B.PvsV.GRYDER_PAX3FOXO1_TOP_ENHANCERS"
175,"Up",0.220874955502313,0.60596716846074,"B.PvsV.HOSHIDA_LIVER_CANCER_SURVIVAL_DN"
278,"Down",0.220984380358951,0.60596716846074,"B.PvsV.FUJII_YBX1_TARGETS_DN"
38,"Up",0.221134439892012,0.60596716846074,"B.PvsV.VALK_AML_WITH_11Q23_REARRANGED"
153,"Up",0.221173108261558,0.60596716846074,"B.PvsV.CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP"
34,"Up",0.221178597038091,0.60596716846074,"B.PvsV.CREIGHTON_AKT1_SIGNALING_VIA_MTOR_DN"
28,"Down",0.221278298629451,0.60596716846074,"B.PvsV.TOMLINS_METASTASIS_DN"
74,"Down",0.221582210039471,0.606499029360512,"B.PvsV.FRASOR_TAMOXIFEN_RESPONSE_UP"
114,"Up",0.222076922753223,0.607552353242243,"B.PvsV.SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP"
63,"Up",0.222309416498311,0.607678431873676,"B.PvsV.REACTOME_CARGO_CONCENTRATION_IN_THE_ER"
31,"Down",0.222342822875827,0.607678431873676,"B.PvsV.GRANDVAUX_IRF3_TARGETS_UP"
40,"Down",0.222755443059275,0.607789383948772,"B.PvsV.CHOW_RASSF1_TARGETS_DN"
65,"Up",0.222801905405347,0.607789383948772,"B.PvsV.MMS_MOUSE_LYMPH_HIGH_4HRS_UP"
10,"Down",0.222832571824102,0.607789383948772,"B.PvsV.TESAR_ALK_TARGETS_HUMAN_ES_5D_UP"
18,"Up",0.222859714952682,0.607789383948772,"B.PvsV.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_1"
52,"Up",0.222933056727819,0.607789383948772,"B.PvsV.REACTOME_DIGESTION_AND_ABSORPTION"
160,"Up",0.223158582978476,0.608042033579822,"B.PvsV.HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS"
46,"Up",0.223245673388866,0.608042033579822,"B.PvsV.PID_ANTHRAX_PATHWAY"
70,"Down",0.22342698277021,0.608236232268089,"B.PvsV.WANG_TARGETS_OF_MLL_CBP_FUSION_UP"
21,"Up",0.223987443630758,0.609044594411855,"B.PvsV.WHITESIDE_CISPLATIN_RESISTANCE_UP"
10,"Up",0.224047142168252,0.609044594411855,"B.PvsV.WEBER_METHYLATED_LCP_IN_SPERM_DN"
12,"Down",0.224054386875332,0.609044594411855,"B.PvsV.WANG_THOC1_TARGETS_UP"
48,"Down",0.22447538807983,0.609426768516018,"B.PvsV.WILLIAMS_ESR1_TARGETS_UP"
29,"Up",0.224520865659722,0.609426768516018,"B.PvsV.REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_CYCLIN_B"
41,"Down",0.224525651558533,0.609426768516018,"B.PvsV.REACTOME_PERK_REGULATES_GENE_EXPRESSION"
48,"Down",0.225041839622166,0.610528131143747,"B.PvsV.GHANDHI_DIRECT_IRRADIATION_DN"
8,"Down",0.225227497795227,0.610732140907213,"B.PvsV.REACTOME_RELAXIN_RECEPTORS"
64,"Down",0.225351725374988,0.610769455685446,"B.PvsV.BYSTROEM_CORRELATED_WITH_IL5_UP"
757,"Up",0.225661701733336,0.611309921060076,"B.PvsV.CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN"
591,"Up",0.226205062664982,0.611932396281243,"B.PvsV.WANG_TUMOR_INVASIVENESS_UP"
1060,"Up",0.226214496076828,0.611932396281243,"B.PvsV.MARTINEZ_RB1_AND_TP53_TARGETS_UP"
22,"Up",0.226284985961728,0.611932396281243,"B.PvsV.LANDIS_ERBB2_BREAST_PRENEOPLASTIC_UP"
1149,"Down",0.22633419251133,0.611932396281243,"B.PvsV.SMID_BREAST_CANCER_BASAL_DN"
8,"Down",0.226495326093601,0.612068747786667,"B.PvsV.REACTOME_HDL_CLEARANCE"
216,"Up",0.226758983936386,0.612481886753432,"B.PvsV.WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_36HR"
5,"Down",0.227063552247655,0.613005068543597,"B.PvsV.WILSON_PROTEASES_AT_TUMOR_BONE_INTERFACE_DN"
21,"Down",0.227318098587447,0.613392760902877,"B.PvsV.NIKOLSKY_BREAST_CANCER_21Q22_AMPLICON"
390,"Down",0.227447799107046,0.613443356713589,"B.PvsV.ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP"
107,"Down",0.22780828846791,0.614116054090237,"B.PvsV.KYNG_RESPONSE_TO_H2O2"
205,"Up",0.228039394118609,0.614258233040404,"B.PvsV.ODONNELL_METASTASIS_UP"
10,"Down",0.228083225254467,0.614258233040404,"B.PvsV.MIKKELSEN_DEDIFFERENTIATED_STATE_UP"
219,"Down",0.228494572867341,0.615016007807623,"B.PvsV.XU_GH1_AUTOCRINE_TARGETS_DN"
515,"Down",0.228587067470549,0.615016007807623,"B.PvsV.SENGUPTA_NASOPHARYNGEAL_CARCINOMA_DN"
450,"Down",0.228891493048309,0.615327883996299,"B.PvsV.ZHOU_INFLAMMATORY_RESPONSE_FIMA_DN"
25,"Down",0.229120615440138,0.615327883996299,"B.PvsV.HOLLERN_PAPILLARY_BREAST_TUMOR"
162,"Up",0.229151994780923,0.615327883996299,"B.PvsV.DASU_IL6_SIGNALING_UP"
18,"Down",0.229156428563839,0.615327883996299,"B.PvsV.LOPEZ_MESOTHELIOMA_SURVIVAL_OVERALL_UP"
128,"Up",0.229493640420304,0.615327883996299,"B.PvsV.REACTOME_HEDGEHOG_OFF_STATE"
346,"Up",0.229685555725772,0.615327883996299,"B.PvsV.REACTOME_TRANSLATION"
13,"Down",0.229820019260341,0.615327883996299,"B.PvsV.KUMAMOTO_RESPONSE_TO_NUTLIN_3A_DN"
725,"Down",0.229821500121917,0.615327883996299,"B.PvsV.PEDRIOLI_MIR31_TARGETS_DN"
6,"Down",0.22982816278995,0.615327883996299,"B.PvsV.REACTOME_ASSEMBLY_OF_THE_ORC_COMPLEX_AT_THE_ORIGIN_OF_REPLICATION"
9,"Up",0.229927620633085,0.615327883996299,"B.PvsV.CALVET_IRINOTECAN_SENSITIVE_VS_REVERTED_UP"
26,"Up",0.229929332086374,0.615327883996299,"B.PvsV.REACTOME_PRESYNAPTIC_FUNCTION_OF_KAINATE_RECEPTORS"
31,"Down",0.230038476437032,0.615327883996299,"B.PvsV.REACTOME_POSTMITOTIC_NUCLEAR_PORE_COMPLEX_NPC_REFORMATION"
7,"Down",0.230343938381502,0.615673592158102,"B.PvsV.ZERBINI_RESPONSE_TO_SULINDAC_DN"
17,"Down",0.230469308338365,0.615673592158102,"B.PvsV.ONGUSAHA_BRCA1_TARGETS_UP"
28,"Down",0.230512304640226,0.615673592158102,"B.PvsV.REACTOME_REGULATION_OF_FZD_BY_UBIQUITINATION"
19,"Up",0.230613132457846,0.615673592158102,"B.PvsV.REACTOME_CARNITINE_METABOLISM"
86,"Down",0.231542248749278,0.617776803120942,"B.PvsV.PID_HNF3A_PATHWAY"
109,"Up",0.231624400953104,0.617776803120942,"B.PvsV.LEE_LIVER_CANCER_MYC_E2F1_UP"
407,"Up",0.232126910360468,0.61881855707957,"B.PvsV.REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES"
178,"Down",0.232349210194229,0.619112666585007,"B.PvsV.LINDGREN_BLADDER_CANCER_WITH_LOH_IN_CHR9Q"
128,"Up",0.232657331709548,0.619422905941927,"B.PvsV.BOYLAN_MULTIPLE_MYELOMA_D_UP"
22,"Up",0.233025511645983,0.619422905941927,"B.PvsV.BIOCARTA_TOB1_PATHWAY"
211,"Up",0.233153962554733,0.619422905941927,"B.PvsV.SCHLOSSER_MYC_TARGETS_REPRESSED_BY_SERUM"
34,"Up",0.233225149003395,0.619422905941927,"B.PvsV.WILLIAMS_ESR2_TARGETS_UP"
886,"Down",0.23325187281128,0.619422905941927,"B.PvsV.FEVR_CTNNB1_TARGETS_DN"
22,"Down",0.233384853566259,0.619422905941927,"B.PvsV.BIOCARTA_PRION_PATHWAY"
9,"Up",0.233438704870533,0.619422905941927,"B.PvsV.DER_IFN_GAMMA_RESPONSE_DN"
9,"Down",0.2334387073503,0.619422905941927,"B.PvsV.ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_2HR"
168,"Up",0.233558424175339,0.619422905941927,"B.PvsV.KANG_IMMORTALIZED_BY_TERT_UP"
24,"Down",0.233646680491006,0.619422905941927,"B.PvsV.REACTOME_CONSTITUTIVE_SIGNALING_BY_EGFRVIII"
17,"Down",0.233707743131938,0.619422905941927,"B.PvsV.REACTOME_INTERLEUKIN_2_SIGNALING"
135,"Up",0.233902760279366,0.619422905941927,"B.PvsV.LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP"
50,"Down",0.233922052379588,0.619422905941927,"B.PvsV.WU_ALZHEIMER_DISEASE_DN"
58,"Up",0.234128815892132,0.619487849476919,"B.PvsV.EPPERT_LSC_R"
17,"Down",0.234226966556062,0.619487849476919,"B.PvsV.FUKUSHIMA_TNFSF11_TARGETS"
204,"Up",0.234282708130989,0.619487849476919,"B.PvsV.GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_UP"
28,"Up",0.234428639838066,0.619577413797642,"B.PvsV.PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_3"
180,"Up",0.234573753046913,0.619607020163976,"B.PvsV.KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY"
93,"Up",0.234885540031035,0.619607020163976,"B.PvsV.WEIGEL_OXIDATIVE_STRESS_BY_TBH_AND_H2O2"
97,"Down",0.234936784679231,0.619607020163976,"B.PvsV.ABRAMSON_INTERACT_WITH_AIRE"
81,"Up",0.234991275989705,0.619607020163976,"B.PvsV.DAZARD_UV_RESPONSE_CLUSTER_G2"
166,"Down",0.235034509563057,0.619607020163976,"B.PvsV.KESHELAVA_MULTIPLE_DRUG_RESISTANCE"
104,"Down",0.235112231561588,0.619607020163976,"B.PvsV.STEIN_ESR1_TARGETS"
170,"Up",0.235347558888681,0.619700195320964,"B.PvsV.JI_RESPONSE_TO_FSH_UP"
36,"Up",0.235735435781903,0.619700195320964,"B.PvsV.BIOCARTA_INTRINSIC_PATHWAY"
39,"Down",0.235899043056386,0.619700195320964,"B.PvsV.REACTOME_N_GLYCAN_TRIMMING_IN_THE_ER_AND_CALNEXIN_CALRETICULIN_CYCLE"
36,"Down",0.236035341415535,0.619700195320964,"B.PvsV.HOLLEMAN_ASPARAGINASE_RESISTANCE_ALL_UP"
26,"Down",0.23607824153835,0.619700195320964,"B.PvsV.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_UP"
63,"Up",0.236091565618613,0.619700195320964,"B.PvsV.REACTOME_G_PROTEIN_MEDIATED_EVENTS"
638,"Down",0.236153473931914,0.619700195320964,"B.PvsV.PEREZ_TP63_TARGETS"
21,"Up",0.236168396853089,0.619700195320964,"B.PvsV.BIOCARTA_MYOSIN_PATHWAY"
171,"Down",0.236198511737547,0.619700195320964,"B.PvsV.DOANE_BREAST_CANCER_ESR1_UP"
42,"Up",0.236309552133865,0.619700195320964,"B.PvsV.REACTOME_DISEASES_OF_CARBOHYDRATE_METABOLISM"
114,"Down",0.236380486875007,0.619700195320964,"B.PvsV.KEGG_ARACHIDONIC_ACID_METABOLISM"
21,"Down",0.236530996932459,0.619783925954556,"B.PvsV.REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_24_HYDROXYCHOLESTEROL"
27,"Up",0.23683202157448,0.619783925954556,"B.PvsV.REACTOME_SHC1_EVENTS_IN_ERBB2_SIGNALING"
43,"Down",0.236915449955426,0.619783925954556,"B.PvsV.NEWMAN_ERCC6_TARGETS_UP"
63,"Up",0.236967928530263,0.619783925954556,"B.PvsV.ZHAN_MULTIPLE_MYELOMA_LB_DN"
76,"Up",0.237067976057447,0.619783925954556,"B.PvsV.HAHTOLA_MYCOSIS_FUNGOIDES_UP"
14,"Down",0.23719641216701,0.619783925954556,"B.PvsV.BIOCARTA_RARRXR_PATHWAY"
41,"Up",0.237210743690668,0.619783925954556,"B.PvsV.REACTOME_INFECTION_WITH_MYCOBACTERIUM_TUBERCULOSIS"
334,"Down",0.237376791559428,0.619783925954556,"B.PvsV.VERHAAK_GLIOBLASTOMA_PRONEURAL"
23,"Up",0.237421297734084,0.619783925954556,"B.PvsV.REACTOME_ADP_SIGNALLING_THROUGH_P2Y_PURINOCEPTOR_12"
18,"Down",0.23758696397064,0.619784698209736,"B.PvsV.RANKIN_ANGIOGENIC_TARGETS_OF_VHL_HIF2A_DN"
51,"Up",0.237712591623593,0.619784698209736,"B.PvsV.PID_AVB3_OPN_PATHWAY"
69,"Up",0.237757884771722,0.619784698209736,"B.PvsV.REACTOME_SIGNALING_BY_PTK6"
36,"Up",0.237976397237317,0.619948969496853,"B.PvsV.AKL_HTLV1_INFECTION_UP"
13,"Up",0.238045155044641,0.619948969496853,"B.PvsV.REACTOME_SODIUM_CALCIUM_EXCHANGERS"
73,"Up",0.238489027310304,0.620691654049222,"B.PvsV.BILANGES_SERUM_SENSITIVE_VIA_TSC2"
116,"Up",0.238657113015861,0.620691654049222,"B.PvsV.REACTOME_INTERFERON_ALPHA_BETA_SIGNALING"
15,"Up",0.238752264463779,0.620691654049222,"B.PvsV.BIOCARTA_AKAP95_PATHWAY"
76,"Up",0.238779372067769,0.620691654049222,"B.PvsV.REACTOME_SIGNALING_BY_PDGF"
709,"Down",0.238924213689452,0.620776305210986,"B.PvsV.MIKKELSEN_MCV6_HCP_WITH_H3K27ME3"
67,"Down",0.239436430542416,0.621657974237738,"B.PvsV.BROWNE_HCMV_INFECTION_2HR_UP"
11,"Down",0.239488421979812,0.621657974237738,"B.PvsV.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_25"
59,"Up",0.239655088256628,0.621710151275389,"B.PvsV.GYORFFY_MITOXANTRONE_RESISTANCE"
134,"Up",0.239733413369349,0.621710151275389,"B.PvsV.CHICAS_RB1_TARGETS_LOW_SERUM"
21,"Up",0.240088322082551,0.621958117713552,"B.PvsV.KYNG_NORMAL_AGING_UP"
19,"Up",0.240112427644036,0.621958117713552,"B.PvsV.REACTOME_BUTYROPHILIN_BTN_FAMILY_INTERACTIONS"
633,"Up",0.240211718661619,0.621958117713552,"B.PvsV.WANG_SMARCE1_TARGETS_DN"
75,"Up",0.240338085142059,0.621958117713552,"B.PvsV.LIU_TARGETS_OF_VMYB_VS_CMYB_DN"
34,"Down",0.240391480838101,0.621958117713552,"B.PvsV.PID_WNT_SIGNALING_PATHWAY"
43,"Down",0.240690391002428,0.622175451463497,"B.PvsV.GROSS_ELK3_TARGETS_UP"
72,"Up",0.240745385554992,0.622175451463497,"B.PvsV.MOSERLE_IFNA_RESPONSE"
27,"Down",0.240813070380156,0.622175451463497,"B.PvsV.BIOCARTA_PML_PATHWAY"
200,"Up",0.240956865496247,0.622256193054064,"B.PvsV.REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2"
415,"Up",0.241485713118605,0.623058174127169,"B.PvsV.TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_UP"
48,"Up",0.241626769282209,0.623058174127169,"B.PvsV.KEGG_PRION_DISEASES"
389,"Down",0.241678548302799,0.623058174127169,"B.PvsV.CHICAS_RB1_TARGETS_GROWING"
86,"Up",0.24171817390175,0.623058174127169,"B.PvsV.REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS"
30,"Down",0.241998882302398,0.623491062558229,"B.PvsV.REACTOME_SEALING_OF_THE_NUCLEAR_ENVELOPE_NE_BY_ESCRT_III"
63,"Down",0.242574336742654,0.624594930191577,"B.PvsV.KORKOLA_EMBRYONAL_CARCINOMA_UP"
129,"Up",0.242653266422772,0.624594930191577,"B.PvsV.VERRECCHIA_EARLY_RESPONSE_TO_TGFB1"
13,"Up",0.242910728592529,0.624872075578707,"B.PvsV.REACTOME_RUNX2_REGULATES_GENES_INVOLVED_IN_CELL_MIGRATION"
15,"Up",0.243020850689132,0.624872075578707,"B.PvsV.REACTOME_APOPTOSIS_INDUCED_DNA_FRAGMENTATION"
203,"Up",0.243193185048059,0.624872075578707,"B.PvsV.MIKKELSEN_MEF_LCP_WITH_H3K4ME3"
14,"Down",0.24325436782952,0.624872075578707,"B.PvsV.REACTOME_PEXOPHAGY"
219,"Down",0.243326022557598,0.624872075578707,"B.PvsV.XU_GH1_EXOGENOUS_TARGETS_DN"
343,"Down",0.243556800137327,0.625174349099017,"B.PvsV.YEGNASUBRAMANIAN_PROSTATE_CANCER"
28,"Up",0.243962309118707,0.625771625320044,"B.PvsV.BIOCARTA_NTHI_PATHWAY"
27,"Up",0.244038864385094,0.625771625320044,"B.PvsV.LEIN_LOCALIZED_TO_DISTAL_AND_PROXIMAL_DENDRITES"
71,"Up",0.244146838966991,0.625771625320044,"B.PvsV.REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES"
104,"Up",0.244680952471237,0.625771625320044,"B.PvsV.MORI_IMMATURE_B_LYMPHOCYTE_UP"
78,"Up",0.2447630395956,0.625771625320044,"B.PvsV.PID_PS1_PATHWAY"
19,"Down",0.245017625782538,0.625771625320044,"B.PvsV.WILLIAMS_ESR2_TARGETS_DN"
110,"Up",0.245030675549841,0.625771625320044,"B.PvsV.STEARMAN_LUNG_CANCER_EARLY_VS_LATE_DN"
34,"Down",0.245081725747575,0.625771625320044,"B.PvsV.HUMMERICH_BENIGN_SKIN_TUMOR_UP"
47,"Down",0.245121070141427,0.625771625320044,"B.PvsV.PID_ATR_PATHWAY"
21,"Down",0.245223436140827,0.625771625320044,"B.PvsV.JOHANSSON_BRAIN_CANCER_EARLY_VS_LATE_UP"
22,"Down",0.245229716678647,0.625771625320044,"B.PvsV.KIM_PTEN_TARGETS_UP"
29,"Up",0.24553843909555,0.625771625320044,"B.PvsV.REACTOME_G_PROTEIN_ACTIVATION"
161,"Up",0.245587080757616,0.625771625320044,"B.PvsV.WANG_ESOPHAGUS_CANCER_VS_NORMAL_DN"
388,"Up",0.245615950494368,0.625771625320044,"B.PvsV.MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_DN"
101,"Up",0.245756587024555,0.625771625320044,"B.PvsV.REACTOME_PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES"
23,"Down",0.245759363484523,0.625771625320044,"B.PvsV.REACTOME_E2F_MEDIATED_REGULATION_OF_DNA_REPLICATION"
463,"Up",0.24576451216412,0.625771625320044,"B.PvsV.MARKEY_RB1_ACUTE_LOF_DN"
56,"Down",0.24588890906525,0.625771625320044,"B.PvsV.MCCABE_HOXC6_TARGETS_CANCER_UP"
8,"Down",0.245939906279699,0.625771625320044,"B.PvsV.LU_TUMOR_ENDOTHELIAL_MARKERS_DN"
58,"Up",0.246081375625235,0.625843572139799,"B.PvsV.SCHLINGEMANN_SKIN_CARCINOGENESIS_TPA_DN"
66,"Down",0.246223347754519,0.625916730912522,"B.PvsV.REACTOME_SIGNALING_BY_NOTCH1_PEST_DOMAIN_MUTANTS_IN_CANCER"
12,"Up",0.24636064577646,0.62597794600094,"B.PvsV.REACTOME_NETRIN_MEDIATED_REPULSION_SIGNALS"
37,"Down",0.247241261247426,0.627926933135976,"B.PvsV.IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_UP"
28,"Up",0.247554645144964,0.628434174934117,"B.PvsV.BIOCARTA_CDK5_PATHWAY"
74,"Down",0.247951146385758,0.629151853312003,"B.PvsV.KLEIN_TARGETS_OF_BCR_ABL1_FUSION"
209,"Up",0.248817543265673,0.630783854061801,"B.PvsV.LANDIS_ERBB2_BREAST_TUMORS_324_UP"
48,"Down",0.248822496963065,0.630783854061801,"B.PvsV.YANG_BREAST_CANCER_ESR1_BULK_UP"
74,"Down",0.25001462559743,0.633515520132077,"B.PvsV.NAKAJIMA_MAST_CELL"
39,"Up",0.250322955706826,0.633886259117297,"B.PvsV.BIOCARTA_RACCYCD_PATHWAY"
99,"Up",0.250390231490717,0.633886259117297,"B.PvsV.REACTOME_ECM_PROTEOGLYCANS"
522,"Down",0.250527817180222,0.633944302603865,"B.PvsV.BROWNE_HCMV_INFECTION_20HR_UP"
199,"Up",0.250937732148643,0.634540568377497,"B.PvsV.GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN"
29,"Up",0.251042014137671,0.634540568377497,"B.PvsV.BIOCARTA_ACE2_PATHWAY"
515,"Up",0.25116525882245,0.634540568377497,"B.PvsV.RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN"
10,"Up",0.251222518390006,0.634540568377497,"B.PvsV.MATZUK_CUMULUS_EXPANSION"
56,"Down",0.251407104948277,0.634716841670788,"B.PvsV.FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_UP"
37,"Up",0.251724058126037,0.635012501730638,"B.PvsV.YANAGIHARA_ESX1_TARGETS"
118,"Up",0.251851817522097,0.635012501730638,"B.PvsV.KEGG_OOCYTE_MEIOSIS"
23,"Up",0.251868767642483,0.635012501730638,"B.PvsV.REACTOME_SIGNALLING_TO_RAS"
302,"Up",0.252065145911935,0.635217954305875,"B.PvsV.MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP"
345,"Down",0.252222587166372,0.63532514097625,"B.PvsV.IVANOVA_HEMATOPOIESIS_STEM_CELL"
24,"Down",0.252362595341938,0.635388337725673,"B.PvsV.REACTOME_RNA_POLYMERASE_III_TRANSCRIPTION_TERMINATION"
187,"Up",0.252513190939895,0.635478121395849,"B.PvsV.ELVIDGE_HYPOXIA_DN"
37,"Down",0.25285854174167,0.636057723971654,"B.PvsV.HOFMANN_MYELODYSPLASTIC_SYNDROM_RISK_UP"
86,"Down",0.253689470548106,0.6377147550116,"B.PvsV.DIRMEIER_LMP1_RESPONSE_LATE_UP"
10,"Down",0.253747958224909,0.6377147550116,"B.PvsV.REACTOME_PHASE_3_RAPID_REPOLARISATION"
69,"Up",0.254145141452903,0.638422756516628,"B.PvsV.CERIBELLI_GENES_INACTIVE_AND_BOUND_BY_NFY"
129,"Down",0.254394151127182,0.638588994352228,"B.PvsV.HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_DN"
19,"Up",0.254473630941565,0.638588994352228,"B.PvsV.LI_CYTIDINE_ANALOGS_CYCTOTOXICITY"
37,"Up",0.254566876169381,0.638588994352228,"B.PvsV.REACTOME_UPTAKE_AND_ACTIONS_OF_BACTERIAL_TOXINS"
32,"Down",0.254906155749903,0.638588994352228,"B.PvsV.LE_NEURONAL_DIFFERENTIATION_UP"
752,"Up",0.254996161975034,0.638588994352228,"B.PvsV.REACTOME_MEMBRANE_TRAFFICKING"
55,"Up",0.255072290479886,0.638588994352228,"B.PvsV.HU_ANGIOGENESIS_DN"
9,"Down",0.255107564360385,0.638588994352228,"B.PvsV.KUWANO_RNA_STABILIZED_BY_NO"
141,"Up",0.255135302681149,0.638588994352228,"B.PvsV.HINATA_NFKB_TARGETS_KERATINOCYTE_UP"
20,"Up",0.255817051847137,0.639789340697578,"B.PvsV.YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_4"
684,"Down",0.255846307159042,0.639789340697578,"B.PvsV.KIM_WT1_TARGETS_DN"
30,"Up",0.256127936311054,0.640204050571345,"B.PvsV.SUZUKI_RESPONSE_TO_TSA_AND_DECITABINE_1B"
40,"Up",0.256415175468246,0.640632401791203,"B.PvsV.REACTOME_ROS_AND_RNS_PRODUCTION_IN_PHAGOCYTES"
29,"Up",0.256707197371098,0.640955888268014,"B.PvsV.REACTOME_INSULIN_RECEPTOR_RECYCLING"
763,"Down",0.256795456546775,0.640955888268014,"B.PvsV.CAIRO_HEPATOBLASTOMA_CLASSES_UP"
370,"Down",0.25689243053028,0.640955888268014,"B.PvsV.HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_UP"
62,"Down",0.257287639156969,0.641313104168867,"B.PvsV.REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS"
168,"Up",0.257359723106492,0.641313104168867,"B.PvsV.NAKAMURA_ADIPOGENESIS_LATE_UP"
36,"Down",0.257455894250146,0.641313104168867,"B.PvsV.NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_UP"
108,"Down",0.257558236399196,0.641313104168867,"B.PvsV.PID_MYC_ACTIV_PATHWAY"
101,"Down",0.25761555513819,0.641313104168867,"B.PvsV.XU_GH1_EXOGENOUS_TARGETS_UP"
137,"Down",0.258279309981039,0.642676104808806,"B.PvsV.REACTOME_SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE"
843,"Down",0.258438088709919,0.642781912945183,"B.PvsV.MCCABE_BOUND_BY_HOXC6"
153,"Up",0.258785500775294,0.643356579940018,"B.PvsV.CASTELLANO_NRAS_TARGETS_UP"
17,"Down",0.258953979526317,0.643486091146519,"B.PvsV.REACTOME_NF_KB_IS_ACTIVATED_AND_SIGNALS_SURVIVAL"
85,"Down",0.259087590867919,0.643528881360612,"B.PvsV.ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN"
164,"Up",0.259591820729199,0.644244453210153,"B.PvsV.ZHU_CMV_24_HR_DN"
20,"Up",0.259608725221961,0.644244453210153,"B.PvsV.BIOCARTA_PGC1A_PATHWAY"
9,"Down",0.259748340504405,0.644301738290201,"B.PvsV.BIOCARTA_PLK3_PATHWAY"
8,"Up",0.260238338182587,0.645130052767974,"B.PvsV.TSAI_DNAJB4_TARGETS_DN"
26,"Down",0.260315635327428,0.645130052767974,"B.PvsV.WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_UP"
645,"Up",0.260570795392953,0.64547308589948,"B.PvsV.MONNIER_POSTRADIATION_TUMOR_ESCAPE_DN"
48,"Down",0.26086065748296,0.645901735433625,"B.PvsV.PID_HIV_NEF_PATHWAY"
97,"Up",0.260999373929446,0.6459559258979,"B.PvsV.KEGG_ECM_RECEPTOR_INTERACTION"
1356,"Up",0.261202728326625,0.646138237248467,"B.PvsV.WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_8D"
24,"Down",0.26130676405997,0.646138237248467,"B.PvsV.HOLLEMAN_DAUNORUBICIN_B_ALL_UP"
15,"Down",0.261860672575476,0.646660754725319,"B.PvsV.DACOSTA_LOW_DOSE_UV_RESPONSE_VIA_ERCC3_XPCS_DN"
296,"Up",0.261862029093718,0.646660754725319,"B.PvsV.REACTOME_HIV_INFECTION"
84,"Up",0.261978678502075,0.646660754725319,"B.PvsV.REACTOME_INTERLEUKIN_17_SIGNALING"
140,"Up",0.26198590895003,0.646660754725319,"B.PvsV.KEGG_LYSOSOME"
9,"Up",0.262878832972465,0.648575219770085,"B.PvsV.MIKHAYLOVA_OXIDATIVE_STRESS_RESPONSE_VIA_VHL_UP"
120,"Down",0.26299899871419,0.648582276490079,"B.PvsV.BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_DN"
12,"Down",0.263238555693443,0.648788939346722,"B.PvsV.KREPPEL_CD99_TARGETS_DN"
82,"Up",0.263317485963835,0.648788939346722,"B.PvsV.LINDSTEDT_DENDRITIC_CELL_MATURATION_A"
59,"Down",0.263441833092534,0.648806189384687,"B.PvsV.PID_HDAC_CLASSIII_PATHWAY"
831,"Down",0.263564904430941,0.648820283436631,"B.PvsV.REACTOME_CELL_CYCLE"
17,"Down",0.263751573190357,0.64899085365798,"B.PvsV.OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_DN"
16,"Up",0.26418162348351,0.649759873772388,"B.PvsV.SHANK_TAL1_TARGETS_DN"
68,"Up",0.264605408001754,0.650512806065674,"B.PvsV.DIRMEIER_LMP1_RESPONSE_LATE_DN"
95,"Down",0.265294275311228,0.65191646586479,"B.PvsV.KEGG_COMPLEMENT_AND_COAGULATION_CASCADES"
82,"Up",0.265726088850476,0.652576809125155,"B.PvsV.AMIT_EGF_RESPONSE_240_HELA"
51,"Up",0.265837875819682,0.652576809125155,"B.PvsV.PID_EPO_PATHWAY"
8,"Up",0.265917082828536,0.652576809125155,"B.PvsV.TERAMOTO_OPN_TARGETS_CLUSTER_8"
172,"Up",0.266599659838246,0.653651662399627,"B.PvsV.YAMASHITA_LIVER_CANCER_STEM_CELL_DN"
31,"Up",0.266628098577519,0.653651662399627,"B.PvsV.KANG_DOXORUBICIN_RESISTANCE_DN"
21,"Down",0.266770097046159,0.653651662399627,"B.PvsV.REACTOME_FRS_MEDIATED_FGFR3_SIGNALING"
63,"Down",0.266933229575021,0.653651662399627,"B.PvsV.TSUNODA_CISPLATIN_RESISTANCE_DN"
8,"Down",0.267089849505063,0.653651662399627,"B.PvsV.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_30"
46,"Up",0.267270018304961,0.653651662399627,"B.PvsV.ZHAN_LATE_DIFFERENTIATION_GENES_UP"
17,"Up",0.267377810674756,0.653651662399627,"B.PvsV.REACTOME_ADVANCED_GLYCOSYLATION_ENDPRODUCT_RECEPTOR_SIGNALING"
8,"Up",0.267606613865266,0.653651662399627,"B.PvsV.ELVIDGE_HIF2A_TARGETS_UP"
25,"Up",0.267941860733965,0.653651662399627,"B.PvsV.KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS_AND_CYCLIC_RGD"
44,"Down",0.268000702607843,0.653651662399627,"B.PvsV.SHIN_B_CELL_LYMPHOMA_CLUSTER_3"
28,"Up",0.268096196802138,0.653651662399627,"B.PvsV.REACTOME_CYTOSOLIC_TRNA_AMINOACYLATION"
28,"Down",0.26855983503925,0.653651662399627,"B.PvsV.MARCINIAK_ER_STRESS_RESPONSE_VIA_CHOP"
168,"Down",0.268570242230852,0.653651662399627,"B.PvsV.REACTOME_DEATH_RECEPTOR_SIGNALLING"
17,"Down",0.268670907965318,0.653651662399627,"B.PvsV.REACTOME_DISEASES_ASSOCIATED_WITH_SURFACTANT_METABOLISM"
117,"Down",0.268731363353589,0.653651662399627,"B.PvsV.REACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING"
57,"Up",0.268985709601461,0.653651662399627,"B.PvsV.TERAO_AOX4_TARGETS_SKIN_UP"
68,"Up",0.269008309178121,0.653651662399627,"B.PvsV.BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_24HR_DN"
12,"Up",0.269037508148492,0.653651662399627,"B.PvsV.REACTOME_VITAMIN_D_CALCIFEROL_METABOLISM"
18,"Down",0.269423378163003,0.653651662399627,"B.PvsV.REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION_IN_TLR7_8_OR_9_SIGNALING"
806,"Up",0.269495383352218,0.653651662399627,"B.PvsV.REACTOME_NEUTROPHIL_DEGRANULATION"
133,"Up",0.269497306057731,0.653651662399627,"B.PvsV.KUNINGER_IGF1_VS_PDGFB_TARGETS_UP"
113,"Up",0.269533727228925,0.653651662399627,"B.PvsV.PID_CD8_TCR_DOWNSTREAM_PATHWAY"
29,"Up",0.269573821393111,0.653651662399627,"B.PvsV.BIOCARTA_NO2IL12_PATHWAY"
40,"Up",0.269585979074912,0.653651662399627,"B.PvsV.KYNG_WERNER_SYNDROM_DN"
193,"Up",0.269594553866186,0.653651662399627,"B.PvsV.ZHU_CMV_24_HR_UP"
18,"Down",0.269618596158039,0.653651662399627,"B.PvsV.MARKS_ACETYLATED_NON_HISTONE_PROTEINS"
85,"Up",0.269633424215257,0.653651662399627,"B.PvsV.ELVIDGE_HIF1A_TARGETS_UP"
118,"Up",0.269765518163417,0.653651662399627,"B.PvsV.KEGG_SMALL_CELL_LUNG_CANCER"
25,"Up",0.269783522082827,0.653651662399627,"B.PvsV.REACTOME_GLUCURONIDATION"
19,"Up",0.26990287580055,0.653654402234445,"B.PvsV.THUM_MIR21_TARGETS_HEART_DISEASE_DN"
90,"Down",0.270068848587244,0.6537699929242,"B.PvsV.KAAB_FAILED_HEART_ATRIUM_UP"
1648,"Up",0.270272746351779,0.653940409143432,"B.PvsV.REACTOME_INNATE_IMMUNE_SYSTEM"
44,"Down",0.270380263769331,0.653940409143432,"B.PvsV.AZARE_STAT3_TARGETS"
84,"Down",0.270494070484903,0.653940409143432,"B.PvsV.REACTOME_ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S"
236,"Up",0.27068797417472,0.654088336845497,"B.PvsV.REACTOME_DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS"
51,"Up",0.270791861645748,0.654088336845497,"B.PvsV.PID_EPHRINB_REV_PATHWAY"
44,"Down",0.271501393346504,0.655236237000509,"B.PvsV.AMIT_SERUM_RESPONSE_40_MCF10A"
87,"Down",0.271504109055555,0.655236237000509,"B.PvsV.SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE"
106,"Up",0.271742067652819,0.655524385712233,"B.PvsV.INGRAM_SHH_TARGETS_DN"
147,"Up",0.271944121586698,0.655651359674429,"B.PvsV.KYNG_DNA_DAMAGE_BY_GAMMA_AND_UV_RADIATION"
317,"Up",0.272031871783892,0.655651359674429,"B.PvsV.TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP"
33,"Up",0.272212870473944,0.655801725860757,"B.PvsV.PID_P38_ALPHA_BETA_PATHWAY"
46,"Down",0.273160690352592,0.657798543971899,"B.PvsV.YANG_BREAST_CANCER_ESR1_DN"
179,"Up",0.273899095252919,0.659289550567432,"B.PvsV.REACTOME_CLATHRIN_MEDIATED_ENDOCYTOSIS"
14,"Up",0.274088836332813,0.659292535566678,"B.PvsV.WEBER_METHYLATED_LCP_IN_FIBROBLAST_DN"
73,"Up",0.274138820630818,0.659292535566678,"B.PvsV.SCHLESINGER_H3K27ME3_IN_NORMAL_AND_METHYLATED_IN_CANCER"
144,"Up",0.274350071997839,0.659513716554805,"B.PvsV.DUTERTRE_ESTRADIOL_RESPONSE_6HR_DN"
6,"Down",0.274646158409493,0.659662089840156,"B.PvsV.REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_TO_LIMIT_CHOLESTEROL_UPTAKE"
57,"Up",0.274650412518003,0.659662089840156,"B.PvsV.PID_INSULIN_PATHWAY"
6,"Down",0.27481626075308,0.659773819237421,"B.PvsV.REACTOME_THE_FATTY_ACID_CYCLING_MODEL"
26,"Up",0.275907817873797,0.66192639534861,"B.PvsV.KEGG_SELENOAMINO_ACID_METABOLISM"
17,"Up",0.275952313488614,0.66192639534861,"B.PvsV.REACTOME_ANDROGEN_BIOSYNTHESIS"
8,"Up",0.276365851744468,0.662630873501806,"B.PvsV.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_5"
36,"Up",0.27666894751308,0.663070052362296,"B.PvsV.UROSEVIC_RESPONSE_TO_IMIQUIMOD"
295,"Up",0.276998205186587,0.663571523603396,"B.PvsV.LI_AMPLIFIED_IN_LUNG_CANCER"
55,"Down",0.277135653571698,0.663578209851629,"B.PvsV.ROY_WOUND_BLOOD_VESSEL_DN"
77,"Down",0.277241031788255,0.663578209851629,"B.PvsV.TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_DN"
527,"Down",0.277423420847953,0.663727431357997,"B.PvsV.DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN"
33,"Down",0.277844779288,0.664091210904325,"B.PvsV.MATZUK_LUTEAL_GENES"
52,"Up",0.277971594491626,0.664091210904325,"B.PvsV.SANCHEZ_MDM2_TARGETS"
46,"Up",0.278022768785199,0.664091210904325,"B.PvsV.REACTOME_PHASE_0_RAPID_DEPOLARISATION"
747,"Down",0.278256730385928,0.664091210904325,"B.PvsV.ODONNELL_TFRC_TARGETS_UP"
12,"Up",0.278271789901484,0.664091210904325,"B.PvsV.REACTOME_MECP2_REGULATES_TRANSCRIPTION_OF_NEURONAL_LIGANDS"
9,"Down",0.278380112304361,0.664091210904325,"B.PvsV.REACTOME_HISTIDINE_CATABOLISM"
13,"Up",0.278416246495971,0.664091210904325,"B.PvsV.KEGG_CIRCADIAN_RHYTHM_MAMMAL"
161,"Up",0.279252762230093,0.665528421062445,"B.PvsV.VANLOO_SP3_TARGETS_DN"
318,"Down",0.27943808087109,0.665528421062445,"B.PvsV.VANTVEER_BREAST_CANCER_ESR1_UP"
31,"Down",0.279510145221748,0.665528421062445,"B.PvsV.REACTOME_INTERLEUKIN_RECEPTOR_SHC_SIGNALING"
827,"Up",0.279537289750868,0.665528421062445,"B.PvsV.REACTOME_TRANSPORT_OF_SMALL_MOLECULES"
18,"Up",0.279620640645335,0.665528421062445,"B.PvsV.XU_RESPONSE_TO_TRETINOIN_DN"
151,"Up",0.279899221877458,0.665618971800231,"B.PvsV.LE_EGR2_TARGETS_DN"
99,"Up",0.279959536665194,0.665618971800231,"B.PvsV.GHANDHI_BYSTANDER_IRRADIATION_UP"
5,"Up",0.280019845977091,0.665618971800231,"B.PvsV.REACTOME_MELANIN_BIOSYNTHESIS"
215,"Down",0.280212392517519,0.66579042467957,"B.PvsV.WINNEPENNINCKX_MELANOMA_METASTASIS_UP"
94,"Down",0.280333642725526,0.665792401473123,"B.PvsV.SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_DN"
22,"Up",0.280548908040138,0.666017566575321,"B.PvsV.PID_ARF6_DOWNSTREAM_PATHWAY"
16,"Up",0.280775093113224,0.666268450567818,"B.PvsV.REACTOME_CLEC7A_DECTIN_1_INDUCES_NFAT_ACTIVATION"
204,"Down",0.281329950097896,0.667298710463863,"B.PvsV.REACTOME_DNA_DOUBLE_STRAND_BREAK_REPAIR"
37,"Down",0.281587354373454,0.667513631884476,"B.PvsV.DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_UP"
88,"Up",0.281662019024504,0.667513631884476,"B.PvsV.REACTOME_DNA_REPLICATION_PRE_INITIATION"
57,"Up",0.28186982876668,0.667719915703074,"B.PvsV.REACTOME_EPH_EPHRIN_MEDIATED_REPULSION_OF_CELLS"
36,"Down",0.282152789725439,0.667888455525993,"B.PvsV.AMUNDSON_DNA_DAMAGE_RESPONSE_TP53"
9,"Down",0.28219667726085,0.667888455525993,"B.PvsV.BIOCARTA_CREM_PATHWAY"
158,"Down",0.282303367799646,0.667888455525993,"B.PvsV.REACTOME_RHO_GTPASE_CYCLE"
95,"Down",0.282634489211604,0.668196946780177,"B.PvsV.WIERENGA_STAT5A_TARGETS_GROUP2"
59,"Down",0.282675467266926,0.668196946780177,"B.PvsV.HOLLEMAN_VINCRISTINE_RESISTANCE_B_ALL_UP"
292,"Down",0.283138666554976,0.669005849308744,"B.PvsV.SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM2"
15,"Down",0.283489690991724,0.669549124943717,"B.PvsV.REACTOME_KERATAN_SULFATE_DEGRADATION"
200,"Up",0.284139528304427,0.670797374891193,"B.PvsV.ELVIDGE_HYPOXIA_BY_DMOG_UP"
757,"Up",0.284447805645268,0.671159894820163,"B.PvsV.SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP"
11,"Up",0.284535864253656,0.671159894820163,"B.PvsV.REACTOME_ABACAVIR_METABOLISM"
340,"Up",0.284792997193383,0.671357457133647,"B.PvsV.AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_DN"
14,"Down",0.284862469603099,0.671357457133647,"B.PvsV.ABBUD_LIF_SIGNALING_2_DN"
31,"Down",0.285461694929668,0.672483046981736,"B.PvsV.PID_WNT_CANONICAL_PATHWAY"
11,"Up",0.28568342536856,0.672718764421962,"B.PvsV.VALK_AML_WITH_T_8_21_TRANSLOCATION"
27,"Down",0.28590502024914,0.672953962093442,"B.PvsV.HEDENFALK_BREAST_CANCER_BRACX_UP"
47,"Up",0.286039845181712,0.672984810216887,"B.PvsV.KEGG_PRIMARY_IMMUNODEFICIENCY"
91,"Down",0.286260091318976,0.673101555596829,"B.PvsV.REACTOME_SPHINGOLIPID_METABOLISM"
60,"Up",0.286332946059639,0.673101555596829,"B.PvsV.BIOCARTA_FCER1_PATHWAY"
505,"Down",0.286638756945282,0.673534078686981,"B.PvsV.REACTOME_GPCR_LIGAND_BINDING"
27,"Down",0.286891764057501,0.673699983929386,"B.PvsV.REACTOME_COMMON_PATHWAY_OF_FIBRIN_CLOT_FORMATION"
238,"Down",0.286958284151641,0.673699983929386,"B.PvsV.YAUCH_HEDGEHOG_SIGNALING_PARACRINE_UP"
32,"Up",0.287074907241388,0.673699983929386,"B.PvsV.REACTOME_EPHRIN_SIGNALING"
166,"Up",0.287606072001644,0.674387603163521,"B.PvsV.LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_UP"
325,"Down",0.28761849026455,0.674387603163521,"B.PvsV.WIERENGA_STAT5A_TARGETS_UP"
30,"Up",0.287733831771161,0.674387603163521,"B.PvsV.SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_UP"
33,"Up",0.288119486714408,0.67500535679829,"B.PvsV.BIOCARTA_TOLL_PATHWAY"
37,"Down",0.288325296473443,0.675201424905406,"B.PvsV.ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_UP"
22,"Down",0.288488749737608,0.675298178365469,"B.PvsV.REACTOME_TRANSCRIPTION_OF_E2F_TARGETS_UNDER_NEGATIVE_CONTROL_BY_DREAM_COMPLEX"
27,"Down",0.288632886467189,0.675349652677567,"B.PvsV.KEGG_HOMOLOGOUS_RECOMBINATION"
69,"Down",0.28908767948475,0.675907092802672,"B.PvsV.SCHEIDEREIT_IKK_INTERACTING_PROTEINS"
30,"Up",0.289115622079638,0.675907092802672,"B.PvsV.MATZUK_SPERMATOGONIA"
6,"Down",0.289271400112122,0.67598544852913,"B.PvsV.REACTOME_LRR_FLII_INTERACTING_PROTEIN_1_LRRFIP1_ACTIVATES_TYPE_I_IFN_PRODUCTION"
99,"Up",0.289722912766082,0.676754535143079,"B.PvsV.BOYLAN_MULTIPLE_MYELOMA_C_DN"
194,"Down",0.290567693870864,0.678079216681251,"B.PvsV.GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_DN"
61,"Down",0.290573486574909,0.678079216681251,"B.PvsV.POMEROY_MEDULLOBLASTOMA_PROGNOSIS_DN"
55,"Up",0.290708400576151,0.678079216681251,"B.PvsV.REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC"
94,"Down",0.290780579264107,0.678079216681251,"B.PvsV.CHIARETTI_ACUTE_LYMPHOBLASTIC_LEUKEMIA_ZAP70"
487,"Up",0.291596687667096,0.679662472467103,"B.PvsV.SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM4"
77,"Up",0.291705380206988,0.679662472467103,"B.PvsV.KEGG_COLORECTAL_CANCER"
103,"Up",0.292245653033739,0.680010228942701,"B.PvsV.BILD_SRC_ONCOGENIC_SIGNATURE"
51,"Down",0.292504848063652,0.680010228942701,"B.PvsV.KORKOLA_TERATOMA"
37,"Down",0.292589964834823,0.680010228942701,"B.PvsV.KEGG_HISTIDINE_METABOLISM"
53,"Down",0.292629210942279,0.680010228942701,"B.PvsV.ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP"
548,"Up",0.292635666733601,0.680010228942701,"B.PvsV.DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN"
356,"Down",0.292668573000658,0.680010228942701,"B.PvsV.LEE_RECENT_THYMIC_EMIGRANT"
2169,"Down",0.292867727054799,0.680010228942701,"B.PvsV.PUJANA_ATM_PCC_NETWORK"
22,"Down",0.292902920822095,0.680010228942701,"B.PvsV.REACTOME_FGFR2_LIGAND_BINDING_AND_ACTIVATION"
28,"Down",0.292961541931907,0.680010228942701,"B.PvsV.NELSON_RESPONSE_TO_ANDROGEN_DN"
40,"Up",0.29319106277179,0.680257400782723,"B.PvsV.DUTTA_APOPTOSIS_VIA_NFKB"
87,"Up",0.293532545049062,0.680764027506821,"B.PvsV.WANG_BARRETTS_ESOPHAGUS_UP"
17,"Down",0.294310749459981,0.682282655666345,"B.PvsV.MURAKAMI_UV_RESPONSE_1HR_DN"
9,"Down",0.294762660003823,0.683043900738112,"B.PvsV.REACTOME_RELEASE_OF_HH_NP_FROM_THE_SECRETING_CELL"
15,"Down",0.294980823234703,0.683236061620018,"B.PvsV.REACTOME_HYALURONAN_UPTAKE_AND_DEGRADATION"
12,"Up",0.295239634223153,0.683236061620018,"B.PvsV.MATZUK_MATERNAL_EFFECT"
385,"Up",0.295338764462345,0.683236061620018,"B.PvsV.RIGGINS_TAMOXIFEN_RESISTANCE_DN"
607,"Up",0.295339878327336,0.683236061620018,"B.PvsV.REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES"
70,"Down",0.295567928725418,0.683403361450708,"B.PvsV.YAMASHITA_LIVER_CANCER_WITH_EPCAM_UP"
34,"Up",0.29565940325377,0.683403361450708,"B.PvsV.THUM_MIR21_TARGETS_HEART_DISEASE_UP"
87,"Down",0.29623387595414,0.68444508990825,"B.PvsV.HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_DN"
81,"Down",0.296556718249605,0.684718072925785,"B.PvsV.LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN"
17,"Up",0.29659970784179,0.684718072925785,"B.PvsV.FU_INTERACT_WITH_ALKBH8"
5,"Up",0.296796210071889,0.684723760919266,"B.PvsV.REACTOME_DOPAMINE_RECEPTORS"
76,"Down",0.296849856198857,0.684723760919266,"B.PvsV.BIOCARTA_HIVNEF_PATHWAY"
12,"Down",0.29698092651907,0.684740426490382,"B.PvsV.REACTOME_ACTIVATION_OF_THE_TFAP2_AP_2_FAMILY_OF_TRANSCRIPTION_FACTORS"
35,"Down",0.297579954634645,0.685835585316778,"B.PvsV.KEGG_BASE_EXCISION_REPAIR"
8,"Down",0.297803802434391,0.685871542615242,"B.PvsV.REACTOME_COMPETING_ENDOGENOUS_RNAS_CERNAS_REGULATE_PTEN_TRANSLATION"
36,"Up",0.297843655962958,0.685871542615242,"B.PvsV.PID_MYC_PATHWAY"
322,"Down",0.298256265033219,0.68653575743908,"B.PvsV.DARWICHE_PAPILLOMA_RISK_HIGH_DN"
14,"Up",0.298498620564736,0.686807687516615,"B.PvsV.REACTOME_ROBO_RECEPTORS_BIND_AKAP5"
59,"Down",0.298688031457926,0.686957623099365,"B.PvsV.VALK_AML_CLUSTER_4"
112,"Up",0.298950322039329,0.687096206249603,"B.PvsV.DELASERNA_MYOD_TARGETS_DN"
43,"Up",0.299105730091819,0.687096206249603,"B.PvsV.WILLERT_WNT_SIGNALING"
284,"Down",0.299137076106004,0.687096206249603,"B.PvsV.BIDUS_METASTASIS_UP"
146,"Up",0.299245372517461,0.687096206249603,"B.PvsV.KONDO_PROSTATE_CANCER_HCP_WITH_H3K27ME3"
31,"Up",0.299518018779804,0.687306308906621,"B.PvsV.REACTOME_VXPX_CARGO_TARGETING_TO_CILIUM"
46,"Down",0.29968293065855,0.687306308906621,"B.PvsV.KEGG_NUCLEOTIDE_EXCISION_REPAIR"
79,"Down",0.299709804806269,0.687306308906621,"B.PvsV.BURTON_ADIPOGENESIS_PEAK_AT_2HR"
25,"Up",0.30058474141523,0.687766063502916,"B.PvsV.STARK_HYPPOCAMPUS_22Q11_DELETION_DN"
402,"Down",0.300612796347784,0.687766063502916,"B.PvsV.WANG_CISPLATIN_RESPONSE_AND_XPC_UP"
45,"Down",0.300799588221247,0.687766063502916,"B.PvsV.REACTOME_SYNTHESIS_OF_PA"
667,"Down",0.300839775506428,0.687766063502916,"B.PvsV.CHYLA_CBFA2T3_TARGETS_UP"
75,"Up",0.300859198534691,0.687766063502916,"B.PvsV.JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP"
24,"Down",0.300997140214163,0.687766063502916,"B.PvsV.SHIN_B_CELL_LYMPHOMA_CLUSTER_9"
16,"Down",0.301014149484142,0.687766063502916,"B.PvsV.BIOCARTA_RB_PATHWAY"
6,"Down",0.301028934517946,0.687766063502916,"B.PvsV.REACTOME_VITAMINS"
142,"Up",0.301029819800517,0.687766063502916,"B.PvsV.REACTOME_ANTIMICROBIAL_PEPTIDES"
62,"Down",0.301207730514971,0.687843840553405,"B.PvsV.REACTOME_APOPTOTIC_CLEAVAGE_OF_CELLULAR_PROTEINS"
6,"Down",0.301408439749782,0.687843840553405,"B.PvsV.REACTOME_SIGNALING_BY_MEMBRANE_TETHERED_FUSIONS_OF_PDGFRA_OR_PDGFRB"
79,"Down",0.301437081870302,0.687843840553405,"B.PvsV.MEDINA_SMARCA4_TARGETS"
26,"Up",0.301582890686826,0.687892657841362,"B.PvsV.REACTOME_UNBLOCKING_OF_NMDA_RECEPTORS_GLUTAMATE_BINDING_AND_ACTIVATION"
83,"Down",0.301838698135904,0.688101029862635,"B.PvsV.CHENG_RESPONSE_TO_NICKEL_ACETATE"
32,"Down",0.302056326560371,0.688101029862635,"B.PvsV.HANSON_HRAS_SIGNALING_VIA_NFKB"
86,"Up",0.30219771592943,0.688101029862635,"B.PvsV.KHETCHOUMIAN_TRIM24_TARGETS_UP"
914,"Down",0.30221406636254,0.688101029862635,"B.PvsV.BENPORATH_CYCLING_GENES"
197,"Up",0.302399423357824,0.688101029862635,"B.PvsV.HUMMERICH_SKIN_CANCER_PROGRESSION_DN"
494,"Down",0.302495386468616,0.688101029862635,"B.PvsV.KAAB_HEART_ATRIUM_VS_VENTRICLE_UP"
159,"Down",0.302545415734503,0.688101029862635,"B.PvsV.CAMPS_COLON_CANCER_COPY_NUMBER_UP"
101,"Down",0.302937299700933,0.688353009737532,"B.PvsV.RIZKI_TUMOR_INVASIVENESS_2D_DN"
110,"Down",0.303084919966857,0.688353009737532,"B.PvsV.LIN_MELANOMA_COPY_NUMBER_UP"
9,"Up",0.303208514945478,0.688353009737532,"B.PvsV.REACTOME_SERINE_BIOSYNTHESIS"
34,"Up",0.303475457005015,0.688353009737532,"B.PvsV.REACTOME_VEGFR2_MEDIATED_VASCULAR_PERMEABILITY"
29,"Up",0.303493630995403,0.688353009737532,"B.PvsV.REACTOME_INSERTION_OF_TAIL_ANCHORED_PROTEINS_INTO_THE_ENDOPLASMIC_RETICULUM_MEMBRANE"
684,"Down",0.303582853816163,0.688353009737532,"B.PvsV.CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_UP"
44,"Up",0.303700141367039,0.688353009737532,"B.PvsV.YANG_BREAST_CANCER_ESR1_LASER_UP"
154,"Up",0.30376374201383,0.688353009737532,"B.PvsV.LEE_AGING_CEREBELLUM_DN"
633,"Down",0.30390123344515,0.688353009737532,"B.PvsV.HADDAD_B_LYMPHOCYTE_PROGENITOR"
83,"Down",0.303924018091978,0.688353009737532,"B.PvsV.KEGG_P53_SIGNALING_PATHWAY"
33,"Up",0.304126027305905,0.688353009737532,"B.PvsV.BIOCARTA_CTCF_PATHWAY"
42,"Up",0.304303043061666,0.688353009737532,"B.PvsV.TERAO_AOX4_TARGETS_HG_UP"
412,"Down",0.304307902425587,0.688353009737532,"B.PvsV.BHAT_ESR1_TARGETS_VIA_AKT1_UP"
36,"Up",0.304399187702707,0.688353009737532,"B.PvsV.KANG_AR_TARGETS_UP"
31,"Down",0.304745199005725,0.688547184180704,"B.PvsV.KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_UV_IN_OLD"
238,"Up",0.304821151942585,0.688547184180704,"B.PvsV.MARKEY_RB1_CHRONIC_LOF_DN"
19,"Down",0.304858655611207,0.688547184180704,"B.PvsV.BIOCARTA_TNFR2_PATHWAY"
166,"Down",0.305001343693207,0.688588170387807,"B.PvsV.REACTOME_RHO_GTPASES_ACTIVATE_FORMINS"
42,"Down",0.305339850947662,0.689071035056988,"B.PvsV.REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS"
63,"Up",0.305682779679726,0.689563479742638,"B.PvsV.AMIT_EGF_RESPONSE_60_HELA"
107,"Up",0.30631018179536,0.690247864514207,"B.PvsV.YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_7"
8,"Down",0.306439654391122,0.690247864514207,"B.PvsV.REACTOME_DEFECTIVE_ST3GAL3_CAUSES_MCT12_AND_EIEE15"
10,"Up",0.306684002553674,0.690247864514207,"B.PvsV.REACTOME_INTERLEUKIN_18_SIGNALING"
174,"Up",0.306694410894211,0.690247864514207,"B.PvsV.YAMASHITA_METHYLATED_IN_PROSTATE_CANCER"
165,"Down",0.306870344697964,0.690247864514207,"B.PvsV.NIKOLSKY_BREAST_CANCER_8Q12_Q22_AMPLICON"
10,"Down",0.306887070050157,0.690247864514207,"B.PvsV.REACTOME_ORGANIC_ANION_TRANSPORTERS"
50,"Up",0.306890092368186,0.690247864514207,"B.PvsV.REACTOME_G_ALPHA_Z_SIGNALLING_EVENTS"
67,"Down",0.306984897601815,0.690247864514207,"B.PvsV.REACTOME_SIGNALING_BY_EGFR"
161,"Down",0.307287819107371,0.690575869114621,"B.PvsV.REACTOME_HCMV_EARLY_EVENTS"
118,"Up",0.307499111752137,0.690575869114621,"B.PvsV.ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_DN"
13,"Down",0.307505478343317,0.690575869114621,"B.PvsV.WANG_ESOPHAGUS_CANCER_PROGRESSION_UP"
309,"Down",0.307994805683467,0.691393942600036,"B.PvsV.DARWICHE_SQUAMOUS_CELL_CARCINOMA_DN"
90,"Up",0.308312808059617,0.691826913864296,"B.PvsV.PID_FCER1_PATHWAY"
71,"Up",0.308783927455229,0.692137662875895,"B.PvsV.ZHENG_FOXP3_TARGETS_IN_T_LYMPHOCYTE_DN"
1768,"Down",0.308787556008629,0.692137662875895,"B.PvsV.PEREZ_TP53_TARGETS"
70,"Up",0.308826842885664,0.692137662875895,"B.PvsV.SIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES"
96,"Down",0.309072518779815,0.692236671500668,"B.PvsV.FIGUEROA_AML_METHYLATION_CLUSTER_6_DN"
21,"Up",0.309237090138529,0.692236671500668,"B.PvsV.IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_UP"
247,"Down",0.309246623007171,0.692236671500668,"B.PvsV.PODAR_RESPONSE_TO_ADAPHOSTIN_UP"
50,"Up",0.309419380554243,0.692274766619776,"B.PvsV.MINGUEZ_LIVER_CANCER_VASCULAR_INVASION_DN"
20,"Down",0.309549996017713,0.692274766619776,"B.PvsV.REACTOME_ACTIVATION_OF_SMO"
40,"Up",0.309639265301267,0.692274766619776,"B.PvsV.SCHEIDEREIT_IKK_TARGETS"
17,"Down",0.310172472424186,0.693186580450011,"B.PvsV.REACTOME_RESPONSE_OF_EIF2AK1_HRI_TO_HEME_DEFICIENCY"
146,"Down",0.310338219249328,0.693276773426074,"B.PvsV.PUJANA_BREAST_CANCER_LIT_INT_NETWORK"
492,"Down",0.310958830891624,0.69405426951135,"B.PvsV.WANG_MLL_TARGETS"
8,"Up",0.311025142340487,0.69405426951135,"B.PvsV.NAISHIRO_CTNNB1_TARGETS_WITH_LEF1_MOTIF"
27,"Up",0.311062846780453,0.69405426951135,"B.PvsV.PID_INTEGRIN5_PATHWAY"
22,"Down",0.31127093325205,0.694238398527869,"B.PvsV.VETTER_TARGETS_OF_PRKCA_AND_ETS1_UP"
48,"Down",0.311586604922,0.694662233311991,"B.PvsV.GRADE_COLON_VS_RECTAL_CANCER_UP"
1007,"Down",0.311793197466585,0.694662462265447,"B.PvsV.MARTINEZ_RB1_AND_TP53_TARGETS_DN"
92,"Down",0.311933330082555,0.694662462265447,"B.PvsV.TIEN_INTESTINE_PROBIOTICS_6HR_UP"
19,"Down",0.311984814666026,0.694662462265447,"B.PvsV.REACTOME_PENTOSE_PHOSPHATE_PATHWAY"
171,"Down",0.312189542244656,0.694662462265447,"B.PvsV.REACTOME_HOMOLOGY_DIRECTED_REPAIR"
28,"Up",0.312325132340714,0.694662462265447,"B.PvsV.PID_HIF1A_PATHWAY"
71,"Down",0.312340546426461,0.694662462265447,"B.PvsV.SCHLINGEMANN_SKIN_CARCINOGENESIS_TPA_UP"
29,"Up",0.312990918945073,0.695829027280783,"B.PvsV.KEGG_ASCORBATE_AND_ALDARATE_METABOLISM"
695,"Down",0.313637365749587,0.696976031176338,"B.PvsV.RATTENBACHER_BOUND_BY_CELF1"
173,"Down",0.313758969361169,0.696976031176338,"B.PvsV.BROWN_MYELOID_CELL_DEVELOPMENT_DN"
12,"Up",0.314696324007179,0.697760976981123,"B.PvsV.REACTOME_SEROTONIN_RECEPTORS"
110,"Up",0.314717961091154,0.697760976981123,"B.PvsV.KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY"
36,"Up",0.314723330048188,0.697760976981123,"B.PvsV.KONG_E2F1_TARGETS"
82,"Up",0.314840812146016,0.697760976981123,"B.PvsV.PID_SHP2_PATHWAY"
20,"Down",0.31529646885407,0.697760976981123,"B.PvsV.BIOCARTA_EGFR_SMRTE_PATHWAY"
7,"Down",0.315300583377933,0.697760976981123,"B.PvsV.REACTOME_ZINC_EFFLUX_AND_COMPARTMENTALIZATION_BY_THE_SLC30_FAMILY"
19,"Down",0.315323631043312,0.697760976981123,"B.PvsV.REACTOME_TFAP2_AP_2_FAMILY_REGULATES_TRANSCRIPTION_OF_GROWTH_FACTORS_AND_THEIR_RECEPTORS"
35,"Down",0.3153485021896,0.697760976981123,"B.PvsV.KANNAN_TP53_TARGETS_DN"
56,"Up",0.315364028074229,0.697760976981123,"B.PvsV.WANG_NFKB_TARGETS"
24,"Down",0.315374331972477,0.697760976981123,"B.PvsV.WHITESIDE_CISPLATIN_RESISTANCE_DN"
78,"Up",0.31565204782242,0.698096068964063,"B.PvsV.AMIT_SERUM_RESPONSE_60_MCF10A"
48,"Down",0.316263416683749,0.699168504935806,"B.PvsV.BONOME_OVARIAN_CANCER_POOR_SURVIVAL_UP"
15,"Down",0.31643066471749,0.699258651168267,"B.PvsV.MCCABE_HOXC6_TARGETS_UP"
94,"Up",0.31666412881087,0.699455511151159,"B.PvsV.MCDOWELL_ACUTE_LUNG_INJURY_UP"
7,"Up",0.316772761787394,0.699455511151159,"B.PvsV.REACTOME_RSK_ACTIVATION"
100,"Up",0.317198415196285,0.700115783481141,"B.PvsV.REACTOME_DAP12_INTERACTIONS"
117,"Up",0.317389880607471,0.700258838738511,"B.PvsV.KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION"
155,"Down",0.317729525496664,0.700728578568431,"B.PvsV.ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_UP"
1063,"Up",0.317962685144128,0.700869882245041,"B.PvsV.MARTINEZ_TP53_TARGETS_UP"
366,"Down",0.318047121460085,0.700869882245041,"B.PvsV.GROSS_HYPOXIA_VIA_ELK3_UP"
272,"Up",0.318688840009848,0.701663608246131,"B.PvsV.REACTOME_FCERI_MEDIATED_NF_KB_ACTIVATION"
342,"Up",0.318758306705923,0.701663608246131,"B.PvsV.JIANG_HYPOXIA_NORMAL"
868,"Down",0.318788023858615,0.701663608246131,"B.PvsV.HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP"
8,"Down",0.319305625673614,0.702318416993787,"B.PvsV.MATZUK_STEROIDOGENESIS"
149,"Up",0.31933957321801,0.702318416993787,"B.PvsV.ZHONG_SECRETOME_OF_LUNG_CANCER_AND_MACROPHAGE"
11,"Up",0.319789396085496,0.702461746736895,"B.PvsV.SCHMAHL_PDGF_SIGNALING"
84,"Down",0.319856303460945,0.702461746736895,"B.PvsV.REACTOME_NUCLEAR_ENVELOPE_NE_REASSEMBLY"
53,"Down",0.319858769428709,0.702461746736895,"B.PvsV.REACTOME_SIGNALING_BY_NOTCH2"
12,"Down",0.31991294597278,0.702461746736895,"B.PvsV.REACTOME_PREGNENOLONE_BIOSYNTHESIS"
8,"Down",0.320819813754865,0.703984187553352,"B.PvsV.BIOCARTA_WNT_LRP6_PATHWAY"
22,"Up",0.320955296706938,0.703984187553352,"B.PvsV.TAGHAVI_NEOPLASTIC_TRANSFORMATION"
37,"Up",0.320988268551637,0.703984187553352,"B.PvsV.BIOCARTA_LIS1_PATHWAY"
127,"Up",0.321389790963363,0.704439121148803,"B.PvsV.BURTON_ADIPOGENESIS_9"
305,"Up",0.321482771402852,0.704439121148803,"B.PvsV.WANG_TUMOR_INVASIVENESS_DN"
11,"Up",0.32157792399703,0.704439121148803,"B.PvsV.MATZUK_FERTILIZATION"
26,"Up",0.322059033947817,0.704669814590767,"B.PvsV.WIKMAN_ASBESTOS_LUNG_CANCER_UP"
674,"Down",0.322144267603103,0.704669814590767,"B.PvsV.ZHANG_BREAST_CANCER_PROGENITORS_UP"
17,"Down",0.322171946553039,0.704669814590767,"B.PvsV.IVANOV_MUTATED_IN_COLON_CANCER"
21,"Down",0.322193035139349,0.704669814590767,"B.PvsV.TOMLINS_METASTASIS_UP"
53,"Up",0.322662721926004,0.705406312609906,"B.PvsV.REACTOME_INOSITOL_PHOSPHATE_METABOLISM"
1053,"Down",0.322786707360648,0.705406312609906,"B.PvsV.PUJANA_CHEK2_PCC_NETWORK"
51,"Down",0.322912529791223,0.705406312609906,"B.PvsV.CHO_NR4A1_TARGETS"
363,"Up",0.323317420202666,0.705767012940799,"B.PvsV.REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION"
16,"Down",0.323438702384978,0.705767012940799,"B.PvsV.REACTOME_TNFR1_INDUCED_PROAPOPTOTIC_SIGNALING"
298,"Up",0.32351779939399,0.705767012940799,"B.PvsV.VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP"
5,"Up",0.323714253634481,0.705767012940799,"B.PvsV.TURJANSKI_MAPK11_TARGETS"
289,"Down",0.323806978226171,0.705767012940799,"B.PvsV.NABA_CORE_MATRISOME"
102,"Up",0.323843536232738,0.705767012940799,"B.PvsV.REACTOME_PLASMA_LIPOPROTEIN_ASSEMBLY_REMODELING_AND_CLEARANCE"
5,"Up",0.32430841226313,0.706304431897048,"B.PvsV.REACTOME_MUSCARINIC_ACETYLCHOLINE_RECEPTORS"
611,"Up",0.324535374337536,0.706304431897048,"B.PvsV.REN_ALVEOLAR_RHABDOMYOSARCOMA_DN"
10,"Up",0.324700247185476,0.706304431897048,"B.PvsV.FUNG_IL2_TARGETS_WITH_STAT5_BINDING_SITES_T1"
126,"Down",0.324879039933288,0.706304431897048,"B.PvsV.REACTOME_NUCLEOTIDE_EXCISION_REPAIR"
20,"Down",0.325026705517239,0.706304431897048,"B.PvsV.REACTOME_KILLING_MECHANISMS"
145,"Up",0.325134509092759,0.706304431897048,"B.PvsV.ELVIDGE_HIF1A_TARGETS_DN"
23,"Up",0.325379663243428,0.706304431897048,"B.PvsV.REACTOME_RAF_INDEPENDENT_MAPK1_3_ACTIVATION"
19,"Down",0.325543329453838,0.706304431897048,"B.PvsV.REACTOME_METABOLISM_OF_AMINE_DERIVED_HORMONES"
318,"Up",0.325902594609602,0.706304431897048,"B.PvsV.REACTOME_FLT3_SIGNALING"
26,"Down",0.325959133155985,0.706304431897048,"B.PvsV.BIOCARTA_41BB_PATHWAY"
24,"Up",0.325969490295804,0.706304431897048,"B.PvsV.REACTOME_RECEPTOR_TYPE_TYROSINE_PROTEIN_PHOSPHATASES"
338,"Up",0.325996337772865,0.706304431897048,"B.PvsV.REACTOME_FC_EPSILON_RECEPTOR_FCERI_SIGNALING"
102,"Up",0.326161936455928,0.706304431897048,"B.PvsV.REACTOME_SEMAPHORIN_INTERACTIONS"
295,"Down",0.326168268749049,0.706304431897048,"B.PvsV.WHITFIELD_CELL_CYCLE_G2_M"
156,"Down",0.326231061664126,0.706304431897048,"B.PvsV.FONTAINE_PAPILLARY_THYROID_CARCINOMA_DN"
54,"Up",0.326294575904866,0.706304431897048,"B.PvsV.BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_UP"
601,"Down",0.326462599152237,0.706304431897048,"B.PvsV.VECCHI_GASTRIC_CANCER_EARLY_UP"
6,"Up",0.326733329758005,0.706304431897048,"B.PvsV.REACTOME_RELEASE_OF_APOPTOTIC_FACTORS_FROM_THE_MITOCHONDRIA"
135,"Down",0.326759653626772,0.706304431897048,"B.PvsV.CORRE_MULTIPLE_MYELOMA_UP"
310,"Up",0.326852409953187,0.706304431897048,"B.PvsV.CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN"
377,"Up",0.326897905908036,0.706304431897048,"B.PvsV.MANALO_HYPOXIA_UP"
436,"Up",0.326900531963202,0.706304431897048,"B.PvsV.VANTVEER_BREAST_CANCER_ESR1_DN"
389,"Down",0.327156050412157,0.706376478045093,"B.PvsV.GAL_LEUKEMIC_STEM_CELL_DN"
23,"Up",0.327189394153279,0.706376478045093,"B.PvsV.CHEOK_RESPONSE_TO_MERCAPTOPURINE_DN"
316,"Down",0.328006423237271,0.707746808124724,"B.PvsV.KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION"
32,"Up",0.328080135507988,0.707746808124724,"B.PvsV.REACTOME_INCRETIN_SYNTHESIS_SECRETION_AND_INACTIVATION"
12,"Down",0.328269112376297,0.707878284839527,"B.PvsV.REACTOME_TRANSPORT_OF_FATTY_ACIDS"
44,"Up",0.328547293678374,0.707988973261963,"B.PvsV.RODRIGUES_NTN1_TARGETS_UP"
342,"Down",0.32865874322049,0.707988973261963,"B.PvsV.DARWICHE_SKIN_TUMOR_PROMOTER_DN"
46,"Down",0.32890534857352,0.707988973261963,"B.PvsV.PARK_TRETINOIN_RESPONSE_AND_PML_RARA_FUSION"
78,"Down",0.329061926706437,0.707988973261963,"B.PvsV.WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_DN"
32,"Down",0.329313601795897,0.707988973261963,"B.PvsV.PID_RHODOPSIN_PATHWAY"
31,"Up",0.329409909989417,0.707988973261963,"B.PvsV.BIOCARTA_AMI_PATHWAY"
35,"Down",0.32955123735912,0.707988973261963,"B.PvsV.CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_LD_MTX_DN"
31,"Down",0.329595434695353,0.707988973261963,"B.PvsV.REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION"
30,"Down",0.32977226342362,0.707988973261963,"B.PvsV.PID_TRAIL_PATHWAY"
38,"Down",0.329817266872004,0.707988973261963,"B.PvsV.REACTOME_KERATAN_SULFATE_KERATIN_METABOLISM"
130,"Down",0.329849690869047,0.707988973261963,"B.PvsV.REACTOME_PROCESSING_OF_DNA_DOUBLE_STRAND_BREAK_ENDS"
13,"Up",0.32985704379143,0.707988973261963,"B.PvsV.TURJANSKI_MAPK14_TARGETS"
440,"Down",0.330183456994608,0.708414564890643,"B.PvsV.DAZARD_RESPONSE_TO_UV_NHEK_DN"
40,"Up",0.330783187136528,0.708882416305175,"B.PvsV.CHEN_ETV5_TARGETS_SERTOLI"
189,"Up",0.330795352893925,0.708882416305175,"B.PvsV.LIU_VAV3_PROSTATE_CARCINOGENESIS_UP"
109,"Up",0.330858031643203,0.708882416305175,"B.PvsV.LEE_EARLY_T_LYMPHOCYTE_DN"
557,"Up",0.331097982668677,0.708882416305175,"B.PvsV.OSMAN_BLADDER_CANCER_UP"
165,"Down",0.331348617168179,0.708882416305175,"B.PvsV.HATADA_METHYLATED_IN_LUNG_CANCER_DN"
11,"Down",0.33135808253063,0.708882416305175,"B.PvsV.REACTOME_ERYTHROPOIETIN_ACTIVATES_STAT5"
135,"Up",0.331414654497859,0.708882416305175,"B.PvsV.SEIDEN_ONCOGENESIS_BY_MET"
133,"Down",0.331526194428492,0.708882416305175,"B.PvsV.SU_LIVER"
1244,"Up",0.331760017383815,0.708882416305175,"B.PvsV.NUYTTEN_NIPP1_TARGETS_UP"
13,"Down",0.331870106978004,0.708882416305175,"B.PvsV.THILLAINADESAN_ZNF217_TARGETS_DN"
29,"Down",0.331956618489341,0.708882416305175,"B.PvsV.REACTOME_RIPK1_MEDIATED_REGULATED_NECROSIS"
13,"Down",0.332026946121661,0.708882416305175,"B.PvsV.REACTOME_REGULATED_PROTEOLYSIS_OF_P75NTR"
12,"Down",0.332068268806367,0.708882416305175,"B.PvsV.REACTOME_REGULATION_OF_SIGNALING_BY_NODAL"
170,"Down",0.332488553644004,0.709431248484823,"B.PvsV.ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_DN"
5,"Down",0.33258198518225,0.709431248484823,"B.PvsV.REACTOME_ACTIVATION_OF_NOXA_AND_TRANSLOCATION_TO_MITOCHONDRIA"
56,"Up",0.332868423528701,0.709768420243034,"B.PvsV.REACTOME_AQUAPORIN_MEDIATED_TRANSPORT"
349,"Down",0.333240357297795,0.710148048825808,"B.PvsV.BENPORATH_MYC_TARGETS_WITH_EBOX"
495,"Down",0.33330334358889,0.710148048825808,"B.PvsV.NIKOLSKY_BREAST_CANCER_17Q21_Q25_AMPLICON"
391,"Up",0.334226143435496,0.711829632152081,"B.PvsV.AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_UP"
176,"Up",0.334350073195687,0.711829632152081,"B.PvsV.RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_UP"
323,"Up",0.335110467974664,0.713173894315595,"B.PvsV.SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_DN"
19,"Up",0.335556386795245,0.713794254641354,"B.PvsV.GALLUZZI_PREVENT_MITOCHONDIAL_PERMEABILIZATION"
19,"Down",0.335660166769311,0.713794254641354,"B.PvsV.KINNEY_DNMT1_METHYLATION_TARGETS"
32,"Down",0.335880244970679,0.713987648766969,"B.PvsV.REACTOME_CASPASE_ACTIVATION_VIA_EXTRINSIC_APOPTOTIC_SIGNALLING_PATHWAY"
136,"Up",0.336091977539178,0.714121196361077,"B.PvsV.DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_DN"
14,"Up",0.336423592150319,0.714121196361077,"B.PvsV.REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_LINKED_TO_LIPOGENESIS"
21,"Up",0.336472737879823,0.714121196361077,"B.PvsV.SILIGAN_TARGETS_OF_EWS_FLI1_FUSION_UP"
454,"Up",0.336493300774408,0.714121196361077,"B.PvsV.KONDO_EZH2_TARGETS"
75,"Down",0.336588865566462,0.714121196361077,"B.PvsV.PID_HEDGEHOG_GLI_PATHWAY"
15,"Up",0.337285932299768,0.715325630872811,"B.PvsV.RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_SMAD4_DN"
47,"Down",0.337423641812476,0.715343295851678,"B.PvsV.CEBALLOS_TARGETS_OF_TP53_AND_MYC_DN"
33,"Down",0.337710111057543,0.715676199324322,"B.PvsV.KORKOLA_YOLK_SAC_TUMOR_UP"
41,"Up",0.337991562713338,0.715998218483542,"B.PvsV.REACTOME_GAMMA_CARBOXYLATION_HYPUSINE_FORMATION_AND_ARYLSULFATASE_ACTIVATION"
39,"Up",0.338435276588754,0.716663594124559,"B.PvsV.MARSON_FOXP3_TARGETS_STIMULATED_UP"
1485,"Up",0.338682112924789,0.716875489689182,"B.PvsV.NUYTTEN_EZH2_TARGETS_UP"
31,"Up",0.338812631324181,0.716875489689182,"B.PvsV.REACTOME_INTERCONVERSION_OF_NUCLEOTIDE_DI_AND_TRIPHOSPHATES"
135,"Up",0.339108796082582,0.716875489689182,"B.PvsV.ANDERSEN_CHOLANGIOCARCINOMA_CLASS1"
9,"Down",0.339314755030533,0.716875489689182,"B.PvsV.REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_WNT_SIGNALING"
344,"Down",0.339490841284501,0.716875489689182,"B.PvsV.LINDGREN_BLADDER_CANCER_CLUSTER_3_DN"
60,"Up",0.33955443842476,0.716875489689182,"B.PvsV.PID_TNF_PATHWAY"
65,"Down",0.339596203270775,0.716875489689182,"B.PvsV.REACTOME_INSULIN_RECEPTOR_SIGNALLING_CASCADE"
37,"Down",0.339789201252172,0.716875489689182,"B.PvsV.GAJATE_RESPONSE_TO_TRABECTEDIN_DN"
10,"Up",0.339956791996241,0.716875489689182,"B.PvsV.BIOCARTA_BBCELL_PATHWAY"
43,"Up",0.340186512857481,0.716875489689182,"B.PvsV.WENDT_COHESIN_TARGETS_UP"
33,"Down",0.340188074860722,0.716875489689182,"B.PvsV.FIGUEROA_AML_METHYLATION_CLUSTER_4_DN"
14,"Down",0.340211714014323,0.716875489689182,"B.PvsV.BIOCARTA_FXR_PATHWAY"
67,"Down",0.34023817165565,0.716875489689182,"B.PvsV.KYNG_DNA_DAMAGE_BY_4NQO"
53,"Up",0.340350544480756,0.716875489689182,"B.PvsV.HU_ANGIOGENESIS_UP"
96,"Up",0.340566437264703,0.717057056982691,"B.PvsV.OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_UP"
107,"Down",0.340959001589237,0.717610323481878,"B.PvsV.REACTOME_BASE_EXCISION_REPAIR"
147,"Down",0.341340418697584,0.718126392115164,"B.PvsV.CHEN_LIVER_METABOLISM_QTL_CIS"
25,"Down",0.341463969048791,0.718126392115164,"B.PvsV.REACTOME_SIGNALING_BY_ERBB2_ECD_MUTANTS"
87,"Up",0.342174877863269,0.719347870610652,"B.PvsV.KYNG_DNA_DAMAGE_BY_UV"
12,"Down",0.342377501360354,0.719500267967084,"B.PvsV.BIOCARTA_RHODOPSIN_PATHWAY"
9,"Up",0.342578965559484,0.719650114201514,"B.PvsV.REACTOME_FATTY_ACIDS_BOUND_TO_GPR40_FFAR1_REGULATE_INSULIN_SECRETION"
8,"Up",0.3434803643599,0.721269629527491,"B.PvsV.REACTOME_SYNTHESIS_OF_KETONE_BODIES"
105,"Down",0.343962667556152,0.722008196248278,"B.PvsV.OUILLETTE_CLL_13Q14_DELETION_DN"
31,"Down",0.344474723972771,0.722473042486738,"B.PvsV.REACTOME_POU5F1_OCT4_SOX2_NANOG_ACTIVATE_GENES_RELATED_TO_PROLIFERATION"
52,"Up",0.344497356115231,0.722473042486738,"B.PvsV.HUNSBERGER_EXERCISE_REGULATED_GENES"
145,"Down",0.344576128239741,0.722473042486738,"B.PvsV.UEDA_CENTRAL_CLOCK"
15,"Up",0.345483421519983,0.723915325122839,"B.PvsV.BERGER_MBD2_TARGETS"
7,"Down",0.345726357888613,0.723915325122839,"B.PvsV.REACTOME_ELECTRIC_TRANSMISSION_ACROSS_GAP_JUNCTIONS"
186,"Up",0.345744259925002,0.723915325122839,"B.PvsV.CHUNG_BLISTER_CYTOTOXICITY_UP"
95,"Up",0.345787732618813,0.723915325122839,"B.PvsV.RAMASWAMY_METASTASIS_DN"
16,"Up",0.346118421166988,0.724224057823537,"B.PvsV.BIOCARTA_P27_PATHWAY"
29,"Up",0.346197175769146,0.724224057823537,"B.PvsV.LEI_HOXC8_TARGETS_UP"
8,"Down",0.346432265059483,0.724441752463646,"B.PvsV.REACTOME_RUNX3_REGULATES_BCL2L11_BIM_TRANSCRIPTION"
33,"Up",0.346770458722068,0.72464289664922,"B.PvsV.TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_DN"
36,"Up",0.346790577777869,0.72464289664922,"B.PvsV.KEGG_SNARE_INTERACTIONS_IN_VESICULAR_TRANSPORT"
101,"Down",0.347744126447377,0.725955223149308,"B.PvsV.BRIDEAU_IMPRINTED_GENES"
90,"Up",0.347944795793781,0.725955223149308,"B.PvsV.KEGG_LONG_TERM_DEPRESSION"
181,"Down",0.34794992480519,0.725955223149308,"B.PvsV.REACTOME_REGULATION_OF_TP53_ACTIVITY"
87,"Up",0.348026484329911,0.725955223149308,"B.PvsV.KEGG_CHRONIC_MYELOID_LEUKEMIA"
144,"Up",0.348075112419753,0.725955223149308,"B.PvsV.TAKAO_RESPONSE_TO_UVB_RADIATION_UP"
63,"Up",0.348427468369973,0.726118764745425,"B.PvsV.REACTOME_SYNTHESIS_OF_SUBSTRATES_IN_N_GLYCAN_BIOSYTHESIS"
44,"Up",0.348574625124362,0.726118764745425,"B.PvsV.REACTOME_CA_DEPENDENT_EVENTS"
121,"Up",0.348768409775359,0.726118764745425,"B.PvsV.LIAN_LIPA_TARGETS_3M"
20,"Up",0.348782146523643,0.726118764745425,"B.PvsV.REACTOME_MAP3K8_TPL2_DEPENDENT_MAPK1_3_ACTIVATION"
17,"Up",0.348810171670076,0.726118764745425,"B.PvsV.REACTOME_ACTIVATION_OF_RAC1"
244,"Up",0.349059316609683,0.726291217710976,"B.PvsV.CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_UP"
214,"Up",0.34915573461309,0.726291217710976,"B.PvsV.FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP"
230,"Up",0.349387756326172,0.726476174575665,"B.PvsV.ZHANG_BREAST_CANCER_PROGENITORS_DN"
198,"Up",0.349611063081509,0.726476174575665,"B.PvsV.REACTOME_TOLL_LIKE_RECEPTOR_CASCADES"
227,"Up",0.349638831713844,0.726476174575665,"B.PvsV.SUNG_METASTASIS_STROMA_UP"
8,"Down",0.350056981678247,0.727071769984608,"B.PvsV.REACTOME_TLR3_MEDIATED_TICAM1_DEPENDENT_PROGRAMMED_CELL_DEATH"
389,"Up",0.350808096898222,0.727896792126086,"B.PvsV.HOSHIDA_LIVER_CANCER_SUBCLASS_S1"
13,"Up",0.350939265617745,0.727896792126086,"B.PvsV.REACTOME_BINDING_OF_TCF_LEF_CTNNB1_TO_TARGET_GENE_PROMOTERS"
140,"Down",0.35122387335996,0.727896792126086,"B.PvsV.WARTERS_RESPONSE_TO_IR_SKIN"
134,"Down",0.3512319436692,0.727896792126086,"B.PvsV.MORI_PRE_BI_LYMPHOCYTE_UP"
53,"Up",0.351329711745913,0.727896792126086,"B.PvsV.GROSS_HYPOXIA_VIA_ELK3_ONLY_UP"
168,"Up",0.351480419094708,0.727896792126086,"B.PvsV.HAHTOLA_MYCOSIS_FUNGOIDES_CD4_DN"
27,"Up",0.351542111979963,0.727896792126086,"B.PvsV.KAMIKUBO_MYELOID_MN1_NETWORK"
67,"Up",0.351742490145124,0.727896792126086,"B.PvsV.REACTOME_SIGNALING_BY_FGFR1"
516,"Up",0.351792990505477,0.727896792126086,"B.PvsV.ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_DN"
88,"Down",0.35179954935082,0.727896792126086,"B.PvsV.SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM6"
91,"Down",0.3519846302066,0.727896792126086,"B.PvsV.REACTOME_SIGNALING_BY_FGFR2"
12,"Up",0.352108273841914,0.727896792126086,"B.PvsV.REACTOME_TANDEM_PORE_DOMAIN_POTASSIUM_CHANNELS"
69,"Down",0.352165657250367,0.727896792126086,"B.PvsV.PEART_HDAC_PROLIFERATION_CLUSTER_UP"
19,"Up",0.35270062587367,0.728730104804007,"B.PvsV.REACTOME_OAS_ANTIVIRAL_RESPONSE"
51,"Up",0.353122137974123,0.729077364483782,"B.PvsV.BIOCARTA_BCR_PATHWAY"
19,"Up",0.353132425770947,0.729077364483782,"B.PvsV.XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_DN"
18,"Up",0.353467876314077,0.729497531967351,"B.PvsV.LOPEZ_MESOTHELIOMA_SURVIVAL_UP"
188,"Up",0.353712533330379,0.72973007342674,"B.PvsV.WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_UP"
13,"Down",0.354106127365817,0.729879189382528,"B.PvsV.PETRETTO_BLOOD_PRESSURE_DN"
170,"Down",0.35412873042283,0.729879189382528,"B.PvsV.KEGG_PURINE_METABOLISM"
106,"Up",0.35418084013625,0.729879189382528,"B.PvsV.WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER"
236,"Up",0.354423421703666,0.730106966691344,"B.PvsV.TIEN_INTESTINE_PROBIOTICS_6HR_DN"
130,"Down",0.354659322658618,0.730320817497019,"B.PvsV.PID_ERA_GENOMIC_PATHWAY"
185,"Up",0.354864517930793,0.730471302918598,"B.PvsV.FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP"
735,"Down",0.355073228549142,0.730608310357078,"B.PvsV.BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP"
80,"Up",0.355264921742071,0.730608310357078,"B.PvsV.GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_UP"
48,"Up",0.355337504731899,0.730608310357078,"B.PvsV.REACTOME_NEGATIVE_REGULATION_OF_FGFR1_SIGNALING"
34,"Up",0.355845791339151,0.730608310357078,"B.PvsV.STEGER_ADIPOGENESIS_UP"
183,"Down",0.35585092408728,0.730608310357078,"B.PvsV.GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP"
193,"Down",0.355920863478242,0.730608310357078,"B.PvsV.ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_DN"
103,"Up",0.355953955993966,0.730608310357078,"B.PvsV.KUMAR_AUTOPHAGY_NETWORK"
12,"Down",0.356010095024791,0.730608310357078,"B.PvsV.REACTOME_BIOSYNTHESIS_OF_EPA_DERIVED_SPMS"
169,"Up",0.356120346611019,0.730608310357078,"B.PvsV.RAMALHO_STEMNESS_DN"
48,"Up",0.356509761577172,0.73113593166179,"B.PvsV.BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_DN"
107,"Down",0.356977462007661,0.731389667428868,"B.PvsV.FONTAINE_PAPILLARY_THYROID_CARCINOMA_UP"
74,"Up",0.357039200108184,0.731389667428868,"B.PvsV.JIANG_HYPOXIA_CANCER"
25,"Up",0.357167231499344,0.731389667428868,"B.PvsV.REACTOME_NITRIC_OXIDE_STIMULATES_GUANYLATE_CYCLASE"
130,"Up",0.357309751354971,0.731389667428868,"B.PvsV.CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_UP"
31,"Up",0.357518511606417,0.731389667428868,"B.PvsV.BIOCARTA_MTOR_PATHWAY"
70,"Up",0.357528543225428,0.731389667428868,"B.PvsV.ZHAN_MULTIPLE_MYELOMA_MS_UP"
218,"Down",0.357559463024097,0.731389667428868,"B.PvsV.KATSANOU_ELAVL1_TARGETS_DN"
342,"Down",0.357723178381529,0.731389897219156,"B.PvsV.ZWANG_CLASS_3_TRANSIENTLY_INDUCED_BY_EGF"
15,"Down",0.357824140346865,0.731389897219156,"B.PvsV.KOMMAGANI_TP63_GAMMA_TARGETS"
121,"Down",0.358805355738801,0.732877555345982,"B.PvsV.REACTOME_UNFOLDED_PROTEIN_RESPONSE_UPR"
10,"Down",0.358817063179883,0.732877555345982,"B.PvsV.NIKOLSKY_BREAST_CANCER_10Q22_AMPLICON"
22,"Up",0.359153063292255,0.73302150482873,"B.PvsV.KEGG_SULFUR_METABOLISM"
23,"Down",0.359164461834429,0.73302150482873,"B.PvsV.BIOCARTA_PS1_PATHWAY"
17,"Up",0.359285273663566,0.73302150482873,"B.PvsV.REACTOME_SIGNALING_BY_PDGFRA_TRANSMEMBRANE_JUXTAMEMBRANE_AND_KINASE_DOMAIN_MUTANTS"
17,"Up",0.359901868948466,0.734008643827395,"B.PvsV.REACTOME_MRNA_DECAY_BY_3_TO_5_EXORIBONUCLEASE"
16,"Up",0.360053423250871,0.734046967977164,"B.PvsV.NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN"
51,"Down",0.360633847791686,0.734583437306915,"B.PvsV.NIKOLSKY_BREAST_CANCER_7P22_AMPLICON"
28,"Up",0.360644534483394,0.734583437306915,"B.PvsV.BIOCARTA_NKT_PATHWAY"
7,"Up",0.361174205242919,0.734583437306915,"B.PvsV.REACTOME_IKBA_VARIANT_LEADS_TO_EDA_ID"
51,"Up",0.361214025139494,0.734583437306915,"B.PvsV.PID_ERBB1_RECEPTOR_PROXIMAL_PATHWAY"
148,"Up",0.361322897771812,0.734583437306915,"B.PvsV.REACTOME_INTERFERON_GAMMA_SIGNALING"
90,"Down",0.361363811547969,0.734583437306915,"B.PvsV.REACTOME_CYTOSOLIC_SENSORS_OF_PATHOGEN_ASSOCIATED_DNA"
276,"Down",0.361484687218765,0.734583437306915,"B.PvsV.FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP"
324,"Up",0.361526170998648,0.734583437306915,"B.PvsV.REACTOME_SIGNALING_BY_NOTCH"
22,"Down",0.361536346432449,0.734583437306915,"B.PvsV.KEGG_ALPHA_LINOLENIC_ACID_METABOLISM"
38,"Down",0.361645164830787,0.734583437306915,"B.PvsV.MALTA_CURATED_STEMNESS_MARKERS"
45,"Down",0.362190250355281,0.73542045325536,"B.PvsV.FINETTI_BREAST_CANCERS_KINOME_BLUE"
20,"Up",0.363022752618596,0.736840234665279,"B.PvsV.REACTOME_BETA_CATENIN_PHOSPHORYLATION_CASCADE"
27,"Up",0.363347046890133,0.736866283098173,"B.PvsV.REACTOME_METABOLISM_OF_NITRIC_OXIDE_ENOS_ACTIVATION_AND_REGULATION"
95,"Down",0.363406569112778,0.736866283098173,"B.PvsV.BURTON_ADIPOGENESIS_PEAK_AT_24HR"
74,"Up",0.363799083485258,0.736866283098173,"B.PvsV.REACTOME_INTRINSIC_PATHWAY_FOR_APOPTOSIS"
7,"Down",0.36391565249072,0.736866283098173,"B.PvsV.REACTOME_ACTIVATION_OF_C3_AND_C5"
36,"Up",0.364008127416433,0.736866283098173,"B.PvsV.LIU_IL13_MEMORY_MODEL_UP"
30,"Down",0.364033944108667,0.736866283098173,"B.PvsV.STEGER_ADIPOGENESIS_DN"
103,"Up",0.364050006092383,0.736866283098173,"B.PvsV.MORI_MATURE_B_LYMPHOCYTE_DN"
100,"Down",0.364155344383106,0.736866283098173,"B.PvsV.CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_DN"
92,"Down",0.364235042811957,0.736866283098173,"B.PvsV.REACTOME_SIGNALING_BY_NOTCH1"
15,"Up",0.3644000998787,0.736930560435016,"B.PvsV.HOLLEMAN_PREDNISOLONE_RESISTANCE_ALL_DN"
52,"Up",0.365023828736691,0.737799507515399,"B.PvsV.XU_RESPONSE_TO_TRETINOIN_UP"
129,"Up",0.365096663512775,0.737799507515399,"B.PvsV.SANA_RESPONSE_TO_IFNG_DN"
12,"Up",0.365270951326705,0.73788202041847,"B.PvsV.SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX2_DN"
630,"Down",0.366044831136524,0.7390218036719,"B.PvsV.FOSTER_TOLERANT_MACROPHAGE_DN"
308,"Up",0.366109884489898,0.7390218036719,"B.PvsV.MISSIAGLIA_REGULATED_BY_METHYLATION_UP"
79,"Up",0.366236162427384,0.7390218036719,"B.PvsV.KEGG_DRUG_METABOLISM_OTHER_ENZYMES"
12,"Up",0.366470238979087,0.739054055167398,"B.PvsV.SHIRAISHI_PLZF_TARGETS_DN"
152,"Up",0.366550295600942,0.739054055167398,"B.PvsV.PID_CMYB_PATHWAY"
221,"Up",0.366653151261381,0.739054055167398,"B.PvsV.REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION"
32,"Up",0.366849445477145,0.739180241998227,"B.PvsV.FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_UP"
314,"Up",0.367573802715874,0.740369965470334,"B.PvsV.REACTOME_BIOLOGICAL_OXIDATIONS"
24,"Up",0.368012090375005,0.740982828726658,"B.PvsV.REACTOME_SYNTHESIS_SECRETION_AND_DEACYLATION_OF_GHRELIN"
26,"Down",0.368394255161287,0.741023363173315,"B.PvsV.REACTOME_TRAFFICKING_AND_PROCESSING_OF_ENDOSOMAL_TLR"
97,"Down",0.368442240391005,0.741023363173315,"B.PvsV.GRADE_COLON_VS_RECTAL_CANCER_DN"
92,"Down",0.368552737392786,0.741023363173315,"B.PvsV.NIKOLSKY_BREAST_CANCER_8P12_P11_AMPLICON"
13,"Down",0.368568321346829,0.741023363173315,"B.PvsV.MIKKELSEN_NPC_ICP_WITH_H3K27ME3"
1127,"Up",0.369010873712088,0.741364629014286,"B.PvsV.REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM"
69,"Up",0.369111455962715,0.741364629014286,"B.PvsV.GENTILE_UV_HIGH_DOSE_UP"
7,"Down",0.369229446816752,0.741364629014286,"B.PvsV.BIOCARTA_FOSB_PATHWAY"
71,"Up",0.369399172071131,0.741364629014286,"B.PvsV.VERRECCHIA_RESPONSE_TO_TGFB1_C2"
57,"Up",0.369408492120521,0.741364629014286,"B.PvsV.WANG_TARGETS_OF_MLL_CBP_FUSION_DN"
267,"Up",0.369908489704889,0.74209870811986,"B.PvsV.REACTOME_PARASITE_INFECTION"
682,"Down",0.370855589105347,0.743198346408157,"B.PvsV.YAGI_AML_WITH_T_8_21_TRANSLOCATION"
10,"Down",0.370896533185746,0.743198346408157,"B.PvsV.REACTOME_SYNTHESIS_OF_12_EICOSATETRAENOIC_ACID_DERIVATIVES"
80,"Up",0.371162962885891,0.743198346408157,"B.PvsV.ROVERSI_GLIOMA_COPY_NUMBER_DN"
127,"Down",0.371288793040549,0.743198346408157,"B.PvsV.MORI_SMALL_PRE_BII_LYMPHOCYTE_DN"
29,"Up",0.371394004538368,0.743198346408157,"B.PvsV.YAN_ESCAPE_FROM_ANOIKIS"
126,"Up",0.371505773499594,0.743198346408157,"B.PvsV.GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN"
5,"Up",0.371576982217066,0.743198346408157,"B.PvsV.BASSO_HAIRY_CELL_LEUKEMIA_DN"
12,"Up",0.371604450499504,0.743198346408157,"B.PvsV.BIOCARTA_GABA_PATHWAY"
160,"Up",0.371666382314804,0.743198346408157,"B.PvsV.HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_UP"
6,"Down",0.372201643787413,0.743999598156402,"B.PvsV.REACTOME_PROTON_COUPLED_MONOCARBOXYLATE_TRANSPORT"
35,"Down",0.372731668114784,0.744698776902239,"B.PvsV.OZANNE_AP1_TARGETS_UP"
77,"Down",0.372820802037511,0.744698776902239,"B.PvsV.ASTIER_INTEGRIN_SIGNALING"
47,"Down",0.373551409678815,0.745888676097569,"B.PvsV.REACTOME_FATTY_ACIDS"
10,"Down",0.37370673129926,0.745929428647513,"B.PvsV.DER_IFN_BETA_RESPONSE_DN"
55,"Up",0.374206886087462,0.746658200352789,"B.PvsV.ANDERSEN_LIVER_CANCER_KRT19_UP"
11,"Up",0.374447020553423,0.746867812640648,"B.PvsV.LINDGREN_BLADDER_CANCER_CLUSTER_2A_UP"
23,"Up",0.374683790604239,0.747020978749439,"B.PvsV.KEGG_NITROGEN_METABOLISM"
66,"Down",0.375119244862634,0.747020978749439,"B.PvsV.REACTOME_TRNA_PROCESSING_IN_THE_NUCLEUS"
90,"Up",0.37527149907209,0.747020978749439,"B.PvsV.ZHAN_MULTIPLE_MYELOMA_MF_UP"
16,"Down",0.375464688035798,0.747020978749439,"B.PvsV.RADAEVA_RESPONSE_TO_IFNA1_DN"
7,"Down",0.375739472674518,0.747020978749439,"B.PvsV.TERAMOTO_OPN_TARGETS_CLUSTER_3"
19,"Down",0.375747176356246,0.747020978749439,"B.PvsV.REACTOME_REGULATION_OF_RUNX1_EXPRESSION_AND_ACTIVITY"
19,"Up",0.375820378779749,0.747020978749439,"B.PvsV.REACTOME_GLYCOGEN_STORAGE_DISEASES"
81,"Up",0.375853939530703,0.747020978749439,"B.PvsV.KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN"
66,"Down",0.375888406986664,0.747020978749439,"B.PvsV.REACTOME_BILE_ACID_AND_BILE_SALT_METABOLISM"
20,"Down",0.375897371417242,0.747020978749439,"B.PvsV.MIKKELSEN_ES_LCP_WITH_H3K4ME3_AND_H3K27ME3"
65,"Down",0.376010016975889,0.747020978749439,"B.PvsV.SESTO_RESPONSE_TO_UV_C3"
71,"Down",0.376216495389371,0.74716271659764,"B.PvsV.PID_AJDISS_2PATHWAY"
11,"Up",0.376442271892051,0.747342664736499,"B.PvsV.REACTOME_BIOTIN_TRANSPORT_AND_METABOLISM"
642,"Down",0.377118171027881,0.748374115625745,"B.PvsV.REACTOME_CELL_CYCLE_MITOTIC"
262,"Down",0.377232530339836,0.748374115625745,"B.PvsV.NOUZOVA_TRETINOIN_AND_H4_ACETYLATION"
327,"Up",0.377655657832817,0.748944810673475,"B.PvsV.LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER"
116,"Up",0.377930031675275,0.749220202629113,"B.PvsV.REACTOME_POST_TRANSLATIONAL_MODIFICATION_SYNTHESIS_OF_GPI_ANCHORED_PROTEINS"
31,"Down",0.378103070393438,0.74929457928506,"B.PvsV.DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_DN"
279,"Down",0.378326182332511,0.749468098214423,"B.PvsV.PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_DN"
321,"Up",0.378517879261983,0.7495419331966,"B.PvsV.BROWN_MYELOID_CELL_DEVELOPMENT_UP"
74,"Up",0.378634584810653,0.7495419331966,"B.PvsV.KENNY_CTNNB1_TARGETS_UP"
46,"Down",0.378975361172504,0.749948021446949,"B.PvsV.REACTOME_ASSEMBLY_AND_CELL_SURFACE_PRESENTATION_OF_NMDA_RECEPTORS"
63,"Up",0.37987904738217,0.751467353479791,"B.PvsV.TRAYNOR_RETT_SYNDROM_UP"
45,"Up",0.380447381059719,0.752149040140727,"B.PvsV.XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_DN"
184,"Down",0.380535165582128,0.752149040140727,"B.PvsV.NIKOLSKY_BREAST_CANCER_20Q12_Q13_AMPLICON"
13,"Up",0.380631762400751,0.752149040140727,"B.PvsV.REACTOME_MASTL_FACILITATES_MITOTIC_PROGRESSION"
14,"Up",0.381316464880495,0.752942162369046,"B.PvsV.BIOCARTA_CELL2CELL_PATHWAY"
15,"Down",0.381366790366377,0.752942162369046,"B.PvsV.BIOCARTA_SODD_PATHWAY"
7,"Up",0.381441670608735,0.752942162369046,"B.PvsV.REACTOME_VITAMIN_B2_RIBOFLAVIN_METABOLISM"
32,"Down",0.382506589565295,0.754622834857023,"B.PvsV.SILIGAN_TARGETS_OF_EWS_FLI1_FUSION_DN"
768,"Up",0.382579148597321,0.754622834857023,"B.PvsV.SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP"
32,"Down",0.382776484424218,0.754622834857023,"B.PvsV.REACTOME_SIGNALING_BY_ERYTHROPOIETIN"
32,"Up",0.383021103784292,0.754622834857023,"B.PvsV.WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_UP"
78,"Up",0.383035262495601,0.754622834857023,"B.PvsV.PID_CASPASE_PATHWAY"
36,"Up",0.383164429581877,0.754622834857023,"B.PvsV.BIOCARTA_TFF_PATHWAY"
141,"Up",0.383518610948554,0.754622834857023,"B.PvsV.FRIDMAN_SENESCENCE_UP"
528,"Up",0.383521385045197,0.754622834857023,"B.PvsV.RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN"
14,"Down",0.383521462461247,0.754622834857023,"B.PvsV.REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_DEATH_RECEPTORS_AND_LIGANDS"
62,"Up",0.383686859416065,0.754679703205771,"B.PvsV.PID_SYNDECAN_2_PATHWAY"
510,"Up",0.38437722006909,0.755768723243955,"B.PvsV.FARMER_BREAST_CANCER_APOCRINE_VS_LUMINAL"
353,"Up",0.384552538769652,0.75580382912912,"B.PvsV.REACTOME_INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS"
48,"Down",0.384668470821007,0.75580382912912,"B.PvsV.YUAN_ZNF143_PARTNERS"
393,"Down",0.38501596234328,0.756060770069079,"B.PvsV.MUELLER_PLURINET"
78,"Up",0.385072730785771,0.756060770069079,"B.PvsV.REACTOME_BIOSYNTHESIS_OF_THE_N_GLYCAN_PRECURSOR_DOLICHOL_LIPID_LINKED_OLIGOSACCHARIDE_LLO_AND_TRANSFER_TO_A_NASCENT_PROTEIN"
19,"Down",0.385254493223837,0.756149127807808,"B.PvsV.REACTOME_TETRAHYDROBIOPTERIN_BH4_SYNTHESIS_RECYCLING_SALVAGE_AND_REGULATION"
1306,"Up",0.385456110103757,0.756276377843744,"B.PvsV.MARSON_BOUND_BY_FOXP3_STIMULATED"
80,"Up",0.38579974329772,0.756682078997196,"B.PvsV.MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_DN"
2390,"Down",0.386697330028859,0.757804693220622,"B.PvsV.PUJANA_BRCA1_PCC_NETWORK"
56,"Up",0.386764379182095,0.757804693220622,"B.PvsV.TSENG_ADIPOGENIC_POTENTIAL_UP"
1973,"Up",0.386783296123819,0.757804693220622,"B.PvsV.CHEN_METABOLIC_SYNDROM_NETWORK"
50,"Up",0.387221206009427,0.757816312575477,"B.PvsV.PID_P38_ALPHA_BETA_DOWNSTREAM_PATHWAY"
217,"Up",0.387304619974287,0.757816312575477,"B.PvsV.NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN"
8,"Up",0.387560455327121,0.757816312575477,"B.PvsV.BIOCARTA_PLCD_PATHWAY"
6,"Down",0.387786436919902,0.757816312575477,"B.PvsV.REACTOME_P75NTR_NEGATIVELY_REGULATES_CELL_CYCLE_VIA_SC1"
10,"Up",0.38786593259966,0.757816312575477,"B.PvsV.BYSTRYKH_HEMATOPOIESIS_STEM_CELL_FGF3"
538,"Down",0.387898809721556,0.757816312575477,"B.PvsV.AFFAR_YY1_TARGETS_DN"
39,"Down",0.388000822651194,0.757816312575477,"B.PvsV.CHEOK_RESPONSE_TO_HD_MTX_DN"
10,"Up",0.388138833964528,0.757816312575477,"B.PvsV.KAPOSI_LIVER_CANCER_MET_DN"
135,"Up",0.388155679154519,0.757816312575477,"B.PvsV.HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP"
57,"Down",0.38834641671126,0.757816312575477,"B.PvsV.SMID_BREAST_CANCER_RELAPSE_IN_LUNG_DN"
587,"Up",0.388585314384973,0.757816312575477,"B.PvsV.DELACROIX_RARG_BOUND_MEF"
21,"Down",0.388616715737635,0.757816312575477,"B.PvsV.REACTOME_TRANSLESION_SYNTHESIS_BY_POLH"
139,"Up",0.388650987452273,0.757816312575477,"B.PvsV.ROSS_AML_WITH_MLL_FUSIONS"
667,"Down",0.388753199528978,0.757816312575477,"B.PvsV.OSMAN_BLADDER_CANCER_DN"
81,"Down",0.388845158035201,0.757816312575477,"B.PvsV.RASHI_RESPONSE_TO_IONIZING_RADIATION_1"
13,"Down",0.389183668135852,0.7582087741801,"B.PvsV.REACTOME_INACTIVATION_OF_CDC42_AND_RAC1"
77,"Up",0.389806452510042,0.758556879949873,"B.PvsV.POMEROY_MEDULLOBLASTOMA_PROGNOSIS_UP"
34,"Down",0.389947894147864,0.758556879949873,"B.PvsV.SHIN_B_CELL_LYMPHOMA_CLUSTER_7"
21,"Up",0.390012167060312,0.758556879949873,"B.PvsV.REACTOME_TNF_RECEPTOR_SUPERFAMILY_TNFSF_MEMBERS_MEDIATING_NON_CANONICAL_NF_KB_PATHWAY"
225,"Down",0.390215147598254,0.758556879949873,"B.PvsV.REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS"
28,"Up",0.390304479593834,0.758556879949873,"B.PvsV.BIOCARTA_ATM_PATHWAY"
8,"Down",0.39030484224963,0.758556879949873,"B.PvsV.REACTOME_SUPPRESSION_OF_APOPTOSIS"
39,"Up",0.390322720827887,0.758556879949873,"B.PvsV.REACTOME_SIGNALING_BY_NTRK2_TRKB"
39,"Down",0.390615856494573,0.758858071742619,"B.PvsV.PID_IL2_STAT5_PATHWAY"
32,"Down",0.390752202975445,0.758858071742619,"B.PvsV.REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR4"
35,"Up",0.39095100807202,0.758929968293809,"B.PvsV.PID_S1P_S1P2_PATHWAY"
29,"Down",0.391063751070548,0.758929968293809,"B.PvsV.TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_DN"
72,"Up",0.391206283149545,0.758940189310117,"B.PvsV.ALONSO_METASTASIS_EMT_UP"
95,"Up",0.391507995873181,0.759229972872796,"B.PvsV.KIM_GERMINAL_CENTER_T_HELPER_UP"
354,"Up",0.39173957926341,0.759229972872796,"B.PvsV.GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN"
36,"Up",0.39176760944223,0.759229972872796,"B.PvsV.PID_ECADHERIN_KERATINOCYTE_PATHWAY"
46,"Up",0.392348618730989,0.759843173151377,"B.PvsV.BIOCARTA_NGF_PATHWAY"
16,"Down",0.392358882139118,0.759843173151377,"B.PvsV.REACTOME_AKT_PHOSPHORYLATES_TARGETS_IN_THE_CYTOSOL"
37,"Up",0.393041673508086,0.760856612627742,"B.PvsV.BIOCARTA_EIF_PATHWAY"
48,"Down",0.393225174330557,0.760856612627742,"B.PvsV.BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_UP"
40,"Down",0.393295026024613,0.760856612627742,"B.PvsV.SIMBULAN_PARP1_TARGETS_DN"
67,"Up",0.393612064033843,0.761203603372899,"B.PvsV.MORI_PLASMA_CELL_UP"
83,"Up",0.393757105838861,0.761217845518553,"B.PvsV.KEGG_EPITHELIAL_CELL_SIGNALING_IN_HELICOBACTER_PYLORI_INFECTION"
37,"Up",0.394085672300393,0.761278546191525,"B.PvsV.WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_36HR"
21,"Up",0.394276758899238,0.761278546191525,"B.PvsV.CHESLER_BRAIN_QTL_TRANS"
18,"Up",0.394490849361998,0.761278546191525,"B.PvsV.REACTOME_EARLY_PHASE_OF_HIV_LIFE_CYCLE"
121,"Down",0.39465480397886,0.761278546191525,"B.PvsV.REACTOME_TRNA_PROCESSING"
11,"Down",0.394850650034605,0.761278546191525,"B.PvsV.REACTOME_ERYTHROPOIETIN_ACTIVATES_PHOSPHOLIPASE_C_GAMMA_PLCG"
1501,"Up",0.395099664062928,0.761278546191525,"B.PvsV.LOPEZ_MBD_TARGETS"
300,"Up",0.395193779808885,0.761278546191525,"B.PvsV.REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1"
35,"Up",0.395200823100681,0.761278546191525,"B.PvsV.NIKOLSKY_BREAST_CANCER_15Q26_AMPLICON"
173,"Down",0.395279081533739,0.761278546191525,"B.PvsV.REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION"
30,"Up",0.395304906918363,0.761278546191525,"B.PvsV.REACTOME_ZBP1_DAI_MEDIATED_INDUCTION_OF_TYPE_I_IFNS"
27,"Up",0.395357726740028,0.761278546191525,"B.PvsV.REACTOME_MITOCHONDRIAL_TRNA_AMINOACYLATION"
74,"Up",0.395440764091528,0.761278546191525,"B.PvsV.DAVIES_MULTIPLE_MYELOMA_VS_MGUS_DN"
119,"Down",0.39564544016752,0.761407462125381,"B.PvsV.WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_DN"
235,"Up",0.397308473296725,0.763454396792214,"B.PvsV.REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION"
208,"Up",0.397375762779259,0.763454396792214,"B.PvsV.REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX"
42,"Up",0.39745250579575,0.763454396792214,"B.PvsV.REACTOME_REGULATION_OF_TP53_EXPRESSION_AND_DEGRADATION"
518,"Down",0.397628081918084,0.763454396792214,"B.PvsV.CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN"
826,"Up",0.397649382937359,0.763454396792214,"B.PvsV.FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP"
73,"Up",0.397672944422026,0.763454396792214,"B.PvsV.PID_ANGIOPOIETIN_RECEPTOR_PATHWAY"
117,"Down",0.39767564889882,0.763454396792214,"B.PvsV.REACTOME_ARACHIDONIC_ACID_METABOLISM"
72,"Up",0.398344581587923,0.764243680969666,"B.PvsV.JIANG_TIP30_TARGETS_UP"
16,"Up",0.398363228170479,0.764243680969666,"B.PvsV.GAUSSMANN_MLL_AF4_FUSION_TARGETS_D_DN"
13,"Down",0.398943565569222,0.764554189178033,"B.PvsV.REACTOME_CASPASE_ACTIVATION_VIA_DEPENDENCE_RECEPTORS_IN_THE_ABSENCE_OF_LIGAND"
144,"Up",0.399232919032767,0.764554189178033,"B.PvsV.YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_9"
9,"Down",0.399331035780721,0.764554189178033,"B.PvsV.REACTOME_LIGAND_RECEPTOR_INTERACTIONS"
135,"Up",0.399339758125353,0.764554189178033,"B.PvsV.FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_DN"
13,"Up",0.3994214682629,0.764554189178033,"B.PvsV.WANG_RESPONSE_TO_FORSKOLIN_DN"
49,"Up",0.399491561166937,0.764554189178033,"B.PvsV.VERRECCHIA_RESPONSE_TO_TGFB1_C5"
162,"Up",0.399493046217279,0.764554189178033,"B.PvsV.PURBEY_TARGETS_OF_CTBP1_AND_SATB1_UP"
39,"Down",0.400207453321865,0.765656404642418,"B.PvsV.REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_ACETYLATION"
134,"Up",0.400366319322063,0.765695392435726,"B.PvsV.DELASERNA_MYOD_TARGETS_UP"
10,"Down",0.40056556142038,0.76570499549479,"B.PvsV.REACTOME_THYROXINE_BIOSYNTHESIS"
15,"Up",0.400648318315505,0.76570499549479,"B.PvsV.REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_TO_CONTROL_BILE_ACID_HOMEOSTASIS"
50,"Up",0.401067992293049,0.766242200894356,"B.PvsV.REACTOME_FORMATION_OF_INCISION_COMPLEX_IN_GG_NER"
10,"Down",0.401288469506179,0.766398600310765,"B.PvsV.BIOCARTA_FBW7_PATHWAY"
330,"Up",0.40150995515668,0.766556817010111,"B.PvsV.TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP"
318,"Down",0.401971541160471,0.76693982626203,"B.PvsV.BHAT_ESR1_TARGETS_NOT_VIA_AKT1_UP"
20,"Down",0.401987993580641,0.76693982626203,"B.PvsV.BIOCARTA_PLC_PATHWAY"
62,"Down",0.402179262700112,0.767002786405675,"B.PvsV.REACTOME_DEACTIVATION_OF_THE_BETA_CATENIN_TRANSACTIVATING_COMPLEX"
180,"Down",0.402496929233116,0.767002786405675,"B.PvsV.DAZARD_RESPONSE_TO_UV_SCC_DN"
15,"Up",0.402521869816682,0.767002786405675,"B.PvsV.BIOCARTA_IL17_PATHWAY"
27,"Down",0.402626507469393,0.767002786405675,"B.PvsV.KARAKAS_TGFB1_SIGNALING"
70,"Down",0.402816262920178,0.767002786405675,"B.PvsV.MA_MYELOID_DIFFERENTIATION_DN"
32,"Down",0.402853335453442,0.767002786405675,"B.PvsV.WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_DN"
49,"Down",0.403074004838094,0.767158751376876,"B.PvsV.KAMMINGA_SENESCENCE"
48,"Up",0.403314831876802,0.767352961268699,"B.PvsV.BIOCARTA_EGF_PATHWAY"
45,"Up",0.403760325334325,0.767381965057015,"B.PvsV.PID_IL1_PATHWAY"
1220,"Up",0.403851741562957,0.767381965057015,"B.PvsV.ONKEN_UVEAL_MELANOMA_UP"
11,"Down",0.404074580150692,0.767381965057015,"B.PvsV.REACTOME_ACTIVATION_OF_CASPASES_THROUGH_APOPTOSOME_MEDIATED_CLEAVAGE"
25,"Down",0.404151078907819,0.767381965057015,"B.PvsV.BIOCARTA_ETS_PATHWAY"
123,"Down",0.404173155740679,0.767381965057015,"B.PvsV.KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_UP"
12,"Up",0.404194041819099,0.767381965057015,"B.PvsV.NADELLA_PRKAR1A_TARGETS_UP"
65,"Up",0.404714016992816,0.767381965057015,"B.PvsV.GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_UP"
37,"Up",0.404823833514818,0.767381965057015,"B.PvsV.REACTOME_DECTIN_2_FAMILY"
47,"Up",0.404881577559529,0.767381965057015,"B.PvsV.PID_NEPHRIN_NEPH1_PATHWAY"
204,"Up",0.404887695298666,0.767381965057015,"B.PvsV.CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_DN"
185,"Down",0.404986764756425,0.767381965057015,"B.PvsV.PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_4"
67,"Down",0.405071916645503,0.767381965057015,"B.PvsV.REACTOME_NEUROTRANSMITTER_RELEASE_CYCLE"
25,"Up",0.40513437438984,0.767381965057015,"B.PvsV.WALLACE_PROSTATE_CANCER_UP"
63,"Down",0.405411186545426,0.767643304934816,"B.PvsV.SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2"
30,"Up",0.405731862128431,0.767776002350966,"B.PvsV.REACTOME_APC_CDC20_MEDIATED_DEGRADATION_OF_NEK2A"
25,"Up",0.405758994188736,0.767776002350966,"B.PvsV.KEGG_GLYCOSPHINGOLIPID_BIOSYNTHESIS_LACTO_AND_NEOLACTO_SERIES"
462,"Down",0.406036495706934,0.768038243162381,"B.PvsV.YAMAZAKI_TCEB3_TARGETS_DN"
79,"Up",0.406650874898156,0.768880929064148,"B.PvsV.SPIRA_SMOKERS_LUNG_CANCER_UP"
337,"Up",0.406856917891732,0.768880929064148,"B.PvsV.MCBRYAN_PUBERTAL_BREAST_6_7WK_UP"
431,"Down",0.406899185827762,0.768880929064148,"B.PvsV.BONOME_OVARIAN_CANCER_SURVIVAL_OPTIMAL_DEBULKING"
276,"Up",0.407184460087584,0.769157116441494,"B.PvsV.AMIT_EGF_RESPONSE_480_HELA"
99,"Down",0.407344257511158,0.769196174787976,"B.PvsV.LY_AGING_OLD_DN"
145,"Up",0.408222900686534,0.770592153600495,"B.PvsV.MORI_PRE_BI_LYMPHOCYTE_DN"
1873,"Down",0.408481660552937,0.770817440681634,"B.PvsV.DODD_NASOPHARYNGEAL_CARCINOMA_DN"
143,"Up",0.408755886436099,0.770846372264556,"B.PvsV.KEGG_NEUROTROPHIN_SIGNALING_PATHWAY"
173,"Down",0.408920581528381,0.770846372264556,"B.PvsV.CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP"
29,"Up",0.409305894455366,0.770846372264556,"B.PvsV.BIOCARTA_CXCR4_PATHWAY"
30,"Up",0.409414381414982,0.770846372264556,"B.PvsV.REACTOME_CD28_DEPENDENT_PI3K_AKT_SIGNALING"
16,"Up",0.409633175090574,0.770846372264556,"B.PvsV.REACTOME_DEFECTIVE_GALNT3_CAUSES_FAMILIAL_HYPERPHOSPHATEMIC_TUMORAL_CALCINOSIS_HFTC"
28,"Up",0.409659705694961,0.770846372264556,"B.PvsV.HOLLEMAN_PREDNISOLONE_RESISTANCE_B_ALL_UP"
83,"Down",0.409681279839188,0.770846372264556,"B.PvsV.HAN_JNK_SINGALING_UP"
8,"Up",0.409688325513261,0.770846372264556,"B.PvsV.REACTOME_FBXW7_MUTANTS_AND_NOTCH1_IN_CANCER"
77,"Up",0.409751761274286,0.770846372264556,"B.PvsV.KEGG_ADIPOCYTOKINE_SIGNALING_PATHWAY"
30,"Up",0.41012372593023,0.771283700907565,"B.PvsV.KEGG_BETA_ALANINE_METABOLISM"
291,"Up",0.41046820905181,0.771501098603046,"B.PvsV.REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT"
248,"Up",0.410565893351476,0.771501098603046,"B.PvsV.ZHU_CMV_ALL_UP"
81,"Down",0.410657936912419,0.771501098603046,"B.PvsV.HENDRICKS_SMARCA4_TARGETS_DN"
10,"Up",0.411036628303312,0.771826213746679,"B.PvsV.REACTOME_RHO_GTPASES_ACTIVATE_RHOTEKIN_AND_RHOPHILINS"
79,"Up",0.411115239443643,0.771826213746679,"B.PvsV.HOWLIN_CITED1_TARGETS_1_UP"
152,"Down",0.41124977856714,0.771826213746679,"B.PvsV.RIGGINS_TAMOXIFEN_RESISTANCE_UP"
131,"Up",0.411826935313391,0.772506229738208,"B.PvsV.GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP"
369,"Down",0.41189154734459,0.772506229738208,"B.PvsV.HAMAI_APOPTOSIS_VIA_TRAIL_DN"
51,"Down",0.412276117963478,0.772953625645295,"B.PvsV.HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_UP"
113,"Up",0.412472665936184,0.772953625645295,"B.PvsV.HOWLIN_CITED1_TARGETS_1_DN"
21,"Down",0.41262934707931,0.772953625645295,"B.PvsV.REACTOME_NRIF_SIGNALS_CELL_DEATH_FROM_THE_NUCLEUS"
298,"Down",0.412689293345073,0.772953625645295,"B.PvsV.SMID_BREAST_CANCER_LUMINAL_B_UP"
136,"Down",0.413513507017646,0.773540309627855,"B.PvsV.ROSS_AML_WITH_PML_RARA_FUSION"
19,"Up",0.413534753050331,0.773540309627855,"B.PvsV.REACTOME_RIP_MEDIATED_NFKB_ACTIVATION_VIA_ZBP1"
53,"Up",0.41355356842018,0.773540309627855,"B.PvsV.REACTOME_SYNDECAN_INTERACTIONS"
61,"Down",0.413746276836455,0.773540309627855,"B.PvsV.REACTOME_FORMATION_OF_TC_NER_PRE_INCISION_COMPLEX"
9,"Up",0.41390692123907,0.773540309627855,"B.PvsV.BIOCARTA_IRES_PATHWAY"
86,"Up",0.413980457775774,0.773540309627855,"B.PvsV.GUILLAUMOND_KLF10_TARGETS_UP"
20,"Up",0.414132013544286,0.773540309627855,"B.PvsV.ONGUSAHA_BRCA1_TARGETS_DN"
106,"Up",0.414292480824664,0.773540309627855,"B.PvsV.KEGG_GAP_JUNCTION"
47,"Up",0.414331420122038,0.773540309627855,"B.PvsV.REACTOME_SEMA4D_IN_SEMAPHORIN_SIGNALING"
50,"Down",0.414514682196212,0.773540309627855,"B.PvsV.TOMIDA_METASTASIS_UP"
15,"Up",0.41460029888453,0.773540309627855,"B.PvsV.PID_INTEGRIN4_PATHWAY"
21,"Up",0.414714487548601,0.773540309627855,"B.PvsV.BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_48HR_UP"
184,"Down",0.414821309105913,0.773540309627855,"B.PvsV.YAGI_AML_SURVIVAL"
80,"Down",0.415058237877591,0.773721172361834,"B.PvsV.KERLEY_RESPONSE_TO_CISPLATIN_UP"
89,"Up",0.415349546073628,0.773793839187626,"B.PvsV.REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH"
24,"Up",0.415448611761416,0.773793839187626,"B.PvsV.REACTOME_DCC_MEDIATED_ATTRACTIVE_SIGNALING"
34,"Down",0.415517075157906,0.773793839187626,"B.PvsV.REACTOME_TIGHT_JUNCTION_INTERACTIONS"
18,"Down",0.416250433240473,0.774898533800194,"B.PvsV.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_DN"
52,"Down",0.416490374591588,0.775084241372229,"B.PvsV.REACTOME_ELASTIC_FIBRE_FORMATION"
18,"Up",0.416689927308033,0.775194686435436,"B.PvsV.REACTOME_GRB2_EVENTS_IN_ERBB2_SIGNALING"
131,"Down",0.417033005266575,0.775571976494751,"B.PvsV.KEGG_CELL_CYCLE"
21,"Up",0.41775462510624,0.776652764698184,"B.PvsV.REACTOME_ERYTHROPOIETIN_ACTIVATES_RAS"
126,"Up",0.418334875879484,0.777451986527742,"B.PvsV.REACTOME_CARGO_RECOGNITION_FOR_CLATHRIN_MEDIATED_ENDOCYTOSIS"
357,"Down",0.418549509695722,0.777451986527742,"B.PvsV.REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS"
58,"Down",0.418649879797348,0.777451986527742,"B.PvsV.PARK_HSC_MARKERS"
58,"Up",0.418855715022202,0.777451986527742,"B.PvsV.WEINMANN_ADAPTATION_TO_HYPOXIA_UP"
385,"Down",0.419100326431894,0.777451986527742,"B.PvsV.COLDREN_GEFITINIB_RESISTANCE_DN"
6,"Down",0.419251631658611,0.777451986527742,"B.PvsV.ZHAN_EARLY_DIFFERENTIATION_GENES_UP"
154,"Up",0.419295173617542,0.777451986527742,"B.PvsV.ANDERSEN_LIVER_CANCER_KRT19_DN"
10,"Down",0.419374143973428,0.777451986527742,"B.PvsV.RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_SMAD4_UP"
130,"Down",0.41962048208928,0.777451986527742,"B.PvsV.REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS"
1060,"Down",0.419672890047597,0.777451986527742,"B.PvsV.MARTINEZ_TP53_TARGETS_DN"
233,"Up",0.419867871984603,0.777451986527742,"B.PvsV.ZHU_CMV_ALL_DN"
420,"Up",0.4198718813116,0.777451986527742,"B.PvsV.NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP"
33,"Up",0.420076251706756,0.777570001903801,"B.PvsV.OZEN_MIR125B1_TARGETS"
202,"Up",0.420477104748382,0.777797033631716,"B.PvsV.HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN"
746,"Down",0.420480694595767,0.777797033631716,"B.PvsV.MITSIADES_RESPONSE_TO_APLIDIN_UP"
194,"Down",0.420620931553415,0.777797033631716,"B.PvsV.ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_UP"
26,"Down",0.42111427968942,0.778121509573948,"B.PvsV.REACTOME_ABC_TRANSPORTERS_IN_LIPID_HOMEOSTASIS"
188,"Up",0.421191610842296,0.778121509573948,"B.PvsV.ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION"
18,"Up",0.421218607009373,0.778121509573948,"B.PvsV.REACTOME_PECAM1_INTERACTIONS"
86,"Up",0.421619165384685,0.77860132445288,"B.PvsV.KENNY_CTNNB1_TARGETS_DN"
700,"Down",0.422204646632527,0.779134434368366,"B.PvsV.MARTENS_BOUND_BY_PML_RARA_FUSION"
37,"Down",0.422276528784897,0.779134434368366,"B.PvsV.REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR2"
34,"Down",0.422330602243081,0.779134434368366,"B.PvsV.REACTOME_INSULIN_PROCESSING"
279,"Down",0.422628599079445,0.779187026979915,"B.PvsV.UEDA_PERIFERAL_CLOCK"
11,"Down",0.42267227231428,0.779187026979915,"B.PvsV.REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_CASPASE_ACTIVATORS_AND_CASPASES"
305,"Up",0.422872259214231,0.779187026979915,"B.PvsV.REACTOME_FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS"
18,"Down",0.423014090390232,0.779187026979915,"B.PvsV.REACTOME_SHC1_EVENTS_IN_EGFR_SIGNALING"
2398,"Down",0.423063746607652,0.779187026979915,"B.PvsV.DODD_NASOPHARYNGEAL_CARCINOMA_UP"
30,"Down",0.423616644181164,0.77920818460923,"B.PvsV.WAGNER_APO2_SENSITIVITY"
20,"Up",0.423648476934716,0.77920818460923,"B.PvsV.PID_TCR_JNK_PATHWAY"
163,"Up",0.423691121595799,0.77920818460923,"B.PvsV.TAYLOR_METHYLATED_IN_ACUTE_LYMPHOBLASTIC_LEUKEMIA"
137,"Down",0.423751574397076,0.77920818460923,"B.PvsV.BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_C"
112,"Down",0.423779889875195,0.77920818460923,"B.PvsV.WIEDERSCHAIN_TARGETS_OF_BMI1_AND_PCGF2"
1586,"Up",0.424764942750319,0.780439484222818,"B.PvsV.BRUINS_UVC_RESPONSE_LATE"
10,"Up",0.425114731592477,0.780439484222818,"B.PvsV.DASU_IL6_SIGNALING_DN"
48,"Up",0.425121745247678,0.780439484222818,"B.PvsV.HEIDENBLAD_AMPLICON_12P11_12_UP"
162,"Down",0.425191012096389,0.780439484222818,"B.PvsV.REACTOME_MEIOTIC_SYNAPSIS"
6,"Down",0.425388922148043,0.780439484222818,"B.PvsV.REACTOME_GDP_FUCOSE_BIOSYNTHESIS"
66,"Up",0.425453932170046,0.780439484222818,"B.PvsV.TING_SILENCED_BY_DICER"
521,"Up",0.425520165984041,0.780439484222818,"B.PvsV.WALLACE_PROSTATE_CANCER_RACE_UP"
198,"Down",0.425578774630457,0.780439484222818,"B.PvsV.NIKOLSKY_BREAST_CANCER_17Q11_Q21_AMPLICON"
338,"Up",0.425970490580807,0.780724295601153,"B.PvsV.TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN"
10,"Down",0.426165952858956,0.780724295601153,"B.PvsV.REACTOME_PTK6_PROMOTES_HIF1A_STABILIZATION"
190,"Up",0.426240772511633,0.780724295601153,"B.PvsV.KOBAYASHI_EGFR_SIGNALING_24HR_UP"
99,"Down",0.42636630090894,0.780724295601153,"B.PvsV.LEE_TARGETS_OF_PTCH1_AND_SUFU_UP"
48,"Down",0.426440110818499,0.780724295601153,"B.PvsV.AIGNER_ZEB1_TARGETS"
23,"Down",0.426596735493049,0.780752515902373,"B.PvsV.DING_LUNG_CANCER_MUTATED_FREQUENTLY"
22,"Up",0.427155185048369,0.781172834377806,"B.PvsV.GRAHAM_CML_DIVIDING_VS_NORMAL_DIVIDING_DN"
13,"Down",0.427156897425282,0.781172834377806,"B.PvsV.REACTOME_SMAC_XIAP_REGULATED_APOPTOTIC_RESPONSE"
123,"Down",0.427250253419875,0.781172834377806,"B.PvsV.FALVELLA_SMOKERS_WITH_LUNG_CANCER"
181,"Up",0.427397691798935,0.781184078663243,"B.PvsV.MCLACHLAN_DENTAL_CARIES_DN"
251,"Up",0.427885531262995,0.781610149954429,"B.PvsV.HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_UP"
56,"Up",0.427985071254652,0.781610149954429,"B.PvsV.KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION"
15,"Up",0.428054898546213,0.781610149954429,"B.PvsV.REACTOME_REMOVAL_OF_AMINOTERMINAL_PROPEPTIDES_FROM_GAMMA_CARBOXYLATED_PROTEINS"
23,"Down",0.428397034535695,0.781890824095487,"B.PvsV.REACTOME_ASSEMBLY_OF_THE_HIV_VIRION"
137,"Down",0.428583089594767,0.781890824095487,"B.PvsV.LEE_AGING_NEOCORTEX_UP"
8,"Up",0.428739888098277,0.781890824095487,"B.PvsV.REACTOME_TRNA_MODIFICATION_IN_THE_MITOCHONDRION"
19,"Up",0.428774277203385,0.781890824095487,"B.PvsV.MOROSETTI_FACIOSCAPULOHUMERAL_MUSCULAR_DISTROPHY_DN"
109,"Down",0.42939798853997,0.782770022630233,"B.PvsV.SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN"
5,"Down",0.429891088840284,0.783182500350562,"B.PvsV.REACTOME_G2_PHASE"
362,"Up",0.429907558069082,0.783182500350562,"B.PvsV.REACTOME_ASPARAGINE_N_LINKED_GLYCOSYLATION"
61,"Up",0.430075956026333,0.78323121240764,"B.PvsV.CHEOK_RESPONSE_TO_HD_MTX_UP"
53,"Down",0.430363873115159,0.783497482533327,"B.PvsV.REACTOME_TNF_SIGNALING"
116,"Up",0.430779266274948,0.783970560036664,"B.PvsV.BURTON_ADIPOGENESIS_4"
9,"Down",0.431033610118422,0.783970560036664,"B.PvsV.REACTOME_TRIF_MEDIATED_PROGRAMMED_CELL_DEATH"
6,"Down",0.431125999772753,0.783970560036664,"B.PvsV.BIOCARTA_ACETAMINOPHEN_PATHWAY"
19,"Down",0.431190897643605,0.783970560036664,"B.PvsV.LU_TUMOR_VASCULATURE_DN"
817,"Up",0.431792875323907,0.784416273737418,"B.PvsV.ACEVEDO_LIVER_CANCER_DN"
1070,"Up",0.432039285646344,0.784416273737418,"B.PvsV.SCHLOSSER_SERUM_RESPONSE_DN"
46,"Up",0.432048131144397,0.784416273737418,"B.PvsV.REACTOME_DETOXIFICATION_OF_REACTIVE_OXYGEN_SPECIES"
22,"Up",0.432285299993156,0.784416273737418,"B.PvsV.REACTOME_ACETYLCHOLINE_NEUROTRANSMITTER_RELEASE_CYCLE"
448,"Up",0.432368090479053,0.784416273737418,"B.PvsV.IVANOVA_HEMATOPOIESIS_MATURE_CELL"
134,"Down",0.432403899201388,0.784416273737418,"B.PvsV.VANHARANTA_UTERINE_FIBROID_DN"
24,"Down",0.432429155787963,0.784416273737418,"B.PvsV.REACTOME_PI_3K_CASCADE_FGFR4"
44,"Up",0.433311248251245,0.785100488229968,"B.PvsV.DANG_MYC_TARGETS_DN"
225,"Down",0.433369388281522,0.785100488229968,"B.PvsV.SENGUPTA_EBNA1_ANTICORRELATED"
112,"Up",0.433372342757971,0.785100488229968,"B.PvsV.BOYAULT_LIVER_CANCER_SUBCLASS_G6_UP"
318,"Up",0.43337433352828,0.785100488229968,"B.PvsV.REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR"
34,"Up",0.433894743661872,0.785785796824924,"B.PvsV.PETRETTO_HEART_MASS_QTL_CIS_DN"
455,"Up",0.43410296347862,0.785905463350783,"B.PvsV.DURCHDEWALD_SKIN_CARCINOGENESIS_DN"
79,"Up",0.434394059982892,0.78617504341912,"B.PvsV.REACTOME_DNA_METHYLATION"
24,"Down",0.434850895961978,0.786611109387303,"B.PvsV.HASINA_NOL7_TARGETS_DN"
11,"Down",0.434919544474043,0.786611109387303,"B.PvsV.STEGMEIER_PREMITOTIC_CELL_CYCLE_REGULATORS"
162,"Up",0.435214240360304,0.786886702077215,"B.PvsV.YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_6"
313,"Up",0.43581244680009,0.787710695769107,"B.PvsV.BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_DN"
232,"Up",0.436453721205369,0.788611968805387,"B.PvsV.SMITH_TERT_TARGETS_UP"
7,"Down",0.436746348261721,0.788882900862155,"B.PvsV.REACTOME_ACROSOME_REACTION_AND_SPERM_OOCYTE_MEMBRANE_BINDING"
89,"Up",0.437416659541336,0.789835633770101,"B.PvsV.REACTOME_CONSTITUTIVE_SIGNALING_BY_ABERRANT_PI3K_IN_CANCER"
14,"Up",0.438247219233526,0.79056442891332,"B.PvsV.BIOCARTA_AMAN_PATHWAY"
185,"Up",0.438267554237472,0.79056442891332,"B.PvsV.MORI_MATURE_B_LYMPHOCYTE_UP"
33,"Up",0.438341590081516,0.79056442891332,"B.PvsV.REACTOME_LONG_TERM_POTENTIATION"
56,"Up",0.438392211801092,0.79056442891332,"B.PvsV.LIAN_NEUTROPHIL_GRANULE_CONSTITUENTS"
58,"Up",0.438776608126174,0.790818041760306,"B.PvsV.HUMMERICH_MALIGNANT_SKIN_TUMOR_UP"
9,"Up",0.438938998163917,0.790818041760306,"B.PvsV.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_2"
97,"Up",0.438961940705802,0.790818041760306,"B.PvsV.REACTOME_ACTIVATED_PKN1_STIMULATES_TRANSCRIPTION_OF_AR_ANDROGEN_RECEPTOR_REGULATED_GENES_KLK2_AND_KLK3"
20,"Up",0.439529789071771,0.791329472755673,"B.PvsV.BARRIER_CANCER_RELAPSE_TUMOR_SAMPLE_UP"
83,"Down",0.439592432226219,0.791329472755673,"B.PvsV.BIOCARTA_NUCLEARRS_PATHWAY"
98,"Up",0.439810621049809,0.791329472755673,"B.PvsV.KIM_LRRC3B_TARGETS"
41,"Up",0.439929204440784,0.791329472755673,"B.PvsV.LU_TUMOR_ANGIOGENESIS_UP"
43,"Down",0.4399614395462,0.791329472755673,"B.PvsV.DISTECHE_ESCAPED_FROM_X_INACTIVATION"
93,"Up",0.440526470786242,0.791690559279019,"B.PvsV.REACTOME_ERCC6_CSB_AND_EHMT2_G9A_POSITIVELY_REGULATE_RRNA_EXPRESSION"
25,"Up",0.440645907910243,0.791690559279019,"B.PvsV.REACTOME_INITIATION_OF_NUCLEAR_ENVELOPE_NE_REFORMATION"
52,"Down",0.440890814360101,0.791690559279019,"B.PvsV.KEGG_ALDOSTERONE_REGULATED_SODIUM_REABSORPTION"
151,"Down",0.441004561723346,0.791690559279019,"B.PvsV.COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP"
71,"Down",0.441057926204925,0.791690559279019,"B.PvsV.WEINMANN_ADAPTATION_TO_HYPOXIA_DN"
54,"Up",0.441144423259751,0.791690559279019,"B.PvsV.MARZEC_IL2_SIGNALING_DN"
69,"Down",0.441198827420179,0.791690559279019,"B.PvsV.KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY"
31,"Down",0.441307705497909,0.791690559279019,"B.PvsV.PID_S1P_META_PATHWAY"
42,"Down",0.441630282811302,0.792012271704083,"B.PvsV.REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR1"
11,"Down",0.441917558066991,0.792270485911931,"B.PvsV.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_LIGHTGREEN_DN"
22,"Down",0.44227561786075,0.792527730847676,"B.PvsV.BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_24HR_DN"
41,"Up",0.442449681506741,0.792527730847676,"B.PvsV.REACTOME_INWARDLY_RECTIFYING_K_CHANNELS"
20,"Down",0.442811725093745,0.792527730847676,"B.PvsV.REACTOME_HDL_ASSEMBLY"
564,"Up",0.442963034664645,0.792527730847676,"B.PvsV.COLINA_TARGETS_OF_4EBP1_AND_4EBP2"
296,"Down",0.443016992618395,0.792527730847676,"B.PvsV.SMIRNOV_RESPONSE_TO_IR_6HR_UP"
167,"Down",0.443083234125133,0.792527730847676,"B.PvsV.SMID_BREAST_CANCER_RELAPSE_IN_BONE_UP"
454,"Up",0.443096757193547,0.792527730847676,"B.PvsV.DOUGLAS_BMI1_TARGETS_DN"
162,"Down",0.443207767006876,0.792527730847676,"B.PvsV.HOEBEKE_LYMPHOID_STEM_CELL_UP"
59,"Down",0.44382087116589,0.793367473868802,"B.PvsV.GEISS_RESPONSE_TO_DSRNA_UP"
9,"Up",0.444230953227553,0.793843872138055,"B.PvsV.REACTOME_SODIUM_PROTON_EXCHANGERS"
45,"Up",0.444832791447432,0.794446894643343,"B.PvsV.REACTOME_AMINE_LIGAND_BINDING_RECEPTORS"
40,"Up",0.444855776056392,0.794446894643343,"B.PvsV.REACTOME_REGULATION_OF_MECP2_EXPRESSION_AND_ACTIVITY"
10,"Down",0.445771992996377,0.795826073386171,"B.PvsV.GERHOLD_RESPONSE_TO_TZD_UP"
209,"Up",0.446094949476452,0.796073705238579,"B.PvsV.KAYO_CALORIE_RESTRICTION_MUSCLE_UP"
47,"Down",0.446558954284542,0.796073705238579,"B.PvsV.REACTOME_METALLOPROTEASE_DUBS"
20,"Up",0.44664880124116,0.796073705238579,"B.PvsV.LI_CYTIDINE_ANALOG_PATHWAY"
78,"Down",0.44666502617892,0.796073705238579,"B.PvsV.FAELT_B_CLL_WITH_VH3_21_UP"
87,"Up",0.446705142484193,0.796073705238579,"B.PvsV.WESTON_VEGFA_TARGETS_6HR"
80,"Down",0.446774589863504,0.796073705238579,"B.PvsV.SU_PANCREAS"
107,"Up",0.447446072179209,0.79632898711522,"B.PvsV.REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS"
97,"Up",0.447722599455229,0.79632898711522,"B.PvsV.HU_GENOTOXIC_DAMAGE_4HR"
95,"Up",0.447763560369109,0.79632898711522,"B.PvsV.BORLAK_LIVER_CANCER_EGF_UP"
67,"Up",0.447790525395085,0.79632898711522,"B.PvsV.PID_ILK_PATHWAY"
19,"Down",0.447854142002525,0.79632898711522,"B.PvsV.REACTOME_SHC_MEDIATED_CASCADE_FGFR3"
95,"Up",0.448315174209112,0.79632898711522,"B.PvsV.KRIEG_HYPOXIA_VIA_KDM3A"
77,"Down",0.44833398858068,0.79632898711522,"B.PvsV.ASTON_MAJOR_DEPRESSIVE_DISORDER_UP"
49,"Down",0.448407473306805,0.79632898711522,"B.PvsV.PID_IL2_PI3K_PATHWAY"
917,"Up",0.448477518658494,0.79632898711522,"B.PvsV.CHICAS_RB1_TARGETS_CONFLUENT"
13,"Up",0.448503328983022,0.79632898711522,"B.PvsV.MCBRYAN_TERMINAL_END_BUD_DN"
892,"Down",0.448558982795478,0.79632898711522,"B.PvsV.DOUGLAS_BMI1_TARGETS_UP"
14,"Up",0.448805256774353,0.79632898711522,"B.PvsV.XU_AKT1_TARGETS_48HR"
142,"Down",0.448912204230045,0.79632898711522,"B.PvsV.QUINTENS_EMBRYONIC_BRAIN_RESPONSE_TO_IR"
105,"Up",0.448934247212541,0.79632898711522,"B.PvsV.SCHUHMACHER_MYC_TARGETS_UP"
2689,"Down",0.449464224301681,0.796480007452715,"B.PvsV.ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY"
156,"Up",0.449498615429286,0.796480007452715,"B.PvsV.LEE_AGING_CEREBELLUM_UP"
43,"Down",0.449644818153283,0.796480007452715,"B.PvsV.KEGG_SPHINGOLIPID_METABOLISM"
28,"Down",0.449784194995027,0.796480007452715,"B.PvsV.SEKI_INFLAMMATORY_RESPONSE_LPS_DN"
1242,"Up",0.449794136130471,0.796480007452715,"B.PvsV.KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3"
8,"Down",0.449883715549797,0.796480007452715,"B.PvsV.REACTOME_PTK6_REGULATES_CELL_CYCLE"
31,"Up",0.450029102041721,0.796482364016861,"B.PvsV.GHANDHI_BYSTANDER_IRRADIATION_DN"
87,"Down",0.450411745825403,0.796883694925524,"B.PvsV.BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN"
68,"Up",0.450544118346389,0.796883694925524,"B.PvsV.REACTOME_TRANSCRIPTIONAL_ACTIVATION_OF_MITOCHONDRIAL_BIOGENESIS"
78,"Down",0.450779815161146,0.796999333278351,"B.PvsV.HANN_RESISTANCE_TO_BCL2_INHIBITOR_DN"
337,"Up",0.451030552243374,0.796999333278351,"B.PvsV.YAMAZAKI_TCEB3_TARGETS_UP"
303,"Up",0.451041944986066,0.796999333278351,"B.PvsV.FOSTER_KDM1A_TARGETS_DN"
12,"Down",0.451595389423261,0.797722334863007,"B.PvsV.GILMORE_CORE_NFKB_PATHWAY"
373,"Down",0.451916138874007,0.798033960981918,"B.PvsV.RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_UP"
668,"Down",0.452963109558427,0.799627405092126,"B.PvsV.HATADA_METHYLATED_IN_LUNG_CANCER_UP"
62,"Up",0.453169029808965,0.799735577980774,"B.PvsV.ZHAN_MULTIPLE_MYELOMA_HP_DN"
40,"Up",0.453476281025923,0.799976230884711,"B.PvsV.KEGG_CYSTEINE_AND_METHIONINE_METABOLISM"
157,"Down",0.453594770089269,0.799976230884711,"B.PvsV.DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN"
114,"Up",0.453849665003242,0.800170535013688,"B.PvsV.HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_UP"
70,"Up",0.454097052581991,0.800351483495641,"B.PvsV.VALK_AML_CLUSTER_3"
8,"Up",0.454480259354639,0.800771623317973,"B.PvsV.REACTOME_ACTIVATION_OF_NIMA_KINASES_NEK9_NEK6_NEK7"
236,"Up",0.45521004274096,0.801660476587538,"B.PvsV.BOSCO_ALLERGEN_INDUCED_TH2_ASSOCIATED_MODULE"
140,"Up",0.455403328048816,0.801660476587538,"B.PvsV.REACTOME_ADORA2B_MEDIATED_ANTI_INFLAMMATORY_CYTOKINES_PRODUCTION"
40,"Up",0.455419706449892,0.801660476587538,"B.PvsV.TAKADA_GASTRIC_CANCER_COPY_NUMBER_DN"
30,"Up",0.456663979812924,0.803288253539313,"B.PvsV.BIOCARTA_IGF1MTOR_PATHWAY"
115,"Up",0.456686231658433,0.803288253539313,"B.PvsV.DARWICHE_PAPILLOMA_PROGRESSION_RISK"
13,"Down",0.45681060595708,0.803288253539313,"B.PvsV.REACTOME_GLUTATHIONE_SYNTHESIS_AND_RECYCLING"
14,"Up",0.456925584623104,0.803288253539313,"B.PvsV.REACTOME_CS_DS_DEGRADATION"
56,"Down",0.457446018654123,0.803585728433928,"B.PvsV.REACTOME_IRS_MEDIATED_SIGNALLING"
116,"Up",0.457524872261911,0.803585728433928,"B.PvsV.REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES"
23,"Up",0.457530814452886,0.803585728433928,"B.PvsV.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_UP"
38,"Up",0.457756161372674,0.803726203947131,"B.PvsV.CAFFAREL_RESPONSE_TO_THC_8HR_3_DN"
23,"Down",0.458000940608351,0.803739127521841,"B.PvsV.REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI"
82,"Down",0.458089131020134,0.803739127521841,"B.PvsV.KIM_LIVER_CANCER_POOR_SURVIVAL_DN"
140,"Down",0.458199625601165,0.803739127521841,"B.PvsV.REACTOME_MITOTIC_SPINDLE_CHECKPOINT"
117,"Up",0.459269555010538,0.804050491796375,"B.PvsV.JIANG_VHL_TARGETS"
63,"Down",0.459374889913988,0.804050491796375,"B.PvsV.DOANE_BREAST_CANCER_CLASSES_DN"
572,"Down",0.45939768907192,0.804050491796375,"B.PvsV.HELLER_HDAC_TARGETS_UP"
334,"Up",0.459417818118457,0.804050491796375,"B.PvsV.KIM_WT1_TARGETS_UP"
38,"Up",0.45955389242917,0.804050491796375,"B.PvsV.PID_S1P_S1P3_PATHWAY"
101,"Up",0.459603424158022,0.804050491796375,"B.PvsV.REACTOME_MEIOTIC_RECOMBINATION"
31,"Up",0.459697878525914,0.804050491796375,"B.PvsV.MEINHOLD_OVARIAN_CANCER_LOW_GRADE_DN"
55,"Up",0.459806754467149,0.804050491796375,"B.PvsV.PID_IL23_PATHWAY"
18,"Down",0.459842470302396,0.804050491796375,"B.PvsV.LI_WILMS_TUMOR_ANAPLASTIC_DN"
140,"Up",0.460124628199123,0.804050491796375,"B.PvsV.BILBAN_B_CLL_LPL_UP"
197,"Down",0.460195731130941,0.804050491796375,"B.PvsV.GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_UP"
65,"Up",0.460213110662607,0.804050491796375,"B.PvsV.REACTOME_SIGNALING_BY_RETINOIC_ACID"
848,"Up",0.460301222411367,0.804050491796375,"B.PvsV.MATSUDA_NATURAL_KILLER_DIFFERENTIATION"
14,"Up",0.460427127878126,0.804050491796375,"B.PvsV.REACTOME_NTRK2_ACTIVATES_RAC1"
65,"Down",0.460558492949741,0.804050491796375,"B.PvsV.PRAMOONJAGO_SOX4_TARGETS_DN"
38,"Down",0.460940214555283,0.804462893395252,"B.PvsV.REACTOME_INFLAMMASOMES"
9,"Up",0.461096818089252,0.804482267975851,"B.PvsV.REACTOME_TERMINAL_PATHWAY_OF_COMPLEMENT"
60,"Up",0.461406346290672,0.804532617669247,"B.PvsV.BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_UP"
9,"Up",0.461479849440625,0.804532617669247,"B.PvsV.REACTOME_DEFECTS_IN_BIOTIN_BTN_METABOLISM"
990,"Up",0.461574943326194,0.804532617669247,"B.PvsV.REACTOME_VESICLE_MEDIATED_TRANSPORT"
12,"Up",0.461714008863478,0.804532617669247,"B.PvsV.REACTOME_ACTIVATED_NTRK3_SIGNALS_THROUGH_PI3K"
103,"Down",0.461853233583322,0.804532617669247,"B.PvsV.BOSCO_EPITHELIAL_DIFFERENTIATION_MODULE"
15,"Up",0.462002498254013,0.804539153652421,"B.PvsV.BIOCARTA_STEM_PATHWAY"
43,"Up",0.462615788436381,0.805353493156407,"B.PvsV.REACTOME_ADRENALINE_NORADRENALINE_INHIBITS_INSULIN_SECRETION"
186,"Down",0.462921628617074,0.805545307060826,"B.PvsV.REACTOME_HCMV_INFECTION"
9,"Up",0.463130008844656,0.805545307060826,"B.PvsV.REACTOME_OREXIN_AND_NEUROPEPTIDES_FF_AND_QRFP_BIND_TO_THEIR_RESPECTIVE_RECEPTORS"
9,"Up",0.46316305500929,0.805545307060826,"B.PvsV.REACTOME_SOS_MEDIATED_SIGNALLING"
77,"Up",0.463372864557986,0.805584176820746,"B.PvsV.MARTINEZ_RESPONSE_TO_TRABECTEDIN"
148,"Up",0.463728975195093,0.805584176820746,"B.PvsV.GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_DN"
15,"Up",0.46390324344847,0.805584176820746,"B.PvsV.BIOCARTA_ERYTH_PATHWAY"
6,"Down",0.463990969344099,0.805584176820746,"B.PvsV.REACTOME_SIGNALING_BY_MST1"
26,"Up",0.463997543973238,0.805584176820746,"B.PvsV.PODAR_RESPONSE_TO_ADAPHOSTIN_DN"
30,"Down",0.464133870760333,0.805584176820746,"B.PvsV.REACTOME_KERATAN_SULFATE_BIOSYNTHESIS"
136,"Down",0.464342131763043,0.805584176820746,"B.PvsV.MIKKELSEN_ES_HCP_WITH_H3_UNMETHYLATED"
20,"Up",0.464476983663995,0.805584176820746,"B.PvsV.REACTOME_SYNTHESIS_OF_PIPS_AT_THE_GOLGI_MEMBRANE"
647,"Down",0.46463970283188,0.805584176820746,"B.PvsV.YAUCH_HEDGEHOG_SIGNALING_PARACRINE_DN"
122,"Up",0.464948077235867,0.805584176820746,"B.PvsV.VANASSE_BCL2_TARGETS_DN"
52,"Up",0.465048201275407,0.805584176820746,"B.PvsV.LEIN_LOCALIZED_TO_PROXIMAL_DENDRITES"
12,"Up",0.465071528253254,0.805584176820746,"B.PvsV.REACTOME_ROLE_OF_ABL_IN_ROBO_SLIT_SIGNALING"
84,"Down",0.465184849858676,0.805584176820746,"B.PvsV.LEIN_ASTROCYTE_MARKERS"
39,"Down",0.465225226367995,0.805584176820746,"B.PvsV.WU_HBX_TARGETS_1_DN"
324,"Down",0.465781624677644,0.806295116732215,"B.PvsV.SERVITJA_LIVER_HNF1A_TARGETS_DN"
87,"Up",0.466450955437759,0.807201043072103,"B.PvsV.KEGG_STEROID_HORMONE_BIOSYNTHESIS"
239,"Down",0.46677618664542,0.807511118886898,"B.PvsV.SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM5"
714,"Up",0.467363591785284,0.807716953236446,"B.PvsV.BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP"
104,"Down",0.467398859467519,0.807716953236446,"B.PvsV.REACTOME_COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC"
34,"Up",0.467497902432351,0.807716953236446,"B.PvsV.BIOCARTA_SPPA_PATHWAY"
9,"Down",0.467576641713828,0.807716953236446,"B.PvsV.REACTOME_ABACAVIR_TRANSMEMBRANE_TRANSPORT"
465,"Down",0.467625604505311,0.807716953236446,"B.PvsV.GRESHOCK_CANCER_COPY_NUMBER_UP"
35,"Down",0.467855394479342,0.807861485345498,"B.PvsV.GENTLES_LEUKEMIC_STEM_CELL_DN"
38,"Down",0.468191911361048,0.808188275015389,"B.PvsV.LUI_THYROID_CANCER_CLUSTER_3"
46,"Down",0.468336992792423,0.808188275015389,"B.PvsV.DELLA_RESPONSE_TO_TSA_AND_BUTYRATE"
76,"Down",0.46861183221607,0.808410240350281,"B.PvsV.PID_P53_REGULATION_PATHWAY"
139,"Up",0.469123589326457,0.808923916882312,"B.PvsV.BRUECKNER_TARGETS_OF_MIRLET7A3_DN"
74,"Down",0.469242465552347,0.808923916882312,"B.PvsV.BURTON_ADIPOGENESIS_PEAK_AT_8HR"
80,"Down",0.469348512454053,0.808923916882312,"B.PvsV.MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_6"
57,"Up",0.46959028990261,0.808963587843768,"B.PvsV.VILIMAS_NOTCH1_TARGETS_DN"
53,"Up",0.469694544504902,0.808963587843768,"B.PvsV.HEIDENBLAD_AMPLICON_8Q24_DN"
55,"Down",0.469938402893125,0.808963587843768,"B.PvsV.KEGG_INOSITOL_PHOSPHATE_METABOLISM"
38,"Up",0.469964098123182,0.808963587843768,"B.PvsV.KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_OLD"
29,"Down",0.470103094183763,0.808963587843768,"B.PvsV.REACTOME_PI_3K_CASCADE_FGFR2"
80,"Up",0.470574231017315,0.809335186802948,"B.PvsV.TONG_INTERACT_WITH_PTTG1"
52,"Down",0.470644288183214,0.809335186802948,"B.PvsV.REACTOME_FORMATION_OF_FIBRIN_CLOT_CLOTTING_CASCADE"
253,"Down",0.47091840469093,0.809335186802948,"B.PvsV.BROWNE_HCMV_INFECTION_24HR_UP"
13,"Down",0.47098305281104,0.809335186802948,"B.PvsV.REACTOME_RRNA_PROCESSING_IN_THE_MITOCHONDRION"
124,"Up",0.471050937082997,0.809335186802948,"B.PvsV.HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_UP"
794,"Up",0.471893073376563,0.809812001351836,"B.PvsV.PILON_KLF1_TARGETS_UP"
233,"Down",0.471902609943581,0.809812001351836,"B.PvsV.REACTOME_CELLULAR_SENESCENCE"
99,"Down",0.472020745058769,0.809812001351836,"B.PvsV.NOUZOVA_METHYLATED_IN_APL"
31,"Down",0.472121708933162,0.809812001351836,"B.PvsV.KYNG_RESPONSE_TO_H2O2_VIA_ERCC6"
818,"Down",0.472122226556284,0.809812001351836,"B.PvsV.LIAO_METASTASIS"
162,"Up",0.472334019844207,0.809812001351836,"B.PvsV.BASSO_CD40_SIGNALING_UP"
8,"Down",0.472353717554652,0.809812001351836,"B.PvsV.HESSON_TUMOR_SUPPRESSOR_CLUSTER_3P21_3"
137,"Down",0.472610253880217,0.810000649009212,"B.PvsV.BROWNE_HCMV_INFECTION_6HR_UP"
36,"Down",0.473040967578344,0.810487607604792,"B.PvsV.REACTOME_RHO_GTPASES_ACTIVATE_IQGAPS"
89,"Up",0.473327995248019,0.810499061026802,"B.PvsV.PID_P75_NTR_PATHWAY"
237,"Down",0.47344420138568,0.810499061026802,"B.PvsV.LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN"
621,"Down",0.473531900471733,0.810499061026802,"B.PvsV.WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_UP"
290,"Up",0.473634014501284,0.810499061026802,"B.PvsV.GREGORY_SYNTHETIC_LETHAL_WITH_IMATINIB"
58,"Up",0.473841176764548,0.810602681414353,"B.PvsV.WANG_RESPONSE_TO_ANDROGEN_UP"
18,"Up",0.474232622958952,0.810772823359796,"B.PvsV.REACTOME_PHASE_4_RESTING_MEMBRANE_POTENTIAL"
50,"Up",0.474379846951437,0.810772823359796,"B.PvsV.REACTOME_RETROGRADE_TRANSPORT_AT_THE_TRANS_GOLGI_NETWORK"
57,"Up",0.474380554090964,0.810772823359796,"B.PvsV.WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_UP"
101,"Down",0.474776184909923,0.811198246714142,"B.PvsV.TCGA_GLIOBLASTOMA_COPY_NUMBER_UP"
21,"Up",0.475414694710542,0.812038259825329,"B.PvsV.HUMMEL_BURKITTS_LYMPHOMA_DN"
31,"Down",0.476187950482243,0.813107837620853,"B.PvsV.REACTOME_EICOSANOIDS"
14,"Down",0.476468292189838,0.813113907257703,"B.PvsV.CHEN_HOXA5_TARGETS_6HR_DN"
103,"Up",0.476727487164547,0.813113907257703,"B.PvsV.NIKOLSKY_BREAST_CANCER_7Q21_Q22_AMPLICON"
44,"Up",0.47676735507649,0.813113907257703,"B.PvsV.REACTOME_BETA_DEFENSINS"
117,"Up",0.476817766457127,0.813113907257703,"B.PvsV.RIZKI_TUMOR_INVASIVENESS_2D_UP"
23,"Down",0.476926822433846,0.813113907257703,"B.PvsV.REACTOME_GAB1_SIGNALOSOME"
60,"Up",0.477890787445603,0.814506215717244,"B.PvsV.STONER_ESOPHAGEAL_CARCINOGENESIS_UP"
303,"Down",0.478249311566668,0.814866084330387,"B.PvsV.PROVENZANI_METASTASIS_UP"
132,"Up",0.478538047397475,0.814998689761844,"B.PvsV.BOSCO_INTERFERON_INDUCED_ANTIVIRAL_MODULE"
240,"Down",0.478723787676834,0.814998689761844,"B.PvsV.NAGASHIMA_NRG1_SIGNALING_UP"
57,"Down",0.47876935148245,0.814998689761844,"B.PvsV.ABBUD_LIF_SIGNALING_1_UP"
7,"Up",0.478938050091307,0.815034927348364,"B.PvsV.REACTOME_LIPID_PARTICLE_ORGANIZATION"
23,"Down",0.479852087984458,0.81633913675879,"B.PvsV.WANG_RECURRENT_LIVER_CANCER_DN"
158,"Down",0.480079441189357,0.816462778748332,"B.PvsV.SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_UP"
14,"Down",0.480220104266518,0.816462778748332,"B.PvsV.BIOCARTA_EXTRINSIC_PATHWAY"
50,"Down",0.480549396176444,0.816771476009702,"B.PvsV.REACTOME_SUMOYLATION_OF_TRANSCRIPTION_COFACTORS"
25,"Down",0.481107796126006,0.817078890480652,"B.PvsV.SMID_BREAST_CANCER_LUMINAL_A_DN"
29,"Up",0.481177288322071,0.817078890480652,"B.PvsV.ELLWOOD_MYC_TARGETS_UP"
165,"Up",0.481188967530065,0.817078890480652,"B.PvsV.RAGHAVACHARI_PLATELET_SPECIFIC_GENES"
38,"Up",0.481321386560948,0.817078890480652,"B.PvsV.REACTOME_TAK1_ACTIVATES_NFKB_BY_PHOSPHORYLATION_AND_ACTIVATION_OF_IKKS_COMPLEX"
63,"Down",0.481943790651178,0.817548909097327,"B.PvsV.KORKOLA_SEMINOMA_UP"
118,"Up",0.482169679217819,0.817548909097327,"B.PvsV.BOYLAN_MULTIPLE_MYELOMA_PCA3_DN"
64,"Down",0.482334758826274,0.817548909097327,"B.PvsV.TIEN_INTESTINE_PROBIOTICS_2HR_UP"
112,"Down",0.482487058349723,0.817548909097327,"B.PvsV.JAZAG_TGFB1_SIGNALING_VIA_SMAD4_DN"
865,"Down",0.482721096233563,0.817548909097327,"B.PvsV.RIGGI_EWING_SARCOMA_PROGENITOR_UP"
8,"Down",0.482766492754425,0.817548909097327,"B.PvsV.KERLEY_RESPONSE_TO_CISPLATIN_DN"
39,"Up",0.483081143507695,0.817548909097327,"B.PvsV.VERRECCHIA_RESPONSE_TO_TGFB1_C1"
50,"Up",0.483082803665753,0.817548909097327,"B.PvsV.REACTOME_GAP_JUNCTION_TRAFFICKING_AND_REGULATION"
701,"Up",0.483204483200001,0.817548909097327,"B.PvsV.ENK_UV_RESPONSE_KERATINOCYTE_DN"
7,"Down",0.483223305561023,0.817548909097327,"B.PvsV.REACTOME_TRNA_PROCESSING_IN_THE_MITOCHONDRION"
829,"Up",0.483255320486042,0.817548909097327,"B.PvsV.IVANOVA_HEMATOPOIESIS_LATE_PROGENITOR"
98,"Down",0.483519571476415,0.817548909097327,"B.PvsV.REACTOME_DNA_DAMAGE_TELOMERE_STRESS_INDUCED_SENESCENCE"
10,"Up",0.48352051596098,0.817548909097327,"B.PvsV.REACTOME_HDR_THROUGH_MMEJ_ALT_NHEJ"
77,"Up",0.483774793740309,0.817728778535667,"B.PvsV.BALDWIN_PRKCI_TARGETS_UP"
1397,"Up",0.484096045956826,0.81777871894242,"B.PvsV.ACEVEDO_LIVER_CANCER_UP"
11,"Up",0.484100153210081,0.81777871894242,"B.PvsV.BIOCARTA_CACAM_PATHWAY"
300,"Down",0.484900326674302,0.818380353827622,"B.PvsV.THUM_SYSTOLIC_HEART_FAILURE_DN"
10,"Up",0.484945880585166,0.818380353827622,"B.PvsV.REACTOME_DIGESTION_OF_DIETARY_LIPID"
1217,"Down",0.485139778744204,0.818380353827622,"B.PvsV.MARTENS_TRETINOIN_RESPONSE_DN"
39,"Down",0.485335110108446,0.818380353827622,"B.PvsV.JOHANSSON_GLIOMAGENESIS_BY_PDGFB_DN"
74,"Down",0.485349674899034,0.818380353827622,"B.PvsV.RASHI_RESPONSE_TO_IONIZING_RADIATION_3"
61,"Down",0.485417483690341,0.818380353827622,"B.PvsV.WINNEPENNINCKX_MELANOMA_METASTASIS_DN"
72,"Down",0.485492414641816,0.818380353827622,"B.PvsV.REACTOME_IRE1ALPHA_ACTIVATES_CHAPERONES"
27,"Up",0.485710706925292,0.818498780429728,"B.PvsV.CHEMELLO_SOLEUS_VS_EDL_MYOFIBERS_UP"
25,"Down",0.48633987064435,0.818930241131095,"B.PvsV.HONRADO_BREAST_CANCER_BRCA1_VS_BRCA2"
20,"Down",0.486421410209429,0.818930241131095,"B.PvsV.REACTOME_FORMATION_OF_SENESCENCE_ASSOCIATED_HETEROCHROMATIN_FOCI_SAHF"
107,"Down",0.4865269127417,0.818930241131095,"B.PvsV.REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX"
72,"Down",0.486695949744653,0.818930241131095,"B.PvsV.PARK_HSC_AND_MULTIPOTENT_PROGENITORS"
182,"Down",0.486834832369497,0.818930241131095,"B.PvsV.EPPERT_PROGENITOR"
26,"Up",0.486968912066394,0.818930241131095,"B.PvsV.REACTOME_THROMBOXANE_SIGNALLING_THROUGH_TP_RECEPTOR"
13,"Down",0.487080632954341,0.818930241131095,"B.PvsV.CASTELLANO_HRAS_AND_NRAS_TARGETS_DN"
23,"Up",0.487355436794343,0.818930241131095,"B.PvsV.STEIN_ESTROGEN_RESPONSE_NOT_VIA_ESRRA"
363,"Up",0.487367064059714,0.818930241131095,"B.PvsV.OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP"
150,"Down",0.487447897189806,0.818930241131095,"B.PvsV.TANAKA_METHYLATED_IN_ESOPHAGEAL_CARCINOMA"
69,"Down",0.487716690941706,0.819045695987713,"B.PvsV.IRITANI_MAD1_TARGETS_DN"
100,"Down",0.48781289146094,0.819045695987713,"B.PvsV.REACTOME_TRANSPORT_OF_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS"
5,"Down",0.488937446364889,0.820684620811012,"B.PvsV.REACTOME_TOXICITY_OF_BOTULINUM_TOXIN_TYPE_D_BONT_D"
66,"Up",0.489259752768886,0.820976380291099,"B.PvsV.LUI_THYROID_CANCER_CLUSTER_2"
648,"Up",0.490072218570865,0.821862445906391,"B.PvsV.SANSOM_APC_TARGETS_DN"
263,"Down",0.490085093896432,0.821862445906391,"B.PvsV.LEE_NEURAL_CREST_STEM_CELL_DN"
15,"Up",0.490617416696934,0.822272361725664,"B.PvsV.SA_MMP_CYTOKINE_CONNECTION"
6,"Down",0.490710662366983,0.822272361725664,"B.PvsV.REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_LINKED_TO_TRIGLYCERIDE_LIPOLYSIS_IN_ADIPOSE"
55,"Down",0.490782063009624,0.822272361725664,"B.PvsV.REACTOME_TRANSPORT_OF_VITAMINS_NUCLEOSIDES_AND_RELATED_MOLECULES"
531,"Up",0.490948638783982,0.822272361725664,"B.PvsV.ENK_UV_RESPONSE_EPIDERMIS_UP"
65,"Up",0.491073130478955,0.822272361725664,"B.PvsV.ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_UP"
119,"Up",0.491250988009258,0.82232113614992,"B.PvsV.REACTOME_PI3K_AKT_SIGNALING_IN_CANCER"
113,"Down",0.491549647074198,0.822572033496743,"B.PvsV.REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE"
14,"Down",0.492246804327915,0.823147468195994,"B.PvsV.CAFFAREL_RESPONSE_TO_THC_24HR_3_UP"
33,"Up",0.492448277266327,0.823147468195994,"B.PvsV.REACTOME_CYTOSOLIC_SULFONATION_OF_SMALL_MOLECULES"
35,"Down",0.492482527329222,0.823147468195994,"B.PvsV.ZIRN_TRETINOIN_RESPONSE_WT1_UP"
42,"Up",0.492489026006936,0.823147468195994,"B.PvsV.REACTOME_FATTY_ACYL_COA_BIOSYNTHESIS"
51,"Up",0.492650153024324,0.823167934745085,"B.PvsV.GUILLAUMOND_KLF10_TARGETS_DN"
77,"Down",0.493054603174772,0.823480925410328,"B.PvsV.REACTOME_NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION"
39,"Up",0.493135348893759,0.823480925410328,"B.PvsV.BIOCARTA_TPO_PATHWAY"
127,"Down",0.493413094508803,0.823695953967141,"B.PvsV.CARD_MIR302A_TARGETS"
185,"Down",0.493741948784732,0.823730337333064,"B.PvsV.REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS"
37,"Down",0.494044710806677,0.823730337333064,"B.PvsV.BIOCARTA_HDAC_PATHWAY"
541,"Up",0.494066325835427,0.823730337333064,"B.PvsV.BOYLAN_MULTIPLE_MYELOMA_C_D_DN"
10,"Down",0.494315586701112,0.823730337333064,"B.PvsV.BIOCARTA_MITR_PATHWAY"
38,"Down",0.494338995206485,0.823730337333064,"B.PvsV.BIOCARTA_FAS_PATHWAY"
45,"Down",0.494401682292791,0.823730337333064,"B.PvsV.SARTIPY_NORMAL_AT_INSULIN_RESISTANCE_UP"
82,"Up",0.494476576163581,0.823730337333064,"B.PvsV.PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_1"
151,"Down",0.494664159619473,0.823794620040983,"B.PvsV.SMITH_TERT_TARGETS_DN"
77,"Up",0.495001346328657,0.824107932505613,"B.PvsV.VARELA_ZMPSTE24_TARGETS_DN"
125,"Up",0.49543346630217,0.824400657478085,"B.PvsV.MORI_LARGE_PRE_BII_LYMPHOCYTE_DN"
71,"Up",0.495475381587932,0.824400657478085,"B.PvsV.MCBRYAN_PUBERTAL_BREAST_3_4WK_DN"
16,"Up",0.495715794309684,0.824446574363967,"B.PvsV.YAGUE_PRETUMOR_DRUG_RESISTANCE_UP"
59,"Down",0.495811948513336,0.824446574363967,"B.PvsV.BRACHAT_RESPONSE_TO_METHOTREXATE_UP"
205,"Up",0.495950317658628,0.824446574363967,"B.PvsV.SENESE_HDAC2_TARGETS_DN"
45,"Up",0.496400959237927,0.824582410883979,"B.PvsV.REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS"
18,"Down",0.496458113963031,0.824582410883979,"B.PvsV.REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING"
25,"Up",0.49647944399218,0.824582410883979,"B.PvsV.KANG_FLUOROURACIL_RESISTANCE_DN"
249,"Up",0.496726968454405,0.824728672438904,"B.PvsV.IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_UP"
58,"Up",0.49686583611756,0.824728672438904,"B.PvsV.PID_PI3K_PLC_TRK_PATHWAY"
18,"Up",0.497429287566458,0.825416125736779,"B.PvsV.BAKER_HEMATOPOIESIS_STAT3_TARGETS"
106,"Up",0.497671398467414,0.825570105648465,"B.PvsV.MAGRANGEAS_MULTIPLE_MYELOMA_IGG_VS_IGA_UP"
412,"Up",0.49796050398118,0.825728488857707,"B.PvsV.CHYLA_CBFA2T3_TARGETS_DN"
14,"Up",0.49806556526324,0.825728488857707,"B.PvsV.REACTOME_REDUCTION_OF_CYTOSOLIC_CA_LEVELS"
143,"Up",0.498639784503836,0.826432664424973,"B.PvsV.REACTOME_INTEGRATION_OF_ENERGY_METABOLISM"
24,"Down",0.498997174908943,0.826777159146402,"B.PvsV.XU_CREBBP_TARGETS_UP"
863,"Down",0.499656997987878,0.827390338291605,"B.PvsV.CHICAS_RB1_TARGETS_SENESCENT"
12,"Down",0.499802523714497,0.827390338291605,"B.PvsV.MUNSHI_MULTIPLE_MYELOMA_DN"
60,"Down",0.499816192782413,0.827390338291605,"B.PvsV.APPEL_IMATINIB_RESPONSE"
18,"Up",0.500124311623807,0.827500569039778,"B.PvsV.FRASOR_TAMOXIFEN_RESPONSE_DN"
24,"Down",0.500182112810805,0.827500569039778,"B.PvsV.REACTOME_ER_QUALITY_CONTROL_COMPARTMENT_ERQC"
11,"Down",0.500646500413123,0.827842777764871,"B.PvsV.MARIADASON_RESPONSE_TO_BUTYRATE_CURCUMIN_SULINDAC_TSA_8"
16,"Up",0.500688415417929,0.827842777764871,"B.PvsV.REACTOME_ACTIVATED_NTRK2_SIGNALS_THROUGH_FYN"
21,"Down",0.501088635491199,0.828185487783772,"B.PvsV.KUROKAWA_LIVER_CANCER_EARLY_RECURRENCE_UP"
256,"Up",0.501195268968078,0.828185487783772,"B.PvsV.TSENG_IRS1_TARGETS_DN"
35,"Up",0.501683996248335,0.828743738231159,"B.PvsV.HAHTOLA_MYCOSIS_FUNGOIDES_DN"
16,"Up",0.501933642239266,0.828743738231159,"B.PvsV.KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_KERATAN_SULFATE"
12,"Down",0.502323406058334,0.828743738231159,"B.PvsV.REACTOME_SLBP_DEPENDENT_PROCESSING_OF_REPLICATION_DEPENDENT_HISTONE_PRE_MRNAS"
9,"Down",0.502373898142039,0.828743738231159,"B.PvsV.REACTOME_CREB3_FACTORS_ACTIVATE_GENES"
92,"Up",0.502399502829582,0.828743738231159,"B.PvsV.REACTOME_RMTS_METHYLATE_HISTONE_ARGININES"
9,"Down",0.50246572266325,0.828743738231159,"B.PvsV.REACTOME_UPTAKE_AND_FUNCTION_OF_DIPHTHERIA_TOXIN"
134,"Up",0.502582339354146,0.828743738231159,"B.PvsV.FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_DN"
181,"Down",0.502850629758083,0.828822764343607,"B.PvsV.LIN_SILENCED_BY_TUMOR_MICROENVIRONMENT"
49,"Up",0.502983695822391,0.828822764343607,"B.PvsV.PID_NECTIN_PATHWAY"
484,"Up",0.50310058040301,0.828822764343607,"B.PvsV.RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP"
119,"Up",0.503330610572409,0.828822764343607,"B.PvsV.MEISSNER_BRAIN_HCP_WITH_H3_UNMETHYLATED"
972,"Up",0.503379787062006,0.828822764343607,"B.PvsV.BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN"
17,"Up",0.503671327767965,0.829055900931551,"B.PvsV.BIOCARTA_SM_PATHWAY"
16,"Down",0.504035039375611,0.829371474547163,"B.PvsV.REACTOME_REGULATION_OF_COMMISSURAL_AXON_PATHFINDING_BY_SLIT_AND_ROBO"
52,"Up",0.504163054069997,0.829371474547163,"B.PvsV.REACTOME_CHONDROITIN_SULFATE_DERMATAN_SULFATE_METABOLISM"
35,"Up",0.504744818921619,0.829836765345304,"B.PvsV.REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS"
35,"Up",0.5047477844344,0.829836765345304,"B.PvsV.PID_PRL_SIGNALING_EVENTS_PATHWAY"
699,"Up",0.504896161805318,0.829836765345304,"B.PvsV.GARY_CD5_TARGETS_UP"
7,"Down",0.505223472454982,0.830050395125942,"B.PvsV.REACTOME_ALPHA_OXIDATION_OF_PHYTANATE"
18,"Up",0.505326393560123,0.830050395125942,"B.PvsV.PID_DNA_PK_PATHWAY"
84,"Up",0.50558040996153,0.830220993964152,"B.PvsV.YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_10"
39,"Up",0.506065455778997,0.830404277480929,"B.PvsV.ZHENG_FOXP3_TARGETS_UP"
45,"Down",0.506130522603081,0.830404277480929,"B.PvsV.LOPES_METHYLATED_IN_COLON_CANCER_DN"
449,"Down",0.506501072841044,0.830404277480929,"B.PvsV.DOANE_RESPONSE_TO_ANDROGEN_DN"
20,"Up",0.506613812840784,0.830404277480929,"B.PvsV.WIEMANN_TELOMERE_SHORTENING_AND_CHRONIC_LIVER_DAMAGE_DN"
55,"Down",0.506718234707836,0.830404277480929,"B.PvsV.AMIT_EGF_RESPONSE_60_MCF10A"
14,"Up",0.506818150782344,0.830404277480929,"B.PvsV.XU_HGF_TARGETS_REPRESSED_BY_AKT1_UP"
10,"Down",0.506892597882976,0.830404277480929,"B.PvsV.SMID_BREAST_CANCER_ERBB2_DN"
39,"Up",0.506948190333349,0.830404277480929,"B.PvsV.FERRANDO_TAL1_NEIGHBORS"
8,"Down",0.507043740418813,0.830404277480929,"B.PvsV.REACTOME_ACYL_CHAIN_REMODELING_OF_DAG_AND_TAG"
5,"Down",0.507867481191818,0.831358498746911,"B.PvsV.REACTOME_TYROSINE_CATABOLISM"
28,"Up",0.508238356897769,0.831358498746911,"B.PvsV.REACTOME_DISEASES_OF_IMMUNE_SYSTEM"
1203,"Down",0.50826353008629,0.831358498746911,"B.PvsV.MIKKELSEN_ES_ICP_WITH_H3K4ME3"
201,"Down",0.508374277022129,0.831358498746911,"B.PvsV.WIERENGA_STAT5A_TARGETS_GROUP1"
49,"Up",0.508378202977628,0.831358498746911,"B.PvsV.REACTOME_THE_PHOTOTRANSDUCTION_CASCADE"
18,"Down",0.508936712028595,0.831886807450489,"B.PvsV.BIOCARTA_NPC_PATHWAY"
782,"Down",0.509254554711477,0.831886807450489,"B.PvsV.CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1"
24,"Down",0.509311287697434,0.831886807450489,"B.PvsV.LIU_TOPBP1_TARGETS"
43,"Down",0.509644126604476,0.831886807450489,"B.PvsV.REACTOME_REGULATION_OF_TNFR1_SIGNALING"
65,"Down",0.509687746083997,0.831886807450489,"B.PvsV.NAKAMURA_METASTASIS_MODEL_UP"
36,"Down",0.509719234761968,0.831886807450489,"B.PvsV.GRAHAM_CML_DIVIDING_VS_NORMAL_DIVIDING_UP"
44,"Down",0.509754477055933,0.831886807450489,"B.PvsV.REACTOME_RA_BIOSYNTHESIS_PATHWAY"
35,"Down",0.510215016709594,0.832107557072004,"B.PvsV.SHARMA_PILOCYTIC_ASTROCYTOMA_LOCATION_UP"
91,"Down",0.510257047268308,0.832107557072004,"B.PvsV.ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_DN"
162,"Down",0.510341241821517,0.832107557072004,"B.PvsV.REACTOME_GENE_SILENCING_BY_RNA"
279,"Up",0.510632299791618,0.832336670267646,"B.PvsV.GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_UP"
34,"Up",0.510949222642792,0.832607796048333,"B.PvsV.YANAGISAWA_LUNG_CANCER_RECURRENCE"
378,"Up",0.511242129737605,0.832754480980292,"B.PvsV.REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL"
48,"Down",0.511660337032656,0.832754480980292,"B.PvsV.BIOCARTA_CARM_ER_PATHWAY"
19,"Up",0.511845395560435,0.832754480980292,"B.PvsV.REACTOME_CGMP_EFFECTS"
51,"Down",0.512167379335399,0.832754480980292,"B.PvsV.SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_DN"
30,"Up",0.512327442421626,0.832754480980292,"B.PvsV.REACTOME_SYNTHESIS_OF_IP3_AND_IP4_IN_THE_CYTOSOL"
177,"Up",0.512682966102698,0.832754480980292,"B.PvsV.JAZAG_TGFB1_SIGNALING_UP"
7,"Up",0.512697230140192,0.832754480980292,"B.PvsV.CAFFAREL_RESPONSE_TO_THC_8HR_3_UP"
9,"Down",0.512929342903039,0.832754480980292,"B.PvsV.CASTELLANO_HRAS_TARGETS_DN"
248,"Up",0.513093052075224,0.832754480980292,"B.PvsV.GOZGIT_ESR1_TARGETS_UP"
413,"Up",0.513222880574294,0.832754480980292,"B.PvsV.AFFAR_YY1_TARGETS_UP"
76,"Down",0.513296526941856,0.832754480980292,"B.PvsV.ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_DN"
103,"Down",0.513605477334906,0.832754480980292,"B.PvsV.MARTIN_VIRAL_GPCR_SIGNALING_DN"
61,"Up",0.513729344185605,0.832754480980292,"B.PvsV.PID_ERBB1_INTERNALIZATION_PATHWAY"
13,"Down",0.513798785545449,0.832754480980292,"B.PvsV.VANLOO_SP3_TARGETS_UP"
36,"Up",0.513818790147463,0.832754480980292,"B.PvsV.GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_UP"
18,"Down",0.513829132815829,0.832754480980292,"B.PvsV.REACTOME_APOPTOTIC_CLEAVAGE_OF_CELL_ADHESION_PROTEINS"
8,"Down",0.513849259688629,0.832754480980292,"B.PvsV.REACTOME_MET_RECEPTOR_ACTIVATION"
65,"Up",0.514564350373493,0.832754480980292,"B.PvsV.CHOI_ATL_STAGE_PREDICTOR"
79,"Down",0.514590461390341,0.832754480980292,"B.PvsV.DAZARD_UV_RESPONSE_CLUSTER_G24"
90,"Up",0.514648387203175,0.832754480980292,"B.PvsV.CAFFAREL_RESPONSE_TO_THC_24HR_5_DN"
9,"Up",0.514651156987528,0.832754480980292,"B.PvsV.REACTOME_RUNX1_REGULATES_EXPRESSION_OF_COMPONENTS_OF_TIGHT_JUNCTIONS"
43,"Down",0.514690364874243,0.832754480980292,"B.PvsV.BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_UP"
37,"Down",0.514828615448712,0.832754480980292,"B.PvsV.SIG_CD40PATHWAYMAP"
12,"Down",0.514900410511441,0.832754480980292,"B.PvsV.BIOCARTA_CDC25_PATHWAY"
228,"Down",0.514916031327024,0.832754480980292,"B.PvsV.REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_BCR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS"
657,"Up",0.515272656659382,0.832754480980292,"B.PvsV.SENESE_HDAC1_TARGETS_UP"
71,"Down",0.515373583078365,0.832754480980292,"B.PvsV.TAVOR_CEBPA_TARGETS_DN"
269,"Down",0.515481598592105,0.832754480980292,"B.PvsV.LEE_NEURAL_CREST_STEM_CELL_UP"
88,"Up",0.515517060784767,0.832754480980292,"B.PvsV.REACTOME_PRC2_METHYLATES_HISTONES_AND_DNA"
13,"Up",0.515827338586597,0.832754480980292,"B.PvsV.PID_ALK2_PATHWAY"
13,"Up",0.515858943273196,0.832754480980292,"B.PvsV.REACTOME_CAMK_IV_MEDIATED_PHOSPHORYLATION_OF_CREB"
13,"Up",0.515858943273196,0.832754480980292,"B.PvsV.REACTOME_CREB1_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_CAMKII_CAMKK_CAMKIV_CASCASDE"
99,"Up",0.516421681631341,0.833276531964628,"B.PvsV.REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS"
107,"Up",0.516571431332322,0.833276531964628,"B.PvsV.RADAEVA_RESPONSE_TO_IFNA1_UP"
103,"Down",0.516634464021477,0.833276531964628,"B.PvsV.SANSOM_WNT_PATHWAY_REQUIRE_MYC"
492,"Up",0.516909042088219,0.83347625946508,"B.PvsV.REACTOME_LEISHMANIA_INFECTION"
402,"Down",0.517433428778723,0.834068252147166,"B.PvsV.BROWNE_HCMV_INFECTION_16HR_UP"
42,"Up",0.517598442341268,0.834068252147166,"B.PvsV.SUZUKI_RESPONSE_TO_TSA_AND_DECITABINE_1A"
106,"Down",0.517728746856407,0.834068252147166,"B.PvsV.VANTVEER_BREAST_CANCER_POOR_PROGNOSIS"
268,"Up",0.518433019351989,0.834829914505533,"B.PvsV.KIM_MYC_AMPLIFICATION_TARGETS_UP"
90,"Up",0.518537041957001,0.834829914505533,"B.PvsV.REACTOME_CIRCADIAN_CLOCK"
61,"Down",0.518654504671099,0.834829914505533,"B.PvsV.FRIDMAN_IMMORTALIZATION_DN"
87,"Down",0.519013504528476,0.835157731512587,"B.PvsV.PID_HDAC_CLASSI_PATHWAY"
359,"Down",0.519350247988841,0.835157731512587,"B.PvsV.MASSARWEH_TAMOXIFEN_RESISTANCE_DN"
138,"Up",0.519364192518288,0.835157731512587,"B.PvsV.WORSCHECH_TUMOR_REJECTION_UP"
1184,"Down",0.519466321508899,0.835157731512587,"B.PvsV.LEE_BMP2_TARGETS_DN"
37,"Up",0.519613419497793,0.835157731512587,"B.PvsV.ONO_AML1_TARGETS_UP"
424,"Up",0.520387566758053,0.835868909562537,"B.PvsV.DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP"
18,"Down",0.520471019903181,0.835868909562537,"B.PvsV.REACTOME_FGFR1C_LIGAND_BINDING_AND_ACTIVATION"
25,"Down",0.520629091773489,0.835868909562537,"B.PvsV.NGO_MALIGNANT_GLIOMA_1P_LOH"
137,"Up",0.520660612142047,0.835868909562537,"B.PvsV.KRASNOSELSKAYA_ILF3_TARGETS_UP"
252,"Down",0.520917775134711,0.836039006885287,"B.PvsV.REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS"
111,"Down",0.521964561550363,0.83705521035625,"B.PvsV.POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN"
14,"Down",0.522010078794766,0.83705521035625,"B.PvsV.REACTOME_HUR_ELAVL1_BINDS_AND_STABILIZES_MRNA"
21,"Down",0.52207793294177,0.83705521035625,"B.PvsV.REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_METHYLATION"
109,"Down",0.522182015397463,0.83705521035625,"B.PvsV.KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_DN"
368,"Down",0.522313697205278,0.83705521035625,"B.PvsV.KYNG_DNA_DAMAGE_UP"
37,"Up",0.522656779396497,0.83705521035625,"B.PvsV.BIOCARTA_PTDINS_PATHWAY"
5,"Up",0.522725409660858,0.83705521035625,"B.PvsV.BIOCARTA_DICER_PATHWAY"
98,"Up",0.523018654194106,0.83705521035625,"B.PvsV.LIANG_SILENCED_BY_METHYLATION_UP"
17,"Up",0.523059437434517,0.83705521035625,"B.PvsV.SHI_SPARC_TARGETS_DN"
24,"Up",0.523469968763133,0.83705521035625,"B.PvsV.BIOCARTA_COMP_PATHWAY"
11,"Down",0.523498294299674,0.83705521035625,"B.PvsV.REACTOME_MISSPLICED_LRP5_MUTANTS_HAVE_ENHANCED_BETA_CATENIN_DEPENDENT_SIGNALING"
97,"Down",0.523544375370193,0.83705521035625,"B.PvsV.KUNINGER_IGF1_VS_PDGFB_TARGETS_DN"
23,"Up",0.523569627452613,0.83705521035625,"B.PvsV.GOUYER_TATI_TARGETS_DN"
527,"Down",0.52398080085421,0.83705521035625,"B.PvsV.OISHI_CHOLANGIOMA_STEM_CELL_LIKE_UP"
32,"Down",0.523986030775838,0.83705521035625,"B.PvsV.TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_TOP20_DN"
105,"Up",0.524038501531998,0.83705521035625,"B.PvsV.HUTTMANN_B_CLL_POOR_SURVIVAL_DN"
429,"Down",0.524256370681152,0.83705521035625,"B.PvsV.HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN"
60,"Up",0.524276034267262,0.83705521035625,"B.PvsV.REACTOME_NCAM1_INTERACTIONS"
315,"Down",0.52464648756061,0.837404858464958,"B.PvsV.BENPORATH_NOS_TARGETS"
90,"Down",0.524870158235388,0.837520087989455,"B.PvsV.PID_LYSOPHOSPHOLIPID_PATHWAY"
19,"Down",0.525034257413979,0.83754022193938,"B.PvsV.REACTOME_CASPASE_ACTIVATION_VIA_DEATH_RECEPTORS_IN_THE_PRESENCE_OF_LIGAND"
65,"Down",0.525203189916324,0.837568052220178,"B.PvsV.HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_UP"
112,"Up",0.525743956324525,0.838032676119275,"B.PvsV.ZHU_CMV_8_HR_UP"
37,"Up",0.52580512602246,0.838032676119275,"B.PvsV.PID_NFKAPPAB_CANONICAL_PATHWAY"
111,"Down",0.525949246904302,0.838032676119275,"B.PvsV.MEISSNER_BRAIN_HCP_WITH_H3K4ME2_AND_H3K27ME3"
33,"Up",0.526409375452471,0.838524182332674,"B.PvsV.MACLACHLAN_BRCA1_TARGETS_UP"
17,"Down",0.52688077967623,0.839033361414136,"B.PvsV.BIOCARTA_CD40_PATHWAY"
93,"Up",0.527164926977666,0.839146239061586,"B.PvsV.SILIGAN_BOUND_BY_EWS_FLT1_FUSION"
7,"Down",0.527255206095126,0.839146239061586,"B.PvsV.MOTAMED_RESPONSE_TO_ANDROGEN_DN"
7,"Down",0.527514805153841,0.839306449643783,"B.PvsV.SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX3"
465,"Down",0.527733670848333,0.839306449643783,"B.PvsV.RICKMAN_METASTASIS_UP"
1437,"Down",0.5278112724564,0.839306449643783,"B.PvsV.NUYTTEN_EZH2_TARGETS_DN"
1681,"Up",0.528115682458712,0.839400118591944,"B.PvsV.REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION"
10,"Down",0.528281742657463,0.839400118591944,"B.PvsV.GALI_TP53_TARGETS_APOPTOTIC_DN"
223,"Down",0.528325630801223,0.839400118591944,"B.PvsV.VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_DN"
248,"Up",0.528643402528577,0.839621766775932,"B.PvsV.CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN"
28,"Down",0.528768853665002,0.839621766775932,"B.PvsV.REACTOME_MECP2_REGULATES_NEURONAL_RECEPTORS_AND_CHANNELS"
262,"Up",0.529082072238831,0.839877914845966,"B.PvsV.CAIRO_LIVER_DEVELOPMENT_UP"
337,"Down",0.529278327069561,0.839948298038921,"B.PvsV.KATSANOU_ELAVL1_TARGETS_UP"
71,"Down",0.530050485087231,0.840709901921674,"B.PvsV.REACTOME_ION_HOMEOSTASIS"
40,"Down",0.5300623472778,0.840709901921674,"B.PvsV.MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_UP"
90,"Up",0.530513791467766,0.841020817981219,"B.PvsV.ZHANG_RESPONSE_TO_CANTHARIDIN_DN"
134,"Up",0.530562599587356,0.841020817981219,"B.PvsV.SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM3"
32,"Up",0.530760245277606,0.841092976824272,"B.PvsV.BIOCARTA_VIP_PATHWAY"
59,"Up",0.531154091572831,0.841336731015771,"B.PvsV.BOYAULT_LIVER_CANCER_SUBCLASS_G12_UP"
41,"Up",0.53127021376094,0.841336731015771,"B.PvsV.ABE_VEGFA_TARGETS_30MIN"
25,"Up",0.531626403440394,0.841336731015771,"B.PvsV.BIOCARTA_ERK5_PATHWAY"
2477,"Up",0.53168129293353,0.841336731015771,"B.PvsV.GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN"
788,"Up",0.53176938890588,0.841336731015771,"B.PvsV.SENESE_HDAC3_TARGETS_DN"
47,"Down",0.531960871270102,0.841336731015771,"B.PvsV.YAGI_AML_RELAPSE_PROGNOSIS"
11,"Up",0.531979238855333,0.841336731015771,"B.PvsV.REACTOME_HORMONE_LIGAND_BINDING_RECEPTORS"
11,"Up",0.53221345361918,0.841372736133211,"B.PvsV.WALLACE_PROSTATE_CANCER_DN"
46,"Up",0.5323063539508,0.841372736133211,"B.PvsV.CHANGOLKAR_H2AFY_TARGETS_DN"
43,"Up",0.532631480252262,0.841534180115397,"B.PvsV.MARTINELLI_IMMATURE_NEUTROPHIL_UP"
250,"Down",0.533038648661094,0.841534180115397,"B.PvsV.KASLER_HDAC7_TARGETS_1_UP"
124,"Up",0.533156261414893,0.841534180115397,"B.PvsV.LU_IL4_SIGNALING"
18,"Down",0.533234093070738,0.841534180115397,"B.PvsV.REACTOME_SIGNALING_BY_NOTCH1_HD_DOMAIN_MUTANTS_IN_CANCER"
173,"Down",0.533293242276647,0.841534180115397,"B.PvsV.HUANG_GATA2_TARGETS_DN"
71,"Up",0.533401889651157,0.841534180115397,"B.PvsV.BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_UP"
180,"Up",0.53347391957035,0.841534180115397,"B.PvsV.WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_UP"
12,"Down",0.534004659260422,0.841919056335766,"B.PvsV.REACTOME_CHYLOMICRON_ASSEMBLY"
1113,"Up",0.534022450817423,0.841919056335766,"B.PvsV.MARTINEZ_RB1_TARGETS_UP"
201,"Up",0.534424740497313,0.842313110093969,"B.PvsV.REACTOME_G2_M_CHECKPOINTS"
388,"Down",0.534913166308448,0.842842660735084,"B.PvsV.PEREZ_TP53_AND_TP63_TARGETS"
30,"Down",0.535426108720874,0.843322239258366,"B.PvsV.KYNG_DNA_DAMAGE_BY_4NQO_OR_GAMMA_RADIATION"
78,"Up",0.535731136655688,0.843322239258366,"B.PvsV.VILIMAS_NOTCH1_TARGETS_UP"
518,"Up",0.536004463675182,0.843322239258366,"B.PvsV.LEI_MYB_TARGETS"
76,"Down",0.536037013408052,0.843322239258366,"B.PvsV.PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_DN"
56,"Up",0.536335727893591,0.843322239258366,"B.PvsV.KEGG_GLUTATHIONE_METABOLISM"
64,"Up",0.536525878064827,0.843322239258366,"B.PvsV.FAELT_B_CLL_WITH_VH3_21_DN"
18,"Down",0.536572885283004,0.843322239258366,"B.PvsV.MIKKELSEN_IPS_LCP_WITH_H3K4ME3_AND_H3K27ME3"
52,"Up",0.536646193101979,0.843322239258366,"B.PvsV.REACTOME_CYCLIN_D_ASSOCIATED_EVENTS_IN_G1"
79,"Down",0.536679727327532,0.843322239258366,"B.PvsV.HESS_TARGETS_OF_HOXA9_AND_MEIS1_UP"
23,"Up",0.536742803391245,0.843322239258366,"B.PvsV.WU_HBX_TARGETS_2_DN"
62,"Up",0.537701709065797,0.844588849268406,"B.PvsV.KEGG_VASOPRESSIN_REGULATED_WATER_REABSORPTION"
71,"Up",0.538014858049034,0.844840712909148,"B.PvsV.HUANG_FOXA2_TARGETS_DN"
111,"Down",0.53820727526168,0.844902903157816,"B.PvsV.MCBRYAN_PUBERTAL_TGFB1_TARGETS_DN"
29,"Up",0.538504097619317,0.845009419052301,"B.PvsV.KEGG_PHENYLALANINE_METABOLISM"
45,"Down",0.538580790873632,0.845009419052301,"B.PvsV.ABE_VEGFA_TARGETS_2HR"
30,"Up",0.539010682025237,0.845357732684548,"B.PvsV.REACTOME_OTHER_INTERLEUKIN_SIGNALING"
110,"Up",0.539108584815648,0.845357732684548,"B.PvsV.ROSS_AML_WITH_CBFB_MYH11_FUSION"
246,"Down",0.539582040695131,0.845860250355367,"B.PvsV.SASAKI_ADULT_T_CELL_LEUKEMIA"
24,"Down",0.540084506847467,0.846407947380852,"B.PvsV.YAGUE_PRETUMOR_DRUG_RESISTANCE_DN"
151,"Down",0.540749496937071,0.846584822651957,"B.PvsV.IGARASHI_ATF4_TARGETS_DN"
72,"Down",0.540822497327852,0.846584822651957,"B.PvsV.SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_DN"
37,"Up",0.540934408751124,0.846584822651957,"B.PvsV.MATZUK_CENTRAL_FOR_FEMALE_FERTILITY"
203,"Up",0.541070643841644,0.846584822651957,"B.PvsV.IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_DN"
165,"Up",0.541228195334548,0.846584822651957,"B.PvsV.SENESE_HDAC2_TARGETS_UP"
13,"Up",0.54155884351285,0.846584822651957,"B.PvsV.REACTOME_REGULATION_OF_LOCALIZATION_OF_FOXO_TRANSCRIPTION_FACTORS"
31,"Down",0.5416428997136,0.846584822651957,"B.PvsV.REACTOME_PI_3K_CASCADE_FGFR1"
43,"Down",0.541942426344131,0.846584822651957,"B.PvsV.VALK_AML_WITH_EVI1"
137,"Up",0.542056055532791,0.846584822651957,"B.PvsV.REACTOME_SENESCENCE_ASSOCIATED_SECRETORY_PHENOTYPE_SASP"
12,"Up",0.542077916091124,0.846584822651957,"B.PvsV.IIZUKA_LIVER_CANCER_PROGRESSION_L1_G1_DN"
42,"Down",0.542105071131773,0.846584822651957,"B.PvsV.ODONNELL_METASTASIS_DN"
264,"Up",0.542243687888591,0.846584822651957,"B.PvsV.POOLA_INVASIVE_BREAST_CANCER_DN"
260,"Down",0.542334333431802,0.846584822651957,"B.PvsV.INGRAM_SHH_TARGETS_UP"
140,"Down",0.542487194784313,0.846584822651957,"B.PvsV.MCCLUNG_COCAINE_REWARD_5D"
75,"Up",0.542627499762309,0.846584822651957,"B.PvsV.PID_IL6_7_PATHWAY"
47,"Down",0.542853386308654,0.846584822651957,"B.PvsV.VALK_AML_CLUSTER_12"
231,"Up",0.542862965914739,0.846584822651957,"B.PvsV.BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_DN"
67,"Up",0.542959829463408,0.846584822651957,"B.PvsV.NGUYEN_NOTCH1_TARGETS_UP"
129,"Up",0.543287733240154,0.846584822651957,"B.PvsV.JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_DN"
15,"Down",0.543364312254605,0.846584822651957,"B.PvsV.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_9"
176,"Up",0.543412829732645,0.846584822651957,"B.PvsV.CADWELL_ATG16L1_TARGETS_UP"
97,"Up",0.543630253757936,0.846684978317641,"B.PvsV.MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_UP"
15,"Up",0.544100024454746,0.847177987949955,"B.PvsV.KEGG_GLYCOSPHINGOLIPID_BIOSYNTHESIS_GLOBO_SERIES"
179,"Down",0.544714913174924,0.847896608936981,"B.PvsV.MIKKELSEN_IPS_HCP_WITH_H3_UNMETHYLATED"
16,"Down",0.545075461661998,0.848219033923216,"B.PvsV.BIOCARTA_RELA_PATHWAY"
9,"Down",0.54534142920824,0.848394136773314,"B.PvsV.REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_BCR_SIGNALING"
7,"Up",0.545573178134363,0.848515921773528,"B.PvsV.REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_LINKED_TO_GLUCONEOGENESIS"
51,"Down",0.545780491629769,0.848598777350276,"B.PvsV.LE_SKI_TARGETS_UP"
66,"Down",0.545933414909555,0.848598777350276,"B.PvsV.REACTOME_REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF"
48,"Up",0.546526170025238,0.84905811492615,"B.PvsV.WIKMAN_ASBESTOS_LUNG_CANCER_DN"
183,"Down",0.54653605191213,0.84905811492615,"B.PvsV.REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION"
25,"Up",0.547029152613858,0.849146821971518,"B.PvsV.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_22"
473,"Up",0.547037504306126,0.849146821971518,"B.PvsV.DURAND_STROMA_S_UP"
32,"Up",0.547185478969594,0.849146821971518,"B.PvsV.KEGG_PROXIMAL_TUBULE_BICARBONATE_RECLAMATION"
8,"Down",0.547248168778349,0.849146821971518,"B.PvsV.NIKOLSKY_BREAST_CANCER_19Q13.4_AMPLICON"
546,"Up",0.547361055074424,0.849146821971518,"B.PvsV.ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_UP"
355,"Up",0.547658392122164,0.849170780939859,"B.PvsV.RIZKI_TUMOR_INVASIVENESS_3D_UP"
277,"Down",0.547683668806572,0.849170780939859,"B.PvsV.REACTOME_ESR_MEDIATED_SIGNALING"
68,"Up",0.548354405586386,0.849972388137687,"B.PvsV.PID_FRA_PATHWAY"
341,"Up",0.548562221281953,0.850056199962982,"B.PvsV.GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_DN"
17,"Down",0.549094801776944,0.850643081822561,"B.PvsV.REACTOME_NOTCH4_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS"
24,"Down",0.549685613544119,0.851319819967909,"B.PvsV.SUZUKI_AMPLIFIED_IN_ORAL_CANCER"
161,"Up",0.549982869286158,0.851329313828756,"B.PvsV.CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_UP"
39,"Up",0.550243414973744,0.851329313828756,"B.PvsV.REACTOME_NEGATIVE_REGULATION_OF_FGFR4_SIGNALING"
28,"Down",0.550336075275351,0.851329313828756,"B.PvsV.WEST_ADRENOCORTICAL_TUMOR_MARKERS_UP"
136,"Down",0.550408585390257,0.851329313828756,"B.PvsV.BENPORATH_ES_CORE_NINE_CORRELATED"
212,"Down",0.550461619992368,0.851329313828756,"B.PvsV.WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_UP"
40,"Up",0.550962187706359,0.851865194582902,"B.PvsV.WU_HBX_TARGETS_2_UP"
134,"Down",0.551205042187693,0.852002426126853,"B.PvsV.MIKKELSEN_IPS_ICP_WITH_H3K27ME3"
152,"Down",0.551503307265354,0.852124120129516,"B.PvsV.LEIN_MIDBRAIN_MARKERS"
18,"Up",0.551654969905173,0.852124120129516,"B.PvsV.REACTOME_SEMA4D_MEDIATED_INHIBITION_OF_CELL_ATTACHMENT_AND_MIGRATION"
750,"Down",0.55174612951052,0.852124120129516,"B.PvsV.ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP"
74,"Up",0.552058397040676,0.8523682985864,"B.PvsV.PLASARI_NFIC_TARGETS_BASAL_UP"
820,"Down",0.552321814634515,0.852536938334515,"B.PvsV.SENESE_HDAC3_TARGETS_UP"
92,"Down",0.552804693298675,0.852665256162828,"B.PvsV.OLSSON_E2F3_TARGETS_DN"
239,"Down",0.552857720318571,0.852665256162828,"B.PvsV.REACTOME_REPRODUCTION"
206,"Up",0.553141856902735,0.852665256162828,"B.PvsV.MIKKELSEN_IPS_ICP_WITH_H3K4ME3_AND_H327ME3"
79,"Up",0.553233033688045,0.852665256162828,"B.PvsV.PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_UP"
28,"Up",0.553686078030466,0.852665256162828,"B.PvsV.REACTOME_TRAF6_MEDIATED_NF_KB_ACTIVATION"
35,"Down",0.553800373298156,0.852665256162828,"B.PvsV.MOROSETTI_FACIOSCAPULOHUMERAL_MUSCULAR_DISTROPHY_UP"
132,"Up",0.553820082811759,0.852665256162828,"B.PvsV.AKL_HTLV1_INFECTION_DN"
217,"Up",0.553995939746641,0.852665256162828,"B.PvsV.YAGI_AML_WITH_T_9_11_TRANSLOCATION"
290,"Up",0.554234552253769,0.852665256162828,"B.PvsV.KEGG_MAPK_SIGNALING_PATHWAY"
64,"Up",0.554283405606085,0.852665256162828,"B.PvsV.MATTIOLI_MULTIPLE_MYELOMA_WITH_14Q32_TRANSLOCATIONS"
36,"Up",0.554318959544192,0.852665256162828,"B.PvsV.REACTOME_NEPHRIN_FAMILY_INTERACTIONS"
24,"Down",0.554485954860339,0.852665256162828,"B.PvsV.REACTOME_FRS_MEDIATED_FGFR4_SIGNALING"
7,"Down",0.554493368363813,0.852665256162828,"B.PvsV.BIOCARTA_RAN_PATHWAY"
32,"Down",0.554654408459384,0.852665256162828,"B.PvsV.XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_UP"
145,"Up",0.554718199749989,0.852665256162828,"B.PvsV.CROMER_METASTASIS_DN"
317,"Down",0.555141297848478,0.853078442413628,"B.PvsV.WU_CELL_MIGRATION"
9,"Up",0.555543781053728,0.853458433805447,"B.PvsV.REACTOME_DNA_DAMAGE_REVERSAL"
41,"Down",0.555697298191284,0.853458433805447,"B.PvsV.BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_UP"
82,"Up",0.556032101013989,0.853735486394432,"B.PvsV.TUOMISTO_TUMOR_SUPPRESSION_BY_COL13A1_UP"
5,"Up",0.556268451658878,0.85386126297111,"B.PvsV.REACTOME_SODIUM_COUPLED_PHOSPHATE_COTRANSPORTERS"
197,"Up",0.556426928886273,0.853867468723897,"B.PvsV.LIU_SOX4_TARGETS_UP"
144,"Up",0.556672751211809,0.853868308155662,"B.PvsV.LIANG_SILENCED_BY_METHYLATION_2"
36,"Up",0.556736344890787,0.853868308155662,"B.PvsV.BIOCARTA_TRKA_PATHWAY"
5,"Up",0.557337991970116,0.853887284482968,"B.PvsV.REACTOME_SUMO_IS_CONJUGATED_TO_E1_UBA2_SAE1"
63,"Up",0.557408548972303,0.853887284482968,"B.PvsV.SNIJDERS_AMPLIFIED_IN_HEAD_AND_NECK_TUMORS"
120,"Down",0.557424043167697,0.853887284482968,"B.PvsV.PID_BETA_CATENIN_NUC_PATHWAY"
42,"Up",0.557441567531135,0.853887284482968,"B.PvsV.BIOCARTA_GLEEVEC_PATHWAY"
896,"Up",0.55755289939724,0.853887284482968,"B.PvsV.REACTOME_METABOLISM_OF_LIPIDS"
193,"Down",0.557798458060923,0.853887284482968,"B.PvsV.KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP"
12,"Down",0.557862643921346,0.853887284482968,"B.PvsV.REACTOME_RUNX2_REGULATES_CHONDROCYTE_MATURATION"
632,"Down",0.558363157054774,0.853887284482968,"B.PvsV.ZHOU_INFLAMMATORY_RESPONSE_LIVE_DN"
13,"Up",0.558376095806014,0.853887284482968,"B.PvsV.FUNG_IL2_SIGNALING_2"
124,"Up",0.558468283905401,0.853887284482968,"B.PvsV.CHEBOTAEV_GR_TARGETS_UP"
167,"Up",0.558587673808675,0.853887284482968,"B.PvsV.HILLION_HMGA1B_TARGETS"
39,"Down",0.55860197286578,0.853887284482968,"B.PvsV.DACOSTA_LOW_DOSE_UV_RESPONSE_VIA_ERCC3_XPCS_UP"
110,"Up",0.559241514790955,0.854129358755102,"B.PvsV.OHGUCHI_LIVER_HNF4A_TARGETS_UP"
55,"Up",0.559253112598537,0.854129358755102,"B.PvsV.CHEN_LUNG_CANCER_SURVIVAL"
22,"Down",0.559286603789635,0.854129358755102,"B.PvsV.MEISSNER_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3"
141,"Down",0.55951436659249,0.854129358755102,"B.PvsV.YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_0"
27,"Up",0.559618255853619,0.854129358755102,"B.PvsV.REACTOME_LISTERIA_MONOCYTOGENES_ENTRY_INTO_HOST_CELLS"
58,"Down",0.559687224953832,0.854129358755102,"B.PvsV.REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION"
2751,"Down",0.560210651213003,0.854543518790011,"B.PvsV.BLALOCK_ALZHEIMERS_DISEASE_UP"
255,"Down",0.560267725739517,0.854543518790011,"B.PvsV.ALCALAY_AML_BY_NPM1_LOCALIZATION_DN"
54,"Down",0.560656434878298,0.85471967942595,"B.PvsV.RIZ_ERYTHROID_DIFFERENTIATION_12HR"
24,"Down",0.560829522107516,0.85471967942595,"B.PvsV.REACTOME_FGFR1_LIGAND_BINDING_AND_ACTIVATION"
278,"Up",0.560846988055226,0.85471967942595,"B.PvsV.REACTOME_SIGNALING_BY_ROBO_RECEPTORS"
12,"Down",0.561021967856833,0.854750746839469,"B.PvsV.FOURNIER_ACINAR_DEVELOPMENT_EARLY_DN"
27,"Up",0.561769463324691,0.855653818931739,"B.PvsV.WILSON_PROTEASES_AT_TUMOR_BONE_INTERFACE_UP"
13,"Up",0.561993092562437,0.85575869148381,"B.PvsV.REACTOME_P75NTR_REGULATES_AXONOGENESIS"
210,"Down",0.562954934500634,0.856987288781389,"B.PvsV.MIKKELSEN_ES_LCP_WITH_H3K4ME3"
50,"Down",0.563309520076909,0.85716109112379,"B.PvsV.REACTOME_ACTIVATION_OF_GENE_EXPRESSION_BY_SREBF_SREBP"
8,"Down",0.5633791653362,0.85716109112379,"B.PvsV.IKEDA_MIR133_TARGETS_DN"
50,"Up",0.563858954229804,0.857455207916061,"B.PvsV.REACTOME_DAG_AND_IP3_SIGNALING"
64,"Down",0.563965180449642,0.857455207916061,"B.PvsV.BIOCARTA_KERATINOCYTE_PATHWAY"
116,"Up",0.564186570611264,0.857455207916061,"B.PvsV.BAUS_TFF2_TARGETS_UP"
98,"Down",0.564192809983474,0.857455207916061,"B.PvsV.VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_UP"
43,"Down",0.564576837476541,0.857803059743829,"B.PvsV.PID_CD40_PATHWAY"
19,"Down",0.564766058938968,0.857811026370223,"B.PvsV.REACTOME_SYNTHESIS_OF_PIPS_AT_THE_EARLY_ENDOSOME_MEMBRANE"
34,"Down",0.564952779455844,0.857811026370223,"B.PvsV.BYSTRYKH_HEMATOPOIESIS_STEM_CELL_IL3RA"
23,"Down",0.565174181928224,0.857811026370223,"B.PvsV.LY_AGING_MIDDLE_UP"
12,"Down",0.565202671200348,0.857811026370223,"B.PvsV.REACTOME_SYNTHESIS_OF_5_EICOSATETRAENOIC_ACIDS"
56,"Down",0.565815508822242,0.858505474280509,"B.PvsV.BOYAULT_LIVER_CANCER_SUBCLASS_G5_DN"
17,"Up",0.566555119001121,0.859377066688644,"B.PvsV.REACTOME_TRYPTOPHAN_CATABOLISM"
279,"Up",0.566909927549474,0.859377066688644,"B.PvsV.BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP"
77,"Up",0.566950908131347,0.859377066688644,"B.PvsV.LINDSTEDT_DENDRITIC_CELL_MATURATION_B"
41,"Down",0.567060924529645,0.859377066688644,"B.PvsV.ZHANG_RESPONSE_TO_CANTHARIDIN_UP"
159,"Up",0.567300414445441,0.859377066688644,"B.PvsV.MAHAJAN_RESPONSE_TO_IL1A_DN"
12,"Up",0.567403304477842,0.859377066688644,"B.PvsV.KEGG_TAURINE_AND_HYPOTAURINE_METABOLISM"
113,"Down",0.567477965360868,0.859377066688644,"B.PvsV.FAELT_B_CLL_WITH_VH_REARRANGEMENTS_UP"
90,"Up",0.567851813464147,0.859662110571519,"B.PvsV.REACTOME_CONDENSATION_OF_PROPHASE_CHROMOSOMES"
59,"Up",0.568067054778921,0.859662110571519,"B.PvsV.GENTILE_UV_RESPONSE_CLUSTER_D7"
169,"Down",0.568132637371736,0.859662110571519,"B.PvsV.GAVIN_FOXP3_TARGETS_CLUSTER_P4"
116,"Down",0.568511842742673,0.860000541319902,"B.PvsV.REACTOME_STIMULI_SENSING_CHANNELS"
86,"Down",0.56883675340617,0.860041668263669,"B.PvsV.MCGARVEY_SILENCED_BY_METHYLATION_IN_COLON_CANCER"
90,"Up",0.568850132183078,0.860041668263669,"B.PvsV.DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP"
89,"Up",0.569247308814009,0.860194125998662,"B.PvsV.VANHARANTA_UTERINE_FIBROID_UP"
16,"Up",0.569373273259127,0.860194125998662,"B.PvsV.REACTOME_GAMMA_CARBOXYLATION_TRANSPORT_AND_AMINO_TERMINAL_CLEAVAGE_OF_PROTEINS"
60,"Down",0.569471005175339,0.860194125998662,"B.PvsV.REACTOME_METABOLIC_DISORDERS_OF_BIOLOGICAL_OXIDATION_ENZYMES"
140,"Down",0.569573285455073,0.860194125998662,"B.PvsV.DUAN_PRDM5_TARGETS"
782,"Down",0.569938548186827,0.860510713524021,"B.PvsV.BONOME_OVARIAN_CANCER_SURVIVAL_SUBOPTIMAL_DEBULKING"
18,"Down",0.570270509241185,0.860670634374163,"B.PvsV.REACTOME_DISEASES_ASSOCIATED_WITH_N_GLYCOSYLATION_OF_PROTEINS"
33,"Up",0.570623947471795,0.860670634374163,"B.PvsV.KORKOLA_CHORIOCARCINOMA_DN"
504,"Up",0.571141938179546,0.860670634374163,"B.PvsV.FARMER_BREAST_CANCER_BASAL_VS_LULMINAL"
49,"Down",0.571269455538327,0.860670634374163,"B.PvsV.VANDESLUIS_NORMAL_EMBRYOS_DN"
9,"Down",0.571541940134129,0.860670634374163,"B.PvsV.REACTOME_HIGHLY_CALCIUM_PERMEABLE_NICOTINIC_ACETYLCHOLINE_RECEPTORS"
83,"Up",0.571584656038518,0.860670634374163,"B.PvsV.PID_TXA2PATHWAY"
7,"Down",0.571638797660705,0.860670634374163,"B.PvsV.REACTOME_APEX1_INDEPENDENT_RESOLUTION_OF_AP_SITES_VIA_THE_SINGLE_NUCLEOTIDE_REPLACEMENT_PATHWAY"
29,"Down",0.571697104091662,0.860670634374163,"B.PvsV.GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_DN"
33,"Up",0.571790243911426,0.860670634374163,"B.PvsV.REACTOME_REGULATION_OF_SIGNALING_BY_CBL"
47,"Down",0.571840581220318,0.860670634374163,"B.PvsV.REACTOME_TRNA_MODIFICATION_IN_THE_NUCLEUS_AND_CYTOSOL"
26,"Down",0.571888845679925,0.860670634374163,"B.PvsV.REACTOME_FORMATION_OF_TUBULIN_FOLDING_INTERMEDIATES_BY_CCT_TRIC"
52,"Up",0.571912445413398,0.860670634374163,"B.PvsV.PID_BMP_PATHWAY"
73,"Down",0.572809440301472,0.861553299288955,"B.PvsV.LIAO_HAVE_SOX4_BINDING_SITES"
63,"Down",0.573068652158867,0.861553299288955,"B.PvsV.KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS"
57,"Down",0.573140741995945,0.861553299288955,"B.PvsV.DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY"
49,"Down",0.573225573776343,0.861553299288955,"B.PvsV.KEGG_ABC_TRANSPORTERS"
125,"Down",0.573278095149949,0.861553299288955,"B.PvsV.IVANOVSKA_MIR106B_TARGETS"
463,"Down",0.573704289961202,0.861680841448772,"B.PvsV.BRUINS_UVC_RESPONSE_EARLY_LATE"
195,"Down",0.573771791407205,0.861680841448772,"B.PvsV.REACTOME_ION_CHANNEL_TRANSPORT"
11,"Up",0.573855110641788,0.861680841448772,"B.PvsV.BIOCARTA_NOTCH_PATHWAY"
179,"Up",0.573986351791613,0.861680841448772,"B.PvsV.BOUDOUKHA_BOUND_BY_IGF2BP2"
35,"Down",0.57444584378669,0.862136555455105,"B.PvsV.TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_GRANULOCYTE_UP"
218,"Up",0.574774198368836,0.862395262627217,"B.PvsV.MCBRYAN_PUBERTAL_BREAST_5_6WK_DN"
6,"Up",0.57527286448676,0.862687335662697,"B.PvsV.BIOCARTA_SUMO_PATHWAY"
51,"Down",0.575428397097337,0.862687335662697,"B.PvsV.BOYAULT_LIVER_CANCER_SUBCLASS_G2"
563,"Up",0.575533353674769,0.862687335662697,"B.PvsV.RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN"
73,"Up",0.575737597148231,0.862687335662697,"B.PvsV.HOFMANN_CELL_LYMPHOMA_DN"
74,"Down",0.575895022928641,0.862687335662697,"B.PvsV.GEORGES_CELL_CYCLE_MIR192_TARGETS"
43,"Up",0.576114606262775,0.862687335662697,"B.PvsV.LA_MEN1_TARGETS"
934,"Up",0.576133445239076,0.862687335662697,"B.PvsV.CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN"
87,"Down",0.576217097233196,0.862687335662697,"B.PvsV.BROWNE_HCMV_INFECTION_8HR_DN"
50,"Up",0.577139465759272,0.863591543610062,"B.PvsV.ABBUD_LIF_SIGNALING_1_DN"
44,"Up",0.577372419933623,0.863591543610062,"B.PvsV.CHIARETTI_T_ALL_RELAPSE_PROGNOSIS"
11,"Down",0.577434604469526,0.863591543610062,"B.PvsV.WORSCHECH_TUMOR_REJECTION_DN"
575,"Down",0.577604037408122,0.863591543610062,"B.PvsV.LINDGREN_BLADDER_CANCER_CLUSTER_1_DN"
5,"Up",0.577637275190166,0.863591543610062,"B.PvsV.REACTOME_MRNA_EDITING_C_TO_U_CONVERSION"
51,"Down",0.577923135662911,0.863591543610062,"B.PvsV.VALK_AML_CLUSTER_13"
17,"Up",0.577941086182165,0.863591543610062,"B.PvsV.SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_UP"
140,"Up",0.57807059195168,0.863591543610062,"B.PvsV.REACTOME_GLYCEROPHOSPHOLIPID_BIOSYNTHESIS"
71,"Down",0.578846960647239,0.864517786444783,"B.PvsV.BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_UP"
33,"Down",0.57915006725119,0.864588816809299,"B.PvsV.REACTOME_PLASMA_LIPOPROTEIN_ASSEMBLY"
110,"Down",0.579510598964994,0.864588816809299,"B.PvsV.TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_UP"
62,"Down",0.579596725359496,0.864588816809299,"B.PvsV.REACTOME_XENOBIOTICS"
323,"Down",0.579780529645895,0.864588816809299,"B.PvsV.DURAND_STROMA_NS_UP"
34,"Down",0.579879980927421,0.864588816809299,"B.PvsV.SYED_ESTRADIOL_RESPONSE"
202,"Down",0.579895111063027,0.864588816809299,"B.PvsV.REACTOME_MEIOSIS"
93,"Up",0.580064548481662,0.864588816809299,"B.PvsV.DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_UP"
20,"Down",0.580145507390577,0.864588816809299,"B.PvsV.REACTOME_ERYTHROCYTES_TAKE_UP_CARBON_DIOXIDE_AND_RELEASE_OXYGEN"
14,"Up",0.580492252981114,0.864643386390605,"B.PvsV.REACTOME_ETHANOL_OXIDATION"
15,"Down",0.580623644381442,0.864643386390605,"B.PvsV.CHESLER_BRAIN_D6MIT150_QTL_CIS"
33,"Up",0.580911734558942,0.864643386390605,"B.PvsV.REACTOME_PURINERGIC_SIGNALING_IN_LEISHMANIASIS_INFECTION"
22,"Down",0.58123741773895,0.864643386390605,"B.PvsV.MEISSNER_NPC_ICP_WITH_H3K4ME3"
1260,"Up",0.581319518876568,0.864643386390605,"B.PvsV.ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_UP"
209,"Up",0.581325324191807,0.864643386390605,"B.PvsV.KANG_IMMORTALIZED_BY_TERT_DN"
34,"Down",0.581337363246959,0.864643386390605,"B.PvsV.REACTOME_IRF3_MEDIATED_INDUCTION_OF_TYPE_I_IFN"
104,"Up",0.581534463886355,0.864643386390605,"B.PvsV.ZHENG_IL22_SIGNALING_DN"
23,"Down",0.582005932990102,0.864643386390605,"B.PvsV.PID_SYNDECAN_3_PATHWAY"
77,"Down",0.582324766518196,0.864643386390605,"B.PvsV.KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM"
13,"Down",0.582532667758159,0.864643386390605,"B.PvsV.REACTOME_INHIBITION_OF_REPLICATION_INITIATION_OF_DAMAGED_DNA_BY_RB1_E2F1"
7,"Up",0.58257656807276,0.864643386390605,"B.PvsV.REACTOME_SUMO_IS_TRANSFERRED_FROM_E1_TO_E2_UBE2I_UBC9"
29,"Down",0.582803288769929,0.864643386390605,"B.PvsV.REACTOME_FRS_MEDIATED_FGFR2_SIGNALING"
25,"Up",0.582860061155306,0.864643386390605,"B.PvsV.BIOCARTA_IL3_PATHWAY"
57,"Down",0.583141469019675,0.864643386390605,"B.PvsV.SCHRAETS_MLL_TARGETS_UP"
28,"Up",0.58339940536838,0.864643386390605,"B.PvsV.TIAN_TNF_SIGNALING_VIA_NFKB"
14,"Down",0.583442104198931,0.864643386390605,"B.PvsV.REACTOME_DEFECTIVE_EXT2_CAUSES_EXOSTOSES_2"
43,"Up",0.583526172265699,0.864643386390605,"B.PvsV.ZWANG_EGF_PERSISTENTLY_UP"
181,"Up",0.583623005228674,0.864643386390605,"B.PvsV.GRADE_COLON_AND_RECTAL_CANCER_DN"
9,"Down",0.583707296868587,0.864643386390605,"B.PvsV.REACTOME_THE_ACTIVATION_OF_ARYLSULFATASES"
83,"Up",0.583810242453478,0.864643386390605,"B.PvsV.PARENT_MTOR_SIGNALING_DN"
478,"Up",0.583812301965106,0.864643386390605,"B.PvsV.DAZARD_RESPONSE_TO_UV_NHEK_UP"
17,"Up",0.583856480283148,0.864643386390605,"B.PvsV.REACTOME_PHOSPHORYLATION_SITE_MUTANTS_OF_CTNNB1_ARE_NOT_TARGETED_TO_THE_PROTEASOME_BY_THE_DESTRUCTION_COMPLEX"
11,"Down",0.583935323708179,0.864643386390605,"B.PvsV.REACTOME_HIGHLY_CALCIUM_PERMEABLE_POSTSYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS"
35,"Down",0.584512729563147,0.865266635007936,"B.PvsV.PID_ALK1_PATHWAY"
10,"Up",0.584928156211981,0.86562254486606,"B.PvsV.REACTOME_NEGATIVE_REGULATION_OF_ACTIVITY_OF_TFAP2_AP_2_FAMILY_TRANSCRIPTION_FACTORS"
13,"Up",0.585154066079449,0.86562254486606,"B.PvsV.PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_DN"
33,"Up",0.585509296599091,0.86562254486606,"B.PvsV.GHO_ATF5_TARGETS_DN"
425,"Down",0.58551197427277,0.86562254486606,"B.PvsV.ALFANO_MYC_TARGETS"
42,"Down",0.585639598836999,0.86562254486606,"B.PvsV.OHM_METHYLATED_IN_ADULT_CANCERS"
88,"Up",0.585692519505142,0.86562254486606,"B.PvsV.KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION"
37,"Up",0.586114329312849,0.86601446466348,"B.PvsV.PID_INSULIN_GLUCOSE_PATHWAY"
23,"Up",0.586700947896018,0.866649623541833,"B.PvsV.ZHANG_ADIPOGENESIS_BY_BMP7"
33,"Up",0.586883074560577,0.866687104499314,"B.PvsV.BUCKANOVICH_T_LYMPHOCYTE_HOMING_ON_TUMOR_DN"
87,"Up",0.587599887857013,0.867513959936295,"B.PvsV.LEE_LIVER_CANCER_MYC_TGFA_UP"
66,"Up",0.588009341424688,0.867886718829978,"B.PvsV.REACTOME_NEUREXINS_AND_NEUROLIGINS"
13,"Up",0.588272771089972,0.868043808742048,"B.PvsV.GALI_TP53_TARGETS_APOPTOTIC_UP"
79,"Up",0.588600007615202,0.868117511491467,"B.PvsV.REACTOME_ACTIVATION_OF_MATRIX_METALLOPROTEINASES"
528,"Up",0.588698993505613,0.868117511491467,"B.PvsV.WANG_LMO4_TARGETS_UP"
154,"Up",0.588946515308657,0.868117511491467,"B.PvsV.RADMACHER_AML_PROGNOSIS"
7,"Down",0.588950766070626,0.868117511491467,"B.PvsV.REACTOME_LTC4_CYSLTR_MEDIATED_IL4_PRODUCTION"
214,"Down",0.589129372485287,0.868149333814273,"B.PvsV.NIKOLSKY_BREAST_CANCER_8Q23_Q24_AMPLICON"
5,"Up",0.590426593330108,0.869599475746943,"B.PvsV.REACTOME_PTK6_REGULATES_PROTEINS_INVOLVED_IN_RNA_PROCESSING"
15,"Up",0.590428003608975,0.869599475746943,"B.PvsV.GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP"
66,"Up",0.590786610061967,0.86989591665316,"B.PvsV.REACTOME_SIGNALING_BY_ERBB2"
54,"Up",0.591295390823701,0.870187865848687,"B.PvsV.REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY"
97,"Down",0.591545497452065,0.870187865848687,"B.PvsV.BEIER_GLIOMA_STEM_CELL_DN"
110,"Up",0.5915704823233,0.870187865848687,"B.PvsV.TOOKER_GEMCITABINE_RESISTANCE_UP"
28,"Down",0.591656285290633,0.870187865848687,"B.PvsV.REACTOME_MICRORNA_MIRNA_BIOGENESIS"
67,"Down",0.591771816891131,0.870187865848687,"B.PvsV.MA_MYELOID_DIFFERENTIATION_UP"
44,"Up",0.5922565343975,0.870583710579754,"B.PvsV.REACTOME_NEGATIVE_REGULATION_OF_FGFR2_SIGNALING"
59,"Up",0.592712555862192,0.870583710579754,"B.PvsV.KAMIKUBO_MYELOID_CEBPA_NETWORK"
29,"Down",0.592734581361944,0.870583710579754,"B.PvsV.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_15"
106,"Up",0.592886586354427,0.870583710579754,"B.PvsV.BILANGES_RAPAMYCIN_SENSITIVE_VIA_TSC1_AND_TSC2"
512,"Up",0.592966635073498,0.870583710579754,"B.PvsV.DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP"
22,"Down",0.593172682022351,0.870583710579754,"B.PvsV.LOPEZ_EPITHELIOID_MESOTHELIOMA"
152,"Down",0.593191933788057,0.870583710579754,"B.PvsV.WONG_ENDMETRIUM_CANCER_DN"
30,"Up",0.593344472556136,0.870583710579754,"B.PvsV.REACTOME_GLUTAMATE_NEUROTRANSMITTER_RELEASE_CYCLE"
305,"Down",0.593458130796725,0.870583710579754,"B.PvsV.PAL_PRMT5_TARGETS_UP"
87,"Up",0.593913966642466,0.871021305455224,"B.PvsV.ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_DN"
666,"Up",0.594225429307218,0.871170409196626,"B.PvsV.FOSTER_KDM1A_TARGETS_UP"
156,"Up",0.59433076207084,0.871170409196626,"B.PvsV.ZAMORA_NOS2_TARGETS_DN"
362,"Up",0.594792365724694,0.871615952847028,"B.PvsV.MULLIGHAN_NPM1_SIGNATURE_3_DN"
16,"Down",0.595680680717079,0.872556057971857,"B.PvsV.ZHOU_PANCREATIC_EXOCRINE_PROGENITOR"
265,"Down",0.595749524117157,0.872556057971857,"B.PvsV.SHEPARD_CRUSH_AND_BURN_MUTANT_UP"
19,"Up",0.596065555387854,0.872787726625913,"B.PvsV.REACTOME_PI3K_EVENTS_IN_ERBB2_SIGNALING"
5,"Up",0.596534816811786,0.873243580130359,"B.PvsV.REACTOME_GALACTOSE_CATABOLISM"
13,"Up",0.596805729366999,0.873408914153027,"B.PvsV.REACTOME_CREATINE_METABOLISM"
10,"Down",0.597216668594195,0.87364073165915,"B.PvsV.BIOCARTA_CB1R_PATHWAY"
181,"Down",0.597547218452791,0.87364073165915,"B.PvsV.MUNSHI_MULTIPLE_MYELOMA_UP"
156,"Down",0.597704086950741,0.87364073165915,"B.PvsV.REACTOME_DISEASES_OF_GLYCOSYLATION"
53,"Down",0.597770100005804,0.87364073165915,"B.PvsV.BIOCARTA_VEGF_PATHWAY"
12,"Down",0.597770614643675,0.87364073165915,"B.PvsV.REACTOME_INTERLEUKIN_21_SIGNALING"
13,"Down",0.597912195441892,0.87364073165915,"B.PvsV.BIOCARTA_EIF2_PATHWAY"
879,"Up",0.598100067846786,0.873684352741052,"B.PvsV.ONKEN_UVEAL_MELANOMA_DN"
43,"Down",0.598628236665314,0.873871337914613,"B.PvsV.REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN"
108,"Up",0.598727074840808,0.873871337914613,"B.PvsV.LEE_LIVER_CANCER_DENA_UP"
61,"Up",0.598793568910063,0.873871337914613,"B.PvsV.ZHAN_MULTIPLE_MYELOMA_MF_DN"
1673,"Down",0.59886028203264,0.873871337914613,"B.PvsV.REACTOME_SIGNALING_BY_GPCR"
17,"Down",0.599275042170391,0.874120498817226,"B.PvsV.REACTOME_VITAMIN_B5_PANTOTHENATE_METABOLISM"
12,"Down",0.599578694914663,0.874120498817226,"B.PvsV.REACTOME_INTERLEUKIN_9_SIGNALING"
111,"Down",0.599638414921059,0.874120498817226,"B.PvsV.REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES"
258,"Down",0.599663420512523,0.874120498817226,"B.PvsV.RUIZ_TNC_TARGETS_UP"
32,"Up",0.600459446500991,0.875050152794935,"B.PvsV.SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_2FC_UP"
109,"Up",0.600794094257129,0.875146112743901,"B.PvsV.KEGG_MELANOGENESIS"
62,"Up",0.600841860006484,0.875146112743901,"B.PvsV.SUBTIL_PROGESTIN_TARGETS"
80,"Up",0.601048694480699,0.875216811109767,"B.PvsV.HOQUE_METHYLATED_IN_CANCER"
64,"Up",0.601289817169464,0.875337387869923,"B.PvsV.REACTOME_COPI_INDEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC"
460,"Down",0.601618544727861,0.875438504821854,"B.PvsV.BOQUEST_STEM_CELL_UP"
174,"Up",0.601675948331171,0.875438504821854,"B.PvsV.UDAYAKUMAR_MED1_TARGETS_UP"
47,"Down",0.602108941056437,0.875838025546182,"B.PvsV.REACTOME_SYNTHESIS_OF_LEUKOTRIENES_LT_AND_EOXINS_EX"
876,"Up",0.602532834634704,0.875935435979669,"B.PvsV.ENK_UV_RESPONSE_KERATINOCYTE_UP"
34,"Up",0.602570651381368,0.875935435979669,"B.PvsV.PARK_HSC_VS_MULTIPOTENT_PROGENITORS_UP"
27,"Up",0.602672361091927,0.875935435979669,"B.PvsV.REACTOME_NEGATIVE_REGULATION_OF_MET_ACTIVITY"
12,"Down",0.602809610038459,0.875935435979669,"B.PvsV.KUMAMOTO_RESPONSE_TO_NUTLIN_3A_UP"
619,"Down",0.60315117785557,0.876008800216757,"B.PvsV.YAGI_AML_WITH_11Q23_REARRANGED"
203,"Down",0.603176976383649,0.876008800216757,"B.PvsV.BORCZUK_MALIGNANT_MESOTHELIOMA_DN"
69,"Up",0.603679221796395,0.876408539738495,"B.PvsV.WAGSCHAL_EHMT2_TARGETS_UP"
518,"Up",0.604022526919321,0.876408539738495,"B.PvsV.FARMER_BREAST_CANCER_APOCRINE_VS_BASAL"
266,"Up",0.604162795175665,0.876408539738495,"B.PvsV.ALCALAY_AML_BY_NPM1_LOCALIZATION_UP"
167,"Down",0.604242657095575,0.876408539738495,"B.PvsV.REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE"
452,"Up",0.604361073631298,0.876408539738495,"B.PvsV.REACTOME_DISEASES_OF_SIGNAL_TRANSDUCTION_BY_GROWTH_FACTOR_RECEPTORS_AND_SECOND_MESSENGERS"
1037,"Up",0.604403284865777,0.876408539738495,"B.PvsV.CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_3"
272,"Up",0.6047905035317,0.876636169386043,"B.PvsV.BOYAULT_LIVER_CANCER_SUBCLASS_G3_UP"
9,"Up",0.604877371352461,0.876636169386043,"B.PvsV.REACTOME_ADRENOCEPTORS"
19,"Up",0.605183453338299,0.876710559349706,"B.PvsV.REACTOME_ORGANIC_CATION_ANION_ZWITTERION_TRANSPORT"
93,"Up",0.605285859537764,0.876710559349706,"B.PvsV.KEGG_FC_EPSILON_RI_SIGNALING_PATHWAY"
41,"Down",0.605404397829115,0.876710559349706,"B.PvsV.HASLINGER_B_CLL_WITH_13Q14_DELETION"
56,"Up",0.60570278584006,0.876912988455012,"B.PvsV.SHAFFER_IRF4_MULTIPLE_MYELOMA_PROGRAM"
88,"Up",0.605948749919364,0.877039434111038,"B.PvsV.LEE_AGING_MUSCLE_DN"
78,"Up",0.606364227402909,0.877411100055138,"B.PvsV.PAL_PRMT5_TARGETS_DN"
498,"Up",0.607396287977045,0.878220290967239,"B.PvsV.JOHNSTONE_PARVB_TARGETS_2_DN"
52,"Down",0.607488197140809,0.878220290967239,"B.PvsV.MAEKAWA_ATF2_TARGETS"
24,"Up",0.607555264030809,0.878220290967239,"B.PvsV.WONG_ENDOMETRIAL_CANCER_LATE"
31,"Down",0.607558801401644,0.878220290967239,"B.PvsV.REACTOME_PLATELET_CALCIUM_HOMEOSTASIS"
45,"Up",0.607986894174347,0.878264951936892,"B.PvsV.WATANABE_COLON_CANCER_MSI_VS_MSS_UP"
254,"Up",0.608173710599791,0.878264951936892,"B.PvsV.CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_DN"
74,"Down",0.608247737852274,0.878264951936892,"B.PvsV.DALESSIO_TSA_RESPONSE"
452,"Up",0.608368180425581,0.878264951936892,"B.PvsV.GABRIELY_MIR21_TARGETS"
706,"Up",0.608383933065346,0.878264951936892,"B.PvsV.JOHNSTONE_PARVB_TARGETS_3_UP"
259,"Down",0.609269247924997,0.879269437043168,"B.PvsV.BROCKE_APOPTOSIS_REVERSED_BY_IL6"
83,"Down",0.609529598513844,0.879269437043168,"B.PvsV.REACTOME_NUCLEOTIDE_BINDING_DOMAIN_LEUCINE_RICH_REPEAT_CONTAINING_RECEPTOR_NLR_SIGNALING_PATHWAYS"
335,"Down",0.609556837074781,0.879269437043168,"B.PvsV.WANG_CISPLATIN_RESPONSE_AND_XPC_DN"
78,"Down",0.609977767012625,0.879647124103495,"B.PvsV.SMIRNOV_RESPONSE_TO_IR_2HR_UP"
98,"Down",0.610152825601178,0.879670136310016,"B.PvsV.ZWANG_EGF_PERSISTENTLY_DN"
10,"Up",0.610492482069936,0.879930378875045,"B.PvsV.AGARWAL_AKT_PATHWAY_TARGETS"
565,"Down",0.610651781110667,0.879930596236871,"B.PvsV.ZHOU_INFLAMMATORY_RESPONSE_LPS_UP"
46,"Up",0.611458988024072,0.880613570195766,"B.PvsV.REACTOME_INTERLEUKIN_7_SIGNALING"
48,"Down",0.611642658734868,0.880613570195766,"B.PvsV.FRASOR_RESPONSE_TO_ESTRADIOL_UP"
20,"Up",0.612006988312821,0.880613570195766,"B.PvsV.REACTOME_SUPPRESSION_OF_PHAGOSOMAL_MATURATION"
54,"Up",0.612126036834211,0.880613570195766,"B.PvsV.PID_ERB_GENOMIC_PATHWAY"
493,"Down",0.612251305910033,0.880613570195766,"B.PvsV.CHANDRAN_METASTASIS_DN"
659,"Down",0.612272288027914,0.880613570195766,"B.PvsV.SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6"
50,"Up",0.612396493154939,0.880613570195766,"B.PvsV.BOWIE_RESPONSE_TO_TAMOXIFEN"
96,"Down",0.612498758523395,0.880613570195766,"B.PvsV.LIU_SMARCA4_TARGETS"
1129,"Up",0.612758319959861,0.880613570195766,"B.PvsV.BENPORATH_MYC_MAX_TARGETS"
837,"Down",0.61312570653623,0.880613570195766,"B.PvsV.GRYDER_PAX3FOXO1_ENHANCERS_KO_DOWN"
251,"Down",0.61319181377536,0.880613570195766,"B.PvsV.SABATES_COLORECTAL_ADENOMA_UP"
183,"Down",0.613346762504567,0.880613570195766,"B.PvsV.REACTOME_CD22_MEDIATED_BCR_REGULATION"
222,"Down",0.613554207116227,0.880613570195766,"B.PvsV.WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP"
123,"Up",0.613664758458295,0.880613570195766,"B.PvsV.LI_WILMS_TUMOR"
120,"Up",0.614033252518446,0.880613570195766,"B.PvsV.CHUNG_BLISTER_CYTOTOXICITY_DN"
69,"Down",0.614060515178881,0.880613570195766,"B.PvsV.REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR"
191,"Down",0.614132022807018,0.880613570195766,"B.PvsV.SESTO_RESPONSE_TO_UV_C0"
74,"Up",0.614167345027251,0.880613570195766,"B.PvsV.YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_15"
38,"Up",0.614289445471271,0.880613570195766,"B.PvsV.REACTOME_PLASMA_LIPOPROTEIN_REMODELING"
32,"Down",0.614467411862815,0.880613570195766,"B.PvsV.REACTOME_SEMA3A_PLEXIN_REPULSION_SIGNALING_BY_INHIBITING_INTEGRIN_ADHESION"
137,"Down",0.614470456468668,0.880613570195766,"B.PvsV.KIM_MYCN_AMPLIFICATION_TARGETS_UP"
117,"Up",0.614831501667713,0.88090266201627,"B.PvsV.ROSS_AML_OF_FAB_M7_TYPE"
13,"Down",0.615041658763063,0.880975474430304,"B.PvsV.REACTOME_FGFRL1_MODULATION_OF_FGFR1_SIGNALING"
100,"Up",0.61544648152019,0.88101905536113,"B.PvsV.FIGUEROA_AML_METHYLATION_CLUSTER_3_DN"
115,"Up",0.615480236889643,0.88101905536113,"B.PvsV.COLDREN_GEFITINIB_RESISTANCE_UP"
64,"Up",0.615550119526143,0.88101905536113,"B.PvsV.PID_LKB1_PATHWAY"
449,"Down",0.616244818099151,0.881367943098944,"B.PvsV.CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_4"
1169,"Down",0.616370941367278,0.881367943098944,"B.PvsV.JOHNSTONE_PARVB_TARGETS_3_DN"
176,"Up",0.616374604562728,0.881367943098944,"B.PvsV.STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_UP"
58,"Up",0.616431513106098,0.881367943098944,"B.PvsV.CHANDRAN_METASTASIS_TOP50_DN"
94,"Down",0.61659508546485,0.88137389543308,"B.PvsV.BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_UP"
16,"Down",0.616852972141616,0.881514624701731,"B.PvsV.REACTOME_PHENYLALANINE_AND_TYROSINE_METABOLISM"
24,"Up",0.617240896526196,0.881841063796728,"B.PvsV.REACTOME_BBSOME_MEDIATED_CARGO_TARGETING_TO_CILIUM"
49,"Down",0.617753543385369,0.882345476976932,"B.PvsV.NIKOLSKY_BREAST_CANCER_1Q21_AMPLICON"
131,"Down",0.618212312599697,0.882596563549659,"B.PvsV.RHODES_UNDIFFERENTIATED_CANCER"
165,"Up",0.61824859660478,0.882596563549659,"B.PvsV.REACTOME_MITOTIC_G1_PHASE_AND_G1_S_TRANSITION"
740,"Down",0.618822680683621,0.883188074728896,"B.PvsV.DELYS_THYROID_CANCER_UP"
439,"Up",0.619309238123907,0.883654394216021,"B.PvsV.LIU_SOX4_TARGETS_DN"
92,"Up",0.620307444772056,0.884850325630727,"B.PvsV.MALONEY_RESPONSE_TO_17AAG_UP"
9,"Down",0.620517361422961,0.884921457649613,"B.PvsV.REACTOME_REGULATION_OF_PTEN_MRNA_TRANSLATION"
72,"Down",0.621046115475451,0.885072120723615,"B.PvsV.GOBERT_CORE_OLIGODENDROCYTE_DIFFERENTIATION"
384,"Down",0.621091266905087,0.885072120723615,"B.PvsV.YAGI_AML_FAB_MARKERS"
74,"Up",0.621103242613063,0.885072120723615,"B.PvsV.SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_DN"
607,"Down",0.621380750783678,0.885079205418766,"B.PvsV.GARY_CD5_TARGETS_DN"
12,"Down",0.621428373202324,0.885079205418766,"B.PvsV.ZERBINI_RESPONSE_TO_SULINDAC_UP"
28,"Up",0.62218928082599,0.88547826588131,"B.PvsV.MARSON_FOXP3_CORE_DIRECT_TARGETS"
267,"Up",0.622239072237534,0.88547826588131,"B.PvsV.MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_DN"
136,"Up",0.622351196025728,0.88547826588131,"B.PvsV.CROMER_METASTASIS_UP"
500,"Down",0.622547867487268,0.88547826588131,"B.PvsV.TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_DN"
122,"Up",0.622580642535095,0.88547826588131,"B.PvsV.BURTON_ADIPOGENESIS_2"
11,"Down",0.622704595263632,0.88547826588131,"B.PvsV.REACTOME_AKT_PHOSPHORYLATES_TARGETS_IN_THE_NUCLEUS"
19,"Up",0.622829621271915,0.88547826588131,"B.PvsV.BIOCARTA_SHH_PATHWAY"
34,"Down",0.623410899450286,0.885923710246152,"B.PvsV.PID_TCR_CALCIUM_PATHWAY"
163,"Up",0.623463403249734,0.885923710246152,"B.PvsV.HILLION_HMGA1_TARGETS"
52,"Down",0.62373839188616,0.885927870443819,"B.PvsV.REACTOME_ATTENUATION_PHASE"
51,"Down",0.623786796823619,0.885927870443819,"B.PvsV.GROSS_ELK3_TARGETS_DN"
38,"Up",0.624373979726143,0.886506791035249,"B.PvsV.ONO_FOXP3_TARGETS_UP"
111,"Up",0.624543664396414,0.886506791035249,"B.PvsV.FONTAINE_FOLLICULAR_THYROID_ADENOMA_DN"
522,"Up",0.624849010032649,0.886506791035249,"B.PvsV.YANG_BCL3_TARGETS_UP"
7,"Down",0.625111744344159,0.886506791035249,"B.PvsV.TESAR_ALK_AND_JAK_TARGETS_MOUSE_ES_D4_DN"
93,"Up",0.625293225413276,0.886506791035249,"B.PvsV.WATANABE_COLON_CANCER_MSI_VS_MSS_DN"
31,"Down",0.625484140107831,0.886506791035249,"B.PvsV.HASLINGER_B_CLL_WITH_17P13_DELETION"
36,"Up",0.625582863146788,0.886506791035249,"B.PvsV.REACTOME_ACTIVATION_OF_BH3_ONLY_PROTEINS"
7,"Down",0.625586236350793,0.886506791035249,"B.PvsV.REACTOME_ALTERNATIVE_COMPLEMENT_ACTIVATION"
161,"Down",0.625695757229813,0.886506791035249,"B.PvsV.MARTIN_VIRAL_GPCR_SIGNALING_UP"
10,"Down",0.625892833598339,0.886506791035249,"B.PvsV.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_21"
22,"Up",0.626024902555,0.886506791035249,"B.PvsV.PYEON_HPV_POSITIVE_TUMORS_DN"
56,"Up",0.626194429177812,0.886506791035249,"B.PvsV.KEGG_BLADDER_CANCER"
299,"Down",0.626278807340149,0.886506791035249,"B.PvsV.TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN"
15,"Up",0.626800093967194,0.886656446158625,"B.PvsV.REACTOME_ADENYLATE_CYCLASE_INHIBITORY_PATHWAY"
34,"Down",0.626996872852125,0.886656446158625,"B.PvsV.WELCH_GATA1_TARGETS"
54,"Down",0.626997115013669,0.886656446158625,"B.PvsV.VALK_AML_CLUSTER_9"
49,"Down",0.627025991043629,0.886656446158625,"B.PvsV.GENTILE_UV_RESPONSE_CLUSTER_D6"
21,"Down",0.62722483335281,0.886710842139526,"B.PvsV.SCHWAB_TARGETS_OF_BMYB_POLYMORPHIC_VARIANTS_UP"
271,"Up",0.627564430846219,0.886819023106815,"B.PvsV.PHONG_TNF_RESPONSE_VIA_P38_PARTIAL"
46,"Up",0.627622144586176,0.886819023106815,"B.PvsV.SCHLOSSER_MYC_AND_SERUM_RESPONSE_SYNERGY"
18,"Up",0.628220365956575,0.886951095744239,"B.PvsV.REACTOME_BLOOD_GROUP_SYSTEMS_BIOSYNTHESIS"
102,"Down",0.628355952458899,0.886951095744239,"B.PvsV.DAWSON_METHYLATED_IN_LYMPHOMA_TCL1"
9,"Down",0.628614787524174,0.886951095744239,"B.PvsV.REACTOME_FGFR1B_LIGAND_BINDING_AND_ACTIVATION"
20,"Down",0.628837405697418,0.886951095744239,"B.PvsV.RODRIGUES_THYROID_CARCINOMA_UP"
233,"Up",0.629420678351675,0.886951095744239,"B.PvsV.RASHI_RESPONSE_TO_IONIZING_RADIATION_6"
18,"Down",0.629501583454976,0.886951095744239,"B.PvsV.REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_LATE_STAGE_BRANCHING_MORPHOGENESIS_PANCREATIC_BUD_PRECURSOR_CELLS"
11,"Up",0.629749740267033,0.886951095744239,"B.PvsV.MIZUSHIMA_AUTOPHAGOSOME_FORMATION"
137,"Up",0.629882963090781,0.886951095744239,"B.PvsV.GAJATE_RESPONSE_TO_TRABECTEDIN_UP"
50,"Up",0.630026280403885,0.886951095744239,"B.PvsV.REACTOME_SPHINGOLIPID_DE_NOVO_BIOSYNTHESIS"
27,"Up",0.630090369819023,0.886951095744239,"B.PvsV.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_CYAN_UP"
28,"Up",0.630185806363435,0.886951095744239,"B.PvsV.REACTOME_SIGNALING_BY_PDGFR_IN_DISEASE"
127,"Down",0.630267335732712,0.886951095744239,"B.PvsV.SANA_TNF_SIGNALING_DN"
196,"Down",0.630454693721058,0.886951095744239,"B.PvsV.REACTOME_METABOLISM_OF_STEROIDS"
74,"Down",0.630577008960379,0.886951095744239,"B.PvsV.KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP"
52,"Up",0.630581209541197,0.886951095744239,"B.PvsV.HUMMERICH_BENIGN_SKIN_TUMOR_DN"
26,"Down",0.630582579077267,0.886951095744239,"B.PvsV.GAVIN_IL2_RESPONSIVE_FOXP3_TARGETS_UP"
101,"Down",0.630674072024344,0.886951095744239,"B.PvsV.KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN"
382,"Up",0.630691748785848,0.886951095744239,"B.PvsV.VERHAAK_GLIOBLASTOMA_MESENCHYMAL"
45,"Down",0.630822414100614,0.886951095744239,"B.PvsV.LOPES_METHYLATED_IN_COLON_CANCER_UP"
153,"Down",0.631200655103908,0.886951095744239,"B.PvsV.XU_CREBBP_TARGETS_DN"
13,"Down",0.631204557351092,0.886951095744239,"B.PvsV.REACTOME_PREVENTION_OF_PHAGOSOMAL_LYSOSOMAL_FUSION"
56,"Down",0.631244811313724,0.886951095744239,"B.PvsV.BARRIER_COLON_CANCER_RECURRENCE_UP"
206,"Down",0.632144607805962,0.887935232480782,"B.PvsV.LIU_VMYB_TARGETS_UP"
207,"Down",0.632310568397594,0.887935232480782,"B.PvsV.MCCLUNG_CREB1_TARGETS_UP"
220,"Up",0.63249580328199,0.887935232480782,"B.PvsV.RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN"
406,"Down",0.632905657156114,0.887935232480782,"B.PvsV.MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN"
15,"Down",0.632997205950087,0.887935232480782,"B.PvsV.REACTOME_SYNTHESIS_OF_PIPS_AT_THE_LATE_ENDOSOME_MEMBRANE"
51,"Up",0.633138715120969,0.887935232480782,"B.PvsV.VALK_AML_CLUSTER_5"
196,"Down",0.633208509092127,0.887935232480782,"B.PvsV.AMBROSINI_FLAVOPIRIDOL_TREATMENT_TP53"
77,"Up",0.633337702647058,0.887935232480782,"B.PvsV.PID_HES_HEY_PATHWAY"
10,"Down",0.6334588948218,0.887935232480782,"B.PvsV.BIOCARTA_IL22BP_PATHWAY"
476,"Down",0.633551183240493,0.887935232480782,"B.PvsV.MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_UP"
19,"Down",0.634149086240158,0.888025624637329,"B.PvsV.REACTOME_KSRP_KHSRP_BINDS_AND_DESTABILIZES_MRNA"
28,"Down",0.634227971507701,0.888025624637329,"B.PvsV.REACTOME_OTHER_SEMAPHORIN_INTERACTIONS"
200,"Up",0.634259885871816,0.888025624637329,"B.PvsV.CAMPS_COLON_CANCER_COPY_NUMBER_DN"
31,"Down",0.634335021708886,0.888025624637329,"B.PvsV.CAFFAREL_RESPONSE_TO_THC_8HR_5_UP"
19,"Down",0.63465698230849,0.888025624637329,"B.PvsV.NIKOLSKY_BREAST_CANCER_12Q24_AMPLICON"
54,"Up",0.634813035899108,0.888025624637329,"B.PvsV.AIYAR_COBRA1_TARGETS_DN"
12,"Up",0.63522870477133,0.888025624637329,"B.PvsV.KORKOLA_CHORIOCARCINOMA"
33,"Down",0.635323007865099,0.888025624637329,"B.PvsV.BIOCARTA_G2_PATHWAY"
34,"Up",0.635467677058243,0.888025624637329,"B.PvsV.KORKOLA_EMBRYONAL_CARCINOMA_DN"
559,"Down",0.635548586890678,0.888025624637329,"B.PvsV.MULLIGHAN_NPM1_SIGNATURE_3_UP"
584,"Up",0.635640290123212,0.888025624637329,"B.PvsV.MULLIGHAN_MLL_SIGNATURE_1_UP"
477,"Down",0.635755783522984,0.888025624637329,"B.PvsV.SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP"
181,"Down",0.636071212995035,0.888025624637329,"B.PvsV.HOSHIDA_LIVER_CANCER_SUBCLASS_S2"
41,"Up",0.636116644854056,0.888025624637329,"B.PvsV.JEON_SMAD6_TARGETS_UP"
720,"Down",0.636226988789377,0.888025624637329,"B.PvsV.SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN"
70,"Up",0.636326310590967,0.888025624637329,"B.PvsV.HONMA_DOCETAXEL_RESISTANCE"
257,"Up",0.636346591186971,0.888025624637329,"B.PvsV.GAVIN_FOXP3_TARGETS_CLUSTER_P3"
453,"Down",0.636506701110098,0.888025624637329,"B.PvsV.HELLER_HDAC_TARGETS_DN"
50,"Down",0.63692194430581,0.888127591428011,"B.PvsV.BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_DN"
15,"Down",0.637166348764625,0.888127591428011,"B.PvsV.BIOCARTA_CPSF_PATHWAY"
12,"Down",0.637200366440867,0.888127591428011,"B.PvsV.SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX1_DN"
41,"Up",0.637222310579656,0.888127591428011,"B.PvsV.PID_IL12_STAT4_PATHWAY"
6,"Down",0.63866372182283,0.889726111361929,"B.PvsV.OHASHI_AURKA_TARGETS"
6,"Up",0.638691071802405,0.889726111361929,"B.PvsV.BIOCARTA_BOTULIN_PATHWAY"
15,"Down",0.639186865860061,0.89002815237599,"B.PvsV.MIKKELSEN_PLURIPOTENT_STATE_DN"
75,"Down",0.639229841397188,0.89002815237599,"B.PvsV.EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_DN"
700,"Down",0.639486517435836,0.89016136830381,"B.PvsV.MILI_PSEUDOPODIA_CHEMOTAXIS_DN"
32,"Up",0.639800543867603,0.890374328478222,"B.PvsV.WEBER_METHYLATED_HCP_IN_SPERM_UP"
11,"Down",0.639990582676902,0.890414678314191,"B.PvsV.KEGG_FOLATE_BIOSYNTHESIS"
73,"Up",0.640351453515592,0.890692625531499,"B.PvsV.REACTOME_SIGNALING_BY_ERBB4"
36,"Up",0.641004455814636,0.890859848397929,"B.PvsV.REACTOME_CREB1_PHOSPHORYLATION_THROUGH_NMDA_RECEPTOR_MEDIATED_ACTIVATION_OF_RAS_SIGNALING"
52,"Down",0.641474185755449,0.890859848397929,"B.PvsV.BIOCARTA_IL2RB_PATHWAY"
27,"Down",0.641478675543501,0.890859848397929,"B.PvsV.REACTOME_SYNTHESIS_OF_EPOXY_EET_AND_DIHYDROXYEICOSATRIENOIC_ACIDS_DHET"
62,"Up",0.641516989673231,0.890859848397929,"B.PvsV.PID_ARF6_PATHWAY"
131,"Down",0.64176432615342,0.890859848397929,"B.PvsV.DITTMER_PTHLH_TARGETS_DN"
297,"Up",0.641917047689164,0.890859848397929,"B.PvsV.OKUMURA_INFLAMMATORY_RESPONSE_LPS"
487,"Down",0.642145623421361,0.890859848397929,"B.PvsV.BENPORATH_OCT4_TARGETS"
43,"Down",0.642154865726407,0.890859848397929,"B.PvsV.REACTOME_PROLACTIN_RECEPTOR_SIGNALING"
421,"Down",0.642427663141684,0.890859848397929,"B.PvsV.KOYAMA_SEMA3B_TARGETS_UP"
745,"Down",0.642506645283093,0.890859848397929,"B.PvsV.MEISSNER_NPC_HCP_WITH_H3K4ME2"
432,"Up",0.642523893955663,0.890859848397929,"B.PvsV.ONDER_CDH1_TARGETS_2_UP"
627,"Down",0.642534436247429,0.890859848397929,"B.PvsV.LIM_MAMMARY_STEM_CELL_DN"
95,"Up",0.642566300490313,0.890859848397929,"B.PvsV.KYNG_DNA_DAMAGE_BY_4NQO_OR_UV"
228,"Down",0.643433086967644,0.891541900744629,"B.PvsV.EPPERT_HSC_R"
835,"Up",0.64352315510626,0.891541900744629,"B.PvsV.ZWANG_CLASS_1_TRANSIENTLY_INDUCED_BY_EGF"
20,"Down",0.643542001423732,0.891541900744629,"B.PvsV.REACTOME_ACTIVATION_OF_THE_PHOTOTRANSDUCTION_CASCADE"
134,"Down",0.644193555291793,0.892012141830922,"B.PvsV.BASSO_HAIRY_CELL_LEUKEMIA_UP"
33,"Up",0.644204102429168,0.892012141830922,"B.PvsV.BIOCARTA_CASPASE_PATHWAY"
15,"Up",0.645038132398048,0.892888533532712,"B.PvsV.YAMANAKA_GLIOBLASTOMA_SURVIVAL_UP"
1130,"Up",0.645160009307864,0.892888533532712,"B.PvsV.FORTSCHEGGER_PHF8_TARGETS_DN"
37,"Down",0.645625565905944,0.892905300382532,"B.PvsV.REACTOME_STING_MEDIATED_INDUCTION_OF_HOST_IMMUNE_RESPONSES"
38,"Down",0.645919066859128,0.892905300382532,"B.PvsV.WANG_METASTASIS_OF_BREAST_CANCER_ESR1_UP"
117,"Up",0.645942903298869,0.892905300382532,"B.PvsV.BHAT_ESR1_TARGETS_VIA_AKT1_DN"
61,"Down",0.646064407284283,0.892905300382532,"B.PvsV.FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_DN"
50,"Down",0.646067628778855,0.892905300382532,"B.PvsV.DASU_IL6_SIGNALING_SCAR_UP"
142,"Up",0.646365747980547,0.892905300382532,"B.PvsV.MAHAJAN_RESPONSE_TO_IL1A_UP"
24,"Up",0.646373432344827,0.892905300382532,"B.PvsV.KIM_GERMINAL_CENTER_T_HELPER_DN"
14,"Up",0.646831453469256,0.892905300382532,"B.PvsV.KEGG_LIMONENE_AND_PINENE_DEGRADATION"
18,"Up",0.646836417935306,0.892905300382532,"B.PvsV.REACTOME_METHYLATION"
124,"Up",0.64692522672008,0.892905300382532,"B.PvsV.MCBRYAN_PUBERTAL_BREAST_6_7WK_DN"
237,"Up",0.646958989124784,0.892905300382532,"B.PvsV.LENAOUR_DENDRITIC_CELL_MATURATION_DN"
31,"Down",0.64711006305531,0.892905300382532,"B.PvsV.VERNOCHET_ADIPOGENESIS"
19,"Up",0.647439247583149,0.892981665042579,"B.PvsV.REACTOME_SYNTHESIS_SECRETION_AND_INACTIVATION_OF_GLUCOSE_DEPENDENT_INSULINOTROPIC_POLYPEPTIDE_GIP"
30,"Down",0.64748842379376,0.892981665042579,"B.PvsV.REACTOME_ATF4_ACTIVATES_GENES_IN_RESPONSE_TO_ENDOPLASMIC_RETICULUM_STRESS"
107,"Down",0.647869863032648,0.893284905912098,"B.PvsV.PHONG_TNF_TARGETS_UP"
738,"Up",0.648098381128172,0.893377200014375,"B.PvsV.CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN"
115,"Up",0.648662796994089,0.893932354082831,"B.PvsV.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_UP"
120,"Up",0.650086588528172,0.895671255412973,"B.PvsV.REACTOME_COPI_MEDIATED_ANTEROGRADE_TRANSPORT"
94,"Up",0.65055721765001,0.896053822052125,"B.PvsV.GARCIA_TARGETS_OF_FLI1_AND_DAX1_UP"
29,"Up",0.650794764354286,0.896053822052125,"B.PvsV.LANDEMAINE_LUNG_METASTASIS"
199,"Down",0.650875828724644,0.896053822052125,"B.PvsV.WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN"
44,"Up",0.651012516401408,0.896053822052125,"B.PvsV.DAZARD_UV_RESPONSE_CLUSTER_G28"
17,"Down",0.651563397296852,0.896116005764678,"B.PvsV.BIOCARTA_RANKL_PATHWAY"
67,"Down",0.651611210676253,0.896116005764678,"B.PvsV.TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN"
81,"Up",0.652005886136869,0.896116005764678,"B.PvsV.HEIDENBLAD_AMPLICON_8Q24_UP"
83,"Down",0.652228116745342,0.896116005764678,"B.PvsV.DELACROIX_RAR_TARGETS_UP"
639,"Down",0.652329147915785,0.896116005764678,"B.PvsV.HAN_SATB1_TARGETS_DN"
176,"Down",0.652364950464827,0.896116005764678,"B.PvsV.NABA_ECM_AFFILIATED"
9,"Up",0.652751091555122,0.896116005764678,"B.PvsV.REACTOME_TRANSPORT_OF_NUCLEOTIDE_SUGARS"
149,"Up",0.652797455100217,0.896116005764678,"B.PvsV.NIKOLSKY_BREAST_CANCER_16P13_AMPLICON"
9,"Up",0.65301849201217,0.896116005764678,"B.PvsV.GROSS_HYPOXIA_VIA_HIF1A_ONLY"
15,"Up",0.653024177099233,0.896116005764678,"B.PvsV.GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_1_UP"
132,"Down",0.653145101019024,0.896116005764678,"B.PvsV.REACTOME_SIGNALING_BY_TGF_BETA_FAMILY_MEMBERS"
189,"Down",0.653184502848407,0.896116005764678,"B.PvsV.ROSS_ACUTE_MYELOID_LEUKEMIA_CBF"
8,"Down",0.653282987948425,0.896116005764678,"B.PvsV.LAU_APOPTOSIS_CDKN2A_DN"
22,"Down",0.653605429346492,0.896116005764678,"B.PvsV.REACTOME_HS_GAG_DEGRADATION"
18,"Up",0.653715265189583,0.896116005764678,"B.PvsV.CHIN_BREAST_CANCER_COPY_NUMBER_DN"
37,"Down",0.653971661016751,0.896116005764678,"B.PvsV.REACTOME_FERTILIZATION"
32,"Down",0.653977677353812,0.896116005764678,"B.PvsV.KEGG_NICOTINATE_AND_NICOTINAMIDE_METABOLISM"
233,"Up",0.654049071894139,0.896116005764678,"B.PvsV.PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_UP"
701,"Down",0.654137131355804,0.896116005764678,"B.PvsV.SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN"
575,"Down",0.654635698673553,0.896576858549931,"B.PvsV.MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP"
46,"Up",0.655077207660605,0.896959356403042,"B.PvsV.BOWIE_RESPONSE_TO_EXTRACELLULAR_MATRIX"
36,"Up",0.65571453913244,0.897609726878747,"B.PvsV.PID_IL3_PATHWAY"
133,"Down",0.656004408198351,0.897784250724922,"B.PvsV.VANTVEER_BREAST_CANCER_METASTASIS_UP"
22,"Down",0.65675229327046,0.897824271527279,"B.PvsV.PID_IL5_PATHWAY"
18,"Down",0.656757158320363,0.897824271527279,"B.PvsV.YEMELYANOV_GR_TARGETS_DN"
12,"Down",0.656763172708813,0.897824271527279,"B.PvsV.REACTOME_PI5P_REGULATES_TP53_ACETYLATION"
204,"Down",0.656808671561548,0.897824271527279,"B.PvsV.BOSCO_TH1_CYTOTOXIC_MODULE"
31,"Down",0.656845573942457,0.897824271527279,"B.PvsV.REACTOME_FRS_MEDIATED_FGFR1_SIGNALING"
22,"Down",0.657025590925957,0.897848366838758,"B.PvsV.ZHENG_RESPONSE_TO_ARSENITE_DN"
130,"Up",0.658117711366188,0.899118563415779,"B.PvsV.KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION"
43,"Down",0.658728057286575,0.899405498511796,"B.PvsV.GENTLES_LEUKEMIC_STEM_CELL_UP"
36,"Down",0.658745898969482,0.899405498511796,"B.PvsV.BIOCARTA_TNFR1_PATHWAY"
134,"Up",0.658857296008691,0.899405498511796,"B.PvsV.HINATA_NFKB_TARGETS_FIBROBLAST_UP"
175,"Up",0.659441918340313,0.899405498511796,"B.PvsV.REACTOME_CELL_CELL_COMMUNICATION"
443,"Down",0.659576180500434,0.899405498511796,"B.PvsV.BILD_HRAS_ONCOGENIC_SIGNATURE"
80,"Up",0.659791292225958,0.899405498511796,"B.PvsV.HU_GENOTOXIC_DAMAGE_24HR"
19,"Down",0.659819590909226,0.899405498511796,"B.PvsV.MIZUKAMI_HYPOXIA_UP"
160,"Up",0.659872877482248,0.899405498511796,"B.PvsV.CUI_GLUCOSE_DEPRIVATION"
18,"Up",0.660008704025377,0.899405498511796,"B.PvsV.PARK_TRETINOIN_RESPONSE"
830,"Down",0.660016188246537,0.899405498511796,"B.PvsV.GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN"
95,"Down",0.660190645570958,0.899405498511796,"B.PvsV.PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP"
181,"Down",0.660279782683918,0.899405498511796,"B.PvsV.PID_P53_DOWNSTREAM_PATHWAY"
38,"Down",0.660766903019842,0.899527180215744,"B.PvsV.DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_UP"
30,"Down",0.661115037951209,0.899527180215744,"B.PvsV.RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_DN"
53,"Up",0.661195483882298,0.899527180215744,"B.PvsV.PID_LIS1_PATHWAY"
15,"Down",0.661304469596692,0.899527180215744,"B.PvsV.REACTOME_SIGNAL_ATTENUATION"
4,"Down",0.661460896526278,0.899527180215744,"B.PvsV.REACTOME_METALLOTHIONEINS_BIND_METALS"
29,"Up",0.661471903236948,0.899527180215744,"B.PvsV.LUND_SILENCED_BY_METHYLATION"
257,"Down",0.661567544445828,0.899527180215744,"B.PvsV.RICKMAN_HEAD_AND_NECK_CANCER_A"
92,"Down",0.661794316061664,0.899527180215744,"B.PvsV.LUCAS_HNF4A_TARGETS_UP"
15,"Down",0.661833345834264,0.899527180215744,"B.PvsV.REACTOME_DOWNREGULATION_OF_ERBB4_SIGNALING"
29,"Up",0.662431185885869,0.899726317536264,"B.PvsV.REACTOME_METABOLISM_OF_COFACTORS"
28,"Up",0.662445521551692,0.899726317536264,"B.PvsV.KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_HEPARAN_SULFATE"
733,"Down",0.662468048234785,0.899726317536264,"B.PvsV.HAN_SATB1_TARGETS_UP"
6,"Down",0.662675960077361,0.899778567509116,"B.PvsV.REACTOME_SYNTHESIS_OF_WYBUTOSINE_AT_G37_OF_TRNA_PHE"
39,"Up",0.662831995924151,0.899778567509116,"B.PvsV.KANG_FLUOROURACIL_RESISTANCE_UP"
559,"Up",0.663069195134256,0.899810229007926,"B.PvsV.REACTOME_SIGNALING_BY_RHO_GTPASES"
17,"Down",0.663197233508088,0.899810229007926,"B.PvsV.TURASHVILI_BREAST_NORMAL_DUCTAL_VS_LOBULAR_DN"
84,"Up",0.663446718770611,0.899810229007926,"B.PvsV.REACTOME_DEFENSINS"
67,"Up",0.663506294748655,0.899810229007926,"B.PvsV.LEONARD_HYPOXIA"
129,"Down",0.664910553934931,0.900701882012427,"B.PvsV.REACTOME_NEGATIVE_EPIGENETIC_REGULATION_OF_RRNA_EXPRESSION"
122,"Down",0.664945240038728,0.900701882012427,"B.PvsV.WNT_SIGNALING"
313,"Up",0.665098214145132,0.900701882012427,"B.PvsV.REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES"
26,"Up",0.665267051806231,0.900701882012427,"B.PvsV.BIOCARTA_BARRESTIN_PATHWAY"
39,"Down",0.665376215310433,0.900701882012427,"B.PvsV.PID_VEGFR1_PATHWAY"
104,"Up",0.665516752666341,0.900701882012427,"B.PvsV.FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP"
383,"Down",0.665693736795321,0.900701882012427,"B.PvsV.MULLIGHAN_MLL_SIGNATURE_1_DN"
51,"Up",0.665919404414636,0.900701882012427,"B.PvsV.XU_AKT1_TARGETS_6HR"
87,"Down",0.665972504515253,0.900701882012427,"B.PvsV.MATTIOLI_MGUS_VS_MULTIPLE_MYELOMA"
80,"Down",0.666092345598304,0.900701882012427,"B.PvsV.MODY_HIPPOCAMPUS_PRENATAL"
26,"Up",0.666117550299482,0.900701882012427,"B.PvsV.SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX1_UP"
107,"Up",0.666118646328235,0.900701882012427,"B.PvsV.KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY"
28,"Down",0.666608514667713,0.900878266059159,"B.PvsV.REACTOME_VEGFR2_MEDIATED_CELL_PROLIFERATION"
26,"Up",0.666632154129023,0.900878266059159,"B.PvsV.PARK_HSC_VS_MULTIPOTENT_PROGENITORS_DN"
462,"Down",0.666737902824033,0.900878266059159,"B.PvsV.MULLIGHAN_MLL_SIGNATURE_2_DN"
44,"Down",0.667479065556751,0.901410525102246,"B.PvsV.COLLIS_PRKDC_SUBSTRATES"
22,"Up",0.667811490277819,0.901410525102246,"B.PvsV.REACTOME_TIE2_SIGNALING"
79,"Down",0.667999918687895,0.901410525102246,"B.PvsV.YOKOE_CANCER_TESTIS_ANTIGENS"
37,"Down",0.668070880533256,0.901410525102246,"B.PvsV.STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_UP"
43,"Down",0.66818638606134,0.901410525102246,"B.PvsV.MATZUK_MALE_REPRODUCTION_SERTOLI"
677,"Up",0.668221063171094,0.901410525102246,"B.PvsV.BASAKI_YBX1_TARGETS_DN"
222,"Up",0.668338105483153,0.901410525102246,"B.PvsV.IKEDA_MIR30_TARGETS_UP"
36,"Up",0.668436092045435,0.901410525102246,"B.PvsV.ZHAN_LATE_DIFFERENTIATION_GENES_DN"
150,"Down",0.668783818538803,0.901619139606924,"B.PvsV.REACTOME_OXIDATIVE_STRESS_INDUCED_SENESCENCE"
84,"Down",0.669021361122503,0.901619139606924,"B.PvsV.BROWNE_HCMV_INFECTION_2HR_DN"
27,"Up",0.669169223590072,0.901619139606924,"B.PvsV.MOREIRA_RESPONSE_TO_TSA_DN"
24,"Up",0.669249550541635,0.901619139606924,"B.PvsV.DEBOSSCHER_NFKB_TARGETS_REPRESSED_BY_GLUCOCORTICOIDS"
115,"Up",0.669406143622069,0.901619139606924,"B.PvsV.MORI_SMALL_PRE_BII_LYMPHOCYTE_UP"
18,"Up",0.669633968322052,0.901706334839899,"B.PvsV.KEGG_RIBOFLAVIN_METABOLISM"
32,"Down",0.670226895236628,0.902057425473075,"B.PvsV.REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS"
13,"Down",0.670625373001401,0.902057425473075,"B.PvsV.REACTOME_MINERALOCORTICOID_BIOSYNTHESIS"
126,"Down",0.671036490578903,0.902057425473075,"B.PvsV.TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN"
87,"Up",0.671163782918911,0.902057425473075,"B.PvsV.KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN"
157,"Down",0.671256348153729,0.902057425473075,"B.PvsV.WILCOX_RESPONSE_TO_PROGESTERONE_DN"
36,"Down",0.671383427540678,0.902057425473075,"B.PvsV.PID_P38_MKK3_6PATHWAY"
31,"Up",0.671590493379815,0.902057425473075,"B.PvsV.LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_QTL"
48,"Up",0.671927142029578,0.902057425473075,"B.PvsV.GENTILE_UV_RESPONSE_CLUSTER_D5"
58,"Down",0.67210991492063,0.902057425473075,"B.PvsV.PID_HDAC_CLASSII_PATHWAY"
105,"Up",0.672128579865981,0.902057425473075,"B.PvsV.HUPER_BREAST_BASAL_VS_LUMINAL_DN"
59,"Down",0.672472414749889,0.902057425473075,"B.PvsV.WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2"
114,"Down",0.67304524142904,0.902057425473075,"B.PvsV.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_DN"
111,"Down",0.673071225350325,0.902057425473075,"B.PvsV.BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_DN"
8,"Up",0.673275304585491,0.902057425473075,"B.PvsV.REACTOME_MRNA_EDITING"
33,"Up",0.673334529176858,0.902057425473075,"B.PvsV.HOEGERKORP_CD44_TARGETS_TEMPORAL_DN"
22,"Up",0.673339598626271,0.902057425473075,"B.PvsV.BIOCARTA_NFKB_PATHWAY"
165,"Down",0.67354294704064,0.902057425473075,"B.PvsV.MALONEY_RESPONSE_TO_17AAG_DN"
8,"Down",0.673849489045523,0.902057425473075,"B.PvsV.REACTOME_DEFECTIVE_B4GALT1_CAUSES_B4GALT1_CDG_CDG_2D"
111,"Up",0.673868596273815,0.902057425473075,"B.PvsV.REACTOME_REGULATION_OF_INSULIN_SECRETION"
142,"Up",0.674029093980985,0.902057425473075,"B.PvsV.KORKOLA_YOLK_SAC_TUMOR"
728,"Down",0.674110964530559,0.902057425473075,"B.PvsV.YAGI_AML_WITH_INV_16_TRANSLOCATION"
88,"Down",0.674160856841348,0.902057425473075,"B.PvsV.WEBER_METHYLATED_ICP_IN_SPERM_DN"
14,"Up",0.674303124893249,0.902057425473075,"B.PvsV.REACTOME_IRAK4_DEFICIENCY_TLR2_4"
43,"Down",0.674308895765164,0.902057425473075,"B.PvsV.REACTOME_DISASSEMBLY_OF_THE_DESTRUCTION_COMPLEX_AND_RECRUITMENT_OF_AXIN_TO_THE_MEMBRANE"
19,"Up",0.674429996825037,0.902057425473075,"B.PvsV.BIOCARTA_IL4_PATHWAY"
162,"Up",0.674437868615074,0.902057425473075,"B.PvsV.WESTON_VEGFA_TARGETS"
342,"Up",0.67444361915411,0.902057425473075,"B.PvsV.HOLLMANN_APOPTOSIS_VIA_CD40_UP"
750,"Up",0.674495108835756,0.902057425473075,"B.PvsV.MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN"
32,"Up",0.674626054319256,0.902057425473075,"B.PvsV.KORKOLA_SEMINOMA_DN"
431,"Down",0.674945544004706,0.90218036624571,"B.PvsV.BROWNE_HCMV_INFECTION_1HR_DN"
240,"Up",0.675044343490415,0.90218036624571,"B.PvsV.TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN"
252,"Up",0.675598945863675,0.902703376433122,"B.PvsV.SERVITJA_LIVER_HNF1A_TARGETS_UP"
16,"Down",0.676413327352391,0.903508183247967,"B.PvsV.BIOCARTA_FREE_PATHWAY"
177,"Up",0.676528102486269,0.903508183247967,"B.PvsV.REACTOME_SIGNALING_BY_HEDGEHOG"
5,"Down",0.677627460131028,0.904642542929917,"B.PvsV.REACTOME_SODIUM_COUPLED_SULPHATE_DI_AND_TRI_CARBOXYLATE_TRANSPORTERS"
574,"Up",0.67815447043032,0.904642542929917,"B.PvsV.WANG_LMO4_TARGETS_DN"
21,"Up",0.678206653064336,0.904642542929917,"B.PvsV.GOERING_BLOOD_HDL_CHOLESTEROL_QTL_CIS"
1874,"Down",0.678207506657908,0.904642542929917,"B.PvsV.KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP"
1090,"Up",0.678246126614029,0.904642542929917,"B.PvsV.LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN"
5,"Up",0.678537906620535,0.904642542929917,"B.PvsV.REACTOME_FREE_FATTY_ACID_RECEPTORS"
29,"Up",0.678559941938936,0.904642542929917,"B.PvsV.JI_CARCINOGENESIS_BY_KRAS_AND_STK11_DN"
31,"Up",0.678686429385657,0.904642542929917,"B.PvsV.OUYANG_PROSTATE_CANCER_PROGRESSION_UP"
44,"Down",0.679436214932856,0.905263536528076,"B.PvsV.REACTOME_DISEASES_ASSOCIATED_WITH_GLYCOSAMINOGLYCAN_METABOLISM"
13,"Up",0.679479775111506,0.905263536528076,"B.PvsV.SCHLESINGER_METHYLATED_IN_COLON_CANCER"
247,"Down",0.679781062429288,0.905446758412801,"B.PvsV.REACTOME_COMPLEMENT_CASCADE"
57,"Up",0.680490870668503,0.905873287717933,"B.PvsV.KEGG_TRYPTOPHAN_METABOLISM"
39,"Up",0.680585805205286,0.905873287717933,"B.PvsV.HASLINGER_B_CLL_WITH_MUTATED_VH_GENES"
89,"Up",0.680592808316204,0.905873287717933,"B.PvsV.ZHAN_MULTIPLE_MYELOMA_MS_DN"
143,"Up",0.680950370138174,0.906131070154985,"B.PvsV.SAFFORD_T_LYMPHOCYTE_ANERGY"
48,"Down",0.681457417127199,0.906587598483225,"B.PvsV.FARDIN_HYPOXIA_11"
87,"Up",0.681633394666934,0.906603569668867,"B.PvsV.GENTILE_UV_RESPONSE_CLUSTER_D4"
62,"Up",0.683121865379066,0.908151635572402,"B.PvsV.REACTOME_SIGNALING_BY_SCF_KIT"
35,"Down",0.683134706564011,0.908151635572402,"B.PvsV.NABA_PROTEOGLYCANS"
31,"Down",0.683290071257224,0.908151635572402,"B.PvsV.LIM_MAMMARY_LUMINAL_PROGENITOR_DN"
20,"Down",0.683646772650824,0.908407355440136,"B.PvsV.ALONSO_METASTASIS_EMT_DN"
96,"Up",0.683913485139653,0.908543406856593,"B.PvsV.GRABARCZYK_BCL11B_TARGETS_DN"
13,"Down",0.684344608332842,0.908815718426355,"B.PvsV.REACTOME_MUCOPOLYSACCHARIDOSES"
24,"Down",0.684743047924294,0.908815718426355,"B.PvsV.REACTOME_NOTCH2_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION"
159,"Up",0.684756897830163,0.908815718426355,"B.PvsV.ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN"
9,"Up",0.684775960022462,0.908815718426355,"B.PvsV.FUNG_IL2_TARGETS_WITH_STAT5_BINDING_SITES"
15,"Down",0.684974161056356,0.908860603907029,"B.PvsV.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_LIGHTYELLOW_UP"
260,"Down",0.685372685584286,0.90917120407762,"B.PvsV.REACTOME_KERATINIZATION"
6,"Up",0.685648929945295,0.909197730359944,"B.PvsV.REACTOME_TRAFFICKING_OF_MYRISTOYLATED_PROTEINS_TO_THE_CILIUM"
38,"Down",0.685721565491222,0.909197730359944,"B.PvsV.MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP"
129,"Up",0.685955072528208,0.909211405690413,"B.PvsV.LEE_CALORIE_RESTRICTION_NEOCORTEX_DN"
718,"Up",0.68634714048161,0.909211405690413,"B.PvsV.REACTOME_NERVOUS_SYSTEM_DEVELOPMENT"
230,"Up",0.686354121184542,0.909211405690413,"B.PvsV.MILI_PSEUDOPODIA_CHEMOTAXIS_UP"
129,"Up",0.68638965587842,0.909211405690413,"B.PvsV.SEKI_INFLAMMATORY_RESPONSE_LPS_UP"
230,"Up",0.687584021780422,0.910575342856037,"B.PvsV.PASINI_SUZ12_TARGETS_UP"
68,"Down",0.688080387261937,0.91101447824982,"B.PvsV.CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_DN"
205,"Down",0.68892266955583,0.911683260371386,"B.PvsV.CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_UP"
20,"Up",0.688937684470719,0.911683260371386,"B.PvsV.REACTOME_WNT5A_DEPENDENT_INTERNALIZATION_OF_FZD4"
119,"Up",0.68908018540279,0.911683260371386,"B.PvsV.LINDVALL_IMMORTALIZED_BY_TERT_DN"
588,"Down",0.689552055987528,0.91173346571718,"B.PvsV.HUTTMANN_B_CLL_POOR_SURVIVAL_UP"
61,"Up",0.689671334204998,0.91173346571718,"B.PvsV.GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP"
30,"Up",0.690113150128008,0.91173346571718,"B.PvsV.LUI_THYROID_CANCER_CLUSTER_5"
36,"Up",0.690192650175846,0.91173346571718,"B.PvsV.GENTILE_UV_RESPONSE_CLUSTER_D9"
35,"Up",0.690242110661789,0.91173346571718,"B.PvsV.REACTOME_RESPONSE_OF_MTB_TO_PHAGOCYTOSIS"
28,"Up",0.690390707698132,0.91173346571718,"B.PvsV.REACTOME_ENDOGENOUS_STEROLS"
35,"Down",0.690749694455401,0.91173346571718,"B.PvsV.GOLUB_ALL_VS_AML_DN"
48,"Up",0.690787965529147,0.91173346571718,"B.PvsV.PID_HIF2PATHWAY"
78,"Up",0.690895353182179,0.91173346571718,"B.PvsV.STEARMAN_TUMOR_FIELD_EFFECT_UP"
25,"Down",0.690927744741195,0.91173346571718,"B.PvsV.REACTOME_PURINE_CATABOLISM"
22,"Down",0.691238446941726,0.91173346571718,"B.PvsV.REACTOME_SEROTONIN_NEUROTRANSMITTER_RELEASE_CYCLE"
11,"Up",0.69125688998942,0.91173346571718,"B.PvsV.REACTOME_CHYLOMICRON_REMODELING"
100,"Up",0.691261835465079,0.91173346571718,"B.PvsV.PID_MYC_REPRESS_PATHWAY"
27,"Up",0.691630550932955,0.911773148451609,"B.PvsV.REACTOME_WNT_LIGAND_BIOGENESIS_AND_TRAFFICKING"
27,"Up",0.691680693064946,0.911773148451609,"B.PvsV.REACTOME_ADP_SIGNALLING_THROUGH_P2Y_PURINOCEPTOR_1"
46,"Up",0.692001302242063,0.911773148451609,"B.PvsV.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_UP"
125,"Up",0.69209129001528,0.911773148451609,"B.PvsV.REACTOME_CELL_JUNCTION_ORGANIZATION"
15,"Up",0.69238651641574,0.911773148451609,"B.PvsV.REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_ASSOCIATION_WITH_CO_FACTORS"
171,"Up",0.692577205312849,0.911773148451609,"B.PvsV.KEGG_WNT_SIGNALING_PATHWAY"
456,"Up",0.692694182874902,0.911773148451609,"B.PvsV.CAIRO_HEPATOBLASTOMA_DN"
22,"Up",0.692931530942173,0.911773148451609,"B.PvsV.REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS"
13,"Down",0.69295852344893,0.911773148451609,"B.PvsV.REACTOME_SIGNALING_BY_FGFR3_FUSIONS_IN_CANCER"
55,"Down",0.692976158965275,0.911773148451609,"B.PvsV.FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN"
188,"Down",0.69317010112889,0.911773148451609,"B.PvsV.BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_UP"
83,"Down",0.69338810442336,0.911773148451609,"B.PvsV.REACTOME_GOLGI_ASSOCIATED_VESICLE_BIOGENESIS"
92,"Up",0.693510023668359,0.911773148451609,"B.PvsV.ZHU_CMV_8_HR_DN"
40,"Up",0.69360062622309,0.911773148451609,"B.PvsV.CHEN_PDGF_TARGETS"
128,"Up",0.694762792616521,0.912724429979298,"B.PvsV.ISSAEVA_MLL2_TARGETS"
27,"Up",0.694768767258473,0.912724429979298,"B.PvsV.REACTOME_NEGATIVE_REGULATION_OF_NMDA_RECEPTOR_MEDIATED_NEURONAL_TRANSMISSION"
415,"Down",0.694819519946259,0.912724429979298,"B.PvsV.WONG_EMBRYONIC_STEM_CELL_CORE"
13,"Down",0.695018624628434,0.912769115337438,"B.PvsV.CLIMENT_BREAST_CANCER_COPY_NUMBER_DN"
201,"Down",0.69540657197924,0.912925467378531,"B.PvsV.BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_CIS"
101,"Down",0.6954679089525,0.912925467378531,"B.PvsV.ZHOU_TNF_SIGNALING_30MIN"
47,"Down",0.695695568410137,0.913007547528993,"B.PvsV.CHUANG_OXIDATIVE_STRESS_RESPONSE_UP"
19,"Down",0.696544761441088,0.913082896414959,"B.PvsV.SASSON_FSH_RESPONSE"
13,"Up",0.69666556390102,0.913082896414959,"B.PvsV.REACTOME_TRIGLYCERIDE_BIOSYNTHESIS"
89,"Up",0.697060906778372,0.913082896414959,"B.PvsV.PID_DELTA_NP63_PATHWAY"
21,"Up",0.697138078990633,0.913082896414959,"B.PvsV.MCBRYAN_TERMINAL_END_BUD_UP"
49,"Up",0.697176070593212,0.913082896414959,"B.PvsV.KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_4NQO_IN_WS"
443,"Up",0.69719680921669,0.913082896414959,"B.PvsV.WEST_ADRENOCORTICAL_TUMOR_UP"
28,"Down",0.697459191757887,0.913082896414959,"B.PvsV.SCHAVOLT_TARGETS_OF_TP53_AND_TP63"
91,"Down",0.697833928850102,0.913082896414959,"B.PvsV.SHAFFER_IRF4_TARGETS_IN_ACTIVATED_DENDRITIC_CELL"
15,"Down",0.697934867121004,0.913082896414959,"B.PvsV.REACTOME_PURINE_SALVAGE"
55,"Up",0.697956387326785,0.913082896414959,"B.PvsV.WONG_ENDMETRIUM_CANCER_UP"
134,"Down",0.698166122414226,0.913082896414959,"B.PvsV.SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_UP"
6,"Up",0.698221182579198,0.913082896414959,"B.PvsV.REACTOME_TRANSPORT_AND_SYNTHESIS_OF_PAPS"
96,"Up",0.698235538067667,0.913082896414959,"B.PvsV.CERIBELLI_PROMOTERS_INACTIVE_AND_BOUND_BY_NFY"
65,"Down",0.698258834743372,0.913082896414959,"B.PvsV.TANG_SENESCENCE_TP53_TARGETS_UP"
50,"Up",0.698262326908496,0.913082896414959,"B.PvsV.REACTOME_LYSOSOME_VESICLE_BIOGENESIS"
15,"Down",0.698468493013281,0.913082896414959,"B.PvsV.RAFFEL_VEGFA_TARGETS_UP"
6,"Down",0.698560436215459,0.913082896414959,"B.PvsV.REACTOME_THE_RETINOID_CYCLE_IN_CONES_DAYLIGHT_VISION"
17,"Up",0.698738601007594,0.913099911361613,"B.PvsV.BIOCARTA_DREAM_PATHWAY"
20,"Down",0.698981712707879,0.913201769745241,"B.PvsV.FERRANDO_LYL1_NEIGHBORS"
347,"Up",0.699803384983981,0.91320989906059,"B.PvsV.BLUM_RESPONSE_TO_SALIRASIB_UP"
6,"Down",0.69985818391887,0.91320989906059,"B.PvsV.PALOMERO_GSI_SENSITIVITY_DN"
12,"Down",0.700306114736187,0.91320989906059,"B.PvsV.BIOCARTA_EEA1_PATHWAY"
341,"Up",0.700431064078357,0.91320989906059,"B.PvsV.LEE_LIVER_CANCER_SURVIVAL_UP"
54,"Down",0.70063295362751,0.91320989906059,"B.PvsV.REACTOME_HDMS_DEMETHYLATE_HISTONES"
26,"Up",0.700643233727968,0.91320989906059,"B.PvsV.MATZUK_EMBRYONIC_GERM_CELL"
278,"Up",0.700656391987764,0.91320989906059,"B.PvsV.LIN_NPAS4_TARGETS_UP"
17,"Down",0.700675751511697,0.91320989906059,"B.PvsV.REACTOME_ZINC_TRANSPORTERS"
127,"Up",0.700820859501057,0.91320989906059,"B.PvsV.VANDESLUIS_COMMD1_TARGETS_GROUP_3_UP"
251,"Up",0.700922330651824,0.91320989906059,"B.PvsV.GROSS_HYPOXIA_VIA_ELK3_DN"
16,"Down",0.700979161489412,0.91320989906059,"B.PvsV.REACTOME_SYNTHESIS_OF_PE"
18,"Up",0.701208549189948,0.91320989906059,"B.PvsV.REACTOME_TRAF6_MEDIATED_INDUCTION_OF_TAK1_COMPLEX_WITHIN_TLR4_COMPLEX"
5,"Down",0.701269139433849,0.91320989906059,"B.PvsV.REACTOME_TACHYKININ_RECEPTORS_BIND_TACHYKININS"
61,"Up",0.701300276977983,0.91320989906059,"B.PvsV.ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_DN"
19,"Down",0.701913398708177,0.913400359130778,"B.PvsV.BIOCARTA_LONGEVITY_PATHWAY"
203,"Down",0.702192617701805,0.913400359130778,"B.PvsV.WHITFIELD_CELL_CYCLE_M_G1"
169,"Up",0.702201208324988,0.913400359130778,"B.PvsV.NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP"
21,"Down",0.702275424242651,0.913400359130778,"B.PvsV.GEISS_RESPONSE_TO_DSRNA_DN"
124,"Down",0.70228185792012,0.913400359130778,"B.PvsV.FONTAINE_FOLLICULAR_THYROID_ADENOMA_UP"
62,"Down",0.702634424565672,0.913400359130778,"B.PvsV.SIG_BCR_SIGNALING_PATHWAY"
1149,"Down",0.702758541882374,0.913400359130778,"B.PvsV.NABA_MATRISOME"
67,"Down",0.702768154773436,0.913400359130778,"B.PvsV.BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_UP"
486,"Down",0.70335415121354,0.913947145019897,"B.PvsV.REACTOME_M_PHASE"
26,"Down",0.703692007160811,0.914171312874089,"B.PvsV.REACTOME_METAL_ION_SLC_TRANSPORTERS"
15,"Up",0.703936692240613,0.914274364904475,"B.PvsV.KEGG_GLYCOSPHINGOLIPID_BIOSYNTHESIS_GANGLIO_SERIES"
90,"Down",0.704389699723873,0.914279842885638,"B.PvsV.GOTTWEIN_TARGETS_OF_KSHV_MIR_K12_11"
59,"Up",0.704668439720066,0.914279842885638,"B.PvsV.WOOD_EBV_EBNA1_TARGETS_DN"
25,"Down",0.704704301132294,0.914279842885638,"B.PvsV.WEBER_METHYLATED_IN_COLON_CANCER"
72,"Up",0.704829473153878,0.914279842885638,"B.PvsV.PIONTEK_PKD1_TARGETS_UP"
361,"Down",0.704962542946494,0.914279842885638,"B.PvsV.MATTIOLI_MGUS_VS_PCL"
11,"Up",0.705262860044445,0.914279842885638,"B.PvsV.REACTOME_ADENYLATE_CYCLASE_ACTIVATING_PATHWAY"
360,"Down",0.705413716943908,0.914279842885638,"B.PvsV.RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN"
181,"Up",0.705425482293577,0.914279842885638,"B.PvsV.RICKMAN_HEAD_AND_NECK_CANCER_E"
49,"Up",0.705507317651014,0.914279842885638,"B.PvsV.PACHER_TARGETS_OF_IGF1_AND_IGF2_UP"
37,"Down",0.705727739547838,0.914279842885638,"B.PvsV.REACTOME_HEME_DEGRADATION"
19,"Up",0.705759878718738,0.914279842885638,"B.PvsV.REACTOME_SIGNAL_REGULATORY_PROTEIN_FAMILY_INTERACTIONS"
710,"Up",0.706106764271324,0.914514944871434,"B.PvsV.DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN"
17,"Down",0.707035288958636,0.915118886749209,"B.PvsV.NAGY_TFTC_COMPONENTS_HUMAN"
55,"Down",0.70734997164728,0.915118886749209,"B.PvsV.VALK_AML_CLUSTER_10"
17,"Down",0.70754799228599,0.915118886749209,"B.PvsV.TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_MONOCYTE_DN"
25,"Down",0.707661710115915,0.915118886749209,"B.PvsV.REACTOME_ACYL_CHAIN_REMODELLING_OF_PS"
124,"Down",0.707668748458105,0.915118886749209,"B.PvsV.REACTOME_G2_M_DNA_DAMAGE_CHECKPOINT"
1388,"Down",0.70768359211243,0.915118886749209,"B.PvsV.REACTOME_DEVELOPMENTAL_BIOLOGY"
1053,"Down",0.707837660867724,0.915118886749209,"B.PvsV.NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN"
149,"Up",0.707897174647561,0.915118886749209,"B.PvsV.GUO_TARGETS_OF_IRS1_AND_IRS2"
9,"Down",0.708258432564552,0.915209158330695,"B.PvsV.REACTOME_WNT_MEDIATED_ACTIVATION_OF_DVL"
135,"Up",0.708298062669026,0.915209158330695,"B.PvsV.REACTOME_DNA_REPLICATION"
526,"Down",0.708851811090556,0.915456301820344,"B.PvsV.SABATES_COLORECTAL_ADENOMA_DN"
1584,"Up",0.709015166481165,0.915456301820344,"B.PvsV.GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS"
155,"Down",0.709242043728267,0.915456301820344,"B.PvsV.LEIN_CEREBELLUM_MARKERS"
73,"Down",0.709291925908504,0.915456301820344,"B.PvsV.ZHAN_V1_LATE_DIFFERENTIATION_GENES_UP"
281,"Up",0.709317199674146,0.915456301820344,"B.PvsV.REACTOME_INTERFERON_SIGNALING"
106,"Up",0.709539347814141,0.915529300831828,"B.PvsV.WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_TBH"
77,"Up",0.709726186431644,0.915556716001064,"B.PvsV.SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_DN"
75,"Down",0.710081592546414,0.915801522087502,"B.PvsV.REACTOME_CHEMOKINE_RECEPTORS_BIND_CHEMOKINES"
415,"Up",0.710666378883572,0.915856733080619,"B.PvsV.FOURNIER_ACINAR_DEVELOPMENT_LATE_2"
9,"Up",0.7106782018855,0.915856733080619,"B.PvsV.REACTOME_SYNTHESIS_OF_DIPHTHAMIDE_EEF2"
352,"Down",0.710783762313396,0.915856733080619,"B.PvsV.REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL"
50,"Up",0.710786985286478,0.915856733080619,"B.PvsV.BIOCARTA_IL1R_PATHWAY"
46,"Down",0.711495917993163,0.916208261943199,"B.PvsV.KEGG_N_GLYCAN_BIOSYNTHESIS"
16,"Down",0.711560929835597,0.916208261943199,"B.PvsV.REACTOME_ERYTHROPOIETIN_ACTIVATES_PHOSPHOINOSITIDE_3_KINASE_PI3K"
363,"Up",0.711660341704905,0.916208261943199,"B.PvsV.ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_DN"
76,"Up",0.711723865354901,0.916208261943199,"B.PvsV.NEMETH_INFLAMMATORY_RESPONSE_LPS_DN"
20,"Down",0.711888351113761,0.916208261943199,"B.PvsV.TERAMOTO_OPN_TARGETS_CLUSTER_1"
105,"Down",0.713641287550061,0.917615818797848,"B.PvsV.REACTOME_SIGNALING_BY_FGFR"
7,"Down",0.713772084911825,0.917615818797848,"B.PvsV.REACTOME_ATTACHMENT_OF_GPI_ANCHOR_TO_UPAR"
30,"Up",0.713844645143479,0.917615818797848,"B.PvsV.HOLLEMAN_VINCRISTINE_RESISTANCE_ALL_DN"
17,"Up",0.713909165854419,0.917615818797848,"B.PvsV.SUZUKI_CTCFL_TARGETS_UP"
22,"Down",0.713964790519341,0.917615818797848,"B.PvsV.MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_4"
125,"Up",0.713977799325075,0.917615818797848,"B.PvsV.PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP"
289,"Up",0.714307711491016,0.917826478464752,"B.PvsV.ZHENG_FOXP3_TARGETS_IN_THYMUS_UP"
44,"Up",0.714646895745244,0.917920997322477,"B.PvsV.LOPEZ_MESOTHELIOMA_SURVIVAL_DN"
17,"Up",0.714824395799658,0.917920997322477,"B.PvsV.PID_S1P_S1P4_PATHWAY"
13,"Up",0.714879329801155,0.917920997322477,"B.PvsV.FUNG_IL2_SIGNALING_1"
246,"Up",0.71555730684049,0.918508563058434,"B.PvsV.SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_UP"
361,"Up",0.715867459729092,0.918508563058434,"B.PvsV.REACTOME_ORGANELLE_BIOGENESIS_AND_MAINTENANCE"
49,"Up",0.715958196740693,0.918508563058434,"B.PvsV.WEBER_METHYLATED_HCP_IN_SPERM_DN"
627,"Down",0.716419994948063,0.918508563058434,"B.PvsV.SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12"
15,"Down",0.716533504057148,0.918508563058434,"B.PvsV.PETRETTO_LEFT_VENTRICLE_MASS_QTL_CIS_DN"
27,"Down",0.716555958893001,0.918508563058434,"B.PvsV.KORKOLA_TERATOMA_UP"
371,"Up",0.716807565234235,0.918508563058434,"B.PvsV.GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_UP"
32,"Up",0.717056495766838,0.918508563058434,"B.PvsV.BIOCARTA_PAR1_PATHWAY"
92,"Up",0.717056977600105,0.918508563058434,"B.PvsV.YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_2"
12,"Down",0.717135655125743,0.918508563058434,"B.PvsV.REACTOME_IRAK2_MEDIATED_ACTIVATION_OF_TAK1_COMPLEX"
214,"Down",0.717164309409163,0.918508563058434,"B.PvsV.REACTOME_ROLE_OF_PHOSPHOLIPIDS_IN_PHAGOCYTOSIS"
38,"Down",0.717660112531183,0.918758497196487,"B.PvsV.MEISSNER_NPC_ICP_WITH_H3_UNMETHYLATED"
8,"Down",0.71769179768342,0.918758497196487,"B.PvsV.REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_INTERLEUKIN_SIGNALING"
110,"Down",0.718080043934377,0.918918942230621,"B.PvsV.MATZUK_MEIOTIC_AND_DNA_REPAIR"
21,"Down",0.718149529639811,0.918918942230621,"B.PvsV.REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_DIFFERENTIATION_OF_KERATINOCYTES"
675,"Down",0.719152009361361,0.919216636245529,"B.PvsV.IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_DN"
313,"Down",0.719367308902437,0.919216636245529,"B.PvsV.CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN"
663,"Up",0.719622887779556,0.919216636245529,"B.PvsV.VECCHI_GASTRIC_CANCER_EARLY_DN"
15,"Up",0.719792023734625,0.919216636245529,"B.PvsV.MIKKELSEN_PARTIALLY_REPROGRAMMED_TO_PLURIPOTENCY"
19,"Up",0.71980352322732,0.919216636245529,"B.PvsV.REACTOME_REGULATION_OF_IFNG_SIGNALING"
67,"Down",0.719805796321052,0.919216636245529,"B.PvsV.JAZAG_TGFB1_SIGNALING_DN"
340,"Up",0.720019422374779,0.919216636245529,"B.PvsV.WINTER_HYPOXIA_METAGENE"
768,"Up",0.720076743442271,0.919216636245529,"B.PvsV.RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_DN"
1133,"Up",0.72016803056145,0.919216636245529,"B.PvsV.KRIEG_HYPOXIA_NOT_VIA_KDM3A"
144,"Up",0.720194928355811,0.919216636245529,"B.PvsV.NEMETH_INFLAMMATORY_RESPONSE_LPS_UP"
29,"Down",0.720210972728456,0.919216636245529,"B.PvsV.NOUSHMEHR_GBM_SOMATIC_MUTATED"
556,"Up",0.721068071630691,0.919948723241407,"B.PvsV.MCLACHLAN_DENTAL_CARIES_UP"
166,"Down",0.721434600852716,0.919948723241407,"B.PvsV.LIU_PROSTATE_CANCER_UP"
237,"Down",0.721498523819326,0.919948723241407,"B.PvsV.DAZARD_UV_RESPONSE_CLUSTER_G6"
21,"Up",0.721518854889868,0.919948723241407,"B.PvsV.FARMER_BREAST_CANCER_CLUSTER_3"
94,"Up",0.722627684440738,0.919948723241407,"B.PvsV.BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_UP"
75,"Up",0.72265012820315,0.919948723241407,"B.PvsV.LUI_THYROID_CANCER_PAX8_PPARG_UP"
72,"Up",0.722695503903888,0.919948723241407,"B.PvsV.DAZARD_UV_RESPONSE_CLUSTER_G4"
50,"Down",0.722704725793238,0.919948723241407,"B.PvsV.JAERVINEN_AMPLIFIED_IN_LARYNGEAL_CANCER"
75,"Down",0.722921415982437,0.919948723241407,"B.PvsV.NUTT_GBM_VS_AO_GLIOMA_DN"
144,"Up",0.722979772539241,0.919948723241407,"B.PvsV.MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_UP"
189,"Down",0.723430096696396,0.919948723241407,"B.PvsV.PUIFFE_INVASION_INHIBITED_BY_ASCITES_DN"
353,"Down",0.723484736119705,0.919948723241407,"B.PvsV.CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP"
92,"Up",0.7236258194816,0.919948723241407,"B.PvsV.REACTOME_DDX58_IFIH1_MEDIATED_INDUCTION_OF_INTERFERON_ALPHA_BETA"
12,"Down",0.723648572048144,0.919948723241407,"B.PvsV.MIZUKAMI_HYPOXIA_DN"
24,"Down",0.724084136259522,0.919948723241407,"B.PvsV.HOLLEMAN_VINCRISTINE_RESISTANCE_B_ALL_DN"
5,"Down",0.72420306350957,0.919948723241407,"B.PvsV.REACTOME_ARACHIDONATE_PRODUCTION_FROM_DAG"
149,"Down",0.724270669355554,0.919948723241407,"B.PvsV.GAVIN_FOXP3_TARGETS_CLUSTER_P6"
25,"Down",0.724356299805902,0.919948723241407,"B.PvsV.REACTOME_REGULATION_OF_INNATE_IMMUNE_RESPONSES_TO_CYTOSOLIC_DNA"
321,"Up",0.724568445741595,0.919948723241407,"B.PvsV.WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN"
172,"Down",0.724662693569782,0.919948723241407,"B.PvsV.KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP"
156,"Down",0.724754476992989,0.919948723241407,"B.PvsV.ZWANG_EGF_INTERVAL_UP"
607,"Down",0.724775621541224,0.919948723241407,"B.PvsV.SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP"
12,"Down",0.724931603773738,0.919948723241407,"B.PvsV.VISALA_AGING_LYMPHOCYTE_UP"
82,"Down",0.725055811630368,0.919948723241407,"B.PvsV.KEGG_GLYCEROPHOSPHOLIPID_METABOLISM"
69,"Down",0.72509901819212,0.919948723241407,"B.PvsV.APPIERTO_RESPONSE_TO_FENRETINIDE_UP"
97,"Down",0.725322120117339,0.919948723241407,"B.PvsV.NADLER_HYPERGLYCEMIA_AT_OBESITY"
7,"Up",0.725369981504237,0.919948723241407,"B.PvsV.REACTOME_RAS_SIGNALING_DOWNSTREAM_OF_NF1_LOSS_OF_FUNCTION_VARIANTS"
106,"Down",0.725443377343559,0.919948723241407,"B.PvsV.PID_AR_PATHWAY"
10,"Up",0.725811043434701,0.920197944216868,"B.PvsV.BIOCARTA_STAT3_PATHWAY"
317,"Down",0.726169487733148,0.920197944216868,"B.PvsV.WANG_CLIM2_TARGETS_DN"
63,"Up",0.726249409923549,0.920197944216868,"B.PvsV.BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_DN"
981,"Up",0.726305630052887,0.920197944216868,"B.PvsV.BROWNE_HCMV_INFECTION_48HR_DN"
40,"Up",0.726642558176243,0.920307126091544,"B.PvsV.REACTOME_AMINO_ACID_TRANSPORT_ACROSS_THE_PLASMA_MEMBRANE"
29,"Up",0.726825069542884,0.920307126091544,"B.PvsV.SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_2FC_DN"
19,"Down",0.726979217160262,0.920307126091544,"B.PvsV.KIM_MYCL1_AMPLIFICATION_TARGETS_UP"
34,"Down",0.727086494249473,0.920307126091544,"B.PvsV.WANG_TNF_TARGETS"
27,"Up",0.727224061113033,0.920307126091544,"B.PvsV.BIOCARTA_TGFB_PATHWAY"
72,"Down",0.727485255228271,0.920399779473033,"B.PvsV.SCHRAETS_MLL_TARGETS_DN"
175,"Up",0.727728800784641,0.920399779473033,"B.PvsV.REACTOME_L1CAM_INTERACTIONS"
75,"Down",0.727796678577699,0.920399779473033,"B.PvsV.VARELA_ZMPSTE24_TARGETS_UP"
7,"Up",0.728031163866786,0.920485777502735,"B.PvsV.TERAO_AOX4_TARGETS_HG_DN"
711,"Up",0.728311644046898,0.920629876528418,"B.PvsV.CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5"
51,"Up",0.728801038709896,0.921037929834747,"B.PvsV.NIKOLSKY_BREAST_CANCER_20Q11_AMPLICON"
179,"Up",0.729243882053792,0.921168718893784,"B.PvsV.MATZUK_SPERMATOZOA"
74,"Down",0.729329986328055,0.921168718893784,"B.PvsV.LEE_AGING_MUSCLE_UP"
169,"Up",0.729523430943013,0.921168718893784,"B.PvsV.SERVITJA_ISLET_HNF1A_TARGETS_DN"
7,"Down",0.729570956779866,0.921168718893784,"B.PvsV.REACTOME_RESPONSE_TO_METAL_IONS"
19,"Up",0.730033200822652,0.921541910353525,"B.PvsV.YIH_RESPONSE_TO_ARSENITE_C5"
24,"Down",0.730888106469116,0.922138909390666,"B.PvsV.SU_THYMUS"
365,"Up",0.730908391104343,0.922138909390666,"B.PvsV.PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP"
81,"Up",0.731006482159394,0.922138909390666,"B.PvsV.BOYAULT_LIVER_CANCER_SUBCLASS_G123_DN"
252,"Down",0.731515919305626,0.922571057901644,"B.PvsV.IWANAGA_CARCINOGENESIS_BY_KRAS_DN"
111,"Up",0.732509350721951,0.923367651861665,"B.PvsV.HOFMANN_CELL_LYMPHOMA_UP"
33,"Down",0.732577410886231,0.923367651861665,"B.PvsV.GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_UP"
234,"Up",0.732770852439155,0.923367651861665,"B.PvsV.DARWICHE_SKIN_TUMOR_PROMOTER_UP"
16,"Down",0.732815564544942,0.923367651861665,"B.PvsV.POS_RESPONSE_TO_HISTAMINE_UP"
35,"Up",0.733036147815141,0.923435147247646,"B.PvsV.REACTOME_ACTIVATION_OF_KAINATE_RECEPTORS_UPON_GLUTAMATE_BINDING"
23,"Down",0.733427701916128,0.923717941661565,"B.PvsV.FIGUEROA_AML_METHYLATION_CLUSTER_2_DN"
17,"Down",0.733900875560128,0.923911204511433,"B.PvsV.BIOCARTA_MONOCYTE_PATHWAY"
382,"Up",0.733915357246196,0.923911204511433,"B.PvsV.CAIRO_HEPATOBLASTOMA_CLASSES_DN"
208,"Down",0.734599945592129,0.924464175853192,"B.PvsV.GAL_LEUKEMIC_STEM_CELL_UP"
383,"Down",0.734689019478916,0.924464175853192,"B.PvsV.DELYS_THYROID_CANCER_DN"
31,"Up",0.734870620763166,0.924482289465198,"B.PvsV.MATZUK_POSTIMPLANTATION_AND_POSTPARTUM"
10,"Up",0.73512506341633,0.924592009924679,"B.PvsV.BIOCARTA_PPARG_PATHWAY"
438,"Down",0.735523921456186,0.92479718287764,"B.PvsV.OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN"
29,"Down",0.735622718447434,0.92479718287764,"B.PvsV.EHRLICH_ICF_SYNDROM_DN"
10,"Up",0.73666359256099,0.925853236532082,"B.PvsV.REACTOME_RECYCLING_OF_EIF2_GDP"
16,"Up",0.736797656129709,0.925853236532082,"B.PvsV.REACTOME_ERKS_ARE_INACTIVATED"
58,"Down",0.737518598885819,0.926209270599641,"B.PvsV.HARRIS_BRAIN_CANCER_PROGENITORS"
45,"Down",0.737605348056225,0.926209270599641,"B.PvsV.MURATA_VIRULENCE_OF_H_PILORI"
66,"Down",0.737645288496449,0.926209270599641,"B.PvsV.FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN"
37,"Up",0.737751063071228,0.926209270599641,"B.PvsV.REACTOME_SUMOYLATION_OF_INTRACELLULAR_RECEPTORS"
65,"Down",0.738386109370163,0.926389844171046,"B.PvsV.JIANG_AGING_CEREBRAL_CORTEX_UP"
8,"Down",0.738394993790548,0.926389844171046,"B.PvsV.RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_MAPK1_DN"
9,"Down",0.738397548066884,0.926389844171046,"B.PvsV.REACTOME_SUMO_IS_PROTEOLYTICALLY_PROCESSED"
50,"Down",0.739127743564796,0.926547503894856,"B.PvsV.LOPEZ_MESOTHELIOMA_SURVIVAL_OVERALL_DN"
18,"Up",0.739270587972628,0.926547503894856,"B.PvsV.STEINER_ERYTHROCYTE_MEMBRANE_GENES"
116,"Up",0.739294730099685,0.926547503894856,"B.PvsV.DAZARD_UV_RESPONSE_CLUSTER_G1"
1026,"Down",0.739666728450533,0.926547503894856,"B.PvsV.GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN"
7,"Down",0.739698267904639,0.926547503894856,"B.PvsV.REACTOME_LOSS_OF_MECP2_BINDING_ABILITY_TO_THE_NCOR_SMRT_COMPLEX"
18,"Down",0.740015583050384,0.926547503894856,"B.PvsV.PID_SMAD2_3PATHWAY"
28,"Down",0.740027265731287,0.926547503894856,"B.PvsV.VISALA_RESPONSE_TO_HEAT_SHOCK_AND_AGING_UP"
33,"Down",0.740051282473522,0.926547503894856,"B.PvsV.YORDY_RECIPROCAL_REGULATION_BY_ETS1_AND_SP100_UP"
163,"Down",0.740306492633841,0.926547503894856,"B.PvsV.RHEIN_ALL_GLUCOCORTICOID_THERAPY_UP"
77,"Up",0.740320195848549,0.926547503894856,"B.PvsV.DORN_ADENOVIRUS_INFECTION_12HR_UP"
9,"Up",0.740366589294171,0.926547503894856,"B.PvsV.REACTOME_TFAP2_AP_2_FAMILY_REGULATES_TRANSCRIPTION_OF_CELL_CYCLE_FACTORS"
9,"Down",0.740581346388239,0.926606531835386,"B.PvsV.KIM_GLIS2_TARGETS_DN"
23,"Up",0.741367124983864,0.92733958606396,"B.PvsV.MARKS_HDAC_TARGETS_DN"
167,"Up",0.74157080986231,0.92733958606396,"B.PvsV.QI_PLASMACYTOMA_DN"
19,"Up",0.741670401442364,0.92733958606396,"B.PvsV.REACTOME_PRESYNAPTIC_DEPOLARIZATION_AND_CALCIUM_CHANNEL_OPENING"
100,"Up",0.742271661275932,0.927756329242699,"B.PvsV.CHANG_IMMORTALIZED_BY_HPV31_UP"
388,"Up",0.742339301965943,0.927756329242699,"B.PvsV.VERHAAK_AML_WITH_NPM1_MUTATED_UP"
16,"Up",0.742526091107565,0.92778005824491,"B.PvsV.REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TN_POLYAGGLUTINATION_SYNDROME_TNPS"
93,"Up",0.74289613798335,0.92796261725207,"B.PvsV.KRASNOSELSKAYA_ILF3_TARGETS_DN"
400,"Up",0.743007868796331,0.92796261725207,"B.PvsV.ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN"
33,"Down",0.743688394885604,0.928602785754856,"B.PvsV.BIOCARTA_ARENRF2_PATHWAY"
789,"Up",0.743941126060782,0.928708621808549,"B.PvsV.DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN"
199,"Up",0.744238650536468,0.928870315759849,"B.PvsV.PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_DN"
67,"Down",0.744734550264924,0.929279469287918,"B.PvsV.YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_8"
149,"Up",0.745134699625986,0.929398728393477,"B.PvsV.NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN"
168,"Down",0.745236917536902,0.929398728393477,"B.PvsV.COATES_MACROPHAGE_M1_VS_M2_UP"
21,"Up",0.745334411592816,0.929398728393477,"B.PvsV.GRATIAS_RETINOBLASTOMA_16Q24"
1198,"Up",0.745593143549017,0.929511722814547,"B.PvsV.FEVR_CTNNB1_TARGETS_UP"
129,"Down",0.746332113075706,0.929830453700496,"B.PvsV.REACTOME_RUNX1_REGULATES_GENES_INVOLVED_IN_MEGAKARYOCYTE_DIFFERENTIATION_AND_PLATELET_FUNCTION"
143,"Down",0.746562302048794,0.929830453700496,"B.PvsV.LAIHO_COLORECTAL_CANCER_SERRATED_DN"
12,"Down",0.746676075297114,0.929830453700496,"B.PvsV.SCIAN_CELL_CYCLE_TARGETS_OF_TP53_AND_TP73_UP"
533,"Down",0.746958193588091,0.929830453700496,"B.PvsV.HORIUCHI_WTAP_TARGETS_UP"
8,"Down",0.747161784078601,0.929830453700496,"B.PvsV.REACTOME_SYNTHESIS_OF_UDP_N_ACETYL_GLUCOSAMINE"
185,"Down",0.747247150980696,0.929830453700496,"B.PvsV.SMIRNOV_RESPONSE_TO_IR_6HR_DN"
60,"Up",0.747270637017643,0.929830453700496,"B.PvsV.MATZUK_SPERMATID_DIFFERENTIATION"
15,"Up",0.747442459081562,0.929830453700496,"B.PvsV.REACTOME_TICAM1_TRAF6_DEPENDENT_INDUCTION_OF_TAK1_COMPLEX"
216,"Up",0.747856022415632,0.929830453700496,"B.PvsV.PECE_MAMMARY_STEM_CELL_DN"
9,"Up",0.747908760364427,0.929830453700496,"B.PvsV.REACTOME_AMPK_INHIBITS_CHREBP_TRANSCRIPTIONAL_ACTIVATION_ACTIVITY"
18,"Down",0.74793351662866,0.929830453700496,"B.PvsV.REACTOME_DEPOLYMERISATION_OF_THE_NUCLEAR_LAMINA"
41,"Up",0.747986924912428,0.929830453700496,"B.PvsV.REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS"
12,"Down",0.748035062047351,0.929830453700496,"B.PvsV.HOFFMAN_CLOCK_TARGETS_DN"
80,"Down",0.748236060517813,0.929871247157336,"B.PvsV.HEIDENBLAD_AMPLIFIED_IN_PANCREATIC_CANCER"
268,"Up",0.749152181809082,0.930800542297172,"B.PvsV.DARWICHE_PAPILLOMA_RISK_LOW_UP"
81,"Up",0.749663922867615,0.93089049814076,"B.PvsV.KEGG_RIG_I_LIKE_RECEPTOR_SIGNALING_PATHWAY"
90,"Down",0.749684981435547,0.93089049814076,"B.PvsV.TENEDINI_MEGAKARYOCYTE_MARKERS"
8,"Up",0.749874548764235,0.93089049814076,"B.PvsV.LIU_IL13_MEMORY_MODEL_DN"
6,"Down",0.750025457438629,0.93089049814076,"B.PvsV.REACTOME_FICOLINS_BIND_TO_REPETITIVE_CARBOHYDRATE_STRUCTURES_ON_THE_TARGET_CELL_SURFACE"
33,"Down",0.750069156616311,0.93089049814076,"B.PvsV.REACTOME_THROMBIN_SIGNALLING_THROUGH_PROTEINASE_ACTIVATED_RECEPTORS_PARS"
34,"Up",0.750321502213693,0.93089049814076,"B.PvsV.KIM_MYCL1_AMPLIFICATION_TARGETS_DN"
27,"Up",0.750403138038229,0.93089049814076,"B.PvsV.KEGG_PRIMARY_BILE_ACID_BIOSYNTHESIS"
192,"Up",0.751223413951783,0.931699025513551,"B.PvsV.BENPORATH_PROLIFERATION"
167,"Down",0.751683397492878,0.932034949322761,"B.PvsV.MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_UP"
211,"Down",0.752076486391567,0.932034949322761,"B.PvsV.REACTOME_INITIAL_TRIGGERING_OF_COMPLEMENT"
892,"Down",0.752355494045371,0.932034949322761,"B.PvsV.IVANOVA_HEMATOPOIESIS_STEM_CELL_AND_PROGENITOR"
16,"Down",0.752370171417996,0.932034949322761,"B.PvsV.REACTOME_SIGNALING_BY_LEPTIN"
14,"Down",0.752525142175581,0.932034949322761,"B.PvsV.REACTOME_GLUTAMATE_AND_GLUTAMINE_METABOLISM"
826,"Up",0.752565437093343,0.932034949322761,"B.PvsV.TARTE_PLASMA_CELL_VS_PLASMABLAST_UP"
314,"Down",0.752674271789858,0.932034949322761,"B.PvsV.SHEPARD_BMYB_MORPHOLINO_DN"
192,"Up",0.75406762265793,0.932803352636266,"B.PvsV.KEGG_JAK_STAT_SIGNALING_PATHWAY"
45,"Down",0.754100180299119,0.932803352636266,"B.PvsV.REACTOME_OVARIAN_TUMOR_DOMAIN_PROTEASES"
140,"Up",0.754168803638989,0.932803352636266,"B.PvsV.NATSUME_RESPONSE_TO_INTERFERON_BETA_UP"
1038,"Up",0.754308460046141,0.932803352636266,"B.PvsV.WEI_MYCN_TARGETS_WITH_E_BOX"
39,"Down",0.754347878763205,0.932803352636266,"B.PvsV.CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_DN"
52,"Up",0.754388644239728,0.932803352636266,"B.PvsV.SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_DN"
82,"Up",0.754805349344443,0.932803352636266,"B.PvsV.LI_LUNG_CANCER"
7,"Down",0.755093642028476,0.932803352636266,"B.PvsV.STONER_ESOPHAGEAL_CARCINOGENESIS_DN"
19,"Down",0.755353061538727,0.932803352636266,"B.PvsV.REACTOME_DIGESTION_OF_DIETARY_CARBOHYDRATE"
10,"Up",0.755363396237795,0.932803352636266,"B.PvsV.REACTOME_ZINC_INFLUX_INTO_CELLS_BY_THE_SLC39_GENE_FAMILY"
17,"Up",0.755550704303832,0.932803352636266,"B.PvsV.REACTOME_DOWNREGULATION_OF_ERBB2_ERBB3_SIGNALING"
89,"Down",0.755674887913064,0.932803352636266,"B.PvsV.CUI_TCF21_TARGETS_DN"
8,"Down",0.755740358689223,0.932803352636266,"B.PvsV.LE_SKI_TARGETS_DN"
102,"Down",0.755763500707146,0.932803352636266,"B.PvsV.HUPER_BREAST_BASAL_VS_LUMINAL_UP"
55,"Up",0.755858891937063,0.932803352636266,"B.PvsV.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_DN"
354,"Up",0.755994180351439,0.932803352636266,"B.PvsV.OHGUCHI_LIVER_HNF4A_TARGETS_DN"
106,"Down",0.756251632230837,0.932858607880824,"B.PvsV.KANNAN_TP53_TARGETS_UP"
523,"Up",0.756754287680664,0.932858607880824,"B.PvsV.GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP"
283,"Down",0.757014849108149,0.932858607880824,"B.PvsV.TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP"
6,"Up",0.75704308616686,0.932858607880824,"B.PvsV.REACTOME_VASOPRESSIN_LIKE_RECEPTORS"
52,"Up",0.757116443992415,0.932858607880824,"B.PvsV.WANG_RESPONSE_TO_FORSKOLIN_UP"
34,"Up",0.757280461386993,0.932858607880824,"B.PvsV.NIKOLSKY_BREAST_CANCER_5P15_AMPLICON"
7,"Down",0.757454078389452,0.932858607880824,"B.PvsV.REACTOME_NECTIN_NECL_TRANS_HETERODIMERIZATION"
77,"Down",0.757619692195171,0.932858607880824,"B.PvsV.MAGRANGEAS_MULTIPLE_MYELOMA_IGLL_VS_IGLK_UP"
102,"Up",0.757663784501949,0.932858607880824,"B.PvsV.KEGG_RETINOL_METABOLISM"
58,"Down",0.757726172543458,0.932858607880824,"B.PvsV.LI_CISPLATIN_RESISTANCE_DN"
27,"Down",0.758081551624152,0.933088356841036,"B.PvsV.BIOCARTA_GCR_PATHWAY"
106,"Up",0.758324109466966,0.933179167870655,"B.PvsV.REACTOME_RNA_POLYMERASE_I_PROMOTER_ESCAPE"
65,"Down",0.758559468574423,0.933261081830883,"B.PvsV.REACTOME_INTERLEUKIN_3_INTERLEUKIN_5_AND_GM_CSF_SIGNALING"
150,"Down",0.759046554681002,0.933652591953562,"B.PvsV.GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP"
19,"Down",0.75932447729712,0.933683831385358,"B.PvsV.HEIDENBLAD_AMPLIFIED_IN_SOFT_TISSUE_CANCER"
669,"Up",0.759494725944538,0.933683831385358,"B.PvsV.KUMAR_TARGETS_OF_MLL_AF9_FUSION"
69,"Down",0.759578562772895,0.933683831385358,"B.PvsV.REACTOME_REGULATION_OF_PTEN_GENE_TRANSCRIPTION"
113,"Up",0.759760481891819,0.93369986761055,"B.PvsV.HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_UP"
20,"Up",0.760212231989769,0.933839746445881,"B.PvsV.SA_PTEN_PATHWAY"
13,"Up",0.760519559079465,0.933839746445881,"B.PvsV.REACTOME_ERBB2_ACTIVATES_PTK6_SIGNALING"
34,"Up",0.760699453480219,0.933839746445881,"B.PvsV.REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION"
54,"Up",0.760826003325021,0.933839746445881,"B.PvsV.CREIGHTON_AKT1_SIGNALING_VIA_MTOR_UP"
316,"Up",0.760834044254692,0.933839746445881,"B.PvsV.SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN"
568,"Down",0.76104177651379,0.933839746445881,"B.PvsV.DAVICIONI_MOLECULAR_ARMS_VS_ERMS_UP"
54,"Up",0.761056592057359,0.933839746445881,"B.PvsV.NAKAMURA_CANCER_MICROENVIRONMENT_DN"
8,"Down",0.761434466285357,0.934096109183878,"B.PvsV.REACTOME_COENZYME_A_BIOSYNTHESIS"
1236,"Down",0.762447549091693,0.934835337124185,"B.PvsV.GEORGES_TARGETS_OF_MIR192_AND_MIR215"
15,"Up",0.762454210305428,0.934835337124185,"B.PvsV.PID_P38_GAMMA_DELTA_PATHWAY"
83,"Up",0.76254428837585,0.934835337124185,"B.PvsV.REACTOME_SIRT1_NEGATIVELY_REGULATES_RRNA_EXPRESSION"
28,"Up",0.763034988546144,0.935167155205984,"B.PvsV.REACTOME_DOPAMINE_NEUROTRANSMITTER_RELEASE_CYCLE"
6,"Down",0.763153229207705,0.935167155205984,"B.PvsV.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_13"
24,"Up",0.763336392914417,0.935184337785024,"B.PvsV.RAY_TARGETS_OF_P210_BCR_ABL_FUSION_DN"
237,"Down",0.763567580345139,0.935260334897713,"B.PvsV.MIKKELSEN_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3"
47,"Up",0.76447472236014,0.936164061999826,"B.PvsV.REACTOME_DNA_DAMAGE_RECOGNITION_IN_GG_NER"
54,"Up",0.764758603072491,0.936304321609345,"B.PvsV.PID_IFNG_PATHWAY"
20,"Up",0.765040130669857,0.936441638803108,"B.PvsV.REACTOME_ABACAVIR_TRANSPORT_AND_METABOLISM"
79,"Up",0.765353231535353,0.936461024632942,"B.PvsV.PID_TAP63_PATHWAY"
75,"Up",0.765394713386917,0.936461024632942,"B.PvsV.PID_INTEGRIN3_PATHWAY"
18,"Down",0.765680941281485,0.936603965563126,"B.PvsV.REACTOME_NEUROFASCIN_INTERACTIONS"
82,"Down",0.765858973884472,0.936607204003339,"B.PvsV.CHEN_ETV5_TARGETS_TESTIS"
474,"Up",0.766152947951304,0.936607204003339,"B.PvsV.REACTOME_NEURONAL_SYSTEM"
9,"Up",0.766259343706676,0.936607204003339,"B.PvsV.REACTOME_MODULATION_BY_MTB_OF_HOST_IMMUNE_SYSTEM"
1549,"Up",0.766423024385549,0.936607204003339,"B.PvsV.DANG_BOUND_BY_MYC"
5,"Down",0.766775432136859,0.936607204003339,"B.PvsV.REACTOME_DISEASES_OF_BASE_EXCISION_REPAIR"
413,"Down",0.767330922892751,0.936607204003339,"B.PvsV.ZHENG_GLIOBLASTOMA_PLASTICITY_UP"
15,"Down",0.767553435793784,0.936607204003339,"B.PvsV.REACTOME_LIPOPHAGY"
7,"Down",0.767560550315956,0.936607204003339,"B.PvsV.REACTOME_MITOCHONDRIAL_UNCOUPLING"
13,"Down",0.767661252574083,0.936607204003339,"B.PvsV.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_29"
15,"Up",0.767855343126988,0.936607204003339,"B.PvsV.HOLLEMAN_DAUNORUBICIN_B_ALL_DN"
35,"Up",0.768036010598518,0.936607204003339,"B.PvsV.OUYANG_PROSTATE_CANCER_MARKERS"
16,"Up",0.768085517061961,0.936607204003339,"B.PvsV.ITO_PTTG1_TARGETS_DN"
6,"Up",0.768245097105372,0.936607204003339,"B.PvsV.REACTOME_NEGATIVE_REGULATION_OF_TCF_DEPENDENT_SIGNALING_BY_DVL_INTERACTING_PROTEINS"
33,"Down",0.768309030039476,0.936607204003339,"B.PvsV.BILANGES_SERUM_SENSITIVE_VIA_TSC1"
6,"Up",0.76831856577053,0.936607204003339,"B.PvsV.REACTOME_G2_M_DNA_REPLICATION_CHECKPOINT"
162,"Down",0.768797254650734,0.936607204003339,"B.PvsV.ZHAN_MULTIPLE_MYELOMA_UP"
241,"Up",0.76879863328913,0.936607204003339,"B.PvsV.BAKKER_FOXO3_TARGETS_DN"
156,"Down",0.768799068987053,0.936607204003339,"B.PvsV.KOHOUTEK_CCNT2_TARGETS"
9,"Down",0.769101251999039,0.936607204003339,"B.PvsV.NAGY_PCAF_COMPONENTS_HUMAN"
74,"Up",0.76918780613755,0.936607204003339,"B.PvsV.MARSON_FOXP3_TARGETS_DN"
36,"Down",0.769343507690988,0.936607204003339,"B.PvsV.REACTOME_SCAVENGING_BY_CLASS_A_RECEPTORS"
20,"Up",0.769410367260475,0.936607204003339,"B.PvsV.REACTOME_DEFECTIVE_B4GALT7_CAUSES_EDS_PROGEROID_TYPE"
50,"Down",0.770046552743792,0.937019038869036,"B.PvsV.PID_AURORA_B_PATHWAY"
54,"Up",0.770107186068459,0.937019038869036,"B.PvsV.REACTOME_GLUCAGON_LIKE_PEPTIDE_1_GLP1_REGULATES_INSULIN_SECRETION"
23,"Down",0.770257104659029,0.937019038869036,"B.PvsV.REACTOME_THE_NLRP3_INFLAMMASOME"
30,"Up",0.770603290967867,0.937056982497193,"B.PvsV.SUZUKI_RESPONSE_TO_TSA"
1187,"Up",0.770755144723566,0.937056982497193,"B.PvsV.KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_DN"
67,"Up",0.770936171215276,0.937056982497193,"B.PvsV.PID_NFAT_3PATHWAY"
25,"Up",0.770966216925254,0.937056982497193,"B.PvsV.GRANDVAUX_IRF3_TARGETS_DN"
23,"Up",0.771709367025458,0.937453929512707,"B.PvsV.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BROWN_UP"
779,"Down",0.771785410072461,0.937453929512707,"B.PvsV.MIKKELSEN_NPC_ICP_WITH_H3K4ME3"
501,"Down",0.771801462677128,0.937453929512707,"B.PvsV.JAATINEN_HEMATOPOIETIC_STEM_CELL_UP"
19,"Up",0.772138318429338,0.937597127891305,"B.PvsV.SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX5_UP"
36,"Up",0.772258513368964,0.937597127891305,"B.PvsV.REACTOME_NEGATIVE_REGULATION_OF_FGFR3_SIGNALING"
21,"Down",0.773077383040728,0.937780332489889,"B.PvsV.TIAN_BHLHA15_TARGETS"
665,"Up",0.773291703555704,0.937780332489889,"B.PvsV.GOLDRATH_ANTIGEN_RESPONSE"
44,"Up",0.773403389411007,0.937780332489889,"B.PvsV.BIOCARTA_GH_PATHWAY"
83,"Up",0.773517197325802,0.937780332489889,"B.PvsV.VALK_AML_WITH_FLT3_ITD"
146,"Down",0.773532813063382,0.937780332489889,"B.PvsV.REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING"
37,"Down",0.77371407878723,0.937780332489889,"B.PvsV.REACTOME_BIOSYNTHESIS_OF_MARESIN_LIKE_SPMS"
79,"Down",0.773791384406272,0.937780332489889,"B.PvsV.JOHANSSON_GLIOMAGENESIS_BY_PDGFB_UP"
41,"Down",0.773873037593091,0.937780332489889,"B.PvsV.CHIN_BREAST_CANCER_COPY_NUMBER_UP"
10,"Down",0.773985573289168,0.937780332489889,"B.PvsV.BYSTRYKH_HEMATOPOIESIS_STEM_CELL_FLI1"
1160,"Down",0.774163367850064,0.937780332489889,"B.PvsV.WONG_ADULT_TISSUE_STEM_MODULE"
82,"Down",0.774275134349131,0.937780332489889,"B.PvsV.HALMOS_CEBPA_TARGETS_UP"
8,"Up",0.774557511357763,0.937894705501706,"B.PvsV.REACTOME_SIGNALING_BY_NOTCH1_T_7_9_NOTCH1_M1580_K2555_TRANSLOCATION_MUTANT"
307,"Down",0.774803253547938,0.937894705501706,"B.PvsV.CAIRO_HEPATOBLASTOMA_UP"
36,"Up",0.774878461698642,0.937894705501706,"B.PvsV.REACTOME_COBALAMIN_CBL_VITAMIN_B12_TRANSPORT_AND_METABOLISM"
54,"Up",0.775445479742956,0.938165180567199,"B.PvsV.QI_HYPOXIA_TARGETS_OF_HIF1A_AND_FOXA2"
977,"Up",0.775720620966891,0.938165180567199,"B.PvsV.WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_8D"
16,"Up",0.775877650223247,0.938165180567199,"B.PvsV.BIOCARTA_CARM1_PATHWAY"
10,"Down",0.775929701585136,0.938165180567199,"B.PvsV.BIERIE_INFLAMMATORY_RESPONSE_TGFB1"
168,"Up",0.775950329306167,0.938165180567199,"B.PvsV.BROWNE_HCMV_INFECTION_16HR_DN"
8,"Up",0.776293009147819,0.938246603133647,"B.PvsV.HOLLEMAN_DAUNORUBICIN_ALL_UP"
292,"Down",0.776357064448623,0.938246603133647,"B.PvsV.LEE_LIVER_CANCER_SURVIVAL_DN"
34,"Up",0.776679079677827,0.938286611513629,"B.PvsV.REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_7ALPHA_HYDROXYCHOLESTEROL"
765,"Up",0.776729575130743,0.938286611513629,"B.PvsV.SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN"
168,"Down",0.777038066554442,0.938407013598875,"B.PvsV.KIM_GASTRIC_CANCER_CHEMOSENSITIVITY"
252,"Up",0.777168695111096,0.938407013598875,"B.PvsV.HUANG_GATA2_TARGETS_UP"
476,"Up",0.777545702944745,0.938657247070196,"B.PvsV.MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_UP"
165,"Down",0.777907955496307,0.93874459290892,"B.PvsV.TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_UP"
51,"Down",0.77827649608139,0.93874459290892,"B.PvsV.BILANGES_SERUM_RESPONSE_TRANSLATION"
36,"Up",0.778531245612172,0.93874459290892,"B.PvsV.KRIGE_AMINO_ACID_DEPRIVATION"
20,"Up",0.778656659435783,0.93874459290892,"B.PvsV.HEDVAT_ELF4_TARGETS_UP"
29,"Up",0.778744035534634,0.93874459290892,"B.PvsV.REACTOME_AFLATOXIN_ACTIVATION_AND_DETOXIFICATION"
222,"Up",0.778782657317414,0.93874459290892,"B.PvsV.GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_DN"
395,"Down",0.778864661879222,0.93874459290892,"B.PvsV.SENESE_HDAC1_AND_HDAC2_TARGETS_UP"
7,"Up",0.779075986550335,0.93874459290892,"B.PvsV.WEBER_METHYLATED_HCP_IN_FIBROBLAST_UP"
154,"Down",0.77914612712227,0.93874459290892,"B.PvsV.NGUYEN_NOTCH1_TARGETS_DN"
325,"Down",0.779469303113887,0.938929363162675,"B.PvsV.LINSLEY_MIR16_TARGETS"
644,"Down",0.780201839433262,0.939476521448411,"B.PvsV.PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_UP"
32,"Down",0.780552204038995,0.939476521448411,"B.PvsV.VETTER_TARGETS_OF_PRKCA_AND_ETS1_DN"
11,"Up",0.780559248425372,0.939476521448411,"B.PvsV.MULLIGAN_NTF3_SIGNALING_VIA_INSR_AND_IGF1R_DN"
19,"Up",0.78060610131836,0.939476521448411,"B.PvsV.REACTOME_ACTIVATION_OF_IRF3_IRF7_MEDIATED_BY_TBK1_IKK_EPSILON"
25,"Up",0.780941249702464,0.939476521448411,"B.PvsV.REACTOME_SYNTHESIS_OF_VERY_LONG_CHAIN_FATTY_ACYL_COAS"
258,"Down",0.78094304441615,0.939476521448411,"B.PvsV.MADAN_DPPA4_TARGETS"
9,"Down",0.781222691347679,0.93950362445134,"B.PvsV.CHEMELLO_SOLEUS_VS_EDL_MYOFIBERS_DN"
66,"Up",0.781305419646818,0.93950362445134,"B.PvsV.WEBER_METHYLATED_HCP_IN_FIBROBLAST_DN"
417,"Up",0.782110412488578,0.940267116905707,"B.PvsV.PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_UP"
13,"Up",0.7830010319039,0.940453493725679,"B.PvsV.BIOCARTA_GHRELIN_PATHWAY"
9,"Down",0.783364563104537,0.940453493725679,"B.PvsV.BRUNEAU_SEPTATION_ATRIAL"
32,"Down",0.783409292784499,0.940453493725679,"B.PvsV.REACTOME_HS_GAG_BIOSYNTHESIS"
7,"Down",0.783508635395917,0.940453493725679,"B.PvsV.BAKER_HEMATOPOESIS_STAT5_TARGETS"
91,"Up",0.783540146061936,0.940453493725679,"B.PvsV.DAUER_STAT3_TARGETS_DN"
1092,"Up",0.783556594512991,0.940453493725679,"B.PvsV.REACTOME_INFECTIOUS_DISEASE"
21,"Up",0.783565834085524,0.940453493725679,"B.PvsV.BIOCARTA_TH1TH2_PATHWAY"
5,"Down",0.783626197430675,0.940453493725679,"B.PvsV.REACTOME_ACTIVATION_OF_RAS_IN_B_CELLS"
7,"Down",0.784193009088857,0.940622491758845,"B.PvsV.REACTOME_DEX_H_BOX_HELICASES_ACTIVATE_TYPE_I_IFN_AND_INFLAMMATORY_CYTOKINES_PRODUCTION"
31,"Down",0.784198205643593,0.940622491758845,"B.PvsV.CARDOSO_RESPONSE_TO_GAMMA_RADIATION_AND_3AB"
89,"Down",0.7842773895837,0.940622491758845,"B.PvsV.REACTOME_PI_METABOLISM"
20,"Down",0.785082370829592,0.941225156464865,"B.PvsV.AMIT_EGF_RESPONSE_40_MCF10A"
259,"Down",0.785120351169463,0.941225156464865,"B.PvsV.MIKKELSEN_MCV6_LCP_WITH_H3K4ME3"
92,"Down",0.7854025600341,0.941359365798512,"B.PvsV.TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_UP"
43,"Down",0.786000449711521,0.941871800271999,"B.PvsV.FOURNIER_ACINAR_DEVELOPMENT_LATE_DN"
100,"Down",0.786245915149796,0.941961790869604,"B.PvsV.RAMASWAMY_METASTASIS_UP"
474,"Down",0.786432174620216,0.941980826142802,"B.PvsV.RIZKI_TUMOR_INVASIVENESS_3D_DN"
57,"Down",0.786626444224876,0.942009445553247,"B.PvsV.THILLAINADESAN_ZNF217_TARGETS_UP"
30,"Up",0.787317451930269,0.942532319055097,"B.PvsV.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_17"
29,"Down",0.787530854489058,0.942532319055097,"B.PvsV.COLLER_MYC_TARGETS_UP"
26,"Up",0.787657290956581,0.942532319055097,"B.PvsV.SA_G1_AND_S_PHASES"
5,"Up",0.78774495322004,0.942532319055097,"B.PvsV.BAFNA_MUC4_TARGETS_UP"
152,"Up",0.788331125169913,0.942574650884277,"B.PvsV.LIAN_LIPA_TARGETS_6M"
32,"Down",0.78852281320043,0.942574650884277,"B.PvsV.SCHMIDT_POR_TARGETS_IN_LIMB_BUD_DN"
33,"Up",0.788684395798591,0.942574650884277,"B.PvsV.HOWLIN_CITED1_TARGETS_2_UP"
107,"Down",0.78882276769005,0.942574650884277,"B.PvsV.SCIBETTA_KDM5B_TARGETS_DN"
6,"Up",0.788843296129468,0.942574650884277,"B.PvsV.REACTOME_N_GLYCAN_TRIMMING_AND_ELONGATION_IN_THE_CIS_GOLGI"
916,"Up",0.789094128706551,0.942574650884277,"B.PvsV.SWEET_LUNG_CANCER_KRAS_UP"
16,"Up",0.789250078716204,0.942574650884277,"B.PvsV.NIKOLSKY_BREAST_CANCER_1Q32_AMPLICON"
96,"Down",0.789364992101635,0.942574650884277,"B.PvsV.MIKKELSEN_ES_HCP_WITH_H3K27ME3"
6,"Down",0.789397072216021,0.942574650884277,"B.PvsV.REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_ENDOCRINE_COMMITTED_NEUROG3_PROGENITOR_CELLS"
39,"Up",0.789518159852505,0.942574650884277,"B.PvsV.REACTOME_NUCLEAR_SIGNALING_BY_ERBB4"
59,"Down",0.789847893560276,0.942574650884277,"B.PvsV.CAFFAREL_RESPONSE_TO_THC_24HR_5_UP"
200,"Down",0.789986299476403,0.942574650884277,"B.PvsV.GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_UP"
20,"Up",0.789996551310859,0.942574650884277,"B.PvsV.BIOCARTA_AKAPCENTROSOME_PATHWAY"
64,"Up",0.790389253858554,0.942839737774314,"B.PvsV.REACTOME_METABOLISM_OF_FAT_SOLUBLE_VITAMINS"
89,"Up",0.791137542796047,0.943517630075065,"B.PvsV.SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES"
14,"Down",0.791625333565223,0.943517630075065,"B.PvsV.REACTOME_ACETYLCHOLINE_BINDING_AND_DOWNSTREAM_EVENTS"
380,"Up",0.79172968867223,0.943517630075065,"B.PvsV.REACTOME_ANTI_INFLAMMATORY_RESPONSE_FAVOURING_LEISHMANIA_PARASITE_INFECTION"
19,"Up",0.791761591342236,0.943517630075065,"B.PvsV.REACTOME_INLB_MEDIATED_ENTRY_OF_LISTERIA_MONOCYTOGENES_INTO_HOST_CELL"
34,"Down",0.791810780167896,0.943517630075065,"B.PvsV.SOUCEK_MYC_TARGETS"
81,"Up",0.792494752387791,0.944129171719908,"B.PvsV.SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_UP"
10,"Down",0.792851665984044,0.944281525344857,"B.PvsV.IKEDA_MIR1_TARGETS_DN"
25,"Up",0.792964210919908,0.944281525344857,"B.PvsV.FINETTI_BREAST_CANCER_KINOME_GREEN"
465,"Up",0.793700507432829,0.944954803099938,"B.PvsV.HSIAO_LIVER_SPECIFIC_GENES"
24,"Up",0.794491578445811,0.945460019798032,"B.PvsV.BIOCARTA_ARF_PATHWAY"
187,"Up",0.794637317599665,0.945460019798032,"B.PvsV.ROSS_AML_WITH_AML1_ETO_FUSION"
17,"Down",0.794637857117283,0.945460019798032,"B.PvsV.BENPORATH_ES_CORE_NINE"
223,"Up",0.79514080819095,0.945800772479562,"B.PvsV.REACTOME_SEPARATION_OF_SISTER_CHROMATIDS"
75,"Up",0.795427428595498,0.945800772479562,"B.PvsV.CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN"
8,"Up",0.795719444261724,0.945800772479562,"B.PvsV.HOLLEMAN_DAUNORUBICIN_ALL_DN"
11,"Up",0.795781443072446,0.945800772479562,"B.PvsV.REACTOME_KETONE_BODY_METABOLISM"
127,"Up",0.795911627413961,0.945800772479562,"B.PvsV.REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK"
53,"Down",0.795950622960283,0.945800772479562,"B.PvsV.WANG_METASTASIS_OF_BREAST_CANCER_ESR1_DN"
34,"Up",0.796904731190644,0.946731039697694,"B.PvsV.KEGG_ALANINE_ASPARTATE_AND_GLUTAMATE_METABOLISM"
279,"Up",0.79789780476988,0.947686097001674,"B.PvsV.REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT"
44,"Up",0.798622530585426,0.947686097001674,"B.PvsV.YANG_BREAST_CANCER_ESR1_BULK_DN"
19,"Down",0.798691372733069,0.947686097001674,"B.PvsV.REACTOME_METABOLISM_OF_FOLATE_AND_PTERINES"
227,"Down",0.798708391560527,0.947686097001674,"B.PvsV.JACKSON_DNMT1_TARGETS_UP"
46,"Up",0.798982085420236,0.947686097001674,"B.PvsV.MEISSNER_BRAIN_ICP_WITH_H3K4ME3"
58,"Up",0.799150808844946,0.947686097001674,"B.PvsV.TOMLINS_PROSTATE_CANCER_UP"
10,"Down",0.799187300623172,0.947686097001674,"B.PvsV.LUDWICZEK_TREATING_IRON_OVERLOAD"
23,"Down",0.799237992890675,0.947686097001674,"B.PvsV.BIOCARTA_MITOCHONDRIA_PATHWAY"
969,"Up",0.799300709032634,0.947686097001674,"B.PvsV.RAO_BOUND_BY_SALL4_ISOFORM_B"
379,"Down",0.799422672529536,0.947686097001674,"B.PvsV.CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP"
497,"Down",0.799667756232665,0.947771882752355,"B.PvsV.DACOSTA_UV_RESPONSE_VIA_ERCC3_UP"
83,"Up",0.799837873923401,0.947771882752355,"B.PvsV.DAUER_STAT3_TARGETS_UP"
26,"Up",0.800874236217743,0.94846289086652,"B.PvsV.SCIBETTA_KDM5B_TARGETS_UP"
650,"Down",0.800937636474383,0.94846289086652,"B.PvsV.ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP"
129,"Down",0.801016712795984,0.94846289086652,"B.PvsV.REACTOME_POSITIVE_EPIGENETIC_REGULATION_OF_RRNA_EXPRESSION"
27,"Down",0.801205249725033,0.94846289086652,"B.PvsV.IGLESIAS_E2F_TARGETS_DN"
381,"Up",0.801278741768406,0.94846289086652,"B.PvsV.SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM1"
217,"Down",0.801481120576221,0.948499382633974,"B.PvsV.MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_UP"
141,"Up",0.802012749210328,0.948869998507984,"B.PvsV.NELSON_RESPONSE_TO_ANDROGEN_UP"
16,"Down",0.802137524511904,0.948869998507984,"B.PvsV.REACTOME_ERYTHROCYTES_TAKE_UP_OXYGEN_AND_RELEASE_CARBON_DIOXIDE"
409,"Down",0.80272509605516,0.948948694170448,"B.PvsV.PEDRIOLI_MIR31_TARGETS_UP"
96,"Up",0.802765481566856,0.948948694170448,"B.PvsV.CORRE_MULTIPLE_MYELOMA_DN"
11,"Up",0.802872338094385,0.948948694170448,"B.PvsV.REACTOME_BH3_ONLY_PROTEINS_ASSOCIATE_WITH_AND_INACTIVATE_ANTI_APOPTOTIC_BCL_2_MEMBERS"
15,"Down",0.802934374867536,0.948948694170448,"B.PvsV.REACTOME_SIGNALING_BY_FGFR4_IN_DISEASE"
92,"Up",0.803223692688608,0.948948694170448,"B.PvsV.BURTON_ADIPOGENESIS_7"
137,"Down",0.803437824208987,0.948948694170448,"B.PvsV.DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN"
455,"Down",0.803549213071772,0.948948694170448,"B.PvsV.SENESE_HDAC1_TARGETS_DN"
96,"Up",0.803577100037265,0.948948694170448,"B.PvsV.REACTOME_NONHOMOLOGOUS_END_JOINING_NHEJ"
16,"Down",0.804210104087628,0.949207475717846,"B.PvsV.REACTOME_GOLGI_CISTERNAE_PERICENTRIOLAR_STACK_REORGANIZATION"
36,"Down",0.804290152741263,0.949207475717846,"B.PvsV.REACTOME_DIGESTION"
9,"Down",0.804467042913151,0.949207475717846,"B.PvsV.REACTOME_PHOSPHATE_BOND_HYDROLYSIS_BY_NTPDASE_PROTEINS"
120,"Down",0.804482950120062,0.949207475717846,"B.PvsV.BILD_CTNNB1_ONCOGENIC_SIGNATURE"
80,"Up",0.805587970980424,0.950308489769739,"B.PvsV.REACTOME_TRANSCRIPTIONAL_REGULATION_BY_MECP2"
78,"Down",0.806374710244697,0.950807170343847,"B.PvsV.WANG_METHYLATED_IN_BREAST_CANCER"
983,"Down",0.806557534796547,0.950807170343847,"B.PvsV.HAMAI_APOPTOSIS_VIA_TRAIL_UP"
106,"Down",0.806667416092715,0.950807170343847,"B.PvsV.RICKMAN_HEAD_AND_NECK_CANCER_B"
9,"Up",0.806839057511175,0.950807170343847,"B.PvsV.REACTOME_LECTIN_PATHWAY_OF_COMPLEMENT_ACTIVATION"
145,"Up",0.806870544990655,0.950807170343847,"B.PvsV.YU_MYC_TARGETS_DN"
78,"Down",0.807266112423493,0.951070602085977,"B.PvsV.KIM_ALL_DISORDERS_CALB1_CORR_DN"
22,"Down",0.807481199305155,0.951121335951896,"B.PvsV.BIOCARTA_CALCINEURIN_PATHWAY"
229,"Down",0.807698524973929,0.951174684681757,"B.PvsV.MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_DN"
210,"Up",0.808233462882405,0.951318546536358,"B.PvsV.HOELZEL_NF1_TARGETS_DN"
270,"Up",0.808312342540907,0.951318546536358,"B.PvsV.KIM_WT1_TARGETS_8HR_UP"
61,"Down",0.80840028776156,0.951318546536358,"B.PvsV.GENTILE_UV_RESPONSE_CLUSTER_D2"
33,"Up",0.80850892569621,0.951318546536358,"B.PvsV.REACTOME_SYNTHESIS_OF_PROSTAGLANDINS_PG_AND_THROMBOXANES_TX"
169,"Up",0.808689251626009,0.951328270689405,"B.PvsV.KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_DN"
28,"Up",0.808989463674128,0.951478992693949,"B.PvsV.HOWLIN_CITED1_TARGETS_2_DN"
168,"Up",0.809689411542683,0.952099692985856,"B.PvsV.LINDGREN_BLADDER_CANCER_CLUSTER_1_UP"
14,"Up",0.810277724887098,0.952195271596232,"B.PvsV.REACTOME_SUMOYLATION_OF_IMMUNE_RESPONSE_PROTEINS"
29,"Up",0.810628939390112,0.952195271596232,"B.PvsV.MULLIGAN_NTF3_SIGNALING_VIA_INSR_AND_IGF1R_UP"
190,"Down",0.810739723849677,0.952195271596232,"B.PvsV.KEGG_CALCIUM_SIGNALING_PATHWAY"
224,"Down",0.811124978630422,0.952195271596232,"B.PvsV.REACTOME_INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC"
1526,"Up",0.811131811699005,0.952195271596232,"B.PvsV.MARSON_BOUND_BY_FOXP3_UNSTIMULATED"
32,"Down",0.81134208898624,0.952195271596232,"B.PvsV.REACTOME_SEMA3A_PAK_DEPENDENT_AXON_REPULSION"
22,"Down",0.811521252191176,0.952195271596232,"B.PvsV.REACTOME_SHC_MEDIATED_CASCADE_FGFR4"
23,"Up",0.811605725859607,0.952195271596232,"B.PvsV.REACTOME_APOPTOTIC_FACTOR_MEDIATED_RESPONSE"
51,"Up",0.811640245870827,0.952195271596232,"B.PvsV.EHLERS_ANEUPLOIDY_UP"
54,"Up",0.811659162467522,0.952195271596232,"B.PvsV.ZHAN_EARLY_DIFFERENTIATION_GENES_DN"
6,"Up",0.811665095864179,0.952195271596232,"B.PvsV.REACTOME_NADE_MODULATES_DEATH_SIGNALLING"
1739,"Down",0.811969726909848,0.952350577022603,"B.PvsV.GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP"
307,"Down",0.812396890374381,0.952460387236776,"B.PvsV.SMID_BREAST_CANCER_ERBB2_UP"
138,"Down",0.812558952293085,0.952460387236776,"B.PvsV.REACTOME_GLYCOSAMINOGLYCAN_METABOLISM"
119,"Up",0.812580149501876,0.952460387236776,"B.PvsV.BRUNO_HEMATOPOIESIS"
45,"Up",0.813189220740744,0.952611442913507,"B.PvsV.PID_EPHA_FWDPATHWAY"
122,"Down",0.813317954438491,0.952611442913507,"B.PvsV.CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_UP"
111,"Down",0.813394705894239,0.952611442913507,"B.PvsV.REACTOME_B_WICH_COMPLEX_POSITIVELY_REGULATES_RRNA_EXPRESSION"
96,"Up",0.813426923214742,0.952611442913507,"B.PvsV.MUELLER_METHYLATED_IN_GLIOBLASTOMA"
52,"Up",0.813570488955974,0.952611442913507,"B.PvsV.REACTOME_SIGNALING_BY_FGFR4"
87,"Down",0.814018322890806,0.952811181694025,"B.PvsV.SATO_SILENCED_BY_DEACETYLATION_IN_PANCREATIC_CANCER"
25,"Up",0.81408573382575,0.952811181694025,"B.PvsV.REACTOME_INTERLEUKIN_20_FAMILY_SIGNALING"
37,"Down",0.814782341799846,0.953268779739021,"B.PvsV.KEGG_ETHER_LIPID_METABOLISM"
14,"Down",0.814872203261074,0.953268779739021,"B.PvsV.BIOCARTA_AKAP13_PATHWAY"
250,"Down",0.814993944985776,0.953268779739021,"B.PvsV.TAVAZOIE_METASTASIS"
89,"Up",0.815747138607553,0.953784646553269,"B.PvsV.LINDGREN_BLADDER_CANCER_HIGH_RECURRENCE"
26,"Down",0.815779995216207,0.953784646553269,"B.PvsV.BIOCARTA_LAIR_PATHWAY"
16,"Up",0.816680259320164,0.95404801564463,"B.PvsV.REACTOME_EGFR_TRANSACTIVATION_BY_GASTRIN"
29,"Down",0.817267801781387,0.95404801564463,"B.PvsV.PID_HEDGEHOG_2PATHWAY"
7,"Up",0.817269673019824,0.95404801564463,"B.PvsV.REACTOME_CLEC7A_INFLAMMASOME_PATHWAY"
60,"Down",0.817286859203587,0.95404801564463,"B.PvsV.REACTOME_SYNTHESIS_OF_PIPS_AT_THE_PLASMA_MEMBRANE"
68,"Down",0.817311752166494,0.95404801564463,"B.PvsV.YANG_BREAST_CANCER_ESR1_LASER_DN"
36,"Down",0.817738135107792,0.95404801564463,"B.PvsV.GAVIN_PDE3B_TARGETS"
115,"Up",0.817801434519837,0.95404801564463,"B.PvsV.REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX"
14,"Up",0.817803676278759,0.95404801564463,"B.PvsV.BIOCARTA_CTBP1_PATHWAY"
238,"Down",0.817880713955967,0.95404801564463,"B.PvsV.TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN"
30,"Up",0.817899176127203,0.95404801564463,"B.PvsV.REACTOME_RHO_GTPASES_ACTIVATE_NADPH_OXIDASES"
66,"Down",0.818027254433751,0.95404801564463,"B.PvsV.VALK_AML_WITH_CEBPA"
10,"Up",0.818075898385096,0.95404801564463,"B.PvsV.BIOCARTA_PEPI_PATHWAY"
89,"Up",0.818681089250448,0.954552455180457,"B.PvsV.REACTOME_DEPOSITION_OF_NEW_CENPA_CONTAINING_NUCLEOSOMES_AT_THE_CENTROMERE"
20,"Up",0.819290393082785,0.955061476566459,"B.PvsV.MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_UP"
108,"Down",0.819712442028998,0.955352042997118,"B.PvsV.GAVIN_FOXP3_TARGETS_CLUSTER_P2"
260,"Up",0.819899598094065,0.955368783532579,"B.PvsV.DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN"
273,"Down",0.820491010135199,0.955737815226583,"B.PvsV.VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP"
1901,"Up",0.820725450952308,0.955737815226583,"B.PvsV.REACTOME_DISEASE"
25,"Down",0.820888784061981,0.955737815226583,"B.PvsV.REACTOME_NUCLEOTIDE_SALVAGE"
1236,"Up",0.821057871814387,0.955737815226583,"B.PvsV.NUYTTEN_NIPP1_TARGETS_DN"
52,"Up",0.821080597273697,0.955737815226583,"B.PvsV.WOTTON_RUNX_TARGETS_DN"
10,"Up",0.821425857533553,0.955879858593286,"B.PvsV.GALIE_TUMOR_ANGIOGENESIS"
80,"Up",0.821548397184897,0.955879858593286,"B.PvsV.LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_DN"
296,"Up",0.822247907313508,0.956248874823028,"B.PvsV.SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP"
303,"Down",0.822293756686701,0.956248874823028,"B.PvsV.FIGUEROA_AML_METHYLATION_CLUSTER_3_UP"
33,"Up",0.822384409438144,0.956248874823028,"B.PvsV.BIOCARTA_CYTOKINE_PATHWAY"
350,"Down",0.822839391227373,0.956385315094242,"B.PvsV.RODWELL_AGING_KIDNEY_NO_BLOOD_UP"
81,"Down",0.822847701917762,0.956385315094242,"B.PvsV.TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP"
202,"Up",0.82313543120953,0.956518663126837,"B.PvsV.MOREAUX_MULTIPLE_MYELOMA_BY_TACI_DN"
16,"Up",0.823545436909853,0.956794015691232,"B.PvsV.REACTOME_GLUCOCORTICOID_BIOSYNTHESIS"
164,"Up",0.824082179211151,0.956914457703918,"B.PvsV.XU_HGF_TARGETS_REPRESSED_BY_AKT1_DN"
39,"Down",0.824130091614881,0.956914457703918,"B.PvsV.REACTOME_TNFR1_INDUCED_NFKAPPAB_SIGNALING_PATHWAY"
18,"Up",0.824168321140542,0.956914457703918,"B.PvsV.BIOCARTA_LYM_PATHWAY"
13,"Down",0.824621007104977,0.95705084456502,"B.PvsV.REACTOME_ALPHA_PROTEIN_KINASE_1_SIGNALING_PATHWAY"
32,"Down",0.824776101458492,0.95705084456502,"B.PvsV.WANG_LSD1_TARGETS_UP"
22,"Down",0.824805077654607,0.95705084456502,"B.PvsV.ISHIKAWA_STING_SIGNALING"
63,"Down",0.825311999226402,0.957438112405115,"B.PvsV.STREICHER_LSM1_TARGETS_UP"
301,"Up",0.825610155227529,0.957558053338189,"B.PvsV.KIM_WT1_TARGETS_12HR_DN"
12,"Up",0.825785605994239,0.957558053338189,"B.PvsV.REACTOME_INTERLEUKIN_23_SIGNALING"
60,"Up",0.826232723316164,0.957558053338189,"B.PvsV.TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_DN"
184,"Down",0.826291655961772,0.957558053338189,"B.PvsV.FIGUEROA_AML_METHYLATION_CLUSTER_1_UP"
31,"Down",0.826593232696983,0.957558053338189,"B.PvsV.BOYAULT_LIVER_CANCER_SUBCLASS_G6_DN"
112,"Up",0.826885382455133,0.957558053338189,"B.PvsV.REACTOME_DNA_DOUBLE_STRAND_BREAK_RESPONSE"
19,"Down",0.827039000734762,0.957558053338189,"B.PvsV.MINGUEZ_LIVER_CANCER_VASCULAR_INVASION_UP"
39,"Up",0.827076390669004,0.957558053338189,"B.PvsV.PID_INTEGRIN2_PATHWAY"
31,"Down",0.827146900074683,0.957558053338189,"B.PvsV.BIOCARTA_AKT_PATHWAY"
27,"Down",0.827204285464787,0.957558053338189,"B.PvsV.REACTOME_TGF_BETA_RECEPTOR_SIGNALING_IN_EMT_EPITHELIAL_TO_MESENCHYMAL_TRANSITION"
9,"Down",0.827480172787462,0.957558053338189,"B.PvsV.TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_GRANULOCYTE_DN"
379,"Up",0.827493647829601,0.957558053338189,"B.PvsV.PHONG_TNF_RESPONSE_VIA_P38_COMPLETE"
159,"Down",0.828011211355373,0.957956473652199,"B.PvsV.FIGUEROA_AML_METHYLATION_CLUSTER_4_UP"
143,"Up",0.828221153526578,0.957998903315575,"B.PvsV.LIN_APC_TARGETS"
81,"Up",0.828631870554354,0.958019974782324,"B.PvsV.VANTVEER_BREAST_CANCER_BRCA1_DN"
459,"Up",0.828648006098797,0.958019974782324,"B.PvsV.LU_AGING_BRAIN_UP"
73,"Down",0.828759185998166,0.958019974782324,"B.PvsV.LUI_TARGETS_OF_PAX8_PPARG_FUSION"
13,"Down",0.829568126723301,0.958176858745573,"B.PvsV.KEGG_NON_HOMOLOGOUS_END_JOINING"
67,"Down",0.829726623480612,0.958176858745573,"B.PvsV.FIRESTEIN_CTNNB1_PATHWAY"
566,"Down",0.8300439363016,0.958176858745573,"B.PvsV.SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP"
126,"Down",0.830100597383656,0.958176858745573,"B.PvsV.LEE_LIVER_CANCER_ACOX1_DN"
1407,"Down",0.83032781127871,0.958176858745573,"B.PvsV.BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_A"
640,"Down",0.830456233800426,0.958176858745573,"B.PvsV.LU_EZH2_TARGETS_DN"
9,"Up",0.830640833685845,0.958176858745573,"B.PvsV.REACTOME_2_LTR_CIRCLE_FORMATION"
22,"Down",0.830655948014211,0.958176858745573,"B.PvsV.TSUNODA_CISPLATIN_RESISTANCE_UP"
58,"Down",0.830723498232564,0.958176858745573,"B.PvsV.PID_FOXO_PATHWAY"
9,"Up",0.830784378103373,0.958176858745573,"B.PvsV.REACTOME_SYNTHESIS_OF_PG"
380,"Down",0.830857275154691,0.958176858745573,"B.PvsV.WAMUNYOKOLI_OVARIAN_CANCER_LMP_UP"
436,"Down",0.831205547895343,0.958176858745573,"B.PvsV.MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED"
78,"Up",0.831349909306448,0.958176858745573,"B.PvsV.MIDORIKAWA_AMPLIFIED_IN_LIVER_CANCER"
28,"Down",0.83137997591876,0.958176858745573,"B.PvsV.RAMPON_ENRICHED_LEARNING_ENVIRONMENT_EARLY_UP"
244,"Down",0.831540165121807,0.958176858745573,"B.PvsV.FIRESTEIN_PROLIFERATION"
102,"Up",0.83166770575511,0.958176858745573,"B.PvsV.MCCLUNG_CREB1_TARGETS_DN"
291,"Down",0.832482146689387,0.958915372717837,"B.PvsV.SHEPARD_BMYB_MORPHOLINO_UP"
42,"Down",0.832907085860877,0.959205015147842,"B.PvsV.PID_S1P_S1P1_PATHWAY"
343,"Up",0.833309802877552,0.95940784453396,"B.PvsV.GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP"
381,"Up",0.833519179864203,0.95940784453396,"B.PvsV.MCBRYAN_PUBERTAL_BREAST_3_4WK_UP"
11,"Up",0.833730216464855,0.95940784453396,"B.PvsV.BIOCARTA_ERBB4_PATHWAY"
56,"Down",0.833777300232534,0.95940784453396,"B.PvsV.HUMMERICH_MALIGNANT_SKIN_TUMOR_DN"
152,"Up",0.834353268023025,0.959587017933144,"B.PvsV.REACTOME_GOLGI_TO_ER_RETROGRADE_TRANSPORT"
227,"Up",0.834372564118086,0.959587017933144,"B.PvsV.REACTOME_FCGR3A_MEDIATED_IL10_SYNTHESIS"
15,"Up",0.834492787949821,0.959587017933144,"B.PvsV.REACTOME_HEME_BIOSYNTHESIS"
82,"Up",0.834627232635285,0.959587017933144,"B.PvsV.PID_FGF_PATHWAY"
120,"Up",0.835220658136764,0.959987911747902,"B.PvsV.HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_DN"
89,"Up",0.83565278448238,0.959987911747902,"B.PvsV.KOHOUTEK_CCNT1_TARGETS"
168,"Down",0.83571233870277,0.959987911747902,"B.PvsV.TOOKER_GEMCITABINE_RESISTANCE_DN"
36,"Up",0.835812679626353,0.959987911747902,"B.PvsV.REACTOME_GLUCAGON_TYPE_LIGAND_RECEPTORS"
48,"Up",0.835994476567439,0.959987911747902,"B.PvsV.LOPEZ_MBD_TARGETS_IMPRINTED_AND_X_LINKED"
119,"Up",0.836017687658916,0.959987911747902,"B.PvsV.HOWLIN_PUBERTAL_MAMMARY_GLAND"
40,"Up",0.83691881106787,0.960527775583128,"B.PvsV.VANASSE_BCL2_TARGETS_UP"
104,"Up",0.836921242273628,0.960527775583128,"B.PvsV.BARIS_THYROID_CANCER_DN"
18,"Up",0.837009011170105,0.960527775583128,"B.PvsV.REACTOME_WNT5A_DEPENDENT_INTERNALIZATION_OF_FZD2_FZD5_AND_ROR2"
14,"Down",0.837228640973486,0.960580443233534,"B.PvsV.BIOCARTA_DSP_PATHWAY"
17,"Up",0.837480890371889,0.960664683181993,"B.PvsV.NIKOLSKY_BREAST_CANCER_14Q22_AMPLICON"
312,"Down",0.837811967089298,0.960664683181993,"B.PvsV.GERY_CEBP_TARGETS"
32,"Down",0.837823313854869,0.960664683181993,"B.PvsV.REACTOME_INTRINSIC_PATHWAY_OF_FIBRIN_CLOT_FORMATION"
103,"Up",0.838161580911253,0.960853282367473,"B.PvsV.LINDVALL_IMMORTALIZED_BY_TERT_UP"
140,"Up",0.838463888586833,0.961000588722347,"B.PvsV.REACTOME_SLC_TRANSPORTER_DISORDERS"
26,"Down",0.838923378235614,0.961155717957803,"B.PvsV.BARRIER_COLON_CANCER_RECURRENCE_DN"
56,"Up",0.839199146454433,0.961155717957803,"B.PvsV.DAIRKEE_CANCER_PRONE_RESPONSE_E2"
142,"Down",0.839447256788164,0.961155717957803,"B.PvsV.REACTOME_VISUAL_PHOTOTRANSDUCTION"
63,"Down",0.839645834462275,0.961155717957803,"B.PvsV.KEGG_NON_SMALL_CELL_LUNG_CANCER"
33,"Down",0.839783654055031,0.961155717957803,"B.PvsV.TURASHVILI_BREAST_CARCINOMA_DUCTAL_VS_LOBULAR_UP"
1333,"Up",0.839787963092559,0.961155717957803,"B.PvsV.KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_DN"
83,"Up",0.839816110228639,0.961155717957803,"B.PvsV.REACTOME_CA2_PATHWAY"
26,"Up",0.840422601732291,0.96117406770157,"B.PvsV.PHESSE_TARGETS_OF_APC_AND_MBD2_UP"
85,"Down",0.840440913973194,0.96117406770157,"B.PvsV.DUNNE_TARGETS_OF_AML1_MTG8_FUSION_UP"
57,"Up",0.840497217047472,0.96117406770157,"B.PvsV.PID_ATM_PATHWAY"
39,"Up",0.840560970374134,0.96117406770157,"B.PvsV.KOBAYASHI_EGFR_SIGNALING_6HR_DN"
38,"Down",0.840872877658361,0.96117406770157,"B.PvsV.CHOW_RASSF1_TARGETS_UP"
11,"Up",0.840875197227798,0.96117406770157,"B.PvsV.BIOCARTA_ALTERNATIVE_PATHWAY"
27,"Up",0.841162131127318,0.961233751694873,"B.PvsV.REACTOME_PHASE_2_PLATEAU_PHASE"
195,"Down",0.84127511746274,0.961233751694873,"B.PvsV.FIGUEROA_AML_METHYLATION_CLUSTER_7_UP"
171,"Down",0.841585465665949,0.961378031336595,"B.PvsV.WOOD_EBV_EBNA1_TARGETS_UP"
175,"Up",0.841749149882521,0.961378031336595,"B.PvsV.COATES_MACROPHAGE_M1_VS_M2_DN"
16,"Up",0.842161068666174,0.961494127659627,"B.PvsV.CHESLER_BRAIN_D6MIT150_QTL_TRANS"
759,"Down",0.842198600154743,0.961494127659627,"B.PvsV.FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN"
23,"Up",0.842403592332645,0.961529616434185,"B.PvsV.GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN"
203,"Down",0.842758131044979,0.961735749545447,"B.PvsV.CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN"
37,"Down",0.84313268862587,0.961964637930755,"B.PvsV.GHO_ATF5_TARGETS_UP"
14,"Down",0.843890995534362,0.962325214998979,"B.PvsV.BIOCARTA_SRCRPTP_PATHWAY"
266,"Up",0.843922446505654,0.962325214998979,"B.PvsV.MIKKELSEN_IPS_LCP_WITH_H3K4ME3"
6,"Down",0.843970874937611,0.962325214998979,"B.PvsV.REACTOME_SYNTHESIS_OF_PI"
24,"Down",0.84531286396104,0.962875192297568,"B.PvsV.REACTOME_RORA_ACTIVATES_GENE_EXPRESSION"
14,"Up",0.845399882707505,0.962875192297568,"B.PvsV.GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_DN"
38,"Up",0.845666862206782,0.962875192297568,"B.PvsV.VALK_AML_CLUSTER_8"
10,"Down",0.845696740781436,0.962875192297568,"B.PvsV.BIOCARTA_TERT_PATHWAY"
24,"Up",0.845719525138589,0.962875192297568,"B.PvsV.BIOCARTA_HCMV_PATHWAY"
309,"Up",0.845833081549866,0.962875192297568,"B.PvsV.CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_UP"
143,"Down",0.845962939720855,0.962875192297568,"B.PvsV.SCHLOSSER_SERUM_RESPONSE_AUGMENTED_BY_MYC"
16,"Up",0.846174023296233,0.962875192297568,"B.PvsV.REACTOME_SYNTHESIS_OF_IP2_IP_AND_INS_IN_THE_CYTOSOL"
104,"Up",0.846190687287833,0.962875192297568,"B.PvsV.REACTOME_HDACS_DEACETYLATE_HISTONES"
23,"Down",0.846194711407829,0.962875192297568,"B.PvsV.REACTOME_SYNAPTIC_ADHESION_LIKE_MOLECULES"
38,"Up",0.846579702619773,0.963115056745828,"B.PvsV.SESTO_RESPONSE_TO_UV_C4"
179,"Down",0.84773273719711,0.96400737339111,"B.PvsV.REACTOME_AUTOPHAGY"
445,"Up",0.84808545953701,0.96400737339111,"B.PvsV.HORIUCHI_WTAP_TARGETS_DN"
8,"Up",0.848558727316182,0.96400737339111,"B.PvsV.REACTOME_AMINO_ACID_CONJUGATION"
8,"Up",0.848558727316182,0.96400737339111,"B.PvsV.REACTOME_CONJUGATION_OF_BENZOATE_WITH_GLYCINE"
126,"Up",0.848838638432287,0.96400737339111,"B.PvsV.YAO_HOXA10_TARGETS_VIA_PROGESTERONE_UP"
34,"Up",0.848892043538035,0.96400737339111,"B.PvsV.KAPOSI_LIVER_CANCER_MET_UP"
384,"Down",0.849046921796611,0.96400737339111,"B.PvsV.SERVITJA_ISLET_HNF1A_TARGETS_UP"
11,"Down",0.849373027454306,0.96400737339111,"B.PvsV.REACTOME_SPERM_MOTILITY_AND_TAXES"
141,"Up",0.849553005234921,0.96400737339111,"B.PvsV.CROONQUIST_STROMAL_STIMULATION_UP"
73,"Up",0.849782589373771,0.96400737339111,"B.PvsV.CHANGOLKAR_H2AFY_TARGETS_UP"
45,"Down",0.849961630487218,0.96400737339111,"B.PvsV.SUMI_HNF4A_TARGETS"
875,"Up",0.850257815126016,0.96400737339111,"B.PvsV.BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_B"
80,"Up",0.850577262899368,0.96400737339111,"B.PvsV.REACTOME_APOPTOTIC_EXECUTION_PHASE"
27,"Up",0.850723879869257,0.96400737339111,"B.PvsV.KASLER_HDAC7_TARGETS_1_DN"
496,"Up",0.85077459849208,0.96400737339111,"B.PvsV.VERHAAK_AML_WITH_NPM1_MUTATED_DN"
12,"Up",0.85091213902999,0.96400737339111,"B.PvsV.LY_AGING_OLD_UP"
154,"Down",0.85092204967043,0.96400737339111,"B.PvsV.REN_ALVEOLAR_RHABDOMYOSARCOMA_UP"
30,"Down",0.850954277522133,0.96400737339111,"B.PvsV.BIOCARTA_CCR5_PATHWAY"
11,"Up",0.851054133510887,0.96400737339111,"B.PvsV.NIKOLSKY_BREAST_CANCER_17P11_AMPLICON"
113,"Down",0.851073246690816,0.96400737339111,"B.PvsV.BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_UP"
16,"Down",0.85126118360994,0.96400737339111,"B.PvsV.REACTOME_TICAM1_DEPENDENT_ACTIVATION_OF_IRF3_IRF7"
11,"Down",0.851362147222539,0.96400737339111,"B.PvsV.REACTOME_SYNTHESIS_OF_LIPOXINS_LX"
122,"Down",0.851374209489743,0.96400737339111,"B.PvsV.BOYLAN_MULTIPLE_MYELOMA_D_DN"
233,"Up",0.853085269787671,0.965448663234881,"B.PvsV.CHEBOTAEV_GR_TARGETS_DN"
274,"Up",0.853190663562014,0.965448663234881,"B.PvsV.CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN"
96,"Down",0.853376644807965,0.965448663234881,"B.PvsV.REACTOME_GLOBAL_GENOME_NUCLEOTIDE_EXCISION_REPAIR_GG_NER"
107,"Up",0.853515406729922,0.965448663234881,"B.PvsV.BERNARD_PPAPDC1B_TARGETS_DN"
17,"Up",0.85354136847934,0.965448663234881,"B.PvsV.BIOCARTA_RANBP2_PATHWAY"
49,"Down",0.853694793734008,0.965448663234881,"B.PvsV.REACTOME_METABOLISM_OF_PORPHYRINS"
482,"Up",0.854627440209606,0.965898345932638,"B.PvsV.HOLLMANN_APOPTOSIS_VIA_CD40_DN"
110,"Up",0.854635882502702,0.965898345932638,"B.PvsV.REACTOME_POTASSIUM_CHANNELS"
11,"Down",0.85498814539746,0.965898345932638,"B.PvsV.REACTOME_PHENYLALANINE_METABOLISM"
53,"Down",0.855001027635908,0.965898345932638,"B.PvsV.SESTO_RESPONSE_TO_UV_C6"
63,"Down",0.855044326738595,0.965898345932638,"B.PvsV.ZHAN_MULTIPLE_MYELOMA_CD2_UP"
390,"Down",0.85519297742064,0.965898345932638,"B.PvsV.REACTOME_SIGNALING_BY_NUCLEAR_RECEPTORS"
158,"Down",0.855315301444419,0.965898345932638,"B.PvsV.REACTOME_HATS_ACETYLATE_HISTONES"
1013,"Down",0.856330934404583,0.966847812195822,"B.PvsV.MARTINEZ_RB1_TARGETS_DN"
83,"Down",0.856677311651658,0.967041416113111,"B.PvsV.KEGG_VEGF_SIGNALING_PATHWAY"
113,"Down",0.857079069391426,0.967088325505114,"B.PvsV.LEIN_OLIGODENDROCYTE_MARKERS"
8,"Up",0.85728549833959,0.967088325505114,"B.PvsV.SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX6_DN"
18,"Down",0.85737041562379,0.967088325505114,"B.PvsV.BIOCARTA_CLASSIC_PATHWAY"
30,"Up",0.857418515396286,0.967088325505114,"B.PvsV.YIH_RESPONSE_TO_ARSENITE_C2"
58,"Up",0.857767884294455,0.967211474649293,"B.PvsV.BAE_BRCA1_TARGETS_DN"
263,"Down",0.857919240005916,0.967211474649293,"B.PvsV.REACTOME_BINDING_AND_UPTAKE_OF_LIGANDS_BY_SCAVENGER_RECEPTORS"
12,"Up",0.858052501927073,0.967211474649293,"B.PvsV.REACTOME_FRUCTOSE_METABOLISM"
11,"Up",0.858249677734456,0.967236540602081,"B.PvsV.REACTOME_ARYL_HYDROCARBON_RECEPTOR_SIGNALLING"
76,"Down",0.858658490765004,0.967358621243813,"B.PvsV.CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_UP"
10,"Down",0.858786321752227,0.967358621243813,"B.PvsV.CHANG_POU5F1_TARGETS_DN"
25,"Down",0.858882885094208,0.967358621243813,"B.PvsV.YIH_RESPONSE_TO_ARSENITE_C4"
6,"Down",0.859229261822603,0.967387190752623,"B.PvsV.REACTOME_VLDL_ASSEMBLY"
12,"Up",0.859258182996226,0.967387190752623,"B.PvsV.REACTOME_FGFR2B_LIGAND_BINDING_AND_ACTIVATION"
72,"Down",0.859928160635065,0.967760223965732,"B.PvsV.ZHAN_MULTIPLE_MYELOMA_LB_UP"
756,"Up",0.859939587691019,0.967760223965732,"B.PvsV.ZHENG_BOUND_BY_FOXP3"
11,"Down",0.860821768641899,0.968555872775958,"B.PvsV.REACTOME_PYRIMIDINE_SALVAGE"
11,"Down",0.861404648114017,0.968874606272604,"B.PvsV.REACTOME_SCAVENGING_BY_CLASS_B_RECEPTORS"
71,"Up",0.861455518979223,0.968874606272604,"B.PvsV.REACTOME_RECOGNITION_AND_ASSOCIATION_OF_DNA_GLYCOSYLASE_WITH_SITE_CONTAINING_AN_AFFECTED_PURINE"
41,"Down",0.861798491085222,0.969034524599633,"B.PvsV.TUOMISTO_TUMOR_SUPPRESSION_BY_COL13A1_DN"
20,"Up",0.862004217291048,0.969034524599633,"B.PvsV.GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_2"
78,"Down",0.862200192664333,0.969034524599633,"B.PvsV.RICKMAN_HEAD_AND_NECK_CANCER_D"
91,"Down",0.862384171721709,0.969034524599633,"B.PvsV.ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_UP"
20,"Up",0.862474027049158,0.969034524599633,"B.PvsV.REACTOME_ENOS_ACTIVATION"
324,"Up",0.86271084822633,0.969035350722237,"B.PvsV.GRUETZMANN_PANCREATIC_CANCER_DN"
161,"Up",0.862825290577965,0.969035350722237,"B.PvsV.FRASOR_RESPONSE_TO_ESTRADIOL_DN"
9,"Up",0.863609810672042,0.969068819901311,"B.PvsV.REACTOME_HIGHLY_SODIUM_PERMEABLE_POSTSYNAPTIC_ACETYLCHOLINE_NICOTINIC_RECEPTORS"
95,"Up",0.863652822853495,0.969068819901311,"B.PvsV.REACTOME_EXTRA_NUCLEAR_ESTROGEN_SIGNALING"
6,"Up",0.863822631447567,0.969068819901311,"B.PvsV.REACTOME_TNFR1_MEDIATED_CERAMIDE_PRODUCTION"
44,"Up",0.863857319154015,0.969068819901311,"B.PvsV.VALK_AML_CLUSTER_7"
15,"Down",0.863859727116985,0.969068819901311,"B.PvsV.REACTOME_PI3K_EVENTS_IN_ERBB4_SIGNALING"
17,"Up",0.863906712478488,0.969068819901311,"B.PvsV.BRUNEAU_SEPTATION_VENTRICULAR"
81,"Down",0.864558903491054,0.969603687099805,"B.PvsV.NEWMAN_ERCC6_TARGETS_DN"
30,"Down",0.865217445224403,0.970145458253037,"B.PvsV.KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_UP"
965,"Down",0.866162713305833,0.971008443201125,"B.PvsV.PATIL_LIVER_CANCER"
770,"Up",0.866468179633583,0.971127503534483,"B.PvsV.BOCHKIS_FOXA2_TARGETS"
89,"Down",0.86662020300943,0.971127503534483,"B.PvsV.CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_UP"
12,"Up",0.867630768937103,0.971771703314686,"B.PvsV.REACTOME_TRANSPORT_OF_NUCLEOSIDES_AND_FREE_PURINE_AND_PYRIMIDINE_BASES_ACROSS_THE_PLASMA_MEMBRANE"
612,"Up",0.867816189674575,0.971771703314686,"B.PvsV.HELLER_SILENCED_BY_METHYLATION_UP"
25,"Up",0.868119606129105,0.971771703314686,"B.PvsV.MIKKELSEN_ES_LCP_WITH_H3K27ME3"
48,"Up",0.868167840692142,0.971771703314686,"B.PvsV.DELPUECH_FOXO3_TARGETS_DN"
100,"Down",0.868394280700483,0.971771703314686,"B.PvsV.DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP"
439,"Down",0.868459539568452,0.971771703314686,"B.PvsV.MCBRYAN_PUBERTAL_BREAST_4_5WK_UP"
14,"Down",0.868562526197811,0.971771703314686,"B.PvsV.REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_SEVERAL_ADDITIONAL_CELL_DEATH_GENES_WHOSE_SPECIFIC_ROLES_IN_P53_DEPENDENT_APOPTOSIS_REMAIN_UNCERTAIN"
17,"Up",0.868745572225872,0.971771703314686,"B.PvsV.FIGUEROA_AML_METHYLATION_CLUSTER_5_UP"
50,"Up",0.869046646367005,0.971771703314686,"B.PvsV.REACTOME_INTRA_GOLGI_TRAFFIC"
39,"Up",0.869147841593558,0.971771703314686,"B.PvsV.ZHAN_V1_LATE_DIFFERENTIATION_GENES_DN"
160,"Up",0.869277257252448,0.971771703314686,"B.PvsV.GAVIN_FOXP3_TARGETS_CLUSTER_P7"
12,"Up",0.869373138022356,0.971771703314686,"B.PvsV.NAGY_STAGA_COMPONENTS_HUMAN"
200,"Up",0.869569032002939,0.971771703314686,"B.PvsV.ALTEMEIER_RESPONSE_TO_LPS_WITH_MECHANICAL_VENTILATION"
214,"Up",0.869778160019679,0.971771703314686,"B.PvsV.RASHI_RESPONSE_TO_IONIZING_RADIATION_2"
206,"Down",0.8698314631406,0.971771703314686,"B.PvsV.HOLLERN_EMT_BREAST_TUMOR_DN"
173,"Up",0.870764039494617,0.972190046447742,"B.PvsV.HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_UP"
978,"Down",0.870883596234414,0.972190046447742,"B.PvsV.MILI_PSEUDOPODIA_HAPTOTAXIS_DN"
1329,"Down",0.870918357000889,0.972190046447742,"B.PvsV.KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_UP"
23,"Down",0.871005143390568,0.972190046447742,"B.PvsV.HE_PTEN_TARGETS_UP"
29,"Up",0.871403388280813,0.972190046447742,"B.PvsV.REACTOME_ACTIVATION_OF_AMPK_DOWNSTREAM_OF_NMDARS"
504,"Down",0.871465026078151,0.972190046447742,"B.PvsV.OISHI_CHOLANGIOMA_STEM_CELL_LIKE_DN"
73,"Down",0.871799629143313,0.972190046447742,"B.PvsV.SHIN_B_CELL_LYMPHOMA_CLUSTER_8"
72,"Up",0.871853324625971,0.972190046447742,"B.PvsV.HAHTOLA_SEZARY_SYNDROM_DN"
107,"Up",0.871959107269424,0.972190046447742,"B.PvsV.REACTOME_SELECTIVE_AUTOPHAGY"
939,"Down",0.872081037602312,0.972190046447742,"B.PvsV.GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP"
35,"Up",0.872402542333594,0.972190046447742,"B.PvsV.BIOCARTA_GSK3_PATHWAY"
65,"Down",0.872576459845577,0.972190046447742,"B.PvsV.ABE_INNER_EAR"
11,"Up",0.872598593073534,0.972190046447742,"B.PvsV.ZHU_SKIL_TARGETS_DN"
45,"Up",0.872959143696429,0.972190046447742,"B.PvsV.REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS"
17,"Down",0.872974583230471,0.972190046447742,"B.PvsV.REACTOME_CYTOCHROME_C_MEDIATED_APOPTOTIC_RESPONSE"
143,"Up",0.873098786890022,0.972190046447742,"B.PvsV.SWEET_KRAS_TARGETS_DN"
18,"Up",0.873290939951033,0.972190046447742,"B.PvsV.REACTOME_NEUROTRANSMITTER_CLEARANCE"
811,"Down",0.873526878158385,0.972190046447742,"B.PvsV.SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1"
42,"Up",0.873811780874947,0.972190046447742,"B.PvsV.REACTOME_SIGNALING_BY_WNT_IN_CANCER"
116,"Up",0.873941635455989,0.972190046447742,"B.PvsV.RASHI_RESPONSE_TO_IONIZING_RADIATION_4"
44,"Up",0.874181460292233,0.972190046447742,"B.PvsV.SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_DN"
1200,"Down",0.874455126466594,0.972190046447742,"B.PvsV.RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN"
17,"Up",0.874512976353553,0.972190046447742,"B.PvsV.BOYAULT_LIVER_CANCER_SUBCLASS_G56_UP"
349,"Down",0.874898288593987,0.972190046447742,"B.PvsV.MIKKELSEN_MEF_ICP_WITH_H3K27ME3"
9,"Down",0.874939868627591,0.972190046447742,"B.PvsV.TESAR_ALK_TARGETS_HUMAN_ES_5D_DN"
51,"Down",0.874956469732126,0.972190046447742,"B.PvsV.REACTOME_INTERLEUKIN_2_FAMILY_SIGNALING"
42,"Up",0.875135327035938,0.972190046447742,"B.PvsV.BONOME_OVARIAN_CANCER_POOR_SURVIVAL_DN"
196,"Down",0.875307528662742,0.972190046447742,"B.PvsV.STEARMAN_LUNG_CANCER_EARLY_VS_LATE_UP"
61,"Up",0.875317710384013,0.972190046447742,"B.PvsV.KEGG_GLYCEROLIPID_METABOLISM"
71,"Up",0.875627901644245,0.972190046447742,"B.PvsV.SHIPP_DLBCL_CURED_VS_FATAL_DN"
49,"Down",0.87590468192952,0.972190046447742,"B.PvsV.DORSAM_HOXA9_TARGETS_DN"
14,"Up",0.876149334709642,0.972190046447742,"B.PvsV.BIOCARTA_NEUTROPHIL_PATHWAY"
58,"Up",0.876206507449445,0.972190046447742,"B.PvsV.REACTOME_RECYCLING_PATHWAY_OF_L1"
336,"Up",0.876454041472728,0.972190046447742,"B.PvsV.IWANAGA_CARCINOGENESIS_BY_KRAS_UP"
12,"Up",0.876524850577643,0.972190046447742,"B.PvsV.REACTOME_CONDENSATION_OF_PROMETAPHASE_CHROMOSOMES"
431,"Up",0.876860215162865,0.972190046447742,"B.PvsV.JAATINEN_HEMATOPOIETIC_STEM_CELL_DN"
1480,"Up",0.876989295566755,0.972190046447742,"B.PvsV.CUI_TCF21_TARGETS_2_DN"
60,"Up",0.877375783927222,0.972190046447742,"B.PvsV.GENTILE_UV_RESPONSE_CLUSTER_D8"
32,"Up",0.877421962700109,0.972190046447742,"B.PvsV.CAFFAREL_RESPONSE_TO_THC_24HR_3_DN"
50,"Down",0.877425379370899,0.972190046447742,"B.PvsV.BRACHAT_RESPONSE_TO_CISPLATIN"
82,"Up",0.877429673133555,0.972190046447742,"B.PvsV.PID_IL2_1PATHWAY"
22,"Down",0.877857305361182,0.972190046447742,"B.PvsV.BIOCARTA_D4GDI_PATHWAY"
34,"Up",0.878010761034418,0.972190046447742,"B.PvsV.HAHTOLA_CTCL_PATHOGENESIS"
47,"Down",0.878039673910614,0.972190046447742,"B.PvsV.LIU_LIVER_CANCER"
25,"Up",0.878944490445037,0.972190046447742,"B.PvsV.BIOCARTA_CHEMICAL_PATHWAY"
217,"Down",0.879020167579184,0.972190046447742,"B.PvsV.REACTOME_FCERI_MEDIATED_CA_2_MOBILIZATION"
131,"Down",0.879122247193334,0.972190046447742,"B.PvsV.SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE"
121,"Up",0.879474358036506,0.972190046447742,"B.PvsV.PEART_HDAC_PROLIFERATION_CLUSTER_DN"
10,"Up",0.879647523032293,0.972190046447742,"B.PvsV.KAUFFMANN_MELANOMA_RELAPSE_DN"
710,"Down",0.879847291728262,0.972190046447742,"B.PvsV.REACTOME_CELLULAR_RESPONSES_TO_EXTERNAL_STIMULI"
19,"Up",0.880017890114943,0.972190046447742,"B.PvsV.KOINUMA_COLON_CANCER_MSI_UP"
202,"Down",0.880154895281753,0.972190046447742,"B.PvsV.REACTOME_CREATION_OF_C4_AND_C2_ACTIVATORS"
10,"Up",0.880174880965722,0.972190046447742,"B.PvsV.REACTOME_SHC_RELATED_EVENTS_TRIGGERED_BY_IGF1R"
316,"Down",0.880368978621728,0.972190046447742,"B.PvsV.MOHANKUMAR_HOXA1_TARGETS_DN"
83,"Up",0.880369961730795,0.972190046447742,"B.PvsV.BAKKER_FOXO3_TARGETS_UP"
11,"Up",0.880558579933743,0.972190046447742,"B.PvsV.MARIADASON_RESPONSE_TO_BUTYRATE_CURCUMIN_SULINDAC_TSA_2"
464,"Down",0.880656874083909,0.972190046447742,"B.PvsV.RAO_BOUND_BY_SALL4_ISOFORM_A"
637,"Down",0.880969142161631,0.972190046447742,"B.PvsV.MOHANKUMAR_HOXA1_TARGETS_UP"
34,"Down",0.881114898266364,0.972190046447742,"B.PvsV.REACTOME_SIGNALING_BY_BMP"
867,"Down",0.881279622416715,0.972190046447742,"B.PvsV.NABA_MATRISOME_ASSOCIATED"
135,"Up",0.881837359790467,0.972190046447742,"B.PvsV.SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_UP"
46,"Up",0.881967081480913,0.972190046447742,"B.PvsV.MARSHALL_VIRAL_INFECTION_RESPONSE_DN"
225,"Up",0.882390402047579,0.972190046447742,"B.PvsV.PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_DN"
117,"Down",0.882763240788385,0.972190046447742,"B.PvsV.TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_UP"
104,"Down",0.882770116643746,0.972190046447742,"B.PvsV.KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_DN"
62,"Down",0.883559635470799,0.972190046447742,"B.PvsV.KEGG_ARGININE_AND_PROLINE_METABOLISM"
65,"Up",0.883594138149529,0.972190046447742,"B.PvsV.PID_TCPTP_PATHWAY"
427,"Up",0.883871761250316,0.972190046447742,"B.PvsV.RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_DN"
84,"Down",0.884277661034966,0.972190046447742,"B.PvsV.LUI_THYROID_CANCER_CLUSTER_1"
761,"Down",0.884518590011544,0.972190046447742,"B.PvsV.KEGG_OLFACTORY_TRANSDUCTION"
27,"Down",0.884816064786041,0.972190046447742,"B.PvsV.MELLMAN_TUT1_TARGETS_UP"
25,"Up",0.88490331651046,0.972190046447742,"B.PvsV.AUJLA_IL22_AND_IL17A_SIGNALING"
29,"Down",0.88496711478001,0.972190046447742,"B.PvsV.PID_ARF_3PATHWAY"
95,"Up",0.885050004448248,0.972190046447742,"B.PvsV.DANG_REGULATED_BY_MYC_UP"
17,"Up",0.885960487220134,0.972190046447742,"B.PvsV.PID_CIRCADIAN_PATHWAY"
127,"Up",0.886017003337086,0.972190046447742,"B.PvsV.HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_DN"
893,"Down",0.886576538346862,0.972190046447742,"B.PvsV.ENK_UV_RESPONSE_EPIDERMIS_DN"
8,"Down",0.886878965052469,0.972190046447742,"B.PvsV.KASLER_HDAC7_TARGETS_2_UP"
41,"Down",0.886923988152501,0.972190046447742,"B.PvsV.BIOCARTA_EIF4_PATHWAY"
73,"Up",0.886973752660843,0.972190046447742,"B.PvsV.REACTOME_NETRIN_1_SIGNALING"
13,"Down",0.88698093222937,0.972190046447742,"B.PvsV.REACTOME_P38MAPK_EVENTS"
25,"Up",0.887044647781308,0.972190046447742,"B.PvsV.MCCOLLUM_GELDANAMYCIN_RESISTANCE_UP"
41,"Up",0.887205174346882,0.972190046447742,"B.PvsV.HOEGERKORP_CD44_TARGETS_DIRECT_UP"
394,"Down",0.887456771922131,0.972190046447742,"B.PvsV.RUTELLA_RESPONSE_TO_HGF_DN"
81,"Up",0.887557140622137,0.972190046447742,"B.PvsV.SESTO_RESPONSE_TO_UV_C5"
66,"Down",0.888039033967816,0.972190046447742,"B.PvsV.SIMBULAN_UV_RESPONSE_IMMORTALIZED_DN"
51,"Up",0.888117257165313,0.972190046447742,"B.PvsV.KASLER_HDAC7_TARGETS_2_DN"
7,"Up",0.888565119099697,0.972190046447742,"B.PvsV.REACTOME_INTERLEUKIN_36_PATHWAY"
265,"Down",0.88859396880935,0.972190046447742,"B.PvsV.TSAI_RESPONSE_TO_IONIZING_RADIATION"
42,"Down",0.888847347331345,0.972190046447742,"B.PvsV.BURTON_ADIPOGENESIS_12"
10,"Down",0.888851125229183,0.972190046447742,"B.PvsV.CASTELLANO_HRAS_AND_NRAS_TARGETS_UP"
33,"Up",0.888994605432238,0.972190046447742,"B.PvsV.REACTOME_SIALIC_ACID_METABOLISM"
26,"Up",0.889075262018344,0.972190046447742,"B.PvsV.PID_NFKAPPAB_ATYPICAL_PATHWAY"
6,"Down",0.889254682228391,0.972190046447742,"B.PvsV.BIOCARTA_SAM68_PATHWAY"
846,"Down",0.889444384586356,0.972190046447742,"B.PvsV.SMID_BREAST_CANCER_NORMAL_LIKE_UP"
242,"Up",0.889584356109864,0.972190046447742,"B.PvsV.REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS"
62,"Up",0.889612657932417,0.972190046447742,"B.PvsV.REACTOME_HSF1_DEPENDENT_TRANSACTIVATION"
12,"Up",0.889856440020902,0.972190046447742,"B.PvsV.REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX_IN_CANCER"
635,"Up",0.890019141885186,0.972190046447742,"B.PvsV.LINDGREN_BLADDER_CANCER_CLUSTER_2B"
97,"Down",0.890197867742059,0.972190046447742,"B.PvsV.BROWNE_HCMV_INFECTION_30MIN_UP"
16,"Up",0.890334925070925,0.972190046447742,"B.PvsV.REACTOME_PHYSIOLOGICAL_FACTORS"
81,"Up",0.890459483736405,0.972190046447742,"B.PvsV.CROMER_TUMORIGENESIS_DN"
29,"Down",0.890466362879314,0.972190046447742,"B.PvsV.REACTOME_SHC_MEDIATED_CASCADE_FGFR1"
315,"Up",0.890473286462591,0.972190046447742,"B.PvsV.KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_DN"
7,"Up",0.890495626997508,0.972190046447742,"B.PvsV.TESAR_ALK_TARGETS_HUMAN_ES_4D_DN"
51,"Down",0.890551334635237,0.972190046447742,"B.PvsV.TERAO_AOX4_TARGETS_SKIN_DN"
301,"Up",0.890840560038021,0.972190046447742,"B.PvsV.ASTON_MAJOR_DEPRESSIVE_DISORDER_DN"
1093,"Down",0.890878241068113,0.972190046447742,"B.PvsV.BENPORATH_SOX2_TARGETS"
25,"Down",0.891145586405016,0.972190046447742,"B.PvsV.BIOCARTA_ERAD_PATHWAY"
34,"Up",0.89133493750817,0.972190046447742,"B.PvsV.GOLUB_ALL_VS_AML_UP"
67,"Down",0.891422851371105,0.972190046447742,"B.PvsV.KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_DN"
810,"Down",0.891651559919866,0.972190046447742,"B.PvsV.SWEET_LUNG_CANCER_KRAS_DN"
33,"Down",0.891814377268513,0.972190046447742,"B.PvsV.REACTOME_BMAL1_CLOCK_NPAS2_ACTIVATES_CIRCADIAN_GENE_EXPRESSION"
87,"Down",0.891847938350911,0.972190046447742,"B.PvsV.GOLDRATH_IMMUNE_MEMORY"
29,"Down",0.891945534346523,0.972190046447742,"B.PvsV.PID_IL27_PATHWAY"
293,"Down",0.892162556042936,0.972190046447742,"B.PvsV.TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP"
833,"Down",0.892192295035219,0.972190046447742,"B.PvsV.BERENJENO_TRANSFORMED_BY_RHOA_UP"
8,"Down",0.892232543092356,0.972190046447742,"B.PvsV.REACTOME_STAT5_ACTIVATION"
331,"Up",0.892645402864991,0.972190046447742,"B.PvsV.LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP"
14,"Down",0.8935328237208,0.972190046447742,"B.PvsV.REACTOME_RUNX1_AND_FOXP3_CONTROL_THE_DEVELOPMENT_OF_REGULATORY_T_LYMPHOCYTES_TREGS"
59,"Down",0.893600922314139,0.972190046447742,"B.PvsV.PID_HNF3B_PATHWAY"
48,"Down",0.89385321311917,0.972190046447742,"B.PvsV.WANG_THOC1_TARGETS_DN"
150,"Down",0.894128461094702,0.972190046447742,"B.PvsV.REACTOME_METABOLISM_OF_WATER_SOLUBLE_VITAMINS_AND_COFACTORS"
241,"Down",0.894457439863252,0.972190046447742,"B.PvsV.KIM_WT1_TARGETS_12HR_UP"
68,"Down",0.894530972935611,0.972190046447742,"B.PvsV.CASORELLI_APL_SECONDARY_VS_DE_NOVO_UP"
22,"Down",0.89458570669108,0.972190046447742,"B.PvsV.REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_27_HYDROXYCHOLESTEROL"
58,"Up",0.894913844839223,0.972190046447742,"B.PvsV.MORI_PLASMA_CELL_DN"
27,"Down",0.895093258129171,0.972190046447742,"B.PvsV.REACTOME_CD163_MEDIATING_AN_ANTI_INFLAMMATORY_RESPONSE"
19,"Up",0.895165679986729,0.972190046447742,"B.PvsV.BIOCARTA_HSWI_SNF_PATHWAY"
116,"Down",0.895202961891032,0.972190046447742,"B.PvsV.PID_P73PATHWAY"
103,"Up",0.895213252900615,0.972190046447742,"B.PvsV.PID_CDC42_PATHWAY"
108,"Up",0.895382185597658,0.972190046447742,"B.PvsV.LIN_NPAS4_TARGETS_DN"
35,"Down",0.895427533870227,0.972190046447742,"B.PvsV.REACTOME_DOWNREGULATION_OF_TGF_BETA_RECEPTOR_SIGNALING"
213,"Up",0.895519775927404,0.972190046447742,"B.PvsV.CERVERA_SDHB_TARGETS_2"
44,"Up",0.895921469750098,0.972190046447742,"B.PvsV.PID_AURORA_A_PATHWAY"
61,"Up",0.896065219847945,0.972190046447742,"B.PvsV.PID_PLK1_PATHWAY"
646,"Down",0.896274603561117,0.972190046447742,"B.PvsV.MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP"
7,"Up",0.896294865017391,0.972190046447742,"B.PvsV.REACTOME_GRB7_EVENTS_IN_ERBB2_SIGNALING"
225,"Up",0.896305034800218,0.972190046447742,"B.PvsV.BIDUS_METASTASIS_DN"
106,"Down",0.896384416238756,0.972190046447742,"B.PvsV.RHODES_CANCER_META_SIGNATURE"
91,"Up",0.896405160613743,0.972190046447742,"B.PvsV.FARMER_BREAST_CANCER_CLUSTER_1"
1318,"Up",0.896628040016977,0.972190046447742,"B.PvsV.GOZGIT_ESR1_TARGETS_DN"
22,"Up",0.896649619435253,0.972190046447742,"B.PvsV.BIOCARTA_GRANULOCYTES_PATHWAY"
18,"Down",0.896755485094954,0.972190046447742,"B.PvsV.BIOCARTA_MRP_PATHWAY"
83,"Up",0.896830837360639,0.972190046447742,"B.PvsV.MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_DN"
32,"Up",0.896897236103142,0.972190046447742,"B.PvsV.MATZUK_IMPLANTATION_AND_UTERINE"
26,"Up",0.896914743013514,0.972190046447742,"B.PvsV.CAIRO_HEPATOBLASTOMA_POOR_SURVIVAL"
470,"Up",0.897069355575094,0.972190046447742,"B.PvsV.HOSHIDA_LIVER_CANCER_SUBCLASS_S3"
6,"Down",0.897073184993684,0.972190046447742,"B.PvsV.ZIRN_TRETINOIN_RESPONSE_WT1_DN"
18,"Down",0.8971669512855,0.972190046447742,"B.PvsV.BIOCARTA_DNAFRAGMENT_PATHWAY"
40,"Down",0.897210769067448,0.972190046447742,"B.PvsV.WIEMANN_TELOMERE_SHORTENING_AND_CHRONIC_LIVER_DAMAGE_UP"
12,"Up",0.897260231735284,0.972190046447742,"B.PvsV.REACTOME_MYOCLONIC_EPILEPSY_OF_LAFORA"
17,"Down",0.897276111158832,0.972190046447742,"B.PvsV.INAMURA_LUNG_CANCER_SCC_SUBTYPES_UP"
19,"Down",0.897510721160148,0.972190046447742,"B.PvsV.TSUTSUMI_FBXW8_TARGETS"
661,"Down",0.897762569231224,0.972190046447742,"B.PvsV.DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_UP"
51,"Down",0.898043802515799,0.972190046447742,"B.PvsV.PID_FAS_PATHWAY"
201,"Down",0.898437047218224,0.972190046447742,"B.PvsV.REACTOME_ROLE_OF_LAT2_NTAL_LAB_ON_CALCIUM_MOBILIZATION"
13,"Down",0.898488782410739,0.972190046447742,"B.PvsV.REACTOME_PROCESSING_AND_ACTIVATION_OF_SUMO"
15,"Down",0.898529830852455,0.972190046447742,"B.PvsV.REACTOME_ORGANIC_CATION_TRANSPORT"
34,"Down",0.898547339847119,0.972190046447742,"B.PvsV.REACTOME_DOWNREGULATION_OF_ERBB2_SIGNALING"
10,"Down",0.898648827001193,0.972190046447742,"B.PvsV.REACTOME_LOSS_OF_FUNCTION_OF_SMAD2_3_IN_CANCER"
499,"Up",0.898691142592586,0.972190046447742,"B.PvsV.KAYO_AGING_MUSCLE_UP"
34,"Up",0.899722040513222,0.972828937772933,"B.PvsV.REACTOME_COOPERATION_OF_PREFOLDIN_AND_TRIC_CCT_IN_ACTIN_AND_TUBULIN_FOLDING"
13,"Down",0.899947279174605,0.972828937772933,"B.PvsV.BIOCARTA_LYMPHOCYTE_PATHWAY"
153,"Down",0.900071729066529,0.972828937772933,"B.PvsV.DE_YY1_TARGETS_DN"
46,"Up",0.900076557793283,0.972828937772933,"B.PvsV.HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_DN"
61,"Down",0.900161484110386,0.972828937772933,"B.PvsV.PID_PI3KCI_PATHWAY"
259,"Down",0.900985579659861,0.973529269091141,"B.PvsV.RICKMAN_HEAD_AND_NECK_CANCER_C"
26,"Down",0.90124283289788,0.973602839412931,"B.PvsV.ZIRN_TRETINOIN_RESPONSE_UP"
184,"Down",0.901405848246481,0.973602839412931,"B.PvsV.JAZAG_TGFB1_SIGNALING_VIA_SMAD4_UP"
158,"Up",0.902100903382297,0.974163260703265,"B.PvsV.NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP"
156,"Up",0.902385029164019,0.974279794229225,"B.PvsV.KEGG_AXON_GUIDANCE"
556,"Up",0.902927943813204,0.974598476907295,"B.PvsV.POOLA_INVASIVE_BREAST_CANCER_UP"
201,"Up",0.903032735973245,0.974598476907295,"B.PvsV.WEI_MIR34A_TARGETS"
413,"Up",0.903882877765168,0.974887483311515,"B.PvsV.KEGG_PATHWAYS_IN_CANCER"
19,"Up",0.903895466294215,0.974887483311515,"B.PvsV.REACTOME_INTERLEUKIN_15_SIGNALING"
25,"Down",0.903987285021274,0.974887483311515,"B.PvsV.REACTOME_SUMOYLATION_OF_TRANSCRIPTION_FACTORS"
1632,"Up",0.904130524295048,0.974887483311515,"B.PvsV.GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN"
92,"Up",0.904182133192521,0.974887483311515,"B.PvsV.KEGG_TGF_BETA_SIGNALING_PATHWAY"
18,"Down",0.904726509455382,0.974923395730058,"B.PvsV.BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_24HR_UP"
182,"Down",0.904831503173154,0.974923395730058,"B.PvsV.LEE_CALORIE_RESTRICTION_NEOCORTEX_UP"
88,"Down",0.905173971900046,0.974923395730058,"B.PvsV.BROWNE_HCMV_INFECTION_10HR_DN"
67,"Up",0.905182383974755,0.974923395730058,"B.PvsV.GYORFFY_DOXORUBICIN_RESISTANCE"
144,"Down",0.905357988548116,0.974923395730058,"B.PvsV.WINZEN_DEGRADED_VIA_KHSRP"
145,"Up",0.905626259211448,0.974923395730058,"B.PvsV.MARCHINI_TRABECTEDIN_RESISTANCE_DN"
173,"Down",0.905790609580805,0.974923395730058,"B.PvsV.RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_UP"
6,"Up",0.90587025021186,0.974923395730058,"B.PvsV.SMID_BREAST_CANCER_RELAPSE_IN_LIVER_UP"
50,"Up",0.906030069586127,0.974923395730058,"B.PvsV.BIOCARTA_ALK_PATHWAY"
107,"Down",0.906031943624906,0.974923395730058,"B.PvsV.ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_UP"
423,"Down",0.906155060708404,0.974923395730058,"B.PvsV.GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP"
34,"Up",0.906810054524927,0.975008251200401,"B.PvsV.REACTOME_IKK_COMPLEX_RECRUITMENT_MEDIATED_BY_RIP1"
28,"Down",0.906938039900383,0.975008251200401,"B.PvsV.SU_KIDNEY"
67,"Down",0.907005740450805,0.975008251200401,"B.PvsV.NAKAMURA_METASTASIS"
320,"Up",0.907113305608772,0.975008251200401,"B.PvsV.KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION"
658,"Down",0.907127155016031,0.975008251200401,"B.PvsV.DELACROIX_RAR_BOUND_ES"
110,"Up",0.907291997183227,0.975008251200401,"B.PvsV.LEE_LIVER_CANCER_MYC_DN"
11,"Down",0.90757412459686,0.975121907286443,"B.PvsV.REACTOME_PEPTIDE_HORMONE_BIOSYNTHESIS"
49,"Up",0.907959169098901,0.97534607459643,"B.PvsV.KEGG_LYSINE_DEGRADATION"
29,"Up",0.908583497698564,0.975524645836614,"B.PvsV.ZHANG_GATA6_TARGETS_UP"
24,"Down",0.908906611571544,0.975524645836614,"B.PvsV.MATZUK_EARLY_ANTRAL_FOLLICLE"
26,"Down",0.909222894902952,0.975524645836614,"B.PvsV.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_DN"
167,"Down",0.909373993928248,0.975524645836614,"B.PvsV.REACTOME_MITOTIC_PROPHASE"
56,"Up",0.90942430222755,0.975524645836614,"B.PvsV.REACTOME_HEPARAN_SULFATE_HEPARIN_HS_GAG_METABOLISM"
62,"Up",0.909450441988895,0.975524645836614,"B.PvsV.HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_DN"
25,"Down",0.909450954652037,0.975524645836614,"B.PvsV.KYNG_ENVIRONMENTAL_STRESS_RESPONSE_DN"
65,"Up",0.90960825307765,0.975524645836614,"B.PvsV.LAU_APOPTOSIS_CDKN2A_UP"
42,"Down",0.909723857713879,0.975524645836614,"B.PvsV.WALLACE_JAK2_TARGETS_UP"
12,"Down",0.909889780896983,0.975524645836614,"B.PvsV.SIMBULAN_UV_RESPONSE_NORMAL_UP"
815,"Down",0.910461915492835,0.97584162585512,"B.PvsV.ONDER_CDH1_TARGETS_2_DN"
46,"Down",0.91053842426959,0.97584162585512,"B.PvsV.CLIMENT_BREAST_CANCER_COPY_NUMBER_UP"
46,"Up",0.911345905559756,0.976158128221792,"B.PvsV.PETRETTO_HEART_MASS_QTL_CIS_UP"
264,"Down",0.911535244611744,0.976158128221792,"B.PvsV.VANTVEER_BREAST_CANCER_METASTASIS_DN"
6,"Down",0.911581041699124,0.976158128221792,"B.PvsV.REACTOME_CHOLINE_CATABOLISM"
194,"Up",0.911685768896724,0.976158128221792,"B.PvsV.RODRIGUES_DCC_TARGETS_DN"
1106,"Down",0.911763235475807,0.976158128221792,"B.PvsV.KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP"
105,"Up",0.911902129622288,0.976158128221792,"B.PvsV.WEBER_METHYLATED_ICP_IN_FIBROBLAST"
24,"Up",0.912198347752357,0.976158128221792,"B.PvsV.REACTOME_SIGNALING_BY_NODAL"
12,"Up",0.912246165404594,0.976158128221792,"B.PvsV.REACTOME_ACTIVATION_OF_RAC1_DOWNSTREAM_OF_NMDARS"
10,"Up",0.913176184720225,0.976800530083199,"B.PvsV.REACTOME_CALCITONIN_LIKE_LIGAND_RECEPTORS"
36,"Down",0.913199844456512,0.976800530083199,"B.PvsV.KEGG_REGULATION_OF_AUTOPHAGY"
16,"Down",0.913803926883659,0.977257623160493,"B.PvsV.KONDO_COLON_CANCER_HCP_WITH_H3K27ME3"
118,"Down",0.914053448818837,0.977335431931803,"B.PvsV.LEE_AGING_NEOCORTEX_DN"
78,"Down",0.914386342111762,0.977477349808893,"B.PvsV.PID_ERBB4_PATHWAY"
104,"Up",0.914679972488733,0.977477349808893,"B.PvsV.FIGUEROA_AML_METHYLATION_CLUSTER_1_DN"
238,"Up",0.914716550535578,0.977477349808893,"B.PvsV.LI_INDUCED_T_TO_NATURAL_KILLER_DN"
567,"Down",0.915055031388514,0.977587428454484,"B.PvsV.PHONG_TNF_RESPONSE_NOT_VIA_P38"
20,"Up",0.915308082847439,0.977587428454484,"B.PvsV.BIOCARTA_CBL_PATHWAY"
6,"Down",0.915350268914236,0.977587428454484,"B.PvsV.REN_MIF_TARGETS_DN"
42,"Up",0.915706145132643,0.977587428454484,"B.PvsV.REACTOME_BIOSYNTHESIS_OF_MARESINS"
189,"Down",0.91592331184479,0.977587428454484,"B.PvsV.HAHTOLA_SEZARY_SYNDROM_UP"
109,"Up",0.916275211243861,0.977587428454484,"B.PvsV.PARK_APL_PATHOGENESIS_DN"
28,"Up",0.916281381360376,0.977587428454484,"B.PvsV.REACTOME_NOTCH4_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION"
94,"Down",0.916558819760001,0.977587428454484,"B.PvsV.ONDER_CDH1_TARGETS_3_DN"
87,"Down",0.916723651273982,0.977587428454484,"B.PvsV.BYSTROEM_CORRELATED_WITH_IL5_DN"
30,"Up",0.916788358012482,0.977587428454484,"B.PvsV.REACTOME_BUDDING_AND_MATURATION_OF_HIV_VIRION"
14,"Down",0.916807750916124,0.977587428454484,"B.PvsV.BIOCARTA_LECTIN_PATHWAY"
161,"Up",0.91739761976177,0.977587428454484,"B.PvsV.REACTOME_CARDIAC_CONDUCTION"
15,"Up",0.917788804221568,0.977587428454484,"B.PvsV.REACTOME_REGULATION_OF_PTEN_LOCALIZATION"
21,"Down",0.917846214739661,0.977587428454484,"B.PvsV.ROETH_TERT_TARGETS_DN"
586,"Down",0.917870138162802,0.977587428454484,"B.PvsV.KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN"
112,"Up",0.917940368105458,0.977587428454484,"B.PvsV.BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_CIS"
19,"Up",0.917944258015632,0.977587428454484,"B.PvsV.EHLERS_ANEUPLOIDY_DN"
227,"Up",0.918013609223489,0.977587428454484,"B.PvsV.REACTOME_PHOSPHOLIPID_METABOLISM"
36,"Up",0.918178968342221,0.977587428454484,"B.PvsV.REACTOME_SIGNAL_AMPLIFICATION"
306,"Up",0.918503433024495,0.977744605543403,"B.PvsV.CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_UP"
24,"Down",0.919351230553338,0.977873981786398,"B.PvsV.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_24"
325,"Down",0.919507326343252,0.977873981786398,"B.PvsV.PURBEY_TARGETS_OF_CTBP1_AND_SATB1_DN"
63,"Down",0.919536536155607,0.977873981786398,"B.PvsV.BOYAULT_LIVER_CANCER_SUBCLASS_G123_UP"
20,"Down",0.919573427788859,0.977873981786398,"B.PvsV.REACTOME_BUTYRATE_RESPONSE_FACTOR_1_BRF1_BINDS_AND_DESTABILIZES_MRNA"
31,"Down",0.919786237983048,0.977873981786398,"B.PvsV.SA_CASPASE_CASCADE"
927,"Up",0.920021920529853,0.977873981786398,"B.PvsV.REACTOME_HEMOSTASIS"
33,"Down",0.920054576363968,0.977873981786398,"B.PvsV.REACTOME_SIGNALING_BY_ERBB2_IN_CANCER"
46,"Up",0.920172563127274,0.977873981786398,"B.PvsV.REACTOME_NOD1_2_SIGNALING_PATHWAY"
309,"Down",0.920357083331315,0.977873981786398,"B.PvsV.NABA_ECM_REGULATORS"
28,"Down",0.920473993910554,0.977873981786398,"B.PvsV.KEGG_DORSO_VENTRAL_AXIS_FORMATION"
46,"Up",0.92066889545362,0.977873981786398,"B.PvsV.REACTOME_RET_SIGNALING"
194,"Down",0.920747323056609,0.977873981786398,"B.PvsV.FIGUEROA_AML_METHYLATION_CLUSTER_6_UP"
115,"Up",0.921046282866375,0.977956010661304,"B.PvsV.BROWNE_HCMV_INFECTION_1HR_UP"
33,"Up",0.921178314979937,0.977956010661304,"B.PvsV.HASLINGER_B_CLL_WITH_CHROMOSOME_12_TRISOMY"
9,"Down",0.921668904149343,0.978121770112901,"B.PvsV.REACTOME_RUNX1_REGULATES_ESTROGEN_RECEPTOR_MEDIATED_TRANSCRIPTION"
131,"Up",0.921731803357563,0.978121770112901,"B.PvsV.HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_UP"
523,"Down",0.921865173459636,0.978121770112901,"B.PvsV.FISCHER_DIRECT_P53_TARGETS_META_ANALYSIS"
84,"Up",0.922113167226445,0.978135250914773,"B.PvsV.KEGG_MELANOMA"
33,"Up",0.922231698863938,0.978135250914773,"B.PvsV.REACTOME_ENDOSOMAL_SORTING_COMPLEX_REQUIRED_FOR_TRANSPORT_ESCRT"
386,"Up",0.922791732644828,0.978541520865603,"B.PvsV.CAIRO_LIVER_DEVELOPMENT_DN"
106,"Up",0.923182756407543,0.978550934164876,"B.PvsV.MARSON_FOXP3_TARGETS_UP"
141,"Down",0.923182764439426,0.978550934164876,"B.PvsV.PID_REG_GR_PATHWAY"
60,"Up",0.923331565118133,0.978550934164876,"B.PvsV.NOUSHMEHR_GBM_SILENCED_BY_METHYLATION"
107,"Down",0.923889782246832,0.978643709307159,"B.PvsV.JOHNSTONE_PARVB_TARGETS_1_DN"
60,"Down",0.923998520817988,0.978643709307159,"B.PvsV.LUI_THYROID_CANCER_PAX8_PPARG_DN"
46,"Up",0.924572473428181,0.978643709307159,"B.PvsV.HWANG_PROSTATE_CANCER_MARKERS"
385,"Down",0.924633101018137,0.978643709307159,"B.PvsV.NABA_SECRETED_FACTORS"
187,"Down",0.924648257846789,0.978643709307159,"B.PvsV.BRUECKNER_TARGETS_OF_MIRLET7A3_UP"
87,"Down",0.924653636371929,0.978643709307159,"B.PvsV.TSENG_ADIPOGENIC_POTENTIAL_DN"
250,"Down",0.92465811854234,0.978643709307159,"B.PvsV.DARWICHE_SQUAMOUS_CELL_CARCINOMA_UP"
734,"Down",0.925523252771527,0.979073399889737,"B.PvsV.FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_UP"
32,"Up",0.925524385527314,0.979073399889737,"B.PvsV.FINAK_BREAST_CANCER_SDPP_SIGNATURE"
302,"Up",0.925661311479519,0.979073399889737,"B.PvsV.XU_GH1_AUTOCRINE_TARGETS_UP"
726,"Down",0.92577242442097,0.979073399889737,"B.PvsV.PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_DN"
37,"Down",0.926353478068374,0.979500550820432,"B.PvsV.REACTOME_CYP2E1_REACTIONS"
231,"Up",0.927389794990934,0.980205531260322,"B.PvsV.REACTOME_MITOTIC_G2_G2_M_PHASES"
330,"Down",0.9274617923453,0.980205531260322,"B.PvsV.ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP"
29,"Down",0.927601535406269,0.980205531260322,"B.PvsV.REACTOME_CHOLESTEROL_BIOSYNTHESIS"
1498,"Up",0.927766040224873,0.980205531260322,"B.PvsV.ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN"
79,"Down",0.927906628796623,0.980205531260322,"B.PvsV.REACTOME_BASE_EXCISION_REPAIR_AP_SITE_FORMATION"
2088,"Down",0.928436886937571,0.980424322764323,"B.PvsV.YOSHIMURA_MAPK8_TARGETS_UP"
37,"Down",0.92853004338374,0.980424322764323,"B.PvsV.REACTOME_SYNTHESIS_OF_16_20_HYDROXYEICOSATETRAENOIC_ACIDS_HETE"
116,"Down",0.928645718632078,0.980424322764323,"B.PvsV.JAIN_NFKB_SIGNALING"
53,"Up",0.929265148778041,0.980721670877018,"B.PvsV.EINAV_INTERFERON_SIGNATURE_IN_CANCER"
54,"Down",0.92928211859734,0.980721670877018,"B.PvsV.HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_24HR"
178,"Up",0.930299533918855,0.981608038747586,"B.PvsV.REACTOME_S_PHASE"
18,"Up",0.930496238755231,0.981628258744071,"B.PvsV.NOUSHMEHR_GBM_GERMLINE_MUTATED"
297,"Up",0.93070289324441,0.981658965423187,"B.PvsV.VANOEVELEN_MYOGENESIS_SIN3A_TARGETS"
215,"Down",0.930919429967349,0.981700081687864,"B.PvsV.REACTOME_FCERI_MEDIATED_MAPK_ACTIVATION"
96,"Down",0.931802504906697,0.982125014076878,"B.PvsV.HUANG_DASATINIB_RESISTANCE_DN"
87,"Down",0.931815457217741,0.982125014076878,"B.PvsV.KEGG_TASTE_TRANSDUCTION"
249,"Down",0.932281999473422,0.982125014076878,"B.PvsV.WHITFIELD_CELL_CYCLE_S"
67,"Down",0.93232975883044,0.982125014076878,"B.PvsV.VANTVEER_BREAST_CANCER_BRCA1_UP"
9,"Up",0.93259436805496,0.982125014076878,"B.PvsV.REACTOME_RUNX3_REGULATES_IMMUNE_RESPONSE_AND_CELL_MIGRATION"
294,"Up",0.932630736676911,0.982125014076878,"B.PvsV.FERNANDEZ_BOUND_BY_MYC"
317,"Down",0.932644444635023,0.982125014076878,"B.PvsV.TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP"
73,"Up",0.932875377642512,0.982125014076878,"B.PvsV.ZHAN_MULTIPLE_MYELOMA_CD2_DN"
19,"Down",0.932921066003213,0.982125014076878,"B.PvsV.REACTOME_INTERACTION_WITH_CUMULUS_CELLS_AND_THE_ZONA_PELLUCIDA"
14,"Down",0.933805566491464,0.9823897605285,"B.PvsV.MONTERO_THYROID_CANCER_POOR_SURVIVAL_UP"
65,"Up",0.933839377936099,0.9823897605285,"B.PvsV.YANG_BREAST_CANCER_ESR1_UP"
25,"Up",0.933911972340103,0.9823897605285,"B.PvsV.MCGOWAN_RSP6_TARGETS_UP"
127,"Down",0.933995107162044,0.9823897605285,"B.PvsV.ZHANG_GATA6_TARGETS_DN"
23,"Down",0.934129511198239,0.9823897605285,"B.PvsV.BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER"
225,"Up",0.934345232898804,0.9823897605285,"B.PvsV.HOOI_ST7_TARGETS_DN"
411,"Up",0.934416305049626,0.9823897605285,"B.PvsV.GRADE_COLON_AND_RECTAL_CANCER_UP"
47,"Down",0.934825042116063,0.98263263457409,"B.PvsV.MIKKELSEN_MCV6_LCP_WITH_H3K27ME3"
19,"Down",0.93518247455251,0.982724569944402,"B.PvsV.MATTHEWS_AP1_TARGETS"
1381,"Up",0.935384275760001,0.982724569944402,"B.PvsV.BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_TRANS"
9,"Up",0.935460122611431,0.982724569944402,"B.PvsV.REACTOME_ESTROGEN_BIOSYNTHESIS"
80,"Down",0.935623464674866,0.982724569944402,"B.PvsV.MARTIN_NFKB_TARGETS_UP"
18,"Up",0.935859253910244,0.982785529889789,"B.PvsV.ROZANOV_MMP14_CORRELATED"
19,"Up",0.936098229337415,0.982845851950235,"B.PvsV.DORN_ADENOVIRUS_INFECTION_24HR_UP"
112,"Down",0.936325262802883,0.982845851950235,"B.PvsV.LEE_LIVER_CANCER_CIPROFIBRATE_DN"
427,"Up",0.936449981565173,0.982845851950235,"B.PvsV.UDAYAKUMAR_MED1_TARGETS_DN"
392,"Up",0.9373135063181,0.983465183951556,"B.PvsV.REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION"
30,"Down",0.937606480336733,0.983465183951556,"B.PvsV.REACTOME_REGULATION_OF_IFNA_SIGNALING"
10,"Down",0.937824819325363,0.983465183951556,"B.PvsV.PID_VEGF_VEGFR_PATHWAY"
30,"Up",0.937906730749462,0.983465183951556,"B.PvsV.HOLLEMAN_ASPARAGINASE_RESISTANCE_ALL_DN"
29,"Down",0.937929447454613,0.983465183951556,"B.PvsV.REACTOME_CONSTITUTIVE_SIGNALING_BY_AKT1_E17K_IN_CANCER"
9,"Up",0.938112379562114,0.983470486651295,"B.PvsV.FUJIWARA_PARK2_IN_LIVER_CANCER_UP"
198,"Up",0.938673169643249,0.983704774429032,"B.PvsV.CERVERA_SDHB_TARGETS_1_UP"
17,"Down",0.938900678948938,0.983704774429032,"B.PvsV.KEGG_TERPENOID_BACKBONE_BIOSYNTHESIS"
355,"Down",0.938910708138952,0.983704774429032,"B.PvsV.REACTOME_CELL_CYCLE_CHECKPOINTS"
30,"Down",0.939047531097202,0.983704774429032,"B.PvsV.BIOCARTA_CARDIACEGF_PATHWAY"
153,"Up",0.939964883196276,0.98447922697333,"B.PvsV.ROSS_LEUKEMIA_WITH_MLL_FUSIONS"
31,"Up",0.940286346374346,0.984629395663591,"B.PvsV.XU_HGF_TARGETS_INDUCED_BY_AKT1_6HR"
37,"Up",0.940595808918849,0.984648235048077,"B.PvsV.OLSSON_E2F3_TARGETS_UP"
15,"Up",0.940712985241523,0.984648235048077,"B.PvsV.TURJANSKI_MAPK1_AND_MAPK2_TARGETS"
29,"Up",0.940945274479038,0.984648235048077,"B.PvsV.REACTOME_BASIGIN_INTERACTIONS"
780,"Down",0.94124277235749,0.984648235048077,"B.PvsV.REACTOME_OLFACTORY_SIGNALING_PATHWAY"
17,"Down",0.941539901454989,0.984648235048077,"B.PvsV.CONRAD_GERMLINE_STEM_CELL"
94,"Up",0.941632992143804,0.984648235048077,"B.PvsV.YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_3"
33,"Down",0.942627201533893,0.984648235048077,"B.PvsV.MAHADEVAN_IMATINIB_RESISTANCE_UP"
14,"Up",0.94277843825622,0.984648235048077,"B.PvsV.SMID_BREAST_CANCER_RELAPSE_IN_LIVER_DN"
129,"Up",0.942853561532225,0.984648235048077,"B.PvsV.DOANE_BREAST_CANCER_CLASSES_UP"
49,"Down",0.943531274848995,0.984648235048077,"B.PvsV.PID_WNT_NONCANONICAL_PATHWAY"
14,"Up",0.943599434187065,0.984648235048077,"B.PvsV.REACTOME_DEGRADATION_OF_CYSTEINE_AND_HOMOCYSTEINE"
165,"Up",0.943703805486632,0.984648235048077,"B.PvsV.DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_UP"
114,"Up",0.943828420425514,0.984648235048077,"B.PvsV.REACTOME_METABOLISM_OF_NUCLEOTIDES"
148,"Up",0.943832339984441,0.984648235048077,"B.PvsV.SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_DN"
202,"Down",0.943874313580864,0.984648235048077,"B.PvsV.BROWNE_HCMV_INFECTION_20HR_DN"
1095,"Up",0.944125272591639,0.984648235048077,"B.PvsV.SMID_BREAST_CANCER_LUMINAL_B_DN"
166,"Down",0.944204691105092,0.984648235048077,"B.PvsV.WALLACE_PROSTATE_CANCER_RACE_DN"
14,"Up",0.944397584901654,0.984648235048077,"B.PvsV.TAKADA_GASTRIC_CANCER_COPY_NUMBER_UP"
394,"Down",0.944408243647143,0.984648235048077,"B.PvsV.SENESE_HDAC1_AND_HDAC2_TARGETS_DN"
1243,"Up",0.944527162741973,0.984648235048077,"B.PvsV.LEE_BMP2_TARGETS_UP"
93,"Up",0.944709349531195,0.984648235048077,"B.PvsV.REACTOME_FOXO_MEDIATED_TRANSCRIPTION"
300,"Down",0.944767588824548,0.984648235048077,"B.PvsV.REACTOME_DISEASES_OF_METABOLISM"
671,"Down",0.944768915521959,0.984648235048077,"B.PvsV.PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_7"
20,"Down",0.944996563784696,0.984648235048077,"B.PvsV.BIOCARTA_TALL1_PATHWAY"
426,"Down",0.945017117700283,0.984648235048077,"B.PvsV.GENTILE_UV_HIGH_DOSE_DN"
42,"Down",0.945063896541696,0.984648235048077,"B.PvsV.REACTOME_SEMA4D_INDUCED_CELL_MIGRATION_AND_GROWTH_CONE_COLLAPSE"
35,"Up",0.945112711774307,0.984648235048077,"B.PvsV.SIG_IL4RECEPTOR_IN_B_LYPHOCYTES"
31,"Down",0.945563682182302,0.984720829247935,"B.PvsV.TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_TOP20_UP"
127,"Up",0.945784713626979,0.984720829247935,"B.PvsV.REACTOME_HCMV_LATE_EVENTS"
133,"Up",0.946000311395619,0.984720829247935,"B.PvsV.GRABARCZYK_BCL11B_TARGETS_UP"
70,"Up",0.94607004867346,0.984720829247935,"B.PvsV.LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_UP"
135,"Down",0.946190557015789,0.984720829247935,"B.PvsV.ROVERSI_GLIOMA_COPY_NUMBER_UP"
22,"Down",0.94644809803221,0.984720829247935,"B.PvsV.FARMER_BREAST_CANCER_CLUSTER_6"
177,"Up",0.946821401872394,0.984720829247935,"B.PvsV.KEGG_CELL_ADHESION_MOLECULES_CAMS"
330,"Down",0.94707166623649,0.984720829247935,"B.PvsV.SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4"
13,"Up",0.947235173398822,0.984720829247935,"B.PvsV.GERHOLD_RESPONSE_TO_TZD_DN"
123,"Up",0.947296727910942,0.984720829247935,"B.PvsV.BILANGES_SERUM_SENSITIVE_GENES"
72,"Up",0.947297674583943,0.984720829247935,"B.PvsV.KEGG_GLIOMA"
455,"Up",0.947635450295182,0.984720829247935,"B.PvsV.RAO_BOUND_BY_SALL4"
27,"Down",0.947748555474238,0.984720829247935,"B.PvsV.LEE_NAIVE_T_LYMPHOCYTE"
36,"Down",0.948025588056364,0.984720829247935,"B.PvsV.REACTOME_METABOLISM_OF_ANGIOTENSINOGEN_TO_ANGIOTENSINS"
52,"Up",0.948037948545193,0.984720829247935,"B.PvsV.VALK_AML_CLUSTER_2"
117,"Up",0.948066030987574,0.984720829247935,"B.PvsV.LIN_TUMOR_ESCAPE_FROM_IMMUNE_ATTACK"
12,"Up",0.948352252127039,0.984720829247935,"B.PvsV.BIOCARTA_RECK_PATHWAY"
27,"Up",0.948388210480241,0.984720829247935,"B.PvsV.TSAI_DNAJB4_TARGETS_UP"
65,"Up",0.948761001969804,0.984909334143428,"B.PvsV.CHIARETTI_T_ALL_REFRACTORY_TO_THERAPY"
122,"Down",0.948926030562858,0.984909334143428,"B.PvsV.ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN"
24,"Down",0.949399040533275,0.98505647127642,"B.PvsV.BIOCARTA_RACC_PATHWAY"
45,"Up",0.949424115650578,0.98505647127642,"B.PvsV.REACTOME_NEGATIVE_REGULATORS_OF_DDX58_IFIH1_SIGNALING"
398,"Down",0.950595530965362,0.985988785361885,"B.PvsV.RICKMAN_METASTASIS_DN"
10,"Down",0.950812456259321,0.985988785361885,"B.PvsV.REACTOME_NEUROTOXICITY_OF_CLOSTRIDIUM_TOXINS"
26,"Down",0.950857696427848,0.985988785361885,"B.PvsV.REACTOME_A_TETRASACCHARIDE_LINKER_SEQUENCE_IS_REQUIRED_FOR_GAG_SYNTHESIS"
27,"Up",0.951229758598458,0.986060072202301,"B.PvsV.REACTOME_GASTRIN_CREB_SIGNALLING_PATHWAY_VIA_PKC_AND_MAPK"
109,"Down",0.951283129883718,0.986060072202301,"B.PvsV.FIGUEROA_AML_METHYLATION_CLUSTER_5_DN"
37,"Down",0.951523873772508,0.986091157953886,"B.PvsV.REACTOME_DOWNREGULATION_OF_SMAD2_3_SMAD4_TRANSCRIPTIONAL_ACTIVITY"
60,"Up",0.951751773075221,0.986091157953886,"B.PvsV.LU_TUMOR_VASCULATURE_UP"
23,"Down",0.951848166033621,0.986091157953886,"B.PvsV.REACTOME_NOREPINEPHRINE_NEUROTRANSMITTER_RELEASE_CYCLE"
65,"Up",0.952888787698954,0.986984283849291,"B.PvsV.GROSS_HYPOXIA_VIA_ELK3_ONLY_DN"
28,"Up",0.953262684508089,0.987092419270337,"B.PvsV.REACTOME_INTERLEUKIN_37_SIGNALING"
28,"Down",0.953414115835508,0.987092419270337,"B.PvsV.HO_LIVER_CANCER_VASCULAR_INVASION"
425,"Up",0.953528777595021,0.987092419270337,"B.PvsV.PLASARI_TGFB1_TARGETS_10HR_DN"
85,"Down",0.954181058008914,0.987565315690546,"B.PvsV.YAMASHITA_LIVER_CANCER_STEM_CELL_UP"
5,"Down",0.954398719634736,0.987565315690546,"B.PvsV.REACTOME_SYNTHESIS_OF_GDP_MANNOSE"
22,"Up",0.954667890954883,0.987565315690546,"B.PvsV.BIOCARTA_ARAP_PATHWAY"
32,"Down",0.954722746397638,0.987565315690546,"B.PvsV.CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_HD_MTX_DN"
344,"Up",0.955247364261513,0.987565315690546,"B.PvsV.DOANE_RESPONSE_TO_ANDROGEN_UP"
39,"Down",0.955330724038746,0.987565315690546,"B.PvsV.PID_RETINOIC_ACID_PATHWAY"
25,"Up",0.955438015329053,0.987565315690546,"B.PvsV.GENTILE_UV_RESPONSE_CLUSTER_D1"
35,"Up",0.955510548373945,0.987565315690546,"B.PvsV.TERAMOTO_OPN_TARGETS_CLUSTER_6"
13,"Up",0.955593134191431,0.987565315690546,"B.PvsV.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_16"
485,"Up",0.956656423279672,0.988344883637163,"B.PvsV.LINDGREN_BLADDER_CANCER_CLUSTER_3_UP"
34,"Down",0.956795716055054,0.988344883637163,"B.PvsV.LEE_DOUBLE_POLAR_THYMOCYTE"
8,"Up",0.956925352055433,0.988344883637163,"B.PvsV.CHOI_ATL_ACUTE_STAGE"
28,"Down",0.957102659799506,0.988344883637163,"B.PvsV.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_23"
18,"Up",0.957241246496113,0.988344883637163,"B.PvsV.REACTOME_CONSTITUTIVE_SIGNALING_BY_OVEREXPRESSED_ERBB2"
51,"Down",0.957776048741478,0.988712429703441,"B.PvsV.REACTOME_SIGNALING_BY_FGFR3"
19,"Down",0.958258198762958,0.988751821418971,"B.PvsV.VERRECCHIA_RESPONSE_TO_TGFB1_C6"
19,"Down",0.958339230307291,0.988751821418971,"B.PvsV.REACTOME_TRISTETRAPROLIN_TTP_ZFP36_BINDS_AND_DESTABILIZES_MRNA"
140,"Down",0.958350698315114,0.988751821418971,"B.PvsV.GU_PDEF_TARGETS_UP"
150,"Down",0.958806221743021,0.989037238809172,"B.PvsV.DING_LUNG_CANCER_EXPRESSION_BY_COPY_NUMBER"
100,"Down",0.959744726259922,0.989310250699271,"B.PvsV.CADWELL_ATG16L1_TARGETS_DN"
23,"Down",0.959794255967476,0.989310250699271,"B.PvsV.FREDERICK_PRKCI_TARGETS"
67,"Up",0.960001617221571,0.989310250699271,"B.PvsV.HUMMEL_BURKITTS_LYMPHOMA_UP"
1255,"Up",0.960369966781234,0.989310250699271,"B.PvsV.DACOSTA_UV_RESPONSE_VIA_ERCC3_DN"
131,"Up",0.960478130053874,0.989310250699271,"B.PvsV.SMID_BREAST_CANCER_RELAPSE_IN_LUNG_UP"
218,"Up",0.960491070407268,0.989310250699271,"B.PvsV.RASHI_RESPONSE_TO_IONIZING_RADIATION_5"
12,"Down",0.960528490432532,0.989310250699271,"B.PvsV.TESAR_JAK_TARGETS_MOUSE_ES_D3_DN"
25,"Down",0.960611070279096,0.989310250699271,"B.PvsV.REACTOME_JNK_C_JUN_KINASES_PHOSPHORYLATION_AND_ACTIVATION_MEDIATED_BY_ACTIVATED_HUMAN_TAK1"
162,"Down",0.960681268946353,0.989310250699271,"B.PvsV.HOSHIDA_LIVER_CANCER_SURVIVAL_UP"
60,"Down",0.961252038113038,0.989713690638173,"B.PvsV.REACTOME_BIOSYNTHESIS_OF_SPECIALIZED_PRORESOLVING_MEDIATORS_SPMS"
33,"Up",0.961768721359028,0.98994277776007,"B.PvsV.MARCHINI_TRABECTEDIN_RESISTANCE_UP"
325,"Down",0.961832628346373,0.98994277776007,"B.PvsV.TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN"
44,"Up",0.96227381136501,0.990212526156177,"B.PvsV.REACTOME_METABOLISM_OF_STEROID_HORMONES"
64,"Up",0.962560000231814,0.990262276362775,"B.PvsV.SAENZ_DETOX_PATHWAY_AND_CARCINOGENESIS_DN"
44,"Down",0.962689357301282,0.990262276362775,"B.PvsV.DING_LUNG_CANCER_BY_MUTATION_RATE"
25,"Up",0.962984265433169,0.990262276362775,"B.PvsV.KEGG_GLYCOSAMINOGLYCAN_DEGRADATION"
60,"Up",0.963038571170672,0.990262276362775,"B.PvsV.CROONQUIST_NRAS_SIGNALING_UP"
10,"Up",0.96333650858942,0.990384447004631,"B.PvsV.REACTOME_FRUCTOSE_CATABOLISM"
176,"Down",0.963856696083542,0.990598725899008,"B.PvsV.MACAEVA_PBMC_RESPONSE_TO_IR"
19,"Down",0.963903263761379,0.990598725899008,"B.PvsV.SA_PROGRAMMED_CELL_DEATH"
266,"Down",0.964439039009039,0.990699515500762,"B.PvsV.KIM_RESPONSE_TO_TSA_AND_DECITABINE_UP"
18,"Up",0.964551714237362,0.990699515500762,"B.PvsV.WEBER_METHYLATED_LCP_IN_SPERM_UP"
8,"Down",0.964778145250674,0.990699515500762,"B.PvsV.IM_SREBF1A_TARGETS"
15,"Up",0.964858230581457,0.990699515500762,"B.PvsV.REACTOME_PTK6_REGULATES_RTKS_AND_THEIR_EFFECTORS_AKT1_AND_DOK1"
1419,"Up",0.96489724922619,0.990699515500762,"B.PvsV.BENPORATH_NANOG_TARGETS"
133,"Up",0.965309016724287,0.990855281189416,"B.PvsV.MIKKELSEN_MEF_LCP_WITH_H3K27ME3"
61,"Down",0.965410661141665,0.990855281189416,"B.PvsV.PID_THROMBIN_PAR1_PATHWAY"
136,"Down",0.965639540690233,0.990855281189416,"B.PvsV.GHANDHI_DIRECT_IRRADIATION_UP"
575,"Down",0.96587358933494,0.990855281189416,"B.PvsV.SHEN_SMARCA2_TARGETS_DN"
30,"Down",0.965977743743836,0.990855281189416,"B.PvsV.BYSTRYKH_HEMATOPOIESIS_STEM_CELL_RUNX1"
133,"Up",0.966124221539545,0.990855281189416,"B.PvsV.GAVIN_FOXP3_TARGETS_CLUSTER_T7"
196,"Down",0.966485549177047,0.990919101476012,"B.PvsV.SU_TESTIS"
523,"Up",0.966623211115878,0.990919101476012,"B.PvsV.KOYAMA_SEMA3B_TARGETS_DN"
222,"Up",0.966836444485192,0.990919101476012,"B.PvsV.HOELZEL_NF1_TARGETS_UP"
45,"Up",0.967081529954749,0.990919101476012,"B.PvsV.MEISSNER_ES_ICP_WITH_H3K4ME3"
488,"Up",0.967082559516108,0.990919101476012,"B.PvsV.BROWNE_HCMV_INFECTION_14HR_DN"
643,"Down",0.967447983360386,0.991109857328066,"B.PvsV.MULLIGHAN_MLL_SIGNATURE_2_UP"
116,"Up",0.968233256755598,0.991537578195413,"B.PvsV.KEGG_GNRH_SIGNALING_PATHWAY"
46,"Down",0.96845701700498,0.991537578195413,"B.PvsV.REACTOME_NUCLEOBASE_CATABOLISM"
18,"Up",0.968480802307529,0.991537578195413,"B.PvsV.KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_4NQO_IN_OLD"
37,"Up",0.968959792789158,0.991537578195413,"B.PvsV.TOMIDA_METASTASIS_DN"
500,"Up",0.968968611331746,0.991537578195413,"B.PvsV.WANG_SMARCE1_TARGETS_UP"
509,"Up",0.969147473818442,0.991537578195413,"B.PvsV.KUMAR_PATHOGEN_LOAD_BY_MACROPHAGES"
87,"Down",0.969213372268944,0.991537578195413,"B.PvsV.STOSSI_RESPONSE_TO_ESTRADIOL"
26,"Up",0.969363370974054,0.991537578195413,"B.PvsV.SCHWAB_TARGETS_OF_BMYB_POLYMORPHIC_VARIANTS_DN"
8,"Up",0.969479498593671,0.991537578195413,"B.PvsV.REACTOME_SYNTHESIS_OF_PIPS_AT_THE_ER_MEMBRANE"
27,"Down",0.970123420265155,0.99193928712999,"B.PvsV.REACTOME_SIGNALING_BY_NTRK3_TRKC"
262,"Down",0.970400035343613,0.99193928712999,"B.PvsV.LIU_CMYB_TARGETS_UP"
15,"Down",0.970410490881916,0.99193928712999,"B.PvsV.PARK_OSTEOBLAST_DIFFERENTIATION_BY_PHENYLAMIL_DN"
430,"Up",0.971108332806664,0.992106925654265,"B.PvsV.LU_EZH2_TARGETS_UP"
178,"Down",0.971251892618325,0.992106925654265,"B.PvsV.LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_DN"
151,"Down",0.971331700826965,0.992106925654265,"B.PvsV.CHANG_IMMORTALIZED_BY_HPV31_DN"
308,"Down",0.971406986656435,0.992106925654265,"B.PvsV.BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_TRANS"
33,"Down",0.971815706440463,0.992106925654265,"B.PvsV.HUI_MAPK14_TARGETS_UP"
102,"Down",0.972076358128533,0.992106925654265,"B.PvsV.PID_IL4_2PATHWAY"
23,"Up",0.972496857902037,0.992106925654265,"B.PvsV.SARTIPY_BLUNTED_BY_INSULIN_RESISTANCE_DN"
99,"Up",0.972664594912083,0.992106925654265,"B.PvsV.BILBAN_B_CLL_LPL_DN"
12,"Up",0.972664836712684,0.992106925654265,"B.PvsV.REACTOME_IRF3_MEDIATED_ACTIVATION_OF_TYPE_1_IFN"
40,"Down",0.972721318339015,0.992106925654265,"B.PvsV.REACTOME_ALPHA_DEFENSINS"
494,"Up",0.972778476145251,0.992106925654265,"B.PvsV.REACTOME_G_ALPHA_I_SIGNALLING_EVENTS"
867,"Down",0.973142634607931,0.992106925654265,"B.PvsV.PARENT_MTOR_SIGNALING_UP"
879,"Down",0.973258867440323,0.992106925654265,"B.PvsV.WEST_ADRENOCORTICAL_TUMOR_DN"
6,"Up",0.973403979020218,0.992106925654265,"B.PvsV.REACTOME_ACYL_CHAIN_REMODELING_OF_CL"
14,"Down",0.973582129876099,0.992106925654265,"B.PvsV.WEBER_METHYLATED_LCP_IN_FIBROBLAST_UP"
75,"Up",0.973782310168771,0.992106925654265,"B.PvsV.LEE_CALORIE_RESTRICTION_MUSCLE_DN"
16,"Down",0.973965868750157,0.992106925654265,"B.PvsV.REACTOME_ROLE_OF_SECOND_MESSENGERS_IN_NETRIN_1_SIGNALING"
27,"Down",0.974355231162581,0.992106925654265,"B.PvsV.OUYANG_PROSTATE_CANCER_PROGRESSION_DN"
858,"Down",0.974429560072892,0.992106925654265,"B.PvsV.RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP"
123,"Up",0.974515117965638,0.992106925654265,"B.PvsV.REACTOME_PEPTIDE_HORMONE_METABOLISM"
184,"Down",0.974931782854786,0.992106925654265,"B.PvsV.REACTOME_PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS"
957,"Down",0.975097767724115,0.992106925654265,"B.PvsV.MASSARWEH_TAMOXIFEN_RESISTANCE_UP"
10,"Down",0.975164372233477,0.992106925654265,"B.PvsV.TURASHVILI_BREAST_CARCINOMA_DUCTAL_VS_LOBULAR_DN"
10,"Up",0.975203492626666,0.992106925654265,"B.PvsV.HEIDENBLAD_AMPLIFIED_IN_BONE_CANCER"
488,"Up",0.975904801342425,0.992106925654265,"B.PvsV.BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_D"
46,"Up",0.976036360574623,0.992106925654265,"B.PvsV.MOREIRA_RESPONSE_TO_TSA_UP"
39,"Down",0.976694033608863,0.992106925654265,"B.PvsV.IKEDA_MIR30_TARGETS_DN"
101,"Up",0.976756085349551,0.992106925654265,"B.PvsV.KEGG_APOPTOSIS"
206,"Up",0.976850149384479,0.992106925654265,"B.PvsV.ROPERO_HDAC2_TARGETS"
140,"Down",0.976993689562656,0.992106925654265,"B.PvsV.MCCLUNG_DELTA_FOSB_TARGETS_2WK"
77,"Down",0.977009732208611,0.992106925654265,"B.PvsV.REACTOME_CELL_CELL_JUNCTION_ORGANIZATION"
28,"Down",0.977027223864482,0.992106925654265,"B.PvsV.REACTOME_CYCLIN_A_B1_B2_ASSOCIATED_EVENTS_DURING_G2_M_TRANSITION"
119,"Down",0.977086430913265,0.992106925654265,"B.PvsV.GUO_HEX_TARGETS_UP"
9,"Up",0.977224079643987,0.992106925654265,"B.PvsV.BIOCARTA_ERBB3_PATHWAY"
44,"Up",0.977343832658613,0.992106925654265,"B.PvsV.JEPSEN_SMRT_TARGETS"
139,"Up",0.977347494947459,0.992106925654265,"B.PvsV.MIKKELSEN_MCV6_ICP_WITH_H3K27ME3"
6,"Down",0.977350179279917,0.992106925654265,"B.PvsV.REACTOME_VITAMIN_B1_THIAMIN_METABOLISM"
103,"Down",0.977393095322623,0.992106925654265,"B.PvsV.WESTON_VEGFA_TARGETS_3HR"
38,"Up",0.977861818213229,0.992330855595656,"B.PvsV.BIOCARTA_BAD_PATHWAY"
129,"Up",0.977972659095809,0.992330855595656,"B.PvsV.REACTOME_RNA_POLYMERASE_I_TRANSCRIPTION"
386,"Down",0.978269006848977,0.992449419975778,"B.PvsV.KONDO_PROSTATE_CANCER_WITH_H3K27ME3"
5,"Down",0.979349778309628,0.993104131868333,"B.PvsV.TOMIDA_LUNG_CANCER_POOR_SURVIVAL"
117,"Up",0.979436785318737,0.993104131868333,"B.PvsV.HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_UP"
345,"Up",0.979572950011783,0.993104131868333,"B.PvsV.DAVICIONI_MOLECULAR_ARMS_VS_ERMS_DN"
237,"Down",0.979801920383172,0.993104131868333,"B.PvsV.DARWICHE_PAPILLOMA_RISK_HIGH_UP"
84,"Down",0.979812450595362,0.993104131868333,"B.PvsV.MIKKELSEN_NPC_LCP_WITH_H3K4ME3"
833,"Up",0.980049013977377,0.993161839860872,"B.PvsV.RODWELL_AGING_KIDNEY_UP"
37,"Up",0.980362143426176,0.993297102987599,"B.PvsV.MATTHEWS_SKIN_CARCINOGENESIS_VIA_JUN"
32,"Up",0.98074130429907,0.993334542094981,"B.PvsV.REACTOME_TICAM1_RIP1_MEDIATED_IKK_COMPLEX_RECRUITMENT"
368,"Down",0.980758412967354,0.993334542094981,"B.PvsV.THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN"
26,"Up",0.981082626902246,0.993480923835626,"B.PvsV.REACTOME_ACTIVATED_TAK1_MEDIATES_P38_MAPK_ACTIVATION"
21,"Down",0.981568809392584,0.993671446619489,"B.PvsV.IRITANI_MAD1_TARGETS_UP"
46,"Up",0.98165432869752,0.993671446619489,"B.PvsV.YAMASHITA_LIVER_CANCER_WITH_EPCAM_DN"
26,"Down",0.981996628252444,0.993671446619489,"B.PvsV.FOURNIER_ACINAR_DEVELOPMENT_LATE_UP"
186,"Down",0.982382559529434,0.993671446619489,"B.PvsV.MATZUK_SPERMATOCYTE"
13,"Up",0.982430094443985,0.993671446619489,"B.PvsV.KOBAYASHI_EGFR_SIGNALING_6HR_UP"
310,"Up",0.982521686796301,0.993671446619489,"B.PvsV.KARLSSON_TGFB1_TARGETS_DN"
59,"Down",0.982938220331719,0.993671446619489,"B.PvsV.REACTOME_HSF1_ACTIVATION"
10,"Up",0.983025606672846,0.993671446619489,"B.PvsV.SA_FAS_SIGNALING"
88,"Up",0.983090022022064,0.993671446619489,"B.PvsV.PID_RB_1PATHWAY"
330,"Down",0.983589785683132,0.993671446619489,"B.PvsV.TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP"
9,"Up",0.983590872279994,0.993671446619489,"B.PvsV.REACTOME_ACTIVATION_OF_PUMA_AND_TRANSLOCATION_TO_MITOCHONDRIA"
8,"Down",0.983609023783312,0.993671446619489,"B.PvsV.REACTOME_OPSINS"
26,"Down",0.983735701234991,0.993671446619489,"B.PvsV.OHASHI_AURKB_TARGETS"
149,"Up",0.983786850930563,0.993671446619489,"B.PvsV.BHAT_ESR1_TARGETS_NOT_VIA_AKT1_DN"
32,"Up",0.98416936134496,0.993876237237677,"B.PvsV.SAGIV_CD24_TARGETS_UP"
9,"Down",0.984547911849046,0.993936496304484,"B.PvsV.BIOCARTA_CIRCADIAN_PATHWAY"
168,"Up",0.984765720923724,0.993936496304484,"B.PvsV.REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA"
128,"Down",0.985047654082986,0.993936496304484,"B.PvsV.TIEN_INTESTINE_PROBIOTICS_2HR_DN"
35,"Down",0.985106831735577,0.993936496304484,"B.PvsV.SA_B_CELL_RECEPTOR_COMPLEXES"
118,"Down",0.985127871178978,0.993936496304484,"B.PvsV.KEGG_PROSTATE_CANCER"
198,"Down",0.985581670342009,0.994112572096884,"B.PvsV.REACTOME_FCGR_ACTIVATION"
8,"Down",0.985679052562643,0.994112572096884,"B.PvsV.REACTOME_ESTROGEN_STIMULATED_SIGNALING_THROUGH_PRKCZ"
25,"Down",0.985912747946568,0.994112572096884,"B.PvsV.BIOCARTA_IFNA_PATHWAY"
140,"Down",0.986173180583195,0.994112572096884,"B.PvsV.HOEBEKE_LYMPHOID_STEM_CELL_DN"
13,"Down",0.986211031120418,0.994112572096884,"B.PvsV.BIOCARTA_MELANOCYTE_PATHWAY"
77,"Up",0.986658972474279,0.994112572096884,"B.PvsV.TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP"
927,"Down",0.986673947185892,0.994112572096884,"B.PvsV.REACTOME_G_ALPHA_S_SIGNALLING_EVENTS"
8,"Up",0.986740784168512,0.994112572096884,"B.PvsV.REACTOME_PHOSPHATE_BOND_HYDROLYSIS_BY_NUDT_PROTEINS"
53,"Down",0.987182696712715,0.994120902501301,"B.PvsV.XU_HGF_SIGNALING_NOT_VIA_AKT1_6HR"
33,"Down",0.987214176824095,0.994120902501301,"B.PvsV.PIEPOLI_LGI1_TARGETS_UP"
99,"Up",0.987288456435999,0.994120902501301,"B.PvsV.REACTOME_TRANS_GOLGI_NETWORK_VESICLE_BUDDING"
49,"Up",0.987668627573052,0.994272156922155,"B.PvsV.LU_TUMOR_ENDOTHELIAL_MARKERS_UP"
212,"Down",0.987867236828778,0.994272156922155,"B.PvsV.REACTOME_SCAVENGING_OF_HEME_FROM_PLASMA"
219,"Up",0.988001161100487,0.994272156922155,"B.PvsV.REACTOME_REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS"
12,"Up",0.988157985582789,0.994272156922155,"B.PvsV.REACTOME_FREE_FATTY_ACIDS_REGULATE_INSULIN_SECRETION"
13,"Down",0.988513612170635,0.994449010496987,"B.PvsV.KHETCHOUMIAN_TRIM24_TARGETS_DN"
137,"Down",0.989213203933637,0.994890500569685,"B.PvsV.KYNG_DNA_DAMAGE_BY_GAMMA_RADIATION"
277,"Up",0.989312348007258,0.994890500569685,"B.PvsV.REACTOME_MITOTIC_METAPHASE_AND_ANAPHASE"
51,"Up",0.989796260577744,0.99512476904402,"B.PvsV.REACTOME_CLASS_C_3_METABOTROPIC_GLUTAMATE_PHEROMONE_RECEPTORS"
18,"Up",0.989958388960849,0.99512476904402,"B.PvsV.BIOCARTA_AHSP_PATHWAY"
129,"Down",0.990085251313285,0.99512476904402,"B.PvsV.MENSE_HYPOXIA_UP"
8,"Down",0.990747090862408,0.995487073852987,"B.PvsV.REACTOME_VEGF_LIGAND_RECEPTOR_INTERACTIONS"
89,"Down",0.99080581794411,0.995487073852987,"B.PvsV.REACTOME_SIGNALING_BY_INSULIN_RECEPTOR"
14,"Down",0.991044764637014,0.995546239767087,"B.PvsV.REACTOME_INLA_MEDIATED_ENTRY_OF_LISTERIA_MONOCYTOGENES_INTO_HOST_CELLS"
86,"Down",0.991890149351975,0.995808946870742,"B.PvsV.CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_DN"
25,"Up",0.9919262405777,0.995808946870742,"B.PvsV.HOLLEMAN_PREDNISOLONE_RESISTANCE_ALL_UP"
27,"Down",0.992010738136374,0.995808946870742,"B.PvsV.REACTOME_RAS_ACTIVATION_UPON_CA2_INFLUX_THROUGH_NMDA_RECEPTOR"
41,"Down",0.992026709959133,0.995808946870742,"B.PvsV.GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_DN"
22,"Down",0.992736223714692,0.996340276078877,"B.PvsV.NADERI_BREAST_CANCER_PROGNOSIS_DN"
73,"Down",0.99343523620884,0.996860874954388,"B.PvsV.ENGELMANN_CANCER_PROGENITORS_UP"
1302,"Down",0.994064758468693,0.997248591391802,"B.PvsV.SMID_BREAST_CANCER_BASAL_UP"
10,"Down",0.99418235408783,0.997248591391802,"B.PvsV.REACTOME_DISPLACEMENT_OF_DNA_GLYCOSYLASE_BY_APEX1"
67,"Down",0.995342741637404,0.998056054340622,"B.PvsV.REACTOME_NR1H2_AND_NR1H3_MEDIATED_SIGNALING"
353,"Down",0.995348360215987,0.998056054340622,"B.PvsV.TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP"
62,"Up",0.996133908968718,0.998437028484497,"B.PvsV.GREENBAUM_E2A_TARGETS_UP"
14,"Up",0.996135440981048,0.998437028484497,"B.PvsV.REACTOME_SIGNALING_BY_ACTIVIN"
1034,"Up",0.996270046328263,0.998437028484497,"B.PvsV.GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP"
117,"Down",0.996690476790628,0.998677355232943,"B.PvsV.REACTOME_TRANSCRIPTIONAL_REGULATION_OF_GRANULOPOIESIS"
46,"Up",0.997444045731893,0.999064123187294,"B.PvsV.ONGUSAHA_TP53_TARGETS"
10,"Up",0.99752885503413,0.999064123187294,"B.PvsV.BAKER_HEMATOPOESIS_STAT1_TARGETS"
50,"Down",0.997791634282154,0.999064123187294,"B.PvsV.LASTOWSKA_COAMPLIFIED_WITH_MYCN"
175,"Down",0.997799256328493,0.999064123187294,"B.PvsV.REACTOME_INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING"
59,"Up",0.998157071907911,0.999241435918675,"B.PvsV.AMIT_EGF_RESPONSE_480_MCF10A"
8,"Up",0.998804678508588,0.999664329905866,"B.PvsV.MOOTHA_ROS"
32,"Down",0.999046260745863,0.999664329905866,"B.PvsV.REACTOME_DISEASES_OF_PROGRAMMED_CELL_DEATH"
45,"Down",0.999217978932172,0.999664329905866,"B.PvsV.RODRIGUES_NTN1_AND_DCC_TARGETS"
84,"Up",0.999448712985429,0.999664329905866,"B.PvsV.ROVERSI_GLIOMA_LOH_REGIONS"
28,"Down",0.999483526084215,0.999664329905866,"B.PvsV.LEE_INTRATHYMIC_T_PROGENITOR"
17,"Down",0.999776134850498,0.999776134850498,"B.PvsV.PID_RANBP2_PATHWAY"
110,"Down",1.16450785571144e-30,6.43856393422858e-27,"B.LvsV.REACTOME_EUKARYOTIC_TRANSLATION_ELONGATION"
104,"Down",3.1913615576184e-29,8.82251902603606e-26,"B.LvsV.KEGG_RIBOSOME"
225,"Down",6.77511873055777e-29,1.2486543820418e-25,"B.LvsV.REACTOME_RRNA_PROCESSING"
119,"Down",8.08942321155894e-26,1.11816052341773e-22,"B.LvsV.REACTOME_RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY"
140,"Down",6.72637877852893e-23,7.43802965329729e-20,"B.LvsV.REACTOME_NONSENSE_MEDIATED_DECAY_NMD"
160,"Down",3.19368694750931e-22,2.94298252212983e-19,"B.LvsV.REACTOME_EUKARYOTIC_TRANSLATION_INITIATION"
189,"Down",7.17562236085605e-22,5.66771657616758e-19,"B.LvsV.REACTOME_INFLUENZA_INFECTION"
137,"Down",1.12626518698549e-21,7.78390027355346e-19,"B.LvsV.REACTOME_SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE"
135,"Down",2.80897256944811e-20,1.72564548183096e-17,"B.LvsV.REACTOME_SELENOAMINO_ACID_METABOLISM"
61,"Down",6.37212306380804e-19,3.52314684197946e-16,"B.LvsV.REACTOME_RRNA_MODIFICATION_IN_THE_NUCLEUS_AND_CYTOSOL"
196,"Down",8.58339550043556e-19,4.31432670199165e-16,"B.LvsV.SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP"
84,"Down",6.61637116923794e-17,3.04849301622638e-14,"B.LvsV.BILANGES_SERUM_AND_RAPAMYCIN_SENSITIVE_GENES"
107,"Down",2.44158322424857e-16,1.03842412668234e-13,"B.LvsV.GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN"
186,"Down",6.29769654024786e-16,2.48714029793074e-13,"B.LvsV.ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER"
58,"Down",3.47101518474583e-15,1.27941619709731e-12,"B.LvsV.ISHIDA_E2F_TARGETS"
47,"Down",2.3033023580793e-14,7.78159705422247e-12,"B.LvsV.WHITFIELD_CELL_CYCLE_LITERATURE"
335,"Down",2.39260535217548e-14,7.78159705422247e-12,"B.LvsV.KOBAYASHI_EGFR_SIGNALING_24HR_DN"
172,"Down",5.73538614029555e-14,1.76171944276078e-11,"B.LvsV.DANG_MYC_TARGETS_UP"
56,"Down",3.12804793064077e-13,9.10261947816465e-11,"B.LvsV.ZHAN_MULTIPLE_MYELOMA_PR_UP"
117,"Down",1.22554513018309e-12,3.38801951239115e-10,"B.LvsV.ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR"
84,"Down",1.40224535733032e-12,3.69191170508539e-10,"B.LvsV.REACTOME_ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S"
100,"Down",1.73447744447924e-12,4.3590571775117e-10,"B.LvsV.CROONQUIST_NRAS_SIGNALING_DN"
83,"Down",3.11087824727818e-12,7.47828079530481e-10,"B.LvsV.CHNG_MULTIPLE_MYELOMA_HYPERPLOID_UP"
69,"Down",5.6042239167426e-12,1.29107308481958e-09,"B.LvsV.KANG_DOXORUBICIN_RESISTANCE_UP"
176,"Down",7.71893158771293e-12,1.70711890993859e-09,"B.LvsV.ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR"
735,"Down",1.0354741434646e-11,2.20197559200606e-09,"B.LvsV.GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP"
49,"Down",1.53267484506505e-11,3.1385774882832e-09,"B.LvsV.YU_MYC_TARGETS_UP"
415,"Down",1.7669980495795e-11,3.48919007718752e-09,"B.LvsV.WONG_EMBRYONIC_STEM_CELL_CORE"
125,"Down",1.91343595076926e-11,3.64806461096664e-09,"B.LvsV.CROONQUIST_IL6_DEPRIVATION_DN"
775,"Down",2.34746180551711e-11,4.32637210756804e-09,"B.LvsV.REACTOME_METABOLISM_OF_RNA"
167,"Down",2.92390347057925e-11,5.21492331897829e-09,"B.LvsV.KONG_E2F3_TARGETS"
414,"Down",3.36184577517981e-11,5.80863915342786e-09,"B.LvsV.DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP"
67,"Down",4.23388307932862e-11,7.09367865018423e-09,"B.LvsV.PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_UP"
131,"Down",4.98299806269702e-11,8.10323420254465e-09,"B.LvsV.LEE_EARLY_T_LYMPHOCYTE_UP"
31,"Down",6.56119124913194e-11,1.03648075475573e-08,"B.LvsV.REICHERT_MITOSIS_LIN9_TARGETS"
22,"Down",8.02621171465269e-11,1.23269234917541e-08,"B.LvsV.EGUCHI_CELL_CYCLE_RB1_TARGETS"
185,"Down",1.10429074695972e-10,1.65016852430818e-08,"B.LvsV.WHITEFORD_PEDIATRIC_CANCER_MARKERS"
219,"Down",1.50870379346671e-10,2.19516401949406e-08,"B.LvsV.REACTOME_REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS"
70,"Down",2.52244756663892e-10,3.57605451178117e-08,"B.LvsV.MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_DN"
763,"Down",2.90216523091884e-10,4.01151789043757e-08,"B.LvsV.CAIRO_HEPATOBLASTOMA_CLASSES_UP"
370,"Down",4.26133362003115e-10,5.74656428906152e-08,"B.LvsV.MANALO_HYPOXIA_DN"
47,"Down",4.4686547847266e-10,5.88266483446508e-08,"B.LvsV.KAMMINGA_EZH2_TARGETS"
69,"Down",5.94366672570786e-10,7.64244961079971e-08,"B.LvsV.IRITANI_MAD1_TARGETS_DN"
221,"Down",6.55110484941517e-10,8.23205879827648e-08,"B.LvsV.HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP"
61,"Down",1.24706856099717e-09,1.5322315719452e-07,"B.LvsV.POMEROY_MEDULLOBLASTOMA_PROGNOSIS_DN"
54,"Up",2.21492859583162e-09,2.66224787094631e-07,"B.LvsV.REACTOME_SMOOTH_MUSCLE_CONTRACTION"
147,"Down",2.26984291775165e-09,2.6702045728189e-07,"B.LvsV.PUJANA_BRCA_CENTERED_NETWORK"
29,"Up",2.5413536810132e-09,2.92732177131708e-07,"B.LvsV.HORTON_SREBF_TARGETS"
1184,"Down",3.95745116463902e-09,4.4654586712835e-07,"B.LvsV.LEE_BMP2_TARGETS_DN"
166,"Down",4.29017496069995e-09,4.69992128995609e-07,"B.LvsV.KEGG_SPLICEOSOME"
346,"Down",4.35865056101349e-09,4.69992128995609e-07,"B.LvsV.REACTOME_TRANSLATION"
23,"Up",4.42025514700157e-09,4.69992128995609e-07,"B.LvsV.BIOCARTA_RAB_PATHWAY"
303,"Down",4.57083316511487e-09,4.76832765470191e-07,"B.LvsV.REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA"
177,"Down",4.75303552277564e-09,4.86658026026417e-07,"B.LvsV.BURTON_ADIPOGENESIS_3"
243,"Down",5.23714823393973e-09,5.26476228826414e-07,"B.LvsV.REACTOME_MRNA_SPLICING"
13,"Down",5.49128937215916e-09,5.42166766761928e-07,"B.LvsV.KUMAMOTO_RESPONSE_TO_NUTLIN_3A_DN"
215,"Down",6.74827678712162e-09,6.54582848350797e-07,"B.LvsV.WINNEPENNINCKX_MELANOMA_METASTASIS_UP"
58,"Down",9.01637138194437e-09,8.50461648594441e-07,"B.LvsV.ODONNELL_TARGETS_OF_MYC_AND_TFRC_DN"
274,"Down",9.07528255870357e-09,8.50461648594441e-07,"B.LvsV.SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP"
151,"Down",1.01225009767616e-08,9.3278846500858e-07,"B.LvsV.MORI_IMMATURE_B_LYMPHOCYTE_DN"
266,"Down",1.27467961357692e-08,1.15536124319127e-06,"B.LvsV.FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_DN"
181,"Down",1.70575859928785e-08,1.52115149926815e-06,"B.LvsV.MISSIAGLIA_REGULATED_BY_METHYLATION_DN"
1217,"Down",2.14355569157779e-08,1.88122530456089e-06,"B.LvsV.FISCHER_DREAM_TARGETS"
36,"Down",2.22033013527752e-08,1.91815708092959e-06,"B.LvsV.FARMER_BREAST_CANCER_CLUSTER_2"
32,"Down",3.438830247975e-08,2.92512191400827e-06,"B.LvsV.REACTOME_G1_S_SPECIFIC_TRANSCRIPTION"
18,"Down",5.01489880551036e-08,4.20111749934345e-06,"B.LvsV.FINETTI_BREAST_CANCER_KINOME_RED"
59,"Up",5.38418803865413e-08,4.44316054712219e-06,"B.LvsV.REACTOME_COMPLEX_I_BIOGENESIS"
292,"Down",5.72366653255045e-08,4.65384592036345e-06,"B.LvsV.GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP"
35,"Down",8.32819303894091e-08,6.67341729163831e-06,"B.LvsV.KEGG_DNA_REPLICATION"
78,"Down",9.45551096700766e-08,7.46631782349759e-06,"B.LvsV.SONG_TARGETS_OF_IE86_CMV_PROTEIN"
38,"Down",9.58778378492185e-08,7.46631782349759e-06,"B.LvsV.LUI_THYROID_CANCER_CLUSTER_3"
156,"Down",1.0667714368725e-07,8.19191565898338e-06,"B.LvsV.YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_11"
45,"Down",1.27765105002528e-07,9.67689404875311e-06,"B.LvsV.REACTOME_EXTENSION_OF_TELOMERES"
35,"Up",1.4954019272069e-07,1.11730773723337e-05,"B.LvsV.SCHMIDT_POR_TARGETS_IN_LIMB_BUD_UP"
20,"Up",1.54259641856658e-07,1.13245047716607e-05,"B.LvsV.REACTOME_RAP1_SIGNALLING"
361,"Down",1.55663295830387e-07,1.13245047716607e-05,"B.LvsV.MARKEY_RB1_ACUTE_LOF_UP"
192,"Down",1.57917140638092e-07,1.13392710465976e-05,"B.LvsV.LE_EGR2_TARGETS_UP"
24,"Down",1.79171797473064e-07,1.27005239516483e-05,"B.LvsV.VISALA_RESPONSE_TO_HEAT_SHOCK_AND_AGING_DN"
246,"Down",1.81711904118193e-07,1.27175331375885e-05,"B.LvsV.CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP"
32,"Down",1.89941484228869e-07,1.31273308287677e-05,"B.LvsV.REACTOME_DNA_STRAND_ELONGATION"
128,"Up",1.9563339798627e-07,1.33537908329146e-05,"B.LvsV.REACTOME_RAB_REGULATION_OF_TRAFFICKING"
75,"Down",2.26128179121074e-07,1.52471061263466e-05,"B.LvsV.FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_DN"
18,"Down",2.36120794227078e-07,1.57290586901387e-05,"B.LvsV.LI_WILMS_TUMOR_ANAPLASTIC_UP"
29,"Up",2.78439337984663e-07,1.83272749966334e-05,"B.LvsV.LEI_HOXC8_TARGETS_DN"
26,"Down",2.94857739922138e-07,1.91796287532882e-05,"B.LvsV.SCIAN_CELL_CYCLE_TARGETS_OF_TP53_AND_TP73_DN"
32,"Down",3.82223139931884e-07,2.45733923335278e-05,"B.LvsV.REACTOME_ACTIVATION_OF_THE_PRE_REPLICATIVE_COMPLEX"
31,"Down",4.21768098289527e-07,2.68040898326758e-05,"B.LvsV.REACTOME_G0_AND_EARLY_G1"
46,"Down",4.48502952388796e-07,2.81792366336097e-05,"B.LvsV.PLASARI_TGFB1_TARGETS_1HR_UP"
17,"Up",4.60228673912052e-07,2.85910599781992e-05,"B.LvsV.KEGG_STEROID_BIOSYNTHESIS"
108,"Down",7.15130322026646e-07,4.39328394498369e-05,"B.LvsV.PID_MYC_ACTIV_PATHWAY"
346,"Down",7.53811174217613e-07,4.55614130077589e-05,"B.LvsV.FISCHER_G2_M_CELL_CYCLE"
25,"Down",7.58120816913333e-07,4.55614130077589e-05,"B.LvsV.SMID_BREAST_CANCER_LUMINAL_A_DN"
63,"Down",9.64712360207613e-07,5.73537058020203e-05,"B.LvsV.KAUFFMANN_MELANOMA_RELAPSE_UP"
80,"Down",1.01585416714672e-06,5.96263507786171e-05,"B.LvsV.MODY_HIPPOCAMPUS_PRENATAL"
95,"Down",1.02450774533706e-06,5.96263507786171e-05,"B.LvsV.DANG_REGULATED_BY_MYC_UP"
42,"Down",1.22067970174386e-06,7.03035215723107e-05,"B.LvsV.REACTOME_INTERACTIONS_OF_REV_WITH_HOST_CELLULAR_PROTEINS"
213,"Down",1.39706340922774e-06,7.9632614325981e-05,"B.LvsV.RUIZ_TNC_TARGETS_DN"
43,"Down",1.45319183364906e-06,8.12226832620398e-05,"B.LvsV.REACTOME_EXPORT_OF_VIRAL_RIBONUCLEOPROTEINS_FROM_NUCLEUS"
8,"Down",1.46790930095203e-06,8.12226832620398e-05,"B.LvsV.GAUTSCHI_SRC_SIGNALING"
393,"Down",1.47645174789573e-06,8.12226832620398e-05,"B.LvsV.MUELLER_PLURINET"
59,"Down",1.48372056600941e-06,8.12226832620398e-05,"B.LvsV.REACTOME_MRNA_SPLICING_MINOR_PATHWAY"
29,"Down",1.67543130188376e-06,9.0818232040346e-05,"B.LvsV.COLLER_MYC_TARGETS_UP"
39,"Down",1.69398898786459e-06,9.09326710087699e-05,"B.LvsV.REACTOME_NUCLEAR_IMPORT_OF_REV_PROTEIN"
48,"Down",1.7285505591945e-06,9.18957311710231e-05,"B.LvsV.REACTOME_VIRAL_MESSENGER_RNA_SYNTHESIS"
62,"Up",1.78086043398505e-06,9.37750222809842e-05,"B.LvsV.BIOCARTA_INTEGRIN_PATHWAY"
34,"Up",1.96328647548516e-06,0.000102405763424127,"B.LvsV.BIOCARTA_MAL_PATHWAY"
29,"Up",2.08504021267671e-06,0.000107740068559715,"B.LvsV.REACTOME_CHOLESTEROL_BIOSYNTHESIS"
254,"Down",2.10924789202107e-06,0.000107981774027634,"B.LvsV.PUJANA_XPRSS_INT_NETWORK"
36,"Up",2.15256498822843e-06,0.000108434576320371,"B.LvsV.REACTOME_RHO_GTPASES_ACTIVATE_PAKS"
151,"Down",2.15731658441687e-06,0.000108434576320371,"B.LvsV.MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_UP"
833,"Down",2.6669478069826e-06,0.000132842832655917,"B.LvsV.BERENJENO_TRANSFORMED_BY_RHOA_UP"
112,"Down",2.77630882230891e-06,0.000137055459629875,"B.LvsV.TANG_SENESCENCE_TP53_TARGETS_DN"
1053,"Down",2.84573211671261e-06,0.000139239405958443,"B.LvsV.PUJANA_CHEK2_PCC_NETWORK"
157,"Down",2.99939034514349e-06,0.000145470431739459,"B.LvsV.MORI_LARGE_PRE_BII_LYMPHOCYTE_UP"
57,"Up",3.13341581468855e-06,0.000150649182951417,"B.LvsV.SIG_REGULATION_OF_THE_ACTIN_CYTOSKELETON_BY_RHO_GTPASES"
103,"Down",3.84369185929959e-06,0.000183204933535064,"B.LvsV.WU_APOPTOSIS_BY_CDKN1A_VIA_TP53"
92,"Up",4.36945431608944e-06,0.000205471980253889,"B.LvsV.REACTOME_RAB_GEFS_EXCHANGE_GTP_FOR_GDP_ON_RABS"
9,"Down",4.39026273773499e-06,0.000205471980253889,"B.LvsV.SEMBA_FHIT_TARGETS_DN"
173,"Down",4.42234864355449e-06,0.000205471980253889,"B.LvsV.BROWN_MYELOID_CELL_DEVELOPMENT_DN"
56,"Down",4.48725092287863e-06,0.000206750086271633,"B.LvsV.FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_UP"
105,"Down",4.79778347209782e-06,0.000217759459767825,"B.LvsV.SCHUHMACHER_MYC_TARGETS_UP"
31,"Down",4.83766351189152e-06,0.000217759459767825,"B.LvsV.REACTOME_POSTMITOTIC_NUCLEAR_PORE_COMPLEX_NPC_REFORMATION"
11,"Up",4.84435043433578e-06,0.000217759459767825,"B.LvsV.BIOCARTA_SALMONELLA_PATHWAY"
134,"Down",4.898006779866e-06,0.000218395802305477,"B.LvsV.MORI_PRE_BI_LYMPHOCYTE_UP"
34,"Up",5.2961875904564e-06,0.000234260969501068,"B.LvsV.REACTOME_RHO_GTPASES_ACTIVATE_ROCKS"
276,"Down",5.88264609099168e-06,0.000258136112992802,"B.LvsV.JISON_SICKLE_CELL_DISEASE_DN"
109,"Down",6.06304148659842e-06,0.00026395713684569,"B.LvsV.REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM"
601,"Down",6.36723164996343e-06,0.000275034560880061,"B.LvsV.VECCHI_GASTRIC_CANCER_EARLY_UP"
13,"Down",6.79096480833026e-06,0.000291063910273318,"B.LvsV.BIOCARTA_RANMS_PATHWAY"
174,"Down",6.84682282307298e-06,0.000291200641452081,"B.LvsV.KARLSSON_TGFB1_TARGETS_UP"
101,"Down",6.93961827075578e-06,0.000292894270374112,"B.LvsV.FURUKAWA_DUSP6_TARGETS_PCI35_DN"
70,"Down",7.1818703785429e-06,0.000300822434264877,"B.LvsV.YAMASHITA_LIVER_CANCER_WITH_EPCAM_UP"
800,"Down",7.34895406420768e-06,0.000305506518954919,"B.LvsV.MARSON_BOUND_BY_E2F4_UNSTIMULATED"
30,"Down",7.4527611053789e-06,0.000307509822027164,"B.LvsV.CAIRO_PML_TARGETS_BOUND_BY_MYC_UP"
278,"Down",7.86095646950393e-06,0.000321949839406572,"B.LvsV.REACTOME_SIGNALING_BY_ROBO_RECEPTORS"
192,"Down",8.40680276113081e-06,0.000341773621075678,"B.LvsV.BENPORATH_PROLIFERATION"
25,"Up",8.68798690201538e-06,0.000350626858257248,"B.LvsV.REACTOME_CELL_EXTRACELLULAR_MATRIX_INTERACTIONS"
30,"Up",9.57330832789719e-06,0.000383556679311185,"B.LvsV.REACTOME_ENERGY_DEPENDENT_REGULATION_OF_MTOR_BY_LKB1_AMPK"
95,"Down",1.17238939960801e-05,0.000466341078448395,"B.LvsV.BURTON_ADIPOGENESIS_PEAK_AT_24HR"
108,"Up",1.21277636818551e-05,0.000478960038549834,"B.LvsV.REACTOME_RESPIRATORY_ELECTRON_TRANSPORT"
544,"Up",1.28812687111112e-05,0.000505110175203786,"B.LvsV.SHEN_SMARCA2_TARGETS_UP"
189,"Up",1.37222076483255e-05,0.000534296380898534,"B.LvsV.REACTOME_THE_CITRIC_ACID_TCA_CYCLE_AND_RESPIRATORY_ELECTRON_TRANSPORT"
49,"Up",1.40288804738926e-05,0.000542417343637428,"B.LvsV.REACTOME_TBC_RABGAPS"
38,"Down",1.41987994576495e-05,0.000545174737509335,"B.LvsV.REACTOME_ACTIVATION_OF_ATR_IN_RESPONSE_TO_REPLICATION_STRESS"
99,"Down",1.52963131399758e-05,0.000583264243799492,"B.LvsV.LY_AGING_OLD_DN"
17,"Down",1.57268195257148e-05,0.00059557250107998,"B.LvsV.REACTOME_POLYMERASE_SWITCHING_ON_THE_C_STRAND_OF_THE_TELOMERE"
29,"Down",1.81798014941745e-05,0.000683783145995176,"B.LvsV.PETROVA_PROX1_TARGETS_UP"
48,"Down",1.87875799608553e-05,0.000701868443267356,"B.LvsV.YU_BAP1_TARGETS"
93,"Down",1.96917953422603e-05,0.000730710982868169,"B.LvsV.VERNELL_RETINOBLASTOMA_PATHWAY_UP"
303,"Down",1.99054774675556e-05,0.0007337158994541,"B.LvsV.SANSOM_APC_TARGETS_REQUIRE_MYC"
149,"Down",2.02581591235163e-05,0.00073811169977001,"B.LvsV.GAVIN_FOXP3_TARGETS_CLUSTER_P6"
173,"Down",2.02917305778697e-05,0.00073811169977001,"B.LvsV.CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP"
74,"Down",2.04885160980674e-05,0.000740398728798787,"B.LvsV.SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_DN"
48,"Down",2.10174283124106e-05,0.000754580267138432,"B.LvsV.HOLLEMAN_ASPARAGINASE_RESISTANCE_B_ALL_UP"
58,"Down",2.1967889319063e-05,0.000783615871258707,"B.LvsV.REACTOME_SNRNP_ASSEMBLY"
36,"Down",2.44146038848239e-05,0.000861395741785689,"B.LvsV.REACTOME_TERMINATION_OF_TRANSLESION_DNA_SYNTHESIS"
7,"Down",2.46131660700156e-05,0.000861395741785689,"B.LvsV.REACTOME_PHOSPHORYLATION_OF_EMI1"
42,"Down",2.48443756790476e-05,0.000861395741785689,"B.LvsV.REACTOME_INTERACTIONS_OF_VPR_WITH_HOST_CELLULAR_PROTEINS"
14,"Down",2.4911572048005e-05,0.000861395741785689,"B.LvsV.REACTOME_POLYMERASE_SWITCHING"
35,"Down",2.4927350096891e-05,0.000861395741785689,"B.LvsV.REACTOME_REGULATION_OF_GLUCOKINASE_BY_GLUCOKINASE_REGULATORY_PROTEIN"
17,"Down",2.55323700192198e-05,0.000876822818858796,"B.LvsV.REACTOME_TELOMERE_EXTENSION_BY_TELOMERASE"
18,"Down",2.63481310763695e-05,0.000899251955069424,"B.LvsV.REACTOME_NUCLEOBASE_BIOSYNTHESIS"
20,"Down",2.67066023215575e-05,0.000905894504514671,"B.LvsV.REACTOME_LAGGING_STRAND_SYNTHESIS"
131,"Down",2.75653611662095e-05,0.000929322450536418,"B.LvsV.RHODES_UNDIFFERENTIATED_CANCER"
77,"Down",2.87720683721011e-05,0.000964125854723314,"B.LvsV.BURTON_ADIPOGENESIS_PEAK_AT_16HR"
106,"Down",3.04999583852007e-05,0.00101586909585406,"B.LvsV.RHODES_CANCER_META_SIGNATURE"
50,"Up",3.29246551719378e-05,0.00109006238590206,"B.LvsV.REACTOME_ACTIVATION_OF_GENE_EXPRESSION_BY_SREBF_SREBP"
73,"Down",3.44264042498566e-05,0.00113299755415153,"B.LvsV.SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_UP"
64,"Up",3.48821559930953e-05,0.00114120378985695,"B.LvsV.REACTOME_RAB_GERANYLGERANYLATION"
121,"Down",3.65776172216588e-05,0.0011873892880898,"B.LvsV.GROSS_HYPOXIA_VIA_HIF1A_UP"
27,"Up",3.67233800440145e-05,0.0011873892880898,"B.LvsV.REACTOME_CITRIC_ACID_CYCLE_TCA_CYCLE"
86,"Down",3.73193811334626e-05,0.00119964452492392,"B.LvsV.ZAMORA_NOS2_TARGETS_UP"
50,"Down",3.81555262540008e-05,0.00121737715252048,"B.LvsV.PID_AURORA_B_PATHWAY"
62,"Down",3.83113808172479e-05,0.00121737715252048,"B.LvsV.LY_AGING_PREMATURE_DN"
33,"Up",3.94643605737561e-05,0.00124684828349884,"B.LvsV.KEGG_CITRATE_CYCLE_TCA_CYCLE"
211,"Down",4.10527489767939e-05,0.00128966277893576,"B.LvsV.SCHLOSSER_MYC_TARGETS_REPRESSED_BY_SERUM"
51,"Down",4.19861262955813e-05,0.00131153272479248,"B.LvsV.REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS"
40,"Down",4.34104744115673e-05,0.00134840737652559,"B.LvsV.REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY"
53,"Down",4.38041872308457e-05,0.00135303548156059,"B.LvsV.REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS"
49,"Up",4.46000169580251e-05,0.00136996385422734,"B.LvsV.PID_MAPK_TRK_PATHWAY"
153,"Down",4.57908129481349e-05,0.00139877019221126,"B.LvsV.REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION"
20,"Down",4.82585139078441e-05,0.00146605122745313,"B.LvsV.REACTOME_POLO_LIKE_KINASE_MEDIATED_EVENTS"
133,"Up",5.39056741332529e-05,0.001628658318485,"B.LvsV.REACTOME_RESPIRATORY_ELECTRON_TRANSPORT_ATP_SYNTHESIS_BY_CHEMIOSMOTIC_COUPLING_AND_HEAT_PRODUCTION_BY_UNCOUPLING_PROTEINS"
62,"Up",5.68920269882561e-05,0.00170954357183733,"B.LvsV.PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_DN"
64,"Down",5.75888432993749e-05,0.00172112818703916,"B.LvsV.REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS"
886,"Down",5.97994600900689e-05,0.00177758717654834,"B.LvsV.FEVR_CTNNB1_TARGETS_DN"
237,"Down",6.08356068444377e-05,0.00179871695317057,"B.LvsV.LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN"
165,"Down",6.46184640225313e-05,0.00190040152968391,"B.LvsV.REACTOME_MITOTIC_G1_PHASE_AND_G1_S_TRANSITION"
265,"Down",6.53957264587492e-05,0.00191308450576944,"B.LvsV.SHEPARD_CRUSH_AND_BURN_MUTANT_UP"
28,"Down",6.63043977834201e-05,0.00192945797549752,"B.LvsV.REACTOME_TELOMERE_C_STRAND_LAGGING_STRAND_SYNTHESIS"
139,"Up",6.95522324576947e-05,0.002013373263134,"B.LvsV.KEGG_OXIDATIVE_PHOSPHORYLATION"
61,"Down",7.20437100517151e-05,0.00207463371289548,"B.LvsV.REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_CELL_CYCLE_GENES"
19,"Down",7.37986885855779e-05,0.00211416035849565,"B.LvsV.REACTOME_TRANSCRIPTION_OF_E2F_TARGETS_UNDER_NEGATIVE_CONTROL_BY_P107_RBL1_AND_P130_RBL2_IN_COMPLEX_WITH_HDAC1"
90,"Down",7.64750940444947e-05,0.0021795401802681,"B.LvsV.ZHANG_RESPONSE_TO_CANTHARIDIN_DN"
14,"Down",7.73971771122415e-05,0.00219450765258248,"B.LvsV.MONTERO_THYROID_CANCER_POOR_SURVIVAL_UP"
28,"Up",7.8094272505057e-05,0.00220297567694112,"B.LvsV.HOLLERN_ADENOMYOEPITHELIAL_BREAST_TUMOR"
11,"Down",8.32791516978502e-05,0.00233472930535031,"B.LvsV.KALMA_E2F1_TARGETS"
6,"Down",8.36094054004995e-05,0.00233472930535031,"B.LvsV.CROSBY_E2F4_TARGETS"
40,"Down",8.43604737505457e-05,0.0023438646199335,"B.LvsV.LY_AGING_MIDDLE_DN"
21,"Down",8.58879802657073e-05,0.00237437321444548,"B.LvsV.REACTOME_PCNA_DEPENDENT_LONG_PATCH_BASE_EXCISION_REPAIR"
14,"Down",9.02978091775862e-05,0.00248006784095238,"B.LvsV.REACTOME_PURINE_RIBONUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHESIS"
12,"Down",9.06083747282295e-05,0.00248006784095238,"B.LvsV.REACTOME_CONDENSATION_OF_PROMETAPHASE_CHROMOSOMES"
73,"Down",9.51296745898569e-05,0.00259099493008532,"B.LvsV.LUI_TARGETS_OF_PAX8_PPARG_FUSION"
24,"Down",0.000102357780293576,0.00277419689825089,"B.LvsV.LOPEZ_MESOTELIOMA_SURVIVAL_TIME_UP"
59,"Down",0.000103064550673325,0.00277972634474543,"B.LvsV.CAFFAREL_RESPONSE_TO_THC_DN"
200,"Down",0.000104262568487105,0.00279838709303497,"B.LvsV.ODONNELL_TFRC_TARGETS_DN"
49,"Up",0.000109787199077012,0.00293243199853527,"B.LvsV.BIOCARTA_FMLP_PATHWAY"
296,"Down",0.000112559220529843,0.00299201889571876,"B.LvsV.DUTERTRE_ESTRADIOL_RESPONSE_6HR_UP"
65,"Down",0.000113702517988538,0.00300794843042405,"B.LvsV.REACTOME_DEADENYLATION_DEPENDENT_MRNA_DECAY"
63,"Up",0.000115962059283771,0.00305311536085699,"B.LvsV.TOMLINS_PROSTATE_CANCER_DN"
143,"Up",0.000119855819396188,0.00314067689782713,"B.LvsV.SASSON_RESPONSE_TO_FORSKOLIN_DN"
8,"Down",0.000123505840350646,0.00320154636059929,"B.LvsV.REACTOME_DNA_REPLICATION_INITIATION"
40,"Down",0.000123819760402289,0.00320154636059929,"B.LvsV.SHIN_B_CELL_LYMPHOMA_CLUSTER_2"
15,"Up",0.000123915883734536,0.00320154636059929,"B.LvsV.REACTOME_RHO_GTPASES_ACTIVATE_KTN1"
15,"Down",0.000125994459507895,0.00324010868194954,"B.LvsV.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_DN"
55,"Down",0.000128294821665158,0.00328399106012342,"B.LvsV.REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA"
211,"Down",0.000134419433627088,0.00342490805771507,"B.LvsV.WELCSH_BRCA1_TARGETS_DN"
24,"Up",0.000135087659924024,0.00342614528311894,"B.LvsV.BIOCARTA_ACTINY_PATHWAY"
69,"Down",0.00013812748373342,0.00348724592494101,"B.LvsV.REACTOME_HDR_THROUGH_HOMOLOGOUS_RECOMBINATION_HRR"
27,"Down",0.000142570401553076,0.00358305340994072,"B.LvsV.KEGG_RNA_POLYMERASE"
54,"Down",0.000143596311130336,0.00359250680651416,"B.LvsV.NAKAMURA_CANCER_MICROENVIRONMENT_DN"
59,"Down",0.000145893917100362,0.00362319685543809,"B.LvsV.REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN"
92,"Down",0.000146133640579254,0.00362319685543809,"B.LvsV.TIEN_INTESTINE_PROBIOTICS_6HR_UP"
278,"Down",0.000147508838137519,0.00364096591992116,"B.LvsV.FUJII_YBX1_TARGETS_DN"
397,"Down",0.000151263716418311,0.00370837629010341,"B.LvsV.BASAKI_YBX1_TARGETS_UP"
625,"Down",0.000151581306124683,0.00370837629010341,"B.LvsV.CUI_TCF21_TARGETS_2_UP"
15,"Down",0.000152487900831184,0.00371412160218332,"B.LvsV.LIANG_SILENCED_BY_METHYLATION_DN"
8,"Down",0.000160829045656249,0.00390010435716405,"B.LvsV.LOPEZ_MESOTHELIOMA_SURVIVAL_WORST_VS_BEST_DN"
22,"Down",0.000168915033563891,0.0040783022732522,"B.LvsV.REACTOME_TRANSCRIPTION_OF_E2F_TARGETS_UNDER_NEGATIVE_CONTROL_BY_DREAM_COMPLEX"
16,"Down",0.000182964946710019,0.0043983182189552,"B.LvsV.REACTOME_ATF6_ATF6_ALPHA_ACTIVATES_CHAPERONE_GENES"
21,"Up",0.000185805299306418,0.00444398241171725,"B.LvsV.REACTOME_BRANCHED_CHAIN_AMINO_ACID_CATABOLISM"
45,"Up",0.000186472041873468,0.00444398241171725,"B.LvsV.KEGG_PYRUVATE_METABOLISM"
546,"Down",0.000190924803906677,0.00452153083995789,"B.LvsV.BLUM_RESPONSE_TO_SALIRASIB_DN"
39,"Down",0.000191361587366639,0.00452153083995789,"B.LvsV.REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS"
27,"Up",0.000194427412949459,0.00457442198381941,"B.LvsV.GRANDVAUX_IFN_RESPONSE_NOT_VIA_IRF3"
54,"Up",0.000197018222424217,0.00460299124532319,"B.LvsV.BIOCARTA_MET_PATHWAY"
25,"Down",0.000197306732707831,0.00460299124532319,"B.LvsV.REACTOME_RESOLUTION_OF_AP_SITES_VIA_THE_MULTIPLE_NUCLEOTIDE_PATCH_REPLACEMENT_PATHWAY"
81,"Down",0.000200387822810584,0.0046552280349568,"B.LvsV.SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_UP"
46,"Up",0.000217234292077512,0.00502119940488202,"B.LvsV.SAKAI_TUMOR_INFILTRATING_MONOCYTES_UP"
22,"Down",0.000217957651866827,0.00502119940488202,"B.LvsV.LE_NEURONAL_DIFFERENTIATION_DN"
59,"Up",0.000223179294829718,0.00512015900876975,"B.LvsV.KEGG_VALINE_LEUCINE_AND_ISOLEUCINE_DEGRADATION"
119,"Down",0.000227383375693607,0.00519505241409072,"B.LvsV.SHEPARD_BMYB_TARGETS"
89,"Down",0.000237097669562051,0.00539470376546742,"B.LvsV.REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION_TERMINATION"
14,"Up",0.000268256999986148,0.00605448083497528,"B.LvsV.REACTOME_CALCINEURIN_ACTIVATES_NFAT"
163,"Down",0.000268285007156619,0.00605448083497528,"B.LvsV.KAUFFMANN_DNA_REPLICATION_GENES"
46,"Up",0.00027400260788733,0.00615837568702866,"B.LvsV.BIOCARTA_GPCR_PATHWAY"
117,"Up",0.000275372370487713,0.00616410460091728,"B.LvsV.PID_FAK_PATHWAY"
79,"Down",0.000280155067115573,0.00624587647613711,"B.LvsV.HESS_TARGETS_OF_HOXA9_AND_MEIS1_UP"
12,"Down",0.000293085805006941,0.00648978287180698,"B.LvsV.REACTOME_UNWINDING_OF_DNA"
31,"Down",0.000294266678794851,0.00648978287180698,"B.LvsV.DEN_INTERACT_WITH_LCA5"
89,"Up",0.000294616657772391,0.00648978287180698,"B.LvsV.GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_UP"
66,"Down",0.000302978176546765,0.00664748546875819,"B.LvsV.BOYAULT_LIVER_CANCER_SUBCLASS_G23_UP"
12,"Up",0.000321683205555566,0.00702998594275385,"B.LvsV.REACTOME_ARMS_MEDIATED_ACTIVATION"
63,"Up",0.000328210056661089,0.00714438347747701,"B.LvsV.REACTOME_EPHB_MEDIATED_FORWARD_SIGNALING"
60,"Up",0.000329882826625848,0.00715263587613457,"B.LvsV.REACTOME_PYRUVATE_METABOLISM_AND_CITRIC_ACID_TCA_CYCLE"
40,"Down",0.000339280271670807,0.00732765867995271,"B.LvsV.CHOW_RASSF1_TARGETS_DN"
20,"Down",0.000345527372352491,0.00743354413127207,"B.LvsV.CAFFAREL_RESPONSE_TO_THC_8HR_5_DN"
59,"Down",0.00034958942124028,0.0074896218943244,"B.LvsV.KEGG_RNA_DEGRADATION"
138,"Down",0.000350843203224818,0.0074896218943244,"B.LvsV.ZHENG_IL22_SIGNALING_UP"
36,"Down",0.000356031388459591,0.00757114441074261,"B.LvsV.REACTOME_HIV_ELONGATION_ARREST_AND_RECOVERY"
63,"Down",0.000358450789396768,0.007593388561589,"B.LvsV.BOYAULT_LIVER_CANCER_SUBCLASS_G123_UP"
106,"Down",0.000361083476228222,0.00761996389338107,"B.LvsV.BILANGES_RAPAMYCIN_SENSITIVE_VIA_TSC1_AND_TSC2"
37,"Up",0.000365547181221537,0.00768483028507179,"B.LvsV.BIOCARTA_ECM_PATHWAY"
284,"Down",0.000372239239422571,0.00779587407108862,"B.LvsV.BIDUS_METASTASIS_UP"
165,"Down",0.000375683294539684,0.00783831296418834,"B.LvsV.BHATTACHARYA_EMBRYONIC_STEM_CELL"
15,"Down",0.000388972692507416,0.00808507525140416,"B.LvsV.REACTOME_PROCESSIVE_SYNTHESIS_ON_THE_LAGGING_STRAND"
112,"Down",0.000394913113860681,0.00816423472789176,"B.LvsV.PID_E2F_PATHWAY"
74,"Down",0.00039573429319497,0.00816423472789176,"B.LvsV.NAKAJIMA_MAST_CELL"
22,"Up",0.000401434308393524,0.00824037960333195,"B.LvsV.BAUS_TFF2_TARGETS_DN"
80,"Down",0.000402405949158912,0.00824037960333195,"B.LvsV.TONG_INTERACT_WITH_PTTG1"
162,"Down",0.000411634984592621,0.00839826505465904,"B.LvsV.MARZEC_IL2_SIGNALING_UP"
10,"Down",0.000415445614253798,0.00844484853385752,"B.LvsV.REACTOME_SCAVENGING_BY_CLASS_F_RECEPTORS"
60,"Up",0.000419675503833798,0.00849086297919752,"B.LvsV.PID_ERBB2_ERBB3_PATHWAY"
93,"Up",0.000420780693850628,0.00849086297919752,"B.LvsV.KEGG_PEROXISOME"
17,"Down",0.000433136378080691,0.00870840376148414,"B.LvsV.BIOCARTA_SM_PATHWAY"
82,"Up",0.00045660714150959,0.0091470321935019,"B.LvsV.BIOCARTA_NFAT_PATHWAY"
10,"Up",0.000462552755525716,0.00923268658953677,"B.LvsV.REACTOME_BETA_OXIDATION_OF_PRISTANOYL_COA"
659,"Down",0.000494222833029495,0.00982934548136719,"B.LvsV.SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6"
45,"Down",0.000504371634722529,0.00997734441640107,"B.LvsV.REACTOME_NS1_MEDIATED_EFFECTS_ON_HOST_PATHWAYS"
109,"Up",0.000505273365272617,0.00997734441640107,"B.LvsV.KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM"
49,"Up",0.000515726909824995,0.0101475234321082,"B.LvsV.REACTOME_STRIATED_MUSCLE_CONTRACTION"
36,"Up",0.0005184608728217,0.0101651424320255,"B.LvsV.KEGG_SNARE_INTERACTIONS_IN_VESICULAR_TRANSPORT"
108,"Down",0.000529737695916824,0.0103495396492018,"B.LvsV.REN_BOUND_BY_E2F"
134,"Down",0.000531637813287691,0.0103500896819283,"B.LvsV.FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_DN"
47,"Up",0.000542103880344767,0.0105168152786885,"B.LvsV.REACTOME_LAMININ_INTERACTIONS"
31,"Up",0.000546940899437545,0.0105735532622035,"B.LvsV.BIOCARTA_UCALPAIN_PATHWAY"
43,"Down",0.000549451677158881,0.0105850812648483,"B.LvsV.REACTOME_TRANSLESION_SYNTHESIS_BY_Y_FAMILY_DNA_POLYMERASES_BYPASSES_LESIONS_ON_DNA_TEMPLATE"
18,"Down",0.000551568561199359,0.0105889672738585,"B.LvsV.BIOCARTA_NPC_PATHWAY"
63,"Down",0.000556332633589553,0.0106434710419261,"B.LvsV.SUNG_METASTASIS_STROMA_DN"
105,"Down",0.000563063754329287,0.0107351017161608,"B.LvsV.KEGG_PYRIMIDINE_METABOLISM"
19,"Up",0.000576858799779821,0.0109218114992979,"B.LvsV.MOOTHA_TCA"
7,"Up",0.000577528725804326,0.0109218114992979,"B.LvsV.REACTOME_PROTEIN_REPAIR"
15,"Up",0.000578782920834561,0.0109218114992979,"B.LvsV.REACTOME_VLDLR_INTERNALISATION_AND_DEGRADATION"
36,"Up",0.000591364795406243,0.0111212787544256,"B.LvsV.ABDULRAHMAN_KIDNEY_CANCER_VHL_DN"
224,"Down",0.000600773352291061,0.0112599181858213,"B.LvsV.PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_UP"
663,"Up",0.000617958968617065,0.0115204965095452,"B.LvsV.BERENJENO_TRANSFORMED_BY_RHOA_DN"
88,"Down",0.000618843816844803,0.0115204965095452,"B.LvsV.REACTOME_DNA_REPLICATION_PRE_INITIATION"
18,"Down",0.000623432629852957,0.011560238255395,"B.LvsV.BIOCARTA_CLASSIC_PATHWAY"
33,"Up",0.000626222190135596,0.011560238255395,"B.LvsV.REACTOME_GP1B_IX_V_ACTIVATION_SIGNALLING"
154,"Up",0.000627251126174445,0.011560238255395,"B.LvsV.SASSON_RESPONSE_TO_GONADOTROPHINS_DN"
43,"Down",0.000636015506075657,0.0116828230335293,"B.LvsV.REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS"
349,"Down",0.00066628371101254,0.0121982868814183,"B.LvsV.BENPORATH_MYC_TARGETS_WITH_EBOX"
50,"Down",0.000694011918282064,0.0126639996573648,"B.LvsV.LOPEZ_TRANSLATION_VIA_FN1_SIGNALING"
12,"Up",0.000701009505717733,0.0127496103852413,"B.LvsV.BIOCARTA_MALATEX_PATHWAY"
51,"Down",0.000705718038261657,0.012793164044422,"B.LvsV.REACTOME_RNA_POLYMERASE_I_TRANSCRIPTION_INITIATION"
43,"Down",0.000708399866917492,0.0127998132816563,"B.LvsV.REACTOME_HOMOLOGOUS_DNA_PAIRING_AND_STRAND_EXCHANGE"
94,"Up",0.000711879056552044,0.0128207794908021,"B.LvsV.MOOTHA_VOXPHOS"
33,"Down",0.000717175185987153,0.0128742259848148,"B.LvsV.REACTOME_DEADENYLATION_OF_MRNA"
45,"Up",0.000722479048533291,0.0129215006378094,"B.LvsV.REACTOME_MTOR_SIGNALLING"
45,"Down",0.000724482763197853,0.0129215006378094,"B.LvsV.BILANGES_RAPAMYCIN_SENSITIVE_GENES"
36,"Down",0.000759403717278501,0.0135007818419062,"B.LvsV.REACTOME_FGFR2_ALTERNATIVE_SPLICING"
18,"Down",0.00076204508345299,0.0135043181615756,"B.LvsV.REACTOME_ATF6_ATF6_ALPHA_ACTIVATES_CHAPERONES"
21,"Up",0.000765100490267262,0.0135151457210469,"B.LvsV.REACTOME_CLASS_I_PEROXISOMAL_MEMBRANE_PROTEIN_IMPORT"
50,"Up",0.000778217663913281,0.013703074725403,"B.LvsV.REACTOME_RETROGRADE_TRANSPORT_AT_THE_TRANS_GOLGI_NETWORK"
15,"Up",0.000831046744206439,0.0145868490435473,"B.LvsV.YAMASHITA_SILENCED_BY_METHYLATION"
87,"Up",0.000859452787302002,0.0150377039904834,"B.LvsV.EBAUER_MYOGENIC_TARGETS_OF_PAX3_FOXO1_FUSION"
27,"Down",0.000865756523972414,0.0151002139465094,"B.LvsV.REACTOME_GAP_FILLING_DNA_REPAIR_SYNTHESIS_AND_LIGATION_IN_GG_NER"
62,"Down",0.000900760704098064,0.0156613394118182,"B.LvsV.REACTOME_FORMATION_OF_RNA_POL_II_ELONGATION_COMPLEX"
66,"Up",0.000906195496926959,0.0156693433746672,"B.LvsV.REACTOME_REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF"
41,"Down",0.000906889108318592,0.0156693433746672,"B.LvsV.REACTOME_SMAD2_SMAD3_SMAD4_HETEROTRIMER_REGULATES_TRANSCRIPTION"
295,"Down",0.000920422254193418,0.015853628172696,"B.LvsV.WHITFIELD_CELL_CYCLE_G2_M"
74,"Down",0.000925296271325063,0.0158880841122866,"B.LvsV.MARSON_FOXP3_TARGETS_DN"
93,"Up",0.000928218067556581,0.0158889092740568,"B.LvsV.ULE_SPLICING_VIA_NOVA2"
36,"Down",0.000939046169117888,0.016024648978558,"B.LvsV.NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_UP"
19,"Up",0.00095753185176247,0.0162898264873683,"B.LvsV.REACTOME_PROLONGED_ERK_ACTIVATION_EVENTS"
37,"Up",0.000968212112840685,0.0164209962328103,"B.LvsV.BURTON_ADIPOGENESIS_10"
96,"Up",0.00097964027925809,0.0165640094924097,"B.LvsV.REACTOME_TRANSLOCATION_OF_SLC2A4_GLUT4_TO_THE_PLASMA_MEMBRANE"
24,"Down",0.000991631540602629,0.016701397432263,"B.LvsV.LEE_METASTASIS_AND_RNA_PROCESSING_UP"
98,"Down",0.00099380715413538,0.016701397432263,"B.LvsV.SLEBOS_HEAD_AND_NECK_CANCER_WITH_HPV_UP"
445,"Down",0.00101473007046111,0.0170013410896349,"B.LvsV.HORIUCHI_WTAP_TARGETS_DN"
51,"Down",0.00102267230860028,0.0170554021253041,"B.LvsV.BILANGES_SERUM_RESPONSE_TRANSLATION"
28,"Up",0.00102412615402441,0.0170554021253041,"B.LvsV.BIOCARTA_EPHA4_PATHWAY"
89,"Up",0.00102950742494541,0.0170935331907603,"B.LvsV.REACTOME_PI_METABOLISM"
209,"Down",0.00103433953969996,0.0171223452544942,"B.LvsV.YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_14"
19,"Down",0.0010411385806911,0.0171772281417728,"B.LvsV.BIOCARTA_EFP_PATHWAY"
22,"Up",0.00104386844920161,0.0171772281417728,"B.LvsV.BIOCARTA_CALCINEURIN_PATHWAY"
135,"Down",0.00105859499416722,0.0173678686135032,"B.LvsV.REACTOME_CHROMOSOME_MAINTENANCE"
341,"Up",0.00106711999893997,0.0174467104435911,"B.LvsV.BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_DN"
12,"Up",0.00106971149220065,0.0174467104435911,"B.LvsV.REACTOME_ACTIVATION_OF_PPARGC1A_PGC_1ALPHA_BY_PHOSPHORYLATION"
17,"Up",0.00108671164293464,0.017671849040546,"B.LvsV.KEGG_TERPENOID_BACKBONE_BIOSYNTHESIS"
26,"Down",0.00111788969088687,0.0181255486830308,"B.LvsV.REACTOME_RESOLUTION_OF_D_LOOP_STRUCTURES_THROUGH_SYNTHESIS_DEPENDENT_STRAND_ANNEALING_SDSA"
84,"Down",0.00112957020067433,0.0182613849109017,"B.LvsV.REACTOME_NUCLEAR_ENVELOPE_NE_REASSEMBLY"
67,"Up",0.00116452791381062,0.0187716467506091,"B.LvsV.LANDIS_ERBB2_BREAST_TUMORS_65_DN"
121,"Down",0.0011851926530581,0.0190047596285751,"B.LvsV.REACTOME_TRNA_PROCESSING"
66,"Down",0.00118586400286822,0.0190047596285751,"B.LvsV.REACTOME_TRNA_PROCESSING_IN_THE_NUCLEUS"
37,"Up",0.00119749186420714,0.0191356431132985,"B.LvsV.BIOCARTA_RHO_PATHWAY"
544,"Down",0.00123188831633417,0.0196285605216473,"B.LvsV.WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN"
14,"Down",0.00123562283128816,0.0196314903281386,"B.LvsV.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_12"
44,"Down",0.00124553520056922,0.0197322754267829,"B.LvsV.LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_UP"
78,"Down",0.00128006481416283,0.0201829308095298,"B.LvsV.REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS"
55,"Down",0.0012812820969696,0.0201829308095298,"B.LvsV.GENTILE_UV_LOW_DOSE_UP"
11,"Up",0.00129117379361362,0.0202809656388912,"B.LvsV.MIZUSHIMA_AUTOPHAGOSOME_FORMATION"
276,"Down",0.001305400971789,0.0204463511983609,"B.LvsV.FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP"
62,"Down",0.0013562821472197,0.0211832881129314,"B.LvsV.GREENBAUM_E2A_TARGETS_UP"
46,"Down",0.00136517769647664,0.0212621619262517,"B.LvsV.MOREIRA_RESPONSE_TO_TSA_UP"
58,"Up",0.00137508992310993,0.0213563825417831,"B.LvsV.NAKAMURA_ADIPOGENESIS_EARLY_DN"
106,"Down",0.00140636507822544,0.0217809314215923,"B.LvsV.REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE"
407,"Down",0.00144732444149113,0.0223526727290628,"B.LvsV.REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES"
15,"Down",0.00145671502418963,0.0224350344533273,"B.LvsV.REACTOME_MRNA_DECAY_BY_5_TO_3_EXORIBONUCLEASE"
5,"Down",0.00146831812211495,0.0225509191588155,"B.LvsV.REACTOME_G2_PHASE"
9,"Up",0.00149291868729557,0.022865228315948,"B.LvsV.REACTOME_SIGNALLING_TO_P38_VIA_RIT_AND_RIN"
52,"Down",0.00151845379972612,0.0231920747477506,"B.LvsV.PID_FOXM1_PATHWAY"
37,"Up",0.00152332044521143,0.0232023105828485,"B.LvsV.SHI_SPARC_TARGETS_UP"
13,"Down",0.00153055809147803,0.0232485046367638,"B.LvsV.MCCOLLUM_GELDANAMYCIN_RESISTANCE_DN"
1873,"Down",0.00153805293237339,0.0232983415427191,"B.LvsV.DODD_NASOPHARYNGEAL_CARCINOMA_DN"
239,"Up",0.00154608688045445,0.0233560501694881,"B.LvsV.KEGG_FOCAL_ADHESION"
373,"Down",0.00156777362306918,0.0236191290516335,"B.LvsV.MEISSNER_BRAIN_HCP_WITH_H3K27ME3"
5,"Up",0.00159371225359889,0.0239446604623593,"B.LvsV.REACTOME_PROPIONYL_COA_CATABOLISM"
411,"Down",0.00161269456882553,0.0241494340718524,"B.LvsV.GRADE_COLON_AND_RECTAL_CANCER_UP"
47,"Down",0.00161607715800061,0.0241494340718524,"B.LvsV.PID_ATR_PATHWAY"
188,"Up",0.00162750451494411,0.024254642757752,"B.LvsV.PID_PDGFRB_PATHWAY"
28,"Down",0.00166887425044578,0.0248043164804159,"B.LvsV.WEST_ADRENOCORTICAL_TUMOR_MARKERS_UP"
28,"Down",0.00167386540128481,0.0248118010823156,"B.LvsV.REACTOME_CYTOSOLIC_TRNA_AMINOACYLATION"
13,"Down",0.00169573573930447,0.0250090341054304,"B.LvsV.FUNG_IL2_SIGNALING_1"
295,"Down",0.00169621772283169,0.0250090341054304,"B.LvsV.LI_AMPLIFIED_IN_LUNG_CANCER"
2390,"Down",0.00171138826665095,0.0251656003359391,"B.LvsV.PUJANA_BRCA1_PCC_NETWORK"
48,"Down",0.00175859735443162,0.0257912062935078,"B.LvsV.DELPUECH_FOXO3_TARGETS_DN"
35,"Down",0.0017645827855727,0.0258105243953214,"B.LvsV.JIANG_TIP30_TARGETS_DN"
590,"Down",0.00177400474424839,0.0258527413251535,"B.LvsV.BENPORATH_ES_1"
151,"Up",0.00178335990645388,0.0258527413251535,"B.LvsV.LE_EGR2_TARGETS_DN"
113,"Up",0.00178380328950549,0.0258527413251535,"B.LvsV.BURTON_ADIPOGENESIS_11"
272,"Down",0.00178617239757798,0.0258527413251535,"B.LvsV.BOYAULT_LIVER_CANCER_SUBCLASS_G3_UP"
37,"Up",0.00180024599747305,0.0259884076240952,"B.LvsV.REACTOME_SUMOYLATION_OF_INTRACELLULAR_RECEPTORS"
21,"Up",0.00180763769961504,0.026027158440551,"B.LvsV.NIKOLSKY_BREAST_CANCER_21Q22_AMPLICON"
607,"Down",0.00182886032659926,0.0262643344045905,"B.LvsV.GARY_CD5_TARGETS_DN"
347,"Down",0.00183551066700229,0.0262915504607659,"B.LvsV.MITSIADES_RESPONSE_TO_APLIDIN_DN"
11,"Down",0.00184419541045846,0.0263476910191856,"B.LvsV.REACTOME_UREA_CYCLE"
63,"Down",0.00186353987264598,0.0265554431852052,"B.LvsV.BENPORATH_ES_2"
24,"Up",0.00191931360435874,0.027279909816194,"B.LvsV.PID_P38_MK2_PATHWAY"
14,"Down",0.0019413940520993,0.0275101986997113,"B.LvsV.ZHOU_PANCREATIC_BETA_CELL"
14,"Down",0.0019454671173064,0.0275101986997113,"B.LvsV.REACTOME_EICOSANOID_LIGAND_BINDING_RECEPTORS"
31,"Down",0.00198521467146672,0.0280006426493355,"B.LvsV.JEON_SMAD6_TARGETS_DN"
9,"Down",0.00200758386305486,0.0282440996916801,"B.LvsV.REACTOME_RUNX1_REGULATES_EXPRESSION_OF_COMPONENTS_OF_TIGHT_JUNCTIONS"
41,"Up",0.00201717364201994,0.0283069874790057,"B.LvsV.REACTOME_EGR2_AND_SOX10_MEDIATED_INITIATION_OF_SCHWANN_CELL_MYELINATION"
83,"Down",0.00202801540848498,0.0283806439486121,"B.LvsV.MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_DN"
119,"Up",0.00203268855193532,0.0283806439486121,"B.LvsV.REACTOME_EPH_EPHRIN_SIGNALING"
28,"Down",0.00206373247524548,0.0287415034146909,"B.LvsV.REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_ADDITIONAL_CELL_CYCLE_GENES_WHOSE_EXACT_ROLE_IN_THE_P53_PATHWAY_REMAIN_UNCERTAIN"
5,"Up",0.00209720145512866,0.0291342383050412,"B.LvsV.JONES_TCOF1_TARGETS"
117,"Up",0.00210648131962194,0.029189812571904,"B.LvsV.KEGG_DILATED_CARDIOMYOPATHY"
23,"Up",0.00214115047578924,0.0295960524515967,"B.LvsV.REACTOME_DEFECTS_IN_VITAMIN_AND_COFACTOR_METABOLISM"
14,"Up",0.00217657887504641,0.0300107346636698,"B.LvsV.BIOCARTA_LEPTIN_PATHWAY"
19,"Up",0.00220476970652634,0.0303238102173735,"B.LvsV.REACTOME_ALPHA_LINOLENIC_OMEGA3_AND_LINOLEIC_OMEGA6_ACID_METABOLISM"
158,"Down",0.00223893066735482,0.0306493933006839,"B.LvsV.NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP"
13,"Down",0.00223952882862657,0.0306493933006839,"B.LvsV.WANG_ESOPHAGUS_CANCER_PROGRESSION_UP"
39,"Down",0.00227108610796848,0.0310045310887845,"B.LvsV.REACTOME_TRANSCRIPTIONAL_REGULATION_BY_E2F6"
74,"Down",0.00229116756778038,0.0311411588146568,"B.LvsV.REACTOME_DUAL_INCISION_IN_TC_NER"
22,"Down",0.00229470650221039,0.0311411588146568,"B.LvsV.SHIN_B_CELL_LYMPHOMA_CLUSTER_5"
16,"Up",0.00229799110081027,0.0311411588146568,"B.LvsV.REACTOME_CLEC7A_DECTIN_1_INDUCES_NFAT_ACTIVATION"
27,"Up",0.0023264366126428,0.0314495550887581,"B.LvsV.KAMIKUBO_MYELOID_MN1_NETWORK"
31,"Up",0.00236947485923399,0.0319532353578165,"B.LvsV.REACTOME_MISCELLANEOUS_TRANSPORT_AND_BINDING_EVENTS"
44,"Up",0.00241543940219639,0.032493830790131,"B.LvsV.REACTOME_RHO_GTPASES_ACTIVATE_WASPS_AND_WAVES"
37,"Up",0.00249902666144671,0.0335366951726672,"B.LvsV.BIOCARTA_CCR3_PATHWAY"
68,"Down",0.00253028057299048,0.0338180846237469,"B.LvsV.REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_DNA_REPAIR_GENES"
15,"Up",0.00253222771463759,0.0338180846237469,"B.LvsV.WORSCHECH_TUMOR_EVASION_AND_TOLEROGENICITY_DN"
12,"Up",0.0026030569288581,0.0346802452039914,"B.LvsV.YAMANAKA_GLIOBLASTOMA_SURVIVAL_DN"
134,"Up",0.00262083221586825,0.0348331281767682,"B.LvsV.SASSON_RESPONSE_TO_GONADOTROPHINS_UP"
5,"Up",0.00264308100108469,0.0350445919784107,"B.LvsV.BASSO_HAIRY_CELL_LEUKEMIA_DN"
74,"Down",0.00268381544481843,0.0354995588382802,"B.LvsV.BURTON_ADIPOGENESIS_PEAK_AT_8HR"
8,"Up",0.00284582776370979,0.0375527009679031,"B.LvsV.REACTOME_NEF_MEDIATED_CD8_DOWN_REGULATION"
41,"Up",0.00286920423132586,0.0377133523970537,"B.LvsV.PID_AR_NONGENOMIC_PATHWAY"
22,"Down",0.00287164430442388,0.0377133523970537,"B.LvsV.SA_REG_CASCADE_OF_CYCLIN_EXPR"
664,"Down",0.00289473280031622,0.0379062126211394,"B.LvsV.PUJANA_BRCA2_PCC_NETWORK"
105,"Up",0.002900041226034,0.0379062126211394,"B.LvsV.PID_VEGFR1_2_PATHWAY"
277,"Down",0.00291441161838931,0.0380042024482889,"B.LvsV.REACTOME_MITOTIC_METAPHASE_AND_ANAPHASE"
33,"Down",0.00294518640575813,0.0383151426763216,"B.LvsV.REACTOME_RESOLUTION_OF_D_LOOP_STRUCTURES"
454,"Up",0.00299351577006739,0.0388327236753754,"B.LvsV.DOUGLAS_BMI1_TARGETS_DN"
144,"Up",0.00299901844987978,0.0388327236753754,"B.LvsV.MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_UP"
15,"Down",0.00303747132392773,0.0392387358644775,"B.LvsV.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TAN_DN"
10,"Down",0.00310382735433081,0.0399251886874117,"B.LvsV.LUDWICZEK_TREATING_IRON_OVERLOAD"
30,"Down",0.00311029109825825,0.0399251886874117,"B.LvsV.IWANAGA_E2F1_TARGETS_INDUCED_BY_SERUM"
60,"Down",0.00311418557448512,0.0399251886874117,"B.LvsV.LUI_THYROID_CANCER_PAX8_PPARG_DN"
49,"Down",0.00311949385295023,0.0399251886874117,"B.LvsV.ONO_AML1_TARGETS_DN"
135,"Down",0.0031610076961515,0.0403345481456521,"B.LvsV.REACTOME_DNA_REPLICATION"
389,"Down",0.00316606870957009,0.0403345481456521,"B.LvsV.GAL_LEUKEMIC_STEM_CELL_DN"
57,"Up",0.00323426136494926,0.0410961601335518,"B.LvsV.REACTOME_MET_PROMOTES_CELL_MOTILITY"
240,"Down",0.00324071727585975,0.0410961601335518,"B.LvsV.REACTOME_MITOTIC_PROMETAPHASE"
63,"Down",0.00325239830816564,0.0411499090294001,"B.LvsV.SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2"
169,"Down",0.00328192973677977,0.0412105359720054,"B.LvsV.REACTOME_HIV_LIFE_CYCLE"
31,"Up",0.0032828476533025,0.0412105359720054,"B.LvsV.KANG_DOXORUBICIN_RESISTANCE_DN"
389,"Down",0.00328284994867148,0.0412105359720054,"B.LvsV.CHICAS_RB1_TARGETS_GROWING"
319,"Down",0.00328700422565642,0.0412105359720054,"B.LvsV.SHEPARD_CRUSH_AND_BURN_MUTANT_DN"
24,"Down",0.00331600438642547,0.0414800639197883,"B.LvsV.BIOCARTA_COMP_PATHWAY"
14,"Down",0.00334388959612395,0.0417344595416915,"B.LvsV.REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_G1_CELL_CYCLE_ARREST"
270,"Down",0.00337381448872379,0.0419316485861511,"B.LvsV.ONDER_CDH1_TARGETS_1_DN"
358,"Down",0.00337485686757773,0.0419316485861511,"B.LvsV.BOQUEST_STEM_CELL_DN"
41,"Up",0.00349279282653018,0.0432996671253035,"B.LvsV.PID_EPHA2_FWD_PATHWAY"
29,"Down",0.00365891229131936,0.0452575527040374,"B.LvsV.MULLIGAN_NTF3_SIGNALING_VIA_INSR_AND_IGF1R_UP"
58,"Up",0.00379070133140618,0.0467830081726446,"B.LvsV.REACTOME_AMINO_ACIDS_REGULATE_MTORC1"
26,"Down",0.00382240332971437,0.0470680652498678,"B.LvsV.REACTOME_FORMATION_OF_TUBULIN_FOLDING_INTERMEDIATES_BY_CCT_TRIC"
35,"Up",0.00383082462695614,0.0470680652498678,"B.LvsV.BIOCARTA_MPR_PATHWAY"
64,"Down",0.00384780862810309,0.0471719155316673,"B.LvsV.RIZ_ERYTHROID_DIFFERENTIATION_CCNE1"
17,"Down",0.00386844209456816,0.0473199476567861,"B.LvsV.REACTOME_INTERLEUKIN_2_SIGNALING"
191,"Down",0.00387851460367259,0.0473384265865469,"B.LvsV.SESTO_RESPONSE_TO_UV_C0"
50,"Down",0.00395709386127655,0.0481911276629913,"B.LvsV.ONO_FOXP3_TARGETS_DN"
183,"Down",0.00396963460199148,0.0482001713552326,"B.LvsV.GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP"
154,"Up",0.00397527186434908,0.0482001713552326,"B.LvsV.LEE_TARGETS_OF_PTCH1_AND_SUFU_DN"
84,"Down",0.00404970288097369,0.0489952018137933,"B.LvsV.YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_10"
15,"Up",0.00409672723471955,0.0494559058531973,"B.LvsV.MONTERO_THYROID_CANCER_POOR_SURVIVAL_DN"
32,"Up",0.00413362315288317,0.0496059068513479,"B.LvsV.REACTOME_GLYOXYLATE_METABOLISM_AND_GLYCINE_DEGRADATION"
38,"Down",0.0041351380068852,0.0496059068513479,"B.LvsV.CEBALLOS_TARGETS_OF_TP53_AND_MYC_UP"
14,"Down",0.00413606855823321,0.0496059068513479,"B.LvsV.REACTOME_FGFR3_LIGAND_BINDING_AND_ACTIVATION"
15,"Down",0.00415268772253104,0.0496974251469137,"B.LvsV.NEBEN_AML_WITH_FLT3_OR_NRAS_UP"
33,"Down",0.00430235623067548,0.0513773814242003,"B.LvsV.PID_BARD1_PATHWAY"
13,"Up",0.00433779516380509,0.0516889428031861,"B.LvsV.REACTOME_REGULATION_OF_CYTOSKELETAL_REMODELING_AND_CELL_SPREADING_BY_IPP_COMPLEX_COMPONENTS"
41,"Down",0.00441664148845987,0.0525152920208487,"B.LvsV.REACTOME_PERK_REGULATES_GENE_EXPRESSION"
1038,"Down",0.00445095313423963,0.0528096993116114,"B.LvsV.WEI_MYCN_TARGETS_WITH_E_BOX"
36,"Up",0.00450218264513439,0.0533031431369337,"B.LvsV.KEGG_PROPANOATE_METABOLISM"
40,"Down",0.00451241021851122,0.053310077132796,"B.LvsV.SIMBULAN_PARP1_TARGETS_DN"
18,"Up",0.00453296015681611,0.0534386710171349,"B.LvsV.XU_RESPONSE_TO_TRETINOIN_DN"
13,"Down",0.00456221393163168,0.0536691081446629,"B.LvsV.MIKKELSEN_NPC_WITH_LCP_H3K27ME3"
23,"Down",0.0046090273307196,0.0540818773734073,"B.LvsV.REACTOME_CHL1_INTERACTIONS"
189,"Up",0.00461686491594289,0.0540818773734073,"B.LvsV.KEGG_ALZHEIMERS_DISEASE"
7,"Down",0.00462696111270497,0.0540855560087648,"B.LvsV.ZERBINI_RESPONSE_TO_SULINDAC_DN"
51,"Down",0.00465201670241028,0.0542637138135579,"B.LvsV.XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_DN"
19,"Down",0.00468471556073266,0.0544208180083831,"B.LvsV.REACTOME_RNA_POLYMERASE_III_CHAIN_ELONGATION"
60,"Up",0.0046906720987303,0.0544208180083831,"B.LvsV.REACTOME_SYNTHESIS_OF_PIPS_AT_THE_PLASMA_MEMBRANE"
37,"Down",0.00469501359920397,0.0544208180083831,"B.LvsV.REACTOME_FGFR2_MUTANT_RECEPTOR_ACTIVATION"
12,"Up",0.00470516097280028,0.0544243410431229,"B.LvsV.VANDESLUIS_NORMAL_EMBRYOS_UP"
415,"Down",0.00471979174288839,0.0544796003056992,"B.LvsV.FOURNIER_ACINAR_DEVELOPMENT_LATE_2"
23,"Down",0.00475284138047591,0.0547467916513569,"B.LvsV.GRASEMANN_RETINOBLASTOMA_WITH_6P_AMPLIFICATION"
191,"Down",0.00482869847316553,0.0553647473392316,"B.LvsV.BOYLAN_MULTIPLE_MYELOMA_C_D_UP"
129,"Down",0.00483868146548458,0.0553647473392316,"B.LvsV.REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS"
136,"Down",0.00484591540310932,0.0553647473392316,"B.LvsV.BENPORATH_ES_CORE_NINE_CORRELATED"
30,"Down",0.00484654326500056,0.0553647473392316,"B.LvsV.MILICIC_FAMILIAL_ADENOMATOUS_POLYPOSIS_DN"
62,"Down",0.00487710640201142,0.0555990129829302,"B.LvsV.VALK_AML_CLUSTER_6"
87,"Down",0.00491224648028365,0.0558843843405109,"B.LvsV.REACTOME_TRANSCRIPTION_COUPLED_NUCLEOTIDE_EXCISION_REPAIR_TC_NER"
20,"Up",0.00500668349520154,0.0568417927001424,"B.LvsV.REACTOME_SYNTHESIS_OF_PIPS_AT_THE_GOLGI_MEMBRANE"
56,"Up",0.00513244764325128,0.0581502111056073,"B.LvsV.WANG_NFKB_TARGETS"
23,"Down",0.00516261641811697,0.0583724052674207,"B.LvsV.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_UP"
32,"Up",0.00524670900482447,0.0591210087406159,"B.LvsV.DORN_ADENOVIRUS_INFECTION_48HR_UP"
10,"Up",0.00525021075992809,0.0591210087406159,"B.LvsV.BIOCARTA_PPARG_PATHWAY"
16,"Up",0.00527425296580777,0.0591660057642993,"B.LvsV.BIOCARTA_CDC42RAC_PATHWAY"
36,"Up",0.00527560876140343,0.0591660057642993,"B.LvsV.KEGG_REGULATION_OF_AUTOPHAGY"
13,"Down",0.00529414205570641,0.0592536668542525,"B.LvsV.REACTOME_EGFR_INTERACTS_WITH_PHOSPHOLIPASE_C_GAMMA"
54,"Down",0.00533664846176442,0.0595649687500034,"B.LvsV.PLASARI_TGFB1_SIGNALING_VIA_NFIC_10HR_DN"
273,"Down",0.00534350235123923,0.0595649687500034,"B.LvsV.PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP"
45,"Up",0.0054482314880681,0.0606102050252083,"B.LvsV.PID_REELIN_PATHWAY"
17,"Down",0.00550663264960364,0.0611054228673176,"B.LvsV.FU_INTERACT_WITH_ALKBH8"
38,"Up",0.00551485006525438,0.0611054228673176,"B.LvsV.REACTOME_PEROXISOMAL_LIPID_METABOLISM"
6,"Up",0.00557271107196293,0.0616145213861679,"B.LvsV.PALOMERO_GSI_SENSITIVITY_DN"
95,"Down",0.00558308468339123,0.0616145213861679,"B.LvsV.KEGG_COMPLEMENT_AND_COAGULATION_CASCADES"
39,"Down",0.00560859865092827,0.0617727927111204,"B.LvsV.REACTOME_RESOLUTION_OF_ABASIC_SITES_AP_SITES"
20,"Up",0.00563626809897247,0.0619541278712104,"B.LvsV.BIOCARTA_PGC1A_PATHWAY"
12,"Up",0.00567365714234516,0.0622413697222745,"B.LvsV.REACTOME_ROLE_OF_ABL_IN_ROBO_SLIT_SIGNALING"
15,"Up",0.00570719332520801,0.0624852908813368,"B.LvsV.REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_TO_CONTROL_BILE_ACID_HOMEOSTASIS"
32,"Up",0.0057474709384073,0.0626627321673877,"B.LvsV.FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_UP"
37,"Up",0.00575847145764556,0.0626627321673877,"B.LvsV.YANAGIHARA_ESX1_TARGETS"
37,"Down",0.00576390725715538,0.0626627321673877,"B.LvsV.SARTIPY_BLUNTED_BY_INSULIN_RESISTANCE_UP"
86,"Down",0.00578241217449612,0.0626627321673877,"B.LvsV.DIRMEIER_LMP1_RESPONSE_LATE_UP"
23,"Down",0.00578420601120782,0.0626627321673877,"B.LvsV.REACTOME_E2F_MEDIATED_REGULATION_OF_DNA_REPLICATION"
32,"Up",0.0057914010015437,0.0626627321673877,"B.LvsV.REACTOME_RHO_GTPASES_ACTIVATE_CIT"
7,"Down",0.00595551430527999,0.0642865548845684,"B.LvsV.BIOCARTA_RAN_PATHWAY"
7,"Up",0.00596473189650634,0.0642865548845684,"B.LvsV.LIU_CMYB_TARGETS_DN"
26,"Down",0.00608284047058787,0.0654319551787555,"B.LvsV.REACTOME_PROTEIN_METHYLATION"
30,"Down",0.00610853953519389,0.0654895811460383,"B.LvsV.REACTOME_RNA_POLYMERASE_III_TRANSCRIPTION_INITIATION_FROM_TYPE_1_PROMOTER"
15,"Up",0.00611188711726456,0.0654895811460383,"B.LvsV.REACTOME_SYNTHESIS_OF_PIPS_AT_THE_LATE_ENDOSOME_MEMBRANE"
1333,"Down",0.00618428730060752,0.0661371846906363,"B.LvsV.KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_DN"
97,"Down",0.00619842652433291,0.0661604251989125,"B.LvsV.AMIT_SERUM_RESPONSE_120_MCF10A"
40,"Up",0.00624897877947204,0.0665714906969189,"B.LvsV.KEGG_FRUCTOSE_AND_MANNOSE_METABOLISM"
70,"Up",0.0062809808349356,0.0667837366083826,"B.LvsV.PETRETTO_CARDIAC_HYPERTROPHY"
20,"Up",0.00633911285710659,0.0672321714939087,"B.LvsV.REACTOME_DISEASES_ASSOCIATED_WITH_GLYCOSYLATION_PRECURSOR_BIOSYNTHESIS"
42,"Up",0.00635762440686347,0.0672321714939087,"B.LvsV.REACTOME_RAF_ACTIVATION"
18,"Down",0.00635963568300131,0.0672321714939087,"B.LvsV.BIOCARTA_MCM_PATHWAY"
32,"Up",0.00646636066676812,0.0682299773407652,"B.LvsV.BIOCARTA_PDZS_PATHWAY"
140,"Down",0.00658131912740787,0.0693106922960726,"B.LvsV.REACTOME_MITOTIC_SPINDLE_CHECKPOINT"
57,"Up",0.00659421204093927,0.0693144455786183,"B.LvsV.WENG_POR_TARGETS_GLOBAL_UP"
61,"Down",0.00666561128994432,0.0698392219852244,"B.LvsV.PID_PLK1_PATHWAY"
65,"Down",0.0066693993865434,0.0698392219852244,"B.LvsV.PRAMOONJAGO_SOX4_TARGETS_DN"
40,"Down",0.00674363113937435,0.0704830558971659,"B.LvsV.REACTOME_HDR_THROUGH_SINGLE_STRAND_ANNEALING_SSA"
34,"Down",0.00678613683711121,0.0707934916460149,"B.LvsV.MAHADEVAN_IMATINIB_RESISTANCE_DN"
178,"Down",0.00689614957900995,0.0718056704752279,"B.LvsV.REACTOME_S_PHASE"
452,"Up",0.00695877695471005,0.072321574779308,"B.LvsV.GABRIELY_MIR21_TARGETS"
63,"Up",0.00700938014518775,0.0725788074150841,"B.LvsV.ZHAN_MULTIPLE_MYELOMA_LB_DN"
48,"Down",0.00700978172538523,0.0725788074150841,"B.LvsV.YANG_BREAST_CANCER_ESR1_BULK_UP"
5,"Up",0.00709514626914722,0.0733253527516168,"B.LvsV.REACTOME_DISINHIBITION_OF_SNARE_FORMATION"
35,"Up",0.00712025666457211,0.0734203116536694,"B.LvsV.GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN"
38,"Down",0.00713089299294998,0.0734203116536694,"B.LvsV.WANG_METASTASIS_OF_BREAST_CANCER_ESR1_UP"
32,"Down",0.00725915987604703,0.0745791877940744,"B.LvsV.REACTOME_RNA_POLYMERASE_I_TRANSCRIPTION_TERMINATION"
170,"Down",0.00727042543335252,0.0745791877940744,"B.LvsV.KEGG_PURINE_METABOLISM"
35,"Up",0.00731501359702068,0.0748976114406062,"B.LvsV.BIOCARTA_MCALPAIN_PATHWAY"
63,"Down",0.00735510319875586,0.0749135447183539,"B.LvsV.KORKOLA_EMBRYONAL_CARCINOMA_UP"
19,"Up",0.00735712723260317,0.0749135447183539,"B.LvsV.TAKAYAMA_BOUND_BY_AR"
257,"Up",0.00735721735975152,0.0749135447183539,"B.LvsV.LANDIS_ERBB2_BREAST_TUMORS_324_DN"
21,"Down",0.00759577126483272,0.0772004031677576,"B.LvsV.KUROKAWA_LIVER_CANCER_EARLY_RECURRENCE_UP"
34,"Down",0.00774318126541995,0.0785542187458842,"B.LvsV.REACTOME_COOPERATION_OF_PREFOLDIN_AND_TRIC_CCT_IN_ACTIN_AND_TUBULIN_FOLDING"
55,"Down",0.00785909254244889,0.0795841074490841,"B.LvsV.REACTOME_DNA_DAMAGE_BYPASS"
238,"Down",0.00794345527563902,0.0802913422650972,"B.LvsV.WHITFIELD_CELL_CYCLE_G2"
103,"Down",0.00796086349239041,0.0803204639588076,"B.LvsV.MORI_MATURE_B_LYMPHOCYTE_DN"
22,"Down",0.00801317286242115,0.0804743463142985,"B.LvsV.KEGG_MISMATCH_REPAIR"
25,"Down",0.00801501561642452,0.0804743463142985,"B.LvsV.REACTOME_INITIATION_OF_NUCLEAR_ENVELOPE_NE_REFORMATION"
47,"Down",0.00803175853860564,0.0804743463142985,"B.LvsV.VALK_AML_CLUSTER_1"
284,"Down",0.00803433517191043,0.0804743463142985,"B.LvsV.ANDERSEN_CHOLANGIOCARCINOMA_CLASS2"
59,"Up",0.00809402504613523,0.0809256138880319,"B.LvsV.PID_CXCR3_PATHWAY"
86,"Up",0.00817006962028897,0.0814876286977173,"B.LvsV.KENNY_CTNNB1_TARGETS_DN"
68,"Down",0.0081863432508002,0.0814876286977173,"B.LvsV.PID_FANCONI_PATHWAY"
67,"Up",0.00819445135755667,0.0814876286977173,"B.LvsV.PID_EPHB_FWD_PATHWAY"
8,"Down",0.0083423299387654,0.0828092320133463,"B.LvsV.LU_TUMOR_ENDOTHELIAL_MARKERS_DN"
166,"Down",0.00838713544375479,0.0831047882948392,"B.LvsV.REACTOME_RHO_GTPASES_ACTIVATE_FORMINS"
66,"Down",0.00853966813867681,0.0844648034682363,"B.LvsV.JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_DN"
9,"Down",0.00857384227899254,0.0846513820724103,"B.LvsV.GLINSKY_CANCER_DEATH_UP"
9,"Down",0.00860051944119916,0.0847634081825136,"B.LvsV.REACTOME_RUNX1_REGULATES_ESTROGEN_RECEPTOR_MEDIATED_TRANSCRIPTION"
29,"Up",0.00865632886613864,0.0851616411047696,"B.LvsV.DORN_ADENOVIRUS_INFECTION_32HR_UP"
16,"Up",0.00872793977746361,0.0856441974903997,"B.LvsV.REACTOME_PI3K_AKT_ACTIVATION"
26,"Up",0.00873635872392574,0.0856441974903997,"B.LvsV.BIOCARTA_MEF2D_PATHWAY"
64,"Down",0.008768926516127,0.0858113180666658,"B.LvsV.REACTOME_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER"
333,"Down",0.00883101059011461,0.0862661794218086,"B.LvsV.BILD_MYC_ONCOGENIC_SIGNATURE"
9,"Up",0.00887585868299449,0.0865513627130098,"B.LvsV.REACTOME_SMALL_INTERFERING_RNA_SIRNA_BIOGENESIS"
54,"Up",0.00889644039576547,0.0865993291341325,"B.LvsV.PID_ERB_GENOMIC_PATHWAY"
16,"Down",0.0089646097929905,0.0870972416459705,"B.LvsV.BIOCARTA_RB_PATHWAY"
165,"Down",0.00897909707690418,0.0870972416459705,"B.LvsV.MALONEY_RESPONSE_TO_17AAG_DN"
7,"Down",0.00900099567935209,0.0871567515081221,"B.LvsV.REACTOME_ACTIVATION_OF_C3_AND_C5"
63,"Down",0.00921099710277274,0.0890263679878741,"B.LvsV.SU_PLACENTA"
127,"Down",0.00922628121849373,0.0890263679878741,"B.LvsV.PYEON_HPV_POSITIVE_TUMORS_UP"
556,"Down",0.00935154608203683,0.0900778715811526,"B.LvsV.POOLA_INVASIVE_BREAST_CANCER_UP"
89,"Up",0.00943286220765254,0.0907031219932364,"B.LvsV.KEGG_LONG_TERM_POTENTIATION"
146,"Up",0.00948209281344657,0.0910182138290731,"B.LvsV.YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_16"
55,"Up",0.00952978640134792,0.0912760445053373,"B.LvsV.NABA_BASEMENT_MEMBRANES"
46,"Down",0.00954197028831343,0.0912760445053373,"B.LvsV.REACTOME_HIV_TRANSCRIPTION_ELONGATION"
28,"Up",0.00958255108246669,0.0913802779502395,"B.LvsV.REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS"
6,"Down",0.00958592172384498,0.0913802779502395,"B.LvsV.SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_DN"
26,"Down",0.00966709118439669,0.0919954340077957,"B.LvsV.CAIRO_HEPATOBLASTOMA_POOR_SURVIVAL"
10,"Up",0.00973922976370114,0.0925226827551609,"B.LvsV.BIOCARTA_ETC_PATHWAY"
34,"Up",0.00978978952330117,0.0928434755991976,"B.LvsV.BIOCARTA_RAS_PATHWAY"
46,"Down",0.0098559680683269,0.0933110401537319,"B.LvsV.SCHLOSSER_MYC_AND_SERUM_RESPONSE_SYNERGY"
91,"Down",0.00988129555727024,0.0933909113438413,"B.LvsV.PID_TELOMERASE_PATHWAY"
88,"Down",0.00990403401219556,0.093446082002439,"B.LvsV.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_DN"
125,"Up",0.00998963941490812,0.0940932135008978,"B.LvsV.ZHENG_GLIOBLASTOMA_PLASTICITY_DN"
53,"Up",0.0101059716846562,0.0950270704837825,"B.LvsV.REACTOME_MAP2K_AND_MAPK_ACTIVATION"
13,"Down",0.0101330376431492,0.0951198049727875,"B.LvsV.BIOCARTA_FIBRINOLYSIS_PATHWAY"
28,"Down",0.010252738195898,0.0960803211612201,"B.LvsV.REACTOME_CYCLIN_A_B1_B2_ASSOCIATED_EVENTS_DURING_G2_M_TRANSITION"
268,"Down",0.0102926698282718,0.0962913223020558,"B.LvsV.KIM_MYC_AMPLIFICATION_TARGETS_UP"
223,"Down",0.0103479370472631,0.0966448377268884,"B.LvsV.REACTOME_SEPARATION_OF_SISTER_CHROMATIDS"
95,"Up",0.0103951359817946,0.0968307443518302,"B.LvsV.KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC"
144,"Up",0.0104146578338368,0.0968307443518302,"B.LvsV.DUTERTRE_ESTRADIOL_RESPONSE_6HR_DN"
255,"Down",0.0104339184918286,0.0968307443518302,"B.LvsV.ALCALAY_AML_BY_NPM1_LOCALIZATION_DN"
27,"Up",0.0104840270248156,0.0968307443518302,"B.LvsV.MOOTHA_FFA_OXYDATION"
23,"Down",0.0104879370926016,0.0968307443518302,"B.LvsV.REACTOME_NA_CL_DEPENDENT_NEUROTRANSMITTER_TRANSPORTERS"
301,"Down",0.0105051224610791,0.0968307443518302,"B.LvsV.KIM_WT1_TARGETS_12HR_DN"
9,"Down",0.0105096527665977,0.0968307443518302,"B.LvsV.RODRIGUES_DCC_TARGETS_UP"
69,"Down",0.010516616234654,0.0968307443518302,"B.LvsV.BOYLAN_MULTIPLE_MYELOMA_C_UP"
31,"Down",0.0105254616305751,0.0968307443518302,"B.LvsV.KYNG_RESPONSE_TO_H2O2_VIA_ERCC6"
453,"Down",0.0106320812947959,0.0976491320247951,"B.LvsV.HELLER_HDAC_TARGETS_DN"
50,"Down",0.0106498920670699,0.0976505028836311,"B.LvsV.TOMIDA_METASTASIS_UP"
135,"Up",0.0107935678215916,0.0988040339165228,"B.LvsV.FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_DN"
119,"Down",0.0108284123862662,0.0989591604688687,"B.LvsV.RIZ_ERYTHROID_DIFFERENTIATION"
33,"Down",0.010912389559926,0.0995620493017015,"B.LvsV.REACTOME_PROCESSING_OF_CAPPED_INTRONLESS_PRE_MRNA"
16,"Up",0.0110304343683028,0.100427054772555,"B.LvsV.REACTOME_SYNTHESIS_OF_IP2_IP_AND_INS_IN_THE_CYTOSOL"
25,"Up",0.0110435249234425,0.100427054772555,"B.LvsV.STARK_HYPPOCAMPUS_22Q11_DELETION_DN"
27,"Up",0.0110821581563172,0.100612894000456,"B.LvsV.ABDELMOHSEN_ELAVL4_TARGETS"
167,"Down",0.0111372233053471,0.100947061729942,"B.LvsV.HILLION_HMGA1B_TARGETS"
40,"Up",0.0111634427049355,0.101019107554154,"B.LvsV.REACTOME_SIGNALLING_TO_ERKS"
51,"Down",0.011187769258751,0.101073817371952,"B.LvsV.KORKOLA_TERATOMA"
77,"Up",0.0112940621640198,0.101797506098056,"B.LvsV.POMEROY_MEDULLOBLASTOMA_PROGNOSIS_UP"
35,"Up",0.0113046968247796,0.101797506098056,"B.LvsV.PID_S1P_S1P2_PATHWAY"
13,"Down",0.0113239338160516,0.101804926941381,"B.LvsV.REACTOME_PROCESSIVE_SYNTHESIS_ON_THE_C_STRAND_OF_THE_TELOMERE"
1187,"Down",0.0113958519136463,0.102285170828816,"B.LvsV.KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_DN"
14,"Up",0.0114216379015275,0.102350463464417,"B.LvsV.REACTOME_REDUCTION_OF_CYTOSOLIC_CA_LEVELS"
1217,"Down",0.0114860841626158,0.102525341421413,"B.LvsV.MARTENS_TRETINOIN_RESPONSE_DN"
61,"Up",0.011492525491749,0.102525341421413,"B.LvsV.PID_ERBB1_INTERNALIZATION_PATHWAY"
17,"Down",0.0114967827240507,0.102525341421413,"B.LvsV.BENPORATH_ES_CORE_NINE"
35,"Down",0.0115418673514929,0.102761649897592,"B.LvsV.KANNAN_TP53_TARGETS_DN"
15,"Down",0.0115772611018347,0.102911055678527,"B.LvsV.REACTOME_MISMATCH_REPAIR"
642,"Down",0.0116038951613848,0.102982241327924,"B.LvsV.REACTOME_CELL_CYCLE_MITOTIC"
56,"Up",0.0118127696969645,0.104522007828528,"B.LvsV.DAVIES_MULTIPLE_MYELOMA_VS_MGUS_UP"
485,"Down",0.0118171896585116,0.104522007828528,"B.LvsV.LINDGREN_BLADDER_CANCER_CLUSTER_3_UP"
35,"Up",0.0118341068729714,0.104522007828528,"B.LvsV.BIOCARTA_CREB_PATHWAY"
337,"Down",0.0118720225227058,0.104689653154769,"B.LvsV.HOLLERN_SQUAMOUS_BREAST_TUMOR"
36,"Up",0.0119091035729285,0.104839079865663,"B.LvsV.HOLLEMAN_ASPARAGINASE_RESISTANCE_B_ALL_DN"
9,"Down",0.0119557893580337,0.104839079865663,"B.LvsV.FUNG_IL2_TARGETS_WITH_STAT5_BINDING_SITES"
19,"Down",0.0119622822435615,0.104839079865663,"B.LvsV.REACTOME_ACYL_CHAIN_REMODELLING_OF_PI"
24,"Up",0.0119740141676801,0.104839079865663,"B.LvsV.PID_THROMBIN_PAR4_PATHWAY"
11,"Down",0.0119837761756373,0.104839079865663,"B.LvsV.KOINUMA_COLON_CANCER_MSI_DN"
21,"Up",0.0120454271104985,0.105060486145895,"B.LvsV.DELASERNA_TARGETS_OF_MYOD_AND_SMARCA4"
10,"Down",0.012049907011209,0.105060486145895,"B.LvsV.PHONG_TNF_TARGETS_DN"
528,"Down",0.0120660894741623,0.105060486145895,"B.LvsV.RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN"
78,"Down",0.0121092872920633,0.105122440174852,"B.LvsV.NAGASHIMA_EGF_SIGNALING_UP"
121,"Down",0.0121112306730657,0.105122440174852,"B.LvsV.REACTOME_UNFOLDED_PROTEIN_RESPONSE_UPR"
136,"Up",0.0121862184078535,0.105607525982793,"B.LvsV.REACTOME_RHO_GTPASES_ACTIVATE_PKNS"
85,"Up",0.0124030354438942,0.107318283207028,"B.LvsV.CHIBA_RESPONSE_TO_TSA"
77,"Up",0.0127124687765401,0.109823812289828,"B.LvsV.KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM"
10,"Down",0.0129370733130821,0.111589825815961,"B.LvsV.TESAR_ALK_TARGETS_EPISC_4D_UP"
45,"Up",0.0129870047864011,0.11184602720251,"B.LvsV.REACTOME_MET_ACTIVATES_PTK2_SIGNALING"
24,"Up",0.0131289452338312,0.112892594397905,"B.LvsV.BIOCARTA_NOS1_PATHWAY"
8,"Down",0.0133243760130348,0.114395147478369,"B.LvsV.KORKOLA_CHORIOCARCINOMA_UP"
48,"Down",0.0133773420716709,0.114671820642277,"B.LvsV.BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_UP"
430,"Down",0.0134816124346965,0.115386741720491,"B.LvsV.TARTE_PLASMA_CELL_VS_PLASMABLAST_DN"
16,"Down",0.0135883560506346,0.116085362933923,"B.LvsV.LOPEZ_MESOTELIOMA_SURVIVAL_TIME_DN"
1874,"Down",0.0136121946307161,0.116085362933923,"B.LvsV.KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP"
121,"Up",0.0136262254556188,0.116085362933923,"B.LvsV.HENDRICKS_SMARCA4_TARGETS_UP"
9,"Down",0.0137177657611502,0.116685425989845,"B.LvsV.REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_BCR_SIGNALING"
25,"Down",0.0137450976454702,0.116738317790791,"B.LvsV.REACTOME_ABORTIVE_ELONGATION_OF_HIV_1_TRANSCRIPT_IN_THE_ABSENCE_OF_TAT"
56,"Up",0.0138489687363866,0.117440104514542,"B.LvsV.PID_RET_PATHWAY"
137,"Up",0.0138759837467567,0.11748899561381,"B.LvsV.KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION"
145,"Up",0.0141588985759011,0.11969464342324,"B.LvsV.SASSON_RESPONSE_TO_FORSKOLIN_UP"
109,"Down",0.0141797777974719,0.11969464342324,"B.LvsV.SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN"
135,"Up",0.0143102371006734,0.120611739221987,"B.LvsV.KEGG_PARKINSONS_DISEASE"
17,"Up",0.0144627298033831,0.121415990637221,"B.LvsV.BIOCARTA_GATA3_PATHWAY"
16,"Down",0.0144704992804438,0.121415990637221,"B.LvsV.BIOCARTA_PRC2_PATHWAY"
28,"Up",0.0144715387646824,0.121415990637221,"B.LvsV.LI_ADIPOGENESIS_BY_ACTIVATED_PPARG"
640,"Up",0.014688095692939,0.12289541272994,"B.LvsV.STEIN_ESRRA_TARGETS_UP"
53,"Down",0.0146923255226063,0.12289541272994,"B.LvsV.BOQUEST_STEM_CELL_CULTURED_VS_FRESH_DN"
111,"Down",0.0147365918416167,0.123079480804076,"B.LvsV.POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN"
15,"Down",0.0147869435551855,0.123221349624192,"B.LvsV.STANHILL_HRAS_TRANSFROMATION_UP"
41,"Down",0.0148177420404331,0.123221349624192,"B.LvsV.REACTOME_FANCONI_ANEMIA_PATHWAY"
538,"Down",0.0148447040642613,0.123221349624192,"B.LvsV.AFFAR_YY1_TARGETS_DN"
36,"Up",0.0148621529698123,0.123221349624192,"B.LvsV.YAO_HOXA10_TARGETS_VIA_PROGESTERONE_DN"
20,"Down",0.0148650099836021,0.123221349624192,"B.LvsV.HEDVAT_ELF4_TARGETS_UP"
413,"Down",0.0149472205145735,0.123717338660295,"B.LvsV.ZHENG_GLIOBLASTOMA_PLASTICITY_UP"
36,"Down",0.0149739218313362,0.123733583372071,"B.LvsV.KONDO_COLON_CANCER_HCP_WITH_H3K27ME1"
48,"Up",0.0150111253811538,0.123733583372071,"B.LvsV.BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_DN"
38,"Up",0.0150163202102839,0.123733583372071,"B.LvsV.BIOCARTA_IGF1R_PATHWAY"
25,"Down",0.0151075117307216,0.124299750534464,"B.LvsV.BIOCARTA_ETS_PATHWAY"
19,"Up",0.0152031812469833,0.124901023944384,"B.LvsV.REACTOME_SYNTHESIS_OF_PIPS_AT_THE_EARLY_ENDOSOME_MEMBRANE"
24,"Down",0.0153203121644849,0.125586309250632,"B.LvsV.REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_BETA_CELLS"
150,"Up",0.0153320236469844,0.125586309250632,"B.LvsV.BURTON_ADIPOGENESIS_8"
246,"Up",0.0154634267808081,0.126348605964935,"B.LvsV.KAAB_FAILED_HEART_ATRIUM_DN"
13,"Up",0.015470791506287,0.126348605964935,"B.LvsV.REACTOME_RECEPTOR_MEDIATED_MITOPHAGY"
79,"Up",0.0155677309824463,0.126952779648887,"B.LvsV.KEGG_RENAL_CELL_CARCINOMA"
100,"Down",0.0156572444309861,0.127494704652315,"B.LvsV.REACTOME_TRANSPORT_OF_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS"
197,"Up",0.0157221478413066,0.127834934433212,"B.LvsV.GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_UP"
90,"Up",0.015839631938685,0.128601064594698,"B.LvsV.JI_RESPONSE_TO_FSH_DN"
710,"Down",0.0158638993222593,0.128609236587641,"B.LvsV.REACTOME_CELLULAR_RESPONSES_TO_EXTERNAL_STIMULI"
50,"Up",0.0159206492930419,0.128695949602076,"B.LvsV.BERENJENO_TRANSFORMED_BY_RHOA_REVERSIBLY_DN"
6,"Down",0.0159211484043806,0.128695949602076,"B.LvsV.REACTOME_G2_M_DNA_REPLICATION_CHECKPOINT"
31,"Down",0.016022648512482,0.129296262243114,"B.LvsV.TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_MONOCYTE_UP"
114,"Up",0.0160421841017862,0.129296262243114,"B.LvsV.STAMBOLSKY_TARGETS_OF_MUTATED_TP53_DN"
10,"Down",0.0161545767583777,0.129943544201645,"B.LvsV.REACTOME_SYNTHESIS_OF_12_EICOSATETRAENOIC_ACID_DERIVATIVES"
24,"Up",0.0161694987178028,0.129943544201645,"B.LvsV.REACTOME_ANCHORING_FIBRIL_FORMATION"
245,"Down",0.016225768374609,0.130031243586439,"B.LvsV.GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN"
92,"Up",0.0162361142273415,0.130031243586439,"B.LvsV.VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1"
24,"Down",0.0162509656932953,0.130031243586439,"B.LvsV.FARMER_BREAST_CANCER_CLUSTER_5"
42,"Up",0.016290958425174,0.130162874469345,"B.LvsV.BIOCARTA_PYK2_PATHWAY"
779,"Up",0.0163915860240205,0.130777891957878,"B.LvsV.MIKKELSEN_NPC_ICP_WITH_H3K4ME3"
575,"Down",0.0164404798687346,0.130902706764702,"B.LvsV.LINDGREN_BLADDER_CANCER_CLUSTER_1_DN"
39,"Up",0.0164545815159102,0.130902706764702,"B.LvsV.IKEDA_MIR30_TARGETS_DN"
48,"Down",0.0164969168826969,0.131050938856941,"B.LvsV.YUAN_ZNF143_PARTNERS"
26,"Down",0.0165268880397229,0.131100665669481,"B.LvsV.WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_UP"
20,"Up",0.0165825386327654,0.131353662035186,"B.LvsV.BIOCARTA_HSP27_PATHWAY"
22,"Up",0.0166224305576374,0.131481285483802,"B.LvsV.REACTOME_CONVERSION_FROM_APC_C_CDC20_TO_APC_C_CDH1_IN_LATE_ANAPHASE"
55,"Down",0.0166872609987553,0.131805522945883,"B.LvsV.HU_ANGIOGENESIS_DN"
346,"Down",0.0167540980030683,0.132144661710363,"B.LvsV.TIEN_INTESTINE_PROBIOTICS_24HR_DN"
23,"Up",0.0168837767998977,0.132977780522272,"B.LvsV.REACTOME_PLATELET_SENSITIZATION_BY_LDL"
6,"Down",0.0169082107501248,0.132980494765131,"B.LvsV.ISHIDA_TARGETS_OF_SYT_SSX_FUSIONS"
256,"Up",0.0169581580075488,0.132980494765131,"B.LvsV.BURTON_ADIPOGENESIS_6"
114,"Down",0.0169637178487529,0.132980494765131,"B.LvsV.REACTOME_METABOLISM_OF_NUCLEOTIDES"
831,"Down",0.0169916664244205,0.132980494765131,"B.LvsV.REACTOME_CELL_CYCLE"
20,"Down",0.0170043786939678,0.132980494765131,"B.LvsV.SABATES_COLORECTAL_ADENOMA_SIZE_DN"
12,"Down",0.0171406074223067,0.13385652321742,"B.LvsV.NADELLA_PRKAR1A_TARGETS_UP"
13,"Up",0.0172186794195949,0.13427655643292,"B.LvsV.REACTOME_NEF_MEDIATED_CD4_DOWN_REGULATION"
37,"Up",0.0172457470490698,0.134298218921559,"B.LvsV.CHANG_POU5F1_TARGETS_UP"
33,"Down",0.0173074733109519,0.134589338869554,"B.LvsV.REACTOME_PIWI_INTERACTING_RNA_PIRNA_BIOGENESIS"
556,"Down",0.0173662685621307,0.134619228655238,"B.LvsV.MEISSNER_NPC_HCP_WITH_H3K4ME2_AND_H3K27ME3"
522,"Up",0.0173701082478393,0.134619228655238,"B.LvsV.PASINI_SUZ12_TARGETS_DN"
28,"Down",0.017384360510009,0.134619228655238,"B.LvsV.WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_DN"
24,"Down",0.0174943455679567,0.135281449853472,"B.LvsV.XU_CREBBP_TARGETS_UP"
31,"Down",0.0178228534712216,0.137455345074249,"B.LvsV.SASAI_TARGETS_OF_CXCR6_AND_PTCH1_UP"
9,"Down",0.0178251912494549,0.137455345074249,"B.LvsV.REACTOME_UPTAKE_AND_FUNCTION_OF_DIPHTHERIA_TOXIN"
12,"Up",0.0178659005514485,0.137577387394093,"B.LvsV.REACTOME_ACTIVATED_NTRK3_SIGNALS_THROUGH_PI3K"
9,"Down",0.0180148233066947,0.138531235135904,"B.LvsV.REACTOME_PROSTANOID_LIGAND_RECEPTORS"
9,"Up",0.0181117045568584,0.139082797909541,"B.LvsV.SCHUHMACHER_MYC_TARGETS_DN"
15,"Down",0.0183364432635001,0.140547121650343,"B.LvsV.BIOCARTA_PTC1_PATHWAY"
33,"Up",0.0183532323804571,0.140547121650343,"B.LvsV.RAMPON_ENRICHED_LEARNING_ENVIRONMENT_LATE_UP"
752,"Up",0.0184269098251292,0.140916161027855,"B.LvsV.REACTOME_MEMBRANE_TRAFFICKING"
77,"Up",0.0185008165059992,0.141285931576892,"B.LvsV.MELLMAN_TUT1_TARGETS_DN"
52,"Down",0.0186063722722225,0.141877071141286,"B.LvsV.LANG_MYB_FAMILY_TARGETS"
31,"Down",0.0186451950873016,0.141877071141286,"B.LvsV.REACTOME_ACYL_CHAIN_REMODELLING_OF_PC"
130,"Up",0.0186552054114152,0.141877071141286,"B.LvsV.WOO_LIVER_CANCER_RECURRENCE_DN"
14,"Up",0.0187180198700045,0.142058384254638,"B.LvsV.REACTOME_DEFECTS_IN_COBALAMIN_B12_METABOLISM"
240,"Down",0.0187304326499605,0.142058384254638,"B.LvsV.GARCIA_TARGETS_OF_FLI1_AND_DAX1_DN"
92,"Up",0.018784189619653,0.142270937543919,"B.LvsV.KEGG_PPAR_SIGNALING_PATHWAY"
412,"Down",0.0189664779090026,0.143330073878968,"B.LvsV.BHAT_ESR1_TARGETS_VIA_AKT1_UP"
7,"Up",0.0189795375454623,0.143330073878968,"B.LvsV.REACTOME_NEGATIVE_FEEDBACK_REGULATION_OF_MAPK_PATHWAY"
16,"Down",0.0190423736488049,0.143330073878968,"B.LvsV.SHIN_B_CELL_LYMPHOMA_CLUSTER_6"
17,"Down",0.0190940162208999,0.143330073878968,"B.LvsV.REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE_FGFR4"
246,"Up",0.0190951355942669,0.143330073878968,"B.LvsV.REACTOME_MUSCLE_CONTRACTION"
130,"Up",0.0191076079377695,0.143330073878968,"B.LvsV.PID_CXCR4_PATHWAY"
126,"Down",0.0191173935056337,0.143330073878968,"B.LvsV.REACTOME_NUCLEOTIDE_EXCISION_REPAIR"
17,"Up",0.0191346237765647,0.143330073878968,"B.LvsV.FUJIWARA_PARK2_IN_LIVER_CANCER_DN"
29,"Down",0.0191734853175924,0.143330073878968,"B.LvsV.REACTOME_BASIGIN_INTERACTIONS"
645,"Up",0.0192165800244534,0.143330073878968,"B.LvsV.MONNIER_POSTRADIATION_TUMOR_ESCAPE_DN"
18,"Up",0.0192270361437385,0.143330073878968,"B.LvsV.PID_TCR_RAS_PATHWAY"
97,"Up",0.0192351084858373,0.143330073878968,"B.LvsV.PID_MTOR_4PATHWAY"
19,"Down",0.0193143524307532,0.14357886059088,"B.LvsV.LU_TUMOR_VASCULATURE_DN"
16,"Down",0.019320432678534,0.14357886059088,"B.LvsV.BIOCARTA_FREE_PATHWAY"
23,"Down",0.0193780493138503,0.143633215183961,"B.LvsV.REACTOME_ASSEMBLY_OF_THE_HIV_VIRION"
56,"Down",0.0193797031157958,0.143633215183961,"B.LvsV.SIG_PIP3_SIGNALING_IN_B_LYMPHOCYTES"
19,"Up",0.0195117254063365,0.144418112144089,"B.LvsV.REACTOME_CARNITINE_METABOLISM"
103,"Down",0.0195905084809332,0.144441084232304,"B.LvsV.SANSOM_WNT_PATHWAY_REQUIRE_MYC"
94,"Down",0.0196012784682344,0.144441084232304,"B.LvsV.GERHOLD_ADIPOGENESIS_DN"
47,"Down",0.0196182769076695,0.144441084232304,"B.LvsV.NOJIMA_SFRP2_TARGETS_UP"
27,"Down",0.0196302266498944,0.144441084232304,"B.LvsV.WU_APOPTOSIS_BY_CDKN1A_NOT_VIA_TP53"
100,"Down",0.0196454504146668,0.144441084232304,"B.LvsV.RAMASWAMY_METASTASIS_UP"
72,"Down",0.0197081517444929,0.144709656036257,"B.LvsV.REACTOME_SIGNALING_BY_FGFR_IN_DISEASE"
30,"Down",0.0197368042512854,0.144727839131773,"B.LvsV.HOLLEMAN_VINCRISTINE_RESISTANCE_ALL_DN"
126,"Down",0.019801591550232,0.144971397763622,"B.LvsV.NADERI_BREAST_CANCER_PROGNOSIS_UP"
11,"Down",0.0198224591624703,0.144971397763622,"B.LvsV.MATHEW_FANCONI_ANEMIA_GENES"
153,"Up",0.0199342472589861,0.145410356121768,"B.LvsV.HUANG_DASATINIB_RESISTANCE_UP"
28,"Up",0.019935078665274,0.145410356121768,"B.LvsV.HEDENFALK_BREAST_CANCER_BRACX_DN"
44,"Up",0.0200960834037098,0.146281034630533,"B.LvsV.MACLACHLAN_BRCA1_TARGETS_DN"
53,"Up",0.0201073587121008,0.146281034630533,"B.LvsV.REACTOME_INOSITOL_PHOSPHATE_METABOLISM"
72,"Up",0.0201547011359248,0.146432776058513,"B.LvsV.MOSERLE_IFNA_RESPONSE"
151,"Up",0.020271178069112,0.147085752682572,"B.LvsV.KEGG_INSULIN_SIGNALING_PATHWAY"
23,"Down",0.0203361802688061,0.147364011410523,"B.LvsV.ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN"
16,"Up",0.0204296533622217,0.147847583036287,"B.LvsV.BIOCARTA_CARM1_PATHWAY"
55,"Up",0.0205406811800266,0.148424108351014,"B.LvsV.KEGG_INOSITOL_PHOSPHATE_METABOLISM"
24,"Down",0.0205699888819796,0.148424108351014,"B.LvsV.SHIN_B_CELL_LYMPHOMA_CLUSTER_9"
99,"Down",0.0206063310700853,0.148424108351014,"B.LvsV.LINDSTEDT_DENDRITIC_CELL_MATURATION_C"
11,"Down",0.0206166965479434,0.148424108351014,"B.LvsV.BIOCARTA_SKP2E2F_PATHWAY"
279,"Down",0.0206865256585492,0.148733160424081,"B.LvsV.BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP"
29,"Down",0.0207654418833581,0.149106659965048,"B.LvsV.REACTOME_TNFS_BIND_THEIR_PHYSIOLOGICAL_RECEPTORS"
18,"Up",0.0209060125202729,0.149921327139544,"B.LvsV.NADELLA_PRKAR1A_TARGETS_DN"
74,"Down",0.0210605115268116,0.150636939219312,"B.LvsV.KLEIN_TARGETS_OF_BCR_ABL1_FUSION"
51,"Up",0.0210703677543867,0.150636939219312,"B.LvsV.BIOCARTA_AGR_PATHWAY"
665,"Down",0.0210875367979287,0.150636939219312,"B.LvsV.GOLDRATH_ANTIGEN_RESPONSE"
25,"Down",0.0212032928214263,0.151268394851182,"B.LvsV.BIOCARTA_CELLCYCLE_PATHWAY"
21,"Up",0.0212937178291847,0.151717739532941,"B.LvsV.BIOCARTA_MYOSIN_PATHWAY"
35,"Down",0.0213225437355924,0.151727598859833,"B.LvsV.REACTOME_RECOGNITION_OF_DNA_DAMAGE_BY_PCNA_CONTAINING_REPLICATION_COMPLEX"
57,"Up",0.021391207256272,0.151957563989507,"B.LvsV.NAKAMURA_ADIPOGENESIS_LATE_DN"
146,"Down",0.0214246219271574,0.151957563989507,"B.LvsV.PUJANA_BREAST_CANCER_LIT_INT_NETWORK"
305,"Down",0.0214373123370982,0.151957563989507,"B.LvsV.PAL_PRMT5_TARGETS_UP"
12,"Down",0.0216176548246266,0.152998082147487,"B.LvsV.REACTOME_SYNTHESIS_OF_15_EICOSATETRAENOIC_ACID_DERIVATIVES"
178,"Down",0.0216394465978178,0.152998082147487,"B.LvsV.WHITFIELD_CELL_CYCLE_G1_S"
57,"Up",0.0216879344572494,0.153145069749849,"B.LvsV.PID_NETRIN_PATHWAY"
87,"Down",0.0218781179140865,0.154222858283305,"B.LvsV.BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN"
47,"Down",0.0218963544497006,0.154222858283305,"B.LvsV.REACTOME_TRNA_MODIFICATION_IN_THE_NUCLEUS_AND_CYTOSOL"
22,"Up",0.0220325637605796,0.154984790117359,"B.LvsV.BIOCARTA_NPP1_PATHWAY"
36,"Up",0.0220824062863182,0.155138023325354,"B.LvsV.REACTOME_PLATELET_ADHESION_TO_EXPOSED_COLLAGEN"
67,"Up",0.022176013824689,0.155597944716631,"B.LvsV.PID_ECADHERIN_NASCENT_AJ_PATHWAY"
72,"Down",0.0222124086455025,0.155655776173616,"B.LvsV.REACTOME_ASSEMBLY_OF_THE_PRE_REPLICATIVE_COMPLEX"
97,"Up",0.022396380261282,0.156395465370385,"B.LvsV.BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_DN"
129,"Down",0.0224017016714138,0.156395465370385,"B.LvsV.SEKI_INFLAMMATORY_RESPONSE_LPS_UP"
18,"Up",0.0224206545919954,0.156395465370385,"B.LvsV.MAINA_VHL_TARGETS_UP"
77,"Down",0.0224424538855243,0.156395465370385,"B.LvsV.DOANE_BREAST_CANCER_ESR1_DN"
8,"Up",0.0224593958227683,0.156395465370385,"B.LvsV.REACTOME_TYSND1_CLEAVES_PEROXISOMAL_PROTEINS"
25,"Down",0.0226359745488956,0.157426796579678,"B.LvsV.NEBEN_AML_WITH_FLT3_OR_NRAS_DN"
40,"Down",0.022740181174499,0.157925641349507,"B.LvsV.MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_UP"
70,"Up",0.0227648283876935,0.157925641349507,"B.LvsV.ROZANOV_MMP14_TARGETS_SUBSET"
41,"Down",0.0228100952369654,0.158041374141832,"B.LvsV.ZHAN_MULTIPLE_MYELOMA_SPIKED"
306,"Down",0.0229419885597376,0.158638362086494,"B.LvsV.CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_UP"
209,"Down",0.0229820319746016,0.158638362086494,"B.LvsV.SANSOM_APC_TARGETS_UP"
13,"Up",0.0229931761255398,0.158638362086494,"B.LvsV.REACTOME_MET_ACTIVATES_RAP1_AND_RAC1"
31,"Up",0.0230110266582327,0.158638362086494,"B.LvsV.REACTOME_VXPX_CARGO_TARGETING_TO_CILIUM"
63,"Up",0.0230499803860405,0.158709018125054,"B.LvsV.BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_48HR_DN"
69,"Down",0.0231293206091314,0.159057230905333,"B.LvsV.PRAMOONJAGO_SOX4_TARGETS_UP"
914,"Down",0.0231887517513411,0.159267836562938,"B.LvsV.BENPORATH_CYCLING_GENES"
116,"Down",0.0233569419701389,0.160223985301362,"B.LvsV.DAZARD_UV_RESPONSE_CLUSTER_G1"
74,"Down",0.0234623568065595,0.160747671354978,"B.LvsV.GEORGES_CELL_CYCLE_MIR192_TARGETS"
7,"Down",0.0235848319475607,0.161386801779781,"B.LvsV.REACTOME_TFAP2A_ACTS_AS_A_TRANSCRIPTIONAL_REPRESSOR_DURING_RETINOIC_ACID_INDUCED_CELL_DIFFERENTIATION"
28,"Down",0.0238100357997776,0.162726437499345,"B.LvsV.TIAN_TNF_SIGNALING_VIA_NFKB"
117,"Down",0.0238858001612643,0.16304270258226,"B.LvsV.TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_UP"
36,"Up",0.0239898253352635,0.163550856077277,"B.LvsV.REACTOME_NEPHRIN_FAMILY_INTERACTIONS"
10,"Down",0.024158063842783,0.164189121672158,"B.LvsV.REICHERT_G1S_REGULATORS_AS_PI3K_TARGETS"
101,"Down",0.0241605104555744,0.164189121672158,"B.LvsV.KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN"
37,"Up",0.0241725348238626,0.164189121672158,"B.LvsV.BIOCARTA_HDAC_PATHWAY"
60,"Up",0.0242218113444279,0.164321956961155,"B.LvsV.HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_4HR"
6,"Up",0.0243774374688585,0.165130094397306,"B.LvsV.REACTOME_MECP2_REGULATES_TRANSCRIPTION_FACTORS"
32,"Up",0.024400666869705,0.165130094397306,"B.LvsV.REACTOME_GLYCOGEN_METABOLISM"
134,"Down",0.0244865158721775,0.165459317132538,"B.LvsV.CHICAS_RB1_TARGETS_LOW_SERUM"
6,"Up",0.0245091663468166,0.165459317132538,"B.LvsV.REACTOME_FORMATION_OF_XYLULOSE_5_PHOSPHATE"
25,"Up",0.0246066156963858,0.16591460754307,"B.LvsV.FINETTI_BREAST_CANCERS_KINOME_GRAY"
38,"Up",0.024643639894347,0.165961857461443,"B.LvsV.SEMBA_FHIT_TARGETS_UP"
10,"Up",0.0247446276173748,0.166439228827817,"B.LvsV.BIOCARTA_S1P_PATHWAY"
762,"Up",0.0249473099609926,0.167598635205745,"B.LvsV.LIM_MAMMARY_STEM_CELL_UP"
402,"Down",0.02508577499278,0.167979418836645,"B.LvsV.WANG_CISPLATIN_RESPONSE_AND_XPC_UP"
58,"Down",0.0250906065187894,0.167979418836645,"B.LvsV.TOMLINS_PROSTATE_CANCER_UP"
99,"Up",0.0250951347366736,0.167979418836645,"B.LvsV.REACTOME_PLATELET_HOMEOSTASIS"
28,"Down",0.0252490493080695,0.168805312725897,"B.LvsV.HOLLERN_MICROACINAR_BREAST_TUMOR_DN"
34,"Up",0.0252963967408243,0.168917605772968,"B.LvsV.SHIN_B_CELL_LYMPHOMA_CLUSTER_7"
16,"Up",0.0253751072109442,0.169139532425635,"B.LvsV.KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_KERATAN_SULFATE"
98,"Down",0.0254087047001481,0.169139532425635,"B.LvsV.VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_UP"
246,"Down",0.0254234092264582,0.169139532425635,"B.LvsV.SASAKI_ADULT_T_CELL_LEUKEMIA"
308,"Down",0.0254519969213471,0.169139532425635,"B.LvsV.PLASARI_TGFB1_TARGETS_10HR_UP"
12,"Down",0.0256389331259952,0.170177264410117,"B.LvsV.REACTOME_FOLDING_OF_ACTIN_BY_CCT_TRIC"
21,"Down",0.0259630503618604,0.172121948981686,"B.LvsV.REACTOME_ACYL_CHAIN_REMODELLING_OF_PG"
58,"Up",0.0260115488245065,0.172236950240355,"B.LvsV.EPPERT_LSC_R"
10,"Down",0.0261931200770788,0.173231771418862,"B.LvsV.REACTOME_CALCITONIN_LIKE_LIGAND_RECEPTORS"
829,"Up",0.0262712054313505,0.173254297809246,"B.LvsV.LIU_PROSTATE_CANCER_DN"
16,"Up",0.0262720610176255,0.173254297809246,"B.LvsV.WAESCH_ANAPHASE_PROMOTING_COMPLEX"
16,"Down",0.0262905328019457,0.173254297809246,"B.LvsV.KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_UV_IN_WS"
104,"Up",0.0264311956164299,0.17397390543243,"B.LvsV.REACTOME_SIGNALING_BY_MET"
43,"Down",0.0265032342806091,0.174240644872161,"B.LvsV.NEWMAN_ERCC6_TARGETS_UP"
13,"Down",0.0266673823688687,0.175111588025505,"B.LvsV.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_7"
96,"Down",0.0267129072512452,0.175202448626494,"B.LvsV.REACTOME_CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY"
9,"Up",0.026769301138079,0.175364296199572,"B.LvsV.REACTOME_DEFECTS_IN_BIOTIN_BTN_METABOLISM"
575,"Down",0.0268862118482251,0.175921734093297,"B.LvsV.MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP"
44,"Up",0.027038515113916,0.176624188650862,"B.LvsV.RODRIGUES_NTN1_TARGETS_UP"
13,"Down",0.0270574584531164,0.176624188650862,"B.LvsV.REACTOME_INHIBITION_OF_REPLICATION_INITIATION_OF_DAMAGED_DNA_BY_RB1_E2F1"
43,"Up",0.0271893696100478,0.177275972374946,"B.LvsV.WENDT_COHESIN_TARGETS_UP"
34,"Down",0.0273001350550328,0.177788512036839,"B.LvsV.REACTOME_TIGHT_JUNCTION_INTERACTIONS"
53,"Up",0.0274119209103192,0.178306483191947,"B.LvsV.EINAV_INTERFERON_SIGNATURE_IN_CANCER"
24,"Down",0.0274516736436819,0.178355233344204,"B.LvsV.REACTOME_RNA_POLYMERASE_III_TRANSCRIPTION_TERMINATION"
5,"Down",0.0275837248783067,0.179002834333518,"B.LvsV.RAFFEL_VEGFA_TARGETS_DN"
8,"Down",0.0277547989408353,0.179451340423248,"B.LvsV.REACTOME_SUPPRESSION_OF_APOPTOSIS"
77,"Up",0.0277606629870333,0.179451340423248,"B.LvsV.PID_ECADHERIN_STABILIZATION_PATHWAY"
9,"Down",0.027767386712608,0.179451340423248,"B.LvsV.REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_WNT_SIGNALING"
177,"Down",0.0277826636647315,0.179451340423248,"B.LvsV.KEGG_CELL_ADHESION_MOLECULES_CAMS"
30,"Down",0.0280349875756424,0.180869832328736,"B.LvsV.STREICHER_LSM1_TARGETS_DN"
10,"Up",0.0280758673115534,0.180922459633542,"B.LvsV.REACTOME_RHO_GTPASES_ACTIVATE_RHOTEKIN_AND_RHOPHILINS"
163,"Down",0.0281833254057486,0.181403499613951,"B.LvsV.HILLION_HMGA1_TARGETS"
34,"Down",0.0282325063074457,0.181508752760311,"B.LvsV.SOUCEK_MYC_TARGETS"
62,"Up",0.0282988812487782,0.181562884298841,"B.LvsV.REACTOME_GPVI_MEDIATED_ACTIVATION_CASCADE"
220,"Up",0.02830660268866,0.181562884298841,"B.LvsV.KEGG_ENDOCYTOSIS"
50,"Up",0.0283795598276233,0.181675219613164,"B.LvsV.REACTOME_INTRA_GOLGI_TRAFFIC"
78,"Down",0.0283898335586496,0.181675219613164,"B.LvsV.FAELT_B_CLL_WITH_VH3_21_UP"
358,"Up",0.0285105324746607,0.182232515119504,"B.LvsV.BROWNE_HCMV_INFECTION_18HR_DN"
46,"Down",0.0285428392283398,0.182232515119504,"B.LvsV.YANG_BREAST_CANCER_ESR1_DN"
23,"Down",0.0288443887080733,0.183901395984093,"B.LvsV.KOBAYASHI_RESPONSE_TO_ROMIDEPSIN"
36,"Down",0.0288707563237824,0.183901395984093,"B.LvsV.REACTOME_SIGNALING_BY_EGFR_IN_CANCER"
54,"Up",0.0289204560107358,0.18400598536635,"B.LvsV.WANG_RESPONSE_TO_BEXAROTENE_DN"
103,"Up",0.0289766312606924,0.184151487632607,"B.LvsV.PID_CDC42_PATHWAY"
33,"Up",0.0290775185311404,0.184580482156918,"B.LvsV.KEGG_GALACTOSE_METABOLISM"
11,"Down",0.0292277938874166,0.185321642664594,"B.LvsV.GALIE_TUMOR_STEMNESS_GENES"
69,"Up",0.0294012819005056,0.186192382450831,"B.LvsV.PID_RHOA_PATHWAY"
237,"Up",0.0294324728272791,0.186192382450831,"B.LvsV.YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_13"
248,"Up",0.0295539184091299,0.186746988438948,"B.LvsV.CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN"
29,"Up",0.0296148043936821,0.18691809759437,"B.LvsV.REACTOME_CONSTITUTIVE_SIGNALING_BY_AKT1_E17K_IN_CANCER"
1480,"Up",0.0297905844771187,0.187605140004171,"B.LvsV.CUI_TCF21_TARGETS_2_DN"
93,"Up",0.0297915197908595,0.187605140004171,"B.LvsV.MCCLUNG_DELTA_FOSB_TARGETS_8WK"
19,"Down",0.0300391438881266,0.188659890386395,"B.LvsV.REACTOME_METABOLISM_OF_FOLATE_AND_PTERINES"
5,"Down",0.0300504451211115,0.188659890386395,"B.LvsV.REACTOME_LEUKOTRIENE_RECEPTORS"
314,"Down",0.0300613788081776,0.188659890386395,"B.LvsV.SHEPARD_BMYB_MORPHOLINO_DN"
92,"Up",0.0300956287459534,0.188660693125143,"B.LvsV.RICKMAN_HEAD_AND_NECK_CANCER_F"
137,"Down",0.0302458368052992,0.189387578365232,"B.LvsV.KIM_MYCN_AMPLIFICATION_TARGETS_UP"
51,"Up",0.0302955792951187,0.1894844546637,"B.LvsV.BERNARD_PPAPDC1B_TARGETS_UP"
29,"Down",0.0303745680247771,0.189687543419312,"B.LvsV.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_DN"
107,"Down",0.0304262287616756,0.189687543419312,"B.LvsV.SCIBETTA_KDM5B_TARGETS_DN"
133,"Up",0.0304309732343877,0.189687543419312,"B.LvsV.KUNINGER_IGF1_VS_PDGFB_TARGETS_UP"
7,"Down",0.0306011765191189,0.190213091137333,"B.LvsV.REACTOME_TELOMERE_C_STRAND_SYNTHESIS_INITIATION"
1555,"Down",0.0306191498770753,0.190213091137333,"B.LvsV.MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3"
37,"Down",0.0306199068317078,0.190213091137333,"B.LvsV.BIOCARTA_EIF_PATHWAY"
31,"Down",0.0306715848734698,0.190213091137333,"B.LvsV.REACTOME_INTERCONVERSION_OF_NUCLEOTIDE_DI_AND_TRIPHOSPHATES"
237,"Up",0.0307080979915427,0.190213091137333,"B.LvsV.KIM_MYCN_AMPLIFICATION_TARGETS_DN"
26,"Up",0.0307217020049988,0.190213091137333,"B.LvsV.REACTOME_MTORC1_MEDIATED_SIGNALLING"
10,"Down",0.0307656376303872,0.19027204749263,"B.LvsV.BIERIE_INFLAMMATORY_RESPONSE_TGFB1"
29,"Down",0.0308392304750598,0.190514084130286,"B.LvsV.REACTOME_ACYL_CHAIN_REMODELLING_OF_PE"
9,"Up",0.0308895233260143,0.190611801863318,"B.LvsV.REACTOME_AMPK_INHIBITS_CHREBP_TRANSCRIPTIONAL_ACTIVATION_ACTIVITY"
73,"Down",0.0310083651813327,0.191131829529084,"B.LvsV.SHIN_B_CELL_LYMPHOMA_CLUSTER_8"
215,"Up",0.0312912110928136,0.192593888844287,"B.LvsV.NIKOLSKY_BREAST_CANCER_11Q12_Q14_AMPLICON"
17,"Down",0.0313152298916647,0.192593888844287,"B.LvsV.REACTOME_RETINOID_CYCLE_DISEASE_EVENTS"
16,"Up",0.0313843902000664,0.192804770462408,"B.LvsV.REACTOME_AKT_PHOSPHORYLATES_TARGETS_IN_THE_CYTOSOL"
114,"Down",0.0315126203984031,0.193377667239479,"B.LvsV.AMIT_EGF_RESPONSE_120_HELA"
38,"Down",0.0316123012750888,0.193774294623022,"B.LvsV.NAKAJIMA_EOSINOPHIL"
95,"Down",0.0317065017932389,0.194136487724051,"B.LvsV.DIRMEIER_LMP1_RESPONSE_EARLY"
30,"Down",0.031780154054689,0.194266514477212,"B.LvsV.CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_UP"
91,"Down",0.0317980096946785,0.194266514477212,"B.LvsV.SHAFFER_IRF4_TARGETS_IN_ACTIVATED_DENDRITIC_CELL"
86,"Up",0.0318622903108515,0.194444374314236,"B.LvsV.REACTOME_PEROXISOMAL_PROTEIN_IMPORT"
26,"Down",0.0319663857547358,0.194864549986697,"B.LvsV.TRAYNOR_RETT_SYNDROM_DN"
11,"Up",0.0324904077060709,0.197774053381688,"B.LvsV.REACTOME_BIOTIN_TRANSPORT_AND_METABOLISM"
23,"Up",0.0325152133340485,0.197774053381688,"B.LvsV.ZEILSTRA_CD44_TARGETS_DN"
56,"Up",0.0326357599609745,0.198289139367283,"B.LvsV.RUAN_RESPONSE_TO_TNF_TROGLITAZONE_DN"
173,"Up",0.0329223236105223,0.199810677543993,"B.LvsV.LIM_MAMMARY_LUMINAL_MATURE_DN"
23,"Down",0.0329875262631245,0.199986877970192,"B.LvsV.REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_G2_CELL_CYCLE_ARREST"
16,"Up",0.0330347570967993,0.200053857599346,"B.LvsV.REACTOME_PYRIMIDINE_CATABOLISM"
33,"Down",0.0330858298224947,0.200143931169117,"B.LvsV.BIOCARTA_G1_PATHWAY"
132,"Up",0.0334111031084791,0.201657985822335,"B.LvsV.BOSCO_INTERFERON_INDUCED_ANTIVIRAL_MODULE"
78,"Down",0.0334225639368564,0.201657985822335,"B.LvsV.HANN_RESISTANCE_TO_BCL2_INHIBITOR_DN"
69,"Up",0.0334455368057662,0.201657985822335,"B.LvsV.SMITH_LIVER_CANCER"
8,"Down",0.0335126260525568,0.201674355502865,"B.LvsV.BIOCARTA_BARD1_PATHWAY"
152,"Down",0.0335212032387653,0.201674355502865,"B.LvsV.LIAN_LIPA_TARGETS_6M"
50,"Up",0.0336111291415761,0.20169521057664,"B.LvsV.BOWIE_RESPONSE_TO_TAMOXIFEN"
48,"Up",0.0336227546272183,0.20169521057664,"B.LvsV.REACTOME_EPHA_MEDIATED_GROWTH_CONE_COLLAPSE"
73,"Up",0.0336341081844207,0.20169521057664,"B.LvsV.HOFMANN_CELL_LYMPHOMA_DN"
65,"Up",0.033705082219938,0.201696106495278,"B.LvsV.NAKAMURA_CANCER_MICROENVIRONMENT_UP"
679,"Down",0.0337271899595971,0.201696106495278,"B.LvsV.HSIAO_HOUSEKEEPING_GENES"
103,"Up",0.0337436966012176,0.201696106495278,"B.LvsV.OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN"
27,"Down",0.033857886932541,0.201996720949469,"B.LvsV.BIOCARTA_STATHMIN_PATHWAY"
355,"Down",0.033867057391962,0.201996720949469,"B.LvsV.REACTOME_CELL_CYCLE_CHECKPOINTS"
28,"Down",0.0339822970899725,0.202465647209545,"B.LvsV.NIKOLSKY_BREAST_CANCER_22Q13_AMPLICON"
34,"Up",0.0342454785398305,0.20381404827419,"B.LvsV.REACTOME_PYRUVATE_METABOLISM"
68,"Up",0.0343493531264426,0.204212444554948,"B.LvsV.GERHOLD_ADIPOGENESIS_UP"
15,"Down",0.0344150605289733,0.204357318656222,"B.LvsV.DACOSTA_LOW_DOSE_UV_RESPONSE_VIA_ERCC3_XPCS_DN"
35,"Down",0.0344623830317512,0.204357318656222,"B.LvsV.ZIRN_TRETINOIN_RESPONSE_WT1_UP"
8,"Down",0.0344846045046581,0.204357318656222,"B.LvsV.REACTOME_POLB_DEPENDENT_LONG_PATCH_BASE_EXCISION_REPAIR"
129,"Down",0.0345447690677838,0.204494676847726,"B.LvsV.SANA_RESPONSE_TO_IFNG_DN"
13,"Up",0.0347158870038082,0.20512979182315,"B.LvsV.REACTOME_GAP_JUNCTION_DEGRADATION"
6,"Up",0.0347262588436369,0.20512979182315,"B.LvsV.BIOCARTA_SLRP_PATHWAY"
21,"Up",0.0347791416678713,0.205222918123437,"B.LvsV.BIOCARTA_NDKDYNAMIN_PATHWAY"
169,"Down",0.034821153845535,0.205251769309129,"B.LvsV.NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP"
21,"Up",0.0348605828427175,0.205265348815106,"B.LvsV.REACTOME_P130CAS_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS"
25,"Up",0.0349562646400212,0.205416888371594,"B.LvsV.VERRECCHIA_RESPONSE_TO_TGFB1_C3"
197,"Up",0.0349606243367101,0.205416888371594,"B.LvsV.HUMMERICH_SKIN_CANCER_PROGRESSION_DN"
339,"Down",0.0353280055831744,0.207355141050288,"B.LvsV.SANSOM_APC_MYC_TARGETS"
59,"Down",0.0355617701055576,0.208505860990061,"B.LvsV.NIKOLSKY_BREAST_CANCER_12Q13_Q21_AMPLICON"
34,"Up",0.0357175680185963,0.209018963090721,"B.LvsV.DEMAGALHAES_AGING_DN"
35,"Up",0.035724890598794,0.209018963090721,"B.LvsV.BIOCARTA_STRESS_PATHWAY"
176,"Up",0.0357981002746289,0.209157100682564,"B.LvsV.LAIHO_COLORECTAL_CANCER_SERRATED_UP"
13,"Up",0.0358241588617087,0.209157100682564,"B.LvsV.REACTOME_LINOLEIC_ACID_LA_METABOLISM"
107,"Down",0.0358800013295211,0.209262159652871,"B.LvsV.GAURNIER_PSMD4_TARGETS"
107,"Down",0.0359462219223275,0.20942746154747,"B.LvsV.ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_UP"
23,"Down",0.0361468046181898,0.210374402877864,"B.LvsV.REACTOME_PROCESSING_OF_INTRONLESS_PRE_MRNAS"
796,"Up",0.0363567297207662,0.211373668376568,"B.LvsV.MILI_PSEUDOPODIA_HAPTOTAXIS_UP"
97,"Down",0.0367614299028387,0.213502044047054,"B.LvsV.ABRAMSON_INTERACT_WITH_AIRE"
29,"Up",0.0368893294233481,0.213774092506929,"B.LvsV.GREENBAUM_E2A_TARGETS_DN"
338,"Down",0.0369146360384343,0.213774092506929,"B.LvsV.MIKKELSEN_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3"
13,"Down",0.036924264486185,0.213774092506929,"B.LvsV.SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX6_UP"
203,"Up",0.0370032366753842,0.213798681059499,"B.LvsV.MIKKELSEN_MEF_LCP_WITH_H3K4ME3"
55,"Down",0.0370058487563647,0.213798681059499,"B.LvsV.ANDERSEN_LIVER_CANCER_KRT19_UP"
6,"Up",0.0374909191063302,0.216343288338929,"B.LvsV.REACTOME_SYNTHESIS_OF_DOLICHYL_PHOSPHATE"
19,"Down",0.0375245457618074,0.216343288338929,"B.LvsV.XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_DN"
44,"Down",0.0378226742220571,0.217623967161695,"B.LvsV.SHIN_B_CELL_LYMPHOMA_CLUSTER_3"
128,"Up",0.0378253992480357,0.217623967161695,"B.LvsV.URS_ADIPOCYTE_DIFFERENTIATION_UP"
27,"Up",0.0379432891213827,0.217927289310888,"B.LvsV.PHESSE_TARGETS_OF_APC_AND_MBD2_DN"
12,"Up",0.0379569505527917,0.217927289310888,"B.LvsV.REACTOME_ACTIVATED_NTRK2_SIGNALS_THROUGH_PI3K"
90,"Up",0.0380184236720632,0.218053801330744,"B.LvsV.IKEDA_MIR133_TARGETS_UP"
23,"Down",0.0382332149630096,0.218717234106231,"B.LvsV.REACTOME_SIGNALING_BY_FGFR2_IIIA_TM"
858,"Down",0.038235526915688,0.218717234106231,"B.LvsV.RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP"
93,"Up",0.0382529320544848,0.218717234106231,"B.LvsV.MODY_HIPPOCAMPUS_POSTNATAL"
46,"Up",0.0383679170025498,0.218717234106231,"B.LvsV.PETRETTO_HEART_MASS_QTL_CIS_UP"
292,"Down",0.0383832644323286,0.218717234106231,"B.LvsV.LEE_LIVER_CANCER_SURVIVAL_DN"
18,"Up",0.0384008831944915,0.218717234106231,"B.LvsV.CLAUS_PGR_POSITIVE_MENINGIOMA_UP"
87,"Down",0.0384110027703293,0.218717234106231,"B.LvsV.SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE"
222,"Down",0.0385304514770328,0.219171673062258,"B.LvsV.WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP"
64,"Down",0.0386508105966887,0.219630351273475,"B.LvsV.LIU_BREAST_CANCER"
115,"Down",0.0387346157732301,0.21984611613357,"B.LvsV.BASSO_CD40_SIGNALING_DN"
22,"Down",0.0387683058835651,0.21984611613357,"B.LvsV.REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE_FGFR2"
20,"Down",0.0388104122495961,0.219859394803296,"B.LvsV.ZHOU_PANCREATIC_ENDOCRINE_PROGENITOR"
226,"Up",0.0388980909831968,0.220038043164389,"B.LvsV.HOLLERN_EMT_BREAST_TUMOR_UP"
30,"Up",0.0389316099664898,0.220038043164389,"B.LvsV.WOTTON_RUNX_TARGETS_UP"
35,"Down",0.0389613391676501,0.220038043164389,"B.LvsV.REACTOME_GAP_JUNCTION_ASSEMBLY"
34,"Up",0.0391953828272544,0.221104195653931,"B.LvsV.PID_TCR_CALCIUM_PATHWAY"
94,"Down",0.0392302000664958,0.221104195653931,"B.LvsV.ONDER_CDH1_TARGETS_3_DN"
117,"Up",0.0392949841143263,0.221104195653931,"B.LvsV.TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_DN"
190,"Up",0.039310078554497,0.221104195653931,"B.LvsV.SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A5"
768,"Up",0.0396034397279098,0.222527864080908,"B.LvsV.RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_DN"
65,"Up",0.0396842916448222,0.222755785283474,"B.LvsV.ZHANG_INTERFERON_RESPONSE"
30,"Up",0.0399940926122282,0.22426707713287,"B.LvsV.REACTOME_SYNTHESIS_OF_IP3_AND_IP4_IN_THE_CYTOSOL"
10,"Up",0.0401000469474945,0.224478292043207,"B.LvsV.BIOCARTA_TUBBY_PATHWAY"
122,"Down",0.0401129594029099,0.224478292043207,"B.LvsV.BURTON_ADIPOGENESIS_2"
13,"Down",0.0402901731586738,0.225127844968517,"B.LvsV.SCHLESINGER_METHYLATED_IN_COLON_CANCER"
73,"Down",0.0403355583129818,0.225127844968517,"B.LvsV.ZHAN_MULTIPLE_MYELOMA_HP_UP"
37,"Up",0.0403511836432991,0.225127844968517,"B.LvsV.BIOCARTA_EDG1_PATHWAY"
55,"Down",0.0405309709208323,0.22588406151831,"B.LvsV.STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_DN"
53,"Up",0.0405684342716009,0.22588406151831,"B.LvsV.HU_ANGIOGENESIS_UP"
34,"Up",0.040877332477833,0.227375021398329,"B.LvsV.MASRI_RESISTANCE_TO_TAMOXIFEN_AND_AROMATASE_INHIBITORS_DN"
203,"Down",0.0409253682521477,0.22741342820716,"B.LvsV.CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN"
13,"Down",0.0410830084317178,0.227893257320779,"B.LvsV.REACTOME_FGFRL1_MODULATION_OF_FGFR1_SIGNALING"
202,"Down",0.0411242160020668,0.227893257320779,"B.LvsV.MOREAUX_MULTIPLE_MYELOMA_BY_TACI_DN"
38,"Down",0.0411353718224159,0.227893257320779,"B.LvsV.BURTON_ADIPOGENESIS_1"
30,"Down",0.0414734592542206,0.229536292509095,"B.LvsV.REACTOME_RNA_POLYMERASE_III_TRANSCRIPTION_INITIATION_FROM_TYPE_3_PROMOTER"
9,"Down",0.0416089594293309,0.230055936684771,"B.LvsV.TESAR_ALK_AND_JAK_TARGETS_MOUSE_ES_D4_UP"
41,"Down",0.0417603892241201,0.230662529490669,"B.LvsV.HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_DN"
12,"Down",0.0419354589264057,0.231242615559007,"B.LvsV.WANG_THOC1_TARGETS_UP"
70,"Down",0.0419752525770127,0.231242615559007,"B.LvsV.ZHAN_MULTIPLE_MYELOMA_CD1_DN"
76,"Down",0.0420113690226775,0.231242615559007,"B.LvsV.CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_UP"
105,"Down",0.0420327054868516,0.231242615559007,"B.LvsV.REACTOME_TELOMERE_MAINTENANCE"
168,"Up",0.0420785024132472,0.231264453124099,"B.LvsV.BROWNE_HCMV_INFECTION_16HR_DN"
16,"Up",0.0421534877953361,0.231320983021153,"B.LvsV.TSUDA_ALVEOLAR_SOFT_PART_SARCOMA"
43,"Down",0.0421724635350555,0.231320983021153,"B.LvsV.REACTOME_TRNA_AMINOACYLATION"
55,"Up",0.0423352607787621,0.231909473312968,"B.LvsV.PID_LYMPH_ANGIOGENESIS_PATHWAY"
31,"Down",0.0423636404496468,0.231909473312968,"B.LvsV.FERRARI_RESPONSE_TO_FENRETINIDE_UP"
86,"Down",0.042420605528568,0.231991620145848,"B.LvsV.CHANDRAN_METASTASIS_TOP50_UP"
57,"Down",0.0425686695052316,0.232424764660063,"B.LvsV.WAKASUGI_HAVE_ZNF143_BINDING_SITES"
170,"Up",0.0425930772243047,0.232424764660063,"B.LvsV.JI_RESPONSE_TO_FSH_UP"
42,"Up",0.0426259199430826,0.232424764660063,"B.LvsV.REACTOME_MYOGENESIS"
133,"Down",0.0427053592168568,0.232600030428109,"B.LvsV.GAVIN_FOXP3_TARGETS_CLUSTER_T7"
621,"Up",0.0428041982706945,0.232600030428109,"B.LvsV.WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_UP"
318,"Down",0.0428184714205275,0.232600030428109,"B.LvsV.BHAT_ESR1_TARGETS_NOT_VIA_AKT1_UP"
23,"Down",0.0428263394783532,0.232600030428109,"B.LvsV.WHITE_NEUROBLASTOMA_WITH_1P36.3_DELETION"
31,"Up",0.0430120080266083,0.23319982112037,"B.LvsV.LIM_MAMMARY_LUMINAL_PROGENITOR_DN"
378,"Up",0.0430211281502581,0.23319982112037,"B.LvsV.EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_UP"
6,"Up",0.0431669737511993,0.233748665233273,"B.LvsV.REACTOME_MOLYBDENUM_COFACTOR_BIOSYNTHESIS"
37,"Down",0.0432069335989156,0.233748665233273,"B.LvsV.MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_DN"
173,"Up",0.0434100940607616,0.234618191653911,"B.LvsV.HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_DN"
51,"Down",0.043485289968283,0.234795086166638,"B.LvsV.REACTOME_SIGNALING_BY_FGFR2_IN_DISEASE"
59,"Up",0.0436735110161318,0.23558130966653,"B.LvsV.BOYAULT_LIVER_CANCER_SUBCLASS_G12_UP"
58,"Up",0.0438281283262357,0.235788609683544,"B.LvsV.PID_SYNDECAN_4_PATHWAY"
67,"Up",0.0438381527501513,0.235788609683544,"B.LvsV.PID_NCADHERIN_PATHWAY"
131,"Down",0.0438398789572588,0.235788609683544,"B.LvsV.KEGG_CELL_CYCLE"
70,"Up",0.0439586947549615,0.236058177187193,"B.LvsV.KEGG_GLYCOLYSIS_GLUCONEOGENESIS"
19,"Down",0.0439753884070915,0.236058177187193,"B.LvsV.THUM_MIR21_TARGETS_HEART_DISEASE_DN"
19,"Down",0.0440684881810856,0.236235718121234,"B.LvsV.REACTOME_TRANSLESION_SYNTHESIS_BY_POLK"
59,"Down",0.0440939159162802,0.236235718121234,"B.LvsV.CAFFAREL_RESPONSE_TO_THC_24HR_5_UP"
57,"Down",0.04416248549391,0.236374039008546,"B.LvsV.RIZ_ERYTHROID_DIFFERENTIATION_HBZ"
67,"Down",0.0443648615451981,0.237013798026891,"B.LvsV.REACTOME_AUF1_HNRNP_D0_BINDS_AND_DESTABILIZES_MRNA"
61,"Down",0.0443677484098086,0.237013798026891,"B.LvsV.REACTOME_FORMATION_OF_TC_NER_PRE_INCISION_COMPLEX"
103,"Up",0.0445037194413641,0.237510680300485,"B.LvsV.BILD_SRC_ONCOGENIC_SIGNATURE"
55,"Up",0.0446181151792021,0.237891570709555,"B.LvsV.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_DN"
50,"Up",0.0451128696324283,0.240297742001634,"B.LvsV.VERRECCHIA_RESPONSE_TO_TGFB1_C4"
20,"Up",0.0452730139848862,0.240918666335357,"B.LvsV.YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_4"
31,"Down",0.0453538745701861,0.24111689663323,"B.LvsV.KEGG_MATURITY_ONSET_DIABETES_OF_THE_YOUNG"
71,"Down",0.045411498103344,0.241191328543121,"B.LvsV.BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_UP"
112,"Up",0.0454769701562117,0.241307262949803,"B.LvsV.LEIN_NEURON_MARKERS"
17,"Up",0.0457793411551466,0.242565535221956,"B.LvsV.REACTOME_GLYCOGEN_BREAKDOWN_GLYCOGENOLYSIS"
37,"Down",0.0458168886901134,0.242565535221956,"B.LvsV.REACTOME_SURFACTANT_METABOLISM"
935,"Up",0.04584571971549,0.242565535221956,"B.LvsV.FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN"
66,"Up",0.0459912833924844,0.242958745934999,"B.LvsV.REACTOME_SIGNALING_BY_MODERATE_KINASE_ACTIVITY_BRAF_MUTANTS"
19,"Down",0.0460079231314785,0.242958745934999,"B.LvsV.KOINUMA_COLON_CANCER_MSI_UP"
9,"Up",0.0460740219117529,0.243019990406798,"B.LvsV.DER_IFN_GAMMA_RESPONSE_DN"
46,"Down",0.0461512810283644,0.243019990406798,"B.LvsV.REACTOME_DUAL_INCISION_IN_GG_NER"
10,"Down",0.0461985673773655,0.243019990406798,"B.LvsV.BIOCARTA_FLUMAZENIL_PATHWAY"
77,"Down",0.0462070856373868,0.243019990406798,"B.LvsV.REACTOME_ORC1_REMOVAL_FROM_CHROMATIN"
556,"Down",0.0462392891857392,0.243019990406798,"B.LvsV.MCLACHLAN_DENTAL_CARIES_UP"
13,"Up",0.046692133669715,0.245166958271466,"B.LvsV.REACTOME_REGULATION_OF_GLYCOLYSIS_BY_FRUCTOSE_2_6_BISPHOSPHATE_METABOLISM"
191,"Down",0.0467593669326024,0.245287039630321,"B.LvsV.VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN"
72,"Down",0.04719598405498,0.246997164613318,"B.LvsV.REACTOME_IRE1ALPHA_ACTIVATES_CHAPERONES"
11,"Down",0.0472013131361587,0.246997164613318,"B.LvsV.REACTOME_CDC6_ASSOCIATION_WITH_THE_ORC_ORIGIN_COMPLEX"
406,"Up",0.0472193892198006,0.246997164613318,"B.LvsV.DANG_REGULATED_BY_MYC_DN"
26,"Up",0.047345185103083,0.247421104380856,"B.LvsV.PLASARI_TGFB1_TARGETS_1HR_DN"
265,"Up",0.0474292379185795,0.247626304487088,"B.LvsV.BROWNE_HCMV_INFECTION_24HR_DN"
47,"Up",0.047500195617194,0.247762812799496,"B.LvsV.BIOCARTA_BIOPEPTIDES_PATHWAY"
13,"Up",0.0475963089173124,0.248012643989209,"B.LvsV.KOBAYASHI_EGFR_SIGNALING_6HR_UP"
51,"Up",0.0476608631532158,0.248012643989209,"B.LvsV.TERAO_AOX4_TARGETS_SKIN_DN"
49,"Down",0.0476826624272977,0.248012643989209,"B.LvsV.UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN"
194,"Up",0.0478202982258601,0.248494763995094,"B.LvsV.RODRIGUES_DCC_TARGETS_DN"
379,"Down",0.0478781782357178,0.248561922502614,"B.LvsV.REACTOME_DNA_REPAIR"
37,"Up",0.0484513875170526,0.251299348707831,"B.LvsV.WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_36HR"
165,"Down",0.0484963655401078,0.251299348707831,"B.LvsV.HELLER_SILENCED_BY_METHYLATION_DN"
10,"Up",0.0487231534636598,0.252238123127879,"B.LvsV.REACTOME_SYNTHESIS_OF_PYROPHOSPHATES_IN_THE_CYTOSOL"
9,"Down",0.0488569921806452,0.252476648246453,"B.LvsV.HE_PTEN_TARGETS_DN"
13,"Up",0.0489043234707649,0.252476648246453,"B.LvsV.SHIRAISHI_PLZF_TARGETS_UP"
154,"Up",0.048980393020866,0.252476648246453,"B.LvsV.PID_ERBB1_DOWNSTREAM_PATHWAY"
49,"Down",0.0490471272182197,0.252476648246453,"B.LvsV.PID_IL2_PI3K_PATHWAY"
1632,"Up",0.0490484196538229,0.252476648246453,"B.LvsV.GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN"
261,"Down",0.0490499627691076,0.252476648246453,"B.LvsV.KAUFFMANN_DNA_REPAIR_GENES"
14,"Up",0.0491190632891965,0.252476648246453,"B.LvsV.REACTOME_ROBO_RECEPTORS_BIND_AKAP5"
60,"Up",0.0491345403351752,0.252476648246453,"B.LvsV.BIOCARTA_FCER1_PATHWAY"
11,"Down",0.0492773216123836,0.252975219308142,"B.LvsV.REACTOME_RUNX3_REGULATES_CDKN1A_TRANSCRIPTION"
18,"Down",0.0493898893658074,0.253317901951344,"B.LvsV.REACTOME_CONSTITUTIVE_SIGNALING_BY_OVEREXPRESSED_ERBB2"
13,"Up",0.0494702217048509,0.253325052694618,"B.LvsV.REACTOME_SODIUM_CALCIUM_EXCHANGERS"
60,"Up",0.0495520273187983,0.253325052694618,"B.LvsV.GENTILE_UV_RESPONSE_CLUSTER_D8"
55,"Down",0.0495798235227033,0.253325052694618,"B.LvsV.NAKAYAMA_FRA2_TARGETS"
39,"Down",0.0496569319413455,0.253325052694618,"B.LvsV.FERRANDO_TAL1_NEIGHBORS"
64,"Down",0.0496594921815341,0.253325052694618,"B.LvsV.POS_HISTAMINE_RESPONSE_NETWORK"
42,"Up",0.0496661886635859,0.253325052694618,"B.LvsV.MOOTHA_GLUCONEOGENESIS"
11,"Up",0.0498570348423226,0.254064097367006,"B.LvsV.NIKOLSKY_BREAST_CANCER_17P11_AMPLICON"
39,"Down",0.0499746560786489,0.254428981085497,"B.LvsV.PID_IL2_STAT5_PATHWAY"
12,"Down",0.0500924914734214,0.254794282756713,"B.LvsV.REACTOME_BIOSYNTHESIS_OF_EPA_DERIVED_SPMS"
19,"Up",0.0502283668834833,0.255250588693731,"B.LvsV.REACTOME_PTK6_REGULATES_RHO_GTPASES_RAS_GTPASE_AND_MAP_KINASES"
142,"Up",0.0502917051079097,0.255337775520324,"B.LvsV.BROWNE_INTERFERON_RESPONSIVE_GENES"
48,"Down",0.0506124627197636,0.2567305563097,"B.LvsV.AIGNER_ZEB1_TARGETS"
24,"Up",0.0506648040235144,0.256760496284153,"B.LvsV.EHRLICH_ICF_SYNDROM_UP"
22,"Down",0.0507462624130218,0.25693780666813,"B.LvsV.MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_4"
31,"Down",0.050901166321407,0.257360768196177,"B.LvsV.INAMURA_LUNG_CANCER_SCC_UP"
31,"Down",0.0509759883592451,0.257360768196177,"B.LvsV.MEINHOLD_OVARIAN_CANCER_LOW_GRADE_DN"
30,"Up",0.051007776981812,0.257360768196177,"B.LvsV.REACTOME_DARPP_32_EVENTS"
54,"Down",0.0510159887760915,0.257360768196177,"B.LvsV.VANDESLUIS_COMMD1_TARGETS_GROUP_3_DN"
975,"Down",0.0511357875630103,0.257729963022684,"B.LvsV.BENPORATH_PRC2_TARGETS"
125,"Down",0.0512496118564304,0.258068400686889,"B.LvsV.TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP"
170,"Up",0.0515573807400287,0.259324431087424,"B.LvsV.KAYO_CALORIE_RESTRICTION_MUSCLE_DN"
19,"Down",0.0515928511839693,0.259324431087424,"B.LvsV.MIZUKAMI_HYPOXIA_UP"
57,"Down",0.0517835299445863,0.260046446016002,"B.LvsV.LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_DN"
38,"Up",0.0518854120156225,0.260321636147348,"B.LvsV.BIOCARTA_INSULIN_PATHWAY"
289,"Up",0.0520294146035791,0.260669083687002,"B.LvsV.ZHENG_FOXP3_TARGETS_IN_THYMUS_UP"
61,"Up",0.0520850820451295,0.260669083687002,"B.LvsV.PID_THROMBIN_PAR1_PATHWAY"
83,"Up",0.0521702675243823,0.260669083687002,"B.LvsV.BAKKER_FOXO3_TARGETS_UP"
29,"Up",0.0522038102777105,0.260669083687002,"B.LvsV.REACTOME_INSULIN_RECEPTOR_RECYCLING"
57,"Up",0.0522300244035136,0.260669083687002,"B.LvsV.KEGG_MTOR_SIGNALING_PATHWAY"
429,"Down",0.0522375374796886,0.260669083687002,"B.LvsV.HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN"
54,"Down",0.0523628689988316,0.261058884305266,"B.LvsV.ZHAN_EARLY_DIFFERENTIATION_GENES_DN"
34,"Up",0.0525407547442588,0.261709759442349,"B.LvsV.REACTOME_CD209_DC_SIGN_SIGNALING"
57,"Down",0.0526429957208966,0.261802982840857,"B.LvsV.THILLAINADESAN_ZNF217_TARGETS_UP"
68,"Down",0.0526541719875263,0.261802982840857,"B.LvsV.CERVERA_SDHB_TARGETS_1_DN"
89,"Up",0.0528578378240748,0.262579501643584,"B.LvsV.LANDIS_ERBB2_BREAST_PRENEOPLASTIC_DN"
39,"Up",0.0529301526163929,0.262702705400392,"B.LvsV.BUCKANOVICH_T_LYMPHOCYTE_HOMING_ON_TUMOR_UP"
17,"Down",0.0530850768043445,0.263235327041453,"B.LvsV.BIOCARTA_BTG2_PATHWAY"
6,"Down",0.0531496329725339,0.263319283785968,"B.LvsV.ZHAN_EARLY_DIFFERENTIATION_GENES_UP"
196,"Up",0.053278365513167,0.263720754630528,"B.LvsV.REACTOME_METABOLISM_OF_STEROIDS"
68,"Down",0.0536829920361409,0.265124411796696,"B.LvsV.YANG_BREAST_CANCER_ESR1_LASER_DN"
109,"Down",0.0536934041999465,0.265124411796696,"B.LvsV.REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS"
35,"Down",0.0537273923318297,0.265124411796696,"B.LvsV.REACTOME_DOWNREGULATION_OF_TGF_BETA_RECEPTOR_SIGNALING"
14,"Down",0.0537537467216669,0.265124411796696,"B.LvsV.BIOCARTA_LECTIN_PATHWAY"
9,"Down",0.0538316477419733,0.265262895276803,"B.LvsV.REACTOME_2_LTR_CIRCLE_FORMATION"
6,"Up",0.0538923567868182,0.265262895276803,"B.LvsV.REACTOME_LRR_FLII_INTERACTING_PROTEIN_1_LRRFIP1_ACTIVATES_TYPE_I_IFN_PRODUCTION"
22,"Down",0.0539257540768904,0.265262895276803,"B.LvsV.BIOCARTA_GRANULOCYTES_PATHWAY"
91,"Up",0.0540131106343076,0.26545643439741,"B.LvsV.DAUER_STAT3_TARGETS_DN"
18,"Down",0.0543071035916103,0.26624013792191,"B.LvsV.MARKS_ACETYLATED_NON_HISTONE_PROTEINS"
42,"Up",0.0544201855926882,0.26624013792191,"B.LvsV.REACTOME_DISEASES_OF_CARBOHYDRATE_METABOLISM"
132,"Up",0.0544532533244791,0.26624013792191,"B.LvsV.REACTOME_SIGNALING_BY_VEGF"
125,"Up",0.0544532841297861,0.26624013792191,"B.LvsV.FLORIO_HUMAN_NEOCORTEX"
59,"Down",0.0544595840033813,0.26624013792191,"B.LvsV.VALK_AML_CLUSTER_15"
32,"Down",0.0544614932157136,0.26624013792191,"B.LvsV.LEE_SP4_THYMOCYTE"
32,"Down",0.0547900264633558,0.267609590385066,"B.LvsV.HOLLEMAN_PREDNISOLONE_RESISTANCE_B_ALL_DN"
12,"Up",0.0548941338252378,0.26788143505714,"B.LvsV.REACTOME_REVERSIBLE_HYDRATION_OF_CARBON_DIOXIDE"
111,"Up",0.0550157577823526,0.268238205272158,"B.LvsV.CHESLER_BRAIN_QTL_CIS"
34,"Down",0.0554260287524598,0.269840793102625,"B.LvsV.LAMB_CCND1_TARGETS"
325,"Down",0.0554420584128381,0.269840793102625,"B.LvsV.WIERENGA_STAT5A_TARGETS_UP"
32,"Down",0.0555940693298781,0.270220866571808,"B.LvsV.NUMATA_CSF3_SIGNALING_VIA_STAT3"
121,"Down",0.0556178958507358,0.270220866571808,"B.LvsV.LIAN_LIPA_TARGETS_3M"
190,"Up",0.0557258955553975,0.270365867225225,"B.LvsV.KOBAYASHI_EGFR_SIGNALING_24HR_UP"
82,"Down",0.055745539634067,0.270365867225225,"B.LvsV.REACTOME_THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT"
51,"Up",0.0560950252147249,0.271822431561975,"B.LvsV.BIOCARTA_BCR_PATHWAY"
140,"Down",0.056181807937966,0.271839700911136,"B.LvsV.REACTOME_SLC_TRANSPORTER_DISORDERS"
27,"Down",0.0562167604817227,0.271839700911136,"B.LvsV.LEE_NAIVE_T_LYMPHOCYTE"
13,"Down",0.0562460875099185,0.271839700911136,"B.LvsV.TESAR_ALK_TARGETS_EPISC_3D_UP"
150,"Up",0.0563109313258686,0.271915405502819,"B.LvsV.BURTON_ADIPOGENESIS_PEAK_AT_0HR"
31,"Up",0.0564623500710322,0.27240866801286,"B.LvsV.MOOTHA_GLYCOLYSIS"
144,"Down",0.0566045465813743,0.272856615560958,"B.LvsV.NEMETH_INFLAMMATORY_RESPONSE_LPS_UP"
25,"Up",0.056734298763957,0.27324384831526,"B.LvsV.REACTOME_TYPE_I_HEMIDESMOSOME_ASSEMBLY"
47,"Down",0.0568510400096223,0.273335780834495,"B.LvsV.HOUSTIS_ROS"
10,"Down",0.0568522604376323,0.273335780834495,"B.LvsV.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_21"
14,"Down",0.0569430846614893,0.273534591740551,"B.LvsV.BIOCARTA_CTBP1_PATHWAY"
19,"Down",0.05715167009488,0.274227882555916,"B.LvsV.REACTOME_TRANSPORT_OF_ORGANIC_ANIONS"
43,"Down",0.0572320011478928,0.274227882555916,"B.LvsV.FOURNIER_ACINAR_DEVELOPMENT_LATE_DN"
31,"Up",0.0572362048235715,0.274227882555916,"B.LvsV.MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH"
17,"Down",0.0574104145387796,0.274824399986937,"B.LvsV.PID_ERBB_NETWORK_PATHWAY"
61,"Down",0.0575324304960142,0.274874795538642,"B.LvsV.RIZ_ERYTHROID_DIFFERENTIATION_6HR"
25,"Down",0.0575567527482386,0.274874795538642,"B.LvsV.RASHI_NFKB1_TARGETS"
35,"Down",0.0575852169165497,0.274874795538642,"B.LvsV.PID_ALK1_PATHWAY"
35,"Down",0.0576198025012274,0.274874795538642,"B.LvsV.CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_LD_MTX_DN"
17,"Up",0.0577594443763367,0.275067229470436,"B.LvsV.REACTOME_REGULATION_OF_PYRUVATE_DEHYDROGENASE_PDH_COMPLEX"
95,"Up",0.0577596406972646,0.275067229470436,"B.LvsV.KIM_GERMINAL_CENTER_T_HELPER_UP"
18,"Down",0.0578696044521045,0.275353737535014,"B.LvsV.PARK_OSTEOBLAST_DIFFERENTIATION_BY_PHENYLAMIL_UP"
203,"Up",0.058072187146114,0.276080071135739,"B.LvsV.VERHAAK_GLIOBLASTOMA_NEURAL"
32,"Up",0.0581228319310814,0.276083451672637,"B.LvsV.BIOCARTA_PAR1_PATHWAY"
28,"Down",0.0582663546920714,0.276527618105119,"B.LvsV.BIOCARTA_TID_PATHWAY"
12,"Down",0.0584214390638447,0.277001658502753,"B.LvsV.REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_EARLY_PANCREATIC_PRECURSOR_CELLS"
24,"Up",0.05846643795853,0.277001658502753,"B.LvsV.CASTELLANO_NRAS_TARGETS_DN"
64,"Down",0.0585235398548748,0.277034804672605,"B.LvsV.PIONTEK_PKD1_TARGETS_DN"
149,"Up",0.0586615567517044,0.277450596475769,"B.LvsV.KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS"
118,"Up",0.0588571005150037,0.278137528843979,"B.LvsV.BOYLAN_MULTIPLE_MYELOMA_PCA3_DN"
107,"Down",0.0593089056148461,0.279869651547928,"B.LvsV.REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX"
64,"Up",0.059327190344767,0.279869651547928,"B.LvsV.REACTOME_CARGO_TRAFFICKING_TO_THE_PERICILIARY_MEMBRANE"
17,"Down",0.0593754930847748,0.279869651547928,"B.LvsV.REACTOME_NF_KB_IS_ACTIVATED_AND_SIGNALS_SURVIVAL"
12,"Down",0.0595277477028916,0.280348310944879,"B.LvsV.BIOCARTA_CDC25_PATHWAY"
45,"Down",0.0596280229311424,0.280581564924499,"B.LvsV.SARTIPY_NORMAL_AT_INSULIN_RESISTANCE_UP"
43,"Down",0.0597553862641008,0.280941777767188,"B.LvsV.REACTOME_VOLTAGE_GATED_POTASSIUM_CHANNELS"
323,"Down",0.0598136007031404,0.280969815088416,"B.LvsV.VILLANUEVA_LIVER_CANCER_KRT19_UP"
58,"Down",0.0599340034677944,0.280969815088416,"B.LvsV.KEGG_BASAL_CELL_CARCINOMA"
79,"Up",0.0599409969378116,0.280969815088416,"B.LvsV.HOLLERN_SOLID_NODULAR_BREAST_TUMOR_DN"
57,"Down",0.0599646196064985,0.280969815088416,"B.LvsV.VILIMAS_NOTCH1_TARGETS_DN"
24,"Up",0.0601439964738129,0.281571682052254,"B.LvsV.REACTOME_G_BETA_GAMMA_SIGNALLING_THROUGH_CDC42"
57,"Down",0.0602388932001428,0.281749511382948,"B.LvsV.STANELLE_E2F1_TARGETS"
8,"Down",0.0602838979862593,0.281749511382948,"B.LvsV.FARMER_BREAST_CANCER_CLUSTER_8"
62,"Up",0.0604021124217135,0.282063580726059,"B.LvsV.KEGG_VASOPRESSIN_REGULATED_WATER_REABSORPTION"
9,"Up",0.0606368997881782,0.28292102863193,"B.LvsV.REACTOME_SERINE_BIOSYNTHESIS"
12,"Up",0.0607460266108872,0.283191215119389,"B.LvsV.REACTOME_MET_RECEPTOR_RECYCLING"
35,"Down",0.0608790868909686,0.283208204267237,"B.LvsV.KEGG_BASE_EXCISION_REPAIR"
19,"Down",0.0608948317551652,0.283208204267237,"B.LvsV.BIOCARTA_P53_PATHWAY"
294,"Down",0.0609033378321115,0.283208204267237,"B.LvsV.FERNANDEZ_BOUND_BY_MYC"
11,"Down",0.0611793708631375,0.284252723951502,"B.LvsV.DING_LUNG_CANCER_MUTATED_RECURRENTLY"
10,"Down",0.0612703591968584,0.284436453400025,"B.LvsV.REACTOME_E2F_ENABLED_INHIBITION_OF_PRE_REPLICATION_COMPLEX_FORMATION"
26,"Down",0.0614116328192598,0.284644339743217,"B.LvsV.OKAWA_NEUROBLASTOMA_1P36_31_DELETION"
13,"Up",0.0614541871860185,0.284644339743217,"B.LvsV.REACTOME_ACETYLCHOLINE_REGULATES_INSULIN_SECRETION"
30,"Down",0.0614695861192623,0.284644339743217,"B.LvsV.RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_DN"
222,"Up",0.061667536623891,0.285322016730957,"B.LvsV.IKEDA_MIR30_TARGETS_UP"
92,"Up",0.0619662217198608,0.286464247398922,"B.LvsV.KEGG_ERBB_SIGNALING_PATHWAY"
57,"Up",0.0623228010146838,0.287871985639254,"B.LvsV.PID_INSULIN_PATHWAY"
10,"Down",0.0624604729509199,0.288028009540289,"B.LvsV.BIOCARTA_FBW7_PATHWAY"
76,"Down",0.0624607674875759,0.288028009540289,"B.LvsV.REACTOME_TRANSCRIPTION_OF_THE_HIV_GENOME"
202,"Up",0.0625779287131885,0.288327806546016,"B.LvsV.BROWNE_HCMV_INFECTION_20HR_DN"
12,"Up",0.0626848197570714,0.288368467754884,"B.LvsV.REACTOME_REGULATION_OF_GENE_EXPRESSION_BY_HYPOXIA_INDUCIBLE_FACTOR"
18,"Down",0.0626910649740226,0.288368467754884,"B.LvsV.REACTOME_EARLY_PHASE_OF_HIV_LIFE_CYCLE"
111,"Down",0.0628543864379205,0.288879387045106,"B.LvsV.REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES"
72,"Down",0.0629368855013454,0.289018305595464,"B.LvsV.NIKOLSKY_BREAST_CANCER_16Q24_AMPLICON"
14,"Up",0.0630071330270618,0.289100778843672,"B.LvsV.REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_LINKED_TO_LIPOGENESIS"
9,"Up",0.0631293664544096,0.289421448695216,"B.LvsV.REACTOME_REELIN_SIGNALLING_PATHWAY"
87,"Down",0.0633119065516094,0.289723553305179,"B.LvsV.HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_DN"
27,"Down",0.0633441401540445,0.289723553305179,"B.LvsV.KARAKAS_TGFB1_SIGNALING"
63,"Down",0.0633568066406958,0.289723553305179,"B.LvsV.TSUNODA_CISPLATIN_RESISTANCE_DN"
30,"Up",0.0634723767834936,0.289723553305179,"B.LvsV.REACTOME_SYNTHESIS_OF_PC"
20,"Up",0.0635139568804752,0.289723553305179,"B.LvsV.REACTOME_RETROGRADE_NEUROTROPHIN_SIGNALLING"
81,"Up",0.0635487356896657,0.289723553305179,"B.LvsV.SESTO_RESPONSE_TO_UV_C5"
26,"Down",0.0635620673103964,0.289723553305179,"B.LvsV.FERRANDO_HOX11_NEIGHBORS"
25,"Down",0.0637030380945772,0.289729456298105,"B.LvsV.AUJLA_IL22_AND_IL17A_SIGNALING"
102,"Up",0.0637068599158623,0.289729456298105,"B.LvsV.KEGG_CARDIAC_MUSCLE_CONTRACTION"
18,"Down",0.0637205677081743,0.289729456298105,"B.LvsV.CROONQUIST_STROMAL_STIMULATION_DN"
6,"Down",0.0640777383555502,0.290497704159935,"B.LvsV.OHASHI_AURKA_TARGETS"
23,"Down",0.0640983626631741,0.290497704159935,"B.LvsV.REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI"
119,"Up",0.0641124608881117,0.290497704159935,"B.LvsV.LANDIS_BREAST_CANCER_PROGRESSION_DN"
166,"Up",0.0641131969620918,0.290497704159935,"B.LvsV.WALLACE_PROSTATE_CANCER_RACE_DN"
5,"Down",0.0642405599206892,0.290497704159935,"B.LvsV.TOMIDA_LUNG_CANCER_POOR_SURVIVAL"
415,"Up",0.0642499922708618,0.290497704159935,"B.LvsV.TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_UP"
24,"Up",0.0642573145573522,0.290497704159935,"B.LvsV.REACTOME_SIGNALING_BY_HIPPO"
36,"Up",0.0643611065638502,0.290528603492971,"B.LvsV.BARIS_THYROID_CANCER_UP"
184,"Down",0.0643692420471856,0.290528603492971,"B.LvsV.NIKOLSKY_BREAST_CANCER_20Q12_Q13_AMPLICON"
31,"Down",0.0644718892597676,0.290678710371859,"B.LvsV.TIAN_TNF_SIGNALING_NOT_VIA_NFKB"
44,"Down",0.0645172105836379,0.290678710371859,"B.LvsV.BIOCARTA_EICOSANOID_PATHWAY"
307,"Up",0.0645602199921583,0.290678710371859,"B.LvsV.MCBRYAN_PUBERTAL_BREAST_4_5WK_DN"
33,"Up",0.0646357035790899,0.29078177794043,"B.LvsV.REACTOME_TRANSFERRIN_ENDOCYTOSIS_AND_RECYCLING"
19,"Up",0.0647909077372726,0.291243031609252,"B.LvsV.SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX5_UP"
113,"Up",0.0651170163855557,0.292471148331225,"B.LvsV.RUAN_RESPONSE_TO_TNF_DN"
448,"Up",0.0651990510525553,0.292601910121411,"B.LvsV.KAAB_HEART_ATRIUM_VS_VENTRICLE_DN"
11,"Down",0.0653958926701897,0.293169450070128,"B.LvsV.BIOCARTA_NOTCH_PATHWAY"
60,"Up",0.0654315611116908,0.293169450070128,"B.LvsV.CROONQUIST_NRAS_VS_STROMAL_STIMULATION_UP"
266,"Up",0.0657451999799948,0.294105586524814,"B.LvsV.PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_DN"
14,"Up",0.0657704082996187,0.294105586524814,"B.LvsV.REACTOME_ACTIVATED_NTRK2_SIGNALS_THROUGH_FRS2_AND_FRS3"
33,"Up",0.0658000742505325,0.294105586524814,"B.LvsV.HOWLIN_CITED1_TARGETS_2_UP"
156,"Down",0.0658905332175396,0.294272017899658,"B.LvsV.LEIN_CHOROID_PLEXUS_MARKERS"
651,"Down",0.0661555782560293,0.295075693626708,"B.LvsV.TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C"
264,"Down",0.0661772219383466,0.295075693626708,"B.LvsV.VANTVEER_BREAST_CANCER_METASTASIS_DN"
49,"Down",0.0662908959775428,0.29534437055587,"B.LvsV.REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT"
55,"Up",0.0664895750243,0.295991030844891,"B.LvsV.STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_DN"
37,"Down",0.0665916013677743,0.296206728851508,"B.LvsV.REACTOME_DOWNREGULATION_OF_SMAD2_3_SMAD4_TRANSCRIPTIONAL_ACTIVITY"
18,"Up",0.066793048091059,0.29672259603898,"B.LvsV.REACTOME_LOSS_OF_FUNCTION_OF_MECP2_IN_RETT_SYNDROME"
82,"Down",0.0668576969192953,0.29672259603898,"B.LvsV.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_DN"
21,"Up",0.0669221435512306,0.29672259603898,"B.LvsV.KRISHNAN_FURIN_TARGETS_DN"
25,"Down",0.0669674272846106,0.29672259603898,"B.LvsV.FINETTI_BREAST_CANCER_KINOME_GREEN"
20,"Up",0.0669759088183481,0.29672259603898,"B.LvsV.ONGUSAHA_BRCA1_TARGETS_DN"
132,"Down",0.0671520862746361,0.297264919945927,"B.LvsV.REACTOME_SIGNALING_BY_TGF_BETA_FAMILY_MEMBERS"
35,"Up",0.0674317386322795,0.298264066318299,"B.LvsV.BIOCARTA_IGF1_PATHWAY"
115,"Down",0.0675386054548092,0.298497961278689,"B.LvsV.DEMAGALHAES_AGING_UP"
19,"Down",0.067685371241987,0.298907681786698,"B.LvsV.SASSON_FSH_RESPONSE"
67,"Down",0.0678436780782097,0.299142696368574,"B.LvsV.MORI_PLASMA_CELL_UP"
15,"Down",0.0678467971145219,0.299142696368574,"B.LvsV.REACTOME_ORGANIC_CATION_TRANSPORT"
46,"Up",0.0679932905795388,0.299549723995434,"B.LvsV.PID_PI3KCI_AKT_PATHWAY"
42,"Up",0.0680578722106056,0.299595521857037,"B.LvsV.PID_IGF1_PATHWAY"
18,"Down",0.0686290579812442,0.301869579616785,"B.LvsV.ZAIDI_OSTEOBLAST_TRANSCRIPTION_FACTORS"
95,"Up",0.0687443644535746,0.302100922945232,"B.LvsV.FAELT_B_CLL_WITH_VH_REARRANGEMENTS_DN"
39,"Down",0.0687909318119093,0.302100922945232,"B.LvsV.REACTOME_ONCOGENE_INDUCED_SENESCENCE"
46,"Down",0.0689167526619105,0.302413274180717,"B.LvsV.REACTOME_TRANSCRIPTIONAL_REGULATION_BY_THE_AP_2_TFAP2_FAMILY_OF_TRANSCRIPTION_FACTORS"
17,"Up",0.0693866823804851,0.304233915052896,"B.LvsV.SANDERSON_PPARA_TARGETS"
65,"Up",0.0695109848060954,0.304537428679003,"B.LvsV.YANG_BREAST_CANCER_ESR1_UP"
54,"Down",0.0696220725767163,0.304611669502942,"B.LvsV.HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_24HR"
63,"Up",0.0697152186505012,0.304611669502942,"B.LvsV.APRELIKOVA_BRCA1_TARGETS"
89,"Up",0.0697584706759472,0.304611669502942,"B.LvsV.ROY_WOUND_BLOOD_VESSEL_UP"
24,"Up",0.0697636083292317,0.304611669502942,"B.LvsV.REACTOME_RORA_ACTIVATES_GENE_EXPRESSION"
65,"Up",0.0698311434847141,0.304611669502942,"B.LvsV.REACTOME_PLATELET_AGGREGATION_PLUG_FORMATION"
61,"Down",0.0701148960238161,0.304611669502942,"B.LvsV.GENTILE_UV_RESPONSE_CLUSTER_D2"
15,"Down",0.0701582356081196,0.304611669502942,"B.LvsV.GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_1_DN"
6,"Down",0.0701757360687914,0.304611669502942,"B.LvsV.REACTOME_VITAMINS"
51,"Down",0.0701758725252529,0.304611669502942,"B.LvsV.BOYAULT_LIVER_CANCER_SUBCLASS_G2"
5,"Up",0.0702651381115407,0.304611669502942,"B.LvsV.TURJANSKI_MAPK11_TARGETS"
37,"Down",0.0703006441511033,0.304611669502942,"B.LvsV.GAJATE_RESPONSE_TO_TRABECTEDIN_DN"
188,"Down",0.070314248063007,0.304611669502942,"B.LvsV.BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_UP"
140,"Up",0.070367383819523,0.304611669502942,"B.LvsV.HECKER_IFNB1_TARGETS"
27,"Up",0.070389522565548,0.304611669502942,"B.LvsV.BIOCARTA_CHREBP_PATHWAY"
97,"Up",0.0703990961064114,0.304611669502942,"B.LvsV.BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_DN"
39,"Down",0.0704094255063773,0.304611669502942,"B.LvsV.DUNNE_TARGETS_OF_AML1_MTG8_FUSION_DN"
37,"Down",0.0705470448990834,0.304968421616131,"B.LvsV.TOMIDA_METASTASIS_DN"
48,"Down",0.0708575000592259,0.305865821789886,"B.LvsV.MILICIC_FAMILIAL_ADENOMATOUS_POLYPOSIS_UP"
12,"Down",0.070865277213392,0.305865821789886,"B.LvsV.REACTOME_PASSIVE_TRANSPORT_BY_AQUAPORINS"
187,"Up",0.0709792806891269,0.306118910241952,"B.LvsV.QI_HYPOXIA"
115,"Up",0.0712218720856648,0.306925744942822,"B.LvsV.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_UP"
13,"Down",0.0713358010535293,0.307177292854333,"B.LvsV.REACTOME_MASTL_FACILITATES_MITOTIC_PROGRESSION"
200,"Up",0.071501674725544,0.30755192919158,"B.LvsV.REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2"
6,"Down",0.0715340533442524,0.30755192919158,"B.LvsV.REACTOME_PROTON_COUPLED_MONOCARBOXYLATE_TRANSPORT"
944,"Down",0.0718389007919902,0.308242607187235,"B.LvsV.MIKKELSEN_MEF_HCP_WITH_H3K27ME3"
26,"Down",0.0718574620287333,0.308242607187235,"B.LvsV.AMIT_DELAYED_EARLY_GENES"
29,"Up",0.0718619498398166,0.308242607187235,"B.LvsV.REACTOME_LDL_CLEARANCE"
1622,"Down",0.071931260888429,0.308300729807848,"B.LvsV.BENPORATH_ES_WITH_H3K27ME3"
90,"Down",0.0721562780542344,0.30902560911066,"B.LvsV.CAFFAREL_RESPONSE_TO_THC_24HR_5_DN"
6,"Down",0.0722673620925659,0.309241015662733,"B.LvsV.CALVET_IRINOTECAN_SENSITIVE_VS_RESISTANT_UP"
183,"Up",0.07231843610995,0.309241015662733,"B.LvsV.DITTMER_PTHLH_TARGETS_UP"
11,"Down",0.0726741742253385,0.310522031910276,"B.LvsV.RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_MAPK1_UP"
40,"Down",0.0728111347353983,0.310642575805834,"B.LvsV.REACTOME_AMINO_ACID_TRANSPORT_ACROSS_THE_PLASMA_MEMBRANE"
104,"Up",0.0728648256680594,0.310642575805834,"B.LvsV.FIGUEROA_AML_METHYLATION_CLUSTER_1_DN"
363,"Up",0.0728709388352626,0.310642575805834,"B.LvsV.REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION"
48,"Up",0.0729374250846013,0.310686458623082,"B.LvsV.LI_PROSTATE_CANCER_EPIGENETIC"
56,"Up",0.0729946446498336,0.310690831615804,"B.LvsV.HASLINGER_B_CLL_WITH_6Q21_DELETION"
236,"Down",0.0733482400896951,0.311904324797392,"B.LvsV.REACTOME_DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS"
38,"Down",0.0734369441218719,0.311904324797392,"B.LvsV.REACTOME_CHAPERONE_MEDIATED_AUTOPHAGY"
64,"Down",0.0734489837016104,0.311904324797392,"B.LvsV.BYSTROEM_CORRELATED_WITH_IL5_UP"
9,"Up",0.0737765616036672,0.313054957104126,"B.LvsV.KIM_GLIS2_TARGETS_DN"
12,"Up",0.0740369205038052,0.313665960000634,"B.LvsV.REACTOME_INTERLEUKIN_6_SIGNALING"
254,"Up",0.0741001876946243,0.313665960000634,"B.LvsV.CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_DN"
99,"Up",0.0741328242685316,0.313665960000634,"B.LvsV.BIOCARTA_MAPK_PATHWAY"
29,"Down",0.074189267285889,0.313665960000634,"B.LvsV.ZHANG_GATA6_TARGETS_UP"
83,"Up",0.074204209745131,0.313665960000634,"B.LvsV.COWLING_MYCN_TARGETS"
10,"Down",0.0742634034874752,0.313676362018526,"B.LvsV.REACTOME_RECYCLING_OF_EIF2_GDP"
46,"Down",0.0743268439685126,0.313704671986188,"B.LvsV.KEGG_NUCLEOTIDE_EXCISION_REPAIR"
709,"Down",0.0743869980858957,0.313719078883995,"B.LvsV.MIKKELSEN_MCV6_HCP_WITH_H3K27ME3"
67,"Up",0.0748113509142705,0.315246228104862,"B.LvsV.PID_NFAT_3PATHWAY"
9,"Up",0.0748899024943982,0.315246228104862,"B.LvsV.REACTOME_SYNTHESIS_OF_PG"
2169,"Down",0.0749472237625841,0.315246228104862,"B.LvsV.PUJANA_ATM_PCC_NETWORK"
26,"Up",0.0749771730797419,0.315246228104862,"B.LvsV.ZHENG_RESPONSE_TO_ARSENITE_UP"
16,"Up",0.0751182156626568,0.31559925106294,"B.LvsV.BIOCARTA_AGPCR_PATHWAY"
343,"Up",0.07518462725785,0.315638423772705,"B.LvsV.GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP"
63,"Up",0.0752770812802635,0.315786784824414,"B.LvsV.KEGG_VIBRIO_CHOLERAE_INFECTION"
172,"Up",0.0753766070764473,0.315964564462227,"B.LvsV.REACTOME_SIGNALING_BY_NTRKS"
24,"Up",0.0758276764550283,0.317614562969584,"B.LvsV.INAMURA_LUNG_CANCER_SCC_DN"
161,"Up",0.076012266920465,0.317899208641581,"B.LvsV.SESTO_RESPONSE_TO_UV_C8"
1092,"Down",0.0760198071050741,0.317899208641581,"B.LvsV.REACTOME_INFECTIOUS_DISEASE"
225,"Down",0.0760681231746811,0.317899208641581,"B.LvsV.REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS"
17,"Down",0.0763255945787355,0.318734299415278,"B.LvsV.INAMURA_LUNG_CANCER_SCC_SUBTYPES_UP"
237,"Down",0.0764752495503898,0.318764451591305,"B.LvsV.DARWICHE_PAPILLOMA_RISK_HIGH_UP"
5,"Up",0.076547139152997,0.318764451591305,"B.LvsV.BIOCARTA_DICER_PATHWAY"
71,"Down",0.0765512772752316,0.318764451591305,"B.LvsV.BEIER_GLIOMA_STEM_CELL_UP"
357,"Down",0.076563427692757,0.318764451591305,"B.LvsV.REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS"
98,"Down",0.0766479391962595,0.318779340964763,"B.LvsV.REACTOME_CLASS_B_2_SECRETIN_FAMILY_RECEPTORS"
584,"Down",0.076682315695991,0.318779340964763,"B.LvsV.MIKKELSEN_NPC_HCP_WITH_H3K27ME3"
154,"Down",0.0770140521477134,0.319729956926969,"B.LvsV.ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_DN"
19,"Down",0.0770346485551713,0.319729956926969,"B.LvsV.REACTOME_TFAP2_AP_2_FAMILY_REGULATES_TRANSCRIPTION_OF_GROWTH_FACTORS_AND_THEIR_RECEPTORS"
145,"Down",0.0770844696298878,0.319729956926969,"B.LvsV.UEDA_CENTRAL_CLOCK"
41,"Up",0.07722935294375,0.319874302244768,"B.LvsV.WANG_METASTASIS_OF_BREAST_CANCER"
24,"Down",0.0772349780243742,0.319874302244768,"B.LvsV.HOLLEMAN_DAUNORUBICIN_B_ALL_UP"
395,"Down",0.0773330808058549,0.319923258783997,"B.LvsV.SENESE_HDAC1_AND_HDAC2_TARGETS_UP"
196,"Up",0.0773998612441446,0.319923258783997,"B.LvsV.STEARMAN_LUNG_CANCER_EARLY_VS_LATE_UP"
256,"Down",0.0775206842189181,0.319923258783997,"B.LvsV.MEISSNER_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3"
92,"Up",0.0775294553578942,0.319923258783997,"B.LvsV.STARK_HYPPOCAMPUS_22Q11_DELETION_UP"
107,"Down",0.07760649856499,0.319923258783997,"B.LvsV.KYNG_RESPONSE_TO_H2O2"
135,"Up",0.0776444841736122,0.319923258783997,"B.LvsV.HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP"
92,"Down",0.0776518381783548,0.319923258783997,"B.LvsV.OLSSON_E2F3_TARGETS_DN"
99,"Up",0.0777393901060305,0.320017115692924,"B.LvsV.MIKKELSEN_ES_ICP_WITH_H3K27ME3"
39,"Up",0.0777903786383234,0.320017115692924,"B.LvsV.PID_RETINOIC_ACID_PATHWAY"
84,"Down",0.0778927146797842,0.320199865772882,"B.LvsV.SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER"
32,"Up",0.0783245824299458,0.321735970471895,"B.LvsV.COLLER_MYC_TARGETS_DN"
439,"Down",0.0784369071149411,0.321958173302531,"B.LvsV.MCBRYAN_PUBERTAL_BREAST_4_5WK_UP"
48,"Down",0.0787848436578528,0.323011807089453,"B.LvsV.WILLIAMS_ESR1_TARGETS_UP"
6,"Down",0.0788104409049867,0.323011807089453,"B.LvsV.SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX2_UP"
136,"Down",0.0788913269267671,0.323103812280071,"B.LvsV.GHANDHI_DIRECT_IRRADIATION_UP"
57,"Down",0.0790723918989973,0.32360566603224,"B.LvsV.WANG_TARGETS_OF_MLL_CBP_FUSION_DN"
33,"Down",0.0792648518711778,0.323724980747039,"B.LvsV.KORKOLA_YOLK_SAC_TUMOR_UP"
361,"Down",0.0792672734132127,0.323724980747039,"B.LvsV.MATTIOLI_MGUS_VS_PCL"
99,"Down",0.079277197310814,0.323724980747039,"B.LvsV.LEE_TARGETS_OF_PTCH1_AND_SUFU_UP"
342,"Down",0.0795202194349386,0.324477707199834,"B.LvsV.ZWANG_CLASS_3_TRANSIENTLY_INDUCED_BY_EGF"
24,"Down",0.0796564235863067,0.32462713550864,"B.LvsV.CAIRO_PML_TARGETS_BOUND_BY_MYC_DN"
23,"Down",0.0797647024727375,0.32462713550864,"B.LvsV.REACTOME_NEGATIVE_REGULATION_OF_TCF_DEPENDENT_SIGNALING_BY_WNT_LIGAND_ANTAGONISTS"
32,"Down",0.0797701299818109,0.32462713550864,"B.LvsV.REACTOME_HS_GAG_BIOSYNTHESIS"
230,"Up",0.0797916941863342,0.32462713550864,"B.LvsV.MILI_PSEUDOPODIA_CHEMOTAXIS_UP"
486,"Down",0.0799171829859614,0.324842763290606,"B.LvsV.REACTOME_M_PHASE"
39,"Up",0.0799814340712087,0.324842763290606,"B.LvsV.KEGG_THYROID_CANCER"
64,"Down",0.0800209519988797,0.324842763290606,"B.LvsV.TIEN_INTESTINE_PROBIOTICS_2HR_UP"
86,"Up",0.0804817273878467,0.326239312369427,"B.LvsV.REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS"
40,"Down",0.0804829846395185,0.326239312369427,"B.LvsV.CHEN_ETV5_TARGETS_SERTOLI"
97,"Up",0.0806977662255184,0.326870292645342,"B.LvsV.MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_UP"
8,"Up",0.0808063555329772,0.327070526897387,"B.LvsV.IM_SREBF1A_TARGETS"
26,"Up",0.0808909060522568,0.327173240353276,"B.LvsV.SMID_BREAST_CANCER_NORMAL_LIKE_DN"
9,"Up",0.081259206412537,0.328422625917337,"B.LvsV.REACTOME_TFAP2_AP_2_FAMILY_REGULATES_TRANSCRIPTION_OF_CELL_CYCLE_FACTORS"
19,"Down",0.0814815695800169,0.329080787587957,"B.LvsV.REACTOME_SHC_MEDIATED_CASCADE_FGFR3"
221,"Up",0.0816972245207096,0.329710915602192,"B.LvsV.RODWELL_AGING_KIDNEY_NO_BLOOD_DN"
32,"Up",0.0822271173927446,0.331381905255425,"B.LvsV.BIOCARTA_VIP_PATHWAY"
201,"Up",0.0823404124186211,0.331381905255425,"B.LvsV.KEGG_HUNTINGTONS_DISEASE"
9,"Down",0.0823488534451484,0.331381905255425,"B.LvsV.REACTOME_TRAIL_SIGNALING"
53,"Down",0.0823510106386244,0.331381905255425,"B.LvsV.WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_UP"
84,"Down",0.0824937319275135,0.331714795510707,"B.LvsV.REACTOME_RNA_POLYMERASE_II_TRANSCRIBES_SNRNA_GENES"
140,"Up",0.0827271346959135,0.332229581255671,"B.LvsV.KEGG_LYSOSOME"
54,"Down",0.082741930437522,0.332229581255671,"B.LvsV.BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_DN"
22,"Up",0.0828342678149203,0.332358974418501,"B.LvsV.REACTOME_GRB2_SOS_PROVIDES_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS"
34,"Down",0.0830371972840212,0.332485223883197,"B.LvsV.WELCH_GATA1_TARGETS"
76,"Up",0.0830728117067871,0.332485223883197,"B.LvsV.GILDEA_METASTASIS"
50,"Up",0.0830868671578451,0.332485223883197,"B.LvsV.ABBUD_LIF_SIGNALING_1_DN"
101,"Up",0.0831322341806526,0.332485223883197,"B.LvsV.REACTOME_COPII_MEDIATED_VESICLE_TRANSPORT"
47,"Up",0.0831664070592261,0.332485223883197,"B.LvsV.REACTOME_SEMA4D_IN_SEMAPHORIN_SIGNALING"
111,"Up",0.0832579910188896,0.332610861519827,"B.LvsV.REACTOME_TOLL_LIKE_RECEPTOR_9_TLR9_CASCADE"
1122,"Down",0.0835062535545902,0.333361787655833,"B.LvsV.RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP"
39,"Down",0.0836213837292198,0.333531765601703,"B.LvsV.ZHAN_V1_LATE_DIFFERENTIATION_GENES_DN"
32,"Up",0.083669480717953,0.333531765601703,"B.LvsV.BIOCARTA_IL6_PATHWAY"
91,"Down",0.083805722966815,0.333834180319539,"B.LvsV.REACTOME_SIGNALING_BY_FGFR2"
21,"Down",0.0839144378999753,0.33402658542042,"B.LvsV.JOHANSSON_BRAIN_CANCER_EARLY_VS_LATE_UP"
66,"Up",0.0840193479341758,0.334203578941049,"B.LvsV.LUI_THYROID_CANCER_CLUSTER_2"
83,"Down",0.0840995997173332,0.334282305418501,"B.LvsV.KEGG_P53_SIGNALING_PATHWAY"
52,"Up",0.0841679587023152,0.334313680793894,"B.LvsV.HUMMERICH_BENIGN_SKIN_TUMOR_DN"
33,"Up",0.0842373728264168,0.334349199107867,"B.LvsV.HAEGERSTRAND_RESPONSE_TO_IMATINIB"
40,"Down",0.0843437245883257,0.334531171627584,"B.LvsV.RIZ_ERYTHROID_DIFFERENTIATION_HEMGN"
7,"Down",0.0845283799227098,0.33502323483345,"B.LvsV.STONER_ESOPHAGEAL_CARCINOGENESIS_DN"
105,"Up",0.0846151456077952,0.335126891164398,"B.LvsV.PID_MET_PATHWAY"
135,"Down",0.0846806868003687,0.335146397508403,"B.LvsV.CORRE_MULTIPLE_MYELOMA_UP"
27,"Up",0.0847612432753602,0.335215742897058,"B.LvsV.REACTOME_ERK_MAPK_TARGETS"
896,"Up",0.0848641701991708,0.335215742897058,"B.LvsV.REACTOME_METABOLISM_OF_LIPIDS"
401,"Up",0.0848800940596638,0.335215742897058,"B.LvsV.WELCSH_BRCA1_TARGETS_UP"
11,"Down",0.0850669739826916,0.335713989400644,"B.LvsV.REACTOME_REMOVAL_OF_THE_FLAP_INTERMEDIATE_FROM_THE_C_STRAND"
20,"Up",0.0852253864662208,0.336099259466287,"B.LvsV.BIOCARTA_EGFR_SMRTE_PATHWAY"
7,"Up",0.0853734736362113,0.33638788806794,"B.LvsV.REACTOME_MET_ACTIVATES_PTPN11"
121,"Down",0.0854202558957112,0.33638788806794,"B.LvsV.PEART_HDAC_PROLIFERATION_CLUSTER_DN"
113,"Up",0.0857778606329918,0.337555723444706,"B.LvsV.HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_UP"
77,"Down",0.0859984557473528,0.337926433493511,"B.LvsV.TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_DN"
227,"Up",0.0860111948053347,0.337926433493511,"B.LvsV.REACTOME_PHOSPHOLIPID_METABOLISM"
7,"Down",0.0860554202132146,0.337926433493511,"B.LvsV.REACTOME_NECTIN_NECL_TRANS_HETERODIMERIZATION"
20,"Down",0.0866093796862458,0.339554073727085,"B.LvsV.VANDESLUIS_COMMD1_TARGETS_GROUP_4_UP"
350,"Down",0.0868168799031809,0.339554073727085,"B.LvsV.RODWELL_AGING_KIDNEY_NO_BLOOD_UP"
9,"Down",0.0869059535579745,0.339554073727085,"B.LvsV.MAINA_HYPOXIA_VHL_TARGETS_UP"
25,"Down",0.0869455261319068,0.339554073727085,"B.LvsV.BOYAULT_LIVER_CANCER_SUBCLASS_G56_DN"
10,"Down",0.0869520747478451,0.339554073727085,"B.LvsV.REACTOME_HYDROLYSIS_OF_LPC"
95,"Down",0.0869701036521581,0.339554073727085,"B.LvsV.KRIEG_HYPOXIA_VIA_KDM3A"
109,"Down",0.0869712217629266,0.339554073727085,"B.LvsV.ENGELMANN_CANCER_PROGENITORS_DN"
45,"Down",0.0870071188648231,0.339554073727085,"B.LvsV.REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS"
173,"Up",0.0870226302172687,0.339554073727085,"B.LvsV.RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_UP"
12,"Up",0.0871316908446703,0.339739858025516,"B.LvsV.BOYAULT_LIVER_CANCER_SUBCLASS_G23_DN"
6,"Down",0.0872306568106564,0.339886047573023,"B.LvsV.REACTOME_SEROTONIN_AND_MELATONIN_BIOSYNTHESIS"
111,"Down",0.0875258747118297,0.340796169916695,"B.LvsV.MCBRYAN_PUBERTAL_TGFB1_TARGETS_DN"
8,"Down",0.0877613990696655,0.341349810910557,"B.LvsV.MOOTHA_ROS"
74,"Up",0.0877915411674464,0.341349810910557,"B.LvsV.LI_CISPLATIN_RESISTANCE_UP"
22,"Up",0.0879014337728768,0.341536913092225,"B.LvsV.TAGHAVI_NEOPLASTIC_TRANSFORMATION"
51,"Down",0.0881573319351541,0.342139330763721,"B.LvsV.KANG_GLIS3_TARGETS"
31,"Down",0.0881802398875571,0.342139330763721,"B.LvsV.MAINA_VHL_TARGETS_DN"
92,"Up",0.0885240896525618,0.343232602867471,"B.LvsV.PID_TRKR_PATHWAY"
7,"Down",0.0889152621260034,0.344507697473492,"B.LvsV.REACTOME_ELECTRIC_TRANSMISSION_ACROSS_GAP_JUNCTIONS"
64,"Up",0.0893585170287347,0.345750236545817,"B.LvsV.REACTOME_COPI_INDEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC"
17,"Down",0.0893610215272151,0.345750236545817,"B.LvsV.TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_MONOCYTE_DN"
52,"Down",0.0894797141317473,0.345967370233868,"B.LvsV.REACTOME_FORMATION_OF_FIBRIN_CLOT_CLOTTING_CASCADE"
7,"Down",0.0897649728784264,0.346827767326918,"B.LvsV.DIERICK_SEROTONIN_FUNCTION_GENES"
22,"Up",0.0898460476857626,0.346898601714093,"B.LvsV.MIKKELSEN_IPS_LCP_WITH_H3K27ME3"
11,"Up",0.0899732330205091,0.347131616320615,"B.LvsV.REACTOME_DERMATAN_SULFATE_BIOSYNTHESIS"
105,"Up",0.0900832974760145,0.347131616320615,"B.LvsV.PID_AVB3_INTEGRIN_PATHWAY"
916,"Down",0.0900947493977359,0.347131616320615,"B.LvsV.SWEET_LUNG_CANCER_KRAS_UP"
103,"Down",0.0901603669344365,0.347142527005919,"B.LvsV.SAMOLS_TARGETS_OF_KHSV_MIRNAS_DN"
59,"Up",0.0904830368056973,0.348073563799913,"B.LvsV.PID_A6B1_A6B4_INTEGRIN_PATHWAY"
7,"Up",0.0907060155352542,0.348073563799913,"B.LvsV.REACTOME_LOSS_OF_MECP2_BINDING_ABILITY_TO_THE_NCOR_SMRT_COMPLEX"
29,"Down",0.090741484968145,0.348073563799913,"B.LvsV.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_15"
27,"Up",0.0907666231329852,0.348073563799913,"B.LvsV.CHEMELLO_SOLEUS_VS_EDL_MYOFIBERS_UP"
38,"Up",0.0907673694231472,0.348073563799913,"B.LvsV.REACTOME_GLUCONEOGENESIS"
79,"Down",0.0908286413150952,0.348073563799913,"B.LvsV.SMIRNOV_RESPONSE_TO_IR_2HR_DN"
66,"Down",0.0908428563145731,0.348073563799913,"B.LvsV.VALK_AML_WITH_CEBPA"
80,"Down",0.0910501307070884,0.348626158365299,"B.LvsV.MARTIN_NFKB_TARGETS_UP"
11,"Up",0.0911771739193144,0.348642118051299,"B.LvsV.BIOCARTA_REELIN_PATHWAY"
182,"Down",0.0911804128598623,0.348642118051299,"B.LvsV.EPPERT_PROGENITOR"
94,"Down",0.0914049684437605,0.349259205615447,"B.LvsV.SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_DN"
95,"Down",0.091630061011204,0.349733623529864,"B.LvsV.WIERENGA_STAT5A_TARGETS_GROUP2"
106,"Down",0.0916556376369638,0.349733623529864,"B.LvsV.VANTVEER_BREAST_CANCER_POOR_PROGNOSIS"
130,"Down",0.0918742545435734,0.350326036807874,"B.LvsV.SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER"
39,"Down",0.0919788353001113,0.350483101567412,"B.LvsV.KOBAYASHI_EGFR_SIGNALING_6HR_DN"
22,"Up",0.0923949611649882,0.351826267411309,"B.LvsV.REACTOME_ACETYLCHOLINE_NEUROTRANSMITTER_RELEASE_CYCLE"
223,"Down",0.0926329282662286,0.35248964926633,"B.LvsV.WILCOX_RESPONSE_TO_PROGESTERONE_UP"
94,"Up",0.0927982245754142,0.352875779695643,"B.LvsV.REACTOME_TP53_REGULATES_METABOLIC_GENES"
175,"Down",0.0930985134054154,0.353774350940578,"B.LvsV.KAN_RESPONSE_TO_ARSENIC_TRIOXIDE"
21,"Down",0.0933468274156423,0.354403475619855,"B.LvsV.REACTOME_TRANSLESION_SYNTHESIS_BY_POLH"
30,"Down",0.0934440471305536,0.354403475619855,"B.LvsV.REACTOME_ATF4_ACTIVATES_GENES_IN_RESPONSE_TO_ENDOPLASMIC_RETICULUM_STRESS"
24,"Down",0.0934563695883069,0.354403475619855,"B.LvsV.HOLLEMAN_VINCRISTINE_RESISTANCE_B_ALL_DN"
171,"Down",0.0935582898858658,0.354546802453017,"B.LvsV.REACTOME_HOMOLOGY_DIRECTED_REPAIR"
153,"Up",0.0936560432651944,0.354674152885794,"B.LvsV.CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP"
129,"Up",0.093982356286378,0.355666288779866,"B.LvsV.VERRECCHIA_EARLY_RESPONSE_TO_TGFB1"
710,"Up",0.0943960595589446,0.356937045347791,"B.LvsV.DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN"
61,"Down",0.094447259421924,0.356937045347791,"B.LvsV.REACTOME_KINESINS"
175,"Down",0.0947973842661711,0.358015531152773,"B.LvsV.REACTOME_INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING"
26,"Up",0.0950903258305092,0.35881985419213,"B.LvsV.REACTOME_UNBLOCKING_OF_NMDA_RECEPTORS_GLUTAMATE_BINDING_AND_ACTIVATION"
35,"Down",0.0951401530558261,0.35881985419213,"B.LvsV.REACTOME_FORMATION_OF_THE_EARLY_ELONGATION_COMPLEX"
21,"Down",0.0952225250993952,0.358885713206923,"B.LvsV.REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_DIFFERENTIATION_OF_KERATINOCYTES"
15,"Up",0.0955737649973571,0.359753924591268,"B.LvsV.MIKKELSEN_PARTIALLY_REPROGRAMMED_TO_PLURIPOTENCY"
108,"Up",0.0955861547432959,0.359753924591268,"B.LvsV.NADLER_OBESITY_UP"
29,"Down",0.0956480862993606,0.359753924591268,"B.LvsV.GESERICK_TERT_TARGETS_DN"
26,"Down",0.0957731741584095,0.359800615096193,"B.LvsV.REACTOME_METAL_ION_SLC_TRANSPORTERS"
5,"Down",0.0957906502842461,0.359800615096193,"B.LvsV.REACTOME_ACTIVATION_OF_NOXA_AND_TRANSLOCATION_TO_MITOCHONDRIA"
43,"Down",0.0963706491126734,0.361733414082805,"B.LvsV.REACTOME_RNA_POLYMERASE_III_TRANSCRIPTION"
6,"Up",0.0966123546964204,0.36239464661907,"B.LvsV.REACTOME_N_GLYCAN_TRIMMING_AND_ELONGATION_IN_THE_CIS_GOLGI"
102,"Down",0.0969535204043161,0.363427806315569,"B.LvsV.REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION"
6,"Down",0.0971363234053593,0.363764637414215,"B.LvsV.REACTOME_SIGNALING_BY_MST1"
116,"Up",0.097174962825248,0.363764637414215,"B.LvsV.REACTOME_INTERFERON_ALPHA_BETA_SIGNALING"
19,"Up",0.0974552159444502,0.364566907277987,"B.LvsV.REACTOME_OAS_ANTIVIRAL_RESPONSE"
87,"Up",0.097744500461858,0.365254157428369,"B.LvsV.WANG_BARRETTS_ESOPHAGUS_UP"
243,"Up",0.0977710531730849,0.365254157428369,"B.LvsV.KEGG_REGULATION_OF_ACTIN_CYTOSKELETON"
1200,"Up",0.0978700863228025,0.36537725001943,"B.LvsV.RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN"
14,"Down",0.0980177482421293,0.365681599211021,"B.LvsV.CHEOK_RESPONSE_TO_MERCAPTOPURINE_UP"
505,"Down",0.0981633772199738,0.365977958630637,"B.LvsV.REACTOME_GPCR_LIGAND_BINDING"
477,"Down",0.0983434605917679,0.366402286800461,"B.LvsV.SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP"
42,"Up",0.0984224045570961,0.366449477977228,"B.LvsV.VANDESLUIS_COMMD1_TARGETS_GROUP_4_DN"
9,"Down",0.0987371622461865,0.3673740040775,"B.LvsV.BIOCARTA_IRES_PATHWAY"
5,"Down",0.0988937917096809,0.367709330439022,"B.LvsV.WILSON_PROTEASES_AT_TUMOR_BONE_INTERFACE_DN"
82,"Down",0.099025002504258,0.367949757289007,"B.LvsV.LINDSTEDT_DENDRITIC_CELL_MATURATION_A"
34,"Down",0.0991516215727773,0.368172811065068,"B.LvsV.KANG_CISPLATIN_RESISTANCE_UP"
867,"Up",0.099402517746203,0.368856725247488,"B.LvsV.PARENT_MTOR_SIGNALING_UP"
46,"Down",0.0995471508852367,0.369145672196159,"B.LvsV.HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_DN"
76,"Down",0.100401102528974,0.372062798848993,"B.LvsV.ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_DN"
10,"Up",0.100793603518792,0.373116806477257,"B.LvsV.BIOCARTA_LDL_PATHWAY"
990,"Up",0.100820493557067,0.373116806477257,"B.LvsV.REACTOME_VESICLE_MEDIATED_TRANSPORT"
104,"Down",0.101659147896709,0.37550200360052,"B.LvsV.LI_DCP2_BOUND_MRNA"
107,"Down",0.101730870649118,0.37550200360052,"B.LvsV.PHONG_TNF_TARGETS_UP"
38,"Up",0.101787255960677,0.37550200360052,"B.LvsV.KANG_AR_TARGETS_DN"
12,"Down",0.101788327611349,0.37550200360052,"B.LvsV.REACTOME_SLBP_DEPENDENT_PROCESSING_OF_REPLICATION_DEPENDENT_HISTONE_PRE_MRNAS"
85,"Down",0.101814804389648,0.37550200360052,"B.LvsV.WINTER_HYPOXIA_DN"
100,"Up",0.101993136744764,0.37550200360052,"B.LvsV.REACTOME_TOLL_LIKE_RECEPTOR_10_TLR10_CASCADE"
27,"Down",0.10200516691492,0.37550200360052,"B.LvsV.ABE_VEGFA_TARGETS"
65,"Down",0.102008321470064,0.37550200360052,"B.LvsV.WONG_PROTEASOME_GENE_MODULE"
72,"Up",0.102177449702214,0.375874330940481,"B.LvsV.ZHAN_MULTIPLE_MYELOMA_CD1_UP"
269,"Down",0.102610518855767,0.377159995417738,"B.LvsV.RIGGI_EWING_SARCOMA_PROGENITOR_DN"
789,"Up",0.102663373684879,0.377159995417738,"B.LvsV.DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN"
886,"Up",0.103052392958125,0.378337769366184,"B.LvsV.STEIN_ESRRA_TARGETS"
49,"Down",0.10337149329954,0.379058644279563,"B.LvsV.KAMMINGA_SENESCENCE"
14,"Down",0.10338586282756,0.379058644279563,"B.LvsV.REACTOME_LYSOSPHINGOLIPID_AND_LPA_RECEPTORS"
250,"Down",0.103495190338352,0.379208023446488,"B.LvsV.DARWICHE_SQUAMOUS_CELL_CARCINOMA_UP"
632,"Up",0.103904806836939,0.380456739736048,"B.LvsV.ZHOU_INFLAMMATORY_RESPONSE_LIVE_DN"
25,"Down",0.104122483704056,0.381001464195716,"B.LvsV.NGO_MALIGNANT_GLIOMA_1P_LOH"
20,"Down",0.104311485807725,0.381440611792932,"B.LvsV.REACTOME_BUTYRATE_RESPONSE_FACTOR_1_BRF1_BINDS_AND_DESTABILIZES_MRNA"
863,"Down",0.104663194119047,0.382356789152008,"B.LvsV.CHICAS_RB1_TARGETS_SENESCENT"
130,"Up",0.104700339803968,0.382356789152008,"B.LvsV.PEDERSEN_TARGETS_OF_611CTF_ISOFORM_OF_ERBB2"
1255,"Up",0.105078626028253,0.383484965881327,"B.LvsV.DACOSTA_UV_RESPONSE_VIA_ERCC3_DN"
60,"Down",0.105188766830579,0.383633701719175,"B.LvsV.LANDIS_BREAST_CANCER_PROGRESSION_UP"
27,"Down",0.105264721882216,0.383643684017395,"B.LvsV.KORKOLA_TERATOMA_UP"
56,"Down",0.105330278954315,0.383643684017395,"B.LvsV.LIAN_NEUTROPHIL_GRANULE_CONSTITUENTS"
60,"Up",0.105464630598375,0.383880146529568,"B.LvsV.PID_TNF_PATHWAY"
14,"Down",0.105803996454605,0.384862037103627,"B.LvsV.REACTOME_SIGNALING_BY_ACTIVIN"
9,"Down",0.106142666773524,0.38564007268118,"B.LvsV.REACTOME_PHOSPHATE_BOND_HYDROLYSIS_BY_NTPDASE_PROTEINS"
53,"Up",0.106157386619779,0.38564007268118,"B.LvsV.REACTOME_SYNDECAN_INTERACTIONS"
37,"Up",0.106274321360709,0.385811374132212,"B.LvsV.SINGH_NFE2L2_TARGETS"
126,"Up",0.106391451019922,0.385983157932513,"B.LvsV.REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS"
9,"Up",0.106656468732856,0.386690895491121,"B.LvsV.REACTOME_ACTIVATED_NTRK2_SIGNALS_THROUGH_CDK5"
7,"Down",0.107038975738817,0.387778999903365,"B.LvsV.REACTOME_DEFECTIVE_LFNG_CAUSES_SCDO3"
39,"Up",0.107200030331943,0.387778999903365,"B.LvsV.BIOCARTA_RACCYCD_PATHWAY"
60,"Up",0.107234345003617,0.387778999903365,"B.LvsV.MIKKELSEN_MCV6_ICP_WITH_H3K4ME3_AND_H3K27ME3"
61,"Up",0.107250698070634,0.387778999903365,"B.LvsV.KEGG_ENDOMETRIAL_CANCER"
44,"Up",0.107307265301528,0.387778999903365,"B.LvsV.DING_LUNG_CANCER_BY_MUTATION_RATE"
32,"Up",0.107581298153165,0.388515347804605,"B.LvsV.KEGG_GLYCINE_SERINE_AND_THREONINE_METABOLISM"
18,"Down",0.107755317277766,0.388889784091886,"B.LvsV.REACTOME_DEPOLYMERISATION_OF_THE_NUCLEAR_LAMINA"
66,"Up",0.107915086898858,0.389127494950773,"B.LvsV.TING_SILENCED_BY_DICER"
27,"Up",0.108089846241193,0.389127494950773,"B.LvsV.REACTOME_ADP_SIGNALLING_THROUGH_P2Y_PURINOCEPTOR_1"
42,"Down",0.108112643078567,0.389127494950773,"B.LvsV.GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_UP"
10,"Down",0.108145931216412,0.389127494950773,"B.LvsV.REACTOME_PHASE_3_RAPID_REPOLARISATION"
17,"Down",0.108173080075843,0.389127494950773,"B.LvsV.SHI_SPARC_TARGETS_DN"
67,"Up",0.108244491807443,0.389131206244053,"B.LvsV.BIOCARTA_TCR_PATHWAY"
123,"Down",0.108371788486638,0.389206452312803,"B.LvsV.FALVELLA_SMOKERS_WITH_LUNG_CANCER"
172,"Down",0.108467693263402,0.389206452312803,"B.LvsV.BAELDE_DIABETIC_NEPHROPATHY_UP"
33,"Up",0.108476603909211,0.389206452312803,"B.LvsV.BIOCARTA_HER2_PATHWAY"
114,"Down",0.108676000986525,0.389521641179875,"B.LvsV.SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP"
1519,"Down",0.108705352204838,0.389521641179875,"B.LvsV.BENPORATH_EED_TARGETS"
8,"Down",0.109280369179845,0.390768434100883,"B.LvsV.HOLLEMAN_DAUNORUBICIN_ALL_UP"
20,"Up",0.109293089811072,0.390768434100883,"B.LvsV.REACTOME_BETA_CATENIN_PHOSPHORYLATION_CASCADE"
137,"Up",0.109319120657902,0.390768434100883,"B.LvsV.DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN"
235,"Up",0.109340575694577,0.390768434100883,"B.LvsV.REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION"
82,"Up",0.109406680410231,0.390768434100883,"B.LvsV.NADLER_OBESITY_DN"
30,"Down",0.109531021080533,0.390959984218377,"B.LvsV.BIOCARTA_TEL_PATHWAY"
36,"Up",0.109841854206185,0.391545283085949,"B.LvsV.AKL_HTLV1_INFECTION_UP"
80,"Up",0.109921865629043,0.391545283085949,"B.LvsV.REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES"
303,"Up",0.109975072236467,0.391545283085949,"B.LvsV.FOSTER_KDM1A_TARGETS_DN"
26,"Down",0.10997826453834,0.391545283085949,"B.LvsV.REACTOME_TRAFFICKING_AND_PROCESSING_OF_ENDOSOMAL_TLR"
23,"Up",0.110137024917321,0.391724503710372,"B.LvsV.MANN_RESPONSE_TO_AMIFOSTINE_UP"
127,"Down",0.110179207569966,0.391724503710372,"B.LvsV.MORI_SMALL_PRE_BII_LYMPHOCYTE_DN"
71,"Down",0.110241151704348,0.391724503710372,"B.LvsV.SCHLINGEMANN_SKIN_CARCINOGENESIS_TPA_UP"
56,"Up",0.110360307135849,0.391896042488189,"B.LvsV.HUMMERICH_MALIGNANT_SKIN_TUMOR_DN"
27,"Up",0.110850968316606,0.393371002775737,"B.LvsV.IIZUKA_LIVER_CANCER_EARLY_RECURRENCE"
41,"Up",0.110917958641233,0.393371002775737,"B.LvsV.REACTOME_CD28_CO_STIMULATION"
67,"Up",0.111023611309615,0.393462535052582,"B.LvsV.REACTOME_NR1H2_AND_NR1H3_MEDIATED_SIGNALING"
934,"Down",0.111100752810423,0.393462535052582,"B.LvsV.CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN"
548,"Up",0.111157258048858,0.393462535052582,"B.LvsV.DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN"
19,"Down",0.111558526508437,0.394432349750621,"B.LvsV.MINGUEZ_LIVER_CANCER_VASCULAR_INVASION_UP"
14,"Up",0.111573918431899,0.394432349750621,"B.LvsV.BIOCARTA_RARRXR_PATHWAY"
14,"Up",0.111669267048843,0.394441544773278,"B.LvsV.WEBER_METHYLATED_LCP_IN_FIBROBLAST_DN"
62,"Down",0.111719200418693,0.394441544773278,"B.LvsV.KEGG_ARGININE_AND_PROLINE_METABOLISM"
84,"Up",0.11220076398667,0.394708937613761,"B.LvsV.BECKER_TAMOXIFEN_RESISTANCE_UP"
159,"Up",0.112205441065371,0.394708937613761,"B.LvsV.TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_DN"
161,"Up",0.11224421250492,0.394708937613761,"B.LvsV.WANG_ESOPHAGUS_CANCER_VS_NORMAL_DN"
330,"Up",0.11227025701533,0.394708937613761,"B.LvsV.SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4"
340,"Up",0.112313542118997,0.394708937613761,"B.LvsV.STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP"
456,"Down",0.112354982937008,0.394708937613761,"B.LvsV.GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN"
8,"Up",0.112381450429244,0.394708937613761,"B.LvsV.TERAMOTO_OPN_TARGETS_CLUSTER_8"
72,"Up",0.112486603160899,0.394708937613761,"B.LvsV.GOBERT_CORE_OLIGODENDROCYTE_DIFFERENTIATION"
54,"Up",0.112585986006418,0.394708937613761,"B.LvsV.MARZEC_IL2_SIGNALING_DN"
42,"Up",0.112622929908887,0.394708937613761,"B.LvsV.REACTOME_FATTY_ACYL_COA_BIOSYNTHESIS"
33,"Up",0.112630917773409,0.394708937613761,"B.LvsV.REACTOME_ENDOSOMAL_SORTING_COMPLEX_REQUIRED_FOR_TRANSPORT_ESCRT"
1106,"Up",0.112651601293998,0.394708937613761,"B.LvsV.KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP"
181,"Up",0.11291548322682,0.394935024874959,"B.LvsV.GRADE_COLON_AND_RECTAL_CANCER_DN"
184,"Down",0.11293744397887,0.394935024874959,"B.LvsV.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP"
36,"Down",0.112948465155536,0.394935024874959,"B.LvsV.HOLLEMAN_ASPARAGINASE_RESISTANCE_ALL_UP"
25,"Up",0.11300184650971,0.394935024874959,"B.LvsV.KEGG_GLYCOSYLPHOSPHATIDYLINOSITOL_GPI_ANCHOR_BIOSYNTHESIS"
352,"Up",0.113165268095745,0.395249232298557,"B.LvsV.ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_UP"
61,"Down",0.113234723089331,0.395249232298557,"B.LvsV.GENTILE_RESPONSE_CLUSTER_D3"
37,"Up",0.113311475047735,0.395267599709101,"B.LvsV.BIOCARTA_LIS1_PATHWAY"
68,"Down",0.113554030800366,0.395863957310985,"B.LvsV.REACTOME_SCF_SKP2_MEDIATED_DEGRADATION_OF_P27_P21"
9,"Down",0.113825522206056,0.396371496784567,"B.LvsV.REACTOME_SYNTHESIS_OF_DIPHTHAMIDE_EEF2"
8,"Up",0.113842998172163,0.396371496784567,"B.LvsV.REACTOME_SYNTHESIS_OF_PIPS_AT_THE_ER_MEMBRANE"
11,"Up",0.114183525119342,0.3971301900226,"B.LvsV.REACTOME_SPERM_MOTILITY_AND_TAXES"
131,"Down",0.11427420415127,0.3971301900226,"B.LvsV.SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE"
27,"Up",0.114276384938679,0.3971301900226,"B.LvsV.REACTOME_NEGATIVE_REGULATION_OF_NMDA_RECEPTOR_MEDIATED_NEURONAL_TRANSMISSION"
103,"Down",0.114420107883684,0.397379884729202,"B.LvsV.BOSCO_EPITHELIAL_DIFFERENTIATION_MODULE"
43,"Down",0.114545585449069,0.397404345393846,"B.LvsV.GROSS_ELK3_TARGETS_UP"
70,"Down",0.114570903700089,0.397404345393846,"B.LvsV.MA_MYELOID_DIFFERENTIATION_DN"
14,"Down",0.114907167917325,0.398320834742877,"B.LvsV.REACTOME_CHK1_CHK2_CDS1_MEDIATED_INACTIVATION_OF_CYCLIN_B_CDK1_COMPLEX"
63,"Up",0.11511866938222,0.398798605787397,"B.LvsV.GAUSSMANN_MLL_AF4_FUSION_TARGETS_D_UP"
18,"Up",0.115189251843457,0.398798605787397,"B.LvsV.REACTOME_SYNTHESIS_OF_GLYCOSYLPHOSPHATIDYLINOSITOL_GPI"
39,"Down",0.115656453955957,0.399854192311991,"B.LvsV.BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_UP"
9,"Down",0.11570174355665,0.399854192311991,"B.LvsV.ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_2HR"
17,"Up",0.115711106474803,0.399854192311991,"B.LvsV.REACTOME_PHOSPHORYLATION_SITE_MUTANTS_OF_CTNNB1_ARE_NOT_TARGETED_TO_THE_PROTEASOME_BY_THE_DESTRUCTION_COMPLEX"
305,"Up",0.115784949725397,0.399859454735615,"B.LvsV.WIERENGA_STAT5A_TARGETS_DN"
226,"Up",0.116052250969378,0.400308481351769,"B.LvsV.WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_WITH_H4K20ME1_MARK"
46,"Down",0.116059774933421,0.400308481351769,"B.LvsV.STAEGE_EWING_FAMILY_TUMOR"
42,"Up",0.116343654472601,0.401037447368462,"B.LvsV.NOJIMA_SFRP2_TARGETS_DN"
161,"Down",0.116494512365443,0.401078524708365,"B.LvsV.MARTIN_VIRAL_GPCR_SIGNALING_UP"
337,"Up",0.116652506358091,0.401078524708365,"B.LvsV.MCBRYAN_PUBERTAL_BREAST_6_7WK_UP"
38,"Up",0.11671194273171,0.401078524708365,"B.LvsV.REACTOME_INTEGRIN_SIGNALING"
44,"Down",0.11671229944783,0.401078524708365,"B.LvsV.ALONSO_METASTASIS_DN"
25,"Up",0.116718275683805,0.401078524708365,"B.LvsV.WANG_RECURRENT_LIVER_CANCER_UP"
59,"Down",0.117112953944972,0.401619311999354,"B.LvsV.AMIT_EGF_RESPONSE_480_MCF10A"
9,"Up",0.117156047538246,0.401619311999354,"B.LvsV.REACTOME_FATTY_ACIDS_BOUND_TO_GPR40_FFAR1_REGULATE_INSULIN_SECRETION"
33,"Up",0.117193630424193,0.401619311999354,"B.LvsV.REACTOME_LONG_TERM_POTENTIATION"
13,"Down",0.117238838321362,0.401619311999354,"B.LvsV.REACTOME_RRNA_PROCESSING_IN_THE_MITOCHONDRION"
41,"Up",0.117238844197316,0.401619311999354,"B.LvsV.HASLINGER_B_CLL_WITH_13Q14_DELETION"
94,"Up",0.117405447609829,0.401941002993649,"B.LvsV.ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_UP"
49,"Up",0.117687351798011,0.40265678718515,"B.LvsV.VERRECCHIA_RESPONSE_TO_TGFB1_C5"
43,"Up",0.117960982311551,0.403302702567511,"B.LvsV.BIOCARTA_AT1R_PATHWAY"
10,"Up",0.118078244289583,0.403302702567511,"B.LvsV.REACTOME_MET_ACTIVATES_PI3K_AKT_SIGNALING"
29,"Up",0.118094967527003,0.403302702567511,"B.LvsV.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_SALMON_DN"
157,"Up",0.11839746035946,0.404086147115713,"B.LvsV.DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN"
14,"Down",0.119042476974758,0.406036924857149,"B.LvsV.BIOCARTA_EXTRINSIC_PATHWAY"
291,"Down",0.119166308054989,0.406208703598048,"B.LvsV.SHEPARD_BMYB_MORPHOLINO_UP"
22,"Up",0.119287223017827,0.406277094517349,"B.LvsV.PID_ARF6_DOWNSTREAM_PATHWAY"
102,"Up",0.119372737811108,0.406277094517349,"B.LvsV.REACTOME_SEMAPHORIN_INTERACTIONS"
317,"Up",0.119415794686471,0.406277094517349,"B.LvsV.WANG_CLIM2_TARGETS_DN"
6,"Down",0.119480295837441,0.406277094517349,"B.LvsV.PASTURAL_RIZ1_TARGETS_DN"
82,"Down",0.119688388795208,0.406659481695635,"B.LvsV.WIERENGA_PML_INTERACTOME"
711,"Up",0.119785815412227,0.406659481695635,"B.LvsV.CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5"
253,"Up",0.119815777604369,0.406659481695635,"B.LvsV.ELVIDGE_HYPOXIA_UP"
17,"Down",0.119886951557946,0.406659481695635,"B.LvsV.REACTOME_P75NTR_RECRUITS_SIGNALLING_COMPLEXES"
120,"Up",0.120257733839205,0.407531684428003,"B.LvsV.REACTOME_COPI_MEDIATED_ANTEROGRADE_TRANSPORT"
35,"Up",0.120291500992313,0.407531684428003,"B.LvsV.REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS"
218,"Down",0.12053900635388,0.408120126228171,"B.LvsV.KATSANOU_ELAVL1_TARGETS_DN"
8,"Up",0.120650816984588,0.408248694680408,"B.LvsV.REACTOME_ACTIVATION_OF_TRKA_RECEPTORS"
28,"Down",0.120782380726331,0.408443903997484,"B.LvsV.MARSON_FOXP3_CORE_DIRECT_TARGETS"
11,"Down",0.121061738807768,0.409138358110117,"B.LvsV.REACTOME_SYNTHESIS_OF_LIPOXINS_LX"
6,"Down",0.121215333163986,0.409407194296687,"B.LvsV.REACTOME_P75NTR_NEGATIVELY_REGULATES_CELL_CYCLE_VIA_SC1"
12,"Up",0.121297135640307,0.409433371767555,"B.LvsV.KREPPEL_CD99_TARGETS_DN"
23,"Up",0.121578038867732,0.410014040931559,"B.LvsV.SA_TRKA_RECEPTOR"
10,"Up",0.121617476420285,0.410014040931559,"B.LvsV.BIOCARTA_VOBESITY_PATHWAY"
1244,"Up",0.122570059237569,0.412800224833925,"B.LvsV.NUYTTEN_NIPP1_TARGETS_UP"
16,"Up",0.122616896279202,0.412800224833925,"B.LvsV.BIOCARTA_EPONFKB_PATHWAY"
17,"Up",0.12266789101142,0.412800224833925,"B.LvsV.REACTOME_CREB1_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_ADENYLATE_CYCLASE"
46,"Up",0.122957026210291,0.413450686963313,"B.LvsV.BOWIE_RESPONSE_TO_EXTRACELLULAR_MATRIX"
138,"Up",0.123010739745822,0.413450686963313,"B.LvsV.LEIN_MEDULLA_MARKERS"
41,"Up",0.123174228325831,0.413522580059959,"B.LvsV.VALK_AML_CLUSTER_16"
317,"Down",0.123181712671144,0.413522580059959,"B.LvsV.BROWNE_HCMV_INFECTION_14HR_UP"
203,"Up",0.123292734897155,0.413644133037847,"B.LvsV.REACTOME_ER_TO_GOLGI_ANTEROGRADE_TRANSPORT"
431,"Down",0.123515923922727,0.41385120367862,"B.LvsV.JAATINEN_HEMATOPOIETIC_STEM_CELL_DN"
205,"Up",0.123646526121511,0.41385120367862,"B.LvsV.ODONNELL_METASTASIS_UP"
425,"Up",0.123668319325789,0.41385120367862,"B.LvsV.PLASARI_TGFB1_TARGETS_10HR_DN"
12,"Down",0.123818140086761,0.41385120367862,"B.LvsV.NAGY_STAGA_COMPONENTS_HUMAN"
101,"Up",0.123874704699298,0.41385120367862,"B.LvsV.PID_ENDOTHELIN_PATHWAY"
78,"Down",0.123905490382963,0.41385120367862,"B.LvsV.STEARMAN_TUMOR_FIELD_EFFECT_UP"
109,"Down",0.123927239173868,0.41385120367862,"B.LvsV.THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP"
27,"Up",0.123953263391535,0.41385120367862,"B.LvsV.TSAI_DNAJB4_TARGETS_UP"
105,"Down",0.124378470618043,0.414774784328815,"B.LvsV.HUPER_BREAST_BASAL_VS_LUMINAL_DN"
27,"Up",0.124387522955908,0.414774784328815,"B.LvsV.BIOCARTA_PLATELETAPP_PATHWAY"
204,"Down",0.124454940712878,0.414774784328815,"B.LvsV.BOSCO_TH1_CYTOTOXIC_MODULE"
61,"Up",0.125037698998559,0.416398637343126,"B.LvsV.HASLINGER_B_CLL_WITH_11Q23_DELETION"
24,"Down",0.125125815544775,0.416398637343126,"B.LvsV.SU_THYMUS"
35,"Down",0.125230595243288,0.416398637343126,"B.LvsV.MAGRANGEAS_MULTIPLE_MYELOMA_IGLL_VS_IGLK_DN"
1130,"Up",0.125243431705845,0.416398637343126,"B.LvsV.FORTSCHEGGER_PHF8_TARGETS_DN"
7,"Up",0.125643832052834,0.417477020485029,"B.LvsV.REACTOME_WAX_AND_PLASMALOGEN_BIOSYNTHESIS"
33,"Up",0.125874485614155,0.417477020485029,"B.LvsV.BIOCARTA_TOLL_PATHWAY"
264,"Up",0.125877541049291,0.417477020485029,"B.LvsV.POOLA_INVASIVE_BREAST_CANCER_DN"
160,"Up",0.125957462609076,0.417477020485029,"B.LvsV.GAVIN_FOXP3_TARGETS_CLUSTER_P7"
11,"Down",0.125961790112631,0.417477020485029,"B.LvsV.LUCAS_HNF4A_TARGETS_DN"
93,"Up",0.126020826042596,0.417477020485029,"B.LvsV.VILLANUEVA_LIVER_CANCER_KRT19_DN"
278,"Up",0.126167717923955,0.41771336071949,"B.LvsV.LIN_NPAS4_TARGETS_UP"
27,"Down",0.126495261541552,0.418547158027073,"B.LvsV.HEDENFALK_BREAST_CANCER_BRACX_UP"
67,"Down",0.126595008333757,0.418626675285492,"B.LvsV.VANTVEER_BREAST_CANCER_BRCA1_UP"
21,"Down",0.126710581770326,0.418654340746587,"B.LvsV.REACTOME_P75NTR_SIGNALS_VIA_NF_KB"
35,"Down",0.126754813964512,0.418654340746587,"B.LvsV.PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN"
68,"Down",0.126885528625121,0.418694473547571,"B.LvsV.REACTOME_INTERLEUKIN_10_SIGNALING"
30,"Down",0.12695424237492,0.418694473547571,"B.LvsV.REACTOME_MRNA_CAPPING"
11,"Down",0.126994145802003,0.418694473547571,"B.LvsV.ZHU_SKIL_TARGETS_DN"
78,"Up",0.127104509590819,0.41880860162553,"B.LvsV.PID_RAC1_PATHWAY"
34,"Up",0.127279771074835,0.418955828853037,"B.LvsV.RUAN_RESPONSE_TO_TROGLITAZONE_UP"
2477,"Up",0.127300740183234,0.418955828853037,"B.LvsV.GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN"
19,"Down",0.127435026370706,0.419148281263315,"B.LvsV.REACTOME_TRISTETRAPROLIN_TTP_ZFP36_BINDS_AND_DESTABILIZES_MRNA"
35,"Down",0.127604887541763,0.419457445433059,"B.LvsV.REACTOME_RESPONSE_OF_MTB_TO_PHAGOCYTOSIS"
97,"Down",0.127845446040205,0.419998497419069,"B.LvsV.AUNG_GASTRIC_CANCER"
179,"Up",0.128212559271495,0.420954418178203,"B.LvsV.REACTOME_AUTOPHAGY"
8,"Up",0.128756683638561,0.422067700294087,"B.LvsV.REACTOME_COENZYME_A_BIOSYNTHESIS"
277,"Up",0.128775368197848,0.422067700294087,"B.LvsV.LU_AGING_BRAIN_DN"
46,"Down",0.128780649375316,0.422067700294087,"B.LvsV.REACTOME_DETOXIFICATION_OF_REACTIVE_OXYGEN_SPECIES"
27,"Up",0.129116488239155,0.422917691631688,"B.LvsV.BIOCARTA_CDMAC_PATHWAY"
33,"Up",0.129397033599162,0.423585671266884,"B.LvsV.KEGG_BIOSYNTHESIS_OF_UNSATURATED_FATTY_ACIDS"
150,"Down",0.129491069726404,0.423642677229163,"B.LvsV.SWEET_KRAS_ONCOGENIC_SIGNATURE"
97,"Up",0.129719408074501,0.424138738760448,"B.LvsV.WENG_POR_TARGETS_LIVER_UP"
26,"Down",0.129801490127029,0.424156287773252,"B.LvsV.BIOCARTA_LAIR_PATHWAY"
64,"Up",0.129932950895516,0.424335077082875,"B.LvsV.FAELT_B_CLL_WITH_VH3_21_DN"
62,"Down",0.130082972041644,0.424428732279976,"B.LvsV.REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS"
96,"Down",0.130115156667491,0.424428732279976,"B.LvsV.REACTOME_APC_C_MEDIATED_DEGRADATION_OF_CELL_CYCLE_PROTEINS"
194,"Down",0.13038623306777,0.424954992338896,"B.LvsV.GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_DN"
97,"Up",0.13043020835578,0.424954992338896,"B.LvsV.KEGG_ECM_RECEPTOR_INTERACTION"
175,"Up",0.13078541440682,0.425637121385363,"B.LvsV.REACTOME_CELL_CELL_COMMUNICATION"
8,"Up",0.130841487378585,0.425637121385363,"B.LvsV.IKEDA_MIR133_TARGETS_DN"
66,"Down",0.130870520230623,0.425637121385363,"B.LvsV.CHEN_NEUROBLASTOMA_COPY_NUMBER_GAINS"
28,"Down",0.130966487357538,0.425698829276793,"B.LvsV.PID_CONE_PATHWAY"
131,"Up",0.131409291042832,0.426643748088367,"B.LvsV.KEGG_T_CELL_RECEPTOR_SIGNALING_PATHWAY"
23,"Up",0.131503052842847,0.426643748088367,"B.LvsV.REACTOME_INHIBITION_OF_THE_PROTEOLYTIC_ACTIVITY_OF_APC_C_REQUIRED_FOR_THE_ONSET_OF_ANAPHASE_BY_MITOTIC_SPINDLE_CHECKPOINT_COMPONENTS"
26,"Up",0.131634004973651,0.426643748088367,"B.LvsV.PODAR_RESPONSE_TO_ADAPHOSTIN_DN"
38,"Up",0.131710560765894,0.426643748088367,"B.LvsV.VALK_AML_CLUSTER_8"
30,"Down",0.131753737107424,0.426643748088367,"B.LvsV.KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_UP"
35,"Down",0.131785528987673,0.426643748088367,"B.LvsV.GENTLES_LEUKEMIC_STEM_CELL_DN"
1356,"Up",0.131797345222451,0.426643748088367,"B.LvsV.WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_8D"
17,"Down",0.132012886344518,0.426678620444998,"B.LvsV.REACTOME_RESPONSE_OF_EIF2AK1_HRI_TO_HEME_DEFICIENCY"
99,"Up",0.132052470846886,0.426678620444998,"B.LvsV.BOYLAN_MULTIPLE_MYELOMA_C_DN"
11,"Up",0.132062008547363,0.426678620444998,"B.LvsV.LINDGREN_BLADDER_CANCER_CLUSTER_2A_UP"
107,"Up",0.132251122238457,0.426678620444998,"B.LvsV.REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS"
15,"Down",0.13226007549032,0.426678620444998,"B.LvsV.REACTOME_MITOTIC_TELOPHASE_CYTOKINESIS"
165,"Up",0.132271144048242,0.426678620444998,"B.LvsV.RAGHAVACHARI_PLATELET_SPECIFIC_GENES"
51,"Up",0.132401280788037,0.426849376954551,"B.LvsV.PID_AVB3_OPN_PATHWAY"
14,"Down",0.132605617914952,0.426900749082003,"B.LvsV.REACTOME_CYTOSOLIC_IRON_SULFUR_CLUSTER_ASSEMBLY"
12,"Down",0.132608154162558,0.426900749082003,"B.LvsV.REACTOME_SYNTHESIS_OF_5_EICOSATETRAENOIC_ACIDS"
20,"Up",0.132721138876528,0.426900749082003,"B.LvsV.REACTOME_ACTIVATION_OF_SMO"
29,"Up",0.132726060349423,0.426900749082003,"B.LvsV.REACTOME_INTERLEUKIN_6_FAMILY_SIGNALING"
27,"Down",0.132829486913012,0.42691343359229,"B.LvsV.REACTOME_COMMON_PATHWAY_OF_FIBRIN_CLOT_FORMATION"
39,"Up",0.132960584996444,0.42691343359229,"B.LvsV.KANG_FLUOROURACIL_RESISTANCE_UP"
1169,"Down",0.132961644537154,0.42691343359229,"B.LvsV.JOHNSTONE_PARVB_TARGETS_3_DN"
48,"Down",0.133243255362643,0.427360129221722,"B.LvsV.GRADE_COLON_VS_RECTAL_CANCER_UP"
19,"Down",0.133286085343296,0.427360129221722,"B.LvsV.REACTOME_KSRP_KHSRP_BINDS_AND_DESTABILIZES_MRNA"
591,"Down",0.133391435632643,0.427360129221722,"B.LvsV.WANG_TUMOR_INVASIVENESS_UP"
148,"Up",0.133409944481225,0.427360129221722,"B.LvsV.REACTOME_INTERFERON_GAMMA_SIGNALING"
223,"Down",0.133554111599506,0.427574222949432,"B.LvsV.VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_DN"
74,"Up",0.133701198626992,0.427785670428642,"B.LvsV.FUJII_YBX1_TARGETS_UP"
599,"Down",0.133774900374592,0.427785670428642,"B.LvsV.IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR"
18,"Up",0.133960689941605,0.428119070106019,"B.LvsV.REACTOME_BETA_OXIDATION_OF_VERY_LONG_CHAIN_FATTY_ACIDS"
30,"Up",0.134060844981887,0.428119070106019,"B.LvsV.PID_TOLL_ENDOGENOUS_PATHWAY"
69,"Up",0.134111454046595,0.428119070106019,"B.LvsV.REACTOME_THE_ROLE_OF_NEF_IN_HIV_1_REPLICATION_AND_DISEASE_PATHOGENESIS"
59,"Up",0.13439401648477,0.428773524030176,"B.LvsV.PID_RHOA_REG_PATHWAY"
25,"Up",0.134728876019083,0.429126039604077,"B.LvsV.REACTOME_NITRIC_OXIDE_STIMULATES_GUANYLATE_CYCLASE"
32,"Down",0.134729925103212,0.429126039604077,"B.LvsV.KEGG_O_GLYCAN_BIOSYNTHESIS"
42,"Down",0.134856335066719,0.429126039604077,"B.LvsV.JI_METASTASIS_REPRESSED_BY_STK11"
29,"Up",0.134870598336786,0.429126039604077,"B.LvsV.REACTOME_G_PROTEIN_ACTIVATION"
33,"Up",0.134918354698192,0.429126039604077,"B.LvsV.BIOCARTA_CTCF_PATHWAY"
14,"Down",0.135079297889592,0.429126039604077,"B.LvsV.REACTOME_LGI_ADAM_INTERACTIONS"
65,"Down",0.135111716989543,0.429126039604077,"B.LvsV.CHOI_ATL_STAGE_PREDICTOR"
37,"Down",0.135125417788153,0.429126039604077,"B.LvsV.BIOCARTA_DEATH_PATHWAY"
18,"Down",0.135292195928444,0.429409042071394,"B.LvsV.REACTOME_SHC1_EVENTS_IN_EGFR_SIGNALING"
201,"Down",0.135659875935583,0.430329004043509,"B.LvsV.REACTOME_G2_M_CHECKPOINTS"
112,"Down",0.136195397515449,0.430878764548996,"B.LvsV.JAZAG_TGFB1_SIGNALING_VIA_SMAD4_DN"
7,"Down",0.13620202499459,0.430878764548996,"B.LvsV.JU_AGING_TERC_TARGETS_UP"
26,"Up",0.136377701699499,0.430878764548996,"B.LvsV.WIKMAN_ASBESTOS_LUNG_CANCER_UP"
5,"Down",0.136391610542514,0.430878764548996,"B.LvsV.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_18"
15,"Up",0.13641744128177,0.430878764548996,"B.LvsV.REACTOME_TRAF3_DEPENDENT_IRF_ACTIVATION_PATHWAY"
85,"Up",0.136418499109355,0.430878764548996,"B.LvsV.GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN"
1549,"Down",0.136426772457283,0.430878764548996,"B.LvsV.DANG_BOUND_BY_MYC"
36,"Up",0.136456631710127,0.430878764548996,"B.LvsV.REACTOME_COBALAMIN_CBL_VITAMIN_B12_TRANSPORT_AND_METABOLISM"
6,"Up",0.137397911281074,0.433603339881882,"B.LvsV.BIOCARTA_BOTULIN_PATHWAY"
8,"Down",0.137541254708607,0.433620359835365,"B.LvsV.REACTOME_ACTIVATION_OF_NIMA_KINASES_NEK9_NEK6_NEK7"
227,"Up",0.137616288471415,0.433620359835365,"B.LvsV.SUNG_METASTASIS_STROMA_UP"
59,"Down",0.137706170094991,0.433620359835365,"B.LvsV.REACTOME_HSF1_ACTIVATION"
12,"Up",0.137717010647658,0.433620359835365,"B.LvsV.REACTOME_PI5P_REGULATES_TP53_ACETYLATION"
1483,"Down",0.137835963409202,0.433747889407786,"B.LvsV.BENPORATH_SUZ12_TARGETS"
5,"Down",0.138032417473817,0.434119019461167,"B.LvsV.REACTOME_PTK6_REGULATES_PROTEINS_INVOLVED_IN_RNA_PROCESSING"
94,"Up",0.138149948714778,0.434241652327462,"B.LvsV.SESTO_RESPONSE_TO_UV_C2"
253,"Down",0.138241779750898,0.434283409228816,"B.LvsV.BROWNE_HCMV_INFECTION_24HR_UP"
13,"Down",0.138483611092045,0.434557668462843,"B.LvsV.BIOCARTA_EIF2_PATHWAY"
9,"Down",0.13848627452189,0.434557668462843,"B.LvsV.REACTOME_DEFECTIVE_CSF2RB_CAUSES_PULMONARY_SURFACTANT_METABOLISM_DYSFUNCTION_5_SMDP5"
97,"Down",0.13876471749804,0.435184414660614,"B.LvsV.NADLER_HYPERGLYCEMIA_AT_OBESITY"
59,"Up",0.139286501473603,0.436573167033758,"B.LvsV.PID_IL8_CXCR2_PATHWAY"
527,"Up",0.139414386062085,0.436632675828058,"B.LvsV.OISHI_CHOLANGIOMA_STEM_CELL_LIKE_UP"
17,"Up",0.139463430188524,0.436632675828058,"B.LvsV.REACTOME_FORMYL_PEPTIDE_RECEPTORS_BIND_FORMYL_PEPTIDES_AND_MANY_OTHER_LIGANDS"
15,"Down",0.139743575176346,0.437231281177934,"B.LvsV.BIOCARTA_STEM_PATHWAY"
21,"Up",0.13981278804894,0.437231281177934,"B.LvsV.WHITESIDE_CISPLATIN_RESISTANCE_UP"
110,"Up",0.140410461103006,0.438852142135964,"B.LvsV.AMIT_SERUM_RESPONSE_240_MCF10A"
101,"Down",0.141020237646576,0.440119884485621,"B.LvsV.BRIDEAU_IMPRINTED_GENES"
36,"Up",0.141101394714756,0.440119884485621,"B.LvsV.PID_ECADHERIN_KERATINOCYTE_PATHWAY"
20,"Up",0.141105451307899,0.440119884485621,"B.LvsV.WU_HBX_TARGETS_3_DN"
52,"Up",0.141156436785062,0.440119884485621,"B.LvsV.SANCHEZ_MDM2_TARGETS"
34,"Down",0.141214084839481,0.440119884485621,"B.LvsV.PID_WNT_SIGNALING_PATHWAY"
26,"Down",0.14141974686603,0.440512552350581,"B.LvsV.BIOCARTA_HIF_PATHWAY"
48,"Up",0.141652133693074,0.440545656099602,"B.LvsV.HEIDENBLAD_AMPLICON_12P11_12_UP"
77,"Up",0.141710017706672,0.440545656099602,"B.LvsV.KEGG_ADIPOCYTOKINE_SIGNALING_PATHWAY"
74,"Down",0.141791731428706,0.440545656099602,"B.LvsV.REACTOME_ASYMMETRIC_LOCALIZATION_OF_PCP_PROTEINS"
114,"Down",0.141803170417985,0.440545656099602,"B.LvsV.KEGG_ARACHIDONIC_ACID_METABOLISM"
42,"Down",0.141836184739848,0.440545656099602,"B.LvsV.REACTOME_EGFR_DOWNREGULATION"
24,"Down",0.141921765501851,0.440545656099602,"B.LvsV.DEBOSSCHER_NFKB_TARGETS_REPRESSED_BY_GLUCOCORTICOIDS"
35,"Up",0.141988127901879,0.440545656099602,"B.LvsV.REACTOME_GLUCAGON_SIGNALING_IN_METABOLIC_REGULATION"
96,"Up",0.142295783972598,0.441252602122544,"B.LvsV.PETROVA_PROX1_TARGETS_DN"
19,"Down",0.142508349862454,0.441664050666764,"B.LvsV.REACTOME_PENTOSE_PHOSPHATE_PATHWAY"
30,"Down",0.142785140077431,0.44216665553964,"B.LvsV.REACTOME_CONSTITUTIVE_SIGNALING_BY_LIGAND_RESPONSIVE_EGFR_CANCER_VARIANTS"
340,"Down",0.142846477500362,0.44216665553964,"B.LvsV.WINTER_HYPOXIA_METAGENE"
156,"Up",0.143033211422522,0.44216665553964,"B.LvsV.KEGG_AXON_GUIDANCE"
67,"Down",0.143048591778869,0.44216665553964,"B.LvsV.KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_DN"
41,"Up",0.143157919687827,0.44216665553964,"B.LvsV.CROONQUIST_IL6_DEPRIVATION_UP"
27,"Up",0.143197661778705,0.44216665553964,"B.LvsV.PID_INTEGRIN_CS_PATHWAY"
46,"Up",0.143230327377735,0.44216665553964,"B.LvsV.REACTOME_MITOCHONDRIAL_FATTY_ACID_BETA_OXIDATION"
6,"Up",0.143320899800797,0.442199361048328,"B.LvsV.REACTOME_SYNTHESIS_OF_WYBUTOSINE_AT_G37_OF_TRNA_PHE"
171,"Down",0.143492090458621,0.442480629194488,"B.LvsV.WOOD_EBV_EBNA1_TARGETS_UP"
83,"Up",0.143759769546824,0.443058955309024,"B.LvsV.KEGG_VEGF_SIGNALING_PATHWAY"
29,"Up",0.144168549055842,0.443766926857713,"B.LvsV.REACTOME_ACTIVATION_OF_AMPK_DOWNSTREAM_OF_NMDARS"
121,"Down",0.144231999134716,0.443766926857713,"B.LvsV.YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_1"
14,"Up",0.144299896816098,0.443766926857713,"B.LvsV.REACTOME_LYSINE_CATABOLISM"
9,"Up",0.144310532553837,0.443766926857713,"B.LvsV.REACTOME_REGULATION_OF_PTEN_MRNA_TRANSLATION"
51,"Up",0.144780855636648,0.444820200001127,"B.LvsV.NIKOLSKY_BREAST_CANCER_20Q11_AMPLICON"
54,"Up",0.145036888673041,0.444820200001127,"B.LvsV.QI_HYPOXIA_TARGETS_OF_HIF1A_AND_FOXA2"
51,"Down",0.145102972105007,0.444820200001127,"B.LvsV.PLASARI_NFIC_TARGETS_BASAL_DN"
212,"Down",0.145113059456,0.444820200001127,"B.LvsV.WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_UP"
7,"Up",0.1452243689297,0.444820200001127,"B.LvsV.REACTOME_NGF_INDEPENDANT_TRKA_ACTIVATION"
12,"Down",0.145243446212522,0.444820200001127,"B.LvsV.REACTOME_INTERLEUKIN_9_SIGNALING"
79,"Down",0.145396159013412,0.444820200001127,"B.LvsV.JOHANSSON_GLIOMAGENESIS_BY_PDGFB_UP"
38,"Up",0.145396608262233,0.444820200001127,"B.LvsV.DELACROIX_RAR_TARGETS_DN"
201,"Down",0.145429503731525,0.444820200001127,"B.LvsV.WIERENGA_STAT5A_TARGETS_GROUP1"
19,"Up",0.145457573087726,0.444820200001127,"B.LvsV.REACTOME_DSCAM_INTERACTIONS"
70,"Down",0.1455934086232,0.444989472790312,"B.LvsV.HONMA_DOCETAXEL_RESISTANCE"
385,"Down",0.14592169112265,0.445746425534328,"B.LvsV.NABA_SECRETED_FACTORS"
19,"Up",0.146528812649955,0.447353840497848,"B.LvsV.BIOCARTA_SHH_PATHWAY"
7,"Down",0.146612123762699,0.447361165719625,"B.LvsV.REACTOME_APOBEC3G_MEDIATED_RESISTANCE_TO_HIV_1_INFECTION"
46,"Up",0.146786931301669,0.447647514157159,"B.LvsV.BIOCARTA_NO1_PATHWAY"
11,"Up",0.147146305434258,0.448496098536943,"B.LvsV.REACTOME_CREB_PHOSPHORYLATION"
127,"Down",0.147599227866089,0.449628722243308,"B.LvsV.PID_SMAD2_3NUCLEAR_PATHWAY"
17,"Down",0.147742389830689,0.449632863513748,"B.LvsV.BIOCARTA_MONOCYTE_PATHWAY"
9,"Down",0.147763232592599,0.449632863513748,"B.LvsV.BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_AND_PAX3"
187,"Down",0.148000534822455,0.450107237092055,"B.LvsV.REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS"
144,"Up",0.148190925936015,0.450438498900621,"B.LvsV.SWEET_KRAS_TARGETS_UP"
10,"Up",0.148461144669212,0.451011905975866,"B.LvsV.REACTOME_CA2_ACTIVATED_K_CHANNELS"
102,"Up",0.148621231668798,0.451250296483681,"B.LvsV.KEGG_ADHERENS_JUNCTION"
101,"Up",0.148903124418878,0.451858054287584,"B.LvsV.REACTOME_ONCOGENIC_MAPK_SIGNALING"
50,"Up",0.14910854988287,0.452233226715519,"B.LvsV.BRACHAT_RESPONSE_TO_CISPLATIN"
17,"Up",0.149336188797144,0.452675322291342,"B.LvsV.STARK_BRAIN_22Q11_DELETION"
43,"Up",0.149956291984707,0.454305938840245,"B.LvsV.KEGG_BUTANOATE_METABOLISM"
34,"Up",0.150576627785119,0.455699637009532,"B.LvsV.FUJIWARA_PARK2_HEPATOCYTE_PROLIFERATION_UP"
79,"Up",0.150649631343683,0.455699637009532,"B.LvsV.PID_TAP63_PATHWAY"
90,"Up",0.150663580476293,0.455699637009532,"B.LvsV.BENNETT_SYSTEMIC_LUPUS_ERYTHEMATOSUS"
87,"Down",0.150864841849709,0.456058890424843,"B.LvsV.PID_HDAC_CLASSI_PATHWAY"
36,"Up",0.151017214604988,0.456270043470479,"B.LvsV.REACTOME_CREB1_PHOSPHORYLATION_THROUGH_NMDA_RECEPTOR_MEDIATED_ACTIVATION_OF_RAS_SIGNALING"
78,"Up",0.151169636522621,0.456481114327456,"B.LvsV.AMIT_SERUM_RESPONSE_60_MCF10A"
156,"Down",0.151415815328398,0.456974914274405,"B.LvsV.MARKEY_RB1_CHRONIC_LOF_UP"
233,"Up",0.151574760445709,0.457022006211276,"B.LvsV.ZHU_CMV_ALL_DN"
115,"Down",0.151596737093775,0.457022006211276,"B.LvsV.MCCLUNG_COCAIN_REWARD_4WK"
80,"Up",0.152056177811713,0.458157279084993,"B.LvsV.ROVERSI_GLIOMA_COPY_NUMBER_DN"
21,"Up",0.152278307956728,0.458480472140468,"B.LvsV.CHESLER_BRAIN_QTL_TRANS"
243,"Up",0.152329286909394,0.458480472140468,"B.LvsV.PROVENZANI_METASTASIS_DN"
310,"Up",0.152414888176748,0.458488529232448,"B.LvsV.KARLSSON_TGFB1_TARGETS_DN"
105,"Down",0.152526097707349,0.458573569452926,"B.LvsV.REACTOME_SIGNALING_BY_FGFR"
58,"Up",0.152852367553776,0.459304750111318,"B.LvsV.CHANDRAN_METASTASIS_TOP50_DN"
7,"Down",0.153051674100075,0.459653832753565,"B.LvsV.REACTOME_TRNA_PROCESSING_IN_THE_MITOCHONDRION"
105,"Up",0.153267568068797,0.459930650563742,"B.LvsV.REACTOME_OPIOID_SIGNALLING"
300,"Up",0.153323861367089,0.459930650563742,"B.LvsV.THUM_SYSTOLIC_HEART_FAILURE_DN"
57,"Up",0.153486480802676,0.459930650563742,"B.LvsV.WESTON_VEGFA_TARGETS_12HR"
271,"Up",0.15351146555145,0.459930650563742,"B.LvsV.REACTOME_NEDDYLATION"
21,"Down",0.153629746816673,0.459930650563742,"B.LvsV.SUH_COEXPRESSED_WITH_ID1_AND_ID2_UP"
83,"Up",0.153679548149189,0.459930650563742,"B.LvsV.CHEN_HOXA5_TARGETS_9HR_DN"
9,"Down",0.153790892666367,0.459930650563742,"B.LvsV.BIOCARTA_PLK3_PATHWAY"
13,"Down",0.153809327707065,0.459930650563742,"B.LvsV.REACTOME_ESTABLISHMENT_OF_SISTER_CHROMATID_COHESION"
6,"Up",0.154180539923978,0.460791462291714,"B.LvsV.MIKI_COEXPRESSED_WITH_CYP19A1"
47,"Down",0.15436916509934,0.460985825357474,"B.LvsV.VALK_AML_CLUSTER_12"
46,"Up",0.154494885283206,0.460985825357474,"B.LvsV.MEISSNER_BRAIN_ICP_WITH_H3K4ME3"
361,"Up",0.154495701643588,0.460985825357474,"B.LvsV.REACTOME_ORGANELLE_BIOGENESIS_AND_MAINTENANCE"
336,"Down",0.154657220860509,0.461178858327899,"B.LvsV.CHANDRAN_METASTASIS_UP"
49,"Down",0.154866746842002,0.461178858327899,"B.LvsV.VANDESLUIS_NORMAL_EMBRYOS_DN"
23,"Up",0.15496268686195,0.461178858327899,"B.LvsV.REACTOME_PHOSPHORYLATION_OF_THE_APC_C"
368,"Up",0.154976794721692,0.461178858327899,"B.LvsV.THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN"
8,"Down",0.155005397639435,0.461178858327899,"B.LvsV.REACTOME_PTK6_REGULATES_CELL_CYCLE"
179,"Up",0.155060860486809,0.461178858327899,"B.LvsV.REACTOME_CLATHRIN_MEDIATED_ENDOCYTOSIS"
92,"Down",0.155366824381216,0.461840415055777,"B.LvsV.TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_UP"
19,"Up",0.155457572666971,0.461861858826266,"B.LvsV.REACTOME_NEF_AND_SIGNAL_TRANSDUCTION"
141,"Down",0.155786465546389,0.462590423204074,"B.LvsV.BRUINS_UVC_RESPONSE_MIDDLE"
17,"Down",0.155901124013463,0.462682401862821,"B.LvsV.REACTOME_ELEVATION_OF_CYTOSOLIC_CA2_LEVELS"
296,"Down",0.156056537595666,0.462895169724482,"B.LvsV.REACTOME_HIV_INFECTION"
244,"Down",0.156856293831783,0.464771550870995,"B.LvsV.CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_UP"
10,"Down",0.156878240104651,0.464771550870995,"B.LvsV.TESAR_ALK_TARGETS_HUMAN_ES_5D_UP"
21,"Up",0.156941306832365,0.464771550870995,"B.LvsV.TIAN_BHLHA15_TARGETS"
33,"Up",0.157035144223645,0.46480048844354,"B.LvsV.HOEGERKORP_CD44_TARGETS_TEMPORAL_DN"
25,"Down",0.157301102704465,0.465338575095231,"B.LvsV.REACTOME_NUCLEOTIDE_SALVAGE"
92,"Up",0.157921649032581,0.466924490642321,"B.LvsV.REACTOME_DDX58_IFIH1_MEDIATED_INDUCTION_OF_INTERFERON_ALPHA_BETA"
8,"Down",0.15803778166824,0.467018115897222,"B.LvsV.REACTOME_RUNX3_REGULATES_BCL2L11_BIM_TRANSCRIPTION"
27,"Down",0.158320941034822,0.467491083972614,"B.LvsV.REACTOME_MITOCHONDRIAL_TRNA_AMINOACYLATION"
12,"Down",0.158373542156909,0.467491083972614,"B.LvsV.REACTOME_INTEGRATION_OF_PROVIRUS"
8,"Down",0.158451490570569,0.467491083972614,"B.LvsV.BIOCARTA_RNAPOL3_PATHWAY"
106,"Up",0.159190421196035,0.469173727117936,"B.LvsV.MARSON_FOXP3_TARGETS_UP"
203,"Up",0.15919151963705,0.469173727117936,"B.LvsV.REACTOME_PROTEIN_LOCALIZATION"
63,"Up",0.159386705413028,0.469498718289096,"B.LvsV.NAKAMURA_METASTASIS_MODEL_DN"
5,"Up",0.159822278765974,0.470531085887684,"B.LvsV.REACTOME_ARACHIDONATE_PRODUCTION_FROM_DAG"
140,"Up",0.160154805826134,0.470998762139231,"B.LvsV.GNATENKO_PLATELET_SIGNATURE"
143,"Up",0.16017687719492,0.470998762139231,"B.LvsV.REACTOME_INTEGRATION_OF_ENERGY_METABOLISM"
14,"Up",0.160268531232034,0.470998762139231,"B.LvsV.BIOCARTA_P35ALZHEIMERS_PATHWAY"
40,"Up",0.160321879245077,0.470998762139231,"B.LvsV.REACTOME_MAPK_TARGETS_NUCLEAR_EVENTS_MEDIATED_BY_MAP_KINASES"
15,"Down",0.160553698658622,0.471429314861137,"B.LvsV.CLAUS_PGR_POSITIVE_MENINGIOMA_DN"
17,"Down",0.160819772663929,0.471959937929332,"B.LvsV.BIOCARTA_CD40_PATHWAY"
50,"Up",0.160966503077265,0.472139944569867,"B.LvsV.PID_P38_ALPHA_BETA_DOWNSTREAM_PATHWAY"
496,"Up",0.161367933155991,0.472860779657054,"B.LvsV.MOOTHA_HUMAN_MITODB_6_2002"
67,"Down",0.161383304614372,0.472860779657054,"B.LvsV.MA_MYELOID_DIFFERENTIATION_UP"
130,"Down",0.161663646465206,0.473263360459391,"B.LvsV.REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS"
73,"Down",0.161734910931996,0.473263360459391,"B.LvsV.JAEGER_METASTASIS_UP"
88,"Down",0.161859688700717,0.473263360459391,"B.LvsV.GALE_APL_WITH_FLT3_MUTATED_UP"
268,"Down",0.161863088194738,0.473263360459391,"B.LvsV.DARWICHE_PAPILLOMA_RISK_LOW_UP"
39,"Down",0.16229345458382,0.473772937946582,"B.LvsV.PID_INTEGRIN2_PATHWAY"
99,"Up",0.16234434281026,0.473772937946582,"B.LvsV.REACTOME_ECM_PROTEOGLYCANS"
81,"Up",0.162419394695502,0.473772937946582,"B.LvsV.KEGG_RIG_I_LIKE_RECEPTOR_SIGNALING_PATHWAY"
462,"Down",0.162419848301543,0.473772937946582,"B.LvsV.YAMAZAKI_TCEB3_TARGETS_DN"
88,"Down",0.162465814857428,0.473772937946582,"B.LvsV.SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM6"
25,"Up",0.162630880231419,0.473908691676467,"B.LvsV.MOOTHA_GLYCOGEN_METABOLISM"
45,"Down",0.162683793959474,0.473908691676467,"B.LvsV.LOPES_METHYLATED_IN_COLON_CANCER_UP"
28,"Down",0.162839535341419,0.474112580780782,"B.LvsV.REACTOME_TRP_CHANNELS"
90,"Up",0.162994887238574,0.474315121864249,"B.LvsV.KEGG_LONG_TERM_DEPRESSION"
23,"Down",0.163231012457182,0.474752376578516,"B.LvsV.MARKS_HDAC_TARGETS_DN"
27,"Down",0.163333268952738,0.47480002315441,"B.LvsV.REACTOME_HYALURONAN_METABOLISM"
188,"Down",0.163748220034295,0.475535230268928,"B.LvsV.DAIRKEE_CANCER_PRONE_RESPONSE_BPA_E2"
26,"Down",0.163758198305668,0.475535230268928,"B.LvsV.REACTOME_ABC_TRANSPORTERS_IN_LIPID_HOMEOSTASIS"
23,"Up",0.164283313499403,0.476809679967559,"B.LvsV.STEIN_ESTROGEN_RESPONSE_NOT_VIA_ESRRA"
231,"Down",0.164859632230137,0.478087138901083,"B.LvsV.BASSO_B_LYMPHOCYTE_NETWORK"
31,"Down",0.164896396072412,0.478087138901083,"B.LvsV.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_PURPLE_DN"
1203,"Up",0.1650581921552,0.478202586437188,"B.LvsV.MIKKELSEN_ES_ICP_WITH_H3K4ME3"
92,"Up",0.165153422690557,0.478202586437188,"B.LvsV.YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_2"
101,"Up",0.165273214917617,0.478202586437188,"B.LvsV.REACTOME_PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES"
6,"Down",0.165282174476662,0.478202586437188,"B.LvsV.BIOCARTA_SAM68_PATHWAY"
23,"Up",0.165400769692777,0.478295426585442,"B.LvsV.REACTOME_SYNAPTIC_ADHESION_LIKE_MOLECULES"
164,"Up",0.165722298551167,0.478974693512496,"B.LvsV.ZHU_CMV_24_HR_DN"
76,"Up",0.166269683007354,0.480181503766238,"B.LvsV.PID_KIT_PATHWAY"
253,"Down",0.166313543084165,0.480181503766238,"B.LvsV.LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_UP"
206,"Down",0.166990877169813,0.481829574213425,"B.LvsV.PECE_MAMMARY_STEM_CELL_UP"
19,"Down",0.167058653240575,0.481829574213425,"B.LvsV.REACTOME_INTERLEUKIN_15_SIGNALING"
364,"Down",0.167293006534571,0.482253927596268,"B.LvsV.RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_UP"
97,"Down",0.167420519782445,0.48237001244249,"B.LvsV.HU_GENOTOXIC_DAMAGE_4HR"
6,"Down",0.167687284240053,0.482886976335027,"B.LvsV.REACTOME_NADE_MODULATES_DEATH_SIGNALLING"
36,"Up",0.167877566367036,0.483064751420286,"B.LvsV.REACTOME_SIGNAL_TRANSDUCTION_BY_L1"
735,"Up",0.1679549508748,0.483064751420286,"B.LvsV.BAELDE_DIABETIC_NEPHROPATHY_DN"
68,"Down",0.168011126240045,0.483064751420286,"B.LvsV.HALMOS_CEBPA_TARGETS_DN"
782,"Up",0.168132623118576,0.483162823920275,"B.LvsV.BONOME_OVARIAN_CANCER_SURVIVAL_SUBOPTIMAL_DEBULKING"
57,"Down",0.168760359877323,0.484714820655439,"B.LvsV.ABBUD_LIF_SIGNALING_1_UP"
232,"Down",0.168863596027098,0.484759513205517,"B.LvsV.SMITH_TERT_TARGETS_UP"
103,"Up",0.169069063326749,0.485097483722676,"B.LvsV.KUMAR_AUTOPHAGY_NETWORK"
89,"Down",0.169178474197596,0.485159638920387,"B.LvsV.REACTOME_DEPOSITION_OF_NEW_CENPA_CONTAINING_NUCLEOSOMES_AT_THE_CENTROMERE"
144,"Down",0.169349143414416,0.48520807283557,"B.LvsV.TAKAO_RESPONSE_TO_UVB_RADIATION_UP"
8,"Up",0.169370877296554,0.48520807283557,"B.LvsV.BIOCARTA_PLCD_PATHWAY"
97,"Down",0.169879020655181,0.48641175826126,"B.LvsV.KUNINGER_IGF1_VS_PDGFB_TARGETS_DN"
563,"Up",0.170442687588681,0.487679222806614,"B.LvsV.RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN"
49,"Up",0.170498089651869,0.487679222806614,"B.LvsV.REACTOME_RUNX2_REGULATES_OSTEOBLAST_DIFFERENTIATION"
31,"Down",0.17088305209841,0.488527608610191,"B.LvsV.DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_DN"
14,"Up",0.171134003462414,0.488992199040666,"B.LvsV.XU_AKT1_TARGETS_48HR"
611,"Up",0.171246242017365,0.489060161215914,"B.LvsV.REN_ALVEOLAR_RHABDOMYOSARCOMA_DN"
91,"Down",0.17148615734408,0.489492495588756,"B.LvsV.ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_DN"
21,"Up",0.171803603892936,0.4901455758122,"B.LvsV.MARIADASON_RESPONSE_TO_BUTYRATE_CURCUMIN_SULINDAC_TSA_1"
96,"Down",0.171958308130096,0.490333927617999,"B.LvsV.REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS"
32,"Down",0.172071741590838,0.490404463533889,"B.LvsV.KEGG_PROXIMAL_TUBULE_BICARBONATE_RECLAMATION"
79,"Down",0.172309184897781,0.490828172745919,"B.LvsV.CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN"
95,"Up",0.17253402512469,0.491164667235041,"B.LvsV.RAMASWAMY_METASTASIS_DN"
173,"Down",0.172604982535302,0.491164667235041,"B.LvsV.REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION"
147,"Up",0.172901762688258,0.491756093571696,"B.LvsV.BAE_BRCA1_TARGETS_UP"
11,"Up",0.17326024459334,0.49218472485526,"B.LvsV.MATZUK_FERTILIZATION"
31,"Down",0.173306944279878,0.49218472485526,"B.LvsV.MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_DN"
216,"Up",0.173319526007088,0.49218472485526,"B.LvsV.PECE_MAMMARY_STEM_CELL_DN"
96,"Down",0.173721822424015,0.493073899477606,"B.LvsV.REACTOME_GLOBAL_GENOME_NUCLEOTIDE_EXCISION_REPAIR_GG_NER"
43,"Down",0.174141870723641,0.494012520898415,"B.LvsV.REACTOME_FGFR1_MUTANT_RECEPTOR_ACTIVATION"
59,"Down",0.174241047175533,0.49404038453001,"B.LvsV.KAMIKUBO_MYELOID_CEBPA_NETWORK"
49,"Down",0.174677025314636,0.494972709314308,"B.LvsV.PACHER_TARGETS_OF_IGF1_AND_IGF2_UP"
36,"Down",0.174775463949023,0.494972709314308,"B.LvsV.REACTOME_SCAVENGING_BY_CLASS_A_RECEPTORS"
16,"Down",0.174838433946617,0.494972709314308,"B.LvsV.REACTOME_ERYTHROCYTES_TAKE_UP_OXYGEN_AND_RELEASE_CARBON_DIOXIDE"
14,"Down",0.174976281111634,0.495109446400319,"B.LvsV.BIOCARTA_SRCRPTP_PATHWAY"
28,"Down",0.175373725409014,0.495742372261311,"B.LvsV.KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_HEPARAN_SULFATE"
67,"Up",0.175379287419628,0.495742372261311,"B.LvsV.PID_ARF6_TRAFFICKING_PATHWAY"
211,"Up",0.175643378617078,0.496108845747588,"B.LvsV.RODWELL_AGING_KIDNEY_DN"
44,"Up",0.175688392109564,0.496108845747588,"B.LvsV.BIOCARTA_GH_PATHWAY"
45,"Up",0.175822948162241,0.496141903895016,"B.LvsV.REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS"
20,"Up",0.175897063313738,0.496141903895016,"B.LvsV.REACTOME_CD28_DEPENDENT_VAV1_PATHWAY"
675,"Up",0.175969302502826,0.496141903895016,"B.LvsV.STARK_PREFRONTAL_CORTEX_22Q11_DELETION_DN"
38,"Up",0.176494353265354,0.497301497329469,"B.LvsV.REACTOME_KERATAN_SULFATE_KERATIN_METABOLISM"
21,"Down",0.176650377513543,0.497301497329469,"B.LvsV.AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_DN"
51,"Up",0.176650414316346,0.497301497329469,"B.LvsV.GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_DN"
51,"Up",0.176985345597164,0.497674545366566,"B.LvsV.SIMBULAN_PARP1_TARGETS_UP"
448,"Up",0.177032766630386,0.497674545366566,"B.LvsV.IVANOVA_HEMATOPOIESIS_MATURE_CELL"
43,"Down",0.177052962694164,0.497674545366566,"B.LvsV.WEST_ADRENOCORTICAL_TUMOR_MARKERS_DN"
63,"Up",0.177458761648503,0.497692809706309,"B.LvsV.JOHANSSON_BRAIN_CANCER_EARLY_VS_LATE_DN"
185,"Down",0.177589185088309,0.497692809706309,"B.LvsV.PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_4"
149,"Up",0.177603032218089,0.497692809706309,"B.LvsV.GUO_TARGETS_OF_IRS1_AND_IRS2"
70,"Up",0.177630171299489,0.497692809706309,"B.LvsV.ZHAN_MULTIPLE_MYELOMA_MS_UP"
77,"Up",0.177757660117136,0.497692809706309,"B.LvsV.BALDWIN_PRKCI_TARGETS_UP"
53,"Down",0.177786724213279,0.497692809706309,"B.LvsV.GROSS_HYPOXIA_VIA_ELK3_ONLY_UP"
122,"Down",0.177828792640838,0.497692809706309,"B.LvsV.ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN"
64,"Up",0.177830069094351,0.497692809706309,"B.LvsV.PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_6"
31,"Down",0.177930680544513,0.497692809706309,"B.LvsV.GOERING_BLOOD_HDL_CHOLESTEROL_QTL_TRANS"
68,"Down",0.178038966535303,0.497692809706309,"B.LvsV.VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_DN"
43,"Up",0.178074642951324,0.497692809706309,"B.LvsV.REACTOME_DISASSEMBLY_OF_THE_DESTRUCTION_COMPLEX_AND_RECRUITMENT_OF_AXIN_TO_THE_MEMBRANE"
17,"Down",0.178139640153515,0.497692809706309,"B.LvsV.PID_CIRCADIAN_PATHWAY"
77,"Up",0.17825958927972,0.497776398549277,"B.LvsV.HAHTOLA_CTCL_CUTANEOUS"
9,"Up",0.178536159132112,0.498260963135821,"B.LvsV.REACTOME_TRANSPORT_OF_NUCLEOTIDE_SUGARS"
455,"Up",0.178613353035847,0.498260963135821,"B.LvsV.DURCHDEWALD_SKIN_CARCINOGENESIS_DN"
16,"Down",0.178853173759586,0.49867836496054,"B.LvsV.REACTOME_SUMOYLATION_OF_DNA_METHYLATION_PROTEINS"
74,"Down",0.179196997097204,0.499385179914537,"B.LvsV.KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP"
134,"Down",0.179872377349722,0.500952806681589,"B.LvsV.SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM3"
357,"Up",0.179940726002828,0.500952806681589,"B.LvsV.JISON_SICKLE_CELL_DISEASE_UP"
12,"Down",0.180095936161133,0.501021027043853,"B.LvsV.REACTOME_IRAK2_MEDIATED_ACTIVATION_OF_TAK1_COMPLEX"
87,"Down",0.180146464417287,0.501021027043853,"B.LvsV.GENTILE_UV_RESPONSE_CLUSTER_D4"
73,"Down",0.180246806683503,0.501048061414324,"B.LvsV.ENGELMANN_CANCER_PROGENITORS_UP"
16,"Up",0.180457366264957,0.50138129551706,"B.LvsV.NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN"
159,"Up",0.181062286169767,0.502475279311199,"B.LvsV.MAHAJAN_RESPONSE_TO_IL1A_DN"
86,"Up",0.181086018987109,0.502475279311199,"B.LvsV.PID_INTEGRIN1_PATHWAY"
453,"Down",0.181181193514569,0.502475279311199,"B.LvsV.SANSOM_APC_TARGETS"
78,"Up",0.181261326569205,0.502475279311199,"B.LvsV.PID_CASPASE_PATHWAY"
147,"Up",0.181305513153525,0.502475279311199,"B.LvsV.KYNG_DNA_DAMAGE_BY_GAMMA_AND_UV_RADIATION"
132,"Up",0.18176469832218,0.503495499510688,"B.LvsV.MILI_PSEUDOPODIA"
80,"Down",0.18214233765989,0.504149036493302,"B.LvsV.MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_6"
34,"Up",0.182182994196711,0.504149036493302,"B.LvsV.REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_7ALPHA_HYDROXYCHOLESTEROL"
385,"Up",0.18232286601624,0.504283704954373,"B.LvsV.RIGGINS_TAMOXIFEN_RESISTANCE_DN"
17,"Down",0.182664224399173,0.504975248351514,"B.LvsV.OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_DN"
85,"Up",0.1829982958639,0.505645965932785,"B.LvsV.SASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION"
187,"Down",0.183481244129802,0.506698356188306,"B.LvsV.ELVIDGE_HYPOXIA_DN"
8,"Down",0.183562453869629,0.506698356188306,"B.LvsV.NIKOLSKY_BREAST_CANCER_19Q13.4_AMPLICON"
83,"Up",0.183775670834852,0.507033774474002,"B.LvsV.REACTOME_CA2_PATHWAY"
83,"Down",0.183998723882953,0.507395982218877,"B.LvsV.DELACROIX_RAR_TARGETS_UP"
49,"Down",0.184095515671607,0.507409823603348,"B.LvsV.REACTOME_NGF_STIMULATED_TRANSCRIPTION"
185,"Up",0.185093930155114,0.509907493685912,"B.LvsV.REACTOME_AMYLOID_FIBER_FORMATION"
204,"Down",0.18560711367214,0.51093540702852,"B.LvsV.CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_DN"
60,"Down",0.185651877865852,0.51093540702852,"B.LvsV.PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_UP"
34,"Down",0.185958905238888,0.511482316263205,"B.LvsV.LEE_DOUBLE_POLAR_THYMOCYTE"
28,"Down",0.186054118477688,0.511482316263205,"B.LvsV.MATZUK_OVULATION"
117,"Down",0.186138102233621,0.511482316263205,"B.LvsV.REACTOME_ARACHIDONIC_ACID_METABOLISM"
14,"Up",0.186220637120244,0.511482316263205,"B.LvsV.BIOCARTA_PKC_PATHWAY"
213,"Down",0.186478813345459,0.511937119655929,"B.LvsV.BROWNE_HCMV_INFECTION_8HR_UP"
205,"Up",0.186707963250876,0.512141734489879,"B.LvsV.SENESE_HDAC2_TARGETS_DN"
24,"Up",0.186782942830722,0.512141734489879,"B.LvsV.REACTOME_RECEPTOR_TYPE_TYROSINE_PROTEIN_PHOSPHATASES"
8,"Up",0.186831231410035,0.512141734489879,"B.LvsV.REACTOME_PHOSPHATE_BOND_HYDROLYSIS_BY_NUDT_PROTEINS"
321,"Up",0.187074621020302,0.512554796640857,"B.LvsV.WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN"
224,"Up",0.187702989598719,0.51390506288394,"B.LvsV.REACTOME_INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC"
31,"Up",0.187780690046746,0.51390506288394,"B.LvsV.REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION"
6,"Down",0.187846289037519,0.51390506288394,"B.LvsV.REACTOME_VLDL_ASSEMBLY"
8,"Down",0.188123483090004,0.514178798727587,"B.LvsV.REACTOME_FGFR3B_LIGAND_BINDING_AND_ACTIVATION"
49,"Up",0.188213535406331,0.514178798727587,"B.LvsV.PID_WNT_NONCANONICAL_PATHWAY"
206,"Down",0.188225337063598,0.514178798727587,"B.LvsV.HOLLERN_EMT_BREAST_TUMOR_DN"
109,"Up",0.188527851500484,0.514615978483152,"B.LvsV.REACTOME_MITOCHONDRIAL_BIOGENESIS"
41,"Up",0.188571526931971,0.514615978483152,"B.LvsV.REACTOME_GLUTATHIONE_CONJUGATION"
62,"Down",0.188909213764392,0.515283198274949,"B.LvsV.HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_DN"
1243,"Up",0.189143637978315,0.515668231943838,"B.LvsV.LEE_BMP2_TARGETS_UP"
19,"Up",0.189637917609382,0.516517087635889,"B.LvsV.REACTOME_TRAFFICKING_OF_GLUR2_CONTAINING_AMPA_RECEPTORS"
43,"Up",0.189641831778053,0.516517087635889,"B.LvsV.WANG_CLASSIC_ADIPOGENIC_TARGETS_OF_PPARG"
76,"Down",0.189896236708027,0.516517292249234,"B.LvsV.PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_DN"
518,"Up",0.189964781480753,0.516517292249234,"B.LvsV.MOOTHA_MITOCHONDRIA"
9,"Down",0.190084822708479,0.516517292249234,"B.LvsV.REACTOME_ABACAVIR_TRANSMEMBRANE_TRANSPORT"
15,"Up",0.190121043844159,0.516517292249234,"B.LvsV.PID_INTEGRIN4_PATHWAY"
249,"Down",0.190187936047216,0.516517292249234,"B.LvsV.IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_UP"
6,"Up",0.190280273915047,0.516517292249234,"B.LvsV.REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_KEY_METABOLIC_FACTORS"
18,"Down",0.190295844512876,0.516517292249234,"B.LvsV.KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_4NQO_IN_OLD"
212,"Up",0.190392695991258,0.516526602618089,"B.LvsV.LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN"
39,"Up",0.190658632188509,0.516994397925583,"B.LvsV.REACTOME_SIGNALING_BY_NTRK2_TRKB"
96,"Down",0.190770033072996,0.517042898461075,"B.LvsV.FIGUEROA_AML_METHYLATION_CLUSTER_6_DN"
114,"Up",0.190892357635407,0.51712094334452,"B.LvsV.KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS"
94,"Down",0.191158320679046,0.517587833023724,"B.LvsV.WARTERS_IR_RESPONSE_5GY"
240,"Down",0.191293706319578,0.517700882154159,"B.LvsV.NAGASHIMA_NRG1_SIGNALING_UP"
65,"Up",0.191471450899293,0.51774063108679,"B.LvsV.BOYAULT_LIVER_CANCER_SUBCLASS_G1_DN"
32,"Down",0.191495675632571,0.51774063108679,"B.LvsV.HANSON_HRAS_SIGNALING_VIA_NFKB"
160,"Up",0.191874540360047,0.518511404521359,"B.LvsV.HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_UP"
1437,"Down",0.191975925613629,0.518531945636422,"B.LvsV.NUYTTEN_EZH2_TARGETS_DN"
706,"Up",0.192244053245641,0.519002622263256,"B.LvsV.JOHNSTONE_PARVB_TARGETS_3_UP"
61,"Up",0.192756605210919,0.519692178581877,"B.LvsV.PID_CERAMIDE_PATHWAY"
251,"Down",0.192813427752747,0.519692178581877,"B.LvsV.SABATES_COLORECTAL_ADENOMA_UP"
266,"Up",0.192858785509327,0.519692178581877,"B.LvsV.ALCALAY_AML_BY_NPM1_LOCALIZATION_UP"
28,"Up",0.192894008861746,0.519692178581877,"B.LvsV.KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS"
199,"Up",0.192969441604014,0.519692178581877,"B.LvsV.WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN"
82,"Down",0.193224282975681,0.520082605446357,"B.LvsV.HALMOS_CEBPA_TARGETS_UP"
57,"Up",0.193302541904913,0.520082605446357,"B.LvsV.SIG_CHEMOTAXIS"
204,"Down",0.193685949316601,0.5208607070873,"B.LvsV.REACTOME_DNA_DOUBLE_STRAND_BREAK_REPAIR"
252,"Down",0.19454508747102,0.522894498661644,"B.LvsV.SERVITJA_LIVER_HNF1A_TARGETS_UP"
9,"Down",0.194631376061795,0.522894498661644,"B.LvsV.NAGY_PCAF_COMPONENTS_HUMAN"
67,"Up",0.194788339316263,0.523062034035755,"B.LvsV.PID_ILK_PATHWAY"
35,"Down",0.195253469328801,0.523801443719468,"B.LvsV.OZANNE_AP1_TARGETS_UP"
9,"Down",0.195484744676673,0.523801443719468,"B.LvsV.KUWANO_RNA_STABILIZED_BY_NO"
46,"Down",0.195613836791713,0.523801443719468,"B.LvsV.PARK_TRETINOIN_RESPONSE_AND_PML_RARA_FUSION"
94,"Down",0.195768589280647,0.523801443719468,"B.LvsV.MAYBURD_RESPONSE_TO_L663536_DN"
23,"Down",0.195773289624569,0.523801443719468,"B.LvsV.BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER"
13,"Up",0.195774352146382,0.523801443719468,"B.LvsV.REACTOME_MUCOPOLYSACCHARIDOSES"
39,"Down",0.195824608535663,0.523801443719468,"B.LvsV.REACTOME_N_GLYCAN_TRIMMING_IN_THE_ER_AND_CALNEXIN_CALRETICULIN_CYCLE"
152,"Down",0.195878499853295,0.523801443719468,"B.LvsV.RIGGINS_TAMOXIFEN_RESISTANCE_UP"
124,"Down",0.195916329464978,0.523801443719468,"B.LvsV.LU_IL4_SIGNALING"
187,"Up",0.196096821801416,0.52403060789755,"B.LvsV.TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP"
22,"Down",0.196257215142596,0.524205865953341,"B.LvsV.REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS"
53,"Down",0.19641485552452,0.524373605115921,"B.LvsV.BIOCARTA_VEGF_PATHWAY"
10,"Up",0.196642839913594,0.524728890869818,"B.LvsV.WEBER_METHYLATED_LCP_IN_SPERM_DN"
200,"Up",0.197023281570845,0.525416799739257,"B.LvsV.ELVIDGE_HYPOXIA_BY_DMOG_UP"
48,"Up",0.197090693192118,0.525416799739257,"B.LvsV.CHIBA_RESPONSE_TO_TSA_DN"
150,"Up",0.197307332388511,0.52574083892823,"B.LvsV.DING_LUNG_CANCER_EXPRESSION_BY_COPY_NUMBER"
115,"Up",0.197736883455665,0.526467972872314,"B.LvsV.SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE"
299,"Down",0.197770660093289,0.526467972872314,"B.LvsV.TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN"
13,"Down",0.197904508467295,0.526570754242384,"B.LvsV.REACTOME_ALPHA_PROTEIN_KINASE_1_SIGNALING_PATHWAY"
12,"Down",0.19826517240895,0.527276641774451,"B.LvsV.REACTOME_INTERLEUKIN_21_SIGNALING"
983,"Up",0.198568842471145,0.527830350972578,"B.LvsV.HAMAI_APOPTOSIS_VIA_TRAIL_UP"
7,"Down",0.198808643668262,0.527843150397373,"B.LvsV.REACTOME_ZINC_EFFLUX_AND_COMPARTMENTALIZATION_BY_THE_SLC30_FAMILY"
101,"Up",0.198833144178183,0.527843150397373,"B.LvsV.TURASHVILI_BREAST_NORMAL_DUCTAL_VS_LOBULAR_UP"
28,"Up",0.198920797557966,0.527843150397373,"B.LvsV.BIOCARTA_CDK5_PATHWAY"
279,"Down",0.199079214998538,0.527843150397373,"B.LvsV.REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT"
85,"Down",0.199094256156309,0.527843150397373,"B.LvsV.DUNNE_TARGETS_OF_AML1_MTG8_FUSION_UP"
512,"Up",0.199276053330776,0.527843150397373,"B.LvsV.DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP"
22,"Down",0.199387111342629,0.527843150397373,"B.LvsV.REACTOME_SHC_MEDIATED_CASCADE_FGFR4"
200,"Down",0.19941781721167,0.527843150397373,"B.LvsV.ALTEMEIER_RESPONSE_TO_LPS_WITH_MECHANICAL_VENTILATION"
133,"Up",0.199432870533571,0.527843150397373,"B.LvsV.GRABARCZYK_BCL11B_TARGETS_UP"
29,"Up",0.199690306596718,0.5282716292695,"B.LvsV.BIOCARTA_CXCR4_PATHWAY"
41,"Down",0.200216134513571,0.529032891394608,"B.LvsV.KEGG_AMINOACYL_TRNA_BIOSYNTHESIS"
51,"Down",0.200225437088651,0.529032891394608,"B.LvsV.REACTOME_SIGNALING_BY_FGFR1_IN_DISEASE"
473,"Up",0.200265118771734,0.529032891394608,"B.LvsV.DURAND_STROMA_S_UP"
61,"Down",0.200632843115928,0.529431266529368,"B.LvsV.MIKKELSEN_MEF_ICP_WITH_H3K4ME3_AND_H3K27ME3"
78,"Down",0.200688954774582,0.529431266529368,"B.LvsV.PAL_PRMT5_TARGETS_DN"
17,"Down",0.200877139672141,0.529431266529368,"B.LvsV.DAZARD_UV_RESPONSE_CLUSTER_G3"
10,"Down",0.201001357462519,0.529431266529368,"B.LvsV.REACTOME_DISEASES_OF_DNA_REPAIR"
70,"Up",0.201026155628339,0.529431266529368,"B.LvsV.SIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES"
9,"Down",0.201090074333108,0.529431266529368,"B.LvsV.REACTOME_HISTIDINE_CATABOLISM"
9,"Down",0.201105530260803,0.529431266529368,"B.LvsV.IIZUKA_LIVER_CANCER_PROGRESSION_G2_G3_DN"
54,"Up",0.20118196617439,0.529431266529368,"B.LvsV.REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY"
12,"Down",0.201499054058877,0.529775748361462,"B.LvsV.MUNSHI_MULTIPLE_MYELOMA_DN"
52,"Up",0.201504503310572,0.529775748361462,"B.LvsV.REACTOME_TRANSCRIPTIONAL_REGULATION_BY_VENTX"
141,"Up",0.201927230807905,0.530468114102963,"B.LvsV.FRIDMAN_SENESCENCE_UP"
37,"Up",0.201965173048613,0.530468114102963,"B.LvsV.BIOCARTA_PTDINS_PATHWAY"
209,"Up",0.202126394013808,0.530468114102963,"B.LvsV.KAYO_CALORIE_RESTRICTION_MUSCLE_UP"
168,"Up",0.202151621706447,0.530468114102963,"B.LvsV.REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA"
252,"Up",0.20263044180935,0.530940679959055,"B.LvsV.REACTOME_CILIUM_ASSEMBLY"
252,"Up",0.202648412081407,0.530940679959055,"B.LvsV.IWANAGA_CARCINOGENESIS_BY_KRAS_DN"
258,"Up",0.202783148374195,0.530940679959055,"B.LvsV.REACTOME_FATTY_ACID_METABOLISM"
274,"Down",0.202834321471047,0.530940679959055,"B.LvsV.CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN"
718,"Down",0.202839411220202,0.530940679959055,"B.LvsV.REACTOME_NERVOUS_SYSTEM_DEVELOPMENT"
38,"Up",0.202907877871854,0.530940679959055,"B.LvsV.RUAN_RESPONSE_TO_TNF_TROGLITAZONE_UP"
320,"Down",0.203129897025582,0.531270198985073,"B.LvsV.KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION"
8,"Down",0.203897320973381,0.532982963312063,"B.LvsV.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_30"
43,"Down",0.203977563821365,0.532982963312063,"B.LvsV.PID_CD40_PATHWAY"
19,"Down",0.204579758035942,0.534303959461843,"B.LvsV.REACTOME_ORGANIC_CATION_ANION_ZWITTERION_TRANSPORT"
9,"Down",0.204922386905152,0.534946117657501,"B.LvsV.REACTOME_ACTIVATION_OF_PUMA_AND_TRANSLOCATION_TO_MITOCHONDRIA"
26,"Up",0.205113665061975,0.535192757964918,"B.LvsV.SCIBETTA_KDM5B_TARGETS_UP"
38,"Down",0.205731258242816,0.536551003219117,"B.LvsV.SESTO_RESPONSE_TO_UV_C4"
34,"Down",0.205964226394378,0.536905331322261,"B.LvsV.REACTOME_DOWNREGULATION_OF_ERBB2_SIGNALING"
49,"Up",0.206223259422691,0.536971335093524,"B.LvsV.WANG_NEOPLASTIC_TRANSFORMATION_BY_CCND1_MYC"
60,"Down",0.206328795411407,0.536971335093524,"B.LvsV.REACTOME_METABOLIC_DISORDERS_OF_BIOLOGICAL_OXIDATION_ENZYMES"
134,"Down",0.206396358414284,0.536971335093524,"B.LvsV.VANHARANTA_UTERINE_FIBROID_DN"
13,"Up",0.206439725192143,0.536971335093524,"B.LvsV.REACTOME_FIBRONECTIN_MATRIX_FORMATION"
158,"Up",0.206600511642476,0.536971335093524,"B.LvsV.REACTOME_RHO_GTPASE_CYCLE"
29,"Down",0.206688191534962,0.536971335093524,"B.LvsV.GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_DN"
50,"Up",0.206692947580325,0.536971335093524,"B.LvsV.REACTOME_SPHINGOLIPID_DE_NOVO_BIOSYNTHESIS"
97,"Up",0.206766498899279,0.536971335093524,"B.LvsV.BROWNE_HCMV_INFECTION_30MIN_UP"
130,"Up",0.207000067994236,0.53732552861039,"B.LvsV.LEE_LIVER_CANCER_E2F1_UP"
154,"Up",0.207102474040394,0.537339079760366,"B.LvsV.LEE_LIVER_CANCER_DENA_DN"
51,"Down",0.207249879062216,0.537446083262035,"B.LvsV.REACTOME_INTERLEUKIN_2_FAMILY_SIGNALING"
143,"Down",0.207365966812438,0.537446083262035,"B.LvsV.SCHLOSSER_SERUM_RESPONSE_AUGMENTED_BY_MYC"
78,"Down",0.207554493245143,0.537446083262035,"B.LvsV.VILIMAS_NOTCH1_TARGETS_UP"
12,"Up",0.207633759148175,0.537446083262035,"B.LvsV.BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_24HR_UP"
28,"Up",0.207679404059314,0.537446083262035,"B.LvsV.REACTOME_MITOCHONDRIAL_CALCIUM_ION_TRANSPORT"
16,"Down",0.207726945185561,0.537446083262035,"B.LvsV.REACTOME_FGFR2C_LIGAND_BINDING_AND_ACTIVATION"
413,"Up",0.208058273300944,0.538051540262356,"B.LvsV.AFFAR_YY1_TARGETS_UP"
51,"Up",0.208331842870732,0.538453737197863,"B.LvsV.PID_ERBB1_RECEPTOR_PROXIMAL_PATHWAY"
92,"Down",0.20840992480062,0.538453737197863,"B.LvsV.LUCAS_HNF4A_TARGETS_UP"
330,"Up",0.208505959728816,0.538453737197863,"B.LvsV.TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP"
1090,"Up",0.208618161544548,0.538491977208126,"B.LvsV.LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN"
84,"Up",0.209370295375224,0.54018122404555,"B.LvsV.MIKKELSEN_NPC_LCP_WITH_H3K4ME3"
11,"Up",0.209782769733268,0.540992972880242,"B.LvsV.BIOCARTA_CACAM_PATHWAY"
4,"Up",0.209978217233912,0.541244551555384,"B.LvsV.DER_IFN_ALPHA_RESPONSE_DN"
63,"Down",0.210084314939908,0.541265693058132,"B.LvsV.SIMBULAN_UV_RESPONSE_NORMAL_DN"
85,"Down",0.210406304564914,0.541842784322036,"B.LvsV.ELVIDGE_HIF1A_TARGETS_UP"
44,"Down",0.210917914147413,0.542178081029566,"B.LvsV.HINATA_NFKB_TARGETS_KERATINOCYTE_DN"
96,"Up",0.210929615413592,0.542178081029566,"B.LvsV.REACTOME_NONHOMOLOGOUS_END_JOINING_NHEJ"
637,"Down",0.210949744381012,0.542178081029566,"B.LvsV.MOHANKUMAR_HOXA1_TARGETS_UP"
323,"Up",0.211021853285538,0.542178081029566,"B.LvsV.SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_DN"
32,"Down",0.211026809617585,0.542178081029566,"B.LvsV.SCHMIDT_POR_TARGETS_IN_LIMB_BUD_DN"
26,"Down",0.211174724779175,0.542306109291248,"B.LvsV.OHASHI_AURKB_TARGETS"
886,"Up",0.211945619491707,0.543653748488998,"B.LvsV.SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_DN"
136,"Down",0.212048550762348,0.543653748488998,"B.LvsV.ROSS_AML_WITH_PML_RARA_FUSION"
11,"Down",0.212119723886867,0.543653748488998,"B.LvsV.REACTOME_PYRIMIDINE_SALVAGE"
981,"Up",0.21216064978623,0.543653748488998,"B.LvsV.BROWNE_HCMV_INFECTION_48HR_DN"
13,"Down",0.212191135691672,0.543653748488998,"B.LvsV.REACTOME_REGULATED_PROTEOLYSIS_OF_P75NTR"
172,"Up",0.212332796802494,0.543764721408517,"B.LvsV.REACTOME_BETA_CATENIN_INDEPENDENT_WNT_SIGNALING"
782,"Down",0.213067705478237,0.545038240368855,"B.LvsV.CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1"
31,"Up",0.213100146280907,0.545038240368855,"B.LvsV.HASLINGER_B_CLL_WITH_17P13_DELETION"
15,"Down",0.213125823056152,0.545038240368855,"B.LvsV.REACTOME_PURINE_SALVAGE"
16,"Down",0.213242894181411,0.545085511756366,"B.LvsV.REACTOME_GOLGI_CISTERNAE_PERICENTRIOLAR_STACK_REORGANIZATION"
31,"Down",0.213671007327261,0.545907789720103,"B.LvsV.REACTOME_POU5F1_OCT4_SOX2_NANOG_ACTIVATE_GENES_RELATED_TO_PROLIFERATION"
82,"Down",0.213762048244533,0.545907789720103,"B.LvsV.DAIRKEE_CANCER_PRONE_RESPONSE_BPA"
8,"Up",0.214068759129696,0.54628126999256,"B.LvsV.NAISHIRO_CTNNB1_TARGETS_WITH_LEF1_MOTIF"
19,"Down",0.214105898367495,0.54628126999256,"B.LvsV.MARTINELLI_IMMATURE_NEUTROPHIL_DN"
29,"Down",0.214376015779313,0.546718169392907,"B.LvsV.REACTOME_RIPK1_MEDIATED_REGULATED_NECROSIS"
103,"Up",0.215001632423558,0.548060869372914,"B.LvsV.DORN_ADENOVIRUS_INFECTION_24HR_DN"
10,"Down",0.215166633759683,0.54822871799875,"B.LvsV.BYSTRYKH_HEMATOPOIESIS_STEM_CELL_FGF3"
353,"Up",0.215308709027355,0.548273106330684,"B.LvsV.TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP"
15,"Down",0.2153823814343,0.548273106330684,"B.LvsV.MIKKELSEN_PLURIPOTENT_STATE_DN"
191,"Up",0.215806699296193,0.549100432769744,"B.LvsV.DER_IFN_ALPHA_RESPONSE_UP"
427,"Up",0.216757034193887,0.551264784755289,"B.LvsV.RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_DN"
26,"Up",0.216879221451494,0.551321938117384,"B.LvsV.KEGG_SELENOAMINO_ACID_METABOLISM"
331,"Up",0.217145729398548,0.551691704042633,"B.LvsV.LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP"
50,"Down",0.217224243027819,0.551691704042633,"B.LvsV.BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_DN"
45,"Up",0.217471864912459,0.55206700693342,"B.LvsV.PID_IL1_PATHWAY"
61,"Up",0.217787963313163,0.552467911393859,"B.LvsV.LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_UP"
16,"Up",0.217829634081862,0.552467911393859,"B.LvsV.REACTOME_NUCLEOTIDE_LIKE_PURINERGIC_RECEPTORS"
1509,"Down",0.218910066290724,0.55443910725565,"B.LvsV.MARTENS_TRETINOIN_RESPONSE_UP"
23,"Up",0.218953208809101,0.55443910725565,"B.LvsV.REACTOME_SPRY_REGULATION_OF_FGF_SIGNALING"
26,"Down",0.218991581452403,0.55443910725565,"B.LvsV.LOPEZ_MESOTHELIOMA_SURVIVAL_WORST_VS_BEST_UP"
77,"Down",0.219007959892628,0.55443910725565,"B.LvsV.TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP"
1220,"Up",0.219517907729321,0.554906291301008,"B.LvsV.ONKEN_UVEAL_MELANOMA_UP"
279,"Up",0.219536523019648,0.554906291301008,"B.LvsV.GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_UP"
256,"Up",0.219606539968772,0.554906291301008,"B.LvsV.TSENG_IRS1_TARGETS_DN"
15,"Up",0.21974782072767,0.554906291301008,"B.LvsV.HOLLEMAN_DAUNORUBICIN_B_ALL_DN"
29,"Down",0.219780371839303,0.554906291301008,"B.LvsV.NOUSHMEHR_GBM_SOMATIC_MUTATED"
49,"Down",0.219794678594539,0.554906291301008,"B.LvsV.KEGG_ABC_TRANSPORTERS"
11,"Up",0.219976887252909,0.555112829585273,"B.LvsV.REACTOME_REGULATION_OF_FOXO_TRANSCRIPTIONAL_ACTIVITY_BY_ACETYLATION"
9,"Down",0.220326392593358,0.555741160879871,"B.LvsV.REACTOME_TRIF_MEDIATED_PROGRAMMED_CELL_DEATH"
23,"Up",0.220933955014039,0.557019533640047,"B.LvsV.REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB"
219,"Down",0.221237525724893,0.557530665329506,"B.LvsV.XU_GH1_AUTOCRINE_TARGETS_DN"
31,"Down",0.221673177146941,0.558374030271269,"B.LvsV.REACTOME_INTERLEUKIN_RECEPTOR_SHC_SIGNALING"
14,"Down",0.221930867342221,0.558485445271751,"B.LvsV.REACTOME_GLUTAMATE_AND_GLUTAMINE_METABOLISM"
75,"Down",0.221952472605891,0.558485445271751,"B.LvsV.NUTT_GBM_VS_AO_GLIOMA_DN"
456,"Down",0.222143736611694,0.558485445271751,"B.LvsV.REACTOME_TRANSCRIPTIONAL_REGULATION_BY_TP53"
97,"Up",0.222181320355556,0.558485445271751,"B.LvsV.REACTOME_ACTIVATED_PKN1_STIMULATES_TRANSCRIPTION_OF_AR_ANDROGEN_RECEPTOR_REGULATED_GENES_KLK2_AND_KLK3"
43,"Up",0.222222459684907,0.558485445271751,"B.LvsV.ZWANG_EGF_PERSISTENTLY_UP"
218,"Up",0.222632750356621,0.559262370159818,"B.LvsV.MCBRYAN_PUBERTAL_BREAST_5_6WK_DN"
67,"Down",0.222852178124616,0.559429206891455,"B.LvsV.LEONARD_HYPOXIA"
33,"Down",0.222901526999797,0.559429206891455,"B.LvsV.REACTOME_NOTCH2_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS"
16,"Down",0.223862476181088,0.561586039385316,"B.LvsV.REACTOME_DEFECTIVE_GALNT3_CAUSES_FAMILIAL_HYPERPHOSPHATEMIC_TUMORAL_CALCINOSIS_HFTC"
8,"Up",0.223994553235103,0.561662532805844,"B.LvsV.REACTOME_SYNTHESIS_OF_KETONE_BODIES"
29,"Down",0.224568916532416,0.562847479377937,"B.LvsV.REACTOME_GABA_SYNTHESIS_RELEASE_REUPTAKE_AND_DEGRADATION"
125,"Up",0.224820732048343,0.563223301991522,"B.LvsV.REACTOME_CELL_JUNCTION_ORGANIZATION"
101,"Down",0.225111495519639,0.563517587061084,"B.LvsV.RIZKI_TUMOR_INVASIVENESS_2D_DN"
143,"Down",0.225142041927642,0.563517587061084,"B.LvsV.LIU_COMMON_CANCER_GENES"
214,"Down",0.225332430637859,0.563738918098065,"B.LvsV.RASHI_RESPONSE_TO_IONIZING_RADIATION_2"
34,"Up",0.225483522894843,0.563861781133238,"B.LvsV.BIOCARTA_SPPA_PATHWAY"
81,"Down",0.22567131919449,0.564076276594184,"B.LvsV.HENDRICKS_SMARCA4_TARGETS_DN"
197,"Up",0.226153871011474,0.565027000823516,"B.LvsV.WOO_LIVER_CANCER_RECURRENCE_UP"
72,"Down",0.226414174915104,0.565058350668964,"B.LvsV.REACTOME_HEDGEHOG_LIGAND_BIOGENESIS"
13,"Up",0.226434480107282,0.565058350668964,"B.LvsV.LIU_TARGETS_OF_VMYB_VS_CMYB_UP"
167,"Down",0.226473015930987,0.565058350668964,"B.LvsV.REACTOME_MITOTIC_PROPHASE"
23,"Up",0.22667209507195,0.565182671490121,"B.LvsV.GOUYER_TATI_TARGETS_DN"
203,"Down",0.226727286193722,0.565182671490121,"B.LvsV.WHITFIELD_CELL_CYCLE_M_G1"
15,"Up",0.226867352254973,0.565276967380687,"B.LvsV.REACTOME_KERATAN_SULFATE_DEGRADATION"
20,"Up",0.227000010245836,0.565352728220373,"B.LvsV.PID_LPA4_PATHWAY"
13,"Down",0.227237348716368,0.56547393397496,"B.LvsV.ZHENG_FOXP3_TARGETS_IN_T_LYMPHOCYTE_UP"
14,"Down",0.227253225048356,0.56547393397496,"B.LvsV.BIOCARTA_DSP_PATHWAY"
11,"Up",0.227675965807662,0.566270991880596,"B.LvsV.REACTOME_CHYLOMICRON_REMODELING"
15,"Up",0.227917257349926,0.566503283692411,"B.LvsV.MCCABE_HOXC6_TARGETS_UP"
46,"Up",0.227974282187667,0.566503283692411,"B.LvsV.VERNELL_RETINOBLASTOMA_PATHWAY_DN"
87,"Down",0.228217546073465,0.566853015381936,"B.LvsV.BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN"
14,"Up",0.228381455765816,0.5670054193665,"B.LvsV.REACTOME_CROSS_PRESENTATION_OF_PARTICULATE_EXOGENOUS_ANTIGENS_PHAGOSOMES"
180,"Down",0.228563786318777,0.567203399711184,"B.LvsV.DAZARD_RESPONSE_TO_UV_SCC_DN"
113,"Up",0.228922309260051,0.567838244907502,"B.LvsV.HOWLIN_CITED1_TARGETS_1_DN"
63,"Down",0.229264482084596,0.56794114685392,"B.LvsV.DOANE_BREAST_CANCER_CLASSES_DN"
8,"Up",0.229274707271437,0.56794114685392,"B.LvsV.ELVIDGE_HIF2A_TARGETS_UP"
33,"Down",0.229459897929983,0.56794114685392,"B.LvsV.CHUANG_OXIDATIVE_STRESS_RESPONSE_DN"
8,"Down",0.229462811711555,0.56794114685392,"B.LvsV.REACTOME_ACYL_CHAIN_REMODELING_OF_DAG_AND_TAG"
52,"Up",0.229492078484983,0.56794114685392,"B.LvsV.PID_GMCSF_PATHWAY"
28,"Down",0.229580116335415,0.56794114685392,"B.LvsV.KEGG_DORSO_VENTRAL_AXIS_FORMATION"
60,"Down",0.229855706262838,0.568368604618619,"B.LvsV.TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_DN"
20,"Down",0.230061052805077,0.568622065694801,"B.LvsV.SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX5_DN"
75,"Down",0.230578377387867,0.569646044940804,"B.LvsV.VARELA_ZMPSTE24_TARGETS_UP"
203,"Up",0.230714476035302,0.569727707904951,"B.LvsV.IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_DN"
5,"Down",0.230882355006041,0.569887741441251,"B.LvsV.REACTOME_TACHYKININ_RECEPTORS_BIND_TACHYKININS"
65,"Up",0.231247336245114,0.570533923292831,"B.LvsV.REACTOME_INTRAFLAGELLAR_TRANSPORT"
12,"Down",0.231423151694786,0.570565175914347,"B.LvsV.REACTOME_TRANSPORT_OF_FATTY_ACIDS"
120,"Up",0.231466393484515,0.570565175914347,"B.LvsV.REACTOME_MYD88_INDEPENDENT_TLR4_CASCADE"
100,"Up",0.231594073158156,0.570625503784066,"B.LvsV.CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_DN"
8,"Down",0.232554120968209,0.572706742548492,"B.LvsV.REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_INTERLEUKIN_SIGNALING"
180,"Down",0.232702186842327,0.572706742548492,"B.LvsV.LIM_MAMMARY_LUMINAL_MATURE_UP"
123,"Down",0.232749511757363,0.572706742548492,"B.LvsV.BILANGES_SERUM_SENSITIVE_GENES"
112,"Up",0.232946936715226,0.572937550310713,"B.LvsV.BOYAULT_LIVER_CANCER_SUBCLASS_G6_UP"
70,"Up",0.233302469732576,0.573556849778308,"B.LvsV.REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK"
586,"Up",0.233566744076073,0.57395134577627,"B.LvsV.KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN"
313,"Down",0.234331486145658,0.575574760950398,"B.LvsV.CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN"
52,"Up",0.234547484233907,0.575849485048522,"B.LvsV.REACTOME_DIGESTION_AND_ABSORPTION"
34,"Up",0.234893236138922,0.576442389086596,"B.LvsV.FARMER_BREAST_CANCER_CLUSTER_7"
149,"Down",0.235063178206539,0.576603510338931,"B.LvsV.ZHONG_SECRETOME_OF_LUNG_CANCER_AND_MACROPHAGE"
1070,"Up",0.235288575383289,0.576900458223593,"B.LvsV.SCHLOSSER_SERUM_RESPONSE_DN"
879,"Down",0.235421206296066,0.576969791494214,"B.LvsV.MEISSNER_NPC_HCP_WITH_H3_UNMETHYLATED"
65,"Down",0.236179244718899,0.57836075108298,"B.LvsV.HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_UP"
32,"Up",0.236210519252995,0.57836075108298,"B.LvsV.KEGG_PENTOSE_PHOSPHATE_PATHWAY"
5,"Down",0.236473757818755,0.57836075108298,"B.LvsV.REACTOME_DISEASES_OF_MISMATCH_REPAIR_MMR"
24,"Up",0.23657985243738,0.57836075108298,"B.LvsV.BIOCARTA_SPRY_PATHWAY"
26,"Up",0.236596498330915,0.57836075108298,"B.LvsV.GAVIN_IL2_RESPONSIVE_FOXP3_TARGETS_UP"
127,"Down",0.236674243837949,0.57836075108298,"B.LvsV.MEISSNER_NPC_HCP_WITH_H3K27ME3"
140,"Up",0.236859942663143,0.57836075108298,"B.LvsV.LEIN_PONS_MARKERS"
45,"Down",0.236938853107043,0.57836075108298,"B.LvsV.REACTOME_AMINE_LIGAND_BINDING_RECEPTORS"
17,"Up",0.237034998754101,0.57836075108298,"B.LvsV.REACTOME_SIGNALING_BY_PDGFRA_TRANSMEMBRANE_JUXTAMEMBRANE_AND_KINASE_DOMAIN_MUTANTS"
36,"Up",0.237247916326797,0.57836075108298,"B.LvsV.KANG_AR_TARGETS_UP"
114,"Down",0.237254777770112,0.57836075108298,"B.LvsV.GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_DN"
193,"Down",0.237369564712087,0.57836075108298,"B.LvsV.KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP"
18,"Up",0.237402524912584,0.57836075108298,"B.LvsV.STEINER_ERYTHROCYTE_MEMBRANE_GENES"
8,"Down",0.237453229328697,0.57836075108298,"B.LvsV.HESSON_TUMOR_SUPPRESSOR_CLUSTER_3P21_3"
330,"Up",0.237588660957451,0.578435802040399,"B.LvsV.TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP"
7,"Down",0.2384420759453,0.580258027245407,"B.LvsV.REACTOME_ALTERNATIVE_COMPLEMENT_ACTIVATION"
27,"Down",0.238821914885415,0.580926690453787,"B.LvsV.MELLMAN_TUT1_TARGETS_UP"
90,"Up",0.239027719499979,0.581171618784251,"B.LvsV.DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP"
977,"Up",0.239422834717324,0.58187641896795,"B.LvsV.WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_8D"
69,"Up",0.23956001381413,0.581944663538183,"B.LvsV.BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_DN"
6,"Down",0.2397808427732,0.581944663538183,"B.LvsV.FIGUEROA_AML_METHYLATION_CLUSTER_7_DN"
51,"Up",0.239810749561186,0.581944663538183,"B.LvsV.JIANG_AGING_HYPOTHALAMUS_DN"
251,"Up",0.239871927690996,0.581944663538183,"B.LvsV.WONG_MITOCHONDRIA_GENE_MODULE"
8,"Down",0.240080081048705,0.582054636497898,"B.LvsV.REACTOME_MET_RECEPTOR_ACTIVATION"
24,"Up",0.240127803554297,0.582054636497898,"B.LvsV.REACTOME_DCC_MEDIATED_ATTRACTIVE_SIGNALING"
90,"Up",0.240423052095828,0.582263655737915,"B.LvsV.PID_FCER1_PATHWAY"
34,"Up",0.240696340467313,0.582263655737915,"B.LvsV.KIM_MYCL1_AMPLIFICATION_TARGETS_DN"
19,"Up",0.240722818465634,0.582263655737915,"B.LvsV.REACTOME_CGMP_EFFECTS"
42,"Up",0.240724852812549,0.582263655737915,"B.LvsV.DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_DN"
13,"Down",0.240740589078834,0.582263655737915,"B.LvsV.KEGG_CIRCADIAN_RHYTHM_MAMMAL"
110,"Down",0.24099399401831,0.582406993804293,"B.LvsV.REACTOME_TNFR2_NON_CANONICAL_NF_KB_PATHWAY"
36,"Down",0.241092817286326,0.582406993804293,"B.LvsV.WANG_BARRETTS_ESOPHAGUS_DN"
23,"Down",0.241115863414366,0.582406993804293,"B.LvsV.WANG_RECURRENT_LIVER_CANCER_DN"
111,"Down",0.241223070291144,0.582411509012985,"B.LvsV.FONTAINE_FOLLICULAR_THYROID_ADENOMA_DN"
330,"Down",0.241354034463899,0.582473355107333,"B.LvsV.ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP"
110,"Down",0.241914616424197,0.583571515798162,"B.LvsV.TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_UP"
21,"Down",0.242090739478929,0.583741691486698,"B.LvsV.BIOCARTA_TH1TH2_PATHWAY"
40,"Up",0.242367766653842,0.584154917972579,"B.LvsV.REACTOME_REGULATION_OF_MECP2_EXPRESSION_AND_ACTIVITY"
117,"Down",0.242663926385158,0.584407781938231,"B.LvsV.KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION"
33,"Up",0.242684078012331,0.584407781938231,"B.LvsV.YORDY_RECIPROCAL_REGULATION_BY_ETS1_AND_SP100_UP"
162,"Up",0.243340187306951,0.585732649377507,"B.LvsV.ZHAN_MULTIPLE_MYELOMA_UP"
95,"Down",0.24379754659047,0.58657817019091,"B.LvsV.PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP"
316,"Down",0.243922773879739,0.586624191727307,"B.LvsV.KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION"
17,"Down",0.244164124818527,0.586949324400711,"B.LvsV.NAGY_TFTC_COMPONENTS_HUMAN"
129,"Down",0.244284825122562,0.586984266885113,"B.LvsV.REACTOME_NEGATIVE_EPIGENETIC_REGULATION_OF_RRNA_EXPRESSION"
18,"Down",0.244681111387474,0.587681088123954,"B.LvsV.REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION_IN_TLR7_8_OR_9_SIGNALING"
794,"Up",0.244948931070382,0.588006539177286,"B.LvsV.PILON_KLF1_TARGETS_UP"
27,"Up",0.245101644725552,0.588006539177286,"B.LvsV.REACTOME_SIGNALING_BY_NTRK3_TRKC"
11,"Down",0.245135661566946,0.588006539177286,"B.LvsV.WILLIAMS_ESR1_TARGETS_DN"
9,"Down",0.245436081986423,0.588013827259981,"B.LvsV.REACTOME_WNT_MEDIATED_ACTIVATION_OF_DVL"
25,"Up",0.245441891717754,0.588013827259981,"B.LvsV.KEGG_GLYCOSAMINOGLYCAN_DEGRADATION"
13,"Up",0.245457752453615,0.588013827259981,"B.LvsV.TURJANSKI_MAPK14_TARGETS"
101,"Up",0.245849265645405,0.588596808944783,"B.LvsV.REACTOME_MEIOTIC_RECOMBINATION"
23,"Up",0.245914022185287,0.588596808944783,"B.LvsV.CHEOK_RESPONSE_TO_MERCAPTOPURINE_DN"
495,"Down",0.246460275507119,0.58964901050578,"B.LvsV.NIKOLSKY_BREAST_CANCER_17Q21_Q25_AMPLICON"
13,"Down",0.247005912091601,0.590698826969924,"B.LvsV.NAKAMURA_LUNG_CANCER_DIFFERENTIATION_MARKERS"
12,"Down",0.247225559839804,0.590968491290219,"B.LvsV.REACTOME_SEROTONIN_RECEPTORS"
117,"Up",0.247348560401825,0.591006996742303,"B.LvsV.LINDSTEDT_DENDRITIC_CELL_MATURATION_D"
26,"Up",0.247496517758724,0.591105074163277,"B.LvsV.VISALA_AGING_LYMPHOCYTE_DN"
53,"Up",0.247730379204838,0.591408146210513,"B.LvsV.BIOCARTA_P38MAPK_PATHWAY"
21,"Up",0.248299745694274,0.592511564067173,"B.LvsV.SILIGAN_TARGETS_OF_EWS_FLI1_FUSION_UP"
28,"Up",0.248736199141398,0.593198630291256,"B.LvsV.HASEGAWA_TUMORIGENESIS_BY_RET_C634R"
207,"Down",0.248802246996821,0.593198630291256,"B.LvsV.GOLDRATH_HOMEOSTATIC_PROLIFERATION"
19,"Down",0.249175151339141,0.593821119136168,"B.LvsV.REACTOME_TRANSPORT_OF_CONNEXONS_TO_THE_PLASMA_MEMBRANE"
49,"Down",0.249310521288515,0.593821119136168,"B.LvsV.GENTILE_UV_RESPONSE_CLUSTER_D6"
266,"Up",0.249446801613071,0.593821119136168,"B.LvsV.MIKKELSEN_IPS_LCP_WITH_H3K4ME3"
14,"Down",0.249566675835798,0.593821119136168,"B.LvsV.SMID_BREAST_CANCER_RELAPSE_IN_LIVER_DN"
221,"Up",0.249701847403339,0.593821119136168,"B.LvsV.REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION"
833,"Down",0.249897178777268,0.593821119136168,"B.LvsV.RODWELL_AGING_KIDNEY_UP"
145,"Up",0.250001181127007,0.593821119136168,"B.LvsV.ELVIDGE_HIF1A_TARGETS_DN"
12,"Up",0.250261379643723,0.593821119136168,"B.LvsV.REACTOME_P2Y_RECEPTORS"
94,"Up",0.250299222539885,0.593821119136168,"B.LvsV.ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_DN"
16,"Down",0.250357928375009,0.593821119136168,"B.LvsV.CHESLER_BRAIN_D6MIT150_QTL_TRANS"
303,"Down",0.250479965290466,0.593821119136168,"B.LvsV.PROVENZANI_METASTASIS_UP"
27,"Up",0.25052038267002,0.593821119136168,"B.LvsV.REACTOME_RAS_ACTIVATION_UPON_CA2_INFLUX_THROUGH_NMDA_RECEPTOR"
19,"Down",0.250565274673666,0.593821119136168,"B.LvsV.KEGG_ONE_CARBON_POOL_BY_FOLATE"
66,"Up",0.250782047818741,0.593821119136168,"B.LvsV.RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_UP"
92,"Down",0.250852788538336,0.593821119136168,"B.LvsV.REACTOME_RMTS_METHYLATE_HISTONE_ARGININES"
79,"Down",0.250889043240586,0.593821119136168,"B.LvsV.MEDINA_SMARCA4_TARGETS"
26,"Up",0.250889154332083,0.593821119136168,"B.LvsV.BIOCARTA_PTEN_PATHWAY"
33,"Up",0.251104174539705,0.594075730008571,"B.LvsV.PID_P38_ALPHA_BETA_PATHWAY"
797,"Up",0.251222793898377,0.594102150326828,"B.LvsV.KIM_ALL_DISORDERS_CALB1_CORR_UP"
56,"Down",0.251459346587388,0.594407322480404,"B.LvsV.THEODOROU_MAMMARY_TUMORIGENESIS"
388,"Up",0.251594410830202,0.594472434820592,"B.LvsV.MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_DN"
7,"Up",0.251921240861144,0.594665766493174,"B.LvsV.REACTOME_PHASE_1_INACTIVATION_OF_FAST_NA_CHANNELS"
18,"Down",0.251953824537114,0.594665766493174,"B.LvsV.BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_24HR_UP"
118,"Down",0.25199889507931,0.594665766493174,"B.LvsV.GENTILE_UV_LOW_DOSE_DN"
60,"Up",0.252954763690568,0.596524601210187,"B.LvsV.PID_ER_NONGENOMIC_PATHWAY"
237,"Down",0.253029718462826,0.596524601210187,"B.LvsV.LENAOUR_DENDRITIC_CELL_MATURATION_DN"
17,"Up",0.253110275716965,0.596524601210187,"B.LvsV.REACTOME_ACTIVATION_OF_RAC1"
28,"Up",0.253292680131015,0.596700139942216,"B.LvsV.REACTOME_DOPAMINE_NEUROTRANSMITTER_RELEASE_CYCLE"
6,"Up",0.253478135416154,0.596882713252093,"B.LvsV.REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_LINKED_TO_TRIGLYCERIDE_LIPOLYSIS_IN_ADIPOSE"
185,"Down",0.253709815609668,0.597058296433769,"B.LvsV.REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS"
867,"Down",0.253768673651538,0.597058296433769,"B.LvsV.NABA_MATRISOME_ASSOCIATED"
20,"Down",0.253958776338981,0.597251414027318,"B.LvsV.FERRANDO_LYL1_NEIGHBORS"
287,"Up",0.254198785038482,0.597561684726942,"B.LvsV.KYNG_DNA_DAMAGE_DN"
11,"Up",0.254909864827264,0.598962026386347,"B.LvsV.REACTOME_BICARBONATE_TRANSPORTERS"
27,"Down",0.255011143084366,0.598962026386347,"B.LvsV.REACTOME_CD163_MEDIATING_AN_ANTI_INFLAMMATORY_RESPONSE"
22,"Down",0.255134282985917,0.598996794322351,"B.LvsV.LANDIS_ERBB2_BREAST_PRENEOPLASTIC_UP"
465,"Down",0.255251784748869,0.599018301305814,"B.LvsV.GRESHOCK_CANCER_COPY_NUMBER_UP"
8,"Up",0.255616847632155,0.599620513601265,"B.LvsV.REACTOME_MRNA_EDITING"
94,"Up",0.255939965450059,0.600123863008216,"B.LvsV.BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_UP"
13,"Down",0.256118642068935,0.600288245866529,"B.LvsV.REACTOME_BINDING_OF_TCF_LEF_CTNNB1_TO_TARGET_GENE_PROMOTERS"
13,"Up",0.25630167579701,0.600462697237994,"B.LvsV.BIOCARTA_MELANOCYTE_PATHWAY"
53,"Up",0.256678138969134,0.601089974739663,"B.LvsV.FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN"
24,"Up",0.256860438763659,0.601097601012313,"B.LvsV.JI_CARCINOGENESIS_BY_KRAS_AND_STK11_UP"
32,"Up",0.256898830022083,0.601097601012313,"B.LvsV.REACTOME_EPHRIN_SIGNALING"
34,"Down",0.257845053882914,0.603056388713465,"B.LvsV.RUNNE_GENDER_EFFECT_UP"
157,"Up",0.258290564823639,0.603842931462959,"B.LvsV.BURTON_ADIPOGENESIS_5"
30,"Down",0.258450237765185,0.603960847254316,"B.LvsV.WAGNER_APO2_SENSITIVITY"
19,"Down",0.258893627533695,0.604572569117914,"B.LvsV.KINNEY_DNMT1_METHYLATION_TARGETS"
18,"Up",0.258930700609734,0.604572569117914,"B.LvsV.PID_DNA_PK_PATHWAY"
14,"Down",0.259454964149065,0.605540944187496,"B.LvsV.REACTOME_POU5F1_OCT4_SOX2_NANOG_REPRESS_GENES_RELATED_TO_DIFFERENTIATION"
12,"Up",0.259930854719554,0.606395652212833,"B.LvsV.BIOCARTA_SARS_PATHWAY"
37,"Down",0.260157206664976,0.606667733298463,"B.LvsV.REACTOME_DECTIN_2_FAMILY"
152,"Down",0.260280033769077,0.606698274329353,"B.LvsV.LEIN_MIDBRAIN_MARKERS"
74,"Up",0.260494980279489,0.606943424342728,"B.LvsV.DAVIES_MULTIPLE_MYELOMA_VS_MGUS_DN"
28,"Up",0.260654768668147,0.607059905630239,"B.LvsV.BIOCARTA_ATM_PATHWAY"
74,"Up",0.26114659127419,0.607949264486313,"B.LvsV.FRASOR_TAMOXIFEN_RESPONSE_UP"
48,"Up",0.261262237499657,0.607962504686701,"B.LvsV.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_UP"
22,"Down",0.262403222361911,0.61018352987413,"B.LvsV.REACTOME_FGFR2_LIGAND_BINDING_AND_ACTIVATION"
32,"Up",0.262437408942066,0.61018352987413,"B.LvsV.LANDIS_ERBB2_BREAST_TUMORS_65_UP"
134,"Down",0.262597968427258,0.610219380690197,"B.LvsV.HINATA_NFKB_TARGETS_FIBROBLAST_UP"
119,"Down",0.26288976676649,0.610219380690197,"B.LvsV.REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT"
9,"Down",0.262927630573875,0.610219380690197,"B.LvsV.REACTOME_RRNA_MODIFICATION_IN_THE_MITOCHONDRION"
134,"Up",0.263300420180584,0.610219380690197,"B.LvsV.DELASERNA_MYOD_TARGETS_UP"
493,"Up",0.263411128981329,0.610219380690197,"B.LvsV.CHANDRAN_METASTASIS_DN"
75,"Down",0.263419742126707,0.610219380690197,"B.LvsV.REACTOME_REGULATION_OF_RAS_BY_GAPS"
40,"Up",0.26353140665903,0.610219380690197,"B.LvsV.REACTOME_ROS_AND_RNS_PRODUCTION_IN_PHAGOCYTES"
46,"Up",0.263611119087243,0.610219380690197,"B.LvsV.REACTOME_PLASMA_LIPOPROTEIN_CLEARANCE"
180,"Down",0.263639887144518,0.610219380690197,"B.LvsV.WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_UP"
17,"Up",0.263742212572369,0.610219380690197,"B.LvsV.TURASHVILI_BREAST_NORMAL_DUCTAL_VS_LOBULAR_DN"
58,"Down",0.263848802342447,0.610219380690197,"B.LvsV.KEGG_LINOLEIC_ACID_METABOLISM"
20,"Up",0.26385441903797,0.610219380690197,"B.LvsV.PID_TCR_JNK_PATHWAY"
81,"Up",0.263887599788436,0.610219380690197,"B.LvsV.REACTOME_COSTIMULATION_BY_THE_CD28_FAMILY"
37,"Down",0.264271302260494,0.610505839585968,"B.LvsV.DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_UP"
231,"Down",0.264348193617647,0.610505839585968,"B.LvsV.REACTOME_MITOTIC_G2_G2_M_PHASES"
167,"Down",0.264521992856395,0.610505839585968,"B.LvsV.SMID_BREAST_CANCER_RELAPSE_IN_BONE_UP"
22,"Up",0.264525927363757,0.610505839585968,"B.LvsV.BOYAULT_LIVER_CANCER_SUBCLASS_G12_DN"
20,"Down",0.264586430315835,0.610505839585968,"B.LvsV.REACTOME_ERYTHROCYTES_TAKE_UP_CARBON_DIOXIDE_AND_RELEASE_OXYGEN"
30,"Down",0.264673991225821,0.610505839585968,"B.LvsV.MATZUK_SPERMATOGONIA"
17,"Down",0.265091734157938,0.611214427922953,"B.LvsV.REACTOME_DISSOLUTION_OF_FIBRIN_CLOT"
51,"Up",0.265308594674571,0.611459449752272,"B.LvsV.VALK_AML_CLUSTER_13"
10,"Up",0.265620017565711,0.611922115467006,"B.LvsV.REACTOME_METABOLISM_OF_INGESTED_SEMET_SEC_MESEC_INTO_H2SE"
96,"Down",0.265810540662515,0.612105988889232,"B.LvsV.REACTOME_ABC_TRANSPORTER_DISORDERS"
140,"Up",0.266024866968534,0.612344500195263,"B.LvsV.BILBAN_B_CLL_LPL_UP"
11,"Up",0.266445277096399,0.613056985878481,"B.LvsV.REACTOME_ACTIVATED_NTRK3_SIGNALS_THROUGH_RAS"
26,"Down",0.266979803637752,0.614015182315684,"B.LvsV.SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_UP"
8,"Down",0.267115913976249,0.614015182315684,"B.LvsV.RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_MAPK1_DN"
10,"Down",0.26735807678451,0.614015182315684,"B.LvsV.GALI_TP53_TARGETS_APOPTOTIC_DN"
226,"Down",0.267458485791251,0.614015182315684,"B.LvsV.REACTOME_SUMOYLATION"
16,"Down",0.267585996674559,0.614015182315684,"B.LvsV.KORKOLA_EMBRYONAL_CARCINOMA"
141,"Down",0.267597283880723,0.614015182315684,"B.LvsV.HINATA_NFKB_TARGETS_KERATINOCYTE_UP"
30,"Up",0.267639100991282,0.614015182315684,"B.LvsV.REACTOME_ZBP1_DAI_MEDIATED_INDUCTION_OF_TYPE_I_IFNS"
25,"Up",0.268426160027414,0.615458412136126,"B.LvsV.KANG_FLUOROURACIL_RESISTANCE_DN"
43,"Down",0.268490810286188,0.615458412136126,"B.LvsV.BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_UP"
63,"Down",0.268637353246243,0.61553913224139,"B.LvsV.KORKOLA_SEMINOMA_UP"
49,"Down",0.268758260253988,0.61556106915671,"B.LvsV.LU_TUMOR_ENDOTHELIAL_MARKERS_UP"
194,"Up",0.268917023200285,0.615584278617852,"B.LvsV.FIGUEROA_AML_METHYLATION_CLUSTER_6_UP"
246,"Up",0.268991068392247,0.615584278617852,"B.LvsV.SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP"
73,"Up",0.269266695398906,0.615960098825217,"B.LvsV.CHESLER_BRAIN_HIGHEST_GENETIC_VARIANCE"
1007,"Down",0.269602537942633,0.616331820679961,"B.LvsV.MARTINEZ_RB1_AND_TP53_TARGETS_DN"
92,"Down",0.269652138582895,0.616331820679961,"B.LvsV.MALONEY_RESPONSE_TO_17AAG_UP"
25,"Down",0.270277250672386,0.616960243462748,"B.LvsV.REACTOME_ACYL_CHAIN_REMODELLING_OF_PS"
122,"Up",0.270294392931076,0.616960243462748,"B.LvsV.BOYLAN_MULTIPLE_MYELOMA_D_DN"
145,"Down",0.27041318814994,0.616960243462748,"B.LvsV.MARCHINI_TRABECTEDIN_RESISTANCE_DN"
917,"Up",0.270479432885432,0.616960243462748,"B.LvsV.CHICAS_RB1_TARGETS_CONFLUENT"
103,"Up",0.270590542114844,0.616960243462748,"B.LvsV.LINDVALL_IMMORTALIZED_BY_TERT_UP"
455,"Up",0.27079611993578,0.616960243462748,"B.LvsV.SENESE_HDAC1_TARGETS_DN"
8,"Down",0.270819134150637,0.616960243462748,"B.LvsV.SA_G2_AND_M_PHASES"
140,"Down",0.270819770461944,0.616960243462748,"B.LvsV.DUAN_PRDM5_TARGETS"
60,"Down",0.271041233891864,0.617210453948978,"B.LvsV.REACTOME_DEGRADATION_OF_AXIN"
56,"Up",0.27131392565769,0.617567120478065,"B.LvsV.KEGG_FATTY_ACID_METABOLISM"
7,"Down",0.271421252082058,0.617567120478065,"B.LvsV.REACTOME_SUMO_IS_TRANSFERRED_FROM_E1_TO_E2_UBE2I_UBC9"
30,"Up",0.271773932457606,0.61781115092118,"B.LvsV.LUI_THYROID_CANCER_CLUSTER_5"
33,"Up",0.271796672155906,0.61781115092118,"B.LvsV.BOYERINAS_ONCOFETAL_TARGETS_OF_LET7A1"
15,"Down",0.27186372403531,0.61781115092118,"B.LvsV.REACTOME_HYALURONAN_UPTAKE_AND_DEGRADATION"
16,"Up",0.272004963804928,0.617878161412262,"B.LvsV.REACTOME_UPTAKE_AND_FUNCTION_OF_ANTHRAX_TOXINS"
56,"Down",0.272518831330464,0.618584266662734,"B.LvsV.KEGG_HEDGEHOG_SIGNALING_PATHWAY"
9,"Down",0.272604679864843,0.618584266662734,"B.LvsV.REACTOME_MODULATION_BY_MTB_OF_HOST_IMMUNE_SYSTEM"
18,"Up",0.272651448337327,0.618584266662734,"B.LvsV.REACTOME_PECAM1_INTERACTIONS"
208,"Down",0.272981058657821,0.619000938488353,"B.LvsV.PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN"
59,"Up",0.273075394700006,0.619000938488353,"B.LvsV.CAFFAREL_RESPONSE_TO_THC_UP"
8,"Up",0.273202351269407,0.619000938488353,"B.LvsV.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_6"
162,"Down",0.273282924733238,0.619000938488353,"B.LvsV.BASSO_CD40_SIGNALING_UP"
65,"Up",0.273793267691881,0.619902939012453,"B.LvsV.CHIARETTI_T_ALL_REFRACTORY_TO_THERAPY"
18,"Up",0.273984147244339,0.620081191205056,"B.LvsV.REACTOME_GLYCOGEN_SYNTHESIS"
588,"Up",0.274461125695772,0.620894507668301,"B.LvsV.YOSHIMURA_MAPK8_TARGETS_DN"
8,"Down",0.274688769291682,0.620894507668301,"B.LvsV.TSAI_DNAJB4_TARGETS_DN"
1485,"Up",0.274935226819624,0.620894507668301,"B.LvsV.NUYTTEN_EZH2_TARGETS_UP"
289,"Up",0.274993759830344,0.620894507668301,"B.LvsV.KRIEG_KDM3A_TARGETS_NOT_HYPOXIA"
22,"Down",0.275248874508726,0.620894507668301,"B.LvsV.VETTER_TARGETS_OF_PRKCA_AND_ETS1_UP"
11,"Up",0.275620601856372,0.620894507668301,"B.LvsV.WALLACE_PROSTATE_CANCER_DN"
35,"Up",0.27581068667345,0.620894507668301,"B.LvsV.SEIDEN_MET_SIGNALING"
9,"Down",0.275982545522587,0.620894507668301,"B.LvsV.REACTOME_RUNX3_REGULATES_IMMUNE_RESPONSE_AND_CELL_MIGRATION"
21,"Down",0.276029309550953,0.620894507668301,"B.LvsV.REACTOME_NRIF_SIGNALS_CELL_DEATH_FROM_THE_NUCLEUS"
6,"Up",0.276086612162954,0.620894507668301,"B.LvsV.REACTOME_SYNTHESIS_OF_PI"
48,"Up",0.276099488030754,0.620894507668301,"B.LvsV.REACTOME_VASOPRESSIN_REGULATES_RENAL_WATER_HOMEOSTASIS_VIA_AQUAPORINS"
81,"Down",0.276117572260211,0.620894507668301,"B.LvsV.RASHI_RESPONSE_TO_IONIZING_RADIATION_1"
195,"Down",0.276138699886394,0.620894507668301,"B.LvsV.REACTOME_ESTROGEN_DEPENDENT_GENE_EXPRESSION"
90,"Up",0.276240987325379,0.620894507668301,"B.LvsV.GOTTWEIN_TARGETS_OF_KSHV_MIR_K12_11"
16,"Down",0.276300144193702,0.620894507668301,"B.LvsV.BIOCARTA_P27_PATHWAY"
31,"Down",0.276438180690921,0.620894507668301,"B.LvsV.ALONSO_METASTASIS_NEURAL_UP"
28,"Down",0.276448281837544,0.620894507668301,"B.LvsV.REACTOME_MECP2_REGULATES_NEURONAL_RECEPTORS_AND_CHANNELS"
9,"Down",0.276458954258584,0.620894507668301,"B.LvsV.TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_GRANULOCYTE_DN"
18,"Down",0.276477170895163,0.620894507668301,"B.LvsV.RANKIN_ANGIOGENIC_TARGETS_OF_VHL_HIF2A_DN"
61,"Down",0.27670491763683,0.62115367016404,"B.LvsV.GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP"
48,"Up",0.277031563756295,0.62163454383464,"B.LvsV.BONOME_OVARIAN_CANCER_POOR_SURVIVAL_UP"
12,"Up",0.277319966452607,0.621734596698676,"B.LvsV.REACTOME_ACTIVATED_NTRK2_SIGNALS_THROUGH_RAS"
30,"Up",0.277362779088798,0.621734596698676,"B.LvsV.REACTOME_BUDDING_AND_MATURATION_OF_HIV_VIRION"
7,"Up",0.277440798519328,0.621734596698676,"B.LvsV.REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_LINKED_TO_GLUCONEOGENESIS"
317,"Down",0.27752595128456,0.621734596698676,"B.LvsV.FISCHER_G1_S_CELL_CYCLE"
7,"Up",0.277892758220089,0.62202460437968,"B.LvsV.WEBER_METHYLATED_HCP_IN_FIBROBLAST_UP"
73,"Up",0.278105313330672,0.62202460437968,"B.LvsV.ELLWOOD_MYC_TARGETS_DN"
21,"Down",0.278107759799093,0.62202460437968,"B.LvsV.REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_24_HYDROXYCHOLESTEROL"
9,"Down",0.27816644460972,0.62202460437968,"B.LvsV.REACTOME_ADRENOCEPTORS"
39,"Up",0.278217914022599,0.62202460437968,"B.LvsV.MCCABE_HOXC6_TARGETS_DN"
303,"Up",0.278528763392186,0.622467879060386,"B.LvsV.FIGUEROA_AML_METHYLATION_CLUSTER_3_UP"
31,"Down",0.278912792658051,0.623005472564058,"B.LvsV.TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_TOP20_UP"
117,"Up",0.279101338067376,0.623005472564058,"B.LvsV.BHAT_ESR1_TARGETS_VIA_AKT1_DN"
249,"Down",0.279107353145446,0.623005472564058,"B.LvsV.RAMALHO_STEMNESS_UP"
63,"Up",0.279886431823665,0.624492365437063,"B.LvsV.REACTOME_G_PROTEIN_MEDIATED_EVENTS"
11,"Down",0.280221211857034,0.624987123984485,"B.LvsV.REACTOME_ACTIVATION_OF_CASPASES_THROUGH_APOPTOSOME_MEDIATED_CLEAVAGE"
1060,"Down",0.280590877767532,0.625291885064274,"B.LvsV.MARTINEZ_TP53_TARGETS_DN"
14,"Up",0.280690123482058,0.625291885064274,"B.LvsV.REACTOME_SUMOYLATION_OF_IMMUNE_RESPONSE_PROTEINS"
166,"Down",0.280697134876022,0.625291885064274,"B.LvsV.LIU_PROSTATE_CANCER_UP"
35,"Down",0.280995916059017,0.625705364434275,"B.LvsV.AMIT_EGF_RESPONSE_240_MCF10A"
14,"Down",0.281241650817074,0.626000437748633,"B.LvsV.REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_SEVERAL_ADDITIONAL_CELL_DEATH_GENES_WHOSE_SPECIFIC_ROLES_IN_P53_DEPENDENT_APOPTOSIS_REMAIN_UNCERTAIN"
82,"Up",0.281508337192046,0.626252991680502,"B.LvsV.PID_SHP2_PATHWAY"
189,"Up",0.281581648999408,0.626252991680502,"B.LvsV.ROESSLER_LIVER_CANCER_METASTASIS_UP"
15,"Down",0.281806686691722,0.626501475962417,"B.LvsV.REACTOME_PTK6_REGULATES_RTKS_AND_THEIR_EFFECTORS_AKT1_AND_DOK1"
11,"Down",0.282155999737669,0.627025933500631,"B.LvsV.REACTOME_ARYL_HYDROCARBON_RECEPTOR_SIGNALLING"
19,"Down",0.282447706119358,0.627422003669719,"B.LvsV.NIKOLSKY_BREAST_CANCER_12Q24_AMPLICON"
588,"Up",0.282604838915135,0.627518937494691,"B.LvsV.MOOTHA_PGC"
324,"Down",0.282786952836763,0.62767124136269,"B.LvsV.SERVITJA_LIVER_HNF1A_TARGETS_DN"
33,"Down",0.283634070343175,0.629069570777653,"B.LvsV.GAZIN_EPIGENETIC_SILENCING_BY_KRAS"
18,"Down",0.28369278237736,0.629069570777653,"B.LvsV.BIOCARTA_AHSP_PATHWAY"
1586,"Up",0.283758276274094,0.629069570777653,"B.LvsV.BRUINS_UVC_RESPONSE_LATE"
26,"Down",0.284219818266664,0.629840230539634,"B.LvsV.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_UP"
75,"Down",0.285075810147751,0.631006675192666,"B.LvsV.LEE_CALORIE_RESTRICTION_MUSCLE_DN"
38,"Down",0.285284859600623,0.631006675192666,"B.LvsV.PID_CDC42_REG_PATHWAY"
9,"Up",0.285299858867007,0.631006675192666,"B.LvsV.CHEMELLO_SOLEUS_VS_EDL_MYOFIBERS_DN"
73,"Down",0.28537899765126,0.631006675192666,"B.LvsV.ZWANG_CLASS_2_TRANSIENTLY_INDUCED_BY_EGF"
34,"Up",0.285391932799954,0.631006675192666,"B.LvsV.REACTOME_MITOPHAGY"
57,"Up",0.28543094495512,0.631006675192666,"B.LvsV.REACTOME_EPH_EPHRIN_MEDIATED_REPULSION_OF_CELLS"
101,"Down",0.285669309644366,0.631108192794428,"B.LvsV.ZHOU_TNF_SIGNALING_30MIN"
173,"Down",0.285705155826452,0.631108192794428,"B.LvsV.HUANG_GATA2_TARGETS_DN"
76,"Up",0.286212780180069,0.631535295677545,"B.LvsV.HAHTOLA_MYCOSIS_FUNGOIDES_UP"
56,"Down",0.286234994259453,0.631535295677545,"B.LvsV.KEGG_GLUTATHIONE_METABOLISM"
154,"Up",0.28624117398588,0.631535295677545,"B.LvsV.REN_ALVEOLAR_RHABDOMYOSARCOMA_UP"
20,"Up",0.286661211829461,0.632209748785436,"B.LvsV.TERAMOTO_OPN_TARGETS_CLUSTER_1"
18,"Up",0.286916065988719,0.632519509111494,"B.LvsV.REACTOME_FORMATION_OF_ATP_BY_CHEMIOSMOTIC_COUPLING"
323,"Down",0.28714345092881,0.632768489511913,"B.LvsV.DURAND_STROMA_NS_UP"
67,"Up",0.287259754253347,0.63277258217799,"B.LvsV.CHESLER_BRAIN_HIGHEST_EXPRESSION"
478,"Down",0.287434272131639,0.63290485488484,"B.LvsV.DAZARD_RESPONSE_TO_UV_NHEK_UP"
114,"Up",0.288175961316727,0.63428538619434,"B.LvsV.REACTOME_TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE"
37,"Down",0.288540970469622,0.634462181072097,"B.LvsV.HOFMANN_MYELODYSPLASTIC_SYNDROM_RISK_UP"
34,"Down",0.288577240507317,0.634462181072097,"B.LvsV.SYED_ESTRADIOL_RESPONSE"
83,"Down",0.288650166240211,0.634462181072097,"B.LvsV.PARENT_MTOR_SIGNALING_DN"
33,"Down",0.288715291658057,0.634462181072097,"B.LvsV.OZEN_MIR125B1_TARGETS"
587,"Up",0.288898643468233,0.634612872362281,"B.LvsV.DELACROIX_RARG_BOUND_MEF"
23,"Up",0.289161339741312,0.634927107426724,"B.LvsV.KEGG_NITROGEN_METABOLISM"
51,"Up",0.289445359591656,0.634927107426724,"B.LvsV.KASLER_HDAC7_TARGETS_2_DN"
89,"Up",0.289510924728572,0.634927107426724,"B.LvsV.ZHAN_MULTIPLE_MYELOMA_MS_DN"
99,"Down",0.289719733795375,0.634927107426724,"B.LvsV.NUTT_GBM_VS_AO_GLIOMA_UP"
145,"Up",0.28973695390306,0.634927107426724,"B.LvsV.YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_12"
22,"Down",0.289992537374451,0.634927107426724,"B.LvsV.REACTOME_POST_CHAPERONIN_TUBULIN_FOLDING_PATHWAY"
35,"Up",0.290138718011358,0.634927107426724,"B.LvsV.PID_PDGFRA_PATHWAY"
112,"Up",0.290138948764969,0.634927107426724,"B.LvsV.REACTOME_DNA_DOUBLE_STRAND_BREAK_RESPONSE"
493,"Up",0.290243150690674,0.634927107426724,"B.LvsV.ROZANOV_MMP14_TARGETS_UP"
27,"Up",0.290294247547143,0.634927107426724,"B.LvsV.BIOCARTA_CERAMIDE_PATHWAY"
154,"Up",0.290356808461955,0.634927107426724,"B.LvsV.LEE_AGING_CEREBELLUM_DN"
19,"Down",0.290431357724703,0.634927107426724,"B.LvsV.BIOCARTA_ACH_PATHWAY"
64,"Down",0.290534559918541,0.634927107426724,"B.LvsV.REACTOME_REGULATION_OF_RUNX3_EXPRESSION_AND_ACTIVITY"
317,"Down",0.291023330996382,0.635649255430273,"B.LvsV.TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP"
118,"Up",0.291200477118432,0.635649255430273,"B.LvsV.ANASTASSIOU_MULTICANCER_INVASIVENESS_SIGNATURE"
492,"Down",0.291209904866139,0.635649255430273,"B.LvsV.WANG_MLL_TARGETS"
27,"Down",0.291359639136709,0.635696045698048,"B.LvsV.KEGG_HOMOLOGOUS_RECOMBINATION"
105,"Up",0.291461290621188,0.635696045698048,"B.LvsV.HUTTMANN_B_CLL_POOR_SURVIVAL_DN"
18,"Up",0.291933273471082,0.636474396301897,"B.LvsV.ROZANOV_MMP14_CORRELATED"
356,"Down",0.292435684466578,0.637265765646632,"B.LvsV.LEE_RECENT_THYMIC_EMIGRANT"
9,"Up",0.292630295666736,0.637265765646632,"B.LvsV.CASTELLANO_HRAS_TARGETS_UP"
29,"Up",0.292642029114993,0.637265765646632,"B.LvsV.KEGG_ASCORBATE_AND_ALDARATE_METABOLISM"
47,"Down",0.292883931598828,0.637541440082645,"B.LvsV.KEGG_PRIMARY_IMMUNODEFICIENCY"
92,"Up",0.293212772433128,0.638006067997939,"B.LvsV.LEE_LIVER_CANCER_CIPROFIBRATE_UP"
19,"Down",0.293993431633868,0.639453061960525,"B.LvsV.YANG_BCL3_TARGETS_DN"
459,"Up",0.294612583464885,0.640547767981655,"B.LvsV.LU_AGING_BRAIN_UP"
100,"Up",0.294884902889379,0.640887825501328,"B.LvsV.FIGUEROA_AML_METHYLATION_CLUSTER_3_DN"
34,"Up",0.295171692453774,0.641259052093091,"B.LvsV.REACTOME_VEGFR2_MEDIATED_VASCULAR_PERMEABILITY"
386,"Down",0.295341722646554,0.641261742975273,"B.LvsV.KONDO_PROSTATE_CANCER_WITH_H3K27ME3"
357,"Up",0.295515567071889,0.641261742975273,"B.LvsV.REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION"
259,"Down",0.295520875583468,0.641261742975273,"B.LvsV.BROWNE_HCMV_INFECTION_30MIN_DN"
233,"Up",0.295762840602373,0.641442527671413,"B.LvsV.CHEBOTAEV_GR_TARGETS_DN"
168,"Up",0.295836217319968,0.641442527671413,"B.LvsV.LINDGREN_BLADDER_CANCER_CLUSTER_1_UP"
225,"Up",0.296224077179812,0.642031721962831,"B.LvsV.BIDUS_METASTASIS_DN"
186,"Down",0.296381763294002,0.642121774785477,"B.LvsV.BROWNE_HCMV_INFECTION_12HR_DN"
20,"Down",0.296555030581428,0.642245501012423,"B.LvsV.MIKKELSEN_ES_LCP_WITH_H3K4ME3_AND_H3K27ME3"
15,"Down",0.29727027831722,0.643446532426515,"B.LvsV.CHESLER_BRAIN_D6MIT150_QTL_CIS"
77,"Down",0.297379198778669,0.643446532426515,"B.LvsV.REACTOME_CELL_CELL_JUNCTION_ORGANIZATION"
34,"Up",0.297458733384368,0.643446532426515,"B.LvsV.THUM_MIR21_TARGETS_HEART_DISEASE_UP"
14,"Up",0.297731139683632,0.643783915256473,"B.LvsV.BIOCARTA_CELL2CELL_PATHWAY"
1901,"Down",0.298148757710668,0.64433694738986,"B.LvsV.REACTOME_DISEASE"
251,"Down",0.29821997619292,0.64433694738986,"B.LvsV.GROSS_HYPOXIA_VIA_ELK3_DN"
9,"Down",0.29856115246506,0.64482211405442,"B.LvsV.BIOCARTA_CREM_PATHWAY"
47,"Up",0.298940697554215,0.644985603790307,"B.LvsV.KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_WS"
10,"Down",0.299055729140049,0.644985603790307,"B.LvsV.NIKOLSKY_BREAST_CANCER_10Q22_AMPLICON"
7,"Up",0.299104724235166,0.644985603790307,"B.LvsV.REACTOME_IKBA_VARIANT_LEADS_TO_EDA_ID"
24,"Up",0.299238509679999,0.644985603790307,"B.LvsV.KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_CHONDROITIN_SULFATE"
248,"Up",0.299325083986313,0.644985603790307,"B.LvsV.GOZGIT_ESR1_TARGETS_UP"
99,"Up",0.299381532783876,0.644985603790307,"B.LvsV.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_UP"
55,"Down",0.299533169845517,0.644985603790307,"B.LvsV.REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC"
39,"Up",0.299702327783458,0.644985603790307,"B.LvsV.REACTOME_TRIGLYCERIDE_METABOLISM"
10,"Up",0.29978082240951,0.644985603790307,"B.LvsV.KIM_ALL_DISORDERS_DURATION_CORR_UP"
30,"Up",0.299803400568111,0.644985603790307,"B.LvsV.REACTOME_KERATAN_SULFATE_BIOSYNTHESIS"
69,"Up",0.300078027035156,0.645325325350983,"B.LvsV.CERIBELLI_GENES_INACTIVE_AND_BOUND_BY_NFY"
6,"Up",0.300417490091201,0.645725736254762,"B.LvsV.REACTOME_MET_INTERACTS_WITH_TNS_PROTEINS"
22,"Up",0.300731344702683,0.645725736254762,"B.LvsV.ISHIKAWA_STING_SIGNALING"
424,"Up",0.300883362667465,0.645725736254762,"B.LvsV.DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP"
52,"Down",0.300888908556416,0.645725736254762,"B.LvsV.REACTOME_ATTENUATION_PHASE"
83,"Down",0.300938055499726,0.645725736254762,"B.LvsV.REACTOME_GLYCOLYSIS"
20,"Down",0.301025368909647,0.645725736254762,"B.LvsV.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_27"
27,"Down",0.301081741375435,0.645725736254762,"B.LvsV.BIOCARTA_GCR_PATHWAY"
24,"Down",0.301473832359253,0.64631594382098,"B.LvsV.BIOCARTA_ATRBRCA_PATHWAY"
325,"Down",0.301962732290117,0.64669210953196,"B.LvsV.LEE_DIFFERENTIATING_T_LYMPHOCYTE"
24,"Up",0.302056035451418,0.64669210953196,"B.LvsV.RUAN_RESPONSE_TO_TROGLITAZONE_DN"
25,"Up",0.302065216445414,0.64669210953196,"B.LvsV.KEGG_GLYCOSPHINGOLIPID_BIOSYNTHESIS_LACTO_AND_NEOLACTO_SERIES"
61,"Down",0.302216650072918,0.64669210953196,"B.LvsV.XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_UP"
112,"Up",0.302257179069026,0.64669210953196,"B.LvsV.BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_CIS"
37,"Up",0.302351076711904,0.64669210953196,"B.LvsV.TERAMOTO_OPN_TARGETS_CLUSTER_4"
25,"Up",0.30249689960992,0.64675381204302,"B.LvsV.HOLLEMAN_PREDNISOLONE_RESISTANCE_ALL_UP"
35,"Up",0.302746583335024,0.647037440765113,"B.LvsV.NIKOLSKY_OVERCONNECTED_IN_BREAST_CANCER"
139,"Up",0.303275414739541,0.647835990748801,"B.LvsV.GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP"
13,"Down",0.303354563220953,0.647835990748801,"B.LvsV.PETRETTO_BLOOD_PRESSURE_DN"
17,"Down",0.303487916253248,0.64784860394416,"B.LvsV.MARSHALL_VIRAL_INFECTION_RESPONSE_UP"
158,"Down",0.303594815123769,0.64784860394416,"B.LvsV.SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_UP"
10,"Down",0.303942207516717,0.648339685709848,"B.LvsV.BAKER_HEMATOPOESIS_STAT1_TARGETS"
107,"Down",0.304467313421219,0.648719674396422,"B.LvsV.FONTAINE_PAPILLARY_THYROID_CARCINOMA_UP"
113,"Up",0.304515540034074,0.648719674396422,"B.LvsV.LEIN_OLIGODENDROCYTE_MARKERS"
8,"Up",0.304539602792796,0.648719674396422,"B.LvsV.REACTOME_SIGNALING_BY_NOTCH1_T_7_9_NOTCH1_M1580_K2555_TRANSLOCATION_MUTANT"
352,"Down",0.3047346693885,0.648719674396422,"B.LvsV.REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL"
29,"Up",0.304929487377802,0.648719674396422,"B.LvsV.PID_HEDGEHOG_2PATHWAY"
28,"Up",0.304930574723207,0.648719674396422,"B.LvsV.REACTOME_TRAF6_MEDIATED_NF_KB_ACTIVATION"
13,"Up",0.305201172272538,0.648719674396422,"B.LvsV.KEGG_NON_HOMOLOGOUS_END_JOINING"
43,"Up",0.305278586132597,0.648719674396422,"B.LvsV.TCGA_GLIOBLASTOMA_COPY_NUMBER_DN"
58,"Up",0.30529099527375,0.648719674396422,"B.LvsV.COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_DN"
39,"Down",0.305354998369746,0.648719674396422,"B.LvsV.CHEOK_RESPONSE_TO_HD_MTX_DN"
17,"Up",0.305410980729587,0.648719674396422,"B.LvsV.SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_UP"
82,"Up",0.305970549629837,0.649658667013583,"B.LvsV.KEGG_GLYCEROPHOSPHOLIPID_METABOLISM"
521,"Down",0.306514798767103,0.650421176558965,"B.LvsV.WALLACE_PROSTATE_CANCER_RACE_UP"
59,"Up",0.306564945941881,0.650421176558965,"B.LvsV.GENTILE_UV_RESPONSE_CLUSTER_D7"
199,"Up",0.306831824657274,0.650542385295639,"B.LvsV.PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_DN"
7,"Up",0.306857395704653,0.650542385295639,"B.LvsV.REACTOME_VLDL_CLEARANCE"
59,"Up",0.307049208271855,0.650582469468696,"B.LvsV.WOOD_EBV_EBNA1_TARGETS_DN"
54,"Up",0.307219156456317,0.650582469468696,"B.LvsV.FARMER_BREAST_CANCER_CLUSTER_4"
10,"Down",0.307229305079176,0.650582469468696,"B.LvsV.GERHOLD_RESPONSE_TO_TZD_UP"
35,"Up",0.307672266222902,0.651066436415028,"B.LvsV.WU_HBX_TARGETS_3_UP"
51,"Up",0.307693361973679,0.651066436415028,"B.LvsV.PID_EPHRINB_REV_PATHWAY"
60,"Down",0.307972682973843,0.651296394114551,"B.LvsV.NOUSHMEHR_GBM_SILENCED_BY_METHYLATION"
17,"Up",0.308037632593516,0.651296394114551,"B.LvsV.WEBER_METHYLATED_ICP_IN_SPERM_UP"
1302,"Down",0.308387973122099,0.651787883559666,"B.LvsV.SMID_BREAST_CANCER_BASAL_UP"
830,"Up",0.30905456214036,0.652947143322143,"B.LvsV.GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN"
120,"Up",0.309400499191588,0.65342832697872,"B.LvsV.CHUNG_BLISTER_CYTOTOXICITY_DN"
269,"Down",0.309886858086953,0.654205589294679,"B.LvsV.LEE_NEURAL_CREST_STEM_CELL_UP"
45,"Down",0.310114099396143,0.654318326365143,"B.LvsV.MURATA_VIRULENCE_OF_H_PILORI"
11,"Up",0.310176945813536,0.654318326365143,"B.LvsV.MARIADASON_RESPONSE_TO_BUTYRATE_CURCUMIN_SULINDAC_TSA_8"
90,"Down",0.310574772934965,0.654907673362862,"B.LvsV.TENEDINI_MEGAKARYOCYTE_MARKERS"
137,"Up",0.311249770437283,0.655541495603423,"B.LvsV.GAVIN_FOXP3_TARGETS_CLUSTER_T4"
497,"Down",0.311249944481134,0.655541495603423,"B.LvsV.DACOSTA_UV_RESPONSE_VIA_ERCC3_UP"
153,"Up",0.311286511548899,0.655541495603423,"B.LvsV.DAZARD_RESPONSE_TO_UV_SCC_UP"
52,"Down",0.311385737012435,0.655541495603423,"B.LvsV.REACTOME_CYCLIN_D_ASSOCIATED_EVENTS_IN_G1"
30,"Down",0.311563716146307,0.655541495603423,"B.LvsV.AMIT_SERUM_RESPONSE_20_MCF10A"
25,"Down",0.311586733667172,0.655541495603423,"B.LvsV.BIOCARTA_IL7_PATHWAY"
140,"Down",0.312098568457664,0.656349987309354,"B.LvsV.HOEBEKE_LYMPHOID_STEM_CELL_DN"
11,"Up",0.31220844033706,0.656349987309354,"B.LvsV.SCHMAHL_PDGF_SIGNALING"
41,"Down",0.312541018312852,0.656799426169426,"B.LvsV.REACTOME_INFECTION_WITH_MYCOBACTERIUM_TUBERCULOSIS"
1060,"Up",0.312926041901546,0.657358695164759,"B.LvsV.MARTINEZ_RB1_AND_TP53_TARGETS_UP"
83,"Down",0.313587521345462,0.658498065142066,"B.LvsV.PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_DN"
156,"Up",0.314347776216465,0.659843908390597,"B.LvsV.ZWANG_EGF_INTERVAL_UP"
92,"Up",0.314889837356351,0.660730895917747,"B.LvsV.NIKOLSKY_BREAST_CANCER_8P12_P11_AMPLICON"
31,"Up",0.315754837107737,0.662294572977495,"B.LvsV.LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_QTL"
92,"Up",0.316059223181193,0.662537239708594,"B.LvsV.ZHU_CMV_8_HR_DN"
171,"Down",0.316167778630446,0.662537239708594,"B.LvsV.DOANE_BREAST_CANCER_ESR1_UP"
45,"Up",0.316230019097663,0.662537239708594,"B.LvsV.XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_UP"
160,"Down",0.316440153485244,0.662709994356292,"B.LvsV.TAKAO_RESPONSE_TO_UVB_RADIATION_DN"
161,"Down",0.316552196616923,0.662709994356292,"B.LvsV.REACTOME_HCMV_EARLY_EVENTS"
26,"Up",0.316908414705272,0.663073041091065,"B.LvsV.REACTOME_TRIGLYCERIDE_CATABOLISM"
10,"Up",0.317279561006823,0.663073041091065,"B.LvsV.REACTOME_NOSTRIN_MEDIATED_ENOS_TRAFFICKING"
51,"Up",0.317288980600484,0.663073041091065,"B.LvsV.PID_EPO_PATHWAY"
206,"Up",0.317321254770869,0.663073041091065,"B.LvsV.ROPERO_HDAC2_TARGETS"
123,"Up",0.317325242670819,0.663073041091065,"B.LvsV.LEE_LIVER_CANCER_ACOX1_UP"
8,"Up",0.317865783623723,0.663337853824966,"B.LvsV.REACTOME_METAL_SEQUESTRATION_BY_ANTIMICROBIAL_PROTEINS"
343,"Down",0.318074048961669,0.663337853824966,"B.LvsV.YEGNASUBRAMANIAN_PROSTATE_CANCER"
6,"Up",0.318093355899504,0.663337853824966,"B.LvsV.REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_TO_LIMIT_CHOLESTEROL_UPTAKE"
8,"Up",0.318116503778862,0.663337853824966,"B.LvsV.IWANAGA_E2F1_TARGETS_NOT_INDUCED_BY_SERUM"
279,"Down",0.318159934574575,0.663337853824966,"B.LvsV.PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_DN"
17,"Down",0.318236888697881,0.663337853824966,"B.LvsV.CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_LD_MTX_UP"
61,"Up",0.318367336627349,0.663337853824966,"B.LvsV.CHEOK_RESPONSE_TO_HD_MTX_UP"
32,"Down",0.318411767779248,0.663337853824966,"B.LvsV.WANG_LSD1_TARGETS_UP"
71,"Up",0.319074916921422,0.664469007780996,"B.LvsV.VERRECCHIA_RESPONSE_TO_TGFB1_C2"
66,"Down",0.319224663196293,0.664530558287765,"B.LvsV.FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN"
12,"Up",0.319420787030046,0.664688570376036,"B.LvsV.REACTOME_NETRIN_MEDIATED_REPULSION_SIGNALS"
48,"Up",0.320256398164199,0.666176683765935,"B.LvsV.JACKSON_DNMT1_TARGETS_DN"
12,"Down",0.320530355019828,0.666495800264997,"B.LvsV.REACTOME_NONCANONICAL_ACTIVATION_OF_NOTCH3"
9,"Up",0.320669606502495,0.666534682087328,"B.LvsV.GROSS_HYPOXIA_VIA_HIF1A_ONLY"
133,"Down",0.32088851619599,0.666739047744318,"B.LvsV.SU_LIVER"
73,"Up",0.321344731889284,0.667436146737736,"B.LvsV.HUANG_FOXA2_TARGETS_UP"
13,"Up",0.321477763892855,0.667461718574387,"B.LvsV.REACTOME_P38MAPK_EVENTS"
196,"Down",0.321901894541225,0.667885884152744,"B.LvsV.SU_TESTIS"
129,"Down",0.321923653692723,0.667885884152744,"B.LvsV.REACTOME_POSITIVE_EPIGENETIC_REGULATION_OF_RRNA_EXPRESSION"
296,"Down",0.32255922251842,0.668807327128515,"B.LvsV.SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP"
12,"Down",0.322609719922545,0.668807327128515,"B.LvsV.SIMBULAN_UV_RESPONSE_NORMAL_UP"
36,"Down",0.322760664568474,0.668869458170574,"B.LvsV.GENTILE_UV_RESPONSE_CLUSTER_D9"
7,"Down",0.323146815891391,0.669418787959348,"B.LvsV.PETRETTO_LEFT_VENTRICLE_MASS_QTL_CIS_UP"
56,"Up",0.323628087040245,0.670026621899479,"B.LvsV.KEGG_STARCH_AND_SUCROSE_METABOLISM"
674,"Down",0.323682602114941,0.670026621899479,"B.LvsV.ZHANG_BREAST_CANCER_PROGENITORS_UP"
43,"Up",0.323891441037593,0.670208000560199,"B.LvsV.REACTOME_REGULATION_OF_TNFR1_SIGNALING"
189,"Up",0.324602871860345,0.670623421574843,"B.LvsV.DURCHDEWALD_SKIN_CARCINOGENESIS_UP"
11,"Up",0.324608467198028,0.670623421574843,"B.LvsV.KIM_RESPONSE_TO_TSA_AND_DECITABINE_DN"
19,"Down",0.324611137820078,0.670623421574843,"B.LvsV.REACTOME_METABOLISM_OF_AMINE_DERIVED_HORMONES"
20,"Up",0.324620393549326,0.670623421574843,"B.LvsV.REACTOME_WNT5A_DEPENDENT_INTERNALIZATION_OF_FZD4"
18,"Down",0.324773851263269,0.670623421574843,"B.LvsV.REACTOME_DISEASES_ASSOCIATED_WITH_N_GLYCOSYLATION_OF_PROTEINS"
54,"Up",0.325066657166772,0.670623421574843,"B.LvsV.RIZ_ERYTHROID_DIFFERENTIATION_12HR"
163,"Down",0.325139003248852,0.670623421574843,"B.LvsV.RHEIN_ALL_GLUCOCORTICOID_THERAPY_UP"
8,"Up",0.325233067265417,0.670623421574843,"B.LvsV.MATZUK_STEROIDOGENESIS"
24,"Down",0.325263787979207,0.670623421574843,"B.LvsV.REACTOME_CONSTITUTIVE_SIGNALING_BY_EGFRVIII"
92,"Down",0.325305121480146,0.670623421574843,"B.LvsV.KEGG_TGF_BETA_SIGNALING_PATHWAY"
165,"Up",0.325702792743875,0.671182948022592,"B.LvsV.HATADA_METHYLATED_IN_LUNG_CANCER_DN"
18,"Up",0.325819322208833,0.671182948022592,"B.LvsV.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_1"
12,"Down",0.326091098492836,0.671492619577985,"B.LvsV.REACTOME_HYALURONAN_BIOSYNTHESIS_AND_EXPORT"
18,"Down",0.32635663830351,0.671789223075244,"B.LvsV.LOPEZ_MESOTHELIOMA_SURVIVAL_OVERALL_UP"
176,"Up",0.326711736794063,0.672201156042164,"B.LvsV.CADWELL_ATG16L1_TARGETS_UP"
19,"Up",0.326831378280269,0.672201156042164,"B.LvsV.VERRECCHIA_RESPONSE_TO_TGFB1_C6"
619,"Up",0.327108632581558,0.672201156042164,"B.LvsV.YAGI_AML_WITH_11Q23_REARRANGED"
1149,"Down",0.327140543666722,0.672201156042164,"B.LvsV.NABA_MATRISOME"
98,"Up",0.327164642957038,0.672201156042164,"B.LvsV.LIANG_SILENCED_BY_METHYLATION_UP"
17,"Down",0.327963295343409,0.673494821097779,"B.LvsV.REACTOME_REPRESSION_OF_WNT_TARGET_GENES"
130,"Down",0.328037900744496,0.673494821097779,"B.LvsV.REACTOME_PROCESSING_OF_DNA_DOUBLE_STRAND_BREAK_ENDS"
759,"Up",0.32911226227013,0.675028593238827,"B.LvsV.FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN"
153,"Up",0.32919300102315,0.675028593238827,"B.LvsV.CASTELLANO_NRAS_TARGETS_UP"
73,"Down",0.32930837077112,0.675028593238827,"B.LvsV.REACTOME_MITOCHONDRIAL_PROTEIN_IMPORT"
21,"Down",0.32945994285945,0.675028593238827,"B.LvsV.REACTOME_FRS_MEDIATED_FGFR3_SIGNALING"
15,"Down",0.329470365922691,0.675028593238827,"B.LvsV.BIOCARTA_SODD_PATHWAY"
10,"Down",0.329547295568102,0.675028593238827,"B.LvsV.REACTOME_SHC_RELATED_EVENTS_TRIGGERED_BY_IGF1R"
44,"Up",0.329639573475282,0.675028593238827,"B.LvsV.YANG_BREAST_CANCER_ESR1_LASER_UP"
7,"Up",0.33035097412583,0.675865301681677,"B.LvsV.CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_HD_MTX_UP"
29,"Down",0.330459694206584,0.675865301681677,"B.LvsV.LANDEMAINE_LUNG_METASTASIS"
162,"Down",0.330470436326693,0.675865301681677,"B.LvsV.REACTOME_GENE_SILENCING_BY_RNA"
24,"Down",0.330604666636078,0.675865301681677,"B.LvsV.HASINA_NOL7_TARGETS_DN"
36,"Up",0.330659367163852,0.675865301681677,"B.LvsV.REACTOME_DIGESTION"
66,"Down",0.33129639385291,0.676905995072234,"B.LvsV.EPPERT_CE_HSC_LSC"
38,"Down",0.33162600866877,0.676905995072234,"B.LvsV.HOLLEMAN_VINCRISTINE_RESISTANCE_ALL_UP"
41,"Down",0.331819024798265,0.676905995072234,"B.LvsV.GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_DN"
26,"Down",0.331821799981673,0.676905995072234,"B.LvsV.MATZUK_EMBRYONIC_GERM_CELL"
89,"Up",0.331901031658234,0.676905995072234,"B.LvsV.REACTOME_SIGNALING_BY_INSULIN_RECEPTOR"
11,"Up",0.332097938877424,0.676905995072234,"B.LvsV.BYSTRYKH_SCP2_QTL"
18,"Down",0.332177878345915,0.676905995072234,"B.LvsV.MARIADASON_RESPONSE_TO_CURCUMIN_SULINDAC_7"
42,"Up",0.332214067628832,0.676905995072234,"B.LvsV.REACTOME_SEMA4D_INDUCED_CELL_MIGRATION_AND_GROWTH_CONE_COLLAPSE"
17,"Down",0.33229515140761,0.676905995072234,"B.LvsV.REACTOME_MRNA_DECAY_BY_3_TO_5_EXORIBONUCLEASE"
195,"Up",0.332392797363197,0.676905995072234,"B.LvsV.FIGUEROA_AML_METHYLATION_CLUSTER_7_UP"
25,"Down",0.332644197660973,0.677166987751728,"B.LvsV.HONRADO_BREAST_CANCER_BRCA1_VS_BRCA2"
19,"Up",0.332765908070437,0.677166987751728,"B.LvsV.TSUTSUMI_FBXW8_TARGETS"
69,"Up",0.332935575661861,0.67726298669405,"B.LvsV.GENTILE_UV_HIGH_DOSE_UP"
41,"Up",0.333262432633919,0.677678554627782,"B.LvsV.WU_ALZHEIMER_DISEASE_UP"
29,"Up",0.333643769026509,0.678204558436606,"B.LvsV.REACTOME_INSERTION_OF_TAIL_ANCHORED_PROTEINS_INTO_THE_ENDOPLASMIC_RETICULUM_MEMBRANE"
42,"Down",0.334500767318836,0.679240221542625,"B.LvsV.REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES"
80,"Down",0.334506528516755,0.679240221542625,"B.LvsV.HU_GENOTOXIC_DAMAGE_24HR"
145,"Up",0.334521816469627,0.679240221542625,"B.LvsV.MORI_PRE_BI_LYMPHOCYTE_DN"
53,"Up",0.334736646781327,0.679426916319367,"B.LvsV.REACTOME_TNF_SIGNALING"
168,"Up",0.335169324872017,0.679673231368788,"B.LvsV.KANG_IMMORTALIZED_BY_TERT_UP"
59,"Up",0.335316544587335,0.679673231368788,"B.LvsV.GALLUZZI_PERMEABILIZE_MITOCHONDRIA"
202,"Down",0.335328278925881,0.679673231368788,"B.LvsV.HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN"
18,"Down",0.335349715169842,0.679673231368788,"B.LvsV.REACTOME_APOPTOTIC_CLEAVAGE_OF_CELL_ADHESION_PROTEINS"
106,"Up",0.335597401705551,0.679792143096927,"B.LvsV.KANNAN_TP53_TARGETS_UP"
14,"Down",0.335737678096549,0.679792143096927,"B.LvsV.CAFFAREL_RESPONSE_TO_THC_24HR_3_UP"
53,"Down",0.33577723689595,0.679792143096927,"B.LvsV.XU_HGF_SIGNALING_NOT_VIA_AKT1_6HR"
71,"Up",0.33616701230382,0.680332141664649,"B.LvsV.HUANG_FOXA2_TARGETS_DN"
75,"Down",0.336589961172329,0.680938856685622,"B.LvsV.REACTOME_CHEMOKINE_RECEPTORS_BIND_CHEMOKINES"
259,"Up",0.337106448585209,0.681734291963285,"B.LvsV.MIKKELSEN_MCV6_LCP_WITH_H3K4ME3"
28,"Up",0.337253231391523,0.681781761010506,"B.LvsV.HOLLEMAN_PREDNISOLONE_RESISTANCE_B_ALL_UP"
15,"Up",0.337503505311572,0.681988245171701,"B.LvsV.REACTOME_LIPOPHAGY"
28,"Down",0.337602066745333,0.681988245171701,"B.LvsV.KRISHNAN_FURIN_TARGETS_UP"
402,"Up",0.338172377098094,0.682576816261952,"B.LvsV.REACTOME_SIGNALING_BY_WNT"
20,"Down",0.338226636857764,0.682576816261952,"B.LvsV.REACTOME_ABACAVIR_TRANSPORT_AND_METABOLISM"
4,"Down",0.338263786680729,0.682576816261952,"B.LvsV.REACTOME_METALLOTHIONEINS_BIND_METALS"
633,"Up",0.338399565249153,0.682601676856099,"B.LvsV.HADDAD_B_LYMPHOCYTE_PROGENITOR"
6,"Down",0.33904716824959,0.683490719229529,"B.LvsV.REACTOME_PRE_NOTCH_PROCESSING_IN_THE_ENDOPLASMIC_RETICULUM"
211,"Down",0.339087546183143,0.683490719229529,"B.LvsV.REACTOME_INITIAL_TRIGGERING_OF_COMPLEMENT"
450,"Up",0.339957514586176,0.68493626993258,"B.LvsV.ZHOU_INFLAMMATORY_RESPONSE_FIMA_DN"
103,"Down",0.340052461740809,0.68493626993258,"B.LvsV.MARTIN_VIRAL_GPCR_SIGNALING_DN"
279,"Down",0.340349806839389,0.685285536057895,"B.LvsV.UEDA_PERIFERAL_CLOCK"
12,"Down",0.34050445850556,0.68533105123539,"B.LvsV.GILMORE_CORE_NFKB_PATHWAY"
151,"Down",0.340620316294963,0.68533105123539,"B.LvsV.COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP"
135,"Up",0.341031115361248,0.68585091511517,"B.LvsV.ANDERSEN_CHOLANGIOCARCINOMA_CLASS1"
25,"Down",0.34112678903359,0.68585091511517,"B.LvsV.BIOCARTA_CHEMICAL_PATHWAY"
21,"Down",0.341424433685669,0.686199816011656,"B.LvsV.FARMER_BREAST_CANCER_CLUSTER_3"
9,"Up",0.342298429279995,0.687458390653465,"B.LvsV.REACTOME_SOS_MEDIATED_SIGNALLING"
35,"Down",0.34231829651705,0.687458390653465,"B.LvsV.ZHAN_MULTIPLE_MYELOMA_SUBGROUPS"
35,"Down",0.342504738820967,0.687458390653465,"B.LvsV.HAHTOLA_MYCOSIS_FUNGOIDES_DN"
27,"Up",0.342547995342792,0.687458390653465,"B.LvsV.BIOCARTA_PML_PATHWAY"
19,"Down",0.343465338184913,0.688702701424619,"B.LvsV.BIOCARTA_IL4_PATHWAY"
18,"Down",0.34350093810526,0.688702701424619,"B.LvsV.PARK_TRETINOIN_RESPONSE"
40,"Down",0.343541698413655,0.688702701424619,"B.LvsV.GUTIERREZ_MULTIPLE_MYELOMA_UP"
35,"Down",0.343706328181953,0.688710046435743,"B.LvsV.TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_GRANULOCYTE_UP"
58,"Up",0.343803196992375,0.688710046435743,"B.LvsV.SCHLINGEMANN_SKIN_CARCINOGENESIS_TPA_DN"
8,"Up",0.343919051945937,0.688710046435743,"B.LvsV.REACTOME_COMPETING_ENDOGENOUS_RNAS_CERNAS_REGULATE_PTEN_TRANSLATION"
22,"Down",0.34417238092675,0.688726805698113,"B.LvsV.BIOCARTA_PRION_PATHWAY"
142,"Down",0.34428176070287,0.688726805698113,"B.LvsV.MAHAJAN_RESPONSE_TO_IL1A_UP"
25,"Down",0.344377946880861,0.688726805698113,"B.LvsV.VICENT_METASTASIS_UP"
25,"Up",0.344476623614678,0.688726805698113,"B.LvsV.MCCOLLUM_GELDANAMYCIN_RESISTANCE_UP"
15,"Down",0.34455025222662,0.688726805698113,"B.LvsV.BIOCARTA_IL17_PATHWAY"
65,"Down",0.34479748055424,0.68897190819819,"B.LvsV.REACTOME_INTERLEUKIN_3_INTERLEUKIN_5_AND_GM_CSF_SIGNALING"
45,"Up",0.345371250486781,0.689659956869648,"B.LvsV.MEISSNER_ES_ICP_WITH_H3K4ME3"
420,"Down",0.345391286050291,0.689659956869648,"B.LvsV.NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP"
160,"Down",0.345607960965644,0.689843471544782,"B.LvsV.CUI_GLUCOSE_DEPRIVATION"
11,"Up",0.346584954059727,0.690899880484312,"B.LvsV.REACTOME_KETONE_BODY_METABOLISM"
17,"Down",0.346683167767833,0.690899880484312,"B.LvsV.REACTOME_DISEASES_ASSOCIATED_WITH_SURFACTANT_METABOLISM"
846,"Down",0.346819234175963,0.690899880484312,"B.LvsV.SMID_BREAST_CANCER_NORMAL_LIKE_UP"
38,"Up",0.346890877038797,0.690899880484312,"B.LvsV.CHOW_RASSF1_TARGETS_UP"
43,"Up",0.346901326679784,0.690899880484312,"B.LvsV.MAGRANGEAS_MULTIPLE_MYELOMA_IGG_VS_IGA_DN"
118,"Up",0.346915633960121,0.690899880484312,"B.LvsV.KEGG_SMALL_CELL_LUNG_CANCER"
9,"Up",0.34706190141961,0.690899880484312,"B.LvsV.BIOCARTA_ERBB3_PATHWAY"
27,"Up",0.347136890574321,0.690899880484312,"B.LvsV.LEIN_LOCALIZED_TO_DISTAL_AND_PROXIMAL_DENDRITES"
32,"Down",0.34749901825719,0.691161969098065,"B.LvsV.WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_DN"
4,"Down",0.347518588188212,0.691161969098065,"B.LvsV.IGARASHI_ATF4_TARGETS_UP"
75,"Down",0.348213310555717,0.692060495645192,"B.LvsV.REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS"
11,"Down",0.348220708787289,0.692060495645192,"B.LvsV.REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_DIFFERENTIATION_OF_MYELOID_CELLS"
23,"Up",0.348466298590515,0.692245511615696,"B.LvsV.REACTOME_ADP_SIGNALLING_THROUGH_P2Y_PURINOCEPTOR_12"
19,"Down",0.348564207693633,0.692245511615696,"B.LvsV.BIOCARTA_SET_PATHWAY"
51,"Down",0.349034626606525,0.6927163610491,"B.LvsV.RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_DN"
73,"Down",0.349055008653851,0.6927163610491,"B.LvsV.IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_DN"
37,"Down",0.349177156491923,0.6927163610491,"B.LvsV.KEGG_HISTIDINE_METABOLISM"
699,"Up",0.349411026754414,0.692931695453785,"B.LvsV.GARY_CD5_TARGETS_UP"
124,"Down",0.35091766211699,0.695670044404747,"B.LvsV.MCBRYAN_PUBERTAL_BREAST_6_7WK_DN"
757,"Up",0.351131302314413,0.695844075446734,"B.LvsV.CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN"
388,"Down",0.351423302654462,0.696173214036733,"B.LvsV.VERHAAK_AML_WITH_NPM1_MUTATED_UP"
28,"Down",0.351652372870498,0.69622182201941,"B.LvsV.REACTOME_OTHER_SEMAPHORIN_INTERACTIONS"
156,"Down",0.351849977972067,0.69622182201941,"B.LvsV.FONTAINE_PAPILLARY_THYROID_CARCINOMA_DN"
43,"Down",0.351905821658026,0.69622182201941,"B.LvsV.DISTECHE_ESCAPED_FROM_X_INACTIVATION"
62,"Down",0.351951526956819,0.69622182201941,"B.LvsV.STAMBOLSKY_TARGETS_OF_MUTATED_TP53_UP"
10,"Down",0.352120719186787,0.696307387833957,"B.LvsV.REACTOME_PTK6_PROMOTES_HIF1A_STABILIZATION"
53,"Down",0.352376268792445,0.696563600340876,"B.LvsV.ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP"
436,"Down",0.352658845162054,0.696873036061829,"B.LvsV.VANTVEER_BREAST_CANCER_ESR1_DN"
71,"Down",0.353076348857667,0.697448779147567,"B.LvsV.SHIPP_DLBCL_CURED_VS_FATAL_DN"
9,"Down",0.353604917244273,0.697767768450318,"B.LvsV.REACTOME_LECTIN_PATHWAY_OF_COMPLEMENT_ACTIVATION"
1095,"Down",0.353619460623253,0.697767768450318,"B.LvsV.SMID_BREAST_CANCER_LUMINAL_B_DN"
119,"Up",0.353653732461939,0.697767768450318,"B.LvsV.REACTOME_PI3K_AKT_SIGNALING_IN_CANCER"
306,"Down",0.353742639711746,0.697767768450318,"B.LvsV.ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP"
75,"Up",0.353911482384785,0.69785184953833,"B.LvsV.PID_AMB2_NEUTROPHILS_PATHWAY"
18,"Down",0.354509600859928,0.698068179630738,"B.LvsV.LI_WILMS_TUMOR_ANAPLASTIC_DN"
10,"Down",0.354551108066707,0.698068179630738,"B.LvsV.REACTOME_ORGANIC_ANION_TRANSPORTERS"
42,"Down",0.354605596703109,0.698068179630738,"B.LvsV.REACTOME_ACTIVATED_NOTCH1_TRANSMITS_SIGNAL_TO_THE_NUCLEUS"
6,"Up",0.354717985156487,0.698068179630738,"B.LvsV.ZIRN_TRETINOIN_RESPONSE_WT1_DN"
25,"Down",0.354721703177654,0.698068179630738,"B.LvsV.REACTOME_SIGNALING_BY_ERBB2_ECD_MUTANTS"
113,"Up",0.354881102292622,0.698068179630738,"B.LvsV.BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_UP"
42,"Up",0.354904983349974,0.698068179630738,"B.LvsV.ABBUD_LIF_SIGNALING_2_UP"
29,"Up",0.355375851672703,0.698745762410518,"B.LvsV.BIOCARTA_CK1_PATHWAY"
185,"Up",0.355866913337224,0.69946255380075,"B.LvsV.GROSS_HYPOXIA_VIA_HIF1A_DN"
48,"Down",0.356069496596786,0.699532095666389,"B.LvsV.IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_DN"
1388,"Down",0.356155335377263,0.699532095666389,"B.LvsV.REACTOME_DEVELOPMENTAL_BIOLOGY"
15,"Up",0.35672391147902,0.700400037843573,"B.LvsV.COLLIS_PRKDC_REGULATORS"
80,"Up",0.357156863593918,0.701001171036838,"B.LvsV.REACTOME_APOPTOTIC_EXECUTION_PHASE"
217,"Up",0.357679985025521,0.70158551402006,"B.LvsV.YAGI_AML_WITH_T_9_11_TRANSLOCATION"
568,"Up",0.357708367520808,0.70158551402006,"B.LvsV.DAVICIONI_MOLECULAR_ARMS_VS_ERMS_UP"
87,"Up",0.35793395231578,0.701779015019131,"B.LvsV.WESTON_VEGFA_TARGETS_6HR"
16,"Up",0.35835669353622,0.702358794243801,"B.LvsV.HOEGERKORP_CD44_TARGETS_TEMPORAL_UP"
62,"Up",0.358490712768598,0.702372484371926,"B.LvsV.PID_SYNDECAN_2_PATHWAY"
137,"Up",0.358948494500707,0.702740529822879,"B.LvsV.KRASNOSELSKAYA_ILF3_TARGETS_UP"
23,"Up",0.35900657614891,0.702740529822879,"B.LvsV.ZHANG_ADIPOGENESIS_BY_BMP7"
9,"Up",0.35905986557237,0.702740529822879,"B.LvsV.CALVET_IRINOTECAN_SENSITIVE_VS_REVERTED_UP"
564,"Down",0.359805814530977,0.703846065188205,"B.LvsV.COLINA_TARGETS_OF_4EBP1_AND_4EBP2"
297,"Down",0.359942505552261,0.703846065188205,"B.LvsV.OKUMURA_INFLAMMATORY_RESPONSE_LPS"
107,"Down",0.360109561142028,0.703846065188205,"B.LvsV.REACTOME_BASE_EXCISION_REPAIR"
135,"Up",0.360336281679954,0.703846065188205,"B.LvsV.SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_UP"
139,"Up",0.360923221712553,0.703846065188205,"B.LvsV.ROSS_AML_WITH_MLL_FUSIONS"
82,"Down",0.360938474240325,0.703846065188205,"B.LvsV.CHEN_ETV5_TARGETS_TESTIS"
49,"Up",0.361015777226623,0.703846065188205,"B.LvsV.WANG_ADIPOGENIC_GENES_REPRESSED_BY_SIRT1"
53,"Up",0.361161670035392,0.703846065188205,"B.LvsV.REACTOME_NEF_MEDIATES_DOWN_MODULATION_OF_CELL_SURFACE_RECEPTORS_BY_RECRUITING_THEM_TO_CLATHRIN_ADAPTERS"
269,"Down",0.361182336398308,0.703846065188205,"B.LvsV.CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN"
24,"Down",0.361296773915707,0.703846065188205,"B.LvsV.WU_HBX_TARGETS_1_UP"
12,"Up",0.361325842715316,0.703846065188205,"B.LvsV.REACTOME_ACTIVATION_OF_THE_TFAP2_AP_2_FAMILY_OF_TRANSCRIPTION_FACTORS"
5,"Up",0.36143185603131,0.703846065188205,"B.LvsV.REACTOME_PTK6_EXPRESSION"
83,"Up",0.361455777248505,0.703846065188205,"B.LvsV.REACTOME_SIRT1_NEGATIVELY_REGULATES_RRNA_EXPRESSION"
38,"Down",0.361498813763935,0.703846065188205,"B.LvsV.REACTOME_INFLAMMASOMES"
25,"Down",0.361534242201936,0.703846065188205,"B.LvsV.HOLLERN_PAPILLARY_BREAST_TUMOR"
130,"Down",0.361711790863195,0.703943854868922,"B.LvsV.PID_ERA_GENOMIC_PATHWAY"
1198,"Up",0.362256334556247,0.704512646875413,"B.LvsV.FEVR_CTNNB1_TARGETS_UP"
79,"Up",0.362258899451401,0.704512646875413,"B.LvsV.REACTOME_DNA_METHYLATION"
84,"Down",0.363431246024153,0.706544078504761,"B.LvsV.BROWNE_HCMV_INFECTION_2HR_DN"
181,"Down",0.364195163887187,0.707780337832075,"B.LvsV.NIKOLSKY_MUTATED_AND_AMPLIFIED_IN_BREAST_CANCER"
1063,"Up",0.364452816853956,0.708001948625661,"B.LvsV.MARTINEZ_TP53_TARGETS_UP"
108,"Down",0.364657770551826,0.708001948625661,"B.LvsV.HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_DN"
48,"Up",0.364693353171619,0.708001948625661,"B.LvsV.WORSCHECH_TUMOR_EVASION_AND_TOLEROGENICITY_UP"
630,"Down",0.365715515417292,0.709656287587009,"B.LvsV.FOSTER_TOLERANT_MACROPHAGE_DN"
41,"Up",0.365802210096397,0.709656287587009,"B.LvsV.JEON_SMAD6_TARGETS_UP"
111,"Down",0.366251622646333,0.710278927257655,"B.LvsV.MEISSNER_BRAIN_HCP_WITH_H3K4ME2_AND_H3K27ME3"
500,"Down",0.366395980605518,0.710280969623992,"B.LvsV.TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_DN"
34,"Down",0.36670398686606,0.710280969623992,"B.LvsV.KEGG_ALANINE_ASPARTATE_AND_GLUTAMATE_METABOLISM"
35,"Down",0.366882303712398,0.710280969623992,"B.LvsV.NIKOLSKY_BREAST_CANCER_15Q26_AMPLICON"
24,"Up",0.366890799708564,0.710280969623992,"B.LvsV.KIM_GERMINAL_CENTER_T_HELPER_DN"
71,"Down",0.367114233763411,0.710280969623992,"B.LvsV.WEINMANN_ADAPTATION_TO_HYPOXIA_DN"
25,"Up",0.367135645102649,0.710280969623992,"B.LvsV.REACTOME_GLUCURONIDATION"
42,"Up",0.367256853329635,0.710280969623992,"B.LvsV.KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM"
84,"Down",0.367430663035172,0.710280969623992,"B.LvsV.KEGG_MELANOMA"
10,"Up",0.367543704883601,0.710280969623992,"B.LvsV.REACTOME_DIGESTION_OF_DIETARY_LIPID"
262,"Down",0.367567412782082,0.710280969623992,"B.LvsV.CAIRO_LIVER_DEVELOPMENT_UP"
33,"Down",0.367665786772267,0.710280969623992,"B.LvsV.MAHADEVAN_IMATINIB_RESISTANCE_UP"
327,"Up",0.367924431775166,0.710465453077668,"B.LvsV.LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER"
91,"Down",0.368080330030918,0.710465453077668,"B.LvsV.PID_ATF2_PATHWAY"
14,"Up",0.368185473713907,0.710465453077668,"B.LvsV.BIOCARTA_AMAN_PATHWAY"
117,"Up",0.368275273742195,0.710465453077668,"B.LvsV.ROSS_AML_OF_FAB_M7_TYPE"
34,"Down",0.368740736186999,0.711115287889053,"B.LvsV.NIKOLSKY_BREAST_CANCER_5P15_AMPLICON"
19,"Up",0.369873245673023,0.713030196067679,"B.LvsV.REACTOME_PI3K_EVENTS_IN_ERBB2_SIGNALING"
12,"Up",0.369991613767077,0.713030196067679,"B.LvsV.LY_AGING_OLD_UP"
67,"Up",0.370760969808919,0.714214809497028,"B.LvsV.HAN_JNK_SINGALING_DN"
56,"Down",0.370987022656765,0.714214809497028,"B.LvsV.TSENG_ADIPOGENIC_POTENTIAL_UP"
10,"Down",0.370993838465448,0.714214809497028,"B.LvsV.FERRARI_RESPONSE_TO_FENRETINIDE_DN"
8,"Up",0.371444297862439,0.714833109252149,"B.LvsV.CHENG_TAF7L_TARGETS"
65,"Up",0.371704125333605,0.715084241116738,"B.LvsV.GROSS_HYPOXIA_VIA_ELK3_ONLY_DN"
79,"Down",0.372459254670424,0.716061100714675,"B.LvsV.BURTON_ADIPOGENESIS_PEAK_AT_2HR"
82,"Down",0.372478972312699,0.716061100714675,"B.LvsV.AMIT_EGF_RESPONSE_240_HELA"
20,"Up",0.37260043167953,0.716061100714675,"B.LvsV.ROETH_TERT_TARGETS_UP"
28,"Up",0.37292831420092,0.716442199171955,"B.LvsV.REACTOME_SIGNALING_BY_PDGFR_IN_DISEASE"
16,"Up",0.373244043768877,0.716799693642973,"B.LvsV.REACTOME_TICAM1_DEPENDENT_ACTIVATION_OF_IRF3_IRF7"
63,"Down",0.374005888634255,0.717785925025245,"B.LvsV.AMIT_EGF_RESPONSE_60_HELA"
26,"Up",0.374017227346307,0.717785925025245,"B.LvsV.BALLIF_DEVELOPMENTAL_DISABILITY_P16_P12_DELETION"
55,"Down",0.374978926722664,0.718868318521364,"B.LvsV.AMIT_EGF_RESPONSE_60_MCF10A"
12,"Up",0.375071352847272,0.718868318521364,"B.LvsV.SHIRAISHI_PLZF_TARGETS_DN"
55,"Up",0.375134594175478,0.718868318521364,"B.LvsV.PID_INTEGRIN_A4B1_PATHWAY"
13,"Down",0.375210977087691,0.718868318521364,"B.LvsV.MIKKELSEN_NPC_ICP_WITH_H3K27ME3"
32,"Up",0.375272406850952,0.718868318521364,"B.LvsV.BIOCARTA_EPO_PATHWAY"
27,"Up",0.375385670279819,0.718868318521364,"B.LvsV.PID_INTEGRIN5_PATHWAY"
93,"Up",0.375491355378857,0.718868318521364,"B.LvsV.SILIGAN_BOUND_BY_EWS_FLT1_FUSION"
30,"Down",0.375858083324044,0.719016710611396,"B.LvsV.SUZUKI_RESPONSE_TO_TSA_AND_DECITABINE_1B"
11,"Up",0.375939816731839,0.719016710611396,"B.LvsV.REACTOME_MAPK1_ERK2_ACTIVATION"
41,"Up",0.37595899988742,0.719016710611396,"B.LvsV.PASTURAL_RIZ1_TARGETS_UP"
35,"Down",0.376223625138286,0.719032793873415,"B.LvsV.SHARMA_PILOCYTIC_ASTROCYTOMA_LOCATION_UP"
604,"Up",0.376328484112947,0.719032793873415,"B.LvsV.GRYDER_PAX3FOXO1_TOP_ENHANCERS"
309,"Down",0.376434025892043,0.719032793873415,"B.LvsV.NABA_ECM_REGULATORS"
58,"Up",0.376487599613589,0.719032793873415,"B.LvsV.PID_PI3K_PLC_TRK_PATHWAY"
22,"Down",0.376761960381871,0.71930831455503,"B.LvsV.PETRETTO_BLOOD_PRESSURE_UP"
17,"Up",0.377035990637926,0.719583014234413,"B.LvsV.REACTOME_ANDROGEN_BIOSYNTHESIS"
13,"Up",0.377224730892156,0.719694802312881,"B.LvsV.REACTOME_SIGNALING_BY_FGFR3_FUSIONS_IN_CANCER"
20,"Up",0.377486986709824,0.719728403884364,"B.LvsV.BARRIER_CANCER_RELAPSE_TUMOR_SAMPLE_UP"
55,"Down",0.377502689684329,0.719728403884364,"B.LvsV.REACTOME_TRANSPORT_OF_VITAMINS_NUCLEOSIDES_AND_RELATED_MOLECULES"
247,"Down",0.377700498099168,0.719730994923184,"B.LvsV.REACTOME_COMPLEMENT_CASCADE"
85,"Down",0.377836792280024,0.719730994923184,"B.LvsV.YAMASHITA_LIVER_CANCER_STEM_CELL_UP"
1863,"Up",0.377894570132393,0.719730994923184,"B.LvsV.BLALOCK_ALZHEIMERS_DISEASE_DN"
28,"Up",0.378154406175325,0.719977862170583,"B.LvsV.BIOCARTA_NTHI_PATHWAY"
14,"Down",0.378309138147984,0.720024518010397,"B.LvsV.ABBUD_LIF_SIGNALING_2_DN"
87,"Down",0.378750893985753,0.720441335226199,"B.LvsV.LIM_MAMMARY_LUMINAL_PROGENITOR_UP"
93,"Up",0.37878874326326,0.720441335226199,"B.LvsV.DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_UP"
99,"Down",0.379120890799002,0.720825104961377,"B.LvsV.REACTOME_SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE"
290,"Up",0.379440077558505,0.721183976906489,"B.LvsV.KEGG_MAPK_SIGNALING_PATHWAY"
23,"Down",0.379726168751679,0.721201876872195,"B.LvsV.FIGUEROA_AML_METHYLATION_CLUSTER_2_DN"
17,"Down",0.379749434986799,0.721201876872195,"B.LvsV.REACTOME_ZINC_TRANSPORTERS"
48,"Down",0.379840814876439,0.721201876872195,"B.LvsV.WANG_THOC1_TARGETS_DN"
432,"Up",0.380793445212339,0.722762429996232,"B.LvsV.ONDER_CDH1_TARGETS_2_UP"
34,"Down",0.381071075234344,0.723001190069973,"B.LvsV.REACTOME_SIGNALING_BY_BMP"
106,"Up",0.381224761857068,0.723001190069973,"B.LvsV.KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450"
80,"Down",0.381311533775374,0.723001190069973,"B.LvsV.LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_DN"
566,"Down",0.381609460307403,0.723318034295382,"B.LvsV.SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP"
77,"Down",0.381889053845726,0.723427815320942,"B.LvsV.REACTOME_PKMTS_METHYLATE_HISTONE_LYSINES"
73,"Down",0.381938303717518,0.723427815320942,"B.LvsV.WANG_LSD1_TARGETS_DN"
176,"Up",0.382171489841449,0.723427815320942,"B.LvsV.MACAEVA_PBMC_RESPONSE_TO_IR"
684,"Down",0.382244175481881,0.723427815320942,"B.LvsV.KIM_WT1_TARGETS_DN"
78,"Down",0.382321590950948,0.723427815320942,"B.LvsV.SMIRNOV_RESPONSE_TO_IR_2HR_UP"
16,"Up",0.3826183218735,0.723741601655347,"B.LvsV.REACTOME_INTESTINAL_ABSORPTION"
73,"Down",0.382846505039279,0.723925556211414,"B.LvsV.REACTOME_G1_S_DNA_DAMAGE_CHECKPOINTS"
181,"Down",0.383143973971529,0.723988307116794,"B.LvsV.RICKMAN_HEAD_AND_NECK_CANCER_E"
222,"Down",0.383207425589709,0.723988307116794,"B.LvsV.HOELZEL_NF1_TARGETS_UP"
68,"Down",0.3832725221434,0.723988307116794,"B.LvsV.CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_DN"
17,"Up",0.383415497496468,0.724011026522532,"B.LvsV.PID_S1P_S1P4_PATHWAY"
175,"Down",0.383642678374868,0.724158042311338,"B.LvsV.COATES_MACROPHAGE_M1_VS_M2_DN"
65,"Up",0.383885262919098,0.724158042311338,"B.LvsV.REACTOME_SIGNALING_BY_RETINOIC_ACID"
731,"Down",0.383886276363634,0.724158042311338,"B.LvsV.TIEN_INTESTINE_PROBIOTICS_24HR_UP"
89,"Up",0.384230908934182,0.724367555366962,"B.LvsV.PID_DELTA_NP63_PATHWAY"
41,"Up",0.384399004666831,0.724367555366962,"B.LvsV.PID_IL12_STAT4_PATHWAY"
42,"Up",0.384430046912274,0.724367555366962,"B.LvsV.BRACHAT_RESPONSE_TO_METHOTREXATE_DN"
63,"Up",0.384521391752945,0.724367555366962,"B.LvsV.SNIJDERS_AMPLIFIED_IN_HEAD_AND_NECK_TUMORS"
13,"Down",0.384832952723964,0.724707559812943,"B.LvsV.PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_DN"
131,"Down",0.385244884378981,0.725236283871769,"B.LvsV.GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP"
87,"Down",0.385939604397439,0.726208205616337,"B.LvsV.MATTIOLI_MGUS_VS_MULTIPLE_MYELOMA"
92,"Up",0.386023858981084,0.726208205616337,"B.LvsV.JIANG_AGING_CEREBRAL_CORTEX_DN"
30,"Down",0.38628823526634,0.726245990574912,"B.LvsV.STEGER_ADIPOGENESIS_DN"
9,"Down",0.386407500471068,0.726245990574912,"B.LvsV.BIOCARTA_PARKIN_PATHWAY"
22,"Up",0.386531454080571,0.726245990574912,"B.LvsV.REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_27_HYDROXYCHOLESTEROL"
46,"Up",0.386623216312012,0.726245990574912,"B.LvsV.OSADA_ASCL1_TARGETS_DN"
10,"Up",0.386700704693894,0.726245990574912,"B.LvsV.FUNG_IL2_TARGETS_WITH_STAT5_BINDING_SITES_T1"
12,"Down",0.38777026901278,0.728007408275606,"B.LvsV.BIOCARTA_GABA_PATHWAY"
9,"Down",0.387973463922744,0.728141643594314,"B.LvsV.REACTOME_RELEASE_OF_HH_NP_FROM_THE_SECRETING_CELL"
96,"Down",0.388111735723202,0.728151025754609,"B.LvsV.MUELLER_METHYLATED_IN_GLIOBLASTOMA"
28,"Up",0.388241856379922,0.728151025754609,"B.LvsV.PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_3"
46,"Down",0.38862683940739,0.728496141532348,"B.LvsV.MARSHALL_VIRAL_INFECTION_RESPONSE_DN"
10,"Down",0.388791660278917,0.728496141532348,"B.LvsV.REACTOME_INTERLEUKIN_18_SIGNALING"
87,"Down",0.388871581839214,0.728496141532348,"B.LvsV.SATO_SILENCED_BY_DEACETYLATION_IN_PANCREATIC_CANCER"
54,"Up",0.389210593417619,0.728496141532348,"B.LvsV.LEE_CALORIE_RESTRICTION_MUSCLE_UP"
27,"Up",0.389469764429616,0.728496141532348,"B.LvsV.REACTOME_METABOLISM_OF_NITRIC_OXIDE_ENOS_ACTIVATION_AND_REGULATION"
51,"Down",0.389673660297665,0.728496141532348,"B.LvsV.REACTOME_HIV_TRANSCRIPTION_INITIATION"
28,"Up",0.390006780259392,0.728496141532348,"B.LvsV.REACTOME_NOTCH4_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION"
57,"Down",0.390086385186276,0.728496141532348,"B.LvsV.TERAO_AOX4_TARGETS_SKIN_UP"
42,"Up",0.390260639171614,0.728496141532348,"B.LvsV.REACTOME_G_PROTEIN_BETA_GAMMA_SIGNALLING"
965,"Down",0.390315199280761,0.728496141532348,"B.LvsV.PATIL_LIVER_CANCER"
120,"Down",0.390372842232759,0.728496141532348,"B.LvsV.REACTOME_UCH_PROTEINASES"
86,"Up",0.390432384183745,0.728496141532348,"B.LvsV.KHETCHOUMIAN_TRIM24_TARGETS_UP"
116,"Up",0.390577755894499,0.728496141532348,"B.LvsV.REACTOME_STIMULI_SENSING_CHANNELS"
87,"Down",0.39079943031308,0.728496141532348,"B.LvsV.BROWNE_HCMV_INFECTION_8HR_DN"
10,"Down",0.390808875901651,0.728496141532348,"B.LvsV.CHANG_POU5F1_TARGETS_DN"
47,"Down",0.390951894945678,0.728496141532348,"B.LvsV.CHUANG_OXIDATIVE_STRESS_RESPONSE_UP"
167,"Up",0.391048571641809,0.728496141532348,"B.LvsV.BOYLAN_MULTIPLE_MYELOMA_PCA3_UP"
61,"Down",0.391126456598386,0.728496141532348,"B.LvsV.PID_PI3KCI_PATHWAY"
19,"Up",0.39116596741581,0.728496141532348,"B.LvsV.REACTOME_ACTIVATION_OF_IRF3_IRF7_MEDIATED_BY_TBK1_IKK_EPSILON"
71,"Down",0.391465260320623,0.728496141532348,"B.LvsV.MCBRYAN_PUBERTAL_BREAST_3_4WK_DN"
139,"Down",0.391538272997799,0.728496141532348,"B.LvsV.BRUECKNER_TARGETS_OF_MIRLET7A3_DN"
219,"Up",0.391623113317971,0.728496141532348,"B.LvsV.XU_GH1_EXOGENOUS_TARGETS_DN"
73,"Up",0.391785648873251,0.728496141532348,"B.LvsV.REACTOME_SIGNALING_BY_ERBB4"
83,"Up",0.391807921542586,0.728496141532348,"B.LvsV.KEGG_EPITHELIAL_CELL_SIGNALING_IN_HELICOBACTER_PYLORI_INFECTION"
62,"Down",0.392115202668403,0.728496141532348,"B.LvsV.SAGIV_CD24_TARGETS_DN"
353,"Up",0.392189542873758,0.728496141532348,"B.LvsV.CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP"
78,"Down",0.392200664310742,0.728496141532348,"B.LvsV.OSADA_ASCL1_TARGETS_UP"
740,"Down",0.392284946287635,0.728496141532348,"B.LvsV.DELYS_THYROID_CANCER_UP"
363,"Up",0.392341650279907,0.728496141532348,"B.LvsV.ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_DN"
7,"Down",0.392414717699169,0.728496141532348,"B.LvsV.CALVET_IRINOTECAN_SENSITIVE_VS_REVERTED_DN"
54,"Down",0.392602786693347,0.728496141532348,"B.LvsV.KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS"
523,"Up",0.392698888099135,0.728496141532348,"B.LvsV.FISCHER_DIRECT_P53_TARGETS_META_ANALYSIS"
58,"Down",0.392773918956037,0.728496141532348,"B.LvsV.PARK_HSC_MARKERS"
46,"Up",0.393342679486949,0.729306396674494,"B.LvsV.BIOCARTA_NGF_PATHWAY"
18,"Down",0.393616021094039,0.729568548652008,"B.LvsV.MALIK_REPRESSED_BY_ESTROGEN"
11,"Down",0.393871996830698,0.729798348015057,"B.LvsV.WORSCHECH_TUMOR_REJECTION_DN"
50,"Down",0.394542315837714,0.730590590908734,"B.LvsV.JAERVINEN_AMPLIFIED_IN_LARYNGEAL_CANCER"
46,"Down",0.394563845985437,0.730590590908734,"B.LvsV.REACTOME_SYNTHESIS_OF_ACTIVE_UBIQUITIN_ROLES_OF_E1_AND_E2_ENZYMES"
155,"Up",0.39507510707014,0.731292355872382,"B.LvsV.ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_UP"
183,"Down",0.395286880052341,0.731439477847855,"B.LvsV.REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION"
41,"Down",0.395488776615549,0.731568232153686,"B.LvsV.BIOCARTA_P53HYPOXIA_PATHWAY"
112,"Up",0.396129454849268,0.732300245384604,"B.LvsV.DELASERNA_MYOD_TARGETS_DN"
189,"Down",0.396149400243326,0.732300245384604,"B.LvsV.HAHTOLA_SEZARY_SYNDROM_UP"
66,"Down",0.396454554068206,0.73261939486735,"B.LvsV.WEBER_METHYLATED_HCP_IN_FIBROBLAST_DN"
82,"Down",0.397381982944786,0.733595112723997,"B.LvsV.LI_LUNG_CANCER"
38,"Down",0.397500518016371,0.733595112723997,"B.LvsV.DE_YY1_TARGETS_UP"
20,"Down",0.397582474808833,0.733595112723997,"B.LvsV.AMIT_EGF_RESPONSE_40_MCF10A"
159,"Up",0.397795823125344,0.733595112723997,"B.LvsV.ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN"
33,"Up",0.397848942604498,0.733595112723997,"B.LvsV.MCCABE_HOXC6_TARGETS_CANCER_DN"
42,"Up",0.397921945533587,0.733595112723997,"B.LvsV.TERAO_AOX4_TARGETS_HG_UP"
40,"Down",0.397976982309539,0.733595112723997,"B.LvsV.STAMBOLSKY_BOUND_BY_MUTATED_TP53"
138,"Down",0.398044011244708,0.733595112723997,"B.LvsV.BONCI_TARGETS_OF_MIR15A_AND_MIR16_1"
25,"Down",0.398236407992145,0.73365635668381,"B.LvsV.YIH_RESPONSE_TO_ARSENITE_C4"
56,"Down",0.39835649984272,0.73365635668381,"B.LvsV.MURAKAMI_UV_RESPONSE_6HR_UP"
15,"Down",0.398475319067007,0.73365635668381,"B.LvsV.BIOCARTA_CPSF_PATHWAY"
50,"Down",0.399330474564792,0.734844414449574,"B.LvsV.REACTOME_GAP_JUNCTION_TRAFFICKING_AND_REGULATION"
19,"Down",0.399404418244783,0.734844414449574,"B.LvsV.EHLERS_ANEUPLOIDY_DN"
30,"Up",0.399581518858591,0.734844414449574,"B.LvsV.REACTOME_REGULATION_OF_IFNA_SIGNALING"
66,"Down",0.399751800509338,0.734844414449574,"B.LvsV.REACTOME_NEGATIVE_REGULATION_OF_NOTCH4_SIGNALING"
21,"Up",0.399785132693854,0.734844414449574,"B.LvsV.REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_METHYLATION"
29,"Down",0.400173378621231,0.735313596010896,"B.LvsV.REACTOME_SHC_MEDIATED_CASCADE_FGFR1"
109,"Down",0.400412154633837,0.735507907963617,"B.LvsV.REACTOME_AURKA_ACTIVATION_BY_TPX2"
52,"Down",0.400685164720468,0.735764953749408,"B.LvsV.FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_UP"
73,"Down",0.400982593343722,0.736066652920796,"B.LvsV.ZHAN_MULTIPLE_MYELOMA_CD2_DN"
99,"Up",0.401253060295921,0.736318675863307,"B.LvsV.REACTOME_TRANS_GOLGI_NETWORK_VESICLE_BUDDING"
119,"Up",0.401794139257005,0.736440068080333,"B.LvsV.WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_DN"
47,"Up",0.401849894595358,0.736440068080333,"B.LvsV.DAZARD_UV_RESPONSE_CLUSTER_G5"
46,"Up",0.401972075215176,0.736440068080333,"B.LvsV.REACTOME_RET_SIGNALING"
42,"Up",0.402042765960226,0.736440068080333,"B.LvsV.REACTOME_SIGNALING_BY_WNT_IN_CANCER"
426,"Down",0.402345040721086,0.736440068080333,"B.LvsV.GENTILE_UV_HIGH_DOSE_DN"
86,"Down",0.402362351094241,0.736440068080333,"B.LvsV.CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_DN"
510,"Up",0.402429872866035,0.736440068080333,"B.LvsV.FARMER_BREAST_CANCER_APOCRINE_VS_LUMINAL"
24,"Up",0.402596825448474,0.736440068080333,"B.LvsV.REACTOME_ER_QUALITY_CONTROL_COMPARTMENT_ERQC"
66,"Up",0.402616449928952,0.736440068080333,"B.LvsV.REACTOME_NEUREXINS_AND_NEUROLIGINS"
80,"Down",0.402651171243778,0.736440068080333,"B.LvsV.GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_UP"
145,"Up",0.402849641995644,0.73655941487894,"B.LvsV.CROMER_METASTASIS_DN"
263,"Down",0.40313069486484,0.73682962377114,"B.LvsV.LEE_NEURAL_CREST_STEM_CELL_DN"
34,"Down",0.40395454986878,0.737996752234425,"B.LvsV.ZHU_SKIL_TARGETS_UP"
39,"Down",0.404083961546471,0.737996752234425,"B.LvsV.REACTOME_NOTCH3_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION"
184,"Up",0.404462516375599,0.737996752234425,"B.LvsV.FIGUEROA_AML_METHYLATION_CLUSTER_1_UP"
746,"Up",0.404674187136181,0.737996752234425,"B.LvsV.MITSIADES_RESPONSE_TO_APLIDIN_UP"
17,"Down",0.404908345089732,0.737996752234425,"B.LvsV.FUKUSHIMA_TNFSF11_TARGETS"
110,"Down",0.404960147523187,0.737996752234425,"B.LvsV.ROSS_AML_WITH_CBFB_MYH11_FUSION"
8,"Down",0.40500876776115,0.737996752234425,"B.LvsV.LE_SKI_TARGETS_DN"
37,"Up",0.405010431725233,0.737996752234425,"B.LvsV.REACTOME_FERTILIZATION"
86,"Down",0.405017893271,0.737996752234425,"B.LvsV.MCGARVEY_SILENCED_BY_METHYLATION_IN_COLON_CANCER"
2398,"Up",0.405104022975489,0.737996752234425,"B.LvsV.DODD_NASOPHARYNGEAL_CARCINOMA_UP"
9,"Up",0.405498931514862,0.738472856503845,"B.LvsV.SHARMA_PILOCYTIC_ASTROCYTOMA_LOCATION_DN"
362,"Up",0.406052354055889,0.739237229362862,"B.LvsV.REACTOME_ASPARAGINE_N_LINKED_GLYCOSYLATION"
12,"Up",0.406357356566965,0.739548987642775,"B.LvsV.REACTOME_TANDEM_PORE_DOMAIN_POTASSIUM_CHANNELS"
126,"Down",0.406520724024261,0.739602857232689,"B.LvsV.GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN"
82,"Down",0.406753589927308,0.739757592350672,"B.LvsV.PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_1"
30,"Up",0.406873365588423,0.739757592350672,"B.LvsV.REACTOME_CD28_DEPENDENT_PI3K_AKT_SIGNALING"
72,"Down",0.407161546613533,0.739766772401619,"B.LvsV.CONRAD_STEM_CELL"
26,"Down",0.407332006482068,0.739766772401619,"B.LvsV.BIOCARTA_41BB_PATHWAY"
181,"Down",0.4075257792687,0.739766772401619,"B.LvsV.PID_P53_DOWNSTREAM_PATHWAY"
494,"Down",0.407546867715388,0.739766772401619,"B.LvsV.KAAB_HEART_ATRIUM_VS_VENTRICLE_UP"
498,"Up",0.40754740255658,0.739766772401619,"B.LvsV.JOHNSTONE_PARVB_TARGETS_2_DN"
11,"Up",0.408440046706054,0.741143753934287,"B.LvsV.BIOCARTA_TCAPOPTOSIS_PATHWAY"
26,"Down",0.408644297961154,0.741216901295766,"B.LvsV.NAM_FXYD5_TARGETS_DN"
159,"Up",0.408748477491552,0.741216901295766,"B.LvsV.FIGUEROA_AML_METHYLATION_CLUSTER_4_UP"
11,"Up",0.409369931496808,0.742100443031426,"B.LvsV.REACTOME_PP2A_MEDIATED_DEPHOSPHORYLATION_OF_KEY_METABOLIC_FACTORS"
487,"Up",0.409655896451097,0.742286826402439,"B.LvsV.SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM4"
25,"Up",0.409741254147268,0.742286826402439,"B.LvsV.GRANDVAUX_IRF3_TARGETS_DN"
8,"Down",0.410003383643599,0.742417836968123,"B.LvsV.REACTOME_RELAXIN_RECEPTORS"
259,"Down",0.410390449641606,0.742417836968123,"B.LvsV.RICKMAN_HEAD_AND_NECK_CANCER_C"
5,"Up",0.410606609841432,0.742417836968123,"B.LvsV.REACTOME_BETA_OXIDATION_OF_HEXANOYL_COA_TO_BUTANOYL_COA"
635,"Down",0.410612895076679,0.742417836968123,"B.LvsV.LINDGREN_BLADDER_CANCER_CLUSTER_2B"
61,"Down",0.41076753071207,0.742417836968123,"B.LvsV.ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_DN"
438,"Up",0.410792915152583,0.742417836968123,"B.LvsV.OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN"
33,"Down",0.410896505777379,0.742417836968123,"B.LvsV.REACTOME_SIGNALING_BY_ERBB2_IN_CANCER"
33,"Down",0.411012324694628,0.742417836968123,"B.LvsV.REACTOME_PLASMA_LIPOPROTEIN_ASSEMBLY"
526,"Down",0.411082758212528,0.742417836968123,"B.LvsV.SABATES_COLORECTAL_ADENOMA_DN"
163,"Up",0.411261242712619,0.742417836968123,"B.LvsV.TAYLOR_METHYLATED_IN_ACUTE_LYMPHOBLASTIC_LEUKEMIA"
75,"Down",0.411324402636481,0.742417836968123,"B.LvsV.MCDOWELL_ACUTE_LUNG_INJURY_DN"
273,"Down",0.411424896449689,0.742417836968123,"B.LvsV.VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP"
44,"Down",0.411599288308736,0.742490200671778,"B.LvsV.CHIARETTI_T_ALL_RELAPSE_PROGNOSIS"
94,"Up",0.411792937171785,0.742597243843053,"B.LvsV.COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_UP"
55,"Down",0.412140072021971,0.742980912360442,"B.LvsV.PID_IL23_PATHWAY"
1306,"Up",0.413094184659676,0.74404920582124,"B.LvsV.MARSON_BOUND_BY_FOXP3_STIMULATED"
28,"Up",0.413194943563701,0.74404920582124,"B.LvsV.HOWLIN_CITED1_TARGETS_2_DN"
77,"Up",0.413240796728629,0.74404920582124,"B.LvsV.ASTON_MAJOR_DEPRESSIVE_DISORDER_UP"
29,"Down",0.413270955159528,0.74404920582124,"B.LvsV.REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR3"
136,"Up",0.41385238479037,0.744750864735262,"B.LvsV.DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_DN"
788,"Up",0.41393007909775,0.744750864735262,"B.LvsV.SENESE_HDAC3_TARGETS_DN"
25,"Up",0.414241494642014,0.744862248548038,"B.LvsV.KYNG_ENVIRONMENTAL_STRESS_RESPONSE_DN"
21,"Down",0.414261424178914,0.744862248548038,"B.LvsV.NIKOLSKY_BREAST_CANCER_7P15_AMPLICON"
29,"Up",0.414432981101735,0.744928463105166,"B.LvsV.YAN_ESCAPE_FROM_ANOIKIS"
25,"Down",0.414664291152272,0.744974675718413,"B.LvsV.INGA_TP53_TARGETS"
18,"Down",0.41472816998757,0.744974675718413,"B.LvsV.YEMELYANOV_GR_TARGETS_DN"
32,"Down",0.415040863903282,0.745183117849919,"B.LvsV.MURAKAMI_UV_RESPONSE_6HR_DN"
34,"Down",0.415210572121322,0.745183117849919,"B.LvsV.KAPOSI_LIVER_CANCER_MET_UP"
40,"Up",0.415248541525701,0.745183117849919,"B.LvsV.WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_DN"
406,"Down",0.415432274553276,0.745270942895867,"B.LvsV.MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN"
22,"Down",0.415936476797594,0.745705603027076,"B.LvsV.BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_24HR_DN"
9,"Up",0.416060698420009,0.745705603027076,"B.LvsV.REACTOME_INTERLEUKIN_1_PROCESSING"
1526,"Up",0.416095598386039,0.745705603027076,"B.LvsV.MARSON_BOUND_BY_FOXP3_UNSTIMULATED"
244,"Up",0.416293921599537,0.745705603027076,"B.LvsV.FIRESTEIN_PROLIFERATION"
62,"Down",0.416568659136342,0.745705603027076,"B.LvsV.REACTOME_DEACTIVATION_OF_THE_BETA_CATENIN_TRANSACTIVATING_COMPLEX"
20,"Down",0.41692330043991,0.745705603027076,"B.LvsV.RODRIGUES_THYROID_CARCINOMA_UP"
97,"Down",0.416968164928332,0.745705603027076,"B.LvsV.GRADE_COLON_VS_RECTAL_CANCER_DN"
84,"Up",0.417039402707062,0.745705603027076,"B.LvsV.GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN"
137,"Up",0.417092562420942,0.745705603027076,"B.LvsV.REACTOME_SENESCENCE_ASSOCIATED_SECRETORY_PHENOTYPE_SASP"
141,"Up",0.417158580051905,0.745705603027076,"B.LvsV.PID_REG_GR_PATHWAY"
107,"Up",0.417258095915819,0.745705603027076,"B.LvsV.KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY"
14,"Down",0.417330615772312,0.745705603027076,"B.LvsV.BIOCARTA_NEUTROPHIL_PATHWAY"
88,"Up",0.417427896793055,0.745705603027076,"B.LvsV.BROWNE_HCMV_INFECTION_10HR_DN"
8,"Up",0.41779614693096,0.746034306507538,"B.LvsV.MOOTHA_PYR"
5,"Up",0.417969969430182,0.746034306507538,"B.LvsV.REACTOME_SODIUM_COUPLED_PHOSPHATE_COTRANSPORTERS"
111,"Up",0.41821828895213,0.746034306507538,"B.LvsV.HOFMANN_CELL_LYMPHOMA_UP"
13,"Down",0.418472321437726,0.746034306507538,"B.LvsV.REACTOME_PROCESSING_AND_ACTIVATION_OF_SUMO"
21,"Up",0.41848472853949,0.746034306507538,"B.LvsV.REACTOME_ERYTHROPOIETIN_ACTIVATES_RAS"
18,"Down",0.41862236171751,0.746034306507538,"B.LvsV.REACTOME_TRAF6_MEDIATED_INDUCTION_OF_TAK1_COMPLEX_WITHIN_TLR4_COMPLEX"
9,"Down",0.418626094739069,0.746034306507538,"B.LvsV.BRUNEAU_SEPTATION_ATRIAL"
421,"Down",0.418691346191515,0.746034306507538,"B.LvsV.FORTSCHEGGER_PHF8_TARGETS_UP"
24,"Up",0.41964466365378,0.747295533860116,"B.LvsV.BIOCARTA_HCMV_PATHWAY"
16,"Up",0.419899583805191,0.747295533860116,"B.LvsV.HASINA_NOL7_TARGETS_UP"
47,"Down",0.419927576158517,0.747295533860116,"B.LvsV.REACTOME_DNA_DAMAGE_RECOGNITION_IN_GG_NER"
81,"Up",0.419939812570697,0.747295533860116,"B.LvsV.VANTVEER_BREAST_CANCER_BRCA1_DN"
6,"Up",0.420223956994102,0.747560572142982,"B.LvsV.REACTOME_NEGATIVE_REGULATION_OF_TCF_DEPENDENT_SIGNALING_BY_DVL_INTERACTING_PROTEINS"
260,"Down",0.420457358880188,0.747735200144278,"B.LvsV.DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN"
217,"Up",0.421483674488061,0.749319368567359,"B.LvsV.NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN"
26,"Up",0.422164404296616,0.750288328947602,"B.LvsV.REACTOME_PRESYNAPTIC_FUNCTION_OF_KAINATE_RECEPTORS"
8,"Down",0.422412893280219,0.750488716885068,"B.LvsV.LAU_APOPTOSIS_CDKN2A_DN"
56,"Up",0.422615158720764,0.750606878434662,"B.LvsV.BIOCARTA_ERK_PATHWAY"
214,"Down",0.422885234904119,0.750845364092767,"B.LvsV.FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP"
32,"Down",0.423180876220318,0.750944240064702,"B.LvsV.CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_HD_MTX_DN"
268,"Down",0.423293131601424,0.750944240064702,"B.LvsV.BROWNE_HCMV_INFECTION_18HR_UP"
28,"Down",0.423358336319982,0.750944240064702,"B.LvsV.NELSON_RESPONSE_TO_ANDROGEN_DN"
230,"Up",0.423484199768808,0.750944240064702,"B.LvsV.KEGG_CHEMOKINE_SIGNALING_PATHWAY"
36,"Down",0.42386577926289,0.751379895333285,"B.LvsV.HEIDENBLAD_AMPLICON_12P11_12_DN"
36,"Up",0.42410699229593,0.751566525770576,"B.LvsV.REACTOME_SIGNAL_AMPLIFICATION"
9,"Up",0.424384479209899,0.751817297517312,"B.LvsV.BIOCARTA_HBX_PATHWAY"
106,"Up",0.42493897050199,0.751963328499147,"B.LvsV.WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_TBH"
227,"Down",0.42501944743376,0.751963328499147,"B.LvsV.JACKSON_DNMT1_TARGETS_UP"
53,"Down",0.425290173438318,0.751963328499147,"B.LvsV.SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_DN"
815,"Down",0.425327708071983,0.751963328499147,"B.LvsV.ONDER_CDH1_TARGETS_2_DN"
16,"Up",0.425338317065827,0.751963328499147,"B.LvsV.REACTOME_ERYTHROPOIETIN_ACTIVATES_PHOSPHOINOSITIDE_3_KINASE_PI3K"
260,"Up",0.425519590585754,0.751963328499147,"B.LvsV.SCHLOSSER_SERUM_RESPONSE_UP"
134,"Down",0.425641076838942,0.751963328499147,"B.LvsV.SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_UP"
58,"Up",0.425748614255708,0.751963328499147,"B.LvsV.WEINMANN_ADAPTATION_TO_HYPOXIA_UP"
471,"Up",0.425811521648804,0.751963328499147,"B.LvsV.REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION"
380,"Down",0.426026845957609,0.751963328499147,"B.LvsV.WAMUNYOKOLI_OVARIAN_CANCER_LMP_UP"
110,"Up",0.426065096115263,0.751963328499147,"B.LvsV.REACTOME_COLLAGEN_FORMATION"
74,"Up",0.426181186464793,0.751963328499147,"B.LvsV.KEGG_ACUTE_MYELOID_LEUKEMIA"
56,"Down",0.426348744984106,0.751963328499147,"B.LvsV.BARRIER_COLON_CANCER_RECURRENCE_UP"
19,"Down",0.426370959458279,0.751963328499147,"B.LvsV.BIOCARTA_TNFR2_PATHWAY"
440,"Down",0.426828595924673,0.752205850442785,"B.LvsV.DAZARD_RESPONSE_TO_UV_NHEK_DN"
37,"Up",0.426867093248298,0.752205850442785,"B.LvsV.BIOCARTA_IL12_PATHWAY"
40,"Up",0.426995311248972,0.752205850442785,"B.LvsV.SCHEIDEREIT_IKK_TARGETS"
22,"Up",0.427086515982473,0.752205850442785,"B.LvsV.BIOCARTA_ARAP_PATHWAY"
21,"Up",0.427188708697838,0.752205850442785,"B.LvsV.REACTOME_IL_6_TYPE_CYTOKINE_RECEPTOR_LIGAND_INTERACTIONS"
15,"Down",0.427496930976047,0.752323331806683,"B.LvsV.SA_MMP_CYTOKINE_CONNECTION"
66,"Down",0.427637375484947,0.752323331806683,"B.LvsV.LEE_LIVER_CANCER_MYC_UP"
43,"Down",0.427663633906385,0.752323331806683,"B.LvsV.LIU_VAV3_PROSTATE_CARCINOGENESIS_DN"
10,"Up",0.427979625512964,0.75250727364398,"B.LvsV.REACTOME_NEUROTOXICITY_OF_CLOSTRIDIUM_TOXINS"
129,"Up",0.428151548035439,0.75250727364398,"B.LvsV.REACTOME_RUNX1_REGULATES_GENES_INVOLVED_IN_MEGAKARYOCYTE_DIFFERENTIATION_AND_PLATELET_FUNCTION"
129,"Down",0.428252686212448,0.75250727364398,"B.LvsV.HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_DN"
10,"Down",0.42835459719461,0.75250727364398,"B.LvsV.BIOCARTA_TERT_PATHWAY"
39,"Up",0.428527528948524,0.75250727364398,"B.LvsV.VERRECCHIA_RESPONSE_TO_TGFB1_C1"
11,"Down",0.428584808230221,0.75250727364398,"B.LvsV.KEGG_FOLATE_BIOSYNTHESIS"
173,"Up",0.429118811078868,0.753205684588908,"B.LvsV.HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_UP"
427,"Up",0.42970611776137,0.753883137785136,"B.LvsV.UDAYAKUMAR_MED1_TARGETS_DN"
66,"Up",0.429777473376515,0.753883137785136,"B.LvsV.KEGG_PATHOGENIC_ESCHERICHIA_COLI_INFECTION"
178,"Up",0.429976795181875,0.753993561865077,"B.LvsV.LINDGREN_BLADDER_CANCER_WITH_LOH_IN_CHR9Q"
110,"Up",0.430137727442011,0.754036618588103,"B.LvsV.KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY"
13,"Down",0.430321709196228,0.754120041250695,"B.LvsV.REACTOME_SMAC_XIAP_REGULATED_APOPTOTIC_RESPONSE"
17,"Up",0.43105016010098,0.754983197719497,"B.LvsV.BIOCARTA_DREAM_PATHWAY"
187,"Up",0.431087349466531,0.754983197719497,"B.LvsV.ROSS_AML_WITH_AML1_ETO_FUSION"
22,"Up",0.431612764676639,0.755664020233418,"B.LvsV.KEGG_SULFUR_METABOLISM"
56,"Down",0.43187866146369,0.755890192856202,"B.LvsV.REACTOME_HEPARAN_SULFATE_HEPARIN_HS_GAG_METABOLISM"
500,"Up",0.432691116987169,0.757008991116895,"B.LvsV.WANG_SMARCE1_TARGETS_UP"
234,"Down",0.432999978465458,0.757008991116895,"B.LvsV.DARWICHE_SKIN_TUMOR_PROMOTER_UP"
209,"Down",0.433481459718501,0.757008991116895,"B.LvsV.NABA_ECM_GLYCOPROTEINS"
28,"Down",0.433601252144364,0.757008991116895,"B.LvsV.REACTOME_REGULATION_OF_FZD_BY_UBIQUITINATION"
117,"Up",0.43364762082901,0.757008991116895,"B.LvsV.RIZKI_TUMOR_INVASIVENESS_2D_UP"
488,"Up",0.433787063923156,0.757008991116895,"B.LvsV.BROWNE_HCMV_INFECTION_14HR_DN"
67,"Down",0.433864094262663,0.757008991116895,"B.LvsV.REACTOME_SIGNALING_BY_EGFR"
308,"Up",0.433882302640549,0.757008991116895,"B.LvsV.MISSIAGLIA_REGULATED_BY_METHYLATION_UP"
129,"Down",0.433989899340874,0.757008991116895,"B.LvsV.REACTOME_RNA_POLYMERASE_I_TRANSCRIPTION"
141,"Up",0.434081903159906,0.757008991116895,"B.LvsV.NELSON_RESPONSE_TO_ANDROGEN_UP"
31,"Up",0.434087412738343,0.757008991116895,"B.LvsV.PID_S1P_META_PATHWAY"
25,"Up",0.434160880960693,0.757008991116895,"B.LvsV.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_22"
18,"Up",0.434513118380803,0.757247641597352,"B.LvsV.KEGG_RIBOFLAVIN_METABOLISM"
150,"Down",0.434571670607415,0.757247641597352,"B.LvsV.GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP"
99,"Down",0.434851838401886,0.757497106025214,"B.LvsV.GHANDHI_BYSTANDER_IRRADIATION_UP"
30,"Up",0.435124547379702,0.757733424397597,"B.LvsV.KEGG_BETA_ALANINE_METABOLISM"
210,"Up",0.43532358112051,0.757841335017412,"B.LvsV.HOELZEL_NF1_TARGETS_DN"
109,"Up",0.435881482903578,0.75857372331567,"B.LvsV.KEGG_MELANOGENESIS"
85,"Down",0.436521946990642,0.7592554769403,"B.LvsV.ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN"
7,"Up",0.436547867822972,0.7592554769403,"B.LvsV.REACTOME_LIPID_PARTICLE_ORGANIZATION"
1318,"Up",0.43707016000733,0.759924815937272,"B.LvsV.GOZGIT_ESR1_TARGETS_DN"
12,"Up",0.437314679945717,0.760110929085152,"B.LvsV.REACTOME_ACTIVATION_OF_RAC1_DOWNSTREAM_OF_NMDARS"
60,"Up",0.437539564114567,0.760262806407743,"B.LvsV.PID_SYNDECAN_1_PATHWAY"
88,"Up",0.437788864092648,0.760391450453621,"B.LvsV.LEE_AGING_MUSCLE_DN"
209,"Down",0.437888655858985,0.760391450453621,"B.LvsV.LANDIS_ERBB2_BREAST_TUMORS_324_UP"
56,"Up",0.438148718111793,0.760441736743133,"B.LvsV.DAIRKEE_CANCER_PRONE_RESPONSE_E2"
30,"Up",0.43834537831093,0.760441736743133,"B.LvsV.REACTOME_GLUTAMATE_NEUROTRANSMITTER_RELEASE_CYCLE"
119,"Down",0.438380132996538,0.760441736743133,"B.LvsV.LINDVALL_IMMORTALIZED_BY_TERT_DN"
313,"Up",0.438467762115592,0.760441736743133,"B.LvsV.BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_DN"
14,"Up",0.438936762013575,0.76100322787336,"B.LvsV.KEGG_LIMONENE_AND_PINENE_DEGRADATION"
214,"Up",0.439066792714057,0.76100322787336,"B.LvsV.NIKOLSKY_BREAST_CANCER_8Q23_Q24_AMPLICON"
36,"Up",0.439282631224119,0.761138723922956,"B.LvsV.BIOCARTA_TFF_PATHWAY"
14,"Down",0.439677016997669,0.761447509072263,"B.LvsV.REACTOME_HUR_ELAVL1_BINDS_AND_STABILIZES_MRNA"
58,"Up",0.439763360404405,0.761447509072263,"B.LvsV.WANG_RESPONSE_TO_ANDROGEN_UP"
151,"Up",0.439873999634076,0.761447509072263,"B.LvsV.SMITH_TERT_TARGETS_DN"
11,"Down",0.440128905578129,0.761650303268067,"B.LvsV.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_25"
14,"Down",0.440309653632413,0.76167082839609,"B.LvsV.REACTOME_RUNX1_AND_FOXP3_CONTROL_THE_DEVELOPMENT_OF_REGULATORY_T_LYMPHOCYTES_TREGS"
30,"Up",0.440416284749918,0.76167082839609,"B.LvsV.BIOCARTA_CCR5_PATHWAY"
22,"Up",0.440583929894506,0.761722497932058,"B.LvsV.FARMER_BREAST_CANCER_CLUSTER_6"
48,"Down",0.441399749764971,0.7627361051009,"B.LvsV.FRASOR_RESPONSE_TO_ESTRADIOL_UP"
11,"Up",0.441572006790257,0.7627361051009,"B.LvsV.REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_CASPASE_ACTIVATORS_AND_CASPASES"
56,"Down",0.44158406084789,0.7627361051009,"B.LvsV.SHAFFER_IRF4_MULTIPLE_MYELOMA_PROGRAM"
70,"Up",0.441809909067632,0.762887878586802,"B.LvsV.VALK_AML_CLUSTER_3"
185,"Down",0.441972563937355,0.762930473309284,"B.LvsV.SMIRNOV_RESPONSE_TO_IR_6HR_DN"
9,"Down",0.442256392848385,0.763182146085743,"B.LvsV.REACTOME_VITAMIN_C_ASCORBATE_METABOLISM"
107,"Up",0.442801060523212,0.763772005413177,"B.LvsV.JOHNSTONE_PARVB_TARGETS_1_DN"
10,"Up",0.442874488940974,0.763772005413177,"B.LvsV.REACTOME_NEGATIVE_REGULATION_OF_ACTIVITY_OF_TFAP2_AP_2_FAMILY_TRANSCRIPTION_FACTORS"
165,"Up",0.443313210343066,0.764039693251146,"B.LvsV.TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_UP"
31,"Up",0.443545970715553,0.764039693251146,"B.LvsV.CARDOSO_RESPONSE_TO_GAMMA_RADIATION_AND_3AB"
394,"Down",0.443718908835193,0.764039693251146,"B.LvsV.RUTELLA_RESPONSE_TO_HGF_DN"
2689,"Down",0.444008248099535,0.764039693251146,"B.LvsV.ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY"
67,"Down",0.444135801103444,0.764039693251146,"B.LvsV.YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_8"
5,"Up",0.444250499362656,0.764039693251146,"B.LvsV.REACTOME_SYNTHESIS_OF_GDP_MANNOSE"
61,"Up",0.444264097344861,0.764039693251146,"B.LvsV.BIOCARTA_NKCELLS_PATHWAY"
155,"Up",0.444271322827052,0.764039693251146,"B.LvsV.LEIN_CEREBELLUM_MARKERS"
64,"Up",0.444492530025825,0.764039693251146,"B.LvsV.MATTIOLI_MULTIPLE_MYELOMA_WITH_14Q32_TRANSLOCATIONS"
97,"Up",0.444625832607729,0.764039693251146,"B.LvsV.WEIGEL_OXIDATIVE_STRESS_RESPONSE"
614,"Up",0.444670007005383,0.764039693251146,"B.LvsV.RUTELLA_RESPONSE_TO_HGF_UP"
55,"Down",0.444687960369359,0.764039693251146,"B.LvsV.ROY_WOUND_BLOOD_VESSEL_DN"
32,"Down",0.444879078961704,0.764130608132731,"B.LvsV.REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS"
34,"Down",0.445216551771696,0.764472768554568,"B.LvsV.HUMMERICH_BENIGN_SKIN_TUMOR_UP"
7,"Down",0.445416994432594,0.764519352197452,"B.LvsV.REACTOME_CLEC7A_INFLAMMASOME_PATHWAY"
34,"Down",0.445520230200794,0.764519352197452,"B.LvsV.REACTOME_IKK_COMPLEX_RECRUITMENT_MEDIATED_BY_RIP1"
46,"Up",0.445835203575415,0.764822476130459,"B.LvsV.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_UP"
701,"Up",0.44620043974955,0.764938251002908,"B.LvsV.ENK_UV_RESPONSE_KERATINOCYTE_DN"
482,"Up",0.446237681986352,0.764938251002908,"B.LvsV.HOLLMANN_APOPTOSIS_VIA_CD40_DN"
41,"Up",0.44658005583886,0.764938251002908,"B.LvsV.MAYBURD_RESPONSE_TO_L663536_UP"
18,"Down",0.446606574313115,0.764938251002908,"B.LvsV.BIOCARTA_DNAFRAGMENT_PATHWAY"
4,"Up",0.446797662211527,0.764938251002908,"B.LvsV.REACTOME_ORGANIC_ANION_TRANSPORT"
258,"Up",0.446844227095025,0.764938251002908,"B.LvsV.RUIZ_TNC_TARGETS_UP"
663,"Up",0.446871143197575,0.764938251002908,"B.LvsV.VECCHI_GASTRIC_CANCER_EARLY_DN"
77,"Up",0.447064890518912,0.765033048492436,"B.LvsV.DORN_ADENOVIRUS_INFECTION_12HR_UP"
61,"Down",0.447490246303547,0.765524001179551,"B.LvsV.FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_DN"
20,"Down",0.448157825120042,0.76626306691958,"B.LvsV.REACTOME_FORMATION_OF_SENESCENCE_ASSOCIATED_HETEROCHROMATIN_FOCI_SAHF"
198,"Up",0.44819944988568,0.76626306691958,"B.LvsV.CERVERA_SDHB_TARGETS_1_UP"
59,"Up",0.4487375515198,0.766788597240781,"B.LvsV.GYORFFY_MITOXANTRONE_RESISTANCE"
44,"Up",0.448784210647706,0.766788597240781,"B.LvsV.REACTOME_CA_DEPENDENT_EVENTS"
70,"Down",0.449517420938564,0.767804084142514,"B.LvsV.LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_UP"
189,"Up",0.449705735456674,0.767888514928953,"B.LvsV.ROSS_ACUTE_MYELOID_LEUKEMIA_CBF"
39,"Up",0.450112606603177,0.768153937406491,"B.LvsV.GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_DN"
228,"Down",0.450245230132247,0.768153937406491,"B.LvsV.REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_BCR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS"
38,"Down",0.45027797271377,0.768153937406491,"B.LvsV.DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_UP"
30,"Down",0.450665271186439,0.768577509065337,"B.LvsV.REACTOME_CALNEXIN_CALRETICULIN_CYCLE"
68,"Up",0.45103288410072,0.76896725753712,"B.LvsV.CASORELLI_APL_SECONDARY_VS_DE_NOVO_UP"
48,"Up",0.451535105286974,0.76950019600345,"B.LvsV.BIOCARTA_EGF_PATHWAY"
12,"Up",0.451623826375691,0.76950019600345,"B.LvsV.REACTOME_MECP2_REGULATES_TRANSCRIPTION_OF_NEURONAL_LIGANDS"
71,"Up",0.451811676649672,0.769583105420837,"B.LvsV.PID_AJDISS_2PATHWAY"
8,"Down",0.452644920447572,0.770666578661884,"B.LvsV.REACTOME_HDL_CLEARANCE"
77,"Up",0.452726541416857,0.770666578661884,"B.LvsV.KEGG_COLORECTAL_CANCER"
45,"Up",0.452951219364752,0.770782773783648,"B.LvsV.SAMOLS_TARGETS_OF_KHSV_MIRNAS_UP"
10,"Down",0.453200404875378,0.770782773783648,"B.LvsV.REACTOME_MULTIFUNCTIONAL_ANION_EXCHANGERS"
12,"Down",0.453316234572774,0.770782773783648,"B.LvsV.BIOCARTA_RHODOPSIN_PATHWAY"
161,"Up",0.453352429072965,0.770782773783648,"B.LvsV.VANLOO_SP3_TARGETS_DN"
1037,"Up",0.453892531956196,0.771213187980352,"B.LvsV.CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_3"
17,"Up",0.4541515659853,0.771213187980352,"B.LvsV.REACTOME_NOTCH4_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS"
43,"Up",0.454365053688913,0.771213187980352,"B.LvsV.ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_DN"
366,"Down",0.45442596143513,0.771213187980352,"B.LvsV.GROSS_HYPOXIA_VIA_ELK3_UP"
198,"Down",0.454702670247541,0.771213187980352,"B.LvsV.NIKOLSKY_BREAST_CANCER_17Q11_Q21_AMPLICON"
24,"Down",0.454707185193153,0.771213187980352,"B.LvsV.REACTOME_SIGNALING_BY_NODAL"
78,"Up",0.454736172925683,0.771213187980352,"B.LvsV.PID_PS1_PATHWAY"
65,"Up",0.454821057233502,0.771213187980352,"B.LvsV.GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_UP"
21,"Up",0.454986283454389,0.771213187980352,"B.LvsV.IRITANI_MAD1_TARGETS_UP"
243,"Up",0.455000437546013,0.771213187980352,"B.LvsV.IGLESIAS_E2F_TARGETS_UP"
54,"Up",0.455216686624189,0.771255394305131,"B.LvsV.ROZANOV_MMP14_TARGETS_DN"
25,"Down",0.455463140338,0.771255394305131,"B.LvsV.KEGG_RENIN_ANGIOTENSIN_SYSTEM"
93,"Up",0.455530127359388,0.771255394305131,"B.LvsV.REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR"
103,"Down",0.4556626566626,0.771255394305131,"B.LvsV.BROWNE_HCMV_INFECTION_4HR_UP"
32,"Down",0.455722802169445,0.771255394305131,"B.LvsV.REACTOME_DISEASES_OF_PROGRAMMED_CELL_DEATH"
18,"Up",0.456002501803214,0.771282792380521,"B.LvsV.REACTOME_PROCESSING_OF_SMDT1"
876,"Down",0.456051743402906,0.771282792380521,"B.LvsV.ENK_UV_RESPONSE_KERATINOCYTE_UP"
16,"Down",0.456157484370466,0.771282792380521,"B.LvsV.REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TN_POLYAGGLUTINATION_SYNDROME_TNPS"
33,"Down",0.456530495873848,0.771490209889505,"B.LvsV.BIOCARTA_CYTOKINE_PATHWAY"
26,"Up",0.456673680847675,0.771490209889505,"B.LvsV.REACTOME_THROMBOXANE_SIGNALLING_THROUGH_TP_RECEPTOR"
32,"Down",0.4567130596176,0.771490209889505,"B.LvsV.REACTOME_CASPASE_ACTIVATION_VIA_EXTRINSIC_APOPTOTIC_SIGNALLING_PATHWAY"
73,"Up",0.456838297554393,0.771490209889505,"B.LvsV.URS_ADIPOCYTE_DIFFERENTIATION_DN"
63,"Up",0.457739045129059,0.772775322295747,"B.LvsV.REACTOME_SYNTHESIS_OF_SUBSTRATES_IN_N_GLYCAN_BIOSYTHESIS"
19,"Down",0.457980510068056,0.772946959757716,"B.LvsV.REACTOME_SYNTHESIS_SECRETION_AND_INACTIVATION_OF_GLUCOSE_DEPENDENT_INSULINOTROPIC_POLYPEPTIDE_GIP"
1026,"Down",0.458179764383018,0.772970652681744,"B.LvsV.GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN"
28,"Up",0.458411286194933,0.772970652681744,"B.LvsV.REACTOME_SULFUR_AMINO_ACID_METABOLISM"
47,"Up",0.458493518970087,0.772970652681744,"B.LvsV.BIOCARTA_PDGF_PATHWAY"
128,"Up",0.45855376031762,0.772970652681744,"B.LvsV.REACTOME_HEDGEHOG_OFF_STATE"
32,"Up",0.459289476493939,0.773794592905507,"B.LvsV.SILIGAN_TARGETS_OF_EWS_FLI1_FUSION_DN"
55,"Down",0.459322455039948,0.773794592905507,"B.LvsV.FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_DN"
6,"Up",0.460076147573966,0.774828211981863,"B.LvsV.REACTOME_MITOCHONDRIAL_FATTY_ACID_BETA_OXIDATION_OF_UNSATURATED_FATTY_ACIDS"
325,"Up",0.461007357454221,0.776160072888059,"B.LvsV.LINSLEY_MIR16_TARGETS"
51,"Up",0.462109778132985,0.776823452322982,"B.LvsV.KEGG_AMINO_SUGAR_AND_NUCLEOTIDE_SUGAR_METABOLISM"
11,"Up",0.462195657119876,0.776823452322982,"B.LvsV.MULLIGAN_NTF3_SIGNALING_VIA_INSR_AND_IGF1R_DN"
667,"Down",0.462242932511485,0.776823452322982,"B.LvsV.CHYLA_CBFA2T3_TARGETS_UP"
26,"Up",0.462258117314116,0.776823452322982,"B.LvsV.BARRIER_COLON_CANCER_RECURRENCE_DN"
17,"Up",0.462424179166854,0.776823452322982,"B.LvsV.REACTOME_PKA_ACTIVATION_IN_GLUCAGON_SIGNALLING"
509,"Up",0.462436648421346,0.776823452322982,"B.LvsV.KUMAR_PATHOGEN_LOAD_BY_MACROPHAGES"
25,"Down",0.462511862557651,0.776823452322982,"B.LvsV.REACTOME_SIGNALING_BY_CYTOSOLIC_FGFR1_FUSION_MUTANTS"
33,"Up",0.462525376206775,0.776823452322982,"B.LvsV.KIM_LIVER_CANCER_POOR_SURVIVAL_UP"
21,"Up",0.462837922191744,0.776871772651848,"B.LvsV.REACTOME_PROSTACYCLIN_SIGNALLING_THROUGH_PROSTACYCLIN_RECEPTOR"
38,"Up",0.463033137591932,0.776871772651848,"B.LvsV.KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_OLD"
113,"Up",0.463144413228276,0.776871772651848,"B.LvsV.PID_CD8_TCR_DOWNSTREAM_PATHWAY"
18,"Down",0.463320645542425,0.776871772651848,"B.LvsV.MIKKELSEN_IPS_LCP_WITH_H3K4ME3_AND_H3K27ME3"
10,"Down",0.463340167604844,0.776871772651848,"B.LvsV.BIOCARTA_IL22BP_PATHWAY"
188,"Up",0.463397197722155,0.776871772651848,"B.LvsV.KIM_MYC_AMPLIFICATION_TARGETS_DN"
168,"Up",0.463975158921386,0.777604926849453,"B.LvsV.REACTOME_DEATH_RECEPTOR_SIGNALLING"
6,"Down",0.464356573967664,0.778008332565823,"B.LvsV.REACTOME_FICOLINS_BIND_TO_REPETITIVE_CARBOHYDRATE_STRUCTURES_ON_THE_TARGET_CELL_SURFACE"
11,"Down",0.464905819928132,0.778516392870631,"B.LvsV.STEGMEIER_PREMITOTIC_CELL_CYCLE_REGULATORS"
307,"Down",0.464941423269818,0.778516392870631,"B.LvsV.SMID_BREAST_CANCER_ERBB2_UP"
18,"Down",0.465376415915427,0.778858699830904,"B.LvsV.REACTOME_NEUROTRANSMITTER_CLEARANCE"
305,"Up",0.465427589842884,0.778858699830904,"B.LvsV.REACTOME_FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS"
94,"Up",0.465734824575009,0.779137018177073,"B.LvsV.GARCIA_TARGETS_OF_FLI1_AND_DAX1_UP"
16,"Down",0.465992622415623,0.779239566609914,"B.LvsV.ZHOU_PANCREATIC_EXOCRINE_PROGENITOR"
10,"Down",0.466077997247058,0.779239566609914,"B.LvsV.DONATO_CELL_CYCLE_TRETINOIN"
118,"Up",0.466393038408765,0.779341577386184,"B.LvsV.KEGG_PROSTATE_CANCER"
46,"Up",0.466420922331504,0.779341577386184,"B.LvsV.ONGUSAHA_TP53_TARGETS"
12,"Down",0.466630695689652,0.779456530655012,"B.LvsV.REACTOME_CHYLOMICRON_ASSEMBLY"
67,"Up",0.467005417726856,0.779846860347867,"B.LvsV.JAZAG_TGFB1_SIGNALING_DN"
71,"Down",0.467403876798858,0.780276580561861,"B.LvsV.REACTOME_SIGNALING_BY_NOTCH3"
14,"Up",0.467968881633658,0.78098398628207,"B.LvsV.REACTOME_CS_DS_DEGRADATION"
533,"Up",0.468320660753796,0.781121871277641,"B.LvsV.HORIUCHI_WTAP_TARGETS_UP"
39,"Up",0.468334057385672,0.781121871277641,"B.LvsV.REACTOME_TNFR1_INDUCED_NFKAPPAB_SIGNALING_PATHWAY"
267,"Up",0.469052630293981,0.781920440941104,"B.LvsV.REACTOME_PARASITE_INFECTION"
195,"Up",0.469095695894672,0.781920440941104,"B.LvsV.REACTOME_ION_CHANNEL_TRANSPORT"
557,"Up",0.469396399046992,0.782185862064743,"B.LvsV.OSMAN_BLADDER_CANCER_UP"
181,"Down",0.470857283424709,0.784224744317057,"B.LvsV.HOSHIDA_LIVER_CANCER_SUBCLASS_S2"
13,"Down",0.470903626538728,0.784224744317057,"B.LvsV.REACTOME_CASPASE_ACTIVATION_VIA_DEPENDENCE_RECEPTORS_IN_THE_ABSENCE_OF_LIGAND"
118,"Up",0.471365418893567,0.784757422783056,"B.LvsV.LEE_AGING_NEOCORTEX_DN"
181,"Down",0.472013155758051,0.785456548677416,"B.LvsV.REACTOME_REGULATION_OF_TP53_ACTIVITY"
45,"Up",0.472143867672625,0.785456548677416,"B.LvsV.REACTOME_GABA_B_RECEPTOR_ACTIVATION"
43,"Down",0.472211533334008,0.785456548677416,"B.LvsV.REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN"
104,"Up",0.472831641546761,0.786251472514901,"B.LvsV.ZHENG_IL22_SIGNALING_DN"
1129,"Down",0.473155828065323,0.786439490179466,"B.LvsV.BENPORATH_MYC_MAX_TARGETS"
177,"Up",0.473229188610433,0.786439490179466,"B.LvsV.REACTOME_SIGNALING_BY_HEDGEHOG"
61,"Up",0.47406189400509,0.787361884097903,"B.LvsV.KEGG_GLYCEROLIPID_METABOLISM"
42,"Down",0.474069038191702,0.787361884097903,"B.LvsV.OHM_METHYLATED_IN_ADULT_CANCERS"
325,"Up",0.474319629100063,0.787541510298573,"B.LvsV.TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN"
44,"Down",0.474479726352576,0.787570821676191,"B.LvsV.YANG_BREAST_CANCER_ESR1_BULK_DN"
37,"Up",0.474723707429025,0.787642540243199,"B.LvsV.MATZUK_CENTRAL_FOR_FEMALE_FERTILITY"
5,"Down",0.474807847102656,0.787642540243199,"B.LvsV.REACTOME_EXTRINSIC_PATHWAY_OF_FIBRIN_CLOT_FORMATION"
28,"Up",0.475199832405808,0.788056350741366,"B.LvsV.SEKI_INFLAMMATORY_RESPONSE_LPS_DN"
648,"Up",0.475578264956857,0.788447444361758,"B.LvsV.SANSOM_APC_TARGETS_DN"
150,"Up",0.475846363260481,0.788475501922835,"B.LvsV.REACTOME_METABOLISM_OF_WATER_SOLUBLE_VITAMINS_AND_COFACTORS"
80,"Up",0.475903479659598,0.788475501922835,"B.LvsV.REACTOME_TRANSCRIPTIONAL_REGULATION_BY_MECP2"
46,"Down",0.476023010565821,0.788475501922835,"B.LvsV.YAMASHITA_LIVER_CANCER_WITH_EPCAM_DN"
202,"Down",0.476240906278842,0.788585286702433,"B.LvsV.REACTOME_CREATION_OF_C4_AND_C2_ACTIVATORS"
18,"Up",0.476374544689117,0.788585286702433,"B.LvsV.REACTOME_ACTIVATION_OF_BAD_AND_TRANSLOCATION_TO_MITOCHONDRIA"
120,"Down",0.476592476382378,0.78870990778754,"B.LvsV.SESTO_RESPONSE_TO_UV_C1"
23,"Down",0.476782040604765,0.788720835582942,"B.LvsV.REACTOME_RAF_INDEPENDENT_MAPK1_3_ACTIVATION"
136,"Up",0.477096752759513,0.788720835582942,"B.LvsV.CROMER_METASTASIS_UP"
61,"Up",0.477129210357019,0.788720835582942,"B.LvsV.REACTOME_RUNX2_REGULATES_BONE_DEVELOPMENT"
385,"Down",0.477169686204547,0.788720835582942,"B.LvsV.BROWNE_HCMV_INFECTION_48HR_UP"
750,"Down",0.477318442274328,0.78873092269419,"B.LvsV.ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP"
50,"Up",0.477940088529944,0.789099226628797,"B.LvsV.MINGUEZ_LIVER_CANCER_VASCULAR_INVASION_DN"
1160,"Up",0.478055904569338,0.789099226628797,"B.LvsV.WONG_ADULT_TISSUE_STEM_MODULE"
19,"Down",0.478432751573775,0.789099226628797,"B.LvsV.HOFFMAN_CLOCK_TARGETS_UP"
457,"Up",0.478502386793946,0.789099226628797,"B.LvsV.ZWANG_DOWN_BY_2ND_EGF_PULSE"
168,"Up",0.478651781011393,0.789099226628797,"B.LvsV.NAKAMURA_ADIPOGENESIS_LATE_UP"
34,"Up",0.478679463596376,0.789099226628797,"B.LvsV.REACTOME_INSULIN_PROCESSING"
27,"Down",0.478680081355913,0.789099226628797,"B.LvsV.WACKER_HYPOXIA_TARGETS_OF_VHL"
116,"Up",0.478720366087102,0.789099226628797,"B.LvsV.MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_DN"
129,"Up",0.478825810334529,0.789099226628797,"B.LvsV.MENSE_HYPOXIA_UP"
31,"Down",0.479459404686623,0.789907940557907,"B.LvsV.MATZUK_POSTIMPLANTATION_AND_POSTPARTUM"
68,"Up",0.480041184278159,0.790630833444724,"B.LvsV.REACTOME_TRANSCRIPTIONAL_ACTIVATION_OF_MITOCHONDRIAL_BIOGENESIS"
159,"Down",0.480488087903422,0.790801486072841,"B.LvsV.CAMPS_COLON_CANCER_COPY_NUMBER_UP"
69,"Down",0.480550729987034,0.790801486072841,"B.LvsV.PEART_HDAC_PROLIFERATION_CLUSTER_UP"
303,"Down",0.480697325866475,0.790801486072841,"B.LvsV.REACTOME_CHROMATIN_MODIFYING_ENZYMES"
49,"Up",0.480854493957716,0.790801486072841,"B.LvsV.KEGG_LYSINE_DEGRADATION"
8,"Down",0.480859937814594,0.790801486072841,"B.LvsV.REACTOME_TRNA_MODIFICATION_IN_THE_MITOCHONDRION"
23,"Up",0.481194440777094,0.790905021397122,"B.LvsV.REACTOME_CTLA4_INHIBITORY_SIGNALING"
10,"Down",0.481337003466025,0.790905021397122,"B.LvsV.REACTOME_THYROXINE_BIOSYNTHESIS"
11,"Down",0.481419120734235,0.790905021397122,"B.LvsV.REACTOME_BH3_ONLY_PROTEINS_ASSOCIATE_WITH_AND_INACTIVATE_ANTI_APOPTOTIC_BCL_2_MEMBERS"
38,"Down",0.481562753657946,0.790905021397122,"B.LvsV.HOEGERKORP_CD44_TARGETS_DIRECT_DN"
84,"Up",0.481638127517473,0.790905021397122,"B.LvsV.REACTOME_INTERLEUKIN_17_SIGNALING"
123,"Down",0.481923723645681,0.791139034452781,"B.LvsV.KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_UP"
38,"Down",0.482521322376263,0.791884948476805,"B.LvsV.MALTA_CURATED_STEMNESS_MARKERS"
15,"Up",0.482763947746122,0.791917702222173,"B.LvsV.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_9"
56,"Down",0.48285712649139,0.791917702222173,"B.LvsV.KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION"
26,"Up",0.483219049778354,0.791917702222173,"B.LvsV.SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX1_UP"
35,"Up",0.483248937314189,0.791917702222173,"B.LvsV.SIG_IL4RECEPTOR_IN_B_LYPHOCYTES"
83,"Down",0.483382597817157,0.791917702222173,"B.LvsV.HAN_JNK_SINGALING_UP"
559,"Up",0.483400659251191,0.791917702222173,"B.LvsV.REACTOME_SIGNALING_BY_RHO_GTPASES"
59,"Up",0.48380545896744,0.792162336960023,"B.LvsV.BRACHAT_RESPONSE_TO_METHOTREXATE_UP"
12,"Down",0.484033756158286,0.792162336960023,"B.LvsV.REACTOME_RUNX2_REGULATES_CHONDROCYTE_MATURATION"
118,"Up",0.484036635082743,0.792162336960023,"B.LvsV.KEGG_DRUG_METABOLISM_CYTOCHROME_P450"
522,"Down",0.484123084931799,0.792162336960023,"B.LvsV.YANG_BCL3_TARGETS_UP"
110,"Down",0.484473321664552,0.792500886237664,"B.LvsV.LEE_LIVER_CANCER_MYC_DN"
37,"Down",0.485067921800124,0.793150113842148,"B.LvsV.IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_UP"
35,"Down",0.485157114308942,0.793150113842148,"B.LvsV.SA_B_CELL_RECEPTOR_COMPLEXES"
89,"Up",0.48533904712486,0.793213003710716,"B.LvsV.REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH"
71,"Up",0.485572060007772,0.79334886835958,"B.LvsV.REACTOME_RECOGNITION_AND_ASSOCIATION_OF_DNA_GLYCOSYLASE_WITH_SITE_CONTAINING_AN_AFFECTED_PURINE"
835,"Up",0.485709155253604,0.79334886835958,"B.LvsV.ZWANG_CLASS_1_TRANSIENTLY_INDUCED_BY_EGF"
90,"Up",0.485919214303955,0.793349736714227,"B.LvsV.PID_LYSOPHOSPHOLIPID_PATHWAY"
115,"Up",0.485996664541705,0.793349736714227,"B.LvsV.DARWICHE_PAPILLOMA_PROGRESSION_RISK"
12,"Down",0.48614940077729,0.793364827891864,"B.LvsV.REACTOME_HDL_REMODELING"
104,"Down",0.486692181723926,0.79365560254225,"B.LvsV.REACTOME_COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC"
20,"Down",0.486983915156857,0.79365560254225,"B.LvsV.BIOCARTA_CBL_PATHWAY"
43,"Up",0.487218000908018,0.79365560254225,"B.LvsV.REACTOME_ADRENALINE_NORADRENALINE_INHIBITS_INSULIN_SECRETION"
423,"Up",0.487367825922187,0.79365560254225,"B.LvsV.GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP"
91,"Up",0.487638888007251,0.79365560254225,"B.LvsV.REACTOME_SPHINGOLIPID_METABOLISM"
13,"Down",0.487684704128474,0.79365560254225,"B.LvsV.VANLOO_SP3_TARGETS_UP"
100,"Up",0.487827727811158,0.79365560254225,"B.LvsV.REACTOME_G_ALPHA_12_13_SIGNALLING_EVENTS"
48,"Up",0.4878669989595,0.79365560254225,"B.LvsV.PIEPOLI_LGI1_TARGETS_DN"
94,"Down",0.487937198405067,0.79365560254225,"B.LvsV.CHIARETTI_ACUTE_LYMPHOBLASTIC_LEUKEMIA_ZAP70"
46,"Up",0.487987379715429,0.79365560254225,"B.LvsV.REACTOME_PHASE_0_RAPID_DEPOLARISATION"
50,"Down",0.488060605435593,0.79365560254225,"B.LvsV.LOPEZ_MESOTHELIOMA_SURVIVAL_OVERALL_DN"
109,"Up",0.488222882297497,0.79365560254225,"B.LvsV.KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_DN"
24,"Up",0.488281405427591,0.79365560254225,"B.LvsV.MATZUK_EARLY_ANTRAL_FOLLICLE"
131,"Up",0.488337196572388,0.79365560254225,"B.LvsV.HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_UP"
289,"Up",0.488524934878845,0.793705420465619,"B.LvsV.BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_DN"
137,"Up",0.488654955916977,0.793705420465619,"B.LvsV.GAJATE_RESPONSE_TO_TRABECTEDIN_UP"
35,"Up",0.48899211133861,0.793747411854267,"B.LvsV.PID_RXR_VDR_PATHWAY"
160,"Up",0.489572494941845,0.793747411854267,"B.LvsV.SANA_RESPONSE_TO_IFNG_UP"
33,"Up",0.489835203796031,0.793747411854267,"B.LvsV.REACTOME_BMAL1_CLOCK_NPAS2_ACTIVATES_CIRCADIAN_GENE_EXPRESSION"
16,"Up",0.489946242948134,0.793747411854267,"B.LvsV.REACTOME_PHENYLALANINE_AND_TYROSINE_METABOLISM"
25,"Down",0.490228753381072,0.793747411854267,"B.LvsV.KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS_AND_CYCLIC_RGD"
677,"Up",0.490323919009061,0.793747411854267,"B.LvsV.BASAKI_YBX1_TARGETS_DN"
102,"Up",0.490366436553861,0.793747411854267,"B.LvsV.REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION"
96,"Up",0.490447670126716,0.793747411854267,"B.LvsV.REACTOME_MITOCHONDRIAL_TRANSLATION"
107,"Up",0.490455328073449,0.793747411854267,"B.LvsV.REACTOME_SELECTIVE_AUTOPHAGY"
79,"Down",0.49056114541602,0.793747411854267,"B.LvsV.SPIRA_SMOKERS_LUNG_CANCER_UP"
25,"Down",0.490595574484566,0.793747411854267,"B.LvsV.REACTOME_JNK_C_JUN_KINASES_PHOSPHORYLATION_AND_ACTIVATION_MEDIATED_BY_ACTIVATED_HUMAN_TAK1"
62,"Down",0.490595686567097,0.793747411854267,"B.LvsV.REACTOME_SIGNALING_BY_SCF_KIT"
18,"Up",0.490646242358676,0.793747411854267,"B.LvsV.FRASOR_TAMOXIFEN_RESPONSE_DN"
143,"Down",0.490690659019332,0.793747411854267,"B.LvsV.SWEET_KRAS_TARGETS_DN"
209,"Up",0.490893712865533,0.793767340954197,"B.LvsV.KANG_IMMORTALIZED_BY_TERT_DN"
48,"Down",0.491229368223803,0.793767340954197,"B.LvsV.PID_HIV_NEF_PATHWAY"
53,"Up",0.491234659616776,0.793767340954197,"B.LvsV.BRACHAT_RESPONSE_TO_CAMPTOTHECIN_UP"
9,"Down",0.491277236524735,0.793767340954197,"B.LvsV.TURJANSKI_MAPK8_AND_MAPK9_TARGETS"
137,"Down",0.491560778359621,0.793770209694564,"B.LvsV.SHIPP_DLBCL_CURED_VS_FATAL_UP"
50,"Up",0.491566141796742,0.793770209694564,"B.LvsV.WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_DN"
51,"Up",0.492795840397688,0.794805936852049,"B.LvsV.EHLERS_ANEUPLOIDY_UP"
10,"Up",0.492929249676679,0.794805936852049,"B.LvsV.SA_FAS_SIGNALING"
957,"Up",0.493107868380138,0.794805936852049,"B.LvsV.MASSARWEH_TAMOXIFEN_RESISTANCE_UP"
81,"Down",0.493371260735237,0.794805936852049,"B.LvsV.DAZARD_UV_RESPONSE_CLUSTER_G2"
46,"Up",0.493450387352228,0.794805936852049,"B.LvsV.PID_ANTHRAX_PATHWAY"
144,"Down",0.493464361987677,0.794805936852049,"B.LvsV.WINZEN_DEGRADED_VIA_KHSRP"
83,"Down",0.493762508693182,0.794805936852049,"B.LvsV.BIOCARTA_NUCLEARRS_PATHWAY"
13,"Up",0.493783811968264,0.794805936852049,"B.LvsV.REACTOME_CAMK_IV_MEDIATED_PHOSPHORYLATION_OF_CREB"
13,"Up",0.493783811968264,0.794805936852049,"B.LvsV.REACTOME_CREB1_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_CAMKII_CAMKK_CAMKIV_CASCASDE"
181,"Down",0.493860403819619,0.794805936852049,"B.LvsV.LIN_SILENCED_BY_TUMOR_MICROENVIRONMENT"
73,"Down",0.493988839219104,0.794805936852049,"B.LvsV.ZHAN_V1_LATE_DIFFERENTIATION_GENES_UP"
243,"Down",0.494039270571234,0.794805936852049,"B.LvsV.ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP"
106,"Down",0.494076325729877,0.794805936852049,"B.LvsV.RICKMAN_HEAD_AND_NECK_CANCER_B"
15,"Up",0.494338464095355,0.794996325765916,"B.LvsV.PID_P38_GAMMA_DELTA_PATHWAY"
123,"Up",0.494605392616274,0.795156672555041,"B.LvsV.LI_WILMS_TUMOR"
161,"Up",0.494746118026594,0.795156672555041,"B.LvsV.CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_UP"
1260,"Down",0.49488303940609,0.795156672555041,"B.LvsV.ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_UP"
9,"Up",0.495203171589588,0.795156672555041,"B.LvsV.REACTOME_CREB3_FACTORS_ACTIVATE_GENES"
96,"Up",0.4953402049382,0.795156672555041,"B.LvsV.MIKKELSEN_ES_HCP_WITH_H3K27ME3"
236,"Up",0.495350947759257,0.795156672555041,"B.LvsV.COULOUARN_TEMPORAL_TGFB1_SIGNATURE_DN"
174,"Up",0.495853366079231,0.795156672555041,"B.LvsV.YAMASHITA_METHYLATED_IN_PROSTATE_CANCER"
31,"Up",0.495857211289657,0.795156672555041,"B.LvsV.PID_WNT_CANONICAL_PATHWAY"
334,"Down",0.495897965687162,0.795156672555041,"B.LvsV.VERHAAK_GLIOBLASTOMA_PRONEURAL"
56,"Down",0.495910626086347,0.795156672555041,"B.LvsV.BOYAULT_LIVER_CANCER_SUBCLASS_G5_DN"
138,"Down",0.496132222612799,0.795156672555041,"B.LvsV.WORSCHECH_TUMOR_REJECTION_UP"
25,"Down",0.496163957372923,0.795156672555041,"B.LvsV.MIKKELSEN_ES_LCP_WITH_H3K27ME3"
196,"Up",0.496394103223478,0.795294986010609,"B.LvsV.AMBROSINI_FLAVOPIRIDOL_TREATMENT_TP53"
46,"Up",0.496817688392973,0.795520435885309,"B.LvsV.REACTOME_NOD1_2_SIGNALING_PATHWAY"
25,"Up",0.496822583670098,0.795520435885309,"B.LvsV.REACTOME_SUMOYLATION_OF_TRANSCRIPTION_FACTORS"
36,"Up",0.497013157186099,0.795595178367672,"B.LvsV.BIOCARTA_INTRINSIC_PATHWAY"
19,"Up",0.497415143460153,0.795818872792886,"B.LvsV.REACTOME_PRESYNAPTIC_DEPOLARIZATION_AND_CALCIUM_CHANNEL_OPENING"
167,"Down",0.497440771273687,0.795818872792886,"B.LvsV.QI_PLASMACYTOMA_DN"
73,"Up",0.498061593027196,0.796401527650828,"B.LvsV.CHANGOLKAR_H2AFY_TARGETS_UP"
140,"Down",0.498093051657906,0.796401527650828,"B.LvsV.NATSUME_RESPONSE_TO_INTERFERON_BETA_UP"
72,"Down",0.498239892851656,0.796406003925067,"B.LvsV.ZHAN_MULTIPLE_MYELOMA_LB_UP"
8,"Down",0.49843245338392,0.796483536057715,"B.LvsV.REACTOME_SYNTHESIS_OF_UDP_N_ACETYL_GLUCOSAMINE"
32,"Down",0.498737956575099,0.796741450997897,"B.LvsV.FINAK_BREAST_CANCER_SDPP_SIGNATURE"
32,"Down",0.499556598012125,0.79774949545486,"B.LvsV.BIOCARTA_RAC1_PATHWAY"
73,"Up",0.499657533506996,0.79774949545486,"B.LvsV.REACTOME_NETRIN_1_SIGNALING"
151,"Up",0.500489339206151,0.798846869650927,"B.LvsV.CHANG_IMMORTALIZED_BY_HPV31_DN"
8,"Down",0.500738317862212,0.798985680763702,"B.LvsV.BIOCARTA_ION_PATHWAY"
45,"Up",0.500913678018085,0.798985680763702,"B.LvsV.REACTOME_NEGATIVE_REGULATORS_OF_DDX58_IFIH1_SIGNALING"
5,"Down",0.501100900964132,0.798985680763702,"B.LvsV.REACTOME_BETA_OXIDATION_OF_LAUROYL_COA_TO_DECANOYL_COA_COA"
173,"Up",0.50167587719336,0.798985680763702,"B.LvsV.KIM_WT1_TARGETS_8HR_DN"
257,"Up",0.501738338271728,0.798985680763702,"B.LvsV.GAVIN_FOXP3_TARGETS_CLUSTER_P3"
5,"Up",0.501835642595429,0.798985680763702,"B.LvsV.REACTOME_TYROSINE_CATABOLISM"
27,"Down",0.501847651292874,0.798985680763702,"B.LvsV.REACTOME_SYNTHESIS_OF_EPOXY_EET_AND_DIHYDROXYEICOSATRIENOIC_ACIDS_DHET"
13,"Down",0.50197373532637,0.798985680763702,"B.LvsV.GOUYER_TUMOR_INVASIVENESS"
74,"Down",0.502009092332546,0.798985680763702,"B.LvsV.KUUSELO_PANCREATIC_CANCER_19Q13_AMPLIFICATION"
105,"Up",0.502021388130422,0.798985680763702,"B.LvsV.LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_DN"
430,"Up",0.502317819302918,0.799227402280815,"B.LvsV.LU_EZH2_TARGETS_UP"
6,"Up",0.502572868386581,0.799308211830349,"B.LvsV.REACTOME_TRANSPORT_AND_SYNTHESIS_OF_PAPS"
10,"Down",0.502657741460323,0.799308211830349,"B.LvsV.KONDO_HYPOXIA"
54,"Up",0.502838854073637,0.799366309422985,"B.LvsV.PID_IFNG_PATHWAY"
27,"Up",0.503305526362604,0.799831066037837,"B.LvsV.REACTOME_WNT_LIGAND_BIOGENESIS_AND_TRAFFICKING"
14,"Down",0.503552776371602,0.799831066037837,"B.LvsV.REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_DEATH_RECEPTORS_AND_LIGANDS"
307,"Up",0.503565190970829,0.799831066037837,"B.LvsV.CAIRO_HEPATOBLASTOMA_UP"
666,"Up",0.503836485049909,0.800032144124338,"B.LvsV.FOSTER_KDM1A_TARGETS_UP"
5,"Down",0.504600793138051,0.801015729331118,"B.LvsV.REACTOME_DISEASES_OF_BASE_EXCISION_REPAIR"
24,"Down",0.504955423387626,0.801186851326886,"B.LvsV.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_24"
45,"Down",0.504998404209477,0.801186851326886,"B.LvsV.ABE_VEGFA_TARGETS_2HR"
240,"Down",0.505342402046052,0.801502622178032,"B.LvsV.TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN"
54,"Up",0.505960244612739,0.802252421125276,"B.LvsV.REACTOME_HDMS_DEMETHYLATE_HISTONES"
105,"Up",0.506593846954211,0.802805161588238,"B.LvsV.REACTOME_HEDGEHOG_ON_STATE"
42,"Up",0.506641612596148,0.802805161588238,"B.LvsV.BONOME_OVARIAN_CANCER_POOR_SURVIVAL_DN"
42,"Up",0.506746009593401,0.802805161588238,"B.LvsV.SUZUKI_RESPONSE_TO_TSA_AND_DECITABINE_1A"
35,"Up",0.506897879096235,0.802805161588238,"B.LvsV.REACTOME_ACTIVATION_OF_KAINATE_RECEPTORS_UPON_GLUTAMATE_BINDING"
12,"Down",0.507034838897835,0.802805161588238,"B.LvsV.NIKOLSKY_BREAST_CANCER_20P13_AMPLICON"
700,"Down",0.507321756137259,0.803029484592873,"B.LvsV.MARTENS_BOUND_BY_PML_RARA_FUSION"
48,"Down",0.507605090914156,0.803237256443088,"B.LvsV.BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_UP"
36,"Down",0.507808023892996,0.803237256443088,"B.LvsV.GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_UP"
17,"Up",0.507888849434805,0.803237256443088,"B.LvsV.REACTOME_ERBB2_REGULATES_CELL_MOTILITY"
73,"Down",0.50861123565649,0.804058581494143,"B.LvsV.LIAO_HAVE_SOX4_BINDING_SITES"
23,"Down",0.508864496418416,0.804058581494143,"B.LvsV.BIOCARTA_PITX2_PATHWAY"
378,"Down",0.508878391972691,0.804058581494143,"B.LvsV.REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL"
32,"Up",0.508989877957949,0.804058581494143,"B.LvsV.TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_TOP20_DN"
51,"Down",0.50923918244345,0.804138675612093,"B.LvsV.CHO_NR4A1_TARGETS"
52,"Down",0.509597426994789,0.804138675612093,"B.LvsV.WOTTON_RUNX_TARGETS_DN"
47,"Up",0.509604062226004,0.804138675612093,"B.LvsV.PID_IL8_CXCR1_PATHWAY"
29,"Down",0.509841032917222,0.804138675612093,"B.LvsV.SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_2FC_DN"
26,"Up",0.509969615326503,0.804138675612093,"B.LvsV.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_DN"
36,"Up",0.510088537744505,0.804138675612093,"B.LvsV.LIU_IL13_MEMORY_MODEL_UP"
454,"Up",0.510202810896754,0.804138675612093,"B.LvsV.KONDO_EZH2_TARGETS"
259,"Up",0.510211047708802,0.804138675612093,"B.LvsV.BROCKE_APOPTOSIS_REVERSED_BY_IL6"
25,"Up",0.510453532511508,0.804138675612093,"B.LvsV.ONDER_CDH1_TARGETS_3_UP"
108,"Down",0.510504930603512,0.804138675612093,"B.LvsV.LIN_NPAS4_TARGETS_DN"
44,"Down",0.510717222367914,0.804138675612093,"B.LvsV.AZARE_STAT3_TARGETS"
162,"Down",0.510892920708407,0.804138675612093,"B.LvsV.HOEBEKE_LYMPHOID_STEM_CELL_UP"
33,"Down",0.510962699223495,0.804138675612093,"B.LvsV.MATZUK_LUTEAL_GENES"
88,"Down",0.511247180305027,0.804138675612093,"B.LvsV.ZHANG_PROLIFERATING_VS_QUIESCENT"
29,"Down",0.511436873149156,0.804138675612093,"B.LvsV.AMIT_EGF_RESPONSE_20_MCF10A"
313,"Up",0.511454692819021,0.804138675612093,"B.LvsV.REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES"
110,"Down",0.511513062421366,0.804138675612093,"B.LvsV.STEARMAN_LUNG_CANCER_EARLY_VS_LATE_DN"
18,"Down",0.511739342410462,0.804265726033953,"B.LvsV.REACTOME_RUNX3_REGULATES_P14_ARF"
12,"Up",0.512009323960556,0.804461367484488,"B.LvsV.IIZUKA_LIVER_CANCER_PROGRESSION_L1_G1_DN"
28,"Down",0.512807026906558,0.80526525082151,"B.LvsV.BIOCARTA_NKT_PATHWAY"
37,"Up",0.513132797369122,0.80526525082151,"B.LvsV.PID_GLYPICAN_1PATHWAY"
96,"Down",0.513153749179169,0.80526525082151,"B.LvsV.OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_UP"
45,"Up",0.513275976896838,0.80526525082151,"B.LvsV.RODRIGUES_NTN1_AND_DCC_TARGETS"
28,"Up",0.513299683367056,0.80526525082151,"B.LvsV.REACTOME_DISEASES_OF_IMMUNE_SYSTEM"
14,"Up",0.513429119818568,0.80526525082151,"B.LvsV.REACTOME_NTRK2_ACTIVATES_RAC1"
939,"Up",0.513882913494621,0.80526525082151,"B.LvsV.GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP"
251,"Down",0.513916971724529,0.80526525082151,"B.LvsV.ONDER_CDH1_TARGETS_1_UP"
59,"Down",0.514047643045685,0.80526525082151,"B.LvsV.WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2"
76,"Down",0.514197223827849,0.80526525082151,"B.LvsV.BIOCARTA_HIVNEF_PATHWAY"
60,"Down",0.514240617269568,0.80526525082151,"B.LvsV.REACTOME_AGGREPHAGY"
33,"Down",0.514268692467128,0.80526525082151,"B.LvsV.REACTOME_SYNTHESIS_OF_PROSTAGLANDINS_PG_AND_THROMBOXANES_TX"
516,"Up",0.514829243248724,0.805800166035357,"B.LvsV.LI_INDUCED_T_TO_NATURAL_KILLER_UP"
747,"Up",0.514901788135814,0.805800166035357,"B.LvsV.ODONNELL_TFRC_TARGETS_UP"
119,"Up",0.515556173155867,0.806203861782302,"B.LvsV.HOWLIN_PUBERTAL_MAMMARY_GLAND"
12,"Up",0.515578630007225,0.806203861782302,"B.LvsV.REACTOME_ASPARTATE_AND_ASPARAGINE_METABOLISM"
95,"Up",0.515597188508269,0.806203861782302,"B.LvsV.REACTOME_EXTRA_NUCLEAR_ESTROGEN_SIGNALING"
837,"Up",0.516441128873502,0.807295165830249,"B.LvsV.GRYDER_PAX3FOXO1_ENHANCERS_KO_DOWN"
16,"Down",0.51677474531859,0.807459599131976,"B.LvsV.RAMPON_ENRICHED_LEARNING_ENVIRONMENT_EARLY_DN"
607,"Up",0.516838401397732,0.807459599131976,"B.LvsV.REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES"
347,"Down",0.51707923441653,0.807607651720055,"B.LvsV.BLUM_RESPONSE_TO_SALIRASIB_UP"
42,"Down",0.517606729824703,0.807611181631187,"B.LvsV.ODONNELL_METASTASIS_DN"
152,"Up",0.517688589544482,0.807611181631187,"B.LvsV.REACTOME_GOLGI_TO_ER_RETROGRADE_TRANSPORT"
13,"Down",0.517859509375915,0.807611181631187,"B.LvsV.JOHNSTONE_PARVB_TARGETS_1_UP"
50,"Up",0.517985622688991,0.807611181631187,"B.LvsV.RIZ_ERYTHROID_DIFFERENTIATION_APOBEC2"
23,"Down",0.518164728821491,0.807611181631187,"B.LvsV.BIOCARTA_MITOCHONDRIA_PATHWAY"
24,"Down",0.518405510634298,0.807611181631187,"B.LvsV.WHITESIDE_CISPLATIN_RESISTANCE_DN"
101,"Down",0.518435115666202,0.807611181631187,"B.LvsV.XU_GH1_EXOGENOUS_TARGETS_UP"
47,"Down",0.518457685247105,0.807611181631187,"B.LvsV.REACTOME_SYNTHESIS_OF_LEUKOTRIENES_LT_AND_EOXINS_EX"
133,"Down",0.518588948923575,0.807611181631187,"B.LvsV.MIKKELSEN_MEF_LCP_WITH_H3K27ME3"
668,"Up",0.518824817064857,0.807611181631187,"B.LvsV.HATADA_METHYLATED_IN_LUNG_CANCER_UP"
143,"Up",0.518871123899869,0.807611181631187,"B.LvsV.KEGG_NEUROTROPHIN_SIGNALING_PATHWAY"
28,"Down",0.518998316683077,0.807611181631187,"B.LvsV.TOMLINS_METASTASIS_DN"
62,"Up",0.519202446931329,0.807611181631187,"B.LvsV.AIYAR_COBRA1_TARGETS_UP"
45,"Up",0.519272517760692,0.807611181631187,"B.LvsV.NABA_COLLAGENS"
45,"Up",0.519272517760692,0.807611181631187,"B.LvsV.REACTOME_COLLAGEN_CHAIN_TRIMERIZATION"
117,"Up",0.519504354259068,0.807744537316757,"B.LvsV.JIANG_VHL_TARGETS"
79,"Down",0.520140607530295,0.808315001806326,"B.LvsV.HOWLIN_CITED1_TARGETS_1_UP"
2088,"Down",0.520163641965438,0.808315001806326,"B.LvsV.YOSHIMURA_MAPK8_TARGETS_UP"
79,"Down",0.520773558473433,0.808885694691093,"B.LvsV.REACTOME_ACTIVATION_OF_MATRIX_METALLOPROTEINASES"
64,"Up",0.520924407888228,0.808885694691093,"B.LvsV.PID_LKB1_PATHWAY"
159,"Up",0.521033319913397,0.808885694691093,"B.LvsV.REACTOME_TOLL_LIKE_RECEPTOR_4_TLR4_CASCADE"
13,"Down",0.521199314564579,0.808885694691093,"B.LvsV.BIOCARTA_LYMPHOCYTE_PATHWAY"
43,"Up",0.521262385636528,0.808885694691093,"B.LvsV.VALK_AML_WITH_EVI1"
19,"Up",0.521445033402431,0.808904022573349,"B.LvsV.REACTOME_RIP_MEDIATED_NFKB_ACTIVATION_VIA_ZBP1"
45,"Up",0.521566800592148,0.808904022573349,"B.LvsV.FINETTI_BREAST_CANCERS_KINOME_BLUE"
18,"Down",0.52183499673294,0.808952531748314,"B.LvsV.REACTOME_FGFR1C_LIGAND_BINDING_AND_ACTIVATION"
47,"Down",0.522286169895172,0.808952531748314,"B.LvsV.REACTOME_FATTY_ACIDS"
126,"Up",0.522561754717185,0.808952531748314,"B.LvsV.YAO_HOXA10_TARGETS_VIA_PROGESTERONE_UP"
99,"Up",0.522577243395053,0.808952531748314,"B.LvsV.REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS"
197,"Up",0.522620154563521,0.808952531748314,"B.LvsV.LIU_SOX4_TARGETS_UP"
12,"Down",0.522652206852994,0.808952531748314,"B.LvsV.OHM_EMBRYONIC_CARCINOMA_UP"
394,"Down",0.522676256085118,0.808952531748314,"B.LvsV.BILD_E2F3_ONCOGENIC_SIGNATURE"
29,"Down",0.522768565009355,0.808952531748314,"B.LvsV.LUND_SILENCED_BY_METHYLATION"
58,"Up",0.523080696732108,0.809209057703365,"B.LvsV.MORI_PLASMA_CELL_DN"
207,"Down",0.523490449892513,0.809616418868729,"B.LvsV.WANG_HCP_PROSTATE_CANCER"
70,"Down",0.523670234439094,0.809667988314808,"B.LvsV.WANG_TARGETS_OF_MLL_CBP_FUSION_UP"
65,"Up",0.524214825649703,0.810232058492212,"B.LvsV.REACTOME_GABA_RECEPTOR_ACTIVATION"
86,"Up",0.524328143477145,0.810232058492212,"B.LvsV.CUI_TCF21_TARGETS_UP"
19,"Down",0.524626656680504,0.810258838671715,"B.LvsV.REACTOME_TETRAHYDROBIOPTERIN_BH4_SYNTHESIS_RECYCLING_SALVAGE_AND_REGULATION"
111,"Up",0.52463856799507,0.810258838671715,"B.LvsV.REACTOME_REGULATION_OF_INSULIN_SECRETION"
190,"Down",0.524939835373098,0.81049772403738,"B.LvsV.MCBRYAN_PUBERTAL_BREAST_5_6WK_UP"
340,"Up",0.526520052574033,0.812710600413688,"B.LvsV.AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_DN"
28,"Up",0.526957461500793,0.813158750945544,"B.LvsV.REACTOME_G_BETA_GAMMA_SIGNALLING_THROUGH_PI3KGAMMA"
19,"Up",0.527224523431056,0.813206585724433,"B.LvsV.REACTOME_DIGESTION_OF_DIETARY_CARBOHYDRATE"
391,"Up",0.527282620694898,0.813206585724433,"B.LvsV.AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_UP"
103,"Down",0.527607954711207,0.81348142264313,"B.LvsV.PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_UP"
73,"Up",0.528079704614618,0.813981791696187,"B.LvsV.IKEDA_MIR1_TARGETS_UP"
26,"Down",0.528235632206316,0.813995209160736,"B.LvsV.REACTOME_A_TETRASACCHARIDE_LINKER_SEQUENCE_IS_REQUIRED_FOR_GAG_SYNTHESIS"
6,"Down",0.528676809196247,0.814295311723534,"B.LvsV.NAKAMURA_BRONCHIAL_AND_BRONCHIOLAR_EPITHELIA"
6,"Down",0.52888623180063,0.814295311723534,"B.LvsV.BIOCARTA_SUMO_PATHWAY"
46,"Down",0.528974577098186,0.814295311723534,"B.LvsV.HWANG_PROSTATE_CANCER_MARKERS"
126,"Up",0.529019489909737,0.814295311723534,"B.LvsV.REACTOME_CARGO_RECOGNITION_FOR_CLATHRIN_MEDIATED_ENDOCYTOSIS"
14,"Down",0.529668511821504,0.815055790282945,"B.LvsV.REACTOME_INLA_MEDIATED_ENTRY_OF_LISTERIA_MONOCYTOGENES_INTO_HOST_CELLS"
8,"Up",0.529837651356613,0.815055790282945,"B.LvsV.REACTOME_BETA_OXIDATION_OF_BUTANOYL_COA_TO_ACETYL_COA"
54,"Down",0.530347235887217,0.815055790282945,"B.LvsV.CREIGHTON_AKT1_SIGNALING_VIA_MTOR_UP"
34,"Down",0.530364653598295,0.815055790282945,"B.LvsV.WANG_TNF_TARGETS"
137,"Down",0.530397737658407,0.815055790282945,"B.LvsV.LEE_AGING_NEOCORTEX_UP"
21,"Up",0.530398034624351,0.815055790282945,"B.LvsV.BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_48HR_UP"
60,"Up",0.530715418086324,0.815316906529393,"B.LvsV.MATZUK_SPERMATID_DIFFERENTIATION"
18,"Up",0.530894081457743,0.815364826772184,"B.LvsV.WEBER_METHYLATED_LCP_IN_SPERM_UP"
31,"Down",0.531224684027605,0.815646008883263,"B.LvsV.REACTOME_EICOSANOIDS"
29,"Up",0.531693707974704,0.815929600318089,"B.LvsV.REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_CYCLIN_B"
52,"Down",0.531704530646785,0.815929600318089,"B.LvsV.HUNSBERGER_EXERCISE_REGULATED_GENES"
175,"Up",0.531852814308722,0.815930690985827,"B.LvsV.HOSHIDA_LIVER_CANCER_SURVIVAL_DN"
18,"Up",0.532562519706861,0.816708479040055,"B.LvsV.REACTOME_METHYLATION"
67,"Down",0.532655231582282,0.816708479040055,"B.LvsV.REACTOME_NEUROTRANSMITTER_RELEASE_CYCLE"
23,"Up",0.532835499450563,0.816758379945152,"B.LvsV.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BROWN_UP"
415,"Up",0.534337298658174,0.818833404734213,"B.LvsV.REACTOME_RHO_GTPASE_EFFECTORS"
32,"Down",0.534651104684934,0.819087270103353,"B.LvsV.MARIADASON_RESPONSE_TO_CURCUMIN_SULINDAC_5"
738,"Up",0.535788998073296,0.82059339619028,"B.LvsV.CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN"
66,"Down",0.535933968194259,0.82059339619028,"B.LvsV.SIMBULAN_UV_RESPONSE_IMMORTALIZED_DN"
87,"Up",0.536079462296851,0.82059339619028,"B.LvsV.KEGG_STEROID_HORMONE_BIOSYNTHESIS"
47,"Up",0.536306178823905,0.820675616921333,"B.LvsV.REACTOME_NEGATIVE_REGULATION_OF_MAPK_PATHWAY"
10,"Up",0.536430037900831,0.820675616921333,"B.LvsV.KAUFFMANN_MELANOMA_RELAPSE_DN"
8,"Up",0.536700619865275,0.820858001427062,"B.LvsV.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_5"
32,"Up",0.536942018705693,0.820858001427062,"B.LvsV.SAGIV_CD24_TARGETS_UP"
27,"Down",0.536994644811301,0.820858001427062,"B.LvsV.BIOCARTA_BCELLSURVIVAL_PATHWAY"
111,"Down",0.537646142808124,0.821626733992847,"B.LvsV.REACTOME_B_WICH_COMPLEX_POSITIVELY_REGULATES_RRNA_EXPRESSION"
875,"Up",0.537837244525898,0.821691662056836,"B.LvsV.BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_B"
30,"Up",0.538881695005818,0.82305991483071,"B.LvsV.REACTOME_SEALING_OF_THE_NUCLEAR_ENVELOPE_NE_BY_ESCRT_III"
44,"Down",0.539241161686923,0.823103642164835,"B.LvsV.SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_DN"
160,"Up",0.539421832410288,0.823103642164835,"B.LvsV.HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS"
106,"Up",0.539465732639434,0.823103642164835,"B.LvsV.WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER"
24,"Down",0.539505805607771,0.823103642164835,"B.LvsV.REACTOME_FGFR1_LIGAND_BINDING_AND_ACTIVATION"
73,"Up",0.54020497887917,0.823811624718077,"B.LvsV.MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_DN"
104,"Down",0.54026785155141,0.823811624718077,"B.LvsV.STEIN_ESR1_TARGETS"
15,"Up",0.540568116390996,0.824042215474447,"B.LvsV.KANG_CISPLATIN_RESISTANCE_DN"
41,"Down",0.540770892714923,0.824124108550388,"B.LvsV.REACTOME_GAMMA_CARBOXYLATION_HYPUSINE_FORMATION_AND_ARYLSULFATASE_ACTIVATION"
16,"Up",0.541078445093487,0.824365589121491,"B.LvsV.BIOCARTA_TCYTOTOXIC_PATHWAY"
129,"Up",0.541587590724613,0.824913991492117,"B.LvsV.DOANE_BREAST_CANCER_CLASSES_UP"
74,"Down",0.542205450452668,0.825342657770902,"B.LvsV.JIANG_HYPOXIA_CANCER"
24,"Up",0.542242332706354,0.825342657770902,"B.LvsV.RAY_TARGETS_OF_P210_BCR_ABL_FUSION_DN"
77,"Down",0.542316852176105,0.825342657770902,"B.LvsV.ASTIER_INTEGRIN_SIGNALING"
1584,"Up",0.542917059309207,0.825809093574502,"B.LvsV.GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS"
1597,"Down",0.54299272222837,0.825809093574502,"B.LvsV.REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION"
199,"Up",0.543219930393313,0.825809093574502,"B.LvsV.GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN"
29,"Up",0.543285049485901,0.825809093574502,"B.LvsV.PID_ARF_3PATHWAY"
32,"Down",0.543627068383432,0.825809093574502,"B.LvsV.VETTER_TARGETS_OF_PRKCA_AND_ETS1_DN"
99,"Up",0.543644351222697,0.825809093574502,"B.LvsV.LEE_LIVER_CANCER_MYC_E2F1_DN"
107,"Up",0.543789693910557,0.825809093574502,"B.LvsV.BERNARD_PPAPDC1B_TARGETS_DN"
8,"Up",0.544438290358816,0.825809093574502,"B.LvsV.TURJANSKI_MAPK7_TARGETS"
14,"Down",0.544524668419007,0.825809093574502,"B.LvsV.REACTOME_REGULATION_BY_C_FLIP"
225,"Up",0.544655144317719,0.825809093574502,"B.LvsV.SENGUPTA_EBNA1_ANTICORRELATED"
25,"Up",0.5446612062417,0.825809093574502,"B.LvsV.BIOCARTA_IFNA_PATHWAY"
242,"Up",0.544672737599921,0.825809093574502,"B.LvsV.REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS"
384,"Down",0.544722129512088,0.825809093574502,"B.LvsV.SERVITJA_ISLET_HNF1A_TARGETS_UP"
32,"Up",0.544805659129278,0.825809093574502,"B.LvsV.WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_UP"
26,"Up",0.54486373184297,0.825809093574502,"B.LvsV.REACTOME_SYNTHESIS_SECRETION_AND_INACTIVATION_OF_GLUCAGON_LIKE_PEPTIDE_1_GLP_1"
89,"Up",0.545229275120648,0.825902299871803,"B.LvsV.SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES"
133,"Up",0.545352877032419,0.825902299871803,"B.LvsV.VANTVEER_BREAST_CANCER_METASTASIS_UP"
607,"Down",0.545390439747619,0.825902299871803,"B.LvsV.REACTOME_SIGNALING_BY_INTERLEUKINS"
40,"Down",0.545522734514709,0.825902299871803,"B.LvsV.WIEMANN_TELOMERE_SHORTENING_AND_CHRONIC_LIVER_DAMAGE_UP"
6,"Up",0.546338927378776,0.826768943006586,"B.LvsV.REACTOME_TRAFFICKING_OF_MYRISTOYLATED_PROTEINS_TO_THE_CILIUM"
38,"Up",0.546394233631048,0.826768943006586,"B.LvsV.CAFFAREL_RESPONSE_TO_THC_8HR_3_DN"
48,"Up",0.546942806565441,0.827108936634893,"B.LvsV.REACTOME_NR1H3_NR1H2_REGULATE_GENE_EXPRESSION_LINKED_TO_CHOLESTEROL_TRANSPORT_AND_EFFLUX"
23,"Up",0.547007824448932,0.827108936634893,"B.LvsV.REACTOME_SIGNALLING_TO_RAS"
104,"Up",0.547193127639733,0.827108936634893,"B.LvsV.KEGG_VIRAL_MYOCARDITIS"
36,"Down",0.547241010075452,0.827108936634893,"B.LvsV.AMUNDSON_DNA_DAMAGE_RESPONSE_TP53"
19,"Down",0.547366901636295,0.827108936634893,"B.LvsV.DORN_ADENOVIRUS_INFECTION_24HR_UP"
24,"Down",0.547596144430355,0.82715639607501,"B.LvsV.REACTOME_FRS_MEDIATED_FGFR4_SIGNALING"
28,"Up",0.547786619031369,0.82715639607501,"B.LvsV.OSAWA_TNF_TARGETS"
16,"Down",0.547937165621687,0.82715639607501,"B.LvsV.SHANK_TAL1_TARGETS_DN"
81,"Down",0.548340699632582,0.82715639607501,"B.LvsV.LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN"
75,"Down",0.548428935423952,0.82715639607501,"B.LvsV.JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP"
16,"Up",0.548612914663134,0.82715639607501,"B.LvsV.REACTOME_ACTIVATED_NTRK2_SIGNALS_THROUGH_FYN"
114,"Down",0.548690252517285,0.82715639607501,"B.LvsV.REACTOME_O_LINKED_GLYCOSYLATION"
239,"Down",0.548774895035788,0.82715639607501,"B.LvsV.SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM5"
100,"Down",0.548798788061254,0.82715639607501,"B.LvsV.REACTOME_DAP12_INTERACTIONS"
7,"Down",0.549146626340648,0.82715639607501,"B.LvsV.REACTOME_RAS_SIGNALING_DOWNSTREAM_OF_NF1_LOSS_OF_FUNCTION_VARIANTS"
246,"Up",0.549289459853225,0.82715639607501,"B.LvsV.SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_UP"
60,"Down",0.549315439870592,0.82715639607501,"B.LvsV.LU_TUMOR_VASCULATURE_UP"
15,"Up",0.549343151815416,0.82715639607501,"B.LvsV.REACTOME_SIGNALING_BY_FGFR4_IN_DISEASE"
978,"Down",0.549547606247206,0.827238964045958,"B.LvsV.MILI_PSEUDOPODIA_HAPTOTAXIS_DN"
40,"Down",0.549853735164322,0.827474496930739,"B.LvsV.DUTTA_APOPTOSIS_VIA_NFKB"
316,"Down",0.550651293669808,0.828153755211861,"B.LvsV.MOHANKUMAR_HOXA1_TARGETS_DN"
135,"Up",0.55090870157641,0.828153755211861,"B.LvsV.ROVERSI_GLIOMA_COPY_NUMBER_UP"
63,"Down",0.551366197598706,0.828153755211861,"B.LvsV.BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_DN"
184,"Down",0.551399904900463,0.828153755211861,"B.LvsV.REACTOME_PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS"
76,"Down",0.551560163117969,0.828153755211861,"B.LvsV.PID_P53_REGULATION_PATHWAY"
865,"Down",0.551691907896682,0.828153755211861,"B.LvsV.RIGGI_EWING_SARCOMA_PROGENITOR_UP"
29,"Up",0.551730296978426,0.828153755211861,"B.LvsV.BIOCARTA_ACE2_PATHWAY"
464,"Up",0.551758788043047,0.828153755211861,"B.LvsV.RAO_BOUND_BY_SALL4_ISOFORM_A"
969,"Up",0.551847564464013,0.828153755211861,"B.LvsV.RAO_BOUND_BY_SALL4_ISOFORM_B"
113,"Down",0.551879002399378,0.828153755211861,"B.LvsV.REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE"
52,"Up",0.5521316732263,0.828153755211861,"B.LvsV.REACTOME_CHONDROITIN_SULFATE_DERMATAN_SULFATE_METABOLISM"
23,"Up",0.552228352334861,0.828153755211861,"B.LvsV.REACTOME_NOREPINEPHRINE_NEUROTRANSMITTER_RELEASE_CYCLE"
40,"Down",0.55225228711632,0.828153755211861,"B.LvsV.BIOCARTA_INFLAM_PATHWAY"
168,"Down",0.552619095336511,0.828479115541097,"B.LvsV.HAHTOLA_MYCOSIS_FUNGOIDES_CD4_DN"
80,"Up",0.553123981038531,0.82875396696642,"B.LvsV.HEIDENBLAD_AMPLIFIED_IN_PANCREATIC_CANCER"
67,"Down",0.553202075596393,0.82875396696642,"B.LvsV.BROWNE_HCMV_INFECTION_2HR_UP"
31,"Up",0.553539223154463,0.82875396696642,"B.LvsV.REACTOME_PLATELET_CALCIUM_HOMEOSTASIS"
17,"Up",0.553660910023447,0.82875396696642,"B.LvsV.REACTOME_VITAMIN_B5_PANTOTHENATE_METABOLISM"
933,"Up",0.553693128679503,0.82875396696642,"B.LvsV.FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP"
27,"Down",0.553846747081032,0.82875396696642,"B.LvsV.WILSON_PROTEASES_AT_TUMOR_BONE_INTERFACE_UP"
63,"Up",0.553978669052093,0.82875396696642,"B.LvsV.ZHAN_MULTIPLE_MYELOMA_CD2_UP"
381,"Down",0.554001566631921,0.82875396696642,"B.LvsV.MCBRYAN_PUBERTAL_BREAST_3_4WK_UP"
465,"Up",0.555415939016386,0.830233583542475,"B.LvsV.RICKMAN_METASTASIS_UP"
20,"Down",0.555475477682165,0.830233583542475,"B.LvsV.SU_SALIVARY_GLAND"
135,"Down",0.555491847952515,0.830233583542475,"B.LvsV.LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP"
15,"Up",0.55577109697984,0.830233583542475,"B.LvsV.REACTOME_APOPTOSIS_INDUCED_DNA_FRAGMENTATION"
180,"Down",0.55585047193915,0.830233583542475,"B.LvsV.LENAOUR_DENDRITIC_CELL_MATURATION_UP"
157,"Up",0.555990791120687,0.830233583542475,"B.LvsV.WILCOX_RESPONSE_TO_PROGESTERONE_DN"
33,"Up",0.556118914060605,0.830233583542475,"B.LvsV.REACTOME_THROMBIN_SIGNALLING_THROUGH_PROTEINASE_ACTIVATED_RECEPTORS_PARS"
8,"Up",0.556191932255621,0.830233583542475,"B.LvsV.REACTOME_DEFECTIVE_CHST14_CAUSES_EDS_MUSCULOCONTRACTURAL_TYPE"
38,"Up",0.556405135691296,0.830327664031626,"B.LvsV.MEISSNER_NPC_ICP_WITH_H3_UNMETHYLATED"
328,"Down",0.55689256393874,0.830830811121774,"B.LvsV.BOYLAN_MULTIPLE_MYELOMA_PCA1_UP"
16,"Up",0.557246950844619,0.831135255252199,"B.LvsV.POS_RESPONSE_TO_HISTAMINE_UP"
145,"Down",0.557638011405094,0.831283194683164,"B.LvsV.YU_MYC_TARGETS_DN"
27,"Up",0.557810364533564,0.831283194683164,"B.LvsV.JIANG_HYPOXIA_VIA_VHL"
7,"Down",0.557861961484871,0.831283194683164,"B.LvsV.BAKER_HEMATOPOESIS_STAT5_TARGETS"
325,"Down",0.558360384728974,0.831283194683164,"B.LvsV.PURBEY_TARGETS_OF_CTBP1_AND_SATB1_DN"
523,"Up",0.558407371629854,0.831283194683164,"B.LvsV.GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP"
81,"Down",0.558462720246503,0.831283194683164,"B.LvsV.CROMER_TUMORIGENESIS_DN"
301,"Up",0.558511656341433,0.831283194683164,"B.LvsV.ASTON_MAJOR_DEPRESSIVE_DISORDER_DN"
26,"Up",0.558548936199666,0.831283194683164,"B.LvsV.ZHENG_FOXP3_TARGETS_IN_THYMUS_DN"
384,"Up",0.558710296911648,0.831299577939855,"B.LvsV.YAGI_AML_FAB_MARKERS"
17,"Down",0.558899186512471,0.831356901325653,"B.LvsV.RAY_ALZHEIMERS_DISEASE"
94,"Up",0.559259556997498,0.831411557593569,"B.LvsV.NAKAMURA_ADIPOGENESIS_EARLY_UP"
35,"Up",0.559314744053061,0.831411557593569,"B.LvsV.TERAMOTO_OPN_TARGETS_CLUSTER_6"
1113,"Up",0.559387049059157,0.831411557593569,"B.LvsV.MARTINEZ_RB1_TARGETS_UP"
10,"Down",0.559884585523914,0.831644037336965,"B.LvsV.BYSTRYKH_HEMATOPOIESIS_STEM_CELL_FLI1"
572,"Up",0.559978113963954,0.831644037336965,"B.LvsV.HELLER_HDAC_TARGETS_UP"
17,"Down",0.560102720475214,0.831644037336965,"B.LvsV.ONGUSAHA_BRCA1_TARGETS_UP"
650,"Down",0.560145124804279,0.831644037336965,"B.LvsV.ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP"
6,"Down",0.560860320462522,0.832482338748263,"B.LvsV.REACTOME_VITAMIN_B1_THIAMIN_METABOLISM"
13,"Down",0.561175750124249,0.832558724018707,"B.LvsV.FIRESTEIN_CTNNB1_PATHWAY_AND_PROLIFERATION"
15,"Up",0.561212943464953,0.832558724018707,"B.LvsV.GOUYER_TATI_TARGETS_UP"
52,"Down",0.561781241018636,0.833178240770397,"B.LvsV.REACTOME_ELASTIC_FIBRE_FORMATION"
22,"Up",0.562233626747826,0.833625562426584,"B.LvsV.REACTOME_CASPASE_MEDIATED_CLEAVAGE_OF_CYTOSKELETAL_PROTEINS"
818,"Down",0.562626766215005,0.83398482316428,"B.LvsV.LIAO_METASTASIS"
18,"Down",0.56286999975285,0.834121744474272,"B.LvsV.REACTOME_NEUROFASCIN_INTERACTIONS"
39,"Up",0.563195330503448,0.834215986419953,"B.LvsV.WU_HBX_TARGETS_1_DN"
29,"Down",0.563241982641948,0.834215986419953,"B.LvsV.REACTOME_FRS_MEDIATED_FGFR2_SIGNALING"
77,"Up",0.563473818076161,0.834215986419953,"B.LvsV.DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_DN"
9,"Down",0.563631847536083,0.834215986419953,"B.LvsV.REACTOME_SODIUM_PROTON_EXCHANGERS"
44,"Down",0.563687995164577,0.834215986419953,"B.LvsV.REACTOME_COOPERATION_OF_PDCL_PHLP1_AND_TRIC_CCT_IN_G_PROTEIN_BETA_FOLDING"
17,"Up",0.564307763429346,0.834909720096563,"B.LvsV.BRUNEAU_SEPTATION_VENTRICULAR"
67,"Up",0.564487949220015,0.834952881550953,"B.LvsV.NAKAMURA_METASTASIS"
129,"Down",0.564653082598318,0.834973761349585,"B.LvsV.JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_DN"
121,"Down",0.565679439947308,0.835814968941445,"B.LvsV.DELPUECH_FOXO3_TARGETS_UP"
6,"Up",0.565838844674945,0.835814968941445,"B.LvsV.REACTOME_CHOLINE_CATABOLISM"
124,"Up",0.565933655438827,0.835814968941445,"B.LvsV.FONTAINE_FOLLICULAR_THYROID_ADENOMA_UP"
48,"Down",0.566054493864089,0.835814968941445,"B.LvsV.FARDIN_HYPOXIA_11"
10,"Up",0.566120523079461,0.835814968941445,"B.LvsV.MIKKELSEN_DEDIFFERENTIATED_STATE_UP"
7,"Up",0.566128967025811,0.835814968941445,"B.LvsV.REACTOME_RSK_ACTIVATION"
32,"Down",0.566606018037929,0.836180071816265,"B.LvsV.CAFFAREL_RESPONSE_TO_THC_24HR_3_DN"
201,"Down",0.566678735593334,0.836180071816265,"B.LvsV.BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_CIS"
22,"Down",0.567095897179544,0.836477572964146,"B.LvsV.KEGG_ALPHA_LINOLENIC_ACID_METABOLISM"
20,"Down",0.567182930193992,0.836477572964146,"B.LvsV.REACTOME_HDL_ASSEMBLY"
186,"Down",0.567555435260865,0.83680373374862,"B.LvsV.MATZUK_SPERMATOCYTE"
14,"Down",0.567770595732747,0.836897793603402,"B.LvsV.REACTOME_ETHANOL_OXIDATION"
26,"Up",0.568173021513237,0.837267760113723,"B.LvsV.SCHWAB_TARGETS_OF_BMYB_POLYMORPHIC_VARIANTS_DN"
59,"Down",0.568616927015585,0.837698638281154,"B.LvsV.HOLLEMAN_VINCRISTINE_RESISTANCE_B_ALL_UP"
47,"Up",0.569354095992991,0.838479723298538,"B.LvsV.PID_NEPHRIN_NEPH1_PATHWAY"
90,"Down",0.569450417975404,0.838479723298538,"B.LvsV.REACTOME_CYTOSOLIC_SENSORS_OF_PATHOGEN_ASSOCIATED_DNA"
7,"Down",0.569767626654547,0.838723431249465,"B.LvsV.REACTOME_RESPONSE_TO_METAL_IONS"
377,"Up",0.570170110392838,0.839092504754326,"B.LvsV.QI_PLASMACYTOMA_UP"
63,"Down",0.570347760704105,0.839130593116816,"B.LvsV.REACTOME_SIGNALING_BY_TYPE_1_INSULIN_LIKE_GROWTH_FACTOR_1_RECEPTOR_IGF1R"
115,"Up",0.570526286142911,0.839169948412916,"B.LvsV.REACTOME_INTERLEUKIN_1_SIGNALING"
13,"Down",0.570794997218867,0.839341712183811,"B.LvsV.MCBRYAN_TERMINAL_END_BUD_DN"
190,"Up",0.570946677432323,0.839341712183811,"B.LvsV.KIM_ALL_DISORDERS_DURATION_CORR_DN"
5,"Down",0.571822128702426,0.840405249759625,"B.LvsV.REACTOME_SUMO_IS_CONJUGATED_TO_E1_UBA2_SAE1"
32,"Down",0.572394932643449,0.840893239944621,"B.LvsV.REACTOME_TICAM1_RIP1_MEDIATED_IKK_COMPLEX_RECRUITMENT"
66,"Up",0.57245833878668,0.840893239944621,"B.LvsV.REACTOME_BILE_ACID_AND_BILE_SALT_METABOLISM"
29,"Down",0.572939830284255,0.8411765563437,"B.LvsV.PID_IL27_PATHWAY"
52,"Up",0.57305729436698,0.8411765563437,"B.LvsV.XU_RESPONSE_TO_TRETINOIN_UP"
36,"Up",0.573107630267086,0.8411765563437,"B.LvsV.UROSEVIC_RESPONSE_TO_IMIQUIMOD"
6,"Up",0.573694731291723,0.841814800772806,"B.LvsV.REACTOME_VASOPRESSIN_LIKE_RECEPTORS"
41,"Up",0.573954784537934,0.841972938103008,"B.LvsV.BIOCARTA_EIF4_PATHWAY"
246,"Down",0.574533031909709,0.842597648124345,"B.LvsV.ZHONG_SECRETOME_OF_LUNG_CANCER_AND_FIBROBLAST"
12,"Up",0.575023185912268,0.842907524668838,"B.LvsV.KEGG_TAURINE_AND_HYPOTAURINE_METABOLISM"
55,"Up",0.575130925150787,0.842907524668838,"B.LvsV.VALK_AML_CLUSTER_10"
308,"Up",0.575201680335599,0.842907524668838,"B.LvsV.BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_TRANS"
45,"Up",0.575793556320463,0.843551291175369,"B.LvsV.XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_DN"
15,"Up",0.576852577890797,0.844878914743899,"B.LvsV.BERGER_MBD2_TARGETS"
342,"Up",0.57744307087487,0.845314544420906,"B.LvsV.JIANG_HYPOXIA_NORMAL"
62,"Up",0.577507918401726,0.845314544420906,"B.LvsV.PID_ARF6_PATHWAY"
633,"Down",0.577608672241306,0.845314544420906,"B.LvsV.WANG_SMARCE1_TARGETS_DN"
67,"Up",0.578019269019609,0.845344986815232,"B.LvsV.NGUYEN_NOTCH1_TARGETS_UP"
13,"Down",0.578117487672856,0.845344986815232,"B.LvsV.BIOCARTA_RNA_PATHWAY"
112,"Up",0.578177545965722,0.845344986815232,"B.LvsV.ZHU_CMV_8_HR_UP"
13,"Down",0.578241045421452,0.845344986815232,"B.LvsV.REACTOME_REGULATION_OF_LOCALIZATION_OF_FOXO_TRANSCRIPTION_FACTORS"
87,"Up",0.578526298601939,0.845538436418219,"B.LvsV.REACTOME_CELLULAR_RESPONSE_TO_HYPOXIA"
23,"Down",0.579007994139145,0.846014233393728,"B.LvsV.GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN"
654,"Up",0.579157871838535,0.846014233393728,"B.LvsV.THUM_SYSTOLIC_HEART_FAILURE_UP"
51,"Up",0.579500321930446,0.846251821093402,"B.LvsV.REACTOME_CLASS_C_3_METABOTROPIC_GLUTAMATE_PHEROMONE_RECEPTORS"
49,"Up",0.579796684276579,0.846251821093402,"B.LvsV.DORSAM_HOXA9_TARGETS_DN"
165,"Down",0.57992496633553,0.846251821093402,"B.LvsV.SENESE_HDAC2_TARGETS_UP"
28,"Down",0.579945097040908,0.846251821093402,"B.LvsV.MARCINIAK_ER_STRESS_RESPONSE_VIA_CHOP"
89,"Up",0.580191051592988,0.846251821093402,"B.LvsV.ZHAN_V2_LATE_DIFFERENTIATION_GENES"
368,"Down",0.580354879335595,0.846251821093402,"B.LvsV.KYNG_DNA_DAMAGE_UP"
30,"Down",0.580543089930601,0.846251821093402,"B.LvsV.SUZUKI_RESPONSE_TO_TSA"
16,"Up",0.580544973305711,0.846251821093402,"B.LvsV.KONDO_COLON_CANCER_HCP_WITH_H3K27ME3"
124,"Down",0.581118253783905,0.846676923947148,"B.LvsV.CHEBOTAEV_GR_TARGETS_UP"
645,"Up",0.581443255541778,0.846676923947148,"B.LvsV.CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_2"
72,"Up",0.581573177218269,0.846676923947148,"B.LvsV.VALK_AML_CLUSTER_11"
53,"Up",0.581676929386035,0.846676923947148,"B.LvsV.PID_LIS1_PATHWAY"
26,"Up",0.581709560173003,0.846676923947148,"B.LvsV.NIKOLSKY_BREAST_CANCER_6P24_P22_AMPLICON"
201,"Down",0.5818638653937,0.846676923947148,"B.LvsV.STEIN_ESRRA_TARGETS_DN"
574,"Up",0.581992139438464,0.846676923947148,"B.LvsV.WANG_LMO4_TARGETS_DN"
42,"Up",0.582174514970121,0.846676923947148,"B.LvsV.BIOCARTA_GLEEVEC_PATHWAY"
71,"Up",0.582214806447288,0.846676923947148,"B.LvsV.TSAI_RESPONSE_TO_RADIATION_THERAPY"
29,"Down",0.582643426207882,0.84707743978527,"B.LvsV.TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_DN"
49,"Up",0.583211421674017,0.84768032345837,"B.LvsV.PID_NECTIN_PATHWAY"
63,"Down",0.583670496518148,0.848029366988222,"B.LvsV.KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS"
28,"Up",0.58375832352273,0.848029366988222,"B.LvsV.HO_LIVER_CANCER_VASCULAR_INVASION"
59,"Down",0.583957773873486,0.848096278367876,"B.LvsV.REACTOME_TRANSCRIPTIONAL_REGULATION_OF_PLURIPOTENT_STEM_CELLS"
188,"Up",0.584462811101953,0.848225554965638,"B.LvsV.ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION"
16,"Down",0.584543795949392,0.848225554965638,"B.LvsV.HOFMANN_MYELODYSPLASTIC_SYNDROM_HIGH_RISK_UP"
17,"Down",0.584599899037776,0.848225554965638,"B.LvsV.REACTOME_IRAK1_RECRUITS_IKK_COMPLEX"
6,"Down",0.584738868602151,0.848225554965638,"B.LvsV.REACTOME_TNFR1_MEDIATED_CERAMIDE_PRODUCTION"
14,"Down",0.584813857031834,0.848225554965638,"B.LvsV.REACTOME_DEFECTIVE_EXT2_CAUSES_EXOSTOSES_2"
34,"Up",0.585592464321108,0.848915347536943,"B.LvsV.KORKOLA_EMBRYONAL_CARCINOMA_DN"
58,"Down",0.585657886985855,0.848915347536943,"B.LvsV.PID_HDAC_CLASSII_PATHWAY"
9,"Down",0.585750054413716,0.848915347536943,"B.LvsV.CASTELLANO_HRAS_TARGETS_DN"
88,"Up",0.586085122698536,0.849178365670914,"B.LvsV.REACTOME_PRC2_METHYLATES_HISTONES_AND_DNA"
69,"Down",0.586490461217155,0.849223479372286,"B.LvsV.JIANG_AGING_HYPOTHALAMUS_UP"
249,"Up",0.586856630669755,0.849223479372286,"B.LvsV.AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_UP"
48,"Down",0.586865957831973,0.849223479372286,"B.LvsV.WIKMAN_ASBESTOS_LUNG_CANCER_DN"
318,"Down",0.586986068545106,0.849223479372286,"B.LvsV.VANTVEER_BREAST_CANCER_ESR1_UP"
7,"Up",0.586986702082923,0.849223479372286,"B.LvsV.SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX3"
83,"Up",0.587037825675688,0.849223479372286,"B.LvsV.VALK_AML_WITH_FLT3_ITD"
14,"Up",0.58755313404205,0.849228495699739,"B.LvsV.BRUNEAU_HEART_GREAT_VESSELS_AND_VALVULOGENESIS"
22,"Up",0.587560531940999,0.849228495699739,"B.LvsV.REACTOME_HS_GAG_DEGRADATION"
97,"Down",0.587585413812442,0.849228495699739,"B.LvsV.BEIER_GLIOMA_STEM_CELL_DN"
48,"Down",0.587655674542811,0.849228495699739,"B.LvsV.KEGG_NOTCH_SIGNALING_PATHWAY"
23,"Up",0.588103591339992,0.849510875232142,"B.LvsV.LIU_IL13_PRIMING_MODEL"
1498,"Up",0.588158370480854,0.849510875232142,"B.LvsV.ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN"
6,"Down",0.588444427016634,0.849702072858441,"B.LvsV.REACTOME_GDP_FUCOSE_BIOSYNTHESIS"
303,"Up",0.588617028203644,0.849729386145679,"B.LvsV.ZWANG_EGF_INTERVAL_DN"
78,"Up",0.588823850103166,0.849806073406527,"B.LvsV.REACTOME_BIOSYNTHESIS_OF_THE_N_GLYCAN_PRECURSOR_DOLICHOL_LIPID_LINKED_OLIGOSACCHARIDE_LLO_AND_TRANSFER_TO_A_NASCENT_PROTEIN"
168,"Up",0.588990955554334,0.849825415777638,"B.LvsV.COATES_MACROPHAGE_M1_VS_M2_UP"
11,"Up",0.589559283902725,0.850423501356161,"B.LvsV.HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_DN"
23,"Up",0.589894976488949,0.85065573710998,"B.LvsV.SARTIPY_BLUNTED_BY_INSULIN_RESISTANCE_DN"
74,"Up",0.590115703479982,0.85065573710998,"B.LvsV.DALESSIO_TSA_RESPONSE"
5,"Up",0.59018184256717,0.85065573710998,"B.LvsV.REACTOME_ACTIVATION_OF_RAS_IN_B_CELLS"
342,"Up",0.590441697810169,0.850808482458281,"B.LvsV.HOLLMANN_APOPTOSIS_VIA_CD40_UP"
222,"Up",0.590629177530992,0.850856884462964,"B.LvsV.DER_IFN_BETA_RESPONSE_UP"
30,"Up",0.591559011967762,0.851849440722333,"B.LvsV.YIH_RESPONSE_TO_ARSENITE_C2"
146,"Up",0.591626307175576,0.851849440722333,"B.LvsV.KONDO_PROSTATE_CANCER_HCP_WITH_H3K27ME3"
5,"Up",0.592094760435566,0.852301986578559,"B.LvsV.REACTOME_MRNA_EDITING_C_TO_U_CONVERSION"
1236,"Up",0.592552029070824,0.85273820112769,"B.LvsV.GEORGES_TARGETS_OF_MIR192_AND_MIR215"
60,"Down",0.59289894986269,0.852825658439989,"B.LvsV.CROONQUIST_NRAS_SIGNALING_UP"
98,"Down",0.592921293370107,0.852825658439989,"B.LvsV.KIM_LRRC3B_TARGETS"
30,"Up",0.593401498536545,0.853093507982536,"B.LvsV.PID_INTEGRIN_A9B1_PATHWAY"
67,"Up",0.593507148493458,0.853093507982536,"B.LvsV.REACTOME_SIGNALING_BY_FGFR1"
65,"Down",0.593636316826286,0.853093507982536,"B.LvsV.NAKAMURA_METASTASIS_MODEL_UP"
640,"Up",0.593724691393886,0.853093507982536,"B.LvsV.LU_EZH2_TARGETS_DN"
10,"Up",0.594052686520263,0.853320661831088,"B.LvsV.KAPOSI_LIVER_CANCER_MET_DN"
61,"Down",0.594254405026264,0.853320661831088,"B.LvsV.WINNEPENNINCKX_MELANOMA_METASTASIS_DN"
460,"Down",0.594354390923981,0.853320661831088,"B.LvsV.BOQUEST_STEM_CELL_UP"
120,"Up",0.594500124683189,0.853320661831088,"B.LvsV.BILD_CTNNB1_ONCOGENIC_SIGNATURE"
159,"Down",0.595185711544756,0.854083000033988,"B.LvsV.OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_UP"
735,"Up",0.595435472040409,0.854219700288381,"B.LvsV.BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP"
21,"Down",0.595959108724013,0.854749134146581,"B.LvsV.IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_UP"
106,"Up",0.597141375680644,0.856222683127147,"B.LvsV.REACTOME_MAPK6_MAPK4_SIGNALING"
16,"Up",0.597482728235981,0.85627508753096,"B.LvsV.YAGUE_PRETUMOR_DRUG_RESISTANCE_UP"
153,"Up",0.597624955136706,0.85627508753096,"B.LvsV.ROSS_LEUKEMIA_WITH_MLL_FUSIONS"
181,"Up",0.597642532606615,0.85627508753096,"B.LvsV.MCLACHLAN_DENTAL_CARIES_DN"
210,"Up",0.598110335151813,0.85672332721616,"B.LvsV.MIKKELSEN_ES_LCP_WITH_H3K4ME3"
93,"Up",0.598367980794636,0.856870387416095,"B.LvsV.REACTOME_FOXO_MEDIATED_TRANSCRIPTION"
83,"Up",0.598790475656984,0.857253376464905,"B.LvsV.PID_TXA2PATHWAY"
19,"Up",0.599528489675747,0.858087760656797,"B.LvsV.REACTOME_GLYCOGEN_STORAGE_DISEASES"
32,"Down",0.600002194335542,0.858358789568308,"B.LvsV.PID_RHODOPSIN_PATHWAY"
338,"Down",0.600375597456218,0.858358789568308,"B.LvsV.TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN"
52,"Up",0.600466567083939,0.858358789568308,"B.LvsV.WANG_RESPONSE_TO_FORSKOLIN_UP"
190,"Down",0.600613268186886,0.858358789568308,"B.LvsV.KEGG_CALCIUM_SIGNALING_PATHWAY"
37,"Down",0.600709702732686,0.858358789568308,"B.LvsV.STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_UP"
488,"Up",0.600794596109061,0.858358789568308,"B.LvsV.BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_D"
117,"Down",0.600804578699467,0.858358789568308,"B.LvsV.HANN_RESISTANCE_TO_BCL2_INHIBITOR_UP"
25,"Down",0.601398140075904,0.858730117812162,"B.LvsV.WALLACE_PROSTATE_CANCER_UP"
43,"Up",0.601564199175503,0.858730117812162,"B.LvsV.KEGG_SPHINGOLIPID_METABOLISM"
84,"Down",0.601825537770019,0.858730117812162,"B.LvsV.LUI_THYROID_CANCER_CLUSTER_1"
216,"Up",0.602157744942537,0.858730117812162,"B.LvsV.WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_36HR"
8,"Down",0.602319192645047,0.858730117812162,"B.LvsV.REACTOME_GLYCEROPHOSPHOLIPID_CATABOLISM"
251,"Down",0.602361372797307,0.858730117812162,"B.LvsV.HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_UP"
8,"Down",0.602365855222939,0.858730117812162,"B.LvsV.BIOCARTA_WNT_LRP6_PATHWAY"
18,"Down",0.602381642074922,0.858730117812162,"B.LvsV.REACTOME_SIGNALING_BY_NOTCH1_HD_DOMAIN_MUTANTS_IN_CANCER"
1130,"Up",0.602510068825671,0.858730117812162,"B.LvsV.REACTOME_ADAPTIVE_IMMUNE_SYSTEM"
16,"Down",0.60261762653485,0.858730117812162,"B.LvsV.GAUSSMANN_MLL_AF4_FUSION_TARGETS_D_DN"
22,"Up",0.602860261987546,0.858854519074759,"B.LvsV.MEISSNER_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3"
1049,"Up",0.603443349840564,0.85930452652351,"B.LvsV.KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_UP"
405,"Up",0.60348697350168,0.85930452652351,"B.LvsV.WANG_CLIM2_TARGETS_UP"
22,"Up",0.603827883149978,0.859431321820855,"B.LvsV.REACTOME_SEROTONIN_NEUROTRANSMITTER_RELEASE_CYCLE"
1034,"Down",0.604150117109753,0.859431321820855,"B.LvsV.GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP"
32,"Down",0.604194512273293,0.859431321820855,"B.LvsV.REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR4"
30,"Down",0.604197784032857,0.859431321820855,"B.LvsV.SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_UP"
38,"Up",0.604411246230213,0.859513832409169,"B.LvsV.BIOCARTA_BARRESTIN_SRC_PATHWAY"
72,"Up",0.605021127847706,0.860011050675589,"B.LvsV.DORSEY_GAB2_TARGETS"
51,"Down",0.605251868738114,0.860011050675589,"B.LvsV.LE_SKI_TARGETS_UP"
8,"Down",0.605523619065424,0.860011050675589,"B.LvsV.REACTOME_TLR3_MEDIATED_TICAM1_DEPENDENT_PROGRAMMED_CELL_DEATH"
127,"Up",0.605710104319745,0.860011050675589,"B.LvsV.BURTON_ADIPOGENESIS_9"
36,"Down",0.605717478852771,0.860011050675589,"B.LvsV.REACTOME_NOTCH3_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS"
449,"Down",0.60588635946683,0.860011050675589,"B.LvsV.CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_4"
44,"Down",0.60603514129967,0.860011050675589,"B.LvsV.KEGG_PROTEASOME"
38,"Down",0.606147283179086,0.860011050675589,"B.LvsV.BIOCARTA_BAD_PATHWAY"
32,"Down",0.606160800232007,0.860011050675589,"B.LvsV.LE_NEURONAL_DIFFERENTIATION_UP"
79,"Up",0.606338419080922,0.860042359953416,"B.LvsV.REACTOME_BASE_EXCISION_REPAIR_AP_SITE_FORMATION"
107,"Down",0.606547586402149,0.860118390668757,"B.LvsV.YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_7"
10,"Up",0.607311613236006,0.860766779389027,"B.LvsV.TURASHVILI_BREAST_CARCINOMA_DUCTAL_VS_LOBULAR_DN"
64,"Down",0.607395779786571,0.860766779389027,"B.LvsV.BIOCARTA_KERATINOCYTE_PATHWAY"
8,"Up",0.607471870713688,0.860766779389027,"B.LvsV.REACTOME_DEFECTIVE_ST3GAL3_CAUSES_MCT12_AND_EIEE15"
18,"Down",0.607748461388792,0.860938058677589,"B.LvsV.SHIN_B_CELL_LYMPHOMA_CLUSTER_1"
8,"Up",0.60819626726725,0.861351731998111,"B.LvsV.ZIRN_TRETINOIN_RESPONSE_DN"
21,"Down",0.608552332380652,0.861558580717476,"B.LvsV.MCBRYAN_TERMINAL_END_BUD_UP"
27,"Up",0.608653972921407,0.861558580717476,"B.LvsV.REACTOME_CELLULAR_HEXOSE_TRANSPORT"
10,"Up",0.608836181797902,0.861595917368979,"B.LvsV.CASTELLANO_HRAS_AND_NRAS_TARGETS_UP"
27,"Up",0.609247997820414,0.861958080846742,"B.LvsV.IGLESIAS_E2F_TARGETS_DN"
72,"Down",0.60956604218415,0.862071363776923,"B.LvsV.SCHRAETS_MLL_TARGETS_DN"
32,"Down",0.609730870448018,0.862071363776923,"B.LvsV.REACTOME_INTRINSIC_PATHWAY_OF_FIBRIN_CLOT_FORMATION"
57,"Down",0.609897034932639,0.862071363776923,"B.LvsV.KEGG_TRYPTOPHAN_METABOLISM"
33,"Down",0.610118128419568,0.862071363776923,"B.LvsV.TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_DN"
58,"Up",0.610188499966264,0.862071363776923,"B.LvsV.HARRIS_BRAIN_CANCER_PROGENITORS"
23,"Up",0.610417294233312,0.862071363776923,"B.LvsV.WU_HBX_TARGETS_2_DN"
36,"Up",0.61067676914244,0.862071363776923,"B.LvsV.BIOCARTA_TRKA_PATHWAY"
310,"Up",0.61073360724329,0.862071363776923,"B.LvsV.CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN"
37,"Down",0.610746277885765,0.862071363776923,"B.LvsV.REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR2"
24,"Up",0.610941776283272,0.862071363776923,"B.LvsV.REACTOME_NOTCH2_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION"
19,"Up",0.611114525609884,0.862071363776923,"B.LvsV.REACTOME_SIGNAL_REGULATORY_PROTEIN_FAMILY_INTERACTIONS"
1242,"Up",0.611199085911654,0.862071363776923,"B.LvsV.BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP"
119,"Down",0.611558916204586,0.862358900202794,"B.LvsV.GALINDO_IMMUNE_RESPONSE_TO_ENTEROTOXIN"
11,"Down",0.611786573651237,0.862459960662338,"B.LvsV.REACTOME_AKT_PHOSPHORYLATES_TARGETS_IN_THE_NUCLEUS"
8,"Down",0.612189301762103,0.862634134700884,"B.LvsV.KASLER_HDAC7_TARGETS_2_UP"
87,"Down",0.612222163965685,0.862634134700884,"B.LvsV.CAVARD_LIVER_CANCER_MALIGNANT_VS_BENIGN"
16,"Up",0.61261726037692,0.862970912770443,"B.LvsV.REACTOME_SIGNALING_BY_LEPTIN"
363,"Down",0.612821510776525,0.863038750148601,"B.LvsV.OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP"
82,"Up",0.613381915859472,0.863607999181823,"B.LvsV.PID_IL2_1PATHWAY"
638,"Down",0.614695927727493,0.865237725154102,"B.LvsV.PEREZ_TP63_TARGETS"
41,"Up",0.6148766026838,0.865271757759921,"B.LvsV.BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_UP"
59,"Down",0.615760748958327,0.866004340488913,"B.LvsV.REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES"
138,"Up",0.61609398384995,0.866004340488913,"B.LvsV.KEGG_TIGHT_JUNCTION"
7,"Up",0.616424200923572,0.866004340488913,"B.LvsV.TERAO_AOX4_TARGETS_HG_DN"
40,"Up",0.616731840959351,0.866004340488913,"B.LvsV.REACTOME_CARBOXYTERMINAL_POST_TRANSLATIONAL_MODIFICATIONS_OF_TUBULIN"
263,"Down",0.61674557863153,0.866004340488913,"B.LvsV.REACTOME_BINDING_AND_UPTAKE_OF_LIGANDS_BY_SCAVENGER_RECEPTORS"
75,"Up",0.617047501433541,0.866004340488913,"B.LvsV.PID_HEDGEHOG_GLI_PATHWAY"
11,"Up",0.617196987586411,0.866004340488913,"B.LvsV.MARIADASON_RESPONSE_TO_BUTYRATE_CURCUMIN_SULINDAC_TSA_2"
201,"Down",0.617333531475674,0.866004340488913,"B.LvsV.CHENG_IMPRINTED_BY_ESTRADIOL"
56,"Up",0.61736618584645,0.866004340488913,"B.LvsV.MARTIN_INTERACT_WITH_HDAC"
312,"Down",0.617583184090712,0.866004340488913,"B.LvsV.GERY_CEBP_TARGETS"
811,"Down",0.617638978815115,0.866004340488913,"B.LvsV.SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1"
68,"Up",0.617667650579187,0.866004340488913,"B.LvsV.BRACHAT_RESPONSE_TO_CAMPTOTHECIN_DN"
71,"Down",0.617692224869407,0.866004340488913,"B.LvsV.KEGG_TYPE_I_DIABETES_MELLITUS"
21,"Up",0.61833944668508,0.866004340488913,"B.LvsV.GRATIAS_RETINOBLASTOMA_16Q24"
29,"Up",0.618344005356323,0.866004340488913,"B.LvsV.RUAN_RESPONSE_TO_TNF_UP"
87,"Down",0.618403456399169,0.866004340488913,"B.LvsV.KEGG_TASTE_TRANSDUCTION"
13,"Up",0.618653270581928,0.866004340488913,"B.LvsV.REACTOME_TRIGLYCERIDE_BIOSYNTHESIS"
103,"Down",0.618762949174872,0.866004340488913,"B.LvsV.WESTON_VEGFA_TARGETS_3HR"
232,"Up",0.618793514162189,0.866004340488913,"B.LvsV.BROWNE_HCMV_INFECTION_12HR_UP"
8,"Up",0.61885179606154,0.866004340488913,"B.LvsV.REACTOME_FBXW7_MUTANTS_AND_NOTCH1_IN_CANCER"
89,"Down",0.61899794567061,0.866004340488913,"B.LvsV.DORN_ADENOVIRUS_INFECTION_48HR_DN"
73,"Down",0.619040068024723,0.866004340488913,"B.LvsV.BIOCARTA_PPARA_PATHWAY"
32,"Up",0.619106453651878,0.866004340488913,"B.LvsV.KORKOLA_SEMINOMA_DN"
36,"Down",0.619156295524086,0.866004340488913,"B.LvsV.ZHAN_LATE_DIFFERENTIATION_GENES_DN"
233,"Up",0.619645677718345,0.86623497212674,"B.LvsV.PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_UP"
25,"Up",0.619765984214341,0.86623497212674,"B.LvsV.BIOCARTA_ERK5_PATHWAY"
171,"Up",0.620184154946641,0.86623497212674,"B.LvsV.KEGG_WNT_SIGNALING_PATHWAY"
200,"Down",0.620389927799011,0.86623497212674,"B.LvsV.GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_UP"
126,"Down",0.620560996997381,0.86623497212674,"B.LvsV.LEE_LIVER_CANCER_ACOX1_DN"
104,"Down",0.620578149747981,0.86623497212674,"B.LvsV.BARIS_THYROID_CANCER_DN"
84,"Up",0.620598819824499,0.86623497212674,"B.LvsV.KEGG_PANCREATIC_CANCER"
143,"Up",0.620618368272898,0.86623497212674,"B.LvsV.PID_AP1_PATHWAY"
42,"Down",0.620809261086818,0.86623497212674,"B.LvsV.WALLACE_JAK2_TARGETS_UP"
10,"Up",0.620887899174945,0.86623497212674,"B.LvsV.BIOCARTA_CB1R_PATHWAY"
1768,"Up",0.621530592215657,0.866331131093594,"B.LvsV.PEREZ_TP53_TARGETS"
45,"Down",0.621536400746614,0.866331131093594,"B.LvsV.LOPES_METHYLATED_IN_COLON_CANCER_DN"
53,"Down",0.621567014633814,0.866331131093594,"B.LvsV.SESTO_RESPONSE_TO_UV_C6"
143,"Down",0.621583576966592,0.866331131093594,"B.LvsV.LIN_APC_TARGETS"
128,"Up",0.622204123952513,0.866977470094114,"B.LvsV.TIEN_INTESTINE_PROBIOTICS_2HR_DN"
14,"Up",0.622621435021516,0.867327631821487,"B.LvsV.REACTOME_DEGRADATION_OF_CYSTEINE_AND_HOMOCYSTEINE"
565,"Down",0.622769162295407,0.867327631821487,"B.LvsV.ZHOU_INFLAMMATORY_RESPONSE_LPS_UP"
34,"Up",0.623106980130618,0.867514348847469,"B.LvsV.REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION"
56,"Up",0.623393978499794,0.867514348847469,"B.LvsV.REACTOME_AQUAPORIN_MEDIATED_TRANSPORT"
135,"Up",0.623586815619903,0.867514348847469,"B.LvsV.PLASARI_TGFB1_SIGNALING_VIA_NFIC_10HR_UP"
78,"Up",0.623681274495068,0.867514348847469,"B.LvsV.PID_ERBB4_PATHWAY"
18,"Down",0.62383159026279,0.867514348847469,"B.LvsV.BIOCARTA_LYM_PATHWAY"
25,"Up",0.623844646593876,0.867514348847469,"B.LvsV.REACTOME_INTERLEUKIN_20_FAMILY_SIGNALING"
15,"Down",0.624379841574493,0.868040267554782,"B.LvsV.BIOCARTA_ERYTH_PATHWAY"
17,"Up",0.624800178001862,0.868406280586299,"B.LvsV.NIKOLSKY_BREAST_CANCER_14Q22_AMPLICON"
40,"Up",0.62527107235182,0.868814813357532,"B.LvsV.CHEN_PDGF_TARGETS"
283,"Down",0.625421908746058,0.868814813357532,"B.LvsV.TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP"
78,"Down",0.625802050911445,0.868814813357532,"B.LvsV.WANG_METHYLATED_IN_BREAST_CANCER"
38,"Up",0.625832788081479,0.868814813357532,"B.LvsV.PID_S1P_S1P3_PATHWAY"
36,"Down",0.625879797721658,0.868814813357532,"B.LvsV.REACTOME_THE_CANONICAL_RETINOID_CYCLE_IN_RODS_TWILIGHT_VISION"
177,"Up",0.626126606282712,0.868939258568553,"B.LvsV.REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS"
35,"Up",0.626887071367267,0.869776315580833,"B.LvsV.NABA_PROTEOGLYCANS"
41,"Down",0.627178532953933,0.869962395560034,"B.LvsV.ZHANG_RESPONSE_TO_CANTHARIDIN_UP"
127,"Up",0.627679044926992,0.870438284274226,"B.LvsV.ZHANG_GATA6_TARGETS_DN"
6,"Up",0.627887081277684,0.870508443426357,"B.LvsV.REACTOME_RELEASE_OF_APOPTOTIC_FACTORS_FROM_THE_MITOCHONDRIA"
48,"Up",0.62826605665388,0.870722873867103,"B.LvsV.REACTOME_NEGATIVE_REGULATION_OF_FGFR1_SIGNALING"
50,"Down",0.628361703359647,0.870722873867103,"B.LvsV.WU_ALZHEIMER_DISEASE_DN"
59,"Up",0.628647464115321,0.870722873867103,"B.LvsV.PID_HDAC_CLASSIII_PATHWAY"
93,"Down",0.6288815196776,0.870722873867103,"B.LvsV.WEIGEL_OXIDATIVE_STRESS_BY_TBH_AND_H2O2"
93,"Down",0.628936686496877,0.870722873867103,"B.LvsV.KRASNOSELSKAYA_ILF3_TARGETS_DN"
17,"Up",0.628986644641926,0.870722873867103,"B.LvsV.PARK_APL_PATHOGENESIS_UP"
161,"Up",0.629798372778885,0.871628336193856,"B.LvsV.FRASOR_RESPONSE_TO_ESTRADIOL_DN"
487,"Down",0.630015513010054,0.871710653511659,"B.LvsV.BENPORATH_OCT4_TARGETS"
20,"Down",0.630861963747393,0.872663446975065,"B.LvsV.ALONSO_METASTASIS_EMT_DN"
12,"Down",0.631625750349215,0.873247169742714,"B.LvsV.HOFFMAN_CLOCK_TARGETS_DN"
5,"Down",0.632058358699165,0.873247169742714,"B.LvsV.REACTOME_FASL_CD95L_SIGNALING"
34,"Down",0.632139495707531,0.873247169742714,"B.LvsV.HAHTOLA_CTCL_PATHOGENESIS"
89,"Up",0.632200683640534,0.873247169742714,"B.LvsV.LINDGREN_BLADDER_CANCER_HIGH_RECURRENCE"
110,"Down",0.632203608014997,0.873247169742714,"B.LvsV.MATZUK_MEIOTIC_AND_DNA_REPAIR"
113,"Down",0.63233008387003,0.873247169742714,"B.LvsV.FAELT_B_CLL_WITH_VH_REARRANGEMENTS_UP"
185,"Down",0.632389522092571,0.873247169742714,"B.LvsV.MORI_MATURE_B_LYMPHOCYTE_UP"
102,"Down",0.633002430832559,0.873673875515383,"B.LvsV.PID_IL4_2PATHWAY"
297,"Down",0.633014567790672,0.873673875515383,"B.LvsV.VANOEVELEN_MYOGENESIS_SIN3A_TARGETS"
75,"Down",0.633505401215203,0.874016301063944,"B.LvsV.CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN"
68,"Up",0.633578827032789,0.874016301063944,"B.LvsV.BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_24HR_DN"
46,"Down",0.634245715331091,0.874718024461362,"B.LvsV.KEGG_N_GLYCAN_BIOSYNTHESIS"
87,"Down",0.634720474031466,0.875090357149243,"B.LvsV.BYSTROEM_CORRELATED_WITH_IL5_DN"
113,"Up",0.634963048030367,0.875090357149243,"B.LvsV.PID_PTP1B_PATHWAY"
34,"Down",0.635091304575091,0.875090357149243,"B.LvsV.PARK_HSC_VS_MULTIPOTENT_PROGENITORS_UP"
409,"Down",0.635184604114499,0.875090357149243,"B.LvsV.CHEN_HOXA5_TARGETS_9HR_UP"
87,"Up",0.635307052558702,0.875090357149243,"B.LvsV.GOLDRATH_IMMUNE_MEMORY"
168,"Down",0.635725000147764,0.875354799701812,"B.LvsV.TOOKER_GEMCITABINE_RESISTANCE_DN"
1329,"Up",0.635887566477072,0.875354799701812,"B.LvsV.KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_UP"
19,"Down",0.635973997178907,0.875354799701812,"B.LvsV.BIOCARTA_HES_PATHWAY"
325,"Up",0.636877881357531,0.876380738184617,"B.LvsV.REACTOME_DEUBIQUITINATION"
35,"Up",0.637192888040618,0.876401106732706,"B.LvsV.HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_DN"
45,"Down",0.637366549882875,0.876401106732706,"B.LvsV.REACTOME_ENDOSOMAL_VACUOLAR_PATHWAY"
39,"Down",0.637415342107921,0.876401106732706,"B.LvsV.MARSON_FOXP3_TARGETS_STIMULATED_UP"
40,"Down",0.637782170911356,0.876401106732706,"B.LvsV.MURAKAMI_UV_RESPONSE_24HR"
27,"Down",0.637865203292241,0.876401106732706,"B.LvsV.REACTOME_TGF_BETA_RECEPTOR_SIGNALING_IN_EMT_EPITHELIAL_TO_MESENCHYMAL_TRANSITION"
102,"Up",0.637875012440988,0.876401106732706,"B.LvsV.REACTOME_E3_UBIQUITIN_LIGASES_UBIQUITINATE_TARGET_PROTEINS"
166,"Up",0.638061040004337,0.876401106732706,"B.LvsV.LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_UP"
91,"Down",0.638160762471672,0.876401106732706,"B.LvsV.MASSARWEH_RESPONSE_TO_ESTRADIOL"
41,"Up",0.638429056813028,0.87651645025044,"B.LvsV.REACTOME_INWARDLY_RECTIFYING_K_CHANNELS"
204,"Down",0.638561812553585,0.87651645025044,"B.LvsV.GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_UP"
36,"Down",0.639130999002371,0.877030494354375,"B.LvsV.KONG_E2F1_TARGETS"
22,"Up",0.639302297998007,0.877030494354375,"B.LvsV.REACTOME_CHONDROITIN_SULFATE_BIOSYNTHESIS"
176,"Down",0.639523871573483,0.877030494354375,"B.LvsV.NABA_ECM_AFFILIATED"
817,"Up",0.639582865336492,0.877030494354375,"B.LvsV.ACEVEDO_LIVER_CANCER_DN"
82,"Down",0.639729423716982,0.877030494354375,"B.LvsV.KIM_LIVER_CANCER_POOR_SURVIVAL_DN"
62,"Up",0.640136675198909,0.877371263553488,"B.LvsV.SUBTIL_PROGESTIN_TARGETS"
58,"Up",0.640450032030762,0.877582708351115,"B.LvsV.BYSTRYKH_HEMATOPOIESIS_STEM_CELL_SCP2_QTL_TRANS"
177,"Down",0.640608394086652,0.877582708351115,"B.LvsV.JAZAG_TGFB1_SIGNALING_UP"
89,"Down",0.641012275194982,0.877918471526642,"B.LvsV.KOHOUTEK_CCNT1_TARGETS"
33,"Up",0.641470767482043,0.878149907239285,"B.LvsV.KORKOLA_CHORIOCARCINOMA_DN"
43,"Down",0.641498910352591,0.878149907239285,"B.LvsV.LA_MEN1_TARGETS"
8,"Up",0.641873114231037,0.878424326286051,"B.LvsV.REACTOME_DEFECTIVE_CHST3_CAUSES_SEDCJD"
46,"Up",0.642026143316826,0.878424326286051,"B.LvsV.ZHAN_LATE_DIFFERENTIATION_GENES_UP"
59,"Down",0.642176004132432,0.878424326286051,"B.LvsV.VALK_AML_CLUSTER_4"
12,"Up",0.642848635137535,0.878937220114694,"B.LvsV.REACTOME_IRF3_MEDIATED_ACTIVATION_OF_TYPE_1_IFN"
31,"Up",0.64286889458199,0.878937220114694,"B.LvsV.GHANDHI_BYSTANDER_IRRADIATION_DN"
7,"Down",0.64334415516124,0.879302460124923,"B.LvsV.REACTOME_INTERLEUKIN_36_PATHWAY"
29,"Down",0.643454106287835,0.879302460124923,"B.LvsV.IVANOVA_HEMATOPOIESIS_STEM_CELL_SHORT_TERM"
204,"Down",0.643969723244379,0.879721567596232,"B.LvsV.SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_DN"
201,"Up",0.644086510644781,0.879721567596232,"B.LvsV.WEI_MIR34A_TARGETS"
16,"Down",0.644238131162442,0.879721567596232,"B.LvsV.NIKOLSKY_BREAST_CANCER_1Q32_AMPLICON"
104,"Up",0.64494247119114,0.880400531833676,"B.LvsV.MORI_IMMATURE_B_LYMPHOCYTE_UP"
162,"Up",0.645282745473911,0.880400531833676,"B.LvsV.HOSHIDA_LIVER_CANCER_SURVIVAL_UP"
644,"Up",0.645334219995661,0.880400531833676,"B.LvsV.PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_UP"
9,"Up",0.645372283509113,0.880400531833676,"B.LvsV.REACTOME_IRS_ACTIVATION"
96,"Down",0.645553746269036,0.880430849314628,"B.LvsV.LIU_SMARCA4_TARGETS"
91,"Up",0.645741134301116,0.88046923096199,"B.LvsV.FARMER_BREAST_CANCER_CLUSTER_1"
125,"Down",0.646159761690827,0.88071737861442,"B.LvsV.PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP"
45,"Down",0.646242961250671,0.88071737861442,"B.LvsV.WATANABE_COLON_CANCER_MSI_VS_MSS_UP"
40,"Down",0.646400998809426,0.88071737861442,"B.LvsV.WU_HBX_TARGETS_2_UP"
17,"Up",0.646893498236885,0.881171261826,"B.LvsV.REACTOME_ADVANCED_GLYCOSYLATION_ENDPRODUCT_RECEPTOR_SIGNALING"
125,"Up",0.647171435776086,0.881301368473969,"B.LvsV.IVANOVSKA_MIR106B_TARGETS"
11,"Up",0.647307805638051,0.881301368473969,"B.LvsV.REACTOME_HORMONE_LIGAND_BINDING_RECEPTORS"
100,"Down",0.647689199938964,0.88158944034708,"B.LvsV.DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP"
71,"Up",0.64784792830761,0.88158944034708,"B.LvsV.REACTOME_ION_HOMEOSTASIS"
169,"Down",0.64801334774019,0.88158944034708,"B.LvsV.KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_DN"
185,"Up",0.64815718484552,0.88158944034708,"B.LvsV.FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP"
317,"Down",0.648413675500716,0.881721399863124,"B.LvsV.WU_CELL_MIGRATION"
38,"Up",0.64866555855624,0.881847030552606,"B.LvsV.VALK_AML_WITH_11Q23_REARRANGED"
19,"Up",0.648917499108555,0.881972677623206,"B.LvsV.MATTHEWS_AP1_TARGETS"
17,"Up",0.649410800332614,0.881973228324045,"B.LvsV.FIGUEROA_AML_METHYLATION_CLUSTER_5_UP"
879,"Up",0.649426822208901,0.881973228324045,"B.LvsV.WEST_ADRENOCORTICAL_TUMOR_DN"
111,"Down",0.649556195209924,0.881973228324045,"B.LvsV.BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_DN"
30,"Up",0.649727561783512,0.881973228324045,"B.LvsV.BYSTRYKH_HEMATOPOIESIS_STEM_CELL_RUNX1"
34,"Down",0.649877886382919,0.881973228324045,"B.LvsV.GOLUB_ALL_VS_AML_UP"
443,"Down",0.650001903198009,0.881973228324045,"B.LvsV.WEST_ADRENOCORTICAL_TUMOR_UP"
400,"Up",0.650164638935059,0.881973228324045,"B.LvsV.ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN"
16,"Up",0.650214725229003,0.881973228324045,"B.LvsV.REACTOME_TNFR1_INDUCED_PROAPOPTOTIC_SIGNALING"
66,"Down",0.650353563370796,0.881973228324045,"B.LvsV.REACTOME_SIGNALING_BY_ERBB2"
129,"Down",0.650527703123543,0.881993053106933,"B.LvsV.LEE_CALORIE_RESTRICTION_NEOCORTEX_DN"
96,"Up",0.65101014133287,0.8821685910297,"B.LvsV.CERIBELLI_PROMOTERS_INACTIVE_AND_BOUND_BY_NFY"
409,"Up",0.651420557196067,0.8821685910297,"B.LvsV.PEDRIOLI_MIR31_TARGETS_UP"
49,"Up",0.65164804620516,0.8821685910297,"B.LvsV.KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_4NQO_IN_WS"
12,"Down",0.651708896594846,0.8821685910297,"B.LvsV.REACTOME_TRANSPORT_OF_NUCLEOSIDES_AND_FREE_PURINE_AND_PYRIMIDINE_BASES_ACROSS_THE_PLASMA_MEMBRANE"
385,"Up",0.651725687064015,0.8821685910297,"B.LvsV.COLDREN_GEFITINIB_RESISTANCE_DN"
262,"Up",0.651919120747751,0.8821685910297,"B.LvsV.NOUZOVA_TRETINOIN_AND_H4_ACETYLATION"
8,"Down",0.651943114393322,0.8821685910297,"B.LvsV.SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX6_DN"
137,"Down",0.652034589341115,0.8821685910297,"B.LvsV.BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_C"
55,"Down",0.652191087404612,0.8821685910297,"B.LvsV.SPIRA_SMOKERS_LUNG_CANCER_DN"
186,"Down",0.652252703948166,0.8821685910297,"B.LvsV.REACTOME_HCMV_INFECTION"
13,"Down",0.652790717310473,0.882680331623773,"B.LvsV.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_16"
35,"Down",0.653252845333419,0.883026139590614,"B.LvsV.OUYANG_PROSTATE_CANCER_MARKERS"
39,"Up",0.653365877566504,0.883026139590614,"B.LvsV.BIOCARTA_TPO_PATHWAY"
92,"Down",0.653857054166691,0.883278982136587,"B.LvsV.PID_NOTCH_PATHWAY"
19,"Up",0.65387246769489,0.883278982136587,"B.LvsV.REACTOME_REGULATION_OF_IFNG_SIGNALING"
46,"Down",0.654347789365451,0.883507824948606,"B.LvsV.PID_RAC1_REG_PATHWAY"
67,"Down",0.654405701417805,0.883507824948606,"B.LvsV.KYNG_DNA_DAMAGE_BY_4NQO"
95,"Down",0.654592005777043,0.883507824948606,"B.LvsV.KYNG_DNA_DAMAGE_BY_4NQO_OR_UV"
595,"Down",0.654681056034443,0.883507824948606,"B.LvsV.BROWNE_HCMV_INFECTION_4HR_DN"
23,"Down",0.655119021471721,0.883693333037137,"B.LvsV.HE_PTEN_TARGETS_UP"
203,"Down",0.655190193820386,0.883693333037137,"B.LvsV.MIKKELSEN_IPS_WITH_HCP_H3K27ME3"
16,"Up",0.655298004241682,0.883693333037137,"B.LvsV.BIOCARTA_THELPER_PATHWAY"
67,"Down",0.656276652728319,0.884757254402324,"B.LvsV.REACTOME_DECTIN_1_MEDIATED_NONCANONICAL_NF_KB_SIGNALING"
36,"Down",0.656406991781214,0.884757254402324,"B.LvsV.PID_IL3_PATHWAY"
32,"Up",0.656807268763083,0.884900602766525,"B.LvsV.DASU_IL6_SIGNALING_SCAR_DN"
72,"Down",0.656993694518102,0.884900602766525,"B.LvsV.NICK_RESPONSE_TO_PROC_TREATMENT_DN"
515,"Down",0.657081824689561,0.884900602766525,"B.LvsV.SENGUPTA_NASOPHARYNGEAL_CARCINOMA_DN"
59,"Up",0.657153531372645,0.884900602766525,"B.LvsV.YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_5"
1053,"Up",0.657649883810507,0.885187411250311,"B.LvsV.NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN"
5,"Down",0.657815370749571,0.885187411250311,"B.LvsV.REACTOME_TOXICITY_OF_BOTULINUM_TOXIN_TYPE_D_BONT_D"
180,"Up",0.658132205690353,0.885187411250311,"B.LvsV.KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY"
178,"Down",0.658209044034081,0.885187411250311,"B.LvsV.LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_DN"
171,"Up",0.658507953889641,0.885187411250311,"B.LvsV.LIU_NASOPHARYNGEAL_CARCINOMA"
99,"Up",0.658558281700141,0.885187411250311,"B.LvsV.BILBAN_B_CLL_LPL_DN"
171,"Up",0.658623654740497,0.885187411250311,"B.LvsV.REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX2"
25,"Up",0.658647315949318,0.885187411250311,"B.LvsV.REACTOME_PURINE_CATABOLISM"
88,"Down",0.659107991142272,0.885300870248543,"B.LvsV.KEGG_LEISHMANIA_INFECTION"
29,"Down",0.659184621702228,0.885300870248543,"B.LvsV.ITO_PTTG1_TARGETS_UP"
7,"Down",0.659212096728748,0.885300870248543,"B.LvsV.MIKHAYLOVA_OXIDATIVE_STRESS_RESPONSE_VIA_VHL_DN"
19,"Down",0.65964713126319,0.885571088607065,"B.LvsV.BIOCARTA_LONGEVITY_PATHWAY"
30,"Up",0.659733643330168,0.885571088607065,"B.LvsV.BIOCARTA_IGF1MTOR_PATHWAY"
64,"Down",0.660136558814499,0.885896852836253,"B.LvsV.WHITEHURST_PACLITAXEL_SENSITIVITY"
476,"Up",0.660832039303929,0.886614983089401,"B.LvsV.MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_UP"
8,"Up",0.661202386801889,0.886895859377843,"B.LvsV.HOLLEMAN_DAUNORUBICIN_ALL_DN"
89,"Up",0.66136220441578,0.886895859377843,"B.LvsV.CUI_TCF21_TARGETS_DN"
62,"Down",0.661547416470971,0.886929113886518,"B.LvsV.AMIT_SERUM_RESPONSE_480_MCF10A"
39,"Down",0.661799904743768,0.887052526867465,"B.LvsV.REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_ACETYLATION"
81,"Up",0.662282956061977,0.887472733874072,"B.LvsV.KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN"
68,"Up",0.662475616047224,0.887472733874072,"B.LvsV.PID_FRA_PATHWAY"
19,"Down",0.662650909837419,0.887472733874072,"B.LvsV.REACTOME_CASPASE_ACTIVATION_VIA_DEATH_RECEPTORS_IN_THE_PRESENCE_OF_LIGAND"
98,"Up",0.662755456351247,0.887472733874072,"B.LvsV.ZWANG_EGF_PERSISTENTLY_DN"
349,"Up",0.662932198049431,0.88749036699039,"B.LvsV.MIKKELSEN_MEF_ICP_WITH_H3K27ME3"
60,"Up",0.663502911869534,0.88749036699039,"B.LvsV.LIN_MELANOMA_COPY_NUMBER_DN"
37,"Down",0.663621492668836,0.88749036699039,"B.LvsV.OLSSON_E2F3_TARGETS_UP"
43,"Down",0.663704966030034,0.88749036699039,"B.LvsV.MARTINELLI_IMMATURE_NEUTROPHIL_UP"
14,"Down",0.663736742645545,0.88749036699039,"B.LvsV.CHEN_HOXA5_TARGETS_6HR_DN"
318,"Down",0.663751319508645,0.88749036699039,"B.LvsV.REACTOME_FLT3_SIGNALING"
31,"Down",0.663892233292142,0.88749036699039,"B.LvsV.GRANDVAUX_IRF3_TARGETS_UP"
56,"Up",0.664204233832509,0.887692823026333,"B.LvsV.KEGG_TYROSINE_METABOLISM"
31,"Up",0.664605830892297,0.888014895844251,"B.LvsV.VERNOCHET_ADIPOGENESIS"
9,"Down",0.664817294784647,0.888082827461781,"B.LvsV.FUJIWARA_PARK2_IN_LIVER_CANCER_UP"
22,"Up",0.664999419639033,0.888111543764302,"B.LvsV.LOPEZ_EPITHELIOID_MESOTHELIOMA"
66,"Down",0.665285681259733,0.88822644991638,"B.LvsV.KEGG_TYPE_II_DIABETES_MELLITUS"
142,"Down",0.665406756294745,0.88822644991638,"B.LvsV.KORKOLA_YOLK_SAC_TUMOR"
30,"Down",0.665608182355891,0.888280868994864,"B.LvsV.REACTOME_CRMPS_IN_SEMA3A_SIGNALING"
362,"Up",0.666120230260295,0.888610958585982,"B.LvsV.MULLIGHAN_NPM1_SIGNATURE_3_DN"
21,"Down",0.666176962079742,0.888610958585982,"B.LvsV.GEISS_RESPONSE_TO_DSRNA_DN"
170,"Up",0.666344519363167,0.888620079006018,"B.LvsV.ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_DN"
217,"Up",0.666658056438327,0.888783294648858,"B.LvsV.MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_UP"
256,"Up",0.666788407705456,0.888783294648858,"B.LvsV.BROWNE_HCMV_INFECTION_6HR_DN"
13,"Up",0.66820052272676,0.890403643486118,"B.LvsV.PID_ALK2_PATHWAY"
892,"Down",0.668326120540313,0.890403643486118,"B.LvsV.DOUGLAS_BMI1_TARGETS_UP"
26,"Up",0.668834652078138,0.89086648791617,"B.LvsV.REACTOME_N_GLYCAN_ANTENNAE_ELONGATION_IN_THE_MEDIAL_TRANS_GOLGI"
383,"Down",0.668997909905196,0.89086932655728,"B.LvsV.MULLIGHAN_MLL_SIGNATURE_1_DN"
124,"Down",0.669323068497515,0.890970833195906,"B.LvsV.REACTOME_G2_M_DNA_DAMAGE_CHECKPOINT"
330,"Up",0.669433503398246,0.890970833195906,"B.LvsV.REACTOME_METABOLISM_OF_CARBOHYDRATES"
17,"Down",0.669557571338215,0.890970833195906,"B.LvsV.MURAKAMI_UV_RESPONSE_1HR_DN"
238,"Down",0.669958521496467,0.891152083324229,"B.LvsV.MARKEY_RB1_CHRONIC_LOF_DN"
64,"Up",0.670092238790801,0.891152083324229,"B.LvsV.REACTOME_METABOLISM_OF_FAT_SOLUBLE_VITAMINS"
51,"Up",0.670177312798362,0.891152083324229,"B.LvsV.XU_AKT1_TARGETS_6HR"
10,"Up",0.670846936360436,0.891828014219008,"B.LvsV.BIOCARTA_MITR_PATHWAY"
30,"Up",0.671188426983854,0.891879187772212,"B.LvsV.PID_TRAIL_PATHWAY"
18,"Up",0.671208048529603,0.891879187772212,"B.LvsV.REACTOME_WNT5A_DEPENDENT_INTERNALIZATION_OF_FZD2_FZD5_AND_ROR2"
412,"Up",0.671735999768255,0.891971236728205,"B.LvsV.CHYLA_CBFA2T3_TARGETS_DN"
93,"Up",0.671888014307691,0.891971236728205,"B.LvsV.REACTOME_ERCC6_CSB_AND_EHMT2_G9A_POSITIVELY_REGULATE_RRNA_EXPRESSION"
10,"Down",0.672031499094241,0.891971236728205,"B.LvsV.REACTOME_DISPLACEMENT_OF_DNA_GLYCOSYLASE_BY_APEX1"
14,"Down",0.672046691281449,0.891971236728205,"B.LvsV.FUJIWARA_PARK2_HEPATOCYTE_PROLIFERATION_DN"
1673,"Down",0.672083952289691,0.891971236728205,"B.LvsV.REACTOME_SIGNALING_BY_GPCR"
29,"Down",0.672378634372737,0.892148180812782,"B.LvsV.EHRLICH_ICF_SYNDROM_DN"
465,"Down",0.672751468041994,0.892428710845533,"B.LvsV.HSIAO_LIVER_SPECIFIC_GENES"
575,"Down",0.672982539548351,0.892521098863715,"B.LvsV.SHEN_SMARCA2_TARGETS_DN"
8,"Up",0.673326854969518,0.892657725363479,"B.LvsV.REACTOME_VEGF_LIGAND_RECEPTOR_INTERACTIONS"
49,"Down",0.67340845948473,0.892657725363479,"B.LvsV.WEBER_METHYLATED_HCP_IN_SPERM_DN"
745,"Down",0.673601854091238,0.892700060227817,"B.LvsV.MEISSNER_NPC_HCP_WITH_H3K4ME2"
88,"Down",0.673834184364464,0.892704345430497,"B.LvsV.PID_RB_1PATHWAY"
5,"Up",0.674051999542379,0.892704345430497,"B.LvsV.REACTOME_MUSCARINIC_ACETYLCHOLINE_RECEPTORS"
7,"Up",0.67418423418353,0.892704345430497,"B.LvsV.REACTOME_VITAMIN_B2_RIBOFLAVIN_METABOLISM"
122,"Down",0.674284292541752,0.892704345430497,"B.LvsV.WNT_SIGNALING"
15,"Down",0.674412380333367,0.892704345430497,"B.LvsV.KOMMAGANI_TP63_GAMMA_TARGETS"
32,"Down",0.674732824151241,0.892914740242272,"B.LvsV.REACTOME_SEMA3A_PAK_DEPENDENT_AXON_REPULSION"
41,"Down",0.674930225091062,0.892962243246826,"B.LvsV.BIOCARTA_DC_PATHWAY"
90,"Up",0.675928583541716,0.893912822841945,"B.LvsV.REACTOME_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE"
44,"Up",0.67597205865476,0.893912822841945,"B.LvsV.REACTOME_METABOLISM_OF_STEROID_HORMONES"
516,"Up",0.676520821197128,0.894385366457762,"B.LvsV.ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_DN"
169,"Up",0.67665291877244,0.894385366457762,"B.LvsV.SERVITJA_ISLET_HNF1A_TARGETS_DN"
32,"Up",0.676906804236686,0.89450710339977,"B.LvsV.KEGG_NICOTINATE_AND_NICOTINAMIDE_METABOLISM"
21,"Up",0.677547839130602,0.895140263453548,"B.LvsV.IYENGAR_RESPONSE_TO_ADIPOCYTE_FACTORS"
12,"Up",0.678128264583263,0.895415115552068,"B.LvsV.SCIAN_CELL_CYCLE_TARGETS_OF_TP53_AND_TP73_UP"
59,"Down",0.678325146318786,0.895415115552068,"B.LvsV.GEISS_RESPONSE_TO_DSRNA_UP"
1407,"Up",0.678436866014981,0.895415115552068,"B.LvsV.BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_A"
108,"Down",0.678570354767986,0.895415115552068,"B.LvsV.GAVIN_FOXP3_TARGETS_CLUSTER_P2"
21,"Down",0.678585204327142,0.895415115552068,"B.LvsV.GOERING_BLOOD_HDL_CHOLESTEROL_QTL_CIS"
43,"Down",0.678978577564829,0.895415115552068,"B.LvsV.MATZUK_MALE_REPRODUCTION_SERTOLI"
23,"Up",0.67909443882656,0.895415115552068,"B.LvsV.REACTOME_ASSEMBLY_OF_ACTIVE_LPL_AND_LIPC_LIPASE_COMPLEXES"
144,"Up",0.67917710200081,0.895415115552068,"B.LvsV.LIANG_SILENCED_BY_METHYLATION_2"
127,"Down",0.679316205676279,0.895415115552068,"B.LvsV.REACTOME_REGULATION_OF_PLK1_ACTIVITY_AT_G2_M_TRANSITION"
1681,"Up",0.679414620798976,0.895415115552068,"B.LvsV.REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION"
15,"Down",0.679557220451557,0.895415115552068,"B.LvsV.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_LIGHTYELLOW_UP"
455,"Up",0.679699265684939,0.895415115552068,"B.LvsV.RAO_BOUND_BY_SALL4"
559,"Up",0.680132279365086,0.895772123060877,"B.LvsV.MULLIGHAN_NPM1_SIGNATURE_3_UP"
8,"Up",0.680467804296902,0.895901403061716,"B.LvsV.REACTOME_DEFECTIVE_CHST6_CAUSES_MCDC1"
20,"Up",0.680892330870996,0.895901403061716,"B.LvsV.SA_PTEN_PATHWAY"
47,"Up",0.681055563775395,0.895901403061716,"B.LvsV.REACTOME_METALLOPROTEASE_DUBS"
11,"Up",0.681120675978741,0.895901403061716,"B.LvsV.REACTOME_PHENYLALANINE_METABOLISM"
13,"Up",0.681372103590905,0.895901403061716,"B.LvsV.REACTOME_INTERLEUKIN_27_SIGNALING"
14,"Down",0.681443786743484,0.895901403061716,"B.LvsV.REACTOME_NRCAM_INTERACTIONS"
29,"Down",0.681707402881709,0.895901403061716,"B.LvsV.REACTOME_METABOLISM_OF_COFACTORS"
15,"Down",0.681856468757616,0.895901403061716,"B.LvsV.REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_ASSOCIATION_WITH_CO_FACTORS"
10,"Down",0.681877950736631,0.895901403061716,"B.LvsV.MATZUK_CUMULUS_EXPANSION"
34,"Down",0.68190674562352,0.895901403061716,"B.LvsV.WILLIAMS_ESR2_TARGETS_UP"
102,"Up",0.682048206965191,0.895901403061716,"B.LvsV.REACTOME_PLASMA_LIPOPROTEIN_ASSEMBLY_REMODELING_AND_CLEARANCE"
16,"Down",0.682324370206104,0.895901403061716,"B.LvsV.REACTOME_REGULATION_OF_COMMISSURAL_AXON_PATHFINDING_BY_SLIT_AND_ROBO"
252,"Down",0.682482176303916,0.895901403061716,"B.LvsV.REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS"
12,"Down",0.682524699340579,0.895901403061716,"B.LvsV.OHM_EMBRYONIC_CARCINOMA_DN"
24,"Down",0.682975607425021,0.895901403061716,"B.LvsV.REACTOME_BBSOME_MEDIATED_CARGO_TARGETING_TO_CILIUM"
102,"Down",0.683017595222499,0.895901403061716,"B.LvsV.MCCLUNG_CREB1_TARGETS_DN"
179,"Up",0.683077082998745,0.895901403061716,"B.LvsV.MATZUK_SPERMATOZOA"
88,"Up",0.683230819086979,0.895901403061716,"B.LvsV.DORN_ADENOVIRUS_INFECTION_12HR_DN"
110,"Up",0.683309136681363,0.895901403061716,"B.LvsV.POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_UP"
152,"Down",0.684443113672756,0.897175432787262,"B.LvsV.WONG_ENDMETRIUM_CANCER_DN"
21,"Down",0.684706982635809,0.897254541690552,"B.LvsV.REACTOME_PI_3K_CASCADE_FGFR3"
41,"Down",0.684893014272621,0.897254541690552,"B.LvsV.CHIN_BREAST_CANCER_COPY_NUMBER_UP"
531,"Down",0.685006060380035,0.897254541690552,"B.LvsV.ENK_UV_RESPONSE_EPIDERMIS_UP"
33,"Up",0.685152590887594,0.897254541690552,"B.LvsV.REACTOME_CYTOSOLIC_SULFONATION_OF_SMALL_MOLECULES"
55,"Down",0.686363278958616,0.89848830490462,"B.LvsV.FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN"
341,"Up",0.686419714219048,0.89848830490462,"B.LvsV.GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_DN"
116,"Down",0.686590017959195,0.898498511076069,"B.LvsV.RASHI_RESPONSE_TO_IONIZING_RADIATION_4"
54,"Down",0.687408135006551,0.899356265606062,"B.LvsV.AIYAR_COBRA1_TARGETS_DN"
31,"Down",0.687678582001144,0.899497250978076,"B.LvsV.BOYAULT_LIVER_CANCER_SUBCLASS_G6_DN"
179,"Down",0.687965461205936,0.899611313465847,"B.LvsV.BOUDOUKHA_BOUND_BY_IGF2BP2"
96,"Down",0.68809119997234,0.899611313465847,"B.LvsV.HUANG_DASATINIB_RESISTANCE_DN"
82,"Up",0.688857513860171,0.900400282300918,"B.LvsV.PID_FGF_PATHWAY"
122,"Down",0.68917618220455,0.900603902483799,"B.LvsV.CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_UP"
225,"Down",0.689437800110611,0.900732891496117,"B.LvsV.PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_DN"
142,"Down",0.690491355057258,0.901736037449304,"B.LvsV.REACTOME_ANTIMICROBIAL_PEPTIDES"
86,"Down",0.690607743943839,0.901736037449304,"B.LvsV.PID_HNF3A_PATHWAY"
154,"Up",0.690694902983867,0.901736037449304,"B.LvsV.ANDERSEN_LIVER_CANCER_KRT19_DN"
10,"Up",0.690912741480713,0.901807494723055,"B.LvsV.REACTOME_HDR_THROUGH_MMEJ_ALT_NHEJ"
51,"Down",0.691812617936557,0.902457244794766,"B.LvsV.REACTOME_SIGNALING_BY_FGFR3"
379,"Up",0.691914970521337,0.902457244794766,"B.LvsV.PHONG_TNF_RESPONSE_VIA_P38_COMPLETE"
80,"Up",0.692045314730428,0.902457244794766,"B.LvsV.MODY_HIPPOCAMPUS_NEONATAL"
522,"Up",0.692152100371629,0.902457244794766,"B.LvsV.BROWNE_HCMV_INFECTION_20HR_UP"
179,"Up",0.692226654942051,0.902457244794766,"B.LvsV.MIKKELSEN_IPS_HCP_WITH_H3_UNMETHYLATED"
51,"Up",0.692939410087839,0.902874063413296,"B.LvsV.WENG_POR_TARGETS_LIVER_DN"
82,"Down",0.692959928946708,0.902874063413296,"B.LvsV.TUOMISTO_TUMOR_SUPPRESSION_BY_COL13A1_UP"
88,"Down",0.693355933490365,0.902874063413296,"B.LvsV.DORN_ADENOVIRUS_INFECTION_32HR_DN"
53,"Down",0.693412175009847,0.902874063413296,"B.LvsV.REACTOME_SIGNALING_BY_NOTCH2"
345,"Down",0.693635717486208,0.902874063413296,"B.LvsV.IVANOVA_HEMATOPOIESIS_STEM_CELL"
337,"Down",0.693792690712678,0.902874063413296,"B.LvsV.KATSANOU_ELAVL1_TARGETS_UP"
41,"Down",0.693971850499278,0.902874063413296,"B.LvsV.ABE_VEGFA_TARGETS_30MIN"
421,"Up",0.694171528882103,0.902874063413296,"B.LvsV.KOYAMA_SEMA3B_TARGETS_UP"
150,"Up",0.694216052017349,0.902874063413296,"B.LvsV.REACTOME_OXIDATIVE_STRESS_INDUCED_SENESCENCE"
63,"Up",0.694443762121958,0.902874063413296,"B.LvsV.KEGG_NON_SMALL_CELL_LUNG_CANCER"
140,"Up",0.694616391166441,0.902874063413296,"B.LvsV.REACTOME_GLYCEROPHOSPHOLIPID_BIOSYNTHESIS"
20,"Down",0.694877785301153,0.902874063413296,"B.LvsV.MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_UP"
51,"Down",0.694954549019662,0.902874063413296,"B.LvsV.VALK_AML_CLUSTER_5"
33,"Down",0.695160665485077,0.902874063413296,"B.LvsV.GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_UP"
8,"Down",0.695184600090639,0.902874063413296,"B.LvsV.REACTOME_STAT5_ACTIVATION"
15,"Up",0.695249940403391,0.902874063413296,"B.LvsV.RAFFEL_VEGFA_TARGETS_UP"
636,"Up",0.695322438418125,0.902874063413296,"B.LvsV.RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP"
77,"Down",0.695741142806376,0.903205630095434,"B.LvsV.SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_DN"
518,"Up",0.696104867776921,0.903294476955338,"B.LvsV.CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN"
35,"Down",0.696173762098313,0.903294476955338,"B.LvsV.MARKS_HDAC_TARGETS_UP"
12,"Up",0.696299703523902,0.903294476955338,"B.LvsV.REACTOME_FREE_FATTY_ACIDS_REGULATE_INSULIN_SECRETION"
89,"Up",0.696731678168828,0.903642845084553,"B.LvsV.PID_P75_NTR_PATHWAY"
35,"Down",0.696914189684244,0.90366080580004,"B.LvsV.BIOCARTA_VDR_PATHWAY"
72,"Up",0.697072406716797,0.90366080580004,"B.LvsV.ALONSO_METASTASIS_EMT_UP"
16,"Up",0.697633056452248,0.904175613953229,"B.LvsV.REACTOME_SYNTHESIS_OF_PE"
258,"Down",0.697936272817979,0.904337239145418,"B.LvsV.MADAN_DPPA4_TARGETS"
33,"Up",0.698084886357867,0.904337239145418,"B.LvsV.SABATES_COLORECTAL_ADENOMA_SIZE_UP"
50,"Up",0.698576125168538,0.904761629434726,"B.LvsV.REACTOME_LYSOSOME_VESICLE_BIOGENESIS"
1013,"Down",0.699296990463849,0.905189643824807,"B.LvsV.MARTINEZ_RB1_TARGETS_DN"
60,"Down",0.699618094998006,0.905189643824807,"B.LvsV.APPEL_IMATINIB_RESPONSE"
116,"Down",0.699687748527075,0.905189643824807,"B.LvsV.REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES"
72,"Down",0.699735394433502,0.905189643824807,"B.LvsV.PARK_HSC_AND_MULTIPOTENT_PROGENITORS"
52,"Down",0.700029498548768,0.905189643824807,"B.LvsV.KEGG_ALDOSTERONE_REGULATED_SODIUM_REABSORPTION"
220,"Up",0.700122185952191,0.905189643824807,"B.LvsV.RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN"
128,"Up",0.700202386225761,0.905189643824807,"B.LvsV.ISSAEVA_MLL2_TARGETS"
56,"Down",0.700233075781845,0.905189643824807,"B.LvsV.SEMENZA_HIF1_TARGETS"
53,"Down",0.70038004996971,0.905189643824807,"B.LvsV.REACTOME_CROSS_PRESENTATION_OF_SOLUBLE_EXOGENOUS_ANTIGENS_ENDOSOMES"
105,"Down",0.700884379621077,0.905629758103513,"B.LvsV.GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_DN"
19,"Up",0.701547958139669,0.905910016953032,"B.LvsV.YIH_RESPONSE_TO_ARSENITE_C5"
879,"Up",0.701740987519905,0.905910016953032,"B.LvsV.ONKEN_UVEAL_MELANOMA_DN"
476,"Up",0.701827922096636,0.905910016953032,"B.LvsV.MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_UP"
30,"Up",0.701965111036354,0.905910016953032,"B.LvsV.REACTOME_APC_CDC20_MEDIATED_DEGRADATION_OF_NEK2A"
183,"Down",0.702155351101441,0.905910016953032,"B.LvsV.YORDY_RECIPROCAL_REGULATION_BY_ETS1_AND_SP100_DN"
484,"Up",0.702365987546577,0.905910016953032,"B.LvsV.RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP"
54,"Up",0.70240248440393,0.905910016953032,"B.LvsV.VALK_AML_CLUSTER_9"
48,"Down",0.702412053296735,0.905910016953032,"B.LvsV.GHANDHI_DIRECT_IRRADIATION_DN"
7,"Up",0.702730312739488,0.906088202269288,"B.LvsV.REACTOME_CHYLOMICRON_CLEARANCE"
5,"Down",0.702877970615478,0.906088202269288,"B.LvsV.REACTOME_GALACTOSE_CATABOLISM"
266,"Up",0.703803675865951,0.906886891506007,"B.LvsV.KIM_RESPONSE_TO_TSA_AND_DECITABINE_UP"
38,"Down",0.703825583550782,0.906886891506007,"B.LvsV.MATTIOLI_MULTIPLE_MYELOMA_SUBGROUPS"
88,"Down",0.70437813981921,0.906940883019712,"B.LvsV.KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION"
236,"Up",0.704527807527823,0.906940883019712,"B.LvsV.TIEN_INTESTINE_PROBIOTICS_6HR_DN"
51,"Up",0.704578009451199,0.906940883019712,"B.LvsV.GUILLAUMOND_KLF10_TARGETS_DN"
68,"Down",0.704912275006588,0.906940883019712,"B.LvsV.DIRMEIER_LMP1_RESPONSE_LATE_DN"
200,"Up",0.705098925340801,0.906940883019712,"B.LvsV.CAMPS_COLON_CANCER_COPY_NUMBER_DN"
276,"Down",0.705147085799885,0.906940883019712,"B.LvsV.AMIT_EGF_RESPONSE_480_HELA"
19,"Up",0.705395903258176,0.906940883019712,"B.LvsV.REACTOME_BUTYROPHILIN_BTN_FAMILY_INTERACTIONS"
1127,"Down",0.705566552888145,0.906940883019712,"B.LvsV.REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM"
342,"Down",0.706007506971906,0.906940883019712,"B.LvsV.DARWICHE_SKIN_TUMOR_PROMOTER_DN"
28,"Up",0.70604216180101,0.906940883019712,"B.LvsV.VISALA_RESPONSE_TO_HEAT_SHOCK_AND_AGING_UP"
63,"Down",0.70636825345326,0.906940883019712,"B.LvsV.AMIT_EGF_RESPONSE_40_HELA"
39,"Up",0.706578200867412,0.906940883019712,"B.LvsV.ZHENG_FOXP3_TARGETS_UP"
765,"Down",0.706777472618789,0.906940883019712,"B.LvsV.SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN"
20,"Down",0.706779070925033,0.906940883019712,"B.LvsV.REACTOME_DEFECTIVE_B4GALT7_CAUSES_EDS_PROGEROID_TYPE"
101,"Up",0.706812264734212,0.906940883019712,"B.LvsV.MARTINEZ_RESPONSE_TO_TRABECTEDIN_UP"
405,"Up",0.706864485479826,0.906940883019712,"B.LvsV.IVANOVA_HEMATOPOIESIS_STEM_CELL_LONG_TERM"
80,"Down",0.707188350684519,0.906940883019712,"B.LvsV.ELVIDGE_HYPOXIA_BY_DMOG_DN"
250,"Up",0.707445670990629,0.906940883019712,"B.LvsV.TAVAZOIE_METASTASIS"
726,"Up",0.707473136607422,0.906940883019712,"B.LvsV.PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_DN"
62,"Down",0.707609420522966,0.906940883019712,"B.LvsV.REACTOME_HSF1_DEPENDENT_TRANSACTIVATION"
12,"Down",0.707765848851738,0.906940883019712,"B.LvsV.GROSS_HIF1A_TARGETS_UP"
373,"Down",0.708386358139733,0.906940883019712,"B.LvsV.RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_UP"
12,"Down",0.708507252110997,0.906940883019712,"B.LvsV.MATZUK_MATERNAL_EFFECT"
16,"Up",0.708523756030506,0.906940883019712,"B.LvsV.ITO_PTTG1_TARGETS_DN"
318,"Down",0.708852979437727,0.906940883019712,"B.LvsV.REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR"
66,"Up",0.708873115202381,0.906940883019712,"B.LvsV.NIKOLSKY_BREAST_CANCER_19Q13.1_AMPLICON"
12,"Up",0.709000504628315,0.906940883019712,"B.LvsV.BIOCARTA_EOSINOPHILS_PATHWAY"
123,"Up",0.70915800126512,0.906940883019712,"B.LvsV.REACTOME_PEPTIDE_HORMONE_METABOLISM"
26,"Down",0.709204562751822,0.906940883019712,"B.LvsV.PARK_HSC_VS_MULTIPOTENT_PROGENITORS_DN"
35,"Down",0.70923191306029,0.906940883019712,"B.LvsV.GOLUB_ALL_VS_AML_DN"
27,"Up",0.709695501748999,0.906940883019712,"B.LvsV.TERAMOTO_OPN_TARGETS_CLUSTER_7"
13,"Down",0.709751412865624,0.906940883019712,"B.LvsV.GALI_TP53_TARGETS_APOPTOTIC_UP"
25,"Down",0.709867709368446,0.906940883019712,"B.LvsV.LEE_LIVER_CANCER_HEPATOBLAST"
53,"Up",0.709999054750182,0.906940883019712,"B.LvsV.HEIDENBLAD_AMPLICON_8Q24_DN"
165,"Up",0.710032686636627,0.906940883019712,"B.LvsV.NIKOLSKY_BREAST_CANCER_8Q12_Q22_AMPLICON"
31,"Down",0.710097366118298,0.906940883019712,"B.LvsV.SA_CASPASE_CASCADE"
6,"Up",0.710408642277688,0.906940883019712,"B.LvsV.REN_MIF_TARGETS_DN"
365,"Up",0.710414022390683,0.906940883019712,"B.LvsV.PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP"
87,"Up",0.710533428478371,0.906940883019712,"B.LvsV.KYNG_DNA_DAMAGE_BY_UV"
42,"Down",0.710547222522138,0.906940883019712,"B.LvsV.BURTON_ADIPOGENESIS_12"
810,"Up",0.710592856798949,0.906940883019712,"B.LvsV.SWEET_LUNG_CANCER_KRAS_DN"
30,"Up",0.710841931828644,0.907047278872725,"B.LvsV.CHOI_ATL_CHRONIC_VS_ACUTE_DN"
28,"Down",0.711004323862252,0.907047278872725,"B.LvsV.RAMPON_ENRICHED_LEARNING_ENVIRONMENT_EARLY_UP"
35,"Up",0.711916193338366,0.90798101812585,"B.LvsV.BIOCARTA_GSK3_PATHWAY"
63,"Up",0.712064694265452,0.90798101812585,"B.LvsV.SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_DN"
288,"Down",0.712317385381753,0.908093803037978,"B.LvsV.FOSTER_TOLERANT_MACROPHAGE_UP"
38,"Up",0.71271897237146,0.908396311259059,"B.LvsV.REACTOME_TAK1_ACTIVATES_NFKB_BY_PHOSPHORYLATION_AND_ACTIVATION_OF_IKKS_COMPLEX"
528,"Up",0.7130993218815,0.908671618041672,"B.LvsV.WANG_LMO4_TARGETS_UP"
60,"Down",0.713271462531691,0.908681547543254,"B.LvsV.PID_NFAT_TFPATHWAY"
193,"Down",0.713529124501728,0.90880039838057,"B.LvsV.ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_DN"
57,"Down",0.713934811687686,0.90893068284991,"B.LvsV.WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_UP"
546,"Up",0.713960201775576,0.90893068284991,"B.LvsV.ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_UP"
24,"Up",0.714188087434503,0.909011495263666,"B.LvsV.BIOCARTA_VITCB_PATHWAY"
115,"Down",0.715066980774752,0.909920675881151,"B.LvsV.REACTOME_RECRUITMENT_OF_MITOTIC_CENTROSOME_PROTEINS_AND_COMPLEXES"
117,"Up",0.715284326349849,0.909987814171264,"B.LvsV.REACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING"
46,"Down",0.715528597606023,0.910089168659697,"B.LvsV.CLIMENT_BREAST_CANCER_COPY_NUMBER_UP"
19,"Down",0.715908617283996,0.910318713437411,"B.LvsV.AMIT_EGF_RESPONSE_20_HELA"
52,"Up",0.716038358607217,0.910318713437411,"B.LvsV.VALK_AML_CLUSTER_2"
6,"Down",0.717316372789253,0.911568561751531,"B.LvsV.REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_ENDOCRINE_COMMITTED_NEUROG3_PROGENITOR_CELLS"
18,"Down",0.717481915136197,0.911568561751531,"B.LvsV.BAKER_HEMATOPOIESIS_STAT3_TARGETS"
58,"Down",0.717656938381048,0.911568561751531,"B.LvsV.LI_CISPLATIN_RESISTANCE_DN"
257,"Down",0.717680945795698,0.911568561751531,"B.LvsV.RICKMAN_HEAD_AND_NECK_CANCER_A"
1419,"Up",0.718988642701122,0.913019799148944,"B.LvsV.BENPORATH_NANOG_TARGETS"
119,"Up",0.719215291754731,0.91302978135671,"B.LvsV.MEISSNER_BRAIN_HCP_WITH_H3_UNMETHYLATED"
893,"Down",0.719326772940826,0.91302978135671,"B.LvsV.ENK_UV_RESPONSE_EPIDERMIS_DN"
14,"Up",0.719705685907445,0.913301064352138,"B.LvsV.TAKADA_GASTRIC_CANCER_COPY_NUMBER_UP"
10,"Up",0.720032596780751,0.913506247728494,"B.LvsV.BIOCARTA_BBCELL_PATHWAY"
23,"Down",0.721110632926478,0.914529401498677,"B.LvsV.LY_AGING_MIDDLE_UP"
155,"Up",0.721191608383763,0.914529401498677,"B.LvsV.ALCALA_APOPTOSIS"
19,"Down",0.721335272189497,0.914529401498677,"B.LvsV.MATZUK_PREOVULATORY_FOLLICLE"
37,"Up",0.722148960965714,0.91463990282345,"B.LvsV.REACTOME_UPTAKE_AND_ACTIONS_OF_BACTERIAL_TOXINS"
254,"Down",0.722175915163498,0.91463990282345,"B.LvsV.MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_UP"
701,"Down",0.722367432468729,0.91463990282345,"B.LvsV.SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN"
119,"Up",0.722738530986256,0.91463990282345,"B.LvsV.GUO_HEX_TARGETS_UP"
20,"Down",0.722768912149441,0.91463990282345,"B.LvsV.REACTOME_KILLING_MECHANISMS"
272,"Down",0.722828650028108,0.91463990282345,"B.LvsV.REACTOME_FCERI_MEDIATED_NF_KB_ACTIVATION"
83,"Down",0.722866420817235,0.91463990282345,"B.LvsV.DAUER_STAT3_TARGETS_UP"
26,"Down",0.722896228650502,0.91463990282345,"B.LvsV.PID_BETA_CATENIN_DEG_PATHWAY"
9,"Down",0.722911263399977,0.91463990282345,"B.LvsV.REACTOME_HIGHLY_CALCIUM_PERMEABLE_NICOTINIC_ACETYLCHOLINE_RECEPTORS"
31,"Up",0.723270752928053,0.914716234386595,"B.LvsV.CAFFAREL_RESPONSE_TO_THC_8HR_5_UP"
18,"Down",0.723339671733337,0.914716234386595,"B.LvsV.PID_SMAD2_3PATHWAY"
474,"Down",0.72346791336093,0.914716234386595,"B.LvsV.RIZKI_TUMOR_INVASIVENESS_3D_DN"
137,"Down",0.72369858042286,0.914798685678553,"B.LvsV.KYNG_DNA_DAMAGE_BY_GAMMA_RADIATION"
7,"Up",0.724028532379135,0.914871057393832,"B.LvsV.REACTOME_GLI_PROTEINS_BIND_PROMOTERS_OF_HH_RESPONSIVE_GENES_TO_PROMOTE_TRANSCRIPTION"
97,"Down",0.724086769244964,0.914871057393832,"B.LvsV.REACTOME_COLLAGEN_DEGRADATION"
5,"Up",0.724469777779275,0.914991705711664,"B.LvsV.REACTOME_BETA_OXIDATION_OF_OCTANOYL_COA_TO_HEXANOYL_COA"
6,"Down",0.724652469853185,0.914991705711664,"B.LvsV.REACTOME_SIGNALING_BY_MEMBRANE_TETHERED_FUSIONS_OF_PDGFRA_OR_PDGFRB"
573,"Down",0.724820606977574,0.914991705711664,"B.LvsV.CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP"
75,"Down",0.725006204943017,0.914991705711664,"B.LvsV.LIU_TARGETS_OF_VMYB_VS_CMYB_DN"
17,"Down",0.725182751109033,0.914991705711664,"B.LvsV.SUZUKI_CTCFL_TARGETS_UP"
19,"Down",0.725338957205204,0.914991705711664,"B.LvsV.BIOCARTA_HSWI_SNF_PATHWAY"
37,"Down",0.725340684777396,0.914991705711664,"B.LvsV.ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_UP"
176,"Up",0.726156905062454,0.915812392356365,"B.LvsV.STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_UP"
44,"Down",0.726996651506742,0.916662368570302,"B.LvsV.COLLIS_PRKDC_SUBSTRATES"
12,"Down",0.727695735662085,0.917334638047348,"B.LvsV.VISALA_AGING_LYMPHOCYTE_UP"
445,"Down",0.728350856208645,0.917576903897738,"B.LvsV.BORCZUK_MALIGNANT_MESOTHELIOMA_UP"
6,"Down",0.728536501222739,0.917576903897738,"B.LvsV.REACTOME_SENSING_OF_DNA_DOUBLE_STRAND_BREAKS"
34,"Down",0.728538894259257,0.917576903897738,"B.LvsV.REACTOME_IRF3_MEDIATED_INDUCTION_OF_TYPE_I_IFN"
647,"Up",0.728925731647996,0.917576903897738,"B.LvsV.YAUCH_HEDGEHOG_SIGNALING_PARACRINE_DN"
6,"Down",0.729649370731571,0.917576903897738,"B.LvsV.REACTOME_THE_FATTY_ACID_CYCLING_MODEL"
6,"Up",0.729663436797301,0.917576903897738,"B.LvsV.MCGOWAN_RSP6_TARGETS_DN"
22,"Up",0.729769084847013,0.917576903897738,"B.LvsV.BIOCARTA_TOB1_PATHWAY"
46,"Up",0.729841617051584,0.917576903897738,"B.LvsV.IIZUKA_LIVER_CANCER_PROGRESSION_G2_G3_UP"
2751,"Up",0.729961586319017,0.917576903897738,"B.LvsV.BLALOCK_ALZHEIMERS_DISEASE_UP"
36,"Down",0.730000247282435,0.917576903897738,"B.LvsV.KEGG_BASAL_TRANSCRIPTION_FACTORS"
65,"Down",0.730069596731534,0.917576903897738,"B.LvsV.REACTOME_DEFECTIVE_CFTR_CAUSES_CYSTIC_FIBROSIS"
94,"Up",0.730082217832347,0.917576903897738,"B.LvsV.BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_UP"
50,"Up",0.730148573505313,0.917576903897738,"B.LvsV.REACTOME_FORMATION_OF_INCISION_COMPLEX_IN_GG_NER"
112,"Down",0.730211317986986,0.917576903897738,"B.LvsV.WIEDERSCHAIN_TARGETS_OF_BMI1_AND_PCGF2"
18,"Down",0.730612149166618,0.917871977446542,"B.LvsV.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_DN"
17,"Down",0.731487865982202,0.917949961369316,"B.LvsV.BIOCARTA_RANBP2_PATHWAY"
56,"Down",0.731573911878947,0.917949961369316,"B.LvsV.MCCABE_HOXC6_TARGETS_CANCER_UP"
19,"Up",0.7318091711515,0.917949961369316,"B.LvsV.KEGG_GLYOXYLATE_AND_DICARBOXYLATE_METABOLISM"
314,"Up",0.731944327378429,0.917949961369316,"B.LvsV.REACTOME_BIOLOGICAL_OXIDATIONS"
15,"Down",0.731963371773686,0.917949961369316,"B.LvsV.REACTOME_TICAM1_TRAF6_DEPENDENT_INDUCTION_OF_TAK1_COMPLEX"
35,"Down",0.732127704761008,0.917949961369316,"B.LvsV.MOROSETTI_FACIOSCAPULOHUMERAL_MUSCULAR_DISTROPHY_UP"
292,"Down",0.732565447728207,0.917949961369316,"B.LvsV.SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM2"
8,"Down",0.732715806470142,0.917949961369316,"B.LvsV.LIU_IL13_MEMORY_MODEL_DN"
848,"Down",0.732927016532415,0.917949961369316,"B.LvsV.MATSUDA_NATURAL_KILLER_DIFFERENTIATION"
22,"Up",0.732949577582034,0.917949961369316,"B.LvsV.ZEILSTRA_CD44_TARGETS_UP"
60,"Down",0.733110791780465,0.917949961369316,"B.LvsV.REACTOME_BIOSYNTHESIS_OF_SPECIALIZED_PRORESOLVING_MEDIATORS_SPMS"
733,"Up",0.733152192037361,0.917949961369316,"B.LvsV.HAN_SATB1_TARGETS_UP"
18,"Up",0.733342254719452,0.917949961369316,"B.LvsV.NOUSHMEHR_GBM_GERMLINE_MUTATED"
324,"Down",0.733487855952116,0.917949961369316,"B.LvsV.GRUETZMANN_PANCREATIC_CANCER_DN"
45,"Down",0.7338764640705,0.917949961369316,"B.LvsV.HOFMANN_MYELODYSPLASTIC_SYNDROM_RISK_DN"
32,"Up",0.734061176366974,0.917949961369316,"B.LvsV.BIOCARTA_MTA3_PATHWAY"
26,"Down",0.734169336994365,0.917949961369316,"B.LvsV.REACTOME_PD_1_SIGNALING"
112,"Down",0.734531402557619,0.917949961369316,"B.LvsV.ASGHARZADEH_NEUROBLASTOMA_POOR_SURVIVAL_DN"
15,"Down",0.73465868600599,0.917949961369316,"B.LvsV.YAMANAKA_GLIOBLASTOMA_SURVIVAL_UP"
36,"Up",0.734824560601189,0.917949961369316,"B.LvsV.PID_P38_MKK3_6PATHWAY"
78,"Up",0.734854266968231,0.917949961369316,"B.LvsV.MIDORIKAWA_AMPLIFIED_IN_LIVER_CANCER"
289,"Down",0.73486975059563,0.917949961369316,"B.LvsV.NABA_CORE_MATRISOME"
1242,"Up",0.734872131193188,0.917949961369316,"B.LvsV.KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3"
81,"Down",0.735044358890298,0.917949961369316,"B.LvsV.HEIDENBLAD_AMPLICON_8Q24_UP"
110,"Up",0.735230925807614,0.917949961369316,"B.LvsV.PID_IL12_2PATHWAY"
27,"Up",0.735395549606771,0.917949961369316,"B.LvsV.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_CYAN_UP"
233,"Down",0.735538543973736,0.917949961369316,"B.LvsV.RASHI_RESPONSE_TO_IONIZING_RADIATION_6"
39,"Down",0.735563136167122,0.917949961369316,"B.LvsV.PID_RAS_PATHWAY"
118,"Down",0.735757177074226,0.917949961369316,"B.LvsV.ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_DN"
100,"Up",0.735848434011723,0.917949961369316,"B.LvsV.PID_MYC_REPRESS_PATHWAY"
584,"Up",0.73584986608027,0.917949961369316,"B.LvsV.MULLIGHAN_MLL_SIGNATURE_1_UP"
518,"Down",0.73598701008323,0.917949961369316,"B.LvsV.LEI_MYB_TARGETS"
41,"Down",0.737151928801557,0.91892318781348,"B.LvsV.REACTOME_MISCELLANEOUS_SUBSTRATES"
20,"Up",0.73724509074137,0.91892318781348,"B.LvsV.REACTOME_ENOS_ACTIVATION"
24,"Up",0.737408817060846,0.91892318781348,"B.LvsV.BIOCARTA_RACC_PATHWAY"
30,"Down",0.737572739092222,0.91892318781348,"B.LvsV.REACTOME_ESTROGEN_DEPENDENT_NUCLEAR_EVENTS_DOWNSTREAM_OF_ESR_MEMBRANE_SIGNALING"
36,"Down",0.737598319319267,0.91892318781348,"B.LvsV.GAVIN_PDE3B_TARGETS"
46,"Up",0.737770143895756,0.918930192746031,"B.LvsV.REACTOME_INTERLEUKIN_7_SIGNALING"
86,"Up",0.738242760752807,0.919260543023576,"B.LvsV.GUILLAUMOND_KLF10_TARGETS_UP"
42,"Up",0.738524424914565,0.919260543023576,"B.LvsV.PID_S1P_S1P1_PATHWAY"
105,"Up",0.73853415303142,0.919260543023576,"B.LvsV.WEBER_METHYLATED_ICP_IN_FIBROBLAST"
1397,"Up",0.739427931315957,0.920165886168338,"B.LvsV.ACEVEDO_LIVER_CANCER_UP"
37,"Down",0.739957128755599,0.920617228823066,"B.LvsV.FRIDMAN_SENESCENCE_DN"
380,"Down",0.740528905754567,0.920976794836589,"B.LvsV.REACTOME_ANTI_INFLAMMATORY_RESPONSE_FAVOURING_LEISHMANIA_PARASITE_INFECTION"
48,"Down",0.740579278322205,0.920976794836589,"B.LvsV.REACTOME_LATE_ENDOSOMAL_MICROAUTOPHAGY"
42,"Down",0.740889928612361,0.921155928782942,"B.LvsV.REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR1"
39,"Up",0.741094882122446,0.921200667699077,"B.LvsV.JOHANSSON_GLIOMAGENESIS_BY_PDGFB_DN"
7,"Down",0.741259137383468,0.921200667699077,"B.LvsV.REACTOME_ATTACHMENT_OF_GPI_ANCHOR_TO_UPAR"
20,"Down",0.741583045158394,0.92139610262489,"B.LvsV.GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_2"
262,"Up",0.742168758499105,0.921916662714345,"B.LvsV.LIU_CMYB_TARGETS_UP"
87,"Up",0.742490093303224,0.921929205641117,"B.LvsV.KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN"
141,"Down",0.742731065626664,0.921929205641117,"B.LvsV.YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_0"
45,"Up",0.742998978287738,0.921929205641117,"B.LvsV.CHNG_MULTIPLE_MYELOMA_HYPERPLOID_DN"
8,"Down",0.743063864419473,0.921929205641117,"B.LvsV.REACTOME_OPSINS"
65,"Up",0.743127924824777,0.921929205641117,"B.LvsV.REACTOME_IRON_UPTAKE_AND_TRANSPORT"
13,"Down",0.743304018419233,0.921929205641117,"B.LvsV.CHASSOT_SKIN_WOUND"
431,"Down",0.743360787747973,0.921929205641117,"B.LvsV.BROWNE_HCMV_INFECTION_1HR_DN"
52,"Up",0.743512810264739,0.921929205641117,"B.LvsV.PID_BMP_PATHWAY"
50,"Up",0.743705089806729,0.921960861332154,"B.LvsV.REACTOME_G_ALPHA_Z_SIGNALLING_EVENTS"
69,"Up",0.74407183027971,0.922034347879917,"B.LvsV.SCHEIDEREIT_IKK_INTERACTING_PROTEINS"
7,"Up",0.744097894780284,0.922034347879917,"B.LvsV.TESAR_ALK_TARGETS_HUMAN_ES_4D_DN"
65,"Down",0.744421968801994,0.92222923269241,"B.LvsV.ABE_INNER_EAR"
104,"Down",0.744972485184746,0.922527246512624,"B.LvsV.KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_DN"
51,"Down",0.744996230001604,0.922527246512624,"B.LvsV.HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_UP"
225,"Up",0.745635878921842,0.922573134014572,"B.LvsV.HOOI_ST7_TARGETS_DN"
13,"Down",0.745638450854728,0.922573134014572,"B.LvsV.BIOCARTA_PLCE_PATHWAY"
16,"Down",0.745681631534277,0.922573134014572,"B.LvsV.REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_CELL_DEATH_GENES"
106,"Down",0.745700729953178,0.922573134014572,"B.LvsV.REACTOME_RNA_POLYMERASE_I_PROMOTER_ESCAPE"
77,"Down",0.746390652243917,0.923220115493651,"B.LvsV.LINDSTEDT_DENDRITIC_CELL_MATURATION_B"
22,"Down",0.746702037500022,0.92339869499835,"B.LvsV.REACTOME_REGULATION_OF_KIT_SIGNALING"
29,"Up",0.746909879131537,0.923449177486196,"B.LvsV.BIOCARTA_BARR_MAPK_PATHWAY"
76,"Down",0.747488683834396,0.923958178609518,"B.LvsV.REACTOME_DAP12_SIGNALING"
29,"Down",0.747885489155222,0.924242036106219,"B.LvsV.KEGG_PHENYLALANINE_METABOLISM"
682,"Down",0.748204797653357,0.924401029107105,"B.LvsV.YAGI_AML_WITH_T_8_21_TRANSLOCATION"
218,"Up",0.748348527090505,0.924401029107105,"B.LvsV.RASHI_RESPONSE_TO_IONIZING_RADIATION_5"
35,"Up",0.748830328599555,0.924713703642482,"B.LvsV.HOFMANN_MYELODYSPLASTIC_SYNDROM_HIGH_RISK_DN"
31,"Up",0.749093750906785,0.924713703642482,"B.LvsV.OUYANG_PROSTATE_CANCER_PROGRESSION_UP"
30,"Up",0.749319683729099,0.924713703642482,"B.LvsV.HOLLEMAN_ASPARAGINASE_RESISTANCE_ALL_DN"
13,"Up",0.749471736193233,0.924713703642482,"B.LvsV.REACTOME_CREATINE_METABOLISM"
47,"Down",0.749526832026801,0.924713703642482,"B.LvsV.CEBALLOS_TARGETS_OF_TP53_AND_MYC_DN"
46,"Down",0.749735060416761,0.924713703642482,"B.LvsV.CHANGOLKAR_H2AFY_TARGETS_DN"
15,"Up",0.750040880231108,0.924713703642482,"B.LvsV.MANN_RESPONSE_TO_AMIFOSTINE_DN"
40,"Up",0.750344620646037,0.924713703642482,"B.LvsV.TAKADA_GASTRIC_CANCER_COPY_NUMBER_DN"
28,"Down",0.750597997656657,0.924713703642482,"B.LvsV.REACTOME_MICRORNA_MIRNA_BIOGENESIS"
34,"Down",0.750716749450406,0.924713703642482,"B.LvsV.PETRETTO_HEART_MASS_QTL_CIS_DN"
72,"Up",0.750908262629486,0.924713703642482,"B.LvsV.SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_DN"
36,"Up",0.751356363372673,0.924713703642482,"B.LvsV.REACTOME_GLUCAGON_TYPE_LIGAND_RECEPTORS"
13,"Down",0.751579773860885,0.924713703642482,"B.LvsV.REACTOME_PREVENTION_OF_PHAGOSOMAL_LYSOSOMAL_FUSION"
756,"Up",0.751597414321222,0.924713703642482,"B.LvsV.ZHENG_BOUND_BY_FOXP3"
128,"Up",0.751612710662784,0.924713703642482,"B.LvsV.BOYLAN_MULTIPLE_MYELOMA_D_UP"
43,"Down",0.751740818406362,0.924713703642482,"B.LvsV.REACTOME_PROLACTIN_RECEPTOR_SIGNALING"
494,"Down",0.751821571784002,0.924713703642482,"B.LvsV.REACTOME_G_ALPHA_I_SIGNALLING_EVENTS"
31,"Up",0.751859692939478,0.924713703642482,"B.LvsV.KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_UV_IN_OLD"
49,"Down",0.751885930672837,0.924713703642482,"B.LvsV.NIKOLSKY_BREAST_CANCER_1Q21_AMPLICON"
19,"Down",0.752040502965251,0.924713703642482,"B.LvsV.HEIDENBLAD_AMPLIFIED_IN_SOFT_TISSUE_CANCER"
51,"Down",0.75220098665095,0.924713703642482,"B.LvsV.REACTOME_GROWTH_HORMONE_RECEPTOR_SIGNALING"
308,"Up",0.752415829618529,0.924713703642482,"B.LvsV.VERHAAK_GLIOBLASTOMA_CLASSICAL"
110,"Down",0.752575721749558,0.924713703642482,"B.LvsV.REACTOME_POTASSIUM_CHANNELS"
14,"Up",0.752615602530506,0.924713703642482,"B.LvsV.MEINHOLD_OVARIAN_CANCER_LOW_GRADE_UP"
233,"Up",0.753070148900228,0.924880142138719,"B.LvsV.REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES"
37,"Up",0.753085621253123,0.924880142138719,"B.LvsV.PID_INSULIN_GLUCOSE_PATHWAY"
31,"Up",0.753669661614313,0.92539186299479,"B.LvsV.BIOCARTA_MTOR_PATHWAY"
115,"Up",0.754166173912918,0.925757208500544,"B.LvsV.REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX"
12,"Up",0.754302084336218,0.925757208500544,"B.LvsV.REACTOME_FGFR2B_LIGAND_BINDING_AND_ACTIVATION"
169,"Down",0.75480389769858,0.926167498973691,"B.LvsV.GAVIN_FOXP3_TARGETS_CLUSTER_P4"
12,"Down",0.755238923706919,0.926473314081361,"B.LvsV.TCGA_GLIOBLASTOMA_MUTATED"
48,"Down",0.755388261869917,0.926473314081361,"B.LvsV.LOPEZ_MBD_TARGETS_IMPRINTED_AND_X_LINKED"
116,"Up",0.755853868098586,0.926816841837945,"B.LvsV.JAIN_NFKB_SIGNALING"
44,"Up",0.75619407449856,0.926816841837945,"B.LvsV.DANG_MYC_TARGETS_DN"
69,"Up",0.756637227685862,0.926816841837945,"B.LvsV.PID_UPA_UPAR_PATHWAY"
64,"Down",0.756860901484723,0.926816841837945,"B.LvsV.REACTOME_DEGRADATION_OF_DVL"
107,"Down",0.757085016333327,0.926816841837945,"B.LvsV.RADAEVA_RESPONSE_TO_IFNA1_UP"
334,"Up",0.757169988252671,0.926816841837945,"B.LvsV.KIM_WT1_TARGETS_UP"
353,"Up",0.75734067563569,0.926816841837945,"B.LvsV.REACTOME_INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS"
69,"Down",0.757499091475986,0.926816841837945,"B.LvsV.KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY"
12,"Up",0.75750206782315,0.926816841837945,"B.LvsV.REACTOME_MAPK3_ERK1_ACTIVATION"
12,"Up",0.75772074043736,0.926816841837945,"B.LvsV.BOYLAN_MULTIPLE_MYELOMA_PCA1_DN"
64,"Down",0.758244537337945,0.926816841837945,"B.LvsV.REACTOME_METABOLISM_OF_POLYAMINES"
10,"Down",0.758413440407554,0.926816841837945,"B.LvsV.RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_SMAD4_UP"
9,"Up",0.758479128669215,0.926816841837945,"B.LvsV.REACTOME_OREXIN_AND_NEUROPEPTIDES_FF_AND_QRFP_BIND_TO_THEIR_RESPECTIVE_RECEPTORS"
79,"Down",0.758501480365716,0.926816841837945,"B.LvsV.PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_UP"
232,"Up",0.758508583662876,0.926816841837945,"B.LvsV.DER_IFN_GAMMA_RESPONSE_UP"
23,"Down",0.758510042454991,0.926816841837945,"B.LvsV.DING_LUNG_CANCER_MUTATED_FREQUENTLY"
265,"Up",0.758518033878948,0.926816841837945,"B.LvsV.TSAI_RESPONSE_TO_IONIZING_RADIATION"
9,"Up",0.758830381131113,0.926993631744129,"B.LvsV.REACTOME_TERMINAL_PATHWAY_OF_COMPLEMENT"
37,"Down",0.759408868844068,0.927477162210061,"B.LvsV.REACTOME_SYNTHESIS_OF_16_20_HYDROXYEICOSATETRAENOIC_ACIDS_HETE"
757,"Up",0.759663482570319,0.927477162210061,"B.LvsV.SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP"
167,"Up",0.759794289389495,0.927477162210061,"B.LvsV.REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE"
75,"Up",0.759897186618118,0.927477162210061,"B.LvsV.PID_IL6_7_PATHWAY"
9,"Down",0.760340721821894,0.927640851916301,"B.LvsV.REACTOME_FGFR1B_LIGAND_BINDING_AND_ACTIVATION"
44,"Down",0.760507019239559,0.927640851916301,"B.LvsV.VALK_AML_CLUSTER_7"
74,"Up",0.760534632254764,0.927640851916301,"B.LvsV.BOYAULT_LIVER_CANCER_SUBCLASS_G3_DN"
60,"Down",0.76165016512865,0.928652443171035,"B.LvsV.STONER_ESOPHAGEAL_CARCINOGENESIS_UP"
35,"Down",0.761948862829562,0.928652443171035,"B.LvsV.KEGG_PROTEIN_EXPORT"
6,"Down",0.762011701575031,0.928652443171035,"B.LvsV.REACTOME_BETA_OXIDATION_OF_DECANOYL_COA_TO_OCTANOYL_COA_COA"
153,"Down",0.762035835533909,0.928652443171035,"B.LvsV.XU_CREBBP_TARGETS_DN"
161,"Up",0.762526504169863,0.928959212542145,"B.LvsV.REACTOME_CARDIAC_CONDUCTION"
154,"Up",0.762623596623042,0.928959212542145,"B.LvsV.OUILLETTE_CLL_13Q14_DELETION_UP"
19,"Down",0.763250510085059,0.929042906590865,"B.LvsV.GALLUZZI_PREVENT_MITOCHONDIAL_PERMEABILIZATION"
386,"Down",0.763321389293338,0.929042906590865,"B.LvsV.CAIRO_LIVER_DEVELOPMENT_DN"
13,"Up",0.76334484830219,0.929042906590865,"B.LvsV.REACTOME_MET_ACTIVATES_RAS_SIGNALING"
31,"Up",0.763965103878807,0.929042906590865,"B.LvsV.REACTOME_CRISTAE_FORMATION"
213,"Up",0.763973121939573,0.929042906590865,"B.LvsV.CERVERA_SDHB_TARGETS_2"
10,"Down",0.764003400391516,0.929042906590865,"B.LvsV.IKEDA_MIR1_TARGETS_DN"
298,"Down",0.764184913235149,0.929042906590865,"B.LvsV.SMID_BREAST_CANCER_LUMINAL_B_UP"
42,"Up",0.764186685881158,0.929042906590865,"B.LvsV.REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS"
22,"Down",0.764320397255061,0.929042906590865,"B.LvsV.NADERI_BREAST_CANCER_PROGNOSIS_DN"
32,"Down",0.764476452865233,0.929042906590865,"B.LvsV.REACTOME_SEMA3A_PLEXIN_REPULSION_SIGNALING_BY_INHIBITING_INTEGRIN_ADHESION"
300,"Up",0.764540644779967,0.929042906590865,"B.LvsV.REACTOME_DISEASES_OF_METABOLISM"
70,"Up",0.764856250433111,0.929222194824142,"B.LvsV.REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_CYTOCHROME_C_RELEASE"
198,"Down",0.765689722339463,0.930030420653535,"B.LvsV.REACTOME_FCGR_ACTIVATION"
5,"Down",0.766457998832378,0.930759120479732,"B.LvsV.REACTOME_SODIUM_COUPLED_SULPHATE_DI_AND_TRI_CARBOXYLATE_TRANSPORTERS"
90,"Up",0.766846625853295,0.930986644476786,"B.LvsV.REACTOME_CIRCADIAN_CLOCK"
8,"Up",0.766982124360962,0.930986644476786,"B.LvsV.REACTOME_UBIQUINOL_BIOSYNTHESIS"
8,"Down",0.767515764323496,0.93128175754737,"B.LvsV.FARDIN_HYPOXIA_9"
13,"Down",0.767610855908765,0.93128175754737,"B.LvsV.REACTOME_RUNX2_REGULATES_GENES_INVOLVED_IN_CELL_MIGRATION"
28,"Down",0.767730557225703,0.93128175754737,"B.LvsV.REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS"
611,"Up",0.768107262367764,0.93138038107538,"B.LvsV.GRUETZMANN_PANCREATIC_CANCER_UP"
172,"Up",0.768532761332362,0.93138038107538,"B.LvsV.YAMASHITA_LIVER_CANCER_STEM_CELL_DN"
155,"Down",0.768696891982731,0.93138038107538,"B.LvsV.WINTER_HYPOXIA_UP"
667,"Down",0.768726435111131,0.93138038107538,"B.LvsV.OSMAN_BLADDER_CANCER_DN"
16,"Up",0.768819724334738,0.93138038107538,"B.LvsV.REACTOME_PHYSIOLOGICAL_FACTORS"
6,"Up",0.769126278314752,0.93138038107538,"B.LvsV.SMID_BREAST_CANCER_RELAPSE_IN_LIVER_UP"
17,"Up",0.769240581452711,0.93138038107538,"B.LvsV.IVANOV_MUTATED_IN_COLON_CANCER"
19,"Up",0.769319517573821,0.93138038107538,"B.LvsV.LIU_CDX2_TARGETS_DN"
137,"Down",0.769327943637414,0.93138038107538,"B.LvsV.KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS"
10,"Up",0.769580298965241,0.931481933664364,"B.LvsV.DASU_IL6_SIGNALING_DN"
59,"Down",0.769990183946796,0.93177407026523,"B.LvsV.PID_HNF3B_PATHWAY"
18,"Down",0.770291850474652,0.931833282304728,"B.LvsV.REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_LATE_STAGE_BRANCHING_MORPHOGENESIS_PANCREATIC_BUD_PRECURSOR_CELLS"
166,"Up",0.770376186184647,0.931833282304728,"B.LvsV.REACTOME_INTERLEUKIN_1_FAMILY_SIGNALING"
504,"Up",0.770757745978786,0.931904218566881,"B.LvsV.OISHI_CHOLANGIOMA_STEM_CELL_LIKE_DN"
5,"Down",0.770771928288361,0.931904218566881,"B.LvsV.REACTOME_MELANIN_BIOSYNTHESIS"
245,"Up",0.771281022709313,0.932235145336902,"B.LvsV.JOHNSTONE_PARVB_TARGETS_2_UP"
30,"Down",0.771413490818007,0.932235145336902,"B.LvsV.BIOCARTA_CTLA4_PATHWAY"
55,"Up",0.771596803093431,0.932235145336902,"B.LvsV.CHEN_LUNG_CANCER_SURVIVAL"
18,"Down",0.772261874824506,0.932235145336902,"B.LvsV.BIOCARTA_TCRA_PATHWAY"
46,"Down",0.772530536789366,0.932235145336902,"B.LvsV.DELLA_RESPONSE_TO_TSA_AND_BUTYRATE"
239,"Up",0.772595495714392,0.932235145336902,"B.LvsV.REACTOME_REPRODUCTION"
227,"Up",0.772660694136088,0.932235145336902,"B.LvsV.BROWNE_HCMV_INFECTION_10HR_UP"
315,"Down",0.772678580130747,0.932235145336902,"B.LvsV.BENPORATH_NOS_TARGETS"
21,"Down",0.772828451510429,0.932235145336902,"B.LvsV.TOMLINS_METASTASIS_UP"
8,"Up",0.772910082618969,0.932235145336902,"B.LvsV.REACTOME_ESTROGEN_STIMULATED_SIGNALING_THROUGH_PRKCZ"
120,"Up",0.773114893275597,0.932235145336902,"B.LvsV.REACTOME_CLEC7A_DECTIN_1_SIGNALING"
162,"Down",0.773180893480014,0.932235145336902,"B.LvsV.YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_6"
20,"Up",0.77353470625028,0.932235145336902,"B.LvsV.WIEMANN_TELOMERE_SHORTENING_AND_CHRONIC_LIVER_DAMAGE_DN"
13,"Up",0.773569953672475,0.932235145336902,"B.LvsV.REACTOME_P75NTR_REGULATES_AXONOGENESIS"
11,"Down",0.773746752916374,0.932235145336902,"B.LvsV.REACTOME_HIGHLY_CALCIUM_PERMEABLE_POSTSYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS"
820,"Up",0.773908957787717,0.932235145336902,"B.LvsV.SENESE_HDAC3_TARGETS_UP"
10,"Down",0.773995730591905,0.932235145336902,"B.LvsV.AGARWAL_AKT_PATHWAY_TARGETS"
188,"Down",0.774082115373001,0.932235145336902,"B.LvsV.WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_UP"
47,"Up",0.774401709681507,0.932235145336902,"B.LvsV.PID_ALPHA_SYNUCLEIN_PATHWAY"
38,"Down",0.77449428951141,0.932235145336902,"B.LvsV.REACTOME_NICOTINATE_METABOLISM"
7,"Down",0.774595797740388,0.932235145336902,"B.LvsV.REACTOME_ALPHA_OXIDATION_OF_PHYTANATE"
25,"Up",0.774755017692723,0.932235145336902,"B.LvsV.REACTOME_PINK_PARKIN_MEDIATED_MITOPHAGY"
16,"Up",0.774993001153782,0.93231860386842,"B.LvsV.BIOCARTA_RELA_PATHWAY"
73,"Up",0.775789844559884,0.932937745557885,"B.LvsV.WENG_POR_DOSAGE"
344,"Up",0.775845135481128,0.932937745557885,"B.LvsV.DOANE_RESPONSE_TO_ANDROGEN_UP"
58,"Down",0.776648313451482,0.93360772370002,"B.LvsV.BAE_BRCA1_TARGETS_DN"
9,"Down",0.776740012483287,0.93360772370002,"B.LvsV.MIKHAYLOVA_OXIDATIVE_STRESS_RESPONSE_VIA_VHL_UP"
19,"Up",0.776912838476833,0.933612493792308,"B.LvsV.MOROSETTI_FACIOSCAPULOHUMERAL_MUSCULAR_DISTROPHY_DN"
33,"Down",0.777158363823295,0.933693959125718,"B.LvsV.BIOCARTA_CASPASE_PATHWAY"
826,"Down",0.777318374725209,0.933693959125718,"B.LvsV.FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP"
19,"Up",0.777653317864504,0.933847979695365,"B.LvsV.KEGG_PANTOTHENATE_AND_COA_BIOSYNTHESIS"
72,"Down",0.778096265012706,0.933847979695365,"B.LvsV.ROESSLER_LIVER_CANCER_METASTASIS_DN"
496,"Up",0.778363040560049,0.933847979695365,"B.LvsV.VERHAAK_AML_WITH_NPM1_MUTATED_DN"
13,"Up",0.778413845652905,0.933847979695365,"B.LvsV.WANG_RESPONSE_TO_FORSKOLIN_DN"
10,"Up",0.779206247641952,0.933847979695365,"B.LvsV.REACTOME_REACTIONS_SPECIFIC_TO_THE_COMPLEX_N_GLYCAN_SYNTHESIS_PATHWAY"
114,"Down",0.779241781097015,0.933847979695365,"B.LvsV.REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES"
23,"Up",0.779265413297765,0.933847979695365,"B.LvsV.REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_CELL_CYCLE_GENES"
96,"Down",0.779543517669192,0.933847979695365,"B.LvsV.CORRE_MULTIPLE_MYELOMA_DN"
30,"Up",0.779716276529527,0.933847979695365,"B.LvsV.IIZUKA_LIVER_CANCER_PROGRESSION_L1_G1_UP"
74,"Down",0.779718903556354,0.933847979695365,"B.LvsV.LEE_AGING_MUSCLE_UP"
25,"Down",0.779866294819435,0.933847979695365,"B.LvsV.BIOCARTA_ERAD_PATHWAY"
102,"Up",0.779979148611658,0.933847979695365,"B.LvsV.KEGG_RETINOL_METABOLISM"
140,"Down",0.779994666054164,0.933847979695365,"B.LvsV.WARTERS_RESPONSE_TO_IR_SKIN"
12,"Up",0.780150760757391,0.933847979695365,"B.LvsV.KORKOLA_CHORIOCARCINOMA"
21,"Down",0.78016227709008,0.933847979695365,"B.LvsV.KYNG_NORMAL_AGING_UP"
31,"Down",0.780210263028908,0.933847979695365,"B.LvsV.REACTOME_FRS_MEDIATED_FGFR1_SIGNALING"
14,"Up",0.780317899474152,0.933847979695365,"B.LvsV.REACTOME_JOSEPHIN_DOMAIN_DUBS"
10,"Down",0.780727903702188,0.933925605433476,"B.LvsV.SMID_BREAST_CANCER_ERBB2_DN"
57,"Down",0.780815674936281,0.933925605433476,"B.LvsV.PID_ATM_PATHWAY"
26,"Up",0.781022056790705,0.933925605433476,"B.LvsV.PHESSE_TARGETS_OF_APC_AND_MBD2_UP"
382,"Up",0.781058419157966,0.933925605433476,"B.LvsV.CAIRO_HEPATOBLASTOMA_CLASSES_DN"
96,"Down",0.781306767173513,0.93399527286056,"B.LvsV.GRABARCZYK_BCL11B_TARGETS_DN"
156,"Down",0.781454536489953,0.93399527286056,"B.LvsV.ZAMORA_NOS2_TARGETS_DN"
26,"Up",0.781868304391236,0.934287844170985,"B.LvsV.FOURNIER_ACINAR_DEVELOPMENT_LATE_UP"
93,"Up",0.782438721684616,0.934767435651306,"B.LvsV.WATANABE_COLON_CANCER_MSI_VS_MSS_DN"
309,"Down",0.782874426677186,0.934921701954963,"B.LvsV.CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_UP"
248,"Down",0.782906037267404,0.934921701954963,"B.LvsV.ZHU_CMV_ALL_UP"
250,"Down",0.783330787228204,0.935188931277178,"B.LvsV.KASLER_HDAC7_TARGETS_1_UP"
164,"Up",0.783554460936031,0.935188931277178,"B.LvsV.XU_HGF_TARGETS_REPRESSED_BY_AKT1_DN"
12,"Down",0.783637243372611,0.935188931277178,"B.LvsV.REACTOME_INTERLEUKIN_23_SIGNALING"
95,"Down",0.78404184484459,0.935469866237751,"B.LvsV.GU_PDEF_TARGETS_DN"
474,"Up",0.784717480861339,0.936073991732975,"B.LvsV.REACTOME_NEURONAL_SYSTEM"
116,"Up",0.784957785729961,0.936158670686142,"B.LvsV.KEGG_GNRH_SIGNALING_PATHWAY"
23,"Up",0.785413328948044,0.936353053198905,"B.LvsV.CHEN_HOXA5_TARGETS_6HR_UP"
19,"Down",0.785925688420554,0.936353053198905,"B.LvsV.BIOCARTA_BLYMPHOCYTE_PATHWAY"
44,"Down",0.786021598208202,0.936353053198905,"B.LvsV.REACTOME_DISEASES_ASSOCIATED_WITH_GLYCOSAMINOGLYCAN_METABOLISM"
354,"Down",0.786022978124041,0.936353053198905,"B.LvsV.OHGUCHI_LIVER_HNF4A_TARGETS_DN"
122,"Up",0.786077136269818,0.936353053198905,"B.LvsV.VANASSE_BCL2_TARGETS_DN"
27,"Up",0.786269407484556,0.936353053198905,"B.LvsV.KASLER_HDAC7_TARGETS_1_DN"
39,"Down",0.786489325385687,0.936353053198905,"B.LvsV.YIH_RESPONSE_TO_ARSENITE_C3"
71,"Down",0.786622309534971,0.936353053198905,"B.LvsV.BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_UP"
96,"Up",0.786644950643681,0.936353053198905,"B.LvsV.PID_BCR_5PATHWAY"
8,"Up",0.787346391314492,0.936828436581705,"B.LvsV.REACTOME_DEFECTIVE_B4GALT1_CAUSES_B4GALT1_CDG_CDG_2D"
33,"Up",0.787383205786794,0.936828436581705,"B.LvsV.REACTOME_REGULATION_OF_SIGNALING_BY_CBL"
143,"Up",0.787822127995192,0.936983355181288,"B.LvsV.LAIHO_COLORECTAL_CANCER_SERRATED_DN"
72,"Up",0.787854789857661,0.936983355181288,"B.LvsV.HAHTOLA_SEZARY_SYNDROM_DN"
8,"Up",0.788054838432006,0.936983355181288,"B.LvsV.KIM_PTEN_TARGETS_DN"
33,"Up",0.788191279607193,0.936983355181288,"B.LvsV.FIGUEROA_AML_METHYLATION_CLUSTER_4_DN"
24,"Down",0.788655217265729,0.937010362546834,"B.LvsV.BIOCARTA_ARF_PATHWAY"
11,"Up",0.788760298807811,0.937010362546834,"B.LvsV.SMID_BREAST_CANCER_RELAPSE_IN_PLEURA_UP"
7,"Down",0.788967543362421,0.937010362546834,"B.LvsV.CAFFAREL_RESPONSE_TO_THC_8HR_3_UP"
104,"Up",0.788996107868118,0.937010362546834,"B.LvsV.CHIBA_RESPONSE_TO_TSA_UP"
65,"Down",0.78921920977429,0.937010362546834,"B.LvsV.SMID_BREAST_CANCER_RELAPSE_IN_PLEURA_DN"
167,"Up",0.789230829875313,0.937010362546834,"B.LvsV.SANA_TNF_SIGNALING_UP"
18,"Down",0.789950527844543,0.937324431266014,"B.LvsV.REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING"
5,"Down",0.789954523283367,0.937324431266014,"B.LvsV.NIKOLSKY_BREAST_CANCER_19P13_AMPLICON"
230,"Up",0.790003951835707,0.937324431266014,"B.LvsV.ZHANG_BREAST_CANCER_PROGENITORS_DN"
20,"Down",0.790282660667937,0.937346640254459,"B.LvsV.LI_CYTIDINE_ANALOG_PATHWAY"
93,"Up",0.790361735732734,0.937346640254459,"B.LvsV.KEGG_FC_EPSILON_RI_SIGNALING_PATHWAY"
152,"Up",0.790709293648778,0.937381407782578,"B.LvsV.PID_CMYB_PATHWAY"
48,"Down",0.790730129480547,0.937381407782578,"B.LvsV.PID_HIF2PATHWAY"
33,"Up",0.79139437499044,0.937840436437918,"B.LvsV.TURASHVILI_BREAST_CARCINOMA_DUCTAL_VS_LOBULAR_UP"
132,"Up",0.791456588247301,0.937840436437918,"B.LvsV.AKL_HTLV1_INFECTION_DN"
18,"Up",0.791888867862421,0.938151607116205,"B.LvsV.CHIN_BREAST_CANCER_COPY_NUMBER_DN"
27,"Down",0.79244069535017,0.938231811187168,"B.LvsV.REACTOME_GASTRIN_CREB_SIGNALLING_PATHWAY_VIA_PKC_AND_MAPK"
64,"Down",0.792448150492373,0.938231811187168,"B.LvsV.SCHOEN_NFKB_SIGNALING"
26,"Down",0.793053661465308,0.938231811187168,"B.LvsV.DORMOY_ELAVL1_TARGETS"
18,"Down",0.793313107407891,0.938231811187168,"B.LvsV.REACTOME_SHC1_EVENTS_IN_ERBB4_SIGNALING"
81,"Down",0.793413975980591,0.938231811187168,"B.LvsV.BOYAULT_LIVER_CANCER_SUBCLASS_G123_DN"
29,"Up",0.79359023656164,0.938231811187168,"B.LvsV.LEI_HOXC8_TARGETS_UP"
64,"Down",0.793631650632553,0.938231811187168,"B.LvsV.KEGG_ALLOGRAFT_REJECTION"
58,"Down",0.793671730693701,0.938231811187168,"B.LvsV.REACTOME_RECYCLING_PATHWAY_OF_L1"
394,"Up",0.793677319734875,0.938231811187168,"B.LvsV.SENESE_HDAC1_AND_HDAC2_TARGETS_DN"
463,"Down",0.793687379066269,0.938231811187168,"B.LvsV.JAEGER_METASTASIS_DN"
95,"Up",0.793823189136114,0.938231811187168,"B.LvsV.BORLAK_LIVER_CANCER_EGF_UP"
100,"Down",0.794212625816427,0.938453043782623,"B.LvsV.LEE_LIVER_CANCER_MYC_TGFA_DN"
58,"Up",0.794349836299995,0.938453043782623,"B.LvsV.REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION"
16,"Down",0.794933198835141,0.938644813017964,"B.LvsV.REACTOME_EGFR_TRANSACTIVATION_BY_GASTRIN"
27,"Up",0.795228162122852,0.938644813017964,"B.LvsV.KEGG_PRIMARY_BILE_ACID_BIOSYNTHESIS"
106,"Down",0.795679242331667,0.938644813017964,"B.LvsV.INGRAM_SHH_TARGETS_DN"
225,"Up",0.795718348390434,0.938644813017964,"B.LvsV.KAYO_AGING_MUSCLE_DN"
27,"Up",0.795815602317526,0.938644813017964,"B.LvsV.REACTOME_NEGATIVE_REGULATION_OF_MET_ACTIVITY"
15,"Down",0.796006832384627,0.938644813017964,"B.LvsV.PETRETTO_LEFT_VENTRICLE_MASS_QTL_CIS_DN"
50,"Up",0.796064530720582,0.938644813017964,"B.LvsV.REACTOME_DAG_AND_IP3_SIGNALING"
34,"Up",0.796315322568194,0.938644813017964,"B.LvsV.STEGER_ADIPOGENESIS_UP"
198,"Up",0.796526217917005,0.938644813017964,"B.LvsV.REACTOME_TOLL_LIKE_RECEPTOR_CASCADES"
117,"Up",0.796527818646081,0.938644813017964,"B.LvsV.REACTOME_TRANSCRIPTIONAL_REGULATION_OF_GRANULOPOIESIS"
390,"Up",0.796642006676326,0.938644813017964,"B.LvsV.REACTOME_SIGNALING_BY_NUCLEAR_RECEPTORS"
7,"Down",0.796686016695608,0.938644813017964,"B.LvsV.GAVIN_IL2_RESPONSIVE_FOXP3_TARGETS_DN"
230,"Up",0.797045249977743,0.938644813017964,"B.LvsV.PASINI_SUZ12_TARGETS_UP"
80,"Up",0.79709309740142,0.938644813017964,"B.LvsV.MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_DN"
115,"Up",0.797191640279433,0.938644813017964,"B.LvsV.MORI_SMALL_PRE_BII_LYMPHOCYTE_UP"
19,"Up",0.79722843948858,0.938644813017964,"B.LvsV.WILLIAMS_ESR2_TARGETS_DN"
72,"Down",0.797681258958549,0.938773817304136,"B.LvsV.KEGG_GLIOMA"
84,"Down",0.797699075678316,0.938773817304136,"B.LvsV.ROVERSI_GLIOMA_LOH_REGIONS"
720,"Down",0.798005847386194,0.938773817304136,"B.LvsV.SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN"
153,"Up",0.79817992578832,0.938773817304136,"B.LvsV.DE_YY1_TARGETS_DN"
84,"Up",0.798223316048047,0.938773817304136,"B.LvsV.LEIN_ASTROCYTE_MARKERS"
139,"Down",0.798356753294275,0.938773817304136,"B.LvsV.MIKKELSEN_MCV6_ICP_WITH_H3K27ME3"
151,"Up",0.798788971109663,0.939082334949038,"B.LvsV.IGARASHI_ATF4_TARGETS_DN"
51,"Down",0.799603333561782,0.939683616939947,"B.LvsV.SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_DN"
102,"Down",0.799640335992485,0.939683616939947,"B.LvsV.DAWSON_METHYLATED_IN_LYMPHOMA_TCL1"
206,"Up",0.800454430512993,0.940388468143462,"B.LvsV.MIKKELSEN_IPS_ICP_WITH_H3K4ME3_AND_H327ME3"
31,"Up",0.800836592402437,0.940388468143462,"B.LvsV.BIOCARTA_AMI_PATHWAY"
14,"Down",0.801042589625217,0.940388468143462,"B.LvsV.REACTOME_RUNX3_REGULATES_WNT_SIGNALING"
69,"Up",0.801058705660481,0.940388468143462,"B.LvsV.WAGSCHAL_EHMT2_TARGETS_UP"
24,"Up",0.801090556150426,0.940388468143462,"B.LvsV.REACTOME_SYNTHESIS_SECRETION_AND_DEACYLATION_OF_GHRELIN"
57,"Down",0.801275067299232,0.940405401633932,"B.LvsV.SCHRAETS_MLL_TARGETS_UP"
214,"Down",0.801817211031821,0.940841969396209,"B.LvsV.REACTOME_ROLE_OF_PHOSPHOLIPIDS_IN_PHAGOCYTOSIS"
176,"Up",0.802071632165337,0.940894279455539,"B.LvsV.ZHONG_SECRETOME_OF_LUNG_CANCER_AND_ENDOTHELIUM"
379,"Up",0.802202140233933,0.940894279455539,"B.LvsV.CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP"
44,"Down",0.802980887593027,0.941158103052562,"B.LvsV.JEPSEN_SMRT_TARGETS"
52,"Down",0.802990035111978,0.941158103052562,"B.LvsV.MAEKAWA_ATF2_TARGETS"
44,"Down",0.8031068879934,0.941158103052562,"B.LvsV.PID_AURORA_A_PATHWAY"
73,"Up",0.803128111721744,0.941158103052562,"B.LvsV.BILANGES_SERUM_SENSITIVE_VIA_TSC2"
22,"Up",0.803402037748464,0.941158103052562,"B.LvsV.PID_IL5_PATHWAY"
13,"Down",0.803474284924501,0.941158103052562,"B.LvsV.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_29"
116,"Up",0.803792180619371,0.941158103052562,"B.LvsV.ZHAN_MULTIPLE_MYELOMA_DN"
117,"Up",0.804081081747503,0.941158103052562,"B.LvsV.HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_UP"
37,"Down",0.804147369986872,0.941158103052562,"B.LvsV.MATTHEWS_SKIN_CARCINOGENESIS_VIA_JUN"
675,"Up",0.804701396809982,0.941158103052562,"B.LvsV.IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_DN"
114,"Down",0.804705192474481,0.941158103052562,"B.LvsV.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_DN"
33,"Up",0.804745383652987,0.941158103052562,"B.LvsV.BIOCARTA_ARENRF2_PATHWAY"
78,"Down",0.804863864717813,0.941158103052562,"B.LvsV.RICKMAN_HEAD_AND_NECK_CANCER_D"
16,"Up",0.804941051386924,0.941158103052562,"B.LvsV.RADAEVA_RESPONSE_TO_IFNA1_DN"
19,"Up",0.804980406825025,0.941158103052562,"B.LvsV.LI_CYTIDINE_ANALOGS_CYCTOTOXICITY"
341,"Up",0.805225063067414,0.941245110718759,"B.LvsV.LEE_LIVER_CANCER_SURVIVAL_UP"
81,"Down",0.805489561805049,0.941355271025178,"B.LvsV.KEGG_AUTOIMMUNE_THYROID_DISEASE"
16,"Down",0.806073236769838,0.941838319125197,"B.LvsV.REACTOME_ROLE_OF_SECOND_MESSENGERS_IN_NETRIN_1_SIGNALING"
8,"Up",0.807279700261174,0.94188764365335,"B.LvsV.KERLEY_RESPONSE_TO_CISPLATIN_DN"
671,"Down",0.80736161302013,0.94188764365335,"B.LvsV.PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_7"
208,"Up",0.807383546015003,0.94188764365335,"B.LvsV.GAL_LEUKEMIC_STEM_CELL_UP"
14,"Up",0.807411211161278,0.94188764365335,"B.LvsV.GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_DN"
87,"Down",0.807440747378103,0.94188764365335,"B.LvsV.STOSSI_RESPONSE_TO_ESTRADIOL"
345,"Down",0.807597506793436,0.94188764365335,"B.LvsV.DAVICIONI_MOLECULAR_ARMS_VS_ERMS_DN"
27,"Up",0.808059689753085,0.94188764365335,"B.LvsV.MOREIRA_RESPONSE_TO_TSA_DN"
13,"Down",0.808088252649926,0.94188764365335,"B.LvsV.REACTOME_RNF_MUTANTS_SHOW_ENHANCED_WNT_SIGNALING_AND_PROLIFERATION"
115,"Down",0.80831629345898,0.94188764365335,"B.LvsV.COLDREN_GEFITINIB_RESISTANCE_UP"
51,"Down",0.808397995476377,0.94188764365335,"B.LvsV.GROSS_ELK3_TARGETS_DN"
29,"Down",0.808427190335862,0.94188764365335,"B.LvsV.TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN"
18,"Up",0.808427522742377,0.94188764365335,"B.LvsV.REACTOME_SEMA4D_MEDIATED_INHIBITION_OF_CELL_ATTACHMENT_AND_MIGRATION"
183,"Down",0.808428537459825,0.94188764365335,"B.LvsV.REACTOME_CD22_MEDIATED_BCR_REGULATION"
398,"Up",0.808657608943695,0.94188764365335,"B.LvsV.RICKMAN_METASTASIS_DN"
54,"Down",0.808670762239547,0.94188764365335,"B.LvsV.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_PINK_DN"
39,"Down",0.808934265745411,0.941996115270931,"B.LvsV.PID_VEGFR1_PATHWAY"
127,"Down",0.809233629757689,0.942097490983422,"B.LvsV.CARD_MIR302A_TARGETS"
104,"Up",0.80949108577814,0.942097490983422,"B.LvsV.LEE_LIVER_CANCER_E2F1_DN"
302,"Down",0.809807609610266,0.942097490983422,"B.LvsV.XU_GH1_AUTOCRINE_TARGETS_UP"
65,"Up",0.809810275880408,0.942097490983422,"B.LvsV.SESTO_RESPONSE_TO_UV_C3"
116,"Down",0.81003766430256,0.942097490983422,"B.LvsV.BAUS_TFF2_TARGETS_UP"
39,"Down",0.810310971997862,0.942097490983422,"B.LvsV.KEGG_ASTHMA"
18,"Up",0.810400611409678,0.942097490983422,"B.LvsV.REACTOME_GRB2_EVENTS_IN_ERBB2_SIGNALING"
150,"Up",0.810569063828942,0.942097490983422,"B.LvsV.JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP"
50,"Down",0.810627509672448,0.942097490983422,"B.LvsV.DASU_IL6_SIGNALING_SCAR_UP"
62,"Down",0.810863730759042,0.942097490983422,"B.LvsV.KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_UP"
142,"Up",0.810961486801786,0.942097490983422,"B.LvsV.REACTOME_VISUAL_PHOTOTRANSDUCTION"
18,"Up",0.811066025878294,0.942097490983422,"B.LvsV.BIOCARTA_PCAF_PATHWAY"
31,"Up",0.811334375577353,0.942211250276661,"B.LvsV.REACTOME_RECYCLING_OF_BILE_ACIDS_AND_SALTS"
6,"Down",0.811558477111455,0.942273586717605,"B.LvsV.BIOCARTA_PELP1_PATHWAY"
12,"Up",0.811932802833912,0.942331372028765,"B.LvsV.REACTOME_PREGNENOLONE_BIOSYNTHESIS"
169,"Down",0.811949114911383,0.942331372028765,"B.LvsV.RAMALHO_STEMNESS_DN"
22,"Up",0.812138276955673,0.942353102473855,"B.LvsV.ZHENG_RESPONSE_TO_ARSENITE_DN"
344,"Up",0.812916965567608,0.943058729043916,"B.LvsV.LINDGREN_BLADDER_CANCER_CLUSTER_3_DN"
37,"Up",0.813188118312093,0.943175394618746,"B.LvsV.SIG_CD40PATHWAYMAP"
41,"Down",0.81392482289189,0.943741435862013,"B.LvsV.REACTOME_GLYCOSPHINGOLIPID_METABOLISM"
106,"Up",0.814200861260052,0.943741435862013,"B.LvsV.KEGG_GAP_JUNCTION"
27,"Down",0.814395861229848,0.943741435862013,"B.LvsV.MEISSNER_BRAIN_HCP_WITH_H3K4ME2"
36,"Down",0.814441126700253,0.943741435862013,"B.LvsV.REACTOME_METABOLISM_OF_ANGIOTENSINOGEN_TO_ANGIOTENSINS"
417,"Down",0.814621254912659,0.943741435862013,"B.LvsV.PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_UP"
165,"Down",0.815096099159925,0.943741435862013,"B.LvsV.DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_UP"
10,"Up",0.815109786872026,0.943741435862013,"B.LvsV.BIOCARTA_PEPI_PATHWAY"
271,"Down",0.815186538928535,0.943741435862013,"B.LvsV.PHONG_TNF_RESPONSE_VIA_P38_PARTIAL"
383,"Down",0.815383751358338,0.943741435862013,"B.LvsV.DELYS_THYROID_CANCER_DN"
33,"Up",0.815460159526836,0.943741435862013,"B.LvsV.KUROKAWA_LIVER_CANCER_EARLY_RECURRENCE_DN"
16,"Up",0.815783764970926,0.943741435862013,"B.LvsV.MARTIN_NFKB_TARGETS_DN"
94,"Down",0.815868386168719,0.943741435862013,"B.LvsV.MCDOWELL_ACUTE_LUNG_INJURY_UP"
187,"Down",0.815895110041675,0.943741435862013,"B.LvsV.BRUECKNER_TARGETS_OF_MIRLET7A3_UP"
74,"Down",0.816357124522914,0.943924111072783,"B.LvsV.YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_15"
49,"Up",0.816615246243308,0.943924111072783,"B.LvsV.REACTOME_METABOLISM_OF_PORPHYRINS"
26,"Up",0.816721977702039,0.943924111072783,"B.LvsV.BIOCARTA_CSK_PATHWAY"
81,"Down",0.81710123493462,0.943924111072783,"B.LvsV.TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP"
20,"Down",0.817235322814385,0.943924111072783,"B.LvsV.REACTOME_REGULATION_OF_TLR_BY_ENDOGENOUS_LIGAND"
13,"Down",0.817322085462804,0.943924111072783,"B.LvsV.REACTOME_IONOTROPIC_ACTIVITY_OF_KAINATE_RECEPTORS"
9,"Down",0.817607312087203,0.943924111072783,"B.LvsV.REACTOME_DNA_DAMAGE_REVERSAL"
42,"Down",0.817637473226298,0.943924111072783,"B.LvsV.REACTOME_GENERATION_OF_SECOND_MESSENGER_MOLECULES"
22,"Up",0.817672928458753,0.943924111072783,"B.LvsV.MEISSNER_NPC_ICP_WITH_H3K4ME3"
165,"Down",0.817760262622288,0.943924111072783,"B.LvsV.IVANOVA_HEMATOPOIESIS_INTERMEDIATE_PROGENITOR"
63,"Up",0.818252174976556,0.944094954106387,"B.LvsV.TRAYNOR_RETT_SYNDROM_UP"
34,"Up",0.818299363650726,0.944094954106387,"B.LvsV.BYSTRYKH_HEMATOPOIESIS_STEM_CELL_IL3RA"
382,"Up",0.818550765532964,0.944094954106387,"B.LvsV.VERHAAK_GLIOBLASTOMA_MESENCHYMAL"
193,"Down",0.81861550949969,0.944094954106387,"B.LvsV.ZHU_CMV_24_HR_UP"
439,"Down",0.818762037428129,0.944094954106387,"B.LvsV.LIU_SOX4_TARGETS_DN"
684,"Down",0.819196274454535,0.944329489521113,"B.LvsV.CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_UP"
156,"Up",0.819475777700483,0.944329489521113,"B.LvsV.REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_DIFFERENTIATION_OF_HSCS"
77,"Up",0.819477824330313,0.944329489521113,"B.LvsV.MARTINEZ_RESPONSE_TO_TRABECTEDIN"
42,"Down",0.819928563519035,0.944652016606948,"B.LvsV.REACTOME_BIOSYNTHESIS_OF_MARESINS"
65,"Up",0.820392282772935,0.944812261907327,"B.LvsV.TANG_SENESCENCE_TP53_TARGETS_UP"
27,"Down",0.820648550299953,0.944812261907327,"B.LvsV.BIOCARTA_TGFB_PATHWAY"
103,"Up",0.820875502110815,0.944812261907327,"B.LvsV.NIKOLSKY_BREAST_CANCER_7Q21_Q22_AMPLICON"
11,"Down",0.82091114395123,0.944812261907327,"B.LvsV.BIOCARTA_ALTERNATIVE_PATHWAY"
74,"Down",0.82101979484122,0.944812261907327,"B.LvsV.RASHI_RESPONSE_TO_IONIZING_RADIATION_3"
6,"Down",0.821141708986906,0.944812261907327,"B.LvsV.REACTOME_ACYL_CHAIN_REMODELING_OF_CL"
57,"Up",0.821274324191532,0.944812261907327,"B.LvsV.SMID_BREAST_CANCER_RELAPSE_IN_LUNG_DN"
47,"Up",0.821434715678879,0.944812261907327,"B.LvsV.GALE_APL_WITH_FLT3_MUTATED_DN"
125,"Down",0.821879422766798,0.944863690409803,"B.LvsV.MORI_LARGE_PRE_BII_LYMPHOCYTE_DN"
52,"Down",0.822137387072174,0.944863690409803,"B.LvsV.ELVIDGE_HIF1A_AND_HIF2A_TARGETS_UP"
74,"Down",0.822299426035281,0.944863690409803,"B.LvsV.KENNY_CTNNB1_TARGETS_UP"
38,"Up",0.822421341413269,0.944863690409803,"B.LvsV.REACTOME_PLASMA_LIPOPROTEIN_REMODELING"
643,"Up",0.822433427438441,0.944863690409803,"B.LvsV.MULLIGHAN_MLL_SIGNATURE_2_UP"
44,"Up",0.822824873491464,0.944863690409803,"B.LvsV.LOPEZ_MESOTHELIOMA_SURVIVAL_DN"
92,"Up",0.823081158104389,0.944863690409803,"B.LvsV.KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP"
116,"Down",0.823123888294642,0.944863690409803,"B.LvsV.BURTON_ADIPOGENESIS_4"
77,"Down",0.823129267685829,0.944863690409803,"B.LvsV.REACTOME_NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION"
15,"Down",0.823188351727984,0.944863690409803,"B.LvsV.TURJANSKI_MAPK1_AND_MAPK2_TARGETS"
236,"Down",0.82368143462226,0.945093361092463,"B.LvsV.BOSCO_ALLERGEN_INDUCED_TH2_ASSOCIATED_MODULE"
43,"Up",0.823852656478842,0.945093361092463,"B.LvsV.GENTLES_LEUKEMIC_STEM_CELL_UP"
695,"Down",0.824233643223636,0.945093361092463,"B.LvsV.RATTENBACHER_BOUND_BY_CELF1"
175,"Up",0.824254207760849,0.945093361092463,"B.LvsV.REACTOME_L1CAM_INTERACTIONS"
7,"Down",0.824260992484515,0.945093361092463,"B.LvsV.TESAR_ALK_AND_JAK_TARGETS_MOUSE_ES_D4_DN"
9,"Up",0.824531014088753,0.945093361092463,"B.LvsV.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_2"
176,"Up",0.824584983525057,0.945093361092463,"B.LvsV.RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_UP"
87,"Up",0.824879535072554,0.945235015423037,"B.LvsV.ZHOU_TNF_SIGNALING_4HR"
90,"Up",0.82508515467661,0.945274724452337,"B.LvsV.REACTOME_CONDENSATION_OF_PROPHASE_CHROMOSOMES"
46,"Up",0.825522108272737,0.9454986392615,"B.LvsV.REACTOME_ASSEMBLY_AND_CELL_SURFACE_PRESENTATION_OF_NMDA_RECEPTORS"
19,"Down",0.825622613556615,0.9454986392615,"B.LvsV.KIM_MYCL1_AMPLIFICATION_TARGETS_UP"
15,"Down",0.825908823601887,0.945519362971099,"B.LvsV.RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_SMAD4_DN"
124,"Down",0.826122066419364,0.945519362971099,"B.LvsV.MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_DN"
945,"Up",0.826153742541758,0.945519362971099,"B.LvsV.KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_UP"
36,"Down",0.826737172989642,0.945832748948067,"B.LvsV.REACTOME_NEGATIVE_REGULATION_OF_FGFR3_SIGNALING"
48,"Down",0.826867327519366,0.945832748948067,"B.LvsV.BIOCARTA_CARM_ER_PATHWAY"
238,"Down",0.827196155113157,0.945832748948067,"B.LvsV.YAUCH_HEDGEHOG_SIGNALING_PARACRINE_UP"
127,"Down",0.827265621942704,0.945832748948067,"B.LvsV.VANDESLUIS_COMMD1_TARGETS_GROUP_3_UP"
11,"Up",0.82734781266035,0.945832748948067,"B.LvsV.KEGG_VALINE_LEUCINE_AND_ISOLEUCINE_BIOSYNTHESIS"
6,"Down",0.827453971181371,0.945832748948067,"B.LvsV.REACTOME_ASSEMBLY_OF_THE_ORC_COMPLEX_AT_THE_ORIGIN_OF_REPLICATION"
89,"Down",0.828498909726605,0.946469277561192,"B.LvsV.CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_UP"
9,"Down",0.828581580898648,0.946469277561192,"B.LvsV.REACTOME_THE_ACTIVATION_OF_ARYLSULFATASES"
22,"Up",0.828612965657763,0.946469277561192,"B.LvsV.REACTOME_YAP1_AND_WWTR1_TAZ_STIMULATED_GENE_EXPRESSION"
261,"Up",0.828808012465538,0.946469277561192,"B.LvsV.YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_17"
13,"Up",0.829049875445547,0.946469277561192,"B.LvsV.KHETCHOUMIAN_TRIM24_TARGETS_DN"
51,"Down",0.829140254114774,0.946469277561192,"B.LvsV.NIKOLSKY_BREAST_CANCER_7P22_AMPLICON"
116,"Down",0.829330138253948,0.946469277561192,"B.LvsV.REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX3"
44,"Down",0.829380294770117,0.946469277561192,"B.LvsV.AMIT_SERUM_RESPONSE_40_MCF10A"
293,"Up",0.829583159191837,0.946470853321886,"B.LvsV.TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP"
15,"Up",0.8297240416081,0.946470853321886,"B.LvsV.REACTOME_DOWNREGULATION_OF_ERBB4_SIGNALING"
156,"Down",0.829995478399797,0.946585189783927,"B.LvsV.KOHOUTEK_CCNT2_TARGETS"
23,"Down",0.830555383034379,0.946907319004978,"B.LvsV.BIOCARTA_PS1_PATHWAY"
16,"Down",0.830620455267525,0.946907319004978,"B.LvsV.KEGG_OTHER_GLYCAN_DEGRADATION"
612,"Down",0.831064612369375,0.94706719211282,"B.LvsV.HELLER_SILENCED_BY_METHYLATION_UP"
381,"Down",0.831103276565637,0.94706719211282,"B.LvsV.SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM1"
27,"Up",0.831756673033569,0.947616452751412,"B.LvsV.FOURNIER_ACINAR_DEVELOPMENT_EARLY_UP"
45,"Down",0.831952311921871,0.947617750377143,"B.LvsV.REACTOME_OVARIAN_TUMOR_DOMAIN_PROTEASES"
36,"Down",0.83222591877676,0.947617750377143,"B.LvsV.REACTOME_RHO_GTPASES_ACTIVATE_IQGAPS"
354,"Down",0.832367432371473,0.947617750377143,"B.LvsV.GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN"
133,"Down",0.832443373771348,0.947617750377143,"B.LvsV.SMID_BREAST_CANCER_LUMINAL_A_UP"
197,"Down",0.832778359705199,0.947687258578626,"B.LvsV.WIELAND_UP_BY_HBV_INFECTION"
20,"Up",0.833112282572491,0.947687258578626,"B.LvsV.BIOCARTA_AKAPCENTROSOME_PATHWAY"
33,"Down",0.83316398814717,0.947687258578626,"B.LvsV.REACTOME_SIALIC_ACID_METABOLISM"
10,"Up",0.833315871352685,0.947687258578626,"B.LvsV.HEIDENBLAD_AMPLIFIED_IN_BONE_CANCER"
166,"Up",0.833521536356797,0.947687258578626,"B.LvsV.HUMMERICH_SKIN_CANCER_PROGRESSION_UP"
103,"Up",0.833532851956567,0.947687258578626,"B.LvsV.REACTOME_PCP_CE_PATHWAY"
222,"Down",0.834747867980277,0.948873553055706,"B.LvsV.GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_DN"
436,"Up",0.835504678869783,0.948989906697243,"B.LvsV.MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED"
627,"Down",0.835633811037932,0.948989906697243,"B.LvsV.SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12"
56,"Up",0.836239945599384,0.948989906697243,"B.LvsV.REACTOME_IRS_MEDIATED_SIGNALLING"
37,"Up",0.836243874142367,0.948989906697243,"B.LvsV.REACTOME_CYP2E1_REACTIONS"
17,"Down",0.836670722138806,0.948989906697243,"B.LvsV.BIOCARTA_IL10_PATHWAY"
194,"Up",0.837012554085907,0.948989906697243,"B.LvsV.ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_UP"
147,"Down",0.837100816956944,0.948989906697243,"B.LvsV.CHEN_LIVER_METABOLISM_QTL_CIS"
67,"Down",0.837188026187251,0.948989906697243,"B.LvsV.BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_UP"
167,"Down",0.837216010855073,0.948989906697243,"B.LvsV.HOOI_ST7_TARGETS_UP"
100,"Up",0.837386543537996,0.948989906697243,"B.LvsV.CADWELL_ATG16L1_TARGETS_DN"
148,"Up",0.837407833457156,0.948989906697243,"B.LvsV.GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_DN"
37,"Down",0.837790407248052,0.948989906697243,"B.LvsV.PID_NFKAPPAB_CANONICAL_PATHWAY"
75,"Up",0.837794152823722,0.948989906697243,"B.LvsV.LUI_THYROID_CANCER_PAX8_PPARG_UP"
11,"Down",0.837849082764449,0.948989906697243,"B.LvsV.REACTOME_ADENYLATE_CYCLASE_ACTIVATING_PATHWAY"
103,"Up",0.837894522517147,0.948989906697243,"B.LvsV.FIGUEROA_AML_METHYLATION_CLUSTER_2_UP"
83,"Down",0.837911762446226,0.948989906697243,"B.LvsV.REACTOME_NUCLEOTIDE_BINDING_DOMAIN_LEUCINE_RICH_REPEAT_CONTAINING_RECEPTOR_NLR_SIGNALING_PATHWAYS"
12,"Up",0.838097781933563,0.948989906697243,"B.LvsV.REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX_IN_CANCER"
14,"Up",0.838288755845492,0.948989906697243,"B.LvsV.WEBER_METHYLATED_LCP_IN_FIBROBLAST_UP"
91,"Up",0.838371806663361,0.948989906697243,"B.LvsV.PID_TCR_PATHWAY"
49,"Up",0.838430183220259,0.948989906697243,"B.LvsV.REACTOME_THE_PHOTOTRANSDUCTION_CASCADE"
191,"Up",0.838454638129143,0.948989906697243,"B.LvsV.ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP"
36,"Down",0.838936711183507,0.94934119446042,"B.LvsV.REACTOME_ACTIVATION_OF_BH3_ONLY_PROTEINS"
25,"Up",0.839956368049589,0.949950617894051,"B.LvsV.BIOCARTA_IL3_PATHWAY"
7,"Up",0.840042298405908,0.949950617894051,"B.LvsV.REACTOME_MITOCHONDRIAL_UNCOUPLING"
23,"Down",0.840335482293277,0.949950617894051,"B.LvsV.PID_SYNDECAN_3_PATHWAY"
142,"Up",0.840790444004079,0.949950617894051,"B.LvsV.QUINTENS_EMBRYONIC_BRAIN_RESPONSE_TO_IR"
7,"Down",0.840795625337462,0.949950617894051,"B.LvsV.MOTAMED_RESPONSE_TO_ANDROGEN_DN"
51,"Up",0.840804302516602,0.949950617894051,"B.LvsV.PID_FAS_PATHWAY"
167,"Down",0.840825372604504,0.949950617894051,"B.LvsV.MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_UP"
71,"Down",0.840849760168835,0.949950617894051,"B.LvsV.TAVOR_CEBPA_TARGETS_DN"
32,"Down",0.84118441130996,0.950134547524569,"B.LvsV.REACTOME_SIGNALING_BY_ERYTHROPOIETIN"
116,"Up",0.841575227143427,0.950381828201799,"B.LvsV.REACTOME_POST_TRANSLATIONAL_MODIFICATION_SYNTHESIS_OF_GPI_ANCHORED_PROTEINS"
36,"Down",0.842094008317702,0.950491741552472,"B.LvsV.KRIGE_AMINO_ACID_DEPRIVATION"
203,"Up",0.842274507407305,0.950491741552472,"B.LvsV.BORCZUK_MALIGNANT_MESOTHELIOMA_DN"
74,"Down",0.842809841807874,0.950491741552472,"B.LvsV.LIEN_BREAST_CARCINOMA_METAPLASTIC"
40,"Down",0.842937340586077,0.950491741552472,"B.LvsV.VANASSE_BCL2_TARGETS_UP"
25,"Up",0.842989685617015,0.950491741552472,"B.LvsV.GENTILE_UV_RESPONSE_CLUSTER_D1"
768,"Down",0.843010984254626,0.950491741552472,"B.LvsV.SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP"
136,"Up",0.843020836221759,0.950491741552472,"B.LvsV.MIKKELSEN_ES_HCP_WITH_H3_UNMETHYLATED"
12,"Down",0.843087267399124,0.950491741552472,"B.LvsV.REACTOME_COHESIN_LOADING_ONTO_CHROMATIN"
607,"Down",0.843219749016979,0.950491741552472,"B.LvsV.SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP"
144,"Up",0.843467428315921,0.950577132319349,"B.LvsV.YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_9"
12,"Up",0.843999929847223,0.950983413924046,"B.LvsV.KUMAMOTO_RESPONSE_TO_NUTLIN_3A_UP"
110,"Up",0.844597595694952,0.951403176145646,"B.LvsV.LIN_MELANOMA_COPY_NUMBER_UP"
45,"Down",0.844716619949172,0.951403176145646,"B.LvsV.SUMI_HNF4A_TARGETS"
6,"Up",0.8449820331759,0.951508281350214,"B.LvsV.REACTOME_METHIONINE_SALVAGE_PATHWAY"
14,"Down",0.845340500735935,0.951545217518256,"B.LvsV.REACTOME_PEXOPHAGY"
10,"Up",0.845490036622843,0.951545217518256,"B.LvsV.RANKIN_ANGIOGENIC_TARGETS_OF_VHL_HIF2A_UP"
61,"Up",0.845531136492529,0.951545217518256,"B.LvsV.LIU_CDX2_TARGETS_UP"
15,"Up",0.846063194593638,0.951950224442048,"B.LvsV.KEGG_GLYCOSPHINGOLIPID_BIOSYNTHESIS_GLOBO_SERIES"
103,"Down",0.846738261805527,0.952515940899849,"B.LvsV.REACTOME_GLUCOSE_METABOLISM"
79,"Down",0.846943811790608,0.952553363586304,"B.LvsV.DAZARD_UV_RESPONSE_CLUSTER_G24"
73,"Down",0.84722591233526,0.952676849563078,"B.LvsV.TAVOR_CEBPA_TARGETS_UP"
137,"Down",0.847464574153144,0.952751449876521,"B.LvsV.BROWNE_HCMV_INFECTION_6HR_UP"
100,"Up",0.848266466221848,0.953459095698434,"B.LvsV.CHANG_IMMORTALIZED_BY_HPV31_UP"
79,"Up",0.849360936404762,0.954431932753399,"B.LvsV.HOLLERN_MICROACINAR_BREAST_TUMOR_UP"
94,"Up",0.849624554265606,0.954431932753399,"B.LvsV.YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_3"
34,"Up",0.849649841384017,0.954431932753399,"B.LvsV.YANAGISAWA_LUNG_CANCER_RECURRENCE"
32,"Up",0.85001785953206,0.954560224101355,"B.LvsV.SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_2FC_UP"
15,"Up",0.850447924778045,0.954560224101355,"B.LvsV.REACTOME_HEME_BIOSYNTHESIS"
64,"Down",0.850692038957296,0.954560224101355,"B.LvsV.SAENZ_DETOX_PATHWAY_AND_CARCINOGENESIS_DN"
189,"Up",0.850714167333434,0.954560224101355,"B.LvsV.PUIFFE_INVASION_INHIBITED_BY_ASCITES_DN"
48,"Up",0.850759506149575,0.954560224101355,"B.LvsV.VIETOR_IFRD1_TARGETS"
6,"Up",0.850799924827542,0.954560224101355,"B.LvsV.REACTOME_THE_RETINOID_CYCLE_IN_CONES_DAYLIGHT_VISION"
26,"Up",0.850988836768515,0.95457846997223,"B.LvsV.ZIRN_TRETINOIN_RESPONSE_UP"
13,"Down",0.851870451426434,0.955158023647031,"B.LvsV.THILLAINADESAN_ZNF217_TARGETS_DN"
60,"Up",0.852255378658678,0.955158023647031,"B.LvsV.REACTOME_GENE_AND_PROTEIN_EXPRESSION_BY_JAK_STAT_SIGNALING_AFTER_INTERLEUKIN_12_STIMULATION"
35,"Down",0.852307478574758,0.955158023647031,"B.LvsV.PID_PRL_SIGNALING_EVENTS_PATHWAY"
87,"Down",0.85255623984023,0.955158023647031,"B.LvsV.ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_DN"
65,"Up",0.852648247508628,0.955158023647031,"B.LvsV.MMS_MOUSE_LYMPH_HIGH_4HRS_UP"
69,"Down",0.852668190878433,0.955158023647031,"B.LvsV.REACTOME_REGULATION_OF_PTEN_GENE_TRANSCRIPTION"
101,"Down",0.852763008123283,0.955158023647031,"B.LvsV.TCGA_GLIOBLASTOMA_COPY_NUMBER_UP"
118,"Down",0.85299551814308,0.955158023647031,"B.LvsV.KEGG_OOCYTE_MEIOSIS"
1133,"Down",0.853111372456832,0.955158023647031,"B.LvsV.KRIEG_HYPOXIA_NOT_VIA_KDM3A"
13,"Down",0.853288891295282,0.955158023647031,"B.LvsV.CLIMENT_BREAST_CANCER_COPY_NUMBER_DN"
9,"Up",0.853405794323808,0.955158023647031,"B.LvsV.PALOMERO_GSI_SENSITIVITY_UP"
156,"Up",0.853629575983057,0.955215123580312,"B.LvsV.LEE_AGING_CEREBELLUM_UP"
12,"Up",0.853967449421079,0.95525768011747,"B.LvsV.REACTOME_MYOCLONIC_EPILEPSY_OF_LAFORA"
29,"Down",0.854013151170312,0.95525768011747,"B.LvsV.ELLWOOD_MYC_TARGETS_UP"
25,"Up",0.85420494868673,0.955278956571386,"B.LvsV.NAKAMURA_LUNG_CANCER"
499,"Up",0.854553409809801,0.955475389856095,"B.LvsV.KAYO_AGING_MUSCLE_UP"
72,"Up",0.855402806561304,0.956231726137777,"B.LvsV.PIONTEK_PKD1_TARGETS_UP"
13,"Down",0.85588334808877,0.956463865285727,"B.LvsV.REACTOME_MITOCHONDRIAL_IRON_SULFUR_CLUSTER_BIOGENESIS"
62,"Down",0.85613532043703,0.956463865285727,"B.LvsV.REACTOME_XENOBIOTICS"
11,"Up",0.856209635058047,0.956463865285727,"B.LvsV.REACTOME_SCAVENGING_BY_CLASS_B_RECEPTORS"
106,"Up",0.856312280441782,0.956463865285727,"B.LvsV.PID_HIF1_TFPATHWAY"
17,"Down",0.856771714842254,0.956463865285727,"B.LvsV.REACTOME_DOWNREGULATION_OF_ERBB2_ERBB3_SIGNALING"
33,"Up",0.856790971647608,0.956463865285727,"B.LvsV.HASLINGER_B_CLL_WITH_CHROMOSOME_12_TRISOMY"
120,"Down",0.856907252394944,0.956463865285727,"B.LvsV.PID_BETA_CATENIN_NUC_PATHWAY"
12,"Down",0.856994391142249,0.956463865285727,"B.LvsV.FOURNIER_ACINAR_DEVELOPMENT_EARLY_DN"
5,"Down",0.857222454082574,0.956493434268668,"B.LvsV.REACTOME_FREE_FATTY_ACID_RECEPTORS"
135,"Up",0.857419187586582,0.956493434268668,"B.LvsV.SEIDEN_ONCOGENESIS_BY_MET"
28,"Up",0.857539872249916,0.956493434268668,"B.LvsV.REACTOME_VEGFR2_MEDIATED_CELL_PROLIFERATION"
1739,"Up",0.8578404664491,0.956618799799666,"B.LvsV.GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP"
7,"Up",0.857998304974958,0.956618799799666,"B.LvsV.BIOCARTA_FOSB_PATHWAY"
728,"Down",0.858521438091976,0.956922702797016,"B.LvsV.YAGI_AML_WITH_INV_16_TRANSLOCATION"
24,"Up",0.858617024520889,0.956922702797016,"B.LvsV.WONG_ENDOMETRIAL_CANCER_LATE"
141,"Up",0.859759974280127,0.958003405440311,"B.LvsV.CROONQUIST_STROMAL_STIMULATION_UP"
41,"Up",0.861046355369034,0.958877581858633,"B.LvsV.HOEGERKORP_CD44_TARGETS_DIRECT_UP"
80,"Down",0.861057892040671,0.958877581858633,"B.LvsV.KERLEY_RESPONSE_TO_CISPLATIN_UP"
20,"Down",0.861076473016831,0.958877581858633,"B.LvsV.BIOCARTA_PLC_PATHWAY"
16,"Up",0.861238211522874,0.958877581858633,"B.LvsV.REACTOME_GAMMA_CARBOXYLATION_TRANSPORT_AND_AMINO_TERMINAL_CLEAVAGE_OF_PROTEINS"
518,"Down",0.861906659454848,0.959428612870114,"B.LvsV.FARMER_BREAST_CANCER_APOCRINE_VS_BASAL"
51,"Up",0.862873977672084,0.959578486477027,"B.LvsV.REACTOME_ASSOCIATION_OF_TRIC_CCT_WITH_TARGET_PROTEINS_DURING_BIOSYNTHESIS"
62,"Down",0.862909979442606,0.959578486477027,"B.LvsV.REACTOME_STABILIZATION_OF_P53"
162,"Up",0.862952327265026,0.959578486477027,"B.LvsV.DASU_IL6_SIGNALING_UP"
18,"Up",0.863320909844059,0.959578486477027,"B.LvsV.LOPEZ_MESOTHELIOMA_SURVIVAL_UP"
75,"Down",0.863468926649332,0.959578486477027,"B.LvsV.NATSUME_RESPONSE_TO_INTERFERON_BETA_DN"
162,"Down",0.863693682741737,0.959578486477027,"B.LvsV.PURBEY_TARGETS_OF_CTBP1_AND_SATB1_UP"
28,"Up",0.863898951115856,0.959578486477027,"B.LvsV.RAHMAN_TP53_TARGETS_PHOSPHORYLATED"
5,"Down",0.864005176999246,0.959578486477027,"B.LvsV.BAFNA_MUC4_TARGETS_UP"
658,"Down",0.864057012969458,0.959578486477027,"B.LvsV.DELACROIX_RAR_BOUND_ES"
15,"Up",0.864095526865711,0.959578486477027,"B.LvsV.REACTOME_REGULATION_OF_PTEN_LOCALIZATION"
305,"Up",0.864123355294062,0.959578486477027,"B.LvsV.WANG_TUMOR_INVASIVENESS_DN"
31,"Up",0.864123943600853,0.959578486477027,"B.LvsV.REACTOME_PI_3K_CASCADE_FGFR1"
1648,"Up",0.864489512096218,0.959660266624329,"B.LvsV.REACTOME_INNATE_IMMUNE_SYSTEM"
236,"Up",0.864544725638593,0.959660266624329,"B.LvsV.REACTOME_PROGRAMMED_CELL_DEATH"
104,"Down",0.864808440017279,0.959758015584199,"B.LvsV.FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP"
206,"Down",0.864979958700681,0.959758015584199,"B.LvsV.LIU_VMYB_TARGETS_UP"
62,"Up",0.865481033713366,0.959769323144355,"B.LvsV.SIG_BCR_SIGNALING_PATHWAY"
89,"Up",0.865489969040888,0.959769323144355,"B.LvsV.VANHARANTA_UTERINE_FIBROID_UP"
14,"Down",0.865510914305978,0.959769323144355,"B.LvsV.REACTOME_ACETYLCHOLINE_BINDING_AND_DOWNSTREAM_EVENTS"
14,"Up",0.865953570786284,0.959857216888263,"B.LvsV.BERENJENO_TRANSFORMED_BY_RHOA_REVERSIBLY_UP"
50,"Up",0.866057731162701,0.959857216888263,"B.LvsV.BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_DN"
11,"Down",0.86628115624444,0.959857216888263,"B.LvsV.REACTOME_ABACAVIR_METABOLISM"
12,"Down",0.866284592561482,0.959857216888263,"B.LvsV.ZERBINI_RESPONSE_TO_SULINDAC_UP"
77,"Down",0.866894049224368,0.96023088841727,"B.LvsV.PID_HES_HEY_PATHWAY"
370,"Down",0.86696917977555,0.96023088841727,"B.LvsV.HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_UP"
7,"Down",0.867979857359477,0.961024962963516,"B.LvsV.REACTOME_LTC4_CYSLTR_MEDIATED_IL4_PRODUCTION"
249,"Down",0.8681756567231,0.961024962963516,"B.LvsV.WHITFIELD_CELL_CYCLE_S"
15,"Down",0.868392127451023,0.961024962963516,"B.LvsV.REACTOME_ADENYLATE_CYCLASE_INHIBITORY_PATHWAY"
36,"Down",0.868502785354581,0.961024962963516,"B.LvsV.GRAHAM_CML_DIVIDING_VS_NORMAL_DIVIDING_UP"
80,"Down",0.868555207076993,0.961024962963516,"B.LvsV.REACTOME_APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1"
50,"Down",0.869280535767562,0.961395370712681,"B.LvsV.BIOCARTA_ALK_PATHWAY"
22,"Up",0.869466610166825,0.961395370712681,"B.LvsV.SARTIPY_NORMAL_AT_INSULIN_RESISTANCE_DN"
227,"Down",0.869536138196961,0.961395370712681,"B.LvsV.REACTOME_FCGR3A_MEDIATED_IL10_SYNTHESIS"
37,"Up",0.869585503514942,0.961395370712681,"B.LvsV.GHO_ATF5_TARGETS_UP"
181,"Up",0.870015730816577,0.961678723647512,"B.LvsV.ONDER_CDH1_SIGNALING_VIA_CTNNB1"
15,"Up",0.870378158724872,0.961887035696546,"B.LvsV.HOLLEMAN_PREDNISOLONE_RESISTANCE_ALL_DN"
11,"Down",0.870569105281906,0.961905791987142,"B.LvsV.VALK_AML_WITH_T_8_21_TRANSLOCATION"
78,"Up",0.870755246807241,0.961919232686761,"B.LvsV.KAAB_FAILED_HEART_VENTRICLE_DN"
13,"Down",0.871406050637067,0.962374127764199,"B.LvsV.REACTOME_GLUTATHIONE_SYNTHESIS_AND_RECYCLING"
71,"Down",0.871826365508028,0.962374127764199,"B.LvsV.KEGG_GRAFT_VERSUS_HOST_DISEASE"
13,"Up",0.87227454637067,0.962374127764199,"B.LvsV.HOLLERN_SOLID_NODULAR_BREAST_TUMOR_UP"
205,"Up",0.872300720551004,0.962374127764199,"B.LvsV.CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_UP"
106,"Down",0.872465896832561,0.962374127764199,"B.LvsV.PID_AR_PATHWAY"
40,"Down",0.872650429329866,0.962374127764199,"B.LvsV.KYNG_WERNER_SYNDROM_DN"
99,"Down",0.872656605083476,0.962374127764199,"B.LvsV.NOUZOVA_METHYLATED_IN_APL"
183,"Up",0.872770128336935,0.962374127764199,"B.LvsV.FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP"
14,"Up",0.872797543655974,0.962374127764199,"B.LvsV.BIOCARTA_FXR_PATHWAY"
36,"Down",0.872907623573424,0.962374127764199,"B.LvsV.WILENSKY_RESPONSE_TO_DARAPLADIB"
71,"Up",0.873188599791674,0.962491979315822,"B.LvsV.ZHENG_FOXP3_TARGETS_IN_T_LYMPHOCYTE_DN"
9,"Up",0.873906987617995,0.96298682571221,"B.LvsV.BIOCARTA_IFNG_PATHWAY"
17,"Up",0.874018992460322,0.96298682571221,"B.LvsV.CONRAD_GERMLINE_STEM_CELL"
156,"Down",0.874160043090899,0.96298682571221,"B.LvsV.REACTOME_DISEASES_OF_GLYCOSYLATION"
195,"Down",0.87467954633515,0.962991608765472,"B.LvsV.BOYAULT_LIVER_CANCER_SUBCLASS_G1_UP"
53,"Up",0.87492452377821,0.962991608765472,"B.LvsV.BIOCARTA_CTL_PATHWAY"
154,"Down",0.874981696190337,0.962991608765472,"B.LvsV.NGUYEN_NOTCH1_TARGETS_DN"
657,"Down",0.875098524201654,0.962991608765472,"B.LvsV.SENESE_HDAC1_TARGETS_UP"
142,"Down",0.875387019136682,0.962991608765472,"B.LvsV.REACTOME_TCR_SIGNALING"
127,"Down",0.875440257464621,0.962991608765472,"B.LvsV.WANG_PROSTATE_CANCER_ANDROGEN_INDEPENDENT"
567,"Down",0.875494449277402,0.962991608765472,"B.LvsV.PHONG_TNF_RESPONSE_NOT_VIA_P38"
1381,"Down",0.875683685730242,0.962991608765472,"B.LvsV.BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_TRANS"
100,"Down",0.875833667951404,0.962991608765472,"B.LvsV.PID_CD8_TCR_PATHWAY"
77,"Up",0.876199165865494,0.962991608765472,"B.LvsV.VARELA_ZMPSTE24_TARGETS_DN"
130,"Down",0.876365287699455,0.962991608765472,"B.LvsV.KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION"
11,"Down",0.876414498036527,0.962991608765472,"B.LvsV.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_LIGHTGREEN_DN"
431,"Up",0.876428608303103,0.962991608765472,"B.LvsV.BONOME_OVARIAN_CANCER_SURVIVAL_OPTIMAL_DEBULKING"
92,"Down",0.876895869197902,0.963191592749227,"B.LvsV.BURTON_ADIPOGENESIS_7"
252,"Up",0.87695903018622,0.963191592749227,"B.LvsV.HUANG_GATA2_TARGETS_UP"
27,"Down",0.878128213110184,0.964176997711461,"B.LvsV.REACTOME_SHC1_EVENTS_IN_ERBB2_SIGNALING"
162,"Down",0.878204984712411,0.964176997711461,"B.LvsV.REACTOME_MEIOTIC_SYNAPSIS"
40,"Down",0.87844478165864,0.964209392474867,"B.LvsV.YIH_RESPONSE_TO_ARSENITE_C1"
58,"Down",0.878841354570905,0.964209392474867,"B.LvsV.HUMMERICH_MALIGNANT_SKIN_TUMOR_UP"
158,"Down",0.878899935064916,0.964209392474867,"B.LvsV.REACTOME_HATS_ACETYLATE_HISTONES"
49,"Down",0.878932056081268,0.964209392474867,"B.LvsV.REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_OXIDATIVE_STRESS_METABOLIC_AND_NEURONAL_GENES"
806,"Down",0.879222069315877,0.96424059113464,"B.LvsV.REACTOME_NEUTROPHIL_DEGRANULATION"
9,"Down",0.879309289292974,0.96424059113464,"B.LvsV.REACTOME_DEFECTIVE_CHSY1_CAUSES_TPBS"
646,"Down",0.880131211876234,0.964435838337283,"B.LvsV.MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP"
108,"Down",0.880273242162305,0.964435838337283,"B.LvsV.LEE_LIVER_CANCER_DENA_UP"
43,"Down",0.880325779768618,0.964435838337283,"B.LvsV.BIOCARTA_WNT_PATHWAY"
65,"Down",0.880334961977019,0.964435838337283,"B.LvsV.JIANG_AGING_CEREBRAL_CORTEX_UP"
413,"Down",0.880379253472824,0.964435838337283,"B.LvsV.KEGG_PATHWAYS_IN_CANCER"
627,"Up",0.88053393234339,0.964435838337283,"B.LvsV.LIM_MAMMARY_STEM_CELL_DN"
270,"Up",0.881070974020709,0.964585520132091,"B.LvsV.KIM_WT1_TARGETS_8HR_UP"
492,"Up",0.882089819348998,0.964585520132091,"B.LvsV.REACTOME_LEISHMANIA_INFECTION"
138,"Up",0.88219713395065,0.964585520132091,"B.LvsV.REACTOME_GLYCOSAMINOGLYCAN_METABOLISM"
85,"Down",0.882252559121229,0.964585520132091,"B.LvsV.PID_AR_TF_PATHWAY"
463,"Down",0.882267105188956,0.964585520132091,"B.LvsV.BRUINS_UVC_RESPONSE_EARLY_LATE"
41,"Up",0.882383905452787,0.964585520132091,"B.LvsV.LUI_THYROID_CANCER_CLUSTER_4"
41,"Down",0.882493445893341,0.964585520132091,"B.LvsV.TUOMISTO_TUMOR_SUPPRESSION_BY_COL13A1_DN"
149,"Down",0.882532167665854,0.964585520132091,"B.LvsV.NIKOLSKY_BREAST_CANCER_16P13_AMPLICON"
124,"Down",0.882654041286454,0.964585520132091,"B.LvsV.HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_UP"
40,"Up",0.882823617090311,0.964585520132091,"B.LvsV.PARK_TRETINOIN_RESPONSE_AND_RARA_PLZF_FUSION"
26,"Down",0.882850594132509,0.964585520132091,"B.LvsV.REACTOME_NICOTINAMIDE_SALVAGING"
109,"Down",0.883021260131465,0.964585520132091,"B.LvsV.PARK_APL_PATHOGENESIS_DN"
277,"Down",0.88311856488458,0.964585520132091,"B.LvsV.REACTOME_ESR_MEDIATED_SIGNALING"
360,"Down",0.883683653008489,0.964585520132091,"B.LvsV.RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN"
714,"Up",0.883700667377126,0.964585520132091,"B.LvsV.BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP"
181,"Up",0.883983149744903,0.964585520132091,"B.LvsV.MUNSHI_MULTIPLE_MYELOMA_UP"
27,"Up",0.88416008217885,0.964585520132091,"B.LvsV.REACTOME_LISTERIA_MONOCYTOGENES_ENTRY_INTO_HOST_CELLS"
61,"Down",0.88434551730409,0.964585520132091,"B.LvsV.FRIDMAN_IMMORTALIZATION_DN"
228,"Up",0.884486838442743,0.964585520132091,"B.LvsV.EPPERT_HSC_R"
260,"Up",0.884667883488479,0.964585520132091,"B.LvsV.REACTOME_KERATINIZATION"
34,"Down",0.884770568800127,0.964585520132091,"B.LvsV.CREIGHTON_AKT1_SIGNALING_VIA_MTOR_DN"
102,"Up",0.884793609780438,0.964585520132091,"B.LvsV.REACTOME_SIGNALING_BY_NOTCH4"
90,"Up",0.884819034991773,0.964585520132091,"B.LvsV.REACTOME_REGULATION_OF_RUNX2_EXPRESSION_AND_ACTIVITY"
377,"Up",0.884857615863622,0.964585520132091,"B.LvsV.MANALO_HYPOXIA_UP"
47,"Up",0.885246273373039,0.9648189721032,"B.LvsV.SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_DN"
32,"Up",0.885673561543978,0.964977308363597,"B.LvsV.REACTOME_INCRETIN_SYNTHESIS_SECRETION_AND_INACTIVATION"
463,"Up",0.885740611312218,0.964977308363597,"B.LvsV.MARKEY_RB1_ACUTE_LOF_DN"
7,"Down",0.886402841643794,0.965175177910056,"B.LvsV.REACTOME_GRB7_EVENTS_IN_ERBB2_SIGNALING"
11,"Down",0.886415572753025,0.965175177910056,"B.LvsV.REACTOME_PEPTIDE_HORMONE_BIOSYNTHESIS"
8,"Down",0.886620497125189,0.965175177910056,"B.LvsV.REACTOME_AMINO_ACID_CONJUGATION"
8,"Down",0.886620497125189,0.965175177910056,"B.LvsV.REACTOME_CONJUGATION_OF_BENZOATE_WITH_GLYCINE"
315,"Up",0.886799454893871,0.965179957895317,"B.LvsV.KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_DN"
54,"Up",0.887102692589087,0.965196385121326,"B.LvsV.REACTOME_GLUCAGON_LIKE_PEPTIDE_1_GLP1_REGULATES_INSULIN_SECRETION"
19,"Up",0.887208916385551,0.965196385121326,"B.LvsV.REACTOME_INTERACTION_WITH_CUMULUS_CELLS_AND_THE_ZONA_PELLUCIDA"
15,"Up",0.887392511773301,0.965196385121326,"B.LvsV.GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_1_UP"
12,"Up",0.887512827266562,0.965196385121326,"B.LvsV.BIOCARTA_EEA1_PATHWAY"
67,"Down",0.887759444928697,0.965274723895922,"B.LvsV.HUMMEL_BURKITTS_LYMPHOMA_UP"
13,"Up",0.887967424509435,0.965311028335168,"B.LvsV.BIOCARTA_GHRELIN_PATHWAY"
12,"Up",0.888333455207981,0.965387195678409,"B.LvsV.REACTOME_FRUCTOSE_METABOLISM"
10,"Down",0.888692729589058,0.965387195678409,"B.LvsV.DER_IFN_BETA_RESPONSE_DN"
15,"Up",0.888856929724049,0.965387195678409,"B.LvsV.PARK_OSTEOBLAST_DIFFERENTIATION_BY_PHENYLAMIL_DN"
29,"Up",0.88892244547115,0.965387195678409,"B.LvsV.REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY"
47,"Up",0.888926055980206,0.965387195678409,"B.LvsV.MIKKELSEN_MCV6_LCP_WITH_H3K27ME3"
82,"Up",0.889085114920322,0.965387195678409,"B.LvsV.REACTOME_REGULATION_OF_PTEN_STABILITY_AND_ACTIVITY"
355,"Down",0.889756546344654,0.965667986394358,"B.LvsV.IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_UP"
182,"Up",0.8899937489278,0.965667986394358,"B.LvsV.KIM_GLIS2_TARGETS_UP"
449,"Up",0.890030486701212,0.965667986394358,"B.LvsV.DOANE_RESPONSE_TO_ANDROGEN_DN"
127,"Down",0.890229937017975,0.965667986394358,"B.LvsV.REACTOME_HCMV_LATE_EVENTS"
215,"Down",0.890237278053693,0.965667986394358,"B.LvsV.REACTOME_FCERI_MEDIATED_MAPK_ACTIVATION"
291,"Down",0.890506473582745,0.965667986394358,"B.LvsV.REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT"
9,"Down",0.890646058052972,0.965667986394358,"B.LvsV.TESAR_ALK_TARGETS_HUMAN_ES_5D_DN"
45,"Up",0.890807096365641,0.965667986394358,"B.LvsV.PID_EPHA_FWDPATHWAY"
700,"Up",0.890915608355511,0.965667986394358,"B.LvsV.MILI_PSEUDOPODIA_CHEMOTAXIS_DN"
47,"Down",0.891331801659482,0.965768057779319,"B.LvsV.YAGI_AML_RELAPSE_PROGNOSIS"
131,"Down",0.891357279589051,0.965768057779319,"B.LvsV.SMID_BREAST_CANCER_RELAPSE_IN_LUNG_UP"
62,"Up",0.891878187997619,0.966137799284048,"B.LvsV.REACTOME_APOPTOTIC_CLEAVAGE_OF_CELLULAR_PROTEINS"
1093,"Up",0.89218412454964,0.966137799284048,"B.LvsV.BENPORATH_SOX2_TARGETS"
29,"Down",0.892399051364581,0.966137799284048,"B.LvsV.BIOCARTA_NO2IL12_PATHWAY"
20,"Down",0.892490040494836,0.966137799284048,"B.LvsV.REACTOME_MAP3K8_TPL2_DEPENDENT_MAPK1_3_ACTIVATION"
23,"Down",0.89264476096138,0.966137799284048,"B.LvsV.REACTOME_GAB1_SIGNALOSOME"
10,"Up",0.892989036695078,0.966137799284048,"B.LvsV.SASAI_TARGETS_OF_CXCR6_AND_PTCH1_DN"
27,"Up",0.893107319847782,0.966137799284048,"B.LvsV.REACTOME_PHASE_2_PLATEAU_PHASE"
32,"Down",0.893138741436987,0.966137799284048,"B.LvsV.MATZUK_IMPLANTATION_AND_UTERINE"
588,"Down",0.89345157358418,0.966137799284048,"B.LvsV.HUTTMANN_B_CLL_POOR_SURVIVAL_UP"
31,"Up",0.893514392507323,0.966137799284048,"B.LvsV.XU_HGF_TARGETS_INDUCED_BY_AKT1_6HR"
44,"Down",0.89364715203013,0.966137799284048,"B.LvsV.DAZARD_UV_RESPONSE_CLUSTER_G28"
26,"Down",0.893795559665061,0.966137799284048,"B.LvsV.PID_NFKAPPAB_ATYPICAL_PATHWAY"
67,"Up",0.894160394558309,0.966137799284048,"B.LvsV.TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN"
103,"Up",0.894273220870813,0.966137799284048,"B.LvsV.NAGASHIMA_NRG1_SIGNALING_DN"
58,"Down",0.894319634063259,0.966137799284048,"B.LvsV.PID_FOXO_PATHWAY"
75,"Up",0.894811890676032,0.966480746932562,"B.LvsV.EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_DN"
39,"Up",0.895692726035758,0.967243180127286,"B.LvsV.HASLINGER_B_CLL_WITH_MUTATED_VH_GENES"
116,"Down",0.895985805882335,0.96737073242012,"B.LvsV.PID_P73PATHWAY"
21,"Down",0.896600147142505,0.967797978737419,"B.LvsV.REACTOME_TNF_RECEPTOR_SUPERFAMILY_TNFSF_MEMBERS_MEDIATING_NON_CANONICAL_NF_KB_PATHWAY"
110,"Up",0.89697616935949,0.967797978737419,"B.LvsV.OHGUCHI_LIVER_HNF4A_TARGETS_UP"
104,"Up",0.89716659682855,0.967797978737419,"B.LvsV.REACTOME_HDACS_DEACETYLATE_HISTONES"
238,"Down",0.897412065255755,0.967797978737419,"B.LvsV.LI_INDUCED_T_TO_NATURAL_KILLER_DN"
892,"Down",0.897446387493892,0.967797978737419,"B.LvsV.IVANOVA_HEMATOPOIESIS_STEM_CELL_AND_PROGENITOR"
27,"Down",0.897582430568889,0.967797978737419,"B.LvsV.VANDESLUIS_COMMD1_TARGETS_GROUP_2_UP"
72,"Down",0.897626420694598,0.967797978737419,"B.LvsV.DAZARD_UV_RESPONSE_CLUSTER_G4"
16,"Down",0.897781847159382,0.967797978737419,"B.LvsV.REACTOME_ERKS_ARE_INACTIVATED"
13,"Up",0.898038347797231,0.967885774848127,"B.LvsV.REACTOME_INACTIVATION_OF_CDC42_AND_RAC1"
149,"Down",0.898808010510907,0.96795818563231,"B.LvsV.NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN"
28,"Down",0.899062733051783,0.96795818563231,"B.LvsV.LEE_INTRATHYMIC_T_PROGENITOR"
23,"Down",0.89921195838039,0.96795818563231,"B.LvsV.REACTOME_THE_NLRP3_INFLAMMASOME"
5,"Down",0.899265786350528,0.96795818563231,"B.LvsV.NAKAMURA_ALVEOLAR_EPITHELIUM"
73,"Up",0.89930130883818,0.96795818563231,"B.LvsV.PID_ANGIOPOIETIN_RECEPTOR_PATHWAY"
120,"Down",0.89956364861398,0.96795818563231,"B.LvsV.HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_DN"
78,"Up",0.899790638460249,0.96795818563231,"B.LvsV.WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_DN"
300,"Down",0.899812194697119,0.96795818563231,"B.LvsV.REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1"
162,"Up",0.899848561681154,0.96795818563231,"B.LvsV.WESTON_VEGFA_TARGETS"
119,"Up",0.899930940299144,0.96795818563231,"B.LvsV.BRUNO_HEMATOPOIESIS"
369,"Down",0.900031295412499,0.96795818563231,"B.LvsV.HAMAI_APOPTOSIS_VIA_TRAIL_DN"
61,"Up",0.900596487029922,0.968377669542675,"B.LvsV.ZHAN_MULTIPLE_MYELOMA_MF_DN"
12,"Down",0.900994567151361,0.968617336531183,"B.LvsV.REACTOME_ACTIVATION_OF_THE_AP_1_FAMILY_OF_TRANSCRIPTION_FACTORS"
37,"Down",0.901258348545444,0.968712560090933,"B.LvsV.KEGG_ETHER_LIPID_METABOLISM"
302,"Down",0.901767480634266,0.968719942369415,"B.LvsV.MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP"
21,"Down",0.901901051713373,0.968719942369415,"B.LvsV.HUMMEL_BURKITTS_LYMPHOMA_DN"
8,"Down",0.902139650089339,0.968719942369415,"B.LvsV.TERAMOTO_OPN_TARGETS_CLUSTER_5"
68,"Up",0.902624967392907,0.968719942369415,"B.LvsV.REACTOME_DEGRADATION_OF_GLI1_BY_THE_PROTEASOME"
64,"Down",0.902672255305594,0.968719942369415,"B.LvsV.HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_UP"
30,"Down",0.902729008172102,0.968719942369415,"B.LvsV.KYNG_DNA_DAMAGE_BY_4NQO_OR_GAMMA_RADIATION"
11,"Up",0.902976878547193,0.968719942369415,"B.LvsV.REACTOME_MISSPLICED_LRP5_MUTANTS_HAVE_ENHANCED_BETA_CATENIN_DEPENDENT_SIGNALING"
33,"Up",0.903170675378311,0.968719942369415,"B.LvsV.HUI_MAPK14_TARGETS_UP"
927,"Down",0.903176659870296,0.968719942369415,"B.LvsV.REACTOME_G_ALPHA_S_SIGNALLING_EVENTS"
9,"Down",0.903196225688547,0.968719942369415,"B.LvsV.BIOCARTA_CIRCADIAN_PATHWAY"
11,"Up",0.903309226385848,0.968719942369415,"B.LvsV.REACTOME_ERYTHROPOIETIN_ACTIVATES_STAT5"
37,"Up",0.903438202641403,0.968719942369415,"B.LvsV.ONO_AML1_TARGETS_UP"
10,"Down",0.903672031028613,0.968719942369415,"B.LvsV.REACTOME_ZINC_INFLUX_INTO_CELLS_BY_THE_SLC39_GENE_FAMILY"
241,"Up",0.903718115887401,0.968719942369415,"B.LvsV.BAKKER_FOXO3_TARGETS_DN"
65,"Up",0.904007723798969,0.968816703821269,"B.LvsV.LAU_APOPTOSIS_CDKN2A_UP"
62,"Down",0.904158833734445,0.968816703821269,"B.LvsV.ZHAN_MULTIPLE_MYELOMA_HP_DN"
15,"Up",0.905857420300217,0.970448687626409,"B.LvsV.REACTOME_REMOVAL_OF_AMINOTERMINAL_PROPEPTIDES_FROM_GAMMA_CARBOXYLATED_PROTEINS"
13,"Down",0.90631945848153,0.970755576509954,"B.LvsV.REACTOME_MINERALOCORTICOID_BIOSYNTHESIS"
65,"Down",0.906527414523169,0.970790252740384,"B.LvsV.AMIT_EGF_RESPONSE_120_MCF10A"
44,"Down",0.906923763262702,0.970912281857942,"B.LvsV.REACTOME_RA_BIOSYNTHESIS_PATHWAY"
50,"Up",0.907094764239688,0.970912281857942,"B.LvsV.REACTOME_SUMOYLATION_OF_TRANSCRIPTION_COFACTORS"
40,"Up",0.90724629778915,0.970912281857942,"B.LvsV.REACTOME_ALPHA_DEFENSINS"
7,"Down",0.907343780133837,0.970912281857942,"B.LvsV.REACTOME_CATION_COUPLED_CHLORIDE_COTRANSPORTERS"
1149,"Down",0.908063364687089,0.971494261485084,"B.LvsV.SMID_BREAST_CANCER_BASAL_DN"
523,"Up",0.908999310355843,0.972133508701238,"B.LvsV.KOYAMA_SEMA3B_TARGETS_DN"
99,"Down",0.909012523057587,0.972133508701238,"B.LvsV.APPIERTO_RESPONSE_TO_FENRETINIDE_DN"
1973,"Up",0.909433308517272,0.972253780814717,"B.LvsV.CHEN_METABOLIC_SYNDROM_NETWORK"
38,"Down",0.909476678309589,0.972253780814717,"B.LvsV.BIOCARTA_FAS_PATHWAY"
19,"Down",0.910078805988771,0.97252955107043,"B.LvsV.SA_PROGRAMMED_CELL_DEATH"
25,"Down",0.91008643466059,0.97252955107043,"B.LvsV.MCGOWAN_RSP6_TARGETS_UP"
79,"Up",0.910836783463521,0.973143299665663,"B.LvsV.KEGG_DRUG_METABOLISM_OTHER_ENZYMES"
207,"Down",0.911254282040797,0.973401260703935,"B.LvsV.MCCLUNG_CREB1_TARGETS_UP"
65,"Down",0.911713711116886,0.973703903566788,"B.LvsV.ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_UP"
12,"Up",0.911945665288159,0.973763534835502,"B.LvsV.TESAR_JAK_TARGETS_MOUSE_ES_D3_DN"
28,"Down",0.912419494820702,0.973792314840803,"B.LvsV.PID_HIF1A_PATHWAY"
35,"Down",0.912606587399097,0.973792314840803,"B.LvsV.MASRI_RESISTANCE_TO_TAMOXIFEN_AND_AROMATASE_INHIBITORS_UP"
36,"Up",0.913021711550958,0.973792314840803,"B.LvsV.BIOCARTA_TNFR1_PATHWAY"
827,"Down",0.913084049575618,0.973792314840803,"B.LvsV.REACTOME_TRANSPORT_OF_SMALL_MOLECULES"
281,"Up",0.913112561668778,0.973792314840803,"B.LvsV.REACTOME_INTERFERON_SIGNALING"
13,"Down",0.913115544214989,0.973792314840803,"B.LvsV.CASTELLANO_HRAS_AND_NRAS_TARGETS_DN"
29,"Down",0.913205489681599,0.973792314840803,"B.LvsV.REACTOME_PI_3K_CASCADE_FGFR2"
13,"Down",0.913510723642419,0.973844319532194,"B.LvsV.REACTOME_ERBB2_ACTIVATES_PTK6_SIGNALING"
7,"Down",0.914382877490846,0.973844319532194,"B.LvsV.REACTOME_APEX1_INDEPENDENT_RESOLUTION_OF_AP_SITES_VIA_THE_SINGLE_NUCLEOTIDE_REPLACEMENT_PATHWAY"
80,"Up",0.914554258304431,0.973844319532194,"B.LvsV.HOQUE_METHYLATED_IN_CANCER"
389,"Up",0.914666245169359,0.973844319532194,"B.LvsV.HOSHIDA_LIVER_CANCER_SUBCLASS_S1"
33,"Up",0.914807526641209,0.973844319532194,"B.LvsV.REACTOME_PURINERGIC_SIGNALING_IN_LEISHMANIASIS_INFECTION"
17,"Down",0.914808859611667,0.973844319532194,"B.LvsV.BIOCARTA_RANKL_PATHWAY"
302,"Up",0.915030021524029,0.973844319532194,"B.LvsV.RODRIGUES_NTN1_TARGETS_DN"
15,"Up",0.915036059722825,0.973844319532194,"B.LvsV.MARSON_FOXP3_TARGETS_STIMULATED_DN"
87,"Down",0.915167580323338,0.973844319532194,"B.LvsV.TSENG_ADIPOGENIC_POTENTIAL_DN"
20,"Up",0.915282294432116,0.973844319532194,"B.LvsV.BIOCARTA_TALL1_PATHWAY"
22,"Up",0.91550436132352,0.973844319532194,"B.LvsV.KIM_PTEN_TARGETS_UP"
109,"Down",0.915568907178916,0.973844319532194,"B.LvsV.LEE_LIVER_CANCER_MYC_E2F1_UP"
12,"Down",0.915598649754755,0.973844319532194,"B.LvsV.SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX2_DN"
11,"Up",0.915720133341992,0.973844319532194,"B.LvsV.REACTOME_RUNX3_REGULATES_YAP1_MEDIATED_TRANSCRIPTION"
13,"Down",0.916101988456124,0.974063056571906,"B.LvsV.GERHOLD_RESPONSE_TO_TZD_DN"
168,"Up",0.91649087869648,0.974289188293182,"B.LvsV.KIM_GASTRIC_CANCER_CHEMOSENSITIVITY"
15,"Up",0.916823082129963,0.974321332550691,"B.LvsV.GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP"
260,"Down",0.916901874758908,0.974321332550691,"B.LvsV.INGRAM_SHH_TARGETS_UP"
140,"Down",0.917266232348693,0.974321332550691,"B.LvsV.MCCLUNG_COCAINE_REWARD_5D"
826,"Down",0.917484640734897,0.974321332550691,"B.LvsV.TARTE_PLASMA_CELL_VS_PLASMABLAST_UP"
32,"Down",0.917594581318909,0.974321332550691,"B.LvsV.XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_UP"
17,"Down",0.917796678218209,0.974321332550691,"B.LvsV.REACTOME_TRYPTOPHAN_CATABOLISM"
14,"Up",0.917892418852424,0.974321332550691,"B.LvsV.BARRIER_CANCER_RELAPSE_TUMOR_SAMPLE_DN"
85,"Down",0.917930877420248,0.974321332550691,"B.LvsV.HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_DN"
78,"Down",0.918347045929525,0.974465265871051,"B.LvsV.KIM_ALL_DISORDERS_CALB1_CORR_DN"
32,"Down",0.918418972771576,0.974465265871051,"B.LvsV.WEBER_METHYLATED_HCP_IN_SPERM_UP"
291,"Down",0.918601671173443,0.974472110498459,"B.LvsV.DARWICHE_PAPILLOMA_RISK_LOW_DN"
29,"Up",0.918858674404057,0.974557761515448,"B.LvsV.REACTOME_AFLATOXIN_ACTIVATION_AND_DETOXIFICATION"
868,"Up",0.919074329394897,0.974599533414726,"B.LvsV.HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP"
18,"Up",0.919746440866014,0.975125229443565,"B.LvsV.REACTOME_PHASE_4_RESTING_MEMBRANE_POTENTIAL"
6,"Up",0.920149950976421,0.975366004399661,"B.LvsV.BIOCARTA_ACETAMINOPHEN_PATHWAY"
780,"Down",0.920392800649171,0.975391029145209,"B.LvsV.REACTOME_OLFACTORY_SIGNALING_PATHWAY"
14,"Up",0.921536553902178,0.975391029145209,"B.LvsV.BIOCARTA_IL5_PATHWAY"
79,"Down",0.921562413252047,0.975391029145209,"B.LvsV.REACTOME_INTERLEUKIN_12_FAMILY_SIGNALING"
12,"Up",0.921664064327801,0.975391029145209,"B.LvsV.REACTOME_VITAMIN_D_CALCIFEROL_METABOLISM"
63,"Down",0.921946990357562,0.975391029145209,"B.LvsV.HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_DN"
14,"Up",0.922209296829164,0.975391029145209,"B.LvsV.XU_HGF_TARGETS_REPRESSED_BY_AKT1_UP"
9,"Down",0.922241422710408,0.975391029145209,"B.LvsV.REACTOME_ESTROGEN_BIOSYNTHESIS"
36,"Up",0.922344575485646,0.975391029145209,"B.LvsV.PID_MYC_PATHWAY"
50,"Down",0.922437570152198,0.975391029145209,"B.LvsV.BIOCARTA_IL1R_PATHWAY"
77,"Down",0.922509164048868,0.975391029145209,"B.LvsV.MAGRANGEAS_MULTIPLE_MYELOMA_IGLL_VS_IGLK_UP"
48,"Up",0.922529134134465,0.975391029145209,"B.LvsV.KEGG_PRION_DISEASES"
114,"Up",0.922816409233674,0.975391029145209,"B.LvsV.HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_UP"
126,"Down",0.923023967704548,0.975391029145209,"B.LvsV.TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN"
12,"Up",0.923052240835805,0.975391029145209,"B.LvsV.BIOCARTA_RECK_PATHWAY"
7,"Down",0.923058631701626,0.975391029145209,"B.LvsV.REACTOME_ACROSOME_REACTION_AND_SPERM_OOCYTE_MEMBRANE_BINDING"
147,"Up",0.923126174367985,0.975391029145209,"B.LvsV.RODRIGUES_THYROID_CARCINOMA_DN"
33,"Down",0.923264711786844,0.975391029145209,"B.LvsV.MACLACHLAN_BRCA1_TARGETS_UP"
80,"Down",0.923349004620369,0.975391029145209,"B.LvsV.SU_PANCREAS"
53,"Down",0.923655380788646,0.975428635001203,"B.LvsV.WANG_METASTASIS_OF_BREAST_CANCER_ESR1_DN"
106,"Down",0.923874370848195,0.975428635001203,"B.LvsV.KEGG_HEMATOPOIETIC_CELL_LINEAGE"
8,"Down",0.92391386534659,0.975428635001203,"B.LvsV.REACTOME_CHREBP_ACTIVATES_METABOLIC_GENE_EXPRESSION"
14,"Up",0.924256625996008,0.975534589905474,"B.LvsV.BIOCARTA_AKAP13_PATHWAY"
18,"Up",0.924367103728482,0.975534589905474,"B.LvsV.BIOCARTA_MRP_PATHWAY"
150,"Up",0.925183381814834,0.975995996078535,"B.LvsV.REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION"
83,"Down",0.925351952529918,0.975995996078535,"B.LvsV.CHENG_RESPONSE_TO_NICKEL_ACETATE"
101,"Down",0.925441437104179,0.975995996078535,"B.LvsV.KEGG_APOPTOSIS"
267,"Up",0.925590995129112,0.975995996078535,"B.LvsV.MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_DN"
63,"Down",0.925800390713789,0.975995996078535,"B.LvsV.STREICHER_LSM1_TARGETS_UP"
72,"Up",0.92601513240394,0.975995996078535,"B.LvsV.JIANG_TIP30_TARGETS_UP"
24,"Down",0.926039970234762,0.975995996078535,"B.LvsV.YAGUE_PRETUMOR_DRUG_RESISTANCE_DN"
26,"Down",0.926286408253194,0.976069668616717,"B.LvsV.BIOCARTA_BARRESTIN_PATHWAY"
45,"Down",0.926591574073914,0.976119168246316,"B.LvsV.REACTOME_SYNTHESIS_OF_PA"
202,"Up",0.926839511497204,0.976119168246316,"B.LvsV.REACTOME_MEIOSIS"
154,"Up",0.926932802252977,0.976119168246316,"B.LvsV.RADMACHER_AML_PROGNOSIS"
238,"Up",0.927592085132216,0.976119168246316,"B.LvsV.TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN"
149,"Down",0.927666866934916,0.976119168246316,"B.LvsV.BHAT_ESR1_TARGETS_NOT_VIA_AKT1_DN"
231,"Down",0.927830795247967,0.976119168246316,"B.LvsV.BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_DN"
41,"Down",0.928003394972813,0.976119168246316,"B.LvsV.LU_TUMOR_ANGIOGENESIS_UP"
155,"Down",0.928358582676656,0.976119168246316,"B.LvsV.REACTOME_ACTIVATION_OF_ANTERIOR_HOX_GENES_IN_HINDBRAIN_DEVELOPMENT_DURING_EARLY_EMBRYOGENESIS"
7,"Down",0.928361366795674,0.976119168246316,"B.LvsV.REACTOME_DEX_H_BOX_HELICASES_ACTIVATE_TYPE_I_IFN_AND_INFLAMMATORY_CYTOKINES_PRODUCTION"
229,"Down",0.928383648438033,0.976119168246316,"B.LvsV.MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_DN"
241,"Up",0.92858584361749,0.976119168246316,"B.LvsV.KIM_WT1_TARGETS_12HR_UP"
336,"Up",0.928606897007545,0.976119168246316,"B.LvsV.IWANAGA_CARCINOGENESIS_BY_KRAS_UP"
105,"Down",0.928628472594615,0.976119168246316,"B.LvsV.SESTO_RESPONSE_TO_UV_C7"
127,"Down",0.928873882374276,0.976130735545566,"B.LvsV.HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_DN"
19,"Down",0.929275331636851,0.976130735545566,"B.LvsV.REACTOME_INLB_MEDIATED_ENTRY_OF_LISTERIA_MONOCYTOGENES_INTO_HOST_CELL"
10,"Down",0.929363372267679,0.976130735545566,"B.LvsV.REACTOME_LOSS_OF_FUNCTION_OF_SMAD2_3_IN_CANCER"
829,"Up",0.929374058589753,0.976130735545566,"B.LvsV.IVANOVA_HEMATOPOIESIS_LATE_PROGENITOR"
21,"Up",0.929676946639227,0.976130735545566,"B.LvsV.SCHWAB_TARGETS_OF_BMYB_POLYMORPHIC_VARIANTS_UP"
24,"Down",0.929698761689808,0.976130735545566,"B.LvsV.LIU_TOPBP1_TARGETS"
17,"Down",0.930295016523775,0.976529102763919,"B.LvsV.REACTOME_CYTOCHROME_C_MEDIATED_APOPTOTIC_RESPONSE"
25,"Up",0.930431418585698,0.976529102763919,"B.LvsV.REACTOME_REGULATION_OF_INNATE_IMMUNE_RESPONSES_TO_CYTOSOLIC_DNA"
76,"Up",0.930832212541909,0.97676433918091,"B.LvsV.REACTOME_SIGNALING_BY_PDGF"
10,"Down",0.931489567335855,0.977144594663202,"B.LvsV.GALIE_TUMOR_ANGIOGENESIS"
37,"Down",0.931560598125906,0.977144594663202,"B.LvsV.REACTOME_HEME_DEGRADATION"
67,"Down",0.931724778995189,0.977144594663202,"B.LvsV.FIRESTEIN_CTNNB1_PATHWAY"
60,"Up",0.932143757319226,0.977398603113598,"B.LvsV.REACTOME_NCAM1_INTERACTIONS"
12,"Up",0.932660706037793,0.977517957652213,"B.LvsV.REACTOME_NF_KB_ACTIVATION_THROUGH_FADD_RIP_1_PATHWAY_MEDIATED_BY_CASPASE_8_AND_10"
48,"Down",0.932701826272781,0.977517957652213,"B.LvsV.GENTILE_UV_RESPONSE_CLUSTER_D5"
14,"Down",0.932787980570279,0.977517957652213,"B.LvsV.BIOCARTA_ASBCELL_PATHWAY"
184,"Up",0.933295712429273,0.977701573303666,"B.LvsV.YAGI_AML_SURVIVAL"
134,"Down",0.933464082244241,0.977701573303666,"B.LvsV.BASSO_HAIRY_CELL_LEUKEMIA_UP"
74,"Down",0.933591385084305,0.977701573303666,"B.LvsV.REACTOME_INTRINSIC_PATHWAY_FOR_APOPTOSIS"
105,"Down",0.933717153798004,0.977701573303666,"B.LvsV.OUILLETTE_CLL_13Q14_DELETION_DN"
10,"Up",0.933847351893047,0.977701573303666,"B.LvsV.PID_VEGF_VEGFR_PATHWAY"
972,"Down",0.934435327281175,0.977966682908239,"B.LvsV.BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN"
140,"Down",0.934454329138041,0.977966682908239,"B.LvsV.MCCLUNG_DELTA_FOSB_TARGETS_2WK"
75,"Down",0.934806837240335,0.978150454788382,"B.LvsV.PID_INTEGRIN3_PATHWAY"
18,"Down",0.935043752482041,0.978213227525677,"B.LvsV.JIANG_CORE_DUPLICON_GENES"
38,"Up",0.935287691247857,0.978283322911351,"B.LvsV.MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP"
184,"Down",0.935912914837901,0.978421461413713,"B.LvsV.JAZAG_TGFB1_SIGNALING_VIA_SMAD4_UP"
296,"Up",0.936034742023062,0.978421461413713,"B.LvsV.SMIRNOV_RESPONSE_TO_IR_6HR_UP"
10,"Down",0.936105555386938,0.978421461413713,"B.LvsV.BIOCARTA_STAT3_PATHWAY"
359,"Up",0.936127605512487,0.978421461413713,"B.LvsV.MASSARWEH_TAMOXIFEN_RESISTANCE_DN"
462,"Down",0.936519062543665,0.978645605141547,"B.LvsV.MULLIGHAN_MLL_SIGNATURE_2_DN"
338,"Up",0.936714690838945,0.978665065315292,"B.LvsV.REACTOME_FC_EPSILON_RECEPTOR_FCERI_SIGNALING"
9,"Down",0.937408459861794,0.979204869559014,"B.LvsV.REACTOME_SUMO_IS_PROTEOLYTICALLY_PROCESSED"
57,"Up",0.938390289963304,0.979719910981733,"B.LvsV.DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY"
115,"Up",0.938503470717591,0.979719910981733,"B.LvsV.REACTOME_PROTEIN_FOLDING"
47,"Up",0.938704784746353,0.979719910981733,"B.LvsV.LIU_LIVER_CANCER"
541,"Down",0.938786235486104,0.979719910981733,"B.LvsV.BOYLAN_MULTIPLE_MYELOMA_C_D_DN"
16,"Down",0.938787500159382,0.979719910981733,"B.LvsV.REACTOME_GLUCOCORTICOID_BIOSYNTHESIS"
41,"Down",0.939706491509174,0.979990610526313,"B.LvsV.REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS"
15,"Up",0.939775764085506,0.979990610526313,"B.LvsV.REACTOME_PI3K_EVENTS_IN_ERBB4_SIGNALING"
24,"Down",0.939838423212853,0.979990610526313,"B.LvsV.REACTOME_PI_3K_CASCADE_FGFR4"
15,"Up",0.940241788198331,0.979990610526313,"B.LvsV.REACTOME_N_GLYCAN_ANTENNAE_ELONGATION"
734,"Up",0.940451242528993,0.979990610526313,"B.LvsV.FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_UP"
52,"Down",0.940650017736672,0.979990610526313,"B.LvsV.WANG_RESPONSE_TO_BEXAROTENE_UP"
84,"Up",0.940677051227124,0.979990610526313,"B.LvsV.REACTOME_DEFENSINS"
30,"Down",0.940713770205784,0.979990610526313,"B.LvsV.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_17"
322,"Up",0.940718815645128,0.979990610526313,"B.LvsV.DARWICHE_PAPILLOMA_RISK_HIGH_DN"
22,"Down",0.940819345392235,0.979990610526313,"B.LvsV.PYEON_HPV_POSITIVE_TUMORS_DN"
661,"Down",0.941217912289437,0.980149012042424,"B.LvsV.DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_UP"
13,"Down",0.941491926614498,0.980149012042424,"B.LvsV.POS_RESPONSE_TO_HISTAMINE_DN"
52,"Up",0.941684306383356,0.980149012042424,"B.LvsV.REACTOME_SIGNALING_BY_FGFR4"
355,"Up",0.941828357144021,0.980149012042424,"B.LvsV.RIZKI_TUMOR_INVASIVENESS_3D_UP"
318,"Up",0.941857786395623,0.980149012042424,"B.LvsV.ALONSO_METASTASIS_UP"
140,"Up",0.942273206734289,0.980267968877119,"B.LvsV.GU_PDEF_TARGETS_UP"
40,"Down",0.942543450184731,0.980267968877119,"B.LvsV.KEGG_CYSTEINE_AND_METHIONINE_METABOLISM"
725,"Up",0.942830206745051,0.980267968877119,"B.LvsV.PEDRIOLI_MIR31_TARGETS_DN"
237,"Up",0.942835881506968,0.980267968877119,"B.LvsV.MIKKELSEN_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3"
12,"Up",0.942883067274153,0.980267968877119,"B.LvsV.SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX1_DN"
29,"Up",0.943035870221993,0.980267968877119,"B.LvsV.JI_CARCINOGENESIS_BY_KRAS_AND_STK11_DN"
61,"Up",0.943358061078462,0.980272665154651,"B.LvsV.DORSAM_HOXA9_TARGETS_UP"
6,"Up",0.943394981242159,0.980272665154651,"B.LvsV.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_13"
127,"Up",0.943645405746261,0.980348637424103,"B.LvsV.SANA_TNF_SIGNALING_DN"
761,"Down",0.943869064866018,0.980396779944432,"B.LvsV.KEGG_OLFACTORY_TRANSDUCTION"
95,"Up",0.945214448985057,0.981609821269418,"B.LvsV.REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_CELL_DEATH_GENES"
39,"Up",0.945684530139348,0.981913571293982,"B.LvsV.REACTOME_NUCLEAR_SIGNALING_BY_ERBB4"
68,"Down",0.94589404009025,0.981946704404617,"B.LvsV.KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY"
115,"Down",0.946640050894393,0.982536670057274,"B.LvsV.BROWNE_HCMV_INFECTION_1HR_UP"
98,"Down",0.947404458423352,0.983145504996756,"B.LvsV.REACTOME_DNA_DAMAGE_TELOMERE_STRESS_INDUCED_SENESCENCE"
217,"Up",0.948020533763161,0.983428678626931,"B.LvsV.REACTOME_FCERI_MEDIATED_CA_2_MOBILIZATION"
60,"Up",0.948033072360561,0.983428678626931,"B.LvsV.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_UP"
33,"Down",0.94827601487205,0.983496170742368,"B.LvsV.BILANGES_SERUM_SENSITIVE_VIA_TSC1"
927,"Up",0.948706709957748,0.983605782080478,"B.LvsV.REACTOME_HEMOSTASIS"
96,"Up",0.948737499698894,0.983605782080478,"B.LvsV.REACTOME_DEGRADATION_OF_BETA_CATENIN_BY_THE_DESTRUCTION_COMPLEX"
70,"Down",0.949092002898869,0.983680846310457,"B.LvsV.REACTOME_INTERLEUKIN_12_SIGNALING"
233,"Down",0.949275924066361,0.983680846310457,"B.LvsV.REACTOME_CELLULAR_SENESCENCE"
371,"Down",0.949534256402661,0.983680846310457,"B.LvsV.GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_UP"
12,"Down",0.949536213816109,0.983680846310457,"B.LvsV.MIKKELSEN_PLURIPOTENT_STATE_UP"
456,"Up",0.949699467825144,0.983680846310457,"B.LvsV.CAIRO_HEPATOBLASTOMA_DN"
43,"Down",0.949883812532388,0.983687506928559,"B.LvsV.WILLERT_WNT_SIGNALING"
443,"Down",0.950765977703165,0.984002907910503,"B.LvsV.BILD_HRAS_ONCOGENIC_SIGNATURE"
112,"Down",0.95082787060186,0.984002907910503,"B.LvsV.LEE_LIVER_CANCER_CIPROFIBRATE_DN"
71,"Down",0.950910758250594,0.984002907910503,"B.LvsV.REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES"
62,"Down",0.950932413632174,0.984002907910503,"B.LvsV.KORKOLA_CORRELATED_WITH_POU5F1"
20,"Down",0.951078231122034,0.984002907910503,"B.LvsV.REACTOME_ACTIVATION_OF_THE_PHOTOTRANSDUCTION_CASCADE"
130,"Up",0.951584466800064,0.984176488415697,"B.LvsV.CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_UP"
17,"Down",0.952289415235205,0.984176488415697,"B.LvsV.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_8"
186,"Up",0.952699367841613,0.984176488415697,"B.LvsV.CHUNG_BLISTER_CYTOTOXICITY_UP"
58,"Down",0.952922829402992,0.984176488415697,"B.LvsV.TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_DN"
39,"Up",0.952988602581286,0.984176488415697,"B.LvsV.CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_DN"
37,"Down",0.953112892518288,0.984176488415697,"B.LvsV.BIOCARTA_IL2_PATHWAY"
172,"Up",0.953285255334872,0.984176488415697,"B.LvsV.KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP"
140,"Down",0.953422934765532,0.984176488415697,"B.LvsV.REACTOME_ADORA2B_MEDIATED_ANTI_INFLAMMATORY_CYTOKINES_PRODUCTION"
669,"Down",0.953647543949692,0.984176488415697,"B.LvsV.KUMAR_TARGETS_OF_MLL_AF9_FUSION"
22,"Up",0.953774211159448,0.984176488415697,"B.LvsV.TSUNODA_CISPLATIN_RESISTANCE_UP"
19,"Down",0.954214825570878,0.984176488415697,"B.LvsV.REACTOME_REGULATION_OF_RUNX1_EXPRESSION_AND_ACTIVITY"
1236,"Up",0.954599533060155,0.984176488415697,"B.LvsV.NUYTTEN_NIPP1_TARGETS_DN"
843,"Down",0.954680274074712,0.984176488415697,"B.LvsV.MCCABE_BOUND_BY_HOXC6"
42,"Up",0.955012778582798,0.984176488415697,"B.LvsV.REACTOME_REGULATION_OF_TP53_EXPRESSION_AND_DEGRADATION"
13,"Down",0.955060707515598,0.984176488415697,"B.LvsV.REACTOME_INTERLEUKIN_35_SIGNALLING"
23,"Down",0.955072800618952,0.984176488415697,"B.LvsV.REACTOME_APOPTOTIC_FACTOR_MEDIATED_RESPONSE"
25,"Down",0.955094862508767,0.984176488415697,"B.LvsV.WEBER_METHYLATED_IN_COLON_CANCER"
22,"Down",0.955421526038153,0.984176488415697,"B.LvsV.BIOCARTA_D4GDI_PATHWAY"
527,"Down",0.955878345995803,0.984176488415697,"B.LvsV.DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN"
69,"Up",0.955920071180511,0.984176488415697,"B.LvsV.REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR"
17,"Down",0.956145692619149,0.984176488415697,"B.LvsV.ZHENG_FOXP3_TARGETS_DN"
201,"Down",0.956276357591934,0.984176488415697,"B.LvsV.REACTOME_ROLE_OF_LAT2_NTAL_LAB_ON_CALCIUM_MOBILIZATION"
37,"Up",0.956295587948371,0.984176488415697,"B.LvsV.REACTOME_STING_MEDIATED_INDUCTION_OF_HOST_IMMUNE_RESPONSES"
349,"Up",0.956324874807619,0.984176488415697,"B.LvsV.REACTOME_MAPK_FAMILY_SIGNALING_CASCADES"
87,"Down",0.956332667493605,0.984176488415697,"B.LvsV.KEGG_CHRONIC_MYELOID_LEUKEMIA"
41,"Up",0.956474919503824,0.984176488415697,"B.LvsV.KYNG_NORMAL_AGING_DN"
46,"Up",0.956605273314152,0.984176488415697,"B.LvsV.RAY_TARGETS_OF_P210_BCR_ABL_FUSION_UP"
60,"Up",0.956794120553411,0.984176488415697,"B.LvsV.BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_UP"
31,"Down",0.956945747491395,0.984176488415697,"B.LvsV.BIOCARTA_AKT_PATHWAY"
52,"Up",0.956991839867334,0.984176488415697,"B.LvsV.SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_DN"
33,"Down",0.95721978401755,0.984176488415697,"B.LvsV.KIM_HYPOXIA"
113,"Down",0.957326328778853,0.984176488415697,"B.LvsV.CROMER_TUMORIGENESIS_UP"
1501,"Up",0.957336770440642,0.984176488415697,"B.LvsV.LOPEZ_MBD_TARGETS"
9,"Up",0.957342493821203,0.984176488415697,"B.LvsV.REACTOME_LIGAND_RECEPTOR_INTERACTIONS"
17,"Down",0.957476095349617,0.984176488415697,"B.LvsV.PID_RANBP2_PATHWAY"
750,"Down",0.957894900168451,0.984261181586396,"B.LvsV.MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN"
36,"Down",0.95791452669857,0.984261181586396,"B.LvsV.GROSS_HIF1A_TARGETS_DN"
392,"Down",0.958235289555813,0.984407825335208,"B.LvsV.REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION"
102,"Up",0.95854506500756,0.984543129189448,"B.LvsV.HUPER_BREAST_BASAL_VS_LUMINAL_UP"
90,"Up",0.958883906891044,0.98470823202091,"B.LvsV.ZHAN_MULTIPLE_MYELOMA_MF_UP"
146,"Down",0.959422388107656,0.98503742479661,"B.LvsV.REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING"
39,"Up",0.959682190742559,0.98503742479661,"B.LvsV.DACOSTA_LOW_DOSE_UV_RESPONSE_VIA_ERCC3_XPCS_UP"
23,"Up",0.959791070759085,0.98503742479661,"B.LvsV.FREDERICK_PRKCI_TARGETS"
470,"Down",0.959917099801797,0.98503742479661,"B.LvsV.HOSHIDA_LIVER_CANCER_SUBCLASS_S3"
7,"Down",0.960299200244476,0.985163349106483,"B.LvsV.TERAMOTO_OPN_TARGETS_CLUSTER_3"
15,"Up",0.960505246328786,0.985163349106483,"B.LvsV.BIOCARTA_AKAP95_PATHWAY"
10,"Up",0.960574356128242,0.985163349106483,"B.LvsV.MIKKELSEN_DEDIFFERENTIATED_STATE_DN"
63,"Down",0.960938964074987,0.985354512680009,"B.LvsV.REACTOME_CARGO_CONCENTRATION_IN_THE_ER"
21,"Down",0.96167987306011,0.985931395911246,"B.LvsV.ROETH_TERT_TARGETS_DN"
109,"Up",0.962050240159369,0.986128249507073,"B.LvsV.LEE_EARLY_T_LYMPHOCYTE_DN"
390,"Down",0.962452877826103,0.98631730584748,"B.LvsV.ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP"
138,"Up",0.962591460002351,0.98631730584748,"B.LvsV.HARRIS_HYPOXIA"
90,"Down",0.963286861505951,0.98684696262116,"B.LvsV.KAAB_FAILED_HEART_ATRIUM_UP"
53,"Down",0.964334274250706,0.987736977090061,"B.LvsV.KIM_TIAL1_TARGETS"
69,"Down",0.965220311973751,0.988360407677496,"B.LvsV.REACTOME_SIGNALING_BY_PTK6"
321,"Down",0.965300452425118,0.988360407677496,"B.LvsV.BROWN_MYELOID_CELL_DEVELOPMENT_UP"
27,"Up",0.965802642186126,0.988591842440581,"B.LvsV.OUYANG_PROSTATE_CANCER_PROGRESSION_DN"
208,"Up",0.965884089865078,0.988591842440581,"B.LvsV.REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX"
28,"Up",0.966883504035228,0.989106121956081,"B.LvsV.REACTOME_ENDOGENOUS_STEROLS"
16,"Up",0.966921494984252,0.989106121956081,"B.LvsV.BIOCARTA_TSP1_PATHWAY"
179,"Up",0.966958813994921,0.989106121956081,"B.LvsV.TSENG_IRS1_TARGETS_UP"
189,"Down",0.967528968971084,0.989106121956081,"B.LvsV.LIU_VAV3_PROSTATE_CARCINOGENESIS_UP"
67,"Down",0.968002651917388,0.989106121956081,"B.LvsV.ZHAN_MULTIPLE_MYELOMA_PR_DN"
22,"Up",0.968024894219516,0.989106121956081,"B.LvsV.KYNG_WERNER_SYNDROM_UP"
69,"Down",0.968055489934341,0.989106121956081,"B.LvsV.APPIERTO_RESPONSE_TO_FENRETINIDE_UP"
38,"Down",0.968162737827181,0.989106121956081,"B.LvsV.ONO_FOXP3_TARGETS_UP"
137,"Down",0.968266589111948,0.989106121956081,"B.LvsV.BECKER_TAMOXIFEN_RESISTANCE_DN"
324,"Down",0.968301732123661,0.989106121956081,"B.LvsV.REACTOME_SIGNALING_BY_NOTCH"
33,"Up",0.968354392864581,0.989106121956081,"B.LvsV.MARCHINI_TRABECTEDIN_RESISTANCE_UP"
106,"Down",0.968710294619522,0.989242223093558,"B.LvsV.MAGRANGEAS_MULTIPLE_MYELOMA_IGG_VS_IGA_UP"
166,"Down",0.968845476225649,0.989242223093558,"B.LvsV.KESHELAVA_MULTIPLE_DRUG_RESISTANCE"
50,"Up",0.969343376355527,0.989567859650981,"B.LvsV.LASTOWSKA_COAMPLIFIED_WITH_MYCN"
639,"Up",0.969621332386941,0.989668884394941,"B.LvsV.HAN_SATB1_TARGETS_DN"
12,"Up",0.970161876875185,0.989933706658796,"B.LvsV.MIZUKAMI_HYPOXIA_DN"
127,"Down",0.970238877985895,0.989933706658796,"B.LvsV.REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK"
92,"Down",0.970588494297255,0.990101579932571,"B.LvsV.REACTOME_SIGNALING_BY_NOTCH1"
14,"Down",0.970980838256732,0.990101579932571,"B.LvsV.REACTOME_MITOCHONDRIAL_FATTY_ACID_BETA_OXIDATION_OF_SATURATED_FATTY_ACIDS"
28,"Down",0.971122664478766,0.990101579932571,"B.LvsV.SU_KIDNEY"
67,"Up",0.971208155884554,0.990101579932571,"B.LvsV.GYORFFY_DOXORUBICIN_RESISTANCE"
17,"Up",0.971298782701079,0.990101579932571,"B.LvsV.BOYAULT_LIVER_CANCER_SUBCLASS_G56_UP"
25,"Down",0.972413873958575,0.990906040814457,"B.LvsV.REACTOME_SYNTHESIS_OF_VERY_LONG_CHAIN_FATTY_ACYL_COAS"
11,"Down",0.972446405762207,0.990906040814457,"B.LvsV.BIOCARTA_ERBB4_PATHWAY"
24,"Up",0.973024760161737,0.991312677157591,"B.LvsV.SUZUKI_AMPLIFIED_IN_ORAL_CANCER"
106,"Up",0.973507200139927,0.991368015791061,"B.LvsV.GUO_HEX_TARGETS_DN"
22,"Up",0.973674648452615,0.991368015791061,"B.LvsV.REACTOME_TIE2_SIGNALING"
298,"Down",0.973897216715192,0.991368015791061,"B.LvsV.VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP"
13,"Down",0.974039413952318,0.991368015791061,"B.LvsV.PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_5"
182,"Down",0.974105428102747,0.991368015791061,"B.LvsV.LEE_CALORIE_RESTRICTION_NEOCORTEX_UP"
316,"Down",0.97415489777407,0.991368015791061,"B.LvsV.SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN"
120,"Up",0.974594005475742,0.991487592797343,"B.LvsV.BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_DN"
22,"Down",0.974631048445208,0.991487592797343,"B.LvsV.BIOCARTA_NFKB_PATHWAY"
354,"Down",0.974957243379187,0.991636975467904,"B.LvsV.MARTORIATI_MDM4_TARGETS_FETAL_LIVER_UP"
388,"Up",0.975532046376237,0.991719329180191,"B.LvsV.PEREZ_TP53_AND_TP63_TARGETS"
515,"Up",0.975596131685365,0.991719329180191,"B.LvsV.RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN"
30,"Up",0.975673841887663,0.991719329180191,"B.LvsV.REACTOME_RHO_GTPASES_ACTIVATE_NADPH_OXIDASES"
6,"Down",0.975755679280202,0.991719329180191,"B.LvsV.BIOCARTA_TERC_PATHWAY"
29,"Down",0.976266943468612,0.991882806127878,"B.LvsV.MURAKAMI_UV_RESPONSE_1HR_UP"
5,"Up",0.976526684818819,0.991882806127878,"B.LvsV.REACTOME_DOPAMINE_RECEPTORS"
130,"Down",0.976862254028427,0.991882806127878,"B.LvsV.REACTOME_PROTEIN_UBIQUITINATION"
82,"Up",0.97727222869462,0.991882806127878,"B.LvsV.PID_TGFBR_PATHWAY"
46,"Up",0.97740462288771,0.991882806127878,"B.LvsV.REACTOME_NUCLEOBASE_CATABOLISM"
76,"Down",0.977449482571832,0.991882806127878,"B.LvsV.NEMETH_INFLAMMATORY_RESPONSE_LPS_DN"
452,"Up",0.977483781401258,0.991882806127878,"B.LvsV.REACTOME_DISEASES_OF_SIGNAL_TRANSDUCTION_BY_GROWTH_FACTOR_RECEPTORS_AND_SECOND_MESSENGERS"
33,"Down",0.977522964054602,0.991882806127878,"B.LvsV.BUCKANOVICH_T_LYMPHOCYTE_HOMING_ON_TUMOR_DN"
117,"Up",0.977599757799237,0.991882806127878,"B.LvsV.LIN_TUMOR_ESCAPE_FROM_IMMUNE_ATTACK"
66,"Up",0.97785183496966,0.991882806127878,"B.LvsV.REACTOME_SIGNALING_BY_NOTCH1_PEST_DOMAIN_MUTANTS_IN_CANCER"
402,"Down",0.978101514297865,0.991882806127878,"B.LvsV.BROWNE_HCMV_INFECTION_16HR_UP"
368,"Up",0.978130397227999,0.991882806127878,"B.LvsV.AMUNDSON_RESPONSE_TO_ARSENITE"
88,"Up",0.978428048326597,0.991882806127878,"B.LvsV.WEBER_METHYLATED_ICP_IN_SPERM_DN"
87,"Down",0.978428074628585,0.991882806127878,"B.LvsV.LEE_LIVER_CANCER_MYC_TGFA_UP"
22,"Up",0.978838015230593,0.992106399654712,"B.LvsV.GRAHAM_CML_DIVIDING_VS_NORMAL_DIVIDING_DN"
10,"Down",0.979057586113704,0.992106399654712,"B.LvsV.REACTOME_FRUCTOSE_CATABOLISM"
52,"Up",0.979186945725405,0.992106399654712,"B.LvsV.LEIN_LOCALIZED_TO_PROXIMAL_DENDRITES"
247,"Down",0.979458550193414,0.992199766218283,"B.LvsV.PODAR_RESPONSE_TO_ADAPHOSTIN_UP"
192,"Down",0.980169481605315,0.992325421972658,"B.LvsV.KEGG_JAK_STAT_SIGNALING_PATHWAY"
15,"Down",0.980252518664527,0.992325421972658,"B.LvsV.REACTOME_SIGNAL_ATTENUATION"
335,"Up",0.980702488132059,0.992325421972658,"B.LvsV.WANG_CISPLATIN_RESPONSE_AND_XPC_DN"
9,"Up",0.9808024142057,0.992325421972658,"B.LvsV.REACTOME_HIGHLY_SODIUM_PERMEABLE_POSTSYNAPTIC_ACETYLCHOLINE_NICOTINIC_RECEPTORS"
770,"Down",0.98158548740476,0.992325421972658,"B.LvsV.BOCHKIS_FOXA2_TARGETS"
83,"Up",0.9816469738145,0.992325421972658,"B.LvsV.REACTOME_GOLGI_ASSOCIATED_VESICLE_BIOGENESIS"
309,"Up",0.98174453451901,0.992325421972658,"B.LvsV.DARWICHE_SQUAMOUS_CELL_CARCINOMA_DN"
109,"Down",0.981815134955785,0.992325421972658,"B.LvsV.FIGUEROA_AML_METHYLATION_CLUSTER_5_DN"
501,"Up",0.981863511098492,0.992325421972658,"B.LvsV.JAATINEN_HEMATOPOIETIC_STEM_CELL_UP"
7,"Up",0.982088458579686,0.992325421972658,"B.LvsV.REACTOME_SULFIDE_OXIDATION_TO_SULFATE"
26,"Up",0.982109809006929,0.992325421972658,"B.LvsV.SA_G1_AND_S_PHASES"
290,"Down",0.982264032187915,0.992325421972658,"B.LvsV.GREGORY_SYNTHETIC_LETHAL_WITH_IMATINIB"
337,"Down",0.982294566301831,0.992325421972658,"B.LvsV.YAMAZAKI_TCEB3_TARGETS_UP"
74,"Down",0.982318703560628,0.992325421972658,"B.LvsV.PLASARI_NFIC_TARGETS_BASAL_UP"
37,"Down",0.98251895368365,0.992325421972658,"B.LvsV.REACTOME_BIOSYNTHESIS_OF_MARESIN_LIKE_SPMS"
79,"Down",0.98261747598358,0.992325421972658,"B.LvsV.YOKOE_CANCER_TESTIS_ANTIGENS"
14,"Up",0.982633692403745,0.992325421972658,"B.LvsV.REACTOME_IRAK4_DEFICIENCY_TLR2_4"
20,"Down",0.983402479120957,0.992706931812549,"B.LvsV.REACTOME_SUPPRESSION_OF_PHAGOSOMAL_MATURATION"
28,"Up",0.983576262130577,0.992706931812549,"B.LvsV.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_23"
33,"Down",0.983798953416068,0.992706931812549,"B.LvsV.BIOCARTA_G2_PATHWAY"
11,"Down",0.984018759977175,0.992706931812549,"B.LvsV.REACTOME_ERYTHROPOIETIN_ACTIVATES_PHOSPHOLIPASE_C_GAMMA_PLCG"
55,"Down",0.984252420909046,0.992706931812549,"B.LvsV.WONG_ENDMETRIUM_CANCER_UP"
73,"Down",0.984430068852939,0.992706931812549,"B.LvsV.SCHLESINGER_H3K27ME3_IN_NORMAL_AND_METHYLATED_IN_CANCER"
33,"Up",0.984460387798575,0.992706931812549,"B.LvsV.PIEPOLI_LGI1_TARGETS_UP"
40,"Down",0.984591354672518,0.992706931812549,"B.LvsV.REACTOME_NEF_MEDIATED_DOWNREGULATION_OF_MHC_CLASS_I_COMPLEX_CELL_SURFACE_EXPRESSION"
212,"Down",0.984650441975983,0.992706931812549,"B.LvsV.REACTOME_SCAVENGING_OF_HEME_FROM_PLASMA"
44,"Down",0.984806930908271,0.992706931812549,"B.LvsV.REACTOME_NEGATIVE_REGULATION_OF_FGFR2_SIGNALING"
41,"Up",0.985119049654201,0.992739518248336,"B.LvsV.BIOCARTA_MHC_PATHWAY"
81,"Up",0.985198360757573,0.992739518248336,"B.LvsV.NEWMAN_ERCC6_TARGETS_DN"
8,"Down",0.986414770600154,0.993784122931533,"B.LvsV.CHOI_ATL_ACUTE_STAGE"
504,"Up",0.987818344990616,0.994616973016708,"B.LvsV.FARMER_BREAST_CANCER_BASAL_VS_LULMINAL"
110,"Down",0.988076774279867,0.994616973016708,"B.LvsV.TOOKER_GEMCITABINE_RESISTANCE_UP"
56,"Down",0.988191887709961,0.994616973016708,"B.LvsV.KEGG_BLADDER_CANCER"
65,"Down",0.988315314343019,0.994616973016708,"B.LvsV.PID_TCPTP_PATHWAY"
51,"Down",0.988322469452659,0.994616973016708,"B.LvsV.JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_UP"
10,"Down",0.988397936216195,0.994616973016708,"B.LvsV.BIOCARTA_MSP_PATHWAY"
16,"Down",0.988599510233038,0.994616973016708,"B.LvsV.BIOCARTA_CFTR_PATHWAY"
39,"Up",0.988798667893772,0.994616973016708,"B.LvsV.REACTOME_NEGATIVE_REGULATION_OF_FGFR4_SIGNALING"
425,"Down",0.988878615599652,0.994616973016708,"B.LvsV.ALFANO_MYC_TARGETS"
13,"Down",0.989040354068704,0.994616973016708,"B.LvsV.SASAKI_TARGETS_OF_TP73_AND_TP63"
12,"Down",0.989702296441103,0.995101654304938,"B.LvsV.REACTOME_REGULATION_OF_SIGNALING_BY_NODAL"
15,"Down",0.989954253195524,0.995117553764324,"B.LvsV.KEGG_GLYCOSPHINGOLIPID_BIOSYNTHESIS_GANGLIO_SERIES"
28,"Down",0.990183288571269,0.995117553764324,"B.LvsV.REACTOME_INTERLEUKIN_37_SIGNALING"
134,"Up",0.990258054044368,0.995117553764324,"B.LvsV.MIKKELSEN_IPS_ICP_WITH_H3K27ME3"
26,"Up",0.990709421774617,0.995390222240934,"B.LvsV.REACTOME_ACTIVATED_TAK1_MEDIATES_P38_MAPK_ACTIVATION"
131,"Up",0.990905923723151,0.995406768216807,"B.LvsV.DITTMER_PTHLH_TARGETS_DN"
144,"Down",0.991464945652458,0.995680760633586,"B.LvsV.REACTOME_ANCHORING_OF_THE_BASAL_BODY_TO_THE_PLASMA_MEMBRANE"
89,"Down",0.991538843922685,0.995680760633586,"B.LvsV.REACTOME_CONSTITUTIVE_SIGNALING_BY_ABERRANT_PI3K_IN_CANCER"
54,"Up",0.991830348314558,0.995792626807915,"B.LvsV.BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_UP"
1893,"Down",0.993285448334395,0.996913429226746,"B.LvsV.DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_UP"
28,"Up",0.993307303601038,0.996913429226746,"B.LvsV.SCHAVOLT_TARGETS_OF_TP53_AND_TP63"
30,"Down",0.993660875613907,0.996963330912966,"B.LvsV.REACTOME_OTHER_INTERLEUKIN_SIGNALING"
150,"Down",0.993847849156013,0.996963330912966,"B.LvsV.TANAKA_METHYLATED_IN_ESOPHAGEAL_CARCINOMA"
165,"Up",0.993897970698547,0.996963330912966,"B.LvsV.FURUKAWA_DUSP6_TARGETS_PCI35_UP"
153,"Down",0.994662909339407,0.997274713903665,"B.LvsV.REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION"
44,"Up",0.994699543281198,0.997274713903665,"B.LvsV.REACTOME_BETA_DEFENSINS"
65,"Up",0.994749511155491,0.997274713903665,"B.LvsV.REACTOME_INSULIN_RECEPTOR_SIGNALLING_CASCADE"
317,"Up",0.995084194472723,0.997341104709642,"B.LvsV.TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP"
174,"Down",0.995176501118303,0.997341104709642,"B.LvsV.UDAYAKUMAR_MED1_TARGETS_UP"
18,"Down",0.995728870752898,0.997681837191589,"B.LvsV.REACTOME_BLOOD_GROUP_SYSTEMS_BIOSYNTHESIS"
113,"Down",0.995926892157264,0.997681837191589,"B.LvsV.JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN"
143,"Up",0.996057829860295,0.997681837191589,"B.LvsV.SAFFORD_T_LYMPHOCYTE_ANERGY"
237,"Up",0.99770185649581,0.998798937534324,"B.LvsV.DAZARD_UV_RESPONSE_CLUSTER_G6"
59,"Up",0.997808176682079,0.998798937534324,"B.LvsV.WENG_POR_TARGETS_GLOBAL_DN"
52,"Up",0.997893381226848,0.998798937534324,"B.LvsV.BIOCARTA_IL2RB_PATHWAY"
91,"Up",0.997938655892306,0.998798937534324,"B.LvsV.ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_UP"
30,"Down",0.998146761979057,0.998798937534324,"B.LvsV.BIOCARTA_CARDIACEGF_PATHWAY"
160,"Up",0.998256995625732,0.998798937534324,"B.LvsV.REACTOME_PTEN_REGULATION"
148,"Down",0.998788465194961,0.99914988674922,"B.LvsV.SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_DN"
13,"Down",0.999123678537936,0.999304417264155,"B.LvsV.FUNG_IL2_SIGNALING_2"
33,"Up",0.999652892799175,0.999652892799175,"B.LvsV.GHO_ATF5_TARGETS_DN"
110,"Down",2.37815855557769e-25,1.3148838653789e-21,"L.LvsP.REACTOME_EUKARYOTIC_TRANSLATION_ELONGATION"
104,"Down",1.72517995621373e-24,4.76925998895287e-21,"L.LvsP.KEGG_RIBOSOME"
140,"Down",2.45114778413247e-23,4.51746536615615e-20,"L.LvsP.REACTOME_NONSENSE_MEDIATED_DECAY_NMD"
119,"Down",1.41198986719993e-20,1.9517229939371e-17,"L.LvsP.REACTOME_RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY"
160,"Down",1.3304985610931e-19,1.47126530885675e-16,"L.LvsP.REACTOME_EUKARYOTIC_TRANSLATION_INITIATION"
84,"Down",2.72012887542779e-19,2.33811039834544e-16,"L.LvsP.BILANGES_SERUM_AND_RAPAMYCIN_SENSITIVE_GENES"
29,"Up",2.96016870834112e-19,2.33811039834544e-16,"L.LvsP.HORTON_SREBF_TARGETS"
225,"Down",5.08381774235534e-17,3.51355353718533e-14,"L.LvsP.REACTOME_RRNA_PROCESSING"
135,"Down",7.37675828983013e-15,4.53178850938564e-12,"L.LvsP.REACTOME_SELENOAMINO_ACID_METABOLISM"
189,"Up",4.8897318673824e-14,2.70353274947573e-11,"L.LvsP.REACTOME_THE_CITRIC_ACID_TCA_CYCLE_AND_RESPIRATORY_ELECTRON_TRANSPORT"
133,"Up",6.16927007014197e-14,3.10089947434681e-11,"L.LvsP.REACTOME_RESPIRATORY_ELECTRON_TRANSPORT_ATP_SYNTHESIS_BY_CHEMIOSMOTIC_COUPLING_AND_HEAT_PRODUCTION_BY_UNCOUPLING_PROTEINS"
35,"Up",9.12070063179973e-14,4.20236281610172e-11,"L.LvsP.SCHMIDT_POR_TARGETS_IN_LIMB_BUD_UP"
94,"Up",1.33670390230953e-13,5.68510451989951e-11,"L.LvsP.MOOTHA_VOXPHOS"
139,"Up",7.62154964483777e-13,3.00996771330772e-10,"L.LvsP.KEGG_OXIDATIVE_PHOSPHORYLATION"
29,"Up",9.18431690247857e-13,3.3853392102536e-10,"L.LvsP.REACTOME_CHOLESTEROL_BIOSYNTHESIS"
108,"Up",1.24331979150859e-12,4.29644695453187e-10,"L.LvsP.REACTOME_RESPIRATORY_ELECTRON_TRANSPORT"
84,"Down",1.54993618273563e-12,5.04093950255605e-10,"L.LvsP.REACTOME_ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S"
46,"Up",2.30714891961801e-12,7.08679243142664e-10,"L.LvsP.KEGG_N_GLYCAN_BIOSYNTHESIS"
189,"Down",3.53289914993953e-12,1.0280736526324e-09,"L.LvsP.REACTOME_INFLUENZA_INFECTION"
59,"Up",7.1368652694068e-12,1.97298640372751e-09,"L.LvsP.REACTOME_COMPLEX_I_BIOGENESIS"
67,"Up",8.36816070195527e-12,2.20321716767194e-09,"L.LvsP.MORI_PLASMA_CELL_UP"
219,"Down",2.60441486555723e-11,6.54536808712088e-09,"L.LvsP.REACTOME_REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS"
278,"Down",3.51025317926769e-11,8.43834340355263e-09,"L.LvsP.REACTOME_SIGNALING_BY_ROBO_RECEPTORS"
83,"Down",3.74113135365175e-11,8.61863135597523e-09,"L.LvsP.CHNG_MULTIPLE_MYELOMA_HYPERPLOID_UP"
21,"Up",1.70445799927307e-10,3.76957931119232e-08,"L.LvsP.REACTOME_BRANCHED_CHAIN_AMINO_ACID_CATABOLISM"
63,"Up",3.77453399889623e-10,8.0266917230374e-08,"L.LvsP.KAUFFMANN_MELANOMA_RELAPSE_UP"
414,"Up",4.9390584781854e-10,1.0114094194773e-07,"L.LvsP.DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP"
125,"Up",5.9417441721927e-10,1.17328226885905e-07,"L.LvsP.CROONQUIST_IL6_DEPRIVATION_DN"
69,"Up",9.23220141444374e-10,1.76016695242964e-07,"L.LvsP.KANG_DOXORUBICIN_RESISTANCE_UP"
17,"Up",1.16715269551131e-09,2.15106241782735e-07,"L.LvsP.KEGG_STEROID_BIOSYNTHESIS"
775,"Down",1.93833315453231e-09,3.4571109714223e-07,"L.LvsP.REACTOME_METABOLISM_OF_RNA"
56,"Down",2.21394715547864e-09,3.82528556957544e-07,"L.LvsP.FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_UP"
186,"Up",2.58931776518211e-09,4.33828421930057e-07,"L.LvsP.ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER"
12,"Up",8.14071037932583e-09,1.32382316727331e-06,"L.LvsP.BIOCARTA_MALATEX_PATHWAY"
78,"Up",1.0439411619167e-08,1.64912876692499e-06,"L.LvsP.REACTOME_BIOSYNTHESIS_OF_THE_N_GLYCAN_PRECURSOR_DOLICHOL_LIPID_LINKED_OLIGOSACCHARIDE_LLO_AND_TRANSFER_TO_A_NASCENT_PROTEIN"
47,"Up",1.16257676446732e-08,1.78552414742773e-06,"L.LvsP.WHITFIELD_CELL_CYCLE_LITERATURE"
77,"Down",1.30176011268194e-08,1.9452518008158e-06,"L.LvsP.PID_ECADHERIN_STABILIZATION_PATHWAY"
135,"Up",1.68293704709158e-08,2.44867340351826e-06,"L.LvsP.KEGG_PARKINSONS_DISEASE"
25,"Down",1.80639702462489e-08,2.56091516644898e-06,"L.LvsP.REACTOME_CELL_EXTRACELLULAR_MATRIX_INTERACTIONS"
108,"Up",2.59751702136011e-08,3.55137803928775e-06,"L.LvsP.REN_BOUND_BY_E2F"
18,"Up",2.63350514759989e-08,3.55137803928775e-06,"L.LvsP.REACTOME_FORMATION_OF_ATP_BY_CHEMIOSMOTIC_COUPLING"
251,"Up",3.03651195497512e-08,3.96979066249798e-06,"L.LvsP.WONG_MITOCHONDRIA_GENE_MODULE"
137,"Down",3.0873756282766e-08,3.96979066249798e-06,"L.LvsP.REACTOME_SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE"
45,"Up",3.6492591367518e-08,4.58562585615924e-06,"L.LvsP.KEGG_PYRUVATE_METABOLISM"
58,"Up",3.88198969725766e-08,4.76967134136392e-06,"L.LvsP.ISHIDA_E2F_TARGETS"
56,"Up",4.39773588905664e-08,5.28588733273787e-06,"L.LvsP.ZHAN_MULTIPLE_MYELOMA_PR_UP"
70,"Down",4.96429572504154e-08,5.83991299228823e-06,"L.LvsP.YAMASHITA_LIVER_CANCER_WITH_EPCAM_UP"
116,"Down",5.12847649070024e-08,5.90736385772533e-06,"L.LvsP.REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX3"
138,"Down",5.39850641295437e-08,6.09149835861729e-06,"L.LvsP.KEGG_TIGHT_JUNCTION"
107,"Up",5.92618804196487e-08,6.55317873680476e-06,"L.LvsP.GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN"
63,"Up",6.4006773321741e-08,6.93908724893933e-06,"L.LvsP.REACTOME_SYNTHESIS_OF_SUBSTRATES_IN_N_GLYCAN_BIOSYTHESIS"
276,"Down",6.6060309673186e-08,7.02398946505856e-06,"L.LvsP.JISON_SICKLE_CELL_DISEASE_DN"
77,"Down",6.87597526784025e-08,7.17306929356392e-06,"L.LvsP.REACTOME_NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION"
42,"Up",8.44053082270551e-08,8.64216572569236e-06,"L.LvsP.REACTOME_FATTY_ACYL_COA_BIOSYNTHESIS"
78,"Down",9.65021393041376e-08,9.5952982082728e-06,"L.LvsP.NAGASHIMA_EGF_SIGNALING_UP"
20,"Down",9.71851509609833e-08,9.5952982082728e-06,"L.LvsP.REACTOME_BETA_CATENIN_PHOSPHORYLATION_CASCADE"
33,"Up",1.08398330490503e-07,1.05146380575788e-05,"L.LvsP.KEGG_CITRATE_CYCLE_TCA_CYCLE"
11,"Up",1.10773433947798e-07,1.05597640740927e-05,"L.LvsP.REACTOME_BIOTIN_TRANSPORT_AND_METABOLISM"
61,"Down",1.34004985263843e-07,1.25578570088777e-05,"L.LvsP.REACTOME_RRNA_MODIFICATION_IN_THE_NUCLEUS_AND_CYTOSOL"
117,"Up",1.54713856363399e-07,1.42568818638872e-05,"L.LvsP.ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR"
17,"Down",1.63909484604821e-07,1.48566482029517e-05,"L.LvsP.REACTOME_PHOSPHORYLATION_SITE_MUTANTS_OF_CTNNB1_ARE_NOT_TARGETED_TO_THE_PROTEASOME_BY_THE_DESTRUCTION_COMPLEX"
93,"Up",1.72402011661126e-07,1.5374366491522e-05,"L.LvsP.VERNELL_RETINOBLASTOMA_PATHWAY_UP"
107,"Up",1.77053992311536e-07,1.553859561096e-05,"L.LvsP.REACTOME_BASE_EXCISION_REPAIR"
66,"Down",1.80887189885218e-07,1.56269573886777e-05,"L.LvsP.KEGG_PATHOGENIC_ESCHERICHIA_COLI_INFECTION"
47,"Down",1.88470078861026e-07,1.60315548618863e-05,"L.LvsP.REACTOME_NEGATIVE_REGULATION_OF_MAPK_PATHWAY"
17,"Up",2.04397526008998e-07,1.7122938201572e-05,"L.LvsP.KEGG_TERPENOID_BACKBONE_BIOSYNTHESIS"
23,"Up",2.12832336257891e-07,1.75634326443266e-05,"L.LvsP.REACTOME_DEFECTS_IN_VITAMIN_AND_COFACTOR_METABOLISM"
90,"Up",2.32933575145095e-07,1.89395549555475e-05,"L.LvsP.REACTOME_CONDENSATION_OF_PROPHASE_CHROMOSOMES"
43,"Up",2.54434100457102e-07,2.03879150931495e-05,"L.LvsP.REACTOME_HOMOLOGOUS_DNA_PAIRING_AND_STRAND_EXCHANGE"
96,"Down",2.68840318483575e-07,2.12345445842241e-05,"L.LvsP.REACTOME_DEGRADATION_OF_BETA_CATENIN_BY_THE_DESTRUCTION_COMPLEX"
33,"Down",2.98541849276382e-07,2.3036021622544e-05,"L.LvsP.REACTOME_DEADENYLATION_OF_MRNA"
51,"Down",2.99980748204589e-07,2.3036021622544e-05,"L.LvsP.BILANGES_SERUM_RESPONSE_TRANSLATION"
166,"Down",3.43174412033558e-07,2.59919359470348e-05,"L.LvsP.KEGG_SPLICEOSOME"
60,"Up",3.49038413371104e-07,2.60788295612004e-05,"L.LvsP.REACTOME_PYRUVATE_METABOLISM_AND_CITRIC_ACID_TCA_CYCLE"
266,"Up",3.72855502930459e-07,2.74869076760334e-05,"L.LvsP.FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_DN"
243,"Down",3.96726063304165e-07,2.87448256046607e-05,"L.LvsP.REACTOME_MRNA_SPLICING"
240,"Down",4.00316797171075e-07,2.87448256046607e-05,"L.LvsP.NAGASHIMA_NRG1_SIGNALING_UP"
101,"Up",4.17003214111555e-07,2.89101222857486e-05,"L.LvsP.REACTOME_MEIOTIC_RECOMBINATION"
37,"Down",4.18163106932744e-07,2.89101222857486e-05,"L.LvsP.BIOCARTA_RHO_PATHWAY"
31,"Up",4.18305260057857e-07,2.89101222857486e-05,"L.LvsP.REACTOME_CRISTAE_FORMATION"
189,"Up",4.35339220223854e-07,2.94019983404191e-05,"L.LvsP.KEGG_ALZHEIMERS_DISEASE"
167,"Up",4.36057852037324e-07,2.94019983404191e-05,"L.LvsP.KONG_E2F3_TARGETS"
42,"Down",4.51163759216748e-07,3.00540292133663e-05,"L.LvsP.REACTOME_EGFR_DOWNREGULATION"
69,"Up",5.17076378367583e-07,3.40347059046948e-05,"L.LvsP.REACTOME_HDR_THROUGH_HOMOLOGOUS_RECOMBINATION_HRR"
33,"Up",5.28978571942507e-07,3.44085002855308e-05,"L.LvsP.REACTOME_RESOLUTION_OF_D_LOOP_STRUCTURES"
96,"Up",5.5876967458005e-07,3.55183895552875e-05,"L.LvsP.REACTOME_MITOCHONDRIAL_TRANSLATION"
22,"Up",5.588894721125e-07,3.55183895552875e-05,"L.LvsP.EGUCHI_CELL_CYCLE_RB1_TARGETS"
34,"Down",5.89888548681528e-07,3.70624293825019e-05,"L.LvsP.REACTOME_RHO_GTPASES_ACTIVATE_ROCKS"
92,"Up",6.09483261657811e-07,3.78632916146746e-05,"L.LvsP.OLSSON_E2F3_TARGETS_DN"
71,"Up",6.35580341351431e-07,3.90458189703562e-05,"L.LvsP.REACTOME_RECOGNITION_AND_ASSOCIATION_OF_DNA_GLYCOSYLASE_WITH_SITE_CONTAINING_AN_AFFECTED_PURINE"
101,"Up",6.71287179879486e-07,4.07862287643262e-05,"L.LvsP.REACTOME_COPII_MEDIATED_VESICLE_TRANSPORT"
214,"Down",6.92150770134919e-07,4.15967566095214e-05,"L.LvsP.RASHI_RESPONSE_TO_IONIZING_RADIATION_2"
35,"Up",7.47582675661676e-07,4.44449958465957e-05,"L.LvsP.KEGG_DNA_REPLICATION"
47,"Down",7.56097187074899e-07,4.44729930567779e-05,"L.LvsP.REACTOME_SEMA4D_IN_SEMAPHORIN_SIGNALING"
8,"Up",7.86274218839531e-07,4.57611595364607e-05,"L.LvsP.REACTOME_CHREBP_ACTIVATES_METABOLIC_GENE_EXPRESSION"
362,"Up",8.10357742878467e-07,4.66715412539067e-05,"L.LvsP.REACTOME_ASPARAGINE_N_LINKED_GLYCOSYLATION"
196,"Up",8.55844700976736e-07,4.87466521913712e-05,"L.LvsP.SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP"
9,"Up",8.64020964867857e-07,4.87466521913712e-05,"L.LvsP.REACTOME_DEFECTS_IN_BIOTIN_BTN_METABOLISM"
102,"Down",8.73131796055028e-07,4.87630878827096e-05,"L.LvsP.KEGG_ADHERENS_JUNCTION"
82,"Down",1.07417833950052e-06,5.9391320390984e-05,"L.LvsP.PID_TGFBR_PATHWAY"
32,"Up",1.21833461180085e-06,6.66947729568999e-05,"L.LvsP.REACTOME_DNA_STRAND_ELONGATION"
27,"Down",1.31835563085829e-06,7.14032048446208e-05,"L.LvsP.REACTOME_TGF_BETA_RECEPTOR_SIGNALING_IN_EMT_EPITHELIAL_TO_MESENCHYMAL_TRANSITION"
34,"Down",1.33017364785602e-06,7.14032048446208e-05,"L.LvsP.REACTOME_CD209_DC_SIGN_SIGNALING"
107,"Down",1.41368795942948e-06,7.51565454585152e-05,"L.LvsP.REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX"
35,"Up",1.46210798363535e-06,7.66740528249986e-05,"L.LvsP.KEGG_PROTEIN_EXPORT"
43,"Down",1.46996737193884e-06,7.66740528249986e-05,"L.LvsP.REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN"
66,"Up",1.70563241150748e-06,8.81349682544377e-05,"L.LvsP.REACTOME_REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF"
27,"Down",1.84521190841398e-06,9.44645985335266e-05,"L.LvsP.REACTOME_LISTERIA_MONOCYTOGENES_ENTRY_INTO_HOST_CELLS"
303,"Down",1.88883315523864e-06,9.58106285808664e-05,"L.LvsP.REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA"
49,"Up",2.27283127839611e-06,0.000114240764893201,"L.LvsP.YU_MYC_TARGETS_UP"
64,"Down",2.39719903666317e-06,0.000119406427691087,"L.LvsP.REACTOME_REGULATION_OF_RUNX3_EXPRESSION_AND_ACTIVITY"
13,"Down",2.4784228793902e-06,0.000122350000894182,"L.LvsP.REACTOME_BINDING_OF_TCF_LEF_CTNNB1_TO_TARGET_GENE_PROMOTERS"
26,"Up",2.50502993737698e-06,0.000122439559762937,"L.LvsP.REACTOME_RESOLUTION_OF_D_LOOP_STRUCTURES_THROUGH_SYNTHESIS_DEPENDENT_STRAND_ANNEALING_SDSA"
132,"Down",2.53744005262811e-06,0.000122439559762937,"L.LvsP.REACTOME_SIGNALING_BY_TGF_BETA_FAMILY_MEMBERS"
171,"Up",2.54667197915314e-06,0.000122439559762937,"L.LvsP.REACTOME_HOMOLOGY_DIRECTED_REPAIR"
32,"Down",2.6869732725196e-06,0.000128071338135869,"L.LvsP.REACTOME_EPHRIN_SIGNALING"
718,"Down",2.97512082284224e-06,0.000140593530166622,"L.LvsP.REACTOME_NERVOUS_SYSTEM_DEVELOPMENT"
100,"Up",3.05067398807677e-06,0.000141852031823911,"L.LvsP.CROONQUIST_NRAS_SIGNALING_DN"
64,"Down",3.0530641683931e-06,0.000141852031823911,"L.LvsP.REACTOME_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER"
131,"Up",3.28621835453998e-06,0.00015141251068543,"L.LvsP.LEE_EARLY_T_LYMPHOCYTE_UP"
50,"Up",3.34585943883693e-06,0.000152886420143218,"L.LvsP.REACTOME_ACTIVATION_OF_GENE_EXPRESSION_BY_SREBF_SREBP"
38,"Down",3.48545934993758e-06,0.000157959874965614,"L.LvsP.LUI_THYROID_CANCER_CLUSTER_3"
16,"Down",3.57378206715735e-06,0.000160645862189537,"L.LvsP.REACTOME_ERKS_ARE_INACTIVATED"
58,"Up",3.73231942953087e-06,0.000165886695109302,"L.LvsP.ODONNELL_TARGETS_OF_MYC_AND_TFRC_DN"
157,"Up",3.75037744414229e-06,0.000165886695109302,"L.LvsP.BURTON_ADIPOGENESIS_5"
496,"Up",3.8828932786713e-06,0.000170385055061695,"L.LvsP.MOOTHA_HUMAN_MITODB_6_2002"
68,"Up",3.92157202023625e-06,0.000170727336219577,"L.LvsP.PID_FANCONI_PATHWAY"
50,"Down",4.10285490491879e-06,0.000176270709957922,"L.LvsP.REACTOME_SUMOYLATION_OF_TRANSCRIPTION_COFACTORS"
79,"Up",4.11852111638809e-06,0.000176270709957922,"L.LvsP.REACTOME_DNA_METHYLATION"
78,"Up",4.14454554069992e-06,0.000176270709957922,"L.LvsP.SONG_TARGETS_OF_IE86_CMV_PROTEIN"
79,"Up",4.34903608203399e-06,0.000183555881660809,"L.LvsP.REACTOME_BASE_EXCISION_REPAIR_AP_SITE_FORMATION"
102,"Down",4.62315431233347e-06,0.000193647122673422,"L.LvsP.REACTOME_SEMAPHORIN_INTERACTIONS"
21,"Up",4.73135007900359e-06,0.00019668898185572,"L.LvsP.REACTOME_PCNA_DEPENDENT_LONG_PATCH_BASE_EXCISION_REPAIR"
11,"Down",5.53997293613132e-06,0.000228585898237836,"L.LvsP.REACTOME_RUNX3_REGULATES_YAP1_MEDIATED_TRANSCRIPTION"
16,"Up",5.6519328841936e-06,0.000231478051234862,"L.LvsP.REACTOME_GOLGI_CISTERNAE_PERICENTRIOLAR_STACK_REORGANIZATION"
57,"Down",5.71252304852906e-06,0.000232239264230273,"L.LvsP.SIG_REGULATION_OF_THE_ACTIN_CYTOSKELETON_BY_RHO_GTPASES"
176,"Up",5.76462139001457e-06,0.000232646654491902,"L.LvsP.ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR"
32,"Up",5.86292380402067e-06,0.000234899316756741,"L.LvsP.REACTOME_GLYOXYLATE_METABOLISM_AND_GLYCINE_DEGRADATION"
37,"Down",6.27013377339122e-06,0.000249406975777554,"L.LvsP.REACTOME_DOWNREGULATION_OF_SMAD2_3_SMAD4_TRANSCRIPTIONAL_ACTIVITY"
55,"Down",7.38673346209936e-06,0.000289764339635356,"L.LvsP.ANDERSEN_LIVER_CANCER_KRT19_UP"
45,"Down",7.39155625291946e-06,0.000289764339635356,"L.LvsP.REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS"
69,"Down",7.44194903747884e-06,0.000289764339635356,"L.LvsP.PID_RHOA_PATHWAY"
36,"Down",7.56061374761884e-06,0.000292326107766326,"L.LvsP.REACTOME_SIGNALING_BY_EGFR_IN_CANCER"
117,"Down",8.34354852318953e-06,0.000317692123482865,"L.LvsP.PID_FAK_PATHWAY"
24,"Down",8.3635145823615e-06,0.000317692123482865,"L.LvsP.PID_P38_MK2_PATHWAY"
63,"Up",8.38904865771356e-06,0.000317692123482865,"L.LvsP.REACTOME_CARGO_CONCENTRATION_IN_THE_ER"
177,"Up",8.70946142212176e-06,0.000327582395938172,"L.LvsP.BURTON_ADIPOGENESIS_3"
62,"Up",9.0720267370991e-06,0.000338913755604195,"L.LvsP.GREENBAUM_E2A_TARGETS_UP"
83,"Up",9.62273344956339e-06,0.000357074451292859,"L.LvsP.REACTOME_SIRT1_NEGATIVELY_REGULATES_RRNA_EXPRESSION"
36,"Up",9.97144375793241e-06,0.000367547416917388,"L.LvsP.KEGG_PROPANOATE_METABOLISM"
43,"Down",1.04208118001233e-05,0.000381567340681336,"L.LvsP.BIOCARTA_WNT_PATHWAY"
19,"Down",1.06066844724004e-05,0.000385818147683563,"L.LvsP.DORN_ADENOVIRUS_INFECTION_24HR_UP"
206,"Down",1.10073031075665e-05,0.000397773718181277,"L.LvsP.HOLLERN_EMT_BREAST_TUMOR_DN"
114,"Down",1.11107212129844e-05,0.000398903750562276,"L.LvsP.AMIT_EGF_RESPONSE_120_HELA"
105,"Up",1.12714915594473e-05,0.000402065011820542,"L.LvsP.REACTOME_TELOMERE_MAINTENANCE"
92,"Down",1.15545315334301e-05,0.0004095192618483,"L.LvsP.TIEN_INTESTINE_PROBIOTICS_6HR_UP"
172,"Down",1.19105099494571e-05,0.000419447194334701,"L.LvsP.REACTOME_SIGNALING_BY_NTRKS"
124,"Up",1.21341822782919e-05,0.000424619581118204,"L.LvsP.REACTOME_G2_M_DNA_DAMAGE_CHECKPOINT"
38,"Up",1.26727769525825e-05,0.000440677885351124,"L.LvsP.REACTOME_ACTIVATION_OF_ATR_IN_RESPONSE_TO_REPLICATION_STRESS"
97,"Up",1.30688660318524e-05,0.000451611001813201,"L.LvsP.REACTOME_ACTIVATED_PKN1_STIMULATES_TRANSCRIPTION_OF_AR_ANDROGEN_RECEPTOR_REGULATED_GENES_KLK2_AND_KLK3"
36,"Down",1.32612005201547e-05,0.000454770205344757,"L.LvsP.REACTOME_RHO_GTPASES_ACTIVATE_PAKS"
334,"Down",1.33247916921415e-05,0.000454770205344757,"L.LvsP.KIM_WT1_TARGETS_UP"
223,"Up",1.36854545417088e-05,0.000464213976448516,"L.LvsP.WILCOX_RESPONSE_TO_PROGESTERONE_UP"
49,"Down",1.39908751316384e-05,0.000471680174407494,"L.LvsP.REACTOME_NGF_STIMULATED_TRANSCRIPTION"
42,"Down",1.41951382482514e-05,0.000473139689678532,"L.LvsP.REACTOME_SEMA4D_INDUCED_CELL_MIGRATION_AND_GROWTH_CONE_COLLAPSE"
45,"Up",1.42053153348953e-05,0.000473139689678532,"L.LvsP.XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_DN"
99,"Down",1.43277605581209e-05,0.000474360407939225,"L.LvsP.BIOCARTA_MAPK_PATHWAY"
27,"Up",1.51874548334223e-05,0.00049831752939799,"L.LvsP.REACTOME_CITRIC_ACID_CYCLE_TCA_CYCLE"
149,"Up",1.52316264185676e-05,0.00049831752939799,"L.LvsP.GAVIN_FOXP3_TARGETS_CLUSTER_P6"
204,"Up",1.57160581995238e-05,0.000511141681089218,"L.LvsP.REACTOME_DNA_DOUBLE_STRAND_BREAK_REPAIR"
23,"Down",1.58284536226616e-05,0.000511786667132726,"L.LvsP.REACTOME_SPRY_REGULATION_OF_FGF_SIGNALING"
23,"Down",1.60114066961895e-05,0.000514692253623442,"L.LvsP.BIOCARTA_PITX2_PATHWAY"
82,"Down",1.67939406196117e-05,0.000536726576218688,"L.LvsP.PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_1"
200,"Up",1.69073495127107e-05,0.000537245606067685,"L.LvsP.ODONNELL_TFRC_TARGETS_DN"
522,"Down",1.70975757657048e-05,0.000540185693763326,"L.LvsP.PASINI_SUZ12_TARGETS_DN"
154,"Down",1.79105122478098e-05,0.00056265467169398,"L.LvsP.PID_ERBB1_DOWNSTREAM_PATHWAY"
103,"Down",1.83596553981218e-05,0.00057350584574133,"L.LvsP.REACTOME_PCP_CE_PATHWAY"
92,"Down",1.91536087864529e-05,0.000594945522361227,"L.LvsP.KEGG_TGF_BETA_SIGNALING_PATHWAY"
60,"Down",1.93237228194062e-05,0.000596876332226238,"L.LvsP.REACTOME_DEGRADATION_OF_AXIN"
33,"Down",1.98921176435338e-05,0.000611019546950547,"L.LvsP.PID_P38_ALPHA_BETA_PATHWAY"
96,"Up",2.02547172970425e-05,0.000617508213474566,"L.LvsP.REACTOME_NONHOMOLOGOUS_END_JOINING_NHEJ"
174,"Down",2.03267308468749e-05,0.000617508213474566,"L.LvsP.KARLSSON_TGFB1_TARGETS_UP"
67,"Down",2.08808972507939e-05,0.000628753311709232,"L.LvsP.REACTOME_SIGNALING_BY_EGFR"
63,"Down",2.09768838798717e-05,0.000628753311709232,"L.LvsP.REACTOME_EPHB_MEDIATED_FORWARD_SIGNALING"
11,"Down",2.10380471452718e-05,0.000628753311709232,"L.LvsP.REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_DIFFERENTIATION_OF_MYELOID_CELLS"
130,"Down",2.12123865350235e-05,0.000630555296516907,"L.LvsP.KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION"
13,"Up",2.18417297094101e-05,0.000645791035098014,"L.LvsP.KUMAMOTO_RESPONSE_TO_NUTLIN_3A_DN"
276,"Down",2.22143699510728e-05,0.000653315167337666,"L.LvsP.AMIT_EGF_RESPONSE_480_HELA"
67,"Down",2.30861257376992e-05,0.000675360789437772,"L.LvsP.REACTOME_DECTIN_1_MEDIATED_NONCANONICAL_NF_KB_SIGNALING"
518,"Up",2.33057778223687e-05,0.000678198134630931,"L.LvsP.MOOTHA_MITOCHONDRIA"
34,"Up",2.39792522449647e-05,0.000694142856871256,"L.LvsP.REACTOME_PYRUVATE_METABOLISM"
8,"Down",2.47013118774413e-05,0.000711320590470693,"L.LvsP.FARMER_BREAST_CANCER_CLUSTER_8"
41,"Down",2.59055717149671e-05,0.000742134228041727,"L.LvsP.REACTOME_SMAD2_SMAD3_SMAD4_HETEROTRIMER_REGULATES_TRANSCRIPTION"
20,"Up",2.81330475939479e-05,0.000801791856427516,"L.LvsP.REACTOME_LAGGING_STRAND_SYNTHESIS"
125,"Down",2.85935551526904e-05,0.00080712279112798,"L.LvsP.REACTOME_CELL_JUNCTION_ORGANIZATION"
154,"Down",2.86120577068338e-05,0.00080712279112798,"L.LvsP.SASSON_RESPONSE_TO_GONADOTROPHINS_DN"
39,"Down",2.90215787153156e-05,0.000814519333588731,"L.LvsP.KOBAYASHI_EGFR_SIGNALING_6HR_DN"
19,"Down",3.02338789975855e-05,0.000840794627988782,"L.LvsP.REACTOME_INLB_MEDIATED_ENTRY_OF_LISTERIA_MONOCYTOGENES_INTO_HOST_CELL"
40,"Up",3.02619155307954e-05,0.000840794627988782,"L.LvsP.LY_AGING_MIDDLE_DN"
15,"Down",3.33242064733827e-05,0.000921247687956665,"L.LvsP.TURJANSKI_MAPK1_AND_MAPK2_TARGETS"
180,"Down",3.39868744351505e-05,0.000934892680357946,"L.LvsP.DAZARD_RESPONSE_TO_UV_SCC_DN"
66,"Down",3.47867131147737e-05,0.000952157112928633,"L.LvsP.REACTOME_SIGNALING_BY_ERBB2"
20,"Up",3.7454658421963e-05,0.00102013205130558,"L.LvsP.REACTOME_DISEASES_ASSOCIATED_WITH_GLYCOSYLATION_PRECURSOR_BIOSYNTHESIS"
63,"Down",3.92029758858766e-05,0.00105804725093598,"L.LvsP.APRELIKOVA_BRCA1_TARGETS"
36,"Up",3.9229460380155e-05,0.00105804725093598,"L.LvsP.FARMER_BREAST_CANCER_CLUSTER_2"
18,"Down",3.97283825951171e-05,0.0010663020746039,"L.LvsP.REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING"
8,"Down",4.0901273422348e-05,0.0010924789408317,"L.LvsP.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_6"
19,"Up",4.12990388430814e-05,0.00109779993155479,"L.LvsP.KEGG_GLYOXYLATE_AND_DICARBOXYLATE_METABOLISM"
73,"Up",4.2005532456673e-05,0.00110006325066648,"L.LvsP.REACTOME_MITOCHONDRIAL_PROTEIN_IMPORT"
21,"Up",4.20630405879882e-05,0.00110006325066648,"L.LvsP.REACTOME_CLASS_I_PEROXISOMAL_MEMBRANE_PROTEIN_IMPORT"
68,"Down",4.21748683157437e-05,0.00110006325066648,"L.LvsP.HALMOS_CEBPA_TARGETS_DN"
52,"Down",4.23897134260069e-05,0.00110006325066648,"L.LvsP.SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_DN"
121,"Down",4.24285685582391e-05,0.00110006325066648,"L.LvsP.DELPUECH_FOXO3_TARGETS_UP"
8,"Down",4.25779590599795e-05,0.00110006325066648,"L.LvsP.REACTOME_RUNX3_REGULATES_BCL2L11_BIM_TRANSCRIPTION"
11,"Up",4.39309749382421e-05,0.00112974121131879,"L.LvsP.KALMA_E2F1_TARGETS"
34,"Down",4.44621734732696e-05,0.00113810813487828,"L.LvsP.REACTOME_COOPERATION_OF_PREFOLDIN_AND_TRIC_CCT_IN_ACTIN_AND_TUBULIN_FOLDING"
130,"Up",4.61788043294613e-05,0.00117305658173301,"L.LvsP.REACTOME_PROCESSING_OF_DNA_DOUBLE_STRAND_BREAK_ENDS"
25,"Up",4.62518239858557e-05,0.00117305658173301,"L.LvsP.REACTOME_RESOLUTION_OF_AP_SITES_VIA_THE_MULTIPLE_NUCLEOTIDE_PATCH_REPLACEMENT_PATHWAY"
335,"Up",4.67976431930403e-05,0.00118148022472292,"L.LvsP.KOBAYASHI_EGFR_SIGNALING_24HR_DN"
60,"Down",5.06219169824228e-05,0.00127222081361734,"L.LvsP.REACTOME_AGGREPHAGY"
35,"Down",5.11058818052043e-05,0.0012731590344174,"L.LvsP.REACTOME_DOWNREGULATION_OF_TGF_BETA_RECEPTOR_SIGNALING"
76,"Up",5.11197876000474e-05,0.0012731590344174,"L.LvsP.HAHTOLA_MYCOSIS_FUNGOIDES_UP"
135,"Up",5.49946295590815e-05,0.00136352155530117,"L.LvsP.REACTOME_CHROMOSOME_MAINTENANCE"
87,"Down",5.8007490338532e-05,0.00142989364368718,"L.LvsP.PID_HDAC_CLASSI_PATHWAY"
89,"Up",5.81888352015945e-05,0.00142989364368718,"L.LvsP.REACTOME_DEPOSITION_OF_NEW_CENPA_CONTAINING_NUCLEOSOMES_AT_THE_CENTROMERE"
93,"Up",5.90057386755858e-05,0.00144355189883767,"L.LvsP.KEGG_PEROXISOME"
800,"Up",6.0204689974596e-05,0.00146539418254156,"L.LvsP.MARSON_BOUND_BY_E2F4_UNSTIMULATED"
36,"Down",6.04286260841882e-05,0.00146539418254156,"L.LvsP.PID_ECADHERIN_KERATINOCYTE_PATHWAY"
34,"Down",6.39640604174985e-05,0.00154435497837707,"L.LvsP.LAMB_CCND1_TARGETS"
171,"Down",6.52113915606755e-05,0.00156762514756076,"L.LvsP.KEGG_WNT_SIGNALING_PATHWAY"
91,"Down",6.92788058809103e-05,0.00165514439372263,"L.LvsP.REACTOME_SIGNALING_BY_FGFR2"
18,"Down",6.9450804728459e-05,0.00165514439372263,"L.LvsP.REACTOME_APOPTOTIC_CLEAVAGE_OF_CELL_ADHESION_PROTEINS"
18,"Down",7.22378385200778e-05,0.00171417600505369,"L.LvsP.REACTOME_CONSTITUTIVE_SIGNALING_BY_OVEREXPRESSED_ERBB2"
67,"Down",7.50084729467502e-05,0.00177231558513924,"L.LvsP.PID_NFAT_3PATHWAY"
43,"Up",7.56621650779531e-05,0.00177690156374418,"L.LvsP.WANG_CLASSIC_ADIPOGENIC_TARGETS_OF_PPARG"
78,"Down",7.58453190529258e-05,0.00177690156374418,"L.LvsP.PID_RAC1_PATHWAY"
15,"Down",7.73850875370608e-05,0.00179906183653404,"L.LvsP.REACTOME_DOWNREGULATION_OF_ERBB4_SIGNALING"
14,"Down",7.74419817498826e-05,0.00179906183653404,"L.LvsP.REACTOME_INLA_MEDIATED_ENTRY_OF_LISTERIA_MONOCYTOGENES_INTO_HOST_CELLS"
49,"Down",7.83697320051108e-05,0.00181299685462869,"L.LvsP.PID_IL2_PI3K_PATHWAY"
23,"Down",8.22802130761247e-05,0.00189553040874122,"L.LvsP.BIOCARTA_PS1_PATHWAY"
60,"Down",8.33577240672854e-05,0.00191238529613287,"L.LvsP.LUI_THYROID_CANCER_PAX8_PPARG_DN"
109,"Down",8.73650400989541e-05,0.00199603845746743,"L.LvsP.REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS"
201,"Up",9.12984954777363e-05,0.00207732255759837,"L.LvsP.KEGG_HUNTINGTONS_DISEASE"
117,"Up",9.28249453764812e-05,0.0021033980450269,"L.LvsP.TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_UP"
18,"Up",9.39461905518404e-05,0.0021201162757597,"L.LvsP.REACTOME_DISEASES_ASSOCIATED_WITH_N_GLYCOSYLATION_OF_PROTEINS"
104,"Up",9.60207873645495e-05,0.00215812574527884,"L.LvsP.REACTOME_COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC"
235,"Up",9.67246219471773e-05,0.0021634138914897,"L.LvsP.REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION"
74,"Down",9.70386408192161e-05,0.0021634138914897,"L.LvsP.REACTOME_ASYMMETRIC_LOCALIZATION_OF_PCP_PROTEINS"
42,"Down",0.000102439903077945,0.00227465953461028,"L.LvsP.REACTOME_RAF_ACTIVATION"
33,"Up",0.000106213675633157,0.00234902165030291,"L.LvsP.REACTOME_SIALIC_ACID_METABOLISM"
243,"Down",0.000106720489893835,0.00235082704630682,"L.LvsP.KEGG_REGULATION_OF_ACTIN_CYTOSKELETON"
290,"Down",0.000113551866763503,0.00249012467748444,"L.LvsP.KEGG_MAPK_SIGNALING_PATHWAY"
7,"Up",0.000113944934600029,0.00249012467748444,"L.LvsP.ZERBINI_RESPONSE_TO_SULINDAC_DN"
30,"Down",0.0001185263647024,0.0025800483088172,"L.LvsP.REACTOME_CONSTITUTIVE_SIGNALING_BY_LIGAND_RESPONSIVE_EGFR_CANCER_VARIANTS"
256,"Up",0.000122022897354934,0.00264564115646152,"L.LvsP.BURTON_ADIPOGENESIS_6"
349,"Down",0.000122578367551987,0.00264564115646152,"L.LvsP.REACTOME_MAPK_FAMILY_SIGNALING_CASCADES"
27,"Down",0.000123079349882911,0.00264564115646152,"L.LvsP.REACTOME_ERK_MAPK_TARGETS"
143,"Down",0.000123789876311434,0.00264564115646152,"L.LvsP.SASSON_RESPONSE_TO_FORSKOLIN_DN"
317,"Up",0.000123932186566021,0.00264564115646152,"L.LvsP.FISCHER_G1_S_CELL_CYCLE"
185,"Up",0.000126944332361588,0.00269952005241238,"L.LvsP.WHITEFORD_PEDIATRIC_CANCER_MARKERS"
22,"Down",0.000128344706261859,0.00271243559764385,"L.LvsP.TAGHAVI_NEOPLASTIC_TRANSFORMATION"
47,"Up",0.00012896110561376,0.00271243559764385,"L.LvsP.KAMMINGA_EZH2_TARGETS"
79,"Up",0.000129023433203171,0.00271243559764385,"L.LvsP.PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_UP"
143,"Down",0.000134205324355624,0.00280162255304474,"L.LvsP.KEGG_NEUROTROPHIN_SIGNALING_PATHWAY"
36,"Down",0.000134279250598093,0.00280162255304474,"L.LvsP.PID_MYC_PATHWAY"
188,"Down",0.000135408429820426,0.00281456093412457,"L.LvsP.PID_PDGFRB_PATHWAY"
19,"Up",0.000137999927267849,0.00285768388713086,"L.LvsP.MOOTHA_TCA"
65,"Down",0.000140371448175337,0.00289594677970687,"L.LvsP.AMIT_EGF_RESPONSE_120_MCF10A"
452,"Down",0.000142179531382916,0.00292234434578491,"L.LvsP.REACTOME_DISEASES_OF_SIGNAL_TRANSDUCTION_BY_GROWTH_FACTOR_RECEPTORS_AND_SECOND_MESSENGERS"
52,"Up",0.000144236920440006,0.00295365160412146,"L.LvsP.SANCHEZ_MDM2_TARGETS"
66,"Up",0.000147429763007556,0.00300667507972736,"L.LvsP.BOYAULT_LIVER_CANCER_SUBCLASS_G23_UP"
119,"Down",0.000147913840058933,0.00300667507972736,"L.LvsP.REACTOME_EPH_EPHRIN_SIGNALING"
51,"Down",0.000152868568246686,0.00309503061762963,"L.LvsP.BIOCARTA_AGR_PATHWAY"
48,"Down",0.000153491761863459,0.00309503061762963,"L.LvsP.REACTOME_LATE_ENDOSOMAL_MICROAUTOPHAGY"
278,"Up",0.000153939848046328,0.00309503061762963,"L.LvsP.FUJII_YBX1_TARGETS_DN"
13,"Down",0.000157059250129603,0.0031463064998789,"L.LvsP.REACTOME_REGULATION_OF_LOCALIZATION_OF_FOXO_TRANSCRIPTION_FACTORS"
221,"Up",0.000158863454757549,0.00317096043810284,"L.LvsP.HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP"
50,"Down",0.000166804623559844,0.00331749195562005,"L.LvsP.LOPEZ_TRANSLATION_VIA_FN1_SIGNALING"
735,"Up",0.0001684728974902,0.0033384325568346,"L.LvsP.GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP"
54,"Down",0.000169065132196363,0.0033384325568346,"L.LvsP.REACTOME_SMOOTH_MUSCLE_CONTRACTION"
27,"Down",0.00017213835131456,0.00338702115451318,"L.LvsP.REACTOME_SHC1_EVENTS_IN_ERBB2_SIGNALING"
12,"Down",0.000176396333243278,0.00345113352271918,"L.LvsP.ZERBINI_RESPONSE_TO_SULINDAC_UP"
226,"Up",0.000176645105250412,0.00345113352271918,"L.LvsP.WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_WITH_H4K20ME1_MARK"
342,"Down",0.000177846032661684,0.00346236167107906,"L.LvsP.ZWANG_CLASS_3_TRANSIENTLY_INDUCED_BY_EGF"
23,"Down",0.000179775312960099,0.00348764107142592,"L.LvsP.BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER"
88,"Up",0.000183629440373447,0.00354995516022653,"L.LvsP.REACTOME_PRC2_METHYLATES_HISTONES_AND_DNA"
48,"Down",0.000187300148964788,0.00360830147604987,"L.LvsP.REACTOME_EPHA_MEDIATED_GROWTH_CONE_COLLAPSE"
39,"Up",0.000188350141444114,0.00361593031959898,"L.LvsP.REACTOME_RESOLUTION_OF_ABASIC_SITES_AP_SITES"
55,"Up",0.000190193457707807,0.00363868383275594,"L.LvsP.STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_DN"
175,"Down",0.000193061014812984,0.00367501039459775,"L.LvsP.REACTOME_CELL_CELL_COMMUNICATION"
48,"Down",0.000193421599715671,0.00367501039459775,"L.LvsP.AIGNER_ZEB1_TARGETS"
22,"Down",0.0001972727520245,0.00373534604775157,"L.LvsP.PID_ARF6_DOWNSTREAM_PATHWAY"
102,"Down",0.000203161247140011,0.00382560440160763,"L.LvsP.REACTOME_SIGNALING_BY_NOTCH4"
67,"Down",0.00020351317302365,0.00382560440160763,"L.LvsP.REACTOME_AUF1_HNRNP_D0_BINDS_AND_DESTABILIZES_MRNA"
23,"Down",0.000204115264690586,0.00382560440160763,"L.LvsP.REACTOME_CTLA4_INHIBITORY_SIGNALING"
61,"Down",0.000206263533072871,0.00385280768364832,"L.LvsP.GENTILE_UV_RESPONSE_CLUSTER_D2"
9,"Down",0.000210827145310181,0.00392479221016832,"L.LvsP.REACTOME_RUNX1_REGULATES_EXPRESSION_OF_COMPONENTS_OF_TIGHT_JUNCTIONS"
12,"Down",0.000211926621021736,0.00393202109942677,"L.LvsP.REACTOME_FOLDING_OF_ACTIN_BY_CCT_TRIC"
318,"Down",0.000213765053183323,0.00395286615067087,"L.LvsP.REACTOME_FLT3_SIGNALING"
65,"Down",0.000223262076376596,0.00409292933612912,"L.LvsP.WONG_PROTEASOME_GENE_MODULE"
53,"Down",0.000223528805626083,0.00409292933612912,"L.LvsP.BIOCARTA_P38MAPK_PATHWAY"
54,"Up",0.000223560256739192,0.00409292933612912,"L.LvsP.NAKAMURA_CANCER_MICROENVIRONMENT_DN"
40,"Down",0.000230477477769269,0.00420564348048279,"L.LvsP.REACTOME_MAPK_TARGETS_NUCLEAR_EVENTS_MEDIATED_BY_MAP_KINASES"
13,"Up",0.00023704245694714,0.00431120968572611,"L.LvsP.REACTOME_PROCESSIVE_SYNTHESIS_ON_THE_C_STRAND_OF_THE_TELOMERE"
13,"Down",0.000251817825707887,0.00456492051914396,"L.LvsP.REACTOME_PREVENTION_OF_PHAGOSOMAL_LYSOSOMAL_FUSION"
46,"Down",0.000255207161574555,0.00461124312531279,"L.LvsP.SAKAI_TUMOR_INFILTRATING_MONOCYTES_UP"
95,"Up",0.000256272931728767,0.0046154170668676,"L.LvsP.BURTON_ADIPOGENESIS_PEAK_AT_24HR"
51,"Up",0.000264000786516755,0.0047332265916711,"L.LvsP.GROSS_ELK3_TARGETS_DN"
122,"Down",0.000264526499697299,0.0047332265916711,"L.LvsP.WNT_SIGNALING"
14,"Up",0.000268382286867604,0.0047867279486806,"L.LvsP.MONTERO_THYROID_CANCER_POOR_SURVIVAL_UP"
58,"Down",0.000270205919444241,0.00480375732671129,"L.LvsP.REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION"
113,"Down",0.000274889295285667,0.00487135549241812,"L.LvsP.JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN"
56,"Up",0.000277266607537344,0.00489778617595519,"L.LvsP.HASLINGER_B_CLL_WITH_6Q21_DELETION"
51,"Down",0.000284538978455824,0.00501024207605813,"L.LvsP.REACTOME_SIGNALING_BY_FGFR3"
127,"Down",0.000292897240079693,0.00514104393777975,"L.LvsP.BURTON_ADIPOGENESIS_9"
65,"Down",0.000311200346506193,0.00544502125263526,"L.LvsP.REACTOME_DEADENYLATION_DEPENDENT_MRNA_DECAY"
203,"Up",0.000312804251208285,0.00545581925845617,"L.LvsP.REACTOME_ER_TO_GOLGI_ANTEROGRADE_TRANSPORT"
25,"Down",0.000314887138001066,0.00547094949116152,"L.LvsP.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_22"
87,"Down",0.0003156507302732,0.00547094949116152,"L.LvsP.GENTILE_UV_RESPONSE_CLUSTER_D4"
36,"Down",0.000318679559654199,0.00549785814286776,"L.LvsP.REACTOME_NEGATIVE_REGULATION_OF_FGFR3_SIGNALING"
103,"Down",0.000322007663879214,0.00549785814286776,"L.LvsP.PID_CDC42_PATHWAY"
42,"Up",0.000322772338007785,0.00549785814286776,"L.LvsP.MOOTHA_GLUCONEOGENESIS"
93,"Down",0.000322898526967457,0.00549785814286776,"L.LvsP.REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR"
38,"Up",0.000323270550119269,0.00549785814286776,"L.LvsP.WANG_METASTASIS_OF_BREAST_CANCER_ESR1_UP"
55,"Down",0.000324119790113621,0.00549785814286776,"L.LvsP.PID_INTEGRIN_A4B1_PATHWAY"
30,"Down",0.000324163818877716,0.00549785814286776,"L.LvsP.REACTOME_SEALING_OF_THE_NUCLEAR_ENVELOPE_NE_BY_ESCRT_III"
17,"Up",0.000327532213872321,0.00553458531279856,"L.LvsP.FUJIWARA_PARK2_IN_LIVER_CANCER_DN"
106,"Down",0.000328331340676059,0.00553458531279856,"L.LvsP.REACTOME_MAPK6_MAPK4_SIGNALING"
64,"Down",0.000330343472866363,0.00555157769446237,"L.LvsP.PID_LKB1_PATHWAY"
98,"Up",0.000331769137577284,0.00555864109595394,"L.LvsP.REACTOME_DNA_DAMAGE_TELOMERE_STRESS_INDUCED_SENESCENCE"
15,"Up",0.000342047398600933,0.00569934911808072,"L.LvsP.REACTOME_PROCESSIVE_SYNTHESIS_ON_THE_LAGGING_STRAND"
75,"Down",0.000343118647583673,0.00569934911808072,"L.LvsP.REACTOME_REGULATION_OF_RAS_BY_GAPS"
49,"Down",0.000343259767827976,0.00569934911808072,"L.LvsP.PID_NECTIN_PATHWAY"
14,"Down",0.000347104508193347,0.00574593061617071,"L.LvsP.REACTOME_SIGNALING_BY_ACTIVIN"
37,"Down",0.000350440927798474,0.00577867496168447,"L.LvsP.MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_DN"
18,"Down",0.000351172867991677,0.00577867496168447,"L.LvsP.REACTOME_SHC1_EVENTS_IN_ERBB4_SIGNALING"
18,"Up",0.000356556925200522,0.00584986124461034,"L.LvsP.FINETTI_BREAST_CANCER_KINOME_RED"
13,"Down",0.000360802477006536,0.00590200264902111,"L.LvsP.REACTOME_REGULATION_OF_CYTOSKELETAL_REMODELING_AND_CELL_SPREADING_BY_IPP_COMPLEX_COMPONENTS"
16,"Down",0.000365519046981758,0.00596151861581753,"L.LvsP.ITO_PTTG1_TARGETS_DN"
56,"Up",0.000374564123594721,0.00609107364516238,"L.LvsP.KEGG_GLUTATHIONE_METABOLISM"
97,"Down",0.000378709535055901,0.0061404252766102,"L.LvsP.AMIT_SERUM_RESPONSE_120_MCF10A"
56,"Down",0.000380859878719796,0.00615723470597004,"L.LvsP.MARTIN_INTERACT_WITH_HDAC"
66,"Down",0.000385165576506131,0.00620868942420524,"L.LvsP.REACTOME_SIGNALING_BY_NOTCH1_PEST_DOMAIN_MUTANTS_IN_CANCER"
150,"Up",0.000387573598250566,0.00622934425792843,"L.LvsP.REACTOME_METABOLISM_OF_WATER_SOLUBLE_VITAMINS_AND_COFACTORS"
13,"Down",0.000393690300334542,0.00630931498710054,"L.LvsP.REACTOME_MET_ACTIVATES_RAP1_AND_RAC1"
292,"Up",0.000399215216559278,0.00637936685652095,"L.LvsP.GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP"
49,"Down",0.000410206512759374,0.00653611472347717,"L.LvsP.PID_MAPK_TRK_PATHWAY"
35,"Down",0.00041400504604504,0.00657768361949145,"L.LvsP.PID_ALK1_PATHWAY"
59,"Up",0.000446784027516889,0.00707813434997386,"L.LvsP.KEGG_VALINE_LEUCINE_AND_ISOLEUCINE_DEGRADATION"
25,"Down",0.000448779294079471,0.00708154482099231,"L.LvsP.REACTOME_SUMOYLATION_OF_TRANSCRIPTION_FACTORS"
66,"Down",0.000449560902906186,0.00708154482099231,"L.LvsP.REACTOME_NEGATIVE_REGULATION_OF_NOTCH4_SIGNALING"
43,"Down",0.000475791099069136,0.00747343462145811,"L.LvsP.DISTECHE_ESCAPED_FROM_X_INACTIVATION"
104,"Down",0.000482838138352475,0.00756264041629132,"L.LvsP.BARIS_THYROID_CANCER_DN"
94,"Down",0.000486368436511554,0.00759641549568469,"L.LvsP.SESTO_RESPONSE_TO_UV_C2"
68,"Down",0.000489977780558277,0.00763123140480765,"L.LvsP.REACTOME_DEGRADATION_OF_GLI1_BY_THE_PROTEASOME"
67,"Down",0.000495998840737991,0.00768470707693221,"L.LvsP.PID_EPHB_FWD_PATHWAY"
34,"Down",0.000496426534869037,0.00768470707693221,"L.LvsP.REACTOME_DOWNREGULATION_OF_ERBB2_SIGNALING"
144,"Up",0.000497580961031241,0.00768470707693221,"L.LvsP.MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_UP"
9,"Down",0.000502064952662062,0.00773235967484273,"L.LvsP.MAINA_HYPOXIA_VHL_TARGETS_UP"
44,"Down",0.000509941691879376,0.00783185448444741,"L.LvsP.REACTOME_NEGATIVE_REGULATION_OF_FGFR2_SIGNALING"
22,"Down",0.000517318819232853,0.00792314612614528,"L.LvsP.REACTOME_REGULATION_OF_KIT_SIGNALING"
46,"Down",0.000520149227522273,0.0079444891684272,"L.LvsP.DELLA_RESPONSE_TO_TSA_AND_BUTYRATE"
7,"Up",0.000527167857229117,0.00802950711465507,"L.LvsP.REACTOME_PHOSPHORYLATION_OF_EMI1"
20,"Down",0.000528782428678857,0.00803197265979506,"L.LvsP.REACTOME_MAP3K8_TPL2_DEPENDENT_MAPK1_3_ACTIVATION"
26,"Up",0.000557490390172663,0.00843560953447631,"L.LvsP.SCIAN_CELL_CYCLE_TARGETS_OF_TP53_AND_TP73_DN"
32,"Up",0.000558407142271356,0.00843560953447631,"L.LvsP.REACTOME_ACTIVATION_OF_THE_PRE_REPLICATIVE_COMPLEX"
15,"Down",0.000561005504593076,0.00845176957737089,"L.LvsP.HOLLEMAN_DAUNORUBICIN_B_ALL_DN"
17,"Down",0.000571760069452135,0.00859038430435015,"L.LvsP.REACTOME_DOWNREGULATION_OF_ERBB2_ERBB3_SIGNALING"
7,"Down",0.000574946137724733,0.00861484334818442,"L.LvsP.REACTOME_NECTIN_NECL_TRANS_HETERODIMERIZATION"
6,"Down",0.00059546092879773,0.00889811750087202,"L.LvsP.REACTOME_LRR_FLII_INTERACTING_PROTEIN_1_LRRFIP1_ACTIVATES_TYPE_I_IFN_PRODUCTION"
301,"Down",0.000600580446535945,0.00895042935012733,"L.LvsP.KIM_WT1_TARGETS_12HR_DN"
13,"Down",0.000605227052328552,0.00898227215221515,"L.LvsP.BIOCARTA_MELANOCYTE_PATHWAY"
17,"Up",0.000605966271075466,0.00898227215221515,"L.LvsP.REACTOME_VITAMIN_B5_PANTOTHENATE_METABOLISM"
51,"Down",0.000609639101472194,0.00900819325154622,"L.LvsP.PID_ERBB1_RECEPTOR_PROXIMAL_PATHWAY"
84,"Down",0.000610973497798848,0.00900819325154622,"L.LvsP.REACTOME_INTERLEUKIN_17_SIGNALING"
145,"Down",0.000637580055647432,0.0093754790629645,"L.LvsP.CROMER_METASTASIS_DN"
53,"Up",0.000645993602452324,0.00947400166567348,"L.LvsP.BRACHAT_RESPONSE_TO_CAMPTOTHECIN_UP"
31,"Up",0.000670708512475206,0.00979242428958325,"L.LvsP.REICHERT_MITOSIS_LIN9_TARGETS"
22,"Up",0.000671247749276913,0.00979242428958325,"L.LvsP.KEGG_MISMATCH_REPAIR"
26,"Up",0.000698269540720993,0.0101598218174904,"L.LvsP.PODAR_RESPONSE_TO_ADAPHOSTIN_DN"
53,"Down",0.0007017809464518,0.0101841124748871,"L.LvsP.XU_HGF_SIGNALING_NOT_VIA_AKT1_6HR"
140,"Down",0.000715880272023239,0.0103615236230798,"L.LvsP.MCCLUNG_COCAINE_REWARD_5D"
13,"Down",0.000722366659539834,0.010428107730015,"L.LvsP.MCBRYAN_TERMINAL_END_BUD_DN"
14,"Down",0.000730851700832119,0.0105231225362,"L.LvsP.BIOCARTA_P35ALZHEIMERS_PATHWAY"
46,"Down",0.000739895409112183,0.0106256667973539,"L.LvsP.REACTOME_TRANSCRIPTIONAL_REGULATION_BY_THE_AP_2_TFAP2_FAMILY_OF_TRANSCRIPTION_FACTORS"
71,"Down",0.000743832653987738,0.0106467219293189,"L.LvsP.PID_AJDISS_2PATHWAY"
61,"Down",0.000746289983393198,0.0106467219293189,"L.LvsP.GENTILE_RESPONSE_CLUSTER_D3"
70,"Up",0.000747891431572173,0.0106467219293189,"L.LvsP.MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_DN"
27,"Down",0.000749063995388869,0.0106467219293189,"L.LvsP.BIOCARTA_TGFB_PATHWAY"
607,"Down",0.000758570206852835,0.0107541914709983,"L.LvsP.REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES"
89,"Down",0.000765505807696497,0.0108247611528234,"L.LvsP.REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION_TERMINATION"
18,"Down",0.000772808510429632,0.0109001486075649,"L.LvsP.REACTOME_SHC1_EVENTS_IN_EGFR_SIGNALING"
5,"Up",0.000779442794044162,0.0109657486215526,"L.LvsP.REACTOME_PROPIONYL_COA_CATABOLISM"
38,"Down",0.000784689890281866,0.011011549247128,"L.LvsP.REACTOME_CHAPERONE_MEDIATED_AUTOPHAGY"
193,"Up",0.00080842206740777,0.0112931913942869,"L.LvsP.ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_DN"
15,"Up",0.000808844961500743,0.0112931913942869,"L.LvsP.REACTOME_N_GLYCAN_ANTENNAE_ELONGATION"
172,"Down",0.000813814145448976,0.0113339506553839,"L.LvsP.REACTOME_BETA_CATENIN_INDEPENDENT_WNT_SIGNALING"
142,"Down",0.000816332476265917,0.0113393456575542,"L.LvsP.REACTOME_TCR_SIGNALING"
64,"Down",0.000820341390437856,0.0113393456575542,"L.LvsP.BIOCARTA_KERATINOCYTE_PATHWAY"
49,"Down",0.000820354180325857,0.0113393456575542,"L.LvsP.VERRECCHIA_RESPONSE_TO_TGFB1_C5"
270,"Down",0.000834916729346759,0.0115118568492724,"L.LvsP.KIM_WT1_TARGETS_8HR_UP"
66,"Down",0.000851525616550196,0.0117116545619553,"L.LvsP.SIMBULAN_UV_RESPONSE_IMMORTALIZED_DN"
177,"Down",0.000862363128854543,0.0118312797504634,"L.LvsP.REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS"
14,"Down",0.000873568619665472,0.0119553487577485,"L.LvsP.REACTOME_JOSEPHIN_DOMAIN_DUBS"
132,"Down",0.000875939745512624,0.0119581996368872,"L.LvsP.REACTOME_SIGNALING_BY_VEGF"
17,"Down",0.000897885844415461,0.0122276128910667,"L.LvsP.BENPORATH_ES_CORE_NINE"
31,"Down",0.000900157459180427,0.0122284289725027,"L.LvsP.DEN_INTERACT_WITH_LCA5"
44,"Down",0.000908478053550581,0.0123112136227479,"L.LvsP.HINATA_NFKB_TARGETS_KERATINOCYTE_DN"
105,"Down",0.000921146842434606,0.0124243858069147,"L.LvsP.REACTOME_SIGNALING_BY_FGFR"
196,"Up",0.000921323599355227,0.0124243858069147,"L.LvsP.REACTOME_METABOLISM_OF_STEROIDS"
39,"Up",0.000929227900151718,0.0125004891969315,"L.LvsP.DACOSTA_LOW_DOSE_UV_RESPONSE_VIA_ERCC3_XPCS_UP"
173,"Up",0.000939852357149478,0.0126127273851443,"L.LvsP.CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP"
10,"Up",0.000962175895666601,0.0128768650172642,"L.LvsP.REICHERT_G1S_REGULATORS_AS_PI3K_TARGETS"
63,"Down",0.000964192822779417,0.0128768650172642,"L.LvsP.AMIT_EGF_RESPONSE_60_HELA"
26,"Down",0.000971922648545587,0.0129365301421194,"L.LvsP.REACTOME_FORMATION_OF_TUBULIN_FOLDING_INTERMEDIATES_BY_CCT_TRIC"
33,"Down",0.000973339941964488,0.0129365301421194,"L.LvsP.REACTOME_SIGNALING_BY_ERBB2_IN_CANCER"
17,"Down",0.000980760612055601,0.012973726862169,"L.LvsP.REACTOME_NF_KB_IS_ACTIVATED_AND_SIGNALS_SURVIVAL"
9,"Up",0.000980831584081508,0.012973726862169,"L.LvsP.SEMBA_FHIT_TARGETS_DN"
215,"Up",0.00098379915997376,0.0129819225668137,"L.LvsP.WINNEPENNINCKX_MELANOMA_METASTASIS_UP"
10,"Up",0.000987945609271466,0.0130055982706237,"L.LvsP.BIOCARTA_ETC_PATHWAY"
24,"Up",0.000996564955773286,0.0130879041341342,"L.LvsP.BIOCARTA_ATRBRCA_PATHWAY"
93,"Up",0.00100537568273822,0.0131723273693355,"L.LvsP.REACTOME_ERCC6_CSB_AND_EHMT2_G9A_POSITIVELY_REGULATE_RRNA_EXPRESSION"
440,"Down",0.00101028712220721,0.0131779302144419,"L.LvsP.DAZARD_RESPONSE_TO_UV_NHEK_DN"
40,"Down",0.00101057015932779,0.0131779302144419,"L.LvsP.REACTOME_SIGNALLING_TO_ERKS"
27,"Up",0.00102551881689665,0.0133228754678017,"L.LvsP.KEGG_HOMOLOGOUS_RECOMBINATION"
48,"Down",0.0010265047837373,0.0133228754678017,"L.LvsP.GENTILE_UV_RESPONSE_CLUSTER_D5"
15,"Up",0.00105388055863187,0.0136196592646985,"L.LvsP.BIOCARTA_PTC1_PATHWAY"
14,"Up",0.00105429809464478,0.0136196592646985,"L.LvsP.REACTOME_POLYMERASE_SWITCHING"
14,"Down",0.00106064723271795,0.0136697402090852,"L.LvsP.REACTOME_RUNX3_REGULATES_WNT_SIGNALING"
31,"Down",0.00106464817747154,0.0136893948214887,"L.LvsP.BIOCARTA_UCALPAIN_PATHWAY"
13,"Down",0.00107259369314842,0.0137595603930803,"L.LvsP.REACTOME_REGULATION_OF_GLYCOLYSIS_BY_FRUCTOSE_2_6_BISPHOSPHATE_METABOLISM"
42,"Down",0.00108444310184246,0.0138682071018129,"L.LvsP.REACTOME_MYOGENESIS"
78,"Down",0.00108832772556691,0.0138682071018129,"L.LvsP.WANG_METHYLATED_IN_BREAST_CANCER"
28,"Down",0.00108974131260422,0.0138682071018129,"L.LvsP.BIOCARTA_NTHI_PATHWAY"
16,"Down",0.00109109605521588,0.0138682071018129,"L.LvsP.REACTOME_EGFR_TRANSACTIVATION_BY_GASTRIN"
19,"Down",0.00109929895671456,0.0139061052002166,"L.LvsP.XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_DN"
39,"Down",0.00110260037352316,0.0139061052002166,"L.LvsP.REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_ACETYLATION"
30,"Down",0.00110288401216924,0.0139061052002166,"L.LvsP.BIOCARTA_TEL_PATHWAY"
22,"Up",0.00110700257024163,0.0139061052002166,"L.LvsP.BOYAULT_LIVER_CANCER_SUBCLASS_G12_DN"
90,"Down",0.00110765525317185,0.0139061052002166,"L.LvsP.REACTOME_REGULATION_OF_RUNX2_EXPRESSION_AND_ACTIVITY"
106,"Down",0.00111126484136233,0.0139061052002166,"L.LvsP.WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_TBH"
30,"Down",0.0011131223159787,0.0139061052002166,"L.LvsP.REACTOME_BUDDING_AND_MATURATION_OF_HIV_VIRION"
33,"Down",0.00111419869844384,0.0139061052002166,"L.LvsP.REACTOME_ENDOSOMAL_SORTING_COMPLEX_REQUIRED_FOR_TRANSPORT_ESCRT"
73,"Up",0.00113504448122616,0.0141343714790528,"L.LvsP.ELLWOOD_MYC_TARGETS_DN"
87,"Down",0.00114042495498018,0.0141694597215403,"L.LvsP.KEGG_CHRONIC_MYELOID_LEUKEMIA"
340,"Down",0.00114535542831178,0.0141988120249682,"L.LvsP.STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP"
20,"Down",0.00114807932033266,0.0142007395125711,"L.LvsP.ONGUSAHA_BRCA1_TARGETS_DN"
22,"Up",0.00115437892322248,0.0142467880948596,"L.LvsP.FARMER_BREAST_CANCER_CLUSTER_6"
88,"Up",0.00116390544468787,0.0143323679369248,"L.LvsP.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_DN"
50,"Up",0.00118371126158297,0.0145438657006494,"L.LvsP.REACTOME_INTRA_GOLGI_TRAFFIC"
61,"Down",0.00119801210260927,0.014686937727997,"L.LvsP.KEGG_ENDOMETRIAL_CANCER"
36,"Down",0.00121798822148024,0.0148987983994784,"L.LvsP.REACTOME_RHO_GTPASES_ACTIVATE_IQGAPS"
106,"Down",0.0012388464794077,0.0151204904738304,"L.LvsP.MARSON_FOXP3_TARGETS_UP"
7,"Down",0.00125178594817003,0.0152447676375156,"L.LvsP.REACTOME_GRB7_EVENTS_IN_ERBB2_SIGNALING"
92,"Down",0.0012712790641031,0.0154481361437935,"L.LvsP.REACTOME_SIGNALING_BY_NOTCH1"
24,"Down",0.00127635002676785,0.0154757440745602,"L.LvsP.HASINA_NOL7_TARGETS_DN"
45,"Down",0.00128254406228091,0.0155168186440944,"L.LvsP.SARTIPY_NORMAL_AT_INSULIN_RESISTANCE_UP"
52,"Down",0.00128573904534736,0.0155215091304051,"L.LvsP.REACTOME_SIGNALING_BY_FGFR4"
75,"Down",0.00130945852415634,0.0157619163718606,"L.LvsP.PID_AMB2_NEUTROPHILS_PATHWAY"
64,"Down",0.00131135495226187,0.0157619163718606,"L.LvsP.BYSTROEM_CORRELATED_WITH_IL5_UP"
195,"Down",0.0013178637998915,0.0158034122666848,"L.LvsP.BOYAULT_LIVER_CANCER_SUBCLASS_G1_UP"
27,"Up",0.0013248399765903,0.0158034122666848,"L.LvsP.GRANDVAUX_IFN_RESPONSE_NOT_VIA_IRF3"
32,"Down",0.00132527354986883,0.0158034122666848,"L.LvsP.XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_UP"
11,"Up",0.00132624042172938,0.0158034122666848,"L.LvsP.REACTOME_REMOVAL_OF_THE_FLAP_INTERMEDIATE_FROM_THE_C_STRAND"
78,"Down",0.00133375507182957,0.0158587780476252,"L.LvsP.PID_PS1_PATHWAY"
26,"Up",0.001343677420955,0.015937398053901,"L.LvsP.REACTOME_METAL_ION_SLC_TRANSPORTERS"
92,"Down",0.00134613219229006,0.015937398053901,"L.LvsP.PID_NOTCH_PATHWAY"
136,"Down",0.00135131847222216,0.015964615027599,"L.LvsP.BENPORATH_ES_CORE_NINE_CORRELATED"
130,"Up",0.00136346663110171,0.016073788919747,"L.LvsP.REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS"
156,"Up",0.0013852990315886,0.0162964220120285,"L.LvsP.REACTOME_DISEASES_OF_GLYCOSYLATION"
38,"Up",0.00140005560305215,0.0164350476205422,"L.LvsP.REACTOME_GLUCONEOGENESIS"
28,"Up",0.00141458624048984,0.01657043924506,"L.LvsP.REACTOME_TELOMERE_C_STRAND_LAGGING_STRAND_SYNTHESIS"
25,"Up",0.00143893449115833,0.0168200186080643,"L.LvsP.KEGG_GLYCOSYLPHOSPHATIDYLINOSITOL_GPI_ANCHOR_BIOSYNTHESIS"
18,"Down",0.00145998039497165,0.0170240178184901,"L.LvsP.REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_LATE_STAGE_BRANCHING_MORPHOGENESIS_PANCREATIC_BUD_PRECURSOR_CELLS"
13,"Up",0.00146338843391033,0.0170240178184901,"L.LvsP.REACTOME_GLUTATHIONE_SYNTHESIS_AND_RECYCLING"
27,"Down",0.001465623527148,0.0170240178184901,"L.LvsP.REACTOME_GASTRIN_CREB_SIGNALLING_PATHWAY_VIA_PKC_AND_MAPK"
17,"Up",0.00150369866295064,0.017429664376214,"L.LvsP.REACTOME_REGULATION_OF_PYRUVATE_DEHYDROGENASE_PDH_COMPLEX"
1217,"Up",0.001508235915621,0.0174456827980512,"L.LvsP.FISCHER_DREAM_TARGETS"
89,"Down",0.00151680526876044,0.0175081760563183,"L.LvsP.KOHOUTEK_CCNT1_TARGETS"
67,"Down",0.00152400252793934,0.0175223697668001,"L.LvsP.PID_ECADHERIN_NASCENT_AJ_PATHWAY"
137,"Up",0.00152437327868165,0.0175223697668001,"L.LvsP.REACTOME_SENESCENCE_ASSOCIATED_SECRETORY_PHENOTYPE_SASP"
105,"Down",0.00153170293221854,0.0175404435236378,"L.LvsP.PID_MET_PATHWAY"
50,"Down",0.00153229050857607,0.0175404435236378,"L.LvsP.BIOCARTA_ALK_PATHWAY"
88,"Down",0.00157035318036148,0.0178930244242249,"L.LvsP.DORN_ADENOVIRUS_INFECTION_32HR_DN"
23,"Up",0.00157045124794358,0.0178930244242249,"L.LvsP.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BROWN_UP"
8,"Down",0.0015737813456257,0.0178930244242249,"L.LvsP.HOLLEMAN_DAUNORUBICIN_ALL_DN"
249,"Up",0.00157832798042914,0.0178930244242249,"L.LvsP.WHITFIELD_CELL_CYCLE_S"
31,"Down",0.00158096278069497,0.0178930244242249,"L.LvsP.KYNG_RESPONSE_TO_H2O2_VIA_ERCC6"
32,"Down",0.00158250839997214,0.0178930244242249,"L.LvsP.REACTOME_RHO_GTPASES_ACTIVATE_CIT"
224,"Up",0.00160802296671694,0.0181444060877101,"L.LvsP.REACTOME_INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC"
56,"Up",0.00161442705267354,0.0181795665462973,"L.LvsP.RUAN_RESPONSE_TO_TNF_TROGLITAZONE_DN"
120,"Down",0.00162877205505568,0.0183038225455343,"L.LvsP.REACTOME_CLEC7A_DECTIN_1_SIGNALING"
137,"Up",0.00163915583581181,0.018383149322928,"L.LvsP.KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS"
63,"Down",0.00164860687811751,0.018451715443546,"L.LvsP.SIMBULAN_UV_RESPONSE_NORMAL_DN"
29,"Down",0.00166114741674427,0.0185545132670285,"L.LvsP.TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN"
35,"Up",0.00168748145936723,0.018806552029757,"L.LvsP.KEGG_BASE_EXCISION_REPAIR"
106,"Up",0.00169051480535164,0.018806552029757,"L.LvsP.REACTOME_RNA_POLYMERASE_I_PROMOTER_ESCAPE"
150,"Down",0.00174211166216181,0.019341637309423,"L.LvsP.BURTON_ADIPOGENESIS_8"
25,"Down",0.00179898324522707,0.0199330227712635,"L.LvsP.BOYAULT_LIVER_CANCER_SUBCLASS_G56_DN"
679,"Down",0.00180328523422339,0.0199407281200423,"L.LvsP.HSIAO_HOUSEKEEPING_GENES"
97,"Up",0.00182519031282654,0.020123816302687,"L.LvsP.HU_GENOTOXIC_DAMAGE_4HR"
12,"Down",0.00182712168275436,0.020123816302687,"L.LvsP.BOYLAN_MULTIPLE_MYELOMA_PCA1_DN"
24,"Down",0.00185261312728129,0.0203640118901357,"L.LvsP.SUZUKI_AMPLIFIED_IN_ORAL_CANCER"
13,"Down",0.0018591410456955,0.0203952199239095,"L.LvsP.PID_ALK2_PATHWAY"
720,"Down",0.00186535939417392,0.0204229150304705,"L.LvsP.SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN"
31,"Up",0.00187031387322291,0.0204366905238132,"L.LvsP.REACTOME_MISCELLANEOUS_TRANSPORT_AND_BINDING_EVENTS"
206,"Down",0.00191355058324366,0.0208678918634205,"L.LvsP.PECE_MAMMARY_STEM_CELL_UP"
203,"Up",0.00191795228249959,0.0208747208069689,"L.LvsP.REACTOME_PROTEIN_LOCALIZATION"
28,"Down",0.00192799802450455,0.0209428311934886,"L.LvsP.BIOCARTA_EPHA4_PATHWAY"
456,"Down",0.00194919031942635,0.0211315162276633,"L.LvsP.GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN"
56,"Up",0.00196345802708385,0.021244539005375,"L.LvsP.BARRIER_COLON_CANCER_RECURRENCE_UP"
160,"Up",0.00197793561430499,0.0213593867411959,"L.LvsP.CUI_GLUCOSE_DEPRIVATION"
13,"Down",0.00201354823875723,0.0217015754621612,"L.LvsP.FIRESTEIN_CTNNB1_PATHWAY_AND_PROLIFERATION"
18,"Up",0.00204288725452164,0.0219749486969847,"L.LvsP.LI_WILMS_TUMOR_ANAPLASTIC_UP"
1242,"Down",0.00205046426765934,0.0220136251182301,"L.LvsP.KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3"
73,"Down",0.00206463538181475,0.0221228081900266,"L.LvsP.ZHAN_MULTIPLE_MYELOMA_HP_UP"
58,"Down",0.00207073093275577,0.022141050181772,"L.LvsP.PID_FOXO_PATHWAY"
17,"Up",0.00207434689711664,0.022141050181772,"L.LvsP.REACTOME_ZINC_TRANSPORTERS"
11,"Down",0.00208117168333597,0.022171094869296,"L.LvsP.KOINUMA_COLON_CANCER_MSI_DN"
12,"Down",0.00210840815128447,0.0224180551316382,"L.LvsP.VISALA_AGING_LYMPHOCYTE_UP"
90,"Down",0.00212820732240273,0.022585140663272,"L.LvsP.IKEDA_MIR133_TARGETS_UP"
30,"Down",0.00215372516623532,0.0227962799144784,"L.LvsP.CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_UP"
274,"Up",0.00215634914003838,0.0227962799144784,"L.LvsP.SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP"
36,"Down",0.00216467582733217,0.0228406348269458,"L.LvsP.WANG_BARRETTS_ESOPHAGUS_DN"
77,"Down",0.00218952656061482,0.0230325771906776,"L.LvsP.PID_HES_HEY_PATHWAY"
89,"Down",0.00219119833646165,0.0230325771906776,"L.LvsP.DORN_ADENOVIRUS_INFECTION_48HR_DN"
39,"Down",0.00221686897027814,0.0232581945667321,"L.LvsP.REACTOME_NEGATIVE_REGULATION_OF_FGFR4_SIGNALING"
34,"Down",0.00223000860841246,0.0233517378710464,"L.LvsP.REACTOME_SIGNALING_BY_BMP"
25,"Up",0.00224198727316918,0.023432793257755,"L.LvsP.BIOCARTA_CELLCYCLE_PATHWAY"
184,"Down",0.00226883136606897,0.0236686200433874,"L.LvsP.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP"
106,"Down",0.00228126125310711,0.0237534716919571,"L.LvsP.BILANGES_RAPAMYCIN_SENSITIVE_VIA_TSC1_AND_TSC2"
14,"Up",0.00229375862479627,0.0238387057077041,"L.LvsP.REACTOME_DEFECTS_IN_COBALAMIN_B12_METABOLISM"
107,"Down",0.00231577193315867,0.0240223321171375,"L.LvsP.REACTOME_SELECTIVE_AUTOPHAGY"
13,"Down",0.00237294664635143,0.0245693296023915,"L.LvsP.PETRETTO_BLOOD_PRESSURE_DN"
73,"Down",0.00238151789142321,0.0245888084345543,"L.LvsP.ZWANG_CLASS_2_TRANSIENTLY_INDUCED_BY_EGF"
94,"Down",0.00238596490285869,0.0245888084345543,"L.LvsP.GERHOLD_ADIPOGENESIS_DN"
8,"Up",0.0023881696743273,0.0245888084345543,"L.LvsP.REACTOME_COENZYME_A_BIOSYNTHESIS"
51,"Up",0.00239786273839592,0.0246427194806525,"L.LvsP.TERAO_AOX4_TARGETS_SKIN_DN"
16,"Down",0.00240859072998481,0.0247070466532208,"L.LvsP.REACTOME_SUMOYLATION_OF_DNA_METHYLATION_PROTEINS"
58,"Down",0.0024254417534154,0.0248338286196921,"L.LvsP.CHANDRAN_METASTASIS_TOP50_DN"
43,"Down",0.0024445837957622,0.0249835560199061,"L.LvsP.REACTOME_DISASSEMBLY_OF_THE_DESTRUCTION_COMPLEX_AND_RECRUITMENT_OF_AXIN_TO_THE_MEMBRANE"
8,"Up",0.00247600411612633,0.0252579829484548,"L.LvsP.REACTOME_UBIQUINOL_BIOSYNTHESIS"
103,"Up",0.00249063093622252,0.0253604022953486,"L.LvsP.WU_APOPTOSIS_BY_CDKN1A_VIA_TP53"
10,"Up",0.002503339043027,0.0254429440604711,"L.LvsP.BIOCARTA_VOBESITY_PATHWAY"
18,"Down",0.0025327433694239,0.0256945653019169,"L.LvsP.PID_SMAD2_3PATHWAY"
19,"Down",0.00254948952660485,0.0258170835029271,"L.LvsP.MOROSETTI_FACIOSCAPULOHUMERAL_MUSCULAR_DISTROPHY_DN"
101,"Down",0.00256216272876621,0.0258866169152774,"L.LvsP.REACTOME_ONCOGENIC_MAPK_SIGNALING"
24,"Down",0.00257369428389169,0.0258866169152774,"L.LvsP.EHRLICH_ICF_SYNDROM_UP"
398,"Down",0.00257737126724095,0.0258866169152774,"L.LvsP.RICKMAN_METASTASIS_DN"
92,"Down",0.00257900559480108,0.0258866169152774,"L.LvsP.KEGG_ERBB_SIGNALING_PATHWAY"
76,"Down",0.00257976594688331,0.0258866169152774,"L.LvsP.PID_P53_REGULATION_PATHWAY"
28,"Up",0.0026042749311961,0.026085210316274,"L.LvsP.HASEGAWA_TUMORIGENESIS_BY_RET_C634R"
1388,"Down",0.00262478342835754,0.0262103089786766,"L.LvsP.REACTOME_DEVELOPMENTAL_BIOLOGY"
32,"Up",0.00262624546467477,0.0262103089786766,"L.LvsP.REACTOME_G1_S_SPECIFIC_TRANSCRIPTION"
128,"Down",0.00264154424531514,0.0262915963058789,"L.LvsP.REACTOME_HEDGEHOG_OFF_STATE"
353,"Down",0.00264608612515342,0.0262915963058789,"L.LvsP.REACTOME_INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS"
12,"Up",0.00264865602140976,0.0262915963058789,"L.LvsP.REACTOME_UNWINDING_OF_DNA"
23,"Down",0.00265708744607828,0.0263280223823778,"L.LvsP.REACTOME_RAF_INDEPENDENT_MAPK1_3_ACTIVATION"
24,"Down",0.00272407944571079,0.0269435335515831,"L.LvsP.REACTOME_SIGNALING_BY_HIPPO"
24,"Down",0.00273856208477671,0.0270384102977329,"L.LvsP.REACTOME_CONSTITUTIVE_SIGNALING_BY_EGFRVIII"
63,"Down",0.00282019700980052,0.0277947758773388,"L.LvsP.SNIJDERS_AMPLIFIED_IN_HEAD_AND_NECK_TUMORS"
21,"Down",0.00283442757192698,0.0278853203650966,"L.LvsP.CHESLER_BRAIN_QTL_TRANS"
52,"Down",0.00284708351388215,0.0279600794818018,"L.LvsP.REACTOME_CYCLIN_D_ASSOCIATED_EVENTS_IN_G1"
32,"Down",0.00285293251983971,0.0279678437982159,"L.LvsP.TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_TOP20_DN"
17,"Up",0.00286360621640593,0.0280227942840857,"L.LvsP.REACTOME_POLYMERASE_SWITCHING_ON_THE_C_STRAND_OF_THE_TELOMERE"
171,"Down",0.00287899379804204,0.0281235984264566,"L.LvsP.REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX2"
113,"Up",0.00288829870052304,0.028161332032158,"L.LvsP.RUAN_RESPONSE_TO_TNF_DN"
59,"Down",0.00289304333410486,0.028161332032158,"L.LvsP.WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2"
120,"Down",0.00291526661245438,0.0283277840074873,"L.LvsP.SESTO_RESPONSE_TO_UV_C1"
86,"Down",0.00292583787682388,0.0283379574679389,"L.LvsP.CHANDRAN_METASTASIS_TOP50_UP"
30,"Down",0.00292656424564896,0.0283379574679389,"L.LvsP.REACTOME_DARPP_32_EVENTS"
143,"Down",0.00297882092696312,0.028747434378059,"L.LvsP.SAFFORD_T_LYMPHOCYTE_ANERGY"
109,"Down",0.00297925120250096,0.028747434378059,"L.LvsP.REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM"
47,"Up",0.00299980805961312,0.0288522612572496,"L.LvsP.DAZARD_UV_RESPONSE_CLUSTER_G5"
26,"Up",0.00300074087163464,0.0288522612572496,"L.LvsP.OHASHI_AURKB_TARGETS"
32,"Down",0.00300933004392287,0.0288522612572496,"L.LvsP.WANG_LSD1_TARGETS_UP"
151,"Up",0.00301098837862779,0.0288522612572496,"L.LvsP.MORI_IMMATURE_B_LYMPHOCYTE_DN"
82,"Up",0.00303031752376455,0.0289872415032772,"L.LvsP.NADLER_OBESITY_DN"
15,"Up",0.0030541164145638,0.0291644380934771,"L.LvsP.REACTOME_SYNTHESIS_OF_PIPS_AT_THE_LATE_ENDOSOME_MEMBRANE"
62,"Down",0.00306330708949001,0.0292017670651557,"L.LvsP.REACTOME_APOPTOTIC_CLEAVAGE_OF_CELLULAR_PROTEINS"
262,"Down",0.00307855607397996,0.0292922729115056,"L.LvsP.CAIRO_LIVER_DEVELOPMENT_UP"
162,"Up",0.00308339714857953,0.0292922729115056,"L.LvsP.REACTOME_GENE_SILENCING_BY_RNA"
74,"Up",0.00311823639818081,0.0294787432666477,"L.LvsP.DALESSIO_TSA_RESPONSE"
11,"Down",0.00311920185313371,0.0294787432666477,"L.LvsP.BIOCARTA_ERBB4_PATHWAY"
61,"Down",0.00312272605123034,0.0294787432666477,"L.LvsP.PID_ERBB1_INTERNALIZATION_PATHWAY"
242,"Up",0.00312435224348988,0.0294787432666477,"L.LvsP.REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS"
11,"Down",0.00313636365140598,0.0295416603554066,"L.LvsP.REACTOME_AKT_PHOSPHORYLATES_TARGETS_IN_THE_NUCLEUS"
9,"Down",0.0031562554476011,0.0296784632139226,"L.LvsP.IIZUKA_LIVER_CANCER_PROGRESSION_G2_G3_DN"
115,"Down",0.00316193211240488,0.0296813627325749,"L.LvsP.REACTOME_INTERLEUKIN_1_SIGNALING"
156,"Down",0.00318885806297214,0.0298833834409711,"L.LvsP.KEGG_AXON_GUIDANCE"
77,"Down",0.00321148434310414,0.0300444956565529,"L.LvsP.REACTOME_CELL_CELL_JUNCTION_ORGANIZATION"
6,"Down",0.00322659808829176,0.0301349000509546,"L.LvsP.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_13"
69,"Down",0.00325783541104439,0.0303753321883042,"L.LvsP.REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR"
28,"Down",0.00331226002566348,0.0308307839762515,"L.LvsP.BIOCARTA_TID_PATHWAY"
17,"Down",0.00335636993861125,0.0311888561186246,"L.LvsP.PID_ERBB_NETWORK_PATHWAY"
87,"Down",0.0033685223548448,0.0312492619126458,"L.LvsP.REACTOME_CELLULAR_RESPONSE_TO_HYPOXIA"
12,"Down",0.00341358098074811,0.0316142198367778,"L.LvsP.SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX1_DN"
29,"Down",0.00346857818041393,0.0320698474239275,"L.LvsP.REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY"
445,"Up",0.00348775659052184,0.0321933325358852,"L.LvsP.HORIUCHI_WTAP_TARGETS_DN"
84,"Down",0.00353000031620799,0.0325289529138566,"L.LvsP.KEGG_PANCREATIC_CANCER"
21,"Down",0.00354604925160802,0.032622473065126,"L.LvsP.KUROKAWA_LIVER_CANCER_EARLY_RECURRENCE_UP"
95,"Down",0.00356934094745058,0.0327620697514046,"L.LvsP.KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC"
8,"Up",0.00357307434619225,0.0327620697514046,"L.LvsP.REACTOME_ACTIVATION_OF_NIMA_KINASES_NEK9_NEK6_NEK7"
57,"Up",0.00360426419385877,0.032993338953386,"L.LvsP.WENG_POR_TARGETS_GLOBAL_UP"
75,"Up",0.00364506638882119,0.0333116893616403,"L.LvsP.FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_DN"
1242,"Down",0.00366253127294019,0.0334160650298454,"L.LvsP.BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP"
50,"Down",0.00370668313695414,0.0337631813249085,"L.LvsP.BERENJENO_TRANSFORMED_BY_RHOA_REVERSIBLY_DN"
236,"Down",0.00372294599783447,0.0338555401678072,"L.LvsP.REACTOME_PROGRAMMED_CELL_DEATH"
12,"Down",0.00373560477930817,0.0339148749175613,"L.LvsP.REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX_IN_CANCER"
84,"Up",0.00377297398507699,0.0341979887926076,"L.LvsP.YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_10"
62,"Down",0.00378031640961066,0.0342084606034981,"L.LvsP.REACTOME_STABILIZATION_OF_P53"
15,"Up",0.00378724833703459,0.0342151896331116,"L.LvsP.REACTOME_MISMATCH_REPAIR"
60,"Down",0.00379513056308439,0.0342304679988477,"L.LvsP.REACTOME_GENE_AND_PROTEIN_EXPRESSION_BY_JAK_STAT_SIGNALING_AFTER_INTERLEUKIN_12_STIMULATION"
8,"Up",0.00383160969186286,0.0344542793703722,"L.LvsP.REACTOME_NEF_MEDIATED_CD8_DOWN_REGULATION"
15,"Down",0.00383240763479452,0.0344542793703722,"L.LvsP.REACTOME_RHO_GTPASES_ACTIVATE_KTN1"
37,"Down",0.00384907612283658,0.0344933166141197,"L.LvsP.BIOCARTA_ECM_PATHWAY"
112,"Up",0.00385141653690675,0.0344933166141197,"L.LvsP.REACTOME_DNA_DOUBLE_STRAND_BREAK_RESPONSE"
18,"Up",0.00386100727135058,0.0344933166141197,"L.LvsP.REACTOME_PROCESSING_OF_SMDT1"
120,"Down",0.00386170428362093,0.0344933166141197,"L.LvsP.BILD_CTNNB1_ONCOGENIC_SIGNATURE"
485,"Up",0.00390044089628604,0.0347831253476863,"L.LvsP.LINDGREN_BLADDER_CANCER_CLUSTER_3_UP"
370,"Up",0.00391483307313901,0.034855252916885,"L.LvsP.MANALO_HYPOXIA_DN"
8,"Down",0.00393963132017072,0.0350196488251189,"L.LvsP.TURJANSKI_MAPK7_TARGETS"
11,"Down",0.003949079928227,0.0350472920115042,"L.LvsP.WORSCHECH_TUMOR_REJECTION_DN"
34,"Up",0.00397633366981726,0.0352326103532366,"L.LvsP.DEMAGALHAES_AGING_DN"
97,"Down",0.00399206374504027,0.0353153927141242,"L.LvsP.MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_UP"
44,"Down",0.00402000472701037,0.0355057606000644,"L.LvsP.KEGG_PROTEASOME"
44,"Down",0.00403981968552756,0.0356238644996521,"L.LvsP.REACTOME_RHO_GTPASES_ACTIVATE_WASPS_AND_WAVES"
97,"Down",0.00408499517104294,0.0359648699055676,"L.LvsP.BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_DN"
15,"Down",0.00416154485179134,0.0365805746988145,"L.LvsP.DACOSTA_LOW_DOSE_UV_RESPONSE_VIA_ERCC3_XPCS_DN"
167,"Down",0.0041790918027473,0.0366765056783966,"L.LvsP.HILLION_HMGA1B_TARGETS"
63,"Down",0.00419287073742359,0.0367391161762521,"L.LvsP.BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_DN"
42,"Down",0.00426476480510534,0.0372172161901247,"L.LvsP.PID_IGF1_PATHWAY"
104,"Down",0.0042722638694916,0.0372172161901247,"L.LvsP.REACTOME_SIGNALING_BY_MET"
68,"Up",0.00427547955491134,0.0372172161901247,"L.LvsP.GERHOLD_ADIPOGENESIS_UP"
96,"Down",0.00428110449365897,0.0372172161901247,"L.LvsP.REACTOME_TRANSLOCATION_OF_SLC2A4_GLUT4_TO_THE_PLASMA_MEMBRANE"
100,"Down",0.00428458625208339,0.0372172161901247,"L.LvsP.REACTOME_TOLL_LIKE_RECEPTOR_10_TLR10_CASCADE"
111,"Down",0.00428782179654719,0.0372172161901247,"L.LvsP.REACTOME_TOLL_LIKE_RECEPTOR_9_TLR9_CASCADE"
13,"Down",0.00431024150127545,0.0373531743895799,"L.LvsP.REACTOME_EGFR_INTERACTS_WITH_PHOSPHOLIPASE_C_GAMMA"
386,"Up",0.00433375904666448,0.0374629036418331,"L.LvsP.CAIRO_LIVER_DEVELOPMENT_DN"
79,"Down",0.00433729678402553,0.0374629036418331,"L.LvsP.MEDINA_SMARCA4_TARGETS"
51,"Up",0.00434777499853152,0.0374629036418331,"L.LvsP.KEGG_AMINO_SUGAR_AND_NUCLEOTIDE_SUGAR_METABOLISM"
135,"Up",0.00435000617436369,0.0374629036418331,"L.LvsP.HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP"
48,"Down",0.00436650334273913,0.0375464960839886,"L.LvsP.HOLLEMAN_ASPARAGINASE_RESISTANCE_B_ALL_UP"
710,"Down",0.00438784142830914,0.0376666550313105,"L.LvsP.DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN"
196,"Down",0.00439410245888864,0.0376666550313105,"L.LvsP.STEARMAN_LUNG_CANCER_EARLY_VS_LATE_UP"
26,"Up",0.00442196387765387,0.0378468084822728,"L.LvsP.REACTOME_N_GLYCAN_ANTENNAE_ELONGATION_IN_THE_MEDIAL_TRANS_GOLGI"
9,"Down",0.0044796450869524,0.0382812328991651,"L.LvsP.REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_BCR_SIGNALING"
12,"Down",0.00451893438395587,0.0385573892112531,"L.LvsP.SCIAN_CELL_CYCLE_TARGETS_OF_TP53_AND_TP73_UP"
19,"Down",0.00454446150703251,0.0387154509589872,"L.LvsP.REACTOME_TFAP2_AP_2_FAMILY_REGULATES_TRANSCRIPTION_OF_GROWTH_FACTORS_AND_THEIR_RECEPTORS"
457,"Up",0.00455497812625879,0.0387453447078228,"L.LvsP.ZWANG_DOWN_BY_2ND_EGF_PULSE"
67,"Down",0.00457350540833458,0.0388431818781596,"L.LvsP.KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_DN"
243,"Down",0.00461364289091283,0.03907065420162,"L.LvsP.IGLESIAS_E2F_TARGETS_UP"
49,"Down",0.00461442163025101,0.03907065420162,"L.LvsP.KAMMINGA_SENESCENCE"
13,"Up",0.00463591695373619,0.0391926373657606,"L.LvsP.REACTOME_TRIGLYCERIDE_BIOSYNTHESIS"
18,"Down",0.00464455922797915,0.0392057526282392,"L.LvsP.BIOCARTA_NPC_PATHWAY"
115,"Down",0.00465617967427997,0.0392439289925213,"L.LvsP.REACTOME_PROTEIN_FOLDING"
58,"Down",0.00469821778051943,0.039537969723732,"L.LvsP.KEGG_BASAL_CELL_CARCINOMA"
110,"Down",0.00472423122117453,0.0396654963814004,"L.LvsP.AMIT_SERUM_RESPONSE_240_MCF10A"
13,"Up",0.00472771968083611,0.0396654963814004,"L.LvsP.REACTOME_LINOLEIC_ACID_LA_METABOLISM"
86,"Down",0.00475173821587151,0.03980660696296,"L.LvsP.DIRMEIER_LMP1_RESPONSE_LATE_UP"
44,"Down",0.00477471001725756,0.0399385350762739,"L.LvsP.DANG_MYC_TARGETS_DN"
25,"Up",0.00481911775987889,0.0402490968192906,"L.LvsP.REACTOME_SYNTHESIS_OF_VERY_LONG_CHAIN_FATTY_ACYL_COAS"
112,"Up",0.0048539598542309,0.0404789502775907,"L.LvsP.TANG_SENESCENCE_TP53_TARGETS_DN"
57,"Up",0.00487066635225313,0.0404987040017552,"L.LvsP.ABBUD_LIF_SIGNALING_1_UP"
120,"Down",0.004870978144541,0.0404987040017552,"L.LvsP.REACTOME_MYD88_INDEPENDENT_TLR4_CASCADE"
68,"Down",0.00488874095141097,0.0405853584389658,"L.LvsP.REACTOME_SCF_SKP2_MEDIATED_DEGRADATION_OF_P27_P21"
54,"Down",0.00490661383071791,0.0406726654723228,"L.LvsP.BIOCARTA_MET_PATHWAY"
46,"Down",0.0049237104891565,0.0407131533506562,"L.LvsP.MOREIRA_RESPONSE_TO_TSA_UP"
167,"Up",0.00492622528334038,0.0407131533506562,"L.LvsP.REACTOME_MITOTIC_PROPHASE"
103,"Down",0.00493785955564276,0.0407483962435057,"L.LvsP.SANSOM_WNT_PATHWAY_REQUIRE_MYC"
33,"Up",0.00497845595244119,0.0410221802698172,"L.LvsP.REACTOME_TRANSFERRIN_ENDOCYTOSIS_AND_RECYCLING"
80,"Down",0.00499499133775047,0.0410743108004497,"L.LvsP.REACTOME_APOPTOTIC_EXECUTION_PHASE"
18,"Down",0.00499964029095725,0.0410743108004497,"L.LvsP.REACTOME_SEMA4D_MEDIATED_INHIBITION_OF_CELL_ATTACHMENT_AND_MIGRATION"
6,"Down",0.00504331553382511,0.0413716492381588,"L.LvsP.REACTOME_FORMATION_OF_XYLULOSE_5_PHOSPHATE"
34,"Up",0.005060933243937,0.0414546665270039,"L.LvsP.FUJIWARA_PARK2_HEPATOCYTE_PROLIFERATION_UP"
23,"Up",0.00510347033431912,0.0417412536663468,"L.LvsP.REACTOME_PHOSPHORYLATION_OF_THE_APC_C"
28,"Down",0.00512830628976741,0.0418824305408035,"L.LvsP.REACTOME_NOTCH4_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION"
18,"Up",0.00518620062136226,0.0422432271361451,"L.LvsP.REACTOME_SYNTHESIS_OF_GLYCOSYLPHOSPHATIDYLINOSITOL_GPI"
6,"Up",0.0052003673922747,0.0422432271361451,"L.LvsP.REACTOME_SYNTHESIS_OF_DOLICHYL_PHOSPHATE"
40,"Up",0.00520260320880153,0.0422432271361451,"L.LvsP.REACTOME_HDR_THROUGH_SINGLE_STRAND_ANNEALING_SSA"
18,"Down",0.00520304533906942,0.0422432271361451,"L.LvsP.REACTOME_RUNX3_REGULATES_P14_ARF"
335,"Down",0.0052387586395712,0.0424708160090751,"L.LvsP.WANG_CISPLATIN_RESPONSE_AND_XPC_DN"
41,"Down",0.00525137965355298,0.0425108024955994,"L.LvsP.REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS"
74,"Down",0.00527487835094261,0.042577272745416,"L.LvsP.RASHI_RESPONSE_TO_IONIZING_RADIATION_3"
10,"Up",0.00527499219218845,0.042577272745416,"L.LvsP.REACTOME_BETA_OXIDATION_OF_PRISTANOYL_COA"
6,"Up",0.00529102360896516,0.0426444162302746,"L.LvsP.REACTOME_G2_M_DNA_REPLICATION_CHECKPOINT"
119,"Down",0.00530545889371472,0.0426985185201582,"L.LvsP.REACTOME_PI3K_AKT_SIGNALING_IN_CANCER"
89,"Down",0.00537504156659503,0.0431956465431743,"L.LvsP.SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES"
9,"Down",0.00542080060009089,0.0434500893733009,"L.LvsP.REACTOME_MODULATION_BY_MTB_OF_HOST_IMMUNE_SYSTEM"
9,"Up",0.00542242026905003,0.0434500893733009,"L.LvsP.REACTOME_FATTY_ACIDS_BOUND_TO_GPR40_FFAR1_REGULATE_INSULIN_SECRETION"
46,"Down",0.00545085356095608,0.0436147168430191,"L.LvsP.REACTOME_SYNTHESIS_OF_ACTIVE_UBIQUITIN_ROLES_OF_E1_AND_E2_ENZYMES"
67,"Down",0.00558334126326529,0.044522078296606,"L.LvsP.REACTOME_SIGNALING_BY_FGFR1"
34,"Down",0.00558461957657217,0.044522078296606,"L.LvsP.PARK_HSC_VS_MULTIPOTENT_PROGENITORS_UP"
10,"Down",0.0055884106235928,0.044522078296606,"L.LvsP.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_21"
69,"Up",0.00565841793956304,0.0450149536515742,"L.LvsP.GENTILE_UV_HIGH_DOSE_UP"
42,"Down",0.00570614460338474,0.0453294159656814,"L.LvsP.REACTOME_SIGNALING_BY_WNT_IN_CANCER"
21,"Down",0.00572620294543354,0.0454234951008638,"L.LvsP.REACTOME_P75NTR_SIGNALS_VIA_NF_KB"
98,"Up",0.00579799291107592,0.0459270813830068,"L.LvsP.LIANG_SILENCED_BY_METHYLATION_UP"
67,"Down",0.00581214518458858,0.0459424506432681,"L.LvsP.NAKAMURA_METASTASIS"
14,"Up",0.00581655189912963,0.0459424506432681,"L.LvsP.REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_LINKED_TO_LIPOGENESIS"
90,"Down",0.0058539331567487,0.0461717495344702,"L.LvsP.PID_LYSOPHOSPHOLIPID_PATHWAY"
33,"Down",0.00586900311604459,0.0462246698413255,"L.LvsP.BIOCARTA_CTCF_PATHWAY"
65,"Up",0.00592252257894985,0.0465798397425515,"L.LvsP.SESTO_RESPONSE_TO_UV_C3"
140,"Up",0.00599953916842707,0.047054680143758,"L.LvsP.KEGG_LYSOSOME"
32,"Down",0.00599991852077218,0.047054680143758,"L.LvsP.REACTOME_SEMA3A_PAK_DEPENDENT_AXON_REPULSION"
11,"Down",0.0060592094444461,0.0474523640486437,"L.LvsP.REACTOME_CREB_PHOSPHORYLATION"
22,"Down",0.00610974427269837,0.0477804470774389,"L.LvsP.VETTER_TARGETS_OF_PRKCA_AND_ETS1_UP"
64,"Down",0.00614534055751957,0.0478692849090399,"L.LvsP.REACTOME_DEGRADATION_OF_DVL"
20,"Down",0.00614678136649057,0.0478692849090399,"L.LvsP.SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX5_DN"
46,"Down",0.00614770827364353,0.0478692849090399,"L.LvsP.PID_PI3KCI_AKT_PATHWAY"
36,"Down",0.00616040664192747,0.0478692849090399,"L.LvsP.REACTOME_FGFR2_ALTERNATIVE_SPLICING"
23,"Down",0.00616439335417552,0.0478692849090399,"L.LvsP.REACTOME_SIGNALLING_TO_RAS"
27,"Down",0.00617539271114189,0.0478874422158535,"L.LvsP.REACTOME_NEGATIVE_REGULATION_OF_MET_ACTIVITY"
22,"Up",0.00621241817332682,0.0481070869472324,"L.LvsP.REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS"
26,"Down",0.00624027288179249,0.0482552010677353,"L.LvsP.BIOCARTA_PTEN_PATHWAY"
789,"Down",0.00626502518968995,0.0483789445164745,"L.LvsP.DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN"
75,"Down",0.00629136249156357,0.0485145651546095,"L.LvsP.JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP"
6,"Down",0.00632155714727116,0.04864173419274,"L.LvsP.REACTOME_MITOCHONDRIAL_FATTY_ACID_BETA_OXIDATION_OF_UNSATURATED_FATTY_ACIDS"
11,"Down",0.0063254488848942,0.04864173419274,"L.LvsP.REACTOME_PP2A_MEDIATED_DEPHOSPHORYLATION_OF_KEY_METABOLIC_FACTORS"
426,"Down",0.00643776592511193,0.049436677499922,"L.LvsP.GENTILE_UV_HIGH_DOSE_DN"
325,"Down",0.00645748604585585,0.0495193347399959,"L.LvsP.TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN"
15,"Up",0.00650209404666488,0.0497923517784074,"L.LvsP.LIANG_SILENCED_BY_METHYLATION_DN"
53,"Down",0.0065132508050279,0.0498088017994458,"L.LvsP.REACTOME_CROSS_PRESENTATION_OF_SOLUBLE_EXOGENOUS_ANTIGENS_ENDOSOMES"
30,"Down",0.00660034653785535,0.0503452650460222,"L.LvsP.SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_UP"
49,"Down",0.00660161279767881,0.0503452650460222,"L.LvsP.PID_WNT_NONCANONICAL_PATHWAY"
17,"Down",0.00666398151324657,0.0507297239132783,"L.LvsP.BIOCARTA_SM_PATHWAY"
67,"Down",0.00667037606890095,0.0507297239132783,"L.LvsP.PID_ILK_PATHWAY"
30,"Down",0.00681932331786326,0.0517912618467939,"L.LvsP.HOLLEMAN_VINCRISTINE_RESISTANCE_ALL_DN"
61,"Down",0.00683033593015496,0.0518037412315868,"L.LvsP.REACTOME_RUNX2_REGULATES_BONE_DEVELOPMENT"
50,"Down",0.00688167110190827,0.0521215883869189,"L.LvsP.REACTOME_GAP_JUNCTION_TRAFFICKING_AND_REGULATION"
19,"Up",0.00690286212841802,0.0522105673160373,"L.LvsP.MINGUEZ_LIVER_CANCER_VASCULAR_INVASION_UP"
84,"Down",0.00692095751281688,0.0522759208857439,"L.LvsP.REACTOME_NUCLEAR_ENVELOPE_NE_REASSEMBLY"
6,"Up",0.00694609679746412,0.0523794507331259,"L.LvsP.REACTOME_MOLYBDENUM_COFACTOR_BIOSYNTHESIS"
7,"Down",0.00695361129284037,0.0523794507331259,"L.LvsP.REACTOME_DEX_H_BOX_HELICASES_ACTIVATE_TYPE_I_IFN_AND_INFLAMMATORY_CYTOKINES_PRODUCTION"
544,"Up",0.00698910270621277,0.0525218047333505,"L.LvsP.WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN"
92,"Down",0.00699150809979127,0.0525218047333505,"L.LvsP.VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1"
96,"Down",0.00700208008347885,0.0525298518067226,"L.LvsP.PETROVA_PROX1_TARGETS_DN"
17,"Up",0.00702551103435733,0.0526342147817909,"L.LvsP.REACTOME_ELEVATION_OF_CYTOSOLIC_CA2_LEVELS"
162,"Down",0.00707013512421181,0.0528968567006321,"L.LvsP.HOEBEKE_LYMPHOID_STEM_CELL_UP"
22,"Down",0.00708388840700979,0.0529281337869691,"L.LvsP.REACTOME_POST_CHAPERONIN_TUBULIN_FOLDING_PATHWAY"
10,"Up",0.00712637100161768,0.0531059815686077,"L.LvsP.REACTOME_E2F_ENABLED_INHIBITION_OF_PRE_REPLICATION_COMPLEX_FORMATION"
92,"Down",0.00712690148741308,0.0531059815686077,"L.LvsP.PID_TRKR_PATHWAY"
107,"Down",0.00715105669345395,0.0532142563366176,"L.LvsP.REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS"
56,"Down",0.0071715584331085,0.0532950894847539,"L.LvsP.MURAKAMI_UV_RESPONSE_6HR_UP"
82,"Down",0.0072063598202518,0.0534818301290902,"L.LvsP.REACTOME_THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT"
567,"Down",0.00731976270925475,0.054250627371943,"L.LvsP.PHONG_TNF_RESPONSE_NOT_VIA_P38"
26,"Down",0.00735655459549103,0.0544503217650199,"L.LvsP.PID_BETA_CATENIN_DEG_PATHWAY"
82,"Down",0.00744445835480678,0.0550272864220945,"L.LvsP.REACTOME_REGULATION_OF_PTEN_STABILITY_AND_ACTIVITY"
17,"Down",0.00746698085542272,0.0551131827058405,"L.LvsP.BIOCARTA_RANBP2_PATHWAY"
31,"Down",0.00747601501707006,0.0551131827058405,"L.LvsP.BIOCARTA_AKT_PATHWAY"
35,"Up",0.00753133240149411,0.0554470530597349,"L.LvsP.TERAMOTO_OPN_TARGETS_CLUSTER_6"
109,"Down",0.00756713592171013,0.055636561849914,"L.LvsP.KEGG_MELANOGENESIS"
251,"Down",0.0075827796801456,0.0556500076064163,"L.LvsP.HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_UP"
305,"Down",0.00758909490599347,0.0556500076064163,"L.LvsP.WANG_TUMOR_INVASIVENESS_DN"
181,"Down",0.00762418493912714,0.0558332695740847,"L.LvsP.HOSHIDA_LIVER_CANCER_SUBCLASS_S2"
106,"Down",0.0076665630601855,0.0560693480949281,"L.LvsP.PID_AR_PATHWAY"
20,"Down",0.00771128463846039,0.0563158439593161,"L.LvsP.BIOCARTA_CBL_PATHWAY"
25,"Down",0.00772639652160741,0.0563158439593161,"L.LvsP.YIH_RESPONSE_TO_ARSENITE_C4"
179,"Down",0.00773082394015572,0.0563158439593161,"L.LvsP.REACTOME_AUTOPHAGY"
300,"Up",0.00775638124491988,0.0564276735567921,"L.LvsP.REACTOME_DISEASES_OF_METABOLISM"
77,"Down",0.00781419241027361,0.0567735477482297,"L.LvsP.KEGG_COLORECTAL_CANCER"
9,"Down",0.00785144565923364,0.0569693478345181,"L.LvsP.REACTOME_UPTAKE_AND_FUNCTION_OF_DIPHTHERIA_TOXIN"
55,"Down",0.00795005711292266,0.0576092605207725,"L.LvsP.VALK_AML_CLUSTER_10"
79,"Down",0.00799429458568162,0.0578539983825048,"L.LvsP.KEGG_RENAL_CELL_CARCINOMA"
25,"Up",0.0080256522415552,0.0580050081615146,"L.LvsP.BIOCARTA_ERAD_PATHWAY"
16,"Down",0.00805996132238855,0.0581769270907132,"L.LvsP.REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_CELL_DEATH_GENES"
180,"Up",0.00812024642488515,0.0585356486091134,"L.LvsP.LIM_MAMMARY_LUMINAL_MATURE_UP"
116,"Down",0.0081893769074891,0.0589571157832125,"L.LvsP.KEGG_GNRH_SIGNALING_PATHWAY"
36,"Down",0.00830967945218853,0.0597454066204816,"L.LvsP.REACTOME_SIGNAL_TRANSDUCTION_BY_L1"
197,"Down",0.00835792760992301,0.0600142620198238,"L.LvsP.WOO_LIVER_CANCER_RECURRENCE_UP"
25,"Down",0.00838726538448971,0.0601468097416908,"L.LvsP.FINETTI_BREAST_CANCERS_KINOME_GRAY"
25,"Up",0.00840858504667086,0.060221589019486,"L.LvsP.REACTOME_PURINE_CATABOLISM"
25,"Down",0.00842839121712625,0.0602853493395745,"L.LvsP.REACTOME_SIGNALING_BY_ERBB2_ECD_MUTANTS"
33,"Down",0.00851175637557063,0.0608029728689018,"L.LvsP.GAZIN_EPIGENETIC_SILENCING_BY_KRAS"
62,"Down",0.00861469564899785,0.0614589061203988,"L.LvsP.BIOCARTA_INTEGRIN_PATHWAY"
48,"Down",0.0086994259610957,0.0619834099728069,"L.LvsP.REACTOME_NEGATIVE_REGULATION_OF_FGFR1_SIGNALING"
8,"Down",0.00871757149840929,0.0620327578052831,"L.LvsP.REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_INTERLEUKIN_SIGNALING"
70,"Up",0.00876339458677513,0.062278674383393,"L.LvsP.KEGG_GLYCOLYSIS_GLUCONEOGENESIS"
24,"Down",0.00890934302845275,0.0632346053970671,"L.LvsP.VISALA_RESPONSE_TO_HEAT_SHOCK_AND_AGING_DN"
465,"Down",0.00901306708698452,0.0638628856538719,"L.LvsP.GRESHOCK_CANCER_COPY_NUMBER_UP"
36,"Down",0.00902096467637438,0.0638628856538719,"L.LvsP.GENTILE_UV_RESPONSE_CLUSTER_D9"
75,"Down",0.00906779361572573,0.0641123157306235,"L.LvsP.PID_HEDGEHOG_GLI_PATHWAY"
23,"Down",0.00910085965364392,0.0642639246807116,"L.LvsP.REACTOME_GAB1_SIGNALOSOME"
138,"Down",0.00911395285790599,0.0642742925400028,"L.LvsP.BONCI_TARGETS_OF_MIR15A_AND_MIR16_1"
17,"Down",0.00916142034503557,0.0644629682997842,"L.LvsP.FU_INTERACT_WITH_ALKBH8"
11,"Down",0.00917321648442501,0.0644629682997842,"L.LvsP.BIOCARTA_NOTCH_PATHWAY"
24,"Down",0.00917568385818958,0.0644629682997842,"L.LvsP.BIOCARTA_ACTINY_PATHWAY"
14,"Down",0.00926888861973031,0.0649754642425708,"L.LvsP.XU_HGF_TARGETS_REPRESSED_BY_AKT1_UP"
11,"Down",0.0092721362429713,0.0649754642425708,"L.LvsP.WILLIAMS_ESR1_TARGETS_DN"
239,"Down",0.00928903518736732,0.0650114880391822,"L.LvsP.KEGG_FOCAL_ADHESION"
30,"Down",0.00934247411829867,0.065257894631781,"L.LvsP.YIH_RESPONSE_TO_ARSENITE_C2"
160,"Down",0.00934784817297351,0.065257894631781,"L.LvsP.REACTOME_PTEN_REGULATION"
120,"Down",0.009400111416065,0.0655399949803573,"L.LvsP.PID_BETA_CATENIN_NUC_PATHWAY"
40,"Up",0.00947735290805591,0.0658933826369712,"L.LvsP.SIMBULAN_PARP1_TARGETS_DN"
92,"Down",0.00948547730356689,0.0658933826369712,"L.LvsP.MALONEY_RESPONSE_TO_17AAG_UP"
18,"Down",0.00948654957117546,0.0658933826369712,"L.LvsP.NADELLA_PRKAR1A_TARGETS_DN"
156,"Down",0.00952966455003595,0.0661098058935368,"L.LvsP.ZAMORA_NOS2_TARGETS_DN"
27,"Down",0.00960769114221728,0.0665045631790198,"L.LvsP.REACTOME_CD163_MEDIATING_AN_ANTI_INFLAMMATORY_RESPONSE"
134,"Down",0.00961062506421357,0.0665045631790198,"L.LvsP.DELASERNA_MYOD_TARGETS_UP"
26,"Down",0.00971622020283175,0.0671512268768209,"L.LvsP.SCHWAB_TARGETS_OF_BMYB_POLYMORPHIC_VARIANTS_DN"
14,"Up",0.00987171294026745,0.0681407001831944,"L.LvsP.REACTOME_IRAK4_DEFICIENCY_TLR2_4"
52,"Down",0.00990100376797998,0.0682576681211488,"L.LvsP.PID_BMP_PATHWAY"
201,"Up",0.00996470245360798,0.0685581767258602,"L.LvsP.REACTOME_G2_M_CHECKPOINTS"
15,"Down",0.00996939303447127,0.0685581767258602,"L.LvsP.REACTOME_PI3K_EVENTS_IN_ERBB4_SIGNALING"
17,"Down",0.00998988837921447,0.0686137799362445,"L.LvsP.REACTOME_REPRESSION_OF_WNT_TARGET_GENES"
18,"Down",0.0100659590322386,0.0690504807558896,"L.LvsP.ZAIDI_OSTEOBLAST_TRANSCRIPTION_FACTORS"
49,"Down",0.010101248586408,0.0692066957053899,"L.LvsP.GENTILE_UV_RESPONSE_CLUSTER_D6"
295,"Down",0.0101475023757855,0.0694003040491399,"L.LvsP.LI_AMPLIFIED_IN_LUNG_CANCER"
5,"Up",0.0101546113177345,0.0694003040491399,"L.LvsP.REACTOME_SYNTHESIS_OF_GDP_MANNOSE"
77,"Up",0.0101999125465875,0.0696238474939287,"L.LvsP.BURTON_ADIPOGENESIS_PEAK_AT_16HR"
35,"Down",0.0102243260473734,0.0697044373809216,"L.LvsP.JIANG_TIP30_TARGETS_DN"
62,"Down",0.0102648063234645,0.0698822858162753,"L.LvsP.VALK_AML_CLUSTER_6"
62,"Down",0.01027569151178,0.0698822858162753,"L.LvsP.REACTOME_FORMATION_OF_RNA_POL_II_ELONGATION_COMPLEX"
202,"Up",0.0103243853140695,0.0701271823114132,"L.LvsP.REACTOME_MEIOSIS"
66,"Down",0.0103669022012423,0.0703295733382439,"L.LvsP.REACTOME_SIGNALING_BY_MODERATE_KINASE_ACTIVITY_BRAF_MUTANTS"
8,"Up",0.0104376042644981,0.0706453967232524,"L.LvsP.REACTOME_SYNTHESIS_OF_KETONE_BODIES"
8,"Up",0.0104390105123706,0.0706453967232524,"L.LvsP.IM_SREBF1A_TARGETS"
185,"Up",0.0105725366207221,0.0714615586503334,"L.LvsP.REACTOME_AMYLOID_FIBER_FORMATION"
17,"Down",0.0105959000078328,0.0715320282580071,"L.LvsP.REACTOME_ERBB2_REGULATES_CELL_MOTILITY"
70,"Down",0.010640591932806,0.0716237098738101,"L.LvsP.REACTOME_INTERLEUKIN_12_SIGNALING"
75,"Down",0.0106466375277791,0.0716237098738101,"L.LvsP.LEE_CALORIE_RESTRICTION_MUSCLE_DN"
34,"Down",0.0106483431933934,0.0716237098738101,"L.LvsP.RUNNE_GENDER_EFFECT_UP"
203,"Up",0.0106715027950052,0.0716922709035043,"L.LvsP.CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN"
28,"Down",0.010687641111983,0.0717135530438761,"L.LvsP.KEGG_DORSO_VENTRAL_AXIS_FORMATION"
1255,"Down",0.0107953488404233,0.0723484651378187,"L.LvsP.DACOSTA_UV_RESPONSE_VIA_ERCC3_DN"
22,"Down",0.010884967346875,0.072860756005898,"L.LvsP.REACTOME_YAP1_AND_WWTR1_TAZ_STIMULATED_GENE_EXPRESSION"
18,"Down",0.010961758462329,0.0732125329557346,"L.LvsP.REACTOME_GRB2_EVENTS_IN_ERBB2_SIGNALING"
546,"Up",0.0109681479870951,0.0732125329557346,"L.LvsP.BLUM_RESPONSE_TO_SALIRASIB_DN"
34,"Down",0.0109772454006699,0.0732125329557346,"L.LvsP.KAPOSI_LIVER_CANCER_MET_UP"
11,"Up",0.0110022289523872,0.0732907516599387,"L.LvsP.REACTOME_KETONE_BODY_METABOLISM"
155,"Up",0.011043013485955,0.0733950694163119,"L.LvsP.REACTOME_ACTIVATION_OF_ANTERIOR_HOX_GENES_IN_HINDBRAIN_DEVELOPMENT_DURING_EARLY_EMBRYOGENESIS"
191,"Down",0.0110444380094721,0.0733950694163119,"L.LvsP.SESTO_RESPONSE_TO_UV_C0"
7,"Up",0.0110740402918636,0.0735034439060187,"L.LvsP.REACTOME_WAX_AND_PLASMALOGEN_BIOSYNTHESIS"
9,"Down",0.0111696059357268,0.0739996222968996,"L.LvsP.REACTOME_INTERLEUKIN_1_PROCESSING"
63,"Down",0.0111886531380437,0.0739996222968996,"L.LvsP.STREICHER_LSM1_TARGETS_UP"
62,"Down",0.011188946326679,0.0739996222968996,"L.LvsP.KEGG_VASOPRESSIN_REGULATED_WATER_REABSORPTION"
32,"Down",0.0112132995374949,0.0740215619547556,"L.LvsP.BIOCARTA_IL6_PATHWAY"
49,"Up",0.0112315326141994,0.0740215619547556,"L.LvsP.WANG_ADIPOGENIC_GENES_REPRESSED_BY_SIRT1"
70,"Down",0.0112554658908134,0.0740215619547556,"L.LvsP.SIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES"
53,"Down",0.011259167963705,0.0740215619547556,"L.LvsP.REACTOME_MAP2K_AND_MAPK_ACTIVATION"
95,"Down",0.0112592030392385,0.0740215619547556,"L.LvsP.GU_PDEF_TARGETS_DN"
57,"Up",0.0113044501531198,0.0741623539748997,"L.LvsP.WAKASUGI_HAVE_ZNF143_BINDING_SITES"
11,"Down",0.0113117203357574,0.0741623539748997,"L.LvsP.BIOCARTA_SALMONELLA_PATHWAY"
19,"Up",0.0113208585195904,0.0741623539748997,"L.LvsP.REACTOME_PENTOSE_PHOSPHATE_PATHWAY"
35,"Down",0.0113571364877258,0.0743119617048945,"L.LvsP.BIOCARTA_GSK3_PATHWAY"
323,"Up",0.0114247525952763,0.0746660249400505,"L.LvsP.VILLANUEVA_LIVER_CANCER_KRT19_UP"
41,"Down",0.0115051246682417,0.0750163199426927,"L.LvsP.PID_EPHA2_FWD_PATHWAY"
51,"Up",0.0115301152184254,0.0750163199426927,"L.LvsP.KORKOLA_TERATOMA"
127,"Up",0.0115393650346801,0.0750163199426927,"L.LvsP.REACTOME_HCMV_LATE_EVENTS"
34,"Down",0.0115407884306373,0.0750163199426927,"L.LvsP.BIOCARTA_MAL_PATHWAY"
344,"Down",0.0115461906802734,0.0750163199426927,"L.LvsP.LINDGREN_BLADDER_CANCER_CLUSTER_3_DN"
26,"Up",0.0116074053669351,0.0753255214481033,"L.LvsP.KEGG_SELENOAMINO_ACID_METABOLISM"
105,"Down",0.0116297743315277,0.0753822066576984,"L.LvsP.HUPER_BREAST_BASAL_VS_LUMINAL_DN"
23,"Down",0.0116570316847542,0.0754066668348556,"L.LvsP.REACTOME_ASSEMBLY_OF_THE_HIV_VIRION"
106,"Down",0.0116608247682766,0.0754066668348556,"L.LvsP.KEGG_GAP_JUNCTION"
41,"Up",0.0117120194438679,0.0756492470854503,"L.LvsP.REACTOME_GLUTATHIONE_CONJUGATION"
54,"Down",0.0117323052800895,0.0756518161658357,"L.LvsP.PID_IFNG_PATHWAY"
50,"Down",0.0117397826497173,0.0756518161658357,"L.LvsP.REACTOME_FORMATION_OF_INCISION_COMPLEX_IN_GG_NER"
76,"Up",0.0117646762135766,0.0756537870463015,"L.LvsP.NEMETH_INFLAMMATORY_RESPONSE_LPS_DN"
58,"Down",0.0117755680072063,0.0756537870463015,"L.LvsP.PARK_HSC_MARKERS"
146,"Up",0.0117811377549042,0.0756537870463015,"L.LvsP.REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING"
36,"Up",0.0118029508369065,0.0757059340803434,"L.LvsP.KEGG_SNARE_INTERACTIONS_IN_VESICULAR_TRANSPORT"
12,"Up",0.0119893375737589,0.0768123377118341,"L.LvsP.REACTOME_CONDENSATION_OF_PROMETAPHASE_CHROMOSOMES"
172,"Down",0.0120201455892257,0.0769205844477188,"L.LvsP.DANG_MYC_TARGETS_UP"
10,"Down",0.0120419543979471,0.0769710588049125,"L.LvsP.BIOCARTA_TERT_PATHWAY"
127,"Down",0.0122302261941397,0.0780842039577346,"L.LvsP.REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK"
109,"Down",0.012277241715118,0.0782939670621541,"L.LvsP.THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP"
23,"Down",0.0123166518566729,0.0784548019764334,"L.LvsP.ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN"
33,"Down",0.0123752029740484,0.0787370509131344,"L.LvsP.BIOCARTA_HER2_PATHWAY"
129,"Down",0.0124221090055821,0.0789446444734061,"L.LvsP.HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_DN"
640,"Up",0.0127217291186322,0.080735139174505,"L.LvsP.STEIN_ESRRA_TARGETS_UP"
48,"Down",0.0127330514306689,0.080735139174505,"L.LvsP.KEGG_NOTCH_SIGNALING_PATHWAY"
65,"Down",0.0127613609965287,0.0808219529780154,"L.LvsP.PID_TCPTP_PATHWAY"
90,"Down",0.0127923502932068,0.0809245251846621,"L.LvsP.REACTOME_CIRCADIAN_CLOCK"
8,"Up",0.0128068293609295,0.0809245251846621,"L.LvsP.REACTOME_DNA_REPLICATION_INITIATION"
19,"Up",0.0128713625262836,0.0812394559450021,"L.LvsP.MATZUK_PREOVULATORY_FOLLICLE"
80,"Down",0.012908866432037,0.0813832639711886,"L.LvsP.MODY_HIPPOCAMPUS_PRENATAL"
11,"Up",0.0129552603884549,0.0815827274348147,"L.LvsP.REACTOME_SCAVENGING_BY_CLASS_B_RECEPTORS"
80,"Down",0.0129953183709406,0.0817418831318894,"L.LvsP.TONG_INTERACT_WITH_PTTG1"
110,"Down",0.0130778481545145,0.0821675255071711,"L.LvsP.REACTOME_TNFR2_NON_CANONICAL_NF_KB_PATHWAY"
39,"Down",0.0131320968006126,0.0824147142004397,"L.LvsP.WU_HBX_TARGETS_1_DN"
105,"Down",0.0132342999944731,0.08296195540753,"L.LvsP.PID_VEGFR1_2_PATHWAY"
22,"Down",0.0133266257880665,0.083404307947618,"L.LvsP.MEISSNER_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3"
25,"Down",0.0133350349476749,0.083404307947618,"L.LvsP.BIOCARTA_IL7_PATHWAY"
30,"Down",0.013364011538956,0.0834910958179524,"L.LvsP.REACTOME_ESTROGEN_DEPENDENT_NUCLEAR_EVENTS_DOWNSTREAM_OF_ESR_MEMBRANE_SIGNALING"
79,"Down",0.0134553712087593,0.0839669835363774,"L.LvsP.REACTOME_INTERLEUKIN_12_FAMILY_SIGNALING"
33,"Up",0.0134758317829881,0.0839998578671266,"L.LvsP.CHUANG_OXIDATIVE_STRESS_RESPONSE_DN"
11,"Down",0.0135749776111642,0.0845225801938363,"L.LvsP.DING_LUNG_CANCER_MUTATED_RECURRENTLY"
9,"Down",0.0135990094043988,0.0845769662507548,"L.LvsP.CASTELLANO_HRAS_TARGETS_DN"
17,"Down",0.0136909705584879,0.0850532317054829,"L.LvsP.OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_DN"
157,"Up",0.0137774830775278,0.0854344097744965,"L.LvsP.MORI_LARGE_PRE_BII_LYMPHOCYTE_UP"
89,"Down",0.0137832326856305,0.0854344097744965,"L.LvsP.REACTOME_CONSTITUTIVE_SIGNALING_BY_ABERRANT_PI3K_IN_CANCER"
51,"Down",0.0138625325736926,0.0858297229562668,"L.LvsP.REACTOME_RNA_POLYMERASE_I_TRANSCRIPTION_INITIATION"
82,"Down",0.0138968490385611,0.0859459489196919,"L.LvsP.LI_LUNG_CANCER"
178,"Up",0.0140524307078124,0.086811049590497,"L.LvsP.WHITFIELD_CELL_CYCLE_G1_S"
105,"Down",0.0141426277877075,0.0872442033350805,"L.LvsP.REACTOME_HEDGEHOG_ON_STATE"
10,"Up",0.0141541056957076,0.0872442033350805,"L.LvsP.REACTOME_METABOLISM_OF_INGESTED_SEMET_SEC_MESEC_INTO_H2SE"
35,"Down",0.0141785845014494,0.0872977658223984,"L.LvsP.BIOCARTA_MCALPAIN_PATHWAY"
56,"Down",0.014215451356413,0.0874273977192516,"L.LvsP.KEGG_BLADDER_CANCER"
113,"Up",0.0142494581728689,0.0875391713753245,"L.LvsP.HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_UP"
16,"Down",0.0144141607385997,0.0884527133448586,"L.LvsP.BIOCARTA_RELA_PATHWAY"
17,"Down",0.0144478553439866,0.0885078245415325,"L.LvsP.REACTOME_DISSOLUTION_OF_FIBRIN_CLOT"
181,"Up",0.0144551574536089,0.0885078245415325,"L.LvsP.MISSIAGLIA_REGULATED_BY_METHYLATION_DN"
203,"Down",0.0145120902763644,0.0887198600283604,"L.LvsP.WHITFIELD_CELL_CYCLE_M_G1"
136,"Down",0.0145218797839874,0.0887198600283604,"L.LvsP.CROMER_METASTASIS_UP"
13,"Up",0.0145700654731085,0.0889159955858906,"L.LvsP.KEGG_NON_HOMOLOGOUS_END_JOINING"
26,"Down",0.014630863305795,0.0890588246290502,"L.LvsP.BIOCARTA_MEF2D_PATHWAY"
45,"Down",0.0146376784502835,0.0890588246290502,"L.LvsP.PID_EPHA_FWDPATHWAY"
213,"Up",0.0146417926546946,0.0890588246290502,"L.LvsP.RUIZ_TNC_TARGETS_DN"
16,"Down",0.0148533661200097,0.0902464409643224,"L.LvsP.BIOCARTA_CDC42RAC_PATHWAY"
34,"Down",0.0148961709564213,0.0904071670889716,"L.LvsP.REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION"
88,"Down",0.0149142875895579,0.0904178685116949,"L.LvsP.PID_RB_1PATHWAY"
67,"Down",0.0149912743388513,0.0907850556621124,"L.LvsP.PID_NCADHERIN_PATHWAY"
42,"Down",0.0150275744006219,0.0909053160405233,"L.LvsP.BIOCARTA_PYK2_PATHWAY"
14,"Up",0.0150798602051452,0.0911219093707629,"L.LvsP.REACTOME_EICOSANOID_LIGAND_BINDING_RECEPTORS"
10,"Down",0.0151074087919497,0.091188715295513,"L.LvsP.REACTOME_LOSS_OF_FUNCTION_OF_SMAD2_3_IN_CANCER"
893,"Down",0.0152838453728116,0.0919656675926131,"L.LvsP.ENK_UV_RESPONSE_EPIDERMIS_DN"
14,"Up",0.0152851212416593,0.0919656675926131,"L.LvsP.BIOCARTA_SRCRPTP_PATHWAY"
46,"Down",0.0152895580973963,0.0919656675926131,"L.LvsP.HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_DN"
18,"Down",0.0153026612742275,0.0919656675926131,"L.LvsP.MALIK_REPRESSED_BY_ESTROGEN"
389,"Up",0.0153644567534474,0.0921581320915709,"L.LvsP.CHICAS_RB1_TARGETS_GROWING"
42,"Down",0.0153680227506653,0.0921581320915709,"L.LvsP.REACTOME_ACTIVATED_NOTCH1_TRANSMITS_SIGNAL_TO_THE_NUCLEUS"
15,"Up",0.0153875559858969,0.0921752947410876,"L.LvsP.BIOCARTA_CPSF_PATHWAY"
13,"Down",0.0154392110581934,0.0923846298060078,"L.LvsP.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_7"
63,"Up",0.015501599839518,0.092657670824535,"L.LvsP.ZHAN_MULTIPLE_MYELOMA_LB_DN"
87,"Down",0.0155220417339778,0.0926796638738265,"L.LvsP.BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN"
25,"Down",0.0156280673682066,0.0932120652414393,"L.LvsP.REACTOME_PINK_PARKIN_MEDIATED_MITOPHAGY"
12,"Up",0.015646661943447,0.093222407204007,"L.LvsP.REACTOME_FREE_FATTY_ACIDS_REGULATE_INSULIN_SECRETION"
69,"Down",0.0157658630859133,0.0938314930053978,"L.LvsP.BOYLAN_MULTIPLE_MYELOMA_C_UP"
79,"Up",0.0157928796207067,0.0938912165837496,"L.LvsP.HOLLERN_MICROACINAR_BREAST_TUMOR_UP"
107,"Down",0.0158998837673454,0.0944258403326025,"L.LvsP.KYNG_RESPONSE_TO_H2O2"
12,"Up",0.0161419225288472,0.095760396633043,"L.LvsP.KREPPEL_CD99_TARGETS_DN"
29,"Down",0.0163057723508186,0.0966287409728575,"L.LvsP.NOUSHMEHR_GBM_SOMATIC_MUTATED"
5,"Down",0.0163552657878261,0.0967766007308983,"L.LvsP.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_18"
42,"Down",0.016365730092854,0.0967766007308983,"L.LvsP.NOJIMA_SFRP2_TARGETS_DN"
17,"Down",0.0164710465578221,0.0971252411626178,"L.LvsP.REACTOME_IRAK1_RECRUITS_IKK_COMPLEX"
115,"Up",0.0164747139298116,0.0971252411626178,"L.LvsP.SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE"
14,"Down",0.0164773876307715,0.0971252411626178,"L.LvsP.BRUNEAU_HEART_GREAT_VESSELS_AND_VALVULOGENESIS"
10,"Down",0.0165033427053992,0.0971746345241237,"L.LvsP.TURASHVILI_BREAST_CARCINOMA_DUCTAL_VS_LOBULAR_DN"
25,"Up",0.0165316222508287,0.0972375951327998,"L.LvsP.SMID_BREAST_CANCER_LUMINAL_A_DN"
133,"Down",0.0166764065413184,0.0979157197893701,"L.LvsP.GAVIN_FOXP3_TARGETS_CLUSTER_T7"
710,"Down",0.016682330989616,0.0979157197893701,"L.LvsP.REACTOME_CELLULAR_RESPONSES_TO_EXTERNAL_STIMULI"
27,"Down",0.0167475287451837,0.098194153162376,"L.LvsP.FOURNIER_ACINAR_DEVELOPMENT_EARLY_UP"
59,"Down",0.0168143141923112,0.0984196193979297,"L.LvsP.PID_IL8_CXCR2_PATHWAY"
96,"Down",0.0168364289443039,0.0984196193979297,"L.LvsP.REACTOME_CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY"
12,"Down",0.0168393850516263,0.0984196193979297,"L.LvsP.REACTOME_ARMS_MEDIATED_ACTIVATION"
14,"Down",0.0170333655443242,0.0993452144018371,"L.LvsP.BIOCARTA_DSP_PATHWAY"
127,"Down",0.0170336884161587,0.0993452144018371,"L.LvsP.PID_SMAD2_3NUCLEAR_PATHWAY"
16,"Up",0.0170997973963138,0.0996256899939082,"L.LvsP.KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_KERATAN_SULFATE"
120,"Down",0.0171272042179914,0.0996803285487097,"L.LvsP.REACTOME_UCH_PROTEINASES"
24,"Down",0.0172065031522324,0.0999745152434046,"L.LvsP.REACTOME_G_BETA_GAMMA_SIGNALLING_THROUGH_CDC42"
77,"Up",0.017213915447951,0.0999745152434046,"L.LvsP.HAHTOLA_CTCL_CUTANEOUS"
52,"Down",0.0172729131956118,0.100211896178948,"L.LvsP.REACTOME_ATTENUATION_PHASE"
21,"Up",0.0173249993131551,0.100408722434418,"L.LvsP.KRISHNAN_FURIN_TARGETS_DN"
19,"Down",0.0174231586448771,0.100871878688508,"L.LvsP.REACTOME_PTK6_REGULATES_RHO_GTPASES_RAS_GTPASE_AND_MAP_KINASES"
7,"Down",0.0174918971993204,0.101163911731216,"L.LvsP.REACTOME_MET_ACTIVATES_PTPN11"
43,"Up",0.0177963091775142,0.102816921047519,"L.LvsP.KEGG_BUTANOATE_METABOLISM"
11,"Up",0.0178514808328724,0.102930657800622,"L.LvsP.MATHEW_FANCONI_ANEMIA_GENES"
71,"Down",0.0178532285821661,0.102930657800622,"L.LvsP.BEIER_GLIOMA_STEM_CELL_UP"
62,"Up",0.0179565114226321,0.103418282974722,"L.LvsP.REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS"
16,"Down",0.0179878370922319,0.10349089623616,"L.LvsP.RAMPON_ENRICHED_LEARNING_ENVIRONMENT_EARLY_DN"
6,"Up",0.0182431302687093,0.104842586953398,"L.LvsP.REACTOME_GDP_FUCOSE_BIOSYNTHESIS"
20,"Down",0.0182607001693114,0.104842586953398,"L.LvsP.MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_UP"
8,"Down",0.0183406443419915,0.105192347061069,"L.LvsP.REACTOME_FBXW7_MUTANTS_AND_NOTCH1_IN_CANCER"
13,"Down",0.0184955960768106,0.105971140630763,"L.LvsP.REACTOME_ERBB2_ACTIVATES_PTK6_SIGNALING"
32,"Down",0.0185504759874428,0.106175550449867,"L.LvsP.REACTOME_SEMA3A_PLEXIN_REPULSION_SIGNALING_BY_INHIBITING_INTEGRIN_ADHESION"
271,"Down",0.0186046733398198,0.106375634845774,"L.LvsP.REACTOME_NEDDYLATION"
107,"Down",0.0187004079274588,0.106716096562667,"L.LvsP.FONTAINE_PAPILLARY_THYROID_CARCINOMA_UP"
8,"Up",0.0187028210470654,0.106716096562667,"L.LvsP.FARDIN_HYPOXIA_9"
70,"Down",0.018752635436429,0.106890021987645,"L.LvsP.ZHAN_MULTIPLE_MYELOMA_MS_UP"
19,"Down",0.0188009482968118,0.107055039271959,"L.LvsP.REACTOME_TRANSPORT_OF_CONNEXONS_TO_THE_PLASMA_MEMBRANE"
32,"Up",0.0188664284811886,0.107239058348218,"L.LvsP.KEGG_O_GLYCAN_BIOSYNTHESIS"
39,"Down",0.0188720571121027,0.107239058348218,"L.LvsP.BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_UP"
17,"Down",0.0189133672380051,0.107277369571082,"L.LvsP.FIGUEROA_AML_METHYLATION_CLUSTER_5_UP"
19,"Up",0.0189176045092793,0.107277369571082,"L.LvsP.REACTOME_SYNTHESIS_OF_PIPS_AT_THE_EARLY_ENDOSOME_MEMBRANE"
71,"Down",0.0190126520102927,0.107705894431259,"L.LvsP.REACTOME_SIGNALING_BY_NOTCH3"
41,"Up",0.0190953902578916,0.108063882022398,"L.LvsP.REACTOME_GLYCOSPHINGOLIPID_METABOLISM"
176,"Up",0.0191462806338938,0.108241089595909,"L.LvsP.CADWELL_ATG16L1_TARGETS_UP"
14,"Up",0.0191800597167307,0.108321297419616,"L.LvsP.BIOCARTA_AMAN_PATHWAY"
8,"Down",0.0192318622546175,0.108503026944674,"L.LvsP.GAUTSCHI_SRC_SIGNALING"
81,"Down",0.0192638976698428,0.108572976775291,"L.LvsP.SESTO_RESPONSE_TO_UV_C5"
15,"Down",0.01929937064627,0.108585638561456,"L.LvsP.BIOCARTA_ERYTH_PATHWAY"
31,"Down",0.0193054228080866,0.108585638561456,"L.LvsP.TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_MONOCYTE_UP"
538,"Up",0.0193347182802724,0.108639895702872,"L.LvsP.AFFAR_YY1_TARGETS_DN"
90,"Down",0.0195222536467007,0.109582274530567,"L.LvsP.KAAB_FAILED_HEART_ATRIUM_UP"
7,"Down",0.0195528449401694,0.109642677154358,"L.LvsP.REACTOME_IKBA_VARIANT_LEADS_TO_EDA_ID"
13,"Up",0.0197541860123175,0.110659467540125,"L.LvsP.REACTOME_SMAC_XIAP_REGULATED_APOPTOTIC_RESPONSE"
6,"Up",0.0198558593036248,0.11111644341067,"L.LvsP.CALVET_IRINOTECAN_SENSITIVE_VS_RESISTANT_UP"
13,"Down",0.0198911582790406,0.1112014298532,"L.LvsP.REACTOME_P38MAPK_EVENTS"
43,"Down",0.0199328238732608,0.111214583096879,"L.LvsP.BIOCARTA_AT1R_PATHWAY"
261,"Up",0.0199337406129512,0.111214583096879,"L.LvsP.KAUFFMANN_DNA_REPAIR_GENES"
20,"Down",0.0199653792252187,0.111278812234107,"L.LvsP.BIOCARTA_HSP27_PATHWAY"
7,"Up",0.0200378573461654,0.111570305404782,"L.LvsP.REACTOME_SULFIDE_OXIDATION_TO_SULFATE"
6,"Up",0.0201189662643391,0.111806073836444,"L.LvsP.CROSBY_E2F4_TARGETS"
16,"Down",0.0201206445048403,0.111806073836444,"L.LvsP.HASINA_NOL7_TARGETS_UP"
67,"Down",0.0202297345588724,0.112226405663127,"L.LvsP.FIRESTEIN_CTNNB1_PATHWAY"
26,"Down",0.020236883061338,0.112226405663127,"L.LvsP.AMIT_DELAYED_EARLY_GENES"
199,"Down",0.0203526002882352,0.112663173459864,"L.LvsP.PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_DN"
25,"Down",0.0203563954216682,0.112663173459864,"L.LvsP.STARK_HYPPOCAMPUS_22Q11_DELETION_DN"
119,"Down",0.0204036014435617,0.112811512381452,"L.LvsP.GUO_HEX_TARGETS_UP"
151,"Up",0.0205609617458929,0.113567989503538,"L.LvsP.LE_EGR2_TARGETS_DN"
166,"Down",0.0207231787062081,0.114349755555514,"L.LvsP.REACTOME_INTERLEUKIN_1_FAMILY_SIGNALING"
117,"Up",0.0207710351277735,0.114499554557786,"L.LvsP.REACTOME_TRANSCRIPTIONAL_REGULATION_OF_GRANULOPOIESIS"
131,"Up",0.0208231782089071,0.114672661670366,"L.LvsP.RHODES_UNDIFFERENTIATED_CANCER"
62,"Down",0.0209236559173075,0.115111336882381,"L.LvsP.REACTOME_DEACTIVATION_OF_THE_BETA_CATENIN_TRANSACTIVATING_COMPLEX"
31,"Down",0.021078350855414,0.115847119164596,"L.LvsP.ALONSO_METASTASIS_NEURAL_UP"
379,"Up",0.0211859132744206,0.116252488758859,"L.LvsP.REACTOME_DNA_REPAIR"
9,"Up",0.0211941596435033,0.116252488758859,"L.LvsP.REACTOME_TRANSPORT_OF_NUCLEOTIDE_SUGARS"
16,"Down",0.0212430655073124,0.116405261833429,"L.LvsP.RADAEVA_RESPONSE_TO_IFNA1_DN"
69,"Up",0.0213754233194947,0.117014569835135,"L.LvsP.SMITH_LIVER_CANCER"
24,"Down",0.0214914013918976,0.117533094258953,"L.LvsP.REACTOME_NOTCH2_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION"
36,"Down",0.0215601062986651,0.117778304391399,"L.LvsP.REACTOME_ACTIVATION_OF_BH3_ONLY_PROTEINS"
10,"Up",0.0215788428917502,0.117778304391399,"L.LvsP.REACTOME_ZINC_INFLUX_INTO_CELLS_BY_THE_SLC39_GENE_FAMILY"
54,"Down",0.0216443074208484,0.118019108214862,"L.LvsP.RIZ_ERYTHROID_DIFFERENTIATION_12HR"
62,"Down",0.0216797666855461,0.118095990152103,"L.LvsP.SAGIV_CD24_TARGETS_DN"
21,"Down",0.0217217256295302,0.118208091541016,"L.LvsP.TOMLINS_METASTASIS_UP"
6,"Down",0.0218334721366558,0.11859254045481,"L.LvsP.MCGOWAN_RSP6_TARGETS_DN"
19,"Down",0.0218352697021154,0.11859254045481,"L.LvsP.REACTOME_NEF_AND_SIGNAL_TRANSDUCTION"
7,"Up",0.0218686720409159,0.118657397168032,"L.LvsP.MIKHAYLOVA_OXIDATIVE_STRESS_RESPONSE_VIA_VHL_DN"
152,"Up",0.0218902101464056,0.118657815587722,"L.LvsP.REACTOME_GOLGI_TO_ER_RETROGRADE_TRANSPORT"
137,"Up",0.0219945971330667,0.119106883005608,"L.LvsP.KRASNOSELSKAYA_ILF3_TARGETS_UP"
158,"Up",0.0220599295947999,0.119343787406701,"L.LvsP.NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP"
32,"Up",0.0221018391738648,0.119453635183088,"L.LvsP.CAFFAREL_RESPONSE_TO_THC_24HR_3_DN"
9,"Down",0.0221977089028916,0.119854621605554,"L.LvsP.REACTOME_TFAP2_AP_2_FAMILY_REGULATES_TRANSCRIPTION_OF_CELL_CYCLE_FACTORS"
58,"Down",0.0225296965787121,0.121493227511758,"L.LvsP.PID_HDAC_CLASSII_PATHWAY"
40,"Up",0.022545135002182,0.121493227511758,"L.LvsP.KEGG_FRUCTOSE_AND_MANNOSE_METABOLISM"
19,"Down",0.0226292658972978,0.121713182684444,"L.LvsP.THUM_MIR21_TARGETS_HEART_DISEASE_DN"
11,"Down",0.0226299786217414,0.121713182684444,"L.LvsP.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_LIGHTGREEN_DN"
10,"Down",0.0229029343325095,0.123061539285175,"L.LvsP.REACTOME_NEGATIVE_REGULATION_OF_ACTIVITY_OF_TFAP2_AP_2_FAMILY_TRANSCRIPTION_FACTORS"
39,"Down",0.0230198015622883,0.123569400813487,"L.LvsP.VERRECCHIA_RESPONSE_TO_TGFB1_C1"
9,"Down",0.0231916225523299,0.124265261052135,"L.LvsP.REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_WNT_SIGNALING"
43,"Down",0.0232078069049241,0.124265261052135,"L.LvsP.ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_DN"
167,"Down",0.0232168592271397,0.124265261052135,"L.LvsP.REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE"
22,"Down",0.0232398260207399,0.124267889814962,"L.LvsP.LOPEZ_EPITHELIOID_MESOTHELIOMA"
5,"Down",0.0233100531378368,0.124507444513447,"L.LvsP.REACTOME_DISINHIBITION_OF_SNARE_FORMATION"
114,"Down",0.0233296640470122,0.124507444513447,"L.LvsP.KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS"
46,"Down",0.0233867143937853,0.124691556300134,"L.LvsP.OSADA_ASCL1_TARGETS_DN"
101,"Up",0.0235083191170539,0.125219168013672,"L.LvsP.FURUKAWA_DUSP6_TARGETS_PCI35_DN"
177,"Down",0.0237331527557674,0.126286099714829,"L.LvsP.REACTOME_SIGNALING_BY_HEDGEHOG"
117,"Down",0.023754303437045,0.126286099714829,"L.LvsP.REACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING"
175,"Down",0.0239302595984298,0.127099332679845,"L.LvsP.REACTOME_L1CAM_INTERACTIONS"
12,"Down",0.0239907743350099,0.127298456140374,"L.LvsP.REACTOME_RUNX2_REGULATES_CHONDROCYTE_MATURATION"
10,"Up",0.0240847486210845,0.127674568673035,"L.LvsP.REACTOME_NEUROTOXICITY_OF_CLOSTRIDIUM_TOXINS"
94,"Up",0.0242808041443256,0.128590580568943,"L.LvsP.COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_UP"
17,"Up",0.0243168984456856,0.128658499048991,"L.LvsP.REACTOME_CYTOCHROME_C_MEDIATED_APOPTOTIC_RESPONSE"
69,"Down",0.024432900824677,0.129088660821159,"L.LvsP.PRAMOONJAGO_SOX4_TARGETS_UP"
110,"Up",0.0244448956194164,0.129088660821159,"L.LvsP.TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_UP"
16,"Down",0.0245427535343838,0.129481759820237,"L.LvsP.REACTOME_UPTAKE_AND_FUNCTION_OF_ANTHRAX_TOXINS"
37,"Down",0.0245782934247334,0.129545647612346,"L.LvsP.SIG_CD40PATHWAYMAP"
96,"Down",0.024637126471619,0.129732068820554,"L.LvsP.OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_UP"
20,"Down",0.0246782846824422,0.129825153196216,"L.LvsP.REACTOME_SUPPRESSION_OF_PHAGOSOMAL_MATURATION"
120,"Up",0.0247440474504657,0.13004737486086,"L.LvsP.REACTOME_COPI_MEDIATED_ANTEROGRADE_TRANSPORT"
10,"Up",0.0248196533636524,0.130171387144591,"L.LvsP.REACTOME_HDR_THROUGH_MMEJ_ALT_NHEJ"
7,"Up",0.0248201012317254,0.130171387144591,"L.LvsP.REACTOME_VITAMIN_B2_RIBOFLAVIN_METABOLISM"
65,"Down",0.0248382733654446,0.130171387144591,"L.LvsP.NAKAMURA_METASTASIS_MODEL_UP"
53,"Down",0.0248929664286267,0.130334480477156,"L.LvsP.REACTOME_SIGNALING_BY_NOTCH2"
664,"Up",0.0252565069462164,0.132026925378841,"L.LvsP.PUJANA_BRCA2_PCC_NETWORK"
15,"Down",0.0252684857916649,0.132026925378841,"L.LvsP.REACTOME_PTK6_REGULATES_RTKS_AND_THEIR_EFFECTORS_AKT1_AND_DOK1"
17,"Down",0.0252878484312158,0.132026925378841,"L.LvsP.SUZUKI_CTCFL_TARGETS_UP"
119,"Up",0.0254015392584541,0.132444306289635,"L.LvsP.BRUNO_HEMATOPOIESIS"
69,"Down",0.0254157006643703,0.132444306289635,"L.LvsP.REACTOME_SIGNALING_BY_PTK6"
7,"Up",0.0254816583449348,0.132662983982245,"L.LvsP.REACTOME_ZINC_EFFLUX_AND_COMPARTMENTALIZATION_BY_THE_SLC30_FAMILY"
28,"Up",0.0255320554475419,0.132706858450238,"L.LvsP.LI_ADIPOGENESIS_BY_ACTIVATED_PPARG"
13,"Down",0.0255380895986713,0.132706858450238,"L.LvsP.WANG_RESPONSE_TO_FORSKOLIN_DN"
31,"Down",0.0255912358993011,0.13285816271102,"L.LvsP.DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_DN"
72,"Down",0.025646299379272,0.132959148088833,"L.LvsP.ZHAN_MULTIPLE_MYELOMA_LB_UP"
188,"Down",0.0256587829645116,0.132959148088833,"L.LvsP.DAIRKEE_CANCER_PRONE_RESPONSE_BPA_E2"
230,"Down",0.0257321618994212,0.133180322139921,"L.LvsP.KEGG_CHEMOKINE_SIGNALING_PATHWAY"
735,"Down",0.0257496408695199,0.133180322139921,"L.LvsP.BAELDE_DIABETIC_NEPHROPATHY_DN"
27,"Up",0.0258984342430994,0.133749846011797,"L.LvsP.REACTOME_GAP_FILLING_DNA_REPAIR_SYNTHESIS_AND_LIGATION_IN_GG_NER"
114,"Down",0.0259081362052152,0.133749846011797,"L.LvsP.REACTOME_TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE"
379,"Down",0.0259868465656767,0.134017018740589,"L.LvsP.CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP"
10,"Down",0.0260083669937877,0.134017018740589,"L.LvsP.BIOCARTA_MITR_PATHWAY"
20,"Down",0.0262798222605911,0.135289699514719,"L.LvsP.BIOCARTA_TALL1_PATHWAY"
1092,"Down",0.0263228442396514,0.135352974887355,"L.LvsP.REACTOME_INFECTIOUS_DISEASE"
30,"Down",0.0263410745123519,0.135352974887355,"L.LvsP.REACTOME_OTHER_INTERLEUKIN_SIGNALING"
59,"Down",0.0264441846742629,0.135756636085422,"L.LvsP.REACTOME_MRNA_SPLICING_MINOR_PATHWAY"
26,"Down",0.0265484119880298,0.136165278183503,"L.LvsP.PID_NFKAPPAB_ATYPICAL_PATHWAY"
31,"Down",0.0268392987835218,0.137520600761956,"L.LvsP.GHANDHI_BYSTANDER_IRRADIATION_DN"
162,"Down",0.0268624070940337,0.137520600761956,"L.LvsP.PURBEY_TARGETS_OF_CTBP1_AND_SATB1_UP"
25,"Down",0.0269278955903612,0.137601962749885,"L.LvsP.VICENT_METASTASIS_UP"
10,"Down",0.0269724797420751,0.137601962749885,"L.LvsP.BYSTRYKH_HEMATOPOIESIS_STEM_CELL_FGF3"
65,"Down",0.0269767851118097,0.137601962749885,"L.LvsP.MMS_MOUSE_LYMPH_HIGH_4HRS_UP"
64,"Down",0.0269778490904097,0.137601962749885,"L.LvsP.WHITEHURST_PACLITAXEL_SENSITIVITY"
43,"Down",0.0270138409811069,0.137658550031834,"L.LvsP.WENDT_COHESIN_TARGETS_UP"
59,"Down",0.027081643253692,0.13787698485236,"L.LvsP.REACTOME_HSF1_ACTIVATION"
24,"Down",0.0271612130223688,0.138154872861709,"L.LvsP.BIOCARTA_ARF_PATHWAY"
62,"Down",0.02725767803761,0.138518108336347,"L.LvsP.REACTOME_HSF1_DEPENDENT_TRANSACTIVATION"
151,"Down",0.0273397304917693,0.138775135967574,"L.LvsP.COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP"
26,"Up",0.0273584550921787,0.138775135967574,"L.LvsP.ZHENG_RESPONSE_TO_ARSENITE_UP"
50,"Up",0.0275177033343567,0.13945497867613,"L.LvsP.BOWIE_RESPONSE_TO_TAMOXIFEN"
31,"Down",0.027632011384352,0.139906035663079,"L.LvsP.HASLINGER_B_CLL_WITH_17P13_DELETION"
591,"Down",0.027677049247173,0.140005860281445,"L.LvsP.WANG_TUMOR_INVASIVENESS_UP"
11,"Down",0.0278448615431005,0.14072599586088,"L.LvsP.REACTOME_BH3_ONLY_PROTEINS_ASSOCIATE_WITH_AND_INACTIVATE_ANTI_APOPTOTIC_BCL_2_MEMBERS"
15,"Down",0.0278805103759561,0.140777481158595,"L.LvsP.REACTOME_TICAM1_TRAF6_DEPENDENT_INDUCTION_OF_TAK1_COMPLEX"
44,"Down",0.0279835540035617,0.141078250924864,"L.LvsP.REACTOME_COOPERATION_OF_PDCL_PHLP1_AND_TRIC_CCT_IN_G_PROTEIN_BETA_FOLDING"
116,"Down",0.0279911089283009,0.141078250924864,"L.LvsP.DAZARD_UV_RESPONSE_CLUSTER_G1"
144,"Up",0.0280324431182537,0.141157903461589,"L.LvsP.LIANG_SILENCED_BY_METHYLATION_2"
14,"Up",0.028125220562266,0.141496218825086,"L.LvsP.REACTOME_CYTOSOLIC_IRON_SULFUR_CLUSTER_ASSEMBLY"
35,"Down",0.0281801710934456,0.141563048023885,"L.LvsP.BIOCARTA_STRESS_PATHWAY"
59,"Up",0.0281897116792001,0.141563048023885,"L.LvsP.BRACHAT_RESPONSE_TO_METHOTREXATE_UP"
95,"Down",0.0282177601779037,0.141575313996034,"L.LvsP.REACTOME_EXTRA_NUCLEAR_ESTROGEN_SIGNALING"
50,"Down",0.0282576871977944,0.141647101102996,"L.LvsP.BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_DN"
45,"Up",0.0287496457506854,0.143982600865525,"L.LvsP.REACTOME_EXTENSION_OF_TELOMERES"
176,"Up",0.0288106399043651,0.144157491430981,"L.LvsP.MACAEVA_PBMC_RESPONSE_TO_IR"
10,"Up",0.0291382533605883,0.145664921185075,"L.LvsP.REACTOME_THYROXINE_BIOSYNTHESIS"
72,"Down",0.0293532949641742,0.146393403471076,"L.LvsP.REACTOME_HEDGEHOG_LIGAND_BIOGENESIS"
80,"Up",0.0293688104063551,0.146393403471076,"L.LvsP.ELVIDGE_HYPOXIA_BY_DMOG_DN"
16,"Up",0.0294051843288511,0.146393403471076,"L.LvsP.WAESCH_ANAPHASE_PROMOTING_COMPLEX"
34,"Down",0.0294211460724698,0.146393403471076,"L.LvsP.CREIGHTON_AKT1_SIGNALING_VIA_MTOR_DN"
9,"Down",0.0294328228774539,0.146393403471076,"L.LvsP.REACTOME_WNT_MEDIATED_ACTIVATION_OF_DVL"
334,"Down",0.0294428404159588,0.146393403471076,"L.LvsP.VERHAAK_GLIOBLASTOMA_PRONEURAL"
20,"Up",0.0297661823956964,0.147661744963392,"L.LvsP.REACTOME_REGULATION_OF_TLR_BY_ENDOGENOUS_LIGAND"
48,"Down",0.0298109054780208,0.147661744963392,"L.LvsP.CHIBA_RESPONSE_TO_TSA_DN"
57,"Down",0.0298473765140399,0.147661744963392,"L.LvsP.SIG_CHEMOTAXIS"
68,"Down",0.0298589877720939,0.147661744963392,"L.LvsP.CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_DN"
37,"Down",0.0298719998081779,0.147661744963392,"L.LvsP.BIOCARTA_EIF_PATHWAY"
26,"Down",0.0298794079816803,0.147661744963392,"L.LvsP.MATZUK_EMBRYONIC_GERM_CELL"
90,"Down",0.0298848783892268,0.147661744963392,"L.LvsP.JI_RESPONSE_TO_FSH_DN"
29,"Down",0.0300049390295736,0.147844633716716,"L.LvsP.GREENBAUM_E2A_TARGETS_DN"
17,"Down",0.030006988833968,0.147844633716716,"L.LvsP.PID_RANBP2_PATHWAY"
16,"Down",0.0300110098725427,0.147844633716716,"L.LvsP.BIOCARTA_CARM1_PATHWAY"
149,"Down",0.030033135229617,0.147844633716716,"L.LvsP.BHAT_ESR1_TARGETS_NOT_VIA_AKT1_DN"
10,"Up",0.030055592023438,0.147844633716716,"L.LvsP.GALI_TP53_TARGETS_APOPTOTIC_DN"
21,"Down",0.0300970714285791,0.147917073714323,"L.LvsP.REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_METHYLATION"
74,"Down",0.0306269124508167,0.150387388046684,"L.LvsP.SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_DN"
12,"Down",0.0307486100192939,0.150808674600341,"L.LvsP.GILMORE_CORE_NFKB_PATHWAY"
20,"Down",0.0307672607974651,0.150808674600341,"L.LvsP.REACTOME_CD28_DEPENDENT_VAV1_PATHWAY"
57,"Down",0.0308267531716028,0.150907890188287,"L.LvsP.REACTOME_EPH_EPHRIN_MEDIATED_REPULSION_OF_CELLS"
20,"Down",0.0308512297060583,0.150907890188287,"L.LvsP.REACTOME_HDL_ASSEMBLY"
500,"Down",0.0308693839397635,0.150907890188287,"L.LvsP.TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_DN"
45,"Down",0.0309123365296008,0.150984371618518,"L.LvsP.BILANGES_RAPAMYCIN_SENSITIVE_GENES"
54,"Up",0.0309771225401774,0.151167264364202,"L.LvsP.PID_ERB_GENOMIC_PATHWAY"
35,"Down",0.0310884352172641,0.151462882625269,"L.LvsP.MAGRANGEAS_MULTIPLE_MYELOMA_IGLL_VS_IGLK_DN"
7,"Up",0.0310924890178478,0.151462882625269,"L.LvsP.REACTOME_CHYLOMICRON_CLEARANCE"
58,"Down",0.0311525313386386,0.151621783249413,"L.LvsP.TOMLINS_PROSTATE_CANCER_UP"
11,"Up",0.0312670279269399,0.151837033198231,"L.LvsP.KEGG_VALINE_LEUCINE_AND_ISOLEUCINE_BIOSYNTHESIS"
5,"Up",0.031287587246962,0.151837033198231,"L.LvsP.REACTOME_TOXICITY_OF_BOTULINUM_TOXIN_TYPE_D_BONT_D"
105,"Up",0.0313180175452639,0.151837033198231,"L.LvsP.SCHUHMACHER_MYC_TARGETS_UP"
43,"Down",0.0313622920751814,0.151837033198231,"L.LvsP.REACTOME_RNA_POLYMERASE_III_TRANSCRIPTION"
37,"Down",0.0313643226648689,0.151837033198231,"L.LvsP.TOMIDA_METASTASIS_DN"
39,"Down",0.0313654591199377,0.151837033198231,"L.LvsP.REACTOME_ONCOGENE_INDUCED_SENESCENCE"
29,"Down",0.0314284448039095,0.151837033198231,"L.LvsP.REACTOME_CONSTITUTIVE_SIGNALING_BY_AKT1_E17K_IN_CANCER"
34,"Down",0.0314481337610819,0.151837033198231,"L.LvsP.MASRI_RESISTANCE_TO_TAMOXIFEN_AND_AROMATASE_INHIBITORS_DN"
32,"Down",0.0315116419448095,0.151837033198231,"L.LvsP.MURAKAMI_UV_RESPONSE_6HR_DN"
49,"Down",0.0315267230888981,0.151837033198231,"L.LvsP.REACTOME_THE_PHOTOTRANSDUCTION_CASCADE"
254,"Up",0.03153930234042,0.151837033198231,"L.LvsP.PUJANA_XPRSS_INT_NETWORK"
15,"Up",0.0315445838536587,0.151837033198231,"L.LvsP.YAMASHITA_SILENCED_BY_METHYLATION"
37,"Down",0.0315537621893232,0.151837033198231,"L.LvsP.IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_UP"
463,"Down",0.0316016179004175,0.151935082931659,"L.LvsP.JAEGER_METASTASIS_DN"
100,"Down",0.031722486047122,0.152355574642075,"L.LvsP.DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP"
14,"Down",0.0317441891820709,0.152355574642075,"L.LvsP.BIOCARTA_CELL2CELL_PATHWAY"
406,"Down",0.0321445107079019,0.153874570954883,"L.LvsP.DANG_REGULATED_BY_MYC_DN"
53,"Down",0.0322037603162441,0.153874570954883,"L.LvsP.PID_LIS1_PATHWAY"
143,"Down",0.032237927091216,0.153874570954883,"L.LvsP.SCHLOSSER_SERUM_RESPONSE_AUGMENTED_BY_MYC"
37,"Down",0.0322755575349618,0.153874570954883,"L.LvsP.PID_GLYPICAN_1PATHWAY"
27,"Down",0.032276171160021,0.153874570954883,"L.LvsP.HEDENFALK_BREAST_CANCER_BRACX_UP"
39,"Down",0.0322808627373922,0.153874570954883,"L.LvsP.FERRANDO_TAL1_NEIGHBORS"
158,"Down",0.032289678910985,0.153874570954883,"L.LvsP.REACTOME_RHO_GTPASE_CYCLE"
659,"Up",0.0323286549819639,0.153874570954883,"L.LvsP.SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6"
12,"Down",0.0323460524160954,0.153874570954883,"L.LvsP.REACTOME_IRAK2_MEDIATED_ACTIVATION_OF_TAK1_COMPLEX"
144,"Down",0.032368130865411,0.153874570954883,"L.LvsP.SWEET_KRAS_TARGETS_UP"
111,"Up",0.0323761755241384,0.153874570954883,"L.LvsP.REACTOME_B_WICH_COMPLEX_POSITIVELY_REGULATES_RRNA_EXPRESSION"
56,"Down",0.0323946465168174,0.153874570954883,"L.LvsP.KEGG_HEDGEHOG_SIGNALING_PATHWAY"
52,"Up",0.0324493315705608,0.154002020818567,"L.LvsP.PID_FOXM1_PATHWAY"
39,"Down",0.032728533320087,0.155193877124152,"L.LvsP.REACTOME_NOTCH3_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION"
95,"Up",0.032982737122436,0.156252278631431,"L.LvsP.PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP"
49,"Up",0.0330082585352706,0.156252278631431,"L.LvsP.KEGG_ABC_TRANSPORTERS"
63,"Up",0.0331041311192828,0.156519975402918,"L.LvsP.JOHANSSON_BRAIN_CANCER_EARLY_VS_LATE_DN"
355,"Up",0.0331324806023458,0.156519975402918,"L.LvsP.REACTOME_CELL_CYCLE_CHECKPOINTS"
77,"Down",0.0331497361542444,0.156519975402918,"L.LvsP.SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_DN"
28,"Up",0.0332733897184358,0.156969771120505,"L.LvsP.REACTOME_MITOCHONDRIAL_CALCIUM_ION_TRANSPORT"
50,"Down",0.0333516342286628,0.157204761850193,"L.LvsP.PID_P38_ALPHA_BETA_DOWNSTREAM_PATHWAY"
9,"Up",0.0334888866364813,0.157717252310992,"L.LvsP.REACTOME_SODIUM_PROTON_EXCHANGERS"
346,"Up",0.0336583563610304,0.158380470059691,"L.LvsP.FISCHER_G2_M_CELL_CYCLE"
14,"Down",0.0339205025024806,0.15939568900157,"L.LvsP.REACTOME_ACTIVATED_NTRK2_SIGNALS_THROUGH_FRS2_AND_FRS3"
16,"Up",0.0339317645062124,0.15939568900157,"L.LvsP.REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TN_POLYAGGLUTINATION_SYNDROME_TNPS"
44,"Up",0.0340762505490092,0.159938530802608,"L.LvsP.CHIARETTI_T_ALL_RELAPSE_PROGNOSIS"
10,"Up",0.0342101577174862,0.160430841407957,"L.LvsP.CHANG_POU5F1_TARGETS_DN"
84,"Down",0.0342794019093395,0.160619333183676,"L.LvsP.ROVERSI_GLIOMA_LOH_REGIONS"
11,"Up",0.034322485939901,0.160685033667835,"L.LvsP.REACTOME_MISSPLICED_LRP5_MUTANTS_HAVE_ENHANCED_BETA_CATENIN_DEPENDENT_SIGNALING"
19,"Down",0.0344042055402283,0.160931347235129,"L.LvsP.REACTOME_PI3K_EVENTS_IN_ERBB2_SIGNALING"
33,"Up",0.0346633030247355,0.162006257332005,"L.LvsP.KEGG_GALACTOSE_METABOLISM"
76,"Down",0.0347067869945488,0.162068301501771,"L.LvsP.BIOCARTA_HIVNEF_PATHWAY"
858,"Up",0.034755575081654,0.162068301501771,"L.LvsP.RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP"
50,"Up",0.0347645153881535,0.162068301501771,"L.LvsP.REACTOME_RETROGRADE_TRANSPORT_AT_THE_TRANS_GOLGI_NETWORK"
255,"Up",0.03492063698435,0.162658973788097,"L.LvsP.ALCALAY_AML_BY_NPM1_LOCALIZATION_DN"
37,"Down",0.0349775531515664,0.162786945601861,"L.LvsP.PID_INSULIN_GLUCOSE_PATHWAY"
757,"Down",0.0350550721947185,0.162899578054073,"L.LvsP.CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN"
22,"Up",0.0350606796679954,0.162899578054073,"L.LvsP.BIOCARTA_ARAP_PATHWAY"
26,"Down",0.0350913505136099,0.162905186389378,"L.LvsP.ZIRN_TRETINOIN_RESPONSE_UP"
114,"Down",0.0352233591172721,0.163281430991413,"L.LvsP.SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP"
23,"Up",0.0352314608740741,0.163281430991413,"L.LvsP.CHEN_HOXA5_TARGETS_6HR_UP"
59,"Up",0.0352990382470174,0.163329082834124,"L.LvsP.WOOD_EBV_EBNA1_TARGETS_DN"
28,"Down",0.0353008236546895,0.163329082834124,"L.LvsP.HEDENFALK_BREAST_CANCER_BRACX_DN"
67,"Down",0.0354395243633617,0.163833720907213,"L.LvsP.HUMMEL_BURKITTS_LYMPHOMA_UP"
314,"Up",0.0355180582467229,0.164026136635772,"L.LvsP.SHEPARD_BMYB_MORPHOLINO_DN"
21,"Down",0.0355624360360942,0.164026136635772,"L.LvsP.MARIADASON_RESPONSE_TO_BUTYRATE_CURCUMIN_SULINDAC_TSA_1"
14,"Up",0.0355701461071244,0.164026136635772,"L.LvsP.REACTOME_LYSINE_CATABOLISM"
8,"Down",0.0356403996071547,0.164213141189965,"L.LvsP.BIOCARTA_PLCD_PATHWAY"
357,"Down",0.0357622390139508,0.164637318491369,"L.LvsP.REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION"
143,"Down",0.035865437299278,0.164898661028502,"L.LvsP.LAIHO_COLORECTAL_CANCER_SERRATED_DN"
159,"Down",0.0358786560349588,0.164898661028502,"L.LvsP.CAMPS_COLON_CANCER_COPY_NUMBER_UP"
377,"Down",0.0360788964872683,0.165681244749258,"L.LvsP.QI_PLASMACYTOMA_UP"
41,"Down",0.0361342594975277,0.165797776565835,"L.LvsP.CHIN_BREAST_CANCER_COPY_NUMBER_UP"
25,"Up",0.0364171548913714,0.166902398749533,"L.LvsP.WALLACE_PROSTATE_CANCER_UP"
238,"Up",0.0364353762508025,0.166902398749533,"L.LvsP.WHITFIELD_CELL_CYCLE_G2"
33,"Down",0.0364764004307499,0.166952001640411,"L.LvsP.TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_DN"
13,"Down",0.0365725465523348,0.167204756912076,"L.LvsP.MCCOLLUM_GELDANAMYCIN_RESISTANCE_DN"
21,"Down",0.0366056753455502,0.167204756912076,"L.LvsP.SILIGAN_TARGETS_OF_EWS_FLI1_FUSION_UP"
750,"Down",0.0366223477338622,0.167204756912076,"L.LvsP.MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN"
109,"Down",0.0366733541919994,0.167221517024441,"L.LvsP.KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM"
162,"Up",0.0366865075331247,0.167221517024441,"L.LvsP.DASU_IL6_SIGNALING_UP"
82,"Down",0.0367235231326524,0.167252355354559,"L.LvsP.PID_SHP2_PATHWAY"
21,"Down",0.036770481074418,0.167328386716426,"L.LvsP.HUMMEL_BURKITTS_LYMPHOMA_DN"
10,"Up",0.0368186850325843,0.167409958507532,"L.LvsP.BIERIE_INFLAMMATORY_RESPONSE_TGFB1"
12,"Down",0.0369473935643609,0.16774681166787,"L.LvsP.REACTOME_INTERLEUKIN_6_SIGNALING"
9,"Down",0.0369534484737685,0.16774681166787,"L.LvsP.CHEMELLO_SOLEUS_VS_EDL_MYOFIBERS_DN"
175,"Up",0.0370149665833758,0.167888228252244,"L.LvsP.HOSHIDA_LIVER_CANCER_SURVIVAL_DN"
59,"Down",0.0370708521742772,0.168003886616048,"L.LvsP.PID_A6B1_A6B4_INTEGRIN_PATHWAY"
63,"Down",0.0371980525809911,0.168339135976647,"L.LvsP.KEGG_NON_SMALL_CELL_LUNG_CANCER"
24,"Up",0.0372057196895392,0.168339135976647,"L.LvsP.RUAN_RESPONSE_TO_TROGLITAZONE_DN"
67,"Down",0.0373096132228133,0.168671178666341,"L.LvsP.VANTVEER_BREAST_CANCER_BRCA1_UP"
42,"Down",0.0375238144138337,0.169416755297169,"L.LvsP.JI_METASTASIS_REPRESSED_BY_STK11"
12,"Down",0.0375642171780704,0.169416755297169,"L.LvsP.NADELLA_PRKAR1A_TARGETS_UP"
7,"Down",0.0375664572245124,0.169416755297169,"L.LvsP.REACTOME_TRNA_PROCESSING_IN_THE_MITOCHONDRION"
74,"Down",0.0378084790792182,0.170369259029338,"L.LvsP.KEGG_ACUTE_MYELOID_LEUKEMIA"
244,"Down",0.0378697176607196,0.170506245070129,"L.LvsP.FIRESTEIN_PROLIFERATION"
65,"Down",0.0380070900387117,0.170985517350722,"L.LvsP.REACTOME_INTERLEUKIN_3_INTERLEUKIN_5_AND_GM_CSF_SIGNALING"
23,"Up",0.0380560716310437,0.171066682965887,"L.LvsP.REACTOME_INHIBITION_OF_THE_PROTEOLYTIC_ACTIVITY_OF_APC_C_REQUIRED_FOR_THE_ONSET_OF_ANAPHASE_BY_MITOTIC_SPINDLE_CHECKPOINT_COMPONENTS"
28,"Down",0.0381410517862888,0.171309403189595,"L.LvsP.REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_ADDITIONAL_CELL_CYCLE_GENES_WHOSE_EXACT_ROLE_IN_THE_P53_PATHWAY_REMAIN_UNCERTAIN"
129,"Down",0.0381924933433526,0.171401214038471,"L.LvsP.SEKI_INFLAMMATORY_RESPONSE_LPS_UP"
26,"Up",0.0383510231083962,0.171973079291422,"L.LvsP.SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_UP"
63,"Down",0.0384277889797277,0.172177670396203,"L.LvsP.DOANE_BREAST_CANCER_CLASSES_DN"
130,"Down",0.0384913514570204,0.172230187850002,"L.LvsP.PID_CXCR4_PATHWAY"
98,"Up",0.0385292573417669,0.172230187850002,"L.LvsP.SLEBOS_HEAD_AND_NECK_CANCER_WITH_HPV_UP"
36,"Down",0.0385329611811273,0.172230187850002,"L.LvsP.REACTOME_NEPHRIN_FAMILY_INTERACTIONS"
18,"Down",0.0386236058187252,0.172495893838232,"L.LvsP.REACTOME_ACTIVATION_OF_BAD_AND_TRANSLOCATION_TO_MITOCHONDRIA"
104,"Up",0.0387311408238166,0.172836543676257,"L.LvsP.STEIN_ESR1_TARGETS"
64,"Down",0.0390057334845238,0.173921532609623,"L.LvsP.REACTOME_METABOLISM_OF_POLYAMINES"
40,"Up",0.0390465195322107,0.173963099511356,"L.LvsP.KYNG_WERNER_SYNDROM_DN"
19,"Down",0.0392323586483384,0.174482381120238,"L.LvsP.REACTOME_PROLONGED_ERK_ACTIVATION_EVENTS"
24,"Down",0.0392671968217256,0.174482381120238,"L.LvsP.HOLLEMAN_VINCRISTINE_RESISTANCE_B_ALL_DN"
47,"Down",0.0393336942973141,0.174482381120238,"L.LvsP.REACTOME_DNA_DAMAGE_RECOGNITION_IN_GG_NER"
39,"Down",0.0393473880707386,0.174482381120238,"L.LvsP.PID_RAS_PATHWAY"
61,"Down",0.03934742201284,0.174482381120238,"L.LvsP.POMEROY_MEDULLOBLASTOMA_PROGNOSIS_DN"
83,"Down",0.0393524198330506,0.174482381120238,"L.LvsP.KEGG_EPITHELIAL_CELL_SIGNALING_IN_HELICOBACTER_PYLORI_INFECTION"
55,"Up",0.039453124456916,0.174788722053116,"L.LvsP.SPIRA_SMOKERS_LUNG_CANCER_DN"
96,"Up",0.0395355082752549,0.175013470979891,"L.LvsP.CORRE_MULTIPLE_MYELOMA_DN"
61,"Down",0.0396312904571772,0.175297123950186,"L.LvsP.DORSAM_HOXA9_TARGETS_UP"
64,"Down",0.0397423778957191,0.175647967534317,"L.LvsP.TIEN_INTESTINE_PROBIOTICS_2HR_UP"
17,"Down",0.0398933212893846,0.176174259911348,"L.LvsP.BRUNEAU_SEPTATION_VENTRICULAR"
18,"Down",0.040014268749272,0.17656735188725,"L.LvsP.REACTOME_BETA_OXIDATION_OF_VERY_LONG_CHAIN_FATTY_ACIDS"
15,"Up",0.0400479300543213,0.176574964330417,"L.LvsP.PETRETTO_LEFT_VENTRICLE_MASS_QTL_CIS_DN"
245,"Down",0.0401186488650831,0.17670535590026,"L.LvsP.GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN"
30,"Down",0.0401583107842755,0.17670535590026,"L.LvsP.BIOCARTA_CARDIACEGF_PATHWAY"
13,"Down",0.0401839473126621,0.17670535590026,"L.LvsP.REACTOME_MET_ACTIVATES_RAS_SIGNALING"
123,"Down",0.0402053423263749,0.17670535590026,"L.LvsP.BILANGES_SERUM_SENSITIVE_GENES"
39,"Down",0.040794674202416,0.179050113305255,"L.LvsP.PID_IL2_STAT5_PATHWAY"
11,"Down",0.0408239649057505,0.179050113305255,"L.LvsP.REACTOME_RUNX3_REGULATES_CDKN1A_TRANSCRIPTION"
60,"Down",0.0408359907538301,0.179050113305255,"L.LvsP.STONER_ESOPHAGEAL_CARCINOGENESIS_UP"
156,"Up",0.0408980369131304,0.179156683307552,"L.LvsP.MARKEY_RB1_CHRONIC_LOF_UP"
35,"Down",0.0409251023724793,0.179156683307552,"L.LvsP.REACTOME_GAP_JUNCTION_ASSEMBLY"
24,"Up",0.0410537030428433,0.179577471616994,"L.LvsP.WU_HBX_TARGETS_1_UP"
33,"Up",0.0411913519036761,0.180037142035909,"L.LvsP.KEGG_BIOSYNTHESIS_OF_UNSATURATED_FATTY_ACIDS"
103,"Up",0.0413516563519392,0.180492875307577,"L.LvsP.BILD_SRC_ONCOGENIC_SIGNATURE"
64,"Down",0.0413896315861255,0.180492875307577,"L.LvsP.REACTOME_COPI_INDEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC"
8,"Down",0.0413935550533564,0.180492875307577,"L.LvsP.LIU_IL13_MEMORY_MODEL_DN"
30,"Up",0.0415694876313648,0.180993502057701,"L.LvsP.PID_TOLL_ENDOGENOUS_PATHWAY"
65,"Down",0.0415738375137059,0.180993502057701,"L.LvsP.REACTOME_DEFECTIVE_CFTR_CAUSES_CYSTIC_FIBROSIS"
16,"Up",0.0416401409157232,0.181139527240782,"L.LvsP.NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN"
455,"Down",0.0417212823127841,0.181349819109578,"L.LvsP.DURCHDEWALD_SKIN_CARCINOGENESIS_DN"
25,"Down",0.0417646541659827,0.181395736750761,"L.LvsP.HOLLEMAN_PREDNISOLONE_RESISTANCE_ALL_UP"
154,"Down",0.0418274472037242,0.181410116540428,"L.LvsP.REN_ALVEOLAR_RHABDOMYOSARCOMA_UP"
43,"Up",0.0418335862884872,0.181410116540428,"L.LvsP.ZWANG_EGF_PERSISTENTLY_UP"
12,"Up",0.04200706631453,0.181955657093747,"L.LvsP.SIMBULAN_UV_RESPONSE_NORMAL_UP"
27,"Down",0.0420571352144883,0.181955657093747,"L.LvsP.BIOCARTA_PML_PATHWAY"
24,"Down",0.0420581171578602,0.181955657093747,"L.LvsP.LEE_METASTASIS_AND_RNA_PROCESSING_UP"
23,"Down",0.0421180178659134,0.182072338374226,"L.LvsP.ZEILSTRA_CD44_TARGETS_DN"
48,"Down",0.0421561345315364,0.182094740488176,"L.LvsP.REACTOME_NR1H3_NR1H2_REGULATE_GENE_EXPRESSION_LINKED_TO_CHOLESTEROL_TRANSPORT_AND_EFFLUX"
307,"Up",0.0423734436357121,0.182778958328261,"L.LvsP.MCBRYAN_PUBERTAL_BREAST_4_5WK_DN"
74,"Up",0.0423806519401031,0.182778958328261,"L.LvsP.KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP"
77,"Down",0.0424690754715145,0.183017551272022,"L.LvsP.MAGRANGEAS_MULTIPLE_MYELOMA_IGLL_VS_IGLK_UP"
39,"Down",0.0425163865865627,0.183078739436998,"L.LvsP.REACTOME_SIGNALING_BY_NTRK2_TRKB"
360,"Down",0.0425729362582788,0.183179583324532,"L.LvsP.RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN"
24,"Down",0.0427025669401381,0.183594473259738,"L.LvsP.BIOCARTA_SPRY_PATHWAY"
36,"Down",0.0429132052722817,0.184264669889709,"L.LvsP.AKL_HTLV1_INFECTION_UP"
93,"Up",0.0429467476350172,0.184264669889709,"L.LvsP.VILLANUEVA_LIVER_CANCER_KRT19_DN"
187,"Up",0.0429584300032256,0.184264669889709,"L.LvsP.QI_HYPOXIA"
770,"Up",0.0432669044018857,0.18544396468064,"L.LvsP.BOCHKIS_FOXA2_TARGETS"
16,"Up",0.0433902279011479,0.185828481847751,"L.LvsP.REACTOME_PHENYLALANINE_AND_TYROSINE_METABOLISM"
162,"Up",0.0435154246287538,0.186220420102461,"L.LvsP.ZHAN_MULTIPLE_MYELOMA_UP"
108,"Down",0.0438184792360196,0.187372290561448,"L.LvsP.PID_MYC_ACTIV_PATHWAY"
54,"Down",0.0439087669143806,0.187613270687489,"L.LvsP.QI_HYPOXIA_TARGETS_OF_HIF1A_AND_FOXA2"
35,"Down",0.0439748753261952,0.187750645311609,"L.LvsP.BIOCARTA_VDR_PATHWAY"
12,"Down",0.0441222739214522,0.188234608419529,"L.LvsP.REACTOME_BIOSYNTHESIS_OF_EPA_DERIVED_SPMS"
81,"Down",0.0443783511946489,0.189181113149741,"L.LvsP.SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_UP"
140,"Down",0.0444216604379231,0.189186342701499,"L.LvsP.HOEBEKE_LYMPHOID_STEM_CELL_DN"
141,"Down",0.0444699087612627,0.189186342701499,"L.LvsP.BRUINS_UVC_RESPONSE_MIDDLE"
185,"Up",0.0444822292479561,0.189186342701499,"L.LvsP.SMIRNOV_RESPONSE_TO_IR_6HR_DN"
18,"Down",0.044547125945705,0.189287620611451,"L.LvsP.REACTOME_TRAF6_MEDIATED_INDUCTION_OF_TAK1_COMPLEX_WITHIN_TLR4_COMPLEX"
26,"Down",0.044574512938345,0.189287620611451,"L.LvsP.NAM_FXYD5_TARGETS_DN"
83,"Down",0.0446270811516558,0.189365411886036,"L.LvsP.PID_TXA2PATHWAY"
117,"Down",0.0446851268245887,0.189466308445668,"L.LvsP.KEGG_DILATED_CARDIOMYOPATHY"
62,"Down",0.0447678414663573,0.189671567408038,"L.LvsP.STAMBOLSKY_TARGETS_OF_MUTATED_TP53_UP"
36,"Up",0.0449495901290758,0.190295776281516,"L.LvsP.REACTOME_COBALAMIN_CBL_VITAMIN_B12_TRANSPORT_AND_METABOLISM"
55,"Up",0.0451058820729161,0.190811340459949,"L.LvsP.REACTOME_TRANSPORT_OF_VITAMINS_NUCLEOSIDES_AND_RELATED_MOLECULES"
56,"Up",0.0452387628694616,0.191227155890866,"L.LvsP.SEMENZA_HIF1_TARGETS"
115,"Down",0.0452866589504657,0.191283374589094,"L.LvsP.BASSO_CD40_SIGNALING_DN"
413,"Down",0.0453511522383728,0.191409557806079,"L.LvsP.KEGG_PATHWAYS_IN_CANCER"
62,"Up",0.0455444781262369,0.192078886010651,"L.LvsP.LY_AGING_PREMATURE_DN"
11,"Up",0.045646174446882,0.192254205489386,"L.LvsP.MATZUK_FERTILIZATION"
266,"Down",0.045655592658268,0.192254205489386,"L.LvsP.PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_DN"
78,"Down",0.0457441227075673,0.192405358138085,"L.LvsP.WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_DN"
19,"Down",0.0457610862636248,0.192405358138085,"L.LvsP.TSUTSUMI_FBXW8_TARGETS"
67,"Up",0.0458916129911191,0.192807544246123,"L.LvsP.PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_UP"
11,"Down",0.0459586042348509,0.192942386343577,"L.LvsP.RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_MAPK1_UP"
346,"Down",0.0460761076517207,0.193186227462909,"L.LvsP.TIEN_INTESTINE_PROBIOTICS_24HR_DN"
54,"Down",0.0460865679188963,0.193186227462909,"L.LvsP.CREIGHTON_AKT1_SIGNALING_VIA_MTOR_UP"
39,"Down",0.0462223562966109,0.193608642396941,"L.LvsP.JOHANSSON_GLIOMAGENESIS_BY_PDGFB_DN"
89,"Up",0.0463736603540792,0.194095358136036,"L.LvsP.ZHAN_V2_LATE_DIFFERENTIATION_GENES"
18,"Down",0.0465449538826163,0.194664939498476,"L.LvsP.REACTOME_SIGNALING_BY_NOTCH1_HD_DOMAIN_MUTANTS_IN_CANCER"
14,"Down",0.0465961015830869,0.194730346536003,"L.LvsP.BIOCARTA_NEUTROPHIL_PATHWAY"
829,"Up",0.046631032521915,0.194730346536003,"L.LvsP.IVANOVA_HEMATOPOIESIS_LATE_PROGENITOR"
61,"Down",0.0467681133522648,0.195155395263904,"L.LvsP.PID_PI3KCI_PATHWAY"
61,"Down",0.0468342481808908,0.195283980537063,"L.LvsP.REACTOME_FORMATION_OF_TC_NER_PRE_INCISION_COMPLEX"
34,"Down",0.0469276137052208,0.195525829823787,"L.LvsP.BIOCARTA_RAS_PATHWAY"
279,"Down",0.047135763269442,0.196245207166223,"L.LvsP.PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_DN"
59,"Down",0.0473856746735004,0.196990029758036,"L.LvsP.VALK_AML_CLUSTER_15"
75,"Down",0.0473891229996085,0.196990029758036,"L.LvsP.PID_IL6_7_PATHWAY"
97,"Down",0.0474215463208439,0.196990029758036,"L.LvsP.NADLER_HYPERGLYCEMIA_AT_OBESITY"
34,"Down",0.0474967050901189,0.197154115948399,"L.LvsP.REACTOME_TIGHT_JUNCTION_INTERACTIONS"
33,"Down",0.0475622364777134,0.197278023619863,"L.LvsP.REACTOME_REGULATION_OF_SIGNALING_BY_CBL"
330,"Down",0.0476666733780137,0.19745186489407,"L.LvsP.TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP"
607,"Down",0.0476755723699735,0.19745186489407,"L.LvsP.REACTOME_SIGNALING_BY_INTERLEUKINS"
8,"Down",0.0477722629601433,0.197704222984006,"L.LvsP.TSAI_DNAJB4_TARGETS_DN"
39,"Down",0.0479060460694311,0.198109595151746,"L.LvsP.KEGG_THYROID_CANCER"
56,"Down",0.0479891585696483,0.198178000764728,"L.LvsP.PID_RET_PATHWAY"
23,"Down",0.0480357723082728,0.198178000764728,"L.LvsP.REACTOME_THE_NLRP3_INFLAMMASOME"
33,"Down",0.0480763654597564,0.198178000764728,"L.LvsP.PIEPOLI_LGI1_TARGETS_UP"
5,"Up",0.0480959721673902,0.198178000764728,"L.LvsP.REACTOME_TYROSINE_CATABOLISM"
9,"Up",0.0481018044901908,0.198178000764728,"L.LvsP.GROSS_HYPOXIA_VIA_HIF1A_ONLY"
119,"Up",0.0483671895977003,0.199103114678387,"L.LvsP.SHEPARD_BMYB_TARGETS"
23,"Down",0.0483983697102102,0.199103114678387,"L.LvsP.WU_HBX_TARGETS_2_DN"
33,"Down",0.0485233948685305,0.199469033626844,"L.LvsP.GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_UP"
25,"Down",0.0488579016824615,0.200658277976479,"L.LvsP.BIOCARTA_ETS_PATHWAY"
368,"Down",0.0488852777056098,0.200658277976479,"L.LvsP.THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN"
205,"Down",0.0489657969684843,0.200839682076224,"L.LvsP.CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_UP"
165,"Up",0.0491268072611134,0.201266378607729,"L.LvsP.HATADA_METHYLATED_IN_LUNG_CANCER_DN"
239,"Up",0.0491426317815942,0.201266378607729,"L.LvsP.REACTOME_REPRODUCTION"
21,"Up",0.0491940628590608,0.20130338749757,"L.LvsP.TIAN_BHLHA15_TARGETS"
173,"Down",0.0492244854217246,0.20130338749757,"L.LvsP.LIM_MAMMARY_LUMINAL_MATURE_DN"
49,"Down",0.0493679893900398,0.2017410298134,"L.LvsP.REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT"
100,"Down",0.0494098435933443,0.201762943299557,"L.LvsP.PID_MYC_REPRESS_PATHWAY"
21,"Down",0.0495518577590987,0.202140076730365,"L.LvsP.REACTOME_NRIF_SIGNALS_CELL_DEATH_FROM_THE_NUCLEUS"
36,"Down",0.049632298487212,0.202140076730365,"L.LvsP.PID_IL3_PATHWAY"
10,"Down",0.0496358431560517,0.202140076730365,"L.LvsP.SMID_BREAST_CANCER_ERBB2_DN"
31,"Up",0.0496484398986862,0.202140076730365,"L.LvsP.VERNOCHET_ADIPOGENESIS"
21,"Down",0.0497043134034423,0.202218652544248,"L.LvsP.SUH_COEXPRESSED_WITH_ID1_AND_ID2_UP"
209,"Down",0.0498518129205816,0.202669612969041,"L.LvsP.KANG_IMMORTALIZED_BY_TERT_DN"
129,"Up",0.0500270855719316,0.203232737786341,"L.LvsP.REACTOME_RUNX1_REGULATES_GENES_INVOLVED_IN_MEGAKARYOCYTE_DIFFERENTIATION_AND_PLATELET_FUNCTION"
41,"Up",0.0501672656597042,0.203652578437962,"L.LvsP.BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_UP"
11,"Up",0.0503527780255885,0.204255693106001,"L.LvsP.REACTOME_CDC6_ASSOCIATION_WITH_THE_ORC_ORIGIN_COMPLEX"
20,"Down",0.0504693739031726,0.204477618939326,"L.LvsP.PID_LPA4_PATHWAY"
30,"Down",0.0504814523154604,0.204477618939326,"L.LvsP.KYNG_DNA_DAMAGE_BY_4NQO_OR_GAMMA_RADIATION"
225,"Up",0.0508351225054331,0.205754699785694,"L.LvsP.PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_DN"
167,"Down",0.0508711656008398,0.205754699785694,"L.LvsP.MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_UP"
13,"Up",0.0509116917616918,0.205768087536838,"L.LvsP.REACTOME_ACETYLCHOLINE_REGULATES_INSULIN_SECRETION"
24,"Down",0.0509564017580004,0.205798353046007,"L.LvsP.LIU_TOPBP1_TARGETS"
51,"Up",0.0510265432718732,0.205931210036633,"L.LvsP.XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_DN"
118,"Down",0.0511047577686238,0.206096430125982,"L.LvsP.KEGG_PROSTATE_CANCER"
30,"Down",0.0512769274541542,0.206537516850726,"L.LvsP.REACTOME_RNA_POLYMERASE_III_TRANSCRIPTION_INITIATION_FROM_TYPE_3_PROMOTER"
47,"Up",0.0512888425820305,0.206537516850726,"L.LvsP.PID_ATR_PATHWAY"
12,"Down",0.0513441123861072,0.206609605082086,"L.LvsP.REACTOME_MET_RECEPTOR_RECYCLING"
17,"Down",0.0513834558692346,0.206617547273453,"L.LvsP.BIOCARTA_RANKL_PATHWAY"
48,"Up",0.0514906653787338,0.206898175057427,"L.LvsP.WILLIAMS_ESR1_TARGETS_UP"
62,"Down",0.0516919838631077,0.207556266361018,"L.LvsP.KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_UP"
49,"Down",0.0518921214079947,0.20820866419797,"L.LvsP.DORSAM_HOXA9_TARGETS_DN"
48,"Down",0.0520305773489656,0.208582632494785,"L.LvsP.BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_UP"
85,"Down",0.0520607764230064,0.208582632494785,"L.LvsP.ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN"
54,"Down",0.0521252778131951,0.208689834199244,"L.LvsP.BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_DN"
19,"Down",0.0523397216856564,0.209396759189576,"L.LvsP.VERRECCHIA_RESPONSE_TO_TGFB1_C6"
65,"Down",0.052502944658368,0.209897889382586,"L.LvsP.LAU_APOPTOSIS_CDKN2A_UP"
37,"Down",0.0526073622928336,0.210163371471876,"L.LvsP.SHI_SPARC_TARGETS_UP"
62,"Down",0.0527807536265949,0.210685670850504,"L.LvsP.SUBTIL_PROGESTIN_TARGETS"
51,"Up",0.0528143135827092,0.210685670850504,"L.LvsP.GUILLAUMOND_KLF10_TARGETS_DN"
14,"Down",0.0528929636251135,0.210847293354905,"L.LvsP.REACTOME_HUR_ELAVL1_BINDS_AND_STABILIZES_MRNA"
45,"Down",0.0530187882431448,0.211196599565092,"L.LvsP.FINETTI_BREAST_CANCERS_KINOME_BLUE"
132,"Up",0.0532424938513662,0.21181756456664,"L.LvsP.BOSCO_INTERFERON_INDUCED_ANTIVIRAL_MODULE"
112,"Up",0.0532771608776472,0.21181756456664,"L.LvsP.ZHU_CMV_8_HR_UP"
15,"Down",0.0532896061335135,0.21181756456664,"L.LvsP.GOUYER_TATI_TARGETS_UP"
20,"Up",0.0534308896789217,0.212226572582441,"L.LvsP.REACTOME_SYNTHESIS_OF_PIPS_AT_THE_GOLGI_MEMBRANE"
29,"Up",0.0535657198740081,0.212526283600883,"L.LvsP.PID_ARF_3PATHWAY"
103,"Up",0.0535832228865312,0.212526283600883,"L.LvsP.LINDVALL_IMMORTALIZED_BY_TERT_UP"
184,"Down",0.0541511697683219,0.214624958888209,"L.LvsP.JAZAG_TGFB1_SIGNALING_VIA_SMAD4_UP"
62,"Down",0.054241611233705,0.214829418704266,"L.LvsP.HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_DN"
82,"Down",0.0543803816920235,0.215224860683749,"L.LvsP.PID_IL2_1PATHWAY"
41,"Up",0.0544478991129712,0.215337935762244,"L.LvsP.KEGG_AMINOACYL_TRNA_BIOSYNTHESIS"
114,"Up",0.0545087830065281,0.215424632768473,"L.LvsP.REACTOME_O_LINKED_GLYCOSYLATION"
87,"Up",0.0546939104611213,0.215940610950695,"L.LvsP.HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_DN"
154,"Down",0.0547868740981216,0.215940610950695,"L.LvsP.RADMACHER_AML_PROGNOSIS"
264,"Up",0.054810113759852,0.215940610950695,"L.LvsP.VANTVEER_BREAST_CANCER_METASTASIS_DN"
17,"Down",0.0548285074236068,0.215940610950695,"L.LvsP.DAZARD_UV_RESPONSE_CLUSTER_G3"
17,"Down",0.0548483943046324,0.215940610950695,"L.LvsP.SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_UP"
241,"Down",0.0548797961584693,0.215940610950695,"L.LvsP.KIM_WT1_TARGETS_12HR_UP"
17,"Down",0.05491273268162,0.215940610950695,"L.LvsP.BIOCARTA_MONOCYTE_PATHWAY"
69,"Down",0.0549857840755019,0.216074200535501,"L.LvsP.IRITANI_MAD1_TARGETS_DN"
44,"Down",0.0551291624388879,0.21610000714821,"L.LvsP.JEPSEN_SMRT_TARGETS"
7,"Up",0.0551414757357063,0.21610000714821,"L.LvsP.REACTOME_LTC4_CYSLTR_MEDIATED_IL4_PRODUCTION"
243,"Down",0.0551424932836175,0.21610000714821,"L.LvsP.PROVENZANI_METASTASIS_DN"
74,"Down",0.0551486905563617,0.21610000714821,"L.LvsP.MARSON_FOXP3_TARGETS_DN"
25,"Up",0.0551978191709844,0.216128872368204,"L.LvsP.AUJLA_IL22_AND_IL17A_SIGNALING"
22,"Down",0.0552342370512338,0.216128872368204,"L.LvsP.MEISSNER_NPC_ICP_WITH_H3K4ME3"
147,"Up",0.0553067342146973,0.216259500334556,"L.LvsP.PUJANA_BRCA_CENTERED_NETWORK"
85,"Down",0.0553868272622601,0.216319179409851,"L.LvsP.PID_AR_TF_PATHWAY"
49,"Down",0.055444439430916,0.216319179409851,"L.LvsP.REACTOME_RUNX2_REGULATES_OSTEOBLAST_DIFFERENTIATION"
60,"Down",0.0554725682222506,0.216319179409851,"L.LvsP.LIN_MELANOMA_COPY_NUMBER_DN"
52,"Up",0.0554784945565508,0.216319179409851,"L.LvsP.ELVIDGE_HIF1A_AND_HIF2A_TARGETS_UP"
162,"Up",0.0557480686845569,0.217173768098125,"L.LvsP.REACTOME_MEIOTIC_SYNAPSIS"
73,"Down",0.0557762254836929,0.217173768098125,"L.LvsP.MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_DN"
92,"Down",0.0558839132162173,0.217439941008069,"L.LvsP.JIANG_AGING_CEREBRAL_CORTEX_DN"
178,"Up",0.0560247687868512,0.217834702266175,"L.LvsP.LINDGREN_BLADDER_CANCER_WITH_LOH_IN_CHR9Q"
11,"Up",0.0561821453295144,0.218169651645937,"L.LvsP.REACTOME_ACTIVATION_OF_CASPASES_THROUGH_APOPTOSOME_MEDIATED_CLEAVAGE"
8,"Up",0.0562505908957915,0.218169651645937,"L.LvsP.REACTOME_SYNTHESIS_OF_UDP_N_ACETYL_GLUCOSAMINE"
17,"Down",0.0562572729069996,0.218169651645937,"L.LvsP.BIOCARTA_GATA3_PATHWAY"
60,"Down",0.0562687508133671,0.218169651645937,"L.LvsP.TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_DN"
68,"Down",0.0563426575572928,0.218303120977065,"L.LvsP.PID_FRA_PATHWAY"
252,"Up",0.0565144645324139,0.218815458263107,"L.LvsP.SERVITJA_LIVER_HNF1A_TARGETS_UP"
363,"Up",0.0569056515403536,0.220096242901583,"L.LvsP.ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_DN"
60,"Down",0.0569248738197257,0.220096242901583,"L.LvsP.PID_ERBB2_ERBB3_PATHWAY"
5,"Up",0.0569866552825984,0.220181143995448,"L.LvsP.REACTOME_SODIUM_COUPLED_PHOSPHATE_COTRANSPORTERS"
129,"Up",0.0570896497562413,0.220425051328393,"L.LvsP.REACTOME_RNA_POLYMERASE_I_TRANSCRIPTION"
53,"Up",0.0572073495256855,0.22072535626484,"L.LvsP.REACTOME_NEF_MEDIATES_DOWN_MODULATION_OF_CELL_SURFACE_RECEPTORS_BY_RECRUITING_THEM_TO_CLATHRIN_ADAPTERS"
518,"Down",0.0573339885043073,0.220915745294158,"L.LvsP.LEI_MYB_TARGETS"
7,"Down",0.0573366059860947,0.220915745294158,"L.LvsP.CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_HD_MTX_UP"
59,"Down",0.0577853396184912,0.222489653726071,"L.LvsP.PID_RHOA_REG_PATHWAY"
46,"Down",0.0578821686929364,0.222609911725035,"L.LvsP.REACTOME_RET_SIGNALING"
443,"Up",0.057897097677808,0.222609911725035,"L.LvsP.WEST_ADRENOCORTICAL_TUMOR_UP"
11,"Down",0.0580558029992883,0.223064999849246,"L.LvsP.REACTOME_ARYL_HYDROCARBON_RECEPTOR_SIGNALLING"
25,"Down",0.0581963636384725,0.223449787886885,"L.LvsP.VERRECCHIA_RESPONSE_TO_TGFB1_C3"
39,"Up",0.0585806618796506,0.224725378901765,"L.LvsP.REACTOME_N_GLYCAN_TRIMMING_IN_THE_ER_AND_CALNEXIN_CALRETICULIN_CYCLE"
325,"Down",0.0586098745480818,0.224725378901765,"L.LvsP.REACTOME_DEUBIQUITINATION"
82,"Down",0.0586783940241425,0.224754469301571,"L.LvsP.PID_FGF_PATHWAY"
58,"Down",0.0586987617419911,0.224754469301571,"L.LvsP.PID_PI3K_PLC_TRK_PATHWAY"
15,"Down",0.058815850662709,0.224993767985241,"L.LvsP.SA_MMP_CYTOKINE_CONNECTION"
59,"Down",0.0588426457780174,0.224993767985241,"L.LvsP.GALLUZZI_PERMEABILIZE_MITOCHONDRIA"
29,"Down",0.0591562146034522,0.226036427465437,"L.LvsP.REACTOME_INTERLEUKIN_6_FAMILY_SIGNALING"
24,"Down",0.0592083987236923,0.226079583248132,"L.LvsP.WHITESIDE_CISPLATIN_RESISTANCE_DN"
57,"Down",0.0593150953769078,0.226330684843977,"L.LvsP.REACTOME_MET_PROMOTES_CELL_MOTILITY"
24,"Down",0.05941424711051,0.2265526705338,"L.LvsP.DEBOSSCHER_NFKB_TARGETS_REPRESSED_BY_GLUCOCORTICOIDS"
1127,"Down",0.0595783913515371,0.227022002606925,"L.LvsP.REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM"
64,"Up",0.0597245821909117,0.227300721535357,"L.LvsP.HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_UP"
277,"Down",0.0597337580739506,0.227300721535357,"L.LvsP.LU_AGING_BRAIN_DN"
73,"Down",0.0601250906185915,0.228632480075786,"L.LvsP.IKEDA_MIR1_TARGETS_UP"
256,"Down",0.0604550422034703,0.229729160373187,"L.LvsP.MEISSNER_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3"
51,"Down",0.0606356772910186,0.230257321251402,"L.LvsP.PID_EPHRINB_REV_PATHWAY"
184,"Down",0.0606864457117792,0.230291941208255,"L.LvsP.YAGI_AML_SURVIVAL"
73,"Down",0.0608749959746195,0.230849007368773,"L.LvsP.LUI_TARGETS_OF_PAX8_PPARG_FUSION"
84,"Down",0.061027845084066,0.23101128683661,"L.LvsP.LUI_THYROID_CANCER_CLUSTER_1"
30,"Down",0.0610558089009548,0.23101128683661,"L.LvsP.REACTOME_RHO_GTPASES_ACTIVATE_NADPH_OXIDASES"
46,"Down",0.0610609420633463,0.23101128683661,"L.LvsP.REACTOME_ASSEMBLY_AND_CELL_SURFACE_PRESENTATION_OF_NMDA_RECEPTORS"
337,"Down",0.0611266653517797,0.23101128683661,"L.LvsP.HOLLERN_SQUAMOUS_BREAST_TUMOR"
13,"Down",0.0611266978914741,0.23101128683661,"L.LvsP.REACTOME_ALPHA_PROTEIN_KINASE_1_SIGNALING_PATHWAY"
115,"Down",0.0614090120873955,0.231919691141537,"L.LvsP.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_UP"
876,"Down",0.0614987223117971,0.232099956083226,"L.LvsP.ENK_UV_RESPONSE_KERATINOCYTE_UP"
674,"Up",0.061811732883293,0.233122149462297,"L.LvsP.ZHANG_BREAST_CANCER_PROGENITORS_UP"
32,"Down",0.0619321700229457,0.23336564422628,"L.LvsP.HANSON_HRAS_SIGNALING_VIA_NFKB"
9,"Up",0.0619607100242682,0.23336564422628,"L.LvsP.REACTOME_PROSTANOID_LIGAND_RECEPTORS"
8,"Down",0.0622456115246331,0.234279091980733,"L.LvsP.ZIRN_TRETINOIN_RESPONSE_DN"
738,"Down",0.0623045930773026,0.23434156130912,"L.LvsP.CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN"
9,"Up",0.0623778601333482,0.234362844468888,"L.LvsP.REACTOME_ADRENOCEPTORS"
91,"Up",0.0623950275019359,0.234362844468888,"L.LvsP.FARMER_BREAST_CANCER_CLUSTER_1"
16,"Down",0.0625425302307565,0.234757399623797,"L.LvsP.NIKOLSKY_BREAST_CANCER_1Q32_AMPLICON"
886,"Up",0.0627497902803812,0.235334782115016,"L.LvsP.STEIN_ESRRA_TARGETS"
35,"Down",0.0627947519912862,0.235334782115016,"L.LvsP.OZANNE_AP1_TARGETS_UP"
835,"Down",0.0628240438418817,0.235334782115016,"L.LvsP.ZWANG_CLASS_1_TRANSIENTLY_INDUCED_BY_EGF"
37,"Down",0.0631564003486786,0.236419592097389,"L.LvsP.REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR2"
15,"Down",0.0634364146687078,0.237307129027933,"L.LvsP.REACTOME_SIGNALING_BY_FGFR4_IN_DISEASE"
73,"Down",0.0636408873002984,0.237760322510661,"L.LvsP.PID_ANGIOPOIETIN_RECEPTOR_PATHWAY"
40,"Down",0.0636435661630996,0.237760322510661,"L.LvsP.CHEN_PDGF_TARGETS"
17,"Down",0.0637936006664173,0.238053183341056,"L.LvsP.REACTOME_CREB1_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_ADENYLATE_CYCLASE"
36,"Up",0.0638722364715036,0.238053183341056,"L.LvsP.UROSEVIC_RESPONSE_TO_IMIQUIMOD"
51,"Down",0.0638768886064981,0.238053183341056,"L.LvsP.HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_UP"
38,"Down",0.0638941805169339,0.238053183341056,"L.LvsP.BURTON_ADIPOGENESIS_1"
27,"Down",0.0640190493677935,0.238357793908775,"L.LvsP.MOREIRA_RESPONSE_TO_TSA_DN"
161,"Down",0.0640788676605981,0.238419959149022,"L.LvsP.SESTO_RESPONSE_TO_UV_C8"
35,"Down",0.0643150089615624,0.239137649326482,"L.LvsP.SIG_IL4RECEPTOR_IN_B_LYPHOCYTES"
153,"Down",0.0646234638417707,0.24012307229916,"L.LvsP.HUANG_DASATINIB_RESISTANCE_UP"
69,"Down",0.0648164050377134,0.240678242749172,"L.LvsP.REACTOME_REGULATION_OF_PTEN_GENE_TRANSCRIPTION"
233,"Down",0.0648667386082693,0.240703488432967,"L.LvsP.REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES"
8,"Up",0.0651203849804154,0.241482634846893,"L.LvsP.SA_G2_AND_M_PHASES"
72,"Down",0.0652133175024141,0.241573539786187,"L.LvsP.KEGG_GLIOMA"
33,"Up",0.0652605931198497,0.241573539786187,"L.LvsP.KUROKAWA_LIVER_CANCER_EARLY_RECURRENCE_DN"
132,"Down",0.065275975482106,0.241573539786187,"L.LvsP.MILI_PSEUDOPODIA"
65,"Up",0.0653549583521795,0.241627403538213,"L.LvsP.TANG_SENESCENCE_TP53_TARGETS_UP"
82,"Down",0.0653958449843065,0.241627403538213,"L.LvsP.BIOCARTA_NFAT_PATHWAY"
92,"Down",0.0654216355754576,0.241627403538213,"L.LvsP.BURTON_ADIPOGENESIS_7"
9,"Up",0.0654992168047848,0.241752449742093,"L.LvsP.REACTOME_THE_ACTIVATION_OF_ARYLSULFATASES"
23,"Down",0.0655465616885816,0.241765803586503,"L.LvsP.PID_SYNDECAN_3_PATHWAY"
171,"Down",0.0656432557543584,0.241961040710565,"L.LvsP.WOOD_EBV_EBNA1_TARGETS_UP"
13,"Down",0.0658015516041267,0.242382930592416,"L.LvsP.PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_DN"
117,"Down",0.0659304452729498,0.242696026573994,"L.LvsP.TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_DN"
77,"Down",0.0662384205707008,0.243667483257089,"L.LvsP.ASTIER_INTEGRIN_SIGNALING"
12,"Down",0.0663403992667827,0.243880364059868,"L.LvsP.REACTOME_ACTIVATED_NTRK2_SIGNALS_THROUGH_RAS"
38,"Down",0.066507971535876,0.24433393662582,"L.LvsP.REACTOME_INFLAMMASOMES"
62,"Down",0.0666499958777885,0.244693112356104,"L.LvsP.REACTOME_SIGNALING_BY_SCF_KIT"
86,"Up",0.0668668077351214,0.245326197722287,"L.LvsP.GUILLAUMOND_KLF10_TARGETS_UP"
41,"Down",0.0670907613448723,0.245984628299601,"L.LvsP.JEON_SMAD6_TARGETS_UP"
27,"Down",0.0673144952285483,0.24651724012408,"L.LvsP.PID_INTEGRIN5_PATHWAY"
46,"Down",0.0673252003232701,0.24651724012408,"L.LvsP.CLIMENT_BREAST_CANCER_COPY_NUMBER_UP"
88,"Down",0.0675767987999891,0.247163854437288,"L.LvsP.ZHANG_PROLIFERATING_VS_QUIESCENT"
20,"Up",0.0675912005623404,0.247163854437288,"L.LvsP.ROETH_TERT_TARGETS_UP"
13,"Down",0.0679693215424217,0.248382272840747,"L.LvsP.REACTOME_CASPASE_ACTIVATION_VIA_DEPENDENCE_RECEPTORS_IN_THE_ABSENCE_OF_LIGAND"
10,"Down",0.0682228376426676,0.249144035222133,"L.LvsP.BIOCARTA_MSP_PATHWAY"
55,"Up",0.0685617557738114,0.250216467111157,"L.LvsP.KEGG_INOSITOL_PHOSPHATE_METABOLISM"
665,"Up",0.0687340181042678,0.250679674207452,"L.LvsP.GOLDRATH_ANTIGEN_RESPONSE"
43,"Down",0.0688172534814001,0.250817794659632,"L.LvsP.MAGRANGEAS_MULTIPLE_MYELOMA_IGG_VS_IGA_DN"
11,"Down",0.068956636139581,0.251160237955035,"L.LvsP.REACTOME_SYNTHESIS_OF_LIPOXINS_LX"
22,"Down",0.0691457451823203,0.251683229172514,"L.LvsP.KYNG_WERNER_SYNDROM_UP"
26,"Down",0.069223006401601,0.251798685785824,"L.LvsP.LOPEZ_MESOTHELIOMA_SURVIVAL_WORST_VS_BEST_UP"
17,"Down",0.0698395621816442,0.253729466493085,"L.LvsP.BIOCARTA_CD40_PATHWAY"
124,"Down",0.0698455865441265,0.253729466493085,"L.LvsP.MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_DN"
8,"Up",0.0699366424709905,0.253893431531259,"L.LvsP.REACTOME_POLB_DEPENDENT_LONG_PATCH_BASE_EXCISION_REPAIR"
65,"Up",0.0704912430134245,0.255738899357758,"L.LvsP.CHIARETTI_T_ALL_REFRACTORY_TO_THERAPY"
29,"Down",0.0707663476960723,0.256568614040383,"L.LvsP.REACTOME_ACTIVATION_OF_AMPK_DOWNSTREAM_OF_NMDARS"
10,"Up",0.0708767174723953,0.256800374118528,"L.LvsP.REACTOME_DISPLACEMENT_OF_DNA_GLYCOSYLASE_BY_APEX1"
1007,"Down",0.0710441782381317,0.257238547137283,"L.LvsP.MARTINEZ_RB1_AND_TP53_TARGETS_DN"
15,"Up",0.0711060876258471,0.257294213667087,"L.LvsP.REACTOME_HEME_BIOSYNTHESIS"
297,"Down",0.0713249964376786,0.25791753126483,"L.LvsP.VANOEVELEN_MYOGENESIS_SIN3A_TARGETS"
439,"Down",0.0717418700637539,0.259255424563722,"L.LvsP.MCBRYAN_PUBERTAL_BREAST_4_5WK_UP"
131,"Up",0.0718409105926423,0.25944375876337,"L.LvsP.HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_UP"
13,"Down",0.0721443711281362,0.260369600500956,"L.LvsP.REACTOME_SIGNALING_BY_FGFR3_FUSIONS_IN_CANCER"
389,"Up",0.0724629026143579,0.261120872939969,"L.LvsP.GAL_LEUKEMIC_STEM_CELL_DN"
83,"Down",0.0725012374021818,0.261120872939969,"L.LvsP.DELACROIX_RAR_TARGETS_UP"
19,"Down",0.0725739146265038,0.261120872939969,"L.LvsP.LI_CYTIDINE_ANALOGS_CYCTOTOXICITY"
455,"Down",0.0725771543916671,0.261120872939969,"L.LvsP.SENESE_HDAC1_TARGETS_DN"
13,"Up",0.0725886745720262,0.261120872939969,"L.LvsP.REACTOME_RNF_MUTANTS_SHOW_ENHANCED_WNT_SIGNALING_AND_PROLIFERATION"
38,"Down",0.0728297581731562,0.26181777174212,"L.LvsP.BIOCARTA_BAD_PATHWAY"
76,"Down",0.0730154932678258,0.262314920258485,"L.LvsP.PID_KIT_PATHWAY"
87,"Down",0.0731977099345933,0.262798791057381,"L.LvsP.ZHOU_TNF_SIGNALING_4HR"
269,"Up",0.073402562866059,0.263256423313712,"L.LvsP.CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN"
73,"Down",0.0734827511708248,0.263256423313712,"L.LvsP.REACTOME_G1_S_DNA_DAMAGE_CHECKPOINTS"
18,"Down",0.0735128629994808,0.263256423313712,"L.LvsP.BIOCARTA_PCAF_PATHWAY"
50,"Down",0.0735395767764348,0.263256423313712,"L.LvsP.REACTOME_G_ALPHA_Z_SIGNALLING_EVENTS"
17,"Down",0.0735632436280855,0.263256423313712,"L.LvsP.FUKUSHIMA_TNFSF11_TARGETS"
38,"Down",0.073786795544055,0.263885635551798,"L.LvsP.VALK_AML_CLUSTER_8"
104,"Up",0.0738588781281685,0.263972680782575,"L.LvsP.REACTOME_HDACS_DEACETYLATE_HISTONES"
63,"Down",0.0742998979480384,0.26537734867875,"L.LvsP.SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2"
296,"Down",0.0743968524273953,0.265552096236971,"L.LvsP.SMIRNOV_RESPONSE_TO_IR_6HR_UP"
49,"Down",0.0746246940293897,0.266193505347416,"L.LvsP.BIOCARTA_FMLP_PATHWAY"
68,"Down",0.074865536741272,0.266880433683103,"L.LvsP.BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_24HR_DN"
90,"Down",0.0750478485495601,0.267357960457808,"L.LvsP.REACTOME_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE"
135,"Down",0.0751076344969523,0.267398654947617,"L.LvsP.LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP"
12,"Down",0.0754720361840597,0.268312721915618,"L.LvsP.TCGA_GLIOBLASTOMA_MUTATED"
13,"Down",0.0754832586065925,0.268312721915618,"L.LvsP.BIOCARTA_RNA_PATHWAY"
94,"Down",0.0755353666515805,0.268312721915618,"L.LvsP.SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_DN"
19,"Up",0.0755735741187707,0.268312721915618,"L.LvsP.REACTOME_ALPHA_LINOLENIC_OMEGA3_AND_LINOLEIC_OMEGA6_ACID_METABOLISM"
18,"Down",0.0756070212958099,0.268312721915618,"L.LvsP.XU_RESPONSE_TO_TRETINOIN_DN"
51,"Up",0.0757265798189385,0.268564631057672,"L.LvsP.REACTOME_GROWTH_HORMONE_RECEPTOR_SIGNALING"
33,"Down",0.0759206441384549,0.269080282975331,"L.LvsP.HASLINGER_B_CLL_WITH_CHROMOSOME_12_TRISOMY"
308,"Down",0.0761861492114169,0.26956551408366,"L.LvsP.PLASARI_TGFB1_TARGETS_10HR_UP"
12,"Up",0.0762415602335549,0.26956551408366,"L.LvsP.BIOCARTA_CDC25_PATHWAY"
796,"Down",0.076276255388021,0.26956551408366,"L.LvsP.MILI_PSEUDOPODIA_HAPTOTAXIS_UP"
163,"Up",0.0762901923084837,0.26956551408366,"L.LvsP.TAYLOR_METHYLATED_IN_ACUTE_LYMPHOBLASTIC_LEUKEMIA"
51,"Down",0.0763013256539932,0.26956551408366,"L.LvsP.PID_AVB3_OPN_PATHWAY"
477,"Up",0.0763925483671622,0.269715453334636,"L.LvsP.SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP"
15,"Up",0.0764769229483483,0.269841038277867,"L.LvsP.WORSCHECH_TUMOR_EVASION_AND_TOLEROGENICITY_DN"
44,"Down",0.0766274144309101,0.270199601013075,"L.LvsP.SHIN_B_CELL_LYMPHOMA_CLUSTER_3"
76,"Down",0.0767975360484918,0.270626881333404,"L.LvsP.REACTOME_SIGNALING_BY_PDGF"
19,"Down",0.0769769734301614,0.270938396332916,"L.LvsP.REACTOME_ACTIVATION_OF_IRF3_IRF7_MEDIATED_BY_TBK1_IKK_EPSILON"
237,"Up",0.0769839429623823,0.270938396332916,"L.LvsP.YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_13"
96,"Down",0.0770600213764852,0.271033624803172,"L.LvsP.MUELLER_METHYLATED_IN_GLIOBLASTOMA"
65,"Up",0.0772540679628304,0.271488201036114,"L.LvsP.PRAMOONJAGO_SOX4_TARGETS_DN"
163,"Down",0.0772953472366755,0.271488201036114,"L.LvsP.HILLION_HMGA1_TARGETS"
5,"Up",0.0773365738165817,0.271488201036114,"L.LvsP.JONES_TCOF1_TARGETS"
219,"Down",0.0774337970789915,0.271657020336132,"L.LvsP.XU_GH1_AUTOCRINE_TARGETS_DN"
1501,"Down",0.0774972667715098,0.271707284704932,"L.LvsP.LOPEZ_MBD_TARGETS"
14,"Down",0.0776004439837968,0.271896612665661,"L.LvsP.REACTOME_MITOCHONDRIAL_FATTY_ACID_BETA_OXIDATION_OF_SATURATED_FATTY_ACIDS"
815,"Down",0.0777853500458705,0.272371881192918,"L.LvsP.ONDER_CDH1_TARGETS_2_DN"
32,"Down",0.0779222104309931,0.272678418653773,"L.LvsP.VETTER_TARGETS_OF_PRKCA_AND_ETS1_DN"
21,"Down",0.0781507025246767,0.273305018506602,"L.LvsP.WHITESIDE_CISPLATIN_RESISTANCE_UP"
5,"Down",0.0783656710750273,0.273622090781526,"L.LvsP.REACTOME_BETA_OXIDATION_OF_HEXANOYL_COA_TO_BUTANOYL_COA"
84,"Down",0.0783817613368191,0.273622090781526,"L.LvsP.BROWNE_HCMV_INFECTION_2HR_DN"
39,"Down",0.0784214687369161,0.273622090781526,"L.LvsP.BIOCARTA_RACCYCD_PATHWAY"
27,"Down",0.0784393224613346,0.273622090781526,"L.LvsP.CHEMELLO_SOLEUS_VS_EDL_MYOFIBERS_UP"
8,"Down",0.0786942935968599,0.274338429569381,"L.LvsP.BIOCARTA_ION_PATHWAY"
29,"Down",0.0787484648008298,0.274354292302324,"L.LvsP.REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR3"
24,"Up",0.0788124417764302,0.274404276185065,"L.LvsP.INAMURA_LUNG_CANCER_SCC_DN"
9,"Down",0.0793686495687311,0.276166937360299,"L.LvsP.REACTOME_ACTIVATED_NTRK2_SIGNALS_THROUGH_CDK5"
588,"Up",0.0797868373797174,0.277207667129249,"L.LvsP.MOOTHA_PGC"
18,"Down",0.0798033129041514,0.277207667129249,"L.LvsP.BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_24HR_UP"
12,"Down",0.0798181598968647,0.277207667129249,"L.LvsP.REACTOME_ROLE_OF_ABL_IN_ROBO_SLIT_SIGNALING"
46,"Up",0.0802017977472387,0.278365185024785,"L.LvsP.REACTOME_INTERLEUKIN_7_SIGNALING"
57,"Down",0.0805657816110659,0.279225292435245,"L.LvsP.NAKAMURA_ADIPOGENESIS_LATE_DN"
6,"Up",0.080595242927372,0.279225292435245,"L.LvsP.REACTOME_TRANSPORT_AND_SYNTHESIS_OF_PAPS"
32,"Down",0.0806781042695001,0.279225292435245,"L.LvsP.REACTOME_RNA_POLYMERASE_I_TRANSCRIPTION_TERMINATION"
22,"Up",0.0806810755186793,0.279225292435245,"L.LvsP.BAUS_TFF2_TARGETS_DN"
185,"Up",0.0807021192460702,0.279225292435245,"L.LvsP.REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS"
31,"Up",0.0807572572290316,0.279241322838847,"L.LvsP.REACTOME_PLATELET_CALCIUM_HOMEOSTASIS"
14,"Down",0.0810007006651756,0.279908046236097,"L.LvsP.REACTOME_SUMOYLATION_OF_IMMUNE_RESPONSE_PROTEINS"
7,"Down",0.0810812712260156,0.280011460717452,"L.LvsP.REACTOME_TFAP2A_ACTS_AS_A_TRANSCRIPTIONAL_REPRESSOR_DURING_RETINOIC_ACID_INDUCED_CELL_DIFFERENTIATION"
74,"Up",0.0812143289754384,0.280295895696129,"L.LvsP.BOYAULT_LIVER_CANCER_SUBCLASS_G3_DN"
77,"Down",0.0817351627043621,0.281748393707762,"L.LvsP.LINDSTEDT_DENDRITIC_CELL_MATURATION_B"
140,"Down",0.0817370995672363,0.281748393707762,"L.LvsP.DUAN_PRDM5_TARGETS"
509,"Up",0.081824916096911,0.281875365171228,"L.LvsP.KUMAR_PATHOGEN_LOAD_BY_MACROPHAGES"
23,"Up",0.0819478774923198,0.28212317226341,"L.LvsP.REACTOME_NEGATIVE_REGULATION_OF_TCF_DEPENDENT_SIGNALING_BY_WNT_LIGAND_ANTAGONISTS"
13,"Down",0.0820935936779543,0.282448960451406,"L.LvsP.REACTOME_INACTIVATION_OF_CDC42_AND_RAC1"
23,"Down",0.0824008002157672,0.283051498505199,"L.LvsP.MANN_RESPONSE_TO_AMIFOSTINE_UP"
700,"Down",0.0824043333552865,0.283051498505199,"L.LvsP.MARTENS_BOUND_BY_PML_RARA_FUSION"
189,"Up",0.0824223028745471,0.283051498505199,"L.LvsP.HAHTOLA_SEZARY_SYNDROM_UP"
50,"Down",0.0824785048951719,0.283064802532975,"L.LvsP.TOMIDA_METASTASIS_UP"
32,"Up",0.0825285696659715,0.283064802532975,"L.LvsP.KORKOLA_SEMINOMA_DN"
13,"Down",0.0828246984265718,0.283904375449793,"L.LvsP.REACTOME_MASTL_FACILITATES_MITOTIC_PROGRESSION"
40,"Up",0.0828788570155927,0.283914002750441,"L.LvsP.WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_DN"
42,"Down",0.0832341057916617,0.284584616057767,"L.LvsP.REACTOME_GENERATION_OF_SECOND_MESSENGER_MOLECULES"
38,"Down",0.0832534787523221,0.284584616057767,"L.LvsP.MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP"
34,"Down",0.0832670891463762,0.284584616057767,"L.LvsP.REACTOME_IKK_COMPLEX_RECRUITMENT_MEDIATED_BY_RIP1"
377,"Down",0.083305969970602,0.284584616057767,"L.LvsP.MANALO_HYPOXIA_UP"
159,"Down",0.0833319756551863,0.284584616057767,"L.LvsP.REACTOME_TOLL_LIKE_RECEPTOR_4_TLR4_CASCADE"
200,"Up",0.0835016996360345,0.284988208202244,"L.LvsP.CAMPS_COLON_CANCER_COPY_NUMBER_DN"
13,"Down",0.0836756466005261,0.285120986529384,"L.LvsP.REACTOME_P75NTR_REGULATES_AXONOGENESIS"
50,"Up",0.0836845399880201,0.285120986529384,"L.LvsP.BRACHAT_RESPONSE_TO_CISPLATIN"
10,"Down",0.0837483834524652,0.285120986529384,"L.LvsP.REACTOME_SHC_RELATED_EVENTS_TRIGGERED_BY_IGF1R"
76,"Down",0.0837925628179509,0.285120986529384,"L.LvsP.PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_DN"
762,"Down",0.0837984451275544,0.285120986529384,"L.LvsP.LIM_MAMMARY_STEM_CELL_UP"
34,"Down",0.0839192643237621,0.285276735569788,"L.LvsP.SYED_ESTRADIOL_RESPONSE"
8,"Up",0.0839639828368864,0.285276735569788,"L.LvsP.REACTOME_METAL_SEQUESTRATION_BY_ANTIMICROBIAL_PROTEINS"
385,"Down",0.0840132130774273,0.285276735569788,"L.LvsP.COLDREN_GEFITINIB_RESISTANCE_DN"
44,"Up",0.0840506063018962,0.285276735569788,"L.LvsP.REACTOME_DISEASES_ASSOCIATED_WITH_GLYCOSAMINOGLYCAN_METABOLISM"
37,"Down",0.0844415800080873,0.286321861603442,"L.LvsP.BIOCARTA_HDAC_PATHWAY"
7,"Down",0.0844621009721856,0.286321861603442,"L.LvsP.CAFFAREL_RESPONSE_TO_THC_8HR_3_UP"
38,"Down",0.0846537055410322,0.286795550206107,"L.LvsP.PID_CDC42_REG_PATHWAY"
103,"Up",0.0847795987231693,0.287046173509126,"L.LvsP.PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_UP"
7,"Down",0.0850865373649383,0.287909097362756,"L.LvsP.REACTOME_APOBEC3G_MEDIATED_RESISTANCE_TO_HIV_1_INFECTION"
48,"Up",0.0855957563096694,0.289428742187957,"L.LvsP.YU_BAP1_TARGETS"
28,"Down",0.0856664290806235,0.289428742187957,"L.LvsP.RAHMAN_TP53_TARGETS_PHOSPHORYLATED"
197,"Down",0.0856926842035965,0.289428742187957,"L.LvsP.LIU_SOX4_TARGETS_UP"
53,"Down",0.0857999117996945,0.28961398799787,"L.LvsP.FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN"
65,"Down",0.0858694142421321,0.289671745786912,"L.LvsP.ABE_INNER_EAR"
133,"Down",0.0865439513351048,0.291497756437115,"L.LvsP.KUNINGER_IGF1_VS_PDGFB_TARGETS_UP"
231,"Down",0.0865596553694873,0.291497756437115,"L.LvsP.REACTOME_MITOTIC_G2_G2_M_PHASES"
58,"Down",0.0865688761204092,0.291497756437115,"L.LvsP.REACTOME_RECYCLING_PATHWAY_OF_L1"
32,"Down",0.08687272334827,0.29234284077455,"L.LvsP.LEE_SP4_THYMOCYTE"
74,"Down",0.0869793147447407,0.292523498311235,"L.LvsP.BURTON_ADIPOGENESIS_PEAK_AT_8HR"
28,"Up",0.0872215160304276,0.293159733818987,"L.LvsP.REACTOME_SULFUR_AMINO_ACID_METABOLISM"
48,"Down",0.0873645004459739,0.293461921607406,"L.LvsP.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_UP"
80,"Down",0.0874575158040632,0.293595995677393,"L.LvsP.MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_6"
630,"Down",0.0875598485094332,0.293761166510107,"L.LvsP.FOSTER_TOLERANT_MACROPHAGE_DN"
29,"Up",0.0878286682603848,0.29448435828482,"L.LvsP.DORN_ADENOVIRUS_INFECTION_32HR_UP"
48,"Down",0.088015335940692,0.294769789759853,"L.LvsP.BIOCARTA_EGF_PATHWAY"
36,"Up",0.0880204237463405,0.294769789759853,"L.LvsP.HOLLEMAN_ASPARAGINASE_RESISTANCE_B_ALL_DN"
245,"Down",0.08840913189974,0.295848281460897,"L.LvsP.JOHNSTONE_PARVB_TARGETS_2_UP"
61,"Down",0.0885194996893141,0.295848281460897,"L.LvsP.LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_UP"
119,"Up",0.088582297320519,0.295848281460897,"L.LvsP.RIZ_ERYTHROID_DIFFERENTIATION"
19,"Up",0.0885995082646668,0.295848281460897,"L.LvsP.REACTOME_METABOLISM_OF_AMINE_DERIVED_HORMONES"
978,"Up",0.08861001159328,0.295848281460897,"L.LvsP.MILI_PSEUDOPODIA_HAPTOTAXIS_DN"
391,"Down",0.088826972662576,0.296221204295799,"L.LvsP.AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_UP"
13,"Up",0.0888288581520047,0.296221204295799,"L.LvsP.KHETCHOUMIAN_TRIM24_TARGETS_DN"
30,"Up",0.0890808029339381,0.296882314298821,"L.LvsP.RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_DN"
186,"Up",0.0891690246475048,0.296997311612081,"L.LvsP.CHUNG_BLISTER_CYTOTOXICITY_UP"
8,"Up",0.089250543673528,0.297089859103514,"L.LvsP.REACTOME_TLR3_MEDIATED_TICAM1_DEPENDENT_PROGRAMMED_CELL_DEATH"
82,"Down",0.0894004149963734,0.29724029573273,"L.LvsP.AMIT_EGF_RESPONSE_240_HELA"
56,"Down",0.0894123971430024,0.29724029573273,"L.LvsP.DAIRKEE_CANCER_PRONE_RESPONSE_E2"
67,"Down",0.0895079275170876,0.29724029573273,"L.LvsP.PID_ARF6_TRAFFICKING_PATHWAY"
302,"Down",0.0895107781506592,0.29724029573273,"L.LvsP.MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP"
21,"Down",0.089641967983565,0.29733731560319,"L.LvsP.AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_DN"
47,"Down",0.0896475502098965,0.29733731560319,"L.LvsP.PID_ALPHA_SYNUCLEIN_PATHWAY"
563,"Down",0.0900620820906692,0.298513186136413,"L.LvsP.RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN"
26,"Down",0.09011005745373,0.298513186136413,"L.LvsP.SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX1_UP"
36,"Up",0.0902510896707907,0.298801362149582,"L.LvsP.BARIS_THYROID_CANCER_UP"
740,"Down",0.0905608022332667,0.299485355342779,"L.LvsP.DELYS_THYROID_CANCER_UP"
19,"Down",0.0905660181105312,0.299485355342779,"L.LvsP.BIOCARTA_HES_PATHWAY"
53,"Down",0.0907149406119463,0.299798509649403,"L.LvsP.ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP"
32,"Down",0.0910280251361497,0.300463538193026,"L.LvsP.BIOCARTA_VIP_PATHWAY"
37,"Down",0.091077068918311,0.300463538193026,"L.LvsP.OLSSON_E2F3_TARGETS_UP"
251,"Down",0.0910791987722033,0.300463538193026,"L.LvsP.GROSS_HYPOXIA_VIA_ELK3_DN"
44,"Down",0.0914357462748325,0.301459893353339,"L.LvsP.YANG_BREAST_CANCER_ESR1_BULK_DN"
105,"Down",0.0916032883303256,0.301832289140864,"L.LvsP.REACTOME_OPIOID_SIGNALLING"
5,"Up",0.0916954096490958,0.30192147474554,"L.LvsP.REACTOME_LEUKOTRIENE_RECEPTORS"
10,"Up",0.0917735910993788,0.30192147474554,"L.LvsP.BIOCARTA_S1P_PATHWAY"
129,"Down",0.0917941759897364,0.30192147474554,"L.LvsP.VERRECCHIA_EARLY_RESPONSE_TO_TGFB1"
37,"Up",0.0919064692322864,0.301997087529104,"L.LvsP.SINGH_NFE2L2_TARGETS"
59,"Down",0.0919879678043063,0.301997087529104,"L.LvsP.AMIT_EGF_RESPONSE_480_MCF10A"
64,"Down",0.0920290015651314,0.301997087529104,"L.LvsP.FAELT_B_CLL_WITH_VH3_21_DN"
20,"Up",0.0920356470404306,0.301997087529104,"L.LvsP.FERRANDO_LYL1_NEIGHBORS"
137,"Down",0.0923237812428766,0.302762862687939,"L.LvsP.DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN"
26,"Up",0.0924615509393246,0.303034923025208,"L.LvsP.REACTOME_ABC_TRANSPORTERS_IN_LIPID_HOMEOSTASIS"
23,"Up",0.0927414756764191,0.303765645827676,"L.LvsP.MARKS_HDAC_TARGETS_DN"
54,"Down",0.0927943888231045,0.303765645827676,"L.LvsP.HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_24HR"
111,"Down",0.0929261561233669,0.304016992429642,"L.LvsP.POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN"
257,"Down",0.0930417504640191,0.304215161629546,"L.LvsP.GAVIN_FOXP3_TARGETS_CLUSTER_P3"
129,"Up",0.0932872988925907,0.304837751523129,"L.LvsP.REACTOME_NEGATIVE_EPIGENETIC_REGULATION_OF_RRNA_EXPRESSION"
36,"Down",0.0934006722628437,0.305027948577237,"L.LvsP.NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_UP"
34,"Down",0.0936154885634276,0.305531023606928,"L.LvsP.REACTOME_MITOPHAGY"
5,"Down",0.0936652351263779,0.305531023606928,"L.LvsP.REACTOME_PTK6_REGULATES_PROTEINS_INVOLVED_IN_RNA_PROCESSING"
221,"Up",0.0937349209427284,0.305578053002562,"L.LvsP.RODWELL_AGING_KIDNEY_NO_BLOOD_DN"
104,"Up",0.094069412096992,0.306487789914124,"L.LvsP.FIGUEROA_AML_METHYLATION_CLUSTER_1_DN"
417,"Up",0.094170940008318,0.30663788416136,"L.LvsP.PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_UP"
449,"Down",0.0942876192015379,0.306837108043145,"L.LvsP.DOANE_RESPONSE_TO_ANDROGEN_DN"
33,"Down",0.0943485164773044,0.306854675060598,"L.LvsP.REACTOME_LONG_TERM_POTENTIATION"
6,"Down",0.0944606263829672,0.307038685050809,"L.LvsP.REACTOME_MET_INTERACTS_WITH_TNS_PROTEINS"
22,"Up",0.0949098719399659,0.308317674474778,"L.LvsP.REACTOME_CONVERSION_FROM_APC_C_CDC20_TO_APC_C_CDH1_IN_LATE_ANAPHASE"
52,"Down",0.0951508818210374,0.308919098995018,"L.LvsP.HUNSBERGER_EXERCISE_REGULATED_GENES"
14,"Up",0.0956131591980785,0.310237768313484,"L.LvsP.REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_G1_CELL_CYCLE_ARREST"
19,"Up",0.0956725338156762,0.310248351593474,"L.LvsP.REACTOME_TRAFFICKING_OF_GLUR2_CONTAINING_AMPA_RECEPTORS"
59,"Down",0.095786437741496,0.310261057002807,"L.LvsP.GYORFFY_MITOXANTRONE_RESISTANCE"
244,"Down",0.0957886822759615,0.310261057002807,"L.LvsP.CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_UP"
74,"Down",0.0962904941057355,0.311703830158438,"L.LvsP.DAVIES_MULTIPLE_MYELOMA_VS_MGUS_DN"
134,"Down",0.0966308387449043,0.312622532136089,"L.LvsP.BASSO_HAIRY_CELL_LEUKEMIA_UP"
9,"Down",0.0969356372204645,0.313425227012835,"L.LvsP.REACTOME_SIGNALLING_TO_P38_VIA_RIT_AND_RIN"
1060,"Down",0.0970155207147606,0.313500183537061,"L.LvsP.MARTINEZ_TP53_TARGETS_DN"
541,"Up",0.0973723816574307,0.314324099103445,"L.LvsP.BOYLAN_MULTIPLE_MYELOMA_C_D_DN"
57,"Up",0.0973872805667162,0.314324099103445,"L.LvsP.PID_ATM_PATHWAY"
43,"Down",0.0974661575361584,0.314324099103445,"L.LvsP.LA_MEN1_TARGETS"
633,"Up",0.0974978893041071,0.314324099103445,"L.LvsP.HADDAD_B_LYMPHOCYTE_PROGENITOR"
9,"Down",0.09761023153884,0.314471695585663,"L.LvsP.REACTOME_RUNX1_REGULATES_ESTROGEN_RECEPTOR_MEDIATED_TRANSCRIPTION"
28,"Down",0.0976574247279043,0.314471695585663,"L.LvsP.MARSON_FOXP3_CORE_DIRECT_TARGETS"
260,"Down",0.0977803195455707,0.31453258497369,"L.LvsP.REACTOME_KERATINIZATION"
17,"Up",0.09783119767328,0.31453258497369,"L.LvsP.REACTOME_TRYPTOPHAN_CATABOLISM"
315,"Down",0.0978469969532912,0.31453258497369,"L.LvsP.BENPORATH_NOS_TARGETS"
13,"Up",0.0980347656699909,0.31487324956318,"L.LvsP.REACTOME_MUCOPOLYSACCHARIDOSES"
8,"Up",0.0980668720831608,0.31487324956318,"L.LvsP.TERAMOTO_OPN_TARGETS_CLUSTER_8"
8,"Up",0.0982334571018958,0.315221209963896,"L.LvsP.MOOTHA_ROS"
46,"Down",0.0982892685798078,0.315221209963896,"L.LvsP.PLASARI_TGFB1_TARGETS_1HR_UP"
216,"Down",0.0984329271238984,0.315498929894513,"L.LvsP.WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_36HR"
226,"Down",0.0985248571292783,0.315610622866616,"L.LvsP.REACTOME_SUMOYLATION"
10,"Down",0.0986926783999694,0.315965152792954,"L.LvsP.REACTOME_PTK6_PROMOTES_HIF1A_STABILIZATION"
55,"Up",0.0992581874468668,0.317591735181555,"L.LvsP.REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC"
10,"Up",0.0993505561002053,0.317703426650107,"L.LvsP.AGARWAL_AKT_PATHWAY_TARGETS"
1236,"Up",0.0994242431108655,0.317755283329466,"L.LvsP.GEORGES_TARGETS_OF_MIR192_AND_MIR215"
75,"Down",0.0996401101649952,0.318025964482869,"L.LvsP.NUTT_GBM_VS_AO_GLIOMA_DN"
110,"Down",0.0996470761921721,0.318025964482869,"L.LvsP.TOOKER_GEMCITABINE_RESISTANCE_UP"
19,"Down",0.0998447781407014,0.318025964482869,"L.LvsP.BIOCARTA_EFP_PATHWAY"
32,"Down",0.0998479418349253,0.318025964482869,"L.LvsP.BIOCARTA_PAR1_PATHWAY"
160,"Up",0.0998611346514249,0.318025964482869,"L.LvsP.SANA_RESPONSE_TO_IFNG_UP"
8,"Down",0.0998849672339313,0.318025964482869,"L.LvsP.CHENG_TAF7L_TARGETS"
476,"Down",0.0999115753855569,0.318025964482869,"L.LvsP.MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_UP"
7,"Up",0.100001991239582,0.318130615399108,"L.LvsP.MOTAMED_RESPONSE_TO_ANDROGEN_DN"
23,"Down",0.100271843624378,0.318805648878198,"L.LvsP.GRASEMANN_RETINOBLASTOMA_WITH_6P_AMPLIFICATION"
209,"Down",0.10035826633268,0.318897042846776,"L.LvsP.SANSOM_APC_TARGETS_UP"
23,"Down",0.100613745625272,0.319525215141947,"L.LvsP.WHITE_NEUROBLASTOMA_WITH_1P36.3_DELETION"
27,"Up",0.100864588832131,0.320137951580282,"L.LvsP.VANDESLUIS_COMMD1_TARGETS_GROUP_2_UP"
349,"Down",0.101078645005034,0.320627640117708,"L.LvsP.BENPORATH_MYC_TARGETS_WITH_EBOX"
153,"Down",0.101134853384931,0.320627640117708,"L.LvsP.DE_YY1_TARGETS_DN"
65,"Down",0.101355245098818,0.321142206390467,"L.LvsP.REACTOME_INTRAFLAGELLAR_TRANSPORT"
5,"Up",0.101528067156121,0.321400989352262,"L.LvsP.REACTOME_SODIUM_COUPLED_SULPHATE_DI_AND_TRI_CARBOXYLATE_TRANSPORTERS"
29,"Up",0.101648785101182,0.321400989352262,"L.LvsP.REACTOME_INSERTION_OF_TAIL_ANCHORED_PROTEINS_INTO_THE_ENDOPLASMIC_RETICULUM_MEMBRANE"
90,"Down",0.101660391583484,0.321400989352262,"L.LvsP.REACTOME_CYTOSOLIC_SENSORS_OF_PATHOGEN_ASSOCIATED_DNA"
9,"Down",0.10171941461269,0.321400989352262,"L.LvsP.BIOCARTA_ERBB3_PATHWAY"
346,"Down",0.101736163184814,0.321400989352262,"L.LvsP.REACTOME_TRANSLATION"
14,"Down",0.101789920460098,0.321400989352262,"L.LvsP.REACTOME_PEXOPHAGY"
933,"Down",0.101843829507174,0.321400989352262,"L.LvsP.FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP"
81,"Down",0.102292042073587,0.322555594712499,"L.LvsP.LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN"
12,"Up",0.102326372422811,0.322555594712499,"L.LvsP.MIZUKAMI_HYPOXIA_DN"
5,"Up",0.10251750166968,0.322820164007897,"L.LvsP.REACTOME_PTK6_EXPRESSION"
12,"Up",0.102573166565523,0.322820164007897,"L.LvsP.REACTOME_ACTIVATED_NTRK3_SIGNALS_THROUGH_PI3K"
6,"Up",0.102624456030586,0.322820164007897,"L.LvsP.REACTOME_FICOLINS_BIND_TO_REPETITIVE_CARBOHYDRATE_STRUCTURES_ON_THE_TARGET_CELL_SURFACE"
35,"Up",0.102643850303108,0.322820164007897,"L.LvsP.REACTOME_RECOGNITION_OF_DNA_DAMAGE_BY_PCNA_CONTAINING_REPLICATION_COMPLEX"
122,"Down",0.102782256798279,0.322902043181306,"L.LvsP.BURTON_ADIPOGENESIS_2"
127,"Up",0.102786687646789,0.322902043181306,"L.LvsP.PYEON_HPV_POSITIVE_TUMORS_UP"
284,"Down",0.102916048609789,0.323124834050837,"L.LvsP.ANDERSEN_CHOLANGIOCARCINOMA_CLASS2"
29,"Down",0.103458819105117,0.324628946183923,"L.LvsP.REACTOME_FRS_MEDIATED_FGFR2_SIGNALING"
51,"Down",0.103512539721877,0.324628946183923,"L.LvsP.REACTOME_ASSOCIATION_OF_TRIC_CCT_WITH_TARGET_PROTEINS_DURING_BIOSYNTHESIS"
126,"Down",0.103593258151096,0.324697916279711,"L.LvsP.REACTOME_NUCLEOTIDE_EXCISION_REPAIR"
19,"Up",0.103747831915988,0.324998165815012,"L.LvsP.REACTOME_SYNTHESIS_SECRETION_AND_INACTIVATION_OF_GLUCOSE_DEPENDENT_INSULINOTROPIC_POLYPEPTIDE_GIP"
21,"Down",0.10386254089652,0.325096141258455,"L.LvsP.REACTOME_IL_6_TYPE_CYTOKINE_RECEPTOR_LIGAND_INTERACTIONS"
18,"Down",0.103896704938269,0.325096141258455,"L.LvsP.STEINER_ERYTHROCYTE_MEMBRANE_GENES"
95,"Down",0.104121643115183,0.325615704063263,"L.LvsP.RAMASWAMY_METASTASIS_DN"
13,"Down",0.104190193775456,0.325645891116164,"L.LvsP.BIOCARTA_LYMPHOCYTE_PATHWAY"
22,"Down",0.104271142968013,0.325714773711947,"L.LvsP.BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_24HR_DN"
820,"Down",0.104563936550782,0.326444949288128,"L.LvsP.SENESE_HDAC3_TARGETS_UP"
564,"Up",0.104691510111629,0.326658780703837,"L.LvsP.COLINA_TARGETS_OF_4EBP1_AND_4EBP2"
81,"Down",0.104895167518925,0.326895298199605,"L.LvsP.REACTOME_COSTIMULATION_BY_THE_CD28_FAMILY"
17,"Down",0.104902032330942,0.326895298199605,"L.LvsP.NIKOLSKY_BREAST_CANCER_14Q22_AMPLICON"
63,"Down",0.10494468336124,0.326895298199605,"L.LvsP.BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_48HR_DN"
361,"Up",0.105066720954154,0.327091159997477,"L.LvsP.MARKEY_RB1_ACUTE_LOF_UP"
51,"Up",0.105339001856661,0.327745684062171,"L.LvsP.NIKOLSKY_BREAST_CANCER_7P22_AMPLICON"
32,"Down",0.105481434490071,0.327745684062171,"L.LvsP.REACTOME_TICAM1_RIP1_MEDIATED_IKK_COMPLEX_RECRUITMENT"
100,"Down",0.105512657940647,0.327745684062171,"L.LvsP.CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_DN"
19,"Down",0.105514074449388,0.327745684062171,"L.LvsP.BIOCARTA_TNFR2_PATHWAY"
18,"Down",0.105795339899854,0.328224911381074,"L.LvsP.CROONQUIST_STROMAL_STIMULATION_DN"
237,"Up",0.105843293623222,0.328224911381074,"L.LvsP.KIM_MYCN_AMPLIFICATION_TARGETS_DN"
81,"Down",0.105862550934029,0.328224911381074,"L.LvsP.TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP"
27,"Up",0.105930827660264,0.328224911381074,"L.LvsP.IGLESIAS_E2F_TARGETS_DN"
33,"Down",0.10596517757555,0.328224911381074,"L.LvsP.REACTOME_PURINERGIC_SIGNALING_IN_LEISHMANIASIS_INFECTION"
16,"Down",0.106086879912761,0.328417894198015,"L.LvsP.REACTOME_INTESTINAL_ABSORPTION"
89,"Down",0.106476179264554,0.329429951533701,"L.LvsP.REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH"
72,"Down",0.106532963165538,0.329429951533701,"L.LvsP.REACTOME_ASSEMBLY_OF_THE_PRE_REPLICATIVE_COMPLEX"
86,"Down",0.107205233678078,0.331142181831867,"L.LvsP.ZAMORA_NOS2_TARGETS_UP"
83,"Up",0.107206457854773,0.331142181831867,"L.LvsP.CHENG_RESPONSE_TO_NICKEL_ACETATE"
20,"Down",0.107267928859056,0.331147056762545,"L.LvsP.REACTOME_RAP1_SIGNALLING"
15,"Down",0.107583525970727,0.331777872489685,"L.LvsP.STANHILL_HRAS_TRANSFROMATION_UP"
35,"Down",0.10762061258354,0.331777872489685,"L.LvsP.PID_PDGFRA_PATHWAY"
34,"Down",0.107652288523511,0.331777872489685,"L.LvsP.REACTOME_VEGFR2_MEDIATED_VASCULAR_PERMEABILITY"
93,"Down",0.107763894654618,0.331936809774586,"L.LvsP.KEGG_FC_EPSILON_RI_SIGNALING_PATHWAY"
83,"Down",0.107865101131732,0.332063554653311,"L.LvsP.REACTOME_CA2_PATHWAY"
88,"Down",0.107963745300831,0.332182274773674,"L.LvsP.LEE_AGING_MUSCLE_DN"
90,"Up",0.108110002322514,0.332447276329911,"L.LvsP.CAFFAREL_RESPONSE_TO_THC_24HR_5_DN"
19,"Up",0.108182836066026,0.332486326075075,"L.LvsP.REACTOME_CARNITINE_METABOLISM"
23,"Down",0.10849902058702,0.333272824903129,"L.LvsP.SARTIPY_BLUNTED_BY_INSULIN_RESISTANCE_DN"
20,"Up",0.108562098597982,0.33328142318059,"L.LvsP.SU_SALIVARY_GLAND"
19,"Down",0.108786270183337,0.333784288481505,"L.LvsP.BIOCARTA_ACH_PATHWAY"
35,"Down",0.109062071943383,0.334263504685943,"L.LvsP.GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN"
20,"Up",0.1090677239749,0.334263504685943,"L.LvsP.REACTOME_POLO_LIKE_KINASE_MEDIATED_EVENTS"
94,"Up",0.109211950324007,0.334263504685943,"L.LvsP.REACTOME_TP53_REGULATES_METABOLIC_GENES"
150,"Down",0.109213022281449,0.334263504685943,"L.LvsP.SWEET_KRAS_ONCOGENIC_SIGNATURE"
40,"Up",0.109337535390522,0.334263504685943,"L.LvsP.REACTOME_NEF_MEDIATED_DOWNREGULATION_OF_MHC_CLASS_I_COMPLEX_CELL_SURFACE_EXPRESSION"
78,"Up",0.109366924767107,0.334263504685943,"L.LvsP.STEARMAN_TUMOR_FIELD_EFFECT_UP"
25,"Down",0.109483847467715,0.334263504685943,"L.LvsP.NEBEN_AML_WITH_FLT3_OR_NRAS_DN"
32,"Up",0.109492785255783,0.334263504685943,"L.LvsP.KEGG_PENTOSE_PHOSPHATE_PATHWAY"
19,"Up",0.109527160737711,0.334263504685943,"L.LvsP.KEGG_PANTOTHENATE_AND_COA_BIOSYNTHESIS"
198,"Down",0.109547019441297,0.334263504685943,"L.LvsP.NIKOLSKY_BREAST_CANCER_17Q11_Q21_AMPLICON"
6,"Down",0.109790665131623,0.334729316383843,"L.LvsP.REACTOME_SIGNALING_BY_MST1"
34,"Up",0.109887273818731,0.334729316383843,"L.LvsP.KORKOLA_EMBRYONAL_CARCINOMA_DN"
782,"Down",0.109953201846781,0.334729316383843,"L.LvsP.CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1"
77,"Down",0.109959341581099,0.334729316383843,"L.LvsP.REACTOME_ORC1_REMOVAL_FROM_CHROMATIN"
12,"Down",0.11000238160055,0.334729316383843,"L.LvsP.SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX2_DN"
26,"Up",0.110286576643897,0.335409506195879,"L.LvsP.BIOCARTA_BARRESTIN_PATHWAY"
181,"Down",0.110561971128625,0.336062198114442,"L.LvsP.MCLACHLAN_DENTAL_CARIES_DN"
522,"Up",0.11072438399028,0.336288400817577,"L.LvsP.YANG_BCL3_TARGETS_UP"
45,"Down",0.110758035429338,0.336288400817577,"L.LvsP.WATANABE_COLON_CANCER_MSI_VS_MSS_UP"
103,"Down",0.110884417330311,0.336487345455152,"L.LvsP.BOSCO_EPITHELIAL_DIFFERENTIATION_MODULE"
12,"Down",0.111472706290406,0.337952182216842,"L.LvsP.NAGY_STAGA_COMPONENTS_HUMAN"
317,"Down",0.111489379700402,0.337952182216842,"L.LvsP.WU_CELL_MIGRATION"
47,"Down",0.111575143646179,0.337955472507068,"L.LvsP.PID_NEPHRIN_NEPH1_PATHWAY"
12,"Up",0.111656911390566,0.337955472507068,"L.LvsP.REACTOME_NF_KB_ACTIVATION_THROUGH_FADD_RIP_1_PATHWAY_MEDIATED_BY_CASPASE_8_AND_10"
12,"Down",0.111684235562724,0.337955472507068,"L.LvsP.REACTOME_ACTIVATION_OF_THE_TFAP2_AP_2_FAMILY_OF_TRANSCRIPTION_FACTORS"
87,"Down",0.111734961791087,0.337955472507068,"L.LvsP.EBAUER_MYOGENIC_TARGETS_OF_PAX3_FOXO1_FUSION"
12,"Down",0.111850034808995,0.338118557932714,"L.LvsP.GROSS_HIF1A_TARGETS_UP"
36,"Down",0.111979291106057,0.338156154710929,"L.LvsP.REACTOME_NOTCH3_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS"
20,"Down",0.112016639174252,0.338156154710929,"L.LvsP.REACTOME_KILLING_MECHANISMS"
8,"Up",0.112045953233934,0.338156154710929,"L.LvsP.LOPEZ_MESOTHELIOMA_SURVIVAL_WORST_VS_BEST_DN"
19,"Down",0.112132473387367,0.338232648859111,"L.LvsP.LU_TUMOR_VASCULATURE_DN"
191,"Down",0.11228757005534,0.338366328375517,"L.LvsP.BOYLAN_MULTIPLE_MYELOMA_C_D_UP"
29,"Up",0.112299188382903,0.338366328375517,"L.LvsP.GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_DN"
47,"Up",0.112753349970575,0.339226976061053,"L.LvsP.GALE_APL_WITH_FLT3_MUTATED_DN"
203,"Down",0.112787801652457,0.339226976061053,"L.LvsP.IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_DN"
33,"Down",0.112827976438025,0.339226976061053,"L.LvsP.MARCHINI_TRABECTEDIN_RESISTANCE_UP"
42,"Down",0.112844469489761,0.339226976061053,"L.LvsP.TERAO_AOX4_TARGETS_HG_UP"
35,"Down",0.112891596301743,0.339226976061053,"L.LvsP.REACTOME_RESPONSE_OF_MTB_TO_PHAGOCYTOSIS"
97,"Down",0.113237989003205,0.340083020748898,"L.LvsP.PID_MTOR_4PATHWAY"
76,"Down",0.113442315408428,0.340511705696634,"L.LvsP.ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_DN"
128,"Down",0.113507886581544,0.340523659744632,"L.LvsP.ISSAEVA_MLL2_TARGETS"
57,"Down",0.113879225848151,0.341452407654246,"L.LvsP.PID_INSULIN_PATHWAY"
223,"Up",0.114327252935712,0.342474213938691,"L.LvsP.VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_DN"
30,"Up",0.114343895628653,0.342474213938691,"L.LvsP.REACTOME_KERATAN_SULFATE_BIOSYNTHESIS"
13,"Down",0.114432350450773,0.342553581831254,"L.LvsP.REACTOME_GAP_JUNCTION_DEGRADATION"
246,"Up",0.114705639263664,0.343076265871701,"L.LvsP.CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP"
41,"Down",0.114731057261128,0.343076265871701,"L.LvsP.HASLINGER_B_CLL_WITH_13Q14_DELETION"
36,"Down",0.114801883059715,0.343102492668736,"L.LvsP.GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_UP"
302,"Down",0.114934421851792,0.343289179323353,"L.LvsP.RODRIGUES_NTN1_TARGETS_DN"
107,"Down",0.114988525973386,0.343289179323353,"L.LvsP.KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY"
8,"Up",0.115341202055964,0.343449491526281,"L.LvsP.BIOCARTA_BARD1_PATHWAY"
135,"Up",0.115353147652539,0.343449491526281,"L.LvsP.SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_UP"
26,"Up",0.11537800514353,0.343449491526281,"L.LvsP.GAVIN_IL2_RESPONSIVE_FOXP3_TARGETS_UP"
70,"Down",0.11540212586385,0.343449491526281,"L.LvsP.MA_MYELOID_DIFFERENTIATION_DN"
18,"Down",0.115408034508516,0.343449491526281,"L.LvsP.MAINA_VHL_TARGETS_UP"
51,"Down",0.115414931317748,0.343449491526281,"L.LvsP.EHLERS_ANEUPLOIDY_UP"
12,"Down",0.11551690565478,0.343568031933986,"L.LvsP.REACTOME_ACTIVATION_OF_RAC1_DOWNSTREAM_OF_NMDARS"
149,"Down",0.115653853004798,0.343697859729643,"L.LvsP.KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS"
12,"Down",0.115722740082345,0.343697859729643,"L.LvsP.BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_24HR_UP"
35,"Down",0.115747045544691,0.343697859729643,"L.LvsP.HAHTOLA_MYCOSIS_FUNGOIDES_DN"
95,"Down",0.115989420610553,0.344126409853405,"L.LvsP.WIERENGA_STAT5A_TARGETS_GROUP2"
32,"Down",0.116015848791236,0.344126409853405,"L.LvsP.BIOCARTA_PDZS_PATHWAY"
10,"Up",0.11639540615285,0.345067131699254,"L.LvsP.REACTOME_DIGESTION_OF_DIETARY_LIPID"
36,"Down",0.116491052368827,0.345165610153936,"L.LvsP.REACTOME_HIV_ELONGATION_ARREST_AND_RECOVERY"
73,"Down",0.116562627764378,0.345192698933716,"L.LvsP.REACTOME_NETRIN_1_SIGNALING"
575,"Down",0.116817082887729,0.345761055292426,"L.LvsP.MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP"
19,"Down",0.116883684257221,0.345773082000092,"L.LvsP.REACTOME_REGULATION_OF_IFNG_SIGNALING"
100,"Down",0.117000989972859,0.345808469108524,"L.LvsP.REACTOME_G_ALPHA_12_13_SIGNALLING_EVENTS"
31,"Down",0.117022335727121,0.345808469108524,"L.LvsP.REACTOME_ACYL_CHAIN_REMODELLING_OF_PC"
111,"Down",0.117083279828388,0.345808469108524,"L.LvsP.REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES"
129,"Down",0.117199775802589,0.345967731133218,"L.LvsP.REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS"
169,"Up",0.117437113433518,0.346483351213405,"L.LvsP.GAVIN_FOXP3_TARGETS_CLUSTER_P4"
31,"Up",0.117604382667925,0.346791803611179,"L.LvsP.SA_CASPASE_CASCADE"
684,"Up",0.117767807884968,0.347088597972276,"L.LvsP.KIM_WT1_TARGETS_DN"
236,"Down",0.118034570119009,0.34768926276589,"L.LvsP.TIEN_INTESTINE_PROBIOTICS_6HR_DN"
95,"Down",0.11809738388033,0.34768926276589,"L.LvsP.KIM_GERMINAL_CENTER_T_HELPER_UP"
72,"Up",0.118209583320878,0.347834372634983,"L.LvsP.PIONTEK_PKD1_TARGETS_UP"
75,"Down",0.118298426881119,0.347898013482106,"L.LvsP.VARELA_ZMPSTE24_TARGETS_UP"
19,"Down",0.118357056133087,0.347898013482106,"L.LvsP.SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX5_UP"
78,"Down",0.118855307000989,0.349176935392385,"L.LvsP.MIDORIKAWA_AMPLIFIED_IN_LIVER_CANCER"
31,"Up",0.118940029021358,0.349240265777529,"L.LvsP.FERRARI_RESPONSE_TO_FENRETINIDE_UP"
191,"Down",0.11932646904254,0.350148903750491,"L.LvsP.VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN"
83,"Up",0.119376140996505,0.350148903750491,"L.LvsP.CHEN_HOXA5_TARGETS_9HR_DN"
134,"Up",0.119634614744516,0.350720988824193,"L.LvsP.CHICAS_RB1_TARGETS_LOW_SERUM"
182,"Up",0.11974720508854,0.350742818886464,"L.LvsP.EPPERT_PROGENITOR"
29,"Down",0.119768935080059,0.350742818886464,"L.LvsP.LANDEMAINE_LUNG_METASTASIS"
18,"Up",0.119912244405925,0.350976601016602,"L.LvsP.BIOCARTA_MCM_PATHWAY"
169,"Up",0.120190633337956,0.351506539183075,"L.LvsP.SERVITJA_ISLET_HNF1A_TARGETS_DN"
389,"Down",0.120220449556013,0.351506539183075,"L.LvsP.HOSHIDA_LIVER_CANCER_SUBCLASS_S1"
146,"Down",0.120373082662825,0.351612333337132,"L.LvsP.KONDO_PROSTATE_CANCER_HCP_WITH_H3K27ME3"
73,"Up",0.120383821126278,0.351612333337132,"L.LvsP.IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_DN"
24,"Down",0.120483532421628,0.351717767032302,"L.LvsP.BIOCARTA_HCMV_PATHWAY"
342,"Down",0.121152546160807,0.353484130724592,"L.LvsP.HOLLMANN_APOPTOSIS_VIA_CD40_UP"
95,"Down",0.121335374402111,0.353830846555522,"L.LvsP.DIRMEIER_LMP1_RESPONSE_EARLY"
72,"Up",0.121455305307967,0.353870911766644,"L.LvsP.REACTOME_IRE1ALPHA_ACTIVATES_CHAPERONES"
9,"Down",0.121477118924415,0.353870911766644,"L.LvsP.BIOCARTA_HBX_PATHWAY"
23,"Up",0.121606044369739,0.354027979338971,"L.LvsP.ZHANG_ADIPOGENESIS_BY_BMP7"
18,"Down",0.1216590994292,0.354027979338971,"L.LvsP.MARKS_ACETYLATED_NON_HISTONE_PROTEINS"
27,"Down",0.121927400192767,0.354622091354974,"L.LvsP.KAMIKUBO_MYELOID_MN1_NETWORK"
35,"Down",0.122074178453403,0.354862320015176,"L.LvsP.BIOCARTA_CREB_PATHWAY"
252,"Down",0.122257877563634,0.354947784643824,"L.LvsP.REACTOME_CILIUM_ASSEMBLY"
465,"Up",0.122294627218131,0.354947784643824,"L.LvsP.HSIAO_LIVER_SPECIFIC_GENES"
36,"Up",0.122387307741257,0.354947784643824,"L.LvsP.BIOCARTA_INTRINSIC_PATHWAY"
24,"Down",0.122417247280346,0.354947784643824,"L.LvsP.REACTOME_BBSOME_MEDIATED_CARGO_TARGETING_TO_CILIUM"
7,"Up",0.122424565982234,0.354947784643824,"L.LvsP.TESAR_ALK_AND_JAK_TARGETS_MOUSE_ES_D4_DN"
104,"Up",0.122716330442734,0.355506947467984,"L.LvsP.ZHENG_IL22_SIGNALING_DN"
220,"Down",0.122746023280228,0.355506947467984,"L.LvsP.RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN"
42,"Down",0.123041856312762,0.356177185106419,"L.LvsP.REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR1"
28,"Down",0.123450883812229,0.35684226950422,"L.LvsP.RAMPON_ENRICHED_LEARNING_ENVIRONMENT_EARLY_UP"
559,"Down",0.123506460623814,0.35684226950422,"L.LvsP.REACTOME_SIGNALING_BY_RHO_GTPASES"
10,"Up",0.123524879795133,0.35684226950422,"L.LvsP.REACTOME_PHASE_3_RAPID_REPOLARISATION"
31,"Down",0.12352977099495,0.35684226950422,"L.LvsP.KANG_DOXORUBICIN_RESISTANCE_DN"
32,"Down",0.123992226954429,0.357991134637616,"L.LvsP.REACTOME_DISEASES_OF_PROGRAMMED_CELL_DEATH"
100,"Up",0.124314174889057,0.35863316662443,"L.LvsP.FIGUEROA_AML_METHYLATION_CLUSTER_3_DN"
69,"Up",0.124344326355404,0.35863316662443,"L.LvsP.BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_DN"
272,"Down",0.124945444858667,0.360179022222924,"L.LvsP.REACTOME_FCERI_MEDIATED_NF_KB_ACTIVATION"
131,"Up",0.125090246299011,0.360408531415963,"L.LvsP.SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE"
16,"Down",0.125298419610787,0.360820292722938,"L.LvsP.MARTIN_NFKB_TARGETS_DN"
25,"Down",0.125489231606436,0.361151921616475,"L.LvsP.REACTOME_INITIATION_OF_NUCLEAR_ENVELOPE_NE_REFORMATION"
104,"Up",0.125544220174871,0.361151921616475,"L.LvsP.LEE_LIVER_CANCER_E2F1_DN"
487,"Down",0.125623002053541,0.361190628369228,"L.LvsP.BENPORATH_OCT4_TARGETS"
153,"Up",0.125895167195589,0.361775941371872,"L.LvsP.DAZARD_RESPONSE_TO_UV_SCC_UP"
5,"Down",0.125957440249747,0.361775941371872,"L.LvsP.REACTOME_BETA_OXIDATION_OF_LAUROYL_COA_TO_DECANOYL_COA_COA"
9,"Up",0.126024624742691,0.361780971029251,"L.LvsP.REACTOME_VITAMIN_C_ASCORBATE_METABOLISM"
18,"Down",0.126308219853218,0.362406926605316,"L.LvsP.KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_4NQO_IN_OLD"
90,"Down",0.126401111865722,0.362485346216585,"L.LvsP.PID_FCER1_PATHWAY"
91,"Up",0.126505593947483,0.362596904580422,"L.LvsP.SHAFFER_IRF4_TARGETS_IN_ACTIVATED_DENDRITIC_CELL"
29,"Down",0.126655202673298,0.362837624653195,"L.LvsP.BIOCARTA_CXCR4_PATHWAY"
170,"Up",0.126805075699807,0.363078852172052,"L.LvsP.JI_RESPONSE_TO_FSH_UP"
45,"Up",0.126947747551465,0.363155417376876,"L.LvsP.REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS"
18,"Down",0.126963179922138,0.363155417376876,"L.LvsP.CHIN_BREAST_CANCER_COPY_NUMBER_DN"
56,"Up",0.127313182325584,0.363968244611248,"L.LvsP.DAVIES_MULTIPLE_MYELOMA_VS_MGUS_UP"
220,"Down",0.127513530405415,0.364183589011488,"L.LvsP.KEGG_ENDOCYTOSIS"
15,"Down",0.127520243864395,0.364183589011488,"L.LvsP.REACTOME_ORGANIC_CATION_TRANSPORT"
105,"Up",0.127733093605841,0.364463509616885,"L.LvsP.KEGG_PYRIMIDINE_METABOLISM"
74,"Down",0.127770060918648,0.364463509616885,"L.LvsP.NAKAJIMA_MAST_CELL"
135,"Up",0.127880537318532,0.364463509616885,"L.LvsP.REACTOME_DNA_REPLICATION"
51,"Down",0.127881933198907,0.364463509616885,"L.LvsP.REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS"
126,"Up",0.12799421477877,0.364556841817529,"L.LvsP.NADERI_BREAST_CANCER_PROGNOSIS_UP"
354,"Down",0.128046552144988,0.364556841817529,"L.LvsP.MARTORIATI_MDM4_TARGETS_FETAL_LIVER_UP"
44,"Up",0.128668650403868,0.366083811228674,"L.LvsP.DAZARD_UV_RESPONSE_CLUSTER_G28"
166,"Down",0.12871530638968,0.366083811228674,"L.LvsP.REACTOME_RHO_GTPASES_ACTIVATE_FORMINS"
119,"Up",0.129146763547999,0.36683999626189,"L.LvsP.HOWLIN_PUBERTAL_MAMMARY_GLAND"
19,"Down",0.129212286672595,0.36683999626189,"L.LvsP.REACTOME_DSCAM_INTERACTIONS"
66,"Down",0.129231923278447,0.36683999626189,"L.LvsP.FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN"
168,"Down",0.129246574917374,0.36683999626189,"L.LvsP.HAHTOLA_MYCOSIS_FUNGOIDES_CD4_DN"
35,"Down",0.129534156899477,0.367361290344636,"L.LvsP.KANNAN_TP53_TARGETS_DN"
18,"Up",0.129563124646779,0.367361290344636,"L.LvsP.REACTOME_BLOOD_GROUP_SYSTEMS_BIOSYNTHESIS"
189,"Down",0.129797454342439,0.367687294306703,"L.LvsP.PUIFFE_INVASION_INHIBITED_BY_ASCITES_DN"
190,"Up",0.129811104808588,0.367687294306703,"L.LvsP.KOBAYASHI_EGFR_SIGNALING_24HR_UP"
42,"Down",0.130136192669906,0.368419359586231,"L.LvsP.REACTOME_REGULATION_OF_TP53_EXPRESSION_AND_DEGRADATION"
131,"Down",0.130228298005782,0.368491432791181,"L.LvsP.KEGG_T_CELL_RECEPTOR_SIGNALING_PATHWAY"
321,"Down",0.130545482611959,0.36919998637418,"L.LvsP.WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN"
48,"Down",0.130728047817756,0.369527288540069,"L.LvsP.WORSCHECH_TUMOR_EVASION_AND_TOLEROGENICITY_UP"
17,"Down",0.13090506186734,0.369838572848504,"L.LvsP.REACTOME_ACTIVATION_OF_RAC1"
8,"Up",0.131250500384215,0.370625136171769,"L.LvsP.REACTOME_DEFECTIVE_B4GALT1_CAUSES_B4GALT1_CDG_CDG_2D"
88,"Down",0.131343142536799,0.370697414541072,"L.LvsP.SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM6"
64,"Down",0.131528305383456,0.370983528439233,"L.LvsP.RIZ_ERYTHROID_DIFFERENTIATION_CCNE1"
71,"Up",0.131578712112378,0.370983528439233,"L.LvsP.BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_UP"
38,"Up",0.131780079026145,0.371361904656248,"L.LvsP.DE_YY1_TARGETS_UP"
37,"Down",0.131894278288172,0.371494378326697,"L.LvsP.PID_NFKAPPAB_CANONICAL_PATHWAY"
23,"Down",0.132124076758973,0.371952148880022,"L.LvsP.BIOCARTA_RAB_PATHWAY"
33,"Up",0.132493234581133,0.372801574554243,"L.LvsP.KORKOLA_CHORIOCARCINOMA_DN"
15,"Down",0.132798469366538,0.373470364764795,"L.LvsP.REACTOME_REGULATION_OF_PTEN_LOCALIZATION"
11,"Down",0.133281366951665,0.374343582189622,"L.LvsP.REACTOME_REGULATION_OF_FOXO_TRANSCRIPTIONAL_ACTIVITY_BY_ACETYLATION"
30,"Down",0.13328399058606,0.374343582189622,"L.LvsP.REACTOME_RNA_POLYMERASE_III_TRANSCRIPTION_INITIATION_FROM_TYPE_1_PROMOTER"
89,"Down",0.13331208416194,0.374343582189622,"L.LvsP.KEGG_LONG_TERM_POTENTIATION"
45,"Up",0.133733452701877,0.375336172583084,"L.LvsP.HOFMANN_MYELODYSPLASTIC_SYNDROM_RISK_DN"
48,"Up",0.134014025064101,0.375932797858657,"L.LvsP.DELPUECH_FOXO3_TARGETS_DN"
74,"Down",0.134142132039131,0.37610134282168,"L.LvsP.LI_CISPLATIN_RESISTANCE_UP"
43,"Down",0.134236851152987,0.376167685743106,"L.LvsP.REACTOME_ADRENALINE_NORADRENALINE_INHIBITS_INSULIN_SECRETION"
64,"Down",0.134301865013003,0.376167685743106,"L.LvsP.LIU_BREAST_CANCER"
187,"Down",0.134429195238444,0.376320041476129,"L.LvsP.REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS"
163,"Up",0.134492385957104,0.376320041476129,"L.LvsP.KAUFFMANN_DNA_REPLICATION_GENES"
879,"Down",0.1347780174847,0.376928507168896,"L.LvsP.ONKEN_UVEAL_MELANOMA_DN"
23,"Down",0.134884360483138,0.377035201775162,"L.LvsP.REACTOME_NA_CL_DEPENDENT_NEUROTRANSMITTER_TRANSPORTERS"
294,"Down",0.135231318789795,0.377604219846623,"L.LvsP.FERNANDEZ_BOUND_BY_MYC"
36,"Down",0.135236995993869,0.377604219846623,"L.LvsP.REACTOME_CREB1_PHOSPHORYLATION_THROUGH_NMDA_RECEPTOR_MEDIATED_ACTIVATION_OF_RAS_SIGNALING"
15,"Down",0.135350350995255,0.377604219846623,"L.LvsP.MONTERO_THYROID_CANCER_POOR_SURVIVAL_DN"
296,"Down",0.13536110756665,0.377604219846623,"L.LvsP.REACTOME_HIV_INFECTION"
405,"Down",0.13550236644973,0.377807657135934,"L.LvsP.IVANOVA_HEMATOPOIESIS_STEM_CELL_LONG_TERM"
34,"Up",0.135921927125269,0.3786748797603,"L.LvsP.FARMER_BREAST_CANCER_CLUSTER_7"
17,"Down",0.136003148416375,0.3786748797603,"L.LvsP.REACTOME_P75NTR_RECRUITS_SIGNALLING_COMPLEXES"
181,"Down",0.136018866197134,0.3786748797603,"L.LvsP.PID_P53_DOWNSTREAM_PATHWAY"
33,"Up",0.136402732547466,0.379521228420906,"L.LvsP.BUCKANOVICH_T_LYMPHOCYTE_HOMING_ON_TUMOR_DN"
97,"Up",0.136460155923451,0.379521228420906,"L.LvsP.WENG_POR_TARGETS_LIVER_UP"
176,"Down",0.136792067040837,0.380253061170833,"L.LvsP.LAIHO_COLORECTAL_CANCER_SERRATED_UP"
279,"Up",0.13736910666824,0.381665221491807,"L.LvsP.REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT"
67,"Down",0.137477417307433,0.381774304516725,"L.LvsP.BIOCARTA_TCR_PATHWAY"
21,"Down",0.137673113263517,0.381892280064454,"L.LvsP.REACTOME_FRS_MEDIATED_FGFR3_SIGNALING"
135,"Down",0.137723215809055,0.381892280064454,"L.LvsP.ROVERSI_GLIOMA_COPY_NUMBER_UP"
78,"Down",0.137727112759725,0.381892280064454,"L.LvsP.AMIT_SERUM_RESPONSE_60_MCF10A"
31,"Down",0.137920267671139,0.38223617040287,"L.LvsP.PID_WNT_CANONICAL_PATHWAY"
338,"Down",0.138410750227141,0.38340332565424,"L.LvsP.REACTOME_FC_EPSILON_RECEPTOR_FCERI_SIGNALING"
21,"Up",0.138808362863599,0.384312187417545,"L.LvsP.NIKOLSKY_BREAST_CANCER_7P15_AMPLICON"
150,"Up",0.138955000122868,0.384525623463133,"L.LvsP.JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP"
14,"Down",0.139288691696527,0.385256216303201,"L.LvsP.TAKADA_GASTRIC_CANCER_COPY_NUMBER_UP"
10,"Down",0.139456311508128,0.385305128801869,"L.LvsP.RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_SMAD4_UP"
363,"Down",0.139666496674016,0.385305128801869,"L.LvsP.REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION"
47,"Down",0.139704072190265,0.385305128801869,"L.LvsP.KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_WS"
83,"Up",0.139772494209785,0.385305128801869,"L.LvsP.MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_DN"
43,"Down",0.139865557980963,0.385305128801869,"L.LvsP.GROSS_ELK3_TARGETS_UP"
22,"Down",0.139911688324416,0.385305128801869,"L.LvsP.BIOCARTA_GRANULOCYTES_PATHWAY"
61,"Up",0.139916159918495,0.385305128801869,"L.LvsP.GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP"
99,"Up",0.14001849305714,0.385305128801869,"L.LvsP.LY_AGING_OLD_DN"
150,"Up",0.140086159607419,0.385305128801869,"L.LvsP.REACTOME_OXIDATIVE_STRESS_INDUCED_SENESCENCE"
23,"Down",0.140202313314153,0.385305128801869,"L.LvsP.REACTOME_ADP_SIGNALLING_THROUGH_P2Y_PURINOCEPTOR_12"
137,"Down",0.140244823195491,0.385305128801869,"L.LvsP.LEE_AGING_NEOCORTEX_UP"
300,"Down",0.140291635966224,0.385305128801869,"L.LvsP.REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1"
27,"Up",0.140295206265157,0.385305128801869,"L.LvsP.REACTOME_COMMON_PATHWAY_OF_FIBRIN_CLOT_FORMATION"
30,"Up",0.140306539100075,0.385305128801869,"L.LvsP.REACTOME_SYNTHESIS_OF_IP3_AND_IP4_IN_THE_CYTOSOL"
77,"Down",0.140351696402055,0.385305128801869,"L.LvsP.DOANE_BREAST_CANCER_ESR1_DN"
15,"Down",0.140429254684502,0.385324934285963,"L.LvsP.REACTOME_LIPOPHAGY"
80,"Down",0.140518078994156,0.385324934285963,"L.LvsP.GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_UP"
24,"Down",0.140567985613092,0.385324934285963,"L.LvsP.MATZUK_EARLY_ANTRAL_FOLLICLE"
56,"Down",0.140683429094293,0.385450287146852,"L.LvsP.WANG_NFKB_TARGETS"
646,"Down",0.14088221239855,0.385803740639715,"L.LvsP.MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP"
28,"Down",0.141057167554401,0.386091623469446,"L.LvsP.KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS"
134,"Up",0.14117257115105,0.386216301778405,"L.LvsP.MORI_PRE_BI_LYMPHOCYTE_UP"
189,"Up",0.141339906412665,0.386482859819794,"L.LvsP.DURCHDEWALD_SKIN_CARCINOGENESIS_UP"
413,"Up",0.141562541733507,0.386807513651122,"L.LvsP.ZHENG_GLIOBLASTOMA_PLASTICITY_UP"
56,"Down",0.141598554463713,0.386807513651122,"L.LvsP.HUMMERICH_MALIGNANT_SKIN_TUMOR_DN"
48,"Up",0.141903099660854,0.387448018777711,"L.LvsP.BONOME_OVARIAN_CANCER_POOR_SURVIVAL_UP"
24,"Up",0.142174234517578,0.387823074327163,"L.LvsP.BIOCARTA_VITCB_PATHWAY"
62,"Down",0.142180750888255,0.387823074327163,"L.LvsP.PID_ARF6_PATHWAY"
15,"Down",0.142285213223386,0.387916639009913,"L.LvsP.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TAN_DN"
68,"Down",0.142392845788474,0.388018750302846,"L.LvsP.YANG_BREAST_CANCER_ESR1_LASER_DN"
16,"Down",0.142746943501084,0.388653463197428,"L.LvsP.SHANK_TAL1_TARGETS_DN"
21,"Down",0.142766356258632,0.388653463197428,"L.LvsP.IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_UP"
72,"Up",0.142839169640478,0.38866031936132,"L.LvsP.MOSERLE_IFNA_RESPONSE"
55,"Down",0.14298805193734,0.388874047792206,"L.LvsP.AMIT_EGF_RESPONSE_60_MCF10A"
156,"Up",0.143126638728548,0.388936756571553,"L.LvsP.LEIN_CHOROID_PLEXUS_MARKERS"
26,"Down",0.143151799533932,0.388936756571553,"L.LvsP.OKAWA_NEUROBLASTOMA_1P36_31_DELETION"
81,"Down",0.143225985306171,0.38894718701268,"L.LvsP.HENDRICKS_SMARCA4_TARGETS_DN"
51,"Up",0.143726608206881,0.39001708876204,"L.LvsP.VALK_AML_CLUSTER_13"
78,"Down",0.143764229301389,0.39001708876204,"L.LvsP.SMIRNOV_RESPONSE_TO_IR_2HR_UP"
166,"Down",0.143831586902839,0.39001708876204,"L.LvsP.LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_UP"
115,"Up",0.144008571309357,0.390046187945914,"L.LvsP.REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX"
6,"Up",0.144051519374702,0.390046187945914,"L.LvsP.REACTOME_VLDL_ASSEMBLY"
59,"Down",0.144053954745082,0.390046187945914,"L.LvsP.PID_CXCR3_PATHWAY"
9,"Up",0.144247109325303,0.390378006588155,"L.LvsP.REACTOME_SMALL_INTERFERING_RNA_SIRNA_BIOGENESIS"
13,"Up",0.144417686827591,0.390648429779722,"L.LvsP.CHASSOT_SKIN_WOUND"
34,"Up",0.144637977313264,0.391052995875323,"L.LvsP.REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_7ALPHA_HYDROXYCHOLESTEROL"
45,"Down",0.145038059520495,0.391943025947615,"L.LvsP.LOPES_METHYLATED_IN_COLON_CANCER_DN"
657,"Down",0.145244898399044,0.392267833833549,"L.LvsP.SENESE_HDAC1_TARGETS_UP"
402,"Down",0.145360759503385,0.392267833833549,"L.LvsP.REACTOME_SIGNALING_BY_WNT"
421,"Down",0.145386478874061,0.392267833833549,"L.LvsP.KOYAMA_SEMA3B_TARGETS_UP"
82,"Down",0.145442043653242,0.392267833833549,"L.LvsP.WIERENGA_PML_INTERACTOME"
8,"Down",0.14560516412954,0.392516310322879,"L.LvsP.IKEDA_MIR133_TARGETS_DN"
292,"Down",0.145831456231485,0.392759171150874,"L.LvsP.LEE_LIVER_CANCER_SURVIVAL_DN"
527,"Up",0.145854841177455,0.392759171150874,"L.LvsP.OISHI_CHOLANGIOMA_STEM_CELL_LIKE_UP"
27,"Up",0.145960760063414,0.392759171150874,"L.LvsP.KARAKAS_TGFB1_SIGNALING"
99,"Up",0.14597939893562,0.392759171150874,"L.LvsP.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_UP"
46,"Down",0.146708379786156,0.394528517430766,"L.LvsP.MEISSNER_BRAIN_ICP_WITH_H3K4ME3"
17,"Down",0.147035927952385,0.395217134491363,"L.LvsP.INAMURA_LUNG_CANCER_SCC_SUBTYPES_UP"
109,"Down",0.147561827627254,0.396404988248364,"L.LvsP.ENGELMANN_CANCER_PROGENITORS_DN"
52,"Down",0.147621246301932,0.396404988248364,"L.LvsP.PID_GMCSF_PATHWAY"
15,"Down",0.147825236659853,0.396672778340769,"L.LvsP.REACTOME_REMOVAL_OF_AMINOTERMINAL_PROPEPTIDES_FROM_GAMMA_CARBOXYLATED_PROTEINS"
47,"Down",0.14786445942491,0.396672778340769,"L.LvsP.PID_IL8_CXCR1_PATHWAY"
122,"Down",0.148048871757416,0.396974884552257,"L.LvsP.BOYLAN_MULTIPLE_MYELOMA_D_DN"
63,"Up",0.148264793799364,0.397361146348367,"L.LvsP.SUNG_METASTASIS_STROMA_DN"
183,"Up",0.148378223042354,0.397472478295143,"L.LvsP.GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP"
23,"Up",0.148520295887543,0.397660395139092,"L.LvsP.REACTOME_APOPTOTIC_FACTOR_MEDIATED_RESPONSE"
650,"Down",0.148713824643132,0.397985835649505,"L.LvsP.ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP"
63,"Down",0.149217243419787,0.399139883342042,"L.LvsP.HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_DN"
7,"Up",0.14934294173368,0.399282942381777,"L.LvsP.REACTOME_PROTEIN_REPAIR"
10,"Down",0.149533491999831,0.399599167359625,"L.LvsP.REACTOME_SYNTHESIS_OF_12_EICOSATETRAENOIC_ACID_DERIVATIVES"
102,"Up",0.150287965020968,0.401255058168158,"L.LvsP.REACTOME_E3_UBIQUITIN_LIGASES_UBIQUITINATE_TARGET_PROTEINS"
31,"Down",0.150298286392884,0.401255058168158,"L.LvsP.MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH"
424,"Down",0.150570813611071,0.401788623772012,"L.LvsP.DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP"
45,"Down",0.150692224186232,0.401829020312466,"L.LvsP.PID_REELIN_PATHWAY"
26,"Down",0.150731305503356,0.401829020312466,"L.LvsP.REACTOME_ACTIVATED_TAK1_MEDIATES_P38_MAPK_ACTIVATION"
11,"Down",0.150861383732255,0.401981971400307,"L.LvsP.REACTOME_ACTIVATED_NTRK3_SIGNALS_THROUGH_RAS"
181,"Down",0.150974980889237,0.401985582498622,"L.LvsP.LIN_SILENCED_BY_TUMOR_MICROENVIRONMENT"
13,"Down",0.151008148824315,0.401985582498622,"L.LvsP.GOUYER_TUMOR_INVASIVENESS"
13,"Down",0.151407760474236,0.402762767839329,"L.LvsP.SHIRAISHI_PLZF_TARGETS_UP"
130,"Down",0.151475269312919,0.402762767839329,"L.LvsP.PEDERSEN_TARGETS_OF_611CTF_ISOFORM_OF_ERBB2"
29,"Up",0.151518639375259,0.402762767839329,"L.LvsP.REACTOME_TNFS_BIND_THEIR_PHYSIOLOGICAL_RECEPTORS"
1093,"Down",0.152214080312176,0.404344750564098,"L.LvsP.BENPORATH_SOX2_TARGETS"
406,"Down",0.152260041720827,0.404344750564098,"L.LvsP.MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN"
651,"Up",0.152499896529755,0.404787291364867,"L.LvsP.TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C"
73,"Down",0.152854071604724,0.405475891558592,"L.LvsP.BILANGES_SERUM_SENSITIVE_VIA_TSC2"
45,"Down",0.152950960627426,0.405475891558592,"L.LvsP.PID_IL1_PATHWAY"
330,"Down",0.152979328954824,0.405475891558592,"L.LvsP.ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP"
556,"Up",0.153263031945994,0.406011937584302,"L.LvsP.POOLA_INVASIVE_BREAST_CANCER_UP"
233,"Down",0.153328436548385,0.406011937584302,"L.LvsP.PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_UP"
8,"Up",0.153688552379375,0.406770706608694,"L.LvsP.REACTOME_SYNTHESIS_OF_PIPS_AT_THE_ER_MEMBRANE"
31,"Up",0.154146456564911,0.407787444185357,"L.LvsP.MOOTHA_GLYCOLYSIS"
44,"Down",0.154773902272227,0.408970243720816,"L.LvsP.PID_AURORA_A_PATHWAY"
11,"Up",0.154787644854795,0.408970243720816,"L.LvsP.REACTOME_UREA_CYCLE"
19,"Down",0.154839552000316,0.408970243720816,"L.LvsP.SA_PROGRAMMED_CELL_DEATH"
15,"Down",0.154889435766213,0.408970243720816,"L.LvsP.REACTOME_ADENYLATE_CYCLASE_INHIBITORY_PATHWAY"
43,"Up",0.155007006358337,0.409085316541884,"L.LvsP.REACTOME_TRNA_AMINOACYLATION"
41,"Down",0.155261012377645,0.409560180074426,"L.LvsP.REACTOME_CD28_CO_STIMULATION"
18,"Up",0.155586215607233,0.410222310964422,"L.LvsP.SHIN_B_CELL_LYMPHOMA_CLUSTER_1"
394,"Down",0.155705373585871,0.410340805794223,"L.LvsP.RUTELLA_RESPONSE_TO_HGF_DN"
35,"Down",0.155836455345591,0.410490596286694,"L.LvsP.AMIT_EGF_RESPONSE_240_MCF10A"
27,"Up",0.155952736847526,0.410601277157129,"L.LvsP.REACTOME_MITOCHONDRIAL_TRNA_AMINOACYLATION"
701,"Down",0.156225436119931,0.411123482297525,"L.LvsP.SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN"
15,"Down",0.156435180829962,0.411306481103828,"L.LvsP.KOMMAGANI_TP63_GAMMA_TARGETS"
189,"Up",0.156443756513176,0.411306481103828,"L.LvsP.ROESSLER_LIVER_CANCER_METASTASIS_UP"
38,"Up",0.156590920822144,0.411497719213706,"L.LvsP.SEMBA_FHIT_TARGETS_UP"
117,"Down",0.15705878176977,0.412531118482214,"L.LvsP.BHAT_ESR1_TARGETS_VIA_AKT1_DN"
249,"Down",0.157361392494041,0.413129695678799,"L.LvsP.IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_UP"
41,"Up",0.157657768239596,0.413711343425119,"L.LvsP.KYNG_NORMAL_AGING_DN"
47,"Down",0.158058789715742,0.414361709862419,"L.LvsP.BIOCARTA_PDGF_PATHWAY"
5,"Up",0.158150453686461,0.414361709862419,"L.LvsP.REACTOME_FASL_CD95L_SIGNALING"
24,"Up",0.158162302780803,0.414361709862419,"L.LvsP.REACTOME_SYNTHESIS_SECRETION_AND_DEACYLATION_OF_GHRELIN"
227,"Up",0.158233973665458,0.414361709862419,"L.LvsP.BROWNE_HCMV_INFECTION_10HR_UP"
972,"Up",0.158280327587164,0.414361709862419,"L.LvsP.BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN"
46,"Up",0.158560045828193,0.414897535912957,"L.LvsP.BOWIE_RESPONSE_TO_EXTRACELLULAR_MATRIX"
5,"Up",0.158803995266179,0.415156960720064,"L.LvsP.TOMIDA_LUNG_CANCER_POOR_SURVIVAL"
648,"Up",0.158841870430121,0.415156960720064,"L.LvsP.SANSOM_APC_TARGETS_DN"
92,"Down",0.158884450874237,0.415156960720064,"L.LvsP.RICKMAN_HEAD_AND_NECK_CANCER_F"
34,"Down",0.159043993445929,0.415377534134409,"L.LvsP.ZHU_SKIL_TARGETS_UP"
52,"Down",0.159174287489342,0.415521546519629,"L.LvsP.HUMMERICH_BENIGN_SKIN_TUMOR_DN"
204,"Up",0.159304898680727,0.415666250498226,"L.LvsP.SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_DN"
46,"Up",0.159753483075989,0.416640098078841,"L.LvsP.KEGG_NUCLEOTIDE_EXCISION_REPAIR"
99,"Down",0.15998982881514,0.417031877933936,"L.LvsP.NOUZOVA_METHYLATED_IN_APL"
627,"Up",0.160088164802373,0.417031877933936,"L.LvsP.LIM_MAMMARY_STEM_CELL_DN"
728,"Down",0.160139273062595,0.417031877933936,"L.LvsP.YAGI_AML_WITH_INV_16_TRANSLOCATION"
28,"Up",0.160218433644367,0.417031877933936,"L.LvsP.KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_HEPARAN_SULFATE"
116,"Up",0.160280835704398,0.417031877933936,"L.LvsP.REACTOME_INTERFERON_ALPHA_BETA_SIGNALING"
86,"Down",0.160551247584407,0.417452029536277,"L.LvsP.KHETCHOUMIAN_TRIM24_TARGETS_UP"
24,"Down",0.160593320098329,0.417452029536277,"L.LvsP.REACTOME_SIGNALING_BY_NODAL"
25,"Up",0.161088137957827,0.41838562851688,"L.LvsP.KEGG_GLYCOSPHINGOLIPID_BIOSYNTHESIS_LACTO_AND_NEOLACTO_SERIES"
61,"Up",0.161103816804564,0.41838562851688,"L.LvsP.ZHAN_MULTIPLE_MYELOMA_MF_DN"
29,"Down",0.16129475750378,0.418684842365445,"L.LvsP.REACTOME_PI_3K_CASCADE_FGFR2"
313,"Down",0.161440300310903,0.418865987995768,"L.LvsP.CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN"
65,"Up",0.161701139550205,0.419168492836615,"L.LvsP.GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_UP"
25,"Down",0.161708517855037,0.419168492836615,"L.LvsP.REACTOME_TYPE_I_HEMIDESMOSOME_ASSEMBLY"
533,"Up",0.161961683779922,0.419519769091409,"L.LvsP.HORIUCHI_WTAP_TARGETS_UP"
107,"Down",0.161995787124282,0.419519769091409,"L.LvsP.YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_7"
14,"Down",0.162205022105735,0.419864965928186,"L.LvsP.REACTOME_RUNX1_AND_FOXP3_CONTROL_THE_DEVELOPMENT_OF_REGULATORY_T_LYMPHOCYTES_TREGS"
10,"Up",0.162327582568126,0.419985589152629,"L.LvsP.MATZUK_CUMULUS_EXPANSION"
125,"Down",0.162519791904332,0.420202723924744,"L.LvsP.PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP"
246,"Down",0.162563506325742,0.420202723924744,"L.LvsP.SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP"
46,"Down",0.163244607047561,0.421766089890637,"L.LvsP.REACTOME_HIV_TRANSCRIPTION_ELONGATION"
38,"Down",0.163351300077777,0.421844623134063,"L.LvsP.HOEGERKORP_CD44_TARGETS_DIRECT_DN"
141,"Down",0.16348501895673,0.421992843049374,"L.LvsP.FRIDMAN_SENESCENCE_UP"
66,"Up",0.163896878170738,0.422845131334643,"L.LvsP.REACTOME_BILE_ACID_AND_BILE_SALT_METABOLISM"
83,"Down",0.163968160893738,0.422845131334643,"L.LvsP.KEGG_VEGF_SIGNALING_PATHWAY"
94,"Down",0.164132803192254,0.423072386410244,"L.LvsP.CHIARETTI_ACUTE_LYMPHOBLASTIC_LEUKEMIA_ZAP70"
16,"Up",0.164406319215856,0.423579934270488,"L.LvsP.REACTOME_SYNTHESIS_OF_PE"
20,"Up",0.164709530752693,0.424163481849855,"L.LvsP.LI_CYTIDINE_ANALOG_PATHWAY"
45,"Down",0.164848691414352,0.424229736764707,"L.LvsP.SUMI_HNF4A_TARGETS"
35,"Down",0.164888714832222,0.424229736764707,"L.LvsP.PID_PRL_SIGNALING_EVENTS_PATHWAY"
31,"Down",0.164990194120651,0.424293387578176,"L.LvsP.CAFFAREL_RESPONSE_TO_THC_8HR_5_UP"
6,"Up",0.165087800738167,0.424347024770491,"L.LvsP.REACTOME_N_GLYCAN_TRIMMING_AND_ELONGATION_IN_THE_CIS_GOLGI"
27,"Down",0.16533706889896,0.424790266701835,"L.LvsP.ABDELMOHSEN_ELAVL4_TARGETS"
155,"Down",0.165715641697855,0.425546401356674,"L.LvsP.WINTER_HYPOXIA_UP"
22,"Up",0.165785304489469,0.425546401356674,"L.LvsP.LANDIS_ERBB2_BREAST_PRENEOPLASTIC_UP"
61,"Up",0.165903184966066,0.425651373400176,"L.LvsP.KEGG_GLYCEROLIPID_METABOLISM"
75,"Down",0.165987970825917,0.425664637235558,"L.LvsP.LUI_THYROID_CANCER_PAX8_PPARG_UP"
45,"Down",0.166158118721309,0.425664637235558,"L.LvsP.XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_UP"
154,"Down",0.166196904195937,0.425664637235558,"L.LvsP.NGUYEN_NOTCH1_TARGETS_DN"
523,"Down",0.166216305261633,0.425664637235558,"L.LvsP.KOYAMA_SEMA3B_TARGETS_DN"
145,"Up",0.166298108227288,0.425676963142906,"L.LvsP.UEDA_CENTRAL_CLOCK"
129,"Up",0.166400674780068,0.42572374443797,"L.LvsP.DOANE_BREAST_CANCER_CLASSES_UP"
146,"Down",0.166470380805732,0.42572374443797,"L.LvsP.YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_16"
173,"Down",0.166767696058478,0.426286912393584,"L.LvsP.HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_UP"
78,"Down",0.166982578649391,0.426638945172127,"L.LvsP.FAELT_B_CLL_WITH_VH3_21_UP"
85,"Down",0.167310294317271,0.427278807057825,"L.LvsP.YAMASHITA_LIVER_CANCER_STEM_CELL_UP"
135,"Down",0.167436537204757,0.427403792338458,"L.LvsP.PLASARI_TGFB1_SIGNALING_VIA_NFIC_10HR_UP"
667,"Down",0.168085204557,0.428730047646001,"L.LvsP.OSMAN_BLADDER_CANCER_DN"
209,"Down",0.168111185258913,0.428730047646001,"L.LvsP.KAYO_CALORIE_RESTRICTION_MUSCLE_UP"
123,"Down",0.168415986361799,0.429309353893217,"L.LvsP.KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_UP"
35,"Down",0.168755951397099,0.429977721324681,"L.LvsP.TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_GRANULOCYTE_UP"
397,"Up",0.169018927641073,0.430449401624824,"L.LvsP.BASAKI_YBX1_TARGETS_UP"
12,"Up",0.169110778635626,0.430485034565551,"L.LvsP.REACTOME_TANDEM_PORE_DOMAIN_POTASSIUM_CHANNELS"
65,"Up",0.16932538818636,0.430818476541032,"L.LvsP.ZHANG_INTERFERON_RESPONSE"
13,"Down",0.169397606800543,0.430818476541032,"L.LvsP.KEGG_CIRCADIAN_RHYTHM_MAMMAL"
393,"Down",0.169788239147699,0.431513910735313,"L.LvsP.MUELLER_PLURINET"
26,"Down",0.169863778064859,0.431513910735313,"L.LvsP.PARK_HSC_VS_MULTIPOTENT_PROGENITORS_DN"
13,"Down",0.169905913932819,0.431513910735313,"L.LvsP.REACTOME_REGULATED_PROTEOLYSIS_OF_P75NTR"
544,"Down",0.170045001826122,0.431513910735313,"L.LvsP.SHEN_SMARCA2_TARGETS_UP"
415,"Down",0.170061278982139,0.431513910735313,"L.LvsP.REACTOME_RHO_GTPASE_EFFECTORS"
43,"Up",0.170474086890515,0.432067468295777,"L.LvsP.BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_UP"
32,"Up",0.1704830093645,0.432067468295777,"L.LvsP.KEGG_NICOTINATE_AND_NICOTINAMIDE_METABOLISM"
73,"Down",0.170548703383394,0.432067468295777,"L.LvsP.HUANG_FOXA2_TARGETS_UP"
105,"Down",0.170592020851814,0.432067468295777,"L.LvsP.LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_DN"
92,"Down",0.170703946719108,0.432152985993566,"L.LvsP.REACTOME_DDX58_IFIH1_MEDIATED_INDUCTION_OF_INTERFERON_ALPHA_BETA"
154,"Up",0.170871545706018,0.432379302612619,"L.LvsP.OUILLETTE_CLL_13Q14_DELETION_UP"
10,"Down",0.171476556064363,0.433711746788592,"L.LvsP.KONDO_HYPOXIA"
8,"Down",0.171593095227495,0.433808058304901,"L.LvsP.IWANAGA_E2F1_TARGETS_NOT_INDUCED_BY_SERUM"
121,"Down",0.171676929713933,0.433821638203079,"L.LvsP.HENDRICKS_SMARCA4_TARGETS_UP"
50,"Down",0.171756309839546,0.433823954820854,"L.LvsP.VERRECCHIA_RESPONSE_TO_TGFB1_C4"
412,"Down",0.171870794363629,0.433914895907079,"L.LvsP.BHAT_ESR1_TARGETS_VIA_AKT1_UP"
93,"Down",0.1720650179958,0.433959845096751,"L.LvsP.ULE_SPLICING_VIA_NOVA2"
15,"Down",0.17220856557528,0.433959845096751,"L.LvsP.BIOCARTA_STEM_PATHWAY"
1874,"Up",0.172430677724272,0.433959845096751,"L.LvsP.KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP"
127,"Down",0.172511656465883,0.433959845096751,"L.LvsP.REACTOME_REGULATION_OF_PLK1_ACTIVITY_AT_G2_M_TRANSITION"
313,"Down",0.17253035120225,0.433959845096751,"L.LvsP.REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES"
339,"Down",0.172541872273166,0.433959845096751,"L.LvsP.SANSOM_APC_MYC_TARGETS"
16,"Down",0.172575415701656,0.433959845096751,"L.LvsP.BIOCARTA_AGPCR_PATHWAY"
402,"Up",0.172598426115128,0.433959845096751,"L.LvsP.WANG_CISPLATIN_RESPONSE_AND_XPC_UP"
79,"Down",0.172613100466096,0.433959845096751,"L.LvsP.PID_TAP63_PATHWAY"
19,"Down",0.172677434368202,0.433959845096751,"L.LvsP.LIU_CDX2_TARGETS_DN"
65,"Down",0.172779253463065,0.433959845096751,"L.LvsP.HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_UP"
71,"Down",0.172830453771576,0.433959845096751,"L.LvsP.MCBRYAN_PUBERTAL_BREAST_3_4WK_DN"
84,"Down",0.172990529551715,0.434164610935739,"L.LvsP.KEGG_MELANOMA"
13,"Down",0.173150387172051,0.434289286051788,"L.LvsP.REACTOME_INHIBITION_OF_REPLICATION_INITIATION_OF_DAMAGED_DNA_BY_RB1_E2F1"
110,"Down",0.173197300731451,0.434289286051788,"L.LvsP.LIN_MELANOMA_COPY_NUMBER_UP"
36,"Down",0.173352350463349,0.434481027067932,"L.LvsP.KONDO_COLON_CANCER_HCP_WITH_H3K27ME1"
169,"Down",0.173517825730765,0.434698712489985,"L.LvsP.REACTOME_HIV_LIFE_CYCLE"
37,"Down",0.1736270628725,0.434775376187525,"L.LvsP.BIOCARTA_DEATH_PATHWAY"
123,"Down",0.174008068982109,0.435393870231211,"L.LvsP.FALVELLA_SMOKERS_WITH_LUNG_CANCER"
41,"Up",0.174075551948401,0.435393870231211,"L.LvsP.REACTOME_FANCONI_ANEMIA_PATHWAY"
111,"Down",0.174157890613059,0.435393870231211,"L.LvsP.FONTAINE_FOLLICULAR_THYROID_ADENOMA_DN"
27,"Down",0.174189047015995,0.435393870231211,"L.LvsP.BIOCARTA_CDMAC_PATHWAY"
1901,"Down",0.174268686828675,0.435396100079415,"L.LvsP.REACTOME_DISEASE"
153,"Down",0.175427250629431,0.437988892085203,"L.LvsP.XU_CREBBP_TARGETS_DN"
143,"Down",0.175628914733292,0.437988892085203,"L.LvsP.PID_AP1_PATHWAY"
333,"Down",0.175647186811377,0.437988892085203,"L.LvsP.BILD_MYC_ONCOGENIC_SIGNATURE"
1437,"Up",0.175652136967211,0.437988892085203,"L.LvsP.NUYTTEN_EZH2_TARGETS_DN"
20,"Down",0.175702543433709,0.437988892085203,"L.LvsP.REACTOME_BUTYRATE_RESPONSE_FACTOR_1_BRF1_BINDS_AND_DESTABILIZES_MRNA"
73,"Down",0.175828438647151,0.438036009252938,"L.LvsP.REACTOME_SIGNALING_BY_ERBB4"
159,"Down",0.175941953492092,0.438036009252938,"L.LvsP.MAHAJAN_RESPONSE_TO_IL1A_DN"
11,"Up",0.17595912037453,0.438036009252938,"L.LvsP.BIOCARTA_TCAPOPTOSIS_PATHWAY"
388,"Down",0.176211062021187,0.438427826289697,"L.LvsP.PEREZ_TP53_AND_TP63_TARGETS"
136,"Up",0.176278807900119,0.438427826289697,"L.LvsP.GHANDHI_DIRECT_IRRADIATION_UP"
9,"Up",0.176354401459267,0.438427826289697,"L.LvsP.REACTOME_LIGAND_RECEPTOR_INTERACTIONS"
12,"Down",0.176434383370565,0.438429530631845,"L.LvsP.MATZUK_MATERNAL_EFFECT"
30,"Up",0.176590210121281,0.438532584225581,"L.LvsP.REACTOME_CALNEXIN_CALRETICULIN_CYCLE"
33,"Up",0.17663448454881,0.438532584225581,"L.LvsP.HAEGERSTRAND_RESPONSE_TO_IMATINIB"
15,"Down",0.176885498954002,0.438958673122387,"L.LvsP.MARSON_FOXP3_TARGETS_STIMULATED_DN"
28,"Down",0.177465626137901,0.44006158794592,"L.LvsP.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_23"
48,"Down",0.177489119392187,0.44006158794592,"L.LvsP.WANG_THOC1_TARGETS_DN"
168,"Down",0.177746992976016,0.440503417375344,"L.LvsP.REACTOME_DEATH_RECEPTOR_SIGNALLING"
131,"Down",0.177855207970693,0.440574124045683,"L.LvsP.DITTMER_PTHLH_TARGETS_DN"
91,"Down",0.178036514310278,0.440825744568531,"L.LvsP.PID_ATF2_PATHWAY"
36,"Down",0.178217540664329,0.441076446881413,"L.LvsP.BIOCARTA_TFF_PATHWAY"
20,"Up",0.17863363315869,0.441908437465054,"L.LvsP.REACTOME_ENOS_ACTIVATION"
12,"Down",0.179219982677701,0.443160681674869,"L.LvsP.BIOCARTA_SARS_PATHWAY"
443,"Down",0.179574984695645,0.443840004641135,"L.LvsP.BILD_HRAS_ONCOGENIC_SIGNATURE"
66,"Down",0.179859318478094,0.444344133988105,"L.LvsP.JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_DN"
30,"Up",0.18027451687008,0.445170970868545,"L.LvsP.WAGNER_APO2_SENSITIVITY"
6,"Down",0.180693111376042,0.446005452142026,"L.LvsP.SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_DN"
129,"Up",0.180956265042349,0.446455684702877,"L.LvsP.REACTOME_POSITIVE_EPIGENETIC_REGULATION_OF_RRNA_EXPRESSION"
379,"Down",0.181384294611605,0.447235809551729,"L.LvsP.PHONG_TNF_RESPONSE_VIA_P38_COMPLETE"
162,"Down",0.181457215081054,0.447235809551729,"L.LvsP.HOSHIDA_LIVER_CANCER_SURVIVAL_UP"
445,"Down",0.181588758239662,0.447235809551729,"L.LvsP.BORCZUK_MALIGNANT_MESOTHELIOMA_UP"
109,"Up",0.181729588337791,0.447235809551729,"L.LvsP.KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_DN"
12,"Down",0.181736451985545,0.447235809551729,"L.LvsP.REACTOME_MYOCLONIC_EPILEPSY_OF_LAFORA"
8,"Up",0.181840438515534,0.447235809551729,"L.LvsP.REACTOME_DEFECTIVE_ST3GAL3_CAUSES_MCT12_AND_EIEE15"
20,"Down",0.181929860948556,0.447235809551729,"L.LvsP.WU_HBX_TARGETS_3_DN"
24,"Up",0.181931503955327,0.447235809551729,"L.LvsP.REACTOME_ER_QUALITY_CONTROL_COMPARTMENT_ERQC"
11,"Down",0.182000465091588,0.447235809551729,"L.LvsP.WALLACE_PROSTATE_CANCER_DN"
80,"Up",0.182090311696372,0.447257811359059,"L.LvsP.ROVERSI_GLIOMA_COPY_NUMBER_DN"
317,"Down",0.182255238960473,0.447464127980663,"L.LvsP.WANG_CLIM2_TARGETS_DN"
17,"Down",0.18235377511616,0.4475073336073,"L.LvsP.PID_S1P_S1P4_PATHWAY"
133,"Up",0.182705707187281,0.448172074107576,"L.LvsP.SMID_BREAST_CANCER_LUMINAL_A_UP"
141,"Up",0.183311779831497,0.449334297648453,"L.LvsP.NELSON_RESPONSE_TO_ANDROGEN_UP"
28,"Down",0.183342046571697,0.449334297648453,"L.LvsP.NELSON_RESPONSE_TO_ANDROGEN_DN"
277,"Down",0.183439169973054,0.449373137253441,"L.LvsP.REACTOME_MITOTIC_METAPHASE_AND_ANAPHASE"
92,"Up",0.183920460500508,0.450352624493936,"L.LvsP.LEE_LIVER_CANCER_CIPROFIBRATE_UP"
46,"Down",0.18402310655288,0.450404495852533,"L.LvsP.PID_RAC1_REG_PATHWAY"
89,"Up",0.184403684984115,0.450948676808441,"L.LvsP.CUI_TCF21_TARGETS_DN"
16,"Up",0.184408565430256,0.450948676808441,"L.LvsP.REACTOME_SYNTHESIS_OF_IP2_IP_AND_INS_IN_THE_CYTOSOL"
65,"Down",0.184813634437045,0.451611711541056,"L.LvsP.REACTOME_INSULIN_RECEPTOR_SIGNALLING_CASCADE"
102,"Down",0.184908445385055,0.451611711541056,"L.LvsP.REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION"
19,"Up",0.184924744968159,0.451611711541056,"L.LvsP.NIKOLSKY_BREAST_CANCER_12Q24_AMPLICON"
24,"Down",0.185247082885388,0.452199170540094,"L.LvsP.REACTOME_RNA_POLYMERASE_III_TRANSCRIPTION_TERMINATION"
41,"Up",0.185470426793651,0.452544567406045,"L.LvsP.WU_ALZHEIMER_DISEASE_UP"
41,"Down",0.185569481213582,0.452586529170663,"L.LvsP.BIOCARTA_P53HYPOXIA_PATHWAY"
33,"Up",0.185678619318295,0.452622922689237,"L.LvsP.PID_BARD1_PATHWAY"
19,"Down",0.18574813014684,0.452622922689237,"L.LvsP.REACTOME_ORGANIC_CATION_ANION_ZWITTERION_TRANSPORT"
219,"Up",0.185945126765057,0.452903350609692,"L.LvsP.XU_GH1_EXOGENOUS_TARGETS_DN"
61,"Down",0.1860803850398,0.45303322275872,"L.LvsP.XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_UP"
114,"Up",0.186237129023502,0.453215266888619,"L.LvsP.REACTOME_METABOLISM_OF_NUCLEOTIDES"
40,"Down",0.18658436336945,0.453843956171773,"L.LvsP.REACTOME_CARBOXYTERMINAL_POST_TRANSLATIONAL_MODIFICATIONS_OF_TUBULIN"
425,"Down",0.186711288704076,0.453843956171773,"L.LvsP.ALFANO_MYC_TARGETS"
896,"Up",0.186805593079962,0.453843956171773,"L.LvsP.REACTOME_METABOLISM_OF_LIPIDS"
299,"Down",0.186877472715288,0.453843956171773,"L.LvsP.TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN"
16,"Down",0.186905894050123,0.453843956171773,"L.LvsP.BIOCARTA_EPONFKB_PATHWAY"
28,"Up",0.187065533247135,0.453932695108229,"L.LvsP.REACTOME_CYCLIN_A_B1_B2_ASSOCIATED_EVENTS_DURING_G2_M_TRANSITION"
103,"Up",0.187233025750848,0.453932695108229,"L.LvsP.WESTON_VEGFA_TARGETS_3HR"
1893,"Down",0.187262937606436,0.453932695108229,"L.LvsP.DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_UP"
222,"Down",0.187326084900594,0.453932695108229,"L.LvsP.IKEDA_MIR30_TARGETS_UP"
50,"Down",0.187352940900159,0.453932695108229,"L.LvsP.RIZ_ERYTHROID_DIFFERENTIATION_APOBEC2"
22,"Up",0.187940048500127,0.454921499069639,"L.LvsP.LE_NEURONAL_DIFFERENTIATION_DN"
56,"Down",0.187945524673427,0.454921499069639,"L.LvsP.BIOCARTA_ERK_PATHWAY"
262,"Up",0.188011846593552,0.454921499069639,"L.LvsP.NOUZOVA_TRETINOIN_AND_H4_ACETYLATION"
222,"Down",0.188100767052197,0.454921499069639,"L.LvsP.HOELZEL_NF1_TARGETS_UP"
46,"Down",0.18817244861137,0.454921499069639,"L.LvsP.PID_ANTHRAX_PATHWAY"
17,"Down",0.18840137653827,0.45527587888116,"L.LvsP.SHI_SPARC_TARGETS_DN"
5,"Up",0.188656812678075,0.455693978723057,"L.LvsP.REACTOME_ACTIVATION_OF_RAS_IN_B_CELLS"
636,"Up",0.188907167457541,0.455895123167189,"L.LvsP.RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP"
7,"Up",0.188975892688438,0.455895123167189,"L.LvsP.REACTOME_VLDL_CLEARANCE"
38,"Up",0.188987452034581,0.455895123167189,"L.LvsP.REACTOME_KERATAN_SULFATE_KERATIN_METABOLISM"
10,"Up",0.189176165104789,0.456151337489917,"L.LvsP.REACTOME_MULTIFUNCTIONAL_ANION_EXCHANGERS"
140,"Up",0.189484022765772,0.456694490789865,"L.LvsP.REACTOME_SLC_TRANSPORTER_DISORDERS"
8,"Down",0.190080746807604,0.457933093289431,"L.LvsP.REACTOME_MET_RECEPTOR_ACTIVATION"
137,"Down",0.190413212452599,0.458525309896183,"L.LvsP.KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION"
9,"Down",0.190492428437608,0.458525309896183,"L.LvsP.BIOCARTA_IRES_PATHWAY"
33,"Down",0.190947349058342,0.459420318948464,"L.LvsP.REACTOME_NOTCH2_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS"
11,"Down",0.191153012900338,0.459715097140482,"L.LvsP.REACTOME_MAPK1_ERK2_ACTIVATION"
15,"Down",0.191285738758349,0.459834282432571,"L.LvsP.CLAUS_PGR_POSITIVE_MENINGIOMA_DN"
28,"Down",0.191767257137788,0.460755748387042,"L.LvsP.REACTOME_OTHER_SEMAPHORIN_INTERACTIONS"
56,"Down",0.191835726675162,0.460755748387042,"L.LvsP.THEODOROU_MAMMARY_TUMORIGENESIS"
45,"Up",0.192003221161218,0.460791431153117,"L.LvsP.REACTOME_ENDOSOMAL_VACUOLAR_PATHWAY"
11,"Up",0.192017264853822,0.460791431153117,"L.LvsP.MARIADASON_RESPONSE_TO_BUTYRATE_CURCUMIN_SULINDAC_TSA_2"
395,"Down",0.192459820710179,0.461653079699167,"L.LvsP.SENESE_HDAC1_AND_HDAC2_TARGETS_UP"
93,"Up",0.192647921528661,0.461802319381513,"L.LvsP.SILIGAN_BOUND_BY_EWS_FLT1_FUSION"
107,"Up",0.192689084972536,0.461802319381513,"L.LvsP.SCIBETTA_KDM5B_TARGETS_DN"
731,"Up",0.192809820370621,0.461891463097559,"L.LvsP.TIEN_INTESTINE_PROBIOTICS_24HR_UP"
233,"Down",0.192993942821231,0.461995859536571,"L.LvsP.ZHU_CMV_ALL_DN"
60,"Down",0.193020516464004,0.461995859536571,"L.LvsP.HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_4HR"
136,"Up",0.19329378515705,0.462333650187154,"L.LvsP.REACTOME_RHO_GTPASES_ACTIVATE_PKNS"
61,"Up",0.193392445206574,0.462333650187154,"L.LvsP.PID_PLK1_PATHWAY"
29,"Down",0.193467487461114,0.462333650187154,"L.LvsP.LEI_HOXC8_TARGETS_UP"
35,"Down",0.193496123446026,0.462333650187154,"L.LvsP.SEIDEN_MET_SIGNALING"
20,"Up",0.193646292767004,0.46249259296275,"L.LvsP.REACTOME_ABACAVIR_TRANSPORT_AND_METABOLISM"
19,"Down",0.19384786378739,0.462746637689074,"L.LvsP.BIOCARTA_HSWI_SNF_PATHWAY"
21,"Up",0.193942774545875,0.462746637689074,"L.LvsP.NIKOLSKY_BREAST_CANCER_21Q22_AMPLICON"
330,"Up",0.19400374501054,0.462746637689074,"L.LvsP.REACTOME_METABOLISM_OF_CARBOHYDRATES"
340,"Down",0.194381582963537,0.463447939717722,"L.LvsP.AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_DN"
63,"Down",0.194478606689747,0.46347940361535,"L.LvsP.TRAYNOR_RETT_SYNDROM_UP"
73,"Up",0.194659935429188,0.463711668672116,"L.LvsP.SHIN_B_CELL_LYMPHOMA_CLUSTER_8"
303,"Down",0.195183235653681,0.464580085947843,"L.LvsP.REACTOME_CHROMATIN_MODIFYING_ENZYMES"
44,"Down",0.19521817702435,0.464580085947843,"L.LvsP.REACTOME_CA_DEPENDENT_EVENTS"
28,"Down",0.195317108365579,0.464580085947843,"L.LvsP.REACTOME_SIGNALING_BY_PDGFR_IN_DISEASE"
28,"Down",0.1953605895874,0.464580085947843,"L.LvsP.PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_3"
14,"Down",0.195457443696773,0.46461057876159,"L.LvsP.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_12"
8,"Up",0.195696177489648,0.464978154422115,"L.LvsP.LE_SKI_TARGETS_DN"
130,"Down",0.196024097371391,0.465557231257053,"L.LvsP.SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER"
23,"Down",0.196206953466969,0.465682487463647,"L.LvsP.REACTOME_CHL1_INTERACTIONS"
7,"Up",0.196245287717543,0.465682487463647,"L.LvsP.REACTOME_GLI_PROTEINS_BIND_PROMOTERS_OF_HH_RESPONSIVE_GENES_TO_PROMOTE_TRANSCRIPTION"
144,"Down",0.196357571329028,0.465749039844785,"L.LvsP.REACTOME_ANCHORING_OF_THE_BASAL_BODY_TO_THE_PLASMA_MEMBRANE"
46,"Down",0.196489131540417,0.465766456118459,"L.LvsP.REACTOME_MITOCHONDRIAL_FATTY_ACID_BETA_OXIDATION"
237,"Down",0.196610358991124,0.465766456118459,"L.LvsP.DAZARD_UV_RESPONSE_CLUSTER_G6"
87,"Up",0.196775755412128,0.465766456118459,"L.LvsP.KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN"
183,"Up",0.19677951659462,0.465766456118459,"L.LvsP.YORDY_RECIPROCAL_REGULATION_BY_ETS1_AND_SP100_DN"
134,"Down",0.196786117108468,0.465766456118459,"L.LvsP.HINATA_NFKB_TARGETS_FIBROBLAST_UP"
208,"Down",0.196923102811113,0.465891243236049,"L.LvsP.GAL_LEUKEMIC_STEM_CELL_UP"
249,"Down",0.19718708763032,0.466316256419178,"L.LvsP.RAMALHO_STEMNESS_UP"
9,"Up",0.197485221278876,0.466788032134314,"L.LvsP.REACTOME_LECTIN_PATHWAY_OF_COMPLEMENT_ACTIVATION"
19,"Up",0.197555434110019,0.466788032134314,"L.LvsP.REACTOME_TRANSCRIPTION_OF_E2F_TARGETS_UNDER_NEGATIVE_CONTROL_BY_P107_RBL1_AND_P130_RBL2_IN_COMPLEX_WITH_HDAC1"
59,"Down",0.1978481422957,0.467050116016501,"L.LvsP.NIKOLSKY_BREAST_CANCER_12Q13_Q21_AMPLICON"
97,"Up",0.198043169656058,0.467050116016501,"L.LvsP.BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_DN"
13,"Down",0.198188181850311,0.467050116016501,"L.LvsP.FUNG_IL2_SIGNALING_2"
116,"Down",0.198207020407036,0.467050116016501,"L.LvsP.MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_DN"
347,"Up",0.198233517517924,0.467050116016501,"L.LvsP.MITSIADES_RESPONSE_TO_APLIDIN_DN"
120,"Up",0.198290475618833,0.467050116016501,"L.LvsP.BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_DN"
27,"Up",0.198329608015934,0.467050116016501,"L.LvsP.TSAI_DNAJB4_TARGETS_UP"
46,"Down",0.198423638122672,0.467050116016501,"L.LvsP.HWANG_PROSTATE_CANCER_MARKERS"
113,"Down",0.198430885583823,0.467050116016501,"L.LvsP.BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_UP"
6,"Up",0.198511082047165,0.467050116016501,"L.LvsP.ZHAN_EARLY_DIFFERENTIATION_GENES_UP"
50,"Down",0.198705622405065,0.467225448516975,"L.LvsP.WU_ALZHEIMER_DISEASE_DN"
18,"Up",0.198830285550507,0.467225448516975,"L.LvsP.NOUSHMEHR_GBM_GERMLINE_MUTATED"
21,"Down",0.198839117446273,0.467225448516975,"L.LvsP.GEISS_RESPONSE_TO_DSRNA_DN"
54,"Up",0.199046440544791,0.467513920888763,"L.LvsP.PLASARI_TGFB1_SIGNALING_VIA_NFIC_10HR_DN"
96,"Down",0.199919214838648,0.468979747767532,"L.LvsP.MIKKELSEN_ES_HCP_WITH_H3K27ME3"
28,"Up",0.19992122228392,0.468979747767532,"L.LvsP.TOMLINS_METASTASIS_DN"
2751,"Down",0.199956911074035,0.468979747767532,"L.LvsP.BLALOCK_ALZHEIMERS_DISEASE_UP"
57,"Down",0.200139869591513,0.468979747767532,"L.LvsP.DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY"
19,"Down",0.200195054884138,0.468979747767532,"L.LvsP.REACTOME_TRISTETRAPROLIN_TTP_ZFP36_BINDS_AND_DESTABILIZES_MRNA"
21,"Down",0.200220025203547,0.468979747767532,"L.LvsP.BIOCARTA_MYOSIN_PATHWAY"
128,"Down",0.200264276447666,0.468979747767532,"L.LvsP.BOYLAN_MULTIPLE_MYELOMA_D_UP"
33,"Up",0.20039060965881,0.469004892004063,"L.LvsP.SABATES_COLORECTAL_ADENOMA_SIZE_UP"
13,"Up",0.200510389398841,0.469004892004063,"L.LvsP.BIOCARTA_GHRELIN_PATHWAY"
25,"Up",0.200529492620294,0.469004892004063,"L.LvsP.NAKAMURA_LUNG_CANCER"
51,"Up",0.200656123965918,0.469102625542308,"L.LvsP.BERNARD_PPAPDC1B_TARGETS_UP"
33,"Down",0.201014176294077,0.46974107385036,"L.LvsP.BIOCARTA_ARENRF2_PATHWAY"
307,"Up",0.201264903063487,0.470128284342213,"L.LvsP.SMID_BREAST_CANCER_ERBB2_UP"
8,"Down",0.201597437139026,0.470401549443076,"L.LvsP.KIM_PTEN_TARGETS_DN"
892,"Down",0.201618152279486,0.470401549443076,"L.LvsP.IVANOVA_HEMATOPOIESIS_STEM_CELL_AND_PROGENITOR"
276,"Up",0.201646339271993,0.470401549443076,"L.LvsP.FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP"
36,"Up",0.201722205413191,0.470401549443076,"L.LvsP.REACTOME_METABOLISM_OF_ANGIOTENSINOGEN_TO_ANGIOTENSINS"
14,"Up",0.201960795943557,0.4706956837335,"L.LvsP.REACTOME_GLUTAMATE_AND_GLUTAMINE_METABOLISM"
32,"Up",0.202023140934666,0.4706956837335,"L.LvsP.LANDIS_ERBB2_BREAST_TUMORS_65_UP"
24,"Down",0.202103735428347,0.4706956837335,"L.LvsP.SU_THYMUS"
191,"Up",0.202304385921306,0.4709646104248,"L.LvsP.ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP"
13,"Down",0.202506711466777,0.471237208627866,"L.LvsP.SASAKI_TARGETS_OF_TP73_AND_TP63"
49,"Down",0.20268632511293,0.471239004200633,"L.LvsP.REACTOME_STRIATED_MUSCLE_CONTRACTION"
195,"Down",0.202733788805925,0.471239004200633,"L.LvsP.FIGUEROA_AML_METHYLATION_CLUSTER_7_UP"
8,"Up",0.202769548966273,0.471239004200633,"L.LvsP.REACTOME_DEFECTIVE_CHST14_CAUSES_EDS_MUSCULOCONTRACTURAL_TYPE"
8,"Up",0.202853636936373,0.471239004200633,"L.LvsP.REACTOME_PHOSPHATE_BOND_HYDROLYSIS_BY_NUDT_PROTEINS"
6,"Down",0.202935627798662,0.471239004200633,"L.LvsP.REACTOME_VASOPRESSIN_LIKE_RECEPTORS"
35,"Down",0.203070793505128,0.471239004200633,"L.LvsP.ZIRN_TRETINOIN_RESPONSE_WT1_UP"
137,"Up",0.203151370370122,0.471239004200633,"L.LvsP.SHIPP_DLBCL_CURED_VS_FATAL_UP"
7,"Down",0.203189326463069,0.471239004200633,"L.LvsP.REACTOME_LOSS_OF_MECP2_BINDING_ABILITY_TO_THE_NCOR_SMRT_COMPLEX"
49,"Up",0.203476101922013,0.471706233763862,"L.LvsP.KEGG_LYSINE_DEGRADATION"
212,"Up",0.203564018889165,0.471712263385664,"L.LvsP.WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_UP"
59,"Down",0.203796995487141,0.472054289086052,"L.LvsP.BOYAULT_LIVER_CANCER_SUBCLASS_G12_UP"
66,"Down",0.204349534880687,0.473135920584304,"L.LvsP.VALK_AML_WITH_CEBPA"
498,"Down",0.204590275542835,0.47349503284903,"L.LvsP.JOHNSTONE_PARVB_TARGETS_2_DN"
180,"Down",0.204901790735461,0.474017573630277,"L.LvsP.LENAOUR_DENDRITIC_CELL_MATURATION_UP"
328,"Up",0.20560573570008,0.47524166541118,"L.LvsP.BOYLAN_MULTIPLE_MYELOMA_PCA1_UP"
13,"Down",0.205688787362806,0.47524166541118,"L.LvsP.REACTOME_CAMK_IV_MEDIATED_PHOSPHORYLATION_OF_CREB"
13,"Down",0.205688787362806,0.47524166541118,"L.LvsP.REACTOME_CREB1_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_CAMKII_CAMKK_CAMKIV_CASCASDE"
181,"Down",0.206088175022411,0.475965547075569,"L.LvsP.GRADE_COLON_AND_RECTAL_CANCER_DN"
18,"Down",0.2068350044663,0.477490914277315,"L.LvsP.REACTOME_LOSS_OF_FUNCTION_OF_MECP2_IN_RETT_SYNDROME"
211,"Down",0.207632077804715,0.479130950827323,"L.LvsP.WELCSH_BRCA1_TARGETS_DN"
165,"Up",0.208014874728419,0.479814035199594,"L.LvsP.IVANOVA_HEMATOPOIESIS_INTERMEDIATE_PROGENITOR"
113,"Down",0.208109501579281,0.479832124366907,"L.LvsP.BURTON_ADIPOGENESIS_11"
74,"Down",0.208228443816436,0.479853235409213,"L.LvsP.LEE_AGING_MUSCLE_UP"
2169,"Down",0.208292234578063,0.479853235409213,"L.LvsP.PUJANA_ATM_PCC_NETWORK"
74,"Down",0.208992029768369,0.480988606959222,"L.LvsP.GEORGES_CELL_CYCLE_MIR192_TARGETS"
27,"Down",0.209032051349107,0.480988606959222,"L.LvsP.BIOCARTA_CHREBP_PATHWAY"
10,"Up",0.209048276852078,0.480988606959222,"L.LvsP.REACTOME_DISEASES_OF_DNA_REPAIR"
7,"Down",0.209153219362071,0.480988606959222,"L.LvsP.REACTOME_CLEC7A_INFLAMMASOME_PATHWAY"
9,"Up",0.209220039742617,0.480988606959222,"L.LvsP.REACTOME_TRAIL_SIGNALING"
74,"Down",0.209489599846209,0.481408145282497,"L.LvsP.FRASOR_TAMOXIFEN_RESPONSE_UP"
83,"Down",0.209946516738461,0.482073595660243,"L.LvsP.REACTOME_NUCLEOTIDE_BINDING_DOMAIN_LEUCINE_RICH_REPEAT_CONTAINING_RECEPTOR_NLR_SIGNALING_PATHWAYS"
23,"Down",0.209953557306903,0.482073595660243,"L.LvsP.REACTOME_PLATELET_SENSITIZATION_BY_LDL"
64,"Down",0.210282369851513,0.482628153968042,"L.LvsP.REACTOME_RAB_GERANYLGERANYLATION"
6,"Up",0.210370558756143,0.482630215503202,"L.LvsP.REACTOME_ASSEMBLY_OF_THE_ORC_COMPLEX_AT_THE_ORIGIN_OF_REPLICATION"
62,"Down",0.210672449998807,0.483079551129217,"L.LvsP.PID_SYNDECAN_2_PATHWAY"
27,"Down",0.210816788507453,0.483079551129217,"L.LvsP.REACTOME_RAS_ACTIVATION_UPON_CA2_INFLUX_THROUGH_NMDA_RECEPTOR"
407,"Down",0.2108554360762,0.483079551129217,"L.LvsP.REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES"
29,"Up",0.210915904580562,0.483079551129217,"L.LvsP.AMIT_EGF_RESPONSE_20_MCF10A"
50,"Down",0.211081693250511,0.483259081566077,"L.LvsP.REACTOME_DAG_AND_IP3_SIGNALING"
10,"Down",0.211282051251259,0.483517575069625,"L.LvsP.REACTOME_RHO_GTPASES_ACTIVATE_RHOTEKIN_AND_RHOPHILINS"
253,"Down",0.211754409983203,0.484168091414906,"L.LvsP.ELVIDGE_HYPOXIA_UP"
65,"Up",0.211788978958643,0.484168091414906,"L.LvsP.REACTOME_SIGNALING_BY_RETINOIC_ACID"
71,"Up",0.211829013046239,0.484168091414906,"L.LvsP.KEGG_GRAFT_VERSUS_HOST_DISEASE"
63,"Down",0.21207711629438,0.484534866112243,"L.LvsP.SU_PLACENTA"
34,"Down",0.212323126814051,0.4848965585109,"L.LvsP.KANG_CISPLATIN_RESISTANCE_UP"
51,"Up",0.212610498645846,0.485352372837689,"L.LvsP.JIANG_AGING_HYPOTHALAMUS_DN"
67,"Down",0.212776707132274,0.485457888080327,"L.LvsP.ZHAN_MULTIPLE_MYELOMA_PR_DN"
10,"Up",0.212832324237061,0.485457888080327,"L.LvsP.BIOCARTA_TUBBY_PATHWAY"
32,"Down",0.213036451136898,0.485723108592128,"L.LvsP.REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR4"
827,"Up",0.213672914488596,0.486973431247918,"L.LvsP.REACTOME_TRANSPORT_OF_SMALL_MOLECULES"
127,"Down",0.21406266142517,0.487660673679342,"L.LvsP.CARD_MIR302A_TARGETS"
37,"Up",0.214577906039368,0.488633131174491,"L.LvsP.STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_UP"
101,"Down",0.214914088138745,0.489197197743566,"L.LvsP.ZHOU_TNF_SIGNALING_30MIN"
37,"Down",0.215086025960698,0.489211525748247,"L.LvsP.REACTOME_UPTAKE_AND_ACTIONS_OF_BACTERIAL_TOXINS"
221,"Down",0.215176976082291,0.489211525748247,"L.LvsP.REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION"
69,"Down",0.215312101990234,0.489211525748247,"L.LvsP.APPIERTO_RESPONSE_TO_FENRETINIDE_UP"
17,"Down",0.21533508451835,0.489211525748247,"L.LvsP.IVANOV_MUTATED_IN_COLON_CANCER"
231,"Up",0.215379858151537,0.489211525748247,"L.LvsP.BASSO_B_LYMPHOCYTE_NETWORK"
91,"Up",0.21562832558147,0.489211525748247,"L.LvsP.ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_DN"
41,"Down",0.215691822901788,0.489211525748247,"L.LvsP.ZHAN_MULTIPLE_MYELOMA_SPIKED"
8,"Down",0.215711521989749,0.489211525748247,"L.LvsP.LU_TUMOR_ENDOTHELIAL_MARKERS_DN"
115,"Up",0.215787154160685,0.489211525748247,"L.LvsP.DEMAGALHAES_AGING_UP"
10,"Up",0.215805192855846,0.489211525748247,"L.LvsP.LUDWICZEK_TREATING_IRON_OVERLOAD"
130,"Up",0.216057085226026,0.489581813202746,"L.LvsP.WOO_LIVER_CANCER_RECURRENCE_DN"
14,"Down",0.21677362904029,0.491004258485769,"L.LvsP.CHEN_HOXA5_TARGETS_6HR_DN"
141,"Down",0.217029937208551,0.491383506480785,"L.LvsP.HINATA_NFKB_TARGETS_KERATINOCYTE_UP"
22,"Up",0.217197422152823,0.491507319422296,"L.LvsP.BIOCARTA_NPP1_PATHWAY"
36,"Down",0.217336269386963,0.491507319422296,"L.LvsP.PID_P38_MKK3_6PATHWAY"
18,"Up",0.21749753108627,0.491507319422296,"L.LvsP.REACTOME_PHASE_4_RESTING_MEMBRANE_POTENTIAL"
45,"Down",0.217509491970862,0.491507319422296,"L.LvsP.REACTOME_OVARIAN_TUMOR_DOMAIN_PROTEASES"
1419,"Down",0.217529103025205,0.491507319422296,"L.LvsP.BENPORATH_NANOG_TARGETS"
162,"Down",0.217679582560546,0.491646410121429,"L.LvsP.MARZEC_IL2_SIGNALING_UP"
75,"Down",0.218329361374205,0.492763528320731,"L.LvsP.NATSUME_RESPONSE_TO_INTERFERON_BETA_DN"
116,"Up",0.218352440655777,0.492763528320731,"L.LvsP.BURTON_ADIPOGENESIS_4"
94,"Up",0.219113343445748,0.494278937540408,"L.LvsP.GARCIA_TARGETS_OF_FLI1_AND_DAX1_UP"
70,"Down",0.219335889357266,0.494437927197061,"L.LvsP.REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK"
48,"Down",0.219445723402698,0.494437927197061,"L.LvsP.PID_HIF2PATHWAY"
27,"Down",0.219452102250242,0.494437927197061,"L.LvsP.PID_INTEGRIN_CS_PATHWAY"
31,"Up",0.219572162652301,0.49450691947233,"L.LvsP.BIOCARTA_AMI_PATHWAY"
66,"Down",0.219836509458384,0.494900676219627,"L.LvsP.LEE_LIVER_CANCER_MYC_UP"
190,"Down",0.220706140813357,0.496474870196709,"L.LvsP.MCBRYAN_PUBERTAL_BREAST_5_6WK_UP"
152,"Up",0.22071536099539,0.496474870196709,"L.LvsP.RIGGINS_TAMOXIFEN_RESISTANCE_UP"
83,"Up",0.220936626283701,0.496644401553473,"L.LvsP.REACTOME_GOLGI_ASSOCIATED_VESICLE_BIOGENESIS"
61,"Up",0.220970379421513,0.496644401553473,"L.LvsP.BIOCARTA_NKCELLS_PATHWAY"
9,"Down",0.221792055518159,0.498288612336409,"L.LvsP.BIOCARTA_IFNG_PATHWAY"
26,"Down",0.221984550850335,0.498518514074534,"L.LvsP.REACTOME_PROTEIN_METHYLATION"
150,"Up",0.222449828205881,0.499360576593714,"L.LvsP.GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP"
137,"Up",0.222831356602567,0.499997786397658,"L.LvsP.GAJATE_RESPONSE_TO_TRABECTEDIN_UP"
63,"Down",0.222961038889113,0.499997786397658,"L.LvsP.REACTOME_SIGNALING_BY_TYPE_1_INSULIN_LIKE_GROWTH_FACTOR_1_RECEPTOR_IGF1R"
291,"Down",0.223004981236503,0.499997786397658,"L.LvsP.REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT"
22,"Down",0.223223938117566,0.50028583455696,"L.LvsP.REACTOME_TIE2_SIGNALING"
10,"Down",0.223665689309158,0.500945508889655,"L.LvsP.KIM_ALL_DISORDERS_DURATION_CORR_UP"
103,"Up",0.223699486606721,0.500945508889655,"L.LvsP.REACTOME_GLUCOSE_METABOLISM"
81,"Up",0.224391614633721,0.502247158625098,"L.LvsP.DAZARD_UV_RESPONSE_CLUSTER_G2"
39,"Up",0.224542215781558,0.502247158625098,"L.LvsP.REACTOME_TRIGLYCERIDE_METABOLISM"
39,"Down",0.22455326028599,0.502247158625098,"L.LvsP.MCCABE_HOXC6_TARGETS_DN"
172,"Up",0.224969045359816,0.502775810744996,"L.LvsP.YAMASHITA_LIVER_CANCER_STEM_CELL_DN"
200,"Down",0.224971487752418,0.502775810744996,"L.LvsP.REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2"
40,"Up",0.225446050178681,0.503294474953606,"L.LvsP.TAKADA_GASTRIC_CANCER_COPY_NUMBER_DN"
336,"Down",0.225449938775651,0.503294474953606,"L.LvsP.CHANDRAN_METASTASIS_UP"
29,"Up",0.225559661397413,0.503294474953606,"L.LvsP.PETROVA_PROX1_TARGETS_UP"
96,"Down",0.225567681124079,0.503294474953606,"L.LvsP.PID_BCR_5PATHWAY"
42,"Down",0.225931684201778,0.503903300504894,"L.LvsP.REACTOME_G_PROTEIN_BETA_GAMMA_SIGNALLING"
47,"Up",0.226077162192758,0.504024447485386,"L.LvsP.REACTOME_METALLOPROTEASE_DUBS"
144,"Down",0.226252045777334,0.504211028255898,"L.LvsP.DUTERTRE_ESTRADIOL_RESPONSE_6HR_DN"
21,"Down",0.226907113009552,0.505467134500328,"L.LvsP.REACTOME_PI_3K_CASCADE_FGFR3"
46,"Down",0.227184800895742,0.505623826398194,"L.LvsP.YANG_BREAST_CANCER_ESR1_DN"
19,"Down",0.227278575475542,0.505623826398194,"L.LvsP.REACTOME_SHC_MEDIATED_CASCADE_FGFR3"
51,"Down",0.227333871399781,0.505623826398194,"L.LvsP.GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_DN"
308,"Down",0.227365605357746,0.505623826398194,"L.LvsP.VERHAAK_GLIOBLASTOMA_CLASSICAL"
58,"Up",0.227478598714059,0.505623826398194,"L.LvsP.WEINMANN_ADAPTATION_TO_HYPOXIA_UP"
156,"Up",0.227561068612234,0.505623826398194,"L.LvsP.ZWANG_EGF_INTERVAL_UP"
46,"Up",0.227620842892843,0.505623826398194,"L.LvsP.REACTOME_NUCLEOBASE_CATABOLISM"
11,"Up",0.227709048242269,0.505623826398194,"L.LvsP.STEGMEIER_PREMITOTIC_CELL_CYCLE_REGULATORS"
168,"Down",0.227913776589646,0.505875259238922,"L.LvsP.KIM_GASTRIC_CANCER_CHEMOSENSITIVITY"
59,"Down",0.228120993287078,0.50610968416763,"L.LvsP.REACTOME_TRANSCRIPTIONAL_REGULATION_OF_PLURIPOTENT_STEM_CELLS"
31,"Up",0.228202467467879,0.50610968416763,"L.LvsP.REACTOME_G0_AND_EARLY_G1"
130,"Down",0.228346292059767,0.506225600961688,"L.LvsP.LEE_LIVER_CANCER_E2F1_UP"
96,"Down",0.228788964715647,0.507003681728582,"L.LvsP.REACTOME_ABC_TRANSPORTER_DISORDERS"
75,"Up",0.22890581846794,0.507059403168766,"L.LvsP.REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS"
71,"Up",0.22930017805492,0.507700179241574,"L.LvsP.KEGG_TYPE_I_DIABETES_MELLITUS"
6,"Down",0.22938457026932,0.507700179241574,"L.LvsP.REACTOME_VITAMIN_B1_THIAMIN_METABOLISM"
34,"Up",0.229470563921992,0.507700179241574,"L.LvsP.PETRETTO_HEART_MASS_QTL_CIS_DN"
17,"Down",0.229829525690454,0.508290979017009,"L.LvsP.RAY_ALZHEIMERS_DISEASE"
66,"Up",0.230058469452983,0.50859387349282,"L.LvsP.NIKOLSKY_BREAST_CANCER_19Q13.1_AMPLICON"
197,"Up",0.230385229335569,0.509112683052104,"L.LvsP.WIELAND_UP_BY_HBV_INFECTION"
65,"Up",0.230969355911798,0.510199588028897,"L.LvsP.ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_UP"
7,"Down",0.231235397610444,0.510583272119866,"L.LvsP.BIOCARTA_RAN_PATHWAY"
52,"Down",0.23147006974416,0.510897411423336,"L.LvsP.REACTOME_ELASTIC_FIBRE_FORMATION"
87,"Up",0.231843113770902,0.511388008219014,"L.LvsP.TSENG_ADIPOGENIC_POTENTIAL_DN"
16,"Down",0.231959127839096,0.511388008219014,"L.LvsP.CHESLER_BRAIN_D6MIT150_QTL_TRANS"
59,"Down",0.232057574238481,0.511388008219014,"L.LvsP.GENTILE_UV_RESPONSE_CLUSTER_D7"
18,"Up",0.23221239544027,0.511388008219014,"L.LvsP.KEGG_RIBOFLAVIN_METABOLISM"
11,"Up",0.232214820203977,0.511388008219014,"L.LvsP.REACTOME_PHENYLALANINE_METABOLISM"
26,"Down",0.232247294020247,0.511388008219014,"L.LvsP.ZHENG_FOXP3_TARGETS_IN_THYMUS_DN"
25,"Down",0.232616602980074,0.511997292148418,"L.LvsP.FINETTI_BREAST_CANCER_KINOME_GREEN"
65,"Up",0.233189648479088,0.513054343987615,"L.LvsP.REACTOME_PLATELET_AGGREGATION_PLUG_FORMATION"
46,"Up",0.233298276270951,0.513089168457474,"L.LvsP.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_UP"
246,"Down",0.233519832325241,0.513170841155717,"L.LvsP.SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_UP"
402,"Down",0.233521041119151,0.513170841155717,"L.LvsP.BROWNE_HCMV_INFECTION_16HR_UP"
185,"Down",0.233669374512423,0.51329279764767,"L.LvsP.GROSS_HYPOXIA_VIA_HIF1A_DN"
32,"Down",0.233934256002846,0.513670572454223,"L.LvsP.REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS"
64,"Up",0.234241629590359,0.51414131401552,"L.LvsP.KEGG_ALLOGRAFT_REJECTION"
24,"Up",0.234400708483284,0.514286316350825,"L.LvsP.BIOCARTA_COMP_PATHWAY"
40,"Down",0.234572485036042,0.514459051870003,"L.LvsP.BIOCARTA_INFLAM_PATHWAY"
303,"Down",0.234857931890812,0.514706184650582,"L.LvsP.ZWANG_EGF_INTERVAL_DN"
19,"Down",0.234931611871362,0.514706184650582,"L.LvsP.REACTOME_KSRP_KHSRP_BINDS_AND_DESTABILIZES_MRNA"
32,"Up",0.234964443852065,0.514706184650582,"L.LvsP.KEGG_GLYCINE_SERINE_AND_THREONINE_METABOLISM"
19,"Down",0.235294662912026,0.515133397316365,"L.LvsP.REACTOME_RNA_POLYMERASE_III_CHAIN_ELONGATION"
38,"Down",0.235448509206728,0.515133397316365,"L.LvsP.PID_S1P_S1P3_PATHWAY"
89,"Down",0.23568816681351,0.515133397316365,"L.LvsP.PID_P75_NTR_PATHWAY"
945,"Down",0.235720541071247,0.515133397316365,"L.LvsP.KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_UP"
25,"Down",0.235886789697979,0.515133397316365,"L.LvsP.MIKKELSEN_ES_LCP_WITH_H3K27ME3"
1160,"Down",0.235963443294244,0.515133397316365,"L.LvsP.WONG_ADULT_TISSUE_STEM_MODULE"
126,"Up",0.235985783491607,0.515133397316365,"L.LvsP.REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS"
94,"Down",0.236088410096875,0.515133397316365,"L.LvsP.WARTERS_IR_RESPONSE_5GY"
15,"Down",0.236099159545618,0.515133397316365,"L.LvsP.REACTOME_MRNA_DECAY_BY_5_TO_3_EXORIBONUCLEASE"
31,"Down",0.236162316842974,0.515133397316365,"L.LvsP.REACTOME_INTERLEUKIN_RECEPTOR_SHC_SIGNALING"
1013,"Down",0.236184330294264,0.515133397316365,"L.LvsP.MARTINEZ_RB1_TARGETS_DN"
208,"Down",0.236294047593713,0.515169475215157,"L.LvsP.PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN"
1260,"Up",0.236539073214268,0.515467902070104,"L.LvsP.ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_UP"
279,"Down",0.236617387493927,0.515467902070104,"L.LvsP.GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_UP"
182,"Down",0.236945592574319,0.515835429937652,"L.LvsP.LEE_CALORIE_RESTRICTION_NEOCORTEX_UP"
274,"Up",0.236972688016212,0.515835429937652,"L.LvsP.CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN"
28,"Down",0.237333345384565,0.516417184821433,"L.LvsP.SCHAVOLT_TARGETS_OF_TP53_AND_TP63"
487,"Up",0.238131387971437,0.517792526869357,"L.LvsP.SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM4"
80,"Down",0.238218616753983,0.517792526869357,"L.LvsP.REACTOME_APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1"
128,"Up",0.238349103618165,0.517792526869357,"L.LvsP.URS_ADIPOCYTE_DIFFERENTIATION_UP"
92,"Up",0.238429086411151,0.517792526869357,"L.LvsP.KEGG_PPAR_SIGNALING_PATHWAY"
90,"Down",0.238433672166645,0.517792526869357,"L.LvsP.GOTTWEIN_TARGETS_OF_KSHV_MIR_K12_11"
706,"Down",0.239080679739614,0.518937235069727,"L.LvsP.JOHNSTONE_PARVB_TARGETS_3_UP"
42,"Up",0.239179048847677,0.518937235069727,"L.LvsP.GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_UP"
345,"Down",0.239242360678737,0.518937235069727,"L.LvsP.IVANOVA_HEMATOPOIESIS_STEM_CELL"
8,"Down",0.23938947896019,0.519052717321919,"L.LvsP.REACTOME_ESTROGEN_STIMULATED_SIGNALING_THROUGH_PRKCZ"
16,"Down",0.239913572924633,0.51945159721132,"L.LvsP.REACTOME_TICAM1_DEPENDENT_ACTIVATION_OF_IRF3_IRF7"
23,"Up",0.239945645168772,0.51945159721132,"L.LvsP.REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI"
8,"Down",0.240065327081275,0.51945159721132,"L.LvsP.RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_MAPK1_DN"
68,"Down",0.240169554412696,0.51945159721132,"L.LvsP.REACTOME_TRANSCRIPTIONAL_ACTIVATION_OF_MITOCHONDRIAL_BIOGENESIS"
30,"Down",0.240206616126652,0.51945159721132,"L.LvsP.REACTOME_CRMPS_IN_SEMA3A_SIGNALING"
35,"Down",0.240219775662947,0.51945159721132,"L.LvsP.NIKOLSKY_OVERCONNECTED_IN_BREAST_CANCER"
54,"Down",0.240251942486092,0.51945159721132,"L.LvsP.AIYAR_COBRA1_TARGETS_DN"
9,"Up",0.240410310982541,0.51945159721132,"L.LvsP.REACTOME_TRIF_MEDIATED_PROGRAMMED_CELL_DEATH"
25,"Up",0.240418997515603,0.51945159721132,"L.LvsP.KEGG_GLYCOSAMINOGLYCAN_DEGRADATION"
13,"Up",0.240625693702026,0.519545888728543,"L.LvsP.THILLAINADESAN_ZNF217_TARGETS_DN"
106,"Up",0.24067711356897,0.519545888728543,"L.LvsP.VANTVEER_BREAST_CANCER_POOR_PROGNOSIS"
115,"Down",0.240744540951805,0.519545888728543,"L.LvsP.REACTOME_RECRUITMENT_OF_MITOTIC_CENTROSOME_PROTEINS_AND_COMPLEXES"
19,"Up",0.240980795354842,0.519852835550886,"L.LvsP.AMIT_EGF_RESPONSE_20_HELA"
51,"Down",0.241105931525779,0.519919928005473,"L.LvsP.REACTOME_SIGNALING_BY_FGFR2_IN_DISEASE"
17,"Down",0.241391603177417,0.520333011293544,"L.LvsP.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_8"
71,"Up",0.241605829961003,0.520591829249566,"L.LvsP.WEINMANN_ADAPTATION_TO_HYPOXIA_DN"
427,"Down",0.242334370654703,0.521958214004618,"L.LvsP.UDAYAKUMAR_MED1_TARGETS_DN"
36,"Up",0.242669380499829,0.522476247968675,"L.LvsP.KEGG_REGULATION_OF_AUTOPHAGY"
81,"Up",0.242764266048747,0.522477083294481,"L.LvsP.KEGG_AUTOIMMUNE_THYROID_DISEASE"
116,"Up",0.243539497299054,0.52385145597744,"L.LvsP.RASHI_RESPONSE_TO_IONIZING_RADIATION_4"
101,"Up",0.243592348221739,0.52385145597744,"L.LvsP.KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN"
254,"Down",0.244013600681851,0.524385831281897,"L.LvsP.MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_UP"
12,"Up",0.244030519784467,0.524385831281897,"L.LvsP.REACTOME_CHYLOMICRON_ASSEMBLY"
64,"Up",0.244294322717713,0.524614480367602,"L.LvsP.REACTOME_METABOLISM_OF_FAT_SOLUBLE_VITAMINS"
7,"Up",0.244369601182932,0.524614480367602,"L.LvsP.REACTOME_LIPID_PARTICLE_ORGANIZATION"
1555,"Down",0.244421577396806,0.524614480367602,"L.LvsP.MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3"
29,"Up",0.244652832662392,0.524907067050976,"L.LvsP.REACTOME_INSULIN_RECEPTOR_RECYCLING"
56,"Down",0.245556087771731,0.52664065527149,"L.LvsP.REACTOME_IRS_MEDIATED_SIGNALLING"
27,"Down",0.245767807978125,0.52689034909308,"L.LvsP.KORKOLA_TERATOMA_UP"
25,"Down",0.246560353021612,0.528384570487013,"L.LvsP.NGO_MALIGNANT_GLIOMA_1P_LOH"
13,"Down",0.246712089762295,0.528504898990985,"L.LvsP.REACTOME_RUNX2_REGULATES_GENES_INVOLVED_IN_CELL_MIGRATION"
12,"Up",0.247284520459473,0.529350923842574,"L.LvsP.BOYAULT_LIVER_CANCER_SUBCLASS_G23_DN"
385,"Up",0.247298505387117,0.529350923842574,"L.LvsP.BROWNE_HCMV_INFECTION_48HR_UP"
39,"Down",0.247756724821457,0.529707165516278,"L.LvsP.PID_INTEGRIN2_PATHWAY"
52,"Up",0.24781243132497,0.529707165516278,"L.LvsP.WANG_RESPONSE_TO_FORSKOLIN_UP"
5,"Down",0.247895059487967,0.529707165516278,"L.LvsP.REACTOME_BETA_OXIDATION_OF_OCTANOYL_COA_TO_HEXANOYL_COA"
30,"Down",0.248021995050937,0.529707165516278,"L.LvsP.BYSTRYKH_HEMATOPOIESIS_STEM_CELL_RUNX1"
15,"Down",0.248053041944249,0.529707165516278,"L.LvsP.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_DN"
50,"Down",0.248108335961774,0.529707165516278,"L.LvsP.BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_DN"
312,"Up",0.248135568581508,0.529707165516278,"L.LvsP.GERY_CEBP_TARGETS"
11,"Up",0.248646448644721,0.530173544612604,"L.LvsP.ZHU_SKIL_TARGETS_DN"
106,"Up",0.248647417730498,0.530173544612604,"L.LvsP.GUO_HEX_TARGETS_DN"
143,"Down",0.248693904498319,0.530173544612604,"L.LvsP.LIN_APC_TARGETS"
188,"Up",0.248737597164965,0.530173544612604,"L.LvsP.BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_UP"
183,"Down",0.249099595361021,0.530628619999667,"L.LvsP.DITTMER_PTHLH_TARGETS_UP"
43,"Up",0.249143045310026,0.530628619999667,"L.LvsP.KEGG_SPHINGOLIPID_METABOLISM"
30,"Down",0.249657421540389,0.531519400730385,"L.LvsP.WOTTON_RUNX_TARGETS_UP"
16,"Down",0.249860806729919,0.53155628382368,"L.LvsP.REACTOME_PYRIMIDINE_CATABOLISM"
37,"Up",0.249867025078268,0.53155628382368,"L.LvsP.FRIDMAN_SENESCENCE_DN"
6,"Up",0.250485745906793,0.532667572737945,"L.LvsP.OHASHI_AURKA_TARGETS"
43,"Down",0.250869384384323,0.53308901309359,"L.LvsP.VALK_AML_WITH_EVI1"
32,"Down",0.25089356428582,0.53308901309359,"L.LvsP.CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_HD_MTX_DN"
23,"Down",0.250973177985642,0.53308901309359,"L.LvsP.STEIN_ESTROGEN_RESPONSE_NOT_VIA_ESRRA"
19,"Up",0.251319217879689,0.533604997482729,"L.LvsP.KEGG_ONE_CARBON_POOL_BY_FOLATE"
154,"Up",0.251409118908032,0.533604997482729,"L.LvsP.LEE_TARGETS_OF_PTCH1_AND_SUFU_DN"
34,"Up",0.251895116612575,0.53443135063351,"L.LvsP.STEGER_ADIPOGENESIS_UP"
497,"Down",0.252514108947387,0.535539128642156,"L.LvsP.DACOSTA_UV_RESPONSE_VIA_ERCC3_UP"
47,"Down",0.252810612106201,0.535962375128523,"L.LvsP.REACTOME_SYNTHESIS_OF_LEUKOTRIENES_LT_AND_EOXINS_EX"
7,"Up",0.253151261378471,0.536325466066298,"L.LvsP.TERAO_AOX4_TARGETS_HG_DN"
310,"Up",0.253241489692205,0.536325466066298,"L.LvsP.CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN"
8,"Up",0.253401353639901,0.536325466066298,"L.LvsP.MATZUK_STEROIDOGENESIS"
12,"Down",0.253444182308273,0.536325466066298,"L.LvsP.REACTOME_FGFR2B_LIGAND_BINDING_AND_ACTIVATION"
44,"Up",0.253466891450757,0.536325466066298,"L.LvsP.AMIT_SERUM_RESPONSE_40_MCF10A"
39,"Up",0.25360963290157,0.536422211290275,"L.LvsP.CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_DN"
179,"Down",0.254129941663957,0.537154860798482,"L.LvsP.REACTOME_CLATHRIN_MEDIATED_ENDOCYTOSIS"
32,"Up",0.254150319379423,0.537154860798482,"L.LvsP.SAGIV_CD24_TARGETS_UP"
126,"Down",0.254446423850843,0.537575192002793,"L.LvsP.GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN"
175,"Up",0.25455032209037,0.537584053684356,"L.LvsP.COATES_MACROPHAGE_M1_VS_M2_DN"
34,"Up",0.25468624632698,0.537584053684356,"L.LvsP.RUAN_RESPONSE_TO_TROGLITAZONE_UP"
161,"Down",0.254742307949541,0.537584053684356,"L.LvsP.WANG_ESOPHAGUS_CANCER_VS_NORMAL_DN"
13,"Down",0.254973591064125,0.537755038249254,"L.LvsP.PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_5"
317,"Up",0.255064233911051,0.537755038249254,"L.LvsP.BROWNE_HCMV_INFECTION_14HR_UP"
18,"Up",0.255165336058227,0.537755038249254,"L.LvsP.BIOCARTA_CLASSIC_PATHWAY"
22,"Up",0.255212374817515,0.537755038249254,"L.LvsP.KEGG_SULFUR_METABOLISM"
26,"Up",0.255754779183079,0.538595683533936,"L.LvsP.PLASARI_TGFB1_TARGETS_1HR_DN"
141,"Down",0.255806161143085,0.538595683533936,"L.LvsP.PID_REG_GR_PATHWAY"
93,"Down",0.256136712245521,0.5387815149685,"L.LvsP.WEIGEL_OXIDATIVE_STRESS_BY_TBH_AND_H2O2"
92,"Down",0.25614112957192,0.5387815149685,"L.LvsP.ZHU_CMV_8_HR_DN"
58,"Down",0.256200867580684,0.5387815149685,"L.LvsP.NAKAMURA_ADIPOGENESIS_EARLY_DN"
35,"Down",0.256284207698889,0.5387815149685,"L.LvsP.REACTOME_FORMATION_OF_THE_EARLY_ELONGATION_COMPLEX"
463,"Down",0.256770170485407,0.539597975147783,"L.LvsP.BRUINS_UVC_RESPONSE_EARLY_LATE"
26,"Down",0.256990496119876,0.539712065322618,"L.LvsP.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_UP"
218,"Down",0.257083985639097,0.539712065322618,"L.LvsP.RASHI_RESPONSE_TO_IONIZING_RADIATION_5"
25,"Down",0.257117305129278,0.539712065322618,"L.LvsP.RASHI_NFKB1_TARGETS"
54,"Down",0.257553706719988,0.540422939072036,"L.LvsP.MARZEC_IL2_SIGNALING_DN"
9,"Down",0.257690319945378,0.540429718289556,"L.LvsP.TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_GRANULOCYTE_DN"
123,"Up",0.25782905356944,0.540429718289556,"L.LvsP.REACTOME_PEPTIDE_HORMONE_METABOLISM"
61,"Down",0.257900945608795,0.540429718289556,"L.LvsP.PID_THROMBIN_PAR1_PATHWAY"
78,"Up",0.257956060105401,0.540429718289556,"L.LvsP.RICKMAN_HEAD_AND_NECK_CANCER_D"
14,"Down",0.258045660387851,0.540429718289556,"L.LvsP.BIOCARTA_PKC_PATHWAY"
25,"Down",0.258297921299906,0.540753202145846,"L.LvsP.WEBER_METHYLATED_IN_COLON_CANCER"
54,"Down",0.258630554185793,0.54124463818821,"L.LvsP.ZHAN_EARLY_DIFFERENTIATION_GENES_DN"
363,"Down",0.259068867801184,0.54195678020157,"L.LvsP.OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP"
476,"Up",0.259276012358842,0.542016772877021,"L.LvsP.MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_UP"
28,"Up",0.259293609017855,0.542016772877021,"L.LvsP.BIOCARTA_CDK5_PATHWAY"
137,"Up",0.259409830736325,0.542054782366267,"L.LvsP.BECKER_TAMOXIFEN_RESISTANCE_DN"
13,"Down",0.259583856867372,0.542066044479835,"L.LvsP.REACTOME_MINERALOCORTICOID_BIOSYNTHESIS"
9,"Up",0.259611301461856,0.542066044479835,"L.LvsP.REACTOME_RRNA_MODIFICATION_IN_THE_MITOCHONDRION"
140,"Down",0.259951104567932,0.54233886918064,"L.LvsP.NATSUME_RESPONSE_TO_INTERFERON_BETA_UP"
265,"Down",0.260029033919362,0.54233886918064,"L.LvsP.SHEPARD_CRUSH_AND_BURN_MUTANT_UP"
29,"Up",0.260036234797952,0.54233886918064,"L.LvsP.BIOCARTA_ACE2_PATHWAY"
34,"Up",0.260466596599206,0.543031603543367,"L.LvsP.THUM_MIR21_TARGETS_HEART_DISEASE_UP"
153,"Down",0.260607147381022,0.543119833347029,"L.LvsP.CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP"
10,"Down",0.26169712348006,0.545185906451112,"L.LvsP.SA_FAS_SIGNALING"
126,"Up",0.261991808181167,0.545594240088012,"L.LvsP.TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN"
99,"Up",0.26247015311447,0.546183004050944,"L.LvsP.APPIERTO_RESPONSE_TO_FENRETINIDE_DN"
156,"Up",0.262510887883611,0.546183004050944,"L.LvsP.YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_11"
7,"Up",0.262570885289819,0.546183004050944,"L.LvsP.REACTOME_INTERLEUKIN_36_PATHWAY"
67,"Down",0.262715070902677,0.546254528581165,"L.LvsP.MA_MYELOID_DIFFERENTIATION_UP"
40,"Down",0.262819854543834,0.546254528581165,"L.LvsP.MURAKAMI_UV_RESPONSE_24HR"
14,"Up",0.26295986054369,0.546254528581165,"L.LvsP.BERENJENO_TRANSFORMED_BY_RHOA_REVERSIBLY_UP"
711,"Down",0.263046403940011,0.546254528581165,"L.LvsP.CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5"
6,"Down",0.263099260193822,0.546254528581165,"L.LvsP.MIKI_COEXPRESSED_WITH_CYP19A1"
359,"Down",0.263614399113775,0.54711862338591,"L.LvsP.MASSARWEH_TAMOXIFEN_RESISTANCE_DN"
58,"Up",0.264075942556988,0.547454502630566,"L.LvsP.REACTOME_AMINO_ACIDS_REGULATE_MTORC1"
33,"Down",0.264087402297828,0.547454502630566,"L.LvsP.REACTOME_THROMBIN_SIGNALLING_THROUGH_PROTEINASE_ACTIVATED_RECEPTORS_PARS"
93,"Down",0.2641154248857,0.547454502630566,"L.LvsP.MCCLUNG_DELTA_FOSB_TARGETS_8WK"
42,"Down",0.264172293908184,0.547454502630566,"L.LvsP.REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES"
36,"Up",0.264668238942657,0.548276767745953,"L.LvsP.REACTOME_TERMINATION_OF_TRANSLESION_DNA_SYNTHESIS"
46,"Down",0.265122348190951,0.549011783950475,"L.LvsP.PARK_TRETINOIN_RESPONSE_AND_PML_RARA_FUSION"
17,"Up",0.265812145732162,0.55023412720072,"L.LvsP.REACTOME_GLYCOGEN_BREAKDOWN_GLYCOGENOLYSIS"
61,"Down",0.265931558599988,0.550275294722805,"L.LvsP.REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_CELL_CYCLE_GENES"
471,"Down",0.266187484649986,0.550598803827076,"L.LvsP.REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION"
168,"Down",0.26642605772619,0.550886190414401,"L.LvsP.LINDGREN_BLADDER_CANCER_CLUSTER_1_UP"
30,"Down",0.266730735477958,0.551113022098476,"L.LvsP.MATZUK_SPERMATOGONIA"
305,"Up",0.266828493367452,0.551113022098476,"L.LvsP.PAL_PRMT5_TARGETS_UP"
6,"Up",0.266834791129973,0.551113022098476,"L.LvsP.PASTURAL_RIZ1_TARGETS_DN"
119,"Down",0.267251707462386,0.551767994981155,"L.LvsP.LINDVALL_IMMORTALIZED_BY_TERT_DN"
17,"Down",0.267654786174898,0.552291355620086,"L.LvsP.TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_MONOCYTE_DN"
750,"Down",0.267738038665834,0.552291355620086,"L.LvsP.ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP"
30,"Down",0.267804869672174,0.552291355620086,"L.LvsP.CHOI_ATL_CHRONIC_VS_ACUTE_DN"
164,"Down",0.268071800058512,0.552635713096015,"L.LvsP.ZHU_CMV_24_HR_DN"
38,"Down",0.268702784410773,0.55334712049477,"L.LvsP.BIOCARTA_FAS_PATHWAY"
9,"Up",0.2687230664208,0.55334712049477,"L.LvsP.REACTOME_IRS_ACTIVATION"
27,"Down",0.268858610228114,0.55334712049477,"L.LvsP.OUYANG_PROSTATE_CANCER_PROGRESSION_DN"
318,"Down",0.268961987952375,0.55334712049477,"L.LvsP.REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR"
218,"Down",0.268983693350059,0.55334712049477,"L.LvsP.MCBRYAN_PUBERTAL_BREAST_5_6WK_DN"
20,"Down",0.269017373827083,0.55334712049477,"L.LvsP.CAFFAREL_RESPONSE_TO_THC_8HR_5_DN"
27,"Up",0.269228926652431,0.553576324083782,"L.LvsP.KEGG_PRIMARY_BILE_ACID_BIOSYNTHESIS"
234,"Down",0.270239729050059,0.555407249806058,"L.LvsP.DARWICHE_SKIN_TUMOR_PROMOTER_UP"
270,"Down",0.270320294669579,0.555407249806058,"L.LvsP.ONDER_CDH1_TARGETS_1_DN"
87,"Down",0.27082472897512,0.556236971212273,"L.LvsP.SATO_SILENCED_BY_DEACETYLATION_IN_PANCREATIC_CANCER"
21,"Down",0.27103169974764,0.556455353845043,"L.LvsP.IYENGAR_RESPONSE_TO_ADIPOCYTE_FACTORS"
54,"Down",0.271433804216638,0.556765263567942,"L.LvsP.WANG_RESPONSE_TO_BEXAROTENE_DN"
63,"Down",0.271469931161985,0.556765263567942,"L.LvsP.BOYAULT_LIVER_CANCER_SUBCLASS_G123_UP"
145,"Down",0.271484744181438,0.556765263567942,"L.LvsP.SASSON_RESPONSE_TO_FORSKOLIN_UP"
34,"Up",0.271590228466954,0.556775073486758,"L.LvsP.MAHADEVAN_IMATINIB_RESISTANCE_DN"
765,"Down",0.27262109283361,0.558681253623807,"L.LvsP.SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN"
23,"Down",0.272758181100582,0.558755088293857,"L.LvsP.HE_PTEN_TARGETS_UP"
68,"Up",0.273139740879151,0.559329491600306,"L.LvsP.CASORELLI_APL_SECONDARY_VS_DE_NOVO_UP"
36,"Up",0.27335739002229,0.559398521746115,"L.LvsP.KONG_E2F1_TARGETS"
557,"Down",0.273375801366975,0.559398521746115,"L.LvsP.OSMAN_BLADDER_CANCER_UP"
17,"Down",0.273675896455237,0.559805413059935,"L.LvsP.STARK_BRAIN_22Q11_DELETION"
74,"Up",0.274193677837402,0.560652563175018,"L.LvsP.LIEN_BREAST_CARCINOMA_METAPLASTIC"
12,"Down",0.274292852846523,0.560652563175018,"L.LvsP.REACTOME_PI5P_REGULATES_TP53_ACETYLATION"
45,"Down",0.274912302301533,0.561711056698143,"L.LvsP.RODRIGUES_NTN1_AND_DCC_TARGETS"
611,"Down",0.275062597535194,0.561810528914698,"L.LvsP.GRUETZMANN_PANCREATIC_CANCER_UP"
39,"Up",0.275370973143129,0.562232684825835,"L.LvsP.IKEDA_MIR30_TARGETS_DN"
137,"Down",0.276059037867778,0.56342946488407,"L.LvsP.KYNG_DNA_DAMAGE_BY_GAMMA_RADIATION"
8,"Down",0.27643498395202,0.56384925019596,"L.LvsP.REACTOME_SIGNALING_BY_NOTCH1_T_7_9_NOTCH1_M1580_K2555_TRANSLOCATION_MUTANT"
12,"Up",0.276468677388542,0.56384925019596,"L.LvsP.REACTOME_VITAMIN_D_CALCIFEROL_METABOLISM"
493,"Up",0.276909736079145,0.564540534948966,"L.LvsP.ROZANOV_MMP14_TARGETS_UP"
94,"Up",0.277189402230076,0.564902397688938,"L.LvsP.ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_DN"
388,"Up",0.277642968138545,0.565574404707338,"L.LvsP.VERHAAK_AML_WITH_NPM1_MUTATED_UP"
19,"Down",0.277723731014727,0.565574404707338,"L.LvsP.TAKAYAMA_BOUND_BY_AR"
29,"Up",0.277844294193059,0.565611598893013,"L.LvsP.REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_CYCLIN_B"
9,"Up",0.27828106068645,0.566292228389909,"L.LvsP.REACTOME_REELIN_SIGNALLING_PATHWAY"
16,"Down",0.278503594705453,0.566446769111902,"L.LvsP.POS_RESPONSE_TO_HISTAMINE_UP"
31,"Down",0.278561903638138,0.566446769111902,"L.LvsP.XU_HGF_TARGETS_INDUCED_BY_AKT1_6HR"
46,"Up",0.278773444310547,0.566668519703313,"L.LvsP.ZHAN_LATE_DIFFERENTIATION_GENES_UP"
63,"Up",0.278972752827117,0.56681702856934,"L.LvsP.KORKOLA_SEMINOMA_UP"
40,"Up",0.279051537667886,0.56681702856934,"L.LvsP.KEGG_CYSTEINE_AND_METHIONINE_METABOLISM"
19,"Down",0.279187572264678,0.566833088214902,"L.LvsP.YANG_BCL3_TARGETS_DN"
67,"Down",0.279285275469723,0.566833088214902,"L.LvsP.TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN"
54,"Up",0.279367004048762,0.566833088214902,"L.LvsP.REACTOME_HDMS_DEMETHYLATE_HISTONES"
92,"Down",0.279650416198753,0.567199982084705,"L.LvsP.KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP"
198,"Down",0.280072400887805,0.567847563076154,"L.LvsP.REACTOME_TOLL_LIKE_RECEPTOR_CASCADES"
190,"Up",0.280305804592989,0.567998181591111,"L.LvsP.SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A5"
83,"Down",0.280352150038369,0.567998181591111,"L.LvsP.PARENT_MTOR_SIGNALING_DN"
19,"Down",0.280699851025889,0.568494313671113,"L.LvsP.BIOCARTA_SHH_PATHWAY"
30,"Down",0.281450772541282,0.569806415738099,"L.LvsP.KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_UP"
133,"Up",0.281639802256649,0.569960242783272,"L.LvsP.GRABARCZYK_BCL11B_TARGETS_UP"
56,"Up",0.281732925217342,0.569960242783272,"L.LvsP.SHAFFER_IRF4_MULTIPLE_MYELOMA_PROGRAM"
102,"Down",0.282220088484541,0.570634245551391,"L.LvsP.DAWSON_METHYLATED_IN_LYMPHOMA_TCL1"
23,"Down",0.282328462084438,0.570634245551391,"L.LvsP.REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB"
10,"Down",0.282375709138833,0.570634245551391,"L.LvsP.NIKOLSKY_BREAST_CANCER_10Q22_AMPLICON"
36,"Up",0.282888856149562,0.571354856024494,"L.LvsP.KRIGE_AMINO_ACID_DEPRIVATION"
53,"Up",0.282938975546223,0.571354856024494,"L.LvsP.SESTO_RESPONSE_TO_UV_C6"
149,"Up",0.283146541359229,0.571565252710908,"L.LvsP.NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN"
161,"Down",0.28331601106156,0.571698622320937,"L.LvsP.CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_UP"
92,"Up",0.283572062901725,0.572006543518291,"L.LvsP.REACTOME_RMTS_METHYLATE_HISTONE_ARGININES"
18,"Up",0.283914891450344,0.572489217661908,"L.LvsP.BAKER_HEMATOPOIESIS_STAT3_TARGETS"
5,"Up",0.284045741556007,0.572544259957405,"L.LvsP.NAKAMURA_ALVEOLAR_EPITHELIUM"
34,"Up",0.284412907120276,0.573075424004376,"L.LvsP.SOUCEK_MYC_TARGETS"
84,"Down",0.284905043717154,0.57385791865652,"L.LvsP.GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN"
37,"Down",0.285297058618722,0.574148077437581,"L.LvsP.CHANG_POU5F1_TARGETS_UP"
50,"Down",0.28530898660371,0.574148077437581,"L.LvsP.BIOCARTA_IL1R_PATHWAY"
53,"Up",0.28536062882953,0.574148077437581,"L.LvsP.BIOCARTA_CTL_PATHWAY"
101,"Down",0.285465990025703,0.574151130902914,"L.LvsP.TCGA_GLIOBLASTOMA_COPY_NUMBER_UP"
12,"Down",0.285935670313089,0.574788791501804,"L.LvsP.REACTOME_NETRIN_MEDIATED_REPULSION_SIGNALS"
20,"Down",0.286037799430411,0.574788791501804,"L.LvsP.REACTOME_FORMATION_OF_SENESCENCE_ASSOCIATED_HETEROCHROMATIN_FOCI_SAHF"
303,"Down",0.286094909425387,0.574788791501804,"L.LvsP.FIGUEROA_AML_METHYLATION_CLUSTER_3_UP"
63,"Down",0.286369258068903,0.575130994501621,"L.LvsP.ZHAN_MULTIPLE_MYELOMA_CD2_UP"
9,"Down",0.286944335265997,0.575919340919239,"L.LvsP.BIOCARTA_PARKIN_PATHWAY"
150,"Down",0.287111788656845,0.575919340919239,"L.LvsP.DING_LUNG_CANCER_EXPRESSION_BY_COPY_NUMBER"
6,"Up",0.287152826313169,0.575919340919239,"L.LvsP.BIOCARTA_ACETAMINOPHEN_PATHWAY"
77,"Up",0.287178445092122,0.575919340919239,"L.LvsP.REACTOME_PKMTS_METHYLATE_HISTONE_LYSINES"
18,"Down",0.287359336064391,0.576009985614463,"L.LvsP.PID_TCR_RAS_PATHWAY"
35,"Up",0.287432004035143,0.576009985614463,"L.LvsP.HOFMANN_MYELODYSPLASTIC_SYNDROM_HIGH_RISK_DN"
91,"Down",0.287582215142444,0.576102198377744,"L.LvsP.PID_TELOMERASE_PATHWAY"
127,"Down",0.288097931033115,0.576926280580258,"L.LvsP.MORI_SMALL_PRE_BII_LYMPHOCYTE_DN"
42,"Down",0.288830673608098,0.57818421230238,"L.LvsP.REACTOME_BIOSYNTHESIS_OF_MARESINS"
47,"Down",0.289054223553641,0.578422295341325,"L.LvsP.VALK_AML_CLUSTER_1"
9,"Down",0.289236881132603,0.578578406578206,"L.LvsP.FUJIWARA_PARK2_IN_LIVER_CANCER_UP"
34,"Down",0.289390419004774,0.578636490639692,"L.LvsP.HUMMERICH_BENIGN_SKIN_TUMOR_UP"
115,"Down",0.289475227547366,0.578636490639692,"L.LvsP.MORI_SMALL_PRE_BII_LYMPHOCYTE_UP"
83,"Up",0.290042232085008,0.57956035460716,"L.LvsP.VALK_AML_WITH_FLT3_ITD"
107,"Down",0.290417757082575,0.580101076195648,"L.LvsP.PHONG_TNF_TARGETS_UP"
160,"Up",0.2905371202251,0.580129916115774,"L.LvsP.HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_UP"
6,"Down",0.290890759471303,0.580415530057973,"L.LvsP.BIOCARTA_PELP1_PATHWAY"
430,"Up",0.290920672955843,0.580415530057973,"L.LvsP.TARTE_PLASMA_CELL_VS_PLASMABLAST_DN"
33,"Down",0.290995089405082,0.580415530057973,"L.LvsP.MAHADEVAN_IMATINIB_RESISTANCE_UP"
116,"Up",0.291335339518206,0.580721160099661,"L.LvsP.BAUS_TFF2_TARGETS_UP"
23,"Down",0.291358382730414,0.580721160099661,"L.LvsP.REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_CELL_CYCLE_GENES"
58,"Down",0.29167796736351,0.581148642001026,"L.LvsP.LI_CISPLATIN_RESISTANCE_DN"
7,"Down",0.291830360789092,0.581177676817451,"L.LvsP.REACTOME_CATION_COUPLED_CHLORIDE_COTRANSPORTERS"
89,"Down",0.291902768768685,0.581177676817451,"L.LvsP.PID_DELTA_NP63_PATHWAY"
213,"Down",0.292069561812261,0.581207968855983,"L.LvsP.BROWNE_HCMV_INFECTION_8HR_UP"
154,"Down",0.292282179470093,0.581207968855983,"L.LvsP.LEE_AGING_CEREBELLUM_DN"
449,"Down",0.292339989774182,0.581207968855983,"L.LvsP.CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_4"
39,"Up",0.292424693572129,0.581207968855983,"L.LvsP.ZHENG_FOXP3_TARGETS_UP"
6,"Up",0.292443582810155,0.581207968855983,"L.LvsP.REACTOME_THE_RETINOID_CYCLE_IN_CONES_DAYLIGHT_VISION"
19,"Down",0.292578462118531,0.581267092006237,"L.LvsP.BIOCARTA_SET_PATHWAY"
51,"Down",0.292822044144072,0.581484356621413,"L.LvsP.LE_SKI_TARGETS_UP"
5,"Up",0.292898161184778,0.581484356621413,"L.LvsP.REACTOME_DISEASES_OF_MISMATCH_REPAIR_MMR"
78,"Down",0.293023356689431,0.581524098756591,"L.LvsP.VILIMAS_NOTCH1_TARGETS_UP"
27,"Down",0.293156897024491,0.581580367294013,"L.LvsP.REACTOME_HYALURONAN_METABOLISM"
44,"Down",0.293804337594922,0.582552736467004,"L.LvsP.LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_UP"
28,"Up",0.293882539182053,0.582552736467004,"L.LvsP.REACTOME_CYTOSOLIC_TRNA_AMINOACYLATION"
96,"Up",0.293963128005596,0.582552736467004,"L.LvsP.GRABARCZYK_BCL11B_TARGETS_DN"
41,"Down",0.294180013430012,0.582773663294353,"L.LvsP.ZHANG_RESPONSE_TO_CANTHARIDIN_UP"
102,"Up",0.294440858685516,0.583081485555952,"L.LvsP.REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION"
177,"Down",0.294689284827662,0.583364502618024,"L.LvsP.KEGG_CELL_ADHESION_MOLECULES_CAMS"
31,"Up",0.29489171152013,0.583539887854158,"L.LvsP.REACTOME_RECYCLING_OF_BILE_ACIDS_AND_SALTS"
79,"Up",0.294988964831321,0.583539887854158,"L.LvsP.SPIRA_SMOKERS_LUNG_CANCER_UP"
22,"Up",0.295602790682039,0.584534293175618,"L.LvsP.REACTOME_ACETYLCHOLINE_NEUROTRANSMITTER_RELEASE_CYCLE"
175,"Up",0.295703096041274,0.584534293175618,"L.LvsP.KAN_RESPONSE_TO_ARSENIC_TRIOXIDE"
37,"Down",0.296063012266497,0.585036595718892,"L.LvsP.BIOCARTA_IL2_PATHWAY"
48,"Down",0.296386950602429,0.585467470482611,"L.LvsP.MILICIC_FAMILIAL_ADENOMATOUS_POLYPOSIS_UP"
37,"Up",0.296654874414184,0.585735427057572,"L.LvsP.GAJATE_RESPONSE_TO_TRABECTEDIN_DN"
31,"Down",0.296734478420738,0.585735427057572,"L.LvsP.MATZUK_POSTIMPLANTATION_AND_POSTPARTUM"
29,"Down",0.29700556727073,0.586055415221277,"L.LvsP.LUND_SILENCED_BY_METHYLATION"
258,"Up",0.297108578199537,0.586055415221277,"L.LvsP.REACTOME_FATTY_ACID_METABOLISM"
7,"Up",0.297479217128293,0.586577243759747,"L.LvsP.CALVET_IRINOTECAN_SENSITIVE_VS_REVERTED_DN"
93,"Up",0.297814641303103,0.587029287616704,"L.LvsP.MODY_HIPPOCAMPUS_POSTNATAL"
11,"Down",0.298214738832937,0.587265431621729,"L.LvsP.LINDGREN_BLADDER_CANCER_CLUSTER_2A_UP"
102,"Down",0.298294467041832,0.587265431621729,"L.LvsP.MCCLUNG_CREB1_TARGETS_DN"
48,"Up",0.298453576677886,0.587265431621729,"L.LvsP.IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_DN"
45,"Down",0.298454086008606,0.587265431621729,"L.LvsP.REACTOME_NEGATIVE_REGULATORS_OF_DDX58_IFIH1_SIGNALING"
56,"Down",0.298465520502271,0.587265431621729,"L.LvsP.BOYAULT_LIVER_CANCER_SUBCLASS_G5_DN"
21,"Up",0.298702666889722,0.587522961662495,"L.LvsP.IRITANI_MAD1_TARGETS_UP"
24,"Up",0.299120282404336,0.587625287667567,"L.LvsP.WONG_ENDOMETRIAL_CANCER_LATE"
114,"Down",0.299148120250947,0.587625287667567,"L.LvsP.REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES"
5,"Up",0.299151126231275,0.587625287667567,"L.LvsP.REACTOME_SUMO_IS_CONJUGATED_TO_E1_UBA2_SAE1"
44,"Down",0.299179812766178,0.587625287667567,"L.LvsP.RODRIGUES_NTN1_TARGETS_UP"
183,"Down",0.299608981351449,0.588259253512841,"L.LvsP.REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION"
37,"Down",0.300029530833673,0.588875852317848,"L.LvsP.REACTOME_FERTILIZATION"
935,"Up",0.300437862552313,0.589260670842734,"L.LvsP.FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN"
137,"Down",0.300668679631186,0.589260670842734,"L.LvsP.KIM_MYCN_AMPLIFICATION_TARGETS_UP"
556,"Down",0.300691722522253,0.589260670842734,"L.LvsP.MEISSNER_NPC_HCP_WITH_H3K4ME2_AND_H3K27ME3"
10,"Down",0.300734511169291,0.589260670842734,"L.LvsP.REACTOME_SYNTHESIS_OF_PYROPHOSPHATES_IN_THE_CYTOSOL"
55,"Down",0.300938829486327,0.589260670842734,"L.LvsP.HU_ANGIOGENESIS_DN"
10,"Down",0.300967343965515,0.589260670842734,"L.LvsP.REACTOME_MET_ACTIVATES_PI3K_AKT_SIGNALING"
31,"Down",0.300971628587426,0.589260670842734,"L.LvsP.REACTOME_FRS_MEDIATED_FGFR1_SIGNALING"
67,"Down",0.301153634784847,0.589408299725813,"L.LvsP.LEONARD_HYPOXIA"
138,"Up",0.301908772816447,0.590495197644709,"L.LvsP.REACTOME_GLYCOSAMINOGLYCAN_METABOLISM"
15,"Down",0.301922576187664,0.590495197644709,"L.LvsP.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_9"
90,"Down",0.302535830853876,0.59148536378751,"L.LvsP.KEGG_LONG_TERM_DEPRESSION"
12,"Down",0.302783139426241,0.591759624562633,"L.LvsP.KORKOLA_CHORIOCARCINOMA"
965,"Up",0.302950641104664,0.591877771967381,"L.LvsP.PATIL_LIVER_CANCER"
33,"Down",0.303282320211043,0.592029490279648,"L.LvsP.FIGUEROA_AML_METHYLATION_CLUSTER_4_DN"
32,"Up",0.30331571351925,0.592029490279648,"L.LvsP.DORN_ADENOVIRUS_INFECTION_48HR_UP"
64,"Down",0.303349529021929,0.592029490279648,"L.LvsP.REACTOME_CARGO_TRAFFICKING_TO_THE_PERICILIARY_MEMBRANE"
187,"Down",0.303491445674157,0.592097460526611,"L.LvsP.BRUECKNER_TARGETS_OF_MIRLET7A3_UP"
383,"Up",0.303783292966487,0.592457787235171,"L.LvsP.DELYS_THYROID_CANCER_DN"
60,"Down",0.304030913080807,0.592731635551403,"L.LvsP.LANDIS_BREAST_CANCER_PROGRESSION_UP"
303,"Down",0.304596344900056,0.593428371706944,"L.LvsP.SANSOM_APC_TARGETS_REQUIRE_MYC"
61,"Up",0.304730271494535,0.593428371706944,"L.LvsP.HASLINGER_B_CLL_WITH_11Q23_DELETION"
124,"Down",0.304761290143784,0.593428371706944,"L.LvsP.FONTAINE_FOLLICULAR_THYROID_ADENOMA_UP"
14,"Up",0.304817611800998,0.593428371706944,"L.LvsP.REACTOME_ETHANOL_OXIDATION"
31,"Down",0.304970308000114,0.593516660659144,"L.LvsP.KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_UV_IN_OLD"
151,"Down",0.30575655564473,0.594696549640165,"L.LvsP.KEGG_INSULIN_SIGNALING_PATHWAY"
23,"Down",0.305791696622714,0.594696549640165,"L.LvsP.DING_LUNG_CANCER_MUTATED_FREQUENTLY"
409,"Down",0.306232691119449,0.595344778199519,"L.LvsP.CHEN_HOXA5_TARGETS_9HR_UP"
94,"Down",0.30643888603779,0.595536239333195,"L.LvsP.ONDER_CDH1_TARGETS_3_DN"
70,"Up",0.306719020119746,0.595871209501784,"L.LvsP.VALK_AML_CLUSTER_3"
62,"Down",0.306852241478111,0.59592063334474,"L.LvsP.PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_DN"
7,"Down",0.307177728731661,0.595947502536529,"L.LvsP.WEBER_METHYLATED_HCP_IN_FIBROBLAST_UP"
27,"Down",0.307184223683167,0.595947502536529,"L.LvsP.BIOCARTA_CERAMIDE_PATHWAY"
68,"Down",0.307329874704558,0.595947502536529,"L.LvsP.CERVERA_SDHB_TARGETS_1_DN"
10,"Down",0.307444871086711,0.595947502536529,"L.LvsP.FUNG_IL2_TARGETS_WITH_STAT5_BINDING_SITES_T1"
39,"Up",0.307448300992454,0.595947502536529,"L.LvsP.KANG_FLUOROURACIL_RESISTANCE_UP"
27,"Up",0.30753892343946,0.595947502536529,"L.LvsP.BIOCARTA_BCELLSURVIVAL_PATHWAY"
57,"Down",0.30762057736286,0.595947502536529,"L.LvsP.PID_NETRIN_PATHWAY"
448,"Up",0.307959327924572,0.596394789525379,"L.LvsP.KAAB_HEART_ATRIUM_VS_VENTRICLE_DN"
214,"Down",0.308177937241324,0.596609178924118,"L.LvsP.FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP"
30,"Down",0.308739141963549,0.5973072907104,"L.LvsP.HOLLEMAN_ASPARAGINASE_RESISTANCE_ALL_DN"
12,"Down",0.308754609667268,0.5973072907104,"L.LvsP.REACTOME_MECP2_REGULATES_TRANSCRIPTION_OF_NEURONAL_LIGANDS"
43,"Down",0.309191644811875,0.597612192201792,"L.LvsP.REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS"
19,"Down",0.309276841865386,0.597612192201792,"L.LvsP.MIZUKAMI_HYPOXIA_UP"
111,"Down",0.309277330222364,0.597612192201792,"L.LvsP.MEISSNER_BRAIN_HCP_WITH_H3K4ME2_AND_H3K27ME3"
15,"Down",0.309344563950358,0.597612192201792,"L.LvsP.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_LIGHTYELLOW_UP"
26,"Down",0.309683702007724,0.598058396227981,"L.LvsP.TRAYNOR_RETT_SYNDROM_DN"
11,"Down",0.310079920536633,0.598605299997444,"L.LvsP.KIM_RESPONSE_TO_TSA_AND_DECITABINE_DN"
15,"Up",0.310183430004101,0.598605299997444,"L.LvsP.MANN_RESPONSE_TO_AMIFOSTINE_DN"
11,"Down",0.310583557046846,0.599168348538733,"L.LvsP.BIOCARTA_CACAM_PATHWAY"
96,"Down",0.310697201523746,0.59917852362218,"L.LvsP.REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS"
18,"Down",0.311029267790948,0.599544574407155,"L.LvsP.REACTOME_DEPOLYMERISATION_OF_THE_NUCLEAR_LAMINA"
38,"Down",0.311206332621508,0.599544574407155,"L.LvsP.MALTA_CURATED_STEMNESS_MARKERS"
15,"Down",0.311257681989382,0.599544574407155,"L.LvsP.KANG_CISPLATIN_RESISTANCE_DN"
400,"Down",0.311320758387221,0.599544574407155,"L.LvsP.ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN"
109,"Up",0.311522933128692,0.599725033867875,"L.LvsP.REACTOME_MITOCHONDRIAL_BIOGENESIS"
194,"Up",0.312280694959675,0.600938727910209,"L.LvsP.GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_DN"
28,"Up",0.31237075493108,0.600938727910209,"L.LvsP.REACTOME_MICRORNA_MIRNA_BIOGENESIS"
36,"Up",0.312912614525183,0.601771772420778,"L.LvsP.REACTOME_DIGESTION"
10,"Down",0.31319402747496,0.602103538911354,"L.LvsP.DER_IFN_BETA_RESPONSE_DN"
25,"Down",0.313541716629931,0.602562443950952,"L.LvsP.REACTOME_ABORTIVE_ELONGATION_OF_HIV_1_TRANSCRIPT_IN_THE_ABSENCE_OF_TAT"
59,"Up",0.313666567922413,0.602592930522245,"L.LvsP.YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_5"
12,"Up",0.313928256912542,0.602886187033499,"L.LvsP.REACTOME_IRF3_MEDIATED_ACTIVATION_OF_TYPE_1_IFN"
382,"Down",0.314534808160342,0.603591085007511,"L.LvsP.VERHAAK_GLIOBLASTOMA_MESENCHYMAL"
12,"Up",0.314588436053618,0.603591085007511,"L.LvsP.REACTOME_ASPARTATE_AND_ASPARAGINE_METABOLISM"
30,"Down",0.314622808282085,0.603591085007511,"L.LvsP.PID_INTEGRIN_A9B1_PATHWAY"
14,"Up",0.315197083375781,0.604483064163959,"L.LvsP.REACTOME_DEGRADATION_OF_CYSTEINE_AND_HOMOCYSTEINE"
421,"Up",0.315328950353275,0.604526271325678,"L.LvsP.FORTSCHEGGER_PHF8_TARGETS_UP"
23,"Down",0.315486114945521,0.604617930514311,"L.LvsP.REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_G2_CELL_CYCLE_ARREST"
19,"Up",0.315701564181928,0.604722985640317,"L.LvsP.REACTOME_TRANSPORT_OF_ORGANIC_ANIONS"
39,"Up",0.315759677978585,0.604722985640317,"L.LvsP.ZHAN_V1_LATE_DIFFERENTIATION_GENES_DN"
74,"Up",0.316203295701715,0.605024574683989,"L.LvsP.KENNY_CTNNB1_TARGETS_UP"
10,"Down",0.31632644675214,0.605024574683989,"L.LvsP.PHONG_TNF_TARGETS_DN"
74,"Up",0.3163717245866,0.605024574683989,"L.LvsP.JIANG_HYPOXIA_CANCER"
701,"Down",0.316415367360804,0.605024574683989,"L.LvsP.ENK_UV_RESPONSE_KERATINOCYTE_DN"
90,"Down",0.316464291912841,0.605024574683989,"L.LvsP.ZHAN_MULTIPLE_MYELOMA_MF_UP"
9,"Up",0.316802698389902,0.605121633909918,"L.LvsP.REACTOME_DEFECTIVE_CHSY1_CAUSES_TPBS"
25,"Down",0.316843504287833,0.605121633909918,"L.LvsP.KANG_FLUOROURACIL_RESISTANCE_DN"
81,"Down",0.31690351475571,0.605121633909918,"L.LvsP.BOYAULT_LIVER_CANCER_SUBCLASS_G123_DN"
15,"Up",0.316952839899281,0.605121633909918,"L.LvsP.RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_SMAD4_DN"
14,"Up",0.317132000134834,0.605231114319656,"L.LvsP.BIOCARTA_ASBCELL_PATHWAY"
19,"Down",0.317338924625832,0.605231114319656,"L.LvsP.REACTOME_REGULATION_OF_RUNX1_EXPRESSION_AND_ACTIVITY"
229,"Down",0.317466824969749,0.605231114319656,"L.LvsP.MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_DN"
107,"Down",0.317575360015619,0.605231114319656,"L.LvsP.BERNARD_PPAPDC1B_TARGETS_DN"
338,"Down",0.317686594741188,0.605231114319656,"L.LvsP.MIKKELSEN_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3"
201,"Down",0.317819927065298,0.605231114319656,"L.LvsP.CHENG_IMPRINTED_BY_ESTRADIOL"
12,"Up",0.317838826809164,0.605231114319656,"L.LvsP.TESAR_JAK_TARGETS_MOUSE_ES_D3_DN"
97,"Up",0.317885902692038,0.605231114319656,"L.LvsP.ABRAMSON_INTERACT_WITH_AIRE"
21,"Down",0.318107974292169,0.605262548755066,"L.LvsP.REACTOME_ERYTHROPOIETIN_ACTIVATES_RAS"
29,"Down",0.318264138053966,0.605262548755066,"L.LvsP.TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_DN"
37,"Down",0.318353234224297,0.605262548755066,"L.LvsP.BIOCARTA_LIS1_PATHWAY"
140,"Up",0.318371905891544,0.605262548755066,"L.LvsP.WARTERS_RESPONSE_TO_IR_SKIN"
25,"Down",0.318449765658977,0.605262548755066,"L.LvsP.ONDER_CDH1_TARGETS_3_UP"
317,"Down",0.318649025541353,0.60543314852857,"L.LvsP.TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP"
52,"Up",0.318889698937781,0.605682289737888,"L.LvsP.LEIN_LOCALIZED_TO_PROXIMAL_DENDRITES"
34,"Up",0.319088325709229,0.605698332869392,"L.LvsP.YANAGISAWA_LUNG_CANCER_RECURRENCE"
80,"Up",0.319117244284417,0.605698332869392,"L.LvsP.HOQUE_METHYLATED_IN_CANCER"
151,"Up",0.319555905205628,0.606151786933223,"L.LvsP.SMITH_TERT_TARGETS_DN"
12,"Up",0.319575413078377,0.606151786933223,"L.LvsP.OHM_EMBRYONIC_CARCINOMA_UP"
16,"Down",0.319988007825387,0.606726232944639,"L.LvsP.BIOCARTA_PRC2_PATHWAY"
99,"Up",0.32014975651616,0.606824821315683,"L.LvsP.REACTOME_TRANS_GOLGI_NETWORK_VESICLE_BUDDING"
438,"Down",0.320297812355492,0.606897397023138,"L.LvsP.OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN"
46,"Up",0.32076800383401,0.607548560389431,"L.LvsP.STAEGE_EWING_FAMILY_TUMOR"
298,"Down",0.320861240068211,0.607548560389431,"L.LvsP.VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP"
51,"Down",0.321052904003762,0.607703357150564,"L.LvsP.PID_EPO_PATHWAY"
23,"Down",0.321261823997022,0.607890699821881,"L.LvsP.WANG_RECURRENT_LIVER_CANCER_DN"
675,"Up",0.321496869652395,0.608127332298355,"L.LvsP.STARK_PREFRONTAL_CORTEX_22Q11_DELETION_DN"
14,"Down",0.321768781127997,0.608433512604888,"L.LvsP.FUJIWARA_PARK2_HEPATOCYTE_PROLIFERATION_DN"
96,"Down",0.322298696237879,0.609165987640629,"L.LvsP.REACTOME_GLOBAL_GENOME_NUCLEOTIDE_EXCISION_REPAIR_GG_NER"
48,"Down",0.322376502050367,0.609165987640629,"L.LvsP.WIKMAN_ASBESTOS_LUNG_CANCER_DN"
125,"Up",0.322841065559708,0.609835412189827,"L.LvsP.TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP"
110,"Up",0.323118482773685,0.609892441981164,"L.LvsP.STEARMAN_LUNG_CANCER_EARLY_VS_LATE_DN"
192,"Down",0.323348586633375,0.609892441981164,"L.LvsP.KEGG_JAK_STAT_SIGNALING_PATHWAY"
291,"Down",0.323370794071645,0.609892441981164,"L.LvsP.SHEPARD_BMYB_MORPHOLINO_UP"
39,"Down",0.32343587465806,0.609892441981164,"L.LvsP.REACTOME_TRANSCRIPTIONAL_REGULATION_BY_E2F6"
18,"Down",0.323624891137246,0.609892441981164,"L.LvsP.PARK_TRETINOIN_RESPONSE"
22,"Down",0.323728199993537,0.609892441981164,"L.LvsP.REACTOME_FGFR2_LIGAND_BINDING_AND_ACTIVATION"
173,"Down",0.323874024738829,0.609892441981164,"L.LvsP.KIM_WT1_TARGETS_8HR_DN"
133,"Up",0.324299521159973,0.609892441981164,"L.LvsP.VANTVEER_BREAST_CANCER_METASTASIS_UP"
33,"Down",0.324517858895407,0.609892441981164,"L.LvsP.YORDY_RECIPROCAL_REGULATION_BY_ETS1_AND_SP100_UP"
246,"Down",0.324652368806574,0.609892441981164,"L.LvsP.REACTOME_MUSCLE_CONTRACTION"
30,"Down",0.324718436406476,0.609892441981164,"L.LvsP.STEGER_ADIPOGENESIS_DN"
135,"Up",0.324733937712768,0.609892441981164,"L.LvsP.CORRE_MULTIPLE_MYELOMA_UP"
5,"Down",0.324751633348205,0.609892441981164,"L.LvsP.REACTOME_ARACHIDONATE_PRODUCTION_FROM_DAG"
51,"Down",0.324769985368828,0.609892441981164,"L.LvsP.NIKOLSKY_BREAST_CANCER_20Q11_AMPLICON"
98,"Down",0.324864304646744,0.609892441981164,"L.LvsP.REACTOME_CLASS_B_2_SECRETIN_FAMILY_RECEPTORS"
11,"Up",0.32488098221227,0.609892441981164,"L.LvsP.REACTOME_ABACAVIR_METABOLISM"
36,"Down",0.324906223443758,0.609892441981164,"L.LvsP.REACTOME_SIGNAL_AMPLIFICATION"
15,"Up",0.324958321303253,0.609892441981164,"L.LvsP.MCCABE_HOXC6_TARGETS_UP"
31,"Down",0.324967106904776,0.609892441981164,"L.LvsP.MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_DN"
45,"Down",0.325110338033079,0.609954210717643,"L.LvsP.MEISSNER_ES_ICP_WITH_H3K4ME3"
94,"Up",0.325451431714939,0.61021675209134,"L.LvsP.ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_UP"
12,"Down",0.325515218107959,0.61021675209134,"L.LvsP.REACTOME_ACTIVATION_OF_PPARGC1A_PGC_1ALPHA_BY_PHOSPHORYLATION"
253,"Down",0.325581374329798,0.61021675209134,"L.LvsP.BROWNE_HCMV_INFECTION_24HR_UP"
13,"Down",0.325803772698922,0.610426655117703,"L.LvsP.REACTOME_INTERLEUKIN_27_SIGNALING"
5,"Up",0.326058542168196,0.610589604690774,"L.LvsP.REACTOME_G2_PHASE"
41,"Down",0.326111611982611,0.610589604690774,"L.LvsP.REACTOME_INFECTION_WITH_MYCOBACTERIUM_TUBERCULOSIS"
50,"Down",0.326294066224141,0.610724404926634,"L.LvsP.LOPEZ_MESOTHELIOMA_SURVIVAL_OVERALL_DN"
454,"Up",0.326788937145064,0.611058379121659,"L.LvsP.DOUGLAS_BMI1_TARGETS_DN"
31,"Down",0.326793414441683,0.611058379121659,"L.LvsP.REACTOME_EICOSANOIDS"
305,"Down",0.326804056260218,0.611058379121659,"L.LvsP.REACTOME_FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS"
172,"Down",0.327404621292096,0.61197435805409,"L.LvsP.KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP"
17,"Down",0.327724001949064,0.612190887384245,"L.LvsP.CONRAD_GERMLINE_STEM_CELL"
82,"Up",0.327741911133544,0.612190887384245,"L.LvsP.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_DN"
21,"Up",0.327946426568482,0.612366022457661,"L.LvsP.SCHWAB_TARGETS_OF_BMYB_POLYMORPHIC_VARIANTS_UP"
233,"Up",0.328174449919728,0.612401876578626,"L.LvsP.REACTOME_CELLULAR_SENESCENCE"
34,"Down",0.328223054823471,0.612401876578626,"L.LvsP.LEE_DOUBLE_POLAR_THYMOCYTE"
12,"Up",0.328297913217408,0.612401876578626,"L.LvsP.REACTOME_HDL_REMODELING"
94,"Down",0.328867736249507,0.612756871797811,"L.LvsP.MCDOWELL_ACUTE_LUNG_INJURY_UP"
818,"Down",0.328877040191853,0.612756871797811,"L.LvsP.LIAO_METASTASIS"
70,"Down",0.328890989891006,0.612756871797811,"L.LvsP.WANG_TARGETS_OF_MLL_CBP_FUSION_UP"
93,"Down",0.328931523873377,0.612756871797811,"L.LvsP.REACTOME_FOXO_MEDIATED_TRANSCRIPTION"
117,"Down",0.329236123697561,0.613117725807954,"L.LvsP.REACTOME_ARACHIDONIC_ACID_METABOLISM"
6,"Down",0.329433787193698,0.613279262422208,"L.LvsP.REACTOME_TNFR1_MEDIATED_CERAMIDE_PRODUCTION"
31,"Down",0.329760490007265,0.613555876071805,"L.LvsP.INAMURA_LUNG_CANCER_SCC_UP"
13,"Down",0.329804316094303,0.613555876071805,"L.LvsP.REACTOME_CREATINE_METABOLISM"
8,"Down",0.32992097042881,0.613566446518968,"L.LvsP.CHOI_ATL_ACUTE_STAGE"
32,"Up",0.33006377787442,0.613625631428268,"L.LvsP.FINAK_BREAST_CANCER_SDPP_SIGNATURE"
281,"Down",0.330394403437309,0.614033834152902,"L.LvsP.REACTOME_INTERFERON_SIGNALING"
85,"Up",0.330546502984968,0.61411008568679,"L.LvsP.SASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION"
11,"Up",0.330899326407865,0.61455907816899,"L.LvsP.REACTOME_PYRIMIDINE_SALVAGE"
144,"Down",0.331150770876574,0.61480854787924,"L.LvsP.NEMETH_INFLAMMATORY_RESPONSE_LPS_UP"
107,"Up",0.331256043431408,0.61480854787924,"L.LvsP.JOHNSTONE_PARVB_TARGETS_1_DN"
16,"Up",0.331816711745665,0.615365522605161,"L.LvsP.REACTOME_DEFECTIVE_GALNT3_CAUSES_FAMILIAL_HYPERPHOSPHATEMIC_TUMORAL_CALCINOSIS_HFTC"
26,"Up",0.331881209508315,0.615365522605161,"L.LvsP.WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_UP"
369,"Down",0.332074555748704,0.615365522605161,"L.LvsP.HAMAI_APOPTOSIS_VIA_TRAIL_DN"
759,"Up",0.332093785980209,0.615365522605161,"L.LvsP.FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN"
38,"Down",0.332112627862868,0.615365522605161,"L.LvsP.REACTOME_TAK1_ACTIVATES_NFKB_BY_PHOSPHORYLATION_AND_ACTIVATION_OF_IKKS_COMPLEX"
575,"Up",0.332559510228209,0.615987112915165,"L.LvsP.LINDGREN_BLADDER_CANCER_CLUSTER_1_DN"
72,"Down",0.332927256039834,0.616457921208432,"L.LvsP.PARK_HSC_AND_MULTIPOTENT_PROGENITORS"
574,"Down",0.333048062982486,0.616457921208432,"L.LvsP.WANG_LMO4_TARGETS_DN"
147,"Up",0.33314817662702,0.616457921208432,"L.LvsP.KYNG_DNA_DAMAGE_BY_GAMMA_AND_UV_RADIATION"
31,"Down",0.333422062545371,0.616629711810498,"L.LvsP.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_PURPLE_DN"
59,"Down",0.333464069146932,0.616629711810498,"L.LvsP.WENG_POR_TARGETS_GLOBAL_DN"
1198,"Up",0.333809250783522,0.616801026918565,"L.LvsP.FEVR_CTNNB1_TARGETS_UP"
12,"Down",0.333850316832237,0.616801026918565,"L.LvsP.REACTOME_ACTIVATED_NTRK2_SIGNALS_THROUGH_PI3K"
373,"Down",0.333891386067511,0.616801026918565,"L.LvsP.MEISSNER_BRAIN_HCP_WITH_H3K27ME3"
89,"Up",0.334139063642771,0.617052399091811,"L.LvsP.REACTOME_PI_METABOLISM"
9,"Down",0.334478597314683,0.617473176812315,"L.LvsP.BIOCARTA_CIRCADIAN_PATHWAY"
37,"Down",0.334815740848744,0.617697468748313,"L.LvsP.BIOCARTA_PTDINS_PATHWAY"
470,"Up",0.334931148263888,0.617697468748313,"L.LvsP.HOSHIDA_LIVER_CANCER_SUBCLASS_S3"
52,"Down",0.335102318504571,0.617697468748313,"L.LvsP.REACTOME_TRANSCRIPTIONAL_REGULATION_BY_VENTX"
66,"Up",0.335104355545341,0.617697468748313,"L.LvsP.WEBER_METHYLATED_HCP_IN_FIBROBLAST_DN"
232,"Down",0.335158691670273,0.617697468748313,"L.LvsP.SMITH_TERT_TARGETS_UP"
59,"Up",0.335416129859219,0.617965938684312,"L.LvsP.CAFFAREL_RESPONSE_TO_THC_UP"
11,"Up",0.335961075772281,0.618596561756731,"L.LvsP.REACTOME_BICARBONATE_TRANSPORTERS"
10,"Up",0.336017420189207,0.618596561756731,"L.LvsP.BIOCARTA_LDL_PATHWAY"
106,"Up",0.33609406249181,0.618596561756731,"L.LvsP.WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER"
49,"Up",0.336320039429977,0.618685589749697,"L.LvsP.REACTOME_METABOLISM_OF_PORPHYRINS"
74,"Up",0.336366229478674,0.618685589749697,"L.LvsP.PLASARI_NFIC_TARGETS_BASAL_UP"
26,"Down",0.336992600836055,0.619499373568112,"L.LvsP.REACTOME_UNBLOCKING_OF_NMDA_RECEPTORS_GLUTAMATE_BINDING_AND_ACTIVATION"
85,"Up",0.337032757405115,0.619499373568112,"L.LvsP.WINTER_HYPOXIA_DN"
85,"Up",0.337439415639633,0.619916143102868,"L.LvsP.HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_DN"
134,"Up",0.337534916346028,0.619916143102868,"L.LvsP.SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM3"
7,"Down",0.337595859447049,0.619916143102868,"L.LvsP.STONER_ESOPHAGEAL_CARCINOGENESIS_DN"
102,"Up",0.337849542336906,0.62017600251685,"L.LvsP.KEGG_CARDIAC_MUSCLE_CONTRACTION"
29,"Down",0.338361638233355,0.620909889741859,"L.LvsP.BIOCARTA_CK1_PATHWAY"
29,"Down",0.338988596857054,0.621767286309227,"L.LvsP.ELLWOOD_MYC_TARGETS_UP"
7,"Up",0.3390537833645,0.621767286309227,"L.LvsP.REACTOME_APEX1_INDEPENDENT_RESOLUTION_OF_AP_SITES_VIA_THE_SINGLE_NUCLEOTIDE_REPLACEMENT_PATHWAY"
260,"Down",0.339230024907935,0.621884220064978,"L.LvsP.SCHLOSSER_SERUM_RESPONSE_UP"
37,"Down",0.339489420911829,0.621953924760053,"L.LvsP.DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_UP"
17,"Down",0.339493026754538,0.621953924760053,"L.LvsP.MURAKAMI_UV_RESPONSE_1HR_DN"
504,"Down",0.339616811863164,0.6219746117229,"L.LvsP.OISHI_CHOLANGIOMA_STEM_CELL_LIKE_DN"
6,"Up",0.340017434047455,0.622297674576519,"L.LvsP.REACTOME_METHIONINE_SALVAGE_PATHWAY"
20,"Up",0.340018317036655,0.622297674576519,"L.LvsP.HEDVAT_ELF4_TARGETS_UP"
330,"Down",0.34032806433576,0.622658460526941,"L.LvsP.SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4"
72,"Down",0.340624819916032,0.622995246217578,"L.LvsP.ALONSO_METASTASIS_EMT_UP"
614,"Up",0.340872162182772,0.623099175207749,"L.LvsP.RUTELLA_RESPONSE_TO_HGF_UP"
194,"Down",0.340907036535258,0.623099175207749,"L.LvsP.FIGUEROA_AML_METHYLATION_CLUSTER_6_UP"
381,"Down",0.341133278287047,0.62330664099441,"L.LvsP.SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM1"
204,"Down",0.341382622008801,0.623556166860476,"L.LvsP.GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_UP"
15,"Up",0.341572417239217,0.623617554347234,"L.LvsP.REACTOME_APOPTOSIS_INDUCED_DNA_FRAGMENTATION"
9,"Down",0.341641810837,0.623617554347234,"L.LvsP.REACTOME_SERINE_BIOSYNTHESIS"
19,"Up",0.342102075335083,0.624166255648301,"L.LvsP.REACTOME_METABOLISM_OF_FOLATE_AND_PTERINES"
67,"Down",0.342168189703382,0.624166255648301,"L.LvsP.REACTOME_NEUROTRANSMITTER_RELEASE_CYCLE"
4,"Down",0.342346535453588,0.624167397234504,"L.LvsP.IGARASHI_ATF4_TARGETS_UP"
154,"Up",0.342445352114655,0.624167397234504,"L.LvsP.ANDERSEN_LIVER_CANCER_KRT19_DN"
37,"Down",0.342715206008227,0.624167397234504,"L.LvsP.KEGG_ETHER_LIPID_METABOLISM"
22,"Up",0.34272158422928,0.624167397234504,"L.LvsP.KIM_PTEN_TARGETS_UP"
10,"Up",0.3427777732152,0.624167397234504,"L.LvsP.FERRARI_RESPONSE_TO_FENRETINIDE_DN"
12,"Up",0.342887235920681,0.624167397234504,"L.LvsP.REACTOME_REGULATION_OF_SIGNALING_BY_NODAL"
6,"Up",0.342959043732759,0.624167397234504,"L.LvsP.ISHIDA_TARGETS_OF_SYT_SSX_FUSIONS"
27,"Down",0.343102003355187,0.624222104820937,"L.LvsP.REACTOME_SIGNALING_BY_NTRK3_TRKC"
10,"Down",0.343663922856805,0.624845125866021,"L.LvsP.BIOCARTA_FBW7_PATHWAY"
32,"Up",0.343670469842389,0.624845125866021,"L.LvsP.KEGG_PROXIMAL_TUBULE_BICARBONATE_RECLAMATION"
60,"Down",0.343857443598965,0.624979554785891,"L.LvsP.REACTOME_BIOSYNTHESIS_OF_SPECIALIZED_PRORESOLVING_MEDIATORS_SPMS"
7,"Up",0.344104683286942,0.625223395955801,"L.LvsP.REACTOME_ELECTRIC_TRANSMISSION_ACROSS_GAP_JUNCTIONS"
41,"Down",0.344265814077614,0.625310672153458,"L.LvsP.LU_TUMOR_ANGIOGENESIS_UP"
256,"Down",0.344921219036476,0.626295376043571,"L.LvsP.BROWNE_HCMV_INFECTION_6HR_DN"
95,"Up",0.345289974754182,0.626533323700297,"L.LvsP.BORLAK_LIVER_CANCER_EGF_UP"
41,"Down",0.345483615075626,0.626533323700297,"L.LvsP.HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_DN"
10,"Down",0.345521996756368,0.626533323700297,"L.LvsP.BIOCARTA_STAT3_PATHWAY"
12,"Up",0.345669223743295,0.626533323700297,"L.LvsP.MIKKELSEN_PLURIPOTENT_STATE_UP"
8,"Up",0.345826053215525,0.626533323700297,"L.LvsP.REACTOME_DEFECTIVE_CHST6_CAUSES_MCDC1"
81,"Up",0.345877098734507,0.626533323700297,"L.LvsP.RASHI_RESPONSE_TO_IONIZING_RADIATION_1"
28,"Down",0.345948477236802,0.626533323700297,"L.LvsP.LEE_INTRATHYMIC_T_PROGENITOR"
1244,"Up",0.346031374008536,0.626533323700297,"L.LvsP.NUYTTEN_NIPP1_TARGETS_UP"
69,"Up",0.34607212345464,0.626533323700297,"L.LvsP.REACTOME_THE_ROLE_OF_NEF_IN_HIV_1_REPLICATION_AND_DISEASE_PATHOGENESIS"
26,"Down",0.346250087703202,0.626650322393126,"L.LvsP.SCIBETTA_KDM5B_TARGETS_UP"
87,"Up",0.346388047067064,0.62669486656865,"L.LvsP.LIM_MAMMARY_LUMINAL_PROGENITOR_UP"
17,"Down",0.346576588659224,0.626708688262125,"L.LvsP.SANDERSON_PPARA_TARGETS"
27,"Up",0.346742180606687,0.626708688262125,"L.LvsP.ABE_VEGFA_TARGETS"
169,"Down",0.346829228553357,0.626708688262125,"L.LvsP.RAMALHO_STEMNESS_DN"
227,"Up",0.346959304287594,0.626708688262125,"L.LvsP.SUNG_METASTASIS_STROMA_UP"
199,"Down",0.346962433490751,0.626708688262125,"L.LvsP.WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN"
151,"Up",0.347721343857361,0.627874366488357,"L.LvsP.CHANG_IMMORTALIZED_BY_HPV31_DN"
11,"Down",0.348897743479369,0.629724225504513,"L.LvsP.REACTOME_SPERM_MOTILITY_AND_TAXES"
296,"Down",0.348973598651804,0.629724225504513,"L.LvsP.SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP"
86,"Up",0.34911747141811,0.629776205118141,"L.LvsP.PID_HNF3A_PATHWAY"
77,"Down",0.349230212496332,0.629776205118141,"L.LvsP.ASTON_MAJOR_DEPRESSIVE_DISORDER_UP"
21,"Down",0.349498917281463,0.62978067210251,"L.LvsP.KYNG_NORMAL_AGING_UP"
39,"Down",0.349545215076993,0.62978067210251,"L.LvsP.MARSON_FOXP3_TARGETS_STIMULATED_UP"
9,"Up",0.349725073075603,0.62978067210251,"L.LvsP.REACTOME_ABACAVIR_TRANSMEMBRANE_TRANSPORT"
55,"Down",0.349760000649004,0.62978067210251,"L.LvsP.NAKAYAMA_FRA2_TARGETS"
209,"Up",0.349930204589828,0.62978067210251,"L.LvsP.YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_14"
587,"Down",0.350041459363721,0.62978067210251,"L.LvsP.DELACROIX_RARG_BOUND_MEF"
68,"Down",0.350161894766422,0.62978067210251,"L.LvsP.DIRMEIER_LMP1_RESPONSE_LATE_DN"
51,"Down",0.350323277555369,0.62978067210251,"L.LvsP.XU_AKT1_TARGETS_6HR"
121,"Down",0.35036647353663,0.62978067210251,"L.LvsP.PEART_HDAC_PROLIFERATION_CLUSTER_DN"
97,"Down",0.350371739444262,0.62978067210251,"L.LvsP.AUNG_GASTRIC_CANCER"
89,"Up",0.350700305750801,0.630005955207892,"L.LvsP.LANDIS_ERBB2_BREAST_PRENEOPLASTIC_DN"
833,"Down",0.350724964754909,0.630005955207892,"L.LvsP.RODWELL_AGING_KIDNEY_UP"
23,"Down",0.351211195786909,0.630404648836153,"L.LvsP.REACTOME_SYNAPTIC_ADHESION_LIKE_MOLECULES"
341,"Up",0.351215160925594,0.630404648836153,"L.LvsP.LEE_LIVER_CANCER_SURVIVAL_UP"
80,"Down",0.351288971435013,0.630404648836153,"L.LvsP.KERLEY_RESPONSE_TO_CISPLATIN_UP"
64,"Down",0.351868464059268,0.631239694284131,"L.LvsP.REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS"
139,"Up",0.35200848853247,0.631286063281228,"L.LvsP.MIKKELSEN_MCV6_ICP_WITH_H3K27ME3"
797,"Down",0.352564782324527,0.631728655169325,"L.LvsP.KIM_ALL_DISORDERS_CALB1_CORR_UP"
17,"Down",0.352715869139161,0.631728655169325,"L.LvsP.REACTOME_INTERLEUKIN_2_SIGNALING"
927,"Down",0.352782690635756,0.631728655169325,"L.LvsP.REACTOME_HEMOSTASIS"
35,"Up",0.352783415472498,0.631728655169325,"L.LvsP.MARKS_HDAC_TARGETS_UP"
29,"Up",0.352826566678039,0.631728655169325,"L.LvsP.IVANOVA_HEMATOPOIESIS_STEM_CELL_SHORT_TERM"
6,"Down",0.353533016060518,0.632788619552802,"L.LvsP.BIOCARTA_TERC_PATHWAY"
60,"Down",0.353957130590914,0.633206368788854,"L.LvsP.NOUSHMEHR_GBM_SILENCED_BY_METHYLATION"
33,"Down",0.354192716346066,0.633206368788854,"L.LvsP.MACLACHLAN_BRCA1_TARGETS_UP"
27,"Up",0.354358624634588,0.633206368788854,"L.LvsP.TERAMOTO_OPN_TARGETS_CLUSTER_7"
25,"Down",0.354418809911365,0.633206368788854,"L.LvsP.REACTOME_ACYL_CHAIN_REMODELLING_OF_PS"
56,"Up",0.354569988926798,0.633206368788854,"L.LvsP.LIAN_NEUTROPHIL_GRANULE_CONSTITUENTS"
14,"Down",0.354607337752185,0.633206368788854,"L.LvsP.CAFFAREL_RESPONSE_TO_THC_24HR_3_UP"
70,"Up",0.354703979545476,0.633206368788854,"L.LvsP.ROZANOV_MMP14_TARGETS_SUBSET"
41,"Down",0.354788368530097,0.633206368788854,"L.LvsP.REACTOME_PERK_REGULATES_GENE_EXPRESSION"
34,"Up",0.354988283115522,0.633206368788854,"L.LvsP.REACTOME_IRF3_MEDIATED_INDUCTION_OF_TYPE_I_IFN"
568,"Down",0.355104869553135,0.633206368788854,"L.LvsP.DAVICIONI_MOLECULAR_ARMS_VS_ERMS_UP"
632,"Up",0.35511733843069,0.633206368788854,"L.LvsP.ZHOU_INFLAMMATORY_RESPONSE_LIVE_DN"
271,"Down",0.35514070349326,0.633206368788854,"L.LvsP.PHONG_TNF_RESPONSE_VIA_P38_PARTIAL"
638,"Down",0.355302028342659,0.633289785527584,"L.LvsP.PEREZ_TP63_TARGETS"
18,"Down",0.355452502194786,0.63335381393328,"L.LvsP.REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION_IN_TLR7_8_OR_9_SIGNALING"
8,"Up",0.355700557679211,0.633591618366095,"L.LvsP.REACTOME_GLYCEROPHOSPHOLIPID_CATABOLISM"
291,"Down",0.355828730477858,0.633615797362988,"L.LvsP.DARWICHE_PAPILLOMA_RISK_LOW_DN"
565,"Down",0.356247195215112,0.633981011756057,"L.LvsP.ZHOU_INFLAMMATORY_RESPONSE_LPS_UP"
837,"Down",0.356263158532477,0.633981011756057,"L.LvsP.GRYDER_PAX3FOXO1_ENHANCERS_KO_DOWN"
12,"Down",0.356924722656496,0.634662322425964,"L.LvsP.REACTOME_HYALURONAN_BIOSYNTHESIS_AND_EXPORT"
39,"Down",0.357094238836929,0.634662322425964,"L.LvsP.CHEOK_RESPONSE_TO_HD_MTX_DN"
358,"Down",0.357102556781891,0.634662322425964,"L.LvsP.BROWNE_HCMV_INFECTION_18HR_DN"
11,"Up",0.35710517002481,0.634662322425964,"L.LvsP.REACTOME_CHYLOMICRON_REMODELING"
28,"Down",0.357493265678468,0.634981470922694,"L.LvsP.REACTOME_MECP2_REGULATES_NEURONAL_RECEPTORS_AND_CHANNELS"
66,"Up",0.357618970545982,0.634981470922694,"L.LvsP.RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_UP"
32,"Down",0.357654435821456,0.634981470922694,"L.LvsP.REACTOME_CASPASE_ACTIVATION_VIA_EXTRINSIC_APOPTOTIC_SIGNALLING_PATHWAY"
30,"Up",0.357744127676649,0.634981470922694,"L.LvsP.AMIT_SERUM_RESPONSE_20_MCF10A"
5,"Up",0.357886742970512,0.635030745148896,"L.LvsP.REACTOME_GALACTOSE_CATABOLISM"
108,"Up",0.358341393598771,0.635391000550488,"L.LvsP.GAVIN_FOXP3_TARGETS_CLUSTER_P2"
91,"Down",0.358394149875776,0.635391000550488,"L.LvsP.PID_TCR_PATHWAY"
699,"Down",0.358434532594859,0.635391000550488,"L.LvsP.GARY_CD5_TARGETS_UP"
33,"Down",0.358554958139278,0.63540075754874,"L.LvsP.REACTOME_SYNTHESIS_OF_PROSTAGLANDINS_PG_AND_THROMBOXANES_TX"
41,"Up",0.358729908182781,0.635507101038961,"L.LvsP.CROONQUIST_IL6_DEPRIVATION_UP"
89,"Down",0.35908859380319,0.635860684313562,"L.LvsP.LINDGREN_BLADDER_CANCER_HIGH_RECURRENCE"
43,"Up",0.359162717354186,0.635860684313562,"L.LvsP.NEWMAN_ERCC6_TARGETS_UP"
53,"Up",0.359274512171382,0.635860684313562,"L.LvsP.REACTOME_INOSITOL_PHOSPHATE_METABOLISM"
108,"Down",0.359456804023716,0.635930351503458,"L.LvsP.LIN_NPAS4_TARGETS_DN"
108,"Up",0.359633033909018,0.635930351503458,"L.LvsP.LEE_LIVER_CANCER_DENA_UP"
92,"Down",0.359697414708349,0.635930351503458,"L.LvsP.YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_2"
77,"Up",0.35977394456553,0.635930351503458,"L.LvsP.VARELA_ZMPSTE24_TARGETS_DN"
12,"Down",0.360006017098835,0.636118460096277,"L.LvsP.REACTOME_COHESIN_LOADING_ONTO_CHROMATIN"
831,"Up",0.360110468457469,0.636118460096277,"L.LvsP.REACTOME_CELL_CYCLE"
237,"Up",0.36028888156419,0.636230350101695,"L.LvsP.LENAOUR_DENDRITIC_CELL_MATURATION_DN"
192,"Up",0.36041526802189,0.636250324678489,"L.LvsP.LE_EGR2_TARGETS_UP"
55,"Up",0.360554604621575,0.636293140425372,"L.LvsP.NABA_BASEMENT_MEMBRANES"
160,"Up",0.360973819776926,0.636668775764831,"L.LvsP.HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS"
30,"Down",0.360997759454286,0.636668775764831,"L.LvsP.CAIRO_PML_TARGETS_BOUND_BY_MYC_UP"
55,"Up",0.361323508702188,0.636727381185481,"L.LvsP.REACTOME_DNA_DAMAGE_BYPASS"
48,"Up",0.361327941328491,0.636727381185481,"L.LvsP.PIEPOLI_LGI1_TARGETS_DN"
26,"Down",0.361475164073897,0.636727381185481,"L.LvsP.FOURNIER_ACINAR_DEVELOPMENT_LATE_UP"
93,"Up",0.361549860347225,0.636727381185481,"L.LvsP.WATANABE_COLON_CANCER_MSI_VS_MSS_DN"
17,"Down",0.361606796332503,0.636727381185481,"L.LvsP.REACTOME_RETINOID_CYCLE_DISEASE_EVENTS"
18,"Down",0.361915473983013,0.637068021538388,"L.LvsP.REACTOME_WNT5A_DEPENDENT_INTERNALIZATION_OF_FZD2_FZD5_AND_ROR2"
88,"Down",0.362052078161855,0.637080648161823,"L.LvsP.KEGG_LEISHMANIA_INFECTION"
9,"Down",0.362247493176734,0.637080648161823,"L.LvsP.RODRIGUES_DCC_TARGETS_UP"
752,"Up",0.362268322991639,0.637080648161823,"L.LvsP.REACTOME_MEMBRANE_TRAFFICKING"
60,"Down",0.362426889633681,0.637082853401655,"L.LvsP.PID_ER_NONGENOMIC_PATHWAY"
20,"Down",0.362500028359849,0.637082853401655,"L.LvsP.BIOCARTA_AKAPCENTROSOME_PATHWAY"
1597,"Down",0.362715522360082,0.637183478080197,"L.LvsP.REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION"
55,"Down",0.362855449167162,0.637183478080197,"L.LvsP.REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA"
5,"Up",0.362903976956254,0.637183478080197,"L.LvsP.REACTOME_DOPAMINE_RECEPTORS"
34,"Down",0.363019651468861,0.637183478080197,"L.LvsP.WANG_TNF_TARGETS"
1584,"Down",0.363169877118689,0.637183478080197,"L.LvsP.GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS"
8,"Down",0.363351746077724,0.637183478080197,"L.LvsP.HOLLEMAN_DAUNORUBICIN_ALL_UP"
29,"Up",0.363363991026743,0.637183478080197,"L.LvsP.YAN_ESCAPE_FROM_ANOIKIS"
31,"Up",0.364152036312018,0.638362907028898,"L.LvsP.BOYAULT_LIVER_CANCER_SUBCLASS_G6_DN"
27,"Down",0.364270316485686,0.638367854151935,"L.LvsP.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_CYAN_UP"
41,"Down",0.365063639340714,0.639525689983083,"L.LvsP.REACTOME_MISCELLANEOUS_SUBSTRATES"
53,"Up",0.36516234459696,0.639525689983083,"L.LvsP.BOQUEST_STEM_CELL_CULTURED_VS_FRESH_DN"
990,"Up",0.365393166992539,0.639720384974075,"L.LvsP.REACTOME_VESICLE_MEDIATED_TRANSPORT"
9,"Up",0.365504918815899,0.639720384974075,"L.LvsP.REACTOME_DNA_DAMAGE_REVERSAL"
144,"Down",0.365645874040829,0.639764568851818,"L.LvsP.YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_9"
80,"Down",0.365914567267235,0.640032155147277,"L.LvsP.HU_GENOTOXIC_DAMAGE_24HR"
9,"Up",0.366193944632741,0.640318254229736,"L.LvsP.BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_AND_PAX3"
103,"Up",0.366547985948419,0.640398205142655,"L.LvsP.NAGASHIMA_NRG1_SIGNALING_DN"
68,"Down",0.366616326997937,0.640398205142655,"L.LvsP.REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_DNA_REPAIR_GENES"
38,"Down",0.366770848813355,0.640398205142655,"L.LvsP.KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_OLD"
73,"Down",0.366771076863444,0.640398205142655,"L.LvsP.LIAO_HAVE_SOX4_BINDING_SITES"
58,"Down",0.366818794662107,0.640398205142655,"L.LvsP.PID_SYNDECAN_4_PATHWAY"
189,"Up",0.366954508173157,0.640432915305993,"L.LvsP.ROSS_ACUTE_MYELOID_LEUKEMIA_CBF"
38,"Down",0.367320789700649,0.64086987890656,"L.LvsP.DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_UP"
8,"Up",0.368014515306184,0.641877683005644,"L.LvsP.REACTOME_DEFECTIVE_CHST3_CAUSES_SEDCJD"
81,"Up",0.368546652182422,0.642591701072635,"L.LvsP.HEIDENBLAD_AMPLICON_8Q24_UP"
21,"Down",0.368789672557933,0.642591701072635,"L.LvsP.REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_DIFFERENTIATION_OF_KERATINOCYTES"
33,"Up",0.369019757224059,0.642591701072635,"L.LvsP.BIOCARTA_G2_PATHWAY"
111,"Down",0.36928121259047,0.642591701072635,"L.LvsP.CHESLER_BRAIN_QTL_CIS"
88,"Up",0.369285630652376,0.642591701072635,"L.LvsP.KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION"
12,"Up",0.36929061477381,0.642591701072635,"L.LvsP.REACTOME_FRUCTOSE_METABOLISM"
125,"Down",0.369308032003885,0.642591701072635,"L.LvsP.MORI_LARGE_PRE_BII_LYMPHOCYTE_DN"
934,"Up",0.369452148425272,0.642591701072635,"L.LvsP.CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN"
31,"Down",0.369478743484162,0.642591701072635,"L.LvsP.REACTOME_POU5F1_OCT4_SOX2_NANOG_ACTIVATE_GENES_RELATED_TO_PROLIFERATION"
38,"Down",0.369586111306019,0.642591701072635,"L.LvsP.CAFFAREL_RESPONSE_TO_THC_8HR_3_DN"
27,"Down",0.369941782318433,0.643007895139458,"L.LvsP.REACTOME_WNT_LIGAND_BIOGENESIS_AND_TRAFFICKING"
207,"Down",0.370232931368916,0.643161633101808,"L.LvsP.WANG_HCP_PROSTATE_CANCER"
60,"Up",0.370262882648409,0.643161633101808,"L.LvsP.APPEL_IMATINIB_RESPONSE"
19,"Down",0.370448306937221,0.643281623447203,"L.LvsP.REACTOME_PRESYNAPTIC_DEPOLARIZATION_AND_CALCIUM_CHANNEL_OPENING"
157,"Down",0.370717456216015,0.643360006015187,"L.LvsP.WILCOX_RESPONSE_TO_PROGESTERONE_DN"
29,"Up",0.370726167329424,0.643360006015187,"L.LvsP.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_15"
9,"Down",0.370965863392902,0.643573975117463,"L.LvsP.REACTOME_RUNX3_REGULATES_IMMUNE_RESPONSE_AND_CELL_MIGRATION"
18,"Up",0.371150996194644,0.643603207729449,"L.LvsP.BIOCARTA_MRP_PATHWAY"
84,"Up",0.371267393794365,0.643603207729449,"L.LvsP.LEIN_ASTROCYTE_MARKERS"
211,"Down",0.371331928496462,0.643603207729449,"L.LvsP.SCHLOSSER_MYC_TARGETS_REPRESSED_BY_SERUM"
57,"Down",0.371620686362471,0.643870722920955,"L.LvsP.VILIMAS_NOTCH1_TARGETS_DN"
20,"Up",0.371719180243026,0.643870722920955,"L.LvsP.BIOCARTA_PLC_PATHWAY"
1203,"Up",0.372125694320579,0.644372992138579,"L.LvsP.MIKKELSEN_ES_ICP_WITH_H3K4ME3"
155,"Up",0.372311733914685,0.644493292678238,"L.LvsP.LEIN_CEREBELLUM_MARKERS"
14,"Up",0.372706406127898,0.644914156888021,"L.LvsP.BIOCARTA_LECTIN_PATHWAY"
584,"Down",0.372788143500473,0.644914156888021,"L.LvsP.MULLIGHAN_MLL_SIGNATURE_1_UP"
35,"Down",0.37308075007168,0.645048713640207,"L.LvsP.PID_RXR_VDR_PATHWAY"
499,"Down",0.373099255963353,0.645048713640207,"L.LvsP.KAYO_AGING_MUSCLE_UP"
117,"Up",0.37330480858098,0.645063858510648,"L.LvsP.HANN_RESISTANCE_TO_BCL2_INHIBITOR_UP"
5,"Down",0.373397099022293,0.645063858510648,"L.LvsP.REACTOME_ACTIVATION_OF_NOXA_AND_TRANSLOCATION_TO_MITOCHONDRIA"
237,"Down",0.373485766852385,0.645063858510648,"L.LvsP.DARWICHE_PAPILLOMA_RISK_HIGH_UP"
34,"Down",0.373634965899261,0.645063858510648,"L.LvsP.SHIN_B_CELL_LYMPHOMA_CLUSTER_7"
32,"Down",0.373780187754977,0.645063858510648,"L.LvsP.SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_2FC_UP"
20,"Down",0.373931949463313,0.645063858510648,"L.LvsP.PID_TCR_JNK_PATHWAY"
6,"Up",0.373999059300092,0.645063858510648,"L.LvsP.REACTOME_CHOLINE_CATABOLISM"
72,"Down",0.374041369214169,0.645063858510648,"L.LvsP.SCHRAETS_MLL_TARGETS_DN"
140,"Up",0.37425304386541,0.645138351852416,"L.LvsP.REACTOME_MITOTIC_SPINDLE_CHECKPOINT"
34,"Down",0.374317929597134,0.645138351852416,"L.LvsP.PID_TCR_CALCIUM_PATHWAY"
83,"Up",0.374540353332096,0.645320540222237,"L.LvsP.KEGG_P53_SIGNALING_PATHWAY"
38,"Down",0.374865139895563,0.64559991517748,"L.LvsP.MEISSNER_NPC_ICP_WITH_H3_UNMETHYLATED"
43,"Up",0.374936033213038,0.64559991517748,"L.LvsP.REACTOME_TRANSLESION_SYNTHESIS_BY_Y_FAMILY_DNA_POLYMERASES_BYPASSES_LESIONS_ON_DNA_TEMPLATE"
10,"Down",0.375504356213133,0.646174095699192,"L.LvsP.SASAI_TARGETS_OF_CXCR6_AND_PTCH1_DN"
261,"Up",0.375606193351974,0.646174095699192,"L.LvsP.YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_17"
34,"Down",0.375620101931127,0.646174095699192,"L.LvsP.BYSTRYKH_HEMATOPOIESIS_STEM_CELL_IL3RA"
756,"Down",0.37576706183543,0.646225842888986,"L.LvsP.ZHENG_BOUND_BY_FOXP3"
341,"Down",0.376235792768408,0.646830751933,"L.LvsP.GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_DN"
24,"Down",0.376565022732023,0.647195527101446,"L.LvsP.REACTOME_FRS_MEDIATED_FGFR4_SIGNALING"
39,"Down",0.377409151607768,0.648277912354929,"L.LvsP.PID_RETINOIC_ACID_PATHWAY"
64,"Up",0.37742930003084,0.648277912354929,"L.LvsP.PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_6"
104,"Down",0.37783646406617,0.648775717335979,"L.LvsP.FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP"
325,"Down",0.378179874828848,0.649005177639253,"L.LvsP.WIERENGA_STAT5A_TARGETS_UP"
25,"Up",0.378204862064328,0.649005177639253,"L.LvsP.REACTOME_NUCLEOTIDE_SALVAGE"
518,"Down",0.378587605027805,0.64933887432812,"L.LvsP.CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN"
843,"Up",0.378634207059841,0.64933887432812,"L.LvsP.MCCABE_BOUND_BY_HOXC6"
599,"Up",0.378784236619231,0.649394742408598,"L.LvsP.IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR"
1133,"Down",0.378969841783953,0.649511548426371,"L.LvsP.KRIEG_HYPOXIA_NOT_VIA_KDM3A"
70,"Down",0.379095892915001,0.649526244786812,"L.LvsP.HONMA_DOCETAXEL_RESISTANCE"
39,"Down",0.379404654693651,0.649853883457621,"L.LvsP.REACTOME_NUCLEAR_SIGNALING_BY_ERBB4"
1184,"Up",0.379621705355145,0.650024282721771,"L.LvsP.LEE_BMP2_TARGETS_DN"
60,"Up",0.379971329333557,0.650421510800383,"L.LvsP.BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_UP"
203,"Up",0.38016658632525,0.650554334816561,"L.LvsP.VERHAAK_GLIOBLASTOMA_NEURAL"
17,"Up",0.380593433082243,0.65108325851229,"L.LvsP.REACTOME_DISEASES_ASSOCIATED_WITH_SURFACTANT_METABOLISM"
67,"Up",0.381206152025932,0.651450950153721,"L.LvsP.NGUYEN_NOTCH1_TARGETS_UP"
25,"Up",0.381292807778219,0.651450950153721,"L.LvsP.WANG_RECURRENT_LIVER_CANCER_UP"
174,"Up",0.381323198862372,0.651450950153721,"L.LvsP.UDAYAKUMAR_MED1_TARGETS_UP"
10,"Down",0.381377805363663,0.651450950153721,"L.LvsP.DONATO_CELL_CYCLE_TRETINOIN"
222,"Up",0.381504807486188,0.651450950153721,"L.LvsP.WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP"
41,"Up",0.381533616801986,0.651450950153721,"L.LvsP.BIOCARTA_MHC_PATHWAY"
99,"Down",0.381633139364786,0.651450950153721,"L.LvsP.LINDSTEDT_DENDRITIC_CELL_MATURATION_C"
25,"Down",0.381802197420286,0.651538379486655,"L.LvsP.REACTOME_REGULATION_OF_INNATE_IMMUNE_RESPONSES_TO_CYTOSOLIC_DNA"
65,"Down",0.382255815855229,0.652111202056019,"L.LvsP.JIANG_AGING_CEREBRAL_CORTEX_UP"
21,"Down",0.382451224165952,0.652243312280552,"L.LvsP.REACTOME_TNF_RECEPTOR_SUPERFAMILY_TNFSF_MEMBERS_MEDIATING_NON_CANONICAL_NF_KB_PATHWAY"
318,"Down",0.38370024368518,0.654111801531754,"L.LvsP.BHAT_ESR1_TARGETS_NOT_VIA_AKT1_UP"
267,"Down",0.383783448032015,0.654111801531754,"L.LvsP.REACTOME_PARASITE_INFECTION"
55,"Down",0.384095383660213,0.654287485310071,"L.LvsP.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_DN"
45,"Up",0.384131538975613,0.654287485310071,"L.LvsP.CHNG_MULTIPLE_MYELOMA_HYPERPLOID_DN"
99,"Up",0.384241538217001,0.654287485310071,"L.LvsP.BILBAN_B_CLL_LPL_DN"
58,"Down",0.384590978360955,0.654680886501762,"L.LvsP.KEGG_LINOLEIC_ACID_METABOLISM"
13,"Down",0.385189346292111,0.655497659479557,"L.LvsP.REACTOME_SODIUM_CALCIUM_EXCHANGERS"
37,"Down",0.385530467231313,0.655876293329825,"L.LvsP.BURTON_ADIPOGENESIS_10"
1873,"Up",0.386577572733062,0.65725391882746,"L.LvsP.DODD_NASOPHARYNGEAL_CARCINOMA_DN"
6,"Up",0.386577996749304,0.65725391882746,"L.LvsP.BIOCARTA_SLRP_PATHWAY"
38,"Up",0.386875138738949,0.65755691425996,"L.LvsP.REACTOME_PLASMA_LIPOPROTEIN_REMODELING"
77,"Down",0.387337015044921,0.658053625451933,"L.LvsP.DORN_ADENOVIRUS_INFECTION_12HR_UP"
22,"Up",0.387417250968297,0.658053625451933,"L.LvsP.ISHIKAWA_STING_SIGNALING"
42,"Down",0.387524435607071,0.658053625451933,"L.LvsP.REACTOME_INTERACTIONS_OF_VPR_WITH_HOST_CELLULAR_PROTEINS"
201,"Down",0.387765763027054,0.65826125384605,"L.LvsP.WEI_MIR34A_TARGETS"
94,"Up",0.388145064898272,0.658428722380481,"L.LvsP.BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_UP"
115,"Down",0.388254763369985,0.658428722380481,"L.LvsP.BROWNE_HCMV_INFECTION_1HR_UP"
30,"Down",0.388333361099273,0.658428722380481,"L.LvsP.REACTOME_MRNA_CAPPING"
5,"Up",0.388340760297115,0.658428722380481,"L.LvsP.REACTOME_FREE_FATTY_ACID_RECEPTORS"
642,"Up",0.389460161769898,0.659799210416277,"L.LvsP.REACTOME_CELL_CYCLE_MITOTIC"
167,"Down",0.389544267329659,0.659799210416277,"L.LvsP.HOOI_ST7_TARGETS_UP"
204,"Up",0.38954796014131,0.659799210416277,"L.LvsP.BOSCO_TH1_CYTOTOXIC_MODULE"
13,"Up",0.389626410202414,0.659799210416277,"L.LvsP.SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX6_UP"
12,"Down",0.390280209466419,0.660704004329403,"L.LvsP.REACTOME_SLBP_DEPENDENT_PROCESSING_OF_REPLICATION_DEPENDENT_HISTONE_PRE_MRNAS"
53,"Down",0.390659085520227,0.661027771179349,"L.LvsP.HEIDENBLAD_AMPLICON_8Q24_DN"
187,"Up",0.390710572655835,0.661027771179349,"L.LvsP.ROSS_AML_WITH_AML1_ETO_FUSION"
82,"Up",0.390864431915264,0.661085788944477,"L.LvsP.CHEN_ETV5_TARGETS_TESTIS"
106,"Down",0.391074712034966,0.661239169064625,"L.LvsP.KEGG_HEMATOPOIETIC_CELL_LINEAGE"
98,"Up",0.391300805022169,0.661419184031664,"L.LvsP.KIM_LRRC3B_TARGETS"
41,"Up",0.391647261079137,0.661578350626524,"L.LvsP.REACTOME_GAMMA_CARBOXYLATION_HYPUSINE_FORMATION_AND_ARYLSULFATASE_ACTIVATION"
211,"Up",0.391689148004148,0.661578350626524,"L.LvsP.RODWELL_AGING_KIDNEY_DN"
86,"Up",0.391753937412053,0.661578350626524,"L.LvsP.CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_DN"
70,"Down",0.391959639964696,0.661601146971009,"L.LvsP.PETRETTO_CARDIAC_HYPERTROPHY"
57,"Down",0.392094446654188,0.661601146971009,"L.LvsP.WESTON_VEGFA_TARGETS_12HR"
133,"Up",0.392207609773009,0.661601146971009,"L.LvsP.SU_LIVER"
35,"Up",0.392246077006867,0.661601146971009,"L.LvsP.MOROSETTI_FACIOSCAPULOHUMERAL_MUSCULAR_DISTROPHY_UP"
35,"Down",0.392554000261658,0.661918593304881,"L.LvsP.BIOCARTA_IGF1_PATHWAY"
13,"Up",0.392767518307108,0.66207670997561,"L.LvsP.REACTOME_NEF_MEDIATED_CD4_DOWN_REGULATION"
16,"Up",0.393496145694143,0.663102770357488,"L.LvsP.YAGUE_PRETUMOR_DRUG_RESISTANCE_UP"
15,"Down",0.393991359061376,0.663734986060435,"L.LvsP.YAMANAKA_GLIOBLASTOMA_SURVIVAL_UP"
176,"Up",0.394487066765648,0.664367649146289,"L.LvsP.RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_UP"
34,"Up",0.39487973898516,0.664678411028976,"L.LvsP.REACTOME_INSULIN_PROCESSING"
70,"Up",0.39508293819701,0.664678411028976,"L.LvsP.LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_UP"
49,"Up",0.395139176946254,0.664678411028976,"L.LvsP.NIKOLSKY_BREAST_CANCER_1Q21_AMPLICON"
32,"Down",0.395191341116148,0.664678411028976,"L.LvsP.NUMATA_CSF3_SIGNALING_VIA_STAT3"
79,"Up",0.395346382824217,0.664678411028976,"L.LvsP.HOWLIN_CITED1_TARGETS_1_UP"
37,"Down",0.39546482465381,0.664678411028976,"L.LvsP.REACTOME_SUMOYLATION_OF_INTRACELLULAR_RECEPTORS"
17,"Down",0.395707112008918,0.664678411028976,"L.LvsP.REACTOME_NOTCH4_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS"
604,"Down",0.395747816764544,0.664678411028976,"L.LvsP.GRYDER_PAX3FOXO1_TOP_ENHANCERS"
464,"Up",0.395753541166104,0.664678411028976,"L.LvsP.RAO_BOUND_BY_SALL4_ISOFORM_A"
745,"Down",0.396079163669772,0.66478490392778,"L.LvsP.MEISSNER_NPC_HCP_WITH_H3K4ME2"
757,"Down",0.396309741185571,0.66478490392778,"L.LvsP.SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP"
16,"Up",0.396376065612844,0.66478490392778,"L.LvsP.KEGG_OTHER_GLYCAN_DEGRADATION"
236,"Up",0.396384969169692,0.66478490392778,"L.LvsP.BOSCO_ALLERGEN_INDUCED_TH2_ASSOCIATED_MODULE"
66,"Up",0.396418127735556,0.66478490392778,"L.LvsP.TING_SILENCED_BY_DICER"
13,"Up",0.396549701091248,0.664803910652975,"L.LvsP.POS_RESPONSE_TO_HISTAMINE_DN"
23,"Down",0.397173353441831,0.665002378766522,"L.LvsP.FREDERICK_PRKCI_TARGETS"
217,"Down",0.397270377863419,0.665002378766522,"L.LvsP.YAGI_AML_WITH_T_9_11_TRANSLOCATION"
10,"Up",0.397285533972543,0.665002378766522,"L.LvsP.REACTOME_RECYCLING_OF_EIF2_GDP"
91,"Up",0.397290903428528,0.665002378766522,"L.LvsP.REACTOME_SPHINGOLIPID_METABOLISM"
25,"Down",0.397324462342275,0.665002378766522,"L.LvsP.REACTOME_JNK_C_JUN_KINASES_PHOSPHORYLATION_AND_ACTIVATION_MEDIATED_BY_ACTIVATED_HUMAN_TAK1"
45,"Down",0.397389737645974,0.665002378766522,"L.LvsP.REACTOME_NS1_MEDIATED_EFFECTS_ON_HOST_PATHWAYS"
210,"Down",0.398235510935484,0.665945657581365,"L.LvsP.HOELZEL_NF1_TARGETS_DN"
528,"Down",0.398297077925514,0.665945657581365,"L.LvsP.WANG_LMO4_TARGETS_UP"
34,"Down",0.39831475666876,0.665945657581365,"L.LvsP.GOLUB_ALL_VS_AML_UP"
15,"Down",0.398519969011657,0.666087336355941,"L.LvsP.NEBEN_AML_WITH_FLT3_OR_NRAS_UP"
16,"Down",0.399525358402402,0.667565943368656,"L.LvsP.REACTOME_GAMMA_CARBOXYLATION_TRANSPORT_AND_AMINO_TERMINAL_CLEAVAGE_OF_PROTEINS"
29,"Up",0.400326617298396,0.668667178602505,"L.LvsP.REACTOME_METABOLISM_OF_COFACTORS"
155,"Down",0.400426302831054,0.668667178602505,"L.LvsP.ALCALA_APOPTOSIS"
71,"Up",0.400787108207672,0.669067609082192,"L.LvsP.BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_UP"
58,"Down",0.401187617181743,0.669499626629507,"L.LvsP.EPPERT_LSC_R"
12,"Up",0.40137374538289,0.669499626629507,"L.LvsP.BIOCARTA_GABA_PATHWAY"
38,"Up",0.401572449457748,0.669499626629507,"L.LvsP.REACTOME_INTEGRIN_SIGNALING"
74,"Down",0.40167517586954,0.669499626629507,"L.LvsP.REACTOME_INTRINSIC_PATHWAY_FOR_APOPTOSIS"
269,"Down",0.401736734126427,0.669499626629507,"L.LvsP.LEE_NEURAL_CREST_STEM_CELL_UP"
57,"Up",0.401772429219878,0.669499626629507,"L.LvsP.KEGG_TRYPTOPHAN_METABOLISM"
33,"Up",0.402021600615485,0.669712994818625,"L.LvsP.RAMPON_ENRICHED_LEARNING_ENVIRONMENT_LATE_UP"
39,"Down",0.40215884445309,0.669739834632872,"L.LvsP.REACTOME_TNFR1_INDUCED_NFKAPPAB_SIGNALING_PATHWAY"
161,"Down",0.402860850402111,0.670426473515704,"L.LvsP.FRASOR_RESPONSE_TO_ESTRADIOL_DN"
216,"Down",0.402929614844584,0.670426473515704,"L.LvsP.PECE_MAMMARY_STEM_CELL_DN"
15,"Up",0.402934919785257,0.670426473515704,"L.LvsP.REACTOME_VLDLR_INTERNALISATION_AND_DEGRADATION"
22,"Down",0.403781450411423,0.670725279874085,"L.LvsP.BIOCARTA_TOB1_PATHWAY"
29,"Down",0.403825954764832,0.670725279874085,"L.LvsP.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_SALMON_DN"
18,"Down",0.403826673980665,0.670725279874085,"L.LvsP.ROZANOV_MMP14_CORRELATED"
26,"Up",0.403860142043001,0.670725279874085,"L.LvsP.FERRANDO_HOX11_NEIGHBORS"
78,"Down",0.403867436086151,0.670725279874085,"L.LvsP.PID_CASPASE_PATHWAY"
492,"Down",0.403888392587764,0.670725279874085,"L.LvsP.REACTOME_LEISHMANIA_INFECTION"
263,"Up",0.403963679142829,0.670725279874085,"L.LvsP.REACTOME_BINDING_AND_UPTAKE_OF_LIGANDS_BY_SCAVENGER_RECEPTORS"
89,"Down",0.404589412903221,0.671551424965981,"L.LvsP.VANHARANTA_UTERINE_FIBROID_UP"
11,"Up",0.404811905296196,0.671551424965981,"L.LvsP.VALK_AML_WITH_T_8_21_TRANSLOCATION"
29,"Down",0.404825628397832,0.671551424965981,"L.LvsP.REACTOME_GABA_SYNTHESIS_RELEASE_REUPTAKE_AND_DEGRADATION"
26,"Down",0.405014084752599,0.671662529873161,"L.LvsP.SA_G1_AND_S_PHASES"
60,"Down",0.405250709417529,0.671745718074858,"L.LvsP.BIOCARTA_FCER1_PATHWAY"
75,"Down",0.405389312932486,0.671745718074858,"L.LvsP.EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_DN"
40,"Down",0.405428732359523,0.671745718074858,"L.LvsP.GUTIERREZ_MULTIPLE_MYELOMA_UP"
37,"Down",0.405583720956784,0.671801196276231,"L.LvsP.HOFMANN_MYELODYSPLASTIC_SYNDROM_RISK_UP"
28,"Down",0.405705844370136,0.671802220282265,"L.LvsP.REACTOME_VEGFR2_MEDIATED_CELL_PROLIFERATION"
12,"Down",0.405952729658905,0.672009773138948,"L.LvsP.REACTOME_MAPK3_ERK1_ACTIVATION"
32,"Down",0.406593100076263,0.672520519819852,"L.LvsP.DASU_IL6_SIGNALING_SCAR_DN"
223,"Down",0.406620795794338,0.672520519819852,"L.LvsP.REACTOME_SEPARATION_OF_SISTER_CHROMATIDS"
122,"Up",0.40681753796759,0.672520519819852,"L.LvsP.VANASSE_BCL2_TARGETS_DN"
57,"Up",0.406838775259672,0.672520519819852,"L.LvsP.SCHRAETS_MLL_TARGETS_UP"
9,"Down",0.406869440911088,0.672520519819852,"L.LvsP.REACTOME_ACTIVATION_OF_PUMA_AND_TRANSLOCATION_TO_MITOCHONDRIA"
67,"Up",0.407557774438785,0.673456944074131,"L.LvsP.BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_UP"
44,"Up",0.408563927068776,0.67491782275568,"L.LvsP.COLLIS_PRKDC_SUBSTRATES"
200,"Down",0.408854748242556,0.675196506282286,"L.LvsP.GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_UP"
23,"Up",0.408984108609295,0.675208461182679,"L.LvsP.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_UP"
1130,"Down",0.409401269816327,0.675444537806821,"L.LvsP.REACTOME_ADAPTIVE_IMMUNE_SYSTEM"
512,"Down",0.409405797864169,0.675444537806821,"L.LvsP.DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP"
450,"Up",0.409493595718659,0.675444537806821,"L.LvsP.ZHOU_INFLAMMATORY_RESPONSE_FIMA_DN"
11,"Up",0.409763254196837,0.675687751999496,"L.LvsP.BIOCARTA_REELIN_PATHWAY"
87,"Down",0.410154842966785,0.676131820740415,"L.LvsP.LEE_LIVER_CANCER_MYC_TGFA_UP"
53,"Up",0.41065223444674,0.676749986365432,"L.LvsP.EINAV_INTERFERON_SIGNATURE_IN_CANCER"
5,"Up",0.410986493869035,0.677099024017252,"L.LvsP.WILSON_PROTEASES_AT_TUMOR_BONE_INTERFACE_DN"
289,"Down",0.411421298942518,0.677428384836443,"L.LvsP.ZHENG_FOXP3_TARGETS_IN_THYMUS_UP"
196,"Up",0.411431455286811,0.677428384836443,"L.LvsP.SU_TESTIS"
121,"Up",0.412719854904457,0.679345476906062,"L.LvsP.REACTOME_UNFOLDED_PROTEIN_RESPONSE_UPR"
983,"Up",0.412841526931519,0.679345476906062,"L.LvsP.HAMAI_APOPTOSIS_VIA_TRAIL_UP"
352,"Up",0.413410960804297,0.680080095890198,"L.LvsP.ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_UP"
142,"Down",0.413846441794866,0.680593984736411,"L.LvsP.KORKOLA_YOLK_SAC_TUMOR"
663,"Up",0.414520770614817,0.68108682275997,"L.LvsP.VECCHI_GASTRIC_CANCER_EARLY_DN"
31,"Down",0.414536680068338,0.68108682275997,"L.LvsP.REACTOME_PI_3K_CASCADE_FGFR1"
43,"Down",0.414679469434881,0.68108682275997,"L.LvsP.PID_CD40_PATHWAY"
170,"Up",0.414712220998784,0.68108682275997,"L.LvsP.KEGG_PURINE_METABOLISM"
29,"Down",0.414958034989701,0.68108682275997,"L.LvsP.REACTOME_ACYL_CHAIN_REMODELLING_OF_PE"
24,"Down",0.414973417301439,0.68108682275997,"L.LvsP.XU_CREBBP_TARGETS_UP"
28,"Up",0.415008411263943,0.68108682275997,"L.LvsP.WEST_ADRENOCORTICAL_TUMOR_MARKERS_UP"
51,"Down",0.415511775765523,0.681710566233702,"L.LvsP.REACTOME_SIGNALING_BY_FGFR1_IN_DISEASE"
47,"Down",0.41570185965873,0.681820107402289,"L.LvsP.MIKKELSEN_MCV6_LCP_WITH_H3K27ME3"
109,"Down",0.415928907026284,0.681990191858934,"L.LvsP.SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN"
55,"Up",0.4161547174046,0.682056739668856,"L.LvsP.WONG_ENDMETRIUM_CANCER_UP"
26,"Down",0.416293270830083,0.682056739668856,"L.LvsP.CAIRO_HEPATOBLASTOMA_POOR_SURVIVAL"
917,"Down",0.416478050349608,0.682056739668856,"L.LvsP.CHICAS_RB1_TARGETS_CONFLUENT"
9,"Down",0.416809831647985,0.682056739668856,"L.LvsP.REACTOME_RELEASE_OF_HH_NP_FROM_THE_SECRETING_CELL"
77,"Down",0.416918005509085,0.682056739668856,"L.LvsP.TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_DN"
287,"Down",0.416986025823817,0.682056739668856,"L.LvsP.KYNG_DNA_DAMAGE_DN"
45,"Down",0.417006821394911,0.682056739668856,"L.LvsP.REACTOME_GABA_B_RECEPTOR_ACTIVATION"
178,"Up",0.417029191573095,0.682056739668856,"L.LvsP.REACTOME_S_PHASE"
6,"Up",0.417079731745416,0.682056739668856,"L.LvsP.REACTOME_SENSING_OF_DNA_DOUBLE_STRAND_BREAKS"
15,"Up",0.417821455193142,0.683067659894406,"L.LvsP.REACTOME_PURINE_SALVAGE"
46,"Down",0.418452620425074,0.683742037169595,"L.LvsP.MARSHALL_VIRAL_INFECTION_RESPONSE_DN"
914,"Up",0.41848129024813,0.683742037169595,"L.LvsP.BENPORATH_CYCLING_GENES"
239,"Down",0.419054448802905,0.684476232623711,"L.LvsP.SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM5"
83,"Up",0.419555444400046,0.684929767007866,"L.LvsP.PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_DN"
29,"Up",0.419579873549583,0.684929767007866,"L.LvsP.REACTOME_BASIGIN_INTERACTIONS"
944,"Down",0.41995085343613,0.685333019081571,"L.LvsP.MIKKELSEN_MEF_HCP_WITH_H3K27ME3"
25,"Down",0.420145861811523,0.685448943628183,"L.LvsP.LEE_LIVER_CANCER_HEPATOBLAST"
181,"Down",0.42073701924622,0.68599016942504,"L.LvsP.NIKOLSKY_MUTATED_AND_AMPLIFIED_IN_BREAST_CANCER"
29,"Down",0.420896877867969,0.68599016942504,"L.LvsP.KEGG_PHENYLALANINE_METABOLISM"
194,"Down",0.420910286466058,0.68599016942504,"L.LvsP.RODRIGUES_DCC_TARGETS_DN"
353,"Up",0.421096168955248,0.68599016942504,"L.LvsP.CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP"
25,"Down",0.421097962566212,0.68599016942504,"L.LvsP.HOLLERN_PAPILLARY_BREAST_TUMOR"
1739,"Down",0.42144071082643,0.686186962015998,"L.LvsP.GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP"
23,"Up",0.421466978297401,0.686186962015998,"L.LvsP.REACTOME_ASSEMBLY_OF_ACTIVE_LPL_AND_LIPC_LIPASE_COMPLEXES"
113,"Up",0.42255943160256,0.687763054851503,"L.LvsP.LEIN_OLIGODENDROCYTE_MARKERS"
71,"Down",0.422932937802657,0.688168397030869,"L.LvsP.SCHLINGEMANN_SKIN_CARCINOGENESIS_TPA_UP"
217,"Up",0.423310451741152,0.688434446086434,"L.LvsP.MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_UP"
875,"Down",0.423345472362792,0.688434446086434,"L.LvsP.BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_B"
31,"Down",0.42356880337934,0.688595093761944,"L.LvsP.LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_QTL"
371,"Down",0.423882174210058,0.68890198154245,"L.LvsP.GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_UP"
36,"Down",0.424026341430908,0.688933776600497,"L.LvsP.WILENSKY_RESPONSE_TO_DARAPLADIB"
309,"Up",0.424455676582574,0.689428741429216,"L.LvsP.CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_UP"
43,"Up",0.424887362009345,0.689734455932317,"L.LvsP.REACTOME_VOLTAGE_GATED_POTASSIUM_CHANNELS"
58,"Down",0.425002693226534,0.689734455932317,"L.LvsP.MORI_PLASMA_CELL_DN"
60,"Down",0.42501813915019,0.689734455932317,"L.LvsP.REACTOME_NCAM1_INTERACTIONS"
364,"Down",0.426438526522195,0.691642826951088,"L.LvsP.RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_UP"
70,"Down",0.426444275108747,0.691642826951088,"L.LvsP.ZHAN_MULTIPLE_MYELOMA_CD1_DN"
192,"Up",0.42670676384335,0.691865600378265,"L.LvsP.BENPORATH_PROLIFERATION"
226,"Up",0.427055485809716,0.692228021413638,"L.LvsP.HOLLERN_EMT_BREAST_TUMOR_UP"
173,"Down",0.427471880746073,0.692318646857922,"L.LvsP.BROWN_MYELOID_CELL_DEVELOPMENT_DN"
25,"Up",0.427650151771162,0.692318646857922,"L.LvsP.KYNG_ENVIRONMENTAL_STRESS_RESPONSE_DN"
463,"Up",0.427724605653859,0.692318646857922,"L.LvsP.MARKEY_RB1_ACUTE_LOF_DN"
141,"Up",0.427798494621022,0.692318646857922,"L.LvsP.CROONQUIST_STROMAL_STIMULATION_UP"
29,"Down",0.427844339815723,0.692318646857922,"L.LvsP.REACTOME_SHC_MEDIATED_CASCADE_FGFR1"
16,"Up",0.427981166072716,0.692318646857922,"L.LvsP.BIOCARTA_FREE_PATHWAY"
104,"Down",0.42820801518728,0.692318646857922,"L.LvsP.MORI_IMMATURE_B_LYMPHOCYTE_UP"
27,"Down",0.428326288016572,0.692318646857922,"L.LvsP.WU_APOPTOSIS_BY_CDKN1A_NOT_VIA_TP53"
5,"Up",0.428363238024611,0.692318646857922,"L.LvsP.BIOCARTA_DICER_PATHWAY"
206,"Down",0.428363554151013,0.692318646857922,"L.LvsP.LIU_VMYB_TARGETS_UP"
338,"Up",0.428670526104628,0.692612314094823,"L.LvsP.TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN"
115,"Down",0.428977827580581,0.692906342007898,"L.LvsP.MCCLUNG_COCAIN_REWARD_4WK"
36,"Up",0.429224223163767,0.693101848677707,"L.LvsP.GROSS_HIF1A_TARGETS_DN"
134,"Down",0.42962098050778,0.693539971161318,"L.LvsP.MIKKELSEN_IPS_ICP_WITH_H3K27ME3"
157,"Down",0.430190507888854,0.694128435898262,"L.LvsP.DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN"
62,"Down",0.430236597906193,0.694128435898262,"L.LvsP.REACTOME_GPVI_MEDIATED_ACTIVATION_CASCADE"
187,"Down",0.430486488166719,0.694286159508493,"L.LvsP.TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP"
12,"Up",0.430585502071735,0.694286159508493,"L.LvsP.REACTOME_ACTIVATION_OF_THE_AP_1_FAMILY_OF_TRANSCRIPTION_FACTORS"
51,"Up",0.430949079662323,0.694498045916579,"L.LvsP.REACTOME_HIV_TRANSCRIPTION_INITIATION"
373,"Up",0.430968130862684,0.694498045916579,"L.LvsP.RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_UP"
37,"Up",0.431191273529683,0.694655172303502,"L.LvsP.TERAMOTO_OPN_TARGETS_CLUSTER_4"
85,"Up",0.431849808124633,0.695372556150584,"L.LvsP.ELVIDGE_HIF1A_TARGETS_UP"
9,"Up",0.431888109571551,0.695372556150584,"L.LvsP.REACTOME_CREB3_FACTORS_ACTIVATE_GENES"
1381,"Down",0.432134980899271,0.695567484539176,"L.LvsP.BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_TRANS"
47,"Down",0.432959328503375,0.696691538793702,"L.LvsP.REACTOME_TRNA_MODIFICATION_IN_THE_NUCLEUS_AND_CYTOSOL"
72,"Down",0.433164497430893,0.696729339688101,"L.LvsP.SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_DN"
115,"Down",0.433234847141923,0.696729339688101,"L.LvsP.COLDREN_GEFITINIB_RESISTANCE_UP"
474,"Down",0.433515524843952,0.696977998506022,"L.LvsP.REACTOME_NEURONAL_SYSTEM"
19,"Down",0.434010190647063,0.697179250684777,"L.LvsP.EHLERS_ANEUPLOIDY_DN"
488,"Down",0.434086274984048,0.697179250684777,"L.LvsP.BROWNE_HCMV_INFECTION_14HR_DN"
118,"Down",0.434176522265002,0.697179250684777,"L.LvsP.KEGG_SMALL_CELL_LUNG_CANCER"
33,"Down",0.434180089787602,0.697179250684777,"L.LvsP.REACTOME_PLASMA_LIPOPROTEIN_ASSEMBLY"
8,"Down",0.434371829764022,0.697179250684777,"L.LvsP.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_30"
9,"Down",0.434397272311278,0.697179250684777,"L.LvsP.REACTOME_SUMO_IS_PROTEOLYTICALLY_PROCESSED"
39,"Down",0.434593786156574,0.697284004398511,"L.LvsP.BIOCARTA_TPO_PATHWAY"
51,"Up",0.434733441194565,0.697284004398511,"L.LvsP.KANG_GLIS3_TARGETS"
34,"Up",0.434922996304102,0.697284004398511,"L.LvsP.HAHTOLA_CTCL_PATHOGENESIS"
13,"Down",0.435047246598588,0.697284004398511,"L.LvsP.FUNG_IL2_SIGNALING_1"
1632,"Down",0.435093111805907,0.697284004398511,"L.LvsP.GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN"
118,"Up",0.435894599705004,0.698366050932763,"L.LvsP.ANASTASSIOU_MULTICANCER_INVASIVENESS_SIGNATURE"
162,"Up",0.436025163169879,0.698370786702084,"L.LvsP.WESTON_VEGFA_TARGETS"
30,"Up",0.436150176611014,0.698370786702084,"L.LvsP.REACTOME_APC_CDC20_MEDIATED_DEGRADATION_OF_NEK2A"
293,"Down",0.436603571261092,0.698623642688757,"L.LvsP.TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP"
99,"Down",0.436650081913368,0.698623642688757,"L.LvsP.REACTOME_ECM_PROTEOGLYCANS"
10,"Up",0.436687160269912,0.698623642688757,"L.LvsP.BIOCARTA_BBCELL_PATHWAY"
279,"Down",0.436951709152713,0.698844662975224,"L.LvsP.UEDA_PERIFERAL_CLOCK"
54,"Up",0.43755171515943,0.699601918194473,"L.LvsP.FARMER_BREAST_CANCER_CLUSTER_4"
48,"Up",0.438058080669142,0.700052481943686,"L.LvsP.GRADE_COLON_VS_RECTAL_CANCER_UP"
11,"Up",0.438286586388265,0.700052481943686,"L.LvsP.REACTOME_ERYTHROPOIETIN_ACTIVATES_STAT5"
54,"Down",0.438691737426062,0.700052481943686,"L.LvsP.BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_UP"
331,"Down",0.438699561771061,0.700052481943686,"L.LvsP.LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP"
158,"Up",0.438795111510549,0.700052481943686,"L.LvsP.REACTOME_HATS_ACETYLATE_HISTONES"
621,"Up",0.438815862402401,0.700052481943686,"L.LvsP.WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_UP"
168,"Down",0.438819333897321,0.700052481943686,"L.LvsP.BROWNE_HCMV_INFECTION_16HR_DN"
100,"Up",0.4388464283626,0.700052481943686,"L.LvsP.LEE_LIVER_CANCER_MYC_TGFA_DN"
14,"Up",0.439452969464824,0.700817844871938,"L.LvsP.REACTOME_CS_DS_DEGRADATION"
98,"Down",0.439611130626969,0.700867918464969,"L.LvsP.VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_UP"
1169,"Up",0.439856596651805,0.700983200600575,"L.LvsP.JOHNSTONE_PARVB_TARGETS_3_DN"
66,"Up",0.439937005983721,0.700983200600575,"L.LvsP.LUI_THYROID_CANCER_CLUSTER_2"
72,"Down",0.44020529981145,0.701023675611073,"L.LvsP.REACTOME_SIGNALING_BY_FGFR_IN_DISEASE"
6,"Up",0.440215988736055,0.701023675611073,"L.LvsP.REACTOME_PROTON_COUPLED_MONOCARBOXYLATE_TRANSPORT"
1302,"Down",0.440374493731359,0.701057456361824,"L.LvsP.SMID_BREAST_CANCER_BASAL_UP"
21,"Up",0.440747589606805,0.701057456361824,"L.LvsP.BIOCARTA_TH1TH2_PATHWAY"
6,"Down",0.440825724254914,0.701057456361824,"L.LvsP.SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX2_UP"
173,"Up",0.440960440977327,0.701057456361824,"L.LvsP.RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_UP"
9,"Down",0.440969278923655,0.701057456361824,"L.LvsP.SHARMA_PILOCYTIC_ASTROCYTOMA_LOCATION_DN"
1217,"Down",0.440997980326718,0.701057456361824,"L.LvsP.MARTENS_TRETINOIN_RESPONSE_DN"
611,"Down",0.441183752243989,0.701151183143724,"L.LvsP.REN_ALVEOLAR_RHABDOMYOSARCOMA_DN"
15,"Up",0.441503944475401,0.70128269342224,"L.LvsP.MIKKELSEN_PARTIALLY_REPROGRAMMED_TO_PLURIPOTENCY"
50,"Down",0.44152017648812,0.70128269342224,"L.LvsP.REACTOME_SPHINGOLIPID_DE_NOVO_BIOSYNTHESIS"
103,"Down",0.442243558000362,0.702224600012763,"L.LvsP.DORN_ADENOVIRUS_INFECTION_24HR_DN"
48,"Down",0.442367205976569,0.702224600012763,"L.LvsP.LOPEZ_MBD_TARGETS_IMPRINTED_AND_X_LINKED"
382,"Down",0.442629875719061,0.702439891748188,"L.LvsP.CAIRO_HEPATOBLASTOMA_CLASSES_DN"
10,"Up",0.442916837868533,0.702603796137113,"L.LvsP.REACTOME_HYDROLYSIS_OF_LPC"
16,"Up",0.443054920940292,0.702603796137113,"L.LvsP.SHIN_B_CELL_LYMPHOMA_CLUSTER_6"
1113,"Down",0.443120795596541,0.702603796137113,"L.LvsP.MARTINEZ_RB1_TARGETS_UP"
5,"Up",0.443241461552948,0.702603796137113,"L.LvsP.REACTOME_DISEASES_OF_BASE_EXCISION_REPAIR"
26,"Down",0.443411204260765,0.702671409675486,"L.LvsP.DORMOY_ELAVL1_TARGETS"
35,"Up",0.443553919194859,0.702696165968016,"L.LvsP.SA_B_CELL_RECEPTOR_COMPLEXES"
116,"Up",0.443859973015672,0.702979602063492,"L.LvsP.REACTOME_STIMULI_SENSING_CHANNELS"
59,"Down",0.444774664565237,0.704226552228292,"L.LvsP.PID_HDAC_CLASSIII_PATHWAY"
28,"Down",0.445792673782013,0.705636327896007,"L.LvsP.REACTOME_G_BETA_GAMMA_SIGNALLING_THROUGH_PI3KGAMMA"
7,"Up",0.446026022222967,0.705694797552342,"L.LvsP.GAVIN_IL2_RESPONSIVE_FOXP3_TARGETS_DN"
87,"Up",0.446084882880347,0.705694797552342,"L.LvsP.BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN"
829,"Down",0.446311402293519,0.70585118514899,"L.LvsP.LIU_PROSTATE_CANCER_DN"
6,"Up",0.44657065116384,0.706059230850693,"L.LvsP.ZIRN_TRETINOIN_RESPONSE_WT1_DN"
257,"Up",0.447105863826276,0.706703350799165,"L.LvsP.LANDIS_ERBB2_BREAST_TUMORS_324_DN"
28,"Down",0.447437807818105,0.707025904380195,"L.LvsP.OSAWA_TNF_TARGETS"
27,"Up",0.447859624064377,0.707490246129126,"L.LvsP.REACTOME_CELLULAR_HEXOSE_TRANSPORT"
1049,"Down",0.448005762830957,0.707518955353431,"L.LvsP.KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_UP"
39,"Down",0.448336022475078,0.707838340452514,"L.LvsP.REACTOME_NUCLEAR_IMPORT_OF_REV_PROTEIN"
206,"Down",0.448643271639795,0.708121224349536,"L.LvsP.ROPERO_HDAC2_TARGETS"
11,"Up",0.448998131848963,0.708479072771951,"L.LvsP.NIKOLSKY_BREAST_CANCER_17P11_AMPLICON"
24,"Down",0.449644272525628,0.708525314967791,"L.LvsP.FARMER_BREAST_CANCER_CLUSTER_5"
32,"Down",0.449647353067785,0.708525314967791,"L.LvsP.BIOCARTA_RAC1_PATHWAY"
159,"Down",0.449662488125131,0.708525314967791,"L.LvsP.FIGUEROA_AML_METHYLATION_CLUSTER_4_UP"
80,"Up",0.44970965529798,0.708525314967791,"L.LvsP.MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_DN"
7,"Up",0.44974653013743,0.708525314967791,"L.LvsP.REACTOME_DEFECTIVE_LFNG_CAUSES_SCDO3"
41,"Up",0.450054191644564,0.708525314967791,"L.LvsP.PASTURAL_RIZ1_TARGETS_UP"
370,"Down",0.450131853767822,0.708525314967791,"L.LvsP.HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_UP"
16,"Down",0.450138985125767,0.708525314967791,"L.LvsP.TSUDA_ALVEOLAR_SOFT_PART_SARCOMA"
361,"Down",0.450300753139574,0.708525314967791,"L.LvsP.REACTOME_ORGANELLE_BIOGENESIS_AND_MAINTENANCE"
15,"Up",0.45041465192019,0.708525314967791,"L.LvsP.BIOCARTA_SODD_PATHWAY"
138,"Up",0.450437055907359,0.708525314967791,"L.LvsP.ZHENG_IL22_SIGNALING_UP"
1200,"Down",0.451364296076692,0.709700698022018,"L.LvsP.RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN"
25,"Up",0.451556913957068,0.709700698022018,"L.LvsP.HONRADO_BREAST_CANCER_BRCA1_VS_BRCA2"
453,"Down",0.451574976200245,0.709700698022018,"L.LvsP.HELLER_HDAC_TARGETS_DN"
40,"Up",0.451697731296705,0.709700698022018,"L.LvsP.REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY"
25,"Down",0.451834212928776,0.709713455478183,"L.LvsP.INGA_TP53_TARGETS"
31,"Up",0.452021238327415,0.70978301513493,"L.LvsP.LIM_MAMMARY_LUMINAL_PROGENITOR_DN"
63,"Down",0.452135246754426,0.70978301513493,"L.LvsP.NAKAMURA_METASTASIS_MODEL_DN"
6,"Up",0.452343835851543,0.709908903895311,"L.LvsP.REACTOME_SEROTONIN_AND_MELATONIN_BIOSYNTHESIS"
12,"Down",0.452651902826317,0.710102012772217,"L.LvsP.IIZUKA_LIVER_CANCER_PROGRESSION_L1_G1_DN"
185,"Down",0.452735997097678,0.710102012772217,"L.LvsP.PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_4"
28,"Down",0.452852178881323,0.710102012772217,"L.LvsP.REACTOME_TRAF6_MEDIATED_NF_KB_ACTIVATION"
129,"Up",0.453437986502047,0.710320497043891,"L.LvsP.MENSE_HYPOXIA_UP"
168,"Up",0.453521760526338,0.710320497043891,"L.LvsP.TOOKER_GEMCITABINE_RESISTANCE_DN"
13,"Up",0.453542145085584,0.710320497043891,"L.LvsP.REACTOME_RECEPTOR_MEDIATED_MITOPHAGY"
47,"Down",0.453563108995013,0.710320497043891,"L.LvsP.SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_DN"
1130,"Down",0.453659741263303,0.710320497043891,"L.LvsP.FORTSCHEGGER_PHF8_TARGETS_DN"
215,"Down",0.453762343201126,0.710320497043891,"L.LvsP.NIKOLSKY_BREAST_CANCER_11Q12_Q14_AMPLICON"
17,"Down",0.454488894811273,0.711256467424719,"L.LvsP.ZHENG_FOXP3_TARGETS_DN"
81,"Up",0.455669227021602,0.712659430787632,"L.LvsP.NEWMAN_ERCC6_TARGETS_DN"
79,"Up",0.455688860650883,0.712659430787632,"L.LvsP.HESS_TARGETS_OF_HOXA9_AND_MEIS1_UP"
16,"Up",0.455813247593683,0.712659430787632,"L.LvsP.REACTOME_PI3K_AKT_ACTIVATION"
22,"Down",0.455900959793065,0.712659430787632,"L.LvsP.MIKKELSEN_IPS_LCP_WITH_H3K27ME3"
33,"Up",0.456230158370439,0.712972454954822,"L.LvsP.KORKOLA_YOLK_SAC_TUMOR_UP"
15,"Up",0.456841650754004,0.713726331454899,"L.LvsP.BERGER_MBD2_TARGETS"
238,"Down",0.457826828396918,0.715063427741967,"L.LvsP.LI_INDUCED_T_TO_NATURAL_KILLER_DN"
16,"Up",0.458341600779329,0.715665267073965,"L.LvsP.REACTOME_REGULATION_OF_COMMISSURAL_AXON_PATHFINDING_BY_SLIT_AND_ROBO"
32,"Down",0.458728225460644,0.716066730257453,"L.LvsP.REACTOME_SIGNALING_BY_ERYTHROPOIETIN"
24,"Up",0.459431188017843,0.716961625331825,"L.LvsP.KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_CHONDROITIN_SULFATE"
18,"Up",0.46057290139925,0.718513563544154,"L.LvsP.REACTOME_NUCLEOBASE_BIOSYNTHESIS"
18,"Down",0.460718763505845,0.718513563544154,"L.LvsP.JIANG_CORE_DUPLICON_GENES"
186,"Down",0.460815535599126,0.718513563544154,"L.LvsP.BROWNE_HCMV_INFECTION_12HR_DN"
319,"Up",0.461482703126539,0.718664775853071,"L.LvsP.SHEPARD_CRUSH_AND_BURN_MUTANT_DN"
65,"Down",0.461491515990065,0.718664775853071,"L.LvsP.REACTOME_GABA_RECEPTOR_ACTIVATION"
38,"Up",0.461564425982212,0.718664775853071,"L.LvsP.REACTOME_PEROXISOMAL_LIPID_METABOLISM"
16,"Down",0.461605193341743,0.718664775853071,"L.LvsP.REACTOME_AKT_PHOSPHORYLATES_TARGETS_IN_THE_CYTOSOL"
83,"Up",0.461743067060369,0.718664775853071,"L.LvsP.BAKKER_FOXO3_TARGETS_UP"
1149,"Up",0.461782869229245,0.718664775853071,"L.LvsP.SMID_BREAST_CANCER_BASAL_DN"
140,"Down",0.461851354645731,0.718664775853071,"L.LvsP.MCCLUNG_DELTA_FOSB_TARGETS_2WK"
21,"Up",0.461952362702444,0.718664775853071,"L.LvsP.BIOCARTA_NDKDYNAMIN_PATHWAY"
207,"Down",0.462612556673221,0.719297910855671,"L.LvsP.MCCLUNG_CREB1_TARGETS_UP"
95,"Up",0.462619528124935,0.719297910855671,"L.LvsP.KEGG_COMPLEMENT_AND_COAGULATION_CASCADES"
50,"Down",0.462971567278103,0.719542909218407,"L.LvsP.MINGUEZ_LIVER_CANCER_VASCULAR_INVASION_DN"
482,"Up",0.463037379453625,0.719542909218407,"L.LvsP.HOLLMANN_APOPTOSIS_VIA_CD40_DN"
79,"Down",0.463215430756407,0.719546015690097,"L.LvsP.SMIRNOV_RESPONSE_TO_IR_2HR_DN"
19,"Up",0.463299659225311,0.719546015690097,"L.LvsP.REACTOME_BUTYROPHILIN_BTN_FAMILY_INTERACTIONS"
89,"Down",0.46400742149534,0.720442862523935,"L.LvsP.ROY_WOUND_BLOOD_VESSEL_UP"
50,"Down",0.464156263432502,0.720471639673864,"L.LvsP.DASU_IL6_SIGNALING_SCAR_UP"
47,"Down",0.464951116248297,0.721491293631754,"L.LvsP.REACTOME_FATTY_ACIDS"
112,"Down",0.465336796948886,0.721491293631754,"L.LvsP.JAZAG_TGFB1_SIGNALING_VIA_SMAD4_DN"
79,"Up",0.465395799173949,0.721491293631754,"L.LvsP.HOLLERN_SOLID_NODULAR_BREAST_TUMOR_DN"
68,"Down",0.465397550146676,0.721491293631754,"L.LvsP.VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_DN"
325,"Down",0.465465625679954,0.721491293631754,"L.LvsP.LEE_DIFFERENTIATING_T_LYMPHOCYTE"
77,"Up",0.46570340981024,0.721657554047314,"L.LvsP.POMEROY_MEDULLOBLASTOMA_PROGNOSIS_UP"
15,"Down",0.466053802851473,0.721913130140275,"L.LvsP.BIOCARTA_AKAP95_PATHWAY"
84,"Down",0.466184938496961,0.721913130140275,"L.LvsP.SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER"
135,"Down",0.46629787753439,0.721913130140275,"L.LvsP.SEIDEN_ONCOGENESIS_BY_MET"
313,"Down",0.466393391637436,0.721913130140275,"L.LvsP.BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_DN"
96,"Down",0.466521181767264,0.721913130140275,"L.LvsP.LIU_SMARCA4_TARGETS"
344,"Up",0.467977485266956,0.723715440421946,"L.LvsP.DOANE_RESPONSE_TO_ANDROGEN_UP"
17,"Down",0.468239492493924,0.723715440421946,"L.LvsP.WEBER_METHYLATED_ICP_IN_SPERM_UP"
78,"Down",0.468323689091701,0.723715440421946,"L.LvsP.HANN_RESISTANCE_TO_BCL2_INHIBITOR_DN"
18,"Up",0.468337034446651,0.723715440421946,"L.LvsP.LOPEZ_MESOTHELIOMA_SURVIVAL_OVERALL_UP"
122,"Up",0.468340359166164,0.723715440421946,"L.LvsP.CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_UP"
19,"Up",0.469382651877322,0.725019998385551,"L.LvsP.REACTOME_TRANSLESION_SYNTHESIS_BY_POLK"
83,"Up",0.469446842868561,0.725019998385551,"L.LvsP.COWLING_MYCN_TARGETS"
14,"Up",0.469904558237214,0.725524239735705,"L.LvsP.BIOCARTA_RARRXR_PATHWAY"
67,"Down",0.470123730811469,0.725631575504605,"L.LvsP.YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_8"
87,"Up",0.47027103773925,0.725631575504605,"L.LvsP.BYSTROEM_CORRELATED_WITH_IL5_DN"
28,"Up",0.470367800073884,0.725631575504605,"L.LvsP.REACTOME_DISEASES_OF_IMMUNE_SYSTEM"
779,"Up",0.470658666847169,0.725721066958507,"L.LvsP.MIKKELSEN_NPC_ICP_WITH_H3K4ME3"
37,"Down",0.470721522739181,0.725721066958507,"L.LvsP.REACTOME_SYNTHESIS_OF_16_20_HYDROXYEICOSATETRAENOIC_ACIDS_HETE"
67,"Up",0.470893219571264,0.725721066958507,"L.LvsP.BROWNE_HCMV_INFECTION_2HR_UP"
150,"Up",0.470977694439538,0.725721066958507,"L.LvsP.TANAKA_METHYLATED_IN_ESOPHAGEAL_CARCINOMA"
63,"Down",0.471082096095873,0.725721066958507,"L.LvsP.TOMLINS_PROSTATE_CANCER_DN"
113,"Down",0.472124219571268,0.726914286611739,"L.LvsP.REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE"
81,"Down",0.472212293039414,0.726914286611739,"L.LvsP.CROMER_TUMORIGENESIS_DN"
27,"Up",0.472385718824555,0.726914286611739,"L.LvsP.KASLER_HDAC7_TARGETS_1_DN"
113,"Down",0.472461085493986,0.726914286611739,"L.LvsP.FAELT_B_CLL_WITH_VH_REARRANGEMENTS_UP"
412,"Up",0.472702458803585,0.726914286611739,"L.LvsP.CHYLA_CBFA2T3_TARGETS_DN"
80,"Down",0.472721657000088,0.726914286611739,"L.LvsP.REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES"
640,"Up",0.472776953274699,0.726914286611739,"L.LvsP.LU_EZH2_TARGETS_DN"
86,"Down",0.473036187646263,0.727110670418735,"L.LvsP.REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS"
250,"Up",0.473285021234801,0.727290962314401,"L.LvsP.TAVAZOIE_METASTASIS"
72,"Down",0.473433534159223,0.72731703538937,"L.LvsP.DORSEY_GAB2_TARGETS"
14,"Up",0.473773976899433,0.727634649021942,"L.LvsP.BIOCARTA_FXR_PATHWAY"
111,"Down",0.473903485463558,0.727634649021942,"L.LvsP.MCBRYAN_PUBERTAL_TGFB1_TARGETS_DN"
25,"Down",0.474235082045727,0.727787757594635,"L.LvsP.MCGOWAN_RSP6_TARGETS_UP"
436,"Down",0.47426646601799,0.727787757594635,"L.LvsP.VANTVEER_BREAST_CANCER_ESR1_DN"
106,"Down",0.475325497169587,0.729002365607371,"L.LvsP.REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE"
4,"Up",0.475342904508552,0.729002365607371,"L.LvsP.REACTOME_METALLOTHIONEINS_BIND_METALS"
19,"Down",0.475453523309853,0.729002365607371,"L.LvsP.REACTOME_INTERACTION_WITH_CUMULUS_CELLS_AND_THE_ZONA_PELLUCIDA"
267,"Down",0.475807630790536,0.72934305257579,"L.LvsP.MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_DN"
1485,"Down",0.476268133431316,0.729846593609132,"L.LvsP.NUYTTEN_EZH2_TARGETS_UP"
39,"Down",0.476419185230387,0.729868208037416,"L.LvsP.PID_VEGFR1_PATHWAY"
51,"Up",0.476546252670478,0.729868208037416,"L.LvsP.PID_FAS_PATHWAY"
63,"Down",0.477011901716777,0.730379065242885,"L.LvsP.AMIT_EGF_RESPONSE_40_HELA"
35,"Down",0.477144983739707,0.730379907480173,"L.LvsP.PID_S1P_S1P2_PATHWAY"
202,"Down",0.477276651424464,0.730379907480173,"L.LvsP.BROWNE_HCMV_INFECTION_20HR_DN"
341,"Down",0.47753746236975,0.730576820542984,"L.LvsP.BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_DN"
355,"Down",0.477742604205065,0.730609001596807,"L.LvsP.RIZKI_TUMOR_INVASIVENESS_3D_UP"
46,"Down",0.477822779846998,0.730609001596807,"L.LvsP.SCHLOSSER_MYC_AND_SERUM_RESPONSE_SYNERGY"
38,"Up",0.478508252229746,0.730824916368855,"L.LvsP.CHOW_RASSF1_TARGETS_UP"
77,"Up",0.478524006016162,0.730824916368855,"L.LvsP.KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM"
12,"Down",0.478647056861482,0.730824916368855,"L.LvsP.LY_AGING_OLD_UP"
510,"Up",0.478719384631079,0.730824916368855,"L.LvsP.FARMER_BREAST_CANCER_APOCRINE_VS_LUMINAL"
195,"Up",0.478774477655304,0.730824916368855,"L.LvsP.REACTOME_ION_CHANNEL_TRANSPORT"
129,"Down",0.478912022796457,0.730824916368855,"L.LvsP.JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_DN"
60,"Down",0.478920915688693,0.730824916368855,"L.LvsP.PID_TNF_PATHWAY"
72,"Down",0.479198949473409,0.730824916368855,"L.LvsP.DAZARD_UV_RESPONSE_CLUSTER_G4"
357,"Up",0.479224212695179,0.730824916368855,"L.LvsP.REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS"
265,"Down",0.479342552738328,0.730824916368855,"L.LvsP.TSAI_RESPONSE_TO_IONIZING_RADIATION"
22,"Down",0.479583924752751,0.730824916368855,"L.LvsP.REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE_FGFR2"
156,"Down",0.479617195531965,0.730824916368855,"L.LvsP.LEE_AGING_CEREBELLUM_UP"
12,"Up",0.479729781063696,0.730824916368855,"L.LvsP.KEGG_TAURINE_AND_HYPOTAURINE_METABOLISM"
36,"Down",0.479814513731044,0.730824916368855,"L.LvsP.AMUNDSON_DNA_DAMAGE_RESPONSE_TP53"
46,"Down",0.480087201885384,0.731038870620845,"L.LvsP.CHANGOLKAR_H2AFY_TARGETS_DN"
22,"Up",0.480444284854432,0.731334317751763,"L.LvsP.TSUNODA_CISPLATIN_RESISTANCE_UP"
18,"Down",0.480545772543345,0.731334317751763,"L.LvsP.MARIADASON_RESPONSE_TO_CURCUMIN_SULINDAC_7"
10,"Up",0.481106727154862,0.731540586387814,"L.LvsP.BIOCARTA_PEPI_PATHWAY"
26,"Down",0.481152147340318,0.731540586387814,"L.LvsP.REACTOME_THROMBOXANE_SIGNALLING_THROUGH_TP_RECEPTOR"
36,"Up",0.481210502945112,0.731540586387814,"L.LvsP.GRAHAM_CML_DIVIDING_VS_NORMAL_DIVIDING_UP"
16,"Up",0.481210546697862,0.731540586387814,"L.LvsP.BIOCARTA_TCYTOTOXIC_PATHWAY"
15,"Up",0.481383467464612,0.731602306655261,"L.LvsP.KEGG_GLYCOSPHINGOLIPID_BIOSYNTHESIS_GLOBO_SERIES"
456,"Up",0.48156644843335,0.731679278205,"L.LvsP.CAIRO_HEPATOBLASTOMA_DN"
18,"Down",0.481789032034396,0.731816362120378,"L.LvsP.REACTOME_PECAM1_INTERACTIONS"
62,"Down",0.482027238777434,0.731862925621651,"L.LvsP.REACTOME_XENOBIOTICS"
188,"Down",0.48208442306277,0.731862925621651,"L.LvsP.KIM_MYC_AMPLIFICATION_TARGETS_DN"
16,"Down",0.482687506612903,0.732160154902742,"L.LvsP.REACTOME_ERYTHROPOIETIN_ACTIVATES_PHOSPHOINOSITIDE_3_KINASE_PI3K"
18,"Up",0.482879198606693,0.732160154902742,"L.LvsP.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_DN"
171,"Down",0.483038126963036,0.732160154902742,"L.LvsP.LIU_NASOPHARYNGEAL_CARCINOMA"
130,"Up",0.483039932528586,0.732160154902742,"L.LvsP.REACTOME_PROTEIN_UBIQUITINATION"
516,"Down",0.483061951441614,0.732160154902742,"L.LvsP.LI_INDUCED_T_TO_NATURAL_KILLER_UP"
152,"Up",0.483200869452089,0.732160154902742,"L.LvsP.WONG_ENDMETRIUM_CANCER_DN"
103,"Down",0.483373924417759,0.732160154902742,"L.LvsP.FIGUEROA_AML_METHYLATION_CLUSTER_2_UP"
105,"Up",0.483424773856593,0.732160154902742,"L.LvsP.GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_DN"
184,"Down",0.483472006791447,0.732160154902742,"L.LvsP.NIKOLSKY_BREAST_CANCER_20Q12_Q13_AMPLICON"
62,"Up",0.484235080754614,0.733114940167651,"L.LvsP.AIYAR_COBRA1_TARGETS_UP"
95,"Down",0.484460372383143,0.733255241967259,"L.LvsP.DANG_REGULATED_BY_MYC_UP"
22,"Up",0.484758089251048,0.733476924087852,"L.LvsP.REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_27_HYDROXYCHOLESTEROL"
37,"Down",0.484975739560172,0.733476924087852,"L.LvsP.REACTOME_BIOSYNTHESIS_OF_MARESIN_LIKE_SPMS"
37,"Up",0.485124701668933,0.733476924087852,"L.LvsP.GHO_ATF5_TARGETS_UP"
36,"Up",0.485137477191042,0.733476924087852,"L.LvsP.GAVIN_PDE3B_TARGETS"
308,"Down",0.48552744448222,0.733752435217455,"L.LvsP.BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_TRANS"
19,"Down",0.485650766009575,0.733752435217455,"L.LvsP.REACTOME_INTERLEUKIN_15_SIGNALING"
1038,"Up",0.486039274080669,0.733752435217455,"L.LvsP.WEI_MYCN_TARGETS_WITH_E_BOX"
31,"Down",0.48622485903362,0.733752435217455,"L.LvsP.REACTOME_POSTMITOTIC_NUCLEAR_PORE_COMPLEX_NPC_REFORMATION"
87,"Up",0.486230821916007,0.733752435217455,"L.LvsP.ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_DN"
147,"Up",0.486279931033162,0.733752435217455,"L.LvsP.CHEN_LIVER_METABOLISM_QTL_CIS"
28,"Up",0.486324477594522,0.733752435217455,"L.LvsP.KRISHNAN_FURIN_TARGETS_UP"
23,"Up",0.486381384531013,0.733752435217455,"L.LvsP.REACTOME_E2F_MEDIATED_REGULATION_OF_DNA_REPLICATION"
22,"Up",0.487136419744679,0.734525351917196,"L.LvsP.MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_4"
19,"Down",0.487207783741118,0.734525351917196,"L.LvsP.REACTOME_CGMP_EFFECTS"
16,"Down",0.487307338391868,0.734525351917196,"L.LvsP.HOFMANN_MYELODYSPLASTIC_SYNDROM_HIGH_RISK_UP"
6,"Down",0.487425125010706,0.734525351917196,"L.LvsP.REACTOME_BETA_OXIDATION_OF_DECANOYL_COA_TO_OCTANOYL_COA_COA"
42,"Up",0.487666886798976,0.734655230693695,"L.LvsP.KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM"
259,"Up",0.487832060800881,0.734655230693695,"L.LvsP.RICKMAN_HEAD_AND_NECK_CANCER_C"
27,"Down",0.487975376979459,0.734655230693695,"L.LvsP.REACTOME_SYNTHESIS_OF_EPOXY_EET_AND_DIHYDROXYEICOSATRIENOIC_ACIDS_DHET"
504,"Down",0.488042803823104,0.734655230693695,"L.LvsP.FARMER_BREAST_CANCER_BASAL_VS_LULMINAL"
40,"Up",0.488629964969567,0.735237039517133,"L.LvsP.SHIN_B_CELL_LYMPHOMA_CLUSTER_2"
64,"Up",0.488695265007318,0.735237039517133,"L.LvsP.PIONTEK_PKD1_TARGETS_DN"
65,"Up",0.489193831915472,0.735659824714368,"L.LvsP.GROSS_HYPOXIA_VIA_ELK3_ONLY_DN"
20,"Up",0.489331239377284,0.735659824714368,"L.LvsP.TERAMOTO_OPN_TARGETS_CLUSTER_1"
197,"Up",0.489436325703037,0.735659824714368,"L.LvsP.GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_UP"
12,"Up",0.489508499751159,0.735659824714368,"L.LvsP.REACTOME_P2Y_RECEPTORS"
62,"Down",0.489679609161758,0.735716999743304,"L.LvsP.KORKOLA_CORRELATED_WITH_POU5F1"
120,"Down",0.490035724738666,0.73605202990494,"L.LvsP.HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_DN"
462,"Down",0.490387308862342,0.736380073519796,"L.LvsP.MULLIGHAN_MLL_SIGNATURE_2_DN"
52,"Down",0.490829882621835,0.736844534622896,"L.LvsP.FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_UP"
140,"Up",0.491127794259279,0.737091632589455,"L.LvsP.GNATENKO_PLATELET_SIGNATURE"
25,"Up",0.491266695863462,0.737100016670036,"L.LvsP.KEGG_RENIN_ANGIOTENSIN_SYSTEM"
27,"Down",0.491920267962856,0.737880401944284,"L.LvsP.REACTOME_NEGATIVE_REGULATION_OF_NMDA_RECEPTOR_MEDIATED_NEURONAL_TRANSMISSION"
61,"Down",0.492122438631015,0.737982976195868,"L.LvsP.FRIDMAN_IMMORTALIZATION_DN"
6,"Up",0.492255600689159,0.737982976195868,"L.LvsP.REACTOME_TRAFFICKING_OF_MYRISTOYLATED_PROTEINS_TO_THE_CILIUM"
65,"Down",0.492484784409265,0.738126422607435,"L.LvsP.CHOI_ATL_STAGE_PREDICTOR"
11,"Down",0.49284615495104,0.738283927431709,"L.LvsP.MULLIGAN_NTF3_SIGNALING_VIA_INSR_AND_IGF1R_DN"
62,"Down",0.492955312621538,0.738283927431709,"L.LvsP.SIG_BCR_SIGNALING_PATHWAY"
30,"Down",0.493110938339137,0.738283927431709,"L.LvsP.REACTOME_ATF4_ACTIVATES_GENES_IN_RESPONSE_TO_ENDOPLASMIC_RETICULUM_STRESS"
9,"Down",0.493123990596003,0.738283927431709,"L.LvsP.CALVET_IRINOTECAN_SENSITIVE_VS_REVERTED_UP"
99,"Up",0.493423271030988,0.738532015573994,"L.LvsP.LEE_LIVER_CANCER_MYC_E2F1_DN"
24,"Down",0.494012479308166,0.738962110639826,"L.LvsP.CAIRO_PML_TARGETS_BOUND_BY_MYC_DN"
49,"Up",0.494097322092917,0.738962110639826,"L.LvsP.ONO_AML1_TARGETS_DN"
59,"Down",0.494111579496372,0.738962110639826,"L.LvsP.KEGG_RNA_DEGRADATION"
15,"Down",0.494568097924421,0.739444838676075,"L.LvsP.REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_TO_CONTROL_BILE_ACID_HOMEOSTASIS"
8,"Up",0.494761553678157,0.739534098482436,"L.LvsP.LAU_APOPTOSIS_CDKN2A_DN"
117,"Down",0.495419655482909,0.740317641936487,"L.LvsP.LINDSTEDT_DENDRITIC_CELL_MATURATION_D"
266,"Up",0.496108327169371,0.741006620654597,"L.LvsP.KIM_RESPONSE_TO_TSA_AND_DECITABINE_UP"
29,"Down",0.496148762825704,0.741006620654597,"L.LvsP.REACTOME_G_PROTEIN_ACTIVATION"
32,"Down",0.4965937821753,0.741470975330066,"L.LvsP.REACTOME_HS_GAG_BIOSYNTHESIS"
224,"Up",0.497125098067094,0.742063895035897,"L.LvsP.PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_UP"
10,"Up",0.498184415352229,0.743372372595244,"L.LvsP.GERHOLD_RESPONSE_TO_TZD_UP"
362,"Down",0.498421503340509,0.743372372595244,"L.LvsP.MULLIGHAN_NPM1_SIGNATURE_3_DN"
137,"Down",0.498470092141969,0.743372372595244,"L.LvsP.BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_C"
19,"Down",0.498539475055736,0.743372372595244,"L.LvsP.REACTOME_GLYCOGEN_STORAGE_DISEASES"
306,"Down",0.49891782192157,0.743471255087983,"L.LvsP.CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_UP"
32,"Down",0.498982959021518,0.743471255087983,"L.LvsP.BIOCARTA_MTA3_PATHWAY"
290,"Down",0.499086562947963,0.743471255087983,"L.LvsP.GREGORY_SYNTHETIC_LETHAL_WITH_IMATINIB"
58,"Up",0.499258963354179,0.743471255087983,"L.LvsP.BYSTRYKH_HEMATOPOIESIS_STEM_CELL_SCP2_QTL_TRANS"
95,"Up",0.49929298758256,0.743471255087983,"L.LvsP.REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_CELL_DEATH_GENES"
1026,"Down",0.499412595658667,0.743471255087983,"L.LvsP.GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN"
26,"Down",0.499946339729236,0.743825452298981,"L.LvsP.BIOCARTA_CSK_PATHWAY"
661,"Up",0.500155397568694,0.743825452298981,"L.LvsP.DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_UP"
26,"Down",0.500213445045061,0.743825452298981,"L.LvsP.BIOCARTA_LAIR_PATHWAY"
83,"Down",0.500318229078617,0.743825452298981,"L.LvsP.HAN_JNK_SINGALING_UP"
297,"Down",0.500323179073958,0.743825452298981,"L.LvsP.OKUMURA_INFLAMMATORY_RESPONSE_LPS"
97,"Down",0.500572411573731,0.743995931072892,"L.LvsP.BEIER_GLIOMA_STEM_CELL_DN"
137,"Down",0.501446496132266,0.744671217847933,"L.LvsP.GAVIN_FOXP3_TARGETS_CLUSTER_T4"
29,"Up",0.501477193493084,0.744671217847933,"L.LvsP.PID_HEDGEHOG_2PATHWAY"
383,"Down",0.501555901062458,0.744671217847933,"L.LvsP.MULLIGHAN_MLL_SIGNATURE_1_DN"
12,"Up",0.501666353903614,0.744671217847933,"L.LvsP.SHIRAISHI_PLZF_TARGETS_DN"
71,"Down",0.501700178419886,0.744671217847933,"L.LvsP.TAVOR_CEBPA_TARGETS_DN"
295,"Down",0.50225465059122,0.74525249451768,"L.LvsP.WHITFIELD_CELL_CYCLE_G2_M"
23,"Up",0.502361375848687,0.74525249451768,"L.LvsP.BIOCARTA_MITOCHONDRIA_PATHWAY"
97,"Down",0.502635815826088,0.745459609898723,"L.LvsP.KUNINGER_IGF1_VS_PDGFB_TARGETS_DN"
166,"Down",0.503208160431083,0.746108318322193,"L.LvsP.HUMMERICH_SKIN_CANCER_PROGRESSION_UP"
15,"Down",0.503387029702538,0.746173428210546,"L.LvsP.REACTOME_HYALURONAN_UPTAKE_AND_DEGRADATION"
24,"Up",0.503589079290243,0.746272361248562,"L.LvsP.BIOCARTA_NOS1_PATHWAY"
7,"Up",0.503723720777651,0.746272361248562,"L.LvsP.BAKER_HEMATOPOESIS_STAT5_TARGETS"
347,"Down",0.503986754204289,0.746399780959336,"L.LvsP.BLUM_RESPONSE_TO_SALIRASIB_UP"
35,"Down",0.504079721848826,0.746399780959336,"L.LvsP.REACTOME_GLUCAGON_SIGNALING_IN_METABOLIC_REGULATION"
18,"Down",0.504477906900506,0.746789383467978,"L.LvsP.RANKIN_ANGIOGENIC_TARGETS_OF_VHL_HIF2A_DN"
30,"Down",0.504928121517872,0.74725577726775,"L.LvsP.BIOCARTA_IGF1MTOR_PATHWAY"
131,"Up",0.505436183302973,0.747641795854103,"L.LvsP.KEGG_CELL_CYCLE"
65,"Up",0.505552118885882,0.747641795854103,"L.LvsP.NAKAMURA_CANCER_MICROENVIRONMENT_UP"
225,"Down",0.50559462374724,0.747641795854103,"L.LvsP.HOOI_ST7_TARGETS_DN"
663,"Down",0.505829802255131,0.747789565954177,"L.LvsP.BERENJENO_TRANSFORMED_BY_RHOA_DN"
12,"Down",0.506346631473076,0.748193993824235,"L.LvsP.REACTOME_REGULATION_OF_GENE_EXPRESSION_BY_HYPOXIA_INDUCIBLE_FACTOR"
46,"Down",0.506500023333752,0.748193993824235,"L.LvsP.BIOCARTA_GPCR_PATHWAY"
10,"Up",0.506516707625909,0.748193993824235,"L.LvsP.REACTOME_REACTIONS_SPECIFIC_TO_THE_COMPLEX_N_GLYCAN_SYNTHESIS_PATHWAY"
306,"Up",0.506644657782227,0.748193993824235,"L.LvsP.ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP"
47,"Down",0.507093893738709,0.748502554690798,"L.LvsP.BIOCARTA_BIOPEPTIDES_PATHWAY"
139,"Up",0.507285901836237,0.748502554690798,"L.LvsP.GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP"
37,"Down",0.507475060178838,0.748502554690798,"L.LvsP.YANAGIHARA_ESX1_TARGETS"
307,"Down",0.507651151255677,0.748502554690798,"L.LvsP.CAIRO_HEPATOBLASTOMA_UP"
36,"Down",0.50777020595016,0.748502554690798,"L.LvsP.KANG_AR_TARGETS_UP"
177,"Down",0.507806316450045,0.748502554690798,"L.LvsP.JAZAG_TGFB1_SIGNALING_UP"
75,"Up",0.50790747347833,0.748502554690798,"L.LvsP.REACTOME_CHEMOKINE_RECEPTORS_BIND_CHEMOKINES"
63,"Up",0.507936622391006,0.748502554690798,"L.LvsP.GAUSSMANN_MLL_AF4_FUSION_TARGETS_D_UP"
199,"Up",0.508203935878934,0.748537059915972,"L.LvsP.GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN"
134,"Up",0.508230805376118,0.748537059915972,"L.LvsP.VANHARANTA_UTERINE_FIBROID_DN"
31,"Down",0.50887992905381,0.749194614027576,"L.LvsP.CARDOSO_RESPONSE_TO_GAMMA_RADIATION_AND_3AB"
30,"Down",0.508948267369791,0.749194614027576,"L.LvsP.REACTOME_CD28_DEPENDENT_PI3K_AKT_SIGNALING"
57,"Down",0.509363521326564,0.749606310730523,"L.LvsP.KEGG_MTOR_SIGNALING_PATHWAY"
23,"Up",0.509546451179271,0.749675978863808,"L.LvsP.FIGUEROA_AML_METHYLATION_CLUSTER_2_DN"
82,"Up",0.509953785218754,0.750075679296219,"L.LvsP.DAIRKEE_CANCER_PRONE_RESPONSE_BPA"
56,"Up",0.510500046790329,0.750679457102056,"L.LvsP.MCCABE_HOXC6_TARGETS_CANCER_UP"
52,"Up",0.510795303263934,0.750880140846152,"L.LvsP.WANG_RESPONSE_TO_BEXAROTENE_UP"
14,"Up",0.510908137070577,0.750880140846152,"L.LvsP.BIOCARTA_EXTRINSIC_PATHWAY"
73,"Up",0.51114706253115,0.750989027458075,"L.LvsP.JAEGER_METASTASIS_UP"
29,"Down",0.511253879427056,0.750989027458075,"L.LvsP.GESERICK_TERT_TARGETS_DN"
49,"Up",0.511601439040655,0.751299961874046,"L.LvsP.WANG_NEOPLASTIC_TRANSFORMATION_BY_CCND1_MYC"
83,"Down",0.511894761142379,0.751531103121672,"L.LvsP.DAUER_STAT3_TARGETS_UP"
78,"Down",0.512124716003408,0.751615850264994,"L.LvsP.PID_ERBB4_PATHWAY"
22,"Up",0.512266572322208,0.751615850264994,"L.LvsP.REACTOME_CHONDROITIN_SULFATE_BIOSYNTHESIS"
478,"Down",0.512360307406179,0.751615850264994,"L.LvsP.DAZARD_RESPONSE_TO_UV_NHEK_UP"
71,"Down",0.512823738944196,0.751669894341278,"L.LvsP.ZHENG_FOXP3_TARGETS_IN_T_LYMPHOCYTE_DN"
127,"Down",0.512904650277553,0.751669894341278,"L.LvsP.VANDESLUIS_COMMD1_TARGETS_GROUP_3_UP"
6,"Down",0.513018965369057,0.751669894341278,"L.LvsP.REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_LINKED_TO_TRIGLYCERIDE_LIPOLYSIS_IN_ADIPOSE"
5,"Down",0.513262765122271,0.751669894341278,"L.LvsP.REACTOME_MRNA_EDITING_C_TO_U_CONVERSION"
58,"Up",0.513283479742422,0.751669894341278,"L.LvsP.WANG_RESPONSE_TO_ANDROGEN_UP"
7,"Down",0.513437426563049,0.751669894341278,"L.LvsP.REACTOME_ALTERNATIVE_COMPLEMENT_ACTIVATION"
30,"Up",0.513468212911571,0.751669894341278,"L.LvsP.IIZUKA_LIVER_CANCER_PROGRESSION_L1_G1_UP"
151,"Down",0.51352505345742,0.751669894341278,"L.LvsP.IGARASHI_ATF4_TARGETS_DN"
33,"Down",0.513620701902938,0.751669894341278,"L.LvsP.TURASHVILI_BREAST_CARCINOMA_DUCTAL_VS_LOBULAR_UP"
74,"Down",0.514130588372209,0.752174223421864,"L.LvsP.FUJII_YBX1_TARGETS_UP"
181,"Up",0.514350960939113,0.752174223421864,"L.LvsP.RICKMAN_HEAD_AND_NECK_CANCER_E"
175,"Down",0.514449040515083,0.752174223421864,"L.LvsP.REACTOME_INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING"
37,"Up",0.514509479649392,0.752174223421864,"L.LvsP.REACTOME_STING_MEDIATED_INDUCTION_OF_HOST_IMMUNE_RESPONSES"
58,"Down",0.514706830040524,0.752263828520766,"L.LvsP.REACTOME_SNRNP_ASSEMBLY"
310,"Down",0.515023317822383,0.752265465215689,"L.LvsP.KARLSSON_TGFB1_TARGETS_DN"
72,"Down",0.515087628557355,0.752265465215689,"L.LvsP.NICK_RESPONSE_TO_PROC_TREATMENT_DN"
385,"Down",0.515232118796745,0.752265465215689,"L.LvsP.NABA_SECRETED_FACTORS"
28,"Down",0.515252182451043,0.752265465215689,"L.LvsP.REACTOME_INTERLEUKIN_37_SIGNALING"
253,"Up",0.516023711348051,0.753050505134572,"L.LvsP.LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_UP"
179,"Down",0.516142776659389,0.753050505134572,"L.LvsP.BOUDOUKHA_BOUND_BY_IGF2BP2"
135,"Down",0.516198483353233,0.753050505134572,"L.LvsP.FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_DN"
29,"Up",0.516838846845514,0.753785804328369,"L.LvsP.SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_2FC_DN"
34,"Down",0.517120950779761,0.753836208219798,"L.LvsP.PID_WNT_SIGNALING_PATHWAY"
155,"Up",0.517146091115517,0.753836208219798,"L.LvsP.ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_UP"
73,"Down",0.517284042416386,0.753838553115498,"L.LvsP.TAVOR_CEBPA_TARGETS_UP"
48,"Down",0.517575893138018,0.754065115457208,"L.LvsP.REACTOME_VASOPRESSIN_REGULATES_RENAL_WATER_HOMEOSTASIS_VIA_AQUAPORINS"
163,"Down",0.518218762376261,0.754802828550671,"L.LvsP.RHEIN_ALL_GLUCOCORTICOID_THERAPY_UP"
969,"Down",0.51839266064218,0.754857261177406,"L.LvsP.RAO_BOUND_BY_SALL4_ISOFORM_B"
96,"Down",0.518603718997818,0.754965761542637,"L.LvsP.REACTOME_APC_C_MEDIATED_DEGRADATION_OF_CELL_CYCLE_PROTEINS"
14,"Up",0.518820281654887,0.755082215654086,"L.LvsP.REACTOME_REGULATION_BY_C_FLIP"
24,"Down",0.519151224919307,0.755365032257591,"L.LvsP.SHIN_B_CELL_LYMPHOMA_CLUSTER_9"
26,"Down",0.519426185786654,0.7555662670914,"L.LvsP.WIKMAN_ASBESTOS_LUNG_CANCER_UP"
266,"Up",0.519730044414273,0.75573833194218,"L.LvsP.MIKKELSEN_IPS_LCP_WITH_H3K4ME3"
42,"Down",0.519817847056631,0.75573833194218,"L.LvsP.REACTOME_INTERACTIONS_OF_REV_WITH_HOST_CELLULAR_PROTEINS"
7,"Down",0.52007669862928,0.755915895562905,"L.LvsP.REACTOME_PHASE_1_INACTIVATION_OF_FAST_NA_CHANNELS"
521,"Up",0.52059216567906,0.75644081944693,"L.LvsP.WALLACE_PROSTATE_CANCER_RACE_UP"
100,"Up",0.520809793710203,0.75644081944693,"L.LvsP.PID_CD8_TCR_PATHWAY"
153,"Down",0.520848290764056,0.75644081944693,"L.LvsP.ROSS_LEUKEMIA_WITH_MLL_FUSIONS"
21,"Down",0.521133883947513,0.756621994874102,"L.LvsP.REACTOME_ACYL_CHAIN_REMODELLING_OF_PG"
26,"Up",0.521246731502162,0.756621994874102,"L.LvsP.NIKOLSKY_BREAST_CANCER_6P24_P22_AMPLICON"
205,"Down",0.521472934218144,0.75668550941602,"L.LvsP.SENESE_HDAC2_TARGETS_DN"
15,"Down",0.52156420263781,0.75668550941602,"L.LvsP.PARK_OSTEOBLAST_DIFFERENTIATION_BY_PHENYLAMIL_DN"
26,"Up",0.522449363938626,0.757474006745216,"L.LvsP.BALLIF_DEVELOPMENTAL_DISABILITY_P16_P12_DELETION"
56,"Up",0.522601393586816,0.757474006745216,"L.LvsP.KEGG_STARCH_AND_SUCROSE_METABOLISM"
241,"Up",0.522621737045085,0.757474006745216,"L.LvsP.BAKKER_FOXO3_TARGETS_DN"
180,"Down",0.522655694652378,0.757474006745216,"L.LvsP.KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY"
11,"Up",0.52296609678555,0.75756373350567,"L.LvsP.REACTOME_HIGHLY_CALCIUM_PERMEABLE_POSTSYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS"
92,"Up",0.523083342258536,0.75756373350567,"L.LvsP.REACTOME_RAB_GEFS_EXCHANGE_GTP_FOR_GDP_ON_RABS"
10,"Up",0.523128655186227,0.75756373350567,"L.LvsP.REACTOME_NOSTRIN_MEDIATED_ENOS_TRAFFICKING"
19,"Down",0.523379131474046,0.757703019986708,"L.LvsP.HEIDENBLAD_AMPLIFIED_IN_SOFT_TISSUE_CANCER"
88,"Up",0.523498921387091,0.757703019986708,"L.LvsP.GALE_APL_WITH_FLT3_MUTATED_UP"
230,"Up",0.524154728856917,0.758453675961763,"L.LvsP.PASINI_SUZ12_TARGETS_UP"
301,"Down",0.524448809794835,0.758680656555637,"L.LvsP.ASTON_MAJOR_DEPRESSIVE_DISORDER_DN"
134,"Down",0.524634172524814,0.758750285087548,"L.LvsP.SASSON_RESPONSE_TO_GONADOTROPHINS_UP"
20,"Down",0.524776763744758,0.758758035236602,"L.LvsP.REACTOME_ACTIVATION_OF_THE_PHOTOTRANSDUCTION_CASCADE"
47,"Down",0.525056722215443,0.7589643443475,"L.LvsP.YAGI_AML_RELAPSE_PROGNOSIS"
51,"Down",0.525535360410067,0.759457660143037,"L.LvsP.RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_DN"
439,"Down",0.526078937226853,0.759899871546982,"L.LvsP.LIU_SOX4_TARGETS_DN"
100,"Down",0.526116243132908,0.759899871546982,"L.LvsP.RAMASWAMY_METASTASIS_UP"
20,"Up",0.526642516562595,0.760461340839537,"L.LvsP.ALONSO_METASTASIS_EMT_DN"
165,"Down",0.527433933937585,0.761405279566817,"L.LvsP.REACTOME_MITOTIC_G1_PHASE_AND_G1_S_TRANSITION"
11,"Down",0.527748251814127,0.761488436407868,"L.LvsP.SCHMAHL_PDGF_SIGNALING"
111,"Down",0.527766990109414,0.761488436407868,"L.LvsP.BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_DN"
19,"Down",0.528028946424414,0.761667634954497,"L.LvsP.GALLUZZI_PREVENT_MITOCHONDIAL_PERMEABILIZATION"
7,"Up",0.528344360023908,0.761923830613507,"L.LvsP.REACTOME_ALPHA_OXIDATION_OF_PHYTANATE"
250,"Down",0.528495675766017,0.76194330933776,"L.LvsP.DARWICHE_SQUAMOUS_CELL_CARCINOMA_UP"
29,"Down",0.528803781396658,0.762188766251856,"L.LvsP.RUAN_RESPONSE_TO_TNF_UP"
78,"Down",0.529164679178815,0.762489005961047,"L.LvsP.REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS"
24,"Down",0.529287901045125,0.762489005961047,"L.LvsP.REACTOME_PI_3K_CASCADE_FGFR4"
29,"Up",0.52951871696689,0.762560227251569,"L.LvsP.LEI_HOXC8_TARGETS_DN"
55,"Down",0.529663131537667,0.762560227251569,"L.LvsP.ROY_WOUND_BLOOD_VESSEL_DN"
32,"Down",0.529751100176031,0.762560227251569,"L.LvsP.BIOCARTA_EPO_PATHWAY"
20,"Down",0.530505270611993,0.76344706955068,"L.LvsP.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_27"
165,"Up",0.530693957580694,0.763519878080578,"L.LvsP.HELLER_SILENCED_BY_METHYLATION_DN"
30,"Down",0.531286990487367,0.764174237878421,"L.LvsP.STREICHER_LSM1_TARGETS_DN"
31,"Down",0.531546327416895,0.764348412038494,"L.LvsP.REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION"
29,"Down",0.531694434191868,0.764362591431835,"L.LvsP.MURAKAMI_UV_RESPONSE_1HR_UP"
145,"Up",0.532278820756061,0.765000178847267,"L.LvsP.MORI_PRE_BI_LYMPHOCYTE_DN"
33,"Down",0.532414665980156,0.765000178847267,"L.LvsP.BIOCARTA_TOLL_PATHWAY"
27,"Up",0.532915384143231,0.765520696006215,"L.LvsP.REACTOME_METABOLISM_OF_NITRIC_OXIDE_ENOS_ACTIVATION_AND_REGULATION"
16,"Up",0.533373853428859,0.76580540276462,"L.LvsP.BIOCARTA_RB_PATHWAY"
74,"Down",0.533390596137918,0.76580540276462,"L.LvsP.REACTOME_DUAL_INCISION_IN_TC_NER"
54,"Down",0.533832285862008,0.76609316984581,"L.LvsP.ROZANOV_MMP14_TARGETS_DN"
57,"Down",0.533868146756358,0.76609316984581,"L.LvsP.LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_DN"
42,"Up",0.534045406271086,0.766148690003331,"L.LvsP.BURTON_ADIPOGENESIS_12"
54,"Down",0.534889428319075,0.767096474800011,"L.LvsP.VANDESLUIS_COMMD1_TARGETS_GROUP_3_DN"
176,"Down",0.535067098342191,0.767096474800011,"L.LvsP.STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_UP"
11,"Down",0.535257484001129,0.767096474800011,"L.LvsP.KEGG_FOLATE_BIOSYNTHESIS"
1622,"Down",0.535331852487186,0.767096474800011,"L.LvsP.BENPORATH_ES_WITH_H3K27ME3"
975,"Down",0.535451660116466,0.767096474800011,"L.LvsP.BENPORATH_PRC2_TARGETS"
17,"Down",0.535538504743723,0.767096474800011,"L.LvsP.REACTOME_RESPONSE_OF_EIF2AK1_HRI_TO_HEME_DEFICIENCY"
174,"Up",0.536095080103433,0.767578920316338,"L.LvsP.YAMASHITA_METHYLATED_IN_PROSTATE_CANCER"
588,"Down",0.53620426448646,0.767578920316338,"L.LvsP.HUTTMANN_B_CLL_POOR_SURVIVAL_UP"
5,"Up",0.536291801262799,0.767578920316338,"L.LvsP.REACTOME_TACHYKININ_RECEPTORS_BIND_TACHYKININS"
26,"Down",0.537174338468275,0.768643094562911,"L.LvsP.BIOCARTA_41BB_PATHWAY"
237,"Up",0.537313385763185,0.768643133217245,"L.LvsP.LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN"
48,"Up",0.537952483622303,0.769075129835958,"L.LvsP.JACKSON_DNMT1_TARGETS_DN"
6,"Down",0.538154518357218,0.769075129835958,"L.LvsP.REACTOME_THE_FATTY_ACID_CYCLING_MODEL"
60,"Down",0.538219523325242,0.769075129835958,"L.LvsP.MATZUK_SPERMATID_DIFFERENTIATION"
73,"Up",0.538252586539943,0.769075129835958,"L.LvsP.SCHLESINGER_H3K27ME3_IN_NORMAL_AND_METHYLATED_IN_CANCER"
58,"Up",0.538369855430128,0.769075129835958,"L.LvsP.SCHLINGEMANN_SKIN_CARCINOGENESIS_TPA_DN"
378,"Up",0.538449959774823,0.769075129835958,"L.LvsP.REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL"
103,"Up",0.539128740721519,0.769541282630701,"L.LvsP.MARTIN_VIRAL_GPCR_SIGNALING_DN"
123,"Up",0.539287979177695,0.769541282630701,"L.LvsP.LI_WILMS_TUMOR"
64,"Up",0.539328148505734,0.769541282630701,"L.LvsP.MATTIOLI_MULTIPLE_MYELOMA_WITH_14Q32_TRANSLOCATIONS"
32,"Up",0.53933305664568,0.769541282630701,"L.LvsP.MARIADASON_RESPONSE_TO_CURCUMIN_SULINDAC_5"
11,"Down",0.540397720120697,0.770856666488624,"L.LvsP.HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_DN"
316,"Up",0.540533784766937,0.770856666488624,"L.LvsP.KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION"
181,"Down",0.541293900637835,0.771741613364257,"L.LvsP.REACTOME_REGULATION_OF_TP53_ACTIVITY"
203,"Down",0.542057309729172,0.77239799964341,"L.LvsP.BORCZUK_MALIGNANT_MESOTHELIOMA_DN"
52,"Up",0.542111939702887,0.77239799964341,"L.LvsP.WOTTON_RUNX_TARGETS_DN"
26,"Up",0.542189677046503,0.77239799964341,"L.LvsP.REACTOME_MTORC1_MEDIATED_SIGNALLING"
833,"Up",0.542313082766453,0.77239799964341,"L.LvsP.BERENJENO_TRANSFORMED_BY_RHOA_UP"
50,"Up",0.542970434233699,0.773135083924317,"L.LvsP.PID_AURORA_B_PATHWAY"
436,"Down",0.543297261409063,0.773401276604198,"L.LvsP.MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED"
46,"Up",0.544287083812223,0.774610884529673,"L.LvsP.REACTOME_PLASMA_LIPOPROTEIN_CLEARANCE"
13,"Up",0.544460977388421,0.77465896654158,"L.LvsP.SCHLESINGER_METHYLATED_IN_COLON_CANCER"
43,"Down",0.544603489605929,0.774662385909746,"L.LvsP.MATZUK_MALE_REPRODUCTION_SERTOLI"
110,"Down",0.545138785605825,0.775224368728036,"L.LvsP.REACTOME_COLLAGEN_FORMATION"
165,"Up",0.545523633309494,0.775380836459842,"L.LvsP.RAGHAVACHARI_PLATELET_SPECIFIC_GENES"
75,"Up",0.545529291703524,0.775380836459842,"L.LvsP.CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN"
187,"Up",0.547070321689058,0.777229475368899,"L.LvsP.ELVIDGE_HYPOXIA_DN"
113,"Down",0.547139275816163,0.777229475368899,"L.LvsP.CROMER_TUMORIGENESIS_UP"
29,"Down",0.547587436622659,0.777229475368899,"L.LvsP.MULLIGAN_NTF3_SIGNALING_VIA_INSR_AND_IGF1R_UP"
52,"Down",0.547639364178849,0.777229475368899,"L.LvsP.VALK_AML_CLUSTER_2"
118,"Up",0.547652408103963,0.777229475368899,"L.LvsP.KEGG_DRUG_METABOLISM_CYTOCHROME_P450"
10,"Up",0.547673365172225,0.777229475368899,"L.LvsP.REACTOME_INTERLEUKIN_18_SIGNALING"
45,"Down",0.548184403698982,0.77760218351775,"L.LvsP.REACTOME_MET_ACTIVATES_PTK2_SIGNALING"
101,"Down",0.548217274616059,0.77760218351775,"L.LvsP.PID_ENDOTHELIN_PATHWAY"
152,"Down",0.548485562369079,0.777743046832307,"L.LvsP.PID_CMYB_PATHWAY"
93,"Down",0.548597916919153,0.777743046832307,"L.LvsP.DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_UP"
13,"Up",0.549030023260115,0.778156113459415,"L.LvsP.REACTOME_MITOCHONDRIAL_IRON_SULFUR_CLUSTER_BIOGENESIS"
127,"Down",0.549276799759063,0.778241012679304,"L.LvsP.HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_DN"
16,"Up",0.549371436514256,0.778241012679304,"L.LvsP.LOPEZ_MESOTELIOMA_SURVIVAL_TIME_DN"
28,"Down",0.549527384559018,0.778262527978179,"L.LvsP.REACTOME_REGULATION_OF_FZD_BY_UBIQUITINATION"
63,"Up",0.549710316404056,0.778322238002054,"L.LvsP.KEGG_VIBRIO_CHOLERAE_INFECTION"
283,"Down",0.549873523464586,0.778353996732129,"L.LvsP.TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP"
18,"Up",0.550877100439434,0.779574990614188,"L.LvsP.REACTOME_EARLY_PHASE_OF_HIV_LIFE_CYCLE"
38,"Down",0.55121455835224,0.779662108240962,"L.LvsP.BIOCARTA_INSULIN_PATHWAY"
33,"Down",0.551296328725324,0.779662108240962,"L.LvsP.BILANGES_SERUM_SENSITIVE_VIA_TSC1"
15,"Up",0.55136170070938,0.779662108240962,"L.LvsP.KEGG_GLYCOSPHINGOLIPID_BIOSYNTHESIS_GANGLIO_SERIES"
22,"Down",0.551934225245319,0.780188426600409,"L.LvsP.REACTOME_SHC_MEDIATED_CASCADE_FGFR4"
78,"Up",0.55201611952628,0.780188426600409,"L.LvsP.KAAB_FAILED_HEART_VENTRICLE_DN"
25,"Down",0.552728988759338,0.780996314554148,"L.LvsP.BIOCARTA_CHEMICAL_PATHWAY"
98,"Up",0.553026897321071,0.781217607380736,"L.LvsP.ZWANG_EGF_PERSISTENTLY_DN"
252,"Down",0.553245735402424,0.781327119039591,"L.LvsP.IWANAGA_CARCINOGENESIS_BY_KRAS_DN"
27,"Up",0.553523973880815,0.781330310979749,"L.LvsP.IIZUKA_LIVER_CANCER_EARLY_RECURRENCE"
454,"Up",0.553530625449029,0.781330310979749,"L.LvsP.KONDO_EZH2_TARGETS"
49,"Up",0.554351769847634,0.782289672150987,"L.LvsP.WEBER_METHYLATED_HCP_IN_SPERM_DN"
19,"Down",0.554497031046919,0.782294994809496,"L.LvsP.MARTINELLI_IMMATURE_NEUTROPHIL_DN"
8,"Up",0.554643978703943,0.782302693432169,"L.LvsP.NAISHIRO_CTNNB1_TARGETS_WITH_LEF1_MOTIF"
31,"Up",0.554871940132757,0.782394453688962,"L.LvsP.REACTOME_INTERCONVERSION_OF_NUCLEOTIDE_DI_AND_TRIPHOSPHATES"
14,"Up",0.554992050527783,0.782394453688962,"L.LvsP.REACTOME_LGI_ADAM_INTERACTIONS"
109,"Down",0.55571761857675,0.783217617412911,"L.LvsP.REACTOME_AURKA_ACTIVATION_BY_TPX2"
1397,"Up",0.555886877328112,0.783228285747043,"L.LvsP.ACEVEDO_LIVER_CANCER_UP"
324,"Down",0.556008504531949,0.783228285747043,"L.LvsP.REACTOME_SIGNALING_BY_NOTCH"
48,"Down",0.556252991143938,0.78337309934662,"L.LvsP.BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_UP"
161,"Up",0.557459963256892,0.78487296583839,"L.LvsP.REACTOME_HCMV_EARLY_EVENTS"
202,"Up",0.557967342920115,0.784897334159112,"L.LvsP.MOREAUX_MULTIPLE_MYELOMA_BY_TACI_DN"
80,"Up",0.558002243209301,0.784897334159112,"L.LvsP.MARTIN_NFKB_TARGETS_UP"
31,"Down",0.558195917128118,0.784897334159112,"L.LvsP.TIAN_TNF_SIGNALING_NOT_VIA_NFKB"
684,"Down",0.558350490810266,0.784897334159112,"L.LvsP.CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_UP"
73,"Down",0.55836245698925,0.784897334159112,"L.LvsP.WENG_POR_DOSAGE"
50,"Down",0.558561518448892,0.784897334159112,"L.LvsP.REACTOME_LYSOSOME_VESICLE_BIOGENESIS"
79,"Down",0.558748951454699,0.784897334159112,"L.LvsP.BURTON_ADIPOGENESIS_PEAK_AT_2HR"
518,"Up",0.558870338380823,0.784897334159112,"L.LvsP.FARMER_BREAST_CANCER_APOCRINE_VS_BASAL"
65,"Up",0.55900735163305,0.784897334159112,"L.LvsP.BOYAULT_LIVER_CANCER_SUBCLASS_G1_DN"
75,"Down",0.559058355348318,0.784897334159112,"L.LvsP.PID_INTEGRIN3_PATHWAY"
116,"Up",0.559118525858489,0.784897334159112,"L.LvsP.ZHAN_MULTIPLE_MYELOMA_DN"
77,"Down",0.559314776186666,0.784897334159112,"L.LvsP.BALDWIN_PRKCI_TARGETS_UP"
27,"Down",0.559322752140875,0.784897334159112,"L.LvsP.JIANG_HYPOXIA_VIA_VHL"
144,"Down",0.559851886473012,0.785256450371102,"L.LvsP.WINZEN_DEGRADED_VIA_KHSRP"
17,"Down",0.559894040453444,0.785256450371102,"L.LvsP.BOYAULT_LIVER_CANCER_SUBCLASS_G56_UP"
289,"Up",0.560004735723143,0.785256450371102,"L.LvsP.KRIEG_KDM3A_TARGETS_NOT_HYPOXIA"
13,"Up",0.560190337347822,0.785309580664127,"L.LvsP.VANLOO_SP3_TARGETS_UP"
54,"Down",0.560592511274604,0.785309580664127,"L.LvsP.VALK_AML_CLUSTER_9"
97,"Up",0.560613006039068,0.785309580664127,"L.LvsP.WEIGEL_OXIDATIVE_STRESS_RESPONSE"
516,"Up",0.560682726670623,0.785309580664127,"L.LvsP.ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_DN"
12,"Down",0.56075279878133,0.785309580664127,"L.LvsP.REACTOME_SYNTHESIS_OF_15_EICOSATETRAENOIC_ACID_DERIVATIVES"
23,"Up",0.561285617020859,0.78571404500095,"L.LvsP.CHEOK_RESPONSE_TO_MERCAPTOPURINE_DN"
92,"Down",0.56151001255464,0.78571404500095,"L.LvsP.TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_UP"
190,"Down",0.561536302588968,0.78571404500095,"L.LvsP.KIM_ALL_DISORDERS_DURATION_CORR_DN"
7,"Up",0.56161003903848,0.78571404500095,"L.LvsP.REACTOME_ATTACHMENT_OF_GPI_ANCHOR_TO_UPAR"
337,"Down",0.561865182008921,0.785872145541949,"L.LvsP.KATSANOU_ELAVL1_TARGETS_UP"
209,"Down",0.562269821404281,0.786239211569112,"L.LvsP.LANDIS_ERBB2_BREAST_TUMORS_324_UP"
40,"Up",0.562544928140699,0.786425008265468,"L.LvsP.PARK_TRETINOIN_RESPONSE_AND_RARA_PLZF_FUSION"
22,"Up",0.563210665992291,0.787013349607786,"L.LvsP.SA_REG_CASCADE_OF_CYCLIN_EXPR"
95,"Down",0.563250465617292,0.787013349607786,"L.LvsP.KRIEG_HYPOXIA_VIA_KDM3A"
100,"Down",0.563434919993713,0.787072176009408,"L.LvsP.CHANG_IMMORTALIZED_BY_HPV31_UP"
323,"Up",0.564145197523304,0.787865318794228,"L.LvsP.SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_DN"
13,"Down",0.5650136188938,0.788699814154522,"L.LvsP.REACTOME_INTERLEUKIN_35_SIGNALLING"
14,"Up",0.565040016233022,0.788699814154522,"L.LvsP.ABBUD_LIF_SIGNALING_2_DN"
7,"Down",0.565170675290326,0.788699814154522,"L.LvsP.REACTOME_RAS_SIGNALING_DOWNSTREAM_OF_NF1_LOSS_OF_FUNCTION_VARIANTS"
41,"Up",0.565509594069341,0.78877373580258,"L.LvsP.PID_IL12_STAT4_PATHWAY"
14,"Down",0.565590773670748,0.78877373580258,"L.LvsP.BIOCARTA_AKAP13_PATHWAY"
8,"Up",0.565672351306049,0.78877373580258,"L.LvsP.REACTOME_ACYL_CHAIN_REMODELING_OF_DAG_AND_TAG"
8,"Down",0.565855539083859,0.78877373580258,"L.LvsP.BIOCARTA_RNAPOL3_PATHWAY"
45,"Up",0.566079613612704,0.78877373580258,"L.LvsP.NABA_COLLAGENS"
45,"Up",0.566079613612704,0.78877373580258,"L.LvsP.REACTOME_COLLAGEN_CHAIN_TRIMERIZATION"
148,"Down",0.566717606328252,0.789463755451979,"L.LvsP.REACTOME_INTERFERON_GAMMA_SIGNALING"
644,"Up",0.566937908187789,0.789571711428284,"L.LvsP.PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_UP"
33,"Up",0.567445521197556,0.790079649131526,"L.LvsP.BIOCARTA_CASPASE_PATHWAY"
45,"Up",0.567712708390161,0.790252659790836,"L.LvsP.REACTOME_AMINE_LIGAND_BINDING_RECEPTORS"
150,"Up",0.568193303906508,0.790722571683635,"L.LvsP.BURTON_ADIPOGENESIS_PEAK_AT_0HR"
27,"Down",0.568499420899791,0.790949496264455,"L.LvsP.KEGG_RNA_POLYMERASE"
53,"Up",0.569036575517766,0.791497666927731,"L.LvsP.WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_UP"
817,"Up",0.569410580374344,0.791818686843498,"L.LvsP.ACEVEDO_LIVER_CANCER_DN"
811,"Down",0.570224776767737,0.792439376689044,"L.LvsP.SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1"
46,"Up",0.570364275360354,0.792439376689044,"L.LvsP.REACTOME_DUAL_INCISION_IN_GG_NER"
20,"Down",0.570437438265069,0.792439376689044,"L.LvsP.AMIT_EGF_RESPONSE_40_MCF10A"
35,"Up",0.570520409182901,0.792439376689044,"L.LvsP.MASRI_RESISTANCE_TO_TAMOXIFEN_AND_AROMATASE_INHIBITORS_UP"
51,"Down",0.570691922780848,0.792439376689044,"L.LvsP.REACTOME_INTERLEUKIN_2_FAMILY_SIGNALING"
27,"Down",0.570716874294768,0.792439376689044,"L.LvsP.MOOTHA_FFA_OXYDATION"
20,"Up",0.571159079545884,0.792536861103464,"L.LvsP.ZHOU_PANCREATIC_ENDOCRINE_PROGENITOR"
69,"Up",0.571184176799874,0.792536861103464,"L.LvsP.PEART_HDAC_PROLIFERATION_CLUSTER_UP"
584,"Down",0.571340032317982,0.792536861103464,"L.LvsP.MIKKELSEN_NPC_HCP_WITH_H3K27ME3"
654,"Down",0.57142128613713,0.792536861103464,"L.LvsP.THUM_SYSTOLIC_HEART_FAILURE_UP"
10,"Up",0.571503791864625,0.792536861103464,"L.LvsP.REACTOME_FRUCTOSE_CATABOLISM"
237,"Down",0.571688660125683,0.792594433760005,"L.LvsP.MIKKELSEN_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3"
196,"Up",0.571854226239698,0.79262522358468,"L.LvsP.AMBROSINI_FLAVOPIRIDOL_TREATMENT_TP53"
12,"Down",0.57254834318723,0.793365067560936,"L.LvsP.BIOCARTA_EOSINOPHILS_PATHWAY"
55,"Down",0.572674983656302,0.793365067560936,"L.LvsP.FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN"
10,"Down",0.573292276843861,0.794021292251931,"L.LvsP.KAUFFMANN_MELANOMA_RELAPSE_DN"
96,"Up",0.573787683081199,0.7943166333402,"L.LvsP.CERIBELLI_PROMOTERS_INACTIVE_AND_BOUND_BY_NFY"
82,"Up",0.573792843834465,0.7943166333402,"L.LvsP.KEGG_GLYCEROPHOSPHOLIPID_METABOLISM"
47,"Down",0.574202909418811,0.794685328204407,"L.LvsP.CEBALLOS_TARGETS_OF_TP53_AND_MYC_DN"
645,"Up",0.574352401031121,0.794693299624892,"L.LvsP.MONNIER_POSTRADIATION_TUMOR_ESCAPE_DN"
25,"Down",0.574825778913042,0.795056430722643,"L.LvsP.BIOCARTA_ERK5_PATHWAY"
345,"Down",0.574902443485102,0.795056430722643,"L.LvsP.DAVICIONI_MOLECULAR_ARMS_VS_ERMS_DN"
38,"Down",0.575382439670336,0.795521257548709,"L.LvsP.NAKAJIMA_EOSINOPHIL"
7,"Up",0.575831493781129,0.795943082278965,"L.LvsP.PETRETTO_LEFT_VENTRICLE_MASS_QTL_CIS_UP"
217,"Down",0.575996164450149,0.795971705384872,"L.LvsP.NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN"
16,"Up",0.57644085554704,0.796369556113711,"L.LvsP.REACTOME_NUCLEOTIDE_LIKE_PURINERGIC_RECEPTORS"
193,"Down",0.576572134766356,0.796369556113711,"L.LvsP.ZHU_CMV_24_HR_UP"
7,"Down",0.577000561708823,0.796519512087511,"L.LvsP.SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX3"
109,"Down",0.577072310209209,0.796519512087511,"L.LvsP.LEE_LIVER_CANCER_MYC_E2F1_UP"
559,"Up",0.577112889387334,0.796519512087511,"L.LvsP.MULLIGHAN_NPM1_SIGNATURE_3_UP"
44,"Up",0.577376827984746,0.796684921868646,"L.LvsP.MACLACHLAN_BRCA1_TARGETS_DN"
24,"Down",0.577951059024909,0.797278294747685,"L.LvsP.REACTOME_RORA_ACTIVATES_GENE_EXPRESSION"
188,"Down",0.57848692914633,0.797680652956386,"L.LvsP.WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_UP"
10,"Up",0.578543941013526,0.797680652956386,"L.LvsP.DASU_IL6_SIGNALING_DN"
18,"Up",0.578675546935805,0.797680652956386,"L.LvsP.LI_WILMS_TUMOR_ANAPLASTIC_DN"
116,"Down",0.57901896122726,0.797723017218368,"L.LvsP.PID_P73PATHWAY"
668,"Up",0.579066649289741,0.797723017218368,"L.LvsP.HATADA_METHYLATED_IN_LUNG_CANCER_UP"
268,"Down",0.579359066780701,0.797723017218368,"L.LvsP.BROWNE_HCMV_INFECTION_18HR_UP"
110,"Up",0.579407382400241,0.797723017218368,"L.LvsP.PID_IL12_2PATHWAY"
21,"Down",0.579525896996302,0.797723017218368,"L.LvsP.DELASERNA_TARGETS_OF_MYOD_AND_SMARCA4"
40,"Up",0.579571958792943,0.797723017218368,"L.LvsP.REACTOME_ROS_AND_RNS_PRODUCTION_IN_PHAGOCYTES"
92,"Down",0.579775264067492,0.797724070044968,"L.LvsP.NIKOLSKY_BREAST_CANCER_8P12_P11_AMPLICON"
16,"Down",0.579861283687959,0.797724070044968,"L.LvsP.REACTOME_FGFR2C_LIGAND_BINDING_AND_ACTIVATION"
1037,"Up",0.580701134373316,0.7985027006744,"L.LvsP.CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_3"
1973,"Down",0.58071610768887,0.7985027006744,"L.LvsP.CHEN_METABOLIC_SYNDROM_NETWORK"
14,"Up",0.58095514099447,0.798632763440682,"L.LvsP.WEBER_METHYLATED_LCP_IN_FIBROBLAST_DN"
14,"Down",0.581274686242487,0.798873412934306,"L.LvsP.REACTOME_DEFECTIVE_EXT2_CAUSES_EXOSTOSES_2"
321,"Down",0.581573680260112,0.799085705307694,"L.LvsP.BROWN_MYELOID_CELL_DEVELOPMENT_UP"
2689,"Down",0.581756015803296,0.799137642577993,"L.LvsP.ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY"
1356,"Up",0.582670957658008,0.800059069874292,"L.LvsP.WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_8D"
252,"Down",0.582716200829042,0.800059069874292,"L.LvsP.HUANG_GATA2_TARGETS_UP"
7,"Down",0.582865943265764,0.800065988161969,"L.LvsP.REACTOME_RESPONSE_TO_METAL_IONS"
73,"Down",0.583403170775272,0.800188243306429,"L.LvsP.BIOCARTA_PPARA_PATHWAY"
17,"Down",0.583435042186627,0.800188243306429,"L.LvsP.PID_CIRCADIAN_PATHWAY"
114,"Down",0.583480020560413,0.800188243306429,"L.LvsP.KEGG_ARACHIDONIC_ACID_METABOLISM"
20,"Up",0.583897948250992,0.800188243306429,"L.LvsP.YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_4"
14,"Down",0.584116505753065,0.800188243306429,"L.LvsP.REACTOME_CALCINEURIN_ACTIVATES_NFAT"
45,"Down",0.584182140341531,0.800188243306429,"L.LvsP.ABE_VEGFA_TARGETS_2HR"
658,"Down",0.584195413077526,0.800188243306429,"L.LvsP.DELACROIX_RAR_BOUND_ES"
29,"Down",0.584249993964588,0.800188243306429,"L.LvsP.KEGG_ASCORBATE_AND_ALDARATE_METABOLISM"
17,"Down",0.58437226780387,0.800188243306429,"L.LvsP.REACTOME_SIGNALING_BY_PDGFRA_TRANSMEMBRANE_JUXTAMEMBRANE_AND_KINASE_DOMAIN_MUTANTS"
42,"Down",0.584402265594386,0.800188243306429,"L.LvsP.DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_DN"
1681,"Up",0.58456537734298,0.800213412064703,"L.LvsP.REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION"
32,"Down",0.584787557121535,0.800226244406875,"L.LvsP.LE_NEURONAL_DIFFERENTIATION_UP"
48,"Down",0.584864216612078,0.800226244406875,"L.LvsP.KEGG_PRION_DISEASES"
16,"Down",0.585036381814385,0.800263769186475,"L.LvsP.REACTOME_GLUCOCORTICOID_BIOSYNTHESIS"
87,"Down",0.585213925451886,0.800308630676101,"L.LvsP.KYNG_DNA_DAMAGE_BY_UV"
82,"Down",0.585894938750908,0.800925789990287,"L.LvsP.LINDSTEDT_DENDRITIC_CELL_MATURATION_A"
128,"Down",0.586007164668541,0.800925789990287,"L.LvsP.TIEN_INTESTINE_PROBIOTICS_2HR_DN"
9,"Up",0.586353810464047,0.800925789990287,"L.LvsP.DER_IFN_GAMMA_RESPONSE_DN"
260,"Up",0.586925265186982,0.800925789990287,"L.LvsP.DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN"
14,"Up",0.586997574141033,0.800925789990287,"L.LvsP.SMID_BREAST_CANCER_RELAPSE_IN_LIVER_DN"
411,"Down",0.587162976432491,0.800925789990287,"L.LvsP.GRADE_COLON_AND_RECTAL_CANCER_UP"
109,"Up",0.587314180676799,0.800925789990287,"L.LvsP.LEE_EARLY_T_LYMPHOCYTE_DN"
106,"Down",0.587391124713074,0.800925789990287,"L.LvsP.INGRAM_SHH_TARGETS_DN"
9,"Up",0.587452092980427,0.800925789990287,"L.LvsP.KIM_GLIS2_TARGETS_DN"
14,"Down",0.587719156647794,0.800925789990287,"L.LvsP.REACTOME_CROSS_PRESENTATION_OF_PARTICULATE_EXOGENOUS_ANTIGENS_PHAGOSOMES"
106,"Down",0.587770951125118,0.800925789990287,"L.LvsP.PID_HIF1_TFPATHWAY"
246,"Down",0.587787318220541,0.800925789990287,"L.LvsP.ZHONG_SECRETOME_OF_LUNG_CANCER_AND_FIBROBLAST"
625,"Down",0.587840601210842,0.800925789990287,"L.LvsP.CUI_TCF21_TARGETS_2_UP"
415,"Down",0.587882995511512,0.800925789990287,"L.LvsP.TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_UP"
131,"Down",0.588094365758084,0.800925789990287,"L.LvsP.GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP"
14,"Up",0.588125417683835,0.800925789990287,"L.LvsP.GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_DN"
25,"Down",0.588195608027169,0.800925789990287,"L.LvsP.REACTOME_GLUCURONIDATION"
12,"Down",0.588272677364904,0.800925789990287,"L.LvsP.REACTOME_NONCANONICAL_ACTIVATION_OF_NOTCH3"
15,"Up",0.588691850488928,0.801299173154427,"L.LvsP.GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP"
1236,"Down",0.589055164267772,0.801446388792065,"L.LvsP.NUYTTEN_NIPP1_TARGETS_DN"
361,"Down",0.589122725722232,0.801446388792065,"L.LvsP.MATTIOLI_MGUS_VS_PCL"
230,"Down",0.589271893909828,0.801446388792065,"L.LvsP.MILI_PSEUDOPODIA_CHEMOTAXIS_UP"
86,"Up",0.589389579512754,0.801446388792065,"L.LvsP.CUI_TCF21_TARGETS_UP"
9,"Down",0.589524771788267,0.801446388792065,"L.LvsP.REACTOME_OREXIN_AND_NEUROPEPTIDES_FF_AND_QRFP_BIND_TO_THEIR_RESPECTIVE_RECEPTORS"
15,"Down",0.590556821388513,0.802224081587643,"L.LvsP.MIKKELSEN_PLURIPOTENT_STATE_DN"
173,"Up",0.590667848371957,0.802224081587643,"L.LvsP.HUANG_GATA2_TARGETS_DN"
106,"Up",0.5906925372917,0.802224081587643,"L.LvsP.KANNAN_TP53_TARGETS_UP"
116,"Up",0.590853963209178,0.802224081587643,"L.LvsP.REACTOME_POST_TRANSLATIONAL_MODIFICATION_SYNTHESIS_OF_GPI_ANCHORED_PROTEINS"
37,"Down",0.590936558809376,0.802224081587643,"L.LvsP.REACTOME_FGFR2_MUTANT_RECEPTOR_ACTIVATION"
10,"Up",0.590971401068822,0.802224081587643,"L.LvsP.RANKIN_ANGIOGENIC_TARGETS_OF_VHL_HIF2A_UP"
74,"Down",0.591116638195813,0.802224081587643,"L.LvsP.KUUSELO_PANCREATIC_CANCER_19Q13_AMPLIFICATION"
124,"Up",0.591257575053291,0.802224081587643,"L.LvsP.MCBRYAN_PUBERTAL_BREAST_6_7WK_DN"
218,"Up",0.591556845549252,0.802433218606923,"L.LvsP.KATSANOU_ELAVL1_TARGETS_DN"
60,"Up",0.591758864400869,0.802510365776896,"L.LvsP.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_UP"
7,"Down",0.592230556699312,0.802953101518022,"L.LvsP.REACTOME_NEGATIVE_FEEDBACK_REGULATION_OF_MAPK_PATHWAY"
168,"Down",0.592596720933915,0.803252579074188,"L.LvsP.KANG_IMMORTALIZED_BY_TERT_UP"
23,"Up",0.593115875273653,0.803514669154017,"L.LvsP.KOBAYASHI_RESPONSE_TO_ROMIDEPSIN"
13,"Down",0.593160092662085,0.803514669154017,"L.LvsP.BIOCARTA_FIBRINOLYSIS_PATHWAY"
105,"Down",0.593386686841786,0.803514669154017,"L.LvsP.OUILLETTE_CLL_13Q14_DELETION_DN"
57,"Up",0.593425477212954,0.803514669154017,"L.LvsP.THILLAINADESAN_ZNF217_TARGETS_UP"
12,"Down",0.593516713478931,0.803514669154017,"L.LvsP.REACTOME_SEROTONIN_RECEPTORS"
233,"Down",0.593664890624747,0.803518526380472,"L.LvsP.RASHI_RESPONSE_TO_IONIZING_RADIATION_6"
38,"Up",0.593854117538768,0.803577928505102,"L.LvsP.DELACROIX_RAR_TARGETS_DN"
11,"Down",0.594030748215253,0.803620261042851,"L.LvsP.SMID_BREAST_CANCER_RELAPSE_IN_PLEURA_UP"
16,"Up",0.594638647017528,0.804151884642712,"L.LvsP.REACTOME_PHYSIOLOGICAL_FACTORS"
251,"Down",0.594887982260074,0.804151884642712,"L.LvsP.ONDER_CDH1_TARGETS_1_UP"
201,"Down",0.594986678169615,0.804151884642712,"L.LvsP.STEIN_ESRRA_TARGETS_DN"
20,"Down",0.595111974084503,0.804151884642712,"L.LvsP.SABATES_COLORECTAL_ADENOMA_SIZE_DN"
33,"Up",0.595150933615117,0.804151884642712,"L.LvsP.REACTOME_CYTOSOLIC_SULFONATION_OF_SMALL_MOLECULES"
119,"Up",0.595793417300503,0.80482330912643,"L.LvsP.LANDIS_BREAST_CANCER_PROGRESSION_DN"
67,"Up",0.596092864748902,0.804886556879908,"L.LvsP.KYNG_DNA_DAMAGE_BY_4NQO"
88,"Up",0.596131389116155,0.804886556879908,"L.LvsP.WEBER_METHYLATED_ICP_IN_SPERM_DN"
20,"Down",0.596361408619207,0.805000544007713,"L.LvsP.BIOCARTA_PGC1A_PATHWAY"
193,"Down",0.597253128399517,0.805939641206194,"L.LvsP.KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP"
162,"Down",0.597348643455052,0.805939641206194,"L.LvsP.YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_6"
246,"Down",0.598147350611862,0.806820371196141,"L.LvsP.KAAB_FAILED_HEART_ATRIUM_DN"
35,"Up",0.599057121835431,0.807850445519048,"L.LvsP.REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS"
142,"Down",0.59945834224914,0.807935487012557,"L.LvsP.QUINTENS_EMBRYONIC_BRAIN_RESPONSE_TO_IR"
51,"Down",0.599522627076184,0.807935487012557,"L.LvsP.BOYAULT_LIVER_CANCER_SUBCLASS_G2"
36,"Down",0.599558564516643,0.807935487012557,"L.LvsP.ABDULRAHMAN_KIDNEY_CANCER_VHL_DN"
81,"Up",0.599860204469753,0.808113371851696,"L.LvsP.VANTVEER_BREAST_CANCER_BRCA1_DN"
48,"Up",0.600086740910609,0.808113371851696,"L.LvsP.FARDIN_HYPOXIA_11"
6,"Down",0.600129047716235,0.808113371851696,"L.LvsP.REACTOME_SYNTHESIS_OF_WYBUTOSINE_AT_G37_OF_TRNA_PHE"
99,"Down",0.600506502618961,0.808424751151749,"L.LvsP.REACTOME_SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE"
9,"Down",0.600951454481901,0.808818524423981,"L.LvsP.PALOMERO_GSI_SENSITIVITY_UP"
892,"Down",0.601091574761827,0.808818524423981,"L.LvsP.DOUGLAS_BMI1_TARGETS_UP"
17,"Down",0.601292829236623,0.808892470279632,"L.LvsP.REACTOME_PKA_ACTIVATION_IN_GLUCAGON_SIGNALLING"
763,"Down",0.601661894042321,0.809192073013863,"L.LvsP.CAIRO_HEPATOBLASTOMA_CLASSES_UP"
36,"Down",0.602326954248282,0.809843897787707,"L.LvsP.REACTOME_THE_CANONICAL_RETINOID_CYCLE_IN_RODS_TWILIGHT_VISION"
161,"Up",0.602439492060199,0.809843897787707,"L.LvsP.REACTOME_CARDIAC_CONDUCTION"
13,"Down",0.602837775600677,0.810091385229883,"L.LvsP.TURJANSKI_MAPK14_TARGETS"
381,"Down",0.602916630533725,0.810091385229883,"L.LvsP.MCBRYAN_PUBERTAL_BREAST_3_4WK_UP"
61,"Down",0.603463012917738,0.810628522454366,"L.LvsP.PID_CERAMIDE_PATHWAY"
80,"Down",0.603616354568289,0.810637557543859,"L.LvsP.REACTOME_TRANSCRIPTIONAL_REGULATION_BY_MECP2"
127,"Down",0.604113979776226,0.810959133971818,"L.LvsP.SANA_TNF_SIGNALING_DN"
142,"Down",0.60414915406582,0.810959133971818,"L.LvsP.MAHAJAN_RESPONSE_TO_IL1A_UP"
94,"Down",0.604521785663229,0.811101177263881,"L.LvsP.NAKAMURA_ADIPOGENESIS_EARLY_UP"
179,"Up",0.604554326560497,0.811101177263881,"L.LvsP.TSENG_IRS1_TARGETS_UP"
14,"Down",0.604695071926518,0.811101177263881,"L.LvsP.BIOCARTA_CTBP1_PATHWAY"
114,"Up",0.604898525803765,0.811177285755279,"L.LvsP.STAMBOLSKY_TARGETS_OF_MUTATED_TP53_DN"
32,"Down",0.605277365039429,0.811488494496363,"L.LvsP.PID_RHODOPSIN_PATHWAY"
38,"Down",0.605913683419709,0.812066731008058,"L.LvsP.BIOCARTA_IGF1R_PATHWAY"
1648,"Down",0.606062062674479,0.812066731008058,"L.LvsP.REACTOME_INNATE_IMMUNE_SYSTEM"
58,"Down",0.606149285380766,0.812066731008058,"L.LvsP.HARRIS_BRAIN_CANCER_PROGENITORS"
380,"Down",0.606917028220136,0.812898316140778,"L.LvsP.WAMUNYOKOLI_OVARIAN_CANCER_LMP_UP"
52,"Down",0.607404872643157,0.813354696256725,"L.LvsP.LANG_MYB_FAMILY_TARGETS"
32,"Down",0.60782616471013,0.813721759002981,"L.LvsP.WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_DN"
48,"Up",0.608253769586374,0.813764678760455,"L.LvsP.YUAN_ZNF143_PARTNERS"
324,"Up",0.608465651549803,0.813764678760455,"L.LvsP.SERVITJA_LIVER_HNF1A_TARGETS_DN"
240,"Up",0.608535526866643,0.813764678760455,"L.LvsP.TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN"
168,"Down",0.60856316892362,0.813764678760455,"L.LvsP.REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA"
1306,"Down",0.608594130344454,0.813764678760455,"L.LvsP.MARSON_BOUND_BY_FOXP3_STIMULATED"
19,"Down",0.609105239757856,0.814251177616341,"L.LvsP.KOINUMA_COLON_CANCER_MSI_UP"
33,"Down",0.609831942522094,0.815025576554183,"L.LvsP.REACTOME_PROCESSING_OF_CAPPED_INTRONLESS_PRE_MRNA"
15,"Up",0.610107673373962,0.815197033853223,"L.LvsP.REACTOME_KERATAN_SULFATE_DEGRADATION"
99,"Up",0.610573177763764,0.815554450489927,"L.LvsP.BOYLAN_MULTIPLE_MYELOMA_C_DN"
61,"Up",0.610671355295244,0.815554450489927,"L.LvsP.ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_DN"
100,"Up",0.61092595501679,0.815554450489927,"L.LvsP.REACTOME_TRANSPORT_OF_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS"
28,"Down",0.610965189714103,0.815554450489927,"L.LvsP.BIOCARTA_ATM_PATHWAY"
527,"Down",0.611275216087903,0.815771341962349,"L.LvsP.DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN"
8,"Up",0.611676073504046,0.8161093171824,"L.LvsP.ELVIDGE_HIF2A_TARGETS_UP"
166,"Up",0.612182677782824,0.816492634730242,"L.LvsP.LIU_PROSTATE_CANCER_UP"
830,"Up",0.6122587201287,0.816492634730242,"L.LvsP.GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN"
8,"Down",0.613415036304163,0.8176959941883,"L.LvsP.REACTOME_PTK6_REGULATES_CELL_CYCLE"
12,"Down",0.613456860895835,0.8176959941883,"L.LvsP.REACTOME_PREGNENOLONE_BIOSYNTHESIS"
61,"Up",0.613720059136345,0.817715121038402,"L.LvsP.REACTOME_KINESINS"
128,"Up",0.61389096351095,0.817715121038402,"L.LvsP.REACTOME_RAB_REGULATION_OF_TRAFFICKING"
88,"Down",0.613914897346791,0.817715121038402,"L.LvsP.REACTOME_DNA_REPLICATION_PRE_INITIATION"
8,"Down",0.614334262257623,0.81799677861059,"L.LvsP.REACTOME_SUPPRESSION_OF_APOPTOSIS"
488,"Down",0.614422250238701,0.81799677861059,"L.LvsP.BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_D"
45,"Up",0.614596048722713,0.818007816244551,"L.LvsP.LOPES_METHYLATED_IN_COLON_CANCER_UP"
73,"Down",0.614726438143626,0.818007816244551,"L.LvsP.ZHAN_MULTIPLE_MYELOMA_CD2_DN"
165,"Down",0.615142691605199,0.818180391085872,"L.LvsP.TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_UP"
12,"Down",0.61515208640694,0.818180391085872,"L.LvsP.REACTOME_SYNTHESIS_OF_5_EICOSATETRAENOIC_ACIDS"
124,"Up",0.615808974745981,0.818792388244449,"L.LvsP.HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_UP"
13,"Down",0.616306219074947,0.818792388244449,"L.LvsP.JOHNSTONE_PARVB_TARGETS_1_UP"
159,"Up",0.616316555364166,0.818792388244449,"L.LvsP.TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_DN"
1122,"Down",0.616554670598291,0.818792388244449,"L.LvsP.RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP"
8,"Up",0.616628568064753,0.818792388244449,"L.LvsP.MOOTHA_PYR"
32,"Down",0.616835560746389,0.818792388244449,"L.LvsP.WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_UP"
159,"Down",0.616844994230265,0.818792388244449,"L.LvsP.ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN"
11,"Down",0.616873126739401,0.818792388244449,"L.LvsP.BYSTRYKH_SCP2_QTL"
19,"Up",0.61694503335619,0.818792388244449,"L.LvsP.SASSON_FSH_RESPONSE"
17,"Up",0.617185625300043,0.818915124138214,"L.LvsP.MARSHALL_VIRAL_INFECTION_RESPONSE_UP"
92,"Down",0.617817427926828,0.81938928771344,"L.LvsP.STARK_HYPPOCAMPUS_22Q11_DELETION_UP"
28,"Up",0.617849846231593,0.81938928771344,"L.LvsP.REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS"
22,"Down",0.617987579990061,0.81938928771344,"L.LvsP.PETRETTO_BLOOD_PRESSURE_UP"
6,"Down",0.618291548539092,0.819595773644843,"L.LvsP.REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_TO_LIMIT_CHOLESTEROL_UPTAKE"
64,"Down",0.619219129859931,0.820628611935657,"L.LvsP.POS_HISTAMINE_RESPONSE_NETWORK"
58,"Down",0.619643132668841,0.820993740840168,"L.LvsP.COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_DN"
7,"Down",0.620250228146984,0.821460506658595,"L.LvsP.TERAMOTO_OPN_TARGETS_CLUSTER_3"
19,"Down",0.620292569234877,0.821460506658595,"L.LvsP.KIM_MYCL1_AMPLIFICATION_TARGETS_UP"
52,"Up",0.620842036199899,0.821991287870987,"L.LvsP.REACTOME_FORMATION_OF_FIBRIN_CLOT_CLOTTING_CASCADE"
528,"Up",0.621539858321779,0.822562134289491,"L.LvsP.RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN"
37,"Up",0.621570735587176,0.822562134289491,"L.LvsP.WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_36HR"
42,"Up",0.622689878328037,0.823813472841017,"L.LvsP.SUZUKI_RESPONSE_TO_TSA_AND_DECITABINE_1A"
315,"Down",0.622814309364343,0.823813472841017,"L.LvsP.KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_DN"
31,"Up",0.623272095111949,0.824014994034609,"L.LvsP.GRANDVAUX_IRF3_TARGETS_UP"
316,"Down",0.623282198420972,0.824014994034609,"L.LvsP.MOHANKUMAR_HOXA1_TARGETS_DN"
89,"Down",0.623515553544853,0.824014994034609,"L.LvsP.REACTOME_SIGNALING_BY_INSULIN_RECEPTOR"
14,"Up",0.623562802503311,0.824014994034609,"L.LvsP.REACTOME_ACETYLCHOLINE_BINDING_AND_DOWNSTREAM_EVENTS"
324,"Up",0.623932599320892,0.82430665272287,"L.LvsP.GRUETZMANN_PANCREATIC_CANCER_DN"
27,"Up",0.624639513076548,0.824716569960497,"L.LvsP.LEIN_LOCALIZED_TO_DISTAL_AND_PROXIMAL_DENDRITES"
12,"Down",0.624648885733943,0.824716569960497,"L.LvsP.REACTOME_INTERLEUKIN_9_SIGNALING"
10,"Down",0.624867588544482,0.824716569960497,"L.LvsP.BIOCARTA_PPARG_PATHWAY"
131,"Up",0.625008297004059,0.824716569960497,"L.LvsP.SMID_BREAST_CANCER_RELAPSE_IN_LUNG_UP"
6,"Down",0.625080111775831,0.824716569960497,"L.LvsP.REACTOME_SYNTHESIS_OF_PI"
9,"Down",0.625399914785841,0.824716569960497,"L.LvsP.KUWANO_RNA_STABILIZED_BY_NO"
43,"Up",0.625431227171863,0.824716569960497,"L.LvsP.WILLERT_WNT_SIGNALING"
60,"Down",0.625436168899324,0.824716569960497,"L.LvsP.CROONQUIST_NRAS_VS_STROMAL_STIMULATION_UP"
47,"Up",0.625681795495045,0.824827744266639,"L.LvsP.LIU_LIVER_CANCER"
70,"Up",0.625982740936879,0.824827744266639,"L.LvsP.REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_CYTOCHROME_C_RELEASE"
130,"Down",0.626059768680396,0.824827744266639,"L.LvsP.PID_ERA_GENOMIC_PATHWAY"
212,"Up",0.626167990829663,0.824827744266639,"L.LvsP.REACTOME_SCAVENGING_OF_HEME_FROM_PLASMA"
165,"Down",0.626374481936672,0.824827744266639,"L.LvsP.BHATTACHARYA_EMBRYONIC_STEM_CELL"
8,"Up",0.626415572106279,0.824827744266639,"L.LvsP.TERAMOTO_OPN_TARGETS_CLUSTER_5"
1483,"Down",0.626671303602444,0.824968008956646,"L.LvsP.BENPORATH_SUZ12_TARGETS"
2390,"Down",0.627259421990652,0.825415440725761,"L.LvsP.PUJANA_BRCA1_PCC_NETWORK"
21,"Down",0.627576375942638,0.825415440725761,"L.LvsP.MCBRYAN_TERMINAL_END_BUD_UP"
886,"Down",0.627675421787813,0.825415440725761,"L.LvsP.SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_DN"
22,"Down",0.627792557981599,0.825415440725761,"L.LvsP.REACTOME_HS_GAG_DEGRADATION"
6,"Up",0.627810754910839,0.825415440725761,"L.LvsP.REACTOME_NADE_MODULATES_DEATH_SIGNALLING"
16,"Down",0.627906916927573,0.825415440725761,"L.LvsP.REACTOME_ROLE_OF_SECOND_MESSENGERS_IN_NETRIN_1_SIGNALING"
272,"Down",0.628168451271845,0.8255405003475,"L.LvsP.BOYAULT_LIVER_CANCER_SUBCLASS_G3_UP"
531,"Down",0.628300673803994,0.8255405003475,"L.LvsP.ENK_UV_RESPONSE_EPIDERMIS_UP"
44,"Down",0.630006666840458,0.827349811952638,"L.LvsP.AZARE_STAT3_TARGETS"
5,"Up",0.630116447444118,0.827349811952638,"L.LvsP.TURJANSKI_MAPK11_TARGETS"
19,"Down",0.630126615686844,0.827349811952638,"L.LvsP.MATTHEWS_AP1_TARGETS"
394,"Down",0.630634524596079,0.827811087224822,"L.LvsP.BILD_E2F3_ONCOGENIC_SIGNATURE"
20,"Down",0.630777375742119,0.827811087224822,"L.LvsP.REACTOME_DEFECTIVE_B4GALT7_CAUSES_EDS_PROGEROID_TYPE"
46,"Up",0.631541046463086,0.828616622186616,"L.LvsP.REACTOME_DETOXIFICATION_OF_REACTIVE_OXYGEN_SPECIES"
473,"Down",0.631759726559334,0.828706886867511,"L.LvsP.DURAND_STROMA_S_UP"
22,"Down",0.632204970584767,0.829050992693007,"L.LvsP.SARTIPY_NORMAL_AT_INSULIN_RESISTANCE_DN"
227,"Up",0.632321945412626,0.829050992693007,"L.LvsP.REACTOME_PHOSPHOLIPID_METABOLISM"
160,"Up",0.633186704689597,0.829987977768797,"L.LvsP.GAVIN_FOXP3_TARGETS_CLUSTER_P7"
135,"Up",0.63340600425668,0.830078643644272,"L.LvsP.ANDERSEN_CHOLANGIOCARCINOMA_CLASS1"
37,"Up",0.63382687034869,0.830433356909456,"L.LvsP.REACTOME_SURFACTANT_METABOLISM"
15,"Down",0.634185838124701,0.830706822788787,"L.LvsP.PID_P38_GAMMA_DELTA_PATHWAY"
59,"Down",0.634450711911683,0.8308569365608,"L.LvsP.GEISS_RESPONSE_TO_DSRNA_UP"
203,"Up",0.634607800541689,0.830865860571867,"L.LvsP.MIKKELSEN_MEF_LCP_WITH_H3K4ME3"
87,"Down",0.635317555922369,0.831598192872817,"L.LvsP.GOLDRATH_IMMUNE_MEMORY"
643,"Down",0.635746114991997,0.831646778631088,"L.LvsP.MULLIGHAN_MLL_SIGNATURE_2_UP"
58,"Up",0.635774211286696,0.831646778631088,"L.LvsP.BAE_BRCA1_TARGETS_DN"
22,"Up",0.63605319459119,0.831646778631088,"L.LvsP.REACTOME_TRANSCRIPTION_OF_E2F_TARGETS_UNDER_NEGATIVE_CONTROL_BY_DREAM_COMPLEX"
317,"Up",0.636108452570527,0.831646778631088,"L.LvsP.TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP"
36,"Down",0.636149397637846,0.831646778631088,"L.LvsP.LIU_IL13_MEMORY_MODEL_UP"
846,"Up",0.636257166505607,0.831646778631088,"L.LvsP.SMID_BREAST_CANCER_NORMAL_LIKE_UP"
32,"Up",0.636882921552201,0.832149675112549,"L.LvsP.SILIGAN_TARGETS_OF_EWS_FLI1_FUSION_DN"
25,"Down",0.636942923688969,0.832149675112549,"L.LvsP.BIOCARTA_IL3_PATHWAY"
7,"Up",0.637505521246353,0.832684651926054,"L.LvsP.BIOCARTA_FOSB_PATHWAY"
101,"Down",0.63765361118736,0.832684651926054,"L.LvsP.BRIDEAU_IMPRINTED_GENES"
62,"Up",0.637893197079439,0.832800823294503,"L.LvsP.KEGG_ARGININE_AND_PROLINE_METABOLISM"
9,"Up",0.638179373855254,0.832977752135434,"L.LvsP.REACTOME_SOS_MEDIATED_SIGNALLING"
455,"Down",0.638388280619114,0.83298233205735,"L.LvsP.RAO_BOUND_BY_SALL4"
59,"Down",0.6384841966466,0.83298233205735,"L.LvsP.KAMIKUBO_MYELOID_CEBPA_NETWORK"
51,"Down",0.638779742580403,0.833002803788491,"L.LvsP.VALK_AML_CLUSTER_5"
13,"Down",0.638801209633424,0.833002803788491,"L.LvsP.BIOCARTA_EIF2_PATHWAY"
7,"Up",0.63897681855428,0.83303532888154,"L.LvsP.JU_AGING_TERC_TARGETS_UP"
41,"Up",0.639169007631225,0.83308944912613,"L.LvsP.GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_DN"
22,"Down",0.639510008592557,0.833337458757542,"L.LvsP.BIOCARTA_PRION_PATHWAY"
52,"Down",0.639746190289044,0.83344879503019,"L.LvsP.MAEKAWA_ATF2_TARGETS"
107,"Up",0.640145891588244,0.833710281970199,"L.LvsP.RADAEVA_RESPONSE_TO_IFNA1_UP"
129,"Down",0.640248482048375,0.833710281970199,"L.LvsP.LEE_CALORIE_RESTRICTION_NEOCORTEX_DN"
465,"Up",0.641039864545495,0.834544245602082,"L.LvsP.RICKMAN_METASTASIS_UP"
309,"Up",0.641507013075563,0.834955808685214,"L.LvsP.NABA_ECM_REGULATORS"
16,"Up",0.641837820360504,0.835189764361785,"L.LvsP.BIOCARTA_THELPER_PATHWAY"
10,"Down",0.642181465297277,0.835370703352097,"L.LvsP.MIKKELSEN_DEDIFFERENTIATED_STATE_UP"
212,"Up",0.642385462993977,0.835370703352097,"L.LvsP.LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN"
619,"Down",0.64243013757517,0.835370703352097,"L.LvsP.YAGI_AML_WITH_11Q23_REARRANGED"
19,"Down",0.642970004223597,0.835510374934547,"L.LvsP.REACTOME_RIP_MEDIATED_NFKB_ACTIVATION_VIA_ZBP1"
51,"Up",0.643078097295669,0.835510374934547,"L.LvsP.REACTOME_CLASS_C_3_METABOTROPIC_GLUTAMATE_PHEROMONE_RECEPTORS"
84,"Down",0.643303310937793,0.835510374934547,"L.LvsP.REACTOME_RNA_POLYMERASE_II_TRANSCRIBES_SNRNA_GENES"
500,"Down",0.64331288013199,0.835510374934547,"L.LvsP.WANG_SMARCE1_TARGETS_UP"
18,"Down",0.643553508636975,0.835510374934547,"L.LvsP.YEMELYANOV_GR_TARGETS_DN"
526,"Up",0.643639399678133,0.835510374934547,"L.LvsP.SABATES_COLORECTAL_ADENOMA_DN"
104,"Down",0.643742165852102,0.835510374934547,"L.LvsP.LI_DCP2_BOUND_MRNA"
22,"Down",0.643746463595799,0.835510374934547,"L.LvsP.BIOCARTA_CALCINEURIN_PATHWAY"
254,"Down",0.64414148345979,0.835826862719827,"L.LvsP.CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_DN"
184,"Down",0.6444536553367,0.835909288647648,"L.LvsP.FIGUEROA_AML_METHYLATION_CLUSTER_1_UP"
82,"Down",0.644542129260074,0.835909288647648,"L.LvsP.HALMOS_CEBPA_TARGETS_UP"
76,"Up",0.644658565164328,0.835909288647648,"L.LvsP.REACTOME_DAP12_SIGNALING"
24,"Down",0.645435943615854,0.8366834381528,"L.LvsP.REACTOME_DCC_MEDIATED_ATTRACTIVE_SIGNALING"
97,"Up",0.645558246908997,0.8366834381528,"L.LvsP.GRADE_COLON_VS_RECTAL_CANCER_DN"
210,"Up",0.645869373208922,0.836890500227825,"L.LvsP.MIKKELSEN_ES_LCP_WITH_H3K4ME3"
59,"Down",0.646156191390647,0.836989375948171,"L.LvsP.VALK_AML_CLUSTER_4"
879,"Down",0.646321547332488,0.836989375948171,"L.LvsP.WEST_ADRENOCORTICAL_TUMOR_DN"
136,"Up",0.646399825519749,0.836989375948171,"L.LvsP.MIKKELSEN_ES_HCP_WITH_H3_UNMETHYLATED"
33,"Down",0.646719889103144,0.83701644315785,"L.LvsP.REACTOME_GP1B_IX_V_ACTIVATION_SIGNALLING"
309,"Down",0.646723502472479,0.83701644315785,"L.LvsP.DARWICHE_SQUAMOUS_CELL_CARCINOMA_DN"
48,"Up",0.646982793233892,0.83715606454252,"L.LvsP.YANG_BREAST_CANCER_ESR1_BULK_UP"
110,"Up",0.647480052336443,0.837603464990219,"L.LvsP.REACTOME_POTASSIUM_CHANNELS"
330,"Up",0.647971244424905,0.83804280945621,"L.LvsP.TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP"
19,"Up",0.648484760639587,0.838510814213349,"L.LvsP.BIOCARTA_LONGEVITY_PATHWAY"
19,"Down",0.649265601506068,0.839278190943613,"L.LvsP.REACTOME_OAS_ANTIVIRAL_RESPONSE"
52,"Up",0.649381823269447,0.839278190943613,"L.LvsP.XU_RESPONSE_TO_TRETINOIN_UP"
103,"Up",0.649581593448824,0.839338348589053,"L.LvsP.OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN"
165,"Up",0.649731982629978,0.839338348589053,"L.LvsP.NIKOLSKY_BREAST_CANCER_8Q12_Q22_AMPLICON"
167,"Down",0.650612912632984,0.840083035804375,"L.LvsP.SANA_TNF_SIGNALING_UP"
6,"Down",0.650667281183474,0.840083035804375,"L.LvsP.FIGUEROA_AML_METHYLATION_CLUSTER_7_DN"
32,"Up",0.650764268828023,0.840083035804375,"L.LvsP.HOLLEMAN_PREDNISOLONE_RESISTANCE_B_ALL_DN"
37,"Up",0.651102635139404,0.840155879120404,"L.LvsP.SARTIPY_BLUNTED_BY_INSULIN_RESISTANCE_UP"
201,"Down",0.651225147453942,0.840155879120404,"L.LvsP.WIERENGA_STAT5A_TARGETS_GROUP1"
40,"Up",0.651276559578595,0.840155879120404,"L.LvsP.WU_HBX_TARGETS_2_UP"
44,"Down",0.651603024577128,0.840380947722636,"L.LvsP.REACTOME_METABOLISM_OF_STEROID_HORMONES"
56,"Down",0.652087213002446,0.840390553803065,"L.LvsP.REACTOME_AQUAPORIN_MEDIATED_TRANSPORT"
57,"Up",0.652194523539215,0.840390553803065,"L.LvsP.WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_UP"
9,"Up",0.652490095960567,0.840390553803065,"L.LvsP.REACTOME_HIGHLY_SODIUM_PERMEABLE_POSTSYNAPTIC_ACETYLCHOLINE_NICOTINIC_RECEPTORS"
30,"Up",0.652545385778781,0.840390553803065,"L.LvsP.PID_TRAIL_PATHWAY"
46,"Down",0.652649720973823,0.840390553803065,"L.LvsP.REACTOME_NOD1_2_SIGNALING_PATHWAY"
51,"Up",0.652697024929539,0.840390553803065,"L.LvsP.SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_DN"
17,"Up",0.652794737985726,0.840390553803065,"L.LvsP.TURASHVILI_BREAST_NORMAL_DUCTAL_VS_LOBULAR_DN"
65,"Up",0.652826447564508,0.840390553803065,"L.LvsP.SMID_BREAST_CANCER_RELAPSE_IN_PLEURA_DN"
55,"Up",0.653062370544904,0.840427376850113,"L.LvsP.GENTILE_UV_LOW_DOSE_UP"
1768,"Down",0.653159059201472,0.840427376850113,"L.LvsP.PEREZ_TP53_TARGETS"
119,"Down",0.653725566512425,0.840960599638715,"L.LvsP.GALINDO_IMMUNE_RESPONSE_TO_ENTEROTOXIN"
43,"Down",0.654405965796221,0.841449659774654,"L.LvsP.REACTOME_REGULATION_OF_TNFR1_SIGNALING"
349,"Up",0.654442718560748,0.841449659774654,"L.LvsP.MIKKELSEN_MEF_ICP_WITH_H3K27ME3"
13,"Down",0.654773648997496,0.841449659774654,"L.LvsP.REACTOME_PROCESSING_AND_ACTIVATION_OF_SUMO"
76,"Down",0.654829417723015,0.841449659774654,"L.LvsP.CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_UP"
167,"Down",0.654866682222886,0.841449659774654,"L.LvsP.SMID_BREAST_CANCER_RELAPSE_IN_BONE_UP"
12,"Up",0.65515200257463,0.841464814459203,"L.LvsP.FOURNIER_ACINAR_DEVELOPMENT_EARLY_DN"
13,"Down",0.65518285878945,0.841464814459203,"L.LvsP.CLIMENT_BREAST_CANCER_COPY_NUMBER_DN"
85,"Down",0.655470339055359,0.841491934695159,"L.LvsP.CHIBA_RESPONSE_TO_TSA"
110,"Up",0.655588469475719,0.841491934695159,"L.LvsP.LEE_LIVER_CANCER_MYC_DN"
73,"Up",0.655660563332745,0.841491934695159,"L.LvsP.CHESLER_BRAIN_HIGHEST_GENETIC_VARIANCE"
726,"Down",0.655993900722561,0.841672447187319,"L.LvsP.PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_DN"
30,"Up",0.656164382213038,0.841672447187319,"L.LvsP.REACTOME_ENERGY_DEPENDENT_REGULATION_OF_MTOR_BY_LKB1_AMPK"
33,"Down",0.656379401541936,0.841672447187319,"L.LvsP.HUI_MAPK14_TARGETS_UP"
388,"Down",0.656508863954225,0.841672447187319,"L.LvsP.MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_DN"
67,"Down",0.656562355709696,0.841672447187319,"L.LvsP.REACTOME_NR1H2_AND_NR1H3_MEDIATED_SIGNALING"
87,"Down",0.656946482253195,0.841969657018525,"L.LvsP.KEGG_STEROID_HORMONE_BIOSYNTHESIS"
137,"Up",0.658032272588203,0.843165801886483,"L.LvsP.BROWNE_HCMV_INFECTION_6HR_UP"
53,"Down",0.658633515662832,0.843740664527293,"L.LvsP.REACTOME_SYNDECAN_INTERACTIONS"
337,"Up",0.658866723777896,0.843789347472868,"L.LvsP.MCBRYAN_PUBERTAL_BREAST_6_7WK_UP"
37,"Up",0.658976741253002,0.843789347472868,"L.LvsP.MATZUK_CENTRAL_FOR_FEMALE_FERTILITY"
200,"Up",0.659287563030349,0.843991881452836,"L.LvsP.ALTEMEIER_RESPONSE_TO_LPS_WITH_MECHANICAL_VENTILATION"
5,"Down",0.659989140712669,0.844694434953783,"L.LvsP.REACTOME_EXTRINSIC_PATHWAY_OF_FIBRIN_CLOT_FORMATION"
152,"Down",0.660211953043198,0.844784051926832,"L.LvsP.LEIN_MIDBRAIN_MARKERS"
13,"Down",0.660612532309898,0.844948773494816,"L.LvsP.ZHENG_FOXP3_TARGETS_IN_T_LYMPHOCYTE_UP"
166,"Down",0.660646328055361,0.844948773494816,"L.LvsP.KESHELAVA_MULTIPLE_DRUG_RESISTANCE"
77,"Down",0.660820629785163,0.844976240074507,"L.LvsP.MARTINEZ_RESPONSE_TO_TRABECTEDIN"
202,"Up",0.66150844825564,0.845372156231691,"L.LvsP.REACTOME_CREATION_OF_C4_AND_C2_ACTIVATORS"
9,"Up",0.661514806303987,0.845372156231691,"L.LvsP.REACTOME_SYNTHESIS_OF_PG"
56,"Down",0.661588952796985,0.845372156231691,"L.LvsP.TSENG_ADIPOGENIC_POTENTIAL_UP"
56,"Down",0.662260877480745,0.845877619992171,"L.LvsP.SIG_PIP3_SIGNALING_IN_B_LYMPHOCYTES"
33,"Down",0.662290507676996,0.845877619992171,"L.LvsP.REACTOME_BMAL1_CLOCK_NPAS2_ACTIVATES_CIRCADIAN_GENE_EXPRESSION"
316,"Up",0.662743532720849,0.846067151586662,"L.LvsP.SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN"
39,"Up",0.662808529991641,0.846067151586662,"L.LvsP.HASLINGER_B_CLL_WITH_MUTATED_VH_GENES"
9,"Up",0.662908945676664,0.846067151586662,"L.LvsP.REACTOME_HIGHLY_CALCIUM_PERMEABLE_NICOTINIC_ACETYLCHOLINE_RECEPTORS"
66,"Up",0.66309705218786,0.846067151586662,"L.LvsP.REACTOME_TRNA_PROCESSING_IN_THE_NUCLEUS"
63,"Up",0.663204021518646,0.846067151586662,"L.LvsP.TSUNODA_CISPLATIN_RESISTANCE_DN"
30,"Up",0.663433134794238,0.846164198910575,"L.LvsP.REACTOME_SYNTHESIS_OF_PC"
25,"Down",0.663745593933606,0.846367478980375,"L.LvsP.REACTOME_INTERLEUKIN_20_FAMILY_SIGNALING"
46,"Up",0.663912373301675,0.84638494627276,"L.LvsP.PETRETTO_HEART_MASS_QTL_CIS_UP"
43,"Up",0.664202662323393,0.846559824800839,"L.LvsP.MARTINELLI_IMMATURE_NEUTROPHIL_UP"
49,"Down",0.664581486463637,0.846727573810976,"L.LvsP.REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_OXIDATIVE_STRESS_METABOLIC_AND_NEURONAL_GENES"
42,"Up",0.664640562550124,0.846727573810976,"L.LvsP.WALLACE_JAK2_TARGETS_UP"
92,"Down",0.664961209945741,0.846935749811703,"L.LvsP.LUCAS_HNF4A_TARGETS_UP"
225,"Up",0.665123053596969,0.846935749811703,"L.LvsP.KAYO_AGING_MUSCLE_DN"
16,"Up",0.665263512648259,0.846935749811703,"L.LvsP.REACTOME_CLEC7A_DECTIN_1_INDUCES_NFAT_ACTIVATION"
77,"Up",0.665439646190553,0.846964964039495,"L.LvsP.TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP"
7,"Up",0.666495032948077,0.848032555705667,"L.LvsP.REACTOME_SUMO_IS_TRANSFERRED_FROM_E1_TO_E2_UBE2I_UBC9"
10,"Up",0.666585184861065,0.848032555705667,"L.LvsP.WEBER_METHYLATED_LCP_IN_SPERM_DN"
45,"Up",0.666904040886887,0.848243027849919,"L.LvsP.SAMOLS_TARGETS_OF_KHSV_MIRNAS_UP"
18,"Up",0.667493440688055,0.848477298920181,"L.LvsP.BIOCARTA_AHSP_PATHWAY"
14,"Up",0.667520444904666,0.848477298920181,"L.LvsP.REACTOME_LYSOSPHINGOLIPID_AND_LPA_RECEPTORS"
49,"Up",0.667681295553586,0.848477298920181,"L.LvsP.UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN"
9,"Up",0.667705620606623,0.848477298920181,"L.LvsP.GLINSKY_CANCER_DEATH_UP"
126,"Down",0.667855526297817,0.848477298920181,"L.LvsP.REACTOME_CARGO_RECOGNITION_FOR_CLATHRIN_MEDIATED_ENDOCYTOSIS"
40,"Down",0.668283637655567,0.848680965572503,"L.LvsP.REACTOME_AMINO_ACID_TRANSPORT_ACROSS_THE_PLASMA_MEMBRANE"
86,"Up",0.66866249970822,0.848680965572503,"L.LvsP.REACTOME_PEROXISOMAL_PROTEIN_IMPORT"
46,"Up",0.668707828537051,0.848680965572503,"L.LvsP.YAMASHITA_LIVER_CANCER_WITH_EPCAM_DN"
31,"Down",0.668736696949409,0.848680965572503,"L.LvsP.BIOCARTA_MTOR_PATHWAY"
33,"Up",0.668783318321468,0.848680965572503,"L.LvsP.MATZUK_LUTEAL_GENES"
93,"Up",0.670037020560367,0.850070933453426,"L.LvsP.KRASNOSELSKAYA_ILF3_TARGETS_DN"
8,"Up",0.67018614558211,0.850070933453426,"L.LvsP.REACTOME_VEGF_LIGAND_RECEPTOR_INTERACTIONS"
99,"Down",0.671206687944572,0.851170132487509,"L.LvsP.MIKKELSEN_ES_ICP_WITH_H3K27ME3"
61,"Down",0.671870545004969,0.85181661163322,"L.LvsP.RIZ_ERYTHROID_DIFFERENTIATION_6HR"
31,"Down",0.672702635709418,0.852676036872391,"L.LvsP.MAINA_VHL_TARGETS_DN"
358,"Down",0.672929588609061,0.852768208897433,"L.LvsP.BOQUEST_STEM_CELL_DN"
140,"Down",0.673576839921719,0.853392838663425,"L.LvsP.GU_PDEF_TARGETS_UP"
55,"Up",0.673833684820915,0.853472835777866,"L.LvsP.CHEN_LUNG_CANCER_SURVIVAL"
85,"Down",0.673948707000572,0.853472835777866,"L.LvsP.DUNNE_TARGETS_OF_AML1_MTG8_FUSION_UP"
86,"Up",0.674447211005985,0.85390854812276,"L.LvsP.KENNY_CTNNB1_TARGETS_DN"
259,"Up",0.674969523410339,0.854374197558554,"L.LvsP.BROWNE_HCMV_INFECTION_30MIN_DN"
11,"Down",0.675847166625508,0.855289307455352,"L.LvsP.REACTOME_ADENYLATE_CYCLASE_ACTIVATING_PATHWAY"
142,"Up",0.677667629559999,0.857396870443304,"L.LvsP.BROWNE_INTERFERON_RESPONSIVE_GENES"
31,"Up",0.678419108757861,0.858045315684413,"L.LvsP.SASAI_TARGETS_OF_CXCR6_AND_PTCH1_UP"
36,"Up",0.678503163424959,0.858045315684413,"L.LvsP.YAO_HOXA10_TARGETS_VIA_PROGESTERONE_DN"
90,"Up",0.678810407570536,0.858045315684413,"L.LvsP.TENEDINI_MEGAKARYOCYTE_MARKERS"
36,"Up",0.678917503909752,0.858045315684413,"L.LvsP.HOLLEMAN_ASPARAGINASE_RESISTANCE_ALL_UP"
1509,"Down",0.679076179842133,0.858045315684413,"L.LvsP.MARTENS_TRETINOIN_RESPONSE_UP"
142,"Down",0.679111286206365,0.858045315684413,"L.LvsP.REACTOME_VISUAL_PHOTOTRANSDUCTION"
23,"Up",0.679278521808675,0.858060531660993,"L.LvsP.REACTOME_NOREPINEPHRINE_NEUROTRANSMITTER_RELEASE_CYCLE"
257,"Up",0.679503355365623,0.858148481456494,"L.LvsP.RICKMAN_HEAD_AND_NECK_CANCER_A"
268,"Down",0.680302889805772,0.858962018208749,"L.LvsP.KIM_MYC_AMPLIFICATION_TARGETS_UP"
16,"Up",0.680821672683724,0.85942078270966,"L.LvsP.BIOCARTA_TSP1_PATHWAY"
96,"Down",0.681221835011667,0.859729633823215,"L.LvsP.FIGUEROA_AML_METHYLATION_CLUSTER_6_DN"
23,"Up",0.681476270823334,0.859854473158881,"L.LvsP.LIU_IL13_PRIMING_MODEL"
34,"Up",0.682900069143315,0.861454365113709,"L.LvsP.WILLIAMS_ESR2_TARGETS_UP"
49,"Down",0.683114253622118,0.861527990026618,"L.LvsP.KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_4NQO_IN_WS"
9,"Down",0.683956420334453,0.862133521310293,"L.LvsP.REACTOME_FGFR1B_LIGAND_BINDING_AND_ACTIVATION"
8,"Up",0.684058443947208,0.862133521310293,"L.LvsP.REACTOME_TRNA_MODIFICATION_IN_THE_MITOCHONDRION"
9,"Down",0.684062173627827,0.862133521310293,"L.LvsP.CASTELLANO_HRAS_TARGETS_UP"
207,"Down",0.684803794983991,0.862535041346494,"L.LvsP.GOLDRATH_HOMEOSTATIC_PROLIFERATION"
303,"Down",0.684841728574047,0.862535041346494,"L.LvsP.PROVENZANI_METASTASIS_UP"
55,"Down",0.684848766777194,0.862535041346494,"L.LvsP.PID_LYMPH_ANGIOGENESIS_PATHWAY"
259,"Up",0.68525946816258,0.862585965208684,"L.LvsP.BROCKE_APOPTOSIS_REVERSED_BY_IL6"
116,"Up",0.685289592039441,0.862585965208684,"L.LvsP.REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES"
12,"Up",0.685423603857502,0.862585965208684,"L.LvsP.BIOCARTA_RHODOPSIN_PATHWAY"
60,"Up",0.685632001923856,0.862585965208684,"L.LvsP.GENTILE_UV_RESPONSE_CLUSTER_D8"
50,"Up",0.685829252199853,0.862585965208684,"L.LvsP.WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_DN"
24,"Up",0.686067913376206,0.862585965208684,"L.LvsP.REACTOME_FGFR1_LIGAND_BINDING_AND_ACTIVATION"
16,"Up",0.686325351358439,0.862585965208684,"L.LvsP.BIOCARTA_P27_PATHWAY"
51,"Up",0.68633219757435,0.862585965208684,"L.LvsP.KASLER_HDAC7_TARGETS_2_DN"
336,"Up",0.686482464681965,0.862585965208684,"L.LvsP.IWANAGA_CARCINOGENESIS_BY_KRAS_UP"
10,"Down",0.686499548171193,0.862585965208684,"L.LvsP.MIKKELSEN_DEDIFFERENTIATED_STATE_DN"
87,"Down",0.686716851672265,0.862585965208684,"L.LvsP.MATTIOLI_MGUS_VS_MULTIPLE_MYELOMA"
77,"Down",0.686882223163802,0.862585965208684,"L.LvsP.MELLMAN_TUT1_TARGETS_DN"
47,"Up",0.686995867050716,0.862585965208684,"L.LvsP.REACTOME_LAMININ_INTERACTIONS"
17,"Down",0.687073356986624,0.862585965208684,"L.LvsP.PARK_APL_PATHOGENESIS_UP"
40,"Down",0.687886171616651,0.863274215201089,"L.LvsP.REACTOME_REGULATION_OF_MECP2_EXPRESSION_AND_ACTIVITY"
21,"Down",0.68793383833894,0.863274215201089,"L.LvsP.GOERING_BLOOD_HDL_CHOLESTEROL_QTL_CIS"
121,"Up",0.688118532834087,0.863310044937524,"L.LvsP.LIAN_LIPA_TARGETS_3M"
26,"Up",0.688582188267036,0.863675069019995,"L.LvsP.VISALA_AGING_LYMPHOCYTE_DN"
69,"Down",0.688721898952642,0.863675069019995,"L.LvsP.SCHEIDEREIT_IKK_INTERACTING_PROTEINS"
57,"Up",0.689005106361753,0.86383429321409,"L.LvsP.WANG_TARGETS_OF_MLL_CBP_FUSION_DN"
460,"Up",0.689361183808294,0.864007160483329,"L.LvsP.BOQUEST_STEM_CELL_UP"
117,"Up",0.689455523974037,0.864007160483329,"L.LvsP.JIANG_VHL_TARGETS"
59,"Down",0.689792237300639,0.864054591520513,"L.LvsP.REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES"
60,"Up",0.689805926382988,0.864054591520513,"L.LvsP.PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_UP"
12,"Down",0.690123808916315,0.8642569738388,"L.LvsP.VANDESLUIS_NORMAL_EMBRYOS_UP"
22,"Down",0.690483603070949,0.864495280005097,"L.LvsP.SHIN_B_CELL_LYMPHOMA_CLUSTER_5"
20,"Up",0.690626813489332,0.864495280005097,"L.LvsP.WIEMANN_TELOMERE_SHORTENING_AND_CHRONIC_LIVER_DAMAGE_DN"
63,"Down",0.690828117316204,0.864551530249274,"L.LvsP.KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS"
566,"Down",0.69126742644841,0.864905544429341,"L.LvsP.SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP"
9,"Down",0.691853404770263,0.865442867641353,"L.LvsP.SCHUHMACHER_MYC_TARGETS_DN"
12,"Up",0.692326140478581,0.865797563089929,"L.LvsP.YAMANAKA_GLIOBLASTOMA_SURVIVAL_DN"
453,"Down",0.692450139986194,0.865797563089929,"L.LvsP.SANSOM_APC_TARGETS"
432,"Up",0.692725552971828,0.865938792729073,"L.LvsP.ONDER_CDH1_TARGETS_2_UP"
41,"Down",0.69287632827517,0.865938792729073,"L.LvsP.REACTOME_INWARDLY_RECTIFYING_K_CHANNELS"
25,"Up",0.693347606178915,0.866304360924461,"L.LvsP.REACTOME_SIGNALING_BY_CYTOSOLIC_FGFR1_FUSION_MUTANTS"
318,"Up",0.69348220319256,0.866304360924461,"L.LvsP.ALONSO_METASTASIS_UP"
26,"Down",0.694306214000599,0.86672751184111,"L.LvsP.PHESSE_TARGETS_OF_APC_AND_MBD2_UP"
53,"Down",0.694322272486473,0.86672751184111,"L.LvsP.SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_DN"
143,"Up",0.694331444586849,0.86672751184111,"L.LvsP.REACTOME_INTEGRATION_OF_ENERGY_METABOLISM"
24,"Up",0.694537012133708,0.86672751184111,"L.LvsP.LOPEZ_MESOTELIOMA_SURVIVAL_TIME_UP"
76,"Down",0.694700302302301,0.86672751184111,"L.LvsP.REACTOME_TRANSCRIPTION_OF_THE_HIV_GENOME"
37,"Down",0.694761499815482,0.86672751184111,"L.LvsP.REACTOME_CYP2E1_REACTIONS"
211,"Up",0.695170900780052,0.866902476236974,"L.LvsP.REACTOME_INITIAL_TRIGGERING_OF_COMPLEMENT"
140,"Up",0.695466832308123,0.866902476236974,"L.LvsP.HECKER_IFNB1_TARGETS"
20,"Down",0.695588531689991,0.866902476236974,"L.LvsP.BARRIER_CANCER_RELAPSE_TUMOR_SAMPLE_UP"
40,"Down",0.69605326511144,0.866902476236974,"L.LvsP.MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_UP"
113,"Down",0.69613802259408,0.866902476236974,"L.LvsP.PID_PTP1B_PATHWAY"
7,"Up",0.696138772285737,0.866902476236974,"L.LvsP.DIERICK_SEROTONIN_FUNCTION_GENES"
85,"Up",0.696293956551274,0.866902476236974,"L.LvsP.GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN"
27,"Down",0.696313123765871,0.866902476236974,"L.LvsP.PHESSE_TARGETS_OF_APC_AND_MBD2_DN"
30,"Down",0.696449698104652,0.866902476236974,"L.LvsP.BIOCARTA_CTLA4_PATHWAY"
43,"Up",0.696640039804484,0.866902476236974,"L.LvsP.FOURNIER_ACINAR_DEVELOPMENT_LATE_DN"
28,"Up",0.696759331355602,0.866902476236974,"L.LvsP.VISALA_RESPONSE_TO_HEAT_SHOCK_AND_AGING_UP"
28,"Up",0.696783252739576,0.866902476236974,"L.LvsP.HOLLERN_ADENOMYOEPITHELIAL_BREAST_TUMOR"
69,"Down",0.697017093041319,0.866998314381429,"L.LvsP.CERIBELLI_GENES_INACTIVE_AND_BOUND_BY_NFY"
200,"Down",0.69764228117049,0.867580785558173,"L.LvsP.ELVIDGE_HYPOXIA_BY_DMOG_UP"
12,"Up",0.697857534366878,0.867653318532599,"L.LvsP.REACTOME_PASSIVE_TRANSPORT_BY_AQUAPORINS"
8,"Up",0.698110976652369,0.867773289098685,"L.LvsP.NIKOLSKY_BREAST_CANCER_19Q13.4_AMPLICON"
486,"Up",0.698595529532094,0.867873867633795,"L.LvsP.REACTOME_M_PHASE"
431,"Up",0.69859929846221,0.867873867633795,"L.LvsP.BROWNE_HCMV_INFECTION_1HR_DN"
5,"Down",0.698802372866485,0.867873867633795,"L.LvsP.RAFFEL_VEGFA_TARGETS_DN"
18,"Down",0.698864440422563,0.867873867633795,"L.LvsP.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_1"
37,"Up",0.699179493300287,0.867873867633795,"L.LvsP.REACTOME_DECTIN_2_FAMILY"
523,"Down",0.699422658465364,0.867873867633795,"L.LvsP.FISCHER_DIRECT_P53_TARGETS_META_ANALYSIS"
11,"Down",0.699554348462019,0.867873867633795,"L.LvsP.REACTOME_PEPTIDE_HORMONE_BIOSYNTHESIS"
44,"Up",0.699645578341037,0.867873867633795,"L.LvsP.YANG_BREAST_CANCER_ESR1_LASER_UP"
523,"Up",0.699661534541388,0.867873867633795,"L.LvsP.GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP"
6,"Up",0.699767340302601,0.867873867633795,"L.LvsP.BIOCARTA_SUMO_PATHWAY"
214,"Up",0.699918534233875,0.867873867633795,"L.LvsP.REACTOME_ROLE_OF_PHOSPHOLIPIDS_IN_PHAGOCYTOSIS"
27,"Up",0.70144461989456,0.869008176993966,"L.LvsP.REACTOME_ADP_SIGNALLING_THROUGH_P2Y_PURINOCEPTOR_1"
13,"Down",0.701482566179428,0.869008176993966,"L.LvsP.REACTOME_RRNA_PROCESSING_IN_THE_MITOCHONDRION"
639,"Down",0.701550062178381,0.869008176993966,"L.LvsP.HAN_SATB1_TARGETS_DN"
32,"Up",0.701795495502999,0.869008176993966,"L.LvsP.WEBER_METHYLATED_HCP_IN_SPERM_UP"
56,"Down",0.701986377493089,0.869008176993966,"L.LvsP.KEGG_TYROSINE_METABOLISM"
32,"Up",0.702115350277939,0.869008176993966,"L.LvsP.REACTOME_GLYCOGEN_METABOLISM"
572,"Up",0.702412295385395,0.869008176993966,"L.LvsP.HELLER_HDAC_TARGETS_UP"
47,"Up",0.702586917053011,0.869008176993966,"L.LvsP.HOUSTIS_ROS"
51,"Down",0.702619482809427,0.869008176993966,"L.LvsP.CHO_NR4A1_TARGETS"
879,"Down",0.702818633245736,0.869008176993966,"L.LvsP.MEISSNER_NPC_HCP_WITH_H3_UNMETHYLATED"
1187,"Up",0.703014007472902,0.869008176993966,"L.LvsP.KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_DN"
308,"Up",0.703122970707521,0.869008176993966,"L.LvsP.MISSIAGLIA_REGULATED_BY_METHYLATION_UP"
8,"Down",0.703126514452597,0.869008176993966,"L.LvsP.REACTOME_STAT5_ACTIVATION"
57,"Down",0.703141527452483,0.869008176993966,"L.LvsP.STANELLE_E2F1_TARGETS"
273,"Up",0.703190917683307,0.869008176993966,"L.LvsP.PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP"
112,"Down",0.704456556817563,0.870377721261298,"L.LvsP.BOYAULT_LIVER_CANCER_SUBCLASS_G6_UP"
10,"Up",0.704756454325797,0.870419053816139,"L.LvsP.BIOCARTA_CB1R_PATHWAY"
31,"Up",0.704804865967599,0.870419053816139,"L.LvsP.OUYANG_PROSTATE_CANCER_PROGRESSION_UP"
118,"Down",0.70659766459389,0.87239019735495,"L.LvsP.KEGG_OOCYTE_MEIOSIS"
289,"Up",0.706716529924547,0.87239019735495,"L.LvsP.NABA_CORE_MATRISOME"
29,"Down",0.707107577226713,0.872625312453266,"L.LvsP.ZHANG_GATA6_TARGETS_UP"
277,"Down",0.707222648779722,0.872625312453266,"L.LvsP.REACTOME_ESR_MEDIATED_SIGNALING"
586,"Down",0.707641116442733,0.872857467901161,"L.LvsP.KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN"
169,"Down",0.708054093607116,0.872857467901161,"L.LvsP.KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_DN"
12,"Down",0.708088165137678,0.872857467901161,"L.LvsP.MUNSHI_MULTIPLE_MYELOMA_DN"
149,"Down",0.708093852260298,0.872857467901161,"L.LvsP.NIKOLSKY_BREAST_CANCER_16P13_AMPLICON"
54,"Up",0.708200144873324,0.872857467901161,"L.LvsP.LEE_CALORIE_RESTRICTION_MUSCLE_UP"
160,"Down",0.709532476736796,0.874221289622184,"L.LvsP.TAKAO_RESPONSE_TO_UVB_RADIATION_DN"
104,"Down",0.709622924185994,0.874221289622184,"L.LvsP.KEGG_VIRAL_MYOCARDITIS"
9,"Up",0.709960599505233,0.8742479955058,"L.LvsP.REACTOME_PHOSPHATE_BOND_HYDROLYSIS_BY_NTPDASE_PROTEINS"
26,"Down",0.709960842796354,0.8742479955058,"L.LvsP.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_DN"
10,"Up",0.710996537468263,0.875257983731743,"L.LvsP.BAKER_HEMATOPOESIS_STAT1_TARGETS"
35,"Up",0.711097642055162,0.875257983731743,"L.LvsP.BIOCARTA_MPR_PATHWAY"
14,"Down",0.712041944541639,0.8759062272045,"L.LvsP.REACTOME_CHK1_CHK2_CDS1_MEDIATED_INACTIVATION_OF_CYCLIN_B_CDK1_COMPLEX"
32,"Up",0.712076198018611,0.8759062272045,"L.LvsP.REACTOME_INCRETIN_SYNTHESIS_SECRETION_AND_INACTIVATION"
415,"Up",0.712099564348748,0.8759062272045,"L.LvsP.FOURNIER_ACINAR_DEVELOPMENT_LATE_2"
1070,"Down",0.712429219360846,0.876116804681076,"L.LvsP.SCHLOSSER_SERUM_RESPONSE_DN"
53,"Up",0.712958535551066,0.876375758096451,"L.LvsP.KIM_TIAL1_TARGETS"
16,"Up",0.713103357941703,0.876375758096451,"L.LvsP.REACTOME_SIGNALING_BY_LEPTIN"
32,"Down",0.713115307591958,0.876375758096451,"L.LvsP.REACTOME_INTRINSIC_PATHWAY_OF_FIBRIN_CLOT_FORMATION"
1519,"Down",0.713556395794938,0.876529729330189,"L.LvsP.BENPORATH_EED_TARGETS"
48,"Up",0.713699165587004,0.876529729330189,"L.LvsP.VIETOR_IFRD1_TARGETS"
106,"Up",0.713963383089166,0.876529729330189,"L.LvsP.RICKMAN_HEAD_AND_NECK_CANCER_B"
11,"Up",0.714114596225752,0.876529729330189,"L.LvsP.REACTOME_DERMATAN_SULFATE_BIOSYNTHESIS"
114,"Up",0.714165120671817,0.876529729330189,"L.LvsP.GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_DN"
145,"Up",0.714191794290559,0.876529729330189,"L.LvsP.YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_12"
247,"Up",0.714504717372628,0.876719170517812,"L.LvsP.REACTOME_COMPLEMENT_CASCADE"
69,"Up",0.714698040361559,0.876761807224109,"L.LvsP.KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY"
71,"Up",0.714880850597002,0.87679153126682,"L.LvsP.HUANG_FOXA2_TARGETS_DN"
23,"Down",0.715069762482966,0.876809329830511,"L.LvsP.REACTOME_SIGNALING_BY_FGFR2_IIIA_TM"
106,"Down",0.715347743916159,0.876809329830511,"L.LvsP.MAGRANGEAS_MULTIPLE_MYELOMA_IGG_VS_IGA_UP"
94,"Up",0.715373064815279,0.876809329830511,"L.LvsP.MAYBURD_RESPONSE_TO_L663536_DN"
36,"Down",0.71566052669452,0.876809329830511,"L.LvsP.REACTOME_GLUCAGON_TYPE_LIGAND_RECEPTORS"
15,"Up",0.71568828097759,0.876809329830511,"L.LvsP.HOLLEMAN_PREDNISOLONE_RESISTANCE_ALL_DN"
343,"Down",0.716052290744674,0.877046133580843,"L.LvsP.GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP"
24,"Down",0.71619882313574,0.877046133580843,"L.LvsP.REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_BETA_CELLS"
33,"Down",0.717495214379866,0.878439114328228,"L.LvsP.GHO_ATF5_TARGETS_DN"
6,"Up",0.717816323838101,0.878637691941745,"L.LvsP.REACTOME_RELEASE_OF_APOPTOTIC_FACTORS_FROM_THE_MITOCHONDRIA"
284,"Down",0.717999655225278,0.87865778175791,"L.LvsP.BIDUS_METASTASIS_UP"
637,"Up",0.718318954515636,0.87865778175791,"L.LvsP.MOHANKUMAR_HOXA1_TARGETS_UP"
13,"Down",0.719067076720371,0.87865778175791,"L.LvsP.REACTOME_IONOTROPIC_ACTIVITY_OF_KAINATE_RECEPTORS"
134,"Up",0.719134835622886,0.87865778175791,"L.LvsP.FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_DN"
42,"Down",0.719155576790131,0.87865778175791,"L.LvsP.REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS"
87,"Down",0.719255647028673,0.87865778175791,"L.LvsP.REACTOME_TRANSCRIPTION_COUPLED_NUCLEOTIDE_EXCISION_REPAIR_TC_NER"
14,"Down",0.719354547742103,0.87865778175791,"L.LvsP.BIOCARTA_IL5_PATHWAY"
645,"Up",0.719364480647457,0.87865778175791,"L.LvsP.CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_2"
384,"Down",0.719392583943602,0.87865778175791,"L.LvsP.SERVITJA_ISLET_HNF1A_TARGETS_UP"
31,"Down",0.719473472261433,0.87865778175791,"L.LvsP.TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_TOP20_UP"
222,"Up",0.719580834834476,0.87865778175791,"L.LvsP.GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_DN"
14,"Down",0.719845721083388,0.878787147686035,"L.LvsP.REACTOME_FGFR3_LIGAND_BINDING_AND_ACTIVATION"
21,"Down",0.720115897831882,0.878922913711363,"L.LvsP.REACTOME_PROSTACYCLIN_SIGNALLING_THROUGH_PROSTACYCLIN_RECEPTOR"
179,"Down",0.720713390657858,0.879302753860127,"L.LvsP.MIKKELSEN_IPS_HCP_WITH_H3_UNMETHYLATED"
15,"Up",0.720745176432283,0.879302753860127,"L.LvsP.RAFFEL_VEGFA_TARGETS_UP"
11,"Up",0.721070616341057,0.879326781073904,"L.LvsP.LUCAS_HNF4A_TARGETS_DN"
7,"Up",0.721082949066573,0.879326781073904,"L.LvsP.TESAR_ALK_TARGETS_HUMAN_ES_4D_DN"
72,"Up",0.722187035359912,0.880308838140441,"L.LvsP.GOBERT_CORE_OLIGODENDROCYTE_DIFFERENTIATION"
16,"Down",0.722360493065538,0.880308838140441,"L.LvsP.BIOCARTA_CFTR_PATHWAY"
30,"Down",0.722365924876683,0.880308838140441,"L.LvsP.BIOCARTA_CCR5_PATHWAY"
13,"Up",0.722723724464094,0.880550787254733,"L.LvsP.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_16"
635,"Down",0.723827638769491,0.881132006747131,"L.LvsP.LINDGREN_BLADDER_CANCER_CLUSTER_2B"
4,"Up",0.724091896866413,0.881132006747131,"L.LvsP.DER_IFN_ALPHA_RESPONSE_DN"
41,"Down",0.724136062412866,0.881132006747131,"L.LvsP.BIOCARTA_EIF4_PATHWAY"
40,"Up",0.724233800052775,0.881132006747131,"L.LvsP.WIEMANN_TELOMERE_SHORTENING_AND_CHRONIC_LIVER_DAMAGE_UP"
129,"Down",0.724626788059763,0.881132006747131,"L.LvsP.SANA_RESPONSE_TO_IFNG_DN"
190,"Down",0.724631885745586,0.881132006747131,"L.LvsP.KEGG_CALCIUM_SIGNALING_PATHWAY"
225,"Up",0.724821694469432,0.881132006747131,"L.LvsP.REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS"
28,"Down",0.725001184813426,0.881132006747131,"L.LvsP.BIOCARTA_NKT_PATHWAY"
71,"Down",0.725255758571634,0.881132006747131,"L.LvsP.VERRECCHIA_RESPONSE_TO_TGFB1_C2"
258,"Down",0.725276601474024,0.881132006747131,"L.LvsP.RUIZ_TNC_TARGETS_UP"
6,"Down",0.725277994506611,0.881132006747131,"L.LvsP.REN_MIF_TARGETS_DN"
5,"Down",0.725401396708611,0.881132006747131,"L.LvsP.REACTOME_MUSCARINIC_ACETYLCHOLINE_RECEPTORS"
57,"Down",0.725439351844197,0.881132006747131,"L.LvsP.RIZ_ERYTHROID_DIFFERENTIATION_HBZ"
32,"Down",0.725472690645769,0.881132006747131,"L.LvsP.COLLER_MYC_TARGETS_DN"
24,"Down",0.725591250989273,0.881132006747131,"L.LvsP.JI_CARCINOGENESIS_BY_KRAS_AND_STK11_UP"
17,"Up",0.726081287149237,0.881533473133099,"L.LvsP.BIOCARTA_IL10_PATHWAY"
35,"Up",0.726746539155639,0.882147445662245,"L.LvsP.HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_DN"
49,"Down",0.727002608857009,0.882168460734848,"L.LvsP.LU_TUMOR_ENDOTHELIAL_MARKERS_UP"
6,"Down",0.727117305638707,0.882168460734848,"L.LvsP.PALOMERO_GSI_SENSITIVITY_DN"
80,"Down",0.727345055387631,0.882168460734848,"L.LvsP.MODY_HIPPOCAMPUS_NEONATAL"
15,"Up",0.7274020641147,0.882168460734848,"L.LvsP.BIOCARTA_IL17_PATHWAY"
73,"Up",0.727894493581067,0.882233324344332,"L.LvsP.WANG_LSD1_TARGETS_DN"
74,"Down",0.727944098296457,0.882233324344332,"L.LvsP.YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_15"
82,"Up",0.728041288775088,0.882233324344332,"L.LvsP.KIM_LIVER_CANCER_POOR_SURVIVAL_DN"
33,"Up",0.728273602151014,0.882233324344332,"L.LvsP.OZEN_MIR125B1_TARGETS"
14,"Up",0.728301957800706,0.882233324344332,"L.LvsP.CHEOK_RESPONSE_TO_MERCAPTOPURINE_UP"
19,"Down",0.728412936449968,0.882233324344332,"L.LvsP.REACTOME_TETRAHYDROBIOPTERIN_BH4_SYNTHESIS_RECYCLING_SALVAGE_AND_REGULATION"
60,"Down",0.728625477839962,0.882297474151807,"L.LvsP.PID_SYNDECAN_1_PATHWAY"
90,"Up",0.72881644075029,0.882335472062262,"L.LvsP.BENNETT_SYSTEMIC_LUPUS_ERYTHEMATOSUS"
209,"Up",0.729353207431798,0.882792006105607,"L.LvsP.NABA_ECM_GLYCOPROTEINS"
601,"Up",0.730743402416204,0.883857657480363,"L.LvsP.VECCHI_GASTRIC_CANCER_EARLY_UP"
62,"Down",0.73076512936901,0.883857657480363,"L.LvsP.AMIT_SERUM_RESPONSE_480_MCF10A"
36,"Down",0.731025639984582,0.883857657480363,"L.LvsP.BIOCARTA_TNFR1_PATHWAY"
1220,"Up",0.731036579742953,0.883857657480363,"L.LvsP.ONKEN_UVEAL_MELANOMA_UP"
401,"Up",0.731456907212919,0.883857657480363,"L.LvsP.WELCSH_BRCA1_TARGETS_UP"
33,"Down",0.731554194238838,0.883857657480363,"L.LvsP.BOYERINAS_ONCOFETAL_TARGETS_OF_LET7A1"
17,"Up",0.731555230082275,0.883857657480363,"L.LvsP.REACTOME_MRNA_DECAY_BY_3_TO_5_EXORIBONUCLEASE"
68,"Down",0.731932095228093,0.883857657480363,"L.LvsP.KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY"
19,"Down",0.731946219436952,0.883857657480363,"L.LvsP.KINNEY_DNMT1_METHYLATION_TARGETS"
42,"Down",0.732023553142811,0.883857657480363,"L.LvsP.ODONNELL_METASTASIS_DN"
27,"Up",0.73211798264345,0.883857657480363,"L.LvsP.WACKER_HYPOXIA_TARGETS_OF_VHL"
9,"Down",0.732151939095689,0.883857657480363,"L.LvsP.NAGY_PCAF_COMPONENTS_HUMAN"
296,"Up",0.733800306157002,0.884978152975584,"L.LvsP.DUTERTRE_ESTRADIOL_RESPONSE_6HR_UP"
180,"Up",0.734102366201193,0.884978152975584,"L.LvsP.WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_UP"
22,"Down",0.734123533902012,0.884978152975584,"L.LvsP.GRAHAM_CML_DIVIDING_VS_NORMAL_DIVIDING_DN"
208,"Up",0.734152400201608,0.884978152975584,"L.LvsP.REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX"
57,"Down",0.734161251758316,0.884978152975584,"L.LvsP.SMID_BREAST_CANCER_RELAPSE_IN_LUNG_DN"
63,"Down",0.73419786123732,0.884978152975584,"L.LvsP.REACTOME_G_PROTEIN_MEDIATED_EVENTS"
29,"Down",0.734200540368783,0.884978152975584,"L.LvsP.EHRLICH_ICF_SYNDROM_DN"
60,"Up",0.734598333666304,0.885264644036834,"L.LvsP.MIKKELSEN_MCV6_ICP_WITH_H3K4ME3_AND_H3K27ME3"
36,"Down",0.735011635449361,0.885569695445526,"L.LvsP.REACTOME_PLATELET_ADHESION_TO_EXPOSED_COLLAGEN"
75,"Down",0.736170203062346,0.886410769623472,"L.LvsP.LIU_TARGETS_OF_VMYB_VS_CMYB_DN"
138,"Up",0.736305191361957,0.886410769623472,"L.LvsP.WORSCHECH_TUMOR_REJECTION_UP"
10,"Up",0.736369189949127,0.886410769623472,"L.LvsP.BIOCARTA_FLUMAZENIL_PATHWAY"
314,"Up",0.73647899975297,0.886410769623472,"L.LvsP.REACTOME_BIOLOGICAL_OXIDATIONS"
320,"Down",0.736542007610192,0.886410769623472,"L.LvsP.KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION"
44,"Up",0.736739352440074,0.886410769623472,"L.LvsP.ALONSO_METASTASIS_DN"
26,"Down",0.736831958254563,0.886410769623472,"L.LvsP.BIOCARTA_HIF_PATHWAY"
675,"Down",0.737396645026722,0.886897117762181,"L.LvsP.IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_DN"
9,"Down",0.737631275687703,0.886986368698849,"L.LvsP.TURJANSKI_MAPK8_AND_MAPK9_TARGETS"
197,"Down",0.737991123295087,0.88722611887335,"L.LvsP.HUMMERICH_SKIN_CANCER_PROGRESSION_DN"
413,"Up",0.738190701567486,0.887273128036224,"L.LvsP.AFFAR_YY1_TARGETS_UP"
170,"Up",0.738651695959072,0.887516588962759,"L.LvsP.KAYO_CALORIE_RESTRICTION_MUSCLE_DN"
195,"Up",0.738714295967918,0.887516588962759,"L.LvsP.REACTOME_ESTROGEN_DEPENDENT_GENE_EXPRESSION"
26,"Down",0.73904654744524,0.887543302463288,"L.LvsP.REACTOME_TRIGLYCERIDE_CATABOLISM"
240,"Up",0.739115259122588,0.887543302463288,"L.LvsP.REACTOME_MITOTIC_PROMETAPHASE"
10,"Up",0.7392181059583,0.887543302463288,"L.LvsP.PID_VEGF_VEGFR_PATHWAY"
746,"Down",0.739741693255041,0.887879530157345,"L.LvsP.MITSIADES_RESPONSE_TO_APLIDIN_UP"
431,"Up",0.739859035834465,0.887879530157345,"L.LvsP.JAATINEN_HEMATOPOIETIC_STEM_CELL_DN"
263,"Down",0.739979901422507,0.887879530157345,"L.LvsP.LEE_NEURAL_CREST_STEM_CELL_DN"
386,"Up",0.740296977656734,0.88806725742332,"L.LvsP.KONDO_PROSTATE_CANCER_WITH_H3K27ME3"
51,"Down",0.740490449971084,0.888106658978334,"L.LvsP.BIOCARTA_BCR_PATHWAY"
265,"Up",0.740769962658127,0.888249213519147,"L.LvsP.BROWNE_HCMV_INFECTION_24HR_DN"
17,"Up",0.741165810029739,0.888531171651003,"L.LvsP.REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE_FGFR4"
22,"Up",0.741728631938378,0.888885672556146,"L.LvsP.REACTOME_SEROTONIN_NEUROTRANSMITTER_RELEASE_CYCLE"
103,"Up",0.741853075957355,0.888885672556146,"L.LvsP.KUMAR_AUTOPHAGY_NETWORK"
39,"Up",0.741943819650319,0.888885672556146,"L.LvsP.YIH_RESPONSE_TO_ARSENITE_C3"
505,"Up",0.742475878840419,0.889170475984433,"L.LvsP.REACTOME_GPCR_LIGAND_BINDING"
318,"Up",0.742503180976691,0.889170475984433,"L.LvsP.VANTVEER_BREAST_CANCER_ESR1_UP"
46,"Up",0.742951407172797,0.889514579960674,"L.LvsP.BIOCARTA_NGF_PATHWAY"
146,"Up",0.743485795617275,0.889961672216479,"L.LvsP.PUJANA_BREAST_CANCER_LIT_INT_NETWORK"
76,"Up",0.743814567349334,0.890162498457677,"L.LvsP.GILDEA_METASTASIS"
42,"Up",0.745236820550573,0.891472890174792,"L.LvsP.PID_S1P_S1P1_PATHWAY"
27,"Down",0.745389871421874,0.891472890174792,"L.LvsP.BIOCARTA_GCR_PATHWAY"
69,"Down",0.745393230471706,0.891472890174792,"L.LvsP.JIANG_AGING_HYPOTHALAMUS_UP"
22,"Up",0.746344449591005,0.892195871051145,"L.LvsP.NADERI_BREAST_CANCER_PROGNOSIS_DN"
17,"Down",0.746636211074976,0.892195871051145,"L.LvsP.REACTOME_TELOMERE_EXTENSION_BY_TELOMERASE"
21,"Down",0.746669265546706,0.892195871051145,"L.LvsP.BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_48HR_UP"
37,"Up",0.746866215642775,0.892195871051145,"L.LvsP.REACTOME_HEME_DEGRADATION"
298,"Down",0.747029006280978,0.892195871051145,"L.LvsP.SMID_BREAST_CANCER_LUMINAL_B_UP"
20,"Down",0.747033150404553,0.892195871051145,"L.LvsP.MIKKELSEN_ES_LCP_WITH_H3K4ME3_AND_H3K27ME3"
101,"Down",0.747127307463701,0.892195871051145,"L.LvsP.XU_GH1_EXOGENOUS_TARGETS_UP"
21,"Down",0.747526262295384,0.892479530173003,"L.LvsP.FARMER_BREAST_CANCER_CLUSTER_3"
695,"Down",0.747765311269428,0.892510230178809,"L.LvsP.RATTENBACHER_BOUND_BY_CELF1"
14,"Up",0.747874823009301,0.892510230178809,"L.LvsP.REACTOME_ROBO_RECEPTORS_BIND_AKAP5"
100,"Up",0.748754453281783,0.8933671498047,"L.LvsP.REACTOME_DAP12_INTERACTIONS"
30,"Down",0.749241963319358,0.893525102436433,"L.LvsP.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_17"
176,"Down",0.74942412280568,0.893525102436433,"L.LvsP.ZHONG_SECRETOME_OF_LUNG_CANCER_AND_ENDOTHELIUM"
384,"Down",0.74961420622992,0.893525102436433,"L.LvsP.YAGI_AML_FAB_MARKERS"
91,"Up",0.749656432205563,0.893525102436433,"L.LvsP.DAUER_STAT3_TARGETS_DN"
29,"Up",0.749720190103046,0.893525102436433,"L.LvsP.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_DN"
17,"Down",0.749856479527048,0.893525102436433,"L.LvsP.REACTOME_ANDROGEN_BIOSYNTHESIS"
8,"Up",0.750216130670428,0.893577591814722,"L.LvsP.REACTOME_RELAXIN_RECEPTORS"
90,"Down",0.750235198310736,0.893577591814722,"L.LvsP.ZHANG_RESPONSE_TO_CANTHARIDIN_DN"
9,"Up",0.750605406479831,0.893577591814722,"L.LvsP.TESAR_ALK_TARGETS_HUMAN_ES_5D_DN"
119,"Down",0.75067277580857,0.893577591814722,"L.LvsP.WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_DN"
118,"Down",0.75070861168012,0.893577591814722,"L.LvsP.GENTILE_UV_LOW_DOSE_DN"
25,"Up",0.751357296532622,0.893850472336788,"L.LvsP.GRANDVAUX_IRF3_TARGETS_DN"
117,"Up",0.751650132043381,0.893850472336788,"L.LvsP.HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_UP"
863,"Up",0.751667311736539,0.893850472336788,"L.LvsP.CHICAS_RB1_TARGETS_SENESCENT"
16,"Down",0.751716108840095,0.893850472336788,"L.LvsP.REACTOME_ATF6_ATF6_ALPHA_ACTIVATES_CHAPERONE_GENES"
44,"Down",0.751761672856328,0.893850472336788,"L.LvsP.LOPEZ_MESOTHELIOMA_SURVIVAL_DN"
132,"Up",0.752007805444609,0.893850472336788,"L.LvsP.AKL_HTLV1_INFECTION_DN"
150,"Down",0.752069523839887,0.893850472336788,"L.LvsP.REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION"
80,"Down",0.752644649600332,0.894341772542496,"L.LvsP.HEIDENBLAD_AMPLIFIED_IN_PANCREATIC_CANCER"
13,"Down",0.753122525181932,0.894452451576283,"L.LvsP.GALI_TP53_TARGETS_APOPTOTIC_UP"
156,"Up",0.753189940370529,0.894452451576283,"L.LvsP.FONTAINE_PAPILLARY_THYROID_CARCINOMA_DN"
5,"Down",0.75322311711687,0.894452451576283,"L.LvsP.NIKOLSKY_BREAST_CANCER_19P13_AMPLICON"
27,"Down",0.753887260753926,0.894889406273414,"L.LvsP.WILSON_PROTEASES_AT_TUMOR_BONE_INTERFACE_UP"
228,"Up",0.753914786475233,0.894889406273414,"L.LvsP.REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_BCR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS"
48,"Up",0.754578008167909,0.895339960883473,"L.LvsP.BIOCARTA_CARM_ER_PATHWAY"
54,"Down",0.754685207845203,0.895339960883473,"L.LvsP.KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS"
44,"Up",0.75478016959267,0.895339960883473,"L.LvsP.DING_LUNG_CANCER_BY_MUTATION_RATE"
868,"Up",0.754988989206002,0.895395564418702,"L.LvsP.HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP"
112,"Down",0.756052024536667,0.896312256008305,"L.LvsP.LEIN_NEURON_MARKERS"
35,"Down",0.756086156994526,0.896312256008305,"L.LvsP.ZHAN_MULTIPLE_MYELOMA_SUBGROUPS"
60,"Down",0.75650981116909,0.896622239218414,"L.LvsP.REACTOME_METABOLIC_DISORDERS_OF_BIOLOGICAL_OXIDATION_ENZYMES"
252,"Down",0.756824343327049,0.896802784881109,"L.LvsP.REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS"
26,"Up",0.757206471356265,0.896812497755431,"L.LvsP.REACTOME_PRESYNAPTIC_FUNCTION_OF_KAINATE_RECEPTORS"
87,"Up",0.757212514569405,0.896812497755431,"L.LvsP.STOSSI_RESPONSE_TO_ESTRADIOL"
40,"Down",0.757727104228769,0.896812497755431,"L.LvsP.STAMBOLSKY_BOUND_BY_MUTATED_TP53"
8,"Down",0.757870965580435,0.896812497755431,"L.LvsP.KERLEY_RESPONSE_TO_CISPLATIN_DN"
647,"Up",0.758072401363663,0.896812497755431,"L.LvsP.YAUCH_HEDGEHOG_SIGNALING_PARACRINE_DN"
107,"Down",0.758455308570031,0.896812497755431,"L.LvsP.ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_UP"
46,"Down",0.758552382044871,0.896812497755431,"L.LvsP.REACTOME_PHASE_0_RAPID_DEPOLARISATION"
201,"Down",0.758624379146615,0.896812497755431,"L.LvsP.BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_CIS"
269,"Up",0.758891480119342,0.896812497755431,"L.LvsP.RIGGI_EWING_SARCOMA_PROGENITOR_DN"
78,"Down",0.759077727474961,0.896812497755431,"L.LvsP.KIM_ALL_DISORDERS_CALB1_CORR_DN"
145,"Down",0.759122456156992,0.896812497755431,"L.LvsP.ELVIDGE_HIF1A_TARGETS_DN"
36,"Up",0.759752809472904,0.896812497755431,"L.LvsP.HEIDENBLAD_AMPLICON_12P11_12_DN"
228,"Up",0.759848099473075,0.896812497755431,"L.LvsP.EPPERT_HSC_R"
18,"Down",0.759904872800199,0.896812497755431,"L.LvsP.REACTOME_NEUROTRANSMITTER_CLEARANCE"
15,"Down",0.760050038231163,0.896812497755431,"L.LvsP.PID_INTEGRIN4_PATHWAY"
7,"Down",0.760118340230614,0.896812497755431,"L.LvsP.REACTOME_TELOMERE_C_STRAND_SYNTHESIS_INITIATION"
42,"Down",0.760387573852196,0.896812497755431,"L.LvsP.ABBUD_LIF_SIGNALING_2_UP"
22,"Up",0.760656445626253,0.896812497755431,"L.LvsP.BIOCARTA_D4GDI_PATHWAY"
355,"Down",0.760726276453596,0.896812497755431,"L.LvsP.IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_UP"
63,"Down",0.760781964301631,0.896812497755431,"L.LvsP.BENPORATH_ES_2"
251,"Down",0.760966491278066,0.896812497755431,"L.LvsP.SABATES_COLORECTAL_ADENOMA_UP"
27,"Down",0.761023605419229,0.896812497755431,"L.LvsP.MEISSNER_BRAIN_HCP_WITH_H3K4ME2"
13,"Up",0.761255129580905,0.896812497755431,"L.LvsP.MIKKELSEN_NPC_WITH_LCP_H3K27ME3"
127,"Up",0.761422768663438,0.896812497755431,"L.LvsP.ZHANG_GATA6_TARGETS_DN"
165,"Up",0.761435258234555,0.896812497755431,"L.LvsP.DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_UP"
80,"Down",0.76172031229997,0.896812497755431,"L.LvsP.LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_DN"
91,"Down",0.761871677591584,0.896812497755431,"L.LvsP.ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_UP"
492,"Up",0.762125095782894,0.896812497755431,"L.LvsP.WANG_MLL_TARGETS"
262,"Down",0.762126780956446,0.896812497755431,"L.LvsP.LIU_CMYB_TARGETS_UP"
167,"Down",0.762148707921039,0.896812497755431,"L.LvsP.QI_PLASMACYTOMA_DN"
125,"Up",0.762255371816657,0.896812497755431,"L.LvsP.FLORIO_HUMAN_NEOCORTEX"
30,"Up",0.762295809272267,0.896812497755431,"L.LvsP.IWANAGA_E2F1_TARGETS_INDUCED_BY_SERUM"
204,"Down",0.762427909598026,0.896812497755431,"L.LvsP.CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_DN"
8,"Up",0.762490754180345,0.896812497755431,"L.LvsP.REACTOME_OPSINS"
588,"Down",0.762509595215823,0.896812497755431,"L.LvsP.YOSHIMURA_MAPK8_TARGETS_DN"
1129,"Up",0.76298019143066,0.897175133649537,"L.LvsP.BENPORATH_MYC_MAX_TARGETS"
573,"Down",0.763301699800329,0.897276512942491,"L.LvsP.CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP"
666,"Up",0.763523114597765,0.897276512942491,"L.LvsP.FOSTER_KDM1A_TARGETS_UP"
6,"Down",0.763572391781261,0.897276512942491,"L.LvsP.BIOCARTA_SAM68_PATHWAY"
50,"Up",0.763715548907102,0.897276512942491,"L.LvsP.ABBUD_LIF_SIGNALING_1_DN"
1480,"Down",0.763953490112783,0.897365380674225,"L.LvsP.CUI_TCF21_TARGETS_2_DN"
725,"Down",0.764245520604788,0.897488533319712,"L.LvsP.PEDRIOLI_MIR31_TARGETS_DN"
30,"Down",0.764382981262891,0.897488533319712,"L.LvsP.KEGG_BETA_ALANINE_METABOLISM"
15,"Down",0.764643236750235,0.8976034938412,"L.LvsP.CHESLER_BRAIN_D6MIT150_QTL_CIS"
41,"Down",0.765044471743958,0.897610267338395,"L.LvsP.VALK_AML_CLUSTER_16"
1034,"Down",0.765122847719673,0.897610267338395,"L.LvsP.GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP"
30,"Down",0.7651360444865,0.897610267338395,"L.LvsP.REACTOME_GLUTAMATE_NEUROTRANSMITTER_RELEASE_CYCLE"
41,"Up",0.765889282749762,0.898128143158769,"L.LvsP.REACTOME_EGR2_AND_SOX10_MEDIATED_INITIATION_OF_SCHWANN_CELL_MYELINATION"
10,"Down",0.765902368419894,0.898128143158769,"L.LvsP.IKEDA_MIR1_TARGETS_DN"
28,"Down",0.7661921386878,0.898277424682962,"L.LvsP.REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS"
15,"Down",0.766677931916504,0.89863781751969,"L.LvsP.GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_1_DN"
8,"Down",0.766970327634257,0.89863781751969,"L.LvsP.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_5"
68,"Down",0.767110780864674,0.89863781751969,"L.LvsP.REACTOME_INTERLEUKIN_10_SIGNALING"
105,"Down",0.767149665164213,0.89863781751969,"L.LvsP.PID_AVB3_INTEGRIN_PATHWAY"
33,"Up",0.767918579875118,0.899182190994371,"L.LvsP.REACTOME_PIWI_INTERACTING_RNA_PIRNA_BIOGENESIS"
13,"Down",0.768014825093073,0.899182190994371,"L.LvsP.LIU_TARGETS_OF_VMYB_VS_CMYB_UP"
90,"Down",0.768230124797885,0.899182190994371,"L.LvsP.DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP"
165,"Down",0.768264906901322,0.899182190994371,"L.LvsP.SENESE_HDAC2_TARGETS_UP"
38,"Down",0.768750162018241,0.899224882651458,"L.LvsP.SESTO_RESPONSE_TO_UV_C4"
113,"Up",0.769102818144347,0.899224882651458,"L.LvsP.HOWLIN_CITED1_TARGETS_1_DN"
120,"Up",0.769105055518294,0.899224882651458,"L.LvsP.CHUNG_BLISTER_CYTOTOXICITY_DN"
30,"Up",0.769105679846476,0.899224882651458,"L.LvsP.MILICIC_FAMILIAL_ADENOMATOUS_POLYPOSIS_DN"
21,"Up",0.769114572266005,0.899224882651458,"L.LvsP.ROETH_TERT_TARGETS_DN"
101,"Up",0.769696094853933,0.899571372666703,"L.LvsP.MARTINEZ_RESPONSE_TO_TRABECTEDIN_UP"
62,"Up",0.769883488044316,0.899571372666703,"L.LvsP.ZHAN_MULTIPLE_MYELOMA_HP_DN"
167,"Up",0.770160575345409,0.899571372666703,"L.LvsP.BOYLAN_MULTIPLE_MYELOMA_PCA3_UP"
11,"Up",0.770276902805318,0.899571372666703,"L.LvsP.MARIADASON_RESPONSE_TO_BUTYRATE_CURCUMIN_SULINDAC_TSA_8"
21,"Down",0.770313874710793,0.899571372666703,"L.LvsP.GRATIAS_RETINOBLASTOMA_16Q24"
42,"Down",0.77038713141198,0.899571372666703,"L.LvsP.OHM_METHYLATED_IN_ADULT_CANCERS"
101,"Up",0.770811639450232,0.899803203489532,"L.LvsP.TURASHVILI_BREAST_NORMAL_DUCTAL_VS_LOBULAR_UP"
139,"Down",0.770911154807363,0.899803203489532,"L.LvsP.ROSS_AML_WITH_MLL_FUSIONS"
51,"Up",0.771765520223201,0.900521558664966,"L.LvsP.SIMBULAN_PARP1_TARGETS_UP"
133,"Down",0.771852354225588,0.900521558664966,"L.LvsP.MIKKELSEN_MEF_LCP_WITH_H3K27ME3"
448,"Up",0.773011390948649,0.901526681381839,"L.LvsP.IVANOVA_HEMATOPOIESIS_MATURE_CELL"
154,"Up",0.77329132588481,0.901526681381839,"L.LvsP.LEE_LIVER_CANCER_DENA_DN"
633,"Down",0.77331240814508,0.901526681381839,"L.LvsP.WANG_SMARCE1_TARGETS_DN"
22,"Up",0.773366078819689,0.901526681381839,"L.LvsP.KEGG_ALPHA_LINOLENIC_ACID_METABOLISM"
118,"Up",0.773954783536999,0.90202276521418,"L.LvsP.ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_DN"
6,"Down",0.774298286131246,0.902091178669816,"L.LvsP.REACTOME_PRE_NOTCH_PROCESSING_IN_THE_ENDOPLASMIC_RETICULUM"
87,"Down",0.774339796340558,0.902091178669816,"L.LvsP.WANG_BARRETTS_ESOPHAGUS_UP"
52,"Down",0.774707713903539,0.902329671407767,"L.LvsP.KEGG_ALDOSTERONE_REGULATED_SODIUM_REABSORPTION"
99,"Down",0.775011120698498,0.90249294152106,"L.LvsP.NUTT_GBM_VS_AO_GLIOMA_UP"
30,"Down",0.775177359439838,0.902496445639685,"L.LvsP.SUZUKI_RESPONSE_TO_TSA"
156,"Up",0.775384852198331,0.902536405675145,"L.LvsP.REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_DIFFERENTIATION_OF_HSCS"
9,"Down",0.775538155789946,0.902536405675145,"L.LvsP.REACTOME_2_LTR_CIRCLE_FORMATION"
13,"Up",0.776040625617414,0.902904923843792,"L.LvsP.WANG_ESOPHAGUS_CANCER_PROGRESSION_UP"
77,"Up",0.776181425760453,0.902904923843792,"L.LvsP.DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_DN"
240,"Up",0.776848051802503,0.903178920690262,"L.LvsP.GARCIA_TARGETS_OF_FLI1_AND_DAX1_DN"
19,"Down",0.777251120668894,0.903178920690262,"L.LvsP.BIOCARTA_P53_PATHWAY"
35,"Down",0.777482386007178,0.903178920690262,"L.LvsP.WU_HBX_TARGETS_3_UP"
9,"Up",0.777553440388676,0.903178920690262,"L.LvsP.BIOCARTA_CREM_PATHWAY"
112,"Up",0.777559100022024,0.903178920690262,"L.LvsP.PID_E2F_PATHWAY"
23,"Down",0.777569648975091,0.903178920690262,"L.LvsP.GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN"
12,"Up",0.777570753656845,0.903178920690262,"L.LvsP.NIKOLSKY_BREAST_CANCER_20P13_AMPLICON"
56,"Up",0.777770046332173,0.903178920690262,"L.LvsP.KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION"
28,"Up",0.77788714420818,0.903178920690262,"L.LvsP.SU_KIDNEY"
112,"Down",0.778310779808469,0.903481062683398,"L.LvsP.ASGHARZADEH_NEUROBLASTOMA_POOR_SURVIVAL_DN"
246,"Up",0.779336780908583,0.90438365469956,"L.LvsP.SASAKI_ADULT_T_CELL_LEUKEMIA"
123,"Up",0.779587468988873,0.90438365469956,"L.LvsP.LEE_LIVER_CANCER_ACOX1_UP"
161,"Up",0.779842732425338,0.90438365469956,"L.LvsP.MARTIN_VIRAL_GPCR_SIGNALING_UP"
9,"Down",0.779869985816857,0.90438365469956,"L.LvsP.REACTOME_HISTIDINE_CATABOLISM"
61,"Up",0.77999009376739,0.90438365469956,"L.LvsP.WINNEPENNINCKX_MELANOMA_METASTASIS_DN"
392,"Down",0.780254198243638,0.90438365469956,"L.LvsP.REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION"
107,"Up",0.781251479541698,0.90438365469956,"L.LvsP.GAURNIER_PSMD4_TARGETS"
50,"Up",0.781270108996591,0.90438365469956,"L.LvsP.ONO_FOXP3_TARGETS_DN"
38,"Down",0.781272973751008,0.90438365469956,"L.LvsP.ONO_FOXP3_TARGETS_UP"
12,"Down",0.781341341771983,0.90438365469956,"L.LvsP.WANG_THOC1_TARGETS_UP"
213,"Down",0.781626006572645,0.90438365469956,"L.LvsP.CERVERA_SDHB_TARGETS_2"
20,"Down",0.781730872865976,0.90438365469956,"L.LvsP.RODRIGUES_THYROID_CARCINOMA_UP"
669,"Down",0.781742542476108,0.90438365469956,"L.LvsP.KUMAR_TARGETS_OF_MLL_AF9_FUSION"
848,"Up",0.781822263271441,0.90438365469956,"L.LvsP.MATSUDA_NATURAL_KILLER_DIFFERENTIATION"
15,"Down",0.781838157315887,0.90438365469956,"L.LvsP.COLLIS_PRKDC_REGULATORS"
18,"Up",0.781919795774057,0.90438365469956,"L.LvsP.MIKKELSEN_IPS_LCP_WITH_H3K4ME3_AND_H3K27ME3"
24,"Down",0.781948606993511,0.90438365469956,"L.LvsP.CASTELLANO_NRAS_TARGETS_DN"
40,"Up",0.782172037255775,0.90438365469956,"L.LvsP.CHOW_RASSF1_TARGETS_DN"
279,"Down",0.782196172322897,0.90438365469956,"L.LvsP.BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP"
87,"Up",0.783199173089462,0.904919421127338,"L.LvsP.KEGG_TASTE_TRANSDUCTION"
29,"Up",0.783471929054866,0.904919421127338,"L.LvsP.BIOCARTA_BARR_MAPK_PATHWAY"
9,"Down",0.783526041956673,0.904919421127338,"L.LvsP.FUNG_IL2_TARGETS_WITH_STAT5_BINDING_SITES"
607,"Down",0.78355875964493,0.904919421127338,"L.LvsP.GARY_CD5_TARGETS_DN"
249,"Down",0.783591159410673,0.904919421127338,"L.LvsP.AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_UP"
10,"Down",0.78364156056388,0.904919421127338,"L.LvsP.REACTOME_CALCITONIN_LIKE_LIGAND_RECEPTORS"
44,"Up",0.784030555454236,0.905157366856403,"L.LvsP.REACTOME_RA_BIOSYNTHESIS_PATHWAY"
214,"Up",0.784175038387081,0.905157366856403,"L.LvsP.NIKOLSKY_BREAST_CANCER_8Q23_Q24_AMPLICON"
154,"Up",0.785230316512678,0.906186270089459,"L.LvsP.ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_DN"
28,"Down",0.785615076373375,0.906301218625066,"L.LvsP.PID_CONE_PATHWAY"
110,"Up",0.785657757437139,0.906301218625066,"L.LvsP.KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY"
59,"Down",0.786498404464418,0.906947772386542,"L.LvsP.PID_HNF3B_PATHWAY"
16,"Down",0.786546313726437,0.906947772386542,"L.LvsP.KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_UV_IN_WS"
939,"Down",0.787140058567026,0.907443157593221,"L.LvsP.GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP"
33,"Down",0.787432836149038,0.907591442790918,"L.LvsP.BIOCARTA_G1_PATHWAY"
81,"Down",0.788034910915495,0.908096086380111,"L.LvsP.KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN"
236,"Up",0.788704171911313,0.908677925921577,"L.LvsP.REACTOME_DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS"
977,"Down",0.789003854843308,0.90873137390032,"L.LvsP.WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_8D"
28,"Up",0.789079277644319,0.90873137390032,"L.LvsP.HOWLIN_CITED1_TARGETS_2_DN"
162,"Down",0.789282595015754,0.908776232370284,"L.LvsP.BASSO_CD40_SIGNALING_UP"
13,"Down",0.79015389026517,0.90942866786638,"L.LvsP.CASTELLANO_HRAS_AND_NRAS_TARGETS_DN"
95,"Down",0.790178209518917,0.90942866786638,"L.LvsP.FAELT_B_CLL_WITH_VH_REARRANGEMENTS_DN"
50,"Up",0.790414912887202,0.90951176968852,"L.LvsP.LASTOWSKA_COAMPLIFIED_WITH_MYCN"
322,"Down",0.791008496832249,0.909728440417582,"L.LvsP.DARWICHE_PAPILLOMA_RISK_HIGH_DN"
431,"Down",0.791046498888647,0.909728440417582,"L.LvsP.BONOME_OVARIAN_CANCER_SURVIVAL_OPTIMAL_DEBULKING"
103,"Down",0.79120996375679,0.909728440417582,"L.LvsP.NIKOLSKY_BREAST_CANCER_7Q21_Q22_AMPLICON"
39,"Down",0.791367508667684,0.909728440417582,"L.LvsP.BUCKANOVICH_T_LYMPHOCYTE_HOMING_ON_TUMOR_UP"
14,"Up",0.791511821435884,0.909728440417582,"L.LvsP.XU_AKT1_TARGETS_48HR"
19,"Down",0.791590437122262,0.909728440417582,"L.LvsP.YIH_RESPONSE_TO_ARSENITE_C5"
12,"Down",0.792094913788558,0.90982672982346,"L.LvsP.REACTOME_INTERLEUKIN_23_SIGNALING"
147,"Up",0.792141624217648,0.90982672982346,"L.LvsP.BAE_BRCA1_TARGETS_UP"
425,"Down",0.79216962875206,0.90982672982346,"L.LvsP.PLASARI_TGFB1_TARGETS_10HR_DN"
118,"Down",0.792907373287355,0.91048491524523,"L.LvsP.LEE_AGING_NEOCORTEX_DN"
9,"Down",0.793631493567414,0.911127186032856,"L.LvsP.BRUNEAU_SEPTATION_ATRIAL"
18,"Up",0.794210193680242,0.911407743374317,"L.LvsP.BIOCARTA_DNAFRAGMENT_PATHWAY"
25,"Down",0.794238052301612,0.911407743374317,"L.LvsP.MCCOLLUM_GELDANAMYCIN_RESISTANCE_UP"
7,"Down",0.794370395247031,0.911407743374317,"L.LvsP.REACTOME_ACROSOME_REACTION_AND_SPERM_OOCYTE_MEMBRANE_BINDING"
72,"Up",0.794766189796814,0.91163876075418,"L.LvsP.VALK_AML_CLUSTER_11"
9,"Down",0.794981059778749,0.91163876075418,"L.LvsP.REACTOME_TERMINAL_PATHWAY_OF_COMPLEMENT"
156,"Up",0.795066396157833,0.91163876075418,"L.LvsP.KOHOUTEK_CCNT2_TARGETS"
1526,"Down",0.795320895612311,0.911699914671168,"L.LvsP.MARSON_BOUND_BY_FOXP3_UNSTIMULATED"
69,"Up",0.795449518606207,0.911699914671168,"L.LvsP.WAGSCHAL_EHMT2_TARGETS_UP"
23,"Up",0.795677205436048,0.911771869192935,"L.LvsP.KEGG_NITROGEN_METABOLISM"
256,"Up",0.795987790924523,0.911938768342662,"L.LvsP.TSENG_IRS1_TARGETS_DN"
29,"Up",0.796169923883536,0.911958464709357,"L.LvsP.REACTOME_LDL_CLEARANCE"
43,"Down",0.796582661738241,0.912061119977046,"L.LvsP.REACTOME_EXPORT_OF_VIRAL_RIBONUCLEOPROTEINS_FROM_NUCLEUS"
9,"Down",0.796589464346022,0.912061119977046,"L.LvsP.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_2"
238,"Up",0.796975539598422,0.912098953105956,"L.LvsP.TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN"
77,"Down",0.797114108848464,0.912098953105956,"L.LvsP.KEGG_ADIPOCYTOKINE_SIGNALING_PATHWAY"
161,"Up",0.797117406657258,0.912098953105956,"L.LvsP.VANLOO_SP3_TARGETS_DN"
225,"Down",0.797328381159053,0.912120510243546,"L.LvsP.SENGUPTA_EBNA1_ANTICORRELATED"
26,"Up",0.797466186745759,0.912120510243546,"L.LvsP.REACTOME_TRAFFICKING_AND_PROCESSING_OF_ENDOSOMAL_TLR"
110,"Down",0.798173967863629,0.91274123439876,"L.LvsP.OHGUCHI_LIVER_HNF4A_TARGETS_UP"
15,"Down",0.798397630937783,0.912808209564724,"L.LvsP.REACTOME_MITOTIC_TELOPHASE_CYTOKINESIS"
39,"Down",0.798867965774388,0.913139948926622,"L.LvsP.REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS"
366,"Up",0.799065938561022,0.913139948926622,"L.LvsP.GROSS_HYPOXIA_VIA_ELK3_UP"
8,"Down",0.799183254269475,0.913139948926622,"L.LvsP.KORKOLA_CHORIOCARCINOMA_UP"
343,"Up",0.799423045865804,0.913172234770102,"L.LvsP.YEGNASUBRAMANIAN_PROSTATE_CANCER"
354,"Down",0.799690105607151,0.913172234770102,"L.LvsP.GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN"
238,"Down",0.79970699235971,0.913172234770102,"L.LvsP.MARKEY_RB1_CHRONIC_LOF_DN"
47,"Down",0.800007356969686,0.913326590271607,"L.LvsP.KEGG_PRIMARY_IMMUNODEFICIENCY"
94,"Down",0.800252842548913,0.91341824245519,"L.LvsP.BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_UP"
184,"Down",0.800436446464394,0.913439238906426,"L.LvsP.REACTOME_PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS"
56,"Up",0.801218367850904,0.91414287161528,"L.LvsP.REACTOME_HEPARAN_SULFATE_HEPARIN_HS_GAG_METABOLISM"
14,"Down",0.801837680300418,0.914467740398127,"L.LvsP.WEBER_METHYLATED_LCP_IN_FIBROBLAST_UP"
273,"Down",0.801980957838952,0.914467740398127,"L.LvsP.VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP"
21,"Down",0.801999289779439,0.914467740398127,"L.LvsP.REACTOME_P130CAS_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS"
427,"Down",0.802571460898789,0.914931465424619,"L.LvsP.RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_DN"
733,"Down",0.803309884313843,0.915584487811016,"L.LvsP.HAN_SATB1_TARGETS_UP"
36,"Up",0.803695501066873,0.915709673896952,"L.LvsP.BIOCARTA_TRKA_PATHWAY"
6,"Down",0.804026512209226,0.915709673896952,"L.LvsP.REACTOME_MECP2_REGULATES_TRANSCRIPTION_FACTORS"
63,"Down",0.804060826547324,0.915709673896952,"L.LvsP.SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_DN"
33,"Down",0.804082196919823,0.915709673896952,"L.LvsP.KIM_LIVER_CANCER_POOR_SURVIVAL_UP"
73,"Up",0.804260985527289,0.915724668241429,"L.LvsP.HOFMANN_CELL_LYMPHOMA_DN"
59,"Up",0.804467728474694,0.915771478430427,"L.LvsP.CAFFAREL_RESPONSE_TO_THC_DN"
165,"Up",0.804905377278475,0.91595852426968,"L.LvsP.MALONEY_RESPONSE_TO_17AAG_DN"
173,"Down",0.8051312664924,0.91595852426968,"L.LvsP.HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_DN"
496,"Down",0.80518855862634,0.91595852426968,"L.LvsP.VERHAAK_AML_WITH_NPM1_MUTATED_DN"
26,"Down",0.805544982644016,0.91595852426968,"L.LvsP.BARRIER_COLON_CANCER_RECURRENCE_DN"
13,"Down",0.805550037107684,0.91595852426968,"L.LvsP.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_29"
80,"Up",0.80562602704349,0.91595852426968,"L.LvsP.SU_PANCREAS"
260,"Down",0.806688730340556,0.916978205191803,"L.LvsP.INGRAM_SHH_TARGETS_UP"
189,"Up",0.806933035932239,0.917067370127307,"L.LvsP.LIU_VAV3_PROSTATE_CARCINOGENESIS_UP"
105,"Up",0.807135231647687,0.91710865100289,"L.LvsP.WEBER_METHYLATED_ICP_IN_FIBROBLAST"
153,"Up",0.808179714548383,0.918106768386688,"L.LvsP.REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION"
1333,"Up",0.809492576214987,0.918801809916225,"L.LvsP.KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_DN"
53,"Up",0.809616712959703,0.918801809916225,"L.LvsP.WANG_METASTASIS_OF_BREAST_CANCER_ESR1_DN"
82,"Down",0.809644889123838,0.918801809916225,"L.LvsP.TUOMISTO_TUMOR_SUPPRESSION_BY_COL13A1_UP"
215,"Down",0.809736648845709,0.918801809916225,"L.LvsP.REACTOME_FCERI_MEDIATED_MAPK_ACTIVATION"
191,"Up",0.80976436236458,0.918801809916225,"L.LvsP.DER_IFN_ALPHA_RESPONSE_UP"
1586,"Up",0.809858810175425,0.918801809916225,"L.LvsP.BRUINS_UVC_RESPONSE_LATE"
1060,"Down",0.809954787761201,0.918801809916225,"L.LvsP.MARTINEZ_RB1_AND_TP53_TARGETS_UP"
22,"Down",0.810343044167613,0.919053680246714,"L.LvsP.PYEON_HPV_POSITIVE_TUMORS_DN"
18,"Down",0.810527429217193,0.919074273203827,"L.LvsP.REACTOME_ATF6_ATF6_ALPHA_ACTIVATES_CHAPERONES"
35,"Down",0.810774787183405,0.919128063586978,"L.LvsP.GOLUB_ALL_VS_AML_DN"
7,"Up",0.810988591870781,0.919128063586978,"L.LvsP.REACTOME_ACTIVATION_OF_C3_AND_C5"
42,"Up",0.811073579714391,0.919128063586978,"L.LvsP.BONOME_OVARIAN_CANCER_POOR_SURVIVAL_DN"
73,"Up",0.811490164137804,0.919185626065251,"L.LvsP.URS_ADIPOCYTE_DIFFERENTIATION_DN"
7,"Up",0.811505042354629,0.919185626065251,"L.LvsP.LIU_CMYB_TARGETS_DN"
152,"Up",0.811623119271217,0.919185626065251,"L.LvsP.LIAN_LIPA_TARGETS_6M"
365,"Down",0.811843706790414,0.919247154381364,"L.LvsP.PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP"
35,"Up",0.812557263084763,0.919569025933833,"L.LvsP.PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN"
26,"Up",0.81258361184324,0.919569025933833,"L.LvsP.REACTOME_PD_1_SIGNALING"
325,"Up",0.812626923623206,0.919569025933833,"L.LvsP.PURBEY_TARGETS_OF_CTBP1_AND_SATB1_DN"
17,"Down",0.813586457354063,0.92046644622685,"L.LvsP.CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_LD_MTX_UP"
67,"Down",0.81428403347402,0.921067189254881,"L.LvsP.CHESLER_BRAIN_HIGHEST_EXPRESSION"
58,"Down",0.8147571758223,0.921413873005011,"L.LvsP.TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_DN"
16,"Down",0.815062100966512,0.921570216000786,"L.LvsP.REACTOME_TNFR1_INDUCED_PROAPOPTOTIC_SIGNALING"
459,"Down",0.815357748939552,0.921580295825495,"L.LvsP.LU_AGING_BRAIN_UP"
6,"Up",0.815499429509591,0.921580295825495,"L.LvsP.REACTOME_ACYL_CHAIN_REMODELING_OF_CL"
264,"Down",0.815788916554821,0.921580295825495,"L.LvsP.POOLA_INVASIVE_BREAST_CANCER_DN"
54,"Down",0.815827285048576,0.921580295825495,"L.LvsP.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_PINK_DN"
148,"Down",0.81590442178799,0.921580295825495,"L.LvsP.GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_DN"
1498,"Down",0.81633831323894,0.921882053492259,"L.LvsP.ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN"
106,"Up",0.816684520951569,0.922083932802889,"L.LvsP.RHODES_CANCER_META_SIGNATURE"
31,"Down",0.816850624501456,0.922083932802889,"L.LvsP.PID_S1P_META_PATHWAY"
102,"Down",0.817612251726714,0.922755284710554,"L.LvsP.HUPER_BREAST_BASAL_VS_LUMINAL_UP"
22,"Up",0.817981137710538,0.922835024152706,"L.LvsP.ZHENG_RESPONSE_TO_ARSENITE_DN"
84,"Up",0.81804837081367,0.922835024152706,"L.LvsP.MIKKELSEN_NPC_LCP_WITH_H3K4ME3"
35,"Up",0.818183629661162,0.922835024152706,"L.LvsP.GENTLES_LEUKEMIC_STEM_CELL_DN"
140,"Up",0.818940268417222,0.923333380483308,"L.LvsP.BILBAN_B_CLL_LPL_UP"
61,"Down",0.818959467876676,0.923333380483308,"L.LvsP.CHEOK_RESPONSE_TO_HD_MTX_UP"
24,"Down",0.819313734430706,0.923544472511187,"L.LvsP.REACTOME_ANCHORING_FIBRIL_FORMATION"
43,"Down",0.820008565564903,0.92405397594428,"L.LvsP.GENTLES_LEUKEMIC_STEM_CELL_UP"
1090,"Down",0.820099992757927,0.92405397594428,"L.LvsP.LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN"
28,"Down",0.820861251212211,0.924723279941384,"L.LvsP.TIAN_TNF_SIGNALING_VIA_NFKB"
40,"Down",0.822010640210287,0.925763946769216,"L.LvsP.CHEN_ETV5_TARGETS_SERTOLI"
33,"Up",0.822283746987712,0.925763946769216,"L.LvsP.MCCABE_HOXC6_TARGETS_CANCER_DN"
34,"Up",0.822287347184594,0.925763946769216,"L.LvsP.WELCH_GATA1_TARGETS"
227,"Down",0.82266761581039,0.926003511363121,"L.LvsP.JACKSON_DNMT1_TARGETS_UP"
19,"Up",0.823073024750461,0.926098095356196,"L.LvsP.REACTOME_SIGNAL_REGULATORY_PROTEIN_FAMILY_INTERACTIONS"
38,"Up",0.823086641450597,0.926098095356196,"L.LvsP.MATTIOLI_MULTIPLE_MYELOMA_SUBGROUPS"
14,"Down",0.8233724446,0.926186914308213,"L.LvsP.REACTOME_REDUCTION_OF_CYTOSOLIC_CA_LEVELS"
101,"Down",0.823798958446718,0.926186914308213,"L.LvsP.RIZKI_TUMOR_INVASIVENESS_2D_DN"
709,"Down",0.823809347086207,0.926186914308213,"L.LvsP.MIKKELSEN_MCV6_HCP_WITH_H3K27ME3"
1243,"Down",0.823873557322651,0.926186914308213,"L.LvsP.LEE_BMP2_TARGETS_UP"
49,"Down",0.824003152736861,0.926186914308213,"L.LvsP.REACTOME_TBC_RABGAPS"
88,"Up",0.824203262386546,0.926223544255125,"L.LvsP.BROWNE_HCMV_INFECTION_10HR_DN"
29,"Up",0.824529881531821,0.9262902785551,"L.LvsP.BIOCARTA_NO2IL12_PATHWAY"
18,"Down",0.824597712253247,0.9262902785551,"L.LvsP.BIOCARTA_LYM_PATHWAY"
168,"Up",0.825397364015206,0.927000208336395,"L.LvsP.COATES_MACROPHAGE_M1_VS_M2_UP"
44,"Up",0.82574859341287,0.927036173049382,"L.LvsP.SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_DN"
222,"Down",0.825866179770473,0.927036173049382,"L.LvsP.DER_IFN_BETA_RESPONSE_UP"
429,"Up",0.826044062150744,0.927036173049382,"L.LvsP.HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN"
205,"Down",0.826100058711215,0.927036173049382,"L.LvsP.ODONNELL_METASTASIS_UP"
20,"Down",0.826490439516469,0.927117700953294,"L.LvsP.REACTOME_ACTIVATION_OF_SMO"
119,"Down",0.826508075239426,0.927117700953294,"L.LvsP.REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT"
153,"Up",0.826831484586101,0.927292348534797,"L.LvsP.CASTELLANO_NRAS_TARGETS_UP"
126,"Up",0.82774807991667,0.927761841187533,"L.LvsP.LEE_LIVER_CANCER_ACOX1_DN"
74,"Up",0.827799012133545,0.927761841187533,"L.LvsP.KLEIN_TARGETS_OF_BCR_ABL1_FUSION"
11,"Down",0.827822538292188,0.927761841187533,"L.LvsP.GALIE_TUMOR_STEMNESS_GENES"
20,"Down",0.828085908557855,0.927761841187533,"L.LvsP.SA_PTEN_PATHWAY"
700,"Down",0.828089109470153,0.927761841187533,"L.LvsP.MILI_PSEUDOPODIA_CHEMOTAXIS_DN"
677,"Up",0.828397375108196,0.927919182936227,"L.LvsP.BASAKI_YBX1_TARGETS_DN"
26,"Up",0.828740872430468,0.927974665376025,"L.LvsP.SMID_BREAST_CANCER_NORMAL_LIKE_DN"
15,"Down",0.828782582316298,0.927974665376025,"L.LvsP.GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_1_UP"
179,"Up",0.828952636194373,0.927977146288457,"L.LvsP.MATZUK_SPERMATOZOA"
13,"Down",0.829371519810173,0.928258124095232,"L.LvsP.TESAR_ALK_TARGETS_EPISC_3D_UP"
87,"Up",0.829840023788549,0.928282294608157,"L.LvsP.SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE"
368,"Up",0.829853052720892,0.928282294608157,"L.LvsP.KYNG_DNA_DAMAGE_UP"
38,"Up",0.82989679548709,0.928282294608157,"L.LvsP.RUAN_RESPONSE_TO_TNF_TROGLITAZONE_UP"
198,"Down",0.830637737024299,0.928460918895941,"L.LvsP.CERVERA_SDHB_TARGETS_1_UP"
43,"Down",0.830683671218536,0.928460918895941,"L.LvsP.REACTOME_PROLACTIN_RECEPTOR_SIGNALING"
19,"Up",0.830811344789101,0.928460918895941,"L.LvsP.REACTOME_CASPASE_ACTIVATION_VIA_DEATH_RECEPTORS_IN_THE_PRESENCE_OF_LIGAND"
37,"Down",0.830834721916999,0.928460918895941,"L.LvsP.KEGG_HISTIDINE_METABOLISM"
24,"Down",0.830896116241113,0.928460918895941,"L.LvsP.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_24"
11,"Down",0.8311939978475,0.928606105091701,"L.LvsP.REACTOME_ERYTHROPOIETIN_ACTIVATES_PHOSPHOLIPASE_C_GAMMA_PLCG"
11,"Up",0.831439257076684,0.928609013391994,"L.LvsP.REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_CASPASE_ACTIVATORS_AND_CASPASES"
14,"Down",0.831532505933037,0.928609013391994,"L.LvsP.REACTOME_PURINE_RIBONUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHESIS"
35,"Up",0.832167050522014,0.928918913840469,"L.LvsP.OUYANG_PROSTATE_CANCER_MARKERS"
25,"Up",0.832328955467803,0.928918913840469,"L.LvsP.GENTILE_UV_RESPONSE_CLUSTER_D1"
145,"Up",0.83243718203556,0.928918913840469,"L.LvsP.MARCHINI_TRABECTEDIN_RESISTANCE_DN"
494,"Down",0.832482043421871,0.928918913840469,"L.LvsP.KAAB_HEART_ATRIUM_VS_VENTRICLE_UP"
1863,"Up",0.833067946565691,0.929385124407124,"L.LvsP.BLALOCK_ALZHEIMERS_DISEASE_DN"
41,"Up",0.833562948619756,0.929607060252765,"L.LvsP.TUOMISTO_TUMOR_SUPPRESSION_BY_COL13A1_DN"
181,"Down",0.833603147898934,0.929607060252765,"L.LvsP.MUNSHI_MULTIPLE_MYELOMA_UP"
20,"Down",0.833917327704097,0.929769894106867,"L.LvsP.REACTOME_WNT5A_DEPENDENT_INTERNALIZATION_OF_FZD4"
60,"Down",0.834854368255945,0.930553117402321,"L.LvsP.CROONQUIST_NRAS_SIGNALING_UP"
768,"Up",0.835023779780565,0.930553117402321,"L.LvsP.SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP"
9,"Down",0.835172564895387,0.930553117402321,"L.LvsP.REACTOME_ESTROGEN_BIOSYNTHESIS"
10,"Down",0.835293022547968,0.930553117402321,"L.LvsP.TESAR_ALK_TARGETS_EPISC_4D_UP"
105,"Down",0.836354648419432,0.931302362584684,"L.LvsP.SESTO_RESPONSE_TO_UV_C7"
55,"Up",0.836468908277965,0.931302362584684,"L.LvsP.STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_DN"
7,"Up",0.83647088670565,0.931302362584684,"L.LvsP.REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_LINKED_TO_GLUCONEOGENESIS"
1106,"Up",0.837203964441577,0.931865104781718,"L.LvsP.KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP"
1673,"Down",0.837313409396921,0.931865104781718,"L.LvsP.REACTOME_SIGNALING_BY_GPCR"
164,"Up",0.838031135191785,0.932476181621127,"L.LvsP.XU_HGF_TARGETS_REPRESSED_BY_AKT1_DN"
78,"Up",0.838860531496639,0.932757749494174,"L.LvsP.PAL_PRMT5_TARGETS_DN"
176,"Down",0.838899464470726,0.932757749494174,"L.LvsP.NABA_ECM_AFFILIATED"
79,"Down",0.838943838736182,0.932757749494174,"L.LvsP.CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN"
115,"Down",0.838958995882534,0.932757749494174,"L.LvsP.DARWICHE_PAPILLOMA_PROGRESSION_RISK"
1095,"Down",0.840251699650811,0.93400716674092,"L.LvsP.SMID_BREAST_CANCER_LUMINAL_B_DN"
217,"Up",0.841206976112221,0.934852291516094,"L.LvsP.REACTOME_FCERI_MEDIATED_CA_2_MOBILIZATION"
2088,"Down",0.841380738113098,0.934852291516094,"L.LvsP.YOSHIMURA_MAPK8_TARGETS_UP"
1063,"Down",0.841689279811869,0.934852291516094,"L.LvsP.MARTINEZ_TP53_TARGETS_UP"
126,"Up",0.841723236123034,0.934852291516094,"L.LvsP.YAO_HOXA10_TARGETS_VIA_PROGESTERONE_UP"
8,"Down",0.841857399070108,0.934852291516094,"L.LvsP.REACTOME_COMPETING_ENDOGENOUS_RNAS_CERNAS_REGULATE_PTEN_TRANSLATION"
140,"Up",0.842410411013528,0.935278546685502,"L.LvsP.LEIN_PONS_MARKERS"
342,"Down",0.842926527704975,0.935663676306124,"L.LvsP.DARWICHE_SKIN_TUMOR_PROMOTER_DN"
169,"Up",0.843306057221029,0.935897067518079,"L.LvsP.NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP"
9,"Down",0.843537671741167,0.935956313612875,"L.LvsP.MIKHAYLOVA_OXIDATIVE_STRESS_RESPONSE_VIA_VHL_UP"
53,"Down",0.843698004530036,0.935956313612875,"L.LvsP.REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS"
53,"Down",0.843882967366491,0.935973706433166,"L.LvsP.BIOCARTA_VEGF_PATHWAY"
24,"Down",0.845522228930089,0.937428985963984,"L.LvsP.YAGUE_PRETUMOR_DRUG_RESISTANCE_DN"
138,"Up",0.845534156809982,0.937428985963984,"L.LvsP.HARRIS_HYPOXIA"
11,"Up",0.845952294119108,0.937704537727456,"L.LvsP.MIZUSHIMA_AUTOPHAGOSOME_FORMATION"
423,"Down",0.846696135906064,0.938340937146648,"L.LvsP.GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP"
8,"Down",0.847050892662793,0.938357921364973,"L.LvsP.REACTOME_AMINO_ACID_CONJUGATION"
8,"Down",0.847050892662793,0.938357921364973,"L.LvsP.REACTOME_CONJUGATION_OF_BENZOATE_WITH_GLYCINE"
8,"Up",0.848104452975375,0.939147781948793,"L.LvsP.REACTOME_HDL_CLEARANCE"
8,"Down",0.84820463372307,0.939147781948793,"L.LvsP.REACTOME_FGFR3B_LIGAND_BINDING_AND_ACTIVATION"
136,"Down",0.848273471342425,0.939147781948793,"L.LvsP.DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_DN"
17,"Up",0.848492137952663,0.939201807956011,"L.LvsP.BIOCARTA_BTG2_PATHWAY"
43,"Up",0.84879768732114,0.939267145270685,"L.LvsP.WEST_ADRENOCORTICAL_TUMOR_MARKERS_DN"
26,"Up",0.84915816851951,0.939267145270685,"L.LvsP.REACTOME_SYNTHESIS_SECRETION_AND_INACTIVATION_OF_GLUCAGON_LIKE_PEPTIDE_1_GLP_1"
409,"Up",0.849332813041795,0.939267145270685,"L.LvsP.PEDRIOLI_MIR31_TARGETS_UP"
342,"Down",0.849490532726876,0.939267145270685,"L.LvsP.JIANG_HYPOXIA_NORMAL"
8,"Up",0.849715258870114,0.939267145270685,"L.LvsP.REACTOME_TYSND1_CLEAVES_PEROXISOMAL_PROTEINS"
117,"Up",0.84974690638645,0.939267145270685,"L.LvsP.RIZKI_TUMOR_INVASIVENESS_2D_UP"
37,"Down",0.849874035266868,0.939267145270685,"L.LvsP.BIOCARTA_CCR3_PATHWAY"
826,"Up",0.850079438593396,0.939267145270685,"L.LvsP.FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP"
102,"Up",0.850080085898807,0.939267145270685,"L.LvsP.KEGG_RETINOL_METABOLISM"
34,"Up",0.850396700934066,0.93942924265024,"L.LvsP.KEGG_ALANINE_ASPARTATE_AND_GLUTAMATE_METABOLISM"
46,"Up",0.851309695669637,0.940249961517664,"L.LvsP.IIZUKA_LIVER_CANCER_PROGRESSION_G2_G3_UP"
54,"Down",0.852231413481502,0.940958736143959,"L.LvsP.REACTOME_GLUCAGON_LIKE_PEPTIDE_1_GLP1_REGULATES_INSULIN_SECRETION"
735,"Down",0.85229179790359,0.940958736143959,"L.LvsP.BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP"
39,"Down",0.852556610821954,0.941053274131893,"L.LvsP.DUNNE_TARGETS_OF_AML1_MTG8_FUSION_DN"
28,"Up",0.852771136809764,0.941053274131893,"L.LvsP.MARCINIAK_ER_STRESS_RESPONSE_VIA_CHOP"
153,"Down",0.85294356552759,0.941053274131893,"L.LvsP.REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION"
278,"Up",0.853140809417261,0.941053274131893,"L.LvsP.LIN_NPAS4_TARGETS_UP"
124,"Down",0.85344298914994,0.941053274131893,"L.LvsP.LU_IL4_SIGNALING"
165,"Up",0.853581128547827,0.941053274131893,"L.LvsP.FURUKAWA_DUSP6_TARGETS_PCI35_UP"
28,"Up",0.853589730949146,0.941053274131893,"L.LvsP.REACTOME_DOPAMINE_NEUROTRANSMITTER_RELEASE_CYCLE"
14,"Up",0.853739052820687,0.941053274131893,"L.LvsP.ZHOU_PANCREATIC_BETA_CELL"
112,"Up",0.854147715060544,0.941316068680436,"L.LvsP.BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_CIS"
24,"Up",0.854405577812998,0.941412602576338,"L.LvsP.RAY_TARGETS_OF_P210_BCR_ABL_FUSION_DN"
595,"Up",0.854727700694622,0.941579887854267,"L.LvsP.BROWNE_HCMV_INFECTION_4HR_DN"
495,"Down",0.854907428067988,0.941590272866117,"L.LvsP.NIKOLSKY_BREAST_CANCER_17Q21_Q25_AMPLICON"
44,"Up",0.855436951589795,0.941854255934061,"L.LvsP.BIOCARTA_EICOSANOID_PATHWAY"
73,"Down",0.855487804901583,0.941854255934061,"L.LvsP.CHANGOLKAR_H2AFY_TARGETS_UP"
323,"Down",0.855840470186976,0.942046724997015,"L.LvsP.DURAND_STROMA_NS_UP"
48,"Down",0.856107582828821,0.942046724997015,"L.LvsP.REACTOME_VIRAL_MESSENGER_RNA_SYNTHESIS"
48,"Up",0.856266761543823,0.942046724997015,"L.LvsP.FRASOR_RESPONSE_TO_ESTRADIOL_UP"
125,"Down",0.856344156237113,0.942046724997015,"L.LvsP.ZHENG_GLIOBLASTOMA_PLASTICITY_DN"
65,"Down",0.856805850120624,0.942102345701403,"L.LvsP.YANG_BREAST_CANCER_ESR1_UP"
231,"Up",0.856821012793998,0.942102345701403,"L.LvsP.BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_DN"
112,"Down",0.857034597425521,0.942102345701403,"L.LvsP.WIEDERSCHAIN_TARGETS_OF_BMI1_AND_PCGF2"
32,"Down",0.857101933656556,0.942102345701403,"L.LvsP.SCHMIDT_POR_TARGETS_IN_LIMB_BUD_DN"
116,"Up",0.857246681357163,0.942102345701403,"L.LvsP.JAIN_NFKB_SIGNALING"
714,"Up",0.857536969621714,0.942234082877277,"L.LvsP.BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP"
29,"Up",0.857935793036023,0.942273791573537,"L.LvsP.REACTOME_AFLATOXIN_ACTIVATION_AND_DETOXIFICATION"
102,"Up",0.858049472487564,0.942273791573537,"L.LvsP.REACTOME_PLASMA_LIPOPROTEIN_ASSEMBLY_REMODELING_AND_CLEARANCE"
34,"Down",0.858266443080549,0.942273791573537,"L.LvsP.BIOCARTA_SPPA_PATHWAY"
38,"Down",0.85827677398841,0.942273791573537,"L.LvsP.BIOCARTA_BARRESTIN_SRC_PATHWAY"
50,"Down",0.858449560826742,0.942273791573537,"L.LvsP.JAERVINEN_AMPLIFIED_IN_LARYNGEAL_CANCER"
24,"Down",0.858807841792222,0.942273791573537,"L.LvsP.HOLLEMAN_DAUNORUBICIN_B_ALL_UP"
18,"Up",0.858840829512699,0.942273791573537,"L.LvsP.BIOCARTA_TCRA_PATHWAY"
867,"Down",0.859028210489426,0.942273791573537,"L.LvsP.NABA_MATRISOME_ASSOCIATED"
26,"Down",0.859267209274153,0.942273791573537,"L.LvsP.REACTOME_A_TETRASACCHARIDE_LINKER_SEQUENCE_IS_REQUIRED_FOR_GAG_SYNTHESIS"
136,"Down",0.859277348003938,0.942273791573537,"L.LvsP.ROSS_AML_WITH_PML_RARA_FUSION"
300,"Up",0.860004668453095,0.942769624314197,"L.LvsP.THUM_SYSTOLIC_HEART_FAILURE_DN"
72,"Down",0.860070534462074,0.942769624314197,"L.LvsP.NIKOLSKY_BREAST_CANCER_16Q24_AMPLICON"
13,"Down",0.860466376241563,0.943016569720436,"L.LvsP.NAKAMURA_LUNG_CANCER_DIFFERENTIATION_MARKERS"
188,"Up",0.860900686899216,0.943305568344384,"L.LvsP.ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION"
41,"Down",0.86136193376839,0.943623961126497,"L.LvsP.HOEGERKORP_CD44_TARGETS_DIRECT_UP"
48,"Up",0.861757874357361,0.943864697870105,"L.LvsP.LI_PROSTATE_CANCER_EPIGENETIC"
8,"Down",0.861977433185067,0.943864697870105,"L.LvsP.BIOCARTA_WNT_LRP6_PATHWAY"
35,"Up",0.862321975814329,0.943864697870105,"L.LvsP.NIKOLSKY_BREAST_CANCER_15Q26_AMPLICON"
494,"Down",0.862561390782296,0.943864697870105,"L.LvsP.REACTOME_G_ALPHA_I_SIGNALLING_EVENTS"
10,"Up",0.862669040374093,0.943864697870105,"L.LvsP.TESAR_ALK_TARGETS_HUMAN_ES_5D_UP"
1329,"Up",0.862765954299314,0.943864697870105,"L.LvsP.KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_UP"
140,"Down",0.862776665407037,0.943864697870105,"L.LvsP.REACTOME_ADORA2B_MEDIATED_ANTI_INFLAMMATORY_CYTOKINES_PRODUCTION"
201,"Down",0.863244766343179,0.944189972920166,"L.LvsP.REACTOME_ROLE_OF_LAT2_NTAL_LAB_ON_CALCIUM_MOBILIZATION"
747,"Up",0.863786497228612,0.944459145706868,"L.LvsP.ODONNELL_TFRC_TARGETS_UP"
17,"Down",0.863878459763288,0.944459145706868,"L.LvsP.REACTOME_FORMYL_PEPTIDE_RECEPTORS_BIND_FORMYL_PEPTIDES_AND_MANY_OTHER_LIGANDS"
53,"Down",0.864205370169993,0.944459145706868,"L.LvsP.HU_ANGIOGENESIS_UP"
238,"Up",0.864404909346444,0.944459145706868,"L.LvsP.YAUCH_HEDGEHOG_SIGNALING_PARACRINE_UP"
100,"Up",0.86441038484818,0.944459145706868,"L.LvsP.CADWELL_ATG16L1_TARGETS_DN"
12,"Up",0.864724768796588,0.944459145706868,"L.LvsP.REACTOME_INTEGRATION_OF_PROVIRUS"
236,"Up",0.865350426944818,0.944459145706868,"L.LvsP.COULOUARN_TEMPORAL_TGFB1_SIGNATURE_DN"
378,"Down",0.865439607675166,0.944459145706868,"L.LvsP.EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_UP"
18,"Up",0.865507237432322,0.944459145706868,"L.LvsP.REACTOME_NEUROFASCIN_INTERACTIONS"
29,"Down",0.865614678580884,0.944459145706868,"L.LvsP.PID_IL27_PATHWAY"
6,"Up",0.865900047065191,0.944459145706868,"L.LvsP.BIOCARTA_BOTULIN_PATHWAY"
102,"Down",0.865918492980357,0.944459145706868,"L.LvsP.PID_IL4_2PATHWAY"
8,"Down",0.865926574666037,0.944459145706868,"L.LvsP.HESSON_TUMOR_SUPPRESSOR_CLUSTER_3P21_3"
33,"Up",0.866030112175576,0.944459145706868,"L.LvsP.BIOCARTA_CYTOKINE_PATHWAY"
18,"Up",0.866053150431149,0.944459145706868,"L.LvsP.CLAUS_PGR_POSITIVE_MENINGIOMA_UP"
125,"Up",0.866590821096721,0.944854520566084,"L.LvsP.IVANOVSKA_MIR106B_TARGETS"
66,"Up",0.866757483868905,0.944854520566084,"L.LvsP.EPPERT_CE_HSC_LSC"
41,"Down",0.867149391652484,0.9449636814293,"L.LvsP.PID_AR_NONGENOMIC_PATHWAY"
16,"Down",0.867591949093067,0.9449636814293,"L.LvsP.ZHOU_PANCREATIC_EXOCRINE_PROGENITOR"
327,"Down",0.867673026414997,0.9449636814293,"L.LvsP.LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER"
501,"Up",0.867697213811,0.9449636814293,"L.LvsP.JAATINEN_HEMATOPOIETIC_STEM_CELL_UP"
826,"Down",0.867712174103193,0.9449636814293,"L.LvsP.TARTE_PLASMA_CELL_VS_PLASMABLAST_UP"
10,"Up",0.868214555834119,0.945324592203002,"L.LvsP.KAPOSI_LIVER_CANCER_MET_DN"
38,"Up",0.868983344273266,0.945335434695755,"L.LvsP.VALK_AML_WITH_11Q23_REARRANGED"
71,"Down",0.86905858330852,0.945335434695755,"L.LvsP.SHIPP_DLBCL_CURED_VS_FATAL_DN"
121,"Down",0.869421921281944,0.945335434695755,"L.LvsP.GROSS_HYPOXIA_VIA_HIF1A_UP"
15,"Down",0.869486523197908,0.945335434695755,"L.LvsP.REACTOME_TRAF3_DEPENDENT_IRF_ACTIVATION_PATHWAY"
248,"Up",0.869665427221157,0.945335434695755,"L.LvsP.ZHU_CMV_ALL_UP"
22,"Down",0.869781522663988,0.945335434695755,"L.LvsP.REACTOME_GRB2_SOS_PROVIDES_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS"
24,"Down",0.869928987764146,0.945335434695755,"L.LvsP.PID_THROMBIN_PAR4_PATHWAY"
68,"Down",0.869989842693972,0.945335434695755,"L.LvsP.BRACHAT_RESPONSE_TO_CAMPTOTHECIN_DN"
53,"Down",0.870076586001658,0.945335434695755,"L.LvsP.GROSS_HYPOXIA_VIA_ELK3_ONLY_UP"
159,"Up",0.870095994413123,0.945335434695755,"L.LvsP.OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_UP"
356,"Up",0.870295605363815,0.945335434695755,"L.LvsP.LEE_RECENT_THYMIC_EMIGRANT"
95,"Down",0.870358524283158,0.945335434695755,"L.LvsP.KYNG_DNA_DAMAGE_BY_4NQO_OR_UV"
40,"Down",0.870506062543545,0.945335434695755,"L.LvsP.VANASSE_BCL2_TARGETS_UP"
127,"Up",0.870618201025643,0.945335434695755,"L.LvsP.MEISSNER_NPC_HCP_WITH_H3K27ME3"
54,"Down",0.870952432926127,0.945512664765081,"L.LvsP.REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY"
127,"Down",0.871552965936309,0.945859281754119,"L.LvsP.WANG_PROSTATE_CANCER_ANDROGEN_INDEPENDENT"
1053,"Down",0.871776582613704,0.945859281754119,"L.LvsP.NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN"
31,"Up",0.871784933951708,0.945859281754119,"L.LvsP.JEON_SMAD6_TARGETS_DN"
305,"Up",0.87198537994657,0.945891144933213,"L.LvsP.WIERENGA_STAT5A_TARGETS_DN"
83,"Up",0.872686224469548,0.94628490545016,"L.LvsP.REACTOME_GLYCOLYSIS"
37,"Down",0.872690673338826,0.94628490545016,"L.LvsP.MATTHEWS_SKIN_CARCINOGENESIS_VIA_JUN"
110,"Up",0.873016937717404,0.946453068360691,"L.LvsP.MATZUK_MEIOTIC_AND_DNA_REPAIR"
42,"Down",0.874140117284422,0.947484945788192,"L.LvsP.VANDESLUIS_COMMD1_TARGETS_GROUP_4_DN"
48,"Down",0.874358124035487,0.947535489571189,"L.LvsP.HEIDENBLAD_AMPLICON_12P11_12_UP"
73,"Down",0.874747730568994,0.947668445263748,"L.LvsP.SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_UP"
198,"Up",0.874823610892778,0.947668445263748,"L.LvsP.REACTOME_FCGR_ACTIVATION"
21,"Down",0.875062075415084,0.947741080307541,"L.LvsP.REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_24_HYDROXYCHOLESTEROL"
112,"Up",0.875310958283044,0.94782496834057,"L.LvsP.DELASERNA_MYOD_TARGETS_DN"
12,"Down",0.875923507512033,0.948302540245551,"L.LvsP.REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_EARLY_PANCREATIC_PRECURSOR_CELLS"
10,"Up",0.876779793931338,0.948859224238018,"L.LvsP.REACTOME_ORGANIC_ANION_TRANSPORTERS"
79,"Up",0.876792460915517,0.948859224238018,"L.LvsP.KEGG_DRUG_METABOLISM_OTHER_ENZYMES"
88,"Down",0.876968812197384,0.948859224238018,"L.LvsP.DORN_ADENOVIRUS_INFECTION_12HR_DN"
46,"Up",0.877124162611776,0.948859224238018,"L.LvsP.RAY_TARGETS_OF_P210_BCR_ABL_FUSION_UP"
25,"Down",0.877704387728505,0.949134216768209,"L.LvsP.BIOCARTA_IFNA_PATHWAY"
232,"Up",0.877786610050177,0.949134216768209,"L.LvsP.DER_IFN_GAMMA_RESPONSE_UP"
49,"Down",0.877893359477776,0.949134216768209,"L.LvsP.VANDESLUIS_NORMAL_EMBRYOS_DN"
99,"Up",0.878348240630686,0.949440356294637,"L.LvsP.REACTOME_PLATELET_HOMEOSTASIS"
35,"Down",0.879242171971145,0.95015173975318,"L.LvsP.REACTOME_ACTIVATION_OF_KAINATE_RECEPTORS_UPON_GLUTAMATE_BINDING"
14,"Down",0.879350054678427,0.95015173975318,"L.LvsP.REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_SEVERAL_ADDITIONAL_CELL_DEATH_GENES_WHOSE_SPECIFIC_ROLES_IN_P53_DEPENDENT_APOPTOSIS_REMAIN_UNCERTAIN"
33,"Down",0.879606788600972,0.950243441612891,"L.LvsP.HOEGERKORP_CD44_TARGETS_TEMPORAL_DN"
380,"Down",0.880698022360808,0.951236445718481,"L.LvsP.REACTOME_ANTI_INFLAMMATORY_RESPONSE_FAVOURING_LEISHMANIA_PARASITE_INFECTION"
368,"Up",0.881578671948924,0.951727233626247,"L.LvsP.AMUNDSON_RESPONSE_TO_ARSENITE"
44,"Up",0.881593749700188,0.951727233626247,"L.LvsP.BIOCARTA_GH_PATHWAY"
10,"Up",0.881668817260561,0.951727233626247,"L.LvsP.HEIDENBLAD_AMPLIFIED_IN_BONE_CANCER"
109,"Down",0.882134017290667,0.952043525590494,"L.LvsP.FIGUEROA_AML_METHYLATION_CLUSTER_5_DN"
181,"Up",0.882535372972894,0.952157661225961,"L.LvsP.ONDER_CDH1_SIGNALING_VIA_CTNNB1"
42,"Up",0.882584194932728,0.952157661225961,"L.LvsP.REACTOME_DISEASES_OF_CARBOHYDRATE_METABOLISM"
11,"Down",0.882863919794893,0.952273627106119,"L.LvsP.REACTOME_HORMONE_LIGAND_BINDING_RECEPTORS"
72,"Down",0.88319543060433,0.952404804769471,"L.LvsP.ZHAN_MULTIPLE_MYELOMA_CD1_UP"
72,"Down",0.883330048626849,0.952404804769471,"L.LvsP.ROESSLER_LIVER_CANCER_METASTASIS_DN"
806,"Up",0.883561029974121,0.952468109714743,"L.LvsP.REACTOME_NEUTROPHIL_DEGRANULATION"
493,"Down",0.883952120240818,0.952693624985178,"L.LvsP.CHANDRAN_METASTASIS_DN"
44,"Up",0.884114847133107,0.952693624985178,"L.LvsP.REACTOME_BETA_DEFENSINS"
42,"Down",0.884770879289703,0.95321476843195,"L.LvsP.BIOCARTA_GLEEVEC_PATHWAY"
21,"Down",0.885208630841532,0.953234831617383,"L.LvsP.REACTOME_TRANSLESION_SYNTHESIS_BY_POLH"
233,"Down",0.885304752676895,0.953234831617383,"L.LvsP.CHEBOTAEV_GR_TARGETS_DN"
9,"Down",0.885549969548532,0.953234831617383,"L.LvsP.REACTOME_REGULATION_OF_PTEN_MRNA_TRANSLATION"
64,"Up",0.885646332881051,0.953234831617383,"L.LvsP.SCHOEN_NFKB_SIGNALING"
556,"Up",0.88565153373458,0.953234831617383,"L.LvsP.MCLACHLAN_DENTAL_CARIES_UP"
110,"Down",0.886296026464352,0.953742843581432,"L.LvsP.POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_UP"
34,"Down",0.886802641900431,0.954102317000873,"L.LvsP.NIKOLSKY_BREAST_CANCER_5P15_AMPLICON"
40,"Up",0.887080586103384,0.954215673261791,"L.LvsP.SCHEIDEREIT_IKK_TARGETS"
46,"Down",0.887372174405845,0.954343659266663,"L.LvsP.BIOCARTA_NO1_PATHWAY"
206,"Up",0.888533298377716,0.955233530396615,"L.LvsP.MIKKELSEN_IPS_ICP_WITH_H3K4ME3_AND_H327ME3"
66,"Down",0.888728124334278,0.955233530396615,"L.LvsP.KEGG_TYPE_II_DIABETES_MELLITUS"
415,"Up",0.888847688867819,0.955233530396615,"L.LvsP.WONG_EMBRYONIC_STEM_CELL_CORE"
172,"Down",0.888890669902439,0.955233530396615,"L.LvsP.BAELDE_DIABETIC_NEPHROPATHY_UP"
37,"Up",0.889271085582299,0.955279852867427,"L.LvsP.ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_UP"
11,"Down",0.889279327673838,0.955279852867427,"L.LvsP.BIOCARTA_ALTERNATIVE_PATHWAY"
89,"Down",0.889653551030391,0.955496208944644,"L.LvsP.GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_UP"
42,"Up",0.889966719525656,0.955646920228657,"L.LvsP.BRACHAT_RESPONSE_TO_METHOTREXATE_DN"
981,"Down",0.890282102039107,0.955799949936742,"L.LvsP.BROWNE_HCMV_INFECTION_48HR_DN"
121,"Up",0.890624350783511,0.955871591913396,"L.LvsP.YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_1"
61,"Up",0.890792259437711,0.955871591913396,"L.LvsP.LIU_CDX2_TARGETS_UP"
9,"Up",0.890867482931765,0.955871591913396,"L.LvsP.ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_2HR"
58,"Up",0.891061269996755,0.955894016649604,"L.LvsP.HUMMERICH_MALIGNANT_SKIN_TUMOR_UP"
51,"Down",0.891539016693898,0.95622099385074,"L.LvsP.JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_UP"
37,"Down",0.891890958988585,0.956412938760257,"L.LvsP.BIOCARTA_IL12_PATHWAY"
10,"Down",0.892373595951078,0.95670092794971,"L.LvsP.GALIE_TUMOR_ANGIOGENESIS"
22,"Down",0.892505586247893,0.95670092794971,"L.LvsP.ZEILSTRA_CD44_TARGETS_UP"
23,"Down",0.892898905915048,0.956842752877344,"L.LvsP.GOUYER_TATI_TARGETS_DN"
886,"Down",0.893080831227543,0.956842752877344,"L.LvsP.FEVR_CTNNB1_TARGETS_DN"
292,"Down",0.893157071369139,0.956842752877344,"L.LvsP.SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM2"
119,"Down",0.89342444712887,0.956943775314902,"L.LvsP.MEISSNER_BRAIN_HCP_WITH_H3_UNMETHYLATED"
12,"Down",0.89381780654255,0.957179673130692,"L.LvsP.HOFFMAN_CLOCK_TARGETS_DN"
43,"Up",0.8943612145771,0.957576133887836,"L.LvsP.TCGA_GLIOBLASTOMA_COPY_NUMBER_DN"
97,"Up",0.894664921749497,0.957715847502995,"L.LvsP.BROWNE_HCMV_INFECTION_30MIN_UP"
89,"Down",0.895311085075988,0.958222026594103,"L.LvsP.CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_UP"
28,"Down",0.896273622336889,0.958302304800868,"L.LvsP.REACTOME_ENDOGENOUS_STEROLS"
118,"Up",0.896293846829294,0.958302304800868,"L.LvsP.BOYLAN_MULTIPLE_MYELOMA_PCA3_DN"
71,"Up",0.896323892359689,0.958302304800868,"L.LvsP.TSAI_RESPONSE_TO_RADIATION_THERAPY"
867,"Up",0.8967808516667,0.958302304800868,"L.LvsP.PARENT_MTOR_SIGNALING_UP"
24,"Up",0.896968288428095,0.958302304800868,"L.LvsP.BIOCARTA_RACC_PATHWAY"
185,"Down",0.897067920249891,0.958302304800868,"L.LvsP.FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP"
25,"Down",0.897120407153615,0.958302304800868,"L.LvsP.KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS_AND_CYCLIC_RGD"
38,"Up",0.897209880051279,0.958302304800868,"L.LvsP.CEBALLOS_TARGETS_OF_TP53_AND_MYC_UP"
22,"Down",0.89730702199341,0.958302304800868,"L.LvsP.REACTOME_CASPASE_MEDIATED_CLEAVAGE_OF_CYTOSKELETAL_PROTEINS"
14,"Up",0.897370602393058,0.958302304800868,"L.LvsP.MEINHOLD_OVARIAN_CANCER_LOW_GRADE_UP"
94,"Down",0.897451047830274,0.958302304800868,"L.LvsP.YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_3"
28,"Down",0.897765437496772,0.958302304800868,"L.LvsP.MATZUK_OVULATION"
15,"Down",0.897903527087256,0.958302304800868,"L.LvsP.REACTOME_SIGNAL_ATTENUATION"
97,"Down",0.898125884742856,0.958302304800868,"L.LvsP.KEGG_ECM_RECEPTOR_INTERACTION"
110,"Down",0.898147911689203,0.958302304800868,"L.LvsP.ROSS_AML_WITH_CBFB_MYH11_FUSION"
41,"Down",0.898173224095614,0.958302304800868,"L.LvsP.MAYBURD_RESPONSE_TO_L663536_UP"
607,"Up",0.898332581982799,0.958302304800868,"L.LvsP.SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP"
21,"Down",0.8986526481105,0.958458813928039,"L.LvsP.JOHANSSON_BRAIN_CANCER_EARLY_VS_LATE_UP"
130,"Up",0.899238885455412,0.958899093092183,"L.LvsP.CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_UP"
67,"Down",0.899683970685806,0.9591887146012,"L.LvsP.GYORFFY_DOXORUBICIN_RESISTANCE"
357,"Down",0.899936533208478,0.959252704420406,"L.LvsP.JISON_SICKLE_CELL_DISEASE_UP"
782,"Up",0.900145900346545,0.959252704420406,"L.LvsP.BONOME_OVARIAN_CANCER_SURVIVAL_SUBOPTIMAL_DEBULKING"
19,"Up",0.900698763261638,0.959252704420406,"L.LvsP.REACTOME_ACYL_CHAIN_REMODELLING_OF_PI"
35,"Down",0.900805055546497,0.959252704420406,"L.LvsP.NABA_PROTEOGLYCANS"
55,"Up",0.900817148579682,0.959252704420406,"L.LvsP.PID_IL23_PATHWAY"
780,"Up",0.900944484030801,0.959252704420406,"L.LvsP.REACTOME_OLFACTORY_SIGNALING_PATHWAY"
41,"Down",0.900958454341684,0.959252704420406,"L.LvsP.ABE_VEGFA_TARGETS_30MIN"
202,"Down",0.90210491590521,0.960288425113575,"L.LvsP.HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN"
13,"Down",0.902508098332216,0.960385366109407,"L.LvsP.MIKKELSEN_NPC_ICP_WITH_H3K27ME3"
12,"Up",0.902543382583555,0.960385366109407,"L.LvsP.REACTOME_TRANSPORT_OF_NUCLEOSIDES_AND_FREE_PURINE_AND_PYRIMIDINE_BASES_ACROSS_THE_PLASMA_MEMBRANE"
30,"Up",0.903111021960903,0.960630524117451,"L.LvsP.SUZUKI_RESPONSE_TO_TSA_AND_DECITABINE_1B"
6,"Up",0.90312126322346,0.960630524117451,"L.LvsP.REACTOME_NEGATIVE_REGULATION_OF_TCF_DEPENDENT_SIGNALING_BY_DVL_INTERACTING_PROTEINS"
268,"Down",0.903554372344129,0.960906352123618,"L.LvsP.DARWICHE_PAPILLOMA_RISK_LOW_UP"
325,"Up",0.903900565364036,0.961089658826492,"L.LvsP.LINSLEY_MIR16_TARGETS"
72,"Down",0.904174262742355,0.961195827475962,"L.LvsP.HAHTOLA_SEZARY_SYNDROM_DN"
73,"Up",0.904521773885862,0.961380409037856,"L.LvsP.ZHAN_V1_LATE_DIFFERENTIATION_GENES_UP"
51,"Up",0.904934609633915,0.961634337241191,"L.LvsP.PLASARI_NFIC_TARGETS_BASAL_DN"
148,"Up",0.905525273962344,0.961906864539648,"L.LvsP.SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_DN"
2477,"Down",0.905539017892724,0.961906864539648,"L.LvsP.GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN"
103,"Up",0.906086933268388,0.962304005770441,"L.LvsP.BROWNE_HCMV_INFECTION_4HR_UP"
56,"Up",0.906316365357897,0.962362816221205,"L.LvsP.KEGG_FATTY_ACID_METABOLISM"
11,"Up",0.907057151967874,0.962964476426723,"L.LvsP.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_25"
46,"Up",0.907401377731279,0.963144983197589,"L.LvsP.ONGUSAHA_TP53_TARGETS"
166,"Up",0.907687844524038,0.963264125215625,"L.LvsP.WALLACE_PROSTATE_CANCER_RACE_DN"
149,"Up",0.908390019973422,0.963671466079109,"L.LvsP.ZHONG_SECRETOME_OF_LUNG_CANCER_AND_MACROPHAGE"
394,"Down",0.908420271514617,0.963671466079109,"L.LvsP.SENESE_HDAC1_AND_HDAC2_TARGETS_DN"
26,"Up",0.90950842699038,0.964571607378768,"L.LvsP.REACTOME_NICOTINAMIDE_SALVAGING"
243,"Down",0.909617717647477,0.964571607378768,"L.LvsP.ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP"
768,"Down",0.909907175848843,0.964639545036159,"L.LvsP.RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_DN"
6,"Down",0.910030722899006,0.964639545036159,"L.LvsP.REACTOME_VITAMINS"
14,"Up",0.910591412143799,0.965048862898805,"L.LvsP.BIOCARTA_LEPTIN_PATHWAY"
39,"Down",0.911033586333713,0.965332445158892,"L.LvsP.KEGG_ASTHMA"
36,"Down",0.91127626546955,0.965404574014398,"L.LvsP.ZHAN_LATE_DIFFERENTIATION_GENES_DN"
9,"Down",0.911546263956492,0.96544438389056,"L.LvsP.TESAR_ALK_AND_JAK_TARGETS_MOUSE_ES_D4_UP"
144,"Down",0.911663072579601,0.96544438389056,"L.LvsP.TAKAO_RESPONSE_TO_UVB_RADIATION_UP"
99,"Up",0.911840781919093,0.965447660519086,"L.LvsP.GHANDHI_BYSTANDER_IRRADIATION_UP"
29,"Down",0.912037411656747,0.965470964780807,"L.LvsP.JI_CARCINOGENESIS_BY_KRAS_AND_STK11_DN"
63,"Down",0.91263570741769,0.965919377165468,"L.LvsP.KORKOLA_EMBRYONAL_CARCINOMA_UP"
10,"Up",0.913294346686497,0.966431472311894,"L.LvsP.REACTOME_CA2_ACTIVATED_K_CHANNELS"
865,"Down",0.913739311112811,0.966717307910971,"L.LvsP.RIGGI_EWING_SARCOMA_PROGENITOR_UP"
99,"Down",0.914554468569366,0.967061233346903,"L.LvsP.REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS"
96,"Up",0.91455659167823,0.967061233346903,"L.LvsP.HUANG_DASATINIB_RESISTANCE_DN"
289,"Down",0.914682880608292,0.967061233346903,"L.LvsP.BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_DN"
101,"Down",0.914851686145898,0.967061233346903,"L.LvsP.REACTOME_PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES"
18,"Down",0.915307659407224,0.967061233346903,"L.LvsP.REACTOME_GLYCOGEN_SYNTHESIS"
232,"Up",0.915628509565052,0.967061233346903,"L.LvsP.BROWNE_HCMV_INFECTION_12HR_UP"
484,"Up",0.915815339635139,0.967061233346903,"L.LvsP.RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP"
288,"Down",0.916136345006526,0.967061233346903,"L.LvsP.FOSTER_TOLERANT_MACROPHAGE_UP"
122,"Down",0.916215414291217,0.967061233346903,"L.LvsP.ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN"
23,"Up",0.916343580554272,0.967061233346903,"L.LvsP.LY_AGING_MIDDLE_UP"
66,"Down",0.916365213239476,0.967061233346903,"L.LvsP.CHEN_NEUROBLASTOMA_COPY_NUMBER_GAINS"
60,"Down",0.916448228605596,0.967061233346903,"L.LvsP.PID_NFAT_TFPATHWAY"
108,"Down",0.916480097990527,0.967061233346903,"L.LvsP.HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_DN"
71,"Up",0.916513087852735,0.967061233346903,"L.LvsP.REACTOME_ION_HOMEOSTASIS"
121,"Down",0.916693302826263,0.967066832918605,"L.LvsP.REACTOME_TRNA_PROCESSING"
20,"Up",0.917370665159453,0.967467514588871,"L.LvsP.REACTOME_RETROGRADE_NEUROTROPHIN_SIGNALLING"
8,"Down",0.917423074514279,0.967467514588871,"L.LvsP.REACTOME_ACTIVATION_OF_TRKA_RECEPTORS"
40,"Up",0.917982117285341,0.967631546865328,"L.LvsP.RIZ_ERYTHROID_DIFFERENTIATION_HEMGN"
24,"Down",0.917986628224234,0.967631546865328,"L.LvsP.KIM_GERMINAL_CENTER_T_HELPER_DN"
114,"Down",0.9181036525331,0.967631546865328,"L.LvsP.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_DN"
69,"Down",0.918358047131756,0.967715197749471,"L.LvsP.PID_UPA_UPAR_PATHWAY"
139,"Down",0.919403914269391,0.96863266806316,"L.LvsP.BRUECKNER_TARGETS_OF_MIRLET7A3_DN"
108,"Down",0.920055562720612,0.969134541109214,"L.LvsP.NADLER_OBESITY_UP"
47,"Up",0.920691361528608,0.969619531026985,"L.LvsP.VALK_AML_CLUSTER_12"
103,"Up",0.92133636051809,0.970022726698642,"L.LvsP.MORI_MATURE_B_LYMPHOCYTE_DN"
84,"Up",0.92142509687489,0.970022726698642,"L.LvsP.REACTOME_DEFENSINS"
794,"Up",0.921947089177411,0.970387484496841,"L.LvsP.PILON_KLF1_TARGETS_UP"
7,"Up",0.922261639894217,0.970533804144485,"L.LvsP.REACTOME_NGF_INDEPENDANT_TRKA_ACTIVATION"
1549,"Down",0.922565276717361,0.970580361674691,"L.LvsP.DANG_BOUND_BY_MYC"
203,"Down",0.92265696888446,0.970580361674691,"L.LvsP.MIKKELSEN_IPS_WITH_HCP_H3K27ME3"
112,"Down",0.923018925483417,0.970697952409691,"L.LvsP.LEE_LIVER_CANCER_CIPROFIBRATE_DN"
8,"Up",0.923119883119942,0.970697952409691,"L.LvsP.REACTOME_MRNA_EDITING"
16,"Down",0.923443070793773,0.970796678519699,"L.LvsP.KONDO_COLON_CANCER_HCP_WITH_H3K27ME3"
266,"Up",0.923691113619353,0.970796678519699,"L.LvsP.ALCALAY_AML_BY_NPM1_LOCALIZATION_UP"
9,"Up",0.923775394802253,0.970796678519699,"L.LvsP.BIOCARTA_PLK3_PATHWAY"
143,"Up",0.923916100989448,0.970796678519699,"L.LvsP.LIU_COMMON_CANCER_GENES"
29,"Up",0.924354026736123,0.971072280794988,"L.LvsP.ITO_PTTG1_TARGETS_UP"
11,"Up",0.925372414287874,0.971783731515657,"L.LvsP.BIOCARTA_SKP2E2F_PATHWAY"
405,"Down",0.925422174517188,0.971783731515657,"L.LvsP.WANG_CLIM2_TARGETS_UP"
20,"Up",0.925605630474026,0.971783731515657,"L.LvsP.GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_2"
109,"Down",0.9257342944281,0.971783731515657,"L.LvsP.PARK_APL_PATHOGENESIS_DN"
149,"Up",0.925965360599153,0.97184177652861,"L.LvsP.GUO_TARGETS_OF_IRS1_AND_IRS2"
84,"Down",0.926899168406521,0.972622827860457,"L.LvsP.BECKER_TAMOXIFEN_RESISTANCE_UP"
6,"Up",0.927061367846737,0.972622827860457,"L.LvsP.REACTOME_SIGNALING_BY_MEMBRANE_TETHERED_FUSIONS_OF_PDGFRA_OR_PDGFRB"
28,"Down",0.928544006109798,0.973756136948634,"L.LvsP.NIKOLSKY_BREAST_CANCER_22Q13_AMPLICON"
430,"Down",0.928570878544875,0.973756136948634,"L.LvsP.LU_EZH2_TARGETS_UP"
13,"Up",0.928669942146888,0.973756136948634,"L.LvsP.GERHOLD_RESPONSE_TO_TZD_DN"
13,"Up",0.929554242379575,0.974498560128303,"L.LvsP.KOBAYASHI_EGFR_SIGNALING_6HR_UP"
28,"Up",0.930370810337788,0.975169708124669,"L.LvsP.PID_HIF1A_PATHWAY"
89,"Up",0.931162071708557,0.975785592720728,"L.LvsP.ZHAN_MULTIPLE_MYELOMA_MS_DN"
37,"Down",0.931350014497983,0.975785592720728,"L.LvsP.BIOCARTA_EDG1_PATHWAY"
16,"Down",0.931506223908681,0.975785592720728,"L.LvsP.KORKOLA_EMBRYONAL_CARCINOMA"
117,"Down",0.931724270641801,0.975785592720728,"L.LvsP.KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION"
72,"Up",0.931840826472317,0.975785592720728,"L.LvsP.CONRAD_STEM_CELL"
14,"Up",0.932407101284282,0.976056835177471,"L.LvsP.REACTOME_POU5F1_OCT4_SOX2_NANOG_REPRESS_GENES_RELATED_TO_DIFFERENTIATION"
12,"Down",0.932612434225057,0.976056835177471,"L.LvsP.KUMAMOTO_RESPONSE_TO_NUTLIN_3A_UP"
8,"Down",0.932629455641631,0.976056835177471,"L.LvsP.KASLER_HDAC7_TARGETS_2_UP"
99,"Up",0.932871487437202,0.976069680782128,"L.LvsP.LEE_TARGETS_OF_PTCH1_AND_SUFU_UP"
337,"Down",0.932994802483911,0.976069680782128,"L.LvsP.YAMAZAKI_TCEB3_TARGETS_UP"
37,"Down",0.933182758278754,0.976081625146279,"L.LvsP.ONO_AML1_TARGETS_UP"
32,"Up",0.933644067008056,0.976379430014667,"L.LvsP.FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_UP"
65,"Up",0.933995698267592,0.976562446240831,"L.LvsP.REACTOME_IRON_UPTAKE_AND_TRANSPORT"
682,"Up",0.934341642389863,0.976739448057015,"L.LvsP.YAGI_AML_WITH_T_8_21_TRANSLOCATION"
61,"Up",0.934732199848783,0.97682552178674,"L.LvsP.MIKKELSEN_MEF_ICP_WITH_H3K4ME3_AND_H3K27ME3"
171,"Up",0.934808391551815,0.97682552178674,"L.LvsP.DOANE_BREAST_CANCER_ESR1_UP"
788,"Down",0.93495399914911,0.97682552178674,"L.LvsP.SENESE_HDAC3_TARGETS_DN"
28,"Up",0.935134181072113,0.976829187067393,"L.LvsP.HOLLERN_MICROACINAR_BREAST_TUMOR_DN"
29,"Up",0.936334957828111,0.977898749873749,"L.LvsP.COLLER_MYC_TARGETS_UP"
33,"Up",0.936795957774426,0.978195439194485,"L.LvsP.HOWLIN_CITED1_TARGETS_2_UP"
27,"Up",0.937111676605478,0.978340343646466,"L.LvsP.BIOCARTA_PLATELETAPP_PATHWAY"
142,"Up",0.937635858273822,0.978702786557667,"L.LvsP.REACTOME_ANTIMICROBIAL_PEPTIDES"
18,"Up",0.938036205366427,0.978935858714793,"L.LvsP.REACTOME_METHYLATION"
28,"Down",0.938258413235818,0.978982971651413,"L.LvsP.HO_LIVER_CANCER_VASCULAR_INVASION"
927,"Up",0.939388684531523,0.979960714182725,"L.LvsP.REACTOME_G_ALPHA_S_SIGNALLING_EVENTS"
303,"Down",0.939625063125344,0.979960714182725,"L.LvsP.FOSTER_KDM1A_TARGETS_DN"
60,"Down",0.939848695966397,0.979960714182725,"L.LvsP.LU_TUMOR_VASCULATURE_UP"
12,"Up",0.940010258900233,0.979960714182725,"L.LvsP.BIOCARTA_EEA1_PATHWAY"
48,"Down",0.940081683491621,0.979960714182725,"L.LvsP.GHANDHI_DIRECT_IRRADIATION_DN"
258,"Up",0.94072372714449,0.980310741430485,"L.LvsP.MADAN_DPPA4_TARGETS"
16,"Down",0.940772073436454,0.980310741430485,"L.LvsP.GAUSSMANN_MLL_AF4_FUSION_TARGETS_D_DN"
7,"Down",0.94100197604923,0.980365540903749,"L.LvsP.REACTOME_RSK_ACTIVATION"
71,"Up",0.941391052785083,0.980586121109406,"L.LvsP.REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES"
17,"Down",0.941839399333216,0.980868344116284,"L.LvsP.ONGUSAHA_BRCA1_TARGETS_UP"
12,"Up",0.942542045627643,0.981415248639404,"L.LvsP.OHM_EMBRYONIC_CARCINOMA_DN"
194,"Down",0.94321821622653,0.981830062326712,"L.LvsP.ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_UP"
350,"Up",0.943295585292004,0.981830062326712,"L.LvsP.RODWELL_AGING_KIDNEY_NO_BLOOD_UP"
12,"Down",0.943545648927898,0.981905494621184,"L.LvsP.REACTOME_REVERSIBLE_HYDRATION_OF_CARBON_DIOXIDE"
23,"Down",0.94430658771027,0.98243894830766,"L.LvsP.REACTOME_PROCESSING_OF_INTRONLESS_PRE_MRNAS"
548,"Up",0.944639062197404,0.98243894830766,"L.LvsP.DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN"
29,"Up",0.944815722088771,0.98243894830766,"L.LvsP.REACTOME_RIPK1_MEDIATED_REGULATED_NECROSIS"
47,"Down",0.9453747811266,0.98243894830766,"L.LvsP.NOJIMA_SFRP2_TARGETS_UP"
6,"Down",0.945501559989566,0.98243894830766,"L.LvsP.REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_ENDOCRINE_COMMITTED_NEUROG3_PROGENITOR_CELLS"
79,"Up",0.945563031849056,0.98243894830766,"L.LvsP.JOHANSSON_GLIOMAGENESIS_BY_PDGFB_UP"
91,"Down",0.945859941845025,0.98243894830766,"L.LvsP.MASSARWEH_RESPONSE_TO_ESTRADIOL"
55,"Up",0.946032549796785,0.98243894830766,"L.LvsP.FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_DN"
41,"Up",0.946050130714594,0.98243894830766,"L.LvsP.LUI_THYROID_CANCER_CLUSTER_4"
12,"Down",0.946425209029109,0.98243894830766,"L.LvsP.BIOCARTA_RECK_PATHWAY"
48,"Up",0.946699074676008,0.98243894830766,"L.LvsP.BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_DN"
45,"Up",0.946847464776199,0.98243894830766,"L.LvsP.MURATA_VIRULENCE_OF_H_PILORI"
13,"Down",0.94715519685329,0.98243894830766,"L.LvsP.REACTOME_FGFRL1_MODULATION_OF_FGFR1_SIGNALING"
140,"Down",0.947181320365271,0.98243894830766,"L.LvsP.REACTOME_GLYCEROPHOSPHOLIPID_BIOSYNTHESIS"
6,"Down",0.947459074172013,0.98243894830766,"L.LvsP.REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_KEY_METABOLIC_FACTORS"
40,"Down",0.94804612175241,0.98243894830766,"L.LvsP.YIH_RESPONSE_TO_ARSENITE_C1"
49,"Up",0.948138457425799,0.98243894830766,"L.LvsP.PACHER_TARGETS_OF_IGF1_AND_IGF2_UP"
14,"Down",0.948184358377546,0.98243894830766,"L.LvsP.REACTOME_NRCAM_INTERACTIONS"
17,"Down",0.948248124473285,0.98243894830766,"L.LvsP.NAGY_TFTC_COMPONENTS_HUMAN"
452,"Up",0.948540275746722,0.98243894830766,"L.LvsP.GABRIELY_MIR21_TARGETS"
67,"Up",0.948551560701969,0.98243894830766,"L.LvsP.LANDIS_ERBB2_BREAST_TUMORS_65_DN"
22,"Up",0.94862355539614,0.98243894830766,"L.LvsP.PID_IL5_PATHWAY"
474,"Up",0.948787515030722,0.98243894830766,"L.LvsP.RIZKI_TUMOR_INVASIVENESS_3D_DN"
52,"Up",0.948849024641043,0.98243894830766,"L.LvsP.BIOCARTA_IL2RB_PATHWAY"
23,"Up",0.94893984897633,0.98243894830766,"L.LvsP.SA_TRKA_RECEPTOR"
250,"Down",0.949006389203213,0.98243894830766,"L.LvsP.KASLER_HDAC7_TARGETS_1_UP"
30,"Down",0.949145201757377,0.98243894830766,"L.LvsP.LUI_THYROID_CANCER_CLUSTER_5"
761,"Up",0.949156001918201,0.98243894830766,"L.LvsP.KEGG_OLFACTORY_TRANSDUCTION"
5,"Down",0.949211224789206,0.98243894830766,"L.LvsP.BASSO_HAIRY_CELL_LEUKEMIA_DN"
340,"Down",0.94955007417096,0.98249946763999,"L.LvsP.WINTER_HYPOXIA_METAGENE"
61,"Up",0.949732720147597,0.98249946763999,"L.LvsP.FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_DN"
456,"Up",0.950271780395018,0.98249946763999,"L.LvsP.REACTOME_TRANSCRIPTIONAL_REGULATION_BY_TP53"
5,"Up",0.950279134451545,0.98249946763999,"L.LvsP.BAFNA_MUC4_TARGETS_UP"
52,"Up",0.950320775348496,0.98249946763999,"L.LvsP.REACTOME_CHONDROITIN_SULFATE_DERMATAN_SULFATE_METABOLISM"
35,"Up",0.950415917615977,0.98249946763999,"L.LvsP.CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_LD_MTX_DN"
36,"Down",0.95051359240483,0.98249946763999,"L.LvsP.REACTOME_SCAVENGING_BY_CLASS_A_RECEPTORS"
173,"Up",0.95101679092919,0.982578165891711,"L.LvsP.REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION"
612,"Down",0.951383239966268,0.982578165891711,"L.LvsP.HELLER_SILENCED_BY_METHYLATION_UP"
53,"Down",0.951385232245208,0.982578165891711,"L.LvsP.REACTOME_TNF_SIGNALING"
114,"Down",0.951388773138251,0.982578165891711,"L.LvsP.HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_UP"
83,"Up",0.951740713477441,0.982578165891711,"L.LvsP.BIOCARTA_NUCLEARRS_PATHWAY"
67,"Down",0.951808412919124,0.982578165891711,"L.LvsP.HAN_JNK_SINGALING_DN"
230,"Down",0.951833723370592,0.982578165891711,"L.LvsP.ZHANG_BREAST_CANCER_PROGENITORS_DN"
106,"Up",0.9523642665003,0.982701363670445,"L.LvsP.KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450"
141,"Up",0.952602929541762,0.982701363670445,"L.LvsP.YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_0"
17,"Down",0.952703150367729,0.982701363670445,"L.LvsP.REACTOME_ADVANCED_GLYCOSYLATION_ENDPRODUCT_RECEPTOR_SIGNALING"
28,"Up",0.952767095141002,0.982701363670445,"L.LvsP.SEKI_INFLAMMATORY_RESPONSE_LPS_DN"
183,"Up",0.952841745457995,0.982701363670445,"L.LvsP.REACTOME_CD22_MEDIATED_BCR_REGULATION"
30,"Down",0.953532384037312,0.983038523843823,"L.LvsP.REACTOME_ZBP1_DAI_MEDIATED_INDUCTION_OF_TYPE_I_IFNS"
6,"Down",0.953537426514132,0.983038523843823,"L.LvsP.REACTOME_P75NTR_NEGATIVELY_REGULATES_CELL_CYCLE_VIA_SC1"
51,"Up",0.95373070506606,0.983038523843823,"L.LvsP.WENG_POR_TARGETS_LIVER_DN"
671,"Up",0.953879848150138,0.983038523843823,"L.LvsP.PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_7"
390,"Up",0.954282741153389,0.983270457666248,"L.LvsP.REACTOME_SIGNALING_BY_NUCLEAR_RECEPTORS"
420,"Up",0.954462923210382,0.983272871703038,"L.LvsP.NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP"
38,"Up",0.955729180772615,0.984238449761936,"L.LvsP.HOLLEMAN_VINCRISTINE_RESISTANCE_ALL_UP"
143,"Down",0.955826406007736,0.984238449761936,"L.LvsP.SWEET_KRAS_TARGETS_DN"
66,"Up",0.956047711740082,0.984238449761936,"L.LvsP.REACTOME_NEUREXINS_AND_NEUROLIGINS"
27,"Down",0.956135908550187,0.984238449761936,"L.LvsP.MELLMAN_TUT1_TARGETS_UP"
101,"Down",0.956290278915016,0.984238449761936,"L.LvsP.KEGG_APOPTOSIS"
170,"Down",0.956829130972131,0.984609764590529,"L.LvsP.ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_DN"
183,"Down",0.95712585327762,0.98473182783252,"L.LvsP.FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP"
25,"Up",0.957628875159085,0.9848876220629,"L.LvsP.MOOTHA_GLYCOGEN_METABOLISM"
57,"Down",0.957649116158986,0.9848876220629,"L.LvsP.TERAO_AOX4_TARGETS_SKIN_UP"
40,"Down",0.957811673690037,0.9848876220629,"L.LvsP.DUTTA_APOPTOSIS_VIA_NFKB"
113,"Up",0.958263749900984,0.985169258683998,"L.LvsP.PID_CD8_TCR_DOWNSTREAM_PATHWAY"
87,"Up",0.95854551784722,0.985275733068838,"L.LvsP.WESTON_VEGFA_TARGETS_6HR"
39,"Up",0.959039874342574,0.985393739556622,"L.LvsP.GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_DN"
31,"Up",0.959348003011086,0.985393739556622,"L.LvsP.REACTOME_VXPX_CARGO_TARGETING_TO_CILIUM"
47,"Down",0.959423038082466,0.985393739556622,"L.LvsP.CHUANG_OXIDATIVE_STRESS_RESPONSE_UP"
7,"Down",0.959641870783983,0.985393739556622,"L.LvsP.REACTOME_MITOCHONDRIAL_UNCOUPLING"
28,"Up",0.959840647512286,0.985393739556622,"L.LvsP.REACTOME_TRP_CHANNELS"
28,"Up",0.959933626134841,0.985393739556622,"L.LvsP.WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_DN"
10,"Up",0.959935685257625,0.985393739556622,"L.LvsP.BIOCARTA_IL22BP_PATHWAY"
10,"Down",0.960234200820341,0.985393739556622,"L.LvsP.CASTELLANO_HRAS_AND_NRAS_TARGETS_UP"
111,"Up",0.960264327858759,0.985393739556622,"L.LvsP.REACTOME_REGULATION_OF_INSULIN_SECRETION"
18,"Down",0.960847105199893,0.985808803980369,"L.LvsP.WEBER_METHYLATED_LCP_IN_SPERM_UP"
1053,"Down",0.961224006077059,0.986012528682757,"L.LvsP.PUJANA_CHEK2_PCC_NETWORK"
13,"Down",0.96163064855266,0.986170953359198,"L.LvsP.BIOCARTA_PLCE_PATHWAY"
9,"Up",0.961735236802502,0.986170953359198,"L.LvsP.HE_PTEN_TARGETS_DN"
182,"Down",0.96191353797543,0.986170953359198,"L.LvsP.KIM_GLIS2_TARGETS_UP"
111,"Down",0.962307546431685,0.986391995591544,"L.LvsP.HOFMANN_CELL_LYMPHOMA_UP"
19,"Up",0.962548832797576,0.98645644050747,"L.LvsP.REACTOME_DIGESTION_OF_DIETARY_CARBOHYDRATE"
64,"Down",0.963105700081748,0.986844220858411,"L.LvsP.SAENZ_DETOX_PATHWAY_AND_CARCINOGENESIS_DN"
105,"Up",0.963948514861068,0.987419511438265,"L.LvsP.HUTTMANN_B_CLL_POOR_SURVIVAL_DN"
8,"Up",0.96432020341719,0.987419511438265,"L.LvsP.SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX6_DN"
168,"Down",0.964428107471089,0.987419511438265,"L.LvsP.NAKAMURA_ADIPOGENESIS_LATE_UP"
546,"Down",0.964600313618523,0.987419511438265,"L.LvsP.ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_UP"
18,"Down",0.964738428647899,0.987419511438265,"L.LvsP.REACTOME_FGFR1C_LIGAND_BINDING_AND_ACTIVATION"
18,"Down",0.964927554490709,0.987419511438265,"L.LvsP.FRASOR_TAMOXIFEN_RESPONSE_DN"
353,"Down",0.965045493647468,0.987419511438265,"L.LvsP.TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP"
43,"Up",0.965179079317912,0.987419511438265,"L.LvsP.LIU_VAV3_PROSTATE_CARCINOGENESIS_DN"
145,"Up",0.965274454571138,0.987419511438265,"L.LvsP.YU_MYC_TARGETS_DN"
117,"Up",0.965621571185657,0.987541293037165,"L.LvsP.LIN_TUMOR_ESCAPE_FROM_IMMUNE_ATTACK"
12,"Up",0.965860420183297,0.987541293037165,"L.LvsP.REACTOME_TRANSPORT_OF_FATTY_ACIDS"
48,"Up",0.966139698315885,0.987541293037165,"L.LvsP.PID_HIV_NEF_PATHWAY"
1407,"Down",0.966227874427799,0.987541293037165,"L.LvsP.BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_A"
248,"Up",0.966419936373066,0.987541293037165,"L.LvsP.GOZGIT_ESR1_TARGETS_UP"
16,"Up",0.966465172115048,0.987541293037165,"L.LvsP.HOEGERKORP_CD44_TARGETS_TEMPORAL_UP"
30,"Down",0.966671304851778,0.987569409557553,"L.LvsP.REACTOME_REGULATION_OF_IFNA_SIGNALING"
75,"Up",0.967102975963529,0.987650948675674,"L.LvsP.MCDOWELL_ACUTE_LUNG_INJURY_DN"
522,"Down",0.967108380562507,0.987650948675674,"L.LvsP.BROWNE_HCMV_INFECTION_20HR_UP"
117,"Down",0.967431268014983,0.987798242078457,"L.LvsP.ROSS_AML_OF_FAB_M7_TYPE"
87,"Down",0.967852550905994,0.988045929460716,"L.LvsP.CAVARD_LIVER_CANCER_MALIGNANT_VS_BENIGN"
10,"Down",0.968863682260564,0.988895569359176,"L.LvsP.REACTOME_SCAVENGING_BY_CLASS_F_RECEPTORS"
1318,"Up",0.96931889435179,0.989177587093216,"L.LvsP.GOZGIT_ESR1_TARGETS_DN"
19,"Down",0.969634100429922,0.989316652754575,"L.LvsP.BIOCARTA_BLYMPHOCYTE_PATHWAY"
67,"Up",0.970189877767707,0.989701076416541,"L.LvsP.JAZAG_TGFB1_SIGNALING_DN"
86,"Up",0.970409131420655,0.989742130165062,"L.LvsP.PID_INTEGRIN1_PATHWAY"
36,"Up",0.970758934336713,0.989789328840488,"L.LvsP.KEGG_BASAL_TRANSCRIPTION_FACTORS"
97,"Down",0.970813443715313,0.989789328840488,"L.LvsP.REACTOME_COLLAGEN_DEGRADATION"
259,"Up",0.971982772585682,0.990595101176693,"L.LvsP.MIKKELSEN_MCV6_LCP_WITH_H3K4ME3"
13,"Up",0.972056326155611,0.990595101176693,"L.LvsP.REACTOME_ESTABLISHMENT_OF_SISTER_CHROMATID_COHESION"
186,"Down",0.972141258633521,0.990595101176693,"L.LvsP.MATZUK_SPERMATOCYTE"
31,"Up",0.972530345215966,0.990639634050488,"L.LvsP.GOERING_BLOOD_HDL_CHOLESTEROL_QTL_TRANS"
20,"Up",0.972640140740505,0.990639634050488,"L.LvsP.BIOCARTA_EGFR_SMRTE_PATHWAY"
138,"Up",0.972722476625086,0.990639634050488,"L.LvsP.LEIN_MEDULLA_MARKERS"
73,"Up",0.973356501292551,0.991102780045398,"L.LvsP.ENGELMANN_CANCER_PROGENITORS_UP"
147,"Down",0.973702304465283,0.991168468352951,"L.LvsP.RODRIGUES_THYROID_CARCINOMA_DN"
13,"Down",0.973916585185201,0.991168468352951,"L.LvsP.BIOCARTA_RANMS_PATHWAY"
78,"Down",0.974171838986042,0.991168468352951,"L.LvsP.OSADA_ASCL1_TARGETS_UP"
14,"Down",0.974293481485627,0.991168468352951,"L.LvsP.BARRIER_CANCER_RELAPSE_TUMOR_SAMPLE_DN"
575,"Down",0.974317349520399,0.991168468352951,"L.LvsP.SHEN_SMARCA2_TARGETS_DN"
957,"Down",0.974778692736644,0.99136028828916,"L.LvsP.MASSARWEH_TAMOXIFEN_RESISTANCE_UP"
44,"Down",0.974864512104931,0.99136028828916,"L.LvsP.VALK_AML_CLUSTER_7"
14,"Down",0.975131580069505,0.991449523023959,"L.LvsP.KEGG_LIMONENE_AND_PINENE_DEGRADATION"
104,"Up",0.975708972093446,0.991563401242542,"L.LvsP.CHIBA_RESPONSE_TO_TSA_UP"
35,"Up",0.975833338397008,0.991563401242542,"L.LvsP.SHARMA_PILOCYTIC_ASTROCYTOMA_LOCATION_UP"
227,"Down",0.976011899074741,0.991563401242542,"L.LvsP.REACTOME_FCGR3A_MEDIATED_IL10_SYNTHESIS"
178,"Down",0.976038355793651,0.991563401242542,"L.LvsP.LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_DN"
104,"Down",0.976539765991864,0.991563401242542,"L.LvsP.KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_DN"
35,"Up",0.97658574446346,0.991563401242542,"L.LvsP.REACTOME_REGULATION_OF_GLUCOKINASE_BY_GLUCOKINASE_REGULATORY_PROTEIN"
225,"Down",0.976644156069915,0.991563401242542,"L.LvsP.BIDUS_METASTASIS_DN"
9,"Down",0.976689024586194,0.991563401242542,"L.LvsP.REACTOME_SYNTHESIS_OF_DIPHTHAMIDE_EEF2"
390,"Down",0.976857631862565,0.991563401242542,"L.LvsP.ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP"
31,"Down",0.977331593605827,0.991804864485216,"L.LvsP.KEGG_MATURITY_ONSET_DIABETES_OF_THE_YOUNG"
38,"Up",0.977928265456719,0.991804864485216,"L.LvsP.REACTOME_NICOTINATE_METABOLISM"
13,"Up",0.977987852742707,0.991804864485216,"L.LvsP.HOLLERN_SOLID_NODULAR_BREAST_TUMOR_UP"
27,"Down",0.978052964417378,0.991804864485216,"L.LvsP.REACTOME_PHASE_2_PLATEAU_PHASE"
24,"Down",0.978199977788925,0.991804864485216,"L.LvsP.REACTOME_RECEPTOR_TYPE_TYROSINE_PROTEIN_PHOSPHATASES"
14,"Down",0.978302479500515,0.991804864485216,"L.LvsP.REACTOME_NTRK2_ACTIVATES_RAC1"
86,"Up",0.97835119025183,0.991804864485216,"L.LvsP.MCGARVEY_SILENCED_BY_METHYLATION_IN_COLON_CANCER"
72,"Down",0.978933933148479,0.992213696861217,"L.LvsP.JIANG_TIP30_TARGETS_UP"
46,"Down",0.97917276223401,0.99227386407475,"L.LvsP.VERNELL_RETINOBLASTOMA_PATHWAY_DN"
32,"Up",0.979474687236546,0.992383132324728,"L.LvsP.MATZUK_IMPLANTATION_AND_UTERINE"
28,"Up",0.979724599772668,0.992383132324728,"L.LvsP.HOLLEMAN_PREDNISOLONE_RESISTANCE_B_ALL_UP"
627,"Up",0.979943958635288,0.992383132324728,"L.LvsP.SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12"
6,"Up",0.979998535448185,0.992383132324728,"L.LvsP.NAKAMURA_BRONCHIAL_AND_BRONCHIOLAR_EPITHELIA"
186,"Down",0.980627681068678,0.992674011518967,"L.LvsP.REACTOME_HCMV_INFECTION"
124,"Down",0.980667867881741,0.992674011518967,"L.LvsP.CHEBOTAEV_GR_TARGETS_UP"
810,"Down",0.980824403134041,0.992674011518967,"L.LvsP.SWEET_LUNG_CANCER_KRAS_DN"
45,"Up",0.981050353787913,0.992720974760866,"L.LvsP.REACTOME_MTOR_SIGNALLING"
515,"Down",0.98125878616754,0.992750197387068,"L.LvsP.SENGUPTA_NASOPHARYNGEAL_CARCINOMA_DN"
41,"Down",0.981752209149032,0.992928086642375,"L.LvsP.BIOCARTA_DC_PATHWAY"
151,"Down",0.981882258997439,0.992928086642375,"L.LvsP.MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_UP"
59,"Down",0.981973372718486,0.992928086642375,"L.LvsP.REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN"
79,"Up",0.982737870276385,0.99351941575391,"L.LvsP.DAZARD_UV_RESPONSE_CLUSTER_G24"
18,"Up",0.983260387090306,0.993726625270058,"L.LvsP.PID_DNA_PK_PATHWAY"
16,"Down",0.983302290984353,0.993726625270058,"L.LvsP.REACTOME_ACTIVATED_NTRK2_SIGNALS_THROUGH_FYN"
5,"Up",0.983905789163461,0.99415480780058,"L.LvsP.REACTOME_MELANIN_BIOSYNTHESIS"
22,"Down",0.984161657659253,0.99423164721323,"L.LvsP.BIOCARTA_NFKB_PATHWAY"
59,"Down",0.984429934763175,0.994320991835147,"L.LvsP.HOLLEMAN_VINCRISTINE_RESISTANCE_B_ALL_UP"
916,"Up",0.98481723920584,0.994474954777717,"L.LvsP.SWEET_LUNG_CANCER_KRAS_UP"
33,"Down",0.985114728148738,0.994474954777717,"L.LvsP.KIM_HYPOXIA"
20,"Up",0.985367140282269,0.994474954777717,"L.LvsP.VANDESLUIS_COMMD1_TARGETS_GROUP_4_UP"
4,"Up",0.985535287598738,0.994474954777717,"L.LvsP.REACTOME_ORGANIC_ANION_TRANSPORT"
247,"Down",0.985652067440101,0.994474954777717,"L.LvsP.PODAR_RESPONSE_TO_ADAPHOSTIN_UP"
462,"Down",0.985754200244696,0.994474954777717,"L.LvsP.YAMAZAKI_TCEB3_TARGETS_DN"
79,"Down",0.985841422885996,0.994474954777717,"L.LvsP.YOKOE_CANCER_TESTIS_ANTIGENS"
248,"Up",0.986025823514498,0.994479529042622,"L.LvsP.CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN"
734,"Down",0.986430411176883,0.994706135946925,"L.LvsP.FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_UP"
6,"Down",0.986895826263703,0.994895954799101,"L.LvsP.SMID_BREAST_CANCER_RELAPSE_IN_LIVER_UP"
16,"Down",0.987155651533476,0.994895954799101,"L.LvsP.REACTOME_ERYTHROCYTES_TAKE_UP_OXYGEN_AND_RELEASE_CARBON_DIOXIDE"
19,"Up",0.987180967422696,0.994895954799101,"L.LvsP.HOFFMAN_CLOCK_TARGETS_UP"
59,"Down",0.987338416347019,0.994895954799101,"L.LvsP.CAFFAREL_RESPONSE_TO_THC_24HR_5_UP"
12,"Down",0.987614907769235,0.99499322613996,"L.LvsP.REACTOME_INTERLEUKIN_21_SIGNALING"
27,"Up",0.98817330308005,0.995374420245873,"L.LvsP.LEE_NAIVE_T_LYMPHOCYTE"
31,"Up",0.989134653962357,0.996161293580669,"L.LvsP.MEINHOLD_OVARIAN_CANCER_LOW_GRADE_DN"
10,"Down",0.989559846824208,0.99629152971598,"L.LvsP.BYSTRYKH_HEMATOPOIESIS_STEM_CELL_FLI1"
103,"Down",0.989624359052299,0.99629152971598,"L.LvsP.SAMOLS_TARGETS_OF_KHSV_MIRNAS_DN"
302,"Up",0.990085906437365,0.996443353815332,"L.LvsP.XU_GH1_AUTOCRINE_TARGETS_UP"
9,"Up",0.990135609669277,0.996443353815332,"L.LvsP.REACTOME_AMPK_INHIBITS_CHREBP_TRANSCRIPTIONAL_ACTIVATION_ACTIVITY"
87,"Down",0.990379379330741,0.996507295417592,"L.LvsP.BROWNE_HCMV_INFECTION_8HR_DN"
385,"Down",0.990981237913071,0.996794747010219,"L.LvsP.RIGGINS_TAMOXIFEN_RESISTANCE_DN"
52,"Up",0.991025632902003,0.996794747010219,"L.LvsP.REACTOME_DIGESTION_AND_ABSORPTION"
667,"Up",0.991988826423645,0.997400715246959,"L.LvsP.CHYLA_CBFA2T3_TARGETS_UP"
14,"Up",0.991988882825652,0.997400715246959,"L.LvsP.REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_DEATH_RECEPTORS_AND_LIGANDS"
60,"Down",0.9923500900292,0.997449162865317,"L.LvsP.REACTOME_SYNTHESIS_OF_PIPS_AT_THE_PLASMA_MEMBRANE"
34,"Down",0.992795694617125,0.997449162865317,"L.LvsP.KIM_MYCL1_AMPLIFICATION_TARGETS_DN"
134,"Down",0.992934049775539,0.997449162865317,"L.LvsP.SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_UP"
40,"Up",0.993009050651568,0.997449162865317,"L.LvsP.REACTOME_ALPHA_DEFENSINS"
45,"Up",0.993149826808742,0.997449162865317,"L.LvsP.REACTOME_SYNTHESIS_OF_PA"
18,"Down",0.993206873559067,0.997449162865317,"L.LvsP.PARK_OSTEOBLAST_DIFFERENTIATION_BY_PHENYLAMIL_UP"
354,"Down",0.99329988980583,0.997449162865317,"L.LvsP.OHGUCHI_LIVER_HNF4A_TARGETS_DN"
41,"Down",0.993806532269032,0.997533369820594,"L.LvsP.WANG_METASTASIS_OF_BREAST_CANCER"
515,"Down",0.993852132741704,0.997533369820594,"L.LvsP.RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN"
20,"Down",0.993977036023367,0.997533369820594,"L.LvsP.REACTOME_ERYTHROCYTES_TAKE_UP_CARBON_DIOXIDE_AND_RELEASE_OXYGEN"
18,"Up",0.994219078125812,0.997533369820594,"L.LvsP.LOPEZ_MESOTHELIOMA_SURVIVAL_UP"
8,"Up",0.994285838502676,0.997533369820594,"L.LvsP.REACTOME_BETA_OXIDATION_OF_BUTANOYL_COA_TO_ACETYL_COA"
43,"Down",0.995077049958895,0.998026281264404,"L.LvsP.REACTOME_FGFR1_MUTANT_RECEPTOR_ACTIVATION"
27,"Down",0.995138160356423,0.998026281264404,"L.LvsP.BIOCARTA_STATHMIN_PATHWAY"
17,"Up",0.995581873344497,0.998290202706152,"L.LvsP.BIOCARTA_DREAM_PATHWAY"
79,"Up",0.995959797507211,0.998488072605144,"L.LvsP.REACTOME_ACTIVATION_OF_MATRIX_METALLOPROTEINASES"
81,"Down",0.996615871153658,0.998737745293838,"L.LvsP.KEGG_RIG_I_LIKE_RECEPTOR_SIGNALING_PATHWAY"
352,"Down",0.99685278619018,0.998737745293838,"L.LvsP.REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL"
19,"Up",0.99714775065724,0.998737745293838,"L.LvsP.BIOCARTA_IL4_PATHWAY"
9,"Down",0.997429170379278,0.998737745293838,"L.LvsP.REACTOME_DEFECTIVE_CSF2RB_CAUSES_PULMONARY_SURFACTANT_METABOLISM_DYSFUNCTION_5_SMDP5"
2398,"Up",0.997465782308199,0.998737745293838,"L.LvsP.DODD_NASOPHARYNGEAL_CARCINOMA_UP"
19,"Up",0.997992938127742,0.998737745293838,"L.LvsP.WILLIAMS_ESR2_TARGETS_DN"
1149,"Up",0.998005888335502,0.998737745293838,"L.LvsP.NABA_MATRISOME"
185,"Up",0.99809794219332,0.998737745293838,"L.LvsP.MORI_MATURE_B_LYMPHOCYTE_UP"
25,"Down",0.998114878137423,0.998737745293838,"L.LvsP.REACTOME_NITRIC_OXIDE_STIMULATES_GUANYLATE_CYCLASE"
158,"Up",0.998142168715018,0.998737745293838,"L.LvsP.SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_UP"
13,"Down",0.998360222027388,0.998737745293838,"L.LvsP.REACTOME_FIBRONECTIN_MATRIX_FORMATION"
15,"Up",0.998376472823122,0.998737745293838,"L.LvsP.REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_ASSOCIATION_WITH_CO_FACTORS"
590,"Down",0.999100295110643,0.999281029606865,"L.LvsP.BENPORATH_ES_1"
38,"Down",0.999888293035439,0.999888293035439,"L.LvsP.KANG_AR_TARGETS_DN"
139,"Up",2.10275854050895e-19,1.1626151970474e-15,"L.PvsV.KEGG_OXIDATIVE_PHOSPHORYLATION"
189,"Up",7.36320575099597e-19,2.03555822986284e-15,"L.PvsV.REACTOME_THE_CITRIC_ACID_TCA_CYCLE_AND_RESPIRATORY_ELECTRON_TRANSPORT"
133,"Up",3.96492887273006e-18,7.30736391244151e-15,"L.PvsV.REACTOME_RESPIRATORY_ELECTRON_TRANSPORT_ATP_SYNTHESIS_BY_CHEMIOSMOTIC_COUPLING_AND_HEAT_PRODUCTION_BY_UNCOUPLING_PROTEINS"
108,"Up",7.48240614858052e-18,1.03425558988754e-14,"L.PvsV.REACTOME_RESPIRATORY_ELECTRON_TRANSPORT"
135,"Up",3.05882059562113e-17,3.38244381463785e-14,"L.PvsV.KEGG_PARKINSONS_DISEASE"
94,"Up",1.15180573990461e-13,1.0613889893221e-10,"L.PvsV.MOOTHA_VOXPHOS"
33,"Up",4.36302980727668e-13,3.44617025777611e-10,"L.PvsV.KEGG_CITRATE_CYCLE_TCA_CYCLE"
59,"Up",8.23080689453868e-12,5.68851641498805e-09,"L.PvsV.REACTOME_COMPLEX_I_BIOGENESIS"
66,"Down",4.98957955275883e-11,3.06526503857818e-08,"L.PvsV.NIKOLSKY_BREAST_CANCER_19Q13.1_AMPLICON"
60,"Up",1.31916579425922e-09,7.29366767645923e-07,"L.PvsV.REACTOME_PYRUVATE_METABOLISM_AND_CITRIC_ACID_TCA_CYCLE"
180,"Down",1.52412080487362e-09,7.66078539104206e-07,"L.PvsV.LIM_MAMMARY_LUMINAL_MATURE_UP"
32,"Up",1.91589749840033e-09,8.4222113492438e-07,"L.PvsV.REACTOME_GLYOXYLATE_METABOLISM_AND_GLYCINE_DEGRADATION"
33,"Up",1.98026311340512e-09,8.4222113492438e-07,"L.PvsV.KEGG_BIOSYNTHESIS_OF_UNSATURATED_FATTY_ACIDS"
35,"Up",2.77713229198566e-09,1.09676888874205e-06,"L.PvsV.KEGG_PROTEIN_EXPORT"
496,"Up",4.67820646939765e-09,1.72438690461997e-06,"L.PvsV.MOOTHA_HUMAN_MITODB_6_2002"
27,"Up",5.33593206170127e-09,1.7894513769426e-06,"L.PvsV.REACTOME_CITRIC_ACID_CYCLE_TCA_CYCLE"
67,"Up",5.50202087321833e-09,1.7894513769426e-06,"L.PvsV.MORI_PLASMA_CELL_UP"
18,"Up",8.69304845158242e-09,2.61062037205387e-06,"L.PvsV.REACTOME_BETA_OXIDATION_OF_VERY_LONG_CHAIN_FATTY_ACIDS"
65,"Up",8.97120402767651e-09,2.61062037205387e-06,"L.PvsV.REACTOME_DEFECTIVE_CFTR_CAUSES_CYSTIC_FIBROSIS"
36,"Up",1.00395228986336e-08,2.77542610532726e-06,"L.PvsV.KEGG_PROPANOATE_METABOLISM"
31,"Up",1.38391972705296e-08,3.5032504017431e-06,"L.PvsV.REACTOME_CRISTAE_FORMATION"
59,"Up",1.39395024124341e-08,3.5032504017431e-06,"L.PvsV.KEGG_VALINE_LEUCINE_AND_ISOLEUCINE_DEGRADATION"
251,"Up",1.66306019205417e-08,3.99785208776849e-06,"L.PvsV.WONG_MITOCHONDRIA_GENE_MODULE"
157,"Up",2.40333364455601e-08,5.5366798836459e-06,"L.PvsV.BURTON_ADIPOGENESIS_5"
518,"Up",4.22779837009178e-08,9.35019887529497e-06,"L.PvsV.MOOTHA_MITOCHONDRIA"
19,"Up",5.25003245147361e-08,1.11643959323837e-05,"L.PvsV.MOOTHA_TCA"
60,"Up",7.73264680611416e-08,1.58347422929649e-05,"L.PvsV.LANDIS_BREAST_CANCER_PROGRESSION_UP"
28,"Up",1.43459034916048e-07,2.83280358589582e-05,"L.PvsV.REACTOME_CYTOSOLIC_TRNA_AMINOACYLATION"
346,"Up",1.68348284504305e-07,3.20964712077346e-05,"L.PvsV.REACTOME_TRANSLATION"
79,"Up",1.7970384878399e-07,3.31194193308893e-05,"L.PvsV.PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_UP"
44,"Up",1.96512807637402e-07,3.50490101105547e-05,"L.PvsV.KEGG_PROTEASOME"
256,"Up",2.41792360638371e-07,4.17771863115486e-05,"L.PvsV.BURTON_ADIPOGENESIS_6"
63,"Up",2.80246164062907e-07,4.69539709425397e-05,"L.PvsV.KEGG_VIBRIO_CHOLERAE_INFECTION"
64,"Down",3.03322061358869e-07,4.93255199192113e-05,"L.PvsV.HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_UP"
29,"Up",3.15510881787053e-07,4.98417047257319e-05,"L.PvsV.PID_ARF_3PATHWAY"
73,"Up",3.93206144307133e-07,6.03899103298372e-05,"L.PvsV.REACTOME_MITOCHONDRIAL_PROTEIN_IMPORT"
18,"Up",5.83157119229235e-07,8.71425868167146e-05,"L.PvsV.REACTOME_FORMATION_OF_ATP_BY_CHEMIOSMOTIC_COUPLING"
226,"Up",6.25663562380827e-07,9.10340483264103e-05,"L.PvsV.WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_WITH_H4K20ME1_MARK"
72,"Up",6.75072471664263e-07,9.57045050213259e-05,"L.PvsV.REACTOME_HEDGEHOG_LIGAND_BIOGENESIS"
60,"Up",7.31063513201858e-07,0.00010069658312435,"L.PvsV.REACTOME_DEGRADATION_OF_AXIN"
27,"Up",7.46710057532712e-07,0.00010069658312435,"L.PvsV.MOOTHA_FFA_OXYDATION"
46,"Up",9.35405316070634e-07,0.000123139428394156,"L.PvsV.REACTOME_MITOCHONDRIAL_FATTY_ACID_BETA_OXIDATION"
13,"Up",1.32371881706582e-06,0.000170205612547835,"L.PvsV.REACTOME_NEF_MEDIATED_CD4_DOWN_REGULATION"
150,"Up",1.35556043840291e-06,0.000170338492362039,"L.PvsV.REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION"
201,"Up",1.41005282347142e-06,0.000173248490243855,"L.PvsV.KEGG_HUNTINGTONS_DISEASE"
55,"Down",1.90992782879051e-06,0.000229565020986582,"L.PvsV.SPIRA_SMOKERS_LUNG_CANCER_DN"
12,"Up",2.23415799646834e-06,0.000262822543882414,"L.PvsV.BIOCARTA_MALATEX_PATHWAY"
203,"Up",2.31964897266873e-06,0.000267194566039279,"L.PvsV.REACTOME_PROTEIN_LOCALIZATION"
362,"Up",2.43823480787492e-06,0.000274922733044638,"L.PvsV.REACTOME_ASPARAGINE_N_LINKED_GLYCOSYLATION"
261,"Up",2.48618857880845e-06,0.000274922733044638,"L.PvsV.YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_17"
43,"Up",3.72490382707544e-06,0.000390886784046087,"L.PvsV.REACTOME_TRNA_AMINOACYLATION"
62,"Up",3.73622387228395e-06,0.000390886784046087,"L.PvsV.REACTOME_STABILIZATION_OF_P53"
53,"Up",3.77781882008366e-06,0.000390886784046087,"L.PvsV.REACTOME_NEF_MEDIATES_DOWN_MODULATION_OF_CELL_SURFACE_RECEPTORS_BY_RECRUITING_THEM_TO_CLATHRIN_ADAPTERS"
96,"Up",3.81766799393899e-06,0.000390886784046087,"L.PvsV.REACTOME_MITOCHONDRIAL_TRANSLATION"
53,"Up",4.12047059139272e-06,0.000413406770064687,"L.PvsV.REACTOME_CROSS_PRESENTATION_OF_SOLUBLE_EXOGENOUS_ANTIGENS_ENDOSOMES"
120,"Up",4.18715484239871e-06,0.000413406770064687,"L.PvsV.REACTOME_COPI_MEDIATED_ANTEROGRADE_TRANSPORT"
21,"Up",4.44142304087024e-06,0.000430818034964413,"L.PvsV.REACTOME_BRANCHED_CHAIN_AMINO_ACID_CATABOLISM"
65,"Up",4.82272121977002e-06,0.000459738372829456,"L.PvsV.REACTOME_IRON_UPTAKE_AND_TRANSPORT"
8,"Up",6.19576558767883e-06,0.000567086966433541,"L.PvsV.REACTOME_CHREBP_ACTIVATES_METABOLIC_GENE_EXPRESSION"
79,"Down",6.25133814625248e-06,0.000567086966433541,"L.PvsV.HOLLERN_SOLID_NODULAR_BREAST_TUMOR_DN"
70,"Down",6.2565210621172e-06,0.000567086966433541,"L.PvsV.REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_CYTOCHROME_C_RELEASE"
96,"Down",6.64950905107287e-06,0.000592986057151321,"L.PvsV.LIU_SMARCA4_TARGETS"
188,"Down",8.05003016697785e-06,0.00070648598084477,"L.PvsV.KIM_MYC_AMPLIFICATION_TARGETS_DN"
64,"Up",8.49272114570526e-06,0.00073090047846246,"L.PvsV.REACTOME_DEGRADATION_OF_DVL"
103,"Down",8.59260826551997e-06,0.00073090047846246,"L.PvsV.WU_APOPTOSIS_BY_CDKN1A_VIA_TP53"
26,"Up",9.90145613053537e-06,0.000829471984026213,"L.PvsV.REACTOME_MTORC1_MEDIATED_SIGNALLING"
55,"Up",1.0793783862109e-05,0.000890728820501504,"L.PvsV.REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC"
42,"Up",1.2171603123282e-05,0.00097859141962998,"L.PvsV.REACTOME_FATTY_ACYL_COA_BIOSYNTHESIS"
64,"Up",1.22124810914213e-05,0.00097859141962998,"L.PvsV.REACTOME_REGULATION_OF_RUNX3_EXPRESSION_AND_ACTIVITY"
147,"Down",1.25904626589212e-05,0.000994466686302504,"L.PvsV.RODRIGUES_THYROID_CARCINOMA_DN"
33,"Up",1.36084866777941e-05,0.00105973694142991,"L.PvsV.REACTOME_TRANSFERRIN_ENDOCYTOSIS_AND_RECYCLING"
83,"Up",1.44249215714644e-05,0.0011077137690087,"L.PvsV.PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_DN"
117,"Down",1.47079353350383e-05,0.00111223729601596,"L.PvsV.HANN_RESISTANCE_TO_BCL2_INHIBITOR_UP"
237,"Down",1.51054664161043e-05,0.00111223729601596,"L.PvsV.KIM_MYCN_AMPLIFICATION_TARGETS_DN"
97,"Down",1.51061669436158e-05,0.00111223729601596,"L.PvsV.WEIGEL_OXIDATIVE_STRESS_RESPONSE"
45,"Up",1.52884851686043e-05,0.00111223729601596,"L.PvsV.KEGG_PYRUVATE_METABOLISM"
31,"Up",1.57815893951632e-05,0.00112143784177245,"L.PvsV.BIOCARTA_MTOR_PATHWAY"
46,"Up",1.58206098133932e-05,0.00112143784177245,"L.PvsV.KEGG_N_GLYCAN_BIOSYNTHESIS"
10,"Up",1.90533577871558e-05,0.00133349386335676,"L.PvsV.BIOCARTA_ETC_PATHWAY"
22,"Up",2.10651618568647e-05,0.00144598016253706,"L.PvsV.BIOCARTA_ARAP_PATHWAY"
588,"Up",2.11836486101468e-05,0.00144598016253706,"L.PvsV.MOOTHA_PGC"
203,"Up",2.15655367187473e-05,0.00145409576241407,"L.PvsV.REACTOME_ER_TO_GOLGI_ANTEROGRADE_TRANSPORT"
45,"Up",2.28486302352979e-05,0.00151018693038734,"L.PvsV.REACTOME_MTOR_SIGNALLING"
8,"Up",2.29436972603611e-05,0.00151018693038734,"L.PvsV.REACTOME_NEF_MEDIATED_CD8_DOWN_REGULATION"
41,"Up",2.35163112048032e-05,0.00152966687825126,"L.PvsV.KEGG_AMINOACYL_TRNA_BIOSYNTHESIS"
87,"Up",2.40860602832784e-05,0.00153933231465847,"L.PvsV.REACTOME_CELLULAR_RESPONSE_TO_HYPOXIA"
65,"Down",2.4221723887735e-05,0.00153933231465847,"L.PvsV.REACTOME_INTRAFLAGELLAR_TRANSPORT"
67,"Up",2.48368363585587e-05,0.00156048713893717,"L.PvsV.REACTOME_DECTIN_1_MEDIATED_NONCANONICAL_NF_KB_SIGNALING"
42,"Down",2.6720983459008e-05,0.00166000356791972,"L.PvsV.PID_S1P_S1P1_PATHWAY"
89,"Up",3.03181954230408e-05,0.00186254780548881,"L.PvsV.LANDIS_ERBB2_BREAST_PRENEOPLASTIC_DN"
11,"Up",3.11649928193853e-05,0.00187850775592142,"L.PvsV.KEGG_VALINE_LEUCINE_AND_ISOLEUCINE_BIOSYNTHESIS"
51,"Down",3.15576568555162e-05,0.00187850775592142,"L.PvsV.XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_DN"
78,"Up",3.15972547116463e-05,0.00187850775592142,"L.PvsV.REACTOME_BIOSYNTHESIS_OF_THE_N_GLYCAN_PRECURSOR_DOLICHOL_LIPID_LINKED_OLIGOSACCHARIDE_LLO_AND_TRANSFER_TO_A_NASCENT_PROTEIN"
67,"Up",3.25887832523933e-05,0.00191684449577109,"L.PvsV.REACTOME_AUF1_HNRNP_D0_BINDS_AND_DESTABILIZES_MRNA"
96,"Up",4.17414174738861e-05,0.00242935049698017,"L.PvsV.REACTOME_DEGRADATION_OF_BETA_CATENIN_BY_THE_DESTRUCTION_COMPLEX"
88,"Down",4.38591751011444e-05,0.00252601436598154,"L.PvsV.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_DN"
105,"Up",4.44714033304675e-05,0.00253486998983665,"L.PvsV.SCHUHMACHER_MYC_TARGETS_UP"
66,"Up",4.62401193471676e-05,0.00260879203949479,"L.PvsV.REACTOME_NEGATIVE_REGULATION_OF_NOTCH4_SIGNALING"
5,"Up",4.83900226377022e-05,0.00270250944609955,"L.PvsV.REACTOME_BETA_OXIDATION_OF_HEXANOYL_COA_TO_BUTANOYL_COA"
189,"Up",4.97547591794544e-05,0.00275094063503203,"L.PvsV.KEGG_ALZHEIMERS_DISEASE"
68,"Up",5.30632735164908e-05,0.00290482019081859,"L.PvsV.REACTOME_DEGRADATION_OF_GLI1_BY_THE_PROTEASOME"
93,"Up",5.4337512653692e-05,0.00294541281825748,"L.PvsV.KEGG_PEROXISOME"
42,"Down",5.91562374786494e-05,0.00317548385455779,"L.PvsV.REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES"
20,"Up",6.10921949550065e-05,0.00324787255679068,"L.PvsV.REACTOME_DISEASES_ASSOCIATED_WITH_GLYCOSYLATION_PRECURSOR_BIOSYNTHESIS"
56,"Down",6.32602982024561e-05,0.00331623048937915,"L.PvsV.KEGG_HEDGEHOG_SIGNALING_PATHWAY"
137,"Down",6.35775785628848e-05,0.00331623048937915,"L.PvsV.BECKER_TAMOXIFEN_RESISTANCE_DN"
17,"Up",6.51854279157445e-05,0.00336831991538459,"L.PvsV.REACTOME_REGULATION_OF_PYRUVATE_DEHYDROGENASE_PDH_COMPLEX"
56,"Up",6.67928439715163e-05,0.00341942253998624,"L.PvsV.KEGG_FATTY_ACID_METABOLISM"
12,"Down",7.07426075227356e-05,0.00358840254122207,"L.PvsV.REACTOME_HYALURONAN_BIOSYNTHESIS_AND_EXPORT"
165,"Down",7.99944931429367e-05,0.00402081411442997,"L.PvsV.BHATTACHARYA_EMBRYONIC_STEM_CELL"
69,"Down",8.60936501710106e-05,0.00428839452068034,"L.PvsV.KANG_DOXORUBICIN_RESISTANCE_UP"
19,"Up",8.89407841373347e-05,0.00437658284971208,"L.PvsV.REACTOME_ALPHA_LINOLENIC_OMEGA3_AND_LINOLEIC_OMEGA6_ACID_METABOLISM"
273,"Down",8.94472530326397e-05,0.00437658284971208,"L.PvsV.VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP"
35,"Down",9.11022310310222e-05,0.00441617954270365,"L.PvsV.ZIRN_TRETINOIN_RESPONSE_WT1_UP"
460,"Down",9.18539785514414e-05,0.00441617954270365,"L.PvsV.BOQUEST_STEM_CELL_UP"
82,"Up",9.51362423228546e-05,0.00453455417071606,"L.PvsV.REACTOME_REGULATION_OF_PTEN_STABILITY_AND_ACTIVITY"
50,"Up",9.89870326704194e-05,0.00467409744894658,"L.PvsV.REACTOME_RETROGRADE_TRANSPORT_AT_THE_TRANS_GOLGI_NETWORK"
58,"Up",9.97546570764508e-05,0.00467409744894658,"L.PvsV.REACTOME_AMINO_ACIDS_REGULATE_MTORC1"
47,"Down",0.00010073382805873,0.00468031374232536,"L.PvsV.VALK_AML_CLUSTER_1"
6,"Up",0.000104078783710066,0.00475010523253143,"L.PvsV.REACTOME_SYNTHESIS_OF_DOLICHYL_PHOSPHATE"
20,"Down",0.000104557433339153,0.00475010523253143,"L.PvsV.REACTOME_ACTIVATION_OF_SMO"
33,"Up",0.000104813318569151,0.00475010523253143,"L.PvsV.REACTOME_ENDOSOMAL_SORTING_COMPLEX_REQUIRED_FOR_TRANSPORT_ESCRT"
101,"Up",0.000108535767402945,0.00487881510545432,"L.PvsV.REACTOME_COPII_MEDIATED_VESICLE_TRANSPORT"
125,"Down",0.000110970081021545,0.00490939979900105,"L.PvsV.ZHENG_GLIOBLASTOMA_PLASTICITY_DN"
254,"Down",0.000110992037416374,0.00490939979900105,"L.PvsV.PUJANA_XPRSS_INT_NETWORK"
235,"Up",0.000115084028558138,0.00504999677696782,"L.PvsV.REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION"
6,"Up",0.00011979260972967,0.00519199413459354,"L.PvsV.REACTOME_BETA_OXIDATION_OF_DECANOYL_COA_TO_OCTANOYL_COA_COA"
12,"Down",0.00012019809173955,0.00519199413459354,"L.PvsV.REACTOME_RUNX2_REGULATES_CHONDROCYTE_MATURATION"
74,"Down",0.000130194048721284,0.00558017748356572,"L.PvsV.KUUSELO_PANCREATIC_CANCER_19Q13_AMPLIFICATION"
29,"Up",0.000144460183678637,0.00614400273507067,"L.PvsV.REACTOME_INSULIN_RECEPTOR_RECYCLING"
224,"Up",0.000168465478821603,0.00711027200308888,"L.PvsV.REACTOME_INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC"
11,"Up",0.000173765725437631,0.00727841436321713,"L.PvsV.MULLIGAN_NTF3_SIGNALING_VIA_INSR_AND_IGF1R_DN"
64,"Up",0.000190372596188991,0.0078810877873739,"L.PvsV.REACTOME_METABOLISM_OF_POLYAMINES"
74,"Up",0.00019100484056938,0.0078810877873739,"L.PvsV.REACTOME_ASYMMETRIC_LOCALIZATION_OF_PCP_PROTEINS"
87,"Down",0.000194306309198019,0.00793924969889119,"L.PvsV.TSENG_ADIPOGENIC_POTENTIAL_DN"
92,"Up",0.000195286301148345,0.00793924969889119,"L.PvsV.KEGG_PPAR_SIGNALING_PATHWAY"
49,"Up",0.000202156818481916,0.00815857700282128,"L.PvsV.WANG_ADIPOGENIC_GENES_REPRESSED_BY_SIRT1"
103,"Down",0.000203701262844023,0.00816133537872902,"L.PvsV.SAMOLS_TARGETS_OF_KHSV_MIRNAS_DN"
96,"Up",0.000207217676079065,0.00824249302907304,"L.PvsV.REACTOME_ABC_TRANSPORTER_DISORDERS"
115,"Up",0.000216794836097347,0.00849184257325778,"L.PvsV.REACTOME_INTERLEUKIN_1_SIGNALING"
84,"Up",0.000218013185723318,0.00849184257325778,"L.PvsV.YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_10"
80,"Up",0.00021809398542279,0.00849184257325778,"L.PvsV.REACTOME_APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1"
73,"Up",0.000222149828950342,0.00856245045579199,"L.PvsV.REACTOME_G1_S_DNA_DAMAGE_CHECKPOINTS"
38,"Up",0.000224385528645043,0.00856245045579199,"L.PvsV.REACTOME_GLUCONEOGENESIS"
47,"Up",0.000224553321774252,0.00856245045579199,"L.PvsV.HOUSTIS_ROS"
31,"Down",0.00022761622746938,0.0086197953539603,"L.PvsV.LIM_MAMMARY_LUMINAL_PROGENITOR_DN"
6,"Up",0.000240392312337352,0.00904169452321917,"L.PvsV.REACTOME_MOLYBDENUM_COFACTOR_BIOSYNTHESIS"
341,"Down",0.00024685417336015,0.00922008922277484,"L.PvsV.BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_DN"
9,"Down",0.000248470481858103,0.00922008922277484,"L.PvsV.REACTOME_FGFR1B_LIGAND_BINDING_AND_ACTIVATION"
53,"Down",0.000251077199150804,0.00925470556069863,"L.PvsV.ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP"
95,"Down",0.000267816694364675,0.00977739293871629,"L.PvsV.REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_CELL_DEATH_GENES"
675,"Up",0.000268794307593575,0.00977739293871629,"L.PvsV.STARK_PREFRONTAL_CORTEX_22Q11_DELETION_DN"
40,"Up",0.000279830202304561,0.010076446100714,"L.PvsV.REACTOME_ROS_AND_RNS_PRODUCTION_IN_PHAGOCYTES"
15,"Down",0.000280660643789104,0.010076446100714,"L.PvsV.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_9"
39,"Up",0.000284209587720462,0.0101380310355254,"L.PvsV.REACTOME_N_GLYCAN_TRIMMING_IN_THE_ER_AND_CALNEXIN_CALRETICULIN_CYCLE"
120,"Up",0.000288037238761455,0.0102087044430262,"L.PvsV.REACTOME_CLEC7A_DECTIN_1_SIGNALING"
86,"Up",0.000297829106514035,0.0104885167510579,"L.PvsV.REACTOME_PEROXISOMAL_PROTEIN_IMPORT"
29,"Down",0.000301727071889967,0.010512477703593,"L.PvsV.JI_CARCINOGENESIS_BY_KRAS_AND_STK11_DN"
38,"Up",0.000302312164020852,0.010512477703593,"L.PvsV.REACTOME_PEROXISOMAL_LIPID_METABOLISM"
14,"Up",0.000306071664298484,0.0105766889494145,"L.PvsV.REACTOME_MITOCHONDRIAL_FATTY_ACID_BETA_OXIDATION_OF_SATURATED_FATTY_ACIDS"
73,"Down",0.000308401951869435,0.0105910210676156,"L.PvsV.IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_DN"
752,"Up",0.000317670397600311,0.0108419730143958,"L.PvsV.REACTOME_MEMBRANE_TRAFFICKING"
45,"Down",0.000323541736741102,0.0109746151070034,"L.PvsV.SAMOLS_TARGETS_OF_KHSV_MIRNAS_UP"
177,"Down",0.000333678808659207,0.0112494520309558,"L.PvsV.BURTON_ADIPOGENESIS_3"
15,"Down",0.000337147106142606,0.0112974930294695,"L.PvsV.CLAUS_PGR_POSITIVE_MENINGIOMA_DN"
39,"Down",0.000343522774783651,0.0114417916974627,"L.PvsV.MCCABE_HOXC6_TARGETS_DN"
40,"Up",0.000354817933534899,0.0117472356557752,"L.PvsV.REACTOME_NEF_MEDIATED_DOWNREGULATION_OF_MHC_CLASS_I_COMPLEX_CELL_SURFACE_EXPRESSION"
75,"Up",0.000358342612532714,0.0117494102986139,"L.PvsV.REACTOME_REGULATION_OF_RAS_BY_GAPS"
40,"Up",0.00035913372046767,0.0117494102986139,"L.PvsV.GUTIERREZ_MULTIPLE_MYELOMA_UP"
42,"Up",0.000365058582843525,0.0118729935561285,"L.PvsV.MOOTHA_GLUCONEOGENESIS"
112,"Down",0.000379324657668344,0.0122648305979431,"L.PvsV.WIEDERSCHAIN_TARGETS_OF_BMI1_AND_PCGF2"
117,"Down",0.000384315396852421,0.0123539524953316,"L.PvsV.ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR"
34,"Up",0.0003886108184943,0.0124198220546531,"L.PvsV.CREIGHTON_AKT1_SIGNALING_VIA_MTOR_DN"
44,"Down",0.000397315291952429,0.0126250359149711,"L.PvsV.DING_LUNG_CANCER_BY_MUTATION_RATE"
137,"Down",0.000401982721706651,0.0127003569618061,"L.PvsV.SHIPP_DLBCL_CURED_VS_FATAL_UP"
57,"Down",0.000406561582915354,0.0127505825928385,"L.PvsV.DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY"
5,"Up",0.000408184684198302,0.0127505825928385,"L.PvsV.REACTOME_BETA_OXIDATION_OF_LAUROYL_COA_TO_DECANOYL_COA_COA"
7,"Down",0.00042576067391134,0.0132248919441337,"L.PvsV.CALVET_IRINOTECAN_SENSITIVE_VS_REVERTED_DN"
159,"Up",0.000437984597565405,0.0134383138370861,"L.PvsV.OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_UP"
68,"Up",0.000438750980446078,0.0134383138370861,"L.PvsV.REACTOME_SCF_SKP2_MEDIATED_DEGRADATION_OF_P27_P21"
128,"Up",0.00044000345097736,0.0134383138370861,"L.PvsV.REACTOME_RAB_REGULATION_OF_TRAFFICKING"
72,"Up",0.000442353611566228,0.0134383138370861,"L.PvsV.REACTOME_IRE1ALPHA_ACTIVATES_CHAPERONES"
34,"Up",0.000455549321453714,0.0136485592996546,"L.PvsV.REACTOME_PYRUVATE_METABOLISM"
18,"Up",0.000456206969484966,0.0136485592996546,"L.PvsV.REACTOME_DISEASES_ASSOCIATED_WITH_N_GLYCOSYLATION_OF_PROTEINS"
10,"Down",0.000456679954862741,0.0136485592996546,"L.PvsV.SMID_BREAST_CANCER_ERBB2_DN"
11,"Up",0.000469444407351802,0.0138864320532499,"L.PvsV.BYSTRYKH_SCP2_QTL"
142,"Up",0.00047078670157944,0.0138864320532499,"L.PvsV.REACTOME_TCR_SIGNALING"
32,"Up",0.00047217385169307,0.0138864320532499,"L.PvsV.KEGG_PENTOSE_PHOSPHATE_PATHWAY"
269,"Down",0.000479607165612497,0.013940329085201,"L.PvsV.RIGGI_EWING_SARCOMA_PROGENITOR_DN"
22,"Up",0.000480118043269502,0.013940329085201,"L.PvsV.BOYAULT_LIVER_CANCER_SUBCLASS_G12_DN"
19,"Up",0.000481570420559483,0.013940329085201,"L.PvsV.MINGUEZ_LIVER_CANCER_VASCULAR_INVASION_UP"
109,"Up",0.000487005512663551,0.0140242368724832,"L.PvsV.REACTOME_MITOCHONDRIAL_BIOGENESIS"
65,"Up",0.000490761638290072,0.0140591766741234,"L.PvsV.WONG_PROTEASOME_GENE_MODULE"
49,"Up",0.000495618310566872,0.014083938546953,"L.PvsV.KEGG_LYSINE_DEGRADATION"
74,"Down",0.000496720567309791,0.014083938546953,"L.PvsV.LIEN_BREAST_CARCINOMA_METAPLASTIC"
23,"Down",0.000513445435822602,0.0144838766054243,"L.PvsV.CHEN_HOXA5_TARGETS_6HR_UP"
52,"Up",0.000520139594873604,0.0145091704696183,"L.PvsV.ELVIDGE_HIF1A_AND_HIF2A_TARGETS_UP"
5,"Up",0.00052099221305293,0.0145091704696183,"L.PvsV.REACTOME_BETA_OXIDATION_OF_OCTANOYL_COA_TO_HEXANOYL_COA"
119,"Up",0.000522214672355586,0.0145091704696183,"L.PvsV.REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT"
45,"Up",0.000542972292938217,0.0149650851206922,"L.PvsV.CHNG_MULTIPLE_MYELOMA_HYPERPLOID_DN"
72,"Up",0.000544037277854788,0.0149650851206922,"L.PvsV.REACTOME_ASSEMBLY_OF_THE_PRE_REPLICATIVE_COMPLEX"
52,"Down",0.000560556273118013,0.0152874110533664,"L.PvsV.REACTOME_ELASTIC_FIBRE_FORMATION"
19,"Up",0.000561284941912351,0.0152874110533664,"L.PvsV.REACTOME_PENTOSE_PHOSPHATE_PATHWAY"
457,"Down",0.000576752153043697,0.0156316796773461,"L.PvsV.ZWANG_DOWN_BY_2ND_EGF_PULSE"
252,"Down",0.000592063462206438,0.0159683847928751,"L.PvsV.REACTOME_CILIUM_ASSEMBLY"
15,"Up",0.000608975610591613,0.0163315159748977,"L.PvsV.REACTOME_VLDLR_INTERNALISATION_AND_DEGRADATION"
72,"Down",0.000611434944258241,0.0163315159748977,"L.PvsV.MOSERLE_IFNA_RESPONSE"
34,"Down",0.000619794502090994,0.0164752105868322,"L.PvsV.PID_WNT_SIGNALING_PATHWAY"
125,"Down",0.000638044845668848,0.0168617585094224,"L.PvsV.TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP"
810,"Down",0.000640435754562978,0.0168617585094224,"L.PvsV.SWEET_LUNG_CANCER_KRAS_DN"
7,"Down",0.000671389267021437,0.017592944347685,"L.PvsV.REACTOME_GLI_PROTEINS_BIND_PROMOTERS_OF_HH_RESPONSIVE_GENES_TO_PROMOTE_TRANSCRIPTION"
23,"Up",0.000695960745294348,0.0181507875506248,"L.PvsV.REACTOME_DEFECTS_IN_VITAMIN_AND_COFACTOR_METABOLISM"
183,"Down",0.000713831914517185,0.0185294678655658,"L.PvsV.YORDY_RECIPROCAL_REGULATION_BY_ETS1_AND_SP100_DN"
152,"Down",0.000763996346895981,0.0196821681390346,"L.PvsV.WONG_ENDMETRIUM_CANCER_DN"
101,"Down",0.00076535831974904,0.0196821681390346,"L.PvsV.TURASHVILI_BREAST_NORMAL_DUCTAL_VS_LOBULAR_UP"
58,"Down",0.000774177629647919,0.0197648270705369,"L.PvsV.KEGG_BASAL_CELL_CARCINOMA"
63,"Up",0.000780016307137789,0.0197648270705369,"L.PvsV.REACTOME_SYNTHESIS_OF_SUBSTRATES_IN_N_GLYCAN_BIOSYTHESIS"
209,"Up",0.000781463889904148,0.0197648270705369,"L.PvsV.YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_14"
12,"Down",0.000782871609413562,0.0197648270705369,"L.PvsV.REACTOME_FGFR2B_LIGAND_BINDING_AND_ACTIVATION"
38,"Down",0.000791427621728508,0.0198900150933497,"L.PvsV.HOEGERKORP_CD44_TARGETS_DIRECT_DN"
248,"Down",0.00081433028738674,0.020372996194395,"L.PvsV.CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN"
24,"Down",0.000835993361778354,0.0208184122166272,"L.PvsV.CAIRO_PML_TARGETS_BOUND_BY_MYC_DN"
83,"Up",0.000843186396004464,0.0208184122166272,"L.PvsV.REACTOME_GOLGI_ASSOCIATED_VESICLE_BIOGENESIS"
57,"Up",0.000843429975859013,0.0208184122166272,"L.PvsV.WANG_TARGETS_OF_MLL_CBP_FUSION_DN"
32,"Down",0.000871153016593984,0.0214071334611028,"L.PvsV.WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_UP"
54,"Down",0.000893961788669877,0.0218704191573263,"L.PvsV.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_PINK_DN"
47,"Down",0.000913195935251406,0.0222425565022248,"L.PvsV.WHITFIELD_CELL_CYCLE_LITERATURE"
30,"Up",0.000993479335010496,0.0240918738740045,"L.PvsV.REACTOME_ENERGY_DEPENDENT_REGULATION_OF_MTOR_BY_LKB1_AMPK"
34,"Up",0.00100855239664517,0.0243505947644156,"L.PvsV.REACTOME_MITOPHAGY"
93,"Up",0.00101721130088849,0.0244528751417933,"L.PvsV.REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR"
477,"Down",0.00103485802242268,0.0247693939652596,"L.PvsV.SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP"
50,"Up",0.00104954604799343,0.0250126728420504,"L.PvsV.REACTOME_INTRA_GOLGI_TRAFFIC"
26,"Down",0.00106872504302747,0.0252620991680396,"L.PvsV.OKAWA_NEUROBLASTOMA_1P36_31_DELETION"
41,"Up",0.00106915015469728,0.0252620991680396,"L.PvsV.BIOCARTA_MHC_PATHWAY"
124,"Down",0.0010743062316717,0.0252632334086259,"L.PvsV.MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_DN"
266,"Down",0.00107833660416634,0.0252632334086259,"L.PvsV.FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_DN"
137,"Up",0.00108302549878361,0.0252660252437747,"L.PvsV.REACTOME_SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE"
70,"Down",0.00108967298292085,0.0252825978594111,"L.PvsV.PETRETTO_CARDIAC_HYPERTROPHY"
99,"Up",0.00109542969910279,0.0252825978594111,"L.PvsV.REACTOME_TRANS_GOLGI_NETWORK_VESICLE_BUDDING"
127,"Down",0.00109799716235823,0.0252825978594111,"L.PvsV.PYEON_HPV_POSITIVE_TUMORS_UP"
46,"Down",0.00110609417094941,0.0252825978594111,"L.PvsV.ZHAN_LATE_DIFFERENTIATION_GENES_UP"
49,"Up",0.00110659950840613,0.0252825978594111,"L.PvsV.REACTOME_TBC_RABGAPS"
110,"Down",0.00112686059058154,0.0256395564005157,"L.PvsV.TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_UP"
28,"Down",0.00113392922249831,0.0256946502917753,"L.PvsV.REACTOME_TELOMERE_C_STRAND_LAGGING_STRAND_SYNTHESIS"
128,"Down",0.00117314038598676,0.0264746660984522,"L.PvsV.ISSAEVA_MLL2_TARGETS"
13,"Down",0.00120365350954971,0.0269906583141492,"L.PvsV.CHASSOT_SKIN_WOUND"
120,"Up",0.00120576824083828,0.0269906583141492,"L.PvsV.REACTOME_UCH_PROTEINASES"
60,"Down",0.00122314761351217,0.0272692869157612,"L.PvsV.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_UP"
46,"Down",0.00126490891257155,0.0280870738056551,"L.PvsV.PID_RAC1_REG_PATHWAY"
50,"Down",0.00128021076802942,0.0283131413457387,"L.PvsV.BOWIE_RESPONSE_TO_TAMOXIFEN"
28,"Down",0.00128612541231306,0.0283306271102746,"L.PvsV.HASEGAWA_TUMORIGENESIS_BY_RET_C634R"
90,"Up",0.00129372761556957,0.0283849999463657,"L.PvsV.REACTOME_REGULATION_OF_RUNX2_EXPRESSION_AND_ACTIVITY"
82,"Down",0.00130183033190179,0.0284498810477669,"L.PvsV.PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_1"
176,"Down",0.00131421924253608,0.0286075519369369,"L.PvsV.ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR"
106,"Up",0.00132813395907843,0.0287769330826864,"L.PvsV.REACTOME_MAPK6_MAPK4_SIGNALING"
155,"Up",0.00133450016365748,0.0287769330826864,"L.PvsV.ALCALA_APOPTOSIS"
220,"Up",0.00133761472277996,0.0287769330826864,"L.PvsV.KEGG_ENDOCYTOSIS"
53,"Down",0.00140719054108529,0.030156420549072,"L.PvsV.BOQUEST_STEM_CELL_CULTURED_VS_FRESH_DN"
85,"Up",0.00144033763064412,0.0307475936673024,"L.PvsV.ELVIDGE_HIF1A_TARGETS_UP"
308,"Down",0.00148366314102157,0.031497025086546,"L.PvsV.VERHAAK_GLIOBLASTOMA_CLASSICAL"
735,"Down",0.00148683732096012,0.031497025086546,"L.PvsV.GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP"
24,"Down",0.00149895463018031,0.0316325196575073,"L.PvsV.JI_CARCINOGENESIS_BY_KRAS_AND_STK11_UP"
118,"Down",0.00152406483167404,0.0320401310050409,"L.PvsV.ANASTASSIOU_MULTICANCER_INVASIVENESS_SIGNATURE"
75,"Down",0.00156797290076105,0.0328383415466206,"L.PvsV.CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN"
37,"Up",0.00161041347405192,0.0335999098038984,"L.PvsV.BIOCARTA_EIF_PATHWAY"
13,"Down",0.00163285486972041,0.0339124919142371,"L.PvsV.REACTOME_RNF_MUTANTS_SHOW_ENHANCED_WNT_SIGNALING_AND_PROLIFERATION"
25,"Down",0.00163766238761102,0.0339124919142371,"L.PvsV.HOLLERN_PAPILLARY_BREAST_TUMOR"
566,"Down",0.00164602203954393,0.0339153563753142,"L.PvsV.SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP"
32,"Down",0.00165851250519148,0.0339153563753142,"L.PvsV.SCHMIDT_POR_TARGETS_IN_LIMB_BUD_DN"
109,"Down",0.00165957539115079,0.0339153563753142,"L.PvsV.KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_DN"
47,"Up",0.00166540009414691,0.0339153563753142,"L.PvsV.GALE_APL_WITH_FLT3_MUTATED_DN"
104,"Down",0.00166847114018547,0.0339153563753142,"L.PvsV.ZHENG_IL22_SIGNALING_DN"
91,"Down",0.00167767525241712,0.0339775328593928,"L.PvsV.PID_ATF2_PATHWAY"
152,"Up",0.00171617143456702,0.0346303352617557,"L.PvsV.REACTOME_GOLGI_TO_ER_RETROGRADE_TRANSPORT"
15,"Down",0.00176281537692357,0.0354411465314387,"L.PvsV.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TAN_DN"
383,"Down",0.00177028343949377,0.0354411465314387,"L.PvsV.DELYS_THYROID_CANCER_DN"
29,"Up",0.00177558285209052,0.0354411465314387,"L.PvsV.COLLER_MYC_TARGETS_UP"
389,"Down",0.00179561194531258,0.0355443323339538,"L.PvsV.CHICAS_RB1_TARGETS_GROWING"
119,"Down",0.00179910412991453,0.0355443323339538,"L.PvsV.WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_DN"
35,"Down",0.00180582132882107,0.0355443323339538,"L.PvsV.KEGG_DNA_REPLICATION"
10,"Up",0.00180646724287231,0.0355443323339538,"L.PvsV.REACTOME_RECYCLING_OF_EIF2_GDP"
77,"Up",0.00181948936468215,0.0356736053096723,"L.PvsV.REACTOME_ORC1_REMOVAL_FROM_CHROMATIN"
30,"Up",0.00184364313679966,0.0360194448882167,"L.PvsV.REACTOME_CALNEXIN_CALRETICULIN_CYCLE"
82,"Down",0.00186492539922736,0.0363069455363665,"L.PvsV.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_DN"
46,"Up",0.00188174009283618,0.0365057578010219,"L.PvsV.IIZUKA_LIVER_CANCER_PROGRESSION_G2_G3_UP"
264,"Down",0.00188880281939104,0.0365146531063394,"L.PvsV.POOLA_INVASIVE_BREAST_CANCER_DN"
27,"Down",0.00191124924906655,0.0368198505159894,"L.PvsV.REACTOME_HYALURONAN_METABOLISM"
94,"Up",0.00192708992504853,0.0369961117902547,"L.PvsV.REACTOME_TP53_REGULATES_METABOLIC_GENES"
92,"Down",0.00197764666402021,0.0378246527729793,"L.PvsV.BURTON_ADIPOGENESIS_7"
432,"Down",0.00198393006043841,0.0378246527729793,"L.PvsV.ONDER_CDH1_TARGETS_2_UP"
30,"Up",0.00201399504546794,0.0382659058638908,"L.PvsV.CHOI_ATL_CHRONIC_VS_ACUTE_DN"
22,"Down",0.0020836103236085,0.0394155328779902,"L.PvsV.LOPEZ_EPITHELIOID_MESOTHELIOMA"
494,"Down",0.00208875947427223,0.0394155328779902,"L.PvsV.KAAB_HEART_ATRIUM_VS_VENTRICLE_UP"
58,"Down",0.00211354773523579,0.0396159542486758,"L.PvsV.ISHIDA_E2F_TARGETS"
37,"Down",0.00211371070778791,0.0396159542486758,"L.PvsV.BIOCARTA_EDG1_PATHWAY"
32,"Down",0.00214330272012707,0.0400348673634547,"L.PvsV.WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_DN"
319,"Down",0.00215686867316377,0.0401512212059666,"L.PvsV.SHEPARD_CRUSH_AND_BURN_MUTANT_DN"
219,"Down",0.00216405569169435,0.0401512212059666,"L.PvsV.XU_GH1_EXOGENOUS_TARGETS_DN"
137,"Down",0.0022152243969133,0.0409631293997781,"L.PvsV.BROWNE_HCMV_INFECTION_6HR_UP"
99,"Down",0.00222999608259355,0.0409852576088264,"L.PvsV.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_UP"
63,"Down",0.00223124661607103,0.0409852576088264,"L.PvsV.SNIJDERS_AMPLIFIED_IN_HEAD_AND_NECK_TUMORS"
546,"Down",0.00225051703220795,0.0412023465929727,"L.PvsV.BLUM_RESPONSE_TO_SALIRASIB_DN"
138,"Down",0.00225891305929438,0.0412195719631638,"L.PvsV.ZHENG_IL22_SIGNALING_UP"
45,"Down",0.00227544684667947,0.0413846895239829,"L.PvsV.HOFMANN_MYELODYSPLASTIC_SYNDROM_RISK_DN"
307,"Up",0.00229326112378879,0.0414595467530141,"L.PvsV.MCBRYAN_PUBERTAL_BREAST_4_5WK_DN"
233,"Down",0.00229455983114891,0.0414595467530141,"L.PvsV.PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_UP"
113,"Up",0.00232923528786718,0.041948996438494,"L.PvsV.RUAN_RESPONSE_TO_TNF_DN"
63,"Down",0.00234002737744907,0.0419675458202936,"L.PvsV.KAUFFMANN_MELANOMA_RELAPSE_UP"
19,"Down",0.00234544613103106,0.0419675458202936,"L.PvsV.VERRECCHIA_RESPONSE_TO_TGFB1_C6"
140,"Up",0.00240463212742518,0.0428178316355334,"L.PvsV.KEGG_LYSOSOME"
228,"Down",0.00241591804389045,0.0428178316355334,"L.PvsV.EPPERT_HSC_R"
32,"Down",0.00241619885517931,0.0428178316355334,"L.PvsV.REACTOME_EPHRIN_SIGNALING"
273,"Down",0.00243608992632797,0.0430324000085219,"L.PvsV.PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP"
92,"Up",0.0024514203390842,0.0431652963528552,"L.PvsV.REACTOME_RAB_GEFS_EXCHANGE_GTP_FOR_GDP_ON_RABS"
56,"Down",0.00248193347938724,0.0435638419286732,"L.PvsV.HUMMERICH_MALIGNANT_SKIN_TUMOR_DN"
177,"Up",0.00250594416662856,0.043597261673269,"L.PvsV.REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS"
65,"Down",0.00250661600961153,0.043597261673269,"L.PvsV.ZHANG_INTERFERON_RESPONSE"
120,"Up",0.00250749307507679,0.043597261673269,"L.PvsV.SESTO_RESPONSE_TO_UV_C1"
414,"Down",0.0025245002295599,0.0437553660477639,"L.PvsV.DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP"
61,"Down",0.00257181879761091,0.0444362066624709,"L.PvsV.REACTOME_RUNX2_REGULATES_BONE_DEVELOPMENT"
206,"Down",0.00262464567852054,0.0450862043297852,"L.PvsV.MIKKELSEN_IPS_ICP_WITH_H3K4ME3_AND_H327ME3"
30,"Up",0.00262859020288608,0.0450862043297852,"L.PvsV.REACTOME_BUDDING_AND_MATURATION_OF_HIV_VIRION"
12,"Down",0.00263702503451757,0.0450862043297852,"L.PvsV.KREPPEL_CD99_TARGETS_DN"
198,"Down",0.00264544455524298,0.0450862043297852,"L.PvsV.CERVERA_SDHB_TARGETS_1_UP"
353,"Down",0.00265021096168931,0.0450862043297852,"L.PvsV.TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP"
54,"Down",0.00268708845123078,0.0455733498369784,"L.PvsV.RIZ_ERYTHROID_DIFFERENTIATION_12HR"
34,"Down",0.00271447211555268,0.045896991825354,"L.PvsV.THUM_MIR21_TARGETS_HEART_DISEASE_UP"
18,"Down",0.00272879354732572,0.0459984741559876,"L.PvsV.ZAIDI_OSTEOBLAST_TRANSCRIPTION_FACTORS"
28,"Up",0.00281190600296567,0.0471463924219985,"L.PvsV.BIOCARTA_NTHI_PATHWAY"
27,"Up",0.0028139463735322,0.0471463924219985,"L.PvsV.VANDESLUIS_COMMD1_TARGETS_GROUP_2_UP"
68,"Up",0.00285574190976765,0.0477021057979013,"L.PvsV.GERHOLD_ADIPOGENESIS_UP"
237,"Up",0.002882503773099,0.0480041065104348,"L.PvsV.YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_13"
91,"Down",0.00294370306102382,0.048876078751954,"L.PvsV.DAUER_STAT3_TARGETS_DN"
25,"Up",0.00296661262935319,0.0491089857116581,"L.PvsV.FINETTI_BREAST_CANCERS_KINOME_GRAY"
191,"Down",0.00308899084669024,0.0508782143705163,"L.PvsV.VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN"
47,"Down",0.00309189365680837,0.0508782143705163,"L.PvsV.REACTOME_SYNTHESIS_OF_LEUKOTRIENES_LT_AND_EOXINS_EX"
53,"Up",0.00314084548371286,0.0514628019372771,"L.PvsV.BIOCARTA_CTL_PATHWAY"
23,"Down",0.00314603491676608,0.0514628019372771,"L.PvsV.REACTOME_NEGATIVE_REGULATION_OF_TCF_DEPENDENT_SIGNALING_BY_WNT_LIGAND_ANTAGONISTS"
52,"Down",0.00322114624068472,0.0525360400139995,"L.PvsV.VALK_AML_CLUSTER_2"
10,"Up",0.00327613972822288,0.0532758134039538,"L.PvsV.BIOCARTA_LDL_PATHWAY"
14,"Down",0.00332512505304136,0.0539138311386091,"L.PvsV.REACTOME_NTRK2_ACTIVATES_RAC1"
43,"Down",0.00337667251699632,0.0545895390247739,"L.PvsV.GENTLES_LEUKEMIC_STEM_CELL_UP"
33,"Up",0.00339687010788758,0.0547559615933249,"L.PvsV.KEGG_GALACTOSE_METABOLISM"
35,"Down",0.00347744276581534,0.0558129952925008,"L.PvsV.TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_GRANULOCYTE_UP"
233,"Up",0.00348263399817558,0.0558129952925008,"L.PvsV.REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES"
256,"Down",0.00350881881066122,0.0558231419674011,"L.PvsV.TSENG_IRS1_TARGETS_DN"
126,"Down",0.00351287980713954,0.0558231419674011,"L.PvsV.TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN"
28,"Up",0.00352193927851287,0.0558231419674011,"L.PvsV.REACTOME_MITOCHONDRIAL_CALCIUM_ION_TRANSPORT"
187,"Up",0.00352365283896238,0.0558231419674011,"L.PvsV.ELVIDGE_HYPOXIA_DN"
103,"Down",0.00361300839608089,0.0570752097769465,"L.PvsV.NAGASHIMA_NRG1_SIGNALING_DN"
15,"Up",0.00363614511458579,0.0572770550955694,"L.PvsV.REACTOME_TICAM1_TRAF6_DEPENDENT_INDUCTION_OF_TAK1_COMPLEX"
112,"Down",0.0036975878966605,0.0580794417063521,"L.PvsV.ASGHARZADEH_NEUROBLASTOMA_POOR_SURVIVAL_DN"
181,"Down",0.00372036289008089,0.0582716329157429,"L.PvsV.MUNSHI_MULTIPLE_MYELOMA_UP"
151,"Down",0.00375900268140518,0.0587105249307605,"L.PvsV.MORI_IMMATURE_B_LYMPHOCYTE_DN"
54,"Down",0.00378691261045726,0.0588739834941705,"L.PvsV.PID_ERB_GENOMIC_PATHWAY"
13,"Down",0.00380219041187753,0.0588739834941705,"L.PvsV.REACTOME_ACETYLCHOLINE_REGULATES_INSULIN_SECRETION"
72,"Down",0.00380748039448552,0.0588739834941705,"L.PvsV.NICK_RESPONSE_TO_PROC_TREATMENT_DN"
14,"Up",0.00381206114865492,0.0588739834941705,"L.PvsV.REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_LINKED_TO_LIPOGENESIS"
218,"Down",0.00384362744081426,0.0591961451817884,"L.PvsV.KATSANOU_ELAVL1_TARGETS_DN"
28,"Up",0.00394372859175904,0.0603120213990703,"L.PvsV.REACTOME_DISEASES_OF_IMMUNE_SYSTEM"
75,"Down",0.00394628981935575,0.0603120213990703,"L.PvsV.PID_INTEGRIN3_PATHWAY"
151,"Down",0.00394880660995903,0.0603120213990703,"L.PvsV.CHANG_IMMORTALIZED_BY_HPV31_DN"
43,"Down",0.00396017765837459,0.0603190696230113,"L.PvsV.REACTOME_HOMOLOGOUS_DNA_PAIRING_AND_STRAND_EXCHANGE"
181,"Down",0.00400139248323519,0.060776972011167,"L.PvsV.LIN_SILENCED_BY_TUMOR_MICROENVIRONMENT"
78,"Up",0.00401222549901899,0.060776972011167,"L.PvsV.PID_RAC1_PATHWAY"
48,"Up",0.00403994860465236,0.0609908917117734,"L.PvsV.IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_DN"
42,"Up",0.00404840970486903,0.0609908917117734,"L.PvsV.KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM"
405,"Down",0.00406830483725839,0.0611240691445697,"L.PvsV.IVANOVA_HEMATOPOIESIS_STEM_CELL_LONG_TERM"
17,"Up",0.00421087337162604,0.0627379941670568,"L.PvsV.REACTOME_ZINC_TRANSPORTERS"
35,"Up",0.00421214923260593,0.0627379941670568,"L.PvsV.JIANG_TIP30_TARGETS_DN"
65,"Up",0.00421558723695896,0.0627379941670568,"L.PvsV.CHOI_ATL_STAGE_PREDICTOR"
265,"Down",0.0042323663879814,0.0627379941670568,"L.PvsV.BROWNE_HCMV_INFECTION_24HR_DN"
40,"Down",0.0042324600875949,0.0627379941670568,"L.PvsV.STAMBOLSKY_BOUND_BY_MUTATED_TP53"
15,"Up",0.00426427158938909,0.0629819139206767,"L.PvsV.REACTOME_HEME_BIOSYNTHESIS"
103,"Up",0.00427355174515645,0.0629819139206767,"L.PvsV.REACTOME_PCP_CE_PATHWAY"
353,"Down",0.00428308910004964,0.0629819139206767,"L.PvsV.CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP"
29,"Down",0.0043005914338928,0.0630715385623164,"L.PvsV.PETROVA_PROX1_TARGETS_UP"
500,"Down",0.00432637221360389,0.0632817776958092,"L.PvsV.WANG_SMARCE1_TARGETS_UP"
192,"Down",0.00435620416960707,0.06343840817295,"L.PvsV.LE_EGR2_TARGETS_UP"
25,"Up",0.0043677147978802,0.06343840817295,"L.PvsV.WALLACE_PROSTATE_CANCER_UP"
104,"Up",0.00437504362618042,0.06343840817295,"L.PvsV.REACTOME_COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC"
63,"Down",0.00439253969090057,0.06343840817295,"L.PvsV.SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_DN"
516,"Up",0.00439444932722732,0.06343840817295,"L.PvsV.ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_DN"
256,"Down",0.00441318675274332,0.0635429936352026,"L.PvsV.BROWNE_HCMV_INFECTION_6HR_DN"
394,"Down",0.00445856598202064,0.0640296397781613,"L.PvsV.SENESE_HDAC1_AND_HDAC2_TARGETS_DN"
96,"Up",0.00448798314946757,0.064285126511415,"L.PvsV.REACTOME_CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY"
71,"Down",0.00451150390500899,0.0643553434608394,"L.PvsV.REACTOME_ION_HOMEOSTASIS"
463,"Down",0.00453118933574541,0.0643553434608394,"L.PvsV.JAEGER_METASTASIS_DN"
176,"Down",0.00453633744697483,0.0643553434608394,"L.PvsV.NABA_ECM_AFFILIATED"
13,"Up",0.0045394436516056,0.0643553434608394,"L.PvsV.REACTOME_LINOLEIC_ACID_LA_METABOLISM"
179,"Up",0.00457235139152128,0.0646560891143763,"L.PvsV.REACTOME_CLATHRIN_MEDIATED_ENDOCYTOSIS"
18,"Up",0.00465832446324267,0.0654400808173371,"L.PvsV.REACTOME_TRAF6_MEDIATED_INDUCTION_OF_TAK1_COMPLEX_WITHIN_TLR4_COMPLEX"
92,"Up",0.00466230919578267,0.0654400808173371,"L.PvsV.JIANG_AGING_CEREBRAL_CORTEX_DN"
40,"Down",0.00466330111087554,0.0654400808173371,"L.PvsV.MURAKAMI_UV_RESPONSE_24HR"
23,"Down",0.00470366495531296,0.0654947890921296,"L.PvsV.WHITE_NEUROBLASTOMA_WITH_1P36.3_DELETION"
167,"Down",0.00471247781628116,0.0654947890921296,"L.PvsV.REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE"
36,"Up",0.00471689893219891,0.0654947890921296,"L.PvsV.GENTILE_UV_RESPONSE_CLUSTER_D9"
8,"Down",0.00472239461006475,0.0654947890921296,"L.PvsV.GAUTSCHI_SRC_SIGNALING"
645,"Down",0.00472642807881348,0.0654947890921296,"L.PvsV.CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_2"
283,"Down",0.00475698214874078,0.0657533857509694,"L.PvsV.TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP"
15,"Down",0.00478036148899343,0.0658913055518424,"L.PvsV.MIKKELSEN_PARTIALLY_REPROGRAMMED_TO_PLURIPOTENCY"
86,"Down",0.00479079486920612,0.0658913055518424,"L.PvsV.REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS"
39,"Down",0.00487325298932336,0.0667951862710576,"L.PvsV.JOHANSSON_GLIOMAGENESIS_BY_PDGFB_DN"
25,"Down",0.00488067557487923,0.0667951862710576,"L.PvsV.VICENT_METASTASIS_UP"
28,"Up",0.00492043746446837,0.0671730833112237,"L.PvsV.RAHMAN_TP53_TARGETS_PHOSPHORYLATED"
14,"Up",0.00494035390650441,0.0672173923164175,"L.PvsV.REACTOME_JOSEPHIN_DOMAIN_DUBS"
8,"Up",0.0049499314494475,0.0672173923164175,"L.PvsV.MOOTHA_PYR"
23,"Up",0.00496015483181377,0.0672173923164175,"L.PvsV.REACTOME_ASSEMBLY_OF_THE_HIV_VIRION"
44,"Up",0.00499129025016097,0.0673715315155735,"L.PvsV.REACTOME_RHO_GTPASES_ACTIVATE_WASPS_AND_WAVES"
407,"Up",0.0049958994251013,0.0673715315155735,"L.PvsV.REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES"
108,"Down",0.00504562460525641,0.067876541222537,"L.PvsV.REN_BOUND_BY_E2F"
25,"Up",0.00508905610957628,0.0682946389073962,"L.PvsV.REACTOME_PINK_PARKIN_MEDIATED_MITOPHAGY"
22,"Down",0.00510285883090315,0.0683140592640763,"L.PvsV.REACTOME_FGFR2_LIGAND_BINDING_AND_ACTIVATION"
35,"Down",0.00515746300251847,0.068860900483039,"L.PvsV.MOROSETTI_FACIOSCAPULOHUMERAL_MUSCULAR_DISTROPHY_UP"
26,"Up",0.0051686152469635,0.068860900483039,"L.PvsV.REACTOME_METAL_ION_SLC_TRANSPORTERS"
10,"Up",0.00518486602623269,0.0688870785755103,"L.PvsV.REACTOME_ZINC_INFLUX_INTO_CELLS_BY_THE_SLC39_GENE_FAMILY"
120,"Down",0.0051954986011915,0.0688870785755103,"L.PvsV.BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_DN"
1217,"Down",0.00521185184318861,0.0689385857439948,"L.PvsV.FISCHER_DREAM_TARGETS"
190,"Down",0.0052837849917936,0.0697232630540019,"L.PvsV.SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A5"
166,"Up",0.0053069359900722,0.0698620216407362,"L.PvsV.REACTOME_INTERLEUKIN_1_FAMILY_SIGNALING"
27,"Up",0.0053560509496496,0.0702927713359893,"L.PvsV.REACTOME_MITOCHONDRIAL_TRNA_AMINOACYLATION"
179,"Up",0.00536508401226035,0.0702927713359893,"L.PvsV.REACTOME_AUTOPHAGY"
16,"Down",0.00539074386361683,0.0702954807679206,"L.PvsV.REACTOME_FGFR2C_LIGAND_BINDING_AND_ACTIVATION"
384,"Down",0.00539098542607986,0.0702954807679206,"L.PvsV.YAGI_AML_FAB_MARKERS"
154,"Down",0.00540343268698974,0.0702954807679206,"L.PvsV.RADMACHER_AML_PROGNOSIS"
405,"Down",0.00546238572045618,0.0708956118507095,"L.PvsV.WANG_CLIM2_TARGETS_UP"
203,"Down",0.00547592434207468,0.0709048845136556,"L.PvsV.IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_DN"
30,"Up",0.00549782604539688,0.0710221500116807,"L.PvsV.BIOCARTA_IGF1MTOR_PATHWAY"
104,"Up",0.00551893014578964,0.0711285892216105,"L.PvsV.LI_DCP2_BOUND_MRNA"
20,"Up",0.00559514579540062,0.0719431653552792,"L.PvsV.TERAMOTO_OPN_TARGETS_CLUSTER_1"
471,"Up",0.00570395677024198,0.073172104368139,"L.PvsV.REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION"
14,"Up",0.00573435791712713,0.0733918169532312,"L.PvsV.REACTOME_PEXOPHAGY"
40,"Down",0.00578329533680585,0.0738472053515001,"L.PvsV.MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_UP"
69,"Up",0.00582694817513962,0.0741730092216424,"L.PvsV.REACTOME_THE_ROLE_OF_NEF_IN_HIV_1_REPLICATION_AND_DISEASE_PATHOGENESIS"
187,"Up",0.00583564098596753,0.0741730092216424,"L.PvsV.REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS"
65,"Down",0.00586182014010524,0.0743348705381694,"L.PvsV.CHIARETTI_T_ALL_REFRACTORY_TO_THERAPY"
1149,"Down",0.00589107120492945,0.0743820205619507,"L.PvsV.SMID_BREAST_CANCER_BASAL_DN"
133,"Down",0.00589244438526577,0.0743820205619507,"L.PvsV.SMID_BREAST_CANCER_LUMINAL_A_UP"
638,"Down",0.00590993878607941,0.0744329192442666,"L.PvsV.PEREZ_TP63_TARGETS"
392,"Down",0.00594478740161264,0.0747016580534461,"L.PvsV.REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION"
17,"Down",0.00598476919237674,0.0750335348404784,"L.PvsV.FUKUSHIMA_TNFSF11_TARGETS"
31,"Down",0.0060063617830526,0.0751338785033888,"L.PvsV.ALONSO_METASTASIS_NEURAL_UP"
16,"Up",0.00607390016718929,0.0758072099873354,"L.PvsV.NIKOLSKY_BREAST_CANCER_1Q32_AMPLICON"
107,"Up",0.00608982117369287,0.0758347325886213,"L.PvsV.YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_7"
289,"Down",0.00611959414727493,0.0760342382927709,"L.PvsV.NABA_CORE_MATRISOME"
205,"Down",0.00614848379165869,0.0762218988432307,"L.PvsV.SENESE_HDAC2_TARGETS_DN"
73,"Down",0.00617284135701557,0.0763526618857697,"L.PvsV.ZWANG_CLASS_2_TRANSIENTLY_INDUCED_BY_EGF"
49,"Down",0.00619416934411419,0.0763843244261641,"L.PvsV.REACTOME_RUNX2_REGULATES_OSTEOBLAST_DIFFERENTIATION"
409,"Down",0.00621104191353841,0.0763843244261641,"L.PvsV.CHEN_HOXA5_TARGETS_9HR_UP"
68,"Down",0.00621684680625319,0.0763843244261641,"L.PvsV.CASORELLI_APL_SECONDARY_VS_DE_NOVO_UP"
19,"Up",0.00624374309779588,0.0765446908818479,"L.PvsV.REACTOME_ACTIVATION_OF_IRF3_IRF7_MEDIATED_BY_TBK1_IKK_EPSILON"
43,"Up",0.00630870469073418,0.0771699739713922,"L.PvsV.KEGG_BUTANOATE_METABOLISM"
17,"Down",0.00632378982971458,0.0771837394447946,"L.PvsV.TURASHVILI_BREAST_NORMAL_DUCTAL_VS_LOBULAR_DN"
71,"Down",0.00634484374199317,0.0772701344702207,"L.PvsV.BEIER_GLIOMA_STEM_CELL_UP"
85,"Down",0.00637633173399827,0.0773768153322073,"L.PvsV.GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN"
251,"Down",0.00638159301708926,0.0773768153322073,"L.PvsV.ONDER_CDH1_TARGETS_1_UP"
51,"Down",0.00643058819563344,0.0778002672508912,"L.PvsV.PID_EPHRINB_REV_PATHWAY"
19,"Down",0.00649644815485005,0.078365764865204,"L.PvsV.BIOCARTA_SHH_PATHWAY"
13,"Up",0.00650567662744233,0.078365764865204,"L.PvsV.REACTOME_GAP_JUNCTION_DEGRADATION"
84,"Up",0.00652919904374763,0.0784781337236536,"L.PvsV.REACTOME_ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S"
31,"Down",0.00654612342463539,0.0785108815939459,"L.PvsV.REACTOME_RECYCLING_OF_BILE_ACIDS_AND_SALTS"
14,"Up",0.00656292525796454,0.0785420211066795,"L.PvsV.REACTOME_IRAK4_DEFICIENCY_TLR2_4"
829,"Down",0.00658789251700109,0.0786705350464341,"L.PvsV.LIU_PROSTATE_CANCER_DN"
330,"Down",0.00666379348513605,0.0792670962042039,"L.PvsV.TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP"
46,"Up",0.00666883102554327,0.0792670962042039,"L.PvsV.REACTOME_SYNTHESIS_OF_ACTIVE_UBIQUITIN_ROLES_OF_E1_AND_E2_ENZYMES"
112,"Down",0.00668085853339826,0.0792670962042039,"L.PvsV.TANG_SENESCENCE_TP53_TARGETS_DN"
16,"Up",0.00671994094998086,0.0795600717611225,"L.PvsV.REACTOME_UPTAKE_AND_FUNCTION_OF_ANTHRAX_TOXINS"
49,"Down",0.00674998330272745,0.0796201190691872,"L.PvsV.UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN"
29,"Up",0.006753813681217,0.0796201190691872,"L.PvsV.HORTON_SREBF_TARGETS"
22,"Down",0.00679460332169575,0.0799305569482038,"L.PvsV.ZEILSTRA_CD44_TARGETS_UP"
762,"Down",0.00682294983621692,0.0799743280098632,"L.PvsV.LIM_MAMMARY_STEM_CELL_UP"
25,"Down",0.00682725317790838,0.0799743280098632,"L.PvsV.LEE_LIVER_CANCER_HEPATOBLAST"
8,"Down",0.00689949567842254,0.0806441014164544,"L.PvsV.SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX6_DN"
365,"Down",0.00691360174921313,0.0806441014164544,"L.PvsV.PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP"
204,"Down",0.00700466635055181,0.0815150207487745,"L.PvsV.SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_DN"
16,"Down",0.00701775183150961,0.0815150207487745,"L.PvsV.REACTOME_ACTIVATED_NTRK2_SIGNALS_THROUGH_FYN"
296,"Up",0.00706844946837428,0.0819317759132943,"L.PvsV.REACTOME_HIV_INFECTION"
35,"Down",0.00711390670416806,0.082046931543233,"L.PvsV.KANNAN_TP53_TARGETS_DN"
346,"Down",0.00712553204683278,0.082046931543233,"L.PvsV.FISCHER_G2_M_CELL_CYCLE"
473,"Down",0.00713577824561494,0.082046931543233,"L.PvsV.DURAND_STROMA_S_UP"
99,"Down",0.00713774173852326,0.082046931543233,"L.PvsV.REACTOME_ECM_PROTEOGLYCANS"
48,"Down",0.00725986731197519,0.0832776065724291,"L.PvsV.REACTOME_EPHA_MEDIATED_GROWTH_CONE_COLLAPSE"
990,"Up",0.00730815658698894,0.0836579663964014,"L.PvsV.REACTOME_VESICLE_MEDIATED_TRANSPORT"
21,"Down",0.00733994742213411,0.0837966361471428,"L.PvsV.NIKOLSKY_BREAST_CANCER_7P15_AMPLICON"
11,"Up",0.00735628139302485,0.0837966361471428,"L.PvsV.REACTOME_BIOTIN_TRANSPORT_AND_METABOLISM"
130,"Up",0.00736573795758933,0.0837966361471428,"L.PvsV.REACTOME_PROTEIN_UBIQUITINATION"
335,"Down",0.00742892075116571,0.0843418949346924,"L.PvsV.KOBAYASHI_EGFR_SIGNALING_24HR_DN"
28,"Up",0.00746775221043897,0.0846090204334367,"L.PvsV.TOMLINS_METASTASIS_DN"
33,"Up",0.00752527297801178,0.085086368702305,"L.PvsV.KUROKAWA_LIVER_CANCER_EARLY_RECURRENCE_DN"
20,"Down",0.00760033156492985,0.0857596596377493,"L.PvsV.REACTOME_LAGGING_STRAND_SYNTHESIS"
113,"Down",0.00769721020757529,0.086675916981026,"L.PvsV.BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_UP"
201,"Down",0.00773775455701422,0.0869553759059586,"L.PvsV.CHENG_IMPRINTED_BY_ESTRADIOL"
99,"Down",0.00776766756033488,0.0871144704687455,"L.PvsV.REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS"
11,"Up",0.00782887360966793,0.0876119917465408,"L.PvsV.HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_DN"
738,"Down",0.0078437214531629,0.0876119917465408,"L.PvsV.CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN"
59,"Up",0.00797721319688667,0.0889234108177146,"L.PvsV.WENG_POR_TARGETS_GLOBAL_DN"
67,"Down",0.00800416165462289,0.0890131740742373,"L.PvsV.NAKAMURA_METASTASIS"
8,"Down",0.00802381357047535,0.0890131740742373,"L.PvsV.REACTOME_SIGNALING_BY_NOTCH1_T_7_9_NOTCH1_M1580_K2555_TRANSLOCATION_MUTANT"
64,"Down",0.00803356372997729,0.0890131740742373,"L.PvsV.SCHOEN_NFKB_SIGNALING"
21,"Up",0.00807039629683774,0.0891577078950305,"L.PvsV.REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_METHYLATION"
385,"Down",0.00807885904420515,0.0891577078950305,"L.PvsV.BROWNE_HCMV_INFECTION_48HR_UP"
94,"Down",0.00813749991845345,0.0895750126648833,"L.PvsV.MAYBURD_RESPONSE_TO_L663536_DN"
66,"Down",0.0081490742214571,0.0895750126648833,"L.PvsV.REACTOME_SIGNALING_BY_NOTCH1_PEST_DOMAIN_MUTANTS_IN_CANCER"
51,"Up",0.00821098976907475,0.0900765127643141,"L.PvsV.KEGG_AMINO_SUGAR_AND_NUCLEOTIDE_SUGAR_METABOLISM"
49,"Down",0.008236435119288,0.0901767322268186,"L.PvsV.LU_TUMOR_ENDOTHELIAL_MARKERS_UP"
29,"Up",0.00828542512757129,0.0903669821942158,"L.PvsV.REACTOME_CONSTITUTIVE_SIGNALING_BY_AKT1_E17K_IN_CANCER"
32,"Down",0.00828650026631713,0.0903669821942158,"L.PvsV.REACTOME_DNA_STRAND_ELONGATION"
144,"Down",0.00834978562276117,0.0907953601058784,"L.PvsV.REACTOME_ANCHORING_OF_THE_BASAL_BODY_TO_THE_PLASMA_MEMBRANE"
20,"Up",0.00837489551325413,0.0907953601058784,"L.PvsV.REACTOME_RETROGRADE_NEUROTROPHIN_SIGNALLING"
15,"Down",0.00837504678133441,0.0907953601058784,"L.PvsV.KEGG_GLYCOSPHINGOLIPID_BIOSYNTHESIS_GLOBO_SERIES"
140,"Up",0.00858168358566252,0.0928124107239886,"L.PvsV.REACTOME_GLYCEROPHOSPHOLIPID_BIOSYNTHESIS"
361,"Down",0.00859467431555112,0.0928124107239886,"L.PvsV.MARKEY_RB1_ACUTE_LOF_UP"
157,"Down",0.00863190868749089,0.0930256830798538,"L.PvsV.WILCOX_RESPONSE_TO_PROGESTERONE_DN"
664,"Down",0.00864807399223094,0.0930256830798538,"L.PvsV.PUJANA_BRCA2_PCC_NETWORK"
67,"Down",0.00872015231697834,0.0935139186837492,"L.PvsV.PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_UP"
49,"Down",0.00872728920976932,0.0935139186837492,"L.PvsV.VERRECCHIA_RESPONSE_TO_TGFB1_C5"
15,"Down",0.00874434751976348,0.093515468929927,"L.PvsV.REACTOME_PROCESSIVE_SYNTHESIS_ON_THE_LAGGING_STRAND"
40,"Down",0.00879826149719757,0.0939104011930605,"L.PvsV.RIZ_ERYTHROID_DIFFERENTIATION_HEMGN"
19,"Down",0.00890387986218208,0.0948546276647489,"L.PvsV.REACTOME_TRANSPORT_OF_ORGANIC_ANIONS"
8,"Up",0.00900017618751638,0.0956961041168809,"L.PvsV.REACTOME_UBIQUINOL_BIOSYNTHESIS"
177,"Up",0.00907006863560539,0.0960972871940251,"L.PvsV.JAZAG_TGFB1_SIGNALING_UP"
33,"Down",0.0090906844977821,0.0960972871940251,"L.PvsV.HAEGERSTRAND_RESPONSE_TO_IMATINIB"
12,"Down",0.00909869295526239,0.0960972871940251,"L.PvsV.MIZUKAMI_HYPOXIA_DN"
7,"Down",0.00912547633779421,0.0960972871940251,"L.PvsV.REACTOME_TELOMERE_C_STRAND_SYNTHESIS_INITIATION"
9,"Up",0.00914489781288962,0.0960972871940251,"L.PvsV.REACTOME_DEFECTS_IN_BIOTIN_BTN_METABOLISM"
459,"Down",0.00919903627329733,0.0960972871940251,"L.PvsV.LU_AGING_BRAIN_UP"
31,"Down",0.00920023795723057,0.0960972871940251,"L.PvsV.REICHERT_MITOSIS_LIN9_TARGETS"
77,"Down",0.00921115420415714,0.0960972871940251,"L.PvsV.TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP"
46,"Down",0.00922691708244856,0.0960972871940251,"L.PvsV.BOWIE_RESPONSE_TO_EXTRACELLULAR_MATRIX"
17,"Up",0.00923314321908202,0.0960972871940251,"L.PvsV.REACTOME_FORMYL_PEPTIDE_RECEPTORS_BIND_FORMYL_PEPTIDES_AND_MANY_OTHER_LIGANDS"
91,"Down",0.00923421217565402,0.0960972871940251,"L.PvsV.MASSARWEH_RESPONSE_TO_ESTRADIOL"
6,"Up",0.00924647436918454,0.0960972871940251,"L.PvsV.REACTOME_MITOCHONDRIAL_FATTY_ACID_BETA_OXIDATION_OF_UNSATURATED_FATTY_ACIDS"
117,"Up",0.00927830513628188,0.0962471840497233,"L.PvsV.TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_UP"
262,"Down",0.00930896224238626,0.0963843674871791,"L.PvsV.CAIRO_LIVER_DEVELOPMENT_UP"
42,"Up",0.00934450775159366,0.0965715576795539,"L.PvsV.TERAO_AOX4_TARGETS_HG_UP"
233,"Down",0.00937922128327008,0.0967494673044782,"L.PvsV.CHEBOTAEV_GR_TARGETS_DN"
32,"Down",0.00941373322766568,0.0969246387630606,"L.PvsV.XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_UP"
325,"Up",0.00950008445568274,0.0976319088391633,"L.PvsV.REACTOME_DEUBIQUITINATION"
105,"Down",0.00965685249800765,0.0990588821177816,"L.PvsV.LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_DN"
26,"Down",0.00968463392947692,0.0991598248113328,"L.PvsV.WIKMAN_ASBESTOS_LUNG_CANCER_UP"
34,"Down",0.00970256198642269,0.0991598248113328,"L.PvsV.BYSTRYKH_HEMATOPOIESIS_STEM_CELL_IL3RA"
68,"Down",0.00974794620061935,0.0993709363288019,"L.PvsV.PID_FANCONI_PATHWAY"
181,"Down",0.00977447907754016,0.0993709363288019,"L.PvsV.MISSIAGLIA_REGULATED_BY_METHYLATION_DN"
269,"Up",0.00977713679921654,0.0993709363288019,"L.PvsV.CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN"
162,"Down",0.00987624483166068,0.0999908450752694,"L.PvsV.ZHAN_MULTIPLE_MYELOMA_UP"
863,"Down",0.00988748118671209,0.0999908450752694,"L.PvsV.CHICAS_RB1_TARGETS_SENESCENT"
1893,"Up",0.00989238420259945,0.0999908450752694,"L.PvsV.DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_UP"
5,"Up",0.00994423483183811,0.10033152260079,"L.PvsV.REACTOME_PROPIONYL_COA_CATABOLISM"
97,"Down",0.0101046376662901,0.101764192453403,"L.PvsV.BROWNE_HCMV_INFECTION_30MIN_UP"
124,"Down",0.0101492373722875,0.102027515329777,"L.PvsV.FONTAINE_FOLLICULAR_THYROID_ADENOMA_UP"
260,"Down",0.0102194518304785,0.102407749845837,"L.PvsV.SCHLOSSER_SERUM_RESPONSE_UP"
167,"Down",0.0102241052477667,0.102407749845837,"L.PvsV.KONG_E2F3_TARGETS"
1160,"Down",0.0102611894235268,0.102593338739023,"L.PvsV.WONG_ADULT_TISSUE_STEM_MODULE"
321,"Down",0.0103140575767216,0.102935784010277,"L.PvsV.WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN"
12,"Up",0.0103403238614205,0.102954934509209,"L.PvsV.REACTOME_REGULATION_OF_GENE_EXPRESSION_BY_HYPOXIA_INDUCIBLE_FACTOR"
96,"Down",0.0103752527197718,0.102954934509209,"L.PvsV.REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS"
27,"Down",0.0103785471223134,0.102954934509209,"L.PvsV.GRANDVAUX_IFN_RESPONSE_NOT_VIA_IRF3"
103,"Up",0.0103904600210054,0.102954934509209,"L.PvsV.PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_UP"
24,"Up",0.0104422180488161,0.103282689788738,"L.PvsV.REACTOME_ER_QUALITY_CONTROL_COMPARTMENT_ERQC"
11,"Down",0.0105870117601154,0.104527835752996,"L.PvsV.KALMA_E2F1_TARGETS"
347,"Up",0.0106071734998641,0.104540217969249,"L.PvsV.BLUM_RESPONSE_TO_SALIRASIB_UP"
417,"Up",0.0106717496679022,0.104989508743472,"L.PvsV.PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_UP"
26,"Up",0.0107640549863679,0.105581004339429,"L.PvsV.NAM_FXYD5_TARGETS_DN"
9,"Up",0.0107700644686992,0.105581004339429,"L.PvsV.BIOCARTA_IRES_PATHWAY"
27,"Down",0.0108478359193464,0.106155194332861,"L.PvsV.KAMIKUBO_MYELOID_MN1_NETWORK"
36,"Down",0.0108729136448861,0.106212614032819,"L.PvsV.REACTOME_SIGNAL_TRANSDUCTION_BY_L1"
73,"Down",0.0109238052468676,0.106521550634799,"L.PvsV.SCHLESINGER_H3K27ME3_IN_NORMAL_AND_METHYLATED_IN_CANCER"
46,"Down",0.0110876427899204,0.107928832720898,"L.PvsV.PLASARI_TGFB1_TARGETS_1HR_UP"
52,"Down",0.0111924484636518,0.108588915846589,"L.PvsV.HUMMERICH_BENIGN_SKIN_TUMOR_DN"
87,"Down",0.0111947335924319,0.108588915846589,"L.PvsV.EBAUER_MYOGENIC_TARGETS_OF_PAX3_FOXO1_FUSION"
625,"Down",0.0112759779647155,0.109185432866746,"L.PvsV.CUI_TCF21_TARGETS_2_UP"
45,"Down",0.0112960286422791,0.109188360774757,"L.PvsV.REACTOME_EXTENSION_OF_TELOMERES"
17,"Up",0.0113807805628918,0.109815594646124,"L.PvsV.NIKOLSKY_BREAST_CANCER_14Q22_AMPLICON"
116,"Up",0.0114769856361731,0.110550964429271,"L.PvsV.REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX3"
493,"Down",0.0115582599336145,0.110672837520625,"L.PvsV.CHANDRAN_METASTASIS_DN"
162,"Down",0.0115648907716572,0.110672837520625,"L.PvsV.HOSHIDA_LIVER_CANCER_SURVIVAL_UP"
7,"Down",0.0115688062755879,0.110672837520625,"L.PvsV.REACTOME_LTC4_CYSLTR_MEDIATED_IL4_PRODUCTION"
59,"Down",0.0115697052065331,0.110672837520625,"L.PvsV.YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_5"
15,"Down",0.0118244231162843,0.112874442950671,"L.PvsV.KOMMAGANI_TP63_GAMMA_TARGETS"
846,"Down",0.0118406903438939,0.112874442950671,"L.PvsV.SMID_BREAST_CANCER_NORMAL_LIKE_UP"
53,"Down",0.0118820465942798,0.112982016960471,"L.PvsV.REACTOME_SYNDECAN_INTERACTIONS"
20,"Up",0.0119219994598453,0.112982016960471,"L.PvsV.MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_UP"
77,"Down",0.0119239293054266,0.112982016960471,"L.PvsV.SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_DN"
117,"Down",0.0119428934123723,0.112982016960471,"L.PvsV.TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_DN"
46,"Up",0.0119680777457891,0.112982016960471,"L.PvsV.PID_PI3KCI_AKT_PATHWAY"
27,"Up",0.011974581649274,0.112982016960471,"L.PvsV.JIANG_HYPOXIA_VIA_VHL"
82,"Up",0.0120190901293238,0.113208772274329,"L.PvsV.REACTOME_THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT"
1318,"Down",0.0120466895752297,0.113214168434898,"L.PvsV.GOZGIT_ESR1_TARGETS_DN"
27,"Down",0.0120606158813809,0.113214168434898,"L.PvsV.TSAI_DNAJB4_TARGETS_UP"
84,"Down",0.0121274711700102,0.113570999276491,"L.PvsV.LEIN_ASTROCYTE_MARKERS"
58,"Up",0.0121511257551422,0.113570999276491,"L.PvsV.WANG_RESPONSE_TO_ANDROGEN_UP"
15,"Down",0.0121602516859618,0.113570999276491,"L.PvsV.BIOCARTA_SODD_PATHWAY"
19,"Down",0.01228840027884,0.114485745446638,"L.PvsV.LU_TUMOR_VASCULATURE_DN"
11,"Down",0.0122996080295357,0.114485745446638,"L.PvsV.REACTOME_MISSPLICED_LRP5_MUTANTS_HAVE_ENHANCED_BETA_CATENIN_DEPENDENT_SIGNALING"
121,"Up",0.0124121501426242,0.115316649069519,"L.PvsV.REACTOME_UNFOLDED_PROTEIN_RESPONSE_UPR"
36,"Down",0.0124305883243685,0.115316649069519,"L.PvsV.UROSEVIC_RESPONSE_TO_IMIQUIMOD"
24,"Down",0.0124849229916794,0.115626698862639,"L.PvsV.RAY_TARGETS_OF_P210_BCR_ABL_FUSION_DN"
25,"Down",0.0125083350557314,0.115649806894881,"L.PvsV.BIOCARTA_CELLCYCLE_PATHWAY"
28,"Down",0.0125746743943224,0.115701822528763,"L.PvsV.SEKI_INFLAMMATORY_RESPONSE_LPS_DN"
249,"Up",0.0125827805649929,0.115701822528763,"L.PvsV.RAMALHO_STEMNESS_UP"
237,"Down",0.0125850238094324,0.115701822528763,"L.PvsV.MIKKELSEN_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3"
200,"Down",0.0125976663342947,0.115701822528763,"L.PvsV.GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_UP"
14,"Up",0.0126488537680535,0.115979291017525,"L.PvsV.REACTOME_LYSINE_CATABOLISM"
153,"Down",0.0127264014296276,0.116497141563594,"L.PvsV.HUANG_DASATINIB_RESISTANCE_UP"
343,"Down",0.0127654141364057,0.116661115306094,"L.PvsV.GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP"
330,"Down",0.0127922389030026,0.116713348011058,"L.PvsV.TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP"
99,"Up",0.0128452231696726,0.11700368847631,"L.PvsV.REACTOME_SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE"
61,"Down",0.0129524891737801,0.117786698424063,"L.PvsV.LIU_CDX2_TARGETS_UP"
70,"Up",0.0129832529577623,0.117807562303172,"L.PvsV.KEGG_GLYCOLYSIS_GLUCONEOGENESIS"
18,"Down",0.012997397902864,0.117807562303172,"L.PvsV.RANKIN_ANGIOGENIC_TARGETS_OF_VHL_HIF2A_DN"
44,"Down",0.0130451510328334,0.118046874076164,"L.PvsV.MACLACHLAN_BRCA1_TARGETS_DN"
69,"Down",0.0131067893517571,0.118266413703489,"L.PvsV.REACTOME_HDR_THROUGH_HOMOLOGOUS_RECOMBINATION_HRR"
37,"Down",0.0131121923675599,0.118266413703489,"L.PvsV.SINGH_NFE2L2_TARGETS"
21,"Down",0.01321166827771,0.118873081303335,"L.PvsV.WHITESIDE_CISPLATIN_RESISTANCE_UP"
92,"Down",0.0132224534276634,0.118873081303335,"L.PvsV.VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1"
29,"Down",0.0132546907996631,0.118969456869054,"L.PvsV.SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_2FC_DN"
31,"Down",0.0132885461403681,0.11908001881701,"L.PvsV.INAMURA_LUNG_CANCER_SCC_UP"
425,"Down",0.0133368010083085,0.119218634469295,"L.PvsV.PLASARI_TGFB1_TARGETS_10HR_DN"
39,"Up",0.0133471395797601,0.119218634469295,"L.PvsV.REACTOME_TRIGLYCERIDE_METABOLISM"
14,"Up",0.0134486190423011,0.119931314007875,"L.PvsV.REACTOME_DEFECTS_IN_COBALAMIN_B12_METABOLISM"
9,"Up",0.0134783524844175,0.119975592663655,"L.PvsV.BIOCARTA_PARKIN_PATHWAY"
81,"Down",0.0134969829330428,0.119975592663655,"L.PvsV.TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP"
88,"Up",0.0135723646627107,0.120452013194426,"L.PvsV.REACTOME_DNA_REPLICATION_PRE_INITIATION"
27,"Down",0.0136117497955456,0.120607956121108,"L.PvsV.CHEMELLO_SOLEUS_VS_EDL_MYOFIBERS_UP"
59,"Down",0.0136590133438077,0.12083309564466,"L.PvsV.PID_RHOA_REG_PATHWAY"
171,"Up",0.0137437655085716,0.121388625394396,"L.PvsV.LIU_NASOPHARYNGEAL_CARCINOMA"
105,"Down",0.0138296056746465,0.121951977312792,"L.PvsV.REACTOME_TELOMERE_MAINTENANCE"
89,"Down",0.0139110151996625,0.122474527132061,"L.PvsV.LINDGREN_BLADDER_CANCER_HIGH_RECURRENCE"
330,"Down",0.013979749702545,0.122488644266657,"L.PvsV.SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4"
17,"Up",0.0139800766370964,0.122488644266657,"L.PvsV.PARK_APL_PATHOGENESIS_UP"
11,"Down",0.0139979399711615,0.122488644266657,"L.PvsV.RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_MAPK1_UP"
31,"Down",0.0140219051118926,0.122488644266657,"L.PvsV.BIOCARTA_AMI_PATHWAY"
56,"Up",0.0140233879220101,0.122488644266657,"L.PvsV.BARRIER_COLON_CANCER_RECURRENCE_UP"
21,"Down",0.0141206122599234,0.123143320481256,"L.PvsV.NIKOLSKY_BREAST_CANCER_21Q22_AMPLICON"
9,"Down",0.0141712753498458,0.123390521904405,"L.PvsV.REACTOME_IRS_ACTIVATION"
8,"Up",0.0142536294141368,0.123746288073685,"L.PvsV.REACTOME_TRNA_MODIFICATION_IN_THE_MITOCHONDRION"
6,"Up",0.0142568973599091,0.123746288073685,"L.PvsV.MIKI_COEXPRESSED_WITH_CYP19A1"
109,"Up",0.0143031444848239,0.123953112627886,"L.PvsV.REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS"
43,"Down",0.0143340696455467,0.124026715289871,"L.PvsV.WEST_ADRENOCORTICAL_TUMOR_MARKERS_DN"
13,"Down",0.0143606521501672,0.124062571466054,"L.PvsV.MIKKELSEN_NPC_WITH_LCP_H3K27ME3"
11,"Up",0.0144200313763979,0.12438120667723,"L.PvsV.KIM_RESPONSE_TO_TSA_AND_DECITABINE_DN"
26,"Down",0.0145356835618662,0.124649375859702,"L.PvsV.MATZUK_EMBRYONIC_GERM_CELL"
157,"Down",0.0145428325837461,0.124649375859702,"L.PvsV.MORI_LARGE_PRE_BII_LYMPHOCYTE_UP"
127,"Down",0.0145671937038904,0.124649375859702,"L.PvsV.HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_DN"
17,"Down",0.0145766400464582,0.124649375859702,"L.PvsV.REACTOME_NOTCH4_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS"
34,"Down",0.0145856788725014,0.124649375859702,"L.PvsV.ZHU_SKIL_TARGETS_UP"
388,"Down",0.0145863892532515,0.124649375859702,"L.PvsV.PEREZ_TP53_AND_TP63_TARGETS"
17,"Up",0.0147988511307964,0.126110818668714,"L.PvsV.REACTOME_IRAK1_RECRUITS_IKK_COMPLEX"
298,"Down",0.0148030242929997,0.126110818668714,"L.PvsV.VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP"
161,"Down",0.0148733252425181,0.126514792716743,"L.PvsV.REACTOME_CARDIAC_CONDUCTION"
6,"Down",0.0149312495171815,0.126685063090929,"L.PvsV.BIOCARTA_BOTULIN_PATHWAY"
13,"Down",0.0149391682284836,0.126685063090929,"L.PvsV.WANG_ESOPHAGUS_CANCER_PROGRESSION_UP"
14,"Down",0.0150074473057681,0.127069182471044,"L.PvsV.TAKADA_GASTRIC_CANCER_COPY_NUMBER_UP"
8,"Down",0.0150429094850675,0.127174688903575,"L.PvsV.REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_INTERLEUKIN_SIGNALING"
413,"Down",0.0151195509952684,0.127627477027235,"L.PvsV.ZHENG_GLIOBLASTOMA_PLASTICITY_UP"
11,"Up",0.0151592401592646,0.127767437256972,"L.PvsV.MIZUSHIMA_AUTOPHAGOSOME_FORMATION"
256,"Down",0.015199328605798,0.127910331600391,"L.PvsV.MEISSNER_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3"
345,"Down",0.0152661549865881,0.128112035563997,"L.PvsV.IVANOVA_HEMATOPOIESIS_STEM_CELL"
9,"Up",0.0152696385307784,0.128112035563997,"L.PvsV.REACTOME_MODULATION_BY_MTB_OF_HOST_IMMUNE_SYSTEM"
42,"Up",0.0153612196727629,0.128670859821256,"L.PvsV.REACTOME_RAF_ACTIVATION"
36,"Up",0.0153827886311901,0.128670859821256,"L.PvsV.KEGG_SNARE_INTERACTIONS_IN_VESICULAR_TRANSPORT"
250,"Down",0.0154592387968546,0.129033945120239,"L.PvsV.TAVAZOIE_METASTASIS"
258,"Up",0.0154931769705215,0.129033945120239,"L.PvsV.REACTOME_FATTY_ACID_METABOLISM"
72,"Down",0.0155165855995243,0.129033945120239,"L.PvsV.ALONSO_METASTASIS_EMT_UP"
209,"Down",0.01552781946109,0.129033945120239,"L.PvsV.NABA_ECM_GLYCOPROTEINS"
81,"Down",0.0155428843281026,0.129033945120239,"L.PvsV.LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN"
145,"Up",0.0155788467263252,0.129138596026765,"L.PvsV.SASSON_RESPONSE_TO_FORSKOLIN_UP"
51,"Up",0.0156905325790751,0.129457914898935,"L.PvsV.JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_UP"
52,"Down",0.0157010289480972,0.129457914898935,"L.PvsV.SANCHEZ_MDM2_TARGETS"
38,"Down",0.0157069270622134,0.129457914898935,"L.PvsV.MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP"
174,"Up",0.0157110256641681,0.129457914898935,"L.PvsV.KARLSSON_TGFB1_TARGETS_UP"
79,"Down",0.0157585333488025,0.129656147151085,"L.PvsV.BURTON_ADIPOGENESIS_PEAK_AT_2HR"
16,"Up",0.0158118727797384,0.129723668592955,"L.PvsV.REACTOME_TICAM1_DEPENDENT_ACTIVATION_OF_IRF3_IRF7"
21,"Up",0.0158211709373471,0.129723668592955,"L.PvsV.FARMER_BREAST_CANCER_CLUSTER_3"
17,"Down",0.0158824095786543,0.129723668592955,"L.PvsV.BIOCARTA_DREAM_PATHWAY"
31,"Down",0.0158835172488747,0.129723668592955,"L.PvsV.TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_TOP20_UP"
46,"Up",0.0158840520234094,0.129723668592955,"L.PvsV.REACTOME_NOD1_2_SIGNALING_PATHWAY"
31,"Up",0.0160011960132115,0.130487629435172,"L.PvsV.BIOCARTA_AKT_PATHWAY"
82,"Down",0.0160462478836223,0.13066230419521,"L.PvsV.HALMOS_CEBPA_TARGETS_UP"
23,"Down",0.016231916552038,0.13197980384738,"L.PvsV.LIU_IL13_PRIMING_MODEL"
266,"Down",0.0163085094821033,0.132407854517693,"L.PvsV.PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_DN"
86,"Down",0.0163527376828241,0.132454162738952,"L.PvsV.CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_DN"
31,"Down",0.0163621257281071,0.132454162738952,"L.PvsV.FERRARI_RESPONSE_TO_FENRETINIDE_UP"
24,"Down",0.0164599320330777,0.133034060472563,"L.PvsV.REACTOME_BBSOME_MEDIATED_CARGO_TARGETING_TO_CILIUM"
165,"Down",0.0164818830572808,0.133034060472563,"L.PvsV.MALONEY_RESPONSE_TO_17AAG_DN"
99,"Down",0.0165510466377581,0.133375632048534,"L.PvsV.BOYLAN_MULTIPLE_MYELOMA_C_DN"
29,"Down",0.0165724469555694,0.133375632048534,"L.PvsV.YAN_ESCAPE_FROM_ANOIKIS"
43,"Up",0.0167520237944447,0.134624912150414,"L.PvsV.DISTECHE_ESCAPED_FROM_X_INACTIVATION"
11,"Down",0.0168232429022686,0.134972597481835,"L.PvsV.REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_DIFFERENTIATION_OF_MYELOID_CELLS"
24,"Down",0.0168441114600228,0.134972597481835,"L.PvsV.LOPEZ_MESOTELIOMA_SURVIVAL_TIME_UP"
1622,"Down",0.016891915222992,0.135159767392074,"L.PvsV.BENPORATH_ES_WITH_H3K27ME3"
284,"Down",0.016924079406936,0.135221437920447,"L.PvsV.ANDERSEN_CHOLANGIOCARCINOMA_CLASS2"
25,"Down",0.0169937959055253,0.135560838047006,"L.PvsV.REACTOME_NITRIC_OXIDE_STIMULATES_GUANYLATE_CYCLASE"
15,"Down",0.0170263333470166,0.135560838047006,"L.PvsV.NEBEN_AML_WITH_FLT3_OR_NRAS_UP"
17,"Up",0.0170401125778023,0.135560838047006,"L.PvsV.KEGG_TERPENOID_BACKBONE_BIOSYNTHESIS"
60,"Down",0.0172090344932139,0.136522664202053,"L.PvsV.LU_TUMOR_VASCULATURE_UP"
18,"Down",0.0172284647389738,0.136522664202053,"L.PvsV.REACTOME_RUNX3_REGULATES_P14_ARF"
191,"Down",0.0172350912666003,0.136522664202053,"L.PvsV.ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP"
197,"Down",0.0172858464438135,0.1367288197251,"L.PvsV.GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_UP"
46,"Down",0.0173309941323922,0.136890095082852,"L.PvsV.CLIMENT_BREAST_CANCER_COPY_NUMBER_UP"
33,"Down",0.0173837308274399,0.137110767111149,"L.PvsV.FIGUEROA_AML_METHYLATION_CLUSTER_4_DN"
85,"Down",0.0174662071580175,0.137452430451911,"L.PvsV.SASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION"
32,"Down",0.0174767695076313,0.137452430451911,"L.PvsV.REACTOME_RHO_GTPASES_ACTIVATE_CIT"
317,"Down",0.0175678575070145,0.137717525947506,"L.PvsV.WU_CELL_MIGRATION"
25,"Up",0.0175718488575926,0.137717525947506,"L.PvsV.REACTOME_SYNTHESIS_OF_VERY_LONG_CHAIN_FATTY_ACYL_COAS"
83,"Up",0.0175916359282041,0.137717525947506,"L.PvsV.MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_DN"
24,"Down",0.017622080231178,0.137717525947506,"L.PvsV.INAMURA_LUNG_CANCER_SCC_DN"
133,"Up",0.0176350168874722,0.137717525947506,"L.PvsV.GAVIN_FOXP3_TARGETS_CLUSTER_T7"
837,"Down",0.0177771015306254,0.13851778075362,"L.PvsV.GRYDER_PAX3FOXO1_ENHANCERS_KO_DOWN"
41,"Down",0.017787597094424,0.13851778075362,"L.PvsV.LU_TUMOR_ANGIOGENESIS_UP"
945,"Up",0.017860461741076,0.138793716790468,"L.PvsV.KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_UP"
188,"Up",0.017883742009276,0.138793716790468,"L.PvsV.WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_UP"
23,"Down",0.0178983396765425,0.138793716790468,"L.PvsV.SARTIPY_BLUNTED_BY_INSULIN_RESISTANCE_DN"
160,"Up",0.0179408355336153,0.13892840289266,"L.PvsV.REACTOME_EUKARYOTIC_TRANSLATION_INITIATION"
59,"Down",0.0179781887957445,0.139022945247093,"L.PvsV.REACTOME_HSF1_ACTIVATION"
632,"Down",0.0182201922639301,0.140697546127472,"L.PvsV.ZHOU_INFLAMMATORY_RESPONSE_LIVE_DN"
289,"Up",0.0183148486908578,0.141178350500052,"L.PvsV.BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_DN"
40,"Up",0.0183584449839142,0.141178350500052,"L.PvsV.KEGG_FRUCTOSE_AND_MANNOSE_METABOLISM"
779,"Down",0.0184037254270197,0.141178350500052,"L.PvsV.MIKKELSEN_NPC_ICP_WITH_H3K4ME3"
13,"Down",0.0184043051648179,0.141178350500052,"L.PvsV.REACTOME_PROCESSIVE_SYNTHESIS_ON_THE_C_STRAND_OF_THE_TELOMERE"
30,"Up",0.0184101267336838,0.141178350500052,"L.PvsV.IIZUKA_LIVER_CANCER_PROGRESSION_L1_G1_UP"
269,"Down",0.0184423333188172,0.141229447257258,"L.PvsV.LEE_NEURAL_CREST_STEM_CELL_UP"
975,"Down",0.0184897734446213,0.141396898167788,"L.PvsV.BENPORATH_PRC2_TARGETS"
80,"Down",0.0185531416695932,0.141660275761365,"L.PvsV.MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_6"
94,"Down",0.0185754566697395,0.141660275761365,"L.PvsV.SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_DN"
89,"Down",0.0186531976337125,0.142057203466662,"L.PvsV.ROY_WOUND_BLOOD_VESSEL_UP"
254,"Down",0.0186990975614819,0.14221088090431,"L.PvsV.CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_DN"
18,"Up",0.0187693434635993,0.142549038475605,"L.PvsV.REACTOME_PROCESSING_OF_SMDT1"
96,"Up",0.0188101177903435,0.142641417866975,"L.PvsV.REACTOME_APC_C_MEDIATED_DEGRADATION_OF_CELL_CYCLE_PROTEINS"
317,"Down",0.0188331045474574,0.142641417866975,"L.PvsV.FISCHER_G1_S_CELL_CYCLE"
26,"Up",0.0189088501268924,0.143019196103403,"L.PvsV.BIOCARTA_PTEN_PATHWAY"
80,"Down",0.0189682692302955,0.143175123668885,"L.PvsV.KERLEY_RESPONSE_TO_CISPLATIN_UP"
49,"Up",0.0190001659258945,0.143175123668885,"L.PvsV.DORSAM_HOXA9_TARGETS_DN"
49,"Down",0.0190529290002052,0.143175123668885,"L.PvsV.YU_MYC_TARGETS_UP"
78,"Down",0.0190563450335597,0.143175123668885,"L.PvsV.SONG_TARGETS_OF_IE86_CMV_PROTEIN"
323,"Down",0.0190589421270211,0.143175123668885,"L.PvsV.VILLANUEVA_LIVER_CANCER_KRT19_UP"
46,"Up",0.0191375288496814,0.143570416567012,"L.PvsV.REACTOME_DETOXIFICATION_OF_REACTIVE_OXYGEN_SPECIES"
701,"Down",0.0191898133029502,0.14361963922413,"L.PvsV.SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN"
246,"Down",0.0191960414879059,0.14361963922413,"L.PvsV.REACTOME_MUSCLE_CONTRACTION"
160,"Up",0.0193574179950217,0.144631302830372,"L.PvsV.REACTOME_PTEN_REGULATION"
28,"Down",0.0194514851007721,0.145138004213453,"L.PvsV.REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS"
450,"Down",0.0194829533742841,0.145176885722934,"L.PvsV.ZHOU_INFLAMMATORY_RESPONSE_FIMA_DN"
11,"Down",0.0195547928226336,0.145516082794537,"L.PvsV.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_LIGHTGREEN_DN"
13,"Up",0.0195884778570098,0.145570825364795,"L.PvsV.REACTOME_RECEPTOR_MEDIATED_MITOPHAGY"
24,"Down",0.0196785996445787,0.146044265013256,"L.PvsV.REACTOME_ANCHORING_FIBRIL_FORMATION"
17,"Up",0.0198242233490612,0.146778268444007,"L.PvsV.REACTOME_REPRESSION_OF_WNT_TARGET_GENES"
107,"Down",0.0198308561428139,0.146778268444007,"L.PvsV.PHONG_TNF_TARGETS_UP"
22,"Down",0.0198571432078346,0.146778268444007,"L.PvsV.REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE_FGFR2"
75,"Up",0.0199577018829027,0.147157155350836,"L.PvsV.JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP"
72,"Up",0.0199616325760766,0.147157155350836,"L.PvsV.PIONTEK_PKD1_TARGETS_UP"
25,"Down",0.0200146783339948,0.147351739691954,"L.PvsV.REACTOME_TYPE_I_HEMIDESMOSOME_ASSEMBLY"
38,"Up",0.0201458955094027,0.14812055355251,"L.PvsV.REACTOME_TAK1_ACTIVATES_NFKB_BY_PHOSPHORYLATION_AND_ACTIVATION_OF_IKKS_COMPLEX"
34,"Down",0.0202917632092646,0.148571282768407,"L.PvsV.KIM_MYCL1_AMPLIFICATION_TARGETS_DN"
32,"Up",0.0202943588607094,0.148571282768407,"L.PvsV.FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_UP"
185,"Down",0.0203232564899409,0.148571282768407,"L.PvsV.PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_4"
292,"Down",0.0203260493513944,0.148571282768407,"L.PvsV.LEE_LIVER_CANCER_SURVIVAL_DN"
86,"Down",0.020341555625915,0.148571282768407,"L.PvsV.CUI_TCF21_TARGETS_UP"
67,"Down",0.0203881873613386,0.148715419420634,"L.PvsV.KYNG_DNA_DAMAGE_BY_4NQO"
640,"Up",0.0204421383110915,0.14880100933914,"L.PvsV.STEIN_ESRRA_TARGETS_UP"
595,"Down",0.0204682607877055,0.14880100933914,"L.PvsV.BROWNE_HCMV_INFECTION_4HR_DN"
10,"Down",0.0204806598131824,0.14880100933914,"L.PvsV.REACTOME_NEUROTOXICITY_OF_CLOSTRIDIUM_TOXINS"
56,"Down",0.020619385699158,0.149571354667921,"L.PvsV.ZHAN_MULTIPLE_MYELOMA_PR_UP"
232,"Down",0.0206447737120693,0.149571354667921,"L.PvsV.BROWNE_HCMV_INFECTION_12HR_UP"
241,"Down",0.0206876035659961,0.149571354667921,"L.PvsV.KIM_WT1_TARGETS_12HR_UP"
36,"Down",0.0206948971461312,0.149571354667921,"L.PvsV.AMUNDSON_DNA_DAMAGE_RESPONSE_TP53"
51,"Down",0.0207685054595673,0.14960033423279,"L.PvsV.REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS"
501,"Down",0.0207791177025356,0.14960033423279,"L.PvsV.JAATINEN_HEMATOPOIETIC_STEM_CELL_UP"
325,"Down",0.0207846567175405,0.14960033423279,"L.PvsV.TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN"
28,"Down",0.0208249339487126,0.14960033423279,"L.PvsV.SCHAVOLT_TARGETS_OF_TP53_AND_TP63"
140,"Down",0.0208341937708895,0.14960033423279,"L.PvsV.GU_PDEF_TARGETS_UP"
8,"Down",0.0210238555958827,0.150588185598792,"L.PvsV.BIOCARTA_PLCD_PATHWAY"
1149,"Down",0.0210262396965577,0.150588185598792,"L.PvsV.NABA_MATRISOME"
38,"Down",0.0211672539559683,0.151402001452198,"L.PvsV.PID_S1P_S1P3_PATHWAY"
37,"Up",0.0212196407080726,0.151533828395417,"L.PvsV.WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_36HR"
6,"Down",0.0212875812759733,0.151533828395417,"L.PvsV.CALVET_IRINOTECAN_SENSITIVE_VS_RESISTANT_UP"
293,"Down",0.0213290189714465,0.151533828395417,"L.PvsV.TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP"
211,"Up",0.0213323707724753,0.151533828395417,"L.PvsV.SCHLOSSER_MYC_TARGETS_REPRESSED_BY_SERUM"
60,"Up",0.0213453222976536,0.151533828395417,"L.PvsV.REACTOME_GENE_AND_PROTEIN_EXPRESSION_BY_JAK_STAT_SIGNALING_AFTER_INTERLEUKIN_12_STIMULATION"
85,"Down",0.0213501270247838,0.151533828395417,"L.PvsV.WINTER_HYPOXIA_DN"
135,"Down",0.0215560990227618,0.152438140943796,"L.PvsV.REACTOME_CHROMOSOME_MAINTENANCE"
97,"Up",0.0215660601985901,0.152438140943796,"L.PvsV.PID_MTOR_4PATHWAY"
43,"Down",0.0215828659594802,0.152438140943796,"L.PvsV.BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_UP"
98,"Down",0.021587821370771,0.152438140943796,"L.PvsV.ZWANG_EGF_PERSISTENTLY_DN"
265,"Down",0.0216815699158725,0.152904847021504,"L.PvsV.TSAI_RESPONSE_TO_IONIZING_RADIATION"
46,"Down",0.0217439836159105,0.153149662945693,"L.PvsV.OSADA_ASCL1_TARGETS_DN"
55,"Down",0.0218196795162282,0.153487287589346,"L.PvsV.GENTILE_UV_LOW_DOSE_UP"
41,"Up",0.0219189817605716,0.153989898544092,"L.PvsV.BIOCARTA_EIF4_PATHWAY"
119,"Down",0.0219804106220732,0.154225495341932,"L.PvsV.HOWLIN_PUBERTAL_MAMMARY_GLAND"
27,"Up",0.0220790197201006,0.154721039331351,"L.PvsV.REACTOME_TGF_BETA_RECEPTOR_SIGNALING_IN_EMT_EPITHELIAL_TO_MESENCHYMAL_TRANSITION"
22,"Up",0.0222435640147117,0.155676791692837,"L.PvsV.KEGG_ALPHA_LINOLENIC_ACID_METABOLISM"
134,"Up",0.0222909119254483,0.155796758691061,"L.PvsV.SASSON_RESPONSE_TO_GONADOTROPHINS_UP"
43,"Up",0.0223170614728378,0.155796758691061,"L.PvsV.WANG_CLASSIC_ADIPOGENIC_TARGETS_OF_PPARG"
70,"Up",0.0225604616585657,0.156984492703044,"L.PvsV.REACTOME_INTERLEUKIN_12_SIGNALING"
8,"Down",0.0225716914966885,0.156984492703044,"L.PvsV.REACTOME_FGFR3B_LIGAND_BINDING_AND_ACTIVATION"
193,"Down",0.022572376867231,0.156984492703044,"L.PvsV.ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_DN"
22,"Up",0.0226409421388665,0.157263529002252,"L.PvsV.BIOCARTA_TOB1_PATHWAY"
71,"Down",0.0228049361908122,0.158009330903317,"L.PvsV.REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES"
82,"Up",0.022805470439654,0.158009330903317,"L.PvsV.PID_TGFBR_PATHWAY"
74,"Down",0.0228765427734041,0.158303385474532,"L.PvsV.GEORGES_CELL_CYCLE_MIR192_TARGETS"
40,"Down",0.0230658349497005,0.158741302437848,"L.PvsV.SIMBULAN_PARP1_TARGETS_DN"
1483,"Down",0.0230714071965517,0.158741302437848,"L.PvsV.BENPORATH_SUZ12_TARGETS"
98,"Down",0.0230852857855974,0.158741302437848,"L.PvsV.REACTOME_CLASS_B_2_SECRETIN_FAMILY_RECEPTORS"
61,"Up",0.0231047811159747,0.158741302437848,"L.PvsV.PID_ERBB1_INTERNALIZATION_PATHWAY"
27,"Down",0.0231089871106289,0.158741302437848,"L.PvsV.KEGG_HOMOLOGOUS_RECOMBINATION"
134,"Down",0.023132247977053,0.158741302437848,"L.PvsV.VANHARANTA_UTERINE_FIBROID_DN"
60,"Down",0.02317663520018,0.158741302437848,"L.PvsV.MIKKELSEN_MCV6_ICP_WITH_H3K4ME3_AND_H3K27ME3"
45,"Down",0.0232209683494625,0.158741302437848,"L.PvsV.NABA_COLLAGENS"
45,"Down",0.0232209683494625,0.158741302437848,"L.PvsV.REACTOME_COLLAGEN_CHAIN_TRIMERIZATION"
51,"Down",0.0232269332017035,0.158741302437848,"L.PvsV.PLASARI_NFIC_TARGETS_BASAL_DN"
143,"Up",0.0232707529128276,0.158844435623486,"L.PvsV.SCHLOSSER_SERUM_RESPONSE_AUGMENTED_BY_MYC"
50,"Down",0.0234715972473602,0.159873327269258,"L.PvsV.RIZ_ERYTHROID_DIFFERENTIATION_APOBEC2"
93,"Down",0.0234793166472486,0.159873327269258,"L.PvsV.ULE_SPLICING_VIA_NOVA2"
156,"Down",0.0235227855917907,0.159972302013544,"L.PvsV.MARKEY_RB1_CHRONIC_LOF_UP"
100,"Down",0.0235669784905095,0.160075950950893,"L.PvsV.REACTOME_G_ALPHA_12_13_SIGNALLING_EVENTS"
93,"Down",0.0236161966326227,0.160184769739456,"L.PvsV.KRASNOSELSKAYA_ILF3_TARGETS_DN"
22,"Down",0.0236546917613018,0.160184769739456,"L.PvsV.KEGG_MISMATCH_REPAIR"
263,"Down",0.0236699144288543,0.160184769739456,"L.PvsV.LEE_NEURAL_CREST_STEM_CELL_DN"
29,"Down",0.0237168688357711,0.160306317595328,"L.PvsV.REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY"
72,"Down",0.0237915764820927,0.160614928412077,"L.PvsV.DORSEY_GAB2_TARGETS"
60,"Up",0.0238366516778395,0.160722984300945,"L.PvsV.STONER_ESOPHAGEAL_CARCINOGENESIS_UP"
252,"Down",0.0239104050538467,0.161023909309036,"L.PvsV.IWANAGA_CARCINOGENESIS_BY_KRAS_DN"
26,"Down",0.0240150044018746,0.161242114711407,"L.PvsV.REACTOME_RESOLUTION_OF_D_LOOP_STRUCTURES_THROUGH_SYNTHESIS_DEPENDENT_STRAND_ANNEALING_SDSA"
59,"Up",0.0240342939239352,0.161242114711407,"L.PvsV.CAFFAREL_RESPONSE_TO_THC_UP"
46,"Up",0.0240448170491467,0.161242114711407,"L.PvsV.SCHLOSSER_MYC_AND_SERUM_RESPONSE_SYNERGY"
176,"Down",0.0240666025358212,0.161242114711407,"L.PvsV.MACAEVA_PBMC_RESPONSE_TO_IR"
64,"Down",0.0240886212247462,0.161242114711407,"L.PvsV.PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_6"
12,"Down",0.0241877531252342,0.161709899672817,"L.PvsV.BIOCARTA_RECK_PATHWAY"
14,"Down",0.024235480084015,0.161833296358115,"L.PvsV.MONTERO_THYROID_CANCER_POOR_SURVIVAL_UP"
143,"Down",0.0242654299185136,0.16183783114531,"L.PvsV.LIU_COMMON_CANCER_GENES"
14,"Down",0.0243431153997771,0.162000591513144,"L.PvsV.BIOCARTA_PKC_PATHWAY"
11,"Up",0.0243484339930227,0.162000591513144,"L.PvsV.REACTOME_SCAVENGING_BY_CLASS_B_RECEPTORS"
56,"Up",0.0244274328579562,0.162330860903414,"L.PvsV.SEMENZA_HIF1_TARGETS"
1555,"Down",0.0245230265564109,0.162770484790391,"L.PvsV.MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3"
117,"Down",0.0245646180187009,0.162851046793042,"L.PvsV.KEGG_DILATED_CARDIOMYOPATHY"
48,"Down",0.0246919538462094,0.16346709710074,"L.PvsV.BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_UP"
35,"Down",0.0247166744757133,0.16346709710074,"L.PvsV.REACTOME_ACTIVATION_OF_KAINATE_RECEPTORS_UPON_GLUTAMATE_BINDING"
41,"Up",0.0247925949376421,0.163655697274564,"L.PvsV.REACTOME_INFECTION_WITH_MYCOBACTERIUM_TUBERCULOSIS"
43,"Up",0.0248043903628296,0.163655697274564,"L.PvsV.WENDT_COHESIN_TARGETS_UP"
53,"Up",0.0248814852546707,0.163968691267073,"L.PvsV.FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN"
25,"Up",0.024941677925848,0.164169687204778,"L.PvsV.REACTOME_JNK_C_JUN_KINASES_PHOSPHORYLATION_AND_ACTIVATION_MEDIATED_BY_ACTIVATED_HUMAN_TAK1"
363,"Down",0.0251488834274404,0.165336713995622,"L.PvsV.ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_DN"
45,"Down",0.0252712588670845,0.165935344618281,"L.PvsV.XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_UP"
50,"Down",0.0253056629849704,0.165935344618281,"L.PvsV.LOPEZ_MESOTHELIOMA_SURVIVAL_OVERALL_DN"
79,"Down",0.0253299748341163,0.165935344618281,"L.PvsV.JOHANSSON_GLIOMAGENESIS_BY_PDGFB_UP"
439,"Up",0.0253675314857712,0.165984711934709,"L.PvsV.LIU_SOX4_TARGETS_DN"
10,"Down",0.0254944605082844,0.166618052187121,"L.PvsV.MIKKELSEN_DEDIFFERENTIATED_STATE_DN"
39,"Down",0.025566088146881,0.166888903617597,"L.PvsV.REACTOME_ONCOGENE_INDUCED_SENESCENCE"
15,"Down",0.0256764423282005,0.167411615132808,"L.PvsV.REACTOME_KERATAN_SULFATE_DEGRADATION"
71,"Down",0.0261822292203844,0.17050829842109,"L.PvsV.ZHENG_FOXP3_TARGETS_IN_T_LYMPHOCYTE_DN"
26,"Up",0.0262488739220519,0.170555164009988,"L.PvsV.REACTOME_TRIGLYCERIDE_CATABOLISM"
747,"Down",0.026251120378459,0.170555164009988,"L.PvsV.ODONNELL_TFRC_TARGETS_UP"
879,"Down",0.026313568949839,0.170697146856133,"L.PvsV.WEST_ADRENOCORTICAL_TUMOR_DN"
865,"Down",0.0263347198893618,0.170697146856133,"L.PvsV.RIGGI_EWING_SARCOMA_PROGENITOR_UP"
274,"Down",0.0264180766590338,0.171036938931848,"L.PvsV.SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP"
66,"Up",0.0265651615822313,0.171788044898429,"L.PvsV.FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN"
86,"Down",0.0266523972716461,0.172150823031462,"L.PvsV.KHETCHOUMIAN_TRIM24_TARGETS_UP"
17,"Down",0.02677271545908,0.172726188766923,"L.PvsV.REACTOME_POLYMERASE_SWITCHING_ON_THE_C_STRAND_OF_THE_TELOMERE"
111,"Down",0.026835135979797,0.17292711752016,"L.PvsV.REACTOME_REGULATION_OF_INSULIN_SECRETION"
26,"Up",0.0269658551540453,0.173567186433896,"L.PvsV.REACTOME_ACTIVATED_TAK1_MEDIATES_P38_MAPK_ACTIVATION"
116,"Up",0.0269998482491587,0.173583908104184,"L.PvsV.REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES"
221,"Up",0.0270438191286099,0.173664664299749,"L.PvsV.RODWELL_AGING_KIDNEY_NO_BLOOD_DN"
226,"Down",0.0272137185980474,0.174552958385851,"L.PvsV.HOLLERN_EMT_BREAST_TUMOR_UP"
25,"Up",0.0273216144531728,0.175041954011115,"L.PvsV.STARK_HYPPOCAMPUS_22Q11_DELETION_DN"
224,"Down",0.0273689583005253,0.17514232690232,"L.PvsV.PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_UP"
67,"Down",0.0274586815078276,0.175352413135535,"L.PvsV.TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN"
135,"Down",0.0274652179011346,0.175352413135535,"L.PvsV.SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_UP"
302,"Down",0.0275375581264838,0.175611486598995,"L.PvsV.RODRIGUES_NTN1_TARGETS_DN"
12,"Down",0.0277517662556149,0.176266769051617,"L.PvsV.REACTOME_HDL_REMODELING"
179,"Down",0.0277555672825033,0.176266769051617,"L.PvsV.MIKKELSEN_IPS_HCP_WITH_H3_UNMETHYLATED"
9,"Down",0.0277680337960565,0.176266769051617,"L.PvsV.REACTOME_LIGAND_RECEPTOR_INTERACTIONS"
153,"Down",0.0277959563296744,0.176266769051617,"L.PvsV.DE_YY1_TARGETS_DN"
197,"Down",0.0277997147066395,0.176266769051617,"L.PvsV.WOO_LIVER_CANCER_RECURRENCE_UP"
19,"Up",0.0278869539233197,0.176617374847691,"L.PvsV.THUM_MIR21_TARGETS_HEART_DISEASE_DN"
38,"Down",0.0279380770194125,0.176714875891853,"L.PvsV.MEISSNER_NPC_ICP_WITH_H3_UNMETHYLATED"
43,"Down",0.0279726248691381,0.176714875891853,"L.PvsV.TCGA_GLIOBLASTOMA_COPY_NUMBER_DN"
455,"Down",0.0279982331852529,0.176714875891853,"L.PvsV.SENESE_HDAC1_TARGETS_DN"
1049,"Up",0.0281370311157945,0.177388420797295,"L.PvsV.KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_UP"
37,"Down",0.0282018403186013,0.177594504694244,"L.PvsV.MATTHEWS_SKIN_CARCINOGENESIS_VIA_JUN"
124,"Down",0.0282804458466814,0.177886899984415,"L.PvsV.REACTOME_G2_M_DNA_DAMAGE_CHECKPOINT"
44,"Down",0.0283212718973611,0.177941264000579,"L.PvsV.LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_UP"
157,"Down",0.0283856243446657,0.178084537176976,"L.PvsV.DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN"
29,"Up",0.0284585324971563,0.178084537176976,"L.PvsV.REACTOME_LDL_CLEARANCE"
31,"Up",0.0285124047079107,0.178084537176976,"L.PvsV.MOOTHA_GLYCOLYSIS"
77,"Down",0.0285179646262937,0.178084537176976,"L.PvsV.DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_DN"
56,"Down",0.0285272291308533,0.178084537176976,"L.PvsV.WANG_NFKB_TARGETS"
14,"Down",0.028537330428432,0.178084537176976,"L.PvsV.REACTOME_POLYMERASE_SWITCHING"
34,"Up",0.0286920389239945,0.178848120868958,"L.PvsV.FARMER_BREAST_CANCER_CLUSTER_7"
36,"Down",0.0287980141699545,0.179306554443332,"L.PvsV.KANG_AR_TARGETS_UP"
66,"Up",0.0288569185949169,0.179402218965265,"L.PvsV.RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_UP"
78,"Down",0.0288782736261685,0.179402218965265,"L.PvsV.WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_DN"
80,"Down",0.0289526810186134,0.17966259635456,"L.PvsV.REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES"
64,"Down",0.0290804239559666,0.180252986605986,"L.PvsV.PIONTEK_PKD1_TARGETS_DN"
14,"Up",0.0293392116777477,0.181616171998639,"L.PvsV.KEGG_LIMONENE_AND_PINENE_DEGRADATION"
14,"Up",0.0293816370664792,0.181616171998639,"L.PvsV.REACTOME_CYTOSOLIC_IRON_SULFUR_CLUSTER_ASSEMBLY"
89,"Down",0.0293988920128019,0.181616171998639,"L.PvsV.VANHARANTA_UTERINE_FIBROID_UP"
73,"Up",0.0296178848047438,0.182734516944817,"L.PvsV.LUI_TARGETS_OF_PAX8_PPARG_FUSION"
868,"Down",0.0296460230963105,0.182734516944817,"L.PvsV.HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP"
30,"Up",0.0296997345227632,0.182861728481468,"L.PvsV.PID_TOLL_ENDOGENOUS_PATHWAY"
46,"Down",0.0298957992430074,0.18386415352012,"L.PvsV.BIOCARTA_NO1_PATHWAY"
129,"Down",0.0300446618568882,0.184510898619027,"L.PvsV.VERRECCHIA_EARLY_RESPONSE_TO_TGFB1"
178,"Down",0.0300677011495286,0.184510898619027,"L.PvsV.WHITFIELD_CELL_CYCLE_G1_S"
8,"Up",0.0302652272943988,0.185152443262188,"L.PvsV.IWANAGA_E2F1_TARGETS_NOT_INDUCED_BY_SERUM"
7,"Up",0.0302886257099884,0.185152443262188,"L.PvsV.LIU_CMYB_TARGETS_DN"
134,"Down",0.0302985090955067,0.185152443262188,"L.PvsV.MORI_PRE_BI_LYMPHOCYTE_UP"
33,"Down",0.0303061966272889,0.185152443262188,"L.PvsV.REACTOME_RESOLUTION_OF_D_LOOP_STRUCTURES"
23,"Down",0.030363814314789,0.185254010946548,"L.PvsV.GOUYER_TATI_TARGETS_DN"
15,"Down",0.0303898332299727,0.185254010946548,"L.PvsV.GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_1_UP"
199,"Down",0.0304687384166907,0.18553045672454,"L.PvsV.GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN"
69,"Down",0.0306314794805161,0.186316226675219,"L.PvsV.PID_UPA_UPAR_PATHWAY"
171,"Down",0.030707866632499,0.186575598473722,"L.PvsV.REACTOME_HOMOLOGY_DIRECTED_REPAIR"
24,"Down",0.0307963568074221,0.186907855969524,"L.PvsV.BIOCARTA_NOS1_PATHWAY"
17,"Up",0.0310781696257998,0.188257966338464,"L.PvsV.RAY_ALZHEIMERS_DISEASE"
158,"Down",0.0311202314881555,0.188257966338464,"L.PvsV.NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP"
90,"Down",0.0311209588050924,0.188257966338464,"L.PvsV.KAAB_FAILED_HEART_ATRIUM_UP"
24,"Up",0.0311782558658067,0.188398444461251,"L.PvsV.REACTOME_SIGNALING_BY_NODAL"
29,"Down",0.0312614061420817,0.188694666549749,"L.PvsV.ELLWOOD_MYC_TARGETS_UP"
917,"Down",0.0313358303598791,0.188777137942578,"L.PvsV.CHICAS_RB1_TARGETS_CONFLUENT"
63,"Down",0.0313433555129837,0.188777137942578,"L.PvsV.STREICHER_LSM1_TARGETS_UP"
522,"Down",0.0315650059059539,0.189630348820219,"L.PvsV.BROWNE_HCMV_INFECTION_20HR_UP"
391,"Up",0.0315780812240219,0.189630348820219,"L.PvsV.AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_UP"
15,"Down",0.0315943176943237,0.189630348820219,"L.PvsV.REACTOME_MISMATCH_REPAIR"
11,"Down",0.0316222068388934,0.189630348820219,"L.PvsV.REACTOME_REMOVAL_OF_THE_FLAP_INTERMEDIATE_FROM_THE_C_STRAND"
39,"Down",0.0316868077679605,0.189811874484348,"L.PvsV.PID_RAS_PATHWAY"
13,"Down",0.0318097830513302,0.190245070308126,"L.PvsV.REACTOME_RUNX2_REGULATES_GENES_INVOLVED_IN_CELL_MIGRATION"
830,"Down",0.0318449031185941,0.190245070308126,"L.PvsV.GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN"
54,"Up",0.0318774215132175,0.190245070308126,"L.PvsV.CREIGHTON_AKT1_SIGNALING_VIA_MTOR_UP"
31,"Down",0.031917386516624,0.190245070308126,"L.PvsV.REACTOME_PLATELET_CALCIUM_HOMEOSTASIS"
51,"Up",0.0319311675250391,0.190245070308126,"L.PvsV.JIANG_AGING_HYPOTHALAMUS_DN"
337,"Down",0.0320000708014178,0.190450367557631,"L.PvsV.KATSANOU_ELAVL1_TARGETS_UP"
156,"Down",0.0324189687904125,0.192688681055314,"L.PvsV.KEGG_AXON_GUIDANCE"
647,"Down",0.0324482458628263,0.192688681055314,"L.PvsV.YAUCH_HEDGEHOG_SIGNALING_PARACRINE_DN"
54,"Down",0.0324807109320949,0.192688681055314,"L.PvsV.FARMER_BREAST_CANCER_CLUSTER_4"
8,"Up",0.0325519273879436,0.192904187061029,"L.PvsV.REACTOME_TYSND1_CLEAVES_PEROXISOMAL_PROTEINS"
126,"Up",0.0327376649644715,0.193797162300389,"L.PvsV.GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN"
20,"Down",0.0327830847034348,0.193858476283733,"L.PvsV.BIOCARTA_PLC_PATHWAY"
79,"Down",0.032864761381258,0.19413383085147,"L.PvsV.SMIRNOV_RESPONSE_TO_IR_2HR_DN"
12,"Up",0.0330260474478229,0.19487835254964,"L.PvsV.BIOCARTA_GABA_PATHWAY"
58,"Down",0.0331386457374809,0.195334298808669,"L.PvsV.PID_SYNDECAN_4_PATHWAY"
27,"Down",0.0332167853517645,0.195475764647119,"L.PvsV.PID_INTEGRIN_CS_PATHWAY"
204,"Up",0.0332633449011876,0.195475764647119,"L.PvsV.CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_DN"
827,"Up",0.033268709447086,0.195475764647119,"L.PvsV.REACTOME_TRANSPORT_OF_SMALL_MOLECULES"
32,"Down",0.0333435424121874,0.195479111948106,"L.PvsV.FINAK_BREAST_CANCER_SDPP_SIGNATURE"
81,"Down",0.0334005051143759,0.195479111948106,"L.PvsV.NEWMAN_ERCC6_TARGETS_DN"
127,"Down",0.0334065745060391,0.195479111948106,"L.PvsV.CARD_MIR302A_TARGETS"
32,"Down",0.0334128221359327,0.195479111948106,"L.PvsV.HANSON_HRAS_SIGNALING_VIA_NFKB"
44,"Down",0.0334460553269865,0.195479111948106,"L.PvsV.SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_DN"
65,"Down",0.0336911602955696,0.196703722570437,"L.PvsV.ABE_INNER_EAR"
31,"Down",0.0337511812363083,0.196846288033279,"L.PvsV.PID_S1P_META_PATHWAY"
102,"Up",0.0337921679210542,0.196877656939419,"L.PvsV.REACTOME_SIGNALING_BY_NOTCH4"
35,"Down",0.0339511432885209,0.197595653939192,"L.PvsV.PID_S1P_S1P2_PATHWAY"
40,"Down",0.0340223914294006,0.197678689983325,"L.PvsV.LY_AGING_MIDDLE_DN"
174,"Up",0.0340369167777402,0.197678689983325,"L.PvsV.UDAYAKUMAR_MED1_TARGETS_UP"
453,"Down",0.0341160357652181,0.197689563055771,"L.PvsV.SANSOM_APC_TARGETS"
110,"Down",0.0341260597397015,0.197689563055771,"L.PvsV.REACTOME_COLLAGEN_FORMATION"
15,"Up",0.0341772405117803,0.197689563055771,"L.PvsV.REACTOME_DOWNREGULATION_OF_ERBB4_SIGNALING"
33,"Down",0.034181809057934,0.197689563055771,"L.PvsV.SABATES_COLORECTAL_ADENOMA_SIZE_UP"
79,"Up",0.0345516492232112,0.19958345962169,"L.PvsV.REACTOME_INTERLEUKIN_12_FAMILY_SIGNALING"
71,"Down",0.0345814712095459,0.19958345962169,"L.PvsV.VERRECCHIA_RESPONSE_TO_TGFB1_C2"
130,"Down",0.0346678205705086,0.199679124323137,"L.PvsV.SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER"
651,"Down",0.0346920118964865,0.199679124323137,"L.PvsV.TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C"
25,"Down",0.0347063914766748,0.199679124323137,"L.PvsV.GRANDVAUX_IRF3_TARGETS_DN"
104,"Down",0.0348801976721695,0.200301095498757,"L.PvsV.STEIN_ESR1_TARGETS"
350,"Down",0.0348869515220298,0.200301095498757,"L.PvsV.RODWELL_AGING_KIDNEY_NO_BLOOD_UP"
41,"Down",0.0350164242368052,0.200835902080183,"L.PvsV.REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS"
45,"Down",0.0351208229956342,0.201225938179131,"L.PvsV.PID_EPHA_FWDPATHWAY"
238,"Down",0.0351605394473451,0.201244950936202,"L.PvsV.TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN"
30,"Down",0.0352999486249114,0.201789380724489,"L.PvsV.AMIT_SERUM_RESPONSE_20_MCF10A"
1243,"Down",0.0353850996545054,0.201789380724489,"L.PvsV.LEE_BMP2_TARGETS_UP"
709,"Down",0.035390845480967,0.201789380724489,"L.PvsV.MIKKELSEN_MCV6_HCP_WITH_H3K27ME3"
504,"Down",0.0354016457411384,0.201789380724489,"L.PvsV.OISHI_CHOLANGIOMA_STEM_CELL_LIKE_DN"
51,"Up",0.0354428413600177,0.201816137878,"L.PvsV.GUILLAUMOND_KLF10_TARGETS_DN"
6,"Down",0.0358027056682811,0.203516001134265,"L.PvsV.REACTOME_PRE_NOTCH_PROCESSING_IN_THE_ENDOPLASMIC_RETICULUM"
714,"Down",0.0358149880816856,0.203516001134265,"L.PvsV.BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP"
92,"Down",0.035869004268742,0.203613680289399,"L.PvsV.RICKMAN_HEAD_AND_NECK_CANCER_F"
14,"Down",0.0360145249568807,0.20423005998625,"L.PvsV.BIOCARTA_RARRXR_PATHWAY"
19,"Down",0.0361006282999801,0.20450857978544,"L.PvsV.REACTOME_NEF_AND_SIGNAL_TRANSDUCTION"
125,"Down",0.0362630924859191,0.205218667712023,"L.PvsV.CROONQUIST_IL6_DEPRIVATION_DN"
55,"Down",0.0363273456832663,0.205324886120686,"L.PvsV.STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_DN"
23,"Up",0.0363740770827425,0.205324886120686,"L.PvsV.BIOCARTA_RAB_PATHWAY"
13,"Down",0.0363932697410512,0.205324886120686,"L.PvsV.FIRESTEIN_CTNNB1_PATHWAY_AND_PROLIFERATION"
19,"Up",0.0364567444771886,0.205473333551861,"L.PvsV.REACTOME_RIP_MEDIATED_NFKB_ACTIVATION_VIA_ZBP1"
13,"Down",0.0365029362579477,0.205524169623415,"L.PvsV.REACTOME_IONOTROPIC_ACTIVITY_OF_KAINATE_RECEPTORS"
27,"Down",0.0365728920052124,0.205671603083316,"L.PvsV.BIOCARTA_PLATELETAPP_PATHWAY"
48,"Down",0.0366035191597002,0.205671603083316,"L.PvsV.WILLIAMS_ESR1_TARGETS_UP"
33,"Down",0.0367141015514462,0.206083520282179,"L.PvsV.KIM_LIVER_CANCER_POOR_SURVIVAL_UP"
134,"Down",0.0368262768963394,0.206503534442049,"L.PvsV.BASSO_HAIRY_CELL_LEUKEMIA_UP"
725,"Down",0.0369224777217014,0.20683321106716,"L.PvsV.PEDRIOLI_MIR31_TARGETS_DN"
30,"Down",0.0369611116385934,0.206840067054436,"L.PvsV.STEGER_ADIPOGENESIS_DN"
37,"Down",0.0373493747126518,0.208801509389536,"L.PvsV.ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_UP"
62,"Up",0.037394700728317,0.208843737703904,"L.PvsV.KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_UP"
61,"Down",0.0375294318871821,0.209173675329035,"L.PvsV.MIKKELSEN_MEF_ICP_WITH_H3K4ME3_AND_H3K27ME3"
106,"Up",0.0375294422004707,0.209173675329035,"L.PvsV.BILANGES_RAPAMYCIN_SENSITIVE_VIA_TSC1_AND_TSC2"
106,"Down",0.0376861489784033,0.209668301962756,"L.PvsV.REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE"
424,"Down",0.0376940300508193,0.209668301962756,"L.PvsV.DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP"
153,"Up",0.037768407490165,0.209704639648794,"L.PvsV.REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION"
19,"Down",0.0377764190794354,0.209704639648794,"L.PvsV.BIOCARTA_P53_PATHWAY"
246,"Down",0.0380268851297554,0.210240612018457,"L.PvsV.CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP"
36,"Up",0.0380793833746279,0.210240612018457,"L.PvsV.AKL_HTLV1_INFECTION_UP"
239,"Down",0.0380830817702675,0.210240612018457,"L.PvsV.SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM5"
110,"Up",0.0381786828445894,0.210240612018457,"L.PvsV.REACTOME_TNFR2_NON_CANONICAL_NF_KB_PATHWAY"
114,"Up",0.0382065092503761,0.210240612018457,"L.PvsV.REACTOME_TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE"
13,"Up",0.0383243201575611,0.210240612018457,"L.PvsV.REACTOME_MET_ACTIVATES_RAS_SIGNALING"
635,"Down",0.0383257061094419,0.210240612018457,"L.PvsV.LINDGREN_BLADDER_CANCER_CLUSTER_2B"
97,"Down",0.0383284130353884,0.210240612018457,"L.PvsV.KUNINGER_IGF1_VS_PDGFB_TARGETS_DN"
26,"Up",0.0383391291318349,0.210240612018457,"L.PvsV.SCIBETTA_KDM5B_TARGETS_UP"
28,"Down",0.0383495724182941,0.210240612018457,"L.PvsV.TIAN_TNF_SIGNALING_VIA_NFKB"
236,"Up",0.0383538334025147,0.210240612018457,"L.PvsV.REACTOME_DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS"
8,"Down",0.0384299626612048,0.210240612018457,"L.PvsV.REACTOME_MRNA_EDITING"
25,"Down",0.0384767890460452,0.210240612018457,"L.PvsV.HONRADO_BREAST_CANCER_BRCA1_VS_BRCA2"
111,"Down",0.0384824254706648,0.210240612018457,"L.PvsV.MEISSNER_BRAIN_HCP_WITH_H3K4ME2_AND_H3K27ME3"
105,"Down",0.038497908296599,0.210240612018457,"L.PvsV.GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_DN"
358,"Down",0.0385123755371417,0.210240612018457,"L.PvsV.BOQUEST_STEM_CELL_DN"
166,"Down",0.0385193959078851,0.210240612018457,"L.PvsV.HUMMERICH_SKIN_CANCER_PROGRESSION_UP"
53,"Down",0.038584518752108,0.21038836704182,"L.PvsV.BRACHAT_RESPONSE_TO_CAMPTOTHECIN_UP"
41,"Up",0.0386504859169452,0.210540430182059,"L.PvsV.PASTURAL_RIZ1_TARGETS_UP"
174,"Down",0.0388353680916929,0.211339321042293,"L.PvsV.YAMASHITA_METHYLATED_IN_PROSTATE_CANCER"
17,"Down",0.0389157369511041,0.211408475749819,"L.PvsV.ONGUSAHA_BRCA1_TARGETS_UP"
76,"Down",0.0389245484379302,0.211408475749819,"L.PvsV.GILDEA_METASTASIS"
32,"Down",0.0391911387037347,0.212647503329685,"L.PvsV.MURAKAMI_UV_RESPONSE_6HR_DN"
31,"Down",0.0392532716011304,0.212775822237892,"L.PvsV.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_PURPLE_DN"
36,"Up",0.0395334758570025,0.213984678681701,"L.PvsV.PID_IL3_PATHWAY"
325,"Down",0.0395716978843015,0.213984678681701,"L.PvsV.LEE_DIFFERENTIATING_T_LYMPHOCYTE"
26,"Down",0.0395923903583614,0.213984678681701,"L.PvsV.ZIRN_TRETINOIN_RESPONSE_UP"
208,"Down",0.0397638534743221,0.214701509628444,"L.PvsV.REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX"
11,"Down",0.0398329336076837,0.214864673089642,"L.PvsV.MATZUK_FERTILIZATION"
19,"Down",0.0398809620007154,0.214914073003855,"L.PvsV.MIZUKAMI_HYPOXIA_UP"
25,"Up",0.0401355604222954,0.216075475730157,"L.PvsV.MOOTHA_GLYCOGEN_METABOLISM"
45,"Up",0.0403400771154046,0.216965259115829,"L.PvsV.REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS"
126,"Up",0.0404678926211045,0.217441183967043,"L.PvsV.REACTOME_CARGO_RECOGNITION_FOR_CLATHRIN_MEDIATED_ENDOCYTOSIS"
35,"Up",0.0406038238460007,0.217844988110157,"L.PvsV.SCHMIDT_POR_TARGETS_IN_LIMB_BUD_UP"
77,"Down",0.0406218453140842,0.217844988110157,"L.PvsV.LINDSTEDT_DENDRITIC_CELL_MATURATION_B"
5,"Up",0.0412734653529427,0.221124990248469,"L.PvsV.WILSON_PROTEASES_AT_TUMOR_BONE_INTERFACE_DN"
24,"Down",0.0414418010168285,0.221811924319501,"L.PvsV.VISALA_RESPONSE_TO_HEAT_SHOCK_AND_AGING_DN"
31,"Down",0.0415035764448265,0.22192773129927,"L.PvsV.GHANDHI_BYSTANDER_IRRADIATION_DN"
173,"Down",0.0416364778442408,0.222423271498365,"L.PvsV.HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_UP"
9,"Up",0.0418950770675369,0.223388527187808,"L.PvsV.CASTELLANO_HRAS_TARGETS_UP"
55,"Down",0.0418979748044415,0.223388527187808,"L.PvsV.FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_DN"
572,"Down",0.0419527217262576,0.223464931044777,"L.PvsV.HELLER_HDAC_TARGETS_UP"
204,"Down",0.04207155876608,0.223799244496856,"L.PvsV.REACTOME_DNA_DOUBLE_STRAND_BREAK_REPAIR"
111,"Down",0.0421287522651222,0.223799244496856,"L.PvsV.MCBRYAN_PUBERTAL_TGFB1_TARGETS_DN"
18,"Down",0.0421369168965865,0.223799244496856,"L.PvsV.LI_WILMS_TUMOR_ANAPLASTIC_DN"
12,"Down",0.042237935599749,0.2241204855384,"L.PvsV.KEGG_TAURINE_AND_HYPOTAURINE_METABOLISM"
590,"Down",0.0423540217298716,0.224520983839367,"L.PvsV.BENPORATH_ES_1"
59,"Down",0.0425658062774659,0.225221622863836,"L.PvsV.PID_HNF3B_PATHWAY"
131,"Down",0.0425676606787319,0.225221622863836,"L.PvsV.LEE_EARLY_T_LYMPHOCYTE_UP"
826,"Down",0.042643417234413,0.225358460933047,"L.PvsV.TARTE_PLASMA_CELL_VS_PLASMABLAST_UP"
114,"Down",0.042677652677741,0.225358460933047,"L.PvsV.AMIT_EGF_RESPONSE_120_HELA"
106,"Up",0.0427158016020678,0.225358460933047,"L.PvsV.PID_HIF1_TFPATHWAY"
14,"Down",0.0427650092632667,0.225402989720307,"L.PvsV.MEINHOLD_OVARIAN_CANCER_LOW_GRADE_UP"
103,"Down",0.0428184646950074,0.225469801236853,"L.PvsV.BROWNE_HCMV_INFECTION_4HR_UP"
113,"Down",0.0429297159577639,0.22584053237914,"L.PvsV.BURTON_ADIPOGENESIS_11"
39,"Down",0.0430058012274629,0.226025736679318,"L.PvsV.REACTOME_NOTCH3_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION"
208,"Down",0.0431001280311837,0.226058361129256,"L.PvsV.GAL_LEUKEMIC_STEM_CELL_UP"
34,"Down",0.0431119732342266,0.226058361129256,"L.PvsV.MAHADEVAN_IMATINIB_RESISTANCE_DN"
674,"Down",0.0431705549447752,0.226058361129256,"L.PvsV.ZHANG_BREAST_CANCER_PROGENITORS_UP"
127,"Down",0.0431755524240359,0.226058361129256,"L.PvsV.ZHANG_GATA6_TARGETS_DN"
51,"Down",0.0432243753748416,0.226099878379848,"L.PvsV.SIMBULAN_PARP1_TARGETS_UP"
26,"Down",0.0433049390784695,0.226307191082097,"L.PvsV.PLASARI_TGFB1_TARGETS_1HR_DN"
30,"Down",0.04338500471174,0.226511511851946,"L.PvsV.BYSTRYKH_HEMATOPOIESIS_STEM_CELL_RUNX1"
172,"Down",0.0435172042147677,0.2269282640222,"L.PvsV.BAELDE_DIABETIC_NEPHROPATHY_UP"
48,"Down",0.0435469141124172,0.2269282640222,"L.PvsV.PIEPOLI_LGI1_TARGETS_DN"
98,"Down",0.0437358083544103,0.227556089610084,"L.PvsV.LIANG_SILENCED_BY_METHYLATION_UP"
130,"Down",0.04374970577962,0.227556089610084,"L.PvsV.REACTOME_PROCESSING_OF_DNA_DOUBLE_STRAND_BREAK_ENDS"
55,"Down",0.043814222381135,0.227677477016255,"L.PvsV.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_DN"
6,"Up",0.043981706611946,0.228333197988215,"L.PvsV.REACTOME_METHIONINE_SALVAGE_PATHWAY"
21,"Down",0.0440505067867205,0.228475846176152,"L.PvsV.REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_DIFFERENTIATION_OF_KERATINOCYTES"
63,"Up",0.0442657113866314,0.229376868094363,"L.PvsV.HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_DN"
30,"Down",0.0444227120315395,0.2298279638069,"L.PvsV.BIOCARTA_TEL_PATHWAY"
61,"Up",0.0444953426552273,0.2298279638069,"L.PvsV.KEGG_ENDOMETRIAL_CANCER"
1509,"Down",0.0445393117782176,0.2298279638069,"L.PvsV.MARTENS_TRETINOIN_RESPONSE_UP"
56,"Up",0.044550344873404,0.2298279638069,"L.PvsV.RUAN_RESPONSE_TO_TNF_TROGLITAZONE_DN"
10,"Down",0.044560603581298,0.2298279638069,"L.PvsV.NIKOLSKY_BREAST_CANCER_10Q22_AMPLICON"
8,"Up",0.0446214503642631,0.229927305744651,"L.PvsV.NAISHIRO_CTNNB1_TARGETS_WITH_LEF1_MOTIF"
63,"Up",0.0447382948171719,0.229975794592686,"L.PvsV.AMIT_EGF_RESPONSE_60_HELA"
43,"Down",0.044752604275772,0.229975794592686,"L.PvsV.FOURNIER_ACINAR_DEVELOPMENT_LATE_DN"
449,"Down",0.0447670807591999,0.229975794592686,"L.PvsV.DOANE_RESPONSE_TO_ANDROGEN_DN"
203,"Down",0.0447972383389985,0.229975794592686,"L.PvsV.CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN"
515,"Down",0.0449154467216227,0.230361381446045,"L.PvsV.SENGUPTA_NASOPHARYNGEAL_CARCINOMA_DN"
6,"Down",0.0449627123271131,0.230361381446045,"L.PvsV.BIOCARTA_TERC_PATHWAY"
41,"Down",0.045061502978591,0.230361381446045,"L.PvsV.REACTOME_INWARDLY_RECTIFYING_K_CHANNELS"
209,"Down",0.0451141262513186,0.230361381446045,"L.PvsV.KANG_IMMORTALIZED_BY_TERT_DN"
35,"Down",0.0451622806591862,0.230361381446045,"L.PvsV.HOFMANN_MYELODYSPLASTIC_SYNDROM_HIGH_RISK_DN"
12,"Up",0.0451639456947215,0.230361381446045,"L.PvsV.REACTOME_IRAK2_MEDIATED_ACTIVATION_OF_TAK1_COMPLEX"
30,"Up",0.0451902293256954,0.230361381446045,"L.PvsV.REACTOME_CONSTITUTIVE_SIGNALING_BY_LIGAND_RESPONSIVE_EGFR_CANCER_VARIANTS"
80,"Up",0.0452056608553009,0.230361381446045,"L.PvsV.GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_UP"
1768,"Down",0.0453844705637779,0.2308936514934,"L.PvsV.PEREZ_TP53_TARGETS"
255,"Down",0.0453936334189413,0.2308936514934,"L.PvsV.ALCALAY_AML_BY_NPM1_LOCALIZATION_DN"
740,"Down",0.0455367735110883,0.231408842594492,"L.PvsV.DELYS_THYROID_CANCER_UP"
186,"Down",0.0456698283248065,0.231871883202805,"L.PvsV.ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER"
91,"Down",0.0457981950010557,0.231967879829617,"L.PvsV.PID_TELOMERASE_PATHWAY"
129,"Down",0.0458305576788977,0.231967879829617,"L.PvsV.HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_DN"
50,"Down",0.0458471846351505,0.231967879829617,"L.PvsV.WU_ALZHEIMER_DISEASE_DN"
1203,"Down",0.0458907924313862,0.231967879829617,"L.PvsV.MIKKELSEN_ES_ICP_WITH_H3K4ME3"
39,"Down",0.045898509772762,0.231967879829617,"L.PvsV.VERRECCHIA_RESPONSE_TO_TGFB1_C1"
83,"Down",0.0460097350112426,0.232317648289644,"L.PvsV.COWLING_MYCN_TARGETS"
105,"Up",0.0460844777636229,0.232482734995503,"L.PvsV.PID_MET_PATHWAY"
327,"Up",0.0462621279120198,0.23316618525575,"L.PvsV.LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER"
17,"Down",0.0463264516797336,0.233277733458331,"L.PvsV.BIOCARTA_BTG2_PATHWAY"
96,"Down",0.046435501770705,0.233522064638655,"L.PvsV.CORRE_MULTIPLE_MYELOMA_DN"
108,"Down",0.0464594449452922,0.233522064638655,"L.PvsV.LEE_LIVER_CANCER_DENA_UP"
67,"Down",0.046512444821181,0.233576119360863,"L.PvsV.NGUYEN_NOTCH1_TARGETS_UP"
21,"Down",0.0467696300766135,0.234654523315423,"L.PvsV.JOHANSSON_BRAIN_CANCER_EARLY_VS_LATE_UP"
8,"Up",0.047025884150429,0.235666182792772,"L.PvsV.HOLLEMAN_DAUNORUBICIN_ALL_UP"
5,"Up",0.0470565139814109,0.235666182792772,"L.PvsV.REACTOME_SYNTHESIS_OF_GDP_MANNOSE"
32,"Down",0.0471047848453034,0.235694439284781,"L.PvsV.REACTOME_ACTIVATION_OF_THE_PRE_REPLICATIVE_COMPLEX"
82,"Up",0.0473548816565697,0.236731591934154,"L.PvsV.NADLER_OBESITY_DN"
7,"Down",0.0474149336418452,0.236756940970401,"L.PvsV.ZERBINI_RESPONSE_TO_SULINDAC_DN"
384,"Down",0.0474816560031855,0.236756940970401,"L.PvsV.SERVITJA_ISLET_HNF1A_TARGETS_UP"
185,"Up",0.0474884151810769,0.236756940970401,"L.PvsV.MORI_MATURE_B_LYMPHOCYTE_UP"
134,"Down",0.0475389238964852,0.236795234435736,"L.PvsV.SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_UP"
879,"Down",0.0476414659908176,0.237092408157723,"L.PvsV.MEISSNER_NPC_HCP_WITH_H3_UNMETHYLATED"
338,"Down",0.0477174930915893,0.23718120698584,"L.PvsV.MIKKELSEN_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3"
18,"Down",0.0477451046075674,0.23718120698584,"L.PvsV.REACTOME_PECAM1_INTERACTIONS"
57,"Down",0.047903840605038,0.237756135282994,"L.PvsV.SMID_BREAST_CANCER_RELAPSE_IN_LUNG_DN"
130,"Up",0.0481315091863864,0.238671851382538,"L.PvsV.WOO_LIVER_CANCER_RECURRENCE_DN"
161,"Up",0.0483387087261005,0.239484516618826,"L.PvsV.WANG_ESOPHAGUS_CANCER_VS_NORMAL_DN"
34,"Down",0.0484201708971445,0.239673343679778,"L.PvsV.SHIN_B_CELL_LYMPHOMA_CLUSTER_7"
29,"Down",0.0486282411228316,0.240487965266669,"L.PvsV.GESERICK_TERT_TARGETS_DN"
70,"Down",0.0487209259778642,0.240731009590359,"L.PvsV.REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK"
227,"Up",0.0489991431524929,0.241763037748567,"L.PvsV.REACTOME_PHOSPHOLIPID_METABOLISM"
89,"Down",0.0490172482033177,0.241763037748567,"L.PvsV.REACTOME_CONSTITUTIVE_SIGNALING_BY_ABERRANT_PI3K_IN_CANCER"
867,"Down",0.0491424133238149,0.242164352288211,"L.PvsV.NABA_MATRISOME_ASSOCIATED"
23,"Down",0.0492043499316799,0.24225365162267,"L.PvsV.HE_PTEN_TARGETS_UP"
101,"Down",0.0493106715469704,0.242561123650533,"L.PvsV.REACTOME_MEIOTIC_RECOMBINATION"
117,"Down",0.0495361006990466,0.243453422902248,"L.PvsV.LINDSTEDT_DENDRITIC_CELL_MATURATION_D"
210,"Down",0.0496286172175878,0.243550761077574,"L.PvsV.HOELZEL_NF1_TARGETS_DN"
46,"Up",0.0496440057396321,0.243550761077574,"L.PvsV.REACTOME_PLASMA_LIPOPROTEIN_CLEARANCE"
272,"Up",0.0498197091129442,0.244068240720019,"L.PvsV.REACTOME_FCERI_MEDIATED_NF_KB_ACTIVATION"
26,"Down",0.049837772431344,0.244068240720019,"L.PvsV.REACTOME_PRESYNAPTIC_FUNCTION_OF_KAINATE_RECEPTORS"
90,"Down",0.0503023818942465,0.246125548224149,"L.PvsV.DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP"
47,"Down",0.050451716308418,0.246580069650097,"L.PvsV.REACTOME_LAMININ_INTERACTIONS"
30,"Down",0.0504844707621468,0.246580069650097,"L.PvsV.REACTOME_REGULATION_OF_IFNA_SIGNALING"
8,"Down",0.0505663103612767,0.246761809344659,"L.PvsV.LE_SKI_TARGETS_DN"
26,"Down",0.0507956963470606,0.247267826798527,"L.PvsV.LOPEZ_MESOTHELIOMA_SURVIVAL_WORST_VS_BEST_UP"
9,"Down",0.0507989675151921,0.247267826798527,"L.PvsV.SEMBA_FHIT_TARGETS_DN"
7,"Down",0.0508041691523109,0.247267826798527,"L.PvsV.DIERICK_SEROTONIN_FUNCTION_GENES"
55,"Down",0.0511145757753695,0.248348776217216,"L.PvsV.AMIT_EGF_RESPONSE_60_MCF10A"
14,"Down",0.0511284315518684,0.248348776217216,"L.PvsV.REACTOME_REDUCTION_OF_CYTOSOLIC_CA_LEVELS"
103,"Down",0.0511610157553644,0.248348776217216,"L.PvsV.OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN"
64,"Down",0.0514827350541807,0.249677346446225,"L.PvsV.LIU_BREAST_CANCER"
436,"Down",0.051567798352406,0.249677346446225,"L.PvsV.MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED"
23,"Down",0.0515701807997087,0.249677346446225,"L.PvsV.REACTOME_SIGNALING_BY_FGFR2_IIIA_TM"
185,"Down",0.051626826419291,0.249732916248696,"L.PvsV.WHITEFORD_PEDIATRIC_CANCER_MARKERS"
8,"Up",0.0516871951286574,0.249806382750303,"L.PvsV.MOOTHA_ROS"
140,"Down",0.0518306218534695,0.250280793212081,"L.PvsV.WARTERS_RESPONSE_TO_IR_SKIN"
15,"Down",0.0520694149300085,0.251040399741106,"L.PvsV.STANHILL_HRAS_TRANSFROMATION_UP"
313,"Down",0.0520787372948179,0.251040399741106,"L.PvsV.CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN"
34,"Up",0.0521412421995441,0.251122759687526,"L.PvsV.RUNNE_GENDER_EFFECT_UP"
48,"Up",0.0523110260182794,0.251576646888976,"L.PvsV.LOPEZ_MBD_TARGETS_IMPRINTED_AND_X_LINKED"
44,"Down",0.0523264865115433,0.251576646888976,"L.PvsV.SHIN_B_CELL_LYMPHOMA_CLUSTER_3"
63,"Down",0.0524763129641513,0.252025392726614,"L.PvsV.JOHANSSON_BRAIN_CANCER_EARLY_VS_LATE_DN"
225,"Down",0.0525538102604244,0.252025392726614,"L.PvsV.HOOI_ST7_TARGETS_DN"
41,"Down",0.052556570413056,0.252025392726614,"L.PvsV.WANG_METASTASIS_OF_BREAST_CANCER"
41,"Down",0.0528147188348373,0.252837338060505,"L.PvsV.ZHAN_MULTIPLE_MYELOMA_SPIKED"
95,"Down",0.0528418470482622,0.252837338060505,"L.PvsV.KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC"
103,"Down",0.0528630788203913,0.252837338060505,"L.PvsV.SANSOM_WNT_PATHWAY_REQUIRE_MYC"
381,"Down",0.053062430531956,0.253571459300938,"L.PvsV.MCBRYAN_PUBERTAL_BREAST_3_4WK_UP"
186,"Down",0.0531120970402848,0.253589623951411,"L.PvsV.BROWNE_HCMV_INFECTION_12HR_DN"
214,"Up",0.0532360565523119,0.253962171421684,"L.PvsV.FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP"
17,"Down",0.0533553809640006,0.254150540216314,"L.PvsV.TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_MONOCYTE_DN"
59,"Down",0.0534599284388839,0.254150540216314,"L.PvsV.CAFFAREL_RESPONSE_TO_THC_DN"
58,"Down",0.0534735212486665,0.254150540216314,"L.PvsV.HARRIS_BRAIN_CANCER_PROGENITORS"
18,"Up",0.0535137436997905,0.254150540216314,"L.PvsV.REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION_IN_TLR7_8_OR_9_SIGNALING"
50,"Up",0.0535457073059349,0.254150540216314,"L.PvsV.BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_DN"
160,"Down",0.0535513437062771,0.254150540216314,"L.PvsV.HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_UP"
109,"Down",0.0536893986263592,0.254587208409211,"L.PvsV.KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM"
11,"Down",0.0538268497808939,0.25499758833013,"L.PvsV.REACTOME_ABACAVIR_METABOLISM"
28,"Down",0.0538681828847154,0.25499758833013,"L.PvsV.HOWLIN_CITED1_TARGETS_2_DN"
11,"Down",0.0539277078622996,0.255060989538627,"L.PvsV.NIKOLSKY_BREAST_CANCER_17P11_AMPLICON"
127,"Down",0.0541258698280713,0.255779431008039,"L.PvsV.PID_SMAD2_3NUCLEAR_PATHWAY"
42,"Down",0.0544412855087982,0.257050271202515,"L.PvsV.REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS"
162,"Down",0.0545868289590857,0.257517557435823,"L.PvsV.WESTON_VEGFA_TARGETS"
30,"Up",0.0546891598369283,0.257780362095802,"L.PvsV.REACTOME_SYNTHESIS_OF_PC"
35,"Down",0.0549056925720069,0.258574420231454,"L.PvsV.TERAMOTO_OPN_TARGETS_CLUSTER_6"
27,"Down",0.0550382868214078,0.258574420231454,"L.PvsV.IIZUKA_LIVER_CANCER_EARLY_RECURRENCE"
19,"Up",0.0550610227865033,0.258574420231454,"L.PvsV.KEGG_GLYOXYLATE_AND_DICARBOXYLATE_METABOLISM"
221,"Down",0.0550706244021268,0.258574420231454,"L.PvsV.HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP"
38,"Down",0.0550914572314438,0.258574420231454,"L.PvsV.DELACROIX_RAR_TARGETS_DN"
5,"Up",0.0551654274016611,0.258701991606263,"L.PvsV.REACTOME_SODIUM_COUPLED_PHOSPHATE_COTRANSPORTERS"
66,"Down",0.0554396488566249,0.259767642820575,"L.PvsV.EPPERT_CE_HSC_LSC"
166,"Down",0.0555733021774708,0.260173401980725,"L.PvsV.LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_UP"
17,"Up",0.0556802533277761,0.260453570769267,"L.PvsV.BENPORATH_ES_CORE_NINE"
38,"Up",0.0558174826457746,0.260874777302187,"L.PvsV.LUI_THYROID_CANCER_CLUSTER_3"
100,"Up",0.0559322421194683,0.261190343478497,"L.PvsV.REACTOME_TOLL_LIKE_RECEPTOR_10_TLR10_CASCADE"
19,"Up",0.0561402943155769,0.26190997021798,"L.PvsV.REACTOME_CARNITINE_METABOLISM"
65,"Down",0.0561810860333739,0.26190997021798,"L.PvsV.GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_UP"
8,"Down",0.0562610042002744,0.262061577273224,"L.PvsV.REACTOME_VEGF_LIGAND_RECEPTOR_INTERACTIONS"
5,"Down",0.0565125686167227,0.262275807364216,"L.PvsV.REACTOME_DISINHIBITION_OF_SNARE_FORMATION"
323,"Down",0.0565304796118873,0.262275807364216,"L.PvsV.DURAND_STROMA_NS_UP"
22,"Up",0.0565991477704569,0.262275807364216,"L.PvsV.BAUS_TFF2_TARGETS_DN"
68,"Down",0.0565998455049513,0.262275807364216,"L.PvsV.CERVERA_SDHB_TARGETS_1_DN"
39,"Down",0.0566185303692,0.262275807364216,"L.PvsV.DUNNE_TARGETS_OF_AML1_MTG8_FUSION_DN"
20,"Up",0.056651990056268,0.262275807364216,"L.PvsV.REACTOME_SUPPRESSION_OF_PHAGOSOMAL_MATURATION"
15,"Up",0.0566537607530719,0.262275807364216,"L.PvsV.REACTOME_PTK6_REGULATES_RTKS_AND_THEIR_EFFECTORS_AKT1_AND_DOK1"
10,"Up",0.0567328319460272,0.262275807364216,"L.PvsV.REACTOME_ORGANIC_ANION_TRANSPORTERS"
130,"Down",0.0567339239659255,0.262275807364216,"L.PvsV.PEDERSEN_TARGETS_OF_611CTF_ISOFORM_OF_ERBB2"
32,"Down",0.0568949233779482,0.262519147010393,"L.PvsV.MATZUK_IMPLANTATION_AND_UTERINE"
11,"Down",0.0569131147541921,0.262519147010393,"L.PvsV.LINDGREN_BLADDER_CANCER_CLUSTER_2A_UP"
73,"Down",0.0570008832616297,0.262519147010393,"L.PvsV.WANG_LSD1_TARGETS_DN"
1597,"Down",0.0570298999731615,0.262519147010393,"L.PvsV.REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION"
109,"Up",0.0571323015006873,0.262519147010393,"L.PvsV.THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP"
52,"Down",0.0571327256803238,0.262519147010393,"L.PvsV.FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_UP"
51,"Down",0.0571735983487536,0.262519147010393,"L.PvsV.PID_AVB3_OPN_PATHWAY"
29,"Down",0.0572459552164033,0.262519147010393,"L.PvsV.PID_HEDGEHOG_2PATHWAY"
39,"Down",0.0572564330268726,0.262519147010393,"L.PvsV.KOBAYASHI_EGFR_SIGNALING_6HR_DN"
14,"Down",0.0572613657613555,0.262519147010393,"L.PvsV.REACTOME_CS_DS_DEGRADATION"
45,"Up",0.0573952935151225,0.26277356882046,"L.PvsV.REACTOME_SYNTHESIS_OF_PA"
7,"Up",0.0574431108752608,0.26277356882046,"L.PvsV.REACTOME_INTERLEUKIN_36_PATHWAY"
63,"Down",0.0574594401707247,0.26277356882046,"L.PvsV.ZHAN_MULTIPLE_MYELOMA_LB_DN"
668,"Down",0.0578275062210274,0.264196573637181,"L.PvsV.HATADA_METHYLATED_IN_LUNG_CANCER_UP"
5,"Down",0.0578661694112182,0.264196573637181,"L.PvsV.REACTOME_TOXICITY_OF_BOTULINUM_TOXIN_TYPE_D_BONT_D"
1863,"Up",0.0580052510380841,0.264321292900817,"L.PvsV.BLALOCK_ALZHEIMERS_DISEASE_DN"
115,"Down",0.0580224127862819,0.264321292900817,"L.PvsV.REACTOME_RECRUITMENT_OF_MITOTIC_CENTROSOME_PROTEINS_AND_COMPLEXES"
671,"Down",0.0580571087928681,0.264321292900817,"L.PvsV.PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_7"
37,"Down",0.0580847116792355,0.264321292900817,"L.PvsV.GHO_ATF5_TARGETS_UP"
46,"Up",0.0582117117118345,0.264681376689748,"L.PvsV.CHANGOLKAR_H2AFY_TARGETS_DN"
357,"Up",0.0582943076977072,0.264839134971753,"L.PvsV.REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION"
259,"Down",0.058410348151592,0.265032535669655,"L.PvsV.MIKKELSEN_MCV6_LCP_WITH_H3K4ME3"
136,"Down",0.0584327475097323,0.265032535669655,"L.PvsV.MIKKELSEN_ES_HCP_WITH_H3_UNMETHYLATED"
58,"Down",0.0585459744105434,0.265328436488438,"L.PvsV.HUMMERICH_MALIGNANT_SKIN_TUMOR_UP"
261,"Down",0.0586392613937665,0.265446724482412,"L.PvsV.KAUFFMANN_DNA_REPAIR_GENES"
154,"Down",0.0586953391835834,0.265446724482412,"L.PvsV.OUILLETTE_CLL_13Q14_DELETION_UP"
103,"Up",0.0587161049090232,0.265446724482412,"L.PvsV.REACTOME_GLUCOSE_METABOLISM"
16,"Up",0.0588124352390948,0.265664995455029,"L.PvsV.REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_CELL_DEATH_GENES"
16,"Down",0.0590292543558951,0.266426732517342,"L.PvsV.BIOCARTA_AGPCR_PATHWAY"
129,"Down",0.0592798836285937,0.267339703574628,"L.PvsV.REACTOME_RUNX1_REGULATES_GENES_INVOLVED_IN_MEGAKARYOCYTE_DIFFERENTIATION_AND_PLATELET_FUNCTION"
93,"Down",0.0593355763767749,0.267372780592656,"L.PvsV.VERNELL_RETINOBLASTOMA_PATHWAY_UP"
12,"Down",0.0594561269211629,0.267697822269633,"L.PvsV.SCIAN_CELL_CYCLE_TARGETS_OF_TP53_AND_TP73_UP"
19,"Down",0.0596182415322626,0.268209322564589,"L.PvsV.BIOCARTA_HES_PATHWAY"
32,"Down",0.0596935948637912,0.268212573459009,"L.PvsV.REACTOME_G1_S_SPECIFIC_TRANSCRIPTION"
66,"Up",0.0597159844326352,0.268212573459009,"L.PvsV.REACTOME_REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF"
8,"Down",0.0600350829637211,0.269231095429647,"L.PvsV.BIOCARTA_ION_PATHWAY"
533,"Down",0.0600401411945658,0.269231095429647,"L.PvsV.HORIUCHI_WTAP_TARGETS_UP"
19,"Down",0.0601405678443216,0.269462884612037,"L.PvsV.MATZUK_PREOVULATORY_FOLLICLE"
59,"Down",0.0602205084862293,0.269489154035588,"L.PvsV.REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN"
125,"Down",0.0602439128934685,0.269489154035588,"L.PvsV.MORI_LARGE_PRE_BII_LYMPHOCYTE_DN"
397,"Down",0.060354953894397,0.269767615264447,"L.PvsV.BASAKI_YBX1_TARGETS_UP"
236,"Up",0.0605127294795671,0.270254346762946,"L.PvsV.REACTOME_PROGRAMMED_CELL_DEATH"
9,"Up",0.0606653391933193,0.270331174358948,"L.PvsV.SCHUHMACHER_MYC_TARGETS_DN"
499,"Down",0.060693511798652,0.270331174358948,"L.PvsV.KAYO_AGING_MUSCLE_UP"
667,"Down",0.0607350928006133,0.270331174358948,"L.PvsV.CHYLA_CBFA2T3_TARGETS_UP"
382,"Down",0.0607528835887202,0.270331174358948,"L.PvsV.CAIRO_HEPATOBLASTOMA_CLASSES_DN"
60,"Down",0.0607743985762655,0.270331174358948,"L.PvsV.REACTOME_METABOLIC_DISORDERS_OF_BIOLOGICAL_OXIDATION_ENZYMES"
12,"Down",0.0608689252215222,0.270533993207232,"L.PvsV.SIMBULAN_UV_RESPONSE_NORMAL_UP"
33,"Up",0.061037434179255,0.271065039017752,"L.PvsV.BIOCARTA_TOLL_PATHWAY"
61,"Down",0.0612192146919606,0.271654123621068,"L.PvsV.REACTOME_KINESINS"
154,"Down",0.0612881283713271,0.271741829803582,"L.PvsV.ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_DN"
462,"Down",0.0614649689282389,0.272307542631597,"L.PvsV.MULLIGHAN_MLL_SIGNATURE_2_DN"
29,"Down",0.0615320642506426,0.2723865358221,"L.PvsV.BIOCARTA_ACE2_PATHWAY"
156,"Down",0.0617692532603105,0.273112691538967,"L.PvsV.LEIN_CHOROID_PLEXUS_MARKERS"
334,"Down",0.0618133219039812,0.273112691538967,"L.PvsV.VERHAAK_GLIOBLASTOMA_PRONEURAL"
16,"Up",0.06184429188041,0.273112691538967,"L.PvsV.YAGUE_PRETUMOR_DRUG_RESISTANCE_UP"
17,"Up",0.0619759261153367,0.273475575013325,"L.PvsV.SANDERSON_PPARA_TARGETS"
102,"Up",0.062065755675956,0.273653559116715,"L.PvsV.REACTOME_E3_UBIQUITIN_LIGASES_UBIQUITINATE_TARGET_PROTEINS"
11,"Up",0.0623269030409275,0.274586013476724,"L.PvsV.BIOCARTA_TCAPOPTOSIS_PATHWAY"
37,"Down",0.062517505957701,0.275206441433224,"L.PvsV.REACTOME_FGFR2_MUTANT_RECEPTOR_ACTIVATION"
266,"Down",0.0626408289250383,0.275485533085526,"L.PvsV.MIKKELSEN_IPS_LCP_WITH_H3K4ME3"
81,"Up",0.0626805571751838,0.275485533085526,"L.PvsV.BOYAULT_LIVER_CANCER_SUBCLASS_G123_DN"
34,"Down",0.0629008667332417,0.27623422729793,"L.PvsV.KANG_CISPLATIN_RESISTANCE_UP"
26,"Down",0.0633674956940122,0.277907733453835,"L.PvsV.SMID_BREAST_CANCER_NORMAL_LIKE_DN"
141,"Down",0.0634244641525376,0.277907733453835,"L.PvsV.CROONQUIST_STROMAL_STIMULATION_UP"
633,"Down",0.0634327291768384,0.277907733453835,"L.PvsV.HADDAD_B_LYMPHOCYTE_PROGENITOR"
682,"Down",0.0637443638040034,0.279051929906837,"L.PvsV.YAGI_AML_WITH_T_8_21_TRANSLOCATION"
496,"Down",0.0637978201292393,0.279064990106459,"L.PvsV.VERHAAK_AML_WITH_NPM1_MUTATED_DN"
77,"Down",0.0638613387506387,0.279117458178091,"L.PvsV.DOANE_BREAST_CANCER_ESR1_DN"
30,"Up",0.0639214351497776,0.279117458178091,"L.PvsV.WOTTON_RUNX_TARGETS_UP"
95,"Down",0.0639612623461099,0.279117458178091,"L.PvsV.RAMASWAMY_METASTASIS_DN"
8,"Down",0.0640850221032154,0.27943697729391,"L.PvsV.BIOCARTA_BARD1_PATHWAY"
439,"Down",0.0642443095916005,0.279822083308697,"L.PvsV.MCBRYAN_PUBERTAL_BREAST_4_5WK_UP"
10,"Up",0.0643543100916018,0.279822083308697,"L.PvsV.KIM_ALL_DISORDERS_DURATION_CORR_UP"
49,"Down",0.0644303045867544,0.279822083308697,"L.PvsV.REACTOME_NGF_STIMULATED_TRANSCRIPTION"
137,"Down",0.06448372039082,0.279822083308697,"L.PvsV.KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS"
318,"Down",0.0645089724499235,0.279822083308697,"L.PvsV.VANTVEER_BREAST_CANCER_ESR1_UP"
114,"Down",0.0646214251847697,0.279822083308697,"L.PvsV.REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES"
57,"Down",0.0647032888477759,0.279822083308697,"L.PvsV.RIZ_ERYTHROID_DIFFERENTIATION_HBZ"
53,"Up",0.0647394001147703,0.279822083308697,"L.PvsV.BIOCARTA_P38MAPK_PATHWAY"
60,"Down",0.0647663985241169,0.279822083308697,"L.PvsV.PID_SYNDECAN_1_PATHWAY"
15,"Up",0.064783381366947,0.279822083308697,"L.PvsV.PID_P38_GAMMA_DELTA_PATHWAY"
14,"Down",0.0647891199025456,0.279822083308697,"L.PvsV.REACTOME_LGI_ADAM_INTERACTIONS"
7,"Up",0.0648095068308181,0.279822083308697,"L.PvsV.REACTOME_VITAMIN_B2_RIBOFLAVIN_METABOLISM"
5,"Down",0.0648312694372294,0.279822083308697,"L.PvsV.NAKAMURA_ALVEOLAR_EPITHELIUM"
167,"Down",0.0649292440853752,0.280026357681778,"L.PvsV.MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_UP"
83,"Up",0.0650596297435777,0.280369986634638,"L.PvsV.KEGG_EPITHELIAL_CELL_SIGNALING_IN_HELICOBACTER_PYLORI_INFECTION"
42,"Down",0.0652635514423677,0.2810297320287,"L.PvsV.REACTOME_SEMA4D_INDUCED_CELL_MIGRATION_AND_GROWTH_CONE_COLLAPSE"
601,"Down",0.0653483653851732,0.281175962812936,"L.PvsV.VECCHI_GASTRIC_CANCER_EARLY_UP"
48,"Down",0.0654774772798122,0.281512419813438,"L.PvsV.MILICIC_FAMILIAL_ADENOMATOUS_POLYPOSIS_UP"
59,"Up",0.0658343729236757,0.282633488774308,"L.PvsV.PID_CXCR3_PATHWAY"
18,"Down",0.0658404654623457,0.282633488774308,"L.PvsV.REACTOME_FGFR1C_LIGAND_BINDING_AND_ACTIVATION"
11,"Up",0.0659935786475531,0.282787863591452,"L.PvsV.REACTOME_REGULATION_OF_FOXO_TRANSCRIPTIONAL_ACTIVITY_BY_ACETYLATION"
52,"Down",0.0660277292616132,0.282787863591452,"L.PvsV.REACTOME_ATTENUATION_PHASE"
15,"Down",0.066095219851831,0.282787863591452,"L.PvsV.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_DN"
19,"Down",0.0661253989536106,0.282787863591452,"L.PvsV.LIU_CDX2_TARGETS_DN"
51,"Down",0.0661321590927379,0.282787863591452,"L.PvsV.LE_SKI_TARGETS_UP"
121,"Down",0.0662019652841025,0.282833211056632,"L.PvsV.HENDRICKS_SMARCA4_TARGETS_UP"
110,"Up",0.0662450729459827,0.282833211056632,"L.PvsV.TOOKER_GEMCITABINE_RESISTANCE_UP"
1519,"Down",0.0666094195962568,0.284038949207511,"L.PvsV.BENPORATH_EED_TARGETS"
58,"Up",0.0666302255601632,0.284038949207511,"L.PvsV.TOMLINS_PROSTATE_CANCER_UP"
8,"Down",0.0666999986132304,0.284117328453429,"L.PvsV.REACTOME_DEFECTIVE_CHST6_CAUSES_MCDC1"
56,"Up",0.0669226195718543,0.284634889673944,"L.PvsV.KEGG_STARCH_AND_SUCROSE_METABOLISM"
22,"Down",0.0669659332285476,0.284634889673944,"L.PvsV.REACTOME_REGULATION_OF_KIT_SIGNALING"
88,"Down",0.0670185774164318,0.284634889673944,"L.PvsV.GALE_APL_WITH_FLT3_MUTATED_UP"
55,"Up",0.0670274238298925,0.284634889673944,"L.PvsV.FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN"
66,"Down",0.0672046742516659,0.285146918337178,"L.PvsV.SIMBULAN_UV_RESPONSE_IMMORTALIZED_DN"
80,"Down",0.0672764663868953,0.285146918337178,"L.PvsV.REACTOME_TRANSCRIPTIONAL_REGULATION_BY_MECP2"
43,"Down",0.0673027181099687,0.285146918337178,"L.PvsV.REACTOME_EXPORT_OF_VIRAL_RIBONUCLEOPROTEINS_FROM_NUCLEUS"
26,"Down",0.0675576746095976,0.285998497649087,"L.PvsV.TRAYNOR_RETT_SYNDROM_DN"
173,"Down",0.0676071688239023,0.285998497649087,"L.PvsV.CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP"
99,"Down",0.067822758022133,0.286691153749521,"L.PvsV.BILBAN_B_CLL_LPL_DN"
14,"Up",0.068021224755151,0.287310429084209,"L.PvsV.XU_HGF_TARGETS_REPRESSED_BY_AKT1_UP"
203,"Down",0.0682283578305912,0.287594310595683,"L.PvsV.MIKKELSEN_IPS_WITH_HCP_H3K27ME3"
110,"Up",0.0682439071944214,0.287594310595683,"L.PvsV.KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY"
50,"Up",0.068244481009502,0.287594310595683,"L.PvsV.REACTOME_LYSOSOME_VESICLE_BIOGENESIS"
92,"Down",0.0683311563089982,0.287740261410854,"L.PvsV.MALONEY_RESPONSE_TO_17AAG_UP"
28,"Down",0.0686334169959382,0.288793122199804,"L.PvsV.OSAWA_TNF_TARGETS"
46,"Down",0.0687429433571068,0.289000867957151,"L.PvsV.MEISSNER_BRAIN_ICP_WITH_H3K4ME3"
37,"Down",0.0688097013072148,0.289000867957151,"L.PvsV.TERAMOTO_OPN_TARGETS_CLUSTER_4"
7,"Down",0.0688395990413398,0.289000867957151,"L.PvsV.REACTOME_SULFIDE_OXIDATION_TO_SULFATE"
74,"Up",0.068934441935443,0.289179460896103,"L.PvsV.SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_DN"
276,"Down",0.0690844384512186,0.289588976646541,"L.PvsV.FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP"
17,"Down",0.0691634612859126,0.289668199176487,"L.PvsV.SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_UP"
102,"Down",0.069208119210009,0.289668199176487,"L.PvsV.HUPER_BREAST_BASAL_VS_LUMINAL_UP"
50,"Down",0.069779284369044,0.291837869346781,"L.PvsV.LASTOWSKA_COAMPLIFIED_WITH_MYCN"
9,"Up",0.0698337794608795,0.291845023914741,"L.PvsV.REACTOME_SERINE_BIOSYNTHESIS"
12,"Up",0.0700782881225187,0.292354386835835,"L.PvsV.BOYAULT_LIVER_CANCER_SUBCLASS_G23_DN"
86,"Down",0.0701165138587323,0.292354386835835,"L.PvsV.PID_INTEGRIN1_PATHWAY"
18,"Down",0.0701207165828181,0.292354386835835,"L.PvsV.BIOCARTA_MCM_PATHWAY"
30,"Up",0.0701671679021799,0.292354386835835,"L.PvsV.REACTOME_CD28_DEPENDENT_PI3K_AKT_SIGNALING"
34,"Down",0.0702278810467848,0.292387013785898,"L.PvsV.REACTOME_SIGNALING_BY_BMP"
165,"Down",0.0705448306616719,0.293339200128432,"L.PvsV.RAGHAVACHARI_PLATELET_SPECIFIC_GENES"
25,"Down",0.0705626941889698,0.293339200128432,"L.PvsV.NAKAMURA_LUNG_CANCER"
28,"Down",0.0707015096223854,0.293695452067745,"L.PvsV.NELSON_RESPONSE_TO_ANDROGEN_DN"
73,"Up",0.0710289102140709,0.294833967397596,"L.PvsV.SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_UP"
150,"Down",0.0711229066645199,0.294933642771399,"L.PvsV.TANAKA_METHYLATED_IN_ESOPHAGEAL_CARCINOMA"
147,"Down",0.0711596092344089,0.294933642771399,"L.PvsV.PUJANA_BRCA_CENTERED_NETWORK"
68,"Down",0.0714596242247058,0.295791755028972,"L.PvsV.PID_FRA_PATHWAY"
121,"Down",0.0714736452737758,0.295791755028972,"L.PvsV.YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_1"
7,"Down",0.071655485135741,0.296154720148382,"L.PvsV.REACTOME_PHOSPHORYLATION_OF_EMI1"
98,"Down",0.0716684781259786,0.296154720148382,"L.PvsV.REACTOME_DNA_DAMAGE_TELOMERE_STRESS_INDUCED_SENESCENCE"
260,"Down",0.0718845163005331,0.296714404299453,"L.PvsV.REACTOME_KERATINIZATION"
128,"Up",0.071952711379797,0.296714404299453,"L.PvsV.TIEN_INTESTINE_PROBIOTICS_2HR_DN"
7,"Down",0.0719649152044793,0.296714404299453,"L.PvsV.REACTOME_ACROSOME_REACTION_AND_SPERM_OOCYTE_MEMBRANE_BINDING"
15,"Down",0.0720698523098176,0.296822368228196,"L.PvsV.CHESLER_BRAIN_D6MIT150_QTL_CIS"
944,"Down",0.072098469981998,0.296822368228196,"L.PvsV.MIKKELSEN_MEF_HCP_WITH_H3K27ME3"
120,"Down",0.0722975575001276,0.297420532305212,"L.PvsV.CHUNG_BLISTER_CYTOTOXICITY_DN"
173,"Down",0.0727816232937225,0.298880743979818,"L.PvsV.HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_DN"
56,"Up",0.0727837367976157,0.298880743979818,"L.PvsV.FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_UP"
14,"Down",0.0728269671720497,0.298880743979818,"L.PvsV.XU_AKT1_TARGETS_48HR"
16,"Down",0.0728687362786751,0.298880743979818,"L.PvsV.REACTOME_SUMOYLATION_OF_DNA_METHYLATION_PROTEINS"
25,"Down",0.0730899017233592,0.299565653542219,"L.PvsV.MIKKELSEN_ES_LCP_WITH_H3K27ME3"
106,"Down",0.0732276382329333,0.299907860585102,"L.PvsV.PID_AR_PATHWAY"
15,"Down",0.0733741178047882,0.300240071392717,"L.PvsV.REACTOME_SIGNAL_ATTENUATION"
92,"Down",0.0734173587489515,0.300240071392717,"L.PvsV.REACTOME_SIGNALING_BY_NOTCH1"
36,"Up",0.0735611995255828,0.300466908611307,"L.PvsV.BARIS_THYROID_CANCER_UP"
52,"Down",0.0736317690139151,0.300466908611307,"L.PvsV.HUNSBERGER_EXERCISE_REGULATED_GENES"
373,"Down",0.0736740125393382,0.300466908611307,"L.PvsV.MEISSNER_BRAIN_HCP_WITH_H3K27ME3"
32,"Down",0.0736902022204616,0.300466908611307,"L.PvsV.BIOCARTA_PAR1_PATHWAY"
24,"Down",0.0739253575347758,0.301068646372615,"L.PvsV.XU_CREBBP_TARGETS_UP"
28,"Down",0.0739466850739756,0.301068646372615,"L.PvsV.PID_CONE_PATHWAY"
87,"Down",0.0740530712621639,0.301279934516927,"L.PvsV.HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_DN"
12,"Up",0.0742070021950198,0.301684202306077,"L.PvsV.REACTOME_REGULATION_OF_SIGNALING_BY_NODAL"
24,"Down",0.0744763928777005,0.302556925952098,"L.PvsV.PID_THROMBIN_PAR4_PATHWAY"
30,"Up",0.0747532435190664,0.303221456882655,"L.PvsV.REACTOME_ZBP1_DAI_MEDIATED_INDUCTION_OF_TYPE_I_IFNS"
26,"Up",0.074757052363611,0.303221456882655,"L.PvsV.PARK_HSC_VS_MULTIPOTENT_PROGENITORS_DN"
69,"Up",0.074841443837709,0.303221456882655,"L.PvsV.JIANG_AGING_HYPOTHALAMUS_UP"
2398,"Down",0.0748860884006666,0.303221456882655,"L.PvsV.DODD_NASOPHARYNGEAL_CARCINOMA_UP"
79,"Up",0.0749462550306239,0.303221456882655,"L.PvsV.HOLLERN_MICROACINAR_BREAST_TUMOR_UP"
52,"Down",0.0749690236134182,0.303221456882655,"L.PvsV.REACTOME_CHONDROITIN_SULFATE_DERMATAN_SULFATE_METABOLISM"
5,"Down",0.0752946179271953,0.304315747455748,"L.PvsV.JONES_TCOF1_TARGETS"
167,"Down",0.0756004740248954,0.305328722340136,"L.PvsV.HOOI_ST7_TARGETS_UP"
55,"Down",0.0757016476344279,0.305514167715877,"L.PvsV.NABA_BASEMENT_MEMBRANES"
8,"Up",0.0763906731086504,0.307760174218723,"L.PvsV.REACTOME_BETA_OXIDATION_OF_BUTANOYL_COA_TO_ACETYL_COA"
32,"Up",0.0764190051249179,0.307760174218723,"L.PvsV.REACTOME_CASPASE_ACTIVATION_VIA_EXTRINSIC_APOPTOTIC_SIGNALLING_PATHWAY"
12,"Up",0.076425161729482,0.307760174218723,"L.PvsV.BIOCARTA_EEA1_PATHWAY"
117,"Down",0.0765374291375644,0.307929877103149,"L.PvsV.HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_UP"
238,"Down",0.0765786907246933,0.307929877103149,"L.PvsV.YAUCH_HEDGEHOG_SIGNALING_PARACRINE_UP"
70,"Down",0.0766705993980261,0.307972524329513,"L.PvsV.ROZANOV_MMP14_TARGETS_SUBSET"
172,"Up",0.0767723853433374,0.307972524329513,"L.PvsV.REACTOME_BETA_CATENIN_INDEPENDENT_WNT_SIGNALING"
103,"Down",0.0767937768305636,0.307972524329513,"L.PvsV.BOSCO_EPITHELIAL_DIFFERENTIATION_MODULE"
11,"Up",0.0768121018358472,0.307972524329513,"L.PvsV.MARIADASON_RESPONSE_TO_BUTYRATE_CURCUMIN_SULINDAC_TSA_2"
14,"Down",0.0770243755684754,0.308491766257422,"L.PvsV.REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_G1_CELL_CYCLE_ARREST"
168,"Up",0.0770888501359291,0.308491766257422,"L.PvsV.TOOKER_GEMCITABINE_RESISTANCE_DN"
12,"Down",0.077108992759587,0.308491766257422,"L.PvsV.KUMAMOTO_RESPONSE_TO_NUTLIN_3A_UP"
50,"Down",0.0772557014920551,0.308855223101643,"L.PvsV.VERRECCHIA_RESPONSE_TO_TGFB1_C4"
886,"Up",0.0773374432995812,0.308958615609382,"L.PvsV.SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_DN"
110,"Up",0.0774458557601797,0.309065535715145,"L.PvsV.PID_IL12_2PATHWAY"
35,"Down",0.0775144825665224,0.309065535715145,"L.PvsV.PID_PRL_SIGNALING_EVENTS_PATHWAY"
30,"Down",0.0775319041484728,0.309065535715145,"L.PvsV.REACTOME_ESTROGEN_DEPENDENT_NUCLEAR_EVENTS_DOWNSTREAM_OF_ESR_MEMBRANE_SIGNALING"
61,"Down",0.0776432640939806,0.309145196963302,"L.PvsV.ZHAN_MULTIPLE_MYELOMA_MF_DN"
137,"Down",0.0777146291267715,0.309145196963302,"L.PvsV.KRASNOSELSKAYA_ILF3_TARGETS_UP"
305,"Down",0.0777196281025482,0.309145196963302,"L.PvsV.WIERENGA_STAT5A_TARGETS_DN"
10,"Down",0.0778124085970868,0.309291737694675,"L.PvsV.BIOCARTA_TUBBY_PATHWAY"
390,"Down",0.0780271708481128,0.309724565681092,"L.PvsV.ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP"
233,"Down",0.078092503825104,0.309724565681092,"L.PvsV.ZHU_CMV_ALL_DN"
78,"Up",0.0780998256379921,0.309724565681092,"L.PvsV.STEARMAN_TUMOR_FIELD_EFFECT_UP"
42,"Up",0.078187735858771,0.309724565681092,"L.PvsV.REACTOME_REGULATION_OF_TP53_EXPRESSION_AND_DEGRADATION"
47,"Down",0.0782013915157902,0.309724565681092,"L.PvsV.REACTOME_SEMA4D_IN_SEMAPHORIN_SIGNALING"
111,"Up",0.0784695955794261,0.310564347858731,"L.PvsV.REACTOME_TOLL_LIKE_RECEPTOR_9_TLR9_CASCADE"
22,"Down",0.0785902720511146,0.310819466502584,"L.PvsV.EGUCHI_CELL_CYCLE_RB1_TARGETS"
10,"Down",0.0787314482784207,0.311051889064769,"L.PvsV.MATZUK_CUMULUS_EXPANSION"
24,"Up",0.0787615562833562,0.311051889064769,"L.PvsV.RUAN_RESPONSE_TO_TROGLITAZONE_DN"
47,"Down",0.0789524533083869,0.311583236503976,"L.PvsV.KAMMINGA_EZH2_TARGETS"
17,"Up",0.0795847262943549,0.31373583200693,"L.PvsV.REACTOME_P75NTR_RECRUITS_SIGNALLING_COMPLEXES"
22,"Down",0.0796406984903179,0.31373583200693,"L.PvsV.BIOCARTA_CALCINEURIN_PATHWAY"
13,"Up",0.0796970319596718,0.31373583200693,"L.PvsV.REACTOME_MITOCHONDRIAL_IRON_SULFUR_CLUSTER_BIOGENESIS"
409,"Down",0.0797248768257799,0.31373583200693,"L.PvsV.PEDRIOLI_MIR31_TARGETS_UP"
19,"Down",0.079961952726979,0.314444976264201,"L.PvsV.SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX5_UP"
57,"Down",0.0800584598900365,0.314453672188718,"L.PvsV.WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_UP"
152,"Down",0.0800779110945407,0.314453672188718,"L.PvsV.RIGGINS_TAMOXIFEN_RESISTANCE_UP"
142,"Down",0.0803614506399009,0.315301437065168,"L.PvsV.KORKOLA_YOLK_SAC_TUMOR"
103,"Down",0.0804078542705528,0.315301437065168,"L.PvsV.WESTON_VEGFA_TARGETS_3HR"
259,"Down",0.0806904828479951,0.316144856476035,"L.PvsV.BROWNE_HCMV_INFECTION_30MIN_DN"
22,"Down",0.0807373010208287,0.316144856476035,"L.PvsV.BIOCARTA_NPP1_PATHWAY"
99,"Down",0.0810036351959064,0.316963268930054,"L.PvsV.LEE_TARGETS_OF_PTCH1_AND_SUFU_UP"
121,"Down",0.0811871925094233,0.317134444928031,"L.PvsV.DELPUECH_FOXO3_TARGETS_UP"
70,"Down",0.0812003722605534,0.317134444928031,"L.PvsV.MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_DN"
71,"Down",0.0812194563244875,0.317134444928031,"L.PvsV.WEINMANN_ADAPTATION_TO_HYPOXIA_DN"
138,"Down",0.0814316416237937,0.317291785561087,"L.PvsV.REACTOME_GLYCOSAMINOGLYCAN_METABOLISM"
44,"Down",0.0814512716384861,0.317291785561087,"L.PvsV.REACTOME_DISEASES_ASSOCIATED_WITH_GLYCOSAMINOGLYCAN_METABOLISM"
103,"Down",0.0814585269988334,0.317291785561087,"L.PvsV.FIGUEROA_AML_METHYLATION_CLUSTER_2_UP"
106,"Down",0.0814892992397799,0.317291785561087,"L.PvsV.RICKMAN_HEAD_AND_NECK_CANCER_B"
20,"Up",0.0815983314987704,0.317423967098898,"L.PvsV.REACTOME_SYNTHESIS_OF_PIPS_AT_THE_GOLGI_MEMBRANE"
17,"Up",0.0816380685864773,0.317423967098898,"L.PvsV.STARK_BRAIN_22Q11_DELETION"
168,"Down",0.0817018851916533,0.317448856798771,"L.PvsV.BROWNE_HCMV_INFECTION_16HR_DN"
75,"Down",0.0821135296613551,0.318824231388787,"L.PvsV.FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_DN"
214,"Down",0.0821757516861422,0.318841916542232,"L.PvsV.NIKOLSKY_BREAST_CANCER_8Q23_Q24_AMPLICON"
134,"Down",0.0823631887503019,0.319154962672643,"L.PvsV.SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM3"
24,"Up",0.0824031401355823,0.319154962672643,"L.PvsV.REACTOME_CONSTITUTIVE_SIGNALING_BY_EGFRVIII"
8,"Down",0.0824994915722794,0.319154962672643,"L.PvsV.REACTOME_ACTIVATION_OF_NIMA_KINASES_NEK9_NEK6_NEK7"
210,"Down",0.0826006121229329,0.319154962672643,"L.PvsV.MIKKELSEN_ES_LCP_WITH_H3K4ME3"
388,"Down",0.0826729436417,0.319154962672643,"L.PvsV.MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_DN"
115,"Up",0.082674855166431,0.319154962672643,"L.PvsV.SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE"
266,"Down",0.0826834690498364,0.319154962672643,"L.PvsV.ALCALAY_AML_BY_NPM1_LOCALIZATION_UP"
735,"Down",0.0828070709646681,0.319154962672643,"L.PvsV.BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP"
15,"Up",0.0828133035011038,0.319154962672643,"L.PvsV.REACTOME_SIGNALING_BY_FGFR4_IN_DISEASE"
8,"Down",0.0828525693114135,0.319154962672643,"L.PvsV.REACTOME_DNA_REPLICATION_INITIATION"
12,"Down",0.0828913956227012,0.319154962672643,"L.PvsV.REACTOME_MECP2_REGULATES_TRANSCRIPTION_OF_NEURONAL_LIGANDS"
87,"Down",0.083177322853309,0.320032997951249,"L.PvsV.WESTON_VEGFA_TARGETS_6HR"
796,"Up",0.0838552046808922,0.32194191879799,"L.PvsV.MILI_PSEUDOPODIA_HAPTOTAXIS_UP"
136,"Down",0.0838992883248424,0.32194191879799,"L.PvsV.DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_DN"
62,"Down",0.0839097524827533,0.32194191879799,"L.PvsV.REACTOME_APOPTOTIC_CLEAVAGE_OF_CELLULAR_PROTEINS"
646,"Down",0.0839723231339327,0.32194191879799,"L.PvsV.MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP"
22,"Up",0.0839960633218036,0.32194191879799,"L.PvsV.LANDIS_ERBB2_BREAST_PRENEOPLASTIC_UP"
161,"Down",0.0840636650224924,0.32194191879799,"L.PvsV.REACTOME_HCMV_EARLY_EVENTS"
46,"Down",0.0841385573883169,0.32194191879799,"L.PvsV.ONGUSAHA_TP53_TARGETS"
233,"Down",0.0841970237791188,0.32194191879799,"L.PvsV.REACTOME_CELLULAR_SENESCENCE"
315,"Down",0.0842317198792191,0.32194191879799,"L.PvsV.BENPORATH_NOS_TARGETS"
257,"Down",0.0842557345814238,0.32194191879799,"L.PvsV.RICKMAN_HEAD_AND_NECK_CANCER_A"
98,"Down",0.0843454617468193,0.322047906764886,"L.PvsV.SLEBOS_HEAD_AND_NECK_CANCER_WITH_HPV_UP"
101,"Down",0.0843999668841238,0.322047906764886,"L.PvsV.FURUKAWA_DUSP6_TARGETS_PCI35_DN"
15,"Up",0.0846469576879181,0.322377313100206,"L.PvsV.REACTOME_N_GLYCAN_ANTENNAE_ELONGATION"
325,"Up",0.0846669028329776,0.322377313100206,"L.PvsV.PURBEY_TARGETS_OF_CTBP1_AND_SATB1_DN"
34,"Up",0.0847215451867537,0.322377313100206,"L.PvsV.DEMAGALHAES_AGING_DN"
88,"Down",0.0847724006773801,0.322377313100206,"L.PvsV.LEE_AGING_MUSCLE_DN"
26,"Down",0.0847778284043588,0.322377313100206,"L.PvsV.SCHWAB_TARGETS_OF_BMYB_POLYMORPHIC_VARIANTS_DN"
324,"Down",0.0850894713356701,0.323296786203601,"L.PvsV.SERVITJA_LIVER_HNF1A_TARGETS_DN"
45,"Up",0.0851365745546109,0.323296786203601,"L.PvsV.PID_IL1_PATHWAY"
522,"Down",0.085197031780609,0.323304316207953,"L.PvsV.PASINI_SUZ12_TARGETS_DN"
56,"Down",0.085292721395411,0.323445443480951,"L.PvsV.MCCABE_HOXC6_TARGETS_CANCER_UP"
33,"Down",0.0854559893055816,0.323842470781741,"L.PvsV.GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_UP"
62,"Down",0.0858148101256614,0.324979510400535,"L.PvsV.LY_AGING_PREMATURE_DN"
78,"Down",0.0860991068445066,0.32563162393883,"L.PvsV.REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS"
35,"Down",0.0861758423981676,0.32563162393883,"L.PvsV.MASRI_RESISTANCE_TO_TAMOXIFEN_AND_AROMATASE_INHIBITORS_UP"
20,"Down",0.0862120453942314,0.32563162393883,"L.PvsV.REACTOME_DEFECTIVE_B4GALT7_CAUSES_EDS_PROGEROID_TYPE"
1236,"Down",0.0862225895182578,0.32563162393883,"L.PvsV.GEORGES_TARGETS_OF_MIR192_AND_MIR215"
38,"Down",0.0865511648281173,0.326649413197721,"L.PvsV.REACTOME_KERATAN_SULFATE_KERATIN_METABOLISM"
32,"Up",0.0866744123676209,0.326712467728533,"L.PvsV.LANDIS_ERBB2_BREAST_TUMORS_65_UP"
102,"Up",0.0867202167087013,0.326712467728533,"L.PvsV.KEGG_CARDIAC_MUSCLE_CONTRACTION"
518,"Down",0.0867498887907786,0.326712467728533,"L.PvsV.CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN"
17,"Up",0.086804234959887,0.326712467728533,"L.PvsV.REACTOME_DOWNREGULATION_OF_ERBB2_ERBB3_SIGNALING"
49,"Up",0.087052446682153,0.327338411590666,"L.PvsV.PACHER_TARGETS_OF_IGF1_AND_IGF2_UP"
21,"Up",0.0871360785170418,0.327338411590666,"L.PvsV.TIAN_BHLHA15_TARGETS"
121,"Down",0.0872021217782846,0.327338411590666,"L.PvsV.PEART_HDAC_PROLIFERATION_CLUSTER_DN"
83,"Up",0.0872218970515912,0.327338411590666,"L.PvsV.CHNG_MULTIPLE_MYELOMA_HYPERPLOID_UP"
63,"Up",0.087266561527336,0.327338411590666,"L.PvsV.REACTOME_CARGO_CONCENTRATION_IN_THE_ER"
30,"Down",0.0874445211580848,0.327518348223456,"L.PvsV.SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_UP"
97,"Down",0.0876052270379147,0.327518348223456,"L.PvsV.KEGG_ECM_RECEPTOR_INTERACTION"
14,"Down",0.0876743194858288,0.327518348223456,"L.PvsV.BIOCARTA_P35ALZHEIMERS_PATHWAY"
342,"Up",0.0876941207244826,0.327518348223456,"L.PvsV.JIANG_HYPOXIA_NORMAL"
27,"Down",0.0877048093191959,0.327518348223456,"L.PvsV.PID_INTEGRIN5_PATHWAY"
19,"Up",0.0877407462815726,0.327518348223456,"L.PvsV.XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_DN"
44,"Down",0.0878497737016594,0.327518348223456,"L.PvsV.AMIT_SERUM_RESPONSE_40_MCF10A"
49,"Down",0.0878617058514065,0.327518348223456,"L.PvsV.REACTOME_STRIATED_MUSCLE_CONTRACTION"
71,"Down",0.0878857090767091,0.327518348223456,"L.PvsV.REACTOME_RECOGNITION_AND_ASSOCIATION_OF_DNA_GLYCOSYLASE_WITH_SITE_CONTAINING_AN_AFFECTED_PURINE"
23,"Up",0.0879333336407736,0.327518348223456,"L.PvsV.MANN_RESPONSE_TO_AMIFOSTINE_UP"
663,"Down",0.0879661325939289,0.327518348223456,"L.PvsV.VECCHI_GASTRIC_CANCER_EARLY_DN"
35,"Down",0.0880857404393229,0.327742973680361,"L.PvsV.NABA_PROTEOGLYCANS"
38,"Down",0.0883647276234639,0.32845755291228,"L.PvsV.REACTOME_ACTIVATION_OF_ATR_IN_RESPONSE_TO_REPLICATION_STRESS"
413,"Down",0.0884513638626199,0.32845755291228,"L.PvsV.AFFAR_YY1_TARGETS_UP"
26,"Down",0.0884560130740433,0.32845755291228,"L.PvsV.BIOCARTA_MEF2D_PATHWAY"
54,"Up",0.0886653495676678,0.329013904536668,"L.PvsV.PID_IFNG_PATHWAY"
209,"Up",0.0887368306341055,0.329058307562689,"L.PvsV.LANDIS_ERBB2_BREAST_TUMORS_324_UP"
443,"Down",0.0888283884666612,0.329177050825851,"L.PvsV.BILD_HRAS_ONCOGENIC_SIGNATURE"
37,"Down",0.089026397766531,0.329689854823275,"L.PvsV.REACTOME_HEME_DEGRADATION"
90,"Down",0.0891506514038295,0.329929017143088,"L.PvsV.TENEDINI_MEGAKARYOCYTE_MARKERS"
23,"Up",0.0894718113755248,0.330734917297869,"L.PvsV.REACTOME_ASSEMBLY_OF_ACTIVE_LPL_AND_LIPC_LIPASE_COMPLEXES"
96,"Down",0.0894880514157374,0.330734917297869,"L.PvsV.MIKKELSEN_ES_HCP_WITH_H3K27ME3"
96,"Down",0.0895662585660385,0.330802834743906,"L.PvsV.REACTOME_NONHOMOLOGOUS_END_JOINING_NHEJ"
30,"Down",0.0897325411696095,0.331195741072611,"L.PvsV.REACTOME_CRMPS_IN_SEMA3A_SIGNALING"
17,"Down",0.0898726152152187,0.331491453985953,"L.PvsV.BIOCARTA_SM_PATHWAY"
8,"Up",0.0899696872527037,0.331628267213466,"L.PvsV.REACTOME_METAL_SEQUESTRATION_BY_ANTIMICROBIAL_PROTEINS"
45,"Down",0.0901536576452987,0.332069005991437,"L.PvsV.MEISSNER_ES_ICP_WITH_H3K4ME3"
21,"Up",0.0902093772832588,0.332069005991437,"L.PvsV.GRATIAS_RETINOBLASTOMA_16Q24"
13,"Down",0.0903178401148213,0.332247064534163,"L.PvsV.BIOCARTA_FIBRINOLYSIS_PATHWAY"
30,"Up",0.0904608614009972,0.332359317818313,"L.PvsV.KEGG_BETA_ALANINE_METABOLISM"
12,"Up",0.090505310744237,0.332359317818313,"L.PvsV.REACTOME_TANDEM_PORE_DOMAIN_POTASSIUM_CHANNELS"
62,"Down",0.0905286910172506,0.332359317818313,"L.PvsV.VALK_AML_CLUSTER_6"
11,"Down",0.0907853716267739,0.332916795142819,"L.PvsV.REACTOME_PEPTIDE_HORMONE_BIOSYNTHESIS"
385,"Down",0.0908596246783794,0.332916795142819,"L.PvsV.COLDREN_GEFITINIB_RESISTANCE_DN"
8,"Down",0.0909139881188004,0.332916795142819,"L.PvsV.LOPEZ_MESOTHELIOMA_SURVIVAL_WORST_VS_BEST_DN"
454,"Down",0.0909213891600031,0.332916795142819,"L.PvsV.KONDO_EZH2_TARGETS"
11,"Down",0.0912884929744528,0.334039760195731,"L.PvsV.REACTOME_RUNX3_REGULATES_CDKN1A_TRANSCRIPTION"
21,"Up",0.0914804711123454,0.334331754239466,"L.PvsV.KYNG_NORMAL_AGING_UP"
42,"Up",0.0915591791376246,0.334331754239466,"L.PvsV.REACTOME_DISEASES_OF_CARBOHYDRATE_METABOLISM"
331,"Down",0.0915598566559143,0.334331754239466,"L.PvsV.LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP"
8,"Up",0.0916101659744604,0.334331754239466,"L.PvsV.FARDIN_HYPOXIA_9"
137,"Down",0.0916802338443462,0.334366763143397,"L.PvsV.REACTOME_SENESCENCE_ASSOCIATED_SECRETORY_PHENOTYPE_SASP"
89,"Down",0.092249616691652,0.336221575931539,"L.PvsV.REACTOME_DEPOSITION_OF_NEW_CENPA_CONTAINING_NUCLEOSOMES_AT_THE_CENTROMERE"
38,"Down",0.093148561127978,0.339216581624189,"L.PvsV.BURTON_ADIPOGENESIS_1"
150,"Up",0.0933000452672975,0.339216581624189,"L.PvsV.REACTOME_METABOLISM_OF_WATER_SOLUBLE_VITAMINS_AND_COFACTORS"
46,"Down",0.0934060730320486,0.339216581624189,"L.PvsV.STAEGE_EWING_FAMILY_TUMOR"
14,"Down",0.0934210681037368,0.339216581624189,"L.PvsV.BIOCARTA_AKAP13_PATHWAY"
40,"Down",0.0934345212765623,0.339216581624189,"L.PvsV.REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY"
1130,"Up",0.0934394743739627,0.339216581624189,"L.PvsV.REACTOME_ADAPTIVE_IMMUNE_SYSTEM"
14,"Up",0.0936778864834053,0.339858946434874,"L.PvsV.FUJIWARA_PARK2_HEPATOCYTE_PROLIFERATION_DN"
107,"Down",0.0939375889149494,0.340577658433282,"L.PvsV.REACTOME_BASE_EXCISION_REPAIR"
116,"Down",0.0940906413667532,0.340899378161272,"L.PvsV.BURTON_ADIPOGENESIS_4"
97,"Down",0.0941496383527332,0.340899378161272,"L.PvsV.REACTOME_COLLAGEN_DEGRADATION"
139,"Down",0.0942398781646997,0.341002805217686,"L.PvsV.MIKKELSEN_MCV6_ICP_WITH_H3K27ME3"
41,"Down",0.094468879233506,0.341360019300227,"L.PvsV.LUI_THYROID_CANCER_CLUSTER_4"
13,"Down",0.094535868321632,0.341360019300227,"L.PvsV.CASTELLANO_HRAS_AND_NRAS_TARGETS_DN"
279,"Up",0.0945690475656298,0.341360019300227,"L.PvsV.REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT"
17,"Up",0.0946517976008052,0.341360019300227,"L.PvsV.REACTOME_NF_KB_IS_ACTIVATED_AND_SIGNALS_SURVIVAL"
112,"Down",0.0947141324353083,0.341360019300227,"L.PvsV.ZHU_CMV_8_HR_UP"
99,"Down",0.0947343726723901,0.341360019300227,"L.PvsV.LY_AGING_OLD_DN"
118,"Down",0.0947707776498188,0.341360019300227,"L.PvsV.GENTILE_UV_LOW_DOSE_DN"
85,"Down",0.0951997089040723,0.34268176466837,"L.PvsV.YAMASHITA_LIVER_CANCER_STEM_CELL_UP"
14,"Down",0.0953769853549126,0.342762216022501,"L.PvsV.BIOCARTA_SRCRPTP_PATHWAY"
42,"Down",0.0954179907814992,0.342762216022501,"L.PvsV.DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_DN"
546,"Down",0.0954484843532271,0.342762216022501,"L.PvsV.ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_UP"
51,"Up",0.0954820182857312,0.342762216022501,"L.PvsV.BERNARD_PPAPDC1B_TARGETS_UP"
102,"Up",0.095532026567313,0.342762216022501,"L.PvsV.REACTOME_PLASMA_LIPOPROTEIN_ASSEMBLY_REMODELING_AND_CLEARANCE"
6,"Down",0.0956706605420143,0.34303701824695,"L.PvsV.REACTOME_MECP2_REGULATES_TRANSCRIPTION_FACTORS"
20,"Down",0.0960346387576859,0.343763957907266,"L.PvsV.WU_HBX_TARGETS_3_DN"
8,"Up",0.0960459912746556,0.343763957907266,"L.PvsV.HESSON_TUMOR_SUPPRESSOR_CLUSTER_3P21_3"
52,"Up",0.0960994807294964,0.343763957907266,"L.PvsV.REACTOME_SIGNALING_BY_FGFR4"
934,"Up",0.096122097834081,0.343763957907266,"L.PvsV.CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN"
6,"Down",0.0963497263497915,0.344355292170651,"L.PvsV.REACTOME_SYNTHESIS_OF_PI"
82,"Up",0.0964897536645943,0.344632976751642,"L.PvsV.KEGG_GLYCEROPHOSPHOLIPID_METABOLISM"
18,"Down",0.0965812213251581,0.344693846107825,"L.PvsV.BIOCARTA_MRP_PATHWAY"
19,"Up",0.0966314815458724,0.344693846107825,"L.PvsV.REACTOME_BUTYROPHILIN_BTN_FAMILY_INTERACTIONS"
39,"Up",0.0967174876958472,0.344778200819045,"L.PvsV.WU_HBX_TARGETS_1_DN"
29,"Up",0.0969219129228321,0.345051219509265,"L.PvsV.REACTOME_BASIGIN_INTERACTIONS"
34,"Down",0.0970865154335211,0.345051219509265,"L.PvsV.HUMMERICH_BENIGN_SKIN_TUMOR_UP"
32,"Down",0.0971013058336916,0.345051219509265,"L.PvsV.COLLER_MYC_TARGETS_DN"
745,"Down",0.0971674154992674,0.345051219509265,"L.PvsV.MEISSNER_NPC_HCP_WITH_H3K4ME2"
169,"Down",0.0971859366026265,0.345051219509265,"L.PvsV.GAVIN_FOXP3_TARGETS_CLUSTER_P4"
80,"Down",0.0972103461083019,0.345051219509265,"L.PvsV.ROVERSI_GLIOMA_COPY_NUMBER_DN"
25,"Up",0.0972309278342259,0.345051219509265,"L.PvsV.REACTOME_CELL_EXTRACELLULAR_MATRIX_INTERACTIONS"
13,"Down",0.0974592888786219,0.345639774348878,"L.PvsV.KUMAMOTO_RESPONSE_TO_NUTLIN_3A_DN"
46,"Down",0.0975520603051231,0.345747013735273,"L.PvsV.DELLA_RESPONSE_TO_TSA_AND_BUTYRATE"
219,"Down",0.097843863850682,0.346510193719652,"L.PvsV.XU_GH1_AUTOCRINE_TARGETS_DN"
274,"Down",0.0979320570066927,0.346510193719652,"L.PvsV.CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN"
54,"Down",0.0979554047357237,0.346510193719652,"L.PvsV.VALK_AML_CLUSTER_9"
168,"Down",0.0982535025934034,0.347181342887305,"L.PvsV.KANG_IMMORTALIZED_BY_TERT_UP"
28,"Up",0.0982707183249469,0.347181342887305,"L.PvsV.LI_ADIPOGENESIS_BY_ACTIVATED_PPARG"
33,"Up",0.09865142484633,0.348303785424878,"L.PvsV.BIOCARTA_CTCF_PATHWAY"
41,"Down",0.0989176672685394,0.349020920438899,"L.PvsV.PID_EPHA2_FWD_PATHWAY"
21,"Up",0.0991671547228611,0.349484279916206,"L.PvsV.REACTOME_CLASS_I_PEROXISOMAL_MEMBRANE_PROTEIN_IMPORT"
52,"Up",0.099195064043794,0.349484279916206,"L.PvsV.PID_GMCSF_PATHWAY"
49,"Down",0.0992386180988322,0.349484279916206,"L.PvsV.VANDESLUIS_NORMAL_EMBRYOS_DN"
227,"Down",0.0994056453414706,0.349735428212246,"L.PvsV.BROWNE_HCMV_INFECTION_10HR_UP"
29,"Down",0.0994548499938942,0.349735428212246,"L.PvsV.REACTOME_GABA_SYNTHESIS_RELEASE_REUPTAKE_AND_DEGRADATION"
42,"Up",0.0994996976990167,0.349735428212246,"L.PvsV.REACTOME_GENERATION_OF_SECOND_MESSENGER_MOLECULES"
50,"Down",0.0995650490086193,0.349742792864458,"L.PvsV.ONO_FOXP3_TARGETS_DN"
164,"Down",0.0997050589485898,0.35001223550905,"L.PvsV.ZHU_CMV_24_HR_DN"
65,"Down",0.0998165554717817,0.350181304063122,"L.PvsV.ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_UP"
27,"Down",0.100079498439141,0.350881133081806,"L.PvsV.ABE_VEGFA_TARGETS"
165,"Up",0.100232957706618,0.351196465880792,"L.PvsV.IVANOVA_HEMATOPOIESIS_INTERMEDIATE_PROGENITOR"
611,"Down",0.100297520813427,0.351200121961646,"L.PvsV.GRUETZMANN_PANCREATIC_CANCER_UP"
238,"Down",0.100907285129319,0.352881052477284,"L.PvsV.WHITFIELD_CELL_CYCLE_G2"
675,"Down",0.100921685618768,0.352881052477284,"L.PvsV.IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_DN"
45,"Up",0.100969040517103,0.352881052477284,"L.PvsV.REACTOME_ENDOSOMAL_VACUOLAR_PATHWAY"
29,"Down",0.101108051577935,0.353140223460906,"L.PvsV.IVANOVA_HEMATOPOIESIS_STEM_CELL_SHORT_TERM"
67,"Down",0.101203440694379,0.353140223460906,"L.PvsV.PID_ILK_PATHWAY"
49,"Down",0.101234808136288,0.353140223460906,"L.PvsV.ONO_AML1_TARGETS_DN"
14,"Up",0.101339952966856,0.353284110941831,"L.PvsV.BERENJENO_TRANSFORMED_BY_RHOA_REVERSIBLY_UP"
619,"Down",0.101463259909473,0.353284197500895,"L.PvsV.YAGI_AML_WITH_11Q23_REARRANGED"
639,"Down",0.101503005418583,0.353284197500895,"L.PvsV.HAN_SATB1_TARGETS_DN"
112,"Down",0.101531667540047,0.353284197500895,"L.PvsV.LEIN_NEURON_MARKERS"
67,"Up",0.102081820884497,0.354975086585148,"L.PvsV.VANTVEER_BREAST_CANCER_BRCA1_UP"
358,"Down",0.102181826474332,0.355084341236269,"L.PvsV.BROWNE_HCMV_INFECTION_18HR_DN"
28,"Up",0.102260063207996,0.355084341236269,"L.PvsV.KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS"
216,"Up",0.102305906237905,0.355084341236269,"L.PvsV.WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_36HR"
19,"Up",0.10255874597906,0.355738586272412,"L.PvsV.REACTOME_GLYCOGEN_STORAGE_DISEASES"
71,"Down",0.102933337100797,0.356143549643687,"L.PvsV.TSAI_RESPONSE_TO_RADIATION_THERAPY"
111,"Down",0.102942219199785,0.356143549643687,"L.PvsV.POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN"
90,"Down",0.102982878036324,0.356143549643687,"L.PvsV.REACTOME_CONDENSATION_OF_PROPHASE_CHROMOSOMES"
112,"Down",0.103078170203803,0.356143549643687,"L.PvsV.DELASERNA_MYOD_TARGETS_DN"
896,"Up",0.103177365254815,0.356143549643687,"L.PvsV.REACTOME_METABOLISM_OF_LIPIDS"
25,"Up",0.103186996703387,0.356143549643687,"L.PvsV.REACTOME_SIGNALING_BY_ERBB2_ECD_MUTANTS"
29,"Down",0.103196115132108,0.356143549643687,"L.PvsV.REACTOME_FRS_MEDIATED_FGFR2_SIGNALING"
20,"Up",0.103284383783298,0.356143549643687,"L.PvsV.REACTOME_REGULATION_OF_TLR_BY_ENDOGENOUS_LIGAND"
91,"Up",0.103291572768306,0.356143549643687,"L.PvsV.PID_TCR_PATHWAY"
1095,"Down",0.103332828837688,0.356143549643687,"L.PvsV.SMID_BREAST_CANCER_LUMINAL_B_DN"
40,"Down",0.103440293563784,0.356143549643687,"L.PvsV.REACTOME_HDR_THROUGH_SINGLE_STRAND_ANNEALING_SSA"
62,"Down",0.103494223633419,0.356143549643687,"L.PvsV.REACTOME_GPVI_MEDIATED_ACTIVATION_CASCADE"
9,"Down",0.103512874711052,0.356143549643687,"L.PvsV.REACTOME_ACTIVATED_NTRK2_SIGNALS_THROUGH_CDK5"
21,"Down",0.103683633092969,0.356354336361864,"L.PvsV.IRITANI_MAD1_TARGETS_UP"
137,"Down",0.103703043444789,0.356354336361864,"L.PvsV.GAJATE_RESPONSE_TO_TRABECTEDIN_UP"
119,"Down",0.103916601386409,0.356866390723886,"L.PvsV.SHEPARD_BMYB_TARGETS"
41,"Down",0.104174029558526,0.357528373326563,"L.PvsV.HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_DN"
500,"Down",0.104485027865016,0.358373274854637,"L.PvsV.TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_DN"
52,"Down",0.104580052479418,0.358441586795889,"L.PvsV.KEGG_ALDOSTERONE_REGULATED_SODIUM_REABSORPTION"
109,"Down",0.104686361698205,0.358441586795889,"L.PvsV.REACTOME_AURKA_ACTIVATION_BY_TPX2"
92,"Down",0.104820831235493,0.358441586795889,"L.PvsV.OLSSON_E2F3_TARGETS_DN"
111,"Down",0.104861324833586,0.358441586795889,"L.PvsV.HOFMANN_CELL_LYMPHOMA_UP"
102,"Down",0.104890744142084,0.358441586795889,"L.PvsV.DAWSON_METHYLATED_IN_LYMPHOMA_TCL1"
54,"Down",0.104893920679282,0.358441586795889,"L.PvsV.REACTOME_GLUCAGON_LIKE_PEPTIDE_1_GLP1_REGULATES_INSULIN_SECRETION"
73,"Down",0.105243357904098,0.359413542836171,"L.PvsV.URS_ADIPOCYTE_DIFFERENTIATION_DN"
58,"Down",0.105380560017071,0.359659948354558,"L.PvsV.PID_HDAC_CLASSII_PATHWAY"
165,"Up",0.105525200427689,0.359712544594209,"L.PvsV.FURUKAWA_DUSP6_TARGETS_PCI35_UP"
23,"Up",0.105581049009855,0.359712544594209,"L.PvsV.REACTOME_SPRY_REGULATION_OF_FGF_SIGNALING"
15,"Up",0.105591148467426,0.359712544594209,"L.PvsV.MARSON_FOXP3_TARGETS_STIMULATED_DN"
161,"Down",0.106036637786045,0.361007740344239,"L.PvsV.FRASOR_RESPONSE_TO_ESTRADIOL_DN"
173,"Down",0.106328916591352,0.361780049128361,"L.PvsV.RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_UP"
305,"Up",0.106530530560434,0.362217315613338,"L.PvsV.WANG_TUMOR_INVASIVENESS_DN"
74,"Down",0.106588455869579,0.362217315613338,"L.PvsV.LI_CISPLATIN_RESISTANCE_UP"
165,"Up",0.106781415313634,0.362547919646231,"L.PvsV.SENESE_HDAC2_TARGETS_UP"
182,"Down",0.10682038630447,0.362547919646231,"L.PvsV.KIM_GLIS2_TARGETS_UP"
60,"Up",0.106882457772356,0.362547919646231,"L.PvsV.CROONQUIST_NRAS_SIGNALING_UP"
50,"Up",0.106978831426294,0.362652335350081,"L.PvsV.WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_DN"
811,"Down",0.107115805701136,0.362894172623516,"L.PvsV.SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1"
50,"Down",0.10734283101706,0.363320405074079,"L.PvsV.BRACHAT_RESPONSE_TO_CISPLATIN"
22,"Down",0.107373040674814,0.363320405074079,"L.PvsV.MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_4"
202,"Up",0.107687850392072,0.364162767472641,"L.PvsV.MOREAUX_MULTIPLE_MYELOMA_BY_TACI_DN"
644,"Down",0.107778333657075,0.364245969920517,"L.PvsV.PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_UP"
27,"Down",0.108234469636602,0.365564070018797,"L.PvsV.REACTOME_GAP_FILLING_DNA_REPAIR_SYNTHESIS_AND_LIGATION_IN_GG_NER"
102,"Down",0.108333271402024,0.36565451567812,"L.PvsV.PID_IL4_2PATHWAY"
62,"Down",0.108393516222904,0.36565451567812,"L.PvsV.SAGIV_CD24_TARGETS_DN"
181,"Down",0.108622266385688,0.366147803659943,"L.PvsV.GRADE_COLON_AND_RECTAL_CANCER_DN"
83,"Down",0.108672191319581,0.366147803659943,"L.PvsV.REACTOME_CA2_PATHWAY"
13,"Down",0.108755899488085,0.366206679823154,"L.PvsV.GALI_TP53_TARGETS_APOPTOTIC_UP"
181,"Down",0.108926366349873,0.366557443425713,"L.PvsV.RICKMAN_HEAD_AND_NECK_CANCER_E"
557,"Up",0.109168343278084,0.366724302669446,"L.PvsV.OSMAN_BLADDER_CANCER_UP"
31,"Down",0.109179322436905,0.366724302669446,"L.PvsV.OUYANG_PROSTATE_CANCER_PROGRESSION_UP"
160,"Down",0.109221473905016,0.366724302669446,"L.PvsV.GAVIN_FOXP3_TARGETS_CLUSTER_P7"
95,"Up",0.109255211029515,0.366724302669446,"L.PvsV.DANG_REGULATED_BY_MYC_UP"
886,"Up",0.109309975290264,0.366724302669446,"L.PvsV.STEIN_ESRRA_TARGETS"
68,"Down",0.109466019294206,0.366724302669446,"L.PvsV.HALMOS_CEBPA_TARGETS_DN"
70,"Up",0.109483476254119,0.366724302669446,"L.PvsV.YAMASHITA_LIVER_CANCER_WITH_EPCAM_UP"
63,"Down",0.10950656967033,0.366724302669446,"L.PvsV.SU_PLACENTA"
64,"Up",0.109737465200987,0.36707842002592,"L.PvsV.KEGG_ALLOGRAFT_REJECTION"
66,"Down",0.109745094646924,0.36707842002592,"L.PvsV.REACTOME_NEUREXINS_AND_NEUROLIGINS"
129,"Down",0.109869027294874,0.367270768992356,"L.PvsV.REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS"
337,"Up",0.110076296152792,0.36753637230293,"L.PvsV.MCBRYAN_PUBERTAL_BREAST_6_7WK_UP"
22,"Down",0.110184648928991,0.36753637230293,"L.PvsV.SHIN_B_CELL_LYMPHOMA_CLUSTER_5"
122,"Down",0.110198220648163,0.36753637230293,"L.PvsV.BOYLAN_MULTIPLE_MYELOMA_D_DN"
584,"Down",0.110273634685281,0.36753637230293,"L.PvsV.MIKKELSEN_NPC_HCP_WITH_H3K27ME3"
658,"Down",0.110338938202036,0.36753637230293,"L.PvsV.DELACROIX_RAR_BOUND_ES"
27,"Up",0.110405091286694,0.36753637230293,"L.PvsV.REACTOME_CELLULAR_HEXOSE_TRANSPORT"
251,"Down",0.110418259806662,0.36753637230293,"L.PvsV.SABATES_COLORECTAL_ADENOMA_UP"
96,"Down",0.110480276861543,0.36753637230293,"L.PvsV.PETROVA_PROX1_TARGETS_DN"
843,"Down",0.110646052212341,0.367866519953116,"L.PvsV.MCCABE_BOUND_BY_HOXC6"
31,"Down",0.110935011787416,0.368330954626084,"L.PvsV.BIOCARTA_UCALPAIN_PATHWAY"
33,"Down",0.110952006436349,0.368330954626084,"L.PvsV.HUI_MAPK14_TARGETS_UP"
317,"Down",0.110985597830902,0.368330954626084,"L.PvsV.TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP"
265,"Up",0.111239662363211,0.368875615407885,"L.PvsV.SHEPARD_CRUSH_AND_BURN_MUTANT_UP"
33,"Down",0.111283148218548,0.368875615407885,"L.PvsV.CHUANG_OXIDATIVE_STRESS_RESPONSE_DN"
27,"Up",0.111486883107074,0.369303626949838,"L.PvsV.WILSON_PROTEASES_AT_TUMOR_BONE_INTERFACE_UP"
206,"Down",0.111545859469385,0.369303626949838,"L.PvsV.ROPERO_HDAC2_TARGETS"
815,"Down",0.112074028163803,0.370830222452223,"L.PvsV.ONDER_CDH1_TARGETS_2_DN"
695,"Down",0.112243687048126,0.371169465125054,"L.PvsV.RATTENBACHER_BOUND_BY_CELF1"
99,"Down",0.112539676556012,0.371716981128534,"L.PvsV.REACTOME_PLATELET_HOMEOSTASIS"
259,"Down",0.112543719733978,0.371716981128534,"L.PvsV.BROCKE_APOPTOSIS_REVERSED_BY_IL6"
13,"Up",0.11280296566538,0.372350804276946,"L.PvsV.BIOCARTA_EIF2_PATHWAY"
207,"Down",0.112960693325793,0.37264896980806,"L.PvsV.WANG_HCP_PROSTATE_CANCER"
77,"Down",0.113189470715861,0.372874226377186,"L.PvsV.ASTON_MAJOR_DEPRESSIVE_DISORDER_UP"
76,"Up",0.113209123098103,0.372874226377186,"L.PvsV.REACTOME_DAP12_SIGNALING"
162,"Down",0.113231294282383,0.372874226377186,"L.PvsV.HOEBEKE_LYMPHOID_STEM_CELL_UP"
117,"Down",0.113305033897556,0.372894959773563,"L.PvsV.REACTOME_ARACHIDONIC_ACID_METABOLISM"
394,"Down",0.113452206288368,0.373157197244726,"L.PvsV.BILD_E2F3_ONCOGENIC_SIGNATURE"
140,"Down",0.113947072895066,0.374237221257713,"L.PvsV.HOEBEKE_LYMPHOID_STEM_CELL_DN"
383,"Down",0.114038162748676,0.374237221257713,"L.PvsV.MULLIGHAN_MLL_SIGNATURE_1_DN"
23,"Down",0.114049204865766,0.374237221257713,"L.PvsV.FIGUEROA_AML_METHYLATION_CLUSTER_2_DN"
6,"Down",0.11405131449073,0.374237221257713,"L.PvsV.BIOCARTA_SAM68_PATHWAY"
51,"Down",0.114181839283263,0.374387263510015,"L.PvsV.BOYAULT_LIVER_CANCER_SUBCLASS_G2"
101,"Down",0.114232467632736,0.374387263510015,"L.PvsV.PID_ENDOTHELIN_PATHWAY"
12,"Up",0.114322612588945,0.374460737561775,"L.PvsV.REACTOME_ASPARTATE_AND_ASPARAGINE_METABOLISM"
61,"Down",0.114739835002522,0.375102790815005,"L.PvsV.FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_DN"
16,"Up",0.11476114269464,0.375102790815005,"L.PvsV.REACTOME_INTESTINAL_ABSORPTION"
39,"Down",0.114764415621656,0.375102790815005,"L.PvsV.ZHAN_V1_LATE_DIFFERENTIATION_GENES_DN"
203,"Down",0.114858872155413,0.375102790815005,"L.PvsV.MIKKELSEN_MEF_LCP_WITH_H3K4ME3"
87,"Down",0.114921758273321,0.375102790815005,"L.PvsV.ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_DN"
14,"Down",0.114928222174679,0.375102790815005,"L.PvsV.REACTOME_LYSOSPHINGOLIPID_AND_LPA_RECEPTORS"
150,"Down",0.115092637097584,0.375102790815005,"L.PvsV.REACTOME_OXIDATIVE_STRESS_INDUCED_SENESCENCE"
385,"Down",0.115168167505913,0.375102790815005,"L.PvsV.NABA_SECRETED_FACTORS"
10,"Down",0.115237685022812,0.375102790815005,"L.PvsV.KAUFFMANN_MELANOMA_RELAPSE_DN"
45,"Down",0.115306940788368,0.375102790815005,"L.PvsV.LOPES_METHYLATED_IN_COLON_CANCER_UP"
136,"Down",0.115348198938048,0.375102790815005,"L.PvsV.ROSS_AML_WITH_PML_RARA_FUSION"
31,"Down",0.115350457726134,0.375102790815005,"L.PvsV.SASAI_TARGETS_OF_CXCR6_AND_PTCH1_UP"
19,"Up",0.115450473302517,0.375102790815005,"L.PvsV.REACTOME_CASPASE_ACTIVATION_VIA_DEATH_RECEPTORS_IN_THE_PRESENCE_OF_LIGAND"
165,"Down",0.115468430089915,0.375102790815005,"L.PvsV.HATADA_METHYLATED_IN_LUNG_CANCER_DN"
19,"Down",0.115590727545474,0.375279584614752,"L.PvsV.REACTOME_REGULATION_OF_RUNX1_EXPRESSION_AND_ACTIVITY"
97,"Down",0.115724760387258,0.375366360245644,"L.PvsV.GRADE_COLON_VS_RECTAL_CANCER_DN"
75,"Down",0.115753236429521,0.375366360245644,"L.PvsV.PID_HEDGEHOG_GLI_PATHWAY"
59,"Down",0.116004264747214,0.375959894365384,"L.PvsV.GEISS_RESPONSE_TO_DSRNA_UP"
31,"Down",0.116549779050725,0.377298125221696,"L.PvsV.TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_MONOCYTE_UP"
782,"Down",0.116553662123107,0.377298125221696,"L.PvsV.CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1"
107,"Down",0.116674276255812,0.377467567828194,"L.PvsV.FONTAINE_PAPILLARY_THYROID_CARCINOMA_UP"
42,"Down",0.116822393454245,0.377725738835392,"L.PvsV.SUZUKI_RESPONSE_TO_TSA_AND_DECITABINE_1A"
1356,"Up",0.116892601500059,0.377731849032042,"L.PvsV.WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_8D"
21,"Down",0.117165613280192,0.378215704503001,"L.PvsV.REACTOME_TNF_RECEPTOR_SUPERFAMILY_TNFSF_MEMBERS_MEDIATING_NON_CANONICAL_NF_KB_PATHWAY"
49,"Up",0.117270195007813,0.378215704503001,"L.PvsV.NIKOLSKY_BREAST_CANCER_1Q21_AMPLICON"
42,"Down",0.117275581023416,0.378215704503001,"L.PvsV.ODONNELL_METASTASIS_DN"
51,"Down",0.117315958260562,0.378215704503001,"L.PvsV.KORKOLA_TERATOMA"
135,"Down",0.117604416760464,0.378924720436249,"L.PvsV.ANDERSEN_CHOLANGIOCARCINOMA_CLASS1"
99,"Up",0.117925816743695,0.379738987056431,"L.PvsV.BIOCARTA_MAPK_PATHWAY"
90,"Down",0.117997166330705,0.37974757429713,"L.PvsV.REACTOME_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE"
109,"Down",0.118336123173126,0.380616884830839,"L.PvsV.PARK_APL_PATHOGENESIS_DN"
262,"Down",0.118465859450861,0.380812637734774,"L.PvsV.NOUZOVA_TRETINOIN_AND_H4_ACETYLATION"
12,"Down",0.118580693199932,0.38096028628845,"L.PvsV.TESAR_JAK_TARGETS_MOUSE_ES_D3_DN"
5,"Down",0.118851676336739,0.381609128028937,"L.PvsV.REACTOME_EXTRINSIC_PATHWAY_OF_FIBRIN_CLOT_FORMATION"
159,"Up",0.119042751184834,0.38200079587983,"L.PvsV.REACTOME_TOLL_LIKE_RECEPTOR_4_TLR4_CASCADE"
32,"Up",0.119265701392503,0.382494236078392,"L.PvsV.REACTOME_GLYCOGEN_METABOLISM"
131,"Down",0.119508189855156,0.383049728527047,"L.PvsV.GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP"
105,"Down",0.119600495702889,0.383123488262616,"L.PvsV.PID_AVB3_INTEGRIN_PATHWAY"
34,"Down",0.119966262506428,0.38378087869125,"L.PvsV.BIOCARTA_SPPA_PATHWAY"
13,"Up",0.119977739493266,0.38378087869125,"L.PvsV.REACTOME_PREVENTION_OF_PHAGOSOMAL_LYSOSOMAL_FUSION"
35,"Up",0.120013951755683,0.38378087869125,"L.PvsV.REACTOME_DOWNREGULATION_OF_TGF_BETA_RECEPTOR_SIGNALING"
105,"Up",0.120175108421381,0.384074089284288,"L.PvsV.REACTOME_HEDGEHOG_ON_STATE"
141,"Down",0.120397867370752,0.384563725414725,"L.PvsV.FRIDMAN_SENESCENCE_UP"
22,"Up",0.120594900323171,0.384970671990077,"L.PvsV.KYNG_WERNER_SYNDROM_UP"
167,"Down",0.120689788524311,0.385051264137864,"L.PvsV.SMID_BREAST_CANCER_RELAPSE_IN_BONE_UP"
9,"Down",0.120826860780191,0.385266270619192,"L.PvsV.REACTOME_HIGHLY_CALCIUM_PERMEABLE_NICOTINIC_ACETYLCHOLINE_RECEPTORS"
55,"Down",0.120926592992327,0.385362036112146,"L.PvsV.VALK_AML_CLUSTER_10"
57,"Up",0.121297672901968,0.386102558296898,"L.PvsV.SIG_REGULATION_OF_THE_ACTIN_CYTOSKELETON_BY_RHO_GTPASES"
80,"Down",0.12131244551945,0.386102558296898,"L.PvsV.REACTOME_APOPTOTIC_EXECUTION_PHASE"
66,"Down",0.121368465603185,0.386102558296898,"L.PvsV.REACTOME_BILE_ACID_AND_BILE_SALT_METABOLISM"
13,"Up",0.121795840973412,0.387083326793683,"L.PvsV.PETRETTO_BLOOD_PRESSURE_DN"
223,"Down",0.121849252146045,0.387083326793683,"L.PvsV.WILCOX_RESPONSE_TO_PROGESTERONE_UP"
117,"Down",0.121886791815482,0.387083326793683,"L.PvsV.REACTOME_TRANSCRIPTIONAL_REGULATION_OF_GRANULOPOIESIS"
100,"Down",0.122093463916965,0.387517084958037,"L.PvsV.FIGUEROA_AML_METHYLATION_CLUSTER_3_DN"
83,"Down",0.122379906040041,0.38820338525266,"L.PvsV.BIOCARTA_NUCLEARRS_PATHWAY"
19,"Down",0.122486695219224,0.388319345107275,"L.PvsV.TSUTSUMI_FBXW8_TARGETS"
122,"Down",0.122634152874666,0.388427680340101,"L.PvsV.VANASSE_BCL2_TARGETS_DN"
106,"Down",0.122661372738979,0.388427680340101,"L.PvsV.WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER"
207,"Up",0.122835483920187,0.388756376986097,"L.PvsV.GOLDRATH_HOMEOSTATIC_PROLIFERATION"
80,"Down",0.123181860352999,0.389484258597626,"L.PvsV.MODY_HIPPOCAMPUS_PRENATAL"
31,"Down",0.123206360695831,0.389484258597626,"L.PvsV.JEON_SMAD6_TARGETS_DN"
338,"Up",0.123363251186256,0.38960337459057,"L.PvsV.REACTOME_FC_EPSILON_RECEPTOR_FCERI_SIGNALING"
51,"Down",0.123384971768509,0.38960337459057,"L.PvsV.XU_AKT1_TARGETS_6HR"
71,"Down",0.123659244961651,0.390233147975141,"L.PvsV.REACTOME_SIGNALING_BY_NOTCH3"
100,"Up",0.123725575764229,0.390233147975141,"L.PvsV.PID_CD8_TCR_PATHWAY"
14,"Down",0.124004841308215,0.390880298283119,"L.PvsV.REACTOME_RUNX1_AND_FOXP3_CONTROL_THE_DEVELOPMENT_OF_REGULATORY_T_LYMPHOCYTES_TREGS"
13,"Down",0.124072151109943,0.390880298283119,"L.PvsV.GOUYER_TUMOR_INVASIVENESS"
34,"Up",0.124285517527826,0.391147781024436,"L.PvsV.NIKOLSKY_BREAST_CANCER_5P15_AMPLICON"
48,"Down",0.124298544268391,0.391147781024436,"L.PvsV.LI_PROSTATE_CANCER_EPIGENETIC"
9,"Up",0.124680256302956,0.391694148860031,"L.PvsV.MAINA_HYPOXIA_VHL_TARGETS_UP"
86,"Down",0.124682367439349,0.391694148860031,"L.PvsV.MCGARVEY_SILENCED_BY_METHYLATION_IN_COLON_CANCER"
71,"Up",0.124684699221135,0.391694148860031,"L.PvsV.KEGG_GRAFT_VERSUS_HOST_DISEASE"
8,"Up",0.124835357204877,0.391944741615994,"L.PvsV.NIKOLSKY_BREAST_CANCER_19Q13.4_AMPLICON"
83,"Down",0.125126304440743,0.392518975021662,"L.PvsV.VALK_AML_WITH_FLT3_ITD"
63,"Down",0.125160237468474,0.392518975021662,"L.PvsV.BENPORATH_ES_2"
69,"Down",0.12525567838106,0.392595604177369,"L.PvsV.GENTILE_UV_HIGH_DOSE_UP"
48,"Down",0.125466861725807,0.393034718686677,"L.PvsV.KEGG_NOTCH_SIGNALING_PATHWAY"
58,"Down",0.125729974355126,0.39359520731543,"L.PvsV.REACTOME_SNRNP_ASSEMBLY"
316,"Down",0.125788159038952,0.39359520731543,"L.PvsV.MOHANKUMAR_HOXA1_TARGETS_DN"
155,"Down",0.125992799129484,0.394012548861378,"L.PvsV.REACTOME_ACTIVATION_OF_ANTERIOR_HOX_GENES_IN_HINDBRAIN_DEVELOPMENT_DURING_EARLY_EMBRYOGENESIS"
16,"Up",0.126082657236176,0.3940706680943,"L.PvsV.REACTOME_GOLGI_CISTERNAE_PERICENTRIOLAR_STACK_REORGANIZATION"
61,"Down",0.126348511060769,0.394678484550844,"L.PvsV.RIZ_ERYTHROID_DIFFERENTIATION_6HR"
100,"Down",0.126621191237045,0.395306926227906,"L.PvsV.CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_DN"
7,"Up",0.126862870061731,0.39563384506522,"L.PvsV.CAFFAREL_RESPONSE_TO_THC_8HR_3_UP"
185,"Down",0.126944291863559,0.39563384506522,"L.PvsV.SMIRNOV_RESPONSE_TO_IR_6HR_DN"
24,"Down",0.126962559432208,0.39563384506522,"L.PvsV.FARMER_BREAST_CANCER_CLUSTER_5"
13,"Down",0.127122961314798,0.39563384506522,"L.PvsV.REACTOME_CREATINE_METABOLISM"
171,"Down",0.127162060765273,0.39563384506522,"L.PvsV.DOANE_BREAST_CANCER_ESR1_UP"
734,"Down",0.127240663669946,0.39563384506522,"L.PvsV.FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_UP"
13,"Down",0.127256611473207,0.39563384506522,"L.PvsV.ZHENG_FOXP3_TARGETS_IN_T_LYMPHOCYTE_UP"
344,"Down",0.127298356008506,0.39563384506522,"L.PvsV.LINDGREN_BLADDER_CANCER_CLUSTER_3_DN"
48,"Down",0.127463706358542,0.395720866452206,"L.PvsV.GRADE_COLON_VS_RECTAL_CANCER_UP"
83,"Down",0.127533715758747,0.395720866452206,"L.PvsV.REACTOME_SIRT1_NEGATIVELY_REGULATES_RRNA_EXPRESSION"
129,"Up",0.127591606804014,0.395720866452206,"L.PvsV.MENSE_HYPOXIA_UP"
42,"Down",0.127612643314213,0.395720866452206,"L.PvsV.NOJIMA_SFRP2_TARGETS_DN"
33,"Down",0.127945284538472,0.396529976576913,"L.PvsV.REACTOME_PURINERGIC_SIGNALING_IN_LEISHMANIASIS_INFECTION"
258,"Down",0.128115692719003,0.396835666690962,"L.PvsV.RUIZ_TNC_TARGETS_UP"
421,"Down",0.128356694181861,0.397359553265122,"L.PvsV.FORTSCHEGGER_PHF8_TARGETS_UP"
94,"Down",0.128679740477356,0.397971614591097,"L.PvsV.ONDER_CDH1_TARGETS_3_DN"
154,"Down",0.12869836261329,0.397971614591097,"L.PvsV.REN_ALVEOLAR_RHABDOMYOSARCOMA_UP"
209,"Down",0.128796330789731,0.39805193568274,"L.PvsV.SANSOM_APC_TARGETS_UP"
33,"Up",0.129444398987219,0.399831330726445,"L.PvsV.KIM_HYPOXIA"
28,"Down",0.129620187608336,0.40006026611388,"L.PvsV.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_23"
12,"Up",0.129690560733116,0.40006026611388,"L.PvsV.GROSS_HIF1A_TARGETS_UP"
74,"Down",0.129821314270414,0.40006026611388,"L.PvsV.YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_15"
43,"Down",0.12982731776975,0.40006026611388,"L.PvsV.REACTOME_VOLTAGE_GATED_POTASSIUM_CHANNELS"
115,"Down",0.129880299814508,0.40006026611388,"L.PvsV.BROWNE_HCMV_INFECTION_1HR_UP"
10,"Up",0.130062500824291,0.400219051166608,"L.PvsV.BIOCARTA_MSP_PATHWAY"
107,"Up",0.130076620536516,0.400219051166608,"L.PvsV.ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_UP"
151,"Down",0.130224551512115,0.400451360016955,"L.PvsV.IGARASHI_ATF4_TARGETS_DN"
74,"Down",0.130439367966605,0.400888974701146,"L.PvsV.FRASOR_TAMOXIFEN_RESPONSE_UP"
28,"Down",0.13059744922252,0.401151831528506,"L.PvsV.PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_3"
67,"Down",0.130842974977811,0.401340421826826,"L.PvsV.PID_NCADHERIN_PATHWAY"
21,"Up",0.130848278458716,0.401340421826826,"L.PvsV.BIOCARTA_NDKDYNAMIN_PATHWAY"
257,"Up",0.130876610698819,0.401340421826826,"L.PvsV.LANDIS_ERBB2_BREAST_TUMORS_324_DN"
54,"Up",0.130993469326886,0.401476104162058,"L.PvsV.MARZEC_IL2_SIGNALING_DN"
84,"Down",0.131372563275215,0.402275697832324,"L.PvsV.GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN"
65,"Down",0.131399875255051,0.402275697832324,"L.PvsV.SESTO_RESPONSE_TO_UV_C3"
30,"Down",0.13147398962159,0.402279849816144,"L.PvsV.STREICHER_LSM1_TARGETS_DN"
99,"Down",0.131674810622083,0.402671475624722,"L.PvsV.NOUZOVA_METHYLATED_IN_APL"
95,"Down",0.131819626701561,0.402891495872267,"L.PvsV.PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP"
71,"Down",0.132058772199751,0.403306375842248,"L.PvsV.TAVOR_CEBPA_TARGETS_DN"
127,"Down",0.132101256402661,0.403306375842248,"L.PvsV.REACTOME_REGULATION_OF_PLK1_ACTIVITY_AT_G2_M_TRANSITION"
23,"Up",0.132189760817878,0.403353856270447,"L.PvsV.REACTOME_CTLA4_INHIBITORY_SIGNALING"
36,"Up",0.13241087581446,0.403445264331464,"L.PvsV.GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_UP"
38,"Down",0.132574720336895,0.403445264331464,"L.PvsV.NAKAJIMA_EOSINOPHIL"
8,"Down",0.132602349862398,0.403445264331464,"L.PvsV.LU_TUMOR_ENDOTHELIAL_MARKERS_DN"
25,"Down",0.132606677750663,0.403445264331464,"L.PvsV.BIOCARTA_ETS_PATHWAY"
75,"Up",0.132623690362328,0.403445264331464,"L.PvsV.LUI_THYROID_CANCER_PAX8_PPARG_UP"
90,"Up",0.13265753129944,0.403445264331464,"L.PvsV.CAFFAREL_RESPONSE_TO_THC_24HR_5_DN"
259,"Down",0.13273242182196,0.403451105142174,"L.PvsV.RICKMAN_HEAD_AND_NECK_CANCER_C"
74,"Down",0.132941596589466,0.403864883265472,"L.PvsV.DALESSIO_TSA_RESPONSE"
9,"Down",0.133085943848889,0.403934844877035,"L.PvsV.REACTOME_FATTY_ACIDS_BOUND_TO_GPR40_FFAR1_REGULATE_INSULIN_SECRETION"
914,"Down",0.133110741068178,0.403934844877035,"L.PvsV.BENPORATH_CYCLING_GENES"
29,"Down",0.13333468769284,0.404303522127311,"L.PvsV.LEI_HOXC8_TARGETS_DN"
488,"Down",0.133470099252739,0.404303522127311,"L.PvsV.BROWNE_HCMV_INFECTION_14HR_DN"
343,"Down",0.133493157107176,0.404303522127311,"L.PvsV.YEGNASUBRAMANIAN_PROSTATE_CANCER"
26,"Up",0.133524729861543,0.404303522127311,"L.PvsV.REACTOME_SYNTHESIS_SECRETION_AND_INACTIVATION_OF_GLUCAGON_LIKE_PEPTIDE_1_GLP_1"
51,"Down",0.133712647153856,0.404585662302902,"L.PvsV.REACTOME_GROWTH_HORMONE_RECEPTOR_SIGNALING"
24,"Down",0.133890578917021,0.404585662302902,"L.PvsV.REACTOME_FGFR1_LIGAND_BINDING_AND_ACTIVATION"
21,"Up",0.133894774658505,0.404585662302902,"L.PvsV.SCHWAB_TARGETS_OF_BMYB_POLYMORPHIC_VARIANTS_UP"
37,"Down",0.133910609877792,0.404585662302902,"L.PvsV.HOFMANN_MYELODYSPLASTIC_SYNDROM_RISK_UP"
112,"Down",0.134045823070751,0.404772996044883,"L.PvsV.PID_E2F_PATHWAY"
10,"Up",0.134131842204257,0.404811656958153,"L.PvsV.REACTOME_SYNTHESIS_OF_PYROPHOSPHATES_IN_THE_CYTOSOL"
44,"Up",0.13429323124315,0.404917137507186,"L.PvsV.YANG_BREAST_CANCER_ESR1_BULK_DN"
68,"Up",0.1343132628302,0.404917137507186,"L.PvsV.REACTOME_TRANSCRIPTIONAL_ACTIVATION_OF_MITOCHONDRIAL_BIOGENESIS"
11,"Up",0.134693506887294,0.405842179607546,"L.PvsV.REACTOME_AKT_PHOSPHORYLATES_TARGETS_IN_THE_NUCLEUS"
33,"Down",0.13487678845224,0.405969240145465,"L.PvsV.KORKOLA_YOLK_SAC_TUMOR_UP"
240,"Down",0.134882527427603,0.405969240145465,"L.PvsV.REACTOME_MITOTIC_PROMETAPHASE"
127,"Down",0.135023387336509,0.406172093897474,"L.PvsV.SANA_TNF_SIGNALING_DN"
1129,"Up",0.135112874117362,0.406220272427892,"L.PvsV.BENPORATH_MYC_MAX_TARGETS"
14,"Up",0.135346986898899,0.40670298400218,"L.PvsV.BIOCARTA_LEPTIN_PATHWAY"
34,"Up",0.135474807670304,0.40686594872847,"L.PvsV.KEGG_ALANINE_ASPARTATE_AND_GLUTAMATE_METABOLISM"
492,"Down",0.135848103171033,0.407577193059165,"L.PvsV.WANG_MLL_TARGETS"
41,"Up",0.135902437944295,0.407577193059165,"L.PvsV.MAYBURD_RESPONSE_TO_L663536_UP"
134,"Down",0.135932780611521,0.407577193059165,"L.PvsV.DELASERNA_MYOD_TARGETS_UP"
750,"Down",0.13620371477777,0.408168205423465,"L.PvsV.ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP"
12,"Down",0.136320674963348,0.408297406214708,"L.PvsV.HOFFMAN_CLOCK_TARGETS_DN"
172,"Down",0.136507848071943,0.408521416591201,"L.PvsV.KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP"
526,"Down",0.136543240705469,0.408521416591201,"L.PvsV.SABATES_COLORECTAL_ADENOMA_DN"
75,"Down",0.136754827808485,0.408705684895464,"L.PvsV.REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS"
16,"Up",0.136810454431491,0.408705684895464,"L.PvsV.BIOCARTA_THELPER_PATHWAY"
33,"Up",0.136826591199404,0.408705684895464,"L.PvsV.HOEGERKORP_CD44_TARGETS_TEMPORAL_DN"
60,"Down",0.137128843123103,0.409387350770861,"L.PvsV.GENTILE_UV_RESPONSE_CLUSTER_D8"
156,"Up",0.137327951140312,0.409760519079754,"L.PvsV.REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_DIFFERENTIATION_OF_HSCS"
95,"Up",0.137602061148503,0.410289961249742,"L.PvsV.KYNG_DNA_DAMAGE_BY_4NQO_OR_UV"
9,"Up",0.13765380324078,0.410289961249742,"L.PvsV.GROSS_HYPOXIA_VIA_HIF1A_ONLY"
31,"Down",0.137763320732848,0.410395151040904,"L.PvsV.LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_QTL"
48,"Down",0.138195619546349,0.410695033311304,"L.PvsV.GHANDHI_DIRECT_IRRADIATION_DN"
59,"Down",0.138247931753742,0.410695033311304,"L.PvsV.AMIT_EGF_RESPONSE_480_MCF10A"
62,"Down",0.138308215761091,0.410695033311304,"L.PvsV.KORKOLA_CORRELATED_WITH_POU5F1"
116,"Down",0.138325450902424,0.410695033311304,"L.PvsV.DAZARD_UV_RESPONSE_CLUSTER_G1"
133,"Down",0.138496552686404,0.410695033311304,"L.PvsV.GRABARCZYK_BCL11B_TARGETS_UP"
55,"Down",0.138567255733845,0.410695033311304,"L.PvsV.STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_DN"
305,"Down",0.138579121516422,0.410695033311304,"L.PvsV.PAL_PRMT5_TARGETS_UP"
22,"Down",0.138609003807943,0.410695033311304,"L.PvsV.REACTOME_CASPASE_MEDIATED_CLEAVAGE_OF_CYTOSKELETAL_PROTEINS"
9,"Down",0.138615435011198,0.410695033311304,"L.PvsV.REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_WNT_SIGNALING"
378,"Down",0.138665543776605,0.410695033311304,"L.PvsV.EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_UP"
78,"Down",0.138681068401556,0.410695033311304,"L.PvsV.NAGASHIMA_EGF_SIGNALING_UP"
169,"Down",0.138782937956663,0.410776693770016,"L.PvsV.SERVITJA_ISLET_HNF1A_TARGETS_DN"
50,"Up",0.139094748612412,0.411355361092962,"L.PvsV.JAERVINEN_AMPLIFIED_IN_LARYNGEAL_CANCER"
699,"Up",0.139127242764304,0.411355361092962,"L.PvsV.GARY_CD5_TARGETS_UP"
36,"Down",0.139363329694737,0.411495651869934,"L.PvsV.GAVIN_PDE3B_TARGETS"
35,"Down",0.139419793973324,0.411495651869934,"L.PvsV.REACTOME_REGULATION_OF_GLUCOKINASE_BY_GLUCOKINASE_REGULATORY_PROTEIN"
36,"Down",0.139514389652869,0.411495651869934,"L.PvsV.BIOCARTA_INTRINSIC_PATHWAY"
67,"Down",0.139516325852693,0.411495651869934,"L.PvsV.GYORFFY_DOXORUBICIN_RESISTANCE"
13,"Down",0.139546816287959,0.411495651869934,"L.PvsV.REACTOME_FGFRL1_MODULATION_OF_FGFR1_SIGNALING"
19,"Down",0.139835103340078,0.411816023275314,"L.PvsV.REACTOME_CGMP_EFFECTS"
12,"Up",0.139865411845162,0.411816023275314,"L.PvsV.FOURNIER_ACINAR_DEVELOPMENT_EARLY_DN"
28,"Down",0.139936772079268,0.411816023275314,"L.PvsV.MARCINIAK_ER_STRESS_RESPONSE_VIA_CHOP"
35,"Down",0.139953392608847,0.411816023275314,"L.PvsV.BIOCARTA_MPR_PATHWAY"
130,"Down",0.140099002332267,0.411865987031431,"L.PvsV.REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS"
20,"Down",0.140119356412755,0.411865987031431,"L.PvsV.GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_2"
151,"Up",0.140367867951003,0.41204836543989,"L.PvsV.KEGG_INSULIN_SIGNALING_PATHWAY"
78,"Down",0.140383276966412,0.41204836543989,"L.PvsV.WANG_METHYLATED_IN_BREAST_CANCER"
79,"Down",0.140404977480331,0.41204836543989,"L.PvsV.REACTOME_BASE_EXCISION_REPAIR_AP_SITE_FORMATION"
797,"Up",0.140588619899481,0.41225689973934,"L.PvsV.KIM_ALL_DISORDERS_CALB1_CORR_UP"
127,"Down",0.140625160591137,0.41225689973934,"L.PvsV.WANG_PROSTATE_CANCER_ANDROGEN_INDEPENDENT"
181,"Down",0.140701065301254,0.412260832035311,"L.PvsV.MCLACHLAN_DENTAL_CARIES_DN"
19,"Down",0.140807338525471,0.412353694230577,"L.PvsV.WILLIAMS_ESR2_TARGETS_DN"
497,"Up",0.140932733058524,0.412502425135298,"L.PvsV.DACOSTA_UV_RESPONSE_VIA_ERCC3_UP"
17,"Up",0.141174413425245,0.412673891991558,"L.PvsV.REACTOME_RESPONSE_OF_EIF2AK1_HRI_TO_HEME_DEFICIENCY"
113,"Down",0.141227488860544,0.412673891991558,"L.PvsV.PID_PTP1B_PATHWAY"
271,"Up",0.141241534741683,0.412673891991558,"L.PvsV.REACTOME_NEDDYLATION"
94,"Up",0.141292318547654,0.412673891991558,"L.PvsV.COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_UP"
181,"Down",0.141403815933144,0.412673891991558,"L.PvsV.ONDER_CDH1_SIGNALING_VIA_CTNNB1"
287,"Up",0.141439143665039,0.412673891991558,"L.PvsV.KYNG_DNA_DAMAGE_DN"
30,"Down",0.141773109533914,0.41343012796045,"L.PvsV.REACTOME_OTHER_INTERLEUKIN_SIGNALING"
16,"Down",0.141875702004031,0.413511205261091,"L.PvsV.MARTIN_NFKB_TARGETS_DN"
14,"Down",0.142006520773953,0.413674422212427,"L.PvsV.BIOCARTA_EXTRINSIC_PATHWAY"
1648,"Up",0.142221121611386,0.413819335509761,"L.PvsV.REACTOME_INNATE_IMMUNE_SYSTEM"
388,"Down",0.142230866990129,0.413819335509761,"L.PvsV.VERHAAK_AML_WITH_NPM1_MUTATED_UP"
78,"Down",0.142280802460491,0.413819335509761,"L.PvsV.OSADA_ASCL1_TARGETS_UP"
806,"Up",0.142365460686296,0.413847861269468,"L.PvsV.REACTOME_NEUTROPHIL_DEGRANULATION"
295,"Down",0.142451365239269,0.413879978143942,"L.PvsV.WHITFIELD_CELL_CYCLE_G2_M"
1480,"Down",0.142699305884234,0.414344102150163,"L.PvsV.CUI_TCF21_TARGETS_2_DN"
19,"Up",0.142760990160257,0.414344102150163,"L.PvsV.SASSON_FSH_RESPONSE"
135,"Down",0.143095450074056,0.41509692731346,"L.PvsV.PLASARI_TGFB1_SIGNALING_VIA_NFIC_10HR_UP"
59,"Up",0.143250443882209,0.415328633573535,"L.PvsV.NIKOLSKY_BREAST_CANCER_12Q13_Q21_AMPLICON"
19,"Down",0.144084134757842,0.417526824463369,"L.PvsV.REACTOME_OAS_ANTIVIRAL_RESPONSE"
29,"Up",0.144237725242867,0.417752950690314,"L.PvsV.GREENBAUM_E2A_TARGETS_DN"
94,"Down",0.144420654627752,0.41806376933866,"L.PvsV.WARTERS_IR_RESPONSE_5GY"
96,"Down",0.144576337298422,0.418152562828225,"L.PvsV.REACTOME_TRANSLOCATION_OF_SLC2A4_GLUT4_TO_THE_PLASMA_MEMBRANE"
202,"Down",0.144648169695093,0.418152562828225,"L.PvsV.BROWNE_HCMV_INFECTION_20HR_DN"
23,"Down",0.144678215353661,0.418152562828225,"L.PvsV.REACTOME_E2F_MEDIATED_REGULATION_OF_DNA_REPLICATION"
42,"Down",0.144818377410954,0.418171372210765,"L.PvsV.JI_METASTASIS_REPRESSED_BY_STK11"
24,"Down",0.144963868907297,0.418171372210765,"L.PvsV.REACTOME_DCC_MEDIATED_ATTRACTIVE_SIGNALING"
33,"Up",0.144973934149949,0.418171372210765,"L.PvsV.REACTOME_SIALIC_ACID_METABOLISM"
91,"Up",0.145032562759185,0.418171372210765,"L.PvsV.SHAFFER_IRF4_TARGETS_IN_ACTIVATED_DENDRITIC_CELL"
120,"Up",0.14506288513298,0.418171372210765,"L.PvsV.REACTOME_MYD88_INDEPENDENT_TLR4_CASCADE"
151,"Down",0.145289226850432,0.418535224882263,"L.PvsV.MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_UP"
16,"Down",0.145340501315599,0.418535224882263,"L.PvsV.REACTOME_PYRIMIDINE_CATABOLISM"
14,"Down",0.145520479704303,0.418835362980267,"L.PvsV.REACTOME_FGFR3_LIGAND_BINDING_AND_ACTIVATION"
175,"Down",0.145779583645672,0.419362808520771,"L.PvsV.KAN_RESPONSE_TO_ARSENIC_TRIOXIDE"
237,"Down",0.146055821854883,0.419907624003465,"L.PvsV.DAZARD_UV_RESPONSE_CLUSTER_G6"
30,"Up",0.146120866084765,0.419907624003465,"L.PvsV.REACTOME_DARPP_32_EVENTS"
18,"Up",0.146404718846212,0.420354689411481,"L.PvsV.REACTOME_GLYCOGEN_SYNTHESIS"
342,"Down",0.146428491916533,0.420354689411481,"L.PvsV.DARWICHE_SKIN_TUMOR_PROMOTER_DN"
84,"Down",0.146543170558628,0.420465589008122,"L.PvsV.BROWNE_HCMV_INFECTION_2HR_DN"
87,"Up",0.146803730290872,0.420869299919166,"L.PvsV.GENTILE_UV_RESPONSE_CLUSTER_D4"
17,"Up",0.146862872086769,0.420869299919166,"L.PvsV.REACTOME_VITAMIN_B5_PANTOTHENATE_METABOLISM"
19,"Down",0.14691223527654,0.420869299919166,"L.PvsV.REACTOME_PTK6_REGULATES_RHO_GTPASES_RAS_GTPASE_AND_MAP_KINASES"
35,"Down",0.147387725912095,0.422012810237169,"L.PvsV.REACTOME_GAP_JUNCTION_ASSEMBLY"
6,"Up",0.147492908845634,0.422095389755441,"L.PvsV.REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_LINKED_TO_TRIGLYCERIDE_LIPOLYSIS_IN_ADIPOSE"
248,"Down",0.147680107217643,0.422248718648935,"L.PvsV.GOZGIT_ESR1_TARGETS_UP"
19,"Down",0.147699226237482,0.422248718648935,"L.PvsV.YANG_BCL3_TARGETS_DN"
150,"Down",0.147963361474822,0.422785232865267,"L.PvsV.GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP"
189,"Down",0.148305574826426,0.423506087446161,"L.PvsV.DURCHDEWALD_SKIN_CARCINOGENESIS_UP"
67,"Down",0.148368835482585,0.423506087446161,"L.PvsV.BROWNE_HCMV_INFECTION_2HR_UP"
81,"Up",0.148714278633029,0.424273089041288,"L.PvsV.KEGG_AUTOIMMUNE_THYROID_DISEASE"
156,"Down",0.14917133253666,0.425056041849415,"L.PvsV.FONTAINE_PAPILLARY_THYROID_CARCINOMA_DN"
7,"Down",0.149179147611041,0.425056041849415,"L.PvsV.MOTAMED_RESPONSE_TO_ANDROGEN_DN"
16,"Down",0.149219348386637,0.425056041849415,"L.PvsV.REACTOME_PHYSIOLOGICAL_FACTORS"
65,"Down",0.149329799804161,0.425151628793619,"L.PvsV.NAKAMURA_METASTASIS_MODEL_UP"
16,"Up",0.14945997500274,0.425303243329978,"L.PvsV.REACTOME_SYNTHESIS_OF_PE"
316,"Down",0.149774515531835,0.425812928129364,"L.PvsV.SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN"
16,"Down",0.14979311723849,0.425812928129364,"L.PvsV.KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_KERATAN_SULFATE"
92,"Down",0.149974719668473,0.426049767637853,"L.PvsV.TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_UP"
52,"Down",0.150030547583812,0.426049767637853,"L.PvsV.PID_BMP_PATHWAY"
11,"Down",0.150110886069828,0.42605908063659,"L.PvsV.MATHEW_FANCONI_ANEMIA_GENES"
35,"Down",0.15034681653285,0.426329415040992,"L.PvsV.NIKOLSKY_OVERCONNECTED_IN_BREAST_CANCER"
72,"Down",0.150387655339656,0.426329415040992,"L.PvsV.JIANG_TIP30_TARGETS_UP"
10,"Up",0.150437455009039,0.426329415040992,"L.PvsV.REACTOME_MULTIFUNCTIONAL_ANION_EXCHANGERS"
112,"Down",0.151048173005749,0.427689270025151,"L.PvsV.LEE_LIVER_CANCER_CIPROFIBRATE_DN"
116,"Down",0.151072010193366,0.427689270025151,"L.PvsV.REACTOME_INTERFERON_ALPHA_BETA_SIGNALING"
63,"Down",0.151288746184385,0.427899658300589,"L.PvsV.TOMLINS_PROSTATE_CANCER_DN"
2689,"Down",0.151416293350804,0.427899658300589,"L.PvsV.ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY"
13,"Up",0.151440967844849,0.427899658300589,"L.PvsV.REACTOME_TRIGLYCERIDE_BIOSYNTHESIS"
17,"Up",0.151455892800552,0.427899658300589,"L.PvsV.REACTOME_GLYCOGEN_BREAKDOWN_GLYCOGENOLYSIS"
16,"Down",0.151658749514626,0.42825394589702,"L.PvsV.LOPEZ_MESOTELIOMA_SURVIVAL_TIME_DN"
10,"Down",0.151859757468816,0.428602653928067,"L.PvsV.TESAR_ALK_TARGETS_HUMAN_ES_5D_UP"
144,"Down",0.15208275184389,0.428894458619003,"L.PvsV.WINZEN_DEGRADED_VIA_KHSRP"
298,"Down",0.152181145526815,0.428894458619003,"L.PvsV.SMID_BREAST_CANCER_LUMINAL_B_UP"
17,"Up",0.152195863232137,0.428894458619003,"L.PvsV.REACTOME_ANDROGEN_BIOSYNTHESIS"
102,"Down",0.152426199943651,0.429324737385861,"L.PvsV.REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION"
29,"Down",0.152802307503754,0.430164948161026,"L.PvsV.NOUSHMEHR_GBM_SOMATIC_MUTATED"
64,"Down",0.153026501842359,0.430576859382394,"L.PvsV.REACTOME_CARGO_TRAFFICKING_TO_THE_PERICILIARY_MEMBRANE"
17,"Down",0.153111412170861,0.430596641857929,"L.PvsV.PID_ERBB_NETWORK_PATHWAY"
14,"Up",0.153368405670052,0.431100109277944,"L.PvsV.SMID_BREAST_CANCER_RELAPSE_IN_LIVER_DN"
22,"Up",0.153877355034291,0.432310922756399,"L.PvsV.FARMER_BREAST_CANCER_CLUSTER_6"
296,"Down",0.153978958371752,0.432376668784873,"L.PvsV.SMIRNOV_RESPONSE_TO_IR_6HR_UP"
11,"Down",0.154321580296248,0.432669617704221,"L.PvsV.WILLIAMS_ESR1_TARGETS_DN"
385,"Down",0.154414573106891,0.432669617704221,"L.PvsV.RIGGINS_TAMOXIFEN_RESISTANCE_DN"
43,"Up",0.154509537820398,0.432669617704221,"L.PvsV.BIOCARTA_WNT_PATHWAY"
19,"Down",0.154591574652357,0.432669617704221,"L.PvsV.REACTOME_TRANSLESION_SYNTHESIS_BY_POLK"
9,"Up",0.154620693588179,0.432669617704221,"L.PvsV.REACTOME_WNT_MEDIATED_ACTIVATION_OF_DVL"
35,"Up",0.154629083307362,0.432669617704221,"L.PvsV.ZHAN_MULTIPLE_MYELOMA_SUBGROUPS"
103,"Down",0.154631066121096,0.432669617704221,"L.PvsV.LINDVALL_IMMORTALIZED_BY_TERT_UP"
193,"Down",0.15471440115175,0.432683825982814,"L.PvsV.KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP"
21,"Down",0.155118663918156,0.433456725577291,"L.PvsV.REACTOME_IL_6_TYPE_CYTOKINE_RECEPTOR_LIGAND_INTERACTIONS"
559,"Down",0.155174263714611,0.433456725577291,"L.PvsV.MULLIGHAN_NPM1_SIGNATURE_3_UP"
34,"Down",0.1554483461262,0.433456725577291,"L.PvsV.PARK_HSC_VS_MULTIPOTENT_PROGENITORS_UP"
218,"Up",0.155564964342901,0.433456725577291,"L.PvsV.MCBRYAN_PUBERTAL_BREAST_5_6WK_DN"
43,"Down",0.155685433079851,0.433456725577291,"L.PvsV.NEWMAN_ERCC6_TARGETS_UP"
113,"Down",0.155686319118261,0.433456725577291,"L.PvsV.JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN"
110,"Down",0.155723720947968,0.433456725577291,"L.PvsV.REACTOME_POTASSIUM_CHANNELS"
23,"Down",0.15578754851342,0.433456725577291,"L.PvsV.REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_G2_CELL_CYCLE_ARREST"
16,"Up",0.155908435043831,0.433456725577291,"L.PvsV.BIOCARTA_TCYTOTOXIC_PATHWAY"
30,"Down",0.155964015631659,0.433456725577291,"L.PvsV.SUZUKI_RESPONSE_TO_TSA_AND_DECITABINE_1B"
8,"Down",0.155967860310136,0.433456725577291,"L.PvsV.CHOI_ATL_ACUTE_STAGE"
9,"Up",0.155974275532318,0.433456725577291,"L.PvsV.REACTOME_TERMINAL_PATHWAY_OF_COMPLEMENT"
29,"Down",0.1561363064441,0.433456725577291,"L.PvsV.DORN_ADENOVIRUS_INFECTION_32HR_UP"
339,"Up",0.156142822297543,0.433456725577291,"L.PvsV.SANSOM_APC_MYC_TARGETS"
574,"Up",0.156166720446729,0.433456725577291,"L.PvsV.WANG_LMO4_TARGETS_DN"
29,"Down",0.156351102244548,0.43375074977928,"L.PvsV.REACTOME_PI_3K_CASCADE_FGFR2"
22,"Down",0.156456555304588,0.433825624011569,"L.PvsV.PYEON_HPV_POSITIVE_TUMORS_DN"
59,"Down",0.157007219180345,0.435003428560018,"L.PvsV.BRACHAT_RESPONSE_TO_METHOTREXATE_UP"
106,"Down",0.15703867668761,0.435003428560018,"L.PvsV.INGRAM_SHH_TARGETS_DN"
175,"Up",0.157182510378615,0.435183825680202,"L.PvsV.HOSHIDA_LIVER_CANCER_SURVIVAL_DN"
51,"Up",0.157580308186202,0.435706817371909,"L.PvsV.VALK_AML_CLUSTER_5"
92,"Up",0.157580310834526,0.435706817371909,"L.PvsV.NIKOLSKY_BREAST_CANCER_8P12_P11_AMPLICON"
37,"Down",0.157629824781537,0.435706817371909,"L.PvsV.BIOCARTA_DEATH_PATHWAY"
196,"Down",0.157686623541543,0.435706817371909,"L.PvsV.AMBROSINI_FLAVOPIRIDOL_TREATMENT_TP53"
13,"Down",0.15785787753572,0.435875715461013,"L.PvsV.SHIRAISHI_PLZF_TARGETS_UP"
983,"Down",0.157905418352037,0.435875715461013,"L.PvsV.HAMAI_APOPTOSIS_VIA_TRAIL_UP"
30,"Down",0.158236184656506,0.436570790901109,"L.PvsV.MATZUK_SPERMATOGONIA"
445,"Up",0.158827351909763,0.437983256214004,"L.PvsV.BORCZUK_MALIGNANT_MESOTHELIOMA_UP"
27,"Up",0.158981144167085,0.438038335727521,"L.PvsV.MELLMAN_TUT1_TARGETS_UP"
32,"Up",0.159005776777923,0.438038335727521,"L.PvsV.KEGG_GLYCINE_SERINE_AND_THREONINE_METABOLISM"
21,"Down",0.159250513681434,0.438372717970745,"L.PvsV.REACTOME_PCNA_DEPENDENT_LONG_PATCH_BASE_EXCISION_REPAIR"
19,"Up",0.159285728052673,0.438372717970745,"L.PvsV.REACTOME_TRAFFICKING_OF_GLUR2_CONTAINING_AMPA_RECEPTORS"
92,"Up",0.159700597845239,0.438985174269764,"L.PvsV.LUCAS_HNF4A_TARGETS_UP"
8,"Down",0.159773784576894,0.438985174269764,"L.PvsV.REACTOME_DEFECTIVE_ST3GAL3_CAUSES_MCT12_AND_EIEE15"
107,"Down",0.159872058272433,0.438985174269764,"L.PvsV.JOHNSTONE_PARVB_TARGETS_1_DN"
66,"Down",0.159897353476132,0.438985174269764,"L.PvsV.LUI_THYROID_CANCER_CLUSTER_2"
31,"Down",0.159905252483144,0.438985174269764,"L.PvsV.REACTOME_FRS_MEDIATED_FGFR1_SIGNALING"
10,"Up",0.160131885220913,0.43938917785927,"L.PvsV.REACTOME_BETA_OXIDATION_OF_PRISTANOYL_COA"
575,"Down",0.160287395938837,0.439597724278684,"L.PvsV.SHEN_SMARCA2_TARGETS_DN"
59,"Down",0.160641813373854,0.440351306962835,"L.PvsV.REACTOME_MRNA_SPLICING_MINOR_PATHWAY"
11,"Down",0.161038365339132,0.441219584717572,"L.PvsV.REACTOME_SYNTHESIS_OF_LIPOXINS_LX"
31,"Down",0.161159287543615,0.441310800721663,"L.PvsV.VERNOCHET_ADIPOGENESIS"
183,"Down",0.161231292721606,0.441310800721663,"L.PvsV.GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP"
57,"Down",0.161735763549433,0.442472556489269,"L.PvsV.WESTON_VEGFA_TARGETS_12HR"
53,"Up",0.162170798505486,0.443443296210105,"L.PvsV.KIM_TIAL1_TARGETS"
60,"Down",0.162463823378946,0.443846847521244,"L.PvsV.PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_UP"
18,"Down",0.162482632885132,0.443846847521244,"L.PvsV.BIOCARTA_PCAF_PATHWAY"
75,"Down",0.162559208940228,0.443846847521244,"L.PvsV.NUTT_GBM_VS_AO_GLIOMA_DN"
52,"Down",0.162673394866448,0.443939388063471,"L.PvsV.PID_FOXM1_PATHWAY"
29,"Down",0.162761128598261,0.443959684272218,"L.PvsV.REACTOME_SHC_MEDIATED_CASCADE_FGFR1"
10,"Down",0.162993145441418,0.444245644548402,"L.PvsV.PID_VEGF_VEGFR_PATHWAY"
30,"Down",0.163026661745109,0.444245644548402,"L.PvsV.LUI_THYROID_CANCER_CLUSTER_5"
12,"Up",0.163356129822924,0.444924158517707,"L.PvsV.REACTOME_REVERSIBLE_HYDRATION_OF_CARBON_DIOXIDE"
114,"Up",0.163454706995506,0.444973449029125,"L.PvsV.HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_UP"
134,"Down",0.163576238625669,0.445085149291991,"L.PvsV.FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_DN"
56,"Down",0.164077726725182,0.446230079224561,"L.PvsV.TSENG_ADIPOGENIC_POTENTIAL_UP"
34,"Down",0.164295587633587,0.446602902667701,"L.PvsV.REACTOME_IRF3_MEDIATED_INDUCTION_OF_TYPE_I_IFN"
24,"Down",0.164519778608638,0.446927992795006,"L.PvsV.BIOCARTA_ATRBRCA_PATHWAY"
35,"Down",0.164596767521756,0.446927992795006,"L.PvsV.MAGRANGEAS_MULTIPLE_MYELOMA_IGLL_VS_IGLK_DN"
33,"Down",0.164657681556055,0.446927992795006,"L.PvsV.PIEPOLI_LGI1_TARGETS_UP"
95,"Down",0.16509178497485,0.447543986669158,"L.PvsV.BURTON_ADIPOGENESIS_PEAK_AT_24HR"
360,"Down",0.165209424345543,0.447543986669158,"L.PvsV.RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN"
19,"Up",0.165282491014109,0.447543986669158,"L.PvsV.BIOCARTA_LONGEVITY_PATHWAY"
35,"Up",0.165282788566985,0.447543986669158,"L.PvsV.REACTOME_RESPONSE_OF_MTB_TO_PHAGOCYTOSIS"
112,"Down",0.165289350837117,0.447543986669158,"L.PvsV.REACTOME_DNA_DOUBLE_STRAND_BREAK_RESPONSE"
278,"Down",0.165373172551478,0.447551772411711,"L.PvsV.FUJII_YBX1_TARGETS_DN"
213,"Down",0.165522143692925,0.447660533944539,"L.PvsV.CERVERA_SDHB_TARGETS_2"
155,"Down",0.165575292442862,0.447660533944539,"L.PvsV.LEIN_CEREBELLUM_MARKERS"
92,"Up",0.165743110159982,0.447766880245871,"L.PvsV.REACTOME_DDX58_IFIH1_MEDIATED_INDUCTION_OF_INTERFERON_ALPHA_BETA"
131,"Up",0.165872207745758,0.447766880245871,"L.PvsV.DITTMER_PTHLH_TARGETS_DN"
12,"Down",0.166067257174141,0.447766880245871,"L.PvsV.OHM_EMBRYONIC_CARCINOMA_DN"
53,"Up",0.166070580520252,0.447766880245871,"L.PvsV.BIOCARTA_VEGF_PATHWAY"
135,"Up",0.166076653919381,0.447766880245871,"L.PvsV.REACTOME_SELENOAMINO_ACID_METABOLISM"
131,"Up",0.166100537418029,0.447766880245871,"L.PvsV.SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE"
46,"Down",0.166612653216047,0.448928537832126,"L.PvsV.SAKAI_TUMOR_INFILTRATING_MONOCYTES_UP"
42,"Up",0.166850748791536,0.449351091119533,"L.PvsV.BRACHAT_RESPONSE_TO_METHOTREXATE_DN"
211,"Up",0.167013461712559,0.44957031636258,"L.PvsV.RODWELL_AGING_KIDNEY_DN"
18,"Up",0.167147587717585,0.449712414837239,"L.PvsV.REACTOME_WNT5A_DEPENDENT_INTERNALIZATION_OF_FZD2_FZD5_AND_ROR2"
34,"Down",0.167234629944873,0.449727757278796,"L.PvsV.MASRI_RESISTANCE_TO_TAMOXIFEN_AND_AROMATASE_INHIBITORS_DN"
237,"Down",0.167557699169762,0.450240101138356,"L.PvsV.LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN"
11,"Up",0.16758801377152,0.450240101138356,"L.PvsV.BIOCARTA_REELIN_PATHWAY"
67,"Down",0.167905663500625,0.450729186099403,"L.PvsV.HAN_JNK_SINGALING_DN"
11,"Up",0.1679331024353,0.450729186099403,"L.PvsV.BIOCARTA_SALMONELLA_PATHWAY"
67,"Up",0.168051821942299,0.450828977932543,"L.PvsV.MA_MYELOID_DIFFERENTIATION_UP"
9,"Up",0.168294294075761,0.451019025800412,"L.PvsV.MIKHAYLOVA_OXIDATIVE_STRESS_RESPONSE_VIA_VHL_UP"
363,"Down",0.168319016825577,0.451019025800412,"L.PvsV.OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP"
21,"Up",0.168433956918859,0.451019025800412,"L.PvsV.REACTOME_P75NTR_SIGNALS_VIA_NF_KB"
55,"Down",0.168515177762344,0.451019025800412,"L.PvsV.PID_LYMPH_ANGIOGENESIS_PATHWAY"
88,"Down",0.168530531254051,0.451019025800412,"L.PvsV.SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM6"
36,"Up",0.168651694053397,0.451065592011486,"L.PvsV.KEGG_REGULATION_OF_AUTOPHAGY"
39,"Down",0.168711095004477,0.451065592011486,"L.PvsV.CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_DN"
26,"Down",0.168949082019747,0.45148355460956,"L.PvsV.SCIAN_CELL_CYCLE_TARGETS_OF_TP53_AND_TP73_DN"
58,"Down",0.169273828627849,0.45212925326539,"L.PvsV.BYSTRYKH_HEMATOPOIESIS_STEM_CELL_SCP2_QTL_TRANS"
10,"Up",0.169354256377758,0.45212925326539,"L.PvsV.REACTOME_THYROXINE_BIOSYNTHESIS"
476,"Down",0.169554181035956,0.452444530380213,"L.PvsV.MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_UP"
16,"Down",0.169876326766776,0.453070898389388,"L.PvsV.REACTOME_PI3K_AKT_ACTIVATION"
135,"Down",0.169985522250308,0.453070898389388,"L.PvsV.ROVERSI_GLIOMA_COPY_NUMBER_UP"
7,"Up",0.170034746637363,0.453070898389388,"L.PvsV.REACTOME_TRNA_PROCESSING_IN_THE_MITOCHONDRION"
33,"Down",0.170223198164372,0.453354558116961,"L.PvsV.BIOCARTA_G1_PATHWAY"
29,"Down",0.170594729928782,0.453929667178177,"L.PvsV.REACTOME_TNFS_BIND_THEIR_PHYSIOLOGICAL_RECEPTORS"
30,"Up",0.170603336660563,0.453929667178177,"L.PvsV.BIOCARTA_CTLA4_PATHWAY"
18,"Down",0.170707166788736,0.453974863911112,"L.PvsV.LI_WILMS_TUMOR_ANAPLASTIC_UP"
69,"Up",0.17081836406552,0.453974863911112,"L.PvsV.SMITH_LIVER_CANCER"
5,"Up",0.170880898029304,0.453974863911112,"L.PvsV.REACTOME_DOPAMINE_RECEPTORS"
28,"Down",0.17094875504846,0.453974863911112,"L.PvsV.VISALA_RESPONSE_TO_HEAT_SHOCK_AND_AGING_UP"
39,"Up",0.171133207488214,0.45414650866957,"L.PvsV.KEGG_THYROID_CANCER"
106,"Down",0.171177667583177,0.45414650866957,"L.PvsV.VANTVEER_BREAST_CANCER_POOR_PROGNOSIS"
45,"Down",0.171393774875482,0.454501765605056,"L.PvsV.XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_DN"
13,"Down",0.171565788494437,0.454739810443788,"L.PvsV.REACTOME_SMAC_XIAP_REGULATED_APOPTOTIC_RESPONSE"
149,"Up",0.171792330847022,0.45512208780699,"L.PvsV.NIKOLSKY_BREAST_CANCER_16P13_AMPLICON"
573,"Down",0.172289543500639,0.455937148015998,"L.PvsV.CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP"
76,"Down",0.172351200593019,0.455937148015998,"L.PvsV.NEMETH_INFLAMMATORY_RESPONSE_LPS_DN"
27,"Down",0.172394085106664,0.455937148015998,"L.PvsV.BIOCARTA_CDMAC_PATHWAY"
296,"Down",0.17243942232545,0.455937148015998,"L.PvsV.DUTERTRE_ESTRADIOL_RESPONSE_6HR_UP"
11,"Down",0.172686873537017,0.455937148015998,"L.PvsV.LUCAS_HNF4A_TARGETS_DN"
380,"Up",0.172690514830034,0.455937148015998,"L.PvsV.WAMUNYOKOLI_OVARIAN_CANCER_LMP_UP"
238,"Down",0.172748706220655,0.455937148015998,"L.PvsV.LI_INDUCED_T_TO_NATURAL_KILLER_DN"
77,"Down",0.17275968983424,0.455937148015998,"L.PvsV.MARTINEZ_RESPONSE_TO_TRABECTEDIN"
74,"Up",0.172881925553671,0.456042064115575,"L.PvsV.JIANG_HYPOXIA_CANCER"
60,"Up",0.173408011073156,0.457211680125646,"L.PvsV.HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_4HR"
150,"Up",0.173827497827293,0.458099254283653,"L.PvsV.SWEET_KRAS_ONCOGENIC_SIGNATURE"
19,"Up",0.17450967228321,0.459677931421567,"L.PvsV.REACTOME_SYNTHESIS_OF_PIPS_AT_THE_EARLY_ENDOSOME_MEMBRANE"
63,"Up",0.174742935309415,0.459921572348245,"L.PvsV.BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_DN"
22,"Down",0.17476853382233,0.459921572348245,"L.PvsV.SA_REG_CASCADE_OF_CYCLIN_EXPR"
8,"Up",0.174907207514876,0.460067531089319,"L.PvsV.IM_SREBF1A_TARGETS"
144,"Down",0.1751051783725,0.460307630886616,"L.PvsV.MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_UP"
107,"Down",0.175164994643776,0.460307630886616,"L.PvsV.BERNARD_PPAPDC1B_TARGETS_DN"
200,"Down",0.175330051174174,0.460522495459386,"L.PvsV.ODONNELL_TFRC_TARGETS_DN"
213,"Down",0.175480342424382,0.460600351768229,"L.PvsV.BROWNE_HCMV_INFECTION_8HR_UP"
733,"Down",0.175526305150237,0.460600351768229,"L.PvsV.HAN_SATB1_TARGETS_UP"
413,"Down",0.175833976246528,0.461035038671004,"L.PvsV.KEGG_PATHWAYS_IN_CANCER"
12,"Down",0.175858726091001,0.461035038671004,"L.PvsV.REACTOME_SEROTONIN_RECEPTORS"
239,"Down",0.176064337644078,0.461355318878723,"L.PvsV.KEGG_FOCAL_ADHESION"
40,"Up",0.176259870055517,0.46152373530959,"L.PvsV.WU_HBX_TARGETS_2_UP"
13,"Up",0.176295555972844,0.46152373530959,"L.PvsV.PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_DN"
52,"Up",0.176457673957172,0.461695553717059,"L.PvsV.WANG_RESPONSE_TO_FORSKOLIN_UP"
20,"Down",0.17668014801427,0.461695553717059,"L.PvsV.CAFFAREL_RESPONSE_TO_THC_8HR_5_DN"
58,"Up",0.176694342981237,0.461695553717059,"L.PvsV.PID_PI3K_PLC_TRK_PATHWAY"
14,"Down",0.176695205582437,0.461695553717059,"L.PvsV.REACTOME_ROBO_RECEPTORS_BIND_AKAP5"
14,"Up",0.177144831902529,0.46256129550331,"L.PvsV.REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_DEATH_RECEPTORS_AND_LIGANDS"
58,"Down",0.17719385492422,0.46256129550331,"L.PvsV.REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION"
40,"Down",0.177846842590196,0.464046811081261,"L.PvsV.CHEN_PDGF_TARGETS"
58,"Down",0.178058569488567,0.464380108821835,"L.PvsV.WEINMANN_ADAPTATION_TO_HYPOXIA_UP"
114,"Down",0.178614081750623,0.465600084763565,"L.PvsV.REACTOME_O_LINKED_GLYCOSYLATION"
46,"Down",0.178694769373898,0.465600084763565,"L.PvsV.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_UP"
19,"Down",0.179067118781942,0.466350494463192,"L.PvsV.REACTOME_METABOLISM_OF_FOLATE_AND_PTERINES"
130,"Up",0.179316122282992,0.466713515138006,"L.PvsV.PID_ERA_GENOMIC_PATHWAY"
323,"Down",0.179375333635063,0.466713515138006,"L.PvsV.SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_DN"
318,"Up",0.17949702553695,0.466810467635839,"L.PvsV.REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR"
8,"Up",0.179751441766984,0.467052980689698,"L.PvsV.REACTOME_SYNTHESIS_OF_UDP_N_ACETYL_GLUCOSAMINE"
5,"Down",0.179759222808406,0.467052980689698,"L.PvsV.BASSO_HAIRY_CELL_LEUKEMIA_DN"
389,"Down",0.18026516867641,0.468147542325914,"L.PvsV.GAL_LEUKEMIC_STEM_CELL_DN"
35,"Down",0.180683050760502,0.468889545658773,"L.PvsV.OZANNE_AP1_TARGETS_UP"
45,"Up",0.180720495894166,0.468889545658773,"L.PvsV.REACTOME_NEGATIVE_REGULATORS_OF_DDX58_IFIH1_SIGNALING"
102,"Down",0.18115232499713,0.469608911223437,"L.PvsV.REACTOME_SEMAPHORIN_INTERACTIONS"
25,"Down",0.181203116929677,0.469608911223437,"L.PvsV.REACTOME_RESOLUTION_OF_AP_SITES_VIA_THE_MULTIPLE_NUCLEOTIDE_PATCH_REPLACEMENT_PATHWAY"
28,"Down",0.18125256222659,0.469608911223437,"L.PvsV.KRISHNAN_FURIN_TARGETS_UP"
564,"Down",0.181439882150312,0.469643937971216,"L.PvsV.COLINA_TARGETS_OF_4EBP1_AND_4EBP2"
22,"Down",0.18147632706345,0.469643937971216,"L.PvsV.REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_27_HYDROXYCHOLESTEROL"
10,"Down",0.181520907116023,0.469643937971216,"L.PvsV.RANKIN_ANGIOGENIC_TARGETS_OF_VHL_HIF2A_UP"
916,"Up",0.181615116366402,0.46964428202233,"L.PvsV.SWEET_LUNG_CANCER_KRAS_UP"
40,"Up",0.181690924081347,0.46964428202233,"L.PvsV.REACTOME_AMINO_ACID_TRANSPORT_ACROSS_THE_PLASMA_MEMBRANE"
31,"Down",0.181994406755097,0.469767072474475,"L.PvsV.REACTOME_G0_AND_EARLY_G1"
49,"Down",0.182023316720346,0.469767072474475,"L.PvsV.WANG_NEOPLASTIC_TRANSFORMATION_BY_CCND1_MYC"
55,"Down",0.182030849112777,0.469767072474475,"L.PvsV.WONG_ENDMETRIUM_CANCER_UP"
226,"Down",0.182078284737349,0.469767072474475,"L.PvsV.REACTOME_SUMOYLATION"
322,"Down",0.182215327495822,0.469829571502379,"L.PvsV.DARWICHE_PAPILLOMA_RISK_HIGH_DN"
22,"Down",0.182301680056257,0.469829571502379,"L.PvsV.REACTOME_CHONDROITIN_SULFATE_BIOSYNTHESIS"
1260,"Up",0.182466271091993,0.469829571502379,"L.PvsV.ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_UP"
39,"Down",0.182575115323933,0.469829571502379,"L.PvsV.IKEDA_MIR30_TARGETS_DN"
22,"Down",0.182624576732753,0.469829571502379,"L.PvsV.LE_NEURONAL_DIFFERENTIATION_DN"
156,"Down",0.182631751693286,0.469829571502379,"L.PvsV.LEE_AGING_CEREBELLUM_UP"
12,"Down",0.182697337444405,0.469829571502379,"L.PvsV.REACTOME_VITAMIN_D_CALCIFEROL_METABOLISM"
48,"Down",0.182879212219158,0.470038311742467,"L.PvsV.FRASOR_RESPONSE_TO_ESTRADIOL_UP"
64,"Down",0.182964817775279,0.470038311742467,"L.PvsV.REACTOME_METABOLISM_OF_FAT_SOLUBLE_VITAMINS"
18,"Down",0.183033547690637,0.470038311742467,"L.PvsV.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_DN"
88,"Down",0.183214916805375,0.470236236112995,"L.PvsV.REACTOME_PRC2_METHYLATES_HISTONES_AND_DNA"
166,"Down",0.183295351681971,0.470236236112995,"L.PvsV.WALLACE_PROSTATE_CANCER_RACE_DN"
54,"Up",0.1833657668764,0.470236236112995,"L.PvsV.LEE_CALORIE_RESTRICTION_MUSCLE_UP"
53,"Down",0.183476122914112,0.470301105049664,"L.PvsV.HEIDENBLAD_AMPLICON_8Q24_DN"
41,"Down",0.183956595349459,0.471100942932547,"L.PvsV.WU_ALZHEIMER_DISEASE_UP"
24,"Up",0.184122563495139,0.471100942932547,"L.PvsV.LEE_METASTASIS_AND_RNA_PROCESSING_UP"
57,"Up",0.184155456503513,0.471100942932547,"L.PvsV.KEGG_TRYPTOPHAN_METABOLISM"
65,"Down",0.18418904961752,0.471100942932547,"L.PvsV.YANG_BREAST_CANCER_ESR1_UP"
5,"Up",0.184268711855895,0.471100942932547,"L.PvsV.REACTOME_GALACTOSE_CATABOLISM"
107,"Up",0.184299392216151,0.471100942932547,"L.PvsV.REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX"
303,"Down",0.184473589035865,0.471328315055127,"L.PvsV.FIGUEROA_AML_METHYLATION_CLUSTER_3_UP"
199,"Down",0.184596522373215,0.471424559908317,"L.PvsV.WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN"
163,"Down",0.184883936908522,0.471940575792807,"L.PvsV.KAUFFMANN_DNA_REPLICATION_GENES"
1187,"Up",0.185164542525843,0.472438742789749,"L.PvsV.KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_DN"
165,"Down",0.185332734817736,0.472649765132501,"L.PvsV.TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_UP"
364,"Down",0.185587023627024,0.472911761807926,"L.PvsV.RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_UP"
118,"Down",0.185647063446078,0.472911761807926,"L.PvsV.KEGG_SMALL_CELL_LUNG_CANCER"
7,"Up",0.185853548383053,0.472911761807926,"L.PvsV.STONER_ESOPHAGEAL_CARCINOGENESIS_DN"
10,"Up",0.185959510374469,0.472911761807926,"L.PvsV.BIOCARTA_VOBESITY_PATHWAY"
118,"Down",0.186013274173721,0.472911761807926,"L.PvsV.BOYLAN_MULTIPLE_MYELOMA_PCA3_DN"
314,"Down",0.186123992066735,0.472911761807926,"L.PvsV.SHEPARD_BMYB_MORPHOLINO_DN"
169,"Down",0.186173849836165,0.472911761807926,"L.PvsV.KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_DN"
260,"Down",0.186243778684644,0.472911761807926,"L.PvsV.DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN"
19,"Down",0.186349553063197,0.472911761807926,"L.PvsV.KINNEY_DNMT1_METHYLATION_TARGETS"
65,"Up",0.186383418891362,0.472911761807926,"L.PvsV.BOYAULT_LIVER_CANCER_SUBCLASS_G1_DN"
48,"Down",0.186404994910415,0.472911761807926,"L.PvsV.REACTOME_VASOPRESSIN_REGULATES_RENAL_WATER_HOMEOSTASIS_VIA_AQUAPORINS"
67,"Down",0.186473667552014,0.472911761807926,"L.PvsV.YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_8"
63,"Down",0.186547396003452,0.472911761807926,"L.PvsV.SIMBULAN_UV_RESPONSE_NORMAL_DN"
10,"Down",0.186937476019191,0.47356291638162,"L.PvsV.BIOCARTA_MITR_PATHWAY"
309,"Down",0.187037860884904,0.47356291638162,"L.PvsV.NABA_ECM_REGULATORS"
112,"Down",0.187123664209345,0.47356291638162,"L.PvsV.JAZAG_TGFB1_SIGNALING_VIA_SMAD4_DN"
75,"Up",0.187169794043206,0.47356291638162,"L.PvsV.NATSUME_RESPONSE_TO_INTERFERON_BETA_DN"
17,"Down",0.187232507724764,0.47356291638162,"L.PvsV.REACTOME_ELEVATION_OF_CYTOSOLIC_CA2_LEVELS"
222,"Down",0.18736043639921,0.473669800114874,"L.PvsV.HOELZEL_NF1_TARGETS_UP"
61,"Up",0.187509241879925,0.47382934111248,"L.PvsV.LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_UP"
415,"Down",0.187847196434898,0.474024755477512,"L.PvsV.TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_UP"
19,"Down",0.187924416592284,0.474024755477512,"L.PvsV.KEGG_ONE_CARBON_POOL_BY_FOLATE"
346,"Up",0.188026595130732,0.474024755477512,"L.PvsV.TIEN_INTESTINE_PROBIOTICS_24HR_DN"
13,"Up",0.188051204226985,0.474024755477512,"L.PvsV.BIOCARTA_RNA_PATHWAY"
220,"Down",0.188103658650458,0.474024755477512,"L.PvsV.RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN"
17,"Down",0.188142111779162,0.474024755477512,"L.PvsV.REACTOME_MRNA_DECAY_BY_3_TO_5_EXORIBONUCLEASE"
76,"Up",0.188186713379117,0.474024755477512,"L.PvsV.PID_P53_REGULATION_PATHWAY"
146,"Down",0.188495208836074,0.474438963208816,"L.PvsV.KONDO_PROSTATE_CANCER_HCP_WITH_H3K27ME3"
58,"Down",0.188612307237165,0.474438963208816,"L.PvsV.SCHLINGEMANN_SKIN_CARCINOGENESIS_TPA_DN"
12,"Up",0.1886884024213,0.474438963208816,"L.PvsV.REACTOME_TRANSPORT_OF_FATTY_ACIDS"
124,"Up",0.188694389599599,0.474438963208816,"L.PvsV.LU_IL4_SIGNALING"
239,"Down",0.188953235191198,0.474725608351855,"L.PvsV.REACTOME_REPRODUCTION"
270,"Down",0.189001062208441,0.474725608351855,"L.PvsV.ONDER_CDH1_TARGETS_1_DN"
43,"Down",0.189065977498785,0.474725608351855,"L.PvsV.REACTOME_DISASSEMBLY_OF_THE_DESTRUCTION_COMPLEX_AND_RECRUITMENT_OF_AXIN_TO_THE_MEMBRANE"
10,"Up",0.189177249962011,0.47478938494778,"L.PvsV.BIOCARTA_FLUMAZENIL_PATHWAY"
9,"Down",0.189488821364439,0.475275355234693,"L.PvsV.CALVET_IRINOTECAN_SENSITIVE_VS_REVERTED_UP"
465,"Down",0.189634376365526,0.475275355234693,"L.PvsV.GRESHOCK_CANCER_COPY_NUMBER_UP"
87,"Up",0.189640031379088,0.475275355234693,"L.PvsV.CAVARD_LIVER_CANCER_MALIGNANT_VS_BENIGN"
87,"Down",0.18971472400126,0.475275355234693,"L.PvsV.BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN"
19,"Down",0.189925276885687,0.475587344158046,"L.PvsV.LI_CYTIDINE_ANALOGS_CYCTOTOXICITY"
337,"Down",0.190111632057786,0.475717129269954,"L.PvsV.HOLLERN_SQUAMOUS_BREAST_TUMOR"
40,"Down",0.190149187138108,0.475717129269954,"L.PvsV.REACTOME_CARBOXYTERMINAL_POST_TRANSLATIONAL_MODIFICATIONS_OF_TUBULIN"
9,"Down",0.19029012272991,0.47585440460139,"L.PvsV.BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_AND_PAX3"
108,"Down",0.190638320750407,0.476509618186709,"L.PvsV.LIN_NPAS4_TARGETS_DN"
87,"Up",0.19074027485445,0.476549019281632,"L.PvsV.KYNG_DNA_DAMAGE_BY_UV"
41,"Down",0.190880124661424,0.476565091686304,"L.PvsV.REACTOME_MISCELLANEOUS_SUBSTRATES"
24,"Down",0.191149834077689,0.476565091686304,"L.PvsV.YAGUE_PRETUMOR_DRUG_RESISTANCE_DN"
37,"Down",0.191178594266332,0.476565091686304,"L.PvsV.MATZUK_CENTRAL_FOR_FEMALE_FERTILITY"
175,"Up",0.191271189872942,0.476565091686304,"L.PvsV.COATES_MACROPHAGE_M1_VS_M2_DN"
56,"Down",0.19131735617131,0.476565091686304,"L.PvsV.REACTOME_AQUAPORIN_MEDIATED_TRANSPORT"
116,"Down",0.191332228338419,0.476565091686304,"L.PvsV.PID_P73PATHWAY"
151,"Down",0.1914020992911,0.476565091686304,"L.PvsV.COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP"
9,"Down",0.191436257665994,0.476565091686304,"L.PvsV.REACTOME_RUNX3_REGULATES_IMMUNE_RESPONSE_AND_CELL_MIGRATION"
8,"Up",0.191802210765346,0.477261216616381,"L.PvsV.REACTOME_COENZYME_A_BIOSYNTHESIS"
16,"Up",0.191942757908555,0.477396090182817,"L.PvsV.REACTOME_SYNTHESIS_OF_IP2_IP_AND_INS_IN_THE_CYTOSOL"
101,"Down",0.192122932809972,0.477629359490258,"L.PvsV.REACTOME_PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES"
63,"Down",0.192463390112368,0.478260711879227,"L.PvsV.REACTOME_G_PROTEIN_MEDIATED_EVENTS"
66,"Down",0.192672742210425,0.478565854304332,"L.PvsV.CHEN_NEUROBLASTOMA_COPY_NUMBER_GAINS"
65,"Up",0.193275737556615,0.479848025572755,"L.PvsV.PRAMOONJAGO_SOX4_TARGETS_DN"
12,"Down",0.193785378086483,0.480897376768475,"L.PvsV.REACTOME_BIOSYNTHESIS_OF_EPA_DERIVED_SPMS"
292,"Down",0.193965369346054,0.481128096507103,"L.PvsV.SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM2"
65,"Up",0.194056998092635,0.481139525764206,"L.PvsV.TANG_SENESCENCE_TP53_TARGETS_UP"
44,"Down",0.194282410053828,0.481482494481225,"L.PvsV.HINATA_NFKB_TARGETS_KERATINOCYTE_DN"
47,"Down",0.194682536020218,0.482106361499889,"L.PvsV.SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_DN"
62,"Down",0.194708537751719,0.482106361499889,"L.PvsV.PID_SYNDECAN_2_PATHWAY"
244,"Down",0.195127931455347,0.482876597874141,"L.PvsV.FIRESTEIN_PROLIFERATION"
75,"Down",0.195194284002298,0.482876597874141,"L.PvsV.PID_AMB2_NEUTROPHILS_PATHWAY"
38,"Down",0.195310857760216,0.482948896492054,"L.PvsV.SEMBA_FHIT_TARGETS_UP"
768,"Down",0.195455747322469,0.483091116202919,"L.PvsV.RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_DN"
29,"Up",0.195547716760327,0.483102469154536,"L.PvsV.REACTOME_METABOLISM_OF_COFACTORS"
759,"Down",0.19567764866305,0.483207556702993,"L.PvsV.FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN"
29,"Up",0.195905911383319,0.483446814505564,"L.PvsV.REACTOME_INSERTION_OF_TAIL_ANCHORED_PROTEINS_INTO_THE_ENDOPLASMIC_RETICULUM_MEMBRANE"
202,"Down",0.19595590113862,0.483446814505564,"L.PvsV.REACTOME_MEIOSIS"
190,"Up",0.196036852617376,0.483446814505564,"L.PvsV.KIM_ALL_DISORDERS_DURATION_CORR_DN"
100,"Up",0.196563155859886,0.484496911012364,"L.PvsV.REACTOME_DAP12_INTERACTIONS"
153,"Down",0.196637921561176,0.484496911012364,"L.PvsV.REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION"
135,"Down",0.196893395021586,0.484793355014289,"L.PvsV.HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP"
14,"Up",0.196996918660264,0.484793355014289,"L.PvsV.CHEOK_RESPONSE_TO_MERCAPTOPURINE_UP"
345,"Down",0.197021282097506,0.484793355014289,"L.PvsV.DAVICIONI_MOLECULAR_ARMS_VS_ERMS_DN"
28,"Down",0.197210298573082,0.484829448895633,"L.PvsV.REACTOME_MICRORNA_MIRNA_BIOGENESIS"
7,"Down",0.197295023574918,0.484829448895633,"L.PvsV.SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX3"
107,"Up",0.197484515377076,0.484829448895633,"L.PvsV.REACTOME_SELECTIVE_AUTOPHAGY"
782,"Down",0.197484804614688,0.484829448895633,"L.PvsV.BONOME_OVARIAN_CANCER_SURVIVAL_SUBOPTIMAL_DEBULKING"
29,"Down",0.197549430058177,0.484829448895633,"L.PvsV.BIOCARTA_CK1_PATHWAY"
19,"Down",0.197562081454487,0.484829448895633,"L.PvsV.REACTOME_TRISTETRAPROLIN_TTP_ZFP36_BINDS_AND_DESTABILIZES_MRNA"
119,"Down",0.198149488542507,0.485751559232124,"L.PvsV.LANDIS_BREAST_CANCER_PROGRESSION_DN"
28,"Down",0.198150274872573,0.485751559232124,"L.PvsV.REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS"
19,"Down",0.198247063234464,0.485751559232124,"L.PvsV.REACTOME_TRANSCRIPTION_OF_E2F_TARGETS_UNDER_NEGATIVE_CONTROL_BY_P107_RBL1_AND_P130_RBL2_IN_COMPLEX_WITH_HDAC1"
487,"Down",0.198454679570027,0.485751559232124,"L.PvsV.BENPORATH_OCT4_TARGETS"
119,"Up",0.198461069013668,0.485751559232124,"L.PvsV.GALINDO_IMMUNE_RESPONSE_TO_ENTEROTOXIN"
33,"Down",0.198464961531085,0.485751559232124,"L.PvsV.TURASHVILI_BREAST_CARCINOMA_DUCTAL_VS_LOBULAR_UP"
77,"Down",0.198766540849957,0.486274426707705,"L.PvsV.DORN_ADENOVIRUS_INFECTION_12HR_UP"
398,"Down",0.198949943267443,0.486507844460722,"L.PvsV.RICKMAN_METASTASIS_DN"
800,"Down",0.199172266277023,0.48683618932169,"L.PvsV.MARSON_BOUND_BY_E2F4_UNSTIMULATED"
105,"Down",0.199395759023508,0.487167101918241,"L.PvsV.HUTTMANN_B_CLL_POOR_SURVIVAL_DN"
249,"Down",0.199519162655677,0.487253290778817,"L.PvsV.AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_UP"
538,"Down",0.199693328423146,0.487308805565676,"L.PvsV.AFFAR_YY1_TARGETS_DN"
76,"Down",0.199718168459364,0.487308805565676,"L.PvsV.ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_DN"
63,"Down",0.199927265485626,0.487543289620872,"L.PvsV.AMIT_EGF_RESPONSE_40_HELA"
93,"Down",0.199990627755496,0.487543289620872,"L.PvsV.WATANABE_COLON_CANCER_MSI_VS_MSS_DN"
31,"Up",0.200234426563254,0.487922496460216,"L.PvsV.KANG_DOXORUBICIN_RESISTANCE_DN"
17,"Down",0.200455539908924,0.487970478526744,"L.PvsV.REACTOME_PKA_ACTIVATION_IN_GLUCAGON_SIGNALLING"
51,"Up",0.200498628861203,0.487970478526744,"L.PvsV.REACTOME_SIGNALING_BY_FGFR3"
17,"Down",0.200538868837331,0.487970478526744,"L.PvsV.REACTOME_DISSOLUTION_OF_FIBRIN_CLOT"
148,"Up",0.200638452382875,0.487970478526744,"L.PvsV.GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_DN"
83,"Down",0.200695400283924,0.487970478526744,"L.PvsV.CHEN_HOXA5_TARGETS_9HR_DN"
162,"Down",0.20098920588138,0.488297337458219,"L.PvsV.REACTOME_GENE_SILENCING_BY_RNA"
9,"Up",0.201006464108321,0.488297337458219,"L.PvsV.REACTOME_TRIF_MEDIATED_PROGRAMMED_CELL_DEATH"
23,"Up",0.201240861416496,0.488652052161531,"L.PvsV.WANG_RECURRENT_LIVER_CANCER_DN"
92,"Down",0.201342932824277,0.48866317493351,"L.PvsV.KEGG_TGF_BETA_SIGNALING_PATHWAY"
9,"Down",0.201550651172655,0.48866317493351,"L.PvsV.REACTOME_ADRENOCEPTORS"
44,"Up",0.201643111348761,0.48866317493351,"L.PvsV.AZARE_STAT3_TARGETS"
7,"Up",0.201725661691911,0.48866317493351,"L.PvsV.REACTOME_ZINC_EFFLUX_AND_COMPARTMENTALIZATION_BY_THE_SLC30_FAMILY"
257,"Down",0.201796552301132,0.48866317493351,"L.PvsV.GAVIN_FOXP3_TARGETS_CLUSTER_P3"
33,"Down",0.201882965124517,0.48866317493351,"L.PvsV.GAZIN_EPIGENETIC_SILENCING_BY_KRAS"
134,"Down",0.201951030357053,0.48866317493351,"L.PvsV.HINATA_NFKB_TARGETS_FIBROBLAST_UP"
115,"Down",0.202017064017869,0.48866317493351,"L.PvsV.BASSO_CD40_SIGNALING_DN"
6,"Up",0.202078998425524,0.48866317493351,"L.PvsV.REACTOME_FORMATION_OF_XYLULOSE_5_PHOSPHATE"
64,"Up",0.202129260458118,0.48866317493351,"L.PvsV.REACTOME_COPI_INDEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC"
16,"Down",0.202433233394111,0.488845269185418,"L.PvsV.SHIN_B_CELL_LYMPHOMA_CLUSTER_6"
76,"Up",0.202536821050968,0.488845269185418,"L.PvsV.PID_KIT_PATHWAY"
33,"Up",0.202698353760179,0.488845269185418,"L.PvsV.REACTOME_SIGNALING_BY_ERBB2_IN_CANCER"
42,"Down",0.202717430327629,0.488845269185418,"L.PvsV.REACTOME_INTERACTIONS_OF_REV_WITH_HOST_CELLULAR_PROTEINS"
20,"Up",0.202727522776288,0.488845269185418,"L.PvsV.SA_PTEN_PATHWAY"
241,"Up",0.202867649569911,0.488845269185418,"L.PvsV.BAKKER_FOXO3_TARGETS_DN"
99,"Down",0.202905251008162,0.488845269185418,"L.PvsV.MIKKELSEN_ES_ICP_WITH_H3K27ME3"
7,"Down",0.202911899580491,0.488845269185418,"L.PvsV.REACTOME_LOSS_OF_MECP2_BINDING_ABILITY_TO_THE_NCOR_SMRT_COMPLEX"
43,"Down",0.203010476051396,0.48886973958544,"L.PvsV.MATZUK_MALE_REPRODUCTION_SERTOLI"
163,"Down",0.20317562670802,0.489054436251041,"L.PvsV.TAYLOR_METHYLATED_IN_ACUTE_LYMPHOBLASTIC_LEUKEMIA"
19,"Up",0.203275282845574,0.489081392016178,"L.PvsV.REACTOME_INLB_MEDIATED_ENTRY_OF_LISTERIA_MONOCYTOGENES_INTO_HOST_CELL"
104,"Down",0.20344923131391,0.489096418136612,"L.PvsV.MORI_IMMATURE_B_LYMPHOCYTE_UP"
431,"Down",0.203461214882455,0.489096418136612,"L.PvsV.BONOME_OVARIAN_CANCER_SURVIVAL_OPTIMAL_DEBULKING"
317,"Down",0.203546908687348,0.489096418136612,"L.PvsV.BROWNE_HCMV_INFECTION_14HR_UP"
37,"Down",0.20373339020986,0.489331848162604,"L.PvsV.REACTOME_SURFACTANT_METABOLISM"
51,"Down",0.203847595476048,0.489393554227994,"L.PvsV.CHO_NR4A1_TARGETS"
100,"Down",0.20474512522478,0.491334981496446,"L.PvsV.CROONQUIST_NRAS_SIGNALING_DN"
53,"Down",0.20491391488627,0.491378234129934,"L.PvsV.SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_DN"
61,"Down",0.204940894900276,0.491378234129934,"L.PvsV.FRIDMAN_IMMORTALIZATION_DN"
60,"Up",0.205093024715641,0.491529836867266,"L.PvsV.MATZUK_SPERMATID_DIFFERENTIATION"
146,"Down",0.206010447470658,0.49315479690716,"L.PvsV.REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING"
35,"Down",0.206015817214193,0.49315479690716,"L.PvsV.OUYANG_PROSTATE_CANCER_MARKERS"
51,"Up",0.206038629201581,0.49315479690716,"L.PvsV.WENG_POR_TARGETS_LIVER_DN"
266,"Down",0.206250848729137,0.493449131381826,"L.PvsV.KIM_RESPONSE_TO_TSA_AND_DECITABINE_UP"
90,"Up",0.206552662446717,0.493957470012067,"L.PvsV.IKEDA_MIR133_TARGETS_UP"
35,"Down",0.206803140614401,0.494342656488121,"L.PvsV.CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_LD_MTX_DN"
5,"Up",0.207347578382826,0.495147761346512,"L.PvsV.REACTOME_PTK6_EXPRESSION"
35,"Down",0.207395090937489,0.495147761346512,"L.PvsV.GOLUB_ALL_VS_AML_DN"
13,"Down",0.207408611915088,0.495147761346512,"L.PvsV.KHETCHOUMIAN_TRIM24_TARGETS_DN"
38,"Down",0.207860665577495,0.496012783762611,"L.PvsV.REACTOME_INFLAMMASOMES"
215,"Down",0.207960407307926,0.496036709234479,"L.PvsV.WINNEPENNINCKX_MELANOMA_METASTASIS_UP"
25,"Down",0.208209061138282,0.496415652882087,"L.PvsV.KEGG_RENIN_ANGIOTENSIN_SYSTEM"
13,"Down",0.208626696128678,0.49699319858842,"L.PvsV.REACTOME_INHIBITION_OF_REPLICATION_INITIATION_OF_DAMAGED_DNA_BY_RB1_E2F1"
119,"Down",0.208631075044985,0.49699319858842,"L.PvsV.LINDVALL_IMMORTALIZED_BY_TERT_DN"
7,"Up",0.208771761406358,0.497114155390075,"L.PvsV.REACTOME_LIPID_PARTICLE_ORGANIZATION"
29,"Down",0.209486289977418,0.498576893622519,"L.PvsV.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_DN"
48,"Down",0.209566413597167,0.498576893622519,"L.PvsV.BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_UP"
106,"Down",0.209680372293886,0.498633453080815,"L.PvsV.KEGG_GAP_JUNCTION"
83,"Down",0.209964927256606,0.498922207232536,"L.PvsV.PARENT_MTOR_SIGNALING_DN"
61,"Down",0.209982270976689,0.498922207232536,"L.PvsV.REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_CELL_CYCLE_GENES"
114,"Up",0.210529113546087,0.500006644671956,"L.PvsV.SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP"
249,"Down",0.210878779649495,0.500622057828278,"L.PvsV.WHITFIELD_CELL_CYCLE_S"
246,"Down",0.211671973501542,0.502289416948509,"L.PvsV.SASAKI_ADULT_T_CELL_LEUKEMIA"
12,"Up",0.211975358863235,0.502793547470967,"L.PvsV.BIOCARTA_SARS_PATHWAY"
189,"Down",0.212107421106307,0.50289105115642,"L.PvsV.LIU_VAV3_PROSTATE_CARCINOGENESIS_UP"
7,"Down",0.212348822658725,0.503243331734956,"L.PvsV.JU_AGING_TERC_TARGETS_UP"
85,"Up",0.212438042371023,0.503243331734956,"L.PvsV.HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_DN"
7,"Down",0.212753443665269,0.503520950736406,"L.PvsV.PETRETTO_LEFT_VENTRICLE_MASS_QTL_CIS_UP"
21,"Down",0.212872803388026,0.503520950736406,"L.PvsV.IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_UP"
523,"Down",0.212957582539619,0.503520950736406,"L.PvsV.KOYAMA_SEMA3B_TARGETS_DN"
71,"Up",0.213000368268664,0.503520950736406,"L.PvsV.KEGG_TYPE_I_DIABETES_MELLITUS"
8,"Down",0.213045591753375,0.503520950736406,"L.PvsV.REACTOME_DEFECTIVE_CHST14_CAUSES_EDS_MUSCULOCONTRACTURAL_TYPE"
60,"Up",0.21313037681386,0.503520950736406,"L.PvsV.PID_ERBB2_ERBB3_PATHWAY"
77,"Down",0.213279853031583,0.503520950736406,"L.PvsV.BURTON_ADIPOGENESIS_PEAK_AT_16HR"
565,"Down",0.213283788501476,0.503520950736406,"L.PvsV.ZHOU_INFLAMMATORY_RESPONSE_LPS_UP"
57,"Down",0.213777805951322,0.504380593881018,"L.PvsV.SCHRAETS_MLL_TARGETS_UP"
35,"Down",0.213830369335704,0.504380593881018,"L.PvsV.PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN"
7,"Down",0.214039558698796,0.504658729230551,"L.PvsV.REACTOME_ALPHA_OXIDATION_OF_PHYTANATE"
56,"Down",0.214284781122043,0.505021549370749,"L.PvsV.MARTIN_INTERACT_WITH_HDAC"
131,"Down",0.214470605630423,0.505244132309591,"L.PvsV.SMID_BREAST_CANCER_RELAPSE_IN_LUNG_UP"
109,"Down",0.214675455103294,0.505353152156168,"L.PvsV.KEGG_MELANOGENESIS"
18,"Down",0.214699684285556,0.505353152156168,"L.PvsV.REACTOME_SIGNALING_BY_NOTCH1_HD_DOMAIN_MUTANTS_IN_CANCER"
309,"Down",0.214830666234775,0.505446278132796,"L.PvsV.DARWICHE_SQUAMOUS_CELL_CARCINOMA_DN"
9,"Down",0.215182774337301,0.506059361680535,"L.PvsV.TURJANSKI_MAPK8_AND_MAPK9_TARGETS"
95,"Down",0.21557906147534,0.506775778442668,"L.PvsV.GU_PDEF_TARGETS_DN"
10,"Up",0.216034940634485,0.507479643883459,"L.PvsV.BIOCARTA_PPARG_PATHWAY"
213,"Down",0.216062051311568,0.507479643883459,"L.PvsV.RUIZ_TNC_TARGETS_DN"
21,"Down",0.21641206187519,0.507849716321321,"L.PvsV.BIOCARTA_MYOSIN_PATHWAY"
136,"Down",0.216485560407168,0.507849716321321,"L.PvsV.GHANDHI_DIRECT_IRRADIATION_UP"
11,"Down",0.21649516754736,0.507849716321321,"L.PvsV.REACTOME_ACTIVATION_OF_CASPASES_THROUGH_APOPTOSOME_MEDIATED_CLEAVAGE"
47,"Up",0.216981104434656,0.508773760143856,"L.PvsV.REACTOME_DNA_DAMAGE_RECOGNITION_IN_GG_NER"
272,"Up",0.217333826044247,0.509384791945165,"L.PvsV.BOYAULT_LIVER_CANCER_SUBCLASS_G3_UP"
28,"Down",0.217553801714662,0.509684309186596,"L.PvsV.REACTOME_MECP2_REGULATES_NEURONAL_RECEPTORS_AND_CHANNELS"
38,"Down",0.217804094630878,0.510054569764559,"L.PvsV.SESTO_RESPONSE_TO_UV_C4"
205,"Down",0.217905487329394,0.510075969282056,"L.PvsV.ODONNELL_METASTASIS_UP"
1200,"Down",0.218000658781474,0.5100827940765,"L.PvsV.RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN"
51,"Up",0.218160606394098,0.510241113685688,"L.PvsV.NIKOLSKY_BREAST_CANCER_7P22_AMPLICON"
19,"Up",0.218605722669739,0.511065979129381,"L.PvsV.REACTOME_SYNTHESIS_SECRETION_AND_INACTIVATION_OF_GLUCOSE_DEPENDENT_INSULINOTROPIC_POLYPEPTIDE_GIP"
430,"Up",0.218960770812681,0.511109339010861,"L.PvsV.TARTE_PLASMA_CELL_VS_PLASMABLAST_DN"
1333,"Up",0.219021999461104,0.511109339010861,"L.PvsV.KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_DN"
77,"Up",0.219076778645956,0.511109339010861,"L.PvsV.KEGG_ADIPOCYTOKINE_SIGNALING_PATHWAY"
13,"Up",0.219080989471075,0.511109339010861,"L.PvsV.REACTOME_RRNA_PROCESSING_IN_THE_MITOCHONDRION"
25,"Down",0.219086477383928,0.511109339010861,"L.PvsV.MCCOLLUM_GELDANAMYCIN_RESISTANCE_UP"
84,"Down",0.219337904307256,0.511480081364328,"L.PvsV.BECKER_TAMOXIFEN_RESISTANCE_UP"
29,"Down",0.219847286097862,0.512384913585752,"L.PvsV.REACTOME_INTERLEUKIN_6_FAMILY_SIGNALING"
24,"Down",0.220085725734524,0.512384913585752,"L.PvsV.BIOCARTA_VITCB_PATHWAY"
268,"Up",0.220194867874231,0.512384913585752,"L.PvsV.KIM_MYC_AMPLIFICATION_TARGETS_UP"
219,"Up",0.220230690495181,0.512384913585752,"L.PvsV.REACTOME_REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS"
114,"Down",0.220232941792431,0.512384913585752,"L.PvsV.STAMBOLSKY_TARGETS_OF_MUTATED_TP53_DN"
28,"Down",0.220310550305698,0.512384913585752,"L.PvsV.REACTOME_OTHER_SEMAPHORIN_INTERACTIONS"
307,"Down",0.220425015919079,0.512384913585752,"L.PvsV.SMID_BREAST_CANCER_ERBB2_UP"
201,"Up",0.220467301396365,0.512384913585752,"L.PvsV.BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_CIS"
650,"Down",0.220756769326103,0.512842091430263,"L.PvsV.ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP"
74,"Down",0.220931590347474,0.513032659819901,"L.PvsV.PLASARI_NFIC_TARGETS_BASAL_UP"
30,"Down",0.221467708242341,0.513876492653451,"L.PvsV.REACTOME_KERATAN_SULFATE_BIOSYNTHESIS"
607,"Up",0.221480861275669,0.513876492653451,"L.PvsV.GARY_CD5_TARGETS_DN"
34,"Up",0.221821599233196,0.514451183792089,"L.PvsV.REACTOME_DOWNREGULATION_OF_ERBB2_SIGNALING"
79,"Down",0.221926186456374,0.514477939168675,"L.PvsV.REACTOME_DNA_METHYLATION"
28,"Down",0.222120899315948,0.514634166515291,"L.PvsV.HOLLERN_ADENOMYOEPITHELIAL_BREAST_TUMOR"
97,"Down",0.222179735118828,0.514634166515291,"L.PvsV.BEIER_GLIOMA_STEM_CELL_DN"
78,"Down",0.222411507412044,0.514955286633665,"L.PvsV.PID_CASPASE_PATHWAY"
105,"Up",0.22273351396778,0.515423574637278,"L.PvsV.WEBER_METHYLATED_ICP_IN_FIBROBLAST"
34,"Down",0.222800206797449,0.515423574637278,"L.PvsV.REACTOME_INSULIN_PROCESSING"
119,"Down",0.223039301922083,0.515760895159849,"L.PvsV.RIZ_ERYTHROID_DIFFERENTIATION"
90,"Down",0.223304476992835,0.516122970972789,"L.PvsV.BENNETT_SYSTEMIC_LUPUS_ERYTHEMATOSUS"
62,"Down",0.223441167698679,0.516122970972789,"L.PvsV.REACTOME_HSF1_DEPENDENT_TRANSACTIVATION"
32,"Down",0.223498715823256,0.516122970972789,"L.PvsV.BIOCARTA_RAC1_PATHWAY"
84,"Down",0.223569273915686,0.516122970972789,"L.PvsV.KEGG_MELANOMA"
25,"Down",0.223703026089829,0.516213739164907,"L.PvsV.INGA_TP53_TARGETS"
52,"Up",0.223795321537038,0.516213739164907,"L.PvsV.REACTOME_DIGESTION_AND_ABSORPTION"
361,"Down",0.224080917191965,0.51665696044803,"L.PvsV.REACTOME_ORGANELLE_BIOGENESIS_AND_MAINTENANCE"
168,"Up",0.224345794527003,0.5170134257683,"L.PvsV.HAHTOLA_MYCOSIS_FUNGOIDES_CD4_DN"
445,"Down",0.224422539671535,0.5170134257683,"L.PvsV.HORIUCHI_WTAP_TARGETS_DN"
379,"Down",0.224550982563087,0.517053433335558,"L.PvsV.REACTOME_DNA_REPAIR"
27,"Up",0.224684713372447,0.517053433335558,"L.PvsV.REACTOME_LISTERIA_MONOCYTOGENES_ENTRY_INTO_HOST_CELLS"
621,"Down",0.224720455833848,0.517053433335558,"L.PvsV.WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_UP"
30,"Down",0.225188331083026,0.51791442702082,"L.PvsV.BIOCARTA_CARDIACEGF_PATHWAY"
225,"Up",0.225385749223966,0.518152934494515,"L.PvsV.BIDUS_METASTASIS_DN"
19,"Down",0.225554182129538,0.518324635492192,"L.PvsV.KOINUMA_COLON_CANCER_MSI_UP"
13,"Up",0.225717006253112,0.518483310167617,"L.PvsV.REACTOME_MASTL_FACILITATES_MITOTIC_PROGRESSION"
73,"Up",0.225913558190058,0.51855830285438,"L.PvsV.CHANGOLKAR_H2AFY_TARGETS_UP"
217,"Down",0.225937231249087,0.51855830285438,"L.PvsV.MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_UP"
1681,"Up",0.226096519341012,0.518708570720521,"L.PvsV.REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION"
9,"Down",0.226428417108104,0.51879030224536,"L.PvsV.ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_2HR"
161,"Down",0.226456984420367,0.51879030224536,"L.PvsV.MARTIN_VIRAL_GPCR_SIGNALING_UP"
48,"Down",0.226554081785417,0.51879030224536,"L.PvsV.YUAN_ZNF143_PARTNERS"
10,"Down",0.226564074748276,0.51879030224536,"L.PvsV.REACTOME_PHASE_3_RAPID_REPOLARISATION"
41,"Down",0.226601298593334,0.51879030224536,"L.PvsV.REACTOME_FANCONI_ANEMIA_PATHWAY"
1407,"Down",0.226949161304494,0.519371652670755,"L.PvsV.BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_A"
204,"Up",0.227228897535696,0.519527020690075,"L.PvsV.GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_UP"
87,"Down",0.227268697392465,0.519527020690075,"L.PvsV.BROWNE_HCMV_INFECTION_8HR_DN"
16,"Down",0.227386257934633,0.519527020690075,"L.PvsV.HOFMANN_MYELODYSPLASTIC_SYNDROM_HIGH_RISK_UP"
7,"Up",0.227392908314339,0.519527020690075,"L.PvsV.REACTOME_WAX_AND_PLASMALOGEN_BIOSYNTHESIS"
886,"Down",0.227856967071375,0.520372230870562,"L.PvsV.FEVR_CTNNB1_TARGETS_DN"
48,"Down",0.228183775778345,0.520903425383349,"L.PvsV.BIOCARTA_CARM_ER_PATHWAY"
62,"Down",0.228796508811187,0.522086626998371,"L.PvsV.KEGG_ARGININE_AND_PROLINE_METABOLISM"
57,"Down",0.228922784954842,0.52215927310863,"L.PvsV.LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_DN"
159,"Down",0.229017502925372,0.522159906669849,"L.PvsV.TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_DN"
29,"Down",0.229159068413097,0.522213420150612,"L.PvsV.REACTOME_AFLATOXIN_ACTIVATION_AND_DETOXIFICATION"
79,"Down",0.229229873522434,0.522213420150612,"L.PvsV.DAZARD_UV_RESPONSE_CLUSTER_G24"
31,"Down",0.229431887210557,0.522287964014149,"L.PvsV.REACTOME_PI_3K_CASCADE_FGFR1"
36,"Up",0.229502453108391,0.522287964014149,"L.PvsV.LIU_IL13_MEMORY_MODEL_UP"
291,"Down",0.229605079719821,0.522287964014149,"L.PvsV.DARWICHE_PAPILLOMA_RISK_LOW_DN"
18,"Up",0.2296404486378,0.522287964014149,"L.PvsV.XU_RESPONSE_TO_TRETINOIN_DN"
57,"Down",0.229738130644744,0.522295281387661,"L.PvsV.ABBUD_LIF_SIGNALING_1_UP"
1437,"Down",0.230136454260046,0.522985801727824,"L.PvsV.NUYTTEN_EZH2_TARGETS_DN"
34,"Up",0.230552329672696,0.523400696156389,"L.PvsV.RUAN_RESPONSE_TO_TROGLITAZONE_UP"
184,"Down",0.23055670749245,0.523400696156389,"L.PvsV.YAGI_AML_SURVIVAL"
17,"Down",0.230603019684747,0.523400696156389,"L.PvsV.REACTOME_ACTIVATION_OF_RAC1"
20,"Down",0.23074248252454,0.523502333146567,"L.PvsV.ONGUSAHA_BRCA1_TARGETS_DN"
209,"Down",0.231145138169847,0.524200766587812,"L.PvsV.KAYO_CALORIE_RESTRICTION_MUSCLE_UP"
8,"Down",0.231715999847147,0.525279935692856,"L.PvsV.BIOCARTA_WNT_LRP6_PATHWAY"
27,"Down",0.231898545870693,0.525478303327485,"L.PvsV.MEISSNER_BRAIN_HCP_WITH_H3K4ME2"
19,"Up",0.233158881513663,0.528021439876263,"L.PvsV.REACTOME_DIGESTION_OF_DIETARY_CARBOHYDRATE"
141,"Down",0.233211856787454,0.528021439876263,"L.PvsV.PID_REG_GR_PATHWAY"
27,"Up",0.233378684601801,0.528182868261711,"L.PvsV.REACTOME_SYNTHESIS_OF_EPOXY_EET_AND_DIHYDROXYEICOSATRIENOIC_ACIDS_DHET"
95,"Down",0.233512032105358,0.528215461225738,"L.PvsV.KRIEG_HYPOXIA_VIA_KDM3A"
32,"Down",0.233584156754735,0.528215461225738,"L.PvsV.BIOCARTA_MTA3_PATHWAY"
140,"Down",0.233914386866664,0.528653249645457,"L.PvsV.HECKER_IFNB1_TARGETS"
15,"Down",0.233968982073148,0.528653249645457,"L.PvsV.REACTOME_MRNA_DECAY_BY_5_TO_3_EXORIBONUCLEASE"
11,"Down",0.234521966016245,0.529686254127377,"L.PvsV.KEGG_FOLATE_BIOSYNTHESIS"
818,"Down",0.234788053137177,0.529728222652159,"L.PvsV.LIAO_METASTASIS"
63,"Down",0.234808788750346,0.529728222652159,"L.PvsV.ZHAN_MULTIPLE_MYELOMA_CD2_UP"
211,"Up",0.234827974990132,0.529728222652159,"L.PvsV.WELCSH_BRCA1_TARGETS_DN"
16,"Up",0.235042332533683,0.529995536940755,"L.PvsV.REACTOME_AKT_PHOSPHORYLATES_TARGETS_IN_THE_CYTOSOL"
46,"Up",0.235522249078875,0.530732202467619,"L.PvsV.MOREIRA_RESPONSE_TO_TSA_UP"
25,"Down",0.235561403929256,0.530732202467619,"L.PvsV.GENTILE_UV_RESPONSE_CLUSTER_D1"
92,"Down",0.235657000733949,0.530732202467619,"L.PvsV.ZHU_CMV_8_HR_DN"
456,"Up",0.235870288942271,0.530798832652285,"L.PvsV.CAIRO_HEPATOBLASTOMA_DN"
23,"Up",0.235902647565713,0.530798832652285,"L.PvsV.WU_HBX_TARGETS_2_DN"
60,"Up",0.235974594078371,0.530798832652285,"L.PvsV.LIN_MELANOMA_COPY_NUMBER_DN"
77,"Down",0.23610488225657,0.530875922731424,"L.PvsV.PID_ECADHERIN_STABILIZATION_PATHWAY"
23,"Down",0.236459901891182,0.530983538220421,"L.PvsV.PID_SYNDECAN_3_PATHWAY"
118,"Down",0.236535376627018,0.530983538220421,"L.PvsV.ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_DN"
240,"Down",0.2365677349907,0.530983538220421,"L.PvsV.NAGASHIMA_NRG1_SIGNALING_UP"
79,"Up",0.236669428671143,0.530983538220421,"L.PvsV.KEGG_RENAL_CELL_CARCINOMA"
72,"Up",0.236683464196638,0.530983538220421,"L.PvsV.ZHAN_MULTIPLE_MYELOMA_LB_UP"
28,"Down",0.236735507255148,0.530983538220421,"L.PvsV.WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_DN"
568,"Down",0.236924863144421,0.530983538220421,"L.PvsV.DAVICIONI_MOLECULAR_ARMS_VS_ERMS_UP"
146,"Down",0.2369932191103,0.530983538220421,"L.PvsV.YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_16"
833,"Down",0.237017068606981,0.530983538220421,"L.PvsV.RODWELL_AGING_KIDNEY_UP"
54,"Up",0.237449858870232,0.531737654796887,"L.PvsV.REACTOME_HDMS_DEMETHYLATE_HISTONES"
794,"Down",0.237574369031512,0.531801087601308,"L.PvsV.PILON_KLF1_TARGETS_UP"
556,"Down",0.238054795531435,0.532660851676772,"L.PvsV.MEISSNER_NPC_HCP_WITH_H3K4ME2_AND_H3K27ME3"
9,"Down",0.238932866165695,0.534409311096329,"L.PvsV.REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_BCR_SIGNALING"
225,"Up",0.239072542816265,0.53450549503887,"L.PvsV.REACTOME_RRNA_PROCESSING"
87,"Down",0.239275467118632,0.534742949757039,"L.PvsV.SATO_SILENCED_BY_DEACETYLATION_IN_PANCREATIC_CANCER"
498,"Down",0.239800244770567,0.535162303140863,"L.PvsV.JOHNSTONE_PARVB_TARGETS_2_DN"
575,"Up",0.239824070832002,0.535162303140863,"L.PvsV.MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP"
1306,"Up",0.239836948507642,0.535162303140863,"L.PvsV.MARSON_BOUND_BY_FOXP3_STIMULATED"
134,"Down",0.239850278021895,0.535162303140863,"L.PvsV.MIKKELSEN_IPS_ICP_WITH_H3K27ME3"
95,"Down",0.239957563036877,0.535170037693509,"L.PvsV.REACTOME_EXTRA_NUCLEAR_ESTROGEN_SIGNALING"
69,"Up",0.240047331068892,0.535170037693509,"L.PvsV.IRITANI_MAD1_TARGETS_DN"
23,"Down",0.240254310544841,0.535415591697875,"L.PvsV.ZHANG_ADIPOGENESIS_BY_BMP7"
13,"Down",0.240352988721037,0.53541969163522,"L.PvsV.REACTOME_EGFR_INTERACTS_WITH_PHOSPHOLIPASE_C_GAMMA"
474,"Down",0.240570950096493,0.535618398662712,"L.PvsV.REACTOME_NEURONAL_SYSTEM"
98,"Up",0.240635938194642,0.535618398662712,"L.PvsV.VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_UP"
57,"Up",0.240815536119999,0.535676650420631,"L.PvsV.KEGG_MTOR_SIGNALING_PATHWAY"
72,"Down",0.240950619580132,0.535676650420631,"L.PvsV.CONRAD_STEM_CELL"
11,"Down",0.240952763537006,0.535676650420631,"L.PvsV.SMID_BREAST_CANCER_RELAPSE_IN_PLEURA_UP"
667,"Down",0.241388920419666,0.536430603295953,"L.PvsV.OSMAN_BLADDER_CANCER_DN"
7,"Down",0.241634437181683,0.536733708205097,"L.PvsV.REACTOME_TFAP2A_ACTS_AS_A_TRANSCRIPTIONAL_REPRESSOR_DURING_RETINOIC_ACID_INDUCED_CELL_DIFFERENTIATION"
195,"Down",0.24171946707012,0.536733708205097,"L.PvsV.REACTOME_ESTROGEN_DEPENDENT_GENE_EXPRESSION"
9,"Down",0.241881437275779,0.536877746566753,"L.PvsV.PALOMERO_GSI_SENSITIVITY_UP"
56,"Down",0.242120307153132,0.537192286617041,"L.PvsV.THEODOROU_MAMMARY_TUMORIGENESIS"
260,"Down",0.24235698159642,0.537501705273407,"L.PvsV.INGRAM_SHH_TARGETS_UP"
133,"Down",0.242502308000989,0.537608364449666,"L.PvsV.VANTVEER_BREAST_CANCER_METASTASIS_UP"
58,"Down",0.242906389974615,0.538061270020713,"L.PvsV.LI_CISPLATIN_RESISTANCE_DN"
80,"Down",0.242907467960388,0.538061270020713,"L.PvsV.SU_PANCREAS"
150,"Up",0.243074813779051,0.538061270020713,"L.PvsV.DING_LUNG_CANCER_EXPRESSION_BY_COPY_NUMBER"
661,"Down",0.243095867699718,0.538061270020713,"L.PvsV.DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_UP"
59,"Down",0.243394752859849,0.538497538561884,"L.PvsV.VALK_AML_CLUSTER_4"
6,"Down",0.243612426677184,0.538497538561884,"L.PvsV.REACTOME_SEROTONIN_AND_MELATONIN_BIOSYNTHESIS"
65,"Down",0.243668700322501,0.538497538561884,"L.PvsV.REACTOME_INSULIN_RECEPTOR_SIGNALLING_CASCADE"
12,"Up",0.24368255407521,0.538497538561884,"L.PvsV.SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX2_DN"
28,"Up",0.243962789482135,0.538901423510476,"L.PvsV.KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_HEPARAN_SULFATE"
131,"Down",0.244403886387417,0.539465547861666,"L.PvsV.RHODES_UNDIFFERENTIATED_CANCER"
24,"Up",0.244592720300245,0.539465547861666,"L.PvsV.REACTOME_SIGNALING_BY_HIPPO"
77,"Down",0.244601888408393,0.539465547861666,"L.PvsV.PID_HES_HEY_PATHWAY"
37,"Down",0.244608451526351,0.539465547861666,"L.PvsV.FRIDMAN_SENESCENCE_DN"
51,"Up",0.245102309079471,0.540339181379743,"L.PvsV.PID_FAS_PATHWAY"
300,"Down",0.245706995430521,0.541456348240474,"L.PvsV.THUM_SYSTOLIC_HEART_FAILURE_DN"
368,"Down",0.246270239320575,0.542312982065965,"L.PvsV.AMUNDSON_RESPONSE_TO_ARSENITE"
93,"Up",0.246446521201575,0.542312982065965,"L.PvsV.VILLANUEVA_LIVER_CANCER_KRT19_DN"
45,"Down",0.246502884939569,0.542312982065965,"L.PvsV.REACTOME_AMINE_LIGAND_BINDING_RECEPTORS"
95,"Down",0.24652314827872,0.542312982065965,"L.PvsV.BORLAK_LIVER_CANCER_EGF_UP"
243,"Down",0.246691267199648,0.542312982065965,"L.PvsV.KEGG_REGULATION_OF_ACTIN_CYTOSKELETON"
97,"Down",0.246794329520995,0.542312982065965,"L.PvsV.ABRAMSON_INTERACT_WITH_AIRE"
149,"Down",0.246805461186561,0.542312982065965,"L.PvsV.GAVIN_FOXP3_TARGETS_CLUSTER_P6"
310,"Down",0.24688040800507,0.542312982065965,"L.PvsV.KARLSSON_TGFB1_TARGETS_DN"
18,"Down",0.24714071340612,0.542669183646718,"L.PvsV.REACTOME_SEMA4D_MEDIATED_INHIBITION_OF_CELL_ATTACHMENT_AND_MIGRATION"
7,"Down",0.247424419765718,0.542837289678961,"L.PvsV.BIOCARTA_FOSB_PATHWAY"
244,"Down",0.247508802857122,0.542837289678961,"L.PvsV.CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_UP"
12,"Up",0.247511811770783,0.542837289678961,"L.PvsV.REACTOME_PI5P_REGULATES_TP53_ACETYLATION"
132,"Up",0.247723528668508,0.543031649100598,"L.PvsV.MILI_PSEUDOPODIA"
330,"Down",0.247796862123496,0.543031649100598,"L.PvsV.ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP"
38,"Down",0.2481184094542,0.543520873958903,"L.PvsV.DE_YY1_TARGETS_UP"
38,"Down",0.248533946932355,0.544215521817422,"L.PvsV.REACTOME_CHAPERONE_MEDIATED_AUTOPHAGY"
7,"Down",0.248655846810173,0.544265511195313,"L.PvsV.REACTOME_ACTIVATION_OF_C3_AND_C5"
6,"Up",0.248837135333542,0.544265511195313,"L.PvsV.PALOMERO_GSI_SENSITIVITY_DN"
32,"Down",0.2488520912103,0.544265511195313,"L.PvsV.NUMATA_CSF3_SIGNALING_VIA_STAT3"
57,"Down",0.249158683857618,0.544562706487287,"L.PvsV.WAKASUGI_HAVE_ZNF143_BINDING_SITES"
34,"Up",0.249221931714443,0.544562706487287,"L.PvsV.REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION"
46,"Down",0.249283452725506,0.544562706487287,"L.PvsV.BIOCARTA_GPCR_PATHWAY"
35,"Down",0.249683553571852,0.545030620479251,"L.PvsV.SEIDEN_MET_SIGNALING"
107,"Down",0.249694802256094,0.545030620479251,"L.PvsV.GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN"
48,"Down",0.250592419765271,0.546774068225012,"L.PvsV.BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_DN"
2169,"Down",0.250835984836591,0.547089609531168,"L.PvsV.PUJANA_ATM_PCC_NETWORK"
42,"Down",0.250974183754512,0.547175182168255,"L.PvsV.ABBUD_LIF_SIGNALING_2_UP"
13,"Up",0.251105983967945,0.54724674235663,"L.PvsV.REACTOME_ALPHA_PROTEIN_KINASE_1_SIGNALING_PATHWAY"
31,"Up",0.251841774554274,0.548307578093131,"L.PvsV.MAINA_VHL_TARGETS_DN"
5,"Down",0.251940464981742,0.548307578093131,"L.PvsV.RAFFEL_VEGFA_TARGETS_DN"
591,"Up",0.251950320060841,0.548307578093131,"L.PvsV.WANG_TUMOR_INVASIVENESS_UP"
56,"Down",0.252025038352838,0.548307578093131,"L.PvsV.DAVIES_MULTIPLE_MYELOMA_VS_MGUS_UP"
116,"Down",0.252088598935203,0.548307578093131,"L.PvsV.REACTOME_POST_TRANSLATIONAL_MODIFICATION_SYNTHESIS_OF_GPI_ANCHORED_PROTEINS"
33,"Down",0.252308765722595,0.548570651073624,"L.PvsV.BOYERINAS_ONCOFETAL_TARGETS_OF_LET7A1"
24,"Down",0.252553901146613,0.548887782798594,"L.PvsV.SHIN_B_CELL_LYMPHOMA_CLUSTER_9"
166,"Down",0.252709901743538,0.549011020330067,"L.PvsV.REACTOME_RHO_GTPASES_ACTIVATE_FORMINS"
78,"Down",0.252839039576745,0.549075824752484,"L.PvsV.VILIMAS_NOTCH1_TARGETS_UP"
19,"Down",0.253225204948815,0.549541277229131,"L.PvsV.KIM_MYCL1_AMPLIFICATION_TARGETS_UP"
9,"Up",0.253383545473065,0.549541277229131,"L.PvsV.BIOCARTA_PLK3_PATHWAY"
144,"Up",0.253446404202382,0.549541277229131,"L.PvsV.TAKAO_RESPONSE_TO_UVB_RADIATION_UP"
563,"Up",0.253450941749735,0.549541277229131,"L.PvsV.RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN"
13,"Down",0.25374906853148,0.549972010941024,"L.PvsV.KEGG_CIRCADIAN_RHYTHM_MAMMAL"
162,"Down",0.254033218705677,0.550011504841049,"L.PvsV.MARZEC_IL2_SIGNALING_UP"
42,"Down",0.254050272400652,0.550011504841049,"L.PvsV.WALLACE_JAK2_TARGETS_UP"
544,"Up",0.254065723162243,0.550011504841049,"L.PvsV.SHEN_SMARCA2_TARGETS_UP"
39,"Down",0.254379749832033,0.5504757874056,"L.PvsV.REACTOME_NUCLEAR_IMPORT_OF_REV_PROTEIN"
9,"Up",0.255066936751354,0.551746906611203,"L.PvsV.REACTOME_ABACAVIR_TRANSMEMBRANE_TRANSPORT"
277,"Down",0.255408619384107,0.55189455127256,"L.PvsV.REACTOME_ESR_MEDIATED_SIGNALING"
94,"Down",0.255541208090293,0.55189455127256,"L.PvsV.GARCIA_TARGETS_OF_FLI1_AND_DAX1_UP"
144,"Down",0.255576615578239,0.55189455127256,"L.PvsV.LIANG_SILENCED_BY_METHYLATION_2"
65,"Down",0.255680469472432,0.55189455127256,"L.PvsV.NAKAMURA_CANCER_MICROENVIRONMENT_UP"
24,"Down",0.255698531212405,0.55189455127256,"L.PvsV.CASTELLANO_NRAS_TARGETS_DN"
194,"Down",0.255758322054747,0.55189455127256,"L.PvsV.ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_UP"
8,"Up",0.255892556830045,0.55189455127256,"L.PvsV.REACTOME_HDL_CLEARANCE"
10,"Up",0.256399232088232,0.55189455127256,"L.PvsV.HEIDENBLAD_AMPLIFIED_IN_BONE_CANCER"
136,"Down",0.256431983972722,0.55189455127256,"L.PvsV.REACTOME_RHO_GTPASES_ACTIVATE_PKNS"
150,"Down",0.256446629745749,0.55189455127256,"L.PvsV.BURTON_ADIPOGENESIS_8"
64,"Down",0.25672999471855,0.55189455127256,"L.PvsV.WHITEHURST_PACLITAXEL_SENSITIVITY"
7,"Down",0.256924272435229,0.55189455127256,"L.PvsV.REACTOME_SUMO_IS_TRANSFERRED_FROM_E1_TO_E2_UBE2I_UBC9"
20,"Up",0.257148864932577,0.55189455127256,"L.PvsV.REACTOME_BETA_CATENIN_PHOSPHORYLATION_CASCADE"
518,"Down",0.257240389023939,0.55189455127256,"L.PvsV.FARMER_BREAST_CANCER_APOCRINE_VS_BASAL"
20,"Down",0.2572545589453,0.55189455127256,"L.PvsV.LI_CYTIDINE_ANALOG_PATHWAY"
135,"Up",0.257275633288017,0.55189455127256,"L.PvsV.REACTOME_DNA_REPLICATION"
75,"Up",0.257306336294597,0.55189455127256,"L.PvsV.PID_IL6_7_PATHWAY"
6,"Down",0.257324677756159,0.55189455127256,"L.PvsV.REN_MIF_TARGETS_DN"
30,"Down",0.257366544931175,0.55189455127256,"L.PvsV.WAGNER_APO2_SENSITIVITY"
493,"Down",0.257470380986807,0.55189455127256,"L.PvsV.ROZANOV_MMP14_TARGETS_UP"
144,"Up",0.257504469834619,0.55189455127256,"L.PvsV.NEMETH_INFLAMMATORY_RESPONSE_LPS_UP"
16,"Up",0.257549870769103,0.55189455127256,"L.PvsV.HOEGERKORP_CD44_TARGETS_TEMPORAL_UP"
160,"Down",0.257564202976743,0.55189455127256,"L.PvsV.HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS"
39,"Down",0.257607290053587,0.55189455127256,"L.PvsV.REACTOME_RESOLUTION_OF_ABASIC_SITES_AP_SITES"
27,"Up",0.25763064511385,0.55189455127256,"L.PvsV.TERAMOTO_OPN_TARGETS_CLUSTER_7"
31,"Up",0.257887105653228,0.552187610097544,"L.PvsV.GRANDVAUX_IRF3_TARGETS_UP"
38,"Down",0.257967190609868,0.552187610097544,"L.PvsV.CHOW_RASSF1_TARGETS_UP"
13,"Down",0.258496593852893,0.553106682435235,"L.PvsV.JOHNSTONE_PARVB_TARGETS_1_UP"
356,"Down",0.25887481180549,0.553701676778551,"L.PvsV.LEE_RECENT_THYMIC_EMIGRANT"
131,"Down",0.2591921392157,0.553998206958152,"L.PvsV.KEGG_CELL_CYCLE"
225,"Up",0.25921384724195,0.553998206958152,"L.PvsV.KAYO_AGING_MUSCLE_DN"
487,"Up",0.259827586372399,0.555095334255408,"L.PvsV.SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM4"
29,"Up",0.260213382735063,0.555565977183914,"L.PvsV.REACTOME_CHOLESTEROL_BIOSYNTHESIS"
6,"Down",0.260288305515381,0.555565977183914,"L.PvsV.NAKAMURA_BRONCHIAL_AND_BRONCHIOLAR_EPITHELIA"
40,"Down",0.260374954950489,0.555565977183914,"L.PvsV.WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_DN"
27,"Up",0.260449812418287,0.555565977183914,"L.PvsV.OUYANG_PROSTATE_CANCER_PROGRESSION_DN"
23,"Down",0.260629466075785,0.555734792878139,"L.PvsV.REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB"
36,"Down",0.260915473536448,0.556082470999144,"L.PvsV.BIOCARTA_TNFR1_PATHWAY"
13,"Up",0.261378760330827,0.556082470999144,"L.PvsV.REACTOME_REGULATION_OF_GLYCOLYSIS_BY_FRUCTOSE_2_6_BISPHOSPHATE_METABOLISM"
30,"Down",0.261395235561872,0.556082470999144,"L.PvsV.CAIRO_PML_TARGETS_BOUND_BY_MYC_UP"
415,"Up",0.261430116019734,0.556082470999144,"L.PvsV.WONG_EMBRYONIC_STEM_CELL_CORE"
44,"Down",0.261467026588052,0.556082470999144,"L.PvsV.RODRIGUES_NTN1_TARGETS_UP"
24,"Down",0.261534939684983,0.556082470999144,"L.PvsV.WHITESIDE_CISPLATIN_RESISTANCE_DN"
454,"Up",0.26158740105277,0.556082470999144,"L.PvsV.DOUGLAS_BMI1_TARGETS_DN"
144,"Down",0.261670909116293,0.556082470999144,"L.PvsV.DUTERTRE_ESTRADIOL_RESPONSE_6HR_DN"
94,"Up",0.261697701128554,0.556082470999144,"L.PvsV.NAKAMURA_ADIPOGENESIS_EARLY_UP"
86,"Down",0.261800945039067,0.556088138732618,"L.PvsV.CHANDRAN_METASTASIS_TOP50_UP"
51,"Down",0.262194447406618,0.556684411887426,"L.PvsV.KASLER_HDAC7_TARGETS_2_DN"
49,"Down",0.262283033634788,0.556684411887426,"L.PvsV.GENTILE_UV_RESPONSE_CLUSTER_D6"
16,"Down",0.262439380466485,0.556802507520796,"L.PvsV.KONDO_COLON_CANCER_HCP_WITH_H3K27ME3"
37,"Down",0.262710254775659,0.557163405697974,"L.PvsV.SHI_SPARC_TARGETS_UP"
36,"Down",0.263254452148336,0.558103476199443,"L.PvsV.REACTOME_TERMINATION_OF_TRANSLESION_DNA_SYNTHESIS"
81,"Down",0.263495492197192,0.558400374227012,"L.PvsV.HENDRICKS_SMARCA4_TARGETS_DN"
82,"Down",0.263961355133865,0.559173307484727,"L.PvsV.PID_IL2_1PATHWAY"
59,"Up",0.264463069456629,0.55976222331757,"L.PvsV.BOYAULT_LIVER_CANCER_SUBCLASS_G12_UP"
38,"Down",0.264526033464879,0.55976222331757,"L.PvsV.BIOCARTA_BAD_PATHWAY"
9,"Down",0.264543080037766,0.55976222331757,"L.PvsV.REACTOME_HIGHLY_SODIUM_PERMEABLE_POSTSYNAPTIC_ACETYLCHOLINE_NICOTINIC_RECEPTORS"
34,"Down",0.264859847891062,0.560207968350902,"L.PvsV.YANAGISAWA_LUNG_CANCER_RECURRENCE"
36,"Up",0.264956382209732,0.560207968350902,"L.PvsV.REACTOME_HIV_ELONGATION_ARREST_AND_RECOVERY"
36,"Down",0.265099123843571,0.560295510600575,"L.PvsV.REACTOME_SCAVENGING_BY_CLASS_A_RECEPTORS"
10,"Down",0.265337939180218,0.560396861936907,"L.PvsV.REACTOME_REACTIONS_SPECIFIC_TO_THE_COMPLEX_N_GLYCAN_SYNTHESIS_PATHWAY"
12,"Down",0.265349789211579,0.560396861936907,"L.PvsV.REACTOME_UNWINDING_OF_DNA"
156,"Down",0.265507462651039,0.560491686999832,"L.PvsV.ZWANG_EGF_INTERVAL_UP"
124,"Down",0.265597435329998,0.560491686999832,"L.PvsV.CHEBOTAEV_GR_TARGETS_UP"
17,"Down",0.266038242746027,0.56120772382403,"L.PvsV.PID_CIRCADIAN_PATHWAY"
92,"Down",0.266894800978914,0.562799906412059,"L.PvsV.REACTOME_RMTS_METHYLATE_HISTONE_ARGININES"
149,"Up",0.267279689609197,0.563396646530404,"L.PvsV.KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS"
13,"Down",0.267481587418356,0.56360735397717,"L.PvsV.THILLAINADESAN_ZNF217_TARGETS_DN"
27,"Down",0.267743969826627,0.563945298731969,"L.PvsV.BIOCARTA_BCELLSURVIVAL_PATHWAY"
191,"Down",0.268296925833546,0.564597161544283,"L.PvsV.BOYLAN_MULTIPLE_MYELOMA_C_D_UP"
57,"Down",0.268298996264601,0.564597161544283,"L.PvsV.STANELLE_E2F1_TARGETS"
32,"Down",0.268464333847278,0.564597161544283,"L.PvsV.LE_NEURONAL_DIFFERENTIATION_UP"
10,"Down",0.268501268666775,0.564597161544283,"L.PvsV.REICHERT_G1S_REGULATORS_AS_PI3K_TARGETS"
76,"Down",0.268608384611816,0.564597161544283,"L.PvsV.BIOCARTA_HIVNEF_PATHWAY"
108,"Down",0.268666147951349,0.564597161544283,"L.PvsV.GAVIN_FOXP3_TARGETS_CLUSTER_P2"
9,"Up",0.268865905542435,0.564802276498528,"L.PvsV.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_2"
423,"Down",0.26907604257033,0.565016405497763,"L.PvsV.GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP"
23,"Down",0.269172221392857,0.565016405497763,"L.PvsV.REACTOME_SYNAPTIC_ADHESION_LIKE_MOLECULES"
18,"Down",0.269435577669968,0.565260114974316,"L.PvsV.REACTOME_DEPOLYMERISATION_OF_THE_NUCLEAR_LAMINA"
65,"Down",0.269558018294843,0.565260114974316,"L.PvsV.REACTOME_PLATELET_AGGREGATION_PLUG_FORMATION"
28,"Down",0.269595030419112,0.565260114974316,"L.PvsV.MATZUK_OVULATION"
26,"Down",0.270191728023954,0.56616105673201,"L.PvsV.REACTOME_PROTEIN_METHYLATION"
17,"Down",0.270283491568597,0.56616105673201,"L.PvsV.BOYAULT_LIVER_CANCER_SUBCLASS_G56_UP"
15,"Down",0.270331920740189,0.56616105673201,"L.PvsV.TURJANSKI_MAPK1_AND_MAPK2_TARGETS"
25,"Down",0.270573727858966,0.566452912280281,"L.PvsV.KEGG_GLYCOSPHINGOLIPID_BIOSYNTHESIS_LACTO_AND_NEOLACTO_SERIES"
6,"Down",0.270908620935782,0.566939350928818,"L.PvsV.SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_DN"
243,"Down",0.271422607832615,0.56780007518219,"L.PvsV.IGLESIAS_E2F_TARGETS_UP"
527,"Down",0.271570074105355,0.567854034206182,"L.PvsV.OISHI_CHOLANGIOMA_STEM_CELL_LIKE_UP"
33,"Down",0.271653810901673,0.567854034206182,"L.PvsV.REACTOME_NOTCH2_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS"
35,"Down",0.272078104993914,0.568020008793487,"L.PvsV.SA_B_CELL_RECEPTOR_COMPLEXES"
12,"Down",0.272083805545232,0.568020008793487,"L.PvsV.YAMANAKA_GLIOBLASTOMA_SURVIVAL_DN"
12,"Down",0.272188012517735,0.568020008793487,"L.PvsV.REACTOME_PASSIVE_TRANSPORT_BY_AQUAPORINS"
43,"Down",0.272199992352843,0.568020008793487,"L.PvsV.BIOCARTA_AT1R_PATHWAY"
191,"Up",0.272473353746638,0.568020008793487,"L.PvsV.SESTO_RESPONSE_TO_UV_C0"
153,"Down",0.272480092278449,0.568020008793487,"L.PvsV.CASTELLANO_NRAS_TARGETS_UP"
87,"Up",0.272532143082949,0.568020008793487,"L.PvsV.LIM_MAMMARY_LUMINAL_PROGENITOR_UP"
14,"Down",0.272578507999852,0.568020008793487,"L.PvsV.GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_DN"
16,"Down",0.272693746144442,0.568020008793487,"L.PvsV.REACTOME_ERYTHROCYTES_TAKE_UP_OXYGEN_AND_RELEASE_CARBON_DIOXIDE"
25,"Up",0.272760557668061,0.568020008793487,"L.PvsV.REACTOME_ABORTIVE_ELONGATION_OF_HIV_1_TRANSCRIPT_IN_THE_ABSENCE_OF_TAT"
9,"Up",0.272973755648918,0.568249960460418,"L.PvsV.REACTOME_ESTROGEN_BIOSYNTHESIS"
20,"Down",0.273255351710481,0.568329689171366,"L.PvsV.REACTOME_FORMATION_OF_SENESCENCE_ASSOCIATED_HETEROCHROMATIN_FOCI_SAHF"
32,"Down",0.273350468587963,0.568329689171366,"L.PvsV.PID_RHODOPSIN_PATHWAY"
8,"Down",0.273364884264274,0.568329689171366,"L.PvsV.REACTOME_RELAXIN_RECEPTORS"
34,"Up",0.273428040009195,0.568329689171366,"L.PvsV.REACTOME_TIGHT_JUNCTION_INTERACTIONS"
58,"Down",0.273526008841564,0.568329689171366,"L.PvsV.EPPERT_LSC_R"
10,"Up",0.274107392046284,0.56932373051236,"L.PvsV.SA_FAS_SIGNALING"
5,"Down",0.274311967030789,0.56953468483411,"L.PvsV.TURJANSKI_MAPK11_TARGETS"
412,"Down",0.274462015199144,0.569632313076601,"L.PvsV.CHYLA_CBFA2T3_TARGETS_DN"
27,"Up",0.275347242821202,0.57114049487703,"L.PvsV.BIOCARTA_TGFB_PATHWAY"
19,"Down",0.275526130028883,0.57114049487703,"L.PvsV.REACTOME_TRANSPORT_OF_CONNEXONS_TO_THE_PLASMA_MEMBRANE"
128,"Down",0.275530095806681,0.57114049487703,"L.PvsV.BOYLAN_MULTIPLE_MYELOMA_D_UP"
24,"Down",0.275601888285751,0.57114049487703,"L.PvsV.PID_P38_MK2_PATHWAY"
27,"Down",0.275849725185801,0.571439914032332,"L.PvsV.WU_APOPTOSIS_BY_CDKN1A_NOT_VIA_TP53"
72,"Down",0.276399438734467,0.572364230997329,"L.PvsV.GOBERT_CORE_OLIGODENDROCYTE_DIFFERENTIATION"
32,"Down",0.277357281870024,0.573633045072011,"L.PvsV.VETTER_TARGETS_OF_PRKCA_AND_ETS1_DN"
108,"Up",0.277433160092434,0.573633045072011,"L.PvsV.PID_MYC_ACTIV_PATHWAY"
154,"Down",0.277740530971498,0.573633045072011,"L.PvsV.LEE_TARGETS_OF_PTCH1_AND_SUFU_DN"
39,"Up",0.277744786398149,0.573633045072011,"L.PvsV.YIH_RESPONSE_TO_ARSENITE_C3"
440,"Down",0.277781359370135,0.573633045072011,"L.PvsV.DAZARD_RESPONSE_TO_UV_NHEK_DN"
6,"Down",0.277820190752832,0.573633045072011,"L.PvsV.BIOCARTA_SLRP_PATHWAY"
140,"Down",0.277906719771888,0.573633045072011,"L.PvsV.DUAN_PRDM5_TARGETS"
70,"Down",0.278002686188984,0.573633045072011,"L.PvsV.VALK_AML_CLUSTER_3"
60,"Down",0.278050442791192,0.573633045072011,"L.PvsV.TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_DN"
38,"Down",0.278230557317659,0.573633045072011,"L.PvsV.ONO_FOXP3_TARGETS_UP"
13,"Down",0.278281319182016,0.573633045072011,"L.PvsV.REACTOME_FIBRONECTIN_MATRIX_FORMATION"
119,"Down",0.278378160936412,0.573633045072011,"L.PvsV.GUO_HEX_TARGETS_UP"
556,"Down",0.278416825652128,0.573633045072011,"L.PvsV.POOLA_INVASIVE_BREAST_CANCER_UP"
94,"Up",0.278530199049875,0.573633045072011,"L.PvsV.SESTO_RESPONSE_TO_UV_C2"
37,"Down",0.278591544940402,0.573633045072011,"L.PvsV.REACTOME_SUMOYLATION_OF_INTRACELLULAR_RECEPTORS"
195,"Up",0.278773869081221,0.573633045072011,"L.PvsV.REACTOME_ION_CHANNEL_TRANSPORT"
252,"Down",0.278775907416982,0.573633045072011,"L.PvsV.REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS"
476,"Down",0.279032097848587,0.573946603052395,"L.PvsV.MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_UP"
431,"Down",0.279248252762162,0.574177608598734,"L.PvsV.JAATINEN_HEMATOPOIETIC_STEM_CELL_DN"
55,"Down",0.279416165986921,0.57430928689282,"L.PvsV.REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA"
9,"Down",0.279627277048127,0.574529622742138,"L.PvsV.REACTOME_SODIUM_PROTON_EXCHANGERS"
18,"Down",0.279820209384062,0.574712458278039,"L.PvsV.REACTOME_NEUROTRANSMITTER_CLEARANCE"
5,"Down",0.280046183603498,0.574962996340044,"L.PvsV.REACTOME_SODIUM_COUPLED_SULPHATE_DI_AND_TRI_CARBOXYLATE_TRANSPORTERS"
26,"Up",0.280334075323419,0.575340424076906,"L.PvsV.PID_NFKAPPAB_ATYPICAL_PATHWAY"
757,"Down",0.280626187814744,0.575726230956482,"L.PvsV.CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN"
9,"Down",0.280813936831094,0.575736106800551,"L.PvsV.BIOCARTA_CREM_PATHWAY"
54,"Down",0.280839262080139,0.575736106800551,"L.PvsV.BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_DN"
73,"Down",0.281536517717753,0.57695159616807,"L.PvsV.PID_ANGIOPOIETIN_RECEPTOR_PATHWAY"
55,"Up",0.28182895378664,0.577217289776063,"L.PvsV.HU_ANGIOGENESIS_DN"
5,"Up",0.281874965164654,0.577217289776063,"L.PvsV.REACTOME_ACTIVATION_OF_RAS_IN_B_CELLS"
17,"Down",0.28204402328312,0.577319053677226,"L.PvsV.PID_S1P_S1P4_PATHWAY"
61,"Up",0.282133493043202,0.577319053677226,"L.PvsV.BIOCARTA_NKCELLS_PATHWAY"
50,"Down",0.282300453319353,0.577446987200407,"L.PvsV.REACTOME_G_ALPHA_Z_SIGNALLING_EVENTS"
47,"Down",0.282866866807963,0.57834166412558,"L.PvsV.PID_ALPHA_SYNUCLEIN_PATHWAY"
59,"Down",0.282947043128901,0.57834166412558,"L.PvsV.REACTOME_TRANSCRIPTIONAL_REGULATION_OF_PLURIPOTENT_STEM_CELLS"
33,"Up",0.283277899411557,0.578803956336474,"L.PvsV.RAMPON_ENRICHED_LEARNING_ENVIRONMENT_LATE_UP"
981,"Down",0.283584794712226,0.579123639838252,"L.PvsV.BROWNE_HCMV_INFECTION_48HR_DN"
935,"Up",0.283718766610546,0.579123639838252,"L.PvsV.FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN"
17,"Down",0.283748587506208,0.579123639838252,"L.PvsV.FIGUEROA_AML_METHYLATION_CLUSTER_5_UP"
13,"Up",0.284004492595124,0.579218310423623,"L.PvsV.REACTOME_CAMK_IV_MEDIATED_PHOSPHORYLATION_OF_CREB"
13,"Up",0.284004492595124,0.579218310423623,"L.PvsV.REACTOME_CREB1_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_CAMKII_CAMKK_CAMKIV_CASCASDE"
77,"Up",0.284425565423616,0.57986318260589,"L.PvsV.ASTIER_INTEGRIN_SIGNALING"
76,"Down",0.284917710611311,0.58049553031304,"L.PvsV.HAHTOLA_MYCOSIS_FUNGOIDES_UP"
9,"Up",0.284945716995766,0.58049553031304,"L.PvsV.REACTOME_TFAP2_AP_2_FAMILY_REGULATES_TRANSCRIPTION_OF_CELL_CYCLE_FACTORS"
36,"Down",0.285072123170474,0.580539141439983,"L.PvsV.REACTOME_PLATELET_ADHESION_TO_EXPOSED_COLLAGEN"
427,"Down",0.285457435787035,0.581109779995035,"L.PvsV.UDAYAKUMAR_MED1_TARGETS_DN"
39,"Up",0.285706241138302,0.581402210987733,"L.PvsV.HASLINGER_B_CLL_WITH_MUTATED_VH_GENES"
73,"Up",0.286243898268519,0.582282013806711,"L.PvsV.REACTOME_SIGNALING_BY_ERBB4"
195,"Down",0.286381401367653,0.582347468981887,"L.PvsV.BOYAULT_LIVER_CANCER_SUBCLASS_G1_UP"
2088,"Down",0.287047119540358,0.583486589683323,"L.PvsV.YOSHIMURA_MAPK8_TARGETS_UP"
32,"Down",0.287536220724021,0.583864109174386,"L.PvsV.KORKOLA_SEMINOMA_DN"
33,"Down",0.287563503175015,0.583864109174386,"L.PvsV.REACTOME_THROMBIN_SIGNALLING_THROUGH_PROTEINASE_ACTIVATED_RECEPTORS_PARS"
60,"Down",0.287602824269591,0.583864109174386,"L.PvsV.NOUSHMEHR_GBM_SILENCED_BY_METHYLATION"
7,"Down",0.287655242067467,0.583864109174386,"L.PvsV.CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_HD_MTX_UP"
26,"Down",0.287881030735185,0.584107970251316,"L.PvsV.REACTOME_A_TETRASACCHARIDE_LINKER_SEQUENCE_IS_REQUIRED_FOR_GAG_SYNTHESIS"
237,"Down",0.288202821763131,0.584546368865867,"L.PvsV.LENAOUR_DENDRITIC_CELL_MATURATION_DN"
64,"Down",0.288340731782449,0.58461162670523,"L.PvsV.TIEN_INTESTINE_PROBIOTICS_2HR_UP"
40,"Down",0.288473089866084,0.584659155927541,"L.PvsV.REACTOME_REGULATION_OF_MECP2_EXPRESSION_AND_ACTIVITY"
31,"Down",0.288575662240235,0.584659155927541,"L.PvsV.KYNG_RESPONSE_TO_H2O2_VIA_ERCC6"
45,"Down",0.288883119062482,0.584951881821453,"L.PvsV.FINETTI_BREAST_CANCERS_KINOME_BLUE"
728,"Down",0.288931739781947,0.584951881821453,"L.PvsV.YAGI_AML_WITH_INV_16_TRANSLOCATION"
137,"Down",0.289141878155037,0.585160884479002,"L.PvsV.KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION"
77,"Down",0.289246644471173,0.585160884479002,"L.PvsV.REACTOME_NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION"
29,"Up",0.289477832699669,0.585414388074788,"L.PvsV.MULLIGAN_NTF3_SIGNALING_VIA_INSR_AND_IGF1R_UP"
43,"Down",0.289590764326146,0.585428642032637,"L.PvsV.REACTOME_ADRENALINE_NORADRENALINE_INHIBITS_INSULIN_SECRETION"
16,"Up",0.289912900365884,0.585865652822724,"L.PvsV.BIOCARTA_EPONFKB_PATHWAY"
37,"Up",0.29008140852743,0.585900925906937,"L.PvsV.BIOCARTA_PTDINS_PATHWAY"
184,"Down",0.290142292482039,0.585900925906937,"L.PvsV.FIGUEROA_AML_METHYLATION_CLUSTER_1_UP"
18,"Down",0.290382805939569,0.585966166512033,"L.PvsV.REACTOME_APOPTOTIC_CLEAVAGE_OF_CELL_ADHESION_PROTEINS"
270,"Down",0.290386561085724,0.585966166512033,"L.PvsV.KIM_WT1_TARGETS_8HR_UP"
342,"Down",0.290498650362977,0.585978488820468,"L.PvsV.ZWANG_CLASS_3_TRANSIENTLY_INDUCED_BY_EGF"
12,"Up",0.290898697888655,0.586571444429751,"L.PvsV.BIOCARTA_CDC25_PATHWAY"
20,"Up",0.291198871360965,0.586962653939036,"L.PvsV.BIOCARTA_TALL1_PATHWAY"
318,"Down",0.291451382428938,0.587189796212166,"L.PvsV.BHAT_ESR1_TARGETS_NOT_VIA_AKT1_UP"
17,"Down",0.291523962850858,0.587189796212166,"L.PvsV.REACTOME_CREB1_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_ADENYLATE_CYCLASE"
69,"Down",0.292124905370472,0.588185943843168,"L.PvsV.REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR"
33,"Up",0.292411103373634,0.58846078886541,"L.PvsV.BIOCARTA_G2_PATHWAY"
78,"Up",0.292474271622743,0.58846078886541,"L.PvsV.MIDORIKAWA_AMPLIFIED_IN_LIVER_CANCER"
17,"Up",0.29274118253739,0.588771575995462,"L.PvsV.WEBER_METHYLATED_ICP_IN_SPERM_UP"
13,"Up",0.292841713508324,0.588771575995462,"L.PvsV.REACTOME_CASPASE_ACTIVATION_VIA_DEPENDENCE_RECEPTORS_IN_THE_ABSENCE_OF_LIGAND"
43,"Down",0.2930929139804,0.589062421445886,"L.PvsV.REACTOME_FGFR1_MUTANT_RECEPTOR_ACTIVATION"
6,"Down",0.293706073782582,0.589899894639222,"L.PvsV.REACTOME_VITAMIN_B1_THIAMIN_METABOLISM"
194,"Down",0.293722989680191,0.589899894639222,"L.PvsV.RODRIGUES_DCC_TARGETS_DN"
18,"Down",0.293855366413886,0.58995146002265,"L.PvsV.REACTOME_LOSS_OF_FUNCTION_OF_MECP2_IN_RETT_SYNDROME"
19,"Down",0.294083462669154,0.590195087149819,"L.PvsV.YIH_RESPONSE_TO_ARSENITE_C5"
139,"Down",0.294304105785503,0.590205159377886,"L.PvsV.GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP"
79,"Up",0.294353990305096,0.590205159377886,"L.PvsV.SPIRA_SMOKERS_LUNG_CANCER_UP"
789,"Down",0.294408723017582,0.590205159377886,"L.PvsV.DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN"
47,"Up",0.294963180113111,0.591102364206376,"L.PvsV.KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_WS"
132,"Down",0.295612986036459,0.591666599741071,"L.PvsV.AKL_HTLV1_INFECTION_DN"
28,"Down",0.295685322695364,0.591666599741071,"L.PvsV.REACTOME_NOTCH4_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION"
231,"Up",0.295741521050315,0.591666599741071,"L.PvsV.BASSO_B_LYMPHOCYTE_NETWORK"
448,"Up",0.295839655927581,0.591666599741071,"L.PvsV.KAAB_HEART_ATRIUM_VS_VENTRICLE_DN"
169,"Down",0.29584984534105,0.591666599741071,"L.PvsV.NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP"
45,"Down",0.295886805622004,0.591666599741071,"L.PvsV.RODRIGUES_NTN1_AND_DCC_TARGETS"
303,"Down",0.296039798991705,0.591758513602725,"L.PvsV.ZWANG_EGF_INTERVAL_DN"
12,"Up",0.296357588434292,0.592016153604552,"L.PvsV.REACTOME_TRANSPORT_OF_NUCLEOSIDES_AND_FREE_PURINE_AND_PYRIMIDINE_BASES_ACROSS_THE_PLASMA_MEMBRANE"
12,"Up",0.296382838339193,0.592016153604552,"L.PvsV.REACTOME_FOLDING_OF_ACTIN_BY_CCT_TRIC"
19,"Down",0.296613362586497,0.592068703812255,"L.PvsV.DORN_ADENOVIRUS_INFECTION_24HR_UP"
111,"Up",0.296677263450696,0.592068703812255,"L.PvsV.CHESLER_BRAIN_QTL_CIS"
45,"Down",0.296730399396592,0.592068703812255,"L.PvsV.REACTOME_MET_ACTIVATES_PTK2_SIGNALING"
95,"Down",0.296936659364599,0.592185514723116,"L.PvsV.DIRMEIER_LMP1_RESPONSE_EARLY"
33,"Up",0.297003152889709,0.592185514723116,"L.PvsV.REACTOME_CYTOSOLIC_SULFONATION_OF_SMALL_MOLECULES"
32,"Down",0.297164236058772,0.592217048131261,"L.PvsV.SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_2FC_UP"
80,"Down",0.297233190190676,0.592217048131261,"L.PvsV.HOQUE_METHYLATED_IN_CANCER"
13,"Up",0.29777706035267,0.593086947654867,"L.PvsV.REACTOME_SIGNALING_BY_FGFR3_FUSIONS_IN_CANCER"
16,"Down",0.298279271772328,0.593873278224416,"L.PvsV.BIOCARTA_CARM1_PATHWAY"
175,"Down",0.298475236304352,0.593988171508559,"L.PvsV.REACTOME_L1CAM_INTERACTIONS"
184,"Down",0.29860377109917,0.593988171508559,"L.PvsV.REACTOME_PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS"
1007,"Down",0.298659272344691,0.593988171508559,"L.PvsV.MARTINEZ_RB1_AND_TP53_TARGETS_DN"
89,"Up",0.298877515227335,0.594208366337016,"L.PvsV.REACTOME_SIGNALING_BY_INSULIN_RECEPTOR"
109,"Down",0.299023231455951,0.594208366337016,"L.PvsV.LEE_LIVER_CANCER_MYC_E2F1_UP"
37,"Down",0.29909240070825,0.594208366337016,"L.PvsV.REACTOME_STING_MEDIATED_INDUCTION_OF_HOST_IMMUNE_RESPONSES"
12,"Up",0.299348841166636,0.594413532461268,"L.PvsV.REACTOME_NETRIN_MEDIATED_REPULSION_SIGNALS"
19,"Up",0.299571856124634,0.594413532461268,"L.PvsV.REACTOME_RNA_POLYMERASE_III_CHAIN_ELONGATION"
57,"Up",0.299817693520591,0.594413532461268,"L.PvsV.SIG_CHEMOTAXIS"
89,"Down",0.299857324574279,0.594413532461268,"L.PvsV.KOHOUTEK_CCNT1_TARGETS"
46,"Down",0.299930004694185,0.594413532461268,"L.PvsV.YANG_BREAST_CANCER_ESR1_DN"
100,"Up",0.299935646148331,0.594413532461268,"L.PvsV.DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP"
90,"Down",0.299987316298313,0.594413532461268,"L.PvsV.KEGG_LONG_TERM_DEPRESSION"
12,"Up",0.300095645314089,0.594413532461268,"L.PvsV.BOYLAN_MULTIPLE_MYELOMA_PCA1_DN"
127,"Down",0.300163245185722,0.594413532461268,"L.PvsV.REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK"
11,"Up",0.300944977070929,0.595702359736314,"L.PvsV.REACTOME_PP2A_MEDIATED_DEPHOSPHORYLATION_OF_KEY_METABOLIC_FACTORS"
8,"Down",0.30102955201723,0.595702359736314,"L.PvsV.BIOCARTA_RNAPOL3_PATHWAY"
23,"Down",0.30120274452426,0.595831833443518,"L.PvsV.BIOCARTA_PS1_PATHWAY"
75,"Down",0.301690344696999,0.596480840579445,"L.PvsV.EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_DN"
156,"Up",0.301746592711287,0.596480840579445,"L.PvsV.YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_11"
15,"Down",0.302068367765718,0.596903504423394,"L.PvsV.LIANG_SILENCED_BY_METHYLATION_DN"
640,"Down",0.302642758262279,0.597824869750676,"L.PvsV.LU_EZH2_TARGETS_DN"
38,"Up",0.302980722573621,0.598278719681983,"L.PvsV.CAFFAREL_RESPONSE_TO_THC_8HR_3_DN"
43,"Up",0.30310349739609,0.598307474867184,"L.PvsV.ZWANG_EGF_PERSISTENTLY_UP"
72,"Up",0.30343306624559,0.59874426240966,"L.PvsV.ZHAN_MULTIPLE_MYELOMA_CD1_UP"
26,"Down",0.304110859285653,0.599867620760034,"L.PvsV.FOURNIER_ACINAR_DEVELOPMENT_LATE_UP"
18,"Down",0.304238144926344,0.599904673073379,"L.PvsV.REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING"
876,"Up",0.304682117572842,0.600450922923121,"L.PvsV.ENK_UV_RESPONSE_KERATINOCYTE_UP"
10,"Down",0.304732372892436,0.600450922923121,"L.PvsV.MIKKELSEN_DEDIFFERENTIATED_STATE_UP"
47,"Down",0.305122738584251,0.600821534716847,"L.PvsV.CHUANG_OXIDATIVE_STRESS_RESPONSE_UP"
88,"Up",0.305197252143592,0.600821534716847,"L.PvsV.WEBER_METHYLATED_ICP_IN_SPERM_DN"
73,"Down",0.305246462474159,0.600821534716847,"L.PvsV.JAEGER_METASTASIS_UP"
14,"Up",0.305474809384583,0.600950953052695,"L.PvsV.REACTOME_INLA_MEDIATED_ENTRY_OF_LISTERIA_MONOCYTOGENES_INTO_HOST_CELLS"
11,"Down",0.305612057197089,0.600950953052695,"L.PvsV.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_25"
60,"Down",0.30563828540137,0.600950953052695,"L.PvsV.REACTOME_BIOSYNTHESIS_OF_SPECIALIZED_PRORESOLVING_MEDIATORS_SPMS"
362,"Down",0.305931189305796,0.601313027256219,"L.PvsV.MULLIGHAN_NPM1_SIGNATURE_3_DN"
74,"Down",0.306593400973937,0.602400466945592,"L.PvsV.KENNY_CTNNB1_TARGETS_UP"
14,"Down",0.306703057663161,0.602401849314251,"L.PvsV.ZHOU_PANCREATIC_BETA_CELL"
10,"Up",0.306820476688875,0.602418471453405,"L.PvsV.BIOCARTA_BBCELL_PATHWAY"
48,"Up",0.307025746334362,0.602607508513556,"L.PvsV.FARDIN_HYPOXIA_11"
57,"Down",0.307441817600749,0.603210010473578,"L.PvsV.REACTOME_EPH_EPHRIN_MEDIATED_REPULSION_OF_CELLS"
359,"Down",0.308021637354781,0.604133250420215,"L.PvsV.MASSARWEH_TAMOXIFEN_RESISTANCE_DN"
39,"Down",0.308220487454245,0.604186301505306,"L.PvsV.KANG_FLUOROURACIL_RESISTANCE_UP"
33,"Down",0.308425585371278,0.604186301505306,"L.PvsV.PID_BARD1_PATHWAY"
50,"Down",0.308545646778341,0.604186301505306,"L.PvsV.DASU_IL6_SIGNALING_SCAR_UP"
28,"Down",0.308563446441916,0.604186301505306,"L.PvsV.BIOCARTA_EPHA4_PATHWAY"
167,"Down",0.308703305660525,0.604186301505306,"L.PvsV.REACTOME_MITOTIC_PROPHASE"
14,"Down",0.308708027764819,0.604186301505306,"L.PvsV.REACTOME_PURINE_RIBONUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHESIS"
8,"Down",0.308813616938686,0.604186301505306,"L.PvsV.TURJANSKI_MAPK7_TARGETS"
58,"Down",0.309147481711887,0.604474582278009,"L.PvsV.ODONNELL_TARGETS_OF_MYC_AND_TFRC_DN"
105,"Down",0.309311149168458,0.604474582278009,"L.PvsV.SESTO_RESPONSE_TO_UV_C7"
1632,"Down",0.309365462169506,0.604474582278009,"L.PvsV.GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN"
612,"Down",0.309494909826781,0.604474582278009,"L.PvsV.HELLER_SILENCED_BY_METHYLATION_UP"
57,"Up",0.309548477117133,0.604474582278009,"L.PvsV.VILIMAS_NOTCH1_TARGETS_DN"
126,"Down",0.309616931996983,0.604474582278009,"L.PvsV.YAO_HOXA10_TARGETS_VIA_PROGESTERONE_UP"
61,"Up",0.310014916038415,0.604530600161805,"L.PvsV.REACTOME_RRNA_MODIFICATION_IN_THE_NUCLEUS_AND_CYTOSOL"
75,"Down",0.310083353309891,0.604530600161805,"L.PvsV.MCDOWELL_ACUTE_LUNG_INJURY_DN"
212,"Up",0.310216434784082,0.604530600161805,"L.PvsV.WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_UP"
104,"Up",0.310281974504456,0.604530600161805,"L.PvsV.FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP"
48,"Up",0.310324055145653,0.604530600161805,"L.PvsV.YANG_BREAST_CANCER_ESR1_BULK_UP"
48,"Down",0.310421061008266,0.604530600161805,"L.PvsV.REACTOME_VIRAL_MESSENGER_RNA_SYNTHESIS"
23,"Down",0.310448409409794,0.604530600161805,"L.PvsV.GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN"
29,"Down",0.310520329980019,0.604530600161805,"L.PvsV.LANDEMAINE_LUNG_METASTASIS"
9,"Up",0.311124159068323,0.605219346685846,"L.PvsV.KIM_GLIS2_TARGETS_DN"
30,"Down",0.311131678348526,0.605219346685846,"L.PvsV.MILICIC_FAMILIAL_ADENOMATOUS_POLYPOSIS_DN"
41,"Down",0.311202496405834,0.605219346685846,"L.PvsV.BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_UP"
92,"Up",0.31160327933355,0.605714380847893,"L.PvsV.KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP"
31,"Up",0.311676146412056,0.605714380847893,"L.PvsV.MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH"
14,"Down",0.311825528896233,0.605791760107967,"L.PvsV.REACTOME_GLUTAMATE_AND_GLUTAMINE_METABOLISM"
31,"Up",0.312241143460198,0.606106014856194,"L.PvsV.CAFFAREL_RESPONSE_TO_THC_8HR_5_UP"
103,"Down",0.312309942039062,0.606106014856194,"L.PvsV.BILD_SRC_ONCOGENIC_SIGNATURE"
299,"Down",0.312316157772707,0.606106014856194,"L.PvsV.TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN"
80,"Up",0.31264003482566,0.606521667561781,"L.PvsV.ELVIDGE_HYPOXIA_BY_DMOG_DN"
75,"Down",0.312817904333338,0.606653873398465,"L.PvsV.LIU_TARGETS_OF_VMYB_VS_CMYB_DN"
26,"Up",0.313122334223105,0.607031341486517,"L.PvsV.BIOCARTA_HIF_PATHWAY"
11,"Down",0.314005304626388,0.608529733361128,"L.PvsV.REACTOME_PYRIMIDINE_SALVAGE"
43,"Up",0.314324996890109,0.608935847163775,"L.PvsV.ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_DN"
30,"Down",0.314516414223173,0.60909325892817,"L.PvsV.RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_DN"
817,"Up",0.314792177855424,0.609317066001496,"L.PvsV.ACEVEDO_LIVER_CANCER_DN"
153,"Down",0.314952966896121,0.609317066001496,"L.PvsV.ROSS_LEUKEMIA_WITH_MLL_FUSIONS"
27,"Down",0.315026680986019,0.609317066001496,"L.PvsV.REACTOME_GASTRIN_CREB_SIGNALLING_PATHWAY_VIA_PKC_AND_MAPK"
67,"Up",0.31507279647283,0.609317066001496,"L.PvsV.PID_ECADHERIN_NASCENT_AJ_PATHWAY"
34,"Up",0.315311981285217,0.609435652825706,"L.PvsV.REACTOME_IKK_COMPLEX_RECRUITMENT_MEDIATED_BY_RIP1"
8,"Down",0.315354567323991,0.609435652825706,"L.PvsV.REACTOME_DEFECTIVE_CHST3_CAUSES_SEDCJD"
64,"Down",0.315689729673463,0.60966153484422,"L.PvsV.POS_HISTAMINE_RESPONSE_NETWORK"
72,"Down",0.315813202962871,0.60966153484422,"L.PvsV.VALK_AML_CLUSTER_11"
51,"Down",0.315821269858938,0.60966153484422,"L.PvsV.BIOCARTA_BCR_PATHWAY"
85,"Down",0.315912515342502,0.60966153484422,"L.PvsV.ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN"
15,"Down",0.31603608451672,0.609687198636757,"L.PvsV.KEGG_GLYCOSPHINGOLIPID_BIOSYNTHESIS_GANGLIO_SERIES"
74,"Down",0.316223591693336,0.609836148752164,"L.PvsV.KLEIN_TARGETS_OF_BCR_ABL1_FUSION"
186,"Up",0.316794805601099,0.610552164710643,"L.PvsV.CHUNG_BLISTER_CYTOTOXICITY_UP"
147,"Down",0.316816134690008,0.610552164710643,"L.PvsV.BAE_BRCA1_TARGETS_UP"
8,"Down",0.316926155311909,0.610552164710643,"L.PvsV.TERAMOTO_OPN_TARGETS_CLUSTER_5"
33,"Down",0.31708378080068,0.610566032454805,"L.PvsV.KORKOLA_CHORIOCARCINOMA_DN"
20,"Down",0.31726932698005,0.610566032454805,"L.PvsV.REACTOME_ENOS_ACTIVATION"
160,"Up",0.317395150047317,0.610566032454805,"L.PvsV.CUI_GLUCOSE_DEPRIVATION"
24,"Down",0.317462001231559,0.610566032454805,"L.PvsV.DEBOSSCHER_NFKB_TARGETS_REPRESSED_BY_GLUCOCORTICOIDS"
455,"Down",0.317534771145689,0.610566032454805,"L.PvsV.RAO_BOUND_BY_SALL4"
58,"Up",0.317703481599047,0.610566032454805,"L.PvsV.REACTOME_RECYCLING_PATHWAY_OF_L1"
68,"Up",0.317771800867444,0.610566032454805,"L.PvsV.CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_DN"
65,"Down",0.317816791717296,0.610566032454805,"L.PvsV.GROSS_HYPOXIA_VIA_ELK3_ONLY_DN"
6,"Down",0.318663884221705,0.611793201364633,"L.PvsV.BIOCARTA_ACETAMINOPHEN_PATHWAY"
31,"Down",0.318683710340528,0.611793201364633,"L.PvsV.DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_DN"
27,"Down",0.318787522722284,0.611793201364633,"L.PvsV.BIOCARTA_PML_PATHWAY"
198,"Up",0.319300799281947,0.612201027754623,"L.PvsV.REACTOME_TOLL_LIKE_RECEPTOR_CASCADES"
148,"Down",0.319326612742167,0.612201027754623,"L.PvsV.SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_DN"
316,"Down",0.319576978117664,0.612201027754623,"L.PvsV.KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION"
40,"Down",0.319590463095496,0.612201027754623,"L.PvsV.YIH_RESPONSE_TO_ARSENITE_C1"
35,"Up",0.319609026921097,0.612201027754623,"L.PvsV.REACTOME_FORMATION_OF_THE_EARLY_ELONGATION_COMPLEX"
178,"Up",0.31975767881295,0.612201027754623,"L.PvsV.REACTOME_S_PHASE"
701,"Up",0.319775107280765,0.612201027754623,"L.PvsV.ENK_UV_RESPONSE_KERATINOCYTE_DN"
393,"Down",0.320154437712664,0.612715086920499,"L.PvsV.MUELLER_PLURINET"
66,"Down",0.320377315486226,0.612929473122265,"L.PvsV.LEE_LIVER_CANCER_MYC_UP"
39,"Down",0.320716346315207,0.61336585222303,"L.PvsV.REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS"
15,"Up",0.321048616994285,0.613789005311687,"L.PvsV.WORSCHECH_TUMOR_EVASION_AND_TOLEROGENICITY_DN"
17,"Up",0.321295263834435,0.613924529513059,"L.PvsV.FUJIWARA_PARK2_IN_LIVER_CANCER_DN"
79,"Down",0.321341578659937,0.613924529513059,"L.PvsV.YOKOE_CANCER_TESTIS_ANTIGENS"
39,"Up",0.32169275223066,0.614383152705809,"L.PvsV.REACTOME_NEGATIVE_REGULATION_OF_FGFR4_SIGNALING"
11,"Down",0.322008568958674,0.614716993712044,"L.PvsV.REACTOME_CDC6_ASSOCIATION_WITH_THE_ORC_ORIGIN_COMPLEX"
66,"Up",0.322109915572283,0.614716993712044,"L.PvsV.REACTOME_SIGNALING_BY_ERBB2"
23,"Down",0.322284296260343,0.614716993712044,"L.PvsV.KOBAYASHI_RESPONSE_TO_ROMIDEPSIN"
16,"Up",0.322312274330117,0.614716993712044,"L.PvsV.REACTOME_PHENYLALANINE_AND_TYROSINE_METABOLISM"
505,"Down",0.322460953886878,0.61478848760019,"L.PvsV.REACTOME_GPCR_LIGAND_BINDING"
32,"Down",0.322807615110614,0.615113360638811,"L.PvsV.DASU_IL6_SIGNALING_SCAR_DN"
39,"Down",0.323004738154591,0.615113360638811,"L.PvsV.FERRANDO_TAL1_NEIGHBORS"
115,"Up",0.32311787802725,0.615113360638811,"L.PvsV.DARWICHE_PAPILLOMA_PROGRESSION_RISK"
117,"Down",0.323162197034347,0.615113360638811,"L.PvsV.PID_FAK_PATHWAY"
97,"Up",0.323187613068502,0.615113360638811,"L.PvsV.MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_UP"
6,"Up",0.323396151072974,0.61516830719566,"L.PvsV.REACTOME_LRR_FLII_INTERACTING_PROTEIN_1_LRRFIP1_ACTIVATES_TYPE_I_IFN_PRODUCTION"
88,"Down",0.323439006876068,0.61516830719566,"L.PvsV.DORN_ADENOVIRUS_INFECTION_12HR_DN"
42,"Down",0.32384226411276,0.61572347946336,"L.PvsV.REACTOME_ACTIVATED_NOTCH1_TRANSMITS_SIGNAL_TO_THE_NUCLEUS"
575,"Down",0.32469962260431,0.616919761924878,"L.PvsV.LINDGREN_BLADDER_CANCER_CLUSTER_1_DN"
51,"Up",0.324788501000013,0.616919761924878,"L.PvsV.EHLERS_ANEUPLOIDY_UP"
22,"Up",0.324806190443719,0.616919761924878,"L.PvsV.NADERI_BREAST_CANCER_PROGNOSIS_DN"
37,"Down",0.325067060029649,0.617037935251436,"L.PvsV.KEGG_HISTIDINE_METABOLISM"
149,"Up",0.325103828361404,0.617037935251436,"L.PvsV.ZHONG_SECRETOME_OF_LUNG_CANCER_AND_MACROPHAGE"
8,"Down",0.325347633739125,0.617037935251436,"L.PvsV.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_30"
165,"Down",0.325399973028086,0.617037935251436,"L.PvsV.NIKOLSKY_BREAST_CANCER_8Q12_Q22_AMPLICON"
74,"Down",0.325426409693107,0.617037935251436,"L.PvsV.NAKAJIMA_MAST_CELL"
377,"Down",0.32560284900518,0.617051523996027,"L.PvsV.MANALO_HYPOXIA_UP"
6,"Up",0.325656781881065,0.617051523996027,"L.PvsV.REACTOME_ACYL_CHAIN_REMODELING_OF_CL"
16,"Down",0.325962682650709,0.617216202473785,"L.PvsV.RADAEVA_RESPONSE_TO_IFNA1_DN"
45,"Up",0.325966958079843,0.617216202473785,"L.PvsV.PID_REELIN_PATHWAY"
80,"Up",0.326813783803752,0.618445480541001,"L.PvsV.HU_GENOTOXIC_DAMAGE_24HR"
16,"Down",0.327010351092378,0.618445480541001,"L.PvsV.BIOCARTA_PRC2_PATHWAY"
44,"Down",0.327062095138119,0.618445480541001,"L.PvsV.REACTOME_CA_DEPENDENT_EVENTS"
170,"Down",0.327063589275075,0.618445480541001,"L.PvsV.JI_RESPONSE_TO_FSH_UP"
86,"Down",0.327292842920182,0.618667394360918,"L.PvsV.GUILLAUMOND_KLF10_TARGETS_UP"
67,"Up",0.327441759425386,0.618737350602515,"L.PvsV.REACTOME_SIGNALING_BY_EGFR"
160,"Up",0.32769943479247,0.618989661880623,"L.PvsV.TAKAO_RESPONSE_TO_UVB_RADIATION_DN"
363,"Down",0.327799191533092,0.618989661880623,"L.PvsV.REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION"
757,"Down",0.328650464326431,0.620385256831968,"L.PvsV.SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP"
9,"Up",0.328911960962846,0.620623962286154,"L.PvsV.REACTOME_PROSTANOID_LIGAND_RECEPTORS"
38,"Down",0.329059959999877,0.620623962286154,"L.PvsV.DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_UP"
25,"Down",0.329113665657986,0.620623962286154,"L.PvsV.BIOCARTA_IFNA_PATHWAY"
41,"Down",0.330126176915521,0.622321047448319,"L.PvsV.BIOCARTA_P53HYPOXIA_PATHWAY"
586,"Down",0.330330481957685,0.622493945038869,"L.PvsV.KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN"
355,"Down",0.330820978859826,0.623205857620436,"L.PvsV.RIZKI_TUMOR_INVASIVENESS_3D_UP"
6,"Up",0.331165925934863,0.623502341576678,"L.PvsV.REACTOME_VLDL_ASSEMBLY"
22,"Up",0.331451051455875,0.623502341576678,"L.PvsV.PID_IL5_PATHWAY"
308,"Down",0.33150890182403,0.623502341576678,"L.PvsV.PLASARI_TGFB1_TARGETS_10HR_UP"
162,"Down",0.331547298814097,0.623502341576678,"L.PvsV.REACTOME_MEIOTIC_SYNAPSIS"
15,"Up",0.331571475120226,0.623502341576678,"L.PvsV.KANG_CISPLATIN_RESISTANCE_DN"
143,"Down",0.33169771009207,0.623502341576678,"L.PvsV.LIN_APC_TARGETS"
18,"Up",0.331767749849627,0.623502341576678,"L.PvsV.REACTOME_CONSTITUTIVE_SIGNALING_BY_OVEREXPRESSED_ERBB2"
114,"Down",0.332455866176202,0.624281191029352,"L.PvsV.GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_DN"
32,"Down",0.332570862738991,0.624281191029352,"L.PvsV.BIOCARTA_VIP_PATHWAY"
8,"Up",0.332768104756562,0.624281191029352,"L.PvsV.REACTOME_ACYL_CHAIN_REMODELING_OF_DAG_AND_TAG"
763,"Up",0.332804221793134,0.624281191029352,"L.PvsV.CAIRO_HEPATOBLASTOMA_CLASSES_UP"
426,"Down",0.333102730788707,0.624281191029352,"L.PvsV.GENTILE_UV_HIGH_DOSE_DN"
32,"Down",0.333190391592938,0.624281191029352,"L.PvsV.SAGIV_CD24_TARGETS_UP"
62,"Down",0.333302739937733,0.624281191029352,"L.PvsV.GREENBAUM_E2A_TARGETS_UP"
77,"Down",0.333344480737272,0.624281191029352,"L.PvsV.HAHTOLA_CTCL_CUTANEOUS"
60,"Up",0.333421274278981,0.624281191029352,"L.PvsV.LUI_THYROID_CANCER_PAX8_PPARG_DN"
23,"Down",0.333439002637552,0.624281191029352,"L.PvsV.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BROWN_UP"
117,"Up",0.333590207449932,0.624281191029352,"L.PvsV.KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION"
242,"Up",0.333673818746851,0.624281191029352,"L.PvsV.REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS"
9,"Up",0.333704542576411,0.624281191029352,"L.PvsV.REACTOME_REELIN_SIGNALLING_PATHWAY"
1037,"Up",0.333762922894332,0.624281191029352,"L.PvsV.CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_3"
173,"Up",0.333949381146316,0.624418710976659,"L.PvsV.HUANG_GATA2_TARGETS_DN"
10,"Up",0.334304150372275,0.624684884868986,"L.PvsV.KAPOSI_LIVER_CANCER_MET_DN"
19,"Up",0.334317701994453,0.624684884868986,"L.PvsV.HEIDENBLAD_AMPLIFIED_IN_SOFT_TISSUE_CANCER"
44,"Down",0.334844475095945,0.625457805001851,"L.PvsV.DAZARD_UV_RESPONSE_CLUSTER_G28"
15,"Down",0.335172686173479,0.625811988764738,"L.PvsV.REACTOME_REMOVAL_OF_AMINOTERMINAL_PROPEPTIDES_FROM_GAMMA_CARBOXYLATED_PROTEINS"
63,"Up",0.33526046495228,0.625811988764738,"L.PvsV.KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS"
60,"Down",0.336200582884752,0.627138496463779,"L.PvsV.REACTOME_AGGREPHAGY"
449,"Down",0.33627960588004,0.627138496463779,"L.PvsV.CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_4"
24,"Down",0.336323163001748,0.627138496463779,"L.PvsV.BIOCARTA_RACC_PATHWAY"
43,"Down",0.336461039121467,0.627138496463779,"L.PvsV.LIU_VAV3_PROSTATE_CARCINOGENESIS_DN"
89,"Down",0.336863926612828,0.627138496463779,"L.PvsV.GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_UP"
277,"Up",0.336917802278671,0.627138496463779,"L.PvsV.REACTOME_MITOTIC_METAPHASE_AND_ANAPHASE"
24,"Down",0.336920348579279,0.627138496463779,"L.PvsV.WONG_ENDOMETRIAL_CANCER_LATE"
5,"Up",0.336936119717317,0.627138496463779,"L.PvsV.REACTOME_TYROSINE_CATABOLISM"
84,"Up",0.336991946643857,0.627138496463779,"L.PvsV.BILANGES_SERUM_AND_RAPAMYCIN_SENSITIVE_GENES"
51,"Down",0.337314113836244,0.627526828869649,"L.PvsV.GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_DN"
110,"Down",0.337687104891898,0.628000613964042,"L.PvsV.LEE_LIVER_CANCER_MYC_DN"
18,"Up",0.337927770473595,0.628000613964042,"L.PvsV.PARK_TRETINOIN_RESPONSE"
21,"Down",0.338004561702409,0.628000613964042,"L.PvsV.SILIGAN_TARGETS_OF_EWS_FLI1_FUSION_UP"
110,"Up",0.338083789645516,0.628000613964042,"L.PvsV.STEARMAN_LUNG_CANCER_EARLY_VS_LATE_DN"
9,"Down",0.338159012841543,0.628000613964042,"L.PvsV.FUJIWARA_PARK2_IN_LIVER_CANCER_UP"
59,"Up",0.33825028547385,0.628000613964042,"L.PvsV.CAFFAREL_RESPONSE_TO_THC_24HR_5_UP"
178,"Up",0.338630581450017,0.628495631029589,"L.PvsV.LINDGREN_BLADDER_CANCER_WITH_LOH_IN_CHR9Q"
14,"Up",0.338812805088979,0.628622818569452,"L.PvsV.BIOCARTA_ASBCELL_PATHWAY"
96,"Up",0.338987684261155,0.628736298651435,"L.PvsV.PID_BCR_5PATHWAY"
636,"Up",0.339105883587302,0.628744611118106,"L.PvsV.RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP"
420,"Down",0.33978640588747,0.629672058845772,"L.PvsV.NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP"
10,"Down",0.339833862108118,0.629672058845772,"L.PvsV.REACTOME_FRUCTOSE_CATABOLISM"
59,"Down",0.34002857047849,0.62981125055343,"L.PvsV.WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2"
56,"Up",0.340136804874759,0.62981125055343,"L.PvsV.LIAN_NEUTROPHIL_GRANULE_CONSTITUENTS"
425,"Down",0.340356985880923,0.630007959469576,"L.PvsV.ALFANO_MYC_TARGETS"
60,"Down",0.340540602580212,0.630027679663646,"L.PvsV.BIOCARTA_FCER1_PATHWAY"
44,"Down",0.340595538888522,0.630027679663646,"L.PvsV.CHIARETTI_T_ALL_RELAPSE_PROGNOSIS"
11,"Up",0.341077246584339,0.630707724536727,"L.PvsV.REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_CASPASE_ACTIVATORS_AND_CASPASES"
50,"Up",0.341353139880176,0.630882104466424,"L.PvsV.PID_P38_ALPHA_BETA_DOWNSTREAM_PATHWAY"
233,"Up",0.341399757019993,0.630882104466424,"L.PvsV.RASHI_RESPONSE_TO_IONIZING_RADIATION_6"
290,"Up",0.342129228727107,0.631918148324224,"L.PvsV.GREGORY_SYNTHETIC_LETHAL_WITH_IMATINIB"
9,"Up",0.342221468515369,0.631918148324224,"L.PvsV.REACTOME_ACTIVATION_OF_PUMA_AND_TRANSLOCATION_TO_MITOCHONDRIA"
19,"Down",0.342363990804433,0.631918148324224,"L.PvsV.BIOCARTA_HSWI_SNF_PATHWAY"
12,"Down",0.342573426001146,0.631918148324224,"L.PvsV.REACTOME_ACTIVATION_OF_RAC1_DOWNSTREAM_OF_NMDARS"
106,"Down",0.342607612118139,0.631918148324224,"L.PvsV.REACTOME_RNA_POLYMERASE_I_PROMOTER_ESCAPE"
23,"Down",0.34278356990241,0.631918148324224,"L.PvsV.MARKS_HDAC_TARGETS_DN"
154,"Up",0.342834183747155,0.631918148324224,"L.PvsV.SASSON_RESPONSE_TO_GONADOTROPHINS_DN"
87,"Down",0.342874741358776,0.631918148324224,"L.PvsV.KEGG_TASTE_TRANSDUCTION"
309,"Down",0.343129772119599,0.632052851142713,"L.PvsV.CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_UP"
31,"Up",0.34317646213247,0.632052851142713,"L.PvsV.REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION"
246,"Up",0.343529539580661,0.632225625013918,"L.PvsV.ZHONG_SECRETOME_OF_LUNG_CANCER_AND_FIBROBLAST"
110,"Down",0.343571533167331,0.632225625013918,"L.PvsV.AMIT_SERUM_RESPONSE_240_MCF10A"
12,"Down",0.343613312202355,0.632225625013918,"L.PvsV.REACTOME_NONCANONICAL_ACTIVATION_OF_NOTCH3"
12,"Up",0.343980995824888,0.632557617919537,"L.PvsV.REACTOME_ARMS_MEDIATED_ACTIVATION"
169,"Up",0.344022564131678,0.632557617919537,"L.PvsV.REACTOME_HIV_LIFE_CYCLE"
1498,"Down",0.344204613394225,0.632578088285953,"L.PvsV.ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN"
67,"Down",0.344262519018346,0.632578088285953,"L.PvsV.BIOCARTA_TCR_PATHWAY"
63,"Down",0.344544953424182,0.632886726738307,"L.PvsV.TRAYNOR_RETT_SYNDROM_UP"
25,"Down",0.344725429871484,0.633007938146608,"L.PvsV.BOYAULT_LIVER_CANCER_SUBCLASS_G56_DN"
56,"Down",0.34493189913061,0.63317678296585,"L.PvsV.SIG_PIP3_SIGNALING_IN_B_LYMPHOCYTES"
1584,"Down",0.345525848644235,0.634056560621964,"L.PvsV.GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS"
19,"Down",0.345771182085827,0.634220526204607,"L.PvsV.REACTOME_TFAP2_AP_2_FAMILY_REGULATES_TRANSCRIPTION_OF_GROWTH_FACTORS_AND_THEIR_RECEPTORS"
19,"Up",0.345844616839734,0.634220526204607,"L.PvsV.REACTOME_SIGNAL_REGULATORY_PROTEIN_FAMILY_INTERACTIONS"
37,"Down",0.346801755157345,0.635756179318001,"L.PvsV.OLSSON_E2F3_TARGETS_UP"
81,"Up",0.346911990052886,0.635756179318001,"L.PvsV.DAZARD_UV_RESPONSE_CLUSTER_G2"
504,"Down",0.347217132383349,0.636104547696335,"L.PvsV.FARMER_BREAST_CANCER_BASAL_VS_LULMINAL"
106,"Down",0.347345087550848,0.636128184520913,"L.PvsV.GUO_HEX_TARGETS_DN"
36,"Up",0.347784031376028,0.636709690475897,"L.PvsV.WILENSKY_RESPONSE_TO_DARAPLADIB"
32,"Up",0.347892923662088,0.636709690475897,"L.PvsV.CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_HD_MTX_DN"
1060,"Up",0.348274441119663,0.637197016859899,"L.PvsV.MARTINEZ_RB1_AND_TP53_TARGETS_UP"
21,"Down",0.348480610067794,0.637217537623805,"L.PvsV.HUMMEL_BURKITTS_LYMPHOMA_DN"
142,"Down",0.348603456230365,0.637217537623805,"L.PvsV.MAHAJAN_RESPONSE_TO_IL1A_UP"
19,"Up",0.348695289942333,0.637217537623805,"L.PvsV.REACTOME_PROLONGED_ERK_ACTIVATION_EVENTS"
27,"Down",0.348851238325764,0.637217537623805,"L.PvsV.REACTOME_COMMON_PATHWAY_OF_FIBRIN_CLOT_FORMATION"
19,"Down",0.3488619074674,0.637217537623805,"L.PvsV.EHLERS_ANEUPLOIDY_DN"
81,"Up",0.349055234918612,0.637360103654229,"L.PvsV.SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_UP"
666,"Down",0.349346440428608,0.637681237745055,"L.PvsV.FOSTER_KDM1A_TARGETS_UP"
10,"Down",0.349559353711151,0.637793351230624,"L.PvsV.FERRARI_RESPONSE_TO_FENRETINIDE_DN"
1388,"Down",0.34963856892386,0.637793351230624,"L.PvsV.REACTOME_DEVELOPMENTAL_BIOLOGY"
11,"Down",0.349858865521072,0.637984718821243,"L.PvsV.VALK_AML_WITH_T_8_21_TRANSLOCATION"
7,"Up",0.350701122813254,0.63921506785076,"L.PvsV.TESAR_ALK_TARGETS_HUMAN_ES_4D_DN"
44,"Down",0.350880092143512,0.63921506785076,"L.PvsV.COLLIS_PRKDC_SUBSTRATES"
207,"Down",0.350880399878288,0.63921506785076,"L.PvsV.MCCLUNG_CREB1_TARGETS_UP"
48,"Down",0.351542509336947,0.6402103208577,"L.PvsV.CHIBA_RESPONSE_TO_TSA_DN"
35,"Down",0.351836433421238,0.640534619817591,"L.PvsV.WU_HBX_TARGETS_3_UP"
73,"Up",0.352933082317362,0.642261228071433,"L.PvsV.ENGELMANN_CANCER_PROGENITORS_UP"
42,"Down",0.353080604699687,0.642261228071433,"L.PvsV.REACTOME_G_PROTEIN_BETA_GAMMA_SIGNALLING"
18,"Down",0.35316819379019,0.642261228071433,"L.PvsV.FINETTI_BREAST_CANCER_KINOME_RED"
302,"Down",0.353249483553125,0.642261228071433,"L.PvsV.MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP"
236,"Down",0.35395331115452,0.642618917362706,"L.PvsV.BOSCO_ALLERGEN_INDUCED_TH2_ASSOCIATED_MODULE"
90,"Up",0.354030797054331,0.642618917362706,"L.PvsV.REACTOME_CYTOSOLIC_SENSORS_OF_PATHOGEN_ASSOCIATED_DNA"
18,"Up",0.354065885425773,0.642618917362706,"L.PvsV.MALIK_REPRESSED_BY_ESTROGEN"
97,"Up",0.354115775189108,0.642618917362706,"L.PvsV.WENG_POR_TARGETS_LIVER_UP"
47,"Up",0.354222316188871,0.642618917362706,"L.PvsV.KEGG_PRIMARY_IMMUNODEFICIENCY"
297,"Up",0.354264651525694,0.642618917362706,"L.PvsV.VANOEVELEN_MYOGENESIS_SIN3A_TARGETS"
196,"Up",0.354469767061379,0.642618917362706,"L.PvsV.SU_TESTIS"
59,"Up",0.354499657866776,0.642618917362706,"L.PvsV.GALLUZZI_PERMEABILIZE_MITOCHONDRIA"
67,"Down",0.354606085733185,0.642618917362706,"L.PvsV.ZHAN_MULTIPLE_MYELOMA_PR_DN"
25,"Down",0.354608485598411,0.642618917362706,"L.PvsV.FINETTI_BREAST_CANCER_KINOME_GREEN"
53,"Down",0.354798953126602,0.642657254293378,"L.PvsV.REACTOME_SIGNALING_BY_NOTCH2"
78,"Up",0.354983903917815,0.642657254293378,"L.PvsV.FAELT_B_CLL_WITH_VH3_21_UP"
412,"Down",0.355063076898461,0.642657254293378,"L.PvsV.BHAT_ESR1_TARGETS_VIA_AKT1_UP"
82,"Down",0.355094576210213,0.642657254293378,"L.PvsV.TUOMISTO_TUMOR_SUPPRESSION_BY_COL13A1_UP"
180,"Up",0.355353236874384,0.642770722241743,"L.PvsV.WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_UP"
20,"Up",0.355491813865559,0.642770722241743,"L.PvsV.BIOCARTA_PGC1A_PATHWAY"
18,"Down",0.355506035198996,0.642770722241743,"L.PvsV.REACTOME_NUCLEOBASE_BIOSYNTHESIS"
700,"Down",0.355701128951764,0.642913220651946,"L.PvsV.MARTENS_BOUND_BY_PML_RARA_FUSION"
7,"Down",0.356308621172386,0.643665083311723,"L.PvsV.REACTOME_CATION_COUPLED_CHLORIDE_COTRANSPORTERS"
431,"Down",0.356482742624685,0.643665083311723,"L.PvsV.BROWNE_HCMV_INFECTION_1HR_DN"
353,"Up",0.356555597999054,0.643665083311723,"L.PvsV.REACTOME_INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS"
152,"Up",0.356679258400772,0.643665083311723,"L.PvsV.LIAN_LIPA_TARGETS_6M"
123,"Down",0.356699188870884,0.643665083311723,"L.PvsV.LI_WILMS_TUMOR"
48,"Down",0.356820866537142,0.643674574578746,"L.PvsV.WANG_THOC1_TARGETS_DN"
30,"Down",0.356978152141598,0.643748272404075,"L.PvsV.KYNG_DNA_DAMAGE_BY_4NQO_OR_GAMMA_RADIATION"
138,"Down",0.357276046732853,0.643864302614637,"L.PvsV.LEIN_MEDULLA_MARKERS"
72,"Down",0.357433724170821,0.643864302614637,"L.PvsV.PARK_HSC_AND_MULTIPOTENT_PROGENITORS"
522,"Down",0.357464454446874,0.643864302614637,"L.PvsV.YANG_BCL3_TARGETS_UP"
31,"Down",0.357607256927307,0.643864302614637,"L.PvsV.REACTOME_EICOSANOIDS"
34,"Down",0.357624755530756,0.643864302614637,"L.PvsV.WANG_TNF_TARGETS"
654,"Down",0.357885744544385,0.644124440620411,"L.PvsV.THUM_SYSTOLIC_HEART_FAILURE_UP"
232,"Up",0.358111760191978,0.644321484575804,"L.PvsV.DER_IFN_GAMMA_RESPONSE_UP"
89,"Down",0.35835992726691,0.644453946153786,"L.PvsV.CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_UP"
12,"Up",0.358449222944752,0.644453946153786,"L.PvsV.REACTOME_CHYLOMICRON_ASSEMBLY"
73,"Up",0.358535058485991,0.644453946153786,"L.PvsV.ELLWOOD_MYC_TARGETS_DN"
7,"Down",0.358797943532323,0.6447168767599,"L.PvsV.REACTOME_DEFECTIVE_LFNG_CAUSES_SCDO3"
29,"Down",0.359007870589019,0.644884508280275,"L.PvsV.REACTOME_G_PROTEIN_ACTIVATION"
116,"Up",0.359529283663105,0.645611370371324,"L.PvsV.BAUS_TFF2_TARGETS_UP"
49,"Up",0.359677350420452,0.645667555348922,"L.PvsV.PID_MAPK_TRK_PATHWAY"
10,"Down",0.359872893938874,0.64579567036093,"L.PvsV.BYSTRYKH_HEMATOPOIESIS_STEM_CELL_FGF3"
26,"Down",0.359995993386055,0.64579567036093,"L.PvsV.PID_BETA_CATENIN_DEG_PATHWAY"
63,"Down",0.360099123118601,0.64579567036093,"L.PvsV.TSUNODA_CISPLATIN_RESISTANCE_DN"
30,"Up",0.360414978844805,0.646152535030133,"L.PvsV.REACTOME_SEALING_OF_THE_NUCLEAR_ENVELOPE_NE_BY_ESCRT_III"
5,"Down",0.360880723181328,0.646777801772954,"L.PvsV.REACTOME_FREE_FATTY_ACID_RECEPTORS"
7,"Down",0.361013776219171,0.646806600361567,"L.PvsV.REACTOME_PHASE_1_INACTIVATION_OF_FAST_NA_CHANNELS"
78,"Down",0.361194252189915,0.646920317576301,"L.PvsV.HANN_RESISTANCE_TO_BCL2_INHIBITOR_DN"
185,"Down",0.361805042547006,0.647417376834888,"L.PvsV.REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS"
41,"Up",0.36183996694129,0.647417376834888,"L.PvsV.VALK_AML_CLUSTER_16"
137,"Up",0.361870552503659,0.647417376834888,"L.PvsV.KYNG_DNA_DAMAGE_BY_GAMMA_RADIATION"
11,"Down",0.36204701875324,0.647417376834888,"L.PvsV.REACTOME_HIGHLY_CALCIUM_PERMEABLE_POSTSYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS"
17,"Down",0.362082870853035,0.647417376834888,"L.PvsV.BIOCARTA_RANKL_PATHWAY"
768,"Up",0.362174343742143,0.647417376834888,"L.PvsV.SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP"
118,"Down",0.362417835346891,0.647469877543938,"L.PvsV.KEGG_DRUG_METABOLISM_CYTOCHROME_P450"
53,"Down",0.362437922047113,0.647469877543938,"L.PvsV.EINAV_INTERFERON_SIGNATURE_IN_CANCER"
20,"Down",0.363096741618718,0.648437301165986,"L.PvsV.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_27"
29,"Down",0.363265355399862,0.648458694305532,"L.PvsV.MURAKAMI_UV_RESPONSE_1HR_UP"
113,"Down",0.363343287205379,0.648458694305532,"L.PvsV.CROMER_TUMORIGENESIS_UP"
93,"Down",0.363677380380679,0.648674025270997,"L.PvsV.REACTOME_ERCC6_CSB_AND_EHMT2_G9A_POSITIVELY_REGULATE_RRNA_EXPRESSION"
10,"Up",0.363698585339137,0.648674025270997,"L.PvsV.IKEDA_MIR1_TARGETS_DN"
38,"Up",0.364193461969622,0.649271700708816,"L.PvsV.KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_OLD"
87,"Down",0.364268550479064,0.649271700708816,"L.PvsV.BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN"
62,"Down",0.364808595720315,0.649755098895643,"L.PvsV.PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_DN"
190,"Down",0.364860350031267,0.649755098895643,"L.PvsV.KEGG_CALCIUM_SIGNALING_PATHWAY"
74,"Down",0.364892310014645,0.649755098895643,"L.PvsV.LEE_AGING_MUSCLE_UP"
13,"Down",0.365545951238574,0.650346777243627,"L.PvsV.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_29"
31,"Up",0.365606204496545,0.650346777243627,"L.PvsV.CARDOSO_RESPONSE_TO_GAMMA_RADIATION_AND_3AB"
18,"Down",0.365642096390634,0.650346777243627,"L.PvsV.NOUSHMEHR_GBM_GERMLINE_MUTATED"
25,"Down",0.365813913669776,0.650346777243627,"L.PvsV.NEBEN_AML_WITH_FLT3_OR_NRAS_DN"
73,"Up",0.365853510062695,0.650346777243627,"L.PvsV.WENG_POR_DOSAGE"
18,"Down",0.365930335323734,0.650346777243627,"L.PvsV.REACTOME_BLOOD_GROUP_SYSTEMS_BIOSYNTHESIS"
77,"Up",0.366412204340636,0.650993919601342,"L.PvsV.KEGG_COLORECTAL_CANCER"
26,"Down",0.36697310820066,0.651608844634611,"L.PvsV.GAVIN_IL2_RESPONSIVE_FOXP3_TARGETS_UP"
443,"Up",0.366994021015044,0.651608844634611,"L.PvsV.WEST_ADRENOCORTICAL_TUMOR_UP"
22,"Up",0.36712982577696,0.651640708417596,"L.PvsV.REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS"
41,"Down",0.367495032023617,0.651837493114481,"L.PvsV.GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_DN"
100,"Up",0.367495048409949,0.651837493114481,"L.PvsV.REACTOME_TRANSPORT_OF_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS"
32,"Up",0.367594375751664,0.651837493114481,"L.PvsV.REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR4"
168,"Up",0.367815070851786,0.652019726431396,"L.PvsV.NAKAMURA_ADIPOGENESIS_LATE_UP"
679,"Up",0.368033240882227,0.652197368217255,"L.PvsV.HSIAO_HOUSEKEEPING_GENES"
320,"Down",0.368347334127944,0.652544828706632,"L.PvsV.KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION"
7,"Up",0.368623845683766,0.652825510181147,"L.PvsV.REACTOME_VLDL_CLEARANCE"
55,"Up",0.369790630149217,0.654035078413421,"L.PvsV.KEGG_INOSITOL_PHOSPHATE_METABOLISM"
20,"Down",0.369865319836622,0.654035078413421,"L.PvsV.REACTOME_BUTYRATE_RESPONSE_FACTOR_1_BRF1_BINDS_AND_DESTABILIZES_MRNA"
19,"Down",0.369871121562169,0.654035078413421,"L.PvsV.BIOCARTA_EFP_PATHWAY"
421,"Down",0.369917350466131,0.654035078413421,"L.PvsV.KOYAMA_SEMA3B_TARGETS_UP"
87,"Up",0.369994744041664,0.654035078413421,"L.PvsV.KEGG_CHRONIC_MYELOID_LEUKEMIA"
69,"Up",0.370016589849372,0.654035078413421,"L.PvsV.PRAMOONJAGO_SOX4_TARGETS_UP"
140,"Down",0.370147744112689,0.654039028465988,"L.PvsV.LEIN_PONS_MARKERS"
9,"Up",0.370255409495124,0.654039028465988,"L.PvsV.REACTOME_AMPK_INHIBITS_CHREBP_TRANSCRIPTIONAL_ACTIVATION_ACTIVITY"
12,"Up",0.37053044086535,0.65405898088862,"L.PvsV.REACTOME_ACTIVATION_OF_THE_TFAP2_AP_2_FAMILY_OF_TRANSCRIPTION_FACTORS"
11,"Down",0.370619852698675,0.65405898088862,"L.PvsV.KOINUMA_COLON_CANCER_MSI_DN"
19,"Up",0.370621592896373,0.65405898088862,"L.PvsV.GALLUZZI_PREVENT_MITOCHONDIAL_PERMEABILIZATION"
140,"Down",0.370888065516868,0.654320393823473,"L.PvsV.REACTOME_MITOTIC_SPINDLE_CHECKPOINT"
35,"Down",0.371275065586622,0.654794206580043,"L.PvsV.KEGG_BASE_EXCISION_REPAIR"
366,"Down",0.371670359209484,0.655127335948187,"L.PvsV.GROSS_HYPOXIA_VIA_ELK3_UP"
10,"Up",0.371813680047701,0.655127335948187,"L.PvsV.REACTOME_LOSS_OF_FUNCTION_OF_SMAD2_3_IN_CANCER"
8,"Up",0.371819421270648,0.655127335948187,"L.PvsV.KIM_PTEN_TARGETS_DN"
32,"Up",0.372223802137322,0.65563090220365,"L.PvsV.REACTOME_INCRETIN_SYNTHESIS_SECRETION_AND_INACTIVATION"
89,"Up",0.372527693184385,0.655957202425625,"L.PvsV.KEGG_LONG_TERM_POTENTIATION"
84,"Up",0.37319167788033,0.656917156001383,"L.PvsV.REACTOME_INTERLEUKIN_17_SIGNALING"
93,"Down",0.373405848337674,0.657084957179821,"L.PvsV.SILIGAN_BOUND_BY_EWS_FLT1_FUSION"
132,"Down",0.373541297382228,0.657114169018879,"L.PvsV.REACTOME_SIGNALING_BY_VEGF"
848,"Down",0.374000101191111,0.657712010014521,"L.PvsV.MATSUDA_NATURAL_KILLER_DIFFERENTIATION"
21,"Up",0.374453317437218,0.65829964772985,"L.PvsV.TOMLINS_METASTASIS_UP"
89,"Down",0.374613578068975,0.658372051221667,"L.PvsV.PID_DELTA_NP63_PATHWAY"
95,"Up",0.374894390981516,0.658480514947658,"L.PvsV.FAELT_B_CLL_WITH_VH_REARRANGEMENTS_DN"
30,"Down",0.375002585779223,0.658480514947658,"L.PvsV.CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_UP"
23,"Down",0.375214612445554,0.658480514947658,"L.PvsV.REACTOME_THE_NLRP3_INFLAMMASOME"
48,"Down",0.3753677894206,0.658480514947658,"L.PvsV.REACTOME_NR1H3_NR1H2_REGULATE_GENE_EXPRESSION_LINKED_TO_CHOLESTEROL_TRANSPORT_AND_EFFLUX"
47,"Down",0.375368259966819,0.658480514947658,"L.PvsV.VALK_AML_CLUSTER_12"
10,"Down",0.375389868532288,0.658480514947658,"L.PvsV.REACTOME_E2F_ENABLED_INHIBITION_OF_PRE_REPLICATION_COMPLEX_FORMATION"
106,"Down",0.37580120064411,0.658724100428336,"L.PvsV.MARSON_FOXP3_TARGETS_UP"
27,"Down",0.375939256612894,0.658724100428336,"L.PvsV.BIOCARTA_STATHMIN_PATHWAY"
158,"Down",0.375999124918754,0.658724100428336,"L.PvsV.REACTOME_HATS_ACETYLATE_HISTONES"
7,"Down",0.376076330622959,0.658724100428336,"L.PvsV.REACTOME_NECTIN_NECL_TRANS_HETERODIMERIZATION"
17,"Up",0.37612443209482,0.658724100428336,"L.PvsV.REACTOME_PHOSPHORYLATION_SITE_MUTANTS_OF_CTNNB1_ARE_NOT_TARGETED_TO_THE_PROTEASOME_BY_THE_DESTRUCTION_COMPLEX"
9,"Down",0.376319110635743,0.658856352978158,"L.PvsV.KUWANO_RNA_STABILIZED_BY_NO"
65,"Down",0.376919914216208,0.659550736860546,"L.PvsV.HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_UP"
197,"Down",0.376954300683546,0.659550736860546,"L.PvsV.HUMMERICH_SKIN_CANCER_PROGRESSION_DN"
56,"Down",0.377149099143869,0.659682812137441,"L.PvsV.REACTOME_IRS_MEDIATED_SIGNALLING"
92,"Up",0.37733310151993,0.65973805334106,"L.PvsV.STARK_HYPPOCAMPUS_22Q11_DELETION_UP"
100,"Up",0.37745196805761,0.65973805334106,"L.PvsV.CADWELL_ATG16L1_TARGETS_DN"
13,"Up",0.377538650890055,0.65973805334106,"L.PvsV.KOBAYASHI_EGFR_SIGNALING_6HR_UP"
223,"Up",0.377787582805048,0.659964469298297,"L.PvsV.REACTOME_SEPARATION_OF_SISTER_CHROMATIDS"
122,"Down",0.377924967146932,0.659995939152048,"L.PvsV.ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN"
28,"Down",0.378155955815448,0.660190805084815,"L.PvsV.NIKOLSKY_BREAST_CANCER_22Q13_AMPLICON"
51,"Down",0.37873299223116,0.660397123642772,"L.PvsV.RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_DN"
74,"Up",0.37887454316971,0.660397123642772,"L.PvsV.BOYAULT_LIVER_CANCER_SUBCLASS_G3_DN"
142,"Down",0.379245530467168,0.660397123642772,"L.PvsV.REACTOME_VISUAL_PHOTOTRANSDUCTION"
107,"Down",0.379340017327771,0.660397123642772,"L.PvsV.REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS"
284,"Down",0.379424389679785,0.660397123642772,"L.PvsV.BIDUS_METASTASIS_UP"
82,"Down",0.379519543523653,0.660397123642772,"L.PvsV.PID_SHP2_PATHWAY"
119,"Up",0.379568177954384,0.660397123642772,"L.PvsV.MEISSNER_BRAIN_HCP_WITH_H3_UNMETHYLATED"
67,"Down",0.379615159923911,0.660397123642772,"L.PvsV.FIRESTEIN_CTNNB1_PATHWAY"
13,"Up",0.37967436722029,0.660397123642772,"L.PvsV.REACTOME_REGULATION_OF_LOCALIZATION_OF_FOXO_TRANSCRIPTION_FACTORS"
12,"Up",0.379761537857287,0.660397123642772,"L.PvsV.VANDESLUIS_NORMAL_EMBRYOS_UP"
66,"Down",0.379806259531034,0.660397123642772,"L.PvsV.KEGG_TYPE_II_DIABETES_MELLITUS"
43,"Down",0.379968787777403,0.660397123642772,"L.PvsV.REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN"
9,"Up",0.380085219594897,0.660397123642772,"L.PvsV.REACTOME_RELEASE_OF_HH_NP_FROM_THE_SECRETING_CELL"
43,"Down",0.38013570149627,0.660397123642772,"L.PvsV.REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS"
324,"Up",0.380172610026484,0.660397123642772,"L.PvsV.GRUETZMANN_PANCREATIC_CANCER_DN"
73,"Down",0.380185213339653,0.660397123642772,"L.PvsV.HUANG_FOXA2_TARGETS_UP"
15,"Down",0.380654800528999,0.661005148280413,"L.PvsV.YAMASHITA_SILENCED_BY_METHYLATION"
67,"Up",0.381001369504883,0.661007079420883,"L.PvsV.LANDIS_ERBB2_BREAST_TUMORS_65_DN"
746,"Down",0.381079794978632,0.661007079420883,"L.PvsV.MITSIADES_RESPONSE_TO_APLIDIN_UP"
735,"Down",0.381104604541314,0.661007079420883,"L.PvsV.BAELDE_DIABETIC_NEPHROPATHY_DN"
87,"Down",0.381468315862467,0.661007079420883,"L.PvsV.KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN"
142,"Down",0.38151744260549,0.661007079420883,"L.PvsV.QUINTENS_EMBRYONIC_BRAIN_RESPONSE_TO_IR"
401,"Down",0.381544812189592,0.661007079420883,"L.PvsV.WELCSH_BRCA1_TARGETS_UP"
36,"Down",0.381551698721994,0.661007079420883,"L.PvsV.REACTOME_FGFR2_ALTERNATIVE_SPLICING"
32,"Down",0.381612334511025,0.661007079420883,"L.PvsV.SILIGAN_TARGETS_OF_EWS_FLI1_FUSION_DN"
162,"Up",0.38179558594418,0.661117380108165,"L.PvsV.YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_6"
349,"Down",0.382007742234274,0.661277647718629,"L.PvsV.MIKKELSEN_MEF_ICP_WITH_H3K27ME3"
6,"Up",0.382892621582218,0.662386644386604,"L.PvsV.REACTOME_VASOPRESSIN_LIKE_RECEPTORS"
15,"Up",0.382948273288278,0.662386644386604,"L.PvsV.GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP"
23,"Up",0.383007795641883,0.662386644386604,"L.PvsV.REACTOME_NA_CL_DEPENDENT_NEUROTRANSMITTER_TRANSPORTERS"
44,"Down",0.383188358362378,0.662491692740959,"L.PvsV.YANG_BREAST_CANCER_ESR1_LASER_UP"
27,"Down",0.383417437789418,0.662506293249069,"L.PvsV.PHESSE_TARGETS_OF_APC_AND_MBD2_DN"
25,"Up",0.383436451147951,0.662506293249069,"L.PvsV.WANG_RECURRENT_LIVER_CANCER_UP"
14,"Down",0.383623368147312,0.662536418720173,"L.PvsV.BRUNEAU_HEART_GREAT_VESSELS_AND_VALVULOGENESIS"
38,"Down",0.383734680978766,0.662536418720173,"L.PvsV.KANG_AR_TARGETS_DN"
203,"Up",0.383922478019347,0.662536418720173,"L.PvsV.VERHAAK_GLIOBLASTOMA_NEURAL"
6,"Down",0.383933204119992,0.662536418720173,"L.PvsV.ISHIDA_TARGETS_OF_SYT_SSX_FUSIONS"
73,"Down",0.384707591265752,0.663458327514477,"L.PvsV.ZHAN_MULTIPLE_MYELOMA_HP_UP"
15,"Down",0.384806304029958,0.663458327514477,"L.PvsV.REACTOME_HYALURONAN_UPTAKE_AND_DEGRADATION"
71,"Down",0.385020076603253,0.663458327514477,"L.PvsV.MCBRYAN_PUBERTAL_BREAST_3_4WK_DN"
5,"Down",0.385080836895892,0.663458327514477,"L.PvsV.REACTOME_MUSCARINIC_ACETYLCHOLINE_RECEPTORS"
32,"Down",0.385108477645686,0.663458327514477,"L.PvsV.REACTOME_SEMA3A_PAK_DEPENDENT_AXON_REPULSION"
55,"Down",0.385187417493483,0.663458327514477,"L.PvsV.ROY_WOUND_BLOOD_VESSEL_DN"
21,"Up",0.385327104573405,0.663492233318703,"L.PvsV.MCBRYAN_TERMINAL_END_BUD_UP"
53,"Up",0.385514955352047,0.663609024950643,"L.PvsV.REACTOME_INOSITOL_PHOSPHATE_METABOLISM"
51,"Down",0.385824607008704,0.663935341472495,"L.PvsV.TERAO_AOX4_TARGETS_SKIN_DN"
13,"Down",0.38596014614817,0.663961931566033,"L.PvsV.PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_5"
47,"Up",0.386473051574167,0.664637481229727,"L.PvsV.REACTOME_NEGATIVE_REGULATION_OF_MAPK_PATHWAY"
26,"Up",0.386675377084477,0.664778656685346,"L.PvsV.BIOCARTA_BARRESTIN_PATHWAY"
114,"Up",0.386967478741627,0.665074041020346,"L.PvsV.KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS"
109,"Down",0.387350629285854,0.665525677228554,"L.PvsV.FIGUEROA_AML_METHYLATION_CLUSTER_5_DN"
34,"Down",0.387660170328299,0.665850600107228,"L.PvsV.KORKOLA_EMBRYONAL_CARCINOMA_DN"
83,"Down",0.388090551120118,0.66622111254912,"L.PvsV.PID_TXA2PATHWAY"
48,"Up",0.388116875297651,0.66622111254912,"L.PvsV.HOLLEMAN_ASPARAGINASE_RESISTANCE_B_ALL_UP"
168,"Down",0.388459629519332,0.666602511363248,"L.PvsV.LINDGREN_BLADDER_CANCER_CLUSTER_1_UP"
83,"Up",0.388822743203823,0.667018599805752,"L.PvsV.REACTOME_GLYCOLYSIS"
12,"Up",0.389131968013244,0.667332571742448,"L.PvsV.OHM_EMBRYONIC_CARCINOMA_UP"
24,"Up",0.389247159318031,0.667332571742448,"L.PvsV.BIOCARTA_ACTINY_PATHWAY"
54,"Down",0.389374813936689,0.667344496669545,"L.PvsV.REACTOME_SMOOTH_MUSCLE_CONTRACTION"
152,"Down",0.389787864161219,0.667845398496244,"L.PvsV.LEIN_MIDBRAIN_MARKERS"
74,"Up",0.389977460444028,0.667963252414818,"L.PvsV.KEGG_ACUTE_MYELOID_LEUKEMIA"
57,"Down",0.390171360910516,0.668088403367681,"L.PvsV.REACTOME_MET_PROMOTES_CELL_MOTILITY"
201,"Down",0.390463932613172,0.668382378767253,"L.PvsV.WIERENGA_STAT5A_TARGETS_GROUP1"
279,"Down",0.390869218098721,0.668834939587436,"L.PvsV.GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_UP"
72,"Down",0.39099105981862,0.668834939587436,"L.PvsV.ROESSLER_LIVER_CANCER_METASTASIS_DN"
17,"Up",0.391091220778836,0.668834939587436,"L.PvsV.FU_INTERACT_WITH_ALKBH8"
171,"Down",0.391722633415801,0.669550866806848,"L.PvsV.KEGG_WNT_SIGNALING_PATHWAY"
25,"Down",0.391752044514406,0.669550866806848,"L.PvsV.REACTOME_NUCLEOTIDE_SALVAGE"
69,"Down",0.391990721441447,0.669751761078418,"L.PvsV.CERIBELLI_GENES_INACTIVE_AND_BOUND_BY_NFY"
130,"Down",0.392154949802796,0.669811519048752,"L.PvsV.LEE_LIVER_CANCER_E2F1_UP"
22,"Down",0.392267986738987,0.669811519048752,"L.PvsV.REACTOME_GRB2_SOS_PROVIDES_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS"
30,"Up",0.393241344597733,0.671162881534679,"L.PvsV.PID_INTEGRIN_A9B1_PATHWAY"
62,"Down",0.393302176916687,0.671162881534679,"L.PvsV.REACTOME_SIGNALING_BY_SCF_KIT"
161,"Down",0.393593595947596,0.671452944151268,"L.PvsV.SESTO_RESPONSE_TO_UV_C8"
645,"Down",0.394141896039554,0.672092959370087,"L.PvsV.MONNIER_POSTRADIATION_TUMOR_ESCAPE_DN"
429,"Down",0.394321192813987,0.672092959370087,"L.PvsV.HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN"
9,"Up",0.394333434653023,0.672092959370087,"L.PvsV.TESAR_ALK_TARGETS_HUMAN_ES_5D_DN"
13,"Up",0.394629257124682,0.672275354005764,"L.PvsV.SASAKI_TARGETS_OF_TP73_AND_TP63"
109,"Down",0.394858054221074,0.672275354005764,"L.PvsV.ENGELMANN_CANCER_PROGENITORS_DN"
33,"Down",0.394932396068101,0.672275354005764,"L.PvsV.BILANGES_SERUM_SENSITIVE_VIA_TSC1"
14,"Down",0.39519550191247,0.672275354005764,"L.PvsV.BIOCARTA_LECTIN_PATHWAY"
165,"Up",0.395378521760966,0.672275354005764,"L.PvsV.REACTOME_MITOTIC_G1_PHASE_AND_G1_S_TRANSITION"
20,"Up",0.395605423554868,0.672275354005764,"L.PvsV.REACTOME_MAP3K8_TPL2_DEPENDENT_MAPK1_3_ACTIVATION"
36,"Up",0.395714060743282,0.672275354005764,"L.PvsV.REACTOME_SIGNALING_BY_EGFR_IN_CANCER"
45,"Down",0.395793928204529,0.672275354005764,"L.PvsV.ABE_VEGFA_TARGETS_2HR"
23,"Down",0.395900497935971,0.672275354005764,"L.PvsV.DING_LUNG_CANCER_MUTATED_FREQUENTLY"
17,"Down",0.39594658639311,0.672275354005764,"L.PvsV.BIOCARTA_MONOCYTE_PATHWAY"
41,"Up",0.395947689164897,0.672275354005764,"L.PvsV.REACTOME_CD28_CO_STIMULATION"
24,"Up",0.396022713840368,0.672275354005764,"L.PvsV.HOLLEMAN_DAUNORUBICIN_B_ALL_UP"
60,"Down",0.396046413598234,0.672275354005764,"L.PvsV.REACTOME_NCAM1_INTERACTIONS"
12,"Down",0.396225413170897,0.672275354005764,"L.PvsV.REACTOME_ROLE_OF_ABL_IN_ROBO_SLIT_SIGNALING"
6,"Down",0.396366599166097,0.672275354005764,"L.PvsV.REACTOME_VITAMINS"
9,"Up",0.396385902343785,0.672275354005764,"L.PvsV.REACTOME_TRANSPORT_OF_NUCLEOTIDE_SUGARS"
34,"Up",0.39728894358377,0.673405534733426,"L.PvsV.BIOCARTA_RAS_PATHWAY"
116,"Down",0.39729586802323,0.673405534733426,"L.PvsV.ZHAN_MULTIPLE_MYELOMA_DN"
465,"Down",0.397577563357448,0.673676478027377,"L.PvsV.RICKMAN_METASTASIS_UP"
29,"Up",0.397984201774564,0.6740479464536,"L.PvsV.KEGG_ASCORBATE_AND_ALDARATE_METABOLISM"
4,"Up",0.398040612257371,0.6740479464536,"L.PvsV.REACTOME_METALLOTHIONEINS_BIND_METALS"
46,"Up",0.398247537106042,0.674191865480498,"L.PvsV.HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_DN"
125,"Down",0.398424547183377,0.674224932598326,"L.PvsV.IVANOVSKA_MIR106B_TARGETS"
26,"Down",0.398510956724784,0.674224932598326,"L.PvsV.REACTOME_THROMBOXANE_SIGNALLING_THROUGH_TP_RECEPTOR"
35,"Down",0.398751012884067,0.674424701815849,"L.PvsV.BIOCARTA_MCALPAIN_PATHWAY"
7,"Down",0.399012351053402,0.674474301858975,"L.PvsV.REACTOME_RAS_SIGNALING_DOWNSTREAM_OF_NF1_LOSS_OF_FUNCTION_VARIANTS"
59,"Up",0.399205585700716,0.674474301858975,"L.PvsV.GYORFFY_MITOXANTRONE_RESISTANCE"
12,"Up",0.39922395852677,0.674474301858975,"L.PvsV.BIOCARTA_EOSINOPHILS_PATHWAY"
63,"Down",0.399268292635997,0.674474301858975,"L.PvsV.REACTOME_SIGNALING_BY_TYPE_1_INSULIN_LIKE_GROWTH_FACTOR_1_RECEPTOR_IGF1R"
21,"Down",0.399913340393478,0.675357623407312,"L.PvsV.REACTOME_ERYTHROPOIETIN_ACTIVATES_RAS"
1397,"Up",0.400251122093612,0.675381965703971,"L.PvsV.ACEVEDO_LIVER_CANCER_UP"
23,"Down",0.400263709834758,0.675381965703971,"L.PvsV.LY_AGING_MIDDLE_UP"
159,"Down",0.400294212626499,0.675381965703971,"L.PvsV.MAHAJAN_RESPONSE_TO_IL1A_DN"
63,"Down",0.400834130407248,0.676086609829675,"L.PvsV.GAUSSMANN_MLL_AF4_FUSION_TARGETS_D_UP"
26,"Down",0.401713902708876,0.677363881694839,"L.PvsV.AMIT_DELAYED_EARLY_GENES"
90,"Down",0.401934484554179,0.677529196676846,"L.PvsV.PID_LYSOPHOSPHOLIPID_PATHWAY"
90,"Up",0.402321516972708,0.677965138055287,"L.PvsV.ZHANG_RESPONSE_TO_CANTHARIDIN_DN"
892,"Down",0.402438340223811,0.677965138055287,"L.PvsV.IVANOVA_HEMATOPOIESIS_STEM_CELL_AND_PROGENITOR"
140,"Up",0.402652826690818,0.678001736639749,"L.PvsV.REACTOME_NONSENSE_MEDIATED_DECAY_NMD"
92,"Down",0.402705317982445,0.678001736639749,"L.PvsV.PID_TRKR_PATHWAY"
731,"Up",0.403424018284926,0.678805598064622,"L.PvsV.TIEN_INTESTINE_PROBIOTICS_24HR_UP"
33,"Up",0.403455848848338,0.678805598064622,"L.PvsV.REACTOME_DEADENYLATION_OF_MRNA"
81,"Down",0.403551094382061,0.678805598064622,"L.PvsV.RASHI_RESPONSE_TO_IONIZING_RADIATION_1"
48,"Up",0.403983838589471,0.679326838066053,"L.PvsV.REACTOME_LATE_ENDOSOMAL_MICROAUTOPHAGY"
14,"Down",0.404417677343144,0.679542708434553,"L.PvsV.WEBER_METHYLATED_LCP_IN_FIBROBLAST_UP"
36,"Up",0.404437811201478,0.679542708434553,"L.PvsV.PID_ECADHERIN_KERATINOCYTE_PATHWAY"
31,"Down",0.404480928460502,0.679542708434553,"L.PvsV.REACTOME_POU5F1_OCT4_SOX2_NANOG_ACTIVATE_GENES_RELATED_TO_PROLIFERATION"
144,"Up",0.40501804942406,0.680238394673642,"L.PvsV.YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_9"
181,"Down",0.405739827642616,0.681243700891596,"L.PvsV.NIKOLSKY_MUTATED_AND_AMPLIFIED_IN_BREAST_CANCER"
206,"Up",0.405980593296721,0.681441014067265,"L.PvsV.HOLLERN_EMT_BREAST_TUMOR_DN"
21,"Down",0.406134793710648,0.681492951267428,"L.PvsV.DELASERNA_TARGETS_OF_MYOD_AND_SMARCA4"
150,"Down",0.406650552726876,0.682151367119811,"L.PvsV.JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP"
13,"Down",0.406784381975505,0.682168895341997,"L.PvsV.TESAR_ALK_TARGETS_EPISC_3D_UP"
39,"Down",0.407267000914371,0.682365414893075,"L.PvsV.PID_VEGFR1_PATHWAY"
181,"Up",0.407406872335938,0.682365414893075,"L.PvsV.REACTOME_REGULATION_OF_TP53_ACTIVITY"
28,"Up",0.407426770478916,0.682365414893075,"L.PvsV.HOLLEMAN_PREDNISOLONE_RESISTANCE_B_ALL_UP"
1873,"Down",0.407483414352274,0.682365414893075,"L.PvsV.DODD_NASOPHARYNGEAL_CARCINOMA_DN"
39,"Up",0.407518647129125,0.682365414893075,"L.PvsV.REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_ACETYLATION"
92,"Up",0.407720387992726,0.682496525949676,"L.PvsV.KEGG_ERBB_SIGNALING_PATHWAY"
35,"Up",0.408061154405565,0.682719649547522,"L.PvsV.HAHTOLA_MYCOSIS_FUNGOIDES_DN"
271,"Down",0.408100640577783,0.682719649547522,"L.PvsV.PHONG_TNF_RESPONSE_VIA_P38_PARTIAL"
39,"Down",0.408610831081103,0.6833663899115,"L.PvsV.BIOCARTA_RACCYCD_PATHWAY"
521,"Down",0.409028451179931,0.683857969934635,"L.PvsV.WALLACE_PROSTATE_CANCER_RACE_UP"
194,"Down",0.409155929088156,0.68386430832177,"L.PvsV.GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_DN"
67,"Down",0.40932545981784,0.683940908834341,"L.PvsV.HUMMEL_BURKITTS_LYMPHOMA_UP"
44,"Down",0.409486524952118,0.683981534581549,"L.PvsV.LOPEZ_MESOTHELIOMA_SURVIVAL_DN"
8,"Up",0.409647416291452,0.683981534581549,"L.PvsV.HOLLEMAN_DAUNORUBICIN_ALL_DN"
43,"Down",0.409901715043464,0.683981534581549,"L.PvsV.VALK_AML_WITH_EVI1"
129,"Down",0.410035398838582,0.683981534581549,"L.PvsV.SEKI_INFLAMMATORY_RESPONSE_LPS_UP"
97,"Down",0.410288315318957,0.683981534581549,"L.PvsV.REACTOME_ACTIVATED_PKN1_STIMULATES_TRANSCRIPTION_OF_AR_ANDROGEN_RECEPTOR_REGULATED_GENES_KLK2_AND_KLK3"
171,"Down",0.410310409354568,0.683981534581549,"L.PvsV.WOOD_EBV_EBNA1_TARGETS_UP"
51,"Up",0.410325125578929,0.683981534581549,"L.PvsV.PID_ERBB1_RECEPTOR_PROXIMAL_PATHWAY"
45,"Up",0.410339437548742,0.683981534581549,"L.PvsV.REACTOME_OVARIAN_TUMOR_DOMAIN_PROTEASES"
302,"Down",0.410618343576175,0.684061434733452,"L.PvsV.XU_GH1_AUTOCRINE_TARGETS_UP"
12,"Down",0.410634816762584,0.684061434733452,"L.PvsV.NIKOLSKY_BREAST_CANCER_20P13_AMPLICON"
12,"Down",0.411058552048869,0.684411034575772,"L.PvsV.REACTOME_ACTIVATION_OF_THE_AP_1_FAMILY_OF_TRANSCRIPTION_FACTORS"
30,"Up",0.411106409189738,0.684411034575772,"L.PvsV.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_17"
12,"Up",0.411216034881663,0.684411034575772,"L.PvsV.REACTOME_MYOCLONIC_EPILEPSY_OF_LAFORA"
116,"Down",0.411654861221331,0.68469839827601,"L.PvsV.RASHI_RESPONSE_TO_IONIZING_RADIATION_4"
20,"Down",0.411699603208105,0.68469839827601,"L.PvsV.REACTOME_CD28_DEPENDENT_VAV1_PATHWAY"
15,"Up",0.411908400675042,0.68469839827601,"L.PvsV.REACTOME_LIPOPHAGY"
80,"Down",0.41198323262851,0.68469839827601,"L.PvsV.LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_DN"
438,"Down",0.412007880460171,0.68469839827601,"L.PvsV.OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN"
8,"Up",0.41214423111608,0.684719186851204,"L.PvsV.CHENG_TAF7L_TARGETS"
40,"Up",0.412500070008934,0.685104501976389,"L.PvsV.CHOW_RASSF1_TARGETS_DN"
23,"Down",0.41263021887971,0.68511485891469,"L.PvsV.REACTOME_CHL1_INTERACTIONS"
62,"Up",0.412872340442741,0.685311068840563,"L.PvsV.REACTOME_FORMATION_OF_RNA_POL_II_ELONGATION_COMPLEX"
30,"Up",0.413277666888587,0.685777977259004,"L.PvsV.IWANAGA_E2F1_TARGETS_INDUCED_BY_SERUM"
19,"Down",0.413782554197245,0.686118426645761,"L.PvsV.REACTOME_KSRP_KHSRP_BINDS_AND_DESTABILIZES_MRNA"
44,"Up",0.413812597681674,0.686118426645761,"L.PvsV.VALK_AML_CLUSTER_7"
20,"Down",0.413985787963487,0.686118426645761,"L.PvsV.BIOCARTA_CBL_PATHWAY"
69,"Down",0.41422220951534,0.686118426645761,"L.PvsV.APPIERTO_RESPONSE_TO_FENRETINIDE_UP"
110,"Up",0.414320920799948,0.686118426645761,"L.PvsV.MATZUK_MEIOTIC_AND_DNA_REPAIR"
13,"Down",0.414333363993138,0.686118426645761,"L.PvsV.MCCOLLUM_GELDANAMYCIN_RESISTANCE_DN"
15,"Down",0.414351496937999,0.686118426645761,"L.PvsV.BIOCARTA_PTC1_PATHWAY"
46,"Up",0.415306874216363,0.687350735117353,"L.PvsV.YAMASHITA_LIVER_CANCER_WITH_EPCAM_DN"
386,"Down",0.415344330986992,0.687350735117353,"L.PvsV.KONDO_PROSTATE_CANCER_WITH_H3K27ME3"
79,"Down",0.415531322185168,0.687454422609752,"L.PvsV.PID_TAP63_PATHWAY"
8,"Down",0.415825177409279,0.687556490226647,"L.PvsV.REACTOME_DEFECTIVE_B4GALT1_CAUSES_B4GALT1_CDG_CDG_2D"
51,"Up",0.415981157738215,0.687556490226647,"L.PvsV.BILANGES_SERUM_RESPONSE_TRANSLATION"
21,"Down",0.416024176753805,0.687556490226647,"L.PvsV.REACTOME_FRS_MEDIATED_FGFR3_SIGNALING"
35,"Down",0.416090435214028,0.687556490226647,"L.PvsV.SHARMA_PILOCYTIC_ASTROCYTOMA_LOCATION_UP"
8,"Down",0.416515206396114,0.687848063896085,"L.PvsV.REACTOME_SUPPRESSION_OF_APOPTOSIS"
17,"Up",0.416536537906353,0.687848063896085,"L.PvsV.SHI_SPARC_TARGETS_DN"
89,"Up",0.416640109601734,0.687848063896085,"L.PvsV.SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES"
56,"Up",0.416857010882122,0.687850546741994,"L.PvsV.BIOCARTA_ERK_PATHWAY"
607,"Down",0.416890429034622,0.687850546741994,"L.PvsV.SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP"
98,"Up",0.417151232215183,0.687925986777735,"L.PvsV.KIM_LRRC3B_TARGETS"
37,"Up",0.417270502465946,0.687925986777735,"L.PvsV.REACTOME_DOWNREGULATION_OF_SMAD2_3_SMAD4_TRANSCRIPTIONAL_ACTIVITY"
9,"Down",0.417309415744714,0.687925986777735,"L.PvsV.REACTOME_SMALL_INTERFERING_RNA_SIRNA_BIOGENESIS"
161,"Down",0.417631629448944,0.688251946117201,"L.PvsV.VANLOO_SP3_TARGETS_DN"
35,"Down",0.418130796152644,0.688869240741349,"L.PvsV.PID_RXR_VDR_PATHWAY"
1302,"Down",0.418368271583505,0.689055160436462,"L.PvsV.SMID_BREAST_CANCER_BASAL_UP"
230,"Up",0.418664562452406,0.689201434541742,"L.PvsV.ZHANG_BREAST_CANCER_PROGENITORS_DN"
46,"Up",0.418706387886727,0.689201434541742,"L.PvsV.PID_ANTHRAX_PATHWAY"
17,"Up",0.418999903974903,0.689479306272987,"L.PvsV.REACTOME_DISEASES_ASSOCIATED_WITH_SURFACTANT_METABOLISM"
116,"Down",0.420041620511901,0.690710155378086,"L.PvsV.JAIN_NFKB_SIGNALING"
107,"Up",0.420072163272477,0.690710155378086,"L.PvsV.GAURNIER_PSMD4_TARGETS"
411,"Down",0.420122671827908,0.690710155378086,"L.PvsV.GRADE_COLON_AND_RECTAL_CANCER_UP"
278,"Up",0.420528797285801,0.691047052821825,"L.PvsV.REACTOME_SIGNALING_BY_ROBO_RECEPTORS"
231,"Down",0.420904150042201,0.691047052821825,"L.PvsV.BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_DN"
10,"Up",0.420914625450248,0.691047052821825,"L.PvsV.CHANG_POU5F1_TARGETS_DN"
56,"Down",0.420992749160847,0.691047052821825,"L.PvsV.DAIRKEE_CANCER_PRONE_RESPONSE_E2"
173,"Down",0.421159451538729,0.691047052821825,"L.PvsV.LIM_MAMMARY_LUMINAL_MATURE_DN"
16,"Up",0.421180736434763,0.691047052821825,"L.PvsV.REACTOME_ROLE_OF_SECOND_MESSENGERS_IN_NETRIN_1_SIGNALING"
303,"Down",0.421284725973744,0.691047052821825,"L.PvsV.REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA"
15,"Down",0.421443031246193,0.691047052821825,"L.PvsV.BIOCARTA_ERYTH_PATHWAY"
31,"Down",0.42145246194885,0.691047052821825,"L.PvsV.REACTOME_INTERLEUKIN_RECEPTOR_SHC_SIGNALING"
64,"Up",0.421732527512003,0.691301258409092,"L.PvsV.REACTOME_RAB_GERANYLGERANYLATION"
31,"Down",0.4219285074696,0.691417521576591,"L.PvsV.PID_WNT_CANONICAL_PATHWAY"
482,"Down",0.422982851021148,0.692939906161757,"L.PvsV.HOLLMANN_APOPTOSIS_VIA_CD40_DN"
145,"Up",0.423180569802718,0.69298178266245,"L.PvsV.MORI_PRE_BI_LYMPHOCYTE_DN"
35,"Down",0.423334168286622,0.69298178266245,"L.PvsV.REACTOME_GLUCAGON_SIGNALING_IN_METABOLIC_REGULATION"
246,"Down",0.423384420660835,0.69298178266245,"L.PvsV.SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP"
53,"Down",0.424032014236234,0.693763827770158,"L.PvsV.WANG_METASTASIS_OF_BREAST_CANCER_ESR1_DN"
70,"Down",0.424222574413817,0.693763827770158,"L.PvsV.ZHAN_MULTIPLE_MYELOMA_MS_UP"
24,"Up",0.424238651056413,0.693763827770158,"L.PvsV.HOLLEMAN_VINCRISTINE_RESISTANCE_B_ALL_DN"
63,"Up",0.424651887813462,0.69394367471954,"L.PvsV.REACTOME_EPHB_MEDIATED_FORWARD_SIGNALING"
54,"Down",0.424676515341846,0.69394367471954,"L.PvsV.PLASARI_TGFB1_SIGNALING_VIA_NFIC_10HR_DN"
31,"Up",0.424725157397527,0.69394367471954,"L.PvsV.MEINHOLD_OVARIAN_CANCER_LOW_GRADE_DN"
99,"Down",0.425120428551892,0.694384298216665,"L.PvsV.GHANDHI_BYSTANDER_IRRADIATION_UP"
9,"Down",0.425459084606107,0.694732214644763,"L.PvsV.REACTOME_DEFECTIVE_CHSY1_CAUSES_TPBS"
68,"Up",0.425822871474456,0.695120949625706,"L.PvsV.BRACHAT_RESPONSE_TO_CAMPTOTHECIN_DN"
18,"Up",0.42631223566816,0.695714389317962,"L.PvsV.CHIN_BREAST_CANCER_COPY_NUMBER_DN"
48,"Down",0.426736272700736,0.696200900490519,"L.PvsV.HEIDENBLAD_AMPLICON_12P11_12_UP"
26,"Up",0.426897322247411,0.6962581990283,"L.PvsV.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_DN"
28,"Up",0.427108307702441,0.696396883894661,"L.PvsV.REACTOME_SIGNALING_BY_PDGFR_IN_DISEASE"
16,"Down",0.427633908640826,0.696883045346586,"L.PvsV.KEGG_OTHER_GLYCAN_DEGRADATION"
110,"Up",0.427658559027124,0.696883045346586,"L.PvsV.POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_UP"
140,"Down",0.427992846299199,0.697222288505677,"L.PvsV.REACTOME_ADORA2B_MEDIATED_ANTI_INFLAMMATORY_CYTOKINES_PRODUCTION"
27,"Down",0.428606868776461,0.698016900578808,"L.PvsV.MOREIRA_RESPONSE_TO_TSA_DN"
30,"Down",0.430122520034873,0.700278979173384,"L.PvsV.YIH_RESPONSE_TO_ARSENITE_C2"
14,"Up",0.430679175347257,0.700938354867992,"L.PvsV.BIOCARTA_FXR_PATHWAY"
8,"Down",0.430856179375993,0.700938354867992,"L.PvsV.REACTOME_COMPETING_ENDOGENOUS_RNAS_CERNAS_REGULATE_PTEN_TRANSLATION"
175,"Down",0.430965843603967,0.700938354867992,"L.PvsV.REACTOME_INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING"
829,"Up",0.431181810908122,0.700938354867992,"L.PvsV.IVANOVA_HEMATOPOIESIS_LATE_PROGENITOR"
67,"Up",0.431322440199493,0.700938354867992,"L.PvsV.CHESLER_BRAIN_HIGHEST_EXPRESSION"
1122,"Down",0.431408204799014,0.700938354867992,"L.PvsV.RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP"
119,"Up",0.431414943319909,0.700938354867992,"L.PvsV.REACTOME_RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY"
41,"Down",0.431663914332494,0.701136833826192,"L.PvsV.ABE_VEGFA_TARGETS_30MIN"
32,"Up",0.432045736383328,0.701335221984454,"L.PvsV.MARIADASON_RESPONSE_TO_CURCUMIN_SULINDAC_5"
65,"Up",0.432225794659703,0.701335221984454,"L.PvsV.PID_TCPTP_PATHWAY"
138,"Down",0.432260585791505,0.701335221984454,"L.PvsV.BONCI_TARGETS_OF_MIR15A_AND_MIR16_1"
73,"Up",0.432293441223191,0.701335221984454,"L.PvsV.LIAO_HAVE_SOX4_BINDING_SITES"
18,"Down",0.432689770709417,0.701772291655139,"L.PvsV.BIOCARTA_CLASSIC_PATHWAY"
66,"Down",0.433409473344205,0.702340083883891,"L.PvsV.JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_DN"
70,"Down",0.433462773568836,0.702340083883891,"L.PvsV.ZHAN_MULTIPLE_MYELOMA_CD1_DN"
6,"Up",0.433529424319225,0.702340083883891,"L.PvsV.REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_TO_LIMIT_CHOLESTEROL_UPTAKE"
27,"Down",0.43357237032234,0.702340083883891,"L.PvsV.LEIN_LOCALIZED_TO_DISTAL_AND_PROXIMAL_DENDRITES"
49,"Down",0.433677714646922,0.702340083883891,"L.PvsV.PID_WNT_NONCANONICAL_PATHWAY"
15,"Down",0.433994360282884,0.702340083883891,"L.PvsV.GOUYER_TATI_TARGETS_UP"
334,"Down",0.434022348127028,0.702340083883891,"L.PvsV.KIM_WT1_TARGETS_UP"
14,"Up",0.434056080056295,0.702340083883891,"L.PvsV.REACTOME_SUMOYLATION_OF_IMMUNE_RESPONSE_PROTEINS"
46,"Down",0.434245267746227,0.702440633519277,"L.PvsV.KEGG_NUCLEOTIDE_EXCISION_REPAIR"
129,"Down",0.434779852245848,0.703027431630154,"L.PvsV.REACTOME_RNA_POLYMERASE_I_TRANSCRIPTION"
111,"Up",0.434862328843394,0.703027431630154,"L.PvsV.BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_DN"
134,"Down",0.435236439930894,0.703325061584412,"L.PvsV.CHICAS_RB1_TARGETS_LOW_SERUM"
26,"Down",0.43531469063859,0.703325061584412,"L.PvsV.OHASHI_AURKB_TARGETS"
406,"Up",0.435428049521332,0.703325061584412,"L.PvsV.MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN"
820,"Down",0.435626995316801,0.703440904528795,"L.PvsV.SENESE_HDAC3_TARGETS_UP"
42,"Down",0.435908835941211,0.703690497494585,"L.PvsV.REACTOME_SIGNALING_BY_WNT_IN_CANCER"
12,"Up",0.436085707383625,0.70377054177585,"L.PvsV.MATZUK_MATERNAL_EFFECT"
12,"Down",0.436361437675602,0.703939328886547,"L.PvsV.REACTOME_PREGNENOLONE_BIOSYNTHESIS"
200,"Down",0.436444930262811,0.703939328886547,"L.PvsV.ELVIDGE_HYPOXIA_BY_DMOG_UP"
57,"Down",0.436845043105826,0.704208912508113,"L.PvsV.PID_ATM_PATHWAY"
1549,"Up",0.436901654476116,0.704208912508113,"L.PvsV.DANG_BOUND_BY_MYC"
19,"Up",0.437021148836793,0.704208912508113,"L.PvsV.BIOCARTA_BLYMPHOCYTE_PATHWAY"
44,"Up",0.437121538746219,0.704208912508113,"L.PvsV.REACTOME_METABOLISM_OF_STEROID_HORMONES"
32,"Up",0.437439748330492,0.704516273964256,"L.PvsV.REACTOME_TICAM1_RIP1_MEDIATED_IKK_COMPLEX_RECRUITMENT"
22,"Down",0.438004576299532,0.705220530681454,"L.PvsV.ISHIKAWA_STING_SIGNALING"
10,"Up",0.43826096623392,0.705237631617429,"L.PvsV.REACTOME_MET_ACTIVATES_PI3K_AKT_SIGNALING"
115,"Down",0.438270302448451,0.705237631617429,"L.PvsV.COLDREN_GEFITINIB_RESISTANCE_UP"
969,"Down",0.438461773361375,0.70534045531424,"L.PvsV.RAO_BOUND_BY_SALL4_ISOFORM_B"
19,"Down",0.438799519374644,0.705433119582522,"L.PvsV.REACTOME_SHC_MEDIATED_CASCADE_FGFR3"
9,"Down",0.438803471385792,0.705433119582522,"L.PvsV.REACTOME_SOS_MEDIATED_SIGNALLING"
35,"Up",0.438902139874096,0.705433119582522,"L.PvsV.HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_DN"
1169,"Down",0.439204254216276,0.705684157809459,"L.PvsV.JOHNSTONE_PARVB_TARGETS_3_DN"
279,"Down",0.439313595800354,0.705684157809459,"L.PvsV.PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_DN"
81,"Up",0.439699405400219,0.705987604712763,"L.PvsV.REACTOME_COSTIMULATION_BY_THE_CD28_FAMILY"
765,"Down",0.439936640561028,0.705987604712763,"L.PvsV.SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN"
53,"Down",0.440010791185735,0.705987604712763,"L.PvsV.REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS"
87,"Down",0.440013254809221,0.705987604712763,"L.PvsV.WANG_BARRETTS_ESOPHAGUS_UP"
42,"Down",0.440649914517753,0.706711559710296,"L.PvsV.BONOME_OVARIAN_CANCER_POOR_SURVIVAL_DN"
117,"Down",0.44084547498537,0.706711559710296,"L.PvsV.RIZKI_TUMOR_INVASIVENESS_2D_UP"
21,"Down",0.44084792357403,0.706711559710296,"L.PvsV.KUROKAWA_LIVER_CANCER_EARLY_RECURRENCE_UP"
166,"Up",0.441066470592328,0.706856961131878,"L.PvsV.LIU_PROSTATE_CANCER_UP"
79,"Down",0.441582964822564,0.707289985453503,"L.PvsV.MEDINA_SMARCA4_TARGETS"
53,"Down",0.441736620877548,0.707289985453503,"L.PvsV.HU_ANGIOGENESIS_UP"
46,"Down",0.441878269373685,0.707289985453503,"L.PvsV.REACTOME_PHASE_0_RAPID_DEPOLARISATION"
24,"Up",0.441890714525912,0.707289985453503,"L.PvsV.WU_HBX_TARGETS_1_UP"
108,"Up",0.441976288613104,0.707289985453503,"L.PvsV.NADLER_OBESITY_UP"
1092,"Up",0.442845421457654,0.708475791446576,"L.PvsV.REACTOME_INFECTIOUS_DISEASE"
6,"Down",0.443023762086585,0.708556083476057,"L.PvsV.REACTOME_SYNTHESIS_OF_WYBUTOSINE_AT_G37_OF_TRNA_PHE"
43,"Down",0.443421698027343,0.708730987337014,"L.PvsV.LA_MEN1_TARGETS"
82,"Up",0.443517209908545,0.708730987337014,"L.PvsV.DAIRKEE_CANCER_PRONE_RESPONSE_BPA"
61,"Down",0.443611941505068,0.708730987337014,"L.PvsV.GENTILE_UV_RESPONSE_CLUSTER_D2"
7,"Up",0.443645857690976,0.708730987337014,"L.PvsV.REACTOME_NEGATIVE_FEEDBACK_REGULATION_OF_MAPK_PATHWAY"
56,"Up",0.444145252494661,0.709323830457245,"L.PvsV.KEGG_TYROSINE_METABOLISM"
10,"Down",0.444622322859668,0.709800078850819,"L.PvsV.BIOCARTA_PEPI_PATHWAY"
485,"Up",0.444875176650007,0.709800078850819,"L.PvsV.LINDGREN_BLADDER_CANCER_CLUSTER_3_UP"
10,"Up",0.444891919441252,0.709800078850819,"L.PvsV.CASTELLANO_HRAS_AND_NRAS_TARGETS_UP"
28,"Up",0.44495696749809,0.709800078850819,"L.PvsV.REACTOME_TRAF6_MEDIATED_NF_KB_ACTIVATION"
51,"Up",0.44527781768819,0.710107024516298,"L.PvsV.GROSS_ELK3_TARGETS_DN"
37,"Down",0.445495346400398,0.710249068698905,"L.PvsV.BIOCARTA_CCR3_PATHWAY"
8,"Down",0.445941997307623,0.710407184691526,"L.PvsV.REACTOME_PTK6_REGULATES_CELL_CYCLE"
35,"Down",0.445960714635539,0.710407184691526,"L.PvsV.REACTOME_RECOGNITION_OF_DNA_DAMAGE_BY_PCNA_CONTAINING_REPLICATION_COMPLEX"
40,"Up",0.446001965944526,0.710407184691526,"L.PvsV.CHEN_ETV5_TARGETS_SERTOLI"
27,"Up",0.446124214204312,0.710407184691526,"L.PvsV.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_CYAN_UP"
379,"Down",0.446236960107374,0.710407184691526,"L.PvsV.CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP"
53,"Up",0.446685470007445,0.710734543172383,"L.PvsV.WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_UP"
32,"Down",0.446699681230608,0.710734543172383,"L.PvsV.DORN_ADENOVIRUS_INFECTION_48HR_UP"
123,"Up",0.448025012007541,0.71263126231012,"L.PvsV.BILANGES_SERUM_SENSITIVE_GENES"
80,"Down",0.448426319733871,0.71263126231012,"L.PvsV.MODY_HIPPOCAMPUS_NEONATAL"
38,"Up",0.448542917811455,0.71263126231012,"L.PvsV.REACTOME_NICOTINATE_METABOLISM"
19,"Down",0.448728770258004,0.71263126231012,"L.PvsV.REACTOME_REGULATION_OF_IFNG_SIGNALING"
258,"Up",0.448750922331211,0.71263126231012,"L.PvsV.MADAN_DPPA4_TARGETS"
37,"Down",0.448831180237886,0.71263126231012,"L.PvsV.REACTOME_FERTILIZATION"
74,"Up",0.448876282218224,0.71263126231012,"L.PvsV.MARSON_FOXP3_TARGETS_DN"
6,"Down",0.448938505315877,0.71263126231012,"L.PvsV.MCGOWAN_RSP6_TARGETS_DN"
36,"Up",0.44937097174583,0.71263126231012,"L.PvsV.PID_MYC_PATHWAY"
43,"Down",0.449715612740224,0.71263126231012,"L.PvsV.REACTOME_TRANSLESION_SYNTHESIS_BY_Y_FAMILY_DNA_POLYMERASES_BYPASSES_LESIONS_ON_DNA_TEMPLATE"
84,"Down",0.449722309958086,0.71263126231012,"L.PvsV.ROVERSI_GLIOMA_LOH_REGIONS"
47,"Down",0.449780397839267,0.71263126231012,"L.PvsV.REACTOME_METALLOPROTEASE_DUBS"
12,"Up",0.449870210340095,0.71263126231012,"L.PvsV.IIZUKA_LIVER_CANCER_PROGRESSION_L1_G1_DN"
35,"Down",0.449876681500852,0.71263126231012,"L.PvsV.BIOCARTA_VDR_PATHWAY"
16,"Up",0.449985279173703,0.71263126231012,"L.PvsV.RAMPON_ENRICHED_LEARNING_ENVIRONMENT_EARLY_DN"
125,"Down",0.450120837175293,0.71263126231012,"L.PvsV.REACTOME_CELL_JUNCTION_ORGANIZATION"
127,"Down",0.450226731115841,0.71263126231012,"L.PvsV.MEISSNER_NPC_HCP_WITH_H3K27ME3"
52,"Down",0.450362008137002,0.71263126231012,"L.PvsV.BIOCARTA_IL2RB_PATHWAY"
34,"Up",0.450464976829492,0.71263126231012,"L.PvsV.REACTOME_CD209_DC_SIGN_SIGNALING"
29,"Down",0.450545742851294,0.71263126231012,"L.PvsV.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_15"
153,"Down",0.450674436352107,0.71263126231012,"L.PvsV.CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP"
102,"Down",0.450727351112044,0.71263126231012,"L.PvsV.MCCLUNG_CREB1_TARGETS_DN"
13,"Down",0.450941394216349,0.71276585723905,"L.PvsV.NAKAMURA_LUNG_CANCER_DIFFERENTIATION_MARKERS"
26,"Up",0.451720500506835,0.713793268734578,"L.PvsV.WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_UP"
19,"Up",0.451858655822514,0.713807573726481,"L.PvsV.BIOCARTA_ACH_PATHWAY"
71,"Up",0.452274438479466,0.714092247788255,"L.PvsV.BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_UP"
267,"Down",0.452363787390293,0.714092247788255,"L.PvsV.MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_DN"
51,"Up",0.452426323747921,0.714092247788255,"L.PvsV.REACTOME_RNA_POLYMERASE_I_TRANSCRIPTION_INITIATION"
40,"Up",0.45262862443696,0.714207666812772,"L.PvsV.VANASSE_BCL2_TARGETS_UP"
54,"Down",0.453295430919475,0.715022939085897,"L.PvsV.VANDESLUIS_COMMD1_TARGETS_GROUP_3_DN"
16,"Up",0.45340394726626,0.715022939085897,"L.PvsV.NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN"
1526,"Up",0.454164841628298,0.716018651087214,"L.PvsV.MARSON_BOUND_BY_FOXP3_UNSTIMULATED"
130,"Up",0.454544155610598,0.716412382089794,"L.PvsV.PID_CXCR4_PATHWAY"
54,"Down",0.455266712906698,0.71725173755461,"L.PvsV.BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_UP"
523,"Down",0.455463903034538,0.71725173755461,"L.PvsV.FISCHER_DIRECT_P53_TARGETS_META_ANALYSIS"
12,"Down",0.45559111035708,0.71725173755461,"L.PvsV.REACTOME_SLBP_DEPENDENT_PROCESSING_OF_REPLICATION_DEPENDENT_HISTONE_PRE_MRNAS"
92,"Down",0.455623863352731,0.71725173755461,"L.PvsV.YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_2"
13,"Down",0.455725330806538,0.71725173755461,"L.PvsV.BIOCARTA_RANMS_PATHWAY"
26,"Down",0.45663282806265,0.718336836989925,"L.PvsV.PHESSE_TARGETS_OF_APC_AND_MBD2_UP"
14,"Up",0.456674621454076,0.718336836989925,"L.PvsV.WEBER_METHYLATED_LCP_IN_FIBROBLAST_DN"
23,"Down",0.45709717447673,0.71870891858374,"L.PvsV.STEIN_ESTROGEN_RESPONSE_NOT_VIA_ESRRA"
50,"Up",0.457270417039894,0.71870891858374,"L.PvsV.REACTOME_FORMATION_OF_INCISION_COMPLEX_IN_GG_NER"
40,"Up",0.457418849529249,0.71870891858374,"L.PvsV.REACTOME_SIGNALLING_TO_ERKS"
12,"Up",0.457431123981946,0.71870891858374,"L.PvsV.REACTOME_MET_RECEPTOR_RECYCLING"
33,"Down",0.457574433583166,0.718729841841285,"L.PvsV.BUCKANOVICH_T_LYMPHOCYTE_HOMING_ON_TUMOR_DN"
55,"Down",0.457783759330061,0.71874467478766,"L.PvsV.CHEN_LUNG_CANCER_SURVIVAL"
195,"Down",0.457843867716068,0.71874467478766,"L.PvsV.FIGUEROA_AML_METHYLATION_CLUSTER_7_UP"
99,"Up",0.458083859488202,0.718917303182023,"L.PvsV.LEE_LIVER_CANCER_MYC_E2F1_DN"
103,"Down",0.458216193658502,0.7189209235919,"L.PvsV.DORN_ADENOVIRUS_INFECTION_24HR_DN"
10,"Down",0.459118859541782,0.720028791366557,"L.PvsV.BIOCARTA_STAT3_PATHWAY"
22,"Down",0.459318071910415,0.720028791366557,"L.PvsV.REACTOME_HS_GAG_DEGRADATION"
8,"Up",0.459368295022538,0.720028791366557,"L.PvsV.MATZUK_STEROIDOGENESIS"
775,"Up",0.45954211608632,0.720028791366557,"L.PvsV.REACTOME_METABOLISM_OF_RNA"
152,"Down",0.459599879636254,0.720028791366557,"L.PvsV.PID_CMYB_PATHWAY"
17,"Up",0.459703677613302,0.720028791366557,"L.PvsV.BRUNEAU_SEPTATION_VENTRICULAR"
109,"Down",0.459976650252548,0.720252307914568,"L.PvsV.LEE_EARLY_T_LYMPHOCYTE_DN"
39,"Down",0.460121126305698,0.720274549078201,"L.PvsV.REACTOME_TRANSCRIPTIONAL_REGULATION_BY_E2F6"
38,"Up",0.460362245880948,0.720279083939355,"L.PvsV.CEBALLOS_TARGETS_OF_TP53_AND_MYC_UP"
12,"Up",0.460384569115877,0.720279083939355,"L.PvsV.REACTOME_SYNTHESIS_OF_5_EICOSATETRAENOIC_ACIDS"
390,"Down",0.460685497640798,0.7205460018263,"L.PvsV.REACTOME_SIGNALING_BY_NUCLEAR_RECEPTORS"
18,"Down",0.461104986219851,0.720998152943879,"L.PvsV.MARKS_ACETYLATED_NON_HISTONE_PROTEINS"
76,"Up",0.461554206962485,0.721496525387498,"L.PvsV.REACTOME_TRANSCRIPTION_OF_THE_HIV_GENOME"
51,"Down",0.461804217344768,0.721573454158381,"L.PvsV.REACTOME_SIGNALING_BY_FGFR2_IN_DISEASE"
71,"Up",0.461864433761351,0.721573454158381,"L.PvsV.SHIPP_DLBCL_CURED_VS_FATAL_DN"
252,"Up",0.462220422884759,0.72174135732373,"L.PvsV.HUANG_GATA2_TARGETS_UP"
106,"Up",0.462232979975281,0.72174135732373,"L.PvsV.RHODES_CANCER_META_SIGNATURE"
10,"Down",0.463094662175812,0.722797526444879,"L.PvsV.GALI_TP53_TARGETS_APOPTOTIC_DN"
34,"Up",0.463170851183615,0.722797526444879,"L.PvsV.SYED_ESTRADIOL_RESPONSE"
47,"Down",0.463479062878642,0.723029696113637,"L.PvsV.PID_ATR_PATHWAY"
1106,"Down",0.4635811670687,0.723029696113637,"L.PvsV.KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP"
36,"Down",0.464025061515464,0.723112922465049,"L.PvsV.FARMER_BREAST_CANCER_CLUSTER_2"
29,"Down",0.464111663566749,0.723112922465049,"L.PvsV.TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_DN"
72,"Down",0.464194701240868,0.723112922465049,"L.PvsV.HAHTOLA_SEZARY_SYNDROM_DN"
13,"Down",0.464257770006279,0.723112922465049,"L.PvsV.REACTOME_INACTIVATION_OF_CDC42_AND_RAC1"
296,"Down",0.464288456276166,0.723112922465049,"L.PvsV.SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP"
19,"Down",0.46469193702803,0.723537516144179,"L.PvsV.REACTOME_DSCAM_INTERACTIONS"
31,"Down",0.465065477904912,0.723915266705028,"L.PvsV.REACTOME_POSTMITOTIC_NUCLEAR_PORE_COMPLEX_NPC_REFORMATION"
243,"Up",0.465599067754729,0.724541864794792,"L.PvsV.PROVENZANI_METASTASIS_DN"
29,"Down",0.466028750494105,0.725006460743362,"L.PvsV.EHRLICH_ICF_SYNDROM_DN"
91,"Up",0.466549392365235,0.725602498843381,"L.PvsV.ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_UP"
154,"Down",0.466674350856767,0.725602498843381,"L.PvsV.LEE_LIVER_CANCER_DENA_DN"
14,"Down",0.467069063129914,0.725774371669179,"L.PvsV.BIOCARTA_CTBP1_PATHWAY"
933,"Up",0.467261175170665,0.725774371669179,"L.PvsV.FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP"
10,"Up",0.467291307495125,0.725774371669179,"L.PvsV.REACTOME_HYDROLYSIS_OF_LPC"
32,"Down",0.467468633633304,0.725774371669179,"L.PvsV.LEE_SP4_THYMOCYTE"
756,"Down",0.467480436148101,0.725774371669179,"L.PvsV.ZHENG_BOUND_BY_FOXP3"
70,"Up",0.467681817805299,0.725774371669179,"L.PvsV.HONMA_DOCETAXEL_RESISTANCE"
217,"Down",0.467797991798158,0.725774371669179,"L.PvsV.YAGI_AML_WITH_T_9_11_TRANSLOCATION"
74,"Up",0.467927998962013,0.725774371669179,"L.PvsV.DAVIES_MULTIPLE_MYELOMA_VS_MGUS_DN"
382,"Down",0.46796629318152,0.725774371669179,"L.PvsV.VERHAAK_GLIOBLASTOMA_MESENCHYMAL"
831,"Down",0.469594942398616,0.728096028188993,"L.PvsV.REACTOME_CELL_CYCLE"
24,"Down",0.469769011652656,0.728161722856052,"L.PvsV.SU_THYMUS"
35,"Up",0.470102844959487,0.728340766999827,"L.PvsV.GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN"
117,"Down",0.470147982894263,0.728340766999827,"L.PvsV.REACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING"
77,"Down",0.470291209151386,0.728358570139499,"L.PvsV.TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_DN"
27,"Up",0.47089982531987,0.728914327688484,"L.PvsV.FOURNIER_ACINAR_DEVELOPMENT_EARLY_UP"
42,"Down",0.470913723730017,0.728914327688484,"L.PvsV.REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR1"
248,"Down",0.471591824608762,0.729233693600044,"L.PvsV.ZHU_CMV_ALL_UP"
41,"Up",0.471606981547389,0.729233693600044,"L.PvsV.CROONQUIST_IL6_DEPRIVATION_UP"
97,"Up",0.471634345358254,0.729233693600044,"L.PvsV.BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_DN"
59,"Down",0.471706589444993,0.729233693600044,"L.PvsV.WOOD_EBV_EBNA1_TARGETS_DN"
183,"Down",0.471779512028822,0.729233693600044,"L.PvsV.REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION"
114,"Down",0.472020063976575,0.729401602494826,"L.PvsV.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_DN"
166,"Down",0.47259487988841,0.730085803549321,"L.PvsV.KEGG_SPLICEOSOME"
133,"Down",0.473179058366407,0.730432712980989,"L.PvsV.KUNINGER_IGF1_VS_PDGFB_TARGETS_UP"
127,"Up",0.47319374199782,0.730432712980989,"L.PvsV.BURTON_ADIPOGENESIS_9"
43,"Up",0.473215767389746,0.730432712980989,"L.PvsV.MAGRANGEAS_MULTIPLE_MYELOMA_IGG_VS_IGA_DN"
10,"Down",0.47355839383769,0.730621084972984,"L.PvsV.BIOCARTA_S1P_PATHWAY"
354,"Up",0.473604328728751,0.730621084972984,"L.PvsV.GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN"
253,"Down",0.473741969942144,0.730621084972984,"L.PvsV.BROWNE_HCMV_INFECTION_24HR_UP"
11,"Down",0.473988277349548,0.730621084972984,"L.PvsV.REACTOME_BH3_ONLY_PROTEINS_ASSOCIATE_WITH_AND_INACTIVATE_ANTI_APOPTOTIC_BCL_2_MEMBERS"
121,"Up",0.473998522661981,0.730621084972984,"L.PvsV.LIAN_LIPA_TARGETS_3M"
12,"Up",0.475773385721825,0.732489752121897,"L.PvsV.REACTOME_ACTIVATION_OF_PPARGC1A_PGC_1ALPHA_BY_PHOSPHORYLATION"
10,"Up",0.475970450775666,0.732489752121897,"L.PvsV.AGARWAL_AKT_PATHWAY_TARGETS"
395,"Down",0.475979113151319,0.732489752121897,"L.PvsV.SENESE_HDAC1_AND_HDAC2_TARGETS_UP"
402,"Down",0.476096089825351,0.732489752121897,"L.PvsV.WANG_CISPLATIN_RESPONSE_AND_XPC_UP"
83,"Up",0.476119426930773,0.732489752121897,"L.PvsV.REACTOME_NUCLEOTIDE_BINDING_DOMAIN_LEUCINE_RICH_REPEAT_CONTAINING_RECEPTOR_NLR_SIGNALING_PATHWAYS"
50,"Up",0.476120233150396,0.732489752121897,"L.PvsV.LOPEZ_TRANSLATION_VIA_FN1_SIGNALING"
13,"Down",0.476222695831651,0.732489752121897,"L.PvsV.FUNG_IL2_SIGNALING_1"
52,"Down",0.476270692508269,0.732489752121897,"L.PvsV.MAEKAWA_ATF2_TARGETS"
15,"Up",0.477141747058166,0.733622186690887,"L.PvsV.REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_ASSOCIATION_WITH_CO_FACTORS"
50,"Down",0.477272382985552,0.733622186690887,"L.PvsV.REACTOME_SPHINGOLIPID_DE_NOVO_BIOSYNTHESIS"
110,"Down",0.478224852885717,0.734857555426822,"L.PvsV.ROSS_AML_WITH_CBFB_MYH11_FUSION"
129,"Down",0.478380414942701,0.734857555426822,"L.PvsV.REACTOME_NEGATIVE_EPIGENETIC_REGULATION_OF_RRNA_EXPRESSION"
67,"Up",0.478474805486807,0.734857555426822,"L.PvsV.PID_EPHB_FWD_PATHWAY"
41,"Down",0.478972136778346,0.735179269584292,"L.PvsV.HOEGERKORP_CD44_TARGETS_DIRECT_UP"
51,"Down",0.479110538993113,0.735179269584292,"L.PvsV.BIOCARTA_AGR_PATHWAY"
5,"Down",0.479182966176063,0.735179269584292,"L.PvsV.REACTOME_LEUKOTRIENE_RECEPTORS"
972,"Down",0.479298778488257,0.735179269584292,"L.PvsV.BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN"
58,"Up",0.479358380681012,0.735179269584292,"L.PvsV.PID_FOXO_PATHWAY"
22,"Down",0.479514438407847,0.735179269584292,"L.PvsV.MIKKELSEN_IPS_LCP_WITH_H3K27ME3"
50,"Up",0.479645849332796,0.735179269584292,"L.PvsV.REACTOME_ACTIVATION_OF_GENE_EXPRESSION_BY_SREBF_SREBP"
5,"Down",0.479748020376221,0.735179269584292,"L.PvsV.BIOCARTA_DICER_PATHWAY"
308,"Up",0.480454948105348,0.735911511384168,"L.PvsV.BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_TRANS"
48,"Down",0.480611098963402,0.735911511384168,"L.PvsV.AIGNER_ZEB1_TARGETS"
11,"Down",0.480625152397944,0.735911511384168,"L.PvsV.BIOCARTA_ERBB4_PATHWAY"
36,"Down",0.480952675482192,0.736192014577694,"L.PvsV.YAO_HOXA10_TARGETS_VIA_PROGESTERONE_DN"
313,"Down",0.481074651595082,0.736192014577694,"L.PvsV.BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_DN"
9,"Up",0.481519159690463,0.736454200328168,"L.PvsV.BIOCARTA_HBX_PATHWAY"
313,"Down",0.481788318397108,0.736454200328168,"L.PvsV.REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES"
89,"Up",0.481938516752487,0.736454200328168,"L.PvsV.REACTOME_PI_METABOLISM"
62,"Down",0.481995167090184,0.736454200328168,"L.PvsV.REACTOME_DEACTIVATION_OF_THE_BETA_CATENIN_TRANSACTIVATING_COMPLEX"
305,"Up",0.4820279300355,0.736454200328168,"L.PvsV.REACTOME_FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS"
627,"Up",0.482045171095612,0.736454200328168,"L.PvsV.LIM_MAMMARY_STEM_CELL_DN"
180,"Up",0.48230363395544,0.736645522690505,"L.PvsV.KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY"
509,"Down",0.482934335124832,0.737090258941798,"L.PvsV.KUMAR_PATHOGEN_LOAD_BY_MACROPHAGES"
140,"Down",0.48294298647518,0.737090258941798,"L.PvsV.BILBAN_B_CLL_LPL_UP"
83,"Down",0.482994756401906,0.737090258941798,"L.PvsV.KEGG_P53_SIGNALING_PATHWAY"
36,"Down",0.483225587954903,0.737158909494502,"L.PvsV.HEIDENBLAD_AMPLICON_12P11_12_DN"
89,"Down",0.483373484259937,0.737158909494502,"L.PvsV.REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH"
190,"Down",0.483439718905238,0.737158909494502,"L.PvsV.KOBAYASHI_EGFR_SIGNALING_24HR_UP"
17,"Up",0.483721992431621,0.737206661527098,"L.PvsV.REACTOME_ADVANCED_GLYCOSYLATION_ENDPRODUCT_RECEPTOR_SIGNALING"
170,"Down",0.483835669116783,0.737206661527098,"L.PvsV.KEGG_PURINE_METABOLISM"
115,"Down",0.483871039009195,0.737206661527098,"L.PvsV.REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX"
8,"Down",0.484300534234481,0.737548530003345,"L.PvsV.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_5"
113,"Down",0.484362219649511,0.737548530003345,"L.PvsV.FAELT_B_CLL_WITH_VH_REARRANGEMENTS_UP"
5,"Up",0.484498160353235,0.737552403246982,"L.PvsV.REACTOME_FASL_CD95L_SIGNALING"
122,"Up",0.484727636478938,0.737698624302793,"L.PvsV.CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_UP"
55,"Up",0.485198655439452,0.73783872603941,"L.PvsV.NAKAYAMA_FRA2_TARGETS"
7,"Up",0.485290922893821,0.73783872603941,"L.PvsV.REACTOME_IKBA_VARIANT_LEADS_TO_EDA_ID"
23,"Down",0.485400851993819,0.73783872603941,"L.PvsV.REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_CELL_CYCLE_GENES"
100,"Up",0.485564239074671,0.73783872603941,"L.PvsV.LEE_LIVER_CANCER_MYC_TGFA_DN"
22,"Up",0.485829043302895,0.73783872603941,"L.PvsV.VETTER_TARGETS_OF_PRKCA_AND_ETS1_UP"
11,"Up",0.48594914762069,0.73783872603941,"L.PvsV.REACTOME_ARYL_HYDROCARBON_RECEPTOR_SIGNALLING"
137,"Down",0.485980401198226,0.73783872603941,"L.PvsV.DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN"
204,"Down",0.485989437936185,0.73783872603941,"L.PvsV.BOSCO_TH1_CYTOTOXIC_MODULE"
8,"Up",0.486065464756865,0.73783872603941,"L.PvsV.REACTOME_POLB_DEPENDENT_LONG_PATCH_BASE_EXCISION_REPAIR"
25,"Up",0.486154183208821,0.73783872603941,"L.PvsV.REACTOME_PURINE_CATABOLISM"
78,"Down",0.486793892258511,0.738473825754203,"L.PvsV.KAAB_FAILED_HEART_VENTRICLE_DN"
200,"Down",0.487062509102731,0.738473825754203,"L.PvsV.REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2"
8,"Up",0.487073297263662,0.738473825754203,"L.PvsV.TERAMOTO_OPN_TARGETS_CLUSTER_8"
62,"Down",0.487106898630056,0.738473825754203,"L.PvsV.PID_ARF6_PATHWAY"
35,"Down",0.48779937508236,0.739320927859202,"L.PvsV.BIOCARTA_IGF1_PATHWAY"
32,"Down",0.488419325030383,0.740057672812548,"L.PvsV.CAFFAREL_RESPONSE_TO_THC_24HR_3_DN"
46,"Up",0.4890283579288,0.740596981393734,"L.PvsV.REACTOME_HIV_TRANSCRIPTION_ELONGATION"
186,"Down",0.489043150491684,0.740596981393734,"L.PvsV.REACTOME_HCMV_INFECTION"
292,"Down",0.489792510790358,0.741445599030264,"L.PvsV.GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP"
33,"Down",0.489871726036816,0.741445599030264,"L.PvsV.REACTOME_SYNTHESIS_OF_PROSTAGLANDINS_PG_AND_THROMBOXANES_TX"
9,"Up",0.490439305870184,0.741959858321626,"L.PvsV.REACTOME_PHOSPHATE_BOND_HYDROLYSIS_BY_NTPDASE_PROTEINS"
1038,"Up",0.490479884638369,0.741959858321626,"L.PvsV.WEI_MYCN_TARGETS_WITH_E_BOX"
143,"Up",0.490903307565643,0.742370526546437,"L.PvsV.SASSON_RESPONSE_TO_FORSKOLIN_DN"
53,"Down",0.491019897916498,0.742370526546437,"L.PvsV.SESTO_RESPONSE_TO_UV_C6"
33,"Down",0.491259267991166,0.742509495204414,"L.PvsV.TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_DN"
100,"Down",0.491454589572217,0.742509495204414,"L.PvsV.CHANG_IMMORTALIZED_BY_HPV31_UP"
99,"Up",0.491514695686047,0.742509495204414,"L.PvsV.APPIERTO_RESPONSE_TO_FENRETINIDE_DN"
15,"Down",0.491968920441162,0.742927832258518,"L.PvsV.BIOCARTA_IL17_PATHWAY"
243,"Down",0.492060358424796,0.742927832258518,"L.PvsV.REACTOME_MRNA_SPLICING"
32,"Down",0.492380707042476,0.743208552890487,"L.PvsV.HOLLEMAN_PREDNISOLONE_RESISTANCE_B_ALL_DN"
116,"Down",0.492774039918176,0.743599254014081,"L.PvsV.KEGG_GNRH_SIGNALING_PATHWAY"
13,"Down",0.493024351536135,0.743626857215421,"L.PvsV.BIOCARTA_LYMPHOCYTE_PATHWAY"
91,"Down",0.493061323666437,0.743626857215421,"L.PvsV.ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_DN"
9,"Down",0.493904508291885,0.744672281506022,"L.PvsV.REACTOME_2_LTR_CIRCLE_FORMATION"
159,"Down",0.494103788127897,0.744672281506022,"L.PvsV.ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN"
72,"Down",0.494376895181555,0.744672281506022,"L.PvsV.DAZARD_UV_RESPONSE_CLUSTER_G4"
63,"Down",0.494419980163839,0.744672281506022,"L.PvsV.NAKAMURA_METASTASIS_MODEL_DN"
24,"Down",0.494528217040583,0.744672281506022,"L.PvsV.BIOCARTA_ARF_PATHWAY"
11,"Up",0.4945626004142,0.744672281506022,"L.PvsV.MARIADASON_RESPONSE_TO_BUTYRATE_CURCUMIN_SULINDAC_TSA_8"
245,"Up",0.494700562261624,0.744677214468967,"L.PvsV.JOHNSTONE_PARVB_TARGETS_2_UP"
10,"Down",0.495463138961809,0.745622127196473,"L.PvsV.DONATO_CELL_CYCLE_TRETINOIN"
22,"Down",0.495730197080139,0.745821023035671,"L.PvsV.PETRETTO_BLOOD_PRESSURE_UP"
39,"Up",0.49602770896697,0.745944286413569,"L.PvsV.GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_DN"
66,"Up",0.49614444715651,0.745944286413569,"L.PvsV.BOYAULT_LIVER_CANCER_SUBCLASS_G23_UP"
10,"Down",0.496238103497055,0.745944286413569,"L.PvsV.BIOCARTA_CB1R_PATHWAY"
46,"Up",0.496575427474172,0.745944286413569,"L.PvsV.HWANG_PROSTATE_CANCER_MARKERS"
34,"Down",0.496704083305197,0.745944286413569,"L.PvsV.REACTOME_RHO_GTPASES_ACTIVATE_ROCKS"
63,"Up",0.496782937849891,0.745944286413569,"L.PvsV.APRELIKOVA_BRCA1_TARGETS"
26,"Up",0.49693739351104,0.745944286413569,"L.PvsV.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_UP"
21,"Up",0.49711262293832,0.745944286413569,"L.PvsV.SUH_COEXPRESSED_WITH_ID1_AND_ID2_UP"
64,"Down",0.497235881433693,0.745944286413569,"L.PvsV.SAENZ_DETOX_PATHWAY_AND_CARCINOGENESIS_DN"
8,"Down",0.497383443411533,0.745944286413569,"L.PvsV.LIU_IL13_MEMORY_MODEL_DN"
10,"Up",0.497429462559186,0.745944286413569,"L.PvsV.FUNG_IL2_TARGETS_WITH_STAT5_BINDING_SITES_T1"
77,"Up",0.497531884421534,0.745944286413569,"L.PvsV.VARELA_ZMPSTE24_TARGETS_DN"
42,"Down",0.497566020671594,0.745944286413569,"L.PvsV.OHM_METHYLATED_IN_ADULT_CANCERS"
12,"Down",0.497808088361208,0.746089253069145,"L.PvsV.SHIRAISHI_PLZF_TARGETS_DN"
77,"Down",0.497932599715165,0.746089253069145,"L.PvsV.REACTOME_CELL_CELL_JUNCTION_ORGANIZATION"
69,"Up",0.498139195576828,0.746196589635406,"L.PvsV.PID_RHOA_PATHWAY"
26,"Down",0.498648318234604,0.746756920779828,"L.PvsV.REACTOME_FORMATION_OF_TUBULIN_FOLDING_INTERMEDIATES_BY_CCT_TRIC"
103,"Up",0.499284943799312,0.747507840310424,"L.PvsV.MORI_MATURE_B_LYMPHOCYTE_DN"
28,"Down",0.499431034839265,0.747524144998997,"L.PvsV.REACTOME_G_BETA_GAMMA_SIGNALLING_THROUGH_PI3KGAMMA"
448,"Up",0.499880386656089,0.747994224038299,"L.PvsV.IVANOVA_HEMATOPOIESIS_MATURE_CELL"
548,"Down",0.500130418555046,0.748165877757265,"L.PvsV.DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN"
85,"Up",0.500367106138097,0.748317481698009,"L.PvsV.PID_AR_TF_PATHWAY"
236,"Up",0.500704475739579,0.748490508824079,"L.PvsV.TIEN_INTESTINE_PROBIOTICS_6HR_DN"
268,"Down",0.501035789915225,0.748490508824079,"L.PvsV.DARWICHE_PAPILLOMA_RISK_LOW_UP"
379,"Up",0.50110187115488,0.748490508824079,"L.PvsV.PHONG_TNF_RESPONSE_VIA_P38_COMPLETE"
6,"Up",0.501121142994128,0.748490508824079,"L.PvsV.REACTOME_TRANSPORT_AND_SYNTHESIS_OF_PAPS"
18,"Down",0.501169031098449,0.748490508824079,"L.PvsV.REACTOME_ATF6_ATF6_ALPHA_ACTIVATES_CHAPERONES"
29,"Down",0.501332822737413,0.748490508824079,"L.PvsV.RUAN_RESPONSE_TO_TNF_UP"
159,"Down",0.501430429496182,0.748490508824079,"L.PvsV.FIGUEROA_AML_METHYLATION_CLUSTER_4_UP"
26,"Down",0.501579971181171,0.748511649301132,"L.PvsV.REACTOME_ABC_TRANSPORTERS_IN_LIPID_HOMEOSTASIS"
93,"Up",0.502386340906319,0.748649026793924,"L.PvsV.MODY_HIPPOCAMPUS_POSTNATAL"
107,"Down",0.502495097930848,0.748649026793924,"L.PvsV.KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY"
186,"Down",0.502581693544947,0.748649026793924,"L.PvsV.MATZUK_SPERMATOCYTE"
74,"Down",0.502679272104894,0.748649026793924,"L.PvsV.RASHI_RESPONSE_TO_IONIZING_RADIATION_3"
21,"Down",0.502800697684092,0.748649026793924,"L.PvsV.AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_DN"
145,"Up",0.502876155644338,0.748649026793924,"L.PvsV.UEDA_CENTRAL_CLOCK"
17,"Down",0.502895000750978,0.748649026793924,"L.PvsV.REACTOME_TRYPTOPHAN_CATABOLISM"
430,"Down",0.502987054746116,0.748649026793924,"L.PvsV.LU_EZH2_TARGETS_UP"
253,"Down",0.502995509033193,0.748649026793924,"L.PvsV.ELVIDGE_HYPOXIA_UP"
24,"Down",0.503244040413309,0.748649026793924,"L.PvsV.EHRLICH_ICF_SYNDROM_UP"
36,"Up",0.503252467361302,0.748649026793924,"L.PvsV.PID_P38_MKK3_6PATHWAY"
145,"Up",0.503296876938509,0.748649026793924,"L.PvsV.YU_MYC_TARGETS_DN"
61,"Down",0.503584406301121,0.748875250790452,"L.PvsV.GENTILE_RESPONSE_CLUSTER_D3"
567,"Down",0.504052172643727,0.748967530008339,"L.PvsV.PHONG_TNF_RESPONSE_NOT_VIA_P38"
25,"Down",0.504072566403626,0.748967530008339,"L.PvsV.KYNG_ENVIRONMENTAL_STRESS_RESPONSE_DN"
95,"Down",0.504110411206435,0.748967530008339,"L.PvsV.KEGG_COMPLEMENT_AND_COAGULATION_CASCADES"
34,"Down",0.504240311168347,0.748967530008339,"L.PvsV.LEE_DOUBLE_POLAR_THYMOCYTE"
927,"Down",0.504323768171649,0.748967530008339,"L.PvsV.REACTOME_HEMOSTASIS"
223,"Down",0.505034985616823,0.749326194709842,"L.PvsV.VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_DN"
9,"Down",0.505069246277179,0.749326194709842,"L.PvsV.HE_PTEN_TARGETS_DN"
36,"Down",0.505103941571321,0.749326194709842,"L.PvsV.REACTOME_THE_CANONICAL_RETINOID_CYCLE_IN_RODS_TWILIGHT_VISION"
12,"Down",0.505141549772997,0.749326194709842,"L.PvsV.REACTOME_ACTIVATED_NTRK3_SIGNALS_THROUGH_PI3K"
83,"Down",0.505304359644107,0.749326194709842,"L.PvsV.HAN_JNK_SINGALING_UP"
201,"Down",0.505396713107529,0.749326194709842,"L.PvsV.STEIN_ESRRA_TARGETS_DN"
8,"Down",0.505513963875513,0.749326194709842,"L.PvsV.SA_G2_AND_M_PHASES"
11,"Down",0.505866309045662,0.749647500057214,"L.PvsV.REACTOME_DERMATAN_SULFATE_BIOSYNTHESIS"
14,"Up",0.506406744141351,0.75004727529303,"L.PvsV.BIOCARTA_AMAN_PATHWAY"
176,"Down",0.506407393501335,0.75004727529303,"L.PvsV.RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_UP"
32,"Up",0.506864184412649,0.75044927945138,"L.PvsV.BIOCARTA_EPO_PATHWAY"
93,"Down",0.506994180536983,0.75044927945138,"L.PvsV.WEIGEL_OXIDATIVE_STRESS_BY_TBH_AND_H2O2"
9,"Up",0.507086002537594,0.75044927945138,"L.PvsV.BIOCARTA_IFNG_PATHWAY"
104,"Up",0.507273175152662,0.750525390799857,"L.PvsV.KEGG_VIRAL_MYOCARDITIS"
10,"Down",0.507728749613876,0.750601873500615,"L.PvsV.REACTOME_SCAVENGING_BY_CLASS_F_RECEPTORS"
347,"Down",0.507734088520198,0.750601873500615,"L.PvsV.MITSIADES_RESPONSE_TO_APLIDIN_DN"
5,"Down",0.507909144742832,0.750601873500615,"L.PvsV.REACTOME_DISEASES_OF_MISMATCH_REPAIR_MMR"
140,"Down",0.50798170536592,0.750601873500615,"L.PvsV.MCCLUNG_COCAINE_REWARD_5D"
141,"Down",0.508110724380517,0.750601873500615,"L.PvsV.HINATA_NFKB_TARGETS_KERATINOCYTE_UP"
27,"Down",0.508139412644746,0.750601873500615,"L.PvsV.REACTOME_PHASE_2_PLATEAU_PHASE"
67,"Down",0.50834949669891,0.750711636551355,"L.PvsV.JAZAG_TGFB1_SIGNALING_DN"
93,"Down",0.508770730409829,0.75113307568383,"L.PvsV.DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_UP"
20,"Up",0.508917039785617,0.751148508535685,"L.PvsV.REACTOME_WNT5A_DEPENDENT_INTERNALIZATION_OF_FZD4"
18,"Up",0.509131289667689,0.751149017156151,"L.PvsV.MARIADASON_RESPONSE_TO_CURCUMIN_SULINDAC_7"
125,"Down",0.509189096817011,0.751149017156151,"L.PvsV.PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP"
20,"Up",0.509936218561726,0.751195948795814,"L.PvsV.RODRIGUES_THYROID_CARCINOMA_UP"
156,"Up",0.510101315591415,0.751195948795814,"L.PvsV.ZAMORA_NOS2_TARGETS_DN"
97,"Down",0.510140083417909,0.751195948795814,"L.PvsV.NADLER_HYPERGLYCEMIA_AT_OBESITY"
9,"Down",0.510225269918165,0.751195948795814,"L.PvsV.RODRIGUES_DCC_TARGETS_UP"
50,"Up",0.510263080301369,0.751195948795814,"L.PvsV.REACTOME_GAP_JUNCTION_TRAFFICKING_AND_REGULATION"
33,"Up",0.51040206183654,0.751195948795814,"L.PvsV.YORDY_RECIPROCAL_REGULATION_BY_ETS1_AND_SP100_UP"
28,"Down",0.510440656688706,0.751195948795814,"L.PvsV.SU_KIDNEY"
77,"Up",0.510441157860698,0.751195948795814,"L.PvsV.MELLMAN_TUT1_TARGETS_DN"
10,"Up",0.510449325026071,0.751195948795814,"L.PvsV.LUDWICZEK_TREATING_IRON_OVERLOAD"
65,"Up",0.510707418399472,0.751195948795814,"L.PvsV.MMS_MOUSE_LYMPH_HIGH_4HRS_UP"
142,"Up",0.510749555561942,0.751195948795814,"L.PvsV.REACTOME_ANTIMICROBIAL_PEPTIDES"
150,"Up",0.510896791113366,0.751195948795814,"L.PvsV.BURTON_ADIPOGENESIS_PEAK_AT_0HR"
36,"Down",0.511061815179648,0.751195948795814,"L.PvsV.REACTOME_RHO_GTPASES_ACTIVATE_IQGAPS"
22,"Down",0.511138679152643,0.751195948795814,"L.PvsV.TAGHAVI_NEOPLASTIC_TRANSFORMATION"
10,"Down",0.511258881410499,0.751195948795814,"L.PvsV.REACTOME_DISEASES_OF_DNA_REPAIR"
22,"Up",0.511568112399019,0.751208942022693,"L.PvsV.MEISSNER_NPC_ICP_WITH_H3K4ME3"
16,"Up",0.511798577893294,0.751208942022693,"L.PvsV.BIOCARTA_FREE_PATHWAY"
90,"Up",0.511842123726177,0.751208942022693,"L.PvsV.JI_RESPONSE_TO_FSH_DN"
46,"Down",0.511945260467926,0.751208942022693,"L.PvsV.REACTOME_ASSEMBLY_AND_CELL_SURFACE_PRESENTATION_OF_NMDA_RECEPTORS"
23,"Down",0.511961231770952,0.751208942022693,"L.PvsV.CHEOK_RESPONSE_TO_MERCAPTOPURINE_DN"
12,"Up",0.512082926837317,0.751208942022693,"L.PvsV.REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX_IN_CANCER"
9,"Down",0.512396762949122,0.751469947571802,"L.PvsV.BIOCARTA_CIRCADIAN_PATHWAY"
342,"Down",0.512865235743242,0.751957541348286,"L.PvsV.HOLLMANN_APOPTOSIS_VIA_CD40_UP"
835,"Down",0.513185064169829,0.752152517891768,"L.PvsV.ZWANG_CLASS_1_TRANSIENTLY_INDUCED_BY_EGF"
63,"Down",0.513270293001562,0.752152517891768,"L.PvsV.BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_48HR_DN"
82,"Up",0.514214169172525,0.753336020496792,"L.PvsV.CHEN_ETV5_TARGETS_TESTIS"
1053,"Down",0.514448651641985,0.753479892696301,"L.PvsV.PUJANA_CHEK2_PCC_NETWORK"
103,"Up",0.51503229233011,0.753988145276855,"L.PvsV.PID_CDC42_PATHWAY"
135,"Down",0.515068407435464,0.753988145276855,"L.PvsV.CORRE_MULTIPLE_MYELOMA_UP"
28,"Up",0.515340253490921,0.75399791248011,"L.PvsV.REACTOME_ENDOGENOUS_STEROLS"
101,"Down",0.515347822619341,0.75399791248011,"L.PvsV.XU_GH1_EXOGENOUS_TARGETS_UP"
140,"Down",0.515692292086142,0.754302297075206,"L.PvsV.MCCLUNG_DELTA_FOSB_TARGETS_2WK"
28,"Up",0.5158309271265,0.754305526602068,"L.PvsV.BIOCARTA_CDK5_PATHWAY"
115,"Down",0.516270801138481,0.754749143176801,"L.PvsV.MORI_SMALL_PRE_BII_LYMPHOCYTE_UP"
341,"Up",0.516729973145468,0.755220729981838,"L.PvsV.LEE_LIVER_CANCER_SURVIVAL_UP"
59,"Down",0.517127923480361,0.755577260540724,"L.PvsV.KEGG_RNA_DEGRADATION"
20,"Down",0.517247229362749,0.755577260540724,"L.PvsV.REACTOME_ABACAVIR_TRANSPORT_AND_METABOLISM"
77,"Down",0.517420355627636,0.755630519351612,"L.PvsV.MAGRANGEAS_MULTIPLE_MYELOMA_IGLL_VS_IGLK_UP"
229,"Down",0.518845026969577,0.756965959391836,"L.PvsV.MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_DN"
33,"Down",0.518884183038617,0.756965959391836,"L.PvsV.OZEN_MIR125B1_TARGETS"
142,"Up",0.51889350777322,0.756965959391836,"L.PvsV.BROWNE_INTERFERON_RESPONSIVE_GENES"
31,"Up",0.518926544699949,0.756965959391836,"L.PvsV.MATZUK_POSTIMPLANTATION_AND_POSTPARTUM"
30,"Down",0.519068839255635,0.756965959391836,"L.PvsV.BIOCARTA_CCR5_PATHWAY"
20,"Up",0.519324211151543,0.756965959391836,"L.PvsV.YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_4"
780,"Up",0.519378200597493,0.756965959391836,"L.PvsV.REACTOME_OLFACTORY_SIGNALING_PATHWAY"
37,"Down",0.519430068716337,0.756965959391836,"L.PvsV.REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR2"
158,"Down",0.51994362152301,0.757434007408047,"L.PvsV.REACTOME_RHO_GTPASE_CYCLE"
13,"Up",0.520160961306871,0.757434007408047,"L.PvsV.REACTOME_SODIUM_CALCIUM_EXCHANGERS"
184,"Down",0.520288855599926,0.757434007408047,"L.PvsV.NIKOLSKY_BREAST_CANCER_20Q12_Q13_AMPLICON"
15,"Down",0.520619902769312,0.757434007408047,"L.PvsV.GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_1_DN"
18,"Down",0.52096630837843,0.757434007408047,"L.PvsV.KEGG_RIBOFLAVIN_METABOLISM"
55,"Up",0.521030609892217,0.757434007408047,"L.PvsV.ANDERSEN_LIVER_CANCER_KRT19_UP"
8,"Down",0.521034965217219,0.757434007408047,"L.PvsV.IKEDA_MIR133_TARGETS_DN"
87,"Up",0.521141269757728,0.757434007408047,"L.PvsV.KEGG_STEROID_HORMONE_BIOSYNTHESIS"
111,"Down",0.521200853046188,0.757434007408047,"L.PvsV.REACTOME_B_WICH_COMPLEX_POSITIVELY_REGULATES_RRNA_EXPRESSION"
88,"Down",0.521299746320717,0.757434007408047,"L.PvsV.BROWNE_HCMV_INFECTION_10HR_DN"
35,"Up",0.521310230074845,0.757434007408047,"L.PvsV.BIOCARTA_GSK3_PATHWAY"
6,"Up",0.521395158653468,0.757434007408047,"L.PvsV.REACTOME_RELEASE_OF_APOPTOTIC_FACTORS_FROM_THE_MITOCHONDRIA"
13,"Up",0.521926274652556,0.75800640203677,"L.PvsV.POS_RESPONSE_TO_HISTAMINE_DN"
1060,"Down",0.52209005387618,0.758045143876418,"L.PvsV.MARTINEZ_TP53_TARGETS_DN"
12,"Up",0.522683312843537,0.75816489268953,"L.PvsV.REACTOME_INTERLEUKIN_23_SIGNALING"
240,"Down",0.522685253268788,0.75816489268953,"L.PvsV.GARCIA_TARGETS_OF_FLI1_AND_DAX1_DN"
79,"Down",0.52279950396738,0.75816489268953,"L.PvsV.HESS_TARGETS_OF_HOXA9_AND_MEIS1_UP"
109,"Down",0.522810397631263,0.75816489268953,"L.PvsV.REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM"
19,"Up",0.522858154426692,0.75816489268953,"L.PvsV.REACTOME_INTERLEUKIN_15_SIGNALING"
167,"Down",0.523005846054106,0.758180210496369,"L.PvsV.BOYLAN_MULTIPLE_MYELOMA_PCA3_UP"
18,"Down",0.523547306208219,0.758679066828377,"L.PvsV.REACTOME_METHYLATION"
202,"Up",0.523624402064946,0.758679066828377,"L.PvsV.HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN"
123,"Up",0.523921395466386,0.758718279719308,"L.PvsV.FALVELLA_SMOKERS_WITH_LUNG_CANCER"
648,"Down",0.523925916434856,0.758718279719308,"L.PvsV.SANSOM_APC_TARGETS_DN"
307,"Down",0.524147024761413,0.758839722415777,"L.PvsV.CAIRO_HEPATOBLASTOMA_UP"
54,"Up",0.524427818616862,0.759047489301735,"L.PvsV.ROZANOV_MMP14_TARGETS_DN"
13,"Up",0.524946421060263,0.75959925727354,"L.PvsV.REACTOME_ESTABLISHMENT_OF_SISTER_CHROMATID_COHESION"
37,"Down",0.52542460658427,0.760092268394669,"L.PvsV.BIOCARTA_HDAC_PATHWAY"
11,"Up",0.525697915221454,0.760173643494108,"L.PvsV.REACTOME_BICARBONATE_TRANSPORTERS"
74,"Down",0.525755835182034,0.760173643494108,"L.PvsV.REACTOME_DUAL_INCISION_IN_TC_NER"
68,"Up",0.526149979757049,0.760421867784254,"L.PvsV.YANG_BREAST_CANCER_ESR1_LASER_DN"
44,"Down",0.526282003647326,0.760421867784254,"L.PvsV.REACTOME_RA_BIOSYNTHESIS_PATHWAY"
389,"Down",0.526340113584797,0.760421867784254,"L.PvsV.HOSHIDA_LIVER_CANCER_SUBCLASS_S1"
13,"Down",0.526670080425015,0.760699810519829,"L.PvsV.VANLOO_SP3_TARGETS_UP"
30,"Down",0.527155490044958,0.761026721875247,"L.PvsV.REACTOME_ATF4_ACTIVATES_GENES_IN_RESPONSE_TO_ENDOPLASMIC_RETICULUM_STRESS"
78,"Up",0.52717170280018,0.761026721875247,"L.PvsV.PAL_PRMT5_TARGETS_DN"
59,"Down",0.527456952400803,0.761061410373627,"L.PvsV.PID_IL8_CXCR2_PATHWAY"
21,"Down",0.527597001801099,0.761061410373627,"L.PvsV.GEISS_RESPONSE_TO_DSRNA_DN"
52,"Down",0.527608678958603,0.761061410373627,"L.PvsV.REACTOME_FORMATION_OF_FIBRIN_CLOT_CLOTTING_CASCADE"
11,"Down",0.527901929271444,0.761182190581957,"L.PvsV.REACTOME_ADENYLATE_CYCLASE_ACTIVATING_PATHWAY"
32,"Down",0.528040001476758,0.761182190581957,"L.PvsV.BIOCARTA_PDZS_PATHWAY"
31,"Down",0.528105422874369,0.761182190581957,"L.PvsV.XU_HGF_TARGETS_INDUCED_BY_AKT1_6HR"
62,"Down",0.528274446275047,0.761227368635584,"L.PvsV.AMIT_SERUM_RESPONSE_480_MCF10A"
10,"Down",0.528503920669892,0.761359608489795,"L.PvsV.GERHOLD_RESPONSE_TO_TZD_UP"
523,"Down",0.528710908196265,0.761459393440258,"L.PvsV.GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP"
17,"Up",0.52890051347756,0.761534098702456,"L.PvsV.KEGG_STEROID_BIOSYNTHESIS"
369,"Down",0.529626554741627,0.762380947973563,"L.PvsV.HAMAI_APOPTOSIS_VIA_TRAIL_DN"
37,"Up",0.529818915943652,0.762459340513391,"L.PvsV.DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_UP"
123,"Up",0.530071919770406,0.762624939997548,"L.PvsV.LEE_LIVER_CANCER_ACOX1_UP"
168,"Down",0.530210286646069,0.762625565782028,"L.PvsV.REACTOME_DEATH_RECEPTOR_SIGNALLING"
28,"Down",0.530661990018406,0.763076760159106,"L.PvsV.KEGG_DORSO_VENTRAL_AXIS_FORMATION"
630,"Down",0.531010476105255,0.763211686800444,"L.PvsV.FOSTER_TOLERANT_MACROPHAGE_DN"
340,"Down",0.531031897110022,0.763211686800444,"L.PvsV.WINTER_HYPOXIA_METAGENE"
5,"Up",0.531549730391501,0.763757395876977,"L.PvsV.NIKOLSKY_BREAST_CANCER_19P13_AMPLICON"
357,"Down",0.532223818363817,0.764357410587438,"L.PvsV.REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS"
6,"Down",0.532243810953452,0.764357410587438,"L.PvsV.BIOCARTA_PELP1_PATHWAY"
74,"Down",0.532690946454796,0.764673219316852,"L.PvsV.FUJII_YBX1_TARGETS_UP"
32,"Up",0.532740322085099,0.764673219316852,"L.PvsV.WANG_LSD1_TARGETS_UP"
17,"Up",0.533357202719614,0.765359972446598,"L.PvsV.ZHENG_FOXP3_TARGETS_DN"
7,"Up",0.533730178256037,0.765550033823646,"L.PvsV.TESAR_ALK_AND_JAK_TARGETS_MOUSE_ES_D4_DN"
138,"Down",0.533766572687675,0.765550033823646,"L.PvsV.WORSCHECH_TUMOR_REJECTION_UP"
25,"Up",0.534182156018358,0.765947391241053,"L.PvsV.AUJLA_IL22_AND_IL17A_SIGNALING"
13,"Down",0.534532396748429,0.766248616326063,"L.PvsV.CLIMENT_BREAST_CANCER_COPY_NUMBER_DN"
40,"Down",0.534748118080572,0.766248616326063,"L.PvsV.SCHEIDEREIT_IKK_TARGETS"
9,"Down",0.534861152956024,0.766248616326063,"L.PvsV.BRUNEAU_SEPTATION_ATRIAL"
118,"Down",0.534946583291482,0.766248616326063,"L.PvsV.KEGG_OOCYTE_MEIOSIS"
587,"Down",0.535151902153389,0.766344176898753,"L.PvsV.DELACROIX_RARG_BOUND_MEF"
24,"Down",0.535740877001545,0.766939599525559,"L.PvsV.BIOCARTA_COMP_PATHWAY"
30,"Down",0.535845120811581,0.766939599525559,"L.PvsV.REACTOME_SYNTHESIS_OF_IP3_AND_IP4_IN_THE_CYTOSOL"
44,"Down",0.536114641637964,0.767003144765149,"L.PvsV.JEPSEN_SMRT_TARGETS"
1244,"Down",0.536270956497517,0.767003144765149,"L.PvsV.NUYTTEN_NIPP1_TARGETS_UP"
25,"Up",0.536305689575342,0.767003144765149,"L.PvsV.BIOCARTA_IL3_PATHWAY"
72,"Down",0.536505152836609,0.767089989664756,"L.PvsV.SCHRAETS_MLL_TARGETS_DN"
344,"Down",0.536906356777641,0.767465162001959,"L.PvsV.DOANE_RESPONSE_TO_ANDROGEN_UP"
86,"Up",0.537227817991767,0.767726183943262,"L.PvsV.KENNY_CTNNB1_TARGETS_DN"
13,"Down",0.53781510738249,0.767948384250375,"L.PvsV.PID_ALK2_PATHWAY"
19,"Up",0.537924158903533,0.767948384250375,"L.PvsV.REACTOME_METABOLISM_OF_AMINE_DERIVED_HORMONES"
2751,"Down",0.53808924578193,0.767948384250375,"L.PvsV.BLALOCK_ALZHEIMERS_DISEASE_UP"
28,"Down",0.538245037598661,0.767948384250375,"L.PvsV.REACTOME_REGULATION_OF_FZD_BY_UBIQUITINATION"
42,"Down",0.538284571480962,0.767948384250375,"L.PvsV.VANDESLUIS_COMMD1_TARGETS_GROUP_4_DN"
123,"Down",0.538455904494843,0.767948384250375,"L.PvsV.REACTOME_PEPTIDE_HORMONE_METABOLISM"
36,"Down",0.538459822349495,0.767948384250375,"L.PvsV.REACTOME_NOTCH3_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS"
105,"Down",0.538587663154391,0.767948384250375,"L.PvsV.HUPER_BREAST_BASAL_VS_LUMINAL_DN"
13,"Down",0.538633357591419,0.767948384250375,"L.PvsV.SCHLESINGER_METHYLATED_IN_COLON_CANCER"
23,"Down",0.539108573398234,0.768427765485649,"L.PvsV.REACTOME_SIGNALLING_TO_RAS"
528,"Up",0.539694577890444,0.769064773493883,"L.PvsV.WANG_LMO4_TARGETS_UP"
27,"Up",0.539852469669212,0.769091549807028,"L.PvsV.KEGG_RNA_POLYMERASE"
27,"Down",0.540335601126811,0.769468414011715,"L.PvsV.REACTOME_NEGATIVE_REGULATION_OF_NMDA_RECEPTOR_MEDIATED_NEURONAL_TRANSMISSION"
11,"Down",0.540395343029027,0.769468414011715,"L.PvsV.REACTOME_ERYTHROPOIETIN_ACTIVATES_PHOSPHOLIPASE_C_GAMMA_PLCG"
43,"Up",0.540919876398164,0.769843313708562,"L.PvsV.MARTINELLI_IMMATURE_NEUTROPHIL_UP"
88,"Down",0.540937108655772,0.769843313708562,"L.PvsV.KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION"
16,"Down",0.541552687679278,0.770499757398661,"L.PvsV.POS_RESPONSE_TO_HISTAMINE_UP"
22,"Down",0.541677076688117,0.770499757398661,"L.PvsV.GRAHAM_CML_DIVIDING_VS_NORMAL_DIVIDING_DN"
33,"Down",0.542152585796795,0.770733649076078,"L.PvsV.MATZUK_LUTEAL_GENES"
27,"Up",0.542321603042003,0.770733649076078,"L.PvsV.REACTOME_ERK_MAPK_TARGETS"
17,"Up",0.542342510195596,0.770733649076078,"L.PvsV.BIOCARTA_IL10_PATHWAY"
20,"Down",0.542399100841928,0.770733649076078,"L.PvsV.REACTOME_KILLING_MECHANISMS"
48,"Up",0.542876249901494,0.771213459842075,"L.PvsV.PID_HIF2PATHWAY"
177,"Down",0.54327359612864,0.771285859473945,"L.PvsV.KEGG_CELL_ADHESION_MOLECULES_CAMS"
73,"Down",0.543341953984187,0.771285859473945,"L.PvsV.BIOCARTA_PPARA_PATHWAY"
633,"Up",0.543439700811915,0.771285859473945,"L.PvsV.WANG_SMARCE1_TARGETS_DN"
6,"Up",0.54348520682049,0.771285859473945,"L.PvsV.REACTOME_GDP_FUCOSE_BIOSYNTHESIS"
18,"Down",0.543985611832499,0.771767911087143,"L.PvsV.SHIN_B_CELL_LYMPHOMA_CLUSTER_1"
138,"Up",0.544104054515768,0.771767911087143,"L.PvsV.KEGG_TIGHT_JUNCTION"
192,"Down",0.544866930300061,0.772389087898593,"L.PvsV.KEGG_JAK_STAT_SIGNALING_PATHWAY"
14,"Down",0.545230916036331,0.772389087898593,"L.PvsV.REACTOME_DEFECTIVE_EXT2_CAUSES_EXOSTOSES_2"
112,"Down",0.54533155130531,0.772389087898593,"L.PvsV.BOYAULT_LIVER_CANCER_SUBCLASS_G6_UP"
45,"Down",0.54555889705799,0.772389087898593,"L.PvsV.MURATA_VIRULENCE_OF_H_PILORI"
1130,"Up",0.545589229727432,0.772389087898593,"L.PvsV.FORTSCHEGGER_PHF8_TARGETS_DN"
167,"Down",0.545792627971486,0.772389087898593,"L.PvsV.QI_PLASMACYTOMA_DN"
231,"Up",0.546024832743208,0.772389087898593,"L.PvsV.REACTOME_MITOTIC_G2_G2_M_PHASES"
24,"Down",0.546027642832368,0.772389087898593,"L.PvsV.REACTOME_NOTCH2_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION"
9,"Up",0.546389670574018,0.772389087898593,"L.PvsV.REACTOME_SUMO_IS_PROTEOLYTICALLY_PROCESSED"
61,"Down",0.546421238079424,0.772389087898593,"L.PvsV.PID_PLK1_PATHWAY"
15,"Down",0.546527760012644,0.772389087898593,"L.PvsV.MIKKELSEN_PLURIPOTENT_STATE_DN"
89,"Up",0.546528609526264,0.772389087898593,"L.PvsV.ZHAN_MULTIPLE_MYELOMA_MS_DN"
32,"Down",0.546538827823861,0.772389087898593,"L.PvsV.TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_TOP20_DN"
33,"Up",0.546704572870758,0.772389087898593,"L.PvsV.MCCABE_HOXC6_TARGETS_CANCER_DN"
8,"Up",0.546765960379698,0.772389087898593,"L.PvsV.KASLER_HDAC7_TARGETS_2_UP"
118,"Down",0.54681819838176,0.772389087898593,"L.PvsV.LEE_AGING_NEOCORTEX_DN"
340,"Up",0.546916852798515,0.772389087898593,"L.PvsV.AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_DN"
64,"Down",0.547227659229899,0.7726306761701,"L.PvsV.REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS"
337,"Down",0.547990228744159,0.773509822498457,"L.PvsV.YAMAZAKI_TCEB3_TARGETS_UP"
22,"Down",0.548223931668222,0.773642194536396,"L.PvsV.BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_24HR_DN"
23,"Up",0.548429948142048,0.773735438447916,"L.PvsV.REACTOME_PLATELET_SENSITIZATION_BY_LDL"
338,"Down",0.548677094501212,0.773886646810511,"L.PvsV.TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN"
167,"Down",0.549042693792822,0.774204808462258,"L.PvsV.HILLION_HMGA1B_TARGETS"
30,"Up",0.549338550031816,0.774424488303394,"L.PvsV.REACTOME_RNA_POLYMERASE_III_TRANSCRIPTION_INITIATION_FROM_TYPE_3_PROMOTER"
17,"Up",0.549989463756662,0.775144467272645,"L.PvsV.IVANOV_MUTATED_IN_COLON_CANCER"
59,"Down",0.55044675652456,0.775591263207006,"L.PvsV.PID_HDAC_CLASSIII_PATHWAY"
43,"Up",0.550856559405642,0.775933881862297,"L.PvsV.KEGG_SPHINGOLIPID_METABOLISM"
170,"Down",0.551010742303264,0.775933881862297,"L.PvsV.ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_DN"
15,"Down",0.551110933997693,0.775933881862297,"L.PvsV.BIOCARTA_STEM_PATHWAY"
69,"Down",0.551539702875598,0.776286343832862,"L.PvsV.BOYLAN_MULTIPLE_MYELOMA_C_UP"
106,"Up",0.551642077214562,0.776286343832862,"L.PvsV.MAGRANGEAS_MULTIPLE_MYELOMA_IGG_VS_IGA_UP"
12,"Down",0.552302124989435,0.776756569610771,"L.PvsV.MIKKELSEN_PLURIPOTENT_STATE_UP"
250,"Down",0.552343916913397,0.776756569610771,"L.PvsV.DARWICHE_SQUAMOUS_CELL_CARCINOMA_UP"
1063,"Up",0.552397690669118,0.776756569610771,"L.PvsV.MARTINEZ_TP53_TARGETS_UP"
28,"Down",0.552938868266847,0.777257722748514,"L.PvsV.REACTOME_TRP_CHANNELS"
42,"Up",0.553035247113882,0.777257722748514,"L.PvsV.PID_IGF1_PATHWAY"
8,"Up",0.553421758395016,0.777479299317039,"L.PvsV.REACTOME_TLR3_MEDIATED_TICAM1_DEPENDENT_PROGRAMMED_CELL_DEATH"
123,"Down",0.553476265288623,0.777479299317039,"L.PvsV.KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_UP"
84,"Up",0.553718295768636,0.777479299317039,"L.PvsV.KEGG_PANCREATIC_CANCER"
6,"Up",0.553755377231054,0.777479299317039,"L.PvsV.ZHAN_EARLY_DIFFERENTIATION_GENES_UP"
39,"Down",0.554111925751417,0.777741703860722,"L.PvsV.DACOSTA_LOW_DOSE_UV_RESPONSE_VIA_ERCC3_XPCS_UP"
23,"Up",0.554223605210932,0.777741703860722,"L.PvsV.ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN"
50,"Down",0.554584323096328,0.777933997851531,"L.PvsV.REACTOME_DAG_AND_IP3_SIGNALING"
11,"Up",0.554680346289535,0.777933997851531,"L.PvsV.REACTOME_PHENYLALANINE_METABOLISM"
16,"Down",0.554810970725912,0.777933997851531,"L.PvsV.TSUDA_ALVEOLAR_SOFT_PART_SARCOMA"
306,"Up",0.554923437787383,0.777933997851531,"L.PvsV.ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP"
336,"Down",0.555464026453283,0.778323937264145,"L.PvsV.CHANDRAN_METASTASIS_UP"
179,"Up",0.555598079269296,0.778323937264145,"L.PvsV.TSENG_IRS1_TARGETS_UP"
875,"Down",0.555822526174808,0.778323937264145,"L.PvsV.BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_B"
53,"Down",0.556038972760253,0.778323937264145,"L.PvsV.XU_HGF_SIGNALING_NOT_VIA_AKT1_6HR"
117,"Down",0.556282744378961,0.778323937264145,"L.PvsV.BHAT_ESR1_TARGETS_VIA_AKT1_DN"
61,"Up",0.556361302734512,0.778323937264145,"L.PvsV.PID_PI3KCI_PATHWAY"
127,"Down",0.556403607747077,0.778323937264145,"L.PvsV.MORI_SMALL_PRE_BII_LYMPHOCYTE_DN"
39,"Up",0.556448364586452,0.778323937264145,"L.PvsV.CHEOK_RESPONSE_TO_HD_MTX_DN"
39,"Down",0.556468533913034,0.778323937264145,"L.PvsV.REACTOME_SIGNALING_BY_NTRK2_TRKB"
29,"Up",0.556686667419803,0.778432115367752,"L.PvsV.LUND_SILENCED_BY_METHYLATION"
16,"Up",0.55748964064433,0.779172799454905,"L.PvsV.REACTOME_ERKS_ARE_INACTIVATED"
16,"Down",0.557559537885298,0.779172799454905,"L.PvsV.BIOCARTA_P27_PATHWAY"
39,"Down",0.557644875163249,0.779172799454905,"L.PvsV.BUCKANOVICH_T_LYMPHOCYTE_HOMING_ON_TUMOR_UP"
370,"Down",0.557780057920513,0.779172799454905,"L.PvsV.HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_UP"
10,"Down",0.557938045526708,0.779196628875263,"L.PvsV.PHONG_TNF_TARGETS_DN"
72,"Down",0.558181174439421,0.779339321584738,"L.PvsV.KEGG_GLIOMA"
1053,"Down",0.558438090280362,0.779501186861935,"L.PvsV.NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN"
212,"Down",0.558699549244075,0.77966931039134,"L.PvsV.REACTOME_SCAVENGING_OF_HEME_FROM_PLASMA"
133,"Down",0.559330759342525,0.780235427044421,"L.PvsV.MIKKELSEN_MEF_LCP_WITH_H3K27ME3"
240,"Down",0.559387453934542,0.780235427044421,"L.PvsV.TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN"
139,"Down",0.560135883107854,0.780701889266491,"L.PvsV.ROSS_AML_WITH_MLL_FUSIONS"
7,"Up",0.560159958775586,0.780701889266491,"L.PvsV.BIOCARTA_RAN_PATHWAY"
9,"Down",0.560258648126841,0.780701889266491,"L.PvsV.FUNG_IL2_TARGETS_WITH_STAT5_BINDING_SITES"
33,"Down",0.560443389640385,0.780701889266491,"L.PvsV.MARCHINI_TRABECTEDIN_RESISTANCE_UP"
246,"Up",0.560549038094258,0.780701889266491,"L.PvsV.SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_UP"
82,"Down",0.560569090321572,0.780701889266491,"L.PvsV.WIERENGA_PML_INTERACTOME"
291,"Up",0.561138732774049,0.78129842697248,"L.PvsV.SHEPARD_BMYB_MORPHOLINO_UP"
192,"Up",0.561600413090404,0.78161902743545,"L.PvsV.BENPORATH_PROLIFERATION"
25,"Up",0.561651726533015,0.78161902743545,"L.PvsV.WEBER_METHYLATED_IN_COLON_CANCER"
13,"Up",0.562251315678643,0.782256548663114,"L.PvsV.LIU_TARGETS_OF_VMYB_VS_CMYB_UP"
7,"Up",0.562836286960782,0.782873416504696,"L.PvsV.REACTOME_MET_ACTIVATES_PTPN11"
22,"Down",0.563592902642772,0.783728661647858,"L.PvsV.REACTOME_POST_CHAPERONIN_TUBULIN_FOLDING_PATHWAY"
52,"Up",0.563898705946725,0.783956737535691,"L.PvsV.LANG_MYB_FAMILY_TARGETS"
18,"Up",0.564197109932335,0.784174414483629,"L.PvsV.BIOCARTA_TCRA_PATHWAY"
9,"Down",0.564948427602544,0.785021326015197,"L.PvsV.CHEMELLO_SOLEUS_VS_EDL_MYOFIBERS_DN"
36,"Up",0.565530152734291,0.785630817682624,"L.PvsV.REACTOME_DIGESTION"
216,"Down",0.565671239861553,0.785630817682624,"L.PvsV.PECE_MAMMARY_STEM_CELL_DN"
761,"Up",0.566047515154605,0.785917921810022,"L.PvsV.KEGG_OLFACTORY_TRANSDUCTION"
76,"Up",0.566162250419482,0.785917921810022,"L.PvsV.CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_UP"
50,"Down",0.566505112021531,0.78619647699976,"L.PvsV.BIOCARTA_ALK_PATHWAY"
73,"Down",0.566649333765911,0.786199288931423,"L.PvsV.REACTOME_NETRIN_1_SIGNALING"
17,"Up",0.567741589405782,0.787396835321423,"L.PvsV.MARSHALL_VIRAL_INFECTION_RESPONSE_UP"
50,"Down",0.567797283853592,0.787396835321423,"L.PvsV.PID_AURORA_B_PATHWAY"
9,"Down",0.568134124489968,0.787666392754522,"L.PvsV.REACTOME_RUNX1_REGULATES_EXPRESSION_OF_COMPONENTS_OF_TIGHT_JUNCTIONS"
17,"Up",0.5683823321063,0.787812964205498,"L.PvsV.CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_LD_MTX_UP"
42,"Up",0.568527150542819,0.78781619432362,"L.PvsV.BIOCARTA_GLEEVEC_PATHWAY"
22,"Down",0.569023219518688,0.788306033755657,"L.PvsV.REACTOME_TRANSCRIPTION_OF_E2F_TARGETS_UNDER_NEGATIVE_CONTROL_BY_DREAM_COMPLEX"
21,"Down",0.56923851887354,0.788406756225401,"L.PvsV.REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_24_HYDROXYCHOLESTEROL"
221,"Down",0.569522323379857,0.788602285491418,"L.PvsV.REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION"
96,"Down",0.570220016938503,0.788913171084382,"L.PvsV.MUELLER_METHYLATED_IN_GLIOBLASTOMA"
196,"Down",0.570263687159418,0.788913171084382,"L.PvsV.SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP"
85,"Up",0.570431198942693,0.788913171084382,"L.PvsV.CHIBA_RESPONSE_TO_TSA"
37,"Up",0.570930291383445,0.788913171084382,"L.PvsV.KEGG_ETHER_LIPID_METABOLISM"
21,"Up",0.57096723797133,0.788913171084382,"L.PvsV.CHESLER_BRAIN_QTL_TRANS"
29,"Up",0.570972350820605,0.788913171084382,"L.PvsV.TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN"
14,"Down",0.571006641573619,0.788913171084382,"L.PvsV.REACTOME_ACETYLCHOLINE_BINDING_AND_DOWNSTREAM_EVENTS"
35,"Down",0.571026606557036,0.788913171084382,"L.PvsV.PID_PDGFRA_PATHWAY"
31,"Down",0.571031020198896,0.788913171084382,"L.PvsV.TIAN_TNF_SIGNALING_NOT_VIA_NFKB"
46,"Up",0.571231737551125,0.788941146780801,"L.PvsV.BIOCARTA_NGF_PATHWAY"
22,"Down",0.571336652506842,0.788941146780801,"L.PvsV.SARTIPY_NORMAL_AT_INSULIN_RESISTANCE_DN"
35,"Down",0.571572603397636,0.789069893679284,"L.PvsV.PID_ALK1_PATHWAY"
7,"Up",0.571797400638245,0.789183182258826,"L.PvsV.MIKHAYLOVA_OXIDATIVE_STRESS_RESPONSE_VIA_VHL_DN"
463,"Up",0.572989083807397,0.790630557616945,"L.PvsV.MARKEY_RB1_ACUTE_LOF_DN"
300,"Up",0.574148196278952,0.792032279747088,"L.PvsV.REACTOME_DISEASES_OF_METABOLISM"
12,"Up",0.574627449698152,0.792270927070407,"L.PvsV.REACTOME_COHESIN_LOADING_ONTO_CHROMATIN"
140,"Down",0.574741511610955,0.792270927070407,"L.PvsV.NATSUME_RESPONSE_TO_INTERFERON_BETA_UP"
71,"Down",0.574862932294701,0.792270927070407,"L.PvsV.HUANG_FOXA2_TARGETS_DN"
9,"Down",0.574894367771111,0.792270927070407,"L.PvsV.TESAR_ALK_AND_JAK_TARGETS_MOUSE_ES_D4_UP"
607,"Up",0.575421996100279,0.792800452638535,"L.PvsV.REACTOME_SIGNALING_BY_INTERLEUKINS"
36,"Up",0.575753039205558,0.792955783783678,"L.PvsV.REACTOME_METABOLISM_OF_ANGIOTENSINOGEN_TO_ANGIOTENSINS"
79,"Down",0.575835859176518,0.792955783783678,"L.PvsV.REACTOME_ACTIVATION_OF_MATRIX_METALLOPROTEINASES"
87,"Down",0.575964989631986,0.792955783783678,"L.PvsV.LEE_LIVER_CANCER_MYC_TGFA_UP"
122,"Down",0.576677720236125,0.793449205352823,"L.PvsV.WNT_SIGNALING"
18,"Down",0.576918764240162,0.793449205352823,"L.PvsV.LOPEZ_MESOTHELIOMA_SURVIVAL_UP"
143,"Up",0.577124909342307,0.793449205352823,"L.PvsV.KEGG_NEUROTROPHIN_SIGNALING_PATHWAY"
49,"Down",0.57724606650382,0.793449205352823,"L.PvsV.WEBER_METHYLATED_HCP_IN_SPERM_DN"
10,"Down",0.577260925538558,0.793449205352823,"L.PvsV.TESAR_ALK_TARGETS_EPISC_4D_UP"
8,"Up",0.577571552640259,0.793449205352823,"L.PvsV.LAU_APOPTOSIS_CDKN2A_DN"
978,"Up",0.577627436775563,0.793449205352823,"L.PvsV.MILI_PSEUDOPODIA_HAPTOTAXIS_DN"
1901,"Up",0.577714079303785,0.793449205352823,"L.PvsV.REACTOME_DISEASE"
128,"Down",0.5777957126609,0.793449205352823,"L.PvsV.URS_ADIPOCYTE_DIFFERENTIATION_UP"
488,"Down",0.577933829203672,0.793449205352823,"L.PvsV.BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_D"
21,"Down",0.578219314196235,0.793449205352823,"L.PvsV.REACTOME_PI_3K_CASCADE_FGFR3"
7,"Up",0.578312058413442,0.793449205352823,"L.PvsV.TERAO_AOX4_TARGETS_HG_DN"
47,"Down",0.578349272869259,0.793449205352823,"L.PvsV.DAZARD_UV_RESPONSE_CLUSTER_G5"
113,"Up",0.578370734386965,0.793449205352823,"L.PvsV.PID_CD8_TCR_DOWNSTREAM_PATHWAY"
80,"Down",0.57847598965043,0.793449205352823,"L.PvsV.MARTIN_NFKB_TARGETS_UP"
67,"Up",0.579764984967863,0.795019990547448,"L.PvsV.PID_ARF6_TRAFFICKING_PATHWAY"
77,"Down",0.579978051227389,0.795114962865419,"L.PvsV.KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM"
54,"Down",0.580517475469719,0.795529216603218,"L.PvsV.WANG_RESPONSE_TO_BEXAROTENE_DN"
222,"Down",0.580746934586146,0.795529216603218,"L.PvsV.GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_DN"
5,"Up",0.581015987378098,0.795529216603218,"L.PvsV.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_18"
48,"Down",0.581365688040558,0.795529216603218,"L.PvsV.BONOME_OVARIAN_CANCER_POOR_SURVIVAL_UP"
310,"Up",0.581382153450552,0.795529216603218,"L.PvsV.CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN"
41,"Down",0.581383077874592,0.795529216603218,"L.PvsV.REACTOME_EGR2_AND_SOX10_MEDIATED_INITIATION_OF_SCHWANN_CELL_MYELINATION"
48,"Down",0.58138519816343,0.795529216603218,"L.PvsV.YU_BAP1_TARGETS"
24,"Up",0.581431283106096,0.795529216603218,"L.PvsV.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_24"
336,"Up",0.581773587708544,0.795800634943231,"L.PvsV.IWANAGA_CARCINOGENESIS_BY_KRAS_UP"
315,"Down",0.582176011706104,0.795912991037773,"L.PvsV.KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_DN"
684,"Down",0.582187243075546,0.795912991037773,"L.PvsV.KIM_WT1_TARGETS_DN"
750,"Up",0.582287583423366,0.795912991037773,"L.PvsV.MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN"
227,"Up",0.582918378687676,0.796578278735582,"L.PvsV.JACKSON_DNMT1_TARGETS_UP"
28,"Up",0.583085361882132,0.796609578909391,"L.PvsV.BIOCARTA_NKT_PATHWAY"
81,"Down",0.583696172680067,0.797247069848836,"L.PvsV.CROMER_TUMORIGENESIS_DN"
37,"Up",0.583923083289999,0.797360021612843,"L.PvsV.REACTOME_UPTAKE_AND_ACTIONS_OF_BACTERIAL_TOXINS"
9,"Down",0.584218847339288,0.797566915293562,"L.PvsV.NAGY_PCAF_COMPONENTS_HUMAN"
87,"Up",0.584534945637498,0.797738392964236,"L.PvsV.SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE"
12,"Down",0.584811175323412,0.797738392964236,"L.PvsV.LY_AGING_OLD_UP"
116,"Down",0.584814056733533,0.797738392964236,"L.PvsV.MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_DN"
29,"Up",0.585029274454763,0.797738392964236,"L.PvsV.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_SALMON_DN"
30,"Up",0.585121883066079,0.797738392964236,"L.PvsV.REACTOME_GLUTAMATE_NEUROTRANSMITTER_RELEASE_CYCLE"
115,"Down",0.585210150454502,0.797738392964236,"L.PvsV.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_UP"
97,"Up",0.585414225457618,0.797819879850917,"L.PvsV.HU_GENOTOXIC_DAMAGE_4HR"
333,"Down",0.585584128441943,0.79785476741141,"L.PvsV.BILD_MYC_ONCOGENIC_SIGNATURE"
77,"Down",0.586342405871288,0.798691096837238,"L.PvsV.POMEROY_MEDULLOBLASTOMA_PROGNOSIS_UP"
126,"Up",0.586912113589419,0.799143012422159,"L.PvsV.NADERI_BREAST_CANCER_PROGNOSIS_UP"
86,"Down",0.586987787171463,0.799143012422159,"L.PvsV.ZAMORA_NOS2_TARGETS_UP"
303,"Down",0.587107780151711,0.799143012422159,"L.PvsV.FOSTER_KDM1A_TARGETS_DN"
27,"Down",0.587494664269422,0.799164739396059,"L.PvsV.REACTOME_WNT_LIGAND_BIOGENESIS_AND_TRAFFICKING"
19,"Up",0.587628529513847,0.799164739396059,"L.PvsV.AMIT_EGF_RESPONSE_20_HELA"
16,"Up",0.587794980316001,0.799164739396059,"L.PvsV.REACTOME_DEFECTIVE_GALNT3_CAUSES_FAMILIAL_HYPERPHOSPHATEMIC_TUMORAL_CALCINOSIS_HFTC"
54,"Down",0.587817758919445,0.799164739396059,"L.PvsV.REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY"
684,"Down",0.587930241619444,0.799164739396059,"L.PvsV.CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_UP"
36,"Down",0.588088946568873,0.799164739396059,"L.PvsV.KONDO_COLON_CANCER_HCP_WITH_H3K27ME1"
378,"Up",0.588399493857515,0.799164739396059,"L.PvsV.REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL"
23,"Down",0.588432751382112,0.799164739396059,"L.PvsV.REACTOME_NOREPINEPHRINE_NEUROTRANSMITTER_RELEASE_CYCLE"
13,"Down",0.58864850741035,0.799164739396059,"L.PvsV.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_7"
93,"Down",0.588693393134411,0.799164739396059,"L.PvsV.MCCLUNG_DELTA_FOSB_TARGETS_8WK"
121,"Up",0.588804836322731,0.799164739396059,"L.PvsV.GROSS_HYPOXIA_VIA_HIF1A_UP"
39,"Up",0.589077106663906,0.799164739396059,"L.PvsV.MARSON_FOXP3_TARGETS_STIMULATED_UP"
73,"Down",0.589136282063434,0.799164739396059,"L.PvsV.ZHAN_V1_LATE_DIFFERENTIATION_GENES_UP"
65,"Up",0.589187410840108,0.799164739396059,"L.PvsV.REACTOME_SIGNALING_BY_RETINOIC_ACID"
93,"Down",0.589291850699536,0.799164739396059,"L.PvsV.REACTOME_FOXO_MEDIATED_TRANSCRIPTION"
36,"Up",0.58948235529237,0.799174012018607,"L.PvsV.GROSS_HIF1A_TARGETS_DN"
81,"Up",0.589649826214466,0.799174012018607,"L.PvsV.KEGG_RIG_I_LIKE_RECEPTOR_SIGNALING_PATHWAY"
262,"Down",0.589732314891647,0.799174012018607,"L.PvsV.LIU_CMYB_TARGETS_UP"
12,"Down",0.590206512218924,0.799620633682537,"L.PvsV.REACTOME_P2Y_RECEPTORS"
25,"Down",0.590876844160928,0.800324248699083,"L.PvsV.REACTOME_INTERLEUKIN_20_FAMILY_SIGNALING"
124,"Down",0.591015356744141,0.800324248699083,"L.PvsV.MCBRYAN_PUBERTAL_BREAST_6_7WK_DN"
27,"Down",0.591492778997778,0.800774626610851,"L.PvsV.KEGG_PRIMARY_BILE_ACID_BIOSYNTHESIS"
49,"Up",0.591654772160735,0.800797854412902,"L.PvsV.KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_4NQO_IN_WS"
106,"Down",0.591841000515016,0.800853864867235,"L.PvsV.KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450"
144,"Down",0.59200921415407,0.80088547713674,"L.PvsV.SWEET_KRAS_TARGETS_UP"
10,"Down",0.592555392588093,0.80142826947641,"L.PvsV.DASU_IL6_SIGNALING_DN"
52,"Up",0.592937975392908,0.801612228243719,"L.PvsV.WANG_RESPONSE_TO_BEXAROTENE_UP"
115,"Up",0.592981373397868,0.801612228243719,"L.PvsV.DEMAGALHAES_AGING_UP"
29,"Down",0.593158201528361,0.801655266744148,"L.PvsV.LEI_HOXC8_TARGETS_UP"
19,"Down",0.593511106245666,0.801936194142787,"L.PvsV.MARTINELLI_IMMATURE_NEUTROPHIL_DN"
47,"Down",0.593937581281066,0.802316366211339,"L.PvsV.REACTOME_TRNA_MODIFICATION_IN_THE_NUCLEUS_AND_CYTOSOL"
95,"Up",0.594850038931805,0.803352678371751,"L.PvsV.WIERENGA_STAT5A_TARGETS_GROUP2"
61,"Up",0.59510610862146,0.803502240431759,"L.PvsV.REACTOME_FORMATION_OF_TC_NER_PRE_INCISION_COMPLEX"
214,"Up",0.595450314664023,0.803770700629244,"L.PvsV.REACTOME_ROLE_OF_PHOSPHOLIPIDS_IN_PHAGOCYTOSIS"
125,"Down",0.595632670460662,0.803820608976568,"L.PvsV.FLORIO_HUMAN_NEOCORTEX"
31,"Up",0.596040901620312,0.804175242815692,"L.PvsV.KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_UV_IN_OLD"
8,"Down",0.597013898198377,0.805281078594716,"L.PvsV.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_6"
196,"Up",0.597151821710677,0.805281078594716,"L.PvsV.REACTOME_METABOLISM_OF_STEROIDS"
87,"Up",0.597876861993325,0.805973568485251,"L.PvsV.BYSTROEM_CORRELATED_WITH_IL5_DN"
145,"Down",0.597956877903147,0.805973568485251,"L.PvsV.YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_12"
67,"Up",0.598367404054168,0.806248323355789,"L.PvsV.PID_NFAT_3PATHWAY"
132,"Down",0.598452363728008,0.806248323355789,"L.PvsV.BOSCO_INTERFERON_INDUCED_ANTIVIRAL_MODULE"
18,"Down",0.598945449429723,0.806716051132019,"L.PvsV.REACTOME_SYNTHESIS_OF_GLYCOSYLPHOSPHATIDYLINOSITOL_GPI"
494,"Down",0.599316985715277,0.806996066494629,"L.PvsV.REACTOME_G_ALPHA_I_SIGNALLING_EVENTS"
12,"Up",0.599445260461827,0.806996066494629,"L.PvsV.SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX1_DN"
6,"Down",0.599989390776762,0.807531972153047,"L.PvsV.CROSBY_E2F4_TARGETS"
63,"Down",0.601359846998824,0.808911160918603,"L.PvsV.BOYAULT_LIVER_CANCER_SUBCLASS_G123_UP"
46,"Down",0.601430819920186,0.808911160918603,"L.PvsV.REACTOME_RET_SIGNALING"
10,"Up",0.601754323068567,0.808911160918603,"L.PvsV.RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_SMAD4_UP"
22,"Down",0.601820400477214,0.808911160918603,"L.PvsV.REACTOME_SEROTONIN_NEUROTRANSMITTER_RELEASE_CYCLE"
187,"Down",0.601826837226549,0.808911160918603,"L.PvsV.TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP"
32,"Down",0.602066397266174,0.808911160918603,"L.PvsV.REACTOME_DISEASES_OF_PROGRAMMED_CELL_DEATH"
166,"Down",0.602145526100491,0.808911160918603,"L.PvsV.KESHELAVA_MULTIPLE_DRUG_RESISTANCE"
59,"Up",0.602589126061542,0.808911160918603,"L.PvsV.KAMIKUBO_MYELOID_CEBPA_NETWORK"
44,"Up",0.602830721345183,0.808911160918603,"L.PvsV.DANG_MYC_TARGETS_DN"
58,"Down",0.602844736744383,0.808911160918603,"L.PvsV.PARK_HSC_MARKERS"
46,"Down",0.602865725783344,0.808911160918603,"L.PvsV.PARK_TRETINOIN_RESPONSE_AND_PML_RARA_FUSION"
61,"Down",0.602926003364348,0.808911160918603,"L.PvsV.GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP"
184,"Down",0.602936030264014,0.808911160918603,"L.PvsV.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP"
5,"Down",0.603062363050549,0.808911160918603,"L.PvsV.REACTOME_MRNA_EDITING_C_TO_U_CONVERSION"
94,"Up",0.603347338584728,0.808924389313154,"L.PvsV.ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_DN"
183,"Down",0.603364836593859,0.808924389313154,"L.PvsV.FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP"
368,"Down",0.604020635296164,0.80960729516424,"L.PvsV.KYNG_DNA_DAMAGE_UP"
10,"Up",0.604580123304177,0.810160809924574,"L.PvsV.REACTOME_SHC_RELATED_EVENTS_TRIGGERED_BY_IGF1R"
129,"Down",0.605175571279889,0.810482899326956,"L.PvsV.DOANE_BREAST_CANCER_CLASSES_UP"
99,"Up",0.605306624373503,0.810482899326956,"L.PvsV.NUTT_GBM_VS_AO_GLIOMA_UP"
16,"Up",0.605409051395391,0.810482899326956,"L.PvsV.HASINA_NOL7_TARGETS_UP"
41,"Up",0.60551341438277,0.810482899326956,"L.PvsV.PID_AR_NONGENOMIC_PATHWAY"
96,"Up",0.605695684021884,0.810482899326956,"L.PvsV.GRABARCZYK_BCL11B_TARGETS_DN"
9,"Down",0.606004712050497,0.810482899326956,"L.PvsV.REACTOME_TRAIL_SIGNALING"
5,"Down",0.606225921055337,0.810482899326956,"L.PvsV.REACTOME_ACTIVATION_OF_NOXA_AND_TRANSLOCATION_TO_MITOCHONDRIA"
87,"Down",0.606228282374904,0.810482899326956,"L.PvsV.STOSSI_RESPONSE_TO_ESTRADIOL"
141,"Up",0.606266013655167,0.810482899326956,"L.PvsV.BRUINS_UVC_RESPONSE_MIDDLE"
104,"Down",0.606286357680646,0.810482899326956,"L.PvsV.REACTOME_HDACS_DEACETYLATE_HISTONES"
28,"Up",0.606724608091938,0.810657997601846,"L.PvsV.BIOCARTA_ATM_PATHWAY"
20,"Down",0.606947910962869,0.810657997601846,"L.PvsV.ALONSO_METASTASIS_EMT_DN"
11,"Up",0.606985985192884,0.810657997601846,"L.PvsV.SCHMAHL_PDGF_SIGNALING"
52,"Down",0.607010029904045,0.810657997601846,"L.PvsV.XU_RESPONSE_TO_TRETINOIN_UP"
35,"Up",0.607150437342963,0.810657997601846,"L.PvsV.BIOCARTA_STRESS_PATHWAY"
28,"Up",0.607395952564483,0.810790010074608,"L.PvsV.PID_HIF1A_PATHWAY"
84,"Down",0.60791643450235,0.811167219481555,"L.PvsV.SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER"
25,"Up",0.607971958316434,0.811167219481555,"L.PvsV.REACTOME_SIGNALING_BY_CYTOSOLIC_FGFR1_FUSION_MUTANTS"
599,"Down",0.608528983200491,0.811400125383709,"L.PvsV.IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR"
133,"Down",0.608703704252659,0.811400125383709,"L.PvsV.SU_LIVER"
69,"Down",0.608717505007406,0.811400125383709,"L.PvsV.REACTOME_SIGNALING_BY_PTK6"
39,"Down",0.608733535918182,0.811400125383709,"L.PvsV.PID_INTEGRIN2_PATHWAY"
25,"Up",0.608950579543442,0.811493794720581,"L.PvsV.SMID_BREAST_CANCER_LUMINAL_A_DN"
318,"Up",0.60961758214296,0.812153962176066,"L.PvsV.REACTOME_FLT3_SIGNALING"
30,"Up",0.609758478040598,0.812153962176066,"L.PvsV.REACTOME_MRNA_CAPPING"
35,"Down",0.60994079371262,0.812153962176066,"L.PvsV.GENTLES_LEUKEMIC_STEM_CELL_DN"
15,"Up",0.610052716546298,0.812153962176066,"L.PvsV.RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_SMAD4_DN"
36,"Down",0.610180423020325,0.812153962176066,"L.PvsV.ABDULRAHMAN_KIDNEY_CANCER_VHL_DN"
65,"Down",0.61034778269095,0.812181201082614,"L.PvsV.REACTOME_DEADENYLATION_DEPENDENT_MRNA_DECAY"
13,"Down",0.610596525138851,0.812316695739343,"L.PvsV.MCBRYAN_TERMINAL_END_BUD_DN"
11,"Up",0.611220347460432,0.812872036895448,"L.PvsV.REACTOME_CREB_PHOSPHORYLATION"
69,"Up",0.611421715431082,0.812872036895448,"L.PvsV.PEART_HDAC_PROLIFERATION_CLUSTER_UP"
277,"Down",0.611504869209788,0.812872036895448,"L.PvsV.LU_AGING_BRAIN_DN"
215,"Up",0.611602038973605,0.812872036895448,"L.PvsV.NIKOLSKY_BREAST_CANCER_11Q12_Q14_AMPLICON"
55,"Down",0.612367066635495,0.813693225529357,"L.PvsV.REACTOME_DNA_DAMAGE_BYPASS"
162,"Up",0.613050609377302,0.814145824059859,"L.PvsV.BASSO_CD40_SIGNALING_UP"
64,"Down",0.61306004587454,0.814145824059859,"L.PvsV.FAELT_B_CLL_WITH_VH3_21_DN"
314,"Down",0.613226692681295,0.814145824059859,"L.PvsV.REACTOME_BIOLOGICAL_OXIDATIONS"
10,"Up",0.613346784693764,0.814145824059859,"L.PvsV.BIOCARTA_FBW7_PATHWAY"
30,"Down",0.613443932543566,0.814145824059859,"L.PvsV.KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_UP"
27,"Down",0.613832357386507,0.814465827691383,"L.PvsV.REACTOME_CD163_MEDIATING_AN_ANTI_INFLAMMATORY_RESPONSE"
104,"Down",0.614648201506788,0.815143684413248,"L.PvsV.FIGUEROA_AML_METHYLATION_CLUSTER_1_DN"
61,"Up",0.614671703543787,0.815143684413248,"L.PvsV.HASLINGER_B_CLL_WITH_11Q23_DELETION"
50,"Down",0.614785524326867,0.815143684413248,"L.PvsV.TOMIDA_METASTASIS_UP"
60,"Up",0.615065054515319,0.815256258070626,"L.PvsV.APPEL_IMATINIB_RESPONSE"
290,"Down",0.615336680365524,0.815256258070626,"L.PvsV.KEGG_MAPK_SIGNALING_PATHWAY"
295,"Up",0.615502926331261,0.815256258070626,"L.PvsV.LI_AMPLIFIED_IN_LUNG_CANCER"
12,"Down",0.615546226913042,0.815256258070626,"L.PvsV.REACTOME_FRUCTOSE_METABOLISM"
16,"Up",0.615730751777301,0.815256258070626,"L.PvsV.GAUSSMANN_MLL_AF4_FUSION_TARGETS_D_DN"
100,"Up",0.61575513360516,0.815256258070626,"L.PvsV.PID_MYC_REPRESS_PATHWAY"
28,"Down",0.616306840795101,0.815540160305479,"L.PvsV.LEE_INTRATHYMIC_T_PROGENITOR"
58,"Down",0.616409517574889,0.815540160305479,"L.PvsV.MORI_PLASMA_CELL_DN"
31,"Up",0.616412069075167,0.815540160305479,"L.PvsV.DEN_INTERACT_WITH_LCA5"
37,"Up",0.617071681291526,0.816217542071973,"L.PvsV.YANAGIHARA_ESX1_TARGETS"
194,"Down",0.617622557150657,0.816560239975815,"L.PvsV.FIGUEROA_AML_METHYLATION_CLUSTER_6_UP"
48,"Down",0.617626139189521,0.816560239975815,"L.PvsV.VIETOR_IFRD1_TARGETS"
13,"Down",0.617781555064807,0.816570456120802,"L.PvsV.REACTOME_REGULATED_PROTEOLYSIS_OF_P75NTR"
37,"Up",0.617963968231736,0.81661634329667,"L.PvsV.BURTON_ADIPOGENESIS_10"
94,"Up",0.618468566725662,0.817087862706377,"L.PvsV.YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_3"
57,"Up",0.619326057379734,0.817648373424932,"L.PvsV.NAKAMURA_ADIPOGENESIS_LATE_DN"
9,"Down",0.619351961722524,0.817648373424932,"L.PvsV.REACTOME_LECTIN_PATHWAY_OF_COMPLEMENT_ACTIVATION"
36,"Down",0.619485273334477,0.817648373424932,"L.PvsV.ZHAN_LATE_DIFFERENTIATION_GENES_DN"
18,"Down",0.619645089173446,0.817648373424932,"L.PvsV.REACTOME_EARLY_PHASE_OF_HIV_LIFE_CYCLE"
18,"Up",0.619778215321573,0.817648373424932,"L.PvsV.BIOCARTA_NPC_PATHWAY"
29,"Down",0.619780128960733,0.817648373424932,"L.PvsV.ZHANG_GATA6_TARGETS_UP"
512,"Down",0.620027350049851,0.817681192292471,"L.PvsV.DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP"
21,"Down",0.62010078482227,0.817681192292471,"L.PvsV.KRISHNAN_FURIN_TARGETS_DN"
10,"Down",0.620974681537333,0.818490493424384,"L.PvsV.GALIE_TUMOR_ANGIOGENESIS"
11,"Down",0.621010602263572,0.818490493424384,"L.PvsV.DING_LUNG_CANCER_MUTATED_RECURRENTLY"
9,"Down",0.621307986252462,0.818687286937526,"L.PvsV.DER_IFN_GAMMA_RESPONSE_DN"
60,"Down",0.621707862991485,0.819019007500577,"L.PvsV.PID_TNF_PATHWAY"
46,"Down",0.621955357133405,0.819149873651881,"L.PvsV.REACTOME_DUAL_INCISION_IN_GG_NER"
12,"Down",0.622144036801687,0.819203233978691,"L.PvsV.REACTOME_ACTIVATED_NTRK2_SIGNALS_THROUGH_PI3K"
48,"Up",0.622477441182133,0.819447088641908,"L.PvsV.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_UP"
15,"Up",0.623184309679021,0.820078249960543,"L.PvsV.REACTOME_TRAF3_DEPENDENT_IRF_ACTIVATION_PATHWAY"
13,"Up",0.623397429592707,0.820078249960543,"L.PvsV.REACTOME_MET_ACTIVATES_RAP1_AND_RAC1"
29,"Up",0.623554110674646,0.820078249960543,"L.PvsV.REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_CYCLIN_B"
9,"Up",0.623706111638267,0.820078249960543,"L.PvsV.REACTOME_SYNTHESIS_OF_PG"
251,"Up",0.62394163551784,0.820078249960543,"L.PvsV.HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_UP"
8,"Up",0.623942896108685,0.820078249960543,"L.PvsV.REACTOME_OPSINS"
263,"Down",0.623995152393562,0.820078249960543,"L.PvsV.REACTOME_BINDING_AND_UPTAKE_OF_LIGANDS_BY_SCAVENGER_RECEPTORS"
101,"Up",0.624439052595064,0.820466616396889,"L.PvsV.RIZKI_TUMOR_INVASIVENESS_2D_DN"
181,"Down",0.625581073779177,0.821771859568798,"L.PvsV.HOSHIDA_LIVER_CANCER_SUBCLASS_S2"
18,"Down",0.625796787737149,0.821859961852422,"L.PvsV.PID_TCR_RAS_PATHWAY"
30,"Up",0.626302995484372,0.822329437671121,"L.PvsV.REACTOME_APC_CDC20_MEDIATED_DEGRADATION_OF_NEK2A"
22,"Down",0.62686823215527,0.822876176540002,"L.PvsV.KEGG_SULFUR_METABOLISM"
394,"Down",0.627214784821509,0.822997724550683,"L.PvsV.RUTELLA_RESPONSE_TO_HGF_DN"
22,"Down",0.62731594804636,0.822997724550683,"L.PvsV.BIOCARTA_PRION_PATHWAY"
143,"Down",0.627407380897292,0.822997724550683,"L.PvsV.REACTOME_INTEGRATION_OF_ENERGY_METABOLISM"
110,"Up",0.628961227696369,0.824727753724252,"L.PvsV.LIN_MELANOMA_COPY_NUMBER_UP"
335,"Down",0.629054455187927,0.824727753724252,"L.PvsV.WANG_CISPLATIN_RESPONSE_AND_XPC_DN"
28,"Up",0.629412084992864,0.824727753724252,"L.PvsV.REACTOME_CYCLIN_A_B1_B2_ASSOCIATED_EVENTS_DURING_G2_M_TRANSITION"
455,"Up",0.629428050149693,0.824727753724252,"L.PvsV.DURCHDEWALD_SKIN_CARCINOGENESIS_DN"
160,"Down",0.62947207826304,0.824727753724252,"L.PvsV.SANA_RESPONSE_TO_IFNG_UP"
107,"Up",0.629791104746079,0.824797737199147,"L.PvsV.RADAEVA_RESPONSE_TO_IFNA1_UP"
10,"Up",0.630007789851517,0.824797737199147,"L.PvsV.REACTOME_SYNTHESIS_OF_12_EICOSATETRAENOIC_ACID_DERIVATIVES"
49,"Up",0.630031443894562,0.824797737199147,"L.PvsV.KAMMINGA_SENESCENCE"
17,"Up",0.630122199661638,0.824797737199147,"L.PvsV.DAZARD_UV_RESPONSE_CLUSTER_G3"
6,"Down",0.630564809328088,0.825181735094675,"L.PvsV.REACTOME_NADE_MODULATES_DEATH_SIGNALLING"
8,"Up",0.63143745172815,0.825932734943209,"L.PvsV.REACTOME_AMINO_ACID_CONJUGATION"
8,"Up",0.63143745172815,0.825932734943209,"L.PvsV.REACTOME_CONJUGATION_OF_BENZOATE_WITH_GLYCINE"
10,"Up",0.631607100326955,0.825959237868433,"L.PvsV.REACTOME_DISPLACEMENT_OF_DNA_GLYCOSYLASE_BY_APEX1"
104,"Up",0.632690115376362,0.827061142692172,"L.PvsV.KEGG_RIBOSOME"
29,"Down",0.632748893757983,0.827061142692172,"L.PvsV.REACTOME_RIPK1_MEDIATED_REGULATED_NECROSIS"
355,"Down",0.632941016018537,0.827116728330535,"L.PvsV.REACTOME_CELL_CYCLE_CHECKPOINTS"
82,"Down",0.633163820190832,0.827150429204716,"L.PvsV.KIM_LIVER_CANCER_POOR_SURVIVAL_DN"
14,"Up",0.633266009553909,0.827150429204716,"L.PvsV.REACTOME_SIGNALING_BY_ACTIVIN"
23,"Down",0.633916176089507,0.827632981439143,"L.PvsV.KEGG_NITROGEN_METABOLISM"
34,"Down",0.633934830239604,0.827632981439143,"L.PvsV.PID_TCR_CALCIUM_PATHWAY"
6,"Down",0.63432263904062,0.827792149181788,"L.PvsV.REACTOME_G2_M_DNA_REPLICATION_CHECKPOINT"
254,"Down",0.634356183049961,0.827792149181788,"L.PvsV.MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_UP"
37,"Down",0.634672454173039,0.827874931681051,"L.PvsV.REACTOME_BIOSYNTHESIS_OF_MARESIN_LIKE_SPMS"
18,"Up",0.634719087610051,0.827874931681051,"L.PvsV.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_1"
89,"Down",0.635339663908035,0.82801856554787,"L.PvsV.DORN_ADENOVIRUS_INFECTION_48HR_DN"
12,"Up",0.635344902707563,0.82801856554787,"L.PvsV.KORKOLA_CHORIOCARCINOMA"
63,"Down",0.635384475535268,0.82801856554787,"L.PvsV.DOANE_BREAST_CANCER_CLASSES_DN"
279,"Up",0.635528772383666,0.82801856554787,"L.PvsV.UEDA_PERIFERAL_CLOCK"
131,"Up",0.635578005459425,0.82801856554787,"L.PvsV.HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_UP"
19,"Up",0.635979038099137,0.828345842555978,"L.PvsV.MOROSETTI_FACIOSCAPULOHUMERAL_MUSCULAR_DISTROPHY_DN"
23,"Up",0.636289001442419,0.828452826880373,"L.PvsV.REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI"
18,"Up",0.636406707290799,0.828452826880373,"L.PvsV.BAKER_HEMATOPOIESIS_STAT3_TARGETS"
62,"Down",0.636510690647102,0.828452826880373,"L.PvsV.KEGG_VASOPRESSIN_REGULATED_WATER_REABSORPTION"
59,"Down",0.637599037659769,0.829616920448195,"L.PvsV.GENTILE_UV_RESPONSE_CLUSTER_D7"
9,"Down",0.63770517487879,0.829616920448195,"L.PvsV.REACTOME_VITAMIN_C_ASCORBATE_METABOLISM"
139,"Down",0.638059421926012,0.82988250854597,"L.PvsV.BRUECKNER_TARGETS_OF_MIRLET7A3_DN"
9,"Down",0.640274851058467,0.832568121237598,"L.PvsV.REACTOME_RUNX1_REGULATES_ESTROGEN_RECEPTOR_MEDIATED_TRANSCRIPTION"
11,"Up",0.640496836041712,0.832660946737509,"L.PvsV.REACTOME_MAPK1_ERK2_ACTIVATION"
26,"Down",0.640679092117847,0.83270209222369,"L.PvsV.REACTOME_TRAFFICKING_AND_PROCESSING_OF_ENDOSOMAL_TLR"
352,"Down",0.640950032938584,0.832789761164897,"L.PvsV.ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_UP"
267,"Up",0.641047788663014,0.832789761164897,"L.PvsV.REACTOME_PARASITE_INFECTION"
63,"Down",0.641372513241286,0.833015885767223,"L.PvsV.SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2"
61,"Down",0.641752967302942,0.833314268721927,"L.PvsV.WINNEPENNINCKX_MELANOMA_METASTASIS_DN"
34,"Up",0.642079822679727,0.833542930170512,"L.PvsV.FUJIWARA_PARK2_HEPATOCYTE_PROLIFERATION_UP"
13,"Down",0.642434592628544,0.833621317849069,"L.PvsV.REACTOME_PROCESSING_AND_ACTIVATION_OF_SUMO"
380,"Down",0.642441749928537,0.833621317849069,"L.PvsV.REACTOME_ANTI_INFLAMMATORY_RESPONSE_FAVOURING_LEISHMANIA_PARASITE_INFECTION"
10,"Down",0.643246317312386,0.834469471708161,"L.PvsV.BIOCARTA_TERT_PATHWAY"
27,"Up",0.643672578593921,0.834744180319094,"L.PvsV.HEDENFALK_BREAST_CANCER_BRACX_UP"
60,"Up",0.644114547675171,0.834744180319094,"L.PvsV.REACTOME_SYNTHESIS_OF_PIPS_AT_THE_PLASMA_MEMBRANE"
6,"Down",0.644268731099632,0.834744180319094,"L.PvsV.PASTURAL_RIZ1_TARGETS_DN"
37,"Down",0.64438043723221,0.834744180319094,"L.PvsV.ONO_AML1_TARGETS_UP"
34,"Down",0.644427816732145,0.834744180319094,"L.PvsV.REACTOME_VEGFR2_MEDIATED_VASCULAR_PERMEABILITY"
137,"Down",0.644584852084876,0.834744180319094,"L.PvsV.KIM_MYCN_AMPLIFICATION_TARGETS_UP"
16,"Down",0.64464142017131,0.834744180319094,"L.PvsV.ZHOU_PANCREATIC_EXOCRINE_PROGENITOR"
181,"Down",0.644708461024246,0.834744180319094,"L.PvsV.PID_P53_DOWNSTREAM_PATHWAY"
518,"Down",0.644816855515075,0.834744180319094,"L.PvsV.LEI_MYB_TARGETS"
33,"Up",0.645086338432683,0.83489755739567,"L.PvsV.HASLINGER_B_CLL_WITH_CHROMOSOME_12_TRISOMY"
173,"Up",0.64538681567769,0.834943401853055,"L.PvsV.KIM_WT1_TARGETS_8HR_DN"
79,"Down",0.645423783599196,0.834943401853055,"L.PvsV.CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN"
19,"Up",0.645931769214519,0.835235813479329,"L.PvsV.KEGG_PANTOTHENATE_AND_COA_BIOSYNTHESIS"
34,"Up",0.646013298568378,0.835235813479329,"L.PvsV.BIOCARTA_MAL_PATHWAY"
25,"Down",0.646103015780627,0.835235813479329,"L.PvsV.NGO_MALIGNANT_GLIOMA_1P_LOH"
47,"Up",0.646466337762164,0.835415865932903,"L.PvsV.LIU_LIVER_CANCER"
10,"Down",0.646544490925464,0.835415865932903,"L.PvsV.REACTOME_CALCITONIN_LIKE_LIGAND_RECEPTORS"
25,"Down",0.646891644466283,0.835649075552212,"L.PvsV.KANG_FLUOROURACIL_RESISTANCE_DN"
14,"Up",0.647123919636769,0.835649075552212,"L.PvsV.BARRIER_CANCER_RELAPSE_TUMOR_SAMPLE_DN"
7,"Down",0.647178394196884,0.835649075552212,"L.PvsV.BAKER_HEMATOPOESIS_STAT5_TARGETS"
70,"Up",0.647516010150903,0.835889801570008,"L.PvsV.LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_UP"
120,"Up",0.648573041647587,0.836827903882894,"L.PvsV.HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_DN"
8,"Down",0.648685512605296,0.836827903882894,"L.PvsV.TSAI_DNAJB4_TARGETS_DN"
710,"Up",0.648696761809022,0.836827903882894,"L.PvsV.REACTOME_CELLULAR_RESPONSES_TO_EXTERNAL_STIMULI"
268,"Down",0.649229727562203,0.837313248115667,"L.PvsV.BROWNE_HCMV_INFECTION_18HR_UP"
24,"Up",0.649375874103812,0.837313248115667,"L.PvsV.REACTOME_SYNTHESIS_SECRETION_AND_DEACYLATION_OF_GHRELIN"
47,"Down",0.649619902748283,0.837432604871825,"L.PvsV.REACTOME_FATTY_ACIDS"
37,"Down",0.650247114702397,0.837954944140507,"L.PvsV.PID_NFKAPPAB_CANONICAL_PATHWAY"
53,"Down",0.650328208592316,0.837954944140507,"L.PvsV.GROSS_HYPOXIA_VIA_ELK3_ONLY_UP"
18,"Down",0.650780288376192,0.83816811941262,"L.PvsV.YEMELYANOV_GR_TARGETS_DN"
22,"Up",0.650796841497265,0.83816811941262,"L.PvsV.BIOCARTA_D4GDI_PATHWAY"
37,"Down",0.651027833643501,0.838270352169287,"L.PvsV.IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_UP"
87,"Down",0.65126013750187,0.838374225901709,"L.PvsV.GOLDRATH_IMMUNE_MEMORY"
172,"Down",0.651597827170743,0.838431288266534,"L.PvsV.YAMASHITA_LIVER_CANCER_STEM_CELL_DN"
88,"Down",0.651607749264116,0.838431288266534,"L.PvsV.DORN_ADENOVIRUS_INFECTION_32HR_DN"
106,"Up",0.652261288412173,0.838906394276325,"L.PvsV.WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_TBH"
8,"Up",0.652280446553432,0.838906394276325,"L.PvsV.ELVIDGE_HIF2A_TARGETS_UP"
15,"Down",0.652662004317647,0.839105402632604,"L.PvsV.REACTOME_PURINE_SALVAGE"
352,"Down",0.652751920331105,0.839105402632604,"L.PvsV.REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL"
153,"Down",0.653052635833701,0.839105402632604,"L.PvsV.XU_CREBBP_TARGETS_DN"
234,"Down",0.653077352810305,0.839105402632604,"L.PvsV.DARWICHE_SKIN_TUMOR_PROMOTER_UP"
32,"Up",0.653194004870813,0.839105402632604,"L.PvsV.WEBER_METHYLATED_HCP_IN_SPERM_UP"
26,"Up",0.653777107683967,0.839659379415715,"L.PvsV.REACTOME_NICOTINAMIDE_SALVAGING"
14,"Down",0.654055463740358,0.839821797264384,"L.PvsV.REACTOME_HUR_ELAVL1_BINDS_AND_STABILIZES_MRNA"
101,"Down",0.654259109431938,0.839888232191591,"L.PvsV.KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN"
27,"Down",0.65488804019652,0.840458563321416,"L.PvsV.BIOCARTA_CERAMIDE_PATHWAY"
464,"Up",0.655272003645482,0.840458563321416,"L.PvsV.RAO_BOUND_BY_SALL4_ISOFORM_A"
15,"Up",0.65529778743819,0.840458563321416,"L.PvsV.COLLIS_PRKDC_REGULATORS"
68,"Down",0.655311424575624,0.840458563321416,"L.PvsV.VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_DN"
154,"Up",0.655831127009074,0.840930032753519,"L.PvsV.PID_ERBB1_DOWNSTREAM_PATHWAY"
26,"Up",0.656265318729835,0.841264330970703,"L.PvsV.CAIRO_HEPATOBLASTOMA_POOR_SURVIVAL"
119,"Down",0.656535129440693,0.841264330970703,"L.PvsV.REACTOME_PI3K_AKT_SIGNALING_IN_CANCER"
137,"Down",0.656548306771312,0.841264330970703,"L.PvsV.LEE_AGING_NEOCORTEX_UP"
28,"Down",0.656790198026317,0.841365808577867,"L.PvsV.HOLLERN_MICROACINAR_BREAST_TUMOR_DN"
20,"Down",0.657131610047474,0.841365808577867,"L.PvsV.BARRIER_CANCER_RELAPSE_TUMOR_SAMPLE_UP"
237,"Down",0.657551029541199,0.841365808577867,"L.PvsV.DARWICHE_PAPILLOMA_RISK_HIGH_UP"
27,"Down",0.657600289585475,0.841365808577867,"L.PvsV.REACTOME_RAS_ACTIVATION_UPON_CA2_INFLUX_THROUGH_NMDA_RECEPTOR"
29,"Down",0.657630618168982,0.841365808577867,"L.PvsV.PID_IL27_PATHWAY"
36,"Down",0.657686385480204,0.841365808577867,"L.PvsV.REACTOME_CREB1_PHOSPHORYLATION_THROUGH_NMDA_RECEPTOR_MEDIATED_ACTIVATION_OF_RAS_SIGNALING"
34,"Down",0.657809996110168,0.841365808577867,"L.PvsV.KAPOSI_LIVER_CANCER_MET_UP"
6,"Up",0.65784488885551,0.841365808577867,"L.PvsV.REACTOME_P75NTR_NEGATIVELY_REGULATES_CELL_CYCLE_VIA_SC1"
165,"Up",0.658185310274646,0.841606517231388,"L.PvsV.DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_UP"
17,"Up",0.658649550908347,0.842005402768151,"L.PvsV.NAGY_TFTC_COMPONENTS_HUMAN"
61,"Up",0.65907234286878,0.842351128923136,"L.PvsV.KEGG_GLYCEROLIPID_METABOLISM"
642,"Down",0.659850840926174,0.842551988029326,"L.PvsV.REACTOME_CELL_CYCLE_MITOTIC"
41,"Up",0.660043649114575,0.842551988029326,"L.PvsV.REACTOME_GLYCOSPHINGOLIPID_METABOLISM"
711,"Down",0.660075372039841,0.842551988029326,"L.PvsV.CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5"
28,"Up",0.660177509989617,0.842551988029326,"L.PvsV.HEDENFALK_BREAST_CANCER_BRACX_DN"
102,"Down",0.660196854165689,0.842551988029326,"L.PvsV.KEGG_RETINOL_METABOLISM"
8,"Up",0.660410931028189,0.842551988029326,"L.PvsV.ZIRN_TRETINOIN_RESPONSE_DN"
72,"Down",0.66043714987303,0.842551988029326,"L.PvsV.SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_DN"
588,"Down",0.660448601215247,0.842551988029326,"L.PvsV.HUTTMANN_B_CLL_POOR_SURVIVAL_UP"
44,"Down",0.661187675635878,0.842867812275772,"L.PvsV.PID_AURORA_A_PATHWAY"
25,"Up",0.661247866617332,0.842867812275772,"L.PvsV.REACTOME_INITIATION_OF_NUCLEAR_ENVELOPE_NE_REFORMATION"
11,"Up",0.661271411031286,0.842867812275772,"L.PvsV.BIOCARTA_CACAM_PATHWAY"
40,"Down",0.661305944954296,0.842867812275772,"L.PvsV.DUTTA_APOPTOSIS_VIA_NFKB"
47,"Down",0.661781490205054,0.843279525084983,"L.PvsV.PID_IL8_CXCR1_PATHWAY"
76,"Down",0.661971827613706,0.843327703888521,"L.PvsV.PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_DN"
96,"Down",0.662359317056979,0.843584179313264,"L.PvsV.HUANG_DASATINIB_RESISTANCE_DN"
21,"Down",0.662910763257407,0.843584179313264,"L.PvsV.REACTOME_P130CAS_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS"
5,"Up",0.663028975796964,0.843584179313264,"L.PvsV.REACTOME_ARACHIDONATE_PRODUCTION_FROM_DAG"
301,"Up",0.663199497697316,0.843584179313264,"L.PvsV.ASTON_MAJOR_DEPRESSIVE_DISORDER_DN"
27,"Up",0.663222790607888,0.843584179313264,"L.PvsV.KASLER_HDAC7_TARGETS_1_DN"
89,"Down",0.663227945814921,0.843584179313264,"L.PvsV.CUI_TCF21_TARGETS_DN"
28,"Down",0.663241169736798,0.843584179313264,"L.PvsV.REACTOME_VEGFR2_MEDIATED_CELL_PROLIFERATION"
16,"Down",0.664257899315047,0.844382703688506,"L.PvsV.REACTOME_GAMMA_CARBOXYLATION_TRANSPORT_AND_AMINO_TERMINAL_CLEAVAGE_OF_PROTEINS"
110,"Up",0.664297761838529,0.844382703688506,"L.PvsV.REACTOME_EUKARYOTIC_TRANSLATION_ELONGATION"
19,"Down",0.664327140720745,0.844382703688506,"L.PvsV.REACTOME_TETRAHYDROBIOPTERIN_BH4_SYNTHESIS_RECYCLING_SALVAGE_AND_REGULATION"
250,"Up",0.664866542460025,0.844685270306079,"L.PvsV.KASLER_HDAC7_TARGETS_1_UP"
5,"Down",0.665028746231634,0.844685270306079,"L.PvsV.REACTOME_G2_PHASE"
44,"Down",0.665035360566938,0.844685270306079,"L.PvsV.BIOCARTA_GH_PATHWAY"
11,"Up",0.665176282675469,0.844685270306079,"L.PvsV.REACTOME_KETONE_BODY_METABOLISM"
87,"Up",0.665363971242188,0.844729597473721,"L.PvsV.ZHOU_TNF_SIGNALING_4HR"
147,"Down",0.66552474216034,0.844739738155307,"L.PvsV.CHEN_LIVER_METABOLISM_QTL_CIS"
1973,"Down",0.665788881094894,0.844881047411905,"L.PvsV.CHEN_METABOLIC_SYNDROM_NETWORK"
167,"Up",0.66596893358523,0.844915611242023,"L.PvsV.SANA_TNF_SIGNALING_UP"
7,"Down",0.666264806204299,0.845097066644544,"L.PvsV.REACTOME_ELECTRIC_TRANSMISSION_ACROSS_GAP_JUNCTIONS"
13,"Down",0.666524476079517,0.845232529413681,"L.PvsV.SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX6_UP"
18,"Down",0.667029834239543,0.845463591149613,"L.PvsV.REACTOME_SHC1_EVENTS_IN_EGFR_SIGNALING"
20,"Up",0.667343242021091,0.845463591149613,"L.PvsV.BIOCARTA_HSP27_PATHWAY"
1329,"Down",0.66735840080872,0.845463591149613,"L.PvsV.KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_UP"
25,"Down",0.667466451954887,0.845463591149613,"L.PvsV.RASHI_NFKB1_TARGETS"
90,"Down",0.667484246716084,0.845463591149613,"L.PvsV.GOTTWEIN_TARGETS_OF_KSHV_MIR_K12_11"
41,"Down",0.667769547980165,0.845463591149613,"L.PvsV.CHIN_BREAST_CANCER_COPY_NUMBER_UP"
77,"Up",0.668066515789273,0.845463591149613,"L.PvsV.BALDWIN_PRKCI_TARGETS_UP"
178,"Down",0.668144859836066,0.845463591149613,"L.PvsV.LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_DN"
105,"Down",0.668179061396016,0.845463591149613,"L.PvsV.OUILLETTE_CLL_13Q14_DELETION_DN"
1133,"Down",0.668235828056395,0.845463591149613,"L.PvsV.KRIEG_HYPOXIA_NOT_VIA_KDM3A"
6,"Up",0.668749155701345,0.845757070237207,"L.PvsV.REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_KEY_METABOLIC_FACTORS"
39,"Up",0.668891809077328,0.845757070237207,"L.PvsV.PID_IL2_STAT5_PATHWAY"
34,"Down",0.669243386679581,0.845757070237207,"L.PvsV.REACTOME_COOPERATION_OF_PREFOLDIN_AND_TRIC_CCT_IN_ACTIN_AND_TUBULIN_FOLDING"
21,"Up",0.669354475516498,0.845757070237207,"L.PvsV.REACTOME_TRANSLESION_SYNTHESIS_BY_POLH"
453,"Down",0.669369877896758,0.845757070237207,"L.PvsV.HELLER_HDAC_TARGETS_DN"
330,"Up",0.669518248786588,0.845757070237207,"L.PvsV.REACTOME_METABOLISM_OF_CARBOHYDRATES"
18,"Up",0.66953855967232,0.845757070237207,"L.PvsV.JIANG_CORE_DUPLICON_GENES"
74,"Up",0.670069056184248,0.846233853732916,"L.PvsV.REACTOME_INTRINSIC_PATHWAY_FOR_APOPTOSIS"
154,"Down",0.670686804211315,0.846820584718968,"L.PvsV.LEE_AGING_CEREBELLUM_DN"
17,"Down",0.671200252121462,0.84699514191314,"L.PvsV.REACTOME_INTERLEUKIN_2_SIGNALING"
115,"Down",0.671351451167117,0.84699514191314,"L.PvsV.REACTOME_PROTEIN_FOLDING"
27,"Down",0.671472306719292,0.84699514191314,"L.PvsV.ABDELMOHSEN_ELAVL4_TARGETS"
892,"Down",0.671669786703132,0.84699514191314,"L.PvsV.DOUGLAS_BMI1_TARGETS_UP"
11,"Down",0.671752968505452,0.84699514191314,"L.PvsV.GALIE_TUMOR_STEMNESS_GENES"
91,"Down",0.671901149317253,0.84699514191314,"L.PvsV.FARMER_BREAST_CANCER_CLUSTER_1"
129,"Down",0.671920669471493,0.84699514191314,"L.PvsV.JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_DN"
18,"Up",0.672050585562117,0.84699514191314,"L.PvsV.ROZANOV_MMP14_CORRELATED"
10,"Up",0.672790494954796,0.847734422653844,"L.PvsV.DER_IFN_BETA_RESPONSE_DN"
67,"Down",0.673262723828857,0.848028196161123,"L.PvsV.REACTOME_NEUROTRANSMITTER_RELEASE_CYCLE"
42,"Down",0.673330399918128,0.848028196161123,"L.PvsV.REACTOME_INTERACTIONS_OF_VPR_WITH_HOST_CELLULAR_PROTEINS"
28,"Down",0.674213955977933,0.848652537204934,"L.PvsV.REACTOME_INTERLEUKIN_37_SIGNALING"
41,"Up",0.674238333912863,0.848652537204934,"L.PvsV.REACTOME_SMAD2_SMAD3_SMAD4_HETEROTRIMER_REGULATES_TRANSCRIPTION"
76,"Up",0.674286597204065,0.848652537204934,"L.PvsV.REACTOME_SIGNALING_BY_PDGF"
143,"Down",0.674722452611268,0.848832090359577,"L.PvsV.SWEET_KRAS_TARGETS_DN"
19,"Up",0.674736306227227,0.848832090359577,"L.PvsV.SA_PROGRAMMED_CELL_DEATH"
63,"Down",0.675318049575822,0.849345986280412,"L.PvsV.KORKOLA_EMBRYONAL_CARCINOMA_UP"
201,"Up",0.675452035028933,0.849345986280412,"L.PvsV.REACTOME_ROLE_OF_LAT2_NTAL_LAB_ON_CALCIUM_MOBILIZATION"
137,"Up",0.675666207325876,0.849422114666841,"L.PvsV.GAVIN_FOXP3_TARGETS_CLUSTER_T4"
456,"Up",0.676543544484991,0.850170689582045,"L.PvsV.GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN"
62,"Down",0.676610430611322,0.850170689582045,"L.PvsV.AIYAR_COBRA1_TARGETS_UP"
168,"Up",0.676722952586468,0.850170689582045,"L.PvsV.REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA"
101,"Down",0.67730185215777,0.85070466619271,"L.PvsV.MARTINEZ_RESPONSE_TO_TRABECTEDIN_UP"
187,"Down",0.677722017552298,0.850953621702089,"L.PvsV.BRUECKNER_TARGETS_OF_MIRLET7A3_UP"
706,"Up",0.677807876646048,0.850953621702089,"L.PvsV.JOHNSTONE_PARVB_TARGETS_3_UP"
1013,"Down",0.678200318058694,0.851130207580076,"L.PvsV.MARTINEZ_RB1_TARGETS_DN"
27,"Up",0.678269840316295,0.851130207580076,"L.PvsV.IGLESIAS_E2F_TARGETS_DN"
14,"Down",0.678452404992171,0.851130207580076,"L.PvsV.BIOCARTA_DSP_PATHWAY"
16,"Down",0.678564289204734,0.851130207580076,"L.PvsV.WAESCH_ANAPHASE_PROMOTING_COMPLEX"
54,"Up",0.678977791107809,0.851455705836942,"L.PvsV.BIOCARTA_MET_PATHWAY"
9,"Down",0.679298426728731,0.851530760349703,"L.PvsV.REACTOME_SYNTHESIS_OF_DIPHTHAMIDE_EEF2"
312,"Up",0.679372638230349,0.851530760349703,"L.PvsV.GERY_CEBP_TARGETS"
11,"Up",0.679499677095839,0.851530760349703,"L.PvsV.REACTOME_CHYLOMICRON_REMODELING"
31,"Down",0.680570192336926,0.85267903771377,"L.PvsV.KEGG_MATURITY_ONSET_DIABETES_OF_THE_YOUNG"
11,"Up",0.681886450391931,0.853817542284544,"L.PvsV.REACTOME_ACTIVATED_NTRK3_SIGNALS_THROUGH_RAS"
65,"Up",0.681907033875894,0.853817542284544,"L.PvsV.LAU_APOPTOSIS_CDKN2A_UP"
927,"Up",0.681942171591345,0.853817542284544,"L.PvsV.REACTOME_G_ALPHA_S_SIGNALLING_EVENTS"
120,"Up",0.682576811850896,0.854418653548473,"L.PvsV.BILD_CTNNB1_ONCOGENIC_SIGNATURE"
252,"Down",0.683039505623646,0.854804306607773,"L.PvsV.SERVITJA_LIVER_HNF1A_TARGETS_UP"
25,"Down",0.683344064767064,0.854814217093226,"L.PvsV.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_22"
643,"Up",0.68335663583868,0.854814217093226,"L.PvsV.MULLIGHAN_MLL_SIGNATURE_2_UP"
69,"Up",0.683664759520317,0.85500621022118,"L.PvsV.REACTOME_REGULATION_OF_PTEN_GENE_TRANSCRIPTION"
25,"Up",0.684411022439799,0.855514460814908,"L.PvsV.HOLLEMAN_PREDNISOLONE_RESISTANCE_ALL_UP"
179,"Down",0.684523314181051,0.855514460814908,"L.PvsV.MATZUK_SPERMATOZOA"
10,"Up",0.684535354430305,0.855514460814908,"L.PvsV.REACTOME_RHO_GTPASES_ACTIVATE_RHOTEKIN_AND_RHOPHILINS"
36,"Down",0.684878721523609,0.855750158486788,"L.PvsV.GRAHAM_CML_DIVIDING_VS_NORMAL_DIVIDING_UP"
16,"Down",0.68524190328065,0.856010502313311,"L.PvsV.REACTOME_SIGNALING_BY_LEPTIN"
68,"Down",0.685450769053458,0.856077999118267,"L.PvsV.DIRMEIER_LMP1_RESPONSE_LATE_DN"
168,"Down",0.685987510174345,0.856554865346421,"L.PvsV.KIM_GASTRIC_CANCER_CHEMOSENSITIVITY"
10,"Up",0.686554130891909,0.857068816821261,"L.PvsV.REACTOME_METABOLISM_OF_INGESTED_SEMET_SEC_MESEC_INTO_H2SE"
15,"Down",0.686912228715918,0.85715100142651,"L.PvsV.REACTOME_RHO_GTPASES_ACTIVATE_KTN1"
788,"Down",0.687133422147792,0.85715100142651,"L.PvsV.SENESE_HDAC3_TARGETS_DN"
559,"Down",0.687228794019264,0.85715100142651,"L.PvsV.REACTOME_SIGNALING_BY_RHO_GTPASES"
50,"Up",0.687256996033011,0.85715100142651,"L.PvsV.BIOCARTA_IL1R_PATHWAY"
17,"Down",0.687450718691447,0.85715100142651,"L.PvsV.BIOCARTA_RANBP2_PATHWAY"
20,"Up",0.687550134079683,0.85715100142651,"L.PvsV.ZHOU_PANCREATIC_ENDOCRINE_PROGENITOR"
70,"Down",0.6882697267242,0.857854670662332,"L.PvsV.WANG_TARGETS_OF_MLL_CBP_FUSION_UP"
20,"Down",0.688472628601998,0.857914168028047,"L.PvsV.BIOCARTA_EGFR_SMRTE_PATHWAY"
495,"Up",0.689340983072192,0.858664443354607,"L.PvsV.NIKOLSKY_BREAST_CANCER_17Q21_Q25_AMPLICON"
99,"Down",0.689385325384536,0.858664443354607,"L.PvsV.LINDSTEDT_DENDRITIC_CELL_MATURATION_C"
22,"Down",0.689870326499691,0.858708251574025,"L.PvsV.TSUNODA_CISPLATIN_RESISTANCE_UP"
13,"Down",0.690108126481659,0.858708251574025,"L.PvsV.REACTOME_INTERLEUKIN_35_SIGNALLING"
25,"Down",0.690178756607094,0.858708251574025,"L.PvsV.MCGOWAN_RSP6_TARGETS_UP"
13,"Down",0.690501672592664,0.858708251574025,"L.PvsV.REACTOME_GLUTATHIONE_SYNTHESIS_AND_RECYCLING"
21,"Up",0.690519945573801,0.858708251574025,"L.PvsV.REACTOME_ACYL_CHAIN_REMODELLING_OF_PG"
16,"Down",0.690594096989463,0.858708251574025,"L.PvsV.REACTOME_ATF6_ATF6_ALPHA_ACTIVATES_CHAPERONE_GENES"
17,"Down",0.690712234643293,0.858708251574025,"L.PvsV.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_8"
33,"Up",0.69082246500632,0.858708251574025,"L.PvsV.REACTOME_PLASMA_LIPOPROTEIN_ASSEMBLY"
67,"Up",0.690962560668955,0.858708251574025,"L.PvsV.REACTOME_SIGNALING_BY_FGFR1"
10,"Down",0.691105005531967,0.858708251574025,"L.PvsV.REACTOME_DIGESTION_OF_DIETARY_LIPID"
104,"Up",0.691128905679944,0.858708251574025,"L.PvsV.REACTOME_SIGNALING_BY_MET"
114,"Down",0.691915843394359,0.859385680726044,"L.PvsV.KEGG_ARACHIDONIC_ACID_METABOLISM"
172,"Down",0.691984997394166,0.859385680726044,"L.PvsV.REACTOME_SIGNALING_BY_NTRKS"
44,"Down",0.692665124318785,0.860037159748162,"L.PvsV.REACTOME_NEGATIVE_REGULATION_OF_FGFR2_SIGNALING"
20,"Down",0.692986857500753,0.860138574146306,"L.PvsV.REACTOME_ERYTHROCYTES_TAKE_UP_CARBON_DIOXIDE_AND_RELEASE_OXYGEN"
893,"Down",0.693135219393036,0.860138574146306,"L.PvsV.ENK_UV_RESPONSE_EPIDERMIS_DN"
146,"Down",0.693213508120083,0.860138574146306,"L.PvsV.PUJANA_BREAST_CANCER_LIT_INT_NETWORK"
140,"Up",0.693466225094814,0.860259088747863,"L.PvsV.REACTOME_SLC_TRANSPORTER_DISORDERS"
73,"Up",0.693631059974492,0.860270554194475,"L.PvsV.CHESLER_BRAIN_HIGHEST_GENETIC_VARIANCE"
46,"Down",0.693796075900575,0.860282238989523,"L.PvsV.REACTOME_INTERLEUKIN_7_SIGNALING"
6,"Down",0.694143533596172,0.860520089070233,"L.PvsV.REACTOME_FICOLINS_BIND_TO_REPETITIVE_CARBOHYDRATE_STRUCTURES_ON_THE_TARGET_CELL_SURFACE"
28,"Down",0.694321707524051,0.860548020825034,"L.PvsV.BIOCARTA_TID_PATHWAY"
452,"Up",0.695106126882929,0.861147104441408,"L.PvsV.REACTOME_DISEASES_OF_SIGNAL_TRANSDUCTION_BY_GROWTH_FACTOR_RECEPTORS_AND_SECOND_MESSENGERS"
1070,"Down",0.695116572096583,0.861147104441408,"L.PvsV.SCHLOSSER_SERUM_RESPONSE_DN"
18,"Up",0.69581429016964,0.861818371493714,"L.PvsV.REACTOME_PHASE_4_RESTING_MEMBRANE_POTENTIAL"
39,"Up",0.696315064700945,0.862245463097765,"L.PvsV.KEGG_ASTHMA"
47,"Down",0.696597596661478,0.86235833137066,"L.PvsV.MIKKELSEN_MCV6_LCP_WITH_H3K27ME3"
21,"Up",0.69671815269176,0.86235833137066,"L.PvsV.REACTOME_NRIF_SIGNALS_CELL_DEATH_FROM_THE_NUCLEUS"
200,"Down",0.697032554311552,0.862395885477588,"L.PvsV.ALTEMEIER_RESPONSE_TO_LPS_WITH_MECHANICAL_VENTILATION"
51,"Down",0.697060447133178,0.862395885477588,"L.PvsV.REACTOME_INTERLEUKIN_2_FAMILY_SIGNALING"
122,"Down",0.697312906238051,0.862416394459704,"L.PvsV.BURTON_ADIPOGENESIS_2"
36,"Up",0.697388985282933,0.862416394459704,"L.PvsV.REACTOME_NEGATIVE_REGULATION_OF_FGFR3_SIGNALING"
6,"Up",0.697905045102153,0.862861581925269,"L.PvsV.REACTOME_N_GLYCAN_TRIMMING_AND_ELONGATION_IN_THE_CIS_GOLGI"
14,"Down",0.698582352293877,0.863156719063071,"L.PvsV.REACTOME_POU5F1_OCT4_SOX2_NANOG_REPRESS_GENES_RELATED_TO_DIFFERENTIATION"
25,"Down",0.698600173288921,0.863156719063071,"L.PvsV.REACTOME_ACYL_CHAIN_REMODELLING_OF_PS"
74,"Down",0.698989994528489,0.863156719063071,"L.PvsV.BURTON_ADIPOGENESIS_PEAK_AT_8HR"
11,"Up",0.69923177401813,0.863156719063071,"L.PvsV.BIOCARTA_NOTCH_PATHWAY"
1673,"Down",0.699233656429333,0.863156719063071,"L.PvsV.REACTOME_SIGNALING_BY_GPCR"
111,"Up",0.699363574512014,0.863156719063071,"L.PvsV.FONTAINE_FOLLICULAR_THYROID_ADENOMA_DN"
20,"Down",0.699373039925022,0.863156719063071,"L.PvsV.VANDESLUIS_COMMD1_TARGETS_GROUP_4_UP"
164,"Up",0.699536536367397,0.863156719063071,"L.PvsV.XU_HGF_TARGETS_REPRESSED_BY_AKT1_DN"
78,"Down",0.699578185758993,0.863156719063071,"L.PvsV.SMIRNOV_RESPONSE_TO_IR_2HR_UP"
677,"Down",0.699704904112983,0.863156719063071,"L.PvsV.BASAKI_YBX1_TARGETS_DN"
37,"Up",0.699919305385812,0.863228605727895,"L.PvsV.GAJATE_RESPONSE_TO_TRABECTEDIN_DN"
149,"Up",0.700265189250898,0.863462585050896,"L.PvsV.BHAT_ESR1_TARGETS_NOT_VIA_AKT1_DN"
16,"Up",0.700839051553751,0.863873640760722,"L.PvsV.BIOCARTA_RB_PATHWAY"
50,"Down",0.701074969194965,0.863873640760722,"L.PvsV.REACTOME_SUMOYLATION_OF_TRANSCRIPTION_COFACTORS"
36,"Down",0.70123069012885,0.863873640760722,"L.PvsV.REACTOME_GLUCAGON_TYPE_LIGAND_RECEPTORS"
169,"Up",0.701431005162434,0.863873640760722,"L.PvsV.RAMALHO_STEMNESS_DN"
44,"Down",0.701485657553158,0.863873640760722,"L.PvsV.BIOCARTA_EICOSANOID_PATHWAY"
18,"Down",0.701536018631876,0.863873640760722,"L.PvsV.MIKKELSEN_IPS_LCP_WITH_H3K4ME3_AND_H3K27ME3"
54,"Down",0.702235365884798,0.864542270758639,"L.PvsV.QI_HYPOXIA_TARGETS_OF_HIF1A_AND_FOXA2"
56,"Down",0.702659146039916,0.864552999624514,"L.PvsV.SHAFFER_IRF4_MULTIPLE_MYELOMA_PROGRAM"
43,"Down",0.702754245402018,0.864552999624514,"L.PvsV.REACTOME_RNA_POLYMERASE_III_TRANSCRIPTION"
977,"Down",0.702792247962803,0.864552999624514,"L.PvsV.WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_8D"
205,"Down",0.702869548437727,0.864552999624514,"L.PvsV.CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_UP"
43,"Down",0.70331945162552,0.864913978656028,"L.PvsV.PID_CD40_PATHWAY"
7,"Down",0.703710912939359,0.86497701919168,"L.PvsV.REACTOME_ALTERNATIVE_COMPLEMENT_ACTIVATION"
162,"Down",0.703810151672561,0.86497701919168,"L.PvsV.DASU_IL6_SIGNALING_UP"
38,"Up",0.703840045097372,0.86497701919168,"L.PvsV.VALK_AML_CLUSTER_8"
19,"Up",0.704257538258778,0.865032916219422,"L.PvsV.TAKAYAMA_BOUND_BY_AR"
159,"Down",0.704272692994835,0.865032916219422,"L.PvsV.CAMPS_COLON_CANCER_COPY_NUMBER_UP"
18,"Up",0.704354890363508,0.865032916219422,"L.PvsV.PID_DNA_PK_PATHWAY"
318,"Down",0.704698081475651,0.865262201305547,"L.PvsV.ALONSO_METASTASIS_UP"
189,"Up",0.7048907007712,0.865306546306386,"L.PvsV.PUIFFE_INVASION_INHIBITED_BY_ASCITES_DN"
86,"Up",0.705349420015118,0.865677456884259,"L.PvsV.DIRMEIER_LMP1_RESPONSE_LATE_UP"
197,"Down",0.705726440425272,0.865947955861369,"L.PvsV.WIELAND_UP_BY_HBV_INFECTION"
58,"Down",0.706094442211421,0.866207271130896,"L.PvsV.TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_DN"
38,"Down",0.706918908434064,0.866960053748035,"L.PvsV.RUAN_RESPONSE_TO_TNF_TROGLITAZONE_UP"
22,"Down",0.707021682465164,0.866960053748035,"L.PvsV.BIOCARTA_NFKB_PATHWAY"
13,"Up",0.707600324464224,0.867052171241243,"L.PvsV.BIOCARTA_GHRELIN_PATHWAY"
185,"Down",0.707728149319069,0.867052171241243,"L.PvsV.GROSS_HYPOXIA_VIA_HIF1A_DN"
276,"Down",0.707840896049474,0.867052171241243,"L.PvsV.AMIT_EGF_RESPONSE_480_HELA"
13,"Up",0.707857908126944,0.867052171241243,"L.PvsV.WANG_RESPONSE_TO_FORSKOLIN_DN"
46,"Up",0.70794931419717,0.867052171241243,"L.PvsV.MARSHALL_VIRAL_INFECTION_RESPONSE_DN"
28,"Down",0.708162908681972,0.867052171241243,"L.PvsV.REACTOME_DOPAMINE_NEUROTRANSMITTER_RELEASE_CYCLE"
55,"Up",0.708194538854305,0.867052171241243,"L.PvsV.PID_IL23_PATHWAY"
10,"Down",0.708696740898904,0.867474934786372,"L.PvsV.REACTOME_CA2_ACTIVATED_K_CHANNELS"
81,"Up",0.709189699423742,0.867886199228391,"L.PvsV.SESTO_RESPONSE_TO_UV_C5"
163,"Up",0.709773486387475,0.868270329850156,"L.PvsV.RHEIN_ALL_GLUCOCORTICOID_THERAPY_UP"
1113,"Up",0.709817668823061,0.868270329850156,"L.PvsV.MARTINEZ_RB1_TARGETS_UP"
117,"Up",0.710161262321709,0.868498478074923,"L.PvsV.JIANG_VHL_TARGETS"
377,"Down",0.710363150177046,0.868553263451767,"L.PvsV.QI_PLASMACYTOMA_UP"
65,"Up",0.710717853689734,0.868794829327999,"L.PvsV.SMID_BREAST_CANCER_RELAPSE_IN_PLEURA_DN"
32,"Up",0.711438166573959,0.869307070752615,"L.PvsV.REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS"
24,"Down",0.711451346564584,0.869307070752615,"L.PvsV.KIM_GERMINAL_CENTER_T_HELPER_DN"
19,"Down",0.712603702111091,0.870008234577764,"L.PvsV.BIOCARTA_TNFR2_PATHWAY"
8,"Down",0.712751480663781,0.870008234577764,"L.PvsV.REACTOME_RUNX3_REGULATES_BCL2L11_BIM_TRANSCRIPTION"
36,"Down",0.712873762335454,0.870008234577764,"L.PvsV.REACTOME_COBALAMIN_CBL_VITAMIN_B12_TRANSPORT_AND_METABOLISM"
24,"Down",0.712887024884014,0.870008234577764,"L.PvsV.REACTOME_G_BETA_GAMMA_SIGNALLING_THROUGH_CDC42"
232,"Up",0.712925498236373,0.870008234577764,"L.PvsV.SMITH_TERT_TARGETS_UP"
31,"Up",0.713060875287092,0.870008234577764,"L.PvsV.HASLINGER_B_CLL_WITH_17P13_DELETION"
29,"Down",0.713126662887761,0.870008234577764,"L.PvsV.REACTOME_ACYL_CHAIN_REMODELLING_OF_PE"
23,"Down",0.713544413628985,0.8703258466699,"L.PvsV.FREDERICK_PRKCI_TARGETS"
132,"Up",0.714018475911036,0.870429492746056,"L.PvsV.REACTOME_SIGNALING_BY_TGF_BETA_FAMILY_MEMBERS"
161,"Up",0.714070349280291,0.870429492746056,"L.PvsV.CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_UP"
1586,"Up",0.714101678259379,0.870429492746056,"L.PvsV.BRUINS_UVC_RESPONSE_LATE"
381,"Up",0.715044744553701,0.871346034865734,"L.PvsV.SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM1"
90,"Down",0.715168801993254,0.871346034865734,"L.PvsV.PID_FCER1_PATHWAY"
17,"Down",0.716021896888985,0.872155558931118,"L.PvsV.REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE_FGFR4"
52,"Up",0.716148713609563,0.872155558931118,"L.PvsV.LEIN_LOCALIZED_TO_PROXIMAL_DENDRITES"
15,"Up",0.716397000442382,0.872199910552737,"L.PvsV.BIOCARTA_AKAP95_PATHWAY"
32,"Down",0.716572757717614,0.872199910552737,"L.PvsV.KEGG_O_GLYCAN_BIOSYNTHESIS"
105,"Up",0.716658381920978,0.872199910552737,"L.PvsV.REACTOME_SIGNALING_BY_FGFR"
614,"Up",0.717185534351717,0.872649388078927,"L.PvsV.RUTELLA_RESPONSE_TO_HGF_UP"
48,"Up",0.717374171467068,0.87268686337545,"L.PvsV.BIOCARTA_EGF_PATHWAY"
38,"Up",0.718345277408957,0.873675987416217,"L.PvsV.BIOCARTA_IGF1R_PATHWAY"
66,"Down",0.718874494868363,0.874075758821171,"L.PvsV.KEGG_PATHOGENIC_ESCHERICHIA_COLI_INFECTION"
199,"Down",0.719086118380242,0.874075758821171,"L.PvsV.PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_DN"
14,"Up",0.719159918350813,0.874075758821171,"L.PvsV.REACTOME_EICOSANOID_LIGAND_BINDING_RECEPTORS"
16,"Up",0.719306330735455,0.874075758821171,"L.PvsV.BIOCARTA_RELA_PATHWAY"
129,"Down",0.719645503665514,0.874295756925209,"L.PvsV.REACTOME_POSITIVE_EPIGENETIC_REGULATION_OF_RRNA_EXPRESSION"
6,"Up",0.719950430150286,0.874474061577533,"L.PvsV.REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_ENDOCRINE_COMMITTED_NEUROG3_PROGENITOR_CELLS"
9,"Up",0.720425980989812,0.874848683389849,"L.PvsV.REACTOME_SIGNALLING_TO_P38_VIA_RIT_AND_RIN"
6,"Up",0.72057531274324,0.874848683389849,"L.PvsV.REACTOME_CHOLINE_CATABOLISM"
303,"Up",0.721864556606515,0.876191509571721,"L.PvsV.PROVENZANI_METASTASIS_UP"
15,"Down",0.721998284971742,0.876191509571721,"L.PvsV.PETRETTO_LEFT_VENTRICLE_MASS_QTL_CIS_DN"
43,"Down",0.722762177676374,0.876743760602512,"L.PvsV.GROSS_ELK3_TARGETS_UP"
184,"Up",0.722770493909613,0.876743760602512,"L.PvsV.JAZAG_TGFB1_SIGNALING_VIA_SMAD4_UP"
27,"Down",0.723139213681903,0.876998620848266,"L.PvsV.WACKER_HYPOXIA_TARGETS_OF_VHL"
37,"Up",0.723367127435163,0.877011301547867,"L.PvsV.SIG_CD40PATHWAYMAP"
21,"Down",0.723466910175406,0.877011301547867,"L.PvsV.REACTOME_PROSTACYCLIN_SIGNALLING_THROUGH_PROSTACYCLIN_RECEPTOR"
16,"Down",0.723811419684007,0.877194395964083,"L.PvsV.REACTOME_EGFR_TRANSACTIVATION_BY_GASTRIN"
84,"Down",0.724067308528426,0.877194395964083,"L.PvsV.REACTOME_RNA_POLYMERASE_II_TRANSCRIBES_SNRNA_GENES"
66,"Down",0.724093909057709,0.877194395964083,"L.PvsV.TING_SILENCED_BY_DICER"
21,"Up",0.724623852648199,0.877644092287381,"L.PvsV.IYENGAR_RESPONSE_TO_ADIPOCYTE_FACTORS"
38,"Up",0.72495784903508,0.877670309302497,"L.PvsV.BIOCARTA_FAS_PATHWAY"
8,"Up",0.72496297749765,0.877670309302497,"L.PvsV.REACTOME_MET_RECEPTOR_ACTIVATION"
17,"Down",0.725826051855857,0.878522819770366,"L.PvsV.PID_RANBP2_PATHWAY"
175,"Down",0.726823101640337,0.879208059585977,"L.PvsV.REACTOME_CELL_CELL_COMMUNICATION"
47,"Up",0.726851589922404,0.879208059585977,"L.PvsV.YAGI_AML_RELAPSE_PROGNOSIS"
21,"Up",0.726869242244077,0.879208059585977,"L.PvsV.BIOCARTA_TH1TH2_PATHWAY"
34,"Down",0.72726739448749,0.87949724937037,"L.PvsV.HAHTOLA_CTCL_PATHOGENESIS"
2477,"Down",0.727527184625363,0.879619025539828,"L.PvsV.GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN"
279,"Up",0.72786392465981,0.879833764635786,"L.PvsV.BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP"
70,"Up",0.728201837787725,0.880049827569034,"L.PvsV.MA_MYELOID_DIFFERENTIATION_DN"
39,"Down",0.728463337314243,0.880173468533752,"L.PvsV.ZHENG_FOXP3_TARGETS_UP"
62,"Up",0.728690363512711,0.880255411811619,"L.PvsV.REACTOME_XENOBIOTICS"
49,"Down",0.728940527245342,0.880285874739822,"L.PvsV.BIOCARTA_FMLP_PATHWAY"
37,"Up",0.729158630843838,0.880285874739822,"L.PvsV.BIOCARTA_IL12_PATHWAY"
9,"Down",0.729193218720995,0.880285874739822,"L.PvsV.REACTOME_HISTIDINE_CATABOLISM"
31,"Up",0.729495906119405,0.880459040588122,"L.PvsV.REACTOME_VXPX_CARGO_TARGETING_TO_CILIUM"
70,"Up",0.730101086340286,0.880826957307909,"L.PvsV.SIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES"
67,"Up",0.730365004941074,0.880826957307909,"L.PvsV.LEONARD_HYPOXIA"
27,"Up",0.730373714436964,0.880826957307909,"L.PvsV.BIOCARTA_CHREBP_PATHWAY"
1419,"Up",0.730437981417392,0.880826957307909,"L.PvsV.BENPORATH_NANOG_TARGETS"
11,"Down",0.731451840739672,0.881742239862386,"L.PvsV.REACTOME_SPERM_MOTILITY_AND_TAXES"
14,"Down",0.731515943976987,0.881742239862386,"L.PvsV.CHEN_HOXA5_TARGETS_6HR_DN"
867,"Up",0.732395164956045,0.882409377388882,"L.PvsV.PARENT_MTOR_SIGNALING_UP"
230,"Down",0.732430017568881,0.882409377388882,"L.PvsV.KEGG_CHEMOKINE_SIGNALING_PATHWAY"
7,"Up",0.732548273487345,0.882409377388882,"L.PvsV.REACTOME_ATTACHMENT_OF_GPI_ANCHOR_TO_UPAR"
7,"Down",0.732707804592576,0.882409377388882,"L.PvsV.REACTOME_CLEC7A_INFLAMMASOME_PATHWAY"
13,"Down",0.733290443881464,0.882918742208322,"L.PvsV.TURJANSKI_MAPK14_TARGETS"
42,"Down",0.734476532057296,0.884154309981448,"L.PvsV.REACTOME_MYOGENESIS"
29,"Up",0.734900529519697,0.884470811353396,"L.PvsV.AMIT_EGF_RESPONSE_20_MCF10A"
25,"Up",0.735111211677538,0.884470811353396,"L.PvsV.KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS_AND_CYCLIC_RGD"
190,"Up",0.735219361363756,0.884470811353396,"L.PvsV.MCBRYAN_PUBERTAL_BREAST_5_6WK_UP"
16,"Down",0.735989475787395,0.885196333979702,"L.PvsV.BIOCARTA_TSP1_PATHWAY"
30,"Up",0.736142655749443,0.885196333979702,"L.PvsV.PID_TRAIL_PATHWAY"
63,"Down",0.736740575782122,0.885530861626557,"L.PvsV.KORKOLA_SEMINOMA_UP"
57,"Up",0.736831328753858,0.885530861626557,"L.PvsV.TERAO_AOX4_TARGETS_SKIN_UP"
8,"Up",0.737203798311397,0.885530861626557,"L.PvsV.REACTOME_PHOSPHATE_BOND_HYDROLYSIS_BY_NUDT_PROTEINS"
179,"Up",0.737509087833459,0.885530861626557,"L.PvsV.BOUDOUKHA_BOUND_BY_IGF2BP2"
9,"Down",0.737631741895014,0.885530861626557,"L.PvsV.REACTOME_UPTAKE_AND_FUNCTION_OF_DIPHTHERIA_TOXIN"
35,"Up",0.737661194084641,0.885530861626557,"L.PvsV.REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS"
129,"Down",0.737681857997641,0.885530861626557,"L.PvsV.LEE_CALORIE_RESTRICTION_NEOCORTEX_DN"
10,"Up",0.73770214300089,0.885530861626557,"L.PvsV.SASAI_TARGETS_OF_CXCR6_AND_PTCH1_DN"
306,"Down",0.737901486479077,0.885577885553032,"L.PvsV.CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_UP"
14,"Up",0.738520442451125,0.88594573836603,"L.PvsV.REACTOME_ETHANOL_OXIDATION"
71,"Down",0.738528469547664,0.88594573836603,"L.PvsV.SCHLINGEMANN_SKIN_CARCINOGENESIS_TPA_UP"
56,"Down",0.739258166869429,0.88604137639742,"L.PvsV.KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION"
14,"Down",0.739387260141235,0.88604137639742,"L.PvsV.BIOCARTA_NEUTROPHIL_PATHWAY"
33,"Down",0.739413086318291,0.88604137639742,"L.PvsV.HOWLIN_CITED1_TARGETS_2_UP"
37,"Down",0.739503150449498,0.88604137639742,"L.PvsV.SARTIPY_BLUNTED_BY_INSULIN_RESISTANCE_UP"
34,"Down",0.739593233071276,0.88604137639742,"L.PvsV.LAMB_CCND1_TARGETS"
130,"Up",0.739889588924626,0.88604137639742,"L.PvsV.CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_UP"
51,"Down",0.739974505236959,0.88604137639742,"L.PvsV.HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_UP"
114,"Down",0.740023139430668,0.88604137639742,"L.PvsV.REACTOME_METABOLISM_OF_NUCLEOTIDES"
25,"Down",0.740050474987029,0.88604137639742,"L.PvsV.VERRECCHIA_RESPONSE_TO_TGFB1_C3"
8,"Up",0.74079788343794,0.886611656214187,"L.PvsV.REACTOME_GLYCEROPHOSPHOLIPID_CATABOLISM"
39,"Up",0.740853501308188,0.886611656214187,"L.PvsV.REACTOME_TNFR1_INDUCED_NFKAPPAB_SIGNALING_PATHWAY"
82,"Up",0.741140401992329,0.886611656214187,"L.PvsV.LINDSTEDT_DENDRITIC_CELL_MATURATION_A"
264,"Up",0.741168217584007,0.886611656214187,"L.PvsV.VANTVEER_BREAST_CANCER_METASTASIS_DN"
465,"Down",0.741659876172898,0.887007885650001,"L.PvsV.HSIAO_LIVER_SPECIFIC_GENES"
36,"Down",0.742677482715409,0.888032829137867,"L.PvsV.HOLLEMAN_ASPARAGINASE_RESISTANCE_B_ALL_DN"
54,"Down",0.743844826143294,0.889236333782978,"L.PvsV.HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_24HR"
16,"Up",0.74414594843077,0.88940400970033,"L.PvsV.ITO_PTTG1_TARGETS_DN"
27,"Down",0.744354413269444,0.889460892795927,"L.PvsV.KARAKAS_TGFB1_SIGNALING"
24,"Up",0.745161770464884,0.890107850583086,"L.PvsV.REACTOME_PI_3K_CASCADE_FGFR4"
462,"Down",0.745217804367716,0.890107850583086,"L.PvsV.YAMAZAKI_TCEB3_TARGETS_DN"
16,"Down",0.745905115750446,0.890618288706758,"L.PvsV.CHESLER_BRAIN_D6MIT150_QTL_TRANS"
162,"Down",0.745967316874841,0.890618288706758,"L.PvsV.PURBEY_TARGETS_OF_CTBP1_AND_SATB1_UP"
56,"Down",0.74648724478016,0.891020562023117,"L.PvsV.BOYAULT_LIVER_CANCER_SUBCLASS_G5_DN"
15,"Down",0.746626562462127,0.891020562023117,"L.PvsV.REACTOME_PI3K_EVENTS_IN_ERBB4_SIGNALING"
14,"Down",0.747123711466481,0.891306704354297,"L.PvsV.REACTOME_RUNX3_REGULATES_WNT_SIGNALING"
62,"Down",0.747561633465226,0.891306704354297,"L.PvsV.REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS"
14,"Down",0.747759855273142,0.891306704354297,"L.PvsV.REACTOME_ACTIVATED_NTRK2_SIGNALS_THROUGH_FRS2_AND_FRS3"
236,"Down",0.747823575948399,0.891306704354297,"L.PvsV.COULOUARN_TEMPORAL_TGFB1_SIGNATURE_DN"
158,"Up",0.747835443063274,0.891306704354297,"L.PvsV.SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_UP"
23,"Up",0.747873271424565,0.891306704354297,"L.PvsV.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_UP"
78,"Up",0.748212508028273,0.891306704354297,"L.PvsV.RICKMAN_HEAD_AND_NECK_CANCER_D"
9,"Up",0.74833574093392,0.891306704354297,"L.PvsV.SHARMA_PILOCYTIC_ASTROCYTOMA_LOCATION_DN"
20,"Down",0.748351183175159,0.891306704354297,"L.PvsV.SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX5_DN"
10,"Down",0.748635168386224,0.891306704354297,"L.PvsV.BIERIE_INFLAMMATORY_RESPONSE_TGFB1"
222,"Up",0.748639597580278,0.891306704354297,"L.PvsV.DER_IFN_BETA_RESPONSE_UP"
12,"Up",0.748971135489507,0.891509452771041,"L.PvsV.VISALA_AGING_LYMPHOCYTE_UP"
47,"Down",0.74926836287562,0.891671282466488,"L.PvsV.BIOCARTA_PDGF_PATHWAY"
20,"Down",0.750122046935389,0.892249763836222,"L.PvsV.SU_SALIVARY_GLAND"
663,"Down",0.750238688532133,0.892249763836222,"L.PvsV.BERENJENO_TRANSFORMED_BY_RHOA_DN"
173,"Down",0.750348939510239,0.892249763836222,"L.PvsV.BROWN_MYELOID_CELL_DEVELOPMENT_DN"
126,"Up",0.7503999641596,0.892249763836222,"L.PvsV.REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS"
54,"Up",0.750905508909069,0.892658903194634,"L.PvsV.KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS"
33,"Down",0.751084290802275,0.892679502116462,"L.PvsV.BIOCARTA_CASPASE_PATHWAY"
341,"Up",0.751274984031707,0.892714246015755,"L.PvsV.GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_DN"
17,"Up",0.751999749303851,0.892995260061692,"L.PvsV.CONRAD_GERMLINE_STEM_CELL"
9,"Down",0.7522319450791,0.892995260061692,"L.PvsV.TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_GRANULOCYTE_DN"
415,"Down",0.752257595742649,0.892995260061692,"L.PvsV.REACTOME_RHO_GTPASE_EFFECTORS"
45,"Down",0.752272871393869,0.892995260061692,"L.PvsV.REACTOME_GABA_B_RECEPTOR_ACTIVATION"
42,"Up",0.752419488204813,0.892995260061692,"L.PvsV.BIOCARTA_PYK2_PATHWAY"
94,"Down",0.753206236290255,0.892995260061692,"L.PvsV.BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_UP"
14,"Up",0.753235741698615,0.892995260061692,"L.PvsV.REACTOME_REGULATION_BY_C_FLIP"
15,"Up",0.753246668810746,0.892995260061692,"L.PvsV.MCCABE_HOXC6_TARGETS_UP"
13,"Down",0.753320993932968,0.892995260061692,"L.PvsV.REACTOME_REGULATION_OF_CYTOSKELETAL_REMODELING_AND_CELL_SPREADING_BY_IPP_COMPLEX_COMPONENTS"
8,"Up",0.75340605121534,0.892995260061692,"L.PvsV.REACTOME_ESTROGEN_STIMULATED_SIGNALING_THROUGH_PRKCZ"
36,"Down",0.753436889041457,0.892995260061692,"L.PvsV.KEGG_BASAL_TRANSCRIPTION_FACTORS"
47,"Up",0.753589294285697,0.892995260061692,"L.PvsV.BIOCARTA_BIOPEPTIDES_PATHWAY"
27,"Down",0.753611120175051,0.892995260061692,"L.PvsV.REACTOME_ADP_SIGNALLING_THROUGH_P2Y_PURINOCEPTOR_1"
492,"Down",0.754311689191453,0.893633882481154,"L.PvsV.REACTOME_LEISHMANIA_INFECTION"
354,"Up",0.754639397510273,0.893707048294988,"L.PvsV.MARTORIATI_MDM4_TARGETS_FETAL_LIVER_UP"
7,"Down",0.754696727887376,0.893707048294988,"L.PvsV.REACTOME_RSK_ACTIVATION"
72,"Up",0.75508727814174,0.893936858179728,"L.PvsV.NIKOLSKY_BREAST_CANCER_16Q24_AMPLICON"
73,"Up",0.755214155282602,0.893936858179728,"L.PvsV.HOFMANN_CELL_LYMPHOMA_DN"
44,"Up",0.755562283818038,0.894107498377068,"L.PvsV.REACTOME_BETA_DEFENSINS"
25,"Down",0.755755088172791,0.894107498377068,"L.PvsV.YIH_RESPONSE_TO_ARSENITE_C4"
143,"Down",0.755843452236285,0.894107498377068,"L.PvsV.SAFFORD_T_LYMPHOCYTE_ANERGY"
73,"Up",0.756344568406088,0.894508902399414,"L.PvsV.ZHAN_MULTIPLE_MYELOMA_CD2_DN"
36,"Up",0.757111030391672,0.894959680447639,"L.PvsV.BIOCARTA_TFF_PATHWAY"
73,"Up",0.757172425573962,0.894959680447639,"L.PvsV.TAVOR_CEBPA_TARGETS_UP"
8,"Down",0.75721131943101,0.894959680447639,"L.PvsV.REACTOME_ACTIVATION_OF_TRKA_RECEPTORS"
1739,"Up",0.757856302007711,0.895530560760981,"L.PvsV.GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP"
16,"Down",0.758474159291767,0.895843729350211,"L.PvsV.BIOCARTA_CDC42RAC_PATHWAY"
13,"Up",0.758502675449302,0.895843729350211,"L.PvsV.REACTOME_P75NTR_REGULATES_AXONOGENESIS"
26,"Up",0.758729405024362,0.895843729350211,"L.PvsV.REACTOME_N_GLYCAN_ANTENNAE_ELONGATION_IN_THE_MEDIAL_TRANS_GOLGI"
105,"Down",0.758976463524547,0.895843729350211,"L.PvsV.PID_VEGFR1_2_PATHWAY"
77,"Down",0.759086260448132,0.895843729350211,"L.PvsV.REACTOME_PKMTS_METHYLATE_HISTONE_LYSINES"
38,"Down",0.75923466801591,0.895843729350211,"L.PvsV.MATTIOLI_MULTIPLE_MYELOMA_SUBGROUPS"
16,"Down",0.759255510170933,0.895843729350211,"L.PvsV.REACTOME_NUCLEOTIDE_LIKE_PURINERGIC_RECEPTORS"
225,"Up",0.759461855479436,0.895896010016173,"L.PvsV.SENGUPTA_EBNA1_ANTICORRELATED"
69,"Down",0.759822998549792,0.896130835960281,"L.PvsV.BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_DN"
17,"Up",0.76023565192928,0.896299329101462,"L.PvsV.INAMURA_LUNG_CANCER_SCC_SUBTYPES_UP"
53,"Up",0.760436783812484,0.896299329101462,"L.PvsV.REACTOME_TNF_SIGNALING"
111,"Down",0.760609937082611,0.896299329101462,"L.PvsV.REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES"
10,"Down",0.760916720770851,0.896299329101462,"L.PvsV.BAKER_HEMATOPOESIS_STAT1_TARGETS"
78,"Down",0.760959510198779,0.896299329101462,"L.PvsV.KIM_ALL_DISORDERS_CALB1_CORR_DN"
40,"Up",0.761288304166315,0.896299329101462,"L.PvsV.PARK_TRETINOIN_RESPONSE_AND_RARA_PLZF_FUSION"
180,"Up",0.761354262633517,0.896299329101462,"L.PvsV.LENAOUR_DENDRITIC_CELL_MATURATION_UP"
38,"Down",0.761407471739902,0.896299329101462,"L.PvsV.BIOCARTA_INSULIN_PATHWAY"
105,"Down",0.761583172495065,0.896299329101462,"L.PvsV.REACTOME_OPIOID_SIGNALLING"
151,"Down",0.761650415157729,0.896299329101462,"L.PvsV.SMITH_TERT_TARGETS_DN"
72,"Down",0.761749059042824,0.896299329101462,"L.PvsV.REACTOME_SIGNALING_BY_FGFR_IN_DISEASE"
94,"Down",0.762803682485866,0.897275770061439,"L.PvsV.GERHOLD_ADIPOGENESIS_DN"
52,"Down",0.762903489791793,0.897275770061439,"L.PvsV.SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_DN"
112,"Up",0.763237345548261,0.897477516702751,"L.PvsV.BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_CIS"
62,"Down",0.763796603632233,0.89780946253943,"L.PvsV.SIG_BCR_SIGNALING_PATHWAY"
13,"Up",0.763844404374295,0.89780946253943,"L.PvsV.FUNG_IL2_SIGNALING_2"
6,"Up",0.76435244709817,0.898215659937467,"L.PvsV.FIGUEROA_AML_METHYLATION_CLUSTER_7_DN"
54,"Up",0.764770132009603,0.898515524836611,"L.PvsV.NAKAMURA_CANCER_MICROENVIRONMENT_DN"
23,"Down",0.765716094422354,0.899277029086926,"L.PvsV.REACTOME_GAB1_SIGNALOSOME"
368,"Up",0.765897880092864,0.899277029086926,"L.PvsV.THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN"
183,"Up",0.766195314110063,0.899277029086926,"L.PvsV.REACTOME_CD22_MEDIATED_BCR_REGULATION"
50,"Up",0.766198198525105,0.899277029086926,"L.PvsV.ABBUD_LIF_SIGNALING_1_DN"
22,"Down",0.766231521799332,0.899277029086926,"L.PvsV.REACTOME_TIE2_SIGNALING"
42,"Down",0.766400743049289,0.89928474285219,"L.PvsV.REACTOME_BIOSYNTHESIS_OF_MARESINS"
20,"Down",0.766897017365898,0.899582690768898,"L.PvsV.AMIT_EGF_RESPONSE_40_MCF10A"
10,"Down",0.766980069503452,0.899582690768898,"L.PvsV.TURASHVILI_BREAST_CARCINOMA_DUCTAL_VS_LOBULAR_DN"
588,"Up",0.767278648457615,0.899742024882747,"L.PvsV.YOSHIMURA_MAPK8_TARGETS_DN"
102,"Down",0.767926976104382,0.900135903742058,"L.PvsV.REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION"
28,"Down",0.767940144321087,0.900135903742058,"L.PvsV.HO_LIVER_CANCER_VASCULAR_INVASION"
206,"Up",0.768710653768817,0.900813210433597,"L.PvsV.LIU_VMYB_TARGETS_UP"
36,"Up",0.769115894943037,0.900813210433597,"L.PvsV.BIOCARTA_TRKA_PATHWAY"
20,"Up",0.769221763191306,0.900813210433597,"L.PvsV.WIEMANN_TELOMERE_SHORTENING_AND_CHRONIC_LIVER_DAMAGE_DN"
6,"Down",0.769274858116956,0.900813210433597,"L.PvsV.BIOCARTA_SUMO_PATHWAY"
13,"Up",0.769332606197766,0.900813210433597,"L.PvsV.REACTOME_MUCOPOLYSACCHARIDOSES"
16,"Up",0.769745399792181,0.900825932838345,"L.PvsV.SHANK_TAL1_TARGETS_DN"
12,"Up",0.769866794634739,0.900825932838345,"L.PvsV.REACTOME_SYNTHESIS_OF_15_EICOSATETRAENOIC_ACID_DERIVATIVES"
23,"Down",0.770020055559527,0.900825932838345,"L.PvsV.REACTOME_RAF_INDEPENDENT_MAPK1_3_ACTIVATION"
33,"Up",0.77011728328837,0.900825932838345,"L.PvsV.REACTOME_PIWI_INTERACTING_RNA_PIRNA_BIOGENESIS"
39,"Up",0.770274972679877,0.900825932838345,"L.PvsV.BIOCARTA_TPO_PATHWAY"
531,"Up",0.770332147886001,0.900825932838345,"L.PvsV.ENK_UV_RESPONSE_EPIDERMIS_UP"
206,"Up",0.770483963898089,0.900825932838345,"L.PvsV.PECE_MAMMARY_STEM_CELL_UP"
94,"Down",0.770843362454647,0.901055592180073,"L.PvsV.CHIARETTI_ACUTE_LYMPHOBLASTIC_LEUKEMIA_ZAP70"
32,"Down",0.77103690230565,0.901091319562025,"L.PvsV.REACTOME_RNA_POLYMERASE_I_TRANSCRIPTION_TERMINATION"
19,"Up",0.771226906181741,0.901122900312521,"L.PvsV.NIKOLSKY_BREAST_CANCER_12Q24_AMPLICON"
230,"Down",0.77159518328822,0.901362723093296,"L.PvsV.MILI_PSEUDOPODIA_CHEMOTAXIS_UP"
25,"Up",0.771818469120006,0.901433104301756,"L.PvsV.REACTOME_REGULATION_OF_INNATE_IMMUNE_RESPONSES_TO_CYTOSOLIC_DNA"
53,"Down",0.772303643503884,0.901643140620156,"L.PvsV.REACTOME_MAP2K_AND_MAPK_ACTIVATION"
91,"Up",0.772324455412743,0.901643140620156,"L.PvsV.REACTOME_SIGNALING_BY_FGFR2"
5,"Down",0.772704691263042,0.901896609244957,"L.PvsV.REACTOME_DISEASES_OF_BASE_EXCISION_REPAIR"
101,"Down",0.773128945481987,0.902201338026574,"L.PvsV.BRIDEAU_IMPRINTED_GENES"
149,"Up",0.77337153198533,0.902293986146211,"L.PvsV.GUO_TARGETS_OF_IRS1_AND_IRS2"
15,"Down",0.77355850571248,0.902321725334241,"L.PvsV.REACTOME_SYNTHESIS_OF_PIPS_AT_THE_LATE_ENDOSOME_MEMBRANE"
528,"Up",0.774089995188405,0.902751230414826,"L.PvsV.RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN"
58,"Down",0.774441414219794,0.90297059873919,"L.PvsV.COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_DN"
48,"Down",0.774937633347182,0.903046419184681,"L.PvsV.WORSCHECH_TUMOR_EVASION_AND_TOLEROGENICITY_UP"
83,"Down",0.775443661690169,0.903046419184681,"L.PvsV.CHENG_RESPONSE_TO_NICKEL_ACETATE"
7,"Down",0.775467034597763,0.903046419184681,"L.PvsV.REACTOME_PROTEIN_REPAIR"
20,"Down",0.775471252547273,0.903046419184681,"L.PvsV.MIKKELSEN_ES_LCP_WITH_H3K4ME3_AND_H3K27ME3"
5,"Down",0.775496251573706,0.903046419184681,"L.PvsV.REACTOME_TACHYKININ_RECEPTORS_BIND_TACHYKININS"
42,"Up",0.775512385041469,0.903046419184681,"L.PvsV.BURTON_ADIPOGENESIS_12"
40,"Up",0.775649745832529,0.903046419184681,"L.PvsV.WIEMANN_TELOMERE_SHORTENING_AND_CHRONIC_LIVER_DAMAGE_UP"
11,"Down",0.776147364626034,0.903435532424704,"L.PvsV.BIOCARTA_SKP2E2F_PATHWAY"
24,"Up",0.776420615151372,0.903563372168372,"L.PvsV.SUZUKI_AMPLIFIED_IN_ORAL_CANCER"
611,"Up",0.776589751853638,0.903570020622636,"L.PvsV.REN_ALVEOLAR_RHABDOMYOSARCOMA_DN"
60,"Down",0.777282777184991,0.903996005601315,"L.PvsV.PID_NFAT_TFPATHWAY"
96,"Up",0.777368331504861,0.903996005601315,"L.PvsV.REACTOME_GLOBAL_GENOME_NUCLEOTIDE_EXCISION_REPAIR_GG_NER"
81,"Up",0.777446374866025,0.903996005601315,"L.PvsV.HEIDENBLAD_AMPLICON_8Q24_UP"
15,"Up",0.777727216636042,0.904132418162464,"L.PvsV.MANN_RESPONSE_TO_AMIFOSTINE_DN"
11,"Down",0.778020403215904,0.904283121585187,"L.PvsV.REACTOME_UREA_CYCLE"
35,"Down",0.779425763882889,0.905664731192279,"L.PvsV.BIOCARTA_CREB_PATHWAY"
185,"Up",0.779536707495759,0.905664731192279,"L.PvsV.FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP"
48,"Down",0.779948953777902,0.905953312066812,"L.PvsV.JACKSON_DNMT1_TARGETS_DN"
13,"Up",0.780659742957091,0.906588472759873,"L.PvsV.REACTOME_MINERALOCORTICOID_BIOSYNTHESIS"
135,"Down",0.78145801315015,0.907324937989748,"L.PvsV.LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP"
176,"Down",0.78166565761304,0.907375482037056,"L.PvsV.LAIHO_COLORECTAL_CANCER_SERRATED_UP"
182,"Up",0.781846357825924,0.907394733925175,"L.PvsV.LEE_CALORIE_RESTRICTION_NEOCORTEX_UP"
18,"Up",0.782324259583622,0.90748485557194,"L.PvsV.STEINER_ERYTHROCYTE_MEMBRANE_GENES"
22,"Up",0.782326009391398,0.90748485557194,"L.PvsV.ZHENG_RESPONSE_TO_ARSENITE_DN"
19,"Up",0.782416405590783,0.90748485557194,"L.PvsV.HOFFMAN_CLOCK_TARGETS_UP"
136,"Up",0.782969576334602,0.907854455786848,"L.PvsV.CROMER_METASTASIS_UP"
38,"Up",0.783130559829304,0.907854455786848,"L.PvsV.WANG_METASTASIS_OF_BREAST_CANCER_ESR1_UP"
197,"Up",0.783227663972376,0.907854455786848,"L.PvsV.LIU_SOX4_TARGETS_UP"
40,"Up",0.783687030697999,0.908196519121617,"L.PvsV.KEGG_CYSTEINE_AND_METHIONINE_METABOLISM"
52,"Down",0.784156351488018,0.908351756111128,"L.PvsV.REACTOME_TRANSCRIPTIONAL_REGULATION_BY_VENTX"
31,"Down",0.784414853960279,0.908351756111128,"L.PvsV.GOERING_BLOOD_HDL_CHOLESTEROL_QTL_TRANS"
198,"Down",0.784440312342543,0.908351756111128,"L.PvsV.NIKOLSKY_BREAST_CANCER_17Q11_Q21_AMPLICON"
18,"Up",0.784589608525695,0.908351756111128,"L.PvsV.BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_24HR_UP"
607,"Down",0.784763952091055,0.908351756111128,"L.PvsV.REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES"
17,"Down",0.784806717117537,0.908351756111128,"L.PvsV.REACTOME_ERBB2_REGULATES_CELL_MOTILITY"
39,"Down",0.785140827830401,0.908380336416596,"L.PvsV.PID_RETINOIC_ACID_PATHWAY"
145,"Up",0.785181423877616,0.908380336416596,"L.PvsV.MARCHINI_TRABECTEDIN_RESISTANCE_DN"
406,"Up",0.785462214688126,0.908380336416596,"L.PvsV.DANG_REGULATED_BY_MYC_DN"
11,"Up",0.785488585351374,0.908380336416596,"L.PvsV.REACTOME_HORMONE_LIGAND_BINDING_RECEPTORS"
82,"Down",0.785958784735364,0.908710999555976,"L.PvsV.LI_LUNG_CANCER"
24,"Down",0.786103221355802,0.908710999555976,"L.PvsV.REACTOME_RORA_ACTIVATES_GENE_EXPRESSION"
1236,"Down",0.786634908147744,0.909060320043452,"L.PvsV.NUYTTEN_NIPP1_TARGETS_DN"
131,"Up",0.78687917142183,0.909060320043452,"L.PvsV.KEGG_T_CELL_RECEPTOR_SIGNALING_PATHWAY"
357,"Down",0.786898660106341,0.909060320043452,"L.PvsV.JISON_SICKLE_CELL_DISEASE_UP"
19,"Up",0.787241299831444,0.909266168115323,"L.PvsV.REACTOME_PI3K_EVENTS_IN_ERBB2_SIGNALING"
324,"Down",0.787949807277997,0.909894420309115,"L.PvsV.REACTOME_SIGNALING_BY_NOTCH"
51,"Down",0.788221094765422,0.910017630603052,"L.PvsV.VALK_AML_CLUSTER_13"
73,"Up",0.788750803587991,0.91043907996618,"L.PvsV.IKEDA_MIR1_TARGETS_UP"
31,"Up",0.789122805960071,0.910678354029062,"L.PvsV.REACTOME_INTERCONVERSION_OF_NUCLEOTIDE_DI_AND_TRIPHOSPHATES"
11,"Down",0.789397209948829,0.910720736595045,"L.PvsV.ZHU_SKIL_TARGETS_DN"
37,"Up",0.789710896003279,0.910720736595045,"L.PvsV.STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_UP"
38,"Down",0.789780716782315,0.910720736595045,"L.PvsV.REACTOME_INTEGRIN_SIGNALING"
19,"Up",0.790100060784379,0.910720736595045,"L.PvsV.REACTOME_ACYL_CHAIN_REMODELLING_OF_PI"
66,"Down",0.790298039622713,0.910720736595045,"L.PvsV.WEBER_METHYLATED_HCP_IN_FIBROBLAST_DN"
31,"Up",0.790362070164473,0.910720736595045,"L.PvsV.REACTOME_MISCELLANEOUS_TRANSPORT_AND_BINDING_EVENTS"
33,"Up",0.790376246195671,0.910720736595045,"L.PvsV.PID_P38_ALPHA_BETA_PATHWAY"
201,"Up",0.790477268026699,0.910720736595045,"L.PvsV.REACTOME_G2_M_CHECKPOINTS"
62,"Up",0.790910372324754,0.911029885121576,"L.PvsV.STAMBOLSKY_TARGETS_OF_MUTATED_TP53_UP"
176,"Down",0.791219235272104,0.911195824165687,"L.PvsV.STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_UP"
7,"Down",0.791868731882747,0.911643287746638,"L.PvsV.REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_LINKED_TO_GLUCONEOGENESIS"
48,"Down",0.791937549474969,0.911643287746638,"L.PvsV.GENTILE_UV_RESPONSE_CLUSTER_D5"
32,"Down",0.792427322973515,0.911846876167407,"L.PvsV.REACTOME_HS_GAG_BIOSYNTHESIS"
18,"Down",0.792577213478509,0.911846876167407,"L.PvsV.WEBER_METHYLATED_LCP_IN_SPERM_UP"
12,"Down",0.792609167455337,0.911846876167407,"L.PvsV.REACTOME_CONDENSATION_OF_PROMETAPHASE_CHROMOSOMES"
104,"Down",0.793496230142686,0.912677482100876,"L.PvsV.CHIBA_RESPONSE_TO_TSA_UP"
354,"Down",0.793807688299192,0.912845821257536,"L.PvsV.OHGUCHI_LIVER_HNF4A_TARGETS_DN"
14,"Down",0.794282880556173,0.913202338655662,"L.PvsV.REACTOME_CROSS_PRESENTATION_OF_PARTICULATE_EXOGENOUS_ANTIGENS_PHAGOSOMES"
1381,"Down",0.795028810621017,0.913705798305331,"L.PvsV.BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_TRANS"
149,"Down",0.795051292394094,0.913705798305331,"L.PvsV.NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN"
34,"Down",0.795831661353953,0.914412563513301,"L.PvsV.PETRETTO_HEART_MASS_QTL_CIS_DN"
69,"Down",0.796126589897012,0.914532158834824,"L.PvsV.KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY"
36,"Up",0.796355684664132,0.914532158834824,"L.PvsV.REACTOME_ACTIVATION_OF_BH3_ONLY_PROTEINS"
10,"Up",0.796609719642311,0.914532158834824,"L.PvsV.WEBER_METHYLATED_LCP_IN_SPERM_DN"
113,"Down",0.796614951153372,0.914532158834824,"L.PvsV.REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE"
69,"Up",0.796762779726415,0.914532158834824,"L.PvsV.SCHEIDEREIT_IKK_INTERACTING_PROTEINS"
46,"Down",0.798177195407675,0.91578149977608,"L.PvsV.VERNELL_RETINOBLASTOMA_PATHWAY_DN"
6,"Up",0.798182500890022,0.91578149977608,"L.PvsV.REACTOME_SENSING_OF_DNA_DOUBLE_STRAND_BREAKS"
43,"Up",0.798852282063032,0.916178904906303,"L.PvsV.REACTOME_REGULATION_OF_TNFR1_SIGNALING"
81,"Down",0.7988866200776,0.916178904906303,"L.PvsV.VANTVEER_BREAST_CANCER_BRCA1_DN"
22,"Down",0.799025986518031,0.916178904906303,"L.PvsV.REACTOME_YAP1_AND_WWTR1_TAZ_STIMULATED_GENE_EXPRESSION"
80,"Down",0.799291651538886,0.916293498104603,"L.PvsV.TONG_INTERACT_WITH_PTTG1"
22,"Up",0.799586453201724,0.916441438588792,"L.PvsV.REACTOME_ACETYLCHOLINE_NEUROTRANSMITTER_RELEASE_CYCLE"
65,"Down",0.800283790398661,0.917050585930404,"L.PvsV.AMIT_EGF_RESPONSE_120_MCF10A"
49,"Up",0.800668393896435,0.91730119143253,"L.PvsV.PID_IL2_PI3K_PATHWAY"
833,"Down",0.800857616835128,0.917327897965905,"L.PvsV.BERENJENO_TRANSFORMED_BY_RHOA_UP"
48,"Down",0.801506015510572,0.917880439055086,"L.PvsV.WIKMAN_ASBESTOS_LUNG_CANCER_DN"
37,"Up",0.80198586478409,0.91810667407449,"L.PvsV.BIOCARTA_ECM_PATHWAY"
25,"Down",0.802141444891125,0.91810667407449,"L.PvsV.BIOCARTA_IL7_PATHWAY"
172,"Up",0.802221708610587,0.91810667407449,"L.PvsV.DANG_MYC_TARGETS_UP"
188,"Up",0.802367778825816,0.91810667407449,"L.PvsV.ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION"
9,"Up",0.802654883925279,0.918115792638339,"L.PvsV.REACTOME_CREB3_FACTORS_ACTIVATE_GENES"
129,"Down",0.802862642001171,0.918115792638339,"L.PvsV.SANA_RESPONSE_TO_IFNG_DN"
6,"Up",0.802873911630742,0.918115792638339,"L.PvsV.REACTOME_SIGNALING_BY_MST1"
88,"Down",0.803145996132495,0.918237016670092,"L.PvsV.PID_RB_1PATHWAY"
155,"Down",0.803542910400613,0.918500878975602,"L.PvsV.ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_UP"
113,"Down",0.804256976112169,0.918894711901453,"L.PvsV.HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_UP"
4,"Down",0.804369701520386,0.918894711901453,"L.PvsV.REACTOME_ORGANIC_ANION_TRANSPORT"
45,"Up",0.804386038271484,0.918894711901453,"L.PvsV.REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS"
19,"Down",0.804952395161594,0.919291943750786,"L.PvsV.REACTOME_PRESYNAPTIC_DEPOLARIZATION_AND_CALCIUM_CHANNEL_OPENING"
15,"Up",0.805153302419309,0.919291943750786,"L.PvsV.BIOCARTA_CPSF_PATHWAY"
33,"Up",0.805272969385124,0.919291943750786,"L.PvsV.MAHADEVAN_IMATINIB_RESISTANCE_UP"
94,"Up",0.805533047189243,0.919291943750786,"L.PvsV.ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_UP"
26,"Up",0.805604695694984,0.919291943750786,"L.PvsV.BIOCARTA_CSK_PATHWAY"
18,"Up",0.806151610171512,0.919291943750786,"L.PvsV.BIOCARTA_LYM_PATHWAY"
40,"Up",0.806206295223404,0.919291943750786,"L.PvsV.REACTOME_MAPK_TARGETS_NUCLEAR_EVENTS_MEDIATED_BY_MAP_KINASES"
26,"Down",0.806279204513851,0.919291943750786,"L.PvsV.BIOCARTA_41BB_PATHWAY"
1034,"Down",0.80639660704314,0.919291943750786,"L.PvsV.GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP"
29,"Down",0.806528684585069,0.919291943750786,"L.PvsV.BIOCARTA_CXCR4_PATHWAY"
201,"Down",0.80656270919426,0.919291943750786,"L.PvsV.WEI_MIR34A_TARGETS"
62,"Down",0.806754187754844,0.919320672732179,"L.PvsV.SUBTIL_PROGESTIN_TARGETS"
25,"Up",0.807608191130297,0.920059783106014,"L.PvsV.REACTOME_GLUCURONIDATION"
8,"Down",0.80773560991076,0.920059783106014,"L.PvsV.FARMER_BREAST_CANCER_CLUSTER_8"
53,"Down",0.808019855885189,0.920193982119302,"L.PvsV.PID_LIS1_PATHWAY"
373,"Down",0.80847083146716,0.920342175442633,"L.PvsV.RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_UP"
10,"Up",0.809009471373434,0.920342175442633,"L.PvsV.REACTOME_NEGATIVE_REGULATION_OF_ACTIVITY_OF_TFAP2_AP_2_FAMILY_TRANSCRIPTION_FACTORS"
34,"Down",0.809095669749328,0.920342175442633,"L.PvsV.GOLUB_ALL_VS_AML_UP"
349,"Up",0.809179214099836,0.920342175442633,"L.PvsV.REACTOME_MAPK_FAMILY_SIGNALING_CASCADES"
15,"Up",0.809206080825809,0.920342175442633,"L.PvsV.MONTERO_THYROID_CANCER_POOR_SURVIVAL_DN"
60,"Down",0.809309407243587,0.920342175442633,"L.PvsV.BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_UP"
6,"Up",0.809315184843929,0.920342175442633,"L.PvsV.REACTOME_THE_RETINOID_CYCLE_IN_CONES_DAYLIGHT_VISION"
151,"Up",0.809715190488627,0.920444941374006,"L.PvsV.LE_EGR2_TARGETS_DN"
56,"Up",0.809738505126274,0.920444941374006,"L.PvsV.KEGG_GLUTATHIONE_METABOLISM"
117,"Down",0.810674009930352,0.921157323925705,"L.PvsV.ROSS_AML_OF_FAB_M7_TYPE"
6,"Up",0.810808501608642,0.921157323925705,"L.PvsV.SMID_BREAST_CANCER_RELAPSE_IN_LIVER_UP"
24,"Down",0.810959909165833,0.921157323925705,"L.PvsV.LIU_TOPBP1_TARGETS"
51,"Down",0.811031624682643,0.921157323925705,"L.PvsV.REACTOME_SIGNALING_BY_FGFR1_IN_DISEASE"
18,"Up",0.811542426665906,0.921548177661901,"L.PvsV.PID_SMAD2_3PATHWAY"
57,"Down",0.811966696114057,0.921840628914707,"L.PvsV.THILLAINADESAN_ZNF217_TARGETS_UP"
22,"Down",0.81241521146368,0.921972293206012,"L.PvsV.MEISSNER_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3"
8,"Down",0.813058012299261,0.921972293206012,"L.PvsV.REACTOME_SYNTHESIS_OF_PIPS_AT_THE_ER_MEMBRANE"
21,"Down",0.813140645536852,0.921972293206012,"L.PvsV.BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_48HR_UP"
1184,"Up",0.8131514302991,0.921972293206012,"L.PvsV.LEE_BMP2_TARGETS_DN"
87,"Up",0.81319741167009,0.921972293206012,"L.PvsV.MATTIOLI_MGUS_VS_MULTIPLE_MYELOMA"
12,"Down",0.813217555544929,0.921972293206012,"L.PvsV.REACTOME_ACTIVATED_NTRK2_SIGNALS_THROUGH_RAS"
515,"Up",0.813259556600151,0.921972293206012,"L.PvsV.RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN"
11,"Up",0.813416684076492,0.921972293206012,"L.PvsV.BIOCARTA_ALTERNATIVE_PATHWAY"
14,"Up",0.813661354856147,0.921981583311556,"L.PvsV.ABBUD_LIF_SIGNALING_2_DN"
516,"Up",0.813758387874913,0.921981583311556,"L.PvsV.LI_INDUCED_T_TO_NATURAL_KILLER_UP"
33,"Up",0.8140929553856,0.92217167595308,"L.PvsV.BIOCARTA_HER2_PATHWAY"
20,"Down",0.81455904352439,0.922510641467913,"L.PvsV.PID_TCR_JNK_PATHWAY"
35,"Up",0.814742769965248,0.922529751205786,"L.PvsV.SIG_IL4RECEPTOR_IN_B_LYPHOCYTES"
97,"Up",0.815108763178984,0.92275519074869,"L.PvsV.AUNG_GASTRIC_CANCER"
20,"Down",0.816309016515133,0.923924780411908,"L.PvsV.SABATES_COLORECTAL_ADENOMA_SIZE_DN"
16,"Down",0.816580367194956,0.924042744621553,"L.PvsV.KORKOLA_EMBRYONAL_CARCINOMA"
75,"Down",0.81708566496945,0.924242830035443,"L.PvsV.REACTOME_CHEMOKINE_RECEPTORS_BIND_CHEMOKINES"
82,"Down",0.817091508991363,0.924242830035443,"L.PvsV.BIOCARTA_NFAT_PATHWAY"
188,"Up",0.817328081136455,0.924321325547855,"L.PvsV.PID_PDGFRB_PATHWAY"
51,"Up",0.817991609422599,0.924882537525061,"L.PvsV.REACTOME_CLASS_C_3_METABOTROPIC_GLUTAMATE_PHEROMONE_RECEPTORS"
51,"Down",0.818205049635905,0.924934720800842,"L.PvsV.KANG_GLIS3_TARGETS"
371,"Down",0.818902303471012,0.92553369499003,"L.PvsV.GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_UP"
965,"Up",0.819458241879425,0.92597274051734,"L.PvsV.PATIL_LIVER_CANCER"
16,"Down",0.81996960732753,0.926361250288907,"L.PvsV.REACTOME_TNFR1_INDUCED_PROAPOPTOTIC_SIGNALING"
12,"Down",0.820236687037813,0.92647367571646,"L.PvsV.REACTOME_INTEGRATION_OF_PROVIRUS"
4,"Down",0.820785869539798,0.926904630858975,"L.PvsV.DER_IFN_ALPHA_RESPONSE_DN"
155,"Up",0.821347789707153,0.927349791564396,"L.PvsV.WINTER_HYPOXIA_UP"
66,"Up",0.821806893513736,0.927678708500908,"L.PvsV.REACTOME_SIGNALING_BY_MODERATE_KINASE_ACTIVITY_BRAF_MUTANTS"
38,"Up",0.822017804171321,0.927727380947792,"L.PvsV.VALK_AML_WITH_11Q23_REARRANGED"
101,"Down",0.822936714702968,0.928574917467901,"L.PvsV.KEGG_APOPTOSIS"
22,"Down",0.82335662455791,0.928576933834025,"L.PvsV.BIOCARTA_GRANULOCYTES_PATHWAY"
54,"Up",0.823390591517471,0.928576933834025,"L.PvsV.ZHAN_EARLY_DIFFERENTIATION_GENES_DN"
59,"Up",0.823442341578626,0.928576933834025,"L.PvsV.PID_A6B1_A6B4_INTEGRIN_PATHWAY"
325,"Down",0.823611121082518,0.928577872851803,"L.PvsV.LINSLEY_MIR16_TARGETS"
43,"Down",0.824251051340484,0.92884303405225,"L.PvsV.REACTOME_PROLACTIN_RECEPTOR_SIGNALING"
14,"Down",0.824379584980949,0.92884303405225,"L.PvsV.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_12"
165,"Up",0.824522689652131,0.92884303405225,"L.PvsV.HELLER_SILENCED_BY_METHYLATION_DN"
64,"Up",0.824834578709824,0.92884303405225,"L.PvsV.REACTOME_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER"
33,"Down",0.824837905847207,0.92884303405225,"L.PvsV.REACTOME_PROCESSING_OF_CAPPED_INTRONLESS_PRE_MRNA"
243,"Down",0.825017321776569,0.92884303405225,"L.PvsV.ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP"
42,"Down",0.825022271700235,0.92884303405225,"L.PvsV.GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_UP"
13,"Down",0.82532540804929,0.928995150876328,"L.PvsV.REACTOME_ERBB2_ACTIVATES_PTK6_SIGNALING"
5,"Down",0.825566370858349,0.929008283463943,"L.PvsV.TOMIDA_LUNG_CANCER_POOR_SURVIVAL"
108,"Down",0.825673124424275,0.929008283463943,"L.PvsV.HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_DN"
17,"Down",0.826333415284286,0.929562045393046,"L.PvsV.REACTOME_TELOMERE_EXTENSION_BY_TELOMERASE"
12,"Up",0.826994994264786,0.929693154708104,"L.PvsV.MUNSHI_MULTIPLE_MYELOMA_DN"
659,"Down",0.827044748424773,0.929693154708104,"L.PvsV.SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6"
52,"Down",0.827187737593159,0.929693154708104,"L.PvsV.REACTOME_CYCLIN_D_ASSOCIATED_EVENTS_IN_G1"
39,"Down",0.827598586604631,0.929693154708104,"L.PvsV.REACTOME_NUCLEAR_SIGNALING_BY_ERBB4"
187,"Up",0.827657399952131,0.929693154708104,"L.PvsV.QI_HYPOXIA"
7,"Down",0.827906598812371,0.929693154708104,"L.PvsV.TERAMOTO_OPN_TARGETS_CLUSTER_3"
26,"Down",0.827951932655431,0.929693154708104,"L.PvsV.REACTOME_UNBLOCKING_OF_NMDA_RECEPTORS_GLUTAMATE_BINDING_AND_ACTIVATION"
13,"Up",0.828206693433898,0.929693154708104,"L.PvsV.HOLLERN_SOLID_NODULAR_BREAST_TUMOR_UP"
294,"Down",0.82822783118874,0.929693154708104,"L.PvsV.FERNANDEZ_BOUND_BY_MYC"
720,"Down",0.828354983680767,0.929693154708104,"L.PvsV.SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN"
7,"Up",0.828366282249875,0.929693154708104,"L.PvsV.REACTOME_CHYLOMICRON_CLEARANCE"
5,"Down",0.828523989640642,0.929693154708104,"L.PvsV.REACTOME_PTK6_REGULATES_PROTEINS_INVOLVED_IN_RNA_PROCESSING"
20,"Up",0.828833854151952,0.929693154708104,"L.PvsV.REACTOME_RAP1_SIGNALLING"
26,"Down",0.829003483779283,0.929693154708104,"L.PvsV.BARRIER_COLON_CANCER_RECURRENCE_DN"
61,"Down",0.829259994753349,0.929693154708104,"L.PvsV.PID_THROMBIN_PAR1_PATHWAY"
6,"Down",0.829262195667942,0.929693154708104,"L.PvsV.ZIRN_TRETINOIN_RESPONSE_WT1_DN"
96,"Up",0.829367108990928,0.929693154708104,"L.PvsV.CERIBELLI_PROMOTERS_INACTIVE_AND_BOUND_BY_NFY"
156,"Up",0.829502745993045,0.929693154708104,"L.PvsV.KOHOUTEK_CCNT2_TARGETS"
230,"Down",0.829973290965269,0.929693154708104,"L.PvsV.PASINI_SUZ12_TARGETS_UP"
12,"Up",0.83006288573811,0.929693154708104,"L.PvsV.WANG_THOC1_TARGETS_UP"
37,"Down",0.830249336635183,0.929693154708104,"L.PvsV.REACTOME_CYP2E1_REACTIONS"
84,"Down",0.830458536106212,0.929693154708104,"L.PvsV.LUI_THYROID_CANCER_CLUSTER_1"
18,"Up",0.830479748857444,0.929693154708104,"L.PvsV.REACTOME_NEUROFASCIN_INTERACTIONS"
87,"Down",0.830552826907516,0.929693154708104,"L.PvsV.REACTOME_TRANSCRIPTION_COUPLED_NUCLEOTIDE_EXCISION_REPAIR_TC_NER"
225,"Down",0.830653677746073,0.929693154708104,"L.PvsV.REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS"
26,"Up",0.830845117990925,0.929719218249712,"L.PvsV.KEGG_SELENOAMINO_ACID_METABOLISM"
91,"Down",0.831110127584195,0.929768732539672,"L.PvsV.REACTOME_SPHINGOLIPID_METABOLISM"
37,"Down",0.831225690892313,0.929768732539672,"L.PvsV.BIOCARTA_LIS1_PATHWAY"
56,"Up",0.831729377085848,0.930008480896373,"L.PvsV.PID_RET_PATHWAY"
71,"Up",0.831776440230161,0.930008480896373,"L.PvsV.BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_UP"
23,"Up",0.832210308280664,0.930305457841445,"L.PvsV.REACTOME_PROCESSING_OF_INTRONLESS_PRE_MRNAS"
18,"Up",0.832542322167342,0.930488477716441,"L.PvsV.BIOCARTA_DNAFRAGMENT_PATHWAY"
15,"Down",0.832806381079245,0.930595489286004,"L.PvsV.REACTOME_REGULATION_OF_PTEN_LOCALIZATION"
20,"Down",0.833147811820114,0.930734831567597,"L.PvsV.REACTOME_HDL_ASSEMBLY"
301,"Up",0.833267754794647,0.930734831567597,"L.PvsV.KIM_WT1_TARGETS_12HR_DN"
36,"Up",0.833588442053349,0.930785478232621,"L.PvsV.KRIGE_AMINO_ACID_DEPRIVATION"
15,"Down",0.833649789873022,0.930785478232621,"L.PvsV.PID_INTEGRIN4_PATHWAY"
222,"Down",0.834058425304083,0.931002331517416,"L.PvsV.WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP"
29,"Up",0.834206367484628,0.931002331517416,"L.PvsV.REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR3"
103,"Down",0.834477120392597,0.931002331517416,"L.PvsV.NIKOLSKY_BREAST_CANCER_7Q21_Q22_AMPLICON"
29,"Down",0.834517553807255,0.931002331517416,"L.PvsV.KEGG_PHENYLALANINE_METABOLISM"
163,"Down",0.83484708910291,0.93118207699213,"L.PvsV.HILLION_HMGA1_TARGETS"
110,"Down",0.835648557061115,0.931851292369254,"L.PvsV.OHGUCHI_LIVER_HNF4A_TARGETS_UP"
104,"Up",0.835784148826032,0.931851292369254,"L.PvsV.KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_DN"
6,"Down",0.836305590447161,0.932229515232452,"L.PvsV.REACTOME_THE_FATTY_ACID_CYCLING_MODEL"
20,"Up",0.836461141167787,0.932229515232452,"L.PvsV.REACTOME_ACTIVATION_OF_THE_PHOTOTRANSDUCTION_CASCADE"
27,"Up",0.836733352803021,0.932229515232452,"L.PvsV.REACTOME_SHC1_EVENTS_IN_ERBB2_SIGNALING"
11,"Up",0.836797808663168,0.932229515232452,"L.PvsV.REACTOME_RUNX3_REGULATES_YAP1_MEDIATED_TRANSCRIPTION"
214,"Down",0.837246158122072,0.932437882840391,"L.PvsV.RASHI_RESPONSE_TO_IONIZING_RADIATION_2"
15,"Down",0.837322135703119,0.932437882840391,"L.PvsV.HOLLEMAN_PREDNISOLONE_RESISTANCE_ALL_DN"
8,"Down",0.837861162507739,0.932850255236667,"L.PvsV.REACTOME_SYNTHESIS_OF_KETONE_BODIES"
23,"Down",0.838756151140188,0.933416410035725,"L.PvsV.BIOCARTA_MITOCHONDRIA_PATHWAY"
141,"Down",0.838839832543335,0.933416410035725,"L.PvsV.YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_0"
7,"Up",0.839003219508158,0.933416410035725,"L.PvsV.REACTOME_MITOCHONDRIAL_UNCOUPLING"
38,"Down",0.839214393467706,0.933416410035725,"L.PvsV.MALTA_CURATED_STEMNESS_MARKERS"
657,"Up",0.839351066522598,0.933416410035725,"L.PvsV.SENESE_HDAC1_TARGETS_UP"
27,"Up",0.839382599149507,0.933416410035725,"L.PvsV.LEE_NAIVE_T_LYMPHOCYTE"
355,"Up",0.839935271016948,0.933586349410716,"L.PvsV.IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_UP"
35,"Up",0.84012645524188,0.933586349410716,"L.PvsV.MARKS_HDAC_TARGETS_UP"
212,"Down",0.840510600837936,0.933586349410716,"L.PvsV.LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN"
18,"Up",0.840535441783269,0.933586349410716,"L.PvsV.KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_4NQO_IN_OLD"
957,"Down",0.840623118177872,0.933586349410716,"L.PvsV.MASSARWEH_TAMOXIFEN_RESISTANCE_UP"
9,"Up",0.840634515973678,0.933586349410716,"L.PvsV.IIZUKA_LIVER_CANCER_PROGRESSION_G2_G3_DN"
30,"Up",0.840795226957212,0.933586349410716,"L.PvsV.REACTOME_RNA_POLYMERASE_III_TRANSCRIPTION_INITIATION_FROM_TYPE_1_PROMOTER"
8,"Up",0.840886239838193,0.933586349410716,"L.PvsV.REACTOME_STAT5_ACTIVATION"
32,"Up",0.841761654775347,0.934140556920931,"L.PvsV.BIOCARTA_IL6_PATHWAY"
238,"Up",0.841862369875467,0.934140556920931,"L.PvsV.MARKEY_RB1_CHRONIC_LOF_DN"
38,"Up",0.842152023175293,0.934140556920931,"L.PvsV.BIOCARTA_BARRESTIN_SRC_PATHWAY"
15,"Down",0.842246890986329,0.934140556920931,"L.PvsV.HOLLEMAN_DAUNORUBICIN_B_ALL_DN"
63,"Down",0.842556832160946,0.934140556920931,"L.PvsV.SUNG_METASTASIS_STROMA_DN"
669,"Down",0.84261980281514,0.934140556920931,"L.PvsV.KUMAR_TARGETS_OF_MLL_AF9_FUSION"
60,"Up",0.842720673953691,0.934140556920931,"L.PvsV.CROONQUIST_NRAS_VS_STROMAL_STIMULATION_UP"
12,"Up",0.842737040680341,0.934140556920931,"L.PvsV.REACTOME_MAPK3_ERK1_ACTIVATION"
37,"Up",0.845132659786178,0.936393234566663,"L.PvsV.TOMIDA_METASTASIS_DN"
4,"Up",0.845320161154339,0.936393234566663,"L.PvsV.IGARASHI_ATF4_TARGETS_UP"
23,"Down",0.845382372271551,0.936393234566663,"L.PvsV.REACTOME_PHOSPHORYLATION_OF_THE_APC_C"
26,"Down",0.845446740270714,0.936393234566663,"L.PvsV.PODAR_RESPONSE_TO_ADAPHOSTIN_DN"
26,"Up",0.845620782643861,0.93639841923451,"L.PvsV.REACTOME_PD_1_SIGNALING"
58,"Up",0.846220814571921,0.936565300716029,"L.PvsV.BAE_BRCA1_TARGETS_DN"
24,"Up",0.846368485802561,0.936565300716029,"L.PvsV.BIOCARTA_SPRY_PATHWAY"
20,"Down",0.846518772126701,0.936565300716029,"L.PvsV.PID_LPA4_PATHWAY"
88,"Up",0.846690264738657,0.936565300716029,"L.PvsV.ZHANG_PROLIFERATING_VS_QUIESCENT"
180,"Up",0.846936606807219,0.936565300716029,"L.PvsV.DAZARD_RESPONSE_TO_UV_SCC_DN"
18,"Up",0.846955319789866,0.936565300716029,"L.PvsV.REACTOME_GRB2_EVENTS_IN_ERBB2_SIGNALING"
23,"Down",0.847104122182215,0.936565300716029,"L.PvsV.REACTOME_APOPTOTIC_FACTOR_MEDIATED_RESPONSE"
29,"Down",0.84712661763083,0.936565300716029,"L.PvsV.ITO_PTTG1_TARGETS_UP"
15,"Down",0.84760191096154,0.936737536238782,"L.PvsV.REACTOME_MITOTIC_TELOPHASE_CYTOKINESIS"
45,"Up",0.84762125046168,0.936737536238782,"L.PvsV.WATANABE_COLON_CANCER_MSI_VS_MSS_UP"
11,"Up",0.848389194503767,0.937145835939106,"L.PvsV.WALLACE_PROSTATE_CANCER_DN"
26,"Down",0.848427344660163,0.937145835939106,"L.PvsV.ZHENG_RESPONSE_TO_ARSENITE_UP"
325,"Down",0.84852892585991,0.937145835939106,"L.PvsV.WIERENGA_STAT5A_TARGETS_UP"
23,"Up",0.848668692448382,0.937145835939106,"L.PvsV.GRASEMANN_RETINOBLASTOMA_WITH_6P_AMPLIFICATION"
22,"Up",0.849547520465632,0.937686181480731,"L.PvsV.PID_ARF6_DOWNSTREAM_PATHWAY"
56,"Down",0.849641074933111,0.937686181480731,"L.PvsV.KEGG_BLADDER_CANCER"
32,"Down",0.849666805791005,0.937686181480731,"L.PvsV.REACTOME_SEMA3A_PLEXIN_REPULSION_SIGNALING_BY_INHIBITING_INTEGRIN_ADHESION"
173,"Down",0.849986579322012,0.937851885266694,"L.PvsV.REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION"
100,"Up",0.850284577278009,0.937993501151259,"L.PvsV.RAMASWAMY_METASTASIS_UP"
143,"Down",0.850661237060191,0.938069113409085,"L.PvsV.LAIHO_COLORECTAL_CANCER_SERRATED_DN"
71,"Up",0.850692446126452,0.938069113409085,"L.PvsV.PID_AJDISS_2PATHWAY"
16,"Up",0.850874015188119,0.938082239277191,"L.PvsV.BIOCARTA_CFTR_PATHWAY"
7,"Up",0.851353799888598,0.938424074877205,"L.PvsV.GAVIN_IL2_RESPONSIVE_FOXP3_TARGETS_DN"
10,"Up",0.851866372648672,0.938801908386388,"L.PvsV.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_21"
154,"Up",0.852123355456617,0.938897973758397,"L.PvsV.ANDERSEN_LIVER_CANCER_KRT19_DN"
22,"Down",0.852839237800157,0.939345217794069,"L.PvsV.REACTOME_CONVERSION_FROM_APC_C_CDC20_TO_APC_C_CDH1_IN_LATE_ANAPHASE"
13,"Down",0.853062457605575,0.939345217794069,"L.PvsV.GERHOLD_RESPONSE_TO_TZD_DN"
82,"Down",0.853325071264649,0.939345217794069,"L.PvsV.AMIT_EGF_RESPONSE_240_HELA"
37,"Down",0.853487468022439,0.939345217794069,"L.PvsV.PID_INSULIN_GLUCOSE_PATHWAY"
36,"Up",0.853500094137504,0.939345217794069,"L.PvsV.REACTOME_NEPHRIN_FAMILY_INTERACTIONS"
218,"Down",0.853548629806006,0.939345217794069,"L.PvsV.RASHI_RESPONSE_TO_IONIZING_RADIATION_5"
710,"Up",0.854136024161297,0.939804592554788,"L.PvsV.DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN"
67,"Up",0.854389283360048,0.939896209251434,"L.PvsV.KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_DN"
470,"Down",0.854674040940471,0.940004177637765,"L.PvsV.HOSHIDA_LIVER_CANCER_SUBCLASS_S3"
41,"Down",0.854827456169774,0.940004177637765,"L.PvsV.REACTOME_PERK_REGULATES_GENE_EXPRESSION"
12,"Down",0.855689190033839,0.940764671246192,"L.PvsV.REACTOME_NF_KB_ACTIVATION_THROUGH_FADD_RIP_1_PATHWAY_MEDIATED_BY_CASPASE_8_AND_10"
193,"Up",0.856006525805262,0.940864237594071,"L.PvsV.ZHU_CMV_24_HR_UP"
23,"Down",0.856120090312131,0.940864237594071,"L.PvsV.BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER"
56,"Up",0.856965067661431,0.941550810614417,"L.PvsV.MURAKAMI_UV_RESPONSE_6HR_UP"
13,"Up",0.857085409626037,0.941550810614417,"L.PvsV.REACTOME_BINDING_OF_TCF_LEF_CTNNB1_TO_TARGET_GENE_PROMOTERS"
49,"Up",0.857398766699294,0.941707942209058,"L.PvsV.REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_OXIDATIVE_STRESS_METABOLIC_AND_NEURONAL_GENES"
14,"Down",0.858077878034464,0.942266650973695,"L.PvsV.BIOCARTA_CELL2CELL_PATHWAY"
57,"Down",0.858607876380278,0.942453169853037,"L.PvsV.WENG_POR_TARGETS_GLOBAL_UP"
92,"Down",0.858643057465421,0.942453169853037,"L.PvsV.LEE_LIVER_CANCER_CIPROFIBRATE_UP"
66,"Down",0.858759101052559,0.942453169853037,"L.PvsV.VALK_AML_WITH_CEBPA"
51,"Down",0.859203137502742,0.94274330524548,"L.PvsV.REACTOME_ASSOCIATION_OF_TRIC_CCT_WITH_TARGET_PROTEINS_DURING_BIOSYNTHESIS"
29,"Up",0.859482288633519,0.94274330524548,"L.PvsV.GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_DN"
33,"Down",0.85968265217398,0.94274330524548,"L.PvsV.BIOCARTA_CYTOKINE_PATHWAY"
82,"Down",0.85970550642932,0.94274330524548,"L.PvsV.PID_FGF_PATHWAY"
18,"Up",0.860535286785155,0.943339162453126,"L.PvsV.BIOCARTA_AHSP_PATHWAY"
64,"Down",0.860590113115132,0.943339162453126,"L.PvsV.RIZ_ERYTHROID_DIFFERENTIATION_CCNE1"
19,"Up",0.860972493889003,0.943446633041573,"L.PvsV.BIOCARTA_SET_PATHWAY"
43,"Up",0.86102942852736,0.943446633041573,"L.PvsV.WILLERT_WNT_SIGNALING"
15,"Up",0.861477432834532,0.94375049061663,"L.PvsV.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_LIGHTYELLOW_UP"
32,"Up",0.861901001633073,0.944027463951914,"L.PvsV.REACTOME_SIGNALING_BY_ERYTHROPOIETIN"
50,"Up",0.862685736579891,0.944645753115496,"L.PvsV.MINGUEZ_LIVER_CANCER_VASCULAR_INVASION_DN"
22,"Up",0.862926253040573,0.944645753115496,"L.PvsV.REACTOME_SHC_MEDIATED_CASCADE_FGFR4"
78,"Down",0.862978060948883,0.944645753115496,"L.PvsV.PID_PS1_PATHWAY"
13,"Down",0.863383606353172,0.944902604815259,"L.PvsV.BIOCARTA_PLCE_PATHWAY"
317,"Up",0.864338148154266,0.945625016713448,"L.PvsV.WANG_CLIM2_TARGETS_DN"
147,"Down",0.8643857541092,0.945625016713448,"L.PvsV.KYNG_DNA_DAMAGE_BY_GAMMA_AND_UV_RADIATION"
51,"Down",0.865125300684393,0.945938688749849,"L.PvsV.SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_DN"
50,"Up",0.865213091305721,0.945938688749849,"L.PvsV.BERENJENO_TRANSFORMED_BY_RHOA_REVERSIBLY_DN"
604,"Up",0.865424870344036,0.945938688749849,"L.PvsV.GRYDER_PAX3FOXO1_TOP_ENHANCERS"
25,"Down",0.865440485489742,0.945938688749849,"L.PvsV.REACTOME_SUMOYLATION_OF_TRANSCRIPTION_FACTORS"
228,"Up",0.865563970123481,0.945938688749849,"L.PvsV.REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_BCR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS"
303,"Down",0.865751018365038,0.945938688749849,"L.PvsV.SANSOM_APC_TARGETS_REQUIRE_MYC"
35,"Up",0.86595930505387,0.945938688749849,"L.PvsV.AMIT_EGF_RESPONSE_240_MCF10A"
45,"Down",0.866041172445602,0.945938688749849,"L.PvsV.BILANGES_RAPAMYCIN_SENSITIVE_GENES"
527,"Down",0.866264702775899,0.945986767095046,"L.PvsV.DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN"
20,"Up",0.866427380822809,0.945986767095046,"L.PvsV.ROETH_TERT_TARGETS_UP"
24,"Up",0.866858115462385,0.946235825375113,"L.PvsV.KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_CHONDROITIN_SULFATE"
56,"Up",0.867137612886029,0.946235825375113,"L.PvsV.REACTOME_HEPARAN_SULFATE_HEPARIN_HS_GAG_METABOLISM"
68,"Down",0.867168914301989,0.946235825375113,"L.PvsV.KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY"
126,"Up",0.867664443966869,0.946589721920445,"L.PvsV.REACTOME_NUCLEOTIDE_EXCISION_REPAIR"
18,"Up",0.868004925268927,0.946774360191733,"L.PvsV.CLAUS_PGR_POSITIVE_MENINGIOMA_UP"
84,"Up",0.868359524383285,0.946905722997232,"L.PvsV.REACTOME_DEFENSINS"
12,"Up",0.868467882314879,0.946905722997232,"L.PvsV.BIOCARTA_RHODOPSIN_PATHWAY"
57,"Up",0.868755884605456,0.94703298225228,"L.PvsV.PID_NETRIN_PATHWAY"
68,"Up",0.869347921592285,0.947461893842593,"L.PvsV.REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_DNA_REPAIR_GENES"
26,"Down",0.869492068974013,0.947461893842593,"L.PvsV.BIOCARTA_LAIR_PATHWAY"
48,"Up",0.870518060761749,0.94800232365575,"L.PvsV.REACTOME_NEGATIVE_REGULATION_OF_FGFR1_SIGNALING"
185,"Up",0.870716593493461,0.94800232365575,"L.PvsV.REACTOME_AMYLOID_FIBER_FORMATION"
92,"Up",0.870773405985942,0.94800232365575,"L.PvsV.TIEN_INTESTINE_PROBIOTICS_6HR_UP"
187,"Up",0.870792690721775,0.94800232365575,"L.PvsV.ROSS_AML_WITH_AML1_ETO_FUSION"
18,"Up",0.870845324985992,0.94800232365575,"L.PvsV.FRASOR_TAMOXIFEN_RESPONSE_DN"
510,"Up",0.871312546972031,0.948062602787948,"L.PvsV.FARMER_BREAST_CANCER_APOCRINE_VS_LUMINAL"
86,"Down",0.87136981884197,0.948062602787948,"L.PvsV.PID_HNF3A_PATHWAY"
7,"Up",0.871415110755716,0.948062602787948,"L.PvsV.REACTOME_APEX1_INDEPENDENT_RESOLUTION_OF_AP_SITES_VIA_THE_SINGLE_NUCLEOTIDE_REPLACEMENT_PATHWAY"
7,"Down",0.871863099472662,0.948363383235166,"L.PvsV.REACTOME_RESPONSE_TO_METAL_IONS"
61,"Down",0.872444146630691,0.94880875033853,"L.PvsV.DORSAM_HOXA9_TARGETS_UP"
168,"Down",0.872984239189794,0.94902945588141,"L.PvsV.COATES_MACROPHAGE_M1_VS_M2_UP"
37,"Up",0.873148323257811,0.94902945588141,"L.PvsV.BIOCARTA_IL2_PATHWAY"
136,"Down",0.873186811638762,0.94902945588141,"L.PvsV.BENPORATH_ES_CORE_NINE_CORRELATED"
41,"Up",0.873333671825757,0.94902945588141,"L.PvsV.REACTOME_GAMMA_CARBOXYLATION_HYPUSINE_FORMATION_AND_ARYLSULFATASE_ACTIVATION"
21,"Down",0.874623081891002,0.949850308593848,"L.PvsV.ROETH_TERT_TARGETS_DN"
10,"Down",0.874678245144967,0.949850308593848,"L.PvsV.REACTOME_PTK6_PROMOTES_HIF1A_STABILIZATION"
276,"Up",0.874723353290638,0.949850308593848,"L.PvsV.JISON_SICKLE_CELL_DISEASE_DN"
247,"Up",0.874840285480617,0.949850308593848,"L.PvsV.REACTOME_COMPLEMENT_CASCADE"
17,"Down",0.874948023452427,0.949850308593848,"L.PvsV.MURAKAMI_UV_RESPONSE_1HR_DN"
718,"Down",0.875387807390367,0.950141183168697,"L.PvsV.REACTOME_NERVOUS_SYSTEM_DEVELOPMENT"
61,"Down",0.875689145656322,0.950281704874152,"L.PvsV.CHEOK_RESPONSE_TO_HD_MTX_UP"
15,"Down",0.876069702649344,0.950508121261426,"L.PvsV.PARK_OSTEOBLAST_DIFFERENTIATION_BY_PHENYLAMIL_DN"
75,"Up",0.876382315809084,0.950660746342638,"L.PvsV.VARELA_ZMPSTE24_TARGETS_UP"
15,"Up",0.876593933474703,0.950703777595456,"L.PvsV.YAMANAKA_GLIOBLASTOMA_SURVIVAL_UP"
47,"Up",0.877455919196721,0.951085964998643,"L.PvsV.CEBALLOS_TARGETS_OF_TP53_AND_MYC_DN"
227,"Up",0.877483878651439,0.951085964998643,"L.PvsV.SUNG_METASTASIS_STROMA_UP"
21,"Up",0.877510483349826,0.951085964998643,"L.PvsV.MARIADASON_RESPONSE_TO_BUTYRATE_CURCUMIN_SULINDAC_TSA_1"
12,"Down",0.877634399244543,0.951085964998643,"L.PvsV.GILMORE_CORE_NFKB_PATHWAY"
37,"Up",0.87791238460886,0.951165502812129,"L.PvsV.MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_DN"
19,"Up",0.8780518586278,0.951165502812129,"L.PvsV.REACTOME_INTERACTION_WITH_CUMULUS_CELLS_AND_THE_ZONA_PELLUCIDA"
15,"Down",0.878240367343157,0.951183347902119,"L.PvsV.REACTOME_APOPTOSIS_INDUCED_DNA_FRAGMENTATION"
58,"Up",0.878746320850823,0.951310669442818,"L.PvsV.KEGG_LINOLEIC_ACID_METABOLISM"
59,"Up",0.878785552411284,0.951310669442818,"L.PvsV.VALK_AML_CLUSTER_15"
83,"Up",0.878874100111035,0.951310669442818,"L.PvsV.KEGG_VEGF_SIGNALING_PATHWAY"
177,"Down",0.879518498471922,0.951821839508956,"L.PvsV.REACTOME_SIGNALING_BY_HEDGEHOG"
109,"Down",0.87982334277766,0.951965413349839,"L.PvsV.SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN"
16,"Up",0.880135845878338,0.952117216173221,"L.PvsV.REACTOME_GLUCOCORTICOID_BIOSYNTHESIS"
46,"Down",0.880400447861267,0.952217151061218,"L.PvsV.PETRETTO_HEART_MASS_QTL_CIS_UP"
27,"Up",0.88069561606985,0.95235009999026,"L.PvsV.BIOCARTA_GCR_PATHWAY"
24,"Up",0.881428766707781,0.952956521534478,"L.PvsV.REACTOME_RNA_POLYMERASE_III_TRANSCRIPTION_TERMINATION"
245,"Up",0.881913500566452,0.952999295371368,"L.PvsV.GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN"
26,"Down",0.881931687791595,0.952999295371368,"L.PvsV.SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX1_UP"
13,"Down",0.882312108505387,0.952999295371368,"L.PvsV.REACTOME_P38MAPK_EVENTS"
12,"Down",0.882379693500572,0.952999295371368,"L.PvsV.REACTOME_INTERLEUKIN_6_SIGNALING"
1090,"Up",0.882498757262892,0.952999295371368,"L.PvsV.LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN"
38,"Up",0.882502512624598,0.952999295371368,"L.PvsV.PID_CDC42_REG_PATHWAY"
80,"Down",0.882764412372029,0.953095964851581,"L.PvsV.MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_DN"
85,"Up",0.883189954703732,0.953186433800035,"L.PvsV.DUNNE_TARGETS_OF_AML1_MTG8_FUSION_UP"
370,"Down",0.883193000607267,0.953186433800035,"L.PvsV.MANALO_HYPOXIA_DN"
12,"Up",0.883637279325953,0.953317503182482,"L.PvsV.ZERBINI_RESPONSE_TO_SULINDAC_UP"
31,"Down",0.883659288082876,0.953317503182482,"L.PvsV.MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_DN"
1198,"Down",0.884300078685502,0.953386539987523,"L.PvsV.FEVR_CTNNB1_TARGETS_UP"
45,"Down",0.884325604602585,0.953386539987523,"L.PvsV.SUMI_HNF4A_TARGETS"
42,"Up",0.88437206180962,0.953386539987523,"L.PvsV.REACTOME_EGFR_DOWNREGULATION"
27,"Up",0.884438281330993,0.953386539987523,"L.PvsV.REACTOME_METABOLISM_OF_NITRIC_OXIDE_ENOS_ACTIVATION_AND_REGULATION"
171,"Up",0.88458544947296,0.953386539987523,"L.PvsV.REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX2"
143,"Up",0.884913992491799,0.953439501950444,"L.PvsV.PID_AP1_PATHWAY"
41,"Up",0.884979476218064,0.953439501950444,"L.PvsV.TUOMISTO_TUMOR_SUPPRESSION_BY_COL13A1_DN"
14,"Down",0.885200007553627,0.953491299778688,"L.PvsV.REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_SEVERAL_ADDITIONAL_CELL_DEATH_GENES_WHOSE_SPECIFIC_ROLES_IN_P53_DEPENDENT_APOPTOSIS_REMAIN_UNCERTAIN"
340,"Up",0.885534593673068,0.953509164764582,"L.PvsV.STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP"
23,"Down",0.885784492723078,0.953509164764582,"L.PvsV.REACTOME_ADP_SIGNALLING_THROUGH_P2Y_PURINOCEPTOR_12"
879,"Up",0.885792604044234,0.953509164764582,"L.PvsV.ONKEN_UVEAL_MELANOMA_DN"
281,"Down",0.885979450758207,0.953509164764582,"L.PvsV.REACTOME_INTERFERON_SIGNALING"
34,"Down",0.886078872953594,0.953509164764582,"L.PvsV.STEGER_ADIPOGENESIS_UP"
217,"Up",0.886327062445102,0.953590645701297,"L.PvsV.REACTOME_FCERI_MEDIATED_CA_2_MOBILIZATION"
104,"Down",0.886866155717732,0.953863850356987,"L.PvsV.LEE_LIVER_CANCER_E2F1_DN"
41,"Down",0.886982411373194,0.953863850356987,"L.PvsV.JEON_SMAD6_TARGETS_UP"
202,"Up",0.887207137770356,0.953863850356987,"L.PvsV.REACTOME_CREATION_OF_C4_AND_C2_ACTIVATORS"
436,"Down",0.887271076575508,0.953863850356987,"L.PvsV.VANTVEER_BREAST_CANCER_ESR1_DN"
297,"Down",0.887803214312175,0.954111426787662,"L.PvsV.OKUMURA_INFLAMMATORY_RESPONSE_LPS"
1026,"Up",0.887876864795212,0.954111426787662,"L.PvsV.GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN"
124,"Up",0.888019063528542,0.954111426787662,"L.PvsV.HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_UP"
1242,"Up",0.888248708459592,0.954172743165549,"L.PvsV.BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP"
135,"Up",0.888807221067484,0.954587242673294,"L.PvsV.FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_DN"
156,"Up",0.889301518467463,0.954730874191936,"L.PvsV.REACTOME_DISEASES_OF_GLYCOSYLATION"
18,"Down",0.889324532514997,0.954730874191936,"L.PvsV.PARK_OSTEOBLAST_DIFFERENTIATION_BY_PHENYLAMIL_UP"
57,"Down",0.889458985885813,0.954730874191936,"L.PvsV.PID_INSULIN_PATHWAY"
41,"Up",0.890112895966033,0.954929302156123,"L.PvsV.PID_IL12_STAT4_PATHWAY"
121,"Up",0.890137331202166,0.954929302156123,"L.PvsV.REACTOME_TRNA_PROCESSING"
33,"Down",0.890339474837424,0.954929302156123,"L.PvsV.REACTOME_LONG_TERM_POTENTIATION"
8,"Down",0.890367796048022,0.954929302156123,"L.PvsV.KERLEY_RESPONSE_TO_CISPLATIN_DN"
17,"Up",0.890600911590565,0.954929302156123,"L.PvsV.REACTOME_SIGNALING_BY_PDGFRA_TRANSMEMBRANE_JUXTAMEMBRANE_AND_KINASE_DOMAIN_MUTANTS"
40,"Up",0.890680125017024,0.954929302156123,"L.PvsV.BIOCARTA_INFLAM_PATHWAY"
6,"Down",0.890967268868918,0.955051963857357,"L.PvsV.REACTOME_ASSEMBLY_OF_THE_ORC_COMPLEX_AT_THE_ORIGIN_OF_REPLICATION"
14,"Down",0.8912626109457,0.955055806402402,"L.PvsV.REACTOME_NRCAM_INTERACTIONS"
83,"Down",0.891316325020147,0.955055806402402,"L.PvsV.DELACROIX_RAR_TARGETS_UP"
251,"Up",0.891588728576301,0.955104768943642,"L.PvsV.GROSS_HYPOXIA_VIA_ELK3_DN"
10,"Down",0.89177323366624,0.955104768943642,"L.PvsV.REACTOME_NOSTRIN_MEDIATED_ENOS_TRAFFICKING"
1485,"Down",0.892003418069392,0.955104768943642,"L.PvsV.NUYTTEN_EZH2_TARGETS_UP"
25,"Down",0.892052998159697,0.955104768943642,"L.PvsV.BIOCARTA_ERAD_PATHWAY"
36,"Down",0.892496929769536,0.955260125598885,"L.PvsV.REACTOME_RHO_GTPASES_ACTIVATE_PAKS"
289,"Down",0.892671347291118,0.955260125598885,"L.PvsV.ZHENG_FOXP3_TARGETS_IN_THYMUS_UP"
28,"Up",0.892716416887219,0.955260125598885,"L.PvsV.MARSON_FOXP3_CORE_DIRECT_TARGETS"
26,"Up",0.892978455212438,0.955355626716248,"L.PvsV.VISALA_AGING_LYMPHOCYTE_DN"
189,"Up",0.893238119435087,0.955448551432887,"L.PvsV.REACTOME_INFLUENZA_INFECTION"
198,"Up",0.893906011156418,0.955810184605841,"L.PvsV.REACTOME_FCGR_ACTIVATION"
196,"Down",0.893943805061528,0.955810184605841,"L.PvsV.STEARMAN_LUNG_CANCER_EARLY_VS_LATE_UP"
36,"Down",0.894094822713223,0.955810184605841,"L.PvsV.KONG_E2F1_TARGETS"
41,"Up",0.894985632791005,0.956577530195528,"L.PvsV.ZHANG_RESPONSE_TO_CANTHARIDIN_UP"
10,"Up",0.896016710004447,0.957494470354578,"L.PvsV.REACTOME_HDR_THROUGH_MMEJ_ALT_NHEJ"
65,"Up",0.896510349536227,0.957589864036194,"L.PvsV.JIANG_AGING_CEREBRAL_CORTEX_UP"
182,"Up",0.896650176726226,0.957589864036194,"L.PvsV.EPPERT_PROGENITOR"
5,"Up",0.896660241630536,0.957589864036194,"L.PvsV.BAFNA_MUC4_TARGETS_UP"
119,"Up",0.896798754924835,0.957589864036194,"L.PvsV.REACTOME_EPH_EPHRIN_SIGNALING"
33,"Up",0.897351710596757,0.957995290189123,"L.PvsV.GHO_ATF5_TARGETS_DN"
5,"Up",0.897677243742529,0.957995351695353,"L.PvsV.REACTOME_SUMO_IS_CONJUGATED_TO_E1_UBA2_SAE1"
28,"Down",0.897906275670941,0.957995351695353,"L.PvsV.WEST_ADRENOCORTICAL_TUMOR_MARKERS_UP"
66,"Up",0.898158482088149,0.957995351695353,"L.PvsV.REACTOME_TRNA_PROCESSING_IN_THE_NUCLEUS"
28,"Up",0.898301958056468,0.957995351695353,"L.PvsV.REACTOME_SULFUR_AMINO_ACID_METABOLISM"
18,"Up",0.898353836381099,0.957995351695353,"L.PvsV.REACTOME_ACTIVATION_OF_BAD_AND_TRANSLOCATION_TO_MITOCHONDRIA"
17,"Up",0.898523360734655,0.957995351695353,"L.PvsV.BIOCARTA_GATA3_PATHWAY"
12,"Down",0.898673773920059,0.957995351695353,"L.PvsV.TCGA_GLIOBLASTOMA_MUTATED"
556,"Down",0.898746377845655,0.957995351695353,"L.PvsV.MCLACHLAN_DENTAL_CARIES_UP"
51,"Down",0.899322618968526,0.957995351695353,"L.PvsV.NIKOLSKY_BREAST_CANCER_20Q11_AMPLICON"
303,"Down",0.899462597675863,0.957995351695353,"L.PvsV.REACTOME_CHROMATIN_MODIFYING_ENZYMES"
113,"Up",0.899799245523916,0.957995351695353,"L.PvsV.HOWLIN_CITED1_TARGETS_1_DN"
38,"Down",0.899813711419783,0.957995351695353,"L.PvsV.HOLLEMAN_VINCRISTINE_RESISTANCE_ALL_UP"
35,"Up",0.899835053542821,0.957995351695353,"L.PvsV.NIKOLSKY_BREAST_CANCER_15Q26_AMPLICON"
36,"Down",0.900160365055837,0.957995351695353,"L.PvsV.REACTOME_SIGNAL_AMPLIFICATION"
12,"Down",0.900263997552184,0.957995351695353,"L.PvsV.REACTOME_FREE_FATTY_ACIDS_REGULATE_INSULIN_SECRETION"
29,"Down",0.90028238133522,0.957995351695353,"L.PvsV.REACTOME_ACTIVATION_OF_AMPK_DOWNSTREAM_OF_NMDARS"
106,"Down",0.900441379179319,0.957995351695353,"L.PvsV.KEGG_HEMATOPOIETIC_CELL_LINEAGE"
62,"Down",0.900470581074471,0.957995351695353,"L.PvsV.ZHAN_MULTIPLE_MYELOMA_HP_DN"
30,"Up",0.900838859645941,0.958202780873876,"L.PvsV.HOLLEMAN_VINCRISTINE_RESISTANCE_ALL_DN"
5,"Up",0.901059035397038,0.958252626795581,"L.PvsV.REACTOME_MELANIN_BIOSYNTHESIS"
13,"Up",0.901265291311339,0.958260128159089,"L.PvsV.KEGG_NON_HOMOLOGOUS_END_JOINING"
107,"Down",0.901412719579567,0.958260128159089,"L.PvsV.KYNG_RESPONSE_TO_H2O2"
31,"Up",0.901593833301578,0.958268416825149,"L.PvsV.REACTOME_ACYL_CHAIN_REMODELLING_OF_PC"
55,"Up",0.902028572826159,0.958448891809132,"L.PvsV.REACTOME_TRANSPORT_OF_VITAMINS_NUCLEOSIDES_AND_RELATED_MOLECULES"
74,"Down",0.90229925638929,0.958448891809132,"L.PvsV.KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP"
145,"Down",0.902409035568544,0.958448891809132,"L.PvsV.ELVIDGE_HIF1A_TARGETS_DN"
36,"Up",0.902457032150179,0.958448891809132,"L.PvsV.NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_UP"
41,"Up",0.903159055623082,0.959010258985984,"L.PvsV.REACTOME_GLUTATHIONE_CONJUGATION"
65,"Down",0.903696939892333,0.959287452418528,"L.PvsV.REACTOME_INTERLEUKIN_3_INTERLEUKIN_5_AND_GM_CSF_SIGNALING"
101,"Down",0.903767107912481,0.959287452418528,"L.PvsV.ZHOU_TNF_SIGNALING_30MIN"
34,"Up",0.904131812669767,0.959490363195996,"L.PvsV.WELCH_GATA1_TARGETS"
1220,"Up",0.904361955924323,0.959550423010091,"L.PvsV.ONKEN_UVEAL_MELANOMA_UP"
400,"Down",0.904856431559558,0.959709603806442,"L.PvsV.ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN"
308,"Down",0.904871701226576,0.959709603806442,"L.PvsV.MISSIAGLIA_REGULATED_BY_METHYLATION_UP"
26,"Up",0.905032713736081,0.959709603806442,"L.PvsV.ZHENG_FOXP3_TARGETS_IN_THYMUS_DN"
90,"Up",0.90533041114915,0.959810683796874,"L.PvsV.REACTOME_CIRCADIAN_CLOCK"
6,"Down",0.905549271693486,0.959810683796874,"L.PvsV.REACTOME_MET_INTERACTS_WITH_TNS_PROTEINS"
12,"Up",0.905720014705822,0.959810683796874,"L.PvsV.NAGY_STAGA_COMPONENTS_HUMAN"
47,"Down",0.905887617073333,0.959810683796874,"L.PvsV.NOJIMA_SFRP2_TARGETS_UP"
30,"Up",0.906358096181191,0.959810683796874,"L.PvsV.REACTOME_RHO_GTPASES_ACTIVATE_NADPH_OXIDASES"
67,"Down",0.906424043900959,0.959810683796874,"L.PvsV.BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_UP"
6,"Up",0.906496051068548,0.959810683796874,"L.PvsV.OHASHI_AURKA_TARGETS"
32,"Down",0.906516800648811,0.959810683796874,"L.PvsV.KEGG_PROXIMAL_TUBULE_BICARBONATE_RECLAMATION"
246,"Up",0.906868738127015,0.959870646780106,"L.PvsV.KAAB_FAILED_HEART_ATRIUM_DN"
44,"Down",0.90693254285927,0.959870646780106,"L.PvsV.ALONSO_METASTASIS_DN"
62,"Down",0.90723481836867,0.959870646780106,"L.PvsV.HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_DN"
26,"Down",0.907281011874893,0.959870646780106,"L.PvsV.DORMOY_ELAVL1_TARGETS"
127,"Down",0.907441466941511,0.959870646780106,"L.PvsV.REACTOME_HCMV_LATE_EVENTS"
402,"Up",0.907661326941731,0.959919563248054,"L.PvsV.REACTOME_SIGNALING_BY_WNT"
83,"Down",0.908382856585965,0.960498912614994,"L.PvsV.DAUER_STAT3_TARGETS_UP"
7,"Down",0.909005428419116,0.960973425187246,"L.PvsV.REACTOME_GRB7_EVENTS_IN_ERBB2_SIGNALING"
21,"Up",0.909592094383578,0.961296991433474,"L.PvsV.GOERING_BLOOD_HDL_CHOLESTEROL_QTL_CIS"
8,"Up",0.909659225751481,0.961296991433474,"L.PvsV.RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_MAPK1_DN"
858,"Up",0.910620029982576,0.962128443679278,"L.PvsV.RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP"
227,"Down",0.91082826047057,0.962164587722924,"L.PvsV.REACTOME_FCGR3A_MEDIATED_IL10_SYNTHESIS"
75,"Down",0.912126535652967,0.963252479214695,"L.PvsV.LEE_CALORIE_RESTRICTION_MUSCLE_DN"
64,"Up",0.91220654389006,0.963252479214695,"L.PvsV.BYSTROEM_CORRELATED_WITH_IL5_UP"
16,"Up",0.912600780856627,0.963271120171875,"L.PvsV.REACTOME_CLEC7A_DECTIN_1_INDUCES_NFAT_ACTIVATION"
105,"Down",0.912683839462807,0.963271120171875,"L.PvsV.KEGG_PYRIMIDINE_METABOLISM"
637,"Up",0.912746861743616,0.963271120171875,"L.PvsV.MOHANKUMAR_HOXA1_TARGETS_UP"
46,"Down",0.912931725304695,0.963282349085812,"L.PvsV.REACTOME_TRANSCRIPTIONAL_REGULATION_BY_THE_AP_2_TFAP2_FAMILY_OF_TRANSCRIPTION_FACTORS"
176,"Up",0.913175424927523,0.963355642897209,"L.PvsV.ZHONG_SECRETOME_OF_LUNG_CANCER_AND_ENDOTHELIUM"
11,"Down",0.91416102198901,0.964139269125983,"L.PvsV.REACTOME_ERYTHROPOIETIN_ACTIVATES_STAT5"
222,"Down",0.91426699005743,0.964139269125983,"L.PvsV.IKEDA_MIR30_TARGETS_UP"
38,"Up",0.914910992514626,0.964634416020856,"L.PvsV.REACTOME_PLASMA_LIPOPROTEIN_REMODELING"
18,"Up",0.9151618678968,0.964676111802563,"L.PvsV.NADELLA_PRKAR1A_TARGETS_DN"
32,"Up",0.915299490417118,0.964676111802563,"L.PvsV.KEGG_NICOTINATE_AND_NICOTINAMIDE_METABOLISM"
12,"Down",0.915824385345719,0.965045364317988,"L.PvsV.BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_24HR_UP"
84,"Up",0.91602760592928,0.96507557796932,"L.PvsV.REACTOME_NUCLEAR_ENVELOPE_NE_REASSEMBLY"
33,"Down",0.916412949069098,0.96529761771824,"L.PvsV.BIOCARTA_ARENRF2_PATHWAY"
137,"Down",0.91691591176479,0.965392656360275,"L.PvsV.BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_C"
46,"Down",0.917006865730356,0.965392656360275,"L.PvsV.RAY_TARGETS_OF_P210_BCR_ABL_FUSION_UP"
58,"Up",0.917360977949385,0.965392656360275,"L.PvsV.NAKAMURA_ADIPOGENESIS_EARLY_DN"
56,"Down",0.917639453330985,0.965392656360275,"L.PvsV.HASLINGER_B_CLL_WITH_6Q21_DELETION"
89,"Up",0.91774952312645,0.965392656360275,"L.PvsV.PID_P75_NTR_PATHWAY"
16,"Up",0.917803780826714,0.965392656360275,"L.PvsV.REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TN_POLYAGGLUTINATION_SYNDROME_TNPS"
48,"Down",0.917895732439031,0.965392656360275,"L.PvsV.PID_HIV_NEF_PATHWAY"
14,"Down",0.91790001708916,0.965392656360275,"L.PvsV.REACTOME_CHK1_CHK2_CDS1_MEDIATED_INACTIVATION_OF_CYCLIN_B_CDK1_COMPLEX"
59,"Up",0.918956179731051,0.966319649625899,"L.PvsV.HOLLEMAN_VINCRISTINE_RESISTANCE_B_ALL_UP"
127,"Up",0.919289690090927,0.966363824101652,"L.PvsV.VANDESLUIS_COMMD1_TARGETS_GROUP_3_UP"
19,"Down",0.919347750908788,0.966363824101652,"L.PvsV.REACTOME_ORGANIC_CATION_ANION_ZWITTERION_TRANSPORT"
288,"Up",0.919676124885784,0.966525241302699,"L.PvsV.FOSTER_TOLERANT_MACROPHAGE_UP"
107,"Down",0.920392962409938,0.967094771791058,"L.PvsV.SCIBETTA_KDM5B_TARGETS_DN"
13,"Down",0.920980524078923,0.967466893459104,"L.PvsV.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_16"
386,"Down",0.921097074908432,0.967466893459104,"L.PvsV.CAIRO_LIVER_DEVELOPMENT_DN"
23,"Down",0.921773874725635,0.967753884737825,"L.PvsV.REACTOME_INHIBITION_OF_THE_PROTEOLYTIC_ACTIVITY_OF_APC_C_REQUIRED_FOR_THE_ONSET_OF_ANAPHASE_BY_MITOTIC_SPINDLE_CHECKPOINT_COMPONENTS"
16,"Down",0.921776062443211,0.967753884737825,"L.PvsV.REACTOME_ERYTHROPOIETIN_ACTIVATES_PHOSPHOINOSITIDE_3_KINASE_PI3K"
97,"Down",0.922013847154207,0.967753884737825,"L.PvsV.AMIT_SERUM_RESPONSE_120_MCF10A"
26,"Up",0.922070440368758,0.967753884737825,"L.PvsV.BALLIF_DEVELOPMENTAL_DISABILITY_P16_P12_DELETION"
189,"Up",0.922291330823633,0.967802005717189,"L.PvsV.HAHTOLA_SEZARY_SYNDROM_UP"
25,"Down",0.922889844916293,0.96822077954782,"L.PvsV.BIOCARTA_ERK5_PATHWAY"
15,"Up",0.923040645504894,0.96822077954782,"L.PvsV.SA_MMP_CYTOKINE_CONNECTION"
50,"Up",0.923395457166881,0.968409234194933,"L.PvsV.BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_DN"
456,"Down",0.923638486275022,0.968451713669353,"L.PvsV.REACTOME_TRANSCRIPTIONAL_REGULATION_BY_TP53"
29,"Up",0.923786279235335,0.968451713669353,"L.PvsV.BIOCARTA_BARR_MAPK_PATHWAY"
9,"Down",0.924005052941122,0.968497428950041,"L.PvsV.REACTOME_OREXIN_AND_NEUROPEPTIDES_FF_AND_QRFP_BIND_TO_THEIR_RESPECTIVE_RECEPTORS"
18,"Up",0.924491906378477,0.968515330836055,"L.PvsV.REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_LATE_STAGE_BRANCHING_MORPHOGENESIS_PANCREATIC_BUD_PRECURSOR_CELLS"
16,"Up",0.924573420817286,0.968515330836055,"L.PvsV.REACTOME_REGULATION_OF_COMMISSURAL_AXON_PATHFINDING_BY_SLIT_AND_ROBO"
49,"Up",0.92474865203931,0.968515330836055,"L.PvsV.REACTOME_THE_PHOTOTRANSDUCTION_CASCADE"
89,"Up",0.924844214330289,0.968515330836055,"L.PvsV.ZHAN_V2_LATE_DIFFERENTIATION_GENES"
25,"Down",0.924943555940891,0.968515330836055,"L.PvsV.KEGG_GLYCOSYLPHOSPHATIDYLINOSITOL_GPI_ANCHOR_BIOSYNTHESIS"
9,"Down",0.925209194597201,0.968515330836055,"L.PvsV.REACTOME_RRNA_MODIFICATION_IN_THE_MITOCHONDRION"
415,"Down",0.925315349977459,0.968515330836055,"L.PvsV.FOURNIER_ACINAR_DEVELOPMENT_LATE_2"
22,"Down",0.925423493001787,0.968515330836055,"L.PvsV.KIM_PTEN_TARGETS_UP"
13,"Up",0.925879268809325,0.968705969332753,"L.PvsV.REACTOME_INTERLEUKIN_27_SIGNALING"
61,"Up",0.926082818718395,0.968705969332753,"L.PvsV.XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_UP"
101,"Up",0.926157624637614,0.968705969332753,"L.PvsV.REACTOME_ONCOGENIC_MAPK_SIGNALING"
20,"Down",0.926306467690769,0.968705969332753,"L.PvsV.FERRANDO_LYL1_NEIGHBORS"
93,"Up",0.926532590427609,0.968741767870708,"L.PvsV.KEGG_FC_EPSILON_RI_SIGNALING_PATHWAY"
349,"Down",0.926691121408605,0.968741767870708,"L.PvsV.BENPORATH_MYC_TARGETS_WITH_EBOX"
8,"Down",0.927442334638859,0.969038329461084,"L.PvsV.REACTOME_FBXW7_MUTANTS_AND_NOTCH1_IN_CANCER"
208,"Up",0.927515796430039,0.969038329461084,"L.PvsV.PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN"
64,"Up",0.92754828711719,0.969038329461084,"L.PvsV.MATTIOLI_MULTIPLE_MYELOMA_WITH_14Q32_TRANSLOCATIONS"
64,"Up",0.927840277406663,0.969038329461084,"L.PvsV.PID_LKB1_PATHWAY"
48,"Down",0.927851133327361,0.969038329461084,"L.PvsV.KEGG_PRION_DISEASES"
140,"Up",0.928228117133289,0.969248963102919,"L.PvsV.GNATENKO_PLATELET_SIGNATURE"
6,"Up",0.928432604074394,0.969279431255159,"L.PvsV.REACTOME_TNFR1_MEDIATED_CERAMIDE_PRODUCTION"
289,"Down",0.929667375155505,0.970008350709676,"L.PvsV.KRIEG_KDM3A_TARGETS_NOT_HYPOXIA"
31,"Up",0.929739235285406,0.970008350709676,"L.PvsV.SA_CASPASE_CASCADE"
203,"Down",0.929831552379503,0.970008350709676,"L.PvsV.WHITFIELD_CELL_CYCLE_M_G1"
69,"Down",0.929832566243675,0.970008350709676,"L.PvsV.WAGSCHAL_EHMT2_TARGETS_UP"
10,"Down",0.930270857986151,0.970138409605038,"L.PvsV.KONDO_HYPOXIA"
102,"Down",0.930384789124986,0.970138409605038,"L.PvsV.KEGG_ADHERENS_JUNCTION"
24,"Up",0.930483629252219,0.970138409605038,"L.PvsV.REACTOME_FRS_MEDIATED_FGFR4_SIGNALING"
328,"Up",0.932116017571651,0.971476735427269,"L.PvsV.BOYLAN_MULTIPLE_MYELOMA_PCA1_UP"
27,"Up",0.932118661863206,0.971476735427269,"L.PvsV.REACTOME_NEGATIVE_REGULATION_OF_MET_ACTIVITY"
103,"Down",0.932488591384902,0.971679122082006,"L.PvsV.MARTIN_VIRAL_GPCR_SIGNALING_DN"
54,"Up",0.932724814310913,0.971742132716231,"L.PvsV.AIYAR_COBRA1_TARGETS_DN"
9,"Up",0.93329122015658,0.972149049782541,"L.PvsV.GLINSKY_CANCER_DEATH_UP"
584,"Up",0.933757242878724,0.972440705677257,"L.PvsV.MULLIGHAN_MLL_SIGNATURE_1_UP"
92,"Up",0.933922978322705,0.972440705677257,"L.PvsV.PID_NOTCH_PATHWAY"
176,"Down",0.934259043179015,0.972607465587794,"L.PvsV.CADWELL_ATG16L1_TARGETS_UP"
9,"Down",0.935452821937377,0.973666915002214,"L.PvsV.REACTOME_DEFECTIVE_CSF2RB_CAUSES_PULMONARY_SURFACTANT_METABOLISM_DYSFUNCTION_5_SMDP5"
665,"Down",0.935828631803713,0.973874742187602,"L.PvsV.GOLDRATH_ANTIGEN_RESPONSE"
12,"Down",0.936635817703005,0.974115910825091,"L.PvsV.REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_EARLY_PANCREATIC_PRECURSOR_CELLS"
12,"Down",0.936856911068235,0.974115910825091,"L.PvsV.REACTOME_INTERLEUKIN_21_SIGNALING"
61,"Up",0.936959924016468,0.974115910825091,"L.PvsV.POMEROY_MEDULLOBLASTOMA_PROGNOSIS_DN"
26,"Up",0.937046428783565,0.974115910825091,"L.PvsV.SA_G1_AND_S_PHASES"
41,"Down",0.937138844387309,0.974115910825091,"L.PvsV.KYNG_NORMAL_AGING_DN"
34,"Up",0.937258579282593,0.974115910825091,"L.PvsV.SOUCEK_MYC_TARGETS"
1501,"Down",0.937293659900431,0.974115910825091,"L.PvsV.LOPEZ_MBD_TARGETS"
30,"Up",0.93797912908221,0.974645105186157,"L.PvsV.HOLLEMAN_ASPARAGINASE_RESISTANCE_ALL_DN"
33,"Up",0.938933498467187,0.975362581766253,"L.PvsV.REACTOME_REGULATION_OF_SIGNALING_BY_CBL"
11,"Up",0.939022431315204,0.975362581766253,"L.PvsV.WORSCHECH_TUMOR_REJECTION_DN"
15,"Up",0.939411125872808,0.975467645291639,"L.PvsV.BERGER_MBD2_TARGETS"
317,"Up",0.939476435373119,0.975467645291639,"L.PvsV.TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP"
191,"Down",0.940321701675123,0.97590787064286,"L.PvsV.DER_IFN_ALPHA_RESPONSE_UP"
49,"Down",0.940367760648448,0.97590787064286,"L.PvsV.KEGG_ABC_TRANSPORTERS"
6,"Down",0.940429939371525,0.97590787064286,"L.PvsV.REACTOME_TRAFFICKING_OF_MYRISTOYLATED_PROTEINS_TO_THE_CILIUM"
78,"Up",0.940929582413562,0.975995431541744,"L.PvsV.AMIT_SERUM_RESPONSE_60_MCF10A"
19,"Down",0.940963708374206,0.975995431541744,"L.PvsV.BIOCARTA_IL4_PATHWAY"
33,"Down",0.941043885973781,0.975995431541744,"L.PvsV.REACTOME_BMAL1_CLOCK_NPAS2_ACTIVATES_CIRCADIAN_GENE_EXPRESSION"
32,"Up",0.941512369751227,0.976259466323815,"L.PvsV.REACTOME_INTRINSIC_PATHWAY_OF_FIBRIN_CLOT_FORMATION"
61,"Down",0.941657900509815,0.976259466323815,"L.PvsV.ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_DN"
59,"Down",0.941894064337613,0.976259466323815,"L.PvsV.REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES"
291,"Up",0.94200474820719,0.976259466323815,"L.PvsV.REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT"
1242,"Down",0.942338824682333,0.976364397244183,"L.PvsV.KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3"
34,"Up",0.94277761157598,0.976364397244183,"L.PvsV.WILLIAMS_ESR2_TARGETS_UP"
7,"Up",0.942881396794128,0.976364397244183,"L.PvsV.REACTOME_DEX_H_BOX_HELICASES_ACTIVATE_TYPE_I_IFN_AND_INFLAMMATORY_CYTOKINES_PRODUCTION"
25,"Up",0.942978850804458,0.976364397244183,"L.PvsV.KEGG_GLYCOSAMINOGLYCAN_DEGRADATION"
321,"Down",0.942988945791994,0.976364397244183,"L.PvsV.BROWN_MYELOID_CELL_DEVELOPMENT_UP"
36,"Down",0.943448062105709,0.976641982034873,"L.PvsV.WANG_BARRETTS_ESOPHAGUS_DN"
97,"Up",0.943617986948959,0.976641982034873,"L.PvsV.BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_DN"
104,"Up",0.943786961478084,0.976641982034873,"L.PvsV.BARIS_THYROID_CANCER_DN"
700,"Down",0.944183137670286,0.97675588796787,"L.PvsV.MILI_PSEUDOPODIA_CHEMOTAXIS_DN"
7,"Up",0.944250356518044,0.97675588796787,"L.PvsV.REACTOME_APOBEC3G_MEDIATED_RESISTANCE_TO_HIV_1_INFECTION"
154,"Down",0.944586390154404,0.976920716641171,"L.PvsV.NGUYEN_NOTCH1_TARGETS_DN"
113,"Down",0.945145641172569,0.97731629886724,"L.PvsV.LEIN_OLIGODENDROCYTE_MARKERS"
1217,"Down",0.946842382093997,0.978887720754994,"L.PvsV.MARTENS_TRETINOIN_RESPONSE_DN"
7,"Down",0.947110684711082,0.978982048189862,"L.PvsV.REACTOME_NGF_INDEPENDANT_TRKA_ACTIVATION"
23,"Up",0.947919757926982,0.979635204033324,"L.PvsV.BIOCARTA_PITX2_PATHWAY"
18,"Up",0.948139468908641,0.979679148494838,"L.PvsV.CROONQUIST_STROMAL_STIMULATION_DN"
73,"Down",0.948756847731863,0.98013389594721,"L.PvsV.MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_DN"
81,"Up",0.949484827073223,0.980702710421792,"L.PvsV.KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN"
60,"Up",0.950273904053862,0.981218303247232,"L.PvsV.PID_ER_NONGENOMIC_PATHWAY"
826,"Down",0.950338942645854,0.981218303247232,"L.PvsV.FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP"
17,"Down",0.951308185792544,0.982035653332147,"L.PvsV.BIOCARTA_CD40_PATHWAY"
17,"Down",0.951731759635484,0.982143518145419,"L.PvsV.OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_DN"
10,"Down",0.951936353495918,0.982143518145419,"L.PvsV.BIOCARTA_IL22BP_PATHWAY"
6,"Down",0.952185020466577,0.982143518145419,"L.PvsV.REACTOME_SIGNALING_BY_MEMBRANE_TETHERED_FUSIONS_OF_PDGFRA_OR_PDGFRB"
96,"Up",0.952926221333586,0.982143518145419,"L.PvsV.FIGUEROA_AML_METHYLATION_CLUSTER_6_DN"
79,"Up",0.952956922567334,0.982143518145419,"L.PvsV.HOWLIN_CITED1_TARGETS_1_UP"
2390,"Down",0.953029012151199,0.982143518145419,"L.PvsV.PUJANA_BRCA1_PCC_NETWORK"
11,"Down",0.953214270371026,0.982143518145419,"L.PvsV.STEGMEIER_PREMITOTIC_CELL_CYCLE_REGULATORS"
31,"Up",0.953420477108872,0.982143518145419,"L.PvsV.BOYAULT_LIVER_CANCER_SUBCLASS_G6_DN"
106,"Down",0.953438095758739,0.982143518145419,"L.PvsV.KANNAN_TP53_TARGETS_UP"
7,"Up",0.953747550532319,0.982143518145419,"L.PvsV.WEBER_METHYLATED_HCP_IN_FIBROBLAST_UP"
45,"Down",0.954050603923993,0.982143518145419,"L.PvsV.REACTOME_NS1_MEDIATED_EFFECTS_ON_HOST_PATHWAYS"
12,"Up",0.954531324824638,0.982143518145419,"L.PvsV.REACTOME_IRF3_MEDIATED_ACTIVATION_OF_TYPE_1_IFN"
64,"Down",0.954598876870434,0.982143518145419,"L.PvsV.BIOCARTA_KERATINOCYTE_PATHWAY"
33,"Up",0.95463860774384,0.982143518145419,"L.PvsV.MACLACHLAN_BRCA1_TARGETS_UP"
49,"Up",0.954935099355153,0.982143518145419,"L.PvsV.PID_NECTIN_PATHWAY"
474,"Down",0.95499019519181,0.982143518145419,"L.PvsV.RIZKI_TUMOR_INVASIVENESS_3D_DN"
25,"Down",0.955041071255254,0.982143518145419,"L.PvsV.ONDER_CDH1_TARGETS_3_UP"
37,"Down",0.955066901549778,0.982143518145419,"L.PvsV.BIOCARTA_RHO_PATHWAY"
170,"Up",0.955209525191635,0.982143518145419,"L.PvsV.KAYO_CALORIE_RESTRICTION_MUSCLE_DN"
6,"Up",0.955221163640638,0.982143518145419,"L.PvsV.REACTOME_PROTON_COUPLED_MONOCARBOXYLATE_TRANSPORT"
28,"Down",0.955236156852685,0.982143518145419,"L.PvsV.RAMPON_ENRICHED_LEARNING_ENVIRONMENT_EARLY_UP"
40,"Down",0.955416116621067,0.982143518145419,"L.PvsV.REACTOME_ALPHA_DEFENSINS"
47,"Up",0.955671736309372,0.982143518145419,"L.PvsV.PID_NEPHRIN_NEPH1_PATHWAY"
300,"Up",0.95567591384018,0.982143518145419,"L.PvsV.REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1"
94,"Up",0.956229945558178,0.982422069234886,"L.PvsV.BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_UP"
30,"Down",0.956302328924246,0.982422069234886,"L.PvsV.SUZUKI_RESPONSE_TO_TSA"
45,"Down",0.957637457870565,0.983593642544494,"L.PvsV.SARTIPY_NORMAL_AT_INSULIN_RESISTANCE_UP"
116,"Down",0.957798547921787,0.983593642544494,"L.PvsV.REACTOME_STIMULI_SENSING_CHANNELS"
16,"Up",0.958194778679372,0.983817814543778,"L.PvsV.KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_UV_IN_WS"
41,"Down",0.958662613847213,0.984115408830531,"L.PvsV.HASLINGER_B_CLL_WITH_13Q14_DELETION"
115,"Down",0.959132520101213,0.984272269875829,"L.PvsV.MCCLUNG_COCAIN_REWARD_4WK"
117,"Down",0.959171457784584,0.984272269875829,"L.PvsV.LIN_TUMOR_ESCAPE_FROM_IMMUNE_ATTACK"
40,"Up",0.959819667243857,0.984674082321843,"L.PvsV.SHIN_B_CELL_LYMPHOMA_CLUSTER_2"
51,"Down",0.959919208485211,0.984674082321843,"L.PvsV.REACTOME_HIV_TRANSCRIPTION_INITIATION"
118,"Up",0.960534853146499,0.984755523324531,"L.PvsV.KEGG_PROSTATE_CANCER"
84,"Up",0.960594519839997,0.984755523324531,"L.PvsV.MIKKELSEN_NPC_LCP_WITH_H3K4ME3"
9,"Down",0.960630964773082,0.984755523324531,"L.PvsV.REACTOME_DNA_DAMAGE_REVERSAL"
73,"Up",0.96071103143652,0.984755523324531,"L.PvsV.SHIN_B_CELL_LYMPHOMA_CLUSTER_8"
26,"Up",0.961404128940814,0.985283304710613,"L.PvsV.SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_UP"
6,"Up",0.961877382532649,0.985295548107408,"L.PvsV.SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX2_UP"
27,"Down",0.96209610909931,0.985295548107408,"L.PvsV.KORKOLA_TERATOMA_UP"
62,"Up",0.962303859248728,0.985295548107408,"L.PvsV.BIOCARTA_INTEGRIN_PATHWAY"
23,"Down",0.962445668486795,0.985295548107408,"L.PvsV.SA_TRKA_RECEPTOR"
1874,"Down",0.962564265170832,0.985295548107408,"L.PvsV.KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP"
726,"Down",0.963134235585485,0.985295548107408,"L.PvsV.PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_DN"
8,"Down",0.963138570109437,0.985295548107408,"L.PvsV.KORKOLA_CHORIOCARCINOMA_UP"
126,"Down",0.963249982818361,0.985295548107408,"L.PvsV.LEE_LIVER_CANCER_ACOX1_DN"
189,"Down",0.963264177487594,0.985295548107408,"L.PvsV.ROESSLER_LIVER_CANCER_METASTASIS_UP"
200,"Up",0.963288273715132,0.985295548107408,"L.PvsV.CAMPS_COLON_CANCER_COPY_NUMBER_DN"
138,"Up",0.963376330813646,0.985295548107408,"L.PvsV.HARRIS_HYPOXIA"
37,"Up",0.963571800129268,0.98531320194465,"L.PvsV.REACTOME_SYNTHESIS_OF_16_20_HYDROXYEICOSATETRAENOIC_ACIDS_HETE"
65,"Down",0.964663046155807,0.986246668305373,"L.PvsV.REACTOME_GABA_RECEPTOR_ACTIVATION"
6,"Down",0.964872719669345,0.986278659096285,"L.PvsV.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_13"
9,"Down",0.965163741951152,0.986393776201094,"L.PvsV.REACTOME_INTERLEUKIN_1_PROCESSING"
452,"Up",0.965691239132391,0.986593746731672,"L.PvsV.GABRIELY_MIR21_TARGETS"
26,"Down",0.965716288173596,0.986593746731672,"L.PvsV.FERRANDO_HOX11_NEIGHBORS"
39,"Down",0.966612505335389,0.986896870166078,"L.PvsV.BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_UP"
153,"Down",0.966622020607062,0.986896870166078,"L.PvsV.DAZARD_RESPONSE_TO_UV_SCC_UP"
58,"Down",0.966697300904645,0.986896870166078,"L.PvsV.CHANDRAN_METASTASIS_TOP50_DN"
51,"Up",0.966726975731503,0.986896870166078,"L.PvsV.PID_EPO_PATHWAY"
78,"Down",0.967359592617967,0.986905669368791,"L.PvsV.PID_ERBB4_PATHWAY"
17,"Down",0.967637696790501,0.986905669368791,"L.PvsV.REACTOME_RETINOID_CYCLE_DISEASE_EVENTS"
89,"Down",0.967642371043186,0.986905669368791,"L.PvsV.REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION_TERMINATION"
215,"Down",0.967698520674578,0.986905669368791,"L.PvsV.REACTOME_FCERI_MEDIATED_MAPK_ACTIVATION"
15,"Down",0.967722258156001,0.986905669368791,"L.PvsV.REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_TO_CONTROL_BILE_ACID_HOMEOSTASIS"
13,"Down",0.967861792368259,0.986905669368791,"L.PvsV.MIKKELSEN_NPC_ICP_WITH_H3K27ME3"
130,"Down",0.967985068726163,0.986905669368791,"L.PvsV.KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION"
23,"Down",0.968796168955451,0.987342130517471,"L.PvsV.ZEILSTRA_CD44_TARGETS_DN"
79,"Up",0.969063307731282,0.987342130517471,"L.PvsV.KEGG_DRUG_METABOLISM_OTHER_ENZYMES"
484,"Down",0.969762302717072,0.987342130517471,"L.PvsV.RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP"
9,"Down",0.969777763984878,0.987342130517471,"L.PvsV.REACTOME_THE_ACTIVATION_OF_ARYLSULFATASES"
9,"Down",0.969825699669015,0.987342130517471,"L.PvsV.REACTOME_REGULATION_OF_PTEN_MRNA_TRANSLATION"
13,"Down",0.969843704714487,0.987342130517471,"L.PvsV.BIOCARTA_MELANOCYTE_PATHWAY"
544,"Down",0.969909492402178,0.987342130517471,"L.PvsV.WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN"
52,"Down",0.970102468138633,0.987342130517471,"L.PvsV.WOTTON_RUNX_TARGETS_DN"
189,"Up",0.97014795230124,0.987342130517471,"L.PvsV.ROSS_ACUTE_MYELOID_LEUKEMIA_CBF"
627,"Down",0.970198913926826,0.987342130517471,"L.PvsV.SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12"
128,"Down",0.970420438983211,0.987385831273127,"L.PvsV.REACTOME_HEDGEHOG_OFF_STATE"
37,"Down",0.97084269548761,0.987633719107819,"L.PvsV.PID_GLYPICAN_1PATHWAY"
1127,"Down",0.971180974060208,0.987776973205758,"L.PvsV.REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM"
44,"Down",0.971340821725395,0.987776973205758,"L.PvsV.REACTOME_COOPERATION_OF_PDCL_PHLP1_AND_TRIC_CCT_IN_G_PROTEIN_BETA_FOLDING"
14,"Up",0.971558809673505,0.987816965554397,"L.PvsV.REACTOME_CALCINEURIN_ACTIVATES_NFAT"
249,"Down",0.972364500662416,0.988382318189359,"L.PvsV.IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_UP"
9,"Up",0.97247238396638,0.988382318189359,"L.PvsV.CASTELLANO_HRAS_TARGETS_DN"
188,"Up",0.973163371072213,0.988902826439674,"L.PvsV.DAIRKEE_CANCER_PRONE_RESPONSE_BPA_E2"
48,"Up",0.97351060475383,0.9890568506536,"L.PvsV.DELPUECH_FOXO3_TARGETS_DN"
17,"Down",0.973672714434354,0.9890568506536,"L.PvsV.REACTOME_CYTOCHROME_C_MEDIATED_APOPTOTIC_RESPONSE"
25,"Up",0.974082552634855,0.989291409536759,"L.PvsV.BIOCARTA_CHEMICAL_PATHWAY"
24,"Up",0.974471775952151,0.989417750024251,"L.PvsV.REACTOME_RECEPTOR_TYPE_TYROSINE_PROTEIN_PHOSPHATASES"
19,"Up",0.974564851986267,0.989417750024251,"L.PvsV.MATTHEWS_AP1_TARGETS"
94,"Down",0.975040110911606,0.989630844847859,"L.PvsV.MCDOWELL_ACUTE_LUNG_INJURY_UP"
141,"Up",0.97513272612247,0.989630844847859,"L.PvsV.NELSON_RESPONSE_TO_ANDROGEN_UP"
18,"Down",0.975736657569029,0.989923805651044,"L.PvsV.LOPEZ_MESOTHELIOMA_SURVIVAL_OVERALL_UP"
14,"Down",0.975952670391722,0.989923805651044,"L.PvsV.REACTOME_DEGRADATION_OF_CYSTEINE_AND_HOMOCYSTEINE"
10,"Down",0.975958521360796,0.989923805651044,"L.PvsV.BYSTRYKH_HEMATOPOIESIS_STEM_CELL_FLI1"
49,"Up",0.976330799009246,0.990032035955573,"L.PvsV.REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT"
20,"Up",0.976423348176115,0.990032035955573,"L.PvsV.REACTOME_POLO_LIKE_KINASE_MEDIATED_EVENTS"
46,"Up",0.976805863792129,0.990238287661658,"L.PvsV.REACTOME_NUCLEOBASE_CATABOLISM"
61,"Up",0.977702352038623,0.990791087232298,"L.PvsV.PID_CERAMIDE_PATHWAY"
37,"Down",0.977709562658603,0.990791087232298,"L.PvsV.REACTOME_DECTIN_2_FAMILY"
247,"Down",0.9781280498918,0.991033532683116,"L.PvsV.PODAR_RESPONSE_TO_ADAPHOSTIN_UP"
24,"Up",0.978707695479461,0.991327195525202,"L.PvsV.BIOCARTA_HCMV_PATHWAY"
225,"Up",0.978940833163313,0.991327195525202,"L.PvsV.PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_DN"
120,"Down",0.978955776373233,0.991327195525202,"L.PvsV.PID_BETA_CATENIN_NUC_PATHWAY"
145,"Down",0.97916947965851,0.991362031318788,"L.PvsV.CROMER_METASTASIS_DN"
12,"Up",0.979569735982146,0.991430502458189,"L.PvsV.REACTOME_INTERLEUKIN_9_SIGNALING"
29,"Up",0.979805080278464,0.991430502458189,"L.PvsV.BIOCARTA_NO2IL12_PATHWAY"
45,"Up",0.979922613412309,0.991430502458189,"L.PvsV.LOPES_METHYLATED_IN_COLON_CANCER_DN"
40,"Down",0.980097815454565,0.991430502458189,"L.PvsV.TAKADA_GASTRIC_CANCER_COPY_NUMBER_DN"
9,"Up",0.980133681757363,0.991430502458189,"L.PvsV.BIOCARTA_ERBB3_PATHWAY"
211,"Up",0.98092884886689,0.992053339196092,"L.PvsV.REACTOME_INITIAL_TRIGGERING_OF_COMPLEMENT"
10,"Up",0.981331360057907,0.992205859431138,"L.PvsV.REACTOME_INTERLEUKIN_18_SIGNALING"
88,"Down",0.981574284714372,0.992205859431138,"L.PvsV.KEGG_LEISHMANIA_INFECTION"
148,"Down",0.981618023347499,0.992205859431138,"L.PvsV.REACTOME_INTERFERON_GAMMA_SIGNALING"
24,"Down",0.982051539938722,0.992462614571594,"L.PvsV.REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_BETA_CELLS"
6,"Up",0.98275664523999,0.992993693627907,"L.PvsV.REACTOME_NEGATIVE_REGULATION_OF_TCF_DEPENDENT_SIGNALING_BY_DVL_INTERACTING_PROTEINS"
361,"Down",0.983396395149208,0.993289168057922,"L.PvsV.MATTIOLI_MGUS_VS_PCL"
119,"Down",0.983408375103828,0.993289168057922,"L.PvsV.BRUNO_HEMATOPOIESIS"
103,"Down",0.9839709154824,0.993675834100856,"L.PvsV.KUMAR_AUTOPHAGY_NETWORK"
73,"Down",0.985246156161826,0.994455966553564,"L.PvsV.BILANGES_SERUM_SENSITIVE_VIA_TSC2"
67,"Down",0.985371017108773,0.994455966553564,"L.PvsV.REACTOME_NR1H2_AND_NR1H3_MEDIATED_SIGNALING"
12,"Up",0.985501475307668,0.994455966553564,"L.PvsV.NADELLA_PRKAR1A_TARGETS_UP"
463,"Down",0.985578825268232,0.994455966553564,"L.PvsV.BRUINS_UVC_RESPONSE_EARLY_LATE"
40,"Down",0.985642737694616,0.994455966553564,"L.PvsV.KYNG_WERNER_SYNDROM_DN"
20,"Down",0.986470155329537,0.995109193361979,"L.PvsV.HEDVAT_ELF4_TARGETS_UP"
87,"Up",0.986705593913994,0.995165127462691,"L.PvsV.PID_HDAC_CLASSI_PATHWAY"
33,"Up",0.987108839655145,0.995383818007355,"L.PvsV.REACTOME_GP1B_IX_V_ACTIVATION_SIGNALLING"
15,"Up",0.987282484708325,0.995383818007355,"L.PvsV.DACOSTA_LOW_DOSE_UV_RESPONSE_VIA_ERCC3_XPCS_DN"
770,"Down",0.987950277882216,0.995875494331955,"L.PvsV.BOCHKIS_FOXA2_TARGETS"
541,"Down",0.9882517894875,0.995906947819277,"L.PvsV.BOYLAN_MULTIPLE_MYELOMA_C_D_DN"
68,"Down",0.988341729550438,0.995906947819277,"L.PvsV.BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_24HR_DN"
90,"Up",0.989545115003246,0.996822920398608,"L.PvsV.ZHAN_MULTIPLE_MYELOMA_MF_UP"
17,"Up",0.989611323940669,0.996822920398608,"L.PvsV.SUZUKI_CTCFL_TARGETS_UP"
15,"Up",0.989922870842536,0.996856655423668,"L.PvsV.RAFFEL_VEGFA_TARGETS_UP"
18,"Down",0.990287105628245,0.996856655423668,"L.PvsV.REACTOME_SHC1_EVENTS_IN_ERBB4_SIGNALING"
34,"Up",0.990425447203393,0.996856655423668,"L.PvsV.REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_7ALPHA_HYDROXYCHOLESTEROL"
24,"Down",0.990447639547195,0.996856655423668,"L.PvsV.HASINA_NOL7_TARGETS_DN"
41,"Up",0.990721597002246,0.996856655423668,"L.PvsV.BIOCARTA_DC_PATHWAY"
427,"Down",0.990906548588302,0.996856655423668,"L.PvsV.RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_DN"
15,"Up",0.990995430531512,0.996856655423668,"L.PvsV.REACTOME_ADENYLATE_CYCLASE_INHIBITORY_PATHWAY"
18,"Down",0.991270024005885,0.996856655423668,"L.PvsV.MAINA_VHL_TARGETS_UP"
68,"Down",0.991289131888774,0.996856655423668,"L.PvsV.REACTOME_INTERLEUKIN_10_SIGNALING"
55,"Down",0.991611239042468,0.996856655423668,"L.PvsV.PID_INTEGRIN_A4B1_PATHWAY"
278,"Up",0.991628071049045,0.996856655423668,"L.PvsV.LIN_NPAS4_TARGETS_UP"
37,"Up",0.992126200738106,0.997176106868022,"L.PvsV.CHANG_POU5F1_TARGETS_UP"
486,"Up",0.992327398380738,0.99719705300747,"L.PvsV.REACTOME_M_PHASE"
26,"Up",0.9925470412753,0.997236523934423,"L.PvsV.NIKOLSKY_BREAST_CANCER_6P24_P22_AMPLICON"
478,"Down",0.992925912464033,0.997239666191214,"L.PvsV.DAZARD_RESPONSE_TO_UV_NHEK_UP"
63,"Down",0.992936136869778,0.997239666191214,"L.PvsV.KEGG_NON_SMALL_CELL_LUNG_CANCER"
939,"Down",0.993091264613641,0.997239666191214,"L.PvsV.GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP"
101,"Up",0.993439219210983,0.997255381307974,"L.PvsV.TCGA_GLIOBLASTOMA_COPY_NUMBER_UP"
27,"Down",0.993467650613913,0.997255381307974,"L.PvsV.REACTOME_SIGNALING_BY_NTRK3_TRKC"
14,"Down",0.994245788115983,0.997740466807087,"L.PvsV.BIOCARTA_IL5_PATHWAY"
36,"Up",0.994732854785731,0.997740466807087,"L.PvsV.HOLLEMAN_ASPARAGINASE_RESISTANCE_ALL_UP"
24,"Down",0.994837546264275,0.997740466807087,"L.PvsV.MATZUK_EARLY_ANTRAL_FOLLICLE"
49,"Up",0.994974271552276,0.997740466807087,"L.PvsV.REACTOME_METABOLISM_OF_PORPHYRINS"
1093,"Up",0.995201245971519,0.997740466807087,"L.PvsV.BENPORATH_SOX2_TARGETS"
15,"Up",0.995468010018048,0.997740466807087,"L.PvsV.REACTOME_ORGANIC_CATION_TRANSPORT"
253,"Up",0.995645194023349,0.997740466807087,"L.PvsV.LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_UP"
135,"Up",0.995949858012114,0.997740466807087,"L.PvsV.SEIDEN_ONCOGENESIS_BY_MET"
183,"Down",0.996064407827466,0.997740466807087,"L.PvsV.DITTMER_PTHLH_TARGETS_UP"
95,"Down",0.996086629197482,0.997740466807087,"L.PvsV.KIM_GERMINAL_CENTER_T_HELPER_UP"
402,"Up",0.996213822632004,0.997740466807087,"L.PvsV.BROWNE_HCMV_INFECTION_16HR_UP"
20,"Up",0.996225104254844,0.997740466807087,"L.PvsV.BIOCARTA_AKAPCENTROSOME_PATHWAY"
188,"Down",0.996296819902682,0.997740466807087,"L.PvsV.BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_UP"
80,"Down",0.997508512903522,0.998773011199488,"L.PvsV.HEIDENBLAD_AMPLIFIED_IN_PANCREATIC_CANCER"
96,"Up",0.998513731946997,0.999165004126619,"L.PvsV.OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_UP"
83,"Up",0.998639386866631,0.999165004126619,"L.PvsV.BAKKER_FOXO3_TARGETS_UP"
203,"Down",0.998716462644475,0.999165004126619,"L.PvsV.BORCZUK_MALIGNANT_MESOTHELIOMA_DN"
28,"Up",0.998871024930172,0.999165004126619,"L.PvsV.REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_ADDITIONAL_CELL_CYCLE_GENES_WHOSE_EXACT_ROLE_IN_THE_P53_PATHWAY_REMAIN_UNCERTAIN"
217,"Down",0.999006656341709,0.999165004126619,"L.PvsV.NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN"
14,"Down",0.999058425404294,0.999165004126619,"L.PvsV.CAFFAREL_RESPONSE_TO_THC_24HR_3_UP"
1255,"Up",0.999165004126619,0.999165004126619,"L.PvsV.DACOSTA_UV_RESPONSE_VIA_ERCC3_DN"
189,"Up",1.40605768379905e-25,7.77409293372496e-22,"L.LvsV.REACTOME_THE_CITRIC_ACID_TCA_CYCLE_AND_RESPIRATORY_ELECTRON_TRANSPORT"
139,"Up",8.43160915899226e-25,1.87599760737792e-21,"L.LvsV.KEGG_OXIDATIVE_PHOSPHORYLATION"
133,"Up",1.01790429049263e-24,1.87599760737792e-21,"L.LvsV.REACTOME_RESPIRATORY_ELECTRON_TRANSPORT_ATP_SYNTHESIS_BY_CHEMIOSMOTIC_COUPLING_AND_HEAT_PRODUCTION_BY_UNCOUPLING_PROTEINS"
108,"Up",5.1630707625012e-24,7.13665456146728e-21,"L.LvsV.REACTOME_RESPIRATORY_ELECTRON_TRANSPORT"
94,"Up",2.3424286956859e-20,2.59025765168947e-17,"L.LvsV.MOOTHA_VOXPHOS"
59,"Up",3.0537962808192e-19,2.81407327277489e-16,"L.LvsV.REACTOME_COMPLEX_I_BIOGENESIS"
135,"Up",4.24540572492192e-18,3.35326403615618e-15,"L.LvsV.KEGG_PARKINSONS_DISEASE"
110,"Down",1.30427764075917e-17,9.0141888446968e-15,"L.LvsV.REACTOME_EUKARYOTIC_TRANSLATION_ELONGATION"
29,"Up",6.06192260998043e-17,3.72404112339798e-14,"L.LvsV.HORTON_SREBF_TARGETS"
104,"Down",2.09255658476626e-16,1.15697453571727e-13,"L.LvsV.KEGG_RIBOSOME"
140,"Down",4.05838782313233e-15,2.03989329764533e-12,"L.LvsV.REACTOME_NONSENSE_MEDIATED_DECAY_NMD"
67,"Up",7.95051482552556e-15,3.6631997058609e-12,"L.LvsV.MORI_PLASMA_CELL_UP"
33,"Up",1.87379357807821e-14,7.96938822553416e-12,"L.LvsV.KEGG_CITRATE_CYCLE_TCA_CYCLE"
46,"Up",1.27173436458882e-13,5.02244235843687e-11,"L.LvsV.KEGG_N_GLYCAN_BIOSYNTHESIS"
251,"Up",6.56217759976421e-13,2.33677836700755e-10,"L.LvsV.WONG_MITOCHONDRIA_GENE_MODULE"
119,"Down",6.76224522917722e-13,2.33677836700755e-10,"L.LvsV.REACTOME_RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY"
60,"Up",9.17724682071935e-13,2.9847645689269e-10,"L.LvsV.REACTOME_PYRUVATE_METABOLISM_AND_CITRIC_ACID_TCA_CYCLE"
29,"Up",1.12513367733886e-12,3.45603561222585e-10,"L.LvsV.REACTOME_CHOLESTEROL_BIOSYNTHESIS"
35,"Up",1.21608758894094e-12,3.53881488381813e-10,"L.LvsV.SCHMIDT_POR_TARGETS_IN_LIMB_BUD_UP"
78,"Up",1.37572653457775e-12,3.8031960048402e-10,"L.LvsV.REACTOME_BIOSYNTHESIS_OF_THE_N_GLYCAN_PRECURSOR_DOLICHOL_LIPID_LINKED_OLIGOSACCHARIDE_LLO_AND_TRANSFER_TO_A_NASCENT_PROTEIN"
84,"Down",1.71696540994152e-12,4.52052464360317e-10,"L.LvsV.BILANGES_SERUM_AND_RAPAMYCIN_SENSITIVE_GENES"
157,"Up",3.81205299907378e-12,9.58038228721769e-10,"L.LvsV.BURTON_ADIPOGENESIS_5"
96,"Up",5.1761852564847e-12,1.24430992535234e-09,"L.LvsV.REACTOME_MITOCHONDRIAL_TRANSLATION"
21,"Up",7.06781193116502e-12,1.62824717364214e-09,"L.LvsV.REACTOME_BRANCHED_CHAIN_AMINO_ACID_CATABOLISM"
27,"Up",7.68304091311714e-12,1.69918132834499e-09,"L.LvsV.REACTOME_CITRIC_ACID_CYCLE_TCA_CYCLE"
496,"Up",1.38334677099261e-11,2.94174011416083e-09,"L.LvsV.MOOTHA_HUMAN_MITODB_6_2002"
31,"Up",3.69197714012341e-11,7.56034874360827e-09,"L.LvsV.REACTOME_CRISTAE_FORMATION"
362,"Up",1.15392437503235e-10,2.23457338436886e-08,"L.LvsV.REACTOME_ASPARAGINE_N_LINKED_GLYCOSYLATION"
32,"Up",1.20192459811166e-10,2.23457338436886e-08,"L.LvsV.REACTOME_GLYOXYLATE_METABOLISM_AND_GLYCINE_DEGRADATION"
18,"Up",1.21246521126905e-10,2.23457338436886e-08,"L.LvsV.REACTOME_FORMATION_OF_ATP_BY_CHEMIOSMOTIC_COUPLING"
36,"Up",1.98728578492851e-10,3.54442035640959e-08,"L.LvsV.KEGG_PROPANOATE_METABOLISM"
518,"Up",2.64738414324507e-10,4.57418341500062e-08,"L.LvsV.MOOTHA_MITOCHONDRIA"
63,"Up",5.18537907198996e-10,8.68786693607045e-08,"L.LvsV.REACTOME_SYNTHESIS_OF_SUBSTRATES_IN_N_GLYCAN_BIOSYTHESIS"
19,"Up",5.4006355367806e-10,8.78238643613527e-08,"L.LvsV.MOOTHA_TCA"
101,"Up",9.41002103684857e-10,1.48651446607816e-07,"L.LvsV.REACTOME_COPII_MEDIATED_VESICLE_TRANSPORT"
12,"Up",9.94090348440771e-10,1.52675709348028e-07,"L.LvsV.BIOCARTA_MALATEX_PATHWAY"
225,"Down",1.28409364533548e-09,1.9188523689351e-07,"L.LvsV.REACTOME_RRNA_PROCESSING"
79,"Up",1.8890890481468e-09,2.7486245650536e-07,"L.LvsV.PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_UP"
73,"Up",2.17019071540214e-09,3.07666268345089e-07,"L.LvsV.REACTOME_MITOCHONDRIAL_PROTEIN_IMPORT"
42,"Up",2.8062710809504e-09,3.84198795663675e-07,"L.LvsV.REACTOME_FATTY_ACYL_COA_BIOSYNTHESIS"
35,"Up",2.84900535760728e-09,3.84198795663675e-07,"L.LvsV.KEGG_PROTEIN_EXPORT"
226,"Up",3.73770889010218e-09,4.92042677461309e-07,"L.LvsV.WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_WITH_H4K20ME1_MARK"
45,"Up",3.89830912524076e-09,5.01250026824562e-07,"L.LvsV.KEGG_PYRUVATE_METABOLISM"
160,"Down",7.79782307355304e-09,9.79867358492608e-07,"L.LvsV.REACTOME_EUKARYOTIC_TRANSLATION_INITIATION"
256,"Up",8.55087887577871e-09,1.05061798453734e-06,"L.LvsV.BURTON_ADIPOGENESIS_6"
77,"Down",8.93720458530713e-09,1.07421313374268e-06,"L.LvsV.PID_ECADHERIN_STABILIZATION_PATHWAY"
17,"Up",1.00078297903319e-08,1.17730406193075e-06,"L.LvsV.KEGG_TERPENOID_BACKBONE_BIOSYNTHESIS"
59,"Up",1.30311731916252e-08,1.50102826201033e-06,"L.LvsV.KEGG_VALINE_LEUCINE_AND_ISOLEUCINE_DEGRADATION"
189,"Up",1.79989765180188e-08,2.03094573812502e-06,"L.LvsV.KEGG_ALZHEIMERS_DISEASE"
93,"Up",2.07968334249338e-08,2.26760121471253e-06,"L.LvsV.KEGG_PEROXISOME"
189,"Down",2.09165603093397e-08,2.26760121471253e-06,"L.LvsV.REACTOME_INFLUENZA_INFECTION"
17,"Up",2.94344825718222e-08,3.12967796422317e-06,"L.LvsV.KEGG_STEROID_BIOSYNTHESIS"
18,"Up",3.34645203978845e-08,3.49104402414912e-06,"L.LvsV.REACTOME_DISEASES_ASSOCIATED_WITH_N_GLYCOSYLATION_OF_PROTEINS"
135,"Down",3.92232426874799e-08,4.0160242373903e-06,"L.LvsV.REACTOME_SELENOAMINO_ACID_METABOLISM"
20,"Up",7.156085049265e-08,7.19381713407021e-06,"L.LvsV.REACTOME_DISEASES_ASSOCIATED_WITH_GLYCOSYLATION_PRECURSOR_BIOSYNTHESIS"
32,"Down",9.07478259369203e-08,8.95972731437915e-06,"L.LvsV.REACTOME_EPHRIN_SIGNALING"
78,"Down",1.2057882975536e-07,1.16961464862699e-05,"L.LvsV.NAGASHIMA_EGF_SIGNALING_UP"
28,"Up",1.34727607346539e-07,1.28432576037761e-05,"L.LvsV.REACTOME_CYTOSOLIC_TRNA_AMINOACYLATION"
82,"Down",1.60228165213514e-07,1.50152800926359e-05,"L.LvsV.PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_1"
203,"Up",1.85695331338436e-07,1.70612798830464e-05,"L.LvsV.REACTOME_PROTEIN_LOCALIZATION"
41,"Up",1.88232604967594e-07,1.70612798830464e-05,"L.LvsV.KEGG_AMINOACYL_TRNA_BIOSYNTHESIS"
8,"Up",2.10405600613032e-07,1.8763428480475e-05,"L.LvsV.REACTOME_CHREBP_ACTIVATES_METABOLIC_GENE_EXPRESSION"
203,"Up",2.17123453149492e-07,1.90551678168816e-05,"L.LvsV.REACTOME_ER_TO_GOLGI_ANTEROGRADE_TRANSPORT"
201,"Up",2.2382314948795e-07,1.93362217737325e-05,"L.LvsV.KEGG_HUNTINGTONS_DISEASE"
23,"Up",2.62965960076731e-07,2.23682891271423e-05,"L.LvsV.REACTOME_DEFECTS_IN_VITAMIN_AND_COFACTOR_METABOLISM"
43,"Up",4.22710130036899e-07,3.54115804390002e-05,"L.LvsV.REACTOME_TRNA_AMINOACYLATION"
77,"Down",4.84842280245775e-07,4.00103427981924e-05,"L.LvsV.REACTOME_NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION"
235,"Up",4.96071484201877e-07,4.03349887669438e-05,"L.LvsV.REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION"
240,"Down",8.48719231696693e-07,6.80082410442176e-05,"L.LvsV.NAGASHIMA_NRG1_SIGNALING_UP"
33,"Up",9.06980295741797e-07,7.16384865022342e-05,"L.LvsV.KEGG_BIOSYNTHESIS_OF_UNSATURATED_FATTY_ACIDS"
278,"Down",1.0983608688538e-06,8.55329189280659e-05,"L.LvsV.REACTOME_SIGNALING_BY_ROBO_RECEPTORS"
33,"Up",1.43157027090514e-06,0.000109932667053257,"L.LvsV.REACTOME_TRANSFERRIN_ENDOCYTOSIS_AND_RECYCLING"
66,"Up",1.61275791273215e-06,0.00012214984245885,"L.LvsV.REACTOME_REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF"
47,"Down",1.70796272644924e-06,0.00012761251235862,"L.LvsV.REACTOME_SEMA4D_IN_SEMAPHORIN_SIGNALING"
63,"Down",2.1492146548329e-06,0.000158440104354281,"L.LvsV.SNIJDERS_AMPLIFIED_IN_HEAD_AND_NECK_TUMORS"
121,"Down",2.20285345878571e-06,0.00016025758912666,"L.LvsV.DELPUECH_FOXO3_TARGETS_UP"
49,"Down",2.44822514702526e-06,0.000175795283609125,"L.LvsV.REACTOME_NGF_STIMULATED_TRANSCRIPTION"
522,"Down",2.58061344417932e-06,0.000182925791447019,"L.LvsV.PASINI_SUZ12_TARGETS_DN"
56,"Down",3.07879004888621e-06,0.000215476331396099,"L.LvsV.KEGG_HEDGEHOG_SIGNALING_PATHWAY"
34,"Up",3.27214510522639e-06,0.000226146128584959,"L.LvsV.REACTOME_PYRUVATE_METABOLISM"
66,"Down",4.44210456642362e-06,0.000303214767256249,"L.LvsV.REACTOME_SIGNALING_BY_NOTCH1_PEST_DOMAIN_MUTANTS_IN_CANCER"
219,"Down",4.57034856026374e-06,0.00030816411206949,"L.LvsV.REACTOME_REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS"
42,"Up",5.05884249613963e-06,0.00033631991425746,"L.LvsV.MOOTHA_GLUCONEOGENESIS"
276,"Down",5.10958090027612e-06,0.00033631991425746,"L.LvsV.JISON_SICKLE_CELL_DISEASE_DN"
11,"Down",5.18903514721802e-06,0.000337531474458452,"L.LvsV.REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_DIFFERENTIATION_OF_MYELOID_CELLS"
140,"Up",5.67035785426146e-06,0.000364551262514089,"L.LvsV.KEGG_LYSOSOME"
48,"Down",5.74376853557382e-06,0.000365026393484916,"L.LvsV.REACTOME_EPHA_MEDIATED_GROWTH_CONE_COLLAPSE"
117,"Down",5.8756063503466e-06,0.000369161676262118,"L.LvsV.PID_FAK_PATHWAY"
37,"Down",6.15507165137024e-06,0.000382375181577821,"L.LvsV.BIOCARTA_RHO_PATHWAY"
114,"Down",7.12742746337122e-06,0.000436778068644843,"L.LvsV.AMIT_EGF_RESPONSE_120_HELA"
19,"Up",7.18878716706108e-06,0.000436778068644843,"L.LvsV.MINGUEZ_LIVER_CANCER_VASCULAR_INVASION_UP"
243,"Down",7.55735313101253e-06,0.000454180494145307,"L.LvsV.REACTOME_MRNA_SPLICING"
16,"Up",7.96158219858043e-06,0.000473328902967217,"L.LvsV.REACTOME_GOLGI_CISTERNAE_PERICENTRIOLAR_STACK_REORGANIZATION"
303,"Down",8.22612495581597e-06,0.000479118634549654,"L.LvsV.REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA"
38,"Up",8.23227894415213e-06,0.000479118634549654,"L.LvsV.REACTOME_GLUCONEOGENESIS"
102,"Down",8.55287829092254e-06,0.00049259233406782,"L.LvsV.REACTOME_SEMAPHORIN_INTERACTIONS"
42,"Down",9.11319299892353e-06,0.000519452000938641,"L.LvsV.REACTOME_EGFR_DOWNREGULATION"
10,"Up",1.01519888327543e-05,0.00057275863526835,"L.LvsV.BIOCARTA_ETC_PATHWAY"
22,"Up",1.06375520649547e-05,0.000588324422075654,"L.LvsV.BOYAULT_LIVER_CANCER_SUBCLASS_G12_DN"
11,"Up",1.06407021536563e-05,0.000588324422075654,"L.LvsV.REACTOME_BIOTIN_TRANSPORT_AND_METABOLISM"
34,"Down",1.09025140177612e-05,0.000596831683209916,"L.LvsV.REACTOME_RHO_GTPASES_ACTIVATE_ROCKS"
8,"Up",1.13380384631458e-05,0.000614588379046404,"L.LvsV.REACTOME_NEF_MEDIATED_CD8_DOWN_REGULATION"
49,"Up",1.15136719368581e-05,0.000618049438241638,"L.LvsV.WANG_ADIPOGENIC_GENES_REPRESSED_BY_SIRT1"
58,"Down",1.17471386882929e-05,0.000620768130385879,"L.LvsV.KEGG_BASAL_CELL_CARCINOMA"
14,"Up",1.18177200421582e-05,0.000620768130385879,"L.LvsV.REACTOME_IRAK4_DEFICIENCY_TLR2_4"
104,"Up",1.1901143393182e-05,0.000620768130385879,"L.LvsV.REACTOME_COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC"
6,"Up",1.20833703738498e-05,0.000623303604218885,"L.LvsV.REACTOME_SYNTHESIS_OF_DOLICHYL_PHOSPHATE"
92,"Down",1.22160606498664e-05,0.000623303604218885,"L.LvsV.KEGG_TGF_BETA_SIGNALING_PATHWAY"
19,"Up",1.22879531307395e-05,0.000623303604218885,"L.LvsV.REACTOME_PENTOSE_PHOSPHATE_PATHWAY"
65,"Down",1.26955688036754e-05,0.000638125453777465,"L.LvsV.REACTOME_INTRAFLAGELLAR_TRANSPORT"
224,"Up",1.31762458938357e-05,0.000656319491414575,"L.LvsV.REACTOME_INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC"
214,"Down",1.36258749006416e-05,0.00067265591362185,"L.LvsV.RASHI_RESPONSE_TO_IONIZING_RADIATION_2"
53,"Up",1.39073068452342e-05,0.000678716932873085,"L.LvsV.REACTOME_NEF_MEDIATES_DOWN_MODULATION_OF_CELL_SURFACE_RECEPTORS_BY_RECRUITING_THEM_TO_CLATHRIN_ADAPTERS"
102,"Down",1.39941635643935e-05,0.000678716932873085,"L.LvsV.KEGG_ADHERENS_JUNCTION"
120,"Up",1.45177711991207e-05,0.000697989190955988,"L.LvsV.REACTOME_COPI_MEDIATED_ANTEROGRADE_TRANSPORT"
50,"Up",1.52218006474865e-05,0.000725528756723733,"L.LvsV.REACTOME_INTRA_GOLGI_TRAFFIC"
125,"Down",1.55265992461352e-05,0.000733731343862237,"L.LvsV.REACTOME_CELL_JUNCTION_ORGANIZATION"
49,"Down",1.61460048178445e-05,0.000756536107100526,"L.LvsV.VERRECCHIA_RESPONSE_TO_TGFB1_C5"
166,"Down",1.80158417709308e-05,0.000837055371020809,"L.LvsV.KEGG_SPLICEOSOME"
138,"Down",1.86257904929436e-05,0.000858183296962375,"L.LvsV.KEGG_TIGHT_JUNCTION"
42,"Down",1.92588563181549e-05,0.000880018318868415,"L.LvsV.REACTOME_SEMA4D_INDUCED_CELL_MIGRATION_AND_GROWTH_CONE_COLLAPSE"
66,"Down",2.05157857760459e-05,0.00092976868488326,"L.LvsV.KEGG_PATHOGENIC_ESCHERICHIA_COLI_INFECTION"
196,"Up",2.13953438501265e-05,0.000961746797945929,"L.LvsV.SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP"
775,"Down",2.22315953540376e-05,0.000991278150907047,"L.LvsV.REACTOME_METABOLISM_OF_RNA"
50,"Up",2.27112174731395e-05,0.00100456257127191,"L.LvsV.REACTOME_RETROGRADE_TRANSPORT_AT_THE_TRANS_GOLGI_NETWORK"
29,"Up",2.3435729013495e-05,0.00102705585049715,"L.LvsV.PID_ARF_3PATHWAY"
90,"Up",2.36073705404798e-05,0.00102705585049715,"L.LvsV.REACTOME_CONDENSATION_OF_PROPHASE_CHROMOSOMES"
39,"Down",2.37770209556222e-05,0.00102705585049715,"L.LvsV.KOBAYASHI_EGFR_SIGNALING_6HR_DN"
43,"Up",2.67809133766454e-05,0.0011478424035618,"L.LvsV.WANG_CLASSIC_ADIPOGENIC_TARGETS_OF_PPARG"
17,"Down",2.78038035495761e-05,0.00118251715250466,"L.LvsV.REACTOME_PHOSPHORYLATION_SITE_MUTANTS_OF_CTNNB1_ARE_NOT_TARGETED_TO_THE_PROTEASOME_BY_THE_DESTRUCTION_COMPLEX"
262,"Down",3.08517884573097e-05,0.00130213388076691,"L.LvsV.CAIRO_LIVER_DEVELOPMENT_UP"
22,"Up",3.2024187281233e-05,0.00133341687586473,"L.LvsV.BIOCARTA_ARAP_PATHWAY"
68,"Down",3.20753200379832e-05,0.00133341687586473,"L.LvsV.HALMOS_CEBPA_TARGETS_DN"
21,"Up",3.2496468451957e-05,0.00134084309008112,"L.LvsV.REACTOME_CLASS_I_PEROXISOMAL_MEMBRANE_PROTEIN_IMPORT"
55,"Up",3.52445631973431e-05,0.00144346066606008,"L.LvsV.REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC"
56,"Down",3.60553181369164e-05,0.00146580774984567,"L.LvsV.FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_UP"
188,"Down",3.75575572041021e-05,0.0015157352830765,"L.LvsV.KIM_MYC_AMPLIFICATION_TARGETS_DN"
61,"Down",3.79157326341422e-05,0.00151910207053748,"L.LvsV.REACTOME_RUNX2_REGULATES_BONE_DEVELOPMENT"
125,"Up",3.92484307135519e-05,0.00156118398140452,"L.LvsV.CROONQUIST_IL6_DEPRIVATION_DN"
17,"Up",4.02621558119231e-05,0.00159006756774373,"L.LvsV.REACTOME_REGULATION_OF_PYRUVATE_DEHYDROGENASE_PDH_COMPLEX"
23,"Down",4.10914484129477e-05,0.00160185042000905,"L.LvsV.BIOCARTA_PITX2_PATHWAY"
19,"Down",4.11399456757615e-05,0.00160185042000905,"L.LvsV.DORN_ADENOVIRUS_INFECTION_24HR_UP"
18,"Down",4.19608125319378e-05,0.0016223869404831,"L.LvsV.REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING"
10,"Down",4.38227996500269e-05,0.00167331583080304,"L.LvsV.SMID_BREAST_CANCER_ERBB2_DN"
22,"Down",4.38833053836935e-05,0.00167331583080304,"L.LvsV.REACTOME_REGULATION_OF_KIT_SIGNALING"
84,"Up",4.54761590171452e-05,0.00172217591236846,"L.LvsV.YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_10"
186,"Up",4.66356920487957e-05,0.00175407307032511,"L.LvsV.ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER"
11,"Up",4.88264349738586e-05,0.00181384810005221,"L.LvsV.KEGG_VALINE_LEUCINE_AND_ISOLEUCINE_BIOSYNTHESIS"
20,"Down",4.88810574982419e-05,0.00181384810005221,"L.LvsV.REACTOME_BETA_CATENIN_PHOSPHORYLATION_CASCADE"
50,"Up",5.06384545698574e-05,0.00186653343544494,"L.LvsV.REACTOME_ACTIVATION_OF_GENE_EXPRESSION_BY_SREBF_SREBP"
26,"Up",5.14537996591192e-05,0.00188318718052529,"L.LvsV.REACTOME_METAL_ION_SLC_TRANSPORTERS"
73,"Down",5.17714688804203e-05,0.00188318718052529,"L.LvsV.ZWANG_CLASS_2_TRANSIENTLY_INDUCED_BY_EGF"
43,"Down",5.22951266876516e-05,0.001889802323242,"L.LvsV.REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN"
46,"Down",5.89704026227028e-05,0.00211719062403197,"L.LvsV.PID_RAC1_REG_PATHWAY"
243,"Down",6.03079279390794e-05,0.00215124215209787,"L.LvsV.KEGG_REGULATION_OF_ACTIN_CYTOSKELETON"
63,"Up",6.61245362884076e-05,0.00234360616114491,"L.LvsV.REACTOME_CARGO_CONCENTRATION_IN_THE_ER"
15,"Down",6.73914367902969e-05,0.00237329461155128,"L.LvsV.TURJANSKI_MAPK1_AND_MAPK2_TARGETS"
11,"Down",6.79794693625799e-05,0.0023788511778842,"L.LvsV.REACTOME_RUNX3_REGULATES_YAP1_MEDIATED_TRANSCRIPTION"
52,"Up",7.14212531295368e-05,0.00248357300976861,"L.LvsV.ELVIDGE_HIF1A_AND_HIF2A_TARGETS_UP"
342,"Down",7.26650001870164e-05,0.00250768911453484,"L.LvsV.ZWANG_CLASS_3_TRANSIENTLY_INDUCED_BY_EGF"
33,"Up",7.30218751022082e-05,0.00250768911453484,"L.LvsV.REACTOME_SIALIC_ACID_METABOLISM"
9,"Up",7.34936168004047e-05,0.00250830992153974,"L.LvsV.REACTOME_DEFECTS_IN_BIOTIN_BTN_METABOLISM"
12,"Down",7.45288001802745e-05,0.00252803519139103,"L.LvsV.REACTOME_RUNX2_REGULATES_CHONDROCYTE_MATURATION"
30,"Down",7.51107151360942e-05,0.00252806649766506,"L.LvsV.CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_UP"
79,"Up",7.54441982482791e-05,0.00252806649766506,"L.LvsV.REACTOME_DNA_METHYLATION"
22,"Down",7.60486008463104e-05,0.00252919058086694,"L.LvsV.TAGHAVI_NEOPLASTIC_TRANSFORMATION"
51,"Down",7.68417153073784e-05,0.00252919058086694,"L.LvsV.BILANGES_SERUM_RESPONSE_TRANSLATION"
334,"Down",7.68500664832061e-05,0.00252919058086694,"L.LvsV.KIM_WT1_TARGETS_UP"
41,"Down",7.81166860538621e-05,0.00255566365202251,"L.LvsV.REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS"
103,"Down",8.08237848247881e-05,0.00261706154770945,"L.LvsV.SANSOM_WNT_PATHWAY_REQUIRE_MYC"
83,"Up",8.13826690111442e-05,0.00261706154770945,"L.LvsV.PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_DN"
67,"Down",8.14133814805615e-05,0.00261706154770945,"L.LvsV.PID_NCADHERIN_PATHWAY"
29,"Down",8.2673004931952e-05,0.0026337449237367,"L.LvsV.REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY"
18,"Down",8.28850817019688e-05,0.0026337449237367,"L.LvsV.ZAIDI_OSTEOBLAST_TRANSCRIPTION_FACTORS"
13,"Down",8.33955580677431e-05,0.00263482308889458,"L.LvsV.FIRESTEIN_CTNNB1_PATHWAY_AND_PROLIFERATION"
6,"Up",8.54870009485537e-05,0.00267339896997214,"L.LvsV.REACTOME_MOLYBDENUM_COFACTOR_BIOSYNTHESIS"
23,"Down",8.60660079628524e-05,0.00267339896997214,"L.LvsV.BIOCARTA_PS1_PATHWAY"
66,"Down",8.60671037538508e-05,0.00267339896997214,"L.LvsV.NIKOLSKY_BREAST_CANCER_19Q13.1_AMPLICON"
39,"Down",9.28535582925832e-05,0.00286202201385291,"L.LvsV.JOHANSSON_GLIOMAGENESIS_BY_PDGFB_DN"
71,"Up",9.31748892193024e-05,0.00286202201385291,"L.LvsV.REACTOME_RECOGNITION_AND_ASSOCIATION_OF_DNA_GLYCOSYLASE_WITH_SITE_CONTAINING_AN_AFFECTED_PURINE"
8,"Up",9.86304748863121e-05,0.00301286130191392,"L.LvsV.REACTOME_UBIQUINOL_BIOSYNTHESIS"
105,"Up",0.000103621628970902,0.00314793399219845,"L.LvsV.SCHUHMACHER_MYC_TARGETS_UP"
43,"Down",0.000105393212133194,0.00318425721248321,"L.LvsV.REACTOME_DISASSEMBLY_OF_THE_DESTRUCTION_COMPLEX_AND_RECRUITMENT_OF_AXIN_TO_THE_MEMBRANE"
50,"Down",0.000106233920710197,0.00319221384568849,"L.LvsV.REACTOME_SUMOYLATION_OF_TRANSCRIPTION_COFACTORS"
718,"Down",0.000107412584805202,0.00321018476425927,"L.LvsV.REACTOME_NERVOUS_SYSTEM_DEVELOPMENT"
117,"Up",0.000116638920056687,0.00346718596233024,"L.LvsV.TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_UP"
5,"Up",0.000118722480785814,0.00351024917788645,"L.LvsV.REACTOME_PROPIONYL_COA_CATABOLISM"
40,"Up",0.000120948351643204,0.00355703955444294,"L.LvsV.REACTOME_NEF_MEDIATED_DOWNREGULATION_OF_MHC_CLASS_I_COMPLEX_CELL_SURFACE_EXPRESSION"
51,"Up",0.000122301634139521,0.00357677931459826,"L.LvsV.KEGG_AMINO_SUGAR_AND_NUCLEOTIDE_SUGAR_METABOLISM"
107,"Up",0.000122913378508531,0.00357677931459826,"L.LvsV.REACTOME_BASE_EXCISION_REPAIR"
172,"Down",0.000133104622199802,0.0038397342408245,"L.LvsV.REACTOME_SIGNALING_BY_NTRKS"
15,"Down",0.000133338573745398,0.0038397342408245,"L.LvsV.CLAUS_PGR_POSITIVE_MENINGIOMA_DN"
17,"Down",0.00013942791426644,0.0039942846527417,"L.LvsV.FUKUSHIMA_TNFSF11_TARGETS"
588,"Up",0.000140315511037888,0.00399899206457982,"L.LvsV.MOOTHA_PGC"
15,"Down",0.000146395845759309,0.00415088528822163,"L.LvsV.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TAN_DN"
34,"Down",0.00014718096816987,0.00415125865389313,"L.LvsV.REACTOME_COOPERATION_OF_PREFOLDIN_AND_TRIC_CCT_IN_ACTIN_AND_TUBULIN_FOLDING"
36,"Down",0.00014791064474895,0.00415125865389313,"L.LvsV.REACTOME_SIGNAL_TRANSDUCTION_BY_L1"
107,"Up",0.000149489878473003,0.00417439160645067,"L.LvsV.GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN"
92,"Down",0.000150250425623176,0.00417454574507809,"L.LvsV.VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1"
83,"Down",0.000154336153745124,0.00425241558545091,"L.LvsV.CHNG_MULTIPLE_MYELOMA_HYPERPLOID_UP"
32,"Down",0.000154591342498758,0.00425241558545091,"L.LvsV.REACTOME_RHO_GTPASES_ACTIVATE_CIT"
25,"Down",0.00015550060265872,0.00425625164405972,"L.LvsV.REACTOME_CELL_EXTRACELLULAR_MATRIX_INTERACTIONS"
34,"Down",0.000156681495786236,0.00426720865568214,"L.LvsV.REACTOME_CD209_DC_SIGN_SIGNALING"
171,"Down",0.000157444486482032,0.00426720865568214,"L.LvsV.KEGG_WNT_SIGNALING_PATHWAY"
47,"Down",0.000159909718489298,0.00431288211476745,"L.LvsV.REACTOME_NEGATIVE_REGULATION_OF_MAPK_PATHWAY"
96,"Down",0.000161958624989429,0.00434347606199603,"L.LvsV.LIU_SMARCA4_TARGETS"
43,"Up",0.000162615218815912,0.00434347606199603,"L.LvsV.KEGG_BUTANOATE_METABOLISM"
113,"Down",0.000164109917915598,0.00436232565459298,"L.LvsV.JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN"
33,"Down",0.000167051706392947,0.0044192769600316,"L.LvsV.REACTOME_DEADENYLATION_OF_MRNA"
97,"Up",0.000176527853931971,0.00464641668838303,"L.LvsV.REACTOME_ACTIVATED_PKN1_STIMULATES_TRANSCRIPTION_OF_AR_ANDROGEN_RECEPTOR_REGULATED_GENES_KLK2_AND_KLK3"
24,"Down",0.000177318488198376,0.00464641668838303,"L.LvsV.PID_P38_MK2_PATHWAY"
130,"Down",0.000178265033956409,0.00464918572049522,"L.LvsV.KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION"
14,"Up",0.000179918141131014,0.00466448851323549,"L.LvsV.REACTOME_DEFECTS_IN_COBALAMIN_B12_METABOLISM"
46,"Down",0.000180539074305009,0.00466448851323549,"L.LvsV.SAKAI_TUMOR_INFILTRATING_MONOCYTES_UP"
63,"Up",0.000182962496976132,0.00470511463153969,"L.LvsV.KAUFFMANN_MELANOMA_RELAPSE_UP"
67,"Down",0.000184638864549148,0.00470912229101863,"L.LvsV.PID_ILK_PATHWAY"
197,"Down",0.000186159302631051,0.00470912229101863,"L.LvsV.WOO_LIVER_CANCER_RECURRENCE_UP"
39,"Down",0.000186596178147762,0.00470912229101863,"L.LvsV.MCCABE_HOXC6_TARGETS_DN"
252,"Down",0.000186639649016498,0.00470912229101863,"L.LvsV.REACTOME_CILIUM_ASSEMBLY"
54,"Down",0.000187376904327021,0.00470912229101863,"L.LvsV.RIZ_ERYTHROID_DIFFERENTIATION_12HR"
8,"Down",0.000192024952610295,0.0048040993800105,"L.LvsV.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_6"
62,"Up",0.000199899225168875,0.00497857124305724,"L.LvsV.GREENBAUM_E2A_TARGETS_UP"
56,"Up",0.000201401932744813,0.00498432656585523,"L.LvsV.ZHAN_MULTIPLE_MYELOMA_PR_UP"
42,"Down",0.000201933288253133,0.00498432656585523,"L.LvsV.REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES"
32,"Up",0.000207546044346825,0.00510009812974932,"L.LvsV.KEGG_PENTOSE_PHOSPHATE_PATHWAY"
113,"Up",0.000209245159558476,0.00511909950087971,"L.LvsV.RUAN_RESPONSE_TO_TNF_DN"
261,"Up",0.000211303187831818,0.00514667544282872,"L.LvsV.YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_17"
14,"Down",0.000213989746650763,0.00518925135628099,"L.LvsV.BIOCARTA_P35ALZHEIMERS_PATHWAY"
75,"Down",0.000215666746772493,0.00520708053670354,"L.LvsV.PID_AMB2_NEUTROPHILS_PATHWAY"
91,"Down",0.000218323204341807,0.0052482999861124,"L.LvsV.PID_ATF2_PATHWAY"
39,"Up",0.000221746398800578,0.00529618925326687,"L.LvsV.REACTOME_N_GLYCAN_TRIMMING_IN_THE_ER_AND_CALNEXIN_CALRETICULIN_CYCLE"
18,"Down",0.000223187045707371,0.00529618925326687,"L.LvsV.REACTOME_APOPTOTIC_CLEAVAGE_OF_CELL_ADHESION_PROTEINS"
77,"Down",0.000223230110094102,0.00529618925326687,"L.LvsV.SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_DN"
92,"Down",0.000224146913594583,0.00529618925326687,"L.LvsV.BURTON_ADIPOGENESIS_7"
84,"Down",0.000225552630331463,0.00530672550256452,"L.LvsV.REACTOME_ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S"
53,"Down",0.000236403345968891,0.00553844957568643,"L.LvsV.ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP"
17,"Up",0.000239018943181017,0.00557610015547614,"L.LvsV.REACTOME_ZINC_TRANSPORTERS"
30,"Down",0.000251332488715152,0.00583872827775662,"L.LvsV.SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_UP"
79,"Up",0.000254526060116427,0.00588817818570596,"L.LvsV.REACTOME_BASE_EXCISION_REPAIR_AP_SITE_FORMATION"
44,"Down",0.000261785582558044,0.00601772355064667,"L.LvsV.HINATA_NFKB_TARGETS_KERATINOCYTE_DN"
36,"Down",0.000262302654314677,0.00601772355064667,"L.LvsV.REACTOME_RHO_GTPASES_ACTIVATE_IQGAPS"
62,"Down",0.000272355638723485,0.00622253853926507,"L.LvsV.REACTOME_APOPTOTIC_CLEAVAGE_OF_CELLULAR_PROTEINS"
32,"Down",0.000275714389810609,0.00626753669224765,"L.LvsV.XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_UP"
92,"Down",0.000276592322826628,0.00626753669224765,"L.LvsV.REACTOME_SIGNALING_BY_NOTCH1"
108,"Up",0.000279919543982506,0.00631704146399704,"L.LvsV.REN_BOUND_BY_E2F"
132,"Down",0.000283084722785645,0.00636250175724323,"L.LvsV.REACTOME_SIGNALING_BY_VEGF"
12,"Down",0.000287835434498627,0.00644308549531542,"L.LvsV.REACTOME_FGFR2B_LIGAND_BINDING_AND_ACTIVATION"
101,"Up",0.000292589235821083,0.00652308824538212,"L.LvsV.REACTOME_MEIOTIC_RECOMBINATION"
19,"Up",0.00030069911577657,0.00667696952260504,"L.LvsV.KEGG_GLYOXYLATE_AND_DICARBOXYLATE_METABOLISM"
70,"Down",0.000305199953572282,0.00673497301631047,"L.LvsV.REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_CYTOCHROME_C_RELEASE"
34,"Down",0.000305747554185916,0.00673497301631047,"L.LvsV.REACTOME_SIGNALING_BY_BMP"
33,"Up",0.000308102900615563,0.0067437726993326,"L.LvsV.KEGG_GALACTOSE_METABOLISM"
13,"Down",0.00030956969895617,0.0067437726993326,"L.LvsV.REACTOME_REGULATION_OF_CYTOSKELETAL_REMODELING_AND_CELL_SPREADING_BY_IPP_COMPLEX_COMPONENTS"
75,"Down",0.000313621941171022,0.0067437726993326,"L.LvsV.PID_HEDGEHOG_GLI_PATHWAY"
89,"Down",0.000314781064897717,0.0067437726993326,"L.LvsV.REACTOME_CONSTITUTIVE_SIGNALING_BY_ABERRANT_PI3K_IN_CANCER"
30,"Down",0.000315084022611091,0.0067437726993326,"L.LvsV.BIOCARTA_TEL_PATHWAY"
44,"Down",0.000315555172349875,0.0067437726993326,"L.LvsV.REACTOME_NEGATIVE_REGULATION_OF_FGFR2_SIGNALING"
26,"Down",0.000316907749006493,0.0067437726993326,"L.LvsV.OKAWA_NEUROBLASTOMA_1P36_31_DELETION"
46,"Down",0.000317943060593473,0.0067437726993326,"L.LvsV.OSADA_ASCL1_TARGETS_DN"
156,"Down",0.000318267202910549,0.0067437726993326,"L.LvsV.KEGG_AXON_GUIDANCE"
19,"Down",0.000318344126338544,0.0067437726993326,"L.LvsV.REACTOME_NEF_AND_SIGNAL_TRANSDUCTION"
22,"Down",0.000324018140806325,0.00683777213938234,"L.LvsV.LOPEZ_EPITHELIOID_MESOTHELIOMA"
38,"Up",0.00033170609861084,0.00697339551033968,"L.LvsV.WANG_METASTASIS_OF_BREAST_CANCER_ESR1_UP"
191,"Down",0.000334306842215897,0.00700144897958976,"L.LvsV.VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN"
46,"Down",0.000338455045915668,0.0070615771655386,"L.LvsV.DELLA_RESPONSE_TO_TSA_AND_BUTYRATE"
59,"Down",0.000347308043162703,0.00721904575431048,"L.LvsV.PID_RHOA_REG_PATHWAY"
290,"Down",0.000351063783049791,0.00724898400291157,"L.LvsV.KEGG_MAPK_SIGNALING_PATHWAY"
18,"Down",0.000351370539479164,0.00724898400291157,"L.LvsV.REACTOME_RUNX3_REGULATES_P14_ARF"
67,"Down",0.000353602819988329,0.00725138230914417,"L.LvsV.REACTOME_SIGNALING_BY_EGFR"
24,"Down",0.000355011038726316,0.00725138230914417,"L.LvsV.VISALA_RESPONSE_TO_HEAT_SHOCK_AND_AGING_DN"
175,"Down",0.000356434129946531,0.00725138230914417,"L.LvsV.REACTOME_CELL_CELL_COMMUNICATION"
96,"Down",0.000357461567299317,0.00725138230914417,"L.LvsV.REACTOME_TRANSLOCATION_OF_SLC2A4_GLUT4_TO_THE_PLASMA_MEMBRANE"
31,"Down",0.000358044378802018,0.00725138230914417,"L.LvsV.LIM_MAMMARY_LUMINAL_PROGENITOR_DN"
137,"Down",0.000359890419505549,0.007262168355643,"L.LvsV.REACTOME_SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE"
167,"Down",0.000362931567170392,0.00729208951354209,"L.LvsV.REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE"
35,"Down",0.00036514088784274,0.00729208951354209,"L.LvsV.ZIRN_TRETINOIN_RESPONSE_WT1_UP"
67,"Down",0.000365329859875413,0.00729208951354209,"L.LvsV.NAKAMURA_METASTASIS"
241,"Down",0.000368811937371342,0.007335112236425,"L.LvsV.KIM_WT1_TARGETS_12HR_UP"
36,"Up",0.000372845082994641,0.00738874718235617,"L.LvsV.FARMER_BREAST_CANCER_CLUSTER_2"
52,"Down",0.00037451375776961,0.00739530916681491,"L.LvsV.SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_DN"
71,"Down",0.000377023664249047,0.00741837665349815,"L.LvsV.BEIER_GLIOMA_STEM_CELL_UP"
122,"Down",0.000379938724715587,0.00743346587836111,"L.LvsV.WNT_SIGNALING"
27,"Up",0.000381585310846936,0.00743346587836111,"L.LvsV.REACTOME_MITOCHONDRIAL_TRNA_AMINOACYLATION"
276,"Down",0.000381823893914732,0.00743346587836111,"L.LvsV.AMIT_EGF_RESPONSE_480_HELA"
15,"Down",0.000384031589251306,0.00745021283147533,"L.LvsV.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_9"
83,"Up",0.000388720879395178,0.00751481728033546,"L.LvsV.REACTOME_SIRT1_NEGATIVELY_REGULATES_RRNA_EXPRESSION"
34,"Down",0.000405264510444524,0.00780734312978319,"L.LvsV.LAMB_CCND1_TARGETS"
92,"Up",0.00041266992346692,0.00792240280155765,"L.LvsV.OLSSON_E2F3_TARGETS_DN"
124,"Down",0.000430491216672143,0.00823593749820165,"L.LvsV.MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_DN"
12,"Down",0.000436546342505391,0.00832298181969762,"L.LvsV.SCIAN_CELL_CYCLE_TARGETS_OF_TP53_AND_TP73_UP"
58,"Down",0.000438520656417568,0.00833189247193379,"L.LvsV.REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION"
69,"Down",0.000440881775918908,0.00834149294607032,"L.LvsV.PID_RHOA_PATHWAY"
140,"Down",0.000442043304973522,0.00834149294607032,"L.LvsV.MCCLUNG_COCAINE_REWARD_5D"
51,"Down",0.00045255003056013,0.00851071128900325,"L.LvsV.PID_EPHRINB_REV_PATHWAY"
20,"Up",0.000475278062957194,0.00890208745588071,"L.LvsV.REACTOME_SYNTHESIS_OF_PIPS_AT_THE_GOLGI_MEMBRANE"
154,"Down",0.000476581278158924,0.00890208745588071,"L.LvsV.PID_ERBB1_DOWNSTREAM_PATHWAY"
45,"Up",0.000489133556177638,0.00910578933369078,"L.LvsV.XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_DN"
45,"Down",0.000491029403761102,0.0091104079644132,"L.LvsV.PID_EPHA_FWDPATHWAY"
70,"Down",0.000495446370721791,0.00916161533016984,"L.LvsV.YAMASHITA_LIVER_CANCER_WITH_EPCAM_UP"
36,"Down",0.000498921915057144,0.00919513089450316,"L.LvsV.REACTOME_SIGNALING_BY_EGFR_IN_CANCER"
19,"Down",0.000503588930389036,0.00925030962166439,"L.LvsV.REACTOME_PTK6_REGULATES_RHO_GTPASES_RAS_GTPASE_AND_MAP_KINASES"
325,"Down",0.00052544724171094,0.00961986026297943,"L.LvsV.TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN"
61,"Down",0.000530312517569615,0.00967689079089902,"L.LvsV.GENTILE_UV_RESPONSE_CLUSTER_D2"
63,"Up",0.000544563532445534,0.00987299776797202,"L.LvsV.KEGG_VIBRIO_CHOLERAE_INFECTION"
45,"Up",0.000544992364142221,0.00987299776797202,"L.LvsV.CHNG_MULTIPLE_MYELOMA_HYPERPLOID_DN"
77,"Down",0.000546416588352222,0.00987299776797202,"L.LvsV.PID_HES_HEY_PATHWAY"
25,"Down",0.000550309706484634,0.00990070101800949,"L.LvsV.VICENT_METASTASIS_UP"
91,"Down",0.000551531183495555,0.00990070101800949,"L.LvsV.REACTOME_SIGNALING_BY_FGFR2"
60,"Down",0.000559945997345528,0.0100192278942506,"L.LvsV.REACTOME_AGGREPHAGY"
463,"Down",0.000563344040383712,0.0100475135460695,"L.LvsV.JAEGER_METASTASIS_DN"
54,"Up",0.000574269514947149,0.0102065724760262,"L.LvsV.NAKAMURA_CANCER_MICROENVIRONMENT_DN"
270,"Down",0.000575954171191926,0.0102065724760262,"L.LvsV.KIM_WT1_TARGETS_8HR_UP"
12,"Down",0.000579999914782297,0.0102454298045729,"L.LvsV.REACTOME_HYALURONAN_BIOSYNTHESIS_AND_EXPORT"
33,"Down",0.000584516583731848,0.0102923318199152,"L.LvsV.PID_P38_ALPHA_BETA_PATHWAY"
57,"Down",0.000589555661868058,0.0103247803527579,"L.LvsV.DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY"
29,"Up",0.00059105712384583,0.0103247803527579,"L.LvsV.REACTOME_INSULIN_RECEPTOR_RECYCLING"
49,"Down",0.000591961543104402,0.0103247803527579,"L.LvsV.PID_NECTIN_PATHWAY"
25,"Up",0.000614648299646546,0.0106520914360815,"L.LvsV.REACTOME_SYNTHESIS_OF_VERY_LONG_CHAIN_FATTY_ACYL_COAS"
16,"Down",0.000615715717856941,0.0106520914360815,"L.LvsV.REACTOME_ERKS_ARE_INACTIVATED"
440,"Down",0.000616507371956245,0.0106520914360815,"L.LvsV.DAZARD_RESPONSE_TO_UV_NHEK_DN"
78,"Down",0.000621844743516631,0.0106928470450004,"L.LvsV.WANG_METHYLATED_IN_BREAST_CANCER"
51,"Down",0.000624583157703985,0.0106928470450004,"L.LvsV.BIOCARTA_AGR_PATHWAY"
233,"Down",0.000624668040429578,0.0106928470450004,"L.LvsV.PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_UP"
188,"Down",0.000630556585101664,0.0107166366486631,"L.LvsV.PID_PDGFRB_PATHWAY"
56,"Up",0.000631414519983553,0.0107166366486631,"L.LvsV.RUAN_RESPONSE_TO_TNF_TROGLITAZONE_DN"
414,"Up",0.000631872589521462,0.0107166366486631,"L.LvsV.DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP"
26,"Down",0.000636734757512192,0.010766074844908,"L.LvsV.REACTOME_FORMATION_OF_TUBULIN_FOLDING_INTERMEDIATES_BY_CCT_TRIC"
74,"Down",0.000648295008149496,0.0109147875005071,"L.LvsV.KUUSELO_PANCREATIC_CANCER_19Q13_AMPLIFICATION"
150,"Up",0.000649478221679659,0.0109147875005071,"L.LvsV.REACTOME_METABOLISM_OF_WATER_SOLUBLE_VITAMINS_AND_COFACTORS"
9,"Down",0.000655575670614715,0.0109838723722084,"L.LvsV.REACTOME_RUNX1_REGULATES_EXPRESSION_OF_COMPONENTS_OF_TIGHT_JUNCTIONS"
62,"Down",0.000662528377388625,0.0110407320290987,"L.LvsV.SAGIV_CD24_TARGETS_DN"
128,"Down",0.000662963109723415,0.0110407320290987,"L.LvsV.ISSAEVA_MLL2_TARGETS"
20,"Down",0.000671029643777591,0.0111230610896491,"L.LvsV.REACTOME_ACTIVATION_OF_SMO"
77,"Down",0.000671930259349393,0.0111230610896491,"L.LvsV.REACTOME_CELL_CELL_JUNCTION_ORGANIZATION"
117,"Down",0.000678709403319108,0.0112017441520936,"L.LvsV.TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_DN"
36,"Down",0.00068743987419612,0.0113120686441379,"L.LvsV.REACTOME_RHO_GTPASES_ACTIVATE_PAKS"
17,"Up",0.000698602959640392,0.0114604353938033,"L.LvsV.REACTOME_VITAMIN_B5_PANTOTHENATE_METABOLISM"
82,"Up",0.000700601765799517,0.0114604353938033,"L.LvsV.NADLER_OBESITY_DN"
9,"Down",0.000725450843033767,0.0118319106523118,"L.LvsV.REACTOME_FGFR1B_LIGAND_BINDING_AND_ACTIVATION"
80,"Down",0.000732799697835943,0.0119166162627498,"L.LvsV.REACTOME_APOPTOTIC_EXECUTION_PHASE"
97,"Up",0.000738025404726997,0.0119664001839753,"L.LvsV.HU_GENOTOXIC_DAMAGE_4HR"
65,"Up",0.000750629359319023,0.0121351746423242,"L.LvsV.REACTOME_IRON_UPTAKE_AND_TRANSPORT"
75,"Down",0.000761035410847965,0.0122675358209283,"L.LvsV.PID_INTEGRIN3_PATHWAY"
127,"Down",0.000764274214775828,0.0122839306206266,"L.LvsV.PID_SMAD2_3NUCLEAR_PATHWAY"
64,"Down",0.000777499809099642,0.0124602795493099,"L.LvsV.REACTOME_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER"
15,"Down",0.000785533194042722,0.0125526388146307,"L.LvsV.HOLLEMAN_DAUNORUBICIN_B_ALL_DN"
66,"Down",0.000790582757739106,0.0125969223848401,"L.LvsV.SIMBULAN_UV_RESPONSE_IMMORTALIZED_DN"
36,"Down",0.000811464425643268,0.0128924908315564,"L.LvsV.PID_ECADHERIN_KERATINOCYTE_PATHWAY"
33,"Up",0.000817790774822399,0.0129557741948225,"L.LvsV.REACTOME_RESOLUTION_OF_D_LOOP_STRUCTURES"
152,"Up",0.000825858107185223,0.0130461984989346,"L.LvsV.REACTOME_GOLGI_TO_ER_RETROGRADE_TRANSPORT"
63,"Down",0.000828987171635617,0.0130583192933713,"L.LvsV.SIMBULAN_UV_RESPONSE_NORMAL_DN"
26,"Up",0.000837932157892283,0.0131277798007233,"L.LvsV.REACTOME_MTORC1_MEDIATED_SIGNALLING"
88,"Up",0.000839033693681166,0.0131277798007233,"L.LvsV.REACTOME_PRC2_METHYLATES_HISTONES_AND_DNA"
48,"Down",0.000843078851249297,0.0131277798007233,"L.LvsV.KEGG_NOTCH_SIGNALING_PATHWAY"
54,"Down",0.000843241047387831,0.0131277798007233,"L.LvsV.REACTOME_SMOOTH_MUSCLE_CONTRACTION"
49,"Down",0.000845268513123078,0.0131277798007233,"L.LvsV.REACTOME_RUNX2_REGULATES_OSTEOBLAST_DIFFERENTIATION"
61,"Down",0.000849219899689883,0.0131522039926761,"L.LvsV.REACTOME_RRNA_MODIFICATION_IN_THE_NUCLEUS_AND_CYTOSOL"
23,"Down",0.000854026727700436,0.0131897032889824,"L.LvsV.WHITE_NEUROBLASTOMA_WITH_1P36.3_DELETION"
8,"Down",0.000857448222559283,0.0132056580014771,"L.LvsV.GAUTSCHI_SRC_SIGNALING"
58,"Up",0.000863392199593666,0.0132602651987594,"L.LvsV.ODONNELL_TARGETS_OF_MYC_AND_TFRC_DN"
19,"Up",0.00086612426994376,0.0132653769765071,"L.LvsV.REACTOME_ALPHA_LINOLENIC_OMEGA3_AND_LINOLEIC_OMEGA6_ACID_METABOLISM"
49,"Down",0.000875222617809878,0.0133676957289249,"L.LvsV.GENTILE_UV_RESPONSE_CLUSTER_D6"
96,"Up",0.000887852587870074,0.013491073692302,"L.LvsV.REACTOME_NONHOMOLOGOUS_END_JOINING_NHEJ"
8,"Down",0.000889861044480025,0.013491073692302,"L.LvsV.REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_INTERLEUKIN_SIGNALING"
26,"Down",0.000890620708571215,0.013491073692302,"L.LvsV.BIOCARTA_MEF2D_PATHWAY"
106,"Down",0.000896691794290926,0.013545926039985,"L.LvsV.PID_AR_PATHWAY"
55,"Down",0.000928528237751863,0.0139886447589375,"L.LvsV.ANDERSEN_LIVER_CANCER_KRT19_UP"
14,"Up",0.000934426497896141,0.0140392502904015,"L.LvsV.REACTOME_CYTOSOLIC_IRON_SULFUR_CLUSTER_ASSEMBLY"
308,"Down",0.000951117402798747,0.0142512957183585,"L.LvsV.VERHAAK_GLIOBLASTOMA_CLASSICAL"
409,"Down",0.000960190407659472,0.0142677946867843,"L.LvsV.CHEN_HOXA5_TARGETS_9HR_UP"
23,"Down",0.000960265357066784,0.0142677946867843,"L.LvsV.HE_PTEN_TARGETS_UP"
201,"Up",0.000961871876485999,0.0142677946867843,"L.LvsV.REACTOME_G2_M_CHECKPOINTS"
78,"Down",0.000962540679719757,0.0142677946867843,"L.LvsV.PID_PS1_PATHWAY"
71,"Down",0.000977537775548707,0.0144232467182647,"L.LvsV.REACTOME_SIGNALING_BY_NOTCH3"
27,"Down",0.000978245165373353,0.0144232467182647,"L.LvsV.REACTOME_LISTERIA_MONOCYTOGENES_ENTRY_INTO_HOST_CELLS"
31,"Down",0.000982898223592684,0.0144533092506488,"L.LvsV.BIOCARTA_UCALPAIN_PATHWAY"
71,"Down",0.000988926016653203,0.0145033738622694,"L.LvsV.PID_AJDISS_2PATHWAY"
38,"Down",0.000992981528264506,0.0145243250523134,"L.LvsV.MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP"
150,"Up",0.000999407648931179,0.0145797490526134,"L.LvsV.REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION"
52,"Down",0.00100462085351979,0.0145884580722258,"L.LvsV.REACTOME_ELASTIC_FIBRE_FORMATION"
239,"Down",0.00100528170112462,0.0145884580722258,"L.LvsV.KEGG_FOCAL_ADHESION"
195,"Down",0.00102724687396927,0.0148523378117194,"L.LvsV.BOYAULT_LIVER_CANCER_SUBCLASS_G1_UP"
17,"Up",0.001028838014449,0.0148523378117194,"L.LvsV.FUJIWARA_PARK2_IN_LIVER_CANCER_DN"
100,"Up",0.00104290620620804,0.0150162198284486,"L.LvsV.CROONQUIST_NRAS_SIGNALING_DN"
25,"Down",0.00105404191278759,0.0151342592416965,"L.LvsV.BOYAULT_LIVER_CANCER_SUBCLASS_G56_DN"
87,"Down",0.00105657877867514,0.0151342592416965,"L.LvsV.PID_HDAC_CLASSI_PATHWAY"
485,"Up",0.00106728115954802,0.0152375304141984,"L.LvsV.LINDGREN_BLADDER_CANCER_CLUSTER_3_UP"
66,"Up",0.00106930037994374,0.0152375304141984,"L.LvsV.BOYAULT_LIVER_CANCER_SUBCLASS_G23_UP"
94,"Down",0.0011051760161272,0.0156648975547106,"L.LvsV.SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_DN"
37,"Down",0.00110765326219083,0.0156648975547106,"L.LvsV.REACTOME_DOWNREGULATION_OF_SMAD2_3_SMAD4_TRANSCRIPTIONAL_ACTIVITY"
33,"Up",0.00111196324010361,0.0156648975547106,"L.LvsV.KUROKAWA_LIVER_CANCER_EARLY_RECURRENCE_DN"
41,"Down",0.00111301853766171,0.0156648975547106,"L.LvsV.PID_EPHA2_FWD_PATHWAY"
56,"Up",0.00111345717833266,0.0156648975547106,"L.LvsV.HASLINGER_B_CLL_WITH_6Q21_DELETION"
56,"Up",0.00111769445241484,0.0156846005771616,"L.LvsV.BARRIER_COLON_CANCER_RECURRENCE_UP"
180,"Down",0.00112169708989669,0.0157009195190855,"L.LvsV.DAZARD_RESPONSE_TO_UV_SCC_DN"
92,"Down",0.00113222846169461,0.0158083110219937,"L.LvsV.PID_TRKR_PATHWAY"
21,"Down",0.00114618842240632,0.0159629113034875,"L.LvsV.WHITESIDE_CISPLATIN_RESISTANCE_UP"
48,"Down",0.00116699175274373,0.0162118025148746,"L.LvsV.AIGNER_ZEB1_TARGETS"
39,"Down",0.00118359424055173,0.0164012344762168,"L.LvsV.REACTOME_NOTCH3_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION"
330,"Down",0.00119048994973133,0.0164237009153147,"L.LvsV.TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP"
38,"Down",0.0011938698314731,0.0164237009153147,"L.LvsV.REACTOME_CHAPERONE_MEDIATED_AUTOPHAGY"
607,"Down",0.00119412692493335,0.0164237009153147,"L.LvsV.REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES"
66,"Down",0.00121002132132533,0.0166010121230961,"L.LvsV.REACTOME_SIGNALING_BY_ERBB2"
34,"Down",0.00121339025602691,0.0166060265484475,"L.LvsV.PID_WNT_SIGNALING_PATHWAY"
762,"Down",0.0012469111230582,0.0170226459244167,"L.LvsV.LIM_MAMMARY_STEM_CELL_UP"
47,"Down",0.00129272344040904,0.0175817379071663,"L.LvsV.VALK_AML_CLUSTER_1"
321,"Down",0.00129422451224754,0.0175817379071663,"L.LvsV.WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN"
97,"Down",0.00130065106393277,0.0176053898049502,"L.LvsV.AMIT_SERUM_RESPONSE_120_MCF10A"
738,"Down",0.0013023339537393,0.0176053898049502,"L.LvsV.CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN"
14,"Down",0.00132421659782373,0.01785754529114,"L.LvsV.BRUNEAU_HEART_GREAT_VESSELS_AND_VALVULOGENESIS"
439,"Down",0.00133609000426319,0.017973823925964,"L.LvsV.MCBRYAN_PUBERTAL_BREAST_4_5WK_UP"
81,"Down",0.00134617954148405,0.0180655987496731,"L.LvsV.LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN"
68,"Up",0.00137008122618866,0.0183382083989514,"L.LvsV.GERHOLD_ADIPOGENESIS_UP"
8,"Down",0.00137312683616674,0.0183382083989514,"L.LvsV.REACTOME_SIGNALING_BY_NOTCH1_T_7_9_NOTCH1_M1580_K2555_TRANSLOCATION_MUTANT"
26,"Down",0.00138213282086321,0.0184140057025366,"L.LvsV.PID_BETA_CATENIN_DEG_PATHWAY"
22,"Down",0.00139863244297689,0.0184725572588144,"L.LvsV.PID_ARF6_DOWNSTREAM_PATHWAY"
56,"Down",0.00139921153025423,0.0184725572588144,"L.LvsV.MARTIN_INTERACT_WITH_HDAC"
25,"Up",0.00139966178750432,0.0184725572588144,"L.LvsV.WALLACE_PROSTATE_CANCER_UP"
78,"Down",0.0013998917510297,0.0184725572588144,"L.LvsV.WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_DN"
55,"Down",0.00142809634868351,0.0187998683615979,"L.LvsV.VALK_AML_CLUSTER_10"
70,"Up",0.00145133229944334,0.0190603712200053,"L.LvsV.KEGG_GLYCOLYSIS_GLUCONEOGENESIS"
266,"Down",0.00145882236376264,0.0191133385053167,"L.LvsV.PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_DN"
11,"Down",0.00147133078714467,0.0192316499340966,"L.LvsV.WILLIAMS_ESR1_TARGETS_DN"
256,"Down",0.00148217975591893,0.0193277638454617,"L.LvsV.BROWNE_HCMV_INFECTION_6HR_DN"
398,"Down",0.0015025871323138,0.0195477747166188,"L.LvsV.RICKMAN_METASTASIS_DN"
26,"Down",0.00151353495681405,0.0196439783479458,"L.LvsV.ZIRN_TRETINOIN_RESPONSE_UP"
34,"Down",0.00152273532194718,0.0197171044380467,"L.LvsV.PARK_HSC_VS_MULTIPOTENT_PROGENITORS_UP"
92,"Down",0.00152707808210385,0.0197271371868042,"L.LvsV.TIEN_INTESTINE_PROBIOTICS_6HR_UP"
11,"Down",0.00153160815992271,0.0197395373338291,"L.LvsV.KOINUMA_COLON_CANCER_MSI_DN"
83,"Up",0.00154205148407049,0.0198279131521529,"L.LvsV.REACTOME_GOLGI_ASSOCIATED_VESICLE_BIOGENESIS"
32,"Down",0.00155434332684523,0.0198928980529278,"L.LvsV.MURAKAMI_UV_RESPONSE_6HR_DN"
10,"Up",0.00155508200401391,0.0198928980529278,"L.LvsV.REACTOME_ZINC_INFLUX_INTO_CELLS_BY_THE_SLC39_GENE_FAMILY"
26,"Down",0.00155789923257691,0.0198928980529278,"L.LvsV.SCHWAB_TARGETS_OF_BMYB_POLYMORPHIC_VARIANTS_DN"
63,"Down",0.00156740159106596,0.0199681184262758,"L.LvsV.STREICHER_LSM1_TARGETS_UP"
789,"Down",0.00160706375249218,0.020347279836728,"L.LvsV.DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN"
219,"Down",0.00160823585540312,0.020347279836728,"L.LvsV.XU_GH1_AUTOCRINE_TARGETS_DN"
165,"Down",0.00161183581923236,0.020347279836728,"L.LvsV.BHATTACHARYA_EMBRYONIC_STEM_CELL"
31,"Down",0.00161188434951833,0.020347279836728,"L.LvsV.ALONSO_METASTASIS_NEURAL_UP"
102,"Up",0.00163321625561216,0.0205632277534612,"L.LvsV.REACTOME_E3_UBIQUITIN_LIGASES_UBIQUITINATE_TARGET_PROTEINS"
25,"Down",0.00163642977238614,0.0205632277534612,"L.LvsV.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_22"
107,"Down",0.00166661536940534,0.0208868351791341,"L.LvsV.FONTAINE_PAPILLARY_THYROID_CARCINOMA_UP"
76,"Up",0.00166973795427333,0.0208868351791341,"L.LvsV.HAHTOLA_MYCOSIS_FUNGOIDES_UP"
94,"Down",0.00168283264017236,0.0210031188882911,"L.LvsV.GERHOLD_ADIPOGENESIS_DN"
8,"Up",0.00168802576674783,0.0210204830278125,"L.LvsV.REACTOME_COENZYME_A_BIOSYNTHESIS"
46,"Down",0.00172097576966115,0.0213826405178798,"L.LvsV.CLIMENT_BREAST_CANCER_COPY_NUMBER_UP"
124,"Up",0.00172659291673679,0.0214043323691429,"L.LvsV.REACTOME_G2_M_DNA_DAMAGE_CHECKPOINT"
105,"Down",0.00178339475524563,0.0220590371403872,"L.LvsV.PID_VEGFR1_2_PATHWAY"
344,"Down",0.00179290839149212,0.0221272109298213,"L.LvsV.LINDGREN_BLADDER_CANCER_CLUSTER_3_DN"
87,"Down",0.00180786488669496,0.0222245072800963,"L.LvsV.EBAUER_MYOGENIC_TARGETS_OF_PAX3_FOXO1_FUSION"
167,"Up",0.00180883130331766,0.0222245072800963,"L.LvsV.KONG_E2F3_TARGETS"
147,"Down",0.00181862885004752,0.0222391730822053,"L.LvsV.RODRIGUES_THYROID_CARCINOMA_DN"
96,"Down",0.0018215557096216,0.0222391730822053,"L.LvsV.PETROVA_PROX1_TARGETS_DN"
42,"Up",0.00182209177179218,0.0222391730822053,"L.LvsV.KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM"
8,"Down",0.00183166117165427,0.0223067282336486,"L.LvsV.FARMER_BREAST_CANCER_CLUSTER_8"
80,"Down",0.00184935158573177,0.0224726701483757,"L.LvsV.MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_6"
273,"Down",0.00186135599543929,0.0225689414447014,"L.LvsV.VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP"
42,"Down",0.0018718956631772,0.0226470702881986,"L.LvsV.REACTOME_MYOGENESIS"
18,"Down",0.00188637182975092,0.02276629693171,"L.LvsV.REACTOME_SEMA4D_MEDIATED_INHIBITION_OF_CELL_ATTACHMENT_AND_MIGRATION"
181,"Down",0.00188998558358743,0.02276629693171,"L.LvsV.LIN_SILENCED_BY_TUMOR_MICROENVIRONMENT"
14,"Down",0.00189609765179359,0.0227902693842755,"L.LvsV.TAKADA_GASTRIC_CANCER_COPY_NUMBER_UP"
56,"Down",0.00190723949348785,0.0228282417635563,"L.LvsV.HUMMERICH_MALIGNANT_SKIN_TUMOR_DN"
28,"Down",0.00190751450438832,0.0228282417635563,"L.LvsV.REACTOME_NOTCH4_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION"
104,"Down",0.00192841899534929,0.0230285715448946,"L.LvsV.BARIS_THYROID_CANCER_DN"
55,"Down",0.00194430344798263,0.0230903178629107,"L.LvsV.PID_INTEGRIN_A4B1_PATHWAY"
65,"Down",0.00194431367871294,0.0230903178629107,"L.LvsV.REACTOME_DEADENYLATION_DEPENDENT_MRNA_DECAY"
18,"Down",0.00194611830785249,0.0230903178629107,"L.LvsV.REACTOME_CONSTITUTIVE_SIGNALING_BY_OVEREXPRESSED_ERBB2"
89,"Up",0.00195624158937001,0.0231607275109781,"L.LvsV.LANDIS_ERBB2_BREAST_PRENEOPLASTIC_DN"
89,"Down",0.00196810997757459,0.0232429128831442,"L.LvsV.KOHOUTEK_CCNT1_TARGETS"
110,"Down",0.0019743699969559,0.0232429128831442,"L.LvsV.AMIT_SERUM_RESPONSE_240_MCF10A"
56,"Up",0.00197972094807118,0.0232429128831442,"L.LvsV.KEGG_GLUTATHIONE_METABOLISM"
17,"Down",0.00197999854728901,0.0232429128831442,"L.LvsV.BIOCARTA_SM_PATHWAY"
36,"Down",0.00199452052759388,0.023363779654802,"L.LvsV.REACTOME_NEGATIVE_REGULATION_OF_FGFR3_SIGNALING"
95,"Down",0.00200729869781362,0.0234501468982688,"L.LvsV.KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC"
26,"Up",0.00201037613126775,0.0234501468982688,"L.LvsV.REACTOME_RESOLUTION_OF_D_LOOP_STRUCTURES_THROUGH_SYNTHESIS_DEPENDENT_STRAND_ANNEALING_SDSA"
11,"Down",0.00202236322129644,0.023497802313129,"L.LvsV.RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_MAPK1_UP"
15,"Up",0.00202296145795793,0.023497802313129,"L.LvsV.WORSCHECH_TUMOR_EVASION_AND_TOLEROGENICITY_DN"
103,"Down",0.00204634817978789,0.0237130107959252,"L.LvsV.PID_CDC42_PATHWAY"
58,"Up",0.00205154489112991,0.0237130107959252,"L.LvsV.REACTOME_AMINO_ACIDS_REGULATE_MTORC1"
119,"Down",0.00205435561064355,0.0237130107959252,"L.LvsV.GUO_HEX_TARGETS_UP"
119,"Down",0.00208277253372722,0.0239900670666777,"L.LvsV.REACTOME_EPH_EPHRIN_SIGNALING"
307,"Up",0.00208703603889889,0.0239900670666777,"L.LvsV.MCBRYAN_PUBERTAL_BREAST_4_5WK_DN"
134,"Down",0.00211507932297785,0.0242619783749886,"L.LvsV.DELASERNA_MYOD_TARGETS_UP"
52,"Down",0.00213110715323755,0.0243556818175104,"L.LvsV.VALK_AML_CLUSTER_2"
45,"Down",0.00213205823832068,0.0243556818175104,"L.LvsV.XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_UP"
162,"Down",0.00214092715140434,0.0244065695260095,"L.LvsV.HOEBEKE_LYMPHOID_STEM_CELL_UP"
10,"Up",0.00215697957332722,0.0245389713187781,"L.LvsV.REACTOME_RECYCLING_OF_EIF2_GDP"
103,"Down",0.00218038614567409,0.024754322380764,"L.LvsV.BOSCO_EPITHELIAL_DIFFERENTIATION_MODULE"
317,"Down",0.00219474736754225,0.0248663077769285,"L.LvsV.WU_CELL_MIGRATION"
150,"Down",0.0022125407705322,0.0250166419637475,"L.LvsV.BURTON_ADIPOGENESIS_8"
13,"Down",0.00223678549806656,0.025239157181245,"L.LvsV.PID_ALK2_PATHWAY"
149,"Up",0.00224640790345338,0.0252961085502928,"L.LvsV.GAVIN_FOXP3_TARGETS_CLUSTER_P6"
13,"Up",0.00226047879824285,0.0254028196656193,"L.LvsV.REACTOME_NEF_MEDIATED_CD4_DOWN_REGULATION"
86,"Down",0.00226883214223932,0.025444975485682,"L.LvsV.CHANDRAN_METASTASIS_TOP50_UP"
31,"Down",0.00228330081352062,0.02553818783212,"L.LvsV.DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_DN"
29,"Down",0.00228638143912089,0.02553818783212,"L.LvsV.REACTOME_FRS_MEDIATED_FGFR2_SIGNALING"
86,"Down",0.00229241958043486,0.0255540077827104,"L.LvsV.REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS"
31,"Down",0.00231386796177853,0.0257411991160432,"L.LvsV.KYNG_RESPONSE_TO_H2O2_VIA_ERCC6"
269,"Up",0.00232907421619355,0.0258583360267754,"L.LvsV.CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN"
9,"Down",0.00234249142543958,0.0258632891159322,"L.LvsV.REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_WNT_SIGNALING"
43,"Down",0.00234293360042053,0.0258632891159322,"L.LvsV.BIOCARTA_WNT_PATHWAY"
12,"Down",0.0023481687642894,0.0258632891159322,"L.LvsV.VISALA_AGING_LYMPHOCYTE_UP"
51,"Down",0.00234823135037041,0.0258632891159322,"L.LvsV.PID_AVB3_OPN_PATHWAY"
19,"Down",0.00237114491037878,0.0260637379910225,"L.LvsV.REACTOME_TFAP2_AP_2_FAMILY_REGULATES_TRANSCRIPTION_OF_GROWTH_FACTORS_AND_THEIR_RECEPTORS"
405,"Down",0.00238844363065613,0.0262017953053526,"L.LvsV.IVANOVA_HEMATOPOIESIS_STEM_CELL_LONG_TERM"
284,"Down",0.00240855278381774,0.0263427961321948,"L.LvsV.ANDERSEN_CHOLANGIOCARCINOMA_CLASS2"
302,"Down",0.0024141857463259,0.0263427961321948,"L.LvsV.RODRIGUES_NTN1_TARGETS_DN"
24,"Down",0.00241559009568146,0.0263427961321948,"L.LvsV.CAIRO_PML_TARGETS_BOUND_BY_MYC_DN"
72,"Up",0.00243093867161674,0.0264579919593877,"L.LvsV.REACTOME_IRE1ALPHA_ACTIVATES_CHAPERONES"
27,"Down",0.00243755164524643,0.0264778448852014,"L.LvsV.REACTOME_SHC1_EVENTS_IN_ERBB2_SIGNALING"
171,"Up",0.00246307593100097,0.02670264082844,"L.LvsV.REACTOME_HOMOLOGY_DIRECTED_REPAIR"
57,"Down",0.00247014962824004,0.0267269222985111,"L.LvsV.SIG_REGULATION_OF_THE_ACTIN_CYTOSKELETON_BY_RHO_GTPASES"
29,"Down",0.00248015304307343,0.0267827464358457,"L.LvsV.JI_CARCINOGENESIS_BY_KRAS_AND_STK11_DN"
13,"Up",0.00253435179376778,0.0272731254526646,"L.LvsV.KUMAMOTO_RESPONSE_TO_NUTLIN_3A_DN"
14,"Up",0.00253542891710428,0.0272731254526646,"L.LvsV.REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_LINKED_TO_LIPOGENESIS"
43,"Up",0.0025422417920506,0.0272933104237821,"L.LvsV.REACTOME_HOMOLOGOUS_DNA_PAIRING_AND_STRAND_EXCHANGE"
56,"Up",0.00255825415256128,0.0273777059385677,"L.LvsV.SEMENZA_HIF1_TARGETS"
30,"Down",0.00256000614401149,0.0273777059385677,"L.LvsV.STEGER_ADIPOGENESIS_DN"
39,"Down",0.0025660576788497,0.0273894457651737,"L.LvsV.PID_RAS_PATHWAY"
18,"Down",0.00260671321495713,0.0277650800833778,"L.LvsV.REACTOME_SHC1_EVENTS_IN_EGFR_SIGNALING"
127,"Down",0.00261129347863202,0.0277650800833778,"L.LvsV.REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK"
184,"Down",0.00263582412533509,0.0278962227826083,"L.LvsV.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP"
48,"Down",0.00263637333285283,0.0278962227826083,"L.LvsV.BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_UP"
86,"Down",0.00263876370325631,0.0278962227826083,"L.LvsV.KHETCHOUMIAN_TRIM24_TARGETS_UP"
20,"Down",0.00265028365703565,0.0279414988803658,"L.LvsV.SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX5_DN"
167,"Down",0.00265315371897125,0.0279414988803658,"L.LvsV.MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_UP"
46,"Down",0.00266891182340768,0.0280540180068842,"L.LvsV.PLASARI_TGFB1_TARGETS_1HR_UP"
27,"Down",0.00268618905505665,0.0280723392719125,"L.LvsV.REACTOME_GASTRIN_CREB_SIGNALLING_PATHWAY_VIA_PKC_AND_MAPK"
39,"Down",0.00268899178206515,0.0280723392719125,"L.LvsV.REACTOME_ONCOGENE_INDUCED_SENESCENCE"
41,"Up",0.00269014649924896,0.0280723392719125,"L.LvsV.BIOCARTA_MHC_PATHWAY"
53,"Down",0.00269096397433779,0.0280723392719125,"L.LvsV.XU_HGF_SIGNALING_NOT_VIA_AKT1_6HR"
31,"Down",0.00271246509022881,0.0282433511937384,"L.LvsV.TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_MONOCYTE_UP"
19,"Down",0.00272093012149558,0.0282782380484005,"L.LvsV.VERRECCHIA_RESPONSE_TO_TGFB1_C6"
83,"Up",0.0027393037855186,0.0284157797938693,"L.LvsV.MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_DN"
334,"Down",0.00277169907056601,0.0286634727599632,"L.LvsV.VERHAAK_GLIOBLASTOMA_PRONEURAL"
132,"Down",0.00277354999576421,0.0286634727599632,"L.LvsV.REACTOME_SIGNALING_BY_TGF_BETA_FAMILY_MEMBERS"
22,"Up",0.00278080294477567,0.0286848124657924,"L.LvsV.EGUCHI_CELL_CYCLE_RB1_TARGETS"
50,"Down",0.00282025284236876,0.0290375753546683,"L.LvsV.BIOCARTA_ALK_PATHWAY"
22,"Down",0.00283324334513248,0.0291171049353856,"L.LvsV.REACTOME_FGFR2_LIGAND_BINDING_AND_ACTIVATION"
196,"Up",0.00285196829589168,0.0292551627235345,"L.LvsV.REACTOME_METABOLISM_OF_STEROIDS"
40,"Up",0.00286116657167885,0.0292951666200228,"L.LvsV.KEGG_FRUCTOSE_AND_MANNOSE_METABOLISM"
11,"Down",0.00289467781719016,0.0295449403007855,"L.LvsV.REACTOME_RUNX3_REGULATES_CDKN1A_TRANSCRIPTION"
30,"Up",0.00289624844330362,0.0295449403007855,"L.LvsV.PID_TOLL_ENDOGENOUS_PATHWAY"
17,"Down",0.0029143638088197,0.0296749861859377,"L.LvsV.REACTOME_NOTCH4_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS"
7,"Down",0.00295928257380004,0.0300769730708464,"L.LvsV.REACTOME_NECTIN_NECL_TRANS_HETERODIMERIZATION"
16,"Down",0.00298288707236326,0.0302612525194431,"L.LvsV.ITO_PTTG1_TARGETS_DN"
87,"Down",0.00300563981024162,0.0304362317048093,"L.LvsV.BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN"
42,"Down",0.00305360868458076,0.0308654523163566,"L.LvsV.NOJIMA_SFRP2_TARGETS_DN"
105,"Down",0.00309061637068993,0.031069972748214,"L.LvsV.REACTOME_SIGNALING_BY_FGFR"
32,"Down",0.00309374986302157,0.031069972748214,"L.LvsV.WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_DN"
77,"Down",0.00309399492616571,0.031069972748214,"L.LvsV.LINDSTEDT_DENDRITIC_CELL_MATURATION_B"
129,"Down",0.00309632030824126,0.031069972748214,"L.LvsV.VERRECCHIA_EARLY_RESPONSE_TO_TGFB1"
203,"Down",0.00311189639797981,0.0310868263155516,"L.LvsV.IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_DN"
38,"Down",0.0031142941863881,0.0310868263155516,"L.LvsV.HOEGERKORP_CD44_TARGETS_DIRECT_DN"
36,"Up",0.00311486738629329,0.0310868263155516,"L.LvsV.KEGG_SNARE_INTERACTIONS_IN_VESICULAR_TRANSPORT"
47,"Up",0.00312270802384621,0.0311089237186409,"L.LvsV.KAMMINGA_EZH2_TARGETS"
95,"Down",0.00314150461467721,0.0312398903139394,"L.LvsV.GU_PDEF_TARGETS_DN"
13,"Down",0.0031569395010675,0.0313370170581728,"L.LvsV.REACTOME_BINDING_OF_TCF_LEF_CTNNB1_TO_TARGET_GENE_PROMOTERS"
209,"Down",0.00318848741742861,0.0315934532812953,"L.LvsV.KANG_IMMORTALIZED_BY_TERT_DN"
18,"Up",0.00320057520605752,0.0316564943010591,"L.LvsV.FINETTI_BREAST_CANCER_KINOME_RED"
82,"Down",0.00321207994156114,0.0316582572747639,"L.LvsV.PID_TGFBR_PATHWAY"
143,"Down",0.00321220516027176,0.0316582572747639,"L.LvsV.KEGG_NEUROTROPHIN_SIGNALING_PATHWAY"
115,"Up",0.0032197836145034,0.0316764832821873,"L.LvsV.SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE"
64,"Down",0.0032407887586337,0.0318265027468663,"L.LvsV.PID_LKB1_PATHWAY"
131,"Up",0.00325234106026567,0.031883322202498,"L.LvsV.LEE_EARLY_T_LYMPHOCYTE_UP"
41,"Down",0.00326822524842433,0.0319823316788286,"L.LvsV.REACTOME_SMAD2_SMAD3_SMAD4_HETEROTRIMER_REGULATES_TRANSCRIPTION"
52,"Down",0.00329200787563815,0.0321581476049528,"L.LvsV.REACTOME_ATTENUATION_PHASE"
243,"Down",0.00330310848011899,0.0322096768722714,"L.LvsV.IGLESIAS_E2F_TARGETS_UP"
40,"Down",0.00331372479037482,0.0322563105034901,"L.LvsV.MURAKAMI_UV_RESPONSE_24HR"
90,"Down",0.00333981752819725,0.0324531654014106,"L.LvsV.KAAB_FAILED_HEART_ATRIUM_UP"
97,"Down",0.00335542023555793,0.0324829584299232,"L.LvsV.WEIGEL_OXIDATIVE_STRESS_RESPONSE"
14,"Up",0.00335783225214339,0.0324829584299232,"L.LvsV.REACTOME_LYSINE_CATABOLISM"
7,"Up",0.00336124395142107,0.0324829584299232,"L.LvsV.REACTOME_VITAMIN_B2_RIBOFLAVIN_METABOLISM"
144,"Down",0.00336638364629155,0.0324829584299232,"L.LvsV.REACTOME_ANCHORING_OF_THE_BASAL_BODY_TO_THE_PLASMA_MEMBRANE"
53,"Down",0.00338739862276429,0.0325725679569519,"L.LvsV.REACTOME_SIGNALING_BY_NOTCH2"
130,"Up",0.00339567234904409,0.0325725679569519,"L.LvsV.REACTOME_PROCESSING_OF_DNA_DOUBLE_STRAND_BREAK_ENDS"
18,"Up",0.00339824139408636,0.0325725679569519,"L.LvsV.REACTOME_PROCESSING_OF_SMDT1"
24,"Down",0.00340379375710848,0.0325725679569519,"L.LvsV.REACTOME_BBSOME_MEDIATED_CARGO_TARGETING_TO_CILIUM"
27,"Up",0.00340512647479077,0.0325725679569519,"L.LvsV.VANDESLUIS_COMMD1_TARGETS_GROUP_2_UP"
341,"Down",0.00341745263617979,0.0326340166242454,"L.LvsV.BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_DN"
237,"Up",0.00342605884564282,0.0326597919957916,"L.LvsV.YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_13"
25,"Down",0.00348904415097075,0.0332029692094962,"L.LvsV.REACTOME_SUMOYLATION_OF_TRANSCRIPTION_FACTORS"
106,"Up",0.00349725805386721,0.0332052491835021,"L.LvsV.REACTOME_RNA_POLYMERASE_I_PROMOTER_ESCAPE"
109,"Down",0.0035045296957916,0.0332052491835021,"L.LvsV.REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM"
349,"Down",0.00350730069147499,0.0332052491835021,"L.LvsV.REACTOME_MAPK_FAMILY_SIGNALING_CASCADES"
47,"Up",0.00352484509727807,0.0333143052014538,"L.LvsV.GALE_APL_WITH_FLT3_MUTATED_DN"
50,"Down",0.00356021352972753,0.0335373647472988,"L.LvsV.LOPEZ_TRANSLATION_VIA_FN1_SIGNALING"
58,"Up",0.00356057751974397,0.0335373647472988,"L.LvsV.ISHIDA_E2F_TARGETS"
1388,"Down",0.0035700474777398,0.0335693750075227,"L.LvsV.REACTOME_DEVELOPMENTAL_BIOLOGY"
15,"Up",0.00360478815898572,0.0338384952988659,"L.LvsV.REACTOME_VLDLR_INTERNALISATION_AND_DEGRADATION"
67,"Down",0.00363877121415632,0.034099603462831,"L.LvsV.REACTOME_SIGNALING_BY_FGFR1"
154,"Down",0.00366671258098766,0.0342471413729858,"L.LvsV.REN_ALVEOLAR_RHABDOMYOSARCOMA_UP"
18,"Down",0.00366690318191492,0.0342471413729858,"L.LvsV.REACTOME_SIGNALING_BY_NOTCH1_HD_DOMAIN_MUTANTS_IN_CANCER"
180,"Down",0.00367482131950592,0.0342609277793901,"L.LvsV.LIM_MAMMARY_LUMINAL_MATURE_UP"
28,"Up",0.00368077249067783,0.0342609277793901,"L.LvsV.REACTOME_MITOCHONDRIAL_CALCIUM_ION_TRANSPORT"
160,"Up",0.00370124508970881,0.034350476405911,"L.LvsV.CUI_GLUCOSE_DEPRIVATION"
65,"Down",0.0037028185816464,0.034350476405911,"L.LvsV.ABE_INNER_EAR"
151,"Down",0.00371084755949643,0.034367296744482,"L.LvsV.COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP"
99,"Up",0.00372979562980676,0.034485016784618,"L.LvsV.REACTOME_TRANS_GOLGI_NETWORK_VESICLE_BUDDING"
8,"Down",0.00374480042245326,0.0345659458025777,"L.LvsV.REACTOME_RUNX3_REGULATES_BCL2L11_BIM_TRANSCRIPTION"
89,"Up",0.00376999575707492,0.0347405109014454,"L.LvsV.REACTOME_DEPOSITION_OF_NEW_CENPA_CONTAINING_NUCLEOSOMES_AT_THE_CENTROMERE"
26,"Up",0.00378948379345722,0.0348619898403078,"L.LvsV.ZHENG_RESPONSE_TO_ARSENITE_UP"
154,"Down",0.0037991918160755,0.0348723765680025,"L.LvsV.RADMACHER_AML_PROGNOSIS"
200,"Up",0.00380322717860472,0.0348723765680025,"L.LvsV.ODONNELL_TFRC_TARGETS_DN"
52,"Down",0.00381763230483049,0.0348904528651158,"L.LvsV.HUMMERICH_BENIGN_SKIN_TUMOR_DN"
49,"Up",0.00381883755482119,0.0348904528651158,"L.LvsV.KEGG_LYSINE_DEGRADATION"
20,"Down",0.0038241299396383,0.0348904528651158,"L.LvsV.BIOCARTA_CBL_PATHWAY"
59,"Down",0.00385403930008738,0.0350477201627513,"L.LvsV.WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2"
11,"Down",0.00385798315103648,0.0350477201627513,"L.LvsV.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_LIGHTGREEN_DN"
103,"Up",0.00386038371841482,0.0350477201627513,"L.LvsV.PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_UP"
51,"Up",0.00388640643698239,0.0352261330984846,"L.LvsV.GROSS_ELK3_TARGETS_DN"
49,"Down",0.00390363985138287,0.0352321700769668,"L.LvsV.PID_WNT_NONCANONICAL_PATHWAY"
46,"Down",0.00390471076790413,0.0352321700769668,"L.LvsV.REACTOME_TRANSCRIPTIONAL_REGULATION_BY_THE_AP_2_TFAP2_FAMILY_OF_TRANSCRIPTION_FACTORS"
51,"Down",0.00390618923081582,0.0352321700769668,"L.LvsV.PID_ERBB1_RECEPTOR_PROXIMAL_PATHWAY"
19,"Down",0.003930577250955,0.0353944000334368,"L.LvsV.BIOCARTA_HES_PATHWAY"
6,"Down",0.00396594242228176,0.0356547896793429,"L.LvsV.REACTOME_LRR_FLII_INTERACTING_PROTEIN_1_LRRFIP1_ACTIVATES_TYPE_I_IFN_PRODUCTION"
100,"Down",0.00397649633779489,0.0356916367721882,"L.LvsV.REACTOME_G_ALPHA_12_13_SIGNALLING_EVENTS"
92,"Down",0.00398841362519229,0.0357405817401753,"L.LvsV.PID_NOTCH_PATHWAY"
15,"Down",0.00403812190271134,0.0361274692558107,"L.LvsV.KOMMAGANI_TP63_GAMMA_TARGETS"
13,"Up",0.00404771891282468,0.0361548269289299,"L.LvsV.REACTOME_LINOLEIC_ACID_LA_METABOLISM"
107,"Down",0.00405595259728802,0.0361699385651701,"L.LvsV.REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS"
21,"Down",0.00407981754710899,0.0363241726537288,"L.LvsV.KUROKAWA_LIVER_CANCER_EARLY_RECURRENCE_UP"
64,"Down",0.00410449016611395,0.0364756209643001,"L.LvsV.BIOCARTA_KERATINOCYTE_PATHWAY"
53,"Up",0.0041100220402892,0.0364756209643001,"L.LvsV.BIOCARTA_CTL_PATHWAY"
345,"Down",0.00414116143834397,0.0366930794753266,"L.LvsV.IVANOVA_HEMATOPOIESIS_STEM_CELL"
39,"Up",0.0041537588959252,0.0367458126969127,"L.LvsV.DACOSTA_LOW_DOSE_UV_RESPONSE_VIA_ERCC3_XPCS_UP"
47,"Up",0.0041642537787752,0.036779806937457,"L.LvsV.WHITFIELD_CELL_CYCLE_LITERATURE"
27,"Down",0.00417990509858746,0.0368419062864884,"L.LvsV.REACTOME_TGF_BETA_RECEPTOR_SIGNALING_IN_EMT_EPITHELIAL_TO_MESENCHYMAL_TRANSITION"
106,"Down",0.00418461152973679,0.0368419062864884,"L.LvsV.KEGG_GAP_JUNCTION"
16,"Down",0.00419655319433538,0.0368448135305101,"L.LvsV.BIOCARTA_CDC42RAC_PATHWAY"
130,"Up",0.00419826958296642,0.0368448135305101,"L.LvsV.REACTOME_PROTEIN_UBIQUITINATION"
86,"Up",0.00423421098203865,0.037101351061318,"L.LvsV.REACTOME_PEROXISOMAL_PROTEIN_IMPORT"
119,"Down",0.00430169307244971,0.0376330079075545,"L.LvsV.WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_DN"
256,"Down",0.00431489914919056,0.0376889058386645,"L.LvsV.MEISSNER_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3"
16,"Down",0.00435998158855301,0.038022615462318,"L.LvsV.REACTOME_SUMOYLATION_OF_DNA_METHYLATION_PROTEINS"
61,"Down",0.00436916735496622,0.0380427185915091,"L.LvsV.GENTILE_RESPONSE_CLUSTER_D3"
452,"Down",0.00443259312080712,0.0384287996429016,"L.LvsV.REACTOME_DISEASES_OF_SIGNAL_TRANSDUCTION_BY_GROWTH_FACTOR_RECEPTORS_AND_SECOND_MESSENGERS"
640,"Up",0.00443793063232096,0.0384287996429016,"L.LvsV.STEIN_ESRRA_TARGETS_UP"
90,"Down",0.00444036933117772,0.0384287996429016,"L.LvsV.PID_LYSOPHOSPHOLIPID_PATHWAY"
41,"Down",0.00444130999671082,0.0384287996429016,"L.LvsV.LU_TUMOR_ANGIOGENESIS_UP"
38,"Up",0.00445949638224262,0.0385258679647179,"L.LvsV.REACTOME_PEROXISOMAL_LIPID_METABOLISM"
68,"Up",0.0044911602650611,0.0387388847200044,"L.LvsV.PID_FANCONI_PATHWAY"
69,"Up",0.00450869196364368,0.0388066082665327,"L.LvsV.REACTOME_HDR_THROUGH_HOMOLOGOUS_RECOMBINATION_HRR"
47,"Up",0.00451304921602107,0.0388066082665327,"L.LvsV.DAZARD_UV_RESPONSE_CLUSTER_G5"
17,"Down",0.00452068335713911,0.0388118917416493,"L.LvsV.PID_ERBB_NETWORK_PATHWAY"
117,"Down",0.00455095963777908,0.0389403357770747,"L.LvsV.HANN_RESISTANCE_TO_BCL2_INHIBITOR_UP"
63,"Down",0.00455978374743905,0.0389403357770747,"L.LvsV.REACTOME_EPHB_MEDIATED_FORWARD_SIGNALING"
59,"Down",0.00456413722212268,0.0389403357770747,"L.LvsV.PID_IL8_CXCR2_PATHWAY"
69,"Down",0.00456879725493939,0.0389403357770747,"L.LvsV.REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR"
26,"Down",0.00457085873020826,0.0389403357770747,"L.LvsV.LOPEZ_MESOTHELIOMA_SURVIVAL_WORST_VS_BEST_UP"
113,"Down",0.00458370367828474,0.0389896886726713,"L.LvsV.BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_UP"
30,"Down",0.00460217000346679,0.0390866327944207,"L.LvsV.REACTOME_OTHER_INTERLEUKIN_SIGNALING"
42,"Down",0.00463487611837982,0.039304033832089,"L.LvsV.REACTOME_SIGNALING_BY_WNT_IN_CANCER"
23,"Down",0.00465947110434686,0.0394481900711248,"L.LvsV.PID_SYNDECAN_3_PATHWAY"
125,"Down",0.0046675596239496,0.0394481900711248,"L.LvsV.ZHENG_GLIOBLASTOMA_PLASTICITY_DN"
143,"Down",0.00467327988724665,0.0394481900711248,"L.LvsV.SASSON_RESPONSE_TO_FORSKOLIN_DN"
94,"Up",0.00468800994256658,0.0394790103573492,"L.LvsV.REACTOME_TP53_REGULATES_METABOLIC_GENES"
720,"Down",0.00469604283288008,0.0394790103573492,"L.LvsV.SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN"
42,"Down",0.00469835210980933,0.0394790103573492,"L.LvsV.REACTOME_ACTIVATED_NOTCH1_TRANSMITS_SIGNAL_TO_THE_NUCLEUS"
12,"Down",0.00471167667419597,0.0394931157493273,"L.LvsV.ZERBINI_RESPONSE_TO_SULINDAC_UP"
7,"Down",0.00471431658429301,0.0394931157493273,"L.LvsV.CALVET_IRINOTECAN_SENSITIVE_VS_REVERTED_DN"
24,"Down",0.00472798692311809,0.0395411425151386,"L.LvsV.WHITESIDE_CISPLATIN_RESISTANCE_DN"
32,"Down",0.00473435274824051,0.0395411425151386,"L.LvsV.REACTOME_SEMA3A_PAK_DEPENDENT_AXON_REPULSION"
13,"Down",0.00476485622889078,0.0397358824879896,"L.LvsV.MCCOLLUM_GELDANAMYCIN_RESISTANCE_DN"
58,"Down",0.00483748728138126,0.040280824064393,"L.LvsV.PARK_HSC_MARKERS"
153,"Down",0.00484691816835852,0.0402986624854951,"L.LvsV.DE_YY1_TARGETS_DN"
32,"Down",0.00487169118322179,0.0404438146426926,"L.LvsV.HANSON_HRAS_SIGNALING_VIA_NFKB"
740,"Down",0.004883261519533,0.0404790898673132,"L.LvsV.DELYS_THYROID_CANCER_UP"
20,"Down",0.00491706912178944,0.0406937216872424,"L.LvsV.ONGUSAHA_BRCA1_TARGETS_DN"
29,"Down",0.00492387408369781,0.0406937216872424,"L.LvsV.REACTOME_PI_3K_CASCADE_FGFR2"
105,"Down",0.00497358384639694,0.0409844026981608,"L.LvsV.LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_DN"
16,"Down",0.00497387126251871,0.0409844026981608,"L.LvsV.REACTOME_EGFR_TRANSACTIVATION_BY_GASTRIN"
22,"Up",0.00499374958302447,0.0410869664353308,"L.LvsV.BAUS_TFF2_TARGETS_DN"
455,"Down",0.00500880243185436,0.0411495819401527,"L.LvsV.SENESE_HDAC1_TARGETS_DN"
31,"Down",0.00503570892593612,0.0413092502247787,"L.LvsV.GHANDHI_BYSTANDER_IRRADIATION_DN"
33,"Down",0.00504453581482334,0.0413203533631974,"L.LvsV.GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_UP"
30,"Down",0.0050550260049669,0.0413450277832278,"L.LvsV.REACTOME_ESTROGEN_DEPENDENT_NUCLEAR_EVENTS_DOWNSTREAM_OF_ESR_MEMBRANE_SIGNALING"
154,"Down",0.00506962291570751,0.0414031685390647,"L.LvsV.SASSON_RESPONSE_TO_GONADOTROPHINS_DN"
49,"Down",0.00513065196517406,0.0418122964004952,"L.LvsV.PID_IL2_PI3K_PATHWAY"
19,"Down",0.00513484341760467,0.0418122964004952,"L.LvsV.REACTOME_INLB_MEDIATED_ENTRY_OF_LISTERIA_MONOCYTOGENES_INTO_HOST_CELL"
26,"Down",0.00514251236349303,0.0418131630261073,"L.LvsV.MATZUK_EMBRYONIC_GERM_CELL"
153,"Down",0.00517525433220742,0.041973960885306,"L.LvsV.HUANG_DASATINIB_RESISTANCE_UP"
93,"Up",0.00517939102258937,0.041973960885306,"L.LvsV.REACTOME_ERCC6_CSB_AND_EHMT2_G9A_POSITIVELY_REGULATE_RRNA_EXPRESSION"
675,"Up",0.00519688424925419,0.041973960885306,"L.LvsV.STARK_PREFRONTAL_CORTEX_22Q11_DELETION_DN"
89,"Up",0.00519945666090389,0.041973960885306,"L.LvsV.ZHAN_V2_LATE_DIFFERENTIATION_GENES"
117,"Down",0.00520024655569445,0.041973960885306,"L.LvsV.KEGG_DILATED_CARDIOMYOPATHY"
64,"Down",0.00522263533219093,0.0420932226700928,"L.LvsV.SCHOEN_NFKB_SIGNALING"
23,"Down",0.00524400248794572,0.0422039152195806,"L.LvsV.REACTOME_GAB1_SIGNALOSOME"
59,"Down",0.00525741936599253,0.0422503948758324,"L.LvsV.REACTOME_HSF1_ACTIVATION"
23,"Down",0.00531361310041395,0.0425841025654738,"L.LvsV.REACTOME_SPRY_REGULATION_OF_FGF_SIGNALING"
9,"Down",0.00531434812265815,0.0425841025654738,"L.LvsV.REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_BCR_SIGNALING"
32,"Down",0.00538659640700765,0.0430536371244764,"L.LvsV.WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_UP"
18,"Down",0.0053886069008178,0.0430536371244764,"L.LvsV.REACTOME_SHC1_EVENTS_IN_ERBB4_SIGNALING"
79,"Up",0.00539630503296476,0.0430536371244764,"L.LvsV.HOLLERN_MICROACINAR_BREAST_TUMOR_UP"
15,"Down",0.00549914516806957,0.0438109130176609,"L.LvsV.REACTOME_RHO_GTPASES_ACTIVATE_KTN1"
85,"Up",0.00550887341526716,0.0438252677885067,"L.LvsV.ELVIDGE_HIF1A_TARGETS_UP"
117,"Down",0.00554957101630528,0.0440856007890114,"L.LvsV.REACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING"
8,"Up",0.00555959721278923,0.0441018837726136,"L.LvsV.REACTOME_SYNTHESIS_OF_UDP_N_ACETYL_GLUCOSAMINE"
92,"Down",0.00559901046094946,0.0443509009148848,"L.LvsV.MALONEY_RESPONSE_TO_17AAG_UP"
40,"Down",0.0056120693263778,0.0443907457876149,"L.LvsV.REACTOME_MAPK_TARGETS_NUCLEAR_EVENTS_MEDIATED_BY_MAP_KINASES"
93,"Up",0.00565517610500149,0.0446285076418347,"L.LvsV.VERNELL_RETINOBLASTOMA_PATHWAY_UP"
24,"Down",0.00565827163265078,0.0446285076418347,"L.LvsV.EHRLICH_ICF_SYNDROM_UP"
318,"Down",0.00568508032484639,0.0447181513101267,"L.LvsV.REACTOME_FLT3_SIGNALING"
51,"Down",0.00568581305317762,0.0447181513101267,"L.LvsV.REACTOME_SIGNALING_BY_FGFR3"
28,"Down",0.0058291072499919,0.0457772841083562,"L.LvsV.BIOCARTA_TID_PATHWAY"
10,"Down",0.00583738802371748,0.0457772841083562,"L.LvsV.BIOCARTA_MITR_PATHWAY"
74,"Down",0.0058453178839753,0.0457772841083562,"L.LvsV.RASHI_RESPONSE_TO_IONIZING_RADIATION_3"
109,"Down",0.00587291189178182,0.0459283307633122,"L.LvsV.KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM"
42,"Down",0.00589774817739474,0.0460574147921123,"L.LvsV.PID_S1P_S1P1_PATHWAY"
105,"Up",0.00591444915617797,0.046122693067007,"L.LvsV.REACTOME_TELOMERE_MAINTENANCE"
12,"Down",0.00597291392796552,0.0465130156446779,"L.LvsV.REACTOME_FOLDING_OF_ACTIN_BY_CCT_TRIC"
9,"Down",0.00599005927903417,0.0465809251108016,"L.LvsV.IIZUKA_LIVER_CANCER_PROGRESSION_G2_G3_DN"
13,"Down",0.0060202217249328,0.0467220917370741,"L.LvsV.BIOCARTA_MELANOCYTE_PATHWAY"
5,"Up",0.00602511329508661,0.0467220917370741,"L.LvsV.REACTOME_SYNTHESIS_OF_GDP_MANNOSE"
37,"Down",0.00608295064441957,0.0470955267837317,"L.LvsV.REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR2"
465,"Down",0.00609030595955293,0.0470955267837317,"L.LvsV.GRESHOCK_CANCER_COPY_NUMBER_UP"
426,"Down",0.00619680542940457,0.047852146954159,"L.LvsV.GENTILE_UV_HIGH_DOSE_DN"
42,"Down",0.00621630774457277,0.047935795703965,"L.LvsV.JI_METASTASIS_REPRESSED_BY_STK11"
16,"Down",0.00625277319290549,0.048149837024477,"L.LvsV.REACTOME_FGFR2C_LIGAND_BINDING_AND_ACTIVATION"
27,"Down",0.00628138026782636,0.0483028532695577,"L.LvsV.REACTOME_ERK_MAPK_TARGETS"
79,"Down",0.00629878375081067,0.0483281141079165,"L.LvsV.HOLLERN_SOLID_NODULAR_BREAST_TUMOR_DN"
103,"Down",0.00630214691116075,0.0483281141079165,"L.LvsV.SAMOLS_TARGETS_OF_KHSV_MIRNAS_DN"
38,"Up",0.00633433136605919,0.0485076428295586,"L.LvsV.REACTOME_ACTIVATION_OF_ATR_IN_RESPONSE_TO_REPLICATION_STRESS"
701,"Down",0.00642779723984553,0.0491081922315353,"L.LvsV.SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN"
16,"Down",0.00643051748519291,0.0491081922315353,"L.LvsV.RADAEVA_RESPONSE_TO_IFNA1_DN"
117,"Up",0.00647200548153311,0.0493568528377884,"L.LvsV.ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR"
50,"Down",0.00651893700959199,0.0496462847466034,"L.LvsV.RIZ_ERYTHROID_DIFFERENTIATION_APOBEC2"
69,"Up",0.00653960227666399,0.0497351595428819,"L.LvsV.KANG_DOXORUBICIN_RESISTANCE_UP"
27,"Down",0.00657249456133392,0.0499166516890319,"L.LvsV.REACTOME_NEGATIVE_REGULATION_OF_MET_ACTIVITY"
18,"Down",0.00658390345062072,0.0499235174554556,"L.LvsV.REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_LATE_STAGE_BRANCHING_MORPHOGENESIS_PANCREATIC_BUD_PRECURSOR_CELLS"
35,"Down",0.00659145735982684,0.0499235174554556,"L.LvsV.KANNAN_TP53_TARGETS_DN"
1160,"Down",0.0066508800726533,0.050251834220981,"L.LvsV.WONG_ADULT_TISSUE_STEM_MODULE"
21,"Up",0.00665298293538761,0.050251834220981,"L.LvsV.REACTOME_PCNA_DEPENDENT_LONG_PATCH_BASE_EXCISION_REPAIR"
36,"Down",0.00668295801893611,0.0503719164629736,"L.LvsV.REACTOME_FGFR2_ALTERNATIVE_SPLICING"
53,"Down",0.00668710195041104,0.0503719164629736,"L.LvsV.REACTOME_MAP2K_AND_MAPK_ACTIVATION"
48,"Down",0.00671143447195459,0.0504864233951523,"L.LvsV.CHIBA_RESPONSE_TO_TSA_DN"
67,"Down",0.00672816518090212,0.0505435126157715,"L.LvsV.PID_ECADHERIN_NASCENT_AJ_PATHWAY"
157,"Down",0.00674982599344226,0.0506374327242093,"L.LvsV.WILCOX_RESPONSE_TO_PROGESTERONE_DN"
385,"Down",0.00682038987201183,0.051097473715926,"L.LvsV.COLDREN_GEFITINIB_RESISTANCE_DN"
13,"Down",0.00683654343560532,0.0511491862726141,"L.LvsV.REACTOME_EGFR_INTERACTS_WITH_PHOSPHOLIPASE_C_GAMMA"
127,"Down",0.00684938262147034,0.0511759952893371,"L.LvsV.BURTON_ADIPOGENESIS_9"
10,"Up",0.00687635529995263,0.0513081895458004,"L.LvsV.REACTOME_BETA_OXIDATION_OF_PRISTANOYL_COA"
95,"Down",0.00690395759148891,0.0514447190341539,"L.LvsV.RAMASWAMY_METASTASIS_DN"
162,"Down",0.00694556647780927,0.0516280805061615,"L.LvsV.HOSHIDA_LIVER_CANCER_SURVIVAL_UP"
32,"Down",0.00695160793958651,0.0516280805061615,"L.LvsV.TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_TOP20_DN"
337,"Down",0.00695963947051765,0.0516280805061615,"L.LvsV.HOLLERN_SQUAMOUS_BREAST_TUMOR"
15,"Down",0.00696591572754503,0.0516280805061615,"L.LvsV.NEBEN_AML_WITH_FLT3_OR_NRAS_UP"
7,"Up",0.00699648539294545,0.0517852312417609,"L.LvsV.REACTOME_WAX_AND_PLASMALOGEN_BIOSYNTHESIS"
181,"Down",0.00702732317874375,0.0519421541604922,"L.LvsV.MCLACHLAN_DENTAL_CARIES_DN"
500,"Down",0.00707819349502602,0.0519421541604922,"L.LvsV.TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_DN"
95,"Down",0.00708010859260384,0.0519421541604922,"L.LvsV.REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_CELL_DEATH_GENES"
116,"Down",0.00708410089809676,0.0519421541604922,"L.LvsV.DAZARD_UV_RESPONSE_CLUSTER_G1"
65,"Up",0.00709580026214519,0.0519421541604922,"L.LvsV.REACTOME_DEFECTIVE_CFTR_CAUSES_CYSTIC_FIBROSIS"
388,"Down",0.00709629309246024,0.0519421541604922,"L.LvsV.PEREZ_TP53_AND_TP63_TARGETS"
22,"Down",0.00710434029219785,0.0519421541604922,"L.LvsV.REACTOME_YAP1_AND_WWTR1_TAZ_STIMULATED_GENE_EXPRESSION"
94,"Down",0.00710694877488582,0.0519421541604922,"L.LvsV.SESTO_RESPONSE_TO_UV_C2"
72,"Down",0.00711852373122771,0.0519421541604922,"L.LvsV.ALONSO_METASTASIS_EMT_UP"
37,"Down",0.00712093131079912,0.0519421541604922,"L.LvsV.BIOCARTA_ECM_PATHWAY"
567,"Down",0.00713103892372317,0.0519421541604922,"L.LvsV.PHONG_TNF_RESPONSE_NOT_VIA_P38"
28,"Up",0.00713188689707211,0.0519421541604922,"L.LvsV.REACTOME_DISEASES_OF_IMMUNE_SYSTEM"
39,"Up",0.00713981500487865,0.0519421541604922,"L.LvsV.REACTOME_TRIGLYCERIDE_METABOLISM"
58,"Down",0.00715094385462498,0.0519547550226301,"L.LvsV.PID_HDAC_CLASSII_PATHWAY"
90,"Down",0.00716297343763352,0.051973858447081,"L.LvsV.REACTOME_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE"
111,"Down",0.00717547959609335,0.0519963652513764,"L.LvsV.MEISSNER_BRAIN_HCP_WITH_H3K4ME2_AND_H3K27ME3"
18,"Up",0.00719978501423527,0.0521042033294592,"L.LvsV.REACTOME_BETA_OXIDATION_OF_VERY_LONG_CHAIN_FATTY_ACIDS"
449,"Down",0.00724686035771133,0.0523763279971058,"L.LvsV.DOANE_RESPONSE_TO_ANDROGEN_DN"
119,"Down",0.00727782685821179,0.0524895665098569,"L.LvsV.REACTOME_PI3K_AKT_SIGNALING_IN_CANCER"
67,"Down",0.00728151519498286,0.0524895665098569,"L.LvsV.TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN"
57,"Up",0.00730570364224327,0.0525953586431811,"L.LvsV.WANG_TARGETS_OF_MLL_CBP_FUSION_DN"
22,"Down",0.00734367392035655,0.0527999650268548,"L.LvsV.REACTOME_POST_CHAPERONIN_TUBULIN_FOLDING_PATHWAY"
23,"Down",0.00742972970647122,0.0533493188923109,"L.LvsV.BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER"
33,"Down",0.00746036744376268,0.0534998334585783,"L.LvsV.GAZIN_EPIGENETIC_SILENCING_BY_KRAS"
40,"Up",0.00747017305563199,0.0535007601354783,"L.LvsV.REACTOME_ROS_AND_RNS_PRODUCTION_IN_PHAGOCYTES"
58,"Down",0.00756497807507568,0.0541096555977923,"L.LvsV.PID_SYNDECAN_4_PATHWAY"
17,"Down",0.0075935513696615,0.054238367006311,"L.LvsV.TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_MONOCYTE_DN"
18,"Down",0.00760259258996039,0.054238367006311,"L.LvsV.REACTOME_PECAM1_INTERACTIONS"
295,"Down",0.00762872879816057,0.0542935653650678,"L.LvsV.LI_AMPLIFIED_IN_LUNG_CANCER"
69,"Down",0.00763016690900157,0.0542935653650678,"L.LvsV.REACTOME_SIGNALING_BY_PTK6"
134,"Down",0.00763978908555304,0.0542935653650678,"L.LvsV.BASSO_HAIRY_CELL_LEUKEMIA_UP"
638,"Down",0.00767887685223421,0.0545012966829306,"L.LvsV.PEREZ_TP63_TARGETS"
9,"Down",0.0076989221852842,0.0545735137979953,"L.LvsV.REACTOME_UPTAKE_AND_FUNCTION_OF_DIPHTHERIA_TOXIN"
34,"Up",0.00771246156922941,0.054599487856939,"L.LvsV.DEMAGALHAES_AGING_DN"
204,"Up",0.00774396318633774,0.0547523944466258,"L.LvsV.REACTOME_DNA_DOUBLE_STRAND_BREAK_REPAIR"
166,"Down",0.00775824202054165,0.0547832951871964,"L.LvsV.LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_UP"
752,"Up",0.00777246562534335,0.0548137276052594,"L.LvsV.REACTOME_MEMBRANE_TRAFFICKING"
35,"Down",0.00780171341461085,0.0549499025087687,"L.LvsV.TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_GRANULOCYTE_UP"
15,"Up",0.00785867797490092,0.0552807004112305,"L.LvsV.REACTOME_HEME_BIOSYNTHESIS"
43,"Down",0.00790470710797995,0.055495373441769,"L.LvsV.BIOCARTA_AT1R_PATHWAY"
292,"Down",0.00790927007996273,0.055495373441769,"L.LvsV.LEE_LIVER_CANCER_SURVIVAL_DN"
185,"Up",0.0079357742630318,0.0556107679344776,"L.LvsV.WHITEFORD_PEDIATRIC_CANCER_MARKERS"
92,"Up",0.00795304690746472,0.0556612612042689,"L.LvsV.KEGG_PPAR_SIGNALING_PATHWAY"
62,"Down",0.00796621125492,0.0556829102761728,"L.LvsV.VALK_AML_CLUSTER_6"
829,"Down",0.00799569964445843,0.0558184638058215,"L.LvsV.LIU_PROSTATE_CANCER_DN"
735,"Down",0.0080081833656613,0.0558351145381354,"L.LvsV.BAELDE_DIABETIC_NEPHROPATHY_DN"
104,"Down",0.0080515433818347,0.0560667296702318,"L.LvsV.REACTOME_SIGNALING_BY_MET"
335,"Down",0.0081223046483233,0.056488330063622,"L.LvsV.WANG_CISPLATIN_RESPONSE_AND_XPC_DN"
99,"Down",0.00824893577798775,0.0572969421061486,"L.LvsV.BIOCARTA_MAPK_PATHWAY"
88,"Down",0.00831134911464106,0.0576021358906197,"L.LvsV.DORN_ADENOVIRUS_INFECTION_32HR_DN"
56,"Down",0.00831455725125519,0.0576021358906197,"L.LvsV.MURAKAMI_UV_RESPONSE_6HR_UP"
40,"Down",0.00832412851810547,0.0576021358906197,"L.LvsV.RIZ_ERYTHROID_DIFFERENTIATION_HEMGN"
72,"Down",0.00836664871715095,0.0578084305650921,"L.LvsV.NICK_RESPONSE_TO_PROC_TREATMENT_DN"
39,"Down",0.00837485130812783,0.0578084305650921,"L.LvsV.VERRECCHIA_RESPONSE_TO_TGFB1_C1"
800,"Up",0.00842606991188307,0.0580894520483809,"L.LvsV.MARSON_BOUND_BY_E2F4_UNSTIMULATED"
24,"Down",0.00848838983743194,0.0584462109728035,"L.LvsV.JI_CARCINOGENESIS_BY_KRAS_AND_STK11_UP"
89,"Down",0.00854549433822645,0.0587662166617588,"L.LvsV.ROY_WOUND_BLOOD_VESSEL_UP"
64,"Down",0.00856602952322971,0.0588342574334622,"L.LvsV.TIEN_INTESTINE_PROBIOTICS_2HR_UP"
68,"Down",0.00857798849575047,0.0588432982543478,"L.LvsV.PID_FRA_PATHWAY"
48,"Down",0.00862653339212501,0.0591029778501353,"L.LvsV.REACTOME_NEGATIVE_REGULATION_OF_FGFR1_SIGNALING"
11,"Up",0.00865436989792399,0.0592203108485417,"L.LvsV.BIOCARTA_TCAPOPTOSIS_PATHWAY"
112,"Down",0.00867875246603919,0.0593137483123989,"L.LvsV.WIEDERSCHAIN_TARGETS_OF_BMI1_AND_PCGF2"
23,"Down",0.00870103624937133,0.059392628917005,"L.LvsV.REACTOME_SIGNALLING_TO_RAS"
30,"Down",0.00871755525232427,0.0594320135512958,"L.LvsV.BIOCARTA_CARDIACEGF_PATHWAY"
137,"Down",0.00876395899429622,0.0596747897530343,"L.LvsV.BECKER_TAMOXIFEN_RESISTANCE_DN"
89,"Down",0.00882898847996962,0.0600436375224502,"L.LvsV.REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION_TERMINATION"
27,"Down",0.00887621902876161,0.0602811276543293,"L.LvsV.PID_INTEGRIN5_PATHWAY"
78,"Up",0.00888571514528457,0.0602811276543293,"L.LvsV.SONG_TARGETS_OF_IE86_CMV_PROTEIN"
27,"Down",0.00892075767681054,0.0604446926410361,"L.LvsV.CHEMELLO_SOLEUS_VS_EDL_MYOFIBERS_UP"
223,"Up",0.00893593284722588,0.0604734060126217,"L.LvsV.WILCOX_RESPONSE_TO_PROGESTERONE_UP"
413,"Down",0.00896156506072684,0.0605144160826291,"L.LvsV.KEGG_PATHWAYS_IN_CANCER"
16,"Down",0.00896388257762222,0.0605144160826291,"L.LvsV.BIOCARTA_CARM1_PATHWAY"
14,"Down",0.00904249654440352,0.0609706870658622,"L.LvsV.REACTOME_INLA_MEDIATED_ENTRY_OF_LISTERIA_MONOCYTOGENES_INTO_HOST_CELLS"
381,"Down",0.00909491852889675,0.0612273864111827,"L.LvsV.MCBRYAN_PUBERTAL_BREAST_3_4WK_UP"
50,"Down",0.00910271507144007,0.0612273864111827,"L.LvsV.LOPEZ_MESOTHELIOMA_SURVIVAL_OVERALL_DN"
19,"Down",0.00912654957391081,0.0613131137231505,"L.LvsV.BIOCARTA_SHH_PATHWAY"
36,"Down",0.00920735986432761,0.0617677714980312,"L.LvsV.PID_MYC_PATHWAY"
23,"Down",0.00921656926856136,0.0617677714980312,"L.LvsV.REACTOME_CTLA4_INHIBITORY_SIGNALING"
265,"Down",0.00923161215668272,0.0617936847630735,"L.LvsV.TSAI_RESPONSE_TO_IONIZING_RADIATION"
127,"Down",0.00927244794569006,0.0619875751088847,"L.LvsV.CARD_MIR302A_TARGETS"
17,"Down",0.00928300093871523,0.0619875751088847,"L.LvsV.REACTOME_DISSOLUTION_OF_FIBRIN_CLOT"
15,"Down",0.00932671285958183,0.0621601514014701,"L.LvsV.STANHILL_HRAS_TRANSFROMATION_UP"
10,"Up",0.00933133037858929,0.0621601514014701,"L.LvsV.BIOCARTA_VOBESITY_PATHWAY"
9,"Up",0.00944899048285586,0.062868192996041,"L.LvsV.REACTOME_TRIF_MEDIATED_PROGRAMMED_CELL_DEATH"
81,"Down",0.00952153406918835,0.0632747137843058,"L.LvsV.TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP"
244,"Down",0.00955854685055067,0.0634444244137991,"L.LvsV.FIRESTEIN_PROLIFERATION"
55,"Down",0.00958301121520999,0.0635305383799713,"L.LvsV.AMIT_EGF_RESPONSE_60_MCF10A"
86,"Down",0.00962405890664237,0.0637262535267373,"L.LvsV.DIRMEIER_LMP1_RESPONSE_LATE_UP"
26,"Up",0.00973054243961744,0.0643542693165608,"L.LvsV.SCIAN_CELL_CYCLE_TARGETS_OF_TP53_AND_TP73_DN"
330,"Down",0.0097520387220943,0.064371433222257,"L.LvsV.SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4"
34,"Up",0.00975642268769242,0.064371433222257,"L.LvsV.FUJIWARA_PARK2_HEPATOCYTE_PROLIFERATION_UP"
181,"Down",0.009784252881445,0.0644746215247619,"L.LvsV.MUNSHI_MULTIPLE_MYELOMA_UP"
39,"Down",0.00980775630099938,0.0644746215247619,"L.LvsV.PID_INTEGRIN2_PATHWAY"
1242,"Down",0.00980786808660648,0.0644746215247619,"L.LvsV.KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3"
62,"Down",0.00982563595489364,0.0644746215247619,"L.LvsV.REACTOME_DEACTIVATION_OF_THE_BETA_CATENIN_TRANSACTIVATING_COMPLEX"
79,"Down",0.00983036823030825,0.0644746215247619,"L.LvsV.BURTON_ADIPOGENESIS_PEAK_AT_2HR"
82,"Down",0.0098660145577677,0.064631747025945,"L.LvsV.PID_FGF_PATHWAY"
242,"Up",0.00990913515747101,0.0648374062552156,"L.LvsV.REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS"
101,"Down",0.00994654739627988,0.0650052725224958,"L.LvsV.REACTOME_ONCOGENIC_MAPK_SIGNALING"
167,"Down",0.0100048992281786,0.0653094307350644,"L.LvsV.HILLION_HMGA1B_TARGETS"
8,"Down",0.0100206724722366,0.0653352571922126,"L.LvsV.TURJANSKI_MAPK7_TARGETS"
109,"Up",0.010042475132468,0.0654002885835286,"L.LvsV.REACTOME_MITOCHONDRIAL_BIOGENESIS"
360,"Down",0.0100940814654802,0.0656462817399429,"L.LvsV.RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN"
292,"Up",0.0101039945307816,0.0656462817399429,"L.LvsV.GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP"
76,"Down",0.0101395238971772,0.0657997976848509,"L.LvsV.BIOCARTA_HIVNEF_PATHWAY"
33,"Down",0.0101685131502065,0.0658768902171307,"L.LvsV.PIEPOLI_LGI1_TARGETS_UP"
34,"Down",0.0101752331787719,0.0658768902171307,"L.LvsV.ZHU_SKIL_TARGETS_UP"
75,"Down",0.0102142943013591,0.0660524364821219,"L.LvsV.NUTT_GBM_VS_AO_GLIOMA_DN"
646,"Down",0.0102491044276082,0.0662001149301935,"L.LvsV.MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP"
22,"Up",0.0103193163988848,0.0665758464054072,"L.LvsV.LANDIS_ERBB2_BREAST_PRENEOPLASTIC_UP"
225,"Down",0.0103336536147384,0.0665906419998699,"L.LvsV.HOOI_ST7_TARGETS_DN"
116,"Down",0.0104314640767548,0.0671426832134774,"L.LvsV.KEGG_GNRH_SIGNALING_PATHWAY"
301,"Down",0.0104660923720328,0.0672872380522897,"L.LvsV.KIM_WT1_TARGETS_12HR_DN"
109,"Down",0.0105307826369006,0.067624503135219,"L.LvsV.KEGG_MELANOGENESIS"
82,"Down",0.0105512456257964,0.0676773051798473,"L.LvsV.PID_SHP2_PATHWAY"
24,"Down",0.010606168190476,0.0679507577348109,"L.LvsV.REACTOME_NOTCH2_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION"
13,"Up",0.0106810771538539,0.0683514763699748,"L.LvsV.REACTOME_GLUTATHIONE_SYNTHESIS_AND_RECYCLING"
66,"Down",0.0107200213379281,0.0685213849449761,"L.LvsV.REACTOME_SIGNALING_BY_MODERATE_KINASE_ACTIVITY_BRAF_MUTANTS"
25,"Down",0.0107376371147449,0.0685547293388277,"L.LvsV.REACTOME_TYPE_I_HEMIDESMOSOME_ASSEMBLY"
19,"Down",0.010852370889721,0.0692073340822003,"L.LvsV.LU_TUMOR_VASCULATURE_DN"
25,"Down",0.0108937477234256,0.0693911649341243,"L.LvsV.YIH_RESPONSE_TO_ARSENITE_C4"
135,"Up",0.0109193468462231,0.0694741872413897,"L.LvsV.REACTOME_DNA_REPLICATION"
12,"Down",0.0109408985351393,0.0695312965526268,"L.LvsV.REACTOME_ACTIVATION_OF_RAC1_DOWNSTREAM_OF_NMDARS"
65,"Down",0.0109998814753308,0.0697907346074742,"L.LvsV.AMIT_EGF_RESPONSE_120_MCF10A"
93,"Down",0.011007032067501,0.0697907346074742,"L.LvsV.ULE_SPLICING_VIA_NOVA2"
21,"Down",0.0110195896748643,0.0697907346074742,"L.LvsV.AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_DN"
12,"Up",0.0110405970535316,0.0698437770125587,"L.LvsV.REACTOME_CONDENSATION_OF_PROMETAPHASE_CHROMOSOMES"
201,"Down",0.0110539792226032,0.0698485155677404,"L.LvsV.CHENG_IMPRINTED_BY_ESTRADIOL"
23,"Down",0.0110836623829552,0.069956129355433,"L.LvsV.REACTOME_RAF_INDEPENDENT_MAPK1_3_ACTIVATION"
140,"Down",0.0111905628393825,0.0705503100786154,"L.LvsV.HOEBEKE_LYMPHOID_STEM_CELL_DN"
41,"Down",0.0112134796005945,0.0706121566006734,"L.LvsV.HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_DN"
115,"Down",0.0112259152924565,0.0706121566006734,"L.LvsV.REACTOME_PROTEIN_FOLDING"
405,"Down",0.0112915198224268,0.0709441057934064,"L.LvsV.WANG_CLIM2_TARGETS_UP"
260,"Down",0.0113441417262138,0.0711055299804321,"L.LvsV.SCHLOSSER_SERUM_RESPONSE_UP"
59,"Down",0.011366257871224,0.0711055299804321,"L.LvsV.REACTOME_MRNA_SPLICING_MINOR_PATHWAY"
298,"Down",0.0113675154084722,0.0711055299804321,"L.LvsV.VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP"
10,"Down",0.0113711526722801,0.0711055299804321,"L.LvsV.BYSTRYKH_HEMATOPOIESIS_STEM_CELL_FGF3"
13,"Up",0.0113842679662608,0.0711055299804321,"L.LvsV.REACTOME_TRIGLYCERIDE_BIOSYNTHESIS"
27,"Down",0.0113943750339416,0.0711055299804321,"L.LvsV.BIOCARTA_PML_PATHWAY"
65,"Down",0.0114808707506268,0.071564525795057,"L.LvsV.NAKAMURA_METASTASIS_MODEL_UP"
73,"Down",0.0115168448733532,0.0716965856078682,"L.LvsV.PID_ANGIOPOIETIN_RECEPTOR_PATHWAY"
87,"Down",0.0115364630591531,0.0716965856078682,"L.LvsV.KEGG_CHRONIC_MYELOID_LEUKEMIA"
815,"Down",0.0115506833169574,0.0716965856078682,"L.LvsV.ONDER_CDH1_TARGETS_2_DN"
89,"Down",0.0115539261668675,0.0716965856078682,"L.LvsV.DORN_ADENOVIRUS_INFECTION_48HR_DN"
47,"Up",0.0115940306919119,0.0718647933806963,"L.LvsV.HOUSTIS_ROS"
73,"Up",0.0116730370998503,0.0722734850224773,"L.LvsV.ELLWOOD_MYC_TARGETS_DN"
30,"Down",0.0116897511615105,0.0722960113780664,"L.LvsV.REACTOME_CONSTITUTIVE_SIGNALING_BY_LIGAND_RESPONSIVE_EGFR_CANCER_VARIANTS"
23,"Down",0.0117583314900262,0.0726388992272118,"L.LvsV.SARTIPY_BLUNTED_BY_INSULIN_RESISTANCE_DN"
48,"Up",0.0118018033258148,0.0728260832460154,"L.LvsV.IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_DN"
52,"Down",0.0118809945637619,0.07312181130126,"L.LvsV.REACTOME_CYCLIN_D_ASSOCIATED_EVENTS_IN_G1"
33,"Down",0.011901429615337,0.07312181130126,"L.LvsV.REACTOME_PURINERGIC_SIGNALING_IN_LEISHMANIASIS_INFECTION"
45,"Down",0.011907500546146,0.07312181130126,"L.LvsV.SAMOLS_TARGETS_OF_KHSV_MIRNAS_UP"
544,"Up",0.0119139591399739,0.07312181130126,"L.LvsV.WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN"
494,"Down",0.0119271150602043,0.07312181130126,"L.LvsV.KAAB_HEART_ATRIUM_VS_VENTRICLE_UP"
28,"Down",0.0119290782770368,0.07312181130126,"L.LvsV.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_23"
42,"Down",0.0119467612045439,0.0731491059799813,"L.LvsV.REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR1"
39,"Down",0.011971109593321,0.0732171072361413,"L.LvsV.FERRANDO_TAL1_NEIGHBORS"
184,"Down",0.0120038653756425,0.0733363222783726,"L.LvsV.YAGI_AML_SURVIVAL"
24,"Down",0.0120619683031139,0.0736099588829105,"L.LvsV.BIOCARTA_ARF_PATHWAY"
17,"Down",0.0120905738647037,0.0737031784982875,"L.LvsV.FIGUEROA_AML_METHYLATION_CLUSTER_5_UP"
504,"Down",0.0121388200036381,0.0739157883261177,"L.LvsV.OISHI_CHOLANGIOMA_STEM_CELL_LIKE_DN"
710,"Down",0.0121652085654304,0.0739949814722382,"L.LvsV.DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN"
206,"Down",0.0122187947159167,0.0741142846607199,"L.LvsV.HOLLERN_EMT_BREAST_TUMOR_DN"
129,"Down",0.0122199064388301,0.0741142846607199,"L.LvsV.HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_DN"
138,"Down",0.0122250366450672,0.0741142846607199,"L.LvsV.BONCI_TARGETS_OF_MIR15A_AND_MIR16_1"
31,"Down",0.0122701553748879,0.07430634070948,"L.LvsV.REACTOME_FRS_MEDIATED_FGFR1_SIGNALING"
33,"Down",0.0122932693980767,0.0743648648818012,"L.LvsV.REACTOME_SIGNALING_BY_ERBB2_IN_CANCER"
26,"Down",0.012316683401348,0.0744250737989654,"L.LvsV.AMIT_DELAYED_EARLY_GENES"
269,"Down",0.0123400946631455,0.0744851347080038,"L.LvsV.LEE_NEURAL_CREST_STEM_CELL_UP"
28,"Down",0.0124873965294355,0.0752110740104957,"L.LvsV.PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_3"
119,"Up",0.0125345784121899,0.0752110740104957,"L.LvsV.REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT"
67,"Down",0.0125350375946966,0.0752110740104957,"L.LvsV.FIRESTEIN_CTNNB1_PATHWAY"
11,"Down",0.0125361088903792,0.0752110740104957,"L.LvsV.REACTOME_BH3_ONLY_PROTEINS_ASSOCIATE_WITH_AND_INACTIVATE_ANTI_APOPTOTIC_BCL_2_MEMBERS"
28,"Down",0.0125702485349486,0.0752110740104957,"L.LvsV.BIOCARTA_EPHA4_PATHWAY"
127,"Up",0.0125904505936815,0.0752110740104957,"L.LvsV.REACTOME_HCMV_LATE_EVENTS"
46,"Up",0.0125919555903558,0.0752110740104957,"L.LvsV.IIZUKA_LIVER_CANCER_PROGRESSION_G2_G3_UP"
24,"Down",0.0125927498390126,0.0752110740104957,"L.LvsV.REACTOME_G_BETA_GAMMA_SIGNALLING_THROUGH_CDC42"
14,"Down",0.0126016103623364,0.0752110740104957,"L.LvsV.REACTOME_ACTIVATED_NTRK2_SIGNALS_THROUGH_FRS2_AND_FRS3"
125,"Down",0.0126099467188161,0.0752110740104957,"L.LvsV.MORI_LARGE_PRE_BII_LYMPHOCYTE_DN"
99,"Down",0.0126099955883034,0.0752110740104957,"L.LvsV.REACTOME_ECM_PROTEOGLYCANS"
33,"Down",0.0129273431848177,0.0769187886835971,"L.LvsV.BIOCARTA_HER2_PATHWAY"
39,"Down",0.0129356619105441,0.0769187886835971,"L.LvsV.REACTOME_SIGNALING_BY_NTRK2_TRKB"
77,"Down",0.0129380491003338,0.0769187886835971,"L.LvsV.DOANE_BREAST_CANCER_ESR1_DN"
54,"Down",0.0129773477243538,0.0770695548527952,"L.LvsV.BIOCARTA_MET_PATHWAY"
40,"Up",0.0129915316092989,0.0770710067251218,"L.LvsV.LY_AGING_MIDDLE_DN"
98,"Up",0.0130067031947845,0.0770783086430476,"L.LvsV.REACTOME_DNA_DAMAGE_TELOMERE_STRESS_INDUCED_SENESCENCE"
19,"Down",0.0130556112233132,0.0772777091626225,"L.LvsV.LIU_CDX2_TARGETS_DN"
26,"Down",0.0130840534297111,0.0772777091626225,"L.LvsV.WIKMAN_ASBESTOS_LUNG_CANCER_UP"
837,"Down",0.0130855597950578,0.0772777091626225,"L.LvsV.GRYDER_PAX3FOXO1_ENHANCERS_KO_DOWN"
51,"Down",0.0130962585432044,0.0772777091626225,"L.LvsV.REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS"
56,"Down",0.0131200925815951,0.0773358122426859,"L.LvsV.WANG_NFKB_TARGETS"
6,"Down",0.0131541592549968,0.0774540431532238,"L.LvsV.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_13"
30,"Up",0.0131773222450431,0.0775078879711099,"L.LvsV.REACTOME_CALNEXIN_CALRETICULIN_CYCLE"
264,"Down",0.0132025637364662,0.0775738309234024,"L.LvsV.POOLA_INVASIVE_BREAST_CANCER_DN"
85,"Down",0.0132347338563574,0.0776803009467092,"L.LvsV.ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN"
208,"Down",0.0132619855456288,0.077757707403798,"L.LvsV.GAL_LEUKEMIC_STEM_CELL_UP"
130,"Down",0.0133035185757833,0.07791859555668,"L.LvsV.PEDERSEN_TARGETS_OF_611CTF_ISOFORM_OF_ERBB2"
31,"Up",0.0134474880083774,0.0786351668776415,"L.LvsV.MOOTHA_GLYCOLYSIS"
12,"Up",0.0134630688900669,0.0786351668776415,"L.LvsV.REACTOME_REGULATION_OF_SIGNALING_BY_NODAL"
384,"Down",0.0134800487018789,0.0786351668776415,"L.LvsV.YAGI_AML_FAB_MARKERS"
70,"Down",0.0134827524326287,0.0786351668776415,"L.LvsV.PETRETTO_CARDIAC_HYPERTROPHY"
370,"Up",0.0135008159411144,0.0786556723994805,"L.LvsV.MANALO_HYPOXIA_DN"
100,"Down",0.0135147203435533,0.0786556723994805,"L.LvsV.CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_DN"
105,"Down",0.0135374911212462,0.0787053505881914,"L.LvsV.HUPER_BREAST_BASAL_VS_LUMINAL_DN"
135,"Up",0.0136578965613725,0.0792509075748933,"L.LvsV.REACTOME_CHROMOSOME_MAINTENANCE"
84,"Down",0.0136599954637137,0.0792509075748933,"L.LvsV.KEGG_MELANOMA"
45,"Up",0.013707156667571,0.0794411626991613,"L.LvsV.REACTOME_MTOR_SIGNALLING"
25,"Down",0.0137235623788761,0.0794438654095166,"L.LvsV.BIOCARTA_IL7_PATHWAY"
185,"Up",0.0137363601612403,0.0794438654095166,"L.LvsV.REACTOME_AMYLOID_FIBER_FORMATION"
205,"Down",0.013862551420644,0.0800064823935451,"L.LvsV.SENESE_HDAC2_TARGETS_DN"
45,"Down",0.0138625809609362,0.0800064823935451,"L.LvsV.BILANGES_RAPAMYCIN_SENSITIVE_GENES"
13,"Down",0.0139083362253863,0.0801450366330264,"L.LvsV.MCBRYAN_TERMINAL_END_BUD_DN"
221,"Up",0.0139155787968358,0.0801450366330264,"L.LvsV.RODWELL_AGING_KIDNEY_NO_BLOOD_DN"
34,"Down",0.0139341185389433,0.0801683053088629,"L.LvsV.REACTOME_DOWNREGULATION_OF_ERBB2_SIGNALING"
48,"Down",0.0139568945787167,0.0802158733115641,"L.LvsV.REACTOME_LATE_ENDOSOMAL_MICROAUTOPHAGY"
34,"Down",0.0139951715044277,0.0803523398213714,"L.LvsV.KAPOSI_LIVER_CANCER_MET_UP"
107,"Down",0.0140251202605433,0.080404709687778,"L.LvsV.REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX"
8,"Down",0.01403337761778,0.080404709687778,"L.LvsV.BIOCARTA_ION_PATHWAY"
25,"Down",0.0140622430825686,0.0804866894446395,"L.LvsV.LEE_LIVER_CANCER_HEPATOBLAST"
92,"Down",0.0140915193697076,0.080570848598876,"L.LvsV.RICKMAN_HEAD_AND_NECK_CANCER_F"
38,"Down",0.0141233162897891,0.080669231163475,"L.LvsV.PID_S1P_S1P3_PATHWAY"
107,"Down",0.0142814677378263,0.0814883747393618,"L.LvsV.PHONG_TNF_TARGETS_UP"
95,"Up",0.0143191837515654,0.0815358436531718,"L.LvsV.BURTON_ADIPOGENESIS_PEAK_AT_24HR"
22,"Down",0.0143192809164822,0.0815358436531718,"L.LvsV.REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE_FGFR2"
460,"Down",0.0143392825103537,0.0815657335388327,"L.LvsV.BOQUEST_STEM_CELL_UP"
175,"Down",0.0143591340705449,0.0815947094306707,"L.LvsV.REACTOME_L1CAM_INTERACTIONS"
45,"Down",0.0144103838545604,0.0818018607103331,"L.LvsV.SARTIPY_NORMAL_AT_INSULIN_RESISTANCE_UP"
196,"Down",0.0144918058732152,0.0821796868441098,"L.LvsV.STEARMAN_LUNG_CANCER_EARLY_VS_LATE_UP"
23,"Up",0.0145302610126174,0.0823133331339772,"L.LvsV.REACTOME_PHOSPHORYLATION_OF_THE_APC_C"
45,"Up",0.0145899815029085,0.0825670498767463,"L.LvsV.REACTOME_ENDOSOMAL_VACUOLAR_PATHWAY"
25,"Up",0.0146771506107092,0.0829754250783345,"L.LvsV.MOOTHA_GLYCOGEN_METABOLISM"
566,"Down",0.0147097005703101,0.0830744989307912,"L.LvsV.SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP"
283,"Down",0.0147910220180236,0.0834485313649518,"L.LvsV.TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP"
43,"Down",0.0149656657202674,0.0843477734631584,"L.LvsV.GENTLES_LEUKEMIC_STEM_CELL_UP"
11,"Up",0.0150343128450441,0.0846483866804979,"L.LvsV.REACTOME_SCAVENGING_BY_CLASS_B_RECEPTORS"
46,"Down",0.0150855637797284,0.0848505413409138,"L.LvsV.MEISSNER_BRAIN_ICP_WITH_H3K4ME3"
20,"Down",0.0151337588762891,0.0850351146615879,"L.LvsV.REACTOME_CD28_DEPENDENT_VAV1_PATHWAY"
64,"Down",0.01517162702275,0.0851613459987665,"L.LvsV.HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_UP"
187,"Up",0.0152593454026556,0.0855668567254389,"L.LvsV.ELVIDGE_HYPOXIA_DN"
35,"Down",0.0154248264459045,0.0862645991538619,"L.LvsV.PID_PDGFRA_PATHWAY"
1555,"Down",0.0154255908833275,0.0862645991538619,"L.LvsV.MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3"
8,"Down",0.0154305821239228,0.0862645991538619,"L.LvsV.BIOCARTA_PLCD_PATHWAY"
206,"Down",0.0154503569389081,0.0862879025406292,"L.LvsV.PECE_MAMMARY_STEM_CELL_UP"
57,"Up",0.0155245492867592,0.0866044370229295,"L.LvsV.WENG_POR_TARGETS_GLOBAL_UP"
156,"Up",0.0155383616434701,0.0866044370229295,"L.LvsV.REACTOME_DISEASES_OF_GLYCOSYLATION"
353,"Down",0.0155717179538704,0.0867029492114295,"L.LvsV.TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP"
129,"Down",0.0156160528940826,0.086842986325069,"L.LvsV.SEKI_INFLAMMATORY_RESPONSE_LPS_UP"
37,"Down",0.0156282820389661,0.086842986325069,"L.LvsV.SHI_SPARC_TARGETS_UP"
417,"Up",0.0157545253449582,0.0874565970203553,"L.LvsV.PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_UP"
8,"Up",0.0158191121352866,0.0877270521524571,"L.LvsV.REACTOME_METAL_SEQUESTRATION_BY_ANTIMICROBIAL_PROTEINS"
116,"Down",0.0158617808427128,0.0878312034165609,"L.LvsV.REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX3"
124,"Down",0.0158696639922489,0.0878312034165609,"L.LvsV.FONTAINE_FOLLICULAR_THYROID_ADENOMA_UP"
52,"Down",0.0160399753748575,0.0886850238475872,"L.LvsV.HUNSBERGER_EXERCISE_REGULATED_GENES"
120,"Down",0.0160714193236592,0.0887701073331787,"L.LvsV.BILD_CTNNB1_ONCOGENIC_SIGNATURE"
67,"Down",0.0161191489157492,0.0889448845860054,"L.LvsV.KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_DN"
33,"Down",0.0161507055942771,0.0890301607485125,"L.LvsV.FIGUEROA_AML_METHYLATION_CLUSTER_4_DN"
76,"Down",0.0162636614830035,0.0894989110083754,"L.LvsV.ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_DN"
12,"Down",0.0162681145891512,0.0894989110083754,"L.LvsV.REACTOME_BIOSYNTHESIS_OF_EPA_DERIVED_SPMS"
25,"Up",0.0164195277227418,0.090242116082544,"L.LvsV.REACTOME_RESOLUTION_OF_AP_SITES_VIA_THE_MULTIPLE_NUCLEOTIDE_PATCH_REPLACEMENT_PATHWAY"
52,"Down",0.0164492715716007,0.0903158118365246,"L.LvsV.PID_BMP_PATHWAY"
27,"Down",0.0165063888801899,0.0905395080541371,"L.LvsV.REACTOME_CD163_MEDIATING_AN_ANTI_INFLAMMATORY_RESPONSE"
6,"Up",0.0166034623011323,0.0909817076937172,"L.LvsV.REACTOME_BETA_OXIDATION_OF_DECANOYL_COA_TO_OCTANOYL_COA_COA"
246,"Down",0.0166288670962613,0.0910306991833946,"L.LvsV.REACTOME_MUSCLE_CONTRACTION"
8,"Up",0.0166549233541016,0.0910831565032914,"L.LvsV.IM_SREBF1A_TARGETS"
8,"Down",0.0167170883700764,0.0912439248288676,"L.LvsV.SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX6_DN"
13,"Down",0.0167173260719195,0.0912439248288676,"L.LvsV.REACTOME_IONOTROPIC_ACTIVITY_OF_KAINATE_RECEPTORS"
1242,"Down",0.0167943621820724,0.0915739926081639,"L.LvsV.BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP"
34,"Down",0.01683647857528,0.0917131921603186,"L.LvsV.MASRI_RESISTANCE_TO_TAMOXIFEN_AND_AROMATASE_INHIBITORS_DN"
313,"Down",0.0168560425135712,0.0917293888361565,"L.LvsV.CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN"
10,"Up",0.0168757768987797,0.0917464803081148,"L.LvsV.REACTOME_THYROXINE_BIOSYNTHESIS"
473,"Down",0.0169203562443913,0.0918984770876618,"L.LvsV.DURAND_STROMA_S_UP"
62,"Down",0.0170617037797659,0.0925752308128808,"L.LvsV.REACTOME_HSF1_DEPENDENT_TRANSACTIVATION"
67,"Down",0.0171134312908355,0.092764864320617,"L.LvsV.PID_EPHB_FWD_PATHWAY"
7,"Down",0.0171721826789515,0.0928683875409879,"L.LvsV.REACTOME_DEX_H_BOX_HELICASES_ACTIVATE_TYPE_I_IFN_AND_INFLAMMATORY_CYTOKINES_PRODUCTION"
13,"Down",0.01718198285723,0.0928683875409879,"L.LvsV.REACTOME_RUNX2_REGULATES_GENES_INVOLVED_IN_CELL_MIGRATION"
269,"Down",0.0171829192357444,0.0928683875409879,"L.LvsV.RIGGI_EWING_SARCOMA_PROGENITOR_DN"
49,"Down",0.0172208141470212,0.092909009628532,"L.LvsV.UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN"
50,"Down",0.0172240432029744,0.092909009628532,"L.LvsV.WU_ALZHEIMER_DISEASE_DN"
31,"Down",0.017396352568684,0.093747011064575,"L.LvsV.DEN_INTERACT_WITH_LCA5"
25,"Down",0.0175117534865192,0.0942770058685149,"L.LvsV.BIOCARTA_ETS_PATHWAY"
80,"Down",0.0176272344171813,0.0948063554003407,"L.LvsV.MODY_HIPPOCAMPUS_PRENATAL"
6,"Up",0.0176443732513928,0.0948063554003407,"L.LvsV.REACTOME_G2_M_DNA_REPLICATION_CHECKPOINT"
82,"Down",0.0176870332089221,0.0949433073904177,"L.LvsV.LI_LUNG_CANCER"
198,"Down",0.0177684256839043,0.0952156012321386,"L.LvsV.CERVERA_SDHB_TARGETS_1_UP"
29,"Down",0.0177802643641562,0.0952156012321386,"L.LvsV.NOUSHMEHR_GBM_SOMATIC_MUTATED"
135,"Down",0.0177894223318501,0.0952156012321386,"L.LvsV.ROVERSI_GLIOMA_COPY_NUMBER_UP"
39,"Down",0.0178089642315978,0.0952280108670254,"L.LvsV.REACTOME_NEGATIVE_REGULATION_OF_FGFR4_SIGNALING"
128,"Up",0.0180630078564095,0.0964931115343848,"L.LvsV.REACTOME_RAB_REGULATION_OF_TRAFFICKING"
81,"Down",0.0181057318239291,0.0966241519032706,"L.LvsV.SESTO_RESPONSE_TO_UV_C5"
6,"Down",0.018127623544033,0.0966241519032706,"L.LvsV.SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_DN"
209,"Down",0.0181523979082984,0.0966241519032706,"L.LvsV.SANSOM_APC_TARGETS_UP"
13,"Down",0.0181574414591243,0.0966241519032706,"L.LvsV.REACTOME_MET_ACTIVATES_RAP1_AND_RAC1"
13,"Down",0.0182114419144345,0.0967488887839579,"L.LvsV.REACTOME_REGULATION_OF_LOCALIZATION_OF_FOXO_TRANSCRIPTION_FACTORS"
27,"Down",0.0182158786804305,0.0967488887839579,"L.LvsV.KAMIKUBO_MYELOID_MN1_NETWORK"
17,"Down",0.0182414225484663,0.0967915789543859,"L.LvsV.REACTOME_ERBB2_REGULATES_CELL_MOTILITY"
62,"Down",0.0183052561510545,0.0969795713262649,"L.LvsV.SUBTIL_PROGESTIN_TARGETS"
19,"Down",0.0183119320789692,0.0969795713262649,"L.LvsV.TSUTSUMI_FBXW8_TARGETS"
19,"Down",0.0185202605638801,0.0979801693432991,"L.LvsV.REACTOME_TRANSPORT_OF_CONNEXONS_TO_THE_PLASMA_MEMBRANE"
73,"Down",0.0185363098450155,0.0979801693432991,"L.LvsV.ZHAN_MULTIPLE_MYELOMA_HP_UP"
32,"Down",0.0185953536810477,0.0981829785940526,"L.LvsV.SCHMIDT_POR_TARGETS_IN_LIMB_BUD_DN"
19,"Up",0.0186164823959982,0.0981829785940526,"L.LvsV.REACTOME_SYNTHESIS_OF_PIPS_AT_THE_EARLY_ENDOSOME_MEMBRANE"
70,"Down",0.0186432307426251,0.0981829785940526,"L.LvsV.REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK"
14,"Up",0.0186457094454251,0.0981829785940526,"L.LvsV.BIOCARTA_AMAN_PATHWAY"
21,"Up",0.0186799451533528,0.0982696638942796,"L.LvsV.TIAN_BHLHA15_TARGETS"
443,"Down",0.0187300355689106,0.0984395120347021,"L.LvsV.BILD_HRAS_ONCOGENIC_SIGNATURE"
42,"Down",0.0187517844371553,0.0984602242668865,"L.LvsV.PID_IGF1_PATHWAY"
424,"Down",0.0188629439299722,0.0988778142417803,"L.LvsV.DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP"
810,"Down",0.0188929658398167,0.0988778142417803,"L.LvsV.SWEET_LUNG_CANCER_KRAS_DN"
146,"Down",0.0188998547110347,0.0988778142417803,"L.LvsV.KONDO_PROSTATE_CANCER_HCP_WITH_H3K27ME3"
158,"Down",0.0189096455588534,0.0988778142417803,"L.LvsV.REACTOME_RHO_GTPASE_CYCLE"
20,"Up",0.018920732043372,0.0988778142417803,"L.LvsV.TERAMOTO_OPN_TARGETS_CLUSTER_1"
33,"Down",0.0189703768604132,0.0990436389624408,"L.LvsV.REACTOME_NOTCH2_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS"
17,"Down",0.0190209060626749,0.0992137637929526,"L.LvsV.SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_UP"
35,"Down",0.0191096381402734,0.0995826477639692,"L.LvsV.PID_ALK1_PATHWAY"
340,"Down",0.0191433394812491,0.099607012624863,"L.LvsV.STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP"
91,"Down",0.0191503444420744,0.099607012624863,"L.LvsV.DAUER_STAT3_TARGETS_DN"
57,"Down",0.0192010127471141,0.0997766912394681,"L.LvsV.REACTOME_EPH_EPHRIN_MEDIATED_REPULSION_OF_CELLS"
93,"Up",0.0192246121363567,0.0998055215980433,"L.LvsV.VILLANUEVA_LIVER_CANCER_KRT19_DN"
19,"Down",0.0193696998851124,0.100464419010119,"L.LvsV.MIZUKAMI_HYPOXIA_UP"
94,"Up",0.0194147573853262,0.100603742814872,"L.LvsV.COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_UP"
39,"Down",0.0196012988518787,0.101475263438237,"L.LvsV.REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_ACETYLATION"
44,"Down",0.0196217603576231,0.101486167462393,"L.LvsV.SHIN_B_CELL_LYMPHOMA_CLUSTER_3"
20,"Up",0.0196474119112181,0.101523869586098,"L.LvsV.REACTOME_REGULATION_OF_TLR_BY_ENDOGENOUS_LIGAND"
44,"Down",0.0196941306264777,0.101670259788791,"L.LvsV.JEPSEN_SMRT_TARGETS"
39,"Up",0.0197409446515067,0.101816868449795,"L.LvsV.REACTOME_RESOLUTION_OF_ABASIC_SITES_AP_SITES"
260,"Down",0.0197794391244036,0.101920334500305,"L.LvsV.REACTOME_KERATINIZATION"
200,"Down",0.0198149898389847,0.102008453277231,"L.LvsV.GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_UP"
24,"Up",0.0199119360156393,0.102247431270589,"L.LvsV.RUAN_RESPONSE_TO_TROGLITAZONE_DN"
7,"Up",0.0199256280429069,0.102247431270589,"L.LvsV.MIKHAYLOVA_OXIDATIVE_STRESS_RESPONSE_VIA_VHL_DN"
63,"Down",0.0199287473737438,0.102247431270589,"L.LvsV.APRELIKOVA_BRCA1_TARGETS"
19,"Down",0.0199353826930177,0.102247431270589,"L.LvsV.REACTOME_REGULATION_OF_IFNG_SIGNALING"
99,"Down",0.020063475493811,0.102809041710177,"L.LvsV.REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS"
48,"Down",0.0201155507294926,0.102965588218939,"L.LvsV.GENTILE_UV_RESPONSE_CLUSTER_D5"
96,"Down",0.020131271634052,0.102965588218939,"L.LvsV.REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS"
10,"Down",0.020159016848709,0.102992993517483,"L.LvsV.BIOCARTA_TERT_PATHWAY"
52,"Down",0.0201813581577647,0.102992993517483,"L.LvsV.REACTOME_SIGNALING_BY_FGFR4"
72,"Down",0.0202049171491483,0.102992993517483,"L.LvsV.DORSEY_GAB2_TARGETS"
14,"Up",0.0202111408874063,0.102992993517483,"L.LvsV.REACTOME_EICOSANOID_LIGAND_BINDING_RECEPTORS"
166,"Down",0.0202729728500205,0.103212952935326,"L.LvsV.HUMMERICH_SKIN_CANCER_PROGRESSION_UP"
111,"Down",0.0204197782514472,0.103864723047149,"L.LvsV.MCBRYAN_PUBERTAL_TGFB1_TARGETS_DN"
41,"Up",0.0207027885628637,0.105207461364038,"L.LvsV.REACTOME_GLUTATHIONE_CONJUGATION"
36,"Down",0.020756431290935,0.10525284803752,"L.LvsV.AMUNDSON_DNA_DAMAGE_RESPONSE_TP53"
249,"Up",0.0207601992079751,0.10525284803752,"L.LvsV.WHITFIELD_CELL_CYCLE_S"
226,"Down",0.0207688293016703,0.10525284803752,"L.LvsV.REACTOME_SUMOYLATION"
39,"Down",0.0209100997254229,0.105871741192182,"L.LvsV.BIOCARTA_RACCYCD_PATHWAY"
31,"Up",0.0209510839013178,0.105938098717513,"L.LvsV.BIOCARTA_MTOR_PATHWAY"
106,"Down",0.0209743323755419,0.105938098717513,"L.LvsV.MARSON_FOXP3_TARGETS_UP"
120,"Down",0.0209806869407988,0.105938098717513,"L.LvsV.PID_BETA_CATENIN_NUC_PATHWAY"
111,"Down",0.0210008672466686,0.105943243619371,"L.LvsV.POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN"
191,"Down",0.0210531186378279,0.106110020919371,"L.LvsV.BOYLAN_MULTIPLE_MYELOMA_C_D_UP"
300,"Up",0.0211155379249858,0.106327695070352,"L.LvsV.REACTOME_DISEASES_OF_METABOLISM"
175,"Up",0.0211957567599401,0.10663452149746,"L.LvsV.HOSHIDA_LIVER_CANCER_SURVIVAL_DN"
21,"Down",0.0212188579082661,0.106653695795276,"L.LvsV.REACTOME_FRS_MEDIATED_FGFR3_SIGNALING"
199,"Down",0.0212894529070088,0.106911339802772,"L.LvsV.WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN"
757,"Down",0.02136182032306,0.107177408862249,"L.LvsV.CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN"
24,"Down",0.0214097430691646,0.107320461858034,"L.LvsV.REACTOME_SIGNALING_BY_HIPPO"
35,"Down",0.0214888976474401,0.107612649425894,"L.LvsV.MAGRANGEAS_MULTIPLE_MYELOMA_IGLL_VS_IGLK_DN"
59,"Up",0.0215100184525099,0.107612649425894,"L.LvsV.CAFFAREL_RESPONSE_TO_THC_UP"
15,"Down",0.021537247317162,0.107612649425894,"L.LvsV.DACOSTA_LOW_DOSE_UV_RESPONSE_VIA_ERCC3_XPCS_DN"
40,"Down",0.0215589085477048,0.107612649425894,"L.LvsV.MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_UP"
101,"Down",0.0215653491705355,0.107612649425894,"L.LvsV.TURASHVILI_BREAST_NORMAL_DUCTAL_VS_LOBULAR_UP"
8,"Down",0.0216119972946919,0.107748181282553,"L.LvsV.LIU_IL13_MEMORY_MODEL_DN"
5,"Down",0.0217714596092119,0.108302460940875,"L.LvsV.REACTOME_DISINHIBITION_OF_SNARE_FORMATION"
107,"Down",0.0217764763727503,0.108302460940875,"L.LvsV.BERNARD_PPAPDC1B_TARGETS_DN"
121,"Down",0.0217998496028637,0.108302460940875,"L.LvsV.HENDRICKS_SMARCA4_TARGETS_UP"
28,"Down",0.021801526320708,0.108302460940875,"L.LvsV.KEGG_DORSO_VENTRAL_AXIS_FORMATION"
112,"Down",0.0218958847718331,0.108673560954637,"L.LvsV.ASGHARZADEH_NEUROBLASTOMA_POOR_SURVIVAL_DN"
38,"Down",0.0220227059055369,0.10920496946342,"L.LvsV.REACTOME_INFLAMMASOMES"
9,"Up",0.0220921225306557,0.109451026408598,"L.LvsV.REACTOME_PROSTANOID_LIGAND_RECEPTORS"
237,"Down",0.0222380787078421,0.110035833956598,"L.LvsV.KIM_MYCN_AMPLIFICATION_TARGETS_DN"
1255,"Down",0.0222574150119239,0.110035833956598,"L.LvsV.DACOSTA_UV_RESPONSE_VIA_ERCC3_DN"
36,"Down",0.022269867642871,0.110035833956598,"L.LvsV.WANG_BARRETTS_ESOPHAGUS_DN"
13,"Down",0.0223453750359716,0.110300272793645,"L.LvsV.REACTOME_INHIBITION_OF_REPLICATION_INITIATION_OF_DAMAGED_DNA_BY_RB1_E2F1"
55,"Up",0.0223632855492269,0.110300272793645,"L.LvsV.KEGG_INOSITOL_PHOSPHATE_METABOLISM"
88,"Down",0.0223842957725222,0.110305500290798,"L.LvsV.PID_RB_1PATHWAY"
12,"Down",0.0224394235818414,0.110478693663402,"L.LvsV.REACTOME_MECP2_REGULATES_TRANSCRIPTION_OF_NEURONAL_LIGANDS"
67,"Down",0.0227228113282017,0.111703459678979,"L.LvsV.PID_NFAT_3PATHWAY"
32,"Down",0.0227285932607798,0.111703459678979,"L.LvsV.VETTER_TARGETS_OF_PRKCA_AND_ETS1_DN"
84,"Down",0.0228194141273649,0.112050213774601,"L.LvsV.KEGG_PANCREATIC_CANCER"
31,"Down",0.0228703504485126,0.112200681126731,"L.LvsV.REACTOME_PI_3K_CASCADE_FGFR1"
26,"Up",0.0229207582862108,0.112311803578928,"L.LvsV.SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_UP"
199,"Down",0.0229336274625809,0.112311803578928,"L.LvsV.PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_DN"
69,"Up",0.0229828439640966,0.112453225024328,"L.LvsV.REACTOME_THE_ROLE_OF_NEF_IN_HIV_1_REPLICATION_AND_DISEASE_PATHOGENESIS"
15,"Up",0.023062045052619,0.112692881599979,"L.LvsV.BIOCARTA_PTC1_PATHWAY"
41,"Up",0.0230827512212378,0.112692881599979,"L.LvsV.PASTURAL_RIZ1_TARGETS_UP"
20,"Down",0.0231099155741376,0.112692881599979,"L.LvsV.WU_HBX_TARGETS_3_DN"
26,"Up",0.023121922661016,0.112692881599979,"L.LvsV.KEGG_SELENOAMINO_ACID_METABOLISM"
278,"Up",0.0231337349640036,0.112692881599979,"L.LvsV.FUJII_YBX1_TARGETS_DN"
43,"Up",0.0233593717968074,0.113597511397717,"L.LvsV.ZWANG_EGF_PERSISTENTLY_UP"
68,"Down",0.023360530016134,0.113597511397717,"L.LvsV.CERVERA_SDHB_TARGETS_1_DN"
22,"Down",0.0234483925756533,0.1139245716615,"L.LvsV.ZEILSTRA_CD44_TARGETS_UP"
20,"Down",0.0235015788058003,0.114082729778112,"L.LvsV.REACTOME_KILLING_MECHANISMS"
35,"Down",0.0235412773615224,0.114175195203384,"L.LvsV.BIOCARTA_MCALPAIN_PATHWAY"
34,"Down",0.0237179775019371,0.114931373889755,"L.LvsV.HUMMERICH_BENIGN_SKIN_TUMOR_UP"
15,"Down",0.0238617336986538,0.11550224792238,"L.LvsV.BIOCARTA_ERYTH_PATHWAY"
17,"Down",0.0238775672590487,0.11550224792238,"L.LvsV.OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_DN"
48,"Down",0.0240589875132636,0.11627809611961,"L.LvsV.REACTOME_NR1H3_NR1H2_REGULATE_GENE_EXPRESSION_LINKED_TO_CHOLESTEROL_TRANSPORT_AND_EFFLUX"
176,"Up",0.0242601409706488,0.117078336569474,"L.LvsV.ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR"
355,"Up",0.0242669151218335,0.117078336569474,"L.LvsV.REACTOME_CELL_CYCLE_CHECKPOINTS"
213,"Down",0.0243561681535613,0.117406498449033,"L.LvsV.BROWNE_HCMV_INFECTION_8HR_UP"
64,"Down",0.0244215412460757,0.117619078004837,"L.LvsV.BYSTROEM_CORRELATED_WITH_IL5_UP"
209,"Up",0.0244442427863927,0.117625951580475,"L.LvsV.YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_14"
296,"Down",0.0245325816919165,0.117948386238788,"L.LvsV.SMIRNOV_RESPONSE_TO_IR_6HR_UP"
79,"Down",0.0246653660029308,0.118417924830666,"L.LvsV.PID_TAP63_PATHWAY"
9,"Down",0.0246730782067149,0.118417924830666,"L.LvsV.REACTOME_ACTIVATED_NTRK2_SIGNALS_THROUGH_CDK5"
233,"Down",0.0247109384862449,0.118456893151094,"L.LvsV.ZHU_CMV_ALL_DN"
72,"Down",0.0247275123589344,0.118456893151094,"L.LvsV.KEGG_GLIOMA"
13,"Up",0.0247454714395937,0.118456893151094,"L.LvsV.REACTOME_RECEPTOR_MEDIATED_MITOPHAGY"
130,"Up",0.0247805178556932,0.118522044311529,"L.LvsV.REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS"
95,"Down",0.024937052384855,0.119139448327151,"L.LvsV.REACTOME_EXTRA_NUCLEAR_ESTROGEN_SIGNALING"
16,"Up",0.024968243569836,0.119139448327151,"L.LvsV.REACTOME_PHENYLALANINE_AND_TYROSINE_METABOLISM"
56,"Down",0.0249742486184063,0.119139448327151,"L.LvsV.KEGG_BLADDER_CANCER"
167,"Down",0.025068056090364,0.119483863899675,"L.LvsV.HOOI_ST7_TARGETS_UP"
69,"Down",0.0252474516757407,0.120131262845712,"L.LvsV.BOYLAN_MULTIPLE_MYELOMA_C_UP"
13,"Down",0.025296578562507,0.120131262845712,"L.LvsV.GOUYER_TUMOR_INVASIVENESS"
53,"Down",0.0252972709453344,0.120131262845712,"L.LvsV.PID_LIS1_PATHWAY"
24,"Down",0.025311232176875,0.120131262845712,"L.LvsV.DEBOSSCHER_NFKB_TARGETS_REPRESSED_BY_GLUCOCORTICOIDS"
56,"Up",0.0253239691849135,0.120131262845712,"L.LvsV.KEGG_FATTY_ACID_METABOLISM"
30,"Up",0.0253342471474227,0.120131262845712,"L.LvsV.REACTOME_ENERGY_DEPENDENT_REGULATION_OF_MTOR_BY_LKB1_AMPK"
46,"Down",0.025394721877294,0.120227931021747,"L.LvsV.REACTOME_ASSEMBLY_AND_CELL_SURFACE_PRESENTATION_OF_NMDA_RECEPTORS"
37,"Down",0.0253981232471335,0.120227931021747,"L.LvsV.BIOCARTA_DEATH_PATHWAY"
52,"Up",0.0254428427984468,0.120301887672941,"L.LvsV.SANCHEZ_MDM2_TARGETS"
60,"Down",0.0254572632623153,0.120301887672941,"L.LvsV.LUI_THYROID_CANCER_PAX8_PPARG_DN"
32,"Down",0.025493876579278,0.120372026991313,"L.LvsV.DASU_IL6_SIGNALING_SCAR_DN"
251,"Down",0.0255570661424884,0.120449162057584,"L.LvsV.ONDER_CDH1_TARGETS_1_UP"
130,"Up",0.0255616566686736,0.120449162057584,"L.LvsV.WOO_LIVER_CANCER_RECURRENCE_DN"
28,"Down",0.0255755681417261,0.120449162057584,"L.LvsV.REACTOME_MECP2_REGULATES_NEURONAL_RECEPTORS_AND_CHANNELS"
83,"Down",0.0256755352560584,0.120817050579359,"L.LvsV.PID_TXA2PATHWAY"
24,"Down",0.025788504140937,0.121180161750185,"L.LvsV.LIU_TOPBP1_TARGETS"
34,"Down",0.025796536512926,0.121180161750185,"L.LvsV.REACTOME_VEGFR2_MEDIATED_VASCULAR_PERMEABILITY"
115,"Down",0.025829910696678,0.121233935689247,"L.LvsV.BASSO_CD40_SIGNALING_DN"
18,"Down",0.0259471909843617,0.121681101740913,"L.LvsV.BIOCARTA_PCAF_PATHWAY"
47,"Down",0.0261909213112666,0.122625364872446,"L.LvsV.REACTOME_SYNTHESIS_OF_LEUKOTRIENES_LT_AND_EOXINS_EX"
679,"Down",0.0261929021367984,0.122625364872446,"L.LvsV.HSIAO_HOUSEKEEPING_GENES"
36,"Down",0.02631904765323,0.12302328485928,"L.LvsV.KANG_AR_TARGETS_UP"
32,"Up",0.0263411473351862,0.12302328485928,"L.LvsV.LANDIS_ERBB2_BREAST_TUMORS_65_UP"
87,"Down",0.0263446498957112,0.12302328485928,"L.LvsV.GENTILE_UV_RESPONSE_CLUSTER_D4"
36,"Down",0.0263725440646615,0.123049616990307,"L.LvsV.REACTOME_NOTCH3_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS"
89,"Down",0.0264225893527016,0.123179170768202,"L.LvsV.LINDGREN_BLADDER_CANCER_HIGH_RECURRENCE"
266,"Up",0.026454304833808,0.12322312672799,"L.LvsV.FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_DN"
61,"Down",0.0265995283237504,0.123795279547152,"L.LvsV.LIU_CDX2_TARGETS_UP"
248,"Down",0.0268674691983979,0.124937121276655,"L.LvsV.CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN"
233,"Down",0.0270211799410406,0.125546305793289,"L.LvsV.CHEBOTAEV_GR_TARGETS_DN"
71,"Down",0.0270482712237524,0.125566659610518,"L.LvsV.VERRECCHIA_RESPONSE_TO_TGFB1_C2"
21,"Down",0.0270942173346204,0.125674435942212,"L.LvsV.SILIGAN_TARGETS_OF_EWS_FLI1_FUSION_UP"
185,"Down",0.0271674165413133,0.125908337013345,"L.LvsV.PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_4"
29,"Up",0.027201993668991,0.125963000834046,"L.LvsV.COLLER_MYC_TARGETS_UP"
25,"Up",0.0272374043923701,0.126021430029636,"L.LvsV.SMID_BREAST_CANCER_LUMINAL_A_DN"
29,"Down",0.0273051439288803,0.12622921470132,"L.LvsV.REACTOME_SHC_MEDIATED_CASCADE_FGFR1"
265,"Down",0.0273664673035751,0.126407015640323,"L.LvsV.BROWNE_HCMV_INFECTION_24HR_DN"
21,"Down",0.0274026370931179,0.126468431125083,"L.LvsV.HUMMEL_BURKITTS_LYMPHOMA_DN"
144,"Up",0.0274528253763558,0.126594388245097,"L.LvsV.MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_UP"
625,"Down",0.0275302258393967,0.126782903192753,"L.LvsV.CUI_TCF21_TARGETS_2_UP"
121,"Up",0.0275395671431537,0.126782903192753,"L.LvsV.REACTOME_UNFOLDED_PROTEIN_RESPONSE_UPR"
518,"Down",0.0276036745102569,0.126972309789692,"L.LvsV.CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN"
7,"Up",0.0276811040230317,0.127144156644196,"L.LvsV.REACTOME_INTERLEUKIN_36_PATHWAY"
29,"Down",0.0276870256103476,0.127144156644196,"L.LvsV.REACTOME_INTERLEUKIN_6_FAMILY_SIGNALING"
156,"Up",0.0278036923056387,0.12748056302574,"L.LvsV.REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_DIFFERENTIATION_OF_HSCS"
462,"Down",0.0278063951906388,0.12748056302574,"L.LvsV.MULLIGHAN_MLL_SIGNATURE_2_DN"
1622,"Down",0.0278510145942585,0.127579336944205,"L.LvsV.BENPORATH_ES_WITH_H3K27ME3"
206,"Down",0.0278749682523882,0.127583360486303,"L.LvsV.MIKKELSEN_IPS_ICP_WITH_H3K4ME3_AND_H327ME3"
82,"Down",0.0279769669380167,0.1277226307409,"L.LvsV.PID_IL2_1PATHWAY"
25,"Down",0.0280009166931088,0.1277226307409,"L.LvsV.HOLLERN_PAPILLARY_BREAST_TUMOR"
205,"Down",0.0280010944866655,0.1277226307409,"L.LvsV.CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_UP"
46,"Up",0.0280474993989596,0.1277226307409,"L.LvsV.REACTOME_MITOCHONDRIAL_FATTY_ACID_BETA_OXIDATION"
171,"Down",0.0280683428006544,0.1277226307409,"L.LvsV.REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX2"
40,"Up",0.0280838168218681,0.1277226307409,"L.LvsV.KYNG_WERNER_SYNDROM_DN"
13,"Down",0.0281052364738381,0.1277226307409,"L.LvsV.REACTOME_REGULATION_OF_GLYCOLYSIS_BY_FRUCTOSE_2_6_BISPHOSPHATE_METABOLISM"
7,"Down",0.0281057425368206,0.1277226307409,"L.LvsV.REACTOME_GRB7_EVENTS_IN_ERBB2_SIGNALING"
60,"Down",0.0281133010692124,0.1277226307409,"L.LvsV.TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_DN"
171,"Down",0.0282057769252597,0.128037553875009,"L.LvsV.WOOD_EBV_EBNA1_TARGETS_UP"
136,"Down",0.0282997833086399,0.128358902308015,"L.LvsV.BENPORATH_ES_CORE_NINE_CORRELATED"
7,"Down",0.0283476361499117,0.128470557600706,"L.LvsV.REACTOME_MET_ACTIVATES_PTPN11"
140,"Down",0.0284298464790958,0.128698147276384,"L.LvsV.GU_PDEF_TARGETS_UP"
80,"Down",0.0284444087487324,0.128698147276384,"L.LvsV.KERLEY_RESPONSE_TO_CISPLATIN_UP"
6,"Down",0.0285064272514909,0.128789123065322,"L.LvsV.REACTOME_PRE_NOTCH_PROCESSING_IN_THE_ENDOPLASMIC_RETICULUM"
63,"Down",0.028511102664488,0.128789123065322,"L.LvsV.SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2"
293,"Down",0.0286126215885651,0.12907735903379,"L.LvsV.TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP"
65,"Down",0.0286261700172077,0.12907735903379,"L.LvsV.PID_TCPTP_PATHWAY"
137,"Up",0.0286484117340223,0.12907735903379,"L.LvsV.REACTOME_SENESCENCE_ASSOCIATED_SECRETORY_PHENOTYPE_SASP"
31,"Down",0.028668293885602,0.12907735903379,"L.LvsV.PID_WNT_CANONICAL_PATHWAY"
38,"Down",0.0287435072518522,0.129283826833538,"L.LvsV.BIOCARTA_BAD_PATHWAY"
127,"Down",0.0287703876442496,0.129283826833538,"L.LvsV.HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_DN"
221,"Up",0.0287842993004315,0.129283826833538,"L.LvsV.HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP"
30,"Down",0.0288192555691007,0.129335766267498,"L.LvsV.REACTOME_SEALING_OF_THE_NUCLEAR_ENVELOPE_NE_BY_ESCRT_III"
11,"Up",0.0288550977766297,0.12939159416625,"L.LvsV.MULLIGAN_NTF3_SIGNALING_VIA_INSR_AND_IGF1R_DN"
829,"Up",0.028890207730215,0.129444050681004,"L.LvsV.IVANOVA_HEMATOPOIESIS_LATE_PROGENITOR"
85,"Down",0.0289804307000819,0.129743158980367,"L.LvsV.YAMASHITA_LIVER_CANCER_STEM_CELL_UP"
34,"Down",0.02900708030761,0.129757400502246,"L.LvsV.SHIN_B_CELL_LYMPHOMA_CLUSTER_7"
41,"Down",0.0290419412997139,0.129808321298398,"L.LvsV.JEON_SMAD6_TARGETS_UP"
84,"Down",0.0291614136345452,0.130119204414225,"L.LvsV.REACTOME_NUCLEAR_ENVELOPE_NE_REASSEMBLY"
17,"Down",0.02919303671865,0.130119204414225,"L.LvsV.REACTOME_ACTIVATION_OF_RAC1"
50,"Down",0.029206837467272,0.130119204414225,"L.LvsV.VERRECCHIA_RESPONSE_TO_TGFB1_C4"
630,"Down",0.0292154797934005,0.130119204414225,"L.LvsV.FOSTER_TOLERANT_MACROPHAGE_DN"
117,"Down",0.0292392669976655,0.130119204414225,"L.LvsV.LINDSTEDT_DENDRITIC_CELL_MATURATION_D"
41,"Down",0.0292526986954027,0.130119204414225,"L.LvsV.CHIN_BREAST_CANCER_COPY_NUMBER_UP"
143,"Down",0.0293524661352034,0.130458026737572,"L.LvsV.SAFFORD_T_LYMPHOCYTE_ANERGY"
392,"Down",0.0294048216369727,0.130561875302242,"L.LvsV.REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION"
18,"Down",0.0294230596177598,0.130561875302242,"L.LvsV.RANKIN_ANGIOGENIC_TARGETS_OF_VHL_HIF2A_DN"
11,"Down",0.0294885456752673,0.13070722532167,"L.LvsV.DING_LUNG_CANCER_MUTATED_RECURRENTLY"
15,"Up",0.0295030958946363,0.13070722532167,"L.LvsV.BIOCARTA_CPSF_PATHWAY"
8,"Down",0.0295282394216888,0.130713879713785,"L.LvsV.HOLLEMAN_DAUNORUBICIN_ALL_DN"
62,"Down",0.0296234240222844,0.130956659376061,"L.LvsV.BIOCARTA_INTEGRIN_PATHWAY"
30,"Down",0.0296304541290383,0.130956659376061,"L.LvsV.HOLLEMAN_VINCRISTINE_RESISTANCE_ALL_DN"
893,"Down",0.0296588801534533,0.130977594543485,"L.LvsV.ENK_UV_RESPONSE_EPIDERMIS_DN"
17,"Down",0.0296968724612791,0.131040708570161,"L.LvsV.BIOCARTA_MONOCYTE_PATHWAY"
71,"Up",0.0298999169672852,0.131816767361472,"L.LvsV.KEGG_GRAFT_VERSUS_HOST_DISEASE"
159,"Up",0.0299204273898802,0.131816767361472,"L.LvsV.OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_UP"
49,"Down",0.0299659660108552,0.131912281906066,"L.LvsV.LU_TUMOR_ENDOTHELIAL_MARKERS_UP"
14,"Down",0.0300234795990293,0.132060317186184,"L.LvsV.BIOCARTA_PKC_PATHWAY"
19,"Down",0.030059251130322,0.132112559220628,"L.LvsV.SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX5_UP"
443,"Up",0.0301408340959792,0.132329701440521,"L.LvsV.WEST_ADRENOCORTICAL_TUMOR_UP"
131,"Up",0.030166950639018,0.132329701440521,"L.LvsV.SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE"
141,"Down",0.0301804582232766,0.132329701440521,"L.LvsV.FRIDMAN_SENESCENCE_UP"
90,"Up",0.0303337339290631,0.132896366793811,"L.LvsV.CAFFAREL_RESPONSE_TO_THC_24HR_5_DN"
650,"Down",0.0303744262082877,0.132967336156146,"L.LvsV.ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP"
164,"Down",0.0303980309099961,0.132967336156146,"L.LvsV.ZHU_CMV_24_HR_DN"
72,"Up",0.0304259142445247,0.132984094749389,"L.LvsV.REACTOME_HEDGEHOG_LIGAND_BIOGENESIS"
57,"Down",0.0305010893029972,0.133207363946502,"L.LvsV.REACTOME_MET_PROMOTES_CELL_MOTILITY"
51,"Up",0.0305747575365531,0.1334237051457,"L.LvsV.NIKOLSKY_BREAST_CANCER_7P22_AMPLICON"
782,"Down",0.0306476250769096,0.133636213762013,"L.LvsV.CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1"
25,"Up",0.0310753386316382,0.13529181575313,"L.LvsV.REACTOME_PURINE_CATABOLISM"
162,"Down",0.0310762535732456,0.13529181575313,"L.LvsV.MARZEC_IL2_SIGNALING_UP"
162,"Up",0.0311584394072289,0.135454556032661,"L.LvsV.REACTOME_GENE_SILENCING_BY_RNA"
15,"Down",0.0311667175589646,0.135454556032661,"L.LvsV.REACTOME_PI3K_EVENTS_IN_ERBB4_SIGNALING"
28,"Down",0.0311977077837135,0.135454556032661,"L.LvsV.HEDENFALK_BREAST_CANCER_BRACX_DN"
330,"Down",0.0312116303826389,0.135454556032661,"L.LvsV.ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP"
40,"Down",0.0312770338391213,0.135457465363192,"L.LvsV.CHEN_PDGF_TARGETS"
168,"Down",0.0312919365791118,0.135457465363192,"L.LvsV.KANG_IMMORTALIZED_BY_TERT_UP"
99,"Down",0.0313102224286836,0.135457465363192,"L.LvsV.NOUZOVA_METHYLATED_IN_APL"
835,"Down",0.0313353105374652,0.135457465363192,"L.LvsV.ZWANG_CLASS_1_TRANSIENTLY_INDUCED_BY_EGF"
7,"Up",0.0313609590749977,0.135457465363192,"L.LvsV.REACTOME_ZINC_EFFLUX_AND_COMPARTMENTALIZATION_BY_THE_SLC30_FAMILY"
917,"Down",0.031374540315057,0.135457465363192,"L.LvsV.CHICAS_RB1_TARGETS_CONFLUENT"
23,"Down",0.0313837969126876,0.135457465363192,"L.LvsV.REACTOME_THE_NLRP3_INFLAMMASOME"
20,"Down",0.0317994680170904,0.137144507540166,"L.LvsV.REACTOME_MAP3K8_TPL2_DEPENDENT_MAPK1_3_ACTIVATION"
34,"Down",0.031858106278366,0.13725249783536,"L.LvsV.BYSTRYKH_HEMATOPOIESIS_STEM_CELL_IL3RA"
57,"Down",0.0318946808541529,0.13725249783536,"L.LvsV.RIZ_ERYTHROID_DIFFERENTIATION_HBZ"
15,"Up",0.0318989798731122,0.13725249783536,"L.LvsV.REACTOME_N_GLYCAN_ANTENNAE_ELONGATION"
476,"Down",0.0320767840217191,0.137910216839879,"L.LvsV.MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_UP"
22,"Up",0.0321646875741535,0.138099929575482,"L.LvsV.REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS"
32,"Down",0.0321708644046339,0.138099929575482,"L.LvsV.BIOCARTA_IL6_PATHWAY"
64,"Up",0.0322222327559297,0.138213130261858,"L.LvsV.KEGG_ALLOGRAFT_REJECTION"
80,"Up",0.0322485482913416,0.138218777909169,"L.LvsV.ELVIDGE_HYPOXIA_BY_DMOG_DN"
64,"Down",0.0323375777585966,0.138493003429342,"L.LvsV.REACTOME_CARGO_TRAFFICKING_TO_THE_PERICILIARY_MEMBRANE"
8,"Up",0.0324932916354755,0.138944049381674,"L.LvsV.FARDIN_HYPOXIA_9"
12,"Up",0.0325006032645209,0.138944049381674,"L.LvsV.BOYAULT_LIVER_CANCER_SUBCLASS_G23_DN"
71,"Down",0.0325182853861252,0.138944049381674,"L.LvsV.REACTOME_ION_HOMEOSTASIS"
72,"Up",0.0325935912211911,0.139158274796884,"L.LvsV.PIONTEK_PKD1_TARGETS_UP"
13,"Down",0.0327328853870828,0.139645156871282,"L.LvsV.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_7"
145,"Down",0.0328823332183018,0.140075582147598,"L.LvsV.CROMER_METASTASIS_DN"
55,"Down",0.0329028904876728,0.140075582147598,"L.LvsV.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_DN"
80,"Up",0.032927527529435,0.140075582147598,"L.LvsV.REACTOME_APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1"
41,"Down",0.0329601848432246,0.140075582147598,"L.LvsV.BIOCARTA_P53HYPOXIA_PATHWAY"
58,"Down",0.0329604507820628,0.140075582147598,"L.LvsV.CHANDRAN_METASTASIS_TOP50_DN"
76,"Down",0.0330158878091972,0.140143741826349,"L.LvsV.PID_P53_REGULATION_PATHWAY"
17,"Down",0.0330271831433772,0.140143741826349,"L.LvsV.BIOCARTA_RANKL_PATHWAY"
74,"Down",0.0331195345699213,0.14042784251311,"L.LvsV.LIEN_BREAST_CARCINOMA_METAPLASTIC"
358,"Down",0.0332532502906383,0.140886759277348,"L.LvsV.BOQUEST_STEM_CELL_DN"
24,"Down",0.0333177460874174,0.141001985324403,"L.LvsV.HASINA_NOL7_TARGETS_DN"
134,"Down",0.0333325305070673,0.141001985324403,"L.LvsV.SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_UP"
54,"Down",0.0333708691214835,0.141001985324403,"L.LvsV.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_PINK_DN"
45,"Down",0.0333938425708676,0.141001985324403,"L.LvsV.MEISSNER_ES_ICP_WITH_H3K4ME3"
990,"Up",0.0334713000199708,0.141001985324403,"L.LvsV.REACTOME_VESICLE_MEDIATED_TRANSPORT"
49,"Up",0.0334754997410393,0.141001985324403,"L.LvsV.REACTOME_TBC_RABGAPS"
700,"Down",0.0334936741022416,0.141001985324403,"L.LvsV.MARTENS_BOUND_BY_PML_RARA_FUSION"
493,"Down",0.0335118938336882,0.141001985324403,"L.LvsV.CHANDRAN_METASTASIS_DN"
50,"Down",0.0335257790048427,0.141001985324403,"L.LvsV.BERENJENO_TRANSFORMED_BY_RHOA_REVERSIBLY_DN"
659,"Up",0.0335354694703544,0.141001985324403,"L.LvsV.SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6"
115,"Down",0.033627856269277,0.141282991879052,"L.LvsV.REACTOME_RECRUITMENT_OF_MITOTIC_CENTROSOME_PROTEINS_AND_COMPLEXES"
14,"Down",0.0337105038137992,0.141522684575927,"L.LvsV.REACTOME_NTRK2_ACTIVATES_RAC1"
516,"Up",0.0337835449732615,0.141612391869438,"L.LvsV.ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_DN"
17,"Down",0.033794758551715,0.141612391869438,"L.LvsV.BOYAULT_LIVER_CANCER_SUBCLASS_G56_UP"
38,"Down",0.0338087099416997,0.141612391869438,"L.LvsV.BURTON_ADIPOGENESIS_1"
237,"Down",0.0338844000605853,0.141734763684868,"L.LvsV.MIKKELSEN_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3"
338,"Down",0.0338891947171995,0.141734763684868,"L.LvsV.MIKKELSEN_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3"
82,"Down",0.0339569736532372,0.141803845176809,"L.LvsV.AMIT_EGF_RESPONSE_240_HELA"
13,"Down",0.0339570068754014,0.141803845176809,"L.LvsV.WANG_RESPONSE_TO_FORSKOLIN_DN"
820,"Down",0.0339952725175822,0.141856499433745,"L.LvsV.SENESE_HDAC3_TARGETS_UP"
9,"Down",0.0340779486660974,0.142094252017234,"L.LvsV.REACTOME_RUNX1_REGULATES_ESTROGEN_RECEPTOR_MEDIATED_TRANSCRIPTION"
9,"Up",0.0341207033688808,0.142118694078677,"L.LvsV.REACTOME_TRANSPORT_OF_NUCLEOTIDE_SUGARS"
13,"Up",0.0341352189792879,0.142118694078677,"L.LvsV.KEGG_NON_HOMOLOGOUS_END_JOINING"
8,"Up",0.0342907051214788,0.14265862198394,"L.LvsV.NAISHIRO_CTNNB1_TARGETS_WITH_LEF1_MOTIF"
37,"Down",0.0343648045368938,0.142859401717659,"L.LvsV.MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_DN"
32,"Down",0.0343973539178085,0.142868211231355,"L.LvsV.REACTOME_SEMA3A_PLEXIN_REPULSION_SIGNALING_BY_INHIBITING_INTEGRIN_ADHESION"
181,"Down",0.0344186032483569,0.142868211231355,"L.LvsV.HOSHIDA_LIVER_CANCER_SUBCLASS_S2"
97,"Down",0.0347516613439312,0.144142487299772,"L.LvsV.BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_DN"
84,"Down",0.0347959993129475,0.14421820105044,"L.LvsV.REACTOME_INTERLEUKIN_17_SIGNALING"
1007,"Down",0.0349373273855359,0.144634443743863,"L.LvsV.MARTINEZ_RB1_AND_TP53_TARGETS_DN"
174,"Up",0.0349692835393454,0.144634443743863,"L.LvsV.UDAYAKUMAR_MED1_TARGETS_UP"
26,"Down",0.0349749052786299,0.144634443743863,"L.LvsV.TRAYNOR_RETT_SYNDROM_DN"
32,"Up",0.0351006650330456,0.145046021650007,"L.LvsV.REACTOME_DNA_STRAND_ELONGATION"
421,"Down",0.0352567498255668,0.145582202976519,"L.LvsV.KOYAMA_SEMA3B_TARGETS_UP"
49,"Down",0.0354783031262693,0.146387714914286,"L.LvsV.KAMMINGA_SENESCENCE"
302,"Down",0.0355399585271221,0.146532759654331,"L.LvsV.MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP"
69,"Up",0.0356843594694422,0.14701849739683,"L.LvsV.SMITH_LIVER_CANCER"
21,"Down",0.0357297195492538,0.147095770206868,"L.LvsV.IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_UP"
112,"Up",0.0357928114284253,0.147245873800419,"L.LvsV.REACTOME_DNA_DOUBLE_STRAND_BREAK_RESPONSE"
37,"Down",0.0358282082728959,0.14726872710332,"L.LvsV.OLSSON_E2F3_TARGETS_UP"
31,"Down",0.0358516380323872,0.14726872710332,"L.LvsV.XU_HGF_TARGETS_INDUCED_BY_AKT1_6HR"
6,"Down",0.0359008571437805,0.147361424757211,"L.LvsV.MCGOWAN_RSP6_TARGETS_DN"
17,"Up",0.0360379095889239,0.147814244894036,"L.LvsV.REACTOME_GLYCOGEN_BREAKDOWN_GLYCOGENOLYSIS"
11,"Down",0.0361900565628188,0.148328259996905,"L.LvsV.LINDGREN_BLADDER_CANCER_CLUSTER_2A_UP"
26,"Up",0.0362311827802622,0.148386821920051,"L.LvsV.OHASHI_AURKB_TARGETS"
373,"Down",0.0363559934309369,0.148627691129944,"L.LvsV.MEISSNER_BRAIN_HCP_WITH_H3K27ME3"
59,"Down",0.036383678490146,0.148627691129944,"L.LvsV.AMIT_EGF_RESPONSE_480_MCF10A"
84,"Down",0.036395435633608,0.148627691129944,"L.LvsV.BROWNE_HCMV_INFECTION_2HR_DN"
12,"Down",0.0364122513418197,0.148627691129944,"L.LvsV.BOYLAN_MULTIPLE_MYELOMA_PCA1_DN"
122,"Down",0.0364630278850933,0.148627691129944,"L.LvsV.BOYLAN_MULTIPLE_MYELOMA_D_DN"
750,"Down",0.0364646693166455,0.148627691129944,"L.LvsV.ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP"
27,"Down",0.0364781654663291,0.148627691129944,"L.LvsV.REACTOME_HYALURONAN_METABOLISM"
27,"Down",0.0365323178537173,0.14869374925766,"L.LvsV.PID_INTEGRIN_CS_PATHWAY"
7,"Down",0.0365481651729354,0.14869374925766,"L.LvsV.REACTOME_TFAP2A_ACTS_AS_A_TRANSCRIPTIONAL_REPRESSOR_DURING_RETINOIC_ACID_INDUCED_CELL_DIFFERENTIATION"
16,"Down",0.036646781268861,0.148985333555539,"L.LvsV.BIOCARTA_RELA_PATHWAY"
103,"Down",0.0366776234950313,0.149001161134481,"L.LvsV.FIGUEROA_AML_METHYLATION_CLUSTER_2_UP"
232,"Down",0.0367276947081009,0.149095024993458,"L.LvsV.BROWNE_HCMV_INFECTION_12HR_UP"
24,"Down",0.0369109497415738,0.149729010360354,"L.LvsV.SUZUKI_AMPLIFIED_IN_ORAL_CANCER"
379,"Down",0.0369451295591745,0.149757786900789,"L.LvsV.CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP"
432,"Down",0.0369863547999322,0.149815059112692,"L.LvsV.ONDER_CDH1_TARGETS_2_UP"
251,"Down",0.0371316259129779,0.150293381898137,"L.LvsV.HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_UP"
7,"Up",0.0372030377910914,0.150472272089937,"L.LvsV.ZERBINI_RESPONSE_TO_SULINDAC_DN"
53,"Down",0.0373602932481151,0.150997851877799,"L.LvsV.REACTOME_SYNDECAN_INTERACTIONS"
46,"Down",0.0375611401315733,0.151698717156661,"L.LvsV.YANG_BREAST_CANCER_ESR1_DN"
335,"Up",0.0375952158655473,0.151725509869059,"L.LvsV.KOBAYASHI_EGFR_SIGNALING_24HR_DN"
74,"Down",0.037867968537396,0.152714805283197,"L.LvsV.LI_CISPLATIN_RESISTANCE_UP"
24,"Down",0.038037980265738,0.153260517888633,"L.LvsV.REACTOME_CONSTITUTIVE_SIGNALING_BY_EGFRVIII"
35,"Down",0.0380587250969603,0.153260517888633,"L.LvsV.BIOCARTA_GSK3_PATHWAY"
30,"Down",0.0382025603806288,0.153727770265281,"L.LvsV.REACTOME_CRMPS_IN_SEMA3A_SIGNALING"
886,"Up",0.0382690995341163,0.15388352823573,"L.LvsV.STEIN_ESRRA_TARGETS"
97,"Down",0.0383090632054422,0.153932275045705,"L.LvsV.NADLER_HYPERGLYCEMIA_AT_OBESITY"
31,"Down",0.0384980872549867,0.154579465819043,"L.LvsV.HASLINGER_B_CLL_WITH_17P13_DELETION"
308,"Down",0.0385781799674788,0.154788648069804,"L.LvsV.PLASARI_TGFB1_TARGETS_10HR_UP"
77,"Down",0.0386100541435319,0.154804198230303,"L.LvsV.ASTON_MAJOR_DEPRESSIVE_DISORDER_UP"
102,"Down",0.0387342582298201,0.155147194403231,"L.LvsV.DAWSON_METHYLATED_IN_LYMPHOMA_TCL1"
5,"Up",0.038751722819834,0.155147194403231,"L.LvsV.REACTOME_TYROSINE_CATABOLISM"
12,"Down",0.0387889846665224,0.155184005948772,"L.LvsV.BIOCARTA_RECK_PATHWAY"
207,"Down",0.0388434439215901,0.155229056050171,"L.LvsV.WANG_HCP_PROSTATE_CANCER"
186,"Up",0.0388610527824843,0.155229056050171,"L.LvsV.CHUNG_BLISTER_CYTOTOXICITY_UP"
173,"Down",0.0389069397906979,0.155229056050171,"L.LvsV.LIM_MAMMARY_LUMINAL_MATURE_DN"
18,"Down",0.0389328642487182,0.155229056050171,"L.LvsV.REACTOME_GRB2_EVENTS_IN_ERBB2_SIGNALING"
11,"Up",0.0389406223081184,0.155229056050171,"L.LvsV.REACTOME_KETONE_BODY_METABOLISM"
565,"Down",0.0390024322487426,0.155318109857869,"L.LvsV.ZHOU_INFLAMMATORY_RESPONSE_LPS_UP"
31,"Down",0.0390411592504377,0.155318109857869,"L.LvsV.TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_TOP20_UP"
342,"Down",0.0390472368787191,0.155318109857869,"L.LvsV.HOLLMANN_APOPTOSIS_VIA_CD40_UP"
51,"Up",0.0391124185285805,0.155376803802745,"L.LvsV.TERAO_AOX4_TARGETS_SKIN_DN"
51,"Down",0.0391448521016861,0.155376803802745,"L.LvsV.XU_AKT1_TARGETS_6HR"
141,"Down",0.0391462990951753,0.155376803802745,"L.LvsV.PID_REG_GR_PATHWAY"
28,"Down",0.0392272652159416,0.155586477316314,"L.LvsV.OSAWA_TNF_TARGETS"
64,"Down",0.0393161573331761,0.155790056309749,"L.LvsV.WHITEHURST_PACLITAXEL_SENSITIVITY"
6,"Up",0.0393349463932735,0.155790056309749,"L.LvsV.REACTOME_METHIONINE_SALVAGE_PATHWAY"
1597,"Down",0.0394525634305949,0.156144039518797,"L.LvsV.REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION"
146,"Down",0.0394872468497636,0.156169519193378,"L.LvsV.YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_16"
22,"Down",0.039516721619009,0.156174377291995,"L.LvsV.VETTER_TARGETS_OF_PRKCA_AND_ETS1_UP"
28,"Down",0.0396931136633837,0.15675944674632,"L.LvsV.REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_ADDITIONAL_CELL_CYCLE_GENES_WHOSE_EXACT_ROLE_IN_THE_P53_PATHWAY_REMAIN_UNCERTAIN"
167,"Up",0.0397370249018988,0.156787573393065,"L.LvsV.REACTOME_MITOTIC_PROPHASE"
12,"Down",0.0397569502436386,0.156787573393065,"L.LvsV.REACTOME_INTERLEUKIN_6_SIGNALING"
97,"Down",0.0398572784756234,0.157071199352617,"L.LvsV.KUNINGER_IGF1_VS_PDGFB_TARGETS_DN"
81,"Up",0.0399188368272158,0.157201744172134,"L.LvsV.KEGG_AUTOIMMUNE_THYROID_DISEASE"
5,"Up",0.0399637894089587,0.157266755617176,"L.LvsV.REACTOME_SODIUM_COUPLED_PHOSPHATE_COTRANSPORTERS"
220,"Down",0.0400452329986503,0.157475173008206,"L.LvsV.RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN"
210,"Down",0.0401309902301825,0.157700245190248,"L.LvsV.HOELZEL_NF1_TARGETS_DN"
36,"Up",0.0401729644587145,0.157727322248906,"L.LvsV.BARIS_THYROID_CANCER_UP"
24,"Down",0.040194935259307,0.157727322248906,"L.LvsV.BIOCARTA_SPRY_PATHWAY"
62,"Down",0.040419903375318,0.158412005113239,"L.LvsV.REACTOME_SIGNALING_BY_SCF_KIT"
363,"Down",0.0404535640757794,0.158412005113239,"L.LvsV.REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION"
19,"Up",0.0404699829098798,0.158412005113239,"L.LvsV.REACTOME_TRAFFICKING_OF_GLUR2_CONTAINING_AMPA_RECEPTORS"
12,"Up",0.0404840230104915,0.158412005113239,"L.LvsV.BIOCARTA_CDC25_PATHWAY"
12,"Down",0.0405722294100273,0.158644877233409,"L.LvsV.REACTOME_ACTIVATED_NTRK2_SIGNALS_THROUGH_RAS"
24,"Up",0.040703536552053,0.159045832930248,"L.LvsV.REACTOME_ER_QUALITY_CONTROL_COMPARTMENT_ERQC"
222,"Down",0.0407337309491512,0.159051411312046,"L.LvsV.HOELZEL_NF1_TARGETS_UP"
315,"Down",0.0409368219018476,0.159731607830145,"L.LvsV.BENPORATH_NOS_TARGETS"
11,"Up",0.0410234224533171,0.159956630990402,"L.LvsV.BYSTRYKH_SCP2_QTL"
26,"Up",0.0411013354936803,0.160147486923579,"L.LvsV.PODAR_RESPONSE_TO_ADAPHOSTIN_DN"
29,"Down",0.0411632764193171,0.160275884029862,"L.LvsV.REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR3"
9,"Down",0.0413092097531316,0.16073090832165,"L.LvsV.CHEMELLO_SOLEUS_VS_EDL_MYOFIBERS_DN"
64,"Down",0.0414066327478664,0.16093985828207,"L.LvsV.LIU_BREAST_CANCER"
35,"Down",0.0414211282936129,0.16093985828207,"L.LvsV.PID_PRL_SIGNALING_EVENTS_PATHWAY"
44,"Down",0.0415356419334998,0.161169701587524,"L.LvsV.SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_DN"
65,"Down",0.0415385828833825,0.161169701587524,"L.LvsV.REACTOME_INSULIN_RECEPTOR_SIGNALLING_CASCADE"
92,"Up",0.0415945923302041,0.161258880518831,"L.LvsV.REACTOME_RAB_GEFS_EXCHANGE_GTP_FOR_GDP_ON_RABS"
38,"Down",0.0416198991680903,0.161258880518831,"L.LvsV.PID_CDC42_REG_PATHWAY"
244,"Down",0.0416770400503055,0.161367194984691,"L.LvsV.CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_UP"
6,"Down",0.0417385506796317,0.161492265015874,"L.LvsV.BIOCARTA_TERC_PATHWAY"
56,"Down",0.041941009205478,0.162162125802159,"L.LvsV.THEODOROU_MAMMARY_TUMORIGENESIS"
29,"Down",0.0419810887399988,0.162203661525824,"L.LvsV.ELLWOOD_MYC_TARGETS_UP"
667,"Down",0.0420948405661688,0.16252959042622,"L.LvsV.OSMAN_BLADDER_CANCER_DN"
21,"Down",0.0421376749052463,0.162581440719544,"L.LvsV.REACTOME_TNF_RECEPTOR_SUPERFAMILY_TNFSF_MEMBERS_MEDIATING_NON_CANONICAL_NF_KB_PATHWAY"
8,"Down",0.0422085432071405,0.162706333834626,"L.LvsV.REACTOME_FGFR3B_LIGAND_BINDING_AND_ACTIVATION"
14,"Down",0.0422438693231424,0.162706333834626,"L.LvsV.BIOCARTA_CELL2CELL_PATHWAY"
34,"Down",0.0422583279773055,0.162706333834626,"L.LvsV.KANG_CISPLATIN_RESISTANCE_UP"
498,"Down",0.0422964947120953,0.162715471687341,"L.LvsV.JOHNSTONE_PARVB_TARGETS_2_DN"
128,"Down",0.0423274902573124,0.162715471687341,"L.LvsV.REACTOME_HEDGEHOG_OFF_STATE"
59,"Down",0.0423760057614126,0.162715471687341,"L.LvsV.PID_A6B1_A6B4_INTEGRIN_PATHWAY"
96,"Down",0.042378419104679,0.162715471687341,"L.LvsV.MIKKELSEN_ES_HCP_WITH_H3K27ME3"
52,"Down",0.0424180108984872,0.162754463745826,"L.LvsV.FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_UP"
63,"Down",0.04246068596471,0.162783081065984,"L.LvsV.SU_PLACENTA"
27,"Down",0.0424979620815317,0.162783081065984,"L.LvsV.MOREIRA_RESPONSE_TO_TSA_DN"
10,"Down",0.0425137943677483,0.162783081065984,"L.LvsV.TURASHVILI_BREAST_CARCINOMA_DUCTAL_VS_LOBULAR_DN"
63,"Down",0.0425532254362234,0.162821303416525,"L.LvsV.DOANE_BREAST_CANCER_CLASSES_DN"
49,"Up",0.0428680387517563,0.163912438629641,"L.LvsV.YU_MYC_TARGETS_UP"
67,"Down",0.0429166000307445,0.163984714284717,"L.LvsV.HUMMEL_BURKITTS_LYMPHOMA_UP"
459,"Down",0.0430394054702059,0.164340381798873,"L.LvsV.LU_AGING_BRAIN_UP"
57,"Down",0.0432038048345836,0.164854269793246,"L.LvsV.SMID_BREAST_CANCER_RELAPSE_IN_LUNG_DN"
14,"Down",0.0434667257266255,0.165743121753457,"L.LvsV.REACTOME_SIGNALING_BY_ACTIVIN"
29,"Down",0.0437388410111599,0.166665783563545,"L.LvsV.REACTOME_ACTIVATION_OF_AMPK_DOWNSTREAM_OF_NMDARS"
21,"Down",0.0439081053245443,0.167195533291602,"L.LvsV.REACTOME_PI_3K_CASCADE_FGFR3"
111,"Up",0.0439455608267147,0.167222990922853,"L.LvsV.REACTOME_B_WICH_COMPLEX_POSITIVELY_REGULATES_RRNA_EXPRESSION"
127,"Down",0.0440407980877815,0.167338267966813,"L.LvsV.REACTOME_REGULATION_OF_PLK1_ACTIVITY_AT_G2_M_TRANSITION"
6,"Down",0.0440555720599523,0.167338267966813,"L.LvsV.REACTOME_SIGNALING_BY_MST1"
24,"Up",0.0440666518646554,0.167338267966813,"L.LvsV.WU_HBX_TARGETS_1_UP"
258,"Up",0.044098340925927,0.167343669855491,"L.LvsV.REACTOME_FATTY_ACID_METABOLISM"
65,"Down",0.0442250713650695,0.167667347867573,"L.LvsV.REACTOME_INTERLEUKIN_3_INTERLEUKIN_5_AND_GM_CSF_SIGNALING"
109,"Down",0.0442460651006938,0.167667347867573,"L.LvsV.ENGELMANN_CANCER_PROGENITORS_DN"
202,"Down",0.044274611663349,0.167667347867573,"L.LvsV.BROWNE_HCMV_INFECTION_20HR_DN"
230,"Down",0.0444167369689117,0.168090444011713,"L.LvsV.KEGG_CHEMOKINE_SIGNALING_PATHWAY"
827,"Up",0.0445768572178336,0.168581014745145,"L.LvsV.REACTOME_TRANSPORT_OF_SMALL_MOLECULES"
102,"Down",0.0446663682883321,0.168804067167593,"L.LvsV.REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION"
30,"Down",0.0446985923978959,0.168810462683037,"L.LvsV.YIH_RESPONSE_TO_ARSENITE_C2"
12,"Down",0.0447675448280486,0.168852440664248,"L.LvsV.NADELLA_PRKAR1A_TARGETS_UP"
37,"Down",0.044770786401481,0.168852440664248,"L.LvsV.BIOCARTA_HDAC_PATHWAY"
114,"Down",0.0448263841324905,0.168946883345971,"L.LvsV.REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES"
32,"Down",0.0450039119769498,0.169500428692477,"L.LvsV.NUMATA_CSF3_SIGNALING_VIA_STAT3"
62,"Down",0.0451440806372668,0.169878813684713,"L.LvsV.KORKOLA_CORRELATED_WITH_POU5F1"
54,"Down",0.0451658267528537,0.169878813684713,"L.LvsV.QI_HYPOXIA_TARGETS_OF_HIF1A_AND_FOXA2"
88,"Down",0.0451966098012427,0.16987903167306,"L.LvsV.LEE_AGING_MUSCLE_DN"
54,"Down",0.0452699641316,0.170039151958979,"L.LvsV.BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_DN"
382,"Down",0.045507925137381,0.170816916554365,"L.LvsV.CAIRO_HEPATOBLASTOMA_CLASSES_DN"
19,"Down",0.0455855679747254,0.17096564444668,"L.LvsV.LI_CYTIDINE_ANALOGS_CYCTOTOXICITY"
24,"Down",0.0456093914919249,0.17096564444668,"L.LvsV.XU_CREBBP_TARGETS_UP"
975,"Down",0.0457160368171248,0.171249300516181,"L.LvsV.BENPORATH_PRC2_TARGETS"
28,"Down",0.0458879291485035,0.171776818051507,"L.LvsV.NELSON_RESPONSE_TO_ANDROGEN_DN"
83,"Down",0.0459425603030256,0.17186496340692,"L.LvsV.REACTOME_CA2_PATHWAY"
161,"Down",0.0460158605848765,0.171977621051983,"L.LvsV.SESTO_RESPONSE_TO_UV_C8"
359,"Down",0.0460348849985413,0.171977621051983,"L.LvsV.MASSARWEH_TAMOXIFEN_RESISTANCE_DN"
113,"Down",0.046142596796426,0.172263617614746,"L.LvsV.PID_PTP1B_PATHWAY"
745,"Down",0.0461890891819686,0.172320832717344,"L.LvsV.MEISSNER_NPC_HCP_WITH_H3K4ME2"
11,"Down",0.0464618535194164,0.173158520459224,"L.LvsV.BIOCARTA_ERBB4_PATHWAY"
32,"Up",0.0464762605103071,0.173158520459224,"L.LvsV.KEGG_GLYCINE_SERINE_AND_THREONINE_METABOLISM"
125,"Down",0.0465398134982217,0.173278537933783,"L.LvsV.TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP"
325,"Down",0.0466125227915185,0.173432461988093,"L.LvsV.LEE_DIFFERENTIATING_T_LYMPHOCYTE"
11,"Up",0.0467062510492661,0.17366433224707,"L.LvsV.MARIADASON_RESPONSE_TO_BUTYRATE_CURCUMIN_SULINDAC_TSA_2"
129,"Down",0.0467567506132528,0.173735264879486,"L.LvsV.REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS"
500,"Down",0.0468276042220175,0.173881681493307,"L.LvsV.WANG_SMARCE1_TARGETS_UP"
194,"Down",0.0469000603235533,0.174033848005991,"L.LvsV.RODRIGUES_DCC_TARGETS_DN"
37,"Down",0.0469371779323275,0.174054766457303,"L.LvsV.IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_UP"
41,"Down",0.0469732161002824,0.174071656714786,"L.LvsV.ZHAN_MULTIPLE_MYELOMA_SPIKED"
25,"Down",0.0470358997208245,0.174141582621499,"L.LvsV.VERRECCHIA_RESPONSE_TO_TGFB1_C3"
10,"Up",0.0470550776698353,0.174141582621499,"L.LvsV.REACTOME_DISPLACEMENT_OF_DNA_GLYCOSYLASE_BY_APEX1"
51,"Down",0.0471279548233495,0.174294623557391,"L.LvsV.SIMBULAN_PARP1_TARGETS_UP"
181,"Down",0.0471935930303413,0.174336544913593,"L.LvsV.GRADE_COLON_AND_RECTAL_CANCER_DN"
51,"Up",0.0472023526380265,0.174336544913593,"L.LvsV.GUILLAUMOND_KLF10_TARGETS_DN"
79,"Down",0.0472892437560779,0.174510494123324,"L.LvsV.MEDINA_SMARCA4_TARGETS"
69,"Down",0.0473387565622292,0.174510494123324,"L.LvsV.PID_UPA_UPAR_PATHWAY"
60,"Down",0.0473752435951894,0.174510494123324,"L.LvsV.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_UP"
896,"Up",0.0473757011537545,0.174510494123324,"L.LvsV.REACTOME_METABOLISM_OF_LIPIDS"
49,"Down",0.0476292464504756,0.175327632240133,"L.LvsV.REACTOME_STRIATED_MUSCLE_CONTRACTION"
7,"Down",0.047794409118096,0.175709165478333,"L.LvsV.REACTOME_ACROSOME_REACTION_AND_SPERM_OOCYTE_MEMBRANE_BINDING"
5,"Up",0.0477964523203856,0.175709165478333,"L.LvsV.REACTOME_GALACTOSE_CATABOLISM"
63,"Down",0.047938136285504,0.176112927257509,"L.LvsV.KEGG_NON_SMALL_CELL_LUNG_CANCER"
22,"Down",0.0481977231779971,0.176949011587746,"L.LvsV.BIOCARTA_GRANULOCYTES_PATHWAY"
40,"Down",0.0482727487211555,0.177106853138201,"L.LvsV.STAMBOLSKY_BOUND_BY_MUTATED_TP53"
14,"Down",0.0483622106038408,0.177317415403605,"L.LvsV.BIOCARTA_NEUTROPHIL_PATHWAY"
45,"Down",0.0485733851169952,0.177925232749031,"L.LvsV.RODRIGUES_NTN1_AND_DCC_TARGETS"
10,"Down",0.0485923496927179,0.177925232749031,"L.LvsV.NIKOLSKY_BREAST_CANCER_10Q22_AMPLICON"
74,"Down",0.0489079991860589,0.178962493381681,"L.LvsV.LEE_AGING_MUSCLE_UP"
27,"Up",0.0489518236906959,0.178994960846147,"L.LvsV.MOOTHA_FFA_OXYDATION"
38,"Down",0.0490579903022768,0.178994960846147,"L.LvsV.LUI_THYROID_CANCER_CLUSTER_3"
136,"Down",0.0490644341260211,0.178994960846147,"L.LvsV.DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_DN"
12,"Up",0.0490892382190436,0.178994960846147,"L.LvsV.BIOCARTA_GABA_PATHWAY"
16,"Down",0.0491081265764724,0.178994960846147,"L.LvsV.POS_RESPONSE_TO_HISTAMINE_UP"
74,"Down",0.0491111151390134,0.178994960846147,"L.LvsV.BURTON_ADIPOGENESIS_PEAK_AT_8HR"
96,"Down",0.0492363143651439,0.179298691131451,"L.LvsV.OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_UP"
270,"Down",0.0492873402355106,0.179298691131451,"L.LvsV.ONDER_CDH1_TARGETS_1_DN"
237,"Down",0.0492917363935261,0.179298691131451,"L.LvsV.DAZARD_UV_RESPONSE_CLUSTER_G6"
6,"Down",0.0494620346960343,0.179732084455346,"L.LvsV.BIOCARTA_PELP1_PATHWAY"
395,"Down",0.0494758966433419,0.179732084455346,"L.LvsV.SENESE_HDAC1_AND_HDAC2_TARGETS_UP"
156,"Down",0.0495560004214436,0.179869881808909,"L.LvsV.LEE_AGING_CEREBELLUM_UP"
8,"Up",0.0496074206916527,0.179869881808909,"L.LvsV.REACTOME_TLR3_MEDIATED_TICAM1_DEPENDENT_PROGRAMMED_CELL_DEATH"
394,"Down",0.0496114251688526,0.179869881808909,"L.LvsV.SENESE_HDAC1_AND_HDAC2_TARGETS_DN"
254,"Down",0.0496737613056905,0.179977867797617,"L.LvsV.CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_DN"
88,"Down",0.0498468113100919,0.180486587906679,"L.LvsV.SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM6"
6,"Up",0.0499727791219499,0.180733191318377,"L.LvsV.REACTOME_GDP_FUCOSE_BIOSYNTHESIS"
6,"Down",0.0500058376337891,0.180733191318377,"L.LvsV.REACTOME_SYNTHESIS_OF_PI"
51,"Up",0.0500129829475704,0.180733191318377,"L.LvsV.BERNARD_PPAPDC1B_TARGETS_UP"
445,"Up",0.0500643250112484,0.180743022697466,"L.LvsV.HORIUCHI_WTAP_TARGETS_DN"
56,"Up",0.0500810835182705,0.180743022697466,"L.LvsV.KEGG_STARCH_AND_SUCROSE_METABOLISM"
137,"Down",0.050137521620359,0.180828673867557,"L.LvsV.BROWNE_HCMV_INFECTION_6HR_UP"
40,"Up",0.0502745089501156,0.181093207391303,"L.LvsV.GUTIERREZ_MULTIPLE_MYELOMA_UP"
40,"Down",0.0502763742712336,0.181093207391303,"L.LvsV.REACTOME_CARBOXYTERMINAL_POST_TRANSLATIONAL_MODIFICATIONS_OF_TUBULIN"
59,"Down",0.0503290983259581,0.181165094169416,"L.LvsV.VALK_AML_CLUSTER_15"
56,"Down",0.0503969466595399,0.181291293481194,"L.LvsV.REACTOME_IRS_MEDIATED_SIGNALLING"
13,"Down",0.0506227491693277,0.181985162650984,"L.LvsV.REACTOME_ERBB2_ACTIVATES_PTK6_SIGNALING"
106,"Down",0.0507891569147033,0.182464748915786,"L.LvsV.WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_TBH"
42,"Down",0.0508488629637164,0.182560625536616,"L.LvsV.REACTOME_RAF_ACTIVATION"
88,"Up",0.0509227409387079,0.182707225600335,"L.LvsV.REACTOME_DNA_REPLICATION_PRE_INITIATION"
82,"Down",0.0509764885082637,0.182781455876907,"L.LvsV.HALMOS_CEBPA_TARGETS_UP"
55,"Down",0.0510789183413962,0.182936803846868,"L.LvsV.SPIRA_SMOKERS_LUNG_CANCER_DN"
32,"Down",0.0511087586681154,0.182936803846868,"L.LvsV.BIOCARTA_PAR1_PATHWAY"
69,"Up",0.0511190743250879,0.182936803846868,"L.LvsV.GENTILE_UV_HIGH_DOSE_UP"
56,"Down",0.0511871056404602,0.183061776899162,"L.LvsV.DAIRKEE_CANCER_PRONE_RESPONSE_E2"
75,"Up",0.0513926899108775,0.183592907189147,"L.LvsV.FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_DN"
37,"Down",0.0514020293595225,0.183592907189147,"L.LvsV.BIOCARTA_EDG1_PATHWAY"
12,"Down",0.0515231828787224,0.183906829009978,"L.LvsV.REACTOME_ROLE_OF_ABL_IN_ROBO_SLIT_SIGNALING"
92,"Down",0.0516355418537285,0.184150124735427,"L.LvsV.KEGG_ERBB_SIGNALING_PATHWAY"
61,"Down",0.051657956857415,0.184150124735427,"L.LvsV.POMEROY_MEDULLOBLASTOMA_PROGNOSIS_DN"
65,"Up",0.0517742359619483,0.184445715614441,"L.LvsV.TANG_SENESCENCE_TP53_TARGETS_UP"
80,"Down",0.0518109937554939,0.184457813569946,"L.LvsV.REACTOME_TRANSCRIPTIONAL_REGULATION_BY_MECP2"
47,"Down",0.0518476378738389,0.184469491508659,"L.LvsV.PID_ALPHA_SYNUCLEIN_PATHWAY"
343,"Down",0.0519502257327163,0.184715625772469,"L.LvsV.GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP"
61,"Down",0.0520283453751919,0.184785604452893,"L.LvsV.REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_CELL_CYCLE_GENES"
10,"Up",0.0520367491649764,0.184785604452893,"L.LvsV.REACTOME_E2F_ENABLED_INHIBITION_OF_PRE_REPLICATION_COMPLEX_FORMATION"
176,"Down",0.0521452804941313,0.184842112795957,"L.LvsV.NABA_ECM_AFFILIATED"
51,"Down",0.052152818356713,0.184842112795957,"L.LvsV.REACTOME_SIGNALING_BY_FGFR2_IN_DISEASE"
64,"Down",0.0521573056874846,0.184842112795957,"L.LvsV.POS_HISTAMINE_RESPONSE_NETWORK"
91,"Down",0.0521863877870299,0.184842112795957,"L.LvsV.PID_TELOMERASE_PATHWAY"
31,"Down",0.0525210078887391,0.185796296547101,"L.LvsV.REACTOME_INTERLEUKIN_RECEPTOR_SHC_SIGNALING"
13,"Down",0.0525229899625825,0.185796296547101,"L.LvsV.BIOCARTA_LYMPHOCYTE_PATHWAY"
9,"Down",0.0525698895166236,0.185796607593489,"L.LvsV.KUWANO_RNA_STABILIZED_BY_NO"
130,"Down",0.0525902859258112,0.185796607593489,"L.LvsV.SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER"
35,"Down",0.0529925334916951,0.187098159435238,"L.LvsV.NIKOLSKY_OVERCONNECTED_IN_BREAST_CANCER"
279,"Up",0.0530749917933937,0.187269706206557,"L.LvsV.REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT"
5,"Up",0.0531442308490816,0.187394421150875,"L.LvsV.REACTOME_FASL_CD95L_SIGNALING"
523,"Down",0.0532189367593517,0.187538241773394,"L.LvsV.KOYAMA_SEMA3B_TARGETS_DN"
453,"Down",0.0533531918162276,0.187891590797403,"L.LvsV.SANSOM_APC_TARGETS"
16,"Down",0.053483488195425,0.18822054639068,"L.LvsV.REACTOME_ACTIVATED_NTRK2_SIGNALS_THROUGH_FYN"
74,"Up",0.0535481781903158,0.18822054639068,"L.LvsV.DALESSIO_TSA_RESPONSE"
16,"Up",0.0535487284269379,0.18822054639068,"L.LvsV.REACTOME_SYNTHESIS_OF_PE"
456,"Down",0.0535960399001013,0.188267156675769,"L.LvsV.GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN"
15,"Down",0.053717980876095,0.188575692865987,"L.LvsV.GOUYER_TATI_TARGETS_UP"
117,"Down",0.0539125086131536,0.189138489925207,"L.LvsV.BHAT_ESR1_TARGETS_VIA_AKT1_DN"
19,"Down",0.0541768107349424,0.189861140092121,"L.LvsV.REACTOME_SHC_MEDIATED_CASCADE_FGFR3"
63,"Down",0.0542017508345323,0.189861140092121,"L.LvsV.ZHAN_MULTIPLE_MYELOMA_CD2_UP"
303,"Down",0.0542427905473485,0.189861140092121,"L.LvsV.FIGUEROA_AML_METHYLATION_CLUSTER_3_UP"
36,"Up",0.0542558512109877,0.189861140092121,"L.LvsV.KEGG_REGULATION_OF_AUTOPHAGY"
173,"Down",0.0543808576381974,0.190178217508914,"L.LvsV.HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_UP"
13,"Up",0.0544900378068597,0.190412447838848,"L.LvsV.REACTOME_MUCOPOLYSACCHARIDOSES"
43,"Down",0.0545167127742623,0.190412447838848,"L.LvsV.WEST_ADRENOCORTICAL_TUMOR_MARKERS_DN"
144,"Down",0.0545556057377172,0.190427995027676,"L.LvsV.SWEET_KRAS_TARGETS_UP"
12,"Up",0.0546838757721169,0.190692734074818,"L.LvsV.REACTOME_TANDEM_PORE_DOMAIN_POTASSIUM_CHANNELS"
12,"Down",0.0547185006040611,0.190692734074818,"L.LvsV.KUMAMOTO_RESPONSE_TO_NUTLIN_3A_UP"
18,"Down",0.054734919330211,0.190692734074818,"L.LvsV.MARKS_ACETYLATED_NON_HISTONE_PROTEINS"
944,"Down",0.0547706661507074,0.190697111553691,"L.LvsV.MIKKELSEN_MEF_HCP_WITH_H3K27ME3"
35,"Down",0.0548637324216537,0.190900929238089,"L.LvsV.REACTOME_ACTIVATION_OF_KAINATE_RECEPTORS_UPON_GLUTAMATE_BINDING"
1483,"Down",0.0552982414022842,0.192291809253603,"L.LvsV.BENPORATH_SUZ12_TARGETS"
7,"Up",0.0554101281014564,0.192559772641705,"L.LvsV.TESAR_ALK_AND_JAK_TARGETS_MOUSE_ES_D4_DN"
13,"Down",0.0554881523238041,0.192651244248839,"L.LvsV.BIOCARTA_FIBRINOLYSIS_PATHWAY"
28,"Down",0.0555061371113043,0.192651244248839,"L.LvsV.SEKI_INFLAMMATORY_RESPONSE_LPS_DN"
134,"Down",0.0555818056166649,0.192705138527985,"L.LvsV.HINATA_NFKB_TARGETS_FIBROBLAST_UP"
44,"Down",0.0555913720296865,0.192705138527985,"L.LvsV.RODRIGUES_NTN1_TARGETS_UP"
63,"Down",0.0556419536183483,0.192759625034992,"L.LvsV.TRAYNOR_RETT_SYNDROM_UP"
24,"Down",0.055707789397726,0.192866855090812,"L.LvsV.REACTOME_DCC_MEDIATED_ATTRACTIVE_SIGNALING"
9,"Up",0.0557985408517299,0.193060157928169,"L.LvsV.SEMBA_FHIT_TARGETS_DN"
62,"Down",0.0560057450579265,0.193655887695607,"L.LvsV.REACTOME_GPVI_MEDIATED_ACTIVATION_CASCADE"
35,"Down",0.0561692921266266,0.194100010105074,"L.LvsV.REACTOME_GAP_JUNCTION_ASSEMBLY"
140,"Down",0.0563117210163931,0.194470646783034,"L.LvsV.DUAN_PRDM5_TARGETS"
23,"Up",0.0563717842794542,0.194556551361487,"L.LvsV.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BROWN_UP"
49,"Down",0.0564516198526437,0.194710546578457,"L.LvsV.PID_MAPK_TRK_PATHWAY"
91,"Down",0.0565109616926703,0.194793707729909,"L.LvsV.MASSARWEH_RESPONSE_TO_ESTRADIOL"
70,"Up",0.0566477012748276,0.195143389625247,"L.LvsV.MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_DN"
28,"Down",0.0567101154153727,0.195236754751928,"L.LvsV.SCHAVOLT_TARGETS_OF_TP53_AND_TP63"
19,"Down",0.0568423133966275,0.19557010004353,"L.LvsV.YANG_BCL3_TARGETS_DN"
215,"Up",0.0570919268769637,0.196306756034038,"L.LvsV.WINNEPENNINCKX_MELANOMA_METASTASIS_UP"
31,"Down",0.0572464439992348,0.196569799829247,"L.LvsV.INAMURA_LUNG_CANCER_SCC_UP"
9,"Up",0.0572515831360144,0.196569799829247,"L.LvsV.REACTOME_VITAMIN_C_ASCORBATE_METABOLISM"
18,"Down",0.0572895319774466,0.196569799829247,"L.LvsV.REACTOME_LOSS_OF_FUNCTION_OF_MECP2_IN_RETT_SYNDROME"
8,"Up",0.057310637967941,0.196569799829247,"L.LvsV.REACTOME_SYNTHESIS_OF_KETONE_BODIES"
11,"Down",0.0574380418097121,0.196805619662536,"L.LvsV.WORSCHECH_TUMOR_REJECTION_DN"
98,"Down",0.0574814615591314,0.196805619662536,"L.LvsV.REACTOME_CLASS_B_2_SECRETIN_FAMILY_RECEPTORS"
11,"Down",0.0574861775646583,0.196805619662536,"L.LvsV.REACTOME_SYNTHESIS_OF_LIPOXINS_LX"
46,"Up",0.0575373864593896,0.196859040676959,"L.LvsV.REACTOME_DETOXIFICATION_OF_REACTIVE_OXYGEN_SPECIES"
879,"Down",0.0578089719292561,0.197574880736967,"L.LvsV.WEST_ADRENOCORTICAL_TUMOR_DN"
73,"Down",0.0578408611818204,0.197574880736967,"L.LvsV.IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_DN"
611,"Down",0.0578538129703652,0.197574880736967,"L.LvsV.GRUETZMANN_PANCREATIC_CANCER_UP"
96,"Up",0.0579719309353625,0.197856053173839,"L.LvsV.REACTOME_ABC_TRANSPORTER_DISORDERS"
17,"Down",0.0580798873967675,0.198102219257697,"L.LvsV.BIOCARTA_RANBP2_PATHWAY"
143,"Down",0.0581772983019917,0.198230589594979,"L.LvsV.LIU_COMMON_CANCER_GENES"
19,"Up",0.0581892289586998,0.198230589594979,"L.LvsV.REACTOME_SYNTHESIS_SECRETION_AND_INACTIVATION_OF_GLUCOSE_DEPENDENT_INSULINOTROPIC_POLYPEPTIDE_GIP"
131,"Up",0.0583599954499116,0.198689910617341,"L.LvsV.HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_UP"
71,"Up",0.0584470851386073,0.198770267303712,"L.LvsV.KEGG_TYPE_I_DIABETES_MELLITUS"
257,"Down",0.0584554991202452,0.198770267303712,"L.LvsV.GAVIN_FOXP3_TARGETS_CLUSTER_P3"
73,"Down",0.0585441447893843,0.198865608472773,"L.LvsV.HUANG_FOXA2_TARGETS_UP"
231,"Up",0.058555473068127,0.198865608472773,"L.LvsV.BASSO_B_LYMPHOCYTE_NETWORK"
32,"Up",0.0587078057560529,0.199260563551391,"L.LvsV.KEGG_O_GLYCAN_BIOSYNTHESIS"
39,"Down",0.0587506399045875,0.199283612289856,"L.LvsV.BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_UP"
42,"Down",0.0589055741456108,0.199632730427407,"L.LvsV.REACTOME_G_PROTEIN_BETA_GAMMA_SIGNALLING"
178,"Up",0.0589257761001135,0.199632730427407,"L.LvsV.LINDGREN_BLADDER_CANCER_WITH_LOH_IN_CHR9Q"
37,"Down",0.0589748506009387,0.199676637460251,"L.LvsV.REACTOME_FGFR2_MUTANT_RECEPTOR_ACTIVATION"
25,"Down",0.0591105491058943,0.200013602207154,"L.LvsV.REACTOME_SIGNALING_BY_ERBB2_ECD_MUTANTS"
8,"Down",0.0592613790390464,0.20007097842623,"L.LvsV.REACTOME_FBXW7_MUTANTS_AND_NOTCH1_IN_CANCER"
44,"Down",0.0592925846201153,0.20007097842623,"L.LvsV.LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_UP"
63,"Down",0.059308306754861,0.20007097842623,"L.LvsV.BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_DN"
11,"Down",0.0593151924075059,0.20007097842623,"L.LvsV.REACTOME_PP2A_MEDIATED_DEPHOSPHORYLATION_OF_KEY_METABOLIC_FACTORS"
129,"Up",0.0593427742013068,0.20007097842623,"L.LvsV.REACTOME_RNA_POLYMERASE_I_TRANSCRIPTION"
44,"Up",0.0593446201155756,0.20007097842623,"L.LvsV.KEGG_PROTEASOME"
80,"Down",0.0595044850206754,0.200487689018473,"L.LvsV.TONG_INTERACT_WITH_PTTG1"
658,"Down",0.0595858054878616,0.200639414459432,"L.LvsV.DELACROIX_RAR_BOUND_ES"
15,"Down",0.0596289709397533,0.200662556497806,"L.LvsV.REACTOME_REMOVAL_OF_AMINOTERMINAL_PROPEPTIDES_FROM_GAMMA_CARBOXYLATED_PROTEINS"
125,"Down",0.059860273883728,0.201318402860786,"L.LvsV.PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP"
121,"Down",0.0599443365503987,0.201426805514387,"L.LvsV.PEART_HDAC_PROLIFERATION_CLUSTER_DN"
21,"Down",0.0599653683987487,0.201426805514387,"L.LvsV.BIOCARTA_MYOSIN_PATHWAY"
77,"Down",0.0600372780279183,0.201515016792995,"L.LvsV.MAGRANGEAS_MULTIPLE_MYELOMA_IGLL_VS_IGLK_UP"
167,"Down",0.0600645230014208,0.201515016792995,"L.LvsV.SMID_BREAST_CANCER_RELAPSE_IN_BONE_UP"
13,"Down",0.0602026713459612,0.201856015689399,"L.LvsV.REACTOME_INACTIVATION_OF_CDC42_AND_RAC1"
40,"Down",0.0603030408394278,0.202023310723296,"L.LvsV.REACTOME_SIGNALLING_TO_ERKS"
42,"Down",0.0603256440593527,0.202023310723296,"L.LvsV.ODONNELL_METASTASIS_DN"
209,"Down",0.0605520254148769,0.202438709361664,"L.LvsV.KAYO_CALORIE_RESTRICTION_MUSCLE_UP"
289,"Down",0.0605522368223786,0.202438709361664,"L.LvsV.NABA_CORE_MATRISOME"
26,"Down",0.0605595270906479,0.202438709361664,"L.LvsV.REACTOME_PROTEIN_METHYLATION"
46,"Down",0.0606830111495539,0.20266738043387,"L.LvsV.ZHAN_LATE_DIFFERENTIATION_GENES_UP"
60,"Down",0.0607012447094391,0.20266738043387,"L.LvsV.NOUSHMEHR_GBM_SILENCED_BY_METHYLATION"
279,"Down",0.0608742071877923,0.202946252461667,"L.LvsV.PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_DN"
200,"Up",0.0608854634970753,0.202946252461667,"L.LvsV.CAMPS_COLON_CANCER_COPY_NUMBER_DN"
32,"Up",0.0608948874722201,0.202946252461667,"L.LvsV.REACTOME_ACTIVATION_OF_THE_PRE_REPLICATIVE_COMPLEX"
35,"Down",0.0610316755872913,0.203279598989237,"L.LvsV.BIOCARTA_VDR_PATHWAY"
137,"Up",0.061098929789624,0.203381085374371,"L.LvsV.KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS"
34,"Down",0.0612237940762897,0.203674101954155,"L.LvsV.REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION"
5,"Up",0.0612778462245367,0.203731336004488,"L.LvsV.REACTOME_BETA_OXIDATION_OF_OCTANOYL_COA_TO_HEXANOYL_COA"
365,"Down",0.0613768732579223,0.203937940049911,"L.LvsV.PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP"
51,"Down",0.0614518169307934,0.204064321808022,"L.LvsV.PLASARI_NFIC_TARGETS_BASAL_DN"
60,"Up",0.0616355484586737,0.204488294732765,"L.LvsV.LANDIS_BREAST_CANCER_PROGRESSION_UP"
23,"Down",0.0616602099266978,0.204488294732765,"L.LvsV.DING_LUNG_CANCER_MUTATED_FREQUENTLY"
103,"Up",0.061690445942169,0.204488294732765,"L.LvsV.REACTOME_GLUCOSE_METABOLISM"
54,"Up",0.0618378809429141,0.2048541903735,"L.LvsV.REACTOME_HDMS_DEMETHYLATE_HISTONES"
35,"Down",0.0619309628043394,0.205039696613888,"L.LvsV.SEIDEN_MET_SIGNALING"
51,"Down",0.0620269321798488,0.205234535022372,"L.LvsV.LE_SKI_TARGETS_UP"
73,"Down",0.0621381774366525,0.205479654932567,"L.LvsV.REACTOME_NETRIN_1_SIGNALING"
499,"Down",0.0621798874506118,0.205494678849033,"L.LvsV.KAYO_AGING_MUSCLE_UP"
118,"Down",0.0622711004038681,0.205673186459371,"L.LvsV.KEGG_SMALL_CELL_LUNG_CANCER"
16,"Down",0.0624858278043776,0.206259189212181,"L.LvsV.BIOCARTA_AGPCR_PATHWAY"
82,"Down",0.0625870753414833,0.206470131004213,"L.LvsV.BIOCARTA_NFAT_PATHWAY"
303,"Down",0.0627828743257333,0.206992553456756,"L.LvsV.ZWANG_EGF_INTERVAL_DN"
159,"Down",0.0628932936581714,0.207233027792628,"L.LvsV.CAMPS_COLON_CANCER_COPY_NUMBER_UP"
239,"Down",0.0629859576313774,0.207414746720599,"L.LvsV.SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM5"
35,"Up",0.0630827147282223,0.207609720078775,"L.LvsV.KEGG_BASE_EXCISION_REPAIR"
12,"Down",0.0631349080907912,0.207657886278396,"L.LvsV.TCGA_GLIOBLASTOMA_MUTATED"
35,"Up",0.0631729460516979,0.207659464161616,"L.LvsV.KEGG_DNA_REPLICATION"
5,"Up",0.0632395319704688,0.207754826063412,"L.LvsV.REACTOME_PTK6_EXPRESSION"
23,"Down",0.063342757493005,0.20788427481755,"L.LvsV.REACTOME_SIGNALING_BY_FGFR2_IIIA_TM"
25,"Down",0.0633541333093817,0.20788427481755,"L.LvsV.MIKKELSEN_ES_LCP_WITH_H3K27ME3"
104,"Up",0.0635092926720135,0.208149128992924,"L.LvsV.REACTOME_HDACS_DEACETYLATE_HISTONES"
59,"Down",0.0635294978768554,0.208149128992924,"L.LvsV.PID_HNF3B_PATHWAY"
14,"Down",0.0635477897883985,0.208149128992924,"L.LvsV.REACTOME_RUNX3_REGULATES_WNT_SIGNALING"
41,"Up",0.063668312649932,0.20830574231619,"L.LvsV.REACTOME_GLYCOSPHINGOLIPID_METABOLISM"
31,"Up",0.063670953972574,0.20830574231619,"L.LvsV.REACTOME_MISCELLANEOUS_TRANSPORT_AND_BINDING_EVENTS"
152,"Down",0.0638413521602019,0.208739702006952,"L.LvsV.WONG_ENDMETRIUM_CANCER_DN"
879,"Down",0.0642531989100461,0.209957579056774,"L.LvsV.MEISSNER_NPC_HCP_WITH_H3_UNMETHYLATED"
38,"Down",0.0642897777795474,0.209957579056774,"L.LvsV.MEISSNER_NPC_ICP_WITH_H3_UNMETHYLATED"
388,"Down",0.0644009537228594,0.210196501259557,"L.LvsV.MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_DN"
67,"Down",0.0646992198146344,0.210957115320314,"L.LvsV.BIOCARTA_TCR_PATHWAY"
331,"Down",0.0647103034153106,0.210957115320314,"L.LvsV.LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP"
17,"Down",0.0647769324778297,0.211008163880176,"L.LvsV.TURASHVILI_BREAST_NORMAL_DUCTAL_VS_LOBULAR_DN"
67,"Down",0.064810608893437,0.211008163880176,"L.LvsV.KYNG_DNA_DAMAGE_BY_4NQO"
103,"Down",0.0648404540481858,0.211008163880176,"L.LvsV.BROWNE_HCMV_INFECTION_4HR_UP"
19,"Down",0.0651622605020035,0.2118061500376,"L.LvsV.REACTOME_OAS_ANTIVIRAL_RESPONSE"
60,"Down",0.0651622827299615,0.2118061500376,"L.LvsV.LU_TUMOR_VASCULATURE_UP"
64,"Down",0.0661433405113342,0.214868701343811,"L.LvsV.PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_6"
55,"Up",0.0664321304114114,0.215680122750848,"L.LvsV.REACTOME_TRANSPORT_OF_VITAMINS_NUCLEOSIDES_AND_RELATED_MOLECULES"
1318,"Down",0.0666379069248253,0.216221236729671,"L.LvsV.GOZGIT_ESR1_TARGETS_DN"
168,"Down",0.0667537095495269,0.216469947272337,"L.LvsV.REACTOME_DEATH_RECEPTOR_SIGNALLING"
30,"Down",0.0668600364009321,0.216687656073126,"L.LvsV.REACTOME_REGULATION_OF_IFNA_SIGNALING"
37,"Up",0.0669251719879444,0.216771690639335,"L.LvsV.WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_36HR"
186,"Down",0.0670541936034597,0.217062433509092,"L.LvsV.BROWNE_HCMV_INFECTION_12HR_DN"
12,"Down",0.0671998060718343,0.217406511276286,"L.LvsV.GILMORE_CORE_NFKB_PATHWAY"
70,"Down",0.0673730743783677,0.217839607156722,"L.LvsV.SIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES"
10,"Up",0.0675184391145341,0.218182027974435,"L.LvsV.REACTOME_HDR_THROUGH_MMEJ_ALT_NHEJ"
62,"Down",0.0676864531198513,0.218597195852604,"L.LvsV.PID_ARF6_PATHWAY"
63,"Down",0.0679056439832924,0.219177061052903,"L.LvsV.SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_DN"
106,"Down",0.0679879296449051,0.219314622524318,"L.LvsV.BILANGES_RAPAMYCIN_SENSITIVE_VIA_TSC1_AND_TSC2"
13,"Down",0.068082347390884,0.219491136282331,"L.LvsV.REACTOME_P38MAPK_EVENTS"
24,"Up",0.0682331831320072,0.219849224671834,"L.LvsV.BIOCARTA_ATRBRCA_PATHWAY"
757,"Down",0.0682965272816978,0.219925159778979,"L.LvsV.SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP"
71,"Down",0.0683444711217512,0.219951444023377,"L.LvsV.ZHENG_FOXP3_TARGETS_IN_T_LYMPHOCYTE_DN"
53,"Down",0.0684360759550323,0.220072238707743,"L.LvsV.BIOCARTA_P38MAPK_PATHWAY"
143,"Down",0.0684616116074007,0.220072238707743,"L.LvsV.LIN_APC_TARGETS"
20,"Down",0.0686018152392179,0.220394791666261,"L.LvsV.CAFFAREL_RESPONSE_TO_THC_8HR_5_DN"
47,"Down",0.0688612913589686,0.221013759878101,"L.LvsV.BIOCARTA_PDGF_PATHWAY"
63,"Down",0.0688744272508534,0.221013759878101,"L.LvsV.REACTOME_SIGNALING_BY_TYPE_1_INSULIN_LIKE_GROWTH_FACTOR_1_RECEPTOR_IGF1R"
107,"Down",0.0690488579439475,0.221444974229748,"L.LvsV.KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY"
25,"Up",0.0691370540722088,0.22151037960814,"L.LvsV.AUJLA_IL22_AND_IL17A_SIGNALING"
11,"Up",0.0691493787671639,0.22151037960814,"L.LvsV.MIZUSHIMA_AUTOPHAGOSOME_FORMATION"
28,"Up",0.0691994427839218,0.221542396729765,"L.LvsV.TOMLINS_METASTASIS_DN"
22,"Up",0.0692497425978261,0.22157513126353,"L.LvsV.FARMER_BREAST_CANCER_CLUSTER_6"
21,"Up",0.0694163301871563,0.221704365831804,"L.LvsV.SCHWAB_TARGETS_OF_BMYB_POLYMORPHIC_VARIANTS_UP"
10,"Down",0.0694170343278261,0.221704365831804,"L.LvsV.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_21"
127,"Down",0.0694202015208038,0.221704365831804,"L.LvsV.SANA_TNF_SIGNALING_DN"
178,"Up",0.0694505266089138,0.221704365831804,"L.LvsV.REACTOME_S_PHASE"
58,"Up",0.0695579094149845,0.221771705873906,"L.LvsV.WANG_RESPONSE_TO_ANDROGEN_UP"
113,"Up",0.0695598354659174,0.221771705873906,"L.LvsV.HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_UP"
10,"Down",0.0695919532811044,0.221771705873906,"L.LvsV.KAUFFMANN_MELANOMA_RELAPSE_DN"
13,"Down",0.0696472889249994,0.221820196121153,"L.LvsV.REACTOME_P75NTR_REGULATES_AXONOGENESIS"
2169,"Down",0.0697659176857432,0.222070097227676,"L.LvsV.PUJANA_ATM_PCC_NETWORK"
34,"Down",0.0698875805887385,0.22232936310422,"L.LvsV.KIM_MYCL1_AMPLIFICATION_TARGETS_DN"
9,"Down",0.0701701218179839,0.223099829517903,"L.LvsV.CALVET_IRINOTECAN_SENSITIVE_VS_REVERTED_UP"
377,"Down",0.0702267946121829,0.22315169391423,"L.LvsV.MANALO_HYPOXIA_UP"
37,"Down",0.0703392556533661,0.223380668872752,"L.LvsV.REACTOME_SUMOYLATION_OF_INTRACELLULAR_RECEPTORS"
59,"Down",0.0703929720313012,0.223422929024721,"L.LvsV.VALK_AML_CLUSTER_4"
172,"Down",0.07052504156965,0.22360087006371,"L.LvsV.KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP"
19,"Down",0.0705299181391048,0.22360087006371,"L.LvsV.REACTOME_PI3K_EVENTS_IN_ERBB2_SIGNALING"
10,"Up",0.0706673299765507,0.223908118876991,"L.LvsV.LUDWICZEK_TREATING_IRON_OVERLOAD"
10,"Up",0.0708679915948006,0.224320469970528,"L.LvsV.BIOCARTA_LDL_PATHWAY"
133,"Down",0.0708786147655113,0.224320469970528,"L.LvsV.KUNINGER_IGF1_VS_PDGFB_TARGETS_UP"
57,"Down",0.0710324851485466,0.224678838893773,"L.LvsV.PID_INSULIN_PATHWAY"
82,"Down",0.0711403983768215,0.224891516652628,"L.LvsV.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_DN"
25,"Up",0.0712386676704383,0.224951653260816,"L.LvsV.BIOCARTA_ERAD_PATHWAY"
177,"Down",0.0712407930655974,0.224951653260816,"L.LvsV.REACTOME_SIGNALING_BY_HEDGEHOG"
1060,"Down",0.0714015432483842,0.225330555148582,"L.LvsV.MARTINEZ_TP53_TARGETS_DN"
89,"Down",0.0715185360092312,0.225571012889355,"L.LvsV.VANHARANTA_UTERINE_FIBROID_UP"
53,"Down",0.071706499133597,0.225962794212977,"L.LvsV.BOQUEST_STEM_CELL_CULTURED_VS_FRESH_DN"
17,"Down",0.0717244897528982,0.225962794212977,"L.LvsV.REACTOME_NF_KB_IS_ACTIVATED_AND_SIGNALS_SURVIVAL"
8,"Down",0.0718435956318014,0.226180797556649,"L.LvsV.CHOI_ATL_ACUTE_STAGE"
430,"Up",0.0718755039441186,0.226180797556649,"L.LvsV.TARTE_PLASMA_CELL_VS_PLASMABLAST_DN"
1509,"Down",0.0720002423421721,0.226444448185364,"L.LvsV.MARTENS_TRETINOIN_RESPONSE_UP"
60,"Down",0.0720417808565323,0.226446279906633,"L.LvsV.PID_SYNDECAN_1_PATHWAY"
27,"Down",0.0721580093188937,0.226616863549013,"L.LvsV.BIOCARTA_TGFB_PATHWAY"
7,"Down",0.0721780243642272,0.226616863549013,"L.LvsV.REACTOME_TELOMERE_C_STRAND_SYNTHESIS_INITIATION"
15,"Down",0.0722641763395078,0.226657538573801,"L.LvsV.MIKKELSEN_PARTIALLY_REPROGRAMMED_TO_PLURIPOTENCY"
81,"Up",0.0722729680784249,0.226657538573801,"L.LvsV.DAZARD_UV_RESPONSE_CLUSTER_G2"
436,"Down",0.0723706787112048,0.226729463424045,"L.LvsV.MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED"
645,"Down",0.0723779169729497,0.226729463424045,"L.LvsV.CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_2"
8,"Up",0.0724394283224248,0.226793657528135,"L.LvsV.MOOTHA_ROS"
273,"Down",0.0725509800419928,0.22694670965038,"L.LvsV.PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP"
94,"Down",0.0726004059400259,0.22694670965038,"L.LvsV.MAYBURD_RESPONSE_TO_L663536_DN"
73,"Down",0.0726312022296858,0.22694670965038,"L.LvsV.IKEDA_MIR1_TARGETS_UP"
934,"Up",0.072652500647707,0.22694670965038,"L.LvsV.CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN"
44,"Up",0.0727194181648228,0.227027477715023,"L.LvsV.CHIARETTI_T_ALL_RELAPSE_PROGNOSIS"
46,"Down",0.0727971436267429,0.227141877602856,"L.LvsV.BIOCARTA_NO1_PATHWAY"
16,"Down",0.0732233230795975,0.22834278246311,"L.LvsV.REACTOME_PYRIMIDINE_CATABOLISM"
15,"Up",0.073547063191243,0.22922306222344,"L.LvsV.LIANG_SILENCED_BY_METHYLATION_DN"
19,"Down",0.0739637939848523,0.230392009544929,"L.LvsV.REACTOME_REGULATION_OF_RUNX1_EXPRESSION_AND_ACTIVITY"
1149,"Down",0.0740057154065954,0.230392793064789,"L.LvsV.SMID_BREAST_CANCER_BASAL_DN"
30,"Down",0.074212727184012,0.230907241755995,"L.LvsV.BYSTRYKH_HEMATOPOIESIS_STEM_CELL_RUNX1"
66,"Down",0.0744069953872453,0.231381483406119,"L.LvsV.LEE_LIVER_CANCER_MYC_UP"
7,"Down",0.0747999539551951,0.232327750675944,"L.LvsV.REACTOME_GLI_PROTEINS_BIND_PROMOTERS_OF_HH_RESPONSIVE_GENES_TO_PROMOTE_TRANSCRIPTION"
33,"Down",0.0748145371462326,0.232327750675944,"L.LvsV.HUI_MAPK14_TARGETS_UP"
19,"Down",0.0748615677899028,0.232327750675944,"L.LvsV.MOROSETTI_FACIOSCAPULOHUMERAL_MUSCULAR_DISTROPHY_DN"
99,"Up",0.0748793727083619,0.232327750675944,"L.LvsV.REACTOME_SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE"
58,"Down",0.075061082402147,0.232760922378839,"L.LvsV.HARRIS_BRAIN_CANCER_PROGENITORS"
412,"Down",0.0751106611486279,0.232784106216796,"L.LvsV.BHAT_ESR1_TARGETS_VIA_AKT1_UP"
32,"Down",0.0751726126597593,0.232845588457036,"L.LvsV.BIOCARTA_VIP_PATHWAY"
12,"Up",0.0753418130757271,0.23316239535811,"L.LvsV.REACTOME_FREE_FATTY_ACIDS_REGULATE_INSULIN_SECRETION"
43,"Down",0.0753888576716219,0.23316239535811,"L.LvsV.VALK_AML_WITH_EVI1"
17,"Down",0.0754014040333333,0.23316239535811,"L.LvsV.REACTOME_DOWNREGULATION_OF_ERBB2_ERBB3_SIGNALING"
425,"Down",0.0754961257088993,0.23332480662074,"L.LvsV.PLASARI_TGFB1_TARGETS_10HR_DN"
361,"Down",0.0756482802487852,0.233664436589684,"L.LvsV.REACTOME_ORGANELLE_BIOGENESIS_AND_MAINTENANCE"
7,"Up",0.0757204812514684,0.233756862556878,"L.LvsV.REACTOME_PHOSPHORYLATION_OF_EMI1"
84,"Down",0.0759259700427447,0.234236972324011,"L.LvsV.GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN"
94,"Down",0.0759607327503981,0.234236972324011,"L.LvsV.WARTERS_IR_RESPONSE_5GY"
8,"Up",0.0760716364116989,0.234322013177392,"L.LvsV.IWANAGA_E2F1_TARGETS_NOT_INDUCED_BY_SERUM"
37,"Down",0.0760730717405351,0.234322013177392,"L.LvsV.SIG_CD40PATHWAYMAP"
142,"Down",0.0761722285972846,0.234496799506897,"L.LvsV.KORKOLA_YOLK_SAC_TUMOR"
141,"Down",0.0762818324492049,0.234703534564081,"L.LvsV.HINATA_NFKB_TARGETS_KERATINOCYTE_UP"
13,"Down",0.076417911979344,0.234991454579418,"L.LvsV.KEGG_CIRCADIAN_RHYTHM_MAMMAL"
25,"Down",0.0765308963294854,0.235124710060542,"L.LvsV.INGA_TP53_TARGETS"
90,"Down",0.0765777316959694,0.235124710060542,"L.LvsV.REACTOME_CIRCADIAN_CLOCK"
26,"Up",0.0765992804203561,0.235124710060542,"L.LvsV.BIOCARTA_BARRESTIN_PATHWAY"
9,"Up",0.0766313488025133,0.235124710060542,"L.LvsV.GROSS_HYPOXIA_VIA_HIF1A_ONLY"
105,"Down",0.0767282681971821,0.235248064058572,"L.LvsV.PID_AVB3_INTEGRIN_PATHWAY"
518,"Down",0.0767566481392049,0.235248064058572,"L.LvsV.LEI_MYB_TARGETS"
19,"Down",0.0768051089448034,0.235266175820398,"L.LvsV.BIOCARTA_HSWI_SNF_PATHWAY"
79,"Down",0.0770219648181111,0.235799802590995,"L.LvsV.KEGG_RENAL_CELL_CARCINOMA"
10,"Up",0.0772364137675505,0.236325474112223,"L.LvsV.REICHERT_G1S_REGULATORS_AS_PI3K_TARGETS"
26,"Up",0.0773616126260338,0.236577630646759,"L.LvsV.REACTOME_TRIGLYCERIDE_CATABOLISM"
94,"Down",0.0774742137465446,0.236689630390829,"L.LvsV.ONDER_CDH1_TARGETS_3_DN"
23,"Up",0.0774838544053898,0.236689630390829,"L.LvsV.REACTOME_INHIBITION_OF_THE_PROTEOLYTIC_ACTIVITY_OF_APC_C_REQUIRED_FOR_THE_ONSET_OF_ANAPHASE_BY_MITOTIC_SPINDLE_CHECKPOINT_COMPONENTS"
110,"Up",0.0775382278489977,0.236719121585934,"L.LvsV.PID_IL12_2PATHWAY"
77,"Down",0.0775791369711906,0.236719121585934,"L.LvsV.TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP"
97,"Up",0.0776605272069949,0.236836764990334,"L.LvsV.WENG_POR_TARGETS_LIVER_UP"
116,"Up",0.0777895546098448,0.237099474883039,"L.LvsV.BAUS_TFF2_TARGETS_UP"
42,"Down",0.0780281303573369,0.237657166740681,"L.LvsV.DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_DN"
66,"Up",0.078115055914611,0.237657166740681,"L.LvsV.RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_UP"
62,"Down",0.078130812446306,0.237657166740681,"L.LvsV.KEGG_VASOPRESSIN_REGULATED_WATER_REABSORPTION"
10,"Up",0.0781455774766416,0.237657166740681,"L.LvsV.CHANG_POU5F1_TARGETS_DN"
635,"Down",0.078233997075225,0.237657166740681,"L.LvsV.LINDGREN_BLADDER_CANCER_CLUSTER_2B"
19,"Down",0.0782791306626914,0.237657166740681,"L.LvsV.REACTOME_DSCAM_INTERACTIONS"
731,"Up",0.0783412746910939,0.237657166740681,"L.LvsV.TIEN_INTESTINE_PROBIOTICS_24HR_UP"
76,"Down",0.0783614098418311,0.237657166740681,"L.LvsV.REACTOME_SIGNALING_BY_PDGF"
76,"Down",0.0783696472788329,0.237657166740681,"L.LvsV.PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_DN"
21,"Down",0.0784023642855854,0.237657166740681,"L.LvsV.REACTOME_P75NTR_SIGNALS_VIA_NF_KB"
29,"Down",0.0785169346176398,0.237874044658044,"L.LvsV.GESERICK_TERT_TARGETS_DN"
11,"Down",0.0787503780092121,0.238450624322527,"L.LvsV.REACTOME_CREB_PHOSPHORYLATION"
71,"Down",0.079380838535541,0.240228054878493,"L.LvsV.MCBRYAN_PUBERTAL_BREAST_3_4WK_DN"
202,"Up",0.0794940160129582,0.240425905148636,"L.LvsV.REACTOME_MEIOSIS"
96,"Up",0.0795331851178976,0.240425905148636,"L.LvsV.REACTOME_APC_C_MEDIATED_DEGRADATION_OF_CELL_CYCLE_PROTEINS"
28,"Up",0.0797599416323126,0.240979626931725,"L.LvsV.KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_HEPARAN_SULFATE"
42,"Down",0.0798054508804049,0.240985438513249,"L.LvsV.BIOCARTA_PYK2_PATHWAY"
29,"Down",0.0800996970359841,0.241741934995609,"L.LvsV.TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN"
97,"Down",0.0804022785443034,0.242403753974136,"L.LvsV.MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_UP"
86,"Down",0.080406671150039,0.242403753974136,"L.LvsV.ZAMORA_NOS2_TARGETS_UP"
385,"Down",0.0804847042816271,0.242506773827311,"L.LvsV.RIGGINS_TAMOXIFEN_RESISTANCE_DN"
438,"Down",0.0805785563403476,0.242526331879703,"L.LvsV.OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN"
174,"Down",0.0805789241568121,0.242526331879703,"L.LvsV.KARLSSON_TGFB1_TARGETS_UP"
119,"Up",0.0806460460418599,0.242579575328423,"L.LvsV.BRUNO_HEMATOPOIESIS"
82,"Down",0.0806843622768982,0.242579575328423,"L.LvsV.WIERENGA_PML_INTERACTOME"
14,"Up",0.0809497873535447,0.243217283847319,"L.LvsV.BIOCARTA_ASBCELL_PATHWAY"
27,"Down",0.0809844491884453,0.243217283847319,"L.LvsV.ABDELMOHSEN_ELAVL4_TARGETS"
165,"Up",0.0810867280045027,0.243392247088434,"L.LvsV.IVANOVA_HEMATOPOIESIS_INTERMEDIATE_PROGENITOR"
709,"Down",0.0811339037814225,0.243401711344267,"L.LvsV.MIKKELSEN_MCV6_HCP_WITH_H3K27ME3"
735,"Down",0.0813947077975526,0.243851144059234,"L.LvsV.BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP"
44,"Down",0.0813952006515543,0.243851144059234,"L.LvsV.DANG_MYC_TARGETS_DN"
29,"Up",0.0814351238515854,0.243851144059234,"L.LvsV.REACTOME_INSERTION_OF_TAIL_ANCHORED_PROTEINS_INTO_THE_ENDOPLASMIC_RETICULUM_MEMBRANE"
25,"Down",0.0814601307790567,0.243851144059234,"L.LvsV.NGO_MALIGNANT_GLIOMA_1P_LOH"
62,"Down",0.0816686528041091,0.244343063503203,"L.LvsV.STAMBOLSKY_TARGETS_OF_MUTATED_TP53_UP"
28,"Down",0.0817637251770524,0.244495206329866,"L.LvsV.RAMPON_ENRICHED_LEARNING_ENVIRONMENT_EARLY_UP"
29,"Down",0.0819110067330693,0.244803219582238,"L.LvsV.BIOCARTA_CK1_PATHWAY"
568,"Down",0.082155785048884,0.245402126167088,"L.LvsV.DAVICIONI_MOLECULAR_ARMS_VS_ERMS_UP"
12,"Up",0.0822016989500962,0.245406691951988,"L.LvsV.REACTOME_ASPARTATE_AND_ASPARAGINE_METABOLISM"
18,"Down",0.0823402558683265,0.245687681973004,"L.LvsV.NADELLA_PRKAR1A_TARGETS_DN"
15,"Down",0.082449595875388,0.245823778576436,"L.LvsV.REACTOME_DOWNREGULATION_OF_ERBB4_SIGNALING"
253,"Down",0.0825061084569464,0.245823778576436,"L.LvsV.ELVIDGE_HYPOXIA_UP"
195,"Down",0.0825192499616324,0.245823778576436,"L.LvsV.FIGUEROA_AML_METHYLATION_CLUSTER_7_UP"
115,"Down",0.0825818959166852,0.2458779227374,"L.LvsV.BROWNE_HCMV_INFECTION_1HR_UP"
725,"Down",0.0828020082075459,0.24637941754256,"L.LvsV.PEDRIOLI_MIR31_TARGETS_DN"
17,"Up",0.0828394532847927,0.24637941754256,"L.LvsV.REACTOME_FORMYL_PEPTIDE_RECEPTORS_BIND_FORMYL_PEPTIDES_AND_MANY_OTHER_LIGANDS"
337,"Down",0.0828990108518528,0.246423995161234,"L.LvsV.KATSANOU_ELAVL1_TARGETS_UP"
27,"Down",0.0830695037102972,0.246724035801705,"L.LvsV.REACTOME_RAS_ACTIVATION_UPON_CA2_INFLUX_THROUGH_NMDA_RECEPTOR"
25,"Up",0.0830891941875159,0.246724035801705,"L.LvsV.KEGG_GLYCOSYLPHOSPHATIDYLINOSITOL_GPI_ANCHOR_BIOSYNTHESIS"
173,"Down",0.0831712800287222,0.246835215930652,"L.LvsV.HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_DN"
5,"Down",0.0832369219240069,0.246897500706993,"L.LvsV.BASSO_HAIRY_CELL_LEUKEMIA_DN"
15,"Down",0.083284346954239,0.246905712766749,"L.LvsV.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_DN"
1768,"Down",0.0834612452461846,0.24717558100727,"L.LvsV.PEREZ_TP53_TARGETS"
110,"Down",0.0834917335827626,0.24717558100727,"L.LvsV.REACTOME_COLLAGEN_FORMATION"
37,"Down",0.083534456701986,0.24717558100727,"L.LvsV.REACTOME_FERTILIZATION"
90,"Down",0.0835857392879991,0.24717558100727,"L.LvsV.PID_FCER1_PATHWAY"
19,"Down",0.083713515483882,0.24717558100727,"L.LvsV.BIOCARTA_EFP_PATHWAY"
16,"Down",0.0837209480899145,0.24717558100727,"L.LvsV.BIOCARTA_PRC2_PATHWAY"
130,"Down",0.0837470481206212,0.24717558100727,"L.LvsV.LEE_LIVER_CANCER_E2F1_UP"
23,"Down",0.0837661257452861,0.24717558100727,"L.LvsV.LIU_IL13_PRIMING_MODEL"
172,"Down",0.0837777245085232,0.24717558100727,"L.LvsV.DANG_MYC_TARGETS_UP"
8,"Up",0.0839966886230443,0.247689435411633,"L.LvsV.REACTOME_POLB_DEPENDENT_LONG_PATCH_BASE_EXCISION_REPAIR"
122,"Down",0.0842112773683938,0.248189846785634,"L.LvsV.BURTON_ADIPOGENESIS_2"
28,"Down",0.0844631752347144,0.248799624865603,"L.LvsV.REACTOME_INTERLEUKIN_37_SIGNALING"
188,"Down",0.0845360926171966,0.248881818999191,"L.LvsV.DAIRKEE_CANCER_PRONE_RESPONSE_BPA_E2"
61,"Up",0.0846637937320294,0.24910980885926,"L.LvsV.BIOCARTA_NKCELLS_PATHWAY"
384,"Down",0.0847036427302241,0.24910980885926,"L.LvsV.SERVITJA_ISLET_HNF1A_TARGETS_UP"
18,"Down",0.0848240565300752,0.24924803543315,"L.LvsV.REACTOME_FGFR1C_LIGAND_BINDING_AND_ACTIVATION"
126,"Up",0.0848408035241793,0.24924803543315,"L.LvsV.NADERI_BREAST_CANCER_PROGNOSIS_UP"
46,"Down",0.0849519564240076,0.249316907420202,"L.LvsV.MOREIRA_RESPONSE_TO_TSA_UP"
6,"Down",0.0849544318284789,0.249316907420202,"L.LvsV.BIOCARTA_BOTULIN_PATHWAY"
21,"Down",0.0851000408779347,0.249611737938515,"L.LvsV.REACTOME_IL_6_TYPE_CYTOKINE_RECEPTOR_LIGAND_INTERACTIONS"
34,"Down",0.0852057018547772,0.249789143984657,"L.LvsV.WANG_TNF_TARGETS"
89,"Down",0.0853904916434415,0.25019821319374,"L.LvsV.SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES"
138,"Down",0.0854697066893911,0.250297673880108,"L.LvsV.ZHENG_IL22_SIGNALING_UP"
113,"Down",0.0855502310354822,0.250400861511478,"L.LvsV.BURTON_ADIPOGENESIS_11"
487,"Down",0.0856247515959513,0.250486376494188,"L.LvsV.BENPORATH_OCT4_TARGETS"
129,"Up",0.0857146575934535,0.250616785739928,"L.LvsV.REACTOME_NEGATIVE_EPIGENETIC_REGULATION_OF_RRNA_EXPRESSION"
15,"Down",0.0859092915070492,0.250975422446693,"L.LvsV.REACTOME_REGULATION_OF_PTEN_LOCALIZATION"
187,"Down",0.0859281017709512,0.250975422446693,"L.LvsV.BRUECKNER_TARGETS_OF_MIRLET7A3_UP"
10,"Up",0.0861531395218178,0.2514412445932,"L.LvsV.REACTOME_MULTIFUNCTIONAL_ANION_EXCHANGERS"
27,"Down",0.0861785419613157,0.2514412445932,"L.LvsV.BIOCARTA_CDMAC_PATHWAY"
176,"Down",0.0863478896657124,0.251681249498891,"L.LvsV.LAIHO_COLORECTAL_CANCER_SERRATED_UP"
145,"Up",0.0864123918987008,0.251681249498891,"L.LvsV.UEDA_CENTRAL_CLOCK"
36,"Down",0.086440303215052,0.251681249498891,"L.LvsV.REACTOME_CREB1_PHOSPHORYLATION_THROUGH_NMDA_RECEPTOR_MEDIATED_ACTIVATION_OF_RAS_SIGNALING"
30,"Down",0.0864428816781324,0.251681249498891,"L.LvsV.KYNG_DNA_DAMAGE_BY_4NQO_OR_GAMMA_RADIATION"
97,"Down",0.0865409814201772,0.251796268783361,"L.LvsV.BEIER_GLIOMA_STEM_CELL_DN"
10,"Down",0.0865734684313926,0.251796268783361,"L.LvsV.MIKKELSEN_DEDIFFERENTIATED_STATE_DN"
858,"Up",0.0867440901176187,0.252159870799324,"L.LvsV.RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP"
162,"Down",0.0870775280473271,0.252904057846667,"L.LvsV.PURBEY_TARGETS_OF_CTBP1_AND_SATB1_UP"
146,"Up",0.0870915764405959,0.252904057846667,"L.LvsV.REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING"
48,"Down",0.0873529916716897,0.253530021497518,"L.LvsV.HOLLEMAN_ASPARAGINASE_RESISTANCE_B_ALL_UP"
31,"Down",0.0875108561401174,0.253777659437461,"L.LvsV.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_PURPLE_DN"
118,"Down",0.0875720736295564,0.253777659437461,"L.LvsV.ANASTASSIOU_MULTICANCER_INVASIVENESS_SIGNATURE"
45,"Down",0.0875760126978977,0.253777659437461,"L.LvsV.FINETTI_BREAST_CANCERS_KINOME_BLUE"
12,"Down",0.0876783184299406,0.253941028077078,"L.LvsV.SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX1_DN"
33,"Up",0.0878335356040193,0.254257391808703,"L.LvsV.CHUANG_OXIDATIVE_STRESS_RESPONSE_DN"
383,"Down",0.0878864688047907,0.254277491377126,"L.LvsV.DELYS_THYROID_CANCER_DN"
50,"Down",0.0880741580132093,0.254687248773553,"L.LvsV.TOMIDA_METASTASIS_UP"
74,"Down",0.088143804820191,0.254755408704044,"L.LvsV.NAKAJIMA_MAST_CELL"
7,"Down",0.0884874400768494,0.255614971883438,"L.LvsV.REACTOME_LOSS_OF_MECP2_BINDING_ABILITY_TO_THE_NCOR_SMRT_COMPLEX"
15,"Down",0.0886268009092178,0.255883854948859,"L.LvsV.MONTERO_THYROID_CANCER_POOR_SURVIVAL_DN"
189,"Up",0.0886996526022725,0.25596053196136,"L.LvsV.HAHTOLA_SEZARY_SYNDROM_UP"
32,"Down",0.0887742289227505,0.256042103137135,"L.LvsV.BIOCARTA_RAC1_PATHWAY"
18,"Up",0.0889294266276089,0.256225781509158,"L.LvsV.LI_WILMS_TUMOR_ANAPLASTIC_UP"
227,"Up",0.0889305977059277,0.256225781509158,"L.LvsV.REACTOME_PHOSPHOLIPID_METABOLISM"
26,"Down",0.089067632087855,0.256486946777995,"L.LvsV.FOURNIER_ACINAR_DEVELOPMENT_LATE_UP"
43,"Down",0.0891356596905235,0.256522788768634,"L.LvsV.TCGA_GLIOBLASTOMA_COPY_NUMBER_DN"
256,"Down",0.0891728703225383,0.256522788768634,"L.LvsV.TSENG_IRS1_TARGETS_DN"
28,"Down",0.0893094180302089,0.256781992870008,"L.LvsV.REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS"
115,"Down",0.0895960179874272,0.257472132771562,"L.LvsV.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_UP"
65,"Up",0.0897299721491813,0.257570622127951,"L.LvsV.PRAMOONJAGO_SOX4_TARGETS_DN"
79,"Down",0.0897901379473177,0.257570622127951,"L.LvsV.SMIRNOV_RESPONSE_TO_IR_2HR_DN"
78,"Up",0.0898111090578322,0.257570622127951,"L.LvsV.STEARMAN_TUMOR_FIELD_EFFECT_UP"
51,"Down",0.0898166322052251,0.257570622127951,"L.LvsV.CHO_NR4A1_TARGETS"
23,"Down",0.089943257754534,0.257800037389745,"L.LvsV.REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_G2_CELL_CYCLE_ARREST"
1243,"Down",0.0901118028526917,0.258086461393385,"L.LvsV.LEE_BMP2_TARGETS_UP"
37,"Down",0.0901365449359065,0.258086461393385,"L.LvsV.MATTHEWS_SKIN_CARCINOGENESIS_VIA_JUN"
377,"Down",0.0905469502872179,0.25903405554528,"L.LvsV.QI_PLASMACYTOMA_UP"
30,"Up",0.0905611917831483,0.25903405554528,"L.LvsV.CHOI_ATL_CHRONIC_VS_ACUTE_DN"
264,"Up",0.0909437532677693,0.259993801353411,"L.LvsV.VANTVEER_BREAST_CANCER_METASTASIS_DN"
151,"Down",0.0910378109374522,0.260023684724641,"L.LvsV.IGARASHI_ATF4_TARGETS_DN"
104,"Down",0.0910482643564668,0.260023684724641,"L.LvsV.MORI_IMMATURE_B_LYMPHOCYTE_UP"
383,"Down",0.0913825307182646,0.260821546964617,"L.LvsV.MULLIGHAN_MLL_SIGNATURE_1_DN"
37,"Down",0.0914616404468254,0.260821546964617,"L.LvsV.PID_NFKAPPAB_CANONICAL_PATHWAY"
65,"Down",0.0914802773785908,0.260821546964617,"L.LvsV.HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_UP"
522,"Down",0.0915163322682867,0.260821546964617,"L.LvsV.BROWNE_HCMV_INFECTION_20HR_UP"
192,"Down",0.091758341303179,0.261376542537494,"L.LvsV.KEGG_JAK_STAT_SIGNALING_PATHWAY"
70,"Down",0.0919136139702592,0.261610104246123,"L.LvsV.ZHAN_MULTIPLE_MYELOMA_MS_UP"
77,"Up",0.0919382438657554,0.261610104246123,"L.LvsV.HAHTOLA_CTCL_CUTANEOUS"
22,"Down",0.0919822829904978,0.261610104246123,"L.LvsV.REACTOME_TIE2_SIGNALING"
330,"Down",0.0921402501892579,0.261924649509721,"L.LvsV.TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP"
10,"Up",0.092269423741502,0.262157062624237,"L.LvsV.BIERIE_INFLAMMATORY_RESPONSE_TGFB1"
22,"Down",0.0923789306186106,0.262287592754488,"L.LvsV.MEISSNER_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3"
10,"Down",0.0924102424825,0.262287592754488,"L.LvsV.KONDO_HYPOXIA"
14,"Down",0.0928339304809531,0.263354952092965,"L.LvsV.MEINHOLD_OVARIAN_CANCER_LOW_GRADE_UP"
23,"Down",0.0929281235691743,0.263486971904597,"L.LvsV.REACTOME_SYNAPTIC_ADHESION_LIKE_MOLECULES"
252,"Down",0.0929776499748608,0.263492274070223,"L.LvsV.IWANAGA_CARCINOGENESIS_BY_KRAS_DN"
20,"Down",0.0931555670629382,0.263861234780218,"L.LvsV.REACTOME_BUTYRATE_RESPONSE_FACTOR_1_BRF1_BINDS_AND_DESTABILIZES_MRNA"
154,"Down",0.093268696397327,0.264046401628685,"L.LvsV.NGUYEN_NOTCH1_TARGETS_DN"
72,"Down",0.0933216837980314,0.264061202517562,"L.LvsV.MOSERLE_IFNA_RESPONSE"
53,"Up",0.0934976137017341,0.264423686013753,"L.LvsV.REACTOME_CROSS_PRESENTATION_OF_SOLUBLE_EXOGENOUS_ANTIGENS_ENDOSOMES"
74,"Down",0.0936258496906979,0.264650983098092,"L.LvsV.FRASOR_TAMOXIFEN_RESPONSE_UP"
78,"Down",0.0937987998926029,0.264952211758234,"L.LvsV.PID_RAC1_PATHWAY"
165,"Down",0.0938282565785173,0.264952211758234,"L.LvsV.MALONEY_RESPONSE_TO_17AAG_DN"
13,"Down",0.0939016347471683,0.26502406254063,"L.LvsV.MIKKELSEN_NPC_WITH_LCP_H3K27ME3"
87,"Down",0.0940136682607385,0.265078539776138,"L.LvsV.LEE_LIVER_CANCER_MYC_TGFA_UP"
62,"Down",0.0940168233859661,0.265078539776138,"L.LvsV.PID_SYNDECAN_2_PATHWAY"
102,"Up",0.0943655078114728,0.265775554370281,"L.LvsV.KEGG_CARDIAC_MUSCLE_CONTRACTION"
20,"Down",0.0943868738315148,0.265775554370281,"L.LvsV.REACTOME_FORMATION_OF_SENESCENCE_ASSOCIATED_HETEROCHROMATIN_FOCI_SAHF"
80,"Down",0.0944476386208472,0.265775554370281,"L.LvsV.REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES"
317,"Up",0.0944616496816885,0.265775554370281,"L.LvsV.FISCHER_G1_S_CELL_CYCLE"
31,"Down",0.0945043841367288,0.265775554370281,"L.LvsV.LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_QTL"
892,"Down",0.0946591015948009,0.265974047987231,"L.LvsV.IVANOVA_HEMATOPOIESIS_STEM_CELL_AND_PROGENITOR"
111,"Down",0.0946711749753788,0.265974047987231,"L.LvsV.REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES"
135,"Down",0.094750451328816,0.266061577144248,"L.LvsV.LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP"
818,"Down",0.0950121429496217,0.26666098394338,"L.LvsV.LIAO_METASTASIS"
20,"Down",0.0952155528499578,0.267096292088999,"L.LvsV.REACTOME_DEFECTIVE_B4GALT7_CAUSES_EDS_PROGEROID_TYPE"
728,"Down",0.0956406563411975,0.268152732713226,"L.LvsV.YAGI_AML_WITH_INV_16_TRANSLOCATION"
833,"Down",0.0959208184976125,0.26876240690301,"L.LvsV.RODWELL_AGING_KIDNEY_UP"
12,"Down",0.0959937811934932,0.26876240690301,"L.LvsV.REACTOME_ACTIVATED_NTRK2_SIGNALS_THROUGH_PI3K"
5,"Up",0.0960039344607423,0.26876240690301,"L.LvsV.WILSON_PROTEASES_AT_TUMOR_BONE_INTERFACE_DN"
128,"Down",0.0962543387633998,0.269327044039897,"L.LvsV.BOYLAN_MULTIPLE_MYELOMA_D_UP"
24,"Down",0.0963383486382713,0.269425761062722,"L.LvsV.MATZUK_EARLY_ANTRAL_FOLLICLE"
291,"Down",0.0964633382905837,0.269599645071718,"L.LvsV.DARWICHE_PAPILLOMA_RISK_LOW_DN"
11,"Down",0.0964980462284193,0.269599645071718,"L.LvsV.BIOCARTA_NOTCH_PATHWAY"
151,"Up",0.096568978774465,0.269661557395968,"L.LvsV.LE_EGR2_TARGETS_DN"
119,"Down",0.0966351991461579,0.269710255466485,"L.LvsV.LINDVALL_IMMORTALIZED_BY_TERT_DN"
47,"Down",0.096697628033391,0.269748327647134,"L.LvsV.PID_NEPHRIN_NEPH1_PATHWAY"
202,"Up",0.0967587359265984,0.269782678234071,"L.LvsV.MOREAUX_MULTIPLE_MYELOMA_BY_TACI_DN"
7,"Down",0.0969234633289971,0.270105760456666,"L.LvsV.REACTOME_RAS_SIGNALING_DOWNSTREAM_OF_NF1_LOSS_OF_FUNCTION_VARIANTS"
137,"Down",0.097584738786725,0.271811597356072,"L.LvsV.DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN"
19,"Up",0.0976849215769351,0.271953641187752,"L.LvsV.KEGG_PANTOTHENATE_AND_COA_BIOSYNTHESIS"
44,"Down",0.0978510318172696,0.272135870682636,"L.LvsV.REACTOME_COOPERATION_OF_PDCL_PHLP1_AND_TRIC_CCT_IN_G_PROTEIN_BETA_FOLDING"
45,"Down",0.0978853420349164,0.272135870682636,"L.LvsV.HOFMANN_MYELODYSPLASTIC_SYNDROM_RISK_DN"
12,"Down",0.0978980370388431,0.272135870682636,"L.LvsV.OHM_EMBRYONIC_CARCINOMA_DN"
363,"Down",0.0981545259740644,0.272557585198902,"L.LvsV.OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP"
206,"Down",0.0981860970344954,0.272557585198902,"L.LvsV.ROPERO_HDAC2_TARGETS"
6,"Down",0.0981976324319429,0.272557585198902,"L.LvsV.REACTOME_MECP2_REGULATES_TRANSCRIPTION_FACTORS"
181,"Down",0.098262165369491,0.272599855658764,"L.LvsV.PID_P53_DOWNSTREAM_PATHWAY"
263,"Down",0.0983886285916218,0.272750525342465,"L.LvsV.LEE_NEURAL_CREST_STEM_CELL_DN"
353,"Down",0.0984286365988953,0.272750525342465,"L.LvsV.REACTOME_INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS"
25,"Down",0.0984970563345472,0.272750525342465,"L.LvsV.REACTOME_NITRIC_OXIDE_STIMULATES_GUANYLATE_CYCLASE"
47,"Down",0.0985137998026591,0.272750525342465,"L.LvsV.PID_IL8_CXCR1_PATHWAY"
7,"Up",0.0986702263684841,0.273046887683358,"L.LvsV.REACTOME_LIPID_PARTICLE_ORGANIZATION"
346,"Up",0.0988089726281677,0.273294051856498,"L.LvsV.REACTOME_TRANSLATION"
33,"Down",0.0988700135941076,0.273326152580911,"L.LvsV.TURASHVILI_BREAST_CARCINOMA_DUCTAL_VS_LOBULAR_UP"
13,"Down",0.0993975224240838,0.274590790131649,"L.LvsV.SHIRAISHI_PLZF_TARGETS_UP"
52,"Up",0.099426797222565,0.274590790131649,"L.LvsV.WANG_RESPONSE_TO_FORSKOLIN_UP"
236,"Up",0.0995471266679748,0.274785852894275,"L.LvsV.REACTOME_DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS"
6,"Up",0.0997630251945319,0.27524439436156,"L.LvsV.REACTOME_TRANSPORT_AND_SYNTHESIS_OF_PAPS"
143,"Down",0.100200064149854,0.276205300873565,"L.LvsV.LAIHO_COLORECTAL_CANCER_SERRATED_DN"
13,"Down",0.1002706915173,0.276205300873565,"L.LvsV.CASTELLANO_HRAS_AND_NRAS_TARGETS_DN"
140,"Up",0.100304019735445,0.276205300873565,"L.LvsV.REACTOME_GLYCEROPHOSPHOLIPID_BIOSYNTHESIS"
157,"Down",0.100311131154661,0.276205300873565,"L.LvsV.DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN"
13,"Down",0.10036844276434,0.276225545069207,"L.LvsV.WANG_ESOPHAGUS_CANCER_PROGRESSION_UP"
95,"Down",0.100488422623065,0.276234381860017,"L.LvsV.KRIEG_HYPOXIA_VIA_KDM3A"
85,"Down",0.100499354062295,0.276234381860017,"L.LvsV.WINTER_HYPOXIA_DN"
135,"Down",0.100521536679753,0.276234381860017,"L.LvsV.PLASARI_TGFB1_SIGNALING_VIA_NFIC_10HR_UP"
14,"Down",0.100842191416925,0.276977881939482,"L.LvsV.BIOCARTA_DSP_PATHWAY"
665,"Up",0.101172283987052,0.277746553209737,"L.LvsV.GOLDRATH_ANTIGEN_RESPONSE"
277,"Down",0.101335459250002,0.277984594582215,"L.LvsV.LU_AGING_BRAIN_DN"
43,"Down",0.101359548322978,0.277984594582215,"L.LvsV.GROSS_ELK3_TARGETS_UP"
17,"Down",0.101551184857812,0.278372087793179,"L.LvsV.REACTOME_CREB1_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_ADENYLATE_CYCLASE"
6,"Up",0.101974592230504,0.279394212310433,"L.LvsV.CROSBY_E2F4_TARGETS"
35,"Down",0.102205768408681,0.279888902194948,"L.LvsV.PID_S1P_S1P2_PATHWAY"
12,"Up",0.102432618857692,0.280371262209988,"L.LvsV.REACTOME_UNWINDING_OF_DNA"
12,"Down",0.102663813273518,0.280865028990242,"L.LvsV.REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX_IN_CANCER"
13,"Down",0.102820324818587,0.28115409293866,"L.LvsV.ZHENG_FOXP3_TARGETS_IN_T_LYMPHOCYTE_UP"
84,"Down",0.10295517095892,0.281383658048377,"L.LvsV.LUI_THYROID_CANCER_CLUSTER_1"
84,"Down",0.103147716041164,0.281770613632213,"L.LvsV.ROVERSI_GLIOMA_LOH_REGIONS"
27,"Down",0.1035908607976,0.282841416962929,"L.LvsV.WU_APOPTOSIS_BY_CDKN1A_NOT_VIA_TP53"
96,"Down",0.103784432132389,0.283230071697918,"L.LvsV.MUELLER_METHYLATED_IN_GLIOBLASTOMA"
162,"Up",0.103877334562658,0.283343750763166,"L.LvsV.DASU_IL6_SIGNALING_UP"
45,"Down",0.104098266755657,0.283806369276147,"L.LvsV.LOPES_METHYLATED_IN_COLON_CANCER_DN"
222,"Down",0.104314610557956,0.284256028474588,"L.LvsV.IKEDA_MIR30_TARGETS_UP"
112,"Down",0.104480560480765,0.284486227560858,"L.LvsV.JAZAG_TGFB1_SIGNALING_VIA_SMAD4_DN"
19,"Up",0.104501994605915,0.284486227560858,"L.LvsV.REACTOME_CASPASE_ACTIVATION_VIA_DEATH_RECEPTORS_IN_THE_PRESENCE_OF_LIGAND"
1149,"Down",0.104584463749126,0.284525190367283,"L.LvsV.NABA_MATRISOME"
15,"Up",0.104619228073193,0.284525190367283,"L.LvsV.REACTOME_SYNTHESIS_OF_PIPS_AT_THE_LATE_ENDOSOME_MEMBRANE"
38,"Down",0.105089014976726,0.285662322421984,"L.LvsV.DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_UP"
49,"Down",0.105258171094434,0.285981537091463,"L.LvsV.REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT"
71,"Down",0.105388807126479,0.286180196744469,"L.LvsV.REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES"
61,"Down",0.10543480932691,0.286180196744469,"L.LvsV.RIZ_ERYTHROID_DIFFERENTIATION_6HR"
173,"Up",0.105587400137223,0.286323205470272,"L.LvsV.CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP"
271,"Down",0.105591068177588,0.286323205470272,"L.LvsV.PHONG_TNF_RESPONSE_VIA_P38_PARTIAL"
33,"Down",0.105687715166327,0.286444792722854,"L.LvsV.REACTOME_LONG_TERM_POTENTIATION"
386,"Up",0.105819670807103,0.28653657171493,"L.LvsV.CAIRO_LIVER_DEVELOPMENT_DN"
209,"Down",0.105825226884046,0.28653657171493,"L.LvsV.NABA_ECM_GLYCOPROTEINS"
14,"Down",0.106166675457235,0.287294624855557,"L.LvsV.REACTOME_HUR_ELAVL1_BINDS_AND_STABILIZES_MRNA"
200,"Down",0.106209117960709,0.287294624855557,"L.LvsV.REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2"
30,"Down",0.106294146252915,0.287384026715094,"L.LvsV.CAIRO_PML_TARGETS_BOUND_BY_MYC_UP"
54,"Down",0.10636863978651,0.287444872619556,"L.LvsV.VALK_AML_CLUSTER_9"
44,"Down",0.106616453340725,0.287951547852356,"L.LvsV.PID_AURORA_A_PATHWAY"
45,"Up",0.106660294809482,0.287951547852356,"L.LvsV.REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS"
13,"Down",0.1068009081513,0.28819044468938,"L.LvsV.JOHNSTONE_PARVB_TARGETS_1_UP"
246,"Down",0.107014184995214,0.288625087238312,"L.LvsV.SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP"
105,"Down",0.107181713853122,0.288761075658859,"L.LvsV.PID_MET_PATHWAY"
90,"Down",0.107183514256845,0.288761075658859,"L.LvsV.KEGG_LONG_TERM_DEPRESSION"
1127,"Down",0.107221285644355,0.288761075658859,"L.LvsV.REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM"
16,"Down",0.10740563085974,0.289116715201317,"L.LvsV.MARTIN_NFKB_TARGETS_DN"
153,"Up",0.107569309716071,0.289414790489637,"L.LvsV.DAZARD_RESPONSE_TO_UV_SCC_UP"
136,"Down",0.107648117806086,0.289414790489637,"L.LvsV.CROMER_METASTASIS_UP"
22,"Down",0.107692099711155,0.289414790489637,"L.LvsV.REACTOME_GRB2_SOS_PROVIDES_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS"
78,"Down",0.107725744045519,0.289414790489637,"L.LvsV.AMIT_SERUM_RESPONSE_60_MCF10A"
77,"Down",0.107812353124768,0.289470099253087,"L.LvsV.DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_DN"
72,"Up",0.107851040777963,0.289470099253087,"L.LvsV.REACTOME_ASSEMBLY_OF_THE_PRE_REPLICATIVE_COMPLEX"
54,"Up",0.107984668689926,0.289688128668898,"L.LvsV.LEE_CALORIE_RESTRICTION_MUSCLE_UP"
15,"Down",0.108194708225871,0.290110835005258,"L.LvsV.REACTOME_MRNA_DECAY_BY_5_TO_3_EXORIBONUCLEASE"
48,"Down",0.108280566013958,0.290200314828491,"L.LvsV.MILICIC_FAMILIAL_ADENOMATOUS_POLYPOSIS_UP"
44,"Down",0.108462530370897,0.290547156211573,"L.LvsV.DING_LUNG_CANCER_BY_MUTATION_RATE"
97,"Down",0.108903268525629,0.291586523815111,"L.LvsV.BROWNE_HCMV_INFECTION_30MIN_UP"
14,"Up",0.108997209596021,0.291594165055608,"L.LvsV.MONTERO_THYROID_CANCER_POOR_SURVIVAL_UP"
64,"Up",0.109011600500984,0.291594165055608,"L.LvsV.REACTOME_METABOLISM_OF_POLYAMINES"
28,"Up",0.109154420126321,0.291808008088617,"L.LvsV.BIOCARTA_CDK5_PATHWAY"
177,"Up",0.109197100512814,0.291808008088617,"L.LvsV.BURTON_ADIPOGENESIS_3"
455,"Down",0.109335150891753,0.292035772599278,"L.LvsV.DURCHDEWALD_SKIN_CARCINOGENESIS_DN"
37,"Down",0.109439925176752,0.292059243139691,"L.LvsV.PID_GLYPICAN_1PATHWAY"
33,"Down",0.109496110264857,0.292059243139691,"L.LvsV.MARCHINI_TRABECTEDIN_RESISTANCE_UP"
14,"Down",0.109502407492961,0.292059243139691,"L.LvsV.REACTOME_REDUCTION_OF_CYTOSOLIC_CA_LEVELS"
15,"Down",0.109778343820906,0.292513464102631,"L.LvsV.BIOCARTA_STEM_PATHWAY"
449,"Down",0.109778520168739,0.292513464102631,"L.LvsV.CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_4"
115,"Down",0.109857664665215,0.292583346789004,"L.LvsV.MORI_SMALL_PRE_BII_LYMPHOCYTE_UP"
17,"Down",0.109965258755734,0.292677160450046,"L.LvsV.BIOCARTA_CD40_PATHWAY"
49,"Up",0.109998759163537,0.292677160450046,"L.LvsV.PACHER_TARGETS_OF_IGF1_AND_IGF2_UP"
51,"Down",0.11009182729983,0.292783892804599,"L.LvsV.REACTOME_ASSOCIATION_OF_TRIC_CCT_WITH_TARGET_PROTEINS_DURING_BIOSYNTHESIS"
29,"Up",0.110204779622215,0.292943378140012,"L.LvsV.GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_DN"
65,"Down",0.110351762414011,0.29319312560647,"L.LvsV.YANG_BREAST_CANCER_ESR1_UP"
61,"Down",0.110445430327106,0.293195316290936,"L.LvsV.FRIDMAN_IMMORTALIZATION_DN"
33,"Down",0.110468196195942,0.293195316290936,"L.LvsV.REACTOME_REGULATION_OF_SIGNALING_BY_CBL"
299,"Down",0.110511672843247,0.293195316290936,"L.LvsV.TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN"
11,"Up",0.110576292501161,0.293226053351999,"L.LvsV.KALMA_E2F1_TARGETS"
61,"Down",0.110642059650685,0.293259802401074,"L.LvsV.PID_THROMBIN_PAR1_PATHWAY"
14,"Down",0.110787936454546,0.293416219129684,"L.LvsV.REACTOME_RUNX1_AND_FOXP3_CONTROL_THE_DEVELOPMENT_OF_REGULATORY_T_LYMPHOCYTES_TREGS"
166,"Down",0.110807210262756,0.293416219129684,"L.LvsV.REACTOME_RHO_GTPASES_ACTIVATE_FORMINS"
8,"Down",0.111030805208236,0.29386755480916,"L.LvsV.TSAI_DNAJB4_TARGETS_DN"
251,"Down",0.111153621060879,0.294051852079233,"L.LvsV.SABATES_COLORECTAL_ADENOMA_UP"
66,"Down",0.111380063320566,0.29450998091794,"L.LvsV.VALK_AML_WITH_CEBPA"
203,"Down",0.111440629629514,0.294529274006492,"L.LvsV.WHITFIELD_CELL_CYCLE_M_G1"
14,"Down",0.111687974951054,0.295041955807157,"L.LvsV.BIOCARTA_AKAP13_PATHWAY"
826,"Down",0.111905631901154,0.295231758746107,"L.LvsV.TARTE_PLASMA_CELL_VS_PLASMABLAST_UP"
137,"Down",0.11192767991212,0.295231758746107,"L.LvsV.SHIPP_DLBCL_CURED_VS_FATAL_UP"
8,"Up",0.111961219044348,0.295231758746107,"L.LvsV.TERAMOTO_OPN_TARGETS_CLUSTER_8"
228,"Down",0.111973412568382,0.295231758746107,"L.LvsV.EPPERT_HSC_R"
259,"Down",0.112165716613011,0.295597829911027,"L.LvsV.MIKKELSEN_MCV6_LCP_WITH_H3K4ME3"
23,"Up",0.112398998862948,0.296071493431748,"L.LvsV.REACTOME_ASSEMBLY_OF_ACTIVE_LPL_AND_LIPC_LIPASE_COMPLEXES"
97,"Up",0.112505192337432,0.296210099254125,"L.LvsV.BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_DN"
1501,"Down",0.112618397214164,0.296270108224792,"L.LvsV.LOPEZ_MBD_TARGETS"
811,"Down",0.112635154184936,0.296270108224792,"L.LvsV.SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1"
865,"Down",0.112758529362783,0.29642330492836,"L.LvsV.RIGGI_EWING_SARCOMA_PROGENITOR_UP"
210,"Down",0.112893638370033,0.29642330492836,"L.LvsV.MIKKELSEN_ES_LCP_WITH_H3K4ME3"
12,"Down",0.112942216663681,0.29642330492836,"L.LvsV.REACTOME_NONCANONICAL_ACTIVATION_OF_NOTCH3"
55,"Up",0.11295336827438,0.29642330492836,"L.LvsV.STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_DN"
31,"Down",0.112961458398274,0.29642330492836,"L.LvsV.PID_S1P_META_PATHWAY"
106,"Down",0.113025393232735,0.296450379119446,"L.LvsV.REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE"
94,"Down",0.1131333811009,0.296592918021277,"L.LvsV.CHIARETTI_ACUTE_LYMPHOBLASTIC_LEUKEMIA_ZAP70"
51,"Down",0.113291663455906,0.296867112439671,"L.LvsV.REACTOME_SIGNALING_BY_FGFR1_IN_DISEASE"
36,"Down",0.113355338112296,0.296893256476971,"L.LvsV.REACTOME_NEPHRIN_FAMILY_INTERACTIONS"
29,"Up",0.113677475239458,0.297596004071478,"L.LvsV.REACTOME_LDL_CLEARANCE"
102,"Down",0.113948638076143,0.297942829707573,"L.LvsV.MCCLUNG_CREB1_TARGETS_DN"
8,"Down",0.113975582485098,0.297942829707573,"L.LvsV.LU_TUMOR_ENDOTHELIAL_MARKERS_DN"
425,"Down",0.113985475826207,0.297942829707573,"L.LvsV.ALFANO_MYC_TARGETS"
9,"Down",0.114025506902012,0.297942829707573,"L.LvsV.MAINA_HYPOXIA_VHL_TARGETS_UP"
10,"Up",0.114227216608984,0.298328899684021,"L.LvsV.BIOCARTA_BBCELL_PATHWAY"
15,"Down",0.11428943451206,0.298350464314061,"L.LvsV.GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_1_UP"
13,"Down",0.114403818850387,0.298508123843223,"L.LvsV.REACTOME_REGULATED_PROTEOLYSIS_OF_P75NTR"
298,"Down",0.114699031499642,0.299137238283736,"L.LvsV.SMID_BREAST_CANCER_LUMINAL_B_UP"
114,"Down",0.114791754962559,0.299237912865625,"L.LvsV.KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS"
82,"Up",0.114905639129143,0.299283970271918,"L.LvsV.DAIRKEE_CANCER_PRONE_RESPONSE_BPA"
19,"Down",0.114978745589697,0.299283970271918,"L.LvsV.MATTHEWS_AP1_TARGETS"
32,"Up",0.114992490969432,0.299283970271918,"L.LvsV.DORN_ADENOVIRUS_INFECTION_48HR_UP"
318,"Down",0.115025942634803,0.299283970271918,"L.LvsV.BHAT_ESR1_TARGETS_NOT_VIA_AKT1_UP"
23,"Down",0.115223533744573,0.299334668286038,"L.LvsV.ZEILSTRA_CD44_TARGETS_DN"
8,"Down",0.11529059053462,0.299334668286038,"L.LvsV.ZIRN_TRETINOIN_RESPONSE_DN"
9,"Down",0.11529716214365,0.299334668286038,"L.LvsV.REACTOME_INTERLEUKIN_1_PROCESSING"
14,"Up",0.115308231163009,0.299334668286038,"L.LvsV.KEGG_LIMONENE_AND_PINENE_DEGRADATION"
70,"Down",0.115316122888273,0.299334668286038,"L.LvsV.ZHAN_MULTIPLE_MYELOMA_CD1_DN"
675,"Down",0.115399545602028,0.299410646472835,"L.LvsV.IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_DN"
20,"Up",0.115574642131596,0.299724294721198,"L.LvsV.REACTOME_LAGGING_STRAND_SYNTHESIS"
53,"Down",0.115827993463274,0.300206293492763,"L.LvsV.HEIDENBLAD_AMPLICON_8Q24_DN"
49,"Down",0.115869095734049,0.300206293492763,"L.LvsV.REACTOME_THE_PHOTOTRANSDUCTION_CASCADE"
33,"Down",0.116079198360519,0.30060978348258,"L.LvsV.HASLINGER_B_CLL_WITH_CHROMOSOME_12_TRISOMY"
619,"Down",0.116302375873178,0.30104673979532,"L.LvsV.YAGI_AML_WITH_11Q23_REARRANGED"
2751,"Down",0.116553688705626,0.301540161392346,"L.LvsV.BLALOCK_ALZHEIMERS_DISEASE_UP"
35,"Down",0.116632995322333,0.301540161392346,"L.LvsV.OZANNE_AP1_TARGETS_UP"
43,"Down",0.116656611542454,0.301540161392346,"L.LvsV.LA_MEN1_TARGETS"
144,"Down",0.116764305811235,0.301677498518839,"L.LvsV.DUTERTRE_ESTRADIOL_RESPONSE_6HR_DN"
515,"Down",0.116875866666387,0.301824692572842,"L.LvsV.SENGUPTA_NASOPHARYNGEAL_CARCINOMA_DN"
126,"Down",0.117289588327657,0.302751696481613,"L.LvsV.TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN"
8,"Down",0.117444497169194,0.303010090923227,"L.LvsV.REACTOME_MET_RECEPTOR_ACTIVATION"
83,"Down",0.117651780534806,0.303403309037753,"L.LvsV.DAUER_STAT3_TARGETS_UP"
258,"Down",0.117827634608656,0.303618835362366,"L.LvsV.RUIZ_TNC_TARGETS_UP"
64,"Down",0.11784518370187,0.303618835362366,"L.LvsV.FAELT_B_CLL_WITH_VH3_21_DN"
118,"Down",0.117973155920779,0.30380697675174,"L.LvsV.GENTILE_UV_LOW_DOSE_DN"
50,"Down",0.118166290984048,0.30406483953574,"L.LvsV.LASTOWSKA_COAMPLIFIED_WITH_MYCN"
13,"Down",0.118183277294684,0.30406483953574,"L.LvsV.REACTOME_SIGNALING_BY_FGFR3_FUSIONS_IN_CANCER"
29,"Down",0.118488807183023,0.304709123216249,"L.LvsV.REACTOME_GABA_SYNTHESIS_RELEASE_REUPTAKE_AND_DEGRADATION"
81,"Down",0.118715000909636,0.305148879604546,"L.LvsV.HENDRICKS_SMARCA4_TARGETS_DN"
379,"Up",0.118829136036428,0.305300322093592,"L.LvsV.REACTOME_DNA_REPAIR"
21,"Down",0.119133676441947,0.30577030749013,"L.LvsV.REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_DIFFERENTIATION_OF_KERATINOCYTES"
42,"Down",0.119151894452437,0.30577030749013,"L.LvsV.REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS"
21,"Down",0.119207641343256,0.30577030749013,"L.LvsV.MARIADASON_RESPONSE_TO_BUTYRATE_CURCUMIN_SULINDAC_TSA_1"
116,"Down",0.119233275990002,0.30577030749013,"L.LvsV.MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_DN"
66,"Down",0.119600404714635,0.306569604852674,"L.LvsV.EPPERT_CE_HSC_LSC"
46,"Up",0.11988435338637,0.307155046280464,"L.LvsV.REACTOME_INTERLEUKIN_7_SIGNALING"
863,"Down",0.11998055544997,0.30722888320504,"L.LvsV.CHICAS_RB1_TARGETS_SENESCENT"
58,"Down",0.120024305972669,0.30722888320504,"L.LvsV.PID_FOXO_PATHWAY"
61,"Down",0.120112564195577,0.307312525422186,"L.LvsV.PID_ERBB1_INTERNALIZATION_PATHWAY"
93,"Down",0.120177293246627,0.307335917835617,"L.LvsV.REACTOME_FOXO_MEDIATED_TRANSCRIPTION"
41,"Up",0.120381099050999,0.307714792719821,"L.LvsV.KYNG_NORMAL_AGING_DN"
63,"Down",0.12062420996221,0.308090678753373,"L.LvsV.AMIT_EGF_RESPONSE_40_HELA"
54,"Down",0.120639594773205,0.308090678753373,"L.LvsV.HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_24HR"
8,"Down",0.120977087004671,0.308809932617186,"L.LvsV.IKEDA_MIR133_TARGETS_DN"
17,"Down",0.121278675255234,0.309436915314346,"L.LvsV.BRUNEAU_SEPTATION_VENTRICULAR"
53,"Up",0.121374820113154,0.309539382105918,"L.LvsV.KIM_TIAL1_TARGETS"
2398,"Down",0.121576106833037,0.309909771636636,"L.LvsV.DODD_NASOPHARYNGEAL_CARCINOMA_UP"
358,"Down",0.121783833692189,0.310296228794522,"L.LvsV.BROWNE_HCMV_INFECTION_18HR_DN"
16,"Down",0.122050325181117,0.310610804515448,"L.LvsV.HOFMANN_MYELODYSPLASTIC_SYNDROM_HIGH_RISK_UP"
249,"Down",0.12213550708621,0.310610804515448,"L.LvsV.IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_UP"
18,"Down",0.122139084549408,0.310610804515448,"L.LvsV.BIOCARTA_NPC_PATHWAY"
34,"Down",0.122187053786332,0.310610804515448,"L.LvsV.REACTOME_TIGHT_JUNCTION_INTERACTIONS"
51,"Down",0.122188189513673,0.310610804515448,"L.LvsV.XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_DN"
86,"Down",0.122248012122783,0.310620063891023,"L.LvsV.PID_INTEGRIN1_PATHWAY"
137,"Down",0.12326194951848,0.31305251212112,"L.LvsV.LEE_AGING_NEOCORTEX_UP"
95,"Down",0.123463378658754,0.313394595560952,"L.LvsV.DIRMEIER_LMP1_RESPONSE_EARLY"
7,"Down",0.123510006100075,0.313394595560952,"L.LvsV.CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_HD_MTX_UP"
117,"Down",0.123636195762183,0.313460176087453,"L.LvsV.REACTOME_ARACHIDONIC_ACID_METABOLISM"
385,"Down",0.123649239292229,0.313460176087453,"L.LvsV.NABA_SECRETED_FACTORS"
8,"Up",0.123815465337863,0.313737721289205,"L.LvsV.REACTOME_TRNA_MODIFICATION_IN_THE_MITOCHONDRION"
183,"Down",0.123924478883889,0.313765617298187,"L.LvsV.YORDY_RECIPROCAL_REGULATION_BY_ETS1_AND_SP100_DN"
74,"Up",0.123939972541009,0.313765617298187,"L.LvsV.BOYAULT_LIVER_CANCER_SUBCLASS_G3_DN"
46,"Down",0.124095673083449,0.313917242579136,"L.LvsV.REACTOME_RET_SIGNALING"
345,"Down",0.124113418751671,0.313917242579136,"L.LvsV.DAVICIONI_MOLECULAR_ARMS_VS_ERMS_DN"
8,"Down",0.124238558198569,0.314090072373062,"L.LvsV.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_30"
17,"Down",0.124562700623299,0.314765617799917,"L.LvsV.PID_RANBP2_PATHWAY"
99,"Down",0.124821215753705,0.315135448292738,"L.LvsV.REACTOME_PLATELET_HOMEOSTASIS"
184,"Down",0.124823047885892,0.315135448292738,"L.LvsV.NIKOLSKY_BREAST_CANCER_20Q12_Q13_AMPLICON"
350,"Down",0.124933479810572,0.315270292045938,"L.LvsV.RODWELL_AGING_KIDNEY_NO_BLOOD_UP"
7,"Down",0.125065031907068,0.315458285316688,"L.LvsV.REACTOME_IKBA_VARIANT_LEADS_TO_EDA_ID"
65,"Up",0.125342367983445,0.315898530066883,"L.LvsV.SESTO_RESPONSE_TO_UV_C3"
50,"Down",0.125409439190134,0.315898530066883,"L.LvsV.REACTOME_G_ALPHA_Z_SIGNALLING_EVENTS"
8,"Up",0.125410973683633,0.315898530066883,"L.LvsV.MATZUK_STEROIDOGENESIS"
39,"Up",0.12601308365443,0.317270646414091,"L.LvsV.HASLINGER_B_CLL_WITH_MUTATED_VH_GENES"
9,"Down",0.126090221193056,0.317320360936007,"L.LvsV.REACTOME_RUNX3_REGULATES_IMMUNE_RESPONSE_AND_CELL_MIGRATION"
87,"Down",0.126155709033661,0.317340725772115,"L.LvsV.SATO_SILENCED_BY_DEACETYLATION_IN_PANCREATIC_CANCER"
118,"Down",0.126274749515881,0.31749572081551,"L.LvsV.KEGG_PROSTATE_CANCER"
63,"Down",0.126339064331947,0.317513039405153,"L.LvsV.BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_48HR_DN"
116,"Up",0.12649634864726,0.317763885356975,"L.LvsV.REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES"
501,"Down",0.127025978913066,0.318949426616866,"L.LvsV.JAATINEN_HEMATOPOIETIC_STEM_CELL_UP"
20,"Up",0.127162359956811,0.319146930640584,"L.LvsV.REACTOME_RETROGRADE_NEUROTROPHIN_SIGNALLING"
40,"Up",0.127329923344572,0.31940139439894,"L.LvsV.REACTOME_HDR_THROUGH_SINGLE_STRAND_ANNEALING_SSA"
76,"Up",0.12743101146343,0.31940139439894,"L.LvsV.REACTOME_DAP12_SIGNALING"
28,"Down",0.127437054809922,0.31940139439894,"L.LvsV.REACTOME_OTHER_SEMAPHORIN_INTERACTIONS"
18,"Up",0.127608933632049,0.319687265089079,"L.LvsV.BAKER_HEMATOPOIESIS_STAT3_TARGETS"
35,"Down",0.127957634078453,0.320415651639386,"L.LvsV.GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN"
394,"Down",0.128085999523836,0.320591892877902,"L.LvsV.BILD_E2F3_ONCOGENIC_SIGNATURE"
17,"Down",0.128182710815227,0.320688781944519,"L.LvsV.PID_S1P_S1P4_PATHWAY"
81,"Up",0.128260839539385,0.320739114343401,"L.LvsV.HEIDENBLAD_AMPLICON_8Q24_UP"
333,"Down",0.128464864033662,0.32109671089678,"L.LvsV.BILD_MYC_ONCOGENIC_SIGNATURE"
188,"Up",0.128563989677133,0.32109671089678,"L.LvsV.WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_UP"
89,"Down",0.128578064374294,0.32109671089678,"L.LvsV.PID_DELTA_NP63_PATHWAY"
51,"Down",0.128661476307234,0.321159955983158,"L.LvsV.GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_DN"
28,"Up",0.128995111513222,0.32184746008872,"L.LvsV.LI_ADIPOGENESIS_BY_ACTIVATED_PPARG"
35,"Down",0.129329746867705,0.322499799289568,"L.LvsV.NABA_PROTEOGLYCANS"
29,"Down",0.129373223878506,0.322499799289568,"L.LvsV.PID_HEDGEHOG_2PATHWAY"
12,"Down",0.129447207318644,0.322538805437035,"L.LvsV.REACTOME_HDL_REMODELING"
266,"Down",0.129672152882747,0.322888563133175,"L.LvsV.MIKKELSEN_IPS_LCP_WITH_H3K4ME3"
115,"Up",0.129757664702201,0.322888563133175,"L.LvsV.REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX"
135,"Up",0.129785229305361,0.322888563133175,"L.LvsV.HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP"
78,"Down",0.129821174867978,0.322888563133175,"L.LvsV.PID_CASPASE_PATHWAY"
92,"Down",0.130520038499589,0.324480797151181,"L.LvsV.ZHU_CMV_8_HR_DN"
66,"Down",0.130631950953622,0.324613059246103,"L.LvsV.JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_DN"
62,"Up",0.130817929625687,0.324861936459716,"L.LvsV.REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS"
89,"Down",0.130911746237951,0.324861936459716,"L.LvsV.REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH"
23,"Down",0.130958674369647,0.324861936459716,"L.LvsV.REACTOME_CHL1_INTERACTIONS"
1260,"Up",0.131010228207127,0.324861936459716,"L.LvsV.ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_UP"
54,"Down",0.131025885025351,0.324861936459716,"L.LvsV.BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_UP"
77,"Down",0.131359252309082,0.325495211362473,"L.LvsV.MARTINEZ_RESPONSE_TO_TRABECTEDIN"
55,"Down",0.131399043545133,0.325495211362473,"L.LvsV.PID_LYMPH_ANGIOGENESIS_PATHWAY"
106,"Down",0.131559761370011,0.325700012189941,"L.LvsV.INGRAM_SHH_TARGETS_DN"
130,"Down",0.131599534677578,0.325700012189941,"L.LvsV.PID_CXCR4_PATHWAY"
43,"Down",0.131675115703893,0.32573011361456,"L.LvsV.REACTOME_EXPORT_OF_VIRAL_RIBONUCLEOPROTEINS_FROM_NUCLEUS"
11,"Up",0.131729523248717,0.32573011361456,"L.LvsV.BIOCARTA_REELIN_PATHWAY"
58,"Down",0.131855866323024,0.325783729922935,"L.LvsV.LI_CISPLATIN_RESISTANCE_DN"
19,"Down",0.131869051829902,0.325783729922935,"L.LvsV.REACTOME_CGMP_EFFECTS"
9,"Up",0.132025931969999,0.325883698600654,"L.LvsV.REACTOME_THE_ACTIVATION_OF_ARYLSULFATASES"
10,"Down",0.132027398239368,0.325883698600654,"L.LvsV.REACTOME_NEGATIVE_REGULATION_OF_ACTIVITY_OF_TFAP2_AP_2_FAMILY_TRANSCRIPTION_FACTORS"
61,"Down",0.132181780957337,0.326028854352074,"L.LvsV.KEGG_ENDOMETRIAL_CANCER"
43,"Down",0.132204140252731,0.326028854352074,"L.LvsV.REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS"
21,"Down",0.132557387717656,0.32671838138648,"L.LvsV.REACTOME_NRIF_SIGNALS_CELL_DEATH_FROM_THE_NUCLEUS"
39,"Down",0.132601925815023,0.32671838138648,"L.LvsV.PID_VEGFR1_PATHWAY"
45,"Down",0.132762877101899,0.326765531843868,"L.LvsV.REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS"
78,"Down",0.132775521278648,0.326765531843868,"L.LvsV.VILIMAS_NOTCH1_TARGETS_UP"
51,"Up",0.132798363185598,0.326765531843868,"L.LvsV.PID_FAS_PATHWAY"
1200,"Down",0.13296679348719,0.327034431134641,"L.LvsV.RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN"
44,"Down",0.133061554033693,0.327067874883049,"L.LvsV.REACTOME_CA_DEPENDENT_EVENTS"
13,"Down",0.133098701118984,0.327067874883049,"L.LvsV.REACTOME_FGFRL1_MODULATION_OF_FGFR1_SIGNALING"
155,"Up",0.133180949886796,0.327124598811236,"L.LvsV.ALCALA_APOPTOSIS"
168,"Down",0.133356164662832,0.327409517948845,"L.LvsV.BROWNE_HCMV_INFECTION_16HR_DN"
23,"Down",0.133443985306743,0.327431766486914,"L.LvsV.REACTOME_PLATELET_SENSITIZATION_BY_LDL"
41,"Up",0.133483668233225,0.327431766486914,"L.LvsV.BIOCARTA_EIF4_PATHWAY"
18,"Down",0.133684739197735,0.327646034316114,"L.LvsV.PID_SMAD2_3PATHWAY"
66,"Down",0.133689537604839,0.327646034316114,"L.LvsV.REACTOME_NEUREXINS_AND_NEUROLIGINS"
26,"Down",0.133805799131292,0.327785672750071,"L.LvsV.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_UP"
45,"Down",0.133977082757584,0.328059916105706,"L.LvsV.REACTOME_MET_ACTIVATES_PTK2_SIGNALING"
556,"Down",0.134134373031107,0.328299667325803,"L.LvsV.MEISSNER_NPC_HCP_WITH_H3K4ME2_AND_H3K27ME3"
20,"Down",0.134266353823181,0.328415717674541,"L.LvsV.REACTOME_HDL_ASSEMBLY"
19,"Up",0.134300585578249,0.328415717674541,"L.LvsV.NIKOLSKY_BREAST_CANCER_12Q24_AMPLICON"
7,"Up",0.134463429581146,0.328474979755379,"L.LvsV.REACTOME_VLDL_CLEARANCE"
74,"Down",0.134487567568033,0.328474979755379,"L.LvsV.GEORGES_CELL_CYCLE_MIR192_TARGETS"
101,"Down",0.134503048320886,0.328474979755379,"L.LvsV.PID_ENDOTHELIN_PATHWAY"
17,"Down",0.134574263579091,0.328503798379158,"L.LvsV.BIOCARTA_DREAM_PATHWAY"
63,"Down",0.134744463843046,0.328774113233981,"L.LvsV.AMIT_EGF_RESPONSE_60_HELA"
26,"Up",0.134863727765552,0.328919960659786,"L.LvsV.REACTOME_N_GLYCAN_ANTENNAE_ELONGATION_IN_THE_MEDIAL_TRANS_GOLGI"
18,"Down",0.134966964493734,0.329026607886179,"L.LvsV.REACTOME_ACTIVATION_OF_BAD_AND_TRANSLOCATION_TO_MITOCHONDRIA"
103,"Down",0.13520131856754,0.329452662124252,"L.LvsV.NAGASHIMA_NRG1_SIGNALING_DN"
55,"Down",0.135549746131192,0.330156187823506,"L.LvsV.REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA"
85,"Up",0.13575821699956,0.33040709651916,"L.LvsV.HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_DN"
6,"Down",0.135827395149221,0.33040709651916,"L.LvsV.REACTOME_MET_INTERACTS_WITH_TNS_PROTEINS"
175,"Up",0.13583203660482,0.33040709651916,"L.LvsV.COATES_MACROPHAGE_M1_VS_M2_DN"
10,"Up",0.135935330270254,0.330452465676465,"L.LvsV.GALI_TP53_TARGETS_APOPTOTIC_DN"
48,"Down",0.135970222357381,0.330452465676465,"L.LvsV.BIOCARTA_EGF_PATHWAY"
8,"Up",0.136196437063262,0.330856810423012,"L.LvsV.NIKOLSKY_BREAST_CANCER_19Q13.4_AMPLICON"
19,"Down",0.136745153871335,0.332043898003781,"L.LvsV.BIOCARTA_P53_PATHWAY"
25,"Down",0.137007350855457,0.332534522774284,"L.LvsV.HOLLEMAN_PREDNISOLONE_RESISTANCE_ALL_UP"
37,"Up",0.137856041662561,0.334322619006272,"L.LvsV.STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_UP"
101,"Down",0.137878604267497,0.334322619006272,"L.LvsV.ZHOU_TNF_SIGNALING_30MIN"
6,"Up",0.137951349312892,0.334322619006272,"L.LvsV.REACTOME_N_GLYCAN_TRIMMING_AND_ELONGATION_IN_THE_CIS_GOLGI"
37,"Down",0.137985931736718,0.334322619006272,"L.LvsV.HOFMANN_MYELODYSPLASTIC_SYNDROM_RISK_UP"
8,"Up",0.138179514965926,0.334645001422079,"L.LvsV.REACTOME_SYNTHESIS_OF_PIPS_AT_THE_ER_MEMBRANE"
144,"Down",0.13834339294235,0.33478563292335,"L.LvsV.WINZEN_DEGRADED_VIA_KHSRP"
36,"Up",0.138358685337286,0.33478563292335,"L.LvsV.HOLLEMAN_ASPARAGINASE_RESISTANCE_B_ALL_DN"
9,"Up",0.138719413887974,0.335511653274983,"L.LvsV.REACTOME_REELIN_SIGNALLING_PATHWAY"
27,"Down",0.138793722232321,0.335520165695823,"L.LvsV.REACTOME_NEGATIVE_REGULATION_OF_NMDA_RECEPTOR_MEDIATED_NEURONAL_TRANSMISSION"
19,"Up",0.138844300797982,0.335520165695823,"L.LvsV.REACTOME_METABOLISM_OF_AMINE_DERIVED_HORMONES"
88,"Down",0.13901248375873,0.335779826431638,"L.LvsV.ZHANG_PROLIFERATING_VS_QUIESCENT"
187,"Up",0.139400117965944,0.336455597360089,"L.LvsV.QI_HYPOXIA"
1519,"Down",0.139459854987049,0.336455597360089,"L.LvsV.BENPORATH_EED_TARGETS"
107,"Down",0.139584861649839,0.336455597360089,"L.LvsV.KYNG_RESPONSE_TO_H2O2"
36,"Down",0.139611166552336,0.336455597360089,"L.LvsV.REACTOME_ACTIVATION_OF_BH3_ONLY_PROTEINS"
33,"Down",0.139698736268251,0.336455597360089,"L.LvsV.BIOCARTA_CTCF_PATHWAY"
117,"Up",0.139707890939834,0.336455597360089,"L.LvsV.REACTOME_TRANSCRIPTIONAL_REGULATION_OF_GRANULOPOIESIS"
406,"Down",0.139718222379954,0.336455597360089,"L.LvsV.DANG_REGULATED_BY_MYC_DN"
427,"Down",0.139998978201352,0.336984915313573,"L.LvsV.UDAYAKUMAR_MED1_TARGETS_DN"
196,"Up",0.140138167098475,0.337173161830927,"L.LvsV.SU_TESTIS"
41,"Down",0.140254469466355,0.337306203427349,"L.LvsV.WANG_METASTASIS_OF_BREAST_CANCER"
682,"Down",0.140386865883527,0.337477818030443,"L.LvsV.YAGI_AML_WITH_T_8_21_TRANSLOCATION"
207,"Down",0.140684078220758,0.33793444729426,"L.LvsV.MCCLUNG_CREB1_TARGETS_UP"
42,"Down",0.140699059083268,0.33793444729426,"L.LvsV.ABBUD_LIF_SIGNALING_2_UP"
29,"Up",0.14085562108397,0.33815215021621,"L.LvsV.DORN_ADENOVIRUS_INFECTION_32HR_UP"
243,"Down",0.14094330407125,0.33815215021621,"L.LvsV.PROVENZANI_METASTASIS_DN"
77,"Up",0.140973178919943,0.33815215021621,"L.LvsV.REACTOME_ORC1_REMOVAL_FROM_CHROMATIN"
24,"Down",0.14108873721729,0.338282579390458,"L.LvsV.PID_THROMBIN_PAR4_PATHWAY"
75,"Down",0.141166211749922,0.338321623218604,"L.LvsV.EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_DN"
33,"Down",0.141305597994283,0.338508947708142,"L.LvsV.KIM_LIVER_CANCER_POOR_SURVIVAL_UP"
21,"Down",0.141537532629751,0.338917721052357,"L.LvsV.GEISS_RESPONSE_TO_DSRNA_DN"
216,"Down",0.141992919667285,0.33976589644323,"L.LvsV.PECE_MAMMARY_STEM_CELL_DN"
15,"Up",0.142014647618069,0.33976589644323,"L.LvsV.MANN_RESPONSE_TO_AMIFOSTINE_DN"
34,"Down",0.142105991674318,0.339837382338799,"L.LvsV.BIOCARTA_MAL_PATHWAY"
16,"Up",0.142421505568064,0.340330582174962,"L.LvsV.BIOCARTA_TCYTOTOXIC_PATHWAY"
39,"Down",0.142451615054775,0.340330582174962,"L.LvsV.PID_IL2_STAT5_PATHWAY"
32,"Down",0.142525323042996,0.340330582174962,"L.LvsV.BIOCARTA_PDZS_PATHWAY"
38,"Down",0.142558442452019,0.340330582174962,"L.LvsV.ONO_FOXP3_TARGETS_UP"
57,"Down",0.142909036914471,0.341020312947825,"L.LvsV.STANELLE_E2F1_TARGETS"
29,"Down",0.143035328105686,0.341029220289611,"L.LvsV.MURAKAMI_UV_RESPONSE_1HR_UP"
109,"Down",0.143036129833895,0.341029220289611,"L.LvsV.REACTOME_AURKA_ACTIVATION_BY_TPX2"
197,"Down",0.143342100211378,0.341472166064967,"L.LvsV.LIU_SOX4_TARGETS_UP"
69,"Up",0.143345432706961,0.341472166064967,"L.LvsV.BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_DN"
16,"Up",0.143546532658388,0.341803953087092,"L.LvsV.REACTOME_SYNTHESIS_OF_IP2_IP_AND_INS_IN_THE_CYTOSOL"
162,"Up",0.143854006428181,0.342388636048822,"L.LvsV.REACTOME_MEIOTIC_SYNAPSIS"
17,"Down",0.144063794223861,0.342677155969651,"L.LvsV.ONGUSAHA_BRCA1_TARGETS_UP"
23,"Down",0.144215728035011,0.342677155969651,"L.LvsV.REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_CELL_CYCLE_GENES"
37,"Down",0.14427403182497,0.342677155969651,"L.LvsV.PID_INSULIN_GLUCOSE_PATHWAY"
87,"Down",0.144334580140992,0.342677155969651,"L.LvsV.ZHOU_TNF_SIGNALING_4HR"
846,"Down",0.144372138781246,0.342677155969651,"L.LvsV.SMID_BREAST_CANCER_NORMAL_LIKE_UP"
73,"Down",0.144380793990626,0.342677155969651,"L.LvsV.BILANGES_SERUM_SENSITIVE_VIA_TSC2"
89,"Up",0.144425627040417,0.342677155969651,"L.LvsV.REACTOME_PI_METABOLISM"
59,"Down",0.144471052733814,0.342677155969651,"L.LvsV.REACTOME_TRANSCRIPTIONAL_REGULATION_OF_PLURIPOTENT_STEM_CELLS"
193,"Down",0.144979853433349,0.343736539293734,"L.LvsV.KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP"
32,"Down",0.145167535534804,0.344033992272581,"L.LvsV.LEE_SP4_THYMOCYTE"
218,"Down",0.145282081982038,0.344157939708093,"L.LvsV.KATSANOU_ELAVL1_TARGETS_DN"
310,"Down",0.145838806209978,0.34532880494003,"L.LvsV.KARLSSON_TGFB1_TARGETS_DN"
46,"Down",0.145994408040121,0.345549264577838,"L.LvsV.HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_DN"
134,"Down",0.146153977590579,0.345778922592346,"L.LvsV.MIKKELSEN_IPS_ICP_WITH_H3K27ME3"
22,"Down",0.146218087612369,0.34578263747168,"L.LvsV.BIOCARTA_CALCINEURIN_PATHWAY"
313,"Down",0.14632220304251,0.34579204043016,"L.LvsV.REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES"
60,"Down",0.146347146790844,0.34579204043016,"L.LvsV.BIOCARTA_FCER1_PATHWAY"
71,"Up",0.14652847072474,0.346072582074791,"L.LvsV.BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_UP"
47,"Down",0.147397766314442,0.347977049510056,"L.LvsV.SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_DN"
16,"Up",0.147617844558708,0.348347871346605,"L.LvsV.NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN"
7,"Up",0.147681909010365,0.348350373258664,"L.LvsV.TESAR_ALK_TARGETS_HUMAN_ES_4D_DN"
35,"Down",0.148001106618362,0.348954421532163,"L.LvsV.HOFMANN_MYELODYSPLASTIC_SYNDROM_HIGH_RISK_DN"
165,"Down",0.148198893985497,0.349271817922343,"L.LvsV.TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_UP"
51,"Down",0.148385406119766,0.349562381949802,"L.LvsV.BOYAULT_LIVER_CANCER_SUBCLASS_G2"
368,"Down",0.148465189733848,0.349601377358793,"L.LvsV.THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN"
12,"Up",0.148603760664759,0.349778711245404,"L.LvsV.REACTOME_NF_KB_ACTIVATION_THROUGH_FADD_RIP_1_PATHWAY_MEDIATED_BY_CASPASE_8_AND_10"
487,"Up",0.149097196988457,0.350790809425181,"L.LvsV.SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM4"
17,"Down",0.149459813365476,0.351387993775878,"L.LvsV.SUZUKI_CTCFL_TARGETS_UP"
5,"Up",0.149501316382991,0.351387993775878,"L.LvsV.REACTOME_SUMO_IS_CONJUGATED_TO_E1_UBA2_SAE1"
25,"Down",0.149541680114784,0.351387993775878,"L.LvsV.RASHI_NFKB1_TARGETS"
211,"Up",0.149616396294571,0.351414212027478,"L.LvsV.RODWELL_AGING_KIDNEY_DN"
176,"Up",0.149814482226728,0.351723089317944,"L.LvsV.CADWELL_ATG16L1_TARGETS_UP"
32,"Down",0.149875130843385,0.351723089317944,"L.LvsV.WANG_LSD1_TARGETS_UP"
636,"Up",0.150114308176888,0.352134921472216,"L.LvsV.RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP"
27,"Up",0.150204625760635,0.352197360403118,"L.LvsV.REACTOME_CELLULAR_HEXOSE_TRANSPORT"
22,"Up",0.150313811293569,0.352303968902986,"L.LvsV.KIM_PTEN_TARGETS_UP"
9,"Down",0.150807300539274,0.353220078268748,"L.LvsV.BIOCARTA_CIRCADIAN_PATHWAY"
6,"Up",0.15083244796392,0.353220078268748,"L.LvsV.REACTOME_VLDL_ASSEMBLY"
27,"Up",0.150948765531677,0.353342813134904,"L.LvsV.KEGG_HOMOLOGOUS_RECOMBINATION"
90,"Down",0.151414458473111,0.354282920396881,"L.LvsV.JI_RESPONSE_TO_FSH_DN"
89,"Down",0.151606117226325,0.354581312243802,"L.LvsV.PID_P75_NTR_PATHWAY"
172,"Down",0.151886387066864,0.355086610610017,"L.LvsV.BAELDE_DIABETIC_NEPHROPATHY_UP"
32,"Down",0.152249554128558,0.355669933508743,"L.LvsV.COLLER_MYC_TARGETS_DN"
25,"Down",0.152405062883353,0.355669933508743,"L.LvsV.NEBEN_AML_WITH_FLT3_OR_NRAS_DN"
474,"Down",0.152413592609111,0.355669933508743,"L.LvsV.REACTOME_NEURONAL_SYSTEM"
67,"Down",0.152449935545738,0.355669933508743,"L.LvsV.ZHAN_MULTIPLE_MYELOMA_PR_DN"
31,"Down",0.152457540679277,0.355669933508743,"L.LvsV.REACTOME_RECYCLING_OF_BILE_ACIDS_AND_SALTS"
57,"Down",0.152586627033228,0.355693060695932,"L.LvsV.WESTON_VEGFA_TARGETS_12HR"
238,"Down",0.152596118641843,0.355693060695932,"L.LvsV.LI_INDUCED_T_TO_NATURAL_KILLER_DN"
179,"Down",0.15275326859945,0.355909322413132,"L.LvsV.MIKKELSEN_IPS_HCP_WITH_H3_UNMETHYLATED"
193,"Up",0.152828206417695,0.355928250225237,"L.LvsV.ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_DN"
16,"Up",0.152890141849329,0.355928250225237,"L.LvsV.REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TN_POLYAGGLUTINATION_SYNDROME_TNPS"
19,"Down",0.153016416472944,0.356020792655449,"L.LvsV.WILLIAMS_ESR2_TARGETS_DN"
41,"Down",0.153065164148481,0.356020792655449,"L.LvsV.HASLINGER_B_CLL_WITH_13Q14_DELETION"
212,"Up",0.153123068354975,0.356020792655449,"L.LvsV.WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_UP"
34,"Down",0.153212422914352,0.35607880886652,"L.LvsV.BIOCARTA_RAS_PATHWAY"
59,"Down",0.153383399013084,0.356326392077033,"L.LvsV.GEISS_RESPONSE_TO_DSRNA_UP"
639,"Down",0.153719076597925,0.356956226169646,"L.LvsV.HAN_SATB1_TARGETS_DN"
488,"Down",0.153901006860661,0.357228659501508,"L.LvsV.BROWNE_HCMV_INFECTION_14HR_DN"
59,"Down",0.154003272239156,0.357316026945151,"L.LvsV.GALLUZZI_PERMEABILIZE_MITOCHONDRIA"
35,"Down",0.154275978982322,0.357798610651535,"L.LvsV.BIOCARTA_IGF1_PATHWAY"
15,"Down",0.154444013135522,0.35789015505308,"L.LvsV.REACTOME_ORGANIC_CATION_TRANSPORT"
867,"Down",0.15445065213281,0.35789015505308,"L.LvsV.NABA_MATRISOME_ASSOCIATED"
45,"Down",0.154509640099783,0.35789015505308,"L.LvsV.WATANABE_COLON_CANCER_MSI_VS_MSS_UP"
17,"Down",0.154623499478253,0.358003906455302,"L.LvsV.BIOCARTA_BTG2_PATHWAY"
312,"Up",0.154786349645416,0.35812512907731,"L.LvsV.GERY_CEBP_TARGETS"
249,"Down",0.154805400342697,0.35812512907731,"L.LvsV.AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_UP"
21,"Down",0.155219491388414,0.35893290166731,"L.LvsV.CHESLER_BRAIN_QTL_TRANS"
88,"Up",0.155442438475085,0.359298178231082,"L.LvsV.WEBER_METHYLATED_ICP_IN_SPERM_DN"
43,"Down",0.15563468931456,0.359580929688323,"L.LvsV.REACTOME_RNA_POLYMERASE_III_TRANSCRIPTION"
126,"Up",0.155710205215756,0.359580929688323,"L.LvsV.REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS"
101,"Down",0.155759870971881,0.359580929688323,"L.LvsV.TCGA_GLIOBLASTOMA_COPY_NUMBER_UP"
756,"Down",0.155840265828276,0.359616373023597,"L.LvsV.ZHENG_BOUND_BY_FOXP3"
349,"Down",0.155973830752285,0.359688191411701,"L.LvsV.BENPORATH_MYC_TARGETS_WITH_EBOX"
175,"Down",0.156045583851642,0.359688191411701,"L.LvsV.REACTOME_INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING"
41,"Down",0.156066552938447,0.359688191411701,"L.LvsV.REACTOME_INWARDLY_RECTIFYING_K_CHANNELS"
192,"Up",0.156393969710608,0.360292607720813,"L.LvsV.BENPORATH_PROLIFERATION"
245,"Down",0.156470727267863,0.360319304899631,"L.LvsV.GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN"
177,"Up",0.156574411782663,0.360407961176662,"L.LvsV.JAZAG_TGFB1_SIGNALING_UP"
587,"Down",0.156785993834107,0.360615868529045,"L.LvsV.DELACROIX_RARG_BOUND_MEF"
43,"Down",0.15679517958832,0.360615868529045,"L.LvsV.DISTECHE_ESCAPED_FROM_X_INACTIVATION"
28,"Up",0.156932448034664,0.360781499036863,"L.LvsV.REACTOME_CYCLIN_A_B1_B2_ASSOCIATED_EVENTS_DURING_G2_M_TRANSITION"
134,"Down",0.157163040684358,0.361161451348219,"L.LvsV.VANHARANTA_UTERINE_FIBROID_DN"
44,"Down",0.157500410883518,0.361786361352293,"L.LvsV.MACLACHLAN_BRCA1_TARGETS_DN"
142,"Down",0.157850793816291,0.36244063081822,"L.LvsV.QUINTENS_EMBRYONIC_BRAIN_RESPONSE_TO_IR"
319,"Down",0.15799978559308,0.36263213555174,"L.LvsV.SHEPARD_CRUSH_AND_BURN_MUTANT_DN"
181,"Down",0.15841240448676,0.363428292285184,"L.LvsV.NIKOLSKY_MUTATED_AND_AMPLIFIED_IN_BREAST_CANCER"
177,"Down",0.158529354167449,0.363545748316809,"L.LvsV.KEGG_CELL_ADHESION_MOLECULES_CAMS"
11,"Up",0.158797746844685,0.363977259027194,"L.LvsV.REACTOME_PHENYLALANINE_METABOLISM"
13,"Down",0.158849181774755,0.363977259027194,"L.LvsV.REACTOME_CREATINE_METABOLISM"
61,"Down",0.159149164846734,0.364513559419052,"L.LvsV.MIKKELSEN_MEF_ICP_WITH_H3K4ME3_AND_H3K27ME3"
8,"Up",0.15922325195552,0.364532240191333,"L.LvsV.MOOTHA_PYR"
161,"Down",0.159577308720741,0.365191614204048,"L.LvsV.REACTOME_CARDIAC_CONDUCTION"
50,"Up",0.159735961086451,0.3652776202149,"L.LvsV.WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_DN"
8,"Up",0.15976175335318,0.3652776202149,"L.LvsV.HESSON_TUMOR_SUPPRESSOR_CLUSTER_3P21_3"
137,"Down",0.159813087954394,0.3652776202149,"L.LvsV.KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION"
389,"Down",0.15989974935569,0.365324675284136,"L.LvsV.HOSHIDA_LIVER_CANCER_SUBCLASS_S1"
1584,"Down",0.160086199024984,0.365599584638223,"L.LvsV.GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS"
123,"Down",0.160409551744114,0.36618679256532,"L.LvsV.KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_UP"
750,"Down",0.160565260466607,0.366390971985089,"L.LvsV.MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN"
17,"Down",0.160654184939898,0.36644265203494,"L.LvsV.FU_INTERACT_WITH_ALKBH8"
32,"Up",0.160729936785369,0.366464255870641,"L.LvsV.CAFFAREL_RESPONSE_TO_THC_24HR_3_DN"
75,"Down",0.16093657267899,0.366784134518605,"L.LvsV.CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN"
5,"Up",0.161255884106326,0.36736043808153,"L.LvsV.REACTOME_BETA_OXIDATION_OF_HEXANOYL_COA_TO_BUTANOYL_COA"
93,"Down",0.161407352688144,0.367362072457262,"L.LvsV.WEIGEL_OXIDATIVE_STRESS_BY_TBH_AND_H2O2"
1480,"Down",0.161433803946934,0.367362072457262,"L.LvsV.CUI_TCF21_TARGETS_2_DN"
2689,"Down",0.161455929837429,0.367362072457262,"L.LvsV.ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY"
747,"Down",0.161563055750356,0.367454601087502,"L.LvsV.ODONNELL_TFRC_TARGETS_UP"
72,"Down",0.161844261541236,0.367942813347655,"L.LvsV.REACTOME_SIGNALING_BY_FGFR_IN_DISEASE"
12,"Down",0.162101531640805,0.36837623035019,"L.LvsV.REACTOME_MET_RECEPTOR_RECYCLING"
49,"Down",0.162188536006387,0.368422520780325,"L.LvsV.BIOCARTA_FMLP_PATHWAY"
42,"Down",0.162304535658114,0.368534610946082,"L.LvsV.OHM_METHYLATED_IN_ADULT_CANCERS"
83,"Down",0.162383324948296,0.368562152561219,"L.LvsV.PARENT_MTOR_SIGNALING_DN"
711,"Down",0.162487310610175,0.368646836423332,"L.LvsV.CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5"
238,"Down",0.162565389350147,0.368672697997113,"L.LvsV.TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN"
65,"Down",0.162679939108713,0.368781214978299,"L.LvsV.ZHANG_INTERFERON_RESPONSE"
163,"Down",0.162897517288452,0.368869270820887,"L.LvsV.HILLION_HMGA1_TARGETS"
17,"Down",0.162916420341409,0.368869270820887,"L.LvsV.PID_CIRCADIAN_PATHWAY"
8,"Up",0.16291892916343,0.368869270820887,"L.LvsV.REACTOME_TYSND1_CLEAVES_PEROXISOMAL_PROTEINS"
61,"Down",0.163407714404053,0.369694658708463,"L.LvsV.XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_UP"
98,"Up",0.163417208515732,0.369694658708463,"L.LvsV.KIM_LRRC3B_TARGETS"
123,"Down",0.163495599343408,0.369720723423192,"L.LvsV.BILANGES_SERUM_SENSITIVE_GENES"
14,"Down",0.163624372077993,0.369860651357,"L.LvsV.REACTOME_FGFR3_LIGAND_BINDING_AND_ACTIVATION"
131,"Down",0.164345292060418,0.371227611163159,"L.LvsV.GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP"
30,"Up",0.164363391594757,0.371227611163159,"L.LvsV.BIOCARTA_IGF1MTOR_PATHWAY"
31,"Up",0.164606367637862,0.371496749485187,"L.LvsV.REICHERT_MITOSIS_LIN9_TARGETS"
33,"Down",0.164616935474536,0.371496749485187,"L.LvsV.BIOCARTA_G1_PATHWAY"
109,"Down",0.164750044467151,0.371504408764304,"L.LvsV.LEE_LIVER_CANCER_MYC_E2F1_UP"
20,"Up",0.16475471338218,0.371504408764304,"L.LvsV.REACTOME_POLO_LIKE_KINASE_MEDIATED_EVENTS"
13,"Down",0.164951588865949,0.371796712123861,"L.LvsV.GALI_TP53_TARGETS_APOPTOTIC_UP"
39,"Down",0.165618184723468,0.373147083674025,"L.LvsV.REACTOME_NUCLEAR_IMPORT_OF_REV_PROTEIN"
21,"Down",0.166049426702545,0.373966305596078,"L.LvsV.TOMLINS_METASTASIS_UP"
17,"Up",0.166590960571527,0.375033151872954,"L.LvsV.REACTOME_CYTOCHROME_C_MEDIATED_APOPTOTIC_RESPONSE"
90,"Down",0.166992845691393,0.375784877422756,"L.LvsV.DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP"
45,"Down",0.167139560040473,0.375809120562739,"L.LvsV.NABA_COLLAGENS"
45,"Down",0.167139560040473,0.375809120562739,"L.LvsV.REACTOME_COLLAGEN_CHAIN_TRIMERIZATION"
77,"Down",0.167629372402375,0.376757235777533,"L.LvsV.KEGG_COLORECTAL_CANCER"
15,"Up",0.167882139110341,0.376893338647292,"L.LvsV.PETRETTO_LEFT_VENTRICLE_MASS_QTL_CIS_DN"
10,"Up",0.167884195488774,0.376893338647292,"L.LvsV.REACTOME_METABOLISM_OF_INGESTED_SEMET_SEC_MESEC_INTO_H2SE"
354,"Down",0.167894428122315,0.376893338647292,"L.LvsV.MARTORIATI_MDM4_TARGETS_FETAL_LIVER_UP"
48,"Down",0.168035555484514,0.376922209327595,"L.LvsV.WANG_THOC1_TARGETS_DN"
23,"Down",0.168043632843647,0.376922209327595,"L.LvsV.ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN"
24,"Down",0.168207490274906,0.37713674522707,"L.LvsV.BIOCARTA_ACTINY_PATHWAY"
69,"Down",0.168361332017282,0.377209625600425,"L.LvsV.APPIERTO_RESPONSE_TO_FENRETINIDE_UP"
22,"Up",0.168376443476551,0.377209625600425,"L.LvsV.KEGG_MISMATCH_REPAIR"
32,"Down",0.168566957597839,0.377439528949608,"L.LvsV.REACTOME_DISEASES_OF_PROGRAMMED_CELL_DEATH"
197,"Down",0.168615597125255,0.377439528949608,"L.LvsV.GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_UP"
33,"Down",0.168792180217399,0.377567577999711,"L.LvsV.TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_DN"
30,"Down",0.168809378335194,0.377567577999711,"L.LvsV.AMIT_SERUM_RESPONSE_20_MCF10A"
57,"Down",0.169016791221568,0.377878624611422,"L.LvsV.SIG_CHEMOTAXIS"
415,"Down",0.169243793038046,0.378194588302252,"L.LvsV.TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_UP"
102,"Down",0.16929491880052,0.378194588302252,"L.LvsV.REACTOME_SIGNALING_BY_NOTCH4"
584,"Down",0.170079000449312,0.379736220085869,"L.LvsV.MIKKELSEN_NPC_HCP_WITH_H3K27ME3"
221,"Down",0.170122376044981,0.379736220085869,"L.LvsV.REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION"
29,"Up",0.170293729509777,0.379965306884405,"L.LvsV.REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_CYCLIN_B"
60,"Down",0.170560172230463,0.380406289738698,"L.LvsV.REACTOME_BIOSYNTHESIS_OF_SPECIALIZED_PRORESOLVING_MEDIATORS_SPMS"
72,"Down",0.170817869194321,0.380827418861049,"L.LvsV.PARK_HSC_AND_MULTIPOTENT_PROGENITORS"
56,"Down",0.171250382269281,0.381637792650888,"L.LvsV.PID_RET_PATHWAY"
22,"Down",0.1713336033483,0.381669416967263,"L.LvsV.BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_24HR_DN"
330,"Up",0.171415536071174,0.381698146974435,"L.LvsV.REACTOME_METABOLISM_OF_CARBOHYDRATES"
9,"Up",0.17157214529726,0.381893072201509,"L.LvsV.REACTOME_FATTY_ACIDS_BOUND_TO_GPR40_FFAR1_REGULATE_INSULIN_SECRETION"
155,"Up",0.171792090047417,0.382228758902282,"L.LvsV.REACTOME_ACTIVATION_OF_ANTERIOR_HOX_GENES_IN_HINDBRAIN_DEVELOPMENT_DURING_EARLY_EMBRYOGENESIS"
28,"Down",0.171975776197125,0.382483534430372,"L.LvsV.HOWLIN_CITED1_TARGETS_2_DN"
105,"Down",0.172348750157997,0.383089246748406,"L.LvsV.GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_DN"
50,"Down",0.172439289530135,0.383089246748406,"L.LvsV.REACTOME_GAP_JUNCTION_TRAFFICKING_AND_REGULATION"
10,"Down",0.172455983931413,0.383089246748406,"L.LvsV.REACTOME_PTK6_PROMOTES_HIF1A_STABILIZATION"
18,"Down",0.172735269675164,0.383555544591961,"L.LvsV.LI_WILMS_TUMOR_ANAPLASTIC_DN"
24,"Down",0.173033239426286,0.383879124874406,"L.LvsV.REACTOME_FRS_MEDIATED_FGFR4_SIGNALING"
168,"Up",0.173064475111563,0.383879124874406,"L.LvsV.TOOKER_GEMCITABINE_RESISTANCE_DN"
11,"Down",0.173089285279778,0.383879124874406,"L.LvsV.SMID_BREAST_CANCER_RELAPSE_IN_PLEURA_UP"
573,"Down",0.173273710516949,0.384025682289354,"L.LvsV.CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP"
9,"Down",0.173357972531274,0.384025682289354,"L.LvsV.SHARMA_PILOCYTIC_ASTROCYTOMA_LOCATION_DN"
58,"Down",0.17336373720279,0.384025682289354,"L.LvsV.REACTOME_SNRNP_ASSEMBLY"
26,"Up",0.173532305799605,0.384245141676419,"L.LvsV.REACTOME_SYNTHESIS_SECRETION_AND_INACTIVATION_OF_GLUCAGON_LIKE_PEPTIDE_1_GLP_1"
978,"Up",0.173682487873282,0.38430669178028,"L.LvsV.MILI_PSEUDOPODIA_HAPTOTAXIS_DN"
11,"Up",0.173699117880072,0.38430669178028,"L.LvsV.MATHEW_FANCONI_ANEMIA_GENES"
24,"Down",0.173894724072068,0.384585571757786,"L.LvsV.SHIN_B_CELL_LYMPHOMA_CLUSTER_9"
171,"Down",0.174652191429207,0.386106344027224,"L.LvsV.DOANE_BREAST_CANCER_ESR1_UP"
190,"Down",0.174728147035653,0.386119874084783,"L.LvsV.SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A5"
336,"Down",0.174873374330717,0.386286410976642,"L.LvsV.CHANDRAN_METASTASIS_UP"
184,"Down",0.175221970493114,0.386901866955443,"L.LvsV.JAZAG_TGFB1_SIGNALING_VIA_SMAD4_UP"
129,"Up",0.175639728517236,0.387669484619479,"L.LvsV.REACTOME_POSITIVE_EPIGENETIC_REGULATION_OF_RRNA_EXPRESSION"
56,"Up",0.175757388921865,0.387774382820826,"L.LvsV.LIAN_NEUTROPHIL_GRANULE_CONSTITUENTS"
13,"Down",0.176079600142368,0.388284601911647,"L.LvsV.CHASSOT_SKIN_WOUND"
91,"Up",0.176129097774355,0.388284601911647,"L.LvsV.SHAFFER_IRF4_TARGETS_IN_ACTIVATED_DENDRITIC_CELL"
42,"Down",0.176372800440036,0.388666884668377,"L.LvsV.REACTOME_INTERACTIONS_OF_REV_WITH_HOST_CELLULAR_PROTEINS"
12,"Down",0.176496312936756,0.388784109253914,"L.LvsV.LY_AGING_OLD_UP"
20,"Down",0.176667346176287,0.389005876944918,"L.LvsV.REACTOME_RAP1_SIGNALLING"
9,"Up",0.176792491233275,0.389126466571965,"L.LvsV.REACTOME_CREB3_FACTORS_ACTIVATE_GENES"
136,"Down",0.177370920191291,0.390218542965213,"L.LvsV.ROSS_AML_WITH_PML_RARA_FUSION"
27,"Down",0.177429809552278,0.390218542965213,"L.LvsV.MEISSNER_BRAIN_HCP_WITH_H3K4ME2"
149,"Down",0.177860903570043,0.391011107689371,"L.LvsV.BHAT_ESR1_TARGETS_NOT_VIA_AKT1_DN"
131,"Up",0.177945082521034,0.391040684125117,"L.LvsV.RHODES_UNDIFFERENTIATED_CANCER"
879,"Down",0.178149305699266,0.391333933735099,"L.LvsV.ONKEN_UVEAL_MELANOMA_DN"
77,"Down",0.178996579610153,0.393038954989886,"L.LvsV.TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_DN"
35,"Down",0.179099099435409,0.393107947907255,"L.LvsV.AMIT_EGF_RESPONSE_240_MCF10A"
68,"Down",0.179311106681345,0.393273523040738,"L.LvsV.CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_DN"
61,"Down",0.179316793558637,0.393273523040738,"L.LvsV.DORSAM_HOXA9_TARGETS_UP"
512,"Down",0.179592735786255,0.393689519009682,"L.LvsV.DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP"
30,"Up",0.179697247762606,0.393689519009682,"L.LvsV.IIZUKA_LIVER_CANCER_PROGRESSION_L1_G1_UP"
108,"Down",0.179720084279334,0.393689519009682,"L.LvsV.LIN_NPAS4_TARGETS_DN"
32,"Up",0.180067443049023,0.394294214898236,"L.LvsV.REACTOME_CASPASE_ACTIVATION_VIA_EXTRINSIC_APOPTOTIC_SIGNALLING_PATHWAY"
92,"Down",0.180179364550731,0.394383098416861,"L.LvsV.TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_UP"
79,"Down",0.180404648290127,0.394662254984258,"L.LvsV.JOHANSSON_GLIOMAGENESIS_BY_PDGFB_UP"
253,"Down",0.18044966189188,0.394662254984258,"L.LvsV.BROWNE_HCMV_INFECTION_24HR_UP"
30,"Up",0.180889770980164,0.395468384242517,"L.LvsV.REACTOME_ZBP1_DAI_MEDIATED_INDUCTION_OF_TYPE_I_IFNS"
184,"Down",0.180967536797029,0.395482020138646,"L.LvsV.FIGUEROA_AML_METHYLATION_CLUSTER_1_UP"
115,"Down",0.181317481419538,0.396074353900656,"L.LvsV.COLDREN_GEFITINIB_RESISTANCE_UP"
13,"Up",0.1813818527901,0.396074353900656,"L.LvsV.POS_RESPONSE_TO_HISTAMINE_DN"
9,"Down",0.181475601852953,0.396122622441759,"L.LvsV.CASTELLANO_HRAS_TARGETS_DN"
35,"Down",0.181986509604883,0.397081062196289,"L.LvsV.SIG_IL4RECEPTOR_IN_B_LYPHOCYTES"
21,"Down",0.18221480671788,0.397373301702366,"L.LvsV.REACTOME_ERYTHROPOIETIN_ACTIVATES_RAS"
90,"Down",0.18236137747783,0.397373301702366,"L.LvsV.IKEDA_MIR133_TARGETS_UP"
100,"Up",0.182387814131573,0.397373301702366,"L.LvsV.REACTOME_DAP12_INTERACTIONS"
33,"Down",0.182442948745786,0.397373301702366,"L.LvsV.BILANGES_SERUM_SENSITIVE_VIA_TSC1"
73,"Up",0.182479799786997,0.397373301702366,"L.LvsV.SHIN_B_CELL_LYMPHOMA_CLUSTER_8"
714,"Down",0.183118399842049,0.398606942018382,"L.LvsV.BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP"
289,"Up",0.183247382429709,0.398730727057797,"L.LvsV.BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_DN"
5,"Up",0.183330777516716,0.398755259201386,"L.LvsV.REACTOME_ACTIVATION_OF_RAS_IN_B_CELLS"
279,"Down",0.183445217188284,0.398847269301621,"L.LvsV.GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_UP"
68,"Down",0.183597702341613,0.398922476085246,"L.LvsV.DIRMEIER_LMP1_RESPONSE_LATE_DN"
318,"Down",0.183624109538244,0.398922476085246,"L.LvsV.VANTVEER_BREAST_CANCER_ESR1_UP"
7,"Up",0.183900674037665,0.399123645737783,"L.LvsV.REACTOME_CHYLOMICRON_CLEARANCE"
63,"Down",0.18392940767711,0.399123645737783,"L.LvsV.TOMLINS_PROSTATE_CANCER_DN"
53,"Down",0.183945287948319,0.399123645737783,"L.LvsV.SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_DN"
21,"Up",0.184073236616383,0.399123645737783,"L.LvsV.FARMER_BREAST_CANCER_CLUSTER_3"
141,"Down",0.184077644534517,0.399123645737783,"L.LvsV.BRUINS_UVC_RESPONSE_MIDDLE"
37,"Down",0.184556679400671,0.400005441162803,"L.LvsV.CHANG_POU5F1_TARGETS_UP"
18,"Up",0.184988194276913,0.40078359175433,"L.LvsV.REACTOME_SYNTHESIS_OF_GLYCOSYLPHOSPHATIDYLINOSITOL_GPI"
463,"Down",0.1853427140866,0.401394385501297,"L.LvsV.BRUINS_UVC_RESPONSE_EARLY_LATE"
59,"Down",0.185496134478105,0.401569352987252,"L.LvsV.GENTILE_UV_RESPONSE_CLUSTER_D7"
48,"Down",0.18564777183192,0.401740325032754,"L.LvsV.BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_UP"
99,"Down",0.186031093231901,0.402147934358895,"L.LvsV.BOYLAN_MULTIPLE_MYELOMA_C_DN"
11,"Down",0.186043222909933,0.402147934358895,"L.LvsV.REACTOME_ACTIVATED_NTRK3_SIGNALS_THROUGH_RAS"
19,"Down",0.186054334615673,0.402147934358895,"L.LvsV.KOINUMA_COLON_CANCER_MSI_UP"
14,"Down",0.186318489642764,0.402452320415416,"L.LvsV.XU_AKT1_TARGETS_48HR"
67,"Down",0.186340737974944,0.402452320415416,"L.LvsV.PID_ARF6_TRAFFICKING_PATHWAY"
51,"Down",0.186532850727658,0.402553872224297,"L.LvsV.REACTOME_RNA_POLYMERASE_I_TRANSCRIPTION_INITIATION"
182,"Up",0.18653337323904,0.402553872224297,"L.LvsV.EPPERT_PROGENITOR"
51,"Up",0.186901728887426,0.403035224555118,"L.LvsV.JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_UP"
68,"Down",0.186914382518853,0.403035224555118,"L.LvsV.BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_24HR_DN"
9,"Down",0.18703618611697,0.403035224555118,"L.LvsV.PALOMERO_GSI_SENSITIVITY_UP"
60,"Down",0.187047998952511,0.403035224555118,"L.LvsV.MIKKELSEN_MCV6_ICP_WITH_H3K4ME3_AND_H3K27ME3"
710,"Down",0.187350272127362,0.403529277207707,"L.LvsV.REACTOME_CELLULAR_RESPONSES_TO_EXTERNAL_STIMULI"
695,"Down",0.187652627273558,0.403983676833999,"L.LvsV.RATTENBACHER_BOUND_BY_CELF1"
9,"Up",0.187707373084924,0.403983676833999,"L.LvsV.TESAR_ALK_TARGETS_HUMAN_ES_5D_DN"
51,"Up",0.18790218298596,0.404245591334387,"L.LvsV.JIANG_AGING_HYPOTHALAMUS_DN"
8,"Up",0.188457657120901,0.405282919572718,"L.LvsV.REACTOME_BETA_OXIDATION_OF_BUTANOYL_COA_TO_ACETYL_COA"
85,"Down",0.188785453771221,0.405757253955856,"L.LvsV.SASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION"
21,"Down",0.188889624120916,0.405757253955856,"L.LvsV.REACTOME_P130CAS_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS"
38,"Down",0.188898385184007,0.405757253955856,"L.LvsV.NAKAJIMA_EOSINOPHIL"
22,"Up",0.188981656026227,0.40577847618214,"L.LvsV.REACTOME_CONVERSION_FROM_APC_C_CDC20_TO_APC_C_CDH1_IN_LATE_ANAPHASE"
48,"Down",0.189544090071024,0.406828134317815,"L.LvsV.WIKMAN_ASBESTOS_LUNG_CANCER_DN"
19,"Up",0.189977256250434,0.407111752108268,"L.LvsV.REACTOME_CARNITINE_METABOLISM"
295,"Down",0.18999226893354,0.407111752108268,"L.LvsV.WHITFIELD_CELL_CYCLE_G2_M"
765,"Down",0.190124553281795,0.407111752108268,"L.LvsV.SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN"
58,"Down",0.190125672304798,0.407111752108268,"L.LvsV.HUMMERICH_MALIGNANT_SKIN_TUMOR_UP"
102,"Down",0.190151169477857,0.407111752108268,"L.LvsV.HUPER_BREAST_BASAL_VS_LUMINAL_UP"
12,"Up",0.190204375598891,0.407111752108268,"L.LvsV.REACTOME_IRF3_MEDIATED_ACTIVATION_OF_TYPE_1_IFN"
44,"Up",0.190254282868287,0.407111752108268,"L.LvsV.VALK_AML_CLUSTER_7"
64,"Up",0.190303465783427,0.407111752108268,"L.LvsV.REACTOME_DEGRADATION_OF_DVL"
364,"Down",0.190381794625638,0.407111752108268,"L.LvsV.RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_UP"
15,"Down",0.190412550362087,0.407111752108268,"L.LvsV.BIOCARTA_SODD_PATHWAY"
382,"Down",0.190620526852221,0.40739887629143,"L.LvsV.VERHAAK_GLIOBLASTOMA_MESENCHYMAL"
140,"Down",0.190996344293204,0.408044353785597,"L.LvsV.NATSUME_RESPONSE_TO_INTERFERON_BETA_UP"
24,"Down",0.191238407563957,0.408403690776795,"L.LvsV.HOLLEMAN_VINCRISTINE_RESISTANCE_B_ALL_DN"
12,"Down",0.191913655439102,0.409687490703781,"L.LvsV.BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_24HR_UP"
73,"Down",0.1921065885644,0.409804406414881,"L.LvsV.MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_DN"
13,"Down",0.192116661498892,0.409804406414881,"L.LvsV.REACTOME_PREVENTION_OF_PHAGOSOMAL_LYSOSOMAL_FUSION"
6,"Down",0.192604532680656,0.410615049569395,"L.LvsV.REACTOME_FORMATION_OF_XYLULOSE_5_PHOSPHATE"
34,"Up",0.192645223111415,0.410615049569395,"L.LvsV.SOUCEK_MYC_TARGETS"
87,"Down",0.192785334486607,0.410755342726955,"L.LvsV.TSENG_ADIPOGENIC_POTENTIAL_DN"
25,"Up",0.192882744948726,0.410804582750965,"L.LvsV.BIOCARTA_CELLCYCLE_PATHWAY"
26,"Down",0.19307120145325,0.411047621422802,"L.LvsV.REACTOME_UNBLOCKING_OF_NMDA_RECEPTORS_GLUTAMATE_BINDING_AND_ACTIVATION"
868,"Down",0.193237575361479,0.41124347735705,"L.LvsV.HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP"
394,"Down",0.193341394903421,0.411306107126209,"L.LvsV.RUTELLA_RESPONSE_TO_HGF_DN"
43,"Down",0.193443890630846,0.411365873576134,"L.LvsV.REACTOME_FGFR1_MUTANT_RECEPTOR_ACTIVATION"
24,"Down",0.193521743127184,0.411373209438755,"L.LvsV.CASTELLANO_NRAS_TARGETS_DN"
140,"Down",0.193689479393679,0.411484899660513,"L.LvsV.MCCLUNG_DELTA_FOSB_TARGETS_2WK"
159,"Down",0.193723131455293,0.411484899660513,"L.LvsV.MAHAJAN_RESPONSE_TO_IL1A_DN"
105,"Up",0.194022949041106,0.411963473597648,"L.LvsV.KEGG_PYRIMIDINE_METABOLISM"
62,"Down",0.194325785501513,0.412448087538527,"L.LvsV.AMIT_SERUM_RESPONSE_480_MCF10A"
42,"Up",0.194535527903106,0.412596102514371,"L.LvsV.REACTOME_DISEASES_OF_CARBOHYDRATE_METABOLISM"
28,"Down",0.194544771071616,0.412596102514371,"L.LvsV.REACTOME_REGULATION_OF_FZD_BY_UBIQUITINATION"
73,"Down",0.195079415588924,0.41351527928352,"L.LvsV.URS_ADIPOCYTE_DIFFERENTIATION_DN"
1356,"Up",0.195127756131435,0.41351527928352,"L.LvsV.WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_8D"
46,"Down",0.195204826400254,0.413520109259389,"L.LvsV.ONGUSAHA_TP53_TARGETS"
35,"Down",0.195325674633082,0.413617638853431,"L.LvsV.REACTOME_DOWNREGULATION_OF_TGF_BETA_RECEPTOR_SIGNALING"
55,"Down",0.195615672042143,0.413993950574277,"L.LvsV.FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_DN"
214,"Down",0.195653136706563,0.413993950574277,"L.LvsV.NIKOLSKY_BREAST_CANCER_8Q23_Q24_AMPLICON"
14,"Up",0.195935204972083,0.414432191388923,"L.LvsV.BERENJENO_TRANSFORMED_BY_RHOA_REVERSIBLY_UP"
25,"Down",0.196065050818781,0.41454675474459,"L.LvsV.GENTILE_UV_RESPONSE_CLUSTER_D1"
27,"Down",0.196139321832492,0.41454675474459,"L.LvsV.HEDENFALK_BREAST_CANCER_BRACX_UP"
29,"Down",0.196374677478388,0.414885591050061,"L.LvsV.BIOCARTA_CXCR4_PATHWAY"
28,"Down",0.19659054887507,0.415030945531446,"L.LvsV.TIAN_TNF_SIGNALING_VIA_NFKB"
41,"Down",0.196593605778053,0.415030945531446,"L.LvsV.REACTOME_MISCELLANEOUS_SUBSTRATES"
43,"Down",0.196809064744495,0.415057254295121,"L.LvsV.REACTOME_ADRENALINE_NORADRENALINE_INHIBITS_INSULIN_SECRETION"
5,"Down",0.196812087241126,0.415057254295121,"L.LvsV.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_18"
14,"Down",0.196850497547879,0.415057254295121,"L.LvsV.BIOCARTA_EXTRINSIC_PATHWAY"
32,"Up",0.196906344368982,0.415057254295121,"L.LvsV.FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_UP"
213,"Up",0.197115683910198,0.415340173909865,"L.LvsV.RUIZ_TNC_TARGETS_DN"
10,"Down",0.197326189843958,0.41535084704274,"L.LvsV.REACTOME_RHO_GTPASES_ACTIVATE_RHOTEKIN_AND_RHOPHILINS"
369,"Down",0.197340662628376,0.41535084704274,"L.LvsV.HAMAI_APOPTOSIS_VIA_TRAIL_DN"
25,"Up",0.197346115966952,0.41535084704274,"L.LvsV.KEGG_GLYCOSAMINOGLYCAN_DEGRADATION"
102,"Down",0.197881056737058,0.416231890979902,"L.LvsV.PID_IL4_2PATHWAY"
19,"Down",0.197915290538282,0.416231890979902,"L.LvsV.BIOCARTA_TNFR2_PATHWAY"
254,"Down",0.198134948145734,0.416535409999149,"L.LvsV.MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_UP"
19,"Down",0.198397252152919,0.416928318948494,"L.LvsV.REACTOME_ORGANIC_CATION_ANION_ZWITTERION_TRANSPORT"
16,"Up",0.198755974973212,0.417376432484949,"L.LvsV.BIOCARTA_THELPER_PATHWAY"
116,"Down",0.19876146622045,0.417376432484949,"L.LvsV.PID_P73PATHWAY"
8,"Up",0.19884861344888,0.417400904995769,"L.LvsV.REACTOME_ACYL_CHAIN_REMODELING_OF_DAG_AND_TAG"
9,"Up",0.198970726883837,0.417478226151115,"L.LvsV.SCHUHMACHER_MYC_TARGETS_DN"
51,"Down",0.1990364630375,0.417478226151115,"L.LvsV.REACTOME_INTERLEUKIN_2_FAMILY_SIGNALING"
189,"Down",0.199399277316351,0.418080623542703,"L.LvsV.PUIFFE_INVASION_INHIBITED_BY_ASCITES_DN"
17,"Up",0.199614855662634,0.418373971553715,"L.LvsV.STARK_BRAIN_22Q11_DELETION"
105,"Up",0.199744305585355,0.418486648571969,"L.LvsV.WEBER_METHYLATED_ICP_IN_FIBROBLAST"
590,"Down",0.200031437188862,0.418773862418438,"L.LvsV.BENPORATH_ES_1"
1632,"Down",0.200032875863103,0.418773862418438,"L.LvsV.GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN"
131,"Down",0.200126529143473,0.418811347325611,"L.LvsV.KEGG_T_CELL_RECEPTOR_SIGNALING_PATHWAY"
93,"Down",0.200403204863481,0.419168297736963,"L.LvsV.KEGG_FC_EPSILON_RI_SIGNALING_PATHWAY"
7,"Down",0.200448721146054,0.419168297736963,"L.LvsV.REACTOME_ALTERNATIVE_COMPLEMENT_ACTIVATION"
18,"Up",0.20091835874649,0.419991533273854,"L.LvsV.REACTOME_PHASE_4_RESTING_MEMBRANE_POTENTIAL"
32,"Down",0.201150682864128,0.420307606907628,"L.LvsV.REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR4"
323,"Down",0.201221601643062,0.420307606907628,"L.LvsV.DURAND_STROMA_NS_UP"
156,"Down",0.201581601560891,0.420900557035561,"L.LvsV.ZAMORA_NOS2_TARGETS_DN"
325,"Up",0.201785785409266,0.421066586536973,"L.LvsV.PURBEY_TARGETS_OF_CTBP1_AND_SATB1_DN"
875,"Down",0.201827687701409,0.421066586536973,"L.LvsV.BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_B"
19,"Down",0.201942882583625,0.421066586536973,"L.LvsV.REACTOME_KSRP_KHSRP_BINDS_AND_DESTABILIZES_MRNA"
92,"Down",0.20196574199603,0.421066586536973,"L.LvsV.YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_2"
5,"Up",0.202224503026658,0.421447145584016,"L.LvsV.REACTOME_DOPAMINE_RECEPTORS"
57,"Down",0.20277309183937,0.422431207528214,"L.LvsV.NAKAMURA_ADIPOGENESIS_LATE_DN"
32,"Down",0.202850284699287,0.422432852769251,"L.LvsV.SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_2FC_UP"
26,"Down",0.203090863664205,0.422774617921457,"L.LvsV.PID_NFKAPPAB_ATYPICAL_PATHWAY"
257,"Up",0.204086788375303,0.424558525753021,"L.LvsV.LANDIS_ERBB2_BREAST_TUMORS_324_DN"
53,"Down",0.204101385684849,0.424558525753021,"L.LvsV.WANG_METASTASIS_OF_BREAST_CANCER_ESR1_DN"
12,"Down",0.204447957000287,0.424961049269824,"L.LvsV.REACTOME_ARMS_MEDIATED_ACTIVATION"
105,"Down",0.204448614768988,0.424961049269824,"L.LvsV.HUTTMANN_B_CLL_POOR_SURVIVAL_DN"
30,"Up",0.204644561781859,0.425208486317886,"L.LvsV.REACTOME_SYNTHESIS_OF_PC"
36,"Down",0.204758648019184,0.425243446335145,"L.LvsV.NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_UP"
73,"Up",0.204857178616994,0.425243446335145,"L.LvsV.REACTOME_G1_S_DNA_DAMAGE_CHECKPOINTS"
203,"Down",0.204892121728491,0.425243446335145,"L.LvsV.MIKKELSEN_IPS_WITH_HCP_H3K27ME3"
362,"Down",0.205193953355866,0.425626983585697,"L.LvsV.MULLIGHAN_NPM1_SIGNATURE_3_DN"
353,"Down",0.205230880491855,0.425626983585697,"L.LvsV.CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP"
64,"Down",0.205746748843342,0.426424672078613,"L.LvsV.RIZ_ERYTHROID_DIFFERENTIATION_CCNE1"
71,"Down",0.20576976399091,0.426424672078613,"L.LvsV.TSAI_RESPONSE_TO_RADIATION_THERAPY"
153,"Up",0.206494553576119,0.427766349465104,"L.LvsV.REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION"
59,"Down",0.206655058259655,0.427938508283757,"L.LvsV.CAFFAREL_RESPONSE_TO_THC_DN"
16,"Down",0.206880913944243,0.428211637170457,"L.LvsV.REACTOME_GAMMA_CARBOXYLATION_TRANSPORT_AND_AMINO_TERMINAL_CLEAVAGE_OF_PROTEINS"
23,"Down",0.206941851061577,0.428211637170457,"L.LvsV.STEIN_ESTROGEN_RESPONSE_NOT_VIA_ESRRA"
9,"Down",0.207241394891882,0.428671033429561,"L.LvsV.TURJANSKI_MAPK8_AND_MAPK9_TARGETS"
27,"Down",0.207427066295305,0.428768744947393,"L.LvsV.BIOCARTA_PLATELETAPP_PATHWAY"
127,"Down",0.207443731729839,0.428768744947393,"L.LvsV.WANG_PROSTATE_CANCER_ANDROGEN_INDEPENDENT"
355,"Down",0.207831965632565,0.429374855093149,"L.LvsV.RIZKI_TUMOR_INVASIVENESS_3D_UP"
250,"Down",0.208049304892894,0.429374855093149,"L.LvsV.TAVAZOIE_METASTASIS"
627,"Up",0.208123309484385,0.429374855093149,"L.LvsV.LIM_MAMMARY_STEM_CELL_DN"
45,"Down",0.208198918648249,0.429374855093149,"L.LvsV.ABE_VEGFA_TARGETS_2HR"
830,"Down",0.208233937332232,0.429374855093149,"L.LvsV.GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN"
33,"Up",0.208244877159109,0.429374855093149,"L.LvsV.RAMPON_ENRICHED_LEARNING_ENVIRONMENT_LATE_UP"
74,"Down",0.208280586247029,0.429374855093149,"L.LvsV.YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_15"
234,"Down",0.208533974337667,0.42973698997874,"L.LvsV.DARWICHE_SKIN_TUMOR_PROMOTER_UP"
28,"Down",0.208684875443327,0.429887733355497,"L.LvsV.REACTOME_G_BETA_GAMMA_SIGNALLING_THROUGH_PI3KGAMMA"
81,"Down",0.209099806940911,0.43058206054983,"L.LvsV.CROMER_TUMORIGENESIS_DN"
378,"Down",0.209342437968742,0.430792973829017,"L.LvsV.EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_UP"
66,"Down",0.209358061254941,0.430792973829017,"L.LvsV.LUI_THYROID_CANCER_CLUSTER_2"
8,"Up",0.209974396314887,0.431866222876888,"L.LvsV.REACTOME_ACTIVATION_OF_NIMA_KINASES_NEK9_NEK6_NEK7"
104,"Up",0.21003586061059,0.431866222876888,"L.LvsV.FIGUEROA_AML_METHYLATION_CLUSTER_1_DN"
19,"Down",0.210155602212,0.431951793542806,"L.LvsV.BIOCARTA_ACH_PATHWAY"
29,"Down",0.210491268717042,0.432480945647166,"L.LvsV.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_DN"
12,"Up",0.210669767620497,0.432582150733593,"L.LvsV.REACTOME_TRANSPORT_OF_FATTY_ACIDS"
402,"Down",0.210697003422964,0.432582150733593,"L.LvsV.BROWNE_HCMV_INFECTION_16HR_UP"
27,"Down",0.210839041602375,0.432713088722914,"L.LvsV.PHESSE_TARGETS_OF_APC_AND_MBD2_DN"
83,"Down",0.211217539140051,0.433127207949342,"L.LvsV.DELACROIX_RAR_TARGETS_UP"
46,"Up",0.21123014931361,0.433127207949342,"L.LvsV.REACTOME_PLASMA_LIPOPROTEIN_CLEARANCE"
43,"Down",0.211275832852121,0.433127207949342,"L.LvsV.MATZUK_MALE_REPRODUCTION_SERTOLI"
817,"Up",0.211439824526926,0.43330273899532,"L.LvsV.ACEVEDO_LIVER_CANCER_DN"
97,"Down",0.211640468461157,0.433553223461185,"L.LvsV.REACTOME_COLLAGEN_DEGRADATION"
77,"Up",0.211783543347586,0.433685633766222,"L.LvsV.VARELA_ZMPSTE24_TARGETS_DN"
48,"Up",0.211892948636292,0.433749023698652,"L.LvsV.DELPUECH_FOXO3_TARGETS_DN"
26,"Down",0.212325660832626,0.43424393656192,"L.LvsV.SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX1_UP"
15,"Down",0.212394478893427,0.43424393656192,"L.LvsV.SA_MMP_CYTOKINE_CONNECTION"
19,"Down",0.212457813889539,0.43424393656192,"L.LvsV.REACTOME_TRISTETRAPROLIN_TTP_ZFP36_BINDS_AND_DESTABILIZES_MRNA"
61,"Up",0.212458931807933,0.43424393656192,"L.LvsV.GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP"
31,"Down",0.212527417677076,0.43424393656192,"L.LvsV.BIOCARTA_AMI_PATHWAY"
28,"Up",0.212648701391708,0.434319023110534,"L.LvsV.WEST_ADRENOCORTICAL_TUMOR_MARKERS_UP"
26,"Down",0.212721272306624,0.434319023110534,"L.LvsV.ZHENG_FOXP3_TARGETS_IN_THYMUS_DN"
591,"Down",0.213037330700495,0.434717329276565,"L.LvsV.WANG_TUMOR_INVASIVENESS_UP"
58,"Down",0.213098851550135,0.434717329276565,"L.LvsV.EPPERT_LSC_R"
294,"Down",0.213190839854662,0.434717329276565,"L.LvsV.FERNANDEZ_BOUND_BY_MYC"
496,"Down",0.213285905149001,0.434717329276565,"L.LvsV.VERHAAK_AML_WITH_NPM1_MUTATED_DN"
25,"Down",0.213377966753319,0.434717329276565,"L.LvsV.REACTOME_INTERLEUKIN_20_FAMILY_SIGNALING"
50,"Down",0.213388104839319,0.434717329276565,"L.LvsV.REACTOME_FORMATION_OF_INCISION_COMPLEX_IN_GG_NER"
33,"Up",0.21363001492224,0.434818908470731,"L.LvsV.REACTOME_CYTOSOLIC_SULFONATION_OF_SMALL_MOLECULES"
86,"Down",0.21373557052562,0.434818908470731,"L.LvsV.CUI_TCF21_TARGETS_UP"
5,"Up",0.213736829412654,0.434818908470731,"L.LvsV.REACTOME_BETA_OXIDATION_OF_LAUROYL_COA_TO_DECANOYL_COA_COA"
32,"Down",0.213771369873957,0.434818908470731,"L.LvsV.MATZUK_IMPLANTATION_AND_UTERINE"
73,"Up",0.213895898892888,0.434818908470731,"L.LvsV.SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_UP"
33,"Up",0.213909826558218,0.434818908470731,"L.LvsV.BIOCARTA_G2_PATHWAY"
27,"Down",0.214070911995724,0.434837247880838,"L.LvsV.FOURNIER_ACINAR_DEVELOPMENT_EARLY_UP"
122,"Up",0.214076141930121,0.434837247880838,"L.LvsV.CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_UP"
78,"Down",0.214349164106302,0.435122096734546,"L.LvsV.SMIRNOV_RESPONSE_TO_IR_2HR_UP"
104,"Up",0.214373773106331,0.435122096734546,"L.LvsV.LEE_LIVER_CANCER_E2F1_DN"
225,"Up",0.214513483717577,0.435245890449351,"L.LvsV.PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_DN"
29,"Up",0.214624265867306,0.435310919288457,"L.LvsV.REACTOME_BASIGIN_INTERACTIONS"
154,"Down",0.21472488508256,0.435355295057379,"L.LvsV.LEE_AGING_CEREBELLUM_DN"
8,"Up",0.214853027515808,0.435396355800152,"L.LvsV.HOLLEMAN_DAUNORUBICIN_ALL_UP"
47,"Down",0.214902632479402,0.435396355800152,"L.LvsV.CHUANG_OXIDATIVE_STRESS_RESPONSE_UP"
115,"Up",0.215126910591318,0.435691094747032,"L.LvsV.DEMAGALHAES_AGING_UP"
28,"Up",0.215271715611419,0.435824721939046,"L.LvsV.REACTOME_SULFUR_AMINO_ACID_METABOLISM"
10,"Down",0.215628621978809,0.436387500337056,"L.LvsV.PHONG_TNF_TARGETS_DN"
19,"Down",0.215718341036938,0.436409333184498,"L.LvsV.REACTOME_TETRAHYDROBIOPTERIN_BH4_SYNTHESIS_RECYCLING_SALVAGE_AND_REGULATION"
24,"Down",0.215897579553655,0.436603098467691,"L.LvsV.REACTOME_RORA_ACTIVATES_GENE_EXPRESSION"
19,"Up",0.21603845425298,0.436603098467691,"L.LvsV.REACTOME_BUTYROPHILIN_BTN_FAMILY_INTERACTIONS"
11,"Up",0.216063278827192,0.436603098467691,"L.LvsV.STEGMEIER_PREMITOTIC_CELL_CYCLE_REGULATORS"
28,"Down",0.216198757196921,0.436603098467691,"L.LvsV.WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_DN"
251,"Down",0.216208949829,0.436603098467691,"L.LvsV.GROSS_HYPOXIA_VIA_ELK3_DN"
7,"Down",0.216587684229264,0.437208216905295,"L.LvsV.REACTOME_CATION_COUPLED_CHLORIDE_COTRANSPORTERS"
65,"Up",0.216734953987345,0.437238099744905,"L.LvsV.BOYAULT_LIVER_CANCER_SUBCLASS_G1_DN"
194,"Down",0.216811718416972,0.437238099744905,"L.LvsV.FIGUEROA_AML_METHYLATION_CLUSTER_6_UP"
13,"Up",0.21683973042151,0.437238099744905,"L.LvsV.REACTOME_PROCESSIVE_SYNTHESIS_ON_THE_C_STRAND_OF_THE_TELOMERE"
51,"Down",0.217100902266378,0.437408909309133,"L.LvsV.RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_DN"
38,"Down",0.217147444026529,0.437408909309133,"L.LvsV.MALTA_CURATED_STEMNESS_MARKERS"
24,"Down",0.217161775375939,0.437408909309133,"L.LvsV.REACTOME_ANCHORING_FIBRIL_FORMATION"
101,"Down",0.217258167334687,0.43744370254679,"L.LvsV.REACTOME_PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES"
27,"Down",0.217443917202246,0.437640938829046,"L.LvsV.TSAI_DNAJB4_TARGETS_UP"
62,"Up",0.217514432972006,0.437640938829046,"L.LvsV.REACTOME_STABILIZATION_OF_P53"
1095,"Down",0.217830751358855,0.438117942620265,"L.LvsV.SMID_BREAST_CANCER_LUMINAL_B_DN"
97,"Down",0.218806631838479,0.439920679067255,"L.LvsV.KEGG_ECM_RECEPTOR_INTERACTION"
12,"Up",0.219091642279648,0.44025989349127,"L.LvsV.REACTOME_TRANSPORT_OF_NUCLEOSIDES_AND_FREE_PURINE_AND_PYRIMIDINE_BASES_ACROSS_THE_PLASMA_MEMBRANE"
274,"Up",0.219134604248142,0.44025989349127,"L.LvsV.SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP"
49,"Up",0.220012548998614,0.441863197752756,"L.LvsV.KEGG_ABC_TRANSPORTERS"
23,"Down",0.220197776568659,0.442074621150368,"L.LvsV.REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB"
10,"Down",0.220410969076989,0.442342013802785,"L.LvsV.GALIE_TUMOR_ANGIOGENESIS"
22,"Up",0.220492141374574,0.442344357641518,"L.LvsV.KEGG_ALPHA_LINOLENIC_ACID_METABOLISM"
35,"Down",0.220612203214018,0.442403509837061,"L.LvsV.GOLUB_ALL_VS_AML_DN"
16,"Up",0.220681656742741,0.442403509837061,"L.LvsV.WAESCH_ANAPHASE_PROMOTING_COMPLEX"
106,"Down",0.220993321469077,0.442867732657675,"L.LvsV.RICKMAN_HEAD_AND_NECK_CANCER_B"
110,"Up",0.221129831226015,0.442980737988636,"L.LvsV.KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY"
37,"Up",0.221544305192857,0.4436502946075,"L.LvsV.GAJATE_RESPONSE_TO_TRABECTEDIN_DN"
48,"Down",0.222113027907812,0.444628143121757,"L.LvsV.LI_PROSTATE_CANCER_EPIGENETIC"
168,"Down",0.222364706602494,0.444970851540062,"L.LvsV.LINDGREN_BLADDER_CANCER_CLUSTER_1_UP"
43,"Up",0.2225453348609,0.445167937097658,"L.LvsV.KEGG_SPHINGOLIPID_METABOLISM"
5,"Down",0.222624226094235,0.445167937097658,"L.LvsV.REACTOME_EXTRINSIC_PATHWAY_OF_FIBRIN_CLOT_FORMATION"
39,"Down",0.222880809513526,0.445352266802381,"L.LvsV.DUNNE_TARGETS_OF_AML1_MTG8_FUSION_DN"
559,"Down",0.222888114919015,0.445352266802381,"L.LvsV.REACTOME_SIGNALING_BY_RHO_GTPASES"
16,"Down",0.222958052904502,0.445352266802381,"L.LvsV.RAMPON_ENRICHED_LEARNING_ENVIRONMENT_EARLY_DN"
40,"Up",0.223174417589254,0.445623457873234,"L.LvsV.KEGG_CYSTEINE_AND_METHIONINE_METABOLISM"
24,"Down",0.22357029692824,0.446182449156904,"L.LvsV.REACTOME_FGFR1_LIGAND_BINDING_AND_ACTIVATION"
667,"Down",0.223615765348848,0.446182449156904,"L.LvsV.CHYLA_CBFA2T3_TARGETS_UP"
19,"Up",0.223856026685216,0.446334600584143,"L.LvsV.SASSON_FSH_RESPONSE"
198,"Down",0.223907711721498,0.446334600584143,"L.LvsV.NIKOLSKY_BREAST_CANCER_17Q11_Q21_AMPLICON"
62,"Down",0.22393419823122,0.446334600584143,"L.LvsV.REACTOME_FORMATION_OF_RNA_POL_II_ELONGATION_COMPLEX"
86,"Down",0.224288368898695,0.446807565478287,"L.LvsV.MCGARVEY_SILENCED_BY_METHYLATION_IN_COLON_CANCER"
67,"Down",0.224337473329892,0.446807565478287,"L.LvsV.GYORFFY_DOXORUBICIN_RESISTANCE"
34,"Down",0.224413928257045,0.446807565478287,"L.LvsV.LEE_DOUBLE_POLAR_THYMOCYTE"
217,"Down",0.22474425279315,0.447182881133912,"L.LvsV.YAGI_AML_WITH_T_9_11_TRANSLOCATION"
85,"Down",0.224888751787926,0.447182881133912,"L.LvsV.PID_AR_TF_PATHWAY"
104,"Up",0.224919618237596,0.447182881133912,"L.LvsV.LI_DCP2_BOUND_MRNA"
538,"Up",0.224925952691881,0.447182881133912,"L.LvsV.AFFAR_YY1_TARGETS_DN"
229,"Down",0.225500406595815,0.448044364779986,"L.LvsV.MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_DN"
59,"Down",0.225521336079345,0.448044364779986,"L.LvsV.REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN"
26,"Up",0.226235920641816,0.449302588084986,"L.LvsV.REACTOME_ABC_TRANSPORTERS_IN_LIPID_HOMEOSTASIS"
120,"Down",0.22651030663577,0.449685991163079,"L.LvsV.BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_DN"
86,"Down",0.22660524078848,0.449712985039305,"L.LvsV.CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_DN"
126,"Down",0.227437802457264,0.451203304551924,"L.LvsV.REACTOME_NUCLEOTIDE_EXCISION_REPAIR"
39,"Down",0.22758237310948,0.451328171062523,"L.LvsV.REACTOME_TRANSCRIPTIONAL_REGULATION_BY_E2F6"
12,"Up",0.227858773096376,0.451560933462378,"L.LvsV.OHM_EMBRYONIC_CARCINOMA_UP"
9,"Down",0.227863086337499,0.451560933462378,"L.LvsV.BIOCARTA_ERBB3_PATHWAY"
657,"Down",0.22815844996993,0.451984260080166,"L.LvsV.SENESE_HDAC1_TARGETS_UP"
181,"Down",0.228386255215736,0.452273497524286,"L.LvsV.ONDER_CDH1_SIGNALING_VIA_CTNNB1"
12,"Down",0.228738822484382,0.452809505734389,"L.LvsV.HOFFMAN_CLOCK_TARGETS_DN"
309,"Down",0.228966409816899,0.453097809548187,"L.LvsV.DARWICHE_SQUAMOUS_CELL_CARCINOMA_DN"
51,"Down",0.229366173740866,0.45372650254499,"L.LvsV.HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_UP"
541,"Up",0.229513238578815,0.453855041524417,"L.LvsV.BOYLAN_MULTIPLE_MYELOMA_C_D_DN"
317,"Down",0.229710720995431,0.454083152085713,"L.LvsV.WANG_CLIM2_TARGETS_DN"
127,"Down",0.229844046711127,0.454184322468128,"L.LvsV.ZHANG_GATA6_TARGETS_DN"
60,"Down",0.229963999969415,0.454259005298642,"L.LvsV.PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_UP"
50,"Down",0.230912672296376,0.455970058973808,"L.LvsV.REACTOME_SPHINGOLIPID_DE_NOVO_BIOSYNTHESIS"
49,"Down",0.231021589654963,0.456022266762688,"L.LvsV.VANDESLUIS_NORMAL_EMBRYOS_DN"
289,"Down",0.231448516763157,0.456701944747857,"L.LvsV.ZHENG_FOXP3_TARGETS_IN_THYMUS_UP"
41,"Up",0.231739121132552,0.457045288749792,"L.LvsV.MAYBURD_RESPONSE_TO_L663536_UP"
27,"Down",0.231818239821936,0.457045288749792,"L.LvsV.REACTOME_WNT_LIGAND_BIOGENESIS_AND_TRAFFICKING"
32,"Down",0.231898907725064,0.457045288749792,"L.LvsV.LE_NEURONAL_DIFFERENTIATION_UP"
370,"Down",0.2319531705972,0.457045288749792,"L.LvsV.HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_UP"
29,"Down",0.232180321889969,0.457175958757083,"L.LvsV.TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_DN"
19,"Up",0.23218486022606,0.457175958757083,"L.LvsV.AMIT_EGF_RESPONSE_20_HELA"
341,"Up",0.232357682287623,0.457236552774095,"L.LvsV.LEE_LIVER_CANCER_SURVIVAL_UP"
1013,"Down",0.232407629071257,0.457236552774095,"L.LvsV.MARTINEZ_RB1_TARGETS_DN"
33,"Down",0.232463727590519,0.457236552774095,"L.LvsV.BOYERINAS_ONCOFETAL_TARGETS_OF_LET7A1"
42,"Down",0.232869472243393,0.457871732586672,"L.LvsV.REACTOME_INTERACTIONS_OF_VPR_WITH_HOST_CELLULAR_PROTEINS"
70,"Down",0.233169872580235,0.45829940472667,"L.LvsV.MA_MYELOID_DIFFERENTIATION_DN"
24,"Down",0.233417932003892,0.458623932498053,"L.LvsV.BIOCARTA_NOS1_PATHWAY"
55,"Down",0.233579964954983,0.458779263316555,"L.LvsV.GENTILE_UV_LOW_DOSE_UP"
15,"Down",0.233929846616307,0.459303310348567,"L.LvsV.REACTOME_KERATAN_SULFATE_DEGRADATION"
296,"Down",0.234066992280155,0.459409442782029,"L.LvsV.SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP"
23,"Down",0.234213438109992,0.459498259040422,"L.LvsV.GOUYER_TATI_TARGETS_DN"
53,"Down",0.234278457629761,0.459498259040422,"L.LvsV.HU_ANGIOGENESIS_UP"
77,"Up",0.234580362164107,0.459927241987713,"L.LvsV.BURTON_ADIPOGENESIS_PEAK_AT_16HR"
39,"Up",0.234870120067255,0.460332114091404,"L.LvsV.ZHENG_FOXP3_TARGETS_UP"
33,"Down",0.234974330206532,0.460373165029027,"L.LvsV.SABATES_COLORECTAL_ADENOMA_SIZE_UP"
572,"Down",0.235132514594913,0.46037380742474,"L.LvsV.HELLER_HDAC_TARGETS_UP"
35,"Down",0.235145148906263,0.46037380742474,"L.LvsV.BIOCARTA_STRESS_PATHWAY"
6,"Down",0.235224453965435,0.46037380742474,"L.LvsV.REACTOME_VITAMIN_B1_THIAMIN_METABOLISM"
34,"Up",0.235383496013985,0.460522062795939,"L.LvsV.FARMER_BREAST_CANCER_CLUSTER_7"
55,"Down",0.235744478941196,0.461065165923549,"L.LvsV.STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_DN"
30,"Up",0.236117391498055,0.461611904724336,"L.LvsV.KEGG_BETA_ALANINE_METABOLISM"
51,"Down",0.236191007137845,0.461611904724336,"L.LvsV.NIKOLSKY_BREAST_CANCER_20Q11_AMPLICON"
342,"Down",0.23632013601767,0.461701071392826,"L.LvsV.DARWICHE_SKIN_TUMOR_PROMOTER_DN"
36,"Up",0.236679498372291,0.462009379871228,"L.LvsV.REACTOME_METABOLISM_OF_ANGIOTENSINOGEN_TO_ANGIOTENSINS"
241,"Up",0.236691896458241,0.462009379871228,"L.LvsV.BAKKER_FOXO3_TARGETS_DN"
735,"Up",0.236728626003832,0.462009379871228,"L.LvsV.GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP"
54,"Down",0.236908582302566,0.462197442325649,"L.LvsV.VANDESLUIS_COMMD1_TARGETS_GROUP_3_DN"
58,"Down",0.237164948097678,0.462534390840234,"L.LvsV.MORI_PLASMA_CELL_DN"
38,"Down",0.237324383741613,0.462682128951827,"L.LvsV.DELACROIX_RAR_TARGETS_DN"
83,"Down",0.237693256357525,0.463237932464137,"L.LvsV.COWLING_MYCN_TARGETS"
99,"Down",0.237802661016145,0.46328784804731,"L.LvsV.LINDSTEDT_DENDRITIC_CELL_MATURATION_C"
248,"Down",0.238428880741317,0.464208117609356,"L.LvsV.GOZGIT_ESR1_TARGETS_UP"
29,"Down",0.238511336089617,0.464208117609356,"L.LvsV.LANDEMAINE_LUNG_METASTASIS"
463,"Up",0.238526905792762,0.464208117609356,"L.LvsV.MARKEY_RB1_ACUTE_LOF_DN"
14,"Up",0.238728285308982,0.464436555057481,"L.LvsV.BIOCARTA_SRCRPTP_PATHWAY"
48,"Up",0.239098149882046,0.464992497607398,"L.LvsV.YU_BAP1_TARGETS"
16,"Down",0.239357821588759,0.465333824038062,"L.LvsV.HASINA_NOL7_TARGETS_UP"
9,"Up",0.239821212744443,0.465941036139716,"L.LvsV.REACTOME_SODIUM_PROTON_EXCHANGERS"
188,"Up",0.239838702993965,0.465941036139716,"L.LvsV.BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_UP"
103,"Down",0.240000776795669,0.466092130278628,"L.LvsV.REACTOME_PCP_CE_PATHWAY"
18,"Down",0.240447770323842,0.466668912560555,"L.LvsV.YEMELYANOV_GR_TARGETS_DN"
73,"Down",0.24046658200127,0.466668912560555,"L.LvsV.SCHLESINGER_H3K27ME3_IN_NORMAL_AND_METHYLATED_IN_CANCER"
176,"Down",0.240827885341712,0.467206097562922,"L.LvsV.STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_UP"
161,"Down",0.241125485577431,0.467619365050024,"L.LvsV.FRASOR_RESPONSE_TO_ESTRADIOL_DN"
173,"Up",0.241660741975123,0.468397075920729,"L.LvsV.HUANG_GATA2_TARGETS_DN"
99,"Up",0.241695940966149,0.468397075920729,"L.LvsV.LEE_LIVER_CANCER_MYC_E2F1_DN"
101,"Up",0.24208174334515,0.468962808659212,"L.LvsV.FURUKAWA_DUSP6_TARGETS_PCI35_DN"
9,"Down",0.242251458799119,0.468962808659212,"L.LvsV.REACTOME_TFAP2_AP_2_FAMILY_REGULATES_TRANSCRIPTION_OF_CELL_CYCLE_FACTORS"
104,"Down",0.242361403021517,0.468962808659212,"L.LvsV.ZHENG_IL22_SIGNALING_DN"
927,"Down",0.242389235622329,0.468962808659212,"L.LvsV.REACTOME_HEMOSTASIS"
10,"Up",0.242411956438421,0.468962808659212,"L.LvsV.REACTOME_ORGANIC_ANION_TRANSPORTERS"
225,"Up",0.242672130413616,0.469010763108718,"L.LvsV.KAYO_AGING_MUSCLE_DN"
310,"Up",0.242751117487058,0.469010763108718,"L.LvsV.CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN"
34,"Up",0.242825012341683,0.469010763108718,"L.LvsV.REACTOME_MITOPHAGY"
13,"Up",0.242938053579352,0.469010763108718,"L.LvsV.REACTOME_MITOCHONDRIAL_IRON_SULFUR_CLUSTER_BIOGENESIS"
10,"Up",0.242991609204554,0.469010763108718,"L.LvsV.BIOCARTA_S1P_PATHWAY"
226,"Down",0.243027158034877,0.469010763108718,"L.LvsV.HOLLERN_EMT_BREAST_TUMOR_UP"
10,"Down",0.243030536499634,0.469010763108718,"L.LvsV.DONATO_CELL_CYCLE_TRETINOIN"
75,"Down",0.243148075373368,0.469073869064672,"L.LvsV.VARELA_ZMPSTE24_TARGETS_UP"
11,"Up",0.243473103996045,0.46953707429164,"L.LvsV.REACTOME_CDC6_ASSOCIATION_WITH_THE_ORC_ORIGIN_COMPLEX"
72,"Down",0.243729857340044,0.469779292638641,"L.LvsV.DAZARD_UV_RESPONSE_CLUSTER_G4"
322,"Down",0.243768636386374,0.469779292638641,"L.LvsV.DARWICHE_PAPILLOMA_RISK_HIGH_DN"
13,"Up",0.24415558628344,0.47036105803524,"L.LvsV.REACTOME_ESTABLISHMENT_OF_SISTER_CHROMATID_COHESION"
203,"Up",0.244257641864491,0.470393765889506,"L.LvsV.CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN"
185,"Down",0.244776693603453,0.471089316451923,"L.LvsV.GROSS_HYPOXIA_VIA_HIF1A_DN"
40,"Down",0.244789654877518,0.471089316451923,"L.LvsV.REACTOME_REGULATION_OF_MECP2_EXPRESSION_AND_ACTIVITY"
11,"Down",0.244874424938113,0.471089316451923,"L.LvsV.REACTOME_PEPTIDE_HORMONE_BIOSYNTHESIS"
37,"Down",0.245327385579145,0.471796561692902,"L.LvsV.ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_UP"
200,"Down",0.245583752150464,0.472125370528483,"L.LvsV.ELVIDGE_HYPOXIA_BY_DMOG_UP"
120,"Down",0.245900985560621,0.472570924283862,"L.LvsV.REACTOME_MYD88_INDEPENDENT_TLR4_CASCADE"
456,"Up",0.246139620433769,0.472865170736036,"L.LvsV.CAIRO_HEPATOBLASTOMA_DN"
117,"Down",0.246498393102393,0.473389932429015,"L.LvsV.HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_UP"
33,"Down",0.246607288187177,0.473434616801007,"L.LvsV.MACLACHLAN_BRCA1_TARGETS_UP"
6,"Up",0.246737367989595,0.473519926280621,"L.LvsV.REACTOME_FICOLINS_BIND_TO_REPETITIVE_CARBOHYDRATE_STRUCTURES_ON_THE_TARGET_CELL_SURFACE"
9,"Up",0.246875638405723,0.473620889918544,"L.LvsV.REACTOME_PHOSPHATE_BOND_HYDROLYSIS_BY_NTPDASE_PROTEINS"
32,"Up",0.247056457216009,0.473656186735213,"L.LvsV.REACTOME_GLYCOGEN_METABOLISM"
166,"Down",0.247133471525373,0.473656186735213,"L.LvsV.WALLACE_PROSTATE_CANCER_RACE_DN"
12,"Up",0.247151039741561,0.473656186735213,"L.LvsV.REACTOME_REGULATION_OF_GENE_EXPRESSION_BY_HYPOXIA_INDUCIBLE_FACTOR"
60,"Down",0.247442648581164,0.47405072903855,"L.LvsV.PID_TNF_PATHWAY"
13,"Down",0.247702542277966,0.474280144294656,"L.LvsV.REACTOME_FIBRONECTIN_MATRIX_FORMATION"
14,"Up",0.247864311415223,0.474280144294656,"L.LvsV.SMID_BREAST_CANCER_RELAPSE_IN_LIVER_DN"
58,"Down",0.247885348749486,0.474280144294656,"L.LvsV.PID_PI3K_PLC_TRK_PATHWAY"
32,"Up",0.247905519445027,0.474280144294656,"L.LvsV.REACTOME_INCRETIN_SYNTHESIS_SECRETION_AND_INACTIVATION"
154,"Down",0.248311428587896,0.474892386254748,"L.LvsV.ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_DN"
455,"Down",0.248758405820709,0.475463540556517,"L.LvsV.RAO_BOUND_BY_SALL4"
409,"Down",0.248864627548205,0.475463540556517,"L.LvsV.PEDRIOLI_MIR31_TARGETS_UP"
41,"Down",0.248927764625859,0.475463540556517,"L.LvsV.LUI_THYROID_CANCER_CLUSTER_4"
7,"Down",0.248954051349451,0.475463540556517,"L.LvsV.REACTOME_APOBEC3G_MEDIATED_RESISTANCE_TO_HIV_1_INFECTION"
33,"Up",0.249225358646282,0.475817337001137,"L.LvsV.BUCKANOVICH_T_LYMPHOCYTE_HOMING_ON_TUMOR_DN"
65,"Down",0.249373020982319,0.475919505119332,"L.LvsV.MMS_MOUSE_LYMPH_HIGH_4HRS_UP"
18,"Down",0.249542333910154,0.475919505119332,"L.LvsV.CROONQUIST_STROMAL_STIMULATION_DN"
431,"Down",0.249725001309182,0.475919505119332,"L.LvsV.BONOME_OVARIAN_CANCER_SURVIVAL_OPTIMAL_DEBULKING"
39,"Down",0.249779134526769,0.475919505119332,"L.LvsV.WU_HBX_TARGETS_1_DN"
9,"Down",0.249839047512388,0.475919505119332,"L.LvsV.TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_GRANULOCYTE_DN"
84,"Down",0.249857661630967,0.475919505119332,"L.LvsV.BECKER_TAMOXIFEN_RESISTANCE_UP"
109,"Down",0.249881411351315,0.475919505119332,"L.LvsV.KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_DN"
1129,"Up",0.250209542847594,0.476269114755821,"L.LvsV.BENPORATH_MYC_MAX_TARGETS"
36,"Down",0.250237254180803,0.476269114755821,"L.LvsV.BIOCARTA_TFF_PATHWAY"
770,"Up",0.250342188288311,0.476304872348958,"L.LvsV.BOCHKIS_FOXA2_TARGETS"
48,"Down",0.251878682618068,0.479063376744168,"L.LvsV.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_UP"
22,"Down",0.252160113565451,0.479433723488095,"L.LvsV.SARTIPY_NORMAL_AT_INSULIN_RESISTANCE_DN"
57,"Down",0.252857260936554,0.480593948339019,"L.LvsV.LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_DN"
113,"Down",0.253160805795493,0.481005531011436,"L.LvsV.CROMER_TUMORIGENESIS_UP"
22,"Down",0.253434091714953,0.481103613877717,"L.LvsV.PETRETTO_BLOOD_PRESSURE_UP"
43,"Down",0.25344590237919,0.481103613877717,"L.LvsV.PID_CD40_PATHWAY"
25,"Down",0.253473472097267,0.481103613877717,"L.LvsV.REACTOME_INITIATION_OF_NUCLEAR_ENVELOPE_NE_REFORMATION"
21,"Up",0.253695387198756,0.481359573034291,"L.LvsV.BIOCARTA_NDKDYNAMIN_PATHWAY"
71,"Down",0.253907226183253,0.48145659318249,"L.LvsV.TAVOR_CEBPA_TARGETS_DN"
25,"Down",0.253966620167483,0.48145659318249,"L.LvsV.STARK_HYPPOCAMPUS_22Q11_DELETION_DN"
34,"Up",0.25400775588955,0.48145659318249,"L.LvsV.REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_7ALPHA_HYDROXYCHOLESTEROL"
204,"Down",0.254175908741588,0.481610212279726,"L.LvsV.SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_DN"
35,"Up",0.254356655963655,0.481719032437693,"L.LvsV.ZHAN_MULTIPLE_MYELOMA_SUBGROUPS"
262,"Down",0.254407591737758,0.481719032437693,"L.LvsV.LIU_CMYB_TARGETS_UP"
24,"Down",0.254531155482237,0.481788003649875,"L.LvsV.FARMER_BREAST_CANCER_CLUSTER_5"
40,"Up",0.254877954503767,0.481970115915877,"L.LvsV.TAKADA_GASTRIC_CANCER_COPY_NUMBER_DN"
75,"Down",0.254885865242632,0.481970115915877,"L.LvsV.PID_IL6_7_PATHWAY"
5,"Down",0.254888880256471,0.481970115915877,"L.LvsV.RAFFEL_VEGFA_TARGETS_DN"
26,"Down",0.255243294747482,0.482229010980541,"L.LvsV.SMID_BREAST_CANCER_NORMAL_LIKE_DN"
9,"Down",0.255253549555147,0.482229010980541,"L.LvsV.FUJIWARA_PARK2_IN_LIVER_CANCER_UP"
187,"Down",0.255287450739744,0.482229010980541,"L.LvsV.TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP"
41,"Up",0.255869550164749,0.483163505075444,"L.LvsV.BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_UP"
34,"Up",0.256411452139625,0.484019602622124,"L.LvsV.KEGG_ALANINE_ASPARTATE_AND_GLUTAMATE_METABOLISM"
73,"Down",0.256584339711789,0.484019602622124,"L.LvsV.BIOCARTA_PPARA_PATHWAY"
35,"Down",0.256585540836579,0.484019602622124,"L.LvsV.REACTOME_REGULATION_OF_GLUCOKINASE_BY_GLUCOKINASE_REGULATORY_PROTEIN"
96,"Up",0.256717752166093,0.48410383756014,"L.LvsV.GRABARCZYK_BCL11B_TARGETS_DN"
504,"Down",0.256830345579897,0.484151033314439,"L.LvsV.FARMER_BREAST_CANCER_BASAL_VS_LULMINAL"
15,"Down",0.257311151177557,0.484892077321306,"L.LvsV.REACTOME_PTK6_REGULATES_RTKS_AND_THEIR_EFFECTORS_AKT1_AND_DOK1"
208,"Down",0.257885964903422,0.485657541856598,"L.LvsV.REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX"
454,"Up",0.258113265203529,0.485657541856598,"L.LvsV.DOUGLAS_BMI1_TARGETS_DN"
35,"Up",0.258142980132401,0.485657541856598,"L.LvsV.REACTOME_RECOGNITION_OF_DNA_DAMAGE_BY_PCNA_CONTAINING_REPLICATION_COMPLEX"
133,"Down",0.258190693185166,0.485657541856598,"L.LvsV.SMID_BREAST_CANCER_LUMINAL_A_UP"
40,"Up",0.258223348953592,0.485657541856598,"L.LvsV.SIMBULAN_PARP1_TARGETS_DN"
172,"Down",0.25827532096013,0.485657541856598,"L.LvsV.REACTOME_BETA_CATENIN_INDEPENDENT_WNT_SIGNALING"
148,"Down",0.258332217507733,0.485657541856598,"L.LvsV.SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_DN"
203,"Up",0.258617415061236,0.486028445912159,"L.LvsV.VERHAAK_GLIOBLASTOMA_NEURAL"
18,"Down",0.259104188585184,0.486650765507743,"L.LvsV.MALIK_REPRESSED_BY_ESTROGEN"
17,"Down",0.259199148523003,0.486650765507743,"L.LvsV.REACTOME_SIGNALING_BY_PDGFRA_TRANSMEMBRANE_JUXTAMEMBRANE_AND_KINASE_DOMAIN_MUTANTS"
42,"Up",0.259212607057389,0.486650765507743,"L.LvsV.BRACHAT_RESPONSE_TO_METHOTREXATE_DN"
25,"Down",0.259469828107637,0.486968323016676,"L.LvsV.GRANDVAUX_IRF3_TARGETS_DN"
185,"Up",0.259722155916234,0.48727648458122,"L.LvsV.MORI_MATURE_B_LYMPHOCYTE_UP"
6,"Up",0.259927240945986,0.487495832832549,"L.LvsV.OHASHI_AURKA_TARGETS"
64,"Down",0.261139624183789,0.489603588373065,"L.LvsV.REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS"
26,"Down",0.261447648278792,0.490014931299472,"L.LvsV.PLASARI_TGFB1_TARGETS_1HR_DN"
595,"Down",0.26165998105837,0.490246707987709,"L.LvsV.BROWNE_HCMV_INFECTION_4HR_DN"
32,"Down",0.262228617296915,0.49114567243721,"L.LvsV.REACTOME_RNA_POLYMERASE_I_TRANSCRIPTION_TERMINATION"
82,"Up",0.262578622971794,0.491634678771097,"L.LvsV.CHEN_ETV5_TARGETS_TESTIS"
7,"Down",0.262909983067026,0.492021869930771,"L.LvsV.REACTOME_TRNA_PROCESSING_IN_THE_MITOCHONDRION"
74,"Down",0.263032570110939,0.492021869930771,"L.LvsV.FUJII_YBX1_TARGETS_UP"
74,"Down",0.263127618916214,0.492021869930771,"L.LvsV.KEGG_ACUTE_MYELOID_LEUKEMIA"
933,"Down",0.263141376267913,0.492021869930771,"L.LvsV.FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP"
238,"Down",0.26331346537566,0.492177197451664,"L.LvsV.YAUCH_HEDGEHOG_SIGNALING_PARACRINE_UP"
44,"Down",0.263521830081815,0.492400202271833,"L.LvsV.AMIT_SERUM_RESPONSE_40_MCF10A"
24,"Up",0.263656556576498,0.492485507199816,"L.LvsV.KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_CHONDROITIN_SULFATE"
607,"Down",0.263931662961399,0.492807303423707,"L.LvsV.REACTOME_SIGNALING_BY_INTERLEUKINS"
27,"Down",0.264101801323187,0.492807303423707,"L.LvsV.IIZUKA_LIVER_CANCER_EARLY_RECURRENCE"
423,"Down",0.264170002577951,0.492807303423707,"L.LvsV.GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP"
13,"Down",0.264185358536421,0.492807303423707,"L.LvsV.CLIMENT_BREAST_CANCER_COPY_NUMBER_DN"
159,"Down",0.264441988853227,0.493098835588675,"L.LvsV.ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN"
34,"Up",0.264520012001449,0.493098835588675,"L.LvsV.KORKOLA_EMBRYONAL_CARCINOMA_DN"
30,"Up",0.26485677177379,0.493560192496557,"L.LvsV.REACTOME_SYNTHESIS_OF_IP3_AND_IP4_IN_THE_CYTOSOL"
7,"Down",0.265129657479854,0.493902249395591,"L.LvsV.REACTOME_ACTIVATION_OF_C3_AND_C5"
30,"Down",0.26537427219433,0.494191428414432,"L.LvsV.REACTOME_RHO_GTPASES_ACTIVATE_NADPH_OXIDASES"
19,"Down",0.265771829772385,0.494765133606572,"L.LvsV.MARTINELLI_IMMATURE_NEUTROPHIL_DN"
182,"Down",0.26660335576982,0.496105804521638,"L.LvsV.KIM_GLIS2_TARGETS_UP"
1187,"Up",0.26674908423913,0.496105804521638,"L.LvsV.KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_DN"
35,"Down",0.266807826431878,0.496105804521638,"L.LvsV.PID_RXR_VDR_PATHWAY"
45,"Up",0.266850906610119,0.496105804521638,"L.LvsV.REACTOME_SYNTHESIS_OF_PA"
11,"Up",0.26732314411561,0.496759338265369,"L.LvsV.REACTOME_BICARBONATE_TRANSPORTERS"
23,"Down",0.267382128898126,0.496759338265369,"L.LvsV.REACTOME_NEGATIVE_REGULATION_OF_TCF_DEPENDENT_SIGNALING_BY_WNT_LIGAND_ANTAGONISTS"
88,"Down",0.267490960262427,0.49679459835101,"L.LvsV.KEGG_LEISHMANIA_INFECTION"
37,"Down",0.267708597494624,0.496884909981913,"L.LvsV.GHO_ATF5_TARGETS_UP"
6,"Down",0.267816917422805,0.496884909981913,"L.LvsV.REN_MIF_TARGETS_DN"
303,"Down",0.267851821967089,0.496884909981913,"L.LvsV.SANSOM_APC_TARGETS_REQUIRE_MYC"
15,"Down",0.267899062516926,0.496884909981913,"L.LvsV.KEGG_GLYCOSPHINGOLIPID_BIOSYNTHESIS_GLOBO_SERIES"
129,"Up",0.268082841683408,0.497059031410986,"L.LvsV.MENSE_HYPOXIA_UP"
26,"Down",0.268185415913208,0.497082522488812,"L.LvsV.REACTOME_PRESYNAPTIC_FUNCTION_OF_KAINATE_RECEPTORS"
706,"Down",0.268396084841295,0.497306284546756,"L.LvsV.JOHNSTONE_PARVB_TARGETS_3_UP"
152,"Down",0.268567354727462,0.49745691935951,"L.LvsV.PID_CMYB_PATHWAY"
965,"Up",0.268817062346461,0.497602704331766,"L.LvsV.PATIL_LIVER_CANCER"
39,"Down",0.268826058570987,0.497602704331766,"L.LvsV.PID_RETINOIC_ACID_PATHWAY"
35,"Down",0.269119748539708,0.497979615018758,"L.LvsV.BIOCARTA_CREB_PATHWAY"
29,"Up",0.269300701837086,0.498147735181415,"L.LvsV.REACTOME_METABOLISM_OF_COFACTORS"
1863,"Up",0.269675243423436,0.498401600879616,"L.LvsV.BLALOCK_ALZHEIMERS_DISEASE_DN"
30,"Down",0.269680456815669,0.498401600879616,"L.LvsV.MATZUK_SPERMATOGONIA"
13,"Down",0.26975167669724,0.498401600879616,"L.LvsV.PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_5"
14,"Down",0.269798515361311,0.498401600879616,"L.LvsV.REACTOME_LGI_ADAM_INTERACTIONS"
140,"Up",0.2700267083033,0.498597700245945,"L.LvsV.REACTOME_SLC_TRANSPORTER_DISORDERS"
78,"Down",0.270141446662389,0.498597700245945,"L.LvsV.HANN_RESISTANCE_TO_BCL2_INHIBITOR_DN"
36,"Down",0.270175205269823,0.498597700245945,"L.LvsV.REACTOME_PLATELET_ADHESION_TO_EXPOSED_COLLAGEN"
24,"Down",0.270273922929748,0.498613453412939,"L.LvsV.BIOCARTA_HCMV_PATHWAY"
11,"Down",0.270615088513036,0.498938217363925,"L.LvsV.REACTOME_SPERM_MOTILITY_AND_TAXES"
647,"Down",0.270630442010203,0.498938217363925,"L.LvsV.YAUCH_HEDGEHOG_SIGNALING_PARACRINE_DN"
84,"Down",0.270785675597029,0.499053526648837,"L.LvsV.LEIN_ASTROCYTE_MARKERS"
305,"Down",0.270873509400101,0.499053526648837,"L.LvsV.WIERENGA_STAT5A_TARGETS_DN"
20,"Down",0.271046969914675,0.499206761045383,"L.LvsV.PID_LPA4_PATHWAY"
54,"Down",0.271244022162302,0.499315091065722,"L.LvsV.REACTOME_GLUCAGON_LIKE_PEPTIDE_1_GLP1_REGULATES_INSULIN_SECRETION"
668,"Down",0.271301631673195,0.499315091065722,"L.LvsV.HATADA_METHYLATED_IN_LUNG_CANCER_UP"
393,"Down",0.271399472657066,0.499315091065722,"L.LvsV.MUELLER_PLURINET"
268,"Down",0.271476590478937,0.499315091065722,"L.LvsV.BROWNE_HCMV_INFECTION_18HR_UP"
26,"Up",0.271557330228726,0.499315091065722,"L.LvsV.BALLIF_DEVELOPMENTAL_DISABILITY_P16_P12_DELETION"
13,"Down",0.271907233687452,0.499792252346383,"L.LvsV.REACTOME_ALPHA_PROTEIN_KINASE_1_SIGNALING_PATHWAY"
32,"Up",0.272139556547742,0.49994485530242,"L.LvsV.KORKOLA_SEMINOMA_DN"
100,"Down",0.272171100463065,0.49994485530242,"L.LvsV.REACTOME_TOLL_LIKE_RECEPTOR_10_TLR10_CASCADE"
317,"Down",0.272288563672831,0.499994509646988,"L.LvsV.TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP"
12,"Down",0.272410771472519,0.500052840462004,"L.LvsV.REACTOME_ACTIVATION_OF_THE_TFAP2_AP_2_FAMILY_OF_TRANSCRIPTION_FACTORS"
65,"Down",0.273100045671772,0.500850577496485,"L.LvsV.LAU_APOPTOSIS_CDKN2A_UP"
153,"Down",0.27326453341515,0.500850577496485,"L.LvsV.ROSS_LEUKEMIA_WITH_MLL_FUSIONS"
24,"Down",0.273331038879256,0.500850577496485,"L.LvsV.REACTOME_PI_3K_CASCADE_FGFR4"
60,"Down",0.273336857099851,0.500850577496485,"L.LvsV.REACTOME_METABOLIC_DISORDERS_OF_BIOLOGICAL_OXIDATION_ENZYMES"
13,"Down",0.273342303953249,0.500850577496485,"L.LvsV.TURJANSKI_MAPK14_TARGETS"
118,"Down",0.273388866501065,0.500850577496485,"L.LvsV.BOYLAN_MULTIPLE_MYELOMA_PCA3_DN"
7,"Up",0.273601053937822,0.500938145769125,"L.LvsV.LIU_CMYB_TARGETS_DN"
18,"Down",0.273739865107495,0.500938145769125,"L.LvsV.KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_4NQO_IN_OLD"
37,"Down",0.27379472886398,0.500938145769125,"L.LvsV.REACTOME_SURFACTANT_METABOLISM"
75,"Down",0.27384195062399,0.500938145769125,"L.LvsV.LEE_CALORIE_RESTRICTION_MUSCLE_DN"
111,"Down",0.273889675286682,0.500938145769125,"L.LvsV.REACTOME_REGULATION_OF_INSULIN_SECRETION"
39,"Down",0.274057313840574,0.500960106413857,"L.LvsV.REACTOME_NUCLEAR_SIGNALING_BY_ERBB4"
25,"Down",0.274090069378801,0.500960106413857,"L.LvsV.MCGOWAN_RSP6_TARGETS_UP"
74,"Up",0.274173500091939,0.500960106413857,"L.LvsV.KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP"
92,"Up",0.274404819712914,0.501110225765563,"L.LvsV.REACTOME_RMTS_METHYLATE_HISTONE_ARGININES"
16,"Up",0.274436925957338,0.501110225765563,"L.LvsV.KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_KERATAN_SULFATE"
78,"Down",0.274751844977922,0.501519627231077,"L.LvsV.REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS"
415,"Up",0.275066412328366,0.501928116753643,"L.LvsV.WONG_EMBRYONIC_STEM_CELL_CORE"
5,"Down",0.27527265323784,0.502138733009574,"L.LvsV.NAKAMURA_ALVEOLAR_EPITHELIUM"
15,"Down",0.275415685746021,0.502212768853164,"L.LvsV.REACTOME_SIGNALING_BY_FGFR4_IN_DISEASE"
111,"Down",0.275494904672029,0.502212768853164,"L.LvsV.REACTOME_TOLL_LIKE_RECEPTOR_9_TLR9_CASCADE"
11,"Up",0.275657621441817,0.502343766958407,"L.LvsV.HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_DN"
59,"Down",0.275801043831315,0.502350728794152,"L.LvsV.YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_5"
28,"Down",0.275877386551856,0.502350728794152,"L.LvsV.LEE_INTRATHYMIC_T_PROGENITOR"
12,"Down",0.275934013989481,0.502350728794152,"L.LvsV.REACTOME_SEROTONIN_RECEPTORS"
239,"Up",0.276397329176663,0.50302858229683,"L.LvsV.REACTOME_REPRODUCTION"
448,"Up",0.276674321557185,0.503211208293244,"L.LvsV.KAAB_HEART_ATRIUM_VS_VENTRICLE_DN"
48,"Down",0.276902907769857,0.503211208293244,"L.LvsV.WORSCHECH_TUMOR_EVASION_AND_TOLEROGENICITY_UP"
113,"Down",0.276942162459384,0.503211208293244,"L.LvsV.FAELT_B_CLL_WITH_VH_REARRANGEMENTS_UP"
94,"Up",0.276944152520633,0.503211208293244,"L.LvsV.ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_DN"
7,"Up",0.276952741334118,0.503211208293244,"L.LvsV.TERAO_AOX4_TARGETS_HG_DN"
100,"Down",0.277432129799134,0.503845380896877,"L.LvsV.RAMASWAMY_METASTASIS_UP"
67,"Down",0.277484026918247,0.503845380896877,"L.LvsV.YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_8"
60,"Down",0.277892077322717,0.504420648561163,"L.LvsV.PID_ER_NONGENOMIC_PATHWAY"
28,"Down",0.278347739995458,0.505041162444598,"L.LvsV.BIOCARTA_NTHI_PATHWAY"
237,"Down",0.278416614782263,0.505041162444598,"L.LvsV.DARWICHE_PAPILLOMA_RISK_HIGH_UP"
12,"Up",0.278748213656249,0.505476836111972,"L.LvsV.REACTOME_CHYLOMICRON_ASSEMBLY"
90,"Down",0.279291039242453,0.506117257146998,"L.LvsV.ZHAN_MULTIPLE_MYELOMA_MF_UP"
32,"Down",0.279339169471974,0.506117257146998,"L.LvsV.BIOCARTA_MTA3_PATHWAY"
135,"Down",0.27940849339583,0.506117257146998,"L.LvsV.SEIDEN_ONCOGENESIS_BY_MET"
10,"Up",0.279468634002688,0.506117257146998,"L.LvsV.AGARWAL_AKT_PATHWAY_TARGETS"
54,"Down",0.279559070958027,0.506117257146998,"L.LvsV.PID_IFNG_PATHWAY"
10,"Down",0.279751936691697,0.506300640906184,"L.LvsV.TESAR_ALK_TARGETS_HUMAN_ES_5D_UP"
22,"Down",0.279845101455893,0.506303522889277,"L.LvsV.MEISSNER_NPC_ICP_WITH_H3K4ME3"
10,"Down",0.280054119387592,0.506488834866086,"L.LvsV.REACTOME_LOSS_OF_FUNCTION_OF_SMAD2_3_IN_CANCER"
107,"Up",0.28013073919705,0.506488834866086,"L.LvsV.ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_UP"
9,"Down",0.280488890174011,0.506970602736877,"L.LvsV.REACTOME_SIGNALLING_TO_P38_VIA_RIT_AND_RIN"
297,"Down",0.280773825071688,0.507319764320707,"L.LvsV.VANOEVELEN_MYOGENESIS_SIN3A_TARGETS"
46,"Up",0.281448950431351,0.508266153041059,"L.LvsV.YAMASHITA_LIVER_CANCER_WITH_EPCAM_DN"
123,"Down",0.28148145426148,0.508266153041059,"L.LvsV.FALVELLA_SMOKERS_WITH_LUNG_CANCER"
26,"Up",0.281979547362453,0.508975771214341,"L.LvsV.WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_UP"
56,"Down",0.282065490204724,0.508975771214341,"L.LvsV.BOYAULT_LIVER_CANCER_SUBCLASS_G5_DN"
81,"Down",0.282150612908655,0.508975771214341,"L.LvsV.NEWMAN_ERCC6_TARGETS_DN"
11,"Down",0.282301558022518,0.509081968136497,"L.LvsV.LUCAS_HNF4A_TARGETS_DN"
32,"Up",0.282482368332647,0.509144797555928,"L.LvsV.KEGG_NICOTINATE_AND_NICOTINAMIDE_METABOLISM"
734,"Down",0.282520571333259,0.509144797555928,"L.LvsV.FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_UP"
14,"Down",0.28268205091547,0.509269814112621,"L.LvsV.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_12"
156,"Up",0.282939214540161,0.509567074004088,"L.LvsV.YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_11"
140,"Up",0.283124441456707,0.509734626119875,"L.LvsV.GNATENKO_PLATELET_SIGNATURE"
93,"Down",0.283470289908524,0.510083867530928,"L.LvsV.KRASNOSELSKAYA_ILF3_TARGETS_DN"
17,"Down",0.28350293451303,0.510083867530928,"L.LvsV.BENPORATH_ES_CORE_NINE"
136,"Up",0.283744211171609,0.510351900965461,"L.LvsV.REACTOME_RHO_GTPASES_ACTIVATE_PKNS"
62,"Down",0.283836933278826,0.510352651739392,"L.LvsV.HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_DN"
75,"Down",0.28403864222269,0.510547120788239,"L.LvsV.MCDOWELL_ACUTE_LUNG_INJURY_DN"
22,"Down",0.284165036642033,0.510547120788239,"L.LvsV.SHIN_B_CELL_LYMPHOMA_CLUSTER_5"
346,"Down",0.284276928192221,0.510547120788239,"L.LvsV.TIEN_INTESTINE_PROBIOTICS_24HR_DN"
1681,"Up",0.284314448346353,0.510547120788239,"L.LvsV.REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION"
4,"Up",0.284484188817694,0.510686064926308,"L.LvsV.REACTOME_METALLOTHIONEINS_BIND_METALS"
87,"Up",0.284624440008236,0.510771998963173,"L.LvsV.REACTOME_CELLULAR_RESPONSE_TO_HYPOXIA"
197,"Down",0.284791798980152,0.510848294648295,"L.LvsV.HUMMERICH_SKIN_CANCER_PROGRESSION_DN"
67,"Down",0.284851743968293,0.510848294648295,"L.LvsV.HAN_JNK_SINGALING_DN"
72,"Down",0.28519579902806,0.511299472382019,"L.LvsV.ZHAN_MULTIPLE_MYELOMA_LB_UP"
60,"Down",0.285508922385205,0.511607225005128,"L.LvsV.PID_ERBB2_ERBB3_PATHWAY"
19,"Down",0.285552522402934,0.511607225005128,"L.LvsV.BIOCARTA_SET_PATHWAY"
26,"Down",0.285735089164998,0.511768483314957,"L.LvsV.BIOCARTA_41BB_PATHWAY"
203,"Down",0.285981669107723,0.512044251456153,"L.LvsV.MIKKELSEN_MEF_LCP_WITH_H3K4ME3"
107,"Down",0.286157220024118,0.512192706219925,"L.LvsV.REACTOME_SELECTIVE_AUTOPHAGY"
44,"Up",0.286360067570315,0.512295859350355,"L.LvsV.DAZARD_UV_RESPONSE_CLUSTER_G28"
733,"Down",0.286400163004512,0.512295859350355,"L.LvsV.HAN_SATB1_TARGETS_UP"
52,"Up",0.286726598943828,0.512555560994878,"L.LvsV.PID_FOXM1_PATHWAY"
127,"Down",0.28673075604217,0.512555560994878,"L.LvsV.MORI_SMALL_PRE_BII_LYMPHOCYTE_DN"
83,"Down",0.287092429719472,0.513036213289904,"L.LvsV.HAN_JNK_SINGALING_UP"
342,"Up",0.287278490443579,0.51313647217345,"L.LvsV.JIANG_HYPOXIA_NORMAL"
8,"Down",0.287381039865336,0.51313647217345,"L.LvsV.REACTOME_MRNA_EDITING"
56,"Down",0.287426958640111,0.51313647217345,"L.LvsV.REACTOME_AQUAPORIN_MEDIATED_TRANSPORT"
10,"Down",0.287840756890462,0.513506817000128,"L.LvsV.BIOCARTA_STAT3_PATHWAY"
19,"Up",0.288062515069645,0.513506817000128,"L.LvsV.REACTOME_SIGNAL_REGULATORY_PROTEIN_FAMILY_INTERACTIONS"
935,"Up",0.288107271343278,0.513506817000128,"L.LvsV.FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN"
112,"Down",0.288126501217686,0.513506817000128,"L.LvsV.LEIN_NEURON_MARKERS"
1133,"Down",0.288171406199386,0.513506817000128,"L.LvsV.KRIEG_HYPOXIA_NOT_VIA_KDM3A"
105,"Down",0.288191653671802,0.513506817000128,"L.LvsV.REACTOME_OPIOID_SIGNALLING"
59,"Down",0.288452668616448,0.513806315973048,"L.LvsV.KEGG_RNA_DEGRADATION"
5,"Down",0.289316996625881,0.51517992732512,"L.LvsV.REACTOME_ACTIVATION_OF_NOXA_AND_TRANSLOCATION_TO_MITOCHONDRIA"
100,"Up",0.289586684656329,0.515494133762023,"L.LvsV.PID_CD8_TCR_PATHWAY"
169,"Down",0.289915786100612,0.515913865899673,"L.LvsV.KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_DN"
205,"Down",0.290155796922746,0.516033710696593,"L.LvsV.ODONNELL_METASTASIS_UP"
93,"Up",0.290249688988748,0.516033710696593,"L.LvsV.MODY_HIPPOCAMPUS_POSTNATAL"
50,"Down",0.290263129004595,0.516033710696593,"L.LvsV.REACTOME_DAG_AND_IP3_SIGNALING"
19,"Down",0.290412378000316,0.516073630869066,"L.LvsV.KINNEY_DNMT1_METHYLATION_TARGETS"
806,"Up",0.290472262482281,0.516073630869066,"L.LvsV.REACTOME_NEUTROPHIL_DEGRANULATION"
22,"Down",0.290622053990332,0.516173895442514,"L.LvsV.PYEON_HPV_POSITIVE_TUMORS_DN"
68,"Down",0.290952255127382,0.516519384662035,"L.LvsV.YANG_BREAST_CANCER_ESR1_LASER_DN"
31,"Down",0.291003415305162,0.516519384662035,"L.LvsV.REACTOME_POSTMITOTIC_NUCLEAR_PORE_COMPLEX_NPC_REFORMATION"
46,"Down",0.291339978176666,0.516877706512492,"L.LvsV.BIOCARTA_GPCR_PATHWAY"
100,"Up",0.291392261023591,0.516877706512492,"L.LvsV.FIGUEROA_AML_METHYLATION_CLUSTER_3_DN"
390,"Down",0.291626545311852,0.517127379419253,"L.LvsV.ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP"
10,"Down",0.291788035019694,0.517247850472552,"L.LvsV.REACTOME_SHC_RELATED_EVENTS_TRIGGERED_BY_IGF1R"
1302,"Down",0.292223449633855,0.517758440292054,"L.LvsV.SMID_BREAST_CANCER_BASAL_UP"
25,"Down",0.292263355426207,0.517758440292054,"L.LvsV.ONDER_CDH1_TARGETS_3_UP"
83,"Down",0.292631848213567,0.51824519179142,"L.LvsV.KEGG_VEGF_SIGNALING_PATHWAY"
19,"Up",0.292979519626412,0.518694769136865,"L.LvsV.REACTOME_RIP_MEDIATED_NFKB_ACTIVATION_VIA_ZBP1"
43,"Down",0.293190759879082,0.518829641513567,"L.LvsV.MAGRANGEAS_MULTIPLE_MYELOMA_IGG_VS_IGA_DN"
190,"Down",0.293243376691969,0.518829641513567,"L.LvsV.MCBRYAN_PUBERTAL_BREAST_5_6WK_UP"
464,"Up",0.294179036992405,0.520318584622842,"L.LvsV.RAO_BOUND_BY_SALL4_ISOFORM_A"
33,"Down",0.294326293639117,0.520412560770923,"L.LvsV.REACTOME_SYNTHESIS_OF_PROSTAGLANDINS_PG_AND_THROMBOXANES_TX"
15,"Down",0.294504385290968,0.520560980266548,"L.LvsV.CHESLER_BRAIN_D6MIT150_QTL_CIS"
21,"Down",0.295060395125303,0.521369905178066,"L.LvsV.NIKOLSKY_BREAST_CANCER_7P15_AMPLICON"
58,"Down",0.295150624562732,0.521369905178066,"L.LvsV.NAKAMURA_ADIPOGENESIS_EARLY_DN"
9,"Up",0.295354461259513,0.52156333960519,"L.LvsV.GLINSKY_CANCER_DEATH_UP"
4,"Down",0.2956283490564,0.521880313516232,"L.LvsV.IGARASHI_ATF4_TARGETS_UP"
213,"Down",0.296078061937457,0.522338270914654,"L.LvsV.CERVERA_SDHB_TARGETS_2"
63,"Down",0.296134254592281,0.522338270914654,"L.LvsV.NAKAMURA_METASTASIS_MODEL_DN"
13,"Down",0.296192105206923,0.522338270914654,"L.LvsV.TESAR_ALK_TARGETS_EPISC_3D_UP"
36,"Up",0.296332404335625,0.522338270914654,"L.LvsV.KONG_E2F1_TARGETS"
99,"Down",0.296360129473552,0.522338270914654,"L.LvsV.MIKKELSEN_ES_ICP_WITH_H3K27ME3"
546,"Down",0.296506139326935,0.522429077227094,"L.LvsV.ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_UP"
57,"Up",0.296908018073017,0.52297051032995,"L.LvsV.KEGG_TRYPTOPHAN_METABOLISM"
250,"Down",0.297373494397506,0.523385430726406,"L.LvsV.DARWICHE_SQUAMOUS_CELL_CARCINOMA_UP"
7,"Down",0.297408899210935,0.523385430726406,"L.LvsV.DIERICK_SEROTONIN_FUNCTION_GENES"
180,"Up",0.297427567976554,0.523385430726406,"L.LvsV.WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_UP"
340,"Down",0.297912870483805,0.524072625168616,"L.LvsV.AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_DN"
32,"Up",0.298135356438164,0.52429719648429,"L.LvsV.WEBER_METHYLATED_HCP_IN_SPERM_UP"
18,"Down",0.298321656963803,0.524458009969116,"L.LvsV.PID_TCR_RAS_PATHWAY"
103,"Down",0.298556753037565,0.524648157809011,"L.LvsV.OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN"
34,"Up",0.298627675282614,0.524648157809011,"L.LvsV.RUAN_RESPONSE_TO_TROGLITAZONE_UP"
20,"Down",0.298714487390625,0.524648157809011,"L.LvsV.BIOCARTA_PLC_PATHWAY"
9,"Up",0.298986645549486,0.52495940401496,"L.LvsV.BIOCARTA_PARKIN_PATHWAY"
64,"Down",0.299669255118964,0.525767835774975,"L.LvsV.REACTOME_COPI_INDEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC"
159,"Down",0.299675584803428,0.525767835774975,"L.LvsV.FIGUEROA_AML_METHYLATION_CLUSTER_4_UP"
73,"Down",0.299732359986023,0.525767835774975,"L.LvsV.REACTOME_SIGNALING_BY_ERBB4"
40,"Down",0.300357350184754,0.526697046993817,"L.LvsV.BIOCARTA_INFLAM_PATHWAY"
79,"Up",0.300829118820924,0.527338141078268,"L.LvsV.SPIRA_SMOKERS_LUNG_CANCER_UP"
450,"Down",0.301012162256017,0.527338141078268,"L.LvsV.ZHOU_INFLAMMATORY_RESPONSE_FIMA_DN"
143,"Down",0.301149009780447,0.527338141078268,"L.LvsV.PID_AP1_PATHWAY"
28,"Down",0.301169751115738,0.527338141078268,"L.LvsV.MATZUK_OVULATION"
281,"Down",0.301199828092814,0.527338141078268,"L.LvsV.REACTOME_INTERFERON_SIGNALING"
30,"Up",0.301447911689169,0.527605414285981,"L.LvsV.REACTOME_APC_CDC20_MEDIATED_DEGRADATION_OF_NEK2A"
160,"Down",0.301571945883168,0.527648585416291,"L.LvsV.GAVIN_FOXP3_TARGETS_CLUSTER_P7"
29,"Down",0.301663443389564,0.527648585416291,"L.LvsV.RUAN_RESPONSE_TO_TNF_UP"
94,"Up",0.302122097504339,0.528227874397272,"L.LvsV.NAKAMURA_ADIPOGENESIS_EARLY_UP"
36,"Down",0.302185705682505,0.528227874397272,"L.LvsV.PID_IL3_PATHWAY"
95,"Down",0.302364612755878,0.528373560027575,"L.LvsV.KIM_GERMINAL_CENTER_T_HELPER_UP"
292,"Down",0.302501340446621,0.528445469614335,"L.LvsV.SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM2"
64,"Down",0.302725194590857,0.52866863715021,"L.LvsV.REACTOME_RAB_GERANYLGERANYLATION"
218,"Down",0.302820324444694,0.52866863715021,"L.LvsV.RASHI_RESPONSE_TO_IONIZING_RADIATION_5"
1092,"Down",0.30295616593954,0.528738838850921,"L.LvsV.REACTOME_INFECTIOUS_DISEASE"
10,"Down",0.303322780534227,0.529211629401623,"L.LvsV.REACTOME_MET_ACTIVATES_PI3K_AKT_SIGNALING"
267,"Down",0.30375366632679,0.52979622117376,"L.LvsV.MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_DN"
654,"Down",0.304028183958881,0.530107798520547,"L.LvsV.THUM_SYSTOLIC_HEART_FAILURE_UP"
70,"Down",0.304243937598592,0.530316749994519,"L.LvsV.HONMA_DOCETAXEL_RESISTANCE"
84,"Down",0.30483135767769,0.531173204097052,"L.LvsV.SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER"
328,"Up",0.305172909528958,0.531600824444111,"L.LvsV.BOYLAN_MULTIPLE_MYELOMA_PCA1_UP"
48,"Down",0.305733215734444,0.532409118045903,"L.LvsV.REACTOME_VASOPRESSIN_REGULATES_RENAL_WATER_HOMEOSTASIS_VIA_AQUAPORINS"
65,"Down",0.306297687014583,0.533224153496104,"L.LvsV.JIANG_AGING_CEREBRAL_CORTEX_UP"
137,"Down",0.306518023163585,0.533333456597985,"L.LvsV.KIM_MYCN_AMPLIFICATION_TARGETS_UP"
259,"Down",0.306561777884284,0.533333456597985,"L.LvsV.BROWNE_HCMV_INFECTION_30MIN_DN"
96,"Down",0.306771518296848,0.533333456597985,"L.LvsV.REACTOME_DEGRADATION_OF_BETA_CATENIN_BY_THE_DESTRUCTION_COMPLEX"
36,"Up",0.306796916476536,0.533333456597985,"L.LvsV.REACTOME_COBALAMIN_CBL_VITAMIN_B12_TRANSPORT_AND_METABOLISM"
15,"Up",0.306842779062795,0.533333456597985,"L.LvsV.MARSON_FOXP3_TARGETS_STIMULATED_DN"
25,"Down",0.307339210848322,0.534028440220104,"L.LvsV.FINETTI_BREAST_CANCER_KINOME_GREEN"
147,"Up",0.307554889073619,0.534160298787668,"L.LvsV.PUJANA_BRCA_CENTERED_NETWORK"
1407,"Down",0.307608318202195,0.534160298787668,"L.LvsV.BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_A"
24,"Down",0.308029449515527,0.534586684472434,"L.LvsV.RAY_TARGETS_OF_P210_BCR_ABL_FUSION_DN"
81,"Down",0.308047237607013,0.534586684472434,"L.LvsV.REACTOME_COSTIMULATION_BY_THE_CD28_FAMILY"
144,"Up",0.308750217915432,0.535638517368819,"L.LvsV.LIANG_SILENCED_BY_METHYLATION_2"
6,"Down",0.309150149127075,0.53616410744153,"L.LvsV.REACTOME_SYNTHESIS_OF_WYBUTOSINE_AT_G37_OF_TRNA_PHE"
29,"Down",0.309337644710815,0.536321052871149,"L.LvsV.EHRLICH_ICF_SYNDROM_DN"
25,"Down",0.309593900097958,0.53659707637668,"L.LvsV.MCCOLLUM_GELDANAMYCIN_RESISTANCE_UP"
14,"Up",0.310282000646777,0.537621178807906,"L.LvsV.REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_DEATH_RECEPTORS_AND_LIGANDS"
38,"Up",0.310454645259488,0.537751796253041,"L.LvsV.DE_YY1_TARGETS_UP"
245,"Down",0.310575627409718,0.537792873143856,"L.LvsV.JOHNSTONE_PARVB_TARGETS_2_UP"
27,"Up",0.311365826893864,0.538935890627389,"L.LvsV.KARAKAS_TGFB1_SIGNALING"
61,"Up",0.311430669299061,0.538935890627389,"L.LvsV.HASLINGER_B_CLL_WITH_11Q23_DELETION"
20,"Down",0.311770874233399,0.539355808396891,"L.LvsV.AMIT_EGF_RESPONSE_40_MCF10A"
31,"Up",0.312546266410918,0.540379247373225,"L.LvsV.GRANDVAUX_IRF3_TARGETS_UP"
37,"Down",0.31270957743264,0.540379247373225,"L.LvsV.TOMIDA_METASTASIS_DN"
23,"Down",0.312760178046226,0.540379247373225,"L.LvsV.GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN"
74,"Up",0.312808805674755,0.540379247373225,"L.LvsV.JIANG_HYPOXIA_CANCER"
34,"Down",0.312927021486528,0.540379247373225,"L.LvsV.SYED_ESTRADIOL_RESPONSE"
78,"Up",0.312948878656008,0.540379247373225,"L.LvsV.RICKMAN_HEAD_AND_NECK_CANCER_D"
72,"Down",0.313717647139955,0.541458713341467,"L.LvsV.ROESSLER_LIVER_CANCER_METASTASIS_DN"
32,"Up",0.313775797874908,0.541458713341467,"L.LvsV.MARIADASON_RESPONSE_TO_CURCUMIN_SULINDAC_5"
6,"Up",0.313959157965346,0.541458713341467,"L.LvsV.REACTOME_SENSING_OF_DNA_DOUBLE_STRAND_BREAKS"
93,"Down",0.31396575058288,0.541458713341467,"L.LvsV.MCCLUNG_DELTA_FOSB_TARGETS_8WK"
151,"Down",0.314140783128468,0.541591640136358,"L.LvsV.CHANG_IMMORTALIZED_BY_HPV31_DN"
98,"Down",0.314409711046955,0.541886313085603,"L.LvsV.ZWANG_EGF_PERSISTENTLY_DN"
16,"Down",0.314745678324566,0.54229630896121,"L.LvsV.SHANK_TAL1_TARGETS_DN"
16,"Down",0.315203512328489,0.542831065662525,"L.LvsV.TSUDA_ALVEOLAR_SOFT_PART_SARCOMA"
99,"Down",0.315252405831501,0.542831065662525,"L.LvsV.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_UP"
76,"Up",0.315435048085041,0.542931212230806,"L.LvsV.NEMETH_INFLAMMATORY_RESPONSE_LPS_DN"
6,"Up",0.315506960553008,0.542931212230806,"L.LvsV.REACTOME_ASSEMBLY_OF_THE_ORC_COMPLEX_AT_THE_ORIGIN_OF_REPLICATION"
47,"Up",0.315867476658941,0.543098004600447,"L.LvsV.PID_ATR_PATHWAY"
779,"Down",0.31589552593321,0.543098004600447,"L.LvsV.MIKKELSEN_NPC_ICP_WITH_H3K4ME3"
315,"Down",0.315898568058426,0.543098004600447,"L.LvsV.KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_DN"
471,"Up",0.315999292983678,0.543102297453141,"L.LvsV.REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION"
11,"Down",0.316447466264591,0.543703555306689,"L.LvsV.REACTOME_AKT_PHOSPHORYLATES_TARGETS_IN_THE_NUCLEUS"
189,"Up",0.316626984500908,0.543842993881802,"L.LvsV.ROESSLER_LIVER_CANCER_METASTASIS_UP"
671,"Down",0.316867748085575,0.544056512569723,"L.LvsV.PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_7"
51,"Down",0.316948096760188,0.544056512569723,"L.LvsV.PID_EPO_PATHWAY"
22,"Down",0.317109817761762,0.54416517144779,"L.LvsV.BIOCARTA_PRION_PATHWAY"
50,"Up",0.317355600272196,0.544417968943521,"L.LvsV.REACTOME_LYSOSOME_VESICLE_BIOGENESIS"
219,"Down",0.317714569269451,0.544864718824688,"L.LvsV.XU_GH1_EXOGENOUS_TARGETS_DN"
105,"Down",0.318882416969132,0.54669794834801,"L.LvsV.REACTOME_HEDGEHOG_ON_STATE"
20,"Up",0.319149077501279,0.546852536542735,"L.LvsV.ROETH_TERT_TARGETS_UP"
34,"Down",0.31929651938081,0.546852536542735,"L.LvsV.RUNNE_GENDER_EFFECT_UP"
37,"Down",0.319334591527096,0.546852536542735,"L.LvsV.BIOCARTA_LIS1_PATHWAY"
47,"Down",0.319368211339572,0.546852536542735,"L.LvsV.KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_WS"
83,"Down",0.319496052457029,0.546902066264678,"L.LvsV.BIOCARTA_NUCLEARRS_PATHWAY"
347,"Up",0.320383885365622,0.547967861061112,"L.LvsV.BLUM_RESPONSE_TO_SALIRASIB_UP"
105,"Down",0.320466222081747,0.547967861061112,"L.LvsV.OUILLETTE_CLL_13Q14_DELETION_DN"
25,"Down",0.320507428277675,0.547967861061112,"L.LvsV.KANG_FLUOROURACIL_RESISTANCE_DN"
72,"Down",0.320515113523537,0.547967861061112,"L.LvsV.GOBERT_CORE_OLIGODENDROCYTE_DIFFERENTIATION"
44,"Down",0.320873889625314,0.548411664834116,"L.LvsV.LOPEZ_MESOTHELIOMA_SURVIVAL_DN"
171,"Up",0.321040456762982,0.548526787837617,"L.LvsV.LIU_NASOPHARYNGEAL_CARCINOMA"
99,"Down",0.321211603999284,0.548649662808786,"L.LvsV.LEE_TARGETS_OF_PTCH1_AND_SUFU_UP"
1122,"Down",0.321675247703863,0.549271909992173,"L.LvsV.RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP"
74,"Down",0.322185201954306,0.549860242805735,"L.LvsV.MARSON_FOXP3_TARGETS_DN"
201,"Down",0.322218698985455,0.549860242805735,"L.LvsV.WEI_MIR34A_TARGETS"
112,"Up",0.323238593370317,0.551430479094255,"L.LvsV.TANG_SENESCENCE_TP53_TARGETS_DN"
73,"Down",0.32364317098941,0.551950367797794,"L.LvsV.WANG_LSD1_TARGETS_DN"
72,"Down",0.32387586757441,0.55217689541132,"L.LvsV.SCHRAETS_MLL_TARGETS_DN"
155,"Down",0.32424168927617,0.552630178794064,"L.LvsV.WINTER_HYPOXIA_UP"
1874,"Up",0.324426787811389,0.552775257260144,"L.LvsV.KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP"
7,"Down",0.324677863721915,0.552961949815793,"L.LvsV.REACTOME_PHASE_1_INACTIVATION_OF_FAST_NA_CHANNELS"
6,"Up",0.324736381090953,0.552961949815793,"L.LvsV.REACTOME_CHOLINE_CATABOLISM"
32,"Down",0.325066706988575,0.553322450467225,"L.LvsV.REACTOME_TICAM1_RIP1_MEDIATED_IKK_COMPLEX_RECRUITMENT"
76,"Down",0.325165485020259,0.553322450467225,"L.LvsV.GILDEA_METASTASIS"
47,"Down",0.325299484372519,0.553322450467225,"L.LvsV.REACTOME_DNA_DAMAGE_RECOGNITION_IN_GG_NER"
46,"Up",0.325396334577353,0.553322450467225,"L.LvsV.REACTOME_NUCLEOBASE_CATABOLISM"
36,"Up",0.325485686041356,0.553322450467225,"L.LvsV.REACTOME_DIGESTION"
46,"Up",0.325548549714213,0.553322450467225,"L.LvsV.REACTOME_NOD1_2_SIGNALING_PATHWAY"
21,"Up",0.325738944763505,0.553356142823986,"L.LvsV.MCBRYAN_TERMINAL_END_BUD_UP"
19,"Up",0.325875465060429,0.553356142823986,"L.LvsV.REACTOME_DIGESTION_OF_DIETARY_CARBOHYDRATE"
18,"Down",0.325911746214351,0.553356142823986,"L.LvsV.REACTOME_DEPOLYMERISATION_OF_THE_NUCLEAR_LAMINA"
53,"Up",0.325968702690852,0.553356142823986,"L.LvsV.REACTOME_INOSITOL_PHOSPHATE_METABOLISM"
196,"Down",0.32607124530251,0.553360317764757,"L.LvsV.AMBROSINI_FLAVOPIRIDOL_TREATMENT_TP53"
78,"Down",0.326382986604125,0.55371940255729,"L.LvsV.MIDORIKAWA_AMPLIFIED_IN_LIVER_CANCER"
111,"Down",0.32685549630166,0.554350932224503,"L.LvsV.BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_DN"
50,"Down",0.327009654809809,0.554442312616815,"L.LvsV.PID_P38_ALPHA_BETA_DOWNSTREAM_PATHWAY"
63,"Up",0.327964913414353,0.555891479542599,"L.LvsV.SUNG_METASTASIS_STROMA_DN"
39,"Down",0.328232425684258,0.556066535333905,"L.LvsV.BUCKANOVICH_T_LYMPHOCYTE_HOMING_ON_TUMOR_UP"
28,"Down",0.328269338276337,0.556066535333905,"L.LvsV.REACTOME_SIGNALING_BY_PDGFR_IN_DISEASE"
21,"Up",0.328489129737942,0.556268422150407,"L.LvsV.GRATIAS_RETINOBLASTOMA_16Q24"
5,"Down",0.32913607275346,0.55719330871215,"L.LvsV.REACTOME_PTK6_REGULATES_PROTEINS_INVOLVED_IN_RNA_PROCESSING"
31,"Down",0.329331752602462,0.557353921071017,"L.LvsV.BIOCARTA_AKT_PATHWAY"
768,"Down",0.329552353822337,0.557556598618024,"L.LvsV.RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_DN"
108,"Down",0.329693157563515,0.557624187264813,"L.LvsV.LEE_LIVER_CANCER_DENA_UP"
642,"Up",0.329815115427231,0.557659869479255,"L.LvsV.REACTOME_CELL_CYCLE_MITOTIC"
39,"Down",0.330565679184086,0.55875806793299,"L.LvsV.BIOCARTA_TPO_PATHWAY"
11,"Down",0.331014667383896,0.559345995099498,"L.LvsV.GALIE_TUMOR_STEMNESS_GENES"
20,"Down",0.331229529100017,0.559538058782154,"L.LvsV.BIOCARTA_AKAPCENTROSOME_PATHWAY"
15,"Up",0.331827534839096,0.560377043410312,"L.LvsV.YAMASHITA_SILENCED_BY_METHYLATION"
26,"Down",0.332184550713987,0.560770119029285,"L.LvsV.BIOCARTA_LAIR_PATHWAY"
61,"Down",0.332306843602732,0.560770119029285,"L.LvsV.REACTOME_FORMATION_OF_TC_NER_PRE_INCISION_COMPLEX"
31,"Down",0.332364565031464,0.560770119029285,"L.LvsV.REACTOME_EICOSANOIDS"
34,"Down",0.332593962339118,0.560939092198818,"L.LvsV.GOLUB_ALL_VS_AML_UP"
892,"Down",0.332667622231855,0.560939092198818,"L.LvsV.DOUGLAS_BMI1_TARGETS_UP"
27,"Up",0.333036912730198,0.561372510622322,"L.LvsV.GRANDVAUX_IFN_RESPONSE_NOT_VIA_IRF3"
53,"Up",0.333127727862514,0.561372510622322,"L.LvsV.BRACHAT_RESPONSE_TO_CAMPTOTHECIN_UP"
31,"Down",0.333475649696141,0.561661050383127,"L.LvsV.KANG_DOXORUBICIN_RESISTANCE_DN"
57,"Up",0.333587056506901,0.561661050383127,"L.LvsV.PID_ATM_PATHWAY"
31,"Down",0.333603705816276,0.561661050383127,"L.LvsV.MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH"
11,"Down",0.333835692264736,0.561880530451058,"L.LvsV.KEGG_FOLATE_BIOSYNTHESIS"
24,"Up",0.334417894188989,0.562689146978369,"L.LvsV.REACTOME_SYNTHESIS_SECRETION_AND_DEACYLATION_OF_GHRELIN"
12,"Up",0.334521138396265,0.562691625857301,"L.LvsV.FOURNIER_ACINAR_DEVELOPMENT_EARLY_DN"
321,"Down",0.334659606587456,0.562749911264334,"L.LvsV.BROWN_MYELOID_CELL_DEVELOPMENT_UP"
8,"Up",0.334820137329849,0.562749911264334,"L.LvsV.REACTOME_GLYCEROPHOSPHOLIPID_CATABOLISM"
23,"Down",0.334966420348646,0.562749911264334,"L.LvsV.REACTOME_ADP_SIGNALLING_THROUGH_P2Y_PURINOCEPTOR_12"
5,"Up",0.335005439596109,0.562749911264334,"L.LvsV.TOMIDA_LUNG_CANCER_POOR_SURVIVAL"
65,"Up",0.335064696668871,0.562749911264334,"L.LvsV.REACTOME_SIGNALING_BY_RETINOIC_ACID"
9,"Down",0.335339570346144,0.56304053581653,"L.LvsV.REACTOME_LIGAND_RECEPTOR_INTERACTIONS"
8,"Up",0.335628193173797,0.563189084224291,"L.LvsV.REACTOME_PHOSPHATE_BOND_HYDROLYSIS_BY_NUDT_PROTEINS"
8,"Up",0.335712577043562,0.563189084224291,"L.LvsV.REACTOME_DNA_REPLICATION_INITIATION"
181,"Down",0.335733626623849,0.563189084224291,"L.LvsV.RICKMAN_HEAD_AND_NECK_CANCER_E"
90,"Down",0.336467060792152,0.564248219326603,"L.LvsV.BENNETT_SYSTEMIC_LUPUS_ERYTHEMATOSUS"
46,"Up",0.336640078734528,0.56436719081965,"L.LvsV.CHANGOLKAR_H2AFY_TARGETS_DN"
1070,"Down",0.33692472701753,0.564628244431813,"L.LvsV.SCHLOSSER_SERUM_RESPONSE_DN"
22,"Down",0.337000037371131,0.564628244431813,"L.LvsV.REACTOME_SHC_MEDIATED_CASCADE_FGFR4"
53,"Up",0.337335265557753,0.565018686237145,"L.LvsV.BIOCARTA_VEGF_PATHWAY"
7,"Down",0.337736882011316,0.56552005470641,"L.LvsV.SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX3"
300,"Down",0.337992354850298,0.565622078071183,"L.LvsV.THUM_SYSTOLIC_HEART_FAILURE_DN"
69,"Down",0.338002413808498,0.565622078071183,"L.LvsV.PRAMOONJAGO_SOX4_TARGETS_UP"
27,"Down",0.338324555703845,0.565986675028638,"L.LvsV.BIOCARTA_GCR_PATHWAY"
684,"Down",0.338565066007741,0.565986675028638,"L.LvsV.CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_UP"
61,"Down",0.338585303649626,0.565986675028638,"L.LvsV.PID_PI3KCI_PATHWAY"
31,"Down",0.338629756012793,0.565986675028638,"L.LvsV.REACTOME_POU5F1_OCT4_SOX2_NANOG_ACTIVATE_GENES_RELATED_TO_PROLIFERATION"
33,"Up",0.33885070298881,0.56618481016172,"L.LvsV.KORKOLA_CHORIOCARCINOMA_DN"
90,"Down",0.339000924900745,0.566264686941456,"L.LvsV.GOTTWEIN_TARGETS_OF_KSHV_MIR_K12_11"
14,"Up",0.339227804405465,0.566472525085418,"L.LvsV.BIOCARTA_FXR_PATHWAY"
124,"Down",0.339365699845546,0.56653168914433,"L.LvsV.CHEBOTAEV_GR_TARGETS_UP"
21,"Down",0.339485819389372,0.566561151646193,"L.LvsV.DELASERNA_TARGETS_OF_MYOD_AND_SMARCA4"
486,"Up",0.339725444228563,0.5667899762039,"L.LvsV.REACTOME_M_PHASE"
14,"Down",0.339991356985243,0.567062507623352,"L.LvsV.XU_HGF_TARGETS_REPRESSED_BY_AKT1_UP"
11,"Up",0.340366953929712,0.567517758829125,"L.LvsV.REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_CASPASE_ACTIVATORS_AND_CASPASES"
27,"Up",0.34056695568312,0.567579732005199,"L.LvsV.TERAMOTO_OPN_TARGETS_CLUSTER_7"
18,"Down",0.340609432228839,0.567579732005199,"L.LvsV.BIOCARTA_LYM_PATHWAY"
183,"Down",0.340916098361629,0.56777090699965,"L.LvsV.REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION"
17,"Up",0.340929537210859,0.56777090699965,"L.LvsV.REACTOME_DISEASES_ASSOCIATED_WITH_SURFACTANT_METABOLISM"
32,"Down",0.341271492925609,0.56816925154643,"L.LvsV.SILIGAN_TARGETS_OF_EWS_FLI1_FUSION_DN"
14,"Up",0.341474632851252,0.568215667880458,"L.LvsV.REACTOME_MITOCHONDRIAL_FATTY_ACID_BETA_OXIDATION_OF_SATURATED_FATTY_ACIDS"
33,"Down",0.341504913070494,0.568215667880458,"L.LvsV.REACTOME_THROMBIN_SIGNALLING_THROUGH_PROTEINASE_ACTIVATED_RECEPTORS_PARS"
305,"Down",0.341621895607303,0.568239308307093,"L.LvsV.WANG_TUMOR_INVASIVENESS_DN"
12,"Down",0.341779181479307,0.568329953202733,"L.LvsV.REACTOME_SLBP_DEPENDENT_PROCESSING_OF_REPLICATION_DEPENDENT_HISTONE_PRE_MRNAS"
16,"Up",0.342643599081287,0.56959604910416,"L.LvsV.HOEGERKORP_CD44_TARGETS_TEMPORAL_UP"
174,"Down",0.342796706997995,0.569679288545812,"L.LvsV.YAMASHITA_METHYLATED_IN_PROSTATE_CANCER"
40,"Up",0.343228545257035,0.570127609543904,"L.LvsV.WU_HBX_TARGETS_2_UP"
14,"Down",0.343272709743472,0.570127609543904,"L.LvsV.CAFFAREL_RESPONSE_TO_THC_24HR_3_UP"
9,"Down",0.343442704247419,0.570238652187381,"L.LvsV.REACTOME_WNT_MEDIATED_ACTIVATION_OF_DVL"
559,"Down",0.343771853946418,0.570613803803586,"L.LvsV.MULLIGHAN_NPM1_SIGNATURE_3_UP"
13,"Down",0.344186623463305,0.571130804660448,"L.LvsV.SASAKI_TARGETS_OF_TP73_AND_TP63"
7,"Down",0.344449648260804,0.571395771147311,"L.LvsV.REACTOME_CLEC7A_INFLAMMASOME_PATHWAY"
378,"Up",0.344913989266798,0.571994435109816,"L.LvsV.REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL"
1093,"Down",0.34517677981154,0.572258595375714,"L.LvsV.BENPORATH_SOX2_TARGETS"
26,"Up",0.346295796725609,0.573941684681023,"L.LvsV.VISALA_AGING_LYMPHOCYTE_DN"
24,"Down",0.346461307296321,0.5740439220981,"L.LvsV.YAGUE_PRETUMOR_DRUG_RESISTANCE_DN"
167,"Down",0.346659163773052,0.574071511011481,"L.LvsV.QI_PLASMACYTOMA_DN"
6,"Down",0.346685616796407,0.574071511011481,"L.LvsV.REACTOME_THE_FATTY_ACID_CYCLING_MODEL"
604,"Down",0.347009695245123,0.574436109284516,"L.LvsV.GRYDER_PAX3FOXO1_TOP_ENHANCERS"
187,"Up",0.347382610520936,0.574881309060238,"L.LvsV.ROSS_AML_WITH_AML1_ETO_FUSION"
129,"Up",0.348205121395829,0.575907795884166,"L.LvsV.REACTOME_RUNX1_REGULATES_GENES_INVOLVED_IN_MEGAKARYOCYTE_DIFFERENTIATION_AND_PLATELET_FUNCTION"
2088,"Down",0.348292423231283,0.575907795884166,"L.LvsV.YOSHIMURA_MAPK8_TARGETS_UP"
59,"Up",0.348315367957433,0.575907795884166,"L.LvsV.WENG_POR_TARGETS_GLOBAL_DN"
67,"Up",0.348447522103345,0.575919957767118,"L.LvsV.BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_UP"
31,"Down",0.34853105058578,0.575919957767118,"L.LvsV.REACTOME_ACYL_CHAIN_REMODELLING_OF_PC"
48,"Down",0.34884062457027,0.576259280922922,"L.LvsV.FRASOR_RESPONSE_TO_ESTRADIOL_UP"
259,"Down",0.348998914391996,0.576348565613305,"L.LvsV.BROCKE_APOPTOSIS_REVERSED_BY_IL6"
1333,"Up",0.349334503187881,0.576730507054582,"L.LvsV.KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_DN"
252,"Up",0.350007330865442,0.577668815628367,"L.LvsV.SERVITJA_LIVER_HNF1A_TARGETS_UP"
136,"Down",0.350173384617461,0.577750932416297,"L.LvsV.MIKKELSEN_ES_HCP_WITH_H3_UNMETHYLATED"
46,"Down",0.350266074418417,0.577750932416297,"L.LvsV.BOWIE_RESPONSE_TO_EXTRACELLULAR_MATRIX"
8,"Up",0.350473253127237,0.577850174701653,"L.LvsV.SA_G2_AND_M_PHASES"
18,"Up",0.350590111785982,0.577850174701653,"L.LvsV.REACTOME_BLOOD_GROUP_SYSTEMS_BIOSYNTHESIS"
15,"Up",0.350639778644248,0.577850174701653,"L.LvsV.REACTOME_PROCESSIVE_SYNTHESIS_ON_THE_LAGGING_STRAND"
60,"Down",0.35078561331464,0.577918252686724,"L.LvsV.GENTILE_UV_RESPONSE_CLUSTER_D8"
77,"Down",0.350923459244694,0.577940306280721,"L.LvsV.DORN_ADENOVIRUS_INFECTION_12HR_UP"
1973,"Down",0.351008057241935,0.577940306280721,"L.LvsV.CHEN_METABOLIC_SYNDROM_NETWORK"
16,"Down",0.351638961570734,0.578634794131871,"L.LvsV.KONDO_COLON_CANCER_HCP_WITH_H3K27ME3"
60,"Down",0.351639158669395,0.578634794131871,"L.LvsV.REACTOME_NCAM1_INTERACTIONS"
19,"Down",0.351812376004726,0.578747583138986,"L.LvsV.EHLERS_ANEUPLOIDY_DN"
20,"Up",0.352010322706254,0.578900973897346,"L.LvsV.WIEMANN_TELOMERE_SHORTENING_AND_CHRONIC_LIVER_DAMAGE_DN"
21,"Up",0.35282539916731,0.579957395597597,"L.LvsV.BIOCARTA_TH1TH2_PATHWAY"
8,"Down",0.352862484859887,0.579957395597597,"L.LvsV.REACTOME_VEGF_LIGAND_RECEPTOR_INTERACTIONS"
51,"Down",0.353312192841655,0.580426225761184,"L.LvsV.KASLER_HDAC7_TARGETS_2_DN"
108,"Down",0.353366243214392,0.580426225761184,"L.LvsV.PID_MYC_ACTIV_PATHWAY"
588,"Down",0.353462669947171,0.580426225761184,"L.LvsV.HUTTMANN_B_CLL_POOR_SURVIVAL_UP"
46,"Up",0.35368311820119,0.580615784006645,"L.LvsV.KEGG_NUCLEOTIDE_EXCISION_REPAIR"
165,"Up",0.353958044437535,0.58089463570648,"L.LvsV.FURUKAWA_DUSP6_TARGETS_PCI35_UP"
43,"Down",0.354246475717288,0.581195479003229,"L.LvsV.LIU_VAV3_PROSTATE_CARCINOGENESIS_DN"
50,"Up",0.354489161783281,0.581421114061039,"L.LvsV.PID_AURORA_B_PATHWAY"
50,"Down",0.3546200978407,0.58146338106798,"L.LvsV.BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_DN"
1381,"Down",0.354940981036472,0.58167236202253,"L.LvsV.BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_TRANS"
103,"Up",0.354957957942488,0.58167236202253,"L.LvsV.BILD_SRC_ONCOGENIC_SIGNATURE"
98,"Up",0.355364715082937,0.582113519244127,"L.LvsV.LIANG_SILENCED_BY_METHYLATION_UP"
21,"Up",0.355437735751162,0.582113519244127,"L.LvsV.KYNG_NORMAL_AGING_UP"
7,"Down",0.356227378498734,0.583233987479864,"L.LvsV.JU_AGING_TERC_TARGETS_UP"
324,"Up",0.356851111261717,0.584039646857679,"L.LvsV.GRUETZMANN_PANCREATIC_CANCER_DN"
45,"Down",0.356930722867082,0.584039646857679,"L.LvsV.REACTOME_NS1_MEDIATED_EFFECTS_ON_HOST_PATHWAYS"
5,"Up",0.357059579947514,0.584077638322427,"L.LvsV.REACTOME_LEUKOTRIENE_RECEPTORS"
252,"Down",0.357378456740601,0.584426349399226,"L.LvsV.REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS"
337,"Up",0.357493079835379,0.584440933888175,"L.LvsV.MCBRYAN_PUBERTAL_BREAST_6_7WK_UP"
150,"Up",0.357935069645615,0.584990540960864,"L.LvsV.BURTON_ADIPOGENESIS_PEAK_AT_0HR"
57,"Up",0.358542775736782,0.585810581279156,"L.LvsV.WAKASUGI_HAVE_ZNF143_BINDING_SITES"
27,"Down",0.358959067906745,0.586317484920648,"L.LvsV.BIOCARTA_BCELLSURVIVAL_PATHWAY"
684,"Up",0.359476227640861,0.586908913936472,"L.LvsV.KIM_WT1_TARGETS_DN"
411,"Down",0.35953345840167,0.586908913936472,"L.LvsV.GRADE_COLON_AND_RECTAL_CANCER_UP"
14,"Down",0.359954924971352,0.587423488833119,"L.LvsV.BIOCARTA_CTBP1_PATHWAY"
32,"Up",0.360714102563417,0.588468739732869,"L.LvsV.REACTOME_G1_S_SPECIFIC_TRANSCRIPTION"
492,"Down",0.360808288604526,0.588468739732869,"L.LvsV.WANG_MLL_TARGETS"
48,"Down",0.361011727727141,0.588626907284979,"L.LvsV.BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_DN"
30,"Down",0.361283402994603,0.588889805002628,"L.LvsV.REACTOME_ATF4_ACTIVATES_GENES_IN_RESPONSE_TO_ENDOPLASMIC_RETICULUM_STRESS"
20,"Down",0.361385984513278,0.588889805002628,"L.LvsV.BARRIER_CANCER_RELAPSE_TUMOR_SAMPLE_UP"
22,"Up",0.361832783876462,0.589314159588258,"L.LvsV.LE_NEURONAL_DIFFERENTIATION_DN"
29,"Down",0.361874978436004,0.589314159588258,"L.LvsV.REACTOME_G_PROTEIN_ACTIVATION"
102,"Up",0.36196615770695,0.589314159588258,"L.LvsV.REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION"
11,"Down",0.362159512175815,0.589455384992664,"L.LvsV.REACTOME_ARYL_HYDROCARBON_RECEPTOR_SIGNALLING"
32,"Down",0.362372665522674,0.589628742694193,"L.LvsV.REACTOME_SIGNALING_BY_ERYTHROPOIETIN"
99,"Up",0.362544437179575,0.589734684661921,"L.LvsV.LY_AGING_OLD_DN"
63,"Down",0.362748731607416,0.589785042267249,"L.LvsV.BOYAULT_LIVER_CANCER_SUBCLASS_G123_UP"
5,"Up",0.362788737339648,0.589785042267249,"L.LvsV.REACTOME_G2_PHASE"
18,"Down",0.363293057399595,0.590431309336379,"L.LvsV.CHIN_BREAST_CANCER_COPY_NUMBER_DN"
454,"Down",0.36377711223213,0.59089849695186,"L.LvsV.KONDO_EZH2_TARGETS"
12,"Down",0.363794263632507,0.59089849695186,"L.LvsV.REACTOME_PREGNENOLONE_BIOSYNTHESIS"
233,"Up",0.364269736890702,0.591026913014416,"L.LvsV.REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES"
58,"Down",0.364273076241081,0.591026913014416,"L.LvsV.TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_DN"
1217,"Up",0.364295630072945,0.591026913014416,"L.LvsV.FISCHER_DREAM_TARGETS"
24,"Down",0.36430090785913,0.591026913014416,"L.LvsV.SU_THYMUS"
30,"Down",0.364466378772857,0.591121915000036,"L.LvsV.KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_UP"
82,"Down",0.364784769475021,0.591464806576947,"L.LvsV.TUOMISTO_TUMOR_SUPPRESSION_BY_COL13A1_UP"
746,"Down",0.365100639807673,0.591803411755094,"L.LvsV.MITSIADES_RESPONSE_TO_APLIDIN_UP"
191,"Down",0.365272437121167,0.591908354291597,"L.LvsV.SESTO_RESPONSE_TO_UV_C0"
214,"Up",0.365382131496053,0.591912629663544,"L.LvsV.REACTOME_ROLE_OF_PHOSPHOLIPIDS_IN_PHAGOCYTOSIS"
36,"Up",0.365820283651536,0.592448842504201,"L.LvsV.GROSS_HIF1A_TARGETS_DN"
94,"Down",0.366077651903513,0.592692046083316,"L.LvsV.MCDOWELL_ACUTE_LUNG_INJURY_UP"
47,"Down",0.366343690867203,0.59294914133629,"L.LvsV.REACTOME_LAMININ_INTERACTIONS"
69,"Down",0.366560371184023,0.59312621957169,"L.LvsV.REACTOME_REGULATION_OF_PTEN_GENE_TRANSCRIPTION"
150,"Down",0.36702950591488,0.59358567042735,"L.LvsV.TANAKA_METHYLATED_IN_ESOPHAGEAL_CARCINOMA"
102,"Up",0.367059754156917,0.59358567042735,"L.LvsV.REACTOME_PLASMA_LIPOPROTEIN_ASSEMBLY_REMODELING_AND_CLEARANCE"
232,"Down",0.367166394078773,0.59358567042735,"L.LvsV.SMITH_TERT_TARGETS_UP"
11,"Up",0.367926854992078,0.594641210538205,"L.LvsV.REACTOME_REMOVAL_OF_THE_FLAP_INTERMEDIATE_FROM_THE_C_STRAND"
37,"Down",0.368164744541323,0.594851803789882,"L.LvsV.BIOCARTA_IL2_PATHWAY"
47,"Down",0.368787833783379,0.595684467714959,"L.LvsV.VALK_AML_CLUSTER_12"
109,"Down",0.369384368017538,0.596354501915658,"L.LvsV.REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS"
9,"Up",0.369443954450385,0.596354501915658,"L.LvsV.KIM_GLIS2_TARGETS_DN"
317,"Down",0.369526229618926,0.596354501915658,"L.LvsV.TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP"
15,"Down",0.369859105553094,0.596503019917147,"L.LvsV.YAMANAKA_GLIOBLASTOMA_SURVIVAL_UP"
316,"Down",0.369874089616328,0.596503019917147,"L.LvsV.MOHANKUMAR_HOXA1_TARGETS_DN"
42,"Down",0.369991136518575,0.596503019917147,"L.LvsV.REACTOME_BIOSYNTHESIS_OF_MARESINS"
23,"Down",0.37004980255305,0.596503019917147,"L.LvsV.FREDERICK_PRKCI_TARGETS"
19,"Down",0.370299832686609,0.596732082461166,"L.LvsV.REACTOME_TRANSPORT_OF_ORGANIC_ANIONS"
67,"Down",0.370593838785437,0.597031857413951,"L.LvsV.REACTOME_NEUROTRANSMITTER_RELEASE_CYCLE"
204,"Up",0.371130465308359,0.597708783665719,"L.LvsV.CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_DN"
39,"Down",0.371230233877388,0.597708783665719,"L.LvsV.REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS"
59,"Down",0.372500367170209,0.599238695581463,"L.LvsV.REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES"
9,"Down",0.372519070278117,0.599238695581463,"L.LvsV.BIOCARTA_HBX_PATHWAY"
152,"Up",0.372538660088155,0.599238695581463,"L.LvsV.LIAN_LIPA_TARGETS_6M"
17,"Down",0.372874736398198,0.599238695581463,"L.LvsV.REACTOME_INTERLEUKIN_2_SIGNALING"
59,"Down",0.372900612695416,0.599238695581463,"L.LvsV.PID_HDAC_CLASSIII_PATHWAY"
35,"Up",0.372918583433748,0.599238695581463,"L.LvsV.MARKS_HDAC_TARGETS_UP"
116,"Up",0.372939112225685,0.599238695581463,"L.LvsV.RASHI_RESPONSE_TO_IONIZING_RADIATION_4"
8,"Up",0.373190864624972,0.599328475936828,"L.LvsV.ELVIDGE_HIF2A_TARGETS_UP"
10,"Down",0.373340674606906,0.599328475936828,"L.LvsV.TESAR_ALK_TARGETS_EPISC_4D_UP"
30,"Down",0.373389228877294,0.599328475936828,"L.LvsV.REACTOME_DARPP_32_EVENTS"
16,"Down",0.37350402120522,0.599328475936828,"L.LvsV.REACTOME_ERYTHROPOIETIN_ACTIVATES_PHOSPHOINOSITIDE_3_KINASE_PI3K"
10,"Down",0.373536973788806,0.599328475936828,"L.LvsV.REACTOME_SYNTHESIS_OF_12_EICOSATETRAENOIC_ACID_DERIVATIVES"
31,"Up",0.373654137801307,0.59934253783099,"L.LvsV.SA_CASPASE_CASCADE"
110,"Down",0.37381828020831,0.599431923222665,"L.LvsV.TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_UP"
413,"Down",0.374072625595986,0.599665858776516,"L.LvsV.AFFAR_YY1_TARGETS_UP"
173,"Down",0.374247409349559,0.599772152548902,"L.LvsV.BROWN_MYELOID_CELL_DEVELOPMENT_DN"
109,"Down",0.374670278532732,0.600182442113163,"L.LvsV.PARK_APL_PATHOGENESIS_DN"
33,"Up",0.374721216207724,0.600182442113163,"L.LvsV.KIM_HYPOXIA"
19,"Down",0.374892883632253,0.600182442113163,"L.LvsV.KIM_MYCL1_AMPLIFICATION_TARGETS_UP"
12,"Down",0.374937629780949,0.600182442113163,"L.LvsV.REACTOME_PASSIVE_TRANSPORT_BY_AQUAPORINS"
14,"Up",0.375388267864424,0.600729879311837,"L.LvsV.REACTOME_POLYMERASE_SWITCHING"
20,"Up",0.37552655967868,0.60077729990261,"L.LvsV.SU_SALIVARY_GLAND"
137,"Down",0.375810710769433,0.601057975077869,"L.LvsV.BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_C"
89,"Down",0.376020033938816,0.601218845473601,"L.LvsV.CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_UP"
77,"Up",0.376421429509495,0.601686638843018,"L.LvsV.REACTOME_PKMTS_METHYLATE_HISTONE_LYSINES"
37,"Down",0.376633519213924,0.601761144102866,"L.LvsV.KEGG_HISTIDINE_METABOLISM"
23,"Up",0.376685715272205,0.601761144102866,"L.LvsV.REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI"
782,"Down",0.376885332211277,0.601831442981523,"L.LvsV.BONOME_OVARIAN_CANCER_SURVIVAL_SUBOPTIMAL_DEBULKING"
15,"Up",0.376984227212374,0.601831442981523,"L.LvsV.REACTOME_MISMATCH_REPAIR"
402,"Down",0.377056270299872,0.601831442981523,"L.LvsV.REACTOME_SIGNALING_BY_WNT"
379,"Down",0.378171963353258,0.603438033298749,"L.LvsV.PHONG_TNF_RESPONSE_VIA_P38_COMPLETE"
23,"Down",0.378431279800122,0.603677595503425,"L.LvsV.CHEN_HOXA5_TARGETS_6HR_UP"
49,"Up",0.378718483198234,0.603694414895387,"L.LvsV.NIKOLSKY_BREAST_CANCER_1Q21_AMPLICON"
48,"Down",0.378748374121143,0.603694414895387,"L.LvsV.REACTOME_VIRAL_MESSENGER_RNA_SYNTHESIS"
208,"Down",0.37876938420548,0.603694414895387,"L.LvsV.PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN"
10,"Up",0.379067172894391,0.603750045649507,"L.LvsV.BIOCARTA_FLUMAZENIL_PATHWAY"
12,"Down",0.379165823591342,0.603750045649507,"L.LvsV.REACTOME_MYOCLONIC_EPILEPSY_OF_LAFORA"
14,"Down",0.379179844294894,0.603750045649507,"L.LvsV.BIOCARTA_RARRXR_PATHWAY"
12,"Down",0.379330697104693,0.603750045649507,"L.LvsV.NAGY_STAGA_COMPONENTS_HUMAN"
35,"Down",0.379350272849772,0.603750045649507,"L.LvsV.SHARMA_PILOCYTIC_ASTROCYTOMA_LOCATION_UP"
168,"Down",0.379536565298113,0.603872710657055,"L.LvsV.KIM_GASTRIC_CANCER_CHEMOSENSITIVITY"
99,"Up",0.37985532960314,0.604206017657009,"L.LvsV.APPIERTO_RESPONSE_TO_FENRETINIDE_DN"
101,"Down",0.380211354876413,0.604536259942201,"L.LvsV.XU_GH1_EXOGENOUS_TARGETS_UP"
173,"Down",0.380369167547052,0.604536259942201,"L.LvsV.RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_UP"
16,"Up",0.380390965516172,0.604536259942201,"L.LvsV.REACTOME_REGULATION_OF_COMMISSURAL_AXON_PATHFINDING_BY_SLIT_AND_ROBO"
100,"Up",0.380885205855063,0.605147788268001,"L.LvsV.LEE_LIVER_CANCER_MYC_TGFA_DN"
76,"Down",0.381289102272015,0.605559512896628,"L.LvsV.PID_KIT_PATHWAY"
21,"Up",0.381363397342387,0.605559512896628,"L.LvsV.REACTOME_TRANSLESION_SYNTHESIS_BY_POLH"
415,"Down",0.381517957869219,0.605631004610656,"L.LvsV.REACTOME_RHO_GTPASE_EFFECTORS"
148,"Down",0.381830779732194,0.605787169673285,"L.LvsV.REACTOME_INTERFERON_GAMMA_SIGNALING"
313,"Down",0.381835465059034,0.605787169673285,"L.LvsV.BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_DN"
142,"Down",0.382027548842582,0.605918048637589,"L.LvsV.REACTOME_VISUAL_PHOTOTRANSDUCTION"
261,"Up",0.38232001531613,0.606208019696841,"L.LvsV.KAUFFMANN_DNA_REPAIR_GENES"
26,"Up",0.382603053740734,0.606482879625148,"L.LvsV.FERRANDO_HOX11_NEIGHBORS"
316,"Down",0.382907977836597,0.606708147917403,"L.LvsV.SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN"
981,"Down",0.382964629450486,0.606708147917403,"L.LvsV.BROWNE_HCMV_INFECTION_48HR_DN"
112,"Down",0.383199842179696,0.606906882673027,"L.LvsV.LEE_LIVER_CANCER_CIPROFIBRATE_DN"
166,"Up",0.383783126035297,0.607656616222553,"L.LvsV.LIU_PROSTATE_CANCER_UP"
15,"Down",0.384402787596503,0.608450393332908,"L.LvsV.GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_1_DN"
1203,"Down",0.384504553138937,0.608450393332908,"L.LvsV.MIKKELSEN_ES_ICP_WITH_H3K4ME3"
15,"Down",0.385053189478565,0.609144230222313,"L.LvsV.PARK_OSTEOBLAST_DIFFERENTIATION_BY_PHENYLAMIL_DN"
48,"Up",0.385452981035266,0.609602268919905,"L.LvsV.LOPEZ_MBD_TARGETS_IMPRINTED_AND_X_LINKED"
260,"Down",0.385681333501997,0.609788988542333,"L.LvsV.INGRAM_SHH_TARGETS_UP"
120,"Down",0.385844031745683,0.60987182719322,"L.LvsV.SESTO_RESPONSE_TO_UV_C1"
154,"Up",0.386138959665034,0.610163563300364,"L.LvsV.ANDERSEN_LIVER_CANCER_KRT19_DN"
28,"Down",0.386367648769908,0.610349286130784,"L.LvsV.PID_CONE_PATHWAY"
54,"Down",0.386477274506036,0.610349286130784,"L.LvsV.AIYAR_COBRA1_TARGETS_DN"
33,"Up",0.386616833938148,0.610395338333529,"L.LvsV.HOEGERKORP_CD44_TARGETS_TEMPORAL_DN"
106,"Up",0.387065126016855,0.610808711321893,"L.LvsV.PID_HIF1_TFPATHWAY"
36,"Down",0.38709960652413,0.610808711321893,"L.LvsV.KONDO_COLON_CANCER_HCP_WITH_H3K27ME1"
68,"Down",0.387536750889401,0.611036581799442,"L.LvsV.CASORELLI_APL_SECONDARY_VS_DE_NOVO_UP"
21,"Down",0.387556024852565,0.611036581799442,"L.LvsV.JOHANSSON_BRAIN_CANCER_EARLY_VS_LATE_UP"
13,"Up",0.387575563821784,0.611036581799442,"L.LvsV.BIOCARTA_EIF2_PATHWAY"
110,"Up",0.387720096242063,0.61109019729828,"L.LvsV.STEARMAN_LUNG_CANCER_EARLY_VS_LATE_DN"
13,"Down",0.387857083288552,0.611106327454959,"L.LvsV.FUNG_IL2_SIGNALING_1"
13,"Down",0.388077414743633,0.611106327454959,"L.LvsV.GERHOLD_RESPONSE_TO_TZD_DN"
72,"Down",0.388078420579074,0.611106327454959,"L.LvsV.JIANG_TIP30_TARGETS_UP"
82,"Up",0.388172440228218,0.611106327454959,"L.LvsV.KEGG_GLYCEROPHOSPHOLIPID_METABOLISM"
185,"Up",0.388528559586831,0.61139012068195,"L.LvsV.SMIRNOV_RESPONSE_TO_IR_6HR_DN"
112,"Down",0.388573862195039,0.61139012068195,"L.LvsV.BOYAULT_LIVER_CANCER_SUBCLASS_G6_UP"
20,"Up",0.388687505139012,0.61139494051596,"L.LvsV.ZHOU_PANCREATIC_ENDOCRINE_PROGENITOR"
23,"Down",0.38881826452344,0.611411681057738,"L.LvsV.WU_HBX_TARGETS_2_DN"
94,"Up",0.388919313127159,0.611411681057738,"L.LvsV.ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_UP"
132,"Up",0.389572436531333,0.612264355196629,"L.LvsV.BOSCO_INTERFERON_INDUCED_ANTIVIRAL_MODULE"
246,"Down",0.38973616614531,0.61234761654374,"L.LvsV.SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_UP"
19,"Down",0.390039017316444,0.612649354188245,"L.LvsV.REACTOME_PROLONGED_ERK_ACTIVATION_EVENTS"
238,"Up",0.390183755257334,0.612702636415166,"L.LvsV.WHITFIELD_CELL_CYCLE_G2"
178,"Down",0.390601484530294,0.613184442921067,"L.LvsV.LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_DN"
6,"Up",0.391222439026101,0.613853433372154,"L.LvsV.REACTOME_RELEASE_OF_APOPTOTIC_FACTORS_FROM_THE_MITOCHONDRIA"
45,"Down",0.391261388769703,0.613853433372154,"L.LvsV.LOPES_METHYLATED_IN_COLON_CANCER_UP"
46,"Down",0.391360707657234,0.613853433372154,"L.LvsV.PARK_TRETINOIN_RESPONSE_AND_PML_RARA_FUSION"
10,"Down",0.392230191412903,0.614900276782851,"L.LvsV.BIOCARTA_MSP_PATHWAY"
201,"Down",0.39225054733462,0.614900276782851,"L.LvsV.WIERENGA_STAT5A_TARGETS_GROUP1"
575,"Down",0.392851318288485,0.615667499664692,"L.LvsV.SHEN_SMARCA2_TARGETS_DN"
886,"Down",0.393052362136309,0.615737266173968,"L.LvsV.FEVR_CTNNB1_TARGETS_DN"
17,"Up",0.393118565670846,0.615737266173968,"L.LvsV.REACTOME_ANDROGEN_BIOSYNTHESIS"
95,"Up",0.393722280776489,0.616508210255793,"L.LvsV.FAELT_B_CLL_WITH_VH_REARRANGEMENTS_DN"
145,"Up",0.394069808982196,0.616877682294043,"L.LvsV.MORI_PRE_BI_LYMPHOCYTE_DN"
29,"Down",0.394669851285691,0.617552392470591,"L.LvsV.LEI_HOXC8_TARGETS_UP"
9,"Up",0.394724209620378,0.617552392470591,"L.LvsV.REACTOME_TERMINAL_PATHWAY_OF_COMPLEMENT"
36,"Down",0.395304002521901,0.618271900660568,"L.LvsV.BIOCARTA_TNFR1_PATHWAY"
43,"Down",0.395407748369645,0.618271900660568,"L.LvsV.BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_UP"
107,"Up",0.396203640761337,0.619341229790623,"L.LvsV.SCIBETTA_KDM5B_TARGETS_DN"
47,"Up",0.396343985958169,0.619385499819874,"L.LvsV.KEGG_PRIMARY_IMMUNODEFICIENCY"
523,"Down",0.396518858316714,0.619483686813538,"L.LvsV.FISCHER_DIRECT_P53_TARGETS_META_ANALYSIS"
389,"Up",0.396693765086795,0.619581872080477,"L.LvsV.GAL_LEUKEMIC_STEM_CELL_DN"
100,"Down",0.39763228564097,0.620872326266287,"L.LvsV.PID_MYC_REPRESS_PATHWAY"
13,"Down",0.398310420524251,0.621755594319194,"L.LvsV.REACTOME_MASTL_FACILITATES_MITOTIC_PROGRESSION"
87,"Down",0.398516769814285,0.621902122580632,"L.LvsV.WESTON_VEGFA_TARGETS_6HR"
8,"Down",0.398677455001103,0.621977327511596,"L.LvsV.CHENG_TAF7L_TARGETS"
56,"Down",0.399039695321075,0.622067500440626,"L.LvsV.TSENG_ADIPOGENIC_POTENTIAL_UP"
10,"Up",0.399185114929363,0.622067500440626,"L.LvsV.KAPOSI_LIVER_CANCER_MET_DN"
488,"Down",0.399216578641115,0.622067500440626,"L.LvsV.BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_D"
93,"Down",0.399220094444979,0.622067500440626,"L.LvsV.DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_UP"
159,"Down",0.399435714071312,0.622067500440626,"L.LvsV.TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_DN"
35,"Down",0.399470629048451,0.622067500440626,"L.LvsV.MOROSETTI_FACIOSCAPULOHUMERAL_MUSCULAR_DISTROPHY_UP"
1485,"Down",0.399588187988263,0.622067500440626,"L.LvsV.NUYTTEN_EZH2_TARGETS_UP"
31,"Down",0.399635333978134,0.622067500440626,"L.LvsV.MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_DN"
148,"Up",0.399783483097401,0.622122960328041,"L.LvsV.GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_DN"
307,"Down",0.40006201314807,0.622381224168734,"L.LvsV.CAIRO_HEPATOBLASTOMA_UP"
206,"Down",0.40075478067972,0.623283595605674,"L.LvsV.LIU_VMYB_TARGETS_UP"
780,"Up",0.400913933304133,0.623340024497887,"L.LvsV.REACTOME_OLFACTORY_SIGNALING_PATHWAY"
153,"Down",0.401016543161328,0.623340024497887,"L.LvsV.XU_CREBBP_TARGETS_DN"
75,"Down",0.401202273548009,0.623453448692226,"L.LvsV.LIU_TARGETS_OF_VMYB_VS_CMYB_DN"
37,"Down",0.401496345995429,0.623735121384862,"L.LvsV.REACTOME_HEME_DEGRADATION"
14,"Down",0.401643338033201,0.623788206737518,"L.LvsV.REACTOME_CS_DS_DEGRADATION"
91,"Up",0.403333472150197,0.626237227609783,"L.LvsV.FARMER_BREAST_CANCER_CLUSTER_1"
27,"Down",0.403909028408576,0.626851418500252,"L.LvsV.REACTOME_SIGNALING_BY_NTRK3_TRKC"
232,"Up",0.403955797452776,0.626851418500252,"L.LvsV.DER_IFN_GAMMA_RESPONSE_UP"
9,"Down",0.40419081620457,0.627019355681147,"L.LvsV.TESAR_ALK_AND_JAK_TARGETS_MOUSE_ES_D4_UP"
1184,"Up",0.404363443689723,0.627019355681147,"L.LvsV.LEE_BMP2_TARGETS_DN"
12,"Up",0.404404236274004,0.627019355681147,"L.LvsV.REACTOME_ACTIVATED_NTRK3_SIGNALS_THROUGH_PI3K"
140,"Down",0.405019741543181,0.627797631340693,"L.LvsV.WARTERS_RESPONSE_TO_IR_SKIN"
26,"Down",0.405346860447044,0.628128585036914,"L.LvsV.REACTOME_A_TETRASACCHARIDE_LINKER_SEQUENCE_IS_REQUIRED_FOR_GAG_SYNTHESIS"
34,"Down",0.406478299394282,0.629705384519749,"L.LvsV.PID_TCR_CALCIUM_PATHWAY"
120,"Up",0.407128130873195,0.630364421051145,"L.LvsV.REACTOME_UCH_PROTEINASES"
59,"Down",0.407131732243378,0.630364421051145,"L.LvsV.GYORFFY_MITOXANTRONE_RESISTANCE"
54,"Down",0.40769395306457,0.630860491821724,"L.LvsV.REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY"
12,"Up",0.407789262581809,0.630860491821724,"L.LvsV.REACTOME_REVERSIBLE_HYDRATION_OF_CARBON_DIOXIDE"
9,"Down",0.407794428969225,0.630860491821724,"L.LvsV.HE_PTEN_TARGETS_DN"
30,"Down",0.408199584755044,0.631126302271038,"L.LvsV.STREICHER_LSM1_TARGETS_DN"
46,"Up",0.408260118326895,0.631126302271038,"L.LvsV.SCHLOSSER_MYC_AND_SERUM_RESPONSE_SYNERGY"
207,"Up",0.408308696549738,0.631126302271038,"L.LvsV.GOLDRATH_HOMEOSTATIC_PROLIFERATION"
25,"Down",0.408610344821443,0.631416041508596,"L.LvsV.BIOCARTA_ERK5_PATHWAY"
14,"Up",0.408830806634048,0.631475859906569,"L.LvsV.REACTOME_REGULATION_BY_C_FLIP"
14,"Down",0.408890255812399,0.631475859906569,"L.LvsV.REACTOME_LYSOSPHINGOLIPID_AND_LPA_RECEPTORS"
400,"Down",0.409059915579921,0.631475859906569,"L.LvsV.ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN"
27,"Down",0.409105901643214,0.631475859906569,"L.LvsV.BIOCARTA_CERAMIDE_PATHWAY"
42,"Down",0.409464485153011,0.631684847828723,"L.LvsV.SUZUKI_RESPONSE_TO_TSA_AND_DECITABINE_1A"
25,"Down",0.409531392144612,0.631684847828723,"L.LvsV.BIOCARTA_IFNA_PATHWAY"
20,"Down",0.409584044034359,0.631684847828723,"L.LvsV.BIOCARTA_HSP27_PATHWAY"
20,"Down",0.410446780612358,0.632838887341251,"L.LvsV.BIOCARTA_TALL1_PATHWAY"
117,"Up",0.410567920091769,0.632849186001502,"L.LvsV.KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION"
18,"Up",0.41080107266103,0.633032087720968,"L.LvsV.LOPEZ_MESOTHELIOMA_SURVIVAL_OVERALL_UP"
41,"Up",0.411045070627116,0.633216961474476,"L.LvsV.REACTOME_INFECTION_WITH_MYCOBACTERIUM_TUBERCULOSIS"
632,"Down",0.411274187840462,0.633216961474476,"L.LvsV.ZHOU_INFLAMMATORY_RESPONSE_LIVE_DN"
149,"Up",0.411349414680002,0.633216961474476,"L.LvsV.ZHONG_SECRETOME_OF_LUNG_CANCER_AND_MACROPHAGE"
28,"Down",0.41137915095249,0.633216961474476,"L.LvsV.HOLLERN_MICROACINAR_BREAST_TUMOR_DN"
36,"Down",0.411543596410996,0.633293778056332,"L.LvsV.UROSEVIC_RESPONSE_TO_IMIQUIMOD"
402,"Up",0.411868832783334,0.633617912203409,"L.LvsV.WANG_CISPLATIN_RESPONSE_AND_XPC_UP"
5,"Down",0.41208392795765,0.633772472233058,"L.LvsV.REACTOME_ARACHIDONATE_PRODUCTION_FROM_DAG"
343,"Down",0.412294819659998,0.633920483287021,"L.LvsV.YEGNASUBRAMANIAN_PROSTATE_CANCER"
17,"Down",0.412682738686925,0.634340523269393,"L.LvsV.REACTOME_RETINOID_CYCLE_DISEASE_EVENTS"
13,"Up",0.413174685494017,0.634707943167626,"L.LvsV.BIOCARTA_GHRELIN_PATHWAY"
24,"Down",0.413245374285967,0.634707943167626,"L.LvsV.LOPEZ_MESOTELIOMA_SURVIVAL_TIME_UP"
14,"Up",0.413266159414624,0.634707943167626,"L.LvsV.REACTOME_ETHANOL_OXIDATION"
107,"Up",0.413490036092902,0.634875426147642,"L.LvsV.YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_7"
5,"Down",0.413768142308117,0.634979691690758,"L.LvsV.REACTOME_MRNA_EDITING_C_TO_U_CONVERSION"
14,"Down",0.413787634140315,0.634979691690758,"L.LvsV.REACTOME_CROSS_PRESENTATION_OF_PARTICULATE_EXOGENOUS_ANTIGENS_PHAGOSOMES"
16,"Down",0.414802242476656,0.636360044021485,"L.LvsV.REACTOME_ERYTHROCYTES_TAKE_UP_OXYGEN_AND_RELEASE_CARBON_DIOXIDE"
105,"Down",0.416699709990711,0.639093674490608,"L.LvsV.SESTO_RESPONSE_TO_UV_C7"
258,"Up",0.416904434862019,0.639230343968969,"L.LvsV.MADAN_DPPA4_TARGETS"
19,"Up",0.417222014510368,0.639333312652958,"L.LvsV.BIOCARTA_LONGEVITY_PATHWAY"
152,"Down",0.417268686887255,0.639333312652958,"L.LvsV.LEIN_MIDBRAIN_MARKERS"
119,"Down",0.417318488942761,0.639333312652958,"L.LvsV.LANDIS_BREAST_CANCER_PROGRESSION_DN"
68,"Up",0.417573492679884,0.639546770367612,"L.LvsV.REACTOME_SCF_SKP2_MEDIATED_DEGRADATION_OF_P27_P21"
794,"Down",0.417967260324371,0.639972578879382,"L.LvsV.PILON_KLF1_TARGETS_UP"
47,"Down",0.418143755364126,0.640065565727645,"L.LvsV.YAGI_AML_RELAPSE_PROGNOSIS"
41,"Down",0.41845112877955,0.640358785226164,"L.LvsV.ABE_VEGFA_TARGETS_30MIN"
17,"Up",0.418949762708182,0.640944448813929,"L.LvsV.REACTOME_RESPONSE_OF_EIF2AK1_HRI_TO_HEME_DEFICIENCY"
22,"Down",0.419271941528041,0.641259907249942,"L.LvsV.REACTOME_CASPASE_MEDIATED_CLEAVAGE_OF_CYTOSKELETAL_PROTEINS"
25,"Down",0.41967072238708,0.641692318605687,"L.LvsV.REACTOME_ACYL_CHAIN_REMODELLING_OF_PS"
103,"Up",0.420222610118012,0.64222136967751,"L.LvsV.MARTIN_VIRAL_GPCR_SIGNALING_DN"
85,"Down",0.420249035176927,0.64222136967751,"L.LvsV.GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN"
37,"Down",0.420752729837212,0.642813441080393,"L.LvsV.ONO_AML1_TARGETS_UP"
80,"Down",0.421117795839669,0.643137458618414,"L.LvsV.MODY_HIPPOCAMPUS_NEONATAL"
6,"Up",0.421197456620958,0.643137458618414,"L.LvsV.ZHAN_EARLY_DIFFERENTIATION_GENES_UP"
1236,"Down",0.421648876821878,0.643454224082072,"L.LvsV.NUYTTEN_NIPP1_TARGETS_DN"
19,"Up",0.421708274626329,0.643454224082072,"L.LvsV.REACTOME_ACTIVATION_OF_IRF3_IRF7_MEDIATED_BY_TBK1_IKK_EPSILON"
20,"Up",0.421754043782498,0.643454224082072,"L.LvsV.LI_CYTIDINE_ANALOG_PATHWAY"
145,"Up",0.42197121714786,0.643607961271867,"L.LvsV.YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_12"
36,"Down",0.422603641458305,0.644394796917531,"L.LvsV.REACTOME_THE_CANONICAL_RETINOID_CYCLE_IN_RODS_TWILIGHT_VISION"
9,"Up",0.422886059890138,0.644647649609201,"L.LvsV.REACTOME_ABACAVIR_TRANSMEMBRANE_TRANSPORT"
30,"Down",0.423077714156011,0.644762040123646,"L.LvsV.SUZUKI_RESPONSE_TO_TSA_AND_DECITABINE_1B"
11,"Down",0.423332451146978,0.6449724779255,"L.LvsV.BIOCARTA_SALMONELLA_PATHWAY"
30,"Down",0.423679476864726,0.645139968568265,"L.LvsV.LUI_THYROID_CANCER_CLUSTER_5"
11,"Up",0.423742350198417,0.645139968568265,"L.LvsV.REACTOME_ERYTHROPOIETIN_ACTIVATES_STAT5"
18,"Down",0.424055311959747,0.645139968568265,"L.LvsV.ROZANOV_MMP14_CORRELATED"
9,"Up",0.42406618877824,0.645139968568265,"L.LvsV.REACTOME_LECTIN_PATHWAY_OF_COMPLEMENT_ACTIVATION"
29,"Down",0.42410651508214,0.645139968568265,"L.LvsV.KEGG_PHENYLALANINE_METABOLISM"
168,"Up",0.424142482500568,0.645139968568265,"L.LvsV.NAKAMURA_ADIPOGENESIS_LATE_UP"
78,"Down",0.424427105407026,0.645395342628011,"L.LvsV.OSADA_ASCL1_TARGETS_UP"
16,"Up",0.424787194764951,0.6456166961834,"L.LvsV.REACTOME_TICAM1_DEPENDENT_ACTIVATION_OF_IRF3_IRF7"
153,"Down",0.424806211017401,0.6456166961834,"L.LvsV.CASTELLANO_NRAS_TARGETS_UP"
12,"Down",0.425254302252079,0.646120098145574,"L.LvsV.REACTOME_ACTIVATION_OF_PPARGC1A_PGC_1ALPHA_BY_PHOSPHORYLATION"
20,"Up",0.425419489544203,0.646193504859862,"L.LvsV.FERRANDO_LYL1_NEIGHBORS"
71,"Up",0.426089997680285,0.647034220591677,"L.LvsV.BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_UP"
50,"Down",0.42622911994967,0.647067766117991,"L.LvsV.DASU_IL6_SIGNALING_SCAR_UP"
92,"Down",0.426707528533161,0.647616229827024,"L.LvsV.KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP"
194,"Down",0.426879876625059,0.647700010389668,"L.LvsV.ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_UP"
92,"Up",0.427215978007298,0.648032137833293,"L.LvsV.LEE_LIVER_CANCER_CIPROFIBRATE_UP"
11,"Up",0.427533199591183,0.648263173565473,"L.LvsV.KIM_RESPONSE_TO_TSA_AND_DECITABINE_DN"
34,"Down",0.427730150129348,0.648263173565473,"L.LvsV.BIOCARTA_SPPA_PATHWAY"
63,"Down",0.42788524961429,0.648263173565473,"L.LvsV.REACTOME_G_PROTEIN_MEDIATED_EVENTS"
13,"Down",0.428007009788923,0.648263173565473,"L.LvsV.REACTOME_INTERLEUKIN_35_SIGNALLING"
56,"Down",0.428153210556802,0.648263173565473,"L.LvsV.SIG_PIP3_SIGNALING_IN_B_LYMPHOCYTES"
36,"Down",0.42817922083306,0.648263173565473,"L.LvsV.PID_P38_MKK3_6PATHWAY"
184,"Down",0.428189023306404,0.648263173565473,"L.LvsV.REACTOME_PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS"
87,"Down",0.428400950017788,0.648406474855831,"L.LvsV.GOLDRATH_IMMUNE_MEMORY"
16,"Up",0.428599212887261,0.648463632982817,"L.LvsV.REACTOME_CLEC7A_DECTIN_1_INDUCES_NFAT_ACTIVATION"
110,"Up",0.428673282429408,0.648463632982817,"L.LvsV.MATZUK_MEIOTIC_AND_DNA_REPAIR"
1397,"Up",0.428933257550369,0.648679425874176,"L.LvsV.ACEVEDO_LIVER_CANCER_UP"
111,"Down",0.429738655709774,0.649585216260215,"L.LvsV.FONTAINE_FOLLICULAR_THYROID_ADENOMA_DN"
421,"Down",0.429767176899958,0.649585216260215,"L.LvsV.FORTSCHEGGER_PHF8_TARGETS_UP"
611,"Down",0.429985069906454,0.649736936734841,"L.LvsV.REN_ALVEOLAR_RHABDOMYOSARCOMA_DN"
121,"Up",0.430955357330613,0.651025183246164,"L.LvsV.LIAN_LIPA_TARGETS_3M"
15,"Down",0.431277583081106,0.651333995316972,"L.LvsV.MIKKELSEN_PLURIPOTENT_STATE_DN"
31,"Down",0.431569766363962,0.65147302242118,"L.LvsV.SASAI_TARGETS_OF_CXCR6_AND_PTCH1_UP"
80,"Down",0.431605295917667,0.65147302242118,"L.LvsV.HEIDENBLAD_AMPLIFIED_IN_PANCREATIC_CANCER"
43,"Down",0.431914764249101,0.651636638907988,"L.LvsV.WENDT_COHESIN_TARGETS_UP"
6,"Up",0.432056072059208,0.651636638907988,"L.LvsV.REACTOME_TRAFFICKING_OF_MYRISTOYLATED_PROTEINS_TO_THE_CILIUM"
67,"Down",0.432067266817993,0.651636638907988,"L.LvsV.LEONARD_HYPOXIA"
83,"Up",0.432212430733484,0.651638160899861,"L.LvsV.CHENG_RESPONSE_TO_NICKEL_ACETATE"
15,"Up",0.432491006291442,0.651638160899861,"L.LvsV.RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_SMAD4_DN"
26,"Down",0.432523321565374,0.651638160899861,"L.LvsV.BIOCARTA_PTEN_PATHWAY"
24,"Up",0.432565703936846,0.651638160899861,"L.LvsV.REACTOME_SIGNALING_BY_NODAL"
303,"Down",0.432756765160623,0.651638160899861,"L.LvsV.REACTOME_CHROMATIN_MODIFYING_ENZYMES"
45,"Down",0.432873386939378,0.651638160899861,"L.LvsV.PID_REELIN_PATHWAY"
32,"Down",0.432893283592908,0.651638160899861,"L.LvsV.PID_RHODOPSIN_PATHWAY"
48,"Down",0.433981509711129,0.652913595130199,"L.LvsV.PIEPOLI_LGI1_TARGETS_DN"
153,"Down",0.434066666791437,0.652913595130199,"L.LvsV.CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP"
78,"Down",0.434094840965565,0.652913595130199,"L.LvsV.PID_ERBB4_PATHWAY"
9,"Up",0.434328485701156,0.653087353125291,"L.LvsV.CASTELLANO_HRAS_TARGETS_UP"
88,"Down",0.434880377340616,0.653709845304511,"L.LvsV.GALE_APL_WITH_FLT3_MUTATED_UP"
15,"Up",0.434978933057569,0.653709845304511,"L.LvsV.BERGER_MBD2_TARGETS"
140,"Down",0.435113850096591,0.653734912278275,"L.LvsV.HECKER_IFNB1_TARGETS"
73,"Up",0.43525182300008,0.653764555655377,"L.LvsV.ENGELMANN_CANCER_PROGENITORS_UP"
29,"Down",0.435613000093046,0.654129352937113,"L.LvsV.PETROVA_PROX1_TARGETS_UP"
34,"Down",0.435897530750479,0.654243018035616,"L.LvsV.REACTOME_INSULIN_PROCESSING"
107,"Up",0.435925353308593,0.654243018035616,"L.LvsV.GAURNIER_PSMD4_TARGETS"
15,"Down",0.436456768073386,0.65470927435239,"L.LvsV.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_LIGHTYELLOW_UP"
33,"Up",0.43647284956826,0.65470927435239,"L.LvsV.REACTOME_PIWI_INTERACTING_RNA_PIRNA_BIOGENESIS"
66,"Down",0.436736754698653,0.654889861529815,"L.LvsV.CHEN_NEUROBLASTOMA_COPY_NUMBER_GAINS"
179,"Up",0.436831003085402,0.654889861529815,"L.LvsV.TSENG_IRS1_TARGETS_UP"
12,"Down",0.436948580065742,0.654889861529815,"L.LvsV.SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX2_DN"
7,"Up",0.437237198176917,0.655144842471592,"L.LvsV.GAVIN_IL2_RESPONSIVE_FOXP3_TARGETS_DN"
13,"Down",0.438518547316127,0.656886764592487,"L.LvsV.REACTOME_INTERLEUKIN_27_SIGNALING"
141,"Up",0.438762529685725,0.656909907763762,"L.LvsV.NELSON_RESPONSE_TO_ANDROGEN_UP"
60,"Up",0.438771620432551,0.656909907763762,"L.LvsV.APPEL_IMATINIB_RESPONSE"
16,"Up",0.439006008604439,0.657082897015144,"L.LvsV.BIOCARTA_RB_PATHWAY"
37,"Down",0.43941666085692,0.657519544757216,"L.LvsV.SINGH_NFE2L2_TARGETS"
465,"Up",0.439592698906246,0.657604987081341,"L.LvsV.HSIAO_LIVER_SPECIFIC_GENES"
45,"Down",0.439812566547483,0.657755931955919,"L.LvsV.SUMI_HNF4A_TARGETS"
87,"Up",0.440286565703823,0.658286755483082,"L.LvsV.BYSTROEM_CORRELATED_WITH_IL5_DN"
41,"Up",0.441210274818606,0.65948948620494,"L.LvsV.WU_ALZHEIMER_DISEASE_UP"
10,"Down",0.441611653619405,0.659911035908566,"L.LvsV.PID_VEGF_VEGFR_PATHWAY"
644,"Down",0.441949179566144,0.660236966717431,"L.LvsV.PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_UP"
201,"Down",0.442577762297031,0.660972783338048,"L.LvsV.STEIN_ESRRA_TARGETS_DN"
190,"Up",0.442680813293686,0.660972783338048,"L.LvsV.KOBAYASHI_EGFR_SIGNALING_24HR_UP"
36,"Down",0.443390033362028,0.661747492897141,"L.LvsV.GAVIN_PDE3B_TARGETS"
18,"Down",0.44357668443165,0.661747492897141,"L.LvsV.FRASOR_TAMOXIFEN_RESPONSE_DN"
52,"Down",0.443615719596938,0.661747492897141,"L.LvsV.REACTOME_CHONDROITIN_SULFATE_DERMATAN_SULFATE_METABOLISM"
151,"Down",0.44367841493393,0.661747492897141,"L.LvsV.MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_UP"
230,"Down",0.444175127524569,0.662309676397881,"L.LvsV.MILI_PSEUDOPODIA_CHEMOTAXIS_UP"
58,"Down",0.444817406987536,0.663088553042353,"L.LvsV.REACTOME_RECYCLING_PATHWAY_OF_L1"
47,"Down",0.446302081505184,0.665006348272839,"L.LvsV.REACTOME_TRNA_MODIFICATION_IN_THE_NUCLEUS_AND_CYTOSOL"
260,"Down",0.446344467071895,0.665006348272839,"L.LvsV.DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN"
60,"Down",0.44660721855872,0.665218564496541,"L.LvsV.LIN_MELANOMA_COPY_NUMBER_DN"
831,"Up",0.446807090904663,0.66533703356097,"L.LvsV.REACTOME_CELL_CYCLE"
22,"Down",0.447039225420062,0.665381841666433,"L.LvsV.MIKKELSEN_IPS_LCP_WITH_H3K27ME3"
18,"Down",0.447077869739699,0.665381841666433,"L.LvsV.BIOCARTA_MRP_PATHWAY"
55,"Down",0.447319684279725,0.665562576529225,"L.LvsV.WONG_ENDMETRIUM_CANCER_UP"
150,"Up",0.447509462704216,0.665665810947433,"L.LvsV.REACTOME_OXIDATIVE_STRESS_INDUCED_SENESCENCE"
663,"Down",0.44783736972077,0.665835999987952,"L.LvsV.BERENJENO_TRANSFORMED_BY_RHOA_DN"
72,"Down",0.447864728514233,0.665835999987952,"L.LvsV.VALK_AML_CLUSTER_11"
190,"Up",0.448051552337638,0.665934686256667,"L.LvsV.KIM_ALL_DISORDERS_DURATION_CORR_DN"
26,"Down",0.44860448766304,0.666326506721864,"L.LvsV.REACTOME_THROMBOXANE_SIGNALLING_THROUGH_TP_RECEPTOR"
16,"Down",0.448723375944505,0.666326506721864,"L.LvsV.REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_CELL_DEATH_GENES"
83,"Down",0.448812965084031,0.666326506721864,"L.LvsV.KEGG_EPITHELIAL_CELL_SIGNALING_IN_HELICOBACTER_PYLORI_INFECTION"
13,"Down",0.448815495961107,0.666326506721864,"L.LvsV.NAKAMURA_LUNG_CANCER_DIFFERENTIATION_MARKERS"
14,"Up",0.448955154688763,0.666326506721864,"L.LvsV.BARRIER_CANCER_RELAPSE_TUMOR_SAMPLE_DN"
37,"Down",0.449087057478532,0.666326506721864,"L.LvsV.BIOCARTA_CCR3_PATHWAY"
23,"Down",0.449158779264313,0.666326506721864,"L.LvsV.LY_AGING_MIDDLE_UP"
79,"Down",0.449297110920383,0.666352930868776,"L.LvsV.YOKOE_CANCER_TESTIS_ANTIGENS"
17,"Down",0.449707136958687,0.666782182956445,"L.LvsV.REACTOME_IRAK1_RECRUITS_IKK_COMPLEX"
67,"Down",0.450058601717503,0.666947523953687,"L.LvsV.REACTOME_NR1H2_AND_NR1H3_MEDIATED_SIGNALING"
46,"Down",0.450059904480232,0.666947523953687,"L.LvsV.PID_PI3KCI_AKT_PATHWAY"
114,"Down",0.450337274015178,0.667155394977897,"L.LvsV.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_DN"
56,"Up",0.45044150650253,0.667155394977897,"L.LvsV.DAVIES_MULTIPLE_MYELOMA_VS_MGUS_UP"
340,"Down",0.450875370696209,0.667540359386722,"L.LvsV.WINTER_HYPOXIA_METAGENE"
139,"Down",0.450942890632918,0.667540359386722,"L.LvsV.BRUECKNER_TARGETS_OF_MIRLET7A3_DN"
16,"Down",0.451067732520636,0.667546438197697,"L.LvsV.REACTOME_PHYSIOLOGICAL_FACTORS"
236,"Down",0.451709247603895,0.668221305581666,"L.LvsV.REACTOME_PROGRAMMED_CELL_DEATH"
41,"Down",0.451765462156677,0.668221305581666,"L.LvsV.REACTOME_CD28_CO_STIMULATION"
381,"Down",0.452093948926899,0.668505068935376,"L.LvsV.SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM1"
26,"Down",0.452199124221072,0.668505068935376,"L.LvsV.DORMOY_ELAVL1_TARGETS"
371,"Down",0.452710501286156,0.669017230593785,"L.LvsV.GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_UP"
38,"Down",0.45288828537589,0.669017230593785,"L.LvsV.BIOCARTA_INSULIN_PATHWAY"
119,"Up",0.452908571914006,0.669017230593785,"L.LvsV.RIZ_ERYTHROID_DIFFERENTIATION"
100,"Down",0.453045989769678,0.669041473674292,"L.LvsV.CHANG_IMMORTALIZED_BY_HPV31_UP"
79,"Down",0.45352948194131,0.669576637023632,"L.LvsV.DAZARD_UV_RESPONSE_CLUSTER_G24"
50,"Down",0.453746506197227,0.669718214833013,"L.LvsV.BOWIE_RESPONSE_TO_TAMOXIFEN"
257,"Down",0.454309981148872,0.670334180033778,"L.LvsV.RICKMAN_HEAD_AND_NECK_CANCER_A"
74,"Down",0.454406313396021,0.670334180033778,"L.LvsV.REACTOME_DUAL_INCISION_IN_TC_NER"
57,"Down",0.45463182117433,0.670416926645943,"L.LvsV.PID_NETRIN_PATHWAY"
9,"Down",0.454704914979614,0.670416926645943,"L.LvsV.BIOCARTA_IFNG_PATHWAY"
66,"Up",0.455015183663954,0.670581522778923,"L.LvsV.WEBER_METHYLATED_HCP_IN_FIBROBLAST_DN"
25,"Down",0.455059119816697,0.670581522778923,"L.LvsV.BIOCARTA_CHEMICAL_PATHWAY"
46,"Down",0.45530855469092,0.670620225874542,"L.LvsV.REACTOME_PHASE_0_RAPID_DEPOLARISATION"
34,"Up",0.455327966708813,0.670620225874542,"L.LvsV.HAHTOLA_CTCL_PATHOGENESIS"
36,"Up",0.455961644052886,0.671374681749243,"L.LvsV.KRIGE_AMINO_ACID_DEPRIVATION"
61,"Up",0.456221621444082,0.671578632844603,"L.LvsV.KEGG_GLYCEROLIPID_METABOLISM"
217,"Down",0.457001326312584,0.672085269522562,"L.LvsV.MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_UP"
27,"Up",0.457025114737174,0.672085269522562,"L.LvsV.KEGG_PRIMARY_BILE_ACID_BIOSYNTHESIS"
586,"Down",0.457037048359809,0.672085269522562,"L.LvsV.KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN"
69,"Down",0.457139600451915,0.672085269522562,"L.LvsV.CERIBELLI_GENES_INACTIVE_AND_BOUND_BY_NFY"
37,"Down",0.457173575452045,0.672085269522562,"L.LvsV.KEGG_ETHER_LIPID_METABOLISM"
20,"Down",0.457366465797222,0.672190108823189,"L.LvsV.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_27"
528,"Up",0.457970538796441,0.672708098186086,"L.LvsV.RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN"
158,"Up",0.45825330006506,0.672708098186086,"L.LvsV.REACTOME_HATS_ACETYLATE_HISTONES"
320,"Down",0.458268819511048,0.672708098186086,"L.LvsV.KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION"
19,"Down",0.458302686531822,0.672708098186086,"L.LvsV.TAKAYAMA_BOUND_BY_AR"
99,"Down",0.458327257346172,0.672708098186086,"L.LvsV.BILBAN_B_CLL_LPL_DN"
430,"Down",0.458815944272382,0.673246644342356,"L.LvsV.LU_EZH2_TARGETS_UP"
29,"Down",0.459278659451179,0.673683775064139,"L.LvsV.LEI_HOXC8_TARGETS_DN"
107,"Up",0.45935753879396,0.673683775064139,"L.LvsV.RADAEVA_RESPONSE_TO_IFNA1_UP"
187,"Up",0.459869169375584,0.673830307201283,"L.LvsV.REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS"
83,"Down",0.45993956765307,0.673830307201283,"L.LvsV.REACTOME_NUCLEOTIDE_BINDING_DOMAIN_LEUCINE_RICH_REPEAT_CONTAINING_RECEPTOR_NLR_SIGNALING_PATHWAYS"
22,"Up",0.459970254495362,0.673830307201283,"L.LvsV.BIOCARTA_TOB1_PATHWAY"
23,"Down",0.460012581924433,0.673830307201283,"L.LvsV.GRASEMANN_RETINOBLASTOMA_WITH_6P_AMPLIFICATION"
34,"Up",0.460075723555581,0.673830307201283,"L.LvsV.WILLIAMS_ESR2_TARGETS_UP"
23,"Up",0.460324793771306,0.673830307201283,"L.LvsV.REACTOME_APOPTOTIC_FACTOR_MEDIATED_RESPONSE"
137,"Down",0.460407743110866,0.673830307201283,"L.LvsV.GAVIN_FOXP3_TARGETS_CLUSTER_T4"
43,"Up",0.460432429120356,0.673830307201283,"L.LvsV.MARTINELLI_IMMATURE_NEUTROPHIL_UP"
12,"Down",0.460587933697916,0.673879514531828,"L.LvsV.MIZUKAMI_HYPOXIA_DN"
33,"Down",0.460954579331332,0.674237531514004,"L.LvsV.HAEGERSTRAND_RESPONSE_TO_IMATINIB"
55,"Up",0.461427088402496,0.674750164447871,"L.LvsV.FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN"
1498,"Down",0.461843454878081,0.675180450031969,"L.LvsV.ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN"
72,"Down",0.462220902110829,0.67555362616198,"L.LvsV.SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_DN"
42,"Down",0.462555975271509,0.675864690083555,"L.LvsV.VANDESLUIS_COMMD1_TARGETS_GROUP_4_DN"
876,"Down",0.462925450859305,0.676083909428664,"L.LvsV.ENK_UV_RESPONSE_KERATINOCYTE_UP"
27,"Up",0.463201099981051,0.676083909428664,"L.LvsV.IGLESIAS_E2F_TARGETS_DN"
607,"Down",0.463201402487185,0.676083909428664,"L.LvsV.SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP"
87,"Up",0.463352719995762,0.676083909428664,"L.LvsV.CAVARD_LIVER_CANCER_MALIGNANT_VS_BENIGN"
156,"Down",0.463391262074143,0.676083909428664,"L.LvsV.LEIN_CHOROID_PLEXUS_MARKERS"
28,"Down",0.463693558639998,0.676083909428664,"L.LvsV.REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS"
29,"Down",0.463713703733899,0.676083909428664,"L.LvsV.GREENBAUM_E2A_TARGETS_DN"
14,"Up",0.463750569804236,0.676083909428664,"L.LvsV.ABBUD_LIF_SIGNALING_2_DN"
9,"Up",0.463939132877104,0.676083909428664,"L.LvsV.REACTOME_TRAIL_SIGNALING"
37,"Down",0.46402004780003,0.676083909428664,"L.LvsV.REACTOME_BIOSYNTHESIS_OF_MARESIN_LIKE_SPMS"
127,"Down",0.464051082706055,0.676083909428664,"L.LvsV.PYEON_HPV_POSITIVE_TUMORS_UP"
54,"Down",0.464295899647711,0.676185921896324,"L.LvsV.PLASARI_TGFB1_SIGNALING_VIA_NFIC_10HR_DN"
106,"Down",0.464365698216737,0.676185921896324,"L.LvsV.KEGG_HEMATOPOIETIC_CELL_LINEAGE"
969,"Down",0.464581994224092,0.676322760943918,"L.LvsV.RAO_BOUND_BY_SALL4_ISOFORM_B"
20,"Up",0.465412662992251,0.677207072836158,"L.LvsV.YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_4"
38,"Down",0.465434414320383,0.677207072836158,"L.LvsV.KANG_AR_TARGETS_DN"
14,"Down",0.465584731661724,0.677247561525302,"L.LvsV.REACTOME_DEFECTIVE_EXT2_CAUSES_EXOSTOSES_2"
166,"Down",0.466174680780101,0.677927356663119,"L.LvsV.KESHELAVA_MULTIPLE_DRUG_RESISTANCE"
33,"Down",0.466914388249911,0.6784371404968,"L.LvsV.REACTOME_GP1B_IX_V_ACTIVATION_SIGNALLING"
35,"Down",0.466938415523347,0.6784371404968,"L.LvsV.CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_LD_MTX_DN"
38,"Down",0.466987240800497,0.6784371404968,"L.LvsV.CHOW_RASSF1_TARGETS_UP"
10,"Down",0.467016052944623,0.6784371404968,"L.LvsV.DER_IFN_BETA_RESPONSE_DN"
8,"Down",0.467210976567982,0.678542025070758,"L.LvsV.BIOCARTA_WNT_LRP6_PATHWAY"
10,"Down",0.467688039378357,0.678970512586067,"L.LvsV.DASU_IL6_SIGNALING_DN"
87,"Down",0.467751615561644,0.678970512586067,"L.LvsV.WANG_BARRETTS_ESOPHAGUS_UP"
11,"Down",0.467933649381858,0.679002766205253,"L.LvsV.NIKOLSKY_BREAST_CANCER_17P11_AMPLICON"
71,"Down",0.468019450535037,0.679002766205253,"L.LvsV.WEINMANN_ADAPTATION_TO_HYPOXIA_DN"
52,"Up",0.468574814927952,0.67963015522997,"L.LvsV.WANG_RESPONSE_TO_BEXAROTENE_UP"
33,"Up",0.468776029942869,0.679743684645717,"L.LvsV.PID_BARD1_PATHWAY"
134,"Up",0.469023163542767,0.679754317858035,"L.LvsV.SASSON_RESPONSE_TO_GONADOTROPHINS_UP"
61,"Down",0.469029249887575,0.679754317858035,"L.LvsV.FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_DN"
601,"Down",0.470378538651691,0.681446207560691,"L.LvsV.VECCHI_GASTRIC_CANCER_EARLY_UP"
62,"Down",0.470903838687708,0.681446207560691,"L.LvsV.SIG_BCR_SIGNALING_PATHWAY"
17,"Down",0.471114000719919,0.681446207560691,"L.LvsV.INAMURA_LUNG_CANCER_SCC_SUBTYPES_UP"
52,"Down",0.471158344058553,0.681446207560691,"L.LvsV.KEGG_ALDOSTERONE_REGULATED_SODIUM_REABSORPTION"
35,"Down",0.471163617461927,0.681446207560691,"L.LvsV.WU_HBX_TARGETS_3_UP"
22,"Up",0.471202952612778,0.681446207560691,"L.LvsV.ISHIKAWA_STING_SIGNALING"
72,"Up",0.471389881213784,0.681446207560691,"L.LvsV.ZHAN_MULTIPLE_MYELOMA_CD1_UP"
8,"Up",0.471417762865145,0.681446207560691,"L.LvsV.REACTOME_OPSINS"
72,"Down",0.471516518871846,0.681446207560691,"L.LvsV.CONRAD_STEM_CELL"
134,"Down",0.471518934294552,0.681446207560691,"L.LvsV.SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM3"
7,"Down",0.471552394669416,0.681446207560691,"L.LvsV.WEBER_METHYLATED_HCP_IN_FIBROBLAST_UP"
266,"Down",0.471769327156384,0.681575302932222,"L.LvsV.ALCALAY_AML_BY_NPM1_LOCALIZATION_UP"
163,"Up",0.472005733744566,0.681575302932222,"L.LvsV.TAYLOR_METHYLATED_IN_ACUTE_LYMPHOBLASTIC_LEUKEMIA"
189,"Up",0.472083613882893,0.681575302932222,"L.LvsV.ROSS_ACUTE_MYELOID_LEUKEMIA_CBF"
34,"Down",0.472257351847995,0.681575302932222,"L.LvsV.THUM_MIR21_TARGETS_HEART_DISEASE_UP"
17,"Down",0.472258850317463,0.681575302932222,"L.LvsV.BIOCARTA_GATA3_PATHWAY"
6,"Up",0.472381363869827,0.681575302932222,"L.LvsV.REACTOME_ACYL_CHAIN_REMODELING_OF_CL"
11,"Up",0.472653753744665,0.681743243211538,"L.LvsV.REACTOME_UREA_CYCLE"
35,"Down",0.472744365070182,0.681743243211538,"L.LvsV.HAHTOLA_MYCOSIS_FUNGOIDES_DN"
43,"Down",0.473111952517619,0.681946779819848,"L.LvsV.REACTOME_VOLTAGE_GATED_POTASSIUM_CHANNELS"
35,"Down",0.473132184371304,0.681946779819848,"L.LvsV.OUYANG_PROSTATE_CANCER_MARKERS"
9,"Down",0.473590953589766,0.682430123116449,"L.LvsV.REACTOME_2_LTR_CIRCLE_FORMATION"
291,"Down",0.473946103130512,0.682549530800676,"L.LvsV.REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT"
607,"Up",0.473995028319269,0.682549530800676,"L.LvsV.GARY_CD5_TARGETS_DN"
296,"Down",0.474044166806764,0.682549530800676,"L.LvsV.DUTERTRE_ESTRADIOL_RESPONSE_6HR_UP"
41,"Down",0.474233698736871,0.682644655120063,"L.LvsV.ZHANG_RESPONSE_TO_CANTHARIDIN_UP"
28,"Down",0.474988166466487,0.683433892857479,"L.LvsV.REACTOME_TRP_CHANNELS"
96,"Up",0.475029200624216,0.683433892857479,"L.LvsV.CERIBELLI_PROMOTERS_INACTIVE_AND_BOUND_BY_NFY"
125,"Down",0.475311106279881,0.683442788051169,"L.LvsV.IVANOVSKA_MIR106B_TARGETS"
43,"Up",0.475387997599556,0.683442788051169,"L.LvsV.WILLERT_WNT_SIGNALING"
17,"Down",0.475406215019858,0.683442788051169,"L.LvsV.DAZARD_UV_RESPONSE_CLUSTER_G3"
183,"Down",0.476075734617099,0.684134011625957,"L.LvsV.DITTMER_PTHLH_TARGETS_UP"
453,"Down",0.476134504745286,0.684134011625957,"L.LvsV.HELLER_HDAC_TARGETS_DN"
33,"Down",0.476421516928353,0.684149955947675,"L.LvsV.REACTOME_BMAL1_CLOCK_NPAS2_ACTIVATES_CIRCADIAN_GENE_EXPRESSION"
477,"Down",0.47644446751784,0.684149955947675,"L.LvsV.SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP"
6,"Up",0.476542861609881,0.684149955947675,"L.LvsV.REACTOME_THE_RETINOID_CYCLE_IN_CONES_DAYLIGHT_VISION"
20,"Down",0.476746645068468,0.684149955947675,"L.LvsV.VANDESLUIS_COMMD1_TARGETS_GROUP_4_UP"
180,"Down",0.476770268134636,0.684149955947675,"L.LvsV.LENAOUR_DENDRITIC_CELL_MATURATION_UP"
327,"Up",0.476952981524653,0.684149955947675,"L.LvsV.LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER"
29,"Down",0.477029966558686,0.684149955947675,"L.LvsV.REACTOME_ACYL_CHAIN_REMODELLING_OF_PE"
141,"Down",0.477135509157937,0.684149955947675,"L.LvsV.CROONQUIST_STROMAL_STIMULATION_UP"
97,"Up",0.477358408098862,0.684188145520809,"L.LvsV.ABRAMSON_INTERACT_WITH_AIRE"
48,"Down",0.477479293542176,0.684188145520809,"L.LvsV.KEGG_PRION_DISEASES"
51,"Up",0.477533379194213,0.684188145520809,"L.LvsV.WENG_POR_TARGETS_LIVER_DN"
87,"Down",0.478033765945701,0.684572356473289,"L.LvsV.BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN"
1901,"Down",0.47818765093667,0.684572356473289,"L.LvsV.REACTOME_DISEASE"
75,"Up",0.478277728556645,0.684572356473289,"L.LvsV.REACTOME_CHEMOKINE_RECEPTORS_BIND_CHEMOKINES"
324,"Down",0.4782968010592,0.684572356473289,"L.LvsV.SERVITJA_LIVER_HNF1A_TARGETS_DN"
1217,"Down",0.478696094243516,0.684966538579814,"L.LvsV.MARTENS_TRETINOIN_RESPONSE_DN"
55,"Up",0.479052569637906,0.685299264560927,"L.LvsV.REACTOME_DNA_DAMAGE_BYPASS"
30,"Up",0.479696084635534,0.6860423310786,"L.LvsV.RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_DN"
44,"Up",0.479907228097356,0.686150268659386,"L.LvsV.ALONSO_METASTASIS_DN"
18,"Down",0.48003017536184,0.686150268659386,"L.LvsV.STEINER_ERYTHROCYTE_MEMBRANE_GENES"
150,"Down",0.480230485295195,0.686150268659386,"L.LvsV.SWEET_KRAS_ONCOGENIC_SIGNATURE"
63,"Down",0.480306849982047,0.686150268659386,"L.LvsV.BENPORATH_ES_2"
40,"Up",0.480392058234849,0.686150268659386,"L.LvsV.PARK_TRETINOIN_RESPONSE_AND_RARA_PLZF_FUSION"
13,"Down",0.480605128090482,0.686277312296559,"L.LvsV.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_29"
18,"Down",0.48087677764121,0.686487917267816,"L.LvsV.BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_24HR_UP"
6,"Up",0.481095032259803,0.686612252079361,"L.LvsV.BIOCARTA_SUMO_PATHWAY"
306,"Up",0.481212240334151,0.686612252079361,"L.LvsV.ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP"
140,"Up",0.481429961180937,0.686662214016098,"L.LvsV.REACTOME_MITOTIC_SPINDLE_CHECKPOINT"
19,"Down",0.481495641841276,0.686662214016098,"L.LvsV.REACTOME_PRESYNAPTIC_DEPOLARIZATION_AND_CALCIUM_CHANNEL_OPENING"
69,"Up",0.48207527648091,0.687311553291117,"L.LvsV.KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY"
17,"Down",0.482214949371586,0.687333450651069,"L.LvsV.SHI_SPARC_TARGETS_DN"
24,"Up",0.482446533365881,0.687486310046381,"L.LvsV.HOLLEMAN_DAUNORUBICIN_B_ALL_UP"
19,"Down",0.483002834997736,0.688101694074332,"L.LvsV.YIH_RESPONSE_TO_ARSENITE_C5"
761,"Up",0.483237652165073,0.688258881715788,"L.LvsV.KEGG_OLFACTORY_TRANSDUCTION"
97,"Down",0.483464801807199,0.688405070613445,"L.LvsV.GRADE_COLON_VS_RECTAL_CANCER_DN"
67,"Up",0.48392876879474,0.688830270299212,"L.LvsV.PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_UP"
112,"Down",0.484012588191795,0.688830270299212,"L.LvsV.DELASERNA_MYOD_TARGETS_DN"
112,"Down",0.484323249426992,0.689095019578445,"L.LvsV.PID_E2F_PATHWAY"
61,"Down",0.484554445723417,0.689246599023611,"L.LvsV.PID_CERAMIDE_PATHWAY"
38,"Down",0.485057020718072,0.689784019431641,"L.LvsV.KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_OLD"
27,"Up",0.485316705266642,0.689863212075602,"L.LvsV.WILSON_PROTEASES_AT_TUMOR_BONE_INTERFACE_UP"
51,"Up",0.485426489636708,0.689863212075602,"L.LvsV.VALK_AML_CLUSTER_5"
95,"Up",0.485487024450383,0.689863212075602,"L.LvsV.PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP"
236,"Down",0.485902033437139,0.690249727847057,"L.LvsV.TIEN_INTESTINE_PROBIOTICS_6HR_DN"
18,"Down",0.486008715953806,0.690249727847057,"L.LvsV.REACTOME_ATF6_ATF6_ALPHA_ACTIVATES_CHAPERONES"
43,"Up",0.486241531933081,0.690403038022087,"L.LvsV.NEWMAN_ERCC6_TARGETS_UP"
32,"Down",0.486555880950319,0.690672006617283,"L.LvsV.REACTOME_HS_GAG_BIOSYNTHESIS"
1419,"Down",0.486862573898279,0.690929972044042,"L.LvsV.BENPORATH_NANOG_TARGETS"
28,"Down",0.487539512482307,0.691466697624987,"L.LvsV.REACTOME_VEGFR2_MEDIATED_CELL_PROLIFERATION"
7,"Down",0.487544314373261,0.691466697624987,"L.LvsV.BIOCARTA_FOSB_PATHWAY"
53,"Down",0.487643028475463,0.691466697624987,"L.LvsV.EINAV_INTERFERON_SIGNATURE_IN_CANCER"
54,"Down",0.487741023826632,0.691466697624987,"L.LvsV.CREIGHTON_AKT1_SIGNALING_VIA_MTOR_UP"
14,"Up",0.488160991814207,0.691744165093687,"L.LvsV.REACTOME_PEXOPHAGY"
54,"Down",0.488186965490246,0.691744165093687,"L.LvsV.WANG_RESPONSE_TO_BEXAROTENE_DN"
31,"Down",0.488351422329135,0.691799901116522,"L.LvsV.MATZUK_POSTIMPLANTATION_AND_POSTPARTUM"
18,"Down",0.488486691309506,0.691806784243452,"L.LvsV.MAINA_VHL_TARGETS_UP"
36,"Down",0.488647684161023,0.691806784243452,"L.LvsV.REACTOME_SCAVENGING_BY_CLASS_A_RECEPTORS"
75,"Down",0.48881656727973,0.691806784243452,"L.LvsV.JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP"
17,"Up",0.488856774469012,0.691806784243452,"L.LvsV.NIKOLSKY_BREAST_CANCER_14Q22_AMPLICON"
277,"Down",0.489205965292742,0.692014415738833,"L.LvsV.REACTOME_ESR_MEDIATED_SIGNALING"
40,"Up",0.489424218756029,0.692014415738833,"L.LvsV.REACTOME_AMINO_ACID_TRANSPORT_ACROSS_THE_PLASMA_MEMBRANE"
5,"Down",0.489576624074479,0.692014415738833,"L.LvsV.JONES_TCOF1_TARGETS"
103,"Down",0.489625942374307,0.692014415738833,"L.LvsV.WU_APOPTOSIS_BY_CDKN1A_VIA_TP53"
37,"Down",0.489629299036049,0.692014415738833,"L.LvsV.TERAMOTO_OPN_TARGETS_CLUSTER_4"
53,"Down",0.490294646818976,0.692777690330211,"L.LvsV.REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS"
1037,"Up",0.490695058999095,0.69316632120746,"L.LvsV.CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_3"
121,"Down",0.490877099483661,0.693246355822519,"L.LvsV.YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_1"
12,"Down",0.491854424698759,0.694353677733938,"L.LvsV.YAMANAKA_GLIOBLASTOMA_SURVIVAL_DN"
296,"Up",0.491912345032345,0.694353677733938,"L.LvsV.REACTOME_HIV_INFECTION"
111,"Down",0.492093595427175,0.694432233056878,"L.LvsV.HOFMANN_CELL_LYMPHOMA_UP"
110,"Down",0.492731361840017,0.694986652713065,"L.LvsV.ROSS_AML_WITH_CBFB_MYH11_FUSION"
106,"Down",0.492737869168966,0.694986652713065,"L.LvsV.WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER"
42,"Up",0.493250637831884,0.695532460232717,"L.LvsV.TERAO_AOX4_TARGETS_HG_UP"
114,"Up",0.49382499361786,0.696164811247616,"L.LvsV.REACTOME_METABOLISM_OF_NUCLEOTIDES"
29,"Down",0.494045057181794,0.696297507305159,"L.LvsV.SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_2FC_DN"
57,"Up",0.494620489311213,0.696930857645692,"L.LvsV.ABBUD_LIF_SIGNALING_1_UP"
62,"Up",0.495498476734554,0.697942655117063,"L.LvsV.ZHAN_MULTIPLE_MYELOMA_HP_DN"
151,"Up",0.495591040692637,0.697942655117063,"L.LvsV.MORI_IMMATURE_B_LYMPHOCYTE_DN"
46,"Down",0.496215999532276,0.698644833566069,"L.LvsV.REACTOME_HIV_TRANSCRIPTION_ELONGATION"
132,"Down",0.496486279875257,0.698747953210733,"L.LvsV.MILI_PSEUDOPODIA"
202,"Up",0.496541998221192,0.698747953210733,"L.LvsV.REACTOME_CREATION_OF_C4_AND_C2_ACTIVATORS"
26,"Up",0.496948075431649,0.699098856180176,"L.LvsV.SCIBETTA_KDM5B_TARGETS_UP"
21,"Up",0.49704424012376,0.699098856180176,"L.LvsV.KRISHNAN_FURIN_TARGETS_DN"
24,"Down",0.497231463298061,0.699184323645722,"L.LvsV.INAMURA_LUNG_CANCER_SCC_DN"
13,"Down",0.498072064732742,0.700188264914145,"L.LvsV.FUNG_IL2_SIGNALING_2"
36,"Down",0.498313477273416,0.700237563559932,"L.LvsV.REACTOME_HIV_ELONGATION_ARREST_AND_RECOVERY"
18,"Up",0.498360429120697,0.700237563559932,"L.LvsV.BIOCARTA_TCRA_PATHWAY"
158,"Up",0.498784384981965,0.700585278619919,"L.LvsV.NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP"
1026,"Down",0.498861320659544,0.700585278619919,"L.LvsV.GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN"
20,"Up",0.499421341499837,0.701019606420393,"L.LvsV.HEDVAT_ELF4_TARGETS_UP"
1049,"Up",0.499578139650877,0.701019606420393,"L.LvsV.KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_UP"
492,"Down",0.499605370752263,0.701019606420393,"L.LvsV.REACTOME_LEISHMANIA_INFECTION"
114,"Down",0.499803746637877,0.701019606420393,"L.LvsV.STAMBOLSKY_TARGETS_OF_MUTATED_TP53_DN"
142,"Up",0.499804537621485,0.701019606420393,"L.LvsV.REACTOME_ANTIMICROBIAL_PEPTIDES"
109,"Down",0.500137644827508,0.701290625290342,"L.LvsV.THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP"
25,"Up",0.500251442601756,0.701290625290342,"L.LvsV.REACTOME_JNK_C_JUN_KINASES_PHOSPHORYLATION_AND_ACTIVATION_MEDIATED_BY_ACTIVATED_HUMAN_TAK1"
101,"Down",0.500662957561028,0.701689605159676,"L.LvsV.BRIDEAU_IMPRINTED_GENES"
231,"Down",0.501354496976485,0.702480743482764,"L.LvsV.REACTOME_MITOTIC_G2_G2_M_PHASES"
17,"Up",0.501628564165566,0.702686681345684,"L.LvsV.REACTOME_POLYMERASE_SWITCHING_ON_THE_C_STRAND_OF_THE_TELOMERE"
51,"Up",0.501989414735819,0.702796325485064,"L.LvsV.REACTOME_HIV_TRANSCRIPTION_INITIATION"
71,"Down",0.502117430576218,0.702796325485064,"L.LvsV.SCHLINGEMANN_SKIN_CARCINOGENESIS_TPA_UP"
518,"Down",0.502259677144812,0.702796325485064,"L.LvsV.FARMER_BREAST_CANCER_APOCRINE_VS_BASAL"
51,"Down",0.502304454005253,0.702796325485064,"L.LvsV.BIOCARTA_BCR_PATHWAY"
59,"Down",0.502342390724719,0.702796325485064,"L.LvsV.NIKOLSKY_BREAST_CANCER_12Q13_Q21_AMPLICON"
114,"Up",0.502907307941367,0.703108867794224,"L.LvsV.REACTOME_O_LINKED_GLYCOSYLATION"
50,"Up",0.502936947979255,0.703108867794224,"L.LvsV.JAERVINEN_AMPLIFIED_IN_LARYNGEAL_CANCER"
110,"Down",0.50294729103385,0.703108867794224,"L.LvsV.REACTOME_POTASSIUM_CHANNELS"
192,"Down",0.503207042134902,0.703294169859422,"L.LvsV.LE_EGR2_TARGETS_UP"
34,"Up",0.503350372880541,0.703316707519968,"L.LvsV.STEGER_ADIPOGENESIS_UP"
24,"Down",0.503807297979816,0.703673276123496,"L.LvsV.LEE_METASTASIS_AND_RNA_PROCESSING_UP"
55,"Down",0.503966000502346,0.703673276123496,"L.LvsV.ROY_WOUND_BLOOD_VESSEL_DN"
40,"Down",0.504096067302791,0.703673276123496,"L.LvsV.REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY"
41,"Up",0.504114640391602,0.703673276123496,"L.LvsV.TUOMISTO_TUMOR_SUPPRESSION_BY_COL13A1_DN"
10,"Up",0.504746904831723,0.704356364949648,"L.LvsV.REACTOME_DISEASES_OF_DNA_REPAIR"
16,"Up",0.504858794410464,0.704356364949648,"L.LvsV.REACTOME_DEFECTIVE_GALNT3_CAUSES_FAMILIAL_HYPERPHOSPHATEMIC_TUMORAL_CALCINOSIS_HFTC"
89,"Up",0.5054818989477,0.704724751522447,"L.LvsV.CUI_TCF21_TARGETS_DN"
189,"Up",0.505499180597773,0.704724751522447,"L.LvsV.DURCHDEWALD_SKIN_CARCINOGENESIS_UP"
135,"Down",0.505680099742086,0.704724751522447,"L.LvsV.ANDERSEN_CHOLANGIOCARCINOMA_CLASS1"
7,"Up",0.505746583118011,0.704724751522447,"L.LvsV.REACTOME_APEX1_INDEPENDENT_RESOLUTION_OF_AP_SITES_VIA_THE_SINGLE_NUCLEOTIDE_REPLACEMENT_PATHWAY"
52,"Down",0.505760139996576,0.704724751522447,"L.LvsV.PID_GMCSF_PATHWAY"
101,"Down",0.505968780179944,0.704755973030824,"L.LvsV.KEGG_APOPTOSIS"
33,"Up",0.506037477470134,0.704755973030824,"L.LvsV.BIOCARTA_TOLL_PATHWAY"
90,"Down",0.506214260765913,0.704824640587946,"L.LvsV.TENEDINI_MEGAKARYOCYTE_MARKERS"
15,"Down",0.507060937256628,0.705825760848917,"L.LvsV.REACTOME_SIGNAL_ATTENUATION"
15,"Up",0.507269335686269,0.705844847036179,"L.LvsV.REACTOME_APOPTOSIS_INDUCED_DNA_FRAGMENTATION"
31,"Down",0.507329973254074,0.705844847036179,"L.LvsV.KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_UV_IN_OLD"
927,"Up",0.507668766458869,0.705981257198206,"L.LvsV.REACTOME_G_ALPHA_S_SIGNALLING_EVENTS"
14,"Down",0.507683392769048,0.705981257198206,"L.LvsV.REACTOME_SUMOYLATION_OF_IMMUNE_RESPONSE_PROTEINS"
15,"Up",0.508354017458776,0.706657383306176,"L.LvsV.REACTOME_PURINE_SALVAGE"
526,"Down",0.508534371266469,0.706657383306176,"L.LvsV.SABATES_COLORECTAL_ADENOMA_DN"
41,"Up",0.508553034576827,0.706657383306176,"L.LvsV.VALK_AML_CLUSTER_16"
563,"Down",0.508931902488364,0.70680911783621,"L.LvsV.RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN"
37,"Down",0.509017010714486,0.70680911783621,"L.LvsV.REACTOME_UPTAKE_AND_ACTIONS_OF_BACTERIAL_TOXINS"
142,"Down",0.509045741946788,0.70680911783621,"L.LvsV.MAHAJAN_RESPONSE_TO_IL1A_UP"
17,"Down",0.509308174182692,0.706995956579489,"L.LvsV.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_8"
1038,"Up",0.509651399743481,0.707294826601834,"L.LvsV.WEI_MYCN_TARGETS_WITH_E_BOX"
79,"Up",0.510412118306309,0.708172798523357,"L.LvsV.HOWLIN_CITED1_TARGETS_1_UP"
39,"Down",0.510778334328658,0.708503113523118,"L.LvsV.CHEOK_RESPONSE_TO_HD_MTX_DN"
448,"Up",0.511031327531417,0.708518885592292,"L.LvsV.IVANOVA_HEMATOPOIESIS_MATURE_CELL"
68,"Down",0.511045996697786,0.708518885592292,"L.LvsV.VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_DN"
110,"Down",0.511424947907458,0.708866517167294,"L.LvsV.OHGUCHI_LIVER_HNF4A_TARGETS_UP"
23,"Down",0.511743100610663,0.709062630931076,"L.LvsV.SA_TRKA_RECEPTOR"
886,"Up",0.511822926396441,0.709062630931076,"L.LvsV.SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_DN"
149,"Down",0.512969692547122,0.710473304131523,"L.LvsV.KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS"
11,"Up",0.513289484926817,0.710738182359221,"L.LvsV.REACTOME_CHYLOMICRON_REMODELING"
54,"Down",0.513533073262348,0.710897436671888,"L.LvsV.PID_ERB_GENOMIC_PATHWAY"
27,"Up",0.5137584648373,0.710958330590962,"L.LvsV.REACTOME_GAP_FILLING_DNA_REPAIR_SYNTHESIS_AND_LIGATION_IN_GG_NER"
81,"Up",0.513834235673989,0.710958330590962,"L.LvsV.RASHI_RESPONSE_TO_IONIZING_RADIATION_1"
40,"Up",0.514591350198958,0.711666268066049,"L.LvsV.CHOW_RASSF1_TARGETS_DN"
173,"Down",0.514603317006342,0.711666268066049,"L.LvsV.KIM_WT1_TARGETS_8HR_DN"
36,"Down",0.514822193892995,0.711762528102872,"L.LvsV.ABDULRAHMAN_KIDNEY_CANCER_VHL_DN"
972,"Up",0.514930387486252,0.711762528102872,"L.LvsV.BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN"
78,"Down",0.515303798137951,0.71210064981373,"L.LvsV.KIM_ALL_DISORDERS_CALB1_CORR_DN"
648,"Up",0.516252596639198,0.713233534937063,"L.LvsV.SANSOM_APC_TARGETS_DN"
36,"Down",0.516449279775657,0.713327021703624,"L.LvsV.HEIDENBLAD_AMPLICON_12P11_12_DN"
14,"Down",0.516643535688387,0.713417110095178,"L.LvsV.WEBER_METHYLATED_LCP_IN_FIBROBLAST_UP"
20,"Down",0.517033321894893,0.713462814489506,"L.LvsV.MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_UP"
91,"Up",0.517058929434141,0.713462814489506,"L.LvsV.ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_DN"
40,"Up",0.517063754324371,0.713462814489506,"L.LvsV.CHEN_ETV5_TARGETS_SERTOLI"
297,"Down",0.517199994927865,0.713472747494054,"L.LvsV.OKUMURA_INFLAMMATORY_RESPONSE_LPS"
17,"Down",0.518225500165726,0.714672378008993,"L.LvsV.REACTOME_P75NTR_RECRUITS_SIGNALLING_COMPLEXES"
157,"Up",0.518328130912654,0.714672378008993,"L.LvsV.MORI_LARGE_PRE_BII_LYMPHOCYTE_UP"
47,"Up",0.519657531172858,0.716326723972757,"L.LvsV.REACTOME_METALLOPROTEASE_DUBS"
8,"Down",0.520008337119539,0.716631629096194,"L.LvsV.REACTOME_DEFECTIVE_CHST3_CAUSES_SEDCJD"
19,"Down",0.520245048954263,0.716746686843791,"L.LvsV.REACTOME_INTERACTION_WITH_CUMULUS_CELLS_AND_THE_ZONA_PELLUCIDA"
5,"Up",0.520420926077652,0.716746686843791,"L.LvsV.REACTOME_DISEASES_OF_MISMATCH_REPAIR_MMR"
16,"Down",0.520568748979407,0.716746686843791,"L.LvsV.REACTOME_ATF6_ATF6_ALPHA_ACTIVATES_CHAPERONE_GENES"
614,"Up",0.520610362518478,0.716746686843791,"L.LvsV.RUTELLA_RESPONSE_TO_HGF_UP"
165,"Up",0.520754080455326,0.716766071903783,"L.LvsV.HELLER_SILENCED_BY_METHYLATION_DN"
30,"Down",0.521280613350403,0.717282746536771,"L.LvsV.REACTOME_RNA_POLYMERASE_III_TRANSCRIPTION_INITIATION_FROM_TYPE_3_PROMOTER"
1053,"Down",0.521420496419388,0.717282746536771,"L.LvsV.NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN"
173,"Up",0.521518654562818,0.717282746536771,"L.LvsV.REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION"
31,"Down",0.521864089505218,0.717510868092627,"L.LvsV.REACTOME_PLATELET_CALCIUM_HOMEOSTASIS"
248,"Down",0.521944060674362,0.717510868092627,"L.LvsV.ZHU_CMV_ALL_UP"
8,"Down",0.522185764891024,0.717664701487067,"L.LvsV.REACTOME_COMPETING_ENDOGENOUS_RNAS_CERNAS_REGULATE_PTEN_TRANSLATION"
18,"Up",0.522598246117569,0.718053107053687,"L.LvsV.REACTOME_TRAF6_MEDIATED_INDUCTION_OF_TAK1_COMPLEX_WITHIN_TLR4_COMPLEX"
314,"Up",0.52298206667694,0.71840194947995,"L.LvsV.SHEPARD_BMYB_MORPHOLINO_DN"
385,"Down",0.523181084497459,0.718496824686152,"L.LvsV.BROWNE_HCMV_INFECTION_48HR_UP"
17,"Up",0.523422983996487,0.718650528561354,"L.LvsV.SANDERSON_PPARA_TARGETS"
10,"Up",0.523846456132685,0.7190533902576,"L.LvsV.REACTOME_DIGESTION_OF_DIETARY_LIPID"
94,"Up",0.524274950901019,0.719462944535054,"L.LvsV.YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_3"
96,"Down",0.52454432609395,0.719653989819715,"L.LvsV.REACTOME_GLOBAL_GENOME_NUCLEOTIDE_EXCISION_REPAIR_GG_NER"
67,"Down",0.524784449210842,0.7198048175854,"L.LvsV.VANTVEER_BREAST_CANCER_BRCA1_UP"
31,"Down",0.52549966325278,0.720607053106304,"L.LvsV.GOERING_BLOOD_HDL_CHOLESTEROL_QTL_TRANS"
49,"Up",0.525631501972097,0.720609118374342,"L.LvsV.REACTOME_METABOLISM_OF_PORPHYRINS"
17,"Down",0.52603386765355,0.720885401993288,"L.LvsV.CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_LD_MTX_UP"
34,"Down",0.526104549896163,0.720885401993288,"L.LvsV.REACTOME_IKK_COMPLEX_RECRUITMENT_MEDIATED_BY_RIP1"
59,"Up",0.526224178412897,0.720885401993288,"L.LvsV.BRACHAT_RESPONSE_TO_METHOTREXATE_UP"
80,"Down",0.527805732808236,0.722872899850566,"L.LvsV.HOQUE_METHYLATED_IN_CANCER"
60,"Up",0.528417162075435,0.7233936059881,"L.LvsV.CROONQUIST_NRAS_SIGNALING_UP"
9,"Up",0.528550950393763,0.7233936059881,"L.LvsV.REACTOME_SERINE_BIOSYNTHESIS"
30,"Down",0.528578435194778,0.7233936059881,"L.LvsV.MILICIC_FAMILIAL_ADENOMATOUS_POLYPOSIS_DN"
93,"Up",0.529360975756402,0.724178155812752,"L.LvsV.SILIGAN_BOUND_BY_EWS_FLT1_FUSION"
21,"Down",0.529413656320337,0.724178155812752,"L.LvsV.SUH_COEXPRESSED_WITH_ID1_AND_ID2_UP"
122,"Down",0.529581311145578,0.724228312966584,"L.LvsV.ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN"
347,"Up",0.529895505103998,0.724386806462214,"L.LvsV.MITSIADES_RESPONSE_TO_APLIDIN_DN"
114,"Up",0.530092375277547,0.724386806462214,"L.LvsV.HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_UP"
65,"Down",0.530209024316486,0.724386806462214,"L.LvsV.REACTOME_PLATELET_AGGREGATION_PLUG_FORMATION"
533,"Down",0.530319536499703,0.724386806462214,"L.LvsV.HORIUCHI_WTAP_TARGETS_UP"
73,"Up",0.530463409593229,0.724386806462214,"L.LvsV.HOFMANN_CELL_LYMPHOMA_DN"
39,"Down",0.530483302471605,0.724386806462214,"L.LvsV.REACTOME_TNFR1_INDUCED_NFKAPPAB_SIGNALING_PATHWAY"
30,"Up",0.531036753474764,0.724963508632586,"L.LvsV.IWANAGA_E2F1_TARGETS_INDUCED_BY_SERUM"
7,"Down",0.531895003743527,0.725632583033997,"L.LvsV.REACTOME_ALPHA_OXIDATION_OF_PHYTANATE"
68,"Down",0.531937205940734,0.725632583033997,"L.LvsV.REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_DNA_REPAIR_GENES"
12,"Up",0.531988779594883,0.725632583033997,"L.LvsV.BIOCARTA_EEA1_PATHWAY"
30,"Up",0.532167439706459,0.725632583033997,"L.LvsV.BIOCARTA_CTLA4_PATHWAY"
137,"Down",0.532183057370746,0.725632583033997,"L.LvsV.GAJATE_RESPONSE_TO_TRABECTEDIN_UP"
60,"Down",0.533121473231917,0.726732895833153,"L.LvsV.PID_NFAT_TFPATHWAY"
31,"Down",0.533559702102929,0.727109026388092,"L.LvsV.JEON_SMAD6_TARGETS_DN"
10,"Down",0.533853811822505,0.727109026388092,"L.LvsV.BIOCARTA_PPARG_PATHWAY"
145,"Up",0.533873438827802,0.727109026388092,"L.LvsV.YU_MYC_TARGETS_DN"
113,"Up",0.533923430482123,0.727109026388092,"L.LvsV.LEIN_OLIGODENDROCYTE_MARKERS"
26,"Up",0.534150477084513,0.727239100664928,"L.LvsV.NIKOLSKY_BREAST_CANCER_6P24_P22_AMPLICON"
70,"Up",0.535176378344282,0.72838114972307,"L.LvsV.LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_UP"
45,"Down",0.535372009361116,0.72838114972307,"L.LvsV.REACTOME_OVARIAN_TUMOR_DOMAIN_PROTEASES"
119,"Up",0.535384516634935,0.72838114972307,"L.LvsV.SHEPARD_BMYB_TARGETS"
74,"Down",0.535657536497136,0.72857331347913,"L.LvsV.REACTOME_INTRINSIC_PATHWAY_FOR_APOPTOSIS"
139,"Down",0.536434399928467,0.729364478445539,"L.LvsV.MIKKELSEN_MCV6_ICP_WITH_H3K27ME3"
12,"Down",0.536503044644241,0.729364478445539,"L.LvsV.MATZUK_MATERNAL_EFFECT"
191,"Down",0.53680322258259,0.729385645630009,"L.LvsV.ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP"
132,"Down",0.536864478655249,0.729385645630009,"L.LvsV.AKL_HTLV1_INFECTION_DN"
82,"Up",0.537126450696544,0.729385645630009,"L.LvsV.REACTOME_REGULATION_OF_PTEN_STABILITY_AND_ACTIVITY"
6,"Up",0.537171934308405,0.729385645630009,"L.LvsV.PASTURAL_RIZ1_TARGETS_DN"
22,"Down",0.537178214687176,0.729385645630009,"L.LvsV.GRAHAM_CML_DIVIDING_VS_NORMAL_DIVIDING_DN"
12,"Down",0.537504263577702,0.729649170960254,"L.LvsV.REACTOME_INTERLEUKIN_9_SIGNALING"
10,"Up",0.537694161122065,0.729657669254968,"L.LvsV.REACTOME_INTERLEUKIN_18_SIGNALING"
42,"Up",0.537774462328449,0.729657669254968,"L.LvsV.GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_UP"
62,"Down",0.538441556948533,0.730191738263177,"L.LvsV.PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_DN"
916,"Up",0.538499085108047,0.730191738263177,"L.LvsV.SWEET_LUNG_CANCER_KRAS_UP"
41,"Down",0.538635812275313,0.730191738263177,"L.LvsV.REACTOME_PERK_REGULATES_GENE_EXPRESSION"
19,"Down",0.538696346604359,0.730191738263177,"L.LvsV.XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_DN"
23,"Up",0.538892444473174,0.730278511150044,"L.LvsV.MARKS_HDAC_TARGETS_DN"
194,"Up",0.539151858376801,0.730451023025076,"L.LvsV.GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_DN"
113,"Up",0.539368219753661,0.730565136457127,"L.LvsV.PID_CD8_TCR_DOWNSTREAM_PATHWAY"
151,"Up",0.54000775752173,0.731157438436468,"L.LvsV.SMITH_TERT_TARGETS_DN"
47,"Down",0.540069990698957,0.731157438436468,"L.LvsV.MIKKELSEN_MCV6_LCP_WITH_H3K27ME3"
26,"Down",0.540416195436421,0.731292648141988,"L.LvsV.SA_G1_AND_S_PHASES"
16,"Down",0.540527187730709,0.731292648141988,"L.LvsV.CHESLER_BRAIN_D6MIT150_QTL_TRANS"
217,"Up",0.540589877009001,0.731292648141988,"L.LvsV.REACTOME_FCERI_MEDIATED_CA_2_MOBILIZATION"
84,"Down",0.540698923061032,0.731292648141988,"L.LvsV.REACTOME_RNA_POLYMERASE_II_TRANSCRIBES_SNRNA_GENES"
65,"Up",0.540919331824095,0.731296601197554,"L.LvsV.SMID_BREAST_CANCER_RELAPSE_IN_PLEURA_DN"
27,"Up",0.541077463665677,0.731296601197554,"L.LvsV.MELLMAN_TUT1_TARGETS_UP"
96,"Down",0.54109864270197,0.731296601197554,"L.LvsV.HUANG_DASATINIB_RESISTANCE_DN"
100,"Up",0.541494994005149,0.731653426650653,"L.LvsV.REACTOME_TRANSPORT_OF_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS"
138,"Down",0.541645574991253,0.731678080656398,"L.LvsV.LEIN_MEDULLA_MARKERS"
796,"Down",0.542999036902492,0.733327228879795,"L.LvsV.MILI_PSEUDOPODIA_HAPTOTAXIS_UP"
81,"Down",0.543741255348276,0.734150281030676,"L.LvsV.SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_UP"
612,"Down",0.544548023812769,0.735060064370312,"L.LvsV.HELLER_SILENCED_BY_METHYLATION_UP"
300,"Down",0.544831728266078,0.735263516129642,"L.LvsV.REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1"
19,"Down",0.545362216143224,0.735799827490455,"L.LvsV.THUM_MIR21_TARGETS_HEART_DISEASE_DN"
97,"Down",0.545928150785378,0.73638369009328,"L.LvsV.AUNG_GASTRIC_CANCER"
223,"Up",0.546701573405286,0.737247073014105,"L.LvsV.REACTOME_SEPARATION_OF_SISTER_CHROMATIDS"
35,"Down",0.547020879874989,0.737497791960208,"L.LvsV.MASRI_RESISTANCE_TO_TAMOXIFEN_AND_AROMATASE_INHIBITORS_UP"
41,"Down",0.547185079799458,0.737539323796003,"L.LvsV.HOEGERKORP_CD44_TARGETS_DIRECT_UP"
43,"Down",0.547327838600433,0.737551942388934,"L.LvsV.REACTOME_PROLACTIN_RECEPTOR_SIGNALING"
272,"Up",0.547712073912677,0.737889877354579,"L.LvsV.BOYAULT_LIVER_CANCER_SUBCLASS_G3_UP"
9,"Up",0.547882648664721,0.737939869541351,"L.LvsV.REACTOME_ESTROGEN_BIOSYNTHESIS"
90,"Up",0.548643316040319,0.738677831225236,"L.LvsV.ZHANG_RESPONSE_TO_CANTHARIDIN_DN"
31,"Down",0.548697748750596,0.738677831225236,"L.LvsV.TIAN_TNF_SIGNALING_NOT_VIA_NFKB"
247,"Up",0.548860498182325,0.738680223855526,"L.LvsV.REACTOME_COMPLEMENT_CASCADE"
41,"Up",0.549021079295196,0.738680223855526,"L.LvsV.REACTOME_GAMMA_CARBOXYLATION_HYPUSINE_FORMATION_AND_ARYLSULFATASE_ACTIVATION"
12,"Up",0.549100329181807,0.738680223855526,"L.LvsV.MIKKELSEN_PLURIPOTENT_STATE_UP"
193,"Down",0.549393289163907,0.738807657424731,"L.LvsV.ZHU_CMV_24_HR_UP"
10,"Down",0.54946230553997,0.738807657424731,"L.LvsV.BIOCARTA_CB1R_PATHWAY"
63,"Down",0.550309901733732,0.739644257131711,"L.LvsV.KORKOLA_EMBRYONAL_CARCINOMA_UP"
6,"Down",0.550352048081002,0.739644257131711,"L.LvsV.REACTOME_TNFR1_MEDIATED_CERAMIDE_PRODUCTION"
165,"Down",0.551141050209553,0.740297321898305,"L.LvsV.NIKOLSKY_BREAST_CANCER_8Q12_Q22_AMPLICON"
129,"Down",0.551235359570035,0.740297321898305,"L.LvsV.LEE_CALORIE_RESTRICTION_NEOCORTEX_DN"
5,"Down",0.55123965893567,0.740297321898305,"L.LvsV.NIKOLSKY_BREAST_CANCER_19P13_AMPLICON"
133,"Down",0.55162827725285,0.740517852580828,"L.LvsV.MIKKELSEN_MEF_LCP_WITH_H3K27ME3"
73,"Down",0.551671737164122,0.740517852580828,"L.LvsV.JAEGER_METASTASIS_UP"
29,"Up",0.551867920338611,0.740601391153442,"L.LvsV.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_15"
13,"Up",0.552674202542433,0.741503437480493,"L.LvsV.KOBAYASHI_EGFR_SIGNALING_6HR_UP"
271,"Down",0.55287454153653,0.741592270780076,"L.LvsV.REACTOME_NEDDYLATION"
32,"Down",0.553153069120241,0.741785912967696,"L.LvsV.REACTOME_INTRINSIC_PATHWAY_OF_FIBRIN_CLOT_FORMATION"
16,"Up",0.553454350419849,0.742009966894119,"L.LvsV.REACTOME_ROLE_OF_SECOND_MESSENGERS_IN_NETRIN_1_SIGNALING"
41,"Up",0.553737304921962,0.742209347615401,"L.LvsV.PID_IL12_STAT4_PATHWAY"
12,"Up",0.554465857340085,0.742941763231427,"L.LvsV.BIOCARTA_RHODOPSIN_PATHWAY"
52,"Down",0.55455247908412,0.742941763231427,"L.LvsV.REACTOME_TRANSCRIPTIONAL_REGULATION_BY_VENTX"
436,"Down",0.554912095533459,0.743156941777977,"L.LvsV.VANTVEER_BREAST_CANCER_ESR1_DN"
429,"Down",0.554981915825875,0.743156941777977,"L.LvsV.HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN"
302,"Down",0.55559763245086,0.743801285670898,"L.LvsV.XU_GH1_AUTOCRINE_TARGETS_UP"
169,"Down",0.556191989888218,0.744411104984363,"L.LvsV.NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP"
17,"Down",0.556322424632915,0.744411104984363,"L.LvsV.REACTOME_PKA_ACTIVATION_IN_GLUCAGON_SIGNALLING"
43,"Down",0.556748526140684,0.744801016460644,"L.LvsV.ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_DN"
306,"Down",0.556925939046422,0.744858131830592,"L.LvsV.CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_UP"
197,"Up",0.557387081141951,0.745294600153289,"L.LvsV.WIELAND_UP_BY_HBV_INFECTION"
14,"Down",0.557750649879809,0.745521183048348,"L.LvsV.REACTOME_PURINE_RIBONUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHESIS"
7,"Up",0.557826213469166,0.745521183048348,"L.LvsV.REACTOME_LTC4_CYSLTR_MEDIATED_IL4_PRODUCTION"
20,"Down",0.558035167778472,0.745539045476262,"L.LvsV.GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_2"
73,"Down",0.558279010068298,0.745539045476262,"L.LvsV.TAVOR_CEBPA_TARGETS_UP"
189,"Down",0.558305877156025,0.745539045476262,"L.LvsV.LIU_VAV3_PROSTATE_CARCINOGENESIS_UP"
7,"Down",0.558588994044819,0.745539045476262,"L.LvsV.REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_LINKED_TO_GLUCONEOGENESIS"
11,"Down",0.558670513073051,0.745539045476262,"L.LvsV.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_25"
29,"Down",0.558708336753702,0.745539045476262,"L.LvsV.ZHANG_GATA6_TARGETS_UP"
2477,"Down",0.558787114689514,0.745539045476262,"L.LvsV.GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN"
60,"Up",0.558918311358131,0.745539045476262,"L.LvsV.MATZUK_SPERMATID_DIFFERENTIATION"
145,"Up",0.559683466591723,0.746379615722537,"L.LvsV.SASSON_RESPONSE_TO_FORSKOLIN_UP"
12,"Down",0.560180538956612,0.746862358305066,"L.LvsV.REACTOME_SYNTHESIS_OF_15_EICOSATETRAENOIC_ACID_DERIVATIVES"
145,"Down",0.560563681727269,0.747193007779669,"L.LvsV.ELVIDGE_HIF1A_TARGETS_DN"
9,"Down",0.560999097170887,0.747593156967422,"L.LvsV.REACTOME_HIGHLY_CALCIUM_PERMEABLE_NICOTINIC_ACETYLCHOLINE_RECEPTORS"
54,"Down",0.561195886536731,0.747675194376285,"L.LvsV.FARMER_BREAST_CANCER_CLUSTER_4"
224,"Down",0.56200072575225,0.748567095322619,"L.LvsV.PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_UP"
64,"Down",0.562563848304484,0.749136685278298,"L.LvsV.PIONTEK_PKD1_TARGETS_DN"
28,"Down",0.562976576202827,0.74950577650504,"L.LvsV.MARSON_FOXP3_CORE_DIRECT_TARGETS"
25,"Down",0.563531657868051,0.749922007847278,"L.LvsV.BIOCARTA_IL3_PATHWAY"
12,"Up",0.56356048880547,0.749922007847278,"L.LvsV.REACTOME_FRUCTOSE_METABOLISM"
30,"Down",0.563976436760357,0.750294927538021,"L.LvsV.REACTOME_BUDDING_AND_MATURATION_OF_HIV_VIRION"
22,"Up",0.564422887669249,0.750708238134058,"L.LvsV.KEGG_SULFUR_METABOLISM"
37,"Down",0.564747415522354,0.750892816955908,"L.LvsV.MATZUK_CENTRAL_FOR_FEMALE_FERTILITY"
14,"Down",0.564833283725741,0.750892816955908,"L.LvsV.REACTOME_NRCAM_INTERACTIONS"
977,"Down",0.565162256223191,0.751149546792793,"L.LvsV.WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_8D"
195,"Up",0.565430081456525,0.751184041767409,"L.LvsV.REACTOME_ION_CHANNEL_TRANSPORT"
6,"Up",0.565467938909974,0.751184041767409,"L.LvsV.MIKI_COEXPRESSED_WITH_CYP19A1"
584,"Down",0.565595797771337,0.751184041767409,"L.LvsV.MULLIGHAN_MLL_SIGNATURE_1_UP"
83,"Up",0.566070278097379,0.751346981140316,"L.LvsV.REACTOME_GLYCOLYSIS"
509,"Up",0.56617994365651,0.751346981140316,"L.LvsV.KUMAR_PATHOGEN_LOAD_BY_MACROPHAGES"
103,"Down",0.566255386117909,0.751346981140316,"L.LvsV.NIKOLSKY_BREAST_CANCER_7Q21_Q22_AMPLICON"
17,"Up",0.566262049269614,0.751346981140316,"L.LvsV.PARK_APL_PATHOGENESIS_UP"
16,"Down",0.567032174405309,0.752136358241908,"L.LvsV.ZHOU_PANCREATIC_EXOCRINE_PROGENITOR"
170,"Down",0.567129042776364,0.752136358241908,"L.LvsV.ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_DN"
89,"Down",0.567547618782576,0.752510979436179,"L.LvsV.GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_UP"
124,"Up",0.568788875439389,0.753975951163842,"L.LvsV.HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_UP"
141,"Down",0.569080016142259,0.754181066455069,"L.LvsV.YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_0"
368,"Down",0.570165520343582,0.755438572245307,"L.LvsV.AMUNDSON_RESPONSE_TO_ARSENITE"
58,"Down",0.570426692895335,0.755603542170174,"L.LvsV.SCHLINGEMANN_SKIN_CARCINOGENESIS_TPA_DN"
81,"Up",0.57106511150434,0.756268024313173,"L.LvsV.KEGG_RIG_I_LIKE_RECEPTOR_SIGNALING_PATHWAY"
167,"Down",0.572442661240139,0.757910793581592,"L.LvsV.BOYLAN_MULTIPLE_MYELOMA_PCA3_UP"
126,"Down",0.572658366114688,0.758014868625356,"L.LvsV.YAO_HOXA10_TARGETS_VIA_PROGESTERONE_UP"
13,"Up",0.572822758975337,0.758050989558314,"L.LvsV.MIKKELSEN_NPC_ICP_WITH_H3K27ME3"
31,"Down",0.573296936794327,0.758496952269882,"L.LvsV.MAINA_VHL_TARGETS_DN"
61,"Down",0.573928384211635,0.759043882318596,"L.LvsV.REACTOME_KINESINS"
169,"Down",0.574037270101191,0.759043882318596,"L.LvsV.REACTOME_HIV_LIFE_CYCLE"
50,"Down",0.574122176859535,0.759043882318596,"L.LvsV.ONO_FOXP3_TARGETS_DN"
49,"Down",0.574428452426423,0.759090059912843,"L.LvsV.ONO_AML1_TARGETS_DN"
34,"Up",0.574442792464865,0.759090059912843,"L.LvsV.YANAGISAWA_LUNG_CANCER_RECURRENCE"
42,"Up",0.574568981865662,0.759090059912843,"L.LvsV.BONOME_OVARIAN_CANCER_POOR_SURVIVAL_DN"
39,"Up",0.574791491565455,0.759202617502485,"L.LvsV.YIH_RESPONSE_TO_ARSENITE_C3"
284,"Down",0.575195197776873,0.759554394198312,"L.LvsV.BIDUS_METASTASIS_UP"
35,"Down",0.575340989388739,0.759565503899317,"L.LvsV.REACTOME_GLUCAGON_SIGNALING_IN_METABOLIC_REGULATION"
8,"Down",0.575532553491855,0.759637022739667,"L.LvsV.LE_SKI_TARGETS_DN"
56,"Down",0.575959098123253,0.76001858079319,"L.LvsV.BIOCARTA_ERK_PATHWAY"
16,"Up",0.576226599064677,0.760190137491911,"L.LvsV.REACTOME_NUCLEOTIDE_LIKE_PURINERGIC_RECEPTORS"
268,"Down",0.576723734581313,0.760664486760515,"L.LvsV.DARWICHE_PAPILLOMA_RISK_LOW_UP"
48,"Up",0.577738887547643,0.761821681195068,"L.LvsV.JACKSON_DNMT1_TARGETS_DN"
30,"Down",0.57815299275483,0.762143986139135,"L.LvsV.BIOCARTA_CCR5_PATHWAY"
52,"Up",0.578292297714301,0.762143986139135,"L.LvsV.REACTOME_DIGESTION_AND_ABSORPTION"
31,"Down",0.578396846778769,0.762143986139135,"L.LvsV.OUYANG_PROSTATE_CANCER_PROGRESSION_UP"
325,"Down",0.578816537755023,0.762515281688712,"L.LvsV.WIERENGA_STAT5A_TARGETS_UP"
34,"Up",0.57903212791469,0.762617588194455,"L.LvsV.PETRETTO_HEART_MASS_QTL_CIS_DN"
14,"Down",0.579374496415655,0.76271899026082,"L.LvsV.REACTOME_ROBO_RECEPTORS_BIND_AKAP5"
9,"Down",0.579565019391147,0.76271899026082,"L.LvsV.FUNG_IL2_TARGETS_WITH_STAT5_BINDING_SITES"
9,"Down",0.579634371727954,0.76271899026082,"L.LvsV.RODRIGUES_DCC_TARGETS_UP"
15,"Down",0.579756630927384,0.76271899026082,"L.LvsV.PID_INTEGRIN4_PATHWAY"
31,"Down",0.579798863459256,0.76271899026082,"L.LvsV.CAFFAREL_RESPONSE_TO_THC_8HR_5_UP"
66,"Down",0.579938122760697,0.762720713783038,"L.LvsV.KEGG_TYPE_II_DIABETES_MELLITUS"
23,"Down",0.580960493657564,0.763719608580565,"L.LvsV.MANN_RESPONSE_TO_AMIFOSTINE_UP"
1106,"Down",0.580973896489394,0.763719608580565,"L.LvsV.KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP"
38,"Up",0.581423648458396,0.763796634946974,"L.LvsV.REACTOME_TAK1_ACTIVATES_NFKB_BY_PHOSPHORYLATION_AND_ACTIVATION_OF_IKKS_COMPLEX"
201,"Up",0.581558247569294,0.763796634946974,"L.LvsV.BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_CIS"
9,"Up",0.58155958871357,0.763796634946974,"L.LvsV.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_2"
407,"Up",0.581585066581074,0.763796634946974,"L.LvsV.REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES"
11,"Up",0.582208679694099,0.764337792407541,"L.LvsV.ZHU_SKIL_TARGETS_DN"
1648,"Up",0.582544835651724,0.764337792407541,"L.LvsV.REACTOME_INNATE_IMMUNE_SYSTEM"
16,"Up",0.582554437107353,0.764337792407541,"L.LvsV.REACTOME_UPTAKE_AND_FUNCTION_OF_ANTHRAX_TOXINS"
14,"Up",0.582612942170855,0.764337792407541,"L.LvsV.CHEOK_RESPONSE_TO_MERCAPTOPURINE_UP"
309,"Down",0.582688333332932,0.764337792407541,"L.LvsV.NABA_ECM_REGULATORS"
29,"Up",0.583376239296739,0.7649017308331,"L.LvsV.BIOCARTA_BARR_MAPK_PATHWAY"
179,"Up",0.583466486836292,0.7649017308331,"L.LvsV.REACTOME_CLATHRIN_MEDIATED_ENDOCYTOSIS"
179,"Down",0.583533279192262,0.7649017308331,"L.LvsV.BOUDOUKHA_BOUND_BY_IGF2BP2"
57,"Down",0.584255975453607,0.765424594951148,"L.LvsV.THILLAINADESAN_ZNF217_TARGETS_UP"
63,"Up",0.584319249213227,0.765424594951148,"L.LvsV.ZHAN_MULTIPLE_MYELOMA_LB_DN"
27,"Down",0.584450553603358,0.765424594951148,"L.LvsV.KORKOLA_TERATOMA_UP"
89,"Up",0.584618134717135,0.765424594951148,"L.LvsV.ZHAN_MULTIPLE_MYELOMA_MS_DN"
52,"Down",0.58462435602798,0.765424594951148,"L.LvsV.MAEKAWA_ATF2_TARGETS"
134,"Down",0.585545485029188,0.766285828201724,"L.LvsV.FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_DN"
11,"Down",0.585559346021393,0.766285828201724,"L.LvsV.BIOCARTA_CACAM_PATHWAY"
21,"Down",0.58593964721693,0.766559196920649,"L.LvsV.REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_METHYLATION"
6,"Down",0.586139304169562,0.766559196920649,"L.LvsV.NAKAMURA_BRONCHIAL_AND_BRONCHIOLAR_EPITHELIA"
38,"Down",0.586184171564569,0.766559196920649,"L.LvsV.REACTOME_INTEGRIN_SIGNALING"
22,"Down",0.586409092012558,0.766646601764977,"L.LvsV.REACTOME_CHONDROITIN_SULFATE_BIOSYNTHESIS"
323,"Up",0.586528327991654,0.766646601764977,"L.LvsV.VILLANUEVA_LIVER_CANCER_KRT19_UP"
30,"Up",0.587437101904734,0.767652974812402,"L.LvsV.PID_TRAIL_PATHWAY"
160,"Up",0.58840727891438,0.768739093836864,"L.LvsV.SANA_RESPONSE_TO_IFNG_UP"
67,"Down",0.588920715910683,0.769228121490708,"L.LvsV.NGUYEN_NOTCH1_TARGETS_UP"
147,"Up",0.589506212021658,0.769811017068433,"L.LvsV.KYNG_DNA_DAMAGE_BY_GAMMA_AND_UV_RADIATION"
65,"Down",0.590448594440278,0.770685019106453,"L.LvsV.GROSS_HYPOXIA_VIA_ELK3_ONLY_DN"
10,"Down",0.590553128812761,0.770685019106453,"L.LvsV.REACTOME_CALCITONIN_LIKE_LIGAND_RECEPTORS"
27,"Down",0.590721313358441,0.770685019106453,"L.LvsV.BIOCARTA_CHREBP_PATHWAY"
137,"Down",0.590736872974995,0.770685019106453,"L.LvsV.KYNG_DNA_DAMAGE_BY_GAMMA_RADIATION"
337,"Down",0.590872453606846,0.770685019106453,"L.LvsV.YAMAZAKI_TCEB3_TARGETS_UP"
10,"Down",0.591143910290042,0.770717884075986,"L.LvsV.REACTOME_SCAVENGING_BY_CLASS_F_RECEPTORS"
575,"Down",0.591265526532312,0.770717884075986,"L.LvsV.MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP"
15,"Up",0.591315837267197,0.770717884075986,"L.LvsV.GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP"
156,"Down",0.591998902304805,0.771308944077732,"L.LvsV.FONTAINE_PAPILLARY_THYROID_CARCINOMA_DN"
115,"Up",0.592048319527201,0.771308944077732,"L.LvsV.DARWICHE_PAPILLOMA_PROGRESSION_RISK"
7,"Up",0.592456021069582,0.77165826631183,"L.LvsV.BAKER_HEMATOPOESIS_STAT5_TARGETS"
9,"Down",0.593074344975029,0.772147026747794,"L.LvsV.BRUNEAU_SEPTATION_ATRIAL"
119,"Down",0.593193457408522,0.772147026747794,"L.LvsV.HOWLIN_PUBERTAL_MAMMARY_GLAND"
140,"Down",0.593291432037072,0.772147026747794,"L.LvsV.BILBAN_B_CLL_LPL_UP"
13,"Up",0.593389892684279,0.772147026747794,"L.LvsV.REACTOME_GAP_JUNCTION_DEGRADATION"
62,"Up",0.593621260896141,0.77226634152818,"L.LvsV.LY_AGING_PREMATURE_DN"
30,"Down",0.593770048849691,0.772278193387424,"L.LvsV.HOLLEMAN_ASPARAGINASE_RESISTANCE_ALL_DN"
116,"Down",0.593938058613116,0.772315034353697,"L.LvsV.REACTOME_POST_TRANSLATIONAL_MODIFICATION_SYNTHESIS_OF_GPI_ANCHORED_PROTEINS"
14,"Down",0.594543140745917,0.772912817019482,"L.LvsV.REACTOME_JOSEPHIN_DOMAIN_DUBS"
220,"Up",0.594677360029097,0.772912817019482,"L.LvsV.KEGG_ENDOCYTOSIS"
10,"Down",0.594834632398731,0.772935530559949,"L.LvsV.REACTOME_NOSTRIN_MEDIATED_ENOS_TRAFFICKING"
11,"Down",0.595030548775404,0.773008436132333,"L.LvsV.REACTOME_DERMATAN_SULFATE_BIOSYNTHESIS"
8,"Down",0.595222540817371,0.773076210518968,"L.LvsV.REACTOME_RELAXIN_RECEPTORS"
45,"Down",0.595552101717966,0.77317033071112,"L.LvsV.MURATA_VIRULENCE_OF_H_PILORI"
13,"Down",0.595574685928497,0.77317033071112,"L.LvsV.REACTOME_MET_ACTIVATES_RAS_SIGNALING"
188,"Up",0.596121621247061,0.773529094255723,"L.LvsV.ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION"
74,"Down",0.596264711782019,0.773529094255723,"L.LvsV.DAVIES_MULTIPLE_MYELOMA_VS_MGUS_DN"
109,"Down",0.596270754154077,0.773529094255723,"L.LvsV.FIGUEROA_AML_METHYLATION_CLUSTER_5_DN"
7,"Up",0.596597095428433,0.77368511392765,"L.LvsV.REACTOME_ELECTRIC_TRANSMISSION_ACROSS_GAP_JUNCTIONS"
94,"Down",0.596736699973348,0.77368511392765,"L.LvsV.BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_UP"
9,"Up",0.596850114197343,0.77368511392765,"L.LvsV.REACTOME_RRNA_MODIFICATION_IN_THE_MITOCHONDRION"
19,"Down",0.596950749867129,0.77368511392765,"L.LvsV.SA_PROGRAMMED_CELL_DEATH"
14,"Down",0.597271187708827,0.773757917213669,"L.LvsV.GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_DN"
14,"Down",0.59739064994871,0.773757917213669,"L.LvsV.REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_SEVERAL_ADDITIONAL_CELL_DEATH_GENES_WHOSE_SPECIFIC_ROLES_IN_P53_DEPENDENT_APOPTOSIS_REMAIN_UNCERTAIN"
22,"Up",0.597443521481166,0.773757917213669,"L.LvsV.REACTOME_ACETYLCHOLINE_NEUROTRANSMITTER_RELEASE_CYCLE"
65,"Up",0.597608441020971,0.773757917213669,"L.LvsV.CHOI_ATL_STAGE_PREDICTOR"
95,"Up",0.597706649379559,0.773757917213669,"L.LvsV.DANG_REGULATED_BY_MYC_UP"
9,"Down",0.597897913473421,0.773824336047413,"L.LvsV.REACTOME_OREXIN_AND_NEUROPEPTIDES_FF_AND_QRFP_BIND_TO_THEIR_RESPECTIVE_RECEPTORS"
6,"Down",0.599016853049266,0.775091078986518,"L.LvsV.SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX2_UP"
25,"Down",0.600248263261773,0.776256969008684,"L.LvsV.WEBER_METHYLATED_IN_COLON_CANCER"
231,"Down",0.600428618392366,0.776256969008684,"L.LvsV.BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_DN"
43,"Down",0.600514855431271,0.776256969008684,"L.LvsV.FOURNIER_ACINAR_DEVELOPMENT_LATE_DN"
15,"Up",0.600587284869396,0.776256969008684,"L.LvsV.RAFFEL_VEGFA_TARGETS_UP"
144,"Up",0.600619879439166,0.776256969008684,"L.LvsV.TAKAO_RESPONSE_TO_UVB_RADIATION_UP"
21,"Down",0.60079899161206,0.776306993368329,"L.LvsV.BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_48HR_UP"
95,"Down",0.600966629288614,0.776342171340361,"L.LvsV.WIERENGA_STAT5A_TARGETS_GROUP2"
18,"Up",0.601590069869946,0.776966011752145,"L.LvsV.SHIN_B_CELL_LYMPHOMA_CLUSTER_1"
19,"Down",0.601892238015844,0.777174727694909,"L.LvsV.REACTOME_TRANSLESION_SYNTHESIS_BY_POLK"
6,"Down",0.602451842345044,0.777357014872006,"L.LvsV.REACTOME_MITOCHONDRIAL_FATTY_ACID_BETA_OXIDATION_OF_UNSATURATED_FATTY_ACIDS"
120,"Down",0.602562458474067,0.777357014872006,"L.LvsV.HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_DN"
22,"Up",0.602662941936,0.777357014872006,"L.LvsV.NADERI_BREAST_CANCER_PROGNOSIS_DN"
645,"Down",0.602682114877235,0.777357014872006,"L.LvsV.MONNIER_POSTRADIATION_TUMOR_ESCAPE_DN"
44,"Up",0.602855506791923,0.777357014872006,"L.LvsV.YANG_BREAST_CANCER_ESR1_BULK_DN"
114,"Down",0.602908482423888,0.777357014872006,"L.LvsV.SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP"
50,"Down",0.603076184287124,0.777357014872006,"L.LvsV.BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_DN"
26,"Down",0.603158182998898,0.777357014872006,"L.LvsV.PHESSE_TARGETS_OF_APC_AND_MBD2_UP"
65,"Down",0.60338333523783,0.777465966098802,"L.LvsV.ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_UP"
29,"Down",0.603648995328201,0.777627049200751,"L.LvsV.IVANOVA_HEMATOPOIESIS_STEM_CELL_SHORT_TERM"
1034,"Down",0.604182409834679,0.778069043614416,"L.LvsV.GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP"
17,"Up",0.604279310107483,0.778069043614416,"L.LvsV.REACTOME_ELEVATION_OF_CYTOSOLIC_CA2_LEVELS"
28,"Up",0.604414277866507,0.778069043614416,"L.LvsV.REACTOME_TELOMERE_C_STRAND_LAGGING_STRAND_SYNTHESIS"
1113,"Down",0.605007483525003,0.778286759262041,"L.LvsV.MARTINEZ_RB1_TARGETS_UP"
14,"Up",0.605069635349074,0.778286759262041,"L.LvsV.WEBER_METHYLATED_LCP_IN_FIBROBLAST_DN"
154,"Down",0.605221764452166,0.778286759262041,"L.LvsV.OUILLETTE_CLL_13Q14_DELETION_UP"
544,"Down",0.605229266180688,0.778286759262041,"L.LvsV.SHEN_SMARCA2_TARGETS_UP"
5,"Down",0.605287224602419,0.778286759262041,"L.LvsV.TURJANSKI_MAPK11_TARGETS"
33,"Down",0.6058360466037,0.778443955771331,"L.LvsV.GHO_ATF5_TARGETS_DN"
190,"Down",0.605850125161484,0.778443955771331,"L.LvsV.KEGG_CALCIUM_SIGNALING_PATHWAY"
46,"Down",0.605950292232022,0.778443955771331,"L.LvsV.REACTOME_SYNTHESIS_OF_ACTIVE_UBIQUITIN_ROLES_OF_E1_AND_E2_ENZYMES"
23,"Down",0.605972650685442,0.778443955771331,"L.LvsV.REACTOME_ASSEMBLY_OF_THE_HIV_VIRION"
233,"Up",0.606335891065342,0.778729649640018,"L.LvsV.RASHI_RESPONSE_TO_IONIZING_RADIATION_6"
88,"Up",0.60662382639658,0.778918517451624,"L.LvsV.KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION"
556,"Up",0.606849696613535,0.779027623073191,"L.LvsV.POOLA_INVASIVE_BREAST_CANCER_UP"
22,"Up",0.607141262564927,0.779072362772046,"L.LvsV.BIOCARTA_D4GDI_PATHWAY"
134,"Up",0.607166361219885,0.779072362772046,"L.LvsV.CHICAS_RB1_TARGETS_LOW_SERUM"
109,"Down",0.607478689229562,0.779174515441395,"L.LvsV.SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN"
8,"Down",0.607614795636951,0.779174515441395,"L.LvsV.RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_MAPK1_DN"
28,"Down",0.607804561651494,0.779174515441395,"L.LvsV.NIKOLSKY_BREAST_CANCER_22Q13_AMPLICON"
165,"Up",0.608008893190148,0.779174515441395,"L.LvsV.HATADA_METHYLATED_IN_LUNG_CANCER_DN"
16,"Down",0.60815826779226,0.779174515441395,"L.LvsV.KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_UV_IN_WS"
12,"Up",0.608404218077229,0.779174515441395,"L.LvsV.VANDESLUIS_NORMAL_EMBRYOS_UP"
156,"Up",0.60841674702026,0.779174515441395,"L.LvsV.KOHOUTEK_CCNT2_TARGETS"
21,"Down",0.608450003851305,0.779174515441395,"L.LvsV.IRITANI_MAD1_TARGETS_UP"
51,"Up",0.608769897831551,0.779174515441395,"L.LvsV.REACTOME_CLASS_C_3_METABOTROPIC_GLUTAMATE_PHEROMONE_RECEPTORS"
95,"Up",0.608939027481249,0.779174515441395,"L.LvsV.KYNG_DNA_DAMAGE_BY_4NQO_OR_UV"
41,"Down",0.609008030258002,0.779174515441395,"L.LvsV.GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_DN"
17,"Up",0.609182738972047,0.779174515441395,"L.LvsV.REACTOME_ADVANCED_GLYCOSYLATION_ENDPRODUCT_RECEPTOR_SIGNALING"
945,"Up",0.609198500712075,0.779174515441395,"L.LvsV.KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_UP"
5,"Down",0.609301061411814,0.779174515441395,"L.LvsV.REACTOME_MUSCARINIC_ACETYLCHOLINE_RECEPTORS"
9,"Up",0.609426082370158,0.779174515441395,"L.LvsV.REACTOME_SMALL_INTERFERING_RNA_SIRNA_BIOGENESIS"
108,"Down",0.609500773970706,0.779174515441395,"L.LvsV.GAVIN_FOXP3_TARGETS_CLUSTER_P2"
139,"Up",0.610203821865056,0.779892956794243,"L.LvsV.GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP"
341,"Down",0.611153166559957,0.780466294689181,"L.LvsV.GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_DN"
8,"Down",0.611259601123242,0.780466294689181,"L.LvsV.BIOCARTA_RNAPOL3_PATHWAY"
11,"Down",0.611357142207205,0.780466294689181,"L.LvsV.REACTOME_ABACAVIR_METABOLISM"
198,"Up",0.611405702586782,0.780466294689181,"L.LvsV.REACTOME_FCGR_ACTIVATION"
30,"Up",0.611441430370778,0.780466294689181,"L.LvsV.REACTOME_CD28_DEPENDENT_PI3K_AKT_SIGNALING"
48,"Down",0.611546920006665,0.780466294689181,"L.LvsV.PID_HIF2PATHWAY"
109,"Up",0.611640523582605,0.780466294689181,"L.LvsV.LEE_EARLY_T_LYMPHOCYTE_DN"
202,"Up",0.612244525283427,0.78100583760383,"L.LvsV.HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN"
17,"Up",0.6123458683329,0.78100583760383,"L.LvsV.BIOCARTA_IL10_PATHWAY"
46,"Down",0.612493584419086,0.781014074781625,"L.LvsV.MARSHALL_VIRAL_INFECTION_RESPONSE_DN"
20,"Down",0.612813795292881,0.781172295272139,"L.LvsV.RODRIGUES_THYROID_CARCINOMA_UP"
20,"Up",0.612900238178792,0.781172295272139,"L.LvsV.SA_PTEN_PATHWAY"
16,"Up",0.613303390551396,0.781398877811803,"L.LvsV.YAGUE_PRETUMOR_DRUG_RESISTANCE_UP"
26,"Up",0.613360667336448,0.781398877811803,"L.LvsV.NAM_FXYD5_TARGETS_DN"
69,"Up",0.613606173456277,0.781531567159584,"L.LvsV.PEART_HDAC_PROLIFERATION_CLUSTER_UP"
12,"Down",0.614378840737427,0.782224265017476,"L.LvsV.TESAR_JAK_TARGETS_MOUSE_ES_D3_DN"
246,"Down",0.614432986610761,0.782224265017476,"L.LvsV.SASAKI_ADULT_T_CELL_LEUKEMIA"
78,"Down",0.614588071241582,0.782241585150715,"L.LvsV.FAELT_B_CLL_WITH_VH3_21_UP"
17,"Up",0.614978951756024,0.782558946895065,"L.LvsV.NAGY_TFTC_COMPONENTS_HUMAN"
13,"Down",0.615267480986022,0.782670365805784,"L.LvsV.SCHLESINGER_METHYLATED_IN_COLON_CANCER"
107,"Down",0.615373621964285,0.782670365805784,"L.LvsV.JOHNSTONE_PARVB_TARGETS_1_DN"
439,"Up",0.615491182948734,0.782670365805784,"L.LvsV.LIU_SOX4_TARGETS_DN"
6,"Down",0.615779139249221,0.782754573635396,"L.LvsV.BIOCARTA_SAM68_PATHWAY"
176,"Down",0.615894109992922,0.782754573635396,"L.LvsV.ZHONG_SECRETOME_OF_LUNG_CANCER_AND_ENDOTHELIUM"
96,"Up",0.615982121520638,0.782754573635396,"L.LvsV.REACTOME_CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY"
66,"Up",0.616164449000907,0.782806350764249,"L.LvsV.REACTOME_TRNA_PROCESSING_IN_THE_NUCLEUS"
12,"Down",0.616493201244357,0.783044086763164,"L.LvsV.KEGG_TAURINE_AND_HYPOTAURINE_METABOLISM"
303,"Down",0.616984627893599,0.783488288383948,"L.LvsV.FOSTER_KDM1A_TARGETS_DN"
17,"Down",0.617357697116548,0.783690970529001,"L.LvsV.REACTOME_REPRESSION_OF_WNT_TARGET_GENES"
114,"Down",0.617427720677217,0.783690970529001,"L.LvsV.GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_DN"
68,"Up",0.617802932287935,0.7838287045597,"L.LvsV.REACTOME_DEGRADATION_OF_GLI1_BY_THE_PROTEASOME"
42,"Up",0.61781976749343,0.7838287045597,"L.LvsV.BURTON_ADIPOGENESIS_12"
55,"Down",0.618140275011605,0.783903522352125,"L.LvsV.NAKAYAMA_FRA2_TARGETS"
15,"Down",0.618286851665062,0.783903522352125,"L.LvsV.REACTOME_LIPOPHAGY"
13,"Down",0.618415158668661,0.783903522352125,"L.LvsV.REACTOME_PROCESSING_AND_ACTIVATION_OF_SUMO"
57,"Down",0.618445860824737,0.783903522352125,"L.LvsV.WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_UP"
41,"Up",0.618803654018297,0.7841772640539,"L.LvsV.REACTOME_FANCONI_ANEMIA_PATHWAY"
8,"Down",0.61983075042229,0.785175975175847,"L.LvsV.REACTOME_PTK6_REGULATES_CELL_CYCLE"
177,"Down",0.619875769875669,0.785175975175847,"L.LvsV.REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS"
181,"Up",0.620357391264411,0.785448142437237,"L.LvsV.MISSIAGLIA_REGULATED_BY_METHYLATION_DN"
13,"Down",0.620730492150001,0.785448142437237,"L.LvsV.REACTOME_CAMK_IV_MEDIATED_PHOSPHORYLATION_OF_CREB"
13,"Down",0.620730492150001,0.785448142437237,"L.LvsV.REACTOME_CREB1_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_CAMKII_CAMKK_CAMKIV_CASCASDE"
9,"Up",0.620833158872365,0.785448142437237,"L.LvsV.REACTOME_DNA_DAMAGE_REVERSAL"
18,"Up",0.620937042761723,0.785448142437237,"L.LvsV.PARK_TRETINOIN_RESPONSE"
18,"Down",0.620942997032585,0.785448142437237,"L.LvsV.REACTOME_NEUROTRANSMITTER_CLEARANCE"
170,"Up",0.621100920242336,0.785468204030164,"L.LvsV.JI_RESPONSE_TO_FSH_UP"
10,"Up",0.621404650221517,0.785672607151788,"L.LvsV.REACTOME_HYDROLYSIS_OF_LPC"
10,"Up",0.622000906159195,0.78624668727805,"L.LvsV.HEIDENBLAD_AMPLIFIED_IN_BONE_CANCER"
62,"Down",0.622420531217514,0.786597283908944,"L.LvsV.KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_UP"
143,"Down",0.622883619737056,0.786943760329476,"L.LvsV.SCHLOSSER_SERUM_RESPONSE_AUGMENTED_BY_MYC"
23,"Down",0.623044499088858,0.786943760329476,"L.LvsV.KOBAYASHI_RESPONSE_TO_ROMIDEPSIN"
40,"Down",0.623121682532546,0.786943760329476,"L.LvsV.DUTTA_APOPTOSIS_VIA_NFKB"
357,"Down",0.623548778390184,0.787303310280733,"L.LvsV.JISON_SICKLE_CELL_DISEASE_UP"
98,"Down",0.623896505255567,0.787562506291787,"L.LvsV.VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_UP"
15,"Down",0.624195646888586,0.787760267438254,"L.LvsV.REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_TO_CONTROL_BILE_ACID_HOMEOSTASIS"
4,"Down",0.624570410200624,0.787940584113528,"L.LvsV.DER_IFN_ALPHA_RESPONSE_DN"
1893,"Up",0.624722226179466,0.787940584113528,"L.LvsV.DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_UP"
8,"Down",0.624780025963018,0.787940584113528,"L.LvsV.REACTOME_DEFECTIVE_CHST6_CAUSES_MCDC1"
129,"Down",0.624908565986222,0.787940584113528,"L.LvsV.SANA_RESPONSE_TO_IFNG_DN"
87,"Up",0.625098822521718,0.788000772850566,"L.LvsV.KYNG_DNA_DAMAGE_BY_UV"
211,"Up",0.625485704147371,0.788308743613134,"L.LvsV.REACTOME_INITIAL_TRIGGERING_OF_COMPLEMENT"
8,"Down",0.625867158137506,0.78857406704184,"L.LvsV.REACTOME_ESTROGEN_STIMULATED_SIGNALING_THROUGH_PRKCZ"
255,"Up",0.625981475899192,0.78857406704184,"L.LvsV.ALCALAY_AML_BY_NPM1_LOCALIZATION_DN"
48,"Down",0.626324419672585,0.788668386098245,"L.LvsV.GRADE_COLON_VS_RECTAL_CANCER_UP"
16,"Up",0.626341632005316,0.788668386098245,"L.LvsV.BIOCARTA_P27_PATHWAY"
50,"Down",0.62654395071053,0.788743511720974,"L.LvsV.BIOCARTA_IL1R_PATHWAY"
56,"Up",0.626810135844838,0.7888989849957,"L.LvsV.REACTOME_HEPARAN_SULFATE_HEPARIN_HS_GAG_METABOLISM"
104,"Down",0.627315606676862,0.789355482320521,"L.LvsV.CHIBA_RESPONSE_TO_TSA_UP"
31,"Down",0.627682547654005,0.789637498516267,"L.LvsV.FERRARI_RESPONSE_TO_FENRETINIDE_UP"
165,"Up",0.628232987661891,0.789979097014446,"L.LvsV.REACTOME_MITOTIC_G1_PHASE_AND_G1_S_TRANSITION"
833,"Up",0.628239842570541,0.789979097014446,"L.LvsV.BERENJENO_TRANSFORMED_BY_RHOA_UP"
12,"Up",0.628542511292495,0.790078472320816,"L.LvsV.WANG_THOC1_TARGETS_UP"
44,"Up",0.628783414623944,0.790078472320816,"L.LvsV.REACTOME_BETA_DEFENSINS"
17,"Up",0.62879949354269,0.790078472320816,"L.LvsV.REACTOME_TRYPTOPHAN_CATABOLISM"
175,"Down",0.629025165069443,0.790078472320816,"L.LvsV.KAN_RESPONSE_TO_ARSENIC_TRIOXIDE"
29,"Down",0.629033357778302,0.790078472320816,"L.LvsV.REACTOME_RIPK1_MEDIATED_REGULATED_NECROSIS"
78,"Up",0.629977677110953,0.791066025160225,"L.LvsV.PAL_PRMT5_TARGETS_DN"
274,"Up",0.630105765021818,0.791066025160225,"L.LvsV.CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN"
28,"Up",0.630555219293246,0.79142003228906,"L.LvsV.PID_HIF1A_PATHWAY"
41,"Down",0.630674021028323,0.79142003228906,"L.LvsV.REACTOME_EGR2_AND_SOX10_MEDIATED_INITIATION_OF_SCHWANN_CELL_MYELINATION"
700,"Down",0.630897496423147,0.791520820903921,"L.LvsV.MILI_PSEUDOPODIA_CHEMOTAXIS_DN"
8,"Up",0.631364301203705,0.791926774354647,"L.LvsV.BIOCARTA_BARD1_PATHWAY"
24,"Down",0.632487588561724,0.793155789784026,"L.LvsV.REACTOME_RNA_POLYMERASE_III_TRANSCRIPTION_TERMINATION"
29,"Down",0.633363499832486,0.794074102170933,"L.LvsV.YAN_ESCAPE_FROM_ANOIKIS"
14,"Up",0.634221405589216,0.794848911902712,"L.LvsV.REACTOME_GLUTAMATE_AND_GLUTAMINE_METABOLISM"
32,"Down",0.634269017781654,0.794848911902712,"L.LvsV.BIOCARTA_EPO_PATHWAY"
60,"Up",0.634714330734312,0.795226724366647,"L.LvsV.BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_UP"
70,"Down",0.635218785880636,0.795434528465065,"L.LvsV.ROZANOV_MMP14_TARGETS_SUBSET"
13,"Down",0.6352395896043,0.795434528465065,"L.LvsV.BIOCARTA_RNA_PATHWAY"
162,"Down",0.635318489994586,0.795434528465065,"L.LvsV.WESTON_VEGFA_TARGETS"
52,"Up",0.635455654228648,0.795434528465065,"L.LvsV.LEIN_LOCALIZED_TO_PROXIMAL_DENDRITES"
272,"Up",0.636024644119435,0.795966558926292,"L.LvsV.REACTOME_FCERI_MEDIATED_NF_KB_ACTIVATION"
13,"Up",0.636534968490336,0.796424946997752,"L.LvsV.BIOCARTA_PLCE_PATHWAY"
52,"Down",0.636805768206449,0.796435948805506,"L.LvsV.REACTOME_FORMATION_OF_FIBRIN_CLOT_CLOTTING_CASCADE"
254,"Down",0.63692011834512,0.796435948805506,"L.LvsV.PUJANA_XPRSS_INT_NETWORK"
52,"Up",0.63703622575833,0.796435948805506,"L.LvsV.XU_RESPONSE_TO_TRETINOIN_UP"
211,"Up",0.637119949641301,0.796435948805506,"L.LvsV.SCHLOSSER_MYC_TARGETS_REPRESSED_BY_SERUM"
21,"Up",0.63765553191994,0.796782414305864,"L.LvsV.ROETH_TERT_TARGETS_DN"
178,"Up",0.637743564986901,0.796782414305864,"L.LvsV.WHITFIELD_CELL_CYCLE_G1_S"
21,"Down",0.637829438545443,0.796782414305864,"L.LvsV.GOERING_BLOOD_HDL_CHOLESTEROL_QTL_CIS"
46,"Down",0.638417259380896,0.797336577166698,"L.LvsV.HWANG_PROSTATE_CANCER_MARKERS"
14,"Up",0.638852325673923,0.797596675045613,"L.LvsV.REACTOME_DEGRADATION_OF_CYSTEINE_AND_HOMOCYSTEINE"
115,"Up",0.638914030344913,0.797596675045613,"L.LvsV.REACTOME_INTERLEUKIN_1_SIGNALING"
325,"Up",0.639689564695136,0.798384560541626,"L.LvsV.REACTOME_DEUBIQUITINATION"
145,"Up",0.639834353027534,0.798385045788588,"L.LvsV.MARCHINI_TRABECTEDIN_RESISTANCE_DN"
67,"Down",0.640110768353331,0.79854973786678,"L.LvsV.JAZAG_TGFB1_SIGNALING_DN"
120,"Down",0.641344653983882,0.799669648064002,"L.LvsV.CHUNG_BLISTER_CYTOTOXICITY_DN"
19,"Down",0.641352656079182,0.799669648064002,"L.LvsV.REACTOME_INTERLEUKIN_15_SIGNALING"
666,"Down",0.641442374600081,0.799669648064002,"L.LvsV.FOSTER_KDM1A_TARGETS_UP"
356,"Down",0.641683596818993,0.799790037604196,"L.LvsV.LEE_RECENT_THYMIC_EMIGRANT"
120,"Up",0.642341111993664,0.800398676744092,"L.LvsV.REACTOME_CLEC7A_DECTIN_1_SIGNALING"
9,"Down",0.642461444635609,0.800398676744092,"L.LvsV.REACTOME_HISTIDINE_CATABOLISM"
172,"Up",0.642749474525389,0.8004077631819,"L.LvsV.YAMASHITA_LIVER_CANCER_STEM_CELL_DN"
1130,"Up",0.642758268860126,0.8004077631819,"L.LvsV.REACTOME_ADAPTIVE_IMMUNE_SYSTEM"
27,"Up",0.643228759731004,0.800813288122658,"L.LvsV.REACTOME_SYNTHESIS_OF_EPOXY_EET_AND_DIHYDROXYEICOSATRIENOIC_ACIDS_DHET"
13,"Up",0.643396414122584,0.800841687006701,"L.LvsV.HOLLERN_SOLID_NODULAR_BREAST_TUMOR_UP"
34,"Up",0.64367052099526,0.801002545708483,"L.LvsV.NIKOLSKY_BREAST_CANCER_5P15_AMPLICON"
228,"Up",0.644365402873112,0.801633234724194,"L.LvsV.REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_BCR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS"
18,"Up",0.644467304819867,0.801633234724194,"L.LvsV.REACTOME_GLYCOGEN_SYNTHESIS"
43,"Down",0.644989635224106,0.802102495086388,"L.LvsV.REACTOME_REGULATION_OF_TNFR1_SIGNALING"
82,"Down",0.64516152943543,0.802116049740516,"L.LvsV.LINDSTEDT_DENDRITIC_CELL_MATURATION_A"
50,"Down",0.645290683531527,0.802116049740516,"L.LvsV.BRACHAT_RESPONSE_TO_CISPLATIN"
133,"Down",0.64560325059539,0.802157660211019,"L.LvsV.VANTVEER_BREAST_CANCER_METASTASIS_UP"
48,"Down",0.64564137389973,0.802157660211019,"L.LvsV.GHANDHI_DIRECT_IRRADIATION_DN"
65,"Down",0.645905573897663,0.802157660211019,"L.LvsV.NAKAMURA_CANCER_MICROENVIRONMENT_UP"
701,"Down",0.646033906697312,0.802157660211019,"L.LvsV.ENK_UV_RESPONSE_KERATINOCYTE_DN"
13,"Down",0.646049567900103,0.802157660211019,"L.LvsV.REACTOME_MINERALOCORTICOID_BIOSYNTHESIS"
110,"Down",0.646480599474986,0.802512625616793,"L.LvsV.LIN_MELANOMA_COPY_NUMBER_UP"
65,"Down",0.646949944676582,0.802914981844404,"L.LvsV.WONG_PROTEASOME_GENE_MODULE"
70,"Down",0.647181686807963,0.803012918461413,"L.LvsV.WANG_TARGETS_OF_MLL_CBP_FUSION_UP"
291,"Down",0.647319330363993,0.803012918461413,"L.LvsV.SHEPARD_BMYB_MORPHOLINO_UP"
183,"Up",0.647713538459937,0.803321703486987,"L.LvsV.GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP"
48,"Down",0.648030039154209,0.803533995623149,"L.LvsV.HEIDENBLAD_AMPLICON_12P11_12_UP"
13,"Down",0.649459299130893,0.804567376775242,"L.LvsV.PETRETTO_BLOOD_PRESSURE_DN"
8,"Down",0.649478124137966,0.804567376775242,"L.LvsV.LOPEZ_MESOTHELIOMA_SURVIVAL_WORST_VS_BEST_DN"
54,"Up",0.649552996812154,0.804567376775242,"L.LvsV.MARZEC_IL2_SIGNALING_DN"
5,"Up",0.649604170143699,0.804567376775242,"L.LvsV.REACTOME_FREE_FATTY_ACID_RECEPTORS"
788,"Down",0.649711579924357,0.804567376775242,"L.LvsV.SENESE_HDAC3_TARGETS_DN"
227,"Up",0.649736541382068,0.804567376775242,"L.LvsV.SUNG_METASTASIS_STROMA_UP"
73,"Down",0.64994652504713,0.804647186964976,"L.LvsV.ZHAN_V1_LATE_DIFFERENTIATION_GENES_UP"
47,"Down",0.650392722807966,0.80501933387178,"L.LvsV.BIOCARTA_BIOPEPTIDES_PATHWAY"
47,"Down",0.650560910573427,0.805047286159462,"L.LvsV.REACTOME_FATTY_ACIDS"
128,"Up",0.65198447570387,0.806312222650476,"L.LvsV.TIEN_INTESTINE_PROBIOTICS_2HR_DN"
20,"Down",0.652042951854775,0.806312222650476,"L.LvsV.REACTOME_ACTIVATION_OF_THE_PHOTOTRANSDUCTION_CASCADE"
243,"Down",0.652131332507156,0.806312222650476,"L.LvsV.ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP"
7,"Up",0.652166442339108,0.806312222650476,"L.LvsV.REACTOME_PROTEIN_REPAIR"
32,"Down",0.652685035956148,0.806473038244545,"L.LvsV.FINAK_BREAST_CANCER_SDPP_SIGNATURE"
106,"Up",0.652710484940165,0.806473038244545,"L.LvsV.KANNAN_TP53_TARGETS_UP"
16,"Down",0.652759025577636,0.806473038244545,"L.LvsV.REACTOME_INTESTINAL_ABSORPTION"
78,"Down",0.652879963679251,0.806473038244545,"L.LvsV.KAAB_FAILED_HEART_VENTRICLE_DN"
137,"Up",0.653647408813305,0.807240679769658,"L.LvsV.KRASNOSELSKAYA_ILF3_TARGETS_UP"
183,"Up",0.654257826035238,0.807814095611619,"L.LvsV.REACTOME_CD22_MEDIATED_BCR_REGULATION"
12,"Up",0.655295016238455,0.808914075637958,"L.LvsV.REACTOME_P2Y_RECEPTORS"
73,"Up",0.655530587243724,0.809024244837177,"L.LvsV.CHESLER_BRAIN_HIGHEST_GENETIC_VARIANCE"
368,"Down",0.655912618038768,0.809315078137993,"L.LvsV.KYNG_DNA_DAMAGE_UP"
21,"Down",0.656558108476939,0.809751221571654,"L.LvsV.IYENGAR_RESPONSE_TO_ADIPOCYTE_FACTORS"
12,"Down",0.656559002768263,0.809751221571654,"L.LvsV.NIKOLSKY_BREAST_CANCER_20P13_AMPLICON"
1053,"Down",0.657241107883142,0.81022955584051,"L.LvsV.PUJANA_CHEK2_PCC_NETWORK"
2390,"Down",0.657351992464613,0.81022955584051,"L.LvsV.PUJANA_BRCA1_PCC_NETWORK"
13,"Down",0.65738646907226,0.81022955584051,"L.LvsV.REACTOME_RNF_MUTANTS_SHOW_ENHANCED_WNT_SIGNALING_AND_PROLIFERATION"
170,"Up",0.657819746125576,0.81053237325862,"L.LvsV.KEGG_PURINE_METABOLISM"
67,"Up",0.657925355613074,0.81053237325862,"L.LvsV.LANDIS_ERBB2_BREAST_TUMORS_65_DN"
63,"Down",0.658221668109567,0.810650155649998,"L.LvsV.TSUNODA_CISPLATIN_RESISTANCE_DN"
60,"Down",0.658314197661148,0.810650155649998,"L.LvsV.REACTOME_GENE_AND_PROTEIN_EXPRESSION_BY_JAK_STAT_SIGNALING_AFTER_INTERLEUKIN_12_STIMULATION"
23,"Down",0.658599993675091,0.81082150189926,"L.LvsV.FIGUEROA_AML_METHYLATION_CLUSTER_2_DN"
637,"Up",0.659255953818338,0.811448390173997,"L.LvsV.MOHANKUMAR_HOXA1_TARGETS_UP"
8,"Up",0.659583506931797,0.811511698417298,"L.LvsV.REACTOME_HDL_CLEARANCE"
9,"Down",0.659600935555677,0.811511698417298,"L.LvsV.REACTOME_SYNTHESIS_OF_DIPHTHAMIDE_EEF2"
10,"Down",0.660304914046473,0.812197078923904,"L.LvsV.SASAI_TARGETS_OF_CXCR6_AND_PTCH1_DN"
126,"Up",0.660470265809478,0.812219773056184,"L.LvsV.REACTOME_CARGO_RECOGNITION_FOR_CLATHRIN_MEDIATED_ENDOCYTOSIS"
225,"Up",0.660783517827652,0.812424298436533,"L.LvsV.BIDUS_METASTASIS_DN"
20,"Down",0.661494200661502,0.813117259994986,"L.LvsV.REACTOME_SUPPRESSION_OF_PHAGOSOMAL_MATURATION"
14,"Down",0.662007820400596,0.813472838991734,"L.LvsV.CHEN_HOXA5_TARGETS_6HR_DN"
6,"Down",0.662309535030752,0.813472838991734,"L.LvsV.REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_TO_LIMIT_CHOLESTEROL_UPTAKE"
12,"Up",0.662321948968888,0.813472838991734,"L.LvsV.REACTOME_NETRIN_MEDIATED_REPULSION_SIGNALS"
69,"Up",0.66237198790754,0.813472838991734,"L.LvsV.JIANG_AGING_HYPOTHALAMUS_UP"
31,"Down",0.662867172038397,0.813746393162029,"L.LvsV.REACTOME_VXPX_CARGO_TARGETING_TO_CILIUM"
48,"Down",0.662889085693937,0.813746393162029,"L.LvsV.VIETOR_IFRD1_TARGETS"
68,"Down",0.663170393901982,0.813836016699869,"L.LvsV.KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY"
27,"Down",0.663256482410854,0.813836016699869,"L.LvsV.ABE_VEGFA_TARGETS"
22,"Down",0.663645370144331,0.814093515130622,"L.LvsV.REACTOME_SEROTONIN_NEUROTRANSMITTER_RELEASE_CYCLE"
23,"Down",0.663808066967856,0.814093515130622,"L.LvsV.REACTOME_E2F_MEDIATED_REGULATION_OF_DNA_REPLICATION"
64,"Down",0.664041878651436,0.814093515130622,"L.LvsV.REACTOME_REGULATION_OF_RUNX3_EXPRESSION_AND_ACTIVITY"
161,"Down",0.664055299916641,0.814093515130622,"L.LvsV.MARTIN_VIRAL_GPCR_SIGNALING_UP"
48,"Up",0.664481484607061,0.814304580056824,"L.LvsV.FARDIN_HYPOXIA_11"
42,"Down",0.664522023008933,0.814304580056824,"L.LvsV.WALLACE_JAK2_TARGETS_UP"
131,"Down",0.664932209127198,0.814504893454292,"L.LvsV.SMID_BREAST_CANCER_RELAPSE_IN_LUNG_UP"
47,"Down",0.664980121007899,0.814504893454292,"L.LvsV.NOJIMA_SFRP2_TARGETS_UP"
67,"Up",0.665652790688746,0.815148234710538,"L.LvsV.CHESLER_BRAIN_HIGHEST_EXPRESSION"
38,"Down",0.666650451481059,0.81618918207236,"L.LvsV.BIOCARTA_FAS_PATHWAY"
217,"Down",0.667508259726936,0.817058483070673,"L.LvsV.NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN"
100,"Down",0.667838400937078,0.817281655330036,"L.LvsV.DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP"
29,"Down",0.66830692089195,0.8173649413993,"L.LvsV.PID_IL27_PATHWAY"
61,"Up",0.668594189689759,0.8173649413993,"L.LvsV.ZHAN_MULTIPLE_MYELOMA_MF_DN"
85,"Down",0.668709130164145,0.8173649413993,"L.LvsV.DUNNE_TARGETS_OF_AML1_MTG8_FUSION_UP"
36,"Down",0.668772460958327,0.8173649413993,"L.LvsV.KEGG_BASAL_TRANSCRIPTION_FACTORS"
58,"Down",0.668867147788012,0.8173649413993,"L.LvsV.WEINMANN_ADAPTATION_TO_HYPOXIA_UP"
30,"Up",0.668927936210141,0.8173649413993,"L.LvsV.WAGNER_APO2_SENSITIVITY"
349,"Down",0.668963677710382,0.8173649413993,"L.LvsV.MIKKELSEN_MEF_ICP_WITH_H3K27ME3"
336,"Up",0.669089116435745,0.8173649413993,"L.LvsV.IWANAGA_CARCINOGENESIS_BY_KRAS_UP"
19,"Up",0.669324966532287,0.8174724409006,"L.LvsV.REACTOME_GLYCOGEN_STORAGE_DISEASES"
136,"Up",0.669631846131621,0.817666624836955,"L.LvsV.GHANDHI_DIRECT_IRRADIATION_UP"
24,"Up",0.66990687978358,0.817746254054014,"L.LvsV.BIOCARTA_COMP_PATHWAY"
431,"Down",0.670102971655552,0.817746254054014,"L.LvsV.JAATINEN_HEMATOPOIETIC_STEM_CELL_DN"
18,"Up",0.670140762727209,0.817746254054014,"L.LvsV.BIOCARTA_MCM_PATHWAY"
246,"Down",0.670589041885251,0.818112712397076,"L.LvsV.KAAB_FAILED_HEART_ATRIUM_DN"
115,"Down",0.670939258761425,0.818350745978417,"L.LvsV.MCCLUNG_COCAIN_REWARD_4WK"
983,"Down",0.671080174039816,0.818350745978417,"L.LvsV.HAMAI_APOPTOSIS_VIA_TRAIL_UP"
37,"Up",0.671630014038424,0.818840649970991,"L.LvsV.BIOCARTA_IL12_PATHWAY"
87,"Down",0.672307771112775,0.819486258042886,"L.LvsV.BROWNE_HCMV_INFECTION_8HR_DN"
11,"Down",0.672473092461953,0.819507103421234,"L.LvsV.MATZUK_FERTILIZATION"
420,"Down",0.672642169280397,0.819532515194207,"L.LvsV.NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP"
8,"Down",0.673197733366026,0.820028699665291,"L.LvsV.REACTOME_SUPPRESSION_OF_APOPTOSIS"
6,"Down",0.674180450574648,0.821015912380099,"L.LvsV.ZIRN_TRETINOIN_RESPONSE_WT1_DN"
164,"Up",0.674305165150665,0.821015912380099,"L.LvsV.XU_HGF_TARGETS_REPRESSED_BY_AKT1_DN"
9,"Up",0.675434937862782,0.82221042964406,"L.LvsV.BIOCARTA_IRES_PATHWAY"
147,"Down",0.67573932572803,0.822399896973427,"L.LvsV.BAE_BRCA1_TARGETS_UP"
28,"Down",0.676370890040139,0.822987379188365,"L.LvsV.REACTOME_DOPAMINE_NEUROTRANSMITTER_RELEASE_CYCLE"
265,"Up",0.676676769416693,0.82317840662374,"L.LvsV.SHEPARD_CRUSH_AND_BURN_MUTANT_UP"
121,"Up",0.676945198427852,0.823323801607477,"L.LvsV.GROSS_HYPOXIA_VIA_HIF1A_UP"
66,"Up",0.67752086897929,0.823832672970641,"L.LvsV.FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN"
106,"Up",0.677744305637643,0.823832672970641,"L.LvsV.MAGRANGEAS_MULTIPLE_MYELOMA_IGG_VS_IGA_UP"
268,"Up",0.67818484247318,0.823832672970641,"L.LvsV.KIM_MYC_AMPLIFICATION_TARGETS_UP"
81,"Down",0.678221061879944,0.823832672970641,"L.LvsV.VANTVEER_BREAST_CANCER_BRCA1_DN"
21,"Down",0.678239647015591,0.823832672970641,"L.LvsV.REACTOME_PROSTACYCLIN_SIGNALLING_THROUGH_PROSTACYCLIN_RECEPTOR"
223,"Up",0.678425894696787,0.823832672970641,"L.LvsV.VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_DN"
8,"Up",0.678651347027545,0.823832672970641,"L.LvsV.REACTOME_DEFECTIVE_B4GALT1_CAUSES_B4GALT1_CDG_CDG_2D"
10,"Up",0.678820188009703,0.823832672970641,"L.LvsV.IKEDA_MIR1_TARGETS_DN"
81,"Up",0.678875680102467,0.823832672970641,"L.LvsV.BOYAULT_LIVER_CANCER_SUBCLASS_G123_DN"
83,"Up",0.678938205300351,0.823832672970641,"L.LvsV.KEGG_P53_SIGNALING_PATHWAY"
24,"Up",0.679002620858602,0.823832672970641,"L.LvsV.BIOCARTA_VITCB_PATHWAY"
144,"Up",0.679342118931289,0.824063750673782,"L.LvsV.YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_9"
15,"Up",0.680149128412833,0.82482018213903,"L.LvsV.MCCABE_HOXC6_TARGETS_UP"
17,"Down",0.680269297386342,0.82482018213903,"L.LvsV.MURAKAMI_UV_RESPONSE_1HR_DN"
19,"Up",0.68041324846014,0.82482018213903,"L.LvsV.REACTOME_TRANSCRIPTION_OF_E2F_TARGETS_UNDER_NEGATIVE_CONTROL_BY_P107_RBL1_AND_P130_RBL2_IN_COMPLEX_WITH_HDAC1"
20,"Down",0.68097831311449,0.825176560027036,"L.LvsV.REACTOME_ENOS_ACTIVATION"
218,"Down",0.681005723169356,0.825176560027036,"L.LvsV.MCBRYAN_PUBERTAL_BREAST_5_6WK_DN"
373,"Up",0.682419609467029,0.826367179208053,"L.LvsV.RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_UP"
155,"Down",0.682435058528341,0.826367179208053,"L.LvsV.LEIN_CEREBELLUM_MARKERS"
6,"Down",0.682648078461411,0.826367179208053,"L.LvsV.REACTOME_VITAMINS"
87,"Up",0.682710652764599,0.826367179208053,"L.LvsV.LIM_MAMMARY_LUMINAL_PROGENITOR_UP"
27,"Down",0.682892491392626,0.826367179208053,"L.LvsV.REACTOME_PHASE_2_PLATEAU_PHASE"
16,"Up",0.682970717504826,0.826367179208053,"L.LvsV.KEGG_OTHER_GLYCAN_DEGRADATION"
401,"Down",0.68303454675001,0.826367179208053,"L.LvsV.WELCSH_BRCA1_TARGETS_UP"
8,"Down",0.683658166055652,0.82684805784033,"L.LvsV.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_5"
1526,"Up",0.683834218255166,0.82684805784033,"L.LvsV.MARSON_BOUND_BY_FOXP3_UNSTIMULATED"
10,"Down",0.683930562405458,0.82684805784033,"L.LvsV.RANKIN_ANGIOGENIC_TARGETS_OF_VHL_HIF2A_UP"
96,"Down",0.684050795619735,0.82684805784033,"L.LvsV.PID_BCR_5PATHWAY"
51,"Up",0.684179754859741,0.82684805784033,"L.LvsV.VALK_AML_CLUSTER_13"
9,"Down",0.68448488255107,0.826993964000375,"L.LvsV.REACTOME_DEFECTIVE_CSF2RB_CAUSES_PULMONARY_SURFACTANT_METABOLISM_DYSFUNCTION_5_SMDP5"
116,"Down",0.684713736649972,0.826993964000375,"L.LvsV.JAIN_NFKB_SIGNALING"
32,"Up",0.684819417486017,0.826993964000375,"L.LvsV.KEGG_PROXIMAL_TUBULE_BICARBONATE_RECLAMATION"
36,"Down",0.684898781182441,0.826993964000375,"L.LvsV.WILENSKY_RESPONSE_TO_DARAPLADIB"
161,"Down",0.685373203239731,0.827386122426304,"L.LvsV.CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_UP"
44,"Down",0.686207353833166,0.828078892514227,"L.LvsV.YANG_BREAST_CANCER_ESR1_LASER_UP"
13,"Up",0.686246606167515,0.828078892514227,"L.LvsV.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_16"
16,"Down",0.686412483785997,0.828098324864232,"L.LvsV.LOPEZ_MESOTELIOMA_SURVIVAL_TIME_DN"
30,"Down",0.686667890362204,0.828225734252318,"L.LvsV.PID_INTEGRIN_A9B1_PATHWAY"
66,"Up",0.686961406916024,0.828399044457731,"L.LvsV.REACTOME_NEGATIVE_REGULATION_OF_NOTCH4_SIGNALING"
527,"Down",0.687383619251675,0.828534909132807,"L.LvsV.DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN"
6,"Up",0.68744481420135,0.828534909132807,"L.LvsV.REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_KEY_METABOLIC_FACTORS"
135,"Down",0.687523632320731,0.828534909132807,"L.LvsV.SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_UP"
126,"Up",0.687762607487264,0.828590656616631,"L.LvsV.LEE_LIVER_CANCER_ACOX1_DN"
470,"Up",0.687869617267198,0.828590656616631,"L.LvsV.HOSHIDA_LIVER_CANCER_SUBCLASS_S3"
9,"Down",0.68822045461547,0.828832693001293,"L.LvsV.REACTOME_DEFECTIVE_CHSY1_CAUSES_TPBS"
768,"Up",0.688655930999927,0.829163622702969,"L.LvsV.SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP"
74,"Down",0.688795174366926,0.829163622702969,"L.LvsV.KLEIN_TARGETS_OF_BCR_ABL1_FUSION"
118,"Down",0.689538216998786,0.829877405700107,"L.LvsV.LEE_AGING_NEOCORTEX_DN"
117,"Down",0.689970667630059,0.830217153716343,"L.LvsV.ROSS_AML_OF_FAB_M7_TYPE"
113,"Down",0.69091443022124,0.831171863510278,"L.LvsV.REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE"
87,"Down",0.691534069567477,0.831736321652943,"L.LvsV.REACTOME_TRANSCRIPTION_COUPLED_NUCLEOTIDE_EXCISION_REPAIR_TC_NER"
84,"Up",0.69219760451856,0.83235331783017,"L.LvsV.REACTOME_DEFENSINS"
11,"Up",0.692452764829299,0.832383983496833,"L.LvsV.VALK_AML_WITH_T_8_21_TRANSLOCATION"
15,"Down",0.692652738276444,0.832383983496833,"L.LvsV.BIOCARTA_AKAP95_PATHWAY"
20,"Up",0.69267475277065,0.832383983496833,"L.LvsV.ALONSO_METASTASIS_EMT_DN"
18,"Up",0.693134061951287,0.832726819300735,"L.LvsV.JIANG_CORE_DUPLICON_GENES"
10,"Up",0.693261267723148,0.832726819300735,"L.LvsV.BAKER_HEMATOPOESIS_STAT1_TARGETS"
14,"Down",0.693692715161342,0.833064079523689,"L.LvsV.ZHOU_PANCREATIC_BETA_CELL"
92,"Up",0.69406140642903,0.83317988631186,"L.LvsV.LUCAS_HNF4A_TARGETS_UP"
452,"Down",0.694090532890654,0.83317988631186,"L.LvsV.GABRIELY_MIR21_TARGETS"
62,"Down",0.694482792922224,0.833295284027076,"L.LvsV.AIYAR_COBRA1_TARGETS_UP"
203,"Down",0.694488093470206,0.833295284027076,"L.LvsV.BORCZUK_MALIGNANT_MESOTHELIOMA_DN"
29,"Up",0.694874411423953,0.833574265197954,"L.LvsV.REACTOME_TNFS_BIND_THEIR_PHYSIOLOGICAL_RECEPTORS"
6,"Up",0.69502213104767,0.833574265197954,"L.LvsV.PALOMERO_GSI_SENSITIVITY_DN"
129,"Down",0.695476164881981,0.83393791273747,"L.LvsV.JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_DN"
201,"Up",0.695632149863355,0.833944092930288,"L.LvsV.REACTOME_ROLE_OF_LAT2_NTAL_LAB_ON_CALCIUM_MOBILIZATION"
24,"Down",0.696108058652352,0.834302692173057,"L.LvsV.BIOCARTA_RACC_PATHWAY"
6,"Up",0.69623306595885,0.834302692173057,"L.LvsV.REACTOME_PROTON_COUPLED_MONOCARBOXYLATE_TRANSPORT"
7,"Down",0.696664653754907,0.834638975213625,"L.LvsV.TERAMOTO_OPN_TARGETS_CLUSTER_3"
843,"Down",0.69740695605477,0.835012744146148,"L.LvsV.MCCABE_BOUND_BY_HOXC6"
48,"Up",0.697501822239643,0.835012744146148,"L.LvsV.BONOME_OVARIAN_CANCER_POOR_SURVIVAL_UP"
13,"Down",0.697747457850342,0.835012744146148,"L.LvsV.REACTOME_SODIUM_CALCIUM_EXCHANGERS"
1130,"Down",0.697795116786391,0.835012744146148,"L.LvsV.FORTSCHEGGER_PHF8_TARGETS_DN"
20,"Down",0.697980098510508,0.835012744146148,"L.LvsV.PID_TCR_JNK_PATHWAY"
16,"Up",0.698004268781703,0.835012744146148,"L.LvsV.BIOCARTA_CFTR_PATHWAY"
46,"Up",0.698033804203924,0.835012744146148,"L.LvsV.BIOCARTA_NGF_PATHWAY"
957,"Down",0.698540949908582,0.835438657158673,"L.LvsV.MASSARWEH_TAMOXIFEN_RESISTANCE_UP"
663,"Down",0.698946918202903,0.835743406302736,"L.LvsV.VECCHI_GASTRIC_CANCER_EARLY_DN"
427,"Down",0.699106442677342,0.83575341006768,"L.LvsV.RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_DN"
67,"Down",0.69960267508707,0.836133756265347,"L.LvsV.MA_MYELOID_DIFFERENTIATION_UP"
56,"Up",0.699727055568776,0.836133756265347,"L.LvsV.SHAFFER_IRF4_MULTIPLE_MYELOMA_PROGRAM"
531,"Down",0.700377410201914,0.836675767639838,"L.LvsV.ENK_UV_RESPONSE_EPIDERMIS_UP"
46,"Up",0.70052268964032,0.836675767639838,"L.LvsV.RAY_TARGETS_OF_P210_BCR_ABL_FUSION_UP"
40,"Up",0.700758727774799,0.836675767639838,"L.LvsV.SCHEIDEREIT_IKK_TARGETS"
307,"Down",0.700785943197701,0.836675767639838,"L.LvsV.SMID_BREAST_CANCER_ERBB2_UP"
61,"Down",0.701127710020938,0.836851986322953,"L.LvsV.LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_UP"
80,"Up",0.701236254771974,0.836851986322953,"L.LvsV.MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_DN"
1306,"Up",0.70260325175715,0.838302412379215,"L.LvsV.MARSON_BOUND_BY_FOXP3_STIMULATED"
38,"Up",0.702821824643401,0.838310955466267,"L.LvsV.MATTIOLI_MULTIPLE_MYELOMA_SUBGROUPS"
5,"Up",0.70291365338065,0.838310955466267,"L.LvsV.REACTOME_TACHYKININ_RECEPTORS_BIND_TACHYKININS"
90,"Down",0.703128966554533,0.838386900168216,"L.LvsV.REACTOME_CYTOSOLIC_SENSORS_OF_PATHOGEN_ASSOCIATED_DNA"
323,"Down",0.703410603211696,0.83854187692054,"L.LvsV.SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_DN"
22,"Down",0.704051908827348,0.839125458914941,"L.LvsV.REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_27_HYDROXYCHOLESTEROL"
77,"Down",0.704408867995989,0.839369963609876,"L.LvsV.ASTIER_INTEGRIN_SIGNALING"
230,"Up",0.704602581854761,0.839419882584567,"L.LvsV.PASINI_SUZ12_TARGETS_UP"
45,"Up",0.705095868720072,0.839762770356302,"L.LvsV.REACTOME_EXTENSION_OF_TELOMERES"
1739,"Down",0.705329246530152,0.839762770356302,"L.LvsV.GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP"
465,"Down",0.705346049110991,0.839762770356302,"L.LvsV.RICKMAN_METASTASIS_UP"
144,"Up",0.705570829924058,0.839849541151801,"L.LvsV.NEMETH_INFLAMMATORY_RESPONSE_LPS_UP"
80,"Down",0.705814485985479,0.839958737196237,"L.LvsV.SU_PANCREAS"
26,"Up",0.706231020939711,0.840202139621158,"L.LvsV.REACTOME_ACTIVATED_TAK1_MEDIATES_P38_MAPK_ACTIVATION"
209,"Up",0.706330570139332,0.840202139621158,"L.LvsV.LANDIS_ERBB2_BREAST_TUMORS_324_UP"
19,"Up",0.706474904521389,0.840202139621158,"L.LvsV.REACTOME_RNA_POLYMERASE_III_CHAIN_ELONGATION"
1437,"Up",0.706709780222737,0.840300725774519,"L.LvsV.NUYTTEN_EZH2_TARGETS_DN"
27,"Up",0.706879263640244,0.840321532717031,"L.LvsV.KEGG_RNA_POLYMERASE"
621,"Down",0.707326061132685,0.840671924334182,"L.LvsV.WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_UP"
52,"Down",0.707628814725138,0.840851002926131,"L.LvsV.BIOCARTA_IL2RB_PATHWAY"
60,"Down",0.707804067354234,0.840878532101753,"L.LvsV.HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_4HR"
308,"Up",0.708188930021179,0.841155014841482,"L.LvsV.MISSIAGLIA_REGULATED_BY_METHYLATION_UP"
26,"Up",0.70864796542417,0.841519458941202,"L.LvsV.GAVIN_IL2_RESPONSIVE_FOXP3_TARGETS_UP"
13,"Down",0.708998187260731,0.841754558162891,"L.LvsV.KHETCHOUMIAN_TRIM24_TARGETS_DN"
726,"Down",0.709192176991398,0.841804110473473,"L.LvsV.PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_DN"
36,"Down",0.709907153725821,0.84247191520714,"L.LvsV.REACTOME_SIGNAL_AMPLIFICATION"
119,"Up",0.71047037455109,0.842600433717647,"L.LvsV.MEISSNER_BRAIN_HCP_WITH_H3_UNMETHYLATED"
74,"Down",0.710540803276338,0.842600433717647,"L.LvsV.REACTOME_ASYMMETRIC_LOCALIZATION_OF_PCP_PROTEINS"
31,"Up",0.710798017668844,0.842600433717647,"L.LvsV.REACTOME_INTERCONVERSION_OF_NUCLEOTIDE_DI_AND_TRIPHOSPHATES"
142,"Up",0.710903457913783,0.842600433717647,"L.LvsV.BROWNE_INTERFERON_RESPONSIVE_GENES"
103,"Down",0.710949219772149,0.842600433717647,"L.LvsV.DORN_ADENOVIRUS_INFECTION_24HR_DN"
276,"Down",0.711020202632231,0.842600433717647,"L.LvsV.FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP"
128,"Up",0.711082225307749,0.842600433717647,"L.LvsV.URS_ADIPOCYTE_DIFFERENTIATION_UP"
25,"Up",0.71146571386922,0.842874208695719,"L.LvsV.WANG_RECURRENT_LIVER_CANCER_UP"
12,"Up",0.711661687161164,0.842925764420324,"L.LvsV.REACTOME_ACTIVATION_OF_THE_AP_1_FAMILY_OF_TRANSCRIPTION_FACTORS"
8,"Down",0.713623513841112,0.844981073095148,"L.LvsV.REACTOME_DEFECTIVE_CHST14_CAUSES_EDS_MUSCULOCONTRACTURAL_TYPE"
168,"Down",0.713825824343646,0.844981073095148,"L.LvsV.HAHTOLA_MYCOSIS_FUNGOIDES_CD4_DN"
33,"Down",0.713944774023628,0.844981073095148,"L.LvsV.REACTOME_PROCESSING_OF_CAPPED_INTRONLESS_PRE_MRNA"
32,"Down",0.714094462772446,0.844981073095148,"L.LvsV.REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS"
18,"Up",0.714161069736593,0.844981073095148,"L.LvsV.BIOCARTA_AHSP_PATHWAY"
74,"Down",0.715034819844782,0.845833872255413,"L.LvsV.SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_DN"
100,"Up",0.715259925735455,0.845919172062317,"L.LvsV.CADWELL_ATG16L1_TARGETS_DN"
70,"Down",0.715875607600422,0.846466260569447,"L.LvsV.VALK_AML_CLUSTER_3"
6,"Down",0.716286999215191,0.846594039321159,"L.LvsV.ISHIDA_TARGETS_OF_SYT_SSX_FUSIONS"
86,"Up",0.716289910642862,0.846594039321159,"L.LvsV.PID_HNF3A_PATHWAY"
9,"Down",0.716569463159818,0.846743441293146,"L.LvsV.REACTOME_MODULATION_BY_MTB_OF_HOST_IMMUNE_SYSTEM"
118,"Down",0.71719802876931,0.847005111243846,"L.LvsV.KEGG_OOCYTE_MEIOSIS"
36,"Down",0.717232371846653,0.847005111243846,"L.LvsV.BIOCARTA_INTRINSIC_PATHWAY"
9,"Up",0.717288743770478,0.847005111243846,"L.LvsV.REACTOME_AMPK_INHIBITS_CHREBP_TRANSCRIPTIONAL_ACTIVATION_ACTIVITY"
92,"Up",0.717403678052981,0.847005111243846,"L.LvsV.NIKOLSKY_BREAST_CANCER_8P12_P11_AMPLICON"
95,"Down",0.71789100535476,0.847302323918041,"L.LvsV.BORLAK_LIVER_CANCER_EGF_UP"
12,"Down",0.717961907678789,0.847302323918041,"L.LvsV.BIOCARTA_SARS_PATHWAY"
38,"Up",0.71818689290901,0.847386967753717,"L.LvsV.REACTOME_PLASMA_LIPOPROTEIN_REMODELING"
56,"Down",0.718891142322116,0.848036937465112,"L.LvsV.MCCABE_HOXC6_TARGETS_CANCER_UP"
12,"Down",0.719287625698505,0.848323652407644,"L.LvsV.REACTOME_PI5P_REGULATES_TP53_ACETYLATION"
1329,"Down",0.719512192225819,0.848407530564418,"L.LvsV.KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_UP"
133,"Down",0.71970147097239,0.848449772496022,"L.LvsV.GRABARCZYK_BCL11B_TARGETS_UP"
27,"Down",0.720193938921708,0.848849347324264,"L.LvsV.OUYANG_PROSTATE_CANCER_PROGRESSION_DN"
110,"Down",0.720661030794873,0.849218848948179,"L.LvsV.LEE_LIVER_CANCER_MYC_DN"
125,"Down",0.720990555626001,0.849426120190956,"L.LvsV.FLORIO_HUMAN_NEOCORTEX"
6,"Down",0.721353587172082,0.849672770233158,"L.LvsV.CALVET_IRINOTECAN_SENSITIVE_VS_RESISTANT_UP"
160,"Up",0.721556208065095,0.849730409881131,"L.LvsV.HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS"
42,"Down",0.722749902266233,0.85081267670588,"L.LvsV.REACTOME_REGULATION_OF_TP53_EXPRESSION_AND_DEGRADATION"
1549,"Up",0.722782988331981,0.85081267670588,"L.LvsV.DANG_BOUND_BY_MYC"
23,"Up",0.722960598701731,0.85084060243122,"L.LvsV.BIOCARTA_RAB_PATHWAY"
476,"Down",0.723658392819313,0.85148058180421,"L.LvsV.MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_UP"
18,"Up",0.724654448154679,0.852471158265366,"L.LvsV.PID_DNA_PK_PATHWAY"
58,"Down",0.725331931998294,0.852957044174187,"L.LvsV.BYSTRYKH_HEMATOPOIESIS_STEM_CELL_SCP2_QTL_TRANS"
6,"Down",0.725376021289027,0.852957044174187,"L.LvsV.REACTOME_SEROTONIN_AND_MELATONIN_BIOSYNTHESIS"
227,"Down",0.725716009892176,0.853175381393544,"L.LvsV.BROWNE_HCMV_INFECTION_10HR_UP"
16,"Down",0.725948133627043,0.853266843287398,"L.LvsV.REACTOME_PI3K_AKT_ACTIVATION"
39,"Down",0.726222736252059,0.853408184641368,"L.LvsV.MARSON_FOXP3_TARGETS_STIMULATED_UP"
39,"Up",0.726847465981957,0.853960824354917,"L.LvsV.GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_DN"
81,"Down",0.727509904784271,0.854354514463512,"L.LvsV.KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN"
61,"Up",0.727616319895636,0.854354514463512,"L.LvsV.ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_DN"
548,"Down",0.727646122012783,0.854354514463512,"L.LvsV.DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN"
41,"Up",0.728869167901925,0.855608838498883,"L.LvsV.CROONQUIST_IL6_DEPRIVATION_UP"
80,"Down",0.729708869116952,0.85628846213823,"L.LvsV.LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_DN"
114,"Down",0.729757864640141,0.85628846213823,"L.LvsV.KEGG_ARACHIDONIC_ACID_METABOLISM"
48,"Down",0.730145482713092,0.856561505181559,"L.LvsV.BIOCARTA_CARM_ER_PATHWAY"
20,"Down",0.730337520330639,0.856605038164638,"L.LvsV.REACTOME_ERYTHROCYTES_TAKE_UP_CARBON_DIOXIDE_AND_RELEASE_OXYGEN"
389,"Down",0.730705884568429,0.856855320419691,"L.LvsV.CHICAS_RB1_TARGETS_GROWING"
763,"Up",0.730987967687099,0.857004341251478,"L.LvsV.CAIRO_HEPATOBLASTOMA_CLASSES_UP"
122,"Down",0.731249213460602,0.85712019153414,"L.LvsV.VANASSE_BCL2_TARGETS_DN"
826,"Down",0.731396828297716,0.85712019153414,"L.LvsV.FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP"
413,"Down",0.731553666445875,0.857122318664811,"L.LvsV.ZHENG_GLIOBLASTOMA_PLASTICITY_UP"
478,"Down",0.731968959301621,0.857427198300564,"L.LvsV.DAZARD_RESPONSE_TO_UV_NHEK_UP"
20,"Down",0.733089772676845,0.858283347692245,"L.LvsV.SABATES_COLORECTAL_ADENOMA_SIZE_DN"
11,"Down",0.733129120189161,0.858283347692245,"L.LvsV.REACTOME_MAPK1_ERK2_ACTIVATION"
13,"Up",0.733171135364924,0.858283347692245,"L.LvsV.REACTOME_SMAC_XIAP_REGULATED_APOPTOTIC_RESPONSE"
49,"Down",0.733320769487821,0.858283347692245,"L.LvsV.WANG_NEOPLASTIC_TRANSFORMATION_BY_CCND1_MYC"
43,"Up",0.733723239329367,0.858572654021602,"L.LvsV.REACTOME_TRANSLESION_SYNTHESIS_BY_Y_FAMILY_DNA_POLYMERASES_BYPASSES_LESIONS_ON_DNA_TEMPLATE"
77,"Down",0.734388627314361,0.859035433364721,"L.LvsV.POMEROY_MEDULLOBLASTOMA_PROGNOSIS_UP"
510,"Up",0.734429461659439,0.859035433364721,"L.LvsV.FARMER_BREAST_CANCER_APOCRINE_VS_LUMINAL"
30,"Up",0.734906544740833,0.859091299337904,"L.LvsV.REACTOME_KERATAN_SULFATE_BIOSYNTHESIS"
318,"Up",0.735098285016792,0.859091299337904,"L.LvsV.REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR"
161,"Down",0.735227389523687,0.859091299337904,"L.LvsV.VANLOO_SP3_TARGETS_DN"
182,"Down",0.735273328912536,0.859091299337904,"L.LvsV.LEE_CALORIE_RESTRICTION_NEOCORTEX_UP"
160,"Up",0.735369160750965,0.859091299337904,"L.LvsV.TAKAO_RESPONSE_TO_UVB_RADIATION_DN"
263,"Up",0.735409498962977,0.859091299337904,"L.LvsV.REACTOME_BINDING_AND_UPTAKE_OF_LIGANDS_BY_SCAVENGER_RECEPTORS"
69,"Down",0.735788266666762,0.85935220245047,"L.LvsV.IRITANI_MAD1_TARGETS_DN"
19,"Up",0.736001663326536,0.859419893671049,"L.LvsV.BIOCARTA_BLYMPHOCYTE_PATHWAY"
12,"Down",0.73666237745464,0.859989829004051,"L.LvsV.REACTOME_IRAK2_MEDIATED_ACTIVATION_OF_TAK1_COMPLEX"
73,"Up",0.736800835592727,0.859989829004051,"L.LvsV.LUI_TARGETS_OF_PAX8_PPARG_FUSION"
58,"Down",0.738401866977484,0.861676640464017,"L.LvsV.KEGG_LINOLEIC_ACID_METABOLISM"
108,"Up",0.738773786344025,0.861928732790909,"L.LvsV.NADLER_OBESITY_UP"
31,"Up",0.73920147403225,0.862245770026226,"L.LvsV.REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION"
669,"Down",0.739377573227368,0.862269268587664,"L.LvsV.KUMAR_TARGETS_OF_MLL_AF9_FUSION"
140,"Down",0.739614850652802,0.862364088835796,"L.LvsV.REACTOME_ADORA2B_MEDIATED_ANTI_INFLAMMATORY_CYTOKINES_PRODUCTION"
36,"Up",0.739955716949096,0.862579624501697,"L.LvsV.LIU_IL13_MEMORY_MODEL_UP"
27,"Down",0.741337596563939,0.864008341357929,"L.LvsV.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_CYAN_UP"
163,"Down",0.741995903076238,0.864593329422238,"L.LvsV.RHEIN_ALL_GLUCOCORTICOID_THERAPY_UP"
222,"Up",0.742221387805068,0.864673841798192,"L.LvsV.WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP"
17,"Down",0.742476852153923,0.864717295208877,"L.LvsV.REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE_FGFR4"
186,"Down",0.742824741991989,0.864717295208877,"L.LvsV.MATZUK_SPERMATOCYTE"
101,"Up",0.742919626049904,0.864717295208877,"L.LvsV.KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN"
5,"Up",0.743354711611116,0.864717295208877,"L.LvsV.BAFNA_MUC4_TARGETS_UP"
8,"Down",0.743369536857468,0.864717295208877,"L.LvsV.REACTOME_STAT5_ACTIVATION"
61,"Up",0.743762608481322,0.864717295208877,"L.LvsV.PID_PLK1_PATHWAY"
28,"Up",0.744001972839885,0.864717295208877,"L.LvsV.REACTOME_ENDOGENOUS_STEROLS"
16,"Down",0.744126595400596,0.864717295208877,"L.LvsV.BIOCARTA_TSP1_PATHWAY"
29,"Up",0.744165070458686,0.864717295208877,"L.LvsV.KEGG_ASCORBATE_AND_ALDARATE_METABOLISM"
523,"Down",0.744280108673697,0.864717295208877,"L.LvsV.GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP"
49,"Down",0.744283767665609,0.864717295208877,"L.LvsV.KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_4NQO_IN_WS"
7,"Down",0.744288749405728,0.864717295208877,"L.LvsV.REACTOME_RESPONSE_TO_METAL_IONS"
30,"Down",0.744291844438243,0.864717295208877,"L.LvsV.REACTOME_GLUTAMATE_NEUROTRANSMITTER_RELEASE_CYCLE"
31,"Down",0.744499158767331,0.864776438828692,"L.LvsV.KEGG_MATURITY_ONSET_DIABETES_OF_THE_YOUNG"
848,"Down",0.746057842107423,0.866404916826704,"L.LvsV.MATSUDA_NATURAL_KILLER_DIFFERENTIATION"
36,"Down",0.746267402313728,0.86646628882667,"L.LvsV.REACTOME_GLUCAGON_TYPE_LIGAND_RECEPTORS"
11,"Down",0.746579407770927,0.86647613046933,"L.LvsV.REACTOME_REGULATION_OF_FOXO_TRANSCRIPTIONAL_ACTIVITY_BY_ACETYLATION"
5,"Up",0.746734642563501,0.86647613046933,"L.LvsV.REACTOME_DISEASES_OF_BASE_EXCISION_REPAIR"
154,"Down",0.746746023093934,0.86647613046933,"L.LvsV.LEE_LIVER_CANCER_DENA_DN"
13,"Up",0.747295976154945,0.866932323155832,"L.LvsV.LIU_TARGETS_OF_VMYB_VS_CMYB_UP"
55,"Down",0.747654234168474,0.867165987144429,"L.LvsV.CHEN_LUNG_CANCER_SURVIVAL"
163,"Up",0.748088273331974,0.867487429373424,"L.LvsV.KAUFFMANN_DNA_REPLICATION_GENES"
55,"Down",0.748687350794793,0.868000076021055,"L.LvsV.NABA_BASEMENT_MEMBRANES"
158,"Up",0.749177099257068,0.8683857823464,"L.LvsV.SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_UP"
33,"Down",0.749931456145565,0.869077975482882,"L.LvsV.REACTOME_PLASMA_LIPOPROTEIN_ASSEMBLY"
176,"Up",0.750670780501251,0.869752461314211,"L.LvsV.RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_UP"
94,"Up",0.75092413217616,0.869846214425953,"L.LvsV.BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_UP"
33,"Down",0.751403543069546,0.869846214425953,"L.LvsV.BIOCARTA_ARENRF2_PATHWAY"
19,"Up",0.751442186841393,0.869846214425953,"L.LvsV.HOFFMAN_CLOCK_TARGETS_UP"
564,"Up",0.751560493178067,0.869846214425953,"L.LvsV.COLINA_TARGETS_OF_4EBP1_AND_4EBP2"
51,"Down",0.751986843682044,0.869846214425953,"L.LvsV.EHLERS_ANEUPLOIDY_UP"
44,"Up",0.75216286344399,0.869846214425953,"L.LvsV.REACTOME_METABOLISM_OF_STEROID_HORMONES"
18,"Down",0.752379856398602,0.869846214425953,"L.LvsV.MARIADASON_RESPONSE_TO_CURCUMIN_SULINDAC_7"
35,"Up",0.752403893597791,0.869846214425953,"L.LvsV.BIOCARTA_MPR_PATHWAY"
211,"Down",0.752460039879662,0.869846214425953,"L.LvsV.WELCSH_BRCA1_TARGETS_DN"
45,"Down",0.752470365777697,0.869846214425953,"L.LvsV.REACTOME_GABA_B_RECEPTOR_ACTIVATION"
13,"Down",0.752482265074938,0.869846214425953,"L.LvsV.BIOCARTA_RANMS_PATHWAY"
17,"Up",0.753341200747475,0.870657085897322,"L.LvsV.RAY_ALZHEIMERS_DISEASE"
16,"Down",0.754001309794064,0.871164018541504,"L.LvsV.REACTOME_AKT_PHOSPHORYLATES_TARGETS_IN_THE_CYTOSOL"
54,"Down",0.754242365599248,0.871164018541504,"L.LvsV.ZHAN_EARLY_DIFFERENTIATION_GENES_DN"
249,"Up",0.754252515239316,0.871164018541504,"L.LvsV.RAMALHO_STEMNESS_UP"
8,"Down",0.755880934075002,0.872862507205657,"L.LvsV.REACTOME_ACTIVATION_OF_TRKA_RECEPTORS"
253,"Up",0.756761429787436,0.873618949764839,"L.LvsV.LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_UP"
50,"Up",0.756857684987095,0.873618949764839,"L.LvsV.ABBUD_LIF_SIGNALING_1_DN"
12,"Down",0.757010017783206,0.873618949764839,"L.LvsV.KORKOLA_CHORIOCARCINOMA"
110,"Down",0.757199808923361,0.873619049291927,"L.LvsV.REACTOME_TNFR2_NON_CANONICAL_NF_KB_PATHWAY"
15,"Down",0.757599631224337,0.873619049291927,"L.LvsV.REACTOME_ADENYLATE_CYCLASE_INHIBITORY_PATHWAY"
16,"Down",0.757645403303502,0.873619049291927,"L.LvsV.NIKOLSKY_BREAST_CANCER_1Q32_AMPLICON"
18,"Up",0.757781352621125,0.873619049291927,"L.LvsV.NOUSHMEHR_GBM_GERMLINE_MUTATED"
456,"Down",0.757800137530128,0.873619049291927,"L.LvsV.REACTOME_TRANSCRIPTIONAL_REGULATION_BY_TP53"
35,"Up",0.758677152019005,0.874269645791119,"L.LvsV.NIKOLSKY_BREAST_CANCER_15Q26_AMPLICON"
58,"Down",0.758806992927144,0.874269645791119,"L.LvsV.COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_DN"
13,"Down",0.758838855154925,0.874269645791119,"L.LvsV.PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_DN"
640,"Down",0.759030516667155,0.874308276385979,"L.LvsV.LU_EZH2_TARGETS_DN"
390,"Down",0.759248545534797,0.874377256459466,"L.LvsV.REACTOME_SIGNALING_BY_NUCLEAR_RECEPTORS"
29,"Up",0.759684020036126,0.874696573673415,"L.LvsV.AMIT_EGF_RESPONSE_20_MCF10A"
87,"Down",0.75990005276229,0.874763146309119,"L.LvsV.ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_DN"
150,"Up",0.760308608912645,0.875051269500003,"L.LvsV.JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP"
45,"Down",0.761833603933513,0.876457545435349,"L.LvsV.REACTOME_AMINE_LIGAND_BINDING_RECEPTORS"
123,"Up",0.761847524572669,0.876457545435349,"L.LvsV.LEE_LIVER_CANCER_ACOX1_UP"
183,"Down",0.762516547861696,0.877044725010883,"L.LvsV.FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP"
406,"Down",0.763214885099414,0.877665370156959,"L.LvsV.MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN"
68,"Down",0.76339567310112,0.877690720851755,"L.LvsV.REACTOME_INTERLEUKIN_10_SIGNALING"
159,"Down",0.763590945813196,0.877732710894212,"L.LvsV.REACTOME_TOLL_LIKE_RECEPTOR_4_TLR4_CASCADE"
114,"Down",0.764001786832096,0.87802242348673,"L.LvsV.REACTOME_TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE"
73,"Up",0.765171407878614,0.879152498253626,"L.LvsV.WENG_POR_DOSAGE"
339,"Down",0.765303124271062,0.879152498253626,"L.LvsV.SANSOM_APC_MYC_TARGETS"
38,"Down",0.765741857783011,0.879388710337273,"L.LvsV.SESTO_RESPONSE_TO_UV_C4"
79,"Down",0.765835698626345,0.879388710337273,"L.LvsV.REACTOME_INTERLEUKIN_12_FAMILY_SIGNALING"
168,"Up",0.765985897808701,0.879388710337273,"L.LvsV.COATES_MACROPHAGE_M1_VS_M2_UP"
27,"Down",0.76625759981574,0.879518013157822,"L.LvsV.BIOCARTA_STATHMIN_PATHWAY"
15,"Down",0.766814042036313,0.879974022087749,"L.LvsV.REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_ASSOCIATION_WITH_CO_FACTORS"
90,"Down",0.767311496423301,0.880267487963016,"L.LvsV.REACTOME_REGULATION_OF_RUNX2_EXPRESSION_AND_ACTIVITY"
23,"Up",0.767457851395325,0.880267487963016,"L.LvsV.ZHANG_ADIPOGENESIS_BY_BMP7"
37,"Down",0.767557791997949,0.880267487963016,"L.LvsV.YANAGIHARA_ESX1_TARGETS"
21,"Down",0.76770660643112,0.880267487963016,"L.LvsV.REACTOME_ACYL_CHAIN_REMODELLING_OF_PG"
19,"Up",0.76792587692955,0.880336341186706,"L.LvsV.KEGG_ONE_CARBON_POOL_BY_FOLATE"
651,"Down",0.768271483838379,0.880549965618242,"L.LvsV.TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C"
77,"Up",0.768699630235143,0.88085808405598,"L.LvsV.KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM"
7,"Down",0.769038608826931,0.881063917986759,"L.LvsV.MOTAMED_RESPONSE_TO_ANDROGEN_DN"
84,"Down",0.769491117283787,0.881246146973986,"L.LvsV.MIKKELSEN_NPC_LCP_WITH_H3K4ME3"
366,"Down",0.76951644015019,0.881246146973986,"L.LvsV.GROSS_HYPOXIA_VIA_ELK3_UP"
39,"Down",0.770069731170868,0.881697151303319,"L.LvsV.CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_DN"
37,"Up",0.770483271220428,0.881987993080279,"L.LvsV.DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_UP"
40,"Up",0.77246020921589,0.883680574048494,"L.LvsV.VANASSE_BCL2_TARGETS_UP"
87,"Up",0.772500637540969,0.883680574048494,"L.LvsV.KEGG_STEROID_HORMONE_BIOSYNTHESIS"
36,"Up",0.772570959588191,0.883680574048494,"L.LvsV.YAO_HOXA10_TARGETS_VIA_PROGESTERONE_DN"
39,"Down",0.772601174706171,0.883680574048494,"L.LvsV.KEGG_THYROID_CANCER"
27,"Up",0.773221462026871,0.884207127931038,"L.LvsV.JIANG_HYPOXIA_VIA_VHL"
37,"Down",0.77423316707153,0.884861949273449,"L.LvsV.REACTOME_CYP2E1_REACTIONS"
8,"Down",0.774303812136925,0.884861949273449,"L.LvsV.KORKOLA_CHORIOCARCINOMA_UP"
165,"Up",0.774358628197766,0.884861949273449,"L.LvsV.DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_UP"
18,"Up",0.774515901360823,0.884861949273449,"L.LvsV.REACTOME_NEUROFASCIN_INTERACTIONS"
445,"Down",0.774594290917615,0.884861949273449,"L.LvsV.BORCZUK_MALIGNANT_MESOTHELIOMA_UP"
35,"Down",0.775283830422595,0.885422593065239,"L.LvsV.REACTOME_RESPONSE_OF_MTB_TO_PHAGOCYTOSIS"
9,"Up",0.775405352798316,0.885422593065239,"L.LvsV.BIOCARTA_PLK3_PATHWAY"
42,"Down",0.775949714217644,0.885838394506504,"L.LvsV.BIOCARTA_GLEEVEC_PATHWAY"
357,"Down",0.776089922768947,0.885838394506504,"L.LvsV.REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION"
198,"Down",0.776360352299577,0.88596416674187,"L.LvsV.REACTOME_TOLL_LIKE_RECEPTOR_CASCADES"
357,"Up",0.776543413260371,0.885990204687699,"L.LvsV.REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS"
124,"Up",0.776916889844451,0.886233440055698,"L.LvsV.MCBRYAN_PUBERTAL_BREAST_6_7WK_DN"
91,"Up",0.777398839589616,0.886600285497316,"L.LvsV.REACTOME_SPHINGOLIPID_METABOLISM"
35,"Up",0.778301765161825,0.887446991045521,"L.LvsV.TERAMOTO_OPN_TARGETS_CLUSTER_6"
1244,"Up",0.778526757703207,0.887520503781656,"L.LvsV.NUYTTEN_NIPP1_TARGETS_UP"
165,"Down",0.779270504292495,0.888185243915317,"L.LvsV.RAGHAVACHARI_PLATELET_SPECIFIC_GENES"
53,"Up",0.779554005024393,0.88832524603872,"L.LvsV.WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_UP"
230,"Up",0.779920238366891,0.888559447337841,"L.LvsV.ZHANG_BREAST_CANCER_PROGENITORS_DN"
67,"Up",0.780111107187005,0.888593801326112,"L.LvsV.REACTOME_AUF1_HNRNP_D0_BINDS_AND_DESTABILIZES_MRNA"
25,"Down",0.780303433753372,0.888629801281646,"L.LvsV.REACTOME_GLUCURONIDATION"
91,"Up",0.780940767545617,0.889172467825312,"L.LvsV.ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_UP"
31,"Up",0.781669953980481,0.889649972281902,"L.LvsV.VERNOCHET_ADIPOGENESIS"
32,"Down",0.781681961538339,0.889649972281902,"L.LvsV.SAGIV_CD24_TARGETS_UP"
18,"Up",0.782012065997014,0.889842501110823,"L.LvsV.BIOCARTA_DNAFRAGMENT_PATHWAY"
227,"Up",0.782525203758705,0.890243179337835,"L.LvsV.REACTOME_FCGR3A_MEDIATED_IL10_SYNTHESIS"
33,"Up",0.782792824845861,0.890364437064958,"L.LvsV.MCCABE_HOXC6_TARGETS_CANCER_DN"
7,"Down",0.783434923761632,0.890732551050859,"L.LvsV.REACTOME_MITOCHONDRIAL_UNCOUPLING"
27,"Down",0.783438668070235,0.890732551050859,"L.LvsV.LEIN_LOCALIZED_TO_DISTAL_AND_PROXIMAL_DENDRITES"
1198,"Up",0.78384238403116,0.890849810760997,"L.LvsV.FEVR_CTNNB1_TARGETS_UP"
8,"Up",0.784154851621411,0.890849810760997,"L.LvsV.REACTOME_AMINO_ACID_CONJUGATION"
8,"Up",0.784154851621411,0.890849810760997,"L.LvsV.REACTOME_CONJUGATION_OF_BENZOATE_WITH_GLYCINE"
10,"Up",0.784263086968177,0.890849810760997,"L.LvsV.REACTOME_REACTIONS_SPECIFIC_TO_THE_COMPLEX_N_GLYCAN_SYNTHESIS_PATHWAY"
12,"Up",0.784415769522955,0.890849810760997,"L.LvsV.KREPPEL_CD99_TARGETS_DN"
80,"Down",0.784508541977807,0.890849810760997,"L.LvsV.ROVERSI_GLIOMA_COPY_NUMBER_DN"
9,"Down",0.785056638265083,0.891289148453315,"L.LvsV.REACTOME_HIGHLY_SODIUM_PERMEABLE_POSTSYNAPTIC_ACETYLCHOLINE_NICOTINIC_RECEPTORS"
474,"Down",0.785618344291712,0.891743753970206,"L.LvsV.RIZKI_TUMOR_INVASIVENESS_3D_DN"
36,"Up",0.786135249029336,0.892147330025287,"L.LvsV.GRAHAM_CML_DIVIDING_VS_NORMAL_DIVIDING_UP"
97,"Down",0.78745825807244,0.893286583242343,"L.LvsV.PID_MTOR_4PATHWAY"
106,"Up",0.78746225478806,0.893286583242343,"L.LvsV.RHODES_CANCER_META_SIGNATURE"
32,"Down",0.78780027576572,0.893486712760752,"L.LvsV.HOLLEMAN_PREDNISOLONE_RESISTANCE_B_ALL_DN"
17,"Up",0.788471572849007,0.893971049061574,"L.LvsV.MARSHALL_VIRAL_INFECTION_RESPONSE_UP"
40,"Down",0.788550697463067,0.893971049061574,"L.LvsV.YIH_RESPONSE_TO_ARSENITE_C1"
176,"Up",0.790525373645239,0.895992068269739,"L.LvsV.MACAEVA_PBMC_RESPONSE_TO_IR"
31,"Up",0.790755939899412,0.895992068269739,"L.LvsV.BOYAULT_LIVER_CANCER_SUBCLASS_G6_DN"
149,"Up",0.790819550218182,0.895992068269739,"L.LvsV.GUO_TARGETS_OF_IRS1_AND_IRS2"
36,"Down",0.792007133365254,0.897153747260088,"L.LvsV.HOLLEMAN_ASPARAGINASE_RESISTANCE_ALL_UP"
68,"Up",0.792708701069251,0.897643947947694,"L.LvsV.BRACHAT_RESPONSE_TO_CAMPTOTHECIN_DN"
98,"Up",0.792764586331812,0.897643947947694,"L.LvsV.SLEBOS_HEAD_AND_NECK_CANCER_WITH_HPV_UP"
18,"Up",0.793224232407757,0.897980503886668,"L.LvsV.REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION_IN_TLR7_8_OR_9_SIGNALING"
266,"Up",0.794125076302901,0.898756756795272,"L.LvsV.KIM_RESPONSE_TO_TSA_AND_DECITABINE_UP"
59,"Down",0.79423503593809,0.898756756795272,"L.LvsV.KAMIKUBO_MYELOID_CEBPA_NETWORK"
13,"Up",0.794609052732614,0.898996000114308,"L.LvsV.THILLAINADESAN_ZNF217_TARGETS_DN"
12,"Down",0.79501375383521,0.899059385368348,"L.LvsV.REACTOME_INTERLEUKIN_23_SIGNALING"
516,"Down",0.795084564285019,0.899059385368348,"L.LvsV.LI_INDUCED_T_TO_NATURAL_KILLER_UP"
57,"Down",0.79518313123673,0.899059385368348,"L.LvsV.SCHRAETS_MLL_TARGETS_UP"
13,"Up",0.795344205151002,0.899059385368348,"L.LvsV.REACTOME_CASPASE_ACTIVATION_VIA_DEPENDENCE_RECEPTORS_IN_THE_ABSENCE_OF_LIGAND"
49,"Down",0.795614687970394,0.899059385368348,"L.LvsV.REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_OXIDATIVE_STRESS_METABOLIC_AND_NEURONAL_GENES"
71,"Up",0.795780950587117,0.899059385368348,"L.LvsV.SHIPP_DLBCL_CURED_VS_FATAL_DN"
33,"Down",0.795803333693741,0.899059385368348,"L.LvsV.MAHADEVAN_IMATINIB_RESISTANCE_UP"
6,"Down",0.796064381463809,0.899145719498591,"L.LvsV.SMID_BREAST_CANCER_RELAPSE_IN_LIVER_UP"
12,"Up",0.79630877719866,0.899145719498591,"L.LvsV.SIMBULAN_UV_RESPONSE_NORMAL_UP"
38,"Down",0.796367623147875,0.899145719498591,"L.LvsV.REACTOME_KERATAN_SULFATE_KERATIN_METABOLISM"
26,"Up",0.796670999156154,0.899275681752035,"L.LvsV.PARK_HSC_VS_MULTIPOTENT_PROGENITORS_DN"
12,"Down",0.796808024037479,0.899275681752035,"L.LvsV.REACTOME_INTERLEUKIN_21_SIGNALING"
18,"Up",0.797480207387795,0.899850625846351,"L.LvsV.CLAUS_PGR_POSITIVE_MENINGIOMA_UP"
36,"Down",0.797963912570118,0.900212706100833,"L.LvsV.GENTILE_UV_RESPONSE_CLUSTER_D9"
24,"Down",0.798751924023259,0.900917867793676,"L.LvsV.REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_BETA_CELLS"
6,"Up",0.798975849686834,0.900986635308689,"L.LvsV.REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_ENDOCRINE_COMMITTED_NEUROG3_PROGENITOR_CELLS"
87,"Down",0.800366323334642,0.90228839284763,"L.LvsV.KEGG_TASTE_TRANSDUCTION"
8,"Up",0.800463875718858,0.90228839284763,"L.LvsV.KASLER_HDAC7_TARGETS_2_UP"
61,"Down",0.800619796583555,0.90228839284763,"L.LvsV.CHEOK_RESPONSE_TO_HD_MTX_UP"
494,"Down",0.801189633083493,0.902746582701983,"L.LvsV.REACTOME_G_ALPHA_I_SIGNALLING_EVENTS"
10,"Down",0.801753680108099,0.903198063838158,"L.LvsV.FUNG_IL2_TARGETS_WITH_STAT5_BINDING_SITES_T1"
412,"Down",0.8023913004108,0.90373222651687,"L.LvsV.CHYLA_CBFA2T3_TARGETS_DN"
10,"Up",0.802584822349343,0.903766086103772,"L.LvsV.CASTELLANO_HRAS_AND_NRAS_TARGETS_UP"
35,"Up",0.803368188971644,0.904452228672912,"L.LvsV.HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_DN"
117,"Down",0.803521314386208,0.904452228672912,"L.LvsV.RIZKI_TUMOR_INVASIVENESS_2D_UP"
23,"Up",0.804164088637665,0.904991501338826,"L.LvsV.BIOCARTA_MITOCHONDRIA_PATHWAY"
10,"Down",0.804430020795339,0.905093726434584,"L.LvsV.FERRARI_RESPONSE_TO_FENRETINIDE_DN"
18,"Up",0.804634601862949,0.905093726434584,"L.LvsV.REACTOME_WNT5A_DEPENDENT_INTERNALIZATION_OF_FZD2_FZD5_AND_ROR2"
70,"Down",0.804746022635633,0.905093726434584,"L.LvsV.REACTOME_INTERLEUKIN_12_SIGNALING"
361,"Down",0.804980241583304,0.905164125029201,"L.LvsV.MATTIOLI_MGUS_VS_PCL"
33,"Down",0.805348254096219,0.905164125029201,"L.LvsV.KORKOLA_YOLK_SAC_TUMOR_UP"
344,"Down",0.805443109067767,0.905164125029201,"L.LvsV.DOANE_RESPONSE_TO_ANDROGEN_UP"
77,"Down",0.805463464486104,0.905164125029201,"L.LvsV.BALDWIN_PRKCI_TARGETS_UP"
127,"Down",0.805921236781209,0.905319510064663,"L.LvsV.MEISSNER_NPC_HCP_WITH_H3K27ME3"
37,"Down",0.805929214783554,0.905319510064663,"L.LvsV.REACTOME_SYNTHESIS_OF_16_20_HYDROXYEICOSATETRAENOIC_ACIDS_HETE"
160,"Down",0.806319697463053,0.905574163573678,"L.LvsV.REACTOME_PTEN_REGULATION"
103,"Up",0.807623955003136,0.906854761822164,"L.LvsV.MORI_MATURE_B_LYMPHOCYTE_DN"
1060,"Up",0.808262672664401,0.907019288068274,"L.LvsV.MARTINEZ_RB1_AND_TP53_TARGETS_UP"
44,"Down",0.808359001177596,0.907019288068274,"L.LvsV.AZARE_STAT3_TARGETS"
34,"Down",0.808364368339486,0.907019288068274,"L.LvsV.MAHADEVAN_IMATINIB_RESISTANCE_DN"
69,"Up",0.808703167956143,0.907019288068274,"L.LvsV.SCHEIDEREIT_IKK_INTERACTING_PROTEINS"
131,"Down",0.808751743199966,0.907019288068274,"L.LvsV.DITTMER_PTHLH_TARGETS_DN"
89,"Down",0.808754764003724,0.907019288068274,"L.LvsV.KEGG_LONG_TERM_POTENTIATION"
29,"Up",0.808956256088437,0.90706127355769,"L.LvsV.REACTOME_CONSTITUTIVE_SIGNALING_BY_AKT1_E17K_IN_CANCER"
58,"Down",0.809158905946103,0.907104539938362,"L.LvsV.TOMLINS_PROSTATE_CANCER_UP"
126,"Up",0.809939569889824,0.907559372952112,"L.LvsV.GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN"
11,"Up",0.810168289516211,0.907559372952112,"L.LvsV.REACTOME_HORMONE_LIGAND_BINDING_RECEPTORS"
59,"Up",0.81028216034222,0.907559372952112,"L.LvsV.CAFFAREL_RESPONSE_TO_THC_24HR_5_UP"
123,"Up",0.810338784279617,0.907559372952112,"L.LvsV.REACTOME_PEPTIDE_HORMONE_METABOLISM"
10,"Down",0.810385354361472,0.907559372952112,"L.LvsV.BIOCARTA_FBW7_PATHWAY"
386,"Down",0.811240854186502,0.908287067443442,"L.LvsV.KONDO_PROSTATE_CANCER_WITH_H3K27ME3"
9,"Down",0.811559970696025,0.908287067443442,"L.LvsV.NAGY_PCAF_COMPONENTS_HUMAN"
677,"Down",0.811657021715115,0.908287067443442,"L.LvsV.BASAKI_YBX1_TARGETS_DN"
33,"Down",0.811738798455445,0.908287067443442,"L.LvsV.REACTOME_ENDOSOMAL_SORTING_COMPLEX_REQUIRED_FOR_TRANSPORT_ESCRT"
227,"Up",0.812005386513378,0.908287067443442,"L.LvsV.JACKSON_DNMT1_TARGETS_UP"
11,"Up",0.812020794786206,0.908287067443442,"L.LvsV.REACTOME_ACTIVATION_OF_CASPASES_THROUGH_APOPTOSOME_MEDIATED_CLEAVAGE"
11,"Down",0.812574968935019,0.908576499130137,"L.LvsV.REACTOME_PYRIMIDINE_SALVAGE"
5,"Down",0.812608209115306,0.908576499130137,"L.LvsV.REACTOME_SODIUM_COUPLED_SULPHATE_DI_AND_TRI_CARBOXYLATE_TRANSPORTERS"
61,"Down",0.813249581100209,0.909109772321685,"L.LvsV.WINNEPENNINCKX_MELANOMA_METASTASIS_DN"
117,"Up",0.814232806065926,0.910024900897211,"L.LvsV.LIN_TUMOR_ESCAPE_FROM_IMMUNE_ATTACK"
112,"Up",0.814658691713963,0.910215987708094,"L.LvsV.ZHU_CMV_8_HR_UP"
30,"Down",0.814796137706218,0.910215987708094,"L.LvsV.REACTOME_RNA_POLYMERASE_III_TRANSCRIPTION_INITIATION_FROM_TYPE_1_PROMOTER"
12,"Up",0.814897655842841,0.910215987708094,"L.LvsV.BIOCARTA_EOSINOPHILS_PATHWAY"
214,"Up",0.815721921475469,0.91088039742713,"L.LvsV.FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP"
110,"Up",0.815821980115599,0.91088039742713,"L.LvsV.TOOKER_GEMCITABINE_RESISTANCE_UP"
161,"Up",0.816669532735175,0.911560254035971,"L.LvsV.WANG_ESOPHAGUS_CANCER_VS_NORMAL_DN"
156,"Down",0.816888551983722,0.911560254035971,"L.LvsV.MARKEY_RB1_CHRONIC_LOF_UP"
14,"Down",0.817068146221068,0.911560254035971,"L.LvsV.FUJIWARA_PARK2_HEPATOCYTE_PROLIFERATION_DN"
27,"Down",0.817090363357257,0.911560254035971,"L.LvsV.LEE_NAIVE_T_LYMPHOCYTE"
338,"Up",0.817262719522753,0.91156860525344,"L.LvsV.REACTOME_FC_EPSILON_RECEPTOR_FCERI_SIGNALING"
25,"Down",0.817729526998646,0.911905315606195,"L.LvsV.HONRADO_BREAST_CANCER_BRCA1_VS_BRCA2"
106,"Down",0.818608737478635,0.912701695809513,"L.LvsV.VANTVEER_BREAST_CANCER_POOR_PROGNOSIS"
149,"Up",0.819669448916441,0.913609259977643,"L.LvsV.NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN"
99,"Down",0.819753217353786,0.913609259977643,"L.LvsV.GHANDHI_BYSTANDER_IRRADIATION_UP"
16,"Down",0.819942469800486,0.91363601683331,"L.LvsV.REACTOME_SIGNALING_BY_LEPTIN"
28,"Down",0.822051718073538,0.915624264274478,"L.LvsV.SU_KIDNEY"
240,"Down",0.822058029997921,0.915624264274478,"L.LvsV.REACTOME_MITOTIC_PROMETAPHASE"
25,"Down",0.822866961549252,0.915880877024525,"L.LvsV.NAKAMURA_LUNG_CANCER"
522,"Up",0.823253981320316,0.915880877024525,"L.LvsV.YANG_BCL3_TARGETS_UP"
83,"Up",0.823267748042349,0.915880877024525,"L.LvsV.BAKKER_FOXO3_TARGETS_UP"
664,"Up",0.823316296517629,0.915880877024525,"L.LvsV.PUJANA_BRCA2_PCC_NETWORK"
140,"Down",0.823411538620678,0.915880877024525,"L.LvsV.LEIN_PONS_MARKERS"
278,"Up",0.823439375623769,0.915880877024525,"L.LvsV.LIN_NPAS4_TARGETS_UP"
338,"Up",0.823447972452326,0.915880877024525,"L.LvsV.TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN"
21,"Down",0.823672333284365,0.915946164667992,"L.LvsV.NIKOLSKY_BREAST_CANCER_21Q22_AMPLICON"
8,"Up",0.824454620828101,0.916631731059435,"L.LvsV.KERLEY_RESPONSE_TO_CISPLATIN_DN"
33,"Up",0.824882185519237,0.91671519000108,"L.LvsV.OZEN_MIR125B1_TARGETS"
63,"Up",0.825069559560208,0.91671519000108,"L.LvsV.KORKOLA_SEMINOMA_UP"
236,"Down",0.825299514806226,0.91671519000108,"L.LvsV.BOSCO_ALLERGEN_INDUCED_TH2_ASSOCIATED_MODULE"
13,"Up",0.82532381030442,0.91671519000108,"L.LvsV.REACTOME_RRNA_PROCESSING_IN_THE_MITOCHONDRION"
11,"Up",0.825452889001552,0.91671519000108,"L.LvsV.BIOCARTA_SKP2E2F_PATHWAY"
30,"Up",0.825731901009264,0.91671519000108,"L.LvsV.SUZUKI_RESPONSE_TO_TSA"
74,"Up",0.825824392708877,0.91671519000108,"L.LvsV.KENNY_CTNNB1_TARGETS_UP"
18,"Down",0.825856097195764,0.91671519000108,"L.LvsV.XU_RESPONSE_TO_TRETINOIN_DN"
27,"Up",0.826136314846224,0.916842168764507,"L.LvsV.WACKER_HYPOXIA_TARGETS_OF_VHL"
160,"Down",0.82677411421317,0.917220909231685,"L.LvsV.HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_UP"
24,"Up",0.826809370882748,0.917220909231685,"L.LvsV.REACTOME_RECEPTOR_TYPE_TYROSINE_PROTEIN_PHOSPHATASES"
28,"Up",0.827607881692208,0.917922563265039,"L.LvsV.HOLLERN_ADENOMYOEPITHELIAL_BREAST_TUMOR"
279,"Down",0.828000018002939,0.918173305162103,"L.LvsV.BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP"
14,"Down",0.828421394631831,0.918456364732182,"L.LvsV.REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_G1_CELL_CYCLE_ARREST"
41,"Down",0.829134872737999,0.919044392849288,"L.LvsV.PID_AR_NONGENOMIC_PATHWAY"
34,"Up",0.829495657131271,0.919044392849288,"L.LvsV.WELCH_GATA1_TARGETS"
31,"Up",0.829643255193951,0.919044392849288,"L.LvsV.REACTOME_G0_AND_EARLY_G1"
240,"Down",0.829652967854256,0.919044392849288,"L.LvsV.GARCIA_TARGETS_OF_FLI1_AND_DAX1_DN"
40,"Up",0.829782891861755,0.919044392849288,"L.LvsV.SHIN_B_CELL_LYMPHOMA_CLUSTER_2"
39,"Up",0.830206659279185,0.919329585250273,"L.LvsV.IKEDA_MIR30_TARGETS_DN"
6,"Up",0.830853848066724,0.919862019615722,"L.LvsV.REACTOME_P75NTR_NEGATIVELY_REGULATES_CELL_CYCLE_VIA_SC1"
15,"Up",0.831631336507264,0.920249154265934,"L.LvsV.REACTOME_TRAF3_DEPENDENT_IRF_ACTIVATION_PATHWAY"
151,"Up",0.831666910018046,0.920249154265934,"L.LvsV.KEGG_INSULIN_SIGNALING_PATHWAY"
279,"Down",0.83170284388983,0.920249154265934,"L.LvsV.UEDA_PERIFERAL_CLOCK"
133,"Up",0.832956988102535,0.921317278600846,"L.LvsV.SU_LIVER"
867,"Up",0.83300146061234,0.921317278600846,"L.LvsV.PARENT_MTOR_SIGNALING_UP"
46,"Down",0.833575942851248,0.921649716845533,"L.LvsV.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_UP"
185,"Up",0.833635419414815,0.921649716845533,"L.LvsV.REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS"
22,"Up",0.834285295689408,0.922062972410489,"L.LvsV.PID_IL5_PATHWAY"
59,"Up",0.834342747507628,0.922062972410489,"L.LvsV.WOOD_EBV_EBNA1_TARGETS_DN"
134,"Up",0.834954905158267,0.92255509005197,"L.LvsV.MORI_PRE_BI_LYMPHOCYTE_UP"
106,"Down",0.835512997528203,0.922722417608219,"L.LvsV.REACTOME_MAPK6_MAPK4_SIGNALING"
30,"Down",0.835757209102205,0.922722417608219,"L.LvsV.WOTTON_RUNX_TARGETS_UP"
7,"Down",0.835804640091959,0.922722417608219,"L.LvsV.REACTOME_DEFECTIVE_LFNG_CAUSES_SCDO3"
27,"Up",0.835895895076051,0.922722417608219,"L.LvsV.REACTOME_ADP_SIGNALLING_THROUGH_P2Y_PURINOCEPTOR_1"
38,"Down",0.836214733960683,0.922722417608219,"L.LvsV.BIOCARTA_IGF1R_PATHWAY"
352,"Down",0.836345697721883,0.922722417608219,"L.LvsV.REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL"
25,"Down",0.836588156760086,0.922722417608219,"L.LvsV.FINETTI_BREAST_CANCERS_KINOME_GRAY"
112,"Up",0.836589299715346,0.922722417608219,"L.LvsV.BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_CIS"
225,"Up",0.836608334141798,0.922722417608219,"L.LvsV.REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS"
6,"Down",0.837201529514539,0.923192512302729,"L.LvsV.REACTOME_VASOPRESSIN_LIKE_RECEPTORS"
38,"Up",0.837641252864382,0.923493217764141,"L.LvsV.CEBALLOS_TARGETS_OF_TP53_AND_MYC_UP"
51,"Up",0.838203509422644,0.923928868340869,"L.LvsV.KANG_GLIS3_TARGETS"
199,"Down",0.839572808632544,0.925253749039134,"L.LvsV.GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN"
65,"Down",0.839955956058554,0.925491526713381,"L.LvsV.CHIARETTI_T_ALL_REFRACTORY_TO_THERAPY"
588,"Down",0.840287613395964,0.925556194753589,"L.LvsV.YOSHIMURA_MAPK8_TARGETS_DN"
505,"Down",0.840349447940499,0.925556194753589,"L.LvsV.REACTOME_GPCR_LIGAND_BINDING"
17,"Down",0.840774050722972,0.925839419726611,"L.LvsV.IVANOV_MUTATED_IN_COLON_CANCER"
27,"Down",0.840957073302614,0.925856562781791,"L.LvsV.REACTOME_METABOLISM_OF_NITRIC_OXIDE_ENOS_ACTIVATION_AND_REGULATION"
67,"Down",0.841769966760072,0.926114441540038,"L.LvsV.BROWNE_HCMV_INFECTION_2HR_UP"
60,"Up",0.841848309508132,0.926114441540038,"L.LvsV.REACTOME_SYNTHESIS_OF_PIPS_AT_THE_PLASMA_MEMBRANE"
24,"Up",0.841911519836988,0.926114441540038,"L.LvsV.KIM_GERMINAL_CENTER_T_HELPER_DN"
29,"Up",0.841957095156968,0.926114441540038,"L.LvsV.LUND_SILENCED_BY_METHYLATION"
88,"Down",0.842028811289884,0.926114441540038,"L.LvsV.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_DN"
169,"Down",0.842788058875481,0.926721051347345,"L.LvsV.RAMALHO_STEMNESS_DN"
13,"Up",0.842915566508554,0.926721051347345,"L.LvsV.SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX6_UP"
391,"Down",0.843361480495772,0.927026963352112,"L.LvsV.AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_UP"
104,"Up",0.843770042801932,0.927083681236288,"L.LvsV.FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP"
9,"Up",0.843968512946432,0.927083681236288,"L.LvsV.REACTOME_SYNTHESIS_OF_PG"
15,"Up",0.844112526296838,0.927083681236288,"L.LvsV.HOLLEMAN_PREDNISOLONE_RESISTANCE_ALL_DN"
39,"Up",0.844121349829855,0.927083681236288,"L.LvsV.ZHAN_V1_LATE_DIFFERENTIATION_GENES_DN"
252,"Down",0.84428899556259,0.927083681236288,"L.LvsV.HUANG_GATA2_TARGETS_UP"
277,"Up",0.844419138850777,0.927083681236288,"L.LvsV.REACTOME_MITOTIC_METAPHASE_AND_ANAPHASE"
759,"Down",0.844622711538657,0.927123083600801,"L.LvsV.FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN"
65,"Down",0.84525774643909,0.927373540183085,"L.LvsV.GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_UP"
9,"Up",0.84529586630902,0.927373540183085,"L.LvsV.REACTOME_ADRENOCEPTORS"
44,"Up",0.845354068099611,0.927373540183085,"L.LvsV.COLLIS_PRKDC_SUBSTRATES"
150,"Up",0.845732516312763,0.927604658340264,"L.LvsV.GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP"
15,"Up",0.846230466163837,0.92770418551294,"L.LvsV.REACTOME_MITOTIC_TELOPHASE_CYTOKINESIS"
309,"Down",0.846279949094702,0.92770418551294,"L.LvsV.CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_UP"
29,"Down",0.846475828077679,0.92770418551294,"L.LvsV.BIOCARTA_ACE2_PATHWAY"
22,"Down",0.846494414164005,0.92770418551294,"L.LvsV.SA_REG_CASCADE_OF_CYCLIN_EXPR"
1169,"Up",0.847121646144902,0.928207606328808,"L.LvsV.JOHNSTONE_PARVB_TARGETS_3_DN"
14,"Up",0.847438128649277,0.928370400891986,"L.LvsV.BIOCARTA_LEPTIN_PATHWAY"
25,"Up",0.847883047781519,0.928673805702063,"L.LvsV.KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS_AND_CYCLIC_RGD"
599,"Up",0.848436833667175,0.929062993121919,"L.LvsV.IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR"
22,"Down",0.84860913632222,0.929062993121919,"L.LvsV.BIOCARTA_NFKB_PATHWAY"
40,"Up",0.848860163630803,0.929062993121919,"L.LvsV.WIEMANN_TELOMERE_SHORTENING_AND_CHRONIC_LIVER_DAMAGE_UP"
352,"Down",0.848910515690348,0.929062993121919,"L.LvsV.ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_UP"
16,"Down",0.849592926848951,0.92962582476704,"L.LvsV.SHIN_B_CELL_LYMPHOMA_CLUSTER_6"
355,"Down",0.84988575476043,0.929762235470997,"L.LvsV.IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_UP"
14,"Down",0.850758968316768,0.93031382488946,"L.LvsV.BIOCARTA_IL5_PATHWAY"
37,"Down",0.851043911639411,0.93031382488946,"L.LvsV.BIOCARTA_PTDINS_PATHWAY"
318,"Up",0.851318207917824,0.93031382488946,"L.LvsV.ALONSO_METASTASIS_UP"
79,"Down",0.851347412595462,0.93031382488946,"L.LvsV.REACTOME_ACTIVATION_OF_MATRIX_METALLOPROTEINASES"
8,"Down",0.851492002416669,0.93031382488946,"L.LvsV.TERAMOTO_OPN_TARGETS_CLUSTER_5"
7,"Down",0.851549385357618,0.93031382488946,"L.LvsV.REACTOME_SULFIDE_OXIDATION_TO_SULFATE"
71,"Down",0.8515677821967,0.93031382488946,"L.LvsV.HUANG_FOXA2_TARGETS_DN"
10,"Down",0.851826894464148,0.930413057979509,"L.LvsV.BIOCARTA_IL22BP_PATHWAY"
35,"Down",0.852665226379443,0.931144783063784,"L.LvsV.PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN"
83,"Down",0.853221582574976,0.931568351117109,"L.LvsV.VALK_AML_WITH_FLT3_ITD"
73,"Up",0.853822820175413,0.931635865075687,"L.LvsV.LIAO_HAVE_SOX4_BINDING_SITES"
46,"Up",0.853879016458185,0.931635865075687,"L.LvsV.VERNELL_RETINOBLASTOMA_PATHWAY_DN"
60,"Down",0.853924653091549,0.931635865075687,"L.LvsV.CROONQUIST_NRAS_VS_STROMAL_STIMULATION_UP"
28,"Down",0.854053653977186,0.931635865075687,"L.LvsV.KRISHNAN_FURIN_TARGETS_UP"
23,"Up",0.85412591789992,0.931635865075687,"L.LvsV.WANG_RECURRENT_LIVER_CANCER_DN"
528,"Down",0.85485995057515,0.932252596988166,"L.LvsV.WANG_LMO4_TARGETS_UP"
104,"Up",0.855029824800285,0.932253973835689,"L.LvsV.STEIN_ESR1_TARGETS"
9,"Down",0.855200388795167,0.932256102060032,"L.LvsV.REACTOME_ACTIVATION_OF_PUMA_AND_TRANSLOCATION_TO_MITOCHONDRIA"
119,"Up",0.855530528580969,0.932297419909506,"L.LvsV.GALINDO_IMMUNE_RESPONSE_TO_ENTEROTOXIN"
1673,"Down",0.85573885265258,0.932297419909506,"L.LvsV.REACTOME_SIGNALING_BY_GPCR"
497,"Up",0.855744150124931,0.932297419909506,"L.LvsV.DACOSTA_UV_RESPONSE_VIA_ERCC3_UP"
87,"Up",0.856785242190622,0.933073942810154,"L.LvsV.HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_DN"
484,"Down",0.856794430755499,0.933073942810154,"L.LvsV.RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP"
111,"Down",0.85780291766503,0.933852741127541,"L.LvsV.CHESLER_BRAIN_QTL_CIS"
5,"Up",0.857847363390628,0.933852741127541,"L.LvsV.REACTOME_MELANIN_BIOSYNTHESIS"
9,"Down",0.858218294220803,0.934072627706066,"L.LvsV.BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_AND_PAX3"
1586,"Up",0.858686544066223,0.934190193934095,"L.LvsV.BRUINS_UVC_RESPONSE_LATE"
33,"Down",0.858846723872944,0.934190193934095,"L.LvsV.MATZUK_LUTEAL_GENES"
23,"Up",0.858976326328761,0.934190193934095,"L.LvsV.CHEOK_RESPONSE_TO_MERCAPTOPURINE_DN"
10,"Down",0.85900216060064,0.934190193934095,"L.LvsV.SA_FAS_SIGNALING"
574,"Up",0.859656232425209,0.934717661569121,"L.LvsV.WANG_LMO4_TARGETS_DN"
38,"Up",0.860641104158374,0.93560453497673,"L.LvsV.HOLLEMAN_VINCRISTINE_RESISTANCE_ALL_UP"
28,"Up",0.860948825633036,0.935729174908276,"L.LvsV.KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS"
643,"Down",0.861094238005663,0.935729174908276,"L.LvsV.MULLIGHAN_MLL_SIGNATURE_2_UP"
195,"Down",0.86167156527454,0.936172545569451,"L.LvsV.REACTOME_ESTROGEN_DEPENDENT_GENE_EXPRESSION"
22,"Down",0.862539584999081,0.936639690507905,"L.LvsV.BIOCARTA_NPP1_PATHWAY"
363,"Up",0.862572859515066,0.936639690507905,"L.LvsV.ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_DN"
18,"Down",0.862609749333741,0.936639690507905,"L.LvsV.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_DN"
22,"Down",0.863251050618992,0.937120193999448,"L.LvsV.MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_4"
185,"Down",0.863423264060328,0.937120193999448,"L.LvsV.FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP"
165,"Up",0.863560750303344,0.937120193999448,"L.LvsV.SENESE_HDAC2_TARGETS_UP"
54,"Up",0.863806413423377,0.93720283748388,"L.LvsV.ROZANOV_MMP14_TARGETS_DN"
139,"Down",0.864290961960325,0.937544580866909,"L.LvsV.ROSS_AML_WITH_MLL_FUSIONS"
60,"Down",0.864990107887622,0.938118930268863,"L.LvsV.STONER_ESOPHAGEAL_CARCINOGENESIS_UP"
19,"Down",0.865645556800854,0.938626094129493,"L.LvsV.HEIDENBLAD_AMPLIFIED_IN_SOFT_TISSUE_CANCER"
23,"Up",0.865797265339196,0.938626094129493,"L.LvsV.REACTOME_PROCESSING_OF_INTRONLESS_PRE_MRNAS"
25,"Up",0.866030715950636,0.938695124189583,"L.LvsV.KEGG_GLYCOSPHINGOLIPID_BIOSYNTHESIS_LACTO_AND_NEOLACTO_SERIES"
92,"Down",0.866403173415494,0.938888961026466,"L.LvsV.STARK_HYPPOCAMPUS_22Q11_DELETION_UP"
27,"Up",0.866549171300064,0.938888961026466,"L.LvsV.KASLER_HDAC7_TARGETS_1_DN"
99,"Down",0.867783757546776,0.93992394022846,"L.LvsV.NUTT_GBM_VS_AO_GLIOMA_UP"
6,"Up",0.867844404931504,0.93992394022846,"L.LvsV.REACTOME_SIGNALING_BY_MEMBRANE_TETHERED_FUSIONS_OF_PDGFRA_OR_PDGFRB"
26,"Up",0.86816235949936,0.940084153088907,"L.LvsV.REACTOME_PD_1_SIGNALING"
247,"Up",0.868732690520961,0.940483042076045,"L.LvsV.PODAR_RESPONSE_TO_ADAPHOSTIN_UP"
59,"Down",0.868870931257811,0.940483042076045,"L.LvsV.PID_CXCR3_PATHWAY"
36,"Up",0.869682987110818,0.941177771723569,"L.LvsV.AKL_HTLV1_INFECTION_UP"
288,"Down",0.870042074375681,0.941241607362559,"L.LvsV.FOSTER_TOLERANT_MACROPHAGE_UP"
16,"Up",0.870137301402951,0.941241607362559,"L.LvsV.BIOCARTA_FREE_PATHWAY"
7,"Down",0.870252685266306,0.941241607362559,"L.LvsV.PETRETTO_LEFT_VENTRICLE_MASS_QTL_CIS_UP"
482,"Down",0.870946726088213,0.941808028269456,"L.LvsV.HOLLMANN_APOPTOSIS_VIA_CD40_DN"
118,"Down",0.871696286979895,0.94243425317009,"L.LvsV.ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_DN"
64,"Up",0.87217893563112,0.942756613705121,"L.LvsV.MATTIOLI_MULTIPLE_MYELOMA_WITH_14Q32_TRANSLOCATIONS"
35,"Down",0.872430302942124,0.942756613705121,"L.LvsV.SA_B_CELL_RECEPTOR_COMPLEXES"
91,"Down",0.872505985228631,0.942756613705121,"L.LvsV.PID_TCR_PATHWAY"
31,"Up",0.873413174291674,0.943389522433885,"L.LvsV.MEINHOLD_OVARIAN_CANCER_LOW_GRADE_DN"
204,"Up",0.873493750537809,0.943389522433885,"L.LvsV.BOSCO_TH1_CYTOTOXIC_MODULE"
9,"Up",0.873736608794181,0.943389522433885,"L.LvsV.REACTOME_RELEASE_OF_HH_NP_FROM_THE_SECRETING_CELL"
169,"Down",0.873774234831601,0.943389522433885,"L.LvsV.GAVIN_FOXP3_TARGETS_CLUSTER_P4"
18,"Up",0.874611922001389,0.94400621183943,"L.LvsV.MIKKELSEN_IPS_LCP_WITH_H3K4ME3_AND_H3K27ME3"
6,"Down",0.874702385782376,0.94400621183943,"L.LvsV.BIOCARTA_ACETAMINOPHEN_PATHWAY"
314,"Up",0.87486927898705,0.94400621183943,"L.LvsV.REACTOME_BIOLOGICAL_OXIDATIONS"
79,"Up",0.875028366011409,0.94400621183943,"L.LvsV.HESS_TARGETS_OF_HOXA9_AND_MEIS1_UP"
661,"Up",0.875372924340919,0.944111490339488,"L.LvsV.DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_UP"
212,"Up",0.875507976354439,0.944111490339488,"L.LvsV.REACTOME_SCAVENGING_OF_HEME_FROM_PLASMA"
48,"Down",0.875638220738089,0.944111490339488,"L.LvsV.PID_HIV_NEF_PATHWAY"
86,"Up",0.875954199607577,0.944268038531934,"L.LvsV.KENNY_CTNNB1_TARGETS_DN"
45,"Up",0.876905554448769,0.945109319794785,"L.LvsV.REACTOME_NEGATIVE_REGULATORS_OF_DDX58_IFIH1_SIGNALING"
25,"Up",0.877435793266509,0.945366922459191,"L.LvsV.REACTOME_REGULATION_OF_INNATE_IMMUNE_RESPONSES_TO_CYTOSOLIC_DNA"
36,"Up",0.877486533923054,0.945366922459191,"L.LvsV.BIOCARTA_TRKA_PATHWAY"
29,"Down",0.878954948102444,0.946747169796984,"L.LvsV.REACTOME_AFLATOXIN_ACTIVATION_AND_DETOXIFICATION"
75,"Down",0.879122909398922,0.946747169796984,"L.LvsV.LUI_THYROID_CANCER_PAX8_PPARG_UP"
33,"Down",0.879369415568721,0.946747169796984,"L.LvsV.YORDY_RECIPROCAL_REGULATION_BY_ETS1_AND_SP100_UP"
28,"Down",0.879452606995354,0.946747169796984,"L.LvsV.HO_LIVER_CANCER_VASCULAR_INVASION"
31,"Up",0.88077681768583,0.94787696813528,"L.LvsV.CARDOSO_RESPONSE_TO_GAMMA_RADIATION_AND_3AB"
20,"Up",0.880844974186846,0.94787696813528,"L.LvsV.REACTOME_ABACAVIR_TRANSPORT_AND_METABOLISM"
44,"Down",0.881091054153237,0.947957275425812,"L.LvsV.REACTOME_RHO_GTPASES_ACTIVATE_WASPS_AND_WAVES"
361,"Down",0.881990548715483,0.948575731928851,"L.LvsV.MARKEY_RB1_ACUTE_LOF_UP"
8,"Up",0.882037688528964,0.948575731928851,"L.LvsV.REACTOME_DEFECTIVE_ST3GAL3_CAUSES_MCT12_AND_EIEE15"
24,"Up",0.882180577605019,0.948575731928851,"L.LvsV.WONG_ENDOMETRIAL_CANCER_LATE"
305,"Down",0.883106174016483,0.949216597123616,"L.LvsV.REACTOME_FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS"
92,"Down",0.883119944945538,0.949216597123616,"L.LvsV.REACTOME_DDX58_IFIH1_MEDIATED_INDUCTION_OF_INTERFERON_ALPHA_BETA"
10,"Up",0.883330847579157,0.949258747573403,"L.LvsV.BIOCARTA_PEPI_PATHWAY"
186,"Up",0.884109483382739,0.949820144091082,"L.LvsV.REACTOME_HCMV_INFECTION"
39,"Up",0.884259119660063,0.949820144091082,"L.LvsV.KANG_FLUOROURACIL_RESISTANCE_UP"
14,"Down",0.884368620325717,0.949820144091082,"L.LvsV.REACTOME_POU5F1_OCT4_SOX2_NANOG_REPRESS_GENES_RELATED_TO_DIFFERENTIATION"
9,"Up",0.884777380879891,0.949929171804065,"L.LvsV.BIOCARTA_CREM_PATHWAY"
222,"Down",0.884813751996913,0.949929171804065,"L.LvsV.DER_IFN_BETA_RESPONSE_UP"
316,"Down",0.885184788027726,0.950005605331881,"L.LvsV.KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION"
575,"Up",0.885415419420852,0.950005605331881,"L.LvsV.LINDGREN_BLADDER_CANCER_CLUSTER_1_DN"
56,"Up",0.885482693209279,0.950005605331881,"L.LvsV.KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION"
8,"Down",0.88599766370362,0.950005605331881,"L.LvsV.LAU_APOPTOSIS_CDKN2A_DN"
9,"Down",0.886018342251639,0.950005605331881,"L.LvsV.ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_2HR"
40,"Up",0.886164533788467,0.950005605331881,"L.LvsV.REACTOME_ALPHA_DEFENSINS"
130,"Up",0.886249568538459,0.950005605331881,"L.LvsV.CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_UP"
18,"Up",0.886259524742601,0.950005605331881,"L.LvsV.REACTOME_METHYLATION"
143,"Down",0.886817086462218,0.950361042817911,"L.LvsV.REACTOME_INTEGRATION_OF_ENERGY_METABOLISM"
25,"Up",0.887026005980256,0.950361042817911,"L.LvsV.REACTOME_PINK_PARKIN_MEDIATED_MITOPHAGY"
66,"Up",0.88725369540878,0.950361042817911,"L.LvsV.REACTOME_BILE_ACID_AND_BILE_SALT_METABOLISM"
6,"Down",0.887278658532476,0.950361042817911,"L.LvsV.REACTOME_NADE_MODULATES_DEATH_SIGNALLING"
38,"Up",0.887687970475445,0.950471166977013,"L.LvsV.BIOCARTA_BARRESTIN_SRC_PATHWAY"
7,"Up",0.887864184538633,0.950471166977013,"L.LvsV.REACTOME_ATTACHMENT_OF_GPI_ANCHOR_TO_UPAR"
28,"Up",0.888155726076953,0.950471166977013,"L.LvsV.HOLLEMAN_PREDNISOLONE_RESISTANCE_B_ALL_UP"
287,"Down",0.888255974389417,0.950471166977013,"L.LvsV.KYNG_DNA_DAMAGE_DN"
10,"Up",0.888347580198786,0.950471166977013,"L.LvsV.REACTOME_SYNTHESIS_OF_PYROPHOSPHATES_IN_THE_CYTOSOL"
40,"Down",0.88841291208848,0.950471166977013,"L.LvsV.WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_DN"
9,"Down",0.888826163789126,0.95068805735701,"L.LvsV.REACTOME_SUMO_IS_PROTEOLYTICALLY_PROCESSED"
74,"Down",0.889065137391587,0.95068805735701,"L.LvsV.PLASARI_NFIC_TARGETS_BASAL_UP"
6,"Down",0.889131478493959,0.95068805735701,"L.LvsV.BIOCARTA_SLRP_PATHWAY"
59,"Down",0.889606854861832,0.951012432430601,"L.LvsV.HOLLEMAN_VINCRISTINE_RESISTANCE_B_ALL_UP"
103,"Down",0.88985021104776,0.951088694545344,"L.LvsV.LINDVALL_IMMORTALIZED_BY_TERT_UP"
1873,"Up",0.890383946828216,0.951317687471436,"L.LvsV.DODD_NASOPHARYNGEAL_CARCINOMA_DN"
103,"Up",0.890429019895489,0.951317687471436,"L.LvsV.KUMAR_AUTOPHAGY_NETWORK"
48,"Down",0.89077781532287,0.951317687471436,"L.LvsV.YUAN_ZNF143_PARTNERS"
7,"Up",0.891083012519512,0.951317687471436,"L.LvsV.REACTOME_NEGATIVE_FEEDBACK_REGULATION_OF_MAPK_PATHWAY"
18,"Down",0.891167578203905,0.951317687471436,"L.LvsV.LOPEZ_MESOTHELIOMA_SURVIVAL_UP"
10,"Down",0.891470476558767,0.951317687471436,"L.LvsV.MIKKELSEN_DEDIFFERENTIATED_STATE_UP"
87,"Down",0.891765091978495,0.951317687471436,"L.LvsV.MATTIOLI_MGUS_VS_MULTIPLE_MYELOMA"
79,"Up",0.89181616207084,0.951317687471436,"L.LvsV.KEGG_DRUG_METABOLISM_OTHER_ENZYMES"
15,"Up",0.891920404087479,0.951317687471436,"L.LvsV.KEGG_GLYCOSPHINGOLIPID_BIOSYNTHESIS_GANGLIO_SERIES"
101,"Down",0.892013550904802,0.951317687471436,"L.LvsV.MARTINEZ_RESPONSE_TO_TRABECTEDIN_UP"
191,"Down",0.892097589131468,0.951317687471436,"L.LvsV.DER_IFN_ALPHA_RESPONSE_UP"
215,"Down",0.892129175174425,0.951317687471436,"L.LvsV.NIKOLSKY_BREAST_CANCER_11Q12_Q14_AMPLICON"
240,"Down",0.892581828071441,0.951369998436531,"L.LvsV.TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN"
10,"Up",0.892621422624576,0.951369998436531,"L.LvsV.KIM_ALL_DISORDERS_DURATION_CORR_UP"
23,"Down",0.89269443875723,0.951369998436531,"L.LvsV.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_UP"
238,"Down",0.892920631018961,0.951427667932903,"L.LvsV.MARKEY_RB1_CHRONIC_LOF_DN"
267,"Down",0.893108587831554,0.951444582296852,"L.LvsV.REACTOME_PARASITE_INFECTION"
131,"Down",0.893346564239122,0.951514766649606,"L.LvsV.KEGG_CELL_CYCLE"
14,"Down",0.893688724476918,0.951695870114191,"L.LvsV.REACTOME_CHK1_CHK2_CDS1_MEDIATED_INACTIVATION_OF_CYCLIN_B_CDK1_COMPLEX"
88,"Down",0.893997079475143,0.951807693221825,"L.LvsV.BROWNE_HCMV_INFECTION_10HR_DN"
116,"Up",0.894157831576456,0.951807693221825,"L.LvsV.BURTON_ADIPOGENESIS_4"
37,"Up",0.894310176575761,0.951807693221825,"L.LvsV.REACTOME_DECTIN_2_FAMILY"
53,"Up",0.894810733367532,0.952144428528919,"L.LvsV.REACTOME_TNF_SIGNALING"
32,"Down",0.894970988436388,0.952144428528919,"L.LvsV.CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_HD_MTX_DN"
10,"Up",0.895175276575087,0.952178550246952,"L.LvsV.GERHOLD_RESPONSE_TO_TZD_UP"
26,"Down",0.895612723978191,0.952366866542939,"L.LvsV.CAIRO_HEPATOBLASTOMA_POOR_SURVIVAL"
87,"Up",0.895696817873626,0.952366866542939,"L.LvsV.SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE"
18,"Up",0.896041929430645,0.952550630229194,"L.LvsV.REACTOME_EARLY_PHASE_OF_HIV_LIFE_CYCLE"
457,"Down",0.896767141170444,0.952740037376805,"L.LvsV.ZWANG_DOWN_BY_2ND_EGF_PULSE"
46,"Up",0.896852963804418,0.952740037376805,"L.LvsV.REACTOME_DUAL_INCISION_IN_GG_NER"
15,"Down",0.896889032555983,0.952740037376805,"L.LvsV.BIOCARTA_IL17_PATHWAY"
380,"Up",0.89691081962695,0.952740037376805,"L.LvsV.WAMUNYOKOLI_OVARIAN_CANCER_LMP_UP"
18,"Down",0.89726659033545,0.952740037376805,"L.LvsV.BIOCARTA_CLASSIC_PATHWAY"
38,"Down",0.897324764283603,0.952740037376805,"L.LvsV.VALK_AML_CLUSTER_8"
216,"Down",0.897426318440658,0.952740037376805,"L.LvsV.WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_36HR"
16,"Down",0.898029005470503,0.953196846083013,"L.LvsV.REACTOME_GLUCOCORTICOID_BIOSYNTHESIS"
64,"Up",0.899609288858473,0.95447985861806,"L.LvsV.REACTOME_METABOLISM_OF_FAT_SOLUBLE_VITAMINS"
19,"Down",0.899621441837467,0.95447985861806,"L.LvsV.REACTOME_ACYL_CHAIN_REMODELLING_OF_PI"
17,"Down",0.899755656197744,0.95447985861806,"L.LvsV.CONRAD_GERMLINE_STEM_CELL"
82,"Up",0.900086359116824,0.954557167461376,"L.LvsV.REACTOME_THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT"
133,"Down",0.900173823683056,0.954557167461376,"L.LvsV.GAVIN_FOXP3_TARGETS_CLUSTER_T7"
28,"Up",0.900590094652504,0.954815461808954,"L.LvsV.RAHMAN_TP53_TARGETS_PHOSPHORYLATED"
11,"Up",0.900959260923722,0.954954526673686,"L.LvsV.SCHMAHL_PDGF_SIGNALING"
1236,"Up",0.901066696628074,0.954954526673686,"L.LvsV.GEORGES_TARGETS_OF_MIR192_AND_MIR215"
12,"Up",0.902772074187548,0.956578535489259,"L.LvsV.REACTOME_VITAMIN_D_CALCIFEROL_METABOLISM"
11,"Down",0.902988516516673,0.956624546430482,"L.LvsV.REACTOME_ADENYLATE_CYCLASE_ACTIVATING_PATHWAY"
7,"Down",0.903338820527391,0.956770606792988,"L.LvsV.STONER_ESOPHAGEAL_CARCINOGENESIS_DN"
259,"Down",0.903472479302983,0.956770606792988,"L.LvsV.RICKMAN_HEAD_AND_NECK_CANCER_C"
36,"Up",0.903972661504883,0.957061594321573,"L.LvsV.REACTOME_TERMINATION_OF_TRANSLESION_DNA_SYNTHESIS"
12,"Down",0.90414852258308,0.957061594321573,"L.LvsV.MUNSHI_MULTIPLE_MYELOMA_DN"
135,"Down",0.904382034847858,0.957061594321573,"L.LvsV.FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_DN"
17,"Up",0.904557995588688,0.957061594321573,"L.LvsV.WEBER_METHYLATED_ICP_IN_SPERM_UP"
87,"Down",0.904675920251029,0.957061594321573,"L.LvsV.STOSSI_RESPONSE_TO_ESTRADIOL"
51,"Up",0.904966980981762,0.957061594321573,"L.LvsV.KORKOLA_TERATOMA"
147,"Up",0.905395482752287,0.957061594321573,"L.LvsV.CHEN_LIVER_METABOLISM_QTL_CIS"
38,"Down",0.905646643833631,0.957061594321573,"L.LvsV.RUAN_RESPONSE_TO_TNF_TROGLITAZONE_UP"
29,"Up",0.905776931332399,0.957061594321573,"L.LvsV.BIOCARTA_NO2IL12_PATHWAY"
69,"Up",0.905790024606723,0.957061594321573,"L.LvsV.WAGSCHAL_EHMT2_TARGETS_UP"
233,"Up",0.905792264799451,0.957061594321573,"L.LvsV.REACTOME_CELLULAR_SENESCENCE"
39,"Up",0.905961552785749,0.957061594321573,"L.LvsV.KEGG_ASTHMA"
35,"Up",0.905997537471354,0.957061594321573,"L.LvsV.JIANG_TIP30_TARGETS_DN"
63,"Down",0.906172637411586,0.957063708165933,"L.LvsV.GAUSSMANN_MLL_AF4_FUSION_TARGETS_D_UP"
18,"Up",0.906904337818785,0.957653568334619,"L.LvsV.PARK_OSTEOBLAST_DIFFERENTIATION_BY_PHENYLAMIL_UP"
14,"Up",0.907157916235523,0.957727638945948,"L.LvsV.REACTOME_ACETYLCHOLINE_BINDING_AND_DOWNSTREAM_EVENTS"
143,"Up",0.9075598165595,0.957727638945948,"L.LvsV.SWEET_KRAS_TARGETS_DN"
102,"Up",0.907610027948728,0.957727638945948,"L.LvsV.KEGG_RETINOL_METABOLISM"
346,"Up",0.907667359029982,0.957727638945948,"L.LvsV.FISCHER_G2_M_CELL_CYCLE"
23,"Down",0.907936941793178,0.95773992502583,"L.LvsV.REACTOME_NOREPINEPHRINE_NEUROTRANSMITTER_RELEASE_CYCLE"
29,"Down",0.908146895295589,0.95773992502583,"L.LvsV.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_SALMON_DN"
104,"Up",0.908198666469602,0.95773992502583,"L.LvsV.KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_DN"
37,"Up",0.908655974955179,0.958039451854917,"L.LvsV.BURTON_ADIPOGENESIS_10"
79,"Down",0.910172850872963,0.959455804094683,"L.LvsV.CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN"
18,"Up",0.911351363309657,0.960451596328524,"L.LvsV.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_1"
15,"Down",0.911464916971562,0.960451596328524,"L.LvsV.KANG_CISPLATIN_RESISTANCE_DN"
75,"Down",0.911756140426838,0.960575400232467,"L.LvsV.REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS"
46,"Up",0.912341888416719,0.960586865607767,"L.LvsV.PETRETTO_HEART_MASS_QTL_CIS_UP"
168,"Down",0.912544594595743,0.960586865607767,"L.LvsV.REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA"
46,"Up",0.912739186834596,0.960586865607767,"L.LvsV.PID_ANTHRAX_PATHWAY"
633,"Up",0.912865571010075,0.960586865607767,"L.LvsV.HADDAD_B_LYMPHOCYTE_PROGENITOR"
162,"Down",0.913077922049507,0.960586865607767,"L.LvsV.BASSO_CD40_SIGNALING_UP"
63,"Down",0.91310663813431,0.960586865607767,"L.LvsV.HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_DN"
29,"Down",0.91323639866717,0.960586865607767,"L.LvsV.MULLIGAN_NTF3_SIGNALING_VIA_INSR_AND_IGF1R_UP"
18,"Down",0.913332293909321,0.960586865607767,"L.LvsV.WEBER_METHYLATED_LCP_IN_SPERM_UP"
26,"Down",0.913452570373742,0.960586865607767,"L.LvsV.BIOCARTA_HIF_PATHWAY"
28,"Down",0.913504384041534,0.960586865607767,"L.LvsV.VISALA_RESPONSE_TO_HEAT_SHOCK_AND_AGING_UP"
15,"Up",0.914150567444216,0.961083568625037,"L.LvsV.REACTOME_TICAM1_TRAF6_DEPENDENT_INDUCTION_OF_TAK1_COMPLEX"
37,"Up",0.914458411998444,0.961224441053117,"L.LvsV.REACTOME_STING_MEDIATED_INDUCTION_OF_HOST_IMMUNE_RESPONSES"
17,"Down",0.915267779189687,0.96148599903971,"L.LvsV.REACTOME_MRNA_DECAY_BY_3_TO_5_EXORIBONUCLEASE"
22,"Down",0.915290596447214,0.96148599903971,"L.LvsV.REACTOME_HS_GAG_DEGRADATION"
546,"Down",0.915582530183522,0.96148599903971,"L.LvsV.BLUM_RESPONSE_TO_SALIRASIB_DN"
96,"Down",0.915675484177288,0.96148599903971,"L.LvsV.CORRE_MULTIPLE_MYELOMA_DN"
22,"Down",0.915703986212894,0.96148599903971,"L.LvsV.REACTOME_TRANSCRIPTION_OF_E2F_TARGETS_UNDER_NEGATIVE_CONTROL_BY_DREAM_COMPLEX"
10,"Down",0.91575063681373,0.96148599903971,"L.LvsV.BIOCARTA_TUBBY_PATHWAY"
557,"Down",0.915977621412837,0.961541725610704,"L.LvsV.OSMAN_BLADDER_CANCER_UP"
179,"Down",0.916320599872129,0.961719171733675,"L.LvsV.REACTOME_AUTOPHAGY"
72,"Down",0.916722292116179,0.961839811956833,"L.LvsV.HAHTOLA_SEZARY_SYNDROM_DN"
7,"Down",0.916865304115001,0.961839811956833,"L.LvsV.BIOCARTA_RAN_PATHWAY"
627,"Down",0.916957433319672,0.961839811956833,"L.LvsV.SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12"
12,"Down",0.917400770807566,0.962122318246402,"L.LvsV.REACTOME_INTEGRATION_OF_PROVIRUS"
58,"Down",0.918298626154682,0.962881301727524,"L.LvsV.BAE_BRCA1_TARGETS_DN"
246,"Up",0.918504730093101,0.962891606823839,"L.LvsV.CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP"
939,"Down",0.918696778282195,0.962891606823839,"L.LvsV.GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP"
62,"Down",0.91883091293228,0.962891606823839,"L.LvsV.KEGG_ARGININE_AND_PROLINE_METABOLISM"
116,"Down",0.919143001280201,0.963036129254923,"L.LvsV.REACTOME_STIMULI_SENSING_CHANNELS"
397,"Up",0.919532562057851,0.963232687729057,"L.LvsV.BASAKI_YBX1_TARGETS_UP"
20,"Down",0.920010226707726,0.963232687729057,"L.LvsV.BIOCARTA_EGFR_SMRTE_PATHWAY"
317,"Up",0.920014106531707,0.963232687729057,"L.LvsV.BROWNE_HCMV_INFECTION_14HR_UP"
161,"Up",0.920076595951475,0.963232687729057,"L.LvsV.REACTOME_HCMV_EARLY_EVENTS"
106,"Down",0.920472475378912,0.963232687729057,"L.LvsV.KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450"
36,"Down",0.920502101383516,0.963232687729057,"L.LvsV.GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_UP"
65,"Down",0.920550103447339,0.963232687729057,"L.LvsV.REACTOME_GABA_RECEPTOR_ACTIVATION"
53,"Up",0.920952835975774,0.963252737970728,"L.LvsV.SESTO_RESPONSE_TO_UV_C6"
64,"Up",0.921143122501836,0.963252737970728,"L.LvsV.SAENZ_DETOX_PATHWAY_AND_CARCINOGENESIS_DN"
462,"Up",0.921188461088349,0.963252737970728,"L.LvsV.YAMAZAKI_TCEB3_TARGETS_DN"
4,"Down",0.921266138250897,0.963252737970728,"L.LvsV.REACTOME_ORGANIC_ANION_TRANSPORT"
129,"Up",0.921964487563696,0.963620023310057,"L.LvsV.DOANE_BREAST_CANCER_CLASSES_UP"
200,"Down",0.921965983597432,0.963620023310057,"L.LvsV.ALTEMEIER_RESPONSE_TO_LPS_WITH_MECHANICAL_VENTILATION"
167,"Down",0.923117854415788,0.964123525062531,"L.LvsV.SANA_TNF_SIGNALING_UP"
60,"Up",0.923171171032399,0.964123525062531,"L.LvsV.REACTOME_DEGRADATION_OF_AXIN"
11,"Up",0.923342225650657,0.964123525062531,"L.LvsV.BIOCARTA_ALTERNATIVE_PATHWAY"
106,"Down",0.923402256352938,0.964123525062531,"L.LvsV.GUO_HEX_TARGETS_DN"
26,"Down",0.923443596044931,0.964123525062531,"L.LvsV.BARRIER_COLON_CANCER_RECURRENCE_DN"
76,"Down",0.923636040772516,0.964123525062531,"L.LvsV.CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_UP"
35,"Down",0.923668350923536,0.964123525062531,"L.LvsV.GENTLES_LEUKEMIC_STEM_CELL_DN"
57,"Up",0.924012679294709,0.964300887848329,"L.LvsV.TERAO_AOX4_TARGETS_SKIN_UP"
11,"Down",0.92461219535453,0.964730212857514,"L.LvsV.WALLACE_PROSTATE_CANCER_DN"
59,"Up",0.92477303818861,0.964730212857514,"L.LvsV.BOYAULT_LIVER_CANCER_SUBCLASS_G12_UP"
83,"Up",0.925147715886228,0.964853267728546,"L.LvsV.CHEN_HOXA5_TARGETS_9HR_DN"
246,"Up",0.925240011846039,0.964853267728546,"L.LvsV.ZHONG_SECRETOME_OF_LUNG_CANCER_AND_FIBROBLAST"
9,"Down",0.925475446241801,0.964916790924178,"L.LvsV.REACTOME_SOS_MEDIATED_SIGNALLING"
493,"Down",0.92607597831552,0.965360875585692,"L.LvsV.ROZANOV_MMP14_TARGETS_UP"
68,"Up",0.926704548253719,0.965834014570181,"L.LvsV.REACTOME_TRANSCRIPTIONAL_ACTIVATION_OF_MITOCHONDRIAL_BIOGENESIS"
54,"Down",0.9269951966627,0.96595485155448,"L.LvsV.KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS"
28,"Down",0.929074738639633,0.96782605694059,"L.LvsV.MARCINIAK_ER_STRESS_RESPONSE_VIA_CHOP"
127,"Down",0.929141021928134,0.96782605694059,"L.LvsV.VANDESLUIS_COMMD1_TARGETS_GROUP_3_UP"
9,"Up",0.929902187299653,0.968313089061355,"L.LvsV.REACTOME_IRS_ACTIVATION"
169,"Down",0.930023563040953,0.968313089061355,"L.LvsV.SERVITJA_ISLET_HNF1A_TARGETS_DN"
15,"Up",0.930273235904392,0.968313089061355,"L.LvsV.REACTOME_HYALURONAN_UPTAKE_AND_DEGRADATION"
52,"Down",0.930328212186075,0.968313089061355,"L.LvsV.LANG_MYB_FAMILY_TARGETS"
10,"Down",0.930484254328627,0.968313089061355,"L.LvsV.REACTOME_CA2_ACTIVATED_K_CHANNELS"
1063,"Up",0.930679993305457,0.968334528224665,"L.LvsV.MARTINEZ_TP53_TARGETS_UP"
12,"Up",0.931065007085317,0.968552854971724,"L.LvsV.IIZUKA_LIVER_CANCER_PROGRESSION_L1_G1_DN"
15,"Down",0.931656280673842,0.968985623748245,"L.LvsV.COLLIS_PRKDC_REGULATORS"
80,"Up",0.93256585431768,0.969718702605265,"L.LvsV.HU_GENOTOXIC_DAMAGE_24HR"
26,"Down",0.932711893733912,0.969718702605265,"L.LvsV.GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_DN"
15,"Down",0.9332567824366,0.970102791895462,"L.LvsV.PID_P38_GAMMA_DELTA_PATHWAY"
26,"Down",0.933689563808495,0.970370225243829,"L.LvsV.REACTOME_NICOTINAMIDE_SALVAGING"
28,"Up",0.933958754289198,0.970467572348238,"L.LvsV.BIOCARTA_NKT_PATHWAY"
110,"Up",0.934478474313439,0.970825156798009,"L.LvsV.POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_UP"
55,"Up",0.934726017492026,0.970899896808831,"L.LvsV.HU_ANGIOGENESIS_DN"
415,"Up",0.936182668464529,0.972230273091732,"L.LvsV.FOURNIER_ACINAR_DEVELOPMENT_LATE_2"
154,"Down",0.936741480321323,0.972567438933596,"L.LvsV.LEE_TARGETS_OF_PTCH1_AND_SUFU_DN"
431,"Up",0.936859139041478,0.972567438933596,"L.LvsV.BROWNE_HCMV_INFECTION_1HR_DN"
67,"Down",0.93733323582965,0.972876940285739,"L.LvsV.REACTOME_DECTIN_1_MEDIATED_NONCANONICAL_NF_KB_SIGNALING"
152,"Down",0.937976842996357,0.973162125475199,"L.LvsV.RIGGINS_TAMOXIFEN_RESISTANCE_UP"
308,"Down",0.937982522661837,0.973162125475199,"L.LvsV.BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_TRANS"
10,"Down",0.938136033420657,0.973162125475199,"L.LvsV.REACTOME_NEUROTOXICITY_OF_CLOSTRIDIUM_TOXINS"
354,"Down",0.940294365759398,0.974313291868523,"L.LvsV.OHGUCHI_LIVER_HNF4A_TARGETS_DN"
170,"Down",0.940349637182137,0.974313291868523,"L.LvsV.KAYO_CALORIE_RESTRICTION_MUSCLE_DN"
108,"Down",0.94051543670853,0.974313291868523,"L.LvsV.HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_DN"
17,"Down",0.940529899068874,0.974313291868523,"L.LvsV.ZHENG_FOXP3_TARGETS_DN"
25,"Down",0.940597158647595,0.974313291868523,"L.LvsV.REACTOME_SIGNALING_BY_CYTOSOLIC_FGFR1_FUSION_MUTANTS"
76,"Up",0.940677655637801,0.974313291868523,"L.LvsV.REACTOME_TRANSCRIPTION_OF_THE_HIV_GENOME"
23,"Down",0.940845785701192,0.974313291868523,"L.LvsV.REACTOME_NA_CL_DEPENDENT_NEUROTRANSMITTER_TRANSPORTERS"
11,"Down",0.941162067392757,0.974313291868523,"L.LvsV.MARIADASON_RESPONSE_TO_BUTYRATE_CURCUMIN_SULINDAC_TSA_8"
16,"Down",0.941287345898861,0.974313291868523,"L.LvsV.KORKOLA_EMBRYONAL_CARCINOMA"
28,"Down",0.941327476625475,0.974313291868523,"L.LvsV.HASEGAWA_TUMORIGENESIS_BY_RET_C634R"
1090,"Down",0.941416691165951,0.974313291868523,"L.LvsV.LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN"
10,"Down",0.941525944646451,0.974313291868523,"L.LvsV.MATZUK_CUMULUS_EXPANSION"
324,"Down",0.941536610318958,0.974313291868523,"L.LvsV.REACTOME_SIGNALING_BY_NOTCH"
38,"Up",0.941817833020692,0.974412336145901,"L.LvsV.CAFFAREL_RESPONSE_TO_THC_8HR_3_DN"
9,"Up",0.941984795930519,0.974412336145901,"L.LvsV.MIKHAYLOVA_OXIDATIVE_STRESS_RESPONSE_VIA_VHL_UP"
22,"Down",0.942906616190167,0.975183441996901,"L.LvsV.ZHENG_RESPONSE_TO_ARSENITE_DN"
14,"Down",0.943296583789826,0.975404303679436,"L.LvsV.REACTOME_CALCINEURIN_ACTIVATES_NFAT"
48,"Up",0.943749699737218,0.975643770132169,"L.LvsV.WILLIAMS_ESR1_TARGETS_UP"
179,"Up",0.943881086351414,0.975643770132169,"L.LvsV.MATZUK_SPERMATOZOA"
25,"Up",0.944933699584143,0.976255065783281,"L.LvsV.KEGG_RENIN_ANGIOTENSIN_SYSTEM"
162,"Down",0.945015312170338,0.976255065783281,"L.LvsV.ZHAN_MULTIPLE_MYELOMA_UP"
138,"Up",0.94512426596464,0.976255065783281,"L.LvsV.HARRIS_HYPOXIA"
380,"Down",0.945206728459649,0.976255065783281,"L.LvsV.REACTOME_ANTI_INFLAMMATORY_RESPONSE_FAVOURING_LEISHMANIA_PARASITE_INFECTION"
92,"Down",0.945560591092592,0.976255065783281,"L.LvsV.JIANG_AGING_CEREBRAL_CORTEX_DN"
87,"Up",0.945616365750548,0.976255065783281,"L.LvsV.KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN"
7,"Down",0.94570847030842,0.976255065783281,"L.LvsV.REACTOME_RSK_ACTIVATION"
9,"Down",0.945969071612213,0.976317867093316,"L.LvsV.DER_IFN_GAMMA_RESPONSE_DN"
50,"Down",0.946122469141977,0.976317867093316,"L.LvsV.MINGUEZ_LIVER_CANCER_VASCULAR_INVASION_DN"
25,"Up",0.947119395282691,0.976421165567426,"L.LvsV.REACTOME_NUCLEOTIDE_SALVAGE"
250,"Up",0.947257890157866,0.976421165567426,"L.LvsV.KASLER_HDAC7_TARGETS_1_UP"
515,"Up",0.947265455670124,0.976421165567426,"L.LvsV.RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN"
237,"Up",0.947401756167415,0.976421165567426,"L.LvsV.LENAOUR_DENDRITIC_CELL_MATURATION_DN"
117,"Up",0.947407570433776,0.976421165567426,"L.LvsV.JIANG_VHL_TARGETS"
22,"Down",0.947510363508631,0.976421165567426,"L.LvsV.TSUNODA_CISPLATIN_RESISTANCE_UP"
93,"Down",0.947677544400817,0.976421165567426,"L.LvsV.WATANABE_COLON_CANCER_MSI_VS_MSS_DN"
101,"Up",0.947722508312187,0.976421165567426,"L.LvsV.RIZKI_TUMOR_INVASIVENESS_2D_DN"
51,"Down",0.947843418268873,0.976421165567426,"L.LvsV.REACTOME_GROWTH_HORMONE_RECEPTOR_SIGNALING"
118,"Down",0.948304784950065,0.976421165567426,"L.LvsV.KEGG_DRUG_METABOLISM_CYTOCHROME_P450"
44,"Down",0.948325473669329,0.976421165567426,"L.LvsV.BIOCARTA_GH_PATHWAY"
94,"Down",0.948341772309111,0.976421165567426,"L.LvsV.GARCIA_TARGETS_OF_FLI1_AND_DAX1_UP"
82,"Up",0.949335084424576,0.977261903143452,"L.LvsV.KIM_LIVER_CANCER_POOR_SURVIVAL_DN"
28,"Up",0.949859551606049,0.977619780496993,"L.LvsV.REACTOME_TRAF6_MEDIATED_NF_KB_ACTIVATION"
30,"Up",0.950196065324107,0.977621301673656,"L.LvsV.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_17"
289,"Up",0.950294728045276,0.977621301673656,"L.LvsV.KRIEG_KDM3A_TARGETS_NOT_HYPOXIA"
35,"Up",0.950391480646754,0.977621301673656,"L.LvsV.REACTOME_FORMATION_OF_THE_EARLY_ELONGATION_COMPLEX"
53,"Down",0.951038747677018,0.978105140607558,"L.LvsV.GROSS_HYPOXIA_VIA_ELK3_ONLY_UP"
914,"Up",0.951571030736403,0.978470565174181,"L.LvsV.BENPORATH_CYCLING_GENES"
57,"Up",0.951865067270969,0.978590917988321,"L.LvsV.VILIMAS_NOTCH1_TARGETS_DN"
495,"Down",0.952208766339614,0.978611028036838,"L.LvsV.NIKOLSKY_BREAST_CANCER_17Q21_Q25_AMPLICON"
38,"Up",0.952238620155216,0.978611028036838,"L.LvsV.REACTOME_NICOTINATE_METABOLISM"
7,"Down",0.952653022143908,0.978854963656135,"L.LvsV.REACTOME_SUMO_IS_TRANSFERRED_FROM_E1_TO_E2_UBE2I_UBC9"
8,"Up",0.953307935279006,0.979299437930348,"L.LvsV.KIM_PTEN_TARGETS_DN"
44,"Down",0.953567804455635,0.979299437930348,"L.LvsV.REACTOME_RA_BIOSYNTHESIS_PATHWAY"
34,"Up",0.953616960357568,0.979299437930348,"L.LvsV.REACTOME_IRF3_MEDIATED_INDUCTION_OF_TYPE_I_IFN"
80,"Up",0.954599183303473,0.97941020056032,"L.LvsV.MARTIN_NFKB_TARGETS_UP"
93,"Down",0.954684210748304,0.97941020056032,"L.LvsV.REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR"
521,"Up",0.954760452707152,0.97941020056032,"L.LvsV.WALLACE_PROSTATE_CANCER_RACE_UP"
37,"Down",0.954764617359059,0.97941020056032,"L.LvsV.SARTIPY_BLUNTED_BY_INSULIN_RESISTANCE_UP"
45,"Down",0.954981941912435,0.97941020056032,"L.LvsV.PID_IL1_PATHWAY"
35,"Up",0.955152409139543,0.97941020056032,"L.LvsV.REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS"
262,"Down",0.955438938672971,0.97941020056032,"L.LvsV.NOUZOVA_TRETINOIN_AND_H4_ACETYLATION"
96,"Down",0.955475535067212,0.97941020056032,"L.LvsV.FIGUEROA_AML_METHYLATION_CLUSTER_6_DN"
11,"Down",0.955621238301709,0.97941020056032,"L.LvsV.REACTOME_ERYTHROPOIETIN_ACTIVATES_PHOSPHOLIPASE_C_GAMMA_PLCG"
130,"Up",0.955624191971649,0.97941020056032,"L.LvsV.PID_ERA_GENOMIC_PATHWAY"
633,"Down",0.955673364446179,0.97941020056032,"L.LvsV.WANG_SMARCE1_TARGETS_DN"
86,"Down",0.955964912150536,0.979527427590866,"L.LvsV.GUILLAUMOND_KLF10_TARGETS_UP"
1220,"Down",0.956513912319378,0.979724776022081,"L.LvsV.ONKEN_UVEAL_MELANOMA_UP"
113,"Down",0.956602284719263,0.979724776022081,"L.LvsV.HOWLIN_CITED1_TARGETS_1_DN"
12,"Down",0.956897434751667,0.979724776022081,"L.LvsV.REACTOME_MAPK3_ERK1_ACTIVATION"
354,"Up",0.956961845936851,0.979724776022081,"L.LvsV.GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN"
63,"Up",0.957043500686428,0.979724776022081,"L.LvsV.KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS"
63,"Up",0.957638924828781,0.979872255925923,"L.LvsV.JOHANSSON_BRAIN_CANCER_EARLY_VS_LATE_DN"
204,"Down",0.957678053307071,0.979872255925923,"L.LvsV.GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_UP"
138,"Down",0.957877450482904,0.979872255925923,"L.LvsV.WORSCHECH_TUMOR_REJECTION_UP"
75,"Up",0.957896462882911,0.979872255925923,"L.LvsV.NATSUME_RESPONSE_TO_INTERFERON_BETA_DN"
325,"Up",0.958089784763778,0.979888719933209,"L.LvsV.LINSLEY_MIR16_TARGETS"
797,"Up",0.958920504310762,0.980478896134208,"L.LvsV.KIM_ALL_DISORDERS_CALB1_CORR_UP"
12,"Up",0.959021499420112,0.980478896134208,"L.LvsV.REACTOME_COHESIN_LOADING_ONTO_CHROMATIN"
33,"Down",0.959253270019778,0.980526728822798,"L.LvsV.BIOCARTA_CYTOKINE_PATHWAY"
19,"Down",0.959422970325798,0.980526728822798,"L.LvsV.GALLUZZI_PREVENT_MITOCHONDIAL_PERMEABILIZATION"
16,"Down",0.961718792136835,0.982294082695021,"L.LvsV.BIOCARTA_EPONFKB_PATHWAY"
12,"Down",0.961974635517533,0.982294082695021,"L.LvsV.REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_EARLY_PANCREATIC_PRECURSOR_CELLS"
135,"Up",0.962030483870398,0.982294082695021,"L.LvsV.CORRE_MULTIPLE_MYELOMA_UP"
124,"Down",0.962068373180441,0.982294082695021,"L.LvsV.LU_IL4_SIGNALING"
146,"Up",0.962132666025187,0.982294082695021,"L.LvsV.PUJANA_BREAST_CANCER_LIT_INT_NETWORK"
77,"Down",0.962347155907779,0.982294082695021,"L.LvsV.KEGG_ADIPOCYTOKINE_SIGNALING_PATHWAY"
47,"Down",0.962395920773906,0.982294082695021,"L.LvsV.LIU_LIVER_CANCER"
29,"Down",0.962856014573829,0.98239006130034,"L.LvsV.ITO_PTTG1_TARGETS_UP"
38,"Up",0.963074700649173,0.98239006130034,"L.LvsV.SEMBA_FHIT_TARGETS_UP"
225,"Up",0.963096529427868,0.98239006130034,"L.LvsV.SENGUPTA_EBNA1_ANTICORRELATED"
162,"Down",0.963365992423793,0.98239006130034,"L.LvsV.YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_6"
73,"Up",0.963550600902902,0.98239006130034,"L.LvsV.ZHAN_MULTIPLE_MYELOMA_CD2_DN"
72,"Down",0.963556032271974,0.98239006130034,"L.LvsV.NIKOLSKY_BREAST_CANCER_16Q24_AMPLICON"
149,"Up",0.964379391489633,0.98304824032931,"L.LvsV.NIKOLSKY_BREAST_CANCER_16P13_AMPLICON"
212,"Up",0.964975922004285,0.983474999587408,"L.LvsV.LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN"
138,"Down",0.96528701261401,0.98361074322574,"L.LvsV.REACTOME_GLYCOSAMINOGLYCAN_METABOLISM"
56,"Down",0.966091192303319,0.984116616029231,"L.LvsV.KEGG_TYROSINE_METABOLISM"
5,"Up",0.966139445072647,0.984116616029231,"L.LvsV.REACTOME_TOXICITY_OF_BOTULINUM_TOXIN_TYPE_D_BONT_D"
37,"Up",0.966473205333674,0.984117628674659,"L.LvsV.BIOCARTA_EIF_PATHWAY"
116,"Down",0.966582819199135,0.984117628674659,"L.LvsV.REACTOME_INTERFERON_ALPHA_BETA_SIGNALING"
62,"Down",0.966674415144162,0.984117628674659,"L.LvsV.REACTOME_XENOBIOTICS"
19,"Up",0.967244984697208,0.984198787842398,"L.LvsV.REACTOME_METABOLISM_OF_FOLATE_AND_PTERINES"
52,"Down",0.967264744543616,0.984198787842398,"L.LvsV.WOTTON_RUNX_TARGETS_DN"
44,"Up",0.967310170867589,0.984198787842398,"L.LvsV.BIOCARTA_EICOSANOID_PATHWAY"
556,"Down",0.967466162402502,0.984198787842398,"L.LvsV.MCLACHLAN_DENTAL_CARIES_UP"
10,"Down",0.967973167113901,0.984464400302792,"L.LvsV.RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_SMAD4_UP"
19,"Up",0.968083368501769,0.984464400302792,"L.LvsV.BIOCARTA_IL4_PATHWAY"
699,"Down",0.96846447733304,0.984670852367484,"L.LvsV.GARY_CD5_TARGETS_UP"
155,"Up",0.968672399341283,0.984701175943731,"L.LvsV.ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_UP"
104,"Down",0.968961128420974,0.984813617470509,"L.LvsV.KEGG_VIRAL_MYOCARDITIS"
215,"Up",0.969529964123798,0.984956987760506,"L.LvsV.REACTOME_FCERI_MEDIATED_MAPK_ACTIVATION"
89,"Up",0.969613631962232,0.984956987760506,"L.LvsV.REACTOME_SIGNALING_BY_INSULIN_RECEPTOR"
7,"Down",0.969636622242799,0.984956987760506,"L.LvsV.REACTOME_NGF_INDEPENDANT_TRKA_ACTIVATION"
16,"Up",0.969954413035204,0.985033663275342,"L.LvsV.GAUSSMANN_MLL_AF4_FUSION_TARGETS_D_DN"
12,"Up",0.970068420425798,0.985033663275342,"L.LvsV.SHIRAISHI_PLZF_TARGETS_DN"
180,"Down",0.970658580338061,0.985301361855365,"L.LvsV.KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY"
10,"Down",0.970688464103124,0.985301361855365,"L.LvsV.REACTOME_PHASE_3_RAPID_REPOLARISATION"
46,"Up",0.971994517660405,0.986445978000069,"L.LvsV.STAEGE_EWING_FAMILY_TUMOR"
181,"Up",0.972394821071705,0.986671126024125,"L.LvsV.REACTOME_REGULATION_OF_TP53_ACTIVITY"
26,"Down",0.97281952567451,0.986920946321902,"L.LvsV.REACTOME_TRAFFICKING_AND_PROCESSING_OF_ENDOSOMAL_TLR"
142,"Up",0.973071888630848,0.986995867224355,"L.LvsV.REACTOME_TCR_SIGNALING"
20,"Down",0.973404257504521,0.987024883222942,"L.LvsV.BIOCARTA_PGC1A_PATHWAY"
527,"Up",0.973627932924195,0.987024883222942,"L.LvsV.OISHI_CHOLANGIOMA_STEM_CELL_LIKE_UP"
80,"Up",0.97363604867027,0.987024883222942,"L.LvsV.GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_UP"
116,"Down",0.974605663715266,0.987194933013249,"L.LvsV.ZHAN_MULTIPLE_MYELOMA_DN"
42,"Up",0.974798261472608,0.987194933013249,"L.LvsV.REACTOME_GENERATION_OF_SECOND_MESSENGER_MOLECULES"
26,"Down",0.975268403299803,0.987194933013249,"L.LvsV.BIOCARTA_CSK_PATHWAY"
6,"Up",0.975500200896923,0.987194933013249,"L.LvsV.REACTOME_NEGATIVE_REGULATION_OF_TCF_DEPENDENT_SIGNALING_BY_DVL_INTERACTING_PROTEINS"
6,"Down",0.975816566147452,0.987194933013249,"L.LvsV.REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_LINKED_TO_TRIGLYCERIDE_LIPOLYSIS_IN_ADIPOSE"
23,"Up",0.975818138816663,0.987194933013249,"L.LvsV.KEGG_NITROGEN_METABOLISM"
28,"Down",0.975903012932507,0.987194933013249,"L.LvsV.BIOCARTA_ATM_PATHWAY"
123,"Up",0.975920295412792,0.987194933013249,"L.LvsV.LI_WILMS_TUMOR"
20,"Up",0.976047583716156,0.987194933013249,"L.LvsV.REACTOME_WNT5A_DEPENDENT_INTERNALIZATION_OF_FZD4"
222,"Up",0.976055436244109,0.987194933013249,"L.LvsV.GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_DN"
16,"Up",0.976230231073518,0.987194933013249,"L.LvsV.REACTOME_TNFR1_INDUCED_PROAPOPTOTIC_SIGNALING"
66,"Down",0.976236943696093,0.987194933013249,"L.LvsV.TING_SILENCED_BY_DICER"
10,"Up",0.976281753788473,0.987194933013249,"L.LvsV.REACTOME_FRUCTOSE_CATABOLISM"
103,"Down",0.976319085174552,0.987194933013249,"L.LvsV.WESTON_VEGFA_TARGETS_3HR"
305,"Down",0.976482020012563,0.987194933013249,"L.LvsV.PAL_PRMT5_TARGETS_UP"
236,"Up",0.976916768239415,0.987336039813947,"L.LvsV.COULOUARN_TEMPORAL_TGFB1_SIGNATURE_DN"
13,"Down",0.976978743682783,0.987336039813947,"L.LvsV.VANLOO_SP3_TARGETS_UP"
30,"Up",0.977201961410083,0.987381148508105,"L.LvsV.REACTOME_MRNA_CAPPING"
290,"Down",0.978540619148711,0.988553093965508,"L.LvsV.GREGORY_SYNTHETIC_LETHAL_WITH_IMATINIB"
28,"Up",0.978794619797834,0.988629056058134,"L.LvsV.REACTOME_MICRORNA_MIRNA_BIOGENESIS"
33,"Down",0.979311527936687,0.988970490951953,"L.LvsV.BIOCARTA_CASPASE_PATHWAY"
48,"Up",0.97991369695059,0.989044577077225,"L.LvsV.YANG_BREAST_CANCER_ESR1_BULK_UP"
11,"Up",0.979931937244696,0.989044577077225,"L.LvsV.REACTOME_MISSPLICED_LRP5_MUTANTS_HAVE_ENHANCED_BETA_CATENIN_DEPENDENT_SIGNALING"
166,"Up",0.980030250451291,0.989044577077225,"L.LvsV.REACTOME_INTERLEUKIN_1_FAMILY_SIGNALING"
388,"Up",0.98010042282621,0.989044577077225,"L.LvsV.VERHAAK_AML_WITH_NPM1_MUTATED_UP"
27,"Down",0.980327030908353,0.989092728812461,"L.LvsV.REACTOME_COMMON_PATHWAY_OF_FIBRIN_CLOT_FORMATION"
19,"Down",0.980534672678268,0.989121730567076,"L.LvsV.MATZUK_PREOVULATORY_FOLLICLE"
156,"Down",0.981197217743928,0.98960952515618,"L.LvsV.ZWANG_EGF_INTERVAL_UP"
77,"Up",0.981454637899024,0.989688618082017,"L.LvsV.MELLMAN_TUT1_TARGETS_DN"
150,"Up",0.981886975204088,0.989690872607885,"L.LvsV.DING_LUNG_CANCER_EXPRESSION_BY_COPY_NUMBER"
25,"Down",0.98207975146317,0.989690872607885,"L.LvsV.REACTOME_ABORTIVE_ELONGATION_OF_HIV_1_TRANSCRIPT_IN_THE_ABSENCE_OF_TAT"
49,"Down",0.982209493165578,0.989690872607885,"L.LvsV.DORSAM_HOXA9_TARGETS_DN"
75,"Down",0.982230601357535,0.989690872607885,"L.LvsV.REACTOME_REGULATION_OF_RAS_BY_GAPS"
49,"Up",0.982351873552554,0.989690872607885,"L.LvsV.WEBER_METHYLATED_HCP_IN_SPERM_DN"
9,"Up",0.984734349939164,0.991910406415311,"L.LvsV.REACTOME_REGULATION_OF_PTEN_MRNA_TRANSLATION"
85,"Down",0.98501518542289,0.992012561057041,"L.LvsV.CHIBA_RESPONSE_TO_TSA"
12,"Up",0.98590751488379,0.99259388938814,"L.LvsV.GROSS_HIF1A_TARGETS_UP"
34,"Down",0.986088232531621,0.99259388938814,"L.LvsV.CREIGHTON_AKT1_SIGNALING_VIA_MTOR_DN"
73,"Down",0.986130988317788,0.99259388938814,"L.LvsV.CHANGOLKAR_H2AFY_TARGETS_UP"
11,"Down",0.986596769775869,0.99288196943771,"L.LvsV.REACTOME_HIGHLY_CALCIUM_PERMEABLE_POSTSYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS"
44,"Down",0.98710072189423,0.99320835147465,"L.LvsV.REACTOME_DISEASES_ASSOCIATED_WITH_GLYCOSAMINOGLYCAN_METABOLISM"
95,"Down",0.987551795238924,0.993481418463612,"L.LvsV.KEGG_COMPLEMENT_AND_COAGULATION_CASCADES"
20,"Down",0.989343817131322,0.994950054426881,"L.LvsV.MIKKELSEN_ES_LCP_WITH_H3K4ME3_AND_H3K27ME3"
57,"Down",0.989371567957857,0.994950054426881,"L.LvsV.KEGG_MTOR_SIGNALING_PATHWAY"
5,"Down",0.989670567731302,0.995069752497976,"L.LvsV.BIOCARTA_DICER_PATHWAY"
121,"Up",0.990210507820113,0.995303886323295,"L.LvsV.REACTOME_TRNA_PROCESSING"
6,"Up",0.990263461505597,0.995303886323295,"L.LvsV.FIGUEROA_AML_METHYLATION_CLUSTER_7_DN"
55,"Up",0.990938979413278,0.995610887726282,"L.LvsV.PID_IL23_PATHWAY"
38,"Down",0.990942479637701,0.995610887726282,"L.LvsV.VALK_AML_WITH_11Q23_REARRANGED"
7,"Up",0.991109120283135,0.995610887726282,"L.LvsV.CAFFAREL_RESPONSE_TO_THC_8HR_3_UP"
24,"Down",0.991390343112122,0.995712480847761,"L.LvsV.MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_24"
18,"Down",0.991998259959159,0.996016239595266,"L.LvsV.REACTOME_NUCLEOBASE_BIOSYNTHESIS"
17,"Down",0.992053071342219,0.996016239595266,"L.LvsV.REACTOME_TELOMERE_EXTENSION_BY_TELOMERASE"
303,"Down",0.992270673739747,0.996053840796489,"L.LvsV.PROVENZANI_METASTASIS_UP"
33,"Down",0.992760320475145,0.996099061889701,"L.LvsV.HOWLIN_CITED1_TARGETS_2_UP"
53,"Down",0.992783370756387,0.996099061889701,"L.LvsV.FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN"
674,"Down",0.992856200049583,0.996099061889701,"L.LvsV.ZHANG_BREAST_CANCER_PROGENITORS_UP"
21,"Up",0.99319662208547,0.996259819214543,"L.LvsV.REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_24_HYDROXYCHOLESTEROL"
10,"Down",0.994386940258764,0.997272880952422,"L.LvsV.WEBER_METHYLATED_LCP_IN_SPERM_DN"
22,"Up",0.9948176740044,0.997429094246523,"L.LvsV.KYNG_WERNER_SYNDROM_UP"
47,"Up",0.99490350059135,0.997429094246523,"L.LvsV.CEBALLOS_TARGETS_OF_TP53_AND_MYC_DN"
301,"Down",0.995270753202896,0.997456143483792,"L.LvsV.ASTON_MAJOR_DEPRESSIVE_DISORDER_DN"
13,"Down",0.995291290215243,0.997456143483792,"L.LvsV.REACTOME_ACETYLCHOLINE_REGULATES_INSULIN_SECRETION"
25,"Up",0.996360905210915,0.99834712666023,"L.LvsV.KYNG_ENVIRONMENTAL_STRESS_RESPONSE_DN"
37,"Up",0.996785794662812,0.998591893221722,"L.LvsV.FRIDMAN_SENESCENCE_DN"
12,"Up",0.997121474133174,0.998693125485388,"L.LvsV.REACTOME_SYNTHESIS_OF_5_EICOSATETRAENOIC_ACIDS"
237,"Down",0.997248100163651,0.998693125485388,"L.LvsV.LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN"
36,"Down",0.998281568653673,0.999232847934014,"L.LvsV.ZHAN_LATE_DIFFERENTIATION_GENES_DN"
153,"Up",0.998561747449665,0.999232847934014,"L.LvsV.REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION"
51,"Up",0.998699416927918,0.999232847934014,"L.LvsV.SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_DN"
14,"Up",0.998837081503009,0.999232847934014,"L.LvsV.BIOCARTA_LECTIN_PATHWAY"
10,"Down",0.998891092059416,0.999232847934014,"L.LvsV.BYSTRYKH_HEMATOPOIESIS_STEM_CELL_FLI1"
18,"Up",0.999089456916536,0.999232847934014,"L.LvsV.KEGG_RIBOFLAVIN_METABOLISM"
41,"Down",0.999123031425959,0.999232847934014,"L.LvsV.BIOCARTA_DC_PATHWAY"
88,"Up",0.999232847934014,0.999232847934014,"L.LvsV.DORN_ADENOVIRUS_INFECTION_12HR_DN"
